PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Laichoubi, KB; Espinosa, J; Castells, MA; Contreras, A				Boumediene Laichoubi, Karim; Espinosa, Javier; Angel Castells, Miguel; Contreras, Asuncion			Mutational Analysis of the Cyanobacterial Nitrogen Regulator PipX	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PROTEIN; SP STRAIN PCC-7942; SYNECHOCOCCUS-SP PCC-7942; ACETYL GLUTAMATE KINASE; YEAST 2-HYBRID SYSTEM; GLNB GENE-PRODUCT; P-II PROTEIN; ACETYLGLUTAMATE KINASE; TRANSCRIPTION FACTOR; DOMAIN INTERACTIONS	PipX provides a functional link between the cyanobacterial global transcriptional regulator NtcA and the signal transduction protein PII, a protein found in all three domains of life as integrators of signals of the nitrogen and carbon balance. PipX, which is toxic in the absence of PII, can form alternative complexes with NtcA and PII and these interactions are respectively stimulated and inhibited by 2-oxoglutarate, providing a mechanism by which PII can modulate expression at the NtcA regulon. Structural information on PipX-NtcA complexes suggests that PipX coactivates NtcA controlled genes by stabilizing the active conformation of NtcA bound to 2-oxoglutarate and by possibly helping recruit RNA polymerase. To get insights into PipX functions, we perform here a mutational analysis of pipX informed by the structures of PipX-PII and PipX-NtcA complexes and evaluate the impact of point mutations on toxicity and gene expression. Two amino acid substitutions (Y32A and E4A) were of particular interest, since they increased PipX toxicity and activated NtcA dependent genes in vivo at lower 2-oxoglutarate levels than wild type PipX. While both mutations impaired complex formation with PII, only Y32A had a negative impact on PipX-NtcA interactions.	[Boumediene Laichoubi, Karim; Espinosa, Javier; Angel Castells, Miguel; Contreras, Asuncion] Univ Alicante, Div Genet, E-03080 Alicante, Spain	Universitat d'Alacant	Laichoubi, KB (corresponding author), Univ Alicante, Div Genet, E-03080 Alicante, Spain.	contrera@ua.es	Espinosa, Javier/B-2595-2012; Contreras, Asunción/K-2159-2012	Espinosa, Javier/0000-0003-0669-4974; Contreras, Asunción/0000-0001-6591-9294	Ministerio de Ciencia e Innovacion [BFU2009-07371]; Generalitat Valenciana [ACOMP2011/211]; Universidad de Alicante	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Universidad de Alicante	This work was supported by the Ministerio de Ciencia e Innovacion (grant BFU2009-07371), the Generalitat Valenciana (ACOMP2011/211), and the Universidad de Alicante. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldehni MF, 2006, ARCH MICROBIOL, V184, P378, DOI 10.1007/s00203-005-0056-6; Aldehni MF, 2003, J BACTERIOL, V185, P2582, DOI 10.1128/JB.185.8.2582-2591.2003; Ausubel F. M., 1999, SHORT PROTOCOLS MOL; Burillo S, 2004, J BACTERIOL, V186, P3346, DOI 10.1128/JB.186.11.3346-3354.2004; Chen YM, 2006, J BIOL CHEM, V281, P5726, DOI 10.1074/jbc.M510945200; Espinosa J, 2007, MICROBIOL-SGM, V153, P711, DOI 10.1099/mic.0.2006/003574-0; Espinosa J, 2006, MOL MICROBIOL, V61, P457, DOI 10.1111/j.1365-2958.2006.05231.x; Espinosa J, 2010, MICROBIOL-SGM, V156, P1517, DOI 10.1099/mic.0.037309-0; Espinosa J, 2009, J BACTERIOL, V191, P4863, DOI 10.1128/JB.00557-09; Fokina O, 2011, BIOCH J; Forchhammer K, 2004, FEMS MICROBIOL REV, V28, P319, DOI 10.1016/j.femsre.2003.11.001; FORCHHAMMER K, 1995, J BACTERIOL, V177, P5812, DOI 10.1128/jb.177.20.5812-5817.1995; FORCHHAMMER K, 1995, J BACTERIOL, V177, P2033, DOI 10.1128/jb.177.8.2033-2040.1995; FORCHHAMMER K, 1994, J BACTERIOL, V176, P84, DOI 10.1128/JB.176.1.84-91.1994; Forchhammer K, 2010, ADV EXP MED BIOL, V675, P71, DOI 10.1007/978-1-4419-1528-3_5; GOLDEN SS, 1984, J BACTERIOL, V158, P36, DOI 10.1128/JB.158.1.36-42.1984; Hanahan D., 1985, DNA CLONING PRACTICA, P109; Herrero A, 2001, J BACTERIOL, V183, P411, DOI 10.1128/JB.183.2.411-425.2001; Laurent S, 2005, P NATL ACAD SCI USA, V102, P9907, DOI 10.1073/pnas.0502337102; Leigh JA, 2007, ANNU REV MICROBIOL, V61, P349, DOI 10.1146/annurev.micro.61.080706.093409; Llacer JL, 2007, P NATL ACAD SCI USA, V104, P17644, DOI 10.1073/pnas.0705987104; Llacer JL, 2010, P NATL ACAD SCI USA, V107, P15397, DOI 10.1073/pnas.1007015107; Luque I, 2001, MOL MICROBIOL, V41, P937, DOI 10.1046/j.1365-2958.2001.02566.x; Maheswaran M, 2004, J BIOL CHEM, V279, P55202, DOI 10.1074/jbc.M410971200; Martinez-Argudo I, 2002, J BACTERIOL, V184, P3746, DOI 10.1128/JB.184.13.3746-3748.2002; Martinez-Argudo I, 2002, J BACTERIOL, V184, P200, DOI 10.1128/JB.184.1.200-206.2002; Martinez-Argudo I, 2001, MOL MICROBIOL, V40, P169, DOI 10.1046/j.1365-2958.2001.02369.x; Muro-Pastor MI, 2001, J BIOL CHEM, V276, P38320; Muro-Pastor MI, 2005, PHOTOSYNTH RES, V83, P135, DOI 10.1007/s11120-004-2082-7; Ohashi Y, 2011, J EXP BOT, V62, P1411, DOI 10.1093/jxb/erq427; Radchenko M, 2011, BIOCHEM SOC T, V39, P189, DOI 10.1042/BST0390189; Salinas P, 2003, MOL GENET GENOMICS, V269, P574, DOI 10.1007/s00438-003-0866-7; Sambrook J., 2002, MOL CLONING LAB MANU; Sauer J, 2000, J BACTERIOL, V182, P5615, DOI 10.1128/JB.182.19.5615-5619.2000; Serebriiskii IG, 2000, ANAL BIOCHEM, V285, P1, DOI 10.1006/abio.2000.4672; Sugiyama K, 2004, PLANT CELL PHYSIOL, V45, P1768, DOI 10.1093/pcp/pch199; Tanigawa R, 2002, P NATL ACAD SCI USA, V99, P4251, DOI 10.1073/pnas.072587199; Valladares A, 2011, J BACTERIOL, V193, P1172, DOI 10.1128/JB.01202-10; Vazquez-Bermudez MF, 2002, FEBS LETT, V512, P71, DOI 10.1016/S0014-5793(02)02219-6; Zhao MX, 2010, J MOL BIOL, V402, P552, DOI 10.1016/j.jmb.2010.08.006; Zhao MX, 2010, P NATL ACAD SCI USA, V107, P12487, DOI 10.1073/pnas.1001556107	41	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35845	10.1371/journal.pone.0035845	http://dx.doi.org/10.1371/journal.pone.0035845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558239	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340200025
J	Almeida, SCP; de Oliveira, VL; Ventura, S; Bofill, M; Parkhouse, RME				Paiva Almeida, Silvia Cristina; de Oliveira, Vivian Leite; Ventura, Sonia; Bofill, Margarita; Evans Parkhouse, Robert Michael			Neoplastic Transformation of T Lymphocytes through Transgenic Expression of a Virus Host Modification Protein	PLOS ONE			English	Article							NF-KAPPA-B; CELLULAR PHOSPHATASE CALCINEURIN; NUCLEAR-FACTOR; TRANSCRIPTIONAL COACTIVATORS; TARGETED DISRUPTION; IMMUNE-RESPONSES; MICE LACKING; CELLS; EVASION; P300	Virus host evasion genes are ready-made tools for gene manipulation and therapy. In this work we have assessed the impact in vivo of the evasion gene A238L of the African Swine Fever Virus, a gene which inhibits transcription mediated by both NF-kappa B and NFAT. The A238L gene has been selectively expressed in mouse T lymphocytes using tissue specific promoter, enhancer and locus control region sequences for CD2. The resulting two independently derived transgenic mice expressed the transgene and developed a metastasic, angiogenic and transplantable CD4(+)CD8(+)CD69(-) lymphoma. The CD4(+)CD8(+)CD69(-) cells also grew vigorously in vitro. The absence of CD69 from the tumour cells suggests that they were derived from T cells at a stage prior to positive selection. In contrast, transgenic mice similarly expressing a mutant A238L, solely inhibiting transcription mediated by NF-kappa B, were indistinguishable from wild type mice. Expression of Rag1, Rag2, TCR beta-V8.2, CD25, FoxP3, Bcl3, Bcl2 l14, Myc, IL-2, NFAT1 and Itk, by purified CD4(+)CD8(+)CD69(-) thymocytes from A238L transgenic mice was consistent with the phenotype. Similarly evaluated expression profiles of CD4(+)CD8(+)CD69(-) thymocytes from the mutant A238L transgenic mice were comparable to those of wild type mice. These features, together with the demonstration of (mono-) oligoclonality, suggest a transgene-NFAT-dependent transformation yielding a lymphoma with a phenotype reminiscent of some acute lymphoblastic lymphomas.	[Paiva Almeida, Silvia Cristina; de Oliveira, Vivian Leite; Ventura, Sonia; Evans Parkhouse, Robert Michael] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Bofill, Margarita] IrsiCaixa, Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Instituto Gulbenkian de Ciencia; ICREA; Institut de Recerca de la Sida - IrsiCaixa	Almeida, SCP (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal.	scpalmeida@gmail.com; parkhous@igc.gulbenkian.pt	de Oliveira, Vivian Leite/AAJ-9491-2020; Almeida, Sílvia C.P./L-3171-2014; de Paiva e Almeida, Silvia Cristina/F-2547-2011	de Oliveira, Vivian Leite/0000-0003-2523-0374; Almeida, Sílvia C.P./0000-0002-2400-6090; de Paiva e Almeida, Silvia Cristina/0000-0002-2400-6090; Parkhouse, Michael/0000-0001-5967-3291	Fundacao para a Ciencia e Tecnologia; Ministerio da Ciencia e Ensino Superior [SFRH/BD/882/2000, POCTI/2000/MGI/36403]; Wellcome Trust [WT075813MA]; ICREA Funding Source: Custom	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Ministerio da Ciencia e Ensino Superior; Wellcome Trust(Wellcome TrustEuropean Commission); ICREA(ICREA)	This work was supported by Fundacao para a Ciencia e Tecnologia, Ministerio da Ciencia e Ensino Superior (SFRH/BD/882/2000; POCTI/2000/MGI/36403) and the Wellcome Trust project WT075813MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bonjardim CA, 2009, IMMUNOL LETT, V122, P1, DOI 10.1016/j.imlet.2008.11.002; Bopp T, 2005, J EXP MED, V201, P181, DOI 10.1084/jem.20041538; BORN W, 1985, P NATL ACAD SCI USA, V82, P2925, DOI 10.1073/pnas.82.9.2925; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P9398, DOI 10.1073/pnas.152665399; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Chang PY, 2006, CANCER RES, V66, P6008, DOI 10.1158/0008-5472.CAN-06-0194; Esslinger CW, 1997, J IMMUNOL, V158, P5075; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Garcia-Rodriguez C, 1998, J EXP MED, V187, P2031, DOI 10.1084/jem.187.12.2031; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Glud SZ, 2005, BLOOD, V106, P3546, DOI 10.1182/blood-2005-02-0493; Granja AG, 2006, J IMMUNOL, V176, P451, DOI 10.4049/jimmunol.176.1.451; Granja AG, 2004, J BIOL CHEM, V279, P53736, DOI 10.1074/jbc.M406620200; Granja AG, J VIROLOGY, V83, P969; Granja AG, 2008, J IMMUNOL, V180, P2429, DOI 10.4049/jimmunol.180.4.2429; Granja AG, 2006, J VIROL, V80, P10487, DOI 10.1128/JVI.00862-06; Guo B, 2001, J BIOL CHEM, V276, P2780, DOI 10.1074/jbc.M005889200; Jonjic S, 2008, CURR OPIN IMMUNOL, V20, P30, DOI 10.1016/j.coi.2007.11.002; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; LEONARDI E, 1992, J CLIN PATHOL, V45, P416, DOI 10.1136/jcp.45.5.416; Loo YM, 2007, CURR TOP MICROBIOL, V316, P295; Luo N, 2009, CLIN IMMUNOL, V132, P349, DOI 10.1016/j.clim.2009.05.010; Medyouf H, 2007, NAT MED, V13, P736, DOI 10.1038/nm1588; Miskin JE, 2000, J VIROL, V74, P9412, DOI 10.1128/JVI.74.20.9412-9420.2000; Miskin JE, 1998, SCIENCE, V281, P562, DOI 10.1126/science.281.5376.562; Ohno H, 2005, INT J HEMATOL, V82, P397, DOI 10.1532/IJH97.05045; Oukka M, 1998, IMMUNITY, V9, P295, DOI 10.1016/S1074-7613(00)80612-3; PALMER MS, 1989, NUCLEIC ACIDS RES, V17, P2353, DOI 10.1093/nar/17.6.2353; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; Powell PP, 1996, J VIROL, V70, P8527, DOI 10.1128/JVI.70.12.8527-8533.1996; Readinger JA, 2009, IMMUNOL REV, V228, P93, DOI 10.1111/j.1600-065X.2008.00757.x; Revilla Y, 1998, J BIOL CHEM, V273, P5405, DOI 10.1074/jbc.273.9.5405; Revilla Y, 2009, CRIT REV IMMUNOL, V29, P131, DOI 10.1615/CritRevImmunol.v29.i2.30; Rudensky AY, 2006, IMMUNOL REV, V241, P260; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; SPANOPOULOU E, 1989, NATURE, V342, P185, DOI 10.1038/342185a0; Tait SW, 2005, J BIOL CHEM, V275, P34656; Unterholzner L, 2008, BIOCHEM PHARMACOL, V75, P589, DOI 10.1016/j.bcp.2007.07.043; Vischer HF, 2006, CURR TOP MICROBIOL, V303, P121, DOI 10.1007/978-3-540-33397-5_6; Wang CG, 2011, CANCER BIOL THER, V11, P615, DOI 10.4161/cbt.11.7.14688; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; WULCZYN FG, 1992, NATURE, V358, P597, DOI 10.1038/358597a0; Zhou F, 2009, INT REV IMMUNOL, V28, P376, DOI 10.1080/08830180903013034; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S	46	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e34140	10.1371/journal.pone.0034140	http://dx.doi.org/10.1371/journal.pone.0034140			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558084	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000010
J	Wong, KA; Wilson, J; Russo, A; Wang, L; Okur, MN; Wang, XR; Martin, NP; Scappini, E; Carnegie, GK; O'Bryan, JP				Wong, Katy A.; Wilson, Jessica; Russo, Angela; Wang, Li; Okur, Mustafa Nazir; Wang, Xuerong; Martin, Negin P.; Scappini, Erica; Carnegie, Graeme K.; O'Bryan, John P.			Intersectin (ITSN) Family of Scaffolds Function as Molecular Hubs in Protein Interaction Networks	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; ADAPTER PROTEIN; EPS15 HOMOLOGY; BINDING; ENDOCYTOSIS; MEMBRANE; RAS; UBIQUITYLATION; VISUALIZATION; PARALLEL	Members of the intersectin (ITSN) family of scaffold proteins consist of multiple modular domains, each with distinct ligand preferences. Although ITSNs were initially implicated in the regulation of endocytosis, subsequent studies have revealed a more complex role for these scaffold proteins in regulation of additional biochemical pathways. In this study, we performed a high throughput yeast two-hybrid screen to identify additional pathways regulated by these scaffolds. Although several known ITSN binding partners were identified, we isolated more than 100 new targets for the two mammalian ITSN proteins, ITSN1 and ITSN2. We present the characterization of several of these new targets which implicate ITSNs in the regulation of the Rab and Arf GTPase pathways as well as regulation of the disrupted in schizophrenia 1 (DISC1) interactome. In addition, we demonstrate that ITSN proteins form homomeric and heteromeric complexes with each other revealing an added level of complexity in the function of these evolutionarily conserved scaffolds.	[Wong, Katy A.; Wilson, Jessica; Russo, Angela; Wang, Li; Okur, Mustafa Nazir; Wang, Xuerong; Carnegie, Graeme K.; O'Bryan, John P.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60680 USA; [Wong, Katy A.; Wilson, Jessica; Russo, Angela; Okur, Mustafa Nazir; Wang, Xuerong; O'Bryan, John P.] Univ Illinois, Coll Med, Cardiovasc Res Ctr, Chicago, IL USA; [Wong, Katy A.; Wilson, Jessica; Russo, Angela; Okur, Mustafa Nazir; Wang, Xuerong; O'Bryan, John P.] Univ Illinois, Coll Med, UIC Canc Ctr, Chicago, IL USA; [Okur, Mustafa Nazir] Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL USA; [Martin, Negin P.; Scappini, Erica] NIEHS, Neurobiol Lab, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Wong, KA (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60680 USA.	obryanj@uic.edu	Scappini, Erica/C-7684-2019	Scappini, Erica/0000-0002-9100-0027; Martin, Negin/0000-0003-3166-8989; O'Bryan, John/0000-0001-5386-1080	Foundation Jerome Lejeune; American Heart Association [11SDG5230003]; National Institutes of Health; National Institutes of Health [HL090651]; Department of Defense [PR080428]; St. Baldrick's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090651] Funding Source: NIH RePORTER	Foundation Jerome Lejeune; American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); St. Baldrick's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	KAW was supported by a grant from the Foundation Jerome Lejeune, and LW and GKC were supported by an American Heart Association grant (11SDG5230003). These studies were supported by funds from the intramural research program of the National Institutes of Health (JPO) and by grants to JPO from the National Institutes of Health (HL090651), Department of Defense (PR080428), the Foundation Jerome Lejeune, and the St. Baldrick's Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A, 2000, J BIOL CHEM, V275, P27414; Boxall R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016263; Chamberlain MD, 2004, J BIOL CHEM, V279, P48607, DOI 10.1074/jbc.M409769200; Chang-Ileto B, 2011, DEV CELL, V20, P206, DOI 10.1016/j.devcel.2010.12.008; Cupers P, 1997, J BIOL CHEM, V272, P33430, DOI 10.1074/jbc.272.52.33430; Das M, 2007, MOL CELL BIOL, V27, P7906, DOI 10.1128/MCB.01369-07; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Jenna S, 2002, J BIOL CHEM, V277, P6366, DOI 10.1074/jbc.M105516200; Karnoub AE, 2001, NAT STRUCT BIOL, V8, P1037, DOI 10.1038/nsb719; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Ko J, 2003, J BIOL CHEM, V278, P42377, DOI 10.1074/jbc.M307561200; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; Marie B, 2004, NEURON, V43, P207, DOI 10.1016/j.neuron.2004.07.001; Martin NP, 2006, MOL PHARMACOL, V70, P1643, DOI 10.1124/mol.106.028274; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Mohney RP, 2003, J BIOL CHEM, V278, P47038, DOI 10.1074/jbc.M303895200; Morris JA, 2003, HUM MOL GENET, V12, P1591, DOI 10.1093/hmg/ddg162; Nakatsu F, 2010, J CELL BIOL, V190, P307, DOI 10.1083/jcb.201005018; Nikolaienko O, 2009, CELL SIGNAL, V21, P753, DOI 10.1016/j.cellsig.2009.01.013; O'Bryan JP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3152re10; O'Bryan JP, 1998, J BIOL CHEM, V273, P20431, DOI 10.1074/jbc.273.32.20431; Okamoto M, 1999, J BIOL CHEM, V274, P18446, DOI 10.1074/jbc.274.26.18446; Okur MN, 2012, MOL CELL BIOL, V32, P817, DOI 10.1128/MCB.05647-11; Pechstein A, 2010, BIOCHEM SOC T, V38, P181, DOI 10.1042/BST0380181; Perkins JR, 2010, STRUCTURE, V18, P1233, DOI 10.1016/j.str.2010.08.007; Pucharcos C, 1999, EUR J HUM GENET, V7, P704, DOI 10.1038/sj.ejhg.5200356; Pucharcos C, 2000, FEBS LETT, V478, P43, DOI 10.1016/S0014-5793(00)01793-2; Roos J, 1998, J BIOL CHEM, V273, P19108, DOI 10.1074/jbc.273.30.19108; Rose S, 2007, MOL BIOL CELL, V18, P5091, DOI 10.1091/mbc.E07-05-0460; Scappini E, 2007, HUM MOL GENET, V16, P1862, DOI 10.1093/hmg/ddm134; Schubert KO, 2011, MOL PSYCHIAT; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Sengar AS, 1999, EMBO J, V18, P1159, DOI 10.1093/emboj/18.5.1159; Serra-Pages C, 1998, J BIOL CHEM, V273, P15611, DOI 10.1074/jbc.273.25.15611; Shin OH, 2001, BIOCHEM BIOPH RES CO, V285, P1267, DOI 10.1006/bbrc.2001.5330; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Tebar F, 1997, J BIOL CHEM, V272, P15413, DOI 10.1074/jbc.272.24.15413; Tong XK, 2000, J BIOL CHEM, V275, P29894, DOI 10.1074/jbc.M004096200; Tong XK, 2000, EMBO J, V19, P1263, DOI 10.1093/emboj/19.6.1263; Tsyba L, 2004, GENOMICS, V84, P106, DOI 10.1016/j.ygeno.2004.02.005; Tsyba L, 2010, GENE; Tsyba L, 2011, GENE, V473, P67, DOI 10.1016/j.gene.2010.11.016; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Wang JB, 2005, J BIOL CHEM, V280, P22883, DOI 10.1074/jbc.M414375200; Wang W, 2008, TRAFFIC, V9, P742, DOI 10.1111/j.1600-0854.2008.00712.x; Wong KA, 2011, JOVE-J VIS EXP, DOI 10.3791/2643; Xie JW, 2008, FEBS LETT, V582, P3011, DOI 10.1016/j.febslet.2008.07.048; Yamabhai M, 1998, J BIOL CHEM, V273, P31401, DOI 10.1074/jbc.273.47.31401; Yamabhai M, 2001, METHOD ENZYMOL, V332, P88; Yu Y, 2008, HUM MOL GENET, V17, P3281, DOI 10.1093/hmg/ddn224; Zwang Yaara, 2009, Traffic, V10, P349, DOI 10.1111/j.1600-0854.2008.00870.x	58	31	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36023	10.1371/journal.pone.0036023	http://dx.doi.org/10.1371/journal.pone.0036023			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558309	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336000102
J	Deribe, K; Beyene, BK; Tolla, A; Memiah, P; Biadgilign, S; Amberbir, A				Deribe, Kebede; Beyene, Biruk Kebede; Tolla, Anbessu; Memiah, Peter; Biadgilign, Sibhatu; Amberbir, Alemayehu			Magnitude and Correlates of Intimate Partner Violence against Women and Its Outcome in Southwest Ethiopia	PLOS ONE			English	Article								Background: Intimate Partner Violence (IPV) is a major public health problem with serious consequences. This study was conducted to assess the magnitude of IPV in Southwest Ethiopia in predominantly rural community. Methods: This community based cross-sectional study was conducted in May, 2009 in Southwest Ethiopia using the World Health Organization core questionnaire to measure violence against women. Trained data collectors interviewed 851 ever-married women. Stata version 10.1 software and SPSS version 12.0.1 for windows were used for data analysis. Result: In this study the life time prevalence of sexual or physical partner violence, or both was 64.7% (95% CI: 61.4%-67.9%). The lifetime sexual violence [50.1% (95% CI: 46.7%-53.4%)] was considerably more prevalent than physical violence [41.1% (95%: 37.8-44.5)]. A sizable proportion [41.5%(95% CI: 38.2%-44.8%)] of women reported physical or sexual violence, or both, in the past year. Men who were controlling were more likely to be violent against their partner. Conclusion: Physical and sexual violence is common among ever-married women in Southwest Ethiopia. Interventions targeting controlling men might help in reducing IPV. Further prospective longitudinal studies among ever-married women are important to identify predictors and to study the dynamics of violence over time.	[Deribe, Kebede] Jimma Univ, Dept Gen Publ Hlth, Jimma, Ethiopia; [Beyene, Biruk Kebede; Tolla, Anbessu] Fayyaa Integrated Dev Org, Addis Ababa, Ethiopia; [Memiah, Peter] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Biadgilign, Sibhatu] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Epidemiol, Jimma, Ethiopia; [Biadgilign, Sibhatu] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Biostat, Jimma, Ethiopia; [Amberbir, Alemayehu] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia; [Amberbir, Alemayehu] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England	Jimma University; University System of Maryland; University of Maryland Baltimore; Jimma University; Jimma University; Addis Ababa University; University of Nottingham	Deribe, K (corresponding author), Jimma Univ, Dept Gen Publ Hlth, Jimma, Ethiopia.	kebededeka@yahoo.com	Deribe, Kebede/I-5422-2019; Memiah, Peter/P-3115-2017; Amberbir, Alemayehu/HGC-2647-2022; Deribe, Kebede/K-7055-2019	Deribe, Kebede/0000-0002-8526-6996; Memiah, Peter/0000-0002-3067-188X; Biadgilign, Sibhatu/0000-0002-7582-5977	United Nation Population Fund-Ethiopia-Ethiopia	United Nation Population Fund-Ethiopia-Ethiopia	This study was financially supported by the United Nation Population Fund-Ethiopia-Ethiopia as part of a grant for ending violence against women to Fayyaa Integrated Development Organization (FIDO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, PUTTING WOMENS SAFET; Assefa M, 2006, GILGEL GIBE FIELD RE; Campbell J. C., 2002, LANCET, P359; *CENTR STAT AG, 2006, ETH DEM HLTH SURV 20; Central Statistical Agency of Ethiopia, 1994, POP HOUS CENS FED GO; Coker AL, 2000, AM J PUBLIC HEALTH, V90, P553, DOI 10.2105/AJPH.90.4.553; Deribew A., 2007, ETHIOP J HEALTH SCI, V17, P99; Dibaba Y, 2008, TROP DOCT, V38, P52, DOI 10.1258/td.2007.060190; Ellsberg M, 2000, SOC SCI MED, V51, P1595, DOI 10.1016/S0277-9536(00)00056-3; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Gossaye Y, 2003, ETHIOP J HEALTH DEV, P1; Heise L, 2002, INT J GYNECOLOGY S1, V78; Heise LL, 1996, SAGE VIOL WOMEN, V3, P7; Heise LL, 1994, VIOLENCE WOMEN; Jewkes R, 2011, PLOS ONE, V6; Joyner K, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000254; Kishor S., 2004, PROFILING DOMESTIC V; Koenig MA, 2003, DEMOGRAPHY, V40, P269, DOI 10.2307/3180801; Lamichhane P, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-19; Tegbar Yigzaw, 2004, Ethiopian Journal of Health Development, V18, P133; Tjaden P, 2000, EXTENT NATURE CONSEQ; Watts C., 2002, HLTH POLICY GLOBALIS, P159; World Health Organization, 2002, WORLD REPORT VIOLENC	23	33	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e36189	10.1371/journal.pone.0036189	http://dx.doi.org/10.1371/journal.pone.0036189			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558376	Green Accepted, gold, Green Published			2022-12-27	WOS:000305345200119
J	Eriksson, ME; Terfelt, F				Eriksson, Mats E.; Terfelt, Fredrik			Exceptionally Preserved Cambrian Trilobite Digestive System Revealed in 3D by Synchrotron-Radiation X-Ray Tomographic Microscopy	PLOS ONE			English	Article							CRUSTACEA; ANATOMY; ORIGIN; LARVAE	The Cambrian 'Orsten' fauna comprises exceptionally preserved and phosphatised microscopic arthropods. The external morphology of these fossils is well known, but their internal soft-tissue anatomy has remained virtually unknown. Here, we report the first non-biomineralised tissues from a juvenile polymerid trilobite, represented by digestive structures, glands, and connective strands harboured in a hypostome from the Swedish 'Orsten' fauna. Synchrotron-radiation X-ray tomographic microscopy enabled three-dimensional internal recordings at sub-micrometre resolution. The specimen provides the first unambiguous evidence for a J-shaped anterior gut and the presence of a crop with a constricted alimentary tract in the Trilobita. Moreover, the gut is Y-shaped in cross section, probably due to a collapsed lumen of that shape, another feature which has not previously been observed in trilobites. The combination of anatomical features suggests that the trilobite hypostome is functionally analogous to the labrum of euarthropods and that it was a sophisticated element closely integrated with the digestive system. This study also briefly addresses the preservational bias of the 'Orsten' fauna, particularly the near-absence of polymerid trilobites, and the taphonomy of the soft-tissue-harbouring hypostome.	[Eriksson, Mats E.; Terfelt, Fredrik] Lund Univ, Dept Geol, Lund, Sweden	Lund University	Eriksson, ME (corresponding author), Lund Univ, Dept Geol, Lund, Sweden.	fredrik.terfelt@geol.lu.se			Swedish Research Council; Royal Physiographic Society, Lund; Faculty of Science, Lund University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Physiographic Society, Lund; Faculty of Science, Lund University	The Swedish Research Council, the Royal Physiographic Society, Lund, and the Faculty of Science, Lund University, funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwmark C, 2011, METEORIT PLANET SCI, V46, P1071, DOI 10.1111/j.1945-5100.2011.01214.x; BITSCH J, 1994, ANN SOC ENTOMOL FR, V30, P103; Butterfield NJ, 2002, PALEOBIOLOGY, V28, P155, DOI 10.1666/0094-8373(2002)028<0155:LGATIO>2.0.CO;2; CHATTERTON BDE, 1994, J PALEONTOL, V68, P294, DOI 10.1017/S0022336000022897; CHATTERTON BDE, 1990, J PALEONTOL, V64, P255, DOI 10.1017/S0022336000018424; Chatterton Brian D.E., 1997, P173; CISNE J L, 1975, Fossils and Strata, V4, P45; Cisne J. L., 1981, PALAEONTOGRAPHICA AM, V9, P95; CISNE JL, 1974, SCIENCE, V186, P13, DOI 10.1126/science.186.4158.13; Dewel RA, 1999, ZOOL ANZ, V238, P191; ELDREDGE N, 1971, Journal of Paleontology, V45, P52; ELOFSSON R, 1992, J CRUSTACEAN BIOL, V12, P571, DOI 10.2307/1548838; Felgenhauer Bruce E., 1999, P223; Fortey RA, 1999, PALAEONTOLOGY, V42, P429, DOI 10.1111/1475-4983.00080; Henningsmoen G., 1957, MATEMATISK NATURVIDE, V1, P1; HerreraAlvarez L, 1996, J MORPHOL, V230, P199, DOI 10.1002/(SICI)1097-4687(199611)230:2<199::AID-JMOR7>3.0.CO;2-C; ICELY JD, 1984, PHILOS T ROY SOC B, V306, P49, DOI 10.1098/rstb.1984.0081; Jeppsson L, 1999, J PALEONTOL, V73, P964, DOI 10.1017/S0022336000040798; Lerosey-Aubril R, 2006, GEOL MAG, V143, P89, DOI 10.1017/S0016756805001421; Lerosey-Aubril R, 2005, J PALEONTOL, V79, P702, DOI 10.1666/0022-3360(2005)079[0702:FCPLT]2.0.CO;2; Lerosey-Aubril R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032934; Lerosey-Aubril R, 2011, LETHAIA, V44, P166, DOI 10.1111/j.1502-3931.2010.00233.x; Maas Andreas, 2003, Fossils and Strata, V49, P1; Maas Andreas, 2006, Palaeoworld, V15, P266, DOI 10.1016/j.palwor.2006.10.005; Maeda H, 2011, PALAIOS, V26, P225, DOI 10.2110/palo.2010.p10-042r; Marone F, 2010, PROC SPIE, V7804, DOI 10.1117/12.859703; MULLER KJ, 1979, LETHAIA, V12, P1, DOI 10.1111/j.1502-3931.1979.tb01234.x; Olesen J, 2005, J MORPHOL, V264, P131, DOI 10.1002/jmor.10202; Richter R., 1923, PALAEONTOLOGIA HUNGA, V1, P77; Robison Richard A., 2011, Paleontological Contributions, P1; SCHMITZ EH, 1967, AM MIDL NAT, V78, P1, DOI 10.2307/2423369; Speyer S.E., 1989, Historical Biology, V3, P27; Stampanoni M, 2006, PROC SPIE, V6318, DOI 10.1117/12.679497; Terfelt F, 2011, LETHAIA, V44, P8, DOI 10.1111/j.1502-3931.2009.00211.x; WALOSSEK D, 1992, ACTA ZOOL-STOCKHOLM, V73, P305, DOI 10.1111/j.1463-6395.1992.tb01096.x; Walossek D, 1987, FOSSILS STRATA, V19, P1; Waloszek Dieter, 2003, Paleontological Research, V7, P71, DOI 10.2517/prpsj.7.71	37	16	20	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35625	10.1371/journal.pone.0035625	http://dx.doi.org/10.1371/journal.pone.0035625			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558180	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345200055
J	Fang, D; Pan, C; Lin, HJ; Lin, Y; Xu, GR; Zhang, GY; Wang, HZ; Xie, LP; Zhang, RQ				Fang, Dong; Pan, Cong; Lin, Huijuan; Lin, Ya; Xu, Guangrui; Zhang, Guiyou; Wang, Hongzhong; Xie, Liping; Zhang, Rongqing			Ubiquitylation Functions in the Calcium Carbonate Biomineralization in the Extracellular Matrix	PLOS ONE			English	Article							OYSTER-PINCTADA-FUCATA; PRISMATIC LAYER FORMATION; PEARL OYSTER; PROTEIN FAMILY; MECHANICAL CHARACTERIZATION; FRAMEWORK FORMATION; SHELL PROTEINS; NACREOUS LAYER; CORTICAL BONE; DUAL ROLE	Mollusks shell formation is mediated by matrix proteins and many of these proteins have been identified and characterized. However, the mechanisms of protein control remain unknown. Here, we report the ubiquitylation of matrix proteins in the prismatic layer of the pearl oyster, Pinctada fucata. The presence of ubiquitylated proteins in the prismatic layer of the shell was detected with a combination of western blot and immunogold assays. The coupled ubiquitins were separated and identified by Edman degradation and liquid chromatography/mass spectrometry (LC/MS). Antibody injection in vivo resulted in large amounts of calcium carbonate randomly accumulating on the surface of the nacreous layer. These ubiquitylated proteins could bind to specific faces of calcite and aragonite, which are the two main mineral components of the shell. In the in vitro calcium carbonate crystallization assay, they could reduce the rate of calcium carbonate precipitation and induce the calcite formation. Furthermore, when the attached ubiquitins were removed, the functions of the EDTA-soluble matrix of the prismatic layer were changed. Their potency to inhibit precipitation of calcium carbonate was decreased and their influence on the morphology of calcium carbonate crystals was changed. Taken together, ubiquitylation is involved in shell formation. Although the ubiquitylation is supposed to be involved in every aspect of biophysical processes, our work connected the biomineralization-related proteins and the ubiquitylation mechanism in the extracellular matrix for the first time. This would promote our understanding of the shell biomineralization and the ubiquitylation processes.	[Fang, Dong; Pan, Cong; Lin, Huijuan; Lin, Ya; Xu, Guangrui; Zhang, Guiyou; Wang, Hongzhong; Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Sch Life Sci, Inst Marine Biotechnol, Beijing 100084, Peoples R China; [Zhang, Guiyou; Wang, Hongzhong; Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Prot Sci Lab, Minist Educ, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Fang, D (corresponding author), Tsinghua Univ, Sch Life Sci, Inst Marine Biotechnol, Beijing 100084, Peoples R China.	lpxie@mail.tsinghua.edu.cn; rqzhang@mail.tsinghua.edu.cn			National Basic Research Program of China [2010CB126405]; National High Technology Research and Development Program of China [2010AA09Z405]; National Natural Science Foundation of China [31172382, 21176138, 40876068, 30871911, U0831001]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20090002110055]; Independent Research Projects of Tsinghua University [20111080964]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Independent Research Projects of Tsinghua University	This work was supported by the National Basic Research Program of China 2010CB126405, the National High Technology Research and Development Program of China 2010AA09Z405, National Natural Science Foundation of China Grants 31172382, 21176138, 40876068, 30871911, U0831001 (Joint Fund with Guangdong), the Specialized Research Fund for the Doctoral Program of Higher Education of China 20090002110055, and the Independent Research Projects of Tsinghua University 20111080964. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDADI L, 1992, ANGEW CHEM INT EDIT, V31, P153, DOI 10.1002/anie.199201531; Barthelat F, 2007, J MECH PHYS SOLIDS, V55, P306, DOI 10.1016/j.jmps.2006.07.007; Bedouet L, 2007, MAR BIOTECHNOL, V9, P638, DOI 10.1007/s10126-007-9017-1; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Chan K, 2005, J MATER RES, V20, P1097; Chan XY, 2011, DEV BIOL, V349, P102, DOI 10.1016/j.ydbio.2010.10.001; Clark MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-362; CLEGG WJ, 1990, NATURE, V347, P455, DOI 10.1038/347455a0; Contri MB, 1996, AM J PATHOL, V148, P569; CURREY JD, 1974, CALC TISS RES, V15, P173, DOI 10.1007/BF02059054; CURREY JD, 1976, J ZOOL, V180, P445; Davis JB, 2000, J EUR CERAM SOC, V20, P583, DOI 10.1016/S0955-2219(99)00256-3; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P306, DOI 10.1038/nrm2685; DiMasi E, 2004, J MATER RES, V19, P1471, DOI 10.1557/JMR.2004.0196; Dunlop JWC, 2010, ANNU REV MATER RES, V40, P1, DOI 10.1146/annurev-matsci-070909-104421; Evans AG, 1997, ACTA MATER, V45, P23, DOI 10.1016/S1359-6454(96)00143-7; EVANS AG, 1994, J MATER SCI, V29, P3857, DOI 10.1007/BF00355946; Feng QL, 1999, J MATER SCI LETT, V18, P1547, DOI 10.1023/A:1006687627323; Fondrk MT, 1999, J BIOMECH ENG-T ASME, V121, P616, DOI 10.1115/1.2800862; Ghosh P, 2007, BIOMACROMOLECULES, V8, P851, DOI 10.1021/bm060942h; Green DJ, 1999, SCIENCE, V283, P1295, DOI 10.1126/science.283.5406.1295; Hazelaar S, 2003, BIOMOL ENG, V20, P163, DOI 10.1016/S1389-0344(03)00044-3; HEUER AH, 1992, SCIENCE, V255, P1098, DOI 10.1126/science.1546311; Inoue H, 2004, BIOCHEM BIOPH RES CO, V318, P649, DOI 10.1016/j.bbrc.2004.04.075; JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056; Kasapi MA, 1997, J EXP BIOL, V200, P1639; Kong YW, 2009, J BIOL CHEM, V284, P10841, DOI 10.1074/jbc.M808357200; Leu JH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-120; Levi CG, 1998, J AM CERAM SOC, V81, P2077; Li XD, 2004, NANO LETT, V4, P613, DOI 10.1021/nl049962k; Li XD, 2007, JOM-US, V59, P71, DOI 10.1007/s11837-007-0043-2; LOWENSTAM HA, 1981, SCIENCE, V211, P1126, DOI 10.1126/science.7008198; Ma ZJ, 2007, J BIOL CHEM, V282, P23253, DOI 10.1074/jbc.M700001200; Marin F, 2005, J BIOL CHEM, V280, P33895, DOI 10.1074/jbc.M506526200; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Marshall DB, 2008, ANNU REV MATER RES, V38, P425, DOI 10.1146/annurev.matsci.38.060407.130214; Mayer G, 2002, EXP MECH, V42, P395, DOI 10.1007/BF02412144; MCMEEKING RM, 1982, J AM CERAM SOC, V65, P242, DOI 10.1111/j.1151-2916.1982.tb10426.x; McNulty JC, 1999, J AM CERAM SOC, V82, P1217, DOI 10.1111/j.1151-2916.1999.tb01899.x; Menig R, 2000, ACTA MATER, V48, P2383, DOI 10.1016/S1359-6454(99)00443-7; Mercer C, 2006, ACTA BIOMATER, V2, P59, DOI 10.1016/j.actbio.2005.08.004; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Oaki K, 2005, ANGEW CHEM INT EDIT, V44, P6571, DOI 10.1002/anie.200500338; Patwardhan SV, 2011, CHEM COMMUN, V47, P7567, DOI 10.1039/c0cc05648k; Ramanathan R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017707; REILLY DT, 1975, J BIOMECH, V8, P393, DOI 10.1016/0021-9290(75)90075-5; Rousseau M, 2005, BIOMATERIALS, V26, P6254, DOI 10.1016/j.biomaterials.2005.03.028; ROWCLIFFE DJ, 1977, J MATER SCI, V12, P35, DOI 10.1007/BF00738469; Samata T, 1999, FEBS LETT, V462, P225, DOI 10.1016/S0014-5793(99)01387-3; Shechter A, 2008, P NATL ACAD SCI USA, V105, P7129, DOI 10.1073/pnas.0800193105; Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607; Song F, 2003, J MATER RES, V18, P1741, DOI 10.1557/JMR.2003.0239; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; Sumitomo T, 2008, J MATER RES, V23, P1466, DOI 10.1557/JMR.2008.0184; Suzuki M, 2004, BIOCHEM J, V382, P205, DOI 10.1042/BJ20040319; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Takagi R, 2010, ZOOL SCI, V27, P416, DOI 10.2108/zsj.27.416; Takahashi T, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-240; Tsukamoto D, 2004, BIOCHEM BIOPH RES CO, V320, P1175, DOI 10.1016/j.bbrc.2004.06.072; Veis A., 1990, SCIENCE, V247, P1129; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang RZ, 2011, ANNU REV MATER RES, V41, P41, DOI 10.1146/annurev-matsci-062910-095806; Wang RZ, 1998, J BIOMECH, V31, P135, DOI 10.1016/S0021-9290(97)00131-0; WEINER S, 1986, CRC CR REV BIOCH MOL, V20, P365, DOI 10.3109/10409238609081998; Wilkinson KD, 2009, J CELL SCI, V122, P2325, DOI 10.1242/jcs.041046; Yano M, 2007, BIOCHEM BIOPH RES CO, V362, P158, DOI 10.1016/j.bbrc.2007.07.172; Yao N, 2009, J R SOC INTERFACE, V6, P367, DOI 10.1098/rsif.2008.0316; Zhang C, 2006, MAR BIOTECHNOL, V8, P624, DOI 10.1007/s10126-006-6037-1; Zhang C, 2006, BIOCHEM BIOPH RES CO, V344, P735, DOI 10.1016/j.bbrc.2006.03.179; Zhang Y, 2003, COMP BIOCHEM PHYS B, V135, P565, DOI 10.1016/S1096-4959(03)00138-6	70	10	11	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35715	10.1371/journal.pone.0035715	http://dx.doi.org/10.1371/journal.pone.0035715			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558208	Green Submitted, gold, Green Published			2022-12-27	WOS:000305345200070
J	Oppert, B; Dowd, SE; Bouffard, P; Li, L; Conesa, A; Lorenzen, MD; Toutges, M; Marshall, J; Huestis, DL; Fabrick, J; Oppert, C; Jurat-Fuentes, JL				Oppert, Brenda; Dowd, Scot E.; Bouffard, Pascal; Li, Lewyn; Conesa, Ana; Lorenzen, Marce D.; Toutges, Michelle; Marshall, Jeremy; Huestis, Diana L.; Fabrick, Jeff; Oppert, Cris; Jurat-Fuentes, Juan Luis			Transcriptome Profiling of the Intoxication Response of Tenebrio molitor Larvae to Bacillus thuringiensis Cry3Aa Protoxin	PLOS ONE			English	Article							TRIBOLIUM-CASTANEUM; CHORISTONEURA-FUMIFERANA; CRYSTAL PROTEINS; DELTA-ENDOTOXIN; CRY1AB TOXIN; RECEPTOR; IDENTIFICATION; RESISTANCE; SEQUENCE; MIDGUT	Bacillus thuringiensis (Bt) crystal (Cry) proteins are effective against a select number of insect pests, but improvements are needed to increase efficacy and decrease time to mortality for coleopteran pests. To gain insight into the Bt intoxication process in Coleoptera, we performed RNA-Seq on cDNA generated from the guts of Tenebrio molitor larvae that consumed either a control diet or a diet containing Cry3Aa protoxin. Approximately 134,090 and 124,287 sequence reads from the control and Cry3Aa-treated groups were assembled into 1,318 and 1,140 contigs, respectively. Enrichment analyses indicated that functions associated with mitochondrial respiration, signalling, maintenance of cell structure, membrane integrity, protein recycling/synthesis, and glycosyl hydrolases were significantly increased in Cry3Aa-treated larvae, whereas functions associated with many metabolic processes were reduced, especially glycolysis, tricarboxylic acid cycle, and fatty acid synthesis. Microarray analysis was used to evaluate temporal changes in gene expression after 6, 12 or 24 h of Cry3Aa exposure. Overall, microarray analysis indicated that transcripts related to allergens, chitin-binding proteins, glycosyl hydrolases, and tubulins were induced, and those related to immunity and metabolism were repressed in Cry3Aa-intoxicated larvae. The 24 h microarray data validated most of the RNA-Seq data. Of the three intoxication intervals, larvae demonstrated more differential expression of transcripts after 12 h exposure to Cry3Aa. Gene expression examined by three different methods in control vs. Cry3Aa-treated larvae at the 24 h time point indicated that transcripts encoding proteins with chitin-binding domain 3 were the most differentially expressed in Cry3Aa-intoxicated larvae. Overall, the data suggest that T. molitor larvae mount a complex response to Cry3Aa during the initial 24 h of intoxication. Data from this study represent the largest genetic sequence dataset for T. molitor to date. Furthermore, the methods in this study are useful for comparative analyses in organisms lacking a sequenced genome.	[Oppert, Brenda; Toutges, Michelle] USDA ARS, Ctr Grain & Anim Hlth Res, Manhattan, KS USA; [Dowd, Scot E.] Mol Res LP, Shallowater, TX USA; [Bouffard, Pascal; Li, Lewyn] 454 Life Sci, Branford, CT USA; [Conesa, Ana] Ctr Invest Principe Felipe, Bioinformat & Genom Dept, Valencia, Spain; [Lorenzen, Marce D.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Marshall, Jeremy; Huestis, Diana L.] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA; [Fabrick, Jeff] USDA ARS, US Arid Land Agr Res Ctr, Maricopa, AZ USA; [Oppert, Cris; Jurat-Fuentes, Juan Luis] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA	United States Department of Agriculture (USDA); Prince Felipe Research Center; University of North Carolina; North Carolina State University; Kansas State University; United States Department of Agriculture (USDA); University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Oppert, B (corresponding author), USDA ARS, Ctr Grain & Anim Hlth Res, Manhattan, KS USA.	bso@ksu.edu	Cegarra, Ana V Conesa/A-9559-2014; Jurat-Fuentes, Juan Luis/A-5104-2014; Dowd, Scot E/M-5386-2017; moreno manzano, Victoria/B-4175-2014	Cegarra, Ana V Conesa/0000-0001-9597-311X; Jurat-Fuentes, Juan Luis/0000-0002-8945-1814; Dowd, Scot E/0000-0002-6296-1427; Lorenzen, Marce/0000-0003-2318-1388; Huestis, Diana/0000-0001-6649-4785; moreno manzano, Victoria/0000-0002-6035-9491; Fabrick, Jeffrey/0000-0002-3893-9545	USDA National Institute of Food and Agriculture [2008-39211-19577]	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	CO was supported by Biotechnology Risk Assessment Program Competitive Grant no. 2008-39211-19577 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altincicek B, 2008, DEV COMP IMMUNOL, V32, P585, DOI 10.1016/j.dci.2007.09.005; Annaert WG, 1997, J CELL BIOL, V139, P1397, DOI 10.1083/jcb.139.6.1397; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bellier A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000689; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bischof LJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000176; Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Cancino-Rodezno A, 2010, INSECT BIOCHEM MOLEC, V40, P58, DOI 10.1016/j.ibmb.2009.12.010; CARROLL J, 1989, BIOCHEM J, V261, P99, DOI 10.1042/bj2610099; Chen CS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009494; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crickmore N, 2011, BACILLUS THURINGIENS; Cristofoletti PT, 2005, INSECT BIOCHEM MOLEC, V35, P883, DOI 10.1016/j.ibmb.2005.03.006; Rodriguez MD, 2007, MOL BIOCHEM PARASIT, V153, P167, DOI 10.1016/j.molbiopara.2007.03.002; Eriksson TLJ, 1999, INT ARCH ALLERGY IMM, V119, P275, DOI 10.1159/000024204; Fabrick J, 2009, J BIOL CHEM, V284, P18401, DOI 10.1074/jbc.M109.001651; Fischer HM, 2008, MOL BIOL EVOL, V25, P809, DOI 10.1093/molbev/msn014; Heckel DG, 2007, J INVERTEBR PATHOL, V95, P192, DOI 10.1016/j.jip.2007.03.008; Hernandez-Martinez P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012795; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Johannessen BR, 2005, FEBS LETT, V579, P1208, DOI 10.1016/j.febslet.2004.11.115; Jurat-Fuentes JL, 2004, EUR J BIOCHEM, V271, P3127, DOI 10.1111/j.1432-1033.2004.04238.x; Kao CY, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001314; Khajuria C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-286; Lee KH, 1998, BIOCHEM J, V334, P99, DOI 10.1042/bj3340099; Levashina EA, 2004, INSECT BIOCHEM MOLEC, V34, P673, DOI 10.1016/j.ibmb.2004.03.020; Meunier L, 2006, INSECT MOL BIOL, V15, P475, DOI 10.1111/j.1365-2583.2006.00659.x; MORGAN NS, 1995, DEV BIOL, V172, P51, DOI 10.1006/dbio.1995.0005; Morris K, 2009, J PROTEOME RES, V8, P3889, DOI 10.1021/pr900168z; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Nguyen M, 2000, MOL CELL BIOL, V20, P6731, DOI 10.1128/MCB.20.18.6731-6740.2000; Ochoa-Campuzano C, 2007, BIOCHEM BIOPH RES CO, V362, P437, DOI 10.1016/j.bbrc.2007.07.197; Oppert B, 2011, PEST MANAG SCI, V67, P568, DOI 10.1002/ps.2099; Paris M, 2011, J INVERTEBR PATHOL; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Prabhakar S, 2007, INSECT MOL BIOL, V16, P455, DOI 10.1111/j.1365-2583.2007.00740.x; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Sayed A, 2010, INSECT MOL BIOL, V19, P381, DOI 10.1111/j.1365-2583.2010.00998.x; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Shelton AM, 2002, ANNU REV ENTOMOL, V47, P845, DOI 10.1146/annurev.ento.47.091201.145309; Sugarbaker DJ, 2008, P NATL ACAD SCI USA, V105, P3521, DOI 10.1073/pnas.0712399105; Tiewsiri K, 2011, P NATL ACAD SCI USA, V108, P14037, DOI 10.1073/pnas.1102555108; van Frankenhuyzen K, 2009, J INVERTEBR PATHOL, V101, P1, DOI 10.1016/j.jip.2009.02.009; van Munster M, 2007, INSECT MOL BIOL, V16, P25, DOI 10.1111/j.1365-2583.2006.00692.x; Vinokurov KS, 2006, COMP BIOCHEM PHYS B, V145, P126, DOI 10.1016/j.cbpb.2006.05.005; Weers PMM, 2006, INSECT BIOCHEM MOLEC, V36, P231, DOI 10.1016/j.ibmb.2006.01.001; Wu SJ, 1996, J MOL BIOL, V255, P628, DOI 10.1006/jmbi.1996.0052; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103; Zhao MY, 2005, J BIOL CHEM, V280, P24744, DOI 10.1074/jbc.M504173200; Zou Z, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r177	55	44	47	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e34624	10.1371/journal.pone.0034624	http://dx.doi.org/10.1371/journal.pone.0034624			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558093	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345200011
J	Okada, T				Okada, Tetsuji			Comparative Analysis of the Heptahelical Transmembrane Bundles of G Protein-Coupled Receptors	PLOS ONE			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTOR; CRYSTAL-STRUCTURE; BETA(1)-ADRENERGIC RECEPTOR; SECONDARY-STRUCTURE; HELIX 6; RHODOPSIN; ANTAGONIST; ACTIVATION; FEATURES; AGONIST	Background: G protein-coupled receptors represent a large family of eukaryotic membrane proteins, and are involved in almost all physiological processes in humans. Recent advances in the crystallographic study of these receptors enable a detailed comparative analysis of the commonly shared heptahelical transmembrane bundle. Systematic comparison of the bundles from a variety of receptors is indispensable for understanding not only of the structural diversification optimized for the binding of respective ligands but also of the structural conservation required for the common mechanism of activation accompanying the interaction changes among the seven helices. Methodology/Principal Findings: We have examined the bundles of 94 polypeptide chains from almost all available structures of 11 receptors, which we classified into either inactivated chain or activated chain, based on the type of bound ligand. For the inactivated chains, superposition of 200 residue bundles by secondary structure matching demonstrated that the bound ligands share a laterally limited cavity in the extracellular section of the bundle. Furthermore, a distinct feature was found for helix III of bovine rhodopsin, which might have evolved to lower its activity in the presence of 11-cis-retinal, to a level that other receptors could hardly achieve with any currently available ligands. Conclusions/Significance: Systematic analysis described here would be valuable for understanding of the rearrangement of seven helices which depends on the ligand specificity and activation state of the receptors.	Gakushuin Univ, Dept Life Sci, Toshima Ku, Tokyo 171, Japan	Gakushuin University	Okada, T (corresponding author), Gakushuin Univ, Dept Life Sci, Toshima Ku, Tokyo 171, Japan.	tetsuji.okada@gakushuin.ac.jp	Okada, Tetsuji/U-8732-2019	Okada, Tetsuji/0000-0003-1913-428X	Ministry of Education, Culture, Sports, Science and Technology	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported in Japan by grants from the Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Congreve M, 2011, J MED CHEM, V54, P4283, DOI 10.1021/jm200371q; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Han M, 1998, BIOCHEMISTRY-US, V37, P8253, DOI 10.1021/bi980147r; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Krishnan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029817; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; Lu ZL, 1999, J BIOL CHEM, V274, P7309, DOI 10.1074/jbc.274.11.7309; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Moukhametzianov R, 2011, P NATL ACAD SCI USA, V108, P8228, DOI 10.1073/pnas.1100185108; Nakamichi H, 2006, P NATL ACAD SCI USA, V103, P12729, DOI 10.1073/pnas.0601765103; Nakamichi H, 2006, ANGEW CHEM INT EDIT, V45, P4270, DOI 10.1002/anie.200600595; Okada T, 2001, CURR OPIN STRUC BIOL, V11, P420, DOI 10.1016/S0959-440X(00)00227-X; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; ROBINSON PR, 1992, NEURON, V9, P719, DOI 10.1016/0896-6273(92)90034-B; SCHERTLER GFX, 1993, NATURE, V362, P770, DOI 10.1038/362770a0; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793	33	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35802	10.1371/journal.pone.0035802	http://dx.doi.org/10.1371/journal.pone.0035802			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545139	Green Submitted, gold, Green Published			2022-12-27	WOS:000305343200059
J	Song, P; Pimplikar, SW				Song, Ping; Pimplikar, Sanjay W.			Knockdown of Amyloid Precursor Protein in Zebrafish Causes Defects in Motor Axon Outgrowth	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; GENE-EXPRESSION; CYTOSKELETAL DYNAMICS; APP; NEURONS; BIOLOGY; ALPHA	Amyloid precursor protein (APP) plays a pivotal role in Alzheimer's disease (AD) pathogenesis, but its normal physiological functions are less clear. Combined deletion of the APP and APP-like protein 2 (APLP2) genes in mice results in post-natal lethality, suggesting that APP performs an essential, if redundant, function during embryogenesis. We previously showed that injection of antisense morpholino to reduce APP levels in zebrafish embryos caused convergent-extension defects. Here we report that a reduction in APP levels causes defective axonal outgrowth of facial branchiomotor and spinal motor neurons, which involves disorganized axonal cytoskeletal elements. The defective outgrowth is caused in a cell-autonomous manner and both extracellular and intracellular domains of human APP are required to rescue the defective phenotype. Interestingly, wild-type human APP rescues the defective phenotype but APPswe mutation, which causes familial AD, does not. Our results show that the zebrafish model provides a powerful system to delineate APP functions in vivo and to study the biological effects of APP mutations.	[Song, Ping; Pimplikar, Sanjay W.] Cleveland Clin, Dept Neurosci, Lerner Res Inst, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Song, P (corresponding author), Cleveland Clin, Dept Neurosci, Lerner Res Inst, Cleveland, OH 44106 USA.	pimplis@ccf.org			Cleveland Clinic	Cleveland Clinic	These studies were funded by funds from Cleveland Clinic and Anonymous Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashe KH, 2010, NEURON, V66, P631, DOI 10.1016/j.neuron.2010.04.031; Barbagallo APM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018006; Barbagallo APM, 2011, J BIOL CHEM, V286, P8717, DOI 10.1074/jbc.C111.219873; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Boon KL, 2009, HUM MOL GENET, V18, P3615, DOI 10.1093/hmg/ddp310; Crews L, 2010, BRAIN STRUCT FUNCT, V214, P111, DOI 10.1007/s00429-009-0232-6; Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2; Gakhar-Koppole N, 2008, EUR J NEUROSCI, V28, P871, DOI 10.1111/j.1460-9568.2008.06398.x; Ghosal K, 2009, P NATL ACAD SCI USA, V106, P18367, DOI 10.1073/pnas.0907652106; Guo QX, 2012, CELL RES, V22, P78, DOI 10.1038/cr.2011.116; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Higashijima S, 2000, J NEUROSCI, V20, P206, DOI 10.1523/JNEUROSCI.20-01-00206.2000; Hornsten A, 2007, P NATL ACAD SCI USA, V104, P1971, DOI 10.1073/pnas.0603997104; Joshi P, 2009, DEV BIOL, V335, P1, DOI 10.1016/j.ydbio.2009.07.041; King GD, 2004, EXP NEUROL, V185, P208, DOI 10.1016/j.expneurol.2003.10.011; Li HM, 2010, P NATL ACAD SCI USA, V107, P17362, DOI 10.1073/pnas.1012568107; Muller T, 2008, PROG NEUROBIOL, V85, P393, DOI 10.1016/j.pneurobio.2008.05.002; Muller T, 2007, MOL BIOL CELL, V18, P201, DOI 10.1091/mbc.E06-04-0283; Musa A, 2001, DEV GENES EVOL, V211, P563, DOI 10.1007/s00427-001-0189-9; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Nornes S, 2009, EXP CELL RES, V315, P2791, DOI 10.1016/j.yexcr.2009.06.023; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Russo C, 2005, BRAIN RES REV, V48, P257, DOI 10.1016/j.brainresrev.2004.12.016; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Steinbach JP, 1998, CELL DEATH DIFFER, V5, P858, DOI 10.1038/sj.cdd.4400391; Uemura O, 2005, DEV BIOL, V278, P587, DOI 10.1016/j.ydbio.2004.11.031; van Tijn P, 2011, PROG NEUROBIOL, V93, P149, DOI 10.1016/j.pneurobio.2010.10.008; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Xia WM, 2010, J ALZHEIMERS DIS, V20, P981, DOI 10.3233/JAD-2010-1412; Young-Pearse TL, 2011, CELL RES        0719, DOI [10.1038/cr.2011.116, DOI 10.1038/CR.2011.116]; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; Zheng H, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-5; Zheng H, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-27	33	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e34209	10.1371/journal.pone.0034209	http://dx.doi.org/10.1371/journal.pone.0034209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545081	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343200004
J	Tang, HY; Tang, XF; Zuo, XB; Gao, JP; Sheng, YJ; Li, Y; Zhou, FS; Yin, XY; Xiao, FL; Du, WD; Yang, S; Sun, LD; Zhang, XJ				Tang, Hua-Yang; Tang, Xian-Fa; Zuo, Xian-Bo; Gao, Jin-Ping; Sheng, Yu-Jun; Li, Yang; Zhou, Fu-Sheng; Yin, Xian-Yong; Xiao, Feng-Li; Du, Wei-Dong; Yang, Sen; Sun, Liang-Dan; Zhang, Xue-Jun			Association Analysis of Single Nucleotide Polymorphisms at Five Loci: Comparison between Atopic Dermatitis and Asthma in the Chinese Han Population	PLOS ONE			English	Article							MAST-CELL CHYMASE; GENOME-WIDE ASSOCIATION; SERUM IGE LEVELS; SUSCEPTIBILITY LOCI; CHROMOSOME 11Q13; PROMOTER REGION; GENE; ECZEMA; VARIANT; DOWNSTREAM	Atopic diseases, such as atopic dermatitis (AD) and asthma, are closely related to clinical phenotypes with hypersensitivity, and often share some similar genetic and pathogenic bases. Our recent GWAS identified three susceptibility gene/loci FLG (rs11204971 and rs3126085), 5q22.1 (rs10067777, rs7701890, rs13360927 and rs13361382) and 20q13.33 (rs6010620) to AD. The effect of these AD associated polymorphisms in asthma is so far unknown. To investigate whether AD relevant genetic variants is identical to asthma and reveal the differences in genetic factors between AD and asthma in Chinese Han population, seven AD associated single nucleotide polymorphisms (SNPs) as well as 3 other SNPs (rs7936562 and rs7124842 at 11q13.5 and rs4982958 at 14q11.2) from our previous AD GWAS were genotyped in 463 asthma patients and 985 controls using Sequenom MassArray system. We found rs4982958 at 14q11.2 was significantly associated with asthma (P = 3.04x10(-4), OR = 0.73). We also detected one significant risk haplotype GGGA from the 4 SNPs (rs10067777, rs7701890, rs13360927 and rs13361382) at 5q22.1 in AD cases (P-correction = 3.60x10(-10), OR = 1.26), and the haplotype was suggestive of risk in asthma cases in this study (P = 0.014, P-correction = 0.084, OR = 1.38). These SNPs (rs11204971, rs3126085, rs7936562, rs712484 and rs6010620) at AD susceptibility genes/loci FLG, 11q13.5 and 20q13.33 were not associated with asthma in this study. Our results further comfirmed that 14q11.2 was an important candidate locus for asthma and demonstrated that 5q22.1 might be shared by AD and asthma in Chinese Han population.	[Tang, Hua-Yang; Tang, Xian-Fa; Gao, Jin-Ping; Sheng, Yu-Jun; Li, Yang; Yin, Xian-Yong; Xiao, Feng-Li; Yang, Sen; Sun, Liang-Dan; Zhang, Xue-Jun] Anhui Med Univ, Hosp 1, Inst Dermatol, Hefei, Anhui, Peoples R China; [Tang, Hua-Yang; Tang, Xian-Fa; Gao, Jin-Ping; Sheng, Yu-Jun; Li, Yang; Yin, Xian-Yong; Xiao, Feng-Li; Yang, Sen; Sun, Liang-Dan; Zhang, Xue-Jun] Anhui Med Univ, Hosp 1, Dept Dermatol, Hefei, Anhui, Peoples R China; [Tang, Hua-Yang; Tang, Xian-Fa; Zuo, Xian-Bo; Gao, Jin-Ping; Sheng, Yu-Jun; Li, Yang; Zhou, Fu-Sheng; Yin, Xian-Yong; Xiao, Feng-Li; Du, Wei-Dong; Yang, Sen; Sun, Liang-Dan; Zhang, Xue-Jun] Anhui Med Univ, Minist Educ, Key Lab Dermatol, Hefei, Anhui, Peoples R China; [Tang, Hua-Yang; Tang, Xian-Fa; Zuo, Xian-Bo; Gao, Jin-Ping; Sheng, Yu-Jun; Li, Yang; Zhou, Fu-Sheng; Yin, Xian-Yong; Xiao, Feng-Li; Du, Wei-Dong; Yang, Sen; Sun, Liang-Dan; Zhang, Xue-Jun] Anhui Med Univ, State Key Lab Incubat Base Dermatol, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University	Tang, HY (corresponding author), Anhui Med Univ, Hosp 1, Inst Dermatol, Hefei, Anhui, Peoples R China.	ahmusld@163.com; ayzxj@vip.sina.com	Chen, Gang/G-2722-2010; SHENG, Yu/GXZ-8269-2022		General Program of National Natural Science Foundation of China [81071284, 81172838, 31171224, 31000528]; Science and Technological Fund of Anhui Province for Outstanding Youth [1108085J10]; National Basic Research Program of China (973 Program) [2012CB722404]	General Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technological Fund of Anhui Province for Outstanding Youth; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This study was funded by General Program of National Natural Science Foundation of China (81071284, 81172838, 31171224, and 31000528), Science and Technological Fund of Anhui Province for Outstanding Youth (1108085J10) and the National Basic Research Program of China (973 Program, 2012CB722404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1987, AM REV RESPIR DIS, V136, P225; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Cookson WOCM, 2002, CURR OPIN ALLERGY CL, V2, P383, DOI 10.1097/00130832-200210000-00003; Esparza-Gordillo J, 2009, NAT GENET, V41, P596, DOI 10.1038/ng.347; Forrest S, 1999, J ALLERGY CLIN IMMUN, V104, P1066, DOI 10.1016/S0091-6749(99)70090-4; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Hart PH, 2001, IMMUNOL CELL BIOL, V79, P149, DOI 10.1046/j.1440-1711.2001.00983.x; He JQ, 2009, J ALLERGY CLIN IMMUN, V124, P222, DOI 10.1016/j.jaci.2009.04.018; Hersberger M, 2010, HUM IMMUNOL; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holloway JW, 2010, J ALLERGY CLIN IMMUN, V125, pS81, DOI 10.1016/j.jaci.2009.10.071; Hossny EM, 2008, J INVEST ALLERG CLIN, V18, P376; Hunninghake GM, 2010, ALLERGY, V65, P1566, DOI 10.1111/j.1398-9995.2010.02415.x; Iwanaga T, 2004, CLIN EXP ALLERGY, V34, P1037, DOI 10.1111/j.1365-2222.2004.02000.x; Kawashima T, 1998, HUM HERED, V48, P271, DOI 10.1159/000022815; Mao XQ, 1998, HUM HERED, V48, P38, DOI 10.1159/000022782; Mao XQ, 1996, LANCET, V348, P581, DOI 10.1016/S0140-6736(95)10244-2; Marenholz I, 2011, HUM MOL GENET, V20, P2443, DOI 10.1093/hmg/ddr117; Marsh DG, 1997, NAT GENET, V15, P389; MOFFATT F, 1994, LANCET, V343, P1597, DOI 10.1016/S0140-6736(94)93057-0; Pascale E, 2001, HUM HERED, V51, P177, DOI 10.1159/000053339; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sharma S, 2005, J HUM GENET, V50, P276, DOI 10.1007/s10038-005-0252-x; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Spergel JM, 2010, ANN ALLERG ASTHMA IM, V105, P99, DOI 10.1016/j.anai.2009.10.002; Sun LD, 2011, NAT GENET, V43, P690, DOI 10.1038/ng.851; Tanaka K, 1999, CLIN EXP ALLERGY, V29, P800	27	9	10	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35334	10.1371/journal.pone.0035334	http://dx.doi.org/10.1371/journal.pone.0035334			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545103	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343200024
J	Rachwal, PA; Rose, HL; Cox, V; Lukaszewski, RA; Murch, AL; Weller, SA				Rachwal, Phillip A.; Rose, Helen L.; Cox, Victoria; Lukaszewski, Roman A.; Murch, Amber L.; Weller, Simon A.			The Potential of TaqMan Array Cards for Detection of Multiple Biological Agents by Real-Time PCR	PLOS ONE			English	Article							YERSINIA-PESTIS; GENES	The TaqMan Array Card architecture, normally used for gene expression studies, was evaluated for its potential to detect multiple bacterial agents by real-time PCR. Ten PCR assays targeting five biological agents (Bacillus anthracis, Burkholderia mallei, Burkholderia pseudomallei, Francisella tularensis, and Yersinia pestis) were incorporated onto Array Cards. A comparison of PCR performance of each PCR in Array Card and singleplex format was conducted using DNA extracted from pure bacterial cultures. When 100 fg of agent DNA was added to Array Card channels the following levels of agent detection (where at least one agent PCR replicate returned a positive result) were observed: Y. pestis 100%, B. mallei & F. tularensis 93%; B. anthracis 71%; B. pseudomallei 43%. For B. mallei & pseudomallei detection the BPM2 PCR, which detects both species, outperformed PCR assays specific to each organism indicating identification of the respective species would not be reproducible at the 100 fg level. Near 100% levels of detection were observed when 100 fg of DNA was added to each PCR in singleplex format with singleplex PCRs also returning sporadic positives at the 10 fg per PCR level. Before evaluating the use of Array Cards for the testing of environmental and clinical sample types, with potential levels of background DNA and PCR inhibitors, users would therefore have to accept a 10-fold reduction in sensitivity of PCR assays on the Array Card format, in order to benefit for the capacity to test multiple samples for multiple agents. A two PCR per agent strategy would allow the testing of 7 samples for the presence of 11 biological agents or 3 samples for 23 biological agents per card (with negative control channels).	[Rachwal, Phillip A.; Rose, Helen L.; Cox, Victoria; Lukaszewski, Roman A.; Murch, Amber L.; Weller, Simon A.] Def Sci & Technol Lab, Salisbury, Wilts, England	Defence Science & Technology Laboratory	Rachwal, PA (corresponding author), Def Sci & Technol Lab, Salisbury, Wilts, England.	sweller@mail.dstl.gov.uk		Weller, Simon/0000-0001-9286-2991	UK Ministry of Defence (Programme Office)	UK Ministry of Defence (Programme Office)	This study was funded by the UK Ministry of Defence (Programme Office). The funding body appproved submission of the manuscript for publication but had no role in study design, data collection and analysis, or preparation of the manuscript.	Cho HB, 2005, P NATL ACAD SCI USA, V102, P14843, DOI 10.1073/pnas.0503458102; Hondow HL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-265; Janse I, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-314; Kodani M, 2011, J CLIN MICROBIOL, V49, P2175, DOI 10.1128/JCM.02270-10; Lossos IS, 2004, NEW ENGL J MED, V350, P1828, DOI 10.1056/NEJMoa032520; Merritt AJ, 2010, J CLIN MICROBIOL, V48, P3758, DOI 10.1128/JCM.00471-10; Mitchell JL, 2010, MOL CELL PROBE, V24, P72, DOI 10.1016/j.mcp.2009.10.004; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Pel J, 2009, P NATL ACAD SCI USA, V106, P14796, DOI 10.1073/pnas.0907402106; Picard FJ, 2009, J CLIN MICROBIOL, V47, P751, DOI 10.1128/JCM.01746-08; Rangel-Moreno J, 2006, J CLIN INVEST, V116, P3183, DOI 10.1172/JCI28756; Riehm JM, 2011, MOL CELL PROBE, V25, P8, DOI 10.1016/j.mcp.2010.09.002; Rose HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022668; Tarberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189; Thurman KA, 2011, DIAGN MICR INFEC DIS, V70, P1, DOI 10.1016/j.diagmicrobio.2010.11.014; Wittwer CT., 2004, MOL MICROBIOLOGY DIA, P71; Worsham PL, 2003, ADV EXP MED BIOL, V529, P129; Zhou ZX, 2010, J APPL MICROBIOL, V108, P898, DOI 10.1111/j.1365-2672.2009.04482.x	18	32	34	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35971	10.1371/journal.pone.0035971	http://dx.doi.org/10.1371/journal.pone.0035971			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22540014	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341000080
J	Stoeckli, S; Hirschi, M; Spirig, C; Calanca, P; Rotach, MW; Samietz, J				Stoeckli, Sibylle; Hirschi, Martin; Spirig, Christoph; Calanca, Pierluigi; Rotach, Mathias W.; Samietz, Joerg			Impact of Climate Change on Voltinism and Prospective Diapause Induction of a Global Pest Insect - Cydia pomonella ( L.)	PLOS ONE			English	Article							CODLING MOTH; PHENOLOGY; LEPIDOPTERA; TEMPERATURE; POPULATIONS; RESISTANCE; EUROPE; MODELS; WALNUT	Global warming will lead to earlier beginnings and prolongation of growing seasons in temperate regions and will have pronounced effects on phenology and life-history adaptation in many species. These changes were not easy to simulate for actual phenologies because of the rudimentary temporal (season) and spatial (regional) resolution of climate model projections. We investigate the effect of climate change on the regional incidence of a pest insect with nearly worldwide distribution and very high potential for adaptation to season length and temperature - the Codling Moth, Cydia pomonella. Seasonal and regional climate change signals were downscaled to the hourly temporal scale of a pest phenology model and the spatial scale of pest habitats using a stochastic weather generator operating at daily scale in combination with a re-sampling approach for simulation of hourly weather data. Under future conditions of increased temperatures (2045-2074), the present risk of below 20% for a pronounced second generation (peak larval emergence) in Switzerland will increase to 70-100%. The risk of an additional third generation will increase from presently 0-2% to 100%. We identified a significant two-week shift to earlier dates in phenological stages, such as overwintering adult flight. The relative extent (magnitude) of first generation pupae and all later stages will significantly increase. The presence of first generation pupae and later stages will be prolonged. A significant decrease in the length of overlap of first and second generation larval emergence was identified. Such shifts in phenology may induce changes in life-history traits regulating the life cycle. An accordingly life-history adaptation in photoperiodic diapause induction to shorter day-length is expected and would thereby even more increase the risk of an additional generation. With respect to Codling Moth management, the shifts in phenology and voltinism projected here will require adaptations of plant protection strategies to maintain their sustainability.	[Stoeckli, Sibylle; Samietz, Joerg] ACW, Agroscope Changins Wadenswil Res Stn, Wadenswil, Switzerland; [Hirschi, Martin; Spirig, Christoph; Rotach, Mathias W.] Fed Off Meteorol & Climatol MeteoSwiss, Zurich, Switzerland; [Calanca, Pierluigi] Agroscope Reckenholz Tanikon Res Stn ART, Zurich, Switzerland; [Rotach, Mathias W.] Univ Innsbruck, Inst Meteorol & Geophys, A-6020 Innsbruck, Austria	Swiss Federal Research Station Agroscope; Federal Office of Meteorology & Climatology (MeteoSwiss); Swiss Federal Research Station Agroscope; Swiss Federal Research Station for Agroecology & Agriculture; University of Innsbruck	Stoeckli, S (corresponding author), ACW, Agroscope Changins Wadenswil Res Stn, Wadenswil, Switzerland.	sibylle.stoeckli@acw.admin.ch	Rotach, Mathias/E-9938-2018; Spirig, Christoph/D-2471-2014; Hirschi, Martin/ABF-1564-2020	Rotach, Mathias/0000-0003-2283-309X; Spirig, Christoph/0000-0001-9535-7333; Hirschi, Martin/0000-0001-9154-756X	Swiss State Secretariat for Education and Research SER [C09.0052]; National Centre of Competence in Research on Climate (NCCR Climate) of the Swiss National Science Foundation	Swiss State Secretariat for Education and Research SER; National Centre of Competence in Research on Climate (NCCR Climate) of the Swiss National Science Foundation	The project was funded by the Swiss State Secretariat for Education and Research SER (grant number C09.0052) in the framework of COST 734 (Impacts of Climate Change and Variability on European Agriculture - CLIVAGRI). The contribution of MeteoSwiss was additionally funded by the National Centre of Competence in Research on Climate (NCCR Climate) of the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford D. V, 2007, PESTS FRUIT CROPS CO; Altermatt F, 2010, P ROY SOC B-BIOL SCI, V277, P1281, DOI 10.1098/rspb.2009.1910; Asser-Kaiser S, 2007, SCIENCE, V317, P1916, DOI 10.1126/science.1146542; Beers Elizabeth H., 2003, P489, DOI 10.1079/9780851995922.0489; Bradshaw WE, 2001, P NATL ACAD SCI USA, V98, P14509, DOI 10.1073/pnas.241391498; Calanca P., 2009, SURVEY AGROMETOEORLO, P237; Charmillot P. J., 2007, Revue Suisse de Viticulture, Arboriculture et Horticulture, V39, P385; Danilevskii A. S., 1961, PHOTOPERIODISM SEASO; Dubrovsky M, 2004, CLIMATIC CHANGE, V63, P145, DOI 10.1023/B:CLIM.0000018504.99914.60; Dubrovsky M, 2011, GEOPH RES ABSTR, V13, P496; Fischer AM, 2012, INT J CLIMATOL, V32, P2348, DOI 10.1002/joc.3396; GARCIASALAZAR C, 1988, ENVIRON ENTOMOL, V17, P626, DOI 10.1093/ee/17.4.626; Gomi T, 2007, ENTOMOL EXP APPL, V125, P179, DOI 10.1111/j.1570-7458.2007.00616.x; Harada T, 2005, APPL ENTOMOL ZOOL, V40, P461, DOI 10.1303/aez.2005.461; Hewitt C. D., 2005, EGGS NEWSLETT, V13, P22; Hill M. G., 1989, IMPACT CLIMATE CHANG; Hirschi M, 2012, EARTH SYST DYNAM, V3, P33, DOI 10.5194/esd-3-33-2012; Hohn H, 2010, PFLANZENSCHUTZEMPFEH; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Jepsen JU, 2011, GLOBAL CHANGE BIOL, V17, P2071, DOI 10.1111/j.1365-2486.2010.02370.x; JERMY T., 1967, ACTA PHYTOPATHOL ACAD SCI HUNG, V2, P49; Legave JM, 2009, ACTA HORTIC, V838, P21; Luedeling E, 2011, GLOBAL CHANGE BIOL, V17, P228, DOI 10.1111/j.1365-2486.2010.02227.x; MANETSCH TJ, 1976, IEEE T SYST MAN CYB, V6, P547, DOI 10.1109/TSMC.1976.4309549; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Morin X, 2009, GLOBAL CHANGE BIOL, V15, P961, DOI 10.1111/j.1365-2486.2008.01735.x; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; PETERSON DM, 1968, J INSECT PHYSIOL, V14, P519, DOI 10.1016/0022-1910(68)90067-X; PHILLIPS PA, 1975, ANN ENTOMOL SOC AM, V68, P1053, DOI 10.1093/aesa/68.6.1053; Reyes M, 2007, PEST MANAG SCI, V63, P890, DOI 10.1002/ps.1421; RICHARDSON CW, 1981, WATER RESOUR RES, V17, P182, DOI 10.1029/WR017i001p00182; RIEDL H, 1978, CAN ENTOMOL, V110, P455, DOI 10.4039/Ent110455-5; Riedl H., 1983, Diapause and life cycle strategies in insects, P233; Samietz J., 2007, Bulletin OEPP, V37, P255, DOI 10.1111/j.1365-2338.2007.01121.x; Scoble M. J., 1995, LEPIDOPTERA FORM FUN; Shel'deshova GG, 1965, AKAD NAUK SSSR T ZOO, V36, P5; Stoeckli S, 2012, ACTA HORT IN PRESS; Tobin PC, 2008, GLOBAL CHANGE BIOL, V14, P951, DOI 10.1111/j.1365-2486.2008.01561.x; VANSICKLE J, 1977, IEEE T SYST MAN CYB, V7, P635, DOI 10.1109/TSMC.1977.4309800; Visser ME, 2001, P ROY SOC B-BIOL SCI, V268, P289, DOI 10.1098/rspb.2000.1363; Vitasse Y, 2011, AGR FOREST METEOROL, V151, P969, DOI 10.1016/j.agrformet.2011.03.003; WILDBOLZ T, 1969, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V42, P58; Willmer P., 2000, ENV PHYSL ANIMALS	44	49	48	1	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35723	10.1371/journal.pone.0035723	http://dx.doi.org/10.1371/journal.pone.0035723			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539997	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341000063
J	Frenette, JJ; Massicotte, P; Lapierre, JF				Frenette, Jean-Jacques; Massicotte, Philippe; Lapierre, Jean-Francois			Colorful Niches of Phytoplankton Shaped by the Spatial Connectivity in a Large River Ecosystem: A Riverscape Perspective	PLOS ONE			English	Article							ST-LAWRENCE-RIVER; FRESH-WATER PICOCYANOBACTERIA; DISSOLVED ORGANIC-CARBON; LANDSCAPE ECOLOGY; SPECTRAL REFLECTANCE; COMMUNITY STRUCTURE; LIGHT QUALITY; LAKES; TERRESTRIAL; PICOPHYTOPLANKTON	Large rivers represent a significant component of inland waters and are considered sentinels and integrators of terrestrial and atmospheric processes. They represent hotspots for the transport and processing of organic and inorganic material from the surrounding landscape, which ultimately impacts the bio-optical properties and food webs of the rivers. In large rivers, hydraulic connectivity operates as a major forcing variable to structure the functioning of the riverscape, and-despite increasing interest in large-river studies-riverscape structural properties, such as the underwater spectral regime, and their impact on autotrophic ecological processes remain poorly studied. Here we used the St. Lawrence River to identify the mechanisms structuring the underwater spectral environment and their consequences on pico- and nanophytoplankton communities, which are good biological tracers of environmental changes. Our results, obtained from a 450 km sampling transect, demonstrate that tributaries exert a profound impact on the receiving river's photosynthetic potential. This occurs mainly through injection of chromophoric dissolved organic matter (CDOM) and non-algal material (tripton). CDOM and tripton in the water column selectively absorbed wavelengths in a gradient from blue to red, and the resulting underwater light climate was in turn a strong driver of the phytoplankton community structure (prokaryote/eukaryote relative and absolute abundances) at scales of many kilometers from the tributary confluence. Our results conclusively demonstrate the proximal impact of watershed properties on underwater spectral composition in a highly dynamic river environment characterized by unique structuring properties such as high directional connectivity, numerous sources and forms of carbon, and a rapidly varying hydrodynamic regime. We surmise that the underwater spectral composition represents a key integrating and structural property of large, heterogeneous river ecosystems and a promising tool to study autotrophic functional properties. It confirms the usefulness of using the riverscape approach to study large-river ecosystems and initiate comparison along latitudinal gradients.	[Frenette, Jean-Jacques; Massicotte, Philippe] Univ Quebec Trois Rivieres, Dept Chim Biol, Trois Rivieres, PQ GA9 5H7, Canada; [Lapierre, Jean-Francois] Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada	University of Quebec; University of Quebec Trois Rivieres; University of Quebec; University of Quebec Montreal	Frenette, JJ (corresponding author), Univ Quebec Trois Rivieres, Dept Chim Biol, CP 500, Trois Rivieres, PQ GA9 5H7, Canada.	Jean-Jacques.Frenette@uqtr.ca	Lapierre, Jean-Francois/F-1838-2010	Lapierre, Jean-Francois/0000-0001-5862-7955; Massicotte, Philippe/0000-0002-5919-4116	Natural Sciences Research Council of Canada (NSERC ship time and discovery programs); Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT)	Natural Sciences Research Council of Canada (NSERC ship time and discovery programs)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT)(FQRNT)	This research was funded by the Natural Sciences Research Council of Canada (NSERC ship time and discovery programs) and the Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT) to Dr. Frenette, a graduate NSERC to Dr. Lapierre, and a postgraduate NSERC to Dr. Massicotte. Quebec-Ocean's logistical support during sampling is greatly acknowledged. This is a contribution of the Groupe de Recherche Interuniversitaire en Limnologie (GRIL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan JD, 2007, STREAM ECOLOGY STRUC, VXIV, P436, DOI DOI 10.1007/978-1-4020-5583-6; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 1957, COLD SPRING HARB SYM; APHA A, 1998, STANDARD METHODS EXA; Assani AA, 2010, J HYDROL, V385, P292, DOI 10.1016/j.jhydrol.2010.02.031; Barton AD, 2010, SCIENCE, V327, P1509, DOI 10.1126/science.1184961; Basu BK, 2000, FRESHWATER BIOL, V45, P373, DOI 10.1046/j.1365-2427.2000.00635.x; Bell T, 2001, LIMNOL OCEANOGR, V46, P1243, DOI 10.4319/lo.2001.46.5.1243; Benda L, 2004, BIOSCIENCE, V54, P413, DOI 10.1641/0006-3568(2004)054[0413:TNDHHC]2.0.CO;2; Blanchet FG, 2008, ECOL MODEL, V215, P325, DOI 10.1016/j.ecolmodel.2008.04.001; Blough NVDV R, 2002, BIOGEOCHEMISTRY MARI, Vxxii, P774; Bouman HA, 2006, SCIENCE, V312, P918, DOI 10.1126/science.1122692; Bukata R.P., 1995, OPTICAL PROPERTIES R; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Butman D, 2011, NAT GEOSCI, V4, P839, DOI [10.1038/ngeo1294, 10.1038/NGEO1294]; Callieri C, 1996, INT REV GES HYDROBIO, V81, P13, DOI 10.1002/iroh.19960810103; Callieri C, 2007, AQUAT ECOL, V41, P511, DOI 10.1007/s10452-007-9125-z; Callieri Cristiana, 2008, Freshwater Reviews, V1, P1, DOI 10.1608/FRJ-1.1.1; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Constant H, 1978, CONTRIBUTION ETUDE Q; Davies-Colley RJ, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000722; DESCY JP, 1993, HYDROBIOLOGIA, V249, P111, DOI 10.1007/BF00008847; Environmental Systems Research Institute (ESRI), 2011, ARCGIS DESKT; Frenette JJ, 2006, LIMNOL OCEANOGR, V51, P2632, DOI 10.4319/lo.2006.51.6.2632; Frenette JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035891; Frenette JJ, 2003, AQUAT ECOL, V37, P77, DOI 10.1023/A:1022133530244; GLOVER HE, 1987, J EXP MAR BIOL ECOL, V105, P137, DOI 10.1016/0022-0981(87)90168-7; Hoeinghaus DJ, 2007, ECOSYSTEMS, V10, P1019, DOI 10.1007/s10021-007-9075-2; Hudon C, 1996, HYDROBIOLOGIA, V337, P11, DOI 10.1007/BF00028503; Humborg C, 2010, GLOBAL CHANGE BIOL, V16, P1966, DOI 10.1111/j.1365-2486.2009.02092.x; Hunter PD, 2008, REMOTE SENS ENVIRON, V112, P1527, DOI 10.1016/j.rse.2007.08.003; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Kahru M, 1998, J GEOPHYS RES-OCEANS, V103, P21601, DOI 10.1029/98JC01945; Katano T, 2007, AQUAT MICROB ECOL, V46, P191, DOI 10.3354/ame046191; KIRK JTO, 1988, J WATER POLLUT CON F, V60, P194; Kirk JTO, 1994, LIGHT PHOTOSYNTHESIS, Vxvi; Kutser T, 2006, ESTUAR COAST SHELF S, V67, P303, DOI 10.1016/j.ecss.2005.11.024; Lapierre JF, 2009, AQUAT SCI, V71, P15, DOI 10.1007/s00027-009-9133-2; Lapierre JF, 2008, MAR ECOL PROG SER, V372, P19, DOI 10.3354/meps07685; Liu HB, 2004, ESTUARIES, V27, P147, DOI 10.1007/BF02803568; Marie D, 2004, ALGAL CULTURING TECH, V17, P253; Massicotte P, 2011, ECOL APPL, V21, P2600, DOI 10.1890/10-1475.1; McClain ME, 2003, ECOSYSTEMS, V6, P301, DOI 10.1007/s10021-003-0161-9; Miller AJ, 2002, SUBSET SELECTION REG, Vxvii, P238; Miller CB, 2004, BIOL OCEANOGRAPHY, Vix; MILLS EL, 1981, HYDROBIOLOGIA, V79, P65, DOI 10.1007/BF00005820; Monteith DT, 2007, NATURE, V450, P537, DOI 10.1038/nature06316; Pace ML, 2004, NATURE, V427, P240, DOI 10.1038/nature02227; Parsons TR, 1984, MANUAL CHEM BIOL MET, Vxiv; PICK FR, 1991, INT REV GES HYDROBIO, V76, P565, DOI 10.1002/iroh.19910760409; PICK FR, 1991, LIMNOL OCEANOGR, V36, P1457, DOI 10.4319/lo.1991.36.7.1457; Platt T, 2010, ESTUAR COAST, V33, P428, DOI 10.1007/s12237-009-9161-0; Pommier J, 2012, AQUATIC SCI; Pommier J, 2010, MAR ECOL PROG SER, V400, P143, DOI 10.3354/meps08413; Poole GC, 2002, FRESHWATER BIOL, V47, P641, DOI 10.1046/j.1365-2427.2002.00922.x; Reynolds CS, 2002, J PLANKTON RES, V24, P417, DOI 10.1093/plankt/24.5.417; Rice SP, 2006, CAN J FISH AQUAT SCI, V63, P2553, DOI 10.1139/F06-145; SAKIA RM, 1992, J ROY STAT SOC D-STA, V41, P169, DOI 10.2307/2348250; Schallenberg M, 2001, FRESHWATER BIOL, V46, P27, DOI 10.1046/j.1365-2427.2001.00647.x; Siegel DA, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC000965; Simons RD, 2010, ATMOS OCEAN, V48, P132, DOI 10.3137/OC316.2010; Somogyi B, 2009, AQUAT ECOL, V43, P735, DOI 10.1007/s10452-009-9269-0; Stomp M, 2007, ISME J, V1, P271, DOI 10.1038/ismej.2007.59; Stomp M, 2007, ECOL LETT, V10, P290, DOI 10.1111/j.1461-0248.2007.01026.x; Svab E, 2005, INT J REMOTE SENS, V26, P919, DOI 10.1080/0143116042000274087; Thorp JH, 2006, RIVER RES APPL, V22, P123, DOI 10.1002/rra.901; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298; Tremblay G, 2009, AQUAT MICROB ECOL, V54, P55, DOI 10.3354/ame01257; TURNER MG, 1989, ANNU REV ECOL SYST, V20, P171, DOI 10.1146/annurev.es.20.110189.001131; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Victoriano V, 2004, OCEANOGRAPHY MARINE, Vxxiv, P616; Vis C, 2007, ECOSYSTEMS, V10, P293, DOI 10.1007/s10021-007-9021-3; Voros L, 1998, HYDROBIOLOGIA, V370, P117; Wang BL, 2009, J LIMNOL, V68, P53, DOI 10.4081/jlimnol.2009.53; Wetzel RG, 2001, LAKE RIVER ECOSYSTEM; Wiens JA, 2002, FRESHWATER BIOL, V47, P501, DOI 10.1046/j.1365-2427.2002.00887.x; Williamson CE, 1999, LIMNOL OCEANOGR, V44, P795, DOI 10.4319/lo.1999.44.3_part_2.0795; Williamson CE, 2008, FRONT ECOL ENVIRON, V6, P247, DOI 10.1890/070140; Williamson CE, 2009, LIMNOL OCEANOGR, V54, P2273, DOI 10.4319/lo.2009.54.6_part_2.2273; Winder M, 2009, J PLANKTON RES, V31, P1307, DOI 10.1093/plankt/fbp074; Xie HX, 2012, MAR CHEM, V128, P44, DOI 10.1016/j.marchem.2011.10.001; YENTSCH CS, 1960, DEEP-SEA RES, V7, P1, DOI 10.1016/0146-6313(60)90002-2; [No title captured]	83	23	23	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35891	10.1371/journal.pone.0035891	http://dx.doi.org/10.1371/journal.pone.0035891			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558259	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340200029
J	Poulsen, AH; Stenager, E; Johansen, C; Bentzen, J; Friis, S; Schuz, J				Poulsen, Aslak Harbo; Stenager, Egon; Johansen, Christoffer; Bentzen, Joan; Friis, Soren; Schuez, Joachim			Mobile Phones and Multiple Sclerosis - A Nationwide Cohort Study in Denmark	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; CELLULAR TELEPHONE USE; ELECTROMAGNETIC-FIELDS; OCULAR SYMPTOMS; RADIOFREQUENCY; EXPOSURE; PERMEABILITY; PREVALENCE; RADIATION; USERS	We investigated the risk of, prognosis of and symptoms of multiple sclerosis (MS) among all Danish residents who owned a mobile phone subscription before 1996. Using the Danish Multiple Sclerosis Registry and Civil Registration System, study subjects were followed up for MS through 2004. Poisson models were used to calculate incidence rate ratios (IRR, age range: 18-64 years) and mortality rate ratios (MRR, age range: 18+) and to compare presenting symptoms among subscribers and all non-subscribers. A total of 405 971 subscription holders accrued four million years of follow up, with men accounting for 86% of the observation time. Among subscription holding men, the IRR of MS was close to unity, overall as well as 13+ years after first subscription (IRR 1.02, 95% CI: 0.48-2.16). Among women, the IRR was 3.43 (95% CI: 0.86-13.72) 13+ years after first subscription, however, based on only two cases. Presenting symptoms of MS differed between subscribers and nonsubscribers (p = 0.03), with slightly increased risk of diplopia in both genders (IRR: 1.38, 95% CI: 1.02-1.86), an increased risk of fatigue among women (IRR: 3.02, 95% CI: 1.45-6.28), and of optic neuritis among men (IRR: 1.38, 95% CI: 1.03-1.86). Overall the MRR was close to one (MRR: 0.91, 95% CI 0.70-1.19) among MS-patients with a subscription and although we observed some increased MRR estimates among women, these were based on small numbers. In conclusion, we found little evidence for a pronounced association between mobile phone use and risk of MS or mortality rate among MS patients. Symptoms of MS differed between subscribers and nonsubscribers for symptoms previously suggested to be associated with mobile phone use. This deserves further attention, as does the increased long-term risk of MS among female subscribers, although small numbers and lack of consistency between genders prevent causal interpretation.	[Poulsen, Aslak Harbo; Johansen, Christoffer; Friis, Soren] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; [Stenager, Egon] Copenhagen Univ Hosp, Danish MS Registry, Copenhagen, Denmark; [Bentzen, Joan] Univ So Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Schuez, Joachim] IARC, Sect Environm & Radiat, Lyon, France; [Stenager, Egon] Univ So Denmark, Inst Reg Hlth Serv, Odense, Denmark; [Stenager, Egon] Sonderborg Hosp, MS Clin So Jutland Sonderborg Vejle Esbjerg, Sonderborg, Denmark	Danish Cancer Society; University of Copenhagen; University of Southern Denmark; World Health Organization; International Agency for Research on Cancer (IARC); University of Southern Denmark	Poulsen, AH (corresponding author), Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark.	Aslak@Cancer.DK	Johansen, Christoffer/AAG-7916-2020; Stenager, Egon/AAU-4463-2020; Stenager, Egon/O-2275-2017	Johansen, Christoffer/0000-0002-4384-206X; stenager, egon/0000-0002-4877-5193	Danish Graduate School in Public Health Science; Sonofon and TeleDenmark Mobile; Danish Multiple Sclerosis Society; Bayer Schering; Merck Serono; Biogen Idec; Sanofi Aventis; Novartis	Danish Graduate School in Public Health Science; Sonofon and TeleDenmark Mobile; Danish Multiple Sclerosis Society; Bayer Schering(Bayer AG); Merck Serono(Merck & Company); Biogen Idec(Biogen); Sanofi Aventis(Sanofi-Aventis); Novartis(Novartis)	AHP was supported by a stipend for PhD students from the Danish Graduate School in Public Health Science. All other authors contributed to this work based on their respective core budget positions. The establishment of the original cohort of subscription holders was supported by Sonofon and TeleDenmark Mobile. The Danish MS Registry is funded by the Danish Multiple Sclerosis Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Since 1994, CJ has been a Consultant to the Danish National Board of Health in the area electromagnetic fields and health and received support from Sonofon and TeleDenmark Mobile for the establishment of the nationwide cohort in 1999. ES has received financial support for congress participation from Bayer Schering, Merck Serono, Biogen Idec, Sanofi Aventis and Novartis and unrestricted research grants from Bayer Schering, Merck Serono, and Biogen Idec. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Baan R, 2011, LANCET ONCOL, V12, P624, DOI 10.1016/S1470-2045(11)70147-4; Balik HH, 2005, PATHOL BIOL, V53, P88, DOI 10.1016/j.patbio.2004.03.012; Bentzen J, 2010, MULT SCLER J, V16, P520, DOI 10.1177/1352458510364197; Bronnum-Hansen H, 2004, BRAIN, V127, P844, DOI 10.1093/brain/awh104; Bronnum-Hansen H, 2011, SCAND J PUBLIC HEALT, V39, P62, DOI 10.1177/1403494810390729; Cardis E, 2008, PHYS MED BIOL, V53, P2771, DOI 10.1088/0031-9155/53/11/001; Chia SE, 2000, ENVIRON HEALTH PERSP, V108, P1059, DOI 10.2307/3434959; Davis SL, 2010, J APPL PHYSIOL, V109, P1531, DOI 10.1152/japplphysiol.00460.2010; de Gannes FP, 2009, RADIAT RES, V172, P359, DOI 10.1667/RR1578.1; DIMBYLOW PJ, 1994, PHYS MED BIOL, V39, P1537, DOI 10.1088/0031-9155/39/10/003; Eberhardt JL, 2008, ELECTROMAGN BIOL MED, V27, P215, DOI 10.1080/15368370802344037; Frei P, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6387; Greer JM, 2011, J NEUROIMMUNOL, V234, P7, DOI 10.1016/j.jneuroim.2011.03.003; GUTHRIE TC, 1995, J NEUROL SCI, V129, P1, DOI 10.1016/0022-510X(94)00248-M; Huss A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-267; Johansen C, 2001, JNCI-J NATL CANCER I, V93, P203, DOI 10.1093/jnci/93.3.203; Kister I, 2010, CURR PAIN HEADACHE R, V14, P441, DOI 10.1007/s11916-010-0143-5; Kleinlogel H, 2008, BIOELECTROMAGNETICS, V29, P488, DOI 10.1002/bem.20418; Koch-Henriksen N, 2001, DAN MED BULL, V48, P91; Kucer N, 2008, ELECTROMAGN BIOL MED, V27, P205, DOI 10.1080/15368370802072174; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Mason K, 2011, ACTA NEUROL SCAND; Masuda H, 2009, RADIAT RES, V172, P66, DOI 10.1667/RR1542.1; McQuade JMS, 2009, RADIAT RES, V171, P615, DOI 10.1667/RR1507.1; Meo Sultan A., 2005, International Journal of Occupational Medicine and Environmental Health, V18, P53; National IT and Telecom Agency D, 2003, TEL YB 2002; Nittby H, 2008, ELECTROMAGN BIOL MED, V27, P103, DOI 10.1080/15368370802061995; Nittby Henrietta, 2009, Pathophysiology, V16, P103, DOI 10.1016/j.pathophys.2009.01.001; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; SALFORD LG, 1994, MICROSC RES TECHNIQ, V27, P535, DOI 10.1002/jemt.1070270608; Schreier N, 2006, SOZ PRAVENTIV MED, V51, P202, DOI 10.1007/s00038-006-5061-2; Schuz J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004389; Schuz J, 2010, CANC EPIDEMIOL; Schuz J, 2006, JNCI-J NATL CANCER I, V98, P1707, DOI 10.1093/jnci/djj464; Schuz J, 2007, BIOELECTROMAGNETICS, V28, P130, DOI 10.1002/bem.20297; Stam R, 2010, BRAIN RES REV, V65, P80, DOI 10.1016/j.brainresrev.2010.06.001; van Rongen E, 2009, J TOXICOL ENV HEAL B, V12, P572, DOI 10.1080/10937400903458940	39	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e34453	10.1371/journal.pone.0034453	http://dx.doi.org/10.1371/journal.pone.0034453			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558088	Green Submitted, Green Published, gold			2022-12-27	WOS:000305340200005
J	Walton, NM; Shin, R; Tajinda, K; Heusner, CL; Kogan, JH; Miyake, S; Chen, Q; Tamura, K; Matsumoto, M				Walton, Noah M.; Shin, Rick; Tajinda, Katsunori; Heusner, Carrie L.; Kogan, Jeffrey H.; Miyake, Shinichi; Chen, Qian; Tamura, Kouichi; Matsumoto, Mitsuyuki			Adult Neurogenesis Transiently Generates Oxidative Stress	PLOS ONE			English	Article							NEURAL STEM-CELLS; MILD COGNITIVE IMPAIRMENT; MOUSE DENTATE GYRUS; II MUTANT MICE; ALZHEIMERS-DISEASE; HIPPOCAMPAL NEUROGENESIS; MAMMALIAN BRAIN; DNA-DAMAGE; OXYGEN; CYCLE	An increasing body of evidence suggests that alterations in neurogenesis and oxidative stress are associated with a wide variety of CNS diseases, including Alzheimer's disease, schizophrenia and Parkinson's disease, as well as routine loss of function accompanying aging. Interestingly, the association between neurogenesis and the production of reactive oxidative species (ROS) remains largely unexamined. The adult CNS harbors two regions of persistent lifelong neurogenesis: the subventricular zone and the dentate gyrus (DG). These regions contain populations of quiescent neural stem cells (NSCs) that generate mature progeny via rapidly-dividing progenitor cells. We hypothesized that the energetic demands of highly proliferative progenitors generates localized oxidative stress that contributes to ROS-mediated damage within the neuropoietic microenvironment. In vivo examination of germinal niches in adult rodents revealed increases in oxidized DNA and lipid markers, particularly in the subgranular zone (SGZ) of the dentate gyrus. To further pinpoint the cell types responsible for oxidative stress, we employed an in vitro cell culture model allowing for the synchronous terminal differentiation of primary hippocampal NSCs. Inducing differentiation in primary NSCs resulted in an immediate increase in total mitochondria number and overall ROS production, suggesting oxidative stress is generated during a transient window of elevated neurogenesis accompanying normal neurogenesis. To confirm these findings in vivo, we identified a set of oxidation-responsive genes, which respond to antioxidant administration and are significantly elevated in genetic-and exercise-induced model of hyperactive hippocampal neurogenesis. While no direct evidence exists coupling neurogenesis-associated stress to CNS disease, our data suggest that oxidative stress is produced as a result of routine adult neurogenesis.	[Walton, Noah M.; Shin, Rick; Tajinda, Katsunori; Heusner, Carrie L.; Kogan, Jeffrey H.; Miyake, Shinichi; Chen, Qian; Tamura, Kouichi; Matsumoto, Mitsuyuki] Astellas Res Inst Amer LLC, CNS, Skokie, IL 60077 USA	Astellas Pharmaceuticals	Walton, NM (corresponding author), Astellas Res Inst Amer LLC, CNS, Skokie, IL 60077 USA.	noah.walton@us.astellas.com	Matsumoto, Mitsuyuki/G-3207-2012	Matsumoto, Mitsuyuki/0000-0002-1172-2354				Acharya MM, 2010, FREE RADICAL BIO MED, V49, P1846, DOI 10.1016/j.freeradbiomed.2010.08.021; Adibhatla RM, 2008, BMB REP, V41, P560, DOI 10.5483/BMBRep.2008.41.8.560; Alam ZI, 1997, J NEUROCHEM, V69, P1196, DOI 10.1046/j.1471-4159.1997.69031196.x; Anantharam V, 2007, NEUROCHEM INT, V50, P834, DOI 10.1016/j.neuint.2007.02.003; Babu H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000388; Babu H, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00089; Beal MF, 2005, NEUROBIOL AGING, V26, P585, DOI 10.1016/j.neurobiolaging.2004.09.022; Bitanihirwe BKY, 2011, NEUROSCI BIOBEHAV R, V35, P878, DOI 10.1016/j.neubiorev.2010.10.008; Bradley MA, 2010, NEUROBIOL AGING; Che Y, 2010, J PSYCHIATR NEUROSCI, V35, P296, DOI 10.1503/jpn.090083; Chen QM, 2000, BIOCHEM J, V347, P543, DOI 10.1042/0264-6021:3470543; Chen SC, 2007, TRANSL RES, V149, P274, DOI 10.1016/j.trsl.2006.08.005; Clay HB, 2011, INT J DEV NEUROSCI, V29, P311, DOI 10.1016/j.ijdevneu.2010.08.007; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Curtis MA, 2011, EUR J NEUROSCI, V33, P1170, DOI 10.1111/j.1460-9568.2011.07616.x; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Fiskum G, 2004, J BIOENERG BIOMEMBR, V36, P347, DOI 10.1023/B:JOBB.0000041766.71376.81; Gallagher J, 2003, FEBS LETT, V551, P8, DOI 10.1016/S0014-5793(03)00823-8; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; INCE PG, 1994, NEUROSCI LETT, V182, P87, DOI 10.1016/0304-3940(94)90213-5; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Kannan, 2000, Pathophysiology, V7, P153, DOI 10.1016/S0928-4680(00)00053-5; Kapogiannis D, 2011, LANCET NEUROL, V10, P187, DOI 10.1016/S1474-4422(10)70277-5; Klein JA, 2003, J CLIN INVEST, V111, P785, DOI 10.1172/JCI200318182; Li Y, 2009, CURR TOP DEV BIOL, V87, P149, DOI 10.1016/S0070-2153(09)01205-8; Lovell MA, 2007, J NEUROSCI RES, V85, P3036, DOI 10.1002/jnr.21346; Madhavan L, 2005, ANN NY ACAD SCI, V1049, P185, DOI 10.1196/annals.1334.017; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; Moh C, 2011, RESULTS PROBL CELL D, V53, P565, DOI 10.1007/978-3-642-19065-0_23; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Moser KV, 2004, BRAIN RES, V1017, P53, DOI 10.1016/j.brainres.2004.05.013; PERO RW, 1990, CANCER RES, V50, P4619; Rehen SK, 2005, J NEUROSCI, V25, P2176, DOI 10.1523/JNEUROSCI.4560-04.2005; Scheffler B, 2005, P NATL ACAD SCI USA, V102, P9353, DOI 10.1073/pnas.0503965102; SCOTT ID, 1980, BIOCHEM J, V186, P21, DOI 10.1042/bj1860021; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Studer L, 2000, J NEUROSCI, V20, P7377; Sugawara T, 2003, ANTIOXID REDOX SIGN, V5, P597, DOI 10.1089/152308603770310266; Taupin Philippe, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P16; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Wang XK, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-12; Yamasaki N, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-6; Yang AH, 2003, J NEUROSCI, V23, P10454; Zalba G, 2005, ANTIOXID REDOX SIGN, V7, P1327, DOI 10.1089/ars.2005.7.1327	49	77	79	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35264	10.1371/journal.pone.0035264	http://dx.doi.org/10.1371/journal.pone.0035264			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558133	Green Submitted, gold, Green Published			2022-12-27	WOS:000305340200011
J	Baamrane, MAA; Shehzad, W; Ouhammou, A; Abbad, A; Naimi, M; Coissac, E; Taberlet, P; Znari, M				Baamrane, Moulay Abdeljalil Ait; Shehzad, Wasim; Ouhammou, Ahmed; Abbad, Abdelaziz; Naimi, Mohamed; Coissac, Eric; Taberlet, Pierre; Znari, Mohammed			Assessment of the Food Habits of the Moroccan Dorcas Gazelle in M'Sabih Talaa, West Central Morocco, Using the trnL Approach	PLOS ONE			English	Article							DIET COMPOSITION; INSECT HERBIVORE; CO2 ENRICHMENT; MOUNTAIN HARES; PAPER BIRCH; PLANT; GROWTH; NUTRITION; AVAILABILITY; SPECTROSCOPY	Food habits of the Moroccan dorcas gazelle, Gazella dorcas massaesyla, previously investigated in the 1980s using microhistological fecal analysis, in the M'Sabih Talaa Reserve, west central Morocco, were re-evaluated over three seasons (spring, summer and autumn 2009) using the trnL approach to determine the diet composition and its seasonal variation from fecal samples. Taxonomic identification was carried out using the identification originating from the database built from EMBL and the list of plant species within the reserve. The total taxonomic richness in the reserve was 130 instead of 171 species in the 1980s. The diet composition revealed to be much more diversified (71 plant taxa belonging to 57 genus and 29 families) than it was 22 years ago (29 identified taxa). Thirty-four taxa were newly identified in the diet while 13 reported in 1986-87 were not found. Moroccan dorcas gazelle showed a high preference to Acacia gummifera, Anagallis arvensis, Glebionis coronaria, Cladanthus arabicus, Diplotaxis tenuisiliqua, Erodium salzmannii, Limonium thouini, Lotus arenarius and Zizyphus lotus. Seasonal variations occurred in both number (40-41 taxa in spring-summer and 49 taxa in autumn vs. respectively 23-22 and 26 in 1986-1987) and taxonomic type of eaten plant taxa. This dietary diversification could be attributed either to the difference in methods of analysis, trnL approach having a higher taxonomic resolution, or a potential change in nutritional quality of plants over time.	[Baamrane, Moulay Abdeljalil Ait; Naimi, Mohamed; Znari, Mohammed] Univ Cadi Ayyad, Fac Sci Semlalia, Lab Biodivers & Dynam Ecosyst BioDEcos, Marrakech, Morocco; [Shehzad, Wasim; Coissac, Eric; Taberlet, Pierre] Univ Grenoble 1, CNRS UMR 5553, Lab Ecol Alpine LECA, Grenoble, France; [Ouhammou, Ahmed] Univ Cadi Ayyad, Fac Sci Semlalia, L2E, Marrakech, Morocco; [Abbad, Abdelaziz] Univ Cadi Ayyad, Fac Sci Semlalia, Lab Biotechnol Protect & Valorisat Ressources Veg, Marrakech, Morocco	Cadi Ayyad University of Marrakech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; Cadi Ayyad University of Marrakech; Cadi Ayyad University of Marrakech	Baamrane, MAA (corresponding author), Univ Cadi Ayyad, Fac Sci Semlalia, Lab Biodivers & Dynam Ecosyst BioDEcos, Marrakech, Morocco.	znarim@gmail.com	Taberlet, Pierre/D-1178-2010; baamrane, moulay abdeljalil ait/AAH-4252-2021; Coissac, Éric/AAE-8735-2019	Taberlet, Pierre/0000-0002-3554-5954; baamrane, moulay abdeljalil ait/0000-0003-0980-6345; Coissac, Éric/0000-0001-7507-6729; OUHAMMOU, Ahmed/0000-0001-9206-1617	People's Trust for Endangered Species (PTES, UK); Laboratory of Alpine Ecology (LECA), Joseph Fourier University, Grenoble, France	People's Trust for Endangered Species (PTES, UK); Laboratory of Alpine Ecology (LECA), Joseph Fourier University, Grenoble, France	The present work has been funded by People's Trust for Endangered Species (PTES, UK) (Project titled: Conservation and management of an isolated population of Moroccan Dorcas gazelles north west of the Atlas mountains, awarded on November 2008. www.ptes.org/files/853_record_of_historic_grants_awarded_2000.pdf). Molecular analyses were funded by the Laboratory of Alpine Ecology (LECA), Joseph Fourier University, Grenoble, France, http://www-leca.ujf-grenoble.fr/equipes/emabio_composition.htm, in collaboration with one of the co-authors, Dr. Taberlet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait Baamrane MA, 2009, 2 DIVERSITAS OP SCI; ALADOS CL, 1987, ISRAEL J ZOOL, V34, P33; AYRES MP, 1993, BIOTIC INTERACTIONS AND GLOBAL CHANGE, P75; BELOVSKY GE, 1981, ECOLOGY, V62, P1020, DOI 10.2307/1937001; Bradley BJ, 2007, AM J PRIMATOL, V69, P699, DOI 10.1002/ajp.20384; Brownstein MJ, 1996, MODULATION NONTEMPLA, P1004; Bugalho MN, 2001, J ZOOL, V255, P285, DOI 10.1017/S0952836901001376; Coley PD, 1998, CLIMATIC CHANGE, V39, P455, DOI 10.1023/A:1005307620024; Cristobal-Azkarate J, 2007, AM J PRIMATOL, V69, P1013, DOI 10.1002/ajp.20420; Cuzin F, 1996, MAMMALIA, V60, P101, DOI 10.1515/mamm.1996.60.1.101; Cuzin F, 2007, ETUDE ELABORATION LI; Cuzin F, 2003, THESIS EPHE MONTPELL; Dove H, 1996, J NUTR, V126, P13, DOI 10.1093/jn/126.1.13; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Duncan AJ, 1999, J AGR SCI, V132, P233, DOI 10.1017/S0021859698006303; FAJER ED, 1989, SCIENCE, V243, P1198, DOI 10.1126/science.243.4895.1198; Fennane M, 2007, TRAV I SCI RABAT, V2, P1; Fennane M, 1999, TRAV I SCI RABAT, V1, P1; Ficetola GF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-434; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Foley WJ, 1998, OECOLOGIA, V116, P293, DOI 10.1007/s004420050591; Forshaw D, 2000, ANIMAL HLTH ANIMAL D; FREELAND WJ, 1974, AM NAT, V108, P269, DOI 10.1086/282907; GORDON IJ, 1995, SMALL RUMINANT RES, V16, P203, DOI 10.1016/0921-4488(95)00635-X; Halsey LA, 1998, FLORIDA BEEF CATTLE, P99; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Henley S. R., 2006, African Journal of Range & Forage Science, V23, P185, DOI 10.2989/10220110609485903; HOLECHEK JL, 1982, J RANGE MANAGE, V35, P309, DOI 10.2307/3898308; HOSS M, 1992, NATURE, V359, P199, DOI 10.1038/359199a0; Hulbert IAR, 2001, OECOLOGIA, V129, P197, DOI 10.1007/s004420100725; Hutchings MR, 2000, J AGR SCI, V135, P65, DOI 10.1017/S002185969900790X; IUCN S, 2010, IUCN 2010 IUCN RED L; JOHNSON MK, 1981, J RANGE MANAGE, V34, P232, DOI 10.2307/3898049; Kaneko H, 2006, MAR MAMMAL SCI, V22, P261, DOI 10.1111/j.1748-7692.2006.00030.x; Kinney KK, 1997, ECOLOGY, V78, P215; Knight AP, 2002, PLANT POISONING ANIM, P41; Korfhage RC, 1974, THESIS WASHINGTON ST; Kowalczyk R, 2011, FOREST ECOL MANAG, V261, P821, DOI 10.1016/j.foreco.2010.11.026; Lagarde FR, 2003, ECOGRAPHY, V26, P236, DOI 10.1034/j.1600-0587.2003.03365.x; LINCOLN DE, 1986, OECOLOGIA, V69, P556, DOI 10.1007/BF00410362; LINCOLN DE, 1984, ENVIRON ENTOMOL, V13, P1527, DOI 10.1093/ee/13.6.1527; LINCOLN DE, 1993, TRENDS ECOL EVOL, V8, P64, DOI 10.1016/0169-5347(93)90161-H; LINDROTH RL, 1995, FUNCT ECOL, V9, P306, DOI 10.2307/2390578; LOGGERS C, 1991, MAMMALIA, V55, P255, DOI 10.1515/mamm.1991.55.2.255; LOGGERS CO, 1992, AFR J ECOL, V30, P301, DOI 10.1111/j.1365-2028.1992.tb00506.x; Magnuson VL, 1996, BIOTECHNIQUES, V21, P700, DOI 10.2144/96214rr03; Marraha Mustapha, 1996, Annales de la Recherche Forestiere au Maroc, V29, P40; Mason Mervyn C., 1999, Chelonian Conservation and Biology, V3, P435; MCINNIS ML, 1983, J RANGE MANAGE, V36, P302, DOI 10.2307/3898474; MORENO-BLACK G, 1978, Primates, V19, P215, DOI 10.1007/BF02373239; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; MOSKOVITS DK, 1990, HERPETOLOGICA, V46, P207; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Negre R, 1962, PETITE FLORE REGIONS, V2, P566; Negre R, 1961, PETITE FLORE REGIONS, V1, P413; NORBY RJ, 1986, PLANT PHYSIOL, V82, P83, DOI 10.1104/pp.82.1.83; OBERBAUER SF, 1986, CAN J BOT, V64, P2993, DOI 10.1139/b86-396; OSBRINK WLA, 1987, ENVIRON ENTOMOL, V16, P639, DOI 10.1093/ee/16.3.639; OWENSMITH N, 1982, AM NAT, V119, P151, DOI 10.1086/283902; Pegard A, 2009, J AGR FOOD CHEM, V57, P5700, DOI 10.1021/jf803680c; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; Quezel P, 1962, NOUVELLE FLORE ALGER, V1, P1; Quezel P, 1963, NOUVELLE FLORE ALGER, V2, P571; Rao SJ, 2003, CAN J ZOOL, V81, P1047, DOI 10.1139/Z03-093; Raye G, 2011, ECOL RES, V26, P265, DOI 10.1007/s11284-010-0780-5; REEKIE EG, 1989, OECOLOGIA, V79, P212, DOI 10.1007/BF00388481; ROTH SK, 1994, BIOCHEM SYST ECOL, V22, P341, DOI 10.1016/0305-1978(94)90025-6; ROTH SK, 1994, OECOLOGIA, V98, P133, DOI 10.1007/BF00341464; SALT CA, 1992, J APPL ECOL, V29, P378, DOI 10.2307/2404507; SLATER J, 1971, J AUST I AGR SCI, V37, P238; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Valdes B, 2002, CHEKLIST VASCULAR PL; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; van Wyk JH, 2000, AFR ZOOL, V35, P9; VAVRA M, 1978, J RANGE MANAGE, V31, P11, DOI 10.2307/3897623; Ward D, 1997, J CHEM ECOL, V23, P333, DOI 10.1023/B:JOEC.0000006363.34360.9d; WESTOBY M, 1978, AM NAT, V112, P627, DOI 10.1086/283303; WILLIAMS RS, 1994, OECOLOGIA, V98, P64, DOI 10.1007/BF00326091; WILLIAMS WE, 1986, OECOLOGIA, V69, P454, DOI 10.1007/BF00377068; WONG SC, 1979, OECOLOGIA, V44, P68, DOI 10.1007/BF00346400	83	46	47	5	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35643	10.1371/journal.pone.0035643	http://dx.doi.org/10.1371/journal.pone.0035643			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558187	Green Published, gold			2022-12-27	WOS:000305336000042
J	Reich, NG; Myers, JA; Obeng, D; Milstone, AM; Perl, TM				Reich, Nicholas G.; Myers, Jessica A.; Obeng, Daniel; Milstone, Aaron M.; Perl, Trish M.			Empirical Power and Sample Size Calculations for Cluster-Randomized and Cluster-Randomized Crossover Studies	PLOS ONE			English	Article							DESIGN	In recent years, the number of studies using a cluster-randomized design has grown dramatically. In addition, the cluster-randomized crossover design has been touted as a methodological advance that can increase efficiency of cluster-randomized studies in certain situations. While the cluster-randomized crossover trial has become a popular tool, standards of design, analysis, reporting and implementation have not been established for this emergent design. We address one particular aspect of cluster-randomized and cluster-randomized crossover trial design: estimating statistical power. We present a general framework for estimating power via simulation in cluster-randomized studies with or without one or more crossover periods. We have implemented this framework in the clusterPower software package for R, freely available online from the Comprehensive R Archive Network. Our simulation framework is easy to implement and users may customize the methods used for data analysis. We give four examples of using the software in practice. The clusterPower package could play an important role in the design of future cluster-randomized and cluster-randomized crossover studies. This work is the first to establish a universal method for calculating power for both cluster-randomized and cluster-randomized clinical trials. More research is needed to develop standardized and recommended methodology for cluster-randomized crossover studies.	[Reich, Nicholas G.] Univ Massachusetts, Div Biostat & Epidemiol, Amherst, MA 01003 USA; [Myers, Jessica A.] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Obeng, Daniel] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Milstone, Aaron M.] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Pediat Infect Dis, Baltimore, MD 21205 USA; [Perl, Trish M.] Johns Hopkins Univ, Sch Med, Div Infect Dis, Dept Med, Baltimore, MD 21205 USA	University of Massachusetts System; University of Massachusetts Amherst; Harvard University; Brigham & Women's Hospital; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University	Reich, NG (corresponding author), Univ Massachusetts, Div Biostat & Epidemiol, Amherst, MA 01003 USA.	nick@schoolph.umass.edu	Reich, Nicholas/L-1168-2019	Reich, Nicholas/0000-0003-3503-9899; Milstone, Aaron/0000-0001-8498-8682	Sage Products, Inc.; ResPECT study [NCT01249625, 09FED905876]	Sage Products, Inc.; ResPECT study	DO, AAM, TMP were funded in part by grants from Sage Products, Inc. NGR and TMP were funded by the ResPECT study (clinicaltrials.gov ID: NCT01249625) through an interagency agreement between the Centers for Disease Control and the United States Department of Veterans Affairs (CDC IAA# 09FED905876). The findings and conclusions in this manuscript are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERAN R, 1986, ANN STAT, V14, P151, DOI 10.1214/aos/1176349847; Gibbons J.D., 2003, NONPARAMETRIC STAT I; Giraudeau B, 2008, STAT MED, V27, P5578, DOI 10.1002/sim.3383; Harrison DA, 2004, STATA J, V4, P142, DOI 10.1177/1536867X0400400205; Hayes RJ, 2009, INTERD STAT, P3; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Imai K, 2009, STAT SCI, V24, P29, DOI 10.1214/08-STS274; Lee A, 2011, INFECT CONT HOSP EP, V32, P395, DOI 10.1086/659154; Lenth RV, 2001, AM STAT, V55, P187, DOI 10.1198/000313001317098149; Miller MR, 2010, PEDIATRICS, V125, P206, DOI 10.1542/peds.2009-1382; Parienti JJ, 2007, CONTEMP CLIN TRIALS, V28, P316, DOI 10.1016/j.cct.2006.10.004; Platt R, 2010, MED CARE, V48, pS52, DOI 10.1097/MLR.0b013e3181dbebcf; Reich N, OBENG D CLUSTERPOWER; Rietbergen C, 2011, J EDUC BEHAV STAT, V36, P472, DOI 10.3102/1076998610379136; Turner RM, 2007, STAT MED, V26, P274, DOI 10.1002/sim.2537; Ukoumunne O C, 1999, Health Technol Assess, V3, piii	17	40	40	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35564	10.1371/journal.pone.0035564	http://dx.doi.org/10.1371/journal.pone.0035564			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558168	Green Published, gold			2022-12-27	WOS:000305336000037
J	Chavez, ASO; Felsheim, RF; Kurtti, TJ; Ku, PS; Brayton, KA; Munderloh, UG				Chavez, Adela S. Oliva; Felsheim, Roderick F.; Kurtti, Timothy J.; Ku, Pei-Shin; Brayton, Kelly A.; Munderloh, Ulrike G.			Expression Patterns of Anaplasma marginale msp2 Variants Change in Response to Growth in Cattle, and Tick Cells versus Mammalian Cells	PLOS ONE			English	Article							SURFACE PROTEIN-2 VARIANTS; ANAPLASMA-MARGINALE RICKETTSIALES; GRANULOCYTIC EHRLICHIOSIS AGENT; ANTIGENIC VARIATION; DERMACENTOR-ANDERSONI; GENE CONVERSION; TRANSMISSION; PATHOGEN; DIVERSITY; INFECTION	Antigenic variation of major surface proteins is considered an immune-evasive maneuver used by pathogens as divergent as bacteria and protozoa. Likewise, major surface protein 2 (Msp2) of the tick-borne pathogen, Anaplasma marginale, is thought to be involved in antigenic variation to evade the mammalian host immune response. However, this dynamic process also works in the tick vector in the absence of immune selection pressure. We examined Msp2 variants expressed during infection of four tick and two mammalian cell-lines to determine if the presence of certain variants correlated with specific host cell types. Anaplasma marginale colonies differed in their development and appearance in each of the cell lines (P<0.001). Using Western blots probed with two Msp2-monospecific and one Msp2-monoclonal antibodies, we detected expression of variants with differences in molecular weight. Immunofluorescence-assay revealed that specific antibodies bound from 25 to 60% of colonies, depending on the host cell-line (P<0.001). Molecular analysis of cloned variant-encoding genes demonstrated expression of different predominant variants in tick (V1) and mammalian (V2) cell-lines. Analysis of the putative secondary structure of the variants revealed a change in structure when A. marginale was transferred from one cell-type to another, suggesting that the expression of particular Msp2 variants depended on the cell-type (tick or mammalian) in which A. marginale developed. Similarly, analysis of the putative secondary structure of over 200 Msp2 variants from ticks, blood samples, and other mammalian cells available in GenBank showed the predominance of a specific structure during infection of a host type (tick versus blood sample), demonstrating that selection of a possible structure also occurred in vivo. The selection of a specific structure in surface proteins may indicate that Msp2 fulfils an important role in infection and adaptation to diverse host systems. Supplemental Abstract in Spanish (File S1) is provided.	[Chavez, Adela S. Oliva; Felsheim, Roderick F.; Kurtti, Timothy J.; Munderloh, Ulrike G.] Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA; [Ku, Pei-Shin; Brayton, Kelly A.] Washington State Univ, Dept Vet Microbiol & Pathol, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA	University of Minnesota System; University of Minnesota Twin Cities; Washington State University	Chavez, ASO (corresponding author), Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA.	chave028@umn.edu		Oliva Chavez, Adela/0000-0003-2397-0846	National Institute of Allergy and Infectious Diseases (NIAID) [5R01AI042792-12]; Alexander and Lydia Anderson Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042792] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Alexander and Lydia Anderson Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institute of Allergy and Infectious Diseases (NIAID) grant 5R01AI042792-12 to UGM, and by Alexander and Lydia Anderson Fellowship to AOC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbet AF, 2000, INFECT IMMUN, V68, P6133, DOI 10.1128/IAI.68.11.6133-6138.2000; Barbet AF, 2003, INFECT IMMUN, V71, P1706, DOI 10.1128/IAI.71.4.1706-1718.2003; Barbet AF, 2001, INFECT IMMUN, V69, P3057, DOI 10.1128/IAI.69.5.3057-3066.2001; Barbour AG, 2000, EMERG INFECT DIS, V6, P449, DOI 10.3201/eid0605.000502; Barbour AG, 2006, P NATL ACAD SCI USA, V103, P18290, DOI 10.1073/pnas.0605302103; Brayton KA, 2001, P NATL ACAD SCI USA, V98, P4130, DOI 10.1073/pnas.071056298; Carreno AD, 2007, VET PATHOL, V44, P116, DOI 10.1354/vp.44-1-116; Dark MJ, 2011, VACCINE, V29, P4923, DOI 10.1016/j.vaccine.2011.04.131; Dark MJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-16; de la Fuente J, 2001, INFECT IMMUN, V69, P5151, DOI 10.1128/IAI.69.8.5151-5156.2001; Dumler JS, 2001, INT J SYST EVOL MICR, V51, P2145, DOI 10.1099/00207713-51-6-2145; Hotopp JCD, 2006, PLOS GENET, V2, P208, DOI 10.1371/journal.pgen.0020021; Eid G, 1996, INFECT IMMUN, V64, P836, DOI 10.1128/IAI.64.3.836-841.1996; Esteves E, 2008, INSECT BIOCHEM MOLEC, V38, P568, DOI 10.1016/j.ibmb.2008.01.006; Felek S, 2004, INFECT IMMUN, V72, P659, DOI 10.1128/IAI.72.2.659-666.2004; Felsheim RF, 2010, VET PARASITOL, V167, P167, DOI 10.1016/j.vetpar.2009.09.018; French DM, 1999, INFECT IMMUN, V67, P5834, DOI 10.1128/IAI.67.11.5834-5840.1999; French DM, 1998, INFECT IMMUN, V66, P1200, DOI 10.1128/IAI.66.3.1200-1207.1998; Fu WJJ, 2006, COMPUT BIOL CHEM, V30, P21, DOI 10.1016/j.compbiolchem.2005.10.005; Futse JE, 2009, INFECT IMMUN, V77, P3181, DOI 10.1128/IAI.00348-09; Futse JE, 2005, MOL MICROBIOL, V57, P212, DOI 10.1111/j.1365-2958.2005.04670.x; Fyumagwa RD, 2009, VET PARASITOL, V161, P154, DOI 10.1016/j.vetpar.2008.12.018; Huang HB, 2007, J BACTERIOL, V189, P1998, DOI 10.1128/JB.01548-06; KIESER ST, 1990, INFECT IMMUN, V58, P1117, DOI 10.1128/IAI.58.4.1117-1119.1990; Kocan KM, 2004, PARASITOLOGY, V129, pS285, DOI 10.1017/S0031182003004700; Kocan KM, 2002, EXP APPL ACAROL, V28, P9, DOI 10.1023/A:1025329728269; KOCAN KM, 1992, AM J VET RES, V53, P499; KOCAN KM, 1980, AM J VET RES, V41, P183; Kurtti TJ, 2005, J INVERTEBR PATHOL, V90, P177, DOI 10.1016/j.jip.2005.09.001; Lohr CV, 2002, INFECT IMMUN, V70, P6005, DOI 10.1128/IAI.70.11.6005-6012.2002; Lohr CV, 2002, INFECT IMMUN, V70, P114, DOI 10.1128/IAI.70.1.114-120.2002; Mattila JT, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.5801; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Munderloh UG, 2004, VET MICROBIOL, V101, P53, DOI 10.1016/j.vetmic.2004.02.011; MUNDERLOH UG, 1994, J PARASITOL, V80, P533, DOI 10.2307/3283188; Munderloh UG, 1996, J MED ENTOMOL, V33, P656, DOI 10.1093/jmedent/33.4.656; Munderloh UG, 1999, J CLIN MICROBIOL, V37, P2518, DOI 10.1128/JCM.37.8.2518-2524.1999; Palmer GH, 2007, TRENDS PARASITOL, V23, P408, DOI 10.1016/j.pt.2007.07.008; Palmer GH, 2006, ANN NY ACAD SCI, V1078, P15, DOI 10.1196/annals.1374.002; Palmer GH, 2007, INFECT IMMUN, V75, P1502, DOI 10.1128/IAI.01801-06; Palmer GH, 2009, CELL MICROBIOL, V11, P1697, DOI 10.1111/j.1462-5822.2009.01366.x; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rodriguez JL, 2005, GENE, V361, P127, DOI 10.1016/j.gene.2005.06.038; Rurangirwa FR, 1999, P NATL ACAD SCI USA, V96, P3171, DOI 10.1073/pnas.96.6.3171; Rurangirwa FR, 2000, INFECT IMMUN, V68, P3023, DOI 10.1128/IAI.68.5.3023-3027.2000; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wamsley HL, 2011, VET MICROBIOL, P26; Zhi N, 2002, INFECT IMMUN, V70, P1175, DOI 10.1128/IAI.70.3.1175-1184.2002	48	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e36012	10.1371/journal.pone.0036012	http://dx.doi.org/10.1371/journal.pone.0036012			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558307	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345200110
J	Kotozaki, Y; Kawashima, R				Kotozaki, Yuka; Kawashima, Ryuta			Effects of the Higashi-Nihon Earthquake: Posttraumatic Stress, Psychological Changes, and Cortisol Levels of Survivors	PLOS ONE			English	Article							HANSHIN-AWAJI EARTHQUAKE; SALIVARY CORTISOL; LIFE-STYLE; EXCRETION; SYMPTOMS; DISORDER; DISASTER; HORMONE; GENDER; MINI	On March 11, 2011, the Pacific side of Japan's northeast was devastated by an earthquake and tsunami. For years, many researchers have been working on ways of examining the psychological effects of earthquakes on survivors in disaster areas who have experienced aftershocks, catastrophic fires, and other damage caused by the earthquake. The goal of this study is to examine scores on psychological measures and salivary cortisol level in these individuals both before and three months after the earthquake. The participants had been measured for these variables before the earthquake. After the earthquake, we carried out PTSD screening using CAPS for participants for another experiment, and then again conducted the aforementioned tests. We collected saliva samples from all survivors. Our results show that social relationship scores on the WHO-QOL26, negative mood scores of the WHO-SUBI, total GHQ score, POMS confusion scores, and CMI emotional status score after the earthquake showed scores indicating significantly decreased compared to before the earthquake. On the other hand, salivary cortisol levels after the earthquake was significantly increased compared to before the earthquake. Moreover, the result of a multiple regression analysis found that negative mood score on the WHO-SUBI and social relationship score on the WHO-QOL26 were significantly related to salivary cortisol levels. Our results thus demonstrate that several psychological stress induced by the earthquake was associated with an increase in salivary cortisol levels. These results show similar findings to previous study. We anticipate that this study will provide a better understanding of posttraumatic responses in the early stages of adaptation to the trauma and expand effective prevention strategies and countermeasures for PTSD.	[Kotozaki, Yuka; Kawashima, Ryuta] Tohoku Univ, Smart Ageing Int Res Ctr, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan	Tohoku University	Kotozaki, Y (corresponding author), Tohoku Univ, Smart Ageing Int Res Ctr, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan.	kotoyuka@idac.tohoku.ac.jp	Kotozaki, Yuka/ABA-2267-2020; Kotozaki, Yuka/ABA-2922-2020	Kotozaki, Yuka/0000-0002-4659-1200	Leave a Nest Company, Ltd., Japan; Leave a Nest Co., Ltd.	Leave a Nest Company, Ltd., Japan; Leave a Nest Co., Ltd.	This study was funded by Leave a Nest Company, Ltd., Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by Leave a Nest Co., Ltd. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Altindag A, 2005, COMPR PSYCHIAT, V46, P328, DOI 10.1016/j.comppsych.2005.01.005; Asukai N, 2003, JPN J TRAUMA STRESS, V1, P47; BAUER M, 1994, PSYCHIAT RES, V51, P75, DOI 10.1016/0165-1781(94)90048-5; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; CANINO G, 1990, INT J MENT HEALTH, V19, P51, DOI 10.1080/00207411.1990.11449153; Cannon W.B., 1932, WISDOM BODY; Carr VJ, 1997, PSYCHOL MED, V27, P167, DOI 10.1017/S0033291796004278; Cook CJ, 2002, PHYSIOL BEHAV, V75, P169, DOI 10.1016/S0031-9384(01)00658-8; COSTA PT, 1977, J CLIN PSYCHOL, V33, P941; Dekarais D, 1993, JAMA-J AM MED ASSOC, V270, P5; Filipovsky J, 1996, J HYPERTENS, V14, P229, DOI 10.1097/00004872-199602000-00012; Flynn BW, 1997, RENAL FAILURE, V19, P611, DOI 10.3109/08860229709109027; Fujimori T, 1996, PSYCHIAT DIAGNOSIS, V7, P65; Fujimori T, 1998, JPN J PERSONALITY, V7, P11; Fukuda S, 1999, PREV MED, V29, P147, DOI 10.1006/pmed.1999.0528; Fukuda S, 2000, ARCH ENVIRON HEALTH, V55, P121, DOI 10.1080/00039890009603398; Gleser GC, 1981, PROLONGED PSYCHOSOCI; Goldberg D.P, 1972, DETECTION PSYCHIAT I; Izawa S, 2007, JPN J COMPL ALTERNAT, V4, P113; Kanehira T., 2001, JAPANESE STYLE CORNE; KIRSCHBAUM C, 1994, PSYCHONEUROENDOCRINO, V19, P313, DOI 10.1016/0306-4530(94)90013-2; KIRSCHBAUM C, 1989, NEUROPSYCHOBIOLOGY, V22, P150, DOI 10.1159/000118611; Luo HR, 2012, BIOL PSYCHIAT, V72, P65, DOI 10.1016/j.biopsych.2011.12.020; LUTGENDORF SK, 1995, PSYCHOSOM MED, V57, P310, DOI 10.1097/00006842-199507000-00002; MADAKASIRA S, 1987, J NERV MENT DIS, V175, P286, DOI 10.1097/00005053-198705000-00008; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; McNair DM., 1992, EDITS MANUAL PROFILE; Nagapal R, 1985, SEARO REGIONAL HLTH; Nakagawa Y, 1996, JAPANESE VERSION GHQ; OCONNOR PJ, 1987, MED SCI SPORT EXER, V19, P224; Ohl F, 1999, LAB ANIM, V33, P269, DOI 10.1258/002367799780578237; Omori T, 2010, YOKOHAMA J SOCIAL SC, V15, P117; Ono Y., 1995, JPN J STRESS SCI, V10, P273; Otsubo T, 2005, PSYCHIAT CLIN NEUROS, V59, P517, DOI 10.1111/j.1440-1819.2005.01408.x; PARKER G, 1977, BRIT J PSYCHIAT, V130, P548, DOI 10.1192/bjp.130.6.548; PITMAN RK, 1990, BIOL PSYCHIAT, V27, P245, DOI 10.1016/0006-3223(90)90654-K; Rapha?l B., 1986, DISASTER STRIKES IND; RIADFAHMY D, 1983, J STEROID BIOCHEM, V19, P265, DOI 10.1016/S0022-4731(83)80035-1; SCHAEFFER MA, 1984, PSYCHOSOM MED, V46, P227, DOI 10.1097/00006842-198405000-00005; Seeman TE, 2001, PSYCHONEUROENDOCRINO, V26, P225, DOI 10.1016/S0306-4530(00)00043-3; Sell H, 1992, SEARO REGIONAL HLTH; Selye H, 1936, NATURE, V138, P32, DOI 10.1038/138032a0; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Song YQ, 2008, PSYCHONEUROENDOCRINO, V33, P1155, DOI 10.1016/j.psyneuen.2008.05.005; Tanaka M, 1997, JPN J EXP SOC PSYCHO, V37, P76; Tasaki M, 1997, WHO QOL26 HLTH DIVIS; Toda Masahiro, 2004, Environ Health Prev Med, V9, P27, DOI 10.1265/ehpm.9.27; Tonan K., 1995, JAP J HLTH PSYCHOL, V8, P12, DOI [DOI 10.11560/JAHP.8.2_12, DOI 10.11560/JAHP.8.2_]; Tsai KY, 2007, J PSYCHIATR RES, V41, P90, DOI 10.1016/j.jpsychires.2005.10.004; TYHURST J S, 1957, Can Med Assoc J, V76, P385; TYHURST JS, 1951, AM J PSYCHIAT, V107, P764, DOI 10.1176/ajp.107.10.764; VanCauter E, 1996, J CLIN ENDOCR METAB, V81, P2468, DOI 10.1210/jc.81.7.2468; Vigil JM, 2009, BEHAV BRAIN SCI, V32, P375, DOI 10.1017/S0140525X09991075; YEHUDA R, 1993, PSYCHOSOM MED, V55, P287, DOI 10.1097/00006842-199305000-00006; Yehuda R, 2002, PSYCHIAT CLIN N AM, V25, P341, DOI 10.1016/S0193-953X(02)00002-3; YEHUDA R, 1991, BIOL PSYCHIAT, V30, P1031, DOI 10.1016/0006-3223(91)90123-4; YEHUDA R, 1993, BIOL PSYCHIAT, V34, P18, DOI 10.1016/0006-3223(93)90252-9; Yokoyama K, 1991, JAPANESE EDITION PRO	59	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e34612	10.1371/journal.pone.0034612	http://dx.doi.org/10.1371/journal.pone.0034612			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558092	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345200010
J	Trost, B; Pajon, R; Jayaprakash, T; Kusalik, A				Trost, Brett; Pajon, Rolando; Jayaprakash, Teenus; Kusalik, Anthony			Comparing the Similarity of Different Groups of Bacteria to the Human Proteome	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; DEINOCOCCUS-RADIODURANS; THERMUS-THERMOPHILUS; RADIATION-RESISTANCE; MOLECULAR MIMICRY; PEPTIDES; PROTEINS; DATABASE; EPITOPES; ARCHAEA	Numerous aspects of the relationship between bacteria and human have been investigated. One aspect that has recently received attention is sequence overlap at the proteomic level. However, there has not yet been a study that comprehensively characterizes the level of sequence overlap between bacteria and human, especially as it relates to bacterial characteristics like pathogenicity, G-C content, and proteome size. In this study, we began by performing a general characterization of the range of bacteria-human similarity at the proteomic level, and identified characteristics of the most- and least-similar bacterial species. We then examined the relationship between proteomic similarity and numerous other variables. While pathogens and nonpathogens had comparable similarity to the human proteome, pathogens causing chronic infections were found to be more similar to the human proteome than those causing acute infections. Although no general correspondence between a bacterium's proteome size and its similarity to the human proteome was noted, no bacteria with small proteomes had high similarity to the human proteome. Finally, we discovered an interesting relationship between similarity and a bacterium's G-C content. While the relationship between bacteria and human has been studied from many angles, their proteomic similarity still needs to be examined in more detail. This paper sheds further light on this relationship, particularly with respect to immunity and pathogenicity.	[Trost, Brett; Kusalik, Anthony] Univ Saskatchewan, Dept Comp Sci, Saskatoon, SK S7N 0W0, Canada; [Pajon, Rolando] Childrens Hosp Oakland, Res Inst, Ctr Immunobiol & Vaccine Dev, Oakland, CA 94609 USA; [Jayaprakash, Teenus] Univ Saskatchewan, Dept Vet Microbiol, Saskatoon, SK S7N 0W0, Canada	University of Saskatchewan; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of Saskatchewan	Trost, B (corresponding author), Univ Saskatchewan, Dept Comp Sci, Saskatoon, SK S7N 0W0, Canada.	brett.trost@usask.ca	Trost, Brett/K-4127-2016	Trost, Brett/0000-0003-4863-7273	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amela I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000512; Anderson MT, 2011, MBIO, V2, DOI 10.1128/mBio.00005-11; Bagwell CE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003878; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Clum A, 2009, STAND GENOMIC SCI, V1, P38, DOI 10.4056/sigs.1463; Degnan PH, 2005, GENOME RES, V15, P1023, DOI 10.1101/gr.3771305; Edgell DR, 1997, CELL, V89, P995, DOI 10.1016/S0092-8674(00)80285-8; Empadinhas N, 2003, APPL ENVIRON MICROB, V69, P3272, DOI 10.1128/AEM.69.6.3272-3279.2003; Ferreira AC, 1999, EXTREMOPHILES, V3, P235, DOI 10.1007/s007920050121; Gardy JL, 2003, NUCLEIC ACIDS RES, V31, P3613, DOI 10.1093/nar/gkg602; Gil R, 2003, P NATL ACAD SCI USA, V100, P9388, DOI 10.1073/pnas.1533499100; Henne A, 2004, NAT BIOTECHNOL, V22, P547, DOI 10.1038/nbt956; Ivanova N, 2010, STAND GENOMIC SCI, V2, P158, DOI 10.4056/sigs.711311; Ivanova N, 2009, STAND GENOMIC SCI, V1, P110, DOI 10.4056/sigs.16197; Kanduc D, 2009, CURR PHARM DESIGN, V15, P3283, DOI 10.2174/138161209789105135; Kersey P, 2005, NUCLEIC ACIDS RES, V33, pD297, DOI 10.1093/nar/gri039; Land M, 2009, STAND GENOMIC SCI, V1, P46, DOI 10.4056/sigs.21137; Lewinsohn DA, 2007, PLOS PATHOG, V3, P1240, DOI 10.1371/journal.ppat.0030127; Lobry JR, 1997, GENE, V205, P309, DOI 10.1016/S0378-1119(97)00403-4; Louzoun Y, 2006, MOL IMMUNOL, V43, P559, DOI 10.1016/j.molimm.2005.04.017; Lucchese G, 2007, AMINO ACIDS, V33, P703, DOI 10.1007/s00726-006-0458-z; Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106; Moran NA, 2009, SCIENCE, V323, P379, DOI 10.1126/science.1167140; Natale C, 2000, IMMUNOL CELL BIOL, V78, P580, DOI 10.1046/j.1440-1711.2000.00949.x; Novitsky V, 2002, J VIROL, V76, P10155, DOI 10.1128/JVI.76.20.10155-10168.2002; Omelchenko MV, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-57; Peters B, 2005, PLOS BIOL, V3, P379, DOI 10.1371/journal.pbio.0030091; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; R Development Core Team, 2006, R LANG ENV STAT COMP; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Rey S, 2005, NUCLEIC ACIDS RES, V33, pD164, DOI 10.1093/nar/gki027; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rolland M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000823; Saha S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-79; Thakar MR, 2005, J INFECT DIS, V192, P749, DOI 10.1086/432547; Thomas SH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002103; Toseland Christopher P, 2005, Immunome Res, V1, P4, DOI 10.1186/1745-7580-1-4; Trost B, 2009, J R SOC INTERFACE, V6, P123, DOI 10.1098/rsif.2008.0320; Vider-Shalit T, 2009, BIOINFORMATICS, V25, pI39, DOI 10.1093/bioinformatics/btp221; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Willers J, 1999, PEPTIDES, V20, P1021, DOI 10.1016/S0196-9781(99)00095-9; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156	45	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e34007	10.1371/journal.pone.0034007	http://dx.doi.org/10.1371/journal.pone.0034007			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558081	gold, Green Submitted, Green Published			2022-12-27	WOS:000305345200006
J	van de Waal, E; Krutzen, M; Hula, J; Goudet, J; Bshary, R				van de Waal, Erica; Kruetzen, Michael; Hula, Josephine; Goudet, Jerome; Bshary, Redouan			Similarity in Food Cleaning Techniques within Matrilines in Wild Vervet Monkeys	PLOS ONE			English	Article							CULTURAL TRANSMISSION; VOCAL TRADITIONS; CHLOROCEBUS-AETHIOPS; SOCIAL TRANSMISSION; JAPANESE MACAQUES; LEARNING-STRATEGY; CAPUCHIN MONKEYS; FIELD EXPERIMENT; MACACA-FUSCATA; ORCINUS-ORCA	Social learning and the formation of traditions rely on the ability and willingness to copy one another. A central question is under which conditions individuals adapt behaviour to social influences. Here, we demonstrate that similarities in food processing techniques emerge on the level of matrilines (mother - offspring) but not on the group level in an experiment on six groups of wild vervet monkeys that involved grapes covered with sand. Monkeys regularly ate unclean grapes but also used four cleaning techniques more similarly within matrilines: rubbing in hands, rubbing on substrate, open with mouth, and open with hands. Individual cleaning techniques evolved over time as they converged within matrilines, stabilised at the end and remained stable in a follow-up session more than one year later. The similarity within matrilines persisted when we analyzed only foraging events of individuals in the absence of other matriline members and matriline members used more similar methods than adult full sisters. Thus, momentary conversion or purely genetic causation are unlikely explanations, favouring social learning as mechanism for within matriline similarities. The restriction of traditions to matriline membership rather than to the group level may restrict the development of culture in monkeys relative to apes or humans.	[van de Waal, Erica; Bshary, Redouan] Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland; [van de Waal, Erica; Hula, Josephine; Bshary, Redouan] Univ S Africa, Appl Behav Ecol & Ecosyst Res Unit, Florida, South Africa; [van de Waal, Erica] Univ St Andrews, Sch Psychol, St Andrews, Fife, Scotland; [Kruetzen, Michael; Hula, Josephine] Univ Zurich, Evolutionary Genet Grp, Anthropol Inst & Museum, Zurich, Switzerland; [Goudet, Jerome] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland	University of Neuchatel; University of South Africa; University of St Andrews; University of Zurich; University of Lausanne	van de Waal, E (corresponding author), Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland.	erica.vandewaal@unine.ch	Krutzen, Michael C/D-9550-2011; Goudet, Jerome/A-9730-2012	Goudet, Jerome/0000-0002-5318-7601; Krutzen, Michael/0000-0003-1055-5299; van de Waal, Erica/0000-0001-7778-418X; Bshary, Redouan/0000-0001-7198-8472	Swiss Science Foundation; Fonds Marguerite Wutrich et A. Mathey-Dupraz from the University of Neuchatel	Swiss Science Foundation(Swiss National Science Foundation (SNSF)); Fonds Marguerite Wutrich et A. Mathey-Dupraz from the University of Neuchatel	The project was funded by the Swiss Science Foundation (grant to RB) and the Fonds Marguerite Wutrich et A. Mathey-Dupraz from the University of Neuchatel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D, IME4 LINEAR MIXED EF; Bonnie KE, 2007, P ROY SOC B-BIOL SCI, V274, P367, DOI 10.1098/rspb.2006.3733; Boyd R., 1985, CULTURE EVOLUTIONARY; Claidiere N, 2012, PSYCHOL B IN PRESS; Csillery K, 2006, GENETICS, V173, P2091, DOI 10.1534/genetics.106.057331; de Waal F., 2001, APE SUSHI MASTER CUL; Dindo M, 2008, P ROY SOC B-BIOL SCI, V275, P187, DOI 10.1098/rspb.2007.1318; Filatova OA, 2010, BIOL BULL+, V37, P965, DOI 10.1134/S1062359010090104; FORD JKB, 1991, CAN J ZOOL, V69, P1454, DOI 10.1139/z91-206; Fruteau C, 2009, P NATL ACAD SCI USA, V106, P12007, DOI 10.1073/pnas.0812280106; Gajdon GK, 2004, LEARN BEHAV, V32, P62; Giraldeau LA, 2002, PHILOS T R SOC B, V357, P1559, DOI 10.1098/rstb.2002.1065; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Henrich J, 2001, EVOL HUM BEHAV, V22, P165, DOI 10.1016/S1090-5138(00)00071-4; HIKAMI K, 1990, J COMP PSYCHOL, V104, P233, DOI 10.1037/0735-7036.104.3.233; Hoppitt W, 2008, ADV STUD BEHAV, V38, P105, DOI 10.1016/S0065-3454(08)00003-X; Horner V, 2006, P NATL ACAD SCI USA, V103, P13878, DOI 10.1073/pnas.0606015103; Jaeggi AV, 2010, AM J PRIMATOL, V72, P62, DOI 10.1002/ajp.20752; Kendal JR, 2009, BEHAV ECOL, V20, P238, DOI 10.1093/beheco/arp016; Kwai M., 1965, PRIMATES, V6, P1, DOI DOI 10.1007/BF01794457; LALAND KN, 1990, ANIM LEARN BEHAV, V18, P246, DOI 10.3758/BF03205282; Laland KN, 2004, LEARN BEHAV, V32, P4; Langen TA, 1996, ETHOLOGY, V102, P157; Leca JB, 2010, ANIM BEHAV, V79, P117, DOI 10.1016/j.anbehav.2009.09.035; LEFEBVRE L, 1986, ETHOLOGY, V71, P295; Lehmann L, 2008, THEOR POPUL BIOL, V73, P506, DOI 10.1016/j.tpb.2008.02.004; Mesoudi A, 2008, EVOL HUM BEHAV, V29, P350, DOI 10.1016/j.evolhumbehav.2008.04.005; Morin PA, 2001, MOL ECOL, V10, P1835, DOI 10.1046/j.0962-1083.2001.01308.x; Muller CA, 2010, CURR BIOL, V20, P1171, DOI 10.1016/j.cub.2010.04.037; Newman TK, 2002, AM J PRIMATOL, V56, P237, DOI 10.1002/ajp.1078; Perry S, 2003, CURR ANTHROPOL, V44, P241, DOI 10.1086/345825; Perry S, 2009, ANIM COGN, V12, P705, DOI 10.1007/s10071-009-0230-3; Pesendorfer MB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004472; Price JJ, 1998, P ROY SOC B-BIOL SCI, V265, P497, DOI 10.1098/rspb.1998.0322; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Richerson PJ., 2005, NOT GENES ALONE CULT; Santorelli CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016863; Tanaka I, 1998, ANIM BEHAV, V56, P1229, DOI 10.1006/anbe.1998.0891; Thornton A, 2009, P ROY SOC B-BIOL SCI, V276, P1269, DOI 10.1098/rspb.2008.1794; van de Waal E, 2011, ANIM BEHAV, V81, P433, DOI 10.1016/j.anbehav.2010.11.013; van de Waal E, 2010, FOLIA PRIMATOL, V81, P282, DOI 10.1159/000322628; van de Waal E, 2010, P ROY SOC B-BIOL SCI, V277, P2105, DOI 10.1098/rspb.2009.2260; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; Voelkl B, 2000, ANIM BEHAV, V60, P195, DOI 10.1006/anbe.2000.1457; Wang JL, 2002, GENETICS, V160, P1203; Wang Y, 2006, THESIS U SYDNEY AUST; Whiten A, 2005, NATURE, V437, P737, DOI 10.1038/nature04047; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; WHITEN A, 2009, QUESTION ANIMAL CULT, P99; Whiten A, 2007, PHILOS T R SOC B, V362, P603, DOI 10.1098/rstb.2006.1998; Whiten A, 2011, PHILOS T R SOC B, V366, P938, DOI 10.1098/rstb.2010.0372; Yeaman S, 2011, ANIM BEHAV, V82, P101, DOI 10.1016/j.anbehav.2011.04.004	54	29	29	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35694	10.1371/journal.pone.0035694	http://dx.doi.org/10.1371/journal.pone.0035694			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558201	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000305345200068
J	Drannik, AG; Nag, K; Yao, XD; Henrick, BM; Sallenave, JM; Rosenthal, KL				Drannik, Anna G.; Nag, Kakon; Yao, Xiao-Dan; Henrick, Bethany M.; Sallenave, Jean-Michel; Rosenthal, Kenneth L.			Trappin-2/Elafin Modulate Innate Immune Responses of Human Endometrial Epithelial Cells to PolyI:C	PLOS ONE			English	Article							ELASTASE-SPECIFIC INHIBITOR; LEUKOCYTE PROTEASE INHIBITOR; FEMALE REPRODUCTIVE-TRACT; DOUBLE-STRANDED-RNA; NF-KAPPA-B; HERPES-SIMPLEX-VIRUS; ADENOVIRUS-MEDIATED EXPRESSION; TOLL-LIKE RECEPTOR-3; HUMAN BETA-DEFENSINS; INDUCIBLE GENE-I	Background: Upon viral recognition, innate and adaptive antiviral immune responses are initiated by genital epithelial cells (ECs) to eradicate or contain viral infection. Such responses, however, are often accompanied by inflammation that contributes to acquisition and progression of sexually transmitted infections (STIs). Hence, interventions/factors enhancing antiviral protection while reducing inflammation may prove beneficial in controlling the spread of STIs. Serine antiprotease trappin-2 (Tr) and its cleaved form, elafin (E), are alarm antimicrobials secreted by multiple cells, including genital epithelia. Methodology and Principal Findings: We investigated whether and how each Tr and E (Tr/E) contribute to antiviral defenses against a synthetic mimic of viral dsRNA, polyinosine-polycytidylic acid (polyI:C) and vesicular stomatitis virus. We show that delivery of a replication-deficient adenovector expressing Tr gene (Ad/Tr) to human endometrial epithelial cells, HEC-1A, resulted in secretion of functional Tr, whereas both Tr/E were detected in response to polyI: C. Moreover, Tr/E were found to significantly reduce viral replication by either acting directly on virus or through enhancing polyI: C-driven antiviral protection. The latter was associated with reduced levels of pro-inflammatory factors IL-8, IL-6, TNF alpha, lowered expression of RIG-I, MDA5 and attenuated NF-kappa B activation. Interestingly, enhanced polyI: C-driven antiviral protection of HEC-Ad/Tr cells was partially mediated through IRF3 activation, but not associated with higher induction of IFN beta, suggesting multiple antiviral mechanisms of Tr/E and the involvement of alternative factors or pathways. Conclusions and Significance: This is the first evidence of both Tr/E altering viral binding/entry, innate recognition and mounting of antiviral and inflammatory responses in genital ECs that could have significant implications for homeostasis of the female genital tract.	[Drannik, Anna G.; Nag, Kakon; Yao, Xiao-Dan; Henrick, Bethany M.; Rosenthal, Kenneth L.] McMaster Univ, Dept Pathol & Mol Med, McMaster Immunol Res Ctr, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON, Canada; [Sallenave, Jean-Michel] Inst Pasteur, Unite Def Innee & Inflammat, Paris, France; [Sallenave, Jean-Michel] INSERM, Unite U874, Paris, France; [Sallenave, Jean-Michel] Univ Paris 07, Paris, France	McMaster University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Drannik, AG (corresponding author), McMaster Univ, Dept Pathol & Mol Med, McMaster Immunol Res Ctr, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON, Canada.	rosenthl@mcmaster.ca	SALLENAVE, Jean-Michel/J-3746-2017; Henrick, Bethany/P-7388-2016	SALLENAVE, Jean-Michel/0000-0002-8595-6970; Henrick, Bethany/0000-0003-1883-6749	Comprehensive T Cell Vaccine Immune Monitoring Consortium (CTC-VIMC), a key component of the Collaboration for AIDS Vaccine Development (CAVD); Bill & Melinda Gates Foundation; Ontario HIV Treatment Network (OHTN)	Comprehensive T Cell Vaccine Immune Monitoring Consortium (CTC-VIMC), a key component of the Collaboration for AIDS Vaccine Development (CAVD); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Ontario HIV Treatment Network (OHTN)	This work was supported by a grant as part of the Comprehensive T Cell Vaccine Immune Monitoring Consortium (CTC-VIMC), a key component of the Collaboration for AIDS Vaccine Development (CAVD) funded by the Bill & Melinda Gates Foundation. A. G. D. was supported by a Studentship and K. L. R. by a Career Scientist Award from the Ontario HIV Treatment Network (OHTN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam SR, 2012, BIOCHEM PHARMACOL, V83, P695, DOI 10.1016/j.bcp.2011.11.003; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Alvarez R, 2008, J VIROL, V82, P471, DOI 10.1128/JVI.00939-07; Ashkar AA, 2004, J INFECT DIS, V190, P1841, DOI 10.1086/425079; Baranger K, 2008, FEBS J, V275, P2008, DOI 10.1111/j.1742-4658.2008.06355.x; Bauer CMT, 2008, J INTERF CYTOK RES, V28, P167, DOI 10.1089/jir.2007.0054; Bellemare A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-253; BETT AJ, 1994, P NATL ACAD SCI USA, V91, P8802, DOI 10.1073/pnas.91.19.8802; Bingle CD, 2008, TRENDS IMMUNOL, V29, P444, DOI 10.1016/j.it.2008.07.001; Butler MW, 2006, J BIOL CHEM, V281, P34730, DOI 10.1074/jbc.M604844200; Dogusan Z, 2008, DIABETES, V57, P1236, DOI 10.2337/db07-0844; Drannik AG, 2011, BIOCHEM SOC T, V39, P1427, DOI 10.1042/BST0391427; DRENTH J, 1980, J BIOL CHEM, V255, P2652; Erhart W, 2011, J INFECT DIS, V204, P391, DOI 10.1093/infdis/jir079; Fahey JV, 2011, AM J REPROD IMMUNOL, V65, P334, DOI 10.1111/j.1600-0897.2010.00949.x; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Ghosh M, 2010, IMMUNOLOGY, V129, P207, DOI 10.1111/j.1365-2567.2009.03165.x; Guo JJ, 2000, VIROLOGY, V267, P209, DOI 10.1006/viro.1999.0135; Guyot N, 2005, BIOCHEMISTRY-US, V44, P15610, DOI 10.1021/bi051418i; Guyot N, 2005, BIOL CHEM, V386, P391, DOI 10.1515/BC.2005.047; Guyot N, 2010, BIOL CHEM, V391, P705, DOI 10.1515/BC.2010.066; Harty RN, 2009, J INNATE IMMUN, V1, P397, DOI 10.1159/000226245; Hasan M, 2011, J IMMUNOL, V187, P5653, DOI 10.4049/jimmunol.1102144; Hazrati E, 2006, J IMMUNOL, V177, P8658, DOI 10.4049/jimmunol.177.12.8658; Henriksen PA, 2004, J IMMUNOL, V172, P4535, DOI 10.4049/jimmunol.172.7.4535; HOBBS DS, 1982, J BIOL CHEM, V257, P4071; Iqbal SM, 2009, AIDS, V23, P1669, DOI 10.1097/QAD.0b013e32832ea643; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; King AE, 2007, PLACENTA, V28, P161, DOI 10.1016/j.placenta.2006.01.006; King AE, 2003, J CLIN ENDOCR METAB, V88, P4426, DOI 10.1210/jc.2003-030239; Lester RT, 2008, AIDS, V22, P685, DOI 10.1097/QAD.0b013e3282f4de35; Lester RT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005644; Li Y, 2009, P NATL ACAD SCI USA, V106, P7945, DOI 10.1073/pnas.0900818106; LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Ma G, 2004, J EXP MED, V200, P1337, DOI 10.1084/jem.20041115; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; MasCasullo V, 2005, VIRAL IMMUNOL, V18, P595, DOI 10.1089/vim.2005.18.595; McAlhany SJ, 2004, PROSTATE, V61, P182, DOI 10.1002/pros.20085; MCELVANEY NG, 1993, AM REV RESPIR DIS, V148, P1056, DOI 10.1164/ajrccm/148.4_Pt_1.1056; McLaren PJ, 2010, J INFECT DIS, V202, pS339, DOI 10.1086/655968; McMichael JW, 2005, AM J RESP CELL MOL, V32, P443, DOI 10.1165/rcmb.2004-0250OC; Moreau T, 2008, BIOCHIMIE, V90, P284, DOI 10.1016/j.biochi.2007.09.007; Mossman KL, 2001, J VIROL, V75, P750, DOI 10.1128/JVI.75.2.750-758.2001; Motta JP, 2011, GASTROENTEROLOGY, V140, P1272, DOI 10.1053/j.gastro.2010.12.050; Mulligan MS, 2000, AM J PATHOL, V156, P1033, DOI 10.1016/S0002-9440(10)64971-1; NARA K, 1994, J BIOCHEM, V115, P441, DOI 10.1093/oxfordjournals.jbchem.a124357; Nazli A, 2009, ANTIVIR RES, V81, P103, DOI 10.1016/j.antiviral.2008.10.005; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Noyce RS, 2006, J VIROL, V80, P226, DOI 10.1128/JVI.80.1.226-235.2006; Paladino P, 2006, J IMMUNOL, V177, P8008, DOI 10.4049/jimmunol.177.11.8008; Pfundt R, 2000, ARCH DERMATOL RES, V292, P180, DOI 10.1007/s004030050475; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; PILETZ JE, 1981, J BIOL CHEM, V256, P1509; Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]; Rapista A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-45; Rebbapragada A, 2007, AIDS, V21, P589, DOI 10.1097/QAD.0b013e328012b896; Roghanian A, 2006, AM J RESP CELL MOL, V34, P634, DOI 10.1165/rcmb.2005-0405OC; Sakurai H, 2008, INT J PHARMACEUT, V354, P9, DOI 10.1016/j.ijpharm.2007.06.012; Sallenave JM, 2010, AM J RESP CELL MOL, V42, P635, DOI 10.1165/rcmb.2010-0095RT; Sallenave JM, 1998, GENE THER, V5, P352, DOI 10.1038/sj.gt.3300610; Sallenave JM, 1997, CHEST, V111, pS128, DOI 10.1378/chest.111.6_Supplement.128S; SALLENAVE JM, 1994, AM J RESP CELL MOL, V11, P733, DOI 10.1165/ajrcmb.11.6.7946401; SALLENAVE JM, 1992, BIOL CHEM H-S, V373, P27, DOI 10.1515/bchm3.1992.373.1.27; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Schaefer TM, 2005, J IMMUNOL, V174, P992, DOI 10.4049/jimmunol.174.2.992; Schalkwijk J, 1999, BIOCHEM J, V340, P569, DOI 10.1042/0264-6021:3400569; SCHALKWIJK J, 1991, BIOCHIM BIOPHYS ACTA, V1096, P148, DOI 10.1016/0925-4439(91)90053-C; SCHALKWIJK J, 1990, BRIT J DERMATOL, V122, P631, DOI 10.1111/j.1365-2133.1990.tb07285.x; Semple F, 2011, EUR J IMMUNOL, V41, P3291, DOI 10.1002/eji.201141648; Shaw L, 2011, BIOCHEM SOC T, V39, P1450, DOI 10.1042/BST0391450; Simpson AJ, 1999, FEBS LETT, V452, P309, DOI 10.1016/S0014-5793(99)00670-5; Simpson AJ, 2001, HUM GENE THER, V12, P1395, DOI 10.1089/104303401750298553; Simpson AJ, 2001, J IMMUNOL, V167, P1778, DOI 10.4049/jimmunol.167.3.1778; Steinstraesser L, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-2; Taggart CC, 2005, J EXP MED, V202, P1659, DOI 10.1084/jem.20050768; Terenzi F, 2006, J BIOL CHEM, V281, P34064, DOI 10.1074/jbc.M605771200; Tsunemi M, 1996, BIOCHEMISTRY-US, V35, P11570, DOI 10.1021/bi960900l; Vandermeeren M, 2001, ARCH DERMATOL RES, V293, P343, DOI 10.1007/s004030100238; Vergnolle NSJ-M, 2011, RECOMBINANT PROBIOTI; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; WIEDOW O, 1990, J BIOL CHEM, V265, P14791; Wilkinson TS, 2009, AM J PATHOL, V174, P1338, DOI 10.2353/ajpath.2009.080746; Wira CR, 2005, AM J REPROD IMMUNOL, V53, P65, DOI 10.1111/j.1600-0897.2004.00248.x; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; Zani ML, 2011, BIOCHEM SOC T, V39, P1441, DOI 10.1042/BST0391441; Zapata W, 2008, CURR HIV RES, V6, P531, DOI 10.2174/157016208786501463	90	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35866	10.1371/journal.pone.0035866	http://dx.doi.org/10.1371/journal.pone.0035866			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545145	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343200065
J	Hahn, DL; Schure, A; Patel, K; Childs, T; Drizik, E; Webley, W				Hahn, David L.; Schure, Allison; Patel, Katir; Childs, Tawanna; Drizik, Eduard; Webley, Wilmore			Chlamydia pneumoniae-Specific IgE Is Prevalent in Asthma and Is Associated with Disease Severity	PLOS ONE			English	Article							CHLAMYDOPHILA-PNEUMONIAE; MYCOPLASMA-PNEUMONIAE; AIRWAY INFLAMMATION; INFECTION; CELLS; COPD; LUNG; TRACHOMATIS; MEMBRANE; PROTEINS	Background: Several Chlamydia pneumoniae (Cp) biomarkers have been associated with asthma but Cp-specific IgE (Cp IgE) has not been investigated extensively. Our objective was to investigate Cp IgE in community adult asthma patients. Methods: (1) Prevalence of Cp IgE (measured by immunoblotting) and Cp DNA (by polymerase chain reaction) in peripheral blood, and biomarker associations with asthma severity. (2) Case-control studies of Cp IgE association with asthma using healthy blood donor (study 1) and non-asthmatic clinic patient (study 2) controls. Results: Of 66 asthma subjects (mean age 40.9 years, range 5-75, 59% male, 45% ever-smokers) 33 (50%) were Cp IgE positive and 16 (24%) were Cp DNA positive (P = 0.001 for association of Cp IgE and DNA). Cp IgE was detected in 21% of mild intermittent asthma v 79% of severe persistent asthma (test for trend over severity categories, P = 0.002). Cp IgE detection was significantly (P = 0.001) associated with asthma when compared to healthy blood donor controls but not when compared to clinic controls. Conclusions: Half of this sample of community asthma patients had detectable IgE against C. pneumoniae. Cp IgE was strongly and positively associated with asthma severity and with asthma when healthy blood donor controls were used. These results support the inclusion of Cp IgE as a biomarker in future studies of infectious contributions to asthma pathogenesis.	[Hahn, David L.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Family Med, Madison, WI 53706 USA; [Hahn, David L.] Univ Wisconsin, Dean Clin, Madison, WI USA; [Schure, Allison; Patel, Katir; Childs, Tawanna; Drizik, Eduard; Webley, Wilmore] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Massachusetts System; University of Massachusetts Amherst	Hahn, DL (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Family Med, Madison, WI 53706 USA.	wilmore@microbio.umass.edu	Webley, Wilmore/I-7145-2012	Webley, Wilmore/0000-0003-4490-395X	Dean Foundation for Health Research and Education, Madison, Wisconsin	Dean Foundation for Health Research and Education, Madison, Wisconsin	The Dean Foundation for Health Research and Education, Madison, Wisconsin funded the study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEGRA L, 1994, EUR RESPIR J, V7, P2165, DOI 10.1183/09031936.94.07122165; Altenburg J, 2011, RESPIRATION, V81, P67, DOI 10.1159/000320319; [Anonymous], 2007, 3 US DEP HLTH HUM SE; Asquith KL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001339; Beigelman A, 2009, CHEST, V136, P498, DOI 10.1378/chest.08-3056; Birmingham N, 2003, J IMMUNOL METHODS, V275, P89, DOI 10.1016/S0022-1759(03)00008-5; Blasi F, 2000, CHLAMYDIA PNEUMONIAE; Blasi F, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-83; Burian K, 2003, IMMUNOL LETT, V89, P229, DOI 10.1016/S0165-2478(03)00154-8; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; Chen CZ, 2009, J FORMOS MED ASSOC, V108, P45, DOI 10.1016/S0929-6646(09)60031-0; CHOBOT R, 1951, J ALLERGY, V22, P106, DOI 10.1016/0021-8707(51)90049-4; CIOCCA DR, 1983, J HISTOCHEM CYTOCHEM, V31, P691, DOI 10.1177/31.5.6341459; da Costa CP, 2002, EUR J IMMUNOL, V32, P2460, DOI 10.1002/1521-4141(200209)32:9<2460::AID-IMMU2460>3.0.CO;2-M; DeGraves FJ, 2003, BIOTECHNIQUES, V34, P106, DOI 10.2144/03341rr01; EMRE U, 1995, J INFECT DIS, V172, P265, DOI 10.1093/infdis/172.1.265; Gaydos CA, 1992, ABSTR AM SOC MICR D, VD-132, P118; Gern JE, 2000, J ALLERGY CLIN IMMUN, V106, P201, DOI 10.1067/mai.2000.108604; Gibson PG, 2009, THORAX, V64, P728, DOI 10.1136/thx.2008.108027; Global Initiative for Asthma (GINA), 2007, GLOB STRAT ASTHM MAN; Hahn DL, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010011; Hahn DL, 2008, ANN ALLERG ASTHMA IM, V101, P614, DOI 10.1016/S1081-1206(10)60224-4; Hahn DL, 2000, ANN ALLERG ASTHMA IM, V84, P227, DOI 10.1016/S1081-1206(10)62760-3; Hahn DL, 1999, ANN ALLERG ASTHMA IM, V83, P271, DOI 10.1016/S1081-1206(10)62666-X; HAHN DL, 1995, J FAM PRACTICE, V41, P345; Hahn DL, 2002, FRONT BIOSCI-LANDMRK, V7, pE66, DOI 10.2741/hahn; Hahn DL, 2004, INFEC AGENT, P239; Hamilton RG, 2010, J ALLERGY CLIN IMMUN, V125, pS284, DOI 10.1016/j.jaci.2009.09.055; Hansbro PM, 2004, PHARMACOL THERAPEUT, V101, P193, DOI 10.1016/j.pharmthera.2003.10.007; Henderson CE, 1998, J IMMUNOL METHODS, V213, P99, DOI 10.1016/S0022-1759(98)00014-3; Herland K, 2005, RESP MED, V99, P11, DOI 10.1016/j.rmed.2004.03.026; Hollams EM, 2010, EUR RESPIR J, V36, P509, DOI 10.1183/09031936.00184109; Horvat JC, 2007, AM J RESP CRIT CARE, V176, P556, DOI 10.1164/rccm.200607-1005OC; Horvat JC, 2010, J ALLERGY CLIN IMMUN, V125, P617, DOI 10.1016/j.jaci.2009.10.018; Horvat JC, 2010, J IMMUNOL, DOI 10,4049/jimmunol.0902287; Ikezawa Shigeru, 2001, Kurume Medical Journal, V48, P165, DOI 10.2739/kurumemedj.48.165; Jahn HU, 2000, J INFECT DIS, V182, P1678, DOI 10.1086/317608; Johnston SL, 2005, AM J RESP CRIT CARE, V172, P1078, DOI 10.1164/rccm.200412-1743PP; Kadooka Y, 2000, INT ARCH ALLERGY IMM, V122, P264, DOI 10.1159/000024408; Kaiko GE, 2008, J IMMUNOL, V180, P2225, DOI 10.4049/jimmunol.180.4.2225; Martin RJ, 2001, J ALLERGY CLIN IMMUN, V107, P595, DOI 10.1067/mai.2001.113563; Montigiani S, 2002, INFECT IMMUN, V70, P368, DOI 10.1128/IAI.70.1.368-379.2002; Morinaga Y, 2009, PULM PHARMACOL THER, V22, P580, DOI 10.1016/j.pupt.2009.08.004; Peters J, 2011, CHEST, V140, P401, DOI 10.1378/chest.11-0221; Redecke V, 1998, AM J RESP CELL MOL, V19, P721, DOI 10.1165/ajrcmb.19.5.3072; Rizzo A, 2011, CYTOKINE, V56, P450, DOI 10.1016/j.cyto.2011.06.027; SAIKKU P, 1993, EUR HEART J, V14, P62; Schroeder NWJ, 2008, J ALLERGY CLIN IMMUN, V122, P595, DOI 10.1016/j.jaci.2008.06.038; SEGGEV JS, 1992, J ALLERGY CLIN IMMUN, V89, P230; SHEMERAVNI Y, 1995, J INFECT DIS, V171, P1274, DOI 10.1093/infdis/171.5.1274; Simpson JL, 2008, AM J RESP CRIT CARE, V177, P148, DOI 10.1164/rccm.200707-1134OC; Souza-Atta MLB, 1999, BRAZ J MED BIOL RES, V32, P1101, DOI 10.1590/S0100-879X1999000900008; Stone KD, 2010, J ALLERGY CLIN IMMUN, V125, pS73, DOI 10.1016/j.jaci.2009.11.017; Tanzer RJ, 2001, J BACTERIOL, V183, P2686, DOI 10.1128/JB.183.8.2686-2690.2001; von Hertzen L, 2002, SCAND J INFECT DIS, V34, P22, DOI 10.1080/00365540110077155; Webley WC, 2009, EUR RESPIR J, V33, P360, DOI 10.1183/09031936.00019508; WELLIVER RC, 1980, NEW ENGL J MED, V303, P1198, DOI 10.1056/NEJM198011203032103; WELLIVER RC, 1982, J PEDIATR-US, V101, P889, DOI 10.1016/S0022-3476(82)80005-X; Wolf K, 2009, CELL MICROBIOL, V11, P769, DOI 10.1111/j.1462-5822.2009.01290.x; YANO T, 1992, American Review of Respiratory Disease, V145, pA497	61	53	55	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35945	10.1371/journal.pone.0035945	http://dx.doi.org/10.1371/journal.pone.0035945			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545149	Green Published, gold			2022-12-27	WOS:000305343200069
J	Rius, M; Turon, X; Ordonez, V; Pascual, M				Rius, Marc; Turon, Xavier; Ordonez, Victor; Pascual, Marta			Tracking Invasion Histories in the Sea: Facing Complex Scenarios Using Multilocus Data	PLOS ONE			English	Article							MICROCOSMUS-SQUAMIGER ASCIDIACEA; GENETIC DIVERSITY; BIOLOGICAL INVASIONS; INTRODUCED POPULATIONS; SPINY LOBSTERS; MICROSATELLITE; PHYLOGEOGRAPHY; CONSEQUENCES; SOFTWARE; SUCCESS	In recent years, new analytical tools have allowed researchers to extract historical information contained in molecular data, which has fundamentally transformed our understanding of processes ruling biological invasions. However, the use of these new analytical tools has been largely restricted to studies of terrestrial organisms despite the growing recognition that the sea contains ecosystems that are amongst the most heavily affected by biological invasions, and that marine invasion histories are often remarkably complex. Here, we studied the routes of invasion and colonisation histories of an invasive marine invertebrate Microcosmus squamiger (Ascidiacea) using microsatellite loci, mitochondrial DNA sequence data and 11 worldwide populations. Discriminant analysis of principal components, clustering methods and approximate Bayesian computation (ABC) methods showed that the most likely source of the introduced populations was a single admixture event that involved populations from two genetically differentiated ancestral regions - the western and eastern coasts of Australia. The ABC analyses revealed that colonisation of the introduced range of M. squamiger consisted of a series of non-independent introductions along the coastlines of Africa, North America and Europe. Furthermore, we inferred that the sequence of colonisation across continents was in line with historical taxonomic records - first the Mediterranean Sea and South Africa from an unsampled ancestral population, followed by sequential introductions in California and, more recently, the NE Atlantic Ocean. We revealed the most likely invasion history for world populations of M. squamiger, which is broadly characterized by the presence of multiple ancestral sources and non-independent introductions within the introduced range. The results presented here illustrate the complexity of marine invasion routes and identify a cause-effect relationship between human-mediated transport and the success of widespread marine non-indigenous species, which benefit from stepping-stone invasions and admixture processes involving different sources for the spread and expansion of their range.	[Rius, Marc] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Turon, Xavier] CSIC, CEAB, Blanes, Spain; [Ordonez, Victor; Pascual, Marta] Univ Barcelona, Dept Genet, Barcelona, Spain; [Ordonez, Victor; Pascual, Marta] Univ Barcelona, IRBio, Barcelona, Spain	University of California System; University of California Davis; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); University of Barcelona; University of Barcelona	Rius, M (corresponding author), Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA.	mrius@ucdavis.edu	Pascual, Marta/M-7626-2015; Turon, Xavier/J-9211-2012; Rius, Marc/C-5088-2011; Pascual, Marta/ABG-3782-2020	Pascual, Marta/0000-0002-6189-0612; Turon, Xavier/0000-0002-9229-5541; Rius, Marc/0000-0002-2195-6605; Pascual, Marta/0000-0002-6189-0612	Marie Curie International Outgoing fellowship (EU - FP7 - PEOPLE - IOF) from the European Community's Seventh Framework Programme [254634]; Spanish Government [CTM2010 - 22218]; Fundacion Banco Bilbao Vizcaya Argentaria (FBBVA) [BIOCON08-187]; FPU (Formacion del Profesorado Universitario) scholarship from the Spanish Ministerio de Educacion [AP2008 - 04209, 2009]; COCONET, EU - FP7 [287844]	Marie Curie International Outgoing fellowship (EU - FP7 - PEOPLE - IOF) from the European Community's Seventh Framework Programme; Spanish Government(Spanish GovernmentEuropean Commission); Fundacion Banco Bilbao Vizcaya Argentaria (FBBVA); FPU (Formacion del Profesorado Universitario) scholarship from the Spanish Ministerio de Educacion(German Research Foundation (DFG)); COCONET, EU - FP7	M.R. was supported by a Marie Curie International Outgoing fellowship (EU - FP7 - PEOPLE - 2009 - IOF, 254634) from the European Community's Seventh Framework Programme. This research was funded by projects CTM2010 - 22218 of the Spanish Government, project 287844 (COCONET, EU - FP7), BIOCON08-187 from the Fundacion Banco Bilbao Vizcaya Argentaria (FBBVA) and a FPU (Formacion del Profesorado Universitario) scholarship to V.O. (AP2008 - 04209, 2009) from the Spanish Ministerio de Educacion. The authors are part of the research groups 2009SGR - 636, and 2009SGR - 484 of the Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul JAH, 2007, J EXP MAR BIOL ECOL, V342, P189, DOI 10.1016/j.jembe.2006.10.041; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Bach J., 1976, MARITIME HIST AUSTR; Barrows TT, 2004, QUATERNARY SCI REV, V23, P697, DOI 10.1016/j.quascirev.2003.10.011; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Beaumont MA, 2004, NAT REV GENET, V5, P251, DOI 10.1038/nrg1318; Beaumont MA, 2002, GENETICS, V162, P2025; Beheregaray LB, 2008, MOL ECOL, V17, P3754, DOI 10.1111/j.1365-294X.2008.03857.x; Belkhir K, 9060 CNRS UPR U MONT; Benjamini Y, 2001, ANN STAT, V29, P1165; Boero F, 2002, CIESM WORKSHOP MONOG, P87; Borsa P, 1997, MAR BIOL, V129, P233, DOI 10.1007/s002270050164; Bryja J, 2010, MOL ECOL, V19, P4708, DOI 10.1111/j.1365-294X.2010.04844.x; Byrnes JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000295; CARLTON JT, 1993, SCIENCE, V261, P78, DOI 10.1126/science.261.5117.78; Carlton JT, 1996, BIOL CONSERV, V78, P97, DOI 10.1016/0006-3207(96)00020-1; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Cohen AN, 1998, SCIENCE, V279, P555, DOI 10.1126/science.279.5350.555; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Cornuet JM, 1996, GENETICS, V144, P2001; Coutts ADM, 2007, MAR POLLUT BULL, V54, P875, DOI 10.1016/j.marpolbul.2007.03.011; Csillery K, 2010, TRENDS ECOL EVOL, V25, P410, DOI 10.1016/j.tree.2010.04.001; deMenocal P, 2000, SCIENCE, V288, P2198, DOI 10.1126/science.288.5474.2198; Dupont L, 2010, BIOL INVASIONS, V12, P2707, DOI 10.1007/s10530-009-9676-0; Estoup A, 2004, EVOLUTION, V58, P2021, DOI 10.1111/j.0014-3820.2004.tb00487.x; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fenwick G., 2005, 200512 MIN AGR FOR; Fitzpatrick BM, 2012, BIOL INVASIONS, V14, P245, DOI 10.1007/s10530-011-0064-1; Galarza JA, 2009, P NATL ACAD SCI USA, V106, P1473, DOI 10.1073/pnas.0806804106; Galil Bella S., 2000, Biological Invasions, V2, P177, DOI 10.1023/A:1010057010476; Geller JB, 2010, ANNU REV MAR SCI, V2, P367, DOI 10.1146/annurev.marine.010908.163745; Gerlach G, 2010, MOL ECOL, V19, P3845, DOI 10.1111/j.1365-294X.2010.04784.x; Gillis NK, 2009, DIVERS DISTRIB, V15, P784, DOI 10.1111/j.1472-4642.2009.00591.x; Goldstien SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016755; Grosholz E, 2002, TRENDS ECOL EVOL, V17, P22, DOI 10.1016/S0169-5347(01)02358-8; Grosholz ED, 2005, P NATL ACAD SCI USA, V102, P1088, DOI 10.1073/pnas.0308547102; Guillemaud T, 2010, HEREDITY, V104, P88, DOI 10.1038/hdy.2009.92; Hickerson MJ, 2010, MOL PHYLOGENET EVOL, V54, P291, DOI 10.1016/j.ympev.2009.09.016; Holland BS, 2000, HYDROBIOLOGIA, V420, P63, DOI 10.1023/A:1003929519809; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Ilves KL, 2010, MOL ECOL, V19, P4505, DOI 10.1111/j.1365-294X.2010.04790.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kaluza P, 2010, J R SOC INTERFACE, V7, P1093, DOI 10.1098/rsif.2009.0495; Keller RP, 2011, DIVERS DISTRIB, V17, P93, DOI 10.1111/j.1472-4642.2010.00696.x; Keller SR, 2010, J EVOLUTION BIOL, V23, P1720, DOI 10.1111/j.1420-9101.2010.02037.x; Kirkpatrick M, 2006, GENETICS, V173, P419, DOI 10.1534/genetics.105.047985; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; KOTT P, 1985, Memoirs of the Queensland Museum, V23, P1; Lambert CC, 1998, MAR BIOL, V130, P675, DOI 10.1007/s002270050289; Lambert CC, 2003, MAR ECOL PROG SER, V259, P145, DOI 10.3354/meps259145; Lambert G, 2007, J EXP MAR BIOL ECOL, V342, P3, DOI 10.1016/j.jembe.2006.10.009; Lambert Gretchen, 2002, Pacific Science, V56, P291, DOI 10.1353/psc.2002.0026; Lindholm AK, 2005, MOL ECOL, V14, P3671, DOI 10.1111/j.1365-294X.2005.02697.x; Liu TK, 2011, MAR POLLUT BULL, V62, P602, DOI 10.1016/j.marpolbul.2010.11.016; Lombaert E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009743; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mastrototaro F, 2008, J MAR BIOL ASSOC UK, V88, P1053, DOI 10.1017/S0025315408001392; Mastrototaro F., 2008, MAR BIODIVERS REC, V1, P12, DOI [DOI 10.1017/S1755267205001247, 10.1017/S1755267205001247]; Mead A, 2011, BIOL INVASIONS, V13, P1991, DOI 10.1007/s10530-011-0016-9; MICHAELSEN W., 1927, ZOOL ANZEIGER, V71, P193; Millar B. H., 1962, Annals of the South African Museum, V46, P113; MILLAR R. H., 1955, PROC ZOOL SOC LONDON, V125, P169; MILLAR RH, 1971, ADV MAR BIOL, V9, P1, DOI 10.1016/S0065-2881(08)60341-7; Miller N, 2005, SCIENCE, V310, P992, DOI 10.1126/science.1115871; MONNIOT C, 1981, Tethys, V10, P59; Monniot Claude, 2001, Annals of the South African Museum, V108, P1; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Naranjo S. A., 1994, Graellsia, V50, P57; Naranjo SA, 1996, MAR ECOL PROG SER, V144, P119, DOI 10.3354/meps144119; Naranjo SA, 1995, THESIS U SEVILLA SEV; OLSON RR, 1985, ECOLOGY, V66, P30, DOI 10.2307/1941304; Palero F, 2010, J CRUSTACEAN BIOL, V30, P658, DOI 10.1651/09-3192.1; Palero F, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-263; Pascual M, 2007, MOL ECOL, V16, P3069, DOI 10.1111/j.1365-294X.2007.03336.x; Patarnello T, 2007, MOL ECOL, V16, P4426, DOI 10.1111/j.1365-294X.2007.03477.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pineda MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025495; Pritchard JK, 2000, GENETICS, V155, P945; Ranasinghe JA, 2005, BIOL INVASIONS, V7, P679, DOI 10.1007/s10530-004-5857-z; Ricciardi A, 2007, CONSERV BIOL, V21, P329, DOI 10.1111/j.1523-1739.2006.00615.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rius M, 2008, MOL ECOL RESOUR, V8, P1405, DOI 10.1111/j.1755-0998.2008.02311.x; Rius M, 2008, DIVERS DISTRIB, V14, P818, DOI 10.1111/j.1472-4642.2008.00485.x; Rius M, 2010, FUNCT ECOL, V24, P685, DOI 10.1111/j.1365-2435.2009.01668.x; Rius M, 2009, BIOL INVASIONS, V11, P2181, DOI 10.1007/s10530-008-9375-2; Rolshausen G, 2009, CURR BIOL, V19, P2097, DOI 10.1016/j.cub.2009.10.061; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Roman J, 2006, P ROY SOC B-BIOL SCI, V273, P2453, DOI 10.1098/rspb.2006.3597; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rovito SM, 2010, MOL ECOL, V19, P4554, DOI 10.1111/j.1365-294X.2010.04825.x; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Simon-Bouhet B, 2006, MOL ECOL, V15, P1699, DOI 10.1111/j.1365-294X.2006.02881.x; Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007; Svane I., 1989, Oceanography and Marine Biology an Annual Review, V27, P45; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Turon X, 2007, J EXP MAR BIOL ECOL, V342, P185, DOI 10.1016/j.jembe.2006.10.040; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wasson K, 2001, BIOL CONSERV, V102, P143, DOI 10.1016/S0006-3207(01)00098-2; Whitlock MC, 2011, MOL ECOL, V20, P1083, DOI 10.1111/j.1365-294X.2010.04996.x; Wonham MJ, 2005, BIOL INVASIONS, V7, P369, DOI 10.1007/s10530-004-2581-7; Zepeda-Paulo FA, 2010, MOL ECOL, V19, P4738, DOI 10.1111/j.1365-294X.2010.04857.x; Zhan AB, 2010, MOL ECOL, V19, P4678, DOI 10.1111/j.1365-294X.2010.04837.x	110	49	49	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35815	10.1371/journal.pone.0035815	http://dx.doi.org/10.1371/journal.pone.0035815			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545140	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000305343200060
J	Bonar, SL; Brydges, SD; Mueller, JL; McGeough, MD; Pena, C; Chen, D; Grimston, SK; Hickman-Brecks, CL; Ravindran, S; McAlinden, A; Novack, DV; Kastner, DL; Civitelli, R; Hoffman, HM; Mbalaviele, G				Bonar, Sheri L.; Brydges, Susannah D.; Mueller, James L.; McGeough, Matthew D.; Pena, Carla; Chen, Debbie; Grimston, Susan K.; Hickman-Brecks, Cynthia L.; Ravindran, Soumya; McAlinden, Audrey; Novack, Deborah V.; Kastner, Daniel L.; Civitelli, Roberto; Hoffman, Hal M.; Mbalaviele, Gabriel			Constitutively Activated NLRP3 Inflammasome Causes Inflammation and Abnormal Skeletal Development in Mice	PLOS ONE			English	Article							CIAS1 MUTATIONS; TNF-ALPHA; BONE; OSTEOCLAST; DISEASE; GROWTH; DIFFERENTIATION; INCREASE; COLLAGEN; BLOOD	The NLRP3 inflammasome complex is responsible for maturation of the pro-inflammatory cytokine, IL-1 beta. Mutations in NLRP3 are responsible for the cryopyrinopathies, a spectrum of conditions including neonatal-onset multisystem inflammatory disease (NOMID). While excessive production of IL-1 beta and systemic inflammation are common to all cryopyrinopathy disorders, skeletal abnormalities, prominently in the knees, and low bone mass are unique features of patients with NOMID. To gain insights into the mechanisms underlying skeletal abnormalities in NOMID, we generated knock-in mice globally expressing the D301N NLRP3 mutation (ortholog of D303N in human NLRP3). NOMID mice exhibit neutrophilia in blood and many tissues, including knee joints, and high levels of serum inflammatory mediators. They also exhibit growth retardation and severe postnatal osteopenia stemming at least in part from abnormally accelerated bone resorption, attended by increased osteoclastogenesis. Histologic analysis of knee joints revealed abnormal growth plates, with loss of chondrocytes and growth arrest in the central region of the epiphyses. Most strikingly, a tissue "spike" was observed in the mid-region of the growth plate in the long bones of all NOMID mice that may be the precursor to more severe deformations analogous to those observed in NOMID patients. These findings provide direct evidence linking a NOMID-associated NLRP3-activating mutation to abnormalities of postnatal skeletal growth and bone remodeling.	[Bonar, Sheri L.; Grimston, Susan K.; Hickman-Brecks, Cynthia L.; Novack, Deborah V.; Civitelli, Roberto; Mbalaviele, Gabriel] Washington Univ, Sch Med, Div Bone & Mineral Dis, St Louis, MO 63130 USA; [Brydges, Susannah D.; Mueller, James L.; McGeough, Matthew D.; Pena, Carla; Chen, Debbie; Hoffman, Hal M.] Univ Calif San Diego, Div Allergy Immunol & Rheumatol, La Jolla, CA 92093 USA; [Brydges, Susannah D.; Mueller, James L.; McGeough, Matthew D.; Pena, Carla; Chen, Debbie; Hoffman, Hal M.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Brydges, Susannah D.; Mueller, James L.; McGeough, Matthew D.; Pena, Carla; Chen, Debbie; Hoffman, Hal M.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Ravindran, Soumya; McAlinden, Audrey] Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO USA; [Kastner, Daniel L.] NHGRI, Med Genet Branch, US Dept HHS, NIH, Bethesda, MD 20892 USA	Washington University (WUSTL); University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Bonar, SL (corresponding author), Washington Univ, Sch Med, Div Bone & Mineral Dis, St Louis, MO 63130 USA.	gmbalavi@DOM.wustl.edu	Civitelli, Roberto/AAA-8260-2019	Civitelli, Roberto/0000-0003-4076-4315; Novack, Deborah/0000-0001-7101-5582; McAlinden, Audrey/0000-0001-8433-4224	National Institute of Arthritis and Musculoskeletal and Skin Diseases; NIH [RO1-AI52430]; National Institutes of Health/Core Center for Musculoskeletal Biology and Medicine [5 P30 AR057235]; Arthritis National Research Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052705, P30AR057235] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/Core Center for Musculoskeletal Biology and Medicine; Arthritis National Research Foundation(National Research Foundation of Korea); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, extramural grants NIH RO1-AI52430, the 5 P30 AR057235 National Institutes of Health/Core Center for Musculoskeletal Biology and Medicine and the Arthritis National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Aksentijevich I, 2007, ARTHRITIS RHEUM-US, V56, P1273, DOI 10.1002/art.22491; Brydges SD, 2009, IMMUNITY, V30, P875, DOI 10.1016/j.immuni.2009.05.005; Cremer M A, 1988, Int Rev Immunol, V4, P65, DOI 10.3109/08830188809044771; Di Benedetto A, 2010, J CELL SCI, V123, P2640, DOI 10.1242/jcs.067777; Ding J, 2009, LIFE SCI, V84, P499, DOI 10.1016/j.lfs.2009.01.013; Doherty TA, 2011, J LEUKOCYTE BIOL, V90, P37, DOI 10.1189/jlb.1110616; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Ford-Hutchinson AF, 2007, J BONE MINER RES, V22, P1245, DOI 10.1359/JBMR.070420; Hill SC, 2007, PEDIATR RADIOL, V37, P145, DOI 10.1007/s00247-006-0358-0; Hjorten R, 2007, BONE, V41, P535, DOI 10.1016/j.bone.2007.06.024; Hoffman HM, 2011, J BIOL CHEM, V286, P10889, DOI 10.1074/jbc.R110.135491; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mbalaviele G, 2006, J PHARMACOL EXP THER, V317, P1044, DOI 10.1124/jpet.105.100362; Meng GX, 2009, IMMUNITY, V30, P860, DOI 10.1016/j.immuni.2009.04.012; Muto A, 2011, J BONE MINER RES, V26, P2978, DOI 10.1002/jbmr.490; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; PACIFICI R, 1989, P NATL ACAD SCI USA, V86, P2398, DOI 10.1073/pnas.86.7.2398; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Sibley CH, 2012, ARTHRITIS RHEUM; Vaira S, 2008, J CLIN INVEST, V118, P2088, DOI 10.1172/JCI33392; Vaira S, 2008, P NATL ACAD SCI USA, V105, P3897, DOI 10.1073/pnas.0708576105; Walsh NC, 2010, IMMUNOL REV, V233, P301, DOI 10.1111/j.0105-2896.2009.00857.x; Watkins M, 2011, MOL BIOL CELL, V22, P1240, DOI 10.1091/mbc.E10-07-0571; Zwerina J, 2007, P NATL ACAD SCI USA, V104, P11742, DOI 10.1073/pnas.0610812104	32	81	82	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35979	10.1371/journal.pone.0035979	http://dx.doi.org/10.1371/journal.pone.0035979			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558291	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000095
J	Bouchard, S; Bernier, F; Boivin, E; Morin, B; Robillard, G				Bouchard, Stephane; Bernier, Francois; Boivin, Eric; Morin, Brian; Robillard, Genevieve			Using Biofeedback while Immersed in a Stressful Videogame Increases the Effectiveness of Stress Management Skills in Soldiers	PLOS ONE			English	Article							MENTAL-HEALTH; RESILIENCE; FITNESS; RESPONSES; MILITARY; NEUROENDOCRINE; CORTISOL; SCIENCE; GENDER; IRAQ	This study assessed the efficacy of using visual and auditory biofeedback while immersed in a tridimensional videogame to practice a stress management skill (tactical breathing). All 41 participants were soldiers who had previously received basic stress management training and first aid training in combat. On the first day, they received a 15-minute refresher briefing and were randomly assigned to either: (a) no additional stress management training (SMT) for three days, or (b) 30-minute sessions (one per day for three days) of biofeedback-assisted SMT while immersed in a horror/first-person shooter game. The training was performed in a dark and enclosed environment using a 50-inch television with active stereoscopic display and loudspeakers. On the last day, all participants underwent a live simulated ambush with an improvised explosive device, where they had to provide first aid to a wounded soldier. Stress levels were measured with salivary cortisol collected when waking-up, before and after the live simulation. Stress was also measured with heart rate at baseline, during an apprehension phase, and during the live simulation. Repeated-measure ANOVAs and ANCOVAs confirmed that practicing SMT was effective in reducing stress. Results are discussed in terms of the advantages of the proposed program for military personnel and the need to practice SMT.	[Bouchard, Stephane; Robillard, Genevieve] Univ Quebec Outaouais, Lab Cyberpsychol, Gatineau, PQ, Canada; [Bernier, Francois; Boivin, Eric] Def Res & Dev Canada ValCartier, Quebec City, PQ, Canada; [Morin, Brian] Clin Psychol Cognit, Quebec City, PQ, Canada	University of Quebec; University Quebec Outaouais	Bouchard, S (corresponding author), Univ Quebec Outaouais, Lab Cyberpsychol, Gatineau, PQ, Canada.	stephane.bouchard@uqo.ca	Bernier, Francois/AAP-2174-2020; Bernier, Francois/V-7150-2018		Public Works and Government Services Canada; Canada Research Chairs program; Natural Science and Engineering Research Council of Canada	Public Works and Government Services Canada; Canada Research Chairs program(Canada Research Chairs); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This project was financially supported by a contract from Public Works and Government Services Canada and the financial support of research awards from the Canada Research Chairs program and the Natural Science and Engineering Research Council of Canada awarded to the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AB, 2009, J CONSULT CLIN PSYCH, V77, P928, DOI 10.1037/a0016877; Algoe SB, 2011, AM PSYCHOL, V66, P35, DOI 10.1037/a0021720; Bandura A., 1986, SOCIAL FDN THOUGHT A; Benoit A, 2005, ENTERFACE 2005 SUMM; Bouchard S, J DEFENSE M IN PRESS; Bouchard S., 2011, J COMPUTER INFORM TE, V1, P20; Bouchard S, 2012, POSTTRAUMATIC STRESS, P271; Bouchard S, 2011, STUD COMPUT INTELL, V337, P109; Bouchard S, 2010, CYBERPSYCH BEH SOC N, V13, P83, DOI 10.1089/cyber.2009.0336; Casey GW, 2011, AM PSYCHOL, V66, P1, DOI 10.1037/a0021930; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cornum R, 2011, AM PSYCHOL, V66, P4, DOI 10.1037/a0021420; Davis SN, 2000, J CLIN ENDOCR METAB, V85, P224, DOI 10.1210/jc.85.1.224; Davydov DM, 2010, CLIN PSYCHOL REV, V30, P479, DOI 10.1016/j.cpr.2010.03.003; Dekker A, P DIGRA TOK JAP; Driskell JE, 2008, PERFORMANCE STRESS, P271; Ferguson K., 2009, GEN PRINCIPLES EMPIR, P532; Good GE, 2005, J CLIN PSYCHOL, V61, P699, DOI 10.1002/jclp.20104; Green G, 2010, SOC SCI MED, V71, P1480, DOI 10.1016/j.socscimed.2010.07.015; Grossman D., 2008, COMBAT PSYCHOL PHYSL; Guest L, 2011, PREDEPLOYEMENT TRAIN; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Homeland Security, 2004, SURV SCOR RES PROJ F; Kashdan TB, 2010, CLIN PSYCHOL REV, V30, P865, DOI 10.1016/j.cpr.2010.03.001; Katertsidis NS, 2009, P 9 INT C INF TECHN; Kennedy R. S., 1993, INT J AVIAT PSYCHOL, V3, P203; Kim PY, 2011, MIL PSYCHOL, V23, P65, DOI 10.1080/08995605.2011.534415; Kirk Roger, 1982, EXPT DESIGN PROCEDUR, V2nd; Lazarus R. S., 1984, STRESS APPRAISAL COP; Leal-Cerro A, 2003, J ENDOCRINOL INVEST, V26, P879, DOI 10.1007/BF03345239; Lester PB, 2011, AM PSYCHOL, V66, P77, DOI 10.1037/a0022083; Levant R. F., 1995, NEW PSYCHOL MEN; Masten AS, 2007, DEV PSYCHOPATHOL, V19, P921, DOI 10.1017/S0954579407000442; Mental Health Advisory Team (MHAT) 6, 2009, OP END FREED 2009 AF; Murphy P, 2008, J OCCUP HEALTH, V24, P541; Nakasone A, 2005, 5 INT WORKSH BIOS IN; O'Donohue W.T., 2009, GEN PRINCIPLES EMPIR; OCONNOR PJ, 1987, MED SCI SPORT EXER, V19, P224; Oman D, 2008, INT J PSYCHOL RELIG, V18, P79, DOI 10.1080/10508610701879316; Orvis KA, 2010, MIL PSYCHOL, V22, P143, DOI 10.1080/08995600903417225; Ravaj N, 2005, P DIGRA 2005 C CHANG, P1; Reivich KJ, 2011, AM PSYCHOL, V66, P25, DOI 10.1037/a0021897; Rimmele U, 2007, PSYCHONEUROENDOCRINO, V32, P627, DOI 10.1016/j.psyneuen.2007.04.005; Rosen LN, 2000, MIL MED, V165, P54, DOI 10.1093/milmed/165.1.54; Routhier C, 2007, PROGRAMME ENTR UNPUB; Routhier C, 2009, IND OP READ PERS PER; RUTTER M, 1987, AM J ORTHOPSYCHIAT, V57, P316, DOI 10.1111/j.1939-0025.1987.tb03541.x; Schwartz M. S., 2003, BIOFEEDBACK PRACTITI, V3rd; Shi Y., 2010, INT S QUAL LIFE TECH, P28; Stetz MC, 2007, AVIAT SPACE ENVIR MD, V78, pB252; Stuempfle KJ, 2010, WILD ENVIRON MED, V21, P22, DOI 10.1016/j.wem.2009.12.020; Taylor MK, 2011, MIL MED, V12, P1362; Thompson MM, 2006, PSYCHOL SERVING PEAC, P54; Timmerman IGH, 1998, BEHAV RES THER, V36, P863, DOI 10.1016/S0005-7967(98)00053-9; Wexler DB, 2009, MEN THERAPY NEW APPR; Wolpe J., 1990, PRACTICE BEHAV THERA; Yun C, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P2195	57	62	64	5	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36169	10.1371/journal.pone.0036169	http://dx.doi.org/10.1371/journal.pone.0036169			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TJ	22558370	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336000145
J	Fan, Q; Yan, X; Wang, JJ; Chen, Y; Wang, XM; Li, CB; Tan, L; You, C; Zhang, TH; Zuo, S; Xu, DR; Chen, KM; Finlayson-Burden, JM; Xiao, ZP				Fan, Qing; Yan, Xu; Wang, Jijun; Chen, Ying; Wang, Xuemei; Li, Chunbo; Tan, Ling; You, Chao; Zhang, Tianhong; Zuo, Sai; Xu, Dongrong; Chen, Kemin; Finlayson-Burden, Jodie Marie; Xiao, Zeping			Abnormalities of White Matter Microstructure in Unmedicated Obsessive-Compulsive Disorder and Changes after Medication	PLOS ONE			English	Article							DRUG-NAIVE PATIENTS; DIFFUSION-TENSOR; CORPUS-CALLOSUM; FRACTIONAL ANISOTROPY; CITALOPRAM TREATMENT; SEROTONIN; SCHIZOPHRENIA; AVAILABILITY; METAANALYSIS; ADOLESCENTS	Background: Abnormalities of myelin integrity have been reported in obsessive-compulsive disorder (OCD) using multi-parameter maps of diffusion tensor imaging (DTI). However, it was still unknown to what degree these abnormalities might be affected by pharmacological treatment. Objective: To investigate whether the abnormalities of white matter microstructure including myelin integrity exist in OCD and whether they are affected by medication. Methodology and Principal Findings: Parameter maps of DTI, including fractional anisotropy (FA), axial diffusivity (AD), radial diffusivity (RD) and mean diffusivity (MD), were acquired from 27 unmedicated OCD patients (including 13 drug-naive individuals) and 23 healthy controls. Voxel-based analysis was then performed to detect regions with significant group difference. We compared the DTI-derived parameters of 15 patients before and after 12-week Selective Serotonin Reuptake Inhibitor (SSRI) therapies. Significant differences of DTI-derived parameters were observed between OCD and healthy groups in multiple structures, mainly within the fronto-striato-thalamo-cortical loop. An increased RD in combination with no change in AD among OCD patients was found in the left medial superior frontal gyrus, temporo-parietal lobe, occipital lobe, striatum, insula and right midbrain. There was no statistical difference in DTI-derived parameters between drug-naive and previously medicated OCD patients. After being medicated, OCD patients showed a reduction in RD of the left striatum and right midbrain, and in MD of the right midbrain. Conclusion: Our preliminary findings suggest that abnormalities of white matter microstructure, particularly in terms of myelin integrity, are primari ly located within the fronto-striato-thalamo-cortical circuit of individuals with OCD. Some abnormalities may be partly reversed by SSRI treatment.	[Fan, Qing; Wang, Jijun; Wang, Xuemei; Li, Chunbo; Zhang, Tianhong; Zuo, Sai; Xiao, Zeping] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China; [Yan, Xu; Xu, Dongrong] E China Normal Univ, Shanghai Key Lab Brain Funct Gen, Shanghai Key Lab Magnet Resonance, Key Lab Brain Funct Gen,Minist Educ, Shanghai 200062, Peoples R China; [Chen, Ying; Chen, Kemin] Shanghai TCM Intergrated Hosp, Shanghai, Peoples R China; [Tan, Ling; You, Chao] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Radiol, Sch Med, Shanghai 200030, Peoples R China; [Finlayson-Burden, Jodie Marie] Univ Nottingham, Nottingham Inst Mental Hlth, Nottingham NG7 2RD, England	Shanghai Jiao Tong University; East China Normal University; Shanghai Jiao Tong University; University of Nottingham	Fan, Q (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China.	dx2103@columbia.edu; xiaozeping@gmail.com	Wang, Xuemei/GXF-3702-2022		Joint Key Project of National High Technology Research and Development Program of China (863 Program) [2007AA02Z420]; Natural Science Foundation of Shanghai Jiao Tong University School of Medicine, China [09XJ21023]; Shanghai Municipal Health Bureau Foundation, China [2010Y028]; Shanghai Commission of Science and Technology [10440710200]; East China Normal University School Psychology and Cognitive Science	Joint Key Project of National High Technology Research and Development Program of China (863 Program); Natural Science Foundation of Shanghai Jiao Tong University School of Medicine, China; Shanghai Municipal Health Bureau Foundation, China; Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee); East China Normal University School Psychology and Cognitive Science	The study was supported by the Joint Key Project of National High Technology Research and Development Program of China (863 Program) (No: 2007AA02Z420), Natural Science Foundation of Shanghai Jiao Tong University School of Medicine, China (No.09XJ21023), Shanghai Municipal Health Bureau Foundation, China (2010Y028), a grant from Shanghai Commission of Science and Technology (No. 10440710200), and two grants from the East China Normal University School Psychology and Cognitive Science. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Alexander AL, 2007, NEUROIMAGE, V34, P61, DOI 10.1016/j.neuroimage.2006.08.032; Ashtari M, 2007, ARCH GEN PSYCHIAT, V64, P1270, DOI 10.1001/archpsyc.64.11.1270; Atmaca M, 2010, J AFFECT DISORDERS, V124, P309, DOI 10.1016/j.jad.2010.03.027; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; BENKELFAT C, 1990, ARCH GEN PSYCHIAT, V47, P840; Bora E, 2011, J PSYCHIATR NEUROSCI, V36, P42, DOI 10.1503/jpn.100082; Cannistraro PA, 2007, DEPRESS ANXIETY, V24, P440, DOI 10.1002/da.20246; Fan Q, 2010, PSYCHIAT CLIN NEUROS, V64, P483, DOI 10.1111/j.1440-1819.2010.02128.x; Garibotto V, 2010, NEUROBIOL DIS, V37, P468, DOI 10.1016/j.nbd.2009.11.003; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Ha TH, 2009, NEUROREPORT, V20, P735, DOI 10.1097/WNR.0b013e32832ad3da; Hasan KM, 2006, RADIOLOGY, V239, P611, DOI 10.1148/radiol.2392051172; Hesse S, 2005, PSYCHIAT RES-NEUROIM, V140, P63, DOI 10.1016/j.pscychresns.2005.07.002; Hunsberger Joshua, 2009, Dialogues Clin Neurosci, V11, P333; Jang JH, 2006, AM J PSYCHIAT, V163, P1202, DOI 10.1176/appi.ajp.163.7.1202; Koprivova J, 2009, NEUROSCI LETT, V464, P62, DOI 10.1016/j.neulet.2009.08.012; Koran LM, 1996, AM J PSYCHIAT, V153, P783; Korgaonkar MS, 2011, HUM BRAIN MAPP, V32, P2161, DOI 10.1002/hbm.21178; Kwon JS, 2009, EXPERT REV NEUROTHER, V9, P255, DOI 10.1586/14737175.9.2.255; Lazaro L, 2008, J PSYCHIATR RES, V42, P1051, DOI 10.1016/j.jpsychires.2007.12.007; Lazaro L, 2009, PSYCHIAT RES-NEUROIM, V172, P140, DOI 10.1016/j.pscychresns.2008.12.007; Lee JE, 2007, NEUROSCI LETT, V424, P127, DOI 10.1016/j.neulet.2007.07.042; Levitt JJ, 2010, PSYCHIAT RES-NEUROIM, V184, P143, DOI 10.1016/j.pscychresns.2010.08.004; Mataix-Cols D, 2004, ARCH GEN PSYCHIAT, V61, P564, DOI 10.1001/archpsyc.61.6.564; Matsumoto R, 2010, NEUROIMAGE, V49, P121, DOI 10.1016/j.neuroimage.2009.07.069; Menzies L, 2008, AM J PSYCHIAT, V165, P1308, DOI 10.1176/appi.ajp.2008.07101677; Michael AM, 2008, IEEE ENG MED BIO, P5494, DOI 10.1109/IEMBS.2008.4650458; Nabeyama M, 2008, PSYCHIAT RES-NEUROIM, V163, P236, DOI 10.1016/j.pscychresns.2007.11.001; Nakamae T, 2008, PROG NEURO-PSYCHOPH, V32, P1221, DOI 10.1016/j.pnpbp.2008.03.010; Nakamae T, 2011, J PSYCHIATR RES, V45, P687, DOI 10.1016/j.jpsychires.2010.09.016; Nakao T, 2009, J PSYCHIATR RES, V43, P784, DOI 10.1016/j.jpsychires.2008.10.013; Pujol J, 2004, ARCH GEN PSYCHIAT, V61, P720, DOI 10.1001/archpsyc.61.7.720; Reimold M, 2007, J NEURAL TRANSM, V114, P1603, DOI 10.1007/s00702-007-0785-6; Rosenberg DR, 1997, ARCH GEN PSYCHIAT, V54, P824; Rotge JY, 2009, BIOL PSYCHIAT, V65, P75, DOI 10.1016/j.biopsych.2008.06.019; Saito Y, 2008, RADIOLOGY, V246, P536, DOI 10.1148/radiol.2462061469; Saxena S, 2002, ARCH GEN PSYCHIAT, V59, P250, DOI 10.1001/archpsyc.59.3.250; Seal ML, 2008, SCHIZOPHR RES, V101, P106, DOI 10.1016/j.schres.2007.12.489; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Stengler-Wenzke K, 2006, NEUROPSYCHOBIOLOGY, V53, P40, DOI 10.1159/000090702; Stengler-Wenzke K, 2004, EUR ARCH PSY CLIN N, V254, P252, DOI 10.1007/s00406-004-0489-y; Stewart SE, 2007, ARCH GEN PSYCHIAT, V64, P209, DOI 10.1001/archpsyc.64.2.209; Szeszko PR, 2005, ARCH GEN PSYCHIAT, V62, P782, DOI 10.1001/archpsyc.62.7.782; Tyszka JM, 2006, NEUROIMAGE, V29, P1058, DOI 10.1016/j.neuroimage.2005.08.037; WEISSMAN MM, 1994, J CLIN PSYCHIAT, V55, P5; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Whiteside SP, 2004, PSYCHIAT RES-NEUROIM, V132, P69, DOI 10.1016/j.pscychresns.2004.07.001; Whitford TJ, 2010, BIOL PSYCHIAT, V68, P70, DOI 10.1016/j.biopsych.2010.03.025; Xiao JH, 2010, NEUROSIGNALS, V18, P186, DOI 10.1159/000323170; Yoo SY, 2007, ACTA PSYCHIAT SCAND, V116, P211, DOI 10.1111/j.1600-0447.2007.01046.x; Zai G, 2004, AM J MED GENET B, V129B, P64, DOI 10.1002/ajmg.b.30077	53	62	65	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35889	10.1371/journal.pone.0035889	http://dx.doi.org/10.1371/journal.pone.0035889			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558258	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000077
J	Liu, MQ; Zhou, DJ; Wang, X; Zhou, W; Ye, L; Li, JL; Wang, YZ; Ho, WZ				Liu, Man-Qing; Zhou, Dun-Jin; Wang, Xu; Zhou, Wang; Ye, Li; Li, Jie-Liang; Wang, Yi-Zhong; Ho, Wen-Zhe			IFN-lambda 3 Inhibits HIV Infection of Macrophages through the JAK-STAT Pathway	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; INTERFERON-LAMBDA; GENETIC-VARIATION; IFN-LAMBDA; INDUCTION; IL28B; ACTIVATION; ALPHA; RECOGNITION; RECRUITMENT	Background: Interferon lambda 3 (IFN-lambda 3) is a newly identified cytokine with antiviral activity, and its single nucleotide polymorphisms are strongly associated with the treatment effectiveness and development of chronic hepatitis C virus infection. We thus examined the potential of IFN-lambda 3 to inhibit HIV replication and the possible mechanisms of the anti-HIV action by IFN-lambda 3 in human macrophages. Principal Findings: Under different conditions (before, during, and after HIV infection), IFN-lambda 3 significantly inhibited viral replication in macrophages, which was associated with the induction of multiple antiviral cellular factors (ISG56, MxA, OAS1, A3G/F and tetherin) and IFN regulatory factors (IRF-1, 3, 5, 7 and 9). This anti-HIV action of IFN-lambda 3 could be compromised by the JAK-STAT inhibitor. In addition, IFN-lambda 3 treatment of macrophages induced the expression of toll-like receptor 3 (TLR3) and two key adaptors (MyD88 and TRIF) in type I IFN pathway activation. However, HIV infection compromised IFN-lambda 3-mediated induction of the key elements in JAK-STAT signaling pathway. Conclusions: These data indicate that IFN-lambda 3 exerts its anti-HIV function by activating JAK-STAT pathway-mediated innate immunity in macrophages. Future in vivo studies are necessary in order to explore the potential for developing IFN-lambda 3-based therapy for HIV disease.	[Liu, Man-Qing; Zhou, Dun-Jin; Zhou, Wang] Wuhan Ctr Dis Prevent & Control, Div Virol, Wuhan, Hubei, Peoples R China; [Wang, Xu; Ho, Wen-Zhe] Wuhan Univ, State Key Lab Virol, Ctr Anim Expt Anim, Wuhan 430072, Hubei, Peoples R China; [Wang, Xu; Ho, Wen-Zhe] Wuhan Univ, State Key Lab Virol, Biosafety Level Lab 3, Wuhan 430072, Hubei, Peoples R China; [Wang, Xu; Ye, Li; Li, Jie-Liang; Wang, Yi-Zhong; Ho, Wen-Zhe] Temple Univ, Sch Med, Dept Med Pathol, Philadelphia, PA 19122 USA; [Wang, Xu; Ye, Li; Li, Jie-Liang; Wang, Yi-Zhong; Ho, Wen-Zhe] Temple Univ, Sch Med, Lab Med, Philadelphia, PA 19122 USA	Wuhan University; Wuhan University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Liu, MQ (corresponding author), Wuhan Ctr Dis Prevent & Control, Div Virol, Wuhan, Hubei, Peoples R China.	wenzheho@temple.edu	Liu, Man-Qing/M-9598-2014	Liu, Man-Qing/0000-0002-9754-3102	National Institutes of Health/National Institute on Drug Abuse [DA12815, DA22177, DA27550]; National Natural Sciences Foundation of China [81001303]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027550, R01DA012815, R01DA022177] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the National Institutes of Health/National Institute on Drug Abuse (No: DA12815, DA22177, and DA27550) and the National Natural Sciences Foundation of China (No: 81001303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474; Ank N, 2009, BIOFACTORS, V35, P82, DOI 10.1002/biof.19; Au WC, 2001, J BIOL CHEM, V276, P41629, DOI 10.1074/jbc.M105121200; Barnes BJ, 2002, MOL CELL BIOL, V22, P5721, DOI 10.1128/MCB.22.16.5721-5740.2002; Barnes BJ, 2001, J BIOL CHEM, V276, P23382, DOI 10.1074/jbc.M101216200; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; HO WZ, 1992, J VIROL, V66, P573, DOI 10.1128/JVI.66.1.573-579.1992; Hou W, 2009, J VIROL, V83, P3834, DOI 10.1128/JVI.01773-08; Iversen MB, 2010, J VIROL, V84, P4579, DOI 10.1128/JVI.02591-09; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Li MC, 2009, J LEUKOCYTE BIOL, V86, P23, DOI [10.1189/JLB.1208761, 10.1189/jlb.1208761]; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Megjugorac NJ, 2010, BLOOD, V115, P4185, DOI 10.1182/blood-2009-09-246157; Miller DM, 2009, ANN NY ACAD SCI, V1182, P80, DOI 10.1111/j.1749-6632.2009.05241.x; Pagliaccetti NE, 2010, VIRUSES-BASEL, V2, P1589, DOI 10.3390/v2081589; Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; WILLEY RL, 1988, J VIROL, V62, P139, DOI 10.1128/JVI.62.1.139-147.1988; Zhang LL, 2011, J HEPATOL, V55, P289, DOI 10.1016/j.jhep.2010.11.019; Zhou Y, 2010, IMMUNOLOGY, V131, P40, DOI 10.1111/j.1365-2567.2010.03270.x	28	60	67	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35902	10.1371/journal.pone.0035902	http://dx.doi.org/10.1371/journal.pone.0035902			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558263	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336000079
J	Marzi, A; Yoshida, R; Miyamoto, H; Ishijima, M; Suzuki, Y; Higuchi, M; Matsuyama, Y; Igarashi, M; Nakayama, E; Kuroda, M; Saijo, M; Feldmann, F; Brining, D; Feldmann, H; Takada, A				Marzi, Andrea; Yoshida, Reiko; Miyamoto, Hiroko; Ishijima, Mari; Suzuki, Yasuhiko; Higuchi, Megumi; Matsuyama, Yukie; Igarashi, Manabu; Nakayama, Eri; Kuroda, Makoto; Saijo, Masayuki; Feldmann, Friederike; Brining, Douglas; Feldmann, Heinz; Takada, Ayato			Protective Efficacy of Neutralizing Monoclonal Antibodies in a Nonhuman Primate Model of Ebola Hemorrhagic Fever	PLOS ONE			English	Article							DEPENDENT ENHANCEMENT; VIRUS GLYCOPROTEIN; INFECTION; EPITOPES; IDENTIFICATION; TROPISM; RNA; GP	Ebola virus (EBOV) is the causative agent of severe hemorrhagic fever in primates, with human case fatality rates up to 90%. Today, there is neither a licensed vaccine nor a treatment available for Ebola hemorrhagic fever (EHF). Single monoclonal antibodies (MAbs) specific for Zaire ebolavirus (ZEBOV) have been successfully used in passive immunization experiments in rodent models, but have failed to protect nonhuman primates from lethal disease. In this study, we used two clones of human-mouse chimeric MAbs (ch133 and ch226) with strong neutralizing activity against ZEBOV and evaluated their protective potential in a rhesus macaque model of EHF. Reduced viral loads and partial protection were observed in animals given MAbs ch133 and ch226 combined intravenously at 24 hours before and 24 and 72 hours after challenge. MAbs circulated in the blood of a surviving animal until virus-induced IgG responses were detected. In contrast, serum MAb concentrations decreased to undetectable levels at terminal stages of disease in animals that succumbed to infection, indicating substantial consumption of these antibodies due to virus replication. Accordingly, the rapid decrease of serum MAbs was clearly associated with increased viremia in non-survivors. Our results indicate that EBOV neutralizing antibodies, particularly in combination with other therapeutic strategies, might be beneficial in reducing viral loads and prolonging disease progression during EHF.	[Marzi, Andrea; Feldmann, Heinz] NIAID, Virol Lab, Rocky Mt Labs, Div Intramural Res,NIH, Hamilton, MT USA; [Yoshida, Reiko; Miyamoto, Hiroko; Ishijima, Mari; Suzuki, Yasuhiko; Higuchi, Megumi; Matsuyama, Yukie; Nakayama, Eri; Kuroda, Makoto; Takada, Ayato] Hokkaido Univ, Div Global Epidemiol, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Igarashi, Manabu] Hokkaido Univ, Res Ctr Zoonosis Control, Div Bioinformat, Sapporo, Hokkaido, Japan; [Saijo, Masayuki] Natl Inst Infect Dis, Dept Virol 1, Tokyo, Japan; [Feldmann, Friederike] NIAID, Off Operat Management, Rocky Mt Labs, Div Intramural Res,NIH, Hamilton, MT USA; [Brining, Douglas] NIAID, Rocky Mt Vet Branch, Rocky Mt Labs, Div Intramural Res,NIH, Hamilton, MT USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Hokkaido University; Hokkaido University; National Institute of Infectious Diseases (NIID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Marzi, A (corresponding author), NIAID, Virol Lab, Rocky Mt Labs, Div Intramural Res,NIH, Hamilton, MT USA.	atakada@czc.hokudai.ac.jp	Igarashi, Manabu/F-6871-2012; Takada, Ayato/A-6679-2012; YOSHIDA, Reiko/F-6883-2012; Suzuki, Yasuhiko/F-6890-2012; Saijo, Masayuki/L-2697-2019; Marzi, Andrea/AAF-4617-2020	Marzi, Andrea/0000-0003-0186-9587; Saijo, Masayuki/0000-0001-5458-7298	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID); Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Science and Technology Agency Basic Research Programs; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIGAI001048, ZIAAI001089] Funding Source: NIH RePORTER	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency Basic Research Programs; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) and the Global COE Program from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and a Grant-in-Aid for JSPS Fellows Japan. The work was further supported by Japan Science and Technology Agency Basic Research Programs. Funding was also provided by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bente D, 2009, DIS MODEL MECH, V2, P12, DOI 10.1242/dmm.000471; Brining DL, 2010, COMPARATIVE MED, V60, P389; Dias JM, 2011, NAT STRUCT MOL BIOL, V18, P1424, DOI 10.1038/nsmb.2150; Dolnik O, 2004, EMBO J, V23, P2175, DOI 10.1038/sj.emboj.7600219; Ebihara H, 2000, J VIROL, V74, P9245, DOI 10.1128/JVI.74.19.9245-9255.2000; Feldmann H, 2007, FIELDS VIROLOGY, P1409; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Geisbert Thomas W., 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404008300; Ito H, 2001, J VIROL, V75, P1576, DOI 10.1128/JVI.75.3.1576-1580.2001; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Maruyama T, 1999, J VIROL, V73, P6024, DOI 10.1128/JVI.73.7.6024-6030.1999; Matsuno K, 2007, FUTURE VIROL, V2, P607, DOI 10.2217/17460794.2.6.607; Mehedi M, 2011, J VIROL, V85, P5406, DOI 10.1128/JVI.02190-10; Nakayama E, 2011, J INFECT DIS, V204, pS978, DOI 10.1093/infdis/jir334; Nakayama E, 2010, CLIN VACCINE IMMUNOL, V17, P1723, DOI 10.1128/CVI.00170-10; Olinger GG, 2005, J VIROL, V79, P14189, DOI 10.1128/JVI.79.22.14189-14196.2005; Oswald WB, 2007, PLOS PATHOG, V3, P62, DOI 10.1371/journal.ppat.0030009; Parren PWHI, 2002, J VIROL, V76, P6408, DOI 10.1128/JVI.76.12.6408-6412.2002; REED L. J., 1938, AMER JOUR HYG, V27, P493; Saijo M, 2001, J CLIN MICROBIOL, V39, P1, DOI 10.1128/JCM.39.1.1-7.2001; Sanchez A, 1996, P NATL ACAD SCI USA, V93, P3602, DOI 10.1073/pnas.93.8.3602; Shedlock DJ, 2010, VIROLOGY, V401, P228, DOI 10.1016/j.virol.2010.02.029; Sullivan NJ, 2006, PLOS MED, V3, P865, DOI 10.1371/journal.pmed.0030177; Takada A, 2003, REV MED VIROL, V13, P387, DOI 10.1002/rmv.405; Takada A, 2003, J VIROL, V77, P7539, DOI 10.1128/JVI.77.13.7539-7544.2003; Takada A, 2003, J VIROL, V77, P1069, DOI 10.1128/JVI.77.2.1069-1074.2003; Takada A, 2001, TRENDS MICROBIOL, V9, P506, DOI 10.1016/S0966-842X(01)02201-6; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Takada A, 2007, J INFECT DIS, V196, pS347, DOI 10.1086/520581; Takada A, 2007, VACCINE, V25, P993, DOI 10.1016/j.vaccine.2006.09.076; Takada A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00034; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Volchkov VE, 1995, VIROLOGY, V214, P421, DOI 10.1006/viro.1995.0052; Wilson JA, 2000, SCIENCE, V287, P1664, DOI 10.1126/science.287.5458.1664; Wool-Lewis RJ, 1998, J VIROL, V72, P3155, DOI 10.1128/JVI.72.4.3155-3160.1998; Zhang M, 2010, BIOTECHNOL BIOENG, V105, P1094, DOI 10.1002/bit.22633	36	102	114	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36192	10.1371/journal.pone.0036192	http://dx.doi.org/10.1371/journal.pone.0036192			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558378	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336000150
J	Meijerink, M; Ferrando, ML; Lammers, G; Taverne, N; Smith, HE; Wells, JM				Meijerink, Marjolein; Ferrando, Maria Laura; Lammers, Geraldine; Taverne, Nico; Smith, Hilde E.; Wells, Jerry M.			Immunomodulatory Effects of Streptococcus suis Capsule Type on Human Dendritic Cell Responses, Phagocytosis and Intracellular Survival	PLOS ONE			English	Article							GENETIC DIVERSITY; DC-SIGN; VIRULENCE; SEROTYPE-2; STRAINS; PIGS; POLYSACCHARIDE; RECOGNITION; PREVALENCE; MECHANISM	Streptococcus suis is a major porcine pathogen of significant commercial importance worldwide and an emerging zoonotic pathogen of humans. Given the important sentinel role of mucosal dendritic cells and their importance in induction of T cell responses we investigated the effect of different S. suis serotype strains and an isogenic capsule mutant of serotype 2 on the maturation, activation and expression of IL-10, IL-12p70 and TNF-alpha in human monocyte-derived dendritic cells. Additionally, we compared phagocytosis levels and bacterial survival after internalization. The capsule of serotype 2, the most common serotype associated with infection in humans and pigs, was highly anti-phagocytic and modulated the IL-10/IL-12 and IL-10/TNF-alpha cytokine production in favor of a more anti-inflammatory profile compared to other serotypes. This may have consequences for the induction of effective immunity to S. suis serotype 2 in humans. A shielding effect of the capsule on innate Toll-like receptor signaling was also demonstrated. Furthermore, we showed that 24 h after phagocytosis, significant numbers of viable intracellular S. suis were still present intracellularly. This may contribute to the dissemination of S. suis in the body.	[Meijerink, Marjolein; Ferrando, Maria Laura; Lammers, Geraldine; Taverne, Nico; Wells, Jerry M.] Wageningen Univ, Wageningen, Netherlands; [Smith, Hilde E.] Wageningen Univ, Anim Sci Grp, Lelystad, Netherlands	Wageningen University & Research; Animal Sciences Group of Wageningen UR; Wageningen University & Research	Meijerink, M (corresponding author), Wageningen Univ, Wageningen, Netherlands.	jerry.wells@wur.nl	Ferrando, Maria Laura/M-3026-2018; Meijerink, Marjolein/B-9258-2014	Ferrando, Maria Laura/0000-0002-1398-8244; Meijerink, Marjolein/0000-0003-3994-9785				Amass S. F., 1996, Swine Health and Production, V4, P196; Benga L, 2004, CELL MICROBIOL, V6, P867, DOI 10.1111/j.1462-5822.2004.00409.x; Celli J, 2002, TRENDS MICROBIOL, V10, P232, DOI 10.1016/S0966-842X(02)02343-0; de Greeff A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-161; Galina L, 1996, CAN J VET RES, V60, P72; Geijtenbeek TBH, 2009, FUTURE MICROBIOL, V4, P879, DOI 10.2217/FMB.09.51; Gottschalk M, 2000, VET MICROBIOL, V76, P259, DOI 10.1016/S0378-1135(00)00250-9; Gottschalk Marcelo, 2007, Animal Health Research Reviews, V8, P29, DOI 10.1017/S1466252307001247; Gottschalk M, 2010, FUTURE MICROBIOL, V5, P371, DOI [10.2217/fmb.10.2, 10.2217/FMB.10.2]; Higgins R, 1996, CAN VET J, V37, P242; Inaba K, 1997, IMMUNOL CELL BIOL, V75, P206, DOI 10.1038/icb.1997.31; Ip M, 2007, DIAGN MICR INFEC DIS, V57, P15, DOI 10.1016/j.diagmicrobio.2006.05.011; JACOBS AAC, 1995, VET REC, V137, P295, DOI 10.1136/vr.137.12.295; Jim K, 2004, GENOME RES, V14, P109; Karczewski J, 2010, AM J PHYSIOL-GASTR L, V298, pG851, DOI 10.1152/ajpgi.00327.2009; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kerdsin A, 2011, LANCET, V378, P960, DOI 10.1016/S0140-6736(11)60923-9; King SJ, 2001, INFECT IMMUN, V69, P7572, DOI 10.1128/IAI.69.12.7572-7582.2001; Kopic J, 2002, SCAND J INFECT DIS, V34, P683, DOI 10.1080/00365540210147769; Lecours MP, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-72; LEVIN D, 1993, J IMMUNOL, V151, P6742; Li M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002080; Lun ZR, 2007, LANCET INFECT DIS, V7, P201, DOI 10.1016/S1473-3099(07)70001-4; MARQUES MB, 1992, INFECT IMMUN, V60, P3986, DOI 10.1128/IAI.60.10.3986-3993.1992; Meijerink M, 2010, BENEF MICROBES, V1, P317, DOI 10.3920/BM2010.0029; Morgan E, 2004, CLIN IMMUNOL, V110, P252, DOI 10.1016/j.clim.2003.11.017; Nghia HDT, 2008, EMERG INFECT DIS, V14, P155, DOI 10.3201/eid1401.070534; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Philpott DJ, 2010, CURR OPIN IMMUNOL, V22, P428, DOI 10.1016/j.coi.2010.04.010; Ram S, 1998, J EXP MED, V187, P743, DOI 10.1084/jem.187.5.743; ROBERTSON ID, 1989, VET REC, V124, P391, DOI 10.1136/vr.124.15.391; Schreur PJW, 2010, VET MICROBIOL, V143, P363, DOI 10.1016/j.vetmic.2009.12.010; Sing A, 2005, P NATL ACAD SCI USA, V102, P16049, DOI 10.1073/pnas.0504728102; Smith HE, 1999, J CLIN MICROBIOL, V37, P3146, DOI 10.1128/JCM.37.10.3146-3152.1999; Smith HE, 1999, INFECT IMMUN, V67, P1750; Smith HE, 1999, FEMS MICROBIOL LETT, V178, P265, DOI 10.1111/j.1574-6968.1999.tb08686.x; Smith HE, 1997, J CLIN MICROBIOL, V35, P1049, DOI 10.1128/JCM.35.5.1049-1053.1997; Smith HE, 1997, ADV EXP MED BIOL, V418, P651; Sriskandan S, 2006, PLOS MED, V3, P595, DOI 10.1371/journal.pmed.0030187; STOCKHOFEZURWIE.N, 1996, 14 IPVS 1996 1996 BO, P299; Tizard, 2004, VET IMMUNOLOGY INTRO; Van Calsteren MR, 2010, BIOCHEM CELL BIOL, V88, P513, DOI [10.1139/O09-170, 10.1139/o09-170]; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; VECHT U, 1992, INFECT IMMUN, V60, P550, DOI 10.1128/IAI.60.2.550-556.1992; Wang KC, 2011, FEMS MICROBIOL LETT, V324, P117, DOI 10.1111/j.1574-6968.2011.02394.x; Watkins EJ, 2001, LANCET, V357, P38, DOI 10.1016/S0140-6736(00)03570-4; Wells JM, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S17; Wells JM, 2011, P NATL ACAD SCI USA, V108, P4607, DOI 10.1073/pnas.1000092107; WIBAWAN IWT, 1991, J GEN MICROBIOL, V137, P2721, DOI 10.1099/00221287-137-12-2721; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194	50	36	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35849	10.1371/journal.pone.0035849	http://dx.doi.org/10.1371/journal.pone.0035849			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558240	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336000066
J	Petkova, VI; Zetterberg, H; Ehrsson, HH				Petkova, Valeria I.; Zetterberg, Hedvig; Ehrsson, H. Henrik			Rubber Hands Feel Touch, but Not in Blind Individuals	PLOS ONE			English	Article							VENTRAL INTRAPARIETAL AREA; TACTILE PERCEPTION; VISUAL-CORTEX; MULTISENSORY REPRESENTATION; NEURONAL REPRESENTATION; PERIPERSONAL SPACE; REFERENCE FRAME; NEURAL BASIS; BODY; ILLUSION	Psychology and neuroscience have a long-standing tradition of studying blind individuals to investigate how visual experience shapes perception of the external world. Here, we study how blind people experience their own body by exposing them to a multisensory body illusion: the somatic rubber hand illusion. In this illusion, healthy blindfolded participants experience that they are touching their own right hand with their left index finger, when in fact they are touching a rubber hand with their left index finger while the experimenter touches their right hand in a synchronized manner (Ehrsson et al. 2005). We compared the strength of this illusion in a group of blind individuals (n = 10), all of whom had experienced severe visual impairment or complete blindness from birth, and a group of age-matched blindfolded sighted participants (n = 12). The illusion was quantified subjectively using questionnaires and behaviorally by asking participants to point to the felt location of the right hand. The results showed that the sighted participants experienced a strong illusion, whereas the blind participants experienced no illusion at all, a difference that was evident in both tests employed. A further experiment testing the participants' basic ability to localize the right hand in space without vision (proprioception) revealed no difference between the two groups. Taken together, these results suggest that blind individuals with impaired visual development have a more veridical percept of self-touch and a less flexible and dynamic representation of their own body in space compared to sighted individuals. We speculate that the multisensory brain systems that re-map somatosensory signals onto external reference frames are less developed in blind individuals and therefore do not allow efficient fusion of tactile and proprioceptive signals from the two upper limbs into a single illusory experience of self-touch as in sighted individuals.	[Petkova, Valeria I.; Zetterberg, Hedvig; Ehrsson, H. Henrik] Karolinska Inst, Dept Neurosci, Brain Body & Self Lab, Stockholm, Sweden	Karolinska Institutet	Petkova, VI (corresponding author), Karolinska Inst, Dept Neurosci, Brain Body & Self Lab, Stockholm, Sweden.	henrik.ehrsson@ki.se			European Research Council; Swedish Foundation for Strategic Research; Soderbergska Stiftelsen; James S. McDonnell Foundation; Human Frontier Science Program; graduate school of the Stockholm Brain Institute	European Research Council(European Research Council (ERC)European Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Soderbergska Stiftelsen; James S. McDonnell Foundation; Human Frontier Science Program(Human Frontier Science Program); graduate school of the Stockholm Brain Institute	This study was funded by the European Research Council, the Swedish Foundation for Strategic Research, Soderbergska Stiftelsen, James S. McDonnell Foundation, and the Human Frontier Science Program. VIP is supported by the graduate school of the Stockholm Brain Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amedi A, 2003, NAT NEUROSCI, V6, P758, DOI 10.1038/nn1072; Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Avillac M, 2005, NAT NEUROSCI, V8, P941, DOI 10.1038/nn1480; Azanon E, 2010, CURR BIOL, V20, P1304, DOI 10.1016/j.cub.2010.05.063; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Botvinick M, 2004, SCIENCE, V305, P782, DOI 10.1126/science.1101836; Brozzoli C, 2010, NEUROPSYCHOLOGIA, V48, P796, DOI 10.1016/j.neuropsychologia.2009.10.009; Brozzoli C, 2011, J NEUROSCI, V31, P9023, DOI 10.1523/JNEUROSCI.1172-11.2011; Buchel C, 1998, BRAIN, V121, P409, DOI 10.1093/brain/121.3.409; Burton H, 2002, J NEUROPHYSIOL, V87, P589, DOI 10.1152/jn.00285.2001; Carriere BN, 2007, J NEUROPHYSIOL, V98, P2858, DOI 10.1152/jn.00587.2007; Cattaneo Z, 2008, NEUROSCI BIOBEHAV R, V32, P1346, DOI 10.1016/j.neubiorev.2008.05.002; Chen AH, 2011, J NEUROSCI, V31, P12036, DOI 10.1523/JNEUROSCI.0395-11.2011; COLBY CL, 1993, J NEUROPHYSIOL, V69, P902, DOI 10.1152/jn.1993.69.3.902; Costantini M, 2007, CONSCIOUS COGN, V16, P229, DOI 10.1016/j.concog.2007.01.001; Duhamel JR, 1998, J NEUROPHYSIOL, V79, P126, DOI 10.1152/jn.1998.79.1.126; Ehrsson H.H., 2012, NEW HDB MULTISENSORY, P775, DOI DOI 10.1126/SCIENCE.1097011; Ehrsson HH, 2007, SCIENCE, V317, P1048, DOI 10.1126/science.1142175; Ehrsson HH, 2005, PLOS BIOL, V3, P2200, DOI 10.1371/journal.pbio.0030412; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fiehler K, 2009, NEUROPSYCHOLOGIA, V47, P897, DOI 10.1016/j.neuropsychologia.2008.12.023; Gentile G, 2011, J NEUROPHYSIOL, V105, P910, DOI 10.1152/jn.00840.2010; Goldreich D, 2003, J NEUROSCI, V23, P3439; Graziano MSA, 2006, NEUROPSYCHOLOGIA, V44, P2621, DOI 10.1016/j.neuropsychologia.2005.09.011; Graziano MSA, 1999, NATURE, V397, P428, DOI 10.1038/17115; Graziano MSA, 1998, CURR OPIN NEUROBIOL, V8, P195, DOI 10.1016/S0959-4388(98)80140-2; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Graziano MSA, 2000, SCIENCE, V290, P1782, DOI 10.1126/science.290.5497.1782; Graziano MSA, 2002, ATTENTION PERFORM, V19, P136; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; Hagura N, 2009, CEREB CORTEX, V19, P176, DOI 10.1093/cercor/bhn068; Held R, 2011, NAT NEUROSCI, V14, P551, DOI 10.1038/nn.2795; Heller M., 1991, PSYCHOL TOUCH, P239; Hotting K, 2009, HEARING RES, V258, P165, DOI 10.1016/j.heares.2009.07.012; KELLOGG WN, 1962, SCIENCE, V137, P399, DOI 10.1126/science.137.3528.399; Kupers R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00019; LACKNER JR, 1988, BRAIN, V111, P281, DOI 10.1093/brain/111.2.281; Lackner JR, 2005, ANNU REV PSYCHOL, V56, P115, DOI 10.1146/annurev.psych.55.090902.142023; Ladavas E., 2006, HUMAN BODY PERCEPTIO, P89; Lloyd DM, 2003, NAT NEUROSCI, V6, P17, DOI 10.1038/nn991; Lloyd DM, 2007, BRAIN COGNITION, V64, P104, DOI 10.1016/j.bandc.2006.09.013; Locke J., 2011, ESSAY HUMAN UNDERSTA; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; Makin TR, 2007, J NEUROSCI, V27, P731, DOI 10.1523/JNEUROSCI.3653-06.2007; Maravita A, 2004, TRENDS COGN SCI, V8, P79, DOI 10.1016/j.tics.2003.12.008; Moseley GL, 2008, P NATL ACAD SCI USA, V105, P13169, DOI 10.1073/pnas.0803768105; Naito E, 1999, J NEUROSCI, V19, P6134, DOI 10.1523/JNEUROSCI.19-14-06134.1999; Naito E, 2002, NEURON, V36, P979, DOI 10.1016/S0896-6273(02)00980-7; Naito E, 2001, NEUROREPORT, V12, P3805, DOI 10.1097/00001756-200112040-00041; Pavani F, 2000, PSYCHOL SCI, V11, P353, DOI 10.1111/1467-9280.00270; Petkova VI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003832; Pouget A, 2002, NAT REV NEUROSCI, V3, P741, DOI 10.1038/nrn914; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; RAUSCHECKER JP, 1995, TRENDS NEUROSCI, V18, P36, DOI 10.1016/0166-2236(95)93948-W; Rauschecker JP, 2004, HDB MULTISENSORY PRO, P695; Roder B, 2004, CURR BIOL, V14, P121, DOI 10.1016/j.cub.2003.12.054; Roder B, 1999, NATURE, V400, P162, DOI 10.1038/22106; Roder B., 2004, HDB MULTISENSORY PRO, P719; Roder B, 2007, P NATL ACAD SCI USA, V104, P4753, DOI 10.1073/pnas.0607158104; Rohde M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021659; Roll JP, 2009, J NEUROPHYSIOL, V101, P816, DOI 10.1152/jn.91075.2008; Sathian K, 2002, BEHAV BRAIN RES, V135, P127, DOI 10.1016/S0166-4328(02)00141-9; Sathian K, 2005, DEV PSYCHOBIOL, V46, P279, DOI 10.1002/dev.20056; Sathian K, 2010, RESTOR NEUROL NEUROS, V28, P271, DOI 10.3233/RNN-2010-0534; Schicke T, 2006, P NATL ACAD SCI USA, V103, P11808, DOI 10.1073/pnas.0601486103; Schutz-Bosbach S, 2009, BRAIN COGNITION, V70, P136, DOI 10.1016/j.bandc.2009.01.006; Serino A, 2007, PSYCHOL SCI, V18, P642, DOI 10.1111/j.1467-9280.2007.01952.x; Serino A, 2011, J COGNITIVE NEUROSCI, V23, P2956, DOI 10.1162/jocn_a_00006; Shimada S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006185; Shore DI, 2002, COGNITIVE BRAIN RES, V14, P153, DOI 10.1016/S0926-6410(02)00070-8; STRELOW ER, 1985, PSYCHOL REV, V92, P226, DOI 10.1037/0033-295X.92.2.226; ThinusBlanc C, 1997, PSYCHOL BULL, V121, P20, DOI 10.1037/0033-2909.121.1.20; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2010, EXP BRAIN RES, V204, P343, DOI 10.1007/s00221-009-2039-3; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; van Beers RJ, 2002, CURR BIOL, V12, P834, DOI 10.1016/S0960-9822(02)00836-9; van Beers RJ, 1998, EXP BRAIN RES, V122, P367, DOI 10.1007/s002210050525; Van Boven RW, 2000, NEUROLOGY, V54, P2230; Von Senden M., 1960, SPACE SIGHT; Wallace MT, 1997, J NEUROSCI, V17, P2429; Wallace MT, 2004, J NEUROSCI, V24, P9580, DOI 10.1523/JNEUROSCI.2535-04.2004; Walsh LD, 2011, J PHYSIOL-LONDON, V589, P3009, DOI 10.1113/jphysiol.2011.204941; WELCH RB, 1986, HDB PERCEPTION HUMAN; White RC, 2011, CONSCIOUS COGN, V20, P956, DOI 10.1016/j.concog.2011.03.021; White RC, 2010, CONSCIOUS COGN, V19, P505, DOI 10.1016/j.concog.2009.08.003; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Wong M, 2011, J NEUROSCI, V31, P7028, DOI 10.1523/JNEUROSCI.6461-10.2011; Yamamoto S, 2001, NAT NEUROSCI, V4, P759, DOI 10.1038/89559	90	37	38	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35912	10.1371/journal.pone.0035912	http://dx.doi.org/10.1371/journal.pone.0035912			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558268	Green Published, gold			2022-12-27	WOS:000305336000083
J	Sardi, ML; Rozzi, FVR				Sardi, Marina L.; Rozzi, Fernando V. Ramirez			Different Cranial Ontogeny in Europeans and Southern Africans	PLOS ONE			English	Article							HETEROCHRONY; GROWTH; APPORTIONMENT; EVOLUTION; SHAPE	Modern human populations differ in developmental processes and in several phenotypic traits. However, the link between ontogenetic variation and human diversification has not been frequently addressed. Here, we analysed craniofacial ontogenies by means of geometric-morphometrics of Europeans and Southern Africans, according to dental and chronological ages. Results suggest that different adult cranial morphologies between Southern Africans and Europeans arise by a combination of processes that involve traits modified during the prenatal life and others that diverge during early postnatal ontogeny. Main craniofacial changes indicate that Europeans differ from Southern Africans by increasing facial developmental rates and extending the attainment of adult size and shape. Since other studies have suggested that native subsaharan populations attain adulthood earlier than Europeans, it is probable that facial ontogeny is linked with other developmental mechanisms that control the timing of maturation in other variables. Southern Africans appear as retaining young features in adulthood. Facial ontogeny in Europeans produces taller and narrower noses, which seems as an adaptation to colder environments. The lack of these morphological traits in Neanderthals, who lived in cold environments, seems a paradox, but it is probably the consequence of a warm-adapted faces together with precocious maturation. When modern Homo sapiens migrated into Asia and Europe, colder environments might establish pressures that constrained facial growth and development in order to depart from the warm-adapted morphology. Our results provide some answers about how cranial growth and development occur in two human populations and when developmental shifts take place providing a better adaptation to environmental constraints.	[Sardi, Marina L.] Univ Nacl La Plata, CONICET, Fac Ciencias Nat & Museo, Div Antropol, La Plata, Buenos Aires, Argentina; [Rozzi, Fernando V. Ramirez] CNRS, UPR 2147, Paris, France	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Museo La Plata; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE)	Sardi, ML (corresponding author), Univ Nacl La Plata, CONICET, Fac Ciencias Nat & Museo, Div Antropol, La Plata, Buenos Aires, Argentina.	msardi@fcnym.unlp.edu.ar		Sardi, Marina L./0000-0003-3614-8341	Agencia Nacional de Promocion Cientifica y Tecnica, Argentina [PICT 1822]; Universidad Nacional de La Plata, Argentina [PI N531]	Agencia Nacional de Promocion Cientifica y Tecnica, Argentina(ANPCyT); Universidad Nacional de La Plata, Argentina(National University of La Plata)	Financial support was provided by: PICT 1822 Agencia Nacional de Promocion Cientifica y Tecnica, Argentina [http://www.agencia.gov.ar/] and PI N531 Universidad Nacional de La Plata, Argentina [www.unlp.edu.ar]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba DM, 2002, HUMAN EVOLUTION THROUGH DEVELOPMENTAL CHANGE, P28; ALBERCH P, 1979, PALEOBIOLOGY, V5, P296, DOI 10.1017/S0094837300006588; Arthur W, 2002, NATURE, V415, P757, DOI 10.1038/415757a; Cobb SN, 2007, J HUM EVOL, V53, P176, DOI 10.1016/j.jhevol.2007.03.006; Cobb SN, 2004, J EXP ZOOL PART B, V302B, P302, DOI 10.1002/jez.b.21005; Dayal MR, 2009, AM J PHYS ANTHROPOL, V140, P324, DOI 10.1002/ajpa.21072; de Leon MSP, 2001, NATURE, V412, P534, DOI 10.1038/35087573; Enlow DH, 1996, CRECIMIENTO FACIAL; EVELETH PB, 1986, HUMAN GROWTH, V3, P221; FRANCISCUS RG, 1991, AM J PHYS ANTHROPOL, V85, P419, DOI 10.1002/ajpa.1330850406; Frelat MA, 2011, AM J HUM BIOL, V23, P796, DOI 10.1002/ajhb.21217; Gerber S, 2007, EVOL DEV, V9, P472, DOI 10.1111/j.1525-142X.2007.00185.x; GODFREY LR, 1995, J HUM EVOL, V29, P405, DOI 10.1006/jhev.1995.1066; Gould S. J., 1977, ONTOGENY PHYLOGENY; Hanihara T, 2000, AM J PHYS ANTHROPOL, V111, P105, DOI 10.1002/(SICI)1096-8644(200001)111:1<105::AID-AJPA7>3.0.CO;2-O; Hennessy RJ, 2002, AM J PHYS ANTHROPOL, V117, P37, DOI 10.1002/ajpa.10005; Holton NE, 2008, J HUM EVOL, V55, P942, DOI 10.1016/j.jhevol.2008.07.001; Howells WW, 1989, SKULL SHAPES MAP; Hubbe M, 2009, ANAT REC, V292, P1720, DOI 10.1002/ar.20976; Klingenberg CP, 1998, BIOL REV, V73, P79, DOI 10.1017/S000632319800512X; Krovitz G.E., 2003, PATTERNS GROWTH DEV, P320; Lahr M. M, 1996, EVOLUTION MODERN HUM; Lieberman DE, 2007, J HUM EVOL, V52, P647, DOI 10.1016/j.jhevol.2006.12.005; Lieberman DE, 2004, J EXP ZOOL PART B, V302B, P284, DOI 10.1002/jez.b.21004; Liversidge H, 2008, TECHNIQUE APPL DENT, P234; McKinney ML, 1991, HETEROCHORONY EVOLUT; Mitteroecker P, 2004, ANN ANAT, V186, P463, DOI 10.1016/S0940-9602(04)80085-2; Mitteroecker P, 2005, EVOL DEV, V7, P244, DOI 10.1111/j.1525-142X.2005.05027.x; MOSS ML, 1960, AM J PHYS ANTHROPOL, V18, P281, DOI 10.1002/ajpa.1330180406; Noback ML, 2011, AM J PHYS ANTHROPOL, V145, P599, DOI 10.1002/ajpa.21523; Olze A, 2007, INT J LEGAL MED, V121, P445, DOI 10.1007/s00414-007-0171-9; PASQUET P, 1996, CAHIERS ANTHR BIOM H, V14, P223; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rae TC, 2006, P R SOC B, V273, P2606; Rae TC, 2011, J HUM EVOL, V60, P234, DOI 10.1016/j.jhevol.2010.10.003; Raff R.A., 1996, SHAPE LIFE; Reid DJ, 2006, J HUM EVOL, V50, P329, DOI 10.1016/j.jhevol.2005.09.003; Relethford JH, 2002, AM J PHYS ANTHROPOL, V118, P393, DOI 10.1002/ajpa.10079; Relethford JH, 2004, AM J HUM BIOL, V16, P379, DOI 10.1002/ajhb.20045; Roseman CC, 2004, AM J PHYS ANTHROPOL, V125, P257, DOI 10.1002/ajpa.10424; Rozzi FVR, 2005, J HUM EVOL, V49, P515, DOI 10.1016/j.jhevol.2005.06.002; Rozzi FVR, 2004, NATURE, V428, P936, DOI 10.1038/nature02428; Sgouros S, 1999, J NEUROSURG, V91, P610, DOI 10.3171/jns.1999.91.4.0610; Smith KK, 1996, AM ZOOL, V36, P70; Sperber G.H., 2001, CRANIOFACIAL DEV; Vioarsdottir US, 2002, J ANAT, V201, P211; Zollikofer CPE, 2010, SEMIN CELL DEV BIOL, V21, P441, DOI 10.1016/j.semcdb.2009.10.012	48	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35917	10.1371/journal.pone.0035917	http://dx.doi.org/10.1371/journal.pone.0035917			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TJ	22558270	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000084
J	Tao, XQ; Chen, XJ; Yang, X; Tian, J				Tao, Xunqiang; Chen, Xinjian; Yang, Xin; Tian, Jie			Fingerprint Recognition with Identical Twin Fingerprints	PLOS ONE			English	Article							VERIFICATION; SIMILARITY; SYSTEMS	Fingerprint recognition with identical twins is a challenging task due to the closest genetics-based relationship existing in the identical twins. Several pioneers have analyzed the similarity between twins' fingerprints. In this work we continue to investigate the topic of the similarity of identical twin fingerprints. Our study was tested based on a large identical twin fingerprint database that contains 83 twin pairs, 4 fingers per individual and six impressions per finger: 3984 (83*2*4*6) images. Compared to the previous work, our contributions are summarized as follows: (1) Two state-of-the-art fingerprint identification methods: P071 and VeriFinger 6.1 were used, rather than one fingerprint identification method in previous studies. (2) Six impressions per finger were captured, rather than just one impression, which makes the genuine distribution of matching scores more realistic. (3) A larger sample (83 pairs) was collected. (4) A novel statistical analysis, which aims at showing the probability distribution of the fingerprint types for the corresponding fingers of identical twins which have same fingerprint type, has been conducted. (5) A novel analysis, which aims at showing which finger from identical twins has higher probability of having same fingerprint type, has been conducted. Our results showed that: (a) A state-of-the-art automatic fingerprint verification system can distinguish identical twins without drastic degradation in performance. (b) The chance that the fingerprints have the same type from identical twins is 0.7440, comparing to 0.3215 from non-identical twins. (c) For the corresponding fingers of identical twins which have same fingerprint type, the probability distribution of five major fingerprint types is similar to the probability distribution for all the fingers' fingerprint type. (d) For each of four fingers of identical twins, the probability of having same fingerprint type is similar.	[Tao, Xunqiang; Yang, Xin; Tian, Jie] Chinese Acad Sci, Inst Automat, Ctr Biometr & Secur Res, Beijing, Peoples R China; [Chen, Xinjian] Univ Iowa, Dept Elect & Comp Engn, Iowa City, IA 52242 USA; [Tian, Jie] Xidian Univ, Sch Elect Engn, Life Sci Res Ctr, Xian 710071, Shaanxi, Peoples R China	Chinese Academy of Sciences; Institute of Automation, CAS; University of Iowa; Xidian University	Tao, XQ (corresponding author), Chinese Acad Sci, Inst Automat, Ctr Biometr & Secur Res, Beijing, Peoples R China.	tian@ieee.org	Tian, Jie/M-5976-2013; Tian, Jie/H-1190-2011; Chen, Xinjian/E-8592-2016	Tian, Jie/0000-0003-0498-0432; Chen, Xinjian/0000-0002-0871-293X	National Natural Science Foundation of China [60875018]; Beijing Natural Science Foundation [4091004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This paper is supported by the Project of National Natural Science Foundation of China under Grant 60875018 and the Beijing Natural Science Foundation under Grant 4091004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariyaeeinia A, 2008, SCI JUSTICE, V48, P182, DOI 10.1016/j.scijus.2008.02.002; Cappelli R, 2006, IEEE T PATTERN ANAL, V28, P3, DOI 10.1109/TPAMI.2006.20; Chen XJ, 2006, IEEE T IMAGE PROCESS, V15, P767, DOI 10.1109/TIP.2005.860597; Flom L., 1987, U.S. Patent, Patent No. [4641349, 4,641,349]; Garris M.D., 2004, 6813 NISTIR US DEP C; Han Y, 2004, LECT NOTES COMPUT SC, V3506, P467; Hollingsworth K, 2010, P 2010 IEEE COMP SOC; Jain AK, 1997, P IEEE, V85, P1365, DOI 10.1109/5.628674; Jain AK, 2002, PATTERN RECOGN, V35, P2653, DOI 10.1016/S0031-3203(01)00218-7; JAIN AK, 1999, BIOMETRICS PERSONAL; Kong AWK, 2006, PATTERN RECOGN, V39, P2149, DOI 10.1016/j.patcog.2006.04.035; Nora J. J., 1994, MED GENETICS PRINCIP; Phillips PJ, 2000, COMPUTER, V33, P56, DOI 10.1109/2.820040; Srihari SN, 2008, J FORENSIC IDENTIFIC, V58, P109; Sun ZN, 2010, BIOMETRIC TECHNOLOGY, VVii, P7667	15	6	6	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35704	10.1371/journal.pone.0035704	http://dx.doi.org/10.1371/journal.pone.0035704			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558204	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000050
J	Beilke, JN; Meagher, CT; Hosiawa, K; Champsaur, M; Bluestone, JA; Lanier, LL				Beilke, Joshua N.; Meagher, Craig T.; Hosiawa, Karoline; Champsaur, Marine; Bluestone, Jeffrey A.; Lanier, Lewis L.			NK Cells Are Not Required for Spontaneous Autoimmune Diabetes in NOD Mice	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; CENTRAL-NERVOUS-SYSTEM; AUTOREACTIVE T-CELLS; IFN-GAMMA; IMMUNITY; ACTIVATION; INDUCTION; MECHANISM; ARTHRITIS; SUBSETS	NK cells have been shown to either promote or protect from autoimmune diseases. Several studies have examined the role of receptors preferentially expressed by NK cells in the spontaneous disease of NOD mice or the direct role of NK cells in acute induced disease models of diabetes. Yet, the role of NK cells in spontaneous diabetes has not been directly addressed. Here, we used the NOD.NK1.1 congenic mouse model to examine the role of NK cells in spontaneous diabetes. Significant numbers of NK cells were only seen in the pancreas of mice with disease. Pancreatic NK cells displayed an activated surface phenotype and proliferated more than NK cells from other tissues in the diseased mice. Nonetheless, depletion of NK cells had no effect on dendritic cell maturation or T cell proliferation. In spontaneous disease, the deletion of NK cells had no significant impact on disease onset. NK cells were also not required to promote disease induced by adoptively transferred pathogenic CD4(+) T cells. Thus, NK cells are not required for spontaneous autoimmune diabetes in NOD mice.	[Beilke, Joshua N.; Champsaur, Marine; Lanier, Lewis L.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Beilke, Joshua N.; Champsaur, Marine; Lanier, Lewis L.] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; [Meagher, Craig T.] Univ Calif San Francisco, Proctor Fdn, San Francisco, CA 94143 USA; [Hosiawa, Karoline] Univ Calif San Francisco, Div Rheumatol, Dept Med, San Francisco, CA USA; [Bluestone, Jeffrey A.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Beilke, JN (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	lewis.lanier@ucsf.edu	Lanier, Lewis L/E-2139-2014	Lanier, Lewis L/0000-0003-1308-3952	NIH [AI066897]; JDRF postdoctoral fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI066897] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF postdoctoral fellowship(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by NIH grant AI066897. L.L.L. is an American Cancer Society Professor and a JDRF postdoctoral fellowship supported J.N.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Brauner H, 2010, J IMMUNOL, V184, P2272, DOI 10.4049/jimmunol.0804358; Cooper MA, 2009, P NATL ACAD SCI USA, V106, P1915, DOI 10.1073/pnas.0813192106; Dilts SM, 1999, J AUTOIMMUN, V13, P285, DOI 10.1006/jaut.1999.0323; Ferlazzo G, 2009, J CLIN IMMUNOL, V29, P265, DOI 10.1007/s10875-009-9283-y; Feuerer M, 2009, IMMUNITY, V31, P654, DOI 10.1016/j.immuni.2009.08.023; Gur C, 2010, NAT IMMUNOL, V11, P121, DOI 10.1038/ni.1834; Hao JW, 2010, J EXP MED, V207, P1907, DOI 10.1084/jem.20092749; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Leavenworth JW, 2010, P NATL ACAD SCI USA, V107, P2562, DOI 10.1073/pnas.0914732107; Lee IF, 2008, EUR J IMMUNOL, V38, P82, DOI 10.1002/eji.200737189; Liao YP, 2007, FRONT BIOSCI-LANDMRK, V12, P3576, DOI 10.2741/2336; Lo CKC, 2008, ARTHRITIS RHEUM, V58, P2700, DOI 10.1002/art.23760; Melli K, 2009, J IMMUNOL, V182, P2590, DOI 10.4049/jimmunol.0803543; Miyake T, 2009, J IMMUNOL, V183, P2522, DOI 10.4049/jimmunol.0901500; Naumov YN, 2001, P NATL ACAD SCI USA, V98, P13838, DOI 10.1073/pnas.251531798; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Ogasawara K, 2004, IMMUNITY, V20, P757, DOI 10.1016/j.immuni.2004.05.008; Poirot L, 2004, P NATL ACAD SCI USA, V101, P8102, DOI 10.1073/pnas.0402065101; Satoh-Takayama N, 2009, J IMMUNOL, V183, P6579, DOI 10.4049/jimmunol.0901935; Schleinitz N, 2010, IMMUNOLOGY, V131, P451, DOI 10.1111/j.1365-2567.2010.03360.x; Shi FD, 2000, J IMMUNOL, V165, P3099, DOI 10.4049/jimmunol.165.6.3099; Shi FD, 2006, NAT REV IMMUNOL, V6, P751, DOI 10.1038/nri1935; Soderstrom K, 2010, P NATL ACAD SCI USA, V107, P13028, DOI 10.1073/pnas.1000546107; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Suwanai H, 2010, P NATL ACAD SCI USA, V107, P9305, DOI 10.1073/pnas.1004492107; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Xu W, 2005, J NEUROIMMUNOL, V163, P24, DOI 10.1016/j.jneuroim.2005.02.011	29	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e36011	10.1371/journal.pone.0036011	http://dx.doi.org/10.1371/journal.pone.0036011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558306	gold, Green Published			2022-12-27	WOS:000305345200109
J	Westerlund, H; Gustafsson, PE; Theorell, T; Janlert, U; Hammarstrom, A				Westerlund, Hugo; Gustafsson, Per E.; Theorell, Tores; Janlert, Urban; Hammarstrom, Anne			Social Adversity in Adolescence Increases the Physiological Vulnerability to Job Strain in Adulthood: A Prospective Population-Based Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MIDDLE-AGED WOMEN; RISK-FACTORS; ALLOSTATIC LOAD; SOCIOECONOMIC-STATUS; PSYCHOSOCIAL FACTORS; CARDIOVASCULAR RISK; CUMULATIVE RISK; WORK STRESS; LIFE-COURSE	Background: It has been argued that the association between job strain and health could be confounded by early life exposures, and studies have shown early adversity to increase individual vulnerability to later stress. We therefore investigated if early life exposure to adversity increases the individual's physiological vulnerability job strain in adulthood. Methodology/Principal Findings: In a population-based cohort (343 women and 330 men, 83% of the eligible participants), we examined the association between on the one hand exposure to adversity in adolescence, measured at age 16, and job strain measured at age 43, and on the other hand allostatic load at age 43. Adversity was operationalised as an index comprising residential mobility and crowding, parental loss, parental unemployment, and parental physical and mental illness (including substance abuse). Allostatic load summarised body fat, blood pressure, inflammatory markers, glucose, blood lipids, and cortisol regulation. There was an interaction between adversity in adolescence and job strain (B = 0.09, 95% CI 0.02 to 0.16 after adjustment for socioeconomic status), particularly psychological demands, indicating that job strain was associated with increased allostatic load only among participants with adversity in adolescence. Job strain was associated with lower allostatic load in men (beta = -0.20, 95% CI -0.35 to -0.06). Conclusions/Significance: Exposure to adversity in adolescence was associated with increased levels of biological stress among those reporting job strain in mid-life, indicating increased vulnerability to environmental stressors.	[Westerlund, Hugo; Theorell, Tores] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Gustafsson, Per E.; Hammarstrom, Anne] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Janlert, Urban] Umea Univ, Dept Publ Hlth & Clin Med Epidemiol & Publ Hlth, Umea, Sweden	Stockholm University; Umea University; Umea University	Westerlund, H (corresponding author), Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden.	hugo.westerlund@stress.su.se	Gustafsson, Per/AAY-5068-2021; Westerlund, Hugo/A-3049-2012	Westerlund, Hugo/0000-0002-8806-5698; Hammarstrom, Anne/0000-0002-4095-7961	Swedish Research Council [VR] [521-2005-4084]; Swedish Council for Working Life and Social Research [FAS] [2006-0950]; Umea University [Young Researcher Award] [223-514-09]	Swedish Research Council [VR](Swedish Research Council); Swedish Council for Working Life and Social Research [FAS](Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Umea University [Young Researcher Award]	This work was supported by the Swedish Research Council [VR, grant number 521-2005-4084] and by the Swedish Council for Working Life and Social Research [FAS, grant number 2006-0950] and PEG by Umea University [Young Researcher Award 2011, grant no. 223-514-09]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam EK, 2009, PSYCHONEUROENDOCRINO, V34, P1423, DOI 10.1016/j.psyneuen.2009.06.011; Alfredsson L, 2002, SCAND J WORK ENV HEA, V28, P238, DOI 10.5271/sjweh.671; Belkic KL, 2004, SCAND J WORK ENV HEA, V30, P85, DOI 10.5271/sjweh.769; Chandola T, 2006, BMJ-BRIT MED J, V332, P521, DOI 10.1136/bmj.38693.435301.80; Dong MX, 2004, CIRCULATION, V110, P1761, DOI 10.1161/01.CIR.0000143074.54995.7F; Eller NH, 2009, CARDIOL REV, V17, P83, DOI 10.1097/CRD.0b013e318198c8e9; Elovainio M, 2007, SOC SCI MED, V65, P187, DOI 10.1016/j.socscimed.2007.02.052; Evans GW, 2007, DEV PSYCHOL, V43, P341, DOI 10.1037/0012-1649.43.2.341; Evans GW, 2003, DEV PSYCHOL, V39, P924, DOI 10.1037/0012-1649.39.5.924; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Glei DA, 2007, PSYCHOSOM MED, V69, P769, DOI 10.1097/PSY.0b013e318157cba6; Guimont C, 2006, AM J PUBLIC HEALTH, V96, P1436, DOI 10.2105/AJPH.2004.057679; Gunnar MR, 2007, PROG BRAIN RES, V167, P137, DOI 10.1016/S0079-6123(07)67010-1; Gustafsson PE, 2012, ANN BEHAV MED, V43, P117, DOI 10.1007/s12160-011-9309-6; Gustafsson PE, 2011, J EPIDEMIOL COMMUN H, V65, P986, DOI 10.1136/jech.2010.108332; Gustafsson PE, 2011, ANN EPIDEMIOL, V21, P103, DOI 10.1016/j.annepidem.2010.08.012; Hammarstrom A, 2005, SOC SCI MED, V61, P2221, DOI 10.1016/j.socscimed.2005.04.020; Hammarstrom A, 1986, THESIS KAROLINSKA I; Hanson LLM, 2009, INT ARCH OCC ENV HEA, V82, P951, DOI 10.1007/s00420-009-0406-9; Hellhammer J, 2007, PSYCHONEUROENDOCRINO, V32, P80, DOI 10.1016/j.psyneuen.2006.10.005; Hemmingsson T, 2006, INT J EPIDEMIOL, V35, P616, DOI 10.1093/ije/dyi308; Hertzman C, 2010, ANNU REV PUBL HEALTH, V31, P329, DOI 10.1146/annurev.publhealth.012809.103538; Hintsa T, 2010, OCCUP ENVIRON MED, V67, P330, DOI 10.1136/oem.2009.048470; Hintsanen M, 2010, STRESS, V13, P425, DOI 10.3109/10253891003692753; Hintsanen M, 2007, ANN BEHAV MED, V33, P148, DOI 10.1007/BF02879896; Howe LD, 2010, INT J OBESITY, V34, P1149, DOI 10.1038/ijo.2010.52; Johansson S, 1970, ADULT POPULATIONS ST; Karasek R, 1990, HLTH WORK STRESS PRO; Kiecolt-Glaser JK, 2011, PSYCHOSOM MED, V73, P16, DOI 10.1097/PSY.0b013e31820573b6; Kivimaki M, 2008, J EPIDEMIOL COMMUN H, V62, P372, DOI 10.1136/jech.2007.063578; Kivimaki M, 2007, AM J PUBLIC HEALTH, V97, P450, DOI 10.2105/AJPH.2005.078873; Kivimaki M, 2006, SCAND J WORK ENV HEA, V32, P431, DOI 10.5271/sjweh.1049; Kivimaki M, 2006, PSYCHOSOM MED, V68, P398, DOI 10.1097/01.psy.0000221252.84351.e2; Landsbergis P, 2000, OCCUP MED, V15, P163; Landsbergis PA, 2008, SCAND J WORK ENV HEA, P41; Macleod J, 2003, J EPIDEMIOL COMMUN H, V57, P565, DOI 10.1136/jech.57.8.565; Maina G, 2009, INT ARCH OCC ENV HEA, V82, P1141, DOI 10.1007/s00420-009-0439-0; McEwen BS, 2000, BRAIN RES, V886, P172, DOI 10.1016/S0006-8993(00)02950-4; McGowan PO, 2010, NEUROBIOL DIS, V39, P66, DOI 10.1016/j.nbd.2009.12.026; McLaughlin KA, 2009, PSYCHOL MED, P1; Miller GE, 2009, P NATL ACAD SCI USA, V106, P14716, DOI 10.1073/pnas.0902971106; Poulton R, 2002, LANCET, V360, P1640, DOI 10.1016/S0140-6736(02)11602-3; Schnorpfeil P, 2003, SOC SCI MED, V57, P647, DOI 10.1016/S0277-9536(02)00407-0; Seeman TE, 2001, P NATL ACAD SCI USA, V98, P4770, DOI 10.1073/pnas.081072698; Statistics Sweden, 1984, 19824 STAT SWED; Steptoe A, 2003, PSYCHOSOM MED, V65, P1029, DOI 10.1097/01.PSY.0000097347.57237.2D; Theorell T, 2004, R OCC ST W, V3, P323; THEORELL T, 1988, SCAND J WORK ENV HEA, V14, P189, DOI 10.5271/sjweh.1932; Theorell T, 2002, EUR HEART J, V23, P1799, DOI 10.1053/euhj.2002.3293; Thomas C, 2010, INT J EPIDEMIOL, V39, P812, DOI 10.1093/ije/dyp365; THORSLUND M, 1985, SOC INDIC RES, V16, P77, DOI 10.1007/BF00317661; Ursin H, 2010, NEUROSCI BIOBEHAV R, V34, P877, DOI 10.1016/j.neubiorev.2009.03.001; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276	53	25	25	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35967	10.1371/journal.pone.0035967	http://dx.doi.org/10.1371/journal.pone.0035967			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VP	22558285	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345200098
J	Yin, ZJ; Li, Y; Han, XL; Shen, FF				Yin, Zujun; Li, Yan; Han, Xiulan; Shen, Fafu			Genome-Wide Profiling of miRNAs and Other Small Non-Coding RNAs in the Verticillium dahliae-Inoculated Cotton Roots	PLOS ONE			English	Article							STRESS-RESPONSIVE MICRORNAS; CONSERVED MICRORNAS; REGULATED MICRORNAS; PLANT MICRORNAS; TARGET GENES; ARABIDOPSIS; IDENTIFICATION; GOSSYPIUM; IMMUNITY; SIRNA	MicroRNAs (miRNAs) and small interfering RNAs (siRNAs) are short (19-25 nucleotides) non-coding RNA molecules that have large-scale regulatory effects on development and stress responses in plants. Verticillium wilt is a vascular disease in plants caused by the fungal pathogen Verticillium dahliae. The objective of this study is to investigate the transcriptional profile of miRNAs and other small non-coding RNAs in Verticillium-inoculated cotton roots. Four small RNA libraries were constructed from mocked and infected roots of two cotton cultured species which are with different Verticillium wilt tolerance ('Hai-7124', Gossypium barbadense L., a Verticillium-tolerant cultivar, and 'Yi-11', Gossypium hirsutum L. a Verticillium-sensitive cultivar). The length distribution of obtained small RNAs was significantly different between libraries. There were a total of 215 miRNA families identified in the two cotton species. Of them 14 were novel miRNAs. There were >65 families with different expression between libraries. We also identified two trans-acting siRNAs and thousands of endogenous siRNA candidates, and hundred of them exhibited altered expression after inoculation of Verticillium. Interesting, many siRNAs were found with a perfect match with retrotransposon sequences, suggested that retrotransposons maybe one of sources for the generation of plant endogenous siRNAs. The profiling of these miRNAs and other small non-coding RNAs lay the foundation for further understanding of small RNAs function in the regulation of Verticillium defence responses in cotton roots.	[Yin, Zujun; Han, Xiulan; Shen, Fafu] Shandong Agr Univ, Coll Agron, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Yin, Zujun; Li, Yan] Chinese Acad Agr Sci, Cotton Res Inst, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China	Shandong Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Yin, ZJ (corresponding author), Shandong Agr Univ, Coll Agron, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	ffshen@sdau.edu.cn			China Key Development Project for Basic Research [2007CB116208]; China Major Projects for Transgenic Breeding [2011ZX005-004, 2011ZX08005-002, 2009ZX08005-020]	China Key Development Project for Basic Research; China Major Projects for Transgenic Breeding	This work was supported by the China Key Development Project for Basic Research (Grant No. 2007CB116208), and the China Major Projects for Transgenic Breeding (Grant No. 2011ZX005-004, 2011ZX08005-002, 2009ZX08005-020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; [Anonymous], COTTON EST DATABASE; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Bhat RG, 1999, PHYTOPATHOLOGY, V89, P1218, DOI 10.1094/PHYTO.1999.89.12.1218; Cai YF, 2009, AFR J BIOTECHNOL, V8, P7363; Carra A, 2007, ANAL BIOCHEM, V360, P318, DOI 10.1016/j.ab.2006.09.022; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Chen XM, 2002, DEVELOPMENT, V129, P1085; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Ellendorff U, 2009, RNA SILENCING IS REQ, P591; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Fahlgren N, 2006, CURR BIOL, V16, P939, DOI 10.1016/j.cub.2006.03.065; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Hawkins JS, 2009, RAPID DNA LOSS COUNT; Hewezi T, 2008, ARABIDOPSIS SMALL RN, P1622; Jagadeeswaran G, 2009, NEW PHYTOL, V184, P85, DOI 10.1111/j.1469-8137.2009.02915.x; Jia Y, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000737; Joshi T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S14; Katiyar-Agarwal S, 2007, GENE DEV, V21, P3123, DOI 10.1101/gad.1595107; Katiyar-Agarwal S, 2006, P NATL ACAD SCI USA, V103, P18002, DOI 10.1073/pnas.0608258103; Krasnikova MS, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/952304; Kuang H, 2009, IDENTIFICATION MINIA, P42; Le Trionnaire G, 2011, J EXP BOT, V62, P1601, DOI 10.1093/jxb/erq399; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li H, 2010, PLANT PHYSIOL, V153, P1759, DOI 10.1104/pp.110.156950; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Seelanan T, 1999, SYST BOT, V24, P183, DOI 10.2307/2419548; Shen D, 2009, PLANT SYST EVOL, V283, P125, DOI 10.1007/s00606-009-0221-5; Subramanian S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-160; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-37; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Vazquez F, 2006, TRENDS PLANT SCI, V11, P460, DOI 10.1016/j.tplants.2006.07.006; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yan YS, 2011, PLANT J, V65, P820, DOI 10.1111/j.1365-313X.2010.04467.x; Yang C, 2008, PLANT SCI, V174, P290, DOI 10.1016/j.plantsci.2007.11.016; Yin ZJ, 2008, GENE, V414, P60, DOI 10.1016/j.gene.2008.02.007; Zaki EA, 2005, DNA SEQUENCE, V16, P288, DOI 10.1080/10425170500097966; Zhang BH, 2006, COMPUT BIOL CHEM, V30, P395, DOI 10.1016/j.compbiolchem.2006.08.006; Zhang BH, 2007, J CELL PHYSIOL, V210, P279, DOI 10.1002/jcp.20869; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhang BH, 2005, CELL RES, V15, P336, DOI 10.1038/sj.cr.7290302; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang WX, 2011, PLANT MOL BIOL, V75, P93, DOI 10.1007/s11103-010-9710-8; Zhou XF, 2009, GENOME RES, V19, P70, DOI 10.1101/gr.084806.108; Zuo K, 2005, Mol Biol (Mosk), V39, P214	57	83	96	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35765	10.1371/journal.pone.0035765	http://dx.doi.org/10.1371/journal.pone.0035765			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558219	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345200075
J	Tadjuidje, E; Sen Wang, T; Pandey, RN; Sumanas, S; Lang, RA; Hegde, RS				Tadjuidje, Emmanuel; Sen Wang, Tim; Pandey, Ram Naresh; Sumanas, Saulius; Lang, Richard A.; Hegde, Rashmi S.			The EYA Tyrosine Phosphatase Activity Is Pro-Angiogenic and Is Inhibited by Benzbromarone	PLOS ONE			English	Article							BRANCHIOOTORENAL BOR SYNDROME; EYES-ABSENT; HUMAN HOMOLOG; MUTATIONS; MODEL; PROLIFERATION; APOPTOSIS; SURVIVAL; H2AX	Eyes Absents (EYA) are multifunctional proteins best known for their role in organogenesis. There is accumulating evidence that overexpression of EYAs in breast and ovarian cancers, and in malignant peripheral nerve sheath tumors, correlates with tumor growth and increased metastasis. The EYA protein is both a transcriptional activator and a tyrosine phosphatase, and the tyrosine phosphatase activity promotes single cell motility of mammary epithelial cells. Since EYAs are expressed in vascular endothelial cells and cell motility is a critical feature of angiogenesis we investigated the role of EYAs in this process. Using RNA interference techniques we show that EYA3 depletion in human umbilical vein endothelial cells inhibits transwell migration as well as Matrigel-induced tube formation. To specifically query the role of the EYA tyrosine phosphatase activity we employed a chemical biology approach. Through an experimental screen the uricosuric agents Benzbromarone and Benzarone were found to be potent EYA inhibitors, and Benzarone in particular exhibited selectivity towards EYA versus a representative classical protein tyrosine phosphatase, PTP1B. These compounds inhibit the motility of mammary epithelial cells over-expressing EYA2 as well as the motility of endothelial cells. Furthermore, they attenuate tubulogenesis in matrigel and sprouting angiogenesis in the ex vivo aortic ring assay in a dose-dependent fashion. The anti-angiogenic effect of the inhibitors was also demonstrated in vivo, as treatment of zebrafish embryos led to significant and dose-dependent defects in the developing vasculature. Taken together our results demonstrate that the EYA tyrosine phosphatase activity is pro-angiogenic and that Benzbromarone and Benzarone are attractive candidates for repurposing as drugs for the treatment of cancer metastasis, tumor angiogenesis, and vasculopathies.	[Tadjuidje, Emmanuel; Sen Wang, Tim; Pandey, Ram Naresh; Sumanas, Saulius; Lang, Richard A.; Hegde, Rashmi S.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH USA; [Lang, Richard A.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Ophthalmol, Visual Syst Grp, Cincinnati, OH USA; [Hegde, Rashmi S.] Univ Cincinnati, Dept Pediat, Cincinnati, OH 45221 USA; [Lang, Richard A.] Univ Cincinnati, Dept Ophthalmol, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Tadjuidje, E (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH USA.	rashmi.hegde@cchmc.org		Wang, Tim/0000-0001-5518-508X; Lang, Richard/0000-0002-5212-254X	National Institutes of Health [RO1 EY014648, R21 EY019125]; NATIONAL EYE INSTITUTE [R01EY014648, R21EY019125] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health grants RO1 EY014648 to RSH and R21 EY019125 to RSH and RAL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Abdelhak S, 1997, HUM MOL GENET, V6, P2247, DOI 10.1093/hmg/6.13.2247; Abdelhak S, 1997, NAT GENET, V15, P157, DOI 10.1038/ng0297-157; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andreu I, 2009, CURR DRUG METAB, V10, P947, DOI 10.2174/138920009790711823; Aplin AC, 2008, METHOD ENZYMOL, V443, P119, DOI 10.1016/S0076-6879(08)02007-7; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Azuma N, 2000, HUM MOL GENET, V9, P363, DOI 10.1093/hmg/9.3.363; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Economopoulou M, 2009, NAT MED, V15, P553, DOI 10.1038/nm.1947; El-Hashash AHK, 2011, DEV BIOL, V350, P112, DOI 10.1016/j.ydbio.2010.11.022; Farabaugh SM, 2011, ONCOGENE; Gerhardt H, 2005, EXP SUPPL, V94, P3; Guo CS, 2011, J CLIN INVEST, V121, P1585, DOI 10.1172/JCI44630; Ikeda K, 2002, MOL CELL BIOL, V22, P6759, DOI 10.1128/MCB.22.19.6759-6766.2002; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Jung SK, 2009, FASEB J; Krishnan N, 2009, J BIOL CHEM; Langheinrich U, 2003, BIOESSAYS, V25, P904, DOI 10.1002/bies.10326; Lee MHH, 2008, DRUG SAFETY, V31, P643, DOI 10.2165/00002018-200831080-00002; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; Melo F, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P187; Miller SJ, 2010, ONCOGENE, V29, P368, DOI 10.1038/onc.2009.360; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Okabe Y, 2009, NATURE, V460, P520, DOI 10.1038/nature08138; Pandey RN, 2010, ONCOGENE, V29, P3715, DOI 10.1038/onc.2010.122; Pandey RN, 2010, ONCOGENE; Park H, 2011, CHEM BIOL DRUG DES, V78, P642, DOI 10.1111/j.1747-0285.2011.01192.x; Rayapureddi JP, 2006, FEBS LETT, V580, P3853, DOI 10.1016/j.febslet.2006.06.009; Rayapureddi JP, 2005, BIOCHEMISTRY-US, V44, P751, DOI 10.1021/bi0481794; Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093; Reed May J, 2011, Open Circ Vasc J, V4, P12; Ryan AJ, 2003, J MED CHEM, V46, P3448, DOI 10.1021/jm0340896; Sapieha P, 2010, J CLIN INVEST, V120, P3022, DOI 10.1172/JCI42142; Schonberger J, 2005, NAT GENET; Shimasaki N, 2004, PEDIATR CARDIOL, V25, P411, DOI 10.1007/s00246-003-0271-3; Shin HJ, 2011, NEPHROLOGY, V16, P156, DOI 10.1111/j.1440-1797.2010.01368.x; Soker T, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-118; Staton CA, 2009, INT J EXP PATHOL, V90, P195, DOI 10.1111/j.1365-2613.2008.00633.x; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; Tran JC, 2011, NATURE; WALTERSACK I, 1990, EUR J CLIN PHARMACOL, V39, P577, DOI 10.1007/BF00316099; Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1; Wayne S, 2001, HUM MOL GENET, V10, P195, DOI 10.1093/hmg/10.3.195; Wiesmann C, 2004, NAT STRUCT MOL BIOL, V11, P730, DOI 10.1038/nsmb803; Wrobel J, 1999, J MED CHEM, V42, P3199, DOI 10.1021/jm990260v; Xiao A, 2009, NATURE, V457, P57, DOI 10.1038/nature07668; Xu PX, 1999, NAT GENET, V23, P113, DOI 10.1038/12722; Zhang L, 2005, CANCER RES, V65, P925	50	37	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e34806	10.1371/journal.pone.0034806	http://dx.doi.org/10.1371/journal.pone.0034806			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545090	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343200013
J	Mohanty, P; Patel, A; Bhardwaj, AK				Mohanty, Priyabrata; Patel, Arati; Bhardwaj, Ashima Kushwaha			Role of H- and D- MATE-Type Transporters from Multidrug Resistant Clinical Isolates of Vibrio fluvialis in Conferring Fluoroquinolone Resistance	PLOS ONE			English	Article							AMINO-ACID-RESIDUES; EFFLUX PUMPS; DRUG-RESISTANCE; ACTIVE EFFLUX; NORM; MECHANISM; GENE; PARAHAEMOLYTICUS; IDENTIFICATION; DETERMINANTS	Background: The study seeks to understand the role of efflux pumps in multidrug resistance displayed by the clinical isolates of Vibrio fluvialis, a pathogen known to cause cholera-like diarrhoea. Methodology: Two putative MATE family efflux pumps (H- and D-type) were PCR amplified from clinical isolates of V. fluvialis obtained from Kolkata, India, in 2006 and sequenced. Bioinformatic analysis of these proteins was done to predict protein structures. Subsequently, the genes were cloned and expressed in a drug hypersusceptible Escherichia coli strain KAM32 using the vector pBR322. The recombinant clones were tested for the functionality of the efflux pump proteins by MIC determination and drug transport assays using fluorimeter. Results: The sequences of the genes were found to be around 99% identical to their counterparts in V. cholerae. Protein structure predicting servers TMHMM and I-TASSER depicted ten-twelve membrane helical structures for both type of pumps. Real time PCR showed that these genes were expressed in the native V. fluvialis isolates. In the drug transport assays, the V. fluvialis clinical isolates as well as recombinant E. coli harbouring the efflux pump genes showed the energy-dependent and sodium ion-dependent drug transport activity. KAM32 cells harbouring the recombinant plasmids showed elevated MIC to the fluoroquinolones, norfloxacin and ciprofloxacin but H- type pumps VCH and VFH from V. cholerae and V. fluvialis respectively, showed decreased MIC to aminoglycosides like gentamicin, kanamycin and streptomycin. Decrease in MIC was also observed for acriflavin, ethidium bromide, safranin and nalidixic acid. Significance: Increased resistance towards fluoroquinolones exhibited due to these efflux pumps from multidrug resistant clinical isolates of V. fluvialis implies that treatment procedure may become more elaborate for this simple but highly infectious disease. To the best of our knowledge, this is the first report of cloning and characterization of efflux pumps from multidrug resistant clinical isolates of V. fluvialis.	[Mohanty, Priyabrata; Patel, Arati; Bhardwaj, Ashima Kushwaha] Indian Inst Adv Res, Dept Human Hlth & Dis, Gandhinagar, Gujarat, India		Mohanty, P (corresponding author), Indian Inst Adv Res, Dept Human Hlth & Dis, Gandhinagar, Gujarat, India.	ashima.bhardwaj@gmail.com		Mohanty, Pryabrata/0000-0001-9339-9935	Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India [BT/PR10304/GBD/27/95/2008, BT/PR/11634/INF/22/104/2008]; Puri Foundation for Education in India; DBT [BT/PR10304/GBD/27/95/2008]	Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Puri Foundation for Education in India; DBT(Department of Biotechnology (DBT) India)	This work was supported by the grants BT/PR10304/GBD/27/95/2008 and BT/PR/11634/INF/22/104/2008 from Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India. The authors thankfully acknowledge the partial funding received from Puri Foundation for Education in India (www.iiar.res.in). Mr. P. B. Mohanty is a recipient of Junior Research Fellowship from the DBT grant BT/PR10304/GBD/27/95/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AM, 2005, FEMS MICROBIOL LETT, V242, P241, DOI 10.1016/j.femsle.2004.11.012; Ahmed AM, 2004, J ANTIMICROB CHEMOTH, V53, P947, DOI 10.1093/jac/dkh221; Baranwal S, 2002, ANTIMICROB AGENTS CH, V46, P2676, DOI 10.1128/AAC.46.8.2676-2678.2002; Begum A, 2005, MICROBIOL IMMUNOL, V49, P951; Bhardwaj AK, 2012, RECENT PAT IN PRESS; Chen J, 2002, J BACTERIOL, V184, P572, DOI 10.1128/JB.184.2.572-576.2002; He XA, 2010, NATURE, V467, P991, DOI 10.1038/nature09408; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Long F, 2008, ANTIMICROB AGENTS CH, V52, P3052, DOI 10.1128/AAC.00475-08; Ma JY, 2009, ANTIMICROB AGENTS CH, V53, P519, DOI 10.1128/AAC.00886-08; MCMURRY L, 1980, P NATL ACAD SCI-BIOL, V77, P3974, DOI 10.1073/pnas.77.7.3974; Misra R, 2009, BBA-PROTEINS PROTEOM, V1794, P817, DOI 10.1016/j.bbapap.2009.02.017; Morita Y, 1998, ANTIMICROB AGENTS CH, V42, P1778, DOI 10.1128/AAC.42.7.1778; Morita Y, 2000, J BACTERIOL, V182, P6694, DOI 10.1128/JB.182.23.6694-6697.2000; Otsuka M, 2005, J BACTERIOL, V187, P1552, DOI 10.1128/JB.187.5.1552-1558.2005; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Rajpara N, 2009, INT J ANTIMICROB AG, V34, P220, DOI 10.1016/j.ijantimicag.2009.03.020; Singh AK, 2006, ANTIMICROB AGENTS CH, V50, P3717, DOI 10.1128/AAC.00460-06; Singh R, 2011, J MED MICROBIOL, V61, P369; Srinivasan VB, 2006, ANTIMICROB AGENTS CH, V50, P2428, DOI 10.1128/AAC.01561-05; Thungapathra M, 2002, ANTIMICROB AGENTS CH, V46, P2948, DOI 10.1128/AAC.46.9.2948-2955.2002; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702	23	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35752	10.1371/journal.pone.0035752	http://dx.doi.org/10.1371/journal.pone.0035752			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22540001	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341000067
J	Burns, F; Edwards, SG; Woods, J; Haidari, G; Calderon, Y; Leider, J; Morris, S; Tobin, R; Cartledge, J; Brown, M				Burns, Fiona; Edwards, Simon G.; Woods, Jeremy; Haidari, Golaleh; Calderon, Yvette; Leider, Jason; Morris, Stephen; Tobin, Rose; Cartledge, Jonathan; Brown, Michael			Acceptability and Feasibility of Universal Offer of Rapid Point of Care Testing for HIV in an Acute Admissions Unit: Results of the RAPID Project	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT; ENGLAND; WALES; UK	Background: UK guidance recommend all acute medical admissions be offered an HIV test. Our aim was to determine whether a dedicated staff member using a multimedia tool, a model found to be effective in the USA, is an acceptable, feasible, and cost-effective model when translated to a UK setting. Design: Between 14th Jan to 12th May 2010, a Health advisor (HA) approached 19-65 year olds at a central London acute medical admissions unit (AAU) and offered a rapid HIV point of care test (POCT) with the aid of an educational video. Patients with negative results had the option to watch a post-test video providing risk-reduction information. For reactive results the HA arranged a confirmatory test, and ensured linkage into HIV specialist care. Feasibility and acceptability were assessed through surveys and uptake rates. Costs per case of HIV identified were established. Results: Of the 606 eligible people admitted during the pilot period, 324 (53.5%) could not be approached or testing was deemed inappropriate. In total 23.0% of eligible admissions had an HIV POCT. Of the patients who watched the video and had not recently tested for HIV, 93.6% (131/140) agreed to an HIV test; four further patients had an HIV test but did not watch the video. Three tests (2.2%, 3/135) were reactive and all were confirmed HIV positive on laboratory testing. 97.5% felt HIV testing in this setting was appropriate, and 90.1% liked receiving the information via video. The cost per patient of the intervention was 21 pound. Discussion: Universal POCT HIV testing in an acute medical setting, facilitated by an educational video and dedicated staff appears to be acceptable, feasible, effective, and low cost. These findings support the recommendation of HIV testing all admissions to AAU in high prevalence settings, although with the model used a significant proportion remained untested.	[Burns, Fiona] UCL, Res Dept Infect & Populat Hlth, London, England; [Edwards, Simon G.; Woods, Jeremy; Tobin, Rose; Cartledge, Jonathan] Cent & N W London Fdn Trust, Mortimer Market Ctr, London, England; [Haidari, Golaleh; Brown, Michael] Univ Coll London Hosp Natl Hlth Serv Fdn Trust, London, England; [Calderon, Yvette; Leider, Jason] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Morris, Stephen] UCL, Univ Coll London Ctr Appl Hlth Res, London, England; [Brown, Michael] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England	University of London; University College London; University of London; University College London; Yeshiva University; Albert Einstein College of Medicine; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Burns, F (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.	f.burns@ucl.ac.uk			Gilead's United Kingdom; Ireland Fellowship Programme; Camden's & Islington's Provider Services; Department of Health's National Institutes of Health Research Biomedical Research Centres funding scheme; United Kingdom and Ireland Fellowship Programme; Gilead	Gilead's United Kingdom; Ireland Fellowship Programme; Camden's & Islington's Provider Services; Department of Health's National Institutes of Health Research Biomedical Research Centres funding scheme; United Kingdom and Ireland Fellowship Programme; Gilead(Gilead Sciences)	Gilead's United Kingdom and Ireland Fellowship Programme and Camden's & Islington's Provider Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was undertaken at University College London Hospital/University College London who received a proportion of funding from the Department of Health's National Institutes of Health Research Biomedical Research Centres funding scheme.; University College London Hospital has received free INSTI-60 second tests from Pasante Healthcare for another testing pilot within the Trust. Gilead funded part of this work through an unrestricted educational grant via their United Kingdom and Ireland Fellowship Programme. JL & YC received funding for HIV testing from Gilead. JC, SE and FB have received funding from various pharmaceutical companies to attend conferences and/or been paid to lecture at educational meetings. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	[Anonymous], 2011, NIC PUBL HLTH GUID 3; [Anonymous], 2021, HIV TESTING NEW HIV; BHIVA Audit & Standards Sub-Committee, 2006, MORT AUD; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Calderon Y, 2006, ANN EMERG MED, V48, P21, DOI 10.1016/j.annemergmed.2006.01.003; Calderon Y, 2009, AIDS PATIENT CARE ST, V23, P749, DOI 10.1089/apc.2008.0270; Chadborn TR, 2006, AIDS, V20, P2371, DOI 10.1097/QAD.0b013e32801138f7; Chadborn TR, 2005, AIDS, V19, P513, DOI 10.1097/01.aids.0000162340.43310.08; Curtis L., 2010, UNIT COSTS HLTH SOCI; De Cock KM, 1998, BMJ-BRIT MED J, V316, P290, DOI 10.1136/bmj.316.7127.290; Department of Health, 2003, SCREEN INF DIS PREGN; Fonseca K, 2004, 15 INT AIDS C 2004 B; Health Protection Agency, 2009, HIV UK 2009 REP; Krentz HB, 2004, HIV MED, V5, P93, DOI 10.1111/j.1468-1293.2004.00193.x; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; National Institute for Health and Clinical Excellence, 2011, INCR UPT HIV TEST ME; Peck L, 2010, QJM-INT J MED, V103, P147, DOI 10.1093/qjmed/hcp185; Simpson WM, 1998, BRIT MED J, V316, P262, DOI 10.1136/bmj.316.7127.262; Streetly A., 2002, POLICY DECISION IMPL; Sullivan AK, 2005, BRIT MED J, V330, P1301, DOI 10.1136/bmj.38398.590602.E0; WILSON JMG, 1968, WHO CHRON, V22, P473	21	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35212	10.1371/journal.pone.0035212	http://dx.doi.org/10.1371/journal.pone.0035212			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558129	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000305336000026
J	Gonzalez-Caro, S; Parra, JL; Graham, CH; McGuire, JA; Cadena, CD				Gonzalez-Caro, Sebastian; Parra, Juan L.; Graham, Catherine H.; McGuire, Jimmy A.; Daniel Cadena, Carlos			Sensitivity of Metrics of Phylogenetic Structure to Scale, Source of Data and Species Pool of Hummingbird Assemblages along Elevational Gradients	PLOS ONE			English	Article							COMMUNITY STRUCTURE; PATTERNS; TRAIT; DIVERSITY; ECOLOGY; COMPETITION; RICHNESS; EXAMPLE; MODEL; SIZE	Patterns of phylogenetic structure of assemblages are increasingly used to gain insight into the ecological and evolutionary processes involved in the assembly of co-occurring species. Metrics of phylogenetic structure can be sensitive to scaling issues and data availability. Here we empirically assess the sensitivity of four metrics of phylogenetic structure of assemblages to changes in (i) the source of data, (ii) the spatial grain at which assemblages are defined, and (iii) the definition of species pools using hummingbird (Trochilidae) assemblages along an elevational gradient in Colombia. We also discuss some of the implications in terms of the potential mechanisms driving these patterns. To explore how source of data influence phylogenetic structure we defined assemblages using three sources of data: field inventories, museum specimens, and range maps. Assemblages were defined at two spatial grains: coarse-grained (elevational bands of 800-m width) and fine-grained (1-km(2) plots). We used three different species pools: all species contained in assemblages, all species within half-degree quadrats, and all species either above or below 2000 m elevation. Metrics considering phylogenetic relationships among all species within assemblages showed phylogenetic clustering at high elevations and phylogenetic evenness in the lowlands, whereas those metrics considering only the closest co-occurring relatives showed the opposite trend. This result suggests that using multiple metrics of phylogenetic structure should provide greater insight into the mechanisms shaping assemblage structure. The source and spatial grain of data had important influences on estimates of both richness and phylogenetic structure. Metrics considering the co-occurrence of close relatives were particularly sensitive to changes in the spatial grain. Assemblages based on range maps included more species and showed less phylogenetic structure than assemblages based on museum or field inventories. Coarse-grained assemblages included more distantly related species and thus showed a more even phylogenetic structure than fine-grained assemblages. Our results emphasize the importance of carefully selecting the scale, source of data and metric used in analysis of the phylogenetic structure of assemblages.	[Gonzalez-Caro, Sebastian; Daniel Cadena, Carlos] Univ Los Andes, Dept Ciencias Biol, Lab Biol Evolut Vertebrados, Bogota, Colombia; [Parra, Juan L.] Univ Antioquia, Fac Ciencias Exactas & Nat, Inst Biol, Medellin, Colombia; [Parra, Juan L.; Graham, Catherine H.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [McGuire, Jimmy A.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	Universidad de los Andes (Colombia); Universidad de Antioquia; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of California System; University of California Berkeley	Gonzalez-Caro, S (corresponding author), Univ Los Andes, Dept Ciencias Biol, Lab Biol Evolut Vertebrados, Bogota, Colombia.	juanluisparra@gmail.com	Graham, Catherine/A-9560-2011; Graham, Catherine/AAN-1237-2020; McGuire, Jimmy/N-7357-2019; Gonzalez-Caro, Sebastian/T-3532-2019	Graham, Catherine/0000-0001-9267-7948; Graham, Catherine/0000-0001-9267-7948; 	National Science Foundation [DEB-563 0820490]	National Science Foundation(National Science Foundation (NSF))	Funding for this work was provided by the National Science Foundation through DEB-563 0820490 to CHG and JLP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DL, 2002, J EXP BIOL, V205, P2325; Bleiweiss R, 1998, BIOL J LINN SOC, V65, P77, DOI 10.1111/j.1095-8312.1998.tb00352.x; Boakes EH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000385; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1549, DOI 10.1098/rspb.2008.0262; Cavender-Bares J, 2006, ECOLOGY, V87, pS109, DOI 10.1890/0012-9658(2006)87[109:PSOFPC]2.0.CO;2; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Colwell R.K., 1984, NULL MODEL NULL MODE, P344; Elias M, 2008, PLOS BIOL, V6, P2642, DOI 10.1371/journal.pbio.0060300; Emerson BC, 2008, TRENDS ECOL EVOL, V23, P619, DOI 10.1016/j.tree.2008.07.005; Fosberg F, 1967, IBP HDB, V4, P73; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Graham CH, 2006, GLOBAL ECOL BIOGEOGR, V15, P578, DOI 10.1111/j.1466-8238.2006.00257.x; Graham CH, 2009, P NATL ACAD SCI USA, V106, P19673, DOI 10.1073/pnas.0901649106; He FL, 2002, ECOLOGY, V83, P1185, DOI 10.1890/0012-9658(2002)083[1185:SDPDFS]2.0.CO;2; Heard SB, 2007, AM NAT, V169, pE107, DOI 10.1086/512690; Helmus MR, 2007, AM NAT, V169, pE68, DOI 10.1086/511334; Hurlbert AH, 2005, ECOL LETT, V8, P319, DOI 10.1111/j.1461-0248.2005.00726.x; Jetz W, 2012, TRENDS ECOL EVOL, V27, P151, DOI 10.1016/j.tree.2011.09.007; Kadmon R, 2004, ECOL APPL, V14, P401, DOI 10.1890/02-5364; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kembel SW, 2009, ECOL LETT, V12, P949, DOI 10.1111/j.1461-0248.2009.01354.x; Kraft NJB, 2007, AM NAT, V170, P271, DOI 10.1086/519400; Kraft NJB, 2010, ECOL MONOGR, V80, P401, DOI 10.1890/09-1672.1; Lennon JJ, 2001, J ANIM ECOL, V70, P966, DOI 10.1046/j.0021-8790.2001.00563.x; Lessard JP, 2012, P ROY SOC B-BIOL SCI, V279, P266, DOI 10.1098/rspb.2011.0552; Lovette IJ, 2006, ECOLOGY, V87, pS14, DOI 10.1890/0012-9658(2006)87[14:SEOPNC]2.0.CO;2; MACARTHUR RH, 1958, ECOLOGY, V39, P599, DOI 10.2307/1931600; McGuire JA, 2007, SYST BIOL, V56, P837, DOI 10.1080/10635150701656360; McPherson JM, 2007, GLOBAL ECOL BIOGEOGR, V16, P657, DOI 10.1111/j.1466-8238.2007.00318.x; Gomez JP, 2010, J ANIM ECOL, V79, P1181, DOI 10.1111/j.1365-2656.2010.01725.x; Parra JL, 2010, AM NAT, V176, P573, DOI 10.1086/656619; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; R Development Core Team, 2005, R LANG ENV STAT COMP; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; SIH A, 1985, ANNU REV ECOL SYST, V16, P269, DOI 10.1146/annurev.es.16.110185.001413; Stiles FG, 2008, ORNITOL NEOTROP, V19, P511; Stiles FG, 2004, ORNITOL NEOTROP, V15, P191; Swenson NG, 2007, ECOLOGY, V88, P1770, DOI 10.1890/06-1499.1; Swenson NG, 2006, ECOLOGY, V87, P2418, DOI 10.1890/0012-9658(2006)87[2418:TPAPOS]2.0.CO;2; Swenson NG, 2009, ECOLOGY, V90, P2161, DOI 10.1890/08-1025.1; TERBORGH J, 1990, ECOL MONOGR, V60, P213, DOI 10.2307/1943045; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Vamosi JC, 2007, DIVERS DISTRIB, V13, P1, DOI 10.1111/j.1472-4642.2006.00299.x; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; WEIHER E, 1995, OIKOS, V74, P159, DOI 10.2307/3545686; WIENS JA, 1981, ECOL MONOGR, V51, P21, DOI 10.2307/2937305; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612	51	17	17	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35472	10.1371/journal.pone.0035472	http://dx.doi.org/10.1371/journal.pone.0035472			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558157	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336000032
J	Kabakyenga, JK; Ostergren, PO; Turyakira, E; Pettersson, KO				Kabakyenga, Jerome K.; Ostergren, Per-Olof; Turyakira, Eleanor; Pettersson, Karen Odberg			Influence of Birth Preparedness, Decision-Making on Location of Birth and Assistance by Skilled Birth Attendants among Women in South-Western Uganda	PLOS ONE			English	Article							MATERNAL HEALTH; COMPLICATION READINESS; MALE INVOLVEMENT; CARE; DELIVERY; SERVICES; DISTRICT; ACCESS; PREGNANCY; MORTALITY	Introduction: Assistance by skilled birth attendants (SBAs) during childbirth is one of the strategies aimed at reducing maternal morbidity and mortality in low-income countries. However, the relationship between birth preparedness and decision-making on location of birth and assistance by skilled birth attendants in this context is not well studied. The aim of this study was to assess the influence of birth preparedness practices and decision-making and assistance by SBAs among women in south-western Uganda. Methods: Community survey methods were used to identify 759 recently delivered women from 120 villages in rural Mbarara district. Interviewer-administered questionnaires were used to collect data. Logistic regression analyses were conducted to assess the relationship between birth preparedness, decision-making on location of birth and assistance by SBAs. Results: 35% of the women had been prepared for childbirth and the prevalence of assistance by SBAs in the sample was 68%. The final decision regarding location of birth was made by the woman herself (36%), the woman with spouse (56%) and the woman with relative/friend (8%). The relationships between birth preparedness and women decision-making on location of birth in consultation with spouse/friends/relatives and choosing assistance by SBAs showed statistical significance which persisted after adjusting for possible confounders (OR 1.5, 95% CI: 1.0-2.4) and (OR 4.4, 95% CI: 3.0-6.7) respectively. Education, household assets and birth preparedness showed clear synergistic effect on the relationship between decision-maker on location of birth and assistance by SBAs. Other factors which showed statistical significant relationships with assistance by SBAs were ANC attendance, parity and residence. Conclusion: Women's decision-making on location of birth in consultation with spouse/friends/relatives and birth preparedness showed significant effect on choosing assistance by SBAs at birth. Education and household assets ownership showed a synergistic effect on the relationship between the decision-maker and assistance by SBAs.	[Kabakyenga, Jerome K.; Ostergren, Per-Olof; Pettersson, Karen Odberg] Lund Univ, Dept Clin Sci Social Med & Global Hlth, Malmo, Sweden; [Kabakyenga, Jerome K.; Turyakira, Eleanor] Mbarara Univ Sci & Technol, Dept Community Hlth, Mbarara, Uganda	Lund University; Mbarara University of Science & Technology	Kabakyenga, JK (corresponding author), Lund Univ, Dept Clin Sci Social Med & Global Hlth, Malmo, Sweden.	Jerome.Kabakyenga@med.lu.se			Swedish International Development Cooperation Agency/SAREC [SWE-2009-084]; Global Health Research Initiative [103460-069]; Mbarara District Health Office	Swedish International Development Cooperation Agency/SAREC; Global Health Research Initiative; Mbarara District Health Office	External funding for this study was made possible by Grants from Swedish International Development Cooperation Agency/SAREC (SWE-2009-084 http://www.sida.se/English/Partners/Universities-and-research/From-funding-research-to-fighting-poverty)and Global Health Research Initiative (Centre File: 103460-069ttp://www.idrc.ca/EN/Programs/Global_Health_Policy/Global_Health_Research_Initiative/Pages/ProjectsList.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the contributions of all study participants and the following research assistants; Phionah Kyomuhendo, Bruce Natukunda, John Baptist Mwebesa, Angella Natukunda, Bob Harold Ashabahebwa, Innocent Tukashaba, Joanita Tumwikirize, Bridget Atuhairwe, Angel Kyompaire, Elizabeth Ayebazibwe, Peace Nagyemba, Eleanor Byaruhanga and Edmund Akatuhamya. The support provided by Mbarara District Health Office is also acknowledged.	Agarwal S, 2010, J HEALTH POPUL NUTR, V28, P383; Ahmed S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011190; Amooti-Kaguna B, 2000, SOC SCI MED, V50, P203, DOI 10.1016/S0277-9536(99)00275-0; Aschengrau A, 2008, ESSENTIALS EPIDEMIOL, P343; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; de Bernis L, 2003, BRIT MED BULL, V67, P39, DOI 10.1093/bmb/ldg017; De Brouwere V, 1998, TROP MED INT HEALTH, V3, P771, DOI 10.1046/j.1365-3156.1998.00310.x; Ensor T, 2004, HEALTH POLICY PLANN, V19, P69, DOI 10.1093/heapol/czh009; Essendi H, 2011, J URBAN HEALTH, V88, P356, DOI 10.1007/s11524-010-9481-1; Fotso Jean-Christophe, 2009, Reprod Health, V6, P9, DOI 10.1186/1742-4755-6-9; Furuta M, 2006, INT FAM PLAN PERSPEC, V32, P17, DOI 10.1363/3201706; Hindin MJ, 2011, J SEX RES, V48, P511, DOI 10.1080/00224499.2011.554918; Iliyasu Zubairu, 2010, Afr J Reprod Health, V14, P21; JHPIEGO, 2004, MON BIRTH PREP COMPL; Kabakyenga JK, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.8529; Kakaire O, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-12; Killewo J, 2006, J HEALTH POPUL NUTR, V24, P403; Koblinsky MA, 1999, B WORLD HEALTH ORGAN, V77, P399; Kyomuhendo GB, 2003, REPROD HEALTH MATTER, V11, P16, DOI 10.1016/S0968-8080(03)02176-1; Mbarara, 2011, MBAR DISTR HLTH SUMM; Merchant N, 2010, DECISION MAKING RELA; Ministry of Finance and Economic Development Uganda, 2010, MILL DEV GOALS REP U; Ministry of Health Uganda, 2008, ROAD MAP ACC RED MAT; Moran AC, 2006, J HEALTH POPUL NUTR, V24, P489; Mpembeni Rose Nm, 2007, BMC Pregnancy Childbirth, V7, P29, DOI 10.1186/1471-2393-7-29; Mullany BC, 2005, SOC SCI MED, V61, P1993, DOI 10.1016/j.socscimed.2005.04.006; Mullany BC, 2007, HEALTH EDUC RES, V22, P166, DOI 10.1093/her/cyl060; Mulogo E M, 2006, East Afr Med J, V83, P74; Orji EO, 2007, J TURK-GER GYNECOL A, V8, P240; Osubor KM, 2006, MATERN CHILD HLTH J, V10, P159, DOI 10.1007/s10995-005-0037-z; Parkhurst JO, 2006, J HEALTH POPUL NUTR, V24, P438; Pathmanathan I., 2003, INT BANK RECONSTRUCT; Perreira Krista M, 2002, Matern Child Health J, V6, P19, DOI 10.1023/A:1014360015605; Post M, 1997, PREVENTING MATERNAL; Sharma SK, 2007, J BIOSOC SCI, V39, P671, DOI 10.1017/S0021932007001952; Starrs AM, 2007, LANCET, V370, P1285, DOI 10.1016/S0140-6736(07)61549-9; Starrs AM, 2006, LANCET, V368, P1130, DOI 10.1016/S0140-6736(06)69385-9; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Tweheyo R, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-53; Uganda Bureau of Statistics Macro International Inc, 2007, UG DEM HLTH SURV 200, P119; United Nations, 2000, UN MILL DECL; United Nations Population Fund, 1994, INT C POP DEV PROGR; World Health Organization department of reproductive health and research, 2004, MAK PREGN SAF CRIT R, P1; Zere E, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-34	44	84	84	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35747	10.1371/journal.pone.0035747	http://dx.doi.org/10.1371/journal.pone.0035747			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TJ	22558214	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000055
J	LoMauro, A; Pochintesta, S; Romei, M; D'Angelo, MG; Pedotti, A; Turconi, AC; Aliverti, A				LoMauro, Antonella; Pochintesta, Simona; Romei, Marianna; D'Angelo, Maria Grazia; Pedotti, Antonio; Turconi, Anna Carla; Aliverti, Andrea			Rib Cage Deformities Alter Respiratory Muscle Action and Chest Wall Function in Patients with Severe Osteogenesis Imperfecta	PLOS ONE			English	Article							MECHANICS; MOTION; VOLUME; LIFE	Background: Osteogenesis imperfecta (OI) is an inherited connective tissue disorder characterized by bone fragility, multiple fractures and significant chest wall deformities. Cardiopulmonary insufficiency is the leading cause of death in these patients. Methods: Seven patients with severe OI type III, 15 with moderate OI type IV and 26 healthy subjects were studied. In addition to standard spirometry, rib cage geometry, breathing pattern and regional chest wall volume changes at rest in seated and supine position were assessed by opto-electronic plethysmography to investigate if structural modifications of the rib cage in OI have consequences on ventilatory pattern. One-way or two-way analysis of variance was performed to compare the results between the three groups and the two postures. Results: Both OI type III and IV patients showed reduced FVC and FEV1 compared to predicted values, on condition that updated reference equations are considered. In both positions, ventilation was lower in OI patients than control because of lower tidal volume (p<0.01). In contrast to OI type IV patients, whose chest wall geometry and function was normal, OI type III patients were characterized by reduced (p<0.01) angle at the sternum (pectus carinatum), paradoxical inspiratory inward motion of the pulmonary rib cage, significant thoraco-abdominal asynchronies and rib cage distortions in supine position (p<0.001). Conclusions: In conclusion, the restrictive respiratory pattern of Osteogenesis Imperfecta is closely related to the severity of the disease and to the sternal deformities. Pectus carinatum characterizes OI type III patients and alters respiratory muscles coordination, leading to chest wall and rib cage distortions and an inefficient ventilator pattern. OI type IV is characterized by lower alterations in the respiratory function. These findings suggest that functional assessment and treatment of OI should be differentiated in these two forms of the disease.	[LoMauro, Antonella; Pedotti, Antonio; Aliverti, Andrea] Politecn Milan, TBMLab, Dipartimento Bioingn, I-20133 Milan, Italy; [Pochintesta, Simona; Romei, Marianna; D'Angelo, Maria Grazia; Turconi, Anna Carla] IRCCS E Medea, Bosisio Parini, Lc, Italy	Polytechnic University of Milan; IRCCS Eugenio Medea	LoMauro, A (corresponding author), Politecn Milan, TBMLab, Dipartimento Bioingn, I-20133 Milan, Italy.	andrea.aliverti@polimi.it	D'Angelo, Maria Grazia/K-4685-2016; Andrea, Aliverti/A-3901-2015; Turconi, Anna Carla/ABE-6747-2020; Turconi, Anna Carla/AAX-6521-2020	D'Angelo, Maria Grazia/0000-0003-1241-4350; Andrea, Aliverti/0000-0002-2950-0231; Turconi, Anna Carla/0000-0002-5482-924X; LoMauro, Antonella/0000-0002-1408-6971	Fondazione Cariplo: Health Innovation Network Technology @ Lecco (HINT@Lecco)	Fondazione Cariplo: Health Innovation Network Technology @ Lecco (HINT@Lecco)	This work was supported by a grant of Fondazione Cariplo: Health Innovation Network Technology @ Lecco (HINT@Lecco). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGOSTONI E, 1966, J APPL PHYSIOL, V21, P1827, DOI 10.1152/jappl.1966.21.6.1827; Aliverti A, 1997, J APPL PHYSIOL, V83, P1256, DOI 10.1152/jappl.1997.83.4.1256; Aliverti A, 2001, ANN BIOMED ENG, V29, P60, DOI 10.1114/1.1332084; Antoniazzi F, 2000, Paediatr Drugs, V2, P465, DOI 10.2165/00128072-200002060-00005; BENSON DR, 1978, J BONE JOINT SURG AM, V60, P925, DOI 10.2106/00004623-197860070-00009; Cala SJ, 1996, J APPL PHYSIOL, V81, P2680, DOI 10.1152/jappl.1996.81.6.2680; Chihara K, 1996, J APPL PHYSIOL, V81, P437, DOI 10.1152/jappl.1996.81.1.437; DETROYER A, 1985, J CLIN INVEST, V75, P850, DOI 10.1172/JCI111782; DRUZ WS, 1981, J APPL PHYSIOL, V51, P1552, DOI 10.1152/jappl.1981.51.6.1552; FALVO KA, 1973, AM REV RESPIR DIS, V108, P1258; Kenyon CM, 1997, J APPL PHYSIOL, V83, P1242, DOI 10.1152/jappl.1997.83.4.1242; KONNO K, 1967, J APPL PHYSIOL, V22, P407, DOI 10.1152/jappl.1967.22.3.407; Kuster SP, 2008, EUR RESPIR J, V31, P860, DOI 10.1183/09031936.00091407; Lo Mauro A, 2010, EUR RESPIR J, V35, P1118, DOI 10.1183/09031936.00037209; McAllion SJ, 1996, J CLIN PATHOL, V49, P627, DOI 10.1136/jcp.49.8.627; PATERSON CR, 1987, ACTA PAEDIATR SCAND, V76, P548, DOI 10.1111/j.1651-2227.1987.tb10519.x; Paterson CR, 1996, BRIT MED J, V312, P351; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rauch F, 2004, LANCET, V363, P1377, DOI 10.1016/S0140-6736(04)16051-0; Romei M, 2010, RESP PHYSIOL NEUROBI, V172, P184, DOI 10.1016/j.resp.2010.05.018; SACKNER MA, 1984, AM REV RESPIR DIS, V130, P588; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; SILLENCE DO, 1986, AM J MED GENET, V23, P821, DOI 10.1002/ajmg.1320230309; Singer R B, 2001, J Insur Med, V33, P216; Stanojevic S, 2010, EUR RESPIR J, V36, P12, DOI 10.1183/09031936.00143209; Takken T, 2004, J PEDIATR-US, V145, P813, DOI 10.1016/j.jpeds.2004.08.003; Van Dijk FS, 2010, EUR J MED GENET, V53, P1, DOI 10.1016/j.ejmg.2009.10.007; Widmann RF, 1999, SPINE, V24, P1673, DOI 10.1097/00007632-199908150-00008	28	47	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35965	10.1371/journal.pone.0035965	http://dx.doi.org/10.1371/journal.pone.0035965			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558284	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000092
J	Osman, W; Okada, Y; Kamatani, Y; Kubo, M; Matsuda, K; Nakamura, Y				Osman, Wael; Okada, Yukinori; Kamatani, Yoichiro; Kubo, Michiaki; Matsuda, Koichi; Nakamura, Yusuke			Association of Common Variants in TNFRSF13B, TNFSF13, and ANXA3 with Serum Levels of Non-Albumin Protein and Immunoglobulin Isotypes in Japanese	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; C-REACTIVE PROTEIN; APRIL; TACI; POPULATION; ANNEXINS; GENE; RECEPTORS; TRAITS; CELLS	We performed a genome-wide association study (GWAS) on levels of serum total protein (TP), albumin (ALB), and nonalbumin protein (NAP). We analyzed SNPs on autosomal chromosomes using data from 9,103 Japanese individuals, followed by a replication study of 1,600 additional individuals. We confirmed the previously-reported association of GCKR on chromosome 2p23.3 with serum ALB (rs1260326, P-meta = 3.1x10(-9)), and additionally identified the significant genome-wide association of rs4985726 in TNFRSF13B on 17p11.2 with both TP and NAP ( P-meta = 1.2x10(-14) and 7.1x10(-24), respectively). For NAP, rs3803800 and rs11552708 in TNFSF13 on 17p13.1 (P-meta = 7.2x10(-15) and 7.5x10(-10), respectively) as well as rs10007186 on 4q21.2 near ANXA3 (Pmeta = 1.3x10(-9)) also indicated significant associations. Interestingly, TNFRSF13B and TNFSF13 encode a tumor necrosis factor (TNF) receptor and its ligand, which together constitute an important receptor-ligand axis for B-cell homeostasis and immunoglobulin production. Furthermore, three SNPs, rs4985726, rs3803800, and rs11552708 in TNFRSF13B and TNFSF13, were indicated to be associated with serum levels of IgG (P<2.3x10(-3)) and IgM (P<0.018), while rs3803800 and rs11552708 were associated with IgA (P<0.013). Rs10007186 in 4q21.2 was associated with serum levels of IgA (P = 0.036), IgM (P = 0.019), and IgE (P = 4.9x10(-4)). Our results should add interesting knowledge about the regulation of major serum components.	[Osman, Wael; Matsuda, Koichi; Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Mol Med Lab, Tokyo, Japan; [Okada, Yukinori] RIKEN, Ctr Genom Med, Inst Phys & Chem Res, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Okada, Yukinori] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan; [Kamatani, Yoichiro] Ctr Etud Polymorphisme Humain, F-75010 Paris, France; [Kubo, Michiaki] RIKEN, Ctr Genom Med, Lab Genotyping Dev, Yokohama, Kanagawa, Japan	University of Tokyo; RIKEN; University of Tokyo; RIKEN	Osman, W (corresponding author), Univ Tokyo, Inst Med Sci, Mol Med Lab, Tokyo, Japan.	yusuke@ims.u-tokyo.ac.jp	Osman, Wael/H-3362-2012; Kamatani, Yoichiro/N-5513-2015; Kubo, Michiaki/N-7947-2015; Matsuda, Koichi/D-4597-2011	OSMAN, WAEL/0000-0002-1921-8021; Matsuda, Koichi/0000-0001-7292-2686	Leading Project for Personalized Medicine in the Ministry of Education, Culture, Sports, Science and Technology, Japan	Leading Project for Personalized Medicine in the Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported by Leading Project for Personalized Medicine in the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bossen C, 2006, SEMIN IMMUNOL, V18, P263, DOI 10.1016/j.smim.2006.04.006; Castigli E, 2005, NAT GENET, V37, P829, DOI 10.1038/ng1601; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; Castigli E, 2004, P NATL ACAD SCI USA, V101, P3903, DOI 10.1073/pnas.0307348101; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Hahne M, 1998, J EXP MED, V188, P1185, DOI 10.1084/jem.188.6.1185; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Koyama T, 2003, RHEUMATOLOGY, V42, P980, DOI 10.1093/rheumatology/keg270; Larsson M, 1997, IMMUNOLOGY, V92, P501, DOI 10.1046/j.1365-2567.1997.00377.x; Lopez-Fraga M, 2001, EMBO REP, V2, P945, DOI 10.1093/embo-reports/kve198; Mackay F, 2002, CURR OPIN IMMUNOL, V14, P783, DOI 10.1016/S0952-7915(02)00407-7; Mackay F, 2008, CYTOKINE GROWTH F R, V19, P263, DOI 10.1016/j.cytogfr.2008.04.006; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Okada Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002067; Olivier M, 2005, MUTAT RES-FUND MOL M, V573, P103, DOI 10.1016/j.mrfmmm.2004.08.016; Orho-Melander M, 2008, DIABETES, V57, P3112, DOI 10.2337/db08-0516; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rahmioglu N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004435; Ridker PM, 2008, AM J HUM GENET, V82, P1185, DOI 10.1016/j.ajhg.2008.03.015; Rosales JL, 1997, J IMMUNOL, V159, P6195; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Sakurai D, 2007, BLOOD, V109, P2961, DOI 10.1182/blood-2006-08-041772; Weidinger S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000166; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290	27	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e32683	10.1371/journal.pone.0032683	http://dx.doi.org/10.1371/journal.pone.0032683			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558069	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000003
J	Rhein, C; Tripal, P; Seebahn, A; Konrad, A; Kramer, M; Nagel, C; Kemper, J; Bode, J; Muhle, C; Gulbins, E; Reichel, M; Becker, CM; Kornhuber, J				Rhein, Cosima; Tripal, Philipp; Seebahn, Angela; Konrad, Alice; Kramer, Marcel; Nagel, Christine; Kemper, Jonas; Bode, Jens; Muehle, Christiane; Gulbins, Erich; Reichel, Martin; Becker, Cord-Michael; Kornhuber, Johannes			Functional Implications of Novel Human Acid Sphingomyelinase Splice Variants	PLOS ONE			English	Article							NIEMANN-PICK-DISEASE; LEUKEMIA-CELL LINE; ENDOTHELIAL APOPTOSIS; MOUSE TRANSCRIPTOME; MASS-SPECTROMETRY; FULL-LENGTH; GENE; IDENTIFICATION; DEFICIENCY; EXPRESSION	Background: Acid sphingomyelinase (ASM) hydrolyses sphingomyelin and generates the lipid messenger ceramide, which mediates a variety of stress-related cellular processes. The pathological effects of dysregulated ASM activity are evident in several human diseases and indicate an important functional role for ASM regulation. We investigated alternative splicing as a possible mechanism for regulating cellular ASM activity. Methodology/Principal Findings: We identified three novel ASM splice variants in human cells, termed ASM-5, -6 and -7, which lack portions of the catalytic- and/or carboxy-terminal domains in comparison to full-length ASM-1. Differential expression patterns in primary blood cells indicated that ASM splicing might be subject to regulatory processes. The newly identified ASM splice variants were catalytically inactive in biochemical in vitro assays, but they decreased the relative cellular ceramide content in overexpression studies and exerted a dominant-negative effect on ASM activity in physiological cell models. Conclusions/Significance: These findings indicate that alternative splicing of ASM is of functional significance for the cellular stress response, possibly representing a mechanism for maintaining constant levels of cellular ASM enzyme activity.	[Rhein, Cosima; Tripal, Philipp; Konrad, Alice; Nagel, Christine; Kemper, Jonas; Bode, Jens; Muehle, Christiane; Reichel, Martin; Kornhuber, Johannes] Univ Erlangen Nurnberg, Univ Hosp, Dept Psychiat & Psychotherapy, D-91054 Erlangen, Germany; [Seebahn, Angela; Becker, Cord-Michael] Univ Erlangen Nurnberg, Inst Biochem, Emil Fischer Ctr, D-91054 Erlangen, Germany; [Gulbins, Erich] Univ Duisburg Essen, Dept Mol Biol, Essen, Germany; [Kramer, Marcel] Jena Univ Hosp, Leibniz Inst Age Res, Fritz Lipmann Inst, Jena, Germany; [Kramer, Marcel] Jena Univ Hosp, Ctr Sepsis Control & Care, Jena, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Duisburg Essen; Friedrich Schiller University of Jena; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Friedrich Schiller University of Jena	Rhein, C (corresponding author), Univ Erlangen Nurnberg, Univ Hosp, Dept Psychiat & Psychotherapy, D-91054 Erlangen, Germany.	Johannes.Kornhuber@uk-erlangen.de	Kornhuber, Johannes/B-9613-2014; Gulbins, Erich/L-6989-2014; MÃhle, Christiane/AAE-7043-2019	Kornhuber, Johannes/0000-0002-8096-3987; Gulbins, Erich/0000-0002-3117-1342; Muhle, Christiane/0000-0001-7517-9154; Tripal, Philipp/0000-0003-0568-1725; Reichel, Martin/0000-0001-7886-2784; Rhein, Cosima/0000-0002-3010-2169	ELAN fonds (Erlanger leistungsbezogene Anschubfinanzierung und Nachwuchsforderung) [09.03.22.1]; Deutsche Forschungsgemeinschaft DFG [GU 335/23-1, KO 947/11-1]; University Erlangen-Nuremberg	ELAN fonds (Erlanger leistungsbezogene Anschubfinanzierung und Nachwuchsforderung); Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); University Erlangen-Nuremberg	This work was supported by grants from ELAN fonds (Erlanger leistungsbezogene Anschubfinanzierung und Nachwuchsforderung/09.03.22.1; to PT) and from the Deutsche Forschungsgemeinschaft DFG (GU 335/23-1, KO 947/11-1, to EG and JKo), and by the Scholarship Programme 'Equality for Women in Research and Teaching', University Erlangen-Nuremberg (to CR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; BRADY RO, 1966, P NATL ACAD SCI USA, V55, P366, DOI 10.1073/pnas.55.2.366; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Calarco JA, 2007, GENE DEV, V21, P2963, DOI 10.1101/gad.1606907; FERLINZ K, 1991, BIOCHEM BIOPH RES CO, V179, P1187, DOI 10.1016/0006-291X(91)91697-B; FERLINZ K, 1995, AM J HUM GENET, V56, P1343; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garcia-Ruiz C, 2003, J CLIN INVEST, V111, P197, DOI 10.1172/JCI200316010; Grabowski PJ, 2001, PROG NEUROBIOL, V65, P289, DOI 10.1016/S0301-0082(01)00007-7; Gulbins E, 2000, METHOD ENZYMOL, V322, P382; HaimovitzFriedman A, 1997, J EXP MED, V186, P1831, DOI 10.1084/jem.186.11.1831; HE X, 2008, NEUROBIOL AGING; Kaufer D, 1998, NATURE, V393, P373, DOI 10.1038/30741; Kornhuber J, 2005, J NEURAL TRANSM, V112, P1583, DOI 10.1007/s00702-005-0374-5; Kramer M, 2011, GENETICS, V187, P761, DOI 10.1534/genetics.110.125096; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langmann T, 1999, J LIPID RES, V40, P870; LeckaCzernik B, 1996, EXP GERONTOL, V31, P159, DOI 10.1016/0531-5565(95)02014-4; Lehner M, 2007, LEUKEMIA RES, V31, P1729, DOI 10.1016/j.leukres.2007.05.001; LEVRAN O, 1993, HUM MUTAT, V2, P317, DOI 10.1002/humu.1380020414; LEVRAN O, 1991, J CLIN INVEST, V88, P806, DOI 10.1172/JCI115380; LEVRAN O, 1992, BLOOD, V80, P2081; Lin T, 2000, J BIOL CHEM, V275, P8657, DOI 10.1074/jbc.275.12.8657; Lohmann C, 2010, J NEUROCHEM, V114, P1119, DOI 10.1111/j.1471-4159.2010.06836.x; Mikati MA, 2008, EPILEPSY RES, V81, P161, DOI 10.1016/j.eplepsyres.2008.05.009; Murate T, 2002, J BIOL CHEM, V277, P9936, DOI 10.1074/jbc.M111594200; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Pick M, 2004, ANN NY ACAD SCI, V1018, P85, DOI 10.1196/annals.1296.010; Qiu HW, 2003, J BIOL CHEM, V278, P32744, DOI 10.1074/jbc.M303022200; QUINTERN LE, 1989, EMBO J, V8, P2469, DOI 10.1002/j.1460-2075.1989.tb08382.x; QUINTERN LE, 1987, BIOCHIM BIOPHYS ACTA, V922, P323, DOI 10.1016/0005-2760(87)90055-5; Rebillard A, 2008, ONCOGENE, V27, P6590, DOI 10.1038/onc.2008.257; Reichel M, 2010, ALCOHOL CLIN EXP RES, V34, P46, DOI 10.1111/j.1530-0277.2009.01064.x; Rodriguez-Pascau L, 2009, HUM MUTAT, V30, P1117, DOI 10.1002/humu.21018; Schiller J, 2004, PROG LIPID RES, V43, P449, DOI 10.1016/j.plipres.2004.08.001; Schissel SL, 1998, J BIOL CHEM, V273, P18250, DOI 10.1074/jbc.273.29.18250; SCHUCHMAN EH, 1991, J BIOL CHEM, V266, P8531; Shah C, 2008, J BIOL CHEM, V283, P13538, DOI 10.1074/jbc.M709950200; Simonaro CM, 2002, AM J HUM GENET, V71, P1413, DOI 10.1086/345074; Skandalis A, 2010, RNA, V16, P2014, DOI 10.1261/rna.2127910; Spassieva SD, 2012, J LIPID RES; Spiegel S, 1998, ANN NY ACAD SCI, V845, P11, DOI 10.1111/j.1749-6632.1998.tb09658.x; Spiegel S, 1996, FASEB J, V10, P1388, DOI 10.1096/fasebj.10.12.8903509; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; TAKAHASHI T, 1992, J BIOL CHEM, V267, P12552; Takahashi Tsutomu, 1992, Human Mutation, V1, P70, DOI 10.1002/humu.1380010111; Truman JP, 2011, CELL MOL LIFE SCI, V68, P3293, DOI 10.1007/s00018-011-0686-6; Wu J, 2005, J LIPID RES, V46, P1944, DOI 10.1194/jlr.M500118-JLR200; Xu Q, 2002, NUCLEIC ACIDS RES, V30, P3754, DOI 10.1093/nar/gkf492; Zavolan M, 2003, GENOME RES, V13, P1290, DOI 10.1101/gr.1017303; Zeidan YH, 2007, J BIOL CHEM, V282, P11549, DOI 10.1074/jbc.M609424200	52	21	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35467	10.1371/journal.pone.0035467	http://dx.doi.org/10.1371/journal.pone.0035467			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558155	Green Published, gold			2022-12-27	WOS:000305336000031
J	Sami, N; Ali, TS; Wasim, S; Saleem, S				Sami, Neelofar; Ali, Tazeen Saeed; Wasim, Saba; Saleem, Sarah			Risk Factors for Secondary Infertility among Women in Karachi, Pakistan	PLOS ONE			English	Article							MORBIDITY; SERVICE; HEALTH	Background: Secondary infertility in developing countries is mostly attributable to blockage of the fallopian tubes due to adhesions caused by reproductive tract infections. There is a dearth of information on the prevalence and causes of secondary infertility from Pakistan. This paper presents results on factors associated with secondary infertility among married women in Karachi, Pakistan. Methods: A matched case-control study was conducted. Cases were women aged 15-35 years with history of at least one previous conception and currently seeking treatment for secondary infertility. Controls were women residing in the neighborhood of cases with at least one live birth and not taking treatment for secondary infertility. The age of controls was matched by +/- 5 years to that of cases. Data was collected from June to August 2003. Conditional logistic regression was used to determine crude and adjusted odds ratios (OR) with corresponding 95% confidence intervals (CI) for factors associated with secondary infertility. Results: The final multivariate logistic regression model revealed that after adjusting for age, cases were more likely to be the housewives (AOR = 2.6, 95% CI: 1.5-4.4), had used inappropriate material to absorb blood during menstruation (AOR = 9.0, 95% CI: 5.0-16.4), and at their last delivery, had a birth attendant who did not wash hands with soap and water (AOR = 3.0, 95% CI: 1.4-5.7). Moreover, women with secondary infertility were more likely to report current or past history of having STI symptoms (AOR = 3.6, 95% CI: 2.4-5.6) and use of intra-vaginal indigenous medicines during their last postpartum period (AOR = 3.1, 95% CI: 1.6-5.7). Conclusion: We recommend health education and awareness messages for safe practices during menstruation, delivery, and the postpartum period for women in general. Additionally, sanitary napkins should be made available at an affordable cost, and safe delivery kits should contain educational/pictorial brochures for appropriate hand washing skills.	[Sami, Neelofar; Ali, Tazeen Saeed; Wasim, Saba; Saleem, Sarah] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan; [Ali, Tazeen Saeed] Aga Khan Univ, Sch Nursing, Karachi, Pakistan	Aga Khan University; Aga Khan University	Sami, N (corresponding author), Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan.	neelofar.sami@aku.edu	S Ali, Tazeen/AAC-8790-2022; Ali, Tazeen Saeed/AAW-5284-2020	S Ali, Tazeen/0000-0002-8896-8766; 	Seed Money Grant [SM 020405]	Seed Money Grant	This work was supported by a Seed Money Grant (ID # SM 020405). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouzahr C, 2003, CONTEMP OBSTET GYNEC, P128; Ali Tazeen Saeed, 2006, J Pak Med Assoc, V56, P99; Ali TS, 2007, J HEALTH POPUL NUTR, V25, P189; Alsaawi M, 2000, GENUS, VLVI, P99; Bhurt Abdul Wahid, 1999, JPMA (Journal of the Pakistan Medical Association), V49, P188; Boivin J, 2007, HUM REPROD, V22, P1506, DOI 10.1093/humrep/dem046; CATES W, 1990, EPIDEMIOL REV, V12, P199, DOI 10.1093/oxfordjournals.epirev.a036054; CHATURVEDI SK, 1993, J PSYCHOSOM RES, V37, P575, DOI 10.1016/0022-3999(93)90051-G; De Silva WI, 1998, SOC BIOL, V45, P223; Durr-e-Nayab, 2005, Pakistan Development Review, V44, P131; Farley TMM, 1988, P AFR POP C DAK; Farr G, 1998, ADV CONTRACEPT, V14, P45, DOI 10.1023/A:1006575610716; Fikree F, 2001, TRADITIONAL PRACTICE; Fikree FF, 2004, SOC SCI MED, V59, P681, DOI 10.1016/j.socscimed.2003.11.034; Ghani Nasreen, 2007, J Pak Med Assoc, V57, P363; Goodburn EA, 1994, INVESTIGATION NATURE; HERNADI Z, 1986, ACTA MED HUNG, V43, P155; Hossain MA, 1989, ROLE TRADITIONAL BIR; Inhorn MC, 1994, ANTHR INFECT DIS INT, P173; KHATAMEE MA, 1988, INT J FERTIL, V33, P246; KOCHAR M, 1980, AM J OBSTET GYNECOL, V138, P872, DOI 10.1016/0002-9378(80)91074-1; Larsen U., 2003, J HLTH POPULATION DE, P1; LARSON E, 1988, INFECT CONT HOSP EP, V9, P28, DOI 10.1086/645729; Lunenfeld B, 2004, HUM REPROD UPDATE, V10, P317, DOI 10.1093/humupd/dmh028; Mathews A, 1995, FOOTSTEPS, V24, P2; Mayaud P., 2001, WOMEN INFERTILITY SU, p71 ; Population Council, 1999, REPR TRACT INF SET F; Qureshi MS, 1991, INFERTILITY PAKISTAN, P222; Saleem S, 2007, OBSTET GYNECOL, V110, P977, DOI 10.1097/01.AOG.0000285653.17869.26; SATHAR Z, 1988, POPUL DEV REV, V14, P415, DOI 10.2307/1972196; Shahid NS, 1996, J DIARRHOEAL DIS RES, V14, P85; Siemer J, 2008, AM J TROP MED HYG, V78, P323, DOI 10.4269/ajtmh.2008.78.323; SPIRA A, 1986, HUM REPROD, V1, P111, DOI 10.1093/oxfordjournals.humrep.a136353; TZONOU A, 1993, J EPIDEMIOL COMMUN H, V47, P36, DOI 10.1136/jech.47.1.36; United Nations, 1993, WOM STAT FERT PAK RE; *WHO, 1991, INF TAB AV DAT PREV; World Health Organization, 1994, CHALL REPR HLTH RES; World Health Organization, 2009, WHO GUID HAND HYG HL; World Health Organization (WHO), 2008, PROP BIRTHS ATT SKIL	39	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35828	10.1371/journal.pone.0035828	http://dx.doi.org/10.1371/journal.pone.0035828			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558233	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336000064
J	Shen, C; Zhang, GL; Meng, Q				Shen, Chong; Zhang, Guoliang; Meng, Qin			Regulation of Epithelial Cell Morphology and Functions Approaching To More In Vivo-Like by Modifying Polyethylene Glycol on Polysulfone Membranes	PLOS ONE			English	Article							3-DIMENSIONAL CULTURE; HUMAN HEPATOCYTES; TISSUE; CYTOCOMPATIBILITY; PROLIFERATION; MORPHOGENESIS; BIOMATERIALS; HYDROGELS; ADHESION; INSIGHTS	Cytocompatibility is critically important in design of biomaterials for application in tissue engineering. However, the currently well-accepted "cytocompatible" biomaterials are those which promote cells to sustain good attachment/spreading. The cells on such materials usually lack the self-assembled cell morphology and high cell functions as in vivo. In our view, biomaterials that can promote the ability of cells to self-assemble and demonstrate cell-specific functions would be cytocompatible. This paper examined the interaction of polyethylene glycol (PEG) modified polysulfone (PSf) membranes with four epithelial cell types (primary liver cells, a liver tumor cell line, and two renal tubular cell lines). Our results show that PSf membranes modified with proper PEG promoted the aggregation of both liver and renal cells, but the liver cells more easily formed aggregates than the renal tubular cells. The culture on PEG-modified PSf membranes also enhanced cell-specific functions. In particular, the cells cultured on F127 membranes with the proper PEG content mimicked the in vivo ultrastructure of liver cells or renal tubules cells and displayed the highest cell functions. Gene expression data for adhesion proteins suggest that the PEG modification impaired cell-membrane interactions and increased cell-cell interactions, thus facilitating cell self-assembly. In conclusion, PEG-modified membrane could be a cytocompatible material which regulates the morphology and functions of epithelial cells in mimicking cell performance in vivo.	[Shen, Chong; Meng, Qin] Zhejiang Univ, Dept Chem & Biol Engn, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Guoliang] Zhejiang Univ Technol, Coll Biol & Environm Engn, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University of Technology	Shen, C (corresponding author), Zhejiang Univ, Dept Chem & Biol Engn, Hangzhou 310003, Zhejiang, Peoples R China.	mengq@zju.edu.cn	chong, shen/AAG-5560-2019		National Natural Science Foundation of China [21076186, 21006089]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by National Natural Science Foundation of China (No 21076186 and 21006089). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attia M, 2011, BIOMATERIALS, V32, P450, DOI 10.1016/j.biomaterials.2010.09.010; BESSEY OA, 1946, J BIOL CHEM, V164, P321; Cho CS, 2006, BIOMATERIALS, V27, P576, DOI 10.1016/j.biomaterials.2005.06.008; Dahe GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025236; Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X; Domhan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021283; Feng ZQ, 2009, BIOMATERIALS, V30, P2753, DOI 10.1016/j.biomaterials.2009.01.053; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Higuchi A, 2003, BIOMATERIALS, V24, P3235, DOI 10.1016/S0142-9612(03)00186-8; Hill E, 2006, P NATL ACAD SCI USA, V103, P2494, DOI 10.1073/pnas.0506004103; ISHIKURA H, 1993, VIRCHOWS ARCH B, V63, P115, DOI 10.1007/BF02899250; Jameson JL, 2010, HARRISONS NEPHROLOGY; Kafi MA, 2012, BIOMATERIALS, V33, P731, DOI 10.1016/j.biomaterials.2011.10.003; Lahiri D, 2010, ACTA BIOMATER, V6, P3524, DOI 10.1016/j.actbio.2010.02.044; Lan SF, 2010, TOXICOL IN VITRO, V24, P1314, DOI 10.1016/j.tiv.2010.02.015; Lang R, 2011, BIOMATERIALS, V32, P7042, DOI 10.1016/j.biomaterials.2011.06.005; Legallais C, 2001, J MEMBRANE SCI, V181, P81, DOI 10.1016/S0376-7388(00)00539-1; Liver Cancer: The New Epidemic, LIVER CANC NEW EPIDE; Lu HF, 2003, BIOMATERIALS, V24, P4893, DOI 10.1016/S0142-9612(03)00404-6; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Malarkey DE, 2005, TOXICOL PATHOL, V33, P27, DOI 10.1080/01926230590881826; MONTESANO R, 1991, CELL, V66, P697, DOI 10.1016/0092-8674(91)90115-F; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Payen L, 2001, BRIT J PHARMACOL, V132, P778, DOI 10.1038/sj.bjp.0703863; Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/nmat2441, 10.1038/NMAT2441]; Powers MJ, 2002, BIOTECHNOL BIOENG, V78, P257, DOI 10.1002/bit.10143; Saito A, 2011, HEMODIAL INT, V15, P183, DOI 10.1111/j.1542-4758.2011.00530.x; Salerno S, 2011, BIOMATERIALS, V32, P8848, DOI 10.1016/j.biomaterials.2011.08.004; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Shen C, 2011, J MEMBRANE SCI, V369, P474, DOI 10.1016/j.memsci.2010.12.016; SZASZ G, 1969, CLIN CHEM, V15, P124; Takahashi H, 2011, BIOMATERIALS, V32, P8830, DOI 10.1016/j.biomaterials.2011.08.006; Teo JCM, 2011, ACTA BIOMATER, V7, P2060, DOI 10.1016/j.actbio.2011.01.009; Vermonden T, 2008, BIOMACROMOLECULES, V9, P919, DOI 10.1021/bm7013075; von Knoch F, 2005, BIOMATERIALS, V26, P6941, DOI 10.1016/j.biomaterials.2005.04.059; Watanabe J, 2005, BIOMACROMOLECULES, V6, P1797, DOI 10.1021/bm050138f; Wilkening S, 2003, J BIOCHEM MOL TOXIC, V17, P207, DOI 10.1002/jbt.10085; Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023; Zhao LZ, 2010, BIOMATERIALS, V31, P2055, DOI 10.1016/j.biomaterials.2009.11.103; Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044	41	3	3	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36110	10.1371/journal.pone.0036110	http://dx.doi.org/10.1371/journal.pone.0036110			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558349	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336000130
J	Wheeler, TJ; Chien, S				Wheeler, Thomas J.; Chien, Sufan			Protection of Rat Cardiac Myocytes by Fructose-1,6-Bisphosphate and 2,3-Butanedione	PLOS ONE			English	Article							HEART PRESERVATION; INTRACELLULAR CA2+; EXCESS ACTIVATION; FRUCTOSE-1,6-DIPHOSPHATE; METABOLISM; INJURY; HYPOXIA; 6-DIPHOSPHATE; REPERFUSION; FRUCTOSE-1	Earlier studies by our group showed that fructose- 1,6-bisphosphate (FBP) enhances the hypothermic preservation of rat cardiac myocytes and the functional recovery of animal hearts after hypothermic storage. However, the mechanisms involved were not clear. We extended the cardiomyocyte studies by testing whether the FBP effects were due to chelation of extracellular calcium, leading to lower intracellular levels. We also tested effects of 2,3-butanedione monoxime (BDM), pyruvate, and adenine nucleotide precursors. Cardiomyocytes were incubated in ischemic suspension at 3 degrees C, and aliquots examined over 48 to 72 hours for retention of rod-shaped morphology, a measure of viability. Cytosolic Ca2+ levels were measured in some experiments. FBP at 5 mM reduced the death rate even when added after one or two days of incubation. It caused cytosolic calcium levels that were 33% lower than controls in freshly-isolated cells and 70% lower after one day of incubation. EGTA protected against cell death similarly to FBP. These results indicated that one of the mechanisms by which FBP exerts protective effects is through chelation of extracellular calcium. BDM was strongly protective and reduced cytosolic calcium by 30% after one day of incubation. As with FBP, BDM was effective when added after one or two days of incubation. BDM may be useful in combination with FBP in preserving heart tissue. Pyruvate, adenine, and ribose provided little or no protection during hypothermia.	[Wheeler, Thomas J.] Univ Louisville, Sch Med, Dept Biochem & Mol Biol, Louisville, KY 40292 USA; [Chien, Sufan] Univ Louisville, Sch Med, Dept Surg, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Wheeler, TJ (corresponding author), Univ Louisville, Sch Med, Dept Biochem & Mol Biol, Louisville, KY 40292 USA.	sufanc@aim.com			National Institutes of Health [HL64186, T35HL071486]; University of Louisville School; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064186, T35HL071486] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Louisville School; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the National Institutes of Health (HL64186, to SC and TJW) and the University of Louisville School of Medicine Summer Research Scholars Program (Paul D. Kelsey and Bradley W. Richmond), with support to PDK coming from National Institutes of Health grant T35HL071486. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azambuja AA, 2011, INFLAMMATION, V34, P67, DOI 10.1007/s10753-010-9212-5; BICKLER PE, 1992, STROKE, V23, P1617, DOI 10.1161/01.STR.23.11.1617; Bickler PE, 1996, J NEUROCHEM, V67, P1463; Calafell R, 2009, EUR J PHARMACOL, V610, P128, DOI 10.1016/j.ejphar.2009.03.044; CAVALLINI L, 1992, BIOCHEM PHARMACOL, V43, P1539, DOI 10.1016/0006-2952(92)90212-2; Chien S, 2000, J HEART LUNG TRANSPL, V19, P277, DOI 10.1016/S1053-2498(99)00142-4; Chu SJ, 2002, CRIT CARE MED, V30, P1605, DOI 10.1097/00003246-200207000-00034; Cobert ML, 2011, J SURG RES IN PRESS; Colston VL, 2001, LIFE SCI, V69, P2383, DOI 10.1016/S0024-3205(01)01325-X; DIDLAKE R, 1985, CIRC SHOCK, V16, P205; Ding Y, 2010, NEUROSCI LETT, V477, P33, DOI 10.1016/j.neulet.2010.04.030; Donohoe PH, 2001, BRAIN RES, V917, P158, DOI 10.1016/S0006-8993(01)02849-9; DOW JW, 1981, CARDIOVASC RES, V15, P483, DOI 10.1093/cvr/15.9.483; Ehringer WD, 2001, MOL CELL BIOCHEM, V221, P33, DOI 10.1023/A:1010973806747; Fahlman CS, 2002, BRAIN RES, V958, P43, DOI 10.1016/S0006-8993(02)03433-9; FISCHER Y, 1991, LIFE SCI, V49, P1679, DOI 10.1016/0024-3205(91)90310-8; Gal J, 2007, J CARDIOVASC SURG, V48, P751; Gawarammana I, 2010, BMC EMERG MED, V10, DOI 10.1186/1471-227X-10-15; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HARDIN CD, 1994, AM J PHYSIOL-HEART C, V267, pH2325, DOI 10.1152/ajpheart.1994.267.6.H2325; HASSINEN IE, 1991, CIRCULATION, V83, P584, DOI 10.1161/01.CIR.83.2.584; Hirokawa F, 2002, TRANSPLANTATION, V74, P779, DOI 10.1097/00007890-200209270-00008; Hua DP, 2003, J HEART LUNG TRANSPL, V22, P574, DOI 10.1016/S1053-2498(02)00661-7; KIVISTO T, 1995, JPN J PHYSIOL, V45, P203, DOI 10.2170/jjphysiol.45.203; Mallet RT, 2000, P SOC EXP BIOL MED, V223, P136, DOI 10.1046/j.1525-1373.2000.22319.x; Niu WY, 1999, J SURG RES, V85, P120, DOI 10.1006/jsre.1999.5658; Poston RS, 2004, ANN THORAC SURG, V78, P1362, DOI 10.1016/j.athoracsur.2004.02.143; Riedel BJ, 2004, ANESTH ANALG, V98, P20, DOI 10.1213/01.ANE.0000094336.97693.90; SELLIN LC, 1994, PHARMACOL TOXICOL, V74, P305, DOI 10.1111/j.1600-0773.1994.tb01365.x; STRINGHAM JC, 1992, TRANSPLANTATION, V53, P287, DOI 10.1097/00007890-199202010-00007; SUN JX, 1990, GASTROENTEROLOGY, V98, P117, DOI 10.1016/0016-5085(90)91299-L; Tamaki T, 2002, DIGEST DIS SCI, V47, P2179, DOI 10.1023/A:1020118823672; Thum T, 2001, Cardiovasc Toxicol, V1, P61, DOI 10.1385/CT:1:1:61; Toledo-Pereyra L.H., 2010, ORGAN PROCUREMENT PR, P82; Wan TC, 2003, PLATELETS, V14, P295, DOI 10.1080/0953710031000154713; Wheeler TJ, 2005, J HEART LUNG TRANSPL, V24, P1378, DOI 10.1016/j.healun.2004.08.013; Wheeler TJ, 2004, MOL CELL BIOCHEM, V259, P105, DOI 10.1023/B:MCBI.0000021356.89867.0d; Xu M, 2010, EXP CLIN ENDOCR DIAB, V118, P459, DOI 10.1055/s-0030-1248325; Yin H, 2008, INT IMMUNOPHARMACOL, V8, P1842, DOI 10.1016/j.intimp.2008.09.004; Zeng Fan-xin, 2003, Yaoxue Xuebao, V38, P325; Zhang J, 1997, ANN THORAC SURG, V63, P388; Zimmer HG, 1996, MOL CELL BIOCHEM, V161, P101, DOI 10.1007/BF00240038	42	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35023	10.1371/journal.pone.0035023	http://dx.doi.org/10.1371/journal.pone.0035023			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558110	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336000022
J	Jorand, R; Le Corre, G; Andilla, J; Maandhui, A; Frongia, C; Lobjois, V; Ducommun, B; Lorenzo, C				Jorand, Raphael; Le Corre, Gwenaele; Andilla, Jordi; Maandhui, Amina; Frongia, Celine; Lobjois, Valerie; Ducommun, Bernard; Lorenzo, Corinne			Deep and Clear Optical Imaging of Thick Inhomogeneous Samples	PLOS ONE			English	Article							ADAPTIVE OPTICS; MICROSCOPY	Inhomogeneity in thick biological specimens results in poor imaging by light microscopy, which deteriorates as the focal plane moves deeper into the specimen. Here, we have combined selective plane illumination microscopy (SPIM) with wavefront sensor adaptive optics (WAO). Our WAOSPIM is based on a direct wavefront measure using a Hartmann-Shack wavefront sensor and fluorescent beads as point source emitters. We demonstrate the use of this WAOSPIM method to correct distortions in three-dimensional biological imaging and to improve the quality of images from deep within thick inhomogeneous samples.	[Jorand, Raphael; Le Corre, Gwenaele; Maandhui, Amina; Frongia, Celine; Lobjois, Valerie; Ducommun, Bernard; Lorenzo, Corinne] Univ Toulouse, ITAV UMS3039, Toulouse, France; [Jorand, Raphael; Le Corre, Gwenaele; Maandhui, Amina; Frongia, Celine; Lobjois, Valerie; Ducommun, Bernard; Lorenzo, Corinne] CNRS, ITAV UMS3039, Toulouse, France; [Andilla, Jordi] Inst Ciences Foton, ICFO, Barcelona, Spain; [Ducommun, Bernard] CHU Toulouse, Toulouse, France	Universite de Toulouse; Centre National de la Recherche Scientifique (CNRS); Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); CHU de Toulouse	Jorand, R (corresponding author), Univ Toulouse, ITAV UMS3039, Toulouse, France.	corinne.lorenzo@itav-recherche.fr	Andilla, Jordi/L-5953-2014	Andilla, Jordi/0000-0002-2516-3434; DUCOMMUN, Bernard/0000-0002-7126-8368; Lobjois, Valerie/0000-0003-2428-2084	Groupe d'interet scientifique "Infrastructures en Biologie Sante et Agronomie"; Centre National de la Recherche Scientifique; l'Universite Paul Sabatier; la Region Midi-Pyrenees; l'Association pour la Recherche contre le cancer; le Canceropole Grand Sud-Ouest; la Fondation InNaBioSante	Groupe d'interet scientifique "Infrastructures en Biologie Sante et Agronomie"; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); l'Universite Paul Sabatier; la Region Midi-Pyrenees(Region Occitanie); l'Association pour la Recherche contre le cancer; le Canceropole Grand Sud-Ouest; la Fondation InNaBioSante	AM was supported by a grant from the Groupe d'interet scientifique "Infrastructures en Biologie Sante et Agronomie." This work was financed by the Centre National de la Recherche Scientifique, l'Universite Paul Sabatier, la Region Midi-Pyrenees, l'Association pour la Recherche contre le cancer, le Canceropole Grand Sud-Ouest and la Fondation InNaBioSante. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrenberg AB, 2010, SCIENCE, V330, P971, DOI 10.1126/science.1195929; Azucena O, 2010, OPT EXPRESS, V18, P17521, DOI 10.1364/OE.18.017521; Debarre D, 2007, OPT EXPRESS, V15, P8176, DOI 10.1364/OE.15.008176; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Ji N, 2010, NAT METHODS, V7, P141, DOI 10.1038/NMETH.1411; Kam Z, 2001, P NATL ACAD SCI USA, V98, P3790, DOI 10.1073/pnas.071275698; Keller PJ, 2010, NAT METHODS, V7, P637, DOI [10.1038/NMETH.1476, 10.1038/nmeth.1476]; Lorenzo C, 2011, CELL DIV, V6, DOI 10.1186/1747-1028-6-22; Ntziachristos V, 2010, NAT METHODS, V7, P603, DOI [10.1038/NMETH.1483, 10.1038/nmeth.1483]; Preibisch S, 2010, NAT METHODS, V7, P418, DOI 10.1038/nmeth0610-418; Schwertner M, 2004, OPT EXPRESS, V12, P6540, DOI 10.1364/OPEX.12.006540; Sena G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021303; Simmonds RD, 2011, J MICROSCPY; SUTHERLAND RM, 1988, SCIENCE, V240, P177, DOI 10.1126/science.2451290; Swoger J, 2007, OPT EXPRESS, V15, P8029, DOI 10.1364/OE.15.008029; Tao XD, 2011, OPT LETT, V36, P1062, DOI 10.1364/OL.36.001062; Tyson RK, 1991, PRINCIPLES ADAPTIVES; Verveer P., 2007, NATURE METHODS, V4, P307	18	44	50	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35795	10.1371/journal.pone.0035795	http://dx.doi.org/10.1371/journal.pone.0035795			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558226	Green Submitted, gold, Green Published			2022-12-27	WOS:000305345200080
J	Nishi, D; Koido, Y; Nakaya, N; Sone, T; Noguchi, H; Hamazaki, K; Hamazaki, T; Matsuoka, Y				Nishi, Daisuke; Koido, Yuichi; Nakaya, Naoki; Sone, Toshimasa; Noguchi, Hiroko; Hamazaki, Kei; Hamazaki, Tomohito; Matsuoka, Yutaka			Peritraumatic Distress, Watching Television, and Posttraumatic Stress Symptoms among Rescue Workers after the Great East Japan Earthquake	PLOS ONE			English	Article							TERRORIST ATTACKS; DISORDER; INVENTORY; SEPTEMBER-11; DISASTER; METAANALYSIS; RELIABILITY; VALIDITY; VERSION; IMAGES	Background: The Great East Japan Earthquake of March 11, 2001 left around 20,000 dead or missing. Previous studies showed that rescue workers, as well as survivors, of disasters are at high risk for posttraumatic stress disorder (PTSD). This study examined the predictive usefulness of the Peritraumatic Distress Inventory (PDI) among rescue workers of Disaster Medical Assistance Teams (DMATs) deployed during the acute disaster phase of the Great East Japan Earthquake. Methodology/Principal Findings: In this prospective observational study, the DMAT members recruited were assessed 1 month after the earthquake on the PDI and 4 months after the earthquake on the Impact of Event Scale-Revised to determine PTSD symptoms. The predictive value of the PDI at initial assessment for PTSD symptoms at the follow-up assessment was examined by univariate and multiple linear regression analysis. Of the 254 rescue workers who participated in the initial assessment, 173 completed the follow-up assessment. Univariate regression analysis revealed that PDI total score and most individual item scores predicted PTSD symptoms. In particular, high predictive values were seen for peritraumatic emotional distress such as losing control of emotions and being ashamed of emotional reactions. In multiple linear regression analysis, PDI total score was an independent predictor for PTSD symptoms after adjusting for covariates. As for covariates specifically, watching earthquake television news reports for more than 4 hours per day predicted PTSD symptoms. Conclusions/Significance: The PDI predicted PTSD symptoms in rescue workers after the Great East Japan Earthquake. Peritraumatic emotional distress appears to be an important factor to screen for individuals at risk for developing PTSD among medical rescue workers. In addition, watching television for extended period of time might require attention at a time of crisis.	[Nishi, Daisuke; Matsuoka, Yutaka] Natl Disaster Med Ctr, Dept Psychiat, Tachikawa, Tokyo, Japan; [Nishi, Daisuke; Koido, Yuichi; Noguchi, Hiroko; Matsuoka, Yutaka] Natl Disaster Med Ctr, Clin Res Inst, Tachikawa, Tokyo, Japan; [Nishi, Daisuke; Nakaya, Naoki; Sone, Toshimasa; Noguchi, Hiroko; Hamazaki, Kei; Hamazaki, Tomohito; Matsuoka, Yutaka] Japan Sci & Technol Agcy, CREST, Tachikawa, Tokyo, Japan; [Koido, Yuichi] Japan Disaster Med Assistance Team, Head Off, Tachikawa, Tokyo, Japan; [Nakaya, Naoki] Kamakura Womens Univ, Fac Family & Consumer Sci, Dept Nutr & Dietet, Kamakura, Kanagawa, Japan; [Sone, Toshimasa] Tohoku Fukushi Univ, Fac Hlth Sci, Dept Rehabil, Sendai, Miyagi, Japan; [Noguchi, Hiroko; Matsuoka, Yutaka] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Adult Mental Hlth, Kodaira, Tokyo, Japan; [Hamazaki, Kei] Toyama Univ, Fac Med, Dept Publ Hlth, Toyama 930, Japan; [Hamazaki, Tomohito] Toyama Univ, Inst Nat Med, Dept Clin Sci, Toyama 930, Japan; [Matsuoka, Yutaka] Natl Ctr Neurol & Psychiat, Translat Med Ctr, Clin Res Training & Consultat Program, Kodaira, Tokyo, Japan	Japan Science & Technology Agency (JST); Kamakura Women's University; National Center for Neurology & Psychiatry - Japan; University of Toyama; University of Toyama; National Center for Neurology & Psychiatry - Japan	Nishi, D (corresponding author), Natl Disaster Med Ctr, Dept Psychiat, Tachikawa, Tokyo, Japan.	yutaka@ncnp.go.jp	Nishi, Daisuke/AAH-7211-2019; Matsuoka, Yutaka/N-1588-2019	Nishi, Daisuke/0000-0001-9349-3294; Matsuoka, Yutaka/0000-0002-8690-8129	Core Research for Evolutional Science and Technology (CREST), the Japan Science and Technology Agency (JST); Ministry of Health, Labor, and Welfare of Japan; Eli Lilly Japan; Toray Industries, Inc.; Foundation for Total Health Promotion; Qol Co., Ltd.; Japan Society for the Promotion of Science; Tamura Foundation for Promotion of Science and Technology; Ichiro Kanehara Foundation for Promotion of Medical Sciences and Medical Care; Polyene Project, Inc.; Otsuka Pharmaceutical Co., Ltd.; Nippon Suisan Kaisha, Ltd.; Open Research Center for Lipid Nutrition (Kinjo Gakuin University); Mochida Pharmaceutical Co., Ltd.; Ono Pharmaceutical Co., Ltd.; Astrazeneca K.K.; Bristol-Myers Squibb Company; National Center of Global Health and Medicine	Core Research for Evolutional Science and Technology (CREST), the Japan Science and Technology Agency (JST); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Eli Lilly Japan(Eli Lilly); Toray Industries, Inc.(Toray Industries, Inc.); Foundation for Total Health Promotion(Foundation for Total Health Promotion); Qol Co., Ltd.; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tamura Foundation for Promotion of Science and Technology; Ichiro Kanehara Foundation for Promotion of Medical Sciences and Medical Care; Polyene Project, Inc.; Otsuka Pharmaceutical Co., Ltd.(Otsuka Pharmaceutical); Nippon Suisan Kaisha, Ltd.; Open Research Center for Lipid Nutrition (Kinjo Gakuin University); Mochida Pharmaceutical Co., Ltd.; Ono Pharmaceutical Co., Ltd.(Ono Pharmaceutical Co Ltd); Astrazeneca K.K.(AstraZeneca); Bristol-Myers Squibb Company(Bristol-Myers Squibb); National Center of Global Health and Medicine	This work was supported by Core Research for Evolutional Science and Technology (CREST), the Japan Science and Technology Agency (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; YM has received another research support from the Ministry of Health, Labor, and Welfare of Japan and a lecture fee from Eli Lilly Japan. DN has received research support from Toray Industries, Inc., and the Foundation for Total Health Promotion and a lecture fee from Qol Co., Ltd. KH has received research support from the Japan Society for the Promotion of Science, the Tamura Foundation for Promotion of Science and Technology, and the Ichiro Kanehara Foundation for Promotion of Medical Sciences and Medical Care, and consultant fees from Polyene Project, Inc., and Otsuka Pharmaceutical Co., Ltd., and a lecture fee from Nippon Suisan Kaisha, Ltd. TM has received research support from the Japan Society for the Promotion of Science, Open Research Center for Lipid Nutrition (Kinjo Gakuin University, and Nippon Suisan Kaisha, Ltd., and consultant fees from Polyene Project, Inc., and Otsuka Pharmaceutical Co., Ltd., and lecture fees from Mochida Pharmaceutical Co., Ltd.) YK has received research support from the Ministry of Health, Labor, and Welfare of Japan, Ono Pharmaceutical Co., Ltd., Astrazeneca K.K., Bristol-Myers Squibb Company, and National Center of Global Health and Medicine. All other authors declare that they have no competing interests. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Ahern J, 2004, J NERV MENT DIS, V192, P217, DOI 10.1097/01.nmd.0000116465.99830.ca; Ahern J, 2002, PSYCHIATRY, V65, P289, DOI 10.1521/psyc.65.4.289.20240; American Psychiatric Association, 2017, DIAGN STAT MAN MENT, V5th; Asukai N, 2002, J NERV MENT DIS, V190, P175, DOI 10.1097/00005053-200203000-00006; Bedard-Gilligan M, 2008, BEHAV RES THER, V46, P1062, DOI 10.1016/j.brat.2008.06.009; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Brunet A, 2001, AM J PSYCHIAT, V158, P1480, DOI 10.1176/appi.ajp.158.9.1480; CHARNEY DS, 1993, ARCH GEN PSYCHIAT, V50, P294; DAVIDSON JRT, 1991, PSYCHOL MED, V21, P713, DOI 10.1017/S0033291700022352; Epstein RS, 1998, AM J PSYCHIAT, V155, P934, DOI 10.1176/ajp.155.7.934; Fullerton CS, 2004, AM J PSYCHIAT, V161, P1370, DOI 10.1176/appi.ajp.161.8.1370; Jehel L, 2005, CAN J PSYCHIAT, V50, P67, DOI 10.1177/070674370505000112; Matsuoka Y, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-132; Nishi D, 2012, POSTTRAUMATIC STRESS, P97; Nishi D, 2010, PSYCHIAT CLIN NEUROS, V64, P149, DOI 10.1111/j.1440-1819.2010.02065.x; Nishi D, 2009, GEN HOSP PSYCHIAT, V31, P75, DOI 10.1016/j.genhosppsych.2008.09.002; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Schlenger WE, 2002, JAMA-J AM MED ASSOC, V288, P581, DOI 10.1001/jama.288.5.581; Schnurr P, 2002, J CLIN GEROPSYCHOL, V8, P175, DOI [DOI 10.1023/A:1015992110544, 10.1023/A:1015992110544]; Silver RC, 2002, JAMA-J AM MED ASSOC, V288, P1235, DOI 10.1001/jama.288.10.1235; Walker EA, 2003, ARCH GEN PSYCHIAT, V60, P369, DOI 10.1001/archpsyc.60.4.369; Weiss DS., 2004, IMPACT EVENT SCALE R, P168	23	57	57	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35248	10.1371/journal.pone.0035248	http://dx.doi.org/10.1371/journal.pone.0035248			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VP	22558130	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345200030
J	Cheadle, C; Berger, AE; Mathai, SC; Grigoryev, DN; Watkins, TN; Sugawara, Y; Barkataki, S; Fan, JS; Boorgula, M; Hummers, L; Zaiman, AL; Girgis, R; McDevitt, MA; Johns, RA; Wigley, F; Barnes, KC; Hassoun, PM				Cheadle, Chris; Berger, Alan E.; Mathai, Stephen C.; Grigoryev, Dmitry N.; Watkins, Tonya N.; Sugawara, Yumiko; Barkataki, Sangjucta; Fan, Jinshui; Boorgula, Meher; Hummers, Laura; Zaiman, Ari L.; Girgis, Reda; McDevitt, Michael A.; Johns, Roger A.; Wigley, Frederick; Barnes, Kathleen C.; Hassoun, Paul M.			Erythroid-Specific Transcriptional Changes in PBMCs from Pulmonary Hypertension Patients	PLOS ONE			English	Article							PERIPHERAL-BLOOD CELLS; EXPERT CONSENSUS DOCUMENTS; FOUNDATION TASK-FORCE; GENE-EXPRESSION; ARTERIAL-HYPERTENSION; SYSTEMIC-SCLEROSIS; IN-VITRO; INTERFERON; LUNG; DIFFERENTIATION	Background: Gene expression profiling of peripheral blood mononuclear cells (PBMCs) is a powerful tool for the identification of surrogate markers involved in disease processes. The hypothesis tested in this study was that chronic exposure of PBMCs to a hypertensive environment in remodeled pulmonary vessels would be reflected by specific transcriptional changes in these cells. Methodology/Principal Findings: The transcript profiles of PBMCs from 30 idiopathic pulmonary arterial hypertension patients (IPAH), 19 patients with systemic sclerosis without pulmonary hypertension (SSc), 42 scleroderma-associated pulmonary arterial hypertensio patients (SSc-PAH), and 8 patients with SSc complicated by interstitial lung disease and pulmonary hypertension (SSc-PH-ILD) were compared to the gene expression profiles of PBMCs from 41 healthy individuals. Multiple gene expression signatures were identified which could distinguish various disease groups from controls. One of these signatures, specific for erythrocyte maturation, is enriched specifically in patients with PH. This association was validated in multiple published datasets. The erythropoiesis signature was strongly correlated with hemodynamic measures of increasing disease severity in IPAH patients. No significant correlation of the same type was noted for SSc-PAH patients, this despite a clear signature enrichment within this group overall. These findings suggest an association of the erythropoiesis signature in PBMCs from patients with PH with a variable presentation among different subtypes of disease. Conclusions/Significance: In PH, the expansion of immature red blood cell precursors may constitute a response to the increasingly hypoxic conditions prevalent in this syndrome. A correlation of this erythrocyte signature with more severe hypertension cases may provide an important biomarker of disease progression.	[Cheadle, Chris; Berger, Alan E.; Watkins, Tonya N.; Sugawara, Yumiko; Barkataki, Sangjucta; Fan, Jinshui; Boorgula, Meher; Barnes, Kathleen C.] Johns Hopkins Univ, Sch Med, Div Allergy & Clin Immunol, Baltimore, MD 21218 USA; [Mathai, Stephen C.; Zaiman, Ari L.; Girgis, Reda; Hassoun, Paul M.] Johns Hopkins Univ, Sch Med, Div Pulm Crit Care Med, Baltimore, MD USA; [Grigoryev, Dmitry N.] Childrens Mercy Hosp & Clin, Med Genet Core, Kansas City, MO USA; [Hummers, Laura; Wigley, Frederick] Johns Hopkins Univ, Sch Med, Div Rheumatol, Baltimore, MD USA; [McDevitt, Michael A.] Johns Hopkins Univ, Sch Med, Div Hematol, Baltimore, MD USA; [Johns, Roger A.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Children's Mercy Hospital; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Cheadle, C (corresponding author), Johns Hopkins Univ, Sch Med, Div Allergy & Clin Immunol, Baltimore, MD 21218 USA.	ccheadl1@jhmi.edu; phassou1@jhmi.edu	Boorgula, Meher Preethi/AAC-6252-2022; Grigoryev, Dmitry/C-9422-2015	Hummers, Laura/0000-0002-4864-4011; Grigoryev, Dmitry/0000-0002-1849-1763	NHLBI (Specialized Center for Clinically-Oriented Research) [P50 Grant HL084946]; Mary Beryl Patch Turnbull Scholar Program; Scleroderma Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL084946] Funding Source: NIH RePORTER	NHLBI (Specialized Center for Clinically-Oriented Research); Mary Beryl Patch Turnbull Scholar Program; Scleroderma Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by NHLBI P50 Grant HL084946 (Specialized Center for Clinically-Oriented Research, to P. M. H.). Supported in part by the Mary Beryl Patch Turnbull Scholar Program (to K. C. B.). The Scleroderma Research Foundation has provided support for the Johns Hopkins Scleroderma Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baechler EC, 2004, GENES IMMUN, V5, P347, DOI 10.1038/sj.gene.6364098; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bendayan D, 2006, ISR MED ASSOC J, V8, P252; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Bull TM, 2004, AM J RESP CRIT CARE, V170, P911, DOI 10.1164/rccm.200312-1686OC; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Burczynski ME, 2006, PHARMACOGENOMICS, V7, P187, DOI 10.2217/14622416.7.2.187; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Cheadle Chris, 2003, Appl Bioinformatics, V2, P209; Cheadle C, 2010, ARTHRITIS RHEUM-US, V62, P1744, DOI 10.1002/art.27398; Christmann RB, 2011, ARTHRITIS RHEUM-US, V63, P1718, DOI 10.1002/art.30318; CRAPO RO, 1982, B EUR PHYSIOPATH RES, V18, P419; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P185; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; De S, 2010, PHYSIOL GENOMICS, V42A, P162, DOI 10.1152/physiolgenomics.00008.2010; Ebert BL, 2008, PLOS MED, V5, P312, DOI 10.1371/journal.pmed.0050035; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fagan KA, 2002, PROG CARDIOVASC DIS, V45, P225, DOI 10.1053/pcad.2002.129975; Fall N, 2007, ARTHRITIS RHEUM-US, V56, P3793, DOI 10.1002/art.22981; Filippone C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009496; Fisher MR, 2006, ARTHRITIS RHEUM-US, V54, P3043, DOI 10.1002/art.22069; FRIEND C, 1971, P NATL ACAD SCI USA, V68, P378; Gaine SP, 1998, LANCET, V352, P719, DOI 10.1016/S0140-6736(98)02111-4; Ghosh S, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-56; Girgis RE, 2007, ANN RHEUM DIS, V66, P1467, DOI 10.1136/ard.2007.069609; Goh SH, 2007, PHYSIOL GENOMICS, V30, P172, DOI 10.1152/physiolgenomics.00247.2006; Greer JP, 2009, WINTROBES CLIN HEMAT; Grigoryev DN, 2008, TRANSL RES, V151, P197, DOI 10.1016/j.trsl.2007.12.010; Hachulla E, 2005, ARTHRITIS RHEUM-US, V52, P3792, DOI 10.1002/art.21433; Harigae H, 1998, BLOOD, V91, P798, DOI 10.1182/blood.V91.3.798.798_798_805; Hassoun Paul M, 2009, Expert Rev Respir Med, V3, P187, DOI 10.1586/ers.09.5; Hassoun PM, 2011, PRESSE MED, V40, pe3, DOI DOI 10.1016/J.LPM.2010.08.006; Hinze CH, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3061; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kaneko K, 2009, FEBS J, V276, P1370, DOI 10.1111/j.1742-4658.2009.06878.x; Le Payec J, 2010, AM J RESP CRIT CARE, V181, P1285, DOI 10.1164/rccm.200909-1331PP; LEROY EC, 1988, J RHEUMATOL, V15, P202; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; MacDonald SLS, 2001, RADIOLOGY, V221, P600, DOI 10.1148/radiol.2213010158; Martinelli S, 2004, J BIOL CHEM, V279, P44123, DOI 10.1074/jbc.M405883200; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; McCall MN, 2011, NUCLEIC ACIDS RES, V39, pD1011, DOI 10.1093/nar/gkq1259; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; Nadon R, 2002, CEL MOL NEU; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; Ohneda K, 2002, ACTA HAEMATOL-BASEL, V108, P237, DOI 10.1159/000065660; Pan W, 2002, BIOINFORMATICS, V18, P546, DOI 10.1093/bioinformatics/18.4.546; PATERAKIS GS, 1993, ACTA HAEMATOL-BASEL, V90, P182; Pendergrass SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012106; Rajkumar R, 2010, AM J PHYSIOL-HEART C, V298, pH1235, DOI 10.1152/ajpheart.00254.2009; RICH S, 1987, ANN INTERN MED, V107, P216, DOI 10.7326/0003-4819-107-2-216; Risbano MG, 2010, CTS-CLIN TRANSL SCI, V3, P210, DOI 10.1111/j.1752-8062.2010.00218.x; Simonneau G, 2002, AM J RESP CRIT CARE, V165, P800, DOI 10.1164/ajrccm.165.6.2106079; Steen VD, 2005, JCR-J CLIN RHEUMATOL, V11, P40, DOI 10.1097/01.rhu.0000152147.38706.db; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van den Akker E, 2010, HAEMATOL-HEMATOL J, V95, P1594, DOI 10.3324/haematol.2009.019828; Yu X, 2009, BLOOD, V113, P5961, DOI 10.1182/blood-2008-12-196030; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85	61	46	46	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e34951	10.1371/journal.pone.0034951	http://dx.doi.org/10.1371/journal.pone.0034951			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545094	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343200016
J	Sanchez, A; Contreras, C; Martinez, MP; Climent, B; Benedito, S; Garcia-Sacristan, A; Hernandez, M; Prieto, D				Sanchez, Ana; Contreras, Cristina; Martinez, Maria Pilar; Climent, Belen; Benedito, Sara; Garcia-Sacristan, Albino; Hernandez, Medardo; Prieto, Dolores			Role of Neural NO Synthase (nNOS) Uncoupling in the Dysfunctional Nitrergic Vasorelaxation of Penile Arteries from Insulin-Resistant Obese Zucker Rats	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ENDOTHELIUM-DEPENDENT RELAXATION; KINASE SIGNALING PATHWAY; ALPHA-LIPOIC ACID; CORPUS-CAVERNOSUM; ERECTILE DYSFUNCTION; DIABETES-MELLITUS; CA2+ SENSITIZATION; MOUSE PENIS; K+ CHANNELS	Objective: Erectile dysfunction (ED) is considered as an early sign of vascular disease due to its high prevalence in patients with cardiovascular risk factors. Endothelial and neural dysfunction involving nitric oxide (NO) are usually implicated in the pathophysiology of the diabetic ED, but the underlying mechanisms are unclear. The present study assessed the role of oxidative stress in the dysfunctional neural vasodilator responses of penile arteries in the obese Zucker rat (OZR), an experimental model of metabolic syndrome/prediabetes. Methods and Results: Electrical field stimulation (EFS) under non-adrenergic non-cholinergic (NANC) conditions evoked relaxations that were significantly reduced in penile arteries of OZR compared with those of lean Zucker rats (LZR). Blockade of NO synthase (NOS) inhibited neural relaxations in both LZR and OZR, while saturating concentrations of the NOS substrate L-arginine reversed the inhibition and restored relaxations in OZR to levels in arteries from LZR. nNOS expression was unchanged in arteries from OZR compared to LZR and nNOS selective inhibition decreased the EFS relaxations in LZR but not in OZR, while endothelium removal did not alter these responses in either strain. Superoxide anion production and nitro-tyrosine immunostaining were elevated in the erectile tissue from OZR. Treatment with the NADPH oxidase inhibitor apocynin or acute incubation with the NOS cofactor tetrahydrobiopterin (BH4) restored neural relaxations in OZR to levels in control arteries, while inhibition of the enzyme of BH4 synthesis GTP-cyclohydrolase (GCH) reduced neural relaxations in arteries from LZR but not OZR. The NO donor SNAP induced decreases in intracellular calcium that were impaired in arteries from OZR compared to controls. Conclusions: The present study demonstrates nitrergic dysfunction and impaired neural NO signalling due to oxidative stress and nNOS uncoupling in penile arteries under conditions of insulin resistance. This dysfunction likely contributes to the metabolic syndrome-associated ED, along with the endothelial dysfunction also involving altered NO signalling.	[Sanchez, Ana; Contreras, Cristina; Climent, Belen; Benedito, Sara; Garcia-Sacristan, Albino; Hernandez, Medardo; Prieto, Dolores] Univ Complutense Madrid, Fac Farm, Dept Fisiol, Madrid, Spain; [Martinez, Maria Pilar] Univ Complutense Madrid, Fac Farm, Dept Anat & Anat Patol Comparadas, Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid	Sanchez, A (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Fisiol, Madrid, Spain.	dprieto@farm.ucm.es	Contreras, Cristina/N-7257-2019; BENEDITO, SARA/H-9730-2015; Pilar Martinez, P Martinez/E-8591-2016; Climent, Belen/P-2416-2015; PRIETO, DOLORES/S-8172-2018	Contreras, Cristina/0000-0002-7015-7922; BENEDITO, SARA/0000-0001-9660-2409; Pilar Martinez, P Martinez/0000-0001-9063-3191; Climent, Belen/0000-0003-0852-9227; PRIETO, DOLORES/0000-0001-7049-5991	Spanish Minister of Science and Innovation [SAF2009-10448]	Spanish Minister of Science and Innovation(Spanish Government)	This study was supported by Grant no SAF2009-10448 from the Spanish Minister of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON KE, 1995, PHYSIOL REV, V75, P191, DOI 10.1152/physrev.1995.75.1.191; Andersson KE, 2003, J UROLOGY, V170, pS6, DOI 10.1097/01.ju.0000075362.08363.a4; AZADZOI KM, 1992, J UROLOGY, V148, P1587, DOI 10.1016/S0022-5347(17)36975-6; Bivalacqua TJ, 2004, P NATL ACAD SCI USA, V101, P9121, DOI 10.1073/pnas.0400520101; Bivalacqua TJ, 2007, AM J PHYSIOL-HEART C, V292, pH1340, DOI 10.1152/ajpheart.00121.2005; Cameron NE, 2001, DIABETOLOGIA, V44, P1973, DOI 10.1007/s001250100001; Carneiro FS, 2010, J SEX MED, V7, P3620, DOI 10.1111/j.1743-6109.2010.02000.x; Carneiro FS, 2008, J SEX MED, V5, P1156, DOI 10.1111/j.1743-6109.2007.00752.x; Cellek S, 2003, DIABETES, V52, P2353, DOI 10.2337/diabetes.52.9.2353; Cellek S, 1997, P NATL ACAD SCI USA, V94, P8226, DOI 10.1073/pnas.94.15.8226; Cellek S, 1999, BRIT J PHARMACOL, V128, P1804, DOI 10.1038/sj.bjp.0702981; Contreras C, 2010, BRIT J PHARMACOL, V161, P350, DOI 10.1111/j.1476-5381.2010.00825.x; DETEJADA IS, 1989, NEW ENGL J MED, V320, P1025, DOI 10.1056/NEJM198904203201601; Feldman EL, 2003, J CLIN INVEST, V111, P431, DOI 10.1172/JCI200317863; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; GRILL V, 1992, METABOLISM, V41, P28, DOI 10.1016/0026-0495(92)90186-E; Gur S, 2007, J UROLOGY, V178, P1543, DOI 10.1016/j.juro.2007.05.121; Guzik TJ, 2002, CIRCULATION, V105, P1656, DOI 10.1161/01.CIR.0000012748.58444.08; Hakim LS, 1996, ENDOCRIN METAB CLIN, V25, P379, DOI 10.1016/S0889-8529(05)70329-7; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Hurt KJ, 2002, P NATL ACAD SCI USA, V99, P4061, DOI 10.1073/pnas.052712499; Jin LM, 2004, AM J PHYSIOL-HEART C, V287, pH1495, DOI 10.1152/ajpheart.01006.2003; Johnson JM, 2011, INT J IMPOT RES, V23, P43, DOI 10.1038/ijir.2011.2; Katakam PV, 2012, J CEREB BLOOD F 0111; Keegan A, 1999, DIABETOLOGIA, V42, P343, DOI 10.1007/s001250051161; Keegan A, 2001, DIABETES-METAB RES, V17, P380, DOI 10.1002/dmrr.215; Li HW, 2004, DIABETES, V53, P2436, DOI 10.2337/diabetes.53.9.2436; Liu YP, 2002, CIRC RES, V91, P1070, DOI 10.1161/01.RES.0000046003.14031.98; Luttrell IP, 2008, AM J PHYSIOL-HEART C, V294, pH2204, DOI 10.1152/ajpheart.00027.2008; Montorsi F, 2003, EUR UROL, V44, P360, DOI 10.1016/S0302-2838(03)00305-1; Moody JA, 1997, J UROLOGY, V158, P942, DOI 10.1016/S0022-5347(01)64368-4; Musicki B, 2007, INT J IMPOT RES, V19, P129, DOI 10.1038/sj.ijir.3901494; Musicki B, 2005, P NATL ACAD SCI USA, V102, P11870, DOI 10.1073/pnas.0502488102; Musicki B, 2010, J SEX MED, V7, P3023, DOI 10.1111/j.1743-6109.2010.01880.x; Nangle MR, 2004, PFLUG ARCH EUR J PHY, V448, P139, DOI 10.1007/s00424-003-1232-7; Nangle MR, 2003, NITRIC OXIDE-BIOL CH, V9, P194, DOI 10.1016/j.niox.2004.01.006; Pieper GM, 1997, J PHARMACOL EXP THER, V283, P684; Podlasek CA, 2001, J UROLOGY, V166, P746, DOI 10.1016/S0022-5347(05)66054-5; Prieto D, 2008, INT J IMPOT RES, V20, P17, DOI 10.1038/sj.ijir.3901581; Prieto D, 1998, BRIT J PHARMACOL, V123, P1609, DOI 10.1038/sj.bjp.0701780; Prieto D, 2010, AM J PHYSIOL-HEART C, V299, pH915, DOI 10.1152/ajpheart.00382.2010; SAENZ DE, 2005, J SEX MED, V2, P26; Sanchez A, 2008, EUR J PHARMACOL, V586, P283, DOI 10.1016/j.ejphar.2008.03.002; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; Schmidt TS, 2007, CLIN SCI, V113, P47, DOI 10.1042/CS20070108; Sullivan ME, 1999, CARDIOVASC RES, V43, P658, DOI 10.1016/S0008-6363(99)00135-2; Touyz RM, 2011, HYPERTENS RES, V34, P5, DOI 10.1038/hr.2010.201; Venardos K, 2009, INT J BIOCHEM CELL B, V41, P2522, DOI 10.1016/j.biocel.2009.08.008; VERNET D, 1995, ENDOCRINOLOGY, V136, P5709, DOI 10.1210/en.136.12.5709; Vickers MA, 2004, AM J MANAG CARE, V10, pS3; Villalba N, 2007, AM J PHYSIOL-HEART C, V292, pH1157, DOI 10.1152/ajpheart.01034.2006; Villalba N, 2011, AM J PHYSIOL-HEART C, V300, pH2044, DOI 10.1152/ajpheart.01204.2010; Villalba N, 2009, AM J PHYSIOL-HEART C, V297, pH696, DOI 10.1152/ajpheart.01308.2008; Wingard C, 2007, J SEX MED, V4, P348, DOI 10.1111/j.1743-6109.2007.00439.x; Xu J, 2007, CIRCULATION, V116, P944, DOI 10.1161/CIRCULATIONAHA.106.684795	55	38	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e36027	10.1371/journal.pone.0036027	http://dx.doi.org/10.1371/journal.pone.0036027			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22540017	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341000083
J	Nguyen, T; Jagannathan, M; Shire, K; Frappier, L				Tin Nguyen; Jagannathan, Madhav; Shire, Kathy; Frappier, Lori			Interactions of the Human MCM-BP Protein with MCM Complex Components and Dbf4	PLOS ONE			English	Article							MINICHROMOSOME MAINTENANCE PROTEINS; MCM4,6,7 HELICASE ACTIVITY; DNA-REPLICATION; S-PHASE; SCHIZOSACCHAROMYCES-POMBE; KINASE COMPLEX; ACTIVE-SITES; HUMAN-CELLS; PHOSPHORYLATION; CDC7	MCM-BP was discovered as a protein that co-purified from human cells with MCM proteins 3 through 7; results which were recapitulated in frogs, yeast and plants. Evidence in all of these organisms supports an important role for MCM-BP in DNA replication, including contributions to MCM complex unloading. However the mechanisms by which MCM-BP functions and associates with MCM complexes are not well understood. Here we show that human MCM-BP is capable of interacting with individual MCM proteins 2 through 7 when co-expressed in insect cells and can greatly increase the recovery of some recombinant MCM proteins. Glycerol gradient sedimentation analysis indicated that MCM-BP interacts most strongly with MCM4 and MCM7. Similar gradient analyses of human cell lysates showed that only a small amount of MCM-BP overlapped with the migration of MCM complexes and that MCM complexes were disrupted by exogenous MCM-BP. In addition, large complexes containing MCM-BP and MCM proteins were detected at mid to late S phase, suggesting that the formation of specific MCM-BP complexes is cell cycle regulated. We also identified an interaction between MCM-BP and the Dbf4 regulatory component of the DDK kinase in both yeast 2-hybrid and insect cell co-expression assays, and this interaction was verified by co-immunoprecipitation of endogenous proteins from human cells. In vitro kinase assays showed that MCM-BP was not a substrate for DDK but could inhibit DDK phosphorylation of MCM4,6,7 within MCM4,6,7 or MCM2-7 complexes, with little effect on DDK phosphorylation of MCM2. Since DDK is known to activate DNA replication through phosphorylation of these MCM proteins, our results suggest that MCM-BP may affect DNA replication in part by regulating MCM phosphorylation by DDK.	[Tin Nguyen; Jagannathan, Madhav; Shire, Kathy; Frappier, Lori] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Toronto	Nguyen, T (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	lori.frappier@utoronto.ca	Jagannathan, Madhav/AAF-8137-2019	Jagannathan, Madhav/0000-0003-3428-6812	Canadian Institutes of Health Research (CIHR) [84306]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by operating grant 84306 from the Canadian Institutes of Health Research (CIHR) to L.F. L.F. is a tier 1 Canada Research Chair in Molecular Virology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bochman ML, 2008, MOL CELL BIOL, V28, P5865, DOI 10.1128/MCB.00161-08; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Bochman ML, 2010, NUCLEIC ACIDS RES, V38, P6078, DOI 10.1093/nar/gkq422; Chibazakura T, 2011, MOL CELL BIOL, V31, P248, DOI 10.1128/MCB.00630-10; Cho WH, 2006, P NATL ACAD SCI USA, V103, P11521, DOI 10.1073/pnas.0604990103; Chuang LC, 2009, MOL CELL, V35, P206, DOI 10.1016/j.molcel.2009.06.014; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; Ding L, 2011, J BIOL CHEM, V286, P32918, DOI 10.1074/jbc.M111.282541; Duch A, 2011, J BIOL CHEM, V286, P2486, DOI 10.1074/jbc.M110.190843; Duncker BP, 2003, MUTAT RES-FUND MOL M, V532, P21, DOI 10.1016/j.mrfmmm.2003.08.007; Ferguson RL, 2008, J CELL SCI, V121, P3224, DOI 10.1242/jcs.034702; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Furuya K, 2010, MOL CELL, V40, P606, DOI 10.1016/j.molcel.2010.10.026; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Hubbi ME, 2011, MOL CELL, V42, P700, DOI 10.1016/j.molcel.2011.03.029; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Ishimi Y, 2000, J BIOL CHEM, V275, P16235, DOI 10.1074/jbc.M909040199; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Ishimi Y, 2001, J BIOL CHEM, V276, P34428, DOI 10.1074/jbc.M104480200; Jagannathan M, 2012, J CELL SCI, V125, P133, DOI 10.1242/jcs.089938; Jiang W, 1999, EMBO J, V18, P5703, DOI 10.1093/emboj/18.20.5703; Jones DR, 2010, CELL CYCLE, V9, P2018, DOI 10.4161/cc.9.10.11752; Kanter DM, 2008, J BIOL CHEM, V283, P31172, DOI 10.1074/jbc.M804686200; Kneissl M, 2003, J MOL BIOL, V327, P111, DOI 10.1016/S0022-2836(03)00079-2; Lee JK, 2000, J BIOL CHEM, V275, P18871, DOI 10.1074/jbc.M001118200; Lei M, 1997, GENE DEV, V11, P3365, DOI 10.1101/gad.11.24.3365; Li JJ, 2011, FEBS LETT, V585, P3850, DOI 10.1016/j.febslet.2011.10.033; Maiorano D, 2006, CURR OPIN CELL BIOL, V18, P130, DOI 10.1016/j.ceb.2006.02.006; Masai H, 2000, J BIOL CHEM, V275, P29042, DOI 10.1074/jbc.M002713200; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Nayyar VK, 2009, J CELL SCI, V122, P4341, DOI 10.1242/jcs.060913; Nishiyama A, 2011, GENE DEV, V25, P165, DOI 10.1101/gad.614411; Prokhorova TA, 2000, J BIOL CHEM, V275, P2491, DOI 10.1074/jbc.275.4.2491; Sakwe AM, 2007, MOL CELL BIOL, V27, P3044, DOI 10.1128/MCB.02384-06; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Shire K, 2006, J VIROL, V80, P5261, DOI 10.1128/JVI.02682-05; Sterner JM, 1998, MOL CELL BIOL, V18, P2748, DOI 10.1128/MCB.18.5.2748; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Takahashi N, 2008, EMBO J, V27, P1840, DOI 10.1038/emboj.2008.107; Takahashi N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000817; Tenca P, 2007, J BIOL CHEM, V282, P208, DOI 10.1074/jbc.M604457200; Tsao CC, 2004, EMBO J, V23, P4660, DOI 10.1038/sj.emboj.7600463; Tsuji T, 2008, MOL CELL, V32, P862, DOI 10.1016/j.molcel.2008.12.005; Tsuji T, 2006, MOL BIOL CELL, V17, P4459, DOI 10.1091/mbc.E06-03-0241; Varrin AE, 2005, MOL CELL BIOL, V25, P7494, DOI 10.1128/MCB.25.17.7494-7504.2005; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; Yu ZL, 2004, J MOL BIOL, V340, P1197, DOI 10.1016/j.jmb.2004.05.024	54	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35931	10.1371/journal.pone.0035931	http://dx.doi.org/10.1371/journal.pone.0035931			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22540012	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341000078
J	Novais, SC; Arrais, J; Lopes, P; Vandenbrouck, T; De Coen, W; Roelofs, D; Soares, AMVM; Amorim, MJB				Novais, Sara C.; Arrais, Joel; Lopes, Pedro; Vandenbrouck, Tine; De Coen, Wim; Roelofs, Dick; Soares, Amadeu M. V. M.; Amorim, Monica J. B.			Enchytraeus albidus Microarray: Enrichment, Design, Annotation and Database (EnchyBASE)	PLOS ONE			English	Article							DIFFERENTIAL GENE-EXPRESSION; SUPPRESSION SUBTRACTIVE HYBRIDIZATION; HEAVY-METAL TOLERANCE; AVOIDANCE-BEHAVIOR; EISENIA-FOETIDA; SOIL ARTHROPOD; OLIGOCHAETA; CADMIUM; ECOTOXICITY; RESPONSES	Enchytraeus albidus (Oligochaeta) is an ecologically relevant species used as standard test organisms for risk assessment. Effects of stressors in this species are commonly determined at the population level using reproduction and survival as endpoints. The assessment of transcriptomic responses can be very useful e.g. to understand underlying mechanisms of toxicity with gene expression fingerprinting. In the present paper the following is being addressed: 1) development of suppressive subtractive hybridization (SSH) libraries enriched for differentially expressed genes after metal and pesticide exposures; 2) sequencing and characterization of all generated cDNA inserts; 3) development of a publicly available genomic database on E. albidus. A total of 2100 Expressed Sequence Tags (ESTs) were isolated, sequenced and assembled into 1124 clusters (947 singletons and 177 contigs). From these sequences, 41% matched known proteins in GenBank (BLASTX, e-value <= 10(-5)) and 37% had at least one Gene Ontology (GO) term assigned. In total, 5.5% of the sequences were assigned to a metabolic pathway, based on KEGG. With this new sequencing information, an Agilent custom oligonucleotide microarray was designed, representing a potential tool for transcriptomic studies. EnchyBASE (http://bioinformatics.ua.pt/enchybase/) was developed as a web freely available database containing genomic information on E. albidus and will be further extended in the near future for other enchytraeid species. The database so far includes all ESTs generated for E. albidus from three cDNA libraries. This information can be downloaded and applied in functional genomics and transcription studies.	[Novais, Sara C.; Soares, Amadeu M. V. M.; Amorim, Monica J. B.] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Novais, Sara C.; Soares, Amadeu M. V. M.; Amorim, Monica J. B.] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal; [Arrais, Joel; Lopes, Pedro] Univ Aveiro, DETI, IEETA, P-3800 Aveiro, Portugal; [Vandenbrouck, Tine; De Coen, Wim] Univ Antwerp, Dept Biol, EBT, B-2020 Antwerp, Belgium; [Roelofs, Dick] Vrije Univ Amsterdam, Inst Ecol Sci, De Boelelaan, Netherlands	Universidade de Aveiro; Universidade de Aveiro; Universidade de Aveiro; University of Antwerp; Vrije Universiteit Amsterdam	Novais, SC (corresponding author), Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal.	sara.novais@ua.pt	Soares, Amadeu/A-8304-2008; Amorim, Mónica J.B./G-8590-2011; Novais, Sara C/A-9032-2012	Soares, Amadeu/0000-0003-0879-9470; Amorim, Mónica J.B./0000-0001-8137-3295; Novais, Sara C/0000-0003-1306-3396; Roelofs, Dick/0000-0003-3954-3590; Lopes, Pedro/0000-0001-5330-6562; Arrais, Joel/0000-0003-4937-2334	Fundacao para a Ciencia e Tecnologia (Portugal) [SFRH/BD/36253/2007, PTDC/BIA-BCM/64745/2006, PTDC/BIA-BEC/103716/2008]; Fundação para a Ciência e a Tecnologia [PTDC/BIA-BEC/103716/2008, PTDC/BIA-BCM/64745/2006] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	This study was sponsored by Fundacao para a Ciencia e Tecnologia (Portugal), through a PhD grant to Sara Novais (SFRH/BD/36253/2007) and through the project references PTDC/BIA-BCM/64745/2006 (REDE) and PTDC/BIA-BEC/103716/2008 (NANOkA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amorim MJB, 2005, CHEMOSPHERE, V59, P501, DOI 10.1016/j.chemosphere.2005.01.057; Amorim MJD, 2005, ENVIRON TOXICOL CHEM, V24, P1875, DOI 10.1897/04-505R.1; Amorim MJB, 2008, ENVIRON POLLUT, V155, P112, DOI 10.1016/j.envpol.2007.10.028; Amorim MJB, 2008, ENVIRON INT, V34, P363, DOI 10.1016/j.envint.2007.08.010; Amorim MJB, 2011, ENVIRON TOXICOL CHEM, V30, P1395, DOI 10.1002/etc.512; [Anonymous], GUID TEST CHEM ENCH; Clark MS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-475; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; de Boer TE, 2011, MOL ECOL, V20, P1144, DOI 10.1111/j.1365-294X.2010.04985.x; de Boer TE, 2010, J INSECT PHYSIOL, V56, P350, DOI 10.1016/j.jinsphys.2009.11.004; Deng W, 2007, BIOINFORMATICS, V23, P2334, DOI 10.1093/bioinformatics/btm331; Diatchenko L, 1999, METHOD ENZYMOL, V303, P349; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Dodard SG, 2005, ENVIRON TOXICOL CHEM, V24, P2579, DOI 10.1897/054-188R.1; Gertz EM, 2005, BLAST SCORING PARAME; Gomes SIL, 2012, COMP BIOCHEM PHYS C, V155, P219, DOI 10.1016/j.cbpc.2011.08.008; Gomes SIL, 2011, SOIL BIOL BIOCHEM, V43, P2078, DOI 10.1016/j.soilbio.2011.06.006; Heckmann LH, 2008, GENOME BIOL, V6, P25; Holmstrup M, 2011, ENVIRON POLLUT, V159, P190, DOI 10.1016/j.envpol.2010.09.005; ISO, 2004, SOIL QUAL EFF POLL E; Jeffrey S, 2010, EUROPEAN ATLAS SOIL; Lee MS, 2005, BIOCHEM BIOPH RES CO, V328, P1196, DOI 10.1016/j.bbrc.2005.01.079; Lock K, 2001, BIOL FERT SOILS, V34, P219, DOI 10.1007/s003740100392; Lock K, 2002, CHEMOSPHERE, V46, P197, DOI 10.1016/S0045-6535(01)00112-6; Lock K, 2001, CHEMOSPHERE, V44, P1669, DOI 10.1016/S0045-6535(00)00565-8; Lokke H., 1998, HDB SOIL INVERTEBRAT; Loureiro S, 2009, ENVIRON POLLUT, V157, P625, DOI 10.1016/j.envpol.2008.08.010; Maraldo K, 2009, J COMP PHYSIOL B, V179, P113, DOI 10.1007/s00360-008-0305-5; Maraldo K, 2010, PEDOBIOLOGIA, V53, P161, DOI 10.1016/j.pedobi.2009.10.003; Nota B, 2008, ENVIRON SCI TECHNOL, V42, P8152, DOI 10.1021/es801472r; Nota B, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-236; Novais SC, 2012, ECOTOXICOLOGY, V21, P213, DOI 10.1007/s10646-011-0780-4; Novais SC, 2011, ENVIRON POLLUT, V159, P1836, DOI 10.1016/j.envpol.2011.03.031; Novais SC, 2010, CHEMOSPHERE, V79, P233, DOI 10.1016/j.chemosphere.2010.01.011; OECD, 2010, BIOACCUMULATION TERR; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Owen J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-266; Parkinson J, 2004, BIOINFORMATICS, V20, P1398, DOI 10.1093/bioinformatics/bth101; Pirooznia M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S7; POSTHUMA L, 1993, COMP BIOCHEM PHYS C, V106, P11, DOI 10.1016/0742-8413(93)90251-F; Poynton HC, 2007, ENVIRON SCI TECHNOL, V41, P1044, DOI 10.1021/es0615573; Rebrikov DV, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.20.e90; Roelofs D, 2007, INSECT BIOCHEM MOLEC, V37, P287, DOI 10.1016/j.ibmb.2006.11.013; Roelofs D, 2009, MOL ECOL, V18, P3227, DOI 10.1111/j.1365-294X.2009.04261.x; Schill RO, 2004, ECOTOXICOLOGY, V13, P787, DOI 10.1007/s10646-003-4476-2; Slotsbo S, 2008, CRYOBIOLOGY, V57, P286, DOI 10.1016/j.cryobiol.2008.09.010; Sturzenbaum SR, 2003, PEDOBIOLOGIA, V47, P447, DOI 10.1078/0031-4056-00211; Timmermans MJTN, 2009, INSECT MOL BIOL, V18, P737, DOI 10.1111/j.1365-2583.2009.00916.x; Timmermans MJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-341; Timmermans MJTN, 2005, ECOTOXICOLOGY, V14, P727, DOI 10.1007/s10646-005-0020-x; Vijver MG, 2004, ENVIRON SCI TECHNOL, V38, P4705, DOI 10.1021/es040354g; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02	54	8	8	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e34266	10.1371/journal.pone.0034266	http://dx.doi.org/10.1371/journal.pone.0034266			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558086	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336000011
J	Seena, S; Duarte, S; Pascoal, C; Cassio, F				Seena, Sahadevan; Duarte, Sofia; Pascoal, Claudia; Cassio, Fernanda			Intraspecific Variation of the Aquatic Fungus Articulospora tetracladia: An Ubiquitous Perspective	PLOS ONE			English	Article							LEAF-LITTER DECOMPOSITION; HYPHOMYCETE DIVERSITY; SPECIES RECOGNITION; BASE SUBSTITUTIONS; GENETIC DIVERSITY; BIOGEOGRAPHY; POPULATIONS; DISPERSAL; RIVERS; STREAM	The worldwide-distributed aquatic fungus Articulospora tetracladia Ingold is a dominant sporulating species in streams of the Northwest Iberian Peninsula. To elucidate the genetic diversity of A. tetracladia, we analyzed isolates collected from various types of plant litter or foam in streams from North and Central Portugal and North Spain, between 2000 and 2010. Genetic diversity of these fungal populations was assessed by denaturing gradient gel electrophoresis (DGGE) fingerprints and by using ITS1-5.8S-ITS2 barcodes. Moreover, ITS1-5.8S-ITS2 barcodes of A. tetracladia reported in other parts of the world (Central Europe, United Kingdom, Canada, Japan and Malaysia) were retrieved from the National Center for Biotechnology (NCBI) and the National Institute of Technology and Evaluation Biological Resource Center (NBRC) to probe into genetic diversity of A. tetracladia. PCR-DGGE of ITS2 region of 50 Iberian fungal isolates distinguished eight operational taxonomic units (OTUs), which were similar to those obtained from neighboring trees based on ITS2 gene sequences. On the other hand, ITS1-5.8S-ITS2 barcodes of 68 fungal isolates yielded nine OTUs, but five fungal isolates were not assigned to any of these OTUs. Molecular diversity was highest for OTU-8, which included only European isolates. Two haplotypes were observed within OTU-8 and OTU-9, while only one haplotype was found within each of the remaining OTUs. Malaysia did not share haplotypes with other countries. Overall results indicate that, apart from the Malaysian genotypes, A. tetracladia genotypes were geographically widespread irrespective of sampling time, sites or substrates. Furthermore, PCR-DGGE appeared to be a rapid tool for assessing intraspecific diversity of aquatic hyphomycetes.	[Seena, Sahadevan; Duarte, Sofia; Pascoal, Claudia; Cassio, Fernanda] Univ Minho, Dept Biol, Ctr Mol & Environm Biol CBMA, Braga, Portugal	Universidade do Minho	Seena, S (corresponding author), Univ Minho, Dept Biol, Ctr Mol & Environm Biol CBMA, Braga, Portugal.	ssahadevan@bio.uminho.pt	Duarte, Sofia/H-3323-2013; Pascoal, Claudia/C-4072-2009; Duarte, Sofia/ABD-8278-2021; Cassio, Fernanda/A-6653-2011	Duarte, Sofia/0000-0002-0181-0676; Pascoal, Claudia/0000-0002-2018-4201; Duarte, Sofia/0000-0002-0181-0676; Cassio, Fernanda/0000-0003-3924-3280; sahadevan, seena/0000-0002-5598-4794	European Regional Development Fund - Operational Competitiveness Programme (FEDER-POFC-COMPETE); Portuguese Foundation for Science and Technology [PEst-C/BIA/UI4050/2011, PTDC/AAC-AMB/113746/2009];  [SFRH/BPD/47574/2008]; Fundação para a Ciência e a Tecnologia [PTDC/AAC-AMB/113746/2009] Funding Source: FCT	European Regional Development Fund - Operational Competitiveness Programme (FEDER-POFC-COMPETE); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); ; Fundação para a Ciência e a Tecnologia	The European Regional Development Fund - Operational Competitiveness Programme (FEDER-POFC-COMPETE) and the Portuguese Foundation for Science and Technology supported this study (PEst-C/BIA/UI4050/2011 and PTDC/AAC-AMB/113746/2009) and S. Duarte (SFRH/BPD/47574/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIMER RD, 1985, NEW ZEAL J BOT, V23, P273, DOI 10.1080/0028825X.1985.10425331; Anderson JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015908; Barlocher F, 2009, MYCOSCIENCE, V50, P3, DOI 10.1007/s10267-008-0449-x; Barlocher F, 2003, OIKOS, V101, P247, DOI 10.1034/j.1600-0706.2003.12372.x; BARLOCHER F, 2005, FUNGAL COMMUNITY ITS, P39, DOI DOI 10.1201/9781420027891.CH3; Baudoin JM, 2008, MICROB ECOL, V56, P260, DOI 10.1007/s00248-007-9344-9; Chan S. Y., 2000, Fungal Diversity, V5, P109; Charcosset JY, 1999, MYCOL RES, V103, P736, DOI 10.1017/S0953756298007606; DELFRATE G, 1983, HYDROBIOLOGIA, V102, P69, DOI 10.1007/BF00006051; Duarte S, 2006, OECOLOGIA, V147, P658, DOI 10.1007/s00442-005-0300-4; Duarte S, 2008, MICROB ECOL, V56, P688, DOI 10.1007/s00248-008-9388-5; Duarte S, 2010, MICROBIOL RES, V165, P351, DOI 10.1016/j.micres.2009.06.002; Duarte S, 2009, APPL ENVIRON MICROB, V75, P6211, DOI 10.1128/AEM.00971-09; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fabre E, 1998, CAN J BOT, V76, P107, DOI 10.1139/b97-156; Fernandes I, 2011, OECOLOGIA, V166, P1019, DOI 10.1007/s00442-011-1930-3; GONCZOL J, 1976, Acta Botanica Academiae Scientiarum Hungaricae, V22, P51; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Halling RE, 2008, MYCOL RES, V112, P437, DOI 10.1016/j.mycres.2007.11.021; Harrington TJ, 1997, BIOL ENVIRON, V97B, P139; Hartl Daniel L., 1997; Hosaka K, 2008, MYCOL RES, V112, P448, DOI 10.1016/j.mycres.2007.06.004; HUDSON RR, 1992, GENETICS, V132, P583; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; INGOLD C. T., 1949, TRANS BRIT MYCOL SOC, V32, P341; Ingold C. T., 1942, TRANS BRIT MYCOL SOC, V25, P339; Iqbal Syed Hussain, 1994, Mycoscience, V35, P331, DOI 10.1007/BF02268503; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Laitung B, 2004, MOL ECOL, V13, P1679, DOI 10.1111/j.1365-294X.2004.02135.x; Lumbsch HT, 2008, MYCOL RES, V112, P423, DOI 10.1016/j.mycres.2008.02.002; Moncalvo JM, 2008, MYCOL RES, V112, P425, DOI 10.1016/j.mycres.2007.12.001; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; Muyzer G., 2004, Molecular microbial ecology manual. Volumes 1 and 2, P743; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; MYERS RM, 1985, NUCLEIC ACIDS RES, V13, P3131, DOI 10.1093/nar/13.9.3131; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nikolcheva LG, 2003, APPL ENVIRON MICROB, V69, P2548, DOI 10.1128/AEM.69.5.2548-2554.2003; Nikolcheva LG, 2005, MYCOL RES, V109, P246, DOI 10.1017/S0953756204001698; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; Pascoal C, 2005, ARCH HYDROBIOL, V162, P481, DOI 10.1127/0003-9136/2005/0162-0481; Pascoal C, 2004, APPL ENVIRON MICROB, V70, P5266, DOI 10.1128/AEM.70.9.5266-5273.2004; Pascoal C, 2010, MICROB ECOL, V59, P84, DOI 10.1007/s00248-009-9567-z; Pelaez F, 1996, MYCOL RES, V100, P831, DOI 10.1016/S0953-7562(96)80030-X; Rajashekhar M, 2003, HYDROBIOLOGIA, V501, P167, DOI 10.1023/A:1026239917232; Ramirez-Flandes S, 2008, BIOINFORMATICS, V24, P2539, DOI 10.1093/bioinformatics/btn466; Schoenlein-Crusius IH, 2003, BRAZ J MICROBIOL, V34, P183, DOI 10.1590/S1517-83822003000300001; Seena S, 2010, FUNGAL DIVERS, V44, P77, DOI 10.1007/s13225-010-0056-y; Seymour FA, 2004, FUNGAL GENET BIOL, V41, P721, DOI 10.1016/j.fgb.2004.02.007; SMITS Gunta, 2007, Acta Bot. Venez., V30, P345; Sridhar KR, 2009, INT REV HYDROBIOL, V94, P399, DOI 10.1002/iroh.200811154; Suberkropp K, 2001, APPL ENVIRON MICROB, V67, P5063, DOI 10.1128/AEM.67.11.5063-5068.2001; Tacao M, 2005, FEMS MICROBIOL LETT, V246, P11, DOI 10.1016/j.femsle.2005.03.033; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor JW, 2006, PHILOS T R SOC B, V361, P1947, DOI 10.1098/rstb.2006.1923; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wilkinson A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012604; Wirtz N, 2008, MYCOL RES, V112, P472, DOI 10.1016/j.mycres.2007.05.006	61	27	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35884	10.1371/journal.pone.0035884	http://dx.doi.org/10.1371/journal.pone.0035884			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558256	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000075
J	Barua, H; Biswas, PK; Olsen, KEP; Christensen, JP				Barua, Himel; Biswas, Paritosh K.; Olsen, Katharina E. P.; Christensen, Jens P.			Prevalence and Characterization of Motile Salmonella in Commercial Layer Poultry Farms in Bangladesh	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; ANTIMICROBIAL RESISTANCE; INTERNATIONAL SPREAD; RISK-FACTORS; KENTUCKY; STRAIN; CIPROFLOXACIN; EPIDEMIOLOGY; POPULATION; SEROTYPES	Salmonella is a globally widespread food-borne pathogen having major impact on public health. All motile serovars of Salmonella enterica of poultry origin are zoonotic, and contaminated meat and raw eggs are an important source to human infections. Information on the prevalence of Salmonella at farm/holding level, and the zoonotic serovars circulating in layer poultry in the South and South-East Asian countries including Bangladesh, where small-scale commercial farms are predominant, is limited. To investigate the prevalence of Salmonella at layer farm level, and to identify the prevalent serovars we conducted a cross-sectional survey by randomly selecting 500 commercial layer poultry farms in Bangladesh. Faecal samples from the selected farms were collected following standard procedure, and examined for the presence of Salmonella using conventional bacteriological procedures. Thirty isolates were randomly selected, from the ninety obtained from the survey, for serotyping and characterized further by plasmid profiling and pulsed-field gel electrophoresis (PFGE). Results of the survey showed that the prevalence of motile Salmonella at layer farm level was 18% (95% confidence interval 15-21%), and Salmonella Kentucky was identified to be the only serovar circulating in the study population. Plasmid analysis of the S. Kentucky and non-serotyped isolates revealed two distinct profiles with a variation of two different sizes (2.7 and 4.8 kb). PFGE of the 30 S. Kentucky and 30 non-serotyped isolates showed that all of them were clonally related because only one genotype and three subtypes were determined based on the variation in two or three bands. This is also the first report on the presence of any specific serovar of Salmonella enterica in poultry in Bangladesh.	[Barua, Himel; Christensen, Jens P.] Univ Copenhagen, Dept Vet Dis Biol, Fac Life Sci, Copenhagen, Denmark; [Barua, Himel; Biswas, Paritosh K.] Chittagong Vet & Anim Sci Univ, Fac Vet Med, Dept Microbiol, Chittagong, Bangladesh; [Olsen, Katharina E. P.] Statens Serum Inst, Natl Reference Lab Enteropathogen Bacteria, Dept Microbiol Diagnost, DK-2300 Copenhagen, Denmark	University of Copenhagen; Statens Serum Institut	Barua, H (corresponding author), Univ Copenhagen, Dept Vet Dis Biol, Fac Life Sci, Copenhagen, Denmark.	hiba@life.ku.dk	Lahti, Elina Tast/R-8664-2016	Christensen, Jens Peter/0000-0002-6430-9010				Aarestrup FM, 2007, EMERG INFECT DIS, V13, P726, DOI 10.3201/eid1305.061489; [Anonymous], 2007, EFSA J, V5, DOI 10.2903/j.efsa.2007.130r; BARBOUR EK, 1983, AVIAN DIS, V27, P616, DOI 10.2307/1590303; Bouzidi N, 2011, FOOD RES INT, DOI [10.1016/j.fooders.2011.05.027, DOI 10.1016/J.FOODERS.2011.05.027]; Carrique-Mas JJ, 2008, REV SCI TECH OIE, V27, P665, DOI 10.20506/rst.27.3.1829; Centers for Disease Control and Prevention, 2009, ON DAY 24 28 H STAND; Centers for Disease Control and Prevention, 2008, SALM SURV ANN SUMM 2; Collard JM, 2007, J ANTIMICROB CHEMOTH, V60, P190, DOI 10.1093/jac/dkm114; Cozens M, 2008, SALMONELLA ENTERITID; Edwards PR, 1938, J HYG-CAMBRIDGE, V38, P306, DOI 10.1017/S0022172400011177; *EUR COMM, 2004, SANCO342004 EUR COMM; FAO, 2008, POULTRY SECTOR COUNT; FAO and OIE in collaboration with WHO, 2005, GLOB STRAT PROGR CON; Foley SL, 2011, APPL ENVIRON MICROB, V77, P4273, DOI 10.1128/AEM.00598-11; Gast RK, 2007, AVIAN DIS, V51, P817, DOI 10.1637/8090-081807.1; Grimont P. A. D., 2007, ANTIGENIC FORMULAE S; Heir E, 2002, EPIDEMIOL INFECT, V128, P373, DOI 10.1017/S0950268802007045; Hunter SB, 2005, J CLIN MICROBIOL, V43, P1045, DOI 10.1128/JCM.43.3.1045-1050.2005; Johnson TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015524; Kabir SML, 2010, INT J ENV RES PUB HE, V7, P89, DOI 10.3390/ijerph7010089; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Keery I., 2010, SALMONELLA ENTERITID; Le Hello S, 2011, J INFECT DIS, V204, P675, DOI 10.1093/infdis/jir409; Li X, 2007, POULTRY SCI, V86, P591, DOI 10.1093/ps/86.3.591; MACRINA FL, 1978, PLASMID, V1, P417, DOI 10.1016/0147-619X(78)90056-2; Mahmud MS, 2011, FOODBORNE PATHOG DIS, V8, P1111, DOI 10.1089/fpd.2011.0917; Majtan V, 2006, JPN J INFECT DIS, V59, P358; MAYER L W, 1988, Clinical Microbiology Reviews, V1, P228; Mollenhorst H, 2005, POULTRY SCI, V84, P1308, DOI 10.1093/ps/84.8.1308; Namata H, 2008, PREV VET MED, V83, P323, DOI 10.1016/j.prevetmed.2007.09.002; Nogrady N, 2007, J ANTIMICROB CHEMOTH, V60, P645, DOI 10.1093/jac/dkm249; Olsen J. E., 2000, Salmonella in domestic animals., P429, DOI 10.1079/9780851992617.0429; OLSEN JE, 1994, J APPL BACTERIOL, V77, P155, DOI 10.1111/j.1365-2672.1994.tb03059.x; Papadopoulou C, 2009, VET REC, V165, P681; Pointon A, 2008, J FOOD PROTECT, V71, P1123, DOI 10.4315/0362-028X-71.6.1123; Poppe C., 2000, Salmonella in domestic animals., P107, DOI 10.1079/9780851992617.0107; Raufu I, 2009, FOODBORNE PATHOG DIS, V6, P425, DOI 10.1089/fpd.2008.0150; ROCHELLE PA, 1986, J GEN MICROBIOL, V132, P53; Rose N, 1999, PREV VET MED, V39, P265, DOI 10.1016/S0167-5877(99)00002-1; Sanchez S, 2002, J AM VET MED ASSOC, V221, P492, DOI 10.2460/javma.2002.221.492; SHIVAPRASAD HL, 2003, DIS POULTRY, P568; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; THRELFALL EJ, 1986, J HYG-CAMBRIDGE, V97, P419, DOI 10.1017/S0022172400063609; Turki Y, 2012, FOOD RES INT, V45, P925, DOI 10.1016/j.foodres.2011.03.044; USDA, 2008, NAT ANT RES MON SYST; van Pelt W, 2003, Euro Surveill, V8, P31; Wegener HC, 2003, EMERG INFECT DIS, V9, P774; Weill FX, 2006, EMERG INFECT DIS, V12, P1611, DOI 10.3201/eid1210.060589; Xi ML, 2008, J FOOD PROTECT, V71, P2067, DOI 10.4315/0362-028X-71.10.2067	49	31	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35914	10.1371/journal.pone.0035914	http://dx.doi.org/10.1371/journal.pone.0035914			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558269	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345200093
J	Durward, M; Radhakrishnan, G; Harms, J; Bareiss, C; Magnani, D; Splitter, GA				Durward, Marina; Radhakrishnan, Girish; Harms, Jerome; Bareiss, Claire; Magnani, Diogo; Splitter, Gary A.			Active Evasion of CTL Mediated Killing and Low Quality Responding CD8+T Cells Contribute to Persistence of Brucellosis	PLOS ONE			English	Article							CHRONIC VIRAL-INFECTION; DOMAIN-CONTAINING PROTEIN; MEMORY T-CELLS; ABORTUS INFECTION; IMMUNE-RESPONSES; VACCINE DESIGN; PROTECTIVE IMMUNITY; REVERSE VACCINOLOGY; CYTOKINE PRODUCTION; MACROPHAGE CONTROL	Brucellosis is a common zoonotic disease that remains endemic in many parts of the world. Dissecting the host immune response during this disease provides insight as to why brucellosis is often difficult to resolve. We used a Brucella epitope specific in vivo killing assay to investigate the ability of CD8+ T cells to kill targets treated with purified pathogenic protein. Importantly, we found the pathogenic protein TcpB to be a novel effector of adaptive immune evasion by inhibiting CD8+ T cell killing of Brucella epitope specific target cells in mice. Further, BALB/c mice show active Brucella melitensis infection beyond one year, many with previously unreported focal infection of the urogenital area. A fraction of CD8+ T cells show a CD8+ Tmem phenotype of LFA-1hi, CD127hi, KLRG-1lo during the course of chronic brucellosis, while the CD8+ T cell pool as a whole had a very weak polyfunctional cytokine response with diminished co-expression of IFN-gamma with TNF alpha and/or IL-2, a hallmark of exhaustion. When investigating the expression of these 3 cytokines individually, we observed significant IFN-gamma expression at 90 and 180 days post-infection. TNF alpha expression did not significantly exceed or fall below background levels at any time. IL-2 expression did not significantly exceeded background, but, interestingly, did fall significantly below that of uninfected mice at 180 days post-infection. Brucella melitensis evades and blunts adaptive immunity during acute infection and our findings provide potential mechanisms for the deficit observed in responding CD8+ T cells during chronic brucellosis.	[Durward, Marina] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pathol & Lab Med, Madison, WI 53715 USA; [Radhakrishnan, Girish; Harms, Jerome; Bareiss, Claire; Magnani, Diogo; Splitter, Gary A.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Durward, M (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Pathol & Lab Med, Madison, WI 53715 USA.	splitter@svm.vetmed.wisc.edu		Radhakrishnan, Girish/0000-0001-9088-0029; Magnani, Diogo/0000-0002-1773-2406; Diioia, Marina/0000-0002-9906-1633	National Institutes of Health [1-R01-AI-073558, 1-R21-AI-088038]; Great Lakes Regional Center of Excellence [1-U54-AI-057153]; Binational Agricultural and Research Foundation (BARD) [US-4378-11]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088038, U54AI057153, R01AI073558] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Great Lakes Regional Center of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Binational Agricultural and Research Foundation (BARD); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant 1-R01-AI-073558, 1-R21-AI-088038, the Great Lakes Regional Center of Excellence grant 1-U54-AI-057153, and Binational Agricultural and Research Foundation (BARD) US-4378-11 (to G. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dahouk S, 2008, PROTEOMICS, V8, P3862, DOI 10.1002/pmic.200800026; Araki K, 2010, IMMUNOL REV, V235, P234, DOI 10.1111/j.0105-2896.2010.00898.x; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Arens R, 2010, IMMUNOL REV, V235, P190, DOI 10.1111/j.0105-2896.2010.00899.x; Baldwin CL, 2002, VET MICROBIOL, V90, P367, DOI 10.1016/S0378-1135(02)00222-5; Baldwin CL, 2006, CRIT REV IMMUNOL, V26, P407, DOI 10.1615/CritRevImmunol.v26.i5.30; Baldwin Cynthia L., 1993, Trends in Microbiology, V1, P99, DOI 10.1016/0966-842X(93)90115-8; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barquero-Calvo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000631; Brandao APMS, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/589494; Capasso L, 2002, J INFECTION, V45, P122, DOI 10.1053/jinf.2002.0996; Celli J, 2004, CURR OPIN MICROBIOL, V7, P93, DOI 10.1016/j.mib.2003.11.001; Chen F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006830; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Colmenero JD, 1996, MEDICINE, V75, P195, DOI 10.1097/00005792-199607000-00003; Colmenero JD, 2002, EUR J CLIN MICROBIOL, V21, P897, DOI 10.1007/s10096-002-0848-4; Commander Nicola J, 2010, Genet Vaccines Ther, V8, P5, DOI 10.1186/1479-0556-8-5; Cox MA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/159152; Cui WG, 2010, IMMUNOL REV, V236, P151, DOI 10.1111/j.1600-065X.2010.00926.x; D'Anastasio R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006439; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Dornand J, 2002, VET MICROBIOL, V90, P383, DOI 10.1016/S0378-1135(02)00223-7; Durward Marina, 2010, J Vis Exp, DOI 10.3791/2250; Durward MA, 2010, INFECT IMMUN, V78, P168, DOI 10.1128/IAI.00994-09; Fooksman DR, 2009, J IMMUNOL, V182, P5179, DOI 10.4049/jimmunol.0801797; Franco MP, 2007, LANCET INFECT DIS, V7, P775, DOI 10.1016/S1473-3099(07)70286-4; Freeman GJ, 2006, J EXP MED, V203, P2223, DOI 10.1084/jem.20061800; Fuller MJ, 2005, J IMMUNOL, V174, P5926, DOI 10.4049/jimmunol.174.10.5926; Fuller MJ, 2004, J IMMUNOL, V172, P4204, DOI 10.4049/jimmunol.172.7.4204; Fuller MJ, 2003, J IMMUNOL, V170, P477, DOI 10.4049/jimmunol.170.1.477; High KP, 2007, BIOGERONTOLOGY, V8, P583, DOI 10.1007/s10522-007-9106-6; Ingulli Elizabeth, 2007, Methods Mol Biol, V380, P365; JIANG XS, 1993, INFECT IMMUN, V61, P124, DOI 10.1128/IAI.61.1.124-134.1993; JIANG XS, 1993, CELL IMMUNOL, V151, P309, DOI 10.1006/cimm.1993.1241; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Ko J, 2002, INFECT IMMUN, V70, P7004, DOI 10.1128/IAI.70.12.7004-7012.2002; Ko JY, 2003, CLIN MICROBIOL REV, V16, P65, DOI 10.1128/CMR.16.1.65-78.2003; Lamkanfi M, 2010, CELL HOST MICROBE, V8, P44, DOI 10.1016/j.chom.2010.06.007; Lapaque N, 2006, CELL MICROBIOL, V8, P197, DOI 10.1111/j.1462-5822.2005.00609.x; Leclerq S, 2002, J MED MICROBIOL, V51, P20, DOI 10.1099/0022-1317-51-1-20; Lee SJ, 2010, J IMMUNOL, V185, P2442, DOI 10.4049/jimmunol.1000743; Lefrancois L, 2010, IMMUNOL REV, V235, P206, DOI 10.1111/j.0105-2896.2010.00895.x; Lin JP, 2010, VACCINE, V28, P5669, DOI 10.1016/j.vaccine.2010.06.053; Lopez-Goni I, 2004, BRUCELLA MOL CELLULA; Magnani DM, 2009, INFECT IMMUN, V77, P5181, DOI 10.1128/IAI.00231-09; Makedonas G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000798; Mantur B G, 2007, Indian J Med Microbiol, V25, P188; Markman B, 2010, ONCOTARGET, V1, P530, DOI 10.18632/oncotarget.188; Martirosyan A, 2011, IMMUNOL REV, V240, P211, DOI 10.1111/j.1600-065X.2010.00982.x; MONTARAZ JA, 1986, INFECT IMMUN, V53, P245, DOI 10.1128/IAI.53.2.245-251.1986; Mora M, 2006, CURR OPIN MICROBIOL, V9, P532, DOI 10.1016/j.mib.2006.07.003; Mueller SN, 2009, P NATL ACAD SCI USA, V106, P8623, DOI 10.1073/pnas.0809818106; Murphy EA, 2001, IMMUNOLOGY, V103, P511, DOI 10.1046/j.1365-2567.2001.01258.x; Obar JJ, 2010, INT IMMUNOL, V22, P619, DOI 10.1093/intimm/dxq053; Obar JJ, 2010, J IMMUNOL, V185, P263, DOI 10.4049/jimmunol.1000492; OLIVEIRA SC, 1995, EUR J IMMUNOL, V25, P2551, DOI 10.1002/eji.1830250922; Pappas G, 2006, CELL MOL LIFE SCI, V63, P2229, DOI 10.1007/s00018-006-6311-4; Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224; Radhakrishnan GK, 2010, BIOCHEM BIOPH RES CO, V397, P59, DOI 10.1016/j.bbrc.2010.05.056; Radhakrishnan GK, 2009, J BIOL CHEM, V284, P9892, DOI 10.1074/jbc.M805458200; Rafiei A, 2006, J INFECTION, V53, P315, DOI 10.1016/j.jinf.2005.11.024; Rajashekara G, 2005, CELL MICROBIOL, V7, P1459, DOI 10.1111/j.1462-5822.2005.00570.x; Rappuoli R, 2000, CURR OPIN MICROBIOL, V3, P445, DOI 10.1016/S1369-5274(00)00119-3; Rueda CM, 2010, TUBERCULOSIS, V90, P346, DOI 10.1016/j.tube.2010.09.003; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Schurig GG, 2002, VET MICROBIOL, V90, P479, DOI 10.1016/S0378-1135(02)00255-9; Sette A, 2003, CURR OPIN IMMUNOL, V15, P461, DOI 10.1016/S0952-7915(03)00083-9; Sette A, 2007, CURR OPIN IMMUNOL, V19, P106, DOI 10.1016/j.coi.2006.11.002; Singh A, 2007, J LEUKOCYTE BIOL, V82, P1201, DOI 10.1189/jlb.0407240; Singh A, 2010, MOL CELL BIOL, V30, P5145, DOI 10.1128/MCB.01045-09; Singh V, 2010, J INFECT DIS, V202, P480, DOI 10.1086/653827; Skendros P, 2011, MICROBES INFECT, V13, P134, DOI 10.1016/j.micinf.2010.10.015; Slifka MK, 2000, IMMUNITY, V12, P451, DOI 10.1016/S1074-7613(00)80197-1; STEVENS MG, 1992, INFECT IMMUN, V60, P4407, DOI 10.1128/IAI.60.10.4407-4409.1992; Suresh M, 2001, J IMMUNOL, V167, P5565, DOI 10.4049/jimmunol.167.10.5565; Titball RW, 2008, DRUG DISCOV TODAY, V13, P596, DOI 10.1016/j.drudis.2008.04.010; Vrioni G, 2008, CLIN INFECT DIS, V46, pE131, DOI 10.1086/588482; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Yi JS, 2010, IMMUNOLOGY, V129, P474, DOI 10.1111/j.1365-2567.2010.03255.x; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zanetti M, 2010, ADV EXP MED BIOL, V684, P108; Zhou SH, 2004, J VIROL, V78, P3578, DOI 10.1128/JVI.78.7.3578-3600.2004	86	39	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e34925	10.1371/journal.pone.0034925	http://dx.doi.org/10.1371/journal.pone.0034925			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558103	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345200015
J	Major, JM; Kiruthu, C; Weinstein, SJ; Horst, RL; Snyder, K; Virtamo, J; Albanes, D				Major, Jacqueline M.; Kiruthu, Christine; Weinstein, Stephanie J.; Horst, Ronald L.; Snyder, Kirk; Virtamo, Jarmo; Albanes, Demetrius			Pre-Diagnostic Circulating Vitamin D and Risk of Melanoma in Men	PLOS ONE			English	Article							MALIGNANT-MELANOMA; CANCER	Purpose: Various studies have examined the association between serum vitamin D levels and different cancers; however, this is the first prospective study of this association with melanoma risk. The aim of this study is to investigate the association between serum vitamin D [25(OH)D] levels and melanoma in a cohort of older, middle-aged Finnish male smokers. Methods: We conducted a nested case-control study within the Alpha-Tocopherol Beta-Carotene Cancer Prevention (ATBC) Study. From the ATBC cohort, 368 subjects were chosen for our study; 92 participants that developed melanoma and 276 matched control subjects. At study baseline, lifestyle questionnaires and blood samples were collected. Serum 25(OH)D was modeled as three sets of categorical variables: clinically-defined categories, season-specific quartiles and season-adjusted residual quartiles. Conditional logistic regression was used to obtain odds ratios (ORs) and 95% confidence intervals (95% CIs) to estimate the association between circulating vitamin D and melanoma risk. Results: Overall no association of serum 25(OH)D and melanoma risk was observed. A decreased risk of developing melanoma was observed in the middle categories compared to the lowest category, albeit not significant. Conclusion: Results indicate no association between serum 25(OH)D levels and melanoma. Additional studies, including possibly consortium efforts, are needed to investigate the association between serum 25(OH)D levels and risk of melanoma in larger, more diverse study populations.	[Major, Jacqueline M.; Kiruthu, Christine; Weinstein, Stephanie J.; Albanes, Demetrius] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Horst, Ronald L.] Heartland Assays Inc, Ames, IA USA; [Snyder, Kirk] Informat Management Serv Inc, Silver Spring, MD USA; [Virtamo, Jarmo] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Information Management Services, Inc.; Finland National Institute for Health & Welfare	Major, JM (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.	jacqueline.major@nih.gov	Albanes, Demetrius/B-9749-2015; Weinstein, Stephanie J/P-1627-2017	Weinstein, Stephanie J/0000-0002-3834-1535	National Cancer Institute, NIH; US Public Health Service from the National Cancer Institute, NIH, DHHS [N01-CN-45165, N01-RC-45035, N01-RC-37004, HHSN261201000006C]; DIVISION OF CANCER PREVENTION AND CONTROL [N01CN045165] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIACP010195] Funding Source: NIH RePORTER	National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US Public Health Service from the National Cancer Institute, NIH, DHHS; DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study is supported by the Intramural Research Program of the National Cancer Institute, NIH, and by US Public Health Service contracts N01-CN-45165, N01-RC-45035, N01-RC-37004, and HHSN261201000006C from the National Cancer Institute, NIH, DHHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Ronald L. Horst is an employee of Heartland Assays, Inc., and Kirk Snyder is an analytic programmer employed by Information Management Services, Inc. These authors played a role in performing the experiments and analysis of the data.	American Cancer Society, 2022, CANC FACTS FIGURES 2; [Anonymous], 1994, Ann Epidemiol, V4, P1, DOI 10.1016/1047-2797(94)90036-1; COLSTON K, 1981, ENDOCRINOLOGY, V108, P1083, DOI 10.1210/endo-108-3-1083; Elwood JM, 1997, INT J CANCER, V73, P198, DOI 10.1002/(SICI)1097-0215(19971009)73:2<198::AID-IJC6>3.0.CO;2-R; Evans SRT, 1996, J SURG RES, V61, P127, DOI 10.1006/jsre.1996.0092; Gallicchio L, 2010, AM J EPIDEMIOL, V172, P10, DOI 10.1093/aje/kwq116; Gandini S, 2005, EUR J CANCER, V41, P45, DOI 10.1016/j.ejca.2004.10.016; Gandini S, 2011, INT J CANCER, V128, P1414, DOI 10.1002/ijc.25439; Giovannucci E, 2009, ANN EPIDEMIOL, V19, P84, DOI 10.1016/j.annepidem.2007.12.002; Gruber SB, 2006, CANC EPIDEMIOLOGY PR, V2005, P1196, DOI DOI 10.1093/ACPROF:OSO/9780195149616.003.0063; Hofmann JN, 2010, CANCER EPIDEM BIOMAR, V19, P927, DOI 10.1158/1055-9965.EPI-09-1121; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hutchinson PE, 2010, J CLIN ONCOL US, P494; Hutchinson PE, 2010, J CLIN ONCOL, V28, pE492, DOI 10.1200/JCO.2010.29.6095; Jorde R, 2010, AM J EPIDEMIOL, V171, P903, DOI 10.1093/aje/kwq005; Millen AE, 2004, CANCER EPIDEM BIOMAR, V13, P1042; Newton-Bishop JA, 2009, J CLIN ONCOL, V27, P5439, DOI 10.1200/JCO.2009.22.1135; Nurnberg B, 2009, ANTICANCER RES, V29, P3669; OSTERLIND A, 1988, INT J CANCER, V42, P319, DOI 10.1002/ijc.2910420303; Randerson-Moor JA, 2009, EUR J CANCER, V45, P3271, DOI 10.1016/j.ejca.2009.06.011; Reichrath R, 2004, CANCER CAUSE CONTROL, V15, P97; Stolzenberg-Solomon RZ, 2009, CANCER RES, V69, P1439, DOI 10.1158/0008-5472.CAN-08-2694; Tang JY, 2011, J CLIN ONCOL, V29, P3078, DOI 10.1200/JCO.2011.34.5967; Tang JY, 2010, CANCER CAUSE CONTROL, V21, P387, DOI 10.1007/s10552-009-9470-4; Tuohimaa P, 2004, INT J CANCER, V108, P104, DOI 10.1002/ijc.11375; Tworoger SS, 2007, CANCER EPIDEM BIOMAR, V16, P783, DOI 10.1158/1055-9965.EPI-06-0981; Vinceti M, 2011, NUTR CANCER, V63, P506, DOI 10.1080/01635581.2011.539314; WEINSTOCK MA, 1992, J INVEST DERMATOL, V98, P809, DOI 10.1111/1523-1747.ep12499962	28	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35112	10.1371/journal.pone.0035112	http://dx.doi.org/10.1371/journal.pone.0035112			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558121	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345200026
J	Rentoukas, E; Tsarouhas, K; Kaplanis, I; Korou, E; Nikolaou, M; Marathonitis, G; Kokkinou, S; Haliassos, A; Mamalaki, A; Kouretas, D; Tsitsimpikou, C				Rentoukas, Elias; Tsarouhas, Konstantinos; Kaplanis, Ioannis; Korou, Eleni; Nikolaou, Maria; Marathonitis, George; Kokkinou, Stavroula; Haliassos, Alexander; Mamalaki, Avgi; Kouretas, Demetrios; Tsitsimpikou, Christina			Connection between Telomerase Activity in PBMC and Markers of Inflammation and Endothelial Dysfunction in Patients with Metabolic Syndrome	PLOS ONE			English	Article							ASYMMETRIC DIMETHYLARGININE ADMA; BLOOD MONONUCLEAR-CELLS; OXIDATIVE STRESS; NITRIC-OXIDE; ASSOCIATION; ATHEROSCLEROSIS; MECHANISMS; EXPRESSION; DISEASE; BIOLOGY	Metabolic syndrome (MS) is a constellation of metabolic derangements associated with vascular endothelial dysfunction and oxidative stress and is widely regarded as an inflammatory condition, accompanied by an increased risk for cardiovascular disease. The present study tried to investigate the implications of telomerase activity with inflammation and impaired endothelial function in patients with metabolic syndrome. Telomerase activity in circulating peripheral blood mononuclear cells (PBMC), TNF-alpha, IL-6 and ADMA were monitored in 39 patients with MS and 20 age and sex-matched healthy volunteers. Telomerase activity in PBMC, TNF-alpha, IL-6 and ADMA were all significantly elevated in patients with MS compared to healthy volunteers. PBMC telomerase was negatively correlated with HDL and positively correlated with ADMA, while no association between TNF-alpha and IL-6 was observed. IL-6 was increasing with increasing systolic pressure both in the patients with MS and in the healthy volunteers, while smoking and diabetes were positively correlated with IL-6 only in the patients' group. In conclusion, in patients with MS characterised by a strong dyslipidemic profile and low diabetes prevalence, significant telomerase activity was detected in circulating PBMC, along with elevated markers of inflammation and endothelial dysfunction. These findings suggest a prolonged activity of inflammatory cells in the studied state of this metabolic disorder that could represent a contributory pathway in the pathogenesis of atherosclerosis.	[Rentoukas, Elias; Kaplanis, Ioannis; Korou, Eleni; Nikolaou, Maria] Amalia Fleming Gen Hosp, Cardiol Dept 2, Athens, Greece; [Tsarouhas, Konstantinos] Gen Hosp Karditsa, Div Cardiol, Terma Tavropou, Karditsa, Greece; [Marathonitis, George] Amalia Fleming Gen Hosp, Pathol Dept A, Athens, Greece; [Kokkinou, Stavroula] Sismanoglio Gen Hosp, Cytogenet Unit, Athens, Greece; [Haliassos, Alexander] Diamed Labs Dept SA, ESEAP Greek Proficiency Testing Scheme Lab Med, Athens, Greece; [Mamalaki, Avgi] Hellenic Pasteur Inst, Dept Biochem, Athens, Greece; [Kouretas, Demetrios] Univ Thessaly, Dept Biochem & Biotechnol, Larisa, Greece; [Tsitsimpikou, Christina] Gen Chem State Lab Greece, Athens, Greece	University of Thessaly	Rentoukas, E (corresponding author), Amalia Fleming Gen Hosp, Cardiol Dept 2, Athens, Greece.	chtsitsi@yahoo.com	Haliassos, Alexander/GYJ-3828-2022; KOURETAS, DEMETRIOS/ABE-8519-2020; Tsarouhas, Konstantinos/H-5793-2019	KOURETAS, DEMETRIOS/0000-0002-7469-6640; Tsarouhas, Konstantinos/0000-0003-2651-3579				Al-Azzawi F, 2009, MATURITAS, V63, P135, DOI 10.1016/j.maturitas.2009.03.009; Antoniades C, 2006, AM J CLIN NUTR, V84, P781, DOI 10.1093/ajcn/84.4.781; Ben-Porath I, 2004, J CLIN INVEST, V113, P8, DOI 10.1172/JCI200420663; Blackburn EH, 2005, FEBS LETT, V579, P859, DOI 10.1016/j.febslet.2004.11.036; Boger RH, 1998, CIRCULATION, V98, P1842, DOI 10.1161/01.CIR.98.18.1842; COLLINS T, 1993, LAB INVEST, V68, P499; Cozma Angela, 2009, Rom J Intern Med, V47, P133; Farzaneh-Far R, 2008, ARTERIOSCL THROM VAS, V28, P1379, DOI 10.1161/ATVBAHA.108.167049; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Garcia RG, 2007, INT J CARDIOL, V122, P176, DOI 10.1016/j.ijcard.2006.11.058; Garlichs CD, 2004, J LEUKOCYTE BIOL, V75, P828, DOI 10.1189/jlb.0703358; Gizard F, 2011, ARTERIOSCL THROM VAS, V31, P245, DOI 10.1161/ATVBAHA.110.219808; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; McGrowder D, 2011, CHOLESTEROL, DOI 10.1155/2011/496925; Narducci ML, 2007, J AM COLL CARDIOL, V50, P2369, DOI 10.1016/j.jacc.2007.08.048; Palomo I, 2011, NITRIC OXIDE-BIOL CH, V24, P224, DOI 10.1016/j.niox.2011.03.002; Rahmati-Yamchi M, 2011, BREAST CANCER-BASIC, V5, P27, DOI 10.4137/BCBCR.S6734; Ramirez R, 2005, AM J KIDNEY DIS, V45, P353, DOI 10.1053/j.ajkd.2004.10.022; Rayssiguier Y, 2010, MAGNESIUM RES, V23, P73, DOI 10.1684/mrh.2010.0208; Rizvi AA, 2010, METAB SYNDR RELAT D, V8, P287, DOI 10.1089/met.2009.0116; Roth A, 2003, BLOOD, V102, P849, DOI 10.1182/blood-2002-07-2015; Satoh M, 2008, ATHEROSCLEROSIS, V198, P347, DOI 10.1016/j.atherosclerosis.2007.09.040; Thewissen M, 2005, IMMUNOL LETT, V100, P205, DOI 10.1016/j.imlet.2005.03.007; Tsiotra PC, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/892864; Tsirpanlis G, 2006, AM J NEPHROL, V26, P91, DOI 10.1159/000092031; Tsirpanlis G, 2006, NEPHROLOGY, V11, P506, DOI 10.1111/j.1440-1797.2006.00697.x; Vaidya D, 2011, EUR J CLIN NUTR, V65, P818, DOI 10.1038/ejcn.2011.47; Vilahur G, 2009, J THROMB HAEMOST, V7, P485, DOI 10.1111/j.1538-7836.2008.03244.x; von Leitner EC, 2011, CIRCULATION, V124, P2735, DOI 10.1161/CIRCULATIONAHA.111.060541; Vykoukal D, 2011, J VASC SURG, V54, P819, DOI 10.1016/j.jvs.2011.01.003; Wascher TC, 2011, MOL MED, V17, P189, DOI 10.2119/molmed.2010.00221; Watanabe T, 1998, INT J CARDIOL, V66, pS45, DOI 10.1016/S0167-5273(98)00147-8; Xing DQ, 2009, ARTERIOSCL THROM VAS, V29, P289, DOI 10.1161/ATVBAHA.108.182279; Zanni MV, 2011, CLIN ENDOCRINOL; Zhu H, 2011, INT J OBES	37	50	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35739	10.1371/journal.pone.0035739	http://dx.doi.org/10.1371/journal.pone.0035739			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558213	Green Submitted, gold, Green Published			2022-12-27	WOS:000305345200073
J	Robbins, BG				Robbins, Blaine G.			A Blessing and a Curse? Political Institutions in the Growth and Decay of Generalized Trust: A Cross-National Panel Analysis, 1980-2009	PLOS ONE			English	Article							SOCIAL TRUST; ECONOMIC-GROWTH; STATE; CULTURE; EUROPE; GOVERNMENT; MULTILEVEL; DEMOCRACY; DIVERSITY; ORIGINS	Despite decades of research on social capital, studies that explore the relationship between political institutions and generalized trust-a key element of social capital-across time are sparse. To address this issue, we use various cross-national public-opinion data sets including the World Values Survey and employ pooled time-series OLS regression and fixed-and random-effects estimation techniques on an unbalanced panel of 74 countries and 248 observations spread over a 29-year time period. With these data and methods, we investigate the impact of five political-institutional factors-legal property rights, market regulations, labor market regulations, universality of socioeconomic provisions, and power-sharing capacity-on generalized trust. We find that generalized trust increases monotonically with the quality of property rights institutions, that labor market regulations increase generalized trust, and that power-sharing capacity of the state decreases generalized trust. While generalized trust increases as the government regulation of credit, business, and economic markets decreases and as the universality of socioeconomic provisions increases, both effects appear to be more sensitive to the countries included and the modeling techniques employed than the other political-institutional factors. In short, we find that political institutions simultaneously promote and undermine generalized trust.	Univ Washington, Dept Sociol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Robbins, BG (corresponding author), Univ Washington, Dept Sociol, Seattle, WA 98195 USA.	adduct@uw.edu						Acemoglu D, 2001, AM ECON REV, V91, P1369, DOI 10.1257/aer.91.5.1369; Acemoglu D, 2005, AM ECON REV, V95, P546, DOI 10.1257/0002828054201305; Aghion P, 2010, Q J ECON, V125, P1015, DOI 10.1162/qjec.2010.125.3.1015; Algan Y, 2010, AM ECON REV, V100, P2060, DOI 10.1257/aer.100.5.2060; Allison PD, 2002, MISSING DATA; ARROW KJ, 1972, PHILOS PUBLIC AFF, V1, P343; Badescu G, 2003, SOCIAL CAPITAL TRANS, P120; Bendix R, 1964, NATION BUILDING CITI, pxii; Berggren N, 2006, KYKLOS, V59, P141, DOI 10.1111/j.1467-6435.2006.00324.x; Bergh A, 2011, KYKLOS, V64, P1, DOI 10.1111/j.1467-6435.2010.00492.x; Bjornskov C, 2008, EUR SOCIOL REV, V24, P271, DOI 10.1093/esr/jcn004; Bjornskov C, 2007, PUBLIC CHOICE, V130, P1, DOI 10.1007/s11127-006-9069-1; Bjornskov C, 2010, PUBLIC CHOICE, V144, P323, DOI 10.1007/s11127-009-9522-z; Bohnet I, 2001, AM POLIT SCI REV, V95, P131, DOI 10.1017/S0003055401000211; Boix C, 1998, BRIT J POLIT SCI, V28, P686, DOI 10.1017/S0007123498000313; Cingranelli David L., 2008, CINGRANELLI RICHARDS; Coleman J., 1990, FDN SOCIAL THEORY; Cook Karen S, 2005, COOPERATION TRUST, P52; Delhey J, 2005, EUR SOCIOL REV, V21, P311, DOI 10.1093/esr/jci022; Delhey J, 2011, AM SOCIOL REV, V76, P786, DOI 10.1177/0003122411420817; Esping-Andersen G, 1990, 3 WORLDS WELFARE CAP; Fehr E, 2009, J EUR ECON ASSOC, V7, P235, DOI 10.1162/JEEA.2009.7.2-3.235; Freitag M, 2009, COMP POLIT STUD, V42, P1537, DOI 10.1177/0010414009332151; Fukuyama F., 1995, TRUST SOCIAL VIRTUES; Gellner E., 1988, TRUST MAKING BREAKIN, P142; Gheorghiu MA, 2009, SOC PSYCHOL QUART, V72, P365, DOI 10.1177/019027250907200408; Glaeser EL, 2000, Q J ECON, V115, P811, DOI 10.1162/003355300554926; Glaeser EL, 2004, J ECON GROWTH, V9, P271, DOI 10.1023/B:JOEG.0000038933.16398.ed; Guiso L, 2008, J EUR ECON ASSOC, V6, P295, DOI 10.1162/JEEA.2008.6.2-3.295; Gwartney J., 2011, 2011 EC FREEDOM DATA; Halaby CN, 2004, ANNU REV SOCIOL, V30, P507, DOI 10.1146/annurev.soc.30.012703.110629; Hardin Russell, 2002, RUSSELL SAGE FDN SER; HAUSMAN JA, 1978, ECONOMETRICA, V46, P1251, DOI 10.2307/1913827; Herreros F, 2004, POLIT EVOL INST CHAN, P1, DOI 10.1057/9781403978806; Herreros F, 2008, RATION SOC, V20, P497, DOI 10.1177/1043463108096790; Herreros F, 2008, INT POLIT SCI REV, V29, P53, DOI 10.1177/0192512107083447; Holm H, 2008, J ECON PSYCHOL, V29, P522, DOI 10.1016/j.joep.2007.07.010; Holm HJ, 2005, ECON J, V115, P505, DOI 10.1111/j.1468-0297.2005.00998.x; Hooghe M, 2009, COMP POLIT STUD, V42, P198, DOI 10.1177/0010414008325286; Inglehart R., 2018, CULTURE SHIFT ADV IN; Kashima ES, 1998, J CROSS CULT PSYCHOL, V29, P461, DOI 10.1177/0022022198293005; Keefer Philip, 1997, Q J ECON, V112, P1251; Knack S, 2002, AM J POLIT SCI, V46, P772, DOI 10.2307/3088433; Knight J., 2001, TRUST SOC, P354; Kutner M. H., 2004, APPL LINEAR REGRESSI; LaPorta R, 1997, AM ECON REV, V87, P333; Letki N, 2005, BRIT J POLIT SCI, V35, P515, DOI 10.1017/S000712340500027X; Levi M, 1996, POLIT SOC, V24, P45, DOI 10.1177/0032329296024001005; Levi M., 1998, TRUST GOVERNANCE, P77; Lijphart A., 2012, PATTERNS DEMOCRACY G; Lipset S.M., 1981, POLITICAL MAN SOCIAL; Marshall T.H., STATES SOC, P248; MULLER EN, 1994, AM POLIT SCI REV, V88, P635, DOI 10.2307/2944800; Murray MP, 2006, J ECON PERSPECT, V20, P111, DOI 10.1257/jep.20.4.111; Nannestad P, 2008, ANNU REV POLIT SCI, V11, P413, DOI 10.1146/annurev.polisci.11.060606.135412; Norris P, 2008, DRIVING DEMOCRACY: DO POWER-SHARING INSTITUTIONS WORK, P1, DOI 10.1017/CBO9780511790614; North D. C., 1990, I I CHANGE EC PERFOR; Offe C., 1999, CAN WE TRUST OUR FEL; Paxton P, 2002, AM SOCIOL REV, V67, P254, DOI 10.2307/3088895; Paxton P, 2007, SOC FORCES, V86, P47, DOI 10.1353/sof.2007.0107; Putnam R.D., 1994, MAKING DEMOCRACY WOR, DOI DOI 10.2307/206637; Putnam RD., 2000, BOWLING ALONE COLLAP; Reeskens T, 2008, SOC INDIC RES, V85, P515, DOI 10.1007/s11205-007-9100-z; Robbins BG, 2011, RATION SOC, V23, P304, DOI 10.1177/1043463111404665; Rose-Ackerman S, 2001, KYKLOS, V54, P415, DOI 10.1111/1467-6435.00161; Roth F, 2009, KYKLOS, V62, P103, DOI 10.1111/j.1467-6435.2009.00424.x; Rothstein B, 2008, COMP POLIT, V40, P441; Rothstein B, 2005, WORLD POLIT, V58, P41, DOI 10.1353/wp.2006.0022; Rothstein B, 2003, GENERATING SOCIAL CAPITAL: CIVIL SOCIETY AND INSTITUTIONS IN COMPARATIVE PERSPECTIVE, P191; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Simmel G., 1950, SOCIOLOGY G SIMMEL; Smith SS, 2010, ANNU REV SOCIOL, V36, P453, DOI 10.1146/annurev.soc.012809.102526; Sovey AJ, 2011, AM J POLIT SCI, V55, P188, DOI 10.1111/j.1540-5907.2010.00477.x; Stolle D, 2008, POLIT STUD-LONDON, V56, P57, DOI 10.1111/j.1467-9248.2007.00717.x; Sturgis P, 2010, INT J PUBLIC OPIN R, V22, P74, DOI 10.1093/ijpor/edq003; Tabellini G, 2008, Q J ECON, V123, P905, DOI 10.1162/qjec.2008.123.3.905; Tabellini G, 2010, J EUR ECON ASSOC, V8, P677; Taylor M., 1987, POSSIBILITY COOPERAT; Taylor Michael, 1982, COMMUNITY ANARCHY LI; Titmuss R., 1970, GIFT RELATIONSHIP HU; Torpe L, 2011, SOC INDIC RES, V103, P481, DOI 10.1007/s11205-010-9713-5; Tsai MC, 2011, SOC INDIC RES, V101, P305, DOI 10.1007/s11205-010-9670-z; Uslaner E., 2002, MORAL FDN TRUST; Wilson SE, 2007, POLIT ANAL, V15, P101, DOI 10.1093/pan/mpl012; Wooldridge JM, 2013, INTRO ECONOMETRICS M, V5th; Zak PJ, 2001, ECON J, V111, P295, DOI 10.1111/1468-0297.00609	86	11	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35120	10.1371/journal.pone.0035120	http://dx.doi.org/10.1371/journal.pone.0035120			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VP	22558122	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345200027
J	Lara, AM; Kigozi, J; Amurwon, J; Muchabaiwa, L; Wakaholi, BN; Mota, REM; Walker, AS; Kasirye, R; Ssali, F; Reid, A; Grosskurth, H; Babiker, AG; Kityo, C; Katabira, E; Munderi, P; Mugyenyi, P; Hakim, J; Darbyshire, J; Gibb, DM; Gilks, CF				Lara, Antonieta Medina; Kigozi, Jesse; Amurwon, Jovita; Muchabaiwa, Lazarus; Wakaholi, Barbara Nyanzi; Mota, Ruben E. Mujica; Walker, A. Sarah; Kasirye, Ronnie; Ssali, Francis; Reid, Andrew; Grosskurth, Heiner; Babiker, Abdel G.; Kityo, Cissy; Katabira, Elly; Munderi, Paula; Mugyenyi, Peter; Hakim, James; Darbyshire, Janet; Gibb, Diana M.; Gilks, Charles F.		DART Trial Team	Cost Effectiveness Analysis of Clinically Driven versus Routine Laboratory Monitoring of Antiretroviral Therapy in Uganda and Zimbabwe	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; CD4 CELL COUNT; VIRAL LOAD; POOR SETTINGS; HIV; STRATEGIES; OUTCOMES; TRIAL	Background: Despite funding constraints for treatment programmes in Africa, the costs and economic consequences of routine laboratory monitoring for efficacy and toxicity of antiretroviral therapy (ART) have rarely been evaluated. Methods: Cost-effectiveness analysis was conducted in the DART trial (ISRCTN13968779). Adults in Uganda/Zimbabwe starting ART were randomised to clinically-driven monitoring (CDM) or laboratory and clinical monitoring (LCM); individual patient data on healthcare resource utilisation and outcomes were valued with primary economic costs and utilities. Total costs of first/second-line ART, routine 12-weekly CD4 and biochemistry/haematology tests, additional diagnostic investigations, clinic visits, concomitant medications and hospitalisations were considered from the public healthcare sector perspective. A Markov model was used to extrapolate costs and benefits 20 years beyond the trial. Results: 3316 (1660LCM; 1656CDM) symptomatic, immunosuppressed ART-naive adults (median (IQR) age 37 (32,42); CD4 86 (31,139) cells/mm(3)) were followed for median 4.9 years. LCM had a mean 0.112 year (41 days) survival benefit at an additional mean cost of $765 [95%CI:685,845], translating into an adjusted incremental cost of $7386 [3277, dominated] per life-year gained and $7793 [4442,39179] per quality-adjusted life year gained. Routine toxicity tests were prominent cost-drivers and had no benefit. With 12-weekly CD4 monitoring from year 2 on ART, low-cost second-line ART, but without toxicity monitoring, CD4 test costs need to fall below $3.78 to become cost-effective (<3xper-capita GDP, following WHO benchmarks). CD4 monitoring at current costs as undertaken in DART was not cost-effective in the long-term. Conclusions: There is no rationale for routine toxicity monitoring, which did not affect outcomes and was costly. Even though beneficial, there is little justification for routine 12-weekly CD4 monitoring of ART at current test costs in low-income African countries. CD4 monitoring, restricted to the second year on ART onwards, could be cost-effective with lower cost second-line therapy and development of a cheaper, ideally point-of-care, CD4 test.	[Lara, Antonieta Medina; Mota, Ruben E. Mujica] Univ Exeter, Hlth Econ Grp, Peninsula Coll Med & Dent, Exeter, Devon, England; [Kigozi, Jesse; Ssali, Francis] Joint Clin Res Ctr, Kampala, Uganda; [Amurwon, Jovita; Wakaholi, Barbara Nyanzi; Kasirye, Ronnie; Grosskurth, Heiner; Munderi, Paula] Uganda Virus Res Inst, Med Res Council, AIDS Res Unit, Entebbe, Uganda; [Muchabaiwa, Lazarus; Reid, Andrew; Hakim, James] Univ Zimbabwe Clin Res Ctr, Harare, Zimbabwe; [Walker, A. Sarah; Darbyshire, Janet; Gibb, Diana M.] MRC, Clin Trial Unit, London, England; [Katabira, Elly] Infect Dis Inst, Kampala, Uganda; [Gilks, Charles F.] Univ London Imperial Coll Sci Technol & Med, Fac Med, London, England	University of Exeter; University of Plymouth; Joint Clinic Research Center - United Arab Emirates; Uganda Virus Research Institute; University of Zimbabwe; Medical Research Council Clinical Trials Unit; Imperial College London	Lara, AM (corresponding author), Univ Exeter, Hlth Econ Grp, Peninsula Coll Med & Dent, Exeter, Devon, England.	gilksc@unaids.org	Gilks, Charles/B-4184-2012; Walker, Sarah/HDM-8717-2022; kasirye, ronnie/AAW-7818-2021	Gilks, Charles/0000-0002-8953-3123; Grosskurth, Heiner/0000-0001-9960-7280; Gibb, Diana/0000-0002-9738-5490; Kasirye, Ronnie/0000-0002-5200-464X; Muchabaiwa, Lazarus/0000-0003-3504-4559	United Kingdom (UK) Medical Research Council [G0600344]; UK Department for International Development (DFID); Rockefeller Foundation; MRC [G0600344, MC_U122886352, MC_U950080931] Funding Source: UKRI	United Kingdom (UK) Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID); Rockefeller Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the United Kingdom (UK) Medical Research Council [grant number G0600344], the UK Department for International Development (DFID) and the Rockefeller Foundation. GlaxoSmithKline, Gilead Sciences, Boehringer-Ingelheim and Abbott Laboratories donated drugs for DART. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GlaxoSmithKline, Gilead Sciences, Boehringer-Ingelheim and Abbott Laboratories donated drugs for DART.	Adam T, 2003, ECONOMETRIC ESTIMATI, DOI [10.1186/1478-7547-1-3, DOI 10.1186/1478-7547-1-3]; Bendavid E, 2008, ARCH INTERN MED, V168, P1910, DOI 10.1001/archinternmed.2008.1; Bishai D, 2007, AIDS, V21, P1333, DOI 10.1097/QAD.0b013e328137709e; Bisson GP, 2006, AIDS, V20, P1613, DOI 10.1097/01.aids.0000238407.00874.dc; Creese A, 1994, COST ANAL PRIMARY HL, P1; DART Trial Team, 2010, LANCET, V375, P23; Deghaye N, 2006, SAMJ S AFR MED J, V96, P140; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Gilks CF, 2011, 18 C RETR OPP INF 27; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Hosmer D. W., 1999, APPL SURVIVAL ANAL; International Monetary Fund, 2009, WORLD EC OUTL DAT 20; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Jourdain G, 2011, 18 C RETR OPP INF BO; Kahn JG, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6884; Kent DM, 2003, CLIN INFECT DIS, V37, pS13, DOI 10.1086/375368; Kenyon C, 2003, SAMJ S AFR MED J, V93, P56; Kimmel AD, 2010, JAIDS-J ACQ IMM DEF, V54, P258, DOI 10.1097/QAI.0b013e3181d0db97; Koethe JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009680; Laurent C, 2011, LANCET INFECT DIS, V11, P825, DOI 10.1016/S1473-3099(11)70168-2; Lin D Y, 2000, Biostatistics, V1, P35, DOI 10.1093/biostatistics/1.1.35; Medicins San Frontieres, 2008, UNT WEB ANT PRIC RED; Mermin J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6792; Moore DM, 2006, JAIDS-J ACQ IMM DEF, V43, P436, DOI 10.1097/01.qai.0000243105.80393.42; Munderi P, 2006, 16 INT AIDS C TOR CA; Nunes EP, 2011, J ANTIMICROB CHEMOTH, V66, P964, DOI 10.1093/jac/dkr020; Phillips AN, 2008, LANCET, V371, P1443, DOI 10.1016/S0140-6736(08)60624-8; Phillips AN, 2011, AIDS, V25, P843, DOI 10.1097/QAD.0b013e328344037a; Phillips AN, 2009, ARCH INTERN MED, V169, P904, DOI 10.1001/archinternmed.2009.88; Rawizza HE, 2011, CLIN INFECT DIS, V53, P1283, DOI 10.1093/cid/cir729; Rosen S, 2008, TROP MED INT HEALTH, V13, P1005, DOI 10.1111/j.1365-3156.2008.02114.x; SACHS J, 2001, REPORT COMMISSION MA; Schreibman T, 2004, CLIN INFECT DIS, V38, P257, DOI 10.1086/380792; Stavem K, 2005, QUAL LIFE RES, V14, P971, DOI 10.1007/s11136-004-3211-7; Ubel PA, 1996, NEW ENGL J MED, V334, P1174, DOI 10.1056/NEJM199605023341807; Walensky RP, 2010, CLIN INFECT DIS, V51, P85, DOI 10.1086/653119; Walker AS, 2008, AIDS, V22, P237, DOI 10.1097/QAD.0b013e3282f2d760; Walker AS, 2010, LANCET, V375, P1278, DOI 10.1016/S0140-6736(10)60057-8; Weidle PJ, 2006, LANCET, V368, P1587, DOI 10.1016/S0140-6736(06)69118-6; World Bank, 2009, GLOBAL ECONOMIC PROSPECTS: COMMODITIES AT THE CROSSROADS, P1, DOI 10.1596/978-0-8213-7799-4; World Health Organisation, 2008, INT DRUG PRIC IND GU; World Health Organization, 2006, ANT THER HIV INF AD; World Health Organization (WHO), 2010, UN ACC SCAL PRIOR HI, P1	44	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e33672	10.1371/journal.pone.0033672	http://dx.doi.org/10.1371/journal.pone.0033672			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545079	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000305343200002
J	Patkar, A; Gilmer, W; Pae, CU; Vohringer, PA; Ziffra, M; Pirok, E; Mulligan, M; Filkowski, MM; Whitham, EA; Holtzman, NS; Thommi, SB; Logvinenko, T; Loebel, A; Masand, P; Ghaemi, SN				Patkar, Ashwin; Gilmer, William; Pae, Chi-un; Voehringer, Paul A.; Ziffra, Michael; Pirok, Edward; Mulligan, Molly; Filkowski, Megan M.; Whitham, Elizabeth A.; Holtzman, Niki S.; Thommi, Sairah B.; Logvinenko, Tanya; Loebel, Antony; Masand, Prakash; Ghaemi, S. Nassir			A 6 Week Randomized Double-Blind Placebo-Controlled Trial of Ziprasidone for the Acute Depressive Mixed State	PLOS ONE			English	Article							BIPOLAR DISORDER; RATING-SCALE; VALIDITY; MANIA; RELIABILITY; EVOLUTION; ILLNESS	Objective: To examine the efficacy of ziprasidone vs. placebo for the depressive mixed state in patients with bipolar disorder type II or major depressive disorder (MDD). Methods: 73 patients were randomized in a double-blinded, placebo-controlled study to ziprasidone (40-160 mg/d) or placebo for 6 weeks. They met DSM-IV criteria for a major depressive episode (MDE), while also meeting 2 or 3 (but not more nor less) DSM-IV manic criteria. They did not meet DSM-IV criteria for a mixed or manic episode. Baseline psychotropic drugs were continued unchanged. The primary endpoint measured was Montgomery-A sberg Depression Rating Scale (MADRS) scores over time. The mean dose of ziprasidone was 129.7 +/- 45.3 mg/day and 126.1 +/- 47.1 mg/day for placebo. Results: The primary outcome analysis indicated efficacy of ziprasidone versus placebo (p = 0.0038). Efficacy was more pronounced in type II bipolar disorder than in MDD (p = 0.036). Overall ziprasidone was well tolerated, without notable worsening of weight or extrapyramidal symptoms. Conclusions: There was a statistically significant benefit with ziprasidone versus placebo in this first RCT of any medication for the provisional diagnostic concept of the depressive mixed state.	[Patkar, Ashwin; Pae, Chi-un; Masand, Prakash] Duke Univ, Med Ctr, Dept Psychiat, Durham, NC 27710 USA; [Gilmer, William; Ziffra, Michael; Pirok, Edward; Mulligan, Molly] Northwestern Univ, Sch Med, Dept Psychiat, Chicago, IL 60611 USA; [Voehringer, Paul A.; Whitham, Elizabeth A.; Holtzman, Niki S.; Thommi, Sairah B.; Ghaemi, S. Nassir] Tufts Med Ctr, Dept Psychiat, Mood Disorders Program, Boston, MA USA; [Voehringer, Paul A.] Univ Chile, Fac Med, Hosp Clin, Santiago 7, Chile; [Filkowski, Megan M.] Emory Univ, Sch Med, Dept Psychiat, Atlanta, GA 30322 USA; [Logvinenko, Tanya] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Biostat Res Ctr, Boston, MA USA; [Loebel, Antony] Sunov Pharmaceut, Ft Lee, NJ USA; [Ghaemi, S. Nassir] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Voehringer, Paul A.] Tufts Univ, Sackler Sch Grad Biomed Sci, Grad Program, Clin & Translat Sci Inst, Boston, MA 02111 USA	Duke University; Northwestern University; Tufts Medical Center; Universidad de Chile; Emory University; Tufts Medical Center; Dainippon Sumitomo Pharmaceutical Company; Sunovion Pharmaceuticals Inc.; Tufts University; Tufts University	Patkar, A (corresponding author), Duke Univ, Med Ctr, Dept Psychiat, Durham, NC 27710 USA.	nghaemi@tuftsmedicalcenter.org	Loebel, Antony D/H-5600-2012; Vöhringer, Paul/B-5860-2013; Pae, Chi-Un/AAG-5752-2020; Ghaemi, Nassir/J-4934-2013	Vöhringer, Paul/0000-0002-2460-4680; Pae, Chi-Un/0000-0001-8703-8455; Whitham, Elizabeth/0000-0002-6448-6658	National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of Health [UL1 RR025752]; Pfizer (Groton, CT, USA; Pfizer) [IIR GA 128000]; National Institutes of Health (NIDA, NIAAA); SAMHSA; AstraZeneca; Bristol-Myers Squibb; Cephalon; Forest; GlaxoSmithKline; Janssen; Jazz Pharmaceuticals; Lundbeck; McNeil Consumer Specialty Inc; Organon; Pfizer; Shire Pharmaceuticals; Sunovion; Ministry for Health, Welfare and Family Affairs; KISTEP; Catholic Medical Center; Catholic University of Korea College of Medicine Alumni; Eli Lilly and Company; Otsuka Korea Pharmaceuticals; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025752] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Pfizer (Groton, CT, USA; Pfizer); National Institutes of Health (NIDA, NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Institute on Drug Abuse (NIDA)NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); SAMHSA; AstraZeneca(AstraZeneca); Bristol-Myers Squibb(Bristol-Myers Squibb); Cephalon; Forest; GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Jazz Pharmaceuticals(Jazz Pharmaceuticals); Lundbeck(Lundbeck Corporation); McNeil Consumer Specialty Inc; Organon; Pfizer(Pfizer); Shire Pharmaceuticals; Sunovion; Ministry for Health, Welfare and Family Affairs; KISTEP; Catholic Medical Center; Catholic University of Korea College of Medicine Alumni; Eli Lilly and Company(Eli Lilly); Otsuka Korea Pharmaceuticals; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The project described was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant Number UL1 RR025752. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. This study was funded by an investigator initiated research grant by Pfizer (Groton, CT, USA; Pfizer reference number: IIR GA 128000). Pfizer did not participate in the conduct of the study; in the collection, management, analysis or interpretation of the data; or in the preparation, or approval of this manuscript. Pfizer researchers were involved in helping to design the study, but final design decisions were made by the academic researchers. Pfizer received the final manuscript, but had no role in editing or revising it.; Dr. Ashwin Patkar is a Consultant for Bristol-Myers Squibb, GlaxoSmithKline, and Reckitt Benckiser; he is on the Speaker's Bureau and received honoraria from Bristol-Myers Squibb, Cephalon/Alkermes, Pfizer, and Reckitt Benckiser; and has received Grant Support from National Institutes of Health (NIDA, NIAAA), SAMHSA, AstraZeneca, Bristol-Myers Squibb, Cephalon, Forest, GlaxoSmithKline, Janssen, Jazz Pharmaceuticals, Lundbeck, McNeil Consumer & Specialty Inc, Organon, Pfizer and Shire Pharmaceuticals. Dr. Prakash Masand is a consultant for Eli Lilly and Company, Pamlabs, Pfizer Inc., Sanofi-Aventis, and Schering Plough; he is on the Speaker's Bureau for Eli Lilly and Company, Grey Healthcare, Forest Pharmaceuticals, GlaxoSmithKline, Insight Medical Communicatiions, Janssen Cilag, and Pfizer Inc.; he also has stock ownership with Orexigen Therapeutics and Titan Pharmaceuticals. Dr. William Gilmer has received honoraria and a research grant from Pfizer, and served on their Speaker's Bureau. Dr. Ghaemi has received research grants from Pfizer and Sunovion and has provided research consultations for Pfizer and Sunovion. Dr. Chi-un Pae has served as a consultant for GlaxoSmithKline, Otsuka Korea Pharmaceuticals, Ltd., Eli Lilly and Company, AstraZeneca, Wyeth Korea; has served on the Speaker's Bureau for Sanofi-Aventis, Schering Plough, Eli Lilly and Company, GlaxoSmithKline, AstraZeneca, Lundbeck Korea, WhanIn Pharmaceuticals, Otsuka Korea Pharmaceuticals, and Wyeth Korea; and has received grants from the Ministry for Health, Welfare and Family Affairs, KISTEP, Catholic Medical Center, The Catholic University of Korea College of Medicine Alumni, Eli Lilly and Company, GlaxoSmithKline, Otsuka Korea Pharmaceuticals, and AstraZeneca. Dr Antony Loebel is currently Executive Vice President for Clinical Research at Sunovion Pharmaceuticals. He was employed by Pfizer at the time the study was conducted. Drs. Michael Ziffra, Edward Pirok, Paul Vohringer, Molly Mulligan, Tanya Logvinenko, and Ms. Megan Filkowski, Elizabeth Whitham, Sairah Thommi, and Niki Holtzman have no conflicts to disclose. The above-stated relationships do not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Akiskal HS, 2004, WORLD J BIOL PSYCHIA, V5, P107, DOI 10.1080/15622970410029919; Barnes TRE, 2003, J PSYCHOPHARMACOL, V17, P365, DOI 10.1177/0269881103174013; Benazzi F, 2001, PSYCHIAT CLIN NEUROS, V55, P647, DOI 10.1046/j.1440-1819.2001.00919.x; Benazzi F, 2008, EUR PSYCHIAT, V23, P40, DOI 10.1016/j.eurpsy.2007.07.003; Cassano GB, 2004, AM J PSYCHIAT, V161, P1264, DOI 10.1176/appi.ajp.161.7.1264; Dunner D., 1998, MANIA CLIN RES PERSP, P3; First M.B., 2016, STRUCTURED CLIN INTE; GALINOWSKI A, 1995, INT CLIN PSYCHOPHARM, V10, P157, DOI 10.1097/00004850-199510030-00004; Goodwin FK, 2007, MANIC DEPRESSIVE ILL; JONES SH, 1995, BRIT J PSYCHIAT, V166, P654, DOI 10.1192/bjp.166.5.654; Koukopoulos A, 1999, PSYCHIAT CLIN N AM, V22, P547, DOI 10.1016/S0193-953X(05)70095-2; MCELROY SL, 1992, AM J PSYCHIAT, V149, P1633; Perugi G, 1997, J AFFECT DISORDERS, V43, P169, DOI 10.1016/S0165-0327(97)01446-8; Sachs G, 2009, LESSONS ZIPRASIDONE; Sachs G, 2010, J CLIN PSYC IN PRESS; Salvatore P, 2002, HARVARD REV PSYCHIAT, V10, P255, DOI 10.1080/10673220216283; SEEGER TF, 1995, J PHARMACOL EXP THER, V275, P101; Simpson G M, 1970, Acta Psychiatr Scand Suppl, V212, P11; Spearing MK, 1997, PSYCHIAT RES, V73, P159, DOI 10.1016/S0165-1781(97)00123-6; Swann AC, 2000, BIPOLAR DISORD, V2, P325, DOI 10.1034/j.1399-5618.2000.020405.x; Trede K, 2005, HARVARD REV PSYCHIAT, V13, P155, DOI 10.1080/10673220500174833; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	22	50	53	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e34757	10.1371/journal.pone.0034757	http://dx.doi.org/10.1371/journal.pone.0034757			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545088	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343200011
J	Schaab, M; Kausch, H; Klammt, J; Nowicki, M; Anderegg, U; Gebhardt, R; Rose-John, S; Scheller, J; Thiery, J; Kratzsch, J				Schaab, Michael; Kausch, Henriette; Klammt, Juergen; Nowicki, Marcin; Anderegg, Ulf; Gebhardt, Rolf; Rose-John, Stefan; Scheller, Juergen; Thiery, Joachim; Kratzsch, Juergen			Novel Regulatory Mechanisms for Generation of the Soluble Leptin Receptor: Implications for Leptin Action	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; TYPE-1 DIABETES-MELLITUS; IN-VIVO; OB-R; RESISTANCE; APOPTOSIS; CLEAVAGE; INSULIN; OBESITY	Background: The adipokine leptin realizes signal transduction via four different membrane-anchored leptin receptor (Ob-R) isoforms in humans. However, the amount of functionally active Ob-R is affected by constitutive shedding of the extracellular domain via a so far unknown mechanism. The product of the cleavage process the so-called soluble leptin receptor (sOb-R) is the main binding protein for leptin in human blood and modulates its bioavailability. sOb-R levels are differentially regulated in metabolic disorders like type 1 diabetes mellitus or obesity and can, therefore, enhance or reduce leptin sensitivity. Methodology/Principal Findings: To describe mechanisms of Ob-R cleavage and to investigate the functional significance of differential sOb-R levels we established a model of HEK293 cells transiently transfected with different human Ob-R isoforms. Using siRNA knockdown experiments we identified ADAM10 (A Disintegrin And Metalloproteinase 10) as a major protease for constitutive and activated Ob-R cleavage. Additionally, the induction of lipotoxicity and apoptosis led to enhanced shedding shown by increased levels of the soluble leptin receptor (sOb-R) in cell supernatants. Conversely, high leptin concentrations and ER stress reduced sOb-R levels. Decreased amounts of sOb-R due to ER stress were accompanied by impaired leptin signaling and reduced leptin binding. Conclusions: Lipotoxicity and apoptosis increased Ob-R cleavage via ADAM10-dependent mechanisms. In contrast high leptin levels and ER stress led to reduced sOb-R levels. While increased sOb-R concentrations seem to directly block leptin action, reduced amounts of sOb-R may reflect decreased membrane expression of Ob-R. These findings could explain changes of leptin sensitivity which are associated with variations of serum sOb-R levels in metabolic diseases.	[Schaab, Michael; Kausch, Henriette; Thiery, Joachim; Kratzsch, Juergen] Univ Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany; [Klammt, Juergen] Univ Leipzig, Hosp Children & Adolescents, Leipzig, Germany; [Nowicki, Marcin] Univ Leipzig, Fac Med, Inst Anat, Leipzig, Germany; [Anderegg, Ulf] Univ Leipzig, Fac Med, Dept Dermatol Venerol & Allergol, Leipzig, Germany; [Gebhardt, Rolf] Univ Leipzig, Fac Med, Inst Biochem, Leipzig, Germany; [Rose-John, Stefan; Scheller, Juergen] Univ Kiel, Inst Biochem, D-2300 Kiel, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University; Leipzig University; University of Kiel	Schaab, M (corresponding author), Univ Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany.	Juergen.Kratzsch@medizin.uni-leipzig.de	Rose-John, Stefan/A-7998-2010; Scheller, Jürgen/K-5290-2015	Rose-John, Stefan/0000-0002-7519-3279; Klammt, Jurgen/0000-0003-2293-9193	Foundation of Pathobiochemistry and Molecular Diagnostics of the German Society of Clinical Chemistry and Laboratory Medicine e.V.; German Science Foundation;  [SFB610 TP B7]	Foundation of Pathobiochemistry and Molecular Diagnostics of the German Society of Clinical Chemistry and Laboratory Medicine e.V.; German Science Foundation(German Research Foundation (DFG)); 	This work was supported by the Foundation of Pathobiochemistry and Molecular Diagnostics of the German Society of Clinical Chemistry and Laboratory Medicine e.V.(http://www.dgkl.de), the SFB610 TP B7 and the German Science Foundation (http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaka Y, 2010, BBA-MOL CELL BIOL L, V1801, P1115, DOI 10.1016/j.bbalip.2010.06.009; Amit T, 1997, J CLIN ENDOCR METAB, V82, P3813, DOI 10.1210/jc.82.11.3813; Atkinson LL, 2002, J BIOL CHEM, V277, P29424, DOI 10.1074/jbc.M203813200; Bacart J, 2010, FEBS LETT, V584, P2213, DOI 10.1016/j.febslet.2010.03.033; Bates SH, 2005, CELL METAB, V1, P169, DOI 10.1016/j.cmet.2005.02.001; Batra A, 2010, ENDOCRINOLOGY, V151, P56, DOI 10.1210/en.2009-0565; Belmokhtar CA, 2001, ONCOGENE, V20, P3354, DOI 10.1038/sj.onc.1204436; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Budagian V, 2004, J BIOL CHEM, V279, P40368, DOI 10.1074/jbc.M404125200; Chalaris A, 2007, BLOOD, V110, P1748, DOI 10.1182/blood-2007-01-067918; Chalaris A, 2010, J EXP MED, V207, P1617, DOI 10.1084/jem.20092366; Chan JL, 2002, DIABETES, V51, P2105, DOI 10.2337/diabetes.51.7.2105; DUKSIN D, 1977, J BIOL CHEM, V252, P955; Fujikawa T, 2010, P NATL ACAD SCI USA, V107, P17391, DOI 10.1073/pnas.1008025107; Ge HF, 2002, J BIOL CHEM, V277, P45898, DOI 10.1074/jbc.M205825200; Gutwein P, 2005, CLIN CANCER RES, V11, P2492, DOI 10.1158/1078-0432.CCR-04-1688; Hakulinen J, 2006, J BIOL CHEM, V281, P21369, DOI 10.1074/jbc.M602053200; Hileman SM, 2002, ENDOCRINOLOGY, V143, P775, DOI 10.1210/en.143.3.775; Hosoi T, 2008, MOL PHARMACOL, V74, P1610, DOI 10.1124/mol.108.050070; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Huo L, 2009, CELL METAB, V9, P537, DOI 10.1016/j.cmet.2009.05.003; Kratzsch J, 2006, EUR J ENDOCRINOL, V155, P609, DOI 10.1530/eje.1.02261; Kratzsch J, 2004, EUR J ENDOCRINOL, V151, P475, DOI 10.1530/eje.0.1510475; Kratzsch J, 2002, J CLIN ENDOCR METAB, V87, P4587, DOI 10.1210/jc.2002-020001; Lam QLK, 2010, P NATL ACAD SCI USA, V107, P13812, DOI 10.1073/pnas.1004185107; Lammert A, 2001, BIOCHEM BIOPH RES CO, V283, P982, DOI 10.1006/bbrc.2001.4885; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Lizama C, 2010, BIOCH BIOPHYS ACTA; Lou PH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011669; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Lund IK, 2005, J MOL ENDOCRINOL, V34, P339, DOI 10.1677/jme.1.01694; Maamra M, 2001, ENDOCRINOLOGY, V142, P4389, DOI 10.1210/en.142.10.4389; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Reed AS, 2010, DIABETES, V59, P894, DOI 10.2337/db09-1024; Reinehr T, 2005, INT J OBESITY, V29, P1230, DOI 10.1038/sj.ijo.0803027; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Shapiro NI, 2010, J IMMUNOL, V185, P517, DOI 10.4049/jimmunol.0903975; Sun Q, 2010, DIABETES, V59, P611, DOI 10.2337/db09-1343; Suzuki A, 2007, MOL CELL BIOL, V27, P4317, DOI 10.1128/MCB.02222-06; Tanaka M, 2010, ENDOCR J, V57, P61, DOI 10.1507/endocrj.K09E-296; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Tu H, 2008, J CELL PHYSIOL, V214, P301, DOI 10.1002/jcp.21195; Uotani S, 1999, DIABETES, V48, P279, DOI 10.2337/diabetes.48.2.279; van Dielen FMH, 2002, J CLIN ENDOCR METAB, V87, P1708, DOI 10.1210/jc.87.4.1708; Wang MY, 2010, P NATL ACAD SCI USA, V107, P4813, DOI 10.1073/pnas.0909422107; Wang Y, 2010, J IMMUNOL, V184, P4447, DOI 10.4049/jimmunol.0902925; Wauman J, 2011, J CELL SCI, V124, P921, DOI 10.1242/jcs.078055; White DW, 1997, J BIOL CHEM, V272, P4065, DOI 10.1074/jbc.272.7.4065; Yang GQ, 2004, MOL ENDOCRINOL, V18, P1354, DOI 10.1210/me.2004-0027; Yu X, 2008, P NATL ACAD SCI USA, V105, P14070, DOI 10.1073/pnas.0806993105; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X; Zastrow O, 2003, INT J OBESITY, V27, P1472, DOI 10.1038/sj.ijo.0802432; Zhang JJ, 2009, BRIT J PHARMACOL, V158, P475, DOI 10.1111/j.1476-5381.2009.00246.x; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zhang Y, 2000, ENDOCRINOLOGY, V141, P4342, DOI 10.1210/en.141.12.4342; Zhou YT, 1998, DIABETES, V47, P1904, DOI 10.2337/diabetes.47.12.1904; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784	61	50	53	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e34787	10.1371/journal.pone.0034787	http://dx.doi.org/10.1371/journal.pone.0034787			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545089	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343200012
J	te Marvelde, L; Schaper, SV; Visser, ME				te Marvelde, Luc; Schaper, Sonja V.; Visser, Marcel E.			A Single Long Day Triggers Follicle Growth in Captive Female Great Tits (Parus major) in Winter but Does Not Affect Laying Dates in the Wild in Spring	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; CLIMATE-CHANGE; FLIGHT PERFORMANCE; JAPANESE-QUAIL; PREDATION RISK; TEMPERATURE; PHOTOPERIOD; PHENOLOGY; CYCLES; FOOD	In many forest passerine bird species, rapid climate warming has led to a phenological mismatch between the period of maximum nestlings' food requirements and the period of maximum food availability (seasonal caterpillar biomass peak) due to an insufficient advancement of the birds' laying dates. The initiation of laying is preceded by the development of the gonads, which in birds are regressed outside the breeding season. Increasing day length in late winter and early spring triggers a cascade of hormones which induces gonadal development. Since day length is not altered by climate change, one potential restriction to advancing laying date is the seasonal timing of gonadal development. To assess the importance of gonadal growth for timing of reproduction we experimentally manipulated the timing of gonadal development. We show that the growth of the largest follicle of captive female great tits (Parus major) increased after being exposed to just a single long day in winter (20 hours of light followed by 4 hours darkness). We then photostimulated wild female great tits from two study areas in a field experiment in spring for a single day and determined their laying date. These populations differed in the availability of food allowing us to test if food availability in combination with photostimulation affected egg laying dates. Despite an expected difference in the onset of gonadal growth, laying dates of photostimulated females did not differ from control females in both populations. These results suggest that wild great tits are not restricted in the advancement of their laying date by limited gonadal development.	[te Marvelde, Luc; Schaper, Sonja V.; Visser, Marcel E.] Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	te Marvelde, L (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands.	l.temarvelde@nioo.knaw.nl	Visser, Marcel E/A-9151-2009; KNAW, NIOO-KNAW/A-4320-2012	Visser, Marcel E/0000-0002-1456-1939; KNAW, NIOO-KNAW/0000-0002-3835-159X				AVERY MI, 1984, IBIS, V126, P33, DOI 10.1111/j.1474-919X.1984.tb03661.x; Caro SP, 2012, GEN COMP EN IN PRESS; CREIGHTON JA, 1987, J ENDOCRINOL, V113, P419, DOI 10.1677/joe.0.1130419; Crick HQP, 1999, NATURE, V399, P423, DOI 10.1038/20839; DAWSON A, 1986, IBIS, V128, P572, DOI 10.1111/j.1474-919X.1986.tb02709.x; Dawson A, 2001, J BIOL RHYTHM, V16, P365, DOI 10.1177/074873001129002079; FARNER DS, 1980, ANNU REV PHYSIOL, V42, P457, DOI 10.1146/annurev.ph.42.030180.002325; FOLLETT BK, 1975, GEN COMP ENDOCR, V26, P126, DOI 10.1016/0016-6480(75)90223-3; HEDENSTROM A, 1992, J THEOR BIOL, V158, P535, DOI 10.1016/S0022-5193(05)80714-3; Lambrechts MM, 2000, P ROY SOC B-BIOL SCI, V267, P585, DOI 10.1098/rspb.2000.1041; METCALFE NB, 1995, P ROY SOC B-BIOL SCI, V261, P395, DOI 10.1098/rspb.1995.0165; Murton RK, 1977, AVIAN BREEDING CYCLE; NICHOLLS TJ, 1983, J ENDOCRINOL, V97, P121, DOI 10.1677/joe.0.0970121; Perfito N, 2008, HORM BEHAV, V53, P567, DOI 10.1016/j.yhbeh.2008.01.002; R Core Team, 2020, R LANG ENV STAT COMP; Saab SS, 2010, J NEUROENDOCRINOL, V22, P196, DOI 10.1111/j.1365-2826.2010.01954.x; Schaper SV, 2012, AM NAT, V179, pE55, DOI 10.1086/663675; Schaper SV, GEN COMP ENDOC UNPUB; Sharp PJ, 2005, ANN NY ACAD SCI, V1040, P189, DOI 10.1196/annals.1327.024; SILVERIN B, 1994, ETHOL ECOL EVOL, V6, P131, DOI 10.1080/08927014.1994.9522990; Silverin B, 2008, HORM BEHAV, V54, P60, DOI 10.1016/j.yhbeh.2008.01.015; Stevenson IR, 2000, NATURE, V406, P366, DOI 10.1038/35019151; te Marvelde L, 2012, OECOLOGIA, V168, P631, DOI 10.1007/s00442-011-2122-x; VANNOORDWIJK AJ, 1995, J ANIM ECOL, V64, P451, DOI 10.2307/5648; Verboven N, 1998, OIKOS, V81, P511, DOI 10.2307/3546771; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Visser ME, 2011, FUNCT ECOL, V25, P868, DOI 10.1111/j.1365-2435.2011.01844.x; Visser ME, 2006, OECOLOGIA, V147, P164, DOI 10.1007/s00442-005-0299-6; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Visser ME, 1999, OIKOS, V85, P445, DOI 10.2307/3546694; WINGFIELD JC, 1993, GEN COMP ENDOCR, V92, P388, DOI 10.1006/gcen.1993.1176; WITTER MS, 1994, ANIM BEHAV, V48, P201, DOI 10.1006/anbe.1994.1227; ZANN RA, 1995, EMU, V95, P208, DOI 10.1071/MU9950208	33	8	8	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35617	10.1371/journal.pone.0035617	http://dx.doi.org/10.1371/journal.pone.0035617			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545123	Green Published, gold			2022-12-27	WOS:000305343200043
J	Zhao, LY; Stancik, AD; Brown, CJ				Zhao, Luyi; Stancik, Amber D.; Brown, Celeste J.			Differential Transcription of Bacteriophage phi X174 Genes at 37 degrees C and 42 degrees C	PLOS ONE			English	Article							EXONUCLEASE-III ANALYSIS; MESSENGER-RNA; ESCHERICHIA-COLI; IN-VIVO; VIRAL ADAPTATION; TERMINATION; STABILITY; EVOLUTION; PROMOTERS; SEQUENCES	To investigate how high temperature affects viral transcription, the absolute amounts of mRNA for six bacteriophage phi X174 genes were compared at 37 degrees C and 42 degrees C using Q-PCR. At 37 degrees C, mRNA levels for all genes were consistent with previous studies, but at 42uC mRNA levels for four genes were significantly different from levels at 37 degrees C. Transcript levels were higher for genes B and D; the promoter before gene B appears to be up-regulated at high temperature. Levels for genes F and G were reduced at high temperature, possibly due to increased efficiency of the transcription termination signal immediately upstream of gene F. These functional changes in phi X174 gene regulation at high temperature have not been described previously. Studies of phage evolution at high temperatures indicate that this difference in transcript levels is subject to adaptation.	[Zhao, Luyi; Stancik, Amber D.; Brown, Celeste J.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA	Idaho; University of Idaho	Zhao, LY (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.	celesteb@uidaho.edu			National Institutes of Health [NCRR P20RR16448]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Institutes of Health (www.nih.gov) grant NCRR P20RR16448. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 1996, BIOCHIMIE, V78, P1035, DOI 10.1016/S0300-9084(97)86727-2; ARQUINT M, 1987, J VIROL, V61, P3694, DOI 10.1128/JVI.61.12.3694-3700.1987; ARQUINT M, 1994, BBA-GENE STRUCT EXPR, V1218, P339, DOI 10.1016/0167-4781(94)90186-4; Bernal RA, 2003, J MOL BIOL, V325, P11, DOI 10.1016/S0022-2836(02)01201-9; Brown CJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-378; Bull JJ, 1997, GENETICS, V147, P1497; Crill WD, 2000, GENETICS, V154, P27; DESMIT MH, 1990, P NATL ACAD SCI USA, V87, P7668, DOI 10.1073/pnas.87.19.7668; Ermolaeva MD, 2000, J MOL BIOL, V301, P27, DOI 10.1006/jmbi.2000.3836; Fane B., 2006, BACTERIOPHAGES, P129; FLOOR E, 1970, Journal of Molecular Biology, V47, P293, DOI 10.1016/0022-2836(70)90303-7; Geissmann T, 2009, RNA BIOL, V6, P153, DOI 10.4161/rna.6.2.8047; HARLEY CB, 1987, NUCLEIC ACIDS RES, V15, P2343, DOI 10.1093/nar/15.5.2343; HAYASHI M, 1976, P NATL ACAD SCI USA, V73, P3519, DOI 10.1073/pnas.73.10.3519; HAYASHI M, 1988, BACTERIOPHAGES, P1; HAYASHI MN, 1983, J VIROL, V48, P186, DOI 10.1128/JVI.48.1.186-196.1983; HAYASHI MN, 1981, J VIROL, V38, P198, DOI 10.1128/JVI.38.1.198-207.1981; HAYASHI MN, 1981, J VIROL, V37, P506, DOI 10.1128/JVI.37.1.506-510.1981; HAYASHI MN, 1989, MOL GEN GENET, V216, P364, DOI 10.1007/BF00334377; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; NEIDHARDT FC, 1984, ANNU REV GENET, V18, P295, DOI 10.1146/annurev.ge.18.120184.001455; Ott, 1993, INTRO STAT METHODS D; Rokyta DR, 2006, J BACTERIOL, V188, P1134, DOI 10.1128/JB.188.3.1134-1142.2006; ROSENBERG M, 1979, ANNU REV GENET, V13, P319, DOI 10.1146/annurev.ge.13.120179.001535; Sorensen SE, 1998, BIOCHEM CELL BIOL, V76, P625, DOI 10.1139/bcb-76-4-625; STERNBERG N, 1973, J MOL BIOL, V76, P25, DOI 10.1016/0022-2836(73)90079-X; Wade JT, 2006, NAT STRUCT MOL BIOL, V13, P806, DOI 10.1038/nsmb1130; Wichman HA, 1999, SCIENCE, V285, P422, DOI 10.1126/science.285.5426.422; WILSON KS, 1994, J MOL BIOL, V244, P36, DOI 10.1006/jmbi.1994.1702	30	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35909	10.1371/journal.pone.0035909	http://dx.doi.org/10.1371/journal.pone.0035909			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22540010	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341000076
J	Wrzodek, C; Buchel, F; Hinselmann, G; Eichner, J; Mittag, F; Zell, A				Wrzodek, Clemens; Buechel, Finja; Hinselmann, Georg; Eichner, Johannes; Mittag, Florian; Zell, Andreas			Linking the Epigenome to the Genome: Correlation of Different Features to DNA Methylation of CpG Islands	PLOS ONE			English	Article							HISTONE MODIFICATIONS; CANCER; PREDICTION; PATTERNS; DATABASE; SITES; RESTRICTION; VERTEBRATE; SEQUENCE; BROWSER	DNA methylation of CpG islands plays a crucial role in the regulation of gene expression. More than half of all human promoters contain CpG islands with a tissue-specific methylation pattern in differentiated cells. Still today, the whole process of how DNA methyltransferases determine which region should be methylated is not completely revealed. There are many hypotheses of which genomic features are correlated to the epigenome that have not yet been evaluated. Furthermore, many explorative approaches of measuring DNA methylation are limited to a subset of the genome and thus, cannot be employed, e. g., for genome-wide biomarker prediction methods. In this study, we evaluated the correlation of genetic, epigenetic and hypothesis-driven features to DNA methylation of CpG islands. To this end, various binary classifiers were trained and evaluated by cross-validation on a dataset comprising DNA methylation data for 190 CpG islands in HEPG2, HEK293, fibroblasts and leukocytes. We achieved an accuracy of up to 91% with an MCC of 0.8 using ten-fold cross-validation and ten repetitions. With these models, we extended the existing dataset to the whole genome and thus, predicted the methylation landscape for the given cell types. The method used for these predictions is also validated on another external whole-genome dataset. Our results reveal features correlated to DNA methylation and confirm or disprove various hypotheses of DNA methylation related features. This study confirms correlations between DNA methylation and histone modifications, DNA structure, DNA sequence, genomic attributes and CpG island properties. Furthermore, the method has been validated on a genome-wide dataset from the ENCODE consortium. The developed software, as well as the predicted datasets and a web-service to compare methylation states of CpG islands are available at http://www.cogsys.cs.uni-tuebingen.de/software/dna-methylation/.	[Wrzodek, Clemens; Buechel, Finja; Hinselmann, Georg; Eichner, Johannes; Mittag, Florian; Zell, Andreas] Univ Tubingen, Ctr Bioinformat Tubingen ZBIT, Tubingen, Germany	Eberhard Karls University of Tubingen	Wrzodek, C (corresponding author), Univ Tubingen, Ctr Bioinformat Tubingen ZBIT, Tubingen, Germany.	clemens.wrzodek@uni-tuebingen.de		Wrzodek, Finja/0000-0001-5031-1016; Mittag, Florian/0000-0002-6472-0221; Wrzodek, Clemens/0000-0003-4995-780X	Innovative Medicine Initiative Joint Undertaking (IMI JU) under (MARCAR project) [115001]	Innovative Medicine Initiative Joint Undertaking (IMI JU) under (MARCAR project)	The research leading to these results has received funding from the Innovative Medicine Initiative Joint Undertaking (IMI JU) under grant agreement nr. 115001 (MARCAR project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTS S, 2003, BIOINFORMATICS S2, V19, P5; [Anonymous], ENCODE HUDSONALPHA M; ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Antequera F, 2003, CELL MOL LIFE SCI, V60, P1647, DOI 10.1007/s00018-003-3088-6; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BIRD AP, 1978, J MOL BIOL, V118, P49, DOI 10.1016/0022-2836(78)90243-7; Bock C, 2008, BIOINFORMATICS, V24, P1, DOI 10.1093/bioinformatics/btm546; Bock C, 2007, PLOS COMPUT BIOL, V3, P1055, DOI 10.1371/journal.pcbi.0030110; Bock C, 2006, PLOS GENET, V2, P243, DOI 10.1371/journal.pgen.0020026; Brena RM, 2007, HUM MOL GENET, V16, pR96, DOI 10.1093/hmg/ddm073; Brena RM, 2006, NAT GENET, V38, P1359, DOI 10.1038/ng1206-1359; Burset M, 2001, NUCLEIC ACIDS RES, V29, P255, DOI 10.1093/nar/29.1.255; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cleary JG, 1995, ED INN EC BUS ADM, P108; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Das R, 2006, P NATL ACAD SCI USA, V103, P10713, DOI 10.1073/pnas.0602949103; De Bustos C, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-7; Dehan P, 2009, EXPERT REV MOL DIAGN, V9, P651, DOI 10.1586/ERM.09.53; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Fan SC, 2008, BIOCHEM BIOPH RES CO, V374, P559, DOI 10.1016/j.bbrc.2008.07.077; Fang F, 2006, BIOINFORMATICS, V22, P2204, DOI 10.1093/bioinformatics/btl377; Feltus FA, 2003, P NATL ACAD SCI USA, V100, P12253, DOI 10.1073/pnas.2037852100; Fuks F, 2005, CURR OPIN GENET DEV, V15, P490, DOI 10.1016/j.gde.2005.08.002; Gardiner EJ, 2003, J MOL BIOL, V332, P1025, DOI 10.1016/j.jmb.2003.08.006; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Hajkova Petra, 2002, Methods Mol Biol, V200, P143; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Handa V, 2005, J MOL BIOL, V348, P1103, DOI 10.1016/j.jmb.2005.02.044; Henckel A, 2009, HUM MOL GENET, V18, P3375, DOI 10.1093/hmg/ddp277; Jeltsch A, 2010, SCIENCE, V328, P837, DOI 10.1126/science.1190738; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim S, 2008, Pac Symp Biocomput, P315; KOCHANEK S, 1993, EMBO J, V12, P1141, DOI 10.1002/j.1460-2075.1993.tb05755.x; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Oka M, 2006, J BIOL CHEM, V281, P9901, DOI 10.1074/jbc.M511100200; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Previti C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-116; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Rollins RA, 2006, GENOME RES, V16, P157, DOI 10.1101/gr.4262006; Schilling E, 2007, GENOMICS, V90, P314, DOI 10.1016/j.ygeno.2007.04.011; Schones DE, 2008, NAT REV GENET, V9, P179, DOI 10.1038/nrg2270; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Thu KL, 2010, J CELL PHYSIOL, V222, P522, DOI 10.1002/jcp.22009; Ting AH, 2006, GENE DEV, V20, P3215, DOI 10.1101/gad.1464906; Wang Y, 2004, BIOINFORMATICS, V20, P1170, DOI 10.1093/bioinformatics/bth059; Wrzodek C, 2010, BIOSYSTEMS, V99, P79, DOI 10.1016/j.biosystems.2009.09.005; Zhang Yingying, 2009, PLoS Genet, V5, pe1000438, DOI 10.1371/journal.pgen.1000438; Zilberman D, 2007, DEVELOPMENT, V134, P3959, DOI 10.1242/dev.001131	66	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35327	10.1371/journal.pone.0035327	http://dx.doi.org/10.1371/journal.pone.0035327			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558141	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340200015
J	Zlotkowska, D; Maddaloni, M; Riccardi, C; Walters, N; Holderness, K; Callis, G; Rynda-Apple, A; Pascual, DW				Zlotkowska, Dagmara; Maddaloni, Massimo; Riccardi, Carol; Walters, Nancy; Holderness, Kathryn; Callis, Gayle; Rynda-Apple, Agnieszka; Pascual, David W.			Loss of Sialic Acid Binding Domain Redirects Protein sigma 1 to Enhance M Cell-Directed Vaccination	PLOS ONE			English	Article							INTESTINAL M-CELLS; TOXIN B-SUBUNIT; CHOLERA-TOXIN; DENDRITIC CELLS; MUCOSAL IMMUNIZATION; REOVIRUS ATTACHMENT; IMMUNE-RESPONSES; ORAL TOLERANCE; ANTIGEN; RECEPTOR	Ovalbumin (OVA) genetically fused to protein sigma 1 (p sigma 1) results in tolerance to both OVA and p sigma 1. P sigma 1 binds in a multi-step fashion, involving both protein-and carbohydrate-based receptors. To assess the relative p sigma 1 components responsible for inducing tolerance and the importance of its sialic binding domain (SABD) for immunization, modified OVA-p sigma 1, termed OVA-p sigma 1(short), was deleted of its SABD, but with its M cell targeting moiety intact, and was found to be immunostimulatory and enhanced CD4(+) and CD8(+) T cell proliferation. When used to nasally immunize mice given with and without cholera toxin (CT) adjuvant, elevated SIgA and serum IgG responses were induced, and OVA-p sigma 1(s) was more efficient for immunization than native OVA+CT. The immune antibodies (Abs) were derived from elevated Ab-forming cells in the upper respiratory tissues and submaxillary glands and were supported by mixed Th cell responses. Thus, these studies show that p sigma 1(s) can be fused to vaccines to effectively elicit improved SIgA responses.	[Zlotkowska, Dagmara] Polish Acad Sci, Inst Food Res, Dept Food Chem, Olsztyn, Poland; [Maddaloni, Massimo; Riccardi, Carol; Walters, Nancy; Holderness, Kathryn; Callis, Gayle; Rynda-Apple, Agnieszka; Pascual, David W.] Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA	Polish Academy of Sciences; Montana State University System; Montana State University Bozeman	Zlotkowska, D (corresponding author), Polish Acad Sci, Inst Food Res, Dept Food Chem, Olsztyn, Poland.	dpascual@montana.edu	Pascual, David/AAC-2248-2022; Zlotkowska, Dagmara/H-7275-2017	Zlotkowska, Dagmara/0000-0002-5624-5707	Public Health Service [AI-078938]; Montana Agricultural Experiment Station; U.S. Department of Agriculture Formula Funds; National Institutes of Health/National Center for Research Resources; Centers of Biomedical Excellence [P20 RR-020185]; M.J. Murdock Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI078938, R01AI078938] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Montana Agricultural Experiment Station; U.S. Department of Agriculture Formula Funds(United States Department of Agriculture (USDA)); National Institutes of Health/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Centers of Biomedical Excellence; M.J. Murdock Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grant AI-078938 and, in part, by Montana Agricultural Experiment Station and U.S. Department of Agriculture Formula Funds. The Immunology and Infectious Diseases' flow cytometry facility was, in part, supported by National Institutes of Health/National Center for Research Resources, Centers of Biomedical Excellence P20 RR-020185, and an equipment grant from the M.J. Murdock Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azizi A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001147; Barton ES, 2001, J BIOL CHEM, V276, P2200, DOI 10.1074/jbc.M004680200; Barton ES, 2001, CELL, V104, P441, DOI 10.1016/S0092-8674(01)00231-8; Bergerot I, 1997, P NATL ACAD SCI USA, V94, P4610, DOI 10.1073/pnas.94.9.4610; Birebent B, 2001, J CANCER RES CLIN, V127, pR27, DOI 10.1007/BF01470996; Bozzacco L, 2007, P NATL ACAD SCI USA, V104, P1289, DOI 10.1073/pnas.0610383104; Chabot S, 2006, J IMMUNOL, V176, P4275, DOI 10.4049/jimmunol.176.7.4275; Chappell JD, 2000, J VIROL, V74, P8472, DOI 10.1128/JVI.74.18.8472-8479.2000; Chappell JD, 2002, EMBO J, V21, P1, DOI 10.1093/emboj/21.1.1; Cohen JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025558; Corr SC, 2008, FEMS IMMUNOL MED MIC, V52, P2, DOI 10.1111/j.1574-695X.2007.00359.x; Corthesy B, 2007, J IMMUNOL, V178, P27, DOI 10.4049/jimmunol.178.1.27; Datta SK, 2010, P NATL ACAD SCI USA, V107, P10638, DOI 10.1073/pnas.1002348107; Do Y, 2008, EUR J IMMUNOL, V38, P20, DOI 10.1002/eji.200737799; Gockel CM, 2005, IMMUNOLOGY, V116, P477, DOI 10.1111/j.1365-2567.2005.02246.x; Harakuni T, 2005, INFECT IMMUN, V73, P5654, DOI 10.1128/IAI.73.9.5654-5665.2005; Harokopakis E, 1998, INFECT IMMUN, V66, P4299; Hathaway LJ, 2000, CELL MOL LIFE SCI, V57, P323, DOI 10.1007/PL00000693; Huarte E, 2011, J AUTOIMMUN, V37, P328, DOI 10.1016/j.jaut.2011.09.005; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; Kato H, 2001, J IMMUNOL, V166, P3114, DOI 10.4049/jimmunol.166.5.3114; Kiyone H., 2008, FUNDAMENTAL IMMUNOLO, P983; Kiyono H, 2004, NAT REV IMMUNOL, V4, P699, DOI 10.1038/nri1439; LEBENS M, 1994, DEV BIOL STAND, V82, P215; Lee JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005190; Liu JL, 2011, FEMS IMMUNOL MED MIC, V61, P179, DOI 10.1111/j.1574-695X.2010.00764.x; Mohamadzadeh M, 2009, P NATL ACAD SCI USA, V106, P4331, DOI 10.1073/pnas.0900029106; NIBERT ML, 1995, J VIROL, V69, P5057, DOI 10.1128/JVI.69.8.5057-5067.1995; Nochi T, 2007, J EXP MED, V204, P2789, DOI 10.1084/jem.20070607; Pascual D. W., 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P203, DOI 10.2174/187153007781662549; Pascual DW, 2008, J IMMUNOL, V181, P1345, DOI 10.4049/jimmunol.181.2.1345; Rynda A, 2008, J IMMUNOL, V180, P5187, DOI 10.4049/jimmunol.180.8.5187; Rynda A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008720; Rynda-Apple A, 2011, EUR J IMMUNOL, V41, P313, DOI 10.1002/eji.201041104; Snider DP, 1997, IMMUNOLOGY, V90, P323, DOI 10.1111/j.1365-2567.1997.00323.x; SPIT BJ, 1989, CELL TISSUE RES, V255, P193; Suzuki H, 2008, GASTROENTEROLOGY, V135, P917, DOI 10.1053/j.gastro.2008.05.037; Tacken PJ, 2005, BLOOD, V106, P1278, DOI 10.1182/blood-2005-01-0318; TURNER DL, 1992, VIROLOGY, V186, P219, DOI 10.1016/0042-6822(92)90076-2; Uto T, 2007, J IMMUNOL, V178, P2979, DOI 10.4049/jimmunol.178.5.2979; Wang XH, 2005, VACCINE, V23, P3836, DOI 10.1016/j.vaccine.2005.02.023; Wang XH, 2003, J IMMUNOL, V171, P4717, DOI 10.4049/jimmunol.171.9.4717; WOLF JL, 1983, GASTROENTEROLOGY, V85, P291; WOLF JL, 1981, SCIENCE, V212, P471, DOI 10.1126/science.6259737; Wu YP, 2001, P NATL ACAD SCI USA, V98, P9318, DOI 10.1073/pnas.161204098	45	2	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36182	10.1371/journal.pone.0036182	http://dx.doi.org/10.1371/journal.pone.0036182			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558374	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340200048
J	Huang, W; Deng, B; Wang, RW; Tan, QY; He, Y; Jiang, YG; Zhou, JH				Huang, Wei; Deng, Bo; Wang, Ru-Wen; Tan, Qun-You; He, Yong; Jiang, Yao-Guang; Zhou, Jing-Hai			BCAR1 Protein Plays Important Roles in Carcinogenesis and Predicts Poor Prognosis in Non-Small-Cell Lung Cancer	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; TYROSINE PHOSPHORYLATION; ANTIESTROGEN RESISTANCE; PULMONARY-DISEASE; SRC; P130CAS; TRANSFORMATION; SUBSTRATE; INVASION; CRK	Objective: Our previous study suggested the potential clinical implications of BCAR1 in non-small-cell lung cancer (NSCLC) (Mol Diagn Ther. 2011. 15(1): 31-40). Herein, we aim to evaluate the predictive power of BCAR1 as a marker for poor prognosis in NSCLC cases, verify the carcinogenic roles of BCAR1 in the A549 lung adenocarcinoma cell line, and testify to the BCAR1/phospho-p38 axis. Methods: Between January 2006 and June 2010, there were a total of 182 patients with NSCLC (151 cases with available follow up data, and 31 cases lost to follow-up due to the invalid contact information). We inspected BCAR1, phospho-BCAR1(Tyr410), phospho-p38(Thr180/Tyr182) and p38 expression in NSCLC tissues and matched adjacent normal tissues by immunoblotting and IHC. After BCAR1 -RNA interference in A549 cells, we inspected the protein expression (BCAR1, phospho-BCAR1, phospho-p38 and p38) and performed cell biology experiments (cell growth, migration and cycle). Results: BCAR1 was overexpressed in NSCLC tissues (177/182) and cell lines (A549 and Calu-3). However, it was not detected in the normal adjacent tissue in 161 of the 182 cases. Higher BCAR1 levels were strongly associated with more poorly differentiated NSCLC and predicted poorer prognosis. BCAR1 knockdown caused cell growth arrest, cell migration inhibition and cell cycle arrest of A549 cells. Overexpression of BCAR1 was associated with activation of p38 in NSCLC cases, and BCAR1 knockdown caused reduction of phospho-p38 levels in A549 cells. Conclusion: Overexpression of BCAR1 is a predictor of poor prognosis in NSCLC and plays important carcinogenic roles in carcinogenesis, probably via activation of p38 MAPK. However, further investigations are required immediately.	[Huang, Wei; Deng, Bo; Wang, Ru-Wen; Tan, Qun-You; He, Yong; Jiang, Yao-Guang; Zhou, Jing-Hai] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Thorac Surg, Chongqing, Peoples R China	Army Medical University	Deng, B (corresponding author), Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Thorac Surg, Chongqing, Peoples R China.	superdb@163.com; wangrw53@126.com	Deng, Bo/AAH-8533-2021		National Natural Science Foundation of China (NSFC) [81101782, CSTC2011BB5020]; NSFC Third Military Medical University [2010XQN36]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC Third Military Medical University	The work was supported by the National Natural Science Foundation of China (NSFC) (No. 81101782), NSFC project CQ CSTC (No. CSTC2011BB5020), and NSFC Third Military Medical University (No. 2010XQN36). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brabek J, 2005, MOL CANCER RES, V3, P307, DOI 10.1158/1541-7786.MCR-05-0015; Brinkman A, 2000, JNCI-J NATL CANCER I, V92, P112, DOI 10.1093/jnci/92.2.112; Chodniewicz D, 2004, BBA-MOL CELL RES, V1692, P63, DOI 10.1016/j.bbamcr.2004.03.006; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Deng B, 2011, MOL DIAGN THER, V15, P31, DOI 10.2165/11588850-000000000-00000; Dorssers LCJ, 2004, CLIN CANCER RES, V10, P6194, DOI 10.1158/1078-0432.CCR-04-0444; Greenberg AK, 2002, AM J RESP CELL MOL, V26, P558, DOI 10.1165/ajrcmb.26.5.4689; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Huang C, 2005, BRIT J CANCER, V92, P1231, DOI 10.1038/sj.bjc.6602481; Ji C, 2010, BRAZ J MED BIOL RES, V43, P821, DOI 10.1590/S0100-879X2010000900003; KANNER SB, 1991, MOL CELL BIOL, V11, P713, DOI 10.1128/MCB.11.2.713; Kim W, 2004, J BIOL CHEM, V279, P8333, DOI 10.1074/jbc.M312026200; Kim W, 2008, MOL BIOL CELL, V19, P2135, DOI 10.1091/mbc.E07-10-0991; Matsuda K, 2002, CANCER RES, V62, P5611; Purnell PR, 2009, J THORAC ONCOL, V4, P448, DOI 10.1097/JTO.0b013e31819c78fb; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P629, DOI 10.1128/MCB.9.2.629; Rooney C, 2011, RESPIRATION, V81, P89, DOI 10.1159/000323946; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Takino T, 2003, J CELL SCI, V116, P3145, DOI 10.1242/jcs.00632; Tikhmyanova N, 2010, CELL MOL LIFE SCI, V67, P1025, DOI 10.1007/s00018-009-0213-1; Ulahannan SV, 2011, CANCER INVEST, V29, P325, DOI 10.3109/07357907.2011.554476; Wei L, 2002, J CELL BIOCHEM, V87, P439, DOI 10.1002/jcb.10322; Wendt MK, 2009, J BIOL CHEM, V284, P34145, DOI 10.1074/jbc.M109.023614; Yu JQ, 2004, J BIOL CHEM, V279, P50446, DOI 10.1074/jbc.M409221200	25	13	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36124	10.1371/journal.pone.0036124	http://dx.doi.org/10.1371/journal.pone.0036124			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558353	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336000132
J	Marongiu, MF; Poddie, D; Porcu, S; Manchinu, MF; Castelli, MP; Sogos, V; Bini, V; Frau, R; Caredda, E; Collu, M; Ristaldi, MS				Marongiu, Maria Franca; Poddie, Daniela; Porcu, Susanna; Manchinu, Maria Francesca; Castelli, Maria Paola; Sogos, Valeria; Bini, Valentina; Frau, Roberto; Caredda, Elisabetta; Collu, Maria; Ristaldi, Maria Serafina			Reversible Disruption of Pre-Pulse Inhibition in Hypomorphic-Inducible and Reversible CB1(-/-) Mice	PLOS ONE			English	Article							CANNABINOID RECEPTOR TRAFFICKING; PREPULSE INHIBITION; GATING DEFICITS; STARTLE REFLEX; CB1 RECEPTORS; MOUSE MODELS; CNR1 GENE; SCHIZOPHRENIA; SUSCEPTIBILITY; BRAIN	Although several genes are implicated in the pathogenesis of schizophrenia, in animal models for such a severe mental illness only some aspects of the pathology can be represented (endophenotypes). Genetically modified mice are currently being used to obtain or characterize such endophenotypes. Since its cloning and characterization CB1 receptor has increasingly become of significant physiological, pharmacological and clinical interest. Recently, its involvement in schizophrenia has been reported. Among the different approaches employed, gene targeting permits to study the multiple roles of the endocannabinoid system using knockout ((-/-)) mice represent a powerful model but with some limitations due to compensation. To overcome such a limitation, we have generated an inducible and reversible tet-off dependent tissue-specific CB1(-/-) mice where the CB1R is re-expressed exclusively in the forebrain at a hypomorphic level due to a mutation (IRh-CB1(-/-)) only in absence of doxycycline (Dox). In such mice, under Dox(+) or vehicle, as well as in wild-type (WT) and CB1(-/-), two endophenotypes motor activity (increased in animal models of schizophrenia) and pre-pulse inhibition (PPI) of startle reflex (disrupted in schizophrenia) were analyzed. Both CB1(-/-) and IRh-CB1(-/-) showed increased motor activity when compared to WT animals. The PPI response, unaltered in WT and CB1(-/-) animals, was on the contrary highly and significantly disrupted only in Dox(+) IRh-CB1(-/-) mice. Such a response was easily reverted after either withdrawal from Dox or haloperidol treatment. This is the first Inducible and Reversible CB1(-/-) mice model to be described in the literature. It is noteworthy that the PPI disruption is not present either in classical full CB1(-/-) mice or following acute administration of rimonabant. Such a hypomorphic model may provide a new tool for additional in vivo and in vitro studies of the physiological and pathological roles of cannabinoid system in schizophrenia and in other psychiatric disorders.	[Marongiu, Maria Franca; Poddie, Daniela; Porcu, Susanna; Manchinu, Maria Francesca; Ristaldi, Maria Serafina] Natl Res Council IRGB CNR, Inst Genet & Biomed Res, Monserrato, Italy; [Castelli, Maria Paola; Sogos, Valeria; Bini, Valentina; Frau, Roberto; Caredda, Elisabetta; Collu, Maria] Univ Cagliari, Dept Biomed Sci, Div Neurosci & Clin Pharmacol, Monserrato, Italy; [Castelli, Maria Paola; Collu, Maria] Univ Cagliari, Ctr Excellence Neurobiol Drug Dependence, Monserrato, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Cagliari; University of Cagliari	Marongiu, MF (corresponding author), Natl Res Council IRGB CNR, Inst Genet & Biomed Res, Monserrato, Italy.	mcollu@unica.it; ristaldi@inn.cnr.it	Ristaldi, Maria S/N-8549-2013; Collu, Maria/F-7113-2012; MARONGIU, MARIAFRANCA/AAC-3152-2021; Castelli, Maria Paola/F-9295-2012; PORCU, SUSANNA/AAY-3325-2020; Sogos, Valeria/B-5471-2012; Porcu, Susanna/AAC-3031-2019; Ristaldi, Maria Serafina/AAW-6270-2020	Collu, Maria/0000-0001-5406-2934; MARONGIU, MARIAFRANCA/0000-0003-3363-8046; Castelli, Maria Paola/0000-0003-3249-4706; PORCU, SUSANNA/0000-0001-8053-7075; Sogos, Valeria/0000-0002-4021-1043; Frau, Roberto/0000-0002-5922-2404; Ristaldi, Maria Serafina/0000-0003-4122-9293	Italian Ministry of University and Scientific Research	Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by a grant from the Italian Ministry of University and Scientific Research (FISR - Fondo Integrativo Speciale Ricerca Anno 1999 - D.M.16/10/2000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Amann LC, 2010, BRAIN RES BULL, V83, P147, DOI 10.1016/j.brainresbull.2010.04.008; Andersson H, 2003, MOL PHARMACOL, V64, P570, DOI 10.1124/mol.64.3.570; Azad SC, 2008, LEARN MEMORY, V15, P143, DOI 10.1101/lm.741908; Ballmaier M, 2007, NEUROPSYCHOPHARMACOL, V32, P2098, DOI 10.1038/sj.npp.1301344; Bodor AL, 2005, J NEUROSCI, V25, P6845, DOI 10.1523/JNEUROSCI.0442-05.2005; Bohn LM, 2007, MOL PHARMACOL, V71, P957, DOI 10.1124/mol.107.034223; Bortolato M, 2005, PSYCHOPHARMACOLOGY, V177, P264, DOI 10.1007/s00213-004-1941-4; Bortolato M, 2007, PSYCHOPHARMACOLOGY, V194, P361, DOI 10.1007/s00213-007-0845-5; Bossong MG, 2010, PROG NEUROBIOL, V92, P370, DOI 10.1016/j.pneurobio.2010.06.010; Braff DL, 2010, CURR TOP BEHAV NEURO, V4, P349, DOI 10.1007/7854_2010_61; Brailoiu GC, 2011, J BIOL CHEM, V286, P29166, DOI 10.1074/jbc.M110.217463; Bucan M, 2002, NAT REV GENET, V3, P114, DOI 10.1038/nrg728; Castelli MP, 2007, NEUROSCIENCE, V147, P197, DOI 10.1016/j.neuroscience.2007.02.062; Chaouloff F, 2011, PHYSIOLOGY, V26, P76, DOI 10.1152/physiol.00050.2010; de Fonseca FR, 2005, ALCOHOL ALCOHOLISM, V40, P2, DOI 10.1093/alcalc/agh110; Denzer AJ, 1995, EMBO J, V14, P6311, DOI 10.1002/j.1460-2075.1995.tb00321.x; Egertova M, 2000, J COMP NEUROL, V422, P159, DOI 10.1002/(SICI)1096-9861(20000626)422:2<159::AID-CNE1>3.0.CO;2-1; El Manira A, 2010, PHYSIOLOGY, V25, P230, DOI 10.1152/physiol.00007.2010; Giakournaki SG, 2007, BIOL PSYCHIAT, V62, P1418, DOI 10.1016/j.biopsych.2006.12.002; Giuffrida A, 2004, NEUROPSYCHOPHARMACOL, V29, P2108, DOI 10.1038/sj.npp.1300558; Grimsey NL, 2008, CLIN EXP PHARMACOL P, V35, P1377, DOI 10.1111/j.1440-1681.2008.04991.x; Haring M, 2007, NEUROSCIENCE, V146, P1212, DOI 10.1016/j.neuroscience.2007.02.021; Haller J, 2009, PSYCHOPHARMACOLOGY, V204, P607, DOI 10.1007/s00213-009-1494-7; Hamdani N, 2008, EUR NEUROPSYCHOPHARM, V18, P34, DOI 10.1016/j.euroneuro.2007.05.005; Haring M, 2012, NEUROSCIENCE; Jones CA, 2011, BRIT J PHARM; Karlsgodt KH, 2011, BIOL PSYCHIAT, V69, P28, DOI 10.1016/j.biopsych.2010.09.012; Kirby BP, 2010, BRAIN RES BULL, V83, P162, DOI 10.1016/j.brainresbull.2009.09.010; Ledent C, 1999, SCIENCE, V283, P401, DOI 10.1126/science.283.5400.401; Leroy S, 2001, AM J MED GENET, V105, P749, DOI 10.1002/ajmg.10038; Leterrier C, 2004, J BIOL CHEM, V279, P36013, DOI 10.1074/jbc.M403990200; Long LE, 2010, INT J NEUROPSYCHOPH, V13, P861, DOI 10.1017/S1461145709990605; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Malone DT, 2010, BRIT J PHARMACOL, V160, P511, DOI 10.1111/j.1476-5381.2010.00721.x; Malone DT, 2004, PHARMACOL BIOCHEM BE, V77, P839, DOI 10.1016/j.pbb.2004.02.010; Mansuy IM, 2000, CURR OPIN NEUROBIOL, V10, P593, DOI 10.1016/S0959-4388(00)00127-6; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Martin RS, 2003, PSYCHOPHARMACOLOGY, V165, P128, DOI 10.1007/s00213-002-1240-x; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; Monory K, 2007, PLOS BIOL, V5, P2354, DOI 10.1371/journal.pbio.0050269; Moore THM, 2007, LANCET, V370, P319, DOI 10.1016/S0140-6736(07)61162-3; Moreira FA, 2005, EUR J PHARMACOL, V512, P199, DOI 10.1016/j.ejphar.2005.02.040; Nagai H, 2006, PHARMACOL BIOCHEM BE, V84, P330, DOI 10.1016/j.pbb.2006.05.018; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nonchev SG, 2000, PRACT APPROACH SER, P61; Ortega-Alvaro A, 2011, NEUROPSYCHOPHARMACOL, V36, P1489, DOI 10.1038/npp.2011.34; Papaleo F, 2012, NEUROPHARMACOLOGY, V62, P1204, DOI 10.1016/j.neuropharm.2011.04.025; Papaleo F, 2011, BIOL PSYCHIAT, V69, P2, DOI 10.1016/j.biopsych.2010.10.028; Parolaro D, 2010, EXP NEUROL, V224, P3, DOI 10.1016/j.expneurol.2010.03.018; Perry W, 2009, ARCH GEN PSYCHIAT, V66, P1072, DOI 10.1001/archgenpsychiatry.2009.58; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Pertwee RG, 2008, ADDICT BIOL, V13, P147, DOI 10.1111/j.1369-1600.2008.00108.x; Pettit DAD, 1998, J NEUROSCI RES, V51, P391; Powell SB, 2009, BEHAV BRAIN RES, V204, P282, DOI 10.1016/j.bbr.2009.04.021; Rozenfeld R, 2008, FASEB J, V22, P2311, DOI 10.1096/fj.07-102731; Rozenfeld R, 2011, TRAFFIC, V12, P12, DOI 10.1111/j.1600-0854.2010.01130.x; Saunders TL, 2008, TRANSGENIC MOUSE MET, P125; Schneider M, 2002, BEHAV PHARMACOL, V13, P29, DOI 10.1097/00008877-200202000-00003; Schonig Kai, 2003, Methods Mol Biol, V209, P69; Seifert J, 2007, NEUROSCI LETT, V426, P29, DOI 10.1016/j.neulet.2007.08.008; Sigel E, 2011, P NATL ACAD SCI USA, V108, P18150, DOI 10.1073/pnas.1113444108; Spano MS, 2010, EUR NEUROPSYCHOPHARM, V20, P25, DOI 10.1016/j.euroneuro.2009.09.004; Steiner H, 1999, PNAS US, V96, P5787; Swerdlow NR, 2008, PSYCHOPHARMACOLOGY, V199, P331, DOI 10.1007/s00213-008-1072-4; Ujike H, 2002, MOL PSYCHIATR, V7, P515, DOI 10.1038/sj.mp.4001029; Valverde O, 2005, HANDB EXP PHARMACOL, V168, P117; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	69	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35013	10.1371/journal.pone.0035013	http://dx.doi.org/10.1371/journal.pone.0035013			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558109	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336000021
J	Milton, JN; Sebastiani, P; Solovieff, N; Hartley, SW; Bhatnagar, P; Arking, DE; Dworkis, DA; Casella, JF; Barron-Casella, E; Bean, CJ; Hooper, WC; DeBaun, MR; Garrett, ME; Soldano, K; Telen, MJ; Ashley-Koch, A; Gladwin, MT; Baldwin, CT; Steinberg, MH; Klings, ES				Milton, Jacqueline N.; Sebastiani, Paola; Solovieff, Nadia; Hartley, Stephen W.; Bhatnagar, Pallav; Arking, Dan E.; Dworkis, Daniel A.; Casella, James F.; Barron-Casella, Emily; Bean, Christopher J.; Hooper, W. Craig; DeBaun, Michael R.; Garrett, Melanie E.; Soldano, Karen; Telen, Marilyn J.; Ashley-Koch, Allison; Gladwin, Mark T.; Baldwin, Clinton T.; Steinberg, Martin H.; Klings, Elizabeth S.			A Genome-Wide Association Study of Total Bilirubin and Cholelithiasis Risk in Sickle Cell Anemia	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; GILBERTS-SYNDROME; UGT1A1-ASTERISK-28 ALLELE; PROMOTER POLYMORPHISMS; ALPHA-THALASSEMIA; HYDROXYUREA THERAPY; UGT1A1 POLYMORPHISM; PLASMA BILIRUBIN; HYPERBILIRUBINEMIA; HEMOLYSIS	Serum bilirubin levels have been associated with polymorphisms in the UGT1A1 promoter in normal populations and in patients with hemolytic anemias, including sickle cell anemia. When hemolysis occurs circulating heme increases, leading to elevated bilirubin levels and an increased incidence of cholelithiasis. We performed the first genome-wide association study (GWAS) of bilirubin levels and cholelithiasis risk in a discovery cohort of 1,117 sickle cell anemia patients. We found 15 single nucleotide polymorphisms (SNPs) associated with total bilirubin levels at the genome-wide significance level (p value <5x10(-8)). SNPs in UGT1A1, UGT1A3, UGT1A6, UGT1A8 and UGT1A10, different isoforms within the UGT1A locus, were identified (most significant rs887829, p = 9.08x10(-25)). All of these associations were validated in 4 independent sets of sickle cell anemia patients. We tested the association of the 15 SNPs with cholelithiasis in the discovery cohort and found a significant association (most significant p value 1.15x10(-4)). These results confirm that the UGT1A region is the major regulator of bilirubin metabolism in African Americans with sickle cell anemia, similar to what is observed in other ethnicities.	[Milton, Jacqueline N.; Sebastiani, Paola; Solovieff, Nadia; Hartley, Stephen W.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA; [Dworkis, Daniel A.; Baldwin, Clinton T.; Steinberg, Martin H.; Klings, Elizabeth S.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Klings, Elizabeth S.] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [Bhatnagar, Pallav; Arking, Dan E.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Casella, James F.; Barron-Casella, Emily] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Pediat Hematol, Baltimore, MD 21205 USA; [Bean, Christopher J.; Hooper, W. Craig] Ctr Dis Control & Prevent, Clin & Mol Hemostasis Lab Branch, Div Blood Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA; [DeBaun, Michael R.] Vanderbilt Univ Sch Med, Nashville, TN USA; [Garrett, Melanie E.; Soldano, Karen; Telen, Marilyn J.; Ashley-Koch, Allison] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Gladwin, Mark T.] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA; [Gladwin, Mark T.] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA USA	Boston University; Boston University; Boston University; Johns Hopkins University; Johns Hopkins University; Centers for Disease Control & Prevention - USA; Vanderbilt University; Duke University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Milton, JN (corresponding author), Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA.	klingon@bu.edu	Bhatnagar, Pallav/A-1280-2013	Ashley-Koch, Allison/0000-0001-5409-9155; Steinberg, Martin/0000-0001-8800-8020; Bean, Christopher/0000-0001-7433-9769; Baldwin, Clinton/0000-0002-3275-9463; Klings, Elizabeth/0000-0003-4879-720X; sebastiani, paola/0000-0001-6419-1545; Telen, Marilyn/0000-0003-3809-1780; Dworkis, Daniel/0000-0003-0706-5117	National Institutes of Health/ National Heart, Lung and Blood Institute [1RC2HL101212]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101212, T32HL007501] Funding Source: NIH RePORTER	National Institutes of Health/ National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by National Institutes of Health/ National Heart, Lung and Blood Institute grant # 1RC2HL101212. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam S, 2008, AM J MED, V121, P916, DOI 10.1016/j.amjmed.2008.04.040; Au WY, 2005, ANN HEMATOL, V84, P671, DOI 10.1007/s00277-005-1091-8; Au WY, 2003, HAEMATOLOGICA, V88, P220; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Benjamin EJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S11; Bosma PJ, 2003, CLIN CHEM, V49, P1180, DOI 10.1373/49.7.1180; BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; Buch S, 2010, GASTROENTEROLOGY, V139, P1942, DOI 10.1053/j.gastro.2010.09.003; Carpenter SL, 2008, AM J HEMATOL, V83, P800, DOI 10.1002/ajh.21264; Cecchin E, 2009, J CLIN ONCOL, V27, P2457, DOI 10.1200/JCO.2008.19.0314; Chaar V, 2005, HAEMATOLOGICA, V90, P188; Chaar V, 2006, AM J HEMATOL, V81, P377, DOI 10.1002/ajh.20574; Chen GM, 2011, EUR ACCOUNT REV, V20, P669, DOI 10.1080/09638180.2011.599929; Clementi M, 2007, DIGEST LIVER DIS, V39, P351, DOI 10.1016/j.dld.2006.12.019; Galanello R, 2001, BRIT J HAEMATOL, V115, P926, DOI 10.1046/j.1365-2141.2001.03200.x; GASTON M, 1982, AM J PEDIAT HEMATOL, V4, P197; Haider MZ, 1998, ACTA HAEMATOL-BASEL, V100, P147, DOI 10.1159/000040890; Haverfield EV, 2005, BLOOD, V105, P968, DOI 10.1182/blood-2004-02-0521; Heeney MM, 2003, J LAB CLIN MED, V141, P279, DOI 10.1067/mlc.2003.28; Horsfall LJ, 2011, ANN HUM GENET, V75, P236, DOI 10.1111/j.1469-1809.2010.00638.x; Hunt SC, 2001, ATHEROSCLEROSIS, V154, P747, DOI 10.1016/S0021-9150(00)00420-2; Italia KY, 2010, CLIN BIOCHEM, V43, P1329, DOI 10.1016/j.clinbiochem.2010.08.006; Johnson AD, 2009, HUM MOL GENET, V18, P2700, DOI 10.1093/hmg/ddp202; Kama NA, 2001, SURG ENDOSC-ULTRAS, V15, P942, DOI 10.1007/s00464-001-0005-7; Kang TW, 2010, HUM MOL GENET, V19, P3672, DOI 10.1093/hmg/ddq281; Kato GJ, 2006, BLOOD, V107, P2279, DOI 10.1182/blood-2005-06-2373; Kato GJ, 2007, BLOOD REV, V21, P37, DOI 10.1016/j.blre.2006.07.001; Kohle C, 2003, BIOCHEM PHARMACOL, V65, P1521, DOI 10.1016/S0006-2952(03)00074-1; Krawczyk M, 2011, SEMIN LIVER DIS, V31, P157, DOI 10.1055/s-0031-1276645; Kronenberg F, 2002, EUR J HUM GENET, V10, P539, DOI 10.1038/sj.ejhg.5200842; Lammert F, 2005, NAT CLIN PRACT GASTR, V2, P423, DOI 10.1038/ncpgasthep0257; Lammert Frank, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P163, DOI 10.2174/1568008054064841; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lin JP, 2006, CIRCULATION, V114, P1476, DOI 10.1161/CIRCULATIONAHA.106.633206; Lingenhel A, 2008, EXP GERONTOL, V43, P1102, DOI 10.1016/j.exger.2008.08.047; Liu Jian, 2009, Zhonghua Yi Xue Za Zhi, V89, P3122; Machado RF, 2011, BLOOD, V118, P855, DOI 10.1182/blood-2010-09-306167; Martins R, 2008, J HUM GENET, V53, P524, DOI 10.1007/s10038-008-0281-3; McDonagh AF, 2010, SEMIN FETAL NEONAT M, V15, P141, DOI 10.1016/j.siny.2009.10.005; Ockenga J, 2003, GASTROENTEROLOGY, V124, P1802, DOI 10.1016/S0016-5085(03)00294-4; Passon RG, 2001, J PEDIAT HEMATOL ONC, V23, P448, DOI 10.1097/00043426-200110000-00011; Perera MA, 2008, PHARMACOTHERAPY, V28, P755, DOI 10.1592/phco.28.6.755; Persico M, 2001, HEPATOLOGY, V33, P627, DOI 10.1053/jhep.2001.22499; Portincasa P, 2006, LANCET, V368, P230, DOI 10.1016/S0140-6736(06)69044-2; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rantner B, 2008, CLIN CHEM, V54, P851, DOI 10.1373/clinchem.2007.102046; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Sanna S, 2009, HUM MOL GENET, V18, P2711, DOI 10.1093/hmg/ddp203; Schwertner HA, 2008, ATHEROSCLEROSIS, V198, P1, DOI 10.1016/j.atherosclerosis.2008.01.001; Sebastiani P, 2010, AM J HEMATOL, V85, P29, DOI 10.1002/ajh.21572; Steinberg MH, 2003, JAMA-J AM MED ASSOC, V289, P1645, DOI 10.1001/jama.289.13.1645; Strassburg CP, 1998, J BIOL CHEM, V273, P8719, DOI 10.1074/jbc.273.15.8719; Taylor JG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002095; Teng HC, 2007, CLIN GENET, V72, P321, DOI 10.1111/j.1399-0004.2007.00873.x; Van Erpecum KJ, 2011, CLIN RES HEPATOL GAS, V35, P281, DOI 10.1016/j.clinre.2011.01.009; Vasavda N, 2007, BRIT J HAEMATOL, V138, P263, DOI 10.1111/j.1365-2141.2007.06643.x; Vogel A, 2001, GASTROENTEROLOGY, V121, P1136, DOI 10.1053/gast.2001.28655; WEST MS, 1992, J CLIN EPIDEMIOL, V45, P893	58	37	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e34741	10.1371/journal.pone.0034741	http://dx.doi.org/10.1371/journal.pone.0034741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558097	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000305336000016
J	Plotkin, SR; Bredella, MA; Cai, WL; Kassarjian, A; Harris, GJ; Esparza, S; Merker, VL; Munn, LL; Muzikansky, A; Askenazi, M; Nguyen, R; Wenzel, R; Mautner, VF				Plotkin, Scott R.; Bredella, Miriam A.; Cai, Wenli; Kassarjian, Ara; Harris, Gordon J.; Esparza, Sonia; Merker, Vanessa L.; Munn, Lance L.; Muzikansky, Alona; Askenazi, Manor; Rosa Nguyen; Wenzel, Ralph; Mautner, Victor F.			Quantitative Assessment of Whole-Body Tumor Burden in Adult Patients with Neurofibromatosis	PLOS ONE			English	Article							DIAGNOSTIC-CRITERIA; TYPE-1; GENE; MUTATION; MORTALITY; SURVIVAL; DELETION; BENIGN	Purpose: Patients with neurofibromatosis 1 (NF1), NF2, and schwannomatosis are at risk for multiple nerve sheath tumors and premature mortality. Traditional magnetic resonance imaging (MRI) has limited ability to assess disease burden accurately. The aim of this study was to establish an international cohort of patients with quantified whole-body internal tumor burden and to correlate tumor burden with clinical features of disease. Methods: We determined the number, volume, and distribution of internal nerve sheath tumors in patients using whole-body MRI (WBMRI) and three-dimensional computerized volumetry. We quantified the distribution of tumor volume across body regions and used unsupervised cluster analysis to group patients based on tumor distribution. We correlated the presence and volume of internal tumors with disease-related and demographic factors. Results: WBMRI identified 1286 tumors in 145/247 patients (59%). Schwannomatosis patients had the highest prevalence of tumors (P = 0.03), but NF1 patients had the highest median tumor volume (P = 0.02). Tumor volume was unevenly distributed across body regions with overrepresentation of the head/neck and pelvis. Risk factors for internal nerve sheath tumors included decreasing numbers of cafe-au-lait macules in NF1 patients (P = 0.003) and history of skeletal abnormalities in NF2 patients (P = 0.09). Risk factors for higher tumor volume included female gender (P = 0.05) and increasing subcutaneous neurofibromas (P = 0.03) in NF1 patients, absence of cutaneous schwannomas in NF2 patients (P = 0.06), and increasing age in schwannomatosis patients (p = 0.10). Conclusion: WBMRI provides a comprehensive phenotype of neurofibromatosis patients, identifies distinct anatomic subgroups, and provides the basis for investigating molecular biomarkers that correlate with unique disease manifestations.	[Plotkin, Scott R.; Esparza, Sonia; Merker, Vanessa L.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Plotkin, Scott R.; Esparza, Sonia; Merker, Vanessa L.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Bredella, Miriam A.; Cai, Wenli; Harris, Gordon J.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Kassarjian, Ara] Corades SL, Dept Radiol, Majadahonda, Spain; [Munn, Lance L.] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Muzikansky, Alona] Massachusetts Gen Hosp, Ctr Biostat, Boston, MA 02114 USA; [Askenazi, Manor] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Askenazi, Manor] Hebrew Univ Jerusalem, Dept Biol Chem, Jerusalem, Israel; [Rosa Nguyen] Univ Hamburg Hosp, Dept Neurol, D-2000 Hamburg, Germany; [Wenzel, Ralph; Mautner, Victor F.] Univ Hamburg Hosp, Dept Radiol, D-2000 Hamburg, Germany	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Hebrew University of Jerusalem; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Plotkin, SR (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.	splotkin@partners.org	Munn, Lance L/L-3950-2016; Merker, Vanessa/AAM-7250-2020	Munn, Lance L/0000-0003-0698-7232; Merker, Vanessa/0000-0002-4542-5227; Askenazi, Manor/0000-0003-1646-833X; Plotkin, Scott/0000-0002-6109-6419; Kassarjian, Ara/0000-0002-9969-3227	Department of Defense [NF0502020]; United States National Institutes of Health/National Institute of Neurologic Disorders and Stroke [P01NS024279]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS024279] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); United States National Institutes of Health/National Institute of Neurologic Disorders and Stroke; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the Department of Defense Neurofibromatosis Research Program (NF0502020) and the United States National Institutes of Health/National Institute of Neurologic Disorders and Stroke (P01NS024279). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghi M, 2006, J NEUROSURG, V104, P201, DOI 10.3171/jns.2006.104.2.201; [Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; Baser ME, 2004, AM J HUM GENET, V75, P231, DOI 10.1086/422700; Baser ME, 2002, NEUROLOGY, V59, P1759, DOI 10.1212/01.WNL.0000035638.74084.F4; Biegel Jaclyn A., 2002, Cancer Research, V62, P323; Cai WL, 2009, RADIOLOGY, V250, P665, DOI 10.1148/radiol.2503080700; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; Cichowski K, 2003, GENE DEV, V17, P449, DOI 10.1101/gad.1054703; Clauser C., 1969, WEIGHT VOLUME CTR MA, DOI DOI 10.21236/AD0710622; Curto M, 2008, BRIT J CANCER, V98, P256, DOI 10.1038/sj.bjc.6604002; Deltas G, 2003, REV ECON STAT, V85, P226, DOI 10.1162/rest.2003.85.1.226; Dugoff L, 1996, AM J MED GENET, V66, P7, DOI 10.1002/(SICI)1096-8628(19961202)66:1<7::AID-AJMG2>3.0.CO;2-R; Evans DGR, 2011, EUR J HUM GENET, V19, P1187, DOI 10.1038/ejhg.2011.113; Friedman JM, 1997, AM J MED GENET, V70, P138, DOI 10.1002/(SICI)1096-8628(19970516)70:2<138::AID-AJMG7>3.0.CO;2-U; Giovannini M, 2000, GENE DEV, V14, P1617; Hulsebos TJM, 2007, AM J HUM GENET, V80, P805, DOI 10.1086/513207; HUSON SM, 1988, BRAIN, V111, P1355, DOI 10.1093/brain/111.6.1355; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; Lammert M, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-16; Li W, 2010, CELL, V140, P477, DOI 10.1016/j.cell.2010.01.029; MacCollin M, 2005, NEUROLOGY, V64, P1838, DOI 10.1212/01.WNL.0000163982.78900.AD; Mautner VF, 1997, ARCH DERMATOL, V133, P1539, DOI 10.1001/archderm.133.12.1539; Mautner VF, 2008, NEURO-ONCOLOGY, V10, P593, DOI 10.1215/15228517-2008-011; McLaughlin ME, 2003, CANCER RES, V63, P752; MULVIHILL JJ, 1990, ANN INTERN MED, V113, P39, DOI 10.7326/0003-4819-113-1-39; NORTH K, 1993, J CHILD NEUROL, V8, P395, DOI 10.1177/088307389300800421; Otsuka G, 2003, J NEUROSURG, V99, P480, DOI 10.3171/jns.2003.99.3.0480; R Core Team, 2018, R LANG ENV STAT COMP; Rasmussen SA, 2001, AM J HUM GENET, V68, P1110, DOI 10.1086/320121; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Ruggieri M, 2001, NEUROLOGY, V56, P1433, DOI 10.1212/WNL.56.11.1433; Sbidian E, 2010, J INVEST DERMATOL, V130, P2173, DOI 10.1038/jid.2010.100; Tonsgard JH, 1998, NEUROLOGY, V50, P1755, DOI 10.1212/WNL.50.6.1755; Trofatter J A, 1993, Cell, V75, P826; Duong TA, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-18; Tucker T, 2005, NEUROLOGY, V65, P205, DOI 10.1212/01.wnl.0000168830.79997.13; Upadhyaya M, 2007, AM J HUM GENET, V80, P140, DOI 10.1086/510781; Vogel KS, 1999, SCIENCE, V286, P2176, DOI 10.1126/science.286.5447.2176; Waggoner DJ, 2000, AM J MED GENET, V92, P132, DOI 10.1002/(SICI)1096-8628(20000515)92:2<132::AID-AJMG10>3.0.CO;2-6; WU BL, 1995, AM J MED GENET, V59, P528, DOI 10.1002/ajmg.1320590427; Yang FC, 2008, CELL, V135, P437, DOI 10.1016/j.cell.2008.08.041	41	94	102	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35711	10.1371/journal.pone.0035711	http://dx.doi.org/10.1371/journal.pone.0035711			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558206	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000051
J	Racca, A; Guo, K; Meints, K; Mills, DS				Racca, Anais; Guo, Kun; Meints, Kerstin; Mills, Daniel S.			Reading Faces: Differential Lateral Gaze Bias in Processing Canine and Human Facial Expressions in Dogs and 4-Year-Old Children	PLOS ONE			English	Article							ASYMMETRICAL BRAIN; FAMILIARIS; CUES; COMPREHENSION; RECOGNITION; EVOLUTION; RESPONSES	Sensitivity to the emotions of others provides clear biological advantages. However, in the case of heterospecific relationships, such as that existing between dogs and humans, there are additional challenges since some elements of the expression of emotions are species-specific. Given that faces provide important visual cues for communicating emotional state in both humans and dogs, and that processing of emotions is subject to brain lateralisation, we investigated lateral gaze bias in adult dogs when presented with pictures of expressive human and dog faces. Our analysis revealed clear differences in laterality of eye movements in dogs towards conspecific faces according to the emotional valence of the expressions. Differences were also found towards human faces, but to a lesser extent. For comparative purpose, a similar experiment was also run with 4-year-old children and it was observed that they showed differential processing of facial expressions compared to dogs, suggesting a species-dependent engagement of the right or left hemisphere in processing emotions.	[Racca, Anais; Guo, Kun; Meints, Kerstin] Lincoln Univ, Sch Psychol, Lincoln, England; [Racca, Anais; Mills, Daniel S.] Lincoln Univ, Sch Life Sci, Lincoln, England	University of Lincoln; University of Lincoln	Racca, A (corresponding author), Lincoln Univ, Sch Psychol, Lincoln, England.	kguo@lincoln.ac.uk		Meints, Kerstin/0000-0003-1048-5091; Mills, Daniel/0000-0002-4765-9625; Guo, Kun/0000-0001-6765-1957				Adachi I, 2007, ANIM COGN, V10, P17, DOI 10.1007/s10071-006-0025-8; ANDREW RJ, 1963, SCIENCE, V142, P1034, DOI 10.1126/science.142.3595.1034; [Anonymous], 1983, COGN PROCESS, DOI [10.1016/B978-0-12-550680-9.50011-X, DOI 10.1016/B978-0-12-550680-9.50011-X]; Batty M, 2006, DEVELOPMENTAL SCI, V9, P207, DOI 10.1111/j.1467-7687.2006.00480.x; Bolwig N., 1964, Behaviour, V22, P167; BULLOCK M, 1985, INT J BEHAV DEV, V8, P15, DOI 10.1177/016502548500800103; Butler S, 2005, NEUROPSYCHOLOGIA, V43, P52, DOI 10.1016/j.neuropsychologia.2004.06.005; Call J, 2003, J COMP PSYCHOL, V117, P257, DOI 10.1037/0735-7036.117.3.257; Chevalier-Skolnikoff S., 1973, DARWIN FACIAL EXPRES, P11; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; DAVIDSON RJ, 1982, SCIENCE, V218, P1235, DOI 10.1126/science.7146906; DAVIS SJM, 1978, NATURE, V276, P608, DOI 10.1038/276608a0; Demaree Heath A, 2005, Behav Cogn Neurosci Rev, V4, P3, DOI 10.1177/1534582305276837; Deputte BL., 2011, J VET BEHAV, V6, P78, DOI [10.1016/j.jveb.2010.09.013, DOI 10.1016/J.JVEB.2010.09.013]; DEWAAL FBM, 1988, BEHAVIOUR, V106, P183, DOI 10.1163/156853988X00269; Dobson SD, 2009, AM J PHYS ANTHROPOL, V138, P70, DOI 10.1002/ajpa.20902; Ehrlichman H, 1986, DUALITY UNITY BRAIN, P194; EKMAN P, 1993, AM PSYCHOL, V48, P384, DOI 10.1037/0003-066X.48.4.384; Ekman P., 1975, PICTURES FACIAL AFFE; Ekman P., 2002, FACIAL ACTION CODING; Farroni T, 2007, EUR J DEV PSYCHOL, V4, P2, DOI 10.1080/17405620601046832; Feddersen-Petersen DU, 2007, BEHAVIOURAL BIOLOGY OF DOGS, P105, DOI 10.1079/9781845931872.0105; FOX MW, 1970, BEHAVIOUR, V36, P49, DOI 10.1163/156853970X00042; Gacsi M, 2004, ANIM COGN, V7, P144, DOI 10.1007/s10071-003-0205-8; Gao XQ, 2010, J EXP CHILD PSYCHOL, V107, P67, DOI 10.1016/j.jecp.2010.05.003; Green JR, 2010, J SPEECH LANG HEAR R, V53, P1529, DOI 10.1044/1092-4388(2010/09-0005); Guo K, 2009, ANIM COGN, V12, P409, DOI 10.1007/s10071-008-0199-3; Hare B., 1998, EVOL COMMUN, V2, P137; Hinde RA, 1962, P ZOOL SOC LOND, V138, P121; Indersmitten T, 2003, J NEUROSCI, V23, P3820; Kaminski J, 2004, SCIENCE, V304, P1682, DOI 10.1126/science.1097859; Lakatos G, 2009, ANIM COGN, V12, P621, DOI 10.1007/s10071-009-0221-4; Lee E, 2008, PSYCHIAT RES, V157, P77, DOI 10.1016/j.psychres.2007.02.005; MCMANUS IC, 1988, BRIT J DEV PSYCHOL, V6, P257, DOI 10.1111/j.2044-835X.1988.tb01099.x; Meints K, 2009, J PEDIATR PSYCHOL, V34, P1084, DOI 10.1093/jpepsy/jsp053; Miklosi A, 1998, Anim Cogn, V1, P113, DOI 10.1007/s100710050016; Miles L, 2007, J NONVERBAL BEHAV, V31, P259, DOI 10.1007/s10919-007-0036-4; MILLOT JL, 1994, BEHAV PROCESS, V33, P177, DOI 10.1016/0376-6357(94)90065-5; Mills DS, 2005, Current Issues and Research in Veterinary Behavioral Medicine, P217; Mitchell RW, 2001, RES LANG SOC INTERAC, V34, P183, DOI 10.1207/S15327973RLSI34-2_2; Mongillo P, 2010, ANIM BEHAV, V80, P1057, DOI 10.1016/j.anbehav.2010.09.014; Nagasawa M, 2011, ANIM COGN, V14, P525, DOI 10.1007/s10071-011-0386-5; Ovodov ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022821; Parr LA, 2008, EMOTION, V8, P216, DOI 10.1037/1528-3542.8.2.216; Parr LA, 2007, CURR DIR PSYCHOL SCI, V16, P117, DOI 10.1111/j.1467-8721.2007.00487.x; Phillips ML, 1997, BRAIN COGNITION, V35, P225, DOI 10.1006/brcg.1997.0939; Phillips ML, 2004, NEUROIMAGE, V21, P1484, DOI 10.1016/j.neuroimage.2003.12.013; Preuschoft S., 1997, NONVERBAL COMMUNICAT, P171; Quaranta A, 2007, CURR BIOL, V17, pR199, DOI 10.1016/j.cub.2007.02.008; Racca A, 2010, ANIM COGN, V13, P525, DOI 10.1007/s10071-009-0303-3; Ruffman T, 2011, J VET BEHAV, V6, P97, DOI DOI 10.1016/J.JVEB.2010.08.009; Siniscalchi M, 2011, ANIM BEHAV, V82, P399, DOI 10.1016/j.anbehav.2011.05.020; Siniscalchi M, 2010, BEHAV BRAIN RES, V208, P516, DOI 10.1016/j.bbr.2009.12.042; Siniscalchi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003349; Soproni K, 2001, J COMP PSYCHOL, V115, P122, DOI 10.1037//0735-7036.115.2.122; Topal J, 2009, ADV STUD BEHAV, V39, P71, DOI 10.1016/S0065-3454(09)39003-8; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P575, DOI 10.1017/S0140525X05000105; VALLORTIGARA G, 1994, BEHAV PROCESS, V33, P41, DOI 10.1016/0376-6357(94)90059-0; Vallortigara G, 2011, WIRES COGN SCI, V2, P146, DOI 10.1002/wcs.100; van Hooff J. A. R. A. M., 1967, PRIMATE ETHOLOGY, P9; Vas J, 2005, APPL ANIM BEHAV SCI, V94, P99, DOI 10.1016/j.applanim.2005.02.001; Viranyi Z, 2006, ANIM COGN, V9, P13, DOI 10.1007/s10071-005-0257-z; Viranyi Z, 2004, BEHAV PROCESS, V66, P161, DOI 10.1016/j.beproc.2004.01.012; Widen SC, 2003, DEV PSYCHOL, V39, P114, DOI 10.1037//0012-1649.39.1.114	64	83	84	3	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36076	10.1371/journal.pone.0036076	http://dx.doi.org/10.1371/journal.pone.0036076			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TJ	22558335	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000305336000121
J	Swarts, DC; Mosterd, C; van Passel, MWJ; Brouns, SJJ				Swarts, Daan C.; Mosterd, Cas; van Passel, Mark W. J.; Brouns, Stan J. J.			CRISPR Interference Directs Strand Specific Spacer Acquisition	PLOS ONE			English	Article							ANTIVIRAL DEFENSE; CRYSTAL-STRUCTURE; IMMUNE-SYSTEM; RNA; DNA; TRANSCRIPTION; RESISTANCE; DIVERSITY; EVOLUTION; HELICASE	Background: CRISPR/Cas is a widespread adaptive immune system in prokaryotes. This system integrates short stretches of DNA derived from invading nucleic acids into genomic CRISPR loci, which function as memory of previously encountered invaders. In Escherichia coli, transcripts of these loci are cleaved into small RNAs and utilized by the Cascade complex to bind invader DNA, which is then likely degraded by Cas3 during CRISPR interference. Results: We describe how a CRISPR-activated E. coli K12 is cured from a high copy number plasmid under non-selective conditions in a CRISPR-mediated way. Cured clones integrated at least one up to five anti-plasmid spacers in genomic CRISPR loci. New spacers are integrated directly downstream of the leader sequence. The spacers are non-randomly selected to target protospacers with an AAG protospacer adjacent motif, which is located directly upstream of the protospacer. A co-occurrence of PAM deviations and CRISPR repeat mutations was observed, indicating that one nucleotide from the PAM is incorporated as the last nucleotide of the repeat during integration of a new spacer. When multiple spacers were integrated in a single clone, all spacer targeted the same strand of the plasmid, implying that CRISPR interference caused by the first integrated spacer directs subsequent spacer acquisition events in a strand specific manner. Conclusions: The E. coli Type I-E CRISPR/Cas system provides resistance against bacteriophage infection, but also enables removal of residing plasmids. We established that there is a positive feedback loop between active spacers in a cluster - in our case the first acquired spacer -and spacers acquired thereafter, possibly through the use of specific DNA degradation products of the CRISPR interference machinery by the CRISPR adaptation machinery. This loop enables a rapid expansion of the spacer repertoire against an actively present DNA element that is already targeted, amplifying the CRISPR interference effect.	[Swarts, Daan C.; Mosterd, Cas; Brouns, Stan J. J.] Wageningen Univ, Dept Agrotechnol & Food Sci, Microbiol Lab, Wageningen, Netherlands	Wageningen University & Research	Swarts, DC (corresponding author), Wageningen Univ, Dept Agrotechnol & Food Sci, Microbiol Lab, Wageningen, Netherlands.	stan.brouns@wur.nl	van Passel, Mark WJ/K-5698-2012; Swarts, Daan/Z-6262-2019	Swarts, Daan/0000-0003-4412-9191; Brouns, Stan/0000-0002-9573-1724	Netherlands Organization for Scientific Research (NWO) [863.08.014, 863.08.016]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was financially supported by a Veni grant from the Netherlands Organization for Scientific Research (NWO, www.nwo.nl) to SJJB (863.08.014), MWJvP (863.08.016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Attar S, 2011, BIOL CHEM, V392, P277, DOI 10.1515/BC.2011.042; Baba Tomoya, 2008, V416, P183, DOI 10.1007/978-1-59745-321-9_12; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; CONRAD SE, 1979, P NATL ACAD SCI USA, V76, P736, DOI 10.1073/pnas.76.2.736; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; DYKHUIZEN DE, 1983, MICROBIOL REV, V47, P150, DOI 10.1128/MMBR.47.2.150-168.1983; Edgar R, 2010, J BACTERIOL, V192, P6291, DOI 10.1128/JB.00644-10; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; HALL KB, 1991, BIOCHEMISTRY-US, V30, P10606, DOI 10.1021/bi00108a002; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Howard JAL, 2011, BIOCHEM J, V439, P85, DOI 10.1042/BJ20110901; Jore MM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a003657; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Karginov FV, 2010, MOL CELL, V37, P7, DOI 10.1016/j.molcel.2009.12.033; Nam KH, 2011, J BIOL CHEM, V286, P30759, DOI 10.1074/jbc.M111.256263; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; MARTIN P, 1988, MOL MICROBIOL, V2, P615, DOI 10.1111/j.1365-2958.1988.tb00070.x; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Nurizzo D, 2003, J MOL BIOL, V327, P491, DOI 10.1016/S0022-2836(03)00121-9; Pougach K, 2010, MOL MICROBIOL, V77, P1367, DOI 10.1111/j.1365-2958.2010.07265.x; Pul U, 2010, MOL MICROBIOL, V75, P1495, DOI 10.1111/j.1365-2958.2010.07073.x; ROBERTS RW, 1992, SCIENCE, V258, P1463, DOI 10.1126/science.1279808; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008; Touchon M, 2011, J BACTERIOL, V193, P2460, DOI 10.1128/JB.01307-10; Touchon M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011126; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; van der Ploeg JR, 2009, MICROBIOL-SGM, V155, P1966, DOI 10.1099/mic.0.027508-0; Westra ER, 2010, MOL MICROBIOL, V77, P1380, DOI 10.1111/j.1365-2958.2010.07315.x; Westra ER, 2012, MOL CELL IN PRESS	37	258	285	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35888	10.1371/journal.pone.0035888	http://dx.doi.org/10.1371/journal.pone.0035888			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558257	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000076
J	Iaffaldano, P; Viterbo, RG; Paolicelli, D; Lucchese, G; Portaccio, E; Goretti, B; Direnzo, V; D'Onghia, M; Zoccolella, S; Amato, MP; Trojano, M				Iaffaldano, Pietro; Viterbo, Rosa Gemma; Paolicelli, Damiano; Lucchese, Guglielmo; Portaccio, Emilio; Goretti, Benedetta; Direnzo, Vita; D'Onghia, Mariangela; Zoccolella, Stefano; Amato, Maria Pia; Trojano, Maria			Impact of Natalizumab on Cognitive Performances and Fatigue in Relapsing Multiple Sclerosis: A Prospective, Open-Label, Two Years Observational Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; MILDLY DISABLED PATIENTS; INTERFERON BETA-1A; IMMUNOMODULATORY TREATMENT; INTELLECTUAL ENRICHMENT; BRAIN ATROPHY; IMPAIRMENT; DYSFUNCTION; DISABILITY; EFFICIENCY	Background and Objectives: Natalizumab reduces the relapse rate and magnetic resonance imaging activity in patients with Relapsing-Remitting Multiple Sclerosis (RRMS). So far the influence of natalizumab on cognitive functions and fatigue in MS remains uncertain. The aim of this prospective, open-label, observational study was to evaluate the possible effects of natalizumab on cognition and fatigue measures in RRMS patients treated for up to two years. Methods: Cognitive performances were examined by the Rao's Brief Repeatable Battery (BRB), the Stroop test (ST) and the Cognitive Impairment Index (CII), every 12 months. Patients who failed in at least 3 tests of the BRB and the ST were classified as cognitively impaired (CI). Fatigue Severity Scale (FSS) was administered every 12 months to assess patient's self-reported fatigue. One hundred and 53 patients completed 1 and 2 year-natalizumab treatment, respectively. Results: After 1 year of treatment the percentage of CI patients decreased from 29% (29/100) at baseline to 19% (19/100) (p = 0.031) and the mean baseline values of CII (13.52 +/- 6.85) and FSS (4.01 +/- 1.63) scores were significantly reduced (10.48 +/- 7.12, p < 0.0001 and 3.61 +/- 1.56, p = 0.008). These significant effects were confirmed in the subgroup of patients treated up to two years. Conclusions: These results demonstrate that a short-term NTZ treatment may significantly improve cognitive performances and fatigue in RRMS patients.	[Iaffaldano, Pietro; Viterbo, Rosa Gemma; Paolicelli, Damiano; Lucchese, Guglielmo; Direnzo, Vita; D'Onghia, Mariangela; Zoccolella, Stefano; Trojano, Maria] Univ Bari Aldo Moro, Dept Neurosci & Sense Organs, Bari, Italy; [Portaccio, Emilio; Goretti, Benedetta; Amato, Maria Pia] Univ Florence, Dept Neurol, Florence, Italy	Universita degli Studi di Bari Aldo Moro; University of Florence	Iaffaldano, P (corresponding author), Univ Bari Aldo Moro, Dept Neurosci & Sense Organs, Bari, Italy.	mtrojano@neurol.uniba.it	Amato, Maria Pia/AAC-5940-2022; Iaffaldano, Pietro/AFE-8061-2022; Lucchese, Guglielmo/AAL-9860-2020; amato, Maria Pia/AAL-5998-2020; zoccolella, stefano/AAA-2515-2020	Iaffaldano, Pietro/0000-0003-2308-1731; Lucchese, Guglielmo/0000-0002-1809-6376; amato, Maria Pia/0000-0003-3325-3760; Portaccio, Emilio/0000-0002-9662-1762; Trojano, Maria/0000-0002-6329-8946	Merck Serono; Biogen; Novartis; Biogen-Idec; Bayer Schering; Sanofi Aventis; Serono Foundation	Merck Serono(Merck & Company); Biogen(Biogen); Novartis(Novartis); Biogen-Idec(Biogen); Bayer Schering(Bayer AG); Sanofi Aventis(Sanofi-Aventis); Serono Foundation	The authors have read the journal's policy and have the following conflicts: Maria Trojano received honoraria for consultancy or speaking from Biogen, Sanofi-Aventis, Merck Serono and Bayer-Schering and research grants from Merck Serono, Biogen and Novartis; Maria Pia Amato serves on scientific advisory boards for Biogen-Idec, Merck Serono, Bayer Schering and Sanofi Aventis and receives research support and honoraria for speaking from Biogen-Idec, Merck Serono, Bayer Schering and Sanofi Aventis; Rosa Gemma Viterbo serves on scientific advisory boards for Biogen-Idec and received honoraria for speaking from Novartis and Biogen; Damiano Paolicelli received honoraria for consultancy and/or speaking from Biogen Idec, Novartis and Bayer-Schering and research grant from Serono Foundation; Emilio Portaccio serves on a scientific advisory board for Biogen Idec and receives research support and honoraria from Merck Serono, Biogen Idec, Bayer Schering, Sanofi Aventis and Novartis; Benedetta Goretti serves on scientific advisory boards for Biogen Idec and honoraria from Merck Serono, Biogen Idec and Novartis; all other authors declare that there is no conflict of interest. Natalizumab is marketed by Biogen Idec. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Amato MP, 2006, MULT SCLER, V12, P787, DOI 10.1177/1352458506070933; Amato M P, 2003, Int MS J, V10, P72; Amato MP, 2006, J NEUROL SCI, V245, P41, DOI 10.1016/j.jns.2005.08.019; Amato MP, 2001, ARCH NEUROL-CHICAGO, V58, P1602, DOI 10.1001/archneur.58.10.1602; Arnon R, 2009, J NEURAL TRANSM, V116, P1443, DOI 10.1007/s00702-009-0272-3; Bakshi R, 2003, MULT SCLER J, V9, P219, DOI 10.1191/1352458503ms904oa; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Benedict RHB, 2005, J NEUROL SCI, V231, P29, DOI 10.1016/j.jns.2004.12.009; Camp SJ, 1999, BRAIN, V122, P1341, DOI 10.1093/brain/122.7.1341; Centonze D, 2009, J NEUROSCI, V29, P3442, DOI 10.1523/JNEUROSCI.5804-08.2009; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Cohen JA, 2002, NEUROLOGY, V59, P679, DOI 10.1212/WNL.59.5.679; Fischer JS, 2000, ANN NEUROL, V48, P885, DOI 10.1002/1531-8249(200012)48:6<885::AID-ANA9>3.3.CO;2-T; Gunnarsson M, 2011, ANN NEUROL, V69, P83, DOI 10.1002/ana.22247; JOHNSON BF, 1991, PROG NEURO-PSYCHOPH, V15, P625, DOI 10.1016/0278-5846(91)90052-3; Kappos L, 2009, LANCET NEUROL, V8, P987, DOI 10.1016/S1474-4422(09)70237-6; Khademi M, 2009, EUR J NEUROL, V16, P528, DOI 10.1111/j.1468-1331.2009.02532.x; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Mandolesi G, 2010, NEUROL SCI, V31, P255, DOI 10.1007/s10072-010-0369-3; Mattioli F, 2011, NEUROL SCI, V31, pS321, DOI 10.1007/s10072-010-0351-0; Mattioli F, 2011, NEUROL SCI, V32, P83, DOI 10.1007/s10072-010-0412-4; Mellergard J, 2010, MULT SCLER J, V16, P208, DOI 10.1177/1352458509355068; Metz LM, 2004, J NEUROL NEUROSUR PS, V75, P1045, DOI 10.1136/jnnp.2002.007724; Patrick E, 2009, MULT SCLER J, V15, P258, DOI 10.1177/1352458508097466; Patti F, 2011, MULT SCLER J, V17, P991, DOI 10.1177/1352458511401943; Patti F, 2010, MULT SCLER, V16, P68, DOI 10.1177/1352458509350309; Piehl F, 2011, NEUROL SCI, V31, pS289, DOI 10.1007/s10072-010-0345-y; Pliskin NH, 1996, NEUROLOGY, V47, P1463, DOI 10.1212/WNL.47.6.1463; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Portaccio E, 2010, MULT SCLER J, V16, P611, DOI 10.1177/1352458510362818; Putzki N, 2009, J NEUROL SCI, V285, P109, DOI 10.1016/j.jns.2009.06.004; RAO SM, 1989, J CLIN EXP NEUROPSYC, V11, P471, DOI 10.1080/01688638908400907; RAO SM, 1989, J CLIN EXP NEUROPSYC, V11, P699, DOI 10.1080/01688638908400926; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Rinaldi F, 2011, NEUROL SCI, V31, pS317, DOI 10.1007/s10072-010-0346-x; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Rudick RA, 1999, ARCH NEUROL-CHICAGO, V56, P1079, DOI 10.1001/archneur.56.9.1079; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396; Rudick RA, 2007, ANN NEUROL, V62, P335, DOI 10.1002/ana.21163; Schneeweiss S, 1997, PHARMACOEPIDEM DR S, V6, pS51, DOI 10.1002/(SICI)1099-1557(199710)6:3+<S51::AID-PDS301>3.3.CO;2-J; Schwid SR, 2007, J NEUROL SCI, V255, P57, DOI 10.1016/j.jns.2007.01.070; Sumowski JF, 2010, NEUROLOGY, V74, P1942, DOI 10.1212/WNL.0b013e3181e396be; Sumowski JF, 2010, BRAIN, V133, P362, DOI 10.1093/brain/awp307; Sumowski JF, 2009, J INT NEUROPSYCH SOC, V15, P606, DOI 10.1017/S1355617709090912; Trojano M, 2009, ANN NEUROL, V66, P513, DOI 10.1002/ana.21757; Trojano M, 2007, ANN NEUROL, V61, P300, DOI 10.1002/ana.21102; Weinstein A, 1999, ARCH NEUROL-CHICAGO, V56, P319, DOI 10.1001/archneur.56.3.319; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Yildiz M, 2011, EUR NEUROL, V65, P231, DOI 10.1159/000324028; Ziemssen T, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-67	52	61	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35843	10.1371/journal.pone.0035843	http://dx.doi.org/10.1371/journal.pone.0035843			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558238	gold, Green Submitted, Green Published			2022-12-27	WOS:000305345200086
J	Lore, NI; Cigana, C; De Fino, I; Riva, C; Juhas, M; Schwager, S; Eberl, L; Bragonzi, A				Lore, Nicola Ivan; Cigana, Cristina; De Fino, Ida; Riva, Camilla; Juhas, Mario; Schwager, Stephan; Eberl, Leo; Bragonzi, Alessandra			Cystic Fibrosis-Niche Adaptation of Pseudomonas aeruginosa Reduces Virulence in Multiple Infection Hosts	PLOS ONE			English	Article							BURKHOLDERIA-CENOCEPACIA STRAINS; INNATE IMMUNITY; LASR MUTANTS; RESISTANT; PHENOTYPES; TOLERANCE; MICE	The opportunistic pathogen Pseudomonas aeruginosa is able to thrive in diverse ecological niches and to cause serious human infection. P. aeruginosa environmental strains are producing various virulence factors that are required for establishing acute infections in several host organisms; however, the P. aeruginosa phenotypic variants favour long-term persistence in the cystic fibrosis (CF) airways. Whether P. aeruginosa strains, which have adapted to the CF-niche, have lost their competitive fitness in the other environment remains to be investigated. In this paper, three P. aeruginosa clonal lineages, including early strains isolated at the onset of infection, and late strains, isolated after several years of chronic lung infection from patients with CF, were analysed in multi-host model systems of acute infection. P. aeruginosa early isolates caused lethality in the three non-mammalian hosts, namely Caenorhabditis elegans, Galleria mellonella, and Drosophila melanogaster, while late adapted clonal isolates were attenuated in acute virulence. When two different mouse genetic background strains, namely C57Bl/6NCrl and Balb/cAnNCrl, were used as acute infection models, early P. aeruginosa CF isolates were lethal, while late isolates exhibited reduced or abolished acute virulence. Severe histopathological lesions, including high leukocytes recruitment and bacterial load, were detected in the lungs of mice infected with P. aeruginosa CF early isolates, while late isolates were progressively cleared. In addition, systemic bacterial spread and invasion of epithelial cells, which were detected for P. aeruginosa CF early strains, were not observed with late strains. Our findings indicate that niche-specific selection in P. aeruginosa reduced its ability to cause acute infections across a broad range of hosts while maintaining the capacity for chronic infection in the CF host.	[Lore, Nicola Ivan; Cigana, Cristina; De Fino, Ida; Riva, Camilla; Bragonzi, Alessandra] Ist Sci San Raffaele, Div Immunol Transplantat & Infect Dis, Infect & Cyst Fibrosis Unit, I-20132 Milan, Italy; [Juhas, Mario; Schwager, Stephan; Eberl, Leo] Univ Zurich, Inst Plant Biol, Dept Microbiol, CH-8008 Zurich, Switzerland	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Zurich	Lore, NI (corresponding author), Ist Sci San Raffaele, Div Immunol Transplantat & Infect Dis, Infect & Cyst Fibrosis Unit, I-20132 Milan, Italy.	bragonzi.alessandra@hsr.it	Cigana, Cristina/D-2883-2016; Lorè, Nicola Ivan/K-9285-2016; Eberl, Leo/A-8380-2012; Riva, Camilla/AAN-3789-2020; Eberl, Leo/AAE-8165-2019; De Fino, Ida/AAN-5189-2020; Bragonzi, Alessandra/AAC-6751-2022	Cigana, Cristina/0000-0003-0436-9721; Lorè, Nicola Ivan/0000-0001-9159-1632; Eberl, Leo/0000-0002-7241-0864; De Fino, Ida/0000-0002-5747-7155; Bragonzi, Alessandra/0000-0002-5808-7669	European Commission [223670]; Italian Cystic Fibrosis Research Foundation (FFC) [20/2011]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK027651] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); Italian Cystic Fibrosis Research Foundation (FFC)(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was supported by the European Commission (http://cordis.europa.eu/fp7/dc/index.cfm) (Grant NABATIVI, EU-FP7-HEALTH-2007-B, contract number 223670) and Italian Cystic Fibrosis Research Foundation (FFC#20/2011) (http://www.fibrosicisticaricerca.it/) with the contribution of the Delegazione FFC di Bergamo Villa d'Alme, Amici della Ricerca di Milano, Latteria Montello 70 degrees compleanno nonno Armando. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apidianakis Y, 2009, NAT PROTOC, V4, P1285, DOI 10.1038/nprot.2009.124; Bernd Rehm HA, 2008, PSEUDOMONAS MODEL OR; Bianconi I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001270; Bragonzi A, 2005, J INFECT DIS, V192, P410, DOI 10.1086/431516; Bragonzi A, 2006, MICROBIOL-SGM, V152, P3261, DOI 10.1099/mic.0.29175-0; Bragonzi A, 2010, INT J MED MICROBIOL, V300, P584, DOI 10.1016/j.ijmm.2010.08.012; Bragonzi A, 2009, AM J RESP CRIT CARE, V180, P138, DOI 10.1164/rccm.200812-1943OC; Cigana C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/852513; Cigana C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008439; D'Argenio DA, 2007, MOL MICROBIOL, V64, P512, DOI 10.1111/j.1365-2958.2007.05678.x; EGAN M, 1992, NATURE, V358, P581, DOI 10.1038/358581a0; Engelmann I, 2010, ADV EXP MED BIOL, V708, P105; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Furukawa S, 2006, J BACTERIOL, V188, P1211, DOI 10.1128/JB.188.4.1211-1217.2006; Garvis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000540; Hoffman LR, 2009, J CYST FIBROS, V8, P66, DOI 10.1016/j.jcf.2008.09.006; Jain M, 2004, J CLIN MICROBIOL, V42, P5229, DOI 10.1128/JCM.42.11.5229-5237.2004; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; Mahajan-Miklos S, 2000, MOL MICROBIOL, V37, P981, DOI 10.1046/j.1365-2958.2000.02056.x; MAHENTHIRALINGAM E, 1994, INFECT IMMUN, V62, P596, DOI 10.1128/IAI.62.2.596-605.1994; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Monk AB, 2008, INFECT IMMUN, V76, P5127, DOI 10.1128/IAI.00606-08; Morissette C, 1996, INFECT IMMUN, V64, P4984, DOI 10.1128/IAI.64.12.4984-4992.1996; MORISSETTE C, 1995, INFECT IMMUN, V63, P1718, DOI 10.1128/IAI.63.5.1718-1724.1995; Mowat E, 2011, AM J RESP CRIT CARE, V183, P1674, DOI 10.1164/rccm.201009-1430OC; Nguyen D, 2006, P NATL ACAD SCI USA, V103, P8305, DOI 10.1073/pnas.0602526103; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Pirone L, 2008, ENVIRON MICROBIOL, V10, P2773, DOI 10.1111/j.1462-2920.2008.01697.x; Raberg L, 2009, PHILOS T R SOC B, V364, P37, DOI 10.1098/rstb.2008.0184; Read AF, 2008, PLOS BIOL, V6, P2638, DOI 10.1371/journal.pbio.1000004; Sapru K, 1999, CLIN EXP IMMUNOL, V115, P103; Sarkar K, 2009, P NATL ACAD SCI USA, V106, P18769, DOI 10.1073/pnas.0910561106; Schwab U, 2002, INFECT IMMUN, V70, P4547, DOI 10.1128/IAI.70.8.4547-4555.2002; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Tam M, 1999, AM J RESP CELL MOL, V20, P710, DOI 10.1165/ajrcmb.20.4.3223; Uehlinger S, 2009, INFECT IMMUN, V77, P4102, DOI 10.1128/IAI.00398-09; Wiehlmann L, 2007, P NATL ACAD SCI USA, V104, P8101, DOI 10.1073/pnas.0609213104; ZEITLIN PL, 1991, AM J RESP CELL MOL, V4, P313, DOI 10.1165/ajrcmb/4.4.313	40	81	82	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35648	10.1371/journal.pone.0035648	http://dx.doi.org/10.1371/journal.pone.0035648			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558188	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000305345200060
J	Ma, XX; Hamadeh, MJ; Christie, BR; Foster, JA; Tarnopolsky, MA				Ma, Xiaoxing; Hamadeh, Mazen J.; Christie, Brain R.; Foster, Jane A.; Tarnopolsky, Mark A.			Impact of Treadmill Running and Sex on Hippocampal Neurogenesis in the Mouse Model of Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; PROGENITOR-CELL PROLIFERATION; CU/ZN SUPEROXIDE-DISMUTASE; GONADAL HORMONE MODULATION; INCREASED OXIDATIVE DAMAGE; MOTOR-NEURON DEGENERATION; HUMAN SPINAL-CORD; NEUROTROPHIC FACTOR; DENTATE GYRUS; TRANSGENIC MICE	Hippocampal neurogenesis in the subgranular zone (SGZ) of dentate gyrus (DG) occurs throughout life and is regulated by pathological and physiological processes. The role of oxidative stress in hippocampal neurogenesis and its response to exercise or neurodegenerative diseases remains controversial. The present study was designed to investigate the impact of oxidative stress, treadmill exercise and sex on hippocampal neurogenesis in a murine model of heightened oxidative stress (G93A mice). G93A and wild type (WT) mice were randomized to a treadmill running (EX) or a sedentary (SED) group for 1 or 4 wk. Immunohistochemistry was used to detect bromodeoxyuridine (BrdU) labeled proliferating cells, surviving cells, and their phenotype, as well as for determination of oxidative stress (3-NT; 8-OHdG). BDNF and IGF1 mRNA expression was assessed by in situ hybridization. Results showed that: (1) G93A-SED mice had greater hippocampal neurogenesis, BDNF mRNA, and 3-NT, as compared to WT-SED mice. (2) Treadmill running promoted hippocampal neurogenesis and BDNF mRNA content and lowered DNA oxidative damage (8-OHdG) in WT mice. (3) Male G93A mice showed significantly higher cell proliferation but a lower level of survival vs. female G93A mice. We conclude that G93A mice show higher hippocampal neurogenesis, in association with higher BDNF expression, yet running did not further enhance these phenomena in G93A mice, probably due to a 'ceiling effect' of an already heightened basal levels of hippocampal neurogenesis and BDNF expression.	[Ma, Xiaoxing; Tarnopolsky, Mark A.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Hamadeh, Mazen J.; Tarnopolsky, Mark A.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada; [Hamadeh, Mazen J.] York Univ, Toronto, ON M3J 2R7, Canada; [Christie, Brain R.] Univ Victoria, Victoria, BC, Canada; [Foster, Jane A.] McMaster Univ, Brain Body Inst, Dept Psychiat & Behav Neurosci, St Josephs Healthcare, Hamilton, ON, Canada	McMaster University; McMaster University; York University - Canada; University of Victoria; McMaster University	Ma, XX (corresponding author), McMaster Univ, Dept Med, Hamilton, ON, Canada.	tarnopol@mcmaster.ca	Foster, Jane/AAW-7163-2021; Christie, Brian Ross/AAF-3766-2019	Christie, Brian Ross/0000-0002-6830-0160; Hamadeh, Mazen/0000-0002-3511-4345	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by the Natural Sciences and Engineering Research Council of Canada. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1997, NEUROL RES, V19, P124; Aberg MAI, 2000, J NEUROSCI, V20, P2896; Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; ADEM A, 1994, J NEURAL TRANSM-GEN, V97, P73, DOI 10.1007/BF01277964; Adlard PA, 2004, NEUROSCIENCE, V124, P985, DOI 10.1016/j.neuroscience.2003.12.039; Adlard PA, 2005, J NEUROSCI, V25, P4217, DOI 10.1523/JNEUROSCI.0496-05.2005; Aguirre N, 2005, FREE RADICAL RES, V39, P383, DOI 10.1080/10715760400027979; Anderson MF, 2002, DEV BRAIN RES, V134, P115; Andrus PK, 1998, J NEUROCHEM, V71, P2041; Babyak M, 2000, PSYCHOSOM MED, V62, P633, DOI 10.1097/00006842-200009000-00006; Barber SC, 2006, BBA-MOL BASIS DIS, V1762, P1051, DOI 10.1016/j.bbadis.2006.03.008; Beal MF, 1997, ANN NEUROL, V42, P644, DOI 10.1002/ana.410420416; Berchtold NC, 2001, EUR J NEUROSCI, V14, P1992, DOI 10.1046/j.0953-816x.2001.01825.x; Biebl M, 2000, NEUROSCI LETT, V291, P17, DOI 10.1016/S0304-3940(00)01368-9; Bjornebekk A, 2005, INT J NEUROPSYCHOPH, V8, P357, DOI 10.1017/S1461145705005122; Bondy CA, 2004, EUR J PHARMACOL, V490, P25, DOI 10.1016/j.ejphar.2004.02.042; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Carro E, 2000, J NEUROSCI, V20, P2926; Cechetti F, 2008, BRAIN RES, V1188, P182, DOI 10.1016/j.brainres.2007.10.012; Cha CI, 2000, BRAIN RES, V853, P156, DOI 10.1016/S0006-8993(99)02302-1; Chan JP, 2008, MOL CELL NEUROSCI, V39, P372, DOI 10.1016/j.mcn.2008.07.017; Cheng AW, 2003, DEV BIOL, V258, P319, DOI 10.1016/S0012-1606(03)00120-9; Chi LY, 2006, STEM CELLS, V24, P34, DOI 10.1634/stemcells.2005-0076; CHIO A, 1991, NEUROEPIDEMIOLOGY, V10, P174, DOI 10.1159/000110267; Chung YH, 2005, BRAIN RES, V1050, P203, DOI 10.1016/j.brainres.2005.05.060; Chung YH, 2004, BRAIN RES, V1016, P272, DOI 10.1016/j.brainres.2004.05.040; Chung YH, 2004, BRAIN RES, V1003, P199, DOI 10.1016/j.brainres.2004.01.010; Chung YH, 2003, BRAIN RES, V990, P215, DOI 10.1016/S0006-8993(03)03457-7; Chung YH, 2003, BRAIN RES, V994, P253, DOI 10.1016/j.brainres.2003.09.047; Chung YH, 2003, BRAIN RES, V967, P226, DOI 10.1016/S0006-8993(03)02238-8; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Crews FT, 2004, ALCOHOL, V33, P63, DOI 10.1016/j.alcohol.2004.04.005; Czlonkowska A, 2006, ENDOCRINE, V29, P243, DOI 10.1385/ENDO:29:2:243; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; Donovan MH, 2006, J COMP NEUROL, V495, P70, DOI 10.1002/cne.20840; Eadie BD, 2005, J COMP NEUROL, V486, P39, DOI 10.1002/cne.20493; Farmer J, 2004, NEUROSCIENCE, V124, P71, DOI 10.1016/j.neuroscience.2003.09.029; Ferrante RJ, 1997, ANN NEUROL, V42, P326, DOI 10.1002/ana.410420309; Ferrante RJ, 1997, J NEUROCHEM, V69, P2064; Foster JA, 2004, J COMP NEUROL, V476, P91, DOI 10.1002/cne.20197; Galea LAM, 2006, HIPPOCAMPUS, V16, P225, DOI 10.1002/hipo.20154; Galea LAM, 1999, NEUROSCIENCE, V89, P955, DOI 10.1016/S0306-4522(98)00345-5; Galea LAM, 2008, BRAIN RES REV, V57, P332, DOI 10.1016/j.brainresrev.2007.05.008; Garza AA, 2004, PHARMACOL BIOCHEM BE, V77, P209, DOI 10.1016/j.pbb.2003.10.020; Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235; Guan YJ, 2007, J NEUROCHEM, V102, P1125, DOI 10.1111/j.1471-4159.2007.04610.x; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hall ED, 1998, J NEUROSCI RES, V53, P66, DOI 10.1002/(SICI)1097-4547(19980701)53:1<66::AID-JNR7>3.3.CO;2-K; Hauser T, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-43; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Holmes MM, 2004, J NEUROSCI RES, V76, P216, DOI 10.1002/jnr.20039; INCE PG, 1994, NEUROSCI LETT, V182, P87, DOI 10.1016/0304-3940(94)90213-5; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; Johnson RA, 2003, BRAIN RES, V983, P108, DOI 10.1016/S0006-8993(03)03039-7; Kempermann G, 1999, SCI AM, V280, P48, DOI 10.1038/scientificamerican0599-48; Kim H, 2007, INT J DEV NEUROSCI, V25, P243, DOI 10.1016/j.ijdevneu.2007.03.003; Kim SH, 2004, NEUROLOGY, V62, P319, DOI 10.1212/01.WNL.0000103291.04985.DC; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Kohl Z, 2007, BRAIN RES, V1155, P24, DOI 10.1016/j.brainres.2007.04.039; Kronenberg G, 2006, NEUROBIOL AGING, V27, P1505, DOI 10.1016/j.neurobiolaging.2005.09.016; Kust BM, 2002, EXP NEUROL, V177, P419, DOI 10.1006/exnr.2002.8011; Lagace DC, 2007, HIPPOCAMPUS, V17, P175, DOI 10.1002/hipo.20265; Leasure JL, 2009, HIPPOCAMPUS; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Linnarsson S, 2000, MOL BRAIN RES, V75, P61, DOI 10.1016/S0169-328X(99)00295-8; Liu RG, 1998, ANN NEUROL, V44, P763, DOI 10.1002/ana.410440510; Liu ZP, 2006, J COMP NEUROL, V497, P468, DOI 10.1002/cne.21012; LLorens-Martin M, 2009, NEUROSCIENTIST, V15, P134, DOI 10.1177/1073858408331371; Mahoney DJ, 2004, MUSCLE NERVE, V29, P656, DOI 10.1002/mus.20004; Mahoney DJ, 2006, MUSCLE NERVE, V33, P809, DOI 10.1002/mus.20542; MATTSON MP, 1995, J NEUROCHEM, V65, P1740; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Minowa O, 2000, P NATL ACAD SCI USA, V97, P4156, DOI 10.1073/pnas.050404497; Naylor AS, 2008, P NATL ACAD SCI USA, V105, P14632, DOI 10.1073/pnas.0711128105; Naylor AS, 2005, J NEUROPHYSIOL, V93, P2406, DOI 10.1152/jn.01085.2004; Offen D, 2009, J MOL NEUROSCI, V38, P85, DOI 10.1007/s12031-007-9004-z; Oliff HS, 1998, MOL BRAIN RES, V61, P147, DOI 10.1016/S0169-328X(98)00222-8; Ormerod BK, 2001, NEUROSCIENCE, V102, P369, DOI 10.1016/S0306-4522(00)00474-7; Ozkaya YG, 2002, DIABETES METAB, V28, P377; Parise G, 2005, FREE RADICAL BIO MED, V39, P289, DOI 10.1016/j.freeradbiomed.2005.03.024; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Perluigi M, 2005, FREE RADICAL BIO MED, V38, P960, DOI 10.1016/j.freeradbiomed.2004.12.021; Popken GJ, 1997, J COMP NEUROL, V386, P8; POWERS SK, 1994, AM J PHYSIOL, V266, pR375, DOI 10.1152/ajpregu.1994.266.2.R375; Przedborski S, 1996, ANN NEUROL, V39, P158, DOI 10.1002/ana.410390204; Radak Z, 2001, NEUROCHEM INT, V38, P17, DOI 10.1016/S0197-0186(00)00063-2; Radak Z, 2001, EXERC IMMUNOL REV, V7, P90; Radak Z, 1999, FREE RADICAL BIO MED, V27, P69, DOI 10.1016/S0891-5849(99)00038-6; Radak Z, 2006, NEUROCHEM INT, V49, P387, DOI 10.1016/j.neuint.2006.02.004; REINHARDT RR, 1994, ENDOCRINOLOGY, V135, P1753, DOI 10.1210/en.135.5.1753; Russo-Neustadt A, 1999, NEUROPSYCHOPHARMACOL, V21, P679, DOI 10.1016/S0893-133X(99)00059-7; Sairanen M, 2005, J NEUROSCI, V25, P1089, DOI 10.1523/JNEUROSCI.3741-04.2005; Shaw PJ, 1997, J NEUROL SCI, V147, P115, DOI 10.1016/S0022-510X(96)05316-6; Simpson EP, 2003, CURR OPIN RHEUMATOL, V15, P730, DOI 10.1097/00002281-200311000-00008; SOMANI SM, 1995, PHARMACOL BIOCHEM BE, V50, P635, DOI 10.1016/0091-3057(94)00357-2; Spalloni A, 2006, EXP NEUROL, V197, P505, DOI 10.1016/j.expneurol.2005.10.014; Stranahan AM, 2006, NAT NEUROSCI, V9, P526, DOI 10.1038/nn1668; Suh H, 2009, ANN REV CELL DEV BIO; Tanapat P, 1999, J NEUROSCI, V19, P5792, DOI 10.1523/JNEUROSCI.19-14-05792.1999; Toldy A, 2005, BRAIN RES BULL, V65, P487, DOI 10.1016/j.brainresbull.2005.02.028; Trejo JL, 2001, J NEUROSCI, V21, P1628, DOI 10.1523/JNEUROSCI.21-05-01628.2001; Uda M, 2006, BRAIN RES, V1104, P64, DOI 10.1016/j.brainres.2006.05.066; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2009, EXERCISE BRAIN SOMET; van Praag H, 2008, NEUROMOL MED, V10, P128, DOI 10.1007/s12017-008-8028-z; Veldink JH, 2003, NEUROMUSCULAR DISORD, V13, P737, DOI 10.1016/S0960-8966(03)00104-4; Wang H, 2006, J NEUROCHEM, V96, P694, DOI 10.1111/j.1471-4159.2005.03572.x; Warita H, 2001, MOL BRAIN RES, V89, P147, DOI 10.1016/S0169-328X(01)00029-8; Wolf SA, 2006, BIOL PSYCHIAT, V60, P1314, DOI 10.1016/j.biopsych.2006.04.004; Zheng WH, 2000, ADV RES NEURODEGENER, V8, P261	115	21	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e36048	10.1371/journal.pone.0036048	http://dx.doi.org/10.1371/journal.pone.0036048			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558322	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345200113
J	Yang, Y; Li, XW; Zhang, ZH; Qian, HZ; Ruan, YH; Zhou, F; Gao, C; Li, MF; Jin, Q; Gao, L				Yang, Yu; Li, Xiangwei; Zhang, Zhihui; Qian, Han-Zhu; Ruan, Yuhua; Zhou, Feng; Gao, Cong; Li, Mufei; Jin, Qi; Gao, Lei			Association of Human Papillomavirus Infection and Abnormal Anal Cytology among HIV-Infected MSM in Beijing, China	PLOS ONE			English	Article							SQUAMOUS INTRAEPITHELIAL LESIONS; ACTIVE ANTIRETROVIRAL THERAPY; POSITIVE MEN; RISK-FACTORS; CANCER; SEX; PREVALENCE; NEOPLASIA; COHORT; AIDS	Background: In the recent years, dramatic increases in HIV transmission among men who have sex with men (MSM) have been observed in China. Human papillomavirus (HPV) infection related anal cancer is more common among HIV-infected MSM as compared to the general population. However, HPV infection and anal cytology has been rarely studied in HIV-infected MSM in China. Methods: HIV-infected MSM in Beijing, China were invited to participate in this study between January and April 2011. Anal swabs were collected for examining cytology and HPV genotypes. Results: Ninety-five eligible participants with complete questionnaire and laboratory data were included in the analyses. Thirty six of them (37.9%) showed abnormal anal cytology as follows: atypical squamous cells of undetermined significance (ASC-US) in 19 (20.0%), atypical squamous cells but cannot exclude HSIL (ASC-H) in 1 (1.1%), low-grade squamous intraepithelial lesion (LSIL) in 15 (15.8%), and high-grade squamous intraepithelial lesion (HSIL) in 1 (1.1%). HPV6 (20.0%), HPV16 (10.9%), HPV56 (10.9%), HPV52 (9.1%) and HPV39 (9.1%) were observed most frequently among those with normal anal cytology, while different distribution was found in the ones with abnormal anal cytology as HPV6 (19.4%), HPV16 (19.4%), HPV45 (16.7%), HPV52 (16.7%) and HPV18 (11.1%). In addition, HPV16, HPV45, HPV52 and HPV18 were the most frequent high-risk types in patients with abnormal anal cytology. HPV multiplicity was found to be significantly related to the prevalence of abnormal anal cytology (p for trend = 0.04). Conclusions: High prevalence of HPV infection and abnormal anal cytology was observed among HIV-infected MSM in China. Infection of multiple HPV types or high-risk types was found to be associated with an increased risk of abnormal anal cytology.	[Yang, Yu; Li, Xiangwei; Zhou, Feng; Gao, Cong; Li, Mufei; Jin, Qi; Gao, Lei] Chinese Acad Med Sci, MOH Key Lab Syst Biol Pathogens, Inst Pathogen Biol, Beijing 100730, Peoples R China; [Yang, Yu; Li, Xiangwei; Zhang, Zhihui; Zhou, Feng; Gao, Cong; Li, Mufei; Jin, Qi; Gao, Lei] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhang, Zhihui] Chinese Acad Med Sci, Hosp Canc, Beijing 100730, Peoples R China; [Qian, Han-Zhu] Vanderbilt Univ, Sch Med, Vanderbilt Inst Global Hlth, Nashville, TN 37212 USA; [Qian, Han-Zhu] Vanderbilt Univ, Sch Med, Div Epidemiol, Nashville, TN 37212 USA; [Ruan, Yuhua] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Vanderbilt University; Vanderbilt University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Yang, Y (corresponding author), Chinese Acad Med Sci, MOH Key Lab Syst Biol Pathogens, Inst Pathogen Biol, Beijing 100730, Peoples R China.	jinqi@ipbcams.ac.cn; gaolei@ipbcams.ac.cn	zhang, zh/GWV-4677-2022	Yang, Yu/0000-0002-5611-8951	National Natural Sciences Foundation of China [81001272]; Vanderbilt University Clinical & Translational Research Scholar (VCTRS) Program	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Vanderbilt University Clinical & Translational Research Scholar (VCTRS) Program	The work was partly supported by National Natural Sciences Foundation of China (Grant No: 81001272) and Vanderbilt University Clinical & Translational Research Scholar (VCTRS) Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A, 2010, ONCOLOGY-NY, V24, P364; Chaturvedi AK, 2009, JNCI-J NATL CANCER I, V101, P1120, DOI 10.1093/jnci/djp205; Chin-Hong PV, 2004, J INFECT DIS, V190, P2070, DOI 10.1086/425906; Cress RD, 2003, PREV MED, V36, P555, DOI 10.1016/S0091-7435(03)00013-6; de Pokomandy A, 2011, CLIN INFECT DIS, V52, P1174, DOI 10.1093/cid/cir064; de Pokomandy A, 2009, J INFECT DIS, V199, P965, DOI 10.1086/597207; De Vuyst H, 2009, INT J CANCER, V124, P1626, DOI 10.1002/ijc.24116; Diamond C, 2005, SEX TRANSM DIS, V32, P314, DOI 10.1097/01.olq.0000162366.60245.02; Fox P, 2009, CURR OPIN HIV AIDS, V4, P64, DOI 10.1097/COH.0b013e32831a6fe0; Frisch M, 2003, AM J EPIDEMIOL, V157, P966, DOI 10.1093/aje/kwg067; Gao L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015256; Goedert JJ, 1998, LANCET, V351, P1833, DOI 10.1016/S0140-6736(97)09028-4; Ho KS, 2010, CURR OPIN INFECT DIS, V23, P21, DOI 10.1097/QCO.0b013e328334fe5a; Hoots BE, 2009, INT J CANCER, V124, P2375, DOI 10.1002/ijc.24215; Jay N, 1997, DIS COLON RECTUM, V40, P919, DOI 10.1007/BF02051199; Kreuter A, 2009, CURR OPIN INFECT DIS, V22, P109, DOI 10.1097/QCO.0b013e3283229fc8; Lam JMC, 2011, AIDS, V25, P635, DOI 10.1097/QAD.0b013e3283434594; Li AH, 2009, SEX TRANSM INFECT, V85, P503, DOI 10.1136/sti.2009.036707; Palefsky JM, 2005, AIDS, V19, P1407, DOI 10.1097/01.aids.0000181012.62385.4a; PALEFSKY JM, 1994, J ACQ IMMUN DEF SYND, V7, P599; Palefsky JM, 1998, AIDS, V12, P495, DOI 10.1097/00002030-199805000-00011; Palefsky JM, 2001, J ACQ IMMUN DEF SYND, V28, P422, DOI 10.1097/00042560-200112150-00003; PALEFSKY JM, 1991, CANCER RES, V51, P1014; Palefsky JM, 1998, J INFECT DIS, V177, P361, DOI 10.1086/514194; Palefsky JM, 2009, OBSTET GYN CLIN N AM, V36, P187, DOI 10.1016/j.ogc.2009.02.003; Panther LA, 2004, CLIN INFECT DIS, V38, P1495; Parisi SG, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-150; Park Ina U, 2010, Curr Infect Dis Rep, V12, P126, DOI 10.1007/s11908-010-0090-7; Piketty C, 2008, AIDS, V22, P1203, DOI 10.1097/QAD.0b013e3283023f78; Salit IE, 2010, AIDS, V24, P1307, DOI 10.1097/QAD.0b013e328339e592; Shah KV, 1997, NEW ENGL J MED, V337, P1386, DOI 10.1056/NEJM199711063371911; Silling S, 2012, J CLIN VIROL; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Vajdic CM, 2009, SEX TRANSM INFECT, V85, P330, DOI 10.1136/sti.2008.034744; van der Snoek EM, 2003, SEX TRANSM DIS, V30, P639, DOI 10.1097/01.OLQ.0000079520.04451.59; Wang N, 2010, INT J EPIDEMIOL, V39, pII21, DOI 10.1093/ije/dyq209	36	25	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35983	10.1371/journal.pone.0035983	http://dx.doi.org/10.1371/journal.pone.0035983			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558293	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345200102
J	Bodilis, J; Nsigue-Meilo, S; Besaury, L; Quillet, L				Bodilis, Josselin; Nsigue-Meilo, Sandrine; Besaury, Ludovic; Quillet, Laurent			Variable Copy Number, Intra-Genomic Heterogeneities and Lateral Transfers of the 16S rRNA Gene in Pseudomonas	PLOS ONE			English	Article							MULTILOCUS SEQUENCE-ANALYSIS; DISTINCT TYPES; PHYLOGENY; OPERONS; FLUORESCENS; DIVERSITY; BACTERIA; SIZE; IDENTIFICATION; RHIZOSPHERE	Even though the 16S rRNA gene is the most commonly used taxonomic marker in microbial ecology, its poor resolution is still not fully understood at the intra-genus level. In this work, the number of rRNA gene operons, intra-genomic heterogeneities and lateral transfers were investigated at a fine-scale resolution, throughout the Pseudomonas genus. In addition to nineteen sequenced Pseudomonas strains, we determined the 16S rRNA copy number in four other Pseudomonas strains by Southern hybridization and Pulsed-Field Gel Electrophoresis, and studied the intra-genomic heterogeneities by Denaturing Gradient Gel Electrophoresis and sequencing. Although the variable copy number (from four to seven) seems to be correlated with the evolutionary distance, some close strains in the P. fluorescens lineage showed a different number of 16S rRNA genes, whereas all the strains in the P. aeruginosa lineage displayed the same number of genes (four copies). Further study of the intra-genomic heterogeneities revealed that most of the Pseudomonas strains (15 out of 19 strains) had at least two different 16S rRNA alleles. A great difference (5 or 19 nucleotides, essentially grouped near the V1 hypervariable region) was observed only in two sequenced strains. In one of our strains studied (MFY30 strain), we found a difference of 12 nucleotides (grouped in the V3 hypervariable region) between copies of the 16S rRNA gene. Finally, occurrence of partial lateral transfers of the 16S rRNA gene was further investigated in 1803 full-length sequences of Pseudomonas available in the databases. Remarkably, we found that the two most variable regions (the V1 and V3 hypervariable regions) had probably been laterally transferred from another evolutionary distant Pseudomonas strain for at least 48.3 and 41.6% of the 16S rRNA sequences, respectively. In conclusion, we strongly recommend removing these regions of the 16S rRNA gene during the intra-genus diversity studies.	[Bodilis, Josselin; Nsigue-Meilo, Sandrine; Besaury, Ludovic; Quillet, Laurent] Univ Rouen, Lab M2C, UMR CNRS 6143, Mont St Aignan, France	Universite de Rouen Normandie	Bodilis, J (corresponding author), Univ Rouen, Lab M2C, UMR CNRS 6143, Mont St Aignan, France.	josselin.bodilis@univ-rouen.fr		BESAURY, Ludovic/0000-0002-1463-1239	GRR VATA 'Vegetal, Agronomie et transformation des Agroressources' de la Region de Haute Normandie	GRR VATA 'Vegetal, Agronomie et transformation des Agroressources' de la Region de Haute Normandie	This research was supported by the GRR VATA 'Vegetal, Agronomie et transformation des Agroressources' de la Region de Haute Normandie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; ANDERSSON SGE, 1995, J BACTERIOL, V177, P4171, DOI 10.1128/jb.177.14.4171-4175.1995; Anzai Y, 1997, INT J SYST BACTERIOL, V47, P249, DOI 10.1099/00207713-47-2-249; Anzai Y, 2000, INT J SYST EVOL MICR, V50, P1563, DOI 10.1099/00207713-50-4-1563; BENTLEY RW, 1995, FEMS IMMUNOL MED MIC, V12, P1; BERCOVIER H, 1986, BIOCHEM BIOPH RES CO, V136, P1136, DOI 10.1016/0006-291X(86)90452-3; Binnerup SJ, 2001, FEMS MICROBIOL ECOL, V37, P231, DOI 10.1111/j.1574-6941.2001.tb00870.x; Bodilis J, 2004, SYST APPL MICROBIOL, V27, P93, DOI 10.1078/0723-2020-00253; Bodilis J, 2011, MOL BIOL EVOL, V28, P2723, DOI 10.1093/molbev/msr099; Candela M, 2004, LETT APPL MICROBIOL, V38, P229, DOI 10.1111/j.1472-765X.2003.01475.x; Case RJ, 2007, APPL ENVIRON MICROB, V73, P278, DOI 10.1128/AEM.01177-06; CHEN HW, 1990, J BACTERIOL, V172, P4206, DOI 10.1128/jb.172.8.4206-4213.1990; Christen R, 2008, MICROBES ENVIRON, V23, P253, DOI 10.1264/jsme2.ME08525; Daubin V, 2003, SCIENCE, V301, P829, DOI 10.1126/science.1086568; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fogel GB, 1999, MICROB ECOL, V38, P93, DOI 10.1007/s002489900162; Frapolli M, 2007, ENVIRON MICROBIOL, V9, P1939, DOI 10.1111/j.1462-2920.2007.01310.x; Gonzalez-Escalona N, 2005, FEMS MICROBIOL LETT, V246, P213, DOI 10.1016/j.femsle.2005.04.009; GUGI B, 1991, J BACTERIOL, V173, P3814; Hashimoto JQ, 2003, J BACTERIOL, V185, P966, DOI 10.1128/JB.185.3.966-972.2003; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Jeraldo P, 2011, ENVIRON MICROBIOL, V13, P3000, DOI 10.1111/j.1462-2920.2011.02577.x; Johansen T, 1996, FEMS MICROBIOL LETT, V136, P325, DOI 10.1016/0378-1097(96)00031-6; Kampfer P, 2011, ENV MICROBIOL   1031; Kiewitz C, 2000, J BACTERIOL, V182, P3125, DOI 10.1128/JB.182.11.3125-3135.2000; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lee C, 2008, APPL MICROBIOL BIOT, V78, P371, DOI 10.1007/s00253-007-1300-6; Liao DQ, 2000, J MOL EVOL, V51, P305, DOI 10.1007/s002390010093; Lopez-Lopez A, 2007, J MOL EVOL, V65, P687, DOI 10.1007/s00239-007-9047-3; Mattatall NR, 1996, J BACTERIOL, V178, P5323, DOI 10.1128/jb.178.17.5323-5326.1996; Michon AL, 2010, MICROBIOL-SGM, V156, P2080, DOI 10.1099/mic.0.038224-0; Moore ERB, 1996, SYST APPL MICROBIOL, V19, P478, DOI 10.1016/S0723-2020(96)80021-X; Mulet M, 2010, ENVIRON MICROBIOL, V12, P1513, DOI 10.1111/j.1462-2920.2010.02181.x; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; MYLVAGANAM S, 1992, GENETICS, V130, P399; NEEFS JM, 1993, NUCLEIC ACIDS RES, V21, P3025, DOI 10.1093/nar/21.13.3025; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Niepceron M, 2010, FEMS MICROBIOL ECOL, V71, P137, DOI 10.1111/j.1574-6941.2009.00788.x; Ortet P, 2011, J BACTERIOL, V193, P3146, DOI 10.1128/JB.00411-11; Pascual J, 2010, INT J SYST EVOL MICR, V60, P154, DOI 10.1099/ijs.0.010702-0; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; Pei AY, 2010, APPL ENVIRON MICROB, V76, P3886, DOI 10.1128/AEM.02953-09; Rainey FA, 1996, MICROBIOL-UK, V142, P2087, DOI 10.1099/13500872-142-8-2087; Ramos-Gonzalez MI, 1998, J BACTERIOL, V180, P3421; Sarkar SF, 2006, GENETICS, V174, P1041, DOI 10.1534/genetics.106.060996; Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51; Smit S, 2007, NUCLEIC ACIDS RES, V35, P3339, DOI 10.1093/nar/gkm101; Smith LM, 1999, ENVIRON MICROBIOL, V1, P495, DOI 10.1046/j.1462-2920.1999.00067.x; Spiers AJ, 2000, MICROBIOL-SGM, V146, P2345, DOI 10.1099/00221287-146-10-2345; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stevenson BS, 2004, APPL ENVIRON MICROB, V70, P6670, DOI 10.1128/AEM.70.11.6670-6677.2004; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tayeb LA, 2005, RES MICROBIOL, V156, P763, DOI 10.1016/j.resmic.2005.02.009; Tsakris A, 2007, J ANTIMICROB CHEMOTH, V60, P649, DOI 10.1093/jac/dkm246; Turmel M, 1997, NUCLEIC ACIDS RES, V25, P2610, DOI 10.1093/nar/25.13.2610; VANELSAS JD, 1988, FEMS MICROBIOL ECOL, V53, P299, DOI 10.1016/0378-1097(88)90487-9; Wang Y, 1997, J BACTERIOL, V179, P3270, DOI 10.1128/jb.179.10.3270-3276.1997; Yamamoto S, 2000, MICROBIOL-SGM, V146, P2385, DOI 10.1099/00221287-146-10-2385; Yap WH, 1999, J BACTERIOL, V181, P5201, DOI 10.1128/JB.181.17.5201-5209.1999	63	34	39	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35647	10.1371/journal.pone.0035647	http://dx.doi.org/10.1371/journal.pone.0035647			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545126	gold, Green Submitted, Green Published			2022-12-27	WOS:000305343200046
J	Hyenne, V; Tremblay-Boudreault, T; Velmurugan, R; Grant, BD; Loerke, D; Labbe, JC				Hyenne, Vincent; Tremblay-Boudreault, Thierry; Velmurugan, Ramraj; Grant, Barth D.; Loerke, Dinah; Labbe, Jean-Claude			RAB-5 Controls the Cortical Organization and Dynamics of PAR Proteins to Maintain C. elegans Early Embryonic Polarity	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; POLARIZATION; TRAFFICKING; DROSOPHILA; ESTABLISHMENT; MAINTENANCE; MATURATION; ENDOSOMES; ASYMMETRY; ROLES	In all organisms, cell polarity is fundamental for most aspects of cell physiology. In many species and cell types, it is controlled by the evolutionarily conserved PAR-3, PAR-6 and aPKC proteins, which are asymmetrically localized at the cell cortex where they define specific domains. While PAR proteins define the antero-posterior axis of the early C. elegans embryo, the mechanism controlling their asymmetric localization is not fully understood. Here we studied the role of endocytic regulators in embryonic polarization and asymmetric division. We found that depleting the early endosome regulator RAB-5 results in polarity-related phenotypes in the early embryo. Using Total Internal Reflection Fluorescence (TIRF) microscopy, we observed that PAR-6 is localized at the cell cortex in highly dynamic puncta and depleting RAB-5 decreased PAR-6 cortical dynamics during the polarity maintenance phase. Depletion of RAB-5 also increased PAR-6 association with clathrin heavy chain (CHC-1) and this increase depended on the presence of the GTPase dynamin, an upstream regulator of endocytosis. Interestingly, further analysis indicated that loss of RAB-5 leads to a disorganization of the actin cytoskeleton and that this occurs independently of dynamin activity. Our results indicate that RAB-5 promotes C. elegans embryonic polarity in both dynamin-dependent and -independent manners, by controlling PAR-6 localization and cortical dynamics through the regulation of its association with the cell cortex and the organization of the actin cytoskeleton.	[Hyenne, Vincent; Tremblay-Boudreault, Thierry; Velmurugan, Ramraj; Labbe, Jean-Claude] Univ Montreal, IRIC, Montreal, PQ, Canada; [Labbe, Jean-Claude] Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ, Canada; [Grant, Barth D.] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA; [Loerke, Dinah] Univ Denver, Dept Phys & Astron, Denver, CO USA	Universite de Montreal; Universite de Montreal; Rutgers State University New Brunswick; University of Denver	Hyenne, V (corresponding author), Univ Montreal, IRIC, Montreal, PQ, Canada.	worm.machine@gmail.com	Hyenne, Vincent/AAW-8244-2020; Hyenne, Vincent/F-7716-2013	Loerke, Dinah/0000-0002-2068-0408; Grant, Barth/0000-0002-5943-8336; Labbe, Jean-Claude/0000-0003-0520-4566; Hyenne, Vincent/0000-0002-1254-2814	Canadian Center of Excellence in Commercialization and Research (CECR); Canada Foundation for Innovation (CFI); Fonds de Recherche en Sante du Quebec (FRSQ); Research Fellow of the Terry Fox Foundation through an award from the National Cancer Institute of Canada; National Institutes of Health (NIH) [GM067237]; Canadian Cancer Society [019378]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067237] Funding Source: NIH RePORTER	Canadian Center of Excellence in Commercialization and Research (CECR); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Fonds de Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Research Fellow of the Terry Fox Foundation through an award from the National Cancer Institute of Canada; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Cancer Society(Canadian Cancer Society (CCS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Institute of Research in Immunology and Cancer is supported in part by the Canadian Center of Excellence in Commercialization and Research (CECR, http://www.nce-rce.gc.ca/ReportsPublications-RapportsPublications/CECR/Program-Guide-Programme_eng.asp), the Canada Foundation for Innovation (CFI, http://www.innovation.ca/en), and the Fonds de Recherche en Sante du Quebec (FRSQ, http://www.frsq.gouv.qc.ca/fr/index.shtml). V. H. was a Research Fellow of the Terry Fox Foundation through an award from the National Cancer Institute of Canada (http://www.terryfox.org). B. D. G. was supported by National Institutes of Health (NIH) grant GM067237 (http://www.nih.gov). This work was supported by grant #019378 from the Canadian Cancer Society (http://www.cancer.ca/Research.aspx) to J.-C.L., who holds the Canada Research Chair in Cell Division and Differentiation (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000493; Audhya A, 2007, J CELL BIOL, V178, P43, DOI 10.1083/jcb.200701139; Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; Beatty A, 2010, DEVELOPMENT, V137, P3995, DOI 10.1242/dev.056028; Boyd L, 1996, DEVELOPMENT, V122, P3075; BRENNER S, 1974, GENETICS, V77, P71; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; Edgar LG, 1995, METHOD CELL BIOL, V48, P303; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Gould GW, 2009, NAT REV MOL CELL BIO, V10, P287, DOI 10.1038/nrm2652; Hung TJ, 1999, DEVELOPMENT, V126, P127; Hyenne V, 2008, DEV BIOL, V321, P368, DOI 10.1016/j.ydbio.2008.06.037; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kinchen JM, 2008, NAT CELL BIOL, V10, P556, DOI 10.1038/ncb1718; Labbe JC, 2006, GENETICS, V174, P285, DOI 10.1534/genetics.106.060517; Lalli G, 2009, J CELL SCI, V122, P1499, DOI 10.1242/jcs.044339; Langevin J, 2005, DEV CELL, V9, P365, DOI 10.1016/j.devcel.2005.07.013; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Li R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003475; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; McCaffrey LM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001370; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Nakayama Y, 2009, DEV CELL, V16, P889, DOI 10.1016/j.devcel.2009.04.009; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Thyagarajan K, 2011, DEVELOPMENT, V138, P2773, DOI 10.1242/dev.063354; Velarde N, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-142; Wallenfang MR, 2000, NATURE, V408, P89, DOI 10.1038/35040562; Watts JL, 1996, DEVELOPMENT, V122, P3133; Zhang HN, 2008, MOL BIOL CELL, V19, P2553, DOI 10.1091/mbc.E07-09-0862	31	13	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35286	10.1371/journal.pone.0035286	http://dx.doi.org/10.1371/journal.pone.0035286			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545101	gold, Green Submitted, Green Published			2022-12-27	WOS:000305343200022
J	Marrocco, K; Criqui, MC; Zervudacki, J; Schott, G; Eisler, H; Parnet, A; Dunoyer, P; Genschik, P				Marrocco, Katia; Criqui, Marie-Claire; Zervudacki, Jerome; Schott, Gregory; Eisler, Herfried; Parnet, Aude; Dunoyer, Patrice; Genschik, Pascal			APC/C-Mediated Degradation of dsRNA-Binding Protein 4 (DRB4) Involved in RNA Silencing	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX; TRANS-ACTING SIRNAS; DICER-LIKE PROTEINS; ARABIDOPSIS; MICRORNA; BIOGENESIS; ENDOREDUPLICATION; PHOSPHORYLATION; REQUIRES; SUBUNIT	Background: Selective protein degradation via the ubiquitin-26S proteasome is a major mechanism underlying DNA replication and cell division in all Eukaryotes. In particular, the APC/C (Anaphase Promoting Complex or Cyclosome) is a master ubiquitin protein ligase (E3) that targets regulatory proteins for degradation allowing sister chromatid separation and exit from mitosis. Interestingly, recent work also indicates that the APC/C remains active in differentiated animal and plant cells. However, its role in post-mitotic cells remains elusive and only a few substrates have been characterized. Methodology/Principal Findings: In order to identify novel APC/C substrates, we performed a yeast two-hybrid screen using as the bait Arabidopsis APC10/DOC1, one core subunit of the APC/C, which is required for substrate recruitment. This screen identified DRB4, a double-stranded RNA binding protein involved in the biogenesis of different classes of small RNA (sRNA). This protein interaction was further confirmed in vitro and in plant cells. Moreover, APC10 interacts with DRB4 through the second dsRNA binding motif (dsRBD2) of DRB4, which is also required for its homodimerization and binding to its Dicer partner DCL4. We further showed that DRB4 protein accumulates when the proteasome is inactivated and, most importantly, we found that DRB4 stability depends on APC/C activity. Hence, depletion of Arabidopsis APC/C activity by RNAi leads to a strong accumulation of endogenous DRB4, far beyond its normal level of accumulation. However, we could not detect any defects in sRNA production in lines where DRB4 was overexpressed. Conclusions/Significance: Our work identified a first plant substrate of the APC/C, which is not a regulator of the cell cycle. Though we cannot exclude that APC/C-dependent degradation of DRB4 has some regulatory roles under specific growth conditions, our work rather points to a housekeeping function of APC/C in maintaining precise cellular-protein concentrations and homeostasis of DRB4.	[Marrocco, Katia; Criqui, Marie-Claire; Zervudacki, Jerome; Schott, Gregory; Eisler, Herfried; Parnet, Aude; Dunoyer, Patrice; Genschik, Pascal] Univ Strasbourg, CNRS, Inst Biol Mol Plantes, Unite Propre Rech 2357, Strasbourg, France; [Schott, Gregory] Swiss Fed Inst Technol, Zurich, Switzerland	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Swiss Federal Institutes of Technology Domain; ETH Zurich	Marrocco, K (corresponding author), Univ Strasbourg, CNRS, Inst Biol Mol Plantes, Unite Propre Rech 2357, Strasbourg, France.	pascal.genschik@ibmp-cnrs.unistra.fr		GENSCHIK, Pascal/0000-0002-4107-5071	French National Research Agency [ANR-05-BLAN-0072-01]; CNRS	French National Research Agency(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS))	K.M. was funded by a grant of the French National Research Agency (ANR-05-BLAN-0072-01). Additional funding was provided by the CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adenot X, 2006, CURR BIOL, V16, P927, DOI 10.1016/j.cub.2006.03.035; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Capron A, 2003, TRENDS PLANT SCI, V8, P83, DOI 10.1016/S1360-1385(02)00028-6; Carroll CW, 2005, CURR BIOL, V15, P11, DOI 10.1016/j.cub.2004.12.066; Carroll CW, 2002, NAT CELL BIOL, V4, P880, DOI 10.1038/ncb871; Cebolla A, 1999, EMBO J, V18, P4476, DOI 10.1093/emboj/18.16.4476; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtin SJ, 2008, FEBS LETT, V582, P2753, DOI 10.1016/j.febslet.2008.07.004; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; da Fonseca PCA, 2011, NATURE, V470, P274, DOI 10.1038/nature09625; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Dunoyer P, 2007, NAT GENET, V39, P848, DOI 10.1038/ng2081; Eamens AL, 2009, RNA, V15, P2219, DOI 10.1261/rna.1646909; Eguren M, 2011, SEMIN CELL DEV BIOL, V22, P572, DOI 10.1016/j.semcdb.2011.03.010; Eloy NB, 2011, PLANT J, V68, P351, DOI 10.1111/j.1365-313X.2011.04691.x; Felippes FF, 2009, EMBO REP, V10, P264, DOI 10.1038/embor.2008.247; Fu AKY, 2011, NAT NEUROSCI, V14, P181, DOI 10.1038/nn.2715; Fukudome A, 2011, RNA, V17, P750, DOI 10.1261/rna.2455411; Gieffers C, 1999, P NATL ACAD SCI USA, V96, P11317, DOI 10.1073/pnas.96.20.11317; Han MH, 2004, P NATL ACAD SCI USA, V101, P1093, DOI 10.1073/pnas.0307969100; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Hiraguri A, 2005, PLANT MOL BIOL, V57, P173, DOI 10.1007/s11103-004-6853-5; James P, 1996, GENETICS, V144, P1425; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kasili R, 2010, GENETICS, V185, P257, DOI 10.1534/genetics.109.113274; Kevei Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020618; Kim YK, 2010, CELL, V143, P703, DOI 10.1016/j.cell.2010.11.018; Kolonin MG, 2000, METHOD ENZYMOL, V328, P26, DOI 10.1016/S0076-6879(00)28388-2; Kwee HS, 2003, PLANT J, V36, P853, DOI 10.1046/j.1365-313X.2003.01925.x; Lammens T, 2008, P NATL ACAD SCI USA, V105, P14721, DOI 10.1073/pnas.0806510105; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Li WQ, 2007, FASEB J, V21, P3606, DOI 10.1096/fj.07-8159com; Marrocco K, 2010, CURR OPIN PLANT BIOL, V13, P631, DOI 10.1016/j.pbi.2010.07.004; Marrocco K, 2009, DEVELOPMENT, V136, P1475, DOI 10.1242/dev.035535; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Montgomery TA, 2008, P NATL ACAD SCI USA, V105, P20055, DOI 10.1073/pnas.0810241105; Mosher RA, 2008, P NATL ACAD SCI USA, V105, P3145, DOI 10.1073/pnas.0709632105; Nakazawa Y, 2007, PLANT MOL BIOL, V63, P777, DOI 10.1007/s11103-006-9125-8; Paroo Z, 2009, CELL, V139, P112, DOI 10.1016/j.cell.2009.06.044; Pelissier T, 2011, RNA, V17, P1502, DOI 10.1261/rna.2680711; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Perez-Perez JM, 2008, PLANT J, V53, P78, DOI 10.1111/j.1365-313X.2007.03312.x; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pontier D, 2005, GENE DEV, V19, P2030, DOI 10.1101/gad.348405; Rybak A, 2009, NAT CELL BIOL, V11, P1411, DOI 10.1038/ncb1987; Stolpe T, 2005, PROTOPLASMA, V226, P137, DOI 10.1007/s00709-005-0122-6; Tang XL, 2010, NUCLEIC ACIDS RES, V38, P6610, DOI 10.1093/nar/gkq547; van Roessel P, 2004, CELL, V119, P707, DOI 10.1016/j.cell.2004.11.028; Vanstraelen M, 2009, P NATL ACAD SCI USA, V106, P11806, DOI 10.1073/pnas.0901193106; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Vinardell JM, 2003, PLANT CELL, V15, P2093, DOI 10.1105/tpc.014373; Vodermaier HC, 2001, CURR BIOL, V11, pR834, DOI 10.1016/S0960-9822(01)00498-5; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Zheng BL, 2011, PLANT CELL, V23, P1033, DOI 10.1105/tpc.111.083980	58	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35173	10.1371/journal.pone.0035173	http://dx.doi.org/10.1371/journal.pone.0035173			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545099	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343200020
J	Neal, AL; Ahmad, S; Gordon-Weeks, R; Ton, J				Neal, Andrew L.; Ahmad, Shakoor; Gordon-Weeks, Ruth; Ton, Jurriaan			Benzoxazinoids in Root Exudates of Maize Attract Pseudomonas putida to the Rhizosphere	PLOS ONE			English	Article							SOIL TRANSFORMATION; DEFENSE CHEMICALS; INNATE IMMUNITY; CHEMOTAXIS; KT2440; METABOLITES; RESISTANCE; INDUCTION; WHEAT; ACIDS	Benzoxazinoids, such as 2,4-dihydroxy-7-methoxy-2H-1,4-benzoxazin-3(4H)-one (DIMBOA), are secondary metabolites in grasses. In addition to their function in plant defence against pests and diseases above-ground, benzoxazinoids (BXs) have also been implicated in defence below-ground, where they can exert allelochemical or antimicrobial activities. We have studied the impact of BXs on the interaction between maize and Pseudomonas putida KT2440, a competitive coloniser of the maize rhizosphere with plant-beneficial traits. Chromatographic analyses revealed that DIMBOA is the main BX compound in root exudates of maize. In vitro analysis of DIMBOA stability indicated that KT2440 tolerance of DIMBOA is based on metabolism-dependent breakdown of this BX compound. Transcriptome analysis of DIMBOA-exposed P. putida identified increased transcription of genes controlling benzoate catabolism and chemotaxis. Chemotaxis assays confirmed motility of P. putida towards DIMBOA. Moreover, colonisation essays in soil with GREEN FLUORESCENT PROTEIN (GFP)-expressing P. putida showed that DIMBOA-producing roots of wild-type maize attract significantly higher numbers of P. putida cells than roots of the DIMBOA-deficient bx1 mutant. Our results demonstrate a central role for DIMBOA as a below-ground semiochemical for recruitment of plant-beneficial rhizobacteria during the relatively young and vulnerable growth stages of maize.	[Neal, Andrew L.; Ahmad, Shakoor; Gordon-Weeks, Ruth] Rothamsted Res, Ctr Sustainable Soils & Grassland Syst, Harpenden, Herts, England; [Ahmad, Shakoor] Univ Utrecht, Inst Environm Biol, Utrecht, Netherlands; [Ton, Jurriaan] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Utrecht University; University of Sheffield	Neal, AL (corresponding author), Rothamsted Res, Ctr Sustainable Soils & Grassland Syst, Harpenden, Herts, England.	andy.neal@rothamsted.ac.uk; j.ton@sheffield.ac.uk	Neal, Andrew L/C-7596-2011; Ton, Jurriaan/G-3295-2014	Neal, Andrew L/0000-0003-4225-1396; Ton, Jurriaan/0000-0002-8512-2802	Biotechnology and Biological Science Research Council of the U.K. (BBSRC); BBSRC-ICPF fellowship [BB/E023959/1]; European Union [FP7-KBBE-2010-4]; BBSRC [BBS/E/C/00005196, BBS/E/C/00004981, BB/E023959/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005196, BB/E023959/1] Funding Source: researchfish	Biotechnology and Biological Science Research Council of the U.K. (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC-ICPF fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Rothamsted Research receives grant in aid from the Biotechnology and Biological Science Research Council of the U.K. (BBSRC). The work was also supported by a BBSRC-ICPF fellowship (BB/E023959/1) and European Union funding ("PURE"; FP7-KBBE-2010-4) to J.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios G. N., 2005, PLANT PATHOL; Ahmad S, 2011, PLANT PHYSIOL, V157, P317, DOI 10.1104/pp.111.180224; ANZAI K, 1960, J ANTIBIOT, V13, P125; BJOSTAD LB, 1992, J CHEM ECOL, V18, P931, DOI 10.1007/BF00980054; Blankenfeldt W, 2004, P NATL ACAD SCI USA, V101, P16431, DOI 10.1073/pnas.0407371101; CHASE WR, 1991, J CHEM ECOL, V17, P1575, DOI 10.1007/BF00984689; Dabney AR, 2007, BIOSTATISTICS, V8, P128, DOI 10.1093/biostatistics/kxj038; de Weert S, 2002, MOL PLANT MICROBE IN, V15, P1173, DOI 10.1094/MPMI.2002.15.11.1173; Dechesne A, 2005, APPL ENVIRON MICROB, V71, P8123, DOI 10.1128/AEM.71.12.8123-8131.2005; Dobbelaere S, 2003, CRIT REV PLANT SCI, V22, P107, DOI 10.1080/713610853; Erb M, 2009, PLANT SIGNAL BEHAV, V4, P636, DOI 10.1111/j.1365-313X.2009.03868.x; Erb M, 2009, PLANT J, V59, P292, DOI 10.1111/j.1365-313X.2009.03868.x; Fischer F, 1999, J BACTERIOL, V181, P5725, DOI 10.1128/JB.181.18.5725-5733.1999; Frey M, 2009, PHYTOCHEMISTRY, V70, P1645, DOI 10.1016/j.phytochem.2009.05.012; Friebe A, 1996, J APPL BOT-ANGEW BOT, V70, P150; Friebe A, 1998, APPL ENVIRON MICROB, V64, P2386; GAGLIARDO RW, 1992, J CHEM ECOL, V18, P1683, DOI 10.1007/BF02751095; GERBER NN, 1964, BIOCHEMISTRY-US, V3, P598, DOI 10.1021/bi00892a022; Glauser G, 2011, PLANT J, V68, P901, DOI 10.1111/j.1365-313X.2011.04740.x; Haichar FE, 2008, ISME J, V2, P1221, DOI 10.1038/ismej.2008.80; Handelsman J, 1996, PLANT CELL, V8, P1855, DOI 10.1105/tpc.8.10.1855; HARWOOD CS, 1984, J BACTERIOL, V160, P622, DOI 10.1128/JB.160.2.622-628.1984; HARWOOD CS, 1994, J BACTERIOL, V176, P6479, DOI 10.1128/JB.176.21.6479-6488.1994; Jones DL, 2009, PLANT SOIL, V321, P5, DOI 10.1007/s11104-009-9925-0; Krogh SS, 2006, J AGR FOOD CHEM, V54, P1064, DOI 10.1021/jf051147i; KUMAR P, 1993, J CHEM ECOL, V19, P2453, DOI 10.1007/BF00980682; LINDERMAN RG, 1988, PHYTOPATHOLOGY, V78, P366; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Lugtenberg BJJ, 1999, ENVIRON MICROBIOL, V1, P9, DOI 10.1046/j.1462-2920.1999.00005.x; Maresh J, 2006, ACS CHEM BIOL, V1, P165, DOI 10.1021/cb600051w; Matilla MA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r179; Matilla MA, 2010, ENV MICROBIOL REP, V2, P381, DOI 10.1111/j.1758-2229.2009.00091.x; Miyakoshi M, 2007, J BACTERIOL, V189, P6849, DOI 10.1128/JB.00684-07; Molina L, 2000, SOIL BIOL BIOCHEM, V32, P315, DOI 10.1016/S0038-0717(99)00156-X; Morant AV, 2008, PHYTOCHEMISTRY, V69, P1795, DOI 10.1016/j.phytochem.2008.03.006; Nakazawa T, 2002, ENVIRON MICROBIOL, V4, P782, DOI 10.1046/j.1462-2920.2002.00310.x; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Niemeyer HM, 2009, J AGR FOOD CHEM, V57, P1677, DOI 10.1021/jf8034034; NIEMEYER HM, 1988, PHYTOCHEMISTRY, V27, P3349, DOI 10.1016/0031-9422(88)80731-3; Niemeyer HM, 1994, ALLELOPATHY, P260; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Parales RE, 2002, CURR OPIN MICROBIOL, V5, P266, DOI 10.1016/S1369-5274(02)00320-X; Ramos-Gonzalez MI, 2005, J BACTERIOL, V187, P4033, DOI 10.1128/JB.187.12.4033-4041.2005; Rangel-Castro JI, 2005, ENVIRON MICROBIOL, V7, P828, DOI 10.1111/j.1462-2920.2005.00756.x; Robert CAM, 2012, ECOL LETT, V15, P55, DOI 10.1111/j.1461-0248.2011.01708.x; Rudrappa T, 2008, PLANT PHYSIOL, V148, P1547, DOI 10.1104/pp.108.127613; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Song YY, 2011, MYCORRHIZA, V21, P721, DOI 10.1007/s00572-011-0380-4; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Van Wees SCM, 2008, CURR OPIN PLANT BIOL, V11, P443, DOI 10.1016/j.pbi.2008.05.005; Whipps JM, 2001, J EXP BOT, V52, P487, DOI 10.1093/jexbot/52.suppl_1.487; Wolanin PM, 2003, BIOCHEMISTRY-US, V42, P14075, DOI 10.1021/bi034883t; WOODWARD MD, 1978, PLANT PHYSIOL, V61, P796, DOI 10.1104/pp.61.5.796	54	279	288	15	222	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35498	10.1371/journal.pone.0035498	http://dx.doi.org/10.1371/journal.pone.0035498			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545111	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000305343200031
J	Wu, KH; Hsieh, YH; Tai, PC				Wu, Kai-Hui; Hsieh, Ying-Hsin; Tai, Phang C.			Mutational Analysis of Cvab, an ABC Transporter Involved in the Secretion of Active Colicin V	PLOS ONE			English	Article							BINDING CASSETTE TRANSPORTER; CYSTEINE PROTEASE; AROMATIC INTERACTIONS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; SERINE PROTEASES; CATALYTIC TRIAD; OXYANION HOLE; SITE; PAPAIN	CvaB is the central membrane transporter of the colicin V secretion system that belongs to an ATP-binding cassette superfamily. Previous data showed that the N-terminal and C-terminal domains of CvaB are essential for the function of CvaB. N-terminal domain of CvaB possesses Ca2+-dependent cysteine proteolytic activity, and two critical residues, Cys32 and His105, have been identified. In this study, we also identify Asp121 as being the third residue of the putative catalytic triad within the active site of the enzyme. The Asp121 mutants lose both their colicin V secretion activity and N-terminal proteolytic activity. The adjacent residue Pro122 also appears to play a critical role in the colicin V secretion. However, the reversal of the two residues D121P - P122D results in loss of activity. Based on molecular modeling and protein sequence alignment, several residues adjacent to the critical residues, Cys32 and His105, were also examined and characterized. Site-directed mutagenesis of Trp101, Asp102, Val108, Leu76, Gly77, and Gln26 indicate that the neighboring residues around the catalytic triad affect colicin V secretion. Several mutated CvaB proteins with defective secretion were also tested, including Asp121 and Pro122, and were found to be structurally stable. These results indicate that the residues surrounding the identified catalytic triad are functionally involved in the secretion of biologically active colicin V.	[Wu, Kai-Hui; Hsieh, Ying-Hsin; Tai, Phang C.] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University	Wu, KH (corresponding author), Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA.	biopct@gsu.edu			National Institutes of Health [GM34766]; Georgia State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034766] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM34766 and Georgia State University's Research Enhancement Program. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; Asp T, 2004, BBA-PROTEINS PROTEOM, V1699, P111, DOI 10.1016/j.bbapap.2004.02.002; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Bromme D, 1996, BIOCHEMISTRY-US, V35, P3970, DOI 10.1021/bi9523015; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; CRAIK CS, 1987, SCIENCE, V237, P909, DOI 10.1126/science.3303334; DESSENS JT, 1991, VIROLOGY, V184, P738, DOI 10.1016/0042-6822(91)90444-G; DRENTH J, 1976, BIOCHEMISTRY-US, V15, P3731, DOI 10.1021/bi00662a014; ENDICOTT JA, 1989, ANNU REV BIOCHEM, V58, P137, DOI 10.1146/annurev.bi.58.070189.001033; FATH MJ, 1994, BIOCHEMISTRY-US, V33, P6911, DOI 10.1021/bi00188a021; GILSON L, 1990, EMBO J, V9, P3875, DOI 10.1002/j.1460-2075.1990.tb07606.x; Hata S, 2001, SEIKAGAKU, V73, P1129; HAVARSTEIN LS, 1995, MOL MICROBIOL, V16, P229, DOI 10.1111/j.1365-2958.1995.tb02295.x; Hwang JW, 1997, J BACTERIOL, V179, P6264, DOI 10.1128/jb.179.20.6264-6270.1997; Im YJ, 2004, J BIOL CHEM, V279, P53451, DOI 10.1074/jbc.M410437200; Ishii S, 2006, J BIOL CHEM, V281, P4726, DOI 10.1074/jbc.M512516200; James R, 1992, BACTERIOCINS MICROCI; Kim MS, 2004, INT J ONCOL, V25, P373; LOEWENTHAL R, 1992, J MOL BIOL, V224, P759, DOI 10.1016/0022-2836(92)90560-7; Maniatis T., 1982, MOL CLONING; MENARD R, 1990, BIOCHEMISTRY-US, V29, P6706, DOI 10.1021/bi00480a021; MENARD R, 1991, BIOCHEMISTRY-US, V30, P8924, DOI 10.1021/bi00101a002; MENARD R, 1992, BIOL CHEM H-S, V373, P393, DOI 10.1515/bchm3.1992.373.2.393; Neuvonen H, 1997, BIOCHEM J, V322, P351, DOI 10.1042/bj3220351; RIORDAN JR, 1989, SCIENCE, V245, P1066; SKVIRSKY RC, 1991, METHOD CELL BIOL, V34, P205; Strobl S, 2000, P NATL ACAD SCI USA, V97, P588, DOI 10.1073/pnas.97.2.588; Tanksale AM, 2000, BIOCHEM BIOPH RES CO, V270, P910, DOI 10.1006/bbrc.2000.2494; Tzeng WP, 2002, J VIROL, V76, P3189, DOI 10.1128/JVI.76.7.3189-3201.2002; VERNET T, 1995, J BIOL CHEM, V270, P16645, DOI 10.1074/jbc.270.28.16645; Wu KH, 2004, J BIOL CHEM, V279, P901, DOI 10.1074/jbc.M308296200; Zhong XT, 1998, J BACTERIOL, V180, P1347, DOI 10.1128/JB.180.6.1347-1353.1998; Zhu MF, 2004, P NATL ACAD SCI USA, V101, P302, DOI 10.1073/pnas.2036536100	33	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35382	10.1371/journal.pone.0035382	http://dx.doi.org/10.1371/journal.pone.0035382			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539970	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341000035
J	Matsuse, M; Sasaki, K; Nishihara, E; Minami, S; Hayashida, C; Kondo, H; Suzuki, K; Saenko, V; Yoshiura, K; Mitsutake, N; Yamashita, S				Matsuse, Michiko; Sasaki, Kensaku; Nishihara, Eijun; Minami, Shigeki; Hayashida, Chisa; Kondo, Hisayoshi; Suzuki, Keiji; Saenko, Vladimir; Yoshiura, Koh-ichiro; Mitsutake, Norisato; Yamashita, Shunichi			Copy Number Alteration and Uniparental Disomy Analysis Categorizes Japanese Papillary Thyroid Carcinomas into Distinct Groups	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; BRAF V600E MUTATION; GENE-EXPRESSION; SIGNALING PATHWAY; WIDE APPRAISAL; CANCER; ACTIVATION; INSTABILITY; HETEROZYGOSITY; BRAF(V600E)	The aim of the present study was to investigate chromosomal aberrations in sporadic Japanese papillary thyroid carcinomas (PTCs), concomitant with the analysis of oncogene mutational status. Twenty-five PTCs (11 with BRAF(V600E), 4 with RET/PTC1, and 10 without mutation in HRAS, KRAS, NRAS, BRAF, RET/PTC1, or RET/PTC3) were analyzed using Genome-Wide Human SNP Array 6.0 which allows us to detect copy number alteration (CNA) and uniparental disomy (UPD), also referred to as copy neutral loss of heterozygosity, in a single experiment. The Japanese PTCs showed relatively stable karyotypes. Seven cases (28%) showed CNA(s), and 6 (24%) showed UPD(s). Interestingly, CNA and UPD were rarely overlapped in the same tumor; the only one advanced case showed both CNA and UPD with a highly complex karyotype. Thirteen (52%) showed neither CNA nor UPD. Regarding CNA, deletions tended to be more frequent than amplifications. The most frequent and recurrent region was the deletion in chromosome 22; however, it was found in only 4 cases (16%). The degree of genomic instability did not depend on the oncogene status. However, in oncogene-positive cases (BRAF(V600E) and RET/PTC1), tumors with CNA/UPD were less frequent (5/15, 33%), whereas tumors with CNA/UPD were more frequent in oncogene-negative cases (7/10, 70%), suggesting that chromosomal aberrations may play a role in the development of PTC, especially in oncogene-negative tumors. These data suggest that Japanese PTCs may be classified into three distinct groups: CNA(+), UPD+, and no chromosomal aberrations. BRAF(V600E) mutational status did not correlate with any parameters of chromosomal defects.	[Matsuse, Michiko; Suzuki, Keiji; Mitsutake, Norisato; Yamashita, Shunichi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Radiat Med Sci, Nagasaki 852, Japan; [Sasaki, Kensaku; Hayashida, Chisa; Yoshiura, Koh-ichiro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Human Genet, Nagasaki 852, Japan; [Nishihara, Eijun] Kuma Hosp, Dept Internal Med, Kobe, Hyogo, Japan; [Minami, Shigeki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, Nagasaki 852, Japan; [Kondo, Hisayoshi] Nagasaki Univ, Grad Sch Biomed Sci, Div Sci Data Registry, Atom Bomb Dis Inst, Nagasaki 852, Japan; [Saenko, Vladimir; Yamashita, Shunichi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Hlth Risk Control, Nagasaki 852, Japan; [Mitsutake, Norisato] Nagasaki Univ, Res Ctr Genom Instabil & Carcinogenesis NRGIC, Nagasaki 852, Japan	Nagasaki University; Nagasaki University; Kuma Hospital; Nagasaki University; Nagasaki University; Nagasaki University; Nagasaki University	Matsuse, M (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Radiat Med Sci, Nagasaki 852, Japan.	mitsu@nagasaki-u.ac.jp	Nishihara, Eijun/AAU-9152-2021; Yamashita, Shunichi/GVS-9508-2022; Mitsutake, Norisato/U-9626-2018	Nishihara, Eijun/0000-0003-1786-0077; Mitsutake, Norisato/0000-0002-2744-8046; matsuse, michiko/0000-0001-6178-3342; Yamashita, Shunichi/0000-0001-6399-6261	Global Centers of Excellence (GCOE) Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan;  [22256004];  [22390189];  [23591357];  [22791204]; Grants-in-Aid for Scientific Research [22390189] Funding Source: KAKEN	Global Centers of Excellence (GCOE) Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-Aid for Scientific Research (#22256004, #22390189, and #23591357), Grant-in-Aid for Young Scientists (#22791204), and the Global Centers of Excellence (GCOE) Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anania MC, 2011, ONCOGENE, V30, P3011, DOI 10.1038/onc.2011.18; Astolfi A, 2010, LAB INVEST, V90, P1285, DOI 10.1038/labinvest.2010.110; Bauer AJ, 2002, CANCER GENET CYTOGEN, V135, P182, DOI 10.1016/S0165-4608(01)00656-2; Cybulski C, 2004, AM J HUM GENET, V75, P1131, DOI 10.1086/426403; Dunbar AJ, 2008, CANCER RES, V68, P10349, DOI 10.1158/0008-5472.CAN-08-2754; Feldt-Rasmussen U, 2001, THYROID, V11, P483, DOI 10.1089/105072501300176435; Finn S, 2007, ARCH PATHOL LAB MED, V131, P65; Frattini M, 2004, ONCOGENE, V23, P7436, DOI 10.1038/sj.onc.1207980; Guan HX, 2009, J CLIN ENDOCR METAB, V94, P1612, DOI 10.1210/jc.2008-2390; Hemmer S, 1999, AM J PATHOL, V154, P1539, DOI 10.1016/S0002-9440(10)65407-7; Higgins ME, 2007, NUCLEIC ACIDS RES, V35, pD721, DOI 10.1093/nar/gkl811; Hsu FF, 2010, ONCOGENE, V29, P2864, DOI 10.1038/onc.2010.40; Hung CJ, 2003, J CLIN ENDOCR METAB, V88, P3694, DOI 10.1210/jc.2003-030080; Ito Y, 2009, ENDOCR J, V56, P89, DOI 10.1507/endocrj.K08E-208; Kimura ET, 2003, CANCER RES, V63, P1454; Knauf JA, 2005, CANCER RES, V65, P4238, DOI 10.1158/0008-5472.CAN-05-0047; Kondo T, 2006, NAT REV CANCER, V6, P292, DOI 10.1038/nrc1836; Kumagai A, 2007, ENDOCR J, V54, P399, DOI 10.1507/endocrj.K06-194; Makishima H, 2011, CLIN CANCER RES, V17, P3913, DOI 10.1158/1078-0432.CCR-10-2900; Mesa C, 2006, CANCER RES, V66, P6521, DOI 10.1158/0008-5472.CAN-06-0739; Mitsutake N, 2005, CANCER RES, V65, P2465, DOI 10.1158/0008-5472.CAN-04-3314; Nakayama H, 2007, ANTICANCER RES, V27, P3645; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Nellore A, 2009, J CLIN ENDOCR METAB, V94, P1026, DOI 10.1210/jc.2008-1042; O'Keefe C, 2010, BLOOD, V115, P2731, DOI 10.1182/blood-2009-10-201848; Richter H, 2004, THYROID, V14, P1061, DOI 10.1089/thy.2004.14.1061; Rodrigues R, 2007, ONCOL REP, V18, P917; Siironen P, 2006, ENDOCR-RELAT CANCER, V13, P465, DOI 10.1677/erc.1.01114; Singh B, 2000, SURGERY, V128, P888, DOI 10.1067/msy.2000.110847; Soares P, 2003, ONCOGENE, V22, P4578, DOI 10.1038/sj.onc.1206706; Soh J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007464; Stein L, 2010, THYROID, V20, P475, DOI 10.1089/thy.2009.0008; Tiu RV, 2009, J CLIN ONCOL, V27, P5219, DOI 10.1200/JCO.2009.21.9840; Tuna M, 2009, TRENDS MOL MED, V15, P120, DOI 10.1016/j.molmed.2009.01.005; Unger K, 2008, ONCOGENE, V27, P4592, DOI 10.1038/onc.2008.99; Viglietto G, 2011, FRONT BIOSCI-LANDMRK, V16, P1461, DOI 10.2741/3799; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Watanabe R, 2009, ENDOCR J, V56, P407, DOI 10.1507/endocrj.K08E-329; Williams ED, 2008, THYROID, V18, P847, DOI 10.1089/thy.2008.0039; Wreesmann VB, 2002, AM J PATHOL, V161, P1549, DOI 10.1016/S0002-9440(10)64433-1; Wreesmann VB, 2004, GENE CHROMOSOME CANC, V40, P355, DOI 10.1002/gcc.20049; Wreesmann VB, 2004, CANCER RES, V64, P3780, DOI 10.1158/0008-5472.CAN-03-1460; Xing MZ, 2007, ENDOCR REV, V28, P742, DOI 10.1210/er.2007-0007; Xing MZ, 2010, THYROID, V20, P697, DOI 10.1089/thy.2010.1646; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809; Zuo H, 2007, PATHOL INT, V57, P12, DOI 10.1111/j.1440-1827.2007.02050.x; Zuo H, 2010, CANCER RES, V70, P1389, DOI 10.1158/0008-5472.CAN-09-2812	47	8	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36063	10.1371/journal.pone.0036063	http://dx.doi.org/10.1371/journal.pone.0036063			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558328	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340200036
J	Fatima, T; Snyder, CL; Schroeder, WR; Cram, D; Datla, R; Wishart, D; Weselake, RJ; Krishna, P				Fatima, Tahira; Snyder, Crystal L.; Schroeder, William R.; Cram, Dustin; Datla, Raju; Wishart, David; Weselake, Randall J.; Krishna, Priti			Fatty Acid Composition of Developing Sea Buckthorn (Hippophae rhamnoides L.) Berry and the Transcriptome of the Mature Seed	PLOS ONE			English	Article							DIETARY PALMITOLEIC ACID; ARABIDOPSIS-THALIANA; OXIDATIVE STRESS; METABOLIC PATHWAYS; GENE-EXPRESSION; TOTAL FLAVONES; PROTEIN; OIL; ACCUMULATION; REVEALS	Background: Sea buckthorn (Hippophae rhamnoides L.) is a hardy, fruit-producing plant known historically for its medicinal and nutraceutical properties. The most recognized product of sea buckthorn is its fruit oil, composed of seed oil that is rich in essential fatty acids, linoleic (18:2 omega-6) and alpha-linolenic (18:3 omega-3) acids, and pulp oil that contains high levels of monounsaturated palmitoleic acid (16:1 omega-7). Sea buckthorn is fast gaining popularity as a source of functional food and nutraceuticals, but currently has few genomic resources; therefore, we explored the fatty acid composition of Canadiangrown cultivars (ssp. mongolica) and the sea buckthorn seed transcriptome using the 454 GS FLX sequencing technology. Results: GC-MS profiling of fatty acids in seeds and pulp of berries indicated that the seed oil contained linoleic and alpha-linolenic acids at 33-36% and 30-36%, respectively, while the pulp oil contained palmitoleic acid at 32-42%. 454 sequencing of sea buckthorn cDNA collections from mature seeds yielded 500,392 sequence reads, which identified 89,141 putative unigenes represented by 37,482 contigs and 51,659 singletons. Functional annotation by Gene Ontology and computational prediction of metabolic pathways indicated that primary metabolism (protein>nucleic acid>carbohydrate>lipid) and fatty acid and lipid biosynthesis pathways were highly represented categories. Sea buckthorn sequences related to fatty acid biosynthesis genes in Arabidopsis were identified, and a subset of these was examined for transcript expression at four developing stages of the berry. Conclusion: This study provides the first comprehensive genomic resources represented by expressed sequences for sea buckthorn, and demonstrates that the seed oil of Canadian-grown sea buckthorn cultivars contains high levels of linoleic acid and alpha-linolenic acid in a close to 1: 1 ratio, which is beneficial for human health. These data provide the foundation for further studies on sea buckthorn oil, the enzymes involved in its biosynthesis, and the genes involved in the general hardiness of sea buckthorn against environmental conditions.	[Fatima, Tahira; Krishna, Priti] Univ Western Ontario, Dept Biol, London, ON, Canada; [Snyder, Crystal L.; Weselake, Randall J.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Schroeder, William R.] Agr & Agri Food Canada, Agroforestry Dev Ctr, Indian Head, SK, Canada; [Cram, Dustin; Datla, Raju] CNR, Inst Plant Biotechnol, Saskatoon, SK, Canada; [Wishart, David] Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada; [Wishart, David] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	Western University (University of Western Ontario); University of Alberta; Agriculture & Agri Food Canada; University of Alberta; University of Alberta	Fatima, T (corresponding author), Univ Western Ontario, Dept Biol, London, ON, Canada.	pkrishna@uwo.ca	Datla, Raju/AGR-7376-2022; Wishart, David Scott/ABI-3181-2020; Datla, Raju/H-3820-2011	Datla, Raju/0000-0003-0790-5569; Fatima, Tahira/0000-0003-4276-321X; Wishart, David S/0000-0002-3207-2434	The Natural Products Genomics Resource and Ontario Ministry of Agriculture, Food and Rural Affairs; AVAC, Ltd; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs	The Natural Products Genomics Resource and Ontario Ministry of Agriculture, Food and Rural Affairs; AVAC, Ltd; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs(Canada Research ChairsCGIAR)	This work was supported by funds from The Natural Products Genomics Resource and Ontario Ministry of Agriculture, Food and Rural Affairs to PK, and from AVAC, Ltd, Natural Sciences and Engineering Research Council of Canada, and the Canada Research Chairs Program to RJW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amini K, 2007, BRIT POULTRY SCI, V48, P661, DOI 10.1080/00071660701708211; Andersson SC, 2009, J AGR FOOD CHEM, V57, P250, DOI 10.1021/jf802599f; Basu M, 2007, PHYTOMEDICINE, V14, P770, DOI 10.1016/j.phymed.2007.03.018; Bates PD, 2009, PLANT PHYSIOL, V150, P55, DOI 10.1104/pp.109.137737; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Cazzonelli CI, 2010, TRENDS PLANT SCI, V15, P266, DOI 10.1016/j.tplants.2010.02.003; Cheng JY, 2003, LIFE SCI, V72, P2263, DOI 10.1016/S0024-3205(03)00114-0; George SDS, 2007, J AGR FOOD CHEM, V55, P8054, DOI 10.1021/jf070772f; Gupta A, 2008, WOUND REPAIR REGEN, V16, P784, DOI 10.1111/j.1524-475X.2008.00431.x; Gupta A, 2006, MOL CELL BIOCHEM, V290, P193, DOI 10.1007/s11010-006-9187-6; Gupta SM, 2009, DEFENCE SCI J, V59, P147, DOI 10.14429/dsj.59.1502; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Hu YP, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-49; Jain Ankit, 2010, Physiology and Molecular Biology of Plants, V16, P375, DOI 10.1007/s12298-010-0037-3; Jako C, 2001, PLANT PHYSIOL, V126, P861, DOI 10.1104/pp.126.2.861; Johansson AK, 2000, J NUTR BIOCHEM, V11, P491, DOI 10.1016/S0955-2863(00)00105-4; Kariola T, 2006, PLANT PHYSIOL, V142, P1559, DOI 10.1104/pp.106.086223; Kim YO, 2005, PLANT J, V42, P890, DOI 10.1111/j.1365-313X.2005.02420.x; Krieger CJ, 2004, NUCLEIC ACIDS RES, V32, pD438, DOI 10.1093/nar/gkh100; Larmo PS, 2010, J NUTR, V140, P1462, DOI 10.3945/jn.109.118901; Lehtonen HM, 2010, EUR J CLIN NUTR, V64, P1465, DOI 10.1038/ejcn.2010.173; Lehtonen HM, 2010, J AGR FOOD CHEM, V58, P620, DOI 10.1021/jf9029942; Lepiniec L, 2006, ANNU REV PLANT BIOL, V57, P405, DOI 10.1146/annurev.arplant.57.032905.105252; Leuendorf JE, 2008, FEBS J, V275, P960, DOI 10.1111/j.1742-4658.2008.06275.x; Liu ZJ, 2009, MOL BIOL REP, V36, P813, DOI 10.1007/s11033-008-9250-3; Lu CF, 2009, P NATL ACAD SCI USA, V106, P18837, DOI 10.1073/pnas.0908848106; Lubaretz O, 2002, PLANTA, V215, P220, DOI 10.1007/s00425-002-0745-1; Martinez-Force E, 2000, PLANTA, V211, P673, DOI 10.1007/s004250000332; Matsukura S, 2010, MOL GENET GENOMICS, V283, P185, DOI 10.1007/s00438-009-0506-y; Matthan NR, 2009, J NUTR, V139, P215, DOI 10.3945/jn.108.099804; Medina J, 2001, PLANT PHYSIOL, V125, P1655, DOI 10.1104/pp.125.4.1655; Miziorko HM, 2011, ARCH BIOCHEM BIOPHYS, V505, P131, DOI 10.1016/j.abb.2010.09.028; Mowla SB, 2006, PLANT J, V48, P743, DOI 10.1111/j.1365-313X.2006.02911.x; Narayanan S, 2005, MOL CELL BIOCHEM, V278, P9, DOI 10.1007/s11010-005-7636-2; NESTEL P, 1994, J LIPID RES, V35, P656; Nguyen HT, 2010, PLANT PHYSIOL, V154, P1897, DOI 10.1104/pp.110.165340; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Arce DP, 2010, J PLANT PHYSIOL, V167, P194, DOI 10.1016/j.jplph.2009.09.003; Pang XF, 2008, J ETHNOPHARMACOL, V117, P325, DOI 10.1016/j.jep.2008.02.002; Patterson AC, 2008, J AM COLL NUTR, V27, P538, DOI 10.1080/07315724.2008.10719736; Peng FY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-286; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Prasinos C, 2005, J EXP BOT, V56, P633, DOI 10.1093/jxb/eri035; Reddy RK, 1998, PLANT SCI, V131, P131, DOI 10.1016/S0168-9452(97)00254-9; Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138; Shukla SK, 2006, ENVIRON MOL MUTAGEN, V47, P647, DOI 10.1002/em.20251; Simopoulos AP, 2006, BIOMED PHARMACOTHER, V60, P502, DOI 10.1016/j.biopha.2006.07.080; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; Singh RK, 2009, J PLANT BIOCHEM BIOT, V18, P77, DOI 10.1007/BF03263299; Singh V, 2005, SEA BUCKTHORN L HIPP, V2; Sridha S, 2006, PLANT J, V46, P124, DOI 10.1111/j.1365-313X.2006.02678.x; Suomela JP, 2006, J AGR FOOD CHEM, V54, P7364, DOI 10.1021/jf061889r; Tiitinen KM, 2006, J AGR FOOD CHEM, V54, P2508, DOI 10.1021/jf053177r; Tiitinen KM, 2005, J AGR FOOD CHEM, V53, P1692, DOI 10.1021/jf0484125; Ursin VM, 2003, J NUTR, V133, P4271, DOI 10.1093/jn/133.12.4271; Venglat P, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-74; Wang C. S., 1994, Plant Molecular Biology Reporter, V12, P132, DOI 10.1007/BF02668374; White JA, 2000, PLANT PHYSIOL, V124, P1582, DOI 10.1104/pp.124.4.1582; Xiang DQ, 2011, PLANT PHYSIOL, V156, P346, DOI 10.1104/pp.110.171702; Xing JF, 2002, FITOTERAPIA, V73, P644, DOI 10.1016/S0367-326X(02)00221-6; Yang B, 2009, FOOD CHEM, V115, P657, DOI 10.1016/j.foodchem.2008.12.073; Yang BR, 2001, J AGR FOOD CHEM, V49, P1939, DOI 10.1021/jf001059s; Zhou CH, 2004, PLANT J, V38, P715, DOI 10.1111/j.1365-313X.2004.02083.x; Zou JT, 1999, PLANT J, V19, P645, DOI 10.1046/j.1365-313x.1999.00555.x; Zuidhof MJ, 2009, POULTRY SCI, V88, P1108, DOI 10.3382/ps.2008-00171	66	87	101	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e34099	10.1371/journal.pone.0034099	http://dx.doi.org/10.1371/journal.pone.0034099			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558083	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336000009
J	Fufezan, C; Simionato, D; Morosinotto, T				Fufezan, Christian; Simionato, Diana; Morosinotto, Tomas			Identification of Key Residues for pH Dependent Activation of Violaxanthin De-Epoxidase from Arabidopsis thaliana	PLOS ONE			English	Article							XANTHOPHYLL-CYCLE; ESCHERICHIA-COLI; IN-VIVO; LIGHT; DIADINOXANTHIN; PROTEINS; BINDING; FIELD; DEEPOXIDATION; SIMULATION	Plants are often exposed to saturating light conditions, which can lead to oxidative stress. The carotenoid zeaxanthin, synthesized from violaxanthin by Violaxanthin De-Epoxidase (VDE) plays a major role in the protection from excess illumination. VDE activation is triggered by a pH reduction in the thylakoids lumen occurring under saturating light. In this work the mechanism of the VDE activation was investigated on a molecular level using multi conformer continuum electrostatic calculations, site directed mutagenesis and molecular dynamics. The pK(a) values of residues of the inactive VDE were determined to identify target residues that could be implicated in the activation. Five such target residues were investigated closer by site directed mutagenesis, whereas variants in four residues (D98, D117, H168 and D206) caused a reduction in enzymatic activity indicating a role in the activation of VDE while D86 mutants did not show any alteration. The analysis of the VDE sequence showed that the four putative activation residues are all conserved in plants but not in diatoms, explaining why VDE in these algae is already activated at higher pH. Molecular dynamics showed that the VDE structure was coherent at pH 7 with a low amount of water penetrating the hydrophobic barrel. Simulations carried out with the candidate residues locked into their protonated state showed instead an increased amount of water penetrating the barrel and the rupture of the H121-Y214 hydrogen bond at the end of the barrel, which is essential for VDE activation. These results suggest that VDE activation relies on a robust and redundant network, in which the four residues identified in this study play a major role.	[Fufezan, Christian] Univ Munster, Inst Biol & Biotechnol Plants, Munster, Germany; [Simionato, Diana; Morosinotto, Tomas] Univ Padua, Dept Biol, Padua, Italy	University of Munster; University of Padua	Fufezan, C (corresponding author), Univ Munster, Inst Biol & Biotechnol Plants, Munster, Germany.	christian@fufezan.net; tomas.morosinotto@unipd.it	Morosinotto, Tomas/AAC-3188-2019	Morosinotto, Tomas/0000-0002-0803-7591; Fufezan, Christian/0000-0002-7048-6822; simionato, diana/0000-0002-2774-6641	Universita di Padova [CPDA089403]	Universita di Padova	The work was supported by Universita di Padova (grant CPDA089403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnoux P, 2009, PLANT CELL, V21, P2036, DOI 10.1105/tpc.109.068007; Ballottari M, 2007, J BIOL CHEM, V282, P8947, DOI 10.1074/jbc.M606417200; BRATT CE, 1995, PHOTOSYNTH RES, V45, P169, DOI 10.1007/BF00032588; Bugos RC, 1996, P NATL ACAD SCI USA, V93, P6320, DOI 10.1073/pnas.93.13.6320; Coesel S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002896; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fufezan C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-258; Goss R, 2005, BIOCHEMISTRY-US, V44, P4028, DOI 10.1021/bi047464k; HAGER A, 1969, PLANTA, V89, P224, DOI 10.1007/BF00385028; HAGER A, 1994, PLANTA, V192, P581, DOI 10.1007/BF00203597; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hieber AD, 2000, BBA-PROTEIN STRUCT M, V1482, P84, DOI 10.1016/S0167-4838(00)00141-2; Hieber AD, 2002, PLANTA, V214, P476, DOI 10.1007/s00425-001-0704-2; Jahns P, 2009, BBA-BIOENERGETICS, V1787, P3, DOI 10.1016/j.bbabio.2008.09.013; Jakob T, 2001, J PLANT PHYSIOL, V158, P383, DOI 10.1078/0176-1617-00288; Kawano M, 2000, FEBS LETT, V481, P101, DOI 10.1016/S0014-5793(00)01991-8; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; Li XP, 2002, FUNCT PLANT BIOL, V29, P1131, DOI 10.1071/FP02065; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Lohr M, 1999, P NATL ACAD SCI USA, V96, P8784, DOI 10.1073/pnas.96.15.8784; Morosinotto T, 2002, J BIOL CHEM, V277, P36913, DOI 10.1074/jbc.M205339200; PFUNDEL EE, 1993, PLANT PHYSIOL, V101, P65, DOI 10.1104/pp.101.1.65; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; Rockholm DC, 1996, PLANT PHYSIOL, V110, P697, DOI 10.1104/pp.110.2.697; Saga G, 2010, J BIOL CHEM, V285, P23763, DOI 10.1074/jbc.M110.115097; Song YF, 2009, J COMPUT CHEM, V30, P2231, DOI 10.1002/jcc.21222; YAMAMOTO HY, 1978, ARCH BIOCHEM BIOPHYS, V190, P514, DOI 10.1016/0003-9861(78)90305-3	30	17	18	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35669	10.1371/journal.pone.0035669	http://dx.doi.org/10.1371/journal.pone.0035669			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558195	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000046
J	Ippolito, GC; Hoi, KH; Reddy, ST; Carroll, SM; Ge, X; Rogosch, T; Zemlin, M; Shultz, LD; Ellington, AD; VanDenBerg, CL; Georgiou, G				Ippolito, Gregory C.; Hoi, Kam Hon; Reddy, Sai T.; Carroll, Sean M.; Ge, Xin; Rogosch, Tobias; Zemlin, Michael; Shultz, Leonard D.; Ellington, Andrew D.; VanDenBerg, Carla L.; Georgiou, George			Antibody Repertoires in Humanized NOD-scid-IL2R gamma(null) Mice and Human B Cells Reveals Human-Like Diversification and Tolerance Checkpoints in the Mouse	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; IMMUNOGLOBULIN REPERTOIRE; CORD BLOOD; GENE USAGE; SEQUENCE-ANALYSIS; IMMUNE-SYSTEM; PLASMA-CELLS; V-REGIONS; DIVERSITY; SELECTION	Immunodeficient mice reconstituted with human hematopoietic stem cells enable the in vivo study of human hematopoiesis. In particular, NOD-scid-IL2R gamma(null) engrafted mice have been shown to have reasonable levels of T and B cell repopulation and can mount T-cell dependent responses; however, antigen-specific B-cell responses in this model are generally poor. We explored whether developmental defects in the immunoglobulin gene repertoire might be partly responsible for the low level of antibody responses in this model. Roche 454 sequencing was used to obtain over 685,000 reads from cDNA encoding immunoglobulin heavy (IGH) and light (IGK and IGL) genes isolated from immature, naive, or total splenic B cells in engrafted NOD-scid-IL2R gamma(null) mice, and compared with over 940,000 reads from peripheral B cells of two healthy volunteers. We find that while naive B-cell repertoires in humanized mice are chiefly indistinguishable from those in human blood B cells, and display highly correlated patterns of immunoglobulin gene segment use, the complementarity-determining region H3 (CDR-H3) repertoires are nevertheless extremely diverse and are specific for each individual. Despite this diversity, preferential D-H-J(H) pairings repeatedly occur within the CDR-H3 interval that are strikingly similar across all repertoires examined, implying a genetic constraint imposed on repertoire generation. Moreover, CDR-H3 length, charged amino-acid content, and hydropathy are indistinguishable between humans and humanized mice, with no evidence of global autoimmune signatures. Importantly, however, a statistically greater usage of the inherently autoreactive IGHV4-34 and IGKV4-1 genes was observed in the newly formed immature B cells relative to naive B or total splenic B cells in the humanized mice, a finding consistent with the deletion of autoreactive B cells in humans. Overall, our results provide evidence that key features of the primary repertoire are shaped by genetic factors intrinsic to human B cells and are principally unaltered by differences between mouse and human stromal microenvironments.	[Ippolito, Gregory C.; Georgiou, George] Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Hoi, Kam Hon; Georgiou, George] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Reddy, Sai T.] ETH, Dept Biosyst Sci & Engn, Zurich, Switzerland; [Carroll, Sean M.; Georgiou, George] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Ge, Xin] Univ Calif Riverside, Riverside, CA 92521 USA; [Shultz, Leonard D.] Jackson Lab, Bar Harbor, ME 04609 USA; [Rogosch, Tobias; Zemlin, Michael] Univ Marburg, Dept Pediat, Marburg, Germany; [Ellington, Andrew D.; Georgiou, George] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [VanDenBerg, Carla L.] Univ Texas Austin, Dept Pharmacol & Toxicol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Texas System; University of Texas Austin; University of California System; University of California Riverside; Jackson Laboratory; Philipps University Marburg; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Ippolito, GC (corresponding author), Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA.	gg@che.utexas.edu	Ippolito, Gregory C./AAR-2930-2021; Rogosch, Tobias/A-1522-2009; Ge, Xin/I-8181-2013; Zemlin, Michael/AAB-5746-2020; Reddy, Sai/B-4190-2012	Ippolito, Gregory C./0000-0002-7565-7002; Rogosch, Tobias/0000-0002-1674-1423; Ge, Xin/0000-0001-7491-7805; Zemlin, Michael/0000-0001-9528-7419; Reddy, Sai/0000-0002-9177-0857	Cancer Prevention and Research Institute of Texas; Clayton Foundation; Defense Advanced Research Projects Agency; Deutsche Forschungsgemeinschaft; National Institutes of Health	Cancer Prevention and Research Institute of Texas; Clayton Foundation; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by the Cancer Prevention and Research Institute of Texas; the Clayton Foundation; the Defense Advanced Research Projects Agency; Deutsche Forschungsgemeinschaft; and the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker P. D., 2010, PLOS ONE, V5; Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; Brehm MA, 2010, CLIN IMMUNOL, V135, P84, DOI 10.1016/j.clim.2009.12.008; BREZINSCHEK HP, 1995, J IMMUNOL, V155, P190; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Cancro MP, 2004, J IMMUNOL, V173, P15, DOI 10.4049/jimmunol.173.1.15; Cappione A, 2005, J CLIN INVEST, V115, P3205, DOI 10.1172/JCI24179; Dorner T, 2005, CLIN EXP MED, V4, P159, DOI 10.1007/s10238-004-0051-2; EISENBERG D, 1984, ANNU REV BIOCHEM, V53, P595, DOI 10.1146/annurev.bi.53.070184.003115; Giassi LJ, 2008, EXP BIOL MED, V233, P997, DOI 10.3181/0802-RM-70; Glanville J, 2011, P NATL ACAD SCI USA, V108, P20066, DOI 10.1073/pnas.1107498108; Glanville J, 2009, P NATL ACAD SCI USA, V106, P20216, DOI 10.1073/pnas.0909775106; Ippolito GC, 2006, J EXP MED, V203, P1567, DOI 10.1084/jem.20052217; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Ishikawa F, 2007, BLOOD, V110, P3591, DOI 10.1182/blood-2007-02-071613; Ito R, 2008, CURR TOP MICROBIOL, V324, P95; JEONG HD, 1989, J IMMUNOL, V143, P2752; Jiang N, 2011, P NATL ACAD SCI USA, V108, P5348, DOI 10.1073/pnas.1014277108; KABAT EA, 1991, J IMMUNOL, V147, P1709; Kolar GR, 2006, SCAND J IMMUNOL, V64, P314, DOI 10.1111/j.1365-3083.2006.01817.x; Kolar GR, 2004, BLOOD, V104, P2981, DOI 10.1182/blood-2003-11-3961; Foreman AL, 2007, AUTOIMMUN REV, V6, P387, DOI 10.1016/j.autrev.2006.12.005; Lim TS, 2010, NEW BIOTECHNOL, V27, P108, DOI 10.1016/j.nbt.2010.01.001; Manz MG, 2007, IMMUNITY, V26, P537, DOI 10.1016/j.immuni.2007.05.001; Manz Markus G, 2009, Nat Immunol, V10, P1039, DOI 10.1038/ni1009-1039; Maynard Jennifer A, 2002, Methods Mol Biol, V182, P149; Meffre E, 2001, J CLIN INVEST, V108, P879, DOI 10.1172/JCI13051; Meyers G, 2011, P NATL ACAD SCI US; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; Nikbakht N, 2011, J IMMUNOL, V187, P37, DOI 10.4049/jimmunol.1003924; PADLAN EA, 1994, MOL IMMUNOL, V31, P169, DOI 10.1016/0161-5890(94)90001-9; PASCUAL V, 1991, J IMMUNOL, V146, P4385; Prak ETL, 2011, ANN NY ACAD SCI, V1217, P96, DOI 10.1111/j.1749-6632.2010.05877.x; Pugh-Bernard AE, 2001, J CLIN INVEST, V108, P1061, DOI 10.1172/JCI12462; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Rao SP, 1999, J IMMUNOL, V163, P2732; Reddy ST, 2010, NAT BIOTECHNOL, V28, P965, DOI 10.1038/nbt.1673; Rogosch T, 2010, J IMMUNOL, V184, P4947, DOI 10.4049/jimmunol.0900859; Rossi MID, 2001, J IMMUNOL, V167, P3033, DOI 10.4049/jimmunol.167.6.3033; Sblattero D, 1998, IMMUNOTECHNOLOGY, V3, P271, DOI 10.1016/S1380-2933(97)10004-5; Schroeder HW, 1998, VACCINE, V16, P1383, DOI 10.1016/S0264-410X(98)00096-6; Schroeder HW, 2006, DEV COMP IMMUNOL, V30, P119, DOI 10.1016/j.dci.2005.06.006; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; SILBERSTEIN LE, 1991, BLOOD, V78, P2372; Stadanlick JE, 2008, CURR OPIN IMMUNOL, V20, P158, DOI 10.1016/j.coi.2008.03.015; Stollar BD, 1995, ANN NY ACAD SCI, V764, P265; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Warren RL, 2010, GENOME RES; Weinstein JA, 2009, SCIENCE, V324, P807, DOI 10.1126/science.1170020; Willinger T, 2011, TRENDS IMMUNOL, V32, P321, DOI 10.1016/j.it.2011.04.005; Wu YC, 2010, BLOOD, V116, P1070, DOI 10.1182/blood-2010-03-275859; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6; YAMADA M, 1991, J EXP MED, V173, P395, DOI 10.1084/jem.173.2.395; Yurasov S, 2005, J EXP MED, V201, P703, DOI 10.1084/jem.20042251; Yurasov S, 2007, CURR OPIN RHEUMATOL, V19, P421, DOI 10.1097/BOR.0b013e328277ef3b; Zheng NY, 2004, J CLIN INVEST, V113, P1188, DOI 10.1172/JCI200420255	57	58	62	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35497	10.1371/journal.pone.0035497	http://dx.doi.org/10.1371/journal.pone.0035497			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558161	Green Published, gold			2022-12-27	WOS:000305336000035
J	Mendez-Rios, JD; Martens, CA; Bruno, DP; Porcella, SF; Zheng, ZM; Moss, B				Mendez-Rios, Jorge D.; Martens, Craig A.; Bruno, Daniel P.; Porcella, Stephen F.; Zheng, Zhi-Ming; Moss, Bernard			Genome Sequence of Erythromelalgia-Related Poxvirus Identifies it as an Ectromelia Virus Strain	PLOS ONE			English	Article							INFECTIOUS ECTROMELIA; CAUSATIVE AGENT; VACCINIA; ANTIBODY	Erythromelagia is a condition characterized by attacks of burning pain and inflammation in the extremeties. An epidemic form of this syndrome occurs in secondary students in rural China and a virus referred to as erythromelalgia-associated poxvirus (ERPV) was reported to have been recovered from throat swabs in 1987. Studies performed at the time suggested that ERPV belongs to the orthopoxvirus genus and has similarities with ectromelia virus, the causative agent of mousepox. We have determined the complete genome sequence of ERPV and demonstrated that it has 99.8% identity to the Naval strain of ectromelia virus and a slighly lower identity to the Moscow strain. Small DNA deletions in the Naval genome that are absent from ERPV may suggest that the sequenced strain of Naval was not the immediate progenitor of ERPV.	[Mendez-Rios, Jorge D.; Moss, Bernard] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA; [Mendez-Rios, Jorge D.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Martens, Craig A.; Bruno, Daniel P.; Porcella, Stephen F.] NIAID, Res Technol Sect, Rocky Mt Labs, NIH, Hamilton, MT USA; [Zheng, Zhi-Ming] NCI, HIV & AIDS Malignancy Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Mendez-Rios, JD (corresponding author), NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA.	bmoss@nih.gov	Zheng, Zhi-Ming/L-6383-2019	Zheng, Zhi-Ming/0000-0001-5547-7912; Moss, Bernard/0000-0002-2154-8564; Mendez Rios, Jorge/0000-0001-8501-9672	Division of Intramural Research; NIAID; NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI001052, ZIAAI000979] Funding Source: NIH RePORTER	Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The word was supported by the Division of Intramural Research, NIAID, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejo A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005175; Carroll DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023086; Chen NH, 2003, VIROLOGY, V317, P165, DOI 10.1016/S0042-6822(03)00520-8; Chen X, 2003, ACAD J GUANGDONG COL, V19, P191; Damon IK, 2007, FIELDS VIROLOGY, P2947; Dick EJ, 1996, LAB ANIM SCI, V46, P602; Earl PL, 1998, CURRENT PROTOCOLS MO; Esteban DJ, 2005, J GEN VIROL, V86, P2645, DOI 10.1099/vir.0.81090-0; FENNER F, 1981, LAB ANIM SCI, V31, P553; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Groppel K., 1962, ARCH EXP VET, V16, P243; Gubser C, 2004, J GEN VIROL, V85, P105, DOI 10.1099/vir.0.19565-0; He J, 1995, CHINESE J ZOONOSES, V11, P54; Davies DH, 2007, PROTEOMICS, V7, P1678, DOI 10.1002/pmic.200600926; KITAMOTO N, 1986, ARCH VIROL, V91, P357, DOI 10.1007/BF01314294; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Labelle P, 2009, COMPARATIVE MED, V59, P180; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lipman NS, 2000, COMPARATIVE MED, V50, P426; Long T., 2005, OCCUPATION HLTH, V21, P713; Marchal J, 1930, J PATHOL BACTERIOL, V33, P713, DOI 10.1002/path.1700330317; MERCHLINSKY M, 1989, J VIROL, V63, P4354, DOI 10.1128/JVI.63.10.4354-4361.1989; Moss B, 2007, FIELDS VIROLOGY; Reed KB, 2009, J EUR ACAD DERMATOL, V23, P13, DOI 10.1111/j.1468-3083.2008.02938.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tcherepanov V, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-150; Waxman SG, 2005, ANN NEUROL, V57, P785, DOI 10.1002/ana.20511; Xie F, 2010, PRACTICAL PREVENTIVE, V17, P1922; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153; ZHENG ZM, 1991, ARCH DERMATOL RES, V283, P535, DOI 10.1007/BF00371930; ZHENG ZM, 1988, LANCET, V1, P296; ZHENG ZM, 1992, J GEN VIROL, V73, P2011, DOI 10.1099/0022-1317-73-8-2011; Zheng ZM, 1988, CHINESE J EXPT CLIN, V2, P43; Zheng ZM, 1987, CHINESE J EXPT CLIN, V1, P34; Zheng ZM, 1988, CHINESE J EXPT CLIN, V2, P4	36	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e34604	10.1371/journal.pone.0034604	http://dx.doi.org/10.1371/journal.pone.0034604			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558090	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000013
J	Porter, TM; Golding, GB				Porter, Teresita M.; Golding, G. Brian			Factors That Affect Large Subunit Ribosomal DNA Amplicon Sequencing Studies of Fungal Communities: Classification Method, Primer Choice, and Error	PLOS ONE			English	Article							GROUP-I INTRONS; SECONDARY STRUCTURE; RARE BIOSPHERE; RNA GENE; PHYLOGENETIC-RELATIONSHIPS; STRUCTURAL CHARACTERISTICS; ECTOMYCORRHIZAL FUNGI; DIVERSITY; RDNA; IDENTIFICATION	Nuclear large subunit ribosomal DNA is widely used in fungal phylogenetics and to an increasing extent also amplicon-based environmental sequencing. The relatively short reads produced by next-generation sequencing, however, makes primer choice and sequence error important variables for obtaining accurate taxonomic classifications. In this simulation study we tested the performance of three classification methods: 1) a similarity-based method (BLAST + Metagenomic Analyzer, MEGAN); 2) a composition-based method (Ribosomal Database Project naive Bayesian classifier, NBC); and, 3) a phylogeny-based method (Statistical Assignment Package, SAP). We also tested the effects of sequence length, primer choice, and sequence error on classification accuracy and perceived community composition. Using a leave-one-out cross validation approach, results for classifications to the genus rank were as follows: BLAST + MEGAN had the lowest error rate and was particularly robust to sequence error; SAP accuracy was highest when long LSU query sequences were classified; and, NBC runs significantly faster than the other tested methods. All methods performed poorly with the shortest 50-100 bp sequences. Increasing simulated sequence error reduced classification accuracy. Community shifts were detected due to sequence error and primer selection even though there was no change in the underlying community composition. Short read datasets from individual primers, as well as pooled datasets, appear to only approximate the true community composition. We hope this work informs investigators of some of the factors that affect the quality and interpretation of their environmental gene surveys.	[Porter, Teresita M.; Golding, G. Brian] McMaster Univ, Hamilton, ON, Canada	McMaster University	Porter, TM (corresponding author), McMaster Univ, Hamilton, ON, Canada.	terri@evol.mcmaster.ca	Porter, Teresita M/H-4072-2011		National Sciences and Engineering Research Council of Canada (NSERC); Genome Canada	National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Genome Canada(Genome Canada)	Funded by an National Sciences and Engineering Research Council of Canada (NSERC) discovery grant and by a Genome Canada grant to GBG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amend AS, 2010, P NATL ACAD SCI USA, V107, P13748, DOI 10.1073/pnas.1000454107; Arnold AE, 2007, MYCOLOGIA, V99, P185, DOI 10.3852/mycologia.99.2.185; Begerow D, 2010, APPL MICROBIOL BIOT, V87, P99, DOI 10.1007/s00253-010-2585-4; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Berger SA, 2011, SYST BIOL, V60, P291, DOI 10.1093/sysbio/syr010; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Brock PM, 2009, NEW PHYTOL, V181, P719, DOI 10.1111/j.1469-8137.2008.02703.x; BRUNS TD, 1991, ANNU REV ECOL SYST, V22, P525, DOI 10.1146/annurev.es.22.110191.002521; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Faith DP, 2009, INT J MOL SCI, V10, P4723, DOI 10.3390/ijms10114723; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Fell JW, 2000, INT J SYST EVOL MICR, V50, P1351, DOI 10.1099/00207713-50-3-1351; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; HASSOUNA N, 1984, NUCLEIC ACIDS RES, V12, P3563, DOI 10.1093/nar/12.8.3563; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; HAWKSWORTH DL, 1991, MYCOL RES, V95, P641, DOI 10.1016/S0953-7562(09)80810-1; Hibbett D, 2011, NEW PHYTOL, V191, P592, DOI 10.1111/j.1469-8137.2011.03819.x; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Hibbett David S., 2011, Fungal Biology Reviews, V25, P38, DOI 10.1016/j.fbr.2011.01.001; Hibbett DS, 1996, MOL BIOL EVOL, V13, P903, DOI 10.1093/oxfordjournals.molbev.a025658; Holst-Jensen A, 1999, MOL BIOL EVOL, V16, P114, DOI 10.1093/oxfordjournals.molbev.a026031; Hopple JS, 1999, MOL PHYLOGENET EVOL, V13, P1, DOI 10.1006/mpev.1999.0634; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Jones MDM, 2011, NATURE, V474, P200, DOI 10.1038/nature09984; Karen O, 1997, NEW PHYTOL, V136, P313, DOI 10.1046/j.1469-8137.1997.00742.x; Kjoller R, 2000, PLANT SOIL, V226, P189, DOI 10.1023/A:1026499923717; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Kruger M, 2009, NEW PHYTOL, V183, P212, DOI 10.1111/j.1469-8137.2009.02835.x; Kuczynski J, 2010, NAT METHODS, V7, P813, DOI [10.1038/NMETH.1499, 10.1038/nmeth.1499]; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Lara E, 2011, PROTIST, V162, P14, DOI 10.1016/j.protis.2010.05.003; Lara E, 2010, PROTIST, V161, P116, DOI 10.1016/j.protis.2009.06.005; Lindner DL, 2011, MYCOLOGIA, V103, P731, DOI 10.3852/10-331; Liu KL, 2012, APPL ENVIRON MICROB, V78, P1523, DOI 10.1128/AEM.06826-11; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Lutzoni F, 2004, AM J BOT, V91, P1446, DOI 10.3732/ajb.91.10.1446; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Meinicke P, 2011, BIOINFORMATICS, V27, P1618, DOI 10.1093/bioinformatics/btr266; MICHOT B, 1982, NUCLEIC ACIDS RES, V10, P5273, DOI 10.1093/nar/10.17.5273; MICHOT B, 1990, EUR J BIOCHEM, V188, P219, DOI 10.1111/j.1432-1033.1990.tb15393.x; MICHOT B, 1984, NUCLEIC ACIDS RES, V12, P4259, DOI 10.1093/nar/12.10.4259; Moncalvo JM, 2002, MOL PHYLOGENET EVOL, V23, P357, DOI 10.1016/S1055-7903(02)00027-1; Moncalvo JM, 2000, SYST BIOL, V49, P278, DOI 10.1093/sysbio/49.2.278; MONCALVO JM, 1993, MYCOLOGIA, V85, P788, DOI 10.2307/3760610; Munch K, 2008, PHILOS T R SOC B, V363, P3997, DOI 10.1098/rstb.2008.0169; Munch K, 2008, SYST BIOL, V57, P750, DOI 10.1080/10635150802422316; Nagahama T, 2011, ENVIRON MICROBIOL, V13, P2359, DOI 10.1111/j.1462-2920.2011.02507.x; Nagy LG, 2011, NEW PHYTOL, V191, P789, DOI 10.1111/j.1469-8137.2011.03707.x; ODONNELL K, 1992, CURR GENET, V22, P213, DOI 10.1007/BF00351728; Ovaskainen O, 2010, FUNGAL ECOL, V3, P274, DOI 10.1016/j.funeco.2010.01.001; Porter TM, 2008, MOL PHYLOGENET EVOL, V46, P635, DOI 10.1016/j.ympev.2007.10.002; Porter TM, 2008, MOL ECOL, V17, P3037, DOI 10.1111/j.1365-294X.2008.03813.x; Porter TM, 2011, NEW PHYTOL, V192, P775, DOI 10.1111/j.1469-8137.2011.03838.x; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Reeder J, 2009, NAT METHODS, V6, P636, DOI 10.1038/nmeth0909-636; REHNER SA, 1994, MYCOL RES, V98, P625, DOI 10.1016/S0953-7562(09)80409-7; Rosen GL, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/495849; Rosen GL, 2011, BIOINFORMATICS, V27, P127, DOI 10.1093/bioinformatics/btq619; Rosling A, 2011, SCIENCE, V333, P876, DOI 10.1126/science.1206958; Schadt CW, 2003, SCIENCE, V301, P1359, DOI 10.1126/science.1086940; Schnare MN, 1996, J MOL BIOL, V256, P701, DOI 10.1006/jmbi.1996.0119; Seifert KA, 2009, MOL ECOL RESOUR, V9, P83, DOI 10.1111/j.1755-0998.2009.02635.x; Simon DM, 2005, CURR GENET, V47, P389, DOI 10.1007/s00294-005-0581-5; Smith ME, 2007, MYCORRHIZA, V18, P15, DOI 10.1007/s00572-007-0148-z; Spatafora J., 2005, MYCOL RES, V109, P755, DOI DOI 10.1017/S0953756205243551; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stockinger H, 2010, NEW PHYTOL, V187, P461, DOI 10.1111/j.1469-8137.2010.03262.x; Stubben C, 2010, GENOMES GENOME SEQUE; Taylor DL, 2007, ENVIRON MICROBIOL, V9, P1329, DOI 10.1111/j.1462-2920.2007.01253.x; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Van Tuinen D, 1998, MOL ECOL, V7, P879, DOI 10.1046/j.1365-294x.1998.00410.x; VELDMAN GM, 1981, NUCLEIC ACIDS RES, V9, P6935, DOI 10.1093/nar/9.24.6935; VILGALYS R, 1990, Journal of Bacteriology, V172, P4238; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; White TJ., 1990, PCR PROTOCOLS GUIDE, P315	93	54	54	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35749	10.1371/journal.pone.0035749	http://dx.doi.org/10.1371/journal.pone.0035749			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558215	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336000056
J	Sarris, PF; Trantas, EA; Mpalantinaki, E; Ververidis, F; Goumas, DE				Sarris, Panagiotis F.; Trantas, Emmanouil A.; Mpalantinaki, Evaggelia; Ververidis, Filippos; Goumas, Dimitrios E.			Pseudomonas viridiflava, a Multi Host Plant Pathogen with Significant Genetic Variation at the Molecular Level	PLOS ONE			English	Article							FRAGMENT LENGTH POLYMORPHISM; NEIGHBOR-JOINING METHOD; FLUORESCENT PSEUDOMONADS; NUCLEOTIDE-SEQUENCES; GENUS PSEUDOMONAS; SYRINGAE; DIVERSITY; STRAINS; TOMATO; DNA	The pectinolytic species Pseudomonas viridiflava has a wide host range among plants, causing foliar and stem necrotic lesions and basal stem and root rots. However, little is known about the molecular evolution of this species. In this study we investigated the intraspecies genetic variation of P. viridiflava amongst local (Cretan), as well as international isolates of the pathogen. The genetic and phenotypic variability were investigated by molecular fingerprinting (rep-PCR) and partial sequencing of three housekeeping genes (gyrB, rpoD and rpoB), and by biochemical and pathogenicity profiling. The biochemical tests and pathogenicity profiling did not reveal any variability among the isolates studied. However, the molecular fingerprinting patterns and housekeeping gene sequences clearly differentiated them. In a broader phylogenetic comparison of housekeeping gene sequences deposited in GenBank, significant genetic variability at the molecular level was found between isolates of P. viridiflava originated from different host species as well as among isolates from the same host. Our results provide a basis for more comprehensive understanding of the biology, sources and shifts in genetic diversity and evolution of P. viridiflava populations and should support the development of molecular identification tools and epidemiological studies in diseases caused by this species.	[Sarris, Panagiotis F.; Trantas, Emmanouil A.; Mpalantinaki, Evaggelia; Ververidis, Filippos; Goumas, Dimitrios E.] Technol Educ Inst Crete, Sch Agr Technol, Dept Plant Sci, Iraklion, Greece	Hellenic Mediterranean University	Sarris, PF (corresponding author), Technol Educ Inst Crete, Sch Agr Technol, Dept Plant Sci, Iraklion, Greece.	sarrispanos@science.agrool.gr; dgoumas@staff.teicrete.gr	Ververidis, Filippos/AAH-9553-2019; Trantas, Emmanouil/AAM-2974-2021; Sarris, Panagiotis F./N-9978-2015	Sarris, Panagiotis/0000-0001-7000-8997; Ververidis, Filippos/0000-0002-3104-6103; Trantas, Emmanouil/0000-0001-7536-101X				ALIVIZATOS A S, 1986, Annales de l'Institut Phytopathologique Benaki, V15, P41; Anzai Y, 2000, INT J SYST EVOL MICR, V50, P1563, DOI 10.1099/00207713-50-4-1563; Aysan Y, 2003, NEW DIS REPORTS, V7; Aysan Y, DISPERSION BACTERIAL, P51; BILLING E, 1970, J APPL BACTERIOL, V33, P492, DOI 10.1111/j.1365-2672.1970.tb02225.x; Bull CT, 2011, PHYTOPATHOLOGY, V101, P847, DOI 10.1094/PHYTO-11-10-0318; BURKHOLDER WH, 1930, MEMOIRS CORNELL U AG, V127, P1; Chen Qing, 2011, Journal of Plant Sciences, V6, P52, DOI 10.3923/jps.2011.52.65; Clerc A, 1998, APPL ENVIRON MICROB, V64, P1180; Cottyn B, 2009, SYST APPL MICROBIOL, V32, P211, DOI 10.1016/j.syapm.2008.11.006; CROSSE JE, 1963, J APPL BACTERIOL, V26, P159, DOI 10.1111/j.1365-2672.1963.tb04764.x; Dawson SL, 2002, J MICROBIOL METH, V50, P9, DOI 10.1016/S0167-7012(02)00003-9; DENNY TP, 1988, J GEN MICROBIOL, V134, P1949; DOWSON W. J., 1939, ZENTRALBL BAKT II ABT, V100, P177; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gardan L, 1999, INT J SYST BACTERIOL, V49, P469, DOI 10.1099/00207713-49-2-469; Gonzalez AJ, 2003, APPL ENVIRON MICROB, V69, P2936, DOI 10.1128/AEM.69.5.2936-2941.2003; Goss EM, 2005, GENETICS, V169, P21, DOI 10.1534/genetics.104.031351; Goumans DE, 1998, EUR J PLANT PATHOL, V104, P181, DOI 10.1023/A:1008675704834; Goumas DE, 1999, EUR J PLANT PATHOL, V105, P927, DOI 10.1023/A:1008725818334; HUGH R, 1953, J BACTERIOL, V66, P24, DOI 10.1128/JB.66.1.24-26.1953; JONES JB, 1986, PLANT DIS, V70, P151, DOI 10.1094/PD-70-151; KING EO, 1954, J LAB CLIN MED, V44, P301; LELLIOTT RA, 1966, J APPL BACTERIOL, V29, P470, DOI 10.1111/j.1365-2672.1966.tb03499.x; Little EL, 1998, APPL ENVIRON MICROB, V64, P3818; Louws FJ, 1999, ANNU REV PHYTOPATHOL, V37, P81, DOI 10.1146/annurev.phyto.37.1.81; MALATHRAKIS NE, 1987, ANN APPL BIOL, V111, P115, DOI 10.1111/j.1744-7348.1987.tb01438.x; MANTEL N, 1967, CANCER RES, V27, P209; MISAGHI I, 1969, PHYTOPATHOLOGY, V59, P1436; Mulet M, 2010, ENVIRON MICROBIOL, V12, P1513, DOI 10.1111/j.1462-2920.2010.02181.x; Palencia ER, 2009, J MICROBIOL METH, V79, P1, DOI 10.1016/j.mimet.2009.07.012; Palleroni N., 1984, BERGEYS MANUAL SYSTE, VVolume 1, P141; Parkinson N, 2011, PLANT PATHOL, V60, P338, DOI 10.1111/j.1365-3059.2010.02366.x; Rademaker JLW, 1997, DNA MARKERS, P151; Ramette A, 2006, FEMS MICROBIOL ECOL, V55, P369, DOI 10.1111/j.1574-6941.2005.00052.x; Rumbou A, 2006, PHYTOPATHOLOGY, V96, P501, DOI 10.1094/PHYTO-96-0501; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANDS DC, 1970, J BACTERIOL, V101, P9, DOI 10.1128/JB.101.1.9-23.1970; Sarris P, 2009, PLANT PATHOL, V58, P933, DOI 10.1111/j.1365-3059.2009.02093.x; Sarris PF, 2011, INFECT GENET EVOL, V11, P1352, DOI 10.1016/j.meegid.2011.04.029; Sarris PF, 2010, MOL PLANT PATHOL, V11, P795, DOI 10.1111/j.1364-3703.2010.00644.x; Sarris PF, 2010, NEW DIS REPORTS, V22; Schaad NW, 2003, ANNU REV PHYTOPATHOL, V41, P305, DOI 10.1146/annurev.phyto.41.052002.095435; Scortichini M, 2005, PHYTOPATHOLOGY, V95, P1316, DOI 10.1094/PHYTO-95-1316; Sneath P.H.A., 1973, NUMERICAL TAXONOMY; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL; Tayeb LA, 2005, RES MICROBIOL, V156, P763, DOI 10.1016/j.resmic.2005.02.009; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ustun N, PITH NECROSIS GREENH, P70; Vinuesa P, 1998, APPL ENVIRON MICROB, V64, P2096; Wilson MK, 2009, MICROB ECOL, V58, P843, DOI 10.1007/s00248-009-9571-3; Woo PCY, 2011, DIAGN MICR INFEC DIS, V70, P316, DOI 10.1016/j.diagmicrobio.2011.03.006; Xie M, 2008, T NONFERR METAL SOC, V18, P1392, DOI 10.1016/S1003-6326(09)60014-5; Yamamoto S, 2000, MICROBIOL-SGM, V146, P2385, DOI 10.1099/00221287-146-10-2385; Yamamoto S, 1998, INT J SYST BACTERIOL, V48, P813, DOI 10.1099/00207713-48-3-813; Yamamoto S, 1999, INT J SYST BACTERIOL, V49, P87, DOI 10.1099/00207713-49-1-87	58	30	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36090	10.1371/journal.pone.0036090	http://dx.doi.org/10.1371/journal.pone.0036090			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558343	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000127
J	Vandrangi, P; Sosa, M; Shyy, JYJ; Rodgers, VGJ				Vandrangi, Prashanthi; Sosa, Martha; Shyy, John Y. -J.; Rodgers, Victor G. J.			Flow-Dependent Mass Transfer May Trigger Endothelial Signaling Cascades	PLOS ONE			English	Article							FLUID SHEAR-STRESS; MESSENGER-RNA LEVELS; ARTERIAL WALL SHEAR; INDUCED ATP RELEASE; CELLS IN-VITRO; FACTOR-B CHAIN; GENE-EXPRESSION; GROWTH-FACTOR; CELLULAR MECHANOTRANSDUCTION; BIOMECHANICAL ACTIVATION	It is well known that fluid mechanical forces directly impact endothelial signaling pathways. But while this general observation is clear, less apparent are the underlying mechanisms that initiate these critical signaling processes. This is because fluid mechanical forces can offer a direct mechanical input to possible mechanotransducers as well as alter critical mass transport characteristics (i.e., concentration gradients) of a host of chemical stimuli present in the blood stream. However, it has recently been accepted that mechanotransduction (direct mechanical force input), and not mass transfer, is the fundamental mechanism for many hemodynamic force-modulated endothelial signaling pathways and their downstream gene products. This conclusion has been largely based, indirectly, on accepted criteria that correlate signaling behavior and shear rate and shear stress, relative to changes in viscosity. However, in this work, we investigate the negative control for these criteria. Here we computationally and experimentally subject mass-transfer limited systems, independent of mechanotransduction, to the purported criteria. The results showed that the negative control (mass-transfer limited system) produced the same trends that have been used to identify mechanotransduction-dominant systems. Thus, the widely used viscosity-related shear stress and shear rate criteria are insufficient in determining mechanotransduction-dominant systems. Thus, research should continue to consider the importance of mass transfer in triggering signaling cascades.	[Vandrangi, Prashanthi; Sosa, Martha; Rodgers, Victor G. J.] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA; [Shyy, John Y. -J.] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Vandrangi, P (corresponding author), Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA.	vrodgers@engr.ucr.edu	Rodgers, Victor G. J./AAF-3838-2021; Rodgers, Victor G/G-3652-2016	Rodgers, Victor G. J./0000-0002-1857-8025; Rodgers, Victor G/0000-0002-1857-8025				ADAMS DJ, 1989, FASEB J, V3, P2389, DOI 10.1096/fasebj.3.12.2477294; ANDO J, 1994, AM J PHYSIOL, V267, pC679, DOI 10.1152/ajpcell.1994.267.3.C679; ANDO J, 1988, IN VITRO CELL DEV B, V24, P871; BACKX PH, 1989, J GEN PHYSIOL, V93, P963, DOI 10.1085/jgp.93.5.963; CARO CG, 1971, PROC R SOC SER B-BIO, V177, P109, DOI 10.1098/rspb.1971.0019; CARO CG, 1969, NATURE, V223, P1159, DOI 10.1038/2231159a0; CARO CG, 1973, CIRC RES, V32, P187, DOI 10.1161/01.RES.32.2.187; Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; Chen KD, 1999, J BIOL CHEM, V274, P18393, DOI 10.1074/jbc.274.26.18393; Chen K, 2007, ANTIOXID REDOX SIGN, V9, P1097, DOI 10.1089/ars.2007.1594; Chien S, 1998, HYPERTENSION, V31, P162, DOI 10.1161/01.HYP.31.1.162; Comerford A, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2838026; David T, 2003, ANN BIOMED ENG, V31, P1231, DOI 10.1114/1.1615574; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; DEWEY CF, 1981, J BIOMECH ENG-T ASME, V103, P177, DOI 10.1115/1.3138276; DIAMOND SL, 1989, SCIENCE, V243, P1483, DOI 10.1126/science.2467379; DIAMOND SL, 1990, J CELL PHYSIOL, V143, P364, DOI 10.1002/jcp.1041430222; DULL RO, 1992, J VASC RES, V29, P410, DOI 10.1159/000158959; Ethier CR, 2002, ANN BIOMED ENG, V30, P461, DOI 10.1114/1.1468890; Fadel AA, 2009, ANN BIOMED ENG, V37, P943, DOI 10.1007/s10439-009-9658-5; Fisher AB, 2001, AM J PHYSIOL-LUNG C, V281, pL529, DOI 10.1152/ajplung.2001.281.3.L529; FRANGOS JA, 1985, SCIENCE, V227, P1477, DOI 10.1126/science.3883488; FRY DL, 1968, CIRC RES, V22, P165, DOI 10.1161/01.RES.22.2.165; Garcia-Cardena G, 2001, ANN NY ACAD SCI, V947, P1; Garcia-Cardena G, 2001, P NATL ACAD SCI USA, V98, P4478, DOI 10.1073/pnas.071052598; Gimbrone MA, 1997, J CLIN INVEST, V99, P1809, DOI 10.1172/JCI119346; Guilak F, 2010, COMPUTATIONAL MODELI, P49; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597; John K, 2001, ANN BIOMED ENG, V29, P740, DOI 10.1114/1.1397792; KAMIYA A, 1980, AM J PHYSIOL, V239, pH14, DOI 10.1152/ajpheart.1980.239.1.H14; Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200; Konstantopoulos K, 1998, ADV DRUG DELIVER REV, V33, P141, DOI 10.1016/S0169-409X(98)00024-6; Korenaga R, 1997, AM J PHYSIOL-CELL PH, V273, pC1506; Korenaga R, 2001, AM J PHYSIOL-HEART C, V280, pH2214, DOI 10.1152/ajpheart.2001.280.5.H2214; Kosaki K, 1998, CIRC RES, V82, P794, DOI 10.1161/01.RES.82.7.794; KU DN, 1985, ARTERIOSCLEROSIS, V5, P293, DOI 10.1161/01.ATV.5.3.293; LEVESQUE MJ, 1990, BIOMATERIALS, V11, P702, DOI 10.1016/0142-9612(90)90031-K; LEVESQUE MJ, 1986, ARTERIOSCLEROSIS, V6, P220, DOI 10.1161/01.ATV.6.2.220; LEVESQUE MJ, 1985, J BIOMECH ENG-T ASME, V107, P341, DOI 10.1115/1.3138567; MALEK AM, 1994, CIRC RES, V74, P852, DOI 10.1161/01.RES.74.5.852; MALEK AM, 1993, J CLIN INVEST, V92, P2013, DOI 10.1172/JCI116796; MALEK AM, 1994, J HYPERTENS, V12, P989; MITSUMATA M, 1993, AM J PHYSIOL, V265, pH3, DOI 10.1152/ajpheart.1993.265.1.H3; NAGEL T, 1994, J CLIN INVEST, V94, P885, DOI 10.1172/JCI117410; Nakatsuka H, 2006, AM J PHYSIOL-GASTR L, V291, pG26, DOI 10.1152/ajpgi.00467.2005; NEREM RM, 1993, J CARDIOVASC PHARM, V21, pS6, DOI 10.1097/00005344-199321001-00002; NEREM RM, 1981, J BIOMECH ENG-T ASME, V103, P172, DOI 10.1115/1.3138275; NEREM RM, 1992, J BIOMECH ENG-T ASME, V114, P274, DOI 10.1115/1.2891384; Nerem RM, 1985, FED PROC, V107, P341; NOLLERT MU, 1989, BIOCHIM BIOPHYS ACTA, V1005, P72, DOI 10.1016/0005-2760(89)90033-7; NOLLERT MU, 1991, BIOTECHNOL BIOENG, V38, P588, DOI 10.1002/bit.260380605; NOLLERT MU, 1990, BIOCHEM BIOPH RES CO, V170, P281, DOI 10.1016/0006-291X(90)91271-S; Obi S, 2009, J APPL PHYSIOL, V106, P203, DOI 10.1152/japplphysiol.00197.2008; Olgac U, 2008, AM J PHYSIOL-HEART C, V294, pH909, DOI 10.1152/ajpheart.01082.2007; PATRICK CW, 1995, BLOOD PURIFICAT, V13, P112; Plank MJ, 2006, PROG BIOPHYS MOL BIO, V91, P287, DOI 10.1016/j.pbiomolbio.2005.07.005; Qin KR, 2008, BIOMECH MODEL MECHAN, V7, P345, DOI 10.1007/s10237-007-0088-8; Quarteroni A, 2002, SIAM J NUMER ANAL, V39, P1488, DOI 10.1137/S0036142900369714; RANJAN V, 1995, AM J PHYSIOL-HEART C, V269, pH550, DOI 10.1152/ajpheart.1995.269.2.H550; Rappitsch G, 1997, INT J NUMER METH FL, V25, P847, DOI 10.1002/(SICI)1097-0363(19971015)25:7<847::AID-FLD590>3.0.CO;2-1; RESNICK N, 1993, P NATL ACAD SCI USA, V90, P4591, DOI 10.1073/pnas.90.10.4591; RESNICK N, 1995, FASEB J, V9, P874, DOI 10.1096/fasebj.9.10.7615157; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SAMPATH R, 1995, ANN BIOMED ENG, V23, P247, DOI 10.1007/BF02584426; Schmidt C, 1998, J BIOL CHEM, V273, P5081, DOI 10.1074/jbc.273.9.5081; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Seliktar D, 2001, ANN BIOMED ENG, V29, P923, DOI 10.1114/1.1415522; SHAREFKIN JB, 1991, J VASC SURG, V14, P1; Shi ZD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012196; Shyy JYJ, 1997, CURR OPIN CELL BIOL, V9, P707, DOI 10.1016/S0955-0674(97)80125-1; Tarbell JM, 2003, ANNU REV BIOMED ENG, V5, P79, DOI 10.1146/annurev.bioeng.5.040202.121529; Truskey G., 2009, TRANSPORT PHENOMENA; TSUBOI H, 1995, BIOCHEM BIOPH RES CO, V206, P988, DOI 10.1006/bbrc.1995.1140; Tzima E, 2002, EMBO J, V21, P6791, DOI 10.1093/emboj/cdf688; Uematsu M, 1995, AM J PHYSIOL-CELL PH, V269, pC1371, DOI 10.1152/ajpcell.1995.269.6.C1371; Urbich C, 2000, CIRC RES, V87, P683, DOI 10.1161/01.RES.87.8.683; Wiesner TF, 1996, AM J PHYSIOL-CELL PH, V270, pC1556, DOI 10.1152/ajpcell.1996.270.5.C1556; Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592; Yamamoto K, 2000, CIRC RES, V87, P385; Yamamoto K, 2000, AM J PHYSIOL-HEART C, V279, pH285, DOI 10.1152/ajpheart.2000.279.1.H285; Yamamoto K, 2005, AM J PHYSIOL-HEART C, V288, pH1915, DOI 10.1152/ajpheart.00956.2004	83	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35260	10.1371/journal.pone.0035260	http://dx.doi.org/10.1371/journal.pone.0035260			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558132	gold, Green Published			2022-12-27	WOS:000305336000027
J	Zhao, JQ; Li, S; Jiang, TF; Liu, Z; Zhang, WW; Jian, GL; Qi, FJ				Zhao, Jingqing; Li, Sha; Jiang, Tengfei; Liu, Zhi; Zhang, Wenwei; Jian, Guiliang; Qi, Fangjun			Chilling Stress-The Key Predisposing Factor for Causing Alternaria alternata Infection and Leading to Cotton (Gossypium hirsutum L.) Leaf Senescence	PLOS ONE			English	Article							LIPID-PEROXIDATION; ABSCISIC-ACID; B RADIATION; CELL-DEATH; XYLEM SAP; LEAVES; ARABIDOPSIS; REFLECTANCE; TEMPERATURE; EXPRESSION	Leaf senescence plays a vital role in nutrient recycling and overall capacity to assimilate carbon dioxide. Cotton premature leaf senescence, often accompanied with unexpected short-term low temperature, has been occurring with an increasing frequency in many cotton-growing areas and causes serious reduction in yield and quality of cotton. The key factors for causing and promoting cotton premature leaf senescence are still unclear. In this case, the relationship between the pre-chilling stress and Alternaria alternata infection for causing cotton leaf senescence was investigated under precisely controlled laboratory conditions with four to five leaves stage cotton plants. The results showed short-term chilling stress could cause a certain degree of physiological impairment to cotton leaves, which could be recovered to normal levels in 2-4 days when the chilling stresses were removed. When these chilling stress injured leaves were further inoculated with A. alternata, the pronounced appearance and development of leaf spot disease, and eventually the pronounced symptoms of leaf senescence, occurred on these cotton leaves. The onset of cotton leaf senescence at this condition was also reflected in various physiological indexes such as irreversible increase in malondialdehyde (MDA) content and electrolyte leakage, irreversible decrease in soluble protein content and chlorophyll content, and irreversible damage in leaves' photosynthesis ability. The presented results demonstrated that chilling stress acted as the key predisposing factor for causing A. alternata infection and leading to cotton leaf senescence. It could be expected that the understanding of the key factors causing and promoting cotton leaf senescence would be helpful for taking appropriate management steps to prevent cotton premature leaf senescence.	[Zhao, Jingqing; Li, Sha; Jiang, Tengfei; Liu, Zhi; Zhang, Wenwei; Jian, Guiliang; Qi, Fangjun] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Zhao, JQ (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	fjqi@ippcaas.cn			Xinjiang Production and Construction Corps [2009JC004]; State Key Laboratory of BPDIP, China [SKL2010SR01]; National Genetically Modified Organisms Breeding Major Project [2011ZX08005-004]	Xinjiang Production and Construction Corps; State Key Laboratory of BPDIP, China; National Genetically Modified Organisms Breeding Major Project	This work was supported by the Xinjiang Production and Construction Corps Fund Project (2009JC004), the Special Funding of State Key Laboratory of BPDIP, China (SKL2010SR01), and the National Genetically Modified Organisms Breeding Major Project (2011ZX08005-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASHAN Y, 1984, PHYTOPATHOL Z, V110, P110; BASHAN Y, 1991, CAN J BOT, V69, P2603, DOI 10.1139/b91-324; Bashan Y., 1992, ALTERNARIA BIOL PLAN, P233; BASHI E, 1983, PHYTOPARASITICA, V11, P89, DOI 10.1007/BF02980716; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buchanan-Wollaston V, 2003, PLANT BIOTECHNOL J, V1, P3, DOI 10.1046/j.1467-7652.2003.00004.x; CASSMAN KG, 1989, AGRON J, V81, P870, DOI 10.2134/agronj1989.00021962008100060006x; COTTY PJ, 1987, PLANT DIS, V71, P1082, DOI 10.1094/PD-71-1082; DAVIS ND, 1977, APPL ENVIRON MICROB, V34, P155, DOI 10.1128/AEM.34.2.155-157.1977; Dong HH, 2008, J EXP BOT, V59, P1295, DOI 10.1093/jxb/ern035; [董合忠 Dong Hezhong], 2005, [棉花学报, Cotton Science], V17, P56; Dong HZ, 2006, FIELD CROP RES, V98, P106, DOI 10.1016/j.fcr.2005.12.008; Dong HZ, 2009, PLANT GROWTH REGUL, V59, P93, DOI 10.1007/s10725-009-9392-x; Fourie PH, 2009, AUSTRALAS PLANT PATH, V38, P173, DOI 10.1071/AP08095; Ganieva Rena A., 1998, Turkish Journal of Botany, V22, P217; Gergoff G, 2010, PLANT SCI, V178, P207, DOI 10.1016/j.plantsci.2009.12.003; Gomez F, 2008, POSTHARVEST BIOL TEC, V49, P229, DOI 10.1016/j.postharvbio.2008.02.012; Hillocks R. J., 1992, P191; HORTENSTEINER S, 2004, PLANT CELL DEATH PRO, P189; Humbeck K, 1996, PLANT CELL ENVIRON, V19, P337, DOI 10.1111/j.1365-3040.1996.tb00256.x; Humbeck K, 2003, J EXP BOT, V54, P375, DOI [10.1093/jxb/54.381.375, 10.1093/jxb/erg012]; ISHIDA Y, 1988, PLANT DIS, V72, P892, DOI 10.1094/PD-72-0892; Jia YJ, 2010, PHYSIOL PLANTARUM, V138, P164, DOI 10.1111/j.1399-3054.2009.01300.x; Kakani VG, 2004, PHYSIOL PLANTARUM, V121, P250, DOI 10.1111/j.0031-9317.2004.00314.x; Kargiotidou A, 2010, J EXP BOT, V61, P2991, DOI 10.1093/jxb/erq124; Kim JI, 2011, J EXP BOT, V62, P3981, DOI 10.1093/jxb/err094; KRAMER GF, 1991, PHYTOCHEMISTRY, V30, P2101, DOI 10.1016/0031-9422(91)83595-C; Li Sha, 2011, Cotton Science, V23, P472; Lichtenthaler HK, 1998, ANN NY ACAD SCI, V851, P271, DOI 10.1111/j.1749-6632.1998.tb09002.x; Lim PO, 2005, CURR TOP DEV BIOL, V67, P49, DOI 10.1016/S0070-2153(05)67002-0; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Liu L, 2010, PLANT PROT, V37, P107; Lv SL, 2009, PLANTA, V229, P899, DOI 10.1007/s00425-008-0880-4; MARANI A, 1985, CROP SCI, V25, P798, DOI 10.2135/cropsci1985.0011183X0025000500018x; Markham JE, 2001, MOL PLANT PATHOL, V2, P229, DOI 10.1046/j.1464-6722.2001.00066.x; Mehta YR, 1998, PLANT DIS, V82, P333, DOI 10.1094/PDIS.1998.82.3.333; MILLER JW, 1969, PHYTOPATHOLOGY, V59, P767; NEWTON MARGARET, 1936, CANADIAN JOUR RES SEC C BOT SCI, V14, P89; NISHIMURA S, 1983, ANNU REV PHYTOPATHOL, V21, P87, DOI 10.1146/annurev.py.21.090183.000511; Padaganur G. M., 1989, Journal of the Indian Society for Cotton Improvement, V14, P144; PEEVER TL, 1989, PLANT PHYSIOL, V90, P867, DOI 10.1104/pp.90.3.867; Pettigrew WT, 2003, AGRON J, V95, P1323, DOI 10.2134/agronj2003.1323; RADIN JW, 1981, PLANT PHYSIOL, V67, P115, DOI 10.1104/pp.67.1.115; SCIUMBATO GL, 1974, PLANT DIS REP, V58, P201; Thomas H, 2003, J EXP BOT, V54, P1127, DOI 10.1093/jxb/erg133; Thomma BPHJ, 2003, MOL PLANT PATHOL, V4, P225, DOI 10.1046/J.1364-3703.2003.00173.X; van Doorn WG, 2004, J EXP BOT, V55, P2147, DOI 10.1093/jxb/erh264; Watkins, 1981, COMPENDIUM COTTON DI; WHITE JL, 1977, PHYTOPATHOLOGY, V67, P60, DOI 10.1094/Phyto-67-60; Wingler A, 2006, J EXP BOT, V57, P391, DOI 10.1093/jxb/eri279; Woo HR, 2004, PLANT CELL PHYSIOL, V45, P923, DOI 10.1093/pcp/pch110; Wright P., 1998, Better Crops International, V12, P14; Wright PR, 1999, PLANT SOIL, V211, P231, DOI 10.1023/A:1004652728420; Yong JWH, 2000, PLANT PHYSIOL, V124, P767, DOI 10.1104/pp.124.2.767; Yu H. X, 2007, CHINA COTTON, V34, P41; [董志强 Zhong Zhiqiang], 2005, [核农学报, Acta Agriculturae Nucleatae Sinica], V19, P62; Zhu JianFen, 2010, Cotton Science, V22, P354	58	26	41	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36126	10.1371/journal.pone.0036126	http://dx.doi.org/10.1371/journal.pone.0036126			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558354	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336000133
J	Bradley, EH; Byam, P; Alpern, R; Thompson, JW; Zerihun, A; Abeb, Y; Curry, LA				Bradley, Elizabeth H.; Byam, Patrick; Alpern, Rachelle; Thompson, Jennifer W.; Zerihun, Abraham; Abeb, Yigeremu; Curry, Leslie A.			A Systems Approach to Improving Rural Care in Ethiopia	PLOS ONE			English	Article							MATERNAL HEALTH-CARE; MOTHERHOOD; TANZANIA; QUALITY; EXPERIENCES; CHALLENGES; SERVICES; BARRIERS; OUTCOMES; PROJECT	Background: Multiple interventions have been launched to improve the quality, access, and utilization of primary health care in rural, low-income settings; however, the success of these interventions varies substantially, even within single studies where the measured impact of interventions differs across sites, centers, and regions. Accordingly, we sought to examine the variation in impact of a health systems strengthening intervention and understand factors that might explain the variation in impact across primary health care units. Methodology/Principal Findings: We conducted a mixed methods positive deviance study of 20 Primary Health Care Units (PHCUs) in rural Ethiopia. Using longitudinal data from the Ethiopia Millennium Rural Initiative (EMRI), we identified PHCUs with consistently higher performance (n = 2), most improved performance (n = 3), or consistently lower performance (n = 2) in the provision of antenatal care, HIV testing in antenatal care, and skilled birth attendance rates. Using data from site visits and in-depth interviews (n = 51), we applied the constant comparative method of qualitative data analysis to identify key themes that distinguished PHCUs with different performance trajectories. Key themes that distinguished PHCUs were 1) managerial problem solving capacity, 2) relationship with the woreda (district) health office, and 3) community engagement. In higher performing PHCUs and those with the greatest improvement after the EMRI intervention, health center and health post staff were more able to solve day-to-day problems, staff had better relationships with the woreda health official, and PHCU communities' leadership, particularly religious leadership, were strongly engaged with the health improvement effort. Distance from the nearest city, quality of roads and transportation, and cultural norms did not differ substantially among PHCUs. Conclusions/Significance: Effective health strengthening efforts may require intensive development of managerial problem solving skills, strong relationships with government offices that oversee front-line providers, and committed community leadership to succeed.	[Bradley, Elizabeth H.; Byam, Patrick; Alpern, Rachelle; Thompson, Jennifer W.; Curry, Leslie A.] Yale Univ, Yale Sch Publ Hlth, GHLI, New Haven, CT 06520 USA; [Zerihun, Abraham; Abeb, Yigeremu] CHAI, EMRI, Addis Ababa, Ethiopia	Yale University	Bradley, EH (corresponding author), Yale Univ, Yale Sch Publ Hlth, GHLI, New Haven, CT 06520 USA.	elizabeth.bradley@yale.edu	curry, leslie/AAA-6100-2022; Curry, Leslie A/ABA-1890-2021	curry, leslie/0000-0002-3419-4654; 	Children's Investment Foundation Fund	Children's Investment Foundation Fund	This research was funded through a grant from the Children's Investment Foundation Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia IB, 2010, GLOB HEALTH PROMOT, V17, P39, DOI 10.1177/1757975909356627; Atherton F, 1999, INT J QUAL HEALTH C, V11, P353, DOI 10.1093/intqhc/11.4.353; Bancheno WM, 2010, AIDS CARE, V22, P1130, DOI 10.1080/09540121003615079; Bhutta ZA, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S7; Bradley EH, 2007, HEALTH SERV RES, V42, P1758, DOI 10.1111/j.1475-6773.2006.00684.x; Bradley EH, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-25; Cowan FM, 2010, AIDS, V24, P2533, DOI 10.1097/QAD.0b013e32833e77c9; Curry LA, 2009, CIRCULATION, V119, P1442, DOI 10.1161/CIRCULATIONAHA.107.742775; Delva W, 2010, TROP MED INT HEALTH, V15, P584, DOI 10.1111/j.1365-3156.2010.02499.x; Gabrysch S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000394; Gage AJ, 2007, SOC SCI MED, V65, P1666, DOI 10.1016/j.socscimed.2007.06.001; Hetzel MW, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-83; Hounton S, 2009, GLOBAL HEALTH ACTION, V2, DOI 10.3402/gha.v2i0.1947; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Mrisho M, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-10; Mushi D, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-14; Otchere SA, 2007, INT J GYNECOL OBSTET, V99, P173, DOI 10.1016/j.ijgo.2007.07.004; Parkhurst JO, 2009, HEALTH POLICY PLANN, V24, P377, DOI 10.1093/heapol/czp023; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Reerink IH, 1996, INT J QUAL HEALTH C, V8, P131, DOI 10.1093/intqhc/8.2.131; Solomon Yodit, 2008, Promot Educ, V15, P32, DOI 10.1177/1025382308097696; United Nations, 2011, HUM DEV REP 2011 SUS; van den Boogaard Jossy, 2008, World Health Popul, V10, P34; World Health Organization (WHO), 1978, INT C PRIM HLTH CAR	24	35	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35042	10.1371/journal.pone.0035042	http://dx.doi.org/10.1371/journal.pone.0035042			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VP	22558113	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345200020
J	Eadsforth, TC; Gardiner, M; Maluf, FV; McElroy, S; James, D; Frearson, J; Gray, D; Hunter, WN				Eadsforth, Thomas C.; Gardiner, Mary; Maluf, Fernando V.; McElroy, Stuart; James, Daniel; Frearson, Julie; Gray, David; Hunter, William N.			Assessment of Pseudomonas aeruginosa N-5,N-10-Methylenetetrahydrofolate Dehydrogenase - Cyclohydrolase as a Potential Antibacterial Drug Target	PLOS ONE			English	Article							DIHYDROFOLATE-REDUCTASE INHIBITORS; TRANSPOSON MUTANT LIBRARY; METHYLENETETRAHYDROFOLATE DEHYDROGENASE; ANTIMICROBIAL RESISTANCE; PTERIDINE REDUCTASE; MECHANISM; DEHYDROGENASE/CYCLOHYDROLASE; ANTIFOLATE; PROTEIN; ACID	The bifunctional enzyme methylenetetrahydrofolate dehydrogenase - cyclohydrolase (FolD) is identified as a potential drug target in Gram-negative bacteria, in particular the troublesome Pseudomonas aeruginosa. In order to provide a comprehensive and realistic assessment of the potential of this target for drug discovery we generated a highly efficient recombinant protein production system and purification protocol, characterized the enzyme, carried out screening of two commercial compound libraries by differential scanning fluorimetry, developed a high-throughput enzyme assay and prosecuted a screening campaign against almost 80,000 compounds. The crystal structure of P. aeruginosa FolD was determined at 2.2 angstrom resolution and provided a template for an assessment of druggability and for modelling of ligand complexes as well as for comparisons with the human enzyme. New FolD inhibitors were identified and characterized but the weak levels of enzyme inhibition suggest that these compounds are not optimal starting points for future development. Furthermore, the close similarity of the bacterial and human enzyme structures suggest that selective inhibition might be difficult to attain. In conclusion, although the preliminary biological data indicates that FolD represents a valuable target for the development of new antibacterial drugs, indeed spurred us to investigate it, our screening results and structural data suggest that this would be a difficult enzyme to target with respect to developing the appropriate lead molecules required to underpin a serious drug discovery effort.	[Eadsforth, Thomas C.; Gardiner, Mary; Maluf, Fernando V.; McElroy, Stuart; James, Daniel; Frearson, Julie; Gray, David; Hunter, William N.] Univ Dundee, Div Biol Chem & Drug Discovery, Coll Life Sci, Dundee, Scotland	University of Dundee	Eadsforth, TC (corresponding author), Univ Dundee, Div Biol Chem & Drug Discovery, Coll Life Sci, Dundee, Scotland.	w.n.hunter@dundee.ac.uk	Hunter, William/AAE-3947-2019; Gray, David W/F-6674-2011	Gray, David W/0000-0001-9512-3828	Wellcome Trust [082596, 083481]; European Commission Seventh Framework Programme (FP7)	Wellcome Trust(Wellcome TrustEuropean Commission); European Commission Seventh Framework Programme (FP7)	Funded by The Wellcome Trust (grants 082596 and 083481) and the European Commission Seventh Framework Programme (FP7/2007-2013; Aeropath). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaire M, 1998, STRUCTURE, V6, P173, DOI 10.1016/S0969-2126(98)00019-7; An JH, 2005, MOL CELL PROTEOMICS, V4, P752, DOI 10.1074/mcp.M400159-MCP200; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Corey GR, 2009, CLIN INFECT DIS, V48, pS254, DOI 10.1086/598186; Dawson A, 2006, MOL MICROBIOL, V61, P1457, DOI 10.1111/j.1365-2958.2006.05332.x; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; DeLano DL, PYMOL MOL GRAPHICS S; Eadsforth TC, 2011, MOL BIOCHEM PARASIT; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fauman EB, 2011, CURR OPIN CHEM BIOL, V15, P463, DOI 10.1016/j.cbpa.2011.05.020; Frearson JA, 2007, TRENDS PARASITOL, V23, P589, DOI 10.1016/j.pt.2007.08.019; Gales AC, 2001, CLIN INFECT DIS, V32, pS146, DOI 10.1086/320186; Gallagher LA, 2007, P NATL ACAD SCI USA, V104, P1009, DOI 10.1073/pnas.0606713104; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gourley DG, 2001, NAT STRUCT BIOL, V8, P521, DOI 10.1038/88584; Hawser S, 2006, BIOCHEM PHARMACOL, V71, P941, DOI 10.1016/j.bcp.2005.10.052; Hunter WN, 2009, J BIOL CHEM, V284, P11749, DOI 10.1074/jbc.R800072200; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kerr KG, 2009, J HOSP INFECT, V73, P338, DOI 10.1016/j.jhin.2009.04.020; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Livermore DM, 2002, CLIN INFECT DIS, V34, P634, DOI 10.1086/338782; Lucock M, 2000, MOL GENET METAB, V71, P121, DOI 10.1006/mgme.2000.3027; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Murta SMF, 2009, MOL MICROBIOL, V71, P1386, DOI 10.1111/j.1365-2958.2009.06610.x; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; O'Shea R, 2008, J MED CHEM, V51, P2871, DOI 10.1021/jm700967e; Obritsch MD, 2004, ANTIMICROB AGENTS CH, V48, P4606, DOI 10.1128/AAC.48.12.4606-4610.2004; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Poole K, 2000, ANTIMICROB AGENTS CH, V44, P2233, DOI 10.1128/AAC.44.9.2233-2241.2000; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; Sainsbury S, 2011, J MOL BIOL, V405, P173, DOI 10.1016/j.jmb.2010.10.024; Schmidt A, 2000, BIOCHEMISTRY-US, V39, P6325, DOI 10.1021/bi992734y; Shen BW, 1999, PROTEIN SCI, V8, P1342, DOI 10.1110/ps.8.6.1342; Shih C, 1997, CANCER RES, V57, P1116; Shlaes DM, 2003, CURR OPIN PHARMACOL, V3, P470, DOI 10.1016/j.coph.2003.04.003; Sundararajan S, 2002, J BIOL CHEM, V277, P18703, DOI 10.1074/jbc.M200127200; TAN LUL, 1977, J BIOL CHEM, V252, P1117; Then RL, 2004, J CHEMOTHERAPY, V16, P3, DOI 10.1179/joc.2004.16.1.3; Tonkinson JL, 1998, J PHARMACOL EXP THER, V287, P315; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	47	15	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35973	10.1371/journal.pone.0035973	http://dx.doi.org/10.1371/journal.pone.0035973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558288	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345200100
J	Ke, YZ; Dramiga, J; Schutz, U; Kril, JJ; Ittner, LM; Schroder, H; Gotz, J				Ke, Yazi; Dramiga, Joe; Schuetz, Ulrich; Kril, Jillian J.; Ittner, Lars M.; Schroeder, Hannsjoerg; Goetz, Juergen			Tau-Mediated Nuclear Depletion and Cytoplasmic Accumulation of SFPQ in Alzheimer's and Pick's Disease	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; RNA-SPLICING FACTOR; TRANSGENIC MICE; BINDING PROTEIN; NEURODEGENERATIVE DISORDERS; GENE-EXPRESSION; ANIMAL-MODELS; PATHOLOGY; TDP-43; BETA	Tau dysfunction characterizes neurodegenerative diseases such as Alzheimer's disease (AD) and frontotemporal lobar degeneration (FTLD). Here, we performed an unbiased SAGE (serial analysis of gene expression) of differentially expressed mRNAs in the amygdala of transgenic pR5 mice that express human tau carrying the P301L mutation previously identified in familial cases of FTLD. SAGE identified 29 deregulated transcripts including Sfpq that encodes a nuclear factor implicated in the splicing and regulation of gene expression. To assess the relevance for human disease we analyzed brains from AD, Pick's disease (PiD, a form of FTLD), and control cases. Strikingly, in AD and PiD, both dementias with a tau pathology, affected brain areas showed a virtually complete nuclear depletion of SFPQ in both neurons and astrocytes, along with cytoplasmic accumulation. Accordingly, neurons harboring either AD tangles or Pick bodies were also depleted of SFPQ. Immunoblot analysis of human entorhinal cortex samples revealed reduced SFPQ levels with advanced Braak stages suggesting that the SFPQ pathology may progress together with the tau pathology in AD. To determine a causal role for tau, we stably expressed both wild-type and P301L human tau in human SH-SY5Y neuroblastoma cells, an established cell culture model of tau pathology. The cells were differentiated by two independent methods, mitomycin C-mediated cell cycle arrest or neuronal differentiation with retinoic acid. Confocal microscopy revealed that SFPQ was confined to nuclei in non-transfected wild-type cells, whereas in wild-type and P301L tau over-expressing cells, irrespective of the differentiation method, it formed aggregates in the cytoplasm, suggesting that pathogenic tau drives SFPQ pathology in post-mitotic cells. Our findings add SFPQ to a growing list of transcription factors with an altered nucleo-cytoplasmic distribution under neurodegenerative conditions.	[Ke, Yazi; Ittner, Lars M.; Goetz, Juergen] Univ Sydney, Brain & Mind Res Inst, Alzheimers & Parkinsons Dis Lab, Camperdown, NSW, Australia; [Dramiga, Joe; Schuetz, Ulrich; Schroeder, Hannsjoerg] Univ Cologne, Dept Anat & Neuroanat 2, D-50931 Cologne, Germany; [Dramiga, Joe; Schuetz, Ulrich; Schroeder, Hannsjoerg] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Kril, Jillian J.] Univ Sydney, Discipline Med, Sydney, NSW 2006, Australia; [Kril, Jillian J.] Univ Sydney, Discipline Pathol, Sydney, NSW 2006, Australia	University of Sydney; University of Cologne; University of Cologne; University of Sydney; University of Sydney	Ke, YZ (corresponding author), Univ Sydney, Brain & Mind Res Inst, Alzheimers & Parkinsons Dis Lab, Camperdown, NSW, Australia.	schroeder.anatomie@uni-koeln.de; juergen.goetz@sydney.edu.au	Götz, Jürgen/C-2448-2014; Ke, Yazi/ABC-3052-2020	Götz, Jürgen/0000-0001-8501-7896; Ke, Yazi/0000-0002-1423-0451; Kril, Jillian/0000-0001-9407-8674; Ittner, Lars/0000-0001-6738-3825	NHMRC (National Health & Medical Research Council); ARC (Australian Research Council); J.O. & J.R. Wicking Trust; Center for Molecular Medicine Cologne [TV79]	NHMRC (National Health & Medical Research Council); ARC (Australian Research Council)(Australian Research Council); J.O. & J.R. Wicking Trust; Center for Molecular Medicine Cologne	The authors acknowledge funding by the NHMRC (National Health & Medical Research Council), the ARC (Australian Research Council), and the J.O. & J.R. Wicking Trust, as well as the Center for Molecular Medicine Cologne (TV79). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Boutin JA, 2009, CELL MOL LIFE SCI, V66, P3009, DOI 10.1007/s00018-009-0056-9; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Chen F, 2004, P NATL ACAD SCI USA, V101, P7687, DOI 10.1073/pnas.0402338101; Choi P, 2003, MOL BRAIN RES, V117, P179, DOI 10.1016/S0169-328X(03)00318-8; Cook C, 2008, EXPERT OPIN BIOL TH, V8, P969, DOI 10.1517/14712598.8.7.969 ; David DC, 2005, PROG NEUROBIOL, V76, P153, DOI 10.1016/j.pneurobio.2005.07.001; David DC, 2005, J BIOL CHEM, V280, P23802, DOI 10.1074/jbc.M500356200; Deters N, 2008, EUR J NEUROSCI, V28, P137, DOI 10.1111/j.1460-9568.2008.06318.x; Deters N, 2009, BIOCHEM BIOPH RES CO, V379, P400, DOI 10.1016/j.bbrc.2008.12.140; DiProspero NA, 2004, J NEUROCYTOL, V33, P517, DOI 10.1007/s11068-004-0514-8; Eckert A, 2008, NEURODEGENER DIS, V5, P157, DOI 10.1159/000113689; Estey MP, 2011, CURR BIOL, V21, pR384, DOI 10.1016/j.cub.2011.03.067; Ferrari A, 2003, J BIOL CHEM, V278, P40162, DOI 10.1074/jbc.M308243200; Gotz J, 2001, BRAIN RES REV, V35, P266, DOI 10.1016/S0165-0173(01)00055-8; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Hall-Pogar T, 2007, RNA, V13, P1103, DOI 10.1261/rna.577707; Harigaya Y, 1996, J NEUROSCI RES, V43, P87, DOI 10.1002/jnr.490430111; HOLT IJ, 1989, LANCET, V1, P524; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; Julien C, 2008, J NEUROSCI RES, V86, P2292, DOI 10.1002/jnr.21667; Kaneko S, 2007, GENE DEV, V21, P1779, DOI 10.1101/gad.1565207; Kovacech B, 2009, CELL MOL NEUROBIOL, V29, P799, DOI 10.1007/s10571-009-9358-6; Krupka N, 2010, PLASMID, V63, P155, DOI 10.1016/j.plasmid.2010.01.002; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lowery LA, 2007, DEV DYNAM, V236, P1347, DOI 10.1002/dvdy.21132; Martin JA, 2011, CURR BIOL, V21, P97, DOI 10.1016/j.cub.2010.12.014; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Patel VP, 2011, INT J CLIN EXP PATHO, V4, P215; PATTON JG, 1993, GENE DEV, V7, P393, DOI 10.1101/gad.7.3.393; Pennanen L, 2006, GENES BRAIN BEHAV, V5, P369, DOI 10.1111/j.1601-183X.2005.00165.x; Pennanen L, 2004, NEUROBIOL DIS, V15, P500, DOI 10.1016/j.nbd.2003.11.020; Rhein V, 2009, P NATL ACAD SCI USA, V106, P20057, DOI 10.1073/pnas.0905529106; SARAIVA MJM, 1986, J LAB CLIN MED, V108, P17; Schild A, 2006, INT J DEV NEUROSCI, V24, P437, DOI 10.1016/j.ijdevneu.2006.08.005; Sewer MB, 2002, ENDOCRINOLOGY, V143, P1280, DOI 10.1210/en.143.4.1280; Shav-Tal Y, 2001, MOL BIOL CELL, V12, P2328, DOI 10.1091/mbc.12.8.2328; Song X, 2005, P NATL ACAD SCI USA, V102, P12189, DOI 10.1073/pnas.0505179102; Stork O, 2001, LEARN MEMORY, V8, P209, DOI 10.1101/lm.39401; Straub T, 1998, J BIOL CHEM, V273, P26261, DOI 10.1074/jbc.273.41.26261; Sultan A, 2011, J BIOL CHEM, V286, P4566, DOI 10.1074/jbc.M110.199976; Tannenberg RK, 2006, NEUROCHEM INT, V49, P631, DOI 10.1016/j.neuint.2006.05.004; Tapia-Paez I, 2008, FASEB J, V22, P3001, DOI 10.1096/fj.07-104455; Urban RJ, 2000, MOL ENDOCRINOL, V14, P774, DOI 10.1210/me.14.6.774; Urwin H, 2010, ACTA NEUROPATHOL, V120, P33, DOI 10.1007/s00401-010-0698-6; van Eersel J, 2010, P NATL ACAD SCI USA, V107, P13888, DOI 10.1073/pnas.1009038107; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Xu J, 2005, HUM MOL GENET, V14, P1231, DOI 10.1093/hmg/ddi134; Yoshida T, 2010, INT J MOL MED, V25, P649, DOI 10.3892/ijmm_00000388; Yu P, 2002, GENOMICS, V79, P869, DOI 10.1006/geno.2002.6770	53	71	73	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35678	10.1371/journal.pone.0035678	http://dx.doi.org/10.1371/journal.pone.0035678			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558197	gold, Green Submitted, Green Published			2022-12-27	WOS:000305345200065
J	O'Dwyer, L; Lamberton, F; Matura, S; Scheibe, M; Miller, J; Rujescu, D; Prvulovic, D; Hampel, H				O'Dwyer, Laurence; Lamberton, Franck; Matura, Silke; Scheibe, Monika; Miller, Julia; Rujescu, Dan; Prvulovic, David; Hampel, Harald			White Matter Differences between Healthy Young ApoE4 Carriers and Non-Carriers Identified with Tractography and Support Vector Machines	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; APOLIPOPROTEIN-E GENOTYPES; E EPSILON-4 CARRIERS; ALZHEIMERS-DISEASE; GENETIC RISK; WORKING-MEMORY; OLDER-ADULTS; LEARNING ALGORITHMS; ENTORHINAL CORTEX; ONSET ALZHEIMERS	The apolipoprotein E4 (ApoE4) is an established risk factor for Alzheimer's disease (AD). Previous work has shown that this allele is associated with functional (fMRI) changes as well structural grey matter (GM) changes in healthy young, middle-aged and older subjects. Here, we assess the diffusion characteristics and the white matter (WM) tracts of healthy young (20-38 years) ApoE4 carriers and non-carriers. No significant differences in diffusion indices were found between young carriers (ApoE4+) and non-carriers (ApoE4-). There were also no significant differences between the groups in terms of normalised GM or WM volume. A feature selection algorithm (ReliefF) was used to select the most salient voxels from the diffusion data for subsequent classification with support vector machines (SVMs). SVMs were capable of classifying ApoE4 carrier and non-carrier groups with an extremely high level of accuracy. The top 500 voxels selected by ReliefF were then used as seeds for tractography which identified a WM network that included regions of the parietal lobe, the cingulum bundle and the dorsolateral frontal lobe. There was a non-significant decrease in volume of this WM network in the ApoE4 carrier group. Our results indicate that there are subtle WM differences between healthy young ApoE4 carriers and non-carriers and that the WM network identified may be particularly vulnerable to further degeneration in ApoE4 carriers as they enter middle and old age.	[O'Dwyer, Laurence; Matura, Silke; Scheibe, Monika; Miller, Julia; Prvulovic, David; Hampel, Harald] Goethe Univ Frankfurt, Dept Psychiat Psychosomat Med & Psychotherapy, Frankfurt, Germany; [Lamberton, Franck] Univ Caen & Paris Descartes, Ctr Imaging Neurosci & Applicat Pathol, CEA, CNRS,UMR 6232, Caen, France; [Rujescu, Dan] Univ Munich, Dept Psychiat, D-8000 Munich, Germany; [Rujescu, Dan] Univ Halle Wittenberg, Dept Psychiat, Halle, Germany	Goethe University Frankfurt; CEA; Centre National de la Recherche Scientifique (CNRS); Universite de Caen Normandie; University of Munich; Martin Luther University Halle Wittenberg	O'Dwyer, L (corresponding author), Goethe Univ Frankfurt, Dept Psychiat Psychosomat Med & Psychotherapy, Frankfurt, Germany.	larodwyer@gmail.com	Lamberton, Franck/GRO-7517-2022; Rujescu, Dan/GRS-3875-2022; O'Dwyer, Laurence/J-1699-2012	Hampel, Harald/0000-0003-0894-8982; Lamberton, Franck/0000-0002-4655-4397	School of Medicine, Goethe University, Frankfurt, Germany; Neurodegeneration & Alzheimer's disease research grant of the LOEWE (Landesoffensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz) program "Neuronal Coordination Research Focus Frankfurt'' (NeFF)	School of Medicine, Goethe University, Frankfurt, Germany; Neurodegeneration & Alzheimer's disease research grant of the LOEWE (Landesoffensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz) program "Neuronal Coordination Research Focus Frankfurt'' (NeFF)	This work was supported by institutional research funds of the School of Medicine, Goethe University, Frankfurt, Germany, to HH. This work was also supported by the Neurodegeneration & Alzheimer's disease research grant of the LOEWE (Landesoffensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz) program "Neuronal Coordination Research Focus Frankfurt'' (NeFF) to HH and DP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Acosta-Cabronero J, 2010, BRAIN, V133, P529, DOI 10.1093/brain/awp257; Barboriak DP, 2000, NEUROLOGY, V54, P2150, DOI 10.1212/WNL.54.11.2150; Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; Becher JC, 2006, J MED GENET, V43, P414, DOI 10.1136/jmg.2005.033936; Beck AT, 1996, PSYCHOL ASSESS; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Benedict R, 1997, BRIEFVISUOSPATIAL ME; Bishop C, 1991, NEURAL COMPUT, V3, P579, DOI 10.1162/neco.1991.3.4.579; Bondi MW, 2005, NEUROLOGY, V64, P501, DOI 10.1212/01.WNL.0000150885.00929.7E; Bondi MW, 2006, ALZHEIMERS DEMENT, V2, pS308, DOI [DOI 10.1016/J.JALZ.2006.05.1085, 10.1016/j.jalz.2006.05.1085]; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Bosch B, 2010, NEUROBIOL AGING; BRUN A, 1986, ANN NEUROL, V19, P253, DOI 10.1002/ana.410190306; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Burggren AC, 2008, NEUROIMAGE, V41, P1177, DOI 10.1016/j.neuroimage.2008.03.039; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Cherbuin N, 2008, J GERONTOL A-BIOL, V63, P501, DOI 10.1093/gerona/63.5.501; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cosentino S, 2008, NEUROLOGY, V70, P1842, DOI 10.1212/01.wnl.0000304038.37421.cc; Cui Y, 2011, NEUROIMAGE; Davis SW, 2012, CEREB CORTEX, V22, P232, DOI 10.1093/cercor/bhr123; Delis DC., 2000, CALIFORNIA VERBAL LE; den Heijer T, 2002, NEUROLOGY, V59, P746, DOI 10.1212/WNL.59.5.746; Dennis NA, 2007, NEUROPSYCHOLOGIA, V45, P3157, DOI 10.1016/j.neuropsychologia.2007.07.003; Dennis NA, 2010, ALZHEIMERS DEMENT, V6, P303, DOI 10.1016/j.jalz.2009.07.003; Du AT, 2006, NEUROBIOL AGING, V27, P733, DOI 10.1016/j.neurobiolaging.2005.03.021; Duan JH, 2006, SURG RADIOL ANAT, V28, P150, DOI 10.1007/s00276-006-0111-2; ENGLUND E, 1990, HISTOPATHOLOGY, V16, P433; Englund E, 1998, DEMENT GERIATR COGN, V9, P6, DOI 10.1159/000051183; Fan Y, 2007, NEUROIMAGE, V36, P1189, DOI 10.1016/j.neuroimage.2007.04.009; Ferrarini L, 2008, NEUROIMAGE, V39, P1832, DOI 10.1016/j.neuroimage.2007.11.003; Filippini N, 2010, NEUROIMAGE; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Filippini N, 2009, NEUROIMAGE, V44, P724, DOI 10.1016/j.neuroimage.2008.10.003; Finch CE, 1999, NEUROBIOL AGING, V20, P407, DOI 10.1016/S0197-4580(99)00053-6; Fouquet M, 2009, BRAIN, V132, P2058, DOI 10.1093/brain/awp132; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Frisoni GB, 1999, NEUROLOGY, V52, P91, DOI 10.1212/WNL.52.1.91; Gold JM, 1997, ARCH GEN PSYCHIAT, V54, P159; Grana M, 2011, NEUROSCI LETT, V502, P225, DOI 10.1016/j.neulet.2011.07.049; Haller S, 2010, J ALZHEIMERS DIS, V22, P315, DOI 10.3233/JAD-2010-100840; Han SD, 2008, ALZHEIMERS DEMENT, V4, P251, DOI 10.1016/j.jalz.2008.02.006; Han SD, 2007, NEUROBIOL AGING, V28, P238, DOI 10.1016/j.neurobiolaging.2005.12.013; Han XL, 2007, J NEUROCHEM, V103, P171, DOI 10.1111/j.1471-4159.2007.04708.x; Hautzinger M., 2006, BECK DEPRESSIONS INV; Heise V., 2010, MOL PSYCHIAT; Hubacek JA, 2001, NEUROPSYCHOBIOLOGY, V43, P200, DOI 10.1159/000054890; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kitamura HW, 2004, NEUROSCI LETT, V369, P173, DOI 10.1016/j.neulet.2004.07.084; Kononenko I, 1997, APPL INTELL, V7, P39, DOI 10.1023/A:1008280620621; Lehrl S., 1995, MEHRFACHWAHL WORTSCH; LEHTOVIRTA M, 1995, NEUROSCIENCE, V67, P65, DOI 10.1016/0306-4522(95)00014-A; Lind J, 2006, BRAIN, V129, P1240, DOI 10.1093/brain/awl054; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Mondadori CRA, 2007, CEREB CORTEX, V17, P1934, DOI 10.1093/cercor/bhl103; Morcom AM, 2003, BRAIN, V126, P213, DOI 10.1093/brain/awg020; Nestor PJ, 2003, ANN NEUROL, V54, P343, DOI 10.1002/ana.10669; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Niemann H., 2008, CALIFORNIA VERBAL LE; Nierenberg J, 2005, NEUROREPORT, V16, P1369, DOI 10.1097/01.wnr.0000174058.49521.16; Noble WS, 2006, NAT BIOTECHNOL, V24, P1565, DOI 10.1038/nbt1206-1565; O'Dwyer L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032441; O'Dwyer L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021745; OKUIZUMI K, 1994, NAT GENET, V7, P10, DOI 10.1038/ng0594-10b; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Persson J, 2006, NEUROLOGY, V66, P1029, DOI 10.1212/01.wnl.0000204180.25361.48; PLATT J, 1999, ADV KERNEL METHODS S, V208, P98; Ravaja N, 1997, J BEHAV MED, V20, P571, DOI 10.1023/A:1025518524884; Reiman EM, 2004, P NATL ACAD SCI USA, V101, P284, DOI 10.1073/pnas.2635903100; Reiman EM, 1998, ANN NEUROL, V44, P288, DOI 10.1002/ana.410440226; Reuter-Lorenz PA, 2000, J COGNITIVE NEUROSCI, V12, P174, DOI 10.1162/089892900561814; Robnik-Sikonja M, 2003, MACH LEARN, V53, P23, DOI 10.1023/A:1025667309714; Rose SE, 2000, J NEUROL NEUROSUR PS, V69, P528, DOI 10.1136/jnnp.69.4.528; Salat DH, 2010, NEUROBIOL AGING, V31, P244, DOI 10.1016/j.neurobiolaging.2008.03.013; Schmidt H, 1996, CLIN GENET, V50, P293; Scholkopf B, 1997, IEEE T SIGNAL PROCES, V45, P2758, DOI 10.1109/78.650102; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Shaw P, 2007, LANCET NEUROL, V6, P494, DOI 10.1016/S1474-4422(07)70106-0; Small GW, 2000, P NATL ACAD SCI USA, V97, P6037, DOI 10.1073/pnas.090106797; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2001, J COMPUT ASSIST TOMO, V25, P466, DOI 10.1097/00004728-200105000-00022; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Supek F, 2008, PROTEOMICS, V8, P28, DOI 10.1002/pmic.200700555; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Wechsler D, 1997, WMS 3 ADM SCORING MA; Wee CY, 2011, NEUROIMAGE, V54, P1812, DOI 10.1016/j.neuroimage.2010.10.026; Wierenga CE, 2010, NEUROIMAGE, V51, P1222, DOI 10.1016/j.neuroimage.2010.03.021; Wishart HA, 2006, NEUROLOGY, V67, P1221, DOI 10.1212/01.wnl.0000238079.00472.3a; Wishart HA, 2006, AM J PSYCHIAT, V163, P1603, DOI 10.1176/appi.ajp.163.9.1603; Witten IH, 2011, MOR KAUF D, P1; Yu VWY, 2000, NEUROSCI LETT, V294, P179, DOI 10.1016/S0304-3940(00)01569-X; ZANNIS VI, 1982, J LIPID RES, V23, P911; Zetterberg H, 2002, NEUROSCI LETT, V324, P189, DOI 10.1016/S0304-3940(02)00198-2; Zhang Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-203; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	100	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e36024	10.1371/journal.pone.0036024	http://dx.doi.org/10.1371/journal.pone.0036024			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558310	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345200111
J	Petrucci, E; Pasquini, L; Bernabei, M; Saulle, E; Biffoni, M; Accarpio, F; Sibio, S; Di Giorgio, A; Di Donato, V; Casorelli, A; Benedetti-Panici, P; Testa, U				Petrucci, Eleonora; Pasquini, Luca; Bernabei, Manuela; Saulle, Ernestina; Biffoni, Mauro; Accarpio, Fabio; Sibio, Simone; Di Giorgio, Angelo; Di Donato, Violante; Casorelli, Assunta; Benedetti-Panici, Pierluigi; Testa, Ugo			A Small Molecule SMAC Mimic LBW242 Potentiates TRAIL- and Anticancer Drug-Mediated Cell Death of Ovarian Cancer Cells	PLOS ONE			English	Article							X-LINKED INHIBITOR; NF-KAPPA-B; APOPTOSIS PROTEINS; ACTIVATION; IAPS; SMAC/DIABLO; COMBINATION; RESISTANCE; THERAPIES; BLOCKADE	Background: Ovarian cancer remains a leading cause of death in women and development of new therapies is essential. Second mitochondria derived activator of caspase (SMAC) has been described to sensitize for apoptosis. We have explored the pro-apoptotic activity of LBW242, a mimic of SMAC/DIABLO, on ovarian cancer cell lines (A2780 cells and its chemoresistant derivative A2780/ADR, SKOV3 and HEY cells) and in primary ovarian cancer cells. The effects of LBW242 on ovarian cancer cell lines and primary ovarian cancer cells was determined by cell proliferation, apoptosis and biochemical assays. Principal Findings: LBW242 added alone elicited only a moderate pro-apoptotic effect; however, it strongly synergizes with tumor necrosis factor-related apoptosis inducing ligand (TRAIL) or anticancer drugs in inducing apoptosis of both ovarian cancer cell lines and primary ovarian cancer cells. Mechanistic studies show that LBW242-induced apoptosis in ovarian cancer cells is associated with activation of caspase-8. In line with this mechanism, c-FLIP overexpression inhibits LBW242-mediated apoptosis. Conclusion: LBW242 sensitizes ovarian cancer cells to the antitumor effects of TRAIL and anticancer drugs commonly used in clinic. These observations suggest that the SMAC/DIABLO mimic LBW242 could be of value for the development of experimental strategies for treatment of ovarian cancer.	[Petrucci, Eleonora; Pasquini, Luca; Bernabei, Manuela; Saulle, Ernestina; Biffoni, Mauro; Testa, Ugo] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Accarpio, Fabio; Sibio, Simone; Di Giorgio, Angelo] Univ Roma La Sapienza, Dept Surg Pietro Valdoni, Policlin Umberto I, Rome, Italy; [Di Giorgio, Angelo; Di Donato, Violante; Casorelli, Assunta] Univ Roma La Sapienza, Dept Obstet & Gynaecol, Rome, Italy	Istituto Superiore di Sanita (ISS); Sapienza University Rome; University Hospital Sapienza Rome; Sapienza University Rome	Petrucci, E (corresponding author), Ist Super Sanita, Dept Hematol Oncol & Mol Med, Viale Regina Elena 299, I-00161 Rome, Italy.	u.testa@iss.it	SAULLE, ERNESTINA/J-8834-2016; Biffoni, Mauro/J-8318-2016; Di Donato, Violante/J-1556-2012; Saulle, Ernestina/AAE-4654-2021; Di Donato, Violante/O-1742-2019; pasquini, luca/J-8319-2016; PETRUCCI, ELEONORA/J-8778-2016; Testa, Ugo/J-6472-2016; sibio, simone/A-3639-2019	Biffoni, Mauro/0000-0002-1304-9060; Di Donato, Violante/0000-0002-9254-5790; Di Donato, Violante/0000-0002-9254-5790; pasquini, luca/0000-0002-3484-6288; PETRUCCI, ELEONORA/0000-0001-6459-490X; Testa, Ugo/0000-0001-7900-8942; sibio, simone/0000-0002-5694-951X; saulle, ernestina/0000-0001-6681-6887; Accarpio, Fabio/0000-0001-8317-2323	Italian Health Ministery, Progetto Oncotecnologico	Italian Health Ministery, Progetto Oncotecnologico	This study was supported by the grants from the Italian Health Ministery, Progetto Oncotecnologico to UT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2010, BIOCHEM J, V430, P199, DOI 10.1042/BJ20100814; Chauhan D, 2007, BLOOD, V109, P1220, DOI 10.1182/blood-2006-04-015149; Cheung HH, 2009, CANCER RES, V69, P7729, DOI 10.1158/0008-5472.CAN-09-1794; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Dai Y, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-392; Darding M, 2011, CELL DEATH DIFFER, V18, P1376, DOI 10.1038/cdd.2011.10; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Engel C, 2010, CANCER EPIDEM BIOMAR, V19, P2859, DOI 10.1158/1055-9965.EPI-10-0517; Ferreira CG, 2000, CANCER RES, V60, P7133; Fraser M, 2003, CANCER RES, V63, P7081; Gaither A, 2007, CANCER RES, V67, P11493, DOI 10.1158/0008-5472.CAN-07-5173; Georgakis GV, 2005, BRIT J HAEMATOL, V130, P501, DOI 10.1111/j.1365-2141.2005.05656.x; Griffith TS, 2003, CANCER CHEMOTH PHARM, V52, P175, DOI 10.1007/s00280-003-0656-2; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Lecis D, 2010, BRIT J CANCER, V102, P1707, DOI 10.1038/sj.bjc.6605687; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Lu JF, 2008, CANCER RES, V68, P9384, DOI 10.1158/0008-5472.CAN-08-2655; Lu JF, 2011, MOL CANCER THER, V10, P902, DOI 10.1158/1535-7163.MCT-10-0864; Mehrotra S, 2010, CANCER CELL, V17, P53, DOI 10.1016/j.ccr.2009.11.021; Petersen SL, 2010, P NATL ACAD SCI USA, V107, P11936, DOI 10.1073/pnas.1005667107; Petronelli A, 2009, CANCER LETT, V282, P214, DOI 10.1016/j.canlet.2009.03.018; Petrucci E, 2007, GYNECOL ONCOL, V105, P481, DOI 10.1016/j.ygyno.2007.01.011; Probst BL, 2010, CELL DEATH DIFFER, V17, P1645, DOI 10.1038/cdd.2010.44; Pukac L, 2005, BRIT J CANCER, V92, P1430, DOI 10.1038/sj.bjc.6602487; Ricci MS, 2007, CANCER CELL, V12, P66, DOI 10.1016/j.ccr.2007.05.006; Schimmer AD, 2006, CELL DEATH DIFFER, V13, P179, DOI 10.1038/sj.cdd.4401826; Sharma SK, 2006, INT J PEPT RES THER, V12, P21, DOI 10.1007/s10989-005-9003-2; Sun T, 2007, NAT GENET, V39, P605, DOI 10.1038/ng2030; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vucic D, 2008, CURR CANCER DRUG TAR, V8, P110, DOI 10.2174/156800908783769373; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Weber A, 2010, CELL DEATH DIFFER, V17, P942, DOI 10.1038/cdd.2009.190; Weisberg E, 2007, MOL CANCER THER, V6, P1951, DOI 10.1158/1535-7163.MCT-06-0810; Xu Y, 2011, CLIN CANCER RES, V17, P5412, DOI 10.1158/1078-0432.CCR-11-0426; Ziegler DS, 2008, J CLIN INVEST, V118, P3109, DOI 10.1172/JCI34120	42	27	27	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35073	10.1371/journal.pone.0035073	http://dx.doi.org/10.1371/journal.pone.0035073			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558117	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345200023
J	Rao, SS; Bentil, S; DeJesus, J; Larison, J; Hissong, A; Dupaix, R; Sarkar, A; Winter, JO				Rao, Shreyas S.; Bentil, Sarah; DeJesus, Jessica; Larison, John; Hissong, Alex; Dupaix, Rebecca; Sarkar, Atom; Winter, Jessica O.			Inherent Interfacial Mechanical Gradients in 3D Hydrogels Influence Tumor Cell Behaviors	PLOS ONE			English	Article							SUBSTRATE STIFFNESS; MICROSCALE CONTROL; FORCE MICROSCOPY; MIGRATION; MATRIX; FEEL; ELASTICITY; MOVEMENT; RIGIDITY; ADHESION	Cells sense and respond to the rigidity of their microenvironment by altering their morphology and migration behavior. To examine this response, hydrogels with a range of moduli or mechanical gradients have been developed. Here, we show that edge effects inherent in hydrogels supported on rigid substrates also influence cell behavior. A Matrigel hydrogel was supported on a rigid glass substrate, an interface which computational techniques revealed to yield relative stiffening close to the rigid substrate support. To explore the influence of these gradients in 3D, hydrogels of varying Matrigel content were synthesized and the morphology, spreading, actin organization, and migration of glioblastoma multiforme (GBM) tumor cells were examined at the lowest (< 50 mu m) and highest (> 500 mu m) gel positions. GBMs adopted bipolar morphologies, displayed actin stress fiber formation, and evidenced fast, mesenchymal migration close to the substrate, whereas away from the interface, they adopted more rounded or ellipsoid morphologies, displayed poor actin architecture, and evidenced slow migration with some amoeboid characteristics. Mechanical gradients produced via edge effects could be observed with other hydrogels and substrates and permit observation of responses to multiple mechanical environments in a single hydrogel. Thus, hydrogel-support edge effects could be used to explore mechanosensitivity in a single 3D hydrogel system and should be considered in 3D hydrogel cell culture systems.	[Rao, Shreyas S.; Larison, John; Winter, Jessica O.] Ohio State Univ, William G Lowrie Dept Chem & Biomol Engn, Columbus, OH 43210 USA; [Bentil, Sarah; Dupaix, Rebecca] Ohio State Univ, Dept Mech & Aerosp Engn, Columbus, OH 43210 USA; [DeJesus, Jessica] Ohio State Univ, Dept Neurol Surg, Columbus, OH 43210 USA; [Hissong, Alex; Winter, Jessica O.] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Sarkar, Atom] Geisinger Hlth Syst, Dept Neurosurg & Lab Nanomed, Danville, PA USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Geisinger Health System	Rao, SS (corresponding author), Ohio State Univ, William G Lowrie Dept Chem & Biomol Engn, Columbus, OH 43210 USA.	winter.63@osu.edu	Winter, Jessica O./AAO-5773-2020	Winter, Jessica O./0000-0002-5370-0137; Rao, Shreyas/0000-0001-7649-0171; Bentil, Sarah/0000-0003-3983-0987	National Science Foundation, Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET), Biomedical Engineering (BME) [0854015]; Women in Philanthropy, OSU; H.C. "Slip" Slider Professorship; Pelotonia Graduate Fellowship	National Science Foundation, Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET), Biomedical Engineering (BME); Women in Philanthropy, OSU; H.C. "Slip" Slider Professorship; Pelotonia Graduate Fellowship	The authors would like to acknowledge financial support from the National Science Foundation, Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET), Biomedical Engineering (BME) Award Number 0854015, (to JOW and AS), Women in Philanthropy, OSU (to JOW), the H.C. "Slip" Slider Professorship (to JOW), and a Pelotonia Graduate Fellowship (to SSR). Any opinions, findings, and conclusions expressed in this material are those of the author(s) and do not necessarily reflect those of the Pelotonia Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNSTEIN JJ, 1994, J NEURO-ONCOL, V18, P151, DOI 10.1007/BF01050421; BERNSTEIN JJ, 1991, NEUROSURGERY, V28, P652, DOI 10.1227/00006123-199105000-00003; Buxboim A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194116; Buxboim A, 2010, J CELL SCI, V123, P297, DOI 10.1242/jcs.041186; Cheung YK, 2009, ANGEW CHEM INT EDIT, V48, P7188, DOI 10.1002/anie.200900807; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015; Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/00001756-200212200-00007; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Isenberg BC, 2009, BIOPHYS J, V97, P1313, DOI 10.1016/j.bpj.2009.06.021; Kidoaki A, 2008, J BIOTECHNOL, V133, P225, DOI 10.1016/j.jbiotec.2007.08.015; Kotlarchyk MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020201; Leong WS, 2010, BIOCHEM BIOPH RES CO, V401, P287, DOI 10.1016/j.bbrc.2010.09.052; Lin YC, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041918; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Maloney JM, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.041923; Marklein RA, 2010, SOFT MATTER, V6, P136, DOI 10.1039/b916933d; Merkel R, 2007, BIOPHYS J, V93, P3314, DOI 10.1529/biophysj.107.111328; Nemir S, 2010, BIOTECHNOL BIOENG, V105, P636, DOI 10.1002/bit.22574; Nemir S, 2010, ANN BIOMED ENG, V38, P2, DOI 10.1007/s10439-009-9811-1; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Sant S, 2010, CAN J CHEM ENG, V88, P899, DOI 10.1002/cjce.20411; Sen S, 2009, CELL MOL BIOENG, V2, P39, DOI 10.1007/s12195-009-0052-z; Soofi SS, 2009, J STRUCT BIOL, V167, P216, DOI 10.1016/j.jsb.2009.05.005; Sundararaghavan HG, 2009, BIOTECHNOL BIOENG, V102, P632, DOI 10.1002/bit.22074; Ulrich TA, 2010, BIOMATERIALS, V31, P1875, DOI 10.1016/j.biomaterials.2009.10.047; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; van Dommelen JAW, 2010, J MECH BEHAV BIOMED, V3, P158, DOI 10.1016/j.jmbbm.2009.09.001; Willits RK, 2004, J BIOMAT SCI-POLYM E, V15, P1521, DOI 10.1163/1568562042459698; Winer JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006382; Wong JY, 2003, LANGMUIR, V19, P1908, DOI 10.1021/la026403p; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Zaari N, 2004, ADV MATER, V16, P2133, DOI 10.1002/adma.200400883; Zaman MH, 2005, BIOPHYS J, V89, P1389, DOI 10.1529/biophysj.105.060723; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	36	38	38	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35852	10.1371/journal.pone.0035852	http://dx.doi.org/10.1371/journal.pone.0035852			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558241	Green Published, gold			2022-12-27	WOS:000305345200087
J	Bailey, H; Thorne, C; Semenenko, I; Malyuta, R; Tereschenko, R; Adeyanova, I; Kulakovskaya, E; Ostrovskaya, L; Kvasha, L; Cortina-Borja, M; Townsend, CL				Bailey, Heather; Thorne, Claire; Semenenko, Igor; Malyuta, Ruslan; Tereschenko, Rostislav; Adeyanova, Irina; Kulakovskaya, Elena; Ostrovskaya, Lyudmila; Kvasha, Liliana; Cortina-Borja, Mario; Townsend, Claire L.			Cervical Screening within HIV Care: Findings from an HIV-Positive Cohort in Ukraine	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; SQUAMOUS INTRAEPITHELIAL LESIONS; ACTIVE ANTIRETROVIRAL THERAPY; BACTERIAL VAGINOSIS; WOMEN; CANCER; IMMUNODEFICIENCY; RISK; PREVALENCE; PREVENTION	Introduction: HIV-positive women have an increased risk of invasive cervical cancer but cytologic screening is effective in reducing incidence. Little is known about cervical screening coverage or the prevalence of abnormal cytology among HIV-positive women in Ukraine, which has the most severe HIV epidemic in Europe. Methods: Poisson regression models were fitted to data from 1120 women enrolled at three sites of the Ukraine Cohort Study of HIV-infected Childbearing Women to investigate factors associated with receiving cervical screening as part of HIV care. All women had been diagnosed as HIV-positive before or during their most recent pregnancy. Prevalence of cervical abnormalities (high/low grade squamous intraepithelial lesions) among women who had been screened was estimated, and associated factors explored. Results: Overall, 30% (337/1120) of women had received a cervical screening test as part of HIV care at study enrolment (median 10 months postpartum), a third (115/334) of whom had been tested >12 months previously. In adjusted analyses, women diagnosed as HIV-positive during (vs before) their most recent pregnancy were significantly less likely to have a screening test reported, on adjusting for other potential risk factors (adjusted prevalence ratio (APR) 0.62, 95% CI 0.51-0.75 p<0.01 for 1st/2nd trimester diagnosis and APR 0.42, 95% CI 0.28-0.63 p<0.01 for 3rd trimester/intrapartum diagnosis). Among those with a cervical screening result reported at any time (including follow-up), 21% (68/325) had a finding of cervical abnormality. In adjusted analyses, Herpes simplex virus 2 seropositivity and a recent diagnosis of bacterial vaginosis were associated with an increased risk of abnormal cervical cytology (APR 1.83 95% CI 1.07-3.11 and APR 3.49 95% CI 2.11-5.76 respectively). Conclusions: In this high risk population, cervical screening coverage as part of HIV care was low and could be improved by an organised cervical screening programme for HIV-positive women. Bacterial vaginosis testing and treatment may reduce vulnerability to cervical abnormalities.	[Bailey, Heather; Thorne, Claire; Cortina-Borja, Mario; Townsend, Claire L.] UCL, UCL Inst Child Hlth, MRC Ctr Epidemiol Child Hlth, London, England; [Semenenko, Igor; Malyuta, Ruslan] Perinatal Prevent AIDS Initiat, Odessa, Ukraine; [Tereschenko, Rostislav] Odessa Reg Ctr HIV AIDS, Odessa, Ukraine; [Adeyanova, Irina] Kiev City Ctr HIV AIDS, Kiev, Ukraine; [Kulakovskaya, Elena] Donetsk Reg Ctr HIV AIDS, Donetsk, Ukraine; [Ostrovskaya, Lyudmila] Mykolaiv Reg Ctr HIV AIDS, Mykolaiv, Ukraine; [Kvasha, Liliana] Kriviy Rig City Ctr HIV AIDS, Kriviy Rig, Ukraine	University of London; University College London	Bailey, H (corresponding author), UCL, UCL Inst Child Hlth, MRC Ctr Epidemiol Child Hlth, London, England.	claire.thorne@ucl.ac.uk	Thorne, Claire/C-5943-2008; Kulakovskaya, Elena/ABI-5390-2020; Borja, Mario Cortina/A-3847-2009	Thorne, Claire/0000-0003-0389-1956; Borja, Mario Cortina/0000-0003-0627-2624; Bailey, Heather/0000-0003-3266-1041	Medical Research Council (MRC) Doctoral Training Account Ph.D. Studentship; WellChild Trust through a research training Fellowship; Wellcome Trust Research Career Development Fellowship [081082]; European Union FP6 [PENTA/ECS018865]; EU Seventh Framework Programme under EuroCoord grant [260694]; UK Department of Health's NIHR Biomedical Research Centres funding scheme; MRC in its capacity as the MRC Centre of Epidemiology for Child Health [G0400546]; MRC [G0400546] Funding Source: UKRI; Medical Research Council [G0400546] Funding Source: researchfish	Medical Research Council (MRC) Doctoral Training Account Ph.D. Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); WellChild Trust through a research training Fellowship; Wellcome Trust Research Career Development Fellowship(Wellcome Trust); European Union FP6(European Commission); EU Seventh Framework Programme under EuroCoord grant; UK Department of Health's NIHR Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR)); MRC in its capacity as the MRC Centre of Epidemiology for Child Health(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	HB is supported by a Medical Research Council (MRC) Doctoral Training Account Ph.D. Studentship. CLT is funded by the WellChild Trust through a research training Fellowship. CT holds a Wellcome Trust Research Career Development Fellowship (grant number 081082) which supports the postnatal cohort. The ECS has previously received funding from the European Union FP6 (PENTA/ECS018865) and receives funding from the EU Seventh Framework Programme (FP7/2007-2013) under EuroCoord grant agreement no 260694. Some of this work was undertaken at GOSH/UCL Institute of Child Health which received a proportion of funding from the UK Department of Health's NIHR Biomedical Research Centres funding scheme. The Centre for Paediatric Epidemiology and Biostatistics also benefits from funding support from the MRC in its capacity as the MRC Centre of Epidemiology for Child Health (grant number G0400546). The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahdieh-Grant L, 2004, JNCI-J NATL CANCER I, V96, P1070, DOI 10.1093/jnci/djh192; Allsworth JE, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.02.060; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Boer K, 2010, HIV MED, V11, P368, DOI 10.1111/j.1468-1293.2009.00800.x; Boyle DCM, 2003, INT J GYNECOL CANCER, V13, P159, DOI 10.1046/j.1525-1438.2003.13007.x; Castellsague X, 2007, HPV CERVICAL CANC WO; Castle Philip E, 2003, J Natl Cancer Inst Monogr, P29; Centers for Disease Control and Prevention, 2009, MMWR, V58; Clifford G, 2006, VACCINE, V24, P26, DOI 10.1016/j.vaccine.2006.05.026; Clifford GM, 2005, JNCI-J NATL CANCER I, V97, P425, DOI 10.1093/jnci/dji072; Del Mistro A, 2004, CLIN INFECT DIS, V38, P737, DOI 10.1086/381681; Fakoya A, 2008, HIV MED, V9, P681, DOI 10.1111/j.1468-1293.2008.00634.x; Flannelly G, 2010, BEST PRACT RES CL OB, V24, P51, DOI 10.1016/j.bpobgyn.2009.07.001; Franceschi S, 2007, CLIN INFECT DIS, V45, P510, DOI 10.1086/520022; Franceschi S, 2010, AIDS, V24, P2570, DOI 10.1097/QAD.0b013e32833f39b2; Frisch M, 2000, JNCI-J NATL CANCER I, V92, P1500, DOI 10.1093/jnci/92.18.1500; Gakidou E, 2008, PLOS MED, V5, P863, DOI 10.1371/journal.pmed.0050132; Gillet E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-10; GUIJON F, 1992, INT J GYNECOL OBSTET, V37, P185, DOI 10.1016/0020-7292(92)90379-W; Gustafsson L, 1997, CANCER CAUSE CONTROL, V8, P755, DOI 10.1023/A:1018435522475; Heard I, 2009, CURR OPIN HIV AIDS, V4, P68, DOI 10.1097/COH.0b013e328319bcbe; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2010, GLOB REP UNAIDS REP; King CC, 2011, INFECT DIS OBSTET GY, V2011, DOI DOI 10.1155/2011/; Kitchener H, 2007, INT J CANCER, V121, P2484, DOI 10.1002/ijc.22947; Kojic EM, 2007, CURR OPIN ONCOL, V19, P464, DOI 10.1097/CCO.0b013e3282c8c84c; Kruglov YV, 2008, SEX TRANSM INFECT, V84, pI37, DOI 10.1136/sti.2008.031195; Leitich H, 2003, AM J OBSTET GYNECOL, V189, P139, DOI 10.1067/mob.2003.339; Maiman M, 1998, GYNECOL ONCOL, V68, P233, DOI 10.1006/gyno.1998.4938; Maiman M, 1998, J Natl Cancer Inst Monogr, P43; Massad LS, 2004, AIDS, V18, P109, DOI 10.1097/00002030-200401020-00013; Mbizvo EM, 2005, INT J STD AIDS, V16, P789, DOI 10.1258/095646205774988046; Ministry of Health of Ukraine, 2010, UKR NAT REP MON PROG; Ministry of Health of Ukraine, 2002, 503 MIN HLTH UKR; Minkoff H, 1998, AM J OBSTET GYNECOL, V178, P982, DOI 10.1016/S0002-9378(98)70535-6; Minkoff H, 2010, J INFECT DIS, V201, P681, DOI 10.1086/650467; Moscicki AB, 2001, JAMA-J AM MED ASSOC, V285, P2995, DOI 10.1001/jama.285.23.2995; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Newmann SJ, 2005, CANCER CAUSE CONTROL, V16, P63, DOI 10.1007/s10552-004-1290-y; NHS Cancer Screening Programmes, 2010, COLP PROGR MAN GUID, P20; PETERS N, 1995, SEX TRANSM DIS, V22, P296, DOI 10.1097/00007435-199509000-00005; Peto J, 2004, LANCET, V364, P249, DOI 10.1016/S0140-6736(04)16674-9; PETRY KU, 1994, INT J CANCER, V57, P836, DOI 10.1002/ijc.2910570612; Phelan DF, 2009, SEX TRANSM DIS, V36, P149, DOI 10.1097/OLQ.0b013e31818d3df3; PLATZCHRISTENSEN JJ, 1994, ACTA OBSTET GYN SCAN, V73, P586, DOI 10.3109/00016349409006278; Sawaya GF, 2009, NEW ENGL J MED, V361, P2503, DOI 10.1056/NEJMp0911380; Saxton J, 2010, HUM REPROD, V25, P2366, DOI 10.1093/humrep/deq093; Shah S, 2006, HIV MED, V7, P46, DOI 10.1111/j.1468-1293.2005.00331.x; Smith JS, 2002, JNCI-J NATL CANCER I, V94, P1604, DOI 10.1093/jnci/94.21.1604; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Sun XW, 1997, NEW ENGL J MED, V337, P1343, DOI 10.1056/NEJM199711063371903; Thorne C, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-40; Uberti-Foppa C, 2003, AIDS, V17, P2136, DOI 10.1097/00002030-200309260-00021; Verteramo R, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-16; Watts DH, 2005, J INFECT DIS, V191, P1129, DOI 10.1086/427777; WHO/ICO Information Centre on HPV and Cervical Cancer, 2010, HUM PAP REL CANC UKR; World Health Organization, 2006, WHO CAS DEF HIV SURV; Wright TC, 2007, AM J OBSTET GYNECOL, V197, P340, DOI 10.1016/j.ajog.2007.07.050	57	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e34706	10.1371/journal.pone.0034706	http://dx.doi.org/10.1371/journal.pone.0034706			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545087	gold, Green Submitted, Green Published			2022-12-27	WOS:000305343200010
J	Linnenbaum, M; Busker, M; Kraehling, JR; Behrends, S				Linnenbaum, Monika; Busker, Mareike; Kraehling, Jan R.; Behrends, Soenke			Heme Oxygenase Isoforms Differ in Their Subcellular Trafficking during Hypoxia and Are Differentially Modulated by Cytochrome P450 Reductase	PLOS ONE			English	Article							THIOL/DISULFIDE REDOX SWITCH; P450 OXIDOREDUCTASE; REGULATORY MOTIFS; OXIDATIVE STRESS; LIVER; EXPRESSION; FORM; BINDING; ENZYME; OLIGOMERIZATION	Heme oxygenase (HO) degrades heme in concert with NADPH cytochrome P450 reductase (CPR) which donates electrons to the reaction. Earlier studies reveal the importance of the hydrophobic carboxy-terminus of HO-1 for anchorage to the endoplasmic reticulum (ER) which facilitates the interaction with CPR. In addition, HO-1 has been shown to undergo regulated intramembrane proteolysis of the carboxy-terminus during hypoxia and subsequent translocation to the nucleus. Translocated nuclear HO-1 was demonstrated to alter binding of transcription factors and to alter gene expression. Little is known about the homologous membrane anchor of the HO-2 isoform. The current work is the first systematic analysis in a eukaryotic system that demonstrates the crucial role of the membrane anchor of HO-2 for localization at the endoplasmic reticulum, oligomerization and interaction with CPR. We show that although the carboxy-terminal deletion mutant of HO-2 is found in the nucleus, translocation of HO-2 to the nucleus does not occur under conditions of hypoxia. Thus, we demonstrate that proteolytic regulation and nuclear translocation under hypoxic conditions is specific for HO-1. In addition we show for the first time that CPR prevents this translocation and promotes oligomerization of HO-1. Based on these findings, CPR may modulate gene expression via the amount of nuclear HO-1. This is of particular relevance as CPR is a highly polymorphic gene and deficiency syndromes of CPR have been described in humans.	[Linnenbaum, Monika; Busker, Mareike; Kraehling, Jan R.; Behrends, Soenke] Tech Univ Carolo Wilhelmina Braunschweig, Inst Technol, Dept Pharmacol Toxicol & Clin Pharm, Braunschweig, Germany	Braunschweig University of Technology	Linnenbaum, M (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Technol, Dept Pharmacol Toxicol & Clin Pharm, Braunschweig, Germany.	s.behrends@tu-braunschweig.de	Behrends, Sönke/A-2551-2010; Kraehling, Jan/D-5327-2009	Behrends, Sönke/0000-0002-9068-0729; Kraehling, Jan/0000-0002-0979-2900	Deutsche Forschungsgemeinschaft [INST 188/286-1, BE 1865/5-1]; European cooperation in science and technology program [BM1005]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European cooperation in science and technology program	The study was supported by the Deutsche Forschungsgemeinschaft (INST 188/286-1; BE 1865/5-1) and the European cooperation in science and technology program BM1005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2004, BIOCHEM BIOPH RES CO, V320, P514, DOI 10.1016/j.bbrc.2004.05.195; BRAGGINS PE, 1986, BIOCHEM BIOPH RES CO, V141, P528, DOI 10.1016/S0006-291X(86)80205-4; Efendiev R, 2006, FEBS LETT, V580, P5067, DOI 10.1016/j.febslet.2006.08.035; Elangovan M, 2003, METHODS, V29, P58, DOI 10.1016/S1046-2023(02)00283-9; Fluck CE, 2004, NAT GENET, V36, P228, DOI 10.1038/ng1300; Gomes AM, 2009, PHARMACOGENOMICS, V10, P579, DOI [10.2217/pgs.09.7, 10.2217/PGS.09.7]; Haase N, 2010, J NEUROCHEM, V112, P542, DOI 10.1111/j.1471-4159.2009.06484.x; Haase T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011617; Higashimoto Y, 2008, BIOCHEM BIOPH RES CO, V367, P852, DOI 10.1016/j.bbrc.2008.01.016; Huang N, 2008, P NATL ACAD SCI USA, V105, P1733, DOI 10.1073/pnas.0711621105; Huber WJ, 2007, BIOCHEMISTRY-US, V46, P12212, DOI 10.1021/bi701496z; Huber WJ, 2009, BIOCHEMISTRY-US, V48, P190, DOI 10.1021/bi801912z; Hwang HW, 2009, J BIOL CHEM, V284, P22672, DOI 10.1074/jbc.M109.028001; ISHIKAWA K, 1991, EUR J BIOCHEM, V202, P161, DOI 10.1111/j.1432-1033.1991.tb16357.x; ISHIKAWA K, 1995, J BIOL CHEM, V270, P6345, DOI 10.1074/jbc.270.11.6345; Kang DH, 2002, B KOREAN CHEM SOC, V23, P1511; Kemp PJ, 2005, BIOCHEM BIOPH RES CO, V338, P648, DOI 10.1016/j.bbrc.2005.08.110; Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200; Lin QS, 2008, FREE RADICAL BIO MED, V44, P847, DOI 10.1016/j.freeradbiomed.2007.11.012; MAINES MD, 1974, P NATL ACAD SCI USA, V71, P4293, DOI 10.1073/pnas.71.11.4293; MAINES MD, 1986, J BIOL CHEM, V261, P411; Marohnic CC, 2011, ARCH BIOCHEM BIOPHYS, V513, P42, DOI 10.1016/j.abb.2011.06.008; Miller WL, 2011, MOL CELL ENDOCRINOL, V336, P174, DOI 10.1016/j.mce.2010.10.022; Reed James R, 2011, Drug Metab Lett, V5, P6; SCHACTER BA, 1972, J BIOL CHEM, V247, P3601; Schuller DJ, 1999, NAT STRUCT BIOL, V6, P860; Szczesna-Skorupa E, 2003, J BIOL CHEM, V278, P31269, DOI 10.1074/jbc.M301489200; TENHUNEN R, 1969, J BIOL CHEM, V244, P6388; TRAKSHEL GM, 1986, J BIOL CHEM, V261, P1131; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Wang JL, 2003, J BIOL CHEM, V278, P20069, DOI 10.1074/jbc.M300989200; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; WILKS A, 1993, J BIOL CHEM, V268, P22357; Williams SEJ, 2004, SCIENCE, V306, P2093, DOI 10.1126/science.1105010; Yi L, 2007, J BIOL CHEM, V282, P21056, DOI 10.1074/jbc.M700664200; Yi L, 2009, J BIOL CHEM, V284, P20556, DOI 10.1074/jbc.M109.015651; YOSHIDA T, 1991, EUR J BIOCHEM, V199, P729, DOI 10.1111/j.1432-1033.1991.tb16177.x; YOSHIDA T, 1989, BIOCHEM BIOPH RES CO, V163, P1086, DOI 10.1016/0006-291X(89)92332-2; Youvan D. C., 1997, BIOTECHNOLOGY, V3, P1	39	39	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35483	10.1371/journal.pone.0035483	http://dx.doi.org/10.1371/journal.pone.0035483			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545110	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343200030
J	Duan, WX; Hua, RX; Yi, W; Shen, LJ; Jin, ZX; Zhao, YH; Yi, DH; Chen, WS; Yu, SQ				Duan, Wei-Xun; Hua, Rui-Xi; Yi, Wei; Shen, Li-Jun; Jin, Zhen-Xiao; Zhao, Yu-Hong; Yi, Ding-Hua; Chen, Wen-Sheng; Yu, Shi-Qiang			The Association between OGG1 Ser326Cys Polymorphism and Lung Cancer Susceptibility: A Meta-Analysis of 27 Studies	PLOS ONE			English	Article							BASE-EXCISION-REPAIR; GENETIC SUSCEPTIBILITY; DNA-DAMAGE; RISK; NUCLEOTIDE; EXPRESSION; SMOKING; ENZYME; COAL	Background: Numerous studies have investigated association of OGG1 Ser326Cys polymorphism with lung cancer susceptibility; however, the findings are inconsistent. Therefore, we performed a meta-analysis based on 27 publications encompass 9663 cases and 11348 controls to comprehensively evaluate such associations. Methods: We searched publications from MEDLINE and EMBASE which were assessing the associations between OGG1 Ser326Cys polymorphism and lung cancer risk. We calculated pooled odds ratio (OR) and 95% confidence interval (CI) by using either fixed-effects or random-effects model. We used genotype based mRNA expression data from HapMap for SNP rs1052133 in normal cell lines among 270 subjects with four different ethnicities. Results: The results showed that individuals carrying the Cys/Cys genotype did not have significantly increased risk for lung cancer (OR = 1.15, 95% CI = 0.98-1.36) when compared with the Ser/Ser genotype; similarly, no significant association was found in recessive, dominant or heterozygous co-dominant model (Ser/Cys vs. Cys/Cys). However, markedly increased risks were found in relatively large sample size (Ser/Ser vs. Cys/Cys: OR = 1.29, 95% CI = 1.13-1.48, and recessive model: OR = 1.19, 95% CI = 1.07-1.32). As to histological types, we found the Cys/Cys was associated with adenocarcinoma risk (Ser/Ser vs. Cys/Cys: OR = 1.32, 95% CI = 1.12-1.56; Ser/Cys vs. Cys/Cys: OR = 1.19, 95% CI = 1.04-1.37, and recessive model OR = 1.23, 95% CI = 1.08-1.40). No significant difference of OGG1 mRNA expression was found among genotypes between different ethnicities. Conclusions: Despite some limitations, this meta-analysis established solid statistical evidence for an association between the OGG1 Cys/Cys genotype and lung cancer risk, particularly for studies with large sample size and adenocarcinoma, but this association warrants additional validation in larger and well designed studies.	[Duan, Wei-Xun; Yi, Wei; Jin, Zhen-Xiao; Yi, Ding-Hua; Chen, Wen-Sheng; Yu, Shi-Qiang] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiothorac Surg, Xian 710032, Peoples R China; [Hua, Rui-Xi] Fudan Univ, Dept Med Oncol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Hua, Rui-Xi] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Shen, Li-Jun; Zhao, Yu-Hong] Wenzhou Med Coll, Zhejiang Prov Key Lab Med Genet, Wenzhou, Peoples R China	Air Force Military Medical University; Fudan University; Fudan University; Wenzhou Medical University	Duan, WX (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Cardiothorac Surg, Xian 710032, Peoples R China.	chenws@fmmu.edu.cn; yushiq@fmmu.edu.cn	Jin, Zhenxiao/AAJ-5777-2020	Hua, Rui-Xi/0000-0001-5319-656X; Yu, Shiqiang/0000-0003-3519-0943; Yi, Wei/0000-0002-4349-910X	National Natural Science Foundation of China [81102687, 81070198]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from the National Natural Science Foundation of China (NO. 81102687, NO. 81070198). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonner MR, 2005, MUTAT RES-GEN TOX EN, V582, P53, DOI 10.1016/j.mrgentox.2004.12.008; Chang CH, 2009, AM J EPIDEMIOL, V170, P695, DOI 10.1093/aje/kwp019; Chang JS, 2009, CARCINOGENESIS, V30, P78, DOI 10.1093/carcin/bgn261; Chevillard S, 1998, ONCOGENE, V16, P3083, DOI 10.1038/sj.onc.1202096; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dianov GL, 2001, PROG NUCLEIC ACID RE, V68, P285; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ezzati M, 2003, LANCET, V362, P847, DOI 10.1016/S0140-6736(03)14338-3; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hatt L, 2008, MUTAT RES-FUND MOL M, V639, P45, DOI 10.1016/j.mrfmmm.2007.11.002; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Hill JW, 2007, CANCER DETECT PREV, V31, P237, DOI 10.1016/j.cdp.2007.05.001; Holm K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-600; Hung RJ, 2005, JNCI-J NATL CANCER I, V97, P567, DOI 10.1093/jnci/dji101; Janik J, 2011, MUTAT RES-FUND MOL M, V709-10, P21, DOI 10.1016/j.mrfmmm.2011.02.009; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Karahalil B, 2002, FASEB J, V16, P1895, DOI 10.1096/fj.02-0463com; Karahalil B, 2008, ARH HIG RADA TOKSIKO, V59, P241, DOI 10.2478/10004-1254-59-2008-1924; Klinchid J, 2009, CANCER GENET CYTOGEN, V195, P143, DOI 10.1016/j.cancergencyto.2009.08.011; Kohno T, 2006, CANCER SCI, V97, P724, DOI 10.1111/j.1349-7006.2006.00240.x; Kohno T, 2011, J THORAC ONCOL, V6, P813, DOI 10.1097/JTO.0b013e3181ee80ef; Lan Q, 2004, CARCINOGENESIS, V25, P2177, DOI 10.1093/carcin/bgh240; Le Marchand L, 2002, CANCER EPIDEM BIOMAR, V11, P409; Lee Chul-Ho, 2006, J Prev Med Public Health, V39, P130; Li HX, 2008, CANCER EPIDEM BIOMAR, V17, P1739, DOI 10.1158/1055-9965.EPI-08-0001; Li Z, 2011, ARCH MED RES, V42, P226, DOI 10.1016/j.arcmed.2011.04.005; Liang GY, 2005, CANCER LETT, V223, P265, DOI 10.1016/j.canlet.2004.12.042; Liu CJ, 2010, ANTICANCER RES, V30, P4141; Livneh Z, 2001, J BIOL CHEM, V276, P25639, DOI 10.1074/jbc.R100019200; Mambo E, 2005, ONCOGENE, V24, P4496, DOI 10.1038/sj.onc.1208669; MANTEL N, 1959, J NATL CANCER I, V22, P719; Matullo G, 2006, CARCINOGENESIS, V27, P997, DOI 10.1093/carcin/bgi280; Miyaishi A, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-10; Nohmi T, 2005, MUTAT RES-FUND MOL M, V591, P60, DOI 10.1016/j.mrfmmm.2005.03.033; Okasaka T, 2009, J HUM GENET, V54, P739, DOI 10.1038/jhg.2009.108; Park J, 2004, PHARMACOGENETICS, V14, P103, DOI 10.1097/00008571-200402000-00004; Qian BY, 2011, LUNG CANCER, V73, P138, DOI 10.1016/j.lungcan.2010.11.018; Scharer OD, 2001, BIOESSAYS, V23, P270, DOI 10.1002/1521-1878(200103)23:3<270::AID-BIES1037>3.0.CO;2-J; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Zienolddiny S, 2006, CARCINOGENESIS, V27, P560, DOI 10.1093/carcin/bgi232	41	33	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35970	10.1371/journal.pone.0035970	http://dx.doi.org/10.1371/journal.pone.0035970			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22540013	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341000079
J	Forrester, TE; Badaloo, AV; Boyne, MS; Osmond, C; Thompson, D; Green, C; Taylor-Bryan, C; Barnett, A; Soares-Wynter, S; Hanson, MA; Beedle, AS; Gluckman, PD				Forrester, Terrence E.; Badaloo, Asha V.; Boyne, Michael S.; Osmond, Clive; Thompson, Debbie; Green, Curtis; Taylor-Bryan, Carolyn; Barnett, Alan; Soares-Wynter, Suzanne; Hanson, Mark A.; Beedle, Alan S.; Gluckman, Peter D.			Prenatal Factors Contribute to the Emergence of Kwashiorkor or Marasmus in Severe Undernutrition: Evidence for the Predictive Adaptation Model	PLOS ONE			English	Article							ERYTHROCYTE GLUTATHIONE SYNTHESIS; PROTEIN-ENERGY MALNUTRITION; CHILD UNDERNUTRITION; KINETIC DIFFERENCES; HEALTH; CONSEQUENCES; DISEASE; PLASTICITY; EVOLUTION; OBESITY	Background: Severe acute malnutrition in childhood manifests as oedematous (kwashiorkor, marasmic kwashiorkor) and non-oedematous (marasmus) syndromes with very different prognoses. Kwashiorkor differs from marasmus in the patterns of protein, amino acid and lipid metabolism when patients are acutely ill as well as after rehabilitation to ideal weight for height. Metabolic patterns among marasmic patients define them as metabolically thrifty, while kwashiorkor patients function as metabolically profligate. Such differences might underlie syndromic presentation and prognosis. However, no fundamental explanation exists for these differences in metabolism, nor clinical pictures, given similar exposures to undernutrition. We hypothesized that different developmental trajectories underlie these clinical-metabolic phenotypes: if so this would be strong evidence in support of predictive adaptation model of developmental plasticity. Methodology/Principal Findings: We reviewed the records of all children admitted with severe acute malnutrition to the Tropical Metabolism Research Unit Ward of the University Hospital of the West Indies, Kingston, Jamaica during 1962-1992. We used Wellcome criteria to establish the diagnoses of kwashiorkor (n = 391), marasmus (n = 383), and marasmic-kwashiorkor (n = 375). We recorded participants' birth weights, as determined from maternal recall at the time of admission. Those who developed kwashiorkor had 333 g (95% confidence interval 217 to 449, p<0.001) higher mean birthweight than those who developed marasmus. Conclusions/Significance: These data are consistent with a model suggesting that plastic mechanisms operative in utero induce potential marasmics to develop with a metabolic physiology more able to adapt to postnatal undernutrition than those of higher birthweight. Given the different mortality risks of these different syndromes, this observation is supportive of the predictive adaptive response hypothesis and is the first empirical demonstration of the advantageous effects of such a response in humans. The study has implications for understanding pathways to obesity and its cardio-metabolic co-morbidities in poor countries and for famine intervention programs.	[Forrester, Terrence E.; Badaloo, Asha V.; Boyne, Michael S.; Thompson, Debbie; Green, Curtis; Taylor-Bryan, Carolyn; Barnett, Alan; Soares-Wynter, Suzanne] Univ W Indies, Res Inst Trop Med, Trop Metab Res Unit, Kingston 7, Jamaica; [Osmond, Clive] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Hanson, Mark A.] Univ Southampton, Inst Dev Sci, Southampton, Hants, England; [Forrester, Terrence E.; Beedle, Alan S.; Gluckman, Peter D.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Forrester, Terrence E.; Beedle, Alan S.; Gluckman, Peter D.] Univ Auckland, Natl Res Ctr Growth & Dev, Auckland 1, New Zealand	University West Indies Mona Jamaica; University of Southampton; University of Southampton; University of Auckland; University of Auckland	Forrester, TE (corresponding author), Univ W Indies, Res Inst Trop Med, Trop Metab Res Unit, Kingston 7, Jamaica.	terrence.forrester@uwimona.edu.jm	Thompson, Debbie S/AAE-8408-2022; Boyne, Michael/AAC-3675-2020; Boyne, Michael S/I-2242-2013; Hanson, Mark/AAE-8236-2019	Thompson, Debbie S/0000-0001-6781-7646; Boyne, Michael/0000-0002-5227-2492; Boyne, Michael S/0000-0002-5227-2492; Hanson, Mark/0000-0002-6907-613X; Osmond, Clive/0000-0002-9054-4655; badaloo, asha/0000-0001-9555-3967	National Institutes of Health [5RO1 DK06689-08-12]; Health Research Council of New Zealand; National Research Centre for Growth and Development (New Zealand); Medical Research Council [MC_UP_A620_1017, MC_UP_A620_1016] Funding Source: researchfish; MRC [MC_UP_A620_1016, MC_UP_A620_1017] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Health Research Council of New Zealand(Health Research Council of New Zealand); National Research Centre for Growth and Development (New Zealand); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the National Institutes of Health (5RO1 DK06689-08-12), the Health Research Council of New Zealand, and the National Research Centre for Growth and Development (New Zealand). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badaloo A, 2002, AM J CLIN NUTR, V76, P646, DOI 10.1093/ajcn/76.3.646; Badaloo AV, 2006, AM J CLIN NUTR, V83, P1283, DOI 10.1093/ajcn/83.6.1283; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Gaskin P, 1997, AM J PUBLIC HEALTH, V87, P114, DOI 10.2105/AJPH.87.1.114; Gluckman PD, 2005, P ROY SOC B-BIOL SCI, V272, P671, DOI 10.1098/rspb.2004.3001; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gluckman PD, 2007, P NATL ACAD SCI USA, V104, P12796, DOI 10.1073/pnas.0705667104; Godfrey KM, 2011, DIABETES, V60, P1528, DOI 10.2337/db10-0979; Golden MH, 2010, INDIAN PEDIATR, V47, P667, DOI 10.1007/s13312-010-0103-5; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Jahoor F, 2005, AM J CLIN NUTR, V82, P792, DOI 10.1093/ajcn/82.4.792; Jahoor F, 2006, TROPICAL METABOLISM, P25; Jahoor F, 2008, ANN TROP PAEDIATR, V28, P87, DOI 10.1179/146532808X302107; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Reid M, 2000, AM J PHYSIOL-ENDOC M, V278, pE405, DOI 10.1152/ajpendo.2000.278.3.E405; Reid M, 2002, AM J CLIN NUTR, V76, P1409, DOI 10.1093/ajcn/76.6.1409; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; World Health Organization, 2009, FACT SHEET 178	21	50	52	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35907	10.1371/journal.pone.0035907	http://dx.doi.org/10.1371/journal.pone.0035907			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558267	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000305340200030
J	Krasniqi, N; Turgut, M; Husmann, M; Roffi, M; Schwarz, U; Greutmann, M; Luscher, TF; Amann, B; Corti, R				Krasniqi, Nazmi; Turgut, Michael; Husmann, Marc; Roffi, Marco; Schwarz, Urs; Greutmann, Matthias; Luescher, Thomas F.; Amann, Beatrice; Corti, Roberto			Carotid Artery Stenting: A Single Center "Real World'' Experience	PLOS ONE			English	Article							ENDARTERECTOMY; STENOSIS; METAANALYSIS; ANGIOPLASTY; DISEASE; TRIAL	Background: Percutaneous carotid artery stenting (CAS) became a widely used procedure in patients with symptomatic and asymptomatic carotid artery stenosis. However its role compared to carotid endarterectomy (CAD) remains questioned. We analysed the safety of carotid artery stenting program of a prospective CAS register program of a tertiary teaching hospital. Method: Between July 2003 and December 2010, 208 patients underwent CAS procedure. Baseline, procedural and follow-up data were prospectively collected. Primary peri-interventional outcome was defined as 30-day major adverse events (MAE), including death, stroke or myocardial infarction, and mid-to long-term follow-up outcome included ipsilateral stroke, myocardial infarction or death. Secondary outcome was restenosis rate >= 50% per lesion. Results: Unilateral carotid artery interventions were performed in 186 patients. In 22 patients CAS was performed bilaterally as stages procedures. The 30-day MAE rate was 1.9% consisting of two contralateral strokes and two ipsilateral stroke. Mean clinically follow-up was 22 months. Mid-to long-term MAE was 8.1% with 6.3% (n = 13) deaths, 1.9% (n = 4) myocardial infarctions and 0.9% (n = 2) ipsilateral stroke. The restenosis rate >= 50% per lesion was 4.3% at a mean follow-up of 22 months. Target lesion revascularization was performed in one patient, because of restenosis at 9 months follow-up after first CAS. Conclusion: Implementation of a carotid artery stenting program at a tertiary, teaching hospital is a safe method for treatment of carotid artery stenosis. The adverse event rate during mid-to-long-term follow-up suggests an appropriate patient selection.	[Krasniqi, Nazmi; Turgut, Michael; Husmann, Marc; Roffi, Marco; Schwarz, Urs; Greutmann, Matthias; Luescher, Thomas F.; Amann, Beatrice; Corti, Roberto] Univ Zurich Hosp, Ctr Cardiovasc, Zurich, Switzerland	University of Zurich; University Zurich Hospital	Krasniqi, N (corresponding author), Univ Zurich Hosp, Ctr Cardiovasc, Zurich, Switzerland.	roberto.corti@usz.ch	Greutmann, Matthias/AFU-2025-2022; Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454	University Hospital Zurich	University Hospital Zurich	This work was funded by University Hospital Zurich. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; Bates ER, 2007, J AM COLL CARDIOL, V49, P126, DOI 10.1016/j.jacc.2006.10.021; Biller J, 1998, CIRCULATION, V97, P501; Bonati LH, 2010, LANCET, V376, P1062, DOI 10.1016/S0140-6736(10)61009-4; Bonati LH, 2009, LANCET NEUROL, V8, P908, DOI 10.1016/S1474-4422(09)70227-3; Brott TG, 2010, NEW ENGL J MED, V363, P11, DOI 10.1056/NEJMoa0912321; Eckstein HH, 2008, LANCET NEUROL, V7, P893, DOI 10.1016/S1474-4422(08)70196-0; Economopoulos KP, 2011, STROKE, V42, P687, DOI 10.1161/STROKEAHA.110.606079; Eskandari MK, 2006, EXPERT REV MED DEVIC, V3, P387, DOI 10.1586/17434440.3.3.387; Hofmann R, 2005, HEART, V91, P1438, DOI 10.1136/hrt.2004.050906; Luebke T, 2007, EUR J VASC ENDOVASC, V34, P470, DOI 10.1016/j.ejvs.2007.06.001; Mas JL, 2008, LANCET NEUROL, V7, P885, DOI 10.1016/S1474-4422(08)70195-9; Meyer SA, 2010, NEUROSURGERY; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Ricotta Joseph J 2nd, 2008, Perspect Vasc Surg Endovasc Ther, V20, P299, DOI 10.1177/1531003508324614; Roffi M, 2008, CATHETER CARDIO INTE, V71, P469, DOI 10.1002/ccd.21434; Zahn R, 2005, Z KARDIOL, V94, P836, DOI 10.1007/s00392-005-0311-5	17	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35300	10.1371/journal.pone.0035300	http://dx.doi.org/10.1371/journal.pone.0035300			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558138	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000305340200013
J	Leong, NL; Hurng, JM; Djomehri, SI; Gansky, SA; Ryder, MI; Ho, SP				Leong, Narita L.; Hurng, Jonathan M.; Djomehri, Sabra I.; Gansky, Stuart A.; Ryder, Mark I.; Ho, Sunita P.			Age-Related Adaptation of Bone-PDL-Tooth Complex: Rattus-Norvegicus as a Model System	PLOS ONE			English	Article							EXPERIMENTAL PERIODONTAL-DISEASE; ALVEOLAR BONE; TEMPOROMANDIBULAR-JOINT; MECHANICAL-PROPERTIES; ALKALINE-PHOSPHATASE; CHEMICAL-COMPOSITION; MOLECULAR REGULATION; CONNECTIVE TISSUES; GNOTOBIOTIC RATS; ADULT-RATS	Functional loads on an organ induce tissue adaptations by converting mechanical energy into chemical energy at a cell-level. The transducing capacity of cells alters physico-chemical properties of tissues, developing a positive feedback commonly recognized as the form-function relationship. In this study, organ and tissue adaptations were mapped in the bone-tooth complex by identifying and correlating biomolecular expressions to physico-chemical properties in rats from 1.5 to 15 months. However, future research using hard and soft chow over relevant age groups would decouple the function related effects from aging affects. Progressive curvature in the distal root with increased root resorption was observed using micro X-ray computed tomography. Resorption was correlated to the increased activity of multinucleated osteoclasts on the distal side of the molars until 6 months using tartrate resistant acid phosphatase (TRAP). Interestingly, mononucleated TRAP positive cells within PDL vasculature were observed in older rats. Higher levels of glycosaminoglycans were identified at PDL-bone and PDL-cementum entheses using alcian blue stain. Decreasing biochemical gradients from coronal to apical zones, specifically biomolecules that can induce osteogenic (biglycan) and fibrogenic (fibromodulin, decorin) phenotypes, and PDL-specific negative regulator of mineralization (asporin) were observed using immunohistochemistry. Heterogeneous distribution of Ca and P in alveolar bone, and relatively lower contents at the entheses, were observed using energy dispersive X-ray analysis. No correlation between age and microhardness of alveolar bone (0.7 +/- 0.1 to 0.9 +/- 0.2 GPa) and cementum (0.6 +/- 0.1 to 0.8 +/- 0.3 GPa) was observed using a microindenter. However, hardness of cementum and alveolar bone at any given age were significantly different (P<0.05). These observations should be taken into account as baseline parameters, during development (1.5 to 4 months), growth (4 to 10 months), followed by a senescent phase (10 to 15 months), from which deviations due to experimentally induced perturbations can be effectively investigated.	[Leong, Narita L.; Hurng, Jonathan M.; Djomehri, Sabra I.; Ho, Sunita P.] Univ Calif San Francisco, Div Biomat & Bioengn, San Francisco, CA 94143 USA; [Gansky, Stuart A.] Univ Calif San Francisco, Dept Prevent & Restorat Dent Sci, Div Oral Epidemiol & Dent Publ Hlth, San Francisco, CA 94143 USA; [Ryder, Mark I.] Univ Calif San Francisco, Dept Orofacial Sci, Div Periodontol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Leong, NL (corresponding author), Univ Calif San Francisco, Div Biomat & Bioengn, San Francisco, CA 94143 USA.	sunita.ho@ucsf.edu	Ho, Sunita P/B-1084-2008	Ho, Sunita/0000-0001-9999-8226	NIH/NIDCR [R01DE022032, R00 DE018212]; NIH/NCRR [1S10RR026645]; Division of Bioengineering and Biomaterials, Department of Preventive and Restorative Dental Sciences, UCSF; Praxis Fund; Benjamin Dienstein Fund, Division of Periodontology, Department of Orofacial Sciences, UCSF; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R00DE018212] Funding Source: NIH RePORTER	NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Division of Bioengineering and Biomaterials, Department of Preventive and Restorative Dental Sciences, UCSF; Praxis Fund; Benjamin Dienstein Fund, Division of Periodontology, Department of Orofacial Sciences, UCSF; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by: NIH/NIDCR R01DE022032 (SPH), NIH/NIDCR R00 DE018212 (SPH) and NIH/NCRR 1S10RR026645 (SPH), Division of Bioengineering and Biomaterials, Department of Preventive and Restorative Dental Sciences, UCSF; The Praxis Fund and the Benjamin Dienstein Fund, Division of Periodontology, Department of Orofacial Sciences, UCSF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achong R, 2003, J PERIODONTOL, V74, P494, DOI 10.1902/jop.2003.74.4.494; Afonso L, 2011, J CLIN HYPERTENS, V13, P551, DOI 10.1111/j.1751-7176.2011.00476.x; [Anonymous], E384 ASTM, P399; APPLEBAUM E, 1947, J DENT RES, V26, P73, DOI 10.1177/00220345470260011001; Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Arai K, 2005, ARCH GERONTOL GERIAT, V40, P225, DOI 10.1016/j.archger.2004.08.005; Baer MJ, 1983, POSTNATAL DEV RAT SK, Vxv; Bailey AJ, 2001, MECH AGEING DEV, V122, P735, DOI 10.1016/S0047-6374(01)00225-1; Bani D, 1999, J DENT RES, V78, P1735, DOI 10.1177/00220345990780111101; Barros Erika M K P, 2002, Spine J, V2, P57, DOI 10.1016/S1529-9430(01)00167-X; BAUMHAMM.A, 1965, J PERIODONTOL, V36, P439, DOI 10.1902/jop.1965.36.6.439; Boissy P, 1998, J CELL SCI, V111, P2563; BOX GEP, 1962, TECHNOMETRICS, V4, P531, DOI 10.2307/1266288; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; BRIDGES T, 1988, AM J ORTHOD DENTOFAC, V93, P245, DOI 10.1016/S0889-5406(88)80010-6; Brinckmann P, 2002, MUSCULOSKELETAL BIOM, Vx; Buffenstein R, 2008, ANIMAL MODELS AGING, P499; Cao JJ, 2007, J BONE MINER RES, V22, P1271, DOI 10.1359/JBMR.070506; Carter DR, 2001, SKELETAL FUNCTION FO, Vxii; CARTER SB, 1967, NATURE, V213, P256, DOI 10.1038/213256a0; Chattah NLT, 2009, ADV MATER, V21, P413, DOI 10.1002/adma.200801187; CRAWFORD JM, 1978, J PERIODONTAL RES, V13, P316, DOI 10.1111/j.1600-0765.1978.tb00186.x; Donahue SW, 2001, AM J PHYSIOL-CELL PH, V281, pC1635, DOI 10.1152/ajpcell.2001.281.5.C1635; Edwards A. L., 1979, MULTIPLE REGRESSION; ENLOW DH, 1967, J DENT RES, V46, P1209, DOI 10.1177/00220345670460061501; Erlebacher A, 1996, J CELL BIOL, V132, P195, DOI 10.1083/jcb.132.1.195; Foster BL, 2011, CELLS TISSUES ORGANS; Foster BL, 2007, CURR TOP DEV BIOL, V78, P47, DOI 10.1016/S0070-2153(06)78003-6; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; FROST HM, 1990, ANAT REC, V226, P403, DOI 10.1002/ar.1092260402; FROST HM, 1992, BONE MINER, V18, P227, DOI 10.1016/0169-6009(92)90809-R; FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104; Frost HM, 1997, J BONE MINER RES, V12, P1539, DOI 10.1359/jbmr.1997.12.10.1539; Frost HM, 1964, BONE BIODYNAMICS, Vxvi; Fujita T, 2009, ARCH ORAL BIOL, V54, P40, DOI 10.1016/j.archoralbio.2008.07.010; GHANADIAN R, 1975, STEROIDS, V25, P753, DOI 10.1016/0039-128X(75)90039-2; GOLDBERG M, 1995, INT J DEV BIOL, V39, P93; Goto KT, 2011, J DENT RES, V90, P793, DOI 10.1177/0022034511400742; GROENEVELD MC, 1995, J DENT RES, V74, P1374, DOI 10.1177/00220345950740070901; Grzesik WJ, 2002, J BIOL CHEM, V277, P43638, DOI 10.1074/jbc.M202124200; GUGGENHEIM B, 1974, INFECT IMMUN, V10, P565, DOI 10.1128/IAI.10.3.565-577.1974; Hakkinen L, 2000, LAB INVEST, V80, P1869, DOI 10.1038/labinvest.3780197; Hall R C, 1997, Adv Dent Res, V11, P478; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; HAYFLICK L, 1970, EXP GERONTOL, V5, P291, DOI 10.1016/0531-5565(70)90012-4; Hayflick L, 2007, ANN NY ACAD SCI, V1100, P1, DOI 10.1196/annals.1395.001; Ho SP, 2010, BIOMATERIALS, V31, P6635, DOI 10.1016/j.biomaterials.2010.05.024; Ho SP, 2009, DENT MATER, V25, P1195, DOI 10.1016/j.dental.2009.04.005; Ho SP, 2009, ACTA BIOMATER, V5, P707, DOI 10.1016/j.actbio.2008.08.013; Hoffman MMaS I, 1940, AM ASS ORTH, P854; Holliday Sean, 2005, World J Orthod, V6, P61; Ijuhin N, 1988, Adv Dent Res, V2, P209; Ingber D E, 2004, Mech Chem Biosyst, V1, P53; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Iozzo RV, 1996, FASEB J, V10, P598, DOI 10.1096/fasebj.10.5.8621059; Ito Y, 2001, EXP ANIM TOKYO, V50, P159, DOI 10.1538/expanim.50.159; JENKINS HG, 1988, J NEUROCHEM, V51, P1634, DOI 10.1111/j.1471-4159.1988.tb01134.x; Keles GC, 2005, INDIAN J MED RES, V121, P176; KING GJ, 1991, AM J ORTHOD DENTOFAC, V99, P456, DOI 10.1016/S0889-5406(05)81579-3; Kingsmill VJ, 2010, J DENT RES, V89, P510, DOI 10.1177/0022034510362970; KLAUSEN B, 1991, J PERIODONTOL, V62, P59, DOI 10.1902/jop.1991.62.1.59; KLAUSEN B, 1989, SCAND J DENT RES, V97, P494; KLAUSEN B, 1991, ARCH ORAL BIOL, V36, P685, DOI 10.1016/0003-9969(91)90022-M; KLINGSBERG J, 1960, J Dent Res, V39, P158, DOI 10.1177/00220345600390011101; Komatsu K, 2004, ARCH ORAL BIOL, V49, P817, DOI 10.1016/j.archoralbio.2004.04.002; Krishnan V, 2006, AM J ORTHOD DENTOFAC, V129, P1, DOI DOI 10.1016/J.AJ0D0.2005.10.007; Krishnan V., 2006, AM J ORTHOD DENTOFAC, V129, pe461; Kuhr A, 2004, J PERIODONTAL RES, V39, P101, DOI 10.1111/j.1600-0765.2004.00710.x; LOURIDIS O, 1972, J PERIODONTOL, V43, P533, DOI 10.1902/jop.1972.43.9.533; Luan XH, 2007, BIOESSAYS, V29, P819, DOI 10.1002/bies.20608; LUKINMAA PL, 1991, J DENT RES, V70, P19, DOI 10.1177/00220345910700010201; Mann S, 2001, BIOMINERALIZATION PR, Vxii; Mariotti A, 1993, Periodontol 2000, V3, P39; McCulloch CAG, 2000, PERIODONTOL 2000, V24, P56, DOI 10.1034/j.1600-0757.2000.2240104.x; Meikle MC, 2006, EUR J ORTHODONT, V28, P221, DOI 10.1093/ejo/cj1001; Melrose J, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2453; Misawa-Kageyama Y, 2007, EUR J ORAL SCI, V115, P124, DOI 10.1111/j.1600-0722.2007.00428.x; Nakamura Y, 2003, J PERIODONTAL RES, V38, P343, DOI 10.1034/j.1600-0765.2003.00671.x; Nakamura Y, 2008, EUR J ORTHODONT, V30, P320, DOI 10.1093/ejo/cjm133; Nanci A, 2007, T CATES ORAL HISTOLO; Nishijima K, 2009, ARCH GERONTOL GERIAT, V48, P178, DOI 10.1016/j.archger.2008.01.006; Niver EL, 2011, J PERIODONTAL RES; Oehmke MJ, 2004, MICROSC RES TECHNIQ, V63, P198, DOI 10.1002/jemt.20027; Okazaki J, 1996, J ORAL REHABIL, V23, P536, DOI 10.1111/j.1365-2842.1996.tb00892.x; Paul RG, 1999, INT J BIOCHEM CELL B, V31, P653, DOI 10.1016/S1357-2725(99)00023-0; PEDLAR J, 1979, ARCH ORAL BIOL, V24, P777, DOI 10.1016/0003-9969(79)90038-4; Pereira FJ, 1996, J ORAL MAXIL SURG, V54, P55, DOI 10.1016/S0278-2391(96)90305-5; Pereira Junior FJ, 1996, J ORAL MAXILLOFAC SU, V54, P61; POSNER AS, 1965, ANN NY ACAD SCI, V131, P737, DOI 10.1111/j.1749-6632.1965.tb34837.x; Qian LH, 2009, DENT MATER, V25, P1285, DOI 10.1016/j.dental.2009.03.014; Ramamurthy NS, 2002, J PERIODONTAL RES, V37, P1, DOI 10.1034/j.1600-0765.2002.00342.x; Ren YJ, 2008, ACTA ODONTOL SCAND, V66, P93, DOI 10.1080/00016350801982522; Ren YJ, 2004, EUR J ORTHODONT, V26, P483, DOI 10.1093/ejo/26.5.483; Robert L, 2000, BIOGERONTOLOGY, V1, P123, DOI 10.1023/A:1010048014925; Roberts W.E., 2006, SEMIN ORTHOD, V12, P216, DOI [10.1053/j.sodo.2006.08.002, DOI 10.1053/J.SODO.2006.08.002]; Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721; Robling AG, 2009, CRIT REV EUKAR GENE, V19, P319, DOI 10.1615/CritRevEukarGeneExpr.v19.i4.50; ROHOLL PJM, 1994, J BONE MINER RES, V9, P355; Roughley PJ, 2006, EUR CELLS MATER, V12, P92, DOI 10.22203/eCM.v012a11; Royce PM, 2002, CONNECTIVE TISSUE IT, Vxvii; Saffar JL, 1997, PERIODONTOL 2000, V13, P76, DOI 10.1111/j.1600-0757.1997.tb00096.x; Santra M, 1997, J CLIN INVEST, V100, P149, DOI 10.1172/JCI119507; Sawyer A, 2003, BIOTECH HISTOCHEM, V78, P271, DOI 10.1080/10520290310001646668; SCHNEIDER B J, 1965, Angle Orthod, V35, P187; Shimizu N, 2000, J GERONTOL A-BIOL, V55, pB489, DOI 10.1093/gerona/55.10.B489; Shimono M, 2003, MICROSC RES TECHNIQ, V60, P491, DOI 10.1002/jemt.10290; Sicher H, 1944, AM J ORTHOD ORAL SUR, V30, pC109; Sievanen H., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P255; Spence JM, 1940, ANGLE ORTHOD, V10, P127; Struillou X, 2010, OPEN DENT J, V4, P37, DOI 10.2174/1874210601004010037; TAKAGI M, 1991, J HISTOCHEM CYTOCHEM, V39, P41, DOI 10.1177/39.1.1898498; Thompson A., 2009, CTR XRAY OPTICS ADV; Wang JHC, 2007, GENE, V391, P1, DOI 10.1016/j.gene.2007.01.014; Wang L, 2001, BONE, V29, P141, DOI 10.1016/S8756-3282(01)00483-5; Weiner J P, 1998, J Ambul Care Manage, V21, P29; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; WHYTE MP, 1994, ENDOCR REV, V15, P439, DOI 10.1210/er.15.4.439; Yamada S, 2007, J BIOL CHEM, V282, P23070, DOI 10.1074/jbc.M611181200	118	34	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35980	10.1371/journal.pone.0035980	http://dx.doi.org/10.1371/journal.pone.0035980			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558292	gold, Green Published, Green Submitted			2022-12-27	WOS:000305340200033
J	Pho, MT; Swaminathan, S; Kumarasamy, N; Losina, E; Ponnuraja, C; Uhler, LM; Scott, CA; Mayer, KH; Freedberg, KA; Walensky, RP				Pho, Mai T.; Swaminathan, Soumya; Kumarasamy, Nagalingeswaran; Losina, Elena; Ponnuraja, C.; Uhler, Lauren M.; Scott, Callie A.; Mayer, Kenneth H.; Freedberg, Kenneth A.; Walensky, Rochelle P.			The Cost-Effectiveness of Tuberculosis Preventive Therapy for HIV-Infected Individuals in Southern India: A Trial-Based Analysis	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; SUB-SAHARAN AFRICA; OBSERVATIONAL DATABASE; COTE-DIVOIRE; ADULTS; RISK; DISEASE; COHORT; COUNTRIES; CRITERIA	Background: Regimens for isoniazid-based preventive therapy (IPT) for tuberculosis (TB) in HIV-infected individuals have not been widely adopted given concerns regarding efficacy, adherence and drug resistance. Further, the cost-effectiveness of IPT has not been studied in India. Methods: We used an HIV/TB model to project TB incidence, life expectancy, cost and incremental cost-effectiveness of six months of isoniazid plus ethambutol (6EH), thirty-six months of isoniazid (36H) and no IPT for HIV-infected patients in India. Model input parameters included a median CD4 count of 324 cells/mm(3), and a rate ratio of developing TB of 0.35 for 6EH and 0.22 for 36H at three years as compared to no IPT. Results of 6EH and 36H were also compared to six months of isoniazid (6H), three months of isoniazid plus rifampin (3RH) and three months of isoniazid plus rifapentine (3RPTH). Results: Projected TB incidence decreased in the 6EH and 36H regimens by 51% and 62% respectively at three-year follow-up compared to no IPT. Without IPT, projected life expectancy was 136.1 months at a lifetime per person cost of $5,630. 6EH increased life expectancy by 0.8 months at an additional per person cost of $100 (incremental cost-effectiveness ratio (ICER) of $1,490/year of life saved (YLS)). 36H further increased life expectancy by 0.2 months with an additional per person cost of $55 (ICER of $3,120/YLS). The projected clinical impact of 6EH was comparable to 6H and 3RH; however when compared to these other options, 6EH was no longer cost-effective given the high cost of ethambutol. Results were sensitive to baseline CD4 count and adherence. Conclusions: Three, six and thirty-six-month regimens of isoniazid-based therapy are effective in preventing TB. Three months of isoniazid plus rifampin and six-months of isoniazid are similarly cost-effective in India, and should be considered part of HIV care.	[Pho, Mai T.] Univ Chicago, Med Ctr, Dept Med, Sect Hosp Med, Chicago, IL 60637 USA; [Swaminathan, Soumya; Ponnuraja, C.] Natl Inst Res TB, Chennai, Tamil Nadu, India; [Kumarasamy, Nagalingeswaran] VHS, YR Gaitonde Ctr AIDS Res & Educ, Chennai, Tamil Nadu, India; [Uhler, Lauren M.; Scott, Callie A.; Freedberg, Kenneth A.; Walensky, Rochelle P.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Gen Med, Boston, MA USA; [Freedberg, Kenneth A.; Walensky, Rochelle P.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Infect Dis, Boston, MA USA; [Walensky, Rochelle P.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Losina, Elena] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Losina, Elena; Freedberg, Kenneth A.; Walensky, Rochelle P.] Harvard Univ, Sch Med, Ctr AIDS Res, Boston, MA USA; [Losina, Elena] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Freedberg, Kenneth A.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Freedberg, Kenneth A.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Mayer, Kenneth H.] Brown Univ, Miriam Hosp, Providence, RI USA	University of Chicago; University of Chicago Medical Center; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Boston University; Boston University; Harvard University; Harvard T.H. Chan School of Public Health; Brown University; Lifespan Health Rhode Island; Miriam Hospital	Pho, MT (corresponding author), Univ Chicago, Med Ctr, Dept Med, Sect Hosp Med, Chicago, IL 60637 USA.	mpho@medicine.bsd.uchicago.edu; rwalensky@partners.org	Kumarasasmy, Nagalingeswaran/AAB-7348-2021	Walensky, Rochelle P./0000-0002-8795-379X; Losina, ELENA/0000-0002-3424-0892	National Institute of Allergy And Infectious Diseases [T32 AI07433, R01-AI058736, K24-AI062476, K24-AR057827]; National Institute of Health - Fogarty International Center [D43-TW000237]; Indian Council of Medical Research; WHO/USAID (Model DOTS Project); FOGARTY INTERNATIONAL CENTER [D43TW000237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093269, R01AI058736, T32AI007433, R37AI042006, K24AI062476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR057827] Funding Source: NIH RePORTER	National Institute of Allergy And Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Health - Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); WHO/USAID (Model DOTS Project)(United States Agency for International Development (USAID)World Health Organization); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institute of Allergy And Infectious Diseases award numbers [T32 AI07433, R01-AI058736, K24-AI062476, and K24-AR057827]; the National Institute of Health - Fogarty International Center [D43-TW000237]; the Indian Council of Medical Research; and the WHO/USAID (Model DOTS Project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; [Anonymous], MONTHLY INDEX MED SP; [Anonymous], 2011, GUID INT TUB CAS FIN; [Anonymous], 2009, UN COSTS COMP HIV RE; Bachani D, 2009, J Indian Med Assoc, V107, P310; Bachani D, 2009, J INDIAN MED ASSOC, V107, P310; Bachani D, 2009, J INDIAN MED ASSOC, V107; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Bell JC, 1999, AIDS, V13, P1549, DOI 10.1097/00002030-199908200-00016; Cecelia AJ, 2006, NATL MED J INDIA, V19, P14; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Freedberg KA, 2007, AIDS, V21, pS117, DOI 10.1097/01.aids.0000279714.60935.a2; Gold R, 1996, COST EFFECTIVENESS H; Golub JE, 2009, AIDS, V23, P631, DOI 10.1097/QAD.0b013e328327964f; Hausler HP, 2006, B WORLD HEALTH ORGAN, V84, P528, DOI 10.2471/BLT.04.018606; Holland DP, 2009, PHARMACOTHERAPY, V29, P503, DOI 10.1592/phco.29.5.503; Homan RK, 2000, EC AN YRG CARE SERV; Hovell M, 2003, SOC SCI MED, V56, P1789, DOI 10.1016/S0277-9536(02)00176-4; Howard AA, 2010, CLIN INFECT DIS, V50, pS238, DOI 10.1086/651497; International Monetary Fund, 2009, WORLD EC OUTL DAT; John KR, 2009, INT J TUBERC LUNG D, V13, P1281; Kumarasamy N, 2005, CLIN INFECT DIS, V41, P1525, DOI 10.1086/497267; Lawn SD, 2010, LANCET INFECT DIS, V10, P489, DOI 10.1016/S1473-3099(10)70078-5; Losina E, 2007, ANTIVIR THER, V12, P543; Machado A, 2009, INT J TUBERC LUNG D, V13, P719; Martinson NA, N ENGL J MED, V365, P11; MASOBE P, 1995, S AFR MED J, V85, P75; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Menzies D, 2008, ANN INTERN MED, V149, P689, DOI 10.7326/0003-4819-149-10-200811180-00003; Menzies D, 2011, INDIAN J MED RES, V133, P257; Minga A, 2007, B WORLD HEALTH ORGAN, V85, P116, DOI 10.2471/BLT.06.032292; Muniyandi M., 2006, Indian Journal of Tuberculosis, V53, P12; NACO, 2010, CAR SUPP TREATM NAT; NACO, 2007, GUID PREV MAN COMM O; Pardeshi Geeta, 2009, Indian J Med Sci, V63, P180, DOI 10.4103/0019-5359.53163; Seyler C, 2007, AIDS RES HUM RETROV, V23, P1338, DOI 10.1089/aid.2006.0308; Shrestha RK, 2007, INT J TUBERC LUNG D, V11, P747; Steinbrook R, 2007, NEW ENGL J MED, V356, P1197, DOI 10.1056/NEJMp078011; Sterling TR, N ENGL J MED, V365, P2155; Sutton BS, 2009, INT J TUBERC LUNG D, V13, P713; Swaminathan S, 2008, INT J TUBERC LUNG D, V12, P168; Swaminathan S, 2000, INT J TUBERC LUNG D, V4, P839; Swaminathan S, 2005, INT J TUBERC LUNG D, V9, P896; SWAMINATHAN S, 2010, 17 C RETR OPP INF SA; Swaminathan S, 2008, J BIOSCIENCES, V33, P527, DOI 10.1007/s12038-008-0071-2; TB India, 2011, RNTCP STAT REP; Tedla Z, 2010, AM J RESP CRIT CARE, V182, P278, DOI 10.1164/rccm.200911-1783OC; Tuboi SH, 2007, JAIDS-J ACQ IMM DEF, V45, P52, DOI 10.1097/QAI.0b013e318042e1c3; Uhler LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012747; Walensky RP, 2007, CLIN INFECT DIS, V45, pS248, DOI 10.1086/522546; Wang B, 2006, 16 INT AIDS C TOR CA; WHO, 2010, ANT THER HIV INF AD; WHO, 2009, 3 IS M INT FIND ICF; WHO, 2010, MULT EXT DRUG REST T; World Health Organization, 2008, GLOB TUB CONTR SURV; World Health Organization, 2001, MACR HLTH INV HLTH E; Zhou J, 2005, JAIDS-J ACQ IMM DEF, V38, P174, DOI 10.1097/01.qai.0000145351.96815.d5	58	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36001	10.1371/journal.pone.0036001	http://dx.doi.org/10.1371/journal.pone.0036001			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558301	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000305340200034
J	Fischer, A; Shapiro, B; Muriuki, C; Heller, M; Schnee, C; Bongcam-Rudloff, E; Vilei, EM; Frey, J; Jores, J				Fischer, Anne; Shapiro, Beth; Muriuki, Cecilia; Heller, Martin; Schnee, Christiane; Bongcam-Rudloff, Erik; Vilei, Edy M.; Frey, Joachim; Jores, Joerg			The Origin of the 'Mycoplasma mycoides Cluster' Coincides with Domestication of Ruminants	PLOS ONE			English	Article							MULTILOCUS SEQUENCE-ANALYSIS; BOVINE PLEURO-PNEUMONIA; SMALL COLONY; MOLECULAR EPIDEMIOLOGY; INFERENCE; GOATS; CAPRIPNEUMONIAE; EVOLUTIONARY; PHYLOGENY; SOFTWARE	The 'Mycoplasma mycoides cluster' comprises the ruminant pathogens Mycoplasma mycoides subsp. mycoides the causative agent of contagious bovine pleuropneumonia (CBPP), Mycoplasma capricolum subsp. capripneumoniae the agent of contagious caprine pleuropneumonia (CCPP), Mycoplasma capricolum subsp. capricolum, Mycoplasma leachii and Mycoplasma mycoides subsp. capri. CBPP and CCPP are major livestock diseases and impact the agricultural sector especially in developing countries through reduced food-supply and international trade restrictions. In addition, these diseases are a threat to disease-free countries. We used a multilocus sequence typing (MLST) approach to gain insights into the demographic history of and phylogenetic relationships among the members of the 'M. mycoides cluster'. We collected partial sequences from seven housekeeping genes representing a total of 3,816 base pairs from 118 strains within this cluster, and five strains isolated from wild Caprinae. Strikingly, the origin of the 'M. mycoides cluster' dates to about 10,000 years ago, suggesting that the establishment and spread of the cluster coincided with livestock domestication. In addition, we show that hybridization and recombination may be important factors in the evolutionary history of the cluster.	[Fischer, Anne] Int Ctr Insect Physiol & Ecol, Dept Mol Biol & Biotechnol, Nairobi, Kenya; [Fischer, Anne; Muriuki, Cecilia; Jores, Joerg] Int Livestock Res Inst, Dept Biotechnol, Nairobi, Kenya; [Shapiro, Beth] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Heller, Martin; Schnee, Christiane] Friedrich Loeffler Inst, Inst Mol Pathogenesis, Jena, Germany; [Bongcam-Rudloff, Erik] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, S-75007 Uppsala, Sweden; [Vilei, Edy M.; Frey, Joachim] Univ Bern, Inst Vet Bacteriol, Bern, Switzerland	International Centre of Insect Physiology & Ecology (ICIPE); CGIAR; International Livestock Research Institute (ILRI); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Loeffler Institute; Swedish University of Agricultural Sciences; University of Bern	Fischer, A (corresponding author), Int Ctr Insect Physiol & Ecol, Dept Mol Biol & Biotechnol, POB 30772, Nairobi, Kenya.	jores@web.de	Vilei, Edy/A-6138-2009	Shapiro, Beth/0000-0002-2733-7776; Schnee, Christiane/0000-0001-7643-9114; Bongcam-Rudloff, Erik/0000-0002-1947-8288; Jores, Joerg/0000-0003-3790-5746	German Federal Ministry for Economic Cooperation and Development [09.7860.1-001.00, 81121408]; Swedish International Development Cooperation (SIDA) [2007-2510, 75000506]	German Federal Ministry for Economic Cooperation and Development; Swedish International Development Cooperation (SIDA)	The work was funded by the German Federal Ministry for Economic Cooperation and Development (Project No: 09.7860.1-001.00, Contract No: 81121408, http://www.bmz.de), and by the Swedish International Development Cooperation (SIDA reference: 2007-2510, Contribution No. 75000506, http://www.sida.se). JJ and AF were supported by the German Federal Ministry for Economic Cooperation and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruford MW, 2003, NAT REV GENET, V4, P900, DOI 10.1038/nrg1203; COTTEW GS, 1987, ISRAEL J MED SCI, V23, P632; DAMASSA AJ, 1983, AM J VET RES, V44, P322; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Fisher J, 2003, MED HIST, V47, P314, DOI 10.1017/S0025727300057033; Fisher J, 2006, AUST VET J, V84, P439, DOI 10.1111/j.1751-0813.2006.00079.x; Fu YX, 1997, GENETICS, V147, P915; Gotherstrom A, 2005, P ROY SOC B-BIOL SCI, V272, P2345, DOI 10.1098/rspb.2005.3243; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hudson RR, 2001, GENETICS, V159, P1805; Hutyra F, 1938, CONTAGIOUS BOVINE PL; Kim KS, 2003, FEMS MICROBIOL LETT, V226, P299, DOI 10.1016/S0378-1097(03)00618-9; Kusiluka LJM, 2001, VET MICROBIOL, V82, P27, DOI 10.1016/S0378-1135(01)00352-2; Lemey P, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P1; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Manso-Silvan L, 2009, INT J SYST EVOL MICR, V59, P1353, DOI 10.1099/ijs.0.005546-0; Manso-Silvan L, 2007, INT J SYST EVOL MICR, V57, P2247, DOI 10.1099/ijs.0.64918-0; Manso-Silvan L, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-86; Mayor D, 2008, VET MICROBIOL, V127, P63, DOI 10.1016/j.vetmic.2007.08.010; McVean G, 2002, GENETICS, V160, P1231; Naderi S, 2008, P NATL ACAD SCI USA, V105, P17659, DOI 10.1073/pnas.0804782105; Nicolas MM, 2005, J CLIN MICROBIOL, V43, P1330, DOI 10.1128/JCM.43.3.1330-1340.2005; Nwankpa ND, 2010, VET MICROBIOL, V146, P354, DOI 10.1016/j.vetmic.2010.05.020; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sirand-Pugnet P, 2007, PLOS GENET, V3, P744, DOI 10.1371/journal.pgen.0030075; Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI [10.1099/ijs.0.02360-0, 10.1099/00207713-52-3-1043]; STIPKOVITS L, 1977, ZBL VET MED B, V24, P218; TAJIMA F, 1989, GENETICS, V123, P585; Thiaucourt F, 2000, VET MICROBIOL, V72, P251, DOI 10.1016/S0378-1135(99)00204-7; Thiaucourt F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-114; Thomas A, 2005, FEMS MICROBIOL LETT, V245, P249, DOI 10.1016/j.femsle.2005.03.013; Thomas P, 1873, RAPPORT MED BOU FRID; Vilei EM, 2006, VET RES, V37, P779, DOI 10.1051/vetres:2006037; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Yaya A, 2008, VET RES, V39, DOI 10.1051/vetres:2007052; Zeder MA, 2000, SCIENCE, V287, P2254, DOI 10.1126/science.287.5461.2254	45	51	53	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36150	10.1371/journal.pone.0036150	http://dx.doi.org/10.1371/journal.pone.0036150			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558362	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336000139
J	Rolo, J; Miragaia, M; Turlej-Rogacka, A; Empel, J; Bouchami, O; Faria, NA; Tavares, A; Hryniewicz, W; Fluit, AC; de Lencastre, H				Rolo, Joana; Miragaia, Maria; Turlej-Rogacka, Agata; Empel, Joanna; Bouchami, Ons; Faria, Nuno A.; Tavares, Ana; Hryniewicz, Waleria; Fluit, Ad C.; de Lencastre, Herminia		CONCORD Working Grp	High Genetic Diversity among Community-Associated Staphylococcus aureus in Europe: Results from a Multicenter Study	PLOS ONE			English	Article							PANTON-VALENTINE-LEUKOCIDIN; CASSETTE CHROMOSOME MEC; METHICILLIN-RESISTANT; NASAL CARRIAGE; UNITED-STATES; PCR STRATEGY; STRAINS; INFECTIONS; SEQUENCE; CLONES	Background: Several studies have addressed the epidemiology of community-associated Staphylococcus aureus (CA-SA) in Europe; nonetheless, a comprehensive perspective remains unclear. In this study, we aimed to describe the population structure of CA-SA and to shed light on the origin of methicillin-resistant S. aureus (MRSA) in this continent. Methods and Findings: A total of 568 colonization and infection isolates, comprising both MRSA and methicillin-susceptible S. aureus (MSSA), were recovered in 16 European countries, from community and community-onset infections. The genetic background of isolates was characterized by molecular typing techniques (spa typing, pulsed-field gel electrophoresis and multilocus sequence typing) and the presence of PVL and ACME was tested by PCR. MRSA were further characterized by SCCmec typing. We found that 59% of all isolates were associated with community-associated clones. Most MRSA were related with USA300 (ST8-IVa and variants) (40%), followed by the European clone (ST80-IVc and derivatives) (28%) and the Taiwan clone (ST59-IVa and related clonal types) (15%). A total of 83% of MRSA carried Panton-Valentine leukocidin (PVL) and 14% carried the arginine catabolic mobile element (ACME). Surprisingly, we found a high genetic diversity among MRSA clonal types (ST-SCCmec), Simpson's index of diversity = 0.852 (0.788-0.916). Specifically, about half of the isolates carried novel associations between genetic background and SCCmec. Analysis by BURP showed that some CA-MSSA and CA-MRSA isolates were highly related, suggesting a probable local acquisition/loss of SCCmec. Conclusions: Our results imply that CA-MRSA origin, epidemiology and population structure in Europe is very dissimilar from that of USA.	[Rolo, Joana; Miragaia, Maria; Bouchami, Ons; Faria, Nuno A.; Tavares, Ana; de Lencastre, Herminia] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal; [Turlej-Rogacka, Agata; Empel, Joanna; Hryniewicz, Waleria] Natl Med Inst, Div Clin Microbiol & Infect Prevent, Warsaw, Poland; [Bouchami, Ons] Lab Natl Bone Marrow Transplantat Ctr, Tunis, Tunisia; [Fluit, Ad C.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [de Lencastre, Herminia] Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA	Universidade Nova de Lisboa; National Medicines Institute Lekow (NIL); Universite de Tunis-El-Manar; Centre Nationale de Greffe de la Moelle Osseuse; Utrecht University; Utrecht University Medical Center; Rockefeller University	Rolo, J (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal.	lencash@mail.rockefeller.edu	Raponi, Giammarco/AAL-2806-2021; Lina, Gerard J/L-9352-2014; Zemlickova, Helena/G-6105-2017; Cantón, Rafael/AAP-8669-2021; Miragaia, Maria/J-2704-2015; Rolo, Joana/G-4447-2011; Faria, Nuno A/B-9229-2009; Hryniewicz, Waleria/J-3168-2012; Codita, Irina/K-1057-2016	Raponi, Giammarco/0000-0002-9665-0811; Zemlickova, Helena/0000-0002-3868-0545; Miragaia, Maria/0000-0002-1323-7184; Rolo, Joana/0000-0002-5291-212X; Faria, Nuno A/0000-0003-3762-9809; Dominguez, M. Angeles/0000-0003-3107-9586; Westh, Henrik/0000-0001-5681-647X; Tavares, Ana/0000-0002-2221-4785; /0000-0001-6816-8932; Bouchami, Ons/0000-0002-9425-3513; Codita, Irina/0000-0002-0892-3120; Empel, Joanna/0000-0002-1127-4053; Canton, Rafael/0000-0003-1675-3173; Lina, Gerard/0000-0002-9236-7998	European Commission [CONCORD-HEALTH-F3-2008-222718]; Fundacao para a Ciencia e Tecnologia (FCT), Portugal [SFRH/BD/72675/2010, SFRH/BPD/66514/2009, SFRH/BD/44220/2008]; Ministry of Science and Higher Education, Poland [1216/7. PR UE/2009/7]; FCT [Pest-OE/EQB/LAO004/2011]; Internal Grant Agency, Ministry of Health [IGA9642-4, IGA NT12395-5/2011]; Hungarian National Scientific Research Fund [OTKA T 46186]	European Commission(European CommissionEuropean Commission Joint Research Centre); Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Internal Grant Agency, Ministry of Health; Hungarian National Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	JR, OB and AT-R were supported by fellowships from project CONCORD-HEALTH-F3-2008-222718 from the European Commission. JR, NAF and AT were supported by grants SFRH/BD/72675/2010, SFRH/BPD/66514/2009 and SFRH/BD/44220/2008 from Fundacao para a Ciencia e Tecnologia (FCT), Portugal. JE and WH were supported by a grant no 1216/7. PR UE/2009/7 from the Ministry of Science and Higher Education, Poland. This work was funded by project CONCORD-HEALTH-F3-2008-222718 from the European Commission. The work performed at Instituto de Tecnologia Quimica e Biologica was supported additionally by FCT through grant #Pest-OE/EQB/LAO004/2011. The work performed at National Medicines Institute was partially supported by the Mikrobank 2 Programme from the Ministry of Science and Higher Education, Poland. The study was partially supported by a grant from the Internal Grant Agency, Ministry of Health (CZ), IGA9642-4 (for Czech Republic - Helena Zemlickova, Marta Fridrichova) and IGA NT12395-5/2011 (Oto Melter, Czech Republic). The isolation and characterization of the Hungarian strains were supported in part by the Hungarian National Scientific Research Fund, Grant No.: OTKA T 46186, to Ferenc Rozgonyi. The other participants did not receive additional funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires-de-Sousa M, 2006, J CLIN MICROBIOL, V44, P619, DOI 10.1128/JCM.44.2.619-621.2006; Balis E, 2007, J CHEMOTHERAPY, V19, P703, DOI 10.1179/joc.2007.19.6.703; Campanile F, 2011, EUR J CLIN IN PRESS; Carpaij N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016419; Chung M, 2000, MICROB DRUG RESIST, V6, P189, DOI 10.1089/mdr.2000.6.189; Clinical and Laboratory Standards Institute, 2009, M100S19 CLSI; Conceicao T, 2011, EUR J CLIN MICROBIOL, V30, P293, DOI 10.1007/s10096-010-1087-8; Coombs GW, 2004, J CLIN MICROBIOL, V42, P4735, DOI 10.1128/JCM.42.10.4735-4743.2004; Costello ME, 2011, EUR J CLIN MICROBIOL, V30, P1163, DOI 10.1007/s10096-011-1203-4; Cremieux AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007204; Daskalaki M, 2010, CLIN MICROBIOL INFEC, V16, P74, DOI 10.1111/j.1469-0691.2009.02830.x; de Sousa MA, 2005, J CLIN MICROBIOL, V43, P5150, DOI 10.1128/JCM.43.10.5150-5157.2005; de Sousa MA, 2003, J CLIN MICROBIOL, V41, P2027, DOI 10.1128/JCM.41.5.2027-2032.2003; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Deurenberg RH, 2009, CURR MOL MED, V9, P100, DOI 10.2174/156652409787581637; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Faria NA, 2008, J CLIN MICROBIOL, V46, P136, DOI 10.1128/JCM.01684-07; Francis JS, 2005, CLIN INFECT DIS, V40, P100, DOI 10.1086/427148; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Ghebremedhin B, 2009, J CLIN MICROBIOL, V47, P2975, DOI 10.1128/JCM.00648-09; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Green SM, 2010, J MED MICROBIOL, V59, P1084, DOI 10.1099/jmm.0.018986-0; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; Huang YC, 2011, INT J ANTIMICROB AG, V38, P2, DOI 10.1016/j.ijantimicag.2011.01.011; Hunt C, 1999, JAMA-J AM MED ASSOC, V282, P1123; Issartel B, 2005, J CLIN MICROBIOL, V43, P3203, DOI 10.1128/JCM.43.7.3203-3207.2005; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Jappe U, 2008, J INVEST DERMATOL, V128, P2655, DOI 10.1038/jid.2008.133; Kanerva M, 2009, J CLIN MICROBIOL, V47, P2655, DOI 10.1128/JCM.00771-09; Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000; Kawaguchiya M, 2011, MICROB DRUG RESIST, V17, P241, DOI 10.1089/mdr.2010.0136; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Larsen AR, 2009, J CLIN MICROBIOL, V47, P73, DOI 10.1128/JCM.01557-08; Larsen AR, 2009, J CLIN MICROBIOL, V47, P3765, DOI 10.1128/JCM.00934-09; Li SS, 2011, ANTIMICROB AGENTS CH, V55, P3046, DOI 10.1128/AAC.01475-10; Loffler B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000715; Lozano C, 2011, INT J MED MICROBIOL, V301, P500, DOI 10.1016/j.ijmm.2011.02.004; Manzur A, 2008, CLIN MICROBIOL INFEC, V14, P377, DOI 10.1111/j.1469-0691.2007.01934.x; Mellmann A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-98; Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Miragaia M, 2005, MICROB DRUG RESIST, V11, P83, DOI 10.1089/mdr.2005.11.83; Nubel U, 2008, P NATL ACAD SCI USA, V105, P14130, DOI 10.1073/pnas.0804178105; Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002; Oliveira DC, 2006, J ANTIMICROB CHEMOTH, V58, P23, DOI 10.1093/jac/dkl208; Otter JA, 2011, J HOSP INFECT, V79, P189, DOI 10.1016/j.jhin.2011.04.028; Otter JA, 2010, LANCET INFECT DIS, V10, P227, DOI 10.1016/S1473-3099(10)70053-0; Robert J, 2011, ANTIMICROB AGENTS CH, V55, P1734, DOI 10.1128/AAC.01221-10; Shore AC, 2011, ANTIMICROB AGENTS CH, V55, P3765, DOI 10.1128/AAC.00187-11; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Skramm I, 2011, APMIS, V119, P522, DOI 10.1111/j.1600-0463.2011.02758.x; Song JH, 2011, J ANTIMICROB CHEMOTH, V66, P1061, DOI 10.1093/jac/dkr024; Stam-Bolink EM, 2007, EUR J CLIN MICROBIOL, V26, P723, DOI 10.1007/s10096-007-0352-y; Tenover FC, 2006, J CLIN MICROBIOL, V44, P108, DOI 10.1128/JCM.44.1.108-118.2006; The European Commission of the European Communities European Union website, 2000, OFFICIAL J EUR COM L, V28; The European Parliament the Council of the EU European Union website, 1998, OFFICIAL J EUR COM L, V268; Tristan A, 2007, EMERG INFECT DIS, V13, P594, DOI 10.3201/eid1304.061316; Tseng CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006387; UDO EE, 1993, J HOSP INFECT, V25, P97, DOI 10.1016/0195-6701(93)90100-E; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	64	125	131	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e34768	10.1371/journal.pone.0034768	http://dx.doi.org/10.1371/journal.pone.0034768			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558099	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000017
J	Smith, TD; Reeves, RR; Josephson, EA; Lund, JN				Smith, Tim D.; Reeves, Randall R.; Josephson, Elizabeth A.; Lund, Judith N.			Spatial and Seasonal Distribution of American Whaling and Whales in the Age of Sail	PLOS ONE			English	Article							WATERS	American whalemen sailed out of ports on the east coast of the United States and in California from the 18th to early 20th centuries, searching for whales throughout the world's oceans. From an initial focus on sperm whales (Physeter macrocephalus) and right whales (Eubalaena spp.), the array of targeted whales expanded to include bowhead whales (Balaena mysticetus), humpback whales (Megaptera novaeangliae), and gray whales (Eschrichtius robustus). Extensive records of American whaling in the form of daily entries in whaling voyage logbooks contain a great deal of information about where and when the whalemen found whales. We plotted daily locations where the several species of whales were observed, both those caught and those sighted but not caught, on world maps to illustrate the spatial and temporal distribution of both American whaling activity and the whales. The patterns shown on the maps provide the basis for various inferences concerning the historical distribution of the target whales prior to and during this episode of global whaling.	[Smith, Tim D.] World Whaling Hist, Redding, CA 96003 USA; [Reeves, Randall R.] Okapi Wildlife Associates, Hudson, PQ, Canada; [Josephson, Elizabeth A.] Integrated Stat, Woods Hole, MA USA; [Lund, Judith N.] New Bedford Whaling Museum, New Bedford, MA USA		Smith, TD (corresponding author), World Whaling Hist, Redding, CA 96003 USA.	TimDenisSmith@gmail.com			Census of Marine Life; Northeast Fisheries Science Center	Census of Marine Life; Northeast Fisheries Science Center	This work was supported by the Census of Marine Life (www.coml.org) and the Northeast Fisheries Science Center (www.nefsc.noaa.gov) through several grants over the period 2000 and 2010. The funders had no role in study design, data collection and analysis, decisions to publish, or preparation of the manuscript.	Bannister J. L., 1981, REPORTS IWC, V31, P821; Bannister John L., 2008, P109; BEST PB, 1987, FISH B-NOAA, V85, P403; Bockstoce J.R., 1983, REPORT INT WHALING C, P107; Brownell Robert L. Jr, 2001, Journal of Cetacean Research and Management Special Issue, V2, P269; Clark A. H., 1887, FISHERIES FISHERY IN; Davis Lance E., 1997, PURSUIT LEVIATHAN TE; Gilmore E. M., 1959, Pacific Naturalist, V1, P9; Henderson D.A., 1984, P159; Jackson BC, 2011, SHIFTING BASELINES F; Jackson J, 2009, TAKING STOCK H UNPUB, P1; Josephson E, 2008, FISH FISH, V9, P155, DOI 10.1111/j.1467-2979.2008.00275.x; Josephson Elizabeth A., 2008, P133; Lund JN, 2010, AM OFFSHORE WHALING, VII; Lund JN, 2010, AM OFFSHORE WHALING, VI; Lyon JD, 1962, CLIPPER SHIPS CAPTAI; Maury M. F., 1852, WHALE CHART WORLD F; Maury MF, 1851, EXPLANATIONS SAILING; McNab R., 1913, OLD WHALING DAYS HIS; Mikhalev YA, 1997, MAR ECOL PROG SER, V149, P13, DOI 10.3354/meps149013; Punt Andre E., 2006, Journal of Cetacean Research and Management, V8, P145; Rasmussen K, 2007, BIOLOGY LETT, V3, P302, DOI 10.1098/rsbl.2007.0067; Reeves R. R., 2010, US NMFS MAR FISH REV, V72, P26; Reeves RR, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P82; Reeves Randall R., 2007, P39; Reeves Randall R., 2008, Journal of Cetacean Research and Management, V10, P247; Reeves RR, 2004, MAR ECOL PROG SER, V282, P295, DOI 10.3354/meps282295; REEVES RR, 1990, AM NEPTUNE, V50, P119; Reeves RR, 2003, ARCTIC, V56, P283; Richards R, 2002, J ROY SOC NEW ZEAL, V32, P355, DOI 10.1080/03014223.2002.9517699; Robinson A.H., 1974, INT YB CARTOGR, V14, P145; ROSS W G, 1974, Arctic and Alpine Research, V6, P85, DOI 10.2307/1550373; Ross W. Gillies, 1993, Society for Marine Mammalogy Special Publication, V2, P511; SCHEVILL W E, 1983, Breviora, P1; Sherman Stuart, 1986, WHALING LOGBOOKS J 1; Smith Tim D., 2008, P149; Starbuck A, 1878, 4 US FISH COMM FISH; Starkey D. J., 2008, OCEANS MANAGEMENT IN; Tillman M. F., 1983, REPORTS INT WHALING, V5, P257; Townsend CH, 1935, ZOOLOGICA NY, V19, P1; Whitehead H, 2002, MAR ECOL PROG SER, V242, P295, DOI 10.3354/meps242295; Williams MJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000531	42	67	70	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e34905	10.1371/journal.pone.0034905	http://dx.doi.org/10.1371/journal.pone.0034905			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558102	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000019
J	Staiger, C; Cadot, S; Kooter, R; Dittrich, M; Muller, T; Klau, GW; Wessels, LFA				Staiger, Christine; Cadot, Sidney; Kooter, Raul; Dittrich, Marcus; Mueller, Tobias; Klau, Gunnar W.; Wessels, Lodewyk F. A.			A Critical Evaluation of Network and Pathway-Based Classifiers for Outcome Prediction in Breast Cancer	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORKS; EXPRESSION SIGNATURE; CLASSIFICATION; MODULES	Recently, several classifiers that combine primary tumor data, like gene expression data, and secondary data sources, such as protein-protein interaction networks, have been proposed for predicting outcome in breast cancer. In these approaches, new composite features are typically constructed by aggregating the expression levels of several genes. The secondary data sources are employed to guide this aggregation. Although many studies claim that these approaches improve classification performance over single genes classifiers, the gain in performance is difficult to assess. This stems mainly from the fact that different breast cancer data sets and validation procedures are employed to assess the performance. Here we address these issues by employing a large cohort of six breast cancer data sets as benchmark set and by performing an unbiased evaluation of the classification accuracies of the different approaches. Contrary to previous claims, we find that composite feature classifiers do not outperform simple single genes classifiers. We investigate the effect of (1) the number of selected features; (2) the specific gene set from which features are selected; (3) the size of the training set and (4) the heterogeneity of the data set on the performance of composite feature and single genes classifiers. Strikingly, we find that randomization of secondary data sources, which destroys all biological information in these sources, does not result in a deterioration in performance of composite feature classifiers. Finally, we show that when a proper correction for gene set size is performed, the stability of single genes sets is similar to the stability of composite feature sets. Based on these results there is currently no reason to prefer prognostic classifiers based on composite features over single genes classifiers for predicting outcome in breast cancer.	[Staiger, Christine; Klau, Gunnar W.] Ctr Wiskunde & Informat, Life Sci Grp, Amsterdam, Netherlands; [Kooter, Raul; Wessels, Lodewyk F. A.] Fac Elect Engn Math & Comp Sci, Delft Bioinformat Lab, Delft, Netherlands; [Dittrich, Marcus; Mueller, Tobias] Univ Wurzburg, Dept Bioinformat, Bioctr, Wurzburg, Germany; [Klau, Gunnar W.] Netherlands Inst Syst Biol, Amsterdam, Netherlands; [Wessels, Lodewyk F. A.] Netherlands Canc Inst, Canc Syst Biol Ctr, Amsterdam, Netherlands	Delft University of Technology; University of Wurzburg; Netherlands Cancer Institute	Staiger, C (corresponding author), Ctr Wiskunde & Informat, Life Sci Grp, Amsterdam, Netherlands.	c.staiger@cwi.nl; gunnar.klau@cwi.nl; l.wessels@nki.nl	Müller, Tobias/A-8952-2008; Klau, Gunnar W./A-6934-2011	Klau, Gunnar W./0000-0002-6340-0090				Abraham G, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-277; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chowdhury SA, 2011, J COMPUT BIOL, V18, P263, DOI 10.1089/cmb.2010.0269; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Dao P, 2010, BIOINFORMATICS, V26, pi625, DOI 10.1093/bioinformatics/btq393; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Dittrich MT, 2008, BIOINFORMATICS, V24, pI223, DOI 10.1093/bioinformatics/btn161; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Gatza ML, 2010, P NATL ACAD SCI USA, V107, P6994, DOI 10.1073/pnas.0912708107; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Ma SG, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-271; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Popovici V, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2468; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Reyal F, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2192; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; ULITSKY I, 2010, PLOS ONE, V0005; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van Vliet MH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-375; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wessels LFA, 2005, BIOINFORMATICS, V21, P3755, DOI 10.1093/bioinformatics/bti429	30	42	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e34796	10.1371/journal.pone.0034796	http://dx.doi.org/10.1371/journal.pone.0034796			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558100	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336000018
J	Huusgaard, RS; Vismann, B; Kuhl, M; Macnaugton, M; Colmander, V; Rouse, GW; Glover, AG; Dahlgren, T; Worsaae, K				Huusgaard, Randi S.; Vismann, Bent; Kuehl, Michael; Macnaugton, Martin; Colmander, Veronica; Rouse, Greg W.; Glover, Adrian G.; Dahlgren, Thomas; Worsaae, Katrine			The Potent Respiratory System of Osedax mucofloris (Siboglinidae, Annelida) - A Prerequisite for the Origin of Bone-Eating Osedax?	PLOS ONE			English	Article							TUBEWORM RIFTIA-PACHYPTILA; WHALE-FALL; MICROBIAL COMMUNITIES; BRANCHIAL PLUME; NORTH-ATLANTIC; MARINE WORMS; DWARF MALES; SULFIDE; ROOTS; ACQUISITION	Members of the conspicuous bone-eating genus, Osedax, are widely distributed on whale falls in the Pacific and Atlantic Oceans. These gutless annelids contain endosymbiotic heterotrophic bacteria in a branching root system embedded in the bones of vertebrates, whereas a trunk and anterior palps extend into the surrounding water. The unique life style within a bone environment is challenged by the high bacterial activity on, and within, the bone matrix possibly causing O-2 depletion, and build-up of potentially toxic sulphide. We measured the O-2 distribution around embedded Osedax and showed that the bone microenvironment is anoxic. Morphological studies showed that ventilation mechanisms in Osedax are restricted to the anterior palps, which are optimized for high O-2 uptake by possessing a large surface area, large surface to volume ratio, and short diffusion distances. The blood vascular system comprises large vessels in the trunk, which facilitate an ample supply of oxygenated blood from the anterior crown to a highly vascularised root structure. Respirometry studies of O. mucofloris showed a high O-2 consumption that exceeded the average O-2 consumption of a broad line of resting annelids without endosymbionts. We regard this combination of features of the respiratory system of O. mucofloris as an adaptation to their unique nutrition strategy with roots embedded in anoxic bones and elevated O-2 demand due to aerobic heterotrophic endosymbionts.	[Huusgaard, Randi S.; Vismann, Bent; Kuehl, Michael; Macnaugton, Martin; Colmander, Veronica; Worsaae, Katrine] Univ Copenhagen, Dept Biol, Marine Biol Sect, Helsingor, Denmark; [Kuehl, Michael] Univ Technol Sydney, Dept Environm Sci, Sydney, NSW 2007, Australia; [Rouse, Greg W.] Univ Calif San Diego, Scripps Inst Oceanog, San Diego, CA 92103 USA; [Glover, Adrian G.] Nat Hist Museum, Dept Zool, London SW7 5BD, England; [Dahlgren, Thomas] Uni Environm Uni Res, Bergen, Norway	University of Copenhagen; University of Technology Sydney; University of California System; University of California San Diego; Scripps Institution of Oceanography; Natural History Museum London	Huusgaard, RS (corresponding author), Univ Copenhagen, Dept Biol, Marine Biol Sect, Helsingor, Denmark.	kworsaae@bio.ku.dk	Vismann, Bent/L-2731-2014; Worsaae, Katrine/L-8739-2014; Worsaae, Katrine/AEX-9585-2022; Rouse, Greg W/F-2611-2010; Rouse, Gregory/AAW-1494-2021; Kühl, Michael/A-1977-2009; Dahlgren, Thomas/X-6610-2019	Vismann, Bent/0000-0002-3613-6511; Worsaae, Katrine/0000-0003-0443-4298; Rouse, Greg W/0000-0001-9036-9263; Rouse, Gregory/0000-0001-9036-9263; Kühl, Michael/0000-0002-1792-4790; Dahlgren, Thomas/0000-0001-6854-2031	Danish Research Council [272-06-0260]; Swedish Research Council [2006-2768]; Natural Environment Research Council [NE/D000483/1] Funding Source: researchfish	Danish Research Council(Det Frie Forskningsrad (DFF)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work was supported by the Danish Research Council (www.fi.dk/raad-og-udvalg/det-frie-forskningsraad; grant # 272-06-0260 to K. Worsaae) and the Swedish Research Council (www.vr.se; grant # 2006-2768 to T. Dahlgren). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AC, 2006, CAN J ZOOL, V84, P1810, DOI 10.1139/Z06-168; Andersen AC, 2002, CAN J ZOOL, V80, P320, DOI 10.1139/Z02-005; ARP AJ, 1987, J EXP BIOL, V128, P139; Braby CE, 2007, DEEP-SEA RES PT I, V54, P1773, DOI 10.1016/j.dsr.2007.05.014; Cammen LM, 1987, ANIMAL ENERGETICS, V1; CHILDRESS JJ, 1984, MAR BIOL, V83, P109, DOI 10.1007/BF00394718; Dahlgren TG, 2006, CAH BIOL MAR, V47, P385; Dattagupta S, 2006, J EXP BIOL, V209, P3795, DOI 10.1242/jeb.02413; Freytag JK, 2001, P NATL ACAD SCI USA, V98, P13408, DOI 10.1073/pnas.231589498; Fujikura K, 2006, ZOOL SCI, V23, P733, DOI 10.2108/zsj.23.733; Gardiner SL., 1993, MICROSCOPIC ANATOMY; Girguis PR, 2006, J EXP BIOL, V209, P3516, DOI 10.1242/jeb.02404; Glover AG, 2005, P ROY SOC B-BIOL SCI, V272, P2587, DOI 10.1098/rspb.2005.3275; Goffredi SK, 2007, APPL ENVIRON MICROB, V73, P2314, DOI 10.1128/AEM.01986-06; Goffredi SK, 2005, ENVIRON MICROBIOL, V7, P1369, DOI 10.1111/j.1462-2920.2005.00824.x; Goffredi SK, 2004, DEEP-SEA RES PT I, V51, P1295, DOI 10.1016/j.dsr.2004.05.009; HENRY EC, 1977, STAIN TECHNOL, V52, P59, DOI 10.3109/10520297709116748; Higgs ND, 2012, HIST BIOL, V24, P269, DOI 10.1080/08912963.2011.621167; Higgs ND, 2011, P ROY SOC B-BIOL SCI, V278, P9, DOI 10.1098/rspb.2010.1267; Hilario A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016309; Hourdez S, 2005, J INORG BIOCHEM, V99, P130, DOI 10.1016/j.jinorgbio.2004.09.017; Jones WJ, 2008, P ROY SOC B-BIOL SCI, V275, P387, DOI 10.1098/rspb.2007.1437; JORGENSEN BB, 1983, APPL ENVIRON MICROB, V45, P1261; JOUIN C, 1989, ACTA ZOOL-STOCKHOLM, V70, P121, DOI 10.1111/j.1463-6395.1989.tb01061.x; Julian D, 1999, J EXP BIOL, V202, P2245; Katz S, 2010, J MORPHOL, V271, P1272, DOI 10.1002/jmor.10873; Kiel S, 2010, P NATL ACAD SCI USA, V107, P8656, DOI 10.1073/pnas.1002014107; Kitazato H, 1996, VIE MILIEU, V46, P1; KNOX GA, 1954, STAIN TECHNOL, V29, P139, DOI 10.3109/10520295409115458; Kuhl M, 2005, METHOD ENZYMOL, V397, P166, DOI 10.1016/S0076-6879(05)97010-9; Kuhl M., 2001, BENTHIC BOUNDARY LAY, P180; Kuhl M, 2008, AQUAT MICROB ECOL, V53, P99, DOI 10.3354/ame01224; NORREVANG ARNE, 1965, SARSIA, V21, P37; Purschke G, 2006, INTEGR COMP BIOL, V46, P497, DOI 10.1093/icb/icj053; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; Rouse GW, 2008, BIOL BULL-US, V214, P67, DOI 10.2307/25066661; Rouse G. W., 2001, POLYCHAETES; Rouse GW, 2011, BIOL LETTERS, V7, P736, DOI 10.1098/rsbl.2011.0202; Rouse GW, 2009, MAR BIOL, V156, P395, DOI 10.1007/s00227-008-1091-z; Rouse GW, 2004, SCIENCE, V305, P668, DOI 10.1126/science.1098650; Ruthensteiner B, 2008, ZOOSYMPOSIA, V1, P63, DOI 10.11646/zoosymposia.1.1.8; Schander Christoffer, 2010, Fauna Norvegica, V30, P5, DOI 10.5324/fn.v30i0.632; SHUMWAY SE, 1979, COMP BIOCHEM PHYS A, V64, P273, DOI 10.1016/0300-9629(79)90660-1; Southward AC, 1993, MICROSCOPIC ANATOMY; Treude T, 2009, MAR ECOL PROG SER, V382, P1, DOI 10.3354/meps07972; Tzetlin AB, 2005, HYDROBIOLOGIA, V535, P113, DOI 10.1007/s10750-004-1409-x; Vismann B, 1996, MAR ECOL PROG SER, V143, P131, DOI 10.3354/meps143131; Vrijenhoek RC, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-74; Weber RE, 1978, PHYSL ANNELIDS; WELLS GP, 1952, PROC R SOC SER B-BIO, V140, P70, DOI 10.1098/rspb.1952.0045; Worsaae K, 2010, J MORPHOL, V271, P127, DOI 10.1002/jmor.10786; Zoond A, 1931, J EXP BIOL, V8, P258	52	18	18	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35975	10.1371/journal.pone.0035975	http://dx.doi.org/10.1371/journal.pone.0035975			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558289	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345200101
J	Rachubinski, AL; Crowley, SK; Sladek, JR; Maclean, KN; Bjugstad, KB				Rachubinski, Angela L.; Crowley, Shannon K.; Sladek, John R., Jr.; Maclean, Kenneth N.; Bjugstad, Kimberly B.			Effects of Neonatal Neural Progenitor Cell Implantation on Adult Neuroanatomy and Cognition in the Ts65Dn Model of Down Syndrome	PLOS ONE			English	Article							AGE-RELATED IMPAIRMENTS; TRAUMATIC BRAIN-INJURY; MORRIS WATER MAZE; STEM-CELLS; MOUSE MODEL; ALZHEIMERS-DISEASE; DENTATE GYRUS; MICE; TRANSPLANTATION; MEMORY	As much of the aberrant neural development in Down syndrome (DS) occurs postnatally, an early opportunity exists to intervene and influence life-long cognitive development. Recent success using neural progenitor cells (NPC) in models of adult neurodegeneration indicate such therapy may be a viable option in diseases such as DS. Murine NPC (mNPC, C17.2 cell line) or saline were implanted bilaterally into the dorsal hippocampus of postnatal day 2 (PND 2) Ts65Dn pups to explore the feasibility of early postnatal treatment in this mouse model of DS. Disomic littermates provided karyotype controls for trisomic pups. Pups were monitored for developmental milestone achievement, and then underwent adult behavior testing at 14 weeks of age. We found that implanted mNPC survived into adulthood and migrated beyond the implant site in both karyotypes. The implantation of mNPC resulted in a significant increase in the density of dentate granule cells. However, mNPC implantation did not elicit cognitive changes in trisomic mice either neonatally or in adulthood. To the best of our knowledge, these results constitute the first assessment of mNPC as an early intervention on cognitive ability in a DS model.	[Rachubinski, Angela L.; Maclean, Kenneth N.; Bjugstad, Kimberly B.] Univ Colorado Denver, Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Crowley, Shannon K.] Univ S Carolina, Dept Exercise Sci, Columbia, SC 29208 USA; [Crowley, Shannon K.] Univ S Carolina, Dept Neuropsychiat & Behav Sci, Columbia, SC 29208 USA; [Sladek, John R., Jr.] Univ Colorado Denver, Sch Med, Dept Neurol, Aurora, CO USA; [Sladek, John R., Jr.] Univ Colorado Denver, Sch Med, Ctr Neurosci, Aurora, CO USA; [Maclean, Kenneth N.; Bjugstad, Kimberly B.] Univ Colorado Denver, Colorado Intellectual & Dev Disabil Res Ctr IDDRC, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Rachubinski, AL (corresponding author), Univ Colorado Denver, Sch Med, Dept Pediat, Anschutz Med Campus, Aurora, CO 80045 USA.	kimberly.bjugstad@ucdenver.edu	Rachubinski, Angela/HGB-4304-2022	Bjugstad, Kimberly/0000-0002-0473-5413	Ruth L. Kirschstein National Research Service Award (NRSA) [F31NS060517]; Anna and John J. Sie Foundation; National Institutes of Health/NCRR Colorado CTSI [TL1 RR025778]; NICHD [R01HD045224-03]; Linda Crnic Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045224] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001081] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR025778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS060517] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Anna and John J. Sie Foundation; National Institutes of Health/NCRR Colorado CTSI; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Linda Crnic Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a Ruth L. Kirschstein National Research Service Award (NRSA) (F31NS060517), The Anna and John J. Sie Foundation, The Linda Crnic Institute, and was supported by National Institutes of Health/NCRR Colorado CTSI Grant Number TL1 RR025778. Contents are the authors' sole responsibility and do not necessarily represent official NIH views. KNM gratefully acknowledges support from the NICHD (R01HD045224-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeson EC, 2001, CYTOGENET CELL GENET, V93, P270, DOI 10.1159/000056997; Arque G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002575; Bakshi A, 2006, EUR J NEUROSCI, V23, P2119, DOI 10.1111/j.1460-9568.2006.04743.x; Bakshi A, 2005, BRAIN RES, V1065, P8, DOI 10.1016/j.brainres.2005.09.059; Bautista A, 2010, DEV PSYCHOBIOL, V52, P35, DOI 10.1002/dev.20409; Belichenko PV, 2007, J COMP NEUROL, V504, P329, DOI 10.1002/cne.21433; Belmadani A, 2006, J NEUROSCI, V26, P3182, DOI 10.1523/JNEUROSCI.0156-06.2006; Bimonte-Nelson HA, 2003, BEHAV BRAIN RES, V139, P47, DOI 10.1016/S0166-4328(02)00082-7; Bjugstad KB, 2006, EXP NEUROL, V198, P561, DOI 10.1016/j.expneurol.2006.02.023; Bjugstad KB, 2004, EXP NEUROL, V187, P204; Bjugstad KB, 2005, CELL TRANSPLANT, V14, P183, DOI 10.3727/000000005783983098; Brustle O, 1998, NAT BIOTECHNOL, V16, P1040, DOI 10.1038/3481; Canfield MA, 2006, BIRTH DEFECTS RES A, V76, P747, DOI 10.1002/bdra.20294; Cearley CN, 2006, MOL THER, V13, P528, DOI 10.1016/j.ymthe.2005.11.015; Chang Q, 2008, NEUROBIOL LEARN MEM, V89, P167, DOI 10.1016/j.nlm.2007.05.007; Contestabile A, 2009, CELL PROLIFERAT, V42, P171, DOI 10.1111/j.1365-2184.2009.00587.x; Contestabile A, 2007, HIPPOCAMPUS, V17, P665, DOI 10.1002/hipo.20308; Davisson M T, 1993, Prog Clin Biol Res, V384, P117; Down JL, 1866, CLIN LECT REPORTS LO, V3, P259; Feng ZQ, 2009, NEUROSCI LETT, V462, P213, DOI 10.1016/j.neulet.2009.07.008; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Fong SP, 2007, J NEUROSCI RES, V85, P1851, DOI 10.1002/jnr.21319; FOX WM, 1965, ANIM BEHAV, V13, P234, DOI 10.1016/0003-3472(65)90041-2; Frotscher M, 2007, HIPPOCAMPUS BOOK, P115; Gordon RJ, 2009, MOL CELL NEUROSCI, V41, P219, DOI 10.1016/j.mcn.2009.03.001; Granholm ACE, 2000, EXP NEUROL, V161, P647, DOI 10.1006/exnr.1999.7289; Hattiangady B, 2007, STEM CELLS, V25, P2104, DOI 10.1634/stemcells.2006-0726; Heyser CJ, 2001, ASSESSMENT DEV MILES; Holtzman DM, 1996, P NATL ACAD SCI USA, V93, P13333, DOI 10.1073/pnas.93.23.13333; Hughes RN, 2007, NEUROSCI BIOBEHAV R, V31, P441, DOI 10.1016/j.neubiorev.2006.11.004; Hunter CL, 2003, BEHAV BRAIN RES, V138, P121, DOI 10.1016/S0166-4328(02)00275-9; Iivonen H, 2003, BEHAV BRAIN RES, V141, P207, DOI 10.1016/S0166-4328(02)00369-8; Insausti AM, 1998, NEUROSCI LETT, V253, P175, DOI 10.1016/S0304-3940(98)00641-7; Jucker Mathias, 1994, V719, P238; Kern DS, 2011, CELL TRANSPLANT, V20, P371, DOI 10.3727/096368910X528085; Lanfranchi S, 2010, J INTELL DISABIL RES, V54, P308, DOI 10.1111/j.1365-2788.2010.01262.x; Lemaire V, 2006, BIOL PSYCHIAT, V59, P786, DOI 10.1016/j.biopsych.2005.11.009; Lockrow J, 2011, BEHAV BRAIN RES, V221, P610, DOI 10.1016/j.bbr.2010.03.036; Lorenzi HA, 2006, BRAIN RES, V1104, P153, DOI 10.1016/j.brainres.2006.05.022; Lott IT, 2010, LANCET NEUROL, V9, P623, DOI 10.1016/S1474-4422(10)70112-5; Lott IT, 2005, NEUROBIOL AGING, V26, P383, DOI 10.1016/j.neurobiolaging.2004.08.005; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; MEANEY MJ, 1988, SCIENCE, V239, P766, DOI 10.1126/science.3340858; Miranda MI, 2003, NEUROBIOL LEARN MEM, V80, P211, DOI 10.1016/S1074-7427(03)00061-3; Moon J, 2010, BEHAV NEUROSCI, V124, P346, DOI 10.1037/a0019590; Nadel L, 2003, GENES BRAIN BEHAV, V2, P156, DOI 10.1034/j.1601-183X.2003.00026.x; Park KI, 2000, YONSEI MED J, V41, P825, DOI 10.3349/ymj.2000.41.6.825; Pennington BF, 2003, CHILD DEV, V74, P75, DOI 10.1111/1467-8624.00522; Redmond DE, 2007, P NATL ACAD SCI USA, V104, P12175, DOI 10.1073/pnas.0704091104; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Rueda N, 2005, NEUROSCI LETT, V380, P197, DOI 10.1016/j.neulet.2005.01.039; RYDER EF, 1990, J NEUROBIOL, V21, P356, DOI 10.1002/neu.480210209; Schmitz C, 1998, ANAT EMBRYOL, V198, P371, DOI 10.1007/s004290050191; Snyder EY, 1996, CURR OPIN NEUROL, V9, P126, DOI 10.1097/00019052-199604000-00013; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; Snyder EY, 1997, P NATL ACAD SCI USA, V94, P11663, DOI 10.1073/pnas.94.21.11663; Stasko MR, 2004, BEHAV BRAIN RES, V154, P1, DOI 10.1016/j.bbr.2004.01.012; Tang Y, 2003, HUM GENE THER, V14, P1247, DOI 10.1089/104303403767740786; Toso L, 2008, OBSTET GYNECOL, V112, P1242, DOI 10.1097/AOG.0b013e31818c91dc; UECKER A, 1993, J CLIN CHILD PSYCHOL, V22, P266, DOI 10.1207/s15374424jccp2202_12; Wainwright PE, 1998, J NUTR, V128, P661, DOI 10.1093/jn/128.3.661; Watson DJ, 2006, HUM GENE THER, V17, P693, DOI 10.1089/hum.2006.17.693; Zigman WB, 2007, MENT RETARD DEV D R, V13, P237, DOI 10.1002/mrdd.20163; Zorrilla EP, 1997, DEV PSYCHOBIOL, V30, P141, DOI 10.1002/(SICI)1098-2302(199703)30:2<141::AID-DEV5>3.0.CO;2-Q	64	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e36082	10.1371/journal.pone.0036082	http://dx.doi.org/10.1371/journal.pone.0036082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558337	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345200114
J	Roche, LM; Latimer, AM; Eastburn, DJ; Tate, KW				Roche, Leslie M.; Latimer, Andrew M.; Eastburn, Danny J.; Tate, Kenneth W.			Cattle Grazing and Conservation of a Meadow-Dependent Amphibian Species in the Sierra Nevada	PLOS ONE			English	Article							TOAD BUFO-CALAMITA; RIPARIAN ECOSYSTEMS; YOSEMITE TOADS; LIVESTOCK; CALIFORNIA; DECLINES; HABITAT; DESICCATION; COMMUNITIES; POPULATIONS	World-wide population declines have sharpened concern for amphibian conservation on working landscapes. Across the Sierra Nevada's national forest lands, where almost half of native amphibian species are considered at risk, permitted livestock grazing is a notably controversial agricultural activity. Cattle (Bos taurus) grazing is thought to degrade the quality, and thus reduce occupancy, of meadow breeding habitat for amphibian species of concern such as the endemic Yosemite toad (Anaxyrus [= Bufo] canorus). However, there is currently little quantitative information correlating cattle grazing intensity, meadow breeding habitat quality, and toad use of meadow habitat. We surveyed biotic and abiotic factors influencing cattle utilization and toad occupancy across 24 Sierra Nevada meadows to establish these correlations and inform conservation planning efforts. We utilized both traditional regression models and Bayesian structural equation modeling to investigate potential drivers of meadow habitat use by cattle and Yosemite toads. Cattle use was negatively related to meadow wetness, while toad occupancy was positively related. In mid and late season (mid July-mid September) grazing periods, cattle selected for higher forage quality diets associated with vegetation in relatively drier meadows, whereas toads were more prevalent in wetter meadows. Because cattle and toads largely occupied divergent zones along the moisture gradient, the potential for indirect or direct negative effects is likely minimized via a partitioning of the meadow habitat. During the early season, when habitat use overlap was highest, overall low grazing levels resulted in no detectable impacts on toad occupancy. Bayesian structural equation analyses supported the hypothesis that meadow hydrology influenced toad meadow occupancy, while cattle grazing intensity did not. These findings suggest cattle production and amphibian conservation can be compatible goals within this working landscape.	[Roche, Leslie M.; Latimer, Andrew M.; Eastburn, Danny J.; Tate, Kenneth W.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Roche, LM (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	lmroche@ucdavis.edu		Roche, Leslie/0000-0003-2954-8056; Latimer, Andrew/0000-0001-8098-0448	USDA Forest Service, Pacific Southwest Region	USDA Forest Service, Pacific Southwest Region(United States Department of Agriculture (USDA)United States Forest Service)	Research was funded by USDA Forest Service, Pacific Southwest Region. Other than providing preliminary data, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aber JD, 2004, FOREST ECOL MANAG, V196, P1, DOI 10.1016/j.foreco.2004.03.009; Adams MJ, 2009, J HERPETOL, V43, P132, DOI 10.1670/08-016R2.1; Alford RA, 1999, ANNU REV ECOL SYST, V30, P133, DOI 10.1146/annurev.ecolsys.30.1.133; ALLENDIAZ BH, 1991, AM MIDL NAT, V126, P30, DOI 10.2307/2426147; Anderson TM, 2007, AM NAT, V170, P343, DOI 10.1086/520120; [Anonymous], CDFG SPEC AN 883 TAX; [Anonymous], 2013, MEASUREMENTS TERREST; AOAC, 1997, 97318 AOAC ASASSA IN; AOAC, 2006, OFFICIAL METHODS ANA, V18th, P30; Bagozzi R.P., 1988, J ACAD MARKET SCI, V16, P74, DOI [10.1007/BF02723327, DOI 10.1007/BF02723327]; Belsky AJ, 1999, J SOIL WATER CONSERV, V54, P419; Bollen KA, 1989, STRUCTURAL EQUATIONS; BOSCH JM, 1982, J HYDROL, V55, P3, DOI 10.1016/0022-1694(82)90117-2; Bull EL, 2000, J RANGE MANAGE, V53, P291, DOI 10.2307/4003434; Burton EC, 2009, J WILDLIFE MANAGE, V73, P269, DOI 10.2193/2007-562; Carstensen B, EPI PACKAGE STAT ANA; Collins JP, 2003, DIVERS DISTRIB, V9, P89, DOI 10.1046/j.1472-4642.2003.00012.x; Congdon P, 2003, APPL BAYSEIAN MODELI; Denton JS, 1997, CONSERV BIOL, V11, P1329, DOI 10.1046/j.1523-1739.1997.96318.x; Drost CA, 1996, CONSERV BIOL, V10, P414, DOI 10.1046/j.1523-1739.1996.10020414.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; FLEISCHNER TL, 1994, CONSERV BIOL, V8, P629, DOI 10.1046/j.1523-1739.1994.08030629.x; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.2277/0521867061; George M, 2001, ANN RANGE FORAGE PRO; Grace J.B., 2006, STRUCT EQ MOD NAT; Grace JB, 1997, AM NAT, V149, P436, DOI 10.1086/285999; Healey M, 1997, AUST J ECOL, V22, P270, DOI 10.1111/j.1442-9993.1997.tb00672.x; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; Interagency, 1996, BLMRSST960041730 USD; Jansen A, 2003, BIOL CONSERV, V109, P207, DOI 10.1016/S0006-3207(02)00148-9; Jennings M. R., 1994, AMPHIBIAN REPTILE SP; Jennings Mark R., 1996, P921; Jofre G, 2007, AMPHIBIA-REPTILIA, V28, P129, DOI 10.1163/156853807779799126; Johnson ML, 2003, DIS AQUAT ORGAN, V57, P255, DOI 10.3354/dao057255; Karlstrom E. L, 1962, U CALIFORNIA PUBLICA, V62, P1; KAUFFMAN JB, 1984, J RANGE MANAGE, V37, P430, DOI 10.2307/3899631; Knutson MG, 2004, ECOL APPL, V14, P669, DOI 10.1890/02-5305; Lee S.Y., 2007, STRUCTURAL EQUATION, DOI 10.1002/9780470024737; Lind A, 2010, DETERMINING EFFECTS; Lind AJ, 2011, DETERMINING EFFECTS; Loheide SP, 2009, HYDROGEOL J, V17, P229, DOI 10.1007/s10040-008-0380-4; McCullagh P, 1989, GEN LINEAR MODELS EX; McIlroy SK, 2008, IDENTIFYING ECOLOGIC; McMenamin SK, 2008, P NATL ACAD SCI USA, V105, P16988, DOI 10.1073/pnas.0809090105; Meyer G.A., 1992, INDUCTIVELY COUPLED, V2, P473; Millar CI, 2004, ARCT ANTARCT ALP RES, V36, P181, DOI 10.1657/1523-0430(2004)036[0181:ROSCIT]2.0.CO;2; Morton ML, 2010, HERPETOL CONSERV BIO, V5, P388; Norman SP, 2005, FOREST ECOL MANAG, V215, P51, DOI 10.1016/j.foreco.2005.05.003; NRC, 1996, NUTR REQ BEEF CATTL; Null SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009932; Papke LE, 1996, J APPL ECONOM, V11, P619, DOI 10.1002/(SICI)1099-1255(199611)11:6<619::AID-JAE418>3.0.CO;2-1; Pinheiro J, 2000, MIXED EFFECTS MODELS; Plummer M, 2010, RJAGS BAYESIAN GRAPH; R Core Team, 2021, R LANGUAGE ENV STAT; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Rannap R, 2007, WETLANDS, V27, P390, DOI 10.1672/0277-5212(2007)27[390:COCMDT]2.0.CO;2; Ratliff R, 1985, PSWGTR84 USDA FOR SE; Ready J, 2010, ECOL MODEL, V221, P467, DOI 10.1016/j.ecolmodel.2009.10.025; Riginos C, 2008, ECOLOGY, V89, P2228, DOI 10.1890/07-1250.1; Roche LM, 2012, RANGELAND ECOL MANAG, V65, P56, DOI 10.2111/REM-D-11-00092.1; Roche LM, 2011, THESIS U CALIFORNIA; SAH RN, 1992, ANAL CHEM, V64, P230, DOI 10.1021/ac00026a026; Sarr DA, 2002, ENVIRON MANAGE, V30, P516, DOI 10.1007/s00267-002-2608-8; Schmutzer AC, 2008, FRESHWATER BIOL, V53, P2613, DOI 10.1111/j.1365-2427.2008.02072.x; SHERMAN CK, 1993, J HERPETOL, V27, P186, DOI 10.2307/1564935; SHERMAN CK, 1984, NAT HIST, V93, P72; Smith MA, 2005, ECOGRAPHY, V28, P110; Spiegelhalter D, OPENBUGS USER MANUAL; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; StataCorp, 2007, STAT STAT SOFTW REL; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Sulak A., 2002, General Technical Report - Pacific Southwest Research Station, USDA Forest Service, P43; Thomas A., 2006, R NEWS, V6, P12, DOI DOI 10.1159/000323281; Toledo ZO, 2001, J AM WATER RESOUR AS, V37, P1653, DOI 10.1111/j.1752-1688.2001.tb03667.x; U.S. Department of Interior Fish and Wildlife Service (USFWS), 2002, FED REGISTER, V67, P75834; U.S. Department of Interior Fish and Wildlife Service (USFWS), 2004, FED REGISTER, V69, P25876; USDAForestService, 2005, FOR SERV MAN FSM 267	77	26	26	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35734	10.1371/journal.pone.0035734	http://dx.doi.org/10.1371/journal.pone.0035734			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558211	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345200072
J	Voyles, J; Vredenburg, VT; Tunstall, TS; Parker, JM; Briggs, CJ; Rosenblum, EB				Voyles, Jamie; Vredenburg, Vance T.; Tunstall, Tate S.; Parker, John M.; Briggs, Cheryl J.; Rosenblum, Erica Bree			Pathophysiology in Mountain Yellow-Legged Frogs (Rana muscosa) during a Chytridiomycosis Outbreak	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASE; BATRACHOCHYTRIUM-DENDROBATIDIS; POPULATION DECLINES; FUNGAL PATHOGEN; AMPHIBIANS; EXTINCTION; DYNAMICS	The disease chytridiomycosis is responsible for declines and extirpations of amphibians worldwide. Chytridiomycosis is caused by a fungal pathogen (Batrachochytrium dendrobatidis) that infects amphibian skin. Although we have a basic understanding of the pathophysiology from laboratory experiments, many mechanistic details remain unresolved and it is unknown if disease development is similar in wild amphibian populations. To gain a better understanding of chytridiomycosis pathophysiology in wild amphibian populations, we collected blood biochemistry measurements during an outbreak in mountain yellow-legged frogs (Rana muscosa) in the Sierra Nevada Mountains of California. We found that pathogen load is associated with disruptions in fluid and electrolyte balance, yet is not associated with fluctuations acid-base balance. These findings enhance our knowledge of the pathophysiology of this disease and indicate that disease development is consistent across multiple species and in both laboratory and natural conditions. We recommend integrating an understanding of chytridiomycosis pathophysiology with mitigation practices to improve amphibian conservation.	[Voyles, Jamie; Rosenblum, Erica Bree] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Vredenburg, Vance T.] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; [Tunstall, Tate S.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Tunstall, Tate S.; Briggs, Cheryl J.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Parker, John M.] Univ Calif San Francisco, Anim Care Facil, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; California State University System; San Francisco State University; University of California System; University of California Berkeley; University of California System; University of California Santa Barbara; University of California System; University of California San Francisco	Voyles, J (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	jamie.voyles@gmail.com	Briggs, Cheryl/F-7456-2013	Vredenburg, Vance/0000-0002-9682-1190	National Institutes of Health [R01ES12067]; National Science Foundation [EF-0723563]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012067] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by National Institutes of Health Grant R01ES12067 and National Science Foundation Grant EF-0723563. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bancila RI, 2010, AMPHIBIA-REPTILIA, V31, P558, DOI 10.1163/017353710X518405; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berger L, 2010, DIS AQUAT ORGAN, V92, P165, DOI 10.3354/dao02238; Boutilier Robert G., 1992, P81; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Briggs CJ, 2005, ECOLOGY, V86, P3149, DOI 10.1890/04-1428; Budaev SV, 2010, ETHOLOGY, V116, P472, DOI 10.1111/j.1439-0310.2010.01758.x; Carver S, 2010, COPEIA, P487, DOI 10.1643/CH-09-128; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; David Rose B, 2001, CLIN PHYSL ACID BASE; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Kinney VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016708; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Marcum RD, 2010, DIS AQUAT ORGAN, V91, P17, DOI 10.3354/dao02235; MUELLER GM, 2004, BIODIVERSITY FUNGI I; Schaechter M., 1993, MECH MICROBIAL DIS; Schloegel LM, 2006, ECOHEALTH, V3, P35, DOI 10.1007/s10393-005-0012-6; Voyles J, 2007, DIS AQUAT ORGAN, V77, P113, DOI 10.3354/dao01838; Voyles J, 2011, MICROBES INFECT, V13, P25, DOI 10.1016/j.micinf.2010.09.015; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Woodhams DC, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-8; Wright KM., 2001, AMPHIBIAN MED CAPTIV	28	50	51	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35374	10.1371/journal.pone.0035374	http://dx.doi.org/10.1371/journal.pone.0035374			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558145	gold, Green Published			2022-12-27	WOS:000305345200035
J	Alberdi, A; Garin, I; Aizpurua, O; Aihartza, J				Alberdi, Antton; Garin, Inazio; Aizpurua, Ostaizka; Aihartza, Joxerra			The Foraging Ecology of the Mountain Long-Eared Bat Plecotus macrobullaris Revealed with DNA Mini-Barcodes	PLOS ONE			English	Article							FOOD-HABITS; ECHOLOCATION CALLS; PREY SELECTION; FECAL ANALYSIS; INSECTIVOROUS BATS; LASIURUS-CINEREUS; DIETARY VARIATION; CHIROPTERA; MOTHS; IDENTIFICATION	Molecular analysis of diet overcomes the considerable limitations of traditional techniques for identifying prey remains in bat faeces. We collected faeces from individual Mountain Long-eared Bats Plecotus macrobullaris trapped using mist nets during the summers of 2009 and 2010 in the Pyrenees. We analysed their diet using DNA mini-barcodes to identify prey species. In addition, we inferred some basic features of the bat's foraging ecology that had not yet been addressed. P. macrobullaris fed almost exclusively on moths (97.8%). As prey we detected one dipteran genus (Tipulidae) and 29 moth taxa: 28 were identified at species level (23 Noctuidae, 1 Crambidae, 1 Geometridae, 1 Pyralidae, 1 Sphingidae, 1 Tortricidae), and one at genus level (Rhyacia sp., Noctuidae). Known ecological information about the prey species allowed us to determine that bats had foraged at elevations between 1,500 and 2,500 m amsl (above mean sea level), mostly in subalpine meadows, followed by other open habitats such as orophilous grasslands and alpine meadows. No forest prey species were identified in the diet. As 96.4% of identified prey species were tympanate moths and no evidence of gleaning behaviour was revealed, we suggest P. macrobullaris probably forages by aerial hawking using faint echolocation pulses to avoid detection by hearing moths. As we could identify 87.8% of the analysed sequences (64.1% of the MOTUs, Molecular Operational Taxonomic Units) at species level, we conclude that DNA mini-barcodes are a very useful tool to analyse the diet of moth-specialist bats.	[Alberdi, Antton; Garin, Inazio; Aizpurua, Ostaizka; Aihartza, Joxerra] Univ Basque Country UPV EHU, Fac Sci & Technol, Dept Zool & Anim Cell Biol, Leioa, The Basque Coun, Spain	University of Basque Country	Alberdi, A (corresponding author), Univ Basque Country UPV EHU, Fac Sci & Technol, Dept Zool & Anim Cell Biol, Leioa, The Basque Coun, Spain.	joxerra.aihartza@ehu.es	Garin, Inazio/B-8115-2009; Aizpurua, Ostaizka/V-9490-2019; Aihartza, Joxerra/Z-3061-2019; Alberdi, Antton/M-2423-2017; Aihartza, Joxerra/GSO-2446-2022	Aizpurua, Ostaizka/0000-0001-8053-3672; Aihartza, Joxerra/0000-0003-0882-8964; Alberdi, Antton/0000-0002-2875-6446; 	Hezkuntza, Unibertsitate eta Ikerketa Saila, Eusko Jaurlaritza - The Basque Government [GIC07/05, IT301-10, BFI-2010-190, BFI-2009-252]; University of The Basque Country, Euskal Herriko Uniberstiatatea UPV/EHU	Hezkuntza, Unibertsitate eta Ikerketa Saila, Eusko Jaurlaritza - The Basque Government; University of The Basque Country, Euskal Herriko Uniberstiatatea UPV/EHU	This work was supported by Hezkuntza, Unibertsitate eta Ikerketa Saila, Eusko Jaurlaritza - The Basque Government (research projects GIC07/05 and IT301-10, and grants BFI-2010-190, and BFI-2009-252) and the University of The Basque Country, Euskal Herriko Uniberstiatatea UPV/EHU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHARYA L, 1992, CAN J ZOOL, V70, P1292, DOI 10.1139/z92-180; Alcalde J. T., 2008, Graellsia, V64, P3; Almenar D, 2008, J ZOOL, V274, P340, DOI 10.1111/j.1469-7998.2007.00390.x; ANDERSON ME, 1991, ANIM BEHAV, V42, P489, DOI 10.1016/S0003-3472(05)80048-X; Animal Behaviour Society, 2006, ANIM BEHAV, V71, P245, DOI DOI 10.1016/J.ANBEHAV.2005.10.001; Ashrafi S, 2010, J ZOOL, V281, P241, DOI 10.1111/j.1469-7998.2010.00697.x; Ashrafi S, 2010, THESIS U BERN SWITZE; Ashrafi S, 2011, EUR J WILDLIFE RES, V57, P843, DOI 10.1007/s10344-011-0496-z; BECK A, 1995, MYOTIS, V32, P109; Beck J, 2010, BASIC APPL ECOL, V11, P714, DOI 10.1016/j.baae.2010.08.009; Benda Petr, 2008, Acta Societatis Zoologicae Bohemicae, V72, P105; Bogdanowicz W, 1999, J ZOOL, V247, P381, DOI 10.1111/j.1469-7998.1999.tb01001.x; Bohmann K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021441; Boye P, 2005, 661 ENGL NAT; Burles DW, 2008, CAN J ZOOL, V86, P1367, DOI 10.1139/Z08-125; Chapman JW, 2008, CURR BIOL, V18, P514, DOI 10.1016/j.cub.2008.02.080; Chiarucci A, 2003, DIVERS DISTRIB, V9, P283, DOI 10.1046/j.1472-4642.2003.00027.x; Clare EL, 2011, MOL ECOL, V20, P1772, DOI 10.1111/j.1365-294X.2011.05040.x; Clare EL, 2009, MOL ECOL, V18, P2532, DOI 10.1111/j.1365-294X.2009.04184.x; Coldea G, 2003, ECOL STU AN, P65; Collin CL, 2010, PLANT ECOL, V206, P1, DOI 10.1007/s11258-009-9620-5; Collin CL, 2003, AM J BOT, V90, P579, DOI 10.3732/ajb.90.4.579; Colwell R.K., 2016, ESTIMATES STAT ESTIM; Davidson P, 2007, BIRDWATCH CAN, V41, P4; Deagle Bruce E, 2006, Front Zool, V3, P11, DOI 10.1186/1742-9994-3-11; DICKMAN CR, 1988, J MAMMAL, V69, P108, DOI 10.2307/1381753; Dietrich S, 2006, ACTA CHIROPTEROL, V8, P465, DOI 10.3161/1733-5329(2006)8[465:ESOTPB]2.0.CO;2; Dinca Vlad, 2008, Nota Lepidopterologica, V31, P263; Dodd LE, 2007, ACTA CHIROPTEROL, V9, P451, DOI 10.3161/1733-5329(2007)9[451:PCBCTI]2.0.CO;2; Dodok I., 2005, Acta Entomologica Serbica, V8, P1; EASTERLA DA, 1972, J MAMMAL, V53, P887, DOI 10.2307/1379227; Eisentraut M, 1951, ZOOL JB, V79, P114; EPA, 2001, NAT LAND COV DAT LAN; FAURE PA, 1990, J COMP PHYSIOL A, V166, P843; Fukui Dai, 2009, Endangered Species Research, V8, P117, DOI 10.3354/esr00156; FULLARD JH, 1988, EXPERIENTIA, V44, P423, DOI 10.1007/BF01940537; Gajdosik M, 2004, FOLIA ZOOL, V53, P7; Garcia-Gonzalez R, 2008, MANAGEMENT NATURA 20; Garin I, 2003, ACTA CHIROPTEROL, V5, P243, DOI 10.3161/001.005.0207; Goerlitz HR, 2010, CURR BIOL, V20, P1568, DOI 10.1016/j.cub.2010.07.046; Goiti U, 2004, MAMMALIA, V68, P397, DOI 10.1515/mamm.2004.039; Grabherr G, 2000, MT RES DEV, V20, P190, DOI 10.1659/0276-4741(2000)020[0190:GAGORI]2.0.CO;2; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hartbauer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012698; Hebert P. D. N., 2004, BARCODES LIFE; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Henry PY, 2011, BIRD STUDY, V58, P160, DOI 10.1080/00063657.2010.543948; Hodkinson ID, 2005, BIOL REV, V80, P489, DOI 10.1017/S1464793105006767; Huemer Peter, 2005, Vorarlberger Naturschau Forschen und Entdecken, V16, P9; Jones M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019259; Juste J, 2004, MOL PHYLOGENET EVOL, V31, P1114, DOI 10.1016/j.ympev.2003.10.005; Kiefer Andreas, 2001, Myotis, V39, P5; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; Korner C, 1999, ALPINE PLANT LIFE FU; KUNZ TH, 1983, CAN J ZOOL, V61, P1317, DOI 10.1139/z83-177; Lacki MJ, 2001, AM MIDL NAT, V145, P213, DOI 10.1674/0003-0031(2001)145[0213:SUOLPB]2.0.CO;2; Lee YF, 2005, J MAMMAL, V86, P67, DOI 10.1644/1545-1542(2005)086&lt;0067:DVOBFB&gt;2.0.CO;2; Martin KM, 2001, WILDLIFE-HABITAT RELATIONSHIPS IN OREGON AND WASHINGTON, P239; Mattei-Roesli Marzia, 2010, Bollettino della Societa Ticinese di Scienze Naturali, V98, P31; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Miehe G, 2000, ERDKUNDE, V54, P34, DOI DOI 10.3112/erdkunde.2000.01.03; Miller L.A., 1984, Series Entomologica (Dordrecht), V27, P134; Miller LA, 2001, BIOSCIENCE, V51, P570, DOI 10.1641/0006-3568(2001)051[0570:HSIDAA]2.0.CO;2; Moulton MJ, 2010, MOL ECOL RESOUR, V10, P615, DOI 10.1111/j.1755-0998.2009.02823.x; Nappi Armando, 2002, Hystrix, V13, P45; Olsson EGA, 2000, LANDSCAPE ECOL, V15, P155, DOI 10.1023/A:1008173628016; Ortiz AS, 2009, SHILAP-REV. LEPIDOPT, V37, P105; Painter ML, 2009, CAN J ZOOL, V87, P865, DOI 10.1139/Z09-075; Pavey CR, 1998, OIKOS, V81, P143, DOI 10.2307/3546476; Pavlinic Igor, 2004, Natura Croatica, V13, P395; PEPIN D, 1992, ONGULES / UNGULATES 91, P327; Perez De-Gregorio JJ, 2001, ATLAS FOTOGRAFICO LE; Poulton EB, 1929, P ZOOL SOC LOND, V1929, P277; Preatoni DG, 2011, ACTA CHIROPTEROL, V13, P355, DOI 10.3161/150811011X624820; RABINOWITZ AR, 1982, ACTA THERIOL, V27, P283, DOI 10.4098/AT.arch.82-25; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Raupach MJ, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-26; Razgour O, 2011, ECOL EVOL, V1, DOI 10.1002/ece3.49; Robineau R, 2007, GUIDE PAPILLONS NOCT; ROEDER KD, 1957, J EXP ZOOL, V134, P127, DOI 10.1002/jez.1401340107; Roeder KD, 1967, NERVE CELLS INSECT B; Ross A., 1967, Proceedings Western Foundation of Vertebrate Zoology, V1, P204; Rostovskaya M. S., 2000, Russian Entomological Journal, V9, P185; RYDELL J, 1994, P ROY SOC B-BIOL SCI, V257, P175, DOI 10.1098/rspb.1994.0112; Rydell J, 1996, ECOGRAPHY, V19, P62, DOI 10.1111/j.1600-0587.1996.tb00155.x; Salsamendi E, 2008, ACTA CHIROPTEROL, V10, P279, DOI 10.3161/150811008X414854; Scalercio S, 2009, EUR J ENTOMOL, V106, P231, DOI 10.14411/eje.2009.031; Schnepf J, 2010, THESIS U WIEN AUSTRI; SCOBLE M. J., 1992, LEPIDOPTERA FORM FUN; Shapiro A.M., 1975, P181; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Spitzenberger F, 2006, ZOOL SCR, V35, P187, DOI 10.1111/j.1463-6409.2006.00224.x; Spitzenberger Friederike, 2003, Natura Croatica, V12, P39; Spitzenberger Friederike, 2002, Natura Croatica, V11, P1; Spitzer Karel, 2003, Opera Corcontica, V40, P275; Stephens D.W., 1986, pi; ter Hofstede HM, 2010, J COMP PHYSIOL A, V196, P349, DOI 10.1007/s00359-010-0518-4; Valdez EW, 2009, SOUTHWEST NAT, V54, P195, DOI 10.1894/PS-45.1; Vare H., 2003, VVolume 167, P133; Varga ZS, 2008, BIOL J LINN SOC, V93, P415, DOI 10.1111/j.1095-8312.2007.00934.x; Vaughan N, 1997, MAMMAL REV, V27, P77, DOI 10.1111/j.1365-2907.1997.tb00373.x; Virgilio M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-206; Waring P, 2003, FIELD GUIDE MOTHS GR; Waters DA, 1996, J EXP BIOL, V199, P847; WATERS DA, 1995, J EXP BIOL, V198, P475; WERNER TK, 1981, CAN J ZOOL, V59, P525, DOI 10.1139/z81-076; Whitaker JO, 1996, J MAMMAL, V77, P716, DOI 10.2307/1382676; Whitaker JO, 2009, ACTA CHIROPTEROL, V11, P393, DOI 10.3161/150811009X485611; Wiebe KL, 1998, IBIS, V140, P14, DOI 10.1111/j.1474-919X.1998.tb04536.x; Wood CR, 2009, B ENTOMOL RES, V99, P525, DOI 10.1017/S0007485308006548; Zeale MRK, 2011, MOL ECOL RESOUR, V11, P236, DOI 10.1111/j.1755-0998.2010.02920.x; Zhang DX, 1996, MOL ECOL, V5, P295, DOI 10.1111/j.1365-294X.1996.tb00317.x	115	40	41	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35692	10.1371/journal.pone.0035692	http://dx.doi.org/10.1371/journal.pone.0035692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545129	gold, Green Published			2022-12-27	WOS:000305343200049
J	Catts, VS; Weickert, CS				Catts, Vibeke Sorensen; Weickert, Cynthia Shannon			Gene Expression Analysis Implicates a Death Receptor Pathway in Schizophrenia Pathology	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; CORTICAL PYRAMIDAL NEURONS; DENDRITIC SPINE DENSITY; ANTERIOR CINGULATE CORTEX; BIPOLAR-DISORDER; SOMAL SIZE; GABAERGIC NEURONS; NADPH-OXIDASE; APOPTOTIC MECHANISMS; SELECTIVE DEFICITS	An increase in apoptotic events may underlie neuropathology in schizophrenia. By data-mining approaches, we identified significant expression changes in death receptor signaling pathways in the dorsolateral prefrontal cortex (DLPFC) of patients with schizophrenia, particularly implicating the Tumor Necrosis Factor Superfamily member 6 (FAS) receptor and the Tumor Necrosis Factor [ ligand] Superfamily member 13 (TNFSF13) in schizophrenia. We sought to confirm and replicate in an independent tissue collection the noted mRNA changes with quantitative real-time RT-PCR. To test for regional and diagnostic specificity, tissue from orbital frontal cortex (OFC) was examined and a bipolar disorder group included. In schizophrenia, we confirmed and replicated significantly increased expression of TNFSF13 mRNA in the DLPFC. Also, a significantly larger proportion of subjects in the schizophrenia group had elevated FAS receptor expression in the DLPFC relative to unaffected controls. These changes were not observed in the bipolar disorder group. In the OFC, there were no significant differences in TNFSF13 or FAS receptor mRNA expression. Decreases in BH3 interacting domain death agonist (BID) mRNA transcript levels were found in the schizophrenia and bipolar disorder groups affecting both the DLPFC and the OFC. We tested if TNFSF13 mRNA expression correlated with neuronal mRNAs in the DLPFC, and found significant negative correlations with interneuron markers, parvalbumin and somatostatin, and a positive correlation with PPP1R9B (spinophilin), but not DLG4 (PSD-95). The expression of TNFSF13 mRNA in DLPFC correlated negatively with tissue pH, but decreasing pH in cultured cells did not cause increased TNFSF13 mRNA nor did exogenous TNFSF13 decrease pH. We concluded that increased TNFSF13 expression may be one of several cell-death cytokine abnormalities that contribute to the observed brain pathology in schizophrenia, and while increased TNFSF13 may be associated with lower brain pH, the change is not necessarily causally related to brain pH.	[Catts, Vibeke Sorensen; Weickert, Cynthia Shannon] Schizophrenia Res Inst, Schizophrenia Res Lab, Sydney, NSW, Australia; [Catts, Vibeke Sorensen; Weickert, Cynthia Shannon] Neurosci Res Australia, Schizophrenia Res Lab, Sydney, NSW, Australia; [Catts, Vibeke Sorensen] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Catts, Vibeke Sorensen; Weickert, Cynthia Shannon] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia	Neuroscience Research Australia; University of New South Wales Sydney; University of New South Wales Sydney	Catts, VS (corresponding author), Schizophrenia Res Inst, Schizophrenia Res Lab, Sydney, NSW, Australia.	v.catts@NeuRA.edu.au	Weickert, Cynthia Shannon/G-3171-2011; Catts, Vibeke S/C-9798-2011	Catts, Vibeke S/0000-0002-9892-0547; Shannon Weickert, Cynthia/0000-0002-4560-0259	Stanley Medical Research Institute (SMRI) [09R-2153]; Schizophrenia Research Institute; NSW Health; Macquarie Group Foundation; Neuroscience Research Australia; University of New South Wales; National Health and Medical Research Council of Australia; National Institute of Alcohol Abuse and Alcoholism (NIH (NIAAA)) [R24AA012725]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R28AA012725, R24AA012725] Funding Source: NIH RePORTER	Stanley Medical Research Institute (SMRI); Schizophrenia Research Institute; NSW Health; Macquarie Group Foundation; Neuroscience Research Australia; University of New South Wales; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Institute of Alcohol Abuse and Alcoholism (NIH (NIAAA))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Grant funding was received from the Stanley Medical Research Institute (SMRI Grant No 09R-2153: www.stanleyresearch.org). This work was also supported by the Schizophrenia Research Institute (www.schizophreniaresearch.org.au), utilizing infrastructure funding from NSW Health, the Macquarie Group Foundation, Neuroscience Research Australia and the University of New South Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Postmortem brain tissue was provided by the SMRI's brain collection courtesy of Drs Michael B Knable, E Fuller Torrey, Maree J Webster, Serge Weis, and Robert H Yolken. Tissues were also received from the New South Wales TRC at the University of Sydney which is supported by the National Health and Medical Research Council of Australia, Schizophrenia Research Institute, National Institute of Alcohol Abuse and Alcoholism (NIH (NIAAA) R24AA012725). We also thank the SMRI for access to array data via the Stanley Online Genomics Database, which uses samples from the SMRI Brain Bank. These samples were processed and run on gene expression arrays by a variety of researchers in collaboration with the SMRI. All of the genomic data have been aggregated in the online database, and a comprehensive set of cross-study analyses have been performed by Dr Michael Elashoff. Thank you to Shan Tsai for capable assistance in the laboratory.	Beasley CL, 1997, SCHIZOPHR RES, V24, P349, DOI 10.1016/S0920-9964(96)00122-3; Beasley CL, 2002, BIOL PSYCHIAT, V52, P708, DOI 10.1016/S0006-3223(02)01360-4; Behrens MM, 2007, SCIENCE, V318, P1645, DOI 10.1126/science.1148045; Behrens MM, 2008, J NEUROSCI, V28, P13957, DOI 10.1523/JNEUROSCI.4457-08.2008; Benes FM, 2003, ARCH GEN PSYCHIAT, V60, P359, DOI 10.1001/archpsyc.60.4.359; Benes FM, 2010, CELL CYCLE, V9, P625, DOI 10.4161/cc.9.4.10820; Benes FM, 2009, P NATL ACAD SCI USA, V106, P11731, DOI 10.1073/pnas.0903066106; Bitanihirwe BKY, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-71; Black JE, 2004, AM J PSYCHIAT, V161, P742, DOI 10.1176/appi.ajp.161.4.742; Broadbelt K, 2002, SCHIZOPHR RES, V58, P75, DOI 10.1016/S0920-9964(02)00201-3; Buttner N, 2007, SCHIZOPHR RES, V93, P33, DOI 10.1016/j.schres.2007.01.030; Catts VS, 2010, SECONDARY SCHIZOPHRE, P141, DOI DOI 10.1017/CBO9780511789977.011; Cerqueira JJ, 2005, J NEUROSCI, V25, P7792, DOI 10.1523/JNEUROSCI.1598-05.2005; Chana G, 2003, BIOL PSYCHIAT, V53, P1086, DOI 10.1016/S0006-3223(03)00114-8; Chang DW, 2002, EMBO J, V21, P3704, DOI 10.1093/emboj/cdf356; Conti B, 2008, NEUROIMMUNE, V6, P21; Corsini NS, 2009, CELL STEM CELL, V5, P178, DOI 10.1016/j.stem.2009.05.004; Dallas PB, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-59; DEFELIPE J, 1992, PROG NEUROBIOL, V39, P563, DOI 10.1016/0301-0082(92)90015-7; Djerbi M, 2001, SCAND J IMMUNOL, V54, P180, DOI 10.1046/j.1365-3083.2001.00941.x; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; FIELD A, 2005, DISCOVERING STAT USI, P32; Franck P, 1996, J BIOTECHNOL, V46, P187, DOI 10.1016/0168-1656(95)00189-1; Fung SJ, 2010, AM J PSYCHIAT, V167, P1479, DOI 10.1176/appi.ajp.2010.09060784; Garey LJ, 1998, J NEUROL NEUROSUR PS, V65, P446, DOI 10.1136/jnnp.65.4.446; Glantz LA, 2006, SCHIZOPHR RES, V81, P47, DOI 10.1016/j.schres.2005.08.014; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Gonzalez-Burgos G, 2010, CURR PSYCHIAT REP, V12, P335, DOI 10.1007/s11920-010-0124-8; Gottfried Y, 2007, SCHIZOPHR RES, V96, P257, DOI 10.1016/j.schres.2007.05.031; Harrison PJ, 1995, NEUROSCI LETT, V200, P151, DOI 10.1016/0304-3940(95)12102-A; Hashimoto T, 2008, MOL PSYCHIATR, V13, P147, DOI 10.1038/sj.mp.4002011; Hashimoto T, 2008, AM J PSYCHIAT, V165, P479, DOI 10.1176/appi.ajp.2007.07081223; HENDERSON LM, 1988, BIOCHEM J, V251, P563, DOI 10.1042/bj2510563; Higgs BW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-70; Hirsch SR, 1997, PHARMACOL BIOCHEM BE, V56, P797, DOI 10.1016/S0091-3057(96)00428-5; Jarskog LF, 2005, PROG NEURO-PSYCHOPH, V29, P846, DOI 10.1016/j.pnpbp.2005.03.010; Jarskog LF, 2004, AM J PSYCHIAT, V161, P109, DOI 10.1176/appi.ajp.161.1.109; Jia PL, 2010, SCHIZOPHR RES, V122, P38, DOI 10.1016/j.schres.2010.07.001; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Kalus P, 2000, NEUROREPORT, V11, P3621, DOI 10.1097/00001756-200011090-00044; Kelly K, 2000, CANCER RES, V60, P1021; Kim S, 2011, MOL PSYCHIATR, V16, P452, DOI 10.1038/mp.2010.23; Kim S, 2010, MOL PSYCHIATR, V15, P326, DOI 10.1038/mp.2008.99; Kim S, 2010, NEUROPSYCHOPHARMACOL, V35, P473, DOI 10.1038/npp.2009.151; KINGSBURY AE, 1995, MOL BRAIN RES, V28, P311, DOI 10.1016/0169-328X(94)00219-5; Kristiansen LV, 2006, MOL PSYCHIATR, V11, P737, DOI 10.1038/sj.mp.4001844; Lavrik I, 2005, J CELL SCI, V118, P265, DOI 10.1242/jcs.01610; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Mackay F, 2003, CYTOKINE GROWTH F R, V14, P311, DOI 10.1016/S1359-6101(03)00023-6; McKernan DP, 2009, PROG NEUROBIOL, V88, P246, DOI 10.1016/j.pneurobio.2009.04.006; Mellios N, 2009, BIOL PSYCHIAT, V65, P1006, DOI 10.1016/j.biopsych.2008.11.019; Mexal S, 2005, MOL BRAIN RES, V139, P317, DOI 10.1016/j.molbrainres.2005.06.006; Mhawech-Fauceglia P, 2006, J LEUKOCYTE BIOL, V80, P697, DOI 10.1189/jlb.1105655; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; Morris HM, 2008, CEREB CORTEX, V18, P1575, DOI 10.1093/cercor/bhm186; Mulkey DK, 2004, AM J PHYSIOL-CELL PH, V286, pC940, DOI 10.1152/ajpcell.00323.2003; PAKKENBERG B, 1993, BIOL PSYCHIAT, V34, P768, DOI 10.1016/0006-3223(93)90065-L; Pennington K, 2008, SCHIZOPHR RES, V106, P164, DOI 10.1016/j.schres.2008.08.022; Pierri JN, 2003, BIOL PSYCHIAT, V54, P111, DOI 10.1016/S0006-3223(03)00294-4; Pierri JN, 2001, ARCH GEN PSYCHIAT, V58, P466, DOI 10.1001/archpsyc.58.5.466; Rajkowska G, 1998, ARCH GEN PSYCHIAT, V55, P215, DOI 10.1001/archpsyc.55.3.215; Reich A, 2008, TRENDS NEUROSCI, V31, P478, DOI 10.1016/j.tins.2008.06.007; Reynolds GP, 2002, J NEURAL TRANSM, V109, P881, DOI 10.1007/s007020200072; Reynolds GP, 2001, J CHEM NEUROANAT, V22, P95, DOI 10.1016/S0891-0618(01)00113-2; Sakai T, 2008, NEUROPATHOLOGY, V28, P143, DOI 10.1111/j.1440-1789.2007.00867.x; Selemon LD, 1998, J COMP NEUROL, V392, P402; SELEMON LD, 1995, ARCH GEN PSYCHIAT, V52, P805; Sweet RA, 2004, BIOL PSYCHIAT, V55, P1128, DOI 10.1016/j.biopsych.2004.03.002; Sweet RA, 2009, NEUROPSYCHOPHARMACOL, V34, P374, DOI 10.1038/npp.2008.67; Thangarajh M, 2007, SCAND J IMMUNOL, V65, P92, DOI 10.1111/j.1365-3083.2006.01867.x; Thompson M, 2009, J PSYCHIATR RES, V43, P970, DOI 10.1016/j.jpsychires.2009.02.005; Thune JJ, 2001, J PSYCHIATR RES, V35, P15, DOI 10.1016/S0022-3956(00)00043-1; Torrey EF, 2005, BIOL PSYCHIAT, V57, P252, DOI 10.1016/j.biopsych.2004.10.019; Weickert CS, 2004, ARCH GEN PSYCHIAT, V61, P544, DOI 10.1001/archpsyc.61.6.544; Weickert CS, 2010, AUST NZ J PSYCHIAT, V44, P59, DOI 10.3109/00048670903393662; Zuliani C, 2006, CELL DEATH DIFFER, V13, P31, DOI 10.1038/sj.cdd.4401720	76	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35511	10.1371/journal.pone.0035511	http://dx.doi.org/10.1371/journal.pone.0035511			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545112	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343200032
J	Justilien, V; Regala, RP; Tseng, IC; Walsh, MP; Batra, J; Radisky, ES; Murray, NR; Fields, AP				Justilien, Verline; Regala, Roderick P.; Tseng, I-Chu; Walsh, Michael P.; Batra, Jyotica; Radisky, Evette S.; Murray, Nicole R.; Fields, Alan P.			Matrix Metalloproteinase-10 Is Required for Lung Cancer Stem Cell Maintenance, Tumor Initiation and Metastatic Potential	PLOS ONE			English	Article							KINASE-C-IOTA; GENE-EXPRESSION; ADENOCARCINOMA; IDENTIFICATION; MARKER; INVOLVEMENT; CARCINOMAS; GROWTH; LINES	Matrix metalloproteinases (Mmps) stimulate tumor invasion and metastasis by degrading the extracellular matrix. Here we reveal an unexpected role for Mmp10 (stromelysin 2) in the maintenance and tumorigenicity of mouse lung cancer stem-like cells (CSC). Mmp10 is highly expressed in oncosphere cultures enriched in CSCs and RNAi-mediated knockdown of Mmp10 leads to a loss of stem cell marker gene expression and inhibition of oncosphere growth, clonal expansion, and transformed growth in vitro. Interestingly, clonal expansion of Mmp10 deficient oncospheres can be restored by addition of exogenous Mmp10 protein to the culture medium, demonstrating a direct role for Mmp10 in the proliferation of these cells. Oncospheres exhibit enhanced tumor-initiating and metastatic activity when injected orthotopically into syngeneic mice, whereas Mmp10-deficient cultures show a severe defect in tumor initiation. Conversely, oncospheres implanted into syngeneic non-transgenic or Mmp10(-/-) mice show no significant difference in tumor initiation, growth or metastasis, demonstrating the importance of Mmp10 produced by cancer cells rather than the tumor microenvironment in lung tumor initiation and maintenance. Analysis of gene expression data from human cancers reveals a strong positive correlation between tumor Mmp10 expression and metastatic behavior in many human tumor types. Thus, Mmp10 is required for maintenance of a highly tumorigenic, cancer-initiating, metastatic stem-like cell population in lung cancer. Our data demonstrate for the first time that Mmp10 is a critical lung cancer stem cell gene and novel therapeutic target for lung cancer stem cells.	[Justilien, Verline; Regala, Roderick P.; Tseng, I-Chu; Walsh, Michael P.; Batra, Jyotica; Radisky, Evette S.; Murray, Nicole R.; Fields, Alan P.] Mayo Clin, Coll Med, Dept Canc Biol, Jacksonville, FL 32224 USA	Mayo Clinic	Justilien, V (corresponding author), Mayo Clin, Coll Med, Dept Canc Biol, Jacksonville, FL 32224 USA.	fields.alan@mayo.edu	Tseng, I-Chu/C-1936-2013; Radisky, Evette S/C-8526-2012	Tseng, I-Chu/0000-0001-8522-6524; Radisky, Evette S/0000-0003-3121-109X	National Institutes of Health/National Cancer Institute [R01 CA081436-13, R21 CA151250-01]; V Foundation for Cancer Research; James and Esther King Biomedical Research Program [1KG-05-33971]; Ruth A. Kirschstein National Cancer Institute Postdoctoral Fellowship [CA115160]; National Institutes of Health Research Supplement to Promote Diversity in Health-related Research Award from the National Cancer Institute; NATIONAL CANCER INSTITUTE [R21CA151250, F32CA115160, R01CA081436] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); V Foundation for Cancer Research; James and Esther King Biomedical Research Program; Ruth A. Kirschstein National Cancer Institute Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Research Supplement to Promote Diversity in Health-related Research Award from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from National Institutes of Health/National Cancer Institute (R01 CA081436-13 and R21 CA151250-01), the V Foundation for Cancer Research, and the James and Esther King Biomedical Research Program (1KG-05-33971) to APF; a Ruth A. Kirschstein National Cancer Institute Postdoctoral Fellowship (CA115160) to RPR; and a National Institutes of Health Research Supplement to Promote Diversity in Health-related Research Award from the National Cancer Institute (VJ). APF is the Monica Flynn Jacoby Professor of Cancer Research, an endowment fund that provides partial support for the investigator's research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Batra J, 2012, J BIOL CHEM UNPUB; Baty F, 2010, AM J RESP CRIT CARE, V181, P181, DOI 10.1164/rccm.200812-1807OC; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bodey B, 2001, IN VIVO, V15, P175; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Bradfute SB, 2005, EXP HEMATOL, V33, P836, DOI 10.1016/j.exphem.2005.04.001; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Delebecq TJ, 2000, CLIN CANCER RES, V6, P1086; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Fan X, 2010, STEM CELLS, V28, P5, DOI 10.1002/stem.254; FRANKS LM, 1976, CANCER RES, V36, P1049; Frederick LA, 2008, ONCOGENE, V27, P4841, DOI 10.1038/onc.2008.119; Gill JH, 2004, NEOPLASIA, V6, P777, DOI 10.1593/neo.04283; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang TY, 2009, CANCER RES, V69, P845, DOI 10.1158/0008-5472.CAN-08-2762; Jonsson G, 2010, CLIN CANCER RES, V16, P3356, DOI 10.1158/1078-0432.CCR-09-2509; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Katoh M, 2007, INT J ONCOL, V31, P461; Katoh Y, 2007, INT J MOL MED, V19, P967; Kren L, 2006, Cesk Patol, V42, P16; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; LAYTON MG, 1984, BRIT J CANCER, V49, P415, DOI 10.1038/bjc.1984.67; Lin AY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016636; Matsuyama T, 2010, INT J CANCER, V127, P2292, DOI 10.1002/ijc.25256; Regala RP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026439; Regala RP, 2009, CANCER RES, V69, P7603, DOI 10.1158/0008-5472.CAN-09-2066; Regala RP, 2005, CANCER RES, V65, P8905, DOI 10.1158/0008-5472.CAN-05-2372; Regala RP, 2005, J BIOL CHEM, V280, P31109, DOI 10.1074/jbc.M505402200; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rice WR, 2002, AM J PHYSIOL-LUNG C, V283, pL256, DOI 10.1152/ajplung.00302.2001; Solar P, 2011, CANCER LETT, V309, P11, DOI 10.1016/j.canlet.2011.05.008; Sullivan JP, 2010, CANCER RES, V70, P9937, DOI 10.1158/0008-5472.CAN-10-0881; Suzuki K, 1998, BIOL CHEM, V379, P185, DOI 10.1515/bchm.1998.379.2.185; Tan XJ, 2008, INT J CANCER, V123, P1080, DOI 10.1002/ijc.23637; Tirino V, 2009, EUR J CARDIO-THORAC, V36, P446, DOI 10.1016/j.ejcts.2009.03.063; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Weiser-Evans MCM, 2009, CANCER RES, V69, P1733, DOI 10.1158/0008-5472.CAN-08-3766; Yuan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009112	44	70	74	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35040	10.1371/journal.pone.0035040	http://dx.doi.org/10.1371/journal.pone.0035040			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545096	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343200018
J	Weghofer, A; Kim, A; Barad, DH; Gleicher, N				Weghofer, Andrea; Kim, Ann; Barad, David H.; Gleicher, Norbert			Follicle Stimulating Hormone and Anti-Mullerian Hormone per Oocyte in Predicting in vitro Fertilization Pregnancy in High Responders: A Cohort Study	PLOS ONE			English	Article							CONTROLLED OVARIAN HYPERSTIMULATION; SMALL ANTRAL FOLLICLES; ASSISTED REPRODUCTION; WOMEN; RESERVE; INFERTILITY; POPULATION; DECLINE; NUMBER; IMPLANTATION	Background: Follicle stimulating hormone (FSH) and Anti-Mullerian hormone (AMH) are utilized to differentiate between good and poor response to controlled ovarian hyperstimulation. Their respective roles in defining functional ovarian reserve remain, however, to be elucidated. To better understand those we investigated AMH and FSH per oocyte retrieved (AMHo and FSHo). Methodology/Principal Findings: Three-hundred and ninety-six women, undergoing first in vitro fertilization cycles, were retrospectively evaluated. Women with oocyte yields >75th percentile for their age group were identified as high responders. In a series of logistic regression analyses, AMHo and FSHo levels were then evaluated as predictive factors for pregnancy potential in high responders. Patients presented with a mean age of 38.0 +/- 5.0 years, mean baseline FSH of 11.8 +/- 8.7 mIU/mL and mean AMH of 1.6 +/- 2.1 ng/mL. Those 88 women, who qualified as high responders, showed mean FSH of 9.7 +/- 6.5 mIU/mL, AMH of 3.1 +/- 3.1 ng/mL and oocyte yields of 15.8 +/- 7.1. Baseline FSH and AMH did not predict pregnancy in high responders. However, a statistically significant association between FSHo and pregnancy was observed in high responders, both after univariate regression (p = 0.02) and when adjusted for age, percentage of usable embryos, and number of embryos transferred (p = 0.03). Rate of useable embryos also significantly affected pregnancy outcome independently of FSHo (p = 0.01). AMHo was also associated with clinical pregnancy chances in high responders (p = 0.03) and remained significant when adjusted for usable embryos and number of embryos transferred (p = 0.04). Conclusions: AMHo and FSHo are predictive of pregnancy potential in high responders, but likely reflect different responsibilities in recruitment and maturation of growing follicle cohorts.	[Weghofer, Andrea] Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria; [Weghofer, Andrea; Kim, Ann; Barad, David H.; Gleicher, Norbert] Ctr Human Reprod, New York, NY USA; [Weghofer, Andrea; Kim, Ann; Barad, David H.; Gleicher, Norbert] Fdn Reprod Med, New York, NY USA; [Barad, David H.] Albert Einstein Coll Med, Dept Epidemiol & Social Med, Bronx, NY 10467 USA; [Barad, David H.] Albert Einstein Coll Med, Dept Obstet, Bronx, NY 10467 USA; [Barad, David H.] Albert Einstein Coll Med, Dept Gynecol & Womens Hlth, Bronx, NY 10467 USA; [Gleicher, Norbert] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA	Medical University of Vienna; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yale University	Weghofer, A (corresponding author), Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria.	andrea.weghofer@meduniwien.ac.at	Barad, David/AAF-4332-2021		extramural funds from the Foundation for Reproductive Medicine; Center for Human Reproduction; CHR	extramural funds from the Foundation for Reproductive Medicine; Center for Human Reproduction; CHR	This study was funded by extramural funds from the Foundation for Reproductive Medicine, a not-for-profit research foundation, and by limited intramural support from the Center for Human Reproduction. Both funding organizations had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript with the following caveats: Authors, NG and DHB, are members of the Board of the Foundation for Reproductive Medicine and author, NG, is owner of the Center for Human Reproduction, a for-profit fertility center.; AW, DHB and NG have received research grant support, travel funds and speaker honoraria from various pharmaceutical and medical device companies, none, however, related to here presented topic. NG and DHB are listed as inventors on already awarded and still pending United States patents, claiming beneficial effects on diminished ovarian reserve and embryo ploidy from DHEA supplementation. NG is owner of Center for Human Reproduction (CHR), a for-profit infertility center, where this research was conducted. NG and DHB are listed as co-inventors on a number of pending, and one already awarded, United States patents claiming diagnostic benefits from dehydroepiandrosterone (DHEA)/androgen supplementation in women with diminished ovarian reserve (DOR). CHR recently received notice that a second United States DHEA patent, including the claim that DHEA/androgen supplementation reduces embryo aneuploidy in women with DOR, would be issued in the near future. NG and DHB are also co-inventors on a number of pending U. S. patent applications, claiming diagnostic relevance for the assessment of CGG triple repeats on the FMR1 gene in determining risk towards DOR and related issues. NG, AW and DHB have in the past received research support, travel funds and speakers; honoraria from different pharma and medical device companies, none, however, in any way related to here presented research data. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors. At time of this submission only one United States user patent with any relevance to this manuscript has been awarded (November 10, 2009; #7615544). It claims benefits from supplementation with DHEA/Androgens on ovarian reserve and pregnancy rates win women with DOR. Above noted second user patent (#8067400) is expected within weeks from this submission, claiming expanded benefits on pregnancy chances and decreased embryo aneuploidy (and, therefore, miscarriage risk) from DHEA/androgen supplementation. Amongst patent applications pending in regards to the FMR1 gene, one describes ovarian genotypes and sub-genotypes used in this manuscript, and claims that they reflect different ovarian aging patterns. All patent applications filed by researchers at CHR are 50% owned by CHR and 50% by the investigators who did the research that led to the application. A full list of all patent information can be provided on request. This study was funded by CHR with no current external funding. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abdalla H, 2004, HUM REPROD, V19, P893, DOI 10.1093/humrep/deh141; Almog B, 2011, FERTIL STERIL, V95, P2359, DOI 10.1016/j.fertnstert.2011.02.057; ANDERSEN CY, 1993, J CLIN ENDOCR METAB, V77, P1227, DOI 10.1210/jc.77.5.1227; Barad D, 2006, HUM REPROD, V21, P2845, DOI 10.1093/humrep/del254; Barad DH, 2007, OBSTET GYNECOL, V109, P1404, DOI 10.1097/01.AOG.0000264065.37661.a0; Barad DH, 2011, REPROD BIOMED ONLINE, V22, P284, DOI 10.1016/j.rbmo.2010.12.002; Barad DH, 2009, FERTIL STERIL, V91, P1553, DOI 10.1016/j.fertnstert.2008.09.069; Buyuk E, 2011, FERTIL STERIL, V95, P2369, DOI 10.1016/j.fertnstert.2011.03.071; Chen QJ, 2007, ACTA OBSTET GYN SCAN, V86, P849, DOI 10.1080/00016340701415152; Deb S, 2009, HUM REPROD, V24, P2124, DOI 10.1093/humrep/dep204; Elgindy EA, 2008, FERTIL STERIL, V89, P1670, DOI 10.1016/j.fertnstert.2007.05.040; Fortune JE, 2004, ANIM REPROD SCI, V82-3, P109, DOI 10.1016/j.anireprosci.2004.04.031; Freour T, 2007, CLIN CHIM ACTA, V375, P162, DOI 10.1016/j.cca.2006.06.013; Gleicher N, J CLIN ENDO IN PRESS; Gleicher N, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-116; Gleicher N, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-23; Gleicher N, 2010, FERTIL STERIL, V94, P2824, DOI 10.1016/j.fertnstert.2010.04.067; Gleicher N, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-64; Haadsma ML, 2007, HUM REPROD, V22, P1925, DOI 10.1093/humrep/dem081; Holte J, 2011, FERTIL STERIL, V96, P594, DOI 10.1016/j.fertnstert.2011.06.071; La Marca A, 2011, GYNECOL ENDOCRINOL; Lin YH, 2011, FERTIL STERIL, V96, P230, DOI 10.1016/j.fertnstert.2011.04.003; Nakhuda GS, 2011, REPROD BIOMED ONLINE, V22, pS88, DOI [10.1016/j.rbmo.2009.10.009, 10.1016/S1472-6483(11)60014-X]; Nardo LG, 2009, FERTIL STERIL, V92, P1586, DOI 10.1016/j.fertnstert.2008.08.127; Nelson SM, 2011, REPROD BIOMED ONLINE, V23, P204, DOI 10.1016/j.rbmo.2011.05.006; Nelson SM, 2009, HUM REPROD, V24, P867, DOI 10.1093/humrep/den480; Onagawa T, 2004, GYNECOL ENDOCRINOL, V18, P335, DOI 10.1080/0951359042000196303; Pellicer A, 1996, FERTIL STERIL, V65, P1190, DOI 10.1016/S0015-0282(16)58337-X; Riggs R, 2011, FERTIL STERIL, V95, P410, DOI 10.1016/j.fertnstert.2010.07.1042; Swanton A, 2010, EUR J OBSTET GYN R B, V149, P68, DOI 10.1016/j.ejogrb.2009.11.017; Tremellen K, 2010, AUST NZ J OBSTET GYN, V50, P568, DOI 10.1111/j.1479-828X.2010.01232.x; van den Berg MH, 2010, HUM REPROD, V25, P1520, DOI 10.1093/humrep/deq071; Weghofer A, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-98; Weghofer A, 2011, HUM REPROD, V26, P1905, DOI 10.1093/humrep/der134; Yates AP, 2011, HUM REPROD, V26, P2353, DOI 10.1093/humrep/der182	35	10	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e34290	10.1371/journal.pone.0034290	http://dx.doi.org/10.1371/journal.pone.0034290			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545082	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343200005
J	Boubou, A; Migeon, A; Roderick, GK; Auger, P; Cornuet, JM; Magalhaes, S; Navajas, M				Boubou, Angham; Migeon, Alain; Roderick, George K.; Auger, Philippe; Cornuet, Jean-Marie; Magalhaes, Sara; Navajas, Maria			Test of Colonisation Scenarios Reveals Complex Invasion History of the Red Tomato Spider Mite Tetranychus evansi	PLOS ONE			English	Article							GENETIC-VARIATION; BIOLOGICAL INVASIONS; SPECIES INVASIONS; EVOLUTION; PEST; DIVERSITY; INFERENCE; ACARI; ABC; HYBRIDIZATION	The spider mite Tetranychus evansi is an emerging pest of solanaceous crops worldwide. Like many other emerging pests, its small size, confusing taxonomy, complex history of associations with humans, and propensity to start new populations from small inocula, make the study of its invasion biology difficult. Here, we use recent developments in Approximate Bayesian Computation (ABC) and variation in multi-locus genetic markers to reconstruct the complex historical demography of this cryptic invasive pest. By distinguishing among multiple pathways and timing of introductions, we find evidence for the "bridgehead effect", in which one invasion serves as source for subsequent invasions. Tetranychus evansi populations in Europe and Africa resulted from at least three independent introductions from South America and involved mites from two distinct sources in Brazil, corresponding to highly divergent mitochondrial DNA lineages. Mites from southwest Brazil (BR-SW) colonized the African continent, and from there Europe through two pathways in a "bridgehead" type pattern. One pathway resulted in a widespread invasion, not only to Europe, but also to other regions in Africa, southern Europe and eastern Asia. The second pathway involved the mixture with a second introduction from BR-SW leading to an admixed population in southern Spain. Admixture was also detected between invasive populations in Portugal. A third introduction from the Brazilian Atlantic region resulted in only a limited invasion in Europe. This study illustrates that ABC methods can provide insights into, and distinguish among, complex invasion scenarios. These processes are critical not only in understanding the biology of invasions, but also in refining management strategies for invasive species. For example, while reported observations of the mite and outbreaks in the invaded areas were largely consistent with estimates of geographical expansion from the ABC approach, historical observations failed to recognize the complex pathways involved and the corresponding effects on genetic diversity.	[Boubou, Angham; Migeon, Alain; Auger, Philippe; Cornuet, Jean-Marie; Navajas, Maria] INRA, UMR CBGP INRA IRD Cirad Montpellier SupAgro, Montferrier Sur Lez, France; [Roderick, George K.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Magalhaes, Sara] Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, Lisbon, Portugal	CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); University of California System; University of California Berkeley; Universidade de Lisboa	Boubou, A (corresponding author), INRA, UMR CBGP INRA IRD Cirad Montpellier SupAgro, CS 30016, Montferrier Sur Lez, France.	navajas@supagro.inra.fr	S., Magalhaes/B-9673-2012; NAVAJAS, Maria/AAM-2294-2020	S., Magalhaes/0000-0002-8609-7768; NAVAJAS, Maria/0000-0002-0702-4238; Roderick, George/0000-0001-7557-2415	PESSOA exchange program, Portugal; "Agence National de la Recherche" [ANR-SVE7, 2010 BLANC 1715 02]	PESSOA exchange program, Portugal; "Agence National de la Recherche"(French National Research Agency (ANR))	Financial support for field trips in Portugal was provided by the PESSOA exchange program accorded to Dr. Magalhaes. This work beneficiated from support of the "Agence National de la Recherche" program ANR-SVE7 to Dr. Navajas; grant ID: 2010 BLANC 1715 02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailly X, 2004, BIOL J LINN SOC, V82, P69, DOI 10.1111/j.1095-8312.2004.00316.x; BAKER EDWARD W., 1960, HILGARDIA, V29, P455; Beaumont MA, 2002, GENETICS, V162, P2025; Bertorelle G, 2010, MOL ECOL, V19, P2609, DOI 10.1111/j.1365-294X.2010.04690.x; Bonato O, 1999, EXP APPL ACAROL, V23, P11, DOI 10.1023/A:1006144610009; Boubou A, 2011, BIOL INVASIONS, V13, P81, DOI 10.1007/s10530-010-9791-y; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Crawford KM, 2010, MOL ECOL, V19, P1253, DOI 10.1111/j.1365-294X.2010.04550.x; Crooks J, 2005, ECOSCIENCE, V12; Cros-Arteil S, 2009, MOL ECOLOGY RESOURCE, V9, P1375; Dana AN, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-119; de Mendonca RS, 2011, EXP APPL ACAROL, V55, P1, DOI 10.1007/s10493-011-9453-5; DEMORAES GJ, 1987, EXP APPL ACAROL, V3, P95, DOI 10.1007/BF01270471; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Dlugosch KM, 2008, ECOL LETT, V11, P701, DOI 10.1111/j.1461-0248.2008.01181.x; Downie DA, 2002, MOL ECOL, V11, P2013, DOI 10.1046/j.1365-294X.2002.01584.x; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2006, ARLEQUIN VER 3 0 INT; Facon B, 2005, J EVOLUTION BIOL, V18, P524, DOI 10.1111/j.1420-9101.2005.00887.x; Facon B, 2008, CURR BIOL, V18, P363, DOI 10.1016/j.cub.2008.01.063; Falush D, 2003, GENETICS, V164, P1567; Ferragut F, 1997, RES 6 JORN SEEA ED U; Ferreira M.A., 1995, P385; Furtado IP, 2006, EXP APPL ACAROL, V40, P157, DOI 10.1007/s10493-006-9045-y; Geller JB, 2010, ANNU REV MAR SCI, V2, P367, DOI 10.1146/annurev.marine.010908.163745; Golani D, 2007, BIOLOGY LETT, V3, P541, DOI 10.1098/rsbl.2007.0308; Gotoh T, 2009, INT J ACAROL, V35, P485, DOI 10.1080/01647950903431156; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016061; Keller SR, 2010, J EVOLUTION BIOL, V23, P1720, DOI 10.1111/j.1420-9101.2010.02037.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knapp M, 2003, AFR ENTOMOL, V11, P300; Kolbe JJ, 2008, BIOL LETTERS, V4, P434, DOI 10.1098/rsbl.2008.0205; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Liebhold AM, 2008, ANNU REV ENTOMOL, V53, P387, DOI 10.1146/annurev.ento.52.110405.091401; Lombaert E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009743; Migeon A., 2005, Phytoma, P38; Migeon A., 2006, SPIDER MITES WEB COM; Migeon A, 2009, EXP APPL ACAROL, V48, P199, DOI 10.1007/s10493-008-9229-8; Miller N, 2005, SCIENCE, V310, P992, DOI 10.1126/science.1115871; Miller NJ, 2009, AGR FOREST ENTOMOL, V11, P47, DOI 10.1111/j.1461-9563.2008.00398.x; MOUTIA L. ANDRE, 1958, BULL ENT RES, V49, P59, DOI 10.1017/S0007485300053438; Muirhead JR, 2008, MOL ECOL, V17, P1020, DOI 10.1111/j.1365-294X.2008.03669.x; Navajas M, 2010, ALIEN TERRESTRIAL AR; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Palevsky E, 2003, PHYTOPARASITICA, V31, P144, DOI 10.1007/BF02980784; Pascual M, 2007, MOL ECOL, V16, P3069, DOI 10.1111/j.1365-294X.2007.03336.x; Pautasso M, 2010, BIOL REV, V85, P729, DOI 10.1111/j.1469-185X.2010.00123.x; Pool JE, 2010, GENOME RES, V20, P291, DOI 10.1101/gr.079509.108; Pritchard JK, 2000, GENETICS, V155, P945; Puillandre N, 2008, BIOL INVASIONS, V10, P319, DOI 10.1007/s10530-007-9132-y; Roderick GK, 2003, NAT REV GENET, V4, P889, DOI 10.1038/nrg1201; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sabelis M.W., 1985, P265; Sax DF, 2007, TRENDS ECOL EVOL, V22, P465, DOI 10.1016/j.tree.2007.06.009; Silva P., 1954, Boletim do Instituto Biologico da Bahia, V1, P1; Solignac M, 2005, P ROY SOC B-BIOL SCI, V272, P411, DOI 10.1098/rspb.2004.2853; Suarez AV, 2001, P NATL ACAD SCI USA, V98, P1095, DOI 10.1073/pnas.98.3.1095; Thomson RC, 2010, MOL ECOL, V19, P2184, DOI 10.1111/j.1365-294X.2010.04650.x; Tixier MS, 2010, B ENTOMOL RES, V100, P569, DOI 10.1017/S0007485309990617; Tobacco Research Board Z, 1982, ANN REP ACC YEAR END; Tsagkarakou A, 2007, PHYTOPARASITICA, V35, P519, DOI 10.1007/BF03020610; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Verdu P, 2009, CURR BIOL, V19, P312, DOI 10.1016/j.cub.2008.12.049; Waage JK, 2008, PHILOS T R SOC B, V363, P863, DOI 10.1098/rstb.2007.2188; Willi Y, 2006, ANNU REV ECOL EVOL S, V37, P433, DOI 10.1146/annurev.ecolsys.37.091305.110145; Xu J, 2010, B ENTOMOL RES, V100, P359, DOI 10.1017/S0007485310000015; [No title captured]	77	52	54	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35601	10.1371/journal.pone.0035601	http://dx.doi.org/10.1371/journal.pone.0035601			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539983	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341000049
J	Jackson, J; Chugh, D; Nilsson, P; Wood, J; Carlstrom, K; Lindvall, O; Ekdahl, CT				Jackson, Johanna; Chugh, Deepti; Nilsson, Per; Wood, James; Carlstrom, Karl; Lindvall, Olle; Ekdahl, Christine T.			Altered Synaptic Properties During Integration of Adult-Born Hippocampal Neurons Following a Seizure Insult	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; GENERATED GRANULE CELLS; GAMMA-AMINOBUTYRIC-ACID; FUNCTIONAL-INTEGRATION; INHIBITORY SYNAPSES; ADHESION MOLECULE; GABA(A) RECEPTORS; DENTATE GYRUS; NEUROLIGIN 2; N-CADHERIN	Pathological conditions affect several stages of neurogenesis in the adult brain, including proliferation, survival, cell fate, migration, and functional integration. Here we explored how a pathological environment modulates the heterogeneous afferent synaptic input that shapes the functional properties of newly formed neurons. We analyzed the expression of adhesion molecules and other synaptic proteins on adult-born hippocampal neurons formed after electrically-induced partial status epilepticus (pSE). New cells were labeled with a GFP-retroviral vector one week after pSE. One and three weeks thereafter, synaptic proteins were present on dendritic spines and shafts, but without differences between pSE and control group. In contrast, at six weeks, we found fewer dendritic spines and decreased expression of the scaffolding protein PSD-95 on spines, without changes in expression of the adhesion molecules N-cadherin or neuroligin-1, primarily located at excitatory synapses. Moreover, we detected an increased expression of the inhibitory scaffolding protein gephyrin in newborn but not mature neurons after SE. However, this increase was not accompanied by a difference in GABA expression, and there was even a region-specific decrease in the adhesion molecule neuroligin-2 expression, both in newborn and mature neurons. Neuroligin-2 clusters co-localized with presynaptic cholecystokinin terminals, which were also reduced. The expression of neuroligin-4 and glycine receptor was unchanged. Increased postsynaptic clustering of gephyrin, without an accompanying increase in GABAergic input or neuroligin-2 and -4 expression, the latter important for clustering of GABA(A) and glycine receptors, respectively, could imply an increased but altered inhibitory connectivity specific for newborn neurons. The changes were transient and expression of both gephyrin and NL-2 was normalized 3 months post-SE. Our findings indicate that seizure-induced brain pathology alters the sub-cellular expression of synaptic adhesion molecules and scaffolding proteins related to particularly inhibitory but also excitatory synapses, which may yield functional consequences for the integration of adult-born neurons.	[Jackson, Johanna; Chugh, Deepti; Nilsson, Per; Wood, James; Carlstrom, Karl; Lindvall, Olle; Ekdahl, Christine T.] Wallenberg Neurosci Ctr, Lab Neurogenesis & Cell Therapy, Lund, Sweden; [Jackson, Johanna; Chugh, Deepti; Nilsson, Per; Wood, James; Carlstrom, Karl; Lindvall, Olle; Ekdahl, Christine T.] Lund Univ, Lund Stem Cell Ctr, Lund, Sweden; [Ekdahl, Christine T.] Div Clin Neurophysiol, Inflammat & Stem Cell Therapy Grp, Lund, Sweden	Lund University	Jackson, J (corresponding author), Lilly UK, Lilly Res Labs, Windlesham, Surrey, England.	Christine.Ekdahl_Clementson@med.lu.se	Carlström, Karl/AAB-4012-2020; Jackson, Johanna/ACQ-6036-2022	Carlström, Karl/0000-0002-3001-2403; Jackson, Johanna/0000-0002-8459-0591; Wood, James/0000-0003-2956-0709	Swedish Research Council; Swedish Government Initiative for Strategic Research Areas (StemTherapy); ALF Grant	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Government Initiative for Strategic Research Areas (StemTherapy); ALF Grant	This work was supported by the Swedish Research Council, Swedish Government Initiative for Strategic Research Areas (StemTherapy), and ALF Grant for funding for medical training and research ("Avtalet mellan Landstinget och Staten om samarbete om Lakarutbildning och Forskning"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AB, 2008, CEREB CORTEX, V18, P1260, DOI 10.1093/cercor/bhm160; Arabadzisz D, 2005, EXP NEUROL, V194, P76, DOI 10.1016/j.expneurol.2005.01.029; Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432; Benson DL, 1998, J NEUROSCI, V18, P6892; Blundell J, 2009, GENES BRAIN BEHAV, V8, P114, DOI 10.1111/j.1601-183X.2008.00455.x; Boulland JL, 2007, J COMP NEUROL, V503, P466, DOI 10.1002/cne.21384; Bozdagi O, 2004, MOL CELL NEUROSCI, V27, P509, DOI 10.1016/j.mcn.2004.08.008; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chiou TT, 2011, J BIOL CHEM, V286, P22456, DOI 10.1074/jbc.M111.236190; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; COTMAN CW, 1973, P NATL ACAD SCI USA, V70, P3473, DOI 10.1073/pnas.70.12.3473; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; El-Hussein AE, 2000, SCIENCE, V290, P1364; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fasen K, 2002, J NEUROPATH EXP NEUR, V61, P903, DOI 10.1093/jnen/61.10.903; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Fritschy JM, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.005.2008; Fu ZY, 2009, MOL CELL NEUROSCI, V42, P45, DOI 10.1016/j.mcn.2009.05.004; Fujita M, 2001, NEUROSCI LETT, V297, P13, DOI 10.1016/S0304-3940(00)01635-9; Gascon E, 2010, ADV EXP MED BIOL, V663, P127, DOI 10.1007/978-1-4419-1170-4_8; Gasser EMS, 2006, NAT PROTOC, V1, P1887, DOI 10.1038/nprot.2006.265; Ge SY, 2008, J PHYSIOL-LONDON, V586, P3759, DOI 10.1113/jphysiol.2008.155655; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; Hoon M, 2011, P NATL ACAD SCI USA, V108, P3053, DOI 10.1073/pnas.1006946108; Hoon M, 2009, J NEUROSCI, V29, P8039, DOI 10.1523/JNEUROSCI.0534-09.2009; Jakubs K, 2006, NEURON, V52, P1047, DOI 10.1016/j.neuron.2006.11.004; Jakubs K, 2008, J NEUROSCI, V28, P12477, DOI 10.1523/JNEUROSCI.3240-08.2008; Jessberger S, 2007, J NEUROSCI, V27, P9400, DOI 10.1523/JNEUROSCI.2002-07.2007; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Liu YWJ, 2008, EUR J NEUROSCI, V28, P2254, DOI 10.1111/j.1460-9568.2008.06518.x; LOTHMAN EW, 1989, EPILEPSY RES, V3, P107, DOI 10.1016/0920-1211(89)90038-7; Mendez P, 2010, J CELL BIOL, V189, P589, DOI 10.1083/jcb.201003007; Mohapel P, 2004, NEUROBIOL DIS, V15, P196, DOI 10.1016/j.nbd.2003.11.010; Murphy BL, 2011, J NEUROSCI, V31, P105, DOI 10.1523/JNEUROSCI.2728-10.2011; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P4095, DOI 10.1523/JNEUROSCI.5508-05.2006; Parent JM, 2002, PROG BRAIN RES, V135, P121; Parent JM, 1997, J NEUROSCI, V17, P3727; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rannals MD, 2011, J NEUROSCI, V31, P17701, DOI 10.1523/JNEUROSCI.4476-11.2011; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shan WS, 2002, J NEUROSCI RES, V69, P292, DOI 10.1002/jnr.10305; Sheffield JB, 2007, MICROSC MICROANAL, V13, P200, DOI 10.1017/S1431927607076611; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Spigelman I, 1998, NEUROSCIENCE, V86, P109, DOI 10.1016/S0306-4522(98)00028-1; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sun CS, 2007, J COMP NEUROL, V500, P876, DOI 10.1002/cne.21207; Sun QJ, 2009, BEHAV BRAIN RES, V201, P292, DOI 10.1016/j.bbr.2009.02.027; Takeichi M, 2005, TRENDS CELL BIOL, V15, P216, DOI 10.1016/j.tcb.2005.02.002; Thind KK, 2010, J COMP NEUROL, V518, P647, DOI 10.1002/cne.22235; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; Toni N, 2011, EUR J NEUROSCI, V33, P1062, DOI 10.1111/j.1460-9568.2011.07604.x; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; van Spronsen M, 2010, CURR NEUROL NEUROSCI, V10, P207, DOI 10.1007/s11910-010-0104-8; Washbourne P, 2004, J NEUROSCI, V24, P9244, DOI 10.1523/JNEUROSCI.3339-04.2004; WONG, 2008, EXPERT REV NEUROTHER, V8, P907; Wood JC, 2011, EXP NEUROL, V229, P484, DOI 10.1016/j.expneurol.2011.03.019; Wyeth MS, 2010, J NEUROSCI, V30, P8993, DOI 10.1523/JNEUROSCI.1183-10.2010; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	64	18	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35557	10.1371/journal.pone.0035557	http://dx.doi.org/10.1371/journal.pone.0035557			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539981	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341000047
J	Li, GD; Thomas, AM; Williams, JA; Kong, B; Liu, J; Inaba, Y; Xie, W; Guo, GL				Li, Guodong; Thomas, Ann M.; Williams, Jessica A.; Kong, Bo; Liu, Jie; Inaba, Yuka; Xie, Wen; Guo, Grace L.			Farnesoid X Receptor Induces Murine Scavenger Receptor Class B Type I via Intron Binding	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; SR-BI; TRANSGENIC MICE; MOUSE-LIVER; CHOLESTEROL; ACTIVATION; IDENTIFICATION; EXPRESSION; FXR; METABOLISM	Farnesoid X receptor (FXR) is a nuclear receptor and a key regulator of liver cholesterol and triglyceride homeostasis. Scavenger receptor class B type I (SR-BI) is critical for reverse cholesterol transport (RCT) by transporting high-density lipoprotein (HDL) into liver. FXR induces SR-BI, however, the underlying molecular mechanism of this induction is not known. The current study confirmed induction of SR-BI mRNA by activated FXR in mouse livers, a human hepatoma cell line, and primary human hepatocytes. Genome-wide FXR binding analysis in mouse livers identified 4 putative FXR response elements in the form of inverse repeat separated by one nucleotide (IR1) at the first intron and 1 IR1 at the downstream of the mouse Sr-bi gene. ChIP-qPCR analysis revealed FXR binding to only the intronic IR1s, but not the downstream one. Luciferase assays and site-directed mutagenesis further showed that 3 out of 4 IR1s were able to activate gene transcription. A 16-week high-fat diet (HFD) feeding in mice increased hepatic Sr-bi gene expression in a FXR-dependent manner. In addition, FXR bound to the 3 bona fide IR1s in vivo, which was increased following HFD feeding. Serum total and HDL cholesterol levels were increased in FXR knockout mice fed the HFD, compared to wild-type mice. In conclusion, the Sr-bi/SR-BI gene is confirmed as a FXR target gene in both mice and humans, and at least in mice, induction of Sr-bi by FXR is via binding to intronic IR1s. This study suggests that FXR may serve as a promising molecular target for increasing reverse cholesterol transport.	[Li, Guodong; Thomas, Ann M.; Williams, Jessica A.; Kong, Bo; Liu, Jie; Guo, Grace L.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA; [Li, Guodong] Harbin Med Univ, Affiliated Hosp 4, Canc Treatment Ctr, Dept Abdominal Surg, Harbin, Peoples R China; [Inaba, Yuka; Xie, Wen] Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA USA; [Inaba, Yuka; Xie, Wen] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA USA	University of Kansas; University of Kansas Medical Center; Harbin Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Li, GD (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA.	lguo@kumc.edu	Xie, Wen/M-1768-2016; Kong, Bo/G-7650-2014	Kong, Bo/0000-0002-8200-7817; Inaba, Yuka/0000-0001-9757-9669	National Institutes of Health [DK081343, P20-RR021940]; University of Kansas Medical Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD073070] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Kansas Medical Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Institutes of Health funding [Grants DK081343 (GLG) and P20-RR021940 (GLG)]; and University of Kansas Medical Center Endowment fund (GLG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ACTON SL, 1994, J BIOL CHEM, V269, P21003; Ahmed RAM, 2009, ENDOCRINE, V35, P233, DOI 10.1007/s12020-008-9142-2; Al-Jarallah A, 2010, BBA-MOL CELL BIOL L, V1801, P1239, DOI 10.1016/j.bbalip.2010.08.006; Chao F, 2010, ATHEROSCLEROSIS, V213, P443, DOI 10.1016/j.atherosclerosis.2010.09.016; Chong HK, 2010, NUCLEIC ACIDS RES, V38, P6007, DOI 10.1093/nar/gkq397; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Flatt B, 2009, J MED CHEM, V52, P904, DOI 10.1021/jm8014124; Fuchs M, 2001, HEPATOLOGY, V33, P1451, DOI 10.1053/jhep.2001.24373; Gadaleta RM, 2010, BBA-MOL CELL BIOL L, V1801, P683, DOI 10.1016/j.bbalip.2010.04.006; Gao H, 2008, MOL ENDOCRINOL, V22, P10, DOI 10.1210/me.2007-0121; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; Han SX, 2010, MOL ENDOCRINOL, V24, P1151, DOI 10.1210/me.2009-0482; Hartman HB, 2009, J LIPID RES, V50, P1090, DOI 10.1194/jlr.M800619-JLR200; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; Kalaany NY, 2006, ANNU REV PHYSIOL, V68, P159, DOI 10.1146/annurev.physiol.68.033104.152158; Kok T, 2003, J BIOL CHEM, V278, P41930, DOI 10.1074/jbc.M306309200; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; Krieger M, 1999, ANNU REV BIOCHEM, V68, P523, DOI 10.1146/annurev.biochem.68.1.523; Lambert G, 2003, J BIOL CHEM, V278, P2563, DOI 10.1074/jbc.M209525200; Landschulz KT, 1996, J CLIN INVEST, V98, P984, DOI 10.1172/JCI118883; Li GD, 2010, MOL ENDOCRINOL, V24, P1404, DOI 10.1210/me.2010-0014; Lopez D, 2006, MOL CELL ENDOCRINOL, V251, P67, DOI 10.1016/j.mce.2006.02.011; Malerod L, 2003, BIOCHEM BIOPH RES CO, V305, P557, DOI 10.1016/S0006-291X(03)00819-2; Malerod L, 2002, BIOCHEM BIOPH RES CO, V299, P916, DOI 10.1016/S0006-291X(02)02760-2; Malerod L, 2005, BIOCHEM BIOPH RES CO, V336, P1096, DOI 10.1016/j.bbrc.2005.08.237; Mardones P, 2003, J BIOL CHEM, V278, P7884, DOI 10.1074/jbc.M211627200; Mencarelli A, 2009, AM J PHYSIOL-HEART C, V296, pH272, DOI 10.1152/ajpheart.01075.2008; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Schoonjans K, 2002, EMBO REP, V3, P1181, DOI 10.1093/embo-reports/kvf238; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Tanaka Y, 2008, J PHARMACOL EXP THER, V325, P655, DOI 10.1124/jpet.107.135822; Teodoro JS, 2011, TRENDS ENDOCRIN MET, V22, P458, DOI 10.1016/j.tem.2011.07.002; Thomas AM, 2010, HEPATOLOGY, V51, P1410, DOI 10.1002/hep.23450; Torra IP, 2003, MOL ENDOCRINOL, V17, P259, DOI 10.1210/me.2002-0120; Ueda Y, 1999, J BIOL CHEM, V274, P7165, DOI 10.1074/jbc.274.11.7165; Van Eck M, 2003, J BIOL CHEM, V278, P23699, DOI 10.1074/jbc.M211233200; Wang N, 1998, J BIOL CHEM, V273, P32920, DOI 10.1074/jbc.273.49.32920; Zhang YQ, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.083899; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103; Zhu Y, 2011, PHARMACOL RES, V63, P259, DOI 10.1016/j.phrs.2010.12.018	42	28	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35895	10.1371/journal.pone.0035895	http://dx.doi.org/10.1371/journal.pone.0035895			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22540009	Green Published, gold			2022-12-27	WOS:000305341000075
J	Shakibaei, M; Shayan, P; Busch, F; Aldinger, C; Buhrmann, C; Lueders, C; Mobasheri, A				Shakibaei, Mehdi; Shayan, Parviz; Busch, Franziska; Aldinger, Constance; Buhrmann, Constanze; Lueders, Cora; Mobasheri, Ali			Resveratrol Mediated Modulation of Sirt-1/Runx2 Promotes Osteogenic Differentiation of Mesenchymal Stem Cells: Potential Role of Runx2 Deacetylation	PLOS ONE			English	Article							NF-KAPPA-B; HUMAN ARTICULAR CHONDROCYTES; MC3T3-E1 CELLS; PPAR-GAMMA; TRABECULAR BONE; IN-VITRO; ACTIVATION; EXPRESSION; RECEPTORS; PROLIFERATION	Objective: Osteogenic repair in response to bone injury is characterized by activation and differentiation of mesenchymal stem cells (MSCs) to osteoblasts. This study determined whether activation of Sirt-1 (a NAD(+)-dependent histone deacetylase) by the phytoestrogen resveratrol affects osteogenic differentiation. Methods: Monolayer and high-density cultures of MSCs and pre-osteoblastic cells were treated with an osteogenic induction medium with/without the Sirt-1 inhibitor nicotinamide or/and resveratrol in a concentration dependent manner. Results: MSCs and pre-osteoblastic cells differentiated to osteoblasts when exposed to osteogenic-induction medium. The osteogenic response was blocked by nicotinamide, resulting in adipogenic differentiation and expression of the adipose transcription regulator PPAR-gamma (peroxisome proliferator-activated receptor). However, in nicotinamide-treated cultures, pretreatment with resveratrol significantly enhanced osteogenesis by increasing expression of Runx2 (bone specific transcription factor) and decreasing expression of PPAR-gamma. Activation of Sirt-1 by resveratrol in MSCs increased its binding to PPAR-gamma and repressed PPAR-gamma activity by involving its cofactor NCoR (nuclear receptor co-repressor). The modulatory effects of resveratrol on nicotinamide-induced expression of PPAR-gamma and its cofactor NCoR were found to be mediated, at least in part, by Sirt-1/Runx2 association and deacetylation of Runx2. Finally, knockdown of Sirt-1 by using antisense oligonucleotides downregulated the expression of Sirt-1 protein and abolished the inhibitory effects of resveratrol, namely nicotinamide-induced Sirt-1 suppression and Runx2 acetylation, suggesting that the acetylated content of Runx2 is related to downregulated Sirt-1 expression. Conclusion: These data support a critical role for Runx2 acetylation/deacetylation during osteogenic differentiation in MSCs in vitro. (242 words in abstract)	[Shakibaei, Mehdi; Busch, Franziska; Aldinger, Constance; Buhrmann, Constanze] Univ Munich, Inst Anat, Munich, Germany; [Shayan, Parviz] Invest Inst Mol Biol Syst Transfer, Tehran, Iran; [Lueders, Cora] German Heart Inst Berlin, Lab Tissue Engn, Dept Thorac & Cardiovasc Surg, Berlin, Germany; [Mobasheri, Ali] Univ Nottingham, Fac Med & Hlth Sci, Sch Vet Med & Sci, Div Vet Med, Loughborough, England	University of Munich; German Heart Center Berlin; University of Nottingham	Shakibaei, M (corresponding author), Univ Munich, Inst Anat, Munich, Germany.	mehdi.shakibaei@med.uni-muenchen.de	Prof. Dr. Shakibaei, Mehdi/AAA-7004-2020; Mobasheri, Ali/D-5770-2011	Prof. Dr. Shakibaei, Mehdi/0000-0002-6304-7506; Mobasheri, Ali/0000-0001-6261-1286; Buhrmann, Constanze/0000-0002-0786-0463				Backesjo CM, 2006, J BONE MINER RES, V21, P993, DOI 10.1359/JBMR.060415; Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x; Bhardwaj A, 2007, BLOOD, V109, P2293, DOI 10.1182/blood-2006-02-003988; Blank RD, 1999, J CLIN DENSITOM, V2, P435, DOI 10.1016/S1094-6950(06)60409-5; Bowers JL, 2000, ENDOCRINOLOGY, V141, P3657, DOI 10.1210/en.141.10.3657; Buhrmann C, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3065; BURKHARDT R, 1987, BONE, V8, P157, DOI 10.1016/8756-3282(87)90015-9; Cao ZX, 2004, EUR J PHARMACOL, V489, P39, DOI 10.1016/j.ejphar.2004.02.031; Chalk AM, 2002, BIOINFORMATICS, V18, P1567, DOI 10.1093/bioinformatics/18.12.1567; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Csaki C, 2007, HISTOCHEM CELL BIOL, V128, P507, DOI 10.1007/s00418-007-0337-z; Ducy P, 2000, DEV DYNAM, V219, P461, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1074>3.0.CO;2-C; Fatokun AA, 2006, BONE, V39, P542, DOI 10.1016/j.bone.2006.02.062; Gehm BD, 1997, P NATL ACAD SCI USA, V94, P14138, DOI 10.1073/pnas.94.25.14138; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Huang ZQ, 2008, BIOCHEM BIOPH RES CO, V374, P517, DOI 10.1016/j.bbrc.2008.07.058; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Kanno T, 2007, J CELL BIOCHEM, V101, P1266, DOI 10.1002/jcb.21249; Kundu JK, 2006, CARCINOGENESIS, V27, P1465, DOI 10.1093/carcin/bgi349; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; Liu BL, 2004, PLANTA MED, V70, P305, DOI 10.1055/s-2004-818940; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Michalik L, 2006, J CLIN INVEST, V116, P598, DOI 10.1172/JCI27958; Mizutani K, 1998, BIOCHEM BIOPH RES CO, V253, P859, DOI 10.1006/bbrc.1998.9870; Nuttall ME, 1998, J BONE MINER RES, V13, P371, DOI 10.1359/jbmr.1998.13.3.371; Nuttall ME, 2004, CURR OPIN PHARMACOL, V4, P290, DOI 10.1016/j.coph.2004.03.002; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; QUARLES LD, 1992, J BONE MINER RES, V7, P683; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Savouret JF, 2002, BIOMED PHARMACOTHER, V56, P84, DOI 10.1016/S0753-3322(01)00158-5; Semple RK, 2006, J CLIN INVEST, V116, P581, DOI 10.1172/JCI28003; Shakibaei M, 1997, CELL BIOL INT, V21, P115, DOI 10.1006/cbir.1996.0118; Shakibaei M, 1998, EXP CELL RES, V240, P95, DOI 10.1006/excr.1998.3933; Shakibaei M, 1999, BIOCHEM J, V342, P615, DOI 10.1042/0264-6021:3420615; Shakibaei M, 2008, BIOCHEM PHARMACOL, V76, P1426, DOI 10.1016/j.bcp.2008.05.029; Shakibaei M, 2007, BIOCHEM PHARMACOL, V73, P1434, DOI 10.1016/j.bcp.2007.01.005; Shakibaei M, 2011, J BIOL CHEM, V286, P11492, DOI 10.1074/jbc.M110.198713; Sherman JM, 1999, MOL BIOL CELL, V10, P3045, DOI 10.1091/mbc.10.9.3045; Shibata H, 1997, MOL ENDOCRINOL, V11, P714, DOI 10.1210/me.11.6.714; Song LH, 2006, TOXICOL IN VITRO, V20, P915, DOI 10.1016/j.tiv.2006.01.016; Tseng PC, 2011, J BONE MINER RES, V26, P2552, DOI 10.1002/jbmr.460; Venkatesan B, 2008, FASEB J, V22, P3469, DOI 10.1096/fj.08-109488; Vihtamaki T, 1999, MATURITAS, V33, P99, DOI 10.1016/S0378-5122(99)00047-X	50	156	172	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35712	10.1371/journal.pone.0035712	http://dx.doi.org/10.1371/journal.pone.0035712			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539994	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341000060
J	Dewhirst, FE; Klein, EA; Thompson, EC; Blanton, JM; Chen, T; Milella, L; Buckley, CMF; Davis, IJ; Bennett, ML; Marshall-Jones, ZV				Dewhirst, Floyd E.; Klein, Erin A.; Thompson, Emily C.; Blanton, Jessica M.; Chen, Tsute; Milella, Lisa; Buckley, Catherine M. F.; Davis, Ian J.; Bennett, Marie-Lousie; Marshall-Jones, Zoe V.			The Canine Oral Microbiome	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; SP-NOV.; GEN. NOV.; EMENDED DESCRIPTION; DOMAIN BACTERIA; PURE-CULTURE; FAM. NOV; PORPHYROMONAS; PHYLOGENY; DIVERSITY	Determining the bacterial composition of the canine oral microbiome is of interest for two primary reasons. First, while the human oral microbiome has been well studied using molecular techniques, the oral microbiomes of other mammals have not been studied in equal depth using culture independent methods. This study allows a comparison of the number of bacterial taxa, based on 16S rRNA-gene sequence comparison, shared between humans and dogs, two divergent mammalian species. Second, canine oral bacteria are of interest to veterinary and human medical communities for understanding their roles in health and infectious diseases. The bacteria involved are mostly unnamed and not linked by 16S rRNA-gene sequence identity to a taxonomic scheme. This manuscript describes the analysis of 5,958 16S rRNA-gene sequences from 65 clone libraries. Full length 16S rRNA reference sequences have been obtained for 353 canine bacterial taxa, which were placed in 14 bacterial phyla, 23 classes, 37 orders, 66 families, and 148 genera. Eighty percent of the taxa are currently unnamed. The bacterial taxa identified in dogs are markedly different from those of humans with only 16.4% of oral taxa are shared between dogs and humans based on a 98.5% 16S rRNA sequence similarity cutoff. This indicates that there is a large divergence in the bacteria comprising the oral microbiomes of divergent mammalian species. The historic practice of identifying animal associated bacteria based on phenotypic similarities to human bacteria is generally invalid. This report describes the diversity of the canine oral microbiome and provides a provisional 16S rRNA based taxonomic scheme for naming and identifying unnamed canine bacterial taxa.	[Dewhirst, Floyd E.; Klein, Erin A.; Thompson, Emily C.; Blanton, Jessica M.; Chen, Tsute] Forsyth Inst, Dept Mol Genet, Cambridge, MA 02142 USA; [Dewhirst, Floyd E.] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA; [Milella, Lisa] Vet Dent Surg, Byfleet, Surrey, England; [Buckley, Catherine M. F.; Davis, Ian J.; Marshall-Jones, Zoe V.] WALTHAM Ctr Pet Nutr, Melton Mowbray, Leics, England; [Bennett, Marie-Lousie] Mars Pet Care Europe, Birstall, W Yorkshire, England	Harvard University; Forsyth Institute; Harvard University; Harvard School of Dental Medicine; Mars; WALTHAM Petcare Science Institute; Mars	Dewhirst, FE (corresponding author), Forsyth Inst, Dept Mol Genet, Cambridge, MA 02142 USA.	fdewhirst@forsyth.org	Chen, Tsute/ABC-2676-2020	Dewhirst, Floyd E./0000-0003-4427-7928	WALTHAM Centre for Pet Nutrition	WALTHAM Centre for Pet Nutrition	This work was supported by the WALTHAM Centre for Pet Nutrition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Allaker RP, 1997, VET REC, V140, P147, DOI 10.1136/vr.140.6.147; ALLISON MJ, 1992, SYST APPL MICROBIOL, V15, P522, DOI 10.1016/S0723-2020(11)80111-6; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P674, DOI 10.1099/00207713-44-4-674; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; de Lillo A, 2006, ORAL MICROBIOL IMMUN, V21, P61, DOI 10.1111/j.1399-302X.2005.00255.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Downes J, 2009, INT J SYST EVOL MICR, V59, P972, DOI 10.1099/ijs.0.000364-0; Elliott DR, 2005, J CLIN MICROBIOL, V43, P5470, DOI 10.1128/JCM.43.11.5470-5476.2005; Fournier D, 2001, INT J SYST EVOL MICR, V51, P1179, DOI 10.1099/00207713-51-3-1179; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Garrity G.M., 2001, BERGEYS MANUAL SYSTE, P601; Garrity GM., 2001, BERGEYS MANUAL SYSTE, P427, DOI DOI 10.1007/978-0-387-21609-6_23; Hardham J, 2005, VET MICROBIOL, V106, P119, DOI 10.1016/j.vetmic.2004.12.018; Hardham JM, 2008, INT J SYST EVOL MICR, V58, P103, DOI 10.1099/ijs.0.63458-0; Harris JK, 2004, APPL ENVIRON MICROB, V70, P845, DOI 10.1128/AEM.70.2.845-849.2004; HIRASAWA M, 1994, INT J SYST BACTERIOL, V44, P637, DOI 10.1099/00207713-44-4-637; Hoyles L, 2002, INT J SYST EVOL MICR, V52, P1201, DOI [10.1099/ijs.0.01934-0, 10.1099/00207713-52-4-1201]; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Hugenholtz P, 2001, APPL ENVIRON MICROB, V67, P411, DOI 10.1128/AEM.67.1.411-419.2001; Iino T, 2010, INT J SYST EVOL MICR, V60, P1376, DOI 10.1099/ijs.0.012484-0; Janssen PH, 2003, ARCH MICROBIOL, V179, P321, DOI 10.1007/s00203-003-0528-5; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; JUKES T H, 1969, P21; Ley RE, 2006, APPL ENVIRON MICROB, V72, P3685, DOI 10.1128/AEM.72.5.3685-3695.2006; Ludwig W., 2009, BERGEYS MANUAL SYSTE; Marchandin H, 2010, INT J SYST EVOL MICR, V60, P1271, DOI 10.1099/ijs.0.013102-0; Nogales B, 2001, APPL ENVIRON MICROB, V67, P1874, DOI 10.1128/AEM.67.4.1874-1884.2001; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; PASTER BJ, 1988, INT J SYST BACTERIOL, V38, P56, DOI 10.1099/00207713-38-1-56; Pei ZH, 2004, P NATL ACAD SCI USA, V101, P4250, DOI 10.1073/pnas.0306398101; Pikuta EV, 2009, INT J SYST EVOL MICR, V59, P2302, DOI 10.1099/ijs.0.002816-0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salzman NH, 2002, MICROBIOL-SGM, V148, P3651, DOI 10.1099/00221287-148-11-3651; Sekiguchi Y, 2003, INT J SYST EVOL MICR, V53, P1843, DOI 10.1099/ijs.0.02699-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van Leeuwenhoek A, 1683, COMMUNICATION   0917; Wouters EGH, 2008, VET MICROBIOL, V128, P419, DOI 10.1016/j.vetmic.2007.10.019; Yabe S, 2010, INT J SYST EVOL MICR, V60, P1794, DOI 10.1099/ijs.0.018069-0; Yamada T, 2006, INT J SYST EVOL MICR, V56, P1331, DOI 10.1099/ijs.0.64169-0	43	138	143	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36067	10.1371/journal.pone.0036067	http://dx.doi.org/10.1371/journal.pone.0036067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558330	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000117
J	Hirst, A; Altman, DG				Hirst, Allison; Altman, Douglas G.			Are Peer Reviewers Encouraged to Use Reporting Guidelines? A Survey of 116 Health Research Journals	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; QUALITATIVE RESEARCH; DIAGNOSTIC-ACCURACY; CONSORT; IMPROVE; IMPACT; TRANSPARENCY; INSTRUCTIONS; MANUSCRIPTS; CHECKLIST	Background: Pre-publication peer review of manuscripts should enhance the value of research publications to readers who may wish to utilize findings in clinical care or health policy-making. Much published research across all medical specialties is not useful, may be misleading, wasteful and even harmful. Reporting guidelines are tools that in addition to helping authors prepare better manuscripts may help peer reviewers in assessing them. We examined journals' instructions to peer reviewers to see if and how reviewers are encouraged to use them. Methods: We surveyed websites of 116 journals from the McMaster list. Main outcomes were 1) identification of online instructions to peer reviewers and 2) presence or absence of key domains within instructions: on journal logistics, reviewer etiquette and addressing manuscript content (11 domains). Findings: Only 41/116 journals (35%) provided online instructions. All 41 guided reviewers about the logistics of their review processes, 38 (93%) outlined standards of behaviour expected and 39 (95%) contained instruction about evaluating the manuscript content. There was great variation in explicit instruction for reviewers about how to evaluate manuscript content. Almost half of the online instructions 19/41 (46%) mentioned reporting guidelines usually as general statements suggesting they may be useful or asking whether authors had followed them rather than clear instructions about how to use them. All 19 named CONSORT for reporting randomized trials but there was little mention of CONSORT extensions. PRISMA, QUOROM (forerunner of PRISMA), STARD, STROBE and MOOSE were mentioned by several journals. No other reporting guideline was mentioned by more than two journals. Conclusions: Although almost half of instructions mentioned reporting guidelines, their value in improving research publications is not being fully realised. Journals have a responsibility to support peer reviewers. We make several recommendations including wider reference to the EQUATOR Network online library (www.equator-network.org/).	[Hirst, Allison; Altman, Douglas G.] Univ Oxford, EQUATOR Network, Ctr Stat Med, Oxford, England	University of Oxford	Hirst, A (corresponding author), Univ Oxford, EQUATOR Network, Ctr Stat Med, Oxford, England.	allison.hirst@csm.ox.ac.uk		Hirst, Allison/0000-0002-5864-4840	Committee on Publication Ethics; EQUATOR Network; Cancer Research United Kingdom; MRC [MC_qA137931, MR/J00488X/1] Funding Source: UKRI; Medical Research Council [MC_qA137931, MR/J00488X/1] Funding Source: researchfish	Committee on Publication Ethics; EQUATOR Network; Cancer Research United Kingdom(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was part-funded by a research grant from the Committee on Publication Ethics (www.publicationethics.org/resources/research). The remainder was from the funders of the salaries of authors. AH is funded by the EQUATOR Network and DGA is funded by Cancer Research United Kingdom. No funder had a role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALTMAN DG, 1994, BRIT MED J, V308, P283, DOI 10.1136/bmj.308.6924.283; Bennett C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001069; Betz CL, 2011, J PEDIATR NURS, V26, P177, DOI 10.1016/j.pedn.2011.02.001; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Callaham M, 2011, ANN EMERG MED, V57, P141, DOI 10.1016/j.annemergmed.2010.07.027; Callaham ML, 2007, PLOS MED, V4, P32, DOI 10.1371/journal.pmed.0040040; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Clark J, 2003, PEER REV HLTH SCI, Vxv, P367; Cobo E, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6783; Cobo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000332; Cummings P, 2002, ARCH PEDIAT ADOL MED, V156, P11, DOI 10.1001/archpedi.156.1.11; da Costa BR, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000048; Davidoff F, 2008, QUAL SAF HEALTH CARE, V17, P3, DOI 10.1136/qshc.2008.029066; DeMaria AN, 2003, J AM COLL CARDIOL, V42, P1314, DOI 10.1016/j.jacc.2003.08.020; Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361; Erb HN, 2010, PREV VET MED, V97, P165, DOI 10.1016/j.prevetmed.2010.09.011; Frank E, 1996, PREV MED, V25, P102, DOI 10.1006/pmed.1996.0035; Freda MC, 2009, J PROF NURS, V25, P101, DOI 10.1016/j.profnurs.2008.08.007; Garmel Gus M, 2010, Perm J, V14, P32; GOODMAN SN, 1994, ANN INTERN MED, V121, P11, DOI 10.7326/0003-4819-121-1-199407010-00003; Groves Trish, 2008, BMJ, V337, pa718, DOI 10.1136/bmj.a718; Hames I, 2007, PEER REV MANUSCRIPT, Vxii; Hopewell S, 2008, LANCET, V371, P281, DOI 10.1016/S0140-6736(07)61835-2; Hopewell S, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-20; Kac G, 2011, CAD SAUDE PUBLICA, V27, P1872, DOI 10.1590/S0102-311X2011001000001; Lang TA, 2009, WRITE PUBLISH PRESEN, Vxx; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Morris C, 2008, DEV MED CHILD NEUROL, V50, P723, DOI 10.1111/j.1469-8749.2008.03107.x; Pandis N, 2011, J APPL ORAL SCI, V19; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; Prady SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001577; Roberts J, 2010, IMPROVING REPORT, V3, P1; Roberts J, 2010, IMPROVING REPORTING, V3, P3; Schriger DL, 2006, ANN EMERG MED, V48, P743, DOI 10.1016/j.annemergmed.2006.03.028; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Smidt N, 2006, NEUROLOGY, V67, P792, DOI 10.1212/01.wnl.0000238386.41398.30; Smith R, 2006, J ROY SOC MED, V99, P178, DOI 10.1258/jrsm.99.4.178; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tite L, 2007, J EPIDEMIOL COMMUN H, V61, P9, DOI 10.1136/jech.2006.049817; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; WARE M, 2011, NEW REV INFORM NETWO, V16, P23, DOI DOI 10.1080/13614576.2011.566812; Winck JC, 2011, REV PORT PNEUMOL, V17, P96; Wynne KE, 2011, J PEDIATR SURG, V46, P131, DOI 10.1016/j.jpedsurg.2010.09.077	49	114	119	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35621	10.1371/journal.pone.0035621	http://dx.doi.org/10.1371/journal.pone.0035621			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TJ	22558178	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336000040
J	Jonsson, F; Gurniak, CB; Fleischer, B; Kirfel, G; Witke, W				Joensson, Friederike; Gurniak, Christine B.; Fleischer, Bernhard; Kirfel, Gregor; Witke, Walter			Immunological Responses and Actin Dynamics in Macrophages Are Controlled by N-Cofilin but Are Independent from ADF	PLOS ONE			English	Article							T-CELL-ACTIVATION; WISKOTT-ALDRICH-SYNDROME; DEPOLYMERIZING FACTOR; SYNAPSE FORMATION; CYTOSKELETAL DYNAMICS; IMMUNE SYNAPSE; F-ACTIN; PROTEIN; BINDING; ADF/COFILIN	Dynamic changes in the actin cytoskeleton are essential for immune cell function and a number of immune deficiencies have been linked to mutations, which disturb the actin cytoskeleton. In macrophages and dendritic cells, actin remodelling is critical for motility, phagocytosis and antigen presentation, however the actin binding proteins, which control antigen presentation have been poorly characterized. Here we dissect the specific roles of the family of ADF/cofilin F-actin depolymerizing factors in macrophages and in local immune responses. Macrophage migration, cell polarization and antigen presentation to T-cells require n-cofilin mediated F-actin remodelling. Using a conditional mouse model, we show that n-cofilin also controls MHC class II-dependent antigen presentation. Other cellular processes such as phagocytosis and antigen processing were found to be independent of n-cofilin. Our data identify n-cofilin as a novel regulator of antigen presentation, while ADF on the other hand is dispensable for macrophage motility and antigen presentation.	[Joensson, Friederike; Fleischer, Bernhard] Bernhard Nocht Inst Trop Med, Dept Immunol, Hamburg, Germany; [Gurniak, Christine B.; Witke, Walter] Univ Bonn, Inst Genet, Cell Motil Unit, Bonn, Germany; [Joensson, Friederike] Inst Pasteur, INSERM, U760, Dept Immunol,Unite Allergol Mol & Cellulaire, F-75724 Paris, France; [Kirfel, Gregor] Univ Bonn, Inst Cell Biol, Bonn, Germany	Bernhard Nocht Institut fur Tropenmedizin; University of Bonn; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Bonn	Jonsson, F (corresponding author), Bernhard Nocht Inst Trop Med, Dept Immunol, Hamburg, Germany.	w.witke@uni-bonn.de	Jönsson, Friederike/H-7525-2014	Jönsson, Friederike/0000-0002-1667-8065	Gottlieb Daimler- and Karl Benz-Foundation; Olympus-Europe-Foundation; Deutsche Forschungsgemeinschaft [SFB704]	Gottlieb Daimler- and Karl Benz-Foundation; Olympus-Europe-Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	FJ was supported by Gottlieb Daimler- and Karl Benz-Foundation and by Olympus-Europe-Foundation fellowships. Running cost for the project were provided by the Project Grant SFB704 of the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE H, 1989, J BIOCHEM-TOKYO, V106, P696, DOI 10.1093/oxfordjournals.jbchem.a122919; Adachi R, 2002, J BIOL CHEM, V277, P45566, DOI 10.1074/jbc.M207419200; Al-Alwan MM, 2003, J IMMUNOL, V171, P4479, DOI 10.4049/jimmunol.171.9.4479; Anderson HA, 2000, NAT IMMUNOL, V1, P156, DOI 10.1038/77842; Bamburg JR, 2008, CURR BIOL, V18, pR273, DOI 10.1016/j.cub.2008.02.002; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; BAMBURG JR, 1987, J CELL BIOL, V105, P2817, DOI 10.1083/jcb.105.6.2817; Barkalow K, 1996, J CELL BIOL, V134, P389, DOI 10.1083/jcb.134.2.389; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bellenchi GC, 2007, GENE DEV, V21, P2347, DOI 10.1101/gad.434307; BERNSTEIN BW, 1982, CELL MOTIL CYTOSKEL, V2, P1, DOI 10.1002/cm.970020102; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Billadeau DD, 2006, TRAFFIC, V7, P1451, DOI 10.1111/j.1600-0854.2006.00491.x; Binks M, 1998, EUR J IMMUNOL, V28, P3259; Bouma G, 2011, BLOOD, V118, P2492, DOI 10.1182/blood-2011-03-340265; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Eibert SM, 2004, P NATL ACAD SCI USA, V101, P1957, DOI 10.1073/pnas.0308282100; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gombos I, 2004, IMMUNOL LETT, V92, P117, DOI 10.1016/j.imlet.2003.11.022; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Guo J, 2011, J VIROL, V85, P9824, DOI 10.1128/JVI.05170-11; Gurniak CB, 2005, DEV BIOL, V278, P231, DOI 10.1016/j.ydbio.2004.11.010; Hiltbold EM, 2003, J IMMUNOL, V170, P1329, DOI 10.4049/jimmunol.170.3.1329; Hotulainen P, 2005, MOL BIOL CELL, V16, P649, DOI 10.1091/mbc.E04-07-0555; IIDA K, 1993, GENE, V124, P115; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lamaze C, 1997, J BIOL CHEM, V272, P20332, DOI 10.1074/jbc.272.33.20332; Linder S, 2000, J IMMUNOL, V165, P221, DOI 10.4049/jimmunol.165.1.221; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Matsui S, 2002, J BIOL CHEM, V277, P544, DOI 10.1074/jbc.M110153200; May RC, 2001, J CELL SCI, V114, P1061; MOON AL, 1993, J CELL BIOL, V120, P421, DOI 10.1083/jcb.120.2.421; MORGAN TE, 1993, J CELL BIOL, V122, P623, DOI 10.1083/jcb.122.3.623; Muller N, 2006, TRAFFIC, V7, P849, DOI 10.1111/j.1600-0854.2006.00426.x; NAGAOKA R, 1995, CELL MOTIL CYTOSKEL, V30, P1, DOI 10.1002/cm.970300102; NISHIDA E, 1984, BIOCHEMISTRY-US, V23, P5307, DOI 10.1021/bi00317a032; Ono S, 1999, J CELL BIOL, V145, P491, DOI 10.1083/jcb.145.3.491; PERRIN D, 1992, J CELL BIOL, V116, P127, DOI 10.1083/jcb.116.1.127; Radtke K, 2006, CELL MICROBIOL, V8, P387, DOI 10.1111/j.1462-5822.2005.00679.x; Rust MB, 2010, EMBO J, V29, P1889, DOI 10.1038/emboj.2010.72; Samstag Y, 1996, J IMMUNOL, V156, P4167; Shaw AS, 1997, IMMUNITY, V6, P361, DOI 10.1016/S1074-7613(00)80279-4; STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552; Stradal Theresia E. B., 2006, V43, P219, DOI 10.1007/022; UNANUE ER, 1984, ANNU REV IMMUNOL, V2, P395, DOI 10.1146/annurev.iy.02.040184.002143; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; Vartiainen MK, 2002, MOL BIOL CELL, V13, P183, DOI 10.1091/mbc.01-07-0331; WEEDS AG, 1991, BIOCHEM SOC T, V19, P1016, DOI 10.1042/bst0191016; White P, 2002, J IMMUNOL, V168, P869, DOI 10.4049/jimmunol.168.2.869; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Witke W, 2001, J CELL BIOL, V154, P775, DOI 10.1083/jcb.200101113; Yeoh S, 2002, J MOL BIOL, V315, P911, DOI 10.1006/jmbi.2001.5280	56	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36034	10.1371/journal.pone.0036034	http://dx.doi.org/10.1371/journal.pone.0036034			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558315	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336000106
J	Wang, N; Frank, GD; Ding, RH; Tan, ZJ; Rachakonda, A; Pandolfi, PP; Senbonmatsu, T; Landon, EJ; Inagami, T				Wang, Ning; Frank, Gerald D.; Ding, Ronghua; Tan, Zhongjia; Rachakonda, Amita; Pandolfi, Pier Paolo; Senbonmatsu, Takaaki; Landon, Erwin J.; Inagami, Tadashi			Promyelocytic Leukemia Zinc Finger Protein Activates GATA4 Transcription and Mediates Cardiac Hypertrophic Signaling from Angiotensin II Receptor 2	PLOS ONE			English	Article							TYPE-2 RECEPTOR; HEART-FAILURE; PLZF; PRESSURE; EXPRESSION; GROWTH; INVOLVEMENT; REPRESSION; INHIBITION; RESPONSES	Background: Pressure overload and prolonged angiotensin II (Ang II) infusion elicit cardiac hypertrophy in Ang II receptor 1 (AT(1)) null mouse, whereas Ang II receptor 2 (AT(2)) gene deletion abolishes the hypertrophic response. The roles and signals of the cardiac AT(2) receptor still remain unsettled. Promyelocytic leukemia zinc finger protein (PLZF) was shown to bind to the AT(2) receptor and transmit the hypertrophic signal. Using PLZF knockout mice we directed our studies on the function of PLZF concerning the cardiac specific transcription factor GATA4, and GATA4 targets. Methodology and Principal Findings: PLZF knockout and age-matched wild-type (WT) mice were treated with Ang II, infused at a rate of 4.2 ng.kg(-1) min(-1) for 3 weeks. Ang II elevated systolic blood pressure to comparable levels in PLZF knockout and WT mice (140 mmHg). WT mice developed prominent cardiac hypertrophy and fibrosis after Ang II infusion. In contrast, there was no obvious cardiac hypertrophy or fibrosis in PLZF knockout mice. An AT(2) receptor blocker given to Ang II-infused wild type mice prevented hypertrophy, verifying the role of AT(2) receptor for cardiac hypertrophy. Chromatin immunoprecipitation and electrophoretic mobility shift assay showed that PLZF bound to the GATA4 gene regulatory region. A Luciferase assay verified that PLZF up-regulated GATA4 gene expression and the absence of PLZF expression in vivo produced a corresponding repression of GATA4 protein. Conclusions: PLZF is an important AT(2) receptor binding protein in mediating Ang II induced cardiac hypertrophy through an AT(2) receptor-dependent signal pathway. The angiotensin II-AT(2)-PLZF-GATA4 signal may further augment Ang II induced pathological effects on cardiomyocytes.	[Wang, Ning; Frank, Gerald D.; Ding, Ronghua; Tan, Zhongjia; Rachakonda, Amita; Landon, Erwin J.; Inagami, Tadashi] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA; Beth Israel Deaconess Canc Ctr, Ctr Life Sci, Boston, MA USA; [Pandolfi, Pier Paolo] Saitama Med Univ, Dept Pathol, Saitama, Japan	Vanderbilt University; Harvard University; Beth Israel Deaconess Medical Center; Saitama Medical University	Wang, N (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA.	tadashi.inagami@vanderbilt.edu		Pandolfi, Pier Paolo/0000-0002-5352-5295	National Institutes of Health (NIH) [HL058205]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL058205, R01HL058205] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) grant HL058205. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins NL, 2006, BIOCHEM CELL BIOL, V84, P559, DOI 10.1139/O06-062; Ago T, 2008, CELL, V133, P978, DOI 10.1016/j.cell.2008.04.041; Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; Barna M, 2000, NAT GENET, V25, P166, DOI 10.1038/76014; Bedecs K, 1997, BIOCHEM J, V325, P449, DOI 10.1042/bj3250449; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Charron F, 2001, GENE DEV, V15, P2702, DOI 10.1101/gad.915701; Clair MJ, 1998, J MOL CELL CARDIOL, V30, P2355, DOI 10.1006/jmcc.1998.0796; Collins T, 2001, MOL CELL BIOL, V21, P3609, DOI 10.1128/MCB.21.11.3609-3615.2001; COOK M, 1995, P NATL ACAD SCI USA, V92, P2249, DOI 10.1073/pnas.92.6.2249; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Crowley SD, 2006, P NATL ACAD SCI USA, V103, P17985, DOI 10.1073/pnas.0605545103; Cui TX, 2001, CARDIOVASC RES, V49, P863, DOI 10.1016/S0008-6363(00)00299-6; D'Amore A, 2005, HYPERTENSION, V46, P1347, DOI 10.1161/01.HYP.0000193504.51489.cf; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Durocher D, 1996, MOL CELL BIOL, V16, P4648, DOI 10.1128/mcb.16.9.4648; Durocher D, 1998, DEV GENET, V22, P250, DOI 10.1002/(SICI)1520-6408(1998)22:3<250::AID-DVG7>3.0.CO;2-5; Filipponi D, 2007, MOL CELL BIOL, V27, P6770, DOI 10.1128/MCB.00479-07; FUJII N, 1995, BIOCHEM BIOPH RES CO, V212, P326, DOI 10.1006/bbrc.1995.1973; Goutsouliak V, 1998, GEN PHARMACOL, V30, P367, DOI 10.1016/S0306-3623(97)00270-X; Hamawaki M, 1998, AM J PHYSIOL-HEART C, V274, pH868, DOI 10.1152/ajpheart.1998.274.3.H868; Harada K, 1998, CIRCULATION, V97, P1952, DOI 10.1161/01.CIR.97.19.1952; Harada K, 1998, CIRC RES, V82, P779, DOI 10.1161/01.RES.82.7.779; Hasin T, 2011, BASIC RES CARDIOL, V106, P175, DOI 10.1007/s00395-010-0145-9; Herzig TC, 1997, P NATL ACAD SCI USA, V94, P7543, DOI 10.1073/pnas.94.14.7543; Ichihara S, 2001, CIRCULATION, V104, P346, DOI 10.1161/01.CIR.104.3.346; ICHIKI T, 1995, NATURE, V377, P748, DOI 10.1038/377748a0; Kijima K, 1996, CIRC RES, V79, P887, DOI 10.1161/01.RES.79.4.887; Kolesnichenko M, 2011, CELL CYCLE, V10, P771, DOI 10.4161/cc.10.5.14829; Kudoh S, 1998, J BIOL CHEM, V273, P24037, DOI 10.1074/jbc.273.37.24037; Li JY, 1997, J BIOL CHEM, V272, P22447, DOI 10.1074/jbc.272.36.22447; Li YH, 2009, ENDOCRINOLOGY, V150, P3759, DOI 10.1210/en.2008-1353; Liang QR, 2002, J MOL CELL CARDIOL, V34, P611, DOI 10.1006/jmcc.2002.2011; Matsubara H, 1998, CIRC RES, V83, P1182, DOI 10.1161/01.RES.83.12.1182; McConnell MJ, 2003, MOL CELL BIOL, V23, P9375, DOI 10.1128/MCB.23.24.9375-9388.2003; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC8297; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Morisco C, 2001, J BIOL CHEM, V276, P28586, DOI 10.1074/jbc.M103166200; Ohara Y, 2006, BIOL PHARM BULL, V29, P410, DOI 10.1248/bpb.29.410; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Olson EN, 2003, GENE DEV, V17, P1937, DOI 10.1101/gad.1110103; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Ozato K, 2009, IMMUNITY, V30, P757, DOI 10.1016/j.immuni.2009.06.003; Porrello ER, 2009, FRONT BIOSCI-LANDMRK, V14, P958, DOI 10.2741/3289; Schefe JH, 2006, CIRC RES, V99, P1355, DOI 10.1161/01.RES.0000251700.00994.0d; Senbonmatsu T, 2003, EMBO J, V22, P6471, DOI 10.1093/emboj/cdg637; Senbonmatsu T, 2000, J CLIN INVEST, V106, pR25, DOI 10.1172/JCI10037; Temsah R, 2005, REGUL PEPTIDES, V128, P177, DOI 10.1016/j.regpep.2004.12.026; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Tu VC, 2007, AM J PHYSIOL-CELL PH, V292, pC1248, DOI 10.1152/ajpcell.00624.2005; Worck RH, 1998, HYPERTENSION, V31, P384, DOI 10.1161/01.HYP.31.1.384; Xu DK, 2009, IMMUNITY, V30, P802, DOI 10.1016/j.immuni.2009.04.013; Yan XH, 2003, AM J PHYSIOL-HEART C, V285, pH2179, DOI 10.1152/ajpheart.00361.2003; Yayama K, 2004, J PHARMACOL EXP THER, V308, P736, DOI 10.1124/jpet.103.058420; Yeyati PL, 1999, ONCOGENE, V18, P925, DOI 10.1038/sj.onc.1202375; Zou YZ, 2004, NAT CELL BIOL, V6, P499, DOI 10.1038/ncb1137	56	27	29	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35632	10.1371/journal.pone.0035632	http://dx.doi.org/10.1371/journal.pone.0035632			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558183	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000041
J	Ward, E; Kerry, BR; Manzanilla-Lopez, RH; Mutua, G; Devonshire, J; Kimenju, J; Hirsch, PR				Ward, Elaine; Kerry, Brian R.; Manzanilla-Lopez, Rosa H.; Mutua, Gerald; Devonshire, Jean; Kimenju, John; Hirsch, Penny R.			The Pochonia chlamydosporia Serine Protease Gene vcp1 Is Subject to Regulation by Carbon, Nitrogen and pH: Implications for Nematode Biocontrol	PLOS ONE			English	Article							FUNGUS VERTICILLIUM-CHLAMYDOSPORIUM; TIME QUANTITATIVE PCR; METARHIZIUM-ANISOPLIAE; AMBIENT PH; REAL-TIME; CATABOLITE REPRESSION; ASPERGILLUS-NIDULANS; NEMATOPHAGOUS FUNGI; BIOLOGICAL-CONTROL; SEQUENCE-ANALYSIS	The alkaline serine protease VCP1 of the fungus Pochonia chlamydosporia belongs to a family of subtilisin-like enzymes that are involved in infection of nematode and insect hosts. It is involved early in the infection process, removing the outer proteinaceous vitelline membrane of nematode eggs. Little is known about the regulation of this gene, even though an understanding of how nutrients and other factors affect its expression is critical for ensuring its efficacy as a biocontrol agent. This paper provides new information on the regulation of vcp1 expression. Sequence analysis of the upstream regulatory region of this gene in 30 isolates revealed that it was highly conserved and contained sequence motifs characteristic of genes that are subject to carbon, nitrogen and pH-regulation. Expression studies, monitoring enzyme activity and mRNA, confirmed that these factors affect VCP1 production. As expected, glucose reduced VCP1 expression and for a few hours so did ammonium chloride. Surprisingly, however, by 24 h VCP1 levels were increased in the presence of ammonium chloride for most isolates. Ambient pH also regulated VCP1 expression, with most isolates producing more VCP1 under alkaline conditions. There were some differences in the response of one isolate with a distinctive upstream sequence including a variant regulatory-motif profile. Cryo-scanning electron microscopy studies indicated that the presence of nematode eggs stimulates VCP1 production by P. chlamydosporia, but only where the two are in close contact. Overall, the results indicate that readily-metabolisable carbon sources and unfavourable pH in the rhizosphere/egg-mass environment may compromise nematode parasitism by P. chlamydosporia. However, contrary to previous indications using other nematophagous and entomopathogenic fungi, ammonium nitrate (e.g. from fertilizers) may enhance biocontrol potential in some circumstances.	[Ward, Elaine; Kerry, Brian R.; Manzanilla-Lopez, Rosa H.; Devonshire, Jean; Hirsch, Penny R.] Rothamsted Res, Plant Pathol & Microbiol Dept, Harpenden, Herts, England; [Mutua, Gerald; Kimenju, John] Univ Nairobi, Dept Plant Sci & Crop Protect, Nairobi, Kenya	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Nairobi	Ward, E (corresponding author), Rothamsted Res, Plant Pathol & Microbiol Dept, Harpenden, Herts, England.	elaine.ward@rothamsted.ac.uk	Hirsch, Penny R/B-5135-2008	Hirsch, Penny R/0000-0002-5909-1934; Manzanilla-Lopez, Rosa Helena/0000-0002-8727-106X	BBSRC; DFID [BB/F003994/1]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004963, BB/F003994/1] Funding Source: researchfish; BBSRC [BB/F003994/1, BBS/E/C/00004963] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); DFID; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by funding from BBSRC (http://www.bbsrc.ac.uk/) and DFID(http://www.dfid.gov.uk/)(Grant BB/F003994/1). Rothamsted Research receives strategic funding from BBSRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahman J, 2002, APPL ENVIRON MICROB, V68, P3408, DOI 10.1128/AEM.68.7.3408-3415.2002; Ahman J, 1996, MICROBIOL-SGM, V142, P1605, DOI 10.1099/13500872-142-7-1605; Aro N, 2005, FEMS MICROBIOL REV, V29, P719, DOI 10.1016/j.femsre.2004.11.006; Atkins SD, 2009, ANN APPL BIOL, V155, P143, DOI 10.1111/j.1744-7348.2009.00333.x; Bourne J. M., 2004, International Journal of Nematology, V14, P111; Bourne JM, 1999, SOIL BIOL BIOCHEM, V31, P75, DOI 10.1016/S0038-0717(98)00107-2; BREY PT, 1986, J INVERTEBR PATHOL, V48, P34, DOI 10.1016/0022-2011(86)90140-0; Caddick CMX, 1995, MOL GEN GENET, V203, P346; CUBERO B, 1994, EMBO J, V13, P407, DOI 10.1002/j.1460-2075.1994.tb06275.x; Druzhinina IS, 2011, NAT REV MICROBIOL, V9, P749, DOI 10.1038/nrmicro2637; Espeso EA, 1997, J MOL BIOL, V274, P466, DOI 10.1006/jmbi.1997.1428; ESPESO EA, 1994, FEBS LETT, V342, P43, DOI 10.1016/0014-5793(94)80581-4; Esteves I, 2009, MYCOL RES, V113, P867, DOI 10.1016/j.mycres.2009.04.005; Fountaine JA, 2007, PHYTOPATHOLOGY, V97, P297, DOI 10.1094/PHYTO-97-3-0297; Hellwig V, 2003, J NAT PROD, V66, P829, DOI 10.1021/np020556v; Hirsch PR, 2000, MYCOL RES, V104, P435, DOI 10.1017/S0953756299001483; Hirsch PR, 2001, PLANT SOIL, V232, P21, DOI 10.1023/A:1010373717186; Jansson HB, 2000, MYCOLOGIA, V92, P10, DOI 10.2307/3761444; Kanda S, 2008, MICROBIOL RES, V163, P63, DOI 10.1016/j.micres.2006.03.005; Kerry BR, 2000, ANNU REV PHYTOPATHOL, V38, P423, DOI 10.1146/annurev.phyto.38.1.423; KUDLA B, 1990, EMBO J, V9, P1355, DOI 10.1002/j.1460-2075.1990.tb08250.x; KULMBURG P, 1993, MOL MICROBIOL, V7, P847, DOI 10.1111/j.1365-2958.1993.tb01175.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockington RA, 2002, MOL MICROBIOL, V43, P1173, DOI 10.1046/j.1365-2958.2002.02811.x; Manzanilla-Lopez RH, 2011, J NEMATOLOG IN PRESS; Marzluf GA, 1997, MICROBIOL MOL BIOL R, V61, P17, DOI 10.1128/.61.1.17-32.1997; Meletiadis J, 2001, J CLIN MICROBIOL, V39, P478, DOI 10.1128/JCM.39.2.478-484.2001; Morton CO, 2004, NEMATOLOGY, V6, P161, DOI 10.1163/1568541041218004; Morton CO, 2003, MYCOL RES, V107, P38, DOI 10.1017/S0953756202007050; Orozco I, 2002, RES MICROBIOL, V153, P611, DOI 10.1016/S0923-2508(02)01373-6; Palma-Guerrero J, 2010, ENZYME MICROB TECH, V46, P568, DOI 10.1016/j.enzmictec.2010.02.009; PATERSON IC, 1994, MICROBIOL-SGM, V140, P185, DOI 10.1099/13500872-140-1-185; Pava-Ripoll M, 2011, MICROBIOL-SGM, V157, P47, DOI 10.1099/mic.0.042200-0; Penalva MA, 2008, TRENDS MICROBIOL, V16, P291, DOI 10.1016/j.tim.2008.03.006; Prusky D, 2003, MOL PLANT PATHOL, V4, P509, DOI [10.1046/j.1364-3703.2003.00196.x, 10.1046/J.1364-3703.2003.00196.X]; Reeves CD, 2008, APPL ENVIRON MICROB, V74, P5121, DOI 10.1128/AEM.00478-08; Rollins JA, 2001, APPL ENVIRON MICROB, V67, P75, DOI 10.1128/AEM.67.1.75-81.2001; RONNE H, 1995, TRENDS GENET, V11, P12, DOI 10.1016/S0168-9525(00)88980-5; Rosso LC, 2011, APPL MICROBIOL BIOT, V90, P1981, DOI 10.1007/s00253-011-3282-7; Ruijter GJG, 1997, FEMS MICROBIOL LETT, V151, P103, DOI 10.1016/S0378-1097(97)00161-4; Screen S, 1997, CURR GENET, V31, P511, DOI 10.1007/s002940050238; Screen S, 1998, GENE, V221, P17, DOI 10.1016/S0378-1119(98)00430-2; Segers R, 1996, MYCOL RES, V100, P421, DOI 10.1016/S0953-7562(96)80138-9; SEGERS R, 1994, MICROBIOL-SGM, V140, P2715, DOI 10.1099/00221287-140-10-2715; SEGERS R, 1996, THESIS U NOTTINGHAM; Seidl V, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-567; SHARON E, 1993, J NEMATOL, V25, P585; SORENSEN AB, 1993, J VIROL, V67, P7118; St Leger RJ, 1999, MICROBIOL-SGM, V145, P2691, DOI 10.1099/00221287-145-10-2691; St Leger RJ, 1998, APPL ENVIRON MICROB, V64, P709; STLEGER RJ, 1988, ARCH MICROBIOL, V150, P413, DOI 10.1007/BF00408316; STLEGER RJ, 1995, CAN J BOT, V73, pS1119, DOI 10.1139/b95-367; Suarez MB, 2007, CURR GENET, V51, P331, DOI 10.1007/s00294-007-0130-5; Sung GH, 2007, STUD MYCOL, P5, DOI 10.3114/sim.2007.57.01; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang CS, 2005, FUNGAL GENET BIOL, V42, P704, DOI 10.1016/j.fgb.2005.04.006; Wong KH, 2008, EUKARYOT CELL, V7, P917, DOI 10.1128/EC.00076-08; Zare R, 2001, NOVA HEDWIGIA, V73, P51; Zare R, 2004, MONOGRAPH VERTICIL S; Zou CG, 2010, ENVIRON MICROBIOL, V12, P3243, DOI 10.1111/j.1462-2920.2010.02296.x; Zou CG, 2010, ENVIRON MICROBIOL, V12, P1868, DOI 10.1111/j.1462-2920.2010.02191.x	61	47	50	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35657	10.1371/journal.pone.0035657	http://dx.doi.org/10.1371/journal.pone.0035657			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558192	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000044
J	Arendash, GW; Mori, T; Dorsey, M; Gonzalez, R; Tajiri, N; Borlongan, C				Arendash, Gary W.; Mori, Takashi; Dorsey, Maggie; Gonzalez, Rich; Tajiri, Naoki; Borlongan, Cesar			Electromagnetic Treatment to Old Alzheimer's Mice Reverses beta-Amyloid Deposition, Modifies Cerebral Blood Flow, and Provides Selected Cognitive Benefit	PLOS ONE			English	Article							HEAD-ONLY EXPOSURE; MOBILE PHONE USE; BRAIN TEMPERATURE; A-BETA; FIELDS; TERM; PERFORMANCE; IMPAIRMENT; DISEASE; MEMORY	Few studies have investigated physiologic and cognitive effects of "long-term" electromagnetic field (EMF) exposure in humans or animals. Our recent studies have provided initial insight into the long-term impact of adulthood EMF exposure (GSM, pulsed/modulated, 918 MHz, 0.25-1.05 W/kg) by showing 6+ months of daily EMF treatment protects against or reverses cognitive impairment in Alzheimer's transgenic (Tg) mice, while even having cognitive benefit to normal mice. Mechanistically, EMF-induced cognitive benefits involve suppression of brain beta-amyloid (A beta) aggregation/deposition in Tg mice and brain mitochondrial enhancement in both Tg and normal mice. The present study extends this work by showing that daily EMF treatment given to very old (21-27 month) Tg mice over a 2-month period reverses their very advanced brain A beta aggregation/deposition. These very old Tg mice and their normal littermates together showed an increase in general memory function in the Y-maze task, although not in more complex tasks. Measurement of both body and brain temperature at intervals during the 2-month EMF treatment, as well as in a separate group of Tg mice during a 12-day treatment period, revealed no appreciable increases in brain temperature (and no/slight increases in body temperature) during EMF "ON" periods. Thus, the neuropathologic/cognitive benefits of EMF treatment occur without brain hyperthermia. Finally, regional cerebral blood flow in cerebral cortex was determined to be reduced in both Tg and normal mice after 2 months of EMF treatment, most probably through cerebrovascular constriction induced by freed/disaggregated A beta (Tg mice) and slight body hyperthermia during "ON" periods. These results demonstrate that long-term EMF treatment can provide general cognitive benefit to very old Alzheimer's Tg mice and normal mice, as well as reversal of advanced A beta neuropathology in Tg mice without brain heating. Results further underscore the potential for EMF treatment against AD.	[Arendash, Gary W.] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA; [Arendash, Gary W.] Florida Alzheimers Dis Res Ctr, Tampa, FL USA; [Mori, Takashi] Saitama Med Ctr, Dept Biomed Sci, Kawagoe, Saitama, Japan; [Mori, Takashi] Saitama Med Ctr, Dept Pathol, Kawagoe, Saitama, Japan; [Mori, Takashi] Saitama Med Univ, Kawagoe, Saitama, Japan; [Dorsey, Maggie] Univ S Florida, Hlth Byrd Alzheimers Inst, Tampa, FL USA; [Gonzalez, Rich] SAI Florida, Redington Beach, FL USA; [Tajiri, Naoki; Borlongan, Cesar] Univ S Florida, Morsani Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL USA	State University System of Florida; University of South Florida; Saitama Medical University; Saitama Medical University; Saitama Medical University; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Arendash, GW (corresponding author), Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA.	arendash@cas.usf.edu	Tajiri, Naoki/K-1230-2012; Borlongan, Cesar/I-5696-2012	Tajiri, Naoki/0000-0003-2189-662X; Borlongan, Cesar/0000-0002-2966-9782	NIA-designated Florida Alzheimer's Disease Research Center [AG025711]; USF/Byrd Alzheimer's Institute; USF Interdisciplinary Research Development Grant; Alzheimer's Drug Discovery Foundation Young Investigator Scholarship; NATIONAL INSTITUTE ON AGING [P50AG025711] Funding Source: NIH RePORTER	NIA-designated Florida Alzheimer's Disease Research Center; USF/Byrd Alzheimer's Institute; USF Interdisciplinary Research Development Grant; Alzheimer's Drug Discovery Foundation Young Investigator Scholarship; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funds from the NIA-designated Florida Alzheimer's Disease Research Center (AG025711) to G. A., the USF/Byrd Alzheimer's Institute to G. A., and a USF Interdisciplinary Research Development Grant to G. A. and C. V. B. N.T. is a recipient of the 2011 Alzheimer's Drug Discovery Foundation Young Investigator Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto S, 2006, J CEREBR BLOOD F MET, V26, P885, DOI 10.1038/sj.jcbfm.9600279; Ammari M, 2008, BRAIN INJURY, V22, P1021, DOI 10.1080/02699050802530599; Arendash GW, 2007, NEUROSCIENCE, V149, P286, DOI 10.1016/j.neuroscience.2007.08.018; Arendash GW, 2006, NEUROSCIENCE, V142, P941, DOI 10.1016/j.neuroscience.2006.07.021; Arendash GW, 2010, J ALZHEIMERS DIS, V19, P191, DOI 10.3233/JAD-2010-1228; Arendash GW, 2009, J ALZHEIMERS DIS, V17, P661, DOI 10.3233/JAD-2009-1087; Arendash GW, 1999, NEUROSCI LETT, V268, P17, DOI 10.1016/S0304-3940(99)00239-6; Arns M, 2007, INT J NEUROSCI, V117, P1341, DOI 10.1080/00207450600936882; Aydin D, 2011, JNCI-J NATL CANCER I, V103, P1264, DOI 10.1093/jnci/djr244; Barth A, 2012, BIOELECTROMAGNETICS, V33, P159, DOI 10.1002/bem.20697; Besset A, 2005, BIOELECTROMAGNETICS, V26, P102, DOI 10.1002/bem.20053; Borlongan CV, 2004, BRAIN RES, V1009, P26, DOI 10.1016/j.brainres.2004.02.050; Borlongan CV, 2004, BRAIN RES, V1010, P108, DOI 10.1016/j.brainres.2004.02.072; Brambrink AM, 1999, J NEUROSCI METH, V92, P111, DOI 10.1016/S0165-0270(99)00100-4; Cardis E, 2010, INT J EPIDEMIOL, V39, P675, DOI 10.1093/ije/dyq079; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Cook CM, 2009, BIOELECTROMAGNETICS, V30, P9, DOI 10.1002/bem.20434; DeBow S, 2003, METHODS, V30, P167, DOI 10.1016/S1046-2023(03)00080-X; Dragicevic N, 2011, NEUROSCIENCE, V185, P135, DOI 10.1016/j.neuroscience.2011.04.012; Dubreuil D, 2003, BEHAV BRAIN RES, V145, P51, DOI 10.1016/S0166-4328(03)00100-1; Dubreuil D, 2002, BEHAV BRAIN RES, V129, P203, DOI 10.1016/S0166-4328(01)00344-8; Echeverria V, 2011, J ALZHEIMERS DIS, V24, P817, DOI 10.3233/JAD-2011-102136; Fritzer G, 2007, BIOELECTROMAGNETICS, V28, P316, DOI 10.1002/bem.20301; Gravitz L, 2011, NATURE, V475, pS9, DOI 10.1038/475S9a; Haarala C, 2003, NEUROREPORT, V14, P2019, DOI 10.1097/00001756-200311140-00003; Hara H, 1996, J CEREBR BLOOD F MET, V16, P605, DOI 10.1097/00004647-199607000-00010; Hardell L, 2008, INT J ONCOL, V32, P1097; Huber R, 2005, EUR J NEUROSCI, V21, P1000, DOI 10.1111/j.1460-9568.2005.03929.x; Ito S, 2007, J NEUROCHEM, V103, P2482, DOI 10.1111/j.1471-4159.2007.04938.x; Juutilainen J, 2011, BIOELECTROMAGNETICS, V32, P511, DOI 10.1002/bem.20652; Khurana VG, 2009, SURG NEUROL, V72, P205, DOI 10.1016/j.surneu.2009.01.019; Krewski D, 2007, J TOXICOL ENV HEAL B, V10, P287, DOI 10.1080/15287390600974973; Kubacki R, 2007, 2 INT C EL FIELDS HL; Kumlin T, 2007, RADIAT RES, V168, P471, DOI 10.1667/RR1002.1; Kwon MS, 2011, BIOELECTROMAGNETICS, V32, P253, DOI 10.1002/bem.20635; Leighty RE, 2004, BEHAV BRAIN RES, V153, P107, DOI 10.1016/j.bbr.2003.11.004; Masuda H, 2011, J APPL PHYSIOL, V110, P142, DOI 10.1152/japplphysiol.01035.2010; Mori T, 2011, J ALZHEIMERS DIS PAR, V1, P2; Mori T, 2012, J BIOL CHEM, V287, P6912, DOI 10.1074/jbc.M111.294025; Nelson MD, 2011, J PHYSIOL-LONDON, V589, P4053, DOI 10.1113/jphysiol.2011.212118; NIGHTINGALE NRV, 1983, PHYS MED BIOL, V28, P897, DOI 10.1088/0031-9155/28/8/002; Nybo L, 2002, J APPL PHYSIOL, V93, P58, DOI 10.1152/japplphysiol.00049.2002; Olcese JM, 2009, J PINEAL RES, V47, P82, DOI 10.1111/j.1600-079X.2009.00692.x; Paris D, 2003, NEUROL RES, V25, P642, DOI 10.1179/016164103101201940; Schuz J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004389; Shimizu H, 1997, MAGNET RESON MED, V37, P833, DOI 10.1002/mrm.1910370606; Sienkiewicz ZJ, 2000, BIOELECTROMAGNETICS, V21, P151, DOI 10.1002/(SICI)1521-186X(200004)21:3<151::AID-BEM1>3.0.CO;2-Q; Swerdlow AJ, 2011, MOBILE PHONES BRAIN, DOI DOI 10.1289/EHP.1103693; Tattersall JEH, 2001, BRAIN RES, V904, P43, DOI 10.1016/S0006-8993(01)02434-9; Valberg PA, 2007, ENVIRON HEALTH PERSP, V115, P416, DOI 10.1289/ehp.9633; Van Leeuwen GMJ, 1999, PHYS MED BIOL, V44, P2367, DOI 10.1088/0031-9155/44/10/301; Volkow ND, 2011, JAMA-J AM MED ASSOC, V305, P808, DOI 10.1001/jama.2011.186	52	70	74	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35751	10.1371/journal.pone.0035751	http://dx.doi.org/10.1371/journal.pone.0035751			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558216	Green Submitted, gold, Green Published			2022-12-27	WOS:000305345200074
J	Liu, WH; Wang, X; You, N; Tao, KS; Wang, T; Tang, LJ; Dou, KF				Liu, Wei-hui; Wang, Xing; You, Nan; Tao, Kai-shan; Wang, Tao; Tang, Li-jun; Dou, Ke-feng			Efficient Enrichment of Hepatic Cancer Stem-Like Cells from a Primary Rat HCC Model via a Density Gradient Centrifugation-Centered Method	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA CELLS; SIDE POPULATION; STEM/PROGENITOR CELLS; BONE-MARROW; IDENTIFICATION; LIVER; EXPRESSION; CD133; SUBPOPULATION; MARKERS	Background: Because few definitive markers are available for hepatic cancer stem cells (HCSCs), based on physical rather than immunochemical properties, we applied a novel method to enrich HCSCs. Methodology: After hepatic tumor cells (HTCs) were first isolated from diethylinitrosamine-induced F344 rat HCC model using percoll discontinuous gradient centrifugation (PDGC) and purified via differential trypsinization and differential attachment (DTDA), they were separated into four fractions using percoll continuous gradient centrifugation (PCGC) and sequentially designated as fractions I-IV (FI-IV). Morphological characteristics, mRNA and protein levels of stem cell markers, proliferative abilities, induced differentiation, in vitro migratory capacities, in vitro chemo-resistant capacities, and in vivo malignant capacities were determined for the cells of each fraction. Findings: As the density of cells increased, 22.18%, 11.62%, 4.73% and 61.47% of primary cultured HTCs were segregated in FI-FIV, respectively. The cells from FIII (density between 1.041 and 1.062 g/ml) displayed a higher nuclear-cytoplasmic ratio and fewer organelles and expressed higher levels of stem cell markers (AFP, EpCAM and CD133) than cells from other fractions (P<0.01). Additionally, in vitro, the cells from FIII showed a greater capacity to self-renew, differentiate into mature HTCs, transit across membranes, close scratches, and carry resistance to chemotherapy than did cells from any other fraction; in vivo, injection of only 1x10(4) cells from FIII could generate tumors not only in subcutaneous tissue but also in the livers of nude mice. Conclusions: Through our novel method, HCSC-like cells were successfully enriched in FIII. This study will greatly contribute to two important areas of biological interest: CSC isolation and HCC therapy.	[Liu, Wei-hui; Wang, Tao; Tang, Li-jun] Gen Hosp Chengdu Army Reg, PLA Ctr Gen Surg, Chengdu, Sichuan Provinc, Peoples R China; [Liu, Wei-hui; Wang, Xing; You, Nan; Tao, Kai-shan; Wang, Tao; Dou, Ke-feng] Fourth Mil Med Univ, Xijing Hosp, Dept Hepatobiliary Surg, Xian 710032, Shaanxi Provinc, Peoples R China	Air Force Military Medical University	Liu, WH (corresponding author), Gen Hosp Chengdu Army Reg, PLA Ctr Gen Surg, Chengdu, Sichuan Provinc, Peoples R China.	whjtlj@yahoo.com.cn; doukf2008@yahoo.cn			National Natural Science Foundation of China [81170419, 81172061, 8100309]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 81170419, 81172061, 8100309). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvi AJ, 2003, BREAST CANCER RES, V5, DOI 10.1186/bcr563; Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Baddoo M, 2003, J CELL BIOCHEM, V89, P1235, DOI 10.1002/jcb.10594; Bongiorno MR, 2008, DERMATOL THER, V21, pS1, DOI 10.1111/j.1529-8019.2008.00193.x; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Chang Yuhan, 2009, Chang Gung Med J, V32, P264; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; Christ Bruno, 2011, Hepatology, V53, P1388, DOI 10.1002/hep.24222; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clay MR, 2010, HEAD NECK-J SCI SPEC, V32, P1195, DOI 10.1002/hed.21315; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Croce AC, 2007, PHOTOCH PHOTOBIO SCI, V6, P1202, DOI 10.1039/b707309g; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dekaney CM, 2005, GASTROENTEROLOGY, V129, P1567, DOI 10.1053/j.gastro.2005.08.011; Dou J, 2007, CELL MOL IMMUNOL, V4, P467; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Fiume L, 2005, J HEPATOL, V43, P645, DOI 10.1016/j.jhep.2005.02.045; Fujii T, 2008, HUM PATHOL, V39, P1185, DOI 10.1016/j.humpath.2007.12.010; Ghani FI, 2011, BIOCHEM BIOPH RES CO, V404, P735, DOI 10.1016/j.bbrc.2010.12.054; Gu GY, 2007, CANCER RES, V67, P4807, DOI 10.1158/0008-5472.CAN-06-4608; Hadnagy A, 2006, EXP CELL RES, V312, P3701, DOI 10.1016/j.yexcr.2006.08.030; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; HOHNE MW, 1993, MOL CARCINOGEN, V7, P180, DOI 10.1002/mc.2940070308; Hu G, 2012, INT J ONCOL, V40, P798, DOI 10.3892/ijo.2011.1254; Ikegami T, 2009, HEPATOL RES, V39, P847, DOI 10.1111/j.1872-034X.2009.00586.x; Janikova M, 2010, BIOMED PAP, V154, P321, DOI 10.5507/bp.2010.048; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Lingala S, 2010, EXP MOL PATHOL, V89, P27, DOI 10.1016/j.yexmp.2010.05.005; Liu CG, 2011, ANN SURG, V253, P1165, DOI 10.1097/SLA.0b013e318214c54e; Liu WH, 2011, STEM CELL REV REP, V7, P94, DOI 10.1007/s12015-010-9119-4; Liu WH, 2010, TOXICOL IN VITRO, V24, P538, DOI 10.1016/j.tiv.2009.11.008; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Ma S, 2008, MOL CANCER RES, V6, P1146, DOI 10.1158/1541-7786.MCR-08-0035; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Nagata T, 2011, ANTICANCER RES, V31, P495; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ono M, 2007, P NATL ACAD SCI USA, V104, P18700, DOI 10.1073/pnas.0704472104; Pogribny IP, 2007, MUTAT RES-FUND MOL M, V619, P30, DOI 10.1016/j.mrfmmm.2006.12.006; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Qiang L, 2009, CANCER LETT, V279, P13, DOI 10.1016/j.canlet.2009.01.016; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rosca AM, 2010, BIOTECHNOL APPL BIOC, V55, P199, DOI 10.1042/BA20090356; Salnikov AV, 2009, CANCER LETT, V275, P185, DOI 10.1016/j.canlet.2008.10.015; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Shen G, 2008, IN VITRO CELL DEV-AN, V44, P280, DOI 10.1007/s11626-008-9115-z; Shi MF, 2010, CELL MOL LIFE SCI, V67, P3915, DOI 10.1007/s00018-010-0420-9; Shigdar S, 2011, CANCER SCI, V102, P991, DOI 10.1111/j.1349-7006.2011.01897.x; Shimano K, 2003, AM J PATHOL, V163, P3, DOI 10.1016/S0002-9440(10)63624-3; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Shupe T, 2005, STEM CELL REV, V1, P261, DOI 10.1385/SCR:1:3:261; Singh SK, 2003, CANCER RES, V63, P5821; Song W, 2008, INT J CLIN PRACT, V62, P1212, DOI 10.1111/j.1742-1241.2008.01777.x; Su J, 2011, ARCH MED RES, V42, P15, DOI 10.1016/j.arcmed.2011.01.007; Suetsugi A, 2006, BIOCHEM BIOPH RES CO, V351, P820, DOI 10.1016/j.bbrc.2006.10.128; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Venere M, 2011, GLIA, V59, P1148, DOI 10.1002/glia.21185; Xu XJ, 2010, J MOL MED, V88, P1181, DOI 10.1007/s00109-010-0659-5; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yanai H, 2010, J BIOCHEM, V148, P85, DOI 10.1093/jb/mvq034; Yang W, 2008, CANCER RES, V68, P4287, DOI 10.1158/0008-5472.CAN-07-6691; Yang ZF, 2008, HEPATOLOGY, V47, P919, DOI 10.1002/hep.22082; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Yu SC, 2008, CANCER LETT, V265, P124, DOI 10.1016/j.canlet.2008.02.010; Zhou ZH, 2009, CANCER LETT, V281, P92, DOI 10.1016/j.canlet.2009.02.033; Zito G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003544	67	12	16	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35720	10.1371/journal.pone.0035720	http://dx.doi.org/10.1371/journal.pone.0035720			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558209	Green Submitted, gold, Green Published			2022-12-27	WOS:000305345200071
J	Lopez-Moliner, J; Keil, MS				Lopez-Moliner, Joan; Keil, Matthias S.			People Favour Imperfect Catching by Assuming a Stable World	PLOS ONE			English	Article							TIME; INFORMATION; COMBINATION; CONSTRAINTS; INTEGRATION; DISPARITY; MOTION; TARGET; SIZE; CUES	The visual angle that is projected by an object (e. g. a ball) on the retina depends on the object's size and distance. Without further information, however, the visual angle is ambiguous with respect to size and distance, because equal visual angles can be obtained from a big ball at a longer distance and a smaller one at a correspondingly shorter distance. Failure to recover the true 3D structure of the object (e. g. a ball's physical size) causing the ambiguous retinal image can lead to a timing error when catching the ball. Two opposing views are currently prevailing on how people resolve this ambiguity when estimating time to contact. One explanation challenges any inference about what causes the retinal image (i.e. the necessity to recover this 3D structure), and instead favors a direct analysis of optic flow. In contrast, the second view suggests that action timing could be rather based on obtaining an estimate of the 3D structure of the scene. With the latter, systematic errors will be predicted if our inference of the 3D structure fails to reveal the underlying cause of the retinal image. Here we show that hand closure in catching virtual balls is triggered by visual angle, using an assumption of a constant ball size. As a consequence of this assumption, hand closure starts when the ball is at similar distance across trials. From that distance on, the remaining arrival time, therefore, depends on ball's speed. In order to time the catch successfully, closing time was coupled with ball's speed during the motor phase. This strategy led to an increased precision in catching but at the cost of committing systematic errors.	[Lopez-Moliner, Joan; Keil, Matthias S.] Univ Barcelona, Dept Psicol Basica, Catalonia, Spain; [Lopez-Moliner, Joan; Keil, Matthias S.] Inst Brain Cognit & Behav IR3C, Catalonia, Spain	University of Barcelona	Lopez-Moliner, J (corresponding author), Univ Barcelona, Dept Psicol Basica, Catalonia, Spain.	j.lopezmoliner@ub.edu		Lopez-Moliner, Joan/0000-0001-5040-8889	Ministry of Science and Innovation [PSI2010-15867]; Catalan government [SGR2009-00308]; Ramon and Cajal program from the Spanish government	Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Catalan government; Ramon and Cajal program from the Spanish government	This research was supported by the Ministry of Science and Innovation: PSI2010-15867, and SGR2009-00308 from the Catalan government. MSK was supported by the Ramon and Cajal program from the Spanish government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battaglia PW, 2005, ACM INT C P SERIES, V95, P145, DOI DOI 10.1145/1080402.1080430; Berniker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012686; Billington J, 2010, P ROYAL SOC B, V278, P1476; Brouwer AM, 2005, EXP BRAIN RES, V165, P28, DOI 10.1007/s00221-005-2277-y; Caljouw SR, 2004, EXP BRAIN RES, V155, P427, DOI 10.1007/s00221-003-1739-3; DeLucia PR, 2003, Q J EXP PSYCHOL-A, V56, P1165, DOI 10.1080/02724980343000053; Dessing JC, 2004, ECOL PSYCHOL, V16, P1, DOI 10.1207/s15326969eco1601_1; Faisal AA, 2009, J NEUROPHYSIOL, V101, P1901, DOI 10.1152/jn.90974.2008; Field DT, 2005, CURR BIOL, V15, P453, DOI 10.1016/j.cub.2004.12.081; Fink PW, 2009, J VISION, V9, DOI 10.1167/9.13.14; Glennerster A, 2006, CURR BIOL, V16, P428, DOI 10.1016/j.cub.2006.01.019; Gray R, 1998, VISION RES, V38, P499, DOI 10.1016/S0042-6989(97)00230-7; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; LACQUANITI F, 1989, J NEUROSCI, V9, P134, DOI 10.1523/JNEUROSCI.09-01-00134.1989; LEE DN, 1981, NATURE, V293, P293, DOI 10.1038/293293a0; LEE DN, 1976, PERCEPTION, V5, P437, DOI 10.1068/p050437; Lopez-Moliner J, 2007, PERCEPT PSYCHOPHYS, V69, P887, DOI 10.3758/BF03193925; Lopez-Moliner J, 2010, EXP BRAIN RES, V206, P409, DOI 10.1007/s00221-010-2421-1; Lopez-Moliner J, 2007, J VISION, V7, DOI 10.1167/7.13.11; MANSFIELD RJ, 1973, VISION RES, V13, P2219, DOI 10.1016/0042-6989(73)90224-1; MCBEATH MK, 1995, SCIENCE, V268, P569, DOI 10.1126/science.7725104; McLeod P, 2006, J EXP PSYCHOL HUMAN, V32, P139, DOI 10.1037/0096-1523.32.1.139; Miyazaki M, 2005, J NEUROPHYSIOL, V94, P395, DOI 10.1152/jn.01168.2004; PARDUCCI A, 1965, PSYCHOL REV, V72, P407, DOI 10.1037/h0022602; PEPER L, 1994, J EXP PSYCHOL HUMAN, V20, P591, DOI 10.1037/0096-1523.20.3.591; REGAN D, 1979, VISION RES, V19, P1331, DOI 10.1016/0042-6989(79)90205-0; REGAN D, 1993, VISION RES, V33, P447, DOI 10.1016/0042-6989(93)90252-R; Rushton SK, 1999, NAT NEUROSCI, V2, P186, DOI 10.1038/5750; Rushton SK, 2004, THEORIES TIME TO CON, P327; SAVELSBERGH GJP, 1991, J EXP PSYCHOL HUMAN, V17, P315, DOI 10.1037/0096-1523.17.2.315; Smith MRH, 2001, J EXP PSYCHOL HUMAN, V27, P395, DOI 10.1037//0096-1523.27.2.395; Sun HJ, 1998, NAT NEUROSCI, V1, P296, DOI 10.1038/1110; Tassinari H, 2006, J NEUROSCI, V26, P10154, DOI 10.1523/JNEUROSCI.2779-06.2006; TRESILIAN JR, 1990, PERCEPTION, V19, P223, DOI 10.1068/p190223; Tresilian JR, 1999, TRENDS COGN SCI, V3, P301, DOI 10.1016/S1364-6613(99)01352-2; Tresilian JR, 2002, EXP BRAIN RES, V142, P193, DOI 10.1007/s00221-001-0920-9; Wann JP, 1996, J EXP PSYCHOL HUMAN, V22, P1031, DOI 10.1037/0096-1523.22.4.1031; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Yuille A, 2006, TRENDS COGN SCI, V10, P301, DOI 10.1016/j.tics.2006.05.002	39	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35705	10.1371/journal.pone.0035705	http://dx.doi.org/10.1371/journal.pone.0035705			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VP	22558205	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345200069
J	Nelson, SA; Sanson, AM; Park, HO; Cooper, JA				Nelson, Scott A.; Sanson, Anthony M.; Park, Hay-Oak; Cooper, John A.			A Novel Role for the GTPase-Activating Protein Bud2 in the Spindle Position Checkpoint	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; SITE-SELECTION; MITOTIC EXIT; BUDDING YEAST; EXCHANGE FACTOR; CELL POLARITY; KINASE KIN4; RAS; LTE1; PATHWAY	The spindle position checkpoint (SPC) ensures correct mitotic spindle position before allowing mitotic exit in the budding yeast Saccharomyces cerevisiae. In a candidate screen for checkpoint genes, we identified bud2 Delta as deficient for the SPC. Bud2 is a GTPase activating protein (GAP), and the only known substrate of Bud2 was Rsr1/Bud1, a Ras-like GTPase and a central component of the bud-site-selection pathway. Mutants lacking Rsr1/Bud1 had no checkpoint defect, as did strains lacking and overexpressing Bud5, a guanine-nucleotide exchange factor (GEF) for Rsr1/Bud1. Thus, the checkpoint function of Bud2 is distinct from its role in bud site selection. The catalytic activity of the Bud2 GAP domain was required for the checkpoint, based on the failure of the known catalytic point mutant Bud2(R682A) to function in the checkpoint. Based on assays of heterozygous diploids, bud2(R682A), was dominant for loss of checkpoint but recessive for bud-site-selection failure, further indicating a separation of function. Tem1 is a Ras-like protein and is the critical regulator of mitotic exit, sitting atop the mitotic exit network (MEN). Tem1 is a likely target for Bud2, supported by genetic analyses that exclude other Ras-like proteins.	[Nelson, Scott A.; Cooper, John A.] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63130 USA; [Sanson, Anthony M.; Park, Hay-Oak] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA	Washington University (WUSTL); University System of Ohio; Ohio State University	Nelson, SA (corresponding author), Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63130 USA.	jcooper@wustl.edu	Cooper, John/E-9389-2012; Cooper, John/D-4448-2014	Park, Hay-Oak/0000-0001-5782-2257; Cooper, John/0000-0002-0933-4571	National Institutes of Health (NIH) [GM 76375, GM 69895, 47337]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069895, R01GM047337, R01GM076375] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grants GM 76375 to Dr. Park and GM 69895 and 47337 to Dr. Cooper, www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberg DC., 2005, METHODS YEAST GENETI; Bardin AJ, 2003, MOL CELL BIOL, V23, P5018, DOI 10.1128/MCB.23.14.5018-5030.2003; BENDER A, 1993, P NATL ACAD SCI USA, V90, P9926, DOI 10.1073/pnas.90.21.9926; BENDER A, 1989, P NATL ACAD SCI USA, V86, P9976, DOI 10.1073/pnas.86.24.9976; Bertazzi DT, 2011, J CELL BIOL, V193, P1033, DOI 10.1083/jcb.201101056; Castillon GA, 2003, CURR BIOL, V13, P654, DOI 10.1016/S0960-9822(03)00247-1; CHANT J, 1995, J CELL BIOL, V129, P751, DOI 10.1083/jcb.129.3.751; CHANT J, 1991, CELL, V65, P1213, DOI 10.1016/0092-8674(91)90016-R; CHANT J, 1991, CELL, V65, P1203, DOI 10.1016/0092-8674(91)90015-Q; D'Aquino KE, 2005, MOL CELL, V19, P223, DOI 10.1016/j.molcel.2005.06.005; Geymonat M, 2009, J CELL BIOL, V187, P497, DOI 10.1083/jcb.200905114; Ho J, 2001, MOL BIOL CELL, V12, P1541, DOI 10.1091/mbc.12.6.1541; Huisman SM, 2005, J CELL SCI, V118, P463, DOI 10.1242/jcs.01650; Kang PJ, 2001, SCIENCE, V292, P1376, DOI 10.1126/science.1060360; Marston AL, 2001, CURR BIOL, V11, P803, DOI 10.1016/S0960-9822(01)00230-5; MORISHITA T, 1995, SCIENCE, V270, P1213, DOI 10.1126/science.270.5239.1213; Nelson SA, 2007, MOL BIOL CELL, V18, P3440, DOI 10.1091/mbc.E07-03-0242; Park HO, 1999, GENE DEV, V13, P1912, DOI 10.1101/gad.13.15.1912; PARK HO, 1993, NATURE, V365, P269, DOI 10.1038/365269a0; Pereira G, 2005, MOL CELL, V19, P209, DOI 10.1016/j.molcel.2005.05.030; Piatti S, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-2; PRINGLE JR, 1989, METHOD CELL BIOL, V31, P357; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Seshan A, 2005, CELL CYCLE, V4, P940, DOI 10.4161/cc.4.7.1785; Wittinghofer A, 1997, FEBS LETT, V410, P63, DOI 10.1016/S0014-5793(97)00321-9; Yoshida S, 2003, J CELL BIOL, V161, P889, DOI 10.1083/jcb.200301128; Zahner JE, 1996, MOL CELL BIOL, V16, P1857	27	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e36127	10.1371/journal.pone.0036127	http://dx.doi.org/10.1371/journal.pone.0036127			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558355	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345200118
J	Preti, MG; Baglio, F; Lagana, MM; Griffanti, L; Nemni, R; Clerici, M; Bozzali, M; Baselli, G				Preti, Maria Giulia; Baglio, Francesca; Lagana, Maria Marcella; Griffanti, Ludovica; Nemni, Raffaello; Clerici, Mario; Bozzali, Marco; Baselli, Giuseppe			Assessing Corpus Callosum Changes in Alzheimer's Disease: Comparison between Tract-Based Spatial Statistics and Atlas-Based Tractography	PLOS ONE			English	Article							MILD-COGNITIVE-IMPAIRMENT; WHITE-MATTER DAMAGE; DIFFUSION ANISOTROPY; POSTERIOR CINGULATE; INTEGRITY; MRI; BRAIN; DEMENTIA; MCI; AD	Tractography based on Diffusion Tensor Imaging (DTI) represents a valuable tool for investigating brain white matter (WM) microstructure, allowing the computation of damage-related diffusion parameters such as Fractional Anisotropy (FA) in specific WM tracts. This technique appears relevant in the study of pathologies in which brain disconnection plays a major role, such as, for instance, Alzheimer's Disease (AD). Previous DTI studies have reported inconsistent results in defining WM abnormalities in AD and in its prodromal stage (i.e., amnestic Mild Cognitive Impairment; aMCI), especially when investigating the corpus callosum (CC). A reason for these inconsistencies is the use of different processing techniques, which may strongly influence the results. The aim of the current study was to compare a novel atlas-based tractography approach, that sub-divides the CC in eight portions, with Tract-Based Spatial Statistics (TBSS) when used to detect specific patterns of CC FA in AD at different clinical stages. FA data were obtained from 76 subjects (37 with mild AD, 19 with aMCI and 20 elderly healthy controls, HC) and analyzed using both methods. Consistent results were obtained for the two methods, concerning the comparisons AD vs. HC (significantly reduced FA in the whole CC of AD patients) and AD vs. aMCI (significantly reduced FA in the frontal portions of the CC in AD patients), thus identifying a relative preservation of the frontal CC regions in aMCI patients compared to AD. Conversely, the atlas-based method but not the TBSS showed the ability to detect a selective FA change in the CC parietal, left temporal and occipital regions of aMCI patients compared to HC. This finding indicates that an analysis including a higher number of voxels (with no restriction to tract skeletons) may detect characteristic pattern of FA in the CC of patients with preclinical AD, when brain atrophy is still modest.	[Preti, Maria Giulia; Baglio, Francesca; Lagana, Maria Marcella; Griffanti, Ludovica] Fdn Don C Gnocchi, Magnet Resonance Lab, Milan, Italy; [Preti, Maria Giulia; Griffanti, Ludovica; Baselli, Giuseppe] Politecn Milan, Dept Bioengn, I-20133 Milan, Italy; [Clerici, Mario] Univ Milan, Dept Biomed Sci & Technol, Don Gnocchi Fdn, I-20133 Milan, Italy; [Bozzali, Marco] Santa Lucia Fdn IRCCS, Neuroimaging Lab, Rome, Italy	IRCCS Fondazione Don Carlo Gnocchi Onlus; Polytechnic University of Milan; IRCCS Fondazione Don Carlo Gnocchi Onlus; University of Milan; IRCCS Santa Lucia	Preti, MG (corresponding author), Fdn Don C Gnocchi, Magnet Resonance Lab, Milan, Italy.	gpreti@dongnocchi.it	baglio, francesca/AAX-6298-2020; Lagana, Maria Marcella/L-8050-2016; Bozzali, Marco/AAC-1031-2022; Baglio, Francesca/K-2808-2016; Preti, Maria Giulia/X-9430-2019; Griffanti, Ludovica/ABA-4218-2020	baglio, francesca/0000-0002-6145-5274; Lagana, Maria Marcella/0000-0001-7848-1711; Baglio, Francesca/0000-0002-6145-5274; Preti, Maria Giulia/0000-0002-5323-5327; Griffanti, Ludovica/0000-0002-0540-9353; Clerici, Mario/0000-0001-5920-6191; Bozzali, Marco/0000-0002-0568-2026	"Ricerca Corrente" of the Italian Ministry of Health	"Ricerca Corrente" of the Italian Ministry of Health	The study was supported by a grant from "Ricerca Corrente" of the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosch B, 2012, NEUROBIOL AGING, V33, P61, DOI 10.1016/j.neurobiolaging.2010.02.004; Bozzali M, 2011, CURR MED CHEM, V18, P2452, DOI 10.2174/092986711795843263; Bozzali M, 2002, J NEUROL NEUROSUR PS, V72, P742, DOI 10.1136/jnnp.72.6.742; BRUN A, 1981, HISTOPATHOLOGY, V5, P549, DOI 10.1111/j.1365-2559.1981.tb01818.x; Brun A, 2002, Histopathology, V41, P40; Chen Shao-qiong, 2007, Journal of Zhejiang University-Science B, V8, P242, DOI 10.1631/jzus.2007.B0242; Chen TF, 2009, PSYCHIAT RES-NEUROIM, V173, P15, DOI 10.1016/j.pscychresns.2008.09.002; Cherbuin N, 2010, FRONT PSYCHIAT, V11, P1; Cho H, 2008, J KOREAN MED SCI, V23, P477, DOI 10.3346/jkms.2008.23.3.477; Choi SJ, 2005, J GERIATR PSYCH NEUR, V18, P12, DOI 10.1177/0891988704271763; Chua TC, 2009, AM J GERIAT PSYCHIAT, V17, P602, DOI 10.1097/JGP.0b013e3181a76e0b; Damoiseaux JS, 2009, HUM BRAIN MAPP, V30, P1051, DOI 10.1002/hbm.20563; Di Paola M, 2010, NEUROLOGY, V74, P1136, DOI 10.1212/WNL.0b013e3181d7d8cb; Di Paola M, 2010, J ALZHEIMERS DIS, V20, P67, DOI 10.3233/JAD-2010-1370; Dickerson BC, 2004, ANN NEUROL, V56, P27, DOI 10.1002/ana.20163; Duan JH, 2006, SURG RADIOL ANAT, V28, P150, DOI 10.1007/s00276-006-0111-2; Fellgiebel A, 2004, DEMENT GERIATR COGN, V18, P101, DOI 10.1159/000077817; Fleisher AS, 2005, ARCH NEUROL-CHICAGO, V62, P1881, DOI 10.1001/archneur.62.12.1881; Gili T, 2011, J NEUROL NEUROSUR PS, V82, P58, DOI 10.1136/jnnp.2009.199935; Grundman M, 2004, ARCH NEUROL-CHICAGO, V61, P59, DOI 10.1001/archneur.61.1.59; Haller S, 2010, J ALZHEIMERS DIS, V22, P315, DOI 10.3233/JAD-2010-100840; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Head D, 2004, CEREB CORTEX, V14, P410, DOI 10.1093/cercor/bhh003; Kakeda S, 2010, NEURORADIOLOGY, V52, P711, DOI 10.1007/s00234-010-0717-2; Karas G, 2008, AM J NEURORADIOL, V29, P944, DOI 10.3174/ajnr.A0949; Lebel C, 2010, NEUROIMAGE, V52, P20, DOI 10.1016/j.neuroimage.2010.03.072; Leube DT, 2008, INT J GERIATR PSYCH, V23, P1114, DOI 10.1002/gps.2036; Liu YW, 2011, NEUROBIOL AGING, V32, P1558, DOI 10.1016/j.neurobiolaging.2009.10.006; Magni E, 1996, EUR J NEUROL, V3, P198, DOI 10.1111/j.1468-1331.1996.tb00423.x; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Medina D, 2006, NEUROBIOL AGING, V27, P663, DOI 10.1016/j.neurobiolaging.2005.03.026; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Morikawa M, 2010, PSYCHOGERIATRICS, V10, P15, DOI 10.1111/j.1479-8301.2010.00312.x; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Naggara O, 2006, PSYCHIAT RES-NEUROIM, V146, P243, DOI 10.1016/j.pscychresns.2006.01.005; Nakata Y, 2008, RADIAT MED, V26, P466, DOI 10.1007/s11604-008-0258-3; Parente DB, 2008, AM J ROENTGENOL, V190, P1369, DOI 10.2214/AJR.07.2617; Peng HL, 2009, NEUROIMAGE, V46, P967, DOI 10.1016/j.neuroimage.2009.03.046; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pievani M, 2010, HUM BRAIN MAPP, V31, P1862, DOI 10.1002/hbm.20978; Reich DS, 2010, NEUROIMAGE, V49, P3047, DOI 10.1016/j.neuroimage.2009.11.043; Risacher SL, 2009, CURR ALZHEIMER RES, V6, P347, DOI 10.2174/156720509788929273; Rogalski EJ, 2009, BEHAV NEUROL, V21, P51, DOI [10.3233/BEN-2009-0235, 10.1155/2009/408037]; ROSEN WG, 1980, ANN NEUROL, V7, P486, DOI 10.1002/ana.410070516; Serra L, 2010, J ALZHEIMERS DIS, V21, P627, DOI 10.3233/JAD-2010-100048; Serra L, 2010, J ALZHEIMERS DIS, V19, P147, DOI 10.3233/JAD-2010-1223; Shi F, 2009, HIPPOCAMPUS, V19, P1055, DOI 10.1002/hipo.20573; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Stahl R, 2007, RADIOLOGY, V243, P483, DOI 10.1148/radiol.2432051714; Stricker NH, 2009, NEUROIMAGE, V45, P10, DOI 10.1016/j.neuroimage.2008.11.027; Takahashi S, 2002, NEUROSCI LETT, V332, P45, DOI 10.1016/S0304-3940(02)00914-X; Taoka T, 2009, AM J NEURORADIOL, V30, P1700, DOI 10.3174/ajnr.A1698; Teipel SJ, 2007, NEUROIMAGE, V34, P985, DOI 10.1016/j.neuroimage.2006.07.047; Ukmar M, 2008, RADIOL MED, V113, P915, DOI 10.1007/s11547-008-0286-1; Vemuri P, 2011, NEUROIMAGE, V54, P985, DOI 10.1016/j.neuroimage.2010.09.004; Wang L, 2009, AM J NEURORADIOL, V30, P893, DOI 10.3174/ajnr.A1484; Xie S, 2006, NEUROLOGY, V66, P1845, DOI 10.1212/01.wnl.0000219625.77625.aa; Zhang Y, 2007, NEUROLOGY, V68, P13, DOI 10.1212/01.wnl.0000250326.77323.01; Zhang Y, 2009, BRAIN, V132, P2579, DOI 10.1093/brain/awp071; Zhuang L, 2010, NEUROIMAGE, V53, P16, DOI 10.1016/j.neuroimage.2010.05.068	62	36	39	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35856	10.1371/journal.pone.0035856	http://dx.doi.org/10.1371/journal.pone.0035856			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545143	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343200063
J	Wu, CM; Feng, JJ; Wang, R; Liu, H; Yang, HX; Rodriguez, PL; Qin, HJ; Liu, X; Wang, DW				Wu, Chongming; Feng, Juanjuan; Wang, Ran; Liu, Hong; Yang, Huixia; Rodriguez, Pedro L.; Qin, Huanju; Liu, Xin; Wang, Daowen			HRS1 Acts as a Negative Regulator of Abscisic Acid Signaling to Promote Timely Germination of Arabidopsis Seeds	PLOS ONE			English	Article							MEMBRANE H+-ATPASE; PROTEIN PHOSPHATASE 2C; ROOT-GROWTH; ABA; ELONGATION; INHIBITION; DORMANCY; GENE; THALIANA; ABI1	In this work, we conducted functional analysis of Arabidopsis HRS1 gene in order to provide new insights into the mechanisms governing seed germination. Compared with wild type (WT) control, HRS1 knockout mutant (hrs1-1) exhibited significant germination delays on either normal medium or those supplemented with abscisic acid (ABA) or sodium chloride (NaCl), with the magnitude of the delay being substantially larger on the latter media. The hypersensitivity of hrs1-1 germination to ABA and NaCl required ABI3, ABI4 and ABI5, and was aggravated in the double mutant hrs1-1abi1-2 and triple mutant hrs1-1hab1-1abi1-2, indicating that HRS1 acts as a negative regulator of ABA signaling during seed germination. Consistent with this notion, HRS1 expression was found in the embryo axis, and was regulated both temporally and spatially, during seed germination. Further analysis showed that the delay of hrs1-1 germination under normal conditions was associated with reduction in the elongation of the cells located in the lower hypocotyl (LH) and transition zone (TZ) of embryo axis. Interestingly, the germination rate of hrs1-1 was more severely reduced by the inhibitor of cell elongation, and more significantly decreased by the suppressors of plasmalemma H+-ATPase activity, than that of WT control. The plasmalemma H+-ATPase activity in the germinating seeds of hrs1-1 was substantially lower than that exhibited by WT control, and fusicoccin, an activator of this pump, corrected the transient germination delay of hrs1-1. Together, our data suggest that HRS1 may be needed for suppressing ABA signaling in germinating embryo axis, which promotes the timely germination of Arabidopsis seeds probably by facilitating the proper function of plasmalemma H+-ATPase and the efficient elongation of LH and TZ cells.	[Wu, Chongming; Feng, Juanjuan; Wang, Ran; Liu, Hong; Yang, Huixia; Qin, Huanju; Liu, Xin; Wang, Daowen] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China; [Wu, Chongming; Feng, Juanjuan; Wang, Ran; Liu, Hong; Yang, Huixia] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Rodriguez, Pedro L.] Univ Politecn Valencia, Consejo Super Invest Cient, Inst Biol Mol & Celular Plantas, E-46071 Valencia, Spain	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Wu, CM (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China.	dwwang@genetics.ac.cn	Wu, Chongming/AAQ-9085-2021; Wu, Chongming/GOJ-9081-2022; Rodriguez, Pedro L./K-4605-2014	Rodriguez, Pedro L./0000-0002-5886-9425; wang, dao wen/0000-0002-6230-8735; Wu, Chongming/0000-0003-2898-370X	National Natural Science Foundation of China [30821061]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (30821061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belin C, 2009, PLANT CELL, V21, P2253, DOI 10.1105/tpc.109.067702; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; BOVE J, 2001, GENOME BIOL, V3, DOI DOI 10.1186/GB-2001-3-1-REVIEWS1002; Brocard IM, 2002, PLANT PHYSIOL, V129, P1533, DOI 10.1104/pp.005793; Brocard-Gifford IM, 2003, PLANT PHYSIOL, V131, P78, DOI 10.1104/pp.011916; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Czechowski T, 2005, THESIS U POTSDAM GER; Drechsel G, 2010, J PLANT PHYSIOL, V167, P1418, DOI 10.1016/j.jplph.2010.05.010; Enriquez-Arredondo C, 2005, PLANT SCI, V169, P11, DOI 10.1016/j.plantsci.2005.01.021; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; GIRAUDAT J, 1992, PLANT CELL, V4, P1251, DOI 10.1105/tpc.4.10.1251; Gosti F, 1999, PLANT CELL, V11, P1897, DOI 10.1105/tpc.11.10.1897; Graeber K, 2010, PLANT MOL BIOL, V73, P67, DOI 10.1007/s11103-009-9583-x; Guo JJ, 2009, J EXP BOT, V60, P3819, DOI 10.1093/jxb/erp221; Hager A, 2003, J PLANT RES, V116, P483, DOI 10.1007/s10265-003-0110-x; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; Hubbard KE, 2010, GENE DEV, V24, P1695, DOI 10.1101/gad.1953910; JOHANSSON F, 1993, PLANT CELL, V5, P321, DOI 10.2307/3869599; Kinoshita N, 2010, PLANT CELL PHYSIOL, V51, P239, DOI 10.1093/pcp/pcp183; Linkies A, 2012, PLANT CELL REP, V31, P253, DOI 10.1007/s00299-011-1180-1; Linkies A, 2009, PLANT CELL, V21, P3803, DOI 10.1105/tpc.109.070201; Liu H, 2009, J INTEGR PLANT BIOL, V51, P382, DOI 10.1111/j.1744-7909.2009.00819.x; Liu PP, 2007, PLANT J, V52, P133, DOI 10.1111/j.1365-313X.2007.03218.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Molina L, 2001, P NATL ACAD SCI USA, V98, P4782, DOI 10.1073/pnas.081594298; Lopez-Molina L, 2002, PLANT J, V32, P317, DOI 10.1046/j.1365-313X.2002.01430.x; Merlot S, 2001, PLANT J, V25, P295, DOI 10.1046/j.1365-313x.2001.00965.x; Mesenko MM, 2005, RUSS J PLANT PHYSL+, V52, P497, DOI 10.1007/s11183-005-0073-y; Mito T, 2011, PLANT BIOTECHNOL J, V9, P736, DOI 10.1111/j.1467-7652.2010.00578.x; Muller K, 2009, PLANT PHYSIOL, V150, P1855, DOI 10.1104/pp.109.139204; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nambara E, 2002, GENETICS, V161, P1247; Nambara E, 2000, DEV BIOL, V220, P412, DOI 10.1006/dbio.2000.9632; Nishimura N, 2007, PLANT J, V50, P935, DOI 10.1111/j.1365-313X.2007.03107.x; Okamoto M, 2006, PLANT PHYSIOL, V141, P97, DOI 10.1104/pp.106.079475; ONEILL SD, 1984, PLANT PHYSIOL, V75, P586, DOI 10.1104/pp.75.3.586; Penfield S, 2006, PLANT CELL, V18, P1887, DOI 10.1105/tpc.106.041277; Penfield S, 2009, P ROY SOC B-BIOL SCI, V276, P3561, DOI 10.1098/rspb.2009.0592; Piskurewicz U, 2008, PLANT CELL, V20, P2729, DOI 10.1105/tpc.108.061515; Qin C, 2008, P NATL ACAD SCI USA, V105, P18308, DOI 10.1073/pnas.0806168105; Roelfsema MRG, 1998, PHYSIOL PLANTARUM, V103, P466, DOI 10.1034/j.1399-3054.1998.1030404.x; Rubio S, 2009, PLANT PHYSIOL, V150, P1345, DOI 10.1104/pp.109.137174; Saez A, 2004, PLANT J, V37, P354, DOI 10.1046/j.1365-313X.2003.01966.x; Saez A, 2006, PLANT PHYSIOL, V141, P1389, DOI 10.1104/pp.106.081018; Sliwinska E, 2009, J EXP BOT, V60, P3587, DOI 10.1093/jxb/erp203; Sveinsdottira H, 2009, J PLANT PHYSIOL, V166, P128, DOI 10.1016/j.jplph.2008.01.012; Taylor NJ, 2007, J PLANT PHYSIOL, V164, P1612, DOI 10.1016/j.jplph.2006.11.008; TIMSON J, 1965, NATURE, V207, P216, DOI 10.1038/207216a0; van den Wijngaard PWJ, 2005, PLANT J, V41, P43, DOI 10.1111/j.1365-313X.2004.02273.x; Weitbrecht K, 2011, J EXP BOT, V62, P3289, DOI 10.1093/jxb/err030; Xi WY, 2010, PLANT CELL, V22, P1733, DOI 10.1105/tpc.109.073072; Yan F, 1998, PLANT PHYSIOL, V117, P311, DOI 10.1104/pp.117.1.311; Yang H, 2009, FUNCT PLANT BIOL, V36, P1; Zhang X, 2004, PLANT PHYSIOL, V136, P4150, DOI 10.1104/pp.104.046573; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	57	32	34	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35764	10.1371/journal.pone.0035764	http://dx.doi.org/10.1371/journal.pone.0035764			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545134	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343200054
J	Jessen, S; Obleser, J; Kotz, SA				Jessen, Sarah; Obleser, Jonas; Kotz, Sonja A.			How Bodies and Voices Interact in Early Emotion Perception	PLOS ONE			English	Article							LIGHT BIOLOGICAL MOTION; AUDIOVISUAL INTEGRATION; MULTISENSORY INTEGRATION; POINT-LIGHT; BODY EXPRESSIONS; INFLUENCE RECOGNITION; OSCILLATORY ACTIVITY; LOOMING SIGNALS; VISUAL SPEECH; MU-RHYTHMS	Successful social communication draws strongly on the correct interpretation of others' body and vocal expressions. Both can provide emotional information and often occur simultaneously. Yet their interplay has hardly been studied. Using electroencephalography, we investigated the temporal development underlying their neural interaction in auditory and visual perception. In particular, we tested whether this interaction qualifies as true integration following multisensory integration principles such as inverse effectiveness. Emotional vocalizations were embedded in either low or high levels of noise and presented with or without video clips of matching emotional body expressions. In both, high and low noise conditions, a reduction in auditory N100 amplitude was observed for audiovisual stimuli. However, only under high noise, the N100 peaked earlier in the audiovisual than the auditory condition, suggesting facilitatory effects as predicted by the inverse effectiveness principle. Similarly, we observed earlier N100 peaks in response to emotional compared to neutral audiovisual stimuli. This was not the case in the unimodal auditory condition. Furthermore, suppression of beta-band oscillations (15-25 Hz) primarily reflecting biological motion perception was modulated 200-400 ms after the vocalization. While larger differences in suppression between audiovisual and audio stimuli in high compared to low noise levels were found for emotional stimuli, no such difference was observed for neutral stimuli. This observation is in accordance with the inverse effectiveness principle and suggests a modulation of integration by emotional content. Overall, results show that ecologically valid, complex stimuli such as joined body and vocal expressions are effectively integrated very early in processing.	[Jessen, Sarah; Kotz, Sonja A.] Max Planck Inst Human Cognit & Brain Sci, Minerva Res Grp Neurocognit Rhythm Commun, Leipzig, Germany; [Jessen, Sarah] Free Univ Berlin, Berlin, Germany; [Obleser, Jonas] Max Planck Inst Human Cognit & Brain Sci, Max Planck Res Grp Auditory Cognit, Leipzig, Germany	Max Planck Society; Free University of Berlin; Max Planck Society	Jessen, S (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Minerva Res Grp Neurocognit Rhythm Commun, Leipzig, Germany.	jessen@cbs.mpg.de	Obleser, Jonas/C-9891-2011; Jessen, Sarah/T-8421-2018	Obleser, Jonas/0000-0002-7619-0459; Jessen, Sarah/0000-0003-4067-271X	Max Planck Society; Cluster of Excellence "Languages of Emotion" at the Free University of Berlin	Max Planck Society(Max Planck SocietyFoundation CELLEX); Cluster of Excellence "Languages of Emotion" at the Free University of Berlin	The research was supported by the Max Planck Society and the Cluster of Excellence "Languages of Emotion" at the Free University of Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson AP, 2004, PERCEPTION, V33, P717, DOI 10.1068/p5096; Beauchamp MS, 2005, NEUROINFORMATICS, V3, P93, DOI 10.1385/NI:3:2:093; Callan DE, 2003, NEUROREPORT, V14, P2213, DOI 10.1097/00001756-200312020-00016; Calvert GA, 2001, NEUROIMAGE, V14, P427, DOI 10.1006/nimg.2001.0812; Campanella S, 2007, TRENDS COGN SCI, V11, P535, DOI 10.1016/j.tics.2007.10.001; Cappe C, 2009, NEUROPSYCHOLOGIA, V47, P1045, DOI 10.1016/j.neuropsychologia.2008.11.003; Cochin S, 1998, ELECTROEN CLIN NEURO, V107, P287, DOI 10.1016/S0013-4694(98)00071-6; Collignon O, 2008, BRAIN RES, V1242, P126, DOI 10.1016/j.brainres.2008.04.023; de Gelder B, 2000, COGNITION EMOTION, V14, P289, DOI 10.1080/026999300378824; de Gelder B, 2006, NAT REV NEUROSCI, V7, P242, DOI 10.1038/nrn1872; de Gelder B, 1999, NEUROSCI LETT, V260, P133, DOI 10.1016/S0304-3940(98)00963-X; Dietrich S, 2008, NEUROREPORT, V19, P1751, DOI 10.1097/WNR.0b013e3283193e9e; Ethofer T, 2006, PROG BRAIN RES, V156, P345, DOI 10.1016/S0079-6123(06)56019-4; Ghazanfar AA, 2005, J NEUROSCI, V25, P5004, DOI 10.1523/JNEUROSCI.0799-05.2005; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Haegens S, 2010, HUM BRAIN MAPP, V31, P26, DOI 10.1002/hbm.20842; Holle H, 2010, NEUROIMAGE, V49, P875, DOI 10.1016/j.neuroimage.2009.08.058; HOLM S, 1979, SCAND J STAT, V6, P65; Jessen S, 2011, NEUROIMAGE, V58, P665, DOI 10.1016/j.neuroimage.2011.06.035; Kiesel A, 2008, PSYCHOPHYSIOLOGY, V45, P250, DOI 10.1111/j.1469-8986.2007.00618.x; Kreifelts B, 2007, NEUROIMAGE, V37, P1445, DOI 10.1016/j.neuroimage.2007.06.020; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Latinus M, 2011, CURR BIOL, V21, pR143, DOI 10.1016/j.cub.2010.12.033; Laurienti PJ, 2005, EXP BRAIN RES, V166, P289, DOI 10.1007/s00221-005-2370-2; Loula F, 2005, J EXP PSYCHOL HUMAN, V31, P210, DOI 10.1037/0096-1523.31.1.210; Macmillan NA, 2005, DETECTION THEORY USE; Maier JX, 2008, CURR BIOL, V18, P963, DOI 10.1016/j.cub.2008.05.043; Maier JX, 2004, NEURON, V43, P177, DOI 10.1016/j.neuron.2004.06.027; Medendorp WP, 2007, CEREB CORTEX, V17, P2364, DOI 10.1093/cercor/bhl145; Meeren HKM, 2005, P NATL ACAD SCI USA, V102, P16518, DOI 10.1073/pnas.0507650102; Muthukumaraswamy SD, 2006, BRAIN RES, V1071, P105, DOI 10.1016/j.brainres.2005.11.053; Muthukumaraswamy SD, 2008, PSYCHOPHYSIOLOGY, V45, P896, DOI 10.1111/j.1469-8986.2008.00711.x; Oberman LM, 2007, NEUROCOMPUTING, V70, P2194, DOI 10.1016/j.neucom.2006.02.024; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Paulmann S, 2008, NEUROREPORT, V19, P209, DOI 10.1097/WNR.0b013e3282f454db; Paulmann S, 2009, J PSYCHOPHYSIOL, V23, P63, DOI 10.1027/0269-8803.23.2.63; Perry A, 2010, SOC NEUROSCI-UK, V5, P272, DOI 10.1080/17470910903395767; Petrini K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019165; Petrini K, 2010, BRAIN RES, V1323, P139, DOI 10.1016/j.brainres.2010.02.012; Pichon S, 2008, SOC NEUROSCI-UK, V3, P199, DOI 10.1080/17470910701394368; Pineda JA, 2005, BRAIN RES REV, V50, P57, DOI 10.1016/j.brainresrev.2005.04.005; Pollick FE, 2005, J EXP PSYCHOL HUMAN, V31, P1247, DOI 10.1037/0096-1523.31.6.1247; Pourtois G, 2002, COGNITIVE BRAIN RES, V14, P99, DOI 10.1016/S0926-6410(02)00064-2; Romei V, 2009, CURR BIOL, V19, P1799, DOI 10.1016/j.cub.2009.09.027; Rosenthal R, 1991, METAANALYTIC  PROCED; Sauter DA, 2010, J COGNITIVE NEUROSCI, V22, P474, DOI 10.1162/jocn.2009.21215; Saygin AP, 2004, J NEUROSCI, V24, P6181, DOI 10.1523/JNEUROSCI.0504-04.2004; Senkowski D, 2007, EXP BRAIN RES, V177, P184, DOI 10.1007/s00221-006-0664-7; Senkowski D, 2011, NEUROIMAGE, V56, P2200, DOI 10.1016/j.neuroimage.2011.03.075; Shahin AJ, 2009, BRAIN COGNITION, V70, P259, DOI 10.1016/j.bandc.2009.02.008; SHARBROUGH F, 1991, CLIN NEUROPHYSIOL, V8, P200, DOI DOI 10.1097/00004691-199104000-00007; Stein BE, 2009, EXP BRAIN RES, V198, P113, DOI 10.1007/s00221-009-1880-8; Stein BE., 1993, MERGING SENSES; Stekelenburg JJ, 2007, J COGNITIVE NEUROSCI, V19, P1964, DOI 10.1162/jocn.2007.19.12.1964; Stevenson RA, 2009, NEUROIMAGE, V44, P1210, DOI 10.1016/j.neuroimage.2008.09.034; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Thomas JP, 2010, J VISION, V10, DOI 10.1167/10.12.14; Ulloa ER, 2007, BEHAV BRAIN RES, V183, P188, DOI 10.1016/j.bbr.2007.06.007; Van den Stock J, 2007, EMOTION, V7, P487, DOI 10.1037/1528-3542.7.3.487; Van den Stock J, 2008, BRAIN RES, V1242, P185, DOI 10.1016/j.brainres.2008.05.040; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102; Werner S, 2010, CEREB CORTEX, V20, P1829, DOI 10.1093/cercor/bhp248; Wheaton KJ, 2004, NEUROIMAGE, V22, P277, DOI 10.1016/j.neuroimage.2003.12.043	66	33	34	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36070	10.1371/journal.pone.0036070	http://dx.doi.org/10.1371/journal.pone.0036070			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UL	22558332	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340200038
J	Karlsson, D; Ronquist, F				Karlsson, Dave; Ronquist, Fredrik			Skeletal Morphology of Opius dissitus and Biosteres carbonarius (Hymenoptera: Braconidae), with a Discussion of Terminology	PLOS ONE			English	Article							PHYLOGENETIC IMPLICATIONS; INSECTA; CLASSIFICATION; CHALCIDOIDEA; NOMENCLATURE; GENITALIA; OPIINAE	The Braconidae, a family of parasitic wasps, constitute a major taxonomic challenge with an estimated diversity of 40,000 to 120,000 species worldwide, only 18,000 of which have been described to date. The skeletal morphology of braconids is still not adequately understood and the terminology is partly idiosyncratic, despite the fact that anatomical features form the basis for most taxonomic work on the group. To help address this problem, we describe the external skeletal morphology of Opius dissitus Muesebeck 1963 and Biosteres carbonarius Nees 1834, two diverse representatives of one of the least known and most diverse braconid subfamilies, the Opiinae. We review the terminology used to describe skeletal features in the Ichneumonoidea in general and the Opiinae in particular, and identify a list of recommend terms, which are linked to the online Hymenoptera Anatomy Ontology. The morphology of the studied species is illustrated with SEM-micrographs, photos and line drawings. Based on the examined species, we discuss intraspecific and interspecific morphological variation in the Opiinae and point out character complexes that merit further study.	[Karlsson, Dave; Ronquist, Fredrik] Swedish Museum Nat Hist, Dept Entomol, S-10405 Stockholm, Sweden	Swedish Museum of Natural History	Karlsson, D (corresponding author), Stn Linne, Farjestaden, Sweden.	dave.karlsson@stationlinne.se	Ronquist, Fredrik/Q-2013-2015	Ronquist, Fredrik/0000-0002-3929-251X	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS) [217-2004-2101]	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas)	This research was funded by grant 217-2004-2101 from the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS) (http://www.formas.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achterberg Cv, 1975, ENTOMOL BER, V35, P175; Alam S.M., 1951, ALIGARH MUSLIM U PUB, V3, P1; ALAM S. MASHHOOD, 1953, ALIGARH MUSLIM UNIV PUBL ZOOL SER ON INDIAN INSECT TYPES, V3, P1; [Anonymous], ZOOLOGISCHE VERHANDE; [Anonymous], 1976, SPHECID WASPS WORLD; BASIBUYUK HH, 1995, ZOOL SCR, V24, P157, DOI 10.1111/j.1463-6409.1995.tb00397.x; Buckingham G.R., 1988, P199; Chapman R. F., 1969, INSECT STRUCTURE FUN; Chi M, 2005, MOL PHYLOGENET EVOL, V37, P104; Comstock JH, 1898, AM NATURALIST, V32; Comstock JH, 1899, AM NATURALIST, V33; Dowton M, 2002, J MOL EVOL, V54, P210, DOI 10.1007/s00239-001-0003-3; Duncan CD, 1939, CONTRIBUTION BIOL N, VVIII, P1; EADY RD, 1974, J ENTOMOL SER B, V43, P63; FARISH DJ, 1972, ANIM BEHAV, V20, P662, DOI 10.1016/S0003-3472(72)80139-8; Fischer M, 1971, HYMENOPTERA BRACONID, P1; Fischer M., 1972, TIERREICH, V91, P1; Fitton M.G., 1988, Handbooks for the Identification of British Insects, V7, P1; Gauld I. D., 1988, HYMENOPTERA BRIT MUS; Gauld I. D., 1981, TAXONOMY DISTRIBUTIO; Gauld ID, 1978, TAXONOMY DISTRIBUTIO; Gauld ID, 1995, HYMENOPTERA COSTA RI, P185; Ghahari HDS, 2006, BIBLIO FAMILY BRACON; GIBSON GAP, 1986, CAN ENTOMOL, V118, P205, DOI 10.4039/Ent118205-3; GIBSON GAP, 1985, CAN ENTOMOL, V117, P1395, DOI 10.4039/Ent1171395-11; GIBSON GAP, 1993, MEM ENTOMOL SOC CAN, P165, DOI 10.4039/entm125165165-1; Gibson GAP, 2011, CHALCID WASPS CHALCI; Gimeno C, 1997, INSECT MOL BIOL, V6, P273, DOI 10.1046/j.1365-2583.1997.00181.x; Goulet H., 1993, HYMENOPTERA WORLD ID, V1894E; Graham M. W. R. de V., 1969, Bull. Br. Mus. nat. Hist. Ent., V16, P1; Grimaldi David, 2005, pi; Gullan PA, 2014, INSECTS OUTLINE ENTO; Karlsson Dave, 2005, Entomologisk Tidskrift, V126, P43; Krogmann L, 2006, INVERTEBR SYST, V20, P615, DOI 10.1071/IS06012; Kula Robert R., 2003, Journal of Hymenoptera Research, V12, P278; Kutter H., 1977, Insecta helv fauna, V6, P1; Liljeblad J, 1998, SYST ENTOMOL, V23, P229, DOI 10.1046/j.1365-3113.1998.00053.x; Liljeblad J, 2008, ZOOTAXA, P1; Linnaeus C., 1758, SYSTEMA NATURAE SIVE; Masner L, 1980, MEMOIRS ENTOMOLOGICA, V113; Medvedev GS, 1997, KEYS INSECTS EUROP 4, VIII; Medvedev GS, 1995, KEYS INSECTS EUROP 5, VIII; Melika G, 2005, ACTA ZOOL ACAD SCI H, V51, P313; Michener Charles Duncan, 1944, BULL AMER MUS NAT HIST, V82, P151; Miko I, 2007, ZOOTAXA, P1; Nachtigall W, 1998, J COMP PHYSIOL B, V168, P323, DOI 10.1007/s003600050152; Nichols SW, 1989, NEW YORK ENTOMOLOGIC, Vxvii, P1; Oeser R., 1961, Mitteilungen aus dem Zoologischen Museum in Berlin, V37, P3; Pitz KM, 2007, MOL PHYLOGENET EVOL, V43, P338, DOI 10.1016/j.ympev.2006.11.010; Pratt DJ, 1940, J NEW YORK ENTOMOL S, VXLVIII, P155; Quicke DLJ, 1990, ZOOLOGISCHE VERHANDE, V258, P1; Richards O. W., 1956, HDB IDENTIFICATION B, V6, P1; RONQUIST F, 1989, ENTOMOL SCAND, P1; Ronquist Fredrik, 1995, Entomologica Scandinavica Supplement, V46, P1; Ross HH, 1937, ILLINOIS BIOL MONOGR, V15, P1, DOI DOI 10.5962/BHL.TITLE.50339; Schulmeister S, 2003, ORG DIVERS EVOL, V3, P253, DOI 10.1078/1439-6092-00078; Schulmeister S, 2001, ACTA ZOOL-STOCKHOLM, V82, P331, DOI 10.1046/j.1463-6395.2001.00094.x; Sharkey M.J., 1992, Journal of Hymenoptera Research, V1, P15; Sharkey MJ, 2005, ZOOTAXA, P43, DOI 10.11646/zootaxa.1070.1.3; Sharkey MJ, 1988, ADV PARASITIC HYMENO, P169; Shaw M.R., 1991, Handbooks for the Identification of British Insects, V7, P1; SHCHERBAKOV DE, 1981, ZOOL ZH, V60, P205; SHENEFELT ROY D., 1965, BEITRAGE ENTOMOL, V15, P243; Snodgrass R. E., 1942, SMITHSONIAN MISC COLL, V103, P1; Snodgrass R.E., 1956, ANATOMY HONEY BEE; Snodgrass R.E., 1935, MCGRAW HILL PUBLICAT; Surekha K, 1995, J NEW YORK ENTOMOL S, V103, P78; Tobias VI, 1986, SUBFAMILY OPIINAC, V3, P7; Townes H, 1969, MEMOIRS AM ENTOMOLOG, P1; Townes H.K., 1962, MEMOIRS AM ENTOMOLOG, V2, P1, DOI [10.5479/si.03629236.216.1-3, DOI 10.5479/SI.03629236.216.1-3]; van Achterberg C., 1974, Entomologische Berichten, V34, P213; van Achterberg C., 2004, Zoologische Mededelingen (Leiden), V78, P1; van Achterberg C., 2004, Zoologische Mededelingen (Leiden), V78, P331; van Achterberg C., 1993, Zoologische Verhandelingen (Leiden), V283, P1; van Achterberg C., 1984, Entomologisk Tidskrift, V105, P41; van Achterberg C., 1976, Tijdschrift voor Entomologie, V119, P33; van Achterberg C., 1990, Zoologische Mededelingen (Leiden), V64, P1; van Achterberg C., 1983, Tijdschrift voor Entomologie, V126, P25; Van Achterberg C., 1993, Zoologische Mededelingen (Leiden), V67, P365; VANACHTERBERG K, 1992, CLADISTICS, V8, P237, DOI 10.1111/j.1096-0031.1992.tb00069.x; Vilhelmsen L, 2000, ZOOL SCR, V29, P319, DOI 10.1046/j.1463-6409.2000.00046.x; Vilhelmsen L, 2000, ZOOL ANZ, V239, P105; Vilhelmsen L, 1999, ZOOL SCR, V28, P75, DOI 10.1046/j.1463-6409.1999.00008.x; Vilhelmsen L, 2010, ZOOLOGICAL J LINNEAN, P1; WATERHOUSE DF, 1993, BIOL CONTROL PACIF S, V2; WHARTON R, 1977, PAN-PAC ENTOMOL, V53, P297; Wharton R. A, 1989, FRUIT FLIES THEIR B, P303; WHARTON RA, 1987, P ENTOMOL SOC WASH, V89, P61; WHARTON RA, 1988, CAN ENTOMOL, V120, P333, DOI 10.4039/Ent120333-4; WHARTON RA, 1992, CLADISTICS, V8, P199, DOI 10.1111/j.1096-0031.1992.tb00068.x; Wharton RA, 1987, B ZOOLOGICAL NOMENCL, V43, P369; WHARTON RA, 1997, SPECIAL PUBLICATION, V1; Wharton RA, 2006, ZOOL SCR, V35, P323, DOI 10.1111/j.1463-6409.2006.00236.x; Yu DSK, 2016, TAXAPAD 2016 ICHNEUM; Zaldivar-Riveron A, 2006, MOL PHYLOGENET EVOL, V38, P130, DOI 10.1016/j.ympev.2005.08.006	95	60	61	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e32573	10.1371/journal.pone.0032573	http://dx.doi.org/10.1371/journal.pone.0032573			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558068	Green Submitted, Green Published, gold			2022-12-27	WOS:000305340200002
J	Gronlund, A; Yi, IG; Kim, BJ				Gronlund, Andreas; Yi, Il Gu; Kim, Beom Jun			Fractal Profit Landscape of the Stock Market	PLOS ONE			English	Article							TECHNICAL ANALYSIS; PERFORMANCE	We investigate the structure of the profit landscape obtained from the most basic, fluctuation based, trading strategy applied for the daily stock price data. The strategy is parameterized by only two variables, p and q Stocks are sold and bought if the log return is bigger than p and less than -q, respectively. Repetition of this simple strategy for a long time gives the profit defined in the underlying two-dimensional parameter space of p and q. It is revealed that the local maxima in the profit landscape are spread in the form of a fractal structure. The fractal structure implies that successful strategies are not localized to any region of the profit landscape and are neither spaced evenly throughout the profit landscape, which makes the optimization notoriously hard and hypersensitive for partial or limited information. The concrete implication of this property is demonstrated by showing that optimization of one stock for future values or other stocks renders worse profit than a strategy that ignores fluctuations, i.e., a long-term buy-and-hold strategy.	[Gronlund, Andreas] Uppsala Univ, Dept Math, S-75238 Uppsala, Sweden; [Yi, Il Gu; Kim, Beom Jun] Sungkyunkwan Univ, Phys Res Div BK21, Suwon, South Korea; [Yi, Il Gu; Kim, Beom Jun] Sungkyunkwan Univ, Dept Phys, Suwon, South Korea	Uppsala University; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU)	Gronlund, A (corresponding author), Uppsala Univ, Dept Math, S-75238 Uppsala, Sweden.	beomjun@skku.edu	Grönlund, Andreas/F-1981-2011; Kim, Beom Jun/C-2380-2008; Chanelian, Serena/ABE-4873-2021	Kim, Beom Jun/0000-0003-0854-8647; Chanelian, Serena/0000-0001-5727-6137; Gronlund, Andreas/0000-0002-1543-7358	National Research Foundation of Korea (NRF); Korea government (MEST) [2011-0015731]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (2011-0015731). http://www.nrf.re.kr/html/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axtell RL, 2001, SCIENCE, V293, P1818, DOI 10.1126/science.1062081; Baek Y, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.026109; Barber BM, 2000, J FINANC, V55, P773, DOI 10.1111/0022-1082.00226; BLACK F, 1973, J POLIT ECON, V81, P637, DOI 10.1086/260062; Cowpertwait PSP, 2009, USE R, P1, DOI 10.1007/978-0-387-88698-5_1; Fusai G, 2008, SPRINGER FINANC, pXV; Gopikrishnan P, 1999, PHYS REV E, V60, P5305, DOI 10.1103/PhysRevE.60.5305; Lo AW, 2000, J FINANC, V55, P1705, DOI 10.1111/0022-1082.00265; Malkiel B.G., 1999, RANDOM WALK WALL STR; MANDELBROT B, 1963, J BUS, V36, P394, DOI 10.1086/294632; Mantegna R. N., 2000, INTRO ECONOPHYSICS; Menkhoff L, 2010, J BANK FINANC, V34, P2573, DOI 10.1016/j.jbankfin.2010.04.014; Park C-H, 2004, 200404 PP AGMAS PROJ, P2004; Schoutens W., 2003, LEVY PROCESSES FINAN; Schulmeister S, 2009, REV FINANC ECON, V18, P190, DOI 10.1016/j.rfe.2008.10.001; Stanley MHR, 1996, NATURE, V379, P804, DOI 10.1038/379804a0; Sullivan R, 1999, J FINANC, V54, P1647, DOI 10.1111/0022-1082.00163; Toth B, 2007, EUR PHYS J B, V55, P115, DOI 10.1140/epjb/e2007-00046-2; WEINBERGER E, 1990, BIOL CYBERN, V63, P325, DOI 10.1007/BF00202749; Yamasaki K, 2005, P NATL ACAD SCI USA, V102, P9424, DOI 10.1073/pnas.0502613102; Yeung CH, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026107	21	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e33960	10.1371/journal.pone.0033960	http://dx.doi.org/10.1371/journal.pone.0033960			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TJ	22558079	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000007
J	Moldavski, O; Levin-Kravets, O; Ziv, T; Adam, Z; Prag, G				Moldavski, Ofer; Levin-Kravets, Olga; Ziv, Tamar; Adam, Zach; Prag, Gali			The Hetero-Hexameric Nature of a Chloroplast AAA plus FtsH Protease Contributes to Its Thermodynamic Stability	PLOS ONE			English	Article							ATP-DEPENDENT PROTEASE; PHOTOSYSTEM-II REPAIR; SYNECHOCYSTIS SP PCC-6803; LEAF VARIEGATION; ARABIDOPSIS-THALIANA; CRYSTAL-STRUCTURE; D1 DEGRADATION; MEMBRANE; COMPLEX; MITOCHONDRIA	FtsH is an evolutionary conserved membrane-bound metalloprotease complex. While in most prokaryotes FtsH is encoded by a single gene, multiple FtsH genes are found in eukaryotes. Genetic and biochemical data suggest that the Arabidopsis chloroplast FtsH is a hetero-hexamer. This raises the question why photosynthetic organisms require a heteromeric complex, whereas in most bacteria a homomeric one is sufficient. To gain structural information of the possible complexes, the Arabidopsis FtsH2 (type B) and FtsH5 (type A) were modeled. An in silico study with mixed models of FtsH2/5 suggests that heteromeric hexamer structure with ratio of 4: 2 is more likely to exists. Specifically, calculation of the buried surface area at the interfaces between neighboring subunits revealed that a hetero-complex should be thermodynamically more stable than a homo-hexamer, due to the presence of additional hydrophobic and hydrophilic interactions. To biochemically assess this model, we generated Arabidopsis transgenic plants, expressing epitope-tagged FtsH2 and immuno-purified the protein. Mass-spectrometry analysis showed that FtsH2 is associated with FtsH1, FtsH5 and FtsH8. Interestingly, we found that 'type B' subunits (FtsH2 and FtsH8) were 2-3 fold more abundant than 'type A' (FtsH1 and FtsH5). The biochemical data corroborate the in silico model and suggest that the thylakoid FtsH hexamer is composed of two 'type A' and four 'type B' subunits.	[Moldavski, Ofer; Adam, Zach] Hebrew Univ Jerusalem, Robert H Smith Inst Plant Sci & Genet Agr, IL-76100 Rehovot, Israel; [Levin-Kravets, Olga; Prag, Gali] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel; [Levin-Kravets, Olga; Prag, Gali] Tel Aviv Univ, George S Wise Fac Life Sci, Inst Biol Struct, IL-69978 Tel Aviv, Israel; [Ziv, Tamar] Technion Israel Inst Technol, Dept Biol, Smoler Prote Ctr, IL-32000 Haifa, Israel	Hebrew University of Jerusalem; Tel Aviv University; Tel Aviv University; Technion Israel Institute of Technology	Moldavski, O (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Inst Plant Sci & Genet Agr, IL-76100 Rehovot, Israel.	prag@post.tau.ac.il		Ziv, Tamar/0000-0003-4299-7454	US - Israel Binational Science Foundation (BSF) [2003302]; US - Israel Binational Agricultural Research and Development Fund (BARD) [4228-09]	US - Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); US - Israel Binational Agricultural Research and Development Fund (BARD)	This research was supported by grants from the US - Israel Binational Science Foundation (BSF; www.bsf.org.il; Grant # 2003302) and the US - Israel Binational Agricultural Research and Development Fund (BARD; http://www.bard-isus.com; Grant # 4228-09) to ZA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam Z, 2005, PHYSIOL PLANTARUM, V123, P386, DOI 10.1111/j.1399-3054.2004.00436.x; Adam Z, 2006, CURR OPIN PLANT BIOL, V9, P234, DOI 10.1016/j.pbi.2006.03.010; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Arlt H, 1996, CELL, V85, P875, DOI 10.1016/S0092-8674(00)81271-4; Aronsson H, 2002, FEBS LETT, V529, P215, DOI 10.1016/S0014-5793(02)03342-2; Augustin S, 2009, MOL CELL, V35, P574, DOI 10.1016/j.molcel.2009.07.018; Bailey S, 2002, J BIOL CHEM, V277, P2006, DOI 10.1074/jbc.M105878200; Bar-Nun S, 2011, BIOCH BIOPHYS ACTA; Beer I, 2004, PROTEOMICS, V4, P950, DOI 10.1002/pmic.200300652; Bieniossek C, 2006, P NATL ACAD SCI USA, V103, P3066, DOI 10.1073/pnas.0600031103; Bieniossek C, 2009, P NATL ACAD SCI USA, V106, P21579, DOI 10.1073/pnas.0910708106; Chen JP, 2006, PLANT J, V48, P73, DOI 10.1111/j.1365-313X.2006.02855.x; Chen M, 2000, PLANT J, V22, P303, DOI 10.1046/j.1365-313x.2000.00738.x; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; CHOTHIA C, 1975, NATURE, V254, P304, DOI 10.1038/254304a0; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dolan Michael A, 2012, Methods Mol Biol, V857, P399, DOI 10.1007/978-1-61779-588-6_18; EISENBERG D, 1986, NATURE, V319, P199, DOI 10.1038/319199a0; Friso G, 2004, PLANT CELL, V16, P478, DOI 10.1105/tpc.017814; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Kato Y, 2009, PLANT PHYSIOL, V151, P1790, DOI 10.1104/pp.109.146589; Komenda J, 2007, PLANT CELL, V19, P2839, DOI 10.1105/tpc.107.053868; Krzywda S, 2002, STRUCTURE, V10, P1073, DOI 10.1016/S0969-2126(02)00806-7; Langer T, 2000, TRENDS BIOCHEM SCI, V25, P247, DOI 10.1016/S0968-0004(99)01541-8; Lindahl M, 2000, PLANT CELL, V12, P419, DOI 10.1105/tpc.12.3.419; Miura E, 2007, PLANT CELL, V19, P1313, DOI 10.1105/tpc.106.049270; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Prag G, 2007, DEV CELL, V12, P973, DOI 10.1016/j.devcel.2007.04.013; Ren XF, 2009, STRUCTURE, V17, P406, DOI 10.1016/j.str.2009.01.012; Sakamoto W, 2003, PLANT CELL, V15, P2843, DOI 10.1105/tpc.017319; Sakamoto W, 2002, GENES CELLS, V7, P769, DOI 10.1046/j.1365-2443.2002.00558.x; Sakamoto W, 2006, ANNU REV PLANT BIOL, V57, P599, DOI 10.1146/annurev.arplant.57.032905.105401; Schroda M, 2008, NEW CHLAMYDOMONAS SO, V2, P671; Silva P, 2003, PLANT CELL, V15, P2152, DOI 10.1105/tpc.012609; Sinvany-Villalobo G, 2004, PLANT PHYSIOL, V135, P1336, DOI 10.1104/pp.104.043299; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Steglich G, 1999, MOL CELL BIOL, V19, P3435; Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0; Suno R, 2006, MOL CELL, V22, P575, DOI 10.1016/j.molcel.2006.04.020; Takechi K, 2000, PLANT CELL PHYSIOL, V41, P1334, DOI 10.1093/pcp/pcd067; Tatsuta T, 2009, RES MICROBIOL, V160, P711, DOI 10.1016/j.resmic.2009.09.005; Urantowka A, 2005, PLANT MOL BIOL, V59, P239, DOI 10.1007/s11103-005-8766-3; Vallone B, 1998, P NATL ACAD SCI USA, V95, P6103, DOI 10.1073/pnas.95.11.6103; Yoshioka M, 2006, J BIOL CHEM, V281, P21660, DOI 10.1074/jbc.M602896200; Yu F, 2005, PLANT PHYSIOL, V138, P1957, DOI 10.1104/pp.105.061234; Yu F, 2004, PLANT J, V37, P864, DOI 10.1111/j.1365-313X.2003.02014.x; Yu F, 2008, PLANT CELL, V20, P1786, DOI 10.1105/tpc.107.054965; Zaltsman A, 2005, PLANT CELL, V17, P2782, DOI 10.1105/tpc.105.035071; Zaltsman A, 2005, PLANT J, V42, P609, DOI 10.1111/j.1365-313X.2005.02401.x	52	20	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36008	10.1371/journal.pone.0036008	http://dx.doi.org/10.1371/journal.pone.0036008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558304	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336000099
J	Muraoka, Y; Ikeda, HO; Nakano, N; Hangai, M; Toda, Y; Okamoto-Furuta, K; Kohda, H; Kondo, M; Terasaki, H; Kakizuka, A; Yoshimura, N				Muraoka, Yuki; Ikeda, Hanako Ohashi; Nakano, Noriko; Hangai, Masanori; Toda, Yoshinobu; Okamoto-Furuta, Keiko; Kohda, Haruyasu; Kondo, Mineo; Terasaki, Hiroko; Kakizuka, Akira; Yoshimura, Nagahisa			Real-Time Imaging of Rabbit Retina with Retinal Degeneration by Using Spectral-Domain Optical Coherence Tomography	PLOS ONE			English	Article							ANIMAL-MODELS; ULTRAHIGH-RESOLUTION; RHODOPSIN MUTATION; GANGLION-CELLS; RODENT RETINA; VISUAL-ACUITY; HIGH-SPEED; DELIVERY; HISTOPATHOLOGY; PIGMENTOSA	Background: Recently, a transgenic rabbit with rhodopsin Pro 347 Leu mutation was generated as a model of retinitis pigmentosa (RP), which is characterized by a gradual loss of vision due to photoreceptor degeneration. The purpose of the current study is to noninvasively visualize and assess time-dependent changes in the retinal structures of a rabbit model of retinal degeneration by using speckle noise-reduced spectral-domain optical coherence tomography (SD-OCT). Methodology/Principal Findings: Wild type (WT) and RP rabbits (aged 4-20 weeks) were investigated using SD-OCT. The total retinal thickness in RP rabbits decreased with age. The thickness of the outer nuclear layer (ONL) and between the external limiting membrane and Bruch's membrane (ELM-BM) were reduced in RP rabbits around the visual streak, compared to WT rabbits even at 4 weeks of age, and the differences increased with age. However, inner nuclear layer (INL) thickness in RP rabbits did not differ from that of WT during the observation period. The ganglion cell complex (GCC) thickness in RP rabbits increased near the optic nerve head but not around the visual streak in the later stages of the observation period. Hyper-reflective change was widely observed in the inner segments (IS) and outer segments (OS) of the photoreceptors in the OCT images of RP rabbits. Ultrastructural findings in RP retinas included the appearance of small rhodopsin-containing vesicles scattered in the extracellular space around the photoreceptors. Conclusions/Significance: In the current study, SD-OCT provided the pattern of photoreceptor degeneration in RP rabbits and the longitudinal changes in each retinal layer through the evaluation of identical areas over time. The time-dependent changes in the retinal structure of RP rabbits showed regional and time-stage variations. In vivo imaging of RP rabbit retinas by using SD-OCT is a powerful method for characterizing disease dynamics and for assessing the therapeutic effects of experimental interventions.	[Muraoka, Yuki; Ikeda, Hanako Ohashi; Nakano, Noriko; Hangai, Masanori; Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan; [Toda, Yoshinobu; Okamoto-Furuta, Keiko; Kohda, Haruyasu] Kyoto Univ, Grad Sch Med, Ctr Anat Studies, Kyoto, Japan; [Kondo, Mineo] Mie Univ, Sch Med, Dept Ophthalmol, Tsu, Mie 514, Japan; [Terasaki, Hiroko] Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Nagoya, Aichi 4648601, Japan; [Kakizuka, Akira] Kyoto Univ, Lab Funct Biol, Grad Sch Biostudies & Solut Oriented Res Sci & Te, Kyoto, Japan	Kyoto University; Kyoto University; Mie University; Nagoya University; Kyoto University	Muraoka, Y (corresponding author), Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan.	hanakoi@kuhp.kyoto-u.ac.jp	Terasaki, Hiroko/M-5054-2014	Ikeda, Hanako/0000-0001-9572-8659	Astellas Foundation for Research on Metabolic Disorders; Japan Foundation for Applied Enzymology; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [22791656]; Grants-in-Aid for Scientific Research [23592603] Funding Source: KAKEN	Astellas Foundation for Research on Metabolic Disorders; Japan Foundation for Applied Enzymology; Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Research grants from the Astellas Foundation for Research on Metabolic Disorders and the Japan Foundation for Applied Enzymology, and a Grant-in-Aid for Young Scientists (22791656) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Aleman TS, 2008, INVEST OPHTH VIS SCI, V49, P1580, DOI 10.1167/iovs.07-1110; BARNETT KC, 1985, J HERED, V76, P168, DOI 10.1093/oxfordjournals.jhered.a110058; Bush RA, 2004, INVEST OPHTH VIS SCI, V45, P2420, DOI 10.1167/iovs.03-1342; Byeon SH, 2009, OPHTHALMOLOGY, V116, P1949, DOI 10.1016/j.ophtha.2009.06.066; Chader GJ, 2002, VISION RES, V42, P393, DOI 10.1016/S0042-6989(01)00212-7; Chen TC, 2006, AM J OPHTHALMOL, V141, P1165, DOI 10.1016/j.ajo.2006.01.086; Chen TC, 2005, ARCH OPHTHALMOL-CHIC, V123, P1715, DOI 10.1001/archopht.123.12.1715; Costa RA, 2004, INVEST OPHTH VIS SCI, V45, P2399, DOI 10.1167/iovs.04-0155; FAMIGLIETTI EV, 1995, VISUAL NEUROSCI, V12, P1151, DOI 10.1017/S0952523800006799; Fischer MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007507; Hangai M, 2009, OPT EXPRESS, V17, P4221, DOI 10.1364/OE.17.004221; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Huber G, 2009, INVEST OPHTH VIS SCI, V50, P5888, DOI 10.1167/iovs.09-3724; Humayun MS, 1999, INVEST OPHTH VIS SCI, V40, P143; Kijas JW, 2002, P NATL ACAD SCI USA, V99, P6328, DOI 10.1073/pnas.082714499; Kim KH, 2008, J VISION, V8, DOI 10.1167/8.1.17; Kondo M, 2009, INVEST OPHTH VIS SCI, V50, P1371, DOI 10.1167/iovs.08-2863; Li TS, 1996, P NATL ACAD SCI USA, V93, P14176, DOI 10.1073/pnas.93.24.14176; MARC RE, 1986, VISION RES, V26, P223, DOI 10.1016/0042-6989(86)90017-9; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Menotti-Raymond M, 2007, J HERED, V98, P211, DOI 10.1093/jhered/esm019; Milam AH, 1998, PROG RETIN EYE RES, V17, P175; Murakami T, 2011, AM J OPHTHALMOL, V151, P310, DOI 10.1016/j.ajo.2010.08.022; Nakano N, 2011, OPHTHALMOLOGY, V118, P2414, DOI 10.1016/j.ophtha.2011.06.015; Nakano N, 2011, INVEST OPHTH VIS SCI, V52, P8754, DOI 10.1167/iovs.10-6654; NARFSTROM K, 1983, J HERED, V74, P273, DOI 10.1093/oxfordjournals.jhered.a109782; Ng Y, 2008, INVEST OPHTH VIS SCI, V49, P2208, DOI 10.1167/iovs.07-1159; Oishi A, 2010, AM J OPHTHALMOL, V150, P27, DOI 10.1016/j.ajo.2010.02.012; Osakada F, 2010, BIOTECHNOL GENET ENG, V26, P297; Petersen-Jones SM, 1998, EYE, V12, P566, DOI 10.1038/eye.1998.146; Petters RM, 1997, NAT BIOTECHNOL, V15, P965, DOI 10.1038/nbt1097-965; Rockhill RL, 2002, J NEUROSCI, V22, P3831; Ruggeri M, 2007, INVEST OPHTH VIS SCI, V48, P1808, DOI 10.1167/iovs.06-0815; Sakamoto A, 2008, OPHTHALMOLOGY, V115, P1071, DOI 10.1016/j.ophtha.2007.09.001; Sandberg MA, 2005, INVEST OPHTH VIS SCI, V46, P3349, DOI 10.1167/iovs.04-1383; Srinivasan VJ, 2006, INVEST OPHTH VIS SCI, V47, P5522, DOI 10.1167/iovs.06-0195; Stanzel BV, 2012, INVEST OPHTH VIS SCI, V53, P490, DOI 10.1167/iovs.11-8260; Tao W, 2002, INVEST OPHTH VIS SCI, V43, P3292; VANEY DI, 1991, VISUAL NEUROSCI, V7, P141, DOI 10.1017/S0952523800011019; Wojtkowski M, 2004, AM J OPHTHALMOL, V138, P412, DOI 10.1016/j.ajo.2004.04.049; Yamauchi Y, 2011, BRIT J OPHTHALMOL, V95, P1161, DOI 10.1136/bjo.2010.198317	42	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36135	10.1371/journal.pone.0036135	http://dx.doi.org/10.1371/journal.pone.0036135			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558356	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000134
J	Schneps, MH; Brockmole, JR; Sonnert, G; Pomplun, M				Schneps, Matthew H.; Brockmole, James R.; Sonnert, Gerhard; Pomplun, Marc			History of Reading Struggles Linked to Enhanced Learning in Low Spatial Frequency Scenes	PLOS ONE			English	Article							REPORT SCALE ASRS; WORKING-MEMORY; VISUAL-SEARCH; PERIPHERAL-VISION; DEVELOPMENTAL DYSLEXIA; MAGNOCELLULAR DEFECT; ATTENTION; CHILDREN; SENSITIVITY; DEFICITS	People with dyslexia, who face lifelong struggles with reading, exhibit numerous associated low-level sensory deficits including deficits in focal attention. Countering this, studies have shown that struggling readers outperform typical readers in some visual tasks that integrate distributed information across an expanse. Though such abilities would be expected to facilitate scene memory, prior investigations using the contextual cueing paradigm failed to find corresponding advantages in dyslexia. We suggest that these studies were confounded by task-dependent effects exaggerating known focal attention deficits in dyslexia, and that, if natural scenes were used as the context, advantages would emerge. Here, we investigate this hypothesis by comparing college students with histories of severe lifelong reading difficulties (SR) and typical readers (TR) in contexts that vary attention load. We find no differences in contextual-cueing when spatial contexts are letter-like objects, or when contexts are natural scenes. However, the SR group significantly outperforms the TR group when contexts are low-pass filtered natural scenes [F(3, 39) = 3.15, p <.05]. These findings suggest that perception or memory for low spatial frequency components in scenes is enhanced in dyslexia. These findings are important because they suggest strengths for spatial learning in a population otherwise impaired, carrying implications for the education and support of students who face challenges in school.	[Schneps, Matthew H.; Sonnert, Gerhard] Harvard Smithsonian Ctr Astrophys, Sci Educ Dept, Cambridge, MA 02138 USA; [Brockmole, James R.] Univ Notre Dame, Dept Psychol, Notre Dame, IN 46556 USA; [Pomplun, Marc] Univ Massachusetts, Dept Comp Sci, Boston, MA 02125 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Notre Dame; University of Massachusetts System; University of Massachusetts Boston	Schneps, MH (corresponding author), Harvard Smithsonian Ctr Astrophys, Sci Educ Dept, 60 Garden St, Cambridge, MA 02138 USA.	mschneps@cfa.harvard.edu	Pomplun, Marc/P-8858-2019	Brockmole, James/0000-0003-3227-1078; Sonnert, Gerhard/0000-0003-4138-2044	National Science Foundation [HRD-0930962]; George E. Burch Foundation	National Science Foundation(National Science Foundation (NSF)); George E. Burch Foundation	This work was supported by National Science Foundation Grant HRD-0930962 (http://www.nsf.gov/awardsearch/showAward.do?AwardNumber = 0930962), and by the George E. Burch Foundation (http://www.si.edu/ofg/) that provided a fellowship to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar M, 2004, TRENDS COGN SCI, V8, P457, DOI 10.1016/j.tics.2004.08.011; Bar M, 2003, J COGNITIVE NEUROSCI, V15, P600, DOI 10.1162/089892903321662976; Bennett IJ, 2008, ANN NY ACAD SCI, V1145, P184, DOI 10.1196/annals.1416.006; Brady TF, 2007, J EXP PSYCHOL HUMAN, V33, P798, DOI 10.1037/0096-1523.33.4.798; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brockmole JR, 2006, J EXP PSYCHOL LEARN, V32, P699, DOI 10.1037/0278-7393.32.4.699; Brockmole JR, 2006, Q J EXP PSYCHOL, V59, P1177, DOI 10.1080/17470210600665996; Brockmole JR, 2010, ATTEN PERCEPT PSYCHO, V72, P1803, DOI 10.3758/APP.72.7.1803; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; CARRASCO M, 1995, PERCEPT PSYCHOPHYS, V57, P1241, DOI 10.3758/BF03208380; Carrasco M, 2003, NAT NEUROSCI, V6, P699, DOI 10.1038/nn1079; Chun MM, 1999, NAT NEUROSCI, V2, P844, DOI 10.1038/12222; Chun MM, 1998, COGNITIVE PSYCHOL, V36, P28, DOI 10.1006/cogp.1998.0681; Craggs JG, 2006, CORTEX, V42, P1107, DOI 10.1016/S0010-9452(08)70222-3; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; DACEY DM, 1994, CIBA F SYMP, V184, P12; DAUTRICH BR, 1993, PERCEPT MOTOR SKILL, V76, P755, DOI 10.2466/pms.1993.76.3.755; Dehaene S, 2010, SCIENCE, V330, P1359, DOI 10.1126/science.1194140; DENCKLA MB, 1976, BRAIN LANG, V3, P1, DOI 10.1016/0093-934X(76)90001-8; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P219, DOI 10.1113/jphysiol.1984.sp015498; Ellemberg D, 2001, SPATIAL VISION, V15, P99, DOI 10.1163/15685680152692042; Facoetti A, 2000, CORTEX, V36, P109, DOI 10.1016/S0010-9452(08)70840-2; Facoetti A, 2000, EXP BRAIN RES, V132, P531, DOI 10.1007/s002219900330; Facoetti A, 2001, NEUROPSYCHOLOGIA, V39, P352, DOI 10.1016/S0028-3932(00)00138-X; Facoetti A, 2008, CORTEX, V44, P1221, DOI 10.1016/j.cortex.2007.10.007; Facoetti A, 2010, DYSLEXIA, V16, P226, DOI 10.1002/dys.413; Facoetti A, 2010, J COGNITIVE NEUROSCI, V22, P1011, DOI 10.1162/jocn.2009.21232; Faust M, 2003, BRAIN COGNITION, V53, P211, DOI 10.1016/S0278-2626(03)00112-X; Fink R., 2006, WHY JANE JOHN COULDN; FINUCCI JM, 1984, DEV MED CHILD NEUROL, V26, P143; GALABURDA A, 1993, ANN NY ACAD SCI, V682, P70, DOI 10.1111/j.1749-6632.1993.tb22960.x; GALABURDA AM, 1985, ANN NEUROL, V18, P222, DOI 10.1002/ana.410180210; Gattass R, 2005, PHILOS T R SOC B, V360, P709, DOI 10.1098/rstb.2005.1629; GEIGER G, 1987, NEW ENGL J MED, V316, P1238, DOI 10.1056/NEJM198705143162003; GEIGER G, 1994, VISION RES, V34, P1223, DOI 10.1016/0042-6989(94)90303-4; GEIGER G, 1992, COGNITIVE BRAIN RES, V1, P39, DOI 10.1016/0926-6410(92)90004-B; Geiger G., 2000, CHILD DEV DISABILITI, VXXVI, P73; Geiger G, 2008, PERCEPTION, V37, P1745, DOI 10.1068/p6036; Geringswald F, 2011, EUR C VIS PERC 2011; Hegde J, 2008, PROG NEUROBIOL, V84, P405, DOI 10.1016/j.pneurobio.2007.09.001; Howard JH, 2006, NEUROPSYCHOLOGIA, V44, P1131, DOI 10.1016/j.neuropsychologia.2005.10.015; Huang TR, 2010, PSYCHOL REV, V117, P1080, DOI 10.1037/a0020664; HUMPHREYS P, 1990, ANN NEUROL, V28, P727, DOI 10.1002/ana.410280602; Jiang YH, 2004, PERCEPT PSYCHOPHYS, V66, P454, DOI 10.3758/BF03194893; Jimenez-Fernandez G, 2011, ANN DYSLEXIA, V61, P85, DOI 10.1007/s11881-010-0048-3; Jones MW, 2010, COGNITION, V116, P56, DOI 10.1016/j.cognition.2010.03.015; Katzir T, 2008, J LEARN DISABIL-US, V41, P47, DOI 10.1177/0022219407311325; KAUFMANN WE, 1989, NEUROLOGY, V39, P238, DOI 10.1212/WNL.39.2.238; Kessels RPC, 2010, AGING NEUROPSYCHOL C, V17, P556, DOI 10.1080/13825585.2010.481354; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Kessler RC, 2007, INT J METH PSYCH RES, V16, P52, DOI 10.1002/mpr.208; Kevan A, 2008, NEUROREPORT, V19, P467, DOI 10.1097/WNR.0b013e3282f5f7ad; Kondo Y, 2005, NEUROIMAGE, V24, P1154, DOI 10.1016/j.neuroimage.2004.10.033; Lefly DL, 2000, J LEARN DISABIL-US, V33, P286, DOI 10.1177/002221940003300306; Li FF, 2002, P NATL ACAD SCI USA, V99, P9596, DOI 10.1073/pnas.092277599; LIVINGSTONE MS, 1991, P NATL ACAD SCI USA, V88, P7943, DOI 10.1073/pnas.88.18.7943; Lorusso Maria Luisa, 2005, Brain Cogn, V57, P135, DOI 10.1016/j.bandc.2004.08.057; Lorusso ML, 2004, VISION RES, V44, P2413, DOI 10.1016/j.visres.2004.05.001; LOVEGROVE WJ, 1980, SCIENCE, V210, P439, DOI 10.1126/science.7433985; McGrath LM, 2010, J CHILD PSYCHOL PSYC; Nakayama K., 1990, VISION CODING EFFICI, P411; Nuzzo R, 2005, P NATL ACAD SCI USA, V102, P8077, DOI 10.1073/pnas.0503019102; Oliva A, 2005, GIST SCENE NEUROBIOL; PERRY AR, 1989, B PSYCHONOMIC SOC, V27, P445; Peyrin C, 2010, J COGNITIVE NEUROSCI, V22, P2768, DOI 10.1162/jocn.2010.21424; Poelmans G, 2011, MOL PSYCHIATR, V16, P365, DOI 10.1038/mp.2010.105; POTTER MC, 1976, J EXP PSYCHOL-HUM L, V2, P509, DOI 10.1037/0278-7393.2.5.509; Prado C, 2007, VISION RES, V47, P2521, DOI 10.1016/j.visres.2007.06.001; *PSYCH CORP, 1997, WECHSL AD INT SCAL; Psychological Corporation, 2002, WECHSL IND ACH TEST; Ramus F, 2004, TRENDS NEUROSCI, V27, P720, DOI 10.1016/j.tins.2004.10.004; Rosen GD, 2007, CEREB CORTEX, V17, P2562, DOI 10.1093/cercor/bhl162; Ruffino M, 2010, NEUROPSYCHOLOGIA, V48, P3793, DOI 10.1016/j.neuropsychologia.2010.09.002; Schneps MH, 2007, MIND BRAIN EDUC, V1, P128, DOI 10.1111/j.1751-228X.2007.00013.x; Schwartz S, 2005, CEREB CORTEX, V15, P770, DOI 10.1093/cercor/bhh178; Shaywitz SE, 2005, BIOL PSYCHIAT, V57, P1301, DOI 10.1016/j.biopsych.2005.01.043; Silva-Pereyra J, 2010, NEUROREPORT, V21, P34, DOI 10.1097/WNR.0b013e328332c566; Sireteanu R, 2008, ANN NY ACAD SCI, V1145, P199, DOI 10.1196/annals.1416.021; Smith-Spark JH, 2003, EUR J COGN PSYCHOL, V15, P567, DOI 10.1080/09541440340000024; Stoodley CJ, 2006, NEUROSCI LETT, V399, P264, DOI 10.1016/j.neulet.2006.02.004; Swanson HL, 2009, J LEARN DISABIL-US, V42, P260, DOI 10.1177/0022219409331958; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; van Asselen M, 2009, ATTEN PERCEPT PSYCHO, V71, P76, DOI 10.3758/APP.71.1.76; Verhaeghen P, 1996, PSYCHOL AGING, V11, P164, DOI 10.1037/0882-7974.11.1.164; Vickery TJ, 2010, J EXP PSYCHOL HUMAN, V36, P1358, DOI 10.1037/a0020558; Vidyasagar TR, 1999, NEUROREPORT, V10, P1283, DOI 10.1097/00001756-199904260-00024; von Karolyi C, 2003, BRAIN LANG, V85, P427, DOI 10.1016/S0093-934X(03)00052-X; Woodcock R.W., 2001, WOODCOCK JOHNSON 3 T	88	21	22	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35724	10.1371/journal.pone.0035724	http://dx.doi.org/10.1371/journal.pone.0035724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TJ	22558210	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000053
J	VanderLaan, DP; Forrester, DL; Petterson, LJ; Vasey, PL				VanderLaan, Doug P.; Forrester, Deanna L.; Petterson, Lanna J.; Vasey, Paul L.			Offspring Production among the Extended Relatives of Samoan Men and Fa'afafine	PLOS ONE			English	Article							MALE SEXUAL ORIENTATION; MALE HOMOSEXUALITY; BIRTH-ORDER; MALE ANDROPHILIA; X-CHROMOSOME; BEHAVIOR; LINKAGE; CHILDHOOD; MARKERS; FECUNDITY	Androphilia refers to sexual attraction to adult males, whereas gynephilia refers to sexual attraction to adult females. Male androphilia is an evolutionary paradox. Its development is at least partially influenced by genetic factors, yet male androphiles exhibit lower reproductive output, thus raising the question of how genetic factors underlying its development persist. The sexual antagonism hypothesis posits that the fitness costs associated with genetic factors underlying male androphilia are offset because these same factors lead to elevated reproduction on the part of the female relatives of androphilic males. Western samples drawn from low fertility populations have yielded inconsistent results when testing this hypothesis. Some studies documented elevated reproduction among the matrilineal female kin of androphilic males, whereas others found such effects in the paternal line. Samoa is a high-fertility population in which individuals reproduce closer to their maximum capacities. This study compared the reproductive output of the paternal and maternal line grandmothers, aunts, and uncles of 86 Samoan androphilic males, known locally as fa'afafine, and 86 Samoan gynephilic males. Reproductive output was elevated in the paternal and maternal line grandmothers, but not aunts or uncles, of fa'afafine. These findings are consistent with the sexual antagonism hypothesis and suggest that male androphilia is associated with elevated reproduction among extended relatives in both the maternal and paternal line. Discussion focuses on how this study, in conjunction with the broader literature, informs various models for the evolution of male androphilia via elevated reproduction on the part of female kin.	[VanderLaan, Doug P.; Forrester, Deanna L.; Petterson, Lanna J.; Vasey, Paul L.] Univ Lethbridge, Dept Psychol, Lethbridge, AB T1K 3M4, Canada	University of Lethbridge	VanderLaan, DP (corresponding author), Univ Lethbridge, Dept Psychol, Lethbridge, AB T1K 3M4, Canada.	doug.vanderlaan@uleth.ca			Government of Alberta; Natural Sciences and Engineering Research Council of Canada; Sigma Xi Grant in Aid of Research; University of Lethbridge; American Psychological Foundation	Government of Alberta; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Sigma Xi Grant in Aid of Research; University of Lethbridge; American Psychological Foundation	The students involved in this research were funded by the Government of Alberta Awards and Federal Scholarships. Government of Alberta Awards include a Ralph Steinhauer Award of Distinction and a Chinook Summer Research Award. Federal scholarships include scholarships from the Social Sciences and Engineering Research Council of Canada (http://www.sshrc-crsh.gc.ca/), and the Natural Sciences and Engineering Research Council of Canada (URL below). The research was funded by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/Index_eng.asp), Sigma Xi Grant in Aid of Research (http://www.sigmaxi.org/), the University of Lethbridge (http://www.uleth.ca/), and a Henry David Travel Grant from the American Psychological Foundation (http://www.apa.org/apf/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanko K, 2010, ARCH SEX BEHAV, V39, P81, DOI 10.1007/s10508-008-9457-3; Bailey JM, 2000, J PERS SOC PSYCHOL, V78, P524, DOI 10.1037//0022-3514.78.3.524; BAILEY JM, 1995, DEV PSYCHOL, V31, P43, DOI 10.1037/0012-1649.31.1.43; Bailey JM, 1999, BEHAV GENET, V29, P79, DOI 10.1023/A:1021652204405; Bartlett NH, 2006, ARCH SEX BEHAV, V35, P659, DOI 10.1007/s10508-006-9055-1; Blanchard R, 2004, J THEOR BIOL, V230, P173, DOI 10.1016/j.jtbi.2004.04.021; Blanchard R, 2007, ARCH SEX BEHAV, V36, P163, DOI 10.1007/s10508-006-9159-7; Bocklandt S, 2006, HUM GENET, V118, P691, DOI 10.1007/s00439-005-0119-4; Bogaert AF, 2011, FRONT NEUROENDOCRIN, V32, P247, DOI 10.1016/j.yfrne.2011.02.004; Camperio-Ciani A, 2004, P ROY SOC B-BIOL SCI, V271, P2217, DOI 10.1098/rspb.2004.2872; Central Intelligence Agency, 2011, WORLD FACTB; CROALL H, 1999, PARADISE BENT GENDER; Dixson A.F., 2010, ANIMAL HOMOSEXUALITY, P381; Gavrilets S, 2006, P ROY SOC B-BIOL SCI, V273, P3031, DOI 10.1098/rspb.2006.3684; HAMER DH, 1993, SCIENCE, V261, P321, DOI 10.1126/science.8332896; HU S, 1995, NAT GENET, V11, P248, DOI 10.1038/ng1195-248; Huang QQ, 2004, AM J HUM GENET, V75, P1106, DOI 10.1086/426000; Iemmola F, 2009, ARCH SEX BEHAV, V38, P393, DOI 10.1007/s10508-008-9381-6; Kendler KS, 2000, AM J PSYCHIAT, V157, P1843, DOI 10.1176/appi.ajp.157.11.1843; King M, 2005, ARCH SEX BEHAV, V34, P117, DOI 10.1007/s10508-005-1006-8; Langstrom N, 2010, ARCH SEX BEHAV, V39, P75, DOI 10.1007/s10508-008-9386-1; Larco Hoyle R, 1998, ARTE EROTICO ANTIGUO; LeVay Simon, 1996, QUEER SCI USE ABUSE; Murray S. O., 2000, HOMOSEXUALITIES; Mustanski BS, 2005, HUM GENET, V116, P272, DOI 10.1007/s00439-004-1241-4; Nash G., 2001, INDECENT EXPOSURE SE, P43; Poasa K. H., 1992, J PSYCHOL HUMAN SEXU, V5, P39, DOI DOI 10.1300/J056V05N03_04; Rahman Q, 2008, ARCH SEX BEHAV, V37, P962, DOI 10.1007/s10508-007-9191-2; Rice G, 1999, SCIENCE, V284, P665, DOI 10.1126/science.284.5414.665; Ringrose Kathryn M., 1996, 3 SEX 3 GENDER SEXUA, P85; Rosenthal AM, 2012, ARCH SEX BEHAV, V41, P135, DOI 10.1007/s10508-011-9881-7; Schmidt J.M., 2003, CURR SOCIOL, V51, P417, DOI DOI 10.1177/0011392103051003014; Schwartz G, 2010, ARCH SEX BEHAV, V39, P93, DOI 10.1007/s10508-009-9499-1; SHORE B, 1981, CULTURAL CONSTRUCTIO, P192; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Vanderlaan DP, 2012, PERS RELATIONSHIP, V19, P326, DOI 10.1111/j.1475-6811.2011.01364.x; VanderLaan DP, 2011, ARCH SEX BEHAV, V40, P1233, DOI 10.1007/s10508-010-9695-z; VanderLaan DP, 2011, ARCH SEX BEHAV, V40, P495, DOI 10.1007/s10508-009-9576-5; Vasey PL, 2007, PERSPECT BIOL MED, V50, P481, DOI 10.1353/pbm.2007.0056; Vasey PL, 2007, P ROY SOC B-BIOL SCI, V274, P1437, DOI 10.1098/rspb.2007.0120; Vasey PL, 2007, EVOL HUM BEHAV, V28, P159, DOI 10.1016/j.evolhumbehav.2006.08.004; Vasey PL, 2010, EVOL HUM BEHAV, V31, P373, DOI 10.1016/j.evolhumbehav.2010.04.001; Vasey PL, 2011, ARCH SEX BEHAV, V40, P511, DOI 10.1007/s10508-009-9589-0; Vasey PL, 2010, PSYCHOL SCI, V21, P292, DOI 10.1177/0956797609359623; Vasey PL, 2009, HUM NATURE-INT BIOS, V20, P269, DOI 10.1007/s12110-009-9066-4; Vasey PL, 2010, ARCH SEX BEHAV, V39, P821, DOI 10.1007/s10508-008-9404-3; VASEY PL, 1995, INT J PRIMATOL, V16, P173, DOI 10.1007/BF02735477; Weeks DE, 2002, GENOME RES, V12, P430, DOI 10.1101/gr.211502; WHITAM FL, 1983, ARCH SEX BEHAV, V12, P207, DOI 10.1007/BF01542072; Yates T., 1993, INTERPRETATIVE ARCHA, P31; Zucker KJ, 2007, PSYCHIAT CLIN NEUROS, V61, P529, DOI 10.1111/j.1440-1819.2007.01703.x	51	29	29	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36088	10.1371/journal.pone.0036088	http://dx.doi.org/10.1371/journal.pone.0036088			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TJ	22558342	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000126
J	Wang, C; Chin-Sang, I; Bendena, WG				Wang, Christine; Chin-Sang, Ian; Bendena, William G.			The FGLamide-Allatostatins Influence Foraging Behavior in Drosophila melanogaster	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; JUVENILE-HORMONE SYNTHESIS; COCKROACH DIPLOPTERA-PUNCTATA; GENOMIC ORGANIZATION; MOLECULAR-CLONING; GENE; EXPRESSION; IDENTIFICATION; RECEPTOR; FAMILY	Allatostatins (ASTs) are multifunctional neuropeptides that generally act in an inhibitory fashion. ASTs were identified as inhibitors of juvenile hormone biosynthesis. Juvenile hormone regulates insect metamorphosis, reproduction, food intake, growth, and development. Drosophila melanogaster RNAi lines of PheGlyLeu-amide-ASTs (FGLa/ASTs) and their cognate receptor, Dar-1, were used to characterize roles these neuropeptides and their respective receptor may play in behavior and physiology. Dar-1 and FGLa/AST RNAi lines showed a significant reduction in larval foraging in the presence of food. The larval foraging defect is not observed in the absence of food. These RNAi lines have decreased for transcript levels which encodes cGMP-dependent protein kinase. A reduction in the for transcript is known to be associated with a naturally occuring allelic variation that creates a sitter phenotype in contrast to the rover phenotype which is caused by a for allele associated with increased for activity. The sitting phenotype of FGLa/AST and Dar-1 RNAi lines is similar to the phenotype of a deletion mutant of an AST/galanin-like receptor (NPR-9) in Caenorhabditis elegans. Associated with the foraging defect in C. elegans npr-9 mutants is accumulation of intestinal lipid. Lipid accumulation was not a phenotype associated with the FGLa/AST and Dar-1 RNAi lines.	[Wang, Christine; Chin-Sang, Ian; Bendena, William G.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Wang, C (corresponding author), Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada.	william.bendena@queensu.ca	Bendena, William/N-6080-2019	Chin-Sang, Ian/0000-0001-7480-9775	Natural Sciences and Engineering Research Council (NSERC) of Canada [RGPIN 36481-08]	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work is supported by the Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery Grant RGPIN 36481-08 to WGB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2003, REGUL PEPTIDES, V115, P171, DOI 10.1016/S0167-0115(03)00165-4; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Bendena WG, 1999, ANN NY ACAD SCI, V897, P311, DOI 10.1111/j.1749-6632.1999.tb07902.x; Bendena WG, 1997, ANN NY ACAD SCI, V814, P53, DOI 10.1111/j.1749-6632.1997.tb46144.x; Bendena WG, 2008, P NATL ACAD SCI USA, V105, P1339, DOI 10.1073/pnas.0709492105; Birgul N, 1999, EMBO J, V18, P5892, DOI 10.1093/emboj/18.21.5892; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; DEBELLE JS, 1987, HEREDITY, V59, P73, DOI 10.1038/hdy.1987.98; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; DUVE H, 1993, P NATL ACAD SCI USA, V90, P2456, DOI 10.1073/pnas.90.6.2456; Fujiwara M, 2002, NEURON, V36, P1091, DOI 10.1016/S0896-6273(02)01093-0; Fuse M, 1999, PEPTIDES, V20, P1285, DOI 10.1016/S0196-9781(99)00133-3; Gronke S, 2003, CURR BIOL, V13, P603, DOI 10.1016/S0960-9822(03)00175-1; Ingram KK, 2005, MOL ECOL, V14, P813, DOI 10.1111/j.1365-294X.2005.02450.x; Kaun KR, 2007, J EXP BIOL, V210, P3547, DOI 10.1242/jeb.006924; Kaun KR, 2009, GENOME, V52, P1, DOI 10.1139/G08-090; LANGE AB, 1995, J INSECT PHYSIOL, V41, P581, DOI 10.1016/0022-1910(95)00008-I; Lenz C, 2000, BIOCHEM BIOPH RES CO, V273, P1126, DOI 10.1006/bbrc.2000.3062; Lenz C, 2000, BIOCHEM BIOPH RES CO, V273, P571, DOI 10.1006/bbrc.2000.2964; Lenz C, 2000, BIOCHEM BIOPH RES CO, V269, P91, DOI 10.1006/bbrc.2000.2251; LORENZ MW, 1995, REGUL PEPTIDES, V57, P227, DOI 10.1016/0167-0115(95)00036-B; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.0.CO;2-L; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; PEREIRA HS, 1995, GENETICS, V141, P263; PEREIRA HS, 1993, P NATL ACAD SCI USA, V90, P5044, DOI 10.1073/pnas.90.11.5044; PRATT GE, 1989, BIOCHEM BIOPH RES CO, V163, P1243, DOI 10.1016/0006-291X(89)91111-X; REICHWALD K, 1994, P NATL ACAD SCI USA, V91, P11894, DOI 10.1073/pnas.91.25.11894; SOKOLOWSKI MB, 1980, BEHAV GENET, V10, P291, DOI 10.1007/BF01067774; SOKOLOWSKI MB, 1992, GENETICA, V85, P205, DOI 10.1007/BF00132272; Sokolowski MB, 2001, NAT REV GENET, V2, P879, DOI 10.1038/35098592; Stay B, 2007, ANNU REV ENTOMOL, V52, P277, DOI 10.1146/annurev.ento.51.110104.151050; Toth AL, 2005, ANIM BEHAV, V69, P427, DOI 10.1016/j.anbehav.2004.03.017; Wang C, 2012, GEN COMP ENDOCRINOL; Williamson M, 2001, BIOCHEM BIOPH RES CO, V282, P124, DOI 10.1006/bbrc.2001.4565; Williamson M, 2001, BIOCHEM BIOPH RES CO, V281, P544, DOI 10.1006/bbrc.2001.4402; WOODHEAD AP, 1989, P NATL ACAD SCI USA, V86, P5997, DOI 10.1073/pnas.86.15.5997; Yagi KJ, 2005, J INSECT PHYSIOL, V51, P357, DOI 10.1016/j.jinsphys.2004.12.006; Yoon JG, 1995, J COMP NEUROL, V363, P475, DOI 10.1002/cne.903630310; YU CG, 1995, J INSECT PHYSIOL, V41, P1035, DOI 10.1016/0022-1910(95)00075-6	39	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36059	10.1371/journal.pone.0036059	http://dx.doi.org/10.1371/journal.pone.0036059			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558326	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336000116
J	You, XY; Zhang, ZP; Fan, JY; Cui, ZQ; Zhang, XE				You, Xiangyu; Zhang, Zhiping; Fan, Jinyu; Cui, Zongqiang; Zhang, Xian-En			Functionally Orthologous Viral and Cellular MicroRNAs Studied by a Novel Dual-Fluorescent Reporter System	PLOS ONE			English	Article							GENE-EXPRESSION; RNAS; INHIBIT; PROTEIN	Recent research raised the possibility that some viral microRNAs (miRNAs) may function as orthologs of cellular miRNAs. In the present work, to study the functional orthologous relationships of viral and cellular miRNAs, we first constructed a dual-fluorescent protein reporter vector system for the easy determination of miRNA function. By expressing the miRNAs and the indicator and internal control fluorescent proteins individually from a single vector, this simple reporter system can be used for miRNA functional assays that include visualizing miRNA activity in live cells. Sequence alignments indicated that the simian virus 40 (SV40) encoded miRNA sv40-mir-S1-5p contains a seed region identical to that of the human miRNA hsa-miR423-5p. Using the new reporter system, it was found that sv40-mir-S1-5p and hsa-miR423-5p downregulate the expression of common artificial target mRNAs and some predicted biological targets of hsa-miR423-5p, demonstrating that they are functional orthologs. The human immunodeficiency virus 1 (HIV-1) encoded hiv1-miR-N367 also contains a seed sequence identical to that of the human miRNA hsa-miR192. Functional assays showed that hiv1-miR-N367 and hsa-miR192 could downregulate common artificial and predicted biological targets, suggesting that these miRNAs may also act as functional orthologs. Thus, this study presents a simple and universal system for testing miRNA function and identifies two new pairs of functional orthologs, sv40-mir-S1-5p and hsa-miR423-5p as well as hiv-1-miR-N367 and hsa-miR192. These findings also expand upon our current knowledge of functional homology and imply that a more general phenomenon of orthologous relationships exists between viral and cellular miRNAs.	[You, Xiangyu; Zhang, Zhiping; Fan, Jinyu; Cui, Zongqiang; Zhang, Xian-En] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China; [You, Xiangyu] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	You, XY (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China.	czq@wh.iov.cn; x.zhang@wh.iov.cn	ZHANG, Xian-En/AAJ-5579-2021		National Nano Project [2011CB933600]; National Natural Science Foundation of China [31070774]; Chinese Academy of Sciences [XDA01020403, KJCX2-YW-M15]	National Nano Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	Z.-Q. Cui is supported by the National Nano Project (no. 2011CB933600 http://program.most.gov.cn/#) and the National Natural Science Foundation of China (no. 31070774 http://www.nsfc.gov.cn/Portal0/default152.htm). The authors also thank the support from the Chinese Academy of Sciences (no. XDA01020403 and KJCX2-YW-M15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brown BD, 2006, NAT MED, V12, P585, DOI 10.1038/nm1398; Cochrane A, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-22; Cullen BR, 2009, NATURE, V457, P421, DOI 10.1038/nature07757; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Houzet L, 2011, BBA-GENE REGUL MECH, V1809, P686, DOI 10.1016/j.bbagrm.2011.05.009; Kato Y, 2010, J BIOCHEM, V147, P63, DOI 10.1093/jb/mvp144; Kato Y, 2009, INT J BIOCHEM CELL B, V41, P2225, DOI 10.1016/j.biocel.2009.04.018; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Marsh K, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-97; Omoto S, 2005, J GEN VIROL, V86, P751, DOI 10.1099/vir.0.80449-0; Omoto Shinya, 2004, Retrovirology, V1, P44, DOI 10.1186/1742-4690-1-44; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Skalsky RL, 2007, J VIROL, V81, P12836, DOI 10.1128/JVI.01804-07; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; Tran N, 2009, BIOCHEM INSIGHTS, V2, P1; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Westerlaken JHAM, 2003, BRAIN RES, V971, P116, DOI 10.1016/S0006-8993(03)02430-2; YANG HD, 1995, MOL CELL BIOL, V15, P6770; Yeung ML, 2009, NUCLEIC ACIDS RES, V37, P6575, DOI 10.1093/nar/gkp707; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zhao YG, 2009, J VIROL, V83, P489, DOI 10.1128/JVI.01166-08	26	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36157	10.1371/journal.pone.0036157	http://dx.doi.org/10.1371/journal.pone.0036157			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558366	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336000141
J	Marazita, MC; Ogara, MF; Sonzogni, SV; Marti, M; Dusetti, NJ; Pignataro, OP; Canepa, ET				Marazita, Mariela C.; Ogara, M. Florencia; Sonzogni, Silvina V.; Marti, Marcelo; Dusetti, Nelson J.; Pignataro, Omar P.; Canepa, Eduardo T.			CDK2 and PKA Mediated-Sequential Phosphorylation Is Critical for p19INK4d Function in the DNA Damage Response	PLOS ONE			English	Article							CELL-CYCLE CHECKPOINTS; DEPENDENT KINASE CDK6; STRAND BREAK REPAIR; PROTEIN-KINASE; HOMOLOGOUS RECOMBINATION; INHIBITOR P19(INK4D); IONIZING-RADIATION; ULTRAVIOLET-LIGHT; STRUCTURAL BASIS; ATR	DNA damage triggers a phosphorylation-based signaling cascade known as the DNA damage response. p19INK4d, a member of the INK4 family of CDK4/6 inhibitors, has been reported to participate in the DNA damage response promoting DNA repair and cell survival. Here, we provide mechanistic insight into the activation mechanism of p19INK4d linked to the response to DNA damage. Results showed that p19INK4d becomes phosphorylated following UV radiation, beta-amyloid peptide and cisplatin treatments. ATM-Chk2/ATR-Chk1 signaling pathways were found to be differentially involved in p19INK4d phosphorylation depending on the type of DNA damage. Two sequential phosphorylation events at serine 76 and threonine 141 were identified using p19INK4d single-point mutants in metabolic labeling assays with P-32-orthophosphate. CDK2 and PKA were found to participate in p19INK4d phosphorylation process and that they would mediate serine 76 and threonine 141 modifications respectively. Nuclear translocation of p19INK4d induced by DNA damage was shown to be dependent on serine 76 phosphorylation. Most importantly, both phosphorylation sites were found to be crucial for p19INK4d function in DNA repair and cell survival. In contrast, serine 76 and threonine 141 were dispensable for CDK4/6 inhibition highlighting the independence of p19INK4d functions, in agreement with our previous findings. These results constitute the first description of the activation mechanism of p19INK4d in response to genotoxic stress and demonstrate the functional relevance of this activation following DNA damage.	[Marazita, Mariela C.; Ogara, M. Florencia; Sonzogni, Silvina V.; Marti, Marcelo; Canepa, Eduardo T.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Lab Biol Mol, Buenos Aires, DF, Argentina; [Dusetti, Nelson J.] INSERM, Stress Cellulaire U624, F-13258 Marseille, France; [Pignataro, Omar P.] Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, Lab Endocrinol Mol Transducc Senales, RA-1033 Buenos Aires, DF, Argentina	University of Buenos Aires; Institut National de la Sante et de la Recherche Medicale (Inserm); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine	Marazita, MC (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Lab Biol Mol, Buenos Aires, DF, Argentina.	ecanepa@qb.fcen.uba.ar	Dusetti, Nelson/O-7919-2017	Dusetti, Nelson/0000-0002-6161-8483; Canepa, Eduardo T./0000-0002-4322-1650; Sonzogni, Silvina/0000-0002-6237-6594; Marti, Marcelo/0000-0002-7911-9340	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Agencia Nacional de Promocion Cientifica y Tecnologica (ANCYPT); Universidad de Buenos Aires	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANCYPT)(ANPCyT); Universidad de Buenos Aires(University of Buenos Aires)	This work was supported by research grants from Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Agencia Nacional de Promocion Cientifica y Tecnologica (ANCYPT) and Universidad de Buenos Aires. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Akbar S, 2001, CELL MOL LIFE SCI, V58, P1708, DOI 10.1007/PL00000808; Al-Mohanna MA, 2007, NUCLEIC ACIDS RES, V35, P223, DOI 10.1093/nar/gkl1075; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Bensimon A, SCI SIGNAL, V3, prs3; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Brotherton DH, 1998, NATURE, V395, P244, DOI 10.1038/26164; Canepa ET, 2007, IUBMB LIFE, V59, P419, DOI 10.1080/15216540701488358; Cerqueira A, 2009, J CELL BIOL, V187, P773, DOI 10.1083/jcb.200903033; Ceruti JM, 2005, ONCOGENE, V24, P4065, DOI 10.1038/sj.onc.1208570; Ceruti JM, 2009, INT J BIOCHEM CELL B, V41, P1344, DOI 10.1016/j.biocel.2008.12.005; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Deans AJ, 2006, CANCER RES, V66, P8219, DOI 10.1158/0008-5472.CAN-05-3945; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Donzelli M, 2003, EMBO REP, V4, P671, DOI 10.1038/sj.embor.embor887; Gatei M, 2003, J BIOL CHEM, V278, P14806, DOI 10.1074/jbc.M210862200; Giono LE, 2007, MOL CELL BIOL, V27, P4166, DOI 10.1128/MCB.01967-06; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; HELLMICH MR, 1992, P NATL ACAD SCI USA, V89, P10867, DOI 10.1073/pnas.89.22.10867; Hickman MJ, 2004, MOL CELL, V14, P105, DOI 10.1016/S1097-2765(04)00162-5; Hiromura K, 2002, ONCOGENE, V21, P1750, DOI 10.1038/sj.onc.1205238; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Jiang KC, 2003, J BIOL CHEM, V278, P25207, DOI 10.1074/jbc.M300070200; Jung CG, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-47; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Lew DJ, 1996, CURR OPIN CELL BIOL, V8, P795, DOI 10.1016/S0955-0674(96)80080-9; Liu QH, 2000, GENE DEV, V14, P1448; Lobrich M, 2007, NAT REV CANCER, V7, P861, DOI 10.1038/nrc2248; Lukas J, 2004, DNA REPAIR, V3, P997, DOI 10.1016/j.dnarep.2004.03.006; Maddika S, 2008, J CELL SCI, V121, P979, DOI 10.1242/jcs.009530; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; Muller-Tidow C, 2004, MOL CELL BIOL, V24, P8917, DOI 10.1128/MCB.24.20.8917-8928.2004; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ortega S, 2002, BBA-REV CANCER, V1602, P73, DOI 10.1016/S0304-419X(02)00037-9; Pei XH, 2005, ONCOGENE, V24, P2787, DOI 10.1038/sj.onc.1208611; Renner C, 1998, J MOL BIOL, V283, P221, DOI 10.1006/jmbi.1998.2079; Russo AA, 1998, NATURE, V395, P237, DOI 10.1038/26155; Sarkaria JN, 1998, CANCER RES, V58, P4375; Scassa ME, 2007, DNA REPAIR, V6, P626, DOI 10.1016/j.dnarep.2006.12.003; Schnoke M, 2009, BONE, V45, P590, DOI 10.1016/j.bone.2009.05.006; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shell SM, 2009, J BIOL CHEM, V284, P24213, DOI 10.1074/jbc.M109.000745; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shiotani B, 2009, MOL CELL, V33, P547, DOI 10.1016/j.molcel.2009.01.024; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Tavera-Mendoza LE, 2006, CELL CYCLE, V5, P596, DOI 10.4161/cc.5.6.2585; Thullberg M, 2000, FEBS LETT, V470, P161, DOI 10.1016/S0014-5793(00)01307-7; Tortora G, 2002, ANN NY ACAD SCI, V968, P139, DOI 10.1111/j.1749-6632.2002.tb04332.x; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	61	17	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35638	10.1371/journal.pone.0035638	http://dx.doi.org/10.1371/journal.pone.0035638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558186	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345200059
J	Perkins, BA; Rabbani, N; Weston, A; Ficociello, LH; Adaikalakoteswari, A; Niewczas, M; Warram, J; Krolewski, AS; Thornalley, P				Perkins, Bruce A.; Rabbani, Naila; Weston, Andrew; Ficociello, Linda H.; Adaikalakoteswari, Antonysunil; Niewczas, Monika; Warram, James; Krolewski, Andrzej S.; Thornalley, Paul			Serum Levels of Advanced Glycation Endproducts and Other Markers of Protein Damage in Early Diabetic Nephropathy in Type 1 Diabetes	PLOS ONE			English	Article							RENAL-FUNCTION DECLINE; DEGRADATION-PRODUCTS; END-PRODUCTS; MICROALBUMINURIA; COMPLICATIONS; RISK; MELLITUS; ALBUMIN; CARBOXYMETHYLLYSINE; OXIDATION	Objective: To determine the role of markers of plasma protein damage by glycation, oxidation and nitration in microalbuminuria onset or subsequent decline of glomerular filtration rate (termed "early GFR decline") in patients with type 1 diabetes. Methods: From the 1st Joslin Kidney Study, we selected 30 patients with longstanding normoalbuminuria and 55 patients with new onset microalbuminuria. Patients with microalbuminuria had 8-12 years follow-up during which 33 had stable GFR and 22 early GFR decline. Mean baseline GFR(CYSTATIN C) was similar between the three groups. Glycation, oxidation and nitration markers were measured in protein and ultrafiltrate at baseline by liquid chromatography-tandem mass spectrometry using the most reliable methods currently available. Results: Though none were significantly different between patients with microalbuminuria with stable or early GFR decline, levels of 6 protein damage adduct residues of plasma protein and 4 related free adducts of plasma ultrafiltrate were significantly different in patients with microalbuminuria compared to normoalbuminuria controls. Three protein damage adduct residues were decreased and 3 increased in microalbuminuria while 3 free adducts were decreased and one increased in microalbuminuria. The most profound differences were of N-formylkynurenine (NFK) protein adduct residue and N-omega-carboxymethylarginine (CMA) free adduct in which levels were markedly lower in microalbuminuria (P<0.001 for both). Conclusions: Complex processes influence levels of plasma protein damage and related proteolysis product free adducts in type 1 diabetes and microalbuminuria. The effects observed point to the possibility that patients who have efficient mechanisms of disposal of damaged proteins might be at an increased risk of developing microalbuminuria but not early renal function decline. The findings support the concept that the mechanisms responsible for microalbuminuria may differ from the mechanisms involved in the initiation of early renal function decline.	[Perkins, Bruce A.] Univ Toronto, Div Endocrinol, Toronto, ON, Canada; [Rabbani, Naila; Weston, Andrew; Adaikalakoteswari, Antonysunil; Thornalley, Paul] Univ Warwick, Warwick Med Sch, Clin Sci Res Inst, Coventry CV4 7AL, W Midlands, England; [Ficociello, Linda H.; Niewczas, Monika; Warram, James; Krolewski, Andrzej S.] Joslin Diabet Ctr, Sect Genet & Epidemiol, Boston, MA 02215 USA	University of Toronto; University of Warwick; Harvard University; Joslin Diabetes Center, Inc.	Perkins, BA (corresponding author), Univ Toronto, Div Endocrinol, Toronto, ON, Canada.	bruce.perkins@uhn.on.ca	Perkins, Bruce A/L-3726-2017	Thornalley, Paul/0000-0001-7659-443X; Rabbani, Naila/0000-0002-5819-2506; Ficociello, Linda/0000-0003-3523-0028	National Institutes of Health [DK041526, DK067638]; Joslin Diabetes Center; Banting and Best Diabetes Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041526, R01DK067638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joslin Diabetes Center; Banting and Best Diabetes Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by National Institutes of Health grants DK041526, DK067638 (to AK) and the Joslin Diabetes Center. BAP was a Canadian Diabetes Association Scholar and was supported by the Banting and Best Diabetes Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalou S, 2005, J AM SOC NEPHROL, V16, P1471, DOI 10.1681/ASN.2004080635; Ahmed N, 2007, DIABETES OBES METAB, V9, P233, DOI 10.1111/j.1463-1326.2006.00595.x; Ahmed N, 2002, BIOCHEM J, V364, P1; Ahmed N, 2005, DIABETOLOGIA, V48, P1590, DOI 10.1007/s00125-005-1810-7; Ahmed N, 2004, J HEPATOL, V41, P913, DOI 10.1016/j.jhep.2004.08.007; Ames JM, 2007, MOL NUTR FOOD RES, V51, P1085, DOI 10.1002/mnfr.200600304; BEISSWENGER PJ, 1995, DIABETES, V44, P824, DOI 10.2337/diabetes.44.7.824; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; CHA T, 1991, DIABETES RES CLIN PR, V12, P149, DOI 10.1016/0168-8227(91)90071-K; de Boer IH, 2011, ARCH INTERN MED, V171, P412, DOI 10.1001/archinternmed.2011.16; Ficociello LH, 2010, DIABETES CARE, V33, P1337, DOI 10.2337/dc10-0227; GARLICK RL, 1984, J CLIN INVEST, V74, P1742, DOI 10.1172/JCI111592; Genuth S, 2005, DIABETES, V54, P3103, DOI 10.2337/diabetes.54.11.3103; Goh SY, 2008, J CLIN ENDOCR METAB, V93, P1143, DOI 10.1210/jc.2007-1817; Karachalias N, 2010, DIABETOLOGIA, V53, P1506, DOI 10.1007/s00125-010-1722-z; KROLEWSKI AS, 1995, NEW ENGL J MED, V332, P1251, DOI 10.1056/NEJM199505113321902; LIARDON R, 1987, J AGR FOOD CHEM, V35, P427, DOI 10.1021/jf00075a035; MacIsaac RJ, 2006, DIABETOLOGIA, V49, P1686, DOI 10.1007/s00125-006-0275-7; MCCANCE DR, 1993, J CLIN INVEST, V91, P2470, DOI 10.1172/JCI116482; Merchant ML, 2009, J AM SOC NEPHROL, V20, P2065, DOI 10.1681/ASN.2008121233; Miura J, 2003, J DIABETES COMPLICAT, V17, P16, DOI 10.1016/S1056-8727(02)00183-6; MOGENSEN CE, 1984, NEW ENGL J MED, V311, P89, DOI 10.1056/NEJM198407123110204; PARVING HH, 1982, ACTA ENDOCRINOL-COP, V100, P550, DOI 10.1530/acta.0.1000550; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Perkins BA, 2003, NEW ENGL J MED, V348, P2285, DOI 10.1056/NEJMoa021835; Perkins BA, 2007, J AM SOC NEPHROL, V18, P1353, DOI 10.1681/ASN.2006080872; Perkins Bruce A, 2005, Curr Diab Rep, V5, P455, DOI 10.1007/s11892-005-0055-7; Perkins BA, 2010, KIDNEY INT, V77, P57, DOI 10.1038/ki.2009.399; Rabbani N, 2009, DIABETOLOGIA, V52, P208, DOI 10.1007/s00125-008-1224-4; Rabbani N, 2007, KIDNEY INT, V72, P1113, DOI 10.1038/sj.ki.5002513; Rabbani N, 2011, AMINO ACIDS IN PRESS; Rosolowsky ET, 2011, J AM SOC NEPHROL, V22, P545, DOI 10.1681/ASN.2010040354; Russo LM, 2002, AM J KIDNEY DIS, V39, P899, DOI 10.1053/ajkd.2002.32764; Scott LJ, 2001, DIABETES, V50, P2842, DOI 10.2337/diabetes.50.12.2842; Sun JK, 2011, DIABETES CARE, V34, P968, DOI 10.2337/dc10-1675; Thornalley P.J., 2006, REDOX PROTEOMICS PRO, P681; Thornalley PJ, 2003, BIOCHEM J, V375, P581, DOI 10.1042/BJ20030763; VIBERTI GC, 1982, LANCET, V1, P1430; Williams ME, 2005, AM J NEPHROL, V25, P77, DOI 10.1159/000084286; Wolkow PP, 2008, J AM SOC NEPHROL, V19, P789, DOI 10.1681/ASN.2007050556	40	38	43	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35655	10.1371/journal.pone.0035655	http://dx.doi.org/10.1371/journal.pone.0035655			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558190	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000305345200062
J	Pitzalis, S; Strappini, F; De Gasperis, M; Bultrini, A; Di Russo, F				Pitzalis, Sabrina; Strappini, Francesca; De Gasperis, Marco; Bultrini, Alessandro; Di Russo, Francesco			Spatio-Temporal Brain Mapping of Motion-Onset VEPs Combined with fMRI and Retinotopic Maps	PLOS ONE			English	Article							FUNCTIONAL MAGNETIC-RESONANCE; HUMAN VISUAL-CORTEX; SURFACE-BASED ANALYSIS; CORTICAL AREA; SPEED DISCRIMINATION; SUPERIOR COLLICULUS; EVOKED-POTENTIALS; RESPONSES; IDENTIFICATION; REPRESENTATION	Neuroimaging studies have identified several motion-sensitive visual areas in the human brain, but the time course of their activation cannot be measured with these techniques. In the present study, we combined electrophysiological and neuroimaging methods (including retinotopic brain mapping) to determine the spatio-temporal profile of motion-onset visual evoked potentials for slow and fast motion stimuli and to localize its neural generators. We found that cortical activity initiates in the primary visual area (V1) for slow stimuli, peaking 100 ms after the onset of motion. Subsequently, activity in the mid-temporal motion-sensitive areas, MT+, peaked at 120 ms, followed by peaks in activity in the more dorsal area, V3A, at 160 ms and the lateral occipital complex at 180 ms. Approximately 250 ms after stimulus onset, activity fast motion stimuli was predominant in area V6 along the parieto-occipital sulcus. Finally, at 350 ms (100 ms after the motion offset) brain activity was visible again in area V1. For fast motion stimuli, the spatio-temporal brain pattern was similar, except that the first activity was detected at 70 ms in area MT+. Comparing functional magnetic resonance data for slow vs. fast motion, we found signs of slow-fast motion stimulus topography along the posterior brain in at least three cortical regions (MT+, V3A and LOR).	[Pitzalis, Sabrina; De Gasperis, Marco; Bultrini, Alessandro; Di Russo, Francesco] Univ Rome Foro Italico, Dept Educ Sci Motor Act & Sport, Rome, Italy; [Pitzalis, Sabrina; Strappini, Francesca; Di Russo, Francesco] IRCCS, Santa Lucia Fdn, Neuropsychol Ctr, Rome, Italy	Foro Italico University of Rome; IRCCS Santa Lucia	Pitzalis, S (corresponding author), Univ Rome Foro Italico, Dept Educ Sci Motor Act & Sport, Rome, Italy.	francesco.dirusso@uniroma4.it	Di Russo, Francesco/N-6686-2015; Pitzalis, Sabrina/AAA-9406-2019	Di Russo, Francesco/0000-0002-3127-9433; Strappini, Francesca/0000-0002-4371-6995; pitzalis, sabrina/0000-0002-4445-0391	University of Rome "Foro Italico" grant [RIC992009]; IRCCS Santa Lucia Foundation	University of Rome "Foro Italico" grant; IRCCS Santa Lucia Foundation	This research was supported by the University of Rome "Foro Italico" grant RIC992009 and the IRCCS Santa Lucia Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlfors SP, 1999, J NEUROPHYSIOL, V82, P2545, DOI 10.1152/jn.1999.82.5.2545; Aine CJ, 1996, CEREB CORTEX, V6, P354, DOI 10.1093/cercor/6.3.354; Berman RA, 2010, J NEUROSCI, V30, P6342, DOI 10.1523/JNEUROSCI.6176-09.2010; Bocker Koen B. E., 1994, Brain Topography, V7, P71, DOI 10.1007/BF01184839; Bonmassar G, 2001, NEUROIMAGE, V13, P1035, DOI 10.1006/nimg.2001.0754; Buchner H, 1997, NEUROREPORT, V8, P2419, DOI 10.1097/00001756-199707280-00002; Castriota-Scanderbeg A, 2005, NEUROIMAGE, V25, P570, DOI 10.1016/j.neuroimage.2004.11.045; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dale AM, 2001, CURR OPIN NEUROBIOL, V11, P202, DOI 10.1016/S0959-4388(00)00197-5; DEVRIES M, 1989, ELECTROEN CLIN NEURO, V74, P81, DOI 10.1016/0168-5597(89)90012-9; Di Russo F, 2005, NEUROIMAGE, V24, P874, DOI 10.1016/j.neuroimage.2004.09.029; Di Russo F, 2003, CEREB CORTEX, V13, P486, DOI 10.1093/cercor/13.5.486; Di Russo F, 2002, HUM BRAIN MAPP, V15, P95, DOI 10.1002/hbm.10010; Di Russo F, 2007, HUM BRAIN MAPP, V28, P323, DOI 10.1002/hbm.20276; Di Russo F, 2012, HUM BRAIN MAPP, V33, P1334, DOI 10.1002/hbm.21285; DUCATI A, 1988, ELECTROEN CLIN NEURO, V71, P89, DOI 10.1016/0168-5597(88)90010-X; Fattori P, 2009, J PHYSIOL-PARIS, V103, P88, DOI 10.1016/j.jphysparis.2009.05.012; ffytche DH, 1995, BRAIN, V118, P1375, DOI 10.1093/brain/118.6.1375; Ffytche DH, 1996, BRAIN, V119, P1971, DOI 10.1093/brain/119.6.1971; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; FRISTON KJ, 1995, NEUROIMAGE, V2, P157, DOI 10.1006/nimg.1995.1018; Galati G, 2008, NEUROIMAGE, V40, P1274, DOI 10.1016/j.neuroimage.2007.12.044; Galati G, 2011, EUR J NEUROSCI, V34, P1871, DOI 10.1111/j.1460-9568.2011.07885.x; Galletti C, 2001, EUR J NEUROSCI, V13, P1572, DOI 10.1046/j.0953-816x.2001.01538.x; Gratton G, 2001, HUM BRAIN MAPP, V13, P13, DOI 10.1002/hbm.1021; Grefkes C, 2004, NEUROIMAGE, V23, P1494, DOI 10.1016/j.neuroimage.2004.08.031; GROSS CG, 1991, NEUROPSYCHOLOGIA, V29, P497, DOI 10.1016/0028-3932(91)90007-U; Hagler DJ, 2007, NEUROIMAGE, V35, P1562, DOI 10.1016/j.neuroimage.2007.01.033; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Huk AC, 2000, J NEUROPHYSIOL, V83, P3525, DOI 10.1152/jn.2000.83.6.3525; Ionta S, 2011, NEURON, V70, P363, DOI 10.1016/j.neuron.2011.03.009; JEFFREYS DA, 1972, EXP BRAIN RES, V16, P1; Kuba M, 2007, VISION RES, V47, P189, DOI 10.1016/j.visres.2006.09.020; Larsson J, 2006, J NEUROSCI, V26, P13128, DOI 10.1523/JNEUROSCI.1657-06.2006; Laycock R, 2007, J NEUROPHYSIOL, V98, P1253, DOI 10.1152/jn.00416.2007; Liu J, 2006, J NEUROSCI, V26, P7779, DOI 10.1523/JNEUROSCI.5052-05.2006; Liu JJ, 2005, J NEUROSCI, V25, P3459, DOI 10.1523/JNEUROSCI.4206-04.2005; Lorteije JAM, 2008, EUR J NEUROSCI, V27, P2341, DOI 10.1111/j.1460-9568.2008.06193.x; MALONEK D, 1994, P ROY SOC B-BIOL SCI, V258, P109, DOI 10.1098/rspb.1994.0150; Mangun GR, 2001, VISION RES, V41, P1423, DOI 10.1016/S0042-6989(01)00046-3; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; McKeefry DJ, 2008, J NEUROSCI, V28, P6848, DOI 10.1523/JNEUROSCI.1287-08.2008; Morrone MC, 2000, NAT NEUROSCI, V3, P1322, DOI 10.1038/81860; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Nover H, 2005, J NEUROSCI, V25, P10049, DOI 10.1523/JNEUROSCI.1661-05.2005; ORBAN GA, 1995, EUR J NEUROSCI, V7, P2261, DOI 10.1111/j.1460-9568.1995.tb00647.x; Pitzalis S, 2010, CEREB CORTEX, V20, P411, DOI 10.1093/cercor/bhp112; Pitzalis S, 2006, J NEUROSCI, V26, P7962, DOI 10.1523/JNEUROSCI.0178-06.2006; Priebe NJ, 2004, J NEUROSCI, V24, P1907, DOI 10.1523/JNEUROSCI.4233-03.2004; PROBST T, 1993, EXP BRAIN RES, V93, P345; Rosa MJ, 2010, J INTEGR NEUROSCI, V9, P453, DOI 10.1142/S0219635210002512; Schellart NAM, 2004, VISION RES, V44, P119, DOI 10.1016/j.visres.2003.09.016; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Schoenfeld MA, 2002, NEUROIMAGE, V17, P769, DOI 10.1006/nimg.2002.1204; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Sereno MI, 2001, SCIENCE, V294, P1350, DOI 10.1126/science.1063695; Sincich LC, 2004, NAT NEUROSCI, V7, P1123, DOI 10.1038/nn1318; Smith AT, 2006, EUR J NEUROSCI, V23, P561, DOI 10.1111/j.1460-9568.2005.04526.x; Smith AT, 1998, J NEUROSCI, V18, P3816; SNYDER AZ, 1995, P NATL ACAD SCI USA, V92, P1689, DOI 10.1073/pnas.92.5.1689; Sunaert S, 2000, NEUROIMAGE, V11, P612, DOI 10.1006/nimg.2000.0587; Swisher JD, 2007, J NEUROSCI, V27, P5326, DOI 10.1523/JNEUROSCI.0991-07.2007; Tootell RBH, 2001, CEREB CORTEX, V11, P298, DOI 10.1093/cercor/11.4.298; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Tootell RBH, 1997, J NEUROSCI, V17, P7060; van Boxtel JJA, 2006, VISION RES, V46, P4634, DOI 10.1016/j.visres.2006.06.015; van de Grind WA, 2001, P ROY SOC B-BIOL SCI, V268, P437, DOI 10.1098/rspb.2000.1380; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Vanni S, 2004, NEUROIMAGE, V21, P801, DOI 10.1016/j.neuroimage.2003.10.047; VanOostende S, 1997, CEREB CORTEX, V7, P690, DOI 10.1093/cercor/7.7.690; Wall MB, 2008, CURR BIOL, V18, P191, DOI 10.1016/j.cub.2007.12.053	73	34	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35771	10.1371/journal.pone.0035771	http://dx.doi.org/10.1371/journal.pone.0035771			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558222	Green Published, gold			2022-12-27	WOS:000305345200077
J	Babirye, JN; Engebretsen, IMS; Makumbi, F; Fadnes, LT; Wamani, H; Tylleskar, T; Nuwaha, F				Babirye, Juliet N.; Engebretsen, Ingunn M. S.; Makumbi, Frederick; Fadnes, Lars T.; Wamani, Henry; Tylleskar, Thorkild; Nuwaha, Fred			Timeliness of Childhood Vaccinations in Kampala Uganda: A Community-Based Cross-Sectional Study	PLOS ONE			English	Article							IMMUNIZATION COVERAGE; CHILDREN; FAILURE; DECADE; STATES; KENYA; AGE	Background: Child survival is dependent on several factors including high vaccination coverage. Timely receipt of vaccines ensures optimal immune response to the vaccines. Yet timeliness is not usually emphasized in estimating population immunity. In addition to examining timeliness of the recommended Expanded Programme for Immunisation (EPI) vaccines, this paper identifies predictors of untimely vaccination among children aged 10 to 23 months in Kampala. Methods: In addition to the household survey interview questions, additional data sources for variables included data collection of child's weight and length. Vaccination dates were obtained from child health cards. Timeliness of vaccinations were assessed with Kaplan-Meier time-to-event analysis for each vaccine based on the following time ranges (lowest-highest target age): BCG (birth-8 weeks), polio 0 (birth-4 weeks), three polio and three pentavalent vaccines (4 weeks-2 months; 8 weeks-4 months; 12 weeks-6 months) and measles vaccine (38 weeks-12 months). Cox regression analysis was used to identify factors associated with vaccination timeliness. Results: About half of 821 children received all vaccines within the recommended time ranges (45.6%; 95% CI 39.8-51.2). Timely receipt of vaccinations was lowest for measles (67.5%; 95% CI 60.5-73.8) and highest for BCG vaccine (92.7%: 95% CI 88.1-95.6). For measles, 10.7% (95% CI 6.8-16.4) of the vaccinations were administered earlier than the recommended time. Vaccinations that were not received within the recommended age ranges were associated with increasing number of children per woman (adjusted hazard ratio (AHR); 1.84, 95% CI 1.29-2.64), non-delivery at health facilities (AHR 1.58, 95% CI 1.02-2.46), being unmarried (AHR 1.49, 95% CI 1.15-1.94) or being in the lowest wealth quintile (AHR 1.38, 95% CI 1.11-1.72). Conclusions: Strategies to improve vaccination practices among the poorest, single, multiparous women and among mothers who do not deliver at health facilities are necessary to improve timeliness of vaccinations.	[Babirye, Juliet N.; Makumbi, Frederick; Wamani, Henry; Nuwaha, Fred] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda; [Babirye, Juliet N.; Engebretsen, Ingunn M. S.; Fadnes, Lars T.; Tylleskar, Thorkild] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Engebretsen, Ingunn M. S.] Haukeland Hosp, Dept Child & Adolescent Psychiat, N-5021 Bergen, Norway	Makerere University; University of Bergen; University of Bergen; Haukeland University Hospital	Babirye, JN (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda.	jnbabirye@yahoo.co.uk	Engebretsen, Ingunn Marie S/N-5692-2017; Fadnes, Lars T/E-9086-2016; Tylleskär, Thorkild/S-5529-2017; Fadnes, Lars T/AAA-8691-2021	Engebretsen, Ingunn Marie S/0000-0001-5852-3611; Fadnes, Lars T/0000-0001-8757-2092; Tylleskär, Thorkild/0000-0003-4801-4324; 	Research Council of Norway [185777]	Research Council of Norway(Research Council of Norway)	This study was part of the mVAC project NFR no. 185777 (GlobVac programme: The programme for Global Health and Vaccination Research) funded by the Research Council of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akmatov MK, 2008, VACCINE, V26, P3805, DOI 10.1016/j.vaccine.2008.05.031; Babirye JN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-723; BENNETT S, 1991, World Health Statistics Quarterly, V44, P98; Bloom DE, 2011, ADV EXP MED BIOL, V697, P1, DOI 10.1007/978-1-4419-7185-2_1; Bloom DE, 2005, ADV HEALTH, V16, P371; Burgess DC, 2006, VACCINE, V24, P3921, DOI 10.1016/j.vaccine.2006.02.033; Clark A, 2009, LANCET, V373, P1543, DOI 10.1016/S0140-6736(09)60317-2; Fadnes LT, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-404; Fadnes LT, 2011, VACCINE, V29, P3564, DOI 10.1016/j.vaccine.2011.02.093; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Garza Cutberto, 2004, Food Nutr Bull, V25, pS5; HMIS, 2007, KAMP DISTR PROF ANN; Levine OS, 2011, LANCET, V378, P439, DOI 10.1016/S0140-6736(11)60406-6; Luman ET, 2009, AM J PREV MED, V36, P105, DOI 10.1016/j.amepre.2008.09.035; Luman ET, 2005, JAMA-J AM MED ASSOC, V293, P1204, DOI 10.1001/jama.293.10.1204; Mbabazi WB, 2009, HEALTH POLICY PLANN, V24, P261, DOI 10.1093/heapol/czp008; Moxon ER, 2011, LANCET, V378, P348, DOI 10.1016/S0140-6736(11)60407-8; Mupere E, 2006, VACCINE, V24, P4111, DOI 10.1016/j.vaccine.2006.02.038; Mutua MK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-6; Nankabirwa V, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-92; Ndiritu M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-132; Rahman M, 2010, SALUD PUBLICA MEXICO, V52, P134; Sadoh AE, 2009, J HEALTH POPUL NUTR, V27, P391; Takum T, 2011, J TROP PEDIATRICS, V57, P251, DOI 10.1093/tropej/fmq086; Uganda Bureau of Statistics (UBOS) ICF International, 2006, UG DEM HLTH SURV 200; Uganda government, 2008, UG BUR STAT SUBN PRO, P5; United Nations Inter-agency Group for Child Mortality Estimation Levels & Trends in Child Mortality, 2011, LEV TRENDS CHILD MOR; World Health Organization, 2009, STAT WORLDS VACC IMM; World Health Organization, 1995, PHYS STAT US INT ANT	29	82	84	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35432	10.1371/journal.pone.0035432	http://dx.doi.org/10.1371/journal.pone.0035432			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UP	22539972	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341000037
J	Chen, MF; Gutierrez, GJ; Ronai, ZA				Chen, Meifan; Gutierrez, Gustavo J.; Ronai, Ze'ev A.			The Anaphase-Promoting Complex or Cyclosome Supports Cell Survival in Response to Endoplasmic Reticulum Stress	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; CYCLE ARREST; DNA-DAMAGE; DEGRADATION; KINASE; INHIBITOR; APOPTOSIS; CDH1; ER; PHOSPHORYLATION	The anaphase-promoting complex or cyclosome (APC/C) is a multi-subunit ubiquitin ligase that regulates exit from mitosis and G1 phase of the cell cycle. Although the regulation and function of APC/C-Cdh1 in the unperturbed cell cycle is well studied, little is known of its role in non-genotoxic stress responses. Here, we demonstrate the role of APC/C-Cdh1 (APC/C activated by Cdh1 protein) in cellular protection from endoplasmic reticulum (ER) stress. Activation of APC/C-Cdh1 under ER stress conditions is evidenced by Cdh1-dependent degradation of its substrates. Importantly, the activity of APC/C-Cdh1 maintains the ER stress checkpoint, as depletion of Cdh1 by RNAi impairs cell cycle arrest and accelerates cell death following ER stress. Our findings identify APC/C-Cdh1 as a regulator of cell cycle checkpoint and cell survival in response to proteotoxic insults.	[Chen, Meifan; Gutierrez, Gustavo J.; Ronai, Ze'ev A.] Sanford Burnham Med Res Inst, Signal Transduct Program, La Jolla, CA USA	Sanford Burnham Prebys Medical Discovery Institute	Chen, MF (corresponding author), Sanford Burnham Med Res Inst, Signal Transduct Program, La Jolla, CA USA.	ronai@smbri.org	Gutierrez, Gustavo/AAO-9957-2021; Gutierrez, Gustavo/B-6771-2013	Gutierrez, Gustavo/0000-0001-8652-972X; Gutierrez, Gustavo/0000-0003-4133-5002; Chen, Meifan/0000-0002-4190-4001; RONAI, ZEEV/0000-0002-3859-0400	National Cancer Institute [CA78419]; NATIONAL CANCER INSTITUTE [R01CA078419, T32CA077109, R01CA138143] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant CA78419 (to ZR) from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agami R, 2000, CELL, V102, P55, DOI 10.1016/S0092-8674(00)00010-6; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Brewer JW, 1999, P NATL ACAD SCI USA, V96, P8505, DOI 10.1073/pnas.96.15.8505; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen M, P NATL ACAD SCI US, V108, P9119; Crasta K, 2008, NAT CELL BIOL, V10, P665, DOI 10.1038/ncb1729; Gutierrez GJ, NAT CELL BIOL, V12, P686; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Jeganathan KB, 2005, NATURE, V438, P1036, DOI 10.1038/nature04221; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Listovsky T, 2004, EMBO J, V23, P1619, DOI 10.1038/sj.emboj.7600149; Liu WJ, 2008, CARCINOGENESIS, V29, P263, DOI 10.1093/carcin/bgm251; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Miller JJ, 2006, GENE DEV, V20, P2410, DOI 10.1101/gad.1454006; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Ohoka N, BIOCH BIOPHYS RES CO, V392, P289; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Raven JF, 2008, J BIOL CHEM, V283, P3097, DOI 10.1074/jbc.M709677200; Reimann JDR, 2001, GENE DEV, V15, P3278, DOI 10.1101/gad.945701; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; SHI L, 1994, SCIENCE, V263, P1143, DOI 10.1126/science.8108732; Simpson-Lavy KJ, 2009, CELL CYCLE, V8, P3003; Sudo T, 2001, EMBO J, V20, P6499, DOI 10.1093/emboj/20.22.6499; TEWARI M, 1995, J IMMUNOL, V154, P1699; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zhang F, 2006, J BIOL CHEM, V281, P30036, DOI 10.1074/jbc.M604674200; Zhou Y, 2003, J BIOL CHEM, V278, P12530, DOI 10.1074/jbc.M212853200	40	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35520	10.1371/journal.pone.0035520	http://dx.doi.org/10.1371/journal.pone.0035520			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539978	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341000044
J	Ullrich, T; Ermantraut, E; Schulz, T; Steinmetzer, K				Ullrich, Thomas; Ermantraut, Eugen; Schulz, Torsten; Steinmetzer, Katrin			Competitive Reporter Monitored Amplification (CMA) - Quantification of Molecular Targets by Real Time Monitoring of Competitive Reporter Hybridization	PLOS ONE			English	Article							RT-PCR; SENSITIVE DETECTION; CLINICAL MICROBIOLOGY; REVERSE-TRANSCRIPTION; INTERNAL CONTROL; ARMORED RNA; DEVICE; HIV-1; ARRAY; ASSAY	Background: State of the art molecular diagnostic tests are based on the sensitive detection and quantification of nucleic acids. However, currently established diagnostic tests are characterized by elaborate and expensive technical solutions hindering the development of simple, affordable and compact point-of-care molecular tests. Methodology and Principal Findings: The described competitive reporter monitored amplification allows the simultaneous amplification and quantification of multiple nucleic acid targets by polymerase chain reaction. Target quantification is accomplished by real-time detection of amplified nucleic acids utilizing a capture probe array and specific reporter probes. The reporter probes are fluorescently labeled oligonucleotides that are complementary to the respective capture probes on the array and to the respective sites of the target nucleic acids in solution. Capture probes and amplified target compete for reporter probes. Increasing amplicon concentration leads to decreased fluorescence signal at the respective capture probe position on the array which is measured after each cycle of amplification. In order to observe reporter probe hybridization in real-time without any additional washing steps, we have developed a mechanical fluorescence background displacement technique. Conclusions and Significance: The system presented in this paper enables simultaneous detection and quantification of multiple targets. Moreover, the presented fluorescence background displacement technique provides a generic solution for real time monitoring of binding events of fluorescently labelled ligands to surface immobilized probes. With the model assay for the detection of human immunodeficiency virus type 1 and 2 (HIV 1/2), we have been able to observe the amplification kinetics of five targets simultaneously and accommodate two additional hybridization controls with a simple instrument set-up. The ability to accommodate multiple controls and targets into a single assay and to perform the assay on simple and robust instrumentation is a prerequisite for the development of novel molecular point of care tests.	[Ullrich, Thomas; Ermantraut, Eugen; Schulz, Torsten; Steinmetzer, Katrin] Alere Technol GmbH, Jena, Germany	Alere	Ullrich, T (corresponding author), Alere Technol GmbH, Jena, Germany.	Thomas.Ullrich@clondiag.com		Ermantraut, Eugen/0000-0001-6876-0565	research and development grant of the Free State of Thuringia [2008-FE-0039]	research and development grant of the Free State of Thuringia	This work was supported by a research and development grant of the Free State of Thuringia (2008-FE-0039). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RC, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e60; Anthony R M, 2001, Expert Rev Mol Diagn, V1, P30, DOI 10.1586/14737159.1.1.30; Applied Biosystems, 2006, APPL NOT APPL BIOS, P1; Avettand-Fenol V, 2009, J MED VIROL, V81, P217, DOI 10.1002/jmv.21390; Benjamin RJ, 2001, SEMIN HEMATOL, V38, P11, DOI 10.1053/shem.2001.28829; Bienvenue JM, 2010, FORENSIC SCI INT-GEN, V4, P178, DOI 10.1016/j.fsigen.2009.02.010; Brightwell C, 1998, MOL CELL PROBE, V12, P367, DOI 10.1006/mcpr.1998.0195; Christopherson C, 1998, ANTIVIR THER, V3, P247; Cirino N.M, 2007, REAL TIME PCR MICROB, P183; Claas E. C. J., 2007, Real-time PCR in microbiology: from diagnosis to characterization, P231; Collins RA, 2003, BIOCHEM BIOPH RES CO, V300, P507, DOI 10.1016/S0006-291X(02)02896-6; Curtis KA, 2008, J VIROL METHODS, V151, P264, DOI 10.1016/j.jviromet.2008.04.011; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; Ferns RB, 2006, J VIROL METHODS, V135, P102, DOI 10.1016/j.jviromet.2006.02.005; Finan JE, 2007, PHARMACOGENOMICS, V8, P85, DOI 10.2217/14622416.8.1.85; Hadd AG, 2005, EXPERT REV MOL DIAGN, V5, P409, DOI 10.1586/14737159.5.3.409; Han SH, 2008, J INVERTEBR PATHOL, V99, P8, DOI 10.1016/j.jip.2008.04.010; Hofmann WP, 2005, J CLIN VIROL, V32, P289, DOI 10.1016/j.jcv.2004.08.011; Kashanchi F, 1997, J MED VIROL, V52, P179, DOI 10.1002/(SICI)1096-9071(199706)52:2&lt;179::AID-JMV11&gt;3.0.CO;2-G; Lamhoujeb S, 2009, CAN J MICROBIOL, V55, P1375, DOI 10.1139/W09-105; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Ling MM, 2007, EXPERT REV MOL DIAGN, V7, P87, DOI 10.1586/14737159.7.1.87; Liu HP, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj006; Liu RH, 2006, ANAL CHEM, V78, P1980, DOI 10.1021/ac0518553; Liu RH, 2006, ANAL CHEM, V78, P4184, DOI 10.1021/ac060450v; Mackay IM, 2004, CLIN MICROBIOL INFEC, V10, P190, DOI 10.1111/j.1198-743X.2004.00722.x; Miller MB, 2009, CLIN MICROBIOL REV, V22, P611, DOI 10.1128/CMR.00019-09; Mrotzek G, 2010, J VIROL METHODS, V168, P262, DOI 10.1016/j.jviromet.2010.05.010; Muska A., 2007, REAL TIME PCR MICROB, P101; Neuzil P, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl416; Pasloske BL, 1998, J CLIN MICROBIOL, V36, P3590, DOI 10.1128/JCM.36.12.3590-3594.1998; Pau CP, 2010, J VIROL METHODS, V164, P55, DOI 10.1016/j.jviromet.2009.11.027; Rebrikov DV, 2006, APPL BIOCHEM MICROB, V42, P520; Saha BK, 2001, J VIROL METHODS, V93, P33, DOI 10.1016/S0166-0934(00)00288-3; SODERLUND H, 1990, ANN BIOL CLIN-PARIS, V48, P489; Stals A, 2009, J MICROBIOL METH, V77, P72, DOI 10.1016/j.mimet.2009.01.018; Stevenson J, 2008, J VIROL METHODS, V150, P73, DOI 10.1016/j.jviromet.2008.02.007; Stranska R, 2004, J CLIN VIROL, V30, P39, DOI 10.1016/j.jcv.2003.08.006; Tang JF, 2009, DIAGN MICR INFEC DIS, V65, P372, DOI 10.1016/j.diagmicrobio.2009.07.017; Valentine-Thon E, 2002, J CLIN VIROL, V25, pS13; Zhao WA, 2008, ANGEW CHEM INT EDIT, V47, P6330, DOI 10.1002/anie.200705982	41	14	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35438	10.1371/journal.pone.0035438	http://dx.doi.org/10.1371/journal.pone.0035438			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539973	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341000038
J	Yamanaka, D; Tamiya, Y; Motoi, M; Ishibashi, K; Miura, NN; Adachi, Y; Ohno, N				Yamanaka, Daisuke; Tamiya, Yumi; Motoi, Masuro; Ishibashi, Ken-ichi; Miura, Noriko N.; Adachi, Yoshiyuki; Ohno, Naohito			The Effect of Enzymatically Polymerised Polyphenols on CD4 Binding and Cytokine Production in Murine Splenocytes	PLOS ONE			English	Article							FACTOR GM-CSF; NF-KAPPA-B; MONOCLONAL-ANTIBODY GK1.5; EPIGALLOCATECHIN GALLATE; LIGNIFIED MATERIALS; VIRUS-INFECTION; TEA POLYPHENOL; CELL-ACTIVITY; CAFFEIC ACID; GREEN TEA	High-molecular weight polymerised polyphenols have been shown to exhibit anti-influenza virus, anti-HIV, and anti-cancer activities. The purpose of this study was to evaluate the immunomodulating activities of enzymatically polymerised polyphenols, and to clarify the underlying mechanisms of their effects. The cytokine-inducing activity of the enzymatically polymerised polyphenols derived from caffeic acid (CA), ferulic acid (FA), and p-coumaric acid (CoA) was investigated using murine splenocytes. Polymerised polyphenols, but not non-polymerised polyphenols, induced cytokine synthesis in murine splenocytes. Polymerised polyphenols induced several cytokines in murine splenocytes, with interferon-gamma (IFN-gamma) and granulocyte-macrophage colony-stimulating factor (GM-CSF) being the most prominent. The underlying mechanisms of the effects of the polymerised polyphenols were then studied using neutralising antibodies and fluorescent-activated cell sorting (FACS) analysis. Our results show that polymerised polyphenols increased IFN-gamma and GM-CSF production in splenocytes. In addition, the anti-CD4 neutralised monoclonal antibody (mAb) inhibited polymerised polyphenol-induced IFN-gamma and GM-CSF secretion. Moreover, polymerised polyphenols bound directly to a recombinant CD4 protein, and FACS analysis confirmed that interaction occurs between polymerised polyphenols and CD4 molecules expressed on the cell surface. In this study, we clearly demonstrated that enzymatic polymerisation confers immunoactivating potential to phenylpropanoic acids, and CD4 plays a key role in their cytokine-inducing activity.	[Yamanaka, Daisuke; Tamiya, Yumi; Motoi, Masuro; Ishibashi, Ken-ichi; Miura, Noriko N.; Adachi, Yoshiyuki; Ohno, Naohito] Tokyo Univ Pharm & Life Sci, Sch Pharm, Lab Immunopharmacol Microbial Prod, Hachioji, Tokyo 19203, Japan	Tokyo University of Pharmacy & Life Sciences	Yamanaka, D (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Pharm, Lab Immunopharmacol Microbial Prod, 1432-1 Horinouchi, Hachioji, Tokyo 19203, Japan.	ohnonao@toyaku.ac.jp			Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN)	Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN)	This work was supported by the the Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN) (http://brain.naro.affrc.go.jp/). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benzie IFF, 1999, J AGR FOOD CHEM, V47, P633, DOI 10.1021/jf9807768; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; DIALYNAS DP, 1983, IMMUNOL REV, V74, P29, DOI 10.1111/j.1600-065X.1983.tb01083.x; DIALYNAS DP, 1983, J IMMUNOL, V131, P2445; DJEU JY, 1982, J EXP MED, V156, P1222, DOI 10.1084/jem.156.4.1222; Fassina G, 2002, AIDS, V16, P939, DOI 10.1097/00002030-200204120-00020; FREUND M, 1992, INFECTION, V20, pS84, DOI 10.1007/BF01705024; FUKUCHI K, 1989, ANTICANCER RES, V9, P313; Gessner DK, 2011, J ANIM PHYS IN PRESS; GIDLUND M, 1978, NATURE, V273, P759, DOI 10.1038/273759a0; Graziani-Bowering GM, 2002, EXP CELL RES, V279, P141, DOI 10.1006/excr.2002.5581; Harada T, 2004, J INTERF CYTOK RES, V24, P478, DOI 10.1089/1079990041689656; Harada T, 2008, INT IMMUNOPHARMACOL, V8, P556, DOI 10.1016/j.intimp.2007.12.011; Hashimoto Satoshi, 2006, International Journal of Medicinal Mushrooms, V8, P329, DOI 10.1615/IntJMedMushr.v8.i4.40; Hirao K, 2010, LIFE SCI, V86, P654, DOI 10.1016/j.lfs.2010.02.017; Ikeda I, 2003, J AGR FOOD CHEM, V51, P7303, DOI 10.1021/jf034728l; Jung CH, 2007, J ETHNOPHARMACOL, V110, P490, DOI 10.1016/j.jep.2006.10.013; Jung WK, 2008, INT J BIOCHEM CELL B, V40, P2572, DOI 10.1016/j.biocel.2008.05.005; Kawai K, 2003, J ALLERGY CLIN IMMUN, V112, P951, DOI 10.1016/S0091-6749(03)02007-4; KURAKATA Y, 1990, In Vivo (Attiki), V4, P377; LAI PK, 1990, AIDS RES HUM RETROV, V6, P205, DOI 10.1089/aid.1990.6.205; Liu Y, 2008, EVID-BASED COMPL ALT, V5, P205, DOI 10.1093/ecam/nem016; Matsumoto-Akanuma Akiko, 2006, International Journal of Medicinal Mushrooms, V8, P67, DOI 10.1615/IntJMedMushr.v8.i1.90; Matsumoto-Akanuma A, 2011, INT J MED MUSHROOMS, V13, P73, DOI 10.1615/IntJMedMushr.v13.i1.90; Milligan SA, 2009, CLIN CANCER RES, V15, P4885, DOI 10.1158/1078-0432.CCR-09-0109; Moon MK, 2009, BIOL PHARM BULL, V32, P1371, DOI 10.1248/bpb.32.1371; Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141; Nagasaka R, 2007, BIOCHEM BIOPH RES CO, V358, P615, DOI 10.1016/j.bbrc.2007.04.178; NAGATA K, 1990, ANTIVIR RES, V13, P11, DOI 10.1016/0166-3542(90)90041-5; NAKASHIMA H, 1992, CHEM PHARM BULL, V40, P2102; Ohno N, 2001, BIOL PHARM BULL, V24, P820, DOI 10.1248/bpb.24.820; Ohno N., 2001, Pharmaceutical and Pharmacological Letters, V11, P87; Rasheed Z, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-1; SAKAGAMI H, 1991, CHEM PHARM BULL, V39, P950; Singh R, 2010, LIFE SCI, V86, P907, DOI 10.1016/j.lfs.2010.04.013; Tada R, 2007, CARBOHYD RES, V342, P2611, DOI 10.1016/j.carres.2007.08.016; Tada R, 2011, IMMUNOPHARM IMMUNOT, V33, P302, DOI 10.3109/08923973.2010.503707; Tada R, 2009, CARBOHYD RES, V344, P400, DOI 10.1016/j.carres.2008.11.005; Toyoda-Ono Y, 2007, BIOSCI BIOTECH BIOCH, V71, P971, DOI 10.1271/bbb.60635; Tucsek Z, 2011, J LEUKOCYTE BIOL, V89, P105, DOI 10.1189/jlb.0610355; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Wasser Solomon P., 2002, International Journal of Medicinal Mushrooms, V4, P267; WEIGENT DA, 1983, INFECT IMMUN, V41, P992, DOI 10.1128/IAI.41.3.992-997.1983; WEISS M, 1992, INFECTION, V20, pS81, DOI 10.1007/BF01705023; WINEMAN JP, 1992, BLOOD, V80, P1717; Yamaguchi K, 2002, ANTIVIR RES, V53, P19, DOI 10.1016/S0166-3542(01)00189-9; Yamanaka D, 2012, IMMUNOPHARM IN PRESS; YEN GC, 1995, J AGR FOOD CHEM, V43, P27, DOI 10.1021/jf00049a007; Yuminamochi E, 2007, IMMUNOLOGY, V121, P197, DOI 10.1111/j.1365-2567.2006.02558.x	49	18	18	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e36025	10.1371/journal.pone.0036025	http://dx.doi.org/10.1371/journal.pone.0036025			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22540016	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341000082
J	Boulanger, J; Muresan, L; Tiemann-Boege, I				Boulanger, Jerome; Muresan, Leila; Tiemann-Boege, Irene			Massively Parallel Haplotyping on Microscopic Beads for the High-Throughput Phase Analysis of Single Molecules	PLOS ONE			English	Article							PCR-MEDIATED RECOMBINATION; DNA-POLYMERASE-I; SEQUENCE VARIANTS; EMULSION-PCR; HUMAN GENOME; LONG-RANGE; AMPLIFICATION; ARTIFACTS; COMPLEX; SPERM	In spite of the many advances in haplotyping methods, it is still very difficult to characterize rare haplotypes in tissues and different environmental samples or to accurately assess the haplotype diversity in large mixtures. This would require a haplotyping method capable of analyzing the phase of single molecules with an unprecedented throughput. Here we describe such a haplotyping method capable of analyzing in parallel hundreds of thousands single molecules in one experiment. In this method, multiple PCR reactions amplify different polymorphic regions of a single DNA molecule on a magnetic bead compartmentalized in an emulsion drop. The allelic states of the amplified polymorphisms are identified with fluorescently labeled probes that are then decoded from images taken of the arrayed beads by a microscope. This method can evaluate the phase of up to 3 polymorphisms separated by up to 5 kilobases in hundreds of thousands single molecules. We tested the sensitivity of the method by measuring the number of mutant haplotypes synthesized by four different commercially available enzymes: Phusion, Platinum Taq, Titanium Taq, and Phire. The digital nature of the method makes it highly sensitive to detecting haplotype ratios of less than 1:10,000. We also accurately quantified chimera formation during the exponential phase of PCR by different DNA polymerases.	[Boulanger, Jerome] Inst Curie, CNRS, Cell & Tissue Imaging Core, F-75231 Paris, France; [Boulanger, Jerome] Austrian Acad Sci, Radon Inst Computat & Appl Math, Linz, Austria; [Muresan, Leila] Johannes Kepler Univ Linz, Dept Knowledge Based Math Syst, A-4040 Linz, Austria; [Tiemann-Boege, Irene] Johannes Kepler Univ Linz, Inst Biophys, A-4040 Linz, Austria	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Austrian Academy of Sciences; Johannes Kepler University Linz; Johannes Kepler University Linz	Boulanger, J (corresponding author), Inst Curie, CNRS, Cell & Tissue Imaging Core, F-75231 Paris, France.	irene.tiemann@jku.at	Muresan, Leila/AGK-4203-2022; Tiemann-Boege, Irene/H-4437-2012	Muresan, Leila/0000-0002-7602-0249; Tiemann-Boege, Irene/0000-0002-3621-7020; Boulanger, Jerome/0000-0003-0237-3743	Austrian Science Fund (FWF) [M1097]; National Center for Research Resources [U54 RR020278]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Austrian Science Fund (FWF) [M1097]. The Broad Institute Center for Genotyping and Analysis was supported by grant U54 RR020278 from the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bansal V, 2008, GENOME RES, V18, P1336, DOI 10.1101/gr.077065.108; Berney C, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-13; CUI XF, 1989, P NATL ACAD SCI USA, V86, P9389, DOI 10.1073/pnas.86.23.9389; Dempster AP, 1977, J ROYAL STAT SOC B, V39, P138; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Ding CM, 2003, P NATL ACAD SCI USA, V100, P7449, DOI 10.1073/pnas.1232475100; Dressman D, 2003, P NATL ACAD SCI USA, V100, P8817, DOI 10.1073/pnas.1133470100; Dudoit S, 2002, STAT SINICA, V12, P111; Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739; Fang GW, 1998, J VIROL METHODS, V76, P139, DOI 10.1016/S0166-0934(98)00133-5; FINDLAY I, 1995, HUM REPROD, V10, P1609, DOI 10.1093/HUMREP/10.6.1609; Goriely A, 2003, SCIENCE, V301, P643, DOI 10.1126/science.1085710; Hayden MJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-80; Huet S, 2006, ESAIM-PROBAB STAT, V10, P164; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Jiang ZH, 2009, INT J BIOL SCI, V5, P298; Judo MSB, 1998, NUCLEIC ACIDS RES, V26, P1819, DOI 10.1093/nar/26.7.1819; Kanagawa T, 2003, J BIOSCI BIOENG, V96, P317, DOI 10.1263/jbb.96.317; Kitzman JO, 2011, NAT BIOTECHNOL, V29, P59, DOI 10.1038/nbt.1740; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Kurata S, 2004, APPL ENVIRON MICROB, V70, P7545, DOI 10.1128/AEM.70.12.7545-7549.2004; Lahr DJG, 2009, BIOTECHNIQUES, V47, P857, DOI 10.2144/000113219; Lenz TL, 2008, GENE, V427, P117, DOI 10.1016/j.gene.2008.09.013; LI HH, 1988, NATURE, V335, P414, DOI 10.1038/335414a0; Li M, 2006, NAT METHODS, V3, P95, DOI 10.1038/NMETH850; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; MEYERHANS A, 1990, NUCLEIC ACIDS RES, V18, P1687, DOI 10.1093/nar/18.7.1687; Mitra RD, 2003, P NATL ACAD SCI USA, V100, P5926, DOI 10.1073/pnas.0936399100; ODELBERG SJ, 1995, NUCLEIC ACIDS RES, V23, P2049, DOI 10.1093/nar/23.11.2049; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Shammas FV, 2001, CLIN CHIM ACTA, V304, P19, DOI 10.1016/S0009-8981(00)00374-0; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Tewhey R, 2011, NAT REV GENET, V12, P215, DOI 10.1038/nrg2950; Tiemann-Boege I, 2006, PLOS GENET, V2, P682, DOI 10.1371/journal.pgen.0020070; Tiemann-Boege I, 2009, ANAL CHEM, V81, P5770, DOI 10.1021/ac900633y; Turner DJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn373; Wetmur JG, 2005, NUCLEIC ACIDS RES, V33, P2615, DOI 10.1093/nar/gki556; Williams R, 2006, NAT METHODS, V3, P545, DOI 10.1038/NMETH896; Xiao M, 2009, NAT METHODS, V6, P199, DOI [10.1038/nmeth.1301, 10.1038/NMETH.1301]; Yu W, 2006, BIOTECHNIQUES, V40, P499, DOI 10.2144/000112124; Zaphiropoulos PG, 1998, NUCLEIC ACIDS RES, V26, P2843, DOI 10.1093/nar/26.12.2843; Zeng Y, 2010, ANAL CHEM, V82, P3183, DOI 10.1021/ac902683t; Zhu J, 2003, SCIENCE, V301, P836, DOI 10.1126/science.1085792; Zylstra P, 1998, IMMUNOL CELL BIOL, V76, P395, DOI 10.1046/j.1440-1711.1998.00772.x	48	12	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36064	10.1371/journal.pone.0036064	http://dx.doi.org/10.1371/journal.pone.0036064			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558329	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340200037
J	Chiron, S; Tomczak, C; Duperray, A; Laine, J; Bonne, G; Eder, A; Hansen, A; Eschenhagen, T; Verdier, C; Coirault, C				Chiron, Stephane; Tomczak, Carole; Duperray, Alain; Laine, Jeanne; Bonne, Gisele; Eder, Alexandra; Hansen, Arne; Eschenhagen, Thomas; Verdier, Claude; Coirault, Catherine			Complex Interactions between Human Myoblasts and the Surrounding 3D Fibrin-Based Matrix	PLOS ONE			English	Article							ENGINEERED SKELETAL-MUSCLE; EXTRACELLULAR-MATRIX; 3-DIMENSIONAL CELL; MORPHOLOGY; CYTOSKELETON; FIBROBLASTS; ADHESIONS; STIFFNESS; PROTEINS; MYOTUBES	Anchorage of muscle cells to the extracellular matrix is crucial for a range of fundamental biological processes including migration, survival and differentiation. Three-dimensional (3D) culture has been proposed to provide a more physiological in vitro model of muscle growth and differentiation than routine 2D cultures. However, muscle cell adhesion and cell-matrix interplay of engineered muscle tissue remain to be determined. We have characterized cell-matrix interactions in 3D muscle culture and analyzed their consequences on cell differentiation. Human myoblasts were embedded in a fibrin matrix cast between two posts, cultured until confluence, and then induced to differentiate. Myoblasts in 3D aligned along the longitudinal axis of the gel. They displayed actin stress fibers evenly distributed around the nucleus and a cortical mesh of thin actin filaments. Adhesion sites in 3D were smaller in size than in rigid 2D culture but expression of adhesion site proteins, including alpha 5 integrin and vinculin, was higher in 3D compared with 2D (p<0.05). Myoblasts and myotubes in 3D exhibited thicker and ellipsoid nuclei instead of the thin disk-like shape of the nuclei in 2D (p<0.001). Differentiation kinetics were faster in 3D as demonstrated by higher mRNA concentrations of a-actinin and myosin. More important, the elastic modulus of engineered muscle tissues increased significantly from 3.5 +/- 0.8 to 7.4 +/- 4.7 kPa during proliferation (p<0.05) and reached 12.2 +/- 6.0 kPa during differentiation (p<0.05), thus attesting the increase of matrix stiffness during proliferation and differentiation of the myocytes. In conclusion, we reported modulations of the adhesion complexes, the actin cytoskeleton and nuclear shape in 3D compared with routine 2D muscle culture. These findings point to complex interactions between muscle cells and the surrounding matrix with dynamic regulation of the cell-matrix stiffness.	[Chiron, Stephane; Tomczak, Carole; Laine, Jeanne; Bonne, Gisele; Coirault, Catherine] INSERM, U974, Paris, France; [Chiron, Stephane; Tomczak, Carole; Bonne, Gisele; Coirault, Catherine] CNRS, UMR7215, Paris, France; [Chiron, Stephane; Tomczak, Carole; Bonne, Gisele; Coirault, Catherine] Univ Paris 06, UM76, IFR14, Paris, France; [Chiron, Stephane; Tomczak, Carole; Bonne, Gisele; Coirault, Catherine] Inst Myol, Paris, France; [Duperray, Alain] INSERM, Inst Albert Bonniot, U823, Grenoble, France; [Laine, Jeanne] Univ Paris 06, Dept Physiol, Paris, France; [Bonne, Gisele] Grp Hosp Pitie Salpetriere, AP HP, UF Cardiogenet & Myogenet, Serv Biochim & Metab, F-75634 Paris, France; [Eder, Alexandra; Hansen, Arne; Eschenhagen, Thomas] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany; [Verdier, Claude] Univ Grenoble 1, CNRS, LIPhy UMR 5588, Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Hamburg; University Medical Center Hamburg-Eppendorf; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Chiron, S (corresponding author), INSERM, U974, Paris, France.	c.coirault@institut-myologie.org	Bonne, Gisèle/G-3121-2013; Duperray, Alain/E-8428-2012; Coirault, Catherine/S-2454-2019; Coirault, Catherine/I-2979-2016; Verdier, Claude/C-1419-2008	Bonne, Gisèle/0000-0002-2516-3258; Duperray, Alain/0000-0002-2719-252X; Coirault, Catherine/0000-0002-5594-1057; Verdier, Claude/0000-0003-3706-7148	Institut National de la Sante et de la Recherche Medicale; Universite Pierre et Marie Curie Paris 06; Centre National de la Recherche Scientifique; Association Francaise contre les Myopathies; Grenoble Nanosciences Foundation; Association pour la Recherche sur le Cancer (Villejuif, France); Nanobio program	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre et Marie Curie Paris 06; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Grenoble Nanosciences Foundation; Association pour la Recherche sur le Cancer (Villejuif, France)(Fondation ARC pour la Recherche sur le Cancer); Nanobio program	This work was financially supported by the Institut National de la Sante et de la Recherche Medicale; the Universite Pierre et Marie Curie Paris 06; the Centre National de la Recherche Scientifique; the Association Francaise contre les Myopathies and the "Grenoble Nanosciences Foundation." The equipment used at the microscopy facility of the Institut Albert Bonniot was partly funded by the Association pour la Recherche sur le Cancer (Villejuif, France) and the Nanobio program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Bian WN, 2009, BIOMATERIALS, V30, P1401, DOI 10.1016/j.biomaterials.2008.11.015; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; Carmignac V, 2011, J PATHOL; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; Dado D, 2009, SEMIN CELL DEV BIOL, V20, P656, DOI 10.1016/j.semcdb.2009.02.001; DeQuach JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013039; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; Engel A.G., 2004, MYOLOGY; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Formigli L, 2007, EUR J HISTOCHEM, V51, P21; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Gerard C, 2011, CELL TRANSPLANT; Hakkinen KM, 2011, TISSUE ENG PT A, V17, P713, DOI 10.1089/ten.TEA.2010.0273; Hansen A, 2010, CIRC RES, V107, P35, DOI 10.1161/CIRCRESAHA.109.211458; HAYWARD LJ, 1988, J CELL BIOL, V106, P2077, DOI 10.1083/jcb.106.6.2077; Huang YC, 2005, J APPL PHYSIOL, V98, P706, DOI 10.1152/japplphysiol.00273.2004; Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327; Kanagawa M, 2006, J HUM GENET, V51, P915, DOI 10.1007/s10038-006-0056-7; Khatau SB, 2009, P NATL ACAD SCI USA, V106, P19017, DOI 10.1073/pnas.0908686106; Koning M, 2009, J TISSUE ENG REGEN M, V3, P407, DOI 10.1002/term.190; Kubow Kristopher E, 2011, Nat Cell Biol, V13, P3, DOI 10.1038/ncb0111-3; Levy-Mishali M, 2009, TISSUE ENG PT A, V15, P935, DOI 10.1089/ten.tea.2008.0111; Liao H, 2009, TISSUE ENG PART B-RE, V15, P319, DOI 10.1089/ten.teb.2009.0092; Matsumoto T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001211; Moore SW, 2010, DEV CELL, V19, P194, DOI 10.1016/j.devcel.2010.07.018; Okano T, 1998, CELL TRANSPLANT, V7, P71, DOI 10.1016/S0963-6897(97)00067-5; Orlando Giuseppe, 2011, Transpl Int, V24, P223, DOI 10.1111/j.1432-2277.2010.01182.x; Rhim C, 2007, MUSCLE NERVE, V36, P71, DOI 10.1002/mus.20788; Sander EA, 2011, ANN BIOMED ENG, V39, P714, DOI 10.1007/s10439-010-0192-2; Schaaf S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026397; Shah R, 2005, BIOMATERIALS, V26, P1497, DOI 10.1016/j.biomaterials.2004.04.049; Simon DN, 2011, NAT REV MOL CELL BIO, V12, P695, DOI 10.1038/nrm3207; Tse JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015978; Vandenburgh H, 2008, MUSCLE NERVE, V37, P438, DOI 10.1002/mus.20931; Vandenburgh H, 2010, TISSUE ENG PART B-RE, V16, P55, DOI [10.1089/ten.teb.2009.0445, 10.1089/ten.TEB.2009.0445]; VANDENBURGH HH, 1988, IN VITRO CELL DEV B, V24, P166, DOI 10.1007/BF02623542; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Williamson MR, 2006, BIOMATERIALS, V27, P1019, DOI 10.1016/j.biomaterials.2005.06.018; Winer JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006382	40	70	70	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36173	10.1371/journal.pone.0036173	http://dx.doi.org/10.1371/journal.pone.0036173			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558372	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336000146
J	Minch, K; Rustad, T; Sherman, DR				Minch, Kyle; Rustad, Tige; Sherman, David R.			Mycobacterium tuberculosis Growth following Aerobic Expression of the DosR Regulon	PLOS ONE			English	Article							HYPOXIC RESPONSE; DORMANCY; SYSTEM	The Mycobacterium tuberculosis regulator DosR is induced by multiple stimuli including hypoxia, nitric oxide and redox stress. Overlap of these stimuli with conditions thought to promote latency in infected patients fuels a model in which DosR regulon expression is correlated with bacteriostasis in vitro and a proxy for latency in vivo. Here, we find that inducing the DosR regulon to wildtype levels in aerobic, replicating M. tuberculosis does not alter bacterial growth kinetics. We conclude that DosR regulon expression alone is insufficient for bacterial latency, but rather is expressed during a range of growth states in a dynamic environment.	[Minch, Kyle; Rustad, Tige; Sherman, David R.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Minch, Kyle; Sherman, David R.] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA	Center for Infectious Disease Research; University of Washington; University of Washington Seattle	Minch, K (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	david.sherman@seattlebiomed.org			Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200800059C]; National Science Foundation Graduate Research Fellowship Program	Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF))	This work was supported by Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under contract No. HHSN272200800059C. KM was supported by the National Science Foundation Graduate Research Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boon C, 2002, J BACTERIOL, V184, P6760, DOI 10.1128/JB.184.24.6760-6767.2002; Chao MC, 2010, ANNU REV MICROBIOL, V64, P293, DOI 10.1146/annurev.micro.112408.134043; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Dasgupta N, 2000, TUBERCLE LUNG DIS, V80, P141, DOI 10.1054/tuld.2000.0240; DYE C, 2008, GLOBAL TUBERCULOSIS; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Fallow A, 2010, J BACTERIOL, V192, P2228, DOI 10.1128/JB.01597-09; Flores Valdez MA, 2010, TUBERCULOSIS EDINB, V90, P197, DOI DOI 10.1016/J.TUBE.2010.04.001; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Leistikow RL, 2010, J BACTERIOL, V192, P1662, DOI 10.1128/JB.00926-09; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Roupie V, 2007, INFECT IMMUN, V75, P941, DOI 10.1128/IAI.01137-06; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Rustad TR, 2009, CELL MICROBIOL, V11, P1151, DOI 10.1111/j.1462-5822.2009.01325.x; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205	18	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35935	10.1371/journal.pone.0035935	http://dx.doi.org/10.1371/journal.pone.0035935			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558276	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336000088
J	Perreault, C; Mathew, S				Perreault, Charles; Mathew, Sarah			Dating the Origin of Language Using Phonemic Diversity	PLOS ONE			English	Article							FOUNDER EFFECT MODEL; PLEISTOCENE HOMO-SAPIENS; Y-CHROMOSOME; LINGUISTIC CHANGE; HUMAN-POPULATIONS; MTDNA VARIATION; MODERN HUMANS; MIDDLE AWASH; SOUTH-AFRICA; EVOLUTION	Language is a key adaptation of our species, yet we do not know when it evolved. Here, we use data on language phonemic diversity to estimate a minimum date for the origin of language. We take advantage of the fact that phonemic diversity evolves slowly and use it as a clock to calculate how long the oldest African languages would have to have been around in order to accumulate the number of phonemes they possess today. We use a natural experiment, the colonization of Southeast Asia and Andaman Islands, to estimate the rate at which phonemic diversity increases through time. Using this rate, we estimate that present-day languages date back to the Middle Stone Age in Africa. Our analysis is consistent with the archaeological evidence suggesting that complex human behavior evolved during the Middle Stone Age in Africa, and does not support the view that language is a recent adaptation that has sparked the dispersal of humans out of Africa. While some of our assumptions require testing and our results rely at present on a single case-study, our analysis constitutes the first estimate of when language evolved that is directly based on linguistic data.	[Perreault, Charles] Santa Fe Inst, Santa Fe, NM 87501 USA; [Mathew, Sarah] Stockholm Univ, Ctr Study Cultural Evolut, S-10691 Stockholm, Sweden	The Santa Fe Institute; Stockholm University	Perreault, C (corresponding author), Santa Fe Inst, Santa Fe, NM 87501 USA.	sarah.mathew@arklab.su.se			Swedish Research Council [2009-2390]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding was provided by the Swedish Research Council [grant number 2009-2390]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, PRINCIPLES LINGUISTI; Atkinson QD., 2011, LINGUIST TYPOL, V15, P321, DOI [DOI 10.1515/LITY.2011.022, 10.1515/lity.2011.022]; Atkinson QD, 2008, MOL BIOL EVOL, V25, P468, DOI 10.1093/molbev/msm277; Atkinson QD, 2012, SCIENCE, V335, DOI 10.1126/science.1210005; Atkinson QD, 2011, SCIENCE, V332, P346, DOI 10.1126/science.1199295; Barker G., 2005, ASIAN PERSPECT, V44, P90, DOI [10.1353/asi.2005.0004, DOI 10.1353/ASI.2005.0004]; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; BERGSLAND K, 1962, CURR ANTHROPOL, V3, P115, DOI 10.1086/200264; Betti L, 2009, P ROY SOC B-BIOL SCI, V276, P809, DOI 10.1098/rspb.2008.1563; Blust R, 2001, TIME DEPTH HIST LING, V2, P311; Bowern C, 2011, LINGUIST TYPOL, V15, P207, DOI DOI 10.1515/LITY.2011.015); Brown KS, 2009, SCIENCE, V325, P859, DOI 10.1126/science.1175028; Bybee Joan, 2011, LINGUIST TYPOL, V15, P147, DOI [10.1515/lity.2011.009, DOI 10.1515/LITY.2011.009]; CAMPBELL L, 2000, TIME DEPTH HIST LING, V1, P3; Chen YS, 2000, AM J HUM GENET, V66, P1362, DOI 10.1086/302848; Clark JD, 2003, NATURE, V423, P747, DOI 10.1038/nature01670; Coop G, 2008, MOL BIOL EVOL, V25, P1257, DOI 10.1093/molbev/msn091; Croft W., 2000, EXPLAINING LANGUAGE; Cysouw M, 2012, SCIENCE, V335, DOI 10.1126/science.1208841; d'Errico F, 2005, J HUM EVOL, V48, P3, DOI 10.1016/j.jhevol.2004.09.002; d'Errico F, 2007, J HUM EVOL, V52, P142, DOI 10.1016/j.jhevol.2006.08.003; Dahl O, 2011, LINGUIST TYPOL, V15, P171, DOI DOI 10.1515/LITY.2011.012); David Lightfoot, 2006, NEW LANGUAGES EMERGE; Diamond J, 2013, RISE FALL 3 CHIMPANZ; Donohue M, 2011, LINGUIST TYPOL, V15, P161, DOI [10.1515/lity.2011.011, DOI 10.1515/LITY.2011.011, DOI 10.1515/LITY.20]; Dryer Matthew S., 2013, WORLD ATLAS LANGUAGE; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Endicott P, 2003, AM J HUM GENET, V72, P178, DOI 10.1086/345487; Ericksen P, 1975, MANKIND, V10, P105; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Fisher SE, 2006, NAT REV GENET, V7, P9, DOI 10.1038/nrg1747; Fisher SE, 2009, TRENDS GENET, V25, P166, DOI 10.1016/j.tig.2009.03.002; Fitch WT, 2000, TRENDS COGN SCI, V4, P258, DOI 10.1016/S1364-6613(00)01494-7; Foley R, 2003, EVOL ANTHROPOL, V12, P109, DOI 10.1002/evan.10108; Forster P, 2005, SCIENCE, V308, P965, DOI 10.1126/science.1113261; Gonder MK, 2007, MOL BIOL EVOL, V24, P757, DOI 10.1093/molbev/msl209; Gray RD, 2009, SCIENCE, V323, P479, DOI 10.1126/science.1166858; Gray RD, 2003, NATURE, V426, P435, DOI 10.1038/nature02029; Gray RD, 2011, PHILOS T R SOC B, V366, P1090, DOI 10.1098/rstb.2010.0378; Greenberg JH, 1971, CURR TRENDS LINGUIST, V8, P809; GREENBERG JH, 1963, LANGUAGES AFRICA; Guldemann T, 2008, ANNU REV ANTHROPOL, V37, P93, DOI 10.1146/annurev.anthro.37.081407.085109; Hay J, 2007, LANGUAGE, V83, P388, DOI 10.1353/lan.2007.0071; Henrich J, 2004, AM ANTIQUITY, V69, P197, DOI 10.2307/4128416; Henshilwood CS, 2003, CURR ANTHROPOL, V44, P627, DOI 10.1086/377665; HOUGHTON P, 1993, AM J PHYS ANTHROPOL, V90, P139, DOI 10.1002/ajpa.1330900202; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Klein R., 2009, HUMAN CAREER; Knight A, 2003, CURR BIOL, V13, P464, DOI 10.1016/S0960-9822(03)00130-1; Krause J, 2007, CURR BIOL, V17, P1908, DOI 10.1016/j.cub.2007.10.008; Labov, 2001, PRINCIPLES LINGUISTI; Labov W., 1994, LANGUAGE; Lees RB, 1953, LANGUAGE, V29, P113, DOI 10.2307/410164; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lieberman DE, 2008, EVOL ANTHROPOL, V17, P55, DOI 10.1002/evan.20154; Lieberman P, 2006, INT C SERIES, V1296, P115, DOI DOI 10.1016/J.ICS.2006.03.039; Lieberman P, 2007, CURR ANTHROPOL, V48, P39, DOI 10.1086/509092; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Maddieson I, 2011, LINGUIST TYPOL, V15, P267, DOI 10.1515/LITY.2011.020; Maddieson I., 1990, UCLA WORKING PAPERS, V74, P104; Maddieson Ian, 1984, PATTERNS SOUNDS; Manica A, 2007, NATURE, V448, P346, DOI 10.1038/nature05951; Marean CW, 2007, NATURE, V449, P905, DOI 10.1038/nature06204; Marean CW, 2011, INTERD CONTRIB ARCH, P421, DOI 10.1007/978-1-4419-8219-3_18; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; MILROY J, 1985, J LINGUIST, V21, P339, DOI 10.1017/S0022226700010306; Nettle D, 1999, LINGUA, V108, P119, DOI 10.1016/S0024-3841(98)00047-3; Nettle D, 1998, J ANTHROPOL ARCHAEOL, V17, P354, DOI 10.1006/jaar.1998.0328; O'Connell JF, 2004, J ARCHAEOL SCI, V31, P835, DOI 10.1016/j.jas.2003.11.005; Pagel M, 2007, NATURE, V449, P717, DOI 10.1038/nature06176; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Pericliev V, 2011, LINGUISTIC TYPOLOGY, V15, P217, DOI [10.1515/lity.2011.016, DOI 10.1515/LITY.2011.016]; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Powell BB., 2009, WRITING THEORY HIST; Prugnolle F, 2005, CURR BIOL, V15, pR159, DOI 10.1016/j.cub.2005.02.038; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Rice K, 2011, LINGUIST TYPOL, V15, P233; Ringe D., 2011, LINGUISTIC TYPOLOGY, V15, P223; Ross B, 2011, LINGUIST TYPOL, V15, P251; Ruhlen M., 1987, GUIDE WORLDS LANGUAG; Sands Bonny., 2009, CRADLE LANGUAGE, P204; Semino O, 2002, AM J HUM GENET, V70, P265, DOI 10.1086/338306; Shennan S, 2001, CAMB ARCHAEOL J, V11, P5, DOI 10.1017/S0959774301000014; Smith TM, 2007, P NATL ACAD SCI USA, V104, P6128, DOI 10.1073/pnas.0700747104; Sproat R., 2011, LINGUIST TYPOL, V15, P199, DOI DOI 10.1515/LITY.2011.014); Stahl, 2005, AFRICAN ARCHAEOLOGY, P93; Swadesh M., 1952, P AM PHILOS SOC, V96, p452 ; Swadesh M, 1955, INT J AM LINGUIST, V21, P121, DOI 10.1086/464321; Tattersall I, 2009, P NATL ACAD SCI USA, V106, P16018, DOI 10.1073/pnas.0903207106; Thangaraj K, 2005, SCIENCE, V308, P996, DOI 10.1126/science.1109987; Thangaraj K, 2003, CURR BIOL, V13, P86, DOI 10.1016/S0960-9822(02)01336-2; Thomason S. G., 1988, LANGUAGE CONTACT CRE; Tishkoff SA, 2007, MOL BIOL EVOL, V24, P2180, DOI 10.1093/molbev/msm155; Trudgill P, 2011, LINGUIST TYPOL, V15, P155, DOI DOI 10.1515/LITY.2011.010); Trudgill Peter, 2004, LINGUIST TYPOL, V8, P305, DOI DOI 10.1515/LITY.2004.8.3.305; Tuyl RV, 2012, SCIENCE, V335, P657; von Cramon-Taubadel N, 2008, AM J PHYS ANTHROPOL, V136, P108, DOI 10.1002/ajpa.20775; Wang CC, 2012, SCIENCE, V335, DOI 10.1126/science.1207846; Watson E, 1996, AM J HUM GENET, V59, P437; White TD, 2003, NATURE, V423, P742, DOI 10.1038/nature01669; Wichmann Soren, 2011, LINGUIST TYPOL, V2011, P177, DOI DOI 10.1515/LITY.2011.013; Wurm S.A., 1971, CURR TRENDS LINGUIST, V8, P721; Wurm Stephen Adolphe, 1975, NEW GUINEA AREA LANG, V1; Yang C., 2003, KNOWLEDGE LEARNING N; Zhang JZ, 2002, GENETICS, V162, P1825	107	28	28	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35289	10.1371/journal.pone.0035289	http://dx.doi.org/10.1371/journal.pone.0035289			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	959TJ	22558135	Green Published, gold			2022-12-27	WOS:000305336000029
J	Roth, ED; Yu, XT; Rao, G; Knierim, JJ				Roth, Eric D.; Yu, Xintian; Rao, Geeta; Knierim, James J.			Functional Differences in the Backward Shifts of CA1 and CA3 Place Fields in Novel and Familiar Environments	PLOS ONE			English	Article							HIPPOCAMPAL SUBFIELDS; MEMORY SYSTEM; UNIT-ACTIVITY; SPATIAL MAP; CELLS; EXPERIENCE; RAT; SELECTIVITY; PLASTICITY; SUBREGION	Insight into the processing dynamics and other neurophysiological properties of different hippocampal subfields is critically important for understanding hippocampal function. In this study, we compared shifts in the center of mass (COM) of CA3 and CA1 place fields in a familiar and completely novel environment. Place fields in CA1 and CA3 were simultaneously recorded as rats ran along a closed loop track in a familiar room followed by a session in a completely novel room. This process was repeated each day over a 4-day period. CA3 place fields shifted backward (opposite to the direction of motion of the rat) only in novel environments. This backward shift gradually diminished across days, as the novel environment became more familiar with repeated exposures. Conversely, CA1 place fields shifted backward across all days in both familiar and novel environments. Prior studies demonstrated that CA1 place fields on average do not exhibit a backward shift during the first exposure to an environment in which the familiar cues are rearranged into a novel configuration, although CA3 place fields showed a strong backward shift. Under the completely novel conditions of the present study, no dissociation was observed between CA3 and CA1 during the first novel session (although a strong dissociation was observed in the familiar sessions and the later novel sessions). In summary, this is the first study to use simultaneous recordings in CA1 and CA3 to compare place field COM shift and other associated properties in truly novel and familiar environments. This study further demonstrates functional differentiation between CA1 and CA3 as the plasticity of CA1 place fields is affected differently by exposure to a completely novel environment in comparison to an altered, familiar environment, whereas the plasticity of CA3 place fields is affected similarly during both types of environmental novelty.	[Roth, Eric D.] Univ Delaware, Dept Psychol, Newark, DE 19716 USA; [Roth, Eric D.; Yu, Xintian; Rao, Geeta; Knierim, James J.] Univ Texas Med Sch Houston, Dept Neurobiol & Anat, Houston, TX USA; [Knierim, James J.] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD USA; [Knierim, James J.] Johns Hopkins Univ, Krieger Mind Brain Inst, Baltimore, MD USA	University of Delaware; University of Texas System; University of Texas Health Science Center Houston; Johns Hopkins University; Johns Hopkins University	Roth, ED (corresponding author), Univ Delaware, Dept Psychol, Newark, DE 19716 USA.	jknierim@jhu.edu		Knierim, James/0000-0002-1796-2930	National Institutes of Health (NIH) [R01 NS039456, K02 MH063297]; National Science Foundation (NSF) [0344213]; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH063297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039456] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grants R01 NS039456 and K02 MH063297 (www.nih.gov) and National Science Foundation (NSF) grant 0344213 (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, NEURAL NETWORKS BRAI; August DA, 1999, J COMPUT NEUROSCI, V6, P71, DOI 10.1023/A:1008861001091; Blum KI, 1996, NEURAL COMPUT, V8, P85, DOI 10.1162/neco.1996.8.1.85; Burke SN, 2008, BEHAV NEUROSCI, V122, P535, DOI 10.1037/0735-7044.122.3.535; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Ekstrom AD, 2001, NEURON, V31, P631, DOI 10.1016/S0896-6273(01)00401-9; Frank LM, 2002, J NEUROSCI, V22, P3817; Gold AE, 2005, HIPPOCAMPUS, V15, P808, DOI 10.1002/hipo.20103; Guzowski JF, 2004, NEURON, V44, P581, DOI 10.1016/j.neuron.2004.11.003; HASSELMO ME, 1994, J NEUROSCI, V14, P3898; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Kesner RP, 2007, LEARN MEMORY, V14, P771, DOI 10.1101/lm.688207; Knierim JJ, 2006, HIPPOCAMPUS, V16, P755, DOI 10.1002/hipo.20203; Knierim JJ, 2002, J NEUROSCI, V22, P6254; Koene RA, 2003, NEURAL NETWORKS, V16, P577, DOI 10.1016/S0893-6080(03)00106-0; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Lee I, 2004, NEURON, V42, P803, DOI 10.1016/j.neuron.2004.05.010; Lee I, 2006, NEURON, V51, P639, DOI 10.1016/j.neuron.2006.06.033; Lee I, 2007, LEARN MEMORY, V14, P807, DOI 10.1101/lm.706207; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Levy W. B., 1989, COMPUTATIONAL MODELS, P243, DOI DOI 10.1016/S0079-7421(08)60113-9; Levy WB, 1996, HIPPOCAMPUS, V6, P579, DOI 10.1002/(SICI)1098-1063(1996)6:6<579::AID-HIPO3>3.0.CO;2-C; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McClelland JL, 1996, HIPPOCAMPUS, V6, P654; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; Mizumori SJY, 2004, NEUROBIOL LEARN MEM, V82, P278, DOI 10.1016/j.nlm.2004.07.007; Mizumori SJY, 1995, BEHAV NEUROSCI, V109, P1081; Myers CE, 2011, HIPPOCAMPUS, V21, P1190, DOI 10.1002/hipo.20828; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; Navratilova Z, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00006; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Rolls ET, 1996, HIPPOCAMPUS, V6, P601, DOI 10.1002/(SICI)1098-1063(1996)6:6<601::AID-HIPO5>3.0.CO;2-J; Shen J, 1997, J NEUROSCI, V17, P6789; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030; Vazdarjanova A, 2004, J NEUROSCI, V24, P6489, DOI 10.1523/JNEUROSCI.0350-04.2004; Vinogradova OS, 2001, HIPPOCAMPUS, V11, P578, DOI 10.1002/hipo.1073; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905; Wilson IA, 2005, J NEUROSCI, V25, P6877, DOI 10.1523/JNEUROSCI.1744-05.2005; Yu X, 2006, NEUROCOMPUTING, V69, P1253, DOI 10.1016/j.neucom.2005.12.087; Yu X, 2006, NEURON, V52, P717, DOI 10.1016/j.neuron.2006.10.003	46	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36035	10.1371/journal.pone.0036035	http://dx.doi.org/10.1371/journal.pone.0036035			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558316	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336000107
J	Sherr, K; Mussa, A; Chilundo, B; Gimbel, S; Pfeiffer, J; Hagopian, A; Gloyd, S				Sherr, Kenneth; Mussa, Antonio; Chilundo, Baltazar; Gimbel, Sarah; Pfeiffer, James; Hagopian, Amy; Gloyd, Stephen			Brain Drain and Health Workforce Distortions in Mozambique	PLOS ONE			English	Article							EXTERNAL RESOURCES; SYSTEMS; AFRICA; ORGANIZATIONS; ACHIEVE; DOCTORS; ACCESS; SECTOR	Introduction: Trained human resources are fundamental for well-functioning health systems, and the lack of health workers undermines public sector capacity to meet population health needs. While external brain drain from low and middle-income countries is well described, there is little understanding of the degree of internal brain drain, and how increases in health sector funding through global health initiatives may contribute to the outflow of health workers from the public sector to donor agencies, non-governmental organisations (NGOs), and the private sector. Methods: An observational study was conducted to estimate the degree of internal and external brain drain among Mozambican nationals qualifying from domestic and foreign medical schools between 1980-2006. Data were collected 26-months apart in 2008 and 2010, and included current employment status, employer, geographic location of employment, and main work duties. Results: Of 723 qualifying physicians between 1980-2006, 95.9% (693) were working full-time, including 71.1% (493) as clinicians, 20.5% (142) as health system managers, and 6.9% (48) as researchers/professors. 25.5% (181) of the sample had left the public sector, of which 62.4% (113) continued working in-country and 37.6% (68) emigrated from Mozambique. Of those cases of internal migration, 66.4% (75) worked for NGOs, 21.2% (24) for donor agencies, and 12.4% (14) in the private sector. Annual incidence of physician migration was estimated to be 3.7%, predominately to work in the growing NGO sector. An estimated 36.3% (41/113) of internal migration cases had previously held senior-level management positions in the public sector. Discussion: Internal migration is an important contributor to capital flight from the public sector, accounting for more cases of physician loss than external migration in Mozambique. Given the urgent need to strengthen public sector health systems, frank reflection by donors and NGOs is needed to assess how hiring practices may undermine the very systems they seek to strengthen.	[Sherr, Kenneth; Gimbel, Sarah; Pfeiffer, James; Hagopian, Amy; Gloyd, Stephen] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Mussa, Antonio] Mozambique Minist Hlth, Human Resources Dept, Maputo, Mozambique; [Chilundo, Baltazar] Eduardo Mondlane Univ, Maputo, Mozambique	University of Washington; University of Washington Seattle; Eduardo Mondlane University	Sherr, K (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	ksherr@u.washington.edu	gimbel, sarah/AAP-3925-2021		Doris Duke Charitable Foundation's Operations Research for AIDS Care and Treatment in Africa initiative (ORACTA) [2005053]; Doris Duke Charitable Foundation's African Health Initiative (AHI). [2009059]; Ministry of Health of Mozambique, Eduardo Mondlane University School of Medicine; Doris Duke Charitable Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	Doris Duke Charitable Foundation's Operations Research for AIDS Care and Treatment in Africa initiative (ORACTA)(Doris Duke Charitable Foundation (DDCF)); Doris Duke Charitable Foundation's African Health Initiative (AHI).; Ministry of Health of Mozambique, Eduardo Mondlane University School of Medicine; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this research was provided from the Doris Duke Charitable Foundation's Operations Research for AIDS Care and Treatment in Africa (ORACTA grant 2005053) initiative and by a Population Health and Implementation Training grant (2009059) through Doris Duke Charitable Foundation's African Health Initiative (AHI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the support of the Ministry of Health of Mozambique, Eduardo Mondlane University School of Medicine, and the Doris Duke Charitable Foundation.	Buse K, 1997, SOC SCI MED, V45, P449, DOI 10.1016/S0277-9536(96)00365-6; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Clemens MA, 2008, HUM RESOUR HEALTH, V6, DOI 10.1186/1478-4491-6-1; Crisp N, 2008, LANCET, V371, P689, DOI 10.1016/S0140-6736(08)60309-8; Dambisya YM, 2004, BMJ-BRIT MED J, V329, P600, DOI 10.1136/bmj.38134.524387.AE; Davey G, 2006, LANCET, V367, P629, DOI 10.1016/S0140-6736(06)68239-1; Dreesch N, 2005, HEALTH POLICY PLANN, V20, P267, DOI 10.1093/heapol/czi036; Forcier Melanie Bourassa, 2004, Hum Resour Health, V2, P12, DOI 10.1186/1478-4491-2-12; Furth R, 2005, RWANDA HUMAN RESOURC; GILSON L, 1994, HEALTH POLICY PLANN, V9, P14, DOI 10.1093/heapol/9.1.14; Hagopian A, 2005, SOC SCI MED, V61, P1750, DOI 10.1016/j.socscimed.2005.03.027; Hagopian Amy, 2004, Hum Resour Health, V2, P17, DOI 10.1186/1478-4491-2-17; Kerac M, 2010, LANCET, V376, P1898, DOI 10.1016/S0140-6736(10)62209-X; Kirigia JM, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-89; Loewenson R, 2004, BMJ-BRIT MED J, V328, P241, DOI 10.1136/bmj.328.7434.241; Martins Z, 1999, BRINGING ITS RESULTS; McCoy D, 2005, AM J PUBLIC HEALTH, V95, P18, DOI 10.2105/AJPH.2004.040121; Mozambique Ministry of Health, 2003, PLAN EC SOC 2003 SEC; Mozambique Ministry of Health, 2000, KAYA KWANG COMM COD; Mozambique Ministry of Health, 2005, COD COND GOV PARTN M; Mozambique Ministry of Health, 2008, PLAN EC SOC 2008 SEC; Ooms G, 2005, LANCET, V365, P1821, DOI 10.1016/S0140-6736(05)66586-5; Pavignani E, 1999, HEALTH POLICY PLANN, V14, P243, DOI 10.1093/heapol/14.3.243; Pfeiffer J, 2003, SOC SCI MED, V56, P725, DOI 10.1016/S0277-9536(02)00068-0; Pfeiffer J, 2008, AM J PUBLIC HEALTH, V98, P2134, DOI 10.2105/AJPH.2007.125989; Price M, 2005, SAMJ S AFR MED J, V95, P414; Riley PL, 2007, HEALTH SERV RES, V42, P1389, DOI 10.1111/j.1475-6773.2007.00715.x; Schoepf B., 2000, DYING GROWTH GLOBAL; Southall D, 2010, LANCET, V376, P498, DOI 10.1016/S0140-6736(10)61157-9; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; Tulenko K, 2010, LANCET, V376, P1899, DOI 10.1016/S0140-6736(10)62210-6; World Health Organization, 2006, WORK TOG HLTH; Zaidi S. A., 1999, Journal of International Development, V11, P259, DOI 10.1002/(SICI)1099-1328(199903/04)11:2&lt;259::AID-JID573&gt;3.0.CO;2-N	33	62	62	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35840	10.1371/journal.pone.0035840	http://dx.doi.org/10.1371/journal.pone.0035840			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TJ	22558237	Green Published, gold			2022-12-27	WOS:000305336000065
J	Goodwin, R; Marshall, T; Fulop, M; Adonu, J; Spiewak, S; Neto, F; Plaza, SH				Goodwin, Robin; Marshall, Tara; Fueloep, Marta; Adonu, Joseph; Spiewak, Slawomir; Neto, Felix; Plaza, Sonia Hernandez			Mate Value and Self-Esteem: Evidence from Eight Cultural Groups	PLOS ONE			English	Article							SEX-DIFFERENCES; PERSONALITY-TRAITS; GENDER-DIFFERENCES; PREFERENCES; EVOLUTION; LOVE; CANT	This paper explores self-perceived mate value (SPMV), and its association with self-esteem, in eight cultures. 1066 participants, from 8 cultural groups in 7 countries, rated themselves on 24 SPMVs and completed a measure of self-esteem. Consistent with evolutionary theory, women were more likely to emphasise their caring and passionate romantic nature. In line with previous cross-cultural research, characteristics indicating passion and romance and social attractiveness were stressed more by respondents from individualistic cultures, and those higher on self-expression (rather than survival) values; characteristics indicative of maturity and confidence were more likely to be mentioned by those from Traditional, rather than Secular, cultures. Contrary to gender role theory, societal equality had only limited interactions with sex and SPMV, with honesty of greater significance for male self-esteem in societies with unequal gender roles. These results point to the importance of cultural and environmental factors in influencing self-perceived mate qualities, and are discussed in relation to broader debates about the impact of gender role equality on sex differences in personality and mating strategies.	[Goodwin, Robin; Marshall, Tara] Brunel Univ, Dept Psychol, London, England; [Fueloep, Marta] Hungarian Acad Sci, Inst Psychol, Budapest, Hungary; [Adonu, Joseph] Univ Bedfordshire, Dept Psychol, Luton, Beds, England; [Spiewak, Slawomir] Jagiellonian Univ, Inst Psychol, Krakow, Poland; [Neto, Felix] Univ Porto, Fac Psicol & Ciencias Educ, P-4100 Oporto, Portugal; [Plaza, Sonia Hernandez] Lisbon Univ Inst, Univ Inst Lisbon ISCTE IUL, Ctr Res & Studies Sociol, Lisbon, Portugal	Brunel University; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; University of Bedfordshire; Jagiellonian University; Universidade do Porto; Instituto Universitario de Lisboa	Goodwin, R (corresponding author), Brunel Univ, Dept Psychol, London, England.	robin.goodwin@brunel.ac.uk	Neto, Félix/H-6575-2013; Fulop, Marta/AAB-7446-2019; Fülöp, Márta/B-3699-2013; Hernández-Plaza, Sonia/J-7207-2012	Neto, Félix/0000-0003-0112-880X; Fülöp, Márta/0000-0003-0348-7806; Hernández-Plaza, Sonia/0000-0002-9533-5756; Marshall, Tara/0000-0002-1379-5290				Anarfi JK, 2011, SEX CULT, V15, P1, DOI 10.1007/s12119-010-9078-6; [Anonymous], 2001, BLACKWELL HDB SOCIAL; BELSKY J, 1991, CHILD DEV, V62, P647, DOI 10.1111/j.1467-8624.1991.tb01558.x; Ben Hamida S, 1998, J PERS SOC PSYCHOL, V75, P953, DOI 10.1037/0022-3514.75.4.953; Brase GL, 2004, PERS INDIV DIFFER, V36, P471, DOI 10.1016/S0191-8869(03)00117-X; Bredow CA, 2011, PERS RELATIONSHIP, V18, P39, DOI 10.1111/j.1475-6811.2010.01302.x; BUSS DM, 1989, BEHAV BRAIN SCI, V12, P1, DOI 10.1017/S0140525X00023992; BUSS DM, 1988, J PERS SOC PSYCHOL, V54, P616, DOI 10.1037/0022-3514.54.4.616; Campbell L, 2009, SELF IDENTITY, V8, P418, DOI 10.1080/15298860802505434; Campbell WK, 2002, J PERS SOC PSYCHOL, V83, P340, DOI [10.1037/0022-3514.83.2.340, 10.1037//0022-3514.83.2.340]; Costa PT, 2001, J PERS SOC PSYCHOL, V81, P322, DOI [10.1037/0022-3514.81.2.322, 10.1037//0022-3514.81.2.322]; Eagly AH, 1999, AM PSYCHOL, V54, P408, DOI 10.1037/0003-066X.54.6.408; Eastwick PW, 2006, SEX ROLES, V54, P603, DOI 10.1007/s11199-006-9027-x; Fisher M., 2008, J SOCIAL EVOLUTIONAR, V2, P156, DOI [10.1037/h0099347, DOI 10.1037/H0099347]; GILBERT P, 1995, NEW IDEAS PSYCHOL, V13, P149, DOI 10.1016/0732-118X(95)00002-X; Goodwin R., 1999, PERSONAL RELATIONSHI; Goodwin R, 2008, PSYCHOL INQ, V19, P179, DOI 10.1080/10478400802592323; Hofstede G., 2009, GEERT HOFSTEDE CULTU; Holcomb HR, 2001, CONCEPTUAL CHALLENGE; Inglehart R, 2002, COMP SOCIOL, V1, P321, DOI 10.1163/156913302100418628; Inglehart R, 2000, AM SOCIOL REV, V65, P19, DOI 10.2307/2657288; Inglehart R, 2005, COMP CULTURES DIMENS, P74; Inglehart R., 2005, MODERNIZATION CULTUR; Inglehart Ronald, 2003, HUMAN VALUES SOCIAL; KENRICK DT, 1992, BEHAV BRAIN SCI, V15, P75, DOI 10.1017/S0140525X00067595; Kirkpatrick LA, 2002, J PERS SOC PSYCHOL, V82, P756, DOI 10.1037//0022-3514.82.5.756; Kirsner BR, 2009, EVOL PSYCHOL-US, V7, P374; Kline SL, 2009, J COMP FAM STUD, V40, P325, DOI 10.3138/jcfs.40.3.325; Kling KC, 1999, PSYCHOL BULL, V125, P470, DOI 10.1037/0033-2909.125.4.470; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; Leary MR, 2000, ADV EXP SOC PSYCHOL, V32, P1, DOI 10.1016/S0065-2601(00)80003-9; Lee AJ, 2011, BIOL LETTERS, V7, P892, DOI 10.1098/rsbl.2011.0454; Medora N. P., 2003, MATE SELECTION CULTU, P209; Michele. K. Surbey, 2007, [心理学报, Acta Psychologica Sinica], V39, P513; OPPONG C, 1980, J FAM HIST, V5, P197, DOI 10.1177/036319908000500205; Regan P. C., 1998, J PSYCHOL HUMAN SEXU, V10, P53, DOI DOI 10.1300/J056V10N01_04; Regan PC, 1998, PERS SOC PSYCHOL B, V24, P1294, DOI 10.1177/01461672982412004; Robins RW, 2001, PERS SOC PSYCHOL B, V27, P151, DOI 10.1177/0146167201272002; Schmitt DP, 2008, J PERS SOC PSYCHOL, V94, P168, DOI 10.1037/0022-3514.94.1.168; Schmitt DP, 2009, J RES PERS, V43, P830, DOI 10.1016/j.jrp.2009.05.008; Schmitt DP, 2005, BEHAV BRAIN SCI, V28, P247, DOI 10.1017/S0140525X05000051; Schwartz SH, 2006, VALUE DIMENSIONS CUL; Sedikides C, 2003, J PERS SOC PSYCHOL, V84, P60, DOI 10.1037/0022-3514.84.1.60; THIESSEN D, 1980, ETHOL SOCIOBIOL, V1, P111, DOI 10.1016/0162-3095(80)90003-5; Vinken H, 2005, COMP CULTURES DIMENS; Wilson M, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P2825; Zhang SY, 2009, J CROSS CULT PSYCHOL, V40, P3, DOI 10.1177/0022022108326192	47	25	25	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e36106	10.1371/journal.pone.0036106	http://dx.doi.org/10.1371/journal.pone.0036106			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VP	22558347	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345200117
J	Priore, SF; Moss, WN; Turner, DH				Priore, Salvatore F.; Moss, Walter N.; Turner, Douglas H.			Influenza A Virus Coding Regions Exhibit Host-Specific Global Ordered RNA Structure	PLOS ONE			English	Article							INTERSPECIES TRANSMISSION; SECONDARY STRUCTURE; PROTEIN; H1N1; EVOLUTION; NUCLEOPROTEIN; REPLICATION; TEMPERATURE; DEPENDENCE; VIRULENCE	Influenza A is a significant public health threat, partially because of its capacity to readily exchange gene segments between different host species to form novel pandemic strains. An understanding of the fundamental factors providing species barriers between different influenza hosts would facilitate identification of strains capable of leading to pandemic outbreaks and could also inform vaccine development. Here, we describe the difference in predicted RNA secondary structure stability that exists between avian, swine and human coding regions. The results predict that global ordered RNA structure exists in influenza A segments 1, 5, 7 and 8, and that ranges of free energies for secondary structure formation differ between host strains. The predicted free energy distributions for strains from avian, swine, and human species suggest criteria for segment reassortment and strains that might be ideal candidates for viral attenuation and vaccine development.	[Priore, Salvatore F.] Univ Rochester, Dept Chem, Rochester, NY 14627 USA; Univ Rochester, Ctr RNA Biol, Rochester, NY USA	University of Rochester; University of Rochester	Priore, SF (corresponding author), Univ Rochester, Dept Chem, Rochester, NY 14627 USA.	turner@chem.rochester.edu	Moss, Walter/H-8096-2019	Moss, Walter/0000-0001-6419-5570	NIH [T32 GM07356, R01 GM22939]; FOGARTY INTERNATIONAL CENTER [R03TW008739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022939, T32GM007356] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	S.F.P. was a trainee in the Medical Scientist Training Program funded by NIH T32 GM07356. This work was also supported by NIH R01 GM22939. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baigent SJ, 2003, BIOESSAYS, V25, P657, DOI 10.1002/bies.10303; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Chen BJ, 2008, J VIROL, V82, P10059, DOI 10.1128/JVI.01184-08; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Clote P, 2005, RNA, V11, P578, DOI 10.1261/rna.7220505; Dushoff J, 2006, AM J EPIDEMIOL, V163, P181, DOI 10.1093/aje/kwj024; Gomez-Puertas P, 2000, J VIROL, V74, P11538, DOI 10.1128/JVI.74.24.11538-11547.2000; Greenberg H, 2011, BIRKHAUSER ADV INFEC, P273, DOI 10.1007/978-3-0346-0279-2_11; Gultyaev AP, 2007, BIOINFORMATICS, V23, P272, DOI 10.1093/bioinformatics/btl559; Gultyaev AP, 2010, INT REV IMMUNOL, V29, P533, DOI 10.3109/08830185.2010.507828; Gultyaev AP, 2010, RNA BIOL, V7, P125, DOI 10.4161/rna.7.2.11287; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hass J, 2011, INFECT GENET EVOL, V11, P437, DOI 10.1016/j.meegid.2010.12.001; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Ilyinskii PO, 2009, OMICS, V13, P421, DOI 10.1089/omi.2009.0036; Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818; Ma Wenjun, 2008, J Mol Genet Med, V3, P158; Massin P, 2010, VET MICROBIOL, V142, P232, DOI 10.1016/j.vetmic.2009.10.012; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; MCCAULEY JW, 1990, VIRUS RES, V17, P191, DOI 10.1016/0168-1702(90)90064-I; Moss WN, 2011, RNA, V17, P991, DOI 10.1261/rna.2619511; MURPHY BR, 1982, INFECT IMMUN, V37, P1119, DOI 10.1128/IAI.37.3.1119-1126.1982; O'Neill RE, 1998, EMBO J, V17, P288, DOI 10.1093/emboj/17.1.288; Simmonds P, 1999, J VIROL, V73, P5787, DOI 10.1128/JVI.73.7.5787-5794.1999; Simmonds P, 2004, RNA, V10, P1337, DOI 10.1261/rna.7640104; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; SNYDER MH, 1987, J VIROL, V61, P2857, DOI 10.1128/JVI.61.9.2857-2863.1987; SOMVANSHI P, 2008, J PROTEOM BIOINFORM, V1, P219, DOI DOI 10.4172/JPB.1000026; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; TIAN SF, 1985, J VIROL, V53, P771, DOI 10.1128/JVI.53.3.771-775.1985; Trifonov V, 2009, NEW ENGL J MED, V361, P115, DOI 10.1056/NEJMp0904572; Wise HM, 2011, NUCLEIC ACIDS RES, V39, P7775, DOI 10.1093/nar/gkr487	32	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35989	10.1371/journal.pone.0035989	http://dx.doi.org/10.1371/journal.pone.0035989			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558296	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345200105
J	Coburn, GA; Fisch, DN; Moorji, SM; de Muys, JM; Murga, JD; Paul, D; Provoncha, KP; Rotshteyn, Y; Han, AQ; Qian, DP; Maddon, PJ; Olson, WC				Coburn, Glen A.; Fisch, Danielle N.; Moorji, Sameer M.; de Muys, Jean-Marc; Murga, Jose D.; Paul, Dorothy; Provoncha, Kathleen P.; Rotshteyn, Yakov; Han, Amy Q.; Qian, Dapeng; Maddon, Paul J.; Olson, William C.			Novel Small-Molecule Inhibitors of Hepatitis C Virus Entry Block Viral Spread and Promote Viral Clearance in Cell Culture	PLOS ONE			English	Article							B TYPE-I; DENSITY-LIPOPROTEIN RECEPTOR; GENOTYPE 1 INFECTION; ENVELOPE GLYCOPROTEIN; CD81; INTERFERON; IDENTIFICATION; CORECEPTOR; RIBAVIRIN; STEP	Combinations of direct-acting anti-virals offer the potential to improve the efficacy, tolerability and duration of the current treatment regimen for hepatitis C virus (HCV) infection. Viral entry represents a distinct therapeutic target that has been validated clinically for a number of pathogenic viruses. To discover novel inhibitors of HCV entry, we conducted a high throughput screen of a proprietary small-molecule compound library using HCV pseudoviral particle (HCVpp) technology. We independently discovered and optimized a series of 1,3,5-triazine compounds that are potent, selective and non-cytotoxic inhibitors of HCV entry. Representative compounds fully suppress both cell-free virus and cell-to-cell spread of HCV in vitro. We demonstrate, for the first time, that long term treatment of an HCV cell culture with a potent entry inhibitor promotes sustained viral clearance in vitro. We have confirmed that a single amino acid variant, V719G, in the transmembrane domain of E2 is sufficient to confer resistance to multiple compounds from the triazine series. Resistance studies were extended by evaluating both the fusogenic properties and growth kinetics of drug-induced and natural amino acid variants in the HCVpp and HCV cell culture assays. Our results indicate that amino acid variations at position 719 incur a significant fitness penalty. Introduction of I719 into a genotype 1b envelope sequence did not affect HCV entry; however, the overall level of HCV replication was reduced compared to the parental genotype 1b/2a HCV strain. Consistent with these findings, I719 represents a significant fraction of the naturally occurring genotype 1b sequences. Importantly, I719, the most relevant natural polymorphism, did not significantly alter the susceptibility of HCV to the triazine compounds. The preclinical properties of these triazine compounds support further investigation of entry inhibitors as a potential novel therapy for HCV infection.	[Coburn, Glen A.; Fisch, Danielle N.; Moorji, Sameer M.; de Muys, Jean-Marc; Murga, Jose D.; Paul, Dorothy; Provoncha, Kathleen P.; Rotshteyn, Yakov; Han, Amy Q.; Qian, Dapeng; Maddon, Paul J.; Olson, William C.] Progen Pharmaceut Inc, Res & Dev, Tarrytown, NY USA		Coburn, GA (corresponding author), Progen Pharmaceut Inc, Res & Dev, Tarrytown, NY USA.	gcoburn@progenics.com			National Institutes of Health [R44AI051134]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI051134] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant R44AI051134 to GAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Baldick CJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001086; Benedicto I, 2008, HEPATOLOGY, V48, P1044, DOI 10.1002/hep.22465; Brimacombe CL, 2011, J VIROL, V85, P596, DOI 10.1128/JVI.01592-10; COBURN G, 2009, Patent No. 2009091388; Cormier EG, 2004, P NATL ACAD SCI USA, V101, P7270, DOI 10.1073/pnas.0402253101; Dahari H, 2007, J THEOR BIOL, V247, P371, DOI 10.1016/j.jtbi.2007.03.006; Deng L, 2008, J VIROL, V82, P10375, DOI 10.1128/JVI.00395-08; Dixit NM, 2004, NATURE, V432, P922, DOI 10.1038/nature03153; Drummer HE, 2002, J VIROL, V76, P11143, DOI 10.1128/JVI.76.21.11143-11147.2002; Dubuisson J, 2008, CELL MICROBIOL, V10, P821, DOI 10.1111/j.1462-5822.2007.01107.x; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Flint M, 1999, J VIROL, V73, P6235, DOI 10.1128/JVI.73.8.6235-6244.1999; Freeman A, 2003, J VIRAL HEPATITIS, V10, P345, DOI 10.1046/j.1365-2893.2003.00454.x; Germi R, 2002, J MED VIROL, V68, P206, DOI 10.1002/jmv.10196; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Grove J, 2007, J VIROL, V81, P3162, DOI 10.1128/JVI.02356-06; Harris HJ, 2008, J VIROL, V82, P5007, DOI 10.1128/JVI.02286-07; Howe AYM, 2004, ANTIMICROB AGENTS CH, V48, P4813, DOI 10.1128/AAC.48.12.4813-4821.2004; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Joyce MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000291; Kuiken C, 2008, NUCLEIC ACIDS RES, V36, pD512, DOI 10.1093/nar/gkm962; Lavillette D, 2005, HEPATOLOGY, V41, P265, DOI 10.1002/hep.20542; Liang YQ, 2009, GASTROENTEROLOGY, V137, P1448, DOI 10.1053/j.gastro.2009.07.050; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Meuleman P, 2008, HEPATOLOGY, V48, P1761, DOI 10.1002/hep.22547; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Olsen DB, 2011, ANTIMICROB AGENTS CH, V55, P937, DOI 10.1128/AAC.00990-10; Owsianka AM, 2006, J VIROL, V80, P8695, DOI 10.1128/JVI.00271-06; Perni RB, 2006, ANTIMICROB AGENTS CH, V50, P899, DOI 10.1128/AAC.50.3.899-909.2006; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Rodriguez-Inigo E, 2005, J MOL DIAGN, V7, P535, DOI 10.1016/S1525-1578(10)60585-5; Rong L, 2010, CRIT REV IMMUNOL, V30, P131, DOI 10.1615/CritRevImmunol.v30.i2.30; Sainz B, 2012, NAT MED, V18, P281, DOI 10.1038/nm.2581; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Syder AJ, 2011, J HEPATOL, V54, P48, DOI 10.1016/j.jhep.2010.06.024; Timpe JM, 2008, HEPATOLOGY, V47, P17, DOI 10.1002/hep.21959; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; Voisset C, 2005, J BIOL CHEM, V280, P7793, DOI 10.1074/jbc.M411600200; Walters KA, 2006, PLOS PATHOG, V2, P591, DOI 10.1371/journal.ppat.0020059; Zeisel MB, 2007, HEPATOLOGY, V46, P1722, DOI 10.1002/hep.21994; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019; Zhang YJ, 2008, ANTIMICROB AGENTS CH, V52, P666, DOI 10.1128/AAC.01133-07; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	53	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35351	10.1371/journal.pone.0035351	http://dx.doi.org/10.1371/journal.pone.0035351			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545104	gold, Green Submitted, Green Published			2022-12-27	WOS:000305343200025
J	Guerra, FM; Gommerman, JL; Corfe, SA; Paige, CJ; Rottapel, R				Guerra, Fiona M.; Gommerman, Jennifer L.; Corfe, Steven A.; Paige, Christopher J.; Rottapel, Robert			Homeodomain-Interacting Protein Kinase (HIPK)-1 Is Required for Splenic B Cell Homeostasis and Optimal T-Independent Type 2 Humoral Response	PLOS ONE			English	Article							MARGINAL-ZONE; C-MYB; BONE-MARROW; CYTOPLASMIC TRANSLOCATION; INDUCED DESUMOYLATION; ADAPTER PROTEIN; GENE-EXPRESSION; FATE DECISION; HIPK2; P53	The homeodomain-interacting protein kinase (HIPK) family is comprised of four highly related serine/threonine kinases originally identified as co-repressors for various homeodomain-containing transcription factors. The HIPKs have been shown to be involved in growth regulation and apoptosis, with numerous studies highlighting HIPK regulation of the tumor suppressor p53. In this study, we have discovered a B cell homeostatic defect in HIPK1-deficient (HIPK1(-/-)) mice. Lymphopoietic populations within the thymus and bone marrow of HIPK1(-/-) mice appeared normal based upon FACS analysis; however, the spleen exhibited a reduced number of total B cells with a significant loss of transitional-1 and follicular B cell populations. Interestingly, the marginal zone B cell population was expanded in HIPK1(-/-) mice, yielding an increased frequency of these cells. HIPK1(-/-) B cells exhibited impaired cell division in response to B cell receptor cross-linking in vitro based upon thymidine incorporation or CFSE dilution; however, the addition of CD40L rescued HIPK1(-/-) proliferation to wild-type levels. Despite the expanded MZ B cell population in the HIPK1(-/-) mice, the T-independent type 2 humoral response was impaired. These data identify HIPK1 as a novel kinase required for optimal B cell function in mice.	[Guerra, Fiona M.; Gommerman, Jennifer L.; Corfe, Steven A.; Paige, Christopher J.; Rottapel, Robert] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Guerra, Fiona M.; Corfe, Steven A.; Paige, Christopher J.; Rottapel, Robert] Ontario Canc Inst, Toronto, ON M4X 1K9, Canada; [Rottapel, Robert] Ontario Inst Canc Res, Toronto, ON, Canada; [Paige, Christopher J.; Rottapel, Robert] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Rottapel, Robert] St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Paige, Christopher J.; Rottapel, Robert] Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Guerra, FM (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	rottapel@uhnresearch.ca		Gommerman, Jennifer/0000-0003-4576-6168; Rottapel, Robert/0000-0002-6024-5558	National Cancer Institute of Canada (NCIC): Terry Fox Group [20003]; Canadian Institutes of Health Research (CIHR) [MOP-86681]; Ontario Graduate Scholarships in Science and Technology (OGSST); Ontario Student Opportunity Trust Funds (OSOTF); Molecular Medicine Canadian Institutes of Health Research (CIHR)	National Cancer Institute of Canada (NCIC): Terry Fox Group; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarships in Science and Technology (OGSST); Ontario Student Opportunity Trust Funds (OSOTF); Molecular Medicine Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was funded in part by the National Cancer Institute of Canada (NCIC): Terry Fox Group Grant: Molecular biology of hemopoietic progression and function: Program Project Grant #20003, Canadian Institutes of Health Research (CIHR) Operating Grant-MOP-86681, Ontario Graduate Scholarships in Science and Technology (OGSST), Ontario Student Opportunity Trust Funds (OSOTF), and the Molecular Medicine Canadian Institutes of Health Research (CIHR) Collaborative Graduate Training Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agenes F, 1999, J EXP MED, V189, P319, DOI 10.1084/jem.189.2.319; Agenes F, 1997, EUR J IMMUNOL, V27, P1801, DOI 10.1002/eji.1830270731; Aikawa Y, 2006, EMBO J, V25, P3955, DOI 10.1038/sj.emboj.7601273; Allman D, 2004, IMMUNOL REV, V197, P147, DOI 10.1111/j.0105-2896.2004.0108.x; Arai S, 2007, FEBS LETT, V581, P5649, DOI 10.1016/j.febslet.2007.11.022; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Calzado MA, 2007, CELL CYCLE, V6, P139, DOI 10.4161/cc.6.2.3788; Cariappa A, 2005, IMMUNITY, V23, P397, DOI 10.1016/j.immuni.2005.09.004; Cariappa A, 2001, IMMUNITY, V14, P603, DOI 10.1016/S1074-7613(01)00135-2; Cariappa A, 2007, BLOOD, V109, P2339, DOI 10.1182/blood-2006-05-021089; Carvalho TL, 2001, J EXP MED, V194, P1141, DOI 10.1084/jem.194.8.1141; Casola S, 2007, CURR OPIN IMMUNOL, V19, P143, DOI 10.1016/j.coi.2007.02.010; Chen G, 2007, MOL CELL BIOL, V27, P3109, DOI 10.1128/MCB.01014-06; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Ecsedy JA, 2003, MOL CELL BIOL, V23, P950, DOI 10.1128/MCB.23.3.950-960.2003; GOLAY J, 1992, J IMMUNOL, V149, P300; Gresko E, 2005, BIOCHEM BIOPH RES CO, V329, P1293, DOI 10.1016/j.bbrc.2005.02.113; Hao ZY, 2001, J EXP MED, V194, P1151, DOI 10.1084/jem.194.8.1151; Harada J, 2003, J BIOL CHEM, V278, P38998, DOI 10.1074/jbc.M307112200; Hardy RR, 2006, J IMMUNOL, V177, P2749, DOI 10.4049/jimmunol.177.5.2749; Hattangadi SM, 2010, BLOOD; He Qin, 2010, Mol Cell Pharmacol, V2, P61; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Iacovelli S, 2009, CELL PROLIFERAT, V42, P373, DOI 10.1111/j.1365-2184.2009.00601.x; Isono K, 2006, MOL CELL BIOL, V26, P2758, DOI 10.1128/MCB.26.7.2758-2771.2006; Kaminski DA, 2006, J IMMUNOL, V177, P6025, DOI 10.4049/jimmunol.177.9.6025; Kanei-Ishii C, 2004, J BIOL CHEM, V279, P44582, DOI 10.1074/jbc.M407831200; Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604; Kanei-Ishii C, 2008, J BIOL CHEM, V283, P30540, DOI 10.1074/jbc.M804340200; Kim EA, 2006, J BIOL CHEM, V281, P7489, DOI 10.1074/jbc.M507227200; Kim EJ, 2002, J BIOL CHEM, V277, P32020, DOI 10.1074/jbc.M200153200; Kim YH, 1998, J BIOL CHEM, V273, P25875, DOI 10.1074/jbc.273.40.25875; Kondo S, 2003, P NATL ACAD SCI USA, V100, P5431, DOI 10.1073/pnas.0530308100; Kurahashi T, 2005, MOL BIOL CELL, V16, P4705, DOI 10.1091/mbc.E05-05-0470; Lee W, 2009, DEV BIOL, V325, P263, DOI 10.1016/j.ydbio.2008.10.029; Lee W, 2009, DEVELOPMENT, V136, P241, DOI 10.1242/dev.025460; Li QX, 2007, CANCER RES, V67, P66, DOI 10.1158/0008-5472.CAN-06-1671; Li X, 2008, CELL DEATH DIFFER, V15, P739, DOI 10.1038/sj.cdd.4402303; Li XH, 2005, J BIOL CHEM, V280, P15061, DOI 10.1074/jbc.M414262200; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; Pierantoni GM, 2007, J CLIN INVEST, V117, P693, DOI 10.1172/JCI29852; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Rui YN, 2004, EMBO J, V23, P4583, DOI 10.1038/sj.emboj.7600475; Samardzic T, 2002, EUR J IMMUNOL, V32, P2481, DOI 10.1002/1521-4141(200209)32:9<2481::AID-IMMU2481>3.0.CO;2-C; Song JJ, 2005, J CELL BIOL, V170, P61, DOI 10.1083/jcb.200502070; Takaki S, 2003, J IMMUNOL, V170, P703, DOI 10.4049/jimmunol.170.2.703; Thomas MD, 2005, IMMUNITY, V23, P275, DOI 10.1016/j.immuni.2005.08.005; Wang JH, 1998, IMMUNITY, V9, P543, DOI 10.1016/S1074-7613(00)80637-8; Wiggins AK, 2004, J CELL BIOL, V167, P257, DOI 10.1083/jcb.200406131; Zhang OH, 2003, CELL, V115, P177, DOI 10.1016/S0092-8674(03)00802-X; Zhang QH, 2005, P NATL ACAD SCI USA, V102, P2802, DOI 10.1073/pnas.0409373102; Zhang QC, 2007, J PROTEOME RES, V6, P4711, DOI 10.1021/pr700571d; Zhang XK, 2008, J IMMUNOL, V181, P1644, DOI 10.4049/jimmunol.181.3.1644	59	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35533	10.1371/journal.pone.0035533	http://dx.doi.org/10.1371/journal.pone.0035533			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545114	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343200034
J	Kusy, S; Ghosn, EEB; Herzenberg, LA; Contag, CH				Kusy, Sophie; Ghosn, Eliver E. B.; Herzenberg, Leonore A.; Contag, Christopher H.			Development of B Cells and Erythrocytes Is Specifically Impaired by the Drug Celastrol in Mice	PLOS ONE			English	Article							KAPPA-B; TRANSCRIPTION FACTORS; RHEUMATOID-ARTHRITIS; GOD VINE; HOOK-F; INHIBITOR; DISEASE; THUNDER; AGENTS; MODEL	Background: Celastrol, an active compound extracted from the root of the Chinese medicine "Thunder of God Vine" (Tripterygium wilfordii), exhibits anticancer, antioxidant and anti-inflammatory activities, and interest in the therapeutic potential of celastrol is increasing. However, described side effects following treatment are significant and require investigation prior to initiating clinical trials. Here, we investigated the effects of celastrol on the adult murine hematopoietic system. Methodology/Principal Findings: Animals were treated daily with celastrol over a four-day period and peripheral blood, bone marrow, spleen, and peritoneal cavity were harvested for cell phenotyping. Treated mice showed specific impairment of the development of B cells and erythrocytes in all tested organs. In bone marrow, these alterations were accompanied by decreases in populations of common lymphoid progenitors (CLP), common myeloid progenitors (CMP) and megakaryocyte-erythrocyte progenitors (MEP). Conclusions/Significance: These results indicate that celastrol acts through regulators of adult hematopoiesis and could be used as a modulator of the hematopoietic system. These observations provide valuable information for further assessment prior to clinical trials.	[Kusy, Sophie; Contag, Christopher H.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Ghosn, Eliver E. B.; Herzenberg, Leonore A.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Contag, Christopher H.] Stanford Univ, Dept Radiol, Sch Med, Stanford, CA 94305 USA; [Contag, Christopher H.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Kusy, Sophie; Contag, Christopher H.] Stanford Univ, Sch Med, Mol Imaging Program Stanford MIPS, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Kusy, S (corresponding author), Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA.	skusy@stanford.edu	Ghosn, Eliver/AAO-5788-2020	Ghosn, Eliver/0000-0001-7258-906X; Contag, Christopher/0000-0002-1011-8278	National Institutes of Health [CA49605, AI076434]; NATIONAL CANCER INSTITUTE [P01CA049605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076434, R56AI076434] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by grants from the National Institutes of Health (CA49605 and AI076434). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2007, CLIN CANCER RES, V13, P6769, DOI 10.1158/1078-0432.CCR-07-1536; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Cao YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020634; Cleren C, 2005, J NEUROCHEM, V94, P995, DOI 10.1111/j.1471-4159.2005.03253.x; Davenport A, 2010, INT J MOL MED, V25, P465, DOI 10.3892/ijmm_00000366; Gerondakis S, 1999, ONCOGENE, V18, P6888, DOI 10.1038/sj.onc.1203236; Grossmann M, 1999, P NATL ACAD SCI USA, V96, P11848, DOI 10.1073/pnas.96.21.11848; Hassane DC, 2008, BLOOD, V111, P5654, DOI 10.1182/blood-2007-11-126003; Kannaiyan R, 2011, CANCER LETT, V303, P9, DOI 10.1016/j.canlet.2010.10.025; Kim DY, 2009, EUR J PHARMACOL, V612, P98, DOI 10.1016/j.ejphar.2009.03.078; Kusy S, 2011, CELL STEM CELL, V8, P412, DOI 10.1016/j.stem.2011.02.005; Lee JH, 2006, BIOCHEM PHARMACOL, V72, P1311, DOI 10.1016/j.bcp.2006.08.014; Lipsky PE, 1997, SEMIN ARTHRITIS RHEU, V26, P713, DOI 10.1016/S0049-0172(97)80040-6; Liu Y, 2006, BLOOD, V108, P123, DOI 10.1182/blood-2005-11-4458; Paris D, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-17; Peng B, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-79; Pinna GF, 2004, BIOCHEM BIOPH RES CO, V322, P778, DOI 10.1016/j.bbrc.2004.07.186; Pyatt DW, 2000, MOL PHARMACOL, V57, P512, DOI 10.1124/mol.57.3.512; TAO XL, 1989, CHINESE MED J-PEKING, V102, P327; Wang SF, 2011, DRUG CHEM TOXICOL, V34, P61, DOI 10.3109/01480545.2010.494664; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Yang Y, 2007, P NATL ACAD SCI USA, V104, P4542, DOI 10.1073/pnas.0700001104; Zhang MY, 1998, BLOOD, V91, P4136, DOI 10.1182/blood.V91.11.4136.411k26_4136_4144	23	16	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35733	10.1371/journal.pone.0035733	http://dx.doi.org/10.1371/journal.pone.0035733			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545133	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343200053
J	Horikawa, M; Yagi, A				Horikawa, Masami; Yagi, Akihiro			The Relationships among Trait Anxiety, State Anxiety and the Goal Performance of Penalty Shoot-Out by University Soccer Players	PLOS ONE			English	Article							PROCESSING EFFICIENCY THEORY; ATTENTIONAL CONTROL; PRESSURE; CHOKING; KICKS	The present study examined how the level of trait anxiety, which is a personality characteristic, influences state anxiety and penalty shoot-out performance under pressure by instruction. The high and low trait anxiety groups were selected by using Spielberger's Trait Anxiety Scale, with trait anxiety scores, and control and pressure conditions manipulated by instructions. The participants were two groups of eight university male soccer players. They individually performed 20 shots from the penalty shoot-out point, aiming at the top right and top left corner areas in the soccer goal. Each condition had 10 trials in a within-subject design. The dependent measures comprised the number of successful goals and the state anxiety scores under each instructional condition. The result showed a significant main effect of instruction. State anxiety scores increased more and the number of successful goals decreased more in high trait anxiety groups than in low trait anxiety groups under pressure instructional condition. These findings suggest that players with higher trait anxiety scores tend to experience increased state anxiety under a pressure-laden condition, and higher state anxiety interferes with goal performance.	[Horikawa, Masami; Yagi, Akihiro] Kwansei Gakuin Univ, Dept Psychol Sci, Nishinomiya, Hyogo, Japan	Kwansei Gakuin University	Horikawa, M (corresponding author), Kwansei Gakuin Univ, Dept Psychol Sci, Nishinomiya, Hyogo, Japan.	horikawa@kwansei.ac.jp						Behan M, 2008, J SPORT SCI, V26, P207, DOI 10.1080/02640410701446919; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; EYSENCK MW, 1992, COGNITION EMOTION, V6, P409, DOI 10.1080/02699939208409696; Hardy L., 1990, STRESS PERFORMANCE S, P81; JONES, 1995, SPORT PSYCHOL, V9, P201; JONES G, 1995, BRIT J PSYCHOL, V86, P449, DOI 10.1111/j.2044-8295.1995.tb02565.x; JONES G, 1994, PERS INDIV DIFFER, V17, P657, DOI 10.1016/0191-8869(94)90138-4; Jordet G, 2009, J SPORT SCI, V27, P97, DOI 10.1080/02640410802509144; Jordet G, 2008, J SPORT EXERCISE PSY, V30, P450, DOI 10.1123/jsep.30.4.450; Jordet G, 2007, J SPORT SCI, V25, P121, DOI 10.1080/02640410600624020; Kishimoto Y., 1986, RES B FACULTY GEN ED, V17, P1; Martons R, 1977, SPORT COMPETITIVE AN; Martons R, 1990, COMPETITIVE ANXIETY; Moll T, 2010, J SPORT SCI, V28, P983, DOI 10.1080/02640414.2010.484068; Murray NP, 2007, J SPORT SCI, V25, P161, DOI 10.1080/02640410600598505; Spielberger C., 1983, STAI MANUAL; Spielberger C. D., 1972, FRONT PSYCHOL, V11, P102; Spielberger CD, 1966, ANXIETY BEHAV; Vine SJ, 2011, ACTA PSYCHOL, V136, P340, DOI 10.1016/j.actpsy.2010.12.008; Vine SJ, 2010, J APPL SPORT PSYCHOL, V22, P361, DOI 10.1080/10413200.2010.495106; Wilson M., 2008, INT REV SPORT EXER P, V1, P184, DOI [https://doi.org/10.1080/17509840802400787, DOI 10.1080/17509840802400787]; Wilson MR, 2009, J SPORT EXERCISE PSY, V31, P761, DOI 10.1123/jsep.31.6.761; Wood G, 2010, J SPORT SCI, V28, P937, DOI 10.1080/02640414.2010.495995; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503	24	45	47	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35727	10.1371/journal.pone.0035727	http://dx.doi.org/10.1371/journal.pone.0035727			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UP	22539998	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341000064
J	Sommeijer, JP; Levelt, CN				Sommeijer, Jean-Pierre; Levelt, Christiaan N.			Synaptotagmin-2 Is a Reliable Marker for Parvalbumin Positive Inhibitory Boutons in the Mouse Visual Cortex	PLOS ONE			English	Article							VESICULAR GABA TRANSPORTER; FAST-SPIKING CELLS; CA2+ SENSORS; NEUROTRANSMITTER RELEASE; TRANSMITTER RELEASE; GABAERGIC INTERNEURONS; POSTNATAL-DEVELOPMENT; DEPENDENT PLASTICITY; CEREBRAL-CORTEX; CRITICAL-PERIOD	Background: Inhibitory innervation by parvalbumin (PV) expressing interneurons has been implicated in the onset of the sensitive period of visual plasticity. Immunohistochemical analysis of the development and plasticity of these inhibitory inputs is difficult because PV expression is low in young animals and strongly influenced by neuronal activity. Moreover, the synaptic boutons that PV neurons form onto each other cannot be distinguished from the innervated cell bodies by immunostaining for this protein because it is present throughout the cells. These problems call for the availability of a synaptic, activity-independent marker for PV+ inhibitory boutons that is expressed before sensitive period onset. We investigated whether synaptotagmin-2 (Syt2) fulfills these properties in the visual cortex. Syt2 is a synaptic vesicle protein involved in fast Ca2+ dependent neurotransmitter release. Its mRNA expression follows a pattern similar to that of PV throughout the brain and is present in 30-40% of hippocampal PV expressing basket cells. Up to now, no quantitative analyses of Syt2 expression in the visual cortex have been carried out. Methodology/Principal Findings: We used immunohistochemistry to analyze colocalization of Syt2 with multiple interneuron markers including vesicular GABA transporter VGAT, calbindin, calretinin, somatostatin and PV in the primary visual cortex of mice during development and after dark-rearing. Conclusions/Significance: We show that in the adult visual cortex Syt2 is only found in inhibitory, VGAT positive boutons. Practically all Syt2 positive boutons also contain PV and vice versa. During development, Syt2 expression can be detected in synaptic boutons prior to PV and in contrast to PV expression, Syt2 is not down-regulated by dark-rearing. These properties of Syt2 make it an excellent marker for analyzing the development and plasticity of perisomatic inhibitory innervations onto both excitatory and inhibitory neurons in the visual cortex.	[Sommeijer, Jean-Pierre; Levelt, Christiaan N.] Netherlands Inst Neurosci, Dept Mol Visual Neurosci, Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Sommeijer, JP (corresponding author), Netherlands Inst Neurosci, Dept Mol Visual Neurosci, Amsterdam, Netherlands.	c.levelt@nin.knaw.nl			AgentschapNL of the Ministry of Health, Welfare and Sports (VWS); European Commission [223326]; Netherlands Organization for Scientific Research (NWO-ALW)	AgentschapNL of the Ministry of Health, Welfare and Sports (VWS); European Commission(European CommissionEuropean Commission Joint Research Centre); Netherlands Organization for Scientific Research (NWO-ALW)(Netherlands Organization for Scientific Research (NWO))	JPS and CNL were funded by a governmental non-commercial grant from AgentschapNL of the Ministry of Health, Welfare and Sports (VWS) to the NeuroBasic PharmaPhenomics Consortium. CNL was funded by an FP7 grant from the European Commission (number 223326, "EuroV1sion") and an "Open Competition" grant from the Netherlands Organization for Scientific Research (NWO-ALW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCANTARA S, 1993, ANAT EMBRYOL, V188, P63; Allen Institute for Brain Science, 2009, ALL MOUS BRAIN ATL; Bucurenciu I, 2008, NEURON, V57, P536, DOI 10.1016/j.neuron.2007.12.026; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; CELLERINO A, 1992, NEUROSCIENCE, V51, P749, DOI 10.1016/0306-4522(92)90514-3; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; DELRIO JA, 1994, DEV BRAIN RES, V81, P247, DOI 10.1016/0165-3806(94)90311-5; Eggermann E, 2012, NAT REV NEUROSCI, V13, P7, DOI 10.1038/nrn3125; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fox MA, 2007, J COMP NEUROL, V503, P280, DOI 10.1002/cne.21381; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Galarreta M, 2002, P NATL ACAD SCI USA, V99, P12438, DOI 10.1073/pnas.192159599; Garcia-Junco-Clemente P, 2010, J NEUROSCI, V30, P7377, DOI 10.1523/JNEUROSCI.0924-10.2010; GEPPERT M, 1991, J BIOL CHEM, V266, P13548; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Hanover JL, 1999, J NEUROSCI, V19, part. no.; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Jiang M, 2005, NEUROSCIENCE, V135, P839, DOI 10.1016/j.neuroscience.2005.06.073; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kerr AM, 2008, P NATL ACAD SCI USA, V105, P15581, DOI 10.1073/pnas.0800621105; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; LI C, 1995, J BIOL CHEM, V270, P24898, DOI 10.1074/jbc.270.42.24898; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Minelli A, 2003, NEUROSCIENCE, V117, P337, DOI 10.1016/S0306-4522(02)00864-3; Muller M, 2007, J NEUROSCI, V27, P2261, DOI 10.1523/JNEUROSCI.5582-06.2007; Nagy G, 2006, J NEUROSCI, V26, P632, DOI 10.1523/JNEUROSCI.2589-05.2006; Pang ZPP, 2006, J NEUROSCI, V26, P13493, DOI 10.1523/JNEUROSCI.3519-06.2006; Pang ZP, 2006, EMBO J, V25, P2039, DOI 10.1038/sj.emboj.7601103; Sugita S, 2002, EMBO J, V21, P270, DOI 10.1093/emboj/21.3.270; Sugiyama S, 2008, CELL, V134, P508, DOI 10.1016/j.cell.2008.05.054; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Tamas G, 1998, J NEUROSCI, V18, P4255; Tropea D, 2006, NAT NEUROSCI, V9, P660, DOI 10.1038/nn1689; ULLRICH B, 1994, NEURON, V13, P1281, DOI 10.1016/0896-6273(94)90415-4; VANBREDERODE JFM, 1991, NEUROSCIENCE, V44, P157, DOI 10.1016/0306-4522(91)90258-P; Xu J, 2007, NEURON, V54, P567, DOI 10.1016/j.neuron.2007.05.004; Yazaki-Sugiyama Y, 2009, NATURE, V462, P218, DOI 10.1038/nature08485; Young SM, 2009, NEURON, V63, P482, DOI 10.1016/j.neuron.2009.07.028	42	47	47	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35323	10.1371/journal.pone.0035323	http://dx.doi.org/10.1371/journal.pone.0035323			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539967	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341000032
J	Barriuso, J; Valverde, JR; Mellado, RP				Barriuso, Jorge; Valverde, Jose R.; Mellado, Rafael P.			Effect of Cry1Ab Protein on Rhizobacterial Communities of Bt-Maize over a Four-Year Cultivation Period	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS; MICROBIAL COMMUNITIES; HERBICIDE GLYPHOSATE; INSECTICIDAL TOXIN; TRANSGENIC PLANTS; RARE BIOSPHERE; IN-SITU; SOIL; DIVERSITY; CORN	Background: Bt-maize is a transgenic variety of maize expressing the Cry toxin from Bacillus turingiensis. The potential accumulation of the relative effect of the transgenic modification and the cry toxin on the rhizobacterial communities of Bt-maize has been monitored over a period of four years. Methodology/Principal Findings: The accumulative effects of the cultivation of this transgenic plant have been monitored by means of high throughput DNA pyrosequencing of the bacterial DNA coding for the 16S rRNA hypervariable V6 region from rhizobacterial communities. The obtained sequences were subjected to taxonomic, phylogenetic and taxonomic-independent diversity studies. The results obtained were consistent, indicating that variations detected in the rhizobacterial community structure were possibly due to climatic factors rather than to the presence of the Bt-gene. No variations were observed in the diversity estimates between non-Bt and Bt-maize. Conclusions/Significance: The cultivation of Bt-maize during the four-year period did not change the maize rhizobacterial communities when compared to those of the non-Bt maize. This is the first study to be conducted with Bt-maize during such a long cultivation period and the first evaluation of rhizobacterial communities to be performed in this transgenic plant using Next Generation Sequencing.	[Barriuso, Jorge; Valverde, Jose R.; Mellado, Rafael P.] CSIC, Ctr Nacl Biotecnol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Barriuso, J (corresponding author), CSIC, Ctr Nacl Biotecnol, Campus Univ Autonoma, Madrid, Spain.	rpmellado@cnb.csic.es	Barriuso, Jorge/AAF-6118-2020; Mellado, Rafael P/D-2680-2009; Valverde, Jose R/K-8853-2014	Valverde, Jose R/0000-0002-6655-7114; Barriuso, Jorge/0000-0003-0916-6560	The Spanish Ministry of the Environment and Rural and Marine affairs [EGO22008]	The Spanish Ministry of the Environment and Rural and Marine affairs	The Spanish Ministry of the Environment and Rural and Marine affairs has commissioned and supported this research (Grant No. EGO22008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2010, APPL SOIL ECOL, V45, P13, DOI 10.1016/j.apsoil.2010.01.005; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Barriuso J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-473; Barriuso J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027558; Barriuso J, 2011, MICROBES ENVIRON, V26, P332, DOI 10.1264/jsme2.ME11137; Barriuso J, 2010, ENVIRON MICROBIOL, V12, P1021, DOI 10.1111/j.1462-2920.2009.02146.x; Blackwood CB, 2004, J ENVIRON QUAL, V33, P832, DOI 10.2134/jeq2004.0832; Brusetti L, 2004, PLANT SOIL, V266, P11; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Coz I, 2008, J ENVIRON QUAL, V37, P647, DOI 10.2134/jeq2007.0352; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hodgson DA, 2000, ADV MICROB PHYSIOL, V42, P47, DOI 10.1016/S0065-2911(00)42003-5; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huson DH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S12; Icoz I, 2008, SOIL BIOL BIOCHEM, V40, P559, DOI 10.1016/j.soilbio.2007.11.002; Jangid K, 2008, SOIL BIOL BIOCHEM, V40, P2843, DOI 10.1016/j.soilbio.2008.07.030; Kersters K, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P3, DOI 10.1007/0-387-30745-1_1; Kielak A, 2009, ISME J, V3, P378, DOI 10.1038/ismej.2008.113; Kielak AM, 2010, APPL ENVIRON MICROB, V76, P6769, DOI 10.1128/AEM.00343-10; Koskella J, 1997, APPL ENVIRON MICROB, V63, P3561, DOI 10.1128/AEM.63.9.3561-3568.1997; Liu B, 2005, PLANT SOIL, V271, P1, DOI 10.1007/s11104-004-1610-8; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Muchaonyerwa P, 2004, PLANT SOIL, V266, P41; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1713, DOI 10.1093/bioinformatics/btp326; Priestley AL, 2009, TRANSGENIC RES, V18, P425, DOI 10.1007/s11248-008-9234-z; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Saxena D, 2000, FEMS MICROBIOL ECOL, V33, P35, DOI 10.1111/j.1574-6941.2000.tb00724.x; Saxena D, 2001, AM J BOT, V88, P1704, DOI 10.2307/3558416; Saxena D, 2001, SOIL BIOL BIOCHEM, V33, P1225, DOI 10.1016/S0038-0717(01)00027-X; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stotzky G, 2004, PLANT SOIL, V266, P77; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; Tan FX, 2010, PLANT SOIL, V329, P349, DOI 10.1007/s11104-009-0163-2; Val G, 2009, MICROB ECOL, V58, P108, DOI 10.1007/s00248-008-9451-2; van Leeuwen W, 2001, J EXP BOT, V52, P949, DOI 10.1093/jexbot/52.358.949; Windels P, 2001, EUR FOOD RES TECHNOL, V213, P107, DOI 10.1007/s002170100336	39	36	39	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35481	10.1371/journal.pone.0035481	http://dx.doi.org/10.1371/journal.pone.0035481			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558158	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340200018
J	Fischer, MD; Willmann, G; Schatz, A; Schommer, K; Zhour, A; Zrenner, E; Bartz-Schmidt, KU; Gekeler, F				Fischer, M. Dominik; Willmann, Gabriel; Schatz, Andreas; Schommer, Kai; Zhour, Ahmad; Zrenner, Eberhart; Bartz-Schmidt, Karl U.; Gekeler, Florian			Structural and Functional Changes of the Human Macula during Acute Exposure to High Altitude	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; ENDOTHELIAL GROWTH-FACTOR; ACUTE MOUNTAIN-SICKNESS; VISUAL-ACUITY TEST; THICKNESS MEASUREMENTS; DIABETIC-RETINOPATHY; PHOTOCOAGULATION; VARIABILITY; INSIGHTS; EVEREST	Background: This study aimed to quantify structural and functional changes at the macula during acute exposure to high altitude and to assess their structure/function relationship. This work is related to the Tuebingen High Altitude Ophthalmology (THAO) study. Methodology/Principal Findings: Spectral domain optical coherence tomography and microperimetry were used to quantify changes of central retinal structure and function in 14 healthy subjects during acute exposure to high altitude (4559 m). High-resolution volume scans and fundus-controlled microperimetry of the posterior pole were performed in addition to best-corrected visual acuity (BCVA) measurements and assessment of acute mountain sickness. Analysis of measurements at altitude vs. baseline revealed increased total retinal thickness (TRT) in all four outer ETDRS grid subfields during acute altitude exposure (TRTouter = 2.80 +/- 1.00 mm; mean change +/- 95% CI). This change was inverted towards the inner four subfields (TRTinner = -1.89 +/- 0.97 mm) with significant reduction of TRT in the fovea (TRTfoveal = -6.62 +/- 0.90 mu m) at altitude. BCVA revealed no significant difference compared to baseline (0.06 +/- 0.08 logMAR). Microperimetry showed stable mean sensitivity in all but the foveal subfield (MSfoveal = -1.12 +/- 0.68 dB). At baseline recordings before and >2 weeks after high altitude exposure, all subjects showed equal levels with no sign of persisting structural or functional sequels. Conclusions/Significance: During acute exposure to high altitude central retinal thickness is subject to minor, yet statistically significant changes. These alterations describe a function of eccentricity with an increase in regions with relatively higher retinal nerve fiber content and vascular arcades. However, these changes did not correlate with measures of central retinal function or acute mountain sickness. For the first time a quantitative approach has been used to assess these changes during acute, non-acclimatized high altitude exposure.	[Fischer, M. Dominik; Willmann, Gabriel; Schatz, Andreas; Zhour, Ahmad; Zrenner, Eberhart; Bartz-Schmidt, Karl U.; Gekeler, Florian] Univ Tubingen, Ctr Ophthalmol, Tubingen, Germany; [Schommer, Kai] Univ Heidelberg Hosp, Med Clin, Dept Sports Med, Heidelberg, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Ruprecht Karls University Heidelberg	Fischer, MD (corresponding author), Univ Oxford, Nuffield Lab Ophthalmol, Walton St, Oxford OX2 6AW, England.	Gabriel.Willmann@med.uni-tuebingen.de			Wilderness Medical Society (WMS); Charles Houston Award; Novartis; Bausch Lomb; Alcon; Allergan; Ursapharm; IMS Gear; OptimaPharma; Wilderness Medical Association; Heidelberg Engineering	Wilderness Medical Society (WMS); Charles Houston Award; Novartis(Novartis); Bausch Lomb; Alcon(Novartis); Allergan(AbbVieAllergan); Ursapharm; IMS Gear; OptimaPharma; Wilderness Medical Association; Heidelberg Engineering	This study was supported by the Wilderness Medical Society (WMS) with the Charles Houston Award. Additional unconditional grants were provided by Novartis, Bausch & Lomb, Alcon, Allergan, Ursapharm, IMS Gear and OptimaPharma. The Heidelberg Spectralis OCT was provided by Heidelberg Engineering. The study also received private donations by Martin Rohrbach, Till Schoeffel, Ulrich Gekeler, Christina Fasser, Eduard Schatz und Norbert Willmann. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests: This study was supported by Wilderness Medical Association, Novartis, Bausch & Lomb, Alcon, Allergan, Ursapharm, OptimaPharma, IMS Gear and Heidelberg Engineering. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Arora R, 2011, SINGAP MED J, V52, P687; Ascaso FJ, 2012, EUR J OPHTHALMOL, V22, P580, DOI 10.5301/ejo.5000091; Bach M, 1996, OPTOMETRY VISION SCI, V73, P49, DOI 10.1097/00006324-199601000-00008; Bach M, 2007, GRAEF ARCH CLIN EXP, V245, P965, DOI 10.1007/s00417-006-0474-4; Bailey DM, 2006, J CEREBR BLOOD F MET, V26, P99, DOI 10.1038/sj.jcbfm.9600169; Bandello F, 2011, CLIN OPHTHALMOL, V5, P1303, DOI 10.2147/OPTH.S17423; Binz N, 2006, FASEB J, V20, P383, DOI 10.1096/fj.05-3890fje; Bosch MM, 2008, ARCH OPHTHALMOL-CHIC, V126, P644, DOI 10.1001/archopht.126.5.644; Bosch MM, 2009, J APPL PHYSIOL, V106, P454, DOI 10.1152/japplphysiol.90904.2008; Bosch MM, 2010, ARCH OPHTHALMOL-CHIC, V128, P184, DOI 10.1001/archophthalmol.2009.385; Bosch MM, 2009, INVEST OPHTH VIS SCI, V51, P1609; Chen FK, 2009, INVEST OPHTH VIS SCI, V50, P3464, DOI 10.1167/iovs.08-2926; Cioffi GA., 2003, ADLERS PHYSL EYE, V10th ed., P747; Connolly DM, 2011, AVIAT SPACE ENVIR MD, V82, P2, DOI 10.3357/ASEM.2904.2011; FERRIS FL, 1987, OPHTHALMOLOGY, V94, P761; Fischer MD, 2011, MOVEMENT DISORD, V26, P914, DOI 10.1002/mds.23523; Grant MB, 2004, EXPERT OPIN INV DRUG, V13, P1275, DOI 10.1517/13543784.13.10.1275; Ho TY, 2011, RETINA-J RET VIT DIS, V31, P1650, DOI 10.1097/IAE.0b013e318207ceab; Issa PC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012864; KELLER HR, 1995, BMJ-BRIT MED J, V310, P1232, DOI 10.1136/bmj.310.6989.1232; Kernstock C, 2012, GRAEF ARCH CLIN EXP, V250, P583, DOI 10.1007/s00417-011-1825-3; Kurtenbach A, 2006, VISUAL NEUROSCI, V23, P651, DOI 10.1017/S095252380623339X; Kurtenbach A, 2010, DOC OPHTHALMOL, V120, P229, DOI 10.1007/s10633-010-9217-2; LIEBERMAN HR, 1982, BEHAV RES METH INSTR, V14, P21, DOI 10.3758/BF03202110; Lutty GA, 1996, ARCH OPHTHALMOL-CHIC, V114, P971, DOI 10.1001/archopht.1996.01100140179011; Menke MN, 2009, AM J OPHTHALMOL, V147, P467, DOI 10.1016/j.ajo.2008.09.005; Modesti PA, 2011, MED SCI SPORT EXER, V43, P1811, DOI 10.1249/MSS.0b013e31821b55df; Nguyen QD, 2004, INVEST OPHTH VIS SCI, V45, P617, DOI 10.1167/iovs.03-0557; Pavlidis M, 2005, OPHTHALMOLOGICA, V219, P404, DOI 10.1159/000088387; Rotsos TG, 2008, CLIN OPHTHALMOL, V2, P919; Seth RK, 2010, SEMIN OPHTHALMOL, V25, P13, DOI 10.3109/08820538.2010.481560; Sutherland AI, 2008, BRIT J SPORT MED, V42, P183, DOI 10.1136/bjsm.2007.045286; Troeger E, 2010, IEEE ENG MED BIO, P6280, DOI 10.1109/IEMBS.2010.5628081; Vinores SA, 1998, J NEUROIMMUNOL, V89, P43, DOI 10.1016/S0165-5728(98)00075-7; Willmann G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027022; Willmann G, 2010, BRIT J OPHTHALMOL, V94, P1393, DOI 10.1136/bjo.2009.178491; Wilson MH, 2008, HIGH ALT MED BIOL, V9, P319, DOI 10.1089/ham.2008.1026; Wolf-Schnurrbusch UEK, 2009, INVEST OPHTH VIS SCI, V50, P3432, DOI 10.1167/iovs.08-2970	38	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36155	10.1371/journal.pone.0036155	http://dx.doi.org/10.1371/journal.pone.0036155			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558365	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340200045
J	Kerkhofs, J; Roberts, SJ; Luyten, FP; Van Oosterwyck, H; Geris, L				Kerkhofs, Johan; Roberts, Scott J.; Luyten, Frank P.; Van Oosterwyck, Hans; Geris, Liesbet			Relating the Chondrocyte Gene Network to Growth Plate Morphology: From Genes to Phenotype	PLOS ONE			English	Article							HORMONE-RELATED PEPTIDE; INDIAN HEDGEHOG; REGULATORY NETWORKS; PARATHYROID-HORMONE; SIGNALING PATHWAYS; BONE-DEVELOPMENT; DUAL ROLES; PTHRP; DIFFERENTIATION; CHONDROGENESIS	During endochondral ossification, chondrocyte growth and differentiation is controlled by many local signalling pathways. Due to crosstalks and feedback mechanisms, these interwoven pathways display a network like structure. In this study, a large-scale literature based logical model of the growth plate network was developed. The network is able to capture the different states (resting, proliferating and hypertrophic) that chondrocytes go through as they progress within the growth plate. In a first corroboration step, the effect of mutations in various signalling pathways of the growth plate network was investigated.	[Kerkhofs, Johan; Geris, Liesbet] Univ Liege, Biomech Res Unit, Liege, Belgium; [Kerkhofs, Johan; Van Oosterwyck, Hans] Katholieke Univ Leuven, Biomech Sect, Louvain, Belgium; [Kerkhofs, Johan; Roberts, Scott J.; Luyten, Frank P.; Van Oosterwyck, Hans; Geris, Liesbet] Katholieke Univ Leuven, Leuven R&D Div Skeletal Tissue Engn, Louvain, Belgium; [Roberts, Scott J.; Luyten, Frank P.] Katholieke Univ Leuven, Dept Rheumatol, Louvain, Belgium	University of Liege; KU Leuven; KU Leuven; KU Leuven	Kerkhofs, J (corresponding author), Univ Liege, Biomech Res Unit, Liege, Belgium.	liesbet.geris@ulg.ac.be	Van Oosterwyck, Hans/C-2528-2016; Luyten, Frank/GPS-7793-2022; geris, liesbet/D-2343-2016	Van Oosterwyck, Hans/0000-0002-2142-9717; geris, liesbet/0000-0002-8180-1445	University of Liege [FRS.D-10/20]	University of Liege(University of Liege)	This work was supported by the Special Research Fund of the University of Liege (FRS.D-10/20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SL, 2007, J CELL PHYSIOL, V213, P635, DOI 10.1002/jcp.21262; Akiyama H, 2008, MOD RHEUMATOL, V18, P213, DOI 10.1007/s10165-008-0048-x; Alvarez J, 2002, DEVELOPMENT, V129, P1913; Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Brouwers JEM, 2006, J BIOMECH, V39, P2774, DOI 10.1016/j.jbiomech.2005.10.004; Burdan F, 2009, FOLIA HISTOCHEM CYTO, V47, P5, DOI 10.2478/v10042-009-0007-1; Chaouiya C, 2003, QUALITATIVE ANAL REG, P830; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Christensen C, 2007, IET SYST BIOL, V1, P61, DOI 10.1049/iet-syb:20060071; Darabos C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025110; Eichberger T, 2006, GENOMICS, V87, P616, DOI 10.1016/j.ygeno.2005.12.003; Enomoto-Iwamoto M, 2002, DEV BIOL, V251, P142, DOI 10.1006/dbio.2002.0802; Fasano A, 2010, J THEOR BIOL, V265, P543, DOI 10.1016/j.jtbi.2010.05.030; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; Garzon-Alvarado DA, 2009, BIOMECH MODEL MECHAN, V8, P381, DOI 10.1007/s10237-008-0144-z; Garzon-Alvarado DA, 2009, COMPUT BIOL MED, V39, P554, DOI 10.1016/j.compbiomed.2009.03.012; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hartmann C, 2000, DEVELOPMENT, V127, P3141; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Hattori T, 2010, DEVELOPMENT, V137, P901, DOI 10.1242/dev.045203; Hecht J, 2007, GENE EXPR PATTERNS, V7, P102, DOI 10.1016/j.modgep.2006.05.014; HUBERMAN BA, 1993, P NATL ACAD SCI USA, V90, P7716, DOI 10.1073/pnas.90.16.7716; Hyman JM, 2009, P NATL ACAD SCI USA, V106, P14132, DOI 10.1073/pnas.0907134106; Jonason JH, 2009, J DENT RES, V88, P693, DOI 10.1177/0022034509341629; Klemm K, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.055101; Kobayashi T, 2002, DEVELOPMENT, V129, P2977; Komori T, 2003, J BONE MINER METAB, V21, P193, DOI 10.1007/s00774-002-0408-0; Kozhemyakina E, 2009, MOL CELL BIOL, V29, P5751, DOI 10.1128/MCB.00415-09; Koziel L, 2005, DEVELOPMENT, V132, P5249, DOI 10.1242/dev.02097; Kronenberg HM, 2006, ANN NY ACAD SCI, V1068, P1, DOI 10.1196/annals.1346.002; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Lefebvre Veronique, 2005, Birth Defects Research, V75, P200, DOI 10.1002/bdrc.20048; Lenas P, 2009, TISSUE ENG PART B-RE, V15, P395, DOI [10.1089/ten.teb.2009.0461, 10.1089/ten.TEB.2009.0461]; Lenas P, 2009, TISSUE ENG PART B-RE, V15, P381, DOI 10.1089/ten.TEB.2008.0575; Li TF, 2005, FRONT BIOSCI-LANDMRK, V10, P681, DOI 10.2741/1563; Liu ZH, 2002, GENE DEV, V16, P859, DOI 10.1101/gad.965602; Mak KK, 2008, DEVELOPMENT, V135, P1947, DOI 10.1242/dev.018044; Mau E, 2007, DEV BIOL, V305, P28, DOI 10.1016/j.ydbio.2007.01.031; Mendoza L, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-13; Morris MK, 2010, BIOCHEMISTRY-US, V49, P3216, DOI 10.1021/bi902202q; Naldi A, 2009, BIOSYSTEMS, V97, P134, DOI 10.1016/j.biosystems.2009.04.008; Naski MC, 1996, NAT GENET, V13, P233, DOI 10.1038/ng0696-233; Naski MC, 1998, DEVELOPMENT, V125, P4977; Nilsson O, 2007, J ENDOCRINOL, V193, P75, DOI 10.1677/joe.1.07099; Ogawa T, 2003, J BONE MINER METAB, V21, P145, DOI 10.1007/s007740300023; Oh CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010113; Oliveira SM, 2009, TISSUE ENG PT A, V15, P635, DOI 10.1089/ten.tea.2008.0052; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Ouyang ZQ, 2009, P NATL ACAD SCI USA, V106, P21521, DOI 10.1073/pnas.0904863106; Plahte E, 1998, J MATH BIOL, V36, P321, DOI 10.1007/s002850050103; Pogue R, 2006, CURR TOP DEV BIOL, V76, P1, DOI 10.1016/S0070-2153(06)76001-X; Retting KN, 2009, DEVELOPMENT, V136, P1093, DOI 10.1242/dev.029926; Riemer S, 2002, J CELL BIOCHEM, V86, P688, DOI 10.1002/jcb.10260; Schipani E, 1996, NEW ENGL J MED, V335, P708, DOI 10.1056/NEJM199609053351004; Schlatter R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000595; Schlitt T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S9; Segre G, 1997, J BONE MINER METAB, V15, P109; Seshadhri C, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.108701; Shum L, 2002, ARTHRITIS RES, V4, P94, DOI 10.1186/ar396; Solomon Lauren A., 2008, Birth Defects Research, V84, P123, DOI 10.1002/bdrc.20124; Susperregui ARG, 2008, J CELL PHYSIOL, V216, P144, DOI 10.1002/jcp.21389; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; van Donkelaar CC, 2007, BIOMECH MODEL MECHAN, V6, P55, DOI 10.1007/s10237-006-0035-0; Verdicchio MP, 2011, BIOCOMPUT-PAC SYM, P350; Vortkamp A, 1998, MECH DEVELOP, V71, P65, DOI 10.1016/S0925-4773(97)00203-7; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wang L, 2010, J BONE MINER RES, V25, P1138, DOI 10.1002/jbmr.5; Weir EC, 1996, P NATL ACAD SCI USA, V93, P10240, DOI 10.1073/pnas.93.19.10240; Wessels L F, 2001, Pac Symp Biocomput, P508; Wuelling M, 2010, PEDIATR NEPHROL, V25, P625, DOI 10.1007/s00467-009-1368-6; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191	74	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e34729	10.1371/journal.pone.0034729	http://dx.doi.org/10.1371/journal.pone.0034729			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558096	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340200006
J	Min, J; Lukowski, ZL; Levine, MA; Meyers, CA; Beattie, AR; Schultz, GS; Samuelson, DA; Sherwood, MB				Min, Jeff; Lukowski, Zachary L.; Levine, Monica A.; Meyers, Craig A.; Beattie, Ashley R.; Schultz, Gregory S.; Samuelson, Don A.; Sherwood, Mark B.			Prevention of Ocular Scarring Post Glaucoma Filtration Surgery Using the Inflammatory Cell and Platelet Binding Modulator Saratin in a Rabbit Model	PLOS ONE			English	Article							TENONS CAPSULE FIBROBLASTS; MITOMYCIN-C; INTRAOPERATIVE 5-FLUOROURACIL; GROWTH-FACTORS; COLLAGEN; TRABECULECTOMY; INHIBITOR; ACTIVATION	Clinical Relevance: Late complications can occur with use of current antimetabolites to prevent scarring following glaucoma filtration surgery (GFS). Safer, more targeted, anti-fibrosis agents are sought. Objectives: The protein saratin has been shown to exhibit anti-fibrotic and anti-thrombotic properties in response to injury, but had not been used for glaucoma surgery. The goal of this study was to compare the efficacy of saratin with that of the widely accepted mitomycin-C (MMC) in prolonging bleb survival following GFS in the rabbit model. Two saratin delivery routes were compared; a single intraoperative topical application versus a combination of intraoperative topical application with two additional postoperative injections. Methods: Twenty-four New Zealand White rabbits underwent GFS and received either intraoperative topical saratin, intraoperative topical saratin plus two injections on post-operative days 4 and 8, balanced saline solution (BSS), or MMC. The bleb tissues and their elevation durations were compared based on clinical and histological findings. Results: Rabbits receiving topical+injections of saratin had a mean bleb survival of 33.6 +/- 8.5 days, significantly higher than the negative BSS controls, which averaged 17.4 +/- 6.0 days (p = 0.018). No improvement over BSS was seen for rabbits receiving topical saratin only (15.5 +/- 4.8 days, p = 0.749). Rabbits receiving saratin did not develop bleb avascularity and thinning associated with MMC treatment and there were no apparent clinical signs of toxicity. Conclusions: Treatment with a single intraoperative topical application plus two additional postoperative injections significantly prolonged bleb elevation comparable to MMC, but without toxicity; however, topical application alone was ineffective.	[Min, Jeff; Lukowski, Zachary L.; Levine, Monica A.; Meyers, Craig A.; Beattie, Ashley R.; Sherwood, Mark B.] Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA; [Schultz, Gregory S.] Univ Florida, Coll Med, Dept Ob Gyn, Gainesville, FL USA; [Schultz, Gregory S.] Univ Florida, Coll Med, Inst Wound Healing, Gainesville, FL USA; [Samuelson, Don A.] Univ Florida, Coll Vet Med, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Min, J (corresponding author), Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA.	Sherwood@ufl.edu	Samuelson, Don/GXA-0970-2022	Min, Jeff/0000-0003-4633-6792	Biovasc Incorporated [00067832]; Research to Prevent Blindness [00068545]; NATIONAL EYE INSTITUTE [P30EY021721] Funding Source: NIH RePORTER	Biovasc Incorporated; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Biovasc Incorporated supplied the protein Saratin used in the study as well as funding for the research with Award # 00067832 (http://www.biovascularinc.com/saratin.html). Research to Prevent Blindness also provided grant support for the study on project # 00068545 (www.rpbusa.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank BioVasc Incorporated for supplying the protein saratin used in the study as well as funding for the research. We also extend thanks to the Research to Prevent Blindness for their generous grant.	Anand N, 2006, BRIT J OPHTHALMOL, V90, P175, DOI 10.1136/bjo.2005.077800; Barnes CS, 2001, SEMIN THROMB HEMOST, V27, P337, DOI 10.1055/s-2001-16887; Beckers HJM, 2003, GRAEF ARCH CLIN EXP, V241, P106, DOI 10.1007/s00417-002-0621-5; Bindlish R, 2002, OPHTHALMOLOGY, V109, P1336, DOI 10.1016/S0161-6420(02)01069-2; Bonnefoy A, 2006, J THROMB HAEMOST, V4, P2151, DOI 10.1111/j.1538-7836.2006.02111.x; Burr J., 2005, COCHRANE DB SYST REV, V18; Connon CJ, 2003, WOUND REPAIR REGEN, V11, P71, DOI 10.1046/j.1524-475X.2003.11111.x; Cordeiro MF, 1997, INVEST OPHTH VIS SCI, V38, P1639; Davis JA, 2004, AM J SURG, V188, P778, DOI 10.1016/j.amjsurg.2004.08.061; DeBry PW, 2002, ARCH OPHTHALMOL-CHIC, V120, P297; Denk PO, 2003, CURR EYE RES, V27, P35, DOI 10.1076/ceyr.27.2.35.15456; DOYLE JW, 1993, INVEST OPHTH VIS SCI, V34, P3313; Dugrillon A, 2002, INT J ORAL MAX SURG, V31, P615, DOI 10.1054/ijom.2002.0322; Francis BA, 2005, ARCH OPHTHALMOL-CHIC, V123, P166, DOI 10.1001/archopht.123.2.166; Gehring S, 1999, TRANSFUSION, V39, P144, DOI 10.1046/j.1537-2995.1999.39299154727.x; Glidden PF, 2010, Patent, Patent No. [US7691839B2, 7691839]; Gronwald W, 2008, J MOL BIOL, V381, P913, DOI 10.1016/j.jmb.2008.06.034; KHAW PT, 1993, OPHTHALMOLOGY, V100, P367; KHAW PT, 1994, EYE, V8, P188, DOI 10.1038/eye.1994.44; Knorr M, 1997, GRAEF ARCH CLIN EXP, V235, P667, DOI 10.1007/BF00946945; Li ZQ, 2009, INVEST OPHTH VIS SCI, V50, P5217, DOI 10.1167/iovs.08-2662; Meyer-Ter-Vehn T, 2008, INVEST OPHTH VIS SCI, V49, P3955, DOI 10.1167/iovs.07-1610; Muckley ED, 2004, OPTOMETRY VISION SCI, V81, P499, DOI 10.1097/00006324-200407000-00010; SCHULTZ G, 1994, EYE, V8, P184, DOI 10.1038/eye.1994.43; Sherwood MB, 2004, J GLAUCOMA, V13, P407, DOI 10.1097/01.ijg.0000131482.86547.5a; Smith Todd P, 2003, Vasc Endovascular Surg, V37, P259, DOI 10.1177/153857440303700405; Vilahur G, 2004, THROMB HAEMOSTASIS, V92, P191, DOI 10.1160/TH03-11-0687; White TC, 2007, FEBS J, V274, P1481, DOI 10.1111/j.1742-4658.2007.05689.x; Xiao YQ, 2009, INVEST OPHTH VIS SCI, V50, P1698, DOI 10.1167/iovs.08-1675	29	22	23	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35627	10.1371/journal.pone.0035627	http://dx.doi.org/10.1371/journal.pone.0035627			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558182	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340200021
J	Wolber, LE; Steves, CJ; Spector, TD; Williams, FMK				Wolber, Lisa E.; Steves, Claire J.; Spector, Tim D.; Williams, Frances M. K.			Hearing Ability with Age in Northern European Women: A New Web-Based Approach to Genetic Studies	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RISK-FACTORS; IMPAIRMENT; SUSCEPTIBILITY; POLYMORPHISM; SMOKING; NOISE	Age-related hearing impairment (ARHI) affects 25-40% of individuals over the age of 65. Despite the high prevalence of this complex trait, ARHI is still poorly understood. We hypothesized that variance in hearing ability with age is largely determined by genetic factors. We collected audiologic data on females of Northern European ancestry and compared different audiogram representations. A web-based speech-to-noise ratio (SNR) hearing test was compared with pure-tone thresholds to see if we could determine accurately hearing ability on people at home and the genetic contribution to each trait compared. Volunteers were recruited from the TwinsUK cohort. Hearing ability was determined using pure-tone audiometry and a web-based hearing test. Different audiogram presentations were compared for age-correlation and reflection of audiogram shape. Using structural equation modelling based on the classical twin model the heritability of ARHI, as measured by the different phenotypes, was estimated and shared variance between the web-based SNR test and pure-tone audiometry determined using bivariate modelling. Pure-tone audiometric data was collected on 1033 older females (age: 41-86). 1970 volunteers (males and females, age: 18-85) participated in the SNR. In the comparison between different ARHI phenotypes the difference between the first two principle components (PC1-PC2) best represented ARHI. The SNR test showed a sensitivity and specificity of 89% and 80%, respectively, in comparison with pure-tone audiogram data. Univariate heritability estimates ranged from 0.70 (95% CI: 0.63-0.76) for (PC1-PC2) to 0.56 (95% CI: 0.48-0.63) for PC2. The genetic correlation of PC1-PC2 and SNR was 20.67 showing that the 2 traits share variances attributed to additive genetic factors. Hearing ability showed considerable heritability in our sample. We have shown that the SNR test provides a useful surrogate marker of hearing. This will enable a much larger sample to be collected at a fraction of the cost, facilitating future genetic association studies.	[Wolber, Lisa E.; Steves, Claire J.; Spector, Tim D.; Williams, Frances M. K.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England	University of London; King's College London	Wolber, LE (corresponding author), Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England.	lisa.wolber@kcl.ac.uk		Williams, Frances/0000-0002-2998-2744; Steves, Claire/0000-0002-4910-0489	Action on Hearing Loss; Research into Ageing; RNID [S20] Funding Source: researchfish	Action on Hearing Loss; Research into Ageing; RNID	The authors would like to acknowledge Action on Hearing Loss and Research into Ageing for the financial support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ActionOnHearingLoss, 2011, CHEK YOUR HEAR ONL H; Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Dalton DS, 2003, GERONTOLOGIST, V43, P661, DOI 10.1093/geront/43.5.661; DeStefano AL, 2003, ARCH OTOLARYNGOL, V129, P285, DOI 10.1001/archotol.129.3.285; Fransen E, 2004, EAR HEARING, V25, P133, DOI 10.1097/01.AUD.0000120362.69077.0B; Fransen E, 2008, JARO-J ASSOC RES OTO, V9, P264, DOI 10.1007/s10162-008-0123-1; Friedman RA, 2009, HUM MOL GENET, V18, P785, DOI 10.1093/hmg/ddn402; Garringer HJ, 2006, ARCH OTOLARYNGOL, V132, P506, DOI 10.1001/archotol.132.5.506; Gates GA, 1999, ARCH OTOLARYNGOL, V125, P654, DOI 10.1001/archotol.125.6.654; Huyghe JR, 2008, AM J HUM GENET, V83, P401, DOI 10.1016/j.ajhg.2008.08.002; Itoh A, 2001, PUBLIC HEALTH, V115, P192; Kakarlapudi V, 2003, OTOL NEUROTOL, V24, P382, DOI 10.1097/00129492-200305000-00006; Karlsson KK, 1997, EAR HEARING, V18, P114, DOI 10.1097/00003446-199704000-00003; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Neale M. C., 2006, MX STAT MODELING, V7th; NEALE MC, 1994, BEHAV GENET, V24, P119, DOI 10.1007/BF01067816; Organization WH, 2011, PREV BLINDN DEAFN; Perry JRB, 2009, NAT GENET, V41, P648, DOI 10.1038/ng.386; SCHUKNECHT HF, 1993, ANN OTO RHINOL LARYN, V102, P1; Smits C, 2004, INT J AUDIOL, V43, P15, DOI 10.1080/14992020400050004; Spector TD, 2006, TWIN RES HUM GENET, V9, P899, DOI 10.1375/twin.9.6.899; Torre P, 2005, J SPEECH LANG HEAR R, V48, P473, DOI 10.1044/1092-4388(2005/032); Unal M, 2005, LARYNGOSCOPE, V115, P2238, DOI 10.1097/01.mlg.0000183694.10583.12; Van Eyken E, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.049205; Van Laer L, 2008, HUM MOL GENET, V17, P159, DOI 10.1093/hmg/ddm292; Van Laer L, 2010, EUR J HUM GENET, V18, P685, DOI 10.1038/ejhg.2009.234; Viljanen A, 2007, J GERONTOL A-BIOL, V62, P447, DOI 10.1093/gerona/62.4.447	28	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35500	10.1371/journal.pone.0035500	http://dx.doi.org/10.1371/journal.pone.0035500			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558162	Green Submitted, Green Published, gold			2022-12-27	WOS:000305340200019
J	Crawford, TO; Paushkin, SV; Kobayashi, DT; Forrest, SJ; Joyce, CL; Finkel, RS; Kaufmann, P; Swoboda, KJ; Tiziano, D; Lomastro, R; Li, RH; Trachtenberg, FL; Plasterer, T; Chen, KS				Crawford, Thomas O.; Paushkin, Sergey V.; Kobayashi, Dione T.; Forrest, Suzanne J.; Joyce, Cynthia L.; Finkel, Richard S.; Kaufmann, Petra; Swoboda, Kathryn J.; Tiziano, Danilo; Lomastro, Rosa; Li, Rebecca H.; Trachtenberg, Felicia L.; Plasterer, Thomas; Chen, Karen S.		Pilot Study Biomarkers Spinal	Evaluation of SMN Protein, Transcript, and Copy Number in the Biomarkers for Spinal Muscular Atrophy (BforSMA) Clinical Study	PLOS ONE			English	Article							SURVIVAL MOTOR-NEURON; PLACEBO-CONTROLLED TRIAL; CRITICAL EXON; MESSENGER-RNA; SPLICING SILENCER; PERIPHERAL-BLOOD; DOUBLE-BLIND; PHENOTYPE; ELEMENT; GENE	Background: The universal presence of a gene (SMN2) nearly identical to the mutated SMN1 gene responsible for Spinal Muscular Atrophy (SMA) has proved an enticing incentive to therapeutics development. Early disappointments from putative SMN-enhancing agent clinical trials have increased interest in improving the assessment of SMN expression in blood as an early "biomarker'' of treatment effect. Methods: A cross-sectional, single visit, multi-center design assessed SMN transcript and protein in 108 SMA and 22 age and gender-matched healthy control subjects, while motor function was assessed by the Modified Hammersmith Functional Motor Scale (MHFMS). Enrollment selectively targeted a broad range of SMA subjects that would permit maximum power to distinguish the relative influence of SMN2 copy number, SMA type, present motor function, and age. Results: SMN2 copy number and levels of full-length SMN2 transcripts correlated with SMA type, and like SMN protein levels, were lower in SMA subjects compared to controls. No measure of SMN expression correlated strongly with MHFMS. A key finding is that SMN2 copy number, levels of transcript and protein showed no correlation with each other. Conclusion: This is a prospective study that uses the most advanced techniques of SMN transcript and protein measurement in a large selectively-recruited cohort of individuals with SMA. There is a relationship between measures of SMN expression in blood and SMA type, but not a strong correlation to motor function as measured by the MHFMS. Low SMN transcript and protein levels in the SMA subjects relative to controls suggest that these measures of SMN in accessible tissues may be amenable to an "early look'' for target engagement in clinical trials of putative SMN-enhancing agents. Full length SMN transcript abundance may provide insight into the molecular mechanism of phenotypic variation as a function of SMN2 copy number.	[Crawford, Thomas O.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA; [Crawford, Thomas O.] Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA; [Paushkin, Sergey V.; Kobayashi, Dione T.; Forrest, Suzanne J.; Joyce, Cynthia L.; Chen, Karen S.] Spinal Muscular Atrophy Fdn, New York, NY USA; [Finkel, Richard S.] Childrens Hosp Philadelphia, Dept Neurol, Philadelphia, PA 19104 USA; [Finkel, Richard S.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Finkel, Richard S.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Kaufmann, Petra] Columbia Univ, Dept Neurol, New York, NY USA; [Swoboda, Kathryn J.] Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT USA; [Swoboda, Kathryn J.] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA; [Tiziano, Danilo; Lomastro, Rosa] Univ Cattolica S Cuore, Inst Med Genet, Rome, Italy; [Li, Rebecca H.; Trachtenberg, Felicia L.] New England Res Inst Inc, Watertown, MA USA; [Plasterer, Thomas] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA	Johns Hopkins University; Johns Hopkins University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Columbia University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; HealthCore, Inc; Northeastern University	Crawford, TO (corresponding author), Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA.	tcrawfo@jhmi.edu	Tiziano, Francesco Danilo/A-7260-2010; SAHIN, MUSTAFA/I-8653-2019	Tiziano, Francesco Danilo/0000-0002-5545-6158; SAHIN, MUSTAFA/0000-0001-7044-2953; kobayashi, dione/0000-0002-5541-7175; Forrest, Suzanne/0000-0002-9797-7947; Joyce, Cynthia/0000-0002-5063-4859; Swoboda, Kathryn/0000-0002-4593-6342	Spinal Muscular Atrophy (SMA) Foundation (New York, New York); National Center for Research Resources (NCRR); National Institutes of Health (NIH) [UL1 RR025758-01, MO1-RR02172]; Columbia University SMA Clinical Research Center [NIH 1 UL1 RR024156]; The Ohio State University [UL1-RR025755]; University of Iowa [1UL1-RR024979, 1KL2-RR024980, 1TL1-RR024981]; University of Utah [UL1-RR025764, C06-RR11234]; The Johns Hopkins University [UL1-RR 025005]; Washington University [UL1- RR024992]; The Children's Hospital - Denver [UL1 RR025780]; Patient Advisory Group of the International Coordinating Committee for SMA Clinical Trials; Children's Hospital Boston [NIH UL1-RR-024134]; Children's Hospital of Philadelphia [NIH 1 UL1 RR024156]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069045] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992, TL1RR024981, UL1RR025764, UL1RR024979, C06RR011234, UL1RR025780, UL1RR024134, M01RR002172, UL1RR025005, UL1RR025758, UL1RR025755, UL1RR024156, KL2RR024980] Funding Source: NIH RePORTER	Spinal Muscular Atrophy (SMA) Foundation (New York, New York); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Columbia University SMA Clinical Research Center; The Ohio State University(Ohio State University); University of Iowa; University of Utah; The Johns Hopkins University(Johns Hopkins University); Washington University; The Children's Hospital - Denver; Patient Advisory Group of the International Coordinating Committee for SMA Clinical Trials; Children's Hospital Boston; Children's Hospital of Philadelphia; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was sponsored by the Spinal Muscular Atrophy (SMA) Foundation (New York, New York), who also had a role in the design of the study, data collection and analysis, decision to publish, and preparation of the manuscript. (www.smafoundation.org). Additional support for the described project was provided by the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) and NIH Roadmap for Medical Research, through grant numbers UL1 RR025758-01 & MO1-RR02172 Children's Hospital Boston; NIH UL1-RR-024134 (The Children's Hospital of Philadelphia), NIH 1 UL1 RR024156 Columbia University SMA Clinical Research Center; UL1-RR025755 The Ohio State University; 1UL1-RR024979, 1KL2-RR024980 & 1TL1-RR024981 University of Iowa; UL1-RR025764 & C06-RR11234 University of Utah; UL1-RR 025005 The Johns Hopkins University; UL1- RR024992 Washington University; UL1 RR025780 The Children's Hospital - Denver. The contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study acknowledges the collaboration of the International Spinal Muscular Atrophy Patient Registry (Indiana University), supported by the Patient Advisory Group of the International Coordinating Committee for SMA Clinical Trials which includes Families of SMA, FightSMA, Muscular Dystrophy Association, SMA Foundation, and other SMA advocacy groups.	Burghes AHM, 1997, AM J HUM GENET, V61, P9, DOI 10.1086/513913; Cartegni L, 2006, AM J HUM GENET, V78, P63, DOI 10.1086/498853; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Chang HCH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003209; Chen HH, 2008, MOL CELL BIOL, V28, P6929, DOI 10.1128/MCB.01332-08; Chen TH, 2010, NEUROLOGY, V75, P2190, DOI 10.1212/WNL.0b013e3182020332; Crawford TO, 2004, NEUROMUSCULAR DISORD, V14, P456, DOI 10.1016/j.nmd.2004.04.004; de Araujo MM, 2009, RNA, V15, P515, DOI 10.1261/rna.1273209; Dimitriadi M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001172; Dominguez E, 2011, HUM MOL GENET, V20, P681, DOI 10.1093/hmg/ddq514; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Finkel RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035462; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; Gomez-Curet I, 2007, NEUROGENETICS, V8, P271, DOI 10.1007/s10048-007-0093-1; Hastings ML, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000208; Hendrickson BC, 2009, J MED GENET, V46, P641, DOI 10.1136/jmg.2009.066969; Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; Kashima T, 2007, P NATL ACAD SCI USA, V104, P3426, DOI 10.1073/pnas.0700343104; Kaufmann P, 2011, ARCH NEUROL-CHICAGO, V0; Kolb SJ, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-6; Krosschell KJ, 2006, NEUROMUSCULAR DISORD, V16, P417, DOI 10.1016/j.nmd.2006.03.015; Lefebvre S, 2002, HUM MOL GENET, V11, P1017, DOI 10.1093/hmg/11.9.1017; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mailman MD, 2002, GENET MED, V4, P20, DOI 10.1097/00125817-200201000-00004; Mattis VB, 2006, HUM GENET, V120, P589, DOI 10.1007/s00439-006-0245-7; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; Mercuri E, 2007, NEUROLOGY, V68, P51, DOI 10.1212/01.wnl.0000249142.82285.d6; MUNSAT TL, 1992, NEUROMUSCULAR DISORD, V2, P423, DOI 10.1016/S0960-8966(06)80015-5; Ogino S, 2004, EUR J HUM GENET, V12, P1015, DOI 10.1038/sj.ejhg.5201288; Oprea GE, 2008, SCIENCE, V320, P524, DOI 10.1126/science.1155085; Oskoui M, 2007, NEUROLOGY, V69, P1931, DOI 10.1212/01.wnl.0000290830.40544.b9; Oskoui M, 2008, NEUROTHERAPEUTICS, V5, P499, DOI 10.1016/j.nurt.2008.08.007; Owen N, 2000, HUM MOL GENET, V9, P675, DOI 10.1093/hmg/9.5.675; Passini MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001777; Passini MA, 2010, J CLIN INVEST, V120, P1253, DOI 10.1172/JCI41615; Paushkin S, 2000, J BIOL CHEM, V275, P23841, DOI 10.1074/jbc.M001441200; Pedrotti S, 2010, EMBO J, V29, P1235, DOI 10.1038/emboj.2010.19; Prior TW, 2009, AM J HUM GENET, V85, P408, DOI 10.1016/j.ajhg.2009.08.002; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Sen A, 2011, J CELL BIOL, V192, P481, DOI 10.1083/jcb.201004016; Simard LR, 2007, NEUROLOGY, V68, P451, DOI 10.1212/01.wnl.0000252934.70676.ab; Singh NN, 2007, NUCLEIC ACIDS RES, V35, P371, DOI 10.1093/nar/gkl1050; Singh NN, 2011, MOL CELL BIOL, V31, P935, DOI 10.1128/MCB.00945-10; Singh NN, 2009, RNA BIOL, V6, P341, DOI 10.4161/rna.6.3.8723; Singh NK, 2006, MOL CELL BIOL, V26, P1333, DOI 10.1128/MCB.26.4.1333-1346.2006; Singh NN, 2004, RNA, V10, P1291, DOI 10.1261/rna.7580704; Sumner CJ, 2006, NEUROLOGY, V66, P1067, DOI 10.1212/01.wnl.0000201929.56928.13; Swoboda KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012140; Tiziano FD, 2010, EUR J HUM GENET, V18, P52, DOI 10.1038/ejhg.2009.116; Valori CF, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000830; Vezain M, 2007, EUR J HUM GENET, V15, P1054, DOI 10.1038/sj.ejhg.5201885; Wang J, 2001, J BIOL CHEM, V276, P45387, DOI 10.1074/jbc.M105059200; Wirth B, 1997, AM J HUM GENET, V61, P1102, DOI 10.1086/301608; Wirth B, 1999, AM J HUM GENET, V64, P1340, DOI 10.1086/302369	55	104	105	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e33572	10.1371/journal.pone.0033572	http://dx.doi.org/10.1371/journal.pone.0033572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558076	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336000006
J	Falcini, F; Jerolmack, DJ; Buongiorno Nardelli, B				Falcini, Frederico; Jerolmack, Douglas J.; Buongiorno Nardelli, Bruno			Mississippi River and Sea Surface Height Effects on Oil Slick Migration	PLOS ONE			English	Article							GULF-OF-MEXICO; SEDIMENT TRANSPORT; PLUME; SATELLITE; VARIABILITY; DISCHARGE; DYNAMICS; FATE	Millions of barrels of oil escaped into the Gulf of Mexico (GoM) after the 20 April, 2010 explosion of Deepwater Horizon (DH). Ocean circulation models were used to forecast oil slick migration in the GoM, however such models do not explicitly treat the effects of secondary eddy-slopes or Mississippi River (MR) hydrodynamics. Here we report oil front migration that appears to be driven by sea surface level (SSL) slopes, and identify a previously unreported effect of the MR plume: under conditions of relatively high river discharge and weak winds, a freshwater mound can form around the MR Delta. We performed temporal oil slick position and altimeter analysis, employing both interpolated altimetry data and along-track measurements for coastal applications. The observed freshwater mound appears to have pushed the DH oil slick seaward from the Delta coastline. We provide a physical mechanism for this novel effect of the MR, using a two-layer pressure-driven flow model. Results show how SSL variations can drive a cross-slope migration of surface oil slicks that may reach velocities of order km/day, and confirm a lag time of order 5-10 days between mound formation and slick migration, as observed form the satellite analysis. Incorporating these effects into more complex ocean models will improve forecasts of slick migration for future spills. More generally, large SSL variations at the MR mouth may also affect the dispersal of freshwater, nutrients and sediment associated with the MR plume.	[Falcini, Frederico] Univ Minnesota, St Anthony Falls Lab, Natl Ctr Earth Surface Dynam, Minneapolis, MN 55455 USA; [Jerolmack, Douglas J.] Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA; [Buongiorno Nardelli, Bruno] CNR, Ist Sci Stmosfera & Clima, Rome, Italy; [Buongiorno Nardelli, Bruno] CNR, Ist Ambiente Marino Costiero, I-80125 Naples, Italy	University of Minnesota System; University of Minnesota Twin Cities; University of Pennsylvania; Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR)	Falcini, F (corresponding author), Univ Minnesota, St Anthony Falls Lab, Natl Ctr Earth Surface Dynam, Minneapolis, MN 55455 USA.	ffalcini@umn.edu	Nardelli, Bruno Buongiorno/AAY-4289-2020; Nardelli, Bruno Buongiorno/I-4810-2012	Nardelli, Bruno Buongiorno/0000-0002-3416-7189; Falcini, Federico/0000-0001-8105-2491	National Science Foundation [EAR-1049969]	National Science Foundation(National Science Foundation (NSF))	This work was supported by The National Science Foundation through contract EAR-1049969 to Douglas J. Jerolmack. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astraldi M, 2001, J PHYS OCEANOGR, V31, P3457, DOI 10.1175/1520-0485(2001)031<3457:DWDATS>2.0.CO;2; BARGER WR, 1970, J APPL METEOROL, V9, P396, DOI DOI 10.1175/1520-0450(1970)009; D'Sa EJ, 2008, SENSORS-BASEL, V8, P4249, DOI 10.3390/s8074249; Dumont J. P., 2009, OSTM JASON 2 PRODUCT; Falcini F, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2010JF001802; Horner-Devine AR, 2009, CONT SHELF RES, V29, P234, DOI 10.1016/j.csr.2007.12.012; Horner-Devine AR, 2006, J FLUID MECH, V555, P203, DOI 10.1017/S0022112006008937; HOULT DP, 1972, ANNU REV FLUID MECH, V4, P341, DOI 10.1146/annurev.fl.04.010172.002013; Jernelov A, 2010, NATURE, V466, P182, DOI 10.1038/466182a; Joye S, 2010, NATURE GEOSCI, V3, P44611; Karadogan E, OCEANS 2009 MTS IEEE, P1; Kourafalou VH, 1996, J GEOPHYS RES-OCEANS, V101, P3415, DOI 10.1029/95JC03024; Lamb MP, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2011JF002079; Lane-Serff GF, 2000, J FLUID MECH, V416, P269, DOI 10.1017/S0022112000008958; Leben RR., 2002, MAR GEOD, V25, P3, DOI [10.1080/014904102753516697, DOI 10.1080/014904102753516697]; Marsaleix P, 1998, J MARINE SYST, V14, P99, DOI 10.1016/S0924-7963(97)00011-0; McCabe RM, 2009, J PHYS OCEANOGR, V39, P2839, DOI 10.1175/2009JPO4061.1; Mercier F., COASTAL HYDROLOGY AL; Mezic I, 2010, SCIENCE, V330, P486, DOI 10.1126/science.1194607; Morehead MD, 1999, MAR GEOL, V154, P29, DOI 10.1016/S0025-3227(98)00101-7; Nof D, 2001, J PHYS OCEANOGR, V31, P3045, DOI 10.1175/1520-0485(2001)031<3045:TBOO>2.0.CO;2; Pozrikidis C., 2001, FLUID DYNAM+; Puckridge JT, 1998, MAR FRESHWATER RES, V49, P55, DOI 10.1071/MF94161; Reed M, 1999, SPILL SCI TECHNOL B, V5, P3, DOI 10.1016/S1353-2561(98)00029-2; Rego JL, 2010, J COASTAL RES, V26, P212, DOI 10.2112/08-1072.1; Schiller RV, 2010, OCEAN MODEL, V33, P101, DOI 10.1016/j.ocemod.2009.12.005; Walker N., 2009, OCEANS 2009 MTS IEEE, P1; Walker N, OCEANS 2009 MTS IEEE, P1; Walker ND, 2005, J COASTAL RES, V21, P1228, DOI 10.2112/04-0347.1; Walker ND, 1996, REMOTE SENS ENVIRON, V58, P21, DOI 10.1016/0034-4257(95)00259-6; WRIGHT LD, 1995, ESTUARIES, V18, P494, DOI 10.2307/1352367; WRIGHT LD, 1977, GEOL SOC AM BULL, V88, P857, DOI 10.1130/0016-7606(1977)88<857:STADAR>2.0.CO;2; Yuan JC, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019335	33	7	7	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36037	10.1371/journal.pone.0036037	http://dx.doi.org/10.1371/journal.pone.0036037			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558317	Green Published, gold			2022-12-27	WOS:000305336000108
J	Liu, F; Zhu, JA; Wei, M; Bao, YQ; Hu, B				Liu, Fang; Zhu, Jiaan; Wei, Mei; Bao, Yuqian; Hu, Bing			Preliminary Evaluation of the Sural Nerve Using 22-MHz Ultrasound: A New Approach for Evaluation of Diabetic Cutaneous Neuropathy	PLOS ONE			English	Article							PERIPHERAL NEUROPATHY	Background: The application of 22-MHz high-frequency ultrasound allows for visualization of the inner part of the sural nerve. The aim of this study was to evaluate the morphological changes of sural nerves in patients with type 2 diabetes mellitus using ultrasound. Materials and Methods: The thickness/width (T/W) ratio, the cross-sectional area (CSA) of the sural nerves and the maximum thickness (MT) of the nerve fascicles were measured in 100 patients with type 2 diabetes mellitus and 50 healthy volunteers using 22-MHz ultrasound. Receiver operating characteristic (ROC) curves were plotted to determine the optimal cut-off values as well as the sensitivities and specificities. All parameters were significantly different between the subject and control groups. The ROC curves demonstrated that the MT was the most predictive of diabetic cutaneous neuropathy, with an optimal cut-off value of 0.365 mm that yielded a sensitivity of 90.3% and a specificity of 87.7%. Conclusions: The results of this study suggest that 22-MHz ultrasound may be a valuable tool for evaluating diabetic cutaneous nerve neuropathy.	[Liu, Fang; Zhu, Jiaan; Wei, Mei; Hu, Bing] Shanghai Jiao Tong Univ, Dept Ultrasound, Affiliated Peoples Hosp 6, Shanghai Inst Ultrasound Med, Shanghai 200030, Peoples R China; [Bao, Yuqian] Shanghai Jiao Tong Univ, Dept Endocrinol & Metab, Affiliated Peoples Hosp 6, Shanghai Diabet Inst, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Liu, F (corresponding author), Shanghai Jiao Tong Univ, Dept Ultrasound, Affiliated Peoples Hosp 6, Shanghai Inst Ultrasound Med, Shanghai 200030, Peoples R China.	zhuja@sjtu.edu.cn		zhu, Jiaan/0000-0001-8700-639X	Science and Technology Commission Foundation of Shanghai [11JC1409500]	Science and Technology Commission Foundation of Shanghai	This work was supported by the Key Programs of the Science and Technology Commission Foundation of Shanghai (Number: 11JC1409500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braune H J, 1999, Electromyogr Clin Neurophysiol, V39, P355; BUCHBERGER W, 1991, J ULTRAS MED, V10, P531, DOI 10.7863/jum.1991.10.10.531; Cartwright MS, 2008, MUSCLE NERVE, V37, P566, DOI 10.1002/mus.21009; Ding J, 2001, CHIN J NEUROL, V34, P26; Fioretti S, 2010, GAIT POSTURE, V32, P317, DOI 10.1016/j.gaitpost.2010.05.017; Flavin R, 2007, INJURY, V38, P845, DOI 10.1016/j.injury.2006.10.016; Hirai A, 2000, J NEUROL SCI, V172, P55, DOI 10.1016/S0022-510X(99)00290-7; Kamm CP, 2009, CLIN NEUROPHYSIOL, V120, P1342, DOI 10.1016/j.clinph.2009.04.016; Lee D, 2005, J AM PODIAT MED ASSN, V95, P433, DOI 10.7547/0950433; Meijer JWG, 2002, DIABETIC MED, V19, P962, DOI 10.1046/j.1464-5491.2002.00819.x; Papanas N, 2007, J DIABETES COMPLICAT, V21, P353, DOI 10.1016/j.jdiacomp.2006.08.003; Pyun SB, 2008, AM J PHYS MED REHAB, V87, P438, DOI 10.1097/PHM.0b013e318174e569; Redborg KE, 2009, REGION ANESTH PAIN M, V34, P24, DOI 10.1097/AAP.0b013e3181933f09; Ricci S, 2010, EUR J VASC ENDOVASC, V39, P636, DOI 10.1016/j.ejvs.2009.11.024; Shankar N, 2010, NEUROL INDIA, V58, P24, DOI 10.4103/0028-3886.60390; Ugrenovic S, 2005, SURG RADIOL ANAT, V27, P25, DOI 10.1007/s00276-004-0276-5; Visser LH, 2008, J NEUROL NEUROSUR PS, V79, P63, DOI 10.1136/jnnp.2007.115337; Watanabe T, 2010, J ULTRAS MED, V29, P697, DOI 10.7863/jum.2010.29.5.697; Yagihashi S, 2007, DIABETES RES CLIN PR, V77, pS184, DOI 10.1016/j.diabres.2007.01.054; Yasuda H, 2003, PROG NEUROBIOL, V69, P229, DOI 10.1016/S0301-0082(03)00034-0; Zhu JA, 2011, MUSCLE NERVE, V43, P560, DOI 10.1002/mus.21918; Ziegler D, 2005, DIABETES CARE, V28, P1169, DOI 10.2337/diacare.28.5.1169	22	42	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e32730	10.1371/journal.pone.0032730	http://dx.doi.org/10.1371/journal.pone.0032730			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558070	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000004
J	Sadegh, MK; Ekman, M; Rippe, C; Uvelius, B; Sward, K; Albinsson, S				Sadegh, Mardjaneh Karbalaei; Ekman, Mari; Rippe, Catarina; Uvelius, Bengt; Sward, Karl; Albinsson, Sebastian			Deletion of Dicer in Smooth Muscle Affects Voiding Pattern and Reduces Detrusor Contractility and Neuroeffector Transmission	PLOS ONE			English	Article							URINARY-BLADDER; CALCIUM-CHANNEL; PURINERGIC NEUROTRANSMISSION; EXPRESSION; MICRORNA; CELLS; GENE; DIFFERENTIATION; CHOLESTEROL; CALPONIN	MicroRNAs have emerged as important regulators of smooth muscle phenotype and may play important roles in pathogenesis of various smooth muscle related disease states. The aim of this study was to investigate the role of miRNAs for urinary bladder function. We used an inducible and smooth muscle specific Dicer knockout (KO) mouse which resulted in significantly reduced levels of miRNAs, including miR-145, miR-143, miR-22, miR125b-5p and miR-27a, from detrusor preparations without mucosa. Deletion of Dicer resulted in a disturbed micturition pattern in vivo and reduced depolarization-induced pressure development in the isolated detrusor. Furthermore, electrical field stimulation revealed a decreased cholinergic but maintained purinergic component of neurogenic activation in Dicer KO bladder strips. The ultrastructure of detrusor smooth muscle cells was well maintained, and the density of nerve terminals was similar. Western blotting demonstrated reduced contents of calponin and desmin. Smooth muscle alpha-actin, SM22 alpha and myocardin were unchanged. Activation of strips with exogenous agonists showed that depolarization-induced contraction was preferentially reduced; ATP- and calyculin A-induced contractions were unchanged. Quantitative real time PCR and western blotting demonstrated reduced expression of Cav1.2 (Cacna1c). It is concluded that smooth muscle miRNAs play an important role for detrusor contractility and voiding pattern of unrestrained mice. This is mediated in part via effects on expression of smooth muscle differentiation markers and L-type Ca2+ channels in the detrusor.	[Sadegh, Mardjaneh Karbalaei; Ekman, Mari; Rippe, Catarina; Sward, Karl; Albinsson, Sebastian] Lund Univ, Dept Expt Med Sci, Biomed Ctr, Lund, Sweden; [Uvelius, Bengt] Lund Univ, Dept Urol, Lund, Sweden	Lund University; Lund University	Sadegh, MK (corresponding author), Lund Univ, Dept Expt Med Sci, Biomed Ctr, Lund, Sweden.	sebastian.albinsson@med.lu.se	sward, karl/J-5798-2012; Albinsson, Sebastian/B-4105-2010; Rippe, Catarina/B-4110-2010	Albinsson, Sebastian/0000-0001-6936-3967; Rippe, Catarina/0000-0001-8621-9836; Sward, Karl/0000-0002-7255-5510; Uvelius, Bengt/0000-0003-0201-8928	Swedish Research Council [K2009-65X-4955-01-3, K2011-67P-20608-02-4]; Swedish Heart and Lung Foundation; Crafoord Foundation; Royal Physiographic Society; Ake Wiberg Foundation; Tore Nilson Foundation; Greta and Johan Kock Foundation; Magnus Bergvall Foundation, regional health care grants (ALF); Medicine at Lund University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Crafoord Foundation; Royal Physiographic Society; Ake Wiberg Foundation; Tore Nilson Foundation; Greta and Johan Kock Foundation; Magnus Bergvall Foundation, regional health care grants (ALF); Medicine at Lund University	This work was supported by the Swedish Research Council (K2009-65X-4955-01-3, K2011-67P-20608-02-4, and repatriation grant), the Swedish Heart and Lung Foundation, The Crafoord Foundation, The Royal Physiographic Society, The Ake Wiberg Foundation, The Tore Nilson Foundation, The Greta and Johan Kock Foundation, The Magnus Bergvall Foundation, regional health care grants (ALF), and the faculty of Medicine at Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albinsson S, 2011, PHYSIOL GENOMICS, V43, P529, DOI 10.1152/physiolgenomics.00146.2010; Albinsson S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018869; Albinsson S, 2010, ARTERIOSCL THROM VAS, V30, P1118, DOI 10.1161/ATVBAHA.109.200873; Andersson K-E, 2011, Handb Exp Pharmacol, P319, DOI 10.1007/978-3-642-16499-6_16; Aschrafi A, 2008, J NEUROSCI, V28, P12581, DOI 10.1523/JNEUROSCI.3338-08.2008; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Ding HL, 2009, J BIOL CHEM, V284, P15541, DOI 10.1074/jbc.M900888200; Ehlert FJ, 2005, J PHARMACOL EXP THER, V313, P368, DOI 10.1124/jpet.104.077909; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Ford APDW, 2006, BRIT J PHARMACOL, V147, pS132, DOI 10.1038/sj.bjp.0706637; Fry CH, 2010, AUTON NEUROSCI-BASIC, V154, P3, DOI 10.1016/j.autneu.2009.10.006; Fujishige A, 2002, ZOOL SCI, V19, P167, DOI 10.2108/zsj.19.167; GABELLA G, 1995, J NEUROCYTOL, V24, P159, DOI 10.1007/BF01181533; Gevaert T, 2007, J CLIN INVEST, V117, P3453, DOI 10.1172/JCI31766; Gollasch M, 1998, FASEB J, V12, P593, DOI 10.1096/fasebj.12.7.593; Gomez M, 1997, AM J PHYSIOL-CELL PH, V273, pC1714, DOI 10.1152/ajpcell.1997.273.5.C1714; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Liu XJ, 2009, CIRC RES, V104, P476, DOI 10.1161/CIRCRESAHA.108.185363; Matsui M, 2000, P NATL ACAD SCI USA, V97, P9579, DOI 10.1073/pnas.97.17.9579; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Narayanan D, 2010, CIRC RES, V107, P631, DOI 10.1161/CIRCRESAHA.110.224345; PALEA S, 1993, J UROLOGY, V150, P2007, DOI 10.1016/S0022-5347(17)35955-4; Park C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018628; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Ren JL, 2010, J BIOL CHEM, V285, P31829, DOI 10.1074/jbc.M109.097576; Ronkainen JJ, 2011, J PHYSIOL-LONDON, V589, P2669, DOI 10.1113/jphysiol.2010.201400; Sadegh MK, 2011, BRIT J PHARMACOL, V162, P1156, DOI 10.1111/j.1476-5381.2010.01115.x; Schaefer A, 2010, UROL ONCOL-SEMIN ORI, V28, P4, DOI 10.1016/j.urolonc.2008.10.021; Schneider T, 2004, J PHARMACOL EXP THER, V309, P1148, DOI 10.1124/jpet.103.063735; Scott RS, 2008, AM J PHYSIOL-CELL PH, V295, pC324, DOI 10.1152/ajpcell.90622.2007; Shakirova Y, 2010, EUR J PHARMACOL, V634, P142, DOI 10.1016/j.ejphar.2010.02.017; Singer HA, 2011, J PHYSL; SJOGREN C, 1982, J UROLOGY, V128, P1368, DOI 10.1016/S0022-5347(17)53509-0; Takahashi K, 2000, BIOCHEM BIOPH RES CO, V279, P150, DOI 10.1006/bbrc.2000.3909; Wamhoff BR, 2004, CIRC RES, V95, P406, DOI 10.1161/01.RES.0000138582.36921.9e; Wegener JW, 2004, FASEB J, V18, P1159, DOI 10.1096/fj.04-1516fje; Winder SJ, 1998, ACTA PHYSIOL SCAND, V164, P415, DOI 10.1111/j.1365-201X.1998.tb10697.x; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Xu L, 2010, CIRC RES, V107, P398, DOI 10.1161/CIRCRESAHA.110.222562; Yoshida M, 2001, EXP GERONTOL, V36, P99, DOI 10.1016/S0531-5565(00)00175-3	48	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35882	10.1371/journal.pone.0035882	http://dx.doi.org/10.1371/journal.pone.0035882			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558254	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000073
J	Van Soest, RWM; Boury-Esnault, N; Vacelet, J; Dohrmann, M; Erpenbeck, D; De Voogd, NJ; Santodomingo, N; Vanhoorne, B; Kelly, M; Hooper, JNA				Van Soest, Rob W. M.; Boury-Esnault, Nicole; Vacelet, Jean; Dohrmann, Martin; Erpenbeck, Dirk; De Voogd, Nicole J.; Santodomingo, Nadiezhda; Vanhoorne, Bart; Kelly, Michelle; Hooper, John N. A.			Global Diversity of Sponges (Porifera)	PLOS ONE			English	Review							NORTH-EAST ATLANTIC; CALCAREOUS SPONGES; ASBESTOPLUMA-HYPOGEA; PHYLOGENETIC-SIGNAL; MOLECULAR PHYLOGENY; CRYPTIC SPECIATION; GLASS SPONGE; DEMOSPONGIAE; EVOLUTION; REEF	With the completion of a single unified classification, the Systema Porifera (SP) and subsequent development of an online species database, the World Porifera Database (WPD), we are now equipped to provide a first comprehensive picture of the global biodiversity of the Porifera. An introductory overview of the four classes of the Porifera is followed by a description of the structure of our main source of data for this paper, the WPD. From this we extracted numbers of all 'known' sponges to date: the number of valid Recent sponges is established at 8,553, with the vast majority, 83%, belonging to the class Demospongiae. We also mapped for the first time the species richness of a comprehensive set of marine ecoregions of the world, data also extracted from the WPD. Perhaps not surprisingly, these distributions appear to show a strong bias towards collection and taxonomy efforts. Only when species richness is accumulated into large marine realms does a pattern emerge that is also recognized in many other marine animal groups: high numbers in tropical regions, lesser numbers in the colder parts of the world oceans. Preliminary similarity analysis of a matrix of species and marine ecoregions extracted from the WPD failed to yield a consistent hierarchical pattern of ecoregions into marine provinces. Global sponge diversity information is mostly generated in regional projects and resources: results obtained demonstrate that regional approaches to analytical biogeography are at present more likely to achieve insights into the biogeographic history of sponges than a global perspective, which appears currently too ambitious. We also review information on invasive sponges that might well have some influence on distribution patterns of the future.	[Van Soest, Rob W. M.; De Voogd, Nicole J.] Netherlands Ctr Biodivers Naturalis, Leiden, Netherlands; [Boury-Esnault, Nicole; Vacelet, Jean] Aix Marseille Univ, Ctr Oceanol Marseille, CNRS, DIMAR,UMR 6540, Marseille, France; [Dohrmann, Martin] Smithsonian Inst, Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC 20560 USA; [Erpenbeck, Dirk] Univ Munich, Dept Earth & Environm Sci, Munich, Germany; [Erpenbeck, Dirk] Univ Munich, GeoBioctr LMU, Munich, Germany; [Santodomingo, Nadiezhda] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; [Vanhoorne, Bart] Flanders Marine Inst VLIZ, Oostende, Belgium; [Kelly, Michelle] Natl Inst Water & Atmospher Res Ltd, Natl Ctr Aquat Biodivers & Biosecur, Auckland, New Zealand; [Hooper, John N. A.] Queensland Museum, Brisbane, Qld, Australia; [Hooper, John N. A.] Griffiths Univ, Eskitis Inst Cell & Mol Therapies, Gold Coast, Qld, Australia	Naturalis Biodiversity Center; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Munich; University of Munich; Natural History Museum London; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Queensland Museum; Griffith University	Van Soest, RWM (corresponding author), Netherlands Ctr Biodivers Naturalis, Leiden, Netherlands.	rob.vansoest@ncbnaturalis.nl	de Voogd, Nicole/I-9280-2012; Dohrmann, Martin/H-6157-2019	de Voogd, Nicole/0000-0002-7985-5604; Hooper, John/0000-0003-1722-5954; Erpenbeck, Dirk/0000-0003-2716-1085				ABRS, 2011, AUSTR FAUN DIR PHYL; Adams Christi L., 1999, Memoirs of the Queensland Museum, V44, P33; Aerts LAM, 1997, MAR ECOL PROG SER, V148, P125, DOI 10.3354/meps148125; Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255; Alvarez B, 2002, NZ J MAR FRESHW RES; Appeltans W, 2011, WORLD REGISTER MARIN; Austin B, 2007, SPONGES COLD TEMPERA; Bakran-Petricioli T, 2007, MAR ECOL-EVOL PERSP, V28, P10, DOI 10.1111/j.1439-0485.2007.00179.x; Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; BERGQUIST P R, 1978, P268; Bergquist PR, 2004, NEW ZEAL J MAR FRESH, V38, P51, DOI 10.1080/00288330.2004.9517217; Bidder GP, 1898, P ROY SOC LONDON, V64, P61, DOI DOI 10.1098/RSPL.1898.0070; Blanquer A, 2008, INVERTEBR SYST, V22, P489, DOI 10.1071/IS07004; Borchiellini C, 2004, MOL PHYLOGENET EVOL, V32, P823, DOI 10.1016/j.ympev.2004.02.021; Borojevic R, 1979, BIOL SPONGIAIRES, P527; Boury-Esnault N, 2006, CAN J ZOOL, V84, P205, DOI 10.1139/Z06-003; Boury-Esnault Nicole, 1994, Memoires du Museum National d'Histoire Naturelle, V160, P1; BOURYESNAULT N, 1995, OPHELIA, V43, P25, DOI 10.1080/00785326.1995.10430575; BOURYESNAULT N, 1992, J NAT HIST, V26, P271, DOI 10.1080/00222939200770131; Butler AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011831; Capon RJ, 2001, EUR J ORG CHEM, V2001, P633; Carballo JL, 1997, J BIOGEOGR, V24, P223, DOI 10.1046/j.1365-2699.1997.00082.x; Cardenas P, 2012, ADV MAR BIOL, V61, P79, DOI 10.1016/B978-0-12-387787-1.00010-6; Colin PL, 1998, CORAL REEFS CHALLENG, P76; CONWAY KW, 1991, CONT SHELF RES, V11, P771, DOI 10.1016/0278-4343(91)90079-L; Conway KW, 2001, GEOSCI CAN, V28, P71; Cook SE, 2008, MAR ENVIRON RES, V66, pS80, DOI 10.1016/j.marenvres.2008.09.002; Dawson Elliot W., 1993, New Zealand Oceanographic Institute Memoir, V100, P1; de Goeij JM, 2008, MAR ECOL PROG SER, V357, P139, DOI 10.3354/meps07403; De Vos L, 1991, ATLAS SPONGE MORPHOL; Debitus C, 2005, DEV MARINE ACTIVE SU; Diaz MC, 2001, B MAR SCI, V69, P535; Dohrmann M, 2009, MOL PHYLOGENET EVOL, V52, P257, DOI 10.1016/j.ympev.2009.01.010; Dohrmann M, 2012, HYDROBIOLOGIA, DOI DOI 10.1007/S10750-011-727-Z; Dohrmann M, 2008, SYST BIOL, V57, P388, DOI 10.1080/10635150802161088; Dohrmann M, 2006, MOL PHYLOGENET EVOL, V40, P830, DOI 10.1016/j.ympev.2006.04.016; Dohrmann M, 2011, ZOOL J LINN SOC-LOND, V163, P1003, DOI 10.1111/j.1096-3642.2011.00753.x; Ereskovsky AV, 2010, COMPARATIVE EMBRYOLOGY OF SPONGES, P1, DOI 10.1007/978-90-481-8575-7; Ereskovsky AV, 2009, P 1 S COR OTH CALC B, P89, DOI DOI 10.1017/S0025315413000295; Ereskovsky AV, 2010, ZOOTAXA, V1376, P37; Erpenbeck D, 2007, ZOOTAXA, P107, DOI 10.11646/zootaxa.1668.1.10; Fromont J, 2006, BIODIVERSITY MARINE; Gazave E, 2012, HYDROBIOLOGIA, V687, P3, DOI 10.1007/s10750-011-0842-x; Gazave E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014290; Grant R.E, 1836, CYCLOPAEDIA ANATOMY, V1, P107, DOI DOI 10.5962/BHL.TITLE.106668; Hajdu E, 2011, SER LIVROS MUS NAC, V45, P1; Hajdu E, 2002, SYSTEMA PORIFERA GUI, P636, DOI DOI 10.1007/978-1-4615-0747-5_68; Hajdu E, 1995, THESIS U AMSTERDAM; Hajdu E, 2008, REV SUISSE ZOOL, V115, P377; Hajdu Eduardo, 1998, P95; HARTMAN WD, 1958, SYST ZOOL, V7, P97, DOI 10.2307/2411971; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Henkel D, 2011, J MAR BIOL ASSOC UK, V91, P347, DOI 10.1017/S0025315410001487; Hentschel U, 2003, MAR MOL BIOTECHNOL, P59; Hill MS, 1998, OECOLOGIA, V117, P143, DOI 10.1007/s004420050642; Hogg MM, 2010, DEEP SEA SPONGE GROU; Hooper JNA, 2002, BIODIVERS CONSERV, V11, P851, DOI 10.1023/A:1015370312077; HOOPER JNA, 1994, SPONGES IN TIME AND SPACE, P191; Hooper JNA, SYSTEMA PORIFERA GUI; Hooper JNA, 1994, ZOOLOGICAL CAALOGUE, V12; Hooper John N.A., 2006, Zootaxa, V1314, P31; Ivanisevic J, 2011, METABOLOMICS, V7, P289, DOI 10.1007/s11306-010-0239-2; Kelly M, 2009, NZ INVENTORY BIODIVE, P1; Kelly Michelle, 2003, Micronesica, V35-36, P100; Kelly Michelle, 2011, Zootaxa, V2976, P55; Kelly Michelle, 2007, NIWA Biodiversity Memoir, V121, P5; Klautau M, 2003, ZOOL J LINN SOC-LOND, V139, P1, DOI 10.1046/j.0024-4082.2003.00063.x; Klautau M, 1999, EVOLUTION, V53, P1414, DOI 10.1111/j.1558-5646.1999.tb05406.x; KOECHLIN N, 1977, CAH BIOL MAR, V18, P325; Krautter M, 2001, FACIES, V44, P265, DOI 10.1007/BF02668178; Lavrov DV, 2008, MOL PHYLOGENET EVOL, V49, P111, DOI 10.1016/j.ympev.2008.05.014; Lee WL, 2007, SPONGES CALIFORNIA G; LEVI C, 1957, SYST ZOOL, V6, P174, DOI 10.2307/2411423; Levi C., 1956, Archives de Zoologie Experimentale et Generale, V93, P1; Levi C, 1998, COLLECTION FAUNE FLO, V33, P1; Levi C., 1973, TRAITE ZOOLOGIE P GR, V3, P577; Leys SP, 2007, ADV MAR BIOL, V52, P1, DOI 10.1016/S0065-2881(06)52001-2; Longo C, 2007, J MAR BIOL ASSOC UK, V87, P1749, DOI 10.1017/S0025315407057748; MALDONADO M, 1995, J BIOGEOGR, V22, P89, DOI 10.2307/2846075; Maldonado Manuel, 2002, P21; Manconi R, 2008, HYDROBIOLOGIA, V595, P27, DOI 10.1007/s10750-007-9000-x; Manuel M, 2006, CAN J ZOOL, V84, P225, DOI 10.1139/Z06-005; Manuel M, 2003, SYST BIOL, V52, P311, DOI 10.1080/10635150390196966; Manuel M, 2002, SYSTEMA PORIFERA GUI, P1103; Manuel M, 2004, B MUS I BIOL U GEN, V68, P449; McClintock JB, 2005, INTEGR COMP BIOL, V45, P359, DOI 10.1093/icb/45.2.359; McMurray SE, 2008, MAR BIOL, V155, P159, DOI 10.1007/s00227-008-1014-z; Messing CG, 2009, S FLORIDA SPONGES GU; Minchin E. A., 1896, Annals of Natural History, V(ser. 6), P349; Morrow CC, 2012, MOL PHYLOGENET EVOL, V62, P174, DOI 10.1016/j.ympev.2011.09.016; Muller WEG, 2003, MAR MOL BIOTECHNOL, P1; Muricy G, 1996, CAN J ZOOL, V74, P881, DOI 10.1139/z96-102; Muricy G, 1998, ZOOL J LINN SOC-LOND, V124, P169, DOI 10.1111/j.1096-3642.1998.tb00572.x; Muricy G, 1996, MAR ECOL PROG SER, V138, P181, DOI 10.3354/meps138181; Muricy Guilherme, 2004, Proceedings of the California Academy of Sciences, V55, P598; Muricy G, 2011, J MAR BIOL ASSOC UK, V91, P303, DOI 10.1017/S0025315410000743; Pansini Maurizio, 2003, Biogeographia, V24, P59; Pawlik JR, 2011, BIOSCIENCE, V61, P888, DOI 10.1525/bio.2011.61.11.8; Pawlik JR, 2008, SCIENCE, V321, P19; Perez T, 2006, CAH BIOL MAR, V47, P205; Perez T, 2011, MAR ECOL-EVOL PERSP, V32, P174, DOI 10.1111/j.1439-0485.2011.00435.x; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Picton BE, SPECIES DIRECTORY MA; Pitcher CR, 2007, SEABED BIODIVERSITY, P1; Poppe J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009950; Pomponi S.A., 1980, International Review of Cytology, V65, P301; Pomponi SA, 2006, CAN J ZOOL, V84, P167, DOI 10.1139/Z05-188; Quinn RJ, 2002, PURE APPL CHEM, V74, P519, DOI 10.1351/pac200274040519; Quinn RJ, 2007, J BIOLAW BUSINESS AU, V2007, P39; Rapp HT, 2006, ZOOL J LINN SOC-LOND, V147, P331, DOI 10.1111/j.1096-3642.2006.00221.x; Rapp HT, 2011, DEEP-SEA RES PT II, V58, P58, DOI 10.1016/j.dsr2.2010.05.022; Redmond NE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024344; REISWIG H M, 1974, Journal of Experimental Marine Biology and Ecology, V14, P231, DOI 10.1016/0022-0981(74)90005-7; Reiswig Henry M., 2007, V28, P517; Reiswig HM, 2002, SYSTEMA PORIFERA GUI, P1201; Reveillaud J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016533; Reveillaud J, 2010, MOL PHYLOGENET EVOL, V56, P104, DOI 10.1016/j.ympev.2010.03.034; Rigby JK, 2003, TREATISE INVERTEBR E, V2; Rios P, 2012, ZOOTAXA, V3131, P52; Rossi AL, 2011, ZOOL J LINN SOC-LOND, V163, P1026, DOI 10.1111/j.1096-3642.2011.00739.x; RUTZLER K, 1975, OECOLOGIA, V19, P203, DOI 10.1007/BF00345306; Rutzler Klaus, 2009, P285; Samaai T, 2006, AFR NAT HIST, V1, P1; Samaai Toufiek, 2005, African Natural History, V1, P1; Samaai Toufiek, 2006, Zootaxa, V1358, P1; SARA M, 1992, POLAR BIOL, V12, P559; Sara M, 1973, SPONGIAIRES ANATOMIE, V3, P462; Sars GO, 1872, SOME REMARKABLE FORM, P62; Shenkar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020657; Soest Van, 1993, COUR SENCKENB FORSCH, V159, P205; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Sperling EA, 2010, GEOBIOLOGY, V8, P24, DOI 10.1111/j.1472-4669.2009.00225.x; Sperling EA, 2009, MOL BIOL EVOL, V26, P2261, DOI 10.1093/molbev/msp148; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Sundar VC, 2003, NATURE, V424, P899, DOI 10.1038/424899a; Sutcliffe Patricia R., 2010, Zootaxa, V2616, P1; TABACHNICK KR, 1994, SPONGES IN TIME AND SPACE, P225; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; VACELET J, 1995, NATURE, V377, P296, DOI 10.1038/377296a0; Vacelet J, 2004, ZOOMORPHOLOGY, V123, P179, DOI 10.1007/s00435-004-0100-0; VACELET J, 1995, NATURE, V373, P333, DOI 10.1038/373333a0; VACELET J, 1994, DEEP-SEA RES PT I, V41, P965, DOI 10.1016/0967-0637(94)90013-2; Vacelet J, 2012, TREATISE PALEONTOLOG; Vacelet J, 2006, ZOOL J LINN SOC-LOND, V148, P553, DOI 10.1111/j.1096-3642.2006.00234.x; Vacelet Jean, 2008, Zootaxa, V1752, P57; Vacelet J, 2009, ZOOTAXA, P57, DOI 10.11646/zootaxa.2073.1.5; Vacelet Jean, 2007, V28, P107; van Soest RWM, 2007, J MAR BIOL ASSOC UK, V87, P1345, DOI 10.1017/S0025315407059048; van Soest RWM, 2007, J MAR BIOL ASSOC UK, V87, P1733, DOI 10.1017/S002531540705816X; Van Soest RWM, 2011, WORLD PORIFERA DATAB; Van Soest RWM, 2000, SPONGES NE ATLANTIC; VANSOEST RWM, 1989, NETH J SEA RES, V23, P223, DOI 10.1016/0077-7579(89)90016-1; VANSOEST RWM, 1994, SPONGES IN TIME AND SPACE, P213; vanSoest RWM, 1997, CLADISTICS, V13, P1, DOI 10.1111/j.1096-0031.1997.tb00238.x; Vishnyakov AE, 2009, MAR BIOL, V156, P1625, DOI 10.1007/s00227-009-1198-x; Voultsiadou E, 2011, REV FISH SCI, V19, P34, DOI 10.1080/10641262.2010.531794; Voultsiadou E, 2008, J NAT HIST, V42, P529, DOI 10.1080/00222930701835506; Watling L, 2007, J MAR BIOL ASSOC UK, V87, P1721, DOI 10.1017/S0025315407058560; WESTINGA E, 1981, MAR BIOL, V62, P139, DOI 10.1007/BF00388176; WILKINSON CR, 1987, SCIENCE, V236, P1654, DOI 10.1126/science.236.4809.1654; WILKINSON CR, 1979, NATURE, V279, P527, DOI 10.1038/279527a0; Worheide G, 2007, J MAR BIOL ASSOC UK, V87, P1629, DOI 10.1017/S0025315407058274; Worheide G, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-24; Worheide G, 2008, MOL PHYLOGENET EVOL, V47, P433, DOI 10.1016/j.ympev.2008.01.021; Worheide Gert, 1999, Memoirs of the Queensland Museum, V43, P859; WULFF JL, 1979, NATURE, V281, P474, DOI 10.1038/281474a0; WULFF JL, 1984, CORAL REEFS, V3, P157, DOI 10.1007/BF00301960; Xavier JR, 2010, MOL PHYLOGENET EVOL, V56, P13, DOI 10.1016/j.ympev.2010.03.030; Xavier JR, 2012, HYDROBIOLOGIA, V687, P107, DOI 10.1007/s10750-011-0880-4; Xavier JR, 2010, CONTRIB ZOOL, V79, P119, DOI 10.1163/18759866-07903004; Zea S, 2009, SPONGE GUIDE PICTURE	171	366	378	13	170	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35105	10.1371/journal.pone.0035105	http://dx.doi.org/10.1371/journal.pone.0035105			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558119	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000024
J	Boys, CA; Rowland, SJ; Gabor, M; Gabor, L; Marsh, IB; Hum, S; Callinan, RB				Boys, Craig A.; Rowland, Stuart J.; Gabor, Melinda; Gabor, Les; Marsh, Ian B.; Hum, Steven; Callinan, Richard B.			Emergence of Epizootic Ulcerative Syndrome in Native Fish of the Murray-Darling River System, Australia: Hosts, Distribution and Possible Vectors	PLOS ONE			English	Article							RED SPOT DISEASE; FRESH-WATER FISH; MUGIL-CEPHALUS L; SYNDROME EUS; APHANOMYCES-INVADANS; MYXOBOLUS-CEREBRALIS; CHANNEL CATFISH; SEA MULLET; ESTUARINE; HISTOPATHOLOGY	Epizootic ulcerative syndrome (EUS) is a fish disease of international significance and reportable to the Office International des Epizootics. In June 2010, bony herring Nematalosa erebi, golden perch Macquaria ambigua, Murray cod Maccullochella peelii and spangled perch Leiopotherapon unicolor with severe ulcers were sampled from the Murray-Darling River System (MDRS) between Bourke and Brewarrina, New South Wales Australia. Histopathology and polymerase chain reaction identified the fungus-like oomycete Aphanomyces invadans, the causative agent of EUS. Apart from one previous record in N. erebi, EUS has been recorded in the wild only from coastal drainages in Australia. This study is the first published account of A. invadans in the wild fish populations of the MDRS, and is the first confirmed record of EUS in M. ambigua, M. peelii and L. unicolor. Ulcerated carp Cyprinus carpio collected at the time of the same epizootic were not found to be infected by EUS, supporting previous accounts of resistance against the disease by this species. The lack of previous clinical evidence, the large number of new hosts (n = 3), the geographic extent (200 km) of this epizootic, the severity of ulceration and apparent high pathogenicity suggest a relatively recent invasion by A. invadans. The epizootic and associated environmental factors are documented and discussed within the context of possible vectors for its entry into the MDRS and recommendations regarding continued surveillance, research and biosecurity are made.	[Boys, Craig A.] New S Wales Dept Primary Ind, Port Stephens Fisheries Inst, Nelson Bay, NSW, Australia; [Rowland, Stuart J.] New S Wales Dept Primary Ind, Grafton Fisheries Ctr, Grafton, NSW, Australia; [Gabor, Melinda; Gabor, Les; Marsh, Ian B.; Hum, Steven] NSW Dept Primary Ind, State Vet Diagnost Lab, Elizabeth Macarthur Agr Inst, Narellan, NSW, Australia; [Callinan, Richard B.] Univ Sydney, Fac Vet Sci, Camden, NSW, Australia	NSW Department of Primary Industries; NSW Department of Primary Industries; NSW Department of Primary Industries; University of Sydney	Boys, CA (corresponding author), New S Wales Dept Primary Ind, Port Stephens Fisheries Inst, Nelson Bay, NSW, Australia.	craig.boys@dpi.nsw.gov.au	Boys, Craig/AAW-8829-2021		Native Fish Strategy Program of the Murray-Darling Basin Authority	Native Fish Strategy Program of the Murray-Darling Basin Authority	Fish were collected during routine sampling carried out as part of the Bourke to Brewarrina Demonstration Reach Project, funded under the Native Fish Strategy Program of the Murray-Darling Basin Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFFA, 2000, AQUAVETPLAN AGR FISH; Ahmed G.U., 1999, Asian Fisheries Science, V12, P381; AHMED M, 1995, J FISH DIS, V18, P263, DOI 10.1111/j.1365-2761.1995.tb00301.x; ANZECC, 2000, AUSTR NZ GUID FRESH, V1; Blazer VS, 1999, J AQUAT ANIM HEALTH, V11, P340, DOI 10.1577/1548-8667(1999)011&lt;0340:AAACOU&gt;2.0.CO;2; Blazer VS, 2002, J AQUAT ANIM HEALTH, V14, P1, DOI 10.1577/1548-8667(2002)014&lt;0001:AIIAMA&gt;2.0.CO;2; Bly J.E., 1992, Fish & Shellfish Immunology, V2, P159, DOI 10.1016/S1050-4648(05)80056-7; Bondad-Reantaso, 2005, DIS ASIAN AQUACULTUR, VV, P555; Bowling LC, 1996, MAR FRESHWATER RES, V47, P643, DOI 10.1071/MF9960643; Brown GG, 1978, MICROORGANISMS FUNGI; Buller N, 2007, FURTHER RES LAB TRIA; Buller N, 2004, MOL DIAGNOSTIC TESTS; Callinan R, 1999, OUTBREAKS EPIZOOTIC; CALLINAN R. B., 1988, POSTGRAD COMM VET SC, V106, P459; Callinan RB, 2005, DIS AQUAT ORGAN, V63, P247, DOI 10.3354/dao063247; CALLINAN RB, 1989, J FISH DIS, V12, P467, DOI 10.1111/j.1365-2761.1989.tb00558.x; CALLINAN RB, 1995, DIS AQUAT ORGAN, V21, P233, DOI 10.3354/dao021233; CALLINAN RB, 1995, SILVER PERCH CULTURE, P67; Callinan RB, 1997, FIND MISS PAK 9 19 M; Charalambidou I, 2005, WETLANDS, V25, P252, DOI 10.1672/2; CHINABUT S, 1995, J FISH DIS, V18, P41, DOI 10.1111/j.1365-2761.1995.tb01264.x; Choongo K, 2009, B ENVIRON CONTAM TOX, V83, P474, DOI 10.1007/s00128-009-9799-0; Egusa S., 1971, FISH PATHOL, V6, P41; FRASER GC, 1992, J FISH DIS, V15, P173, DOI 10.1111/j.1365-2761.1992.tb00651.x; Gates KK, 2008, N AM J FISH MANAGE, V28, P1453, DOI 10.1577/M08-025.1; Hall KC, 2006, SCI TOTAL ENVIRON, V370, P235, DOI 10.1016/j.scitotenv.2006.07.019; HATAI K, 1977, Fish Pathology, V12, P129; Hawke JP, 2003, J AQUAT ANIM HEALTH, V15, P120, DOI 10.1577/H02-039; Hopley D, 2008, SCIENCE, V57, P1359; Hrubec TC, 1996, VET IMMUNOL IMMUNOP, V50, P157, DOI 10.1016/0165-2427(95)05491-X; Ingram BA, 2005, RES REPORT SERIES; Johnson LE, 2001, ECOL APPL, V11, P1789, DOI 10.1890/1051-0761(2001)011[1789:ODOAIS]2.0.CO;2; Johnson PTJ, 2011, FRESHWATER BIOL, V56, P638, DOI 10.1111/j.1365-2427.2010.02546.x; Khan M.H., 1998, Bulletin of the European Association of Fish Pathologists, V18, P192; Koel TM, 2010, T AM FISH SOC, V139, P976, DOI 10.1577/T09-051.1; Lilley JH, 1997, VET REC, V140, P653, DOI 10.1136/vr.140.25.653; Lilley JH, 1997, J FISH DIS, V20, P135, DOI 10.1046/j.1365-2761.1997.d01-116.x; Lilley JH., 1998, EPIZOOTIC ULCERATIVE; MCKENZIE RA, 1976, AUST VET J, V52, P230, DOI 10.1111/j.1751-0813.1976.tb00076.x; MEYERS TU, 1970, NATURE, V227, P622, DOI 10.1038/227622b0; OIE, 2003, MAN DIAGN TESTS AQ A; Paperna I., 1991, Annual Review of Fish Diseases, V1, P155, DOI 10.1016/0959-8030(91)90028-I; Pathiratne A, 2001, J APPL ICHTHYOL, V17, P30, DOI 10.1046/j.1439-0426.2001.00235.x; Pradhan P.K., 2008, DIS ASIAN AQUACULTUR, P105; PUCKRIDGE JT, 1989, J FISH DIS, V12, P205, DOI 10.1111/j.1365-2761.1989.tb00305.x; Quiniou SMA, 1998, FISH SHELLFISH IMMUN, V8, P1, DOI 10.1006/fsim.1997.0115; ROBERTS RJ, 1993, J FISH DIS, V16, P169, DOI 10.1111/j.1365-2761.1993.tb01248.x; RODGERS LJ, 1981, J FISH DIS, V4, P297, DOI 10.1111/j.1365-2761.1981.tb01137.x; Rowland S. J., 2004, HATCHERY QUALITY ASS; Rowland SJ, 2007, NSW DEP PRIMARY IND; ROWLAND SJ, 1995, ASIAN FISH SCI, V8, P73; Sammut J, 1996, MAR FRESHWATER RES, V47, P669, DOI 10.1071/MF9960669; Sammut J, 1995, AUSTR GEOGRAPHICAL S, V33, P89, DOI DOI 10.1111/J.1467-8470.1995.TB00687.X; SANAULLAH M., 2001, ASIAN FISH SCI, V14, P301; Saylor RK, 2010, DIS AQUAT ORGAN, V88, P169, DOI 10.3354/dao02158; Sosa ER, 2007, J AQUAT ANIM HEALTH, V19, P14, DOI 10.1577/H06-012.1; Taylor Peter W., 1992, Journal of Aquatic Animal Health, V4, P240, DOI 10.1577/1548-8667(1992)004&lt;0240:FEBAPV&gt;2.3.CO;2; Van West Pieter, 2006, Mycologist, V20, P99, DOI 10.1016/j.mycol.2006.06.004; VIRGONA JL, 1992, J FISH DIS, V15, P363, DOI 10.1111/j.1365-2761.1992.tb01236.x; Vishwanath TS, 1998, AQUACULTURE, V165, P1, DOI 10.1016/S0044-8486(98)00227-0; Wedemeyer G.A., 1996, PHYSL FISH INTENSIVE; Willumsen B, 1998, J FISH DIS, V12, P275	62	31	34	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35568	10.1371/journal.pone.0035568	http://dx.doi.org/10.1371/journal.pone.0035568			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558170	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345200049
J	Costa, FO; Landi, M; Martins, R; Costa, MH; Costa, ME; Carneiro, M; Alves, MJ; Steinke, D; Carvalho, GR				Costa, Filipe O.; Landi, Monica; Martins, Rogelia; Costa, Maria H.; Costa, Maria E.; Carneiro, Miguel; Alves, Maria J.; Steinke, Dirk; Carvalho, Gary R.			A Ranking System for Reference Libraries of DNA Barcodes: Application to Marine Fish Species from Portugal	PLOS ONE			English	Article							DIVERGENCE	Background: The increasing availability of reference libraries of DNA barcodes (RLDB) offers the opportunity to the screen the level of consistency in DNA barcode data among libraries, in order to detect possible disagreements generated from taxonomic uncertainty or operational shortcomings. We propose a ranking system to attribute a confidence level to species identifications associated with DNA barcode records from a RLDB. Here we apply the proposed ranking system to a newly generated RLDB for marine fish of Portugal. Methodology/Principal Findings: Specimens (n = 659) representing 102 marine fish species were collected along the continental shelf of Portugal, morphologically identified and archived in a museum collection. Samples were sequenced at the barcode region of the cytochrome oxidase subunit I gene (COI-5P). Resultant DNA barcodes had average intra-specific and inter-specific Kimura-2-parameter distances (0.32% and 8.84%, respectively) within the range usually observed for marine fishes. All specimens were ranked in five different levels (A-E), according to the reliability of the match between their species identification and the respective diagnostic DNA barcodes. Grades A to E were attributed upon submission of individual specimen sequences to BOLD-IDS and inspection of the clustering pattern in the NJ tree generated. Overall, our study resulted in 73.5% of unambiguous species IDs (grade A), 7.8% taxonomically congruent barcode clusters within our dataset, but awaiting external confirmation (grade B), and 18.7% of species identifications with lower levels of reliability (grades C/E). Conclusion/Significance: We highlight the importance of implementing a system to rank barcode records in RLDB, in order to flag taxa in need of taxonomic revision, or reduce ambiguities of discordant data. With increasing DNA barcode records publicly available, this cross-validation system would provide a metric of relative accuracy of barcodes, while enabling the continuous revision and annotation required in taxonomic work.	[Costa, Filipe O.; Landi, Monica] Univ Minho, CBMA Ctr Mol & Environm Biol, Dept Biol, Braga, Portugal; [Martins, Rogelia; Carneiro, Miguel] IP IPIMAR, INRB, Lisbon, Portugal; [Costa, Maria H.] Univ Nova Lisboa, Fac Ciencias & Tecnol, IMAR Inst Mar, Dept Ciencias & Engn Ambiente, Caparica, Portugal; [Costa, Maria E.] Univ Algarve, FCT, Ctr Ciencias Mar CCMAR, Faro, Portugal; [Alves, Maria J.] Univ Lisbon, Museu Nacl Hist Nat, P-1699 Lisbon, Portugal; [Alves, Maria J.] Univ Lisbon, Ctr Biol Ambiental, P-1699 Lisbon, Portugal; [Steinke, Dirk] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Carvalho, Gary R.] Bangor Univ, Sch Biol Sci, Mol Ecol & Fisheries Genet Lab, Bangor, Gwynedd, Wales	Universidade do Minho; Portuguese Institute of Sea & Fisheries Research (IPIMAR); Universidade Nova de Lisboa; Universidade do Algarve; Universidade de Lisboa; Universidade de Lisboa; University of Guelph; Bangor University	Costa, FO (corresponding author), Univ Minho, CBMA Ctr Mol & Environm Biol, Dept Biol, Campus Gualtar, Braga, Portugal.	fcosta@bio.uminho.pt	Costa, Maria Helena/F-4957-2012; Costa, Filipe/B-5890-2009; Landi, Monica/J-3611-2012; Costa, Filipe/M-9623-2019; Costa, Filipe/GSD-2439-2022; Alves, Maria Judite/K-9315-2014; Steinke, Dirk/D-4700-2009	Costa, Maria Helena/0000-0001-8479-4941; Costa, Filipe/0000-0001-5398-3942; Landi, Monica/0000-0003-2180-5062; Costa, Filipe/0000-0001-5398-3942; Alves, Maria Judite/0000-0002-0550-4190; Steinke, Dirk/0000-0002-8992-575X; Martins, Rogelia/0000-0002-6273-8372	FEDER through POFC-COMPETE; national funds from "Fundacao para a Ciencia e a Tecnologia (FCT)" [FCOMP-01-0124-FEDER-007381, FCOMP-01-0124-FEDER-010596, PEst-C/BIA/UI4050/2011]; Marie Curie Fellowship [MEIF-CT-2005-024966]; European Reintegration Grant by European Commission [PERG02-GA-2007-224890]; FCT [SFRH/BPD/45246/2008]; Canadian Centre for DNA Barcoding from Ontario Genomics Institute [2008-OGI-ICI-03]; Genome Canada; Ontario Ministry of Research and Innovation; Natural Sciences and Engineering Research Council of Canada; Alfred P. Sloan Foundation	FEDER through POFC-COMPETE; national funds from "Fundacao para a Ciencia e a Tecnologia (FCT)"(Portuguese Foundation for Science and Technology); Marie Curie Fellowship(European Commission); European Reintegration Grant by European Commission; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Canadian Centre for DNA Barcoding from Ontario Genomics Institute; Genome Canada(Genome Canada); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	This work was supported by FEDER through POFC-COMPETE and by national funds from "Fundacao para a Ciencia e a Tecnologia (FCT)" in the scope of the grants FCOMP-01-0124-FEDER-007381, FCOMP-01-0124-FEDER-010596 and PEst-C/BIA/UI4050/2011. FOC benefitted from Marie Curie Fellowship MEIF-CT-2005-024966 and from an European Reintegration Grant PERG02-GA-2007-224890 provided by the European Commission. ML benefit from a fellowship (SFRH/BPD/45246/2008) granted by the FCT. Sequencing at the Biodiversity Institute of Ontario was supported by funding to the International Barcode of Life Project (iBOL) through the Canadian Centre for DNA Barcoding, from the Ontario Genomics Institute (2008-OGI-ICI-03), Genome Canada, the Ontario Ministry of Research and Innovation, and the Natural Sciences and Engineering Research Council of Canada. DS was supported by funding from the Alfred P. Sloan Foundation to MarBOL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borges TC, 2007, BIODIVERSITY FISHERI; Bortolus A, 2008, AMBIO, V37, P114, DOI 10.1579/0044-7447(2008)37[114:ECITBS]2.0.CO;2; Castilho R, 2007, J FISH BIOL, V70, P346, DOI 10.1111/j.1095-8649.2007.01455.x; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Cochrane G, 2011, NUCLEIC ACIDS RES, V39, pD15, DOI 10.1093/nar/gkq1150; Costa FO., 2007, GENOMICS SOC POLICY, V3, P29; Frose R, 2010, FISHBASE; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Kim S, 2010, MOL CELLS, V30, P507, DOI 10.1007/s10059-010-0148-2; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kochzius M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012620; Lleonart J, 2006, MAR ECOL PROG SER, V316, P231, DOI 10.3354/meps316231; Page TJ, 2011, ZOOTAXA, P65; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Robalo JI, 2009, MAR BIOL, V156, P1733, DOI 10.1007/s00227-009-1197-y; Sirovich L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009266; Sirovich L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007051; Steinke D, 2011, MITOCHONDR DNA, V22, P10, DOI 10.3109/19401736.2010.536538; Steinke D, 2009, MAR BIOL, V156, P2641, DOI 10.1007/s00227-009-1284-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; WALTERS C, 2006, DNA BANKS PROVIDING, P25; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2009, MOL ECOL RESOUR, V9, P1077, DOI 10.1111/j.1755-0998.2009.02541.x; Wilson EO, 2003, TRENDS ECOL EVOL, V18, P77, DOI 10.1016/S0169-5347(02)00040-X	27	91	94	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35858	10.1371/journal.pone.0035858	http://dx.doi.org/10.1371/journal.pone.0035858			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558244	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345200088
J	Montalvo, C; Villar, AV; Merino, D; Garcia, R; Ares, M; Llano, M; Cobo, M; Hurle, MA; Nistal, JF				Montalvo, Cecilia; Villar, Ana V.; Merino, David; Garcia, Raquel; Ares, Miguel; Llano, Miguel; Cobo, Manuel; Hurle, Maria A.; Nistal, J. Francisco			Androgens Contribute to Sex Differences in Myocardial Remodeling under Pressure Overload by a Mechanism Involving TGF-beta	PLOS ONE			English	Article							LEFT-VENTRICULAR FUNCTION; RENIN-ANGIOTENSIN SYSTEM; GENDER-DIFFERENCES; CARDIAC-HYPERTROPHY; HEART-FAILURE; EXPRESSION; FIBROSIS; MICE; TGF-BETA-1; GROWTH	Background: In clinical studies, myocardial remodeling in aortic valve stenosis appears to be more favorable in women than in men, even after menopause. In the present study, we assessed whether circulating androgens contribute to a less favorable myocardial remodeling under pressure overload in males. We examined sex-related differences in one-year-old male and female mice. Whereas male mice at this age exhibited circulating androgen levels within the normal range for young adults, the circulating estrogens in females were reduced. The contribution of gonadal androgens to cardiac remodeling was analyzed in a group of same-age castrated mice. Methodology/Principal Findings: Animals were subjected to transverse aortic constriction (TAC). Echocardiography was performed 2 weeks after TAC and myocardial mRNA levels of TGF-beta s, Smads 2 and 3, collagens, fibronectin, beta-myosin heavy chain and a-myosin heavy chain were determined by q-PCR. Protein detection of p-SMAD2/3 was performed by Western Blot. Histological staining of fibrosis was performed with picrosirius red and Masson's trichrome. Compared with females, males developed more severe tissue fibrosis, LV dilation and hemodynamic dysfunction. TAC-males showed higher myocardial expression levels of TGF-beta s and the treatment with a neutralizing antibody to TGF-beta prevented myocardial fibrosis development. Orchiectomy diminished TAC-induced up-regulation of TGF-beta s and TGF-beta target genes, and it also reduced fibrosis and hemodynamic dysfunction. The capability of androgens to induce TGF-beta expression was confirmed in NIH-3T3 fibroblasts and H9C2 cardiomyocytes exposed to dihydrotestosterone. Conclusions/Significance: Our results indicate that circulating androgens are responsible for the detrimental effects in the myocardium of older male mice subjected to pressure overload through a mechanism involving TGF-beta s.	[Montalvo, Cecilia; Villar, Ana V.; Merino, David; Hurle, Maria A.] Univ Cantabria, Fac Med, Dept Fisiol & Farmacol, E-39005 Santander, Spain; [Garcia, Raquel; Nistal, J. Francisco] Hosp Univ Marques Valdecilla, Serv Cirugia Cardiovasc, Santander, Spain; [Ares, Miguel] Hosp Comarcal Laredo, Cantabria, Spain; [Llano, Miguel; Cobo, Manuel] Hosp Univ Marque Valdecilla, Serv Cardiol, Santander, Spain; [Montalvo, Cecilia; Villar, Ana V.; Merino, David; Garcia, Raquel; Ares, Miguel; Llano, Miguel; Cobo, Manuel; Hurle, Maria A.; Nistal, J. Francisco] IFIMAV, Santander, Spain	Universidad de Cantabria; Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV)	Montalvo, C (corresponding author), Univ Cantabria, Fac Med, Dept Fisiol & Farmacol, E-39005 Santander, Spain.	hurlem@unican.es	Villar, Ana/I-5190-2015; Garcia, Raquel/Z-2467-2019	Villar, Ana/0000-0003-4588-9598; Hurle, Maria Amor/0000-0002-7710-1358; Garcia, Raquel/0000-0002-1621-5474	Instituto de Salud Carlos III [PS09/01097]; Fundacion Marques de Valdecilla-Universidad de Cantabria [FMV-UC 09/01]; Instituto de Formacion e Investigacion Marques de Valdecilla [FMV-API 10/20]; Ministerio de Ciencia e Innovacion [SAF2010-16894]; Comunidad Autonoma de Cantabria	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacion Marques de Valdecilla-Universidad de Cantabria; Instituto de Formacion e Investigacion Marques de Valdecilla; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Comunidad Autonoma de Cantabria	This work was supported by Instituto de Salud Carlos III (PS09/01097); Fundacion Marques de Valdecilla-Universidad de Cantabria (FMV-UC 09/01); Instituto de Formacion e Investigacion Marques de Valdecilla (FMV-API 10/20); and Ministerio de Ciencia e Innovacion (SAF2010-16894). Dr. Nistal is in the Scientist Stabilization and Research Activity Intensification Program of the National Health System, funded by the Instituto de Salud Carlos III and Comunidad Autonoma de Cantabria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antus B, 2001, KIDNEY INT, V60, P1955, DOI 10.1046/j.1523-1755.2001.00007.x; AURIGEMMA GP, 1995, CARDIOLOGY, V86, P310, DOI 10.1159/000176895; Baggish AL, 2010, CIRC-HEART FAIL, V3, P472, DOI 10.1161/CIRCHEARTFAILURE.109.931063; CARROLL JD, 1992, CIRCULATION, V86, P1099, DOI 10.1161/01.CIR.86.4.1099; Cavasin MA, 2006, AM J PHYSIOL-HEART C, V290, pH2043, DOI 10.1152/ajpheart.01121.2005; DESIMONE G, 1995, HYPERTENSION, V26, P979, DOI 10.1161/01.HYP.26.6.979; Dobaczewski M, 2011, J MOL CELL CARDIOL, V51, P600, DOI 10.1016/j.yjmcc.2010.10.033; Donaldson C, 2009, CIRC RES, V104, P265, DOI 10.1161/CIRCRESAHA.108.190397; Fanton L, 2009, EXP TOXICOL PATHOL, V61, P317, DOI 10.1016/j.etp.2008.09.007; Fielitz J, 2001, J AM COLL CARDIOL, V37, P1443, DOI 10.1016/S0735-1097(01)01170-6; Gao XM, 2003, ENDOCRINOLOGY, V144, P4097, DOI 10.1210/en.2002-0214; Gonzalez A, 2010, HYPERTENSION, V55, P1418, DOI 10.1161/HYPERTENSIONAHA.109.149112; Gupta MP, 2007, J MOL CELL CARDIOL, V43, P388, DOI 10.1016/j.yjmcc.2007.07.045; Hein S, 2003, CIRCULATION, V107, P984, DOI 10.1161/01.CIR.0000051865.66123.B7; Henein MY, 1999, HEART, V81, P229, DOI 10.1136/hrt.81.3.229; Heymans S, 2005, CIRCULATION, V112, P1136, DOI 10.1161/CIRCULATIONAHA.104.516963; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Hu P, 2003, AM J PHYSIOL-HEART C, V285, pH1261, DOI 10.1152/ajpheart.00108.2003; Hung CL, 2010, J AM COLL CARDIOL, V56, P1812, DOI 10.1016/j.jacc.2010.06.044; Ikeda Y, 2005, J BIOL CHEM, V280, P29661, DOI 10.1074/jbc.M411694200; Inui S, 2002, FASEB J, V16, P1967, DOI 10.1096/fj.02-0043fje; KASPERK C, 1990, J CLIN ENDOCR METAB, V71, P1322, DOI 10.1210/jcem-71-5-1322; Li YH, 2004, ENDOCRINOLOGY, V145, P951, DOI 10.1210/en.2003-0816; Maclver DH, 2008, HEART, V94, P446, DOI 10.1136/hrt.2006.114082; Malkin CJ, 2003, J ENDOCRINOL, V178, P373, DOI 10.1677/joe.0.1780373; Marwick TH, 2004, CURR OPIN CARDIOL, V19, P442, DOI 10.1097/01.hco.0000131535.32657.87; Montisci R, 2010, J AM SOC ECHOCARDIOG, V23, P516, DOI 10.1016/j.echo.2010.03.005; Moreo A, 2009, CIRC-CARDIOVASC IMAG, V2, P437, DOI 10.1161/CIRCIMAGING.108.838367; Otto CM, 1999, NEW ENGL J MED, V341, P142, DOI 10.1056/NEJM199907153410302; Pandya K, 2006, P NATL ACAD SCI USA, V103, P16864, DOI 10.1073/pnas.0607700103; Parker MW, 2010, CIRC-HEART FAIL, V3, P470, DOI 10.1161/CIRCHEARTFAILURE.110.957720; Piro M, 2010, J AM COLL CARDIOL, V55, P1057, DOI 10.1016/j.jacc.2009.09.065; Qi W, 2008, BIOCHEM J, V416, P453, DOI 10.1042/BJ20080651; Regitz-Zagrosek V, 2007, PROG CARDIOVASC DIS, V49, P241, DOI 10.1016/j.pcad.2006.08.011; Regitz-Zagrosek V, 2010, CIRC J, V74, P1265, DOI 10.1253/circj.CJ-10-0196; Rocha FL, 2007, AM J PHYSIOL-HEART C, V293, pH3575, DOI 10.1152/ajpheart.01251.2006; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Rosenkranz S, 2002, AM J PHYSIOL-HEART C, V283, pH1253, DOI 10.1152/ajpheart.00578.2001; Schultz JEJ, 2002, J CLIN INVEST, V109, P787, DOI 10.1172/JCI200214190; Skavdahl M, 2005, AM J PHYSIOL-HEART C, V288, pH469, DOI 10.1152/ajpheart.00723.2004; Vaneckova I, 2011, KIDNEY BLOOD PRESS R, V34, P46, DOI 10.1159/000322618; Villar AV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008476; Villar AV, 2009, J MOL CELL CARDIOL, V46, P526, DOI 10.1016/j.yjmcc.2008.12.024; VILLARI B, 1995, EUR HEART J, V16, P1410, DOI 10.1093/oxfordjournals.eurheartj.a060749; Vinereanu D, 2005, EUR J HEART FAIL, V7, P820, DOI 10.1016/j.ejheart.2005.02.003; Weidemann F, 2009, CIRCULATION, V120, P577, DOI 10.1161/CIRCULATIONAHA.108.847772; Weinberg EO, 1999, J AM COLL CARDIOL, V34, P264, DOI 10.1016/S0735-1097(99)00165-5; Witt H, 2008, J MOL MED, V86, P1013, DOI 10.1007/s00109-008-0385-4; Wu JC, 2003, J AM SOC ECHOCARDIOG, V16, P1158, DOI 10.1067/S0894-7317(03)00648-5; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613	50	33	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35635	10.1371/journal.pone.0035635	http://dx.doi.org/10.1371/journal.pone.0035635			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558184	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345200057
J	Zhang, LH; Guo, DF; Niu, SL; Wang, CH; Shao, CL; Li, LH				Zhang, Lihua; Guo, Dufa; Niu, Shuli; Wang, Changhui; Shao, Changliang; Li, Linghao			Effects of Mowing on Methane Uptake in a Semiarid Grassland in Northern China	PLOS ONE			English	Article							SOIL MICROBIAL BIOMASS; LAND-USE CHANGE; CARBON-DIOXIDE; NITROGEN-FERTILIZATION; ATMOSPHERIC METHANE; BACTERIAL COMMUNITY; PINUS-RADIATA; PLANT BIOMASS; CH4 UPTAKE; FLUXES	Background: Mowing is a widely adopted management practice for the semiarid steppe in China and affects CH4 exchange. However, the magnitude and the underlying mechanisms for CH4 uptake in response to mowing remain uncertain. Methodology/Principal Findings: In two consecutive growing seasons, we measured the effect of mowing on CH4 uptake in a steppe community. Vegetation was mowed to 2 cm (M2), 5 cm (M5), 10 cm (M10), 15 cm (M15) above soil surface, respectively, and control was set as non-mowing (NM). Compared with control, CH4 uptake was substantially enhanced at almost all the mowing treatments except for M15 plots of 2009. CH4 uptake was significantly correlated with soil microbial biomass carbon, microbial biomass nitrogen, and soil moisture. Mowing affects CH4 uptake primarily through its effect on some biotic factors, such as net primary productivity, soil microbial C\N supply and soil microbial activities, while soil temperature and moisture were less important. Conclusions/Significance: This study found that mowing affects the fluxes of CH4 in the semiarid temperate steppe of north China.	[Zhang, Lihua; Niu, Shuli; Wang, Changhui; Shao, Changliang; Li, Linghao] Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China; [Guo, Dufa] Shandong Normal Univ, Jinan, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Shandong Normal University	Zhang, LH (corresponding author), Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China.	llinghao@ibcas.ac.cn	shao, changliang/ACG-3396-2022	Niu, Shuli/0000-0002-2394-2864	National Natural Science Foundation of China [40801037]; State Key Research Development Program of China [2010CB951301-2]; State Key Laboratory of Vegetation and Environmental Change Youth Funds; open funding of State Key Laboratory of Vegetation and Environmental Change, Institute of Botany	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Research Development Program of China(State Key Development Program for Basic Research of China); State Key Laboratory of Vegetation and Environmental Change Youth Funds; open funding of State Key Laboratory of Vegetation and Environmental Change, Institute of Botany	This work was funded by the National Natural Science Foundation of China (40801037), the State Key Research Development Program of China (2010CB951301-2) and State Key Laboratory of Vegetation and Environmental Change Youth Funds, and an open funding of the State Key Laboratory of Vegetation and Environmental Change, Institute of Botany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard V, 2007, AGR ECOSYST ENVIRON, V121, P47, DOI 10.1016/j.agee.2006.12.004; Bahn M, 2006, GLOBAL CHANGE BIOL, V12, P995, DOI 10.1111/j.1365-2486.2006.01144.x; Borken W, 2006, SOIL BIOL BIOCHEM, V38, P1388, DOI 10.1016/j.soilbio.2005.10.011; Bubier J, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002351; Chen QS, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003538; Chen WW, 2011, GLOBAL CHANGE BIOL, V17, P2803, DOI 10.1111/j.1365-2486.2011.02444.x; Chen WW, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013783; CHRISTENSEN TR, 1993, BIOGEOCHEMISTRY, V21, P117, DOI 10.1007/BF00000874; Dalal RC, 2008, PLANT SOIL, V309, P43, DOI 10.1007/s11104-007-9446-7; Dlugokencky EJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018126; Foster BL, 2009, ECOL APPL, V19, P1884, DOI 10.1890/08-0849.1; GARCIA FO, 1994, SOIL SCI SOC AM J, V58, P816, DOI 10.2136/sssaj1994.03615995005800030026x; Gavrichkova O, 2010, AGR ECOSYST ENVIRON, V136, P87, DOI 10.1016/j.agee.2009.11.015; Gulledge J, 2004, FEMS MICROBIOL ECOL, V49, P389, DOI 10.1016/j.femsec.2004.04.013; Hirota M, 2005, ATMOS ENVIRON, V39, P5255, DOI 10.1016/j.atmosenv.2005.05.036; Huang Y, 2010, GLOBAL CHANGE BIOL, V16, P680, DOI 10.1111/j.1365-2486.2009.01976.x; Ilmarinen K, 2009, RESTOR ECOL, V17, P78, DOI 10.1111/j.1526-100X.2007.00341.x; Ilmarinen K, 2009, ACTA OECOL, V35, P838, DOI 10.1016/j.actao.2009.08.008; IPCC, 2007, CLIM CHANG 2007 PHYS; Jin HM, 2010, J PLANT ECOL, V3, P209, DOI 10.1093/jpe/rtq001; Kaleita AL, 2005, APPL ENG AGRIC, V21, P865; Kaye JP, 2004, ECOL APPL, V14, P975, DOI 10.1890/03-5115; Li LH, 1998, ACTA BOT SIN, V40, P955; Li LH, 2002, ACTA BOT SIN, V44, P593; Lin XW, 2009, SOIL BIOL BIOCHEM, V41, P718, DOI 10.1016/j.soilbio.2009.01.007; Lipson DA, 2004, APPL ENVIRON MICROB, V70, P2867, DOI 10.1128/AEM.70.5.2867-2879.2004; Liu CY, 2007, ATMOS ENVIRON, V41, P5948, DOI 10.1016/j.atmosenv.2007.03.017; Liu CY, 2009, ATMOS ENVIRON, V43, P3086, DOI 10.1016/j.atmosenv.2009.03.014; Liu WX, 2007, BIOL FERT SOILS, V44, P259, DOI 10.1007/s00374-007-0198-6; Livesley SJ, 2009, GLOBAL CHANGE BIOL, V15, P425, DOI 10.1111/j.1365-2486.2008.01759.x; Luo YQ, 2009, GCB BIOENERGY, V1, P62, DOI 10.1111/j.1757-1707.2008.01005.x; Menyailo OV, 2008, GLOBAL CHANGE BIOL, V14, P2405, DOI 10.1111/j.1365-2486.2008.01648.x; Merino A, 2004, SOIL BIOL BIOCHEM, V36, P917, DOI 10.1016/j.soilbio.2004.02.006; MOSIER A, 1991, NATURE, V350, P330, DOI 10.1038/350330a0; Mosier AR, 1997, GLOBAL BIOGEOCHEM CY, V11, P29, DOI 10.1029/96GB03612; Nitschke N, 2010, J PLANT ECOL, V3, P109, DOI 10.1093/jpe/rtp036; PARR TW, 1988, J APPL ECOL, V25, P1073, DOI 10.2307/2403767; Peichl M, 2010, GLOBAL CHANGE BIOL, V16, P2198, DOI 10.1111/j.1365-2486.2009.02066.x; Pinares-Patino CS, 2007, AGR ECOSYST ENVIRON, V121, P30, DOI 10.1016/j.agee.2006.03.024; Potter CS, 1996, CHEMOSPHERE, V32, P2219, DOI 10.1016/0045-6535(96)00119-1; Prieme A, 1997, SOIL BIOL BIOCHEM, V29, P1269, DOI 10.1016/S0038-0717(97)00017-5; [齐玉春 Qi Yuchun], 2005, [资源科学, Resources science], V27, P103; Reay DS, 2004, SOIL BIOL BIOCHEM, V36, P2059, DOI 10.1016/j.soilbio.2004.06.002; Robson TM, 2007, SOIL BIOL BIOCHEM, V39, P930, DOI 10.1016/j.soilbio.2006.11.004; Sihgh BK, 2007, FEMS MICROBIO LETT, V275, P89; Smith KA, 2000, GLOBAL CHANGE BIOL, V6, P791, DOI 10.1046/j.1365-2486.2000.00356.x; Tate KR, 2007, SOIL BIOL BIOCHEM, V39, P1437, DOI 10.1016/j.soilbio.2007.01.005; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wan S, 2002, GLOBAL CHANGE BIOL, V8, P754, DOI 10.1046/j.1365-2486.2002.00510.x; Wang YS, 2005, CHEMOSPHERE, V58, P205, DOI 10.1016/j.chemosphere.2004.04.043; Wang YS, 2003, ADV ATMOS SCI, V20, P842, DOI 10.1007/BF02915410; Wang ZP, 2009, ATMOS ENVIRON, V43, P2148, DOI 10.1016/j.atmosenv.2009.01.021; WHITING GJ, 1993, NATURE, V364, P794, DOI 10.1038/364794a0; Xia JY, 2009, GLOBAL CHANGE BIOL, V15, P1544, DOI 10.1111/j.1365-2486.2008.01807.x; Zhao N, 2008, CHINESE J PLANT ECOL, V32, P591; Zhou XQ, 2008, SOIL BIOL BIOCHEM, V40, P258, DOI 10.1016/j.soilbio.2007.05.020; Zhou X, 2007, GLOBAL CHANGE BIOL, V13, P761, DOI 10.1111/j.1365-2486.2007.01333.x	57	8	9	4	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35952	10.1371/journal.pone.0035952	http://dx.doi.org/10.1371/journal.pone.0035952			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558280	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345200095
J	Tang, ZQ; Lu, Y				Tang, Zheng-Quan; Lu, Yong			Development of GPCR Modulation of GABAergic Transmission in Chicken Nucleus Laminaris Neurons	PLOS ONE			English	Article							SUPERIOR OLIVARY NUCLEUS; STEM AUDITORY NUCLEI; METABOTROPIC GLUTAMATE RECEPTORS; AVIAN COCHLEAR NUCLEUS; COINCIDENCE DETECTION; SYNAPTIC-TRANSMISSION; GABA(B) RECEPTORS; PATCH-CLAMP; MAGNOCELLULARIS; SPILLOVER	Neurons in the nucleus laminaris (NL) of birds act as coincidence detectors and encode interaural time difference to localize the sound source in the azimuth plane. GABAergic transmission in a number of CNS nuclei including the NL is subject to a dual modulation by presynaptic GABA(B) receptors (GABA(B)Rs) and metabotropic glutamate receptors (mGluRs). Here, using in vitro whole-cell patch clamp recordings from acute brain slices of the chick, we characterized the following important but unknown properties pertaining to such a dual modulation: (1) emergence of functional GABA synapses in NL neurons; (2) the temporal onset of neuromodulation mediated by GABA(B)Rs and mGluRs; and (3) the physiological conditions under which GABA(B)Rs and mGluRs are activated by endogenous transmitters. We found that (1) GABA(A)R-mediated synaptic responses were observed in about half of the neurons at embryonic day 11 (E11); (2) GABA(B)R-mediated modulation of the GABAergic transmission was detectable at E11, whereas the modulation by mGluRs did not emerge until E15; and (3) endogenous activity of GABA(B)Rs was induced by both low- (5 or 10 Hz) and high-frequency (200 Hz) stimulation of the GABAergic pathway, whereas endogenous activity of mGluRs was induced by high- (200 Hz) but not low-frequency (5 or 10 Hz) stimulation of the glutamatergic pathway. Furthermore, the endogenous activity of mGluRs was mediated by group II but not group III members. Therefore, autoreceptor-mediated modulation of GABAergic transmission emerges at the same time when the GABA synapses become functional. Heteroreceptor-mediated modulation appears at a later time and is receptor type dependent in vitro.	[Tang, Zheng-Quan; Lu, Yong] NE Ohio Med Univ, Coll Med, Dept Anat & Neurobiol, Rootstown, OH USA	Northeast Ohio Medical University (NEOMED)	Tang, ZQ (corresponding author), NE Ohio Med Univ, Coll Med, Dept Anat & Neurobiol, Rootstown, OH USA.	ylu@neomed.edu			National Institute on Deafness and other Communication Disorders (NIDCD) [R01 DC008984]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008984] Funding Source: NIH RePORTER	National Institute on Deafness and other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institute on Deafness and other Communication Disorders (NIDCD) Grant R01 DC008984 (YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; Barbour B, 1997, TRENDS NEUROSCI, V20, P377; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; Bellone C, 2008, CELL MOL LIFE SCI, V65, P2913, DOI 10.1007/s00018-008-8263-3; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Burger RM, 2005, J COMP NEUROL, V481, P6, DOI 10.1002/cne.20334; Cartmell J, 2000, J NEUROCHEM, V75, P889, DOI 10.1046/j.1471-4159.2000.0750889.x; Chalifoux JR, 2011, CURR OPIN NEUROBIOL, V21, P339, DOI 10.1016/j.conb.2011.02.004; CODE RA, 1989, J COMP NEUROL, V284, P504, DOI 10.1002/cne.902840403; de Jong APH, 2009, CURR OPIN NEUROBIOL, V19, P245, DOI 10.1016/j.conb.2009.06.005; Drew GM, 2008, J NEUROSCI, V28, P808, DOI 10.1523/JNEUROSCI.4876-07.2008; Fujino K, 2003, P NATL ACAD SCI USA, V100, P265, DOI 10.1073/pnas.0135345100; Fukui I, 2006, J NEUROPHYSIOL, V96, P633, DOI 10.1152/jn.00916.2005; Galvan A, 2006, NEUROSCIENCE, V143, P351, DOI 10.1016/j.neuroscience.2006.09.019; Gao H, 2008, NEUROSCIENCE, V153, P131, DOI 10.1016/j.neuroscience.2008.01.059; Gladding CM, 2009, PHARMACOL REV, V61, P395, DOI 10.1124/pr.109.001735; Hendricks SJ, 2006, J COMP NEUROL, V498, P433, DOI 10.1002/cne.21031; Hyson RL, 2005, PHYSIOL BEHAV, V86, P297, DOI 10.1016/j.physbeh.2005.08.003; Korn MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027383; Kullmann DM, 2000, PROG BRAIN RES, V125, P339; LACHICA EA, 1994, J COMP NEUROL, V348, P403, DOI 10.1002/cne.903480307; LANZA M, 1993, EUR J PHARMACOL, V237, P191, DOI 10.1016/0014-2999(93)90268-M; LIPPE WR, 1994, J NEUROSCI, V14, P1486, DOI 10.1523/JNEUROSCI.14-03-01486.1994; Lu Y, 2005, J NEUROPHYSIOL, V93, P1429, DOI 10.1152/jn.00786.2004; Lu Y, 2007, J NEUROPHYSIOL, V97, P1018, DOI 10.1152/jn.00883.2006; Luo B, 2011, HEARING RES, V280, P157, DOI 10.1016/j.heares.2011.05.018; Mitchell SJ, 2000, NATURE, V404, P498, DOI 10.1038/35006649; Nicoletti E, 2011, NEUROPHARMACOLOGY, V60, P1017, DOI 10.1016/j.neuropharm.2010.10.022; Nishino E, 2008, J NEUROSCI, V28, P7153, DOI 10.1523/JNEUROSCI.4398-07.2008; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Okubo Y, 2011, J PHYSIOL-LONDON, V589, P481, DOI 10.1113/jphysiol.2010.199539; Panatier A, 2004, NEUROPHARMACOLOGY, V47, P333, DOI 10.1016/j.neuropharm.2004.05.003; PARKS TN, 1983, J COMP NEUROL, V214, P32, DOI 10.1002/cne.902140104; PARKS TN, 1981, J COMP NEUROL, V203, P425, DOI 10.1002/cne.902030307; Pinheiro PS, 2008, NAT REV NEUROSCI, V9, P423, DOI 10.1038/nrn2379; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Ryugo DK, 2003, BRAIN RES BULL, V60, P435, DOI 10.1016/S0361-9230(03)00049-2; Sanchez JT, 2010, J NEUROPHYSIOL, V104, P1774, DOI 10.1152/jn.00468.2010; Sanes DH, 1998, J NEUROPHYSIOL, V80, P209, DOI 10.1152/jn.1998.80.1.209; SAUNDERS JC, 1973, BRAIN RES, V63, P59, DOI 10.1016/0006-8993(73)90076-0; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; SMITH DJ, 1979, J COMP NEUROL, V186, P213, DOI 10.1002/cne.901860207; SMITH ZDJ, 1981, J COMP NEUROL, V203, P309, DOI 10.1002/cne.902030302; Stephens GJ, 2009, TRENDS PHARMACOL SCI, V30, P421, DOI 10.1016/j.tips.2009.05.008; Tabor KM, 2011, J COMP NEUROL, V519, P358, DOI 10.1002/cne.22523; Tang ZQ, 2011, J NEUROSCI, V31, P6121, DOI 10.1523/JNEUROSCI.4733-10.2011; Tang ZQ, 2009, J NEUROPHYSIOL, V102, P1672, DOI 10.1152/jn.00419.2009; Toms NJ, 1996, BRIT J PHARMACOL, V119, P851, DOI 10.1111/j.1476-5381.1996.tb15750.x; Tsukada S, 2005, NEUROPHARMACOLOGY, V48, P479, DOI 10.1016/j.neuropharm.2004.11.006; Ulrich D, 2007, CURR OPIN NEUROBIOL, V17, P298, DOI 10.1016/j.conb.2007.04.001; WARCHOL ME, 1990, J COMP PHYSIOL A, V166, P721; Yang LC, 1999, J NEUROSCI, V19, P2313; Ye JH, 2006, J NEUROSCI METH, V158, P251, DOI 10.1016/j.jneumeth.2006.06.006; YOUNG SR, 1983, J NEUROSCI, V3, P1373; ZHANG S, 1994, J NEUROPHYSIOL, V72, P705, DOI 10.1152/jn.1994.72.2.705	56	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35831	10.1371/journal.pone.0035831	http://dx.doi.org/10.1371/journal.pone.0035831			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545142	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343200062
J	Corbett, HJ; Connell, MG; Fernig, DG; Losty, PD; Jesudason, EC				Corbett, Harriet Jane; Connell, Marilyn Gwen; Fernig, David Garth; Losty, Paul Damion; Jesudason, Edwin Chitran			ANG-1 TIE-2 and BMPR Signalling Defects Are Not Seen in the Nitrofen Model of Pulmonary Hypertension and Congenital Diaphragmatic Hernia	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; EXPERIMENTAL LUNG HYPOPLASIA; ARTERIAL-HYPERTENSION; CELL-PROLIFERATION; PROTEIN-RECEPTOR; RAT MODEL; ANGIOPOIETIN-1; VASCULATURE; MICE; SUSCEPTIBILITY	Background: Pulmonary hypertension (PH) is a lethal disease that is associated with characteristic histological abnormalities of the lung vasculature and defects of angiopoetin-1 (ANG-1), TIE-2 and bone morphogenetic protein receptor (BMPR)related signalling. We hypothesized that if these signalling defects cause PH generically, they will be readily identifiable perinatally in congenital diaphragmatic hernia (CDH), where the typical pulmonary vascular changes are present before birth and are accompanied by PH after birth. Methods: CDH (predominantly left-sided, LCDH) was created in Sprague-Dawley rat pups by e9.5 maternal nitrofen administration. Left lungs from normal and LCDH pups were compared at fetal and postnatal time points for ANG-1, TIE-2, phosphorylated-TIE-2, phosphorylated-SMAD1/5/8 and phosphorylated-ERK1/2 by immunoprecipitation and Western blotting of lung protein extracts and by immunohistochemistry on lung sections. Results: In normal lung, pulmonary ANG-1 protein levels fall between fetal and postnatal life, while TIE-2 levels increase. Over the corresponding time period, LCDH lung retained normal expression of ANG-1, TIE-2, phosphorylated-TIE-2 and, downstream of BMPR, phosphorylated-SMAD1/5/8 and phosphorylated-p44/42. Conclusion: In PH and CDH defects of ANG-1/TIE-2/BMPR-related signalling are not essential for the lethal vasculopathy.	[Corbett, Harriet Jane; Connell, Marilyn Gwen; Losty, Paul Damion; Jesudason, Edwin Chitran] Univ Liverpool, Div Child Hlth, Inst Translat Med, Liverpool L69 3BX, Merseyside, England; [Corbett, Harriet Jane; Losty, Paul Damion; Jesudason, Edwin Chitran] Alder Hey Childrens Natl Hlth Serv NHS Fdn Trust, Dept Paediat Surg, Liverpool, Merseyside, England; [Fernig, David Garth] Univ Liverpool, Dept Chem & Struct Biol, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England	University of Liverpool; Alder Hey Children's NHS Foundation Trust; University of Liverpool	Corbett, HJ (corresponding author), Univ Liverpool, Div Child Hlth, Inst Translat Med, Liverpool L69 3BX, Merseyside, England.	harriet.corbett@alderhey.nhs.uk	Fernig, David G/A-3590-2008	Fernig, David G/0000-0003-4875-4293	Royal College of Surgeons of England; Medical Research Council [G84/6485]; Cancer and Polio Research Fund Laboratories; North West Cancer Research Fund; University of Liverpool; MRC [G0802057, G84/6485] Funding Source: UKRI; Medical Research Council [G0802057] Funding Source: researchfish	Royal College of Surgeons of England; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer and Polio Research Fund Laboratories; North West Cancer Research Fund; University of Liverpool; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	HJC was supported by a Clinical Training Fellowship awarded by the Royal College of Surgeons of England, and Medical Research Council (Medical Research Council grant number G84/6485). ECJ is supported by a Medical Research Council New Investigator Award. DGF is funded by Cancer and Polio Research Fund Laboratories and North West Cancer Research Fund. MGC was the Senior Experimental Officer, Funded by The University of Liverpool. PDL is Professor of Paediatric Surgery, funded by the University of Liverpool. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boucherat O, 2010, AM J PHYSIOL-LUNG C, V298, pL849, DOI 10.1152/ajplung.00333.2009; Brindle NPJ, 2006, CIRC RES, V98, P1014, DOI 10.1161/01.RES.0000218275.54089.12; Chen C, 2005, AM J PHYSIOL-LUNG C, V288, pL1033, DOI 10.1152/ajplung.00277.2004; Chinoy MR, 2002, AM J PHYSIOL-LUNG C, V283, pL60, DOI 10.1152/ajplung.00317.2001; Cilley RE, 1997, AM J PHYSIOL-LUNG C, V272, pL362, DOI 10.1152/ajplung.1997.272.2.L362; Coleman C, 1998, AM J PHYSIOL-LUNG C, V274, pL636, DOI 10.1152/ajplung.1998.274.4.L636; Du Lingling, 2003, New England Journal of Medicine, V348, P500, DOI 10.1056/NEJMoa021650; Featherstone NC, 2006, AM J RESP CELL MOL, V35, P571, DOI 10.1165/rcmb.2006-0079OC; Finer NN, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000399.pub2; Frank DB, 2008, AM J PHYSIOL-LUNG C, V294, pL98, DOI 10.1152/ajplung.00034.2007; Gallot D, 2007, ULTRASOUND OBST GYN, V29, P276, DOI 10.1002/uog.3863; GEGGEL RL, 1985, J PEDIATR-US, V107, P457, DOI 10.1016/S0022-3476(85)80534-5; Harrison RE, 2003, J MED GENET, V40, P865, DOI 10.1136/jmg.40.12.865; Ihida-Stansbury K, 2006, AM J PHYSIOL-LUNG C, V291, pL694, DOI 10.1152/ajplung.00119.2006; Jesudason EC, 2000, J PEDIATR SURG, V35, P124, DOI 10.1016/S0022-3468(00)80028-7; Jesudason EC, 2000, PEDIATR SURG INT, V16, P247, DOI 10.1007/s003830050738; Jesudason EC, 2000, J PEDIATR SURG, V35, P914, DOI 10.1053/jpsu.2000.6919; Jesudason EC, 2000, J PEDIATR SURG, V35, P129, DOI 10.1016/S0022-3468(00)80092-5; Kanai M, 2001, J PEDIATR SURG, V36, P839, DOI 10.1053/jpsu.2001.23950; Kling DE, 2001, J PEDIATR SURG, V36, P1490, DOI 10.1053/jpsu.2001.27029; KLUTH D, 1990, J PEDIATR SURG, V25, P850, DOI 10.1016/0022-3468(90)90190-K; Kugathasan L, 2009, J EXP MED, V206, P2221, DOI 10.1084/jem.20090389; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Long L, 2006, CIRC RES, V98, P818, DOI 10.1161/01.RES.0000215809.47923.fd; Machado RD, 2001, AM J HUM GENET, V68, P92, DOI 10.1086/316947; Maniscalco WM, 2002, AM J PHYSIOL-LUNG C, V282, pL811, DOI 10.1152/ajplung.00325.2001; Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018; Mugford M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001340.pub2; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; Okoye BO, 1998, J PEDIATR SURG, V33, P76, DOI 10.1016/S0022-3468(98)90366-9; Okoye BO, 1998, ARCH DIS CHILD-FETAL, V78, pF204, DOI 10.1136/fn.78.3.F204; Perreault T, 2006, PAEDIATR RESPIR REV, V7, pS175, DOI 10.1016/j.prrv.2006.04.211; Reynolds AM, 2012, EUR RESPIR J, V39, P329, DOI 10.1183/09031936.00187310; Richter A, 2004, AM J RESP CRIT CARE, V170, P1340, DOI 10.1164/rccm.200311-1602OC; Rocha GM, 2008, EUR J PEDIATR SURG, V18, P219, DOI 10.1055/s-2008-1038502; Solari V, 2003, J PEDIATR SURG, V38, P808, DOI 10.1016/jpsu.2003.50172; Stewart DJ, 2005, CIRC RES, V96, P1033, DOI 10.1161/01.RES.0000168922.54339.47; Sun LJ, 2007, BIOCHEM BIOPH RES CO, V357, P779, DOI 10.1016/j.bbrc.2007.04.010; Taira Y, 1998, PEDIATR SURG INT, V14, P30, DOI 10.1007/s003830050429; Takahashi H, 2006, AM J PHYSIOL-LUNG C, V290, pL450, DOI 10.1152/ajplung.00206.2005; TENBRINCK R, 1992, J PEDIATR SURG, V27, P862, DOI 10.1016/0022-3468(92)90385-K; Thompson Sophie M, 2011, BMC Dev Biol, V11, P38, DOI 10.1186/1471-213X-11-38; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; West J, 2005, CHEST, V128, p553S, DOI 10.1378/chest.128.6_suppl.553S; Yang XD, 2005, CIRC RES, V96, P1053, DOI 10.1161/01.RES.0000166926.54293.68; Yu PB, 2005, J BIOL CHEM, V280, P24443, DOI 10.1074/jbc.M502825200; Zhao YD, 2003, CIRC RES, V92, P984, DOI 10.1161/01.RES.0000070587.79937.F0	47	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35364	10.1371/journal.pone.0035364	http://dx.doi.org/10.1371/journal.pone.0035364			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539968	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341000033
J	Timpka, S; Petersson, IF; Rylance, R; Kedza, L; Englund, M				Timpka, Simon; Petersson, Ingemar F.; Rylance, Rebecca; Kedza, Ljuba; Englund, Martin			Performance in Physical Education and Health Impairment 30 Years Later-A Community Based Cohort Study	PLOS ONE			English	Article							SICKNESS ABSENCE; RISK-FACTORS; CARDIOVASCULAR-DISEASE; EUROPEAN YOUTH; US CHILDREN; PREVALENCE; OBESITY; ADOLESCENTS; OVERWEIGHT; CHILDHOOD	Objective: A main purpose of physical education (PE) in school is to promote future health. However, there is very limited evidence of the effects of PE on the adult health. We hypothesized that a low performance in PE was associated with an increased risk of health impairment by middle age. Methods: We performed a cohort study in a community-based setting in Sweden spanning over three decades. We followed up on 1712 of 2225 students (76.9%) who in 1974-1976 graduated with a grade in PE after 9 years of education (mean subject age 16 years). The grade in PE (compulsory subject) was retrieved from municipal archives. We defined three proxies for health impairment: total number of visits to primary care physicians in 2003-2007, having been hospitalized 2003-2007, and total number of days with sick leave in 2004-2007. Using binomial regression models, we adjusted the risk estimates for level of education and occupation. Subjects with an average grade in PE served as reference category. Results: In both the crude and adjusted model, women with a low grade in PE had more physician visits (adjusted IRR 1.30, 95% confidence interval 1.06-1.60) and an increased number of days with sick leave (adjusted IRR 1.44, 1.05-1.95). An increased, although not significant, risk was also observed for having received in-patient care (adjusted RR 1.26; 0.88-1.80). No significant results or similar pattern were observed in men. Conclusion: Women with a low grade in PE in adolescence seem to have an increased risk of health impairment by middle age, raising the question of early primary prevention towards these students in particular.	[Timpka, Simon; Petersson, Ingemar F.; Rylance, Rebecca; Kedza, Ljuba; Englund, Martin] Lund Univ, Dept Orthoped, Lund, Sweden; [Englund, Martin] Boston Univ, Sch Med, Clin Epidemiol Res & Training Unit, Boston, MA 02118 USA	Lund University; Boston University	Timpka, S (corresponding author), Lund Univ, Dept Orthoped, Lund, Sweden.	simon.timpka@med.lu.se	Timpka, Simon/ABG-2173-2020; Englund, Martin/J-7245-2012	Timpka, Simon/0000-0001-7445-7212; Englund, Martin/0000-0003-3320-2437; Rylance, Rebecca/0000-0002-5921-3786; Petersson, Ingemar/0000-0001-9139-1892	Regional Health Service Authorities in Skane (Region Skane); Swedish Social Insurance Agency (Forsakringskassan); Swedish Research Council (Vetenskapsradet) [K2009-53X-21075-01]; Faculty of Medicine at Lund University	Regional Health Service Authorities in Skane (Region Skane); Swedish Social Insurance Agency (Forsakringskassan); Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Faculty of Medicine at Lund University	The study was funded by grants from the Regional Health Service Authorities in Skane (Region Skane), the Swedish Social Insurance Agency (Forsakringskassan), the Swedish Research Council (Vetenskapsradet) www.vr.se (Grant number K2009-53X-21075-01), and the Faculty of Medicine at Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Windi A, 2002, J CLIN EPIDEMIOL, V55, P60, DOI 10.1016/S0895-4356(01)00423-1; Allebeck P, 2004, SCAND J PUBLIC HEALT, V32, P49, DOI 10.1080/14034950410021853; Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Anandacoomarasamy A, 2009, CURR OPIN RHEUMATOL, V21, P71, DOI 10.1097/BOR.0b013e32831bc0d7; Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Armstrong N, 2006, SPORTS MED, V36, P1067, DOI 10.2165/00007256-200636120-00005; Barnekow-Bergkvist M, 2001, SCAND J PUBLIC HEALT, V29, P208, DOI 10.1177/14034948010290031001; Biddle SJH, 2004, J SPORT SCI, V22, P679, DOI 10.1080/02640410410001712412; Burke V, 1997, PREV MED, V26, P724, DOI 10.1006/pmed.1997.0198; Cannon M, 1999, ARCH GEN PSYCHIAT, V56, P457, DOI 10.1001/archpsyc.56.5.457; Dale D, 1998, PEDIATR EXERC SCI, V10, P97, DOI 10.1123/pes.10.2.97; Denton M, 2004, SOC SCI MED, V58, P2585, DOI 10.1016/j.socscimed.2003.09.008; Englund M, 2010, RHEUMATOLOGY OXFORD; Engstrom L. M., 2008, Physical Education and Sport Pedagogy, V13, P319, DOI 10.1080/17408980802400510; Eriksson Hans-G, 2008, BMC Public Health, V8, P426, DOI 10.1186/1471-2458-8-426; European Commission, 2009, ECTS US GUID; Fogelholm M, 2008, INT J PEDIATR OBES, V3, P10, DOI 10.1080/17477160801896481; Friedenberg FK, 2008, AM J GASTROENTEROL, V103, P2111, DOI 10.1111/j.1572-0241.2008.01946.x; Green CA, 1999, SOC SCI MED, V48, P1363, DOI 10.1016/S0277-9536(98)00440-7; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Kimm SYS, 2002, NEW ENGL J MED, V347, P709, DOI 10.1056/NEJMoa003277; Kivimaki M, 2003, BRIT MED J, V327, P364, DOI 10.1136/bmj.327.7411.364; Kriemler S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c785; MacCabe JH, 2008, PSYCHOL MED, V38, P1133, DOI 10.1017/S0033291707002048; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; MARMOT M, 1995, J EPIDEMIOL COMMUN H, V49, P124, DOI 10.1136/jech.49.2.124; McKenzie TL, 2009, AM J LIFESTYLE MED, V3, P219, DOI 10.1177/1559827609331562; Miilunpalo S, 1997, J CLIN EPIDEMIOL, V50, P517, DOI 10.1016/S0895-4356(97)00045-0; Nilsson M, 2004, GUT, V53, P1730, DOI 10.1136/gut.2004.043265; Olofsson T, 2010, ANN RHEUM DIS, V69, P2131, DOI 10.1136/ard.2009.127852; Palmer KT, 2003, ANN RHEUM DIS, V62, P33, DOI 10.1136/ard.62.1.33; Pate RR, 1996, AM J PUBLIC HEALTH, V86, P1577, DOI 10.2105/AJPH.86.11.1577; Piha K, 2010, EUR J PUBLIC HEALTH, V20, P276, DOI 10.1093/eurpub/ckp162; Poortinga W, 2007, PREV MED, V44, P124, DOI 10.1016/j.ypmed.2006.10.006; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Sallis JF, 1997, AM J PUBLIC HEALTH, V87, P1328, DOI 10.2105/AJPH.87.8.1328; Shephard RJ, 1999, MED SCI SPORT EXER, V31, P111, DOI 10.1097/00005768-199901000-00018; Skoloverstyrelsen, 1969, LAR GRUNDSK 1 ALL ST; Stamatakis E, 2010, INT J OBESITY, V34, P41, DOI 10.1038/ijo.2009.217; STARFIELD B, 1991, HEALTH SERV RES, V26, P53; Strombeck B, 2009, RHEUMATOLOGY, V48, P289, DOI 10.1093/rheumatology/ken497; Telama R, 1997, AM J PREV MED, V13, P317, DOI 10.1016/S0749-3797(18)30182-X; Timpka S, 2010, PAIN, V150, P414, DOI 10.1016/j.pain.2010.03.035; Trudeau F, 2008, SPORTS MED, V38, P265, DOI 10.2165/00007256-200838040-00001; Vahtera J, 2004, J EPIDEMIOL COMMUN H, V58, P321, DOI 10.1136/jech.2003.011817; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Westerstahl M, 2003, ACTA PAEDIATR, V92, P602, DOI 10.1080/08035250310002713; Whitt-Glover MC, 2009, J PUBLIC HEALTH POL, V30, pS309, DOI 10.1057/jphp.2008.46	51	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35718	10.1371/journal.pone.0035718	http://dx.doi.org/10.1371/journal.pone.0035718			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UP	22539996	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341000062
J	Harrison, FE; Best, JL; Meredith, ME; Gamlin, CR; Borza, DB; May, JM				Harrison, Fiona Edith; Best, Jennifer Lee; Meredith, Martha Elizabeth; Gamlin, Clare Ruth; Borza, Dorin-Bogdan; May, James Michael			Increased Expression of SVCT2 in a New Mouse Model Raises Ascorbic Acid in Tissues and Protects against Paraquat-Induced Oxidative Damage in Lung	PLOS ONE			English	Article							VITAMIN-C TRANSPORTERS; MICE; BRAIN; STRESS; CELLS; DEFICITS	A new transgenic mouse model for global increases in the Sodium Dependent Vitamin C transporter 2 (SVCT2) has been generated. The SVCT2-Tg mouse shows increased SVCT2 mRNA levels in all organs tested and correspondingly increased ascorbic acid (ASC) levels in all organs except liver. The extent of the increase in transporter mRNA expression differed among mice and among organs. The increased ASC levels did not have any adverse effects on behavior in the SVCT2-Tg mice, which did not differ from wild-type mice on tests of locomotor activity, anxiety, sensorimotor or cognitive ability. High levels of SVCT2 and ASC were found in the kidneys of SVCT2-Tg mice and urinary albumin excretion was lower in these mice than in wild-types. No gross pathological changes were noted in kidneys from SVCT2-Tg mice. SVCT2 immunoreactivity was detected in both SVCT2 and wild-type mice, and a stronger signal was seen in tubules than in glomeruli. Six treatments with Paraquat (3x10 and 3x15 mg/kg i.p.) were used to induce oxidative stress in mice. SVCT2-Tg mice showed a clear attenuation of Paraquat-induced oxidative stress in lung, as measured by F2-isoprostanes. Paraquat also decreased SVCT2 mRNA signal in liver, lung and kidney in SVCT2-Tg mice.	[Harrison, Fiona Edith; Best, Jennifer Lee; Meredith, Martha Elizabeth; Gamlin, Clare Ruth; May, James Michael] Vanderbilt Univ, Med Ctr, Div Endocrinol Diabet & Metab, Nashville, TN 37240 USA; [Borza, Dorin-Bogdan] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Harrison, FE (corresponding author), Vanderbilt Univ, Med Ctr, Div Endocrinol Diabet & Metab, Nashville, TN 37240 USA.	Fiona.Harrison@Vanderbilt.edu	Borza, Dorin-Bogdan/AAF-2156-2020; Meredith, Elizabeth/AAM-4574-2021	Borza, Dorin-Bogdan/0000-0003-4568-279X; Harrison, Fiona/0000-0003-1121-0647	National Institutes of Health [NS057674]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057674] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a grant from the National Institutes of Health (NS057674 to JMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano A, 2010, ARCH BIOCHEM BIOPHYS, V496, P38, DOI 10.1016/j.abb.2010.01.012; Awadalla EA, 2012, EXP TOXICOL PATHOL, V64, P431, DOI 10.1016/j.etp.2010.10.009; Boyer JC, 2005, BIOCHEM BIOPH RES CO, V334, P150, DOI 10.1016/j.bbrc.2005.06.069; Corpe CP, 2010, J CLIN INVEST, V120, P1069, DOI 10.1172/JCI39191; Craven PA, 1997, J AM SOC NEPHROL, V8, P1405; Dinis-Oliveira RJ, 2008, CRIT REV TOXICOL, V38, P13, DOI 10.1080/10408440701669959; DIXON SJ, 1992, J BONE MINER RES, V7, P675; Fan XJ, 2006, P NATL ACAD SCI USA, V103, P16912, DOI 10.1073/pnas.0605101103; Gess B, 2011, J NEUROSCI, V31, P17180, DOI 10.1523/JNEUROSCI.3457-11.2011; Harrison FE, 2010, FREE RADICAL BIO MED, V49, P821, DOI 10.1016/j.freeradbiomed.2010.06.008; Harrison FE, 2009, BEHAV BRAIN RES, V205, P550, DOI 10.1016/j.bbr.2009.08.017; Harrison FE, 2009, NUTR NEUROSCI, V12, P203, DOI 10.1179/147683009X423364; Harrison FE, 2009, PHARMACOL BIOCHEM BE, V93, P443, DOI 10.1016/j.pbb.2009.06.006; Harrison FE, 2008, J NEUROCHEM, V106, P1198, DOI 10.1111/j.1471-4159.2008.05469.x; Harrison FE, 2009, FREE RADICAL BIO MED, V46, P719, DOI 10.1016/j.freeradbiomed.2008.12.018; Ma LJ, 2003, KIDNEY INT, V64, P350, DOI 10.1046/j.1523-1755.2003.00058.x; Maeda N, 2000, P NATL ACAD SCI USA, V97, P841, DOI 10.1073/pnas.97.2.841; May JM, 2009, AM J PHYSIOL-CELL PH, V297, pC169, DOI 10.1152/ajpcell.00674.2008; May JM, 1998, ARCH BIOCHEM BIOPHYS, V349, P281, DOI 10.1006/abbi.1997.0473; Meredith ME, 2011, BIOCHEM BIOPH RES CO, V414, P737, DOI 10.1016/j.bbrc.2011.09.146; Milne GL, 2007, NAT PROTOC, V2, P221, DOI 10.1038/nprot.2006.375; Moon JM, 2011, HUM EXP TOXICOL, V30, P844, DOI 10.1177/0960327110385633; Mun GH, 2006, J NEUROSCI RES, V83, P919, DOI 10.1002/jnr.20751; Pachla L A, 1979, Methods Enzymol, V62, P15, DOI 10.1016/0076-6879(79)62183-3; Prasad K, 2009, EXP NEUROL, V215, P358, DOI 10.1016/j.expneurol.2008.11.003; Qiao H, 2008, BRAIN RES, V1208, P79, DOI 10.1016/j.brainres.2008.02.102; Savini I, 2008, AMINO ACIDS, V34, P347, DOI 10.1007/s00726-007-0555-7; Savini I, 2007, BIOCHEM BIOPH RES CO, V361, P385, DOI 10.1016/j.bbrc.2007.07.007; Sotiriou S, 2002, NAT MED, V8, P514, DOI 10.1038/nm0502-514; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986	30	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35623	10.1371/journal.pone.0035623	http://dx.doi.org/10.1371/journal.pone.0035623			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558179	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340200020
J	Chootong, P; Panichakul, T; Permmongkol, C; Barnes, SJ; Udomsangpetch, R; Adams, JH				Chootong, Patchanee; Panichakul, Tasanee; Permmongkol, Chongrak; Barnes, Samantha J.; Udomsangpetch, Rachanee; Adams, John H.			Characterization of Inhibitory Anti-Duffy Binding Protein II Immunity: Approach to Plasmodium vivax Vaccine Development in Thailand	PLOS ONE			English	Article							MALARIA; RESPONSES; RECEPTOR; IDENTIFICATION; FALCIPARUM; KNOWLESI; FAMILY; AREA	Plasmodium vivax Duffy binding protein region II (DBPII) is an important vaccine candidate for antibody-mediated immunity against vivax malaria. A significant challenge for vaccine development of DBPII is its highly polymorphic nature that alters sensitivity to neutralizing antibody responses. Here, we aim to characterize naturally-acquired neutralizing antibodies against DBPII in individual Thai residents to give insight into P. vivax vaccine development in Thailand. Anti-DBPII IgG significantly increased in acute vivax infections compared to uninfected residents and naive controls. Antibody titers and functional anti-DBPII inhibition varied widely and there was no association between titer and inhibition activity. Most high titer plasmas had only a moderate to no functional inhibitory effect on DBP binding to erythrocytes, indicating the protective immunity against DBPII binding is strain specific. Only 5 of 54 samples were highly inhibitory against DBP erythrocyte-binding function. Previously identified target epitopes of inhibitory anti-DBPPII IgG (H1, H2 and H3) were localized to the dimer interface that forms the DARC binding pocket. Amino acid polymorphisms (monomorphic or dimorphic) in H1 and H3 protective epitopes change sensitivity of immune inhibition by alteration of neutralizing antibody recognition. The present study indicates Thai variant H1.T1 (R308S), H3.T1 (D384G) and H3.T3 (K386N) are the most important variants for a DBPII candidate vaccine needed to protect P. vivax in Thai residents.	[Chootong, Patchanee; Permmongkol, Chongrak] Mahidol Univ, Fac Med Technol, Dept Clin Microbiol & Appl Technol, Bangkok 10700, Thailand; [Panichakul, Tasanee] Suan Dusit Rajabhat Univ, Dept Sci & Technol, Bangkok, Thailand; [Barnes, Samantha J.; Adams, John H.] Univ S Florida, Dept Global Hlth Infect Dis Res Program, Tampa, FL USA; [Udomsangpetch, Rachanee] Mahidol Univ, Fac Sci, Dept Pathobiol, Bangkok 10400, Thailand	Mahidol University; Suan Dusit University; State University System of Florida; University of South Florida; Mahidol University	Chootong, P (corresponding author), Mahidol Univ, Fac Med Technol, Dept Clin Microbiol & Appl Technol, Bangkok 10700, Thailand.	pchooton@gmail.com	Adams, John/G-1800-2015; Adams, John H./ABB-8458-2020	Adams, John/0000-0003-3707-7979; Adams, John H./0000-0003-3707-7979	National Institutes of Health [R01AI064478]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064478] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Institutes of Health R01AI064478 (to J.H.A.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ADAMS JH, 1992, MOL BIOCHEM PARASIT, V56, P181, DOI 10.1016/0166-6851(92)90166-H; ADAMS JH, 1990, CELL, V63, P141, DOI 10.1016/0092-8674(90)90295-P; ADAMS JH, 1992, P NATL ACAD SCI USA, V89, P7085, DOI 10.1073/pnas.89.15.7085; BARNWELL JW, 1995, ANN TROP MED PARASIT, V89, P113, DOI 10.1080/00034983.1995.11812941; Batchelor JD, 2011, NAT STRUCT MOL BIOL, V18, P908, DOI 10.1038/nsmb.2088; Beeson JG, 2008, TRENDS PARASITOL, V24, P578, DOI 10.1016/j.pt.2008.08.008; Ceravolo IP, 2008, SCAND J IMMUNOL, V67, P270, DOI 10.1111/j.1365-3083.2007.02059.x; CHITNIS CE, 1994, J EXP MED, V180, P497, DOI 10.1084/jem.180.2.497; Chootong P, 2010, INFECT IMMUN, V78, P1089, DOI 10.1128/IAI.01036-09; Cole-Tobian J, 2003, MOL BIOCHEM PARASIT, V127, P121, DOI 10.1016/S0166-6851(02)00327-4; de Sousa TN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022944; Fraser T, 1997, INFECT IMMUN, V65, P2772, DOI 10.1128/IAI.65.7.2772-2777.1997; Gosi P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-112; Grimberg BT, 2007, PLOS MED, V4, P1940, DOI 10.1371/journal.pmed.0040337; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; HO M, 1986, J INFECT DIS, V153, P763, DOI 10.1093/infdis/153.4.763; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; Jia XL, 2002, J IMMUNOL, V169, P3200, DOI 10.4049/jimmunol.169.6.3200; Kho Weon-Gyu, 2001, Korean Journal of Parasitology, V39, P143, DOI 10.3347/kjp.2001.39.2.143; King CL, 2008, P NATL ACAD SCI USA, V105, P8363, DOI 10.1073/pnas.0800371105; McHenry AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020192; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Michon P, 2000, INFECT IMMUN, V68, P3164, DOI 10.1128/IAI.68.6.3164-3171.2000; Michon PA, 1998, AM J TROP MED HYG, V59, P597, DOI 10.4269/ajtmh.1998.59.597; Ohas EA, 2004, INFECT IMMUN, V72, P735, DOI 10.1128/IAI.72.2.735-741.2004; RILEY EM, 1989, INFECT IMMUN, V57, P3181, DOI 10.1128/IAI.57.10.3181-3188.1989; Sattabongkot J, 2004, TRENDS PARASITOL, V20, P192, DOI 10.1016/j.pt.2004.02.001; TSUBOI T, 1994, INFECT IMMUN, V62, P5581, DOI 10.1128/IAI.62.12.5581-5586.1994; WHO, 2003, WORLD HLTH REP; WHO, 2001, WHOCDCRBM200133	30	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35769	10.1371/journal.pone.0035769	http://dx.doi.org/10.1371/journal.pone.0035769			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558221	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000059
J	Djafarzadeh, R; Sauter, M; Notohamiprodjo, S; Noessner, E; Goyal, P; Siess, W; Wornle, M; Ribeiro, A; Himmelein, S; Sitter, T; Nelson, PJ				Djafarzadeh, Roghieh; Sauter, Matthias; Notohamiprodjo, Susan; Noessner, Elfriede; Goyal, Pankaj; Siess, Wolfgang; Woernle, Markus; Ribeiro, Andrea; Himmelein, Susanne; Sitter, Thomas; Nelson, Peter J.			Recombinant GPI-Anchored TIMP-1 Stimulates Growth and Migration of Peritoneal Mesothelial Cells	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; TISSUE INHIBITORS; GELATINASE-B; EXPRESSION; SECRETION; DIALYSATE; CYTOKINES; MEMBRANE; BIOLOGY; ALPHA	Background: Mesothelial cells are critical in the pathogenesis of post-surgical intraabdominal adhesions as well as in the deterioration of the peritoneal membrane associated with long-term peritoneal dialysis. Mesothelial denudation is a pathophysiolocigally important finding in these processes. Matrix metalloproteinase (MMP) biology underlies aspects of mesothelial homeostasis as well as wound repair. The endogenous tissue inhibitors of metalloproteinases (TIMPs) moderate MMP activity. Methods and Finding: By modifying human TIMP-1 through the addition of a glycosylphosphatidylinositol (GPI) anchor, a recombinant protein was generated that efficiently focuses TIMP-1 on the cell surface. Treatment of primary mesothelial cells with TIMP-1-GPI facilitates their mobilization and migration leading to a dramatic increase in the rate of wound experimental closure. Mesothelial cells treated with TIMP-1-GPI showed a dose dependent increase in cell proliferation, reduced secretion of MMP-2, MMP-9, TNF-alpha and urokinase-type plasminogen activator (uPA), but increased tissue plasminogen activator (t-PA). Treatment resulted in reduced expression and processing of latent TGF-beta 1. Conclusions: TIMP-1-GPI stimulated rapid and efficient in vitro wound closure. The agent enhanced mesothelial cell proliferation and migration and was bioactive in the nanogram range. The application of TIMP-1-GPI may represent a new approach for limiting or repairing damaged mesothelium.	[Djafarzadeh, Roghieh; Notohamiprodjo, Susan; Nelson, Peter J.] Univ Munich, Med Klin & Poliklin 4, Arbeitsgrp Klin Biochem, Munich, Germany; [Noessner, Elfriede] Helmholtz Zentrum Munchen, Inst Mol Immunol, Munich, Germany; [Goyal, Pankaj; Siess, Wolfgang] Klinikum LMU, Inst Prophylaxe & Epidemiol Kreislaufkrankheiten, Munich, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Djafarzadeh, R (corresponding author), Univ Munich, Med Klin & Poliklin 4, Arbeitsgrp Klin Biochem, Munich, Germany.	peter.nelson@med.uni-muenchen.de	Notohamiprodjo, Susan/AAP-3030-2020; Siess, Wolfgang/A-6430-2009	Notohamiprodjo, Susan/0000-0002-1312-1245; Siess, Wolfgang/0000-0003-0698-6416	Deutsche Forschungsgemeinschaft [NE 468/2-3, SFB-TR36 B6, SFB-TR36 B1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by grants from the Deutsche Forschungsgemeinschaft NE 468/2-3 and SFB-TR36 B6 to Dr. Nelson and B1 to Dr. Noessner. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banas B, 2002, J IMMUNOL, V168, P4301, DOI 10.4049/jimmunol.168.9.4301; BARICOS WH, 1995, KIDNEY INT, V47, P1039, DOI 10.1038/ki.1995.150; Brauner A, 1996, AM J KIDNEY DIS, V27, P402, DOI 10.1016/S0272-6386(96)90364-9; Chen JY, 2003, NEPHROL DIAL TRANSPL, V18, P1741, DOI 10.1093/ndt/gfg275; Cohen CD, 2003, METH MOLEC MED, V86, P285; diZeregal GS, 2001, HUM REPROD UPDATE, V7, P547, DOI 10.1093/humupd/7.6.547; Djafarzadeh R, 2006, ONCOGENE, V25, P1496, DOI 10.1038/sj.onc.1209188; Djafarzadeh R, 2004, BIOL CHEM, V385, P655, DOI 10.1515/BC.2004.081; Djafarzadeh R, 2009, CANCER IMMUNOL IMMUN, V58, P361, DOI 10.1007/s00262-008-0559-5; Dobbie JW, 1997, PERITON DIALYSIS INT, V17, pS27; Edwards JG, 2003, BRIT J CANCER, V88, P1553, DOI 10.1038/sj.bjc.6600920; Eming SA, 2007, PROG HISTOCHEM CYTO, V42, P115, DOI 10.1016/j.proghi.2007.06.001; Fukudome K, 2001, NEPHRON, V87, P35, DOI 10.1159/000045882; Gotloib Lazaro, 2009, Adv Perit Dial, V25, P6; Hardman MJ, 2005, AM J PATHOL, V167, P1561, DOI 10.1016/S0002-9440(10)61241-2; Haslinger B, 2001, NEPHRON, V87, P346, DOI 10.1159/000045941; Haslinger-Loffler B, 2007, THROMB HAEMOSTASIS, V98, P813, DOI 10.1160/TH07-01-0003; JONJIC N, 1992, J EXP MED, V176, P1165, DOI 10.1084/jem.176.4.1165; Kim JJ, 2008, NEPHROL DIAL TRANSPL, V23, P534, DOI 10.1093/ndt/gfm553; KIRBY AC, 1995, BIOCHEM BIOPH RES CO, V214, P200, DOI 10.1006/bbrc.1995.2275; Klier CM, 2001, BIOL CHEM, V382, P1405, DOI 10.1515/BC.2001.173; Lakhiaev AV, 2007, THROMB RES, V120, P715, DOI 10.1016/j.thromres.2006.12.001; Li FK, 1998, KIDNEY INT, V54, P2170, DOI 10.1046/j.1523-1755.1998.00174.x; Loureiro J, 2011, J AM SOC NEPHROL, V22, P1682, DOI 10.1681/ASN.2010111197; Lv ZD, 2011, INT J MOL MED, V27, P187, DOI 10.3892/ijmm.2010.574; MACK M, 1995, P NATL ACAD SCI USA, V92, P7021, DOI 10.1073/pnas.92.15.7021; MARSHALL BC, 1993, J CLIN INVEST, V91, P1792, DOI 10.1172/JCI116390; Medof ME, 1996, FASEB J, V10, P574, DOI 10.1096/fasebj.10.5.8621057; Morrison CJ, 2009, CURR OPIN CELL BIOL, V21, P645, DOI 10.1016/j.ceb.2009.06.006; Nagase H, 2003, BIOCHEM SOC SYMP, V70, P201, DOI 10.1042/bss0700201; Nagase H, 1998, Cell Res, V8, P179; Raggi MC, 2009, BIOL CHEM, V390, P893, DOI 10.1515/BC.2009.098; Roberts AB, 1998, MINER ELECTROL METAB, V24, P111, DOI 10.1159/000057358; SCOTTCOOMBES DM, 1995, EUR J SURG, V161, P395; Singer CF, 1999, EUR J BIOCHEM, V259, P40, DOI 10.1046/j.1432-1327.1999.00001.x; SITTER T, 1995, NEPHROL DIAL TRANSPL, V10, P677; Sitter T, 1996, AM J PHYSIOL-REG I, V271, pR1256, DOI 10.1152/ajpregu.1996.271.5.R1256; van der Wal JBC, 2007, COLORECTAL DIS, V9, P9, DOI 10.1111/j.1463-1318.2007.01345.x; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786; WHITAKER D, 1982, J PATHOL, V136, P291, DOI 10.1002/path.1711360404; Williams JD, 2002, J AM SOC NEPHROL, V13, P470, DOI 10.1681/ASN.V132470; Williams JD, 2003, KIDNEY INT, V63, pS158, DOI 10.1046/j.1523-1755.63.s84.46.x; Wornle M, 2009, THROMB HAEMOSTASIS, V101, P1128, DOI 10.1160/TH08-11-0744; WojtowiczPraga SM, 1997, INVEST NEW DRUG, V15, P61, DOI 10.1023/A:1005722729132; Yao V, 2004, ANZ J SURG, V74, P997, DOI 10.1111/j.1445-1433.2004.03220.x; Yu AE, 1997, DRUG AGING, V11, P229, DOI 10.2165/00002512-199711030-00006; Yu Q, 2000, GENE DEV, V14, P163; Yung S, 2009, PERITON DIALYSIS INT, V29, pS21	49	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e33963	10.1371/journal.pone.0033963	http://dx.doi.org/10.1371/journal.pone.0033963			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558080	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000008
J	Finkel, RS; Crawford, TO; Swoboda, KJ; Kaufmann, P; Juhasz, P; Li, XH; Guo, Y; Li, RH; Trachtenberg, F; Forrest, SJ; Kobayashi, DT; Chen, KS; Joyce, CL; Plasterer, T				Finkel, Richard S.; Crawford, Thomas O.; Swoboda, Kathryn J.; Kaufmann, Petra; Juhasz, Peter; Li, Xiaohong; Guo, Yu; Li, Rebecca H.; Trachtenberg, Felicia; Forrest, Suzanne J.; Kobayashi, Dione T.; Chen, Karen S.; Joyce, Cynthia L.; Plasterer, Thomas		Pilot Study Biomarkers Spinal	Candidate Proteins, Metabolites and Transcripts in the Biomarkers for Spinal Muscular Atrophy (BforSMA) Clinical Study	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FUNCTIONAL MOTOR SCALE; DISEASE; GENE; PLASMA; SMN; PHENYLBUTYRATE; IDENTIFICATION; EXPRESSION; PREDICTION	Background: Spinal Muscular Atrophy (SMA) is a neurodegenerative motor neuron disorder resulting from a homozygous mutation of the survival of motor neuron 1 (SMN1) gene. The gene product, SMN protein, functions in RNA biosynthesis in all tissues. In humans, a nearly identical gene, SMN2, rescues an otherwise lethal phenotype by producing a small amount of full-length SMN protein. SMN2 copy number inversely correlates with disease severity. Identifying other novel biomarkers could inform clinical trial design and identify novel therapeutic targets. Objective:: To identify novel candidate biomarkers associated with disease severity in SMA using unbiased proteomic, metabolomic and transcriptomic approaches. Materials and Methods:: A cross-sectional single evaluation was performed in 108 children with genetically confirmed SMA, aged 2-12 years, manifesting a broad range of disease severity and selected to distinguish factors associated with SMA type and present functional ability independent of age. Blood and urine specimens from these and 22 age-matched healthy controls were interrogated using proteomic, metabolomic and transcriptomic discovery platforms. Analyte associations were evaluated against a primary measure of disease severity, the Modified Hammersmith Functional Motor Scale (MHFMS) and to a number of secondary clinical measures. Results: A total of 200 candidate biomarkers correlate with MHFMS scores: 97 plasma proteins, 59 plasma metabolites (9 amino acids, 10 free fatty acids, 12 lipids and 28 GC/MS metabolites) and 44 urine metabolites. No transcripts correlated with MHFMS. Discussion: In this cross-sectional study, "BforSMA" (Biomarkers for SMA), candidate protein and metabolite markers were identified. No transcript biomarker candidates were identified. Additional mining of this rich dataset may yield important insights into relevant SMA-related pathophysiology and biological network associations. Additional prospective studies are needed to confirm these findings, demonstrate sensitivity to change with disease progression, and assess potential impact on clinical trial design.	[Finkel, Richard S.] Childrens Hosp Philadelphia, Dept Neurol, Philadelphia, PA 19104 USA; [Finkel, Richard S.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Finkel, Richard S.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Crawford, Thomas O.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA; [Crawford, Thomas O.] Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA; [Swoboda, Kathryn J.] Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT USA; [Swoboda, Kathryn J.] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA; [Kaufmann, Petra] Columbia Univ, Dept Neurol, New York, NY USA; [Juhasz, Peter; Li, Xiaohong; Guo, Yu] BG Med Inc, Waltham, MA USA; [Li, Rebecca H.; Trachtenberg, Felicia] New England Res Inst Inc, Watertown, MA USA; [Forrest, Suzanne J.; Kobayashi, Dione T.; Chen, Karen S.; Joyce, Cynthia L.] Spinal Muscular Atrophy Fdn, New York, NY USA; [Plasterer, Thomas] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Johns Hopkins University; Johns Hopkins University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Columbia University; HealthCore, Inc; Northeastern University	Finkel, RS (corresponding author), Childrens Hosp Philadelphia, Dept Neurol, Philadelphia, PA 19104 USA.	finkel@email.chop.edu	SAHIN, MUSTAFA/I-8653-2019	SAHIN, MUSTAFA/0000-0001-7044-2953; Swoboda, Kathryn/0000-0002-4593-6342; Forrest, Suzanne/0000-0002-9797-7947; kobayashi, dione/0000-0002-5541-7175; Joyce, Cynthia/0000-0002-5063-4859	Spinal Muscular Atrophy (SMA) Foundation, New York, New York; Children's Hospital of Philadelphia from the National Center for Research Resources (NCRR) [1 NIH UL1-RR-024134]; Children's Hospital Boston from the National Center for Research Resources (NCRR) [UL1 RR025758-01, MO1-RR02172]; Columbia University SMA Clinical Research Center from the National Center for Research Resources (NCRR) [NIH 1 UL1 RR024156]; Ohio State University from the National Center for Research Resources (NCRR) [UL1-RR025755]; University of Iowa from the National Center for Research Resources (NCRR) [1UL1-RR024979, 1KL2-RR024980, 1TL1-RR024981]; University of Utah from the National Center for Research Resources (NCRR) [UL1-RR025764, C06-RR11234]; Johns Hopkins University from the National Center for Research Resources (NCRR) [UL1-RR 025005]; Washington University from the National Center for Research Resources (NCRR) [UL1-RR024992]; Children's Hospital - Denver from the National Center for Research Resources (NCRR) [UL1 RR025780]; National Institutes of Health (NIH); NIH Roadmap for Medical Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069045] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD054599] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755, UL1RR024992, KL2RR024980, TL1RR024981, UL1RR025764, UL1RR025780, UL1RR024156, UL1RR025758, UL1RR024134, UL1RR025005, C06RR011234, M01RR002172, UL1RR024979] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078387, U19AI082726, R41AI071927, U01AI063623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [RC1AR058606] Funding Source: NIH RePORTER	Spinal Muscular Atrophy (SMA) Foundation, New York, New York; Children's Hospital of Philadelphia from the National Center for Research Resources (NCRR); Children's Hospital Boston from the National Center for Research Resources (NCRR); Columbia University SMA Clinical Research Center from the National Center for Research Resources (NCRR); Ohio State University from the National Center for Research Resources (NCRR); University of Iowa from the National Center for Research Resources (NCRR); University of Utah from the National Center for Research Resources (NCRR); Johns Hopkins University from the National Center for Research Resources (NCRR); Washington University from the National Center for Research Resources (NCRR); Children's Hospital - Denver from the National Center for Research Resources (NCRR); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was sponsored by the Spinal Muscular Atrophy (SMA) Foundation, New York, New York, who also had a role in the design of the study, data collection and analysis, decision to publish, and preparation of the manuscript (http://www.smafoundation.org/). Additional support for the described project by grant numbers CTSA Award 1 NIH UL1-RR-024134 (The Children's Hospital of Philadelphia), UL1 RR025758-01 & MO1-RR02172 Children's Hospital Boston; NIH 1 UL1 RR024156 Columbia University SMA Clinical Research Center; UL1-RR025755 The Ohio State University; 1UL1-RR024979, 1KL2-RR024980 & 1TL1-RR024981 University of Iowa; UL1-RR025764 & C06-RR11234 University of Utah; UL1-RR 025005 The Johns Hopkins University; UL1-RR024992 Washington University; UL1 RR025780 The Children's Hospital - Denver; all from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) and NIH Roadmap for Medical Research, and its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adourian A, 2008, MOL BIOSYST, V4, P249, DOI 10.1039/b708489g; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buhler D, 1999, HUM MOL GENET, V8, P2351, DOI 10.1093/hmg/8.13.2351; Clish CB, 2004, OMICS, V8, P3, DOI 10.1089/153623104773547453; Crawford TO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033572; Crawford TO, 2004, NEUROMUSCULAR DISORD, V14, P456, DOI 10.1016/j.nmd.2004.04.004; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; Dahabreh IJ, 2011, ANN ONCOL, V22, P545, DOI 10.1093/annonc/mdq432; Davidov E, 2004, OMICS, V8, P267, DOI 10.1089/omi.2004.8.267; de Planell-Saguer M, 2009, HUM MOL GENET, V18, P2115, DOI 10.1093/hmg/ddp134; Dominguez E, 2011, HUM MOL GENET, V20, P681, DOI 10.1093/hmg/ddq514; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; Goldknopf IL, 2006, BIOCHEM BIOPH RES CO, V342, P1034, DOI 10.1016/j.bbrc.2006.02.051; Hastings ML, 2009, SCI TRANSL MED, V1, p5ra12; Hye A, 2006, BRAIN, V129, P3042, DOI 10.1093/brain/awl279; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Juhasz P, 2011, J PROTEOME RES, V10, P34, DOI 10.1021/pr100659e; Kaufmann P, 2011, ARCH NEUROL-CHICAGO, V0; Kolb SJ, 2010, MUSCLE NERVE, V41, P5, DOI 10.1002/mus.21428; Krosschell KJ, 2006, NEUROMUSCULAR DISORD, V16, P417, DOI 10.1016/j.nmd.2006.03.015; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Landers JE, 2009, P NATL ACAD SCI USA, V106, P9004, DOI 10.1073/pnas.0812937106; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liang WC, 2008, J NEUROL SCI, V268, P87, DOI 10.1016/j.jns.2007.11.012; Lopez MF, 2005, CLIN CHEM, V51, P1946, DOI 10.1373/clinchem.2005.053090; Main M, 2003, EUR J PAEDIATR NEURO, V7, P155, DOI 10.1016/S1090-3798(03)00060-6; Mattis VB, 2006, HUM GENET, V120, P589, DOI 10.1007/s00439-006-0245-7; Mayhew A, 2011, DEV MED CHILD NEUROL, V0; McBurney RN, 2009, TOXICOL PATHOL, V37, P52, DOI 10.1177/0192623308329287; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Mercuri E, 2007, NEUROLOGY, V68, P51, DOI 10.1212/01.wnl.0000249142.82285.d6; Mercuri E, 2004, NEUROMUSCULAR DISORD, V14, P130, DOI 10.1016/j.nmd.2003.11.006; Mitchell RM, 2009, NEUROLOGY, V72, P14, DOI 10.1212/01.wnl.0000333251.36681.a5; Mitsumoto H, 2008, AMYOTROPH LATERAL SC, V9, P177, DOI 10.1080/17482960801933942; Munsat T, 1996, NEUROMUSCULAR DISORD, V6, P125, DOI 10.1016/0960-8966(95)00032-1; Oresic Matej, 2004, Appl Bioinformatics, V3, P205; Oskoui M, 2008, NEUROTHERAPEUTICS, V5, P499, DOI 10.1016/j.nurt.2008.08.007; Passini MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001777; Passini MA, 2010, J CLIN INVEST, V120, P1253, DOI 10.1172/JCI41615; PEARN J, 1978, J MED GENET, V15, P409, DOI 10.1136/jmg.15.6.409; Pellizzoni L, 1998, CELL, V95, P615, DOI 10.1016/S0092-8674(00)81632-3; Qian WJ, 2008, MOL CELL PROTEOMICS, V7, P1963, DOI 10.1074/mcp.M800008-MCP200; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; Rozen S, 2005, METABOLOMICS, V1, P101, DOI 10.1007/s11306-005-4810-1; Shanmugarajan S, 2007, J CHILD NEUROL, V22, P967, DOI 10.1177/0883073807305664; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Swoboda KJ, 2007, J CHILD NEUROL, V22, P957, DOI 10.1177/0883073807305665; Swoboda KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005268; Underwood BR, 2006, BRAIN, V129, P877, DOI 10.1093/brain/awl027; Valori CF, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000830; van der Greef J, 2007, J PROTEOME RES, V6, P1540, DOI 10.1021/pr0606530; Van Meerbeke JP, 2011, DISCOV MED, V12, P291; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wong B, 2009, NEUROGENETICS, V10, P117, DOI 10.1007/s10048-008-0167-8; Zerres K, 1999, Neuromuscul Disord, V9, P272, DOI 10.1016/S0960-8966(99)00016-4; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	60	56	56	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35462	10.1371/journal.pone.0035462	http://dx.doi.org/10.1371/journal.pone.0035462			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558154	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000030
J	Kinoshita, Y; Kalir, T; Dottino, P; Kohtz, DS				Kinoshita, Yayoi; Kalir, Tamara; Dottino, Peter; Kohtz, D. Stave			Nuclear Distributions of NUP62 and NUP214 Suggest Architectural Diversity and Spatial Patterning among Nuclear Pore Complexes	PLOS ONE			English	Article							MESSENGER-RNA EXPORT; NUCLEOPORIN DOMAIN TOPOLOGY; FUNCTIONAL-CHARACTERIZATION; P62 COMPLEX; PROTEIN; PHOSPHORYLATION; LOCALIZES; TRANSPORT; INTERACTS; CHROMATIN	The shape of nuclei in many adherent cultured cells approximates an oblate ellipsoid, with contralateral flattened surfaces facing the culture plate or the medium. Observations of cultured cell nuclei from orthogonal perspectives revealed that nucleoporin p62 (NUP62) and nucleoporin 214 (NUP214) are differentially distributed between nuclear pore complexes on the flattened surfaces and peripheral rim of the nucleus. High resolution stimulated emission depletion (STED) immunofluorescence microscopy resolved individual NPCs, and suggested both heterogeneity and microheterogeneity in NUP62 and NUP214 immunolabeling among in NPC populations. Similar to nuclear domains and interphase chromosome territories, architectural diversity and spatial patterning of NPCs may be an intrinsic property of the nucleus that is linked to the functions and organization of underlying chromatin.	[Kinoshita, Yayoi; Kalir, Tamara; Kohtz, D. Stave] Mt Sinai Sch Med, Dept Pathol, New York, NY 10029 USA; [Kohtz, D. Stave] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Kinoshita, Y (corresponding author), Mt Sinai Sch Med, Dept Pathol, New York, NY 10029 USA.	stave.kohtz@mssm.edu			Ruttenberg family; National Institutes of Health/National Cancer Institute (NIH/NCI) [1R03CA141318, 5R24 CA095823-04]; NSF [DBI-9724504]; NIH [1 S10 RR0 9145-01]; NATIONAL CANCER INSTITUTE [R03CA141318, R24CA095823] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR009145] Funding Source: NIH RePORTER	Ruttenberg family; National Institutes of Health/National Cancer Institute (NIH/NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was funded by a generous grant from the Ruttenberg family, and by National Institutes of Health/National Cancer Institute (NIH/NCI) grant number 1R03CA141318 (to DSK). Widefield, confocal laser scanning, and STED microscopy were performed at the MSSM-Microscopy Shared Resource Facility, which is supported by NIH/NCI shared resources grant 5R24 CA095823-04, NSF Major Research Instrumentation grant DBI-9724504, and NIH shared instrumentation grant 1 S10 RR0 9145-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2007, TRENDS GENET, V23, P396, DOI 10.1016/j.tig.2007.05.009; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Belgareh N, 1998, MOL BIOL CELL, V9, P3475, DOI 10.1091/mbc.9.12.3475; Bernad R, 2004, MOL CELL BIOL, V24, P2373, DOI 10.1128/MCB.24.6.2373-2384.2004; Bernad R, 2006, J BIOL CHEM, V281, P19378, DOI 10.1074/jbc.M512585200; BIEDLER JL, 1978, CANCER RES, V38, P3751; Braun IC, 2002, MOL CELL BIOL, V22, P5405, DOI 10.1128/MCB.22.15.5405-5418.2002; Capelson M, 2010, CELL, V140, P372, DOI 10.1016/j.cell.2009.12.054; Cole CN, 2006, CURR OPIN CELL BIOL, V18, P299, DOI 10.1016/j.ceb.2006.04.006; DAVIS LI, 1987, P NATL ACAD SCI USA, V84, P7552, DOI 10.1073/pnas.84.21.7552; Echeverria PC, 2009, MOL CELL BIOL, V29, P4788, DOI 10.1128/MCB.00649-09; Fahrenkrog B, 2002, J STRUCT BIOL, V140, P254, DOI 10.1016/S1047-8477(02)00524-5; Favreau C, 1996, BIOCHEMISTRY-US, V35, P8035, DOI 10.1021/bi9600660; Fontoura BMA, 1999, J CELL BIOL, V144, P1097, DOI 10.1083/jcb.144.6.1097; Fornerod M, 1997, EMBO J, V16, P807, DOI 10.1093/emboj/16.4.807; Gillespie PJ, 2007, CURR BIOL, V17, P1657, DOI 10.1016/j.cub.2007.08.041; Griffis ER, 2003, MOL BIOL CELL, V14, P600, DOI 10.1091/mbc.E02-09-0582; GUAN TL, 1995, MOL BIOL CELL, V6, P1591, DOI 10.1091/mbc.6.11.1591; HANOVER JA, 1987, J BIOL CHEM, V262, P9887; Hawryluk-Gara LA, 2005, MOL BIOL CELL, V16, P2382, DOI 10.1091/mbc.e04-10-0857; Hu TH, 1996, J CELL BIOL, V134, P589, DOI 10.1083/jcb.134.3.589; Hutten S, 2009, J CELL SCI, V122, P1100, DOI 10.1242/jcs.040154; Kalverda B, 2007, DEV CELL, V13, P164, DOI 10.1016/j.devcel.2007.07.008; Kalverda B, 2010, CELL, V140, P360, DOI 10.1016/j.cell.2010.01.011; Kelly SM, 2009, TRAFFIC, V10, P1199, DOI 10.1111/j.1600-0854.2009.00944.x; Kendirgi F, 2005, MOL BIOL CELL, V16, P4304, DOI 10.1091/mbc.E04-11-0998; Kinoshita Y, 2012, AM J PATHOL, V180, P375, DOI 10.1016/j.ajpath.2011.09.024; KRAEMER D, 1994, P NATL ACAD SCI USA, V91, P1519, DOI 10.1073/pnas.91.4.1519; Krull S, 2004, MOL BIOL CELL, V15, P4261, DOI 10.1091/mbc.E04-03-0165; Leng YM, 2007, J BIOL CHEM, V282, P19321, DOI 10.1074/jbc.M703222200; Lim RYH, 2008, INT REV CEL MOL BIO, V267, P299, DOI 10.1016/S1937-6448(08)00632-1; Lim RYH, 2006, CURR OPIN CELL BIOL, V18, P342, DOI 10.1016/j.ceb.2006.03.006; Liu HL, 2009, MOL BIOL CELL, V20, P616, DOI 10.1091/mbc.E08-06-0628; Lyman SK, 2001, J CELL BIOL, V154, P17, DOI 10.1083/jcb.200106071; Maeshima K, 2006, J CELL SCI, V119, P4442, DOI 10.1242/jcs.03207; Meister P, 2010, GENE DEV, V24, P766, DOI 10.1101/gad.559610; Napetschnig J, 2009, P NATL ACAD SCI USA, V106, P3089, DOI 10.1073/pnas.0813267106; Onischenko EA, 2004, TRAFFIC, V5, P152, DOI 10.1111/j.1600-0854.2004.0166.x; Pante N, 1996, CRIT REV BIOCHEM MOL, V31, P153, DOI 10.3109/10409239609106583; PANTE N, 1994, J CELL BIOL, V126, P603, DOI 10.1083/jcb.126.3.603; Paulillo SM, 2006, J MOL BIOL, V363, P39, DOI 10.1016/j.jmb.2006.08.021; Paulillo SM, 2005, J MOL BIOL, V351, P784, DOI 10.1016/j.jmb.2005.06.034; Porter FW, 2010, J VIROL, V84, P12538, DOI 10.1128/JVI.01484-09; Porter FW, 2009, J VIROL, V83, P1941, DOI 10.1128/JVI.01752-08; Provencher DM, 2000, IN VITRO CELL DEV-AN, V36, P357; Rasala BA, 2008, MOL BIOL CELL, V19, P3982, DOI 10.1091/mbc.E08-01-0012; Rayala HJ, 2004, MOL CELL PROTEOMICS, V3, P145, DOI 10.1074/mcp.M300106-MCP200; Roth P, 2003, J CELL BIOL, V163, P701, DOI 10.1083/jcb.200304046; Sabri N, 2007, J CELL BIOL, V178, P557, DOI 10.1083/jcb.200612135; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Schwartz TU, 2005, CURR OPIN STRUC BIOL, V15, P221, DOI 10.1016/j.sbi.2005.03.003; Stavru F, 2006, J CELL BIOL, V173, P509, DOI 10.1083/jcb.200601001; Stavru F, 2006, J CELL BIOL, V173, P477, DOI 10.1083/jcb.200601002; Steggerda SM, 2002, INT REV CYTOL, V217, P41; Stochaj U, 2006, EXP CELL RES, V312, P2490, DOI 10.1016/j.yexcr.2006.04.007; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Terry LJ, 2007, J CELL BIOL, V178, P1121, DOI 10.1083/jcb.200704174; Towbin BD, 2009, CURR OPIN GENET DEV, V19, P180, DOI 10.1016/j.gde.2009.01.006; vanDeursen J, 1996, EMBO J, V15, P5574, DOI 10.1002/j.1460-2075.1996.tb00942.x; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Wu XS, 2001, P NATL ACAD SCI USA, V98, P3191, DOI 10.1073/pnas.051631598; Xylourgidis N, 2006, J CELL SCI, V119, P4409, DOI 10.1242/jcs.03201; Yasuharaa N, 2009, SEMIN CELL DEV BIOL, V20, P590, DOI 10.1016/j.semcdb.2009.05.003	64	20	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36137	10.1371/journal.pone.0036137	http://dx.doi.org/10.1371/journal.pone.0036137			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558357	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000135
J	Li, Y; Qin, W; Jiang, TZ; Zhang, YT; Yu, CS				Li, Ying; Qin, Wen; Jiang, Tianzi; Zhang, Yunting; Yu, Chunshui			Sex-Dependent Correlations between the Personality Dimension of Harm Avoidance and the Resting-State Functional Connectivity of Amygdala Subregions	PLOS ONE			English	Article							GENERALIZED ANXIETY DISORDER; POSITRON-EMISSION-TOMOGRAPHY; CEREBRAL GLUCOSE-METABOLISM; MAJOR DEPRESSION; SOCIAL COGNITION; CYTOARCHITECTONIC MAPS; INDIVIDUAL-DIFFERENCES; HIPPOCAMPAL VOLUME; ANTERIOR CINGULATE; GENDER-DIFFERENCES	Harm avoidance (HA) is a personality dimension involving the tendency to respond intensely to signals of aversive stimuli. Many previous neuroimaging studies have associated HA scores with the structural and functional organization of the amygdala, but none of these studies have evaluated the correlation between HA score and amygdala resting-state functional connectivity (rsFC). Moreover, the amygdala is not a homogeneous structure, and it has been divided into several structurally and functionally distinct subregions. Investigating the associations between HA score and properties of subregions of the amygdala could greatly improve our understanding of HA. In the present study, using a large sample of 291 healthy young adults, we aimed to uncover correlations between HA scores and the rsFCs of each amygdala subregion and to uncover possible sex-based differences in these correlations. We found that subregions of the amygdala showed different rsFC patterns, which contributed differently to individual HA scores. More specifically, HA scores were correlated with rsFCs between the laterobasal amygdala subregion and temporal and occipital cortices related to emotional information input, between the centromedial subregion and the frontal cortices associated with emotional output control, and between the superficial subregion and the frontal and temporal areas involved in both functions. Moreover, significant gender-based differences were uncovered in these correlations. Our findings provide a more detailed model of association between HA scores and amygdala rsFC, extend our understanding of the connectivity of subregions of the amygdala, and confirm sex-based differences in HA associations.	[Li, Ying; Qin, Wen; Zhang, Yunting; Yu, Chunshui] Tianjin Med Univ Gen Hosp, Dept Radiol, Tianjin, Peoples R China; [Jiang, Tianzi] Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, LIAMA Ctr Computat Med, Beijing, Peoples R China	Tianjin Medical University; Chinese Academy of Sciences; Institute of Automation, CAS	Li, Y (corresponding author), Tianjin Med Univ Gen Hosp, Dept Radiol, Tianjin, Peoples R China.	cjr.zhangyunting@vip.163.com; chunshuiyu@yahoo.cn	QIN, WEN/F-3783-2015; Jiang, Tianzi/I-4256-2012	QIN, WEN/0000-0002-9121-8296; Jiang, Tianzi/0000-0001-9531-291X; Yu, Chunshui/0000-0001-5648-5199	Natural Science Foundation of Tianjin [11JCZDJC19300]; Natural Science Foundation of China [30870694, 30730036]; National Basic Research Program of China (973 program) [2010CB732506]	Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 program)(National Basic Research Program of China)	This work was supported by Natural Science Foundation of Tianjin (No. 11JCZDJC19300), Natural Science Foundation of China (Nos. 30870694 and 30730036) and National Basic Research Program of China (973 program, No. 2010CB732506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2010, ANN NY ACAD SCI, V1191, P42, DOI 10.1111/j.1749-6632.2010.05445.x; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Baeken C, 2010, NEUROSCI LETT, V478, P97, DOI 10.1016/j.neulet.2010.04.073; Ball T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000307; BAYLIS GC, 1987, EXP BRAIN RES, V65, P614; Beck AT., 1993, BDI BECK DEPRESSION; Blair K, 2008, AM J PSYCHIAT, V165, P1193, DOI 10.1176/appi.ajp.2008.07071060; Bowley MP, 2002, BIOL PSYCHIAT, V52, P404, DOI 10.1016/S0006-3223(02)01404-X; BOYCE P, 1991, BRIT J PSYCHIAT, V159, P106, DOI 10.1192/bjp.159.1.106; Bremner JD, 2000, AM J PSYCHIAT, V157, P115, DOI 10.1176/ajp.157.1.115; BROWN SL, 1992, J PSYCHIAT RES, V26, P197, DOI 10.1016/0022-3956(92)90023-H; Buckholtz JW, 2008, MOL PSYCHIATR, V13, P313, DOI 10.1038/sj.mp.4002020; Carmichael ST, 1995, J COMP NEUROL, V363, P615, DOI 10.1002/cne.903630408; Celikel FC, 2009, COMPR PSYCHIAT, V50, P556, DOI 10.1016/j.comppsych.2008.11.012; Chen WJ, 2002, COMPR PSYCHIAT, V43, P158, DOI 10.1053/comp.2002.30797; Chouinard PA, 2010, NEUROPSYCHOLOGIA, V48, P409, DOI 10.1016/j.neuropsychologia.2009.09.032; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Costa PT, 1997, J PERS ASSESS, V68, P86, DOI 10.1207/s15327752jpa6801_7; Davey CG, 2011, BIOL PSYCHIAT, V69, P734, DOI 10.1016/j.biopsych.2010.12.004; Davis M, 1997, J NEUROPSYCH CLIN N, V9, P382; DEIBER MP, 1991, EXP BRAIN RES, V84, P393; Domes G, 2010, HUM BRAIN MAPP, V31, P758, DOI 10.1002/hbm.20903; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2006, NEUROIMAGE, V32, P570, DOI 10.1016/j.neuroimage.2006.04.204; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Etkin A, 2009, ARCH GEN PSYCHIAT, V66, P1361, DOI 10.1001/archgenpsychiatry.2009.104; Farmer A, 2003, ARCH GEN PSYCHIAT, V60, P490, DOI 10.1001/archpsyc.60.5.490; Fischer H, 2004, NEUROREPORT, V15, P235, DOI 10.1097/00001756-200402090-00004; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Frodl T, 2002, BIOL PSYCHIAT, V51, P708, DOI 10.1016/S0006-3223(01)01359-2; Gardini S, 2009, BRAIN RES BULL, V79, P265, DOI 10.1016/j.brainresbull.2009.03.005; Goossens L, 2009, HUM BRAIN MAPP, V30, P3332, DOI 10.1002/hbm.20755; Gundel H, 2004, PSYCHOSOM MED, V66, P132, DOI 10.1097/01.PSY.0000097348.45087.96; GUR RC, 1995, SCIENCE, V267, P528, DOI 10.1126/science.7824953; Habel U, 2005, NEUROIMAGE, V26, P206, DOI 10.1016/j.neuroimage.2005.01.014; Hakamata Y, 2006, NEUROSCI LETT, V396, P33, DOI 10.1016/j.neulet.2005.11.017; Hakamata Y, 2009, PSYCHIAT RES-NEUROIM, V173, P206, DOI 10.1016/j.pscychresns.2008.10.002; Hamann S, 2005, NEUROSCIENTIST, V11, P288, DOI 10.1177/1073858404271981; Hamann S, 2004, NAT NEUROSCI, V7, P411, DOI 10.1038/nn1208; Hampson M, 2010, MAGN RESON IMAGING, V28, P1051, DOI 10.1016/j.mri.2010.03.021; Heim S, 2009, HUM BRAIN MAPP, V30, P392, DOI 10.1002/hbm.20512; Hurlemann R, 2008, J NEUROSCI METH, V172, P13, DOI 10.1016/j.jneumeth.2008.04.004; Iidaka T, 2006, BRAIN RES, V1125, P85, DOI 10.1016/j.brainres.2006.09.015; Ionta S, 2011, NEURON, V70, P363, DOI 10.1016/j.neuron.2011.03.009; Jylha P, 2006, EUR PSYCHIAT, V21, P389, DOI 10.1016/j.eurpsy.2005.09.003; Kilpatrick LA, 2006, NEUROIMAGE, V30, P452, DOI 10.1016/j.neuroimage.2005.09.065; Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009; Kuo PH, 2004, COMPR PSYCHIAT, V45, P20, DOI 10.1016/j.comppsych.2003.09.011; Lange C, 2004, PSYCHOL MED, V34, P1059, DOI 10.1017/S0033291703001806; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; LeDoux J, 2007, CURR BIOL, V17, pR868, DOI 10.1016/j.cub.2007.08.005; Liao W, 2011, BRAIN RES, V1388, P167, DOI 10.1016/j.brainres.2011.03.018; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015238; Lochner C, 2007, EUR NEUROPSYCHOPHARM, V17, P321, DOI 10.1016/j.euroneuro.2006.06.010; Matthews SC, 2004, NEUROREPORT, V15, P2123, DOI 10.1097/00001756-200409150-00025; McClure EB, 2007, ARCH GEN PSYCHIAT, V64, P97, DOI 10.1001/archpsyc.64.1.97; Miettunen J, 2004, ACTA PSYCHIAT SCAND, V110, P150, DOI 10.1111/j.1600-0047.2004.00344.x; Moreno N, 2007, J ANAT, V211, P151, DOI 10.1111/j.1469-7580.2007.00780.x; Most SB, 2006, NEUROIMAGE, V31, P934, DOI 10.1016/j.neuroimage.2005.12.031; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Neufang S, 2009, CEREB CORTEX, V19, P464, DOI 10.1093/cercor/bhn100; Nyman E, 2011, J AFFECT DISORDERS, V131, P393, DOI 10.1016/j.jad.2010.12.008; O'Gorman RL, 2006, NEUROIMAGE, V31, P489, DOI 10.1016/j.neuroimage.2005.12.048; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Omura K, 2005, NEUROREPORT, V16, P1905, DOI 10.1097/01.wnr.0000186596.64458.76; Paus T, 2005, TRENDS COGN SCI, V9, P60, DOI 10.1016/j.tics.2004.12.008; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Postuma RB, 2006, CEREB CORTEX, V16, P1508, DOI 10.1093/cercor/bhj088; Price JL, 2003, ANN NY ACAD SCI, V985, P50; Pujol J, 2002, NEUROIMAGE, V15, P847, DOI 10.1006/nimg.2001.1004; Roy AK, 2009, NEUROIMAGE, V45, P614, DOI 10.1016/j.neuroimage.2008.11.030; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Scheff SW, 2011, J ALZHEIMERS DIS, V24, P547, DOI 10.3233/JAD-2011-101782; Schienle A, 2005, NEUROREPORT, V16, P277, DOI 10.1097/00001756-200502280-00015; Schneider S, 2011, NEUROIMAGE, V56, P1847, DOI 10.1016/j.neuroimage.2011.02.019; Schnell K, 2011, NEUROIMAGE, V54, P1743, DOI 10.1016/j.neuroimage.2010.08.024; Sheline YI, 1998, NEUROREPORT, V9, P2023, DOI 10.1097/00001756-199806220-00021; Starcevic V, 1996, J AFFECT DISORDERS, V37, P75, DOI 10.1016/0165-0327(95)00058-5; STEPHAN H, 1977, ACTA ANAT, V98, P130; Sugiura M, 2000, NEUROIMAGE, V11, P541, DOI 10.1006/nimg.2000.0564; Surguladze SA, 2010, J PSYCHIATR RES, V44, P894, DOI 10.1016/j.jpsychires.2010.02.010; Svrakic DM, 2002, ACTA PSYCHIAT SCAND, V106, P189, DOI 10.1034/j.1600-0447.2002.02196.x; Van Heeringen K, 2010, PSYCHIAT RES-NEUROIM, V181, P141, DOI 10.1016/j.pscychresns.2009.07.011; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Van Schuerbeek P, 2011, BRAIN RES, V1371, P32, DOI 10.1016/j.brainres.2010.11.073; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Wrase J, 2003, NEUROSCI LETT, V348, P41, DOI 10.1016/S0304-3940(03)00565-2; Yamasue H, 2008, CEREB CORTEX, V18, P46, DOI 10.1093/cercor/bhm030; Zuckerman M, 1996, PERSONALITY INDIVIDU	92	41	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35925	10.1371/journal.pone.0035925	http://dx.doi.org/10.1371/journal.pone.0035925			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558274	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000087
J	Macho, AP; Zumaquero, A; Gonzalez-Plaza, JJ; Ortiz-Martin, I; Rufian, JS; Beuzon, CR				Macho, Alberto P.; Zumaquero, Adela; Gonzalez-Plaza, Juan J.; Ortiz-Martin, Inmaculada; Rufian, Jose S.; Beuzon, Carmen R.			Genetic Analysis of the Individual Contribution to Virulence of the Type III Effector Inventory of Pseudomonas syringae pv. phaseolicola	PLOS ONE			English	Article							SECRETION SYSTEM CONTRIBUTE; ALTERNATE SIGMA-FACTOR; E3 UBIQUITIN LIGASE; PLANT IMMUNITY; PATHOGENICITY ISLAND; INNATE IMMUNITY; TOMATO DC3000; COMPETITIVE INDEX; DISEASE RESISTANCE; BACTERIAL DISEASE	Several reports have recently contributed to determine the effector inventory of the sequenced strain Pseudomonas syringae pv. phaseolicola (Pph) 1448a. However, the contribution to virulence of most of these effectors remains to be established. Genetic analysis of the contribution to virulence of individual P. syringae effectors has been traditionally hindered by the lack of phenotypes of the corresponding knockout mutants, largely attributed to a high degree of functional redundancy within their effector inventories. In support of this notion, effectors from Pseudomonas syringae pv. tomato (Pto) DC3000 have been classified into redundant effector groups (REGs), analysing virulence of polymutants in the model plant Nicotiana benthamiana. However, using competitive index (CI) as a virulence assay, we were able to establish the individual contribution of AvrPto1(PtoDC3000) to Pto DC3000 virulence in tomato, its natural host, even though typically, contribution to virulence of AvrPto1 is only shown in strains also lacking AvrPtoB (also called HopAB2), a member of its REG. This report raised the possibility that even effectors targeting the same defence signalling pathway may have an individual contribution to virulence, and pointed out to CI assays as the means to establish such a contribution for individual effectors. In this work, we have analysed the individual contribution to virulence of the majority of previously uncharacterised Pph 1448a effectors, by monitoring the development of disease symptoms and determining the CI of single knockout mutants at different stages of growth within bean, its natural host. Despite their potential functional redundancy, we have found individual contributions to virulence for six out of the fifteen effectors analysed. In addition, we have analysed the functional relationships between effectors displaying individual contribution to virulence, highlighting the diversity that these relationships may present, and the interest of analysing their functions within the context of the infection.	[Macho, Alberto P.; Zumaquero, Adela; Gonzalez-Plaza, Juan J.; Ortiz-Martin, Inmaculada; Rufian, Jose S.; Beuzon, Carmen R.] Univ Malaga Consejo Super Invest Cient IHSM UMA C, Inst Hortofruticultura Subtrop & Mediterranea, Dept Biol Celular Genet & Fisiol, Malaga, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM)	Macho, AP (corresponding author), Sainsbury Lab, Norwich, Norfolk, England.	cbl@uma.es	Plaza, José Sebastián Rufián/AAR-2553-2021; Macho, Alberto/L-1393-2014; Beuzon, Carmen/G-7302-2011; Plaza, Juan José González/C-7470-2015	Plaza, José Sebastián Rufián/0000-0002-3871-3706; Beuzon, Carmen/0000-0002-6888-3845; Plaza, Juan José González/0000-0001-9586-6197; Macho, Alberto P/0000-0001-9935-8026	Ministerio de Ciencia e Innovacion, Gobiemo de Espana [BIO2009-11516]; Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia [P06-CVI-02088]; FEDER	Ministerio de Ciencia e Innovacion, Gobiemo de Espana; Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia(Junta de Andalucia); FEDER(European Commission)	This work has been funded by Ministerio de Ciencia e Innovacion, Gobiemo de Espana (URL: http://www.micinn.es/)(Grant No:BIO2009-11516), and Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia (URL:http://www.juntadeandalucia.es/organismos/economiainnovacionyciencia.html)(Grant No: P06-CVI-02088) and co-funded by FEDER. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alfano JR, 2000, P NATL ACAD SCI USA, V97, P4856, DOI 10.1073/pnas.97.9.4856; Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Alfano JR, 1997, J BACTERIOL, V179, P5655, DOI 10.1128/jb.179.18.5655-5662.1997; ASHFIELD T, 1995, GENETICS, V141, P1597; Badel JL, 2006, MOL PLANT MICROBE IN, V19, P99, DOI 10.1094/MPMI-19-0099; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Beuzon CR, 2001, MICROBES INFECT, V3, P1345, DOI 10.1016/S1286-4579(01)01496-4; Beuzon CR, 2001, INFECT IMMUN, V69, P7254, DOI 10.1128/IAI.69.12.7254-7261.2001; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Bogdanove AJ, 1998, P NATL ACAD SCI USA, V95, P1325, DOI 10.1073/pnas.95.3.1325; Brooks DM, 2004, MOL PLANT MICROBE IN, V17, P162, DOI 10.1094/MPMI.2004.17.2.162; Chang JH, 2005, P NATL ACAD SCI USA, V102, P2549, DOI 10.1073/pnas.0409660102; Cunnac S, 2011, P NATL ACAD SCI USA, V108, P2975, DOI 10.1073/pnas.1013031108; de Torres M, 2006, PLANT J, V47, P368, DOI 10.1111/j.1365-313X.2006.02798.x; DebRoy S, 2004, P NATL ACAD SCI USA, V101, P9927, DOI 10.1073/pnas.0401601101; Eitas TK, 2008, P NATL ACAD SCI USA, V105, P6475, DOI 10.1073/pnas.0802157105; Fouts DE, 2002, P NATL ACAD SCI USA, V99, P2275, DOI 10.1073/pnas.032514099; FRETER R, 1981, INFECT IMMUN, V34, P241, DOI 10.1128/IAI.34.1.241-249.1981; Gaudriault S, 1997, MOL MICROBIOL, V26, P1057, DOI 10.1046/j.1365-2958.1997.6442015.x; Gohre V, 2008, ANNU REV PHYTOPATHOL, V46, P189, DOI 10.1146/annurev.phyto.46.120407.110050; Guo M, 2009, MOL PLANT MICROBE IN, V22, P1069, DOI 10.1094/MPMI-22-9-1069; He P, 2006, CELL, V125, P563, DOI 10.1016/j.cell.2006.02.047; Jackson RW, 1999, P NATL ACAD SCI USA, V96, P10875, DOI 10.1073/pnas.96.19.10875; Jackson RW, 2002, MOL PLANT PATHOL, V3, P205, DOI 10.1046/j.1364-3703.2002.00121.x; Janjusevic R, 2006, SCIENCE, V311, P222, DOI 10.1126/science.1120131; Jelenska J, 2007, CURR BIOL, V17, P499, DOI 10.1016/j.cub.2007.02.028; Jelenska J, 2010, P NATL ACAD SCI USA, V107, P13177, DOI 10.1073/pnas.0910943107; Keith LW, 1997, MOL PLANT MICROBE IN, V10, P416, DOI 10.1094/MPMI.1997.10.3.416; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kvitko BH, 2007, J BACTERIOL, V189, P8059, DOI 10.1128/JB.01146-07; Kvitko BH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000388; Lim MTS, 2005, MOL PLANT MICROBE IN, V18, P626, DOI 10.1094/MPMI-18-0626; Lindeberg M, 2005, MOL PLANT MICROBE IN, V18, P275, DOI 10.1094/MPMI-18-0275; Losada L, 2004, MOL PLANT MICROBE IN, V17, P254, DOI 10.1094/MPMI.2004.17.3.254; Macho AP, 2007, MOL PLANT PATHOL, V8, P437, DOI 10.1111/J.1364-3703.2007.00404.X; Macho AP, 2010, PLANT SIGNAL BEHAV, V5, P1590, DOI 10.4161/psb.5.12.13843; Macho AP, 2010, MOL PLANT MICROBE IN, V23, P1197, DOI 10.1094/MPMI-23-9-1197; Macho AP, 2010, NEW PHYTOL, V187, P1018, DOI 10.1111/j.1469-8137.2010.03381.x; Macho AP, 2009, MOL PLANT PATHOL, V10, P69, DOI 10.1111/j.1364-3703.2008.00511.x; Melotto M, 2008, ANNU REV PHYTOPATHOL, V46, P101, DOI 10.1146/annurev.phyto.121107.104959; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Oh HS, 2007, J BACTERIOL, V189, P8277, DOI 10.1128/JB.00998-07; Ortiz-Martin I, 2006, J MICROBIOL METH, V67, P395, DOI 10.1016/j.mimet.2006.04.011; Ortiz-Martin I, 2010, MOL PLANT MICROBE IN, V23, P682, DOI 10.1094/MPMI-23-5-0682; Ortiz-Martin I, 2010, MOL PLANT MICROBE IN, V23, P665, DOI 10.1094/MPMI-23-5-0665; Qian W, 2005, GENOME RES, V15, P757, DOI 10.1101/gr.3378705; RITTER C, 1995, MOL PLANT MICROBE IN, V8, P444, DOI 10.1094/MPMI-8-0444; Rosebrock TR, 2007, NATURE, V448, P370, DOI 10.1038/nature05966; Ruiz-Albert J, 2002, MOL MICROBIOL, V44, P645, DOI 10.1046/j.1365-2958.2002.02912.x; Shan LB, 2008, CELL HOST MICROBE, V4, P17, DOI 10.1016/j.chom.2008.05.017; Shang YL, 2006, P NATL ACAD SCI USA, V103, P19200, DOI 10.1073/pnas.0607279103; Shea JE, 1999, INFECT IMMUN, V67, P213, DOI 10.1128/IAI.67.1.213-219.1999; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; Teverson DM, 1991, THESIS U BIRMINGHAM; Vencato M, 2006, MOL PLANT MICROBE IN, V19, P1193, DOI 10.1094/MPMI-19-1193; Xiang TT, 2008, CURR BIOL, V18, P74, DOI 10.1016/j.cub.2007.12.020; XIAO YX, 1994, J BACTERIOL, V176, P3089, DOI 10.1128/JB.176.10.3089-3091.1994; XIAO YX, 1994, J BACTERIOL, V176, P1025, DOI 10.1128/JB.176.4.1025-1036.1994; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zumaquero A, 2010, J BACTERIOL, V192, P4474, DOI 10.1128/JB.00260-10	60	15	16	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35871	10.1371/journal.pone.0035871	http://dx.doi.org/10.1371/journal.pone.0035871			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558247	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336000069
J	Su, JM; Wang, YS; Li, RZ; Peng, H; Hua, S; Li, Q; Quan, FS; Guo, ZK; Zhang, Y				Su, Jianmin; Wang, Yongsheng; Li, Ruizhe; Peng, Hui; Hua, Song; Li, Qian; Quan, Fusheng; Guo, Zekun; Zhang, Yong			Oocytes Selected Using BCB Staining Enhance Nuclear Reprogramming and the In Vivo Development of SCNT Embryos in Cattle	PLOS ONE			English	Article							BRILLIANT CRESYL BLUE; BLASTOCYST DEVELOPMENT RATE; HISTONE DEACETYLASE; DNA METHYLATION; GENE-EXPRESSION; CLONING EFFICIENCY; VITRO DEVELOPMENT; IMPRINTED GENES; BOVINE OOCYTES; FOLLICLE SIZE	The selection of good quality oocytes is crucial for in vitro fertilization and somatic cloning. Brilliant cresyl blue (BCB) staining has been used for selection of oocytes from several mammalian species. However, the effects of differential oocyte selection by BCB staining on nuclear reprogramming and in vivo development of SCNT embryos are not well understood. Immature compact cumulus-oocyte complexes (COCs) were divided into control (not exposed to BCB), BCB+ (blue cytoplasm) and BCB- (colorless cytoplasm) groups. We found that BCB+ oocytes yielded a significantly higher somatic cell nuclear transfer (SCNT) blastocyst rate and full term development rate of bovine SCNT embryos than the BCB- and control oocytes. BCB+ embryos (embryos developed from BCB+ oocytes) showed increased acetylation levels of histone H3 at K9 and K18 (AcH3K9, AcH3K18), and methylation levels of histone H3 at K4 (H3K4me2) than BCB- embryos (embryos developed from BCB- oocytes) at the two-cell stage. Furthermore, BCB+ embryos generated more total cells, trophectoderm (TE) cells, and inner cell mass (ICM) cells, and fewer apoptotic cells than BCB- embryos. The expression of SOX2, CDX2, and anti-apoptotic microRNA-21 were up-regulated in the BCB+ blastocysts compared with BCB- blastocysts, whereas the expression of pro-apoptotic gene Bax was down-regulated in BCB+ blastocysts. These results strongly suggest that BCB+ oocytes have a higher nuclear reprogramming capacity, and that BCB staining can be used to select developmentally competent oocytes for nuclear transfer.	[Su, Jianmin; Wang, Yongsheng; Li, Ruizhe; Peng, Hui; Hua, Song; Li, Qian; Quan, Fusheng; Zhang, Yong] NW A&F Univ, Coll Vet Med, Key Lab Anim Reprod Physiol & Embryo Technol, Minist Agr, Yangling, Shaanxi, Peoples R China; [Guo, Zekun] NW A&F Univ, Dept Biochem & Mol Biol, Coll Life Sci, Yangling, Shaanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Northwest A&F University - China	Zhang, Y (corresponding author), NW A&F Univ, Coll Vet Med, Key Lab Anim Reprod Physiol & Embryo Technol, Minist Agr, Yangling, Shaanxi, Peoples R China.	zhangylab@gmail.com	Zhang, Yong/K-7945-2016	Zhang, Yong/0000-0001-8642-4071; Su, Jianmin/0000-0001-7353-1265	National Key Project for Production of Transgenic Livestock, People's Republic of China [2008ZX08007-004]	National Key Project for Production of Transgenic Livestock, People's Republic of China	This work was supported by the National Key Project for Production of Transgenic Livestock, People's Republic of China (No. 2008ZX08007-004) [http://www.nmp.gov.cn/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Katanani YM, 2002, J DAIRY SCI, V85, P390, DOI 10.3168/jds.S0022-0302(02)74086-1; Alm H, 2005, THERIOGENOLOGY, V63, P2194, DOI 10.1016/j.theriogenology.2004.09.050; Bhojwani S, 2007, THERIOGENOLOGY, V67, P341, DOI 10.1016/j.theriogenology.2006.08.006; Blondin P, 2002, BIOL REPROD, V66, P38, DOI 10.1095/biolreprod66.1.38; Bui HT, 2010, BIOL REPROD, V83, P454, DOI 10.1095/biolreprod.109.083337; Buscaglia Lindsey E Becker, 2011, Chin J Cancer, V30, P371; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Cui XS, 2011, CELL REPROGRAM, V13, P179, DOI 10.1089/cell.2010.0060; Cui XS, 2009, BIOCHEM BIOPH RES CO, V379, P390, DOI 10.1016/j.bbrc.2008.12.148; Dai XP, 2010, J BIOL CHEM, V285, P31002, DOI 10.1074/jbc.M110.136085; Das ZC, 2010, CELL REPROGRAM, V12, P95, DOI 10.1089/cell.2009.0068; Ding X, 2008, THERIOGENOLOGY, V70, P622, DOI 10.1016/j.theriogenology.2008.04.042; Esteves TC, 2011, AGING CELL, V10, P80, DOI 10.1111/j.1474-9726.2010.00644.x; Fouladi-Nashta AA, 2007, BIOL REPROD, V77, P9, DOI 10.1095/biolreprod.106.058578; Catala MG, 2011, REPRODUCTION, V142, P517, DOI 10.1530/REP-10-0528; Grunder E, 2011, EUR J CANCER, V47, P2479, DOI 10.1016/j.ejca.2011.06.041; Hwang JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010630; Iager AE, 2008, CLONING STEM CELLS, V10, P371, DOI 10.1089/clo.2007.0002; Jeon K, 2008, ANIM REPROD SCI, V108, P319, DOI 10.1016/j.anireprosci.2007.09.003; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li J, 2008, THERIOGENOLOGY, V70, P800, DOI 10.1016/j.theriogenology.2008.05.046; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LONERGAN P, 1994, MOL REPROD DEV, V37, P48, DOI 10.1002/mrd.1080370107; Machatkova M, 2004, THERIOGENOLOGY, V61, P329, DOI 10.1016/S0093-691X(03)00216-4; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ono T, 2010, BIOL REPROD, V83, P929, DOI 10.1095/biolreprod.110.085282; Park SY, 2007, MOL REPROD DEV, V74, P582, DOI 10.1002/mrd.20641; Pujol M, 2004, THERIOGENOLOGY, V61, P735, DOI 10.1016/S0093-691X(03)00250-4; Rizos D, 2005, THERIOGENOLOGY, V63, P939, DOI 10.1016/j.theriogenology.2004.05.008; Roca J, 1998, REPROD FERT DEVELOP, V10, P479, DOI 10.1071/RD98060; Rodrigues BA, 2009, REPROD DOMEST ANIM, V44, P255, DOI 10.1111/j.1439-0531.2009.01408.x; Rodriguez-Gonzalez E, 2003, REPROD NUTR DEV, V43, P179, DOI 10.1051/rnd:2003012; Rodriguez-Gonzalez E, 2002, THERIOGENOLOGY, V57, P1397, DOI 10.1016/S0093-691X(02)00645-3; Sartori R, 2002, J DAIRY SCI, V85, P2803, DOI 10.3168/jds.S0022-0302(02)74367-1; Shao GB, 2008, J REPROD DEVELOP, V54, P233, DOI 10.1262/jrd.19173; Shao GB, 2008, IN VITRO CELL DEV-AN, V44, P115, DOI 10.1007/s11626-008-9082-4; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; STOCK AE, 1993, ENDOCRINOLOGY, V132, P1108, DOI 10.1210/en.132.3.1108; Su JM, 2011, THERIOGENOLOGY, V75, P1346, DOI 10.1016/j.theriogenology.2010.11.045; Su JM, 2011, LIVEST SCI, V141, P24, DOI 10.1016/j.livsci.2011.04.012; Su JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023805; Torner H, 2008, REPRODUCTION, V135, P197, DOI 10.1530/REP-07-0348; Van Thuan N, 2009, REPRODUCTION, V138, P309, DOI 10.1530/REP-08-0299; VanSoom A, 1996, MOL REPROD DEV, V45, P171, DOI 10.1002/(SICI)1098-2795(199610)45:2&lt;171::AID-MRD10&gt;3.0.CO;2-4; Vassena R, 2003, THERIOGENOLOGY, V60, P923, DOI 10.1016/S0093-691X(03)00101-8; Wang YS, 2011, REPROD DOMEST ANIM, V46, P404, DOI 10.1111/j.1439-0531.2010.01679.x; Wang YS, 2011, ANIM REPROD SCI, V124, P48, DOI 10.1016/j.anireprosci.2011.01.015; Wang YS, 2011, CELL REPROGRAM, V13, P297, DOI 10.1089/cell.2010.0098; Warzych E, 2007, ANIM REPROD SCI, V97, P334, DOI 10.1016/j.anireprosci.2006.01.011; Wee G, 2007, REPRODUCTION, V134, P781, DOI 10.1530/REP-07-0338; Wu YG, 2007, CELL RES, V17, P722, DOI 10.1038/cr.2007.66; Yamanaka K, 2009, J REPROD DEVELOP, V55, P638, DOI 10.1262/jrd.20245; Yang CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014242; Yu Y, 2007, REPRODUCTION, V133, P947, DOI 10.1530/REP-06-0358	57	57	58	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36181	10.1371/journal.pone.0036181	http://dx.doi.org/10.1371/journal.pone.0036181			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558373	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000147
J	Chen, QR; Huang, Y				Chen Qingrong; Huang Yan			Processing Coordinate Structures in Chinese: Evidence from Eye Movements	PLOS ONE			English	Article							SENTENCE COMPREHENSION; RELATIVE CLAUSES; TIME-COURSE; WRAP-UP; CONTEXT; PREDICTABILITY; COMPETITION; ATTACHMENT; REANALYSIS; HYPOTHESIS	This article reports the results of an eye-tracking experiment that investigated the processing of coordinate structures in Chinese sentence comprehension. The study tracked the eye movements of native Chinese readers as they read sentences consisting of two independent clauses connected by the word huo zhe. The data strongly confirmed readers' preference for an initial noun phrase (NP)-coordination parsing in Chinese coordination structure. When huo zhe was absent from the beginning of a sentence, we identified a cost associated with abandoning the NP-coordination analysis, which was evident with regard to the second NP when the coordination was unambiguous. Otherwise, this cost was evident with regard to the verb, the syntactically disambiguating region, when the coordination was ambiguous. However, the presence of a sentence-initial huo zhe reduced reading times and regressions in the huo zhe NP and the verb regions. We believe that the word huo zhe at the beginning of a sentence helps the reader predict that the sentence contains a parallel structure. Before the corresponding phrases appear, the readers can use the word huo zhe and the language structure thereafter to predicatively construct the syntactic structure. Such predictive capability can eliminate the reader's preference for NP-coordination analysis. Implications for top-down parsing theory and models of initial syntactic analysis and reanalysis are discussed.	[Chen Qingrong] Nanjing Normal Univ, Dept Psychol, Nanjing, Jiangsu, Peoples R China; [Huang Yan] Nanjing Univ, Dept Appl Foreign Language Studies, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University; Nanjing University	Chen, QR (corresponding author), Nanjing Normal Univ, Dept Psychol, Nanjing, Jiangsu, Peoples R China.	jscqr80@sina.com			Natural Science Foundation, China [31100814]; Humanities and Social Science Research Foundation; Ministry of Education, China [10YJC740044]; Philosophy and Social Science Foundation, Jiangsu Province, China [1105007]; Nanjing Normal University [1109008]	Natural Science Foundation, China(National Natural Science Foundation of China (NSFC)); Humanities and Social Science Research Foundation; Ministry of Education, China(Ministry of Education, China); Philosophy and Social Science Foundation, Jiangsu Province, China; Nanjing Normal University	This work was supported by the Natural Science Foundation, China (31100814), the Humanities and Social Science Research Foundation, the Ministry of Education, China (10YJC740044), the Philosophy and Social Science Foundation, Jiangsu Province, China (1105007), and the Nanjing Normal University Fellowship (1109008) to Qingrong Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABNEY SP, 1989, J PSYCHOLINGUIST RES, V18, P129, DOI 10.1007/BF01069051; ALTMANN GTM, 1992, J MEM LANG, V31, P685, DOI 10.1016/0749-596X(92)90035-V; BADER M, 1994, PERSPECTIVES ON SENTENCE PROCESSING, P225; Calvo MG, 2001, PSYCHOL RES-PSYCH FO, V65, P158, DOI 10.1007/s004260000050; Chen BG, 2008, ACTA PSYCHOL, V129, P61, DOI 10.1016/j.actpsy.2008.04.005; Chen E, 2005, J MEM LANG, V52, P144, DOI 10.1016/j.jml.2004.10.001; [陈庆荣 Chen Qingrong], 2010, [心理学报, Acta Psychologica Sinica], V42, P672; CRAIN S, 1985, NATURAL LANGUAGE PAR, P320, DOI DOI 10.1017/CBO9780511597855.011; CROCKER MW, 1994, PERSPECTIVES ON SENTENCE PROCESSING, P245; ELMAN JL, 1990, COGNITIVE SCI, V14, P179, DOI 10.1207/s15516709cog1402_1; Engelhardt PE, 2004, 45 ANN PSYCH SOC M M; FODOR JD, 1980, COGNITION, V8, P417, DOI 10.1016/0010-0277(80)90003-7; FRAZIER L, 1982, COGNITIVE PSYCHOL, V14, P178, DOI 10.1016/0010-0285(82)90008-1; FRAZIER L, 1987, ATTENTION PERFORM, P559; FRAZIER L, 1978, COGNITION, V6, P291, DOI 10.1016/0010-0277(78)90002-1; Frazier L, 2000, J PSYCHOLINGUIST RES, V29, P125, DOI 10.1023/A:1005136826534; FRAZIER L, 1987, NAT LANG LINGUIST TH, V5, P519, DOI 10.1007/BF00138988; [高兵 GAO Bing], 2008, [心理学报, Acta Psychologica Sinica], V40, P381; Gibson Edward, LANGUAGE CO IN PRESS; GROBER EH, 1978, COGNITION, V6, P117, DOI 10.1016/0010-0277(78)90018-5; Hirotani M, 2006, J MEM LANG, V54, P425, DOI 10.1016/j.jml.2005.12.001; Hoeks JCJ, 2002, J MEM LANG, V46, P99, DOI 10.1006/jmla.2001.2800; Hsiao F, 2003, COGNITION, V90, P3, DOI 10.1016/S0010-0277(03)00124-0; Huang YT, 2011, J EXP PSYCHOL LEARN, V37, P966, DOI 10.1037/a0023218; Institute of Language Teaching and Research, 1986, FREQ DICT MOD CHIN; JUST MA, 1980, PSYCHOL REV, V87, P329, DOI 10.1037/0033-295X.87.4.329; Just MA, 1987, PSYCHOL READING LANG, P305; Kamide Y, 1999, LANG COGNITIVE PROC, V14, P631, DOI 10.1080/016909699386211; Konieczny L, 1997, LANG COGNITIVE PROC, V12, P307, DOI 10.1080/016909697386871; LARSON RK, 1985, NAT LANG LINGUIST TH, V3, P217, DOI 10.1007/BF00133841; Law SP, 2000, BRAIN LANG, V74, P260, DOI 10.1006/brln.2000.2341; Law SP, 2000, BRAIN LANG, V72, P310, DOI 10.1006/brln.2000.2298; MACDONALD MC, 1994, PSYCHOL REV, V101, P676, DOI 10.1037/0033-295X.101.4.676; MACDONALD MC, 1993, J MEM LANG, V32, P692, DOI 10.1006/jmla.1993.1035; McRae K, 1998, J MEM LANG, V38, P283, DOI 10.1006/jmla.1997.2543; Miao X.-C., 1996, ACTA PSYCHOL SIN, V28, P352; Nakatani K, 2008, LINGUISTICS, V46, P63, DOI 10.1515/LING.2008.003; Pickering MJ, 2001, J EXP PSYCHOL LEARN, V27, P556, DOI 10.1037//0278-7393.27.2.556; Pritchett B.L., 1992, GRAMMATICAL COMPETEN; Qiao XM, LANGUAGE CO IN PRESS; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Rayner K, 2000, Q J EXP PSYCHOL-A, V53, P1061, DOI 10.1080/02724980050156290; Rayner K, 2005, PSYCHON B REV, V12, P1089, DOI 10.3758/BF03206448; Rayner K, 1996, PSYCHON B REV, V3, P504, DOI 10.3758/BF03214555; Rayner K, 2004, J EXP PSYCHOL LEARN, V30, P1290, DOI 10.1037/0278-7393.30.6.1290; Rayner K, 2004, J EXP PSYCHOL HUMAN, V30, P720, DOI 10.1037/0096-1523.30.4.720; Rayner K., 1989, PSYCHOL READING; Reichle ED, 2003, BEHAV BRAIN SCI, V26, P445, DOI 10.1017/S0140525X03000104; Schneider D, 2001, J MEM LANG, V45, P308, DOI 10.1006/jmla.2001.2777; Schneider D, 1999, THESIS U DELAWARE; Schwarz B, 1999, NAT LANG LINGUIST TH, V17, P339, DOI 10.1023/A:1006046306942; Staub A, 2006, J EXP PSYCHOL LEARN, V32, P425, DOI 10.1037/0278-7393.32.2.425; Staub A., 2007, OXFORD HDB PSYCHOLIN, P327, DOI DOI 10.1093/OXFORDHB/9780198568971.001.0001; Staub A, 2007, J MEM LANG, V57, P299, DOI 10.1016/j.jml.2006.09.001; Sturt P, 2005, COGNITIVE SCI, V29, P291, DOI 10.1207/s15516709cog0000_8; Sturt P, 1999, J MEM LANG, V40, P136, DOI 10.1006/jmla.1998.2606; Su IR, 2001, APPL PSYCHOLINGUIST, V22, P167, DOI 10.1017/S0142716401002028; Su YC, 2007, BRAIN LANG, V101, P1, DOI 10.1016/j.bandl.2006.12.001; Traxler MJ, 1998, J MEM LANG, V39, P558, DOI 10.1006/jmla.1998.2600; van Gompel RPG, 2005, J MEM LANG, V52, P284, DOI 10.1016/j.jml.2004.11.003; van Gompel RPG, 2001, J MEM LANG, V45, P225, DOI 10.1006/jmla.2001.2773; WRIGHT B, 1984, MEM COGNITION, V12, P31, DOI 10.3758/BF03196995; [武宁宁 Wu Ningning], 2002, [心理学报, Acta Psychologica Sinica], V34, P454; Yang HM, 1999, READING CHINESE SCRIPT, P207; Yang JM, 2009, MEM COGNITION, V37, P1164, DOI 10.3758/MC.37.8.1164; Zhang W. T., 1987, ACTA PSYCHOL SINICA, V1, P79; [张亚旭 Zhang Yaxu], 2002, [心理学报, Acta Psychologica Sinica], V34, P126; Zhou ZJ, 2003, PSYCHOL SCI CHINA, V26, P976; 陈永明, 1997, [心理学报, Acta Psychologica Sinica], V29, P1; 石东方, 2001, [心理学报, Acta Psychologica Sinica], V33, P7; 彭聃龄, 1993, [心理学报, Acta Psychologica Sinica], V25, P132; 陈永明, 1994, [心理学报, Acta Psychologica Sinica], V26, P113	72	5	7	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35517	10.1371/journal.pone.0035517	http://dx.doi.org/10.1371/journal.pone.0035517			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	959VP	22558163	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345200044
J	Chhatwal, P; Bankwitz, D; Gentzsch, J; Frentzen, A; Schult, P; Lohmann, V; Pietschmann, T				Chhatwal, Patrick; Bankwitz, Dorothea; Gentzsch, Juliane; Frentzen, Anne; Schult, Philipp; Lohmann, Volker; Pietschmann, Thomas			Bile Acids Specifically Increase Hepatitis C Virus RNA-Replication	PLOS ONE			English	Article							INFECTION; SYSTEM; CELLS; IDENTIFICATION; SECRETION; FXR	Background: Hepatitis C virus (HCV) patients with high serum levels of bile acids (BAs) respond poorly to IFN therapy. BAs have been shown to increase RNA-replication of genotype 1 but not genotype 2a replicons. Since BAs modulate lipid metabolism including lipoprotein secretion and as HCV depends on lipids and lipoproteins during RNA-replication, virus production and cell entry, BAs may affect multiple steps of the HCV life cycle. Therefore, we analyzed the influence of BAs on individual steps of virus replication. Methods: We measured replication of subgenomic genotype (GT) 1b and 2a RNAs as well as full-length GT2a genomes in the presence of BAs using quantitative RT-PCR and luciferase assays. Cell entry was determined using HCV pseudoparticles (HCVpp). Virus assembly and release were quantified using a core-specific ELISA. Replicon chimeras were employed to characterize genotype-specific modulation of HCV by BAs. Lunet CD81/GFP-NLS-MAVS cells were used to determine infection of Con1 particles. Results: BAs increased RNA-replication of GT1b replicons up to 10-fold but had no effect on subgenomic GT2a replicons both in Huh-7 and HuH6 cells. They did not increase viral RNA translation, virus assembly and release or cell entry. Lowering replication efficiency of GT2a replicons rendered them susceptible to stimulation by BAs. Moreover, replication of full length GT1b with or without replication enhancing mutations and GT2a genomes were also stimulated by BAs. Conclusions: Bile acids specifically enhance RNA-replication. This is not limited to GT1, but also holds true for GT2a full length genomes and subgenomic replicons with low replication capacity. The increase of HCV replication by BAs may influence the efficacy of antiviral treatment in vivo and may improve replication of primary HCV genomes in cell culture.	[Chhatwal, Patrick; Bankwitz, Dorothea; Gentzsch, Juliane; Frentzen, Anne; Pietschmann, Thomas] TWINCORE, Ctr Expt & Clin Infect Res, Dept Expt Virol, Hannover, Germany; [Schult, Philipp; Lohmann, Volker] Univ Heidelberg, Dept Infect Dis, Heidelberg, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Ruprecht Karls University Heidelberg	Chhatwal, P (corresponding author), TWINCORE, Ctr Expt & Clin Infect Res, Dept Expt Virol, Hannover, Germany.	thomas.pietschmann@twincore.de	Lohmann, Volker/H-4211-2019; Pietschmann, Thomas/E-9241-2015	Lohmann, Volker/0000-0001-8719-7608; Pietschmann, Thomas/0000-0001-5138-6239; Schult, Philipp/0000-0002-0533-7046	Deutsche Forschungsgemeinschaft [SFB 900, Teilprojekt A6]; Initiative and Networking Fund of the Helmholtz Association [SO-024]; Indo German Science Centre for Infectious Diseases [IG-SCIDTwin-Pro03]; international research training group 1273 (IRTG 1273) by DFG; Hannover Medical School STRUCMED program; DFG [LO1556/1-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Initiative and Networking Fund of the Helmholtz Association; Indo German Science Centre for Infectious Diseases; international research training group 1273 (IRTG 1273) by DFG; Hannover Medical School STRUCMED program; DFG(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (SFB 900, Teilprojekt A6), by grants from the Initiative and Networking Fund of the Helmholtz Association SO-024 and the Indo German Science Centre for Infectious Diseases IG-SCIDTwin-Pro03 to TP. DB and AF were funded by stipends from the international research training group 1273 (IRTG 1273) provided by the DFG. PC was supported by an intramural grant of the Hannover Medical School STRUCMED program. PS and VL were supported by DFG grant LO1556/1-2. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreo U, 2007, CELL MICROBIOL, V9, P2445, DOI 10.1111/j.1462-5822.2007.00972.x; Backes P, 2010, J VIROL, V84, P5775, DOI 10.1128/JVI.02343-09; Bartenschlager R, 2004, ADV VIRUS RES, V63, P71, DOI 10.1016/S0065-3527(04)63002-8; Binder M, 2007, J VIROL, V81, P5270, DOI 10.1128/JVI.00032-07; Bitzegeio J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000978; Blasiole DA, 2007, MOL BIOSYST, V3, P608, DOI 10.1039/b700706j; Brohm C, 2009, J VIROL, V83, P11682, DOI 10.1128/JVI.00691-09; Bukh J, 2002, P NATL ACAD SCI USA, V99, P14416, DOI 10.1073/pnas.212532699; Chang KO, 2007, J VIROL, V81, P9633, DOI 10.1128/JVI.00795-07; Drexler JF, 2009, PLOS MED, V6, P210, DOI 10.1371/journal.pmed.1000031; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Gentzsch J, ANTIVIRAL RES, V89, P136; Haid S, J VIROL, V84, P964; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Ishizaki K, 2005, HEPATOL RES, V33, P174, DOI 10.1016/j.hepres.2005.09.029; Iwata R, 2010, J VIRAL HEPATITIS; Iwata R, 2011, CLIN SCI, V120, P287, DOI 10.1042/CS20100246; Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604; Jorquera F, 2005, J GASTROEN HEPATOL, V20, P547, DOI 10.1111/j.1440-1746.2005.03725.x; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; PENNINGTON CR, 1978, SCAND J GASTROENTERO, V13, P77, DOI 10.3109/00365527809179809; Pietschmann T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000475; RUSSELL DW, 1992, BIOCHEMISTRY-US, V31, P4737, DOI 10.1021/bi00135a001; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Scholtes C, 2008, J HEPATOL, V48, P192, DOI 10.1016/j.jhep.2007.09.015; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Steinmann E, 2008, J VIROL, V82, P7034, DOI 10.1128/JVI.00118-08; TRINCHET JC, 1994, J HEPATOL, V21, P235, DOI 10.1016/S0168-8278(05)80401-5; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Windisch MP, 2005, J VIROL, V79, P13778, DOI 10.1128/JVI.79.21.13778-13793.2005	33	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e36029	10.1371/journal.pone.0036029	http://dx.doi.org/10.1371/journal.pone.0036029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558311	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345200112
J	Cho, YG; Kim, JY; Cho, HH; Cha, PR; Suh, DW; Lee, JK; Han, HN				Cho, Yi-Gil; Kim, Jin-You; Cho, Hoon-Hwe; Cha, Pil-Ryung; Suh, Dong-Woo; Lee, Jae Kon; Han, Heung Nam			Analysis of Transformation Plasticity in Steel Using a Finite Element Method Coupled with a Phase Field Model	PLOS ONE			English	Article							EXTERNALLY APPLIED STRESS; LOW-CARBON STEEL; AUSTENITE; FERRITE; ALLOYS; SUPERPLASTICITY; TRIP; RECRYSTALLIZATION; SOLIDIFICATION; DEFORMATION	An implicit finite element model was developed to analyze the deformation behavior of low carbon steel during phase transformation. The finite element model was coupled hierarchically with a phase field model that could simulate the kinetics and micro-structural evolution during the austenite-to-ferrite transformation of low carbon steel. Thermo-elastic-plastic constitutive equations for each phase were adopted to confirm the transformation plasticity due to the weaker phase yielding that was proposed by Greenwood and Johnson. From the simulations under various possible plastic properties of each phase, a more quantitative understanding of the origin of transformation plasticity was attempted by a comparison with the experimental observation.	[Cho, Yi-Gil; Cho, Hoon-Hwe; Han, Heung Nam] Seoul Natl Univ, Dept Mat Sci & Engn, Seoul, South Korea; [Cho, Yi-Gil; Cho, Hoon-Hwe; Han, Heung Nam] Seoul Natl Univ, Ctr Iron & Steel Res, RIAM, Seoul, South Korea; [Kim, Jin-You; Lee, Jae Kon] POSCO, Sheet Prod & Proc Res Grp, Tech Res Labs, Pohang, South Korea; [Cha, Pil-Ryung] Kookmin Univ, Sch Adv Mat Engn, Seoul, South Korea; [Suh, Dong-Woo] Pohang Univ Sci & Technol, Grad Inst Ferrous Technol, Pohang, South Korea	Seoul National University (SNU); Seoul National University (SNU); POSCO; Kookmin University; Pohang University of Science & Technology (POSTECH)	Cho, YG (corresponding author), Seoul Natl Univ, Dept Mat Sci & Engn, Seoul, South Korea.	hnhan@snu.ac.kr	Han, Heung Nam/I-7675-2016; Han, Heung Nam/D-6461-2013	Han, Heung Nam/0000-0001-5271-9023; Suh, Dong-Woo/0000-0002-3719-0202	National Research Foundation of Korea; Ministry of Education, Science and Technology [2010-0018936]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by a National Research Foundation of Korea grant funded by the Ministry of Education, Science and Technology (Grant No. 2010-0018936). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, ABAQUS US MAN VERS 6; Bhadeshia HKDH, 2002, ISIJ INT, V42, P1059, DOI 10.2355/isijinternational.42.1059; Cha PR, 2010, MATER MANUF PROCESS, V25, P106, DOI 10.1080/10426910903153166; Cha PR, 2001, ACTA MATER, V49, P3295, DOI 10.1016/S1359-6454(01)00184-7; Cho YG, 2011, METALL MATER TRANS A, V42A, P2094, DOI 10.1007/s11661-010-0598-3; Choi I, 2010, MET MATER INT, V16, P27, DOI 10.1007/s12540-010-0027-6; Choi JM, 2010, KOREAN J MET MATER, V48, P187, DOI 10.3365/KJMM.2010.48.03.187; Coret M, 2002, INT J PLASTICITY, V18, P1707, DOI 10.1016/S0749-6419(01)00067-5; Fischer FD, 2000, INT J PLASTICITY, V16, P723, DOI 10.1016/S0749-6419(99)00078-9; GREENWOOD GW, 1965, PROC R SOC LON SER-A, V283, P403, DOI 10.1098/rspa.1965.0029; Han HN, 2007, PHILOS MAG, V87, P159, DOI 10.1080/14786430600953731; Han HN, 2008, PHILOS MAG, V88, P1811, DOI 10.1080/14786430802320119; Han HN, 2005, MATER LETT, V59, P158, DOI 10.1016/j.matlet.2004.07.030; Han HN, 2004, ACTA MATER, V52, P5203, DOI 10.1016/j.actamat.2004.07.031; Han HN, 2003, ACTA MATER, V51, P4907, DOI 10.1016/S1359-6454(03)00333-1; Han HN, 2002, ISIJ INT, V42, P200, DOI 10.2355/isijinternational.42.200; Huang CJ, 2006, ACTA MATER, V54, P11, DOI 10.1016/j.actamat.2005.08.033; Kim SG, 2007, ACTA MATER, V55, P6513, DOI 10.1016/j.actamat.2007.07.058; Kim SG, 2004, J CRYST GROWTH, V263, P620, DOI 10.1016/j.jcrysgro.2003.12.003; Kim SG, 1999, PHYS REV E, V60, P7186, DOI 10.1103/PhysRevE.60.7186; Kundu S, 2004, SCRIPTA MATER, V50, P891, DOI 10.1016/j.scriptamat.2003.12.007; Lan YJ, 2004, ACTA MATER, V52, P1721, DOI 10.1016/j.actamat.2003.12.045; LEBLOND JB, 1989, INT J PLASTICITY, V5, P551, DOI 10.1016/0749-6419(89)90001-6; Loginova I, 2003, ACTA MATER, V51, P1327, DOI 10.1016/S1359-6454(02)00527-X; Magee CL, 1966, THESIS CARNEGIE I TE; Mecozzi MG, 2005, METALL MATER TRANS A, V36A, P2327, DOI 10.1007/s11661-005-0105-4; Miettinen J., 1995, TKKVB113 HELS U TECH; Nagayama K, 2000, KEY ENG MAT, V177-1, P443, DOI 10.4028/www.scientific.net/KEM.177-180.443; Steinbach I, 1996, PHYSICA D, V94, P135, DOI 10.1016/0167-2789(95)00298-7; Suzuki H, 1968, STUDIES STRESS METAL, V18; Taleb L, 2003, INT J PLASTICITY, V19, P1821, DOI 10.1016/S0749-6419(03)00020-2; Taleb L, 2001, INT J PLASTICITY, V17, P1, DOI 10.1016/S0749-6419(99)00090-X; Warren JA, 2003, ACTA MATER, V51, P6035, DOI 10.1016/S1359-6454(03)00388-4; Wits JJ, 2000, MAT SCI ENG A-STRUCT, V283, P234, DOI 10.1016/S0921-5093(00)00735-8; Wray PJ, 1980, MODELING CASTING WEL, P245; Yeon DH, 2001, SCRIPTA MATER, V45, P661, DOI 10.1016/S1359-6462(01)01077-6; Zwigl P, 1997, ACTA MATER, V45, P5285, DOI 10.1016/S1359-6454(97)00186-9; Zwigl P, 1999, MAT SCI ENG A-STRUCT, V262, P166, DOI 10.1016/S0921-5093(98)00991-5	38	9	9	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35987	10.1371/journal.pone.0035987	http://dx.doi.org/10.1371/journal.pone.0035987			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558295	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345200104
J	Gerber, YN; Sabourin, JC; Rabano, M; Vivanco, MD; Perrin, FE				Gerber, Yannick Nicolas; Sabourin, Jean-Charles; Rabano, Miriam; Vivanco, Maria dM.; Perrin, Florence Evelyne			Early Functional Deficit and Microglial Disturbances in a Mouse Model of Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							MOTOR-NEURON DISEASE; TREADMILL GAIT ANALYSIS; SUPEROXIDE-DISMUTASE; FAMILIAL ALS; SPINAL-CORD; PARKINSONS-DISEASE; TRANSGENIC MICE; NERVOUS-SYSTEM; ANIMAL-MODELS; ASTROCYTES	Background: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterized by selective motoneurons degeneration. There is today no clear-cut pathogenesis sequence nor any treatment. However growing evidences are in favor of the involvement, besides neurons, of several partners such as glia and muscles. To better characterize the time course of pathological events in an animal model that recapitulates human ALS symptoms, we investigated functional and cellular characteristics of hSOD1(G93A) mice. Methods and Findings: We have evaluated locomotor function of hSOD1(G93A) mice through dynamic walking patterns and spontaneous motor activity analysis. We detected early functional deficits that redefine symptoms onset at 60 days of age, i.e. 20 days earlier than previously described. Moreover, sequential combination of these approaches allows monitoring of motor activity up to disease end stage. To tentatively correlate early functional deficit with cellular alterations we have used flow cytometry and immunohistochemistry approaches to characterize neuromuscular junctions, astrocytes and microglia. We show that (1) decrease in neuromuscular junction's number correlates with motor impairment, (2) astrocytes number is not altered at pre- and early-symptomatic ages but intraspinal repartition is modified at symptoms onset, and (3) microglia modifications precede disease onset. At pre-symptomatic age, we show a decrease in microglia number whereas at onset of the disease two distinct microglia sub-populations emerge. Conclusions: In conclusion, precise motor analysis updates the onset of the disease in hSOD1(G93A) mice and allows locomotor monitoring until the end stage of the disease. Early functional deficits coincide with alterations of neuromuscular junctions. Importantly, we identify different sets of changes in microglia before disease onset as well as at early-symptomatic stage. This finding not only brings a new sequence of cellular events in the natural history of the disease, but it may also provide clues in the search for biomarkers of the disease, and potential therapeutic targets.	[Gerber, Yannick Nicolas; Perrin, Florence Evelyne] St Elio Hosp, INSERM U1051, Inst Neurosci Montpellier, Montpellier, France; [Gerber, Yannick Nicolas; Perrin, Florence Evelyne] IKERBASQUE Basque Fdn Sci, Bilbao, Spain; [Sabourin, Jean-Charles; Perrin, Florence Evelyne] Univ Basque Country, Dept Neurosci, Leioa, Spain; [Rabano, Miriam; Vivanco, Maria dM.] CIC bioGUNE, Cell Biol & Stem Cells Unit, Derio, Spain	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Basque Foundation for Science; University of Basque Country; CIC bioGUNE	Gerber, YN (corresponding author), St Elio Hosp, INSERM U1051, Inst Neurosci Montpellier, Montpellier, France.	f.perrin@ikerbasque.org	cancer, biogune/H-7276-2012; Vivanco, Maria/G-2393-2011; PERRIN, Florence/AAY-6815-2021	Vivanco, Maria/0000-0002-9540-247X; PERRIN, Florence/0000-0002-7630-0515	Spanish Government, Plan Nacional de I+D+I2008-2011; Institudo de Salud Carlos III-Subdireccion General de Evaluacion y Fomento de la investigacion [PI10/00709]; Fondation pour la Recherche Medicale; patient organization "Demain Debout Aquitaine''; patient organization "Verticale"	Spanish Government, Plan Nacional de I+D+I2008-2011; Institudo de Salud Carlos III-Subdireccion General de Evaluacion y Fomento de la investigacion; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); patient organization "Demain Debout Aquitaine''; patient organization "Verticale"	This work was supported by the Spanish Government, Plan Nacional de I+D+I2008-2011 and the Institudo de Salud Carlos III-Subdireccion General de Evaluacion y Fomento de la investigacion [PI10/00709 to FEP], the "Fondation pour la Recherche Medicale" to FEP and the patient organizations "Demain Debout Aquitaine'' (to YNG) and "Verticale" (to FEP). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexianu ME, 2001, NEUROLOGY, V57, P1282, DOI 10.1212/WNL.57.7.1282; Appel S H, 2011, Acta Myol, V30, P4; Banerjee R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002740; Barbeito AG, 2010, J NEURAL TRANSM, V117, P981, DOI 10.1007/s00702-010-0429-0; Bilsland LG, 2010, P NATL ACAD SCI USA, V107, P20523, DOI 10.1073/pnas.1006869107; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Chiu IM, 2009, P NATL ACAD SCI USA, V106, P20960, DOI 10.1073/pnas.0911405106; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Ferraiuolo L, 2011, BRAIN, V134, P2627, DOI 10.1093/brain/awr193; Ferrer-Alcon M, 2008, NEUROSCIENCE, V152, P291, DOI 10.1016/j.neuroscience.2007.11.058; Finkelstein A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022374; Frey D, 2000, J NEUROSCI, V20, P2534; Guillot TS, 2008, J MOTOR BEHAV, V40, P568, DOI 10.3200/JMBR.40.6.568-577; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hall ED, 1998, J NEUROSCI RES, V53, P66, DOI 10.1002/(SICI)1097-4547(19980701)53:1<66::AID-JNR7>3.3.CO;2-K; Hampton TG, 2010, J MOTOR BEHAV, V42, P1, DOI 10.1080/00222890903272025; Henkel JS, 2009, J NEUROIMMUNE PHARM, V4, P389, DOI 10.1007/s11481-009-9171-5; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Julien JP, 2007, NAT NEUROSCI, V10, P535, DOI 10.1038/nn0507-535; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; Kaspar BK, 2005, ANN NEUROL, V57, P649, DOI 10.1002/ana.20451; Levine JB, 1999, GLIA, V28, P215; Mahoney DJ, 2004, MUSCLE NERVE, V29, P656, DOI 10.1002/mus.20004; Mancuso R, 2011, BRAIN RES, V1406, P65, DOI 10.1016/j.brainres.2011.06.033; Mead RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023244; Morrison BM, 1999, BRAIN RES REV, V29, P121, DOI 10.1016/S0165-0173(98)00049-6; Philips T, 2011, LANCET NEUROL, V10, P253, DOI 10.1016/S1474-4422(11)70015-1; Romero-Sandoval A, 2008, BRAIN RES, V1219, P116, DOI 10.1016/j.brainres.2008.05.004; Rossi D, 2008, CELL DEATH DIFFER, V15, P1691, DOI 10.1038/cdd.2008.99; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Sanagi T, 2010, J NEUROSCI RES, V88, P2736, DOI 10.1002/jnr.22424; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; Schiffer D, 1996, J NEUROL SCI, V139, P27, DOI 10.1016/0022-510X(96)00073-1; Schiffer D, 2004, AMYOTROPH LATERAL SC, V5, P22, DOI 10.1080/14660820310016822; Solomon JN, 2006, GLIA, V53, P744, DOI 10.1002/glia.20331; Van Damme P, 2009, CURR OPIN NEUROL, V22, P486, DOI 10.1097/WCO.0b013e32832ffbe3; Van Den Bosch L, 2008, EXP NEUROL, V211, P1, DOI 10.1016/j.expneurol.2008.01.008; Vandeputte C, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-92; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7	41	47	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e36000	10.1371/journal.pone.0036000	http://dx.doi.org/10.1371/journal.pone.0036000			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558300	gold, Green Published			2022-12-27	WOS:000305345200107
J	Huang, GJ; Ben-David, E; Piella, AST; Edwards, A; Flint, J; Shifman, S				Huang, Guo-Jen; Ben-David, Eyal; Piella, Agne S. Tort; Edwards, Andrew; Flint, Jonathan; Shifman, Sagiv			Neurogenomic Evidence for a Shared Mechanism of the Antidepressant Effects of Exercise and Chronic Fluoxetine in Mice	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; LARGE GENE LISTS; ENVIRONMENTAL ENRICHMENT; BEHAVIOR; DEPRESSION; RESPONSES; NEURONS; ANXIETY; STRESS; MODEL	Several different interventions improve depressed mood, including medication and environmental factors such as regular physical exercise. The molecular pathways underlying these effects are still not fully understood. In this study, we sought to identify shared mechanisms underlying antidepressant interventions. We studied three groups of mice: mice treated with a widely used antidepressant drug - fluoxetine, mice engaged in voluntary exercise, and mice living in an enriched environment. The hippocampi of treated mice were investigated at the molecular and cellular levels. Mice treated with fluoxetine and mice who exercised daily showed, not only similar antidepressant behavior, but also similar changes in gene expression and hippocampal neurons. These changes were not observed in mice with environmental enrichment. An increase in neurogenesis and dendritic spine density was observed following four weeks of fluoxetine treatment and voluntary exercise. A weighted gene co-expression network analysis revealed four different modules of co-expressed genes that were correlated with the antidepressant effect. This network analysis enabled us to identify genes involved in the molecular pathways underlying the effects of fluoxetine and exercise. The existence of both neuronal and gene expression changes common to antidepressant drug and exercise suggests a shared mechanism underlying their effect. Further studies of these findings may be used to uncover the molecular mechanisms of depression, and to identify new avenues of therapy.	[Huang, Guo-Jen] Chang Gung Univ, Coll Med, Dept & Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Ben-David, Eyal; Shifman, Sagiv] Hebrew Univ Jerusalem, Dept Genet, Inst Life Sci, IL-91904 Jerusalem, Israel; [Piella, Agne S. Tort; Edwards, Andrew; Flint, Jonathan] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	Chang Gung University; Hebrew University of Jerusalem; University of Oxford; Wellcome Centre for Human Genetics	Huang, GJ (corresponding author), Chang Gung Univ, Coll Med, Dept & Grad Inst Biomed Sci, Tao Yuan, Taiwan.	gjh30@mail.cgu.edu.tw; sagiv@vms.huji.ac.il	Shifman, Sagiv/D-8749-2017; Ben-David, Eyal/AAV-4126-2021	Shifman, Sagiv/0000-0003-4071-5361; Ben-David, Eyal/0000-0003-0514-0400; Huang, Guo-Jen/0000-0002-6392-2155; Flint, Jonathan/0000-0002-9427-4429	Chang Gung Memorial Hospital [CMRPD1A0211]; National Science Council of Taiwan [NSC100-2320-B-182-003]; Wellcome Trust; Legacy Heritage Fund program of Israel Science Foundation [1998/08]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Wellcome Trust(Wellcome Trust); Legacy Heritage Fund program of Israel Science Foundation	This study was supported by grants from the Chang Gung Memorial Hospital (CMRPD1A0211) and the National Science Council (NSC100-2320-B-182-003) of Taiwan (to GJH), by the Wellcome Trust (to JF), and by the Legacy Heritage Fund program of the Israel Science Foundation (grant no. 1998/08) (to SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson IM, 2008, J PSYCHOPHARMACOL, V22, P343, DOI 10.1177/0269881107088441; Bjornebekk A, 2005, INT J NEUROPSYCHOPH, V8, P357, DOI 10.1017/S1461145705005122; BODNOFF SR, 1989, PSYCHOPHARMACOLOGY, V97, P277, DOI 10.1007/BF00442264; Dulawa SC, 2005, NEUROSCI BIOBEHAV R, V29, P771, DOI 10.1016/j.neubiorev.2005.03.017; Duman CH, 2008, BRAIN RES, V1199, P148, DOI 10.1016/j.brainres.2007.12.047; Fox C, 2006, BEHAV BRAIN RES, V175, P1, DOI 10.1016/j.bbr.2006.08.016; Greenwood BN, 2003, J NEUROSCI, V23, P2889; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang GJ, 2008, MOL PSYCHIATR, V13, P119, DOI 10.1038/sj.mp.4002104; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Lawlor DA, 2001, BMJ-BRIT MED J, V322, P763, DOI 10.1136/bmj.322.7289.763; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Miller BH, 2008, NEUROPSYCHOPHARMACOL, V33, P1312, DOI 10.1038/sj.npp.1301497; NJUNGE K, 1991, PHARMACOL BIOCHEM BE, V38, P63, DOI 10.1016/0091-3057(91)90590-X; Russo-Neustadt AA, 2000, NEUROSCIENCE, V101, P305, DOI 10.1016/S0306-4522(00)00349-3; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	22	36	38	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35901	10.1371/journal.pone.0035901	http://dx.doi.org/10.1371/journal.pone.0035901			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558262	gold, Green Published, Green Submitted			2022-12-27	WOS:000305345200092
J	Pathak, S; Rege, M; Gogtay, NJ; Aigal, U; Sharma, SK; Valecha, N; Bhanot, G; Kshirsagar, NA; Sharma, S				Pathak, Sulabha; Rege, Mayuri; Gogtay, Nithya J.; Aigal, Umesh; Sharma, Surya Kant; Valecha, Neena; Bhanot, Gyan; Kshirsagar, Nilima A.; Sharma, Shobhona			Age-Dependent Sex Bias in Clinical Malarial Disease in Hypoendemic Regions	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; ANOPHELES-GAMBIAE; PARASITE DENSITY; VIVAX MALARIA; EPIDEMIOLOGY; TRANSMISSION; POPULATION; CHILDREN; ORISSA; INDIA	Background and Objectives: Experimental models show a male bias in murine malaria; however, extant literature on biases in human clinical malaria is inconclusive. Studies in hyperendemic areas document an absence of sexual dimorphism in clinical malaria. Data on sex bias in clinical malaria in hypoendemic areas is ambiguous-some reports note a male bias but do not investigate the role of differential mosquito exposure in that bias. Moreover, these studies do not examine whether the bias is age related. This study investigates whether clinical malaria in hypoendemic regions exhibits a sex bias and whether this bias is age-dependent. We also consider the role of vector exposure in this bias. Methods: Retrospective passive clinical malaria datasets (2002-2007) and active surveillance datasets (2000-2009) were captured for the hypoendemic Mumbai region in Western India. To validate findings, passive retrospective data was captured from a primary malaria clinic (2006-2007) in hypoendemic Rourkela (Eastern India). Data was normalized by determining percent slide-positivity rates (SPRs) for males and females, and parasite-positivity distributions were established across age groups. The Mann-Whitney test, Wilcoxon Signed Rank test, and Chi-square analysis were used to determine statistical significances. Results: In both the Mumbai and Rourkela regions, clinical malaria exhibited an adult male bias (p<0.01). A sex bias was not observed in children aged <= 10. Post-puberty, male SPRs were significantly greater than females SPRs (p<0.01). This adult male bias was observed for both vivax and falciparum clinical disease. Analysis of active surveillance data did not reveal an age or sex bias in the frequency of parasite positivity. Conclusion: This study demonstrates an age-dependent sex bias in clinical malaria in hypoendemic regions and enhanced incidence of clinical malaria in males following puberty. Possible roles of sex hormones, vector exposure, co-infections, and other factors in this enhanced susceptibility are discussed.	[Pathak, Sulabha; Rege, Mayuri; Sharma, Shobhona] Tata Inst Fundamental Res, Dept Biol Sci, Mumbai 400005, Maharashtra, India; [Gogtay, Nithya J.; Kshirsagar, Nilima A.] King Edward Mem Hosp, Dept Clin Pharmacol, Seth GS Med Coll, Bombay, Maharashtra, India; [Sharma, Surya Kant] Natl Inst Malaria Res, Field Stn, Odisha, India; [Aigal, Umesh] Kasturba Hosp Infect Dis, Mumbai, Maharashtra, India; [Valecha, Neena] Natl Inst Malaria Res ICMR, New Delhi, India; [Bhanot, Gyan] Rutgers State Univ, Dept Phys, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	Tata Institute of Fundamental Research (TIFR); Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Rutgers State University New Brunswick	Pathak, S (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd, Mumbai 400005, Maharashtra, India.	suepathak@tifr.res.in			Homi Bhabha Research Council, Tata Institute of Fundamental Research, Mumbai, India; Homi Bhabha Fellowship	Homi Bhabha Research Council, Tata Institute of Fundamental Research, Mumbai, India; Homi Bhabha Fellowship	This work was supported by the Homi Bhabha Research Council, Tata Institute of Fundamental Research, Mumbai, India. Dr. Pathak is the recipient of Homi Bhabha Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1977, BIONOMICS MALARIA VE; Balmer P, 2000, PARASITOLOGY, V121, P473, DOI 10.1017/S0031182099006757; Barik TK, 2009, ACTA TROP, V109, P87, DOI 10.1016/j.actatropica.2008.09.017; Basu S, 2005, INDIAN PEDIATR, V42, P593; Benegal V, 2005, ADDICTION, V100, P1051, DOI 10.1111/j.1360-0443.2005.01176.x; Bhaskaran Mythili, 2003, Indian J Physiol Pharmacol, V47, P361; Camargo LMA, 1996, AM J TROP MED HYG, V55, P32, DOI 10.4269/ajtmh.1996.55.32; CARNEVALE P, 1978, B WORLD HEALTH ORGAN, V56, P147; CATTANI JA, 1986, AM J TROP MED HYG, V35, P3, DOI 10.4269/ajtmh.1986.35.3; Cernetich A, 2006, INFECT IMMUN, V74, P3190, DOI 10.1128/IAI.00008-06; Das A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-377; Delic D, 2011, STEROIDS, V76, P1204, DOI 10.1016/j.steroids.2011.05.013; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Golenda CF, 1999, AM J TROP MED HYG, V60, P654, DOI 10.4269/ajtmh.1999.60.654; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Hati AK, 1997, INDIAN J MED RES, V106, P149; Iyer A, 2007, INT J HEALTH SERV, V37, P537, DOI 10.2190/1146-7828-5L5H-7757; Kakkar V, 2007, MATURITAS, V57, P306, DOI 10.1016/j.maturitas.2007.02.026; Kamat V., 2000, Parassitologia (Rome), V42, P135; Khasnis AA, 2005, ARCH MED RES, V36, P689, DOI 10.1016/j.arcmed.2005.03.041; Klein SL, 2004, PARASITE IMMUNOL, V26, P247, DOI 10.1111/j.0141-9838.2004.00710.x; Kleinschmidt I, 2001, TROP MED INT HEALTH, V6, P986, DOI 10.1046/j.1365-3156.2001.00817.x; Krucken J, 2005, PARASITE IMMUNOL, V27, P205, DOI 10.1111/j.1365-3024.2005.00763.x; Kshirsagar NA, 2000, AM J TROP MED HYG, V62, P402, DOI 10.4269/ajtmh.2000.62.402; Kumar A, 2007, AM J TROP MED HYG, V77, P69, DOI 10.4269/ajtmh.2007.77.69; Kurtis JD, 2001, INFECT IMMUN, V69, P123, DOI 10.1128/IAI.69.1.123-128.2001; LANDGRAF B, 1994, T ROY SOC TROP MED H, V88, P73, DOI 10.1016/0035-9203(94)90505-3; Leenstra T, 2003, J INFECT DIS, V188, P297, DOI 10.1086/376508; Lefevre T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009546; Luxemburger C, 1997, T ROY SOC TROP MED H, V91, P256, DOI 10.1016/S0035-9203(97)90066-3; Luxemburger C, 1996, T ROY SOC TROP MED H, V90, P105, DOI 10.1016/S0035-9203(96)90102-9; Mannoor MK, 2002, J IMMUNOL, V169, P301, DOI 10.4049/jimmunol.169.1.301; Marwaha RK, 2011, CLIN ENDOCRINOL OXF, DOI [10.1111/j.1365-2265, DOI 10.1111/J.1365-2265]; METSELAAR D., 1959, Tropical and Geographical Medicine, V11, P157; Mohanty S, 2003, T ROY SOC TROP MED H, V97, P69, DOI 10.1016/S0035-9203(03)90027-7; Molineaux, 1980, GARKI PROJECT, P109; Moon Jung Ju, 2001, Korean Journal of Parasitology, V39, P293, DOI 10.3347/kjp.2001.39.4.293; Muturi EJ, 2008, PARASITOL RES, V102, P175, DOI 10.1007/s00436-007-0779-1; Nacher M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-259; Nirmalan PK, 2004, INVEST OPHTH VIS SCI, V45, P4273, DOI 10.1167/iovs.04-0285; Nyakeriga AM, 2004, J INFECT DIS, V190, P439, DOI 10.1086/422331; OKOJIE CEE, 1994, SOC SCI MED, V39, P1237, DOI 10.1016/0277-9536(94)90356-5; Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103; Pierce SK, 2009, J IMMUNOL, V182, P5171, DOI 10.4049/jimmunol.0804153; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Proos LA, 2009, INDIAN J MED RES, V130, P646; Qiu YT, 2006, MED VET ENTOMOL, V20, P280, DOI 10.1111/j.1365-2915.2006.00627.x; Raghavendra K, 2002, ICMR B, P10; Rajgor DD, 2003, T ROY SOC TROP MED H, V97, P438, DOI 10.1016/S0035-9203(03)90082-4; Schofield L, 2006, CURR MOL MED, V6, P205, DOI 10.2174/156652406776055221; Sharma SK, 2004, AM J TROP MED HYG, V71, P457, DOI 10.4269/ajtmh.2004.71.457; Sharma SK, 2006, T ROY SOC TROP MED H, V100, P917, DOI 10.1016/j.trstmh.2006.01.007; SHARP P T, 1980, Papua New Guinea Medical Journal, V23, P132; Smallegange RC, 2011, TRENDS PARASITOL, V27, P143, DOI 10.1016/j.pt.2010.12.009; Snow RW, 1998, BRIT MED BULL, V54, P293, DOI 10.1093/oxfordjournals.bmb.a011689; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Steketee RW, 1996, AM J TROP MED HYG, V55, P2, DOI 10.4269/ajtmh.1996.55.2; Sur D, 2006, T ROY SOC TROP MED H, V100, P725, DOI 10.1016/j.trstmh.2005.10.019; Troye-Blomberg M, 2008, MICROBES INFECT, V10, P948, DOI 10.1016/j.micinf.2008.07.014; WILSON D. Bagster, 1936, Transactions of the Royal Society of Tropical Medicine and Hygiene, V29, P583, DOI 10.1016/S0035-9203(36)90040-8; WUNDERLICH F, 1991, PARASITE IMMUNOL, V13, P357, DOI 10.1111/j.1365-3024.1991.tb00289.x; Zuk M, 1996, INT J PARASITOL, V26, P1009, DOI [10.1016/S0020-7519(96)00086-0, 10.1016/S0020-7519(96)80001-4]	63	39	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35592	10.1371/journal.pone.0035592	http://dx.doi.org/10.1371/journal.pone.0035592			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558172	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345200051
J	Seko, Y; Azuma, N; Kaneda, M; Nakatani, K; Miyagawa, Y; Noshiro, Y; Kurokawa, R; Okano, H; Umezawa, A				Seko, Yuko; Azuma, Noriyuki; Kaneda, Makoto; Nakatani, Kei; Miyagawa, Yoshitaka; Noshiro, Yuuki; Kurokawa, Reiko; Okano, Hideyuki; Umezawa, Akihiro			Derivation of Human Differential Photoreceptor-like Cells from the Iris by Defined Combinations of CRX, RX and NEUROD	PLOS ONE			English	Article							RETINAL STEM-CELLS; PIGMENT EPITHELIAL-CELLS; GANGLION-CELLS; PROGENITOR CELLS; VISUAL FUNCTION; HOMEOBOX GENE; EXPRESSION; MELANOPSIN; EYE; TRANSPLANTATION	Examples of direct differentiation by defined transcription factors have been provided for beta-cells, cardiomyocytes and neurons. In the human visual system, there are four kinds of photoreceptors in the retina. Neural retina and iris-pigmented epithelium (IPE) share a common developmental origin, leading us to test whether human iris cells could differentiate to retinal neurons. We here define the transcription factor combinations that can determine human photoreceptor cell fate. Expression of rhodopsin, blue opsin and green/red opsin in induced photoreceptor cells were dependent on combinations of transcription factors: A combination of CRX and NEUROD induced rhodopsin and blue opsin, but did not induce green opsin; a combination of CRX and RX induced blue opsin and green/red opsin, but did not induce rhodopsin. Phototransduction-related genes as well as opsin genes were up-regulated in those cells. Functional analysis; i.e. patch clamp recordings, clearly revealed that generated photoreceptor cells, induced by CRX, RX and NEUROD, responded to light. The response was an inward current instead of the typical outward current. These data suggest that photosensitive photoreceptor cells can be generated by combinations of transcription factors. The combination of CRX and RX generate immature photoreceptors: and additional NEUROD promotes maturation. These findings contribute substantially to a major advance toward eventual cell-based therapy for retinal degenerative diseases.	[Seko, Yuko; Kurokawa, Reiko; Umezawa, Akihiro] Natl Inst Child Hlth & Dev, Ctr Regenerat Med, Dept Reprod Biol, Okura, Setagaya, Japan; [Seko, Yuko; Miyagawa, Yoshitaka; Noshiro, Yuuki] Natl Rehabil Ctr Persons Disabil, Res Inst, Sensory Funct Sect, Tokorozawa, Saitama, Japan; [Azuma, Noriyuki] Natl Ctr Child Hlth & Dev, Dept Ophthalmol, Tokyo, Japan; [Kaneda, Makoto; Okano, Hideyuki] Keio Univ, Dept Physiol, Sch Med, Shinanomachi, Japan; [Nakatani, Kei] Univ Tsukuba, Inst Biol Sci, Ten Noudai, Japan	National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; Keio University; University of Tsukuba	Seko, Y (corresponding author), Natl Inst Child Hlth & Dev, Ctr Regenerat Med, Dept Reprod Biol, Okura, Setagaya, Japan.	umezawa@1985.jukuin.keio.ac.jp	Okano, Hideyuki/I-7584-2019	Miyagawa, Yoshitaka/0000-0003-2629-7503	MEXT; Grants-in-Aid for Scientific Research [24659770, 22390327] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-aid for the Global COE program from MEXT to Keio University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akagi T, 2005, INVEST OPHTH VIS SCI, V46, P3411, DOI 10.1167/iovs.04-1112; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Coles BLK, 2004, P NATL ACAD SCI USA, V101, P15772, DOI 10.1073/pnas.0401596101; Fischer AJ, 2001, NAT NEUROSCI, V4, P247, DOI 10.1038/85090; Foster RG, 1998, NEURON, V20, P829, DOI 10.1016/S0896-6273(00)80464-X; Froen RC, 2011, ACTA OPHTHALMOL, V89, pe635, DOI 10.1111/j.1755-3768.2011.02198.x; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; Hartwick ATE, 2007, J NEUROSCI, V27, P13468, DOI 10.1523/JNEUROSCI.3626-07.2007; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Inoue T, 2010, STEM CELLS, V28, P489, DOI 10.1002/stem.279; Kohyama J, 2001, DIFFERENTIATION, V68, P235, DOI 10.1046/j.1432-0436.2001.680411.x; Lamba DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008763; Lamba DA, 2009, CELL STEM CELL, V4, P73, DOI 10.1016/j.stem.2008.10.015; Liu H, 2008, J NEUROSCI, V28, P749, DOI 10.1523/JNEUROSCI.4832-07.2008; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; MacNeil A, 2007, STEM CELLS, V25, P2430, DOI 10.1634/stemcells.2007-0035; Manavathi B, 2007, P NATL ACAD SCI USA, V104, P13128, DOI 10.1073/pnas.0705878104; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Miyagawa Y, 2008, MOL CELL BIOL, V28, P2125, DOI 10.1128/MCB.00740-07; Morrow EM, 1999, DEVELOPMENT, V126, P23; Ochocinska MJ, 2009, MECH DEVELOP, V126, P128, DOI 10.1016/j.mod.2008.11.009; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Radke ND, 2004, ARCH OPHTHALMOL-CHIC, V122, P1159, DOI 10.1001/archopht.122.8.1159; Rehemtulla A, 1996, P NATL ACAD SCI USA, V93, P191, DOI 10.1073/pnas.93.1.191; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Sidman RL, 1961, STRUCTURE EYE, P487; Sun GW, 2006, DEV BIOL, V289, P243, DOI 10.1016/j.ydbio.2005.10.035; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Xue T, 2011, NATURE, V479, P67, DOI 10.1038/nature10567; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	38	31	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35611	10.1371/journal.pone.0035611	http://dx.doi.org/10.1371/journal.pone.0035611			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558175	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345200052
J	Choi, H; Wang, L; Lin, XH; Spengler, JD; Perera, FP				Choi, Hyunok; Wang, Lu; Lin, Xihong; Spengler, John D.; Perera, Frederica P.			Fetal Window of Vulnerability to Airborne Polycyclic Aromatic Hydrocarbons on Proportional Intrauterine Growth Restriction	PLOS ONE			English	Article							IN-UTERO EXPOSURE; BODY PROPORTIONALITY; PRENATAL EXPOSURE; DNA-ADDUCTS; BENZO(A)PYRENE; RETARDATION; PREGNANCY; RECEPTOR; MOTHERS; IMPACT	Background: Although the entire duration of fetal development is generally considered a highly susceptible period, it is of public health interest to determine a narrower window of heightened vulnerability to polycyclic aromatic hydrocarbons (PAHs) in humans. We posited that exposure to PAHs during the first trimester impairs fetal growth more severely than a similar level of exposure during the subsequent trimesters. Methods: In a group of healthy, non-smoking pregnant women with no known risks of adverse birth outcomes, personal exposure to eight airborne PAHs was monitored once during the second trimester for the entire cohort (n = 344), and once each trimester within a subset (n = 77). Both air monitoring and self-reported PAH exposure data were used in order to statistically estimate PAH exposure during the entire gestational period for each individual newborn. Results: One natural-log unit increase in prenatal exposure to the eight summed PAHs during the first trimester was associated with the largest decrement in the Fetal Growth Ratio (FGR) (-3%, 95% Confidence Interval (CI), -5 to -0%), birthweight (-105 g, 95% CI, -188 to -22 g), and birth length (-0.78 cm, 95% CI, -1.30 to -0.26 cm), compared to the unit effects of PAHs during the subsequent trimesters, after accounting for confounders. Furthermore, a unit exposure during the first trimester was associated with the largest elevation in Cephalization Index (head to weight ratio) (3 mu m/g, 95% CI, 1 to 5 mu m/g). PAH exposure was not associated with evidence of asymmetric growth restriction in this cohort. Conclusion: PAH exposure appears to exert the greatest adverse effect on fetal growth during the first trimester. The present data support the need for the protection of pregnant women and the embryo/fetus, particularly during the earliest stage of pregnancy.	[Choi, Hyunok; Spengler, John D.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Wang, Lu] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Lin, Xihong] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Perera, Frederica P.] Mailman Sch Publ Hlth, Columbia Ctr Childrens Environm Hlth, New York, NY USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Michigan System; University of Michigan; Harvard University; Harvard T.H. Chan School of Public Health	Choi, H (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.	hchoi@albany.edu			National Institute of Environmental Health Sciences (NIEHS) [5 P01 ES009600, R01ES014939, 5 R01 ES008977, 5 R01ES11158, 5 R01 ES012468, 5 R01ES10165]; US Environmental Protection Agency [R827027, 82860901, RD-832141]; US National Research Service Award [T32 ES 07069]; Irving General Clinical Research Center [RR00645]; Gladys & Roland Harriman Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007069, R01ES012468, R01ES008977, R01ES010165, R01ES011158, P01ES009600, R01ES015282] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); US Environmental Protection Agency(United States Environmental Protection Agency); US National Research Service Award; Irving General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Gladys & Roland Harriman Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by The National Institute of Environmental Health Sciences (NIEHS) (grant numbers 5 P01 ES009600, R01ES014939, 5 R01 ES008977, 5 R01ES11158, 5 R01 ES012468, 5 R01ES10165), the US Environmental Protection Agency (grant numbers R827027, 82860901, RD-832141), the US National Research Service Award (T32 ES 07069), Irving General Clinical Research Center (grant number RR00645), and The Gladys & Roland Harriman Foundation. None of the authors has any actual or potential competing financial interests. E. Evans, R. Whyatt, H. Andrews, L. Hoepner, W. Jedrychowski, R. Jacek, E. Mroz, A. Pac, E. Flak, W. Tsai, D. Tang, and J. Yu contributed to the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATSDR (Agency for Toxic Substances and Disease Registry), 1995, TOX PROF POL AR HYDR; Barker DJP, 2006, CLIN OBSTET GYNECOL, V49, P270, DOI 10.1097/00003081-200606000-00009; Bocskay KA, 2005, CANCER EPIDEM BIOMAR, V14, P506, DOI 10.1158/1055-9965.EPI-04-0566; Bostrom CE, 2002, ENVIRON HEALTH PERSP, V110, P451, DOI 10.1289/ehp.02110s3451; Brown LA, 2007, NEUROTOXICOLOGY, V28, P965, DOI 10.1016/j.neuro.2007.05.005; Castro DJ, 2008, TOXICOL APPL PHARM, V233, P454, DOI 10.1016/j.taap.2008.09.009; Chaddha Vandana, 2004, Semin Fetal Neonatal Med, V9, P357, DOI 10.1016/j.siny.2004.03.006; Choi H, 2008, ENVIRON HEALTH PERSP, V116, P1509, DOI 10.1289/ehp.10972; Choi H, 2008, ENVIRON HEALTH PERSP, V116, P658, DOI 10.1289/ehp.10958; Choi H, 2006, ENVIRON HEALTH PERSP, V114, P1744, DOI 10.1289/ehp.8982; Dejmek J, 2000, ENVIRON HEALTH PERSP, V108, P1159, DOI 10.2307/3434828; Detmar J, 2008, AM J PHYSIOL-ENDOC M, V295, pE519, DOI 10.1152/ajpendo.90436.2008; FinlaysonPitts BJ, 1997, SCIENCE, V276, P1045, DOI 10.1126/science.276.5315.1045; GUYDA HJ, 1990, MOL PHARMACOL, V37, P137; Hemachandra AH, 2006, AM J HUM BIOL, V18, P791, DOI 10.1002/ajhb.20552; IARC (International Agency of Research on Cancer), 1983, IARC MON EV CARC RIS, V32; Junninen H, 2009, ENVIRON SCI TECHNOL, V43, P7964, DOI 10.1021/es8032082; KRAMER MS, 1990, PEDIATRICS, V86, P707; KRAMER MS, 1989, PEDIATRICS, V84, P717; Leitner Y, 2007, J CHILD NEUROL, V22, P580, DOI 10.1177/0883073807302605; Lipsett J, 2006, PEDIATR PULM, V41, P1138, DOI 10.1002/ppul.20480; LU LJW, 1993, CARCINOGENESIS, V14, P1805, DOI 10.1093/carcin/14.9.1805; Malinowski A, 1998, LODZKI CHILD METHODS, P70; Martin-Gronert MS, 2007, J INTERN MED, V261, P437, DOI 10.1111/j.1365-2796.2007.01800.x; Milani S, 2005, PEDIATR RES, V57, P205, DOI 10.1203/01.PDR.0000148452.98518.D5; Nepomnyaschy L, 2006, AM J PUBLIC HEALTH, V96, P1604, DOI 10.2105/AJPH.2005.079400; Neufeld L, 1999, AM J HUM BIOL, V11, P638, DOI 10.1002/(SICI)1520-6300(199909/10)11:5<638::AID-AJHB7>3.0.CO;2-Q; Perera F, 2005, CANCER EPIDEM BIOMAR, V14, P709, DOI 10.1158/1055-9965.EPI-04-0457; Perera F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004488; Perera FP, 2009, PEDIATRICS, V124, pE195, DOI 10.1542/peds.2008-3506; R Core Team, 2018, R LANG ENV STAT COMP; Ramsay J.O., 1997, FUNCTIONAL DATA ANAL; Rodriguez JW, 2002, IMMUNOPHARM IMMUNOT, V24, P365, DOI 10.1081/IPH-120014723; SANYAL MK, 1993, AM J OBSTET GYNECOL, V168, P1587, DOI 10.1016/S0002-9378(11)90803-5; Sanyal MK, 2007, BIRTH DEFECTS RES B, V80, P367, DOI 10.1002/bdrb.20122; Sizonenko SV, 2006, MOL CELL ENDOCRINOL, V254, P163, DOI 10.1016/j.mce.2006.04.035; Smith GCS, 2004, SEMIN PERINATOL, V28, P41, DOI 10.1053/j.semperi.2003.10.012; Sram RJ, 1999, MUTAT RES-FUND MOL M, V428, P203, DOI 10.1016/S1383-5742(99)00048-4; van Wassenaer Aleid, 2005, Pediatr Endocrinol Rev, V2, P372; VILLAR J, 1990, AM J OBSTET GYNECOL, V163, P151, DOI 10.1016/S0002-9378(11)90690-5; Wang S, 2010, ANN HUM GENET, V74, P46, DOI 10.1111/j.1469-1809.2009.00550.x; WHO, 1998, ENV HLTH CRIT 202 SE; World Health Organization, 2000, AIR QUALITY GUIDELIN, V2nd; Xu Y, 2006, FASEB J, V20, P1251, DOI 10.1096/fj.05-4917fje; Yu Z, 2006, CANCER RES, V66, P755, DOI 10.1158/0008-5472.CAN-05-3390; Zhang LY, 1997, BIOCHEM BIOPH RES CO, V231, P117, DOI 10.1006/bbrc.1997.6053	46	49	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35464	10.1371/journal.pone.0035464	http://dx.doi.org/10.1371/journal.pone.0035464			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545107	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343200028
J	Eamens, AL; Kim, KW; Curtin, SJ; Waterhouse, PM				Eamens, Andrew L.; Kim, Ki Wook; Curtin, Shaun J.; Waterhouse, Peter M.			DRB2 Is Required for MicroRNA Biogenesis in Arabidopsis thaliana	PLOS ONE			English	Article							SHAPED-COTYLEDON GENES; DSRNA-BINDING PROTEINS; TRANS-ACTING SIRNAS; DICER-LIKE PROTEINS; ARTIFICIAL MICRORNAS; TRANSCRIPTION FACTOR; MERISTEM FORMATION; PLANT DEVELOPMENT; RNA BIOGENESIS; PRI-MIRNA	Background: The Arabidopsis thaliana (Arabidopsis) DOUBLE-STRANDED RNA BINDING (DRB) protein family consists of five members, DRB1 to DRB5. The biogenesis of two developmentally important small RNA (sRNA) species, the microRNAs (miRNAs) and trans-acting small interfering RNAs (tasiRNAs) by DICER-LIKE (DCL) endonucleases requires the assistance of DRB1 and DRB4 respectively. The importance of miRNA-directed target gene expression in plant development is exemplified by the phenotypic consequence of loss of DRB1 activity (drb1 plants). Principal Findings: Here we report that the developmental phenotype of the drb235 triple mutant plant is the result of deregulated miRNA biogenesis in the shoot apical meristem (SAM) region. The expression of DRB2, DRB3 and DRB5 in wild-type seedlings is restricted to the SAM region. Small RNA sequencing of the corresponding tissue of drb235 plants revealed altered miRNA accumulation. Approximately half of the miRNAs detected remained at levels equivalent to those of wild-type plants. However, the accumulation of the remaining miRNAs was either elevated or reduced in the triple mutant. Examination of different single and multiple drb mutants revealed a clear association between the loss of DRB2 activity and altered accumulation for both the elevated and reduced miRNA classes. Furthermore, we show that the constitutive overexpression of DRB2 outside of its wild-type expression domain can compensate for the loss of DRB1 activity in drb1 plants. Conclusions/Significance: Our results suggest that in the SAM region, DRB2 is both antagonistic and synergistic to the role of DRB1 in miRNA biogenesis, adding an additional layer of gene regulatory complexity in this developmentally important tissue.	[Eamens, Andrew L.; Kim, Ki Wook; Waterhouse, Peter M.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Curtin, Shaun J.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN USA; [Waterhouse, Peter M.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Waterhouse, Peter M.] CSIRO Plant Ind, Canberra, ACT, Australia	University of Sydney; University of Minnesota System; University of Minnesota Twin Cities; University of Sydney; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Eamens, AL (corresponding author), Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.	andrew.eamens@sydney.edu.au; peter.waterhouse@sydney.edu.au	Kim, Ki Wook/AAV-6899-2020	Kim, Ki Wook/0000-0001-9579-6408; Waterhouse, Peter/0000-0002-2812-3753; Curtin, Shaun/0000-0002-9528-3335; Eamens, Andrew/0000-0002-6327-3618	Australian Research Council Discovery Grant [DP0989050]	Australian Research Council Discovery Grant(Australian Research Council)	This work was funded by the Australian Research Council Discovery Grant (DP0989050). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adenot X, 2006, CURR BIOL, V16, P927, DOI 10.1016/j.cub.2006.03.035; Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Allen RS, 2007, P NATL ACAD SCI USA, V104, P16371, DOI 10.1073/pnas.0707653104; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Baker CC, 2005, CURR BIOL, V15, P303, DOI 10.1016/j.cub.2005.02.017; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Boisnard-Lorig C, 2001, PLANT CELL, V13, P495, DOI 10.1105/tpc.13.3.495; Boutet S, 2003, CURR BIOL, V13, P843, DOI 10.1016/S0960-9822(03)00293-8; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtin SJ, 2008, FEBS LETT, V582, P2753, DOI 10.1016/j.febslet.2008.07.004; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Dong Z, 2008, P NATL ACAD SCI USA, V105, P9970, DOI 10.1073/pnas.0803356105; Eamens AL, 2011, MOL PLANT, V4, P157, DOI 10.1093/mp/ssq061; Eamens AL, 2009, RNA, V15, P2219, DOI 10.1261/rna.1646909; Fang YD, 2007, CURR BIOL, V17, P818, DOI 10.1016/j.cub.2007.04.005; Fujioka Y, 2007, PLANT CELL PHYSIOL, V48, P1243, DOI 10.1093/pcp/pcm099; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Han MH, 2004, P NATL ACAD SCI USA, V101, P1093, DOI 10.1073/pnas.0307969100; Hasson A, 2011, PLANT CELL, V23, P54, DOI 10.1105/tpc.110.081448; Hiraguri A, 2005, PLANT MOL BIOL, V57, P173, DOI 10.1007/s11103-004-6853-5; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kurihara Y, 2006, RNA, V12, P206, DOI 10.1261/rna.2146906; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Larue CT, 2009, PLANT J, V58, P450, DOI 10.1111/j.1365-313X.2009.03796.x; Laufs P, 2004, DEVELOPMENT, V131, P4311, DOI 10.1242/dev.01320; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Lu C, 2000, PLANT CELL, V12, P2351, DOI 10.1105/tpc.12.12.2351; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Margis R, 2006, FEBS LETT, V580, P2442, DOI 10.1016/j.febslet.2006.03.072; Nakazawa Y, 2007, PLANT MOL BIOL, V63, P777, DOI 10.1007/s11103-006-9125-8; Nikovics K, 2006, PLANT CELL, V18, P2929, DOI 10.1105/tpc.106.045617; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Pelissier T, 2011, RNA, V17, P1502, DOI 10.1261/rna.2680711; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Raman S, 2008, PLANT J, V55, P65, DOI 10.1111/j.1365-313X.2008.03483.x; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Schwab R, 2010, METHODS MOL BIOL, V592, P71, DOI 10.1007/978-1-60327-005-2_6; Song L, 2007, P NATL ACAD SCI USA, V104, P5437, DOI 10.1073/pnas.0701061104; Takada S, 2001, DEVELOPMENT, V128, P1127; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Vaucheret H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006442; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1	49	53	56	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35933	10.1371/journal.pone.0035933	http://dx.doi.org/10.1371/journal.pone.0035933			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545148	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343200068
J	Liu, C; Qin, XQ; Liu, HJ; Xiang, Y				Liu, Chi; Qin, Xiaoqun; Liu, Huijun; Xiang, Yang			Downregulation of Integrin beta 4 Decreases the Ability of Airway Epithelial Cells to Present Antigens	PLOS ONE			English	Article							EXPRESSION; ASTHMA; LUNG; PATHOGENESIS; IMMUNITY; INNATE; B7-H1	Airway epithelial cells have been demonstrated to be accessory antigen presentation cells (APC) capable of activating T cells and may play an important role in the development of allergic airway inflammation of asthma. In asthmatic airways, loss of expression of the adhesion molecule integrin beta 4 (ITGB4) and an increase in Th2 inflammation bias has been observed in our previous study. Given that ITGB4 is engaged in multiple signaling pathways, we studied whether disruption of ITGB4-mediated cell adhesion may contribute to the adaptive immune response of epithelial cells, including their ability to present antigens, induce the activate and differentiate of T cells. We silenced ITGB4 expression in bronchial epithelial cells with an effective siRNA vector and studied the effects of ITGB4 silencing on the antigen presentation ability of airway epithelial cells. T cell proliferation and cytokine production was investigated after co-culturing with ITGB4-silenced epithelial cells. Surface expression of B7 homologs and the major histocompatibility complex (MHC) class II was also detected after ITGB4 was silenced. Our results demonstrated that silencing of ITGB4 resulted in impaired antigen presentation processes and suppressed T cell proliferation. Meanwhile, decrease in Th1 cytokine production and increase in Th17 cytokine production was induced after co-culturing with ITGB4-silenced epithelial cells. Moreover, HLA-DR was decreased and the B7 homologs expression was different after ITGB4 silencing. Overall, this study suggested that downregulation of ITGB4 expression in airway epithelial cells could impair the antigen presentation ability of these cells, which further regulate airway inflammation reaction in allergic asthma.	[Liu, Chi; Qin, Xiaoqun; Liu, Huijun; Xiang, Yang] Cent S Univ, Xiangya Med Sch, Dept Physiol, Changsha, Hunan, Peoples R China	Central South University	Liu, C (corresponding author), Cent S Univ, Xiangya Med Sch, Dept Physiol, Changsha, Hunan, Peoples R China.	liuchi7669@gmail.com			National Natural Science Foundation of China [81100016, 81170024]; National Basic Research Program of China [10K079]; key project from Hunan Science and Technology plans [2007FJ3009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); key project from Hunan Science and Technology plans	This work was supported by grants 81100016 and 81170024 from National Natural Science Foundation of China, grant 10K079 from National Basic Research Program of China and the key project (grant 2007FJ3009) from Hunan Science and Technology plans. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bugeon L, 2000, AM J RESP CRIT CARE, V162, pS164, DOI 10.1164/ajrccm.162.supplement_3.15tac5; CUNNINGHAM AC, 1994, J CELL SCI, V107, P443; Evans CM, 2009, PHARMACOL THERAPEUT, V121, P332, DOI 10.1016/j.pharmthera.2008.11.001; Flohe S, 2004, INTENS CARE MED, V30, P96, DOI 10.1007/s00134-003-2041-3; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Hackett TL, 2007, CURR OPIN ALLERGY CL, V7, P63, DOI 10.1097/ACI.0b013e328013d61b; Haczku A, 1999, AM J RESP CRIT CARE, V159, P1638, DOI 10.1164/ajrccm.159.5.9711040; Hammad H, 2008, NAT REV IMMUNOL, V8, P193, DOI 10.1038/nri2275; Heijink IH, 2007, J IMMUNOL, V178, P7678, DOI 10.4049/jimmunol.178.12.7678; Heinecke L, 2008, J ALLERGY CLIN IMMUN, V121, P1155, DOI 10.1016/j.jaci.2008.02.009; Holgate Stephen T, 2008, Allergol Int, V57, P1, DOI 10.2332/allergolint.R-07-154; Holgate ST, 2008, CLIN EXP ALLERGY, V38, P872, DOI 10.1111/j.1365-2222.2008.02971.x; Holgate ST, 2007, TRENDS IMMUNOL, V28, P248, DOI 10.1016/j.it.2007.04.007; Holgate Stephen T, 2009, Proc Am Thorac Soc, V6, P655, DOI 10.1513/pats.200907-072DP; Holgate ST, 2009, IMMUNITY, V31, P362, DOI 10.1016/j.immuni.2009.08.013; Holt PG, 2008, NAT REV IMMUNOL, V8, P142, DOI 10.1038/nri2236; Knight DA, 2003, RESPIROLOGY, V8, P432, DOI 10.1046/j.1440-1843.2003.00493.x; Koff JL, 2008, AM J PHYSIOL-LUNG C, V294, pL1068, DOI 10.1152/ajplung.00025.2008; Kurosawa S, 2003, AM J RESP CELL MOL, V28, P563, DOI 10.1165/rcmb.2002-0199OC; Liu C, 2010, ACTA BIOCH BIOPH SIN, V42, P538, DOI 10.1093/abbs/gmq058; Liu C, 2010, MOL CELL BIOCHEM, V341, P259, DOI 10.1007/s11010-010-0457-y; Liu JZ, 2007, BLOOD, V110, P296, DOI 10.1182/blood-2006-10-051482; Nakajima Hiroshi, 2010, Immune Netw, V10, P1, DOI 10.4110/in.2010.10.1.1; Nembrini C, 2009, J ALLERGY CLIN IMMUN, V123, P986, DOI 10.1016/j.jaci.2009.03.033; Oei E, 2004, AM J PHYSIOL-LUNG C, V287, pL318, DOI 10.1152/ajplung.00174.2003; Park HJ, 2009, INT IMMUNOPHARMACOL, V9, P261, DOI 10.1016/j.intimp.2008.10.021; Prasad DVR, 2004, J IMMUNOL, V173, P2500, DOI 10.4049/jimmunol.173.4.2500; Salik E, 1999, AM J RESP CELL MOL, V21, P365, DOI 10.1165/ajrcmb.21.3.3529; Siddiqui S, 2008, CURR ALLERGY ASTHM R, V8, P540, DOI 10.1007/s11882-008-0098-3; Song CW, 2008, J IMMUNOL, V181, P6117, DOI 10.4049/jimmunol.181.9.6117; Takizawa Hajime, 2005, Current Drug Targets - Inflammation and Allergy, V4, P305, DOI 10.2174/1568010054022123; Wan X, 2009, ONCOGENE, V28, P3401, DOI 10.1038/onc.2009.206; Wang YL, 2008, RESP MED, V102, P949, DOI 10.1016/j.rmed.2008.01.017; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC	34	31	35	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e32060	10.1371/journal.pone.0032060	http://dx.doi.org/10.1371/journal.pone.0032060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545078	Green Submitted, gold, Green Published			2022-12-27	WOS:000305343200001
J	Tang, L; Guo, T; Yang, R; Mei, H; Wang, HF; Lu, X; Yu, JM; Wang, QY; Hu, Y				Tang, Liang; Guo, Tao; Yang, Rui; Mei, Heng; Wang, Huafang; Lu, Xuan; Yu, Jianming; Wang, Qingyun; Hu, Yu			Genetic Background Analysis of Protein C Deficiency Demonstrates a Recurrent Mutation Associated with Venous Thrombosis in Chinese Population	PLOS ONE			English	Article							MISSENSE MUTATIONS; BLOOD-COAGULATION; MESSENGER-RNA; RISK-FACTOR; ANTITHROMBIN; SEQUENCE; DOMAIN; MODEL; THROMBOEMBOLISM; MECHANISM	Background: Protein C (PC) is one of the most important physiological inhibitors of coagulation proteases. Hereditary PC deficiency causes a predisposition to venous thrombosis (VT). The genetic characteristics of PC deficiency in the Chinese population remain unknown. Methods: Thirty-four unrelated probands diagnosed with hereditary PC deficiency were investigated. PC activity and antigen levels were measured. Mutation analysis was performed by sequencing the PROC gene. In silico analyses, including PolyPhen-2, SIFT, multiple sequence alignment, splicing prediction, and protein molecular modeling were performed to predict the consequences of each variant identified. One recurrent mutation and its relative risk for thrombosis in relatives were analyzed in 11 families. The recurrent mutation was subsequently detected in a case (VT patients)-control study, and the adjusted odds ratio (OR) for VT risk was calculated by logistic regression analysis. Results: A total of 18 different mutations, including 12 novel variants, were identified. One common mutation, PROC c.565C>T (rs146922325: C>T), was found in 17 of the 34 probands. The family study showed that first-degree relatives bearing this variant had an 8.8-fold (95% CI = 1.1-71.6) increased risk of venous thrombosis. The case-control (1003 vs. 1031) study identified this mutation in 5.88% patients and in 0.87% controls, respectively. The mutant allele conferred a high predisposition to venous thrombosis (adjusted OR = 7.34, 95% CI = 3.61-14.94). The plasma PC activity and antigen levels in heterozygotes were 51.73 +/- 6.92 U/dl and 75.17 +/- 4.84 U/dl, respectively. Conclusions: This is the first study on the genetic background of PC deficiency in the Chinese population. The PROC c.565C>T mutation is the most frequent cause of PC deficiency as well as a prevalent risk factor for VT in Chinese individuals. The inclusion of this variant in routine thrombophilic detection may improve the diagnosis and prevention of venous thrombosis.	[Tang, Liang; Guo, Tao; Yang, Rui; Mei, Heng; Wang, Huafang; Lu, Xuan; Yu, Jianming; Wang, Qingyun; Hu, Yu] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Inst Hematol, Wuhan, Hubei, Peoples R China; [Tang, Liang; Guo, Tao; Yang, Rui; Mei, Heng; Wang, Huafang; Lu, Xuan; Yu, Jianming; Wang, Qingyun; Hu, Yu] Hubei Clin & Res Ctr Thrombosis & Hemostasis, Wuhan, Hubei, Peoples R China; [Tang, Liang; Guo, Tao; Yang, Rui; Mei, Heng; Wang, Huafang; Lu, Xuan; Yu, Jianming; Wang, Qingyun; Hu, Yu] Minist Educ, Targeted Biotherapy Key Lab, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology	Tang, L (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Inst Hematol, Wuhan, Hubei, Peoples R China.	dr_huyu@126.com			National Basic Scientific Research Program of China (973 Program) [2007 CB935803]; National Natural Sciences Foundation of China [30825018]; State Ministry of Health Key Clinical Construction Project [58]	National Basic Scientific Research Program of China (973 Program)(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); State Ministry of Health Key Clinical Construction Project	This work was supported by the National Basic Scientific Research Program of China (973 Program, No. 2007 CB935803), the National Natural Sciences Foundation of China (No. 30825018), and the State Ministry of Health Key Clinical Construction Project (2010 No. 58). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; ALLAART CF, 1993, LANCET, V341, P134, DOI 10.1016/0140-6736(93)90003-Y; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; BECKMANN RJ, 1985, NUCLEIC ACIDS RES, V13, P5233, DOI 10.1093/nar/13.14.5233; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Bounameaux H, 2011, CIRCULATION, V123, P2189, DOI 10.1161/CIRCULATIONAHA.111.031690; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; Corral J, 2007, BLOOD, V109, P4258, DOI 10.1182/blood-2006-08-040774; Dahlback B, 2005, ARTERIOSCL THROM VAS, V25, P1311, DOI 10.1161/01.ATV.0000168421.13467.82; Dahlback B, 2003, J THROMB HAEMOST, V1, P1525, DOI 10.1046/j.1538-7836.2003.00299.x; Dahlback B, 2008, BLOOD, V112, P19, DOI 10.1182/blood-2008-01-077909; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Dogan RI, 2007, NUCLEIC ACIDS RES, V35, pW285, DOI 10.1093/nar/gkm407; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Esmon CT, 2003, CHEST, V124, p26S, DOI 10.1378/chest.124.3_suppl.26S; FISHER CL, 1994, PROTEIN SCI, V3, P588; FOSTER DC, 1985, P NATL ACAD SCI USA, V82, P4673, DOI 10.1073/pnas.82.14.4673; FOSTER DC, 1987, BIOCHEMISTRY-US, V26, P7003, DOI 10.1021/bi00396a022; GANDRILLE S, 1995, BLOOD, V86, P2598; GREENGARD JS, 1994, PROTEINS, V18, P367, DOI 10.1002/prot.340180407; GRUNDY CB, 1992, HUM GENET, V89, P685; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; KISIEL W, 1979, J CLIN INVEST, V64, P761, DOI 10.1172/JCI109521; KOSTER T, 1995, BLOOD, V85, P2756, DOI 10.1182/blood.V85.10.2756.bloodjournal85102756; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; MARLAR RA, 1982, BLOOD, V59, P1067; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; MILETICH J, 1987, NEW ENGL J MED, V317, P991, DOI 10.1056/NEJM198710153171604; Millar DS, 2000, HUM GENET, V106, P646, DOI 10.1007/s004390050038; Miyata T, 1996, THROMB HAEMOSTASIS, V76, P302; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Perera L, 2000, BIOPHYS J, V79, P2925, DOI 10.1016/S0006-3495(00)76530-1; PLUTZKY J, 1986, P NATL ACAD SCI USA, V83, P546, DOI 10.1073/pnas.83.3.546; POORT SR, 1993, BLOOD COAGUL FIBRIN, V4, P273, DOI 10.1097/00001721-199304000-00009; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; REITSMA PH, 1991, BLOOD, V78, P890, DOI 10.1182/blood.V78.4.890.bloodjournal784890; REITSMA PH, 1995, THROMB HAEMOSTASIS, V73, P876; Roberts LN, 2009, BRIT J HAEMATOL, V146, P369, DOI 10.1111/j.1365-2141.2009.07786.x; Sakata T, 2004, J THROMB HAEMOST, V2, P528, DOI 10.1111/j.1538-7836.2004.00603.x; Schmidt AE, 2002, J BIOL CHEM, V277, P28987, DOI 10.1074/jbc.M201892200; Singh G, 2003, TRENDS BIOCHEM SCI, V28, P464, DOI 10.1016/S0968-0004(03)00176-2; Suehisa E, 2001, BLOOD COAGUL FIBRIN, V12, P95, DOI 10.1097/00001721-200103000-00002; TAIT RC, 1995, THROMB HAEMOSTASIS, V73, P87; Taschner PEM, 2011, HUM MUTAT, V32, P507, DOI 10.1002/humu.21427; WACEY AI, 1993, BRIT J HAEMATOL, V84, P290, DOI 10.1111/j.1365-2141.1993.tb03067.x; Wang M, 2006, GENE, V366, P219, DOI 10.1016/j.gene.2005.07.015; Wildeman M, 2008, HUM MUTAT, V29, P6, DOI 10.1002/humu.20654; Yang YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026861; Zhu TA, 2011, HAEMATOL-HEMATOL J, V96, P1033, DOI 10.3324/haematol.2010.037515	49	32	42	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35773	10.1371/journal.pone.0035773	http://dx.doi.org/10.1371/journal.pone.0035773			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545135	Green Submitted, gold, Green Published			2022-12-27	WOS:000305343200055
J	Bleicken, S; Garcia-Saez, AJ; Conte, E; Bordignon, E				Bleicken, Stephanie; Garcia-Saez, Ana J.; Conte, Elena; Bordignon, Enrica			Dynamic Interaction of cBid with Detergents, Liposomes and Mitochondria	PLOS ONE			English	Article							CYTOCHROME-C RELEASE; N-TERMINAL FRAGMENT; MEMBRANE PERMEABILIZATION; APOPTOSIS INDUCTION; CONFORMATIONAL-CHANGES; BH3-ONLY PROTEINS; LIPID-MEMBRANES; BH3 DOMAINS; BAX; BCL-X(L)	The BH3-only protein Bid plays a key role in the induction of mitochondrial apoptosis, but its mechanism of action is still not completely understood. Here we studied the two main activation events of Bid: Caspase-8 cleavage and interaction with the membrane bilayer. We found a striking reversible behaviour of the dissociation-association events between the Bid fragments p15 and p7. Caspase-8 cleavage does not induce per se separation of the two Bid fragments, which remain in a stable complex resembling the full length Bid. Detergents trigger a complete dissociation, which can be fully reversed by detergent removal in a range of protein concentrations from 100 mu M down to 500 nM. Incubation of cBid with cardiolipin-containing liposomes leads to partial dissociation of the complex. Only p15 (tBid) fragments are found at the membrane, while p7 shows no tendency to interact with the bilayer, but complete removal of p7 strongly increases the propensity of tBid to become membrane-associated. Despite the striking structural similarities of inactive Bid and Bax, Bid does not form oligomers and reacts differently in the presence of detergents and membranes, highlighting clear differences in the modes of action of the two proteins. The partial dissociation of cBid triggered by the membrane is suggested to depend on the strong and specific interaction between p15 and p7. The reversible disassembly and re-assembly of the cBid molecules at the membrane was as well proven by EPR using spin labeled cBid in the presence of isolated mitochondria. The observed dynamic dissociation of the two Bid fragments could allow the assistance to the pore-forming Bax to occur repeatedly and may explain the proposed "hit-and-run'' mode of action of Bid at the bilayer.	[Bleicken, Stephanie] Max Planck Inst Biochem, Dept Membrane Biochem, D-82152 Martinsried, Germany; [Bleicken, Stephanie; Garcia-Saez, Ana J.] German Canc Res Ctr, D-6900 Heidelberg, Germany; [Bleicken, Stephanie; Garcia-Saez, Ana J.] Max Planck Inst Intelligent Syst, BIOQUANT, Dept Membrane Biophys, Heidelberg, Germany; [Conte, Elena] Univ Bari, Dipartimento Biochim & Biol Mol, CNR, Ctr Studio Mitocondri & Metab Energet, Bari, Italy; [Bordignon, Enrica] ETH, Phys Chem Lab, Zurich, Switzerland	Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ); Max Planck Society; Ruprecht Karls University Heidelberg; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomembrane e Bioenergetica (IBBE-CNR); Universita degli Studi di Bari Aldo Moro; Swiss Federal Institutes of Technology Domain; ETH Zurich	Bleicken, S (corresponding author), Max Planck Inst Biochem, Dept Membrane Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany.	enrica.bordignon@phys.chem.ethz.ch	Conte, Elena/AAF-4055-2019; Conte, Elena/AAV-3153-2020; Saez, Ana J. Garcia/U-1611-2019	Conte, Elena/0000-0001-8571-5125; Bordignon, Enrica/0000-0003-2450-5161; Bleicken, Stephanie/0000-0002-4789-0974				Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Azarkh M, 2011, J MAGN RESON, V212, P450, DOI 10.1016/j.jmr.2011.07.014; Billen LP, 2008, ONCOGENE, V27, pS93, DOI 10.1038/onc.2009.47; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Bleicken S, 2010, J BIOL CHEM, V285, P6636, DOI 10.1074/jbc.M109.081539; Bleicken S, 2009, J BIOENERG BIOMEMBR, V41, P29, DOI 10.1007/s10863-009-9202-1; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Breitschopf K, 2000, J BIOL CHEM, V275, P21648, DOI 10.1074/jbc.M001083200; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Dewson G, 2009, MOL CELL, V36, P696, DOI 10.1016/j.molcel.2009.11.008; DIMITROV DS, 1988, BIOELECTROCH BIOENER, V19, P323, DOI 10.1016/0302-4598(88)80013-8; Edlich F, 2011, CELL, V145, P104, DOI 10.1016/j.cell.2011.02.034; Franco R, 2009, CELL DEATH DIFFER, V16, P1303, DOI 10.1038/cdd.2009.107; Garcia-Saez AJ, 2004, BIOCHEMISTRY-US, V43, P10930, DOI 10.1021/bi036044c; Garcia-Saez AJ, 2009, NAT STRUCT MOL BIOL, V16, P1178, DOI 10.1038/nsmb.1671; Gong XM, 2004, J BIOL CHEM, V279, P28954, DOI 10.1074/jbc.M403490200; Grinberg M, 2002, J BIOL CHEM, V277, P12237, DOI 10.1074/jbc.M104893200; Hinds MG, 2007, CELL DEATH DIFFER, V14, P128, DOI 10.1038/sj.cdd.4401934; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Johnson  D., 1967, METHOD ENZYMOL, V10, P94, DOI DOI 10.1016/0076-6879(67)10018-9; Krstic I, 2011, ANGEW CHEM INT EDIT, V50, P5070, DOI 10.1002/anie.201100886; Kudla G, 2000, J BIOL CHEM, V275, P22713, DOI 10.1074/jbc.M003807200; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2003, CURR OPIN CELL BIOL, V15, P691, DOI 10.1016/j.ceb.2003.10.004; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; NAKAMURA GR, 1952, ANAL CHEM, V24, P1372, DOI 10.1021/ac60068a036; Oh KJ, 2005, J BIOL CHEM, V280, P753, DOI 10.1074/jbc.M405428200; Oh KJ, CONFORMATIONAL CHANG, P28924; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tait SWG, 2007, J CELL BIOL, V179, P1453, DOI 10.1083/jcb.200707063; Tan KO, 1999, J BIOL CHEM, V274, P23687, DOI 10.1074/jbc.274.34.23687; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zaltsman Y, 2010, NAT CELL BIOL, V12, P553, DOI 10.1038/ncb2057	50	24	24	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35910	10.1371/journal.pone.0035910	http://dx.doi.org/10.1371/journal.pone.0035910			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22540011	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341000077
J	Drozdov, I; Bornschein, J; Wex, T; Valeyev, NV; Tsoka, S; Malfertheiner, P				Drozdov, Ignat; Bornschein, Jan; Wex, Thomas; Valeyev, Najl V.; Tsoka, Sophia; Malfertheiner, Peter			Functional and Topological Properties in Hepatocellular Carcinoma Transcriptome	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; GENE-COEXPRESSION NETWORK; VASCULAR INVASION; PROSTATE-CANCER; CELL-CYCLE; EXPRESSION; OVEREXPRESSION; BREAST; RISK; TOOL	Hepatocellular carcinoma (HCC) is a leading cause of global cancer mortality. However, little is known about the precise molecular mechanisms involved in tumor formation and pathogenesis. The primary goal of this study was to elucidate genome-wide molecular networks involved in development of HCC with multiple etiologies by exploring high quality microarray data. We undertook a comparative network analysis across 264 human microarray profiles monitoring transcript changes in healthy liver, liver cirrhosis, and HCC with viral and alcoholic etiologies. Gene co-expression profiling was used to derive a consensus gene relevance network of HCC progression that consisted of 798 genes and 2,012 links. The HCC interactome was further confirmed to be phenotype-specific and non-random. Additionally, we confirmed that co-expressed genes are more likely to share biological function, but not sub-cellular localization. Analysis of individual HCC genes revealed that they are topologically central in a human protein-protein interaction network. We used quantitative RT-PCR in a cohort of normal liver tissue (n = 8), hepatitis C virus (HCV)-induced chronic liver disease (n = 9), and HCC (n=7) to validate co-expressions of several well-connected genes, namely ASPM, CDKN3, NEK2, RACGAP1, and TOP2A. We show that HCC is a heterogeneous disorder, underpinned by complex cross talk between immune response, cell cycle, and mRNA translation pathways. Our work provides a systems-wide resource for deeper understanding of molecular mechanisms in HCC progression and may be used further to define novel targets for efficient treatment or diagnosis of this disease.	[Drozdov, Ignat] Kings Coll London, British Heart Fdn Ctr Excellence, London WC2R 2LS, England; [Drozdov, Ignat; Tsoka, Sophia] Kings Coll London, Sch Nat & Math Sci, Ctr Bioinformat, Dept Informat, London WC2R 2LS, England; [Bornschein, Jan; Wex, Thomas; Malfertheiner, Peter] Univ Magdeburg, Dept Gastroenterol Hepatol & Infect Dis, D-39106 Magdeburg, Germany; [Valeyev, Najl V.] Univ Exeter, Coll Engn Math & Phys Sci, Ctr Syst Dynam & Control, Exeter, Devon, England	University of London; King's College London; University of London; King's College London; Otto von Guericke University; University of Exeter	Drozdov, I (corresponding author), Kings Coll London, British Heart Fdn Ctr Excellence, London WC2R 2LS, England.	ignat.drozdov@kcl.ac.uk; peter.malfertheiner@med.ovgu.de	Bornschein, Jan/U-9402-2018	Bornschein, Jan/0000-0001-8673-3122; Tsoka, Sophia/0000-0001-8403-1282; Drozdov, Ignat/0000-0001-6727-4688	BHF Centre of Excellence, Cardiovascular Division, Kinga s College London	BHF Centre of Excellence, Cardiovascular Division, Kinga s College London	I.D. holds a pre-doctoral Fellowship from the BHF Centre of Excellence, Cardiovascular Division, Kinga s College London. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hamid NM, 2009, J MEMBRANE BIOL, V230, P155, DOI 10.1007/s00232-009-9196-y; Aggarwal A, 2006, CANCER RES, V66, P232, DOI 10.1158/0008-5472.CAN-05-2232; Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Ancona N, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-387; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bae I, 2005, CELL CYCLE, V4, P1641, DOI 10.4161/cc.4.11.2152; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barrenas F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008090; Berg J, 2006, P NATL ACAD SCI USA, V103, P10967, DOI 10.1073/pnas.0602294103; Birney E, 2004, GENOME RES, V14, P925, DOI 10.1101/gr.1860604; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Braconi C, 2009, CANCER-AM CANCER SOC, V115, P3738, DOI 10.1002/cncr.24417; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; Carter SL, 2004, BIOINFORMATICS, V20, P2242, DOI 10.1093/bioinformatics/bth234; Chen RX, 2010, MOL BIOL REP; Cheung ST, 2002, CANCER RES, V62, P4711; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; de Souto MCP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-497; Drozdov Ignat, 2011, BMC Res Notes, V4, P462, DOI 10.1186/1756-0500-4-462; Drozdov I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-557; Durkin ME, 2007, ONCOGENE, V26, P4580, DOI 10.1038/sj.onc.1210244; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; El-Serag HB, 2006, CLIN GASTROENTEROL H, V4, P369, DOI 10.1016/j.cgh.2005.12.007; Elo LL, 2007, BIOINFORMATICS, V23, P2096, DOI 10.1093/bioinformatics/btm309; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fliri AF, 2009, J MED CHEM, V52, P8038, DOI 10.1021/jm901001p; Florez AF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-484; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Forsyth CB, 2010, ALCOHOL CLIN EXP RES, V34, P19, DOI 10.1111/j.1530-0277.2009.01061.x; Friedel CC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-297; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; He B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018516; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Hoshida Y, 2010, SEMIN LIVER DIS, V30, P35, DOI 10.1055/s-0030-1247131; Hu L, 2004, ONCOGENE, V23, P298, DOI 10.1038/sj.onc.1206483; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jones WM, 2010, J CELL SCI, V123, P2179, DOI 10.1242/jcs.067868; Koziol JA, 2009, BIOINFORMATICS, V25, P54, DOI 10.1093/bioinformatics/btn354; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lee SW, 2000, MOL CELL BIOL, V20, P1723, DOI 10.1128/MCB.20.5.1723-1732.2000; Lin SY, 2008, CLIN CANCER RES, V14, P4814, DOI 10.1158/1078-0432.CCR-07-5262; Mas VR, 2006, MOL MED, V12, P97, DOI 10.2119/2006-00032.Mas; Masaki T, 2000, HEPATOLOGY, V32, P711, DOI 10.1053/jhep.2000.17705; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Minguez B, 2011, J HEPATOL, V55, P1325, DOI 10.1016/j.jhep.2011.02.034; MOLLER H, 1994, EUR J CANCER, V30A, P344, DOI 10.1016/0959-8049(94)90254-2; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Ni IBP, 2010, PATHOL RES PRACT, V206, P223, DOI 10.1016/j.prp.2009.11.006; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Prieto C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003911; Rives AW, 2003, P NATL ACAD SCI USA, V100, P1128, DOI 10.1073/pnas.0237338100; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Schutte K, 2009, DIGEST DIS, V27, P80, DOI 10.1159/000218339; Seitz HK, 2006, BIOL CHEM, V387, P349, DOI 10.1515/BC.2006.047; Shi ZA, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-74; Shuda M, 2000, ANTICANCER RES, V20, P2489; Skawran B, 2008, MODERN PATHOL, V21, P1479, DOI 10.1038/modpathol.2008.147; Small M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.066112; Stone R, 2010, CANCER PREV RES, V3, P776, DOI 10.1158/1940-6207.CAPR-09-0189; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Su WH, 2007, NUCLEIC ACIDS RES, V35, pD727, DOI 10.1093/nar/gkl845; Sun JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S3-S5; Sun Y, 2010, CELL BIOCHEM BIOPHYS, V56, P59, DOI 10.1007/s12013-009-9071-6; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92; Wex T, 2003, CLIN CHEM LAB MED, V41, P1033, DOI 10.1515/CCLM.2003.159; Wong CM, 2005, CANCER RES, V65, P8861, DOI 10.1158/0008-5472.CAN-05-1318; Wong N, 2009, INT J CANCER, V124, P644, DOI 10.1002/ijc.23968; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; Xulvi-Brunet R, 2010, BIOINFORMATICS, V26, P205, DOI 10.1093/bioinformatics/btp632; Yu GC, 2010, BIOINFORMATICS, V26, P976, DOI 10.1093/bioinformatics/btq064; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Zhang YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022426; Zotenko E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000140	82	21	23	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35510	10.1371/journal.pone.0035510	http://dx.doi.org/10.1371/journal.pone.0035510			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539975	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341000041
J	Hancock, R				Hancock, Ronald			Structure of Metaphase Chromosomes: A Role for Effects of Macromolecular Crowding	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; MITOTIC CHROMOSOMES; FLEXIBLE POLYELECTROLYTES; INTERPHASE CHROMOSOMES; POLY(ETHYLENE GLYCOL); ELECTRON-MICROSCOPY; OSMOTIC-PRESSURE; PHYSICAL STATE; POOR SOLVENTS; LIVING CELLS	In metaphase chromosomes, chromatin is compacted to a concentration of several hundred mg/ml by mechanisms which remain elusive. Effects mediated by the ionic environment are considered most frequently because mono- and di-valent cations cause polynucleosome chains to form compact similar to 30-nm diameter fibres in vitro, but this conformation is not detected in chromosomes in situ. A further unconsidered factor is predicted to influence the compaction of chromosomes, namely the forces which arise from crowding by macromolecules in the surrounding cytoplasm whose measured concentration is 100-200 mg/ml. To mimic these conditions, chromosomes were released from mitotic CHO cells in solutions containing an inert volume-occupying macromolecule (8 kDa polyethylene glycol, 10.5 kDa dextran, or 70 kDa Ficoll) in 100 mu M K-Hepes buffer, with contaminating cations at only low micromolar concentrations. Optical and electron microscopy showed that these chromosomes conserved their characteristic structure and compaction, and their volume varied inversely with the concentration of a crowding macromolecule. They showed a canonical nucleosomal structure and contained the characteristic proteins topoisomerase II alpha and the condensin subunit SMC2. These observations, together with evidence that the cytoplasm is crowded in vivo, suggest that macromolecular crowding effects should be considered a significant and perhaps major factor in compacting chromosomes. This model may explain why similar to 30-nm fibres characteristic of cation-mediated compaction are not seen in chromosomes in situ. Considering that crowding by cytoplasmic macromolecules maintains the compaction of bacterial chromosomes and has been proposed to form the liquid crystalline chromosomes of dinoflagellates, a crowded environment may be an essential characteristic of all genomes.	Univ Laval, Canc Res Ctr, Hop Hotel Dieu, Quebec City, PQ, Canada	Laval University	Hancock, R (corresponding author), Univ Laval, Canc Res Ctr, Hop Hotel Dieu, Quebec City, PQ, Canada.	ronald.hancock@crhdq.ulaval.ca	Hancock, Ronald/F-8009-2016					ADOLPH KW, 1980, CHROMOSOMA, V76, P23, DOI 10.1007/BF00292223; ArrioDupont M, 1996, BIOPHYS J, V70, P2327, DOI 10.1016/S0006-3495(96)79798-9; ASAKURA S, 1954, J CHEM PHYS, V22, P1255, DOI 10.1063/1.1740347; BELMONT AS, 1989, CHROMOSOMA, V98, P129, DOI 10.1007/BF00291049; BENNETT MD, 1983, J CELL SCI, V63, P173; BLUMENTHAL AB, 1979, J CELL BIOL, V81, P255, DOI 10.1083/jcb.81.1.255; Bohn M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014428; Chang RW, 2006, MACROMOLECULES, V39, P821, DOI 10.1021/ma051095y; CHORAZY M, 1963, J CELL BIOL, V19, P59, DOI 10.1083/jcb.19.1.59; Chow MH, 2010, EUKARYOT CELL, V9, P1577, DOI 10.1128/EC.00026-10; Christensen MO, 2002, J CELL BIOL, V157, P31, DOI 10.1083/jcb.200112023; Cole A., 1967, THEORETICAL BIOPHYSI, V1, P305; Compton JL, 1976, EUR J BIOCHEM, V7, P555; Cooke IR, 2004, MACROMOLECULES, V37, P5778, DOI 10.1021/ma0355406; CUNEO P, 1992, BIOCHEM J, V281, P507, DOI 10.1042/bj2810507; Cunha S, 2001, J STRUCT BIOL, V136, P53, DOI 10.1006/jsbi.2001.4420; Daban JR, 2000, BIOCHEMISTRY-US, V39, P3861, DOI 10.1021/bi992628w; Danilowicz C, 2009, P NATL ACAD SCI USA, V106, P19824, DOI 10.1073/pnas.0911214106; DEAVEN LL, 1973, CHROMOSOMA, V41, P129, DOI 10.1007/BF00319690; del Alamo M, 2005, J VIROL, V79, P14271, DOI 10.1128/JVI.79.22.14271-14281.2005; EARNSHAW WC, 1983, J CELL BIOL, V96, P84, DOI 10.1083/jcb.96.1.84; EDELMANN L, 1989, SCANNING MICROSCOPY, V3, P1219; Eltsov M, 2008, P NATL ACAD SCI USA, V105, P19732, DOI 10.1073/pnas.0810057105; Feng B, 2010, CHEM COMMUN, V46, P8231, DOI 10.1039/c0cc03117h; FINCH JT, 1976, P NATL ACAD SCI USA, V73, P1897, DOI 10.1073/pnas.73.6.1897; Galan A, 2001, J BIOL CHEM, V276, P957, DOI 10.1074/jbc.M006861200; GOODERHAM K, 1983, EXP CELL RES, V144, P1, DOI 10.1016/0014-4827(83)90435-4; Gunther T, 2006, MAGNESIUM RES, V19, P225; Hancock R, 2004, J STRUCT BIOL, V146, P281, DOI 10.1016/j.jsb.2003.12.008; Hancock R, 2011, GENOME ORG FUNCTION, P169; Hancock R, 2007, SEMIN CELL DEV BIOL, V18, P668, DOI 10.1016/j.semcdb.2007.08.006; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; HERZOG W, 1978, EUR J BIOCHEM, V91, P249, DOI 10.1111/j.1432-1033.1978.tb20959.x; HOROWITZ SB, 1979, BIOPHYS J, V25, P45, DOI 10.1016/S0006-3495(79)85277-7; HOWELL WM, 1979, CHROMOSOMA, V73, P61, DOI 10.1007/BF00294845; HUNGERFORD DA, 1958, J BIOPHYS BIOCHEM CY, V4, P391, DOI 10.1083/jcb.4.4.391; Jun S, 2010, BACTERIAL CHROMATIN, P97, DOI 10.1007/978-90-481-3473-1_6; KELLENBERGER E, 1992, FEMS MICROBIOL LETT, V100, P361, DOI 10.1016/0378-1097(92)90233-E; KELLERMAYER M, 1986, P NATL ACAD SCI USA, V83, P1011, DOI 10.1073/pnas.83.4.1011; Kim JS, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.168102; Kireeva N, 2004, J CELL BIOL, V166, P775, DOI 10.1083/jcb.200406049; LAVERY PE, 1992, J BIOL CHEM, V267, P9307; LEWIS CD, 1982, CELL, V29, P171, DOI 10.1016/0092-8674(82)90101-5; LING GN, 1990, SCANNING MICROSCOPY, V4, P737; Livolant F, 2006, PHILOS T R SOC A, V364, P2615, DOI 10.1098/rsta.2006.1843; Loh P, 2008, MACROMOLECULES, V41, P9352, DOI 10.1021/ma8014239; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Maeshima K, 2005, CHROMOSOMA, V114, P365, DOI 10.1007/s00412-005-0023-7; Marenduzzo D, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/09/L09002; Maughan DW, 2001, BIOPHYS J, V80, P435, DOI 10.1016/S0006-3495(01)76026-2; Micka U, 1999, LANGMUIR, V15, P4033, DOI 10.1021/la981191a; Mora-Bermudez F, 2007, NAT CELL BIOL, V9, P822, DOI 10.1038/ncb1606; Negendank M, 2005, J CELL PHYSL, V104, P443; Parsegian VA, 1995, METHOD ENZYMOL, V259, P43; Pastre D, 2007, BIOMACROMOLECULES, V8, P3712, DOI 10.1021/bm700856u; PAUL JS, 1970, EXP CELL RES, V59, P227, DOI 10.1016/0014-4827(70)90595-1; PAULSON JR, 1983, J CELL BIOL, V96, P1132, DOI 10.1083/jcb.96.4.1132; Pielak GJ, 2005, P NATL ACAD SCI USA, V102, P5901, DOI 10.1073/pnas.0501812102; Pliss A, 2010, BIOPHYS J, V99, P3483, DOI 10.1016/j.bpj.2010.06.069; Poirier MG, 2002, J CELL BIOCHEM, V85, P422, DOI 10.1002/jcb.10132; Rattner JB, 1996, J CELL BIOL, V134, P1097, DOI 10.1083/jcb.134.5.1097; SAITOH N, 1995, BIOESSAYS, V17, P759, DOI 10.1002/bies.950170905; SIKORAV JL, 1994, BIOPHYS J, V66, P827, DOI 10.1016/S0006-3495(94)80859-8; Spitzer JJ, 2005, TRENDS BIOCHEM SCI, V30, P536, DOI 10.1016/j.tibs.2005.08.002; St-Jean P, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.061923; Stanley CB, 2003, MACROMOLECULES, V36, P6888, DOI 10.1021/ma034079e; Strukov YG, 2003, J CELL BIOL, V162, P23, DOI 10.1083/jcb.200303098; Vasilevskaya VV, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2191049; Vergani L, 1998, MOL BIOL REP, V25, P237, DOI 10.1023/A:1006937212430; Weiss M, 2004, BIOPHYS J, V87, P3518, DOI 10.1529/biophysj.104.044263; WIDOM J, 1986, J MOL BIOL, V190, P411, DOI 10.1016/0022-2836(86)90012-4; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029225; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; ZIMMERMAN SB, 1988, NUCLEIC ACIDS RES, V16, P6309, DOI 10.1093/nar/16.14.6309; ZIMMERMAN SB, 1993, BIOCHIM BIOPHYS ACTA, V1216, P175, DOI 10.1016/0167-4781(93)90142-Z	75	25	25	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e36045	10.1371/journal.pone.0036045	http://dx.doi.org/10.1371/journal.pone.0036045			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22540018	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341000084
J	Ben-Dov, N; Korenstein, R				Ben-Dov, Nadav; Korenstein, Rafi			Enhancement of Cell Membrane Invaginations, Vesiculation and Uptake of Macromolecules by Protonation of the Cell Surface	PLOS ONE			English	Article							LATERAL INTERCELLULAR SPACES; FLUID-PHASE PINOCYTOSIS; INTERFACIAL-TENSION; MOLECULAR-MECHANISM; HISTIDINE-RESIDUES; ELASTIC PROPERTIES; RAT HEPATOCYTES; LIPID RAFTS; PH; ENDOCYTOSIS	The different pathways of endocytosis share an initial step involving local inward curvature of the cell's lipid bilayer. It has been shown that to generate membrane curvature, proteins or lipids enforce transversal asymmetry of the plasma membrane. Thus it emerges as a general phenomenon that transversal membrane asymmetry is the common required element for the formation of membrane curvature. The present study demonstrates that elevating proton concentration at the cell surface stimulates the formation of membrane invaginations and vesiculation accompanied by efficient uptake of macromolecules (Dextran-FITC, 70 kD), relative to the constitutive one. The insensitivity of proton induced uptake to inhibiting treatments and agents of the known endocytic pathways suggests the entry of macromolecules to proceeds via a yet undefined route. This is in line with the fact that neither ATP depletion, nor the lowering of temperature, abolishes the uptake process. In addition, fusion mechanism such as associated with low pH uptake of toxins and viral proteins can be disregarded by employing the polysaccharide dextran as the uptake molecule. The proton induced uptake increases linearly in the extracellular pH range of 6.5 to 4.5, and possesses a steep increase at the range of 4> pH > 3, reaching a plateau at pH <= 3. The kinetics of the uptake implies that the induced vesicles release their content to the cytosol and undergo rapid recycling to the plasma membrane. We suggest that protonation of the cell's surface induces local charge asymmetries across the cell membrane bilayer, inducing inward curvature of the cell membrane and consequent vesiculation and uptake.	[Ben-Dov, Nadav; Korenstein, Rafi] Tel Aviv Univ, Dept Physiol & Pharmacol, Fac Med, IL-69978 Tel Aviv, Israel	Tel Aviv University	Ben-Dov, N (corresponding author), Tel Aviv Univ, Dept Physiol & Pharmacol, Fac Med, IL-69978 Tel Aviv, Israel.	korens@post.tau.ac.il			Israel Science Foundation [1029/03]	Israel Science Foundation(Israel Science Foundation)	The study was supported by the Israel Science Foundation founded by the Israel Academy of Sciences and Humanities (grant 1029/03 to RK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain JM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.158104; Amyere M, 2002, INT J MED MICROBIOL, V291, P487; Anderle P, 1998, J PHARM SCI, V87, P757, DOI 10.1021/js970372e; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Baumgart T, 2011, ANNU REV PHYS CHEM, V62, P483, DOI 10.1146/annurev.physchem.012809.103450; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; CARO I, 1995, INT J PHARMACEUT, V116, P147, DOI 10.1016/0378-5173(94)00280-I; CHATTON JY, 1994, J MEMBRANE BIOL, V140, P89; CHERNOMORDIK L, 1995, J MEMBRANE BIOL, V146, P1; CLAGUE MJ, 1995, FEBS LETT, V367, P272, DOI 10.1016/0014-5793(95)00576-U; Dai JW, 1997, J GEN PHYSIOL, V110, P1, DOI 10.1085/jgp.110.1.1; de Figueiredo RCBQ, 2000, PARASITOL RES, V86, P413, DOI 10.1007/s004360050686; DeCoursey TE, 2008, J PHYSIOL-LONDON, V586, P5305, DOI 10.1113/jphysiol.2008.161703; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Galatola P, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.041930; Gandhavadi M, 2002, BIOPHYS J, V82, P1469, DOI 10.1016/S0006-3495(02)75501-X; Garlid KD, 2003, BBA-BIOENERGETICS, V1606, P23, DOI 10.1016/S0005-2728(03)00108-7; Graham TR, 2010, CURR OPIN CELL BIOL, V22, P430, DOI 10.1016/j.ceb.2010.05.002; Hanzal-Bayer MF, 2007, FEBS LETT, V581, P2098, DOI 10.1016/j.febslet.2007.03.019; HARRIS PJ, 1994, AM J PHYSIOL, V266, pC73, DOI 10.1152/ajpcell.1994.266.1.C73; HAUSER H, 1989, P NATL ACAD SCI USA, V86, P5351, DOI 10.1073/pnas.86.14.5351; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; HOLEN I, 1995, BIOCHEM J, V311, P317, DOI 10.1042/bj3110317; Huotari V, 1996, J CELL PHYSIOL, V167, P121, DOI 10.1002/(SICI)1097-4652(199604)167:1<121::AID-JCP14>3.0.CO;2-E; IACOPETTA BJ, 1983, J BIOL CHEM, V258, P9108; Janmey PA, 2006, TRENDS CELL BIOL, V16, P538, DOI 10.1016/j.tcb.2006.08.009; JONES AT, 1995, BIOCHEM J, V311, P31, DOI 10.1042/bj3110031; JULICHER F, 1993, PHYS REV LETT, V70, P2964, DOI 10.1103/PhysRevLett.70.2964; Kaasik A, 2007, AM J PHYSIOL-CELL PH, V292, pC157, DOI 10.1152/ajpcell.00272.2006; Kampmann T, 2006, STRUCTURE, V14, P1481, DOI 10.1016/j.str.2006.07.011; Khalifat N, 2008, BIOPHYS J, V95, P4924, DOI 10.1529/biophysj.108.136077; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Kozlov MM, 2010, TRENDS BIOCHEM SCI, V35, P699, DOI 10.1016/j.tibs.2010.06.003; KOZLOV MM, 1992, J PHYS II, V2, P175, DOI 10.1051/jp2:1992122; Kuzmin PI, 2005, BIOPHYS J, V88, P1120, DOI 10.1529/biophysj.104.048223; LERCHE D, 1987, BIORHEOLOGY, V24, P23; LESUFFLEUR T, 1990, CANCER RES, V50, P6334; Li L, 2010, NATURE, V468, P705, DOI 10.1038/nature09546; Li Y, 2005, EUROPHYS LETT, V70, P411, DOI 10.1209/epl/i2004-10498-4; Lim HWG, 2002, P NATL ACAD SCI USA, V99, P16766, DOI 10.1073/pnas.202617299; Lindberg M, 2001, BIOCHEMISTRY-US, V40, P3141, DOI 10.1021/bi0008985; Lipowsky R, 2002, J BIOL PHYS, V28, P195, DOI 10.1023/A:1019994628793; Liu J, 2006, P NATL ACAD SCI USA, V103, P10277, DOI 10.1073/pnas.0601045103; Lundmark R, 2010, SEMIN CELL DEV BIOL, V21, P363, DOI 10.1016/j.semcdb.2009.11.014; Martin WC, 2010, GROUND LEVEL IONIZAT; MASOLIVA J, 1980, BRIT J PHARMACOL, V70, P617, DOI 10.1111/j.1476-5381.1980.tb09780.x; Matsuyama S, 2000, CELL DEATH DIFFER, V7, P1155, DOI 10.1038/sj.cdd.4400779; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mosiman VL, 1997, CYTOMETRY, V30, P151; Motizuki M, 2004, J BIOCHEM, V135, P713, DOI 10.1093/jb/mvh087; MUIR EM, 1983, BIOCHEM J, V216, P467, DOI 10.1042/bj2160467; Odell LR, 2009, CHEMMEDCHEM, V4, P1182, DOI 10.1002/cmdc.200900054; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; Orlowski S, 1996, BIOCHEM J, V317, P515, DOI 10.1042/bj3170515; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Petelska AD, 2006, BIOPHYS CHEM, V120, P199, DOI 10.1016/j.bpc.2005.10.008; Petelska AD, 2002, BBA-BIOMEMBRANES, V1561, P135, DOI 10.1016/S0005-2736(01)00463-1; Petrache HI, 2006, P NATL ACAD SCI USA, V103, P7982, DOI 10.1073/pnas.0509967103; PRATTEN MK, 1979, BIOCHEM J, V180, P567, DOI 10.1042/bj1800567; Prego C, 2005, J CONTROL RELEASE, V101, P151, DOI 10.1016/j.jconrel.2004.07.030; Qin ZL, 2009, J VIROL, V83, P4670, DOI 10.1128/JVI.02646-08; RINK TJ, 1982, J CELL BIOL, V95, P189, DOI 10.1083/jcb.95.1.189; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Safran S. A., 1994, STAT THERMODYNAMICS; Sandvig K, 2005, GENE THER, V12, P865, DOI 10.1038/sj.gt.3302525; SANDVIG K, 1987, J CELL BIOL, V105, P679, DOI 10.1083/jcb.105.2.679; Sandvig K, 2008, HISTOCHEM CELL BIOL, V129, P267, DOI 10.1007/s00418-007-0376-5; SCHNITZER JE, 1988, YALE J BIOL MED, V61, P427; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457; Stan RV, 2005, BBA-MOL CELL RES, V1746, P334, DOI 10.1016/j.bbamcr.2005.08.008; Thaokar RM, 2010, PHYS FLUIDS, V22; Thoennes S, 2008, VIROLOGY, V370, P403, DOI 10.1016/j.virol.2007.08.035; WAGNER RC, 1976, J ULTRA MOL STRUCT R, V57, P132, DOI 10.1016/S0022-5320(76)80103-7; WEIGEL PH, 1981, J BIOL CHEM, V256, P2615; WHITE J, 1980, P NATL ACAD SCI-BIOL, V77, P3273, DOI 10.1073/pnas.77.6.3273; WINTERHALTER M, 1988, J PHYS CHEM-US, V92, P6865, DOI 10.1021/j100335a004; Yuan CB, 2002, BIOPHYS J, V82, P2526, DOI 10.1016/S0006-3495(02)75596-3; Zemel A, 2003, BIOPHYS J, V84, P2242, DOI 10.1016/S0006-3495(03)75030-9; Zhou Y, 2007, BIOPHYS J, V92, P2451, DOI 10.1529/biophysj.106.096362; Zorko M, 2005, ADV DRUG DELIVER REV, V57, P529, DOI 10.1016/j.addr.2004.10.010	81	22	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35204	10.1371/journal.pone.0035204	http://dx.doi.org/10.1371/journal.pone.0035204			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558127	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340200010
J	Paschali, AA; Mitsopoulou, E; Tsaggarakis, V; Karademas, EC				Paschali, Antonia A.; Mitsopoulou, Efi; Tsaggarakis, Valentinos; Karademas, Evangelos C.			Changes in Health Perceptions after Exposure to Human Suffering: Using Discrete Emotions to Understand Underlying Processes	PLOS ONE			English	Article							PSYCHOLOGY; TRAUMA; WORRY; RISK	Background: The aim of this study was to examine whether exposure to human suffering is associated with negative changes in perceptions about personal health. We further examined the relation of possible health perception changes, to changes in five discrete emotions (i.e., fear, guilt, hostility/anger, and joviality), as a guide to understand the processes underlying health perception changes, provided that each emotion conveys information regarding triggering conditions. Methodology/Findings: An experimental group (N = 47) was exposed to images of human affliction, whereas a control group (N = 47) was exposed to relaxing images. Participants in the experimental group reported more health anxiety and health value, as well as lower health-related optimism and internal health locus of control, in comparison to participants exposed to relaxing images. They also reported more fear, guilt, hostility and sadness, as well as less joviality. Changes in each health perception were related to changes in particular emotions. Conclusion: These findings imply that health perceptions are shaped in a constant dialogue with the representations about the broader world. Furthermore, it seems that the core of health perception changes lies in the acceptance that personal well-being is subject to several potential threats, as well as that people cannot fully control many of the factors the determine their own well-being.	[Paschali, Antonia A.] Univ Athens, Dept Nursing, Athens, Greece; [Mitsopoulou, Efi; Tsaggarakis, Valentinos; Karademas, Evangelos C.] Univ Crete, Dept Psychol, Rethimnon, Greece	National & Kapodistrian University of Athens; University of Crete	Paschali, AA (corresponding author), Univ Athens, Dept Nursing, Athens, Greece.	anpascha@nurs.uoa.gr	Karademas, Evangelos C./V-1601-2019					Aguiar P, 2008, SOC JUSTICE RES, V21, P50, DOI 10.1007/s11211-007-0059-3; Averill J. R., 2000, HDB EMOTIONS, P663; Bandura A., 1986, SOCIAL FDN THOUGHT A; Benyamini Y, 2003, PSYCHO-ONCOLOGY, V12, P161, DOI 10.1002/pon.637; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Chapman GB, 2006, HEALTH PSYCHOL, V25, P82, DOI 10.1037/0278-6133.25.1.82; Chipperfield JG, 2003, J GERONTOL B-PSYCHOL, V58, pP23, DOI 10.1093/geronb/58.1.P23; Cohen S, 1996, ANNU REV PSYCHOL, V47, P113, DOI 10.1146/annurev.psych.47.1.113; Consedine N.S., 2008, HDB EMOTIONS, V3rd ed., P676; Consedine NS, 2007, APPL PREV PSYCHOL, V12, P59, DOI 10.1016/j.appsy.2007.09.001; Consedine NS, 2002, REV GEN PSYCHOL, V6, P204, DOI 10.1037//1089-2680.6.2.204; Crocker J., 1998, HDB SOCIAL PSYCHOL, V4th ed, P504, DOI DOI 10.1002/9780470561119; Dalbert C., 2001, JUSTICE MOTIVE PERSO; de Ridder D.T., 2006, SELF REGULATION HLTH; Ekman P., 2005, HDB COGNITION EMOTIO, P45, DOI 10.1002/0470013494.ch3; Fiske ST., 2004, SOCIAL BEINGS CORE M; Greco V, 2003, PERS INDIV DIFFER, V34, P1057, DOI 10.1016/S0191-8869(02)00091-0; Izard C. E., 1977, HUMAN EMOTIONS; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Karademas EC, 2009, HEALTH, V13, P491, DOI 10.1177/1363459308336793; Kleinman A, 1999, FINISH ANTHR, V14, P23; Kleinman A., 1988, ILLNESS NARRATIVES; LAU RR, 1986, HEALTH PSYCHOL, V5, P25, DOI 10.1037/0278-6133.5.1.25; Lazarus R.S., 1991, EMOTION ADAPTATION; LEVENTHAL H, 1992, COGNITIVE THER RES, V16, P143, DOI 10.1007/BF01173486; MARKS IM, 1994, ETHOL SOCIOBIOL, V15, P247, DOI 10.1016/0162-3095(94)90002-7; Mayne TJ, 2001, EMO SOC BEH, P361; Miller RB, 2005, J PSYCHOTHER INTEGR, V15, P299, DOI 10.1037/1053-0479.15.3.299; Nerenz, 1980, CONTRIBUTIONS MED PS, V2, P7, DOI DOI 10.1093/GERONJ/46.4.P181; Ogden J, 2003, HEALTH PSYCHOL, V22, P424, DOI 10.1037/0278-6133.22.4.424; Regehr C, 2002, AM J ORTHOPSYCHIAT, V72, P505, DOI 10.1037/0002-9432.72.4.505; Rogers R.W., 1983, SOCIAL PSYCHOPHYSIOL; Smith TW, 2004, HA CL HE PS, V3, P143; Snell WE, 1997, AM J HEALTH BEHAV, V21, P33; Stein N.L., 2008, HDB EMOTIONS, P574; van Kleef GA, 2008, PSYCHOL SCI, V19, P1315, DOI 10.1111/j.1467-9280.2008.02241.x; WALLSTON KA, 1978, HEALTH EDUC QUART, V6, P160, DOI 10.1177/109019817800600107; Watson D, 1994, PANAS 10 MANUAL POSI; Wilkinson I, 2006, HEALTH RISK SOC, V8, P1, DOI 10.1080/13698570500532256	39	1	1	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35854	10.1371/journal.pone.0035854	http://dx.doi.org/10.1371/journal.pone.0035854			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UL	22558242	gold, Green Published, Green Submitted			2022-12-27	WOS:000305340200026
J	Sequeira, A; Morgan, L; Walsh, DM; Cartagena, PM; Choudary, P; Li, J; Schatzberg, AF; Watson, SJ; Akil, H; Myers, RM; Jones, EG; Bunney, WE; Vawter, MP				Sequeira, Adolfo; Morgan, Ling; Walsh, David M.; Cartagena, Preston M.; Choudary, Prabhakara; Li, Jun; Schatzberg, Alan F.; Watson, Stanley J.; Akil, Huda; Myers, Richard M.; Jones, Edward G.; Bunney, William E.; Vawter, Marquis P.			Gene Expression Changes in the Prefrontal Cortex, Anterior Cingulate Cortex and Nucleus Accumbens of Mood Disorders Subjects That Committed Suicide	PLOS ONE			English	Article							METALLOTHIONEIN MESSENGER-RNA; BIPOLAR AFFECTIVE-DISORDER; ADENYLYL-CYCLASE ACTIVITY; PITUITARY-ADRENAL AXIS; POSTMORTEM HUMAN-BRAIN; SEROTONIN 2A RECEPTOR; MAJOR DEPRESSION; FRONTAL-CORTEX; URINARY 17-HYDROXYCORTICOSTEROIDS; WOLFRAM-SYNDROME	Suicidal behaviors are frequent in mood disorders patients but only a subset of them ever complete suicide. Understanding predisposing factors for suicidal behaviors in high risk populations is of major importance for the prevention and treatment of suicidal behaviors. The objective of this project was to investigate gene expression changes associated with suicide in brains of mood disorder patients by microarrays (Affymetrix HG-U133 Plus2.0) in the dorsolateral prefrontal cortex (DLPFC: 6 Non-suicides, 15 suicides), the anterior cingulate cortex (ACC: 6NS, 9S) and the nucleus accumbens (NAcc: 8NS, 13S). ANCOVA was used to control for age, gender, pH and RNA degradation, with P <= 0.01 and fold change +/- 1.25 as criteria for significance. Pathway analysis revealed serotonergic signaling alterations in the DLPFC and glucocorticoid signaling alterations in the ACC and NAcc. The gene with the lowest p-value in the DLPFC was the 5-HT2A gene, previously associated both with suicide and mood disorders. In the ACC 6 metallothionein genes were down-regulated in suicide (MT1E, MT1F, MT1G, MT1H, MT1X, MT2A) and three were down-regulated in the NAcc (MT1F, MT1G, MT1H). Differential expression of selected genes was confirmed by qPCR, we confirmed the 5-HT2A alterations and the global down-regulation of members of the metallothionein subfamilies MT 1 and 2 in suicide completers. MTs 1 and 2 are neuro-protective following stress and glucocorticoid stimulations, suggesting that in suicide victims neuroprotective response to stress and cortisol may be diminished. Our results thus suggest that suicide-specific expression changes in mood disorders involve both glucocorticoids regulated metallothioneins and serotonergic signaling in different regions of the brain.	[Sequeira, Adolfo; Morgan, Ling; Walsh, David M.; Cartagena, Preston M.; Bunney, William E.; Vawter, Marquis P.] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA; [Choudary, Prabhakara; Jones, Edward G.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Li, Jun] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Schatzberg, Alan F.] Stanford Univ, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA; [Watson, Stanley J.; Akil, Huda] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Myers, Richard M.] HudsonAlpha Inst Biotechnol, Huntsville, MI USA	University of California System; University of California Irvine; University of California System; University of California Davis; University of Michigan System; University of Michigan; Stanford University; University of Michigan System; University of Michigan; HudsonAlpha Institute for Biotechnology	Sequeira, A (corresponding author), Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA.	psequeir@uci.edu	Sequeira, Adolfo/K-7278-2015	Sequeira, Adolfo/0000-0003-3040-1190; Li, Jun/0000-0001-6727-0812; Choudary, Prabhakara/0000-0002-7163-6466	Pritzker Neuropsychiatric Disorders Research Fund L.L.C.; William Lion Penzner Foundation (Dept of Psychiatry, UCI); Della Martin Foundation; National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085801] Funding Source: NIH RePORTER	Pritzker Neuropsychiatric Disorders Research Fund L.L.C.; William Lion Penzner Foundation (Dept of Psychiatry, UCI); Della Martin Foundation; National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors are members of the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, Stanford University, the Weill Medical College of Cornell University, HudsonAlpha Institute of Biotechnology, the Universities of California at Davis (UCD), and at Irvine (UCI), to encourage the development of appropriate findings for research and clinical applications. The research was further supported by the William Lion Penzner Foundation (Dept of Psychiatry, UCI), Della Martin Foundation (to WEB, AS) and the National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award (to AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atz M, 2007, J NEUROSCI METH, V163, P295, DOI 10.1016/j.jneumeth.2007.03.022; BARRACLOUGH B, 1974, BRIT J PSYCHIAT, V125, P355, DOI 10.1192/bjp.125.4.355; BARTON AJL, 1993, J NEUROCHEM, V61, P1, DOI 10.1111/j.1471-4159.1993.tb03532.x; Bostwick JM, 2000, AM J PSYCHIAT, V157, P1925, DOI 10.1176/appi.ajp.157.12.1925; BOURNE HR, 1968, LANCET, V2, P805; BRENT DA, 1988, ARCH GEN PSYCHIAT, V45, P581, DOI 10.1001/archpsyc.1988.01800300079011; Bunney WE, 2000, NEUROPSYCHOPHARMACOL, V22, P335, DOI 10.1016/S0893-133X(99)00145-1; BUNNEY WE, 1965, PSYCHOSOM MED, V27, P299, DOI 10.1097/00006842-196507000-00001; BUNNEY WE, 1965, ARCH GEN PSYCHIAT, V13, P232; BUNNEY WE, 1969, ARCH GEN PSYCHIAT, V21, P138; BUNNEY WE, 1965, ARCH GEN PSYCHIAT, V13, P483; Chang XL, 2009, EXP BIOL MED, V234, P666, DOI 10.3181/0811-RM-336; Chung RS, 2008, J BIOL CHEM, V283, P15349, DOI 10.1074/jbc.M708446200; COWBURN RF, 1994, BRAIN RES, V633, P297, DOI 10.1016/0006-8993(94)91552-0; Cowen PJ, 2009, PSYCHOL MED, P1; Coyle P, 2002, CELL MOL LIFE SCI, V59, P627, DOI 10.1007/s00018-002-8454-2; Dowlatshahi D, 1999, J NEUROCHEM, V73, P1121, DOI 10.1046/j.1471-4159.1999.0731121.x; Dwivedi Y, 2003, ARCH GEN PSYCHIAT, V60, P273, DOI 10.1001/archpsyc.60.3.273; Garbett Krassimira, 2008, Neuropsychopharmacol Hung, V10, P9; GASULL T, 1994, AM J PHYSIOL, V266, pE760, DOI 10.1152/ajpendo.1994.266.5.E760; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Ghoshal K, 1998, J BIOL CHEM, V273, P27904, DOI 10.1074/jbc.273.43.27904; Goldsmith S.K., 2002, REDUCING SUICIDE NAT; Goodwin FK, 1990, SUICIDE MANIC DEPRES, P227; Greydanus DE, 2007, PRIMARY CARE, V34, P259, DOI 10.1016/j.pop.2007.04.013; Gross-Isseroff R, 1998, NEUROSCI BIOBEHAV R, V22, P653, DOI 10.1016/S0149-7634(97)00061-4; GROSSISSEROFF R, 1990, BRAIN RES, V507, P208, DOI 10.1016/0006-8993(90)90274-F; GUZE SB, 1970, BRIT J PSYCHIAT, V117, P437, DOI 10.1192/bjp.117.539.437; Hidalgo, 1997, Stress, V1, P231; HIDALGO J, 1994, CHEM-BIOL INTERACT, V93, P197, DOI 10.1016/0009-2797(94)90020-5; Hidalgo J, 2001, BRAIN RES BULL, V55, P133, DOI 10.1016/S0361-9230(01)00452-X; Hrdina PD, 2001, AM J PSYCHIAT, V158, P147, DOI 10.1176/appi.ajp.158.1.147-a; Inskip HM, 1998, BRIT J PSYCHIAT, V172, P35, DOI 10.1192/bjp.172.1.35; Jacob ST, 1999, GENE EXPRESSION, V7, P301; Jamison KR, 2000, J CLIN PSYCHIAT, V61, P47; Jokinen J, 2009, PSYCHIAT RES, V165, P96, DOI 10.1016/j.psychres.2007.10.007; JONES EG, 1992, J NEUROSCI METH, V44, P133, DOI 10.1016/0165-0270(92)90006-Y; KARIN M, 1984, NATURE, V308, P513, DOI 10.1038/308513a0; Kelly EJ, 1997, P NATL ACAD SCI USA, V94, P10045, DOI 10.1073/pnas.94.19.10045; Kelly TM, 1996, ACTA PSYCHIAT SCAND, V94, P337, DOI 10.1111/j.1600-0447.1996.tb09869.x; Kim S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-413; KLEMPAN TA, 2007, MOL PSYCHIAT; Kramer KK, 1996, TOXICOL APPL PHARM, V141, P1; Kramer KK, 1996, TOXICOL APPL PHARM, V136, P94, DOI 10.1006/taap.1996.0011; LESAGE AD, 1994, AM J PSYCHIAT, V151, P1063; Li JZ, 2004, HUM MOL GENET, V13, P609, DOI 10.1093/hmg/ddh065; Lopez JF, 1997, ANN NY ACAD SCI, V836, P106, DOI 10.1111/j.1749-6632.1997.tb52357.x; LOPEZDURAN NL, 2009, PSYCHONEUROENDOCRINO; Mann JJ, 2003, NAT REV NEUROSCI, V4, P819, DOI 10.1038/nrn1220; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; McMahon FJ, 2006, AM J HUM GENET, V78, P804, DOI 10.1086/503820; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; Oquendo MA, 2000, PSYCHIAT CLIN N AM, V23, P11, DOI 10.1016/S0193-953X(05)70140-4; Oquendo MA, 2008, AM J PSYCHIAT, V165, P1383, DOI 10.1176/appi.ajp.2008.08020281; Pandey GN, 2002, AM J PSYCHIAT, V159, P419, DOI 10.1176/appi.ajp.159.3.419; Pedersen MO, 2009, BIOFACTORS, V35, P315, DOI 10.1002/biof.44; Rahman S, 1997, J NEUROCHEM, V68, P297; ROBINS E, 1959, AM J PUBLIC HEALTH N, V49, P888, DOI 10.2105/AJPH.49.7.888; Rosel P, 2000, PSYCHIAT RES-NEUROIM, V99, P173, DOI 10.1016/S0925-4927(00)00076-7; Sequeira A, 2007, MOL PSYCHIATR, V12, P640, DOI 10.1038/sj.mp.4001969; Sequeira A, 2006, ARCH GEN PSYCHIAT, V63, P35, DOI 10.1001/archpsyc.63.1.35; Sequeira A, 2003, AM J MED GENET B, V119B, P108, DOI 10.1002/ajmg.b.20011; Sequeira A, 2006, OMICS, V10, P444, DOI 10.1089/omi.2006.10.444; Serretti A, 2007, CURR MED CHEM, V14, P2053; Shelton RC, 2009, NEUROSCIENCE, V158, P1406, DOI 10.1016/j.neuroscience.2008.11.036; Shelton RC, 2010, MOL PSYCHIAT; Sibille E, 2004, NEUROPSYCHOPHARMACOL, V29, P351, DOI 10.1038/sj.npp.1300335; STANLEY M, 1983, LANCET, V1, P214; Stockmeier CA, 1997, NEUROPSYCHOPHARMACOL, V16, P162, DOI 10.1016/S0893-133X(96)00170-4; Swift M, 2005, MOL PSYCHIATR, V10, P799, DOI 10.1038/sj.mp.4001681; SWIFT RG, 1990, LANCET, V336, P667, DOI 10.1016/0140-6736(90)92157-D; Thalmeier A, 2008, INT J NEUROPSYCHOPH, V11, P217, DOI 10.1017/S1461145707007894; Tochigi M, 2008, NEUROSCI RES, V60, P184, DOI 10.1016/j.neures.2007.10.010; Tomita H, 2004, BIOL PSYCHIAT, V55, P346, DOI 10.1016/j.biopsych.2003.10.013; Turecki G, 1999, AM J PSYCHIAT, V156, P1456; Underwood MD, 2011, INT J NEUROPSYCHOPH, P1; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vawter MP, 2006, MOL PSYCHIAT, P615; Vreeburg SA, 2009, ARCH GEN PSYCHIAT, V66, P617, DOI 10.1001/archgenpsychiatry.2009.50; Wann BP, 2009, BRAIN RES BULL, V79, P32, DOI 10.1016/j.brainresbull.2008.12.008; WESTER P, 1985, NEUROCHEM PATHOL, V3, P169, DOI 10.1007/BF02834269; World Health Organization, 2000, WORLD HLTH REP 2000; Yanagi M, 2005, J HUM GENET, V50, P210, DOI 10.1007/s10038-005-0241-0; YOUNG LT, 1993, J NEUROCHEM, V61, P890, DOI 10.1111/j.1471-4159.1993.tb03600.x; ZHENG H, 1995, NEUROCHEM INT, V27, P43, DOI 10.1016/0197-0186(94)00167-S	86	59	62	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35367	10.1371/journal.pone.0035367	http://dx.doi.org/10.1371/journal.pone.0035367			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558144	Green Published, gold			2022-12-27	WOS:000305340200016
J	Vandeberg, L; Eerland, A; Zwaan, RA				Vandeberg, Lisa; Eerland, Anita; Zwaan, Rolf A.			Out of Mind, Out of Sight: Language Affects Perceptual Vividness in Memory	PLOS ONE			English	Article							NARRATIVE COMPREHENSION; SITUATION MODELS; MENTAL MODELS; INFORMATION; ACTIVATION; NEGATION; WORDS; ACCESSIBILITY; RECOGNITION; METAPHORS	We examined whether language affects the strength of a visual representation in memory. Participants studied a picture, read a story about the depicted object, and then selected out of two pictures the one whose transparency level most resembled that of the previously presented picture. The stories contained two linguistic manipulations that have been demonstrated to affect concept availability in memory, i.e., object presence and goal-relevance. The results show that described absence of an object caused people to select the most transparent picture more often than described presence of the object. This effect was not moderated by goal-relevance, suggesting that our paradigm tapped into the perceptual quality of representations rather than, for example, their linguistic availability. We discuss the implications of these findings within a framework of grounded cognition.	[Vandeberg, Lisa; Eerland, Anita; Zwaan, Rolf A.] Erasmus Univ, Dept Psychol, Rotterdam, Netherlands	Erasmus University Rotterdam	Vandeberg, L (corresponding author), Erasmus Univ, Dept Psychol, Rotterdam, Netherlands.	vandeberg@fsw.eur.nl		Vandeberg, Lisa/0000-0002-7229-2378; Zwaan, Rolf/0000-0001-9967-7879				ALBRECHT JE, 1995, J EXP PSYCHOL LEARN, V21, P1459, DOI 10.1037/0278-7393.21.6.1459; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Borghi AM, 2009, BRAIN RES, V1253, P117, DOI 10.1016/j.brainres.2008.11.064; BOWER GH, 1990, SCIENCE, V247, P44, DOI 10.1126/science.2403694; Dils AT, 2010, P NATL ACAD SCI USA, V107, P16396, DOI 10.1073/pnas.1009438107; DOPKINS S, 1993, J EXP PSYCHOL LEARN, V19, P70, DOI 10.1037/0278-7393.19.1.70; Ferguson HJ, 2008, BRAIN RES, V1236, P113, DOI 10.1016/j.brainres.2008.07.099; Fincher-Kiefer R, 2001, MEM COGNITION, V29, P336, DOI 10.3758/BF03194928; Giora R, 2006, J PRAGMATICS, V38, P981, DOI 10.1016/j.pragma.2005.12.006; Glenberg AM, 2002, PSYCHON B REV, V9, P558, DOI 10.3758/BF03196313; GLENBERG AM, 1987, J MEM LANG, V26, P69, DOI 10.1016/0749-596X(87)90063-5; Hasson U, 2006, J PRAGMATICS, V38, P1015, DOI 10.1016/j.pragma.2005.12.005; Hirschfeld G, 2011, BRAIN RES, V1377, P78, DOI 10.1016/j.brainres.2010.12.063; Holmes KJ, 2011, P 33 ANN C COGN SCI, P2884; Holt LE, 2006, PSYCHON B REV, V13, P694, DOI 10.3758/BF03193983; Horton WS, 2003, PSYCHON B REV, V10, P104, DOI 10.3758/BF03196473; Johnson-Laird P.N., 1983, MENTAL MODELS COGNIT; Kaschak MP, 2005, COGNITION, V94, pB79, DOI 10.1016/j.cognition.2004.06.005; Kaup B, 2006, J PRAGMATICS, V38, P1033, DOI 10.1016/j.pragma.2005.09.012; Lincoln AE, 2007, NEUROPSYCHOLOGIA, V45, P397, DOI 10.1016/j.neuropsychologia.2006.06.010; Lupyan G, 2012, J EXP PSYCHOL GEN, V141, P170, DOI 10.1037/a0024904; Lutz MF, 1997, J MEM LANG, V36, P293, DOI 10.1006/jmla.1996.2491; MACDONALD MC, 1989, J EXP PSYCHOL LEARN, V15, P633, DOI 10.1037/0278-7393.15.4.633; Magliano JR, 2005, MEM COGNITION, V33, P1357, DOI 10.3758/BF03193368; MURPHY GL, 1985, PSYCHOL REV, V92, P289, DOI 10.1037/0033-295X.92.3.289; POLLATSEK A, 1995, J EXP PSYCHOL LEARN, V21, P785, DOI 10.1037/0278-7393.21.3.785; Pulvermuller F, 1999, BEHAV BRAIN SCI, V22, P253, DOI 10.1017/S0140525X9900182X; Risen JL, 2011, J PERS SOC PSYCHOL, V100, P777, DOI 10.1037/a0022460; Stanfield RA, 2001, PSYCHOL SCI, V12, P153, DOI 10.1111/1467-9280.00326; SUH SY, 1993, J MEM LANG, V32, P279, DOI 10.1006/jmla.1993.1015; Tucker M, 2004, ACTA PSYCHOL, V116, P185, DOI 10.1016/j.actpsy.2004.01.004; van Dijk T., 1983, STRATEGIES DISCOURSE; Yaxley RH, 2007, COGNITION, V105, P229, DOI 10.1016/j.cognition.2006.09.003; Zwaan RA, 2002, PSYCHOL SCI, V13, P168, DOI 10.1111/1467-9280.00430; Zwaan RA, 2004, COGNITIVE SCI, V28, P611, DOI 10.1016/j.cogsci.2004.03.004; Zwaan RA, 2004, PSYCHOL LEARN MOTIV, V44, P35; Zwaan RA, 1998, PSYCHOL BULL, V123, P162, DOI 10.1037/0033-2909.123.2.162	37	6	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36154	10.1371/journal.pone.0036154	http://dx.doi.org/10.1371/journal.pone.0036154			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UL	22558364	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340200044
J	Xie, W; Meng, QS; Wu, QJ; Wang, SL; Yang, X; Yang, NN; Li, RM; Jiao, XG; Pan, HP; Liu, BM; Su, Q; Xu, BY; Hu, SN; Zhou, XG; Zhang, YJ				Xie, Wen; Meng, Qing-shu; Wu, Qing-jun; Wang, Shao-li; Yang, Xin; Yang, Ni-na; Li, Ru-mei; Jiao, Xiao-guo; Pan, Hui-peng; Liu, Bai-ming; Su, Qi; Xu, Bao-yun; Hu, Song-nian; Zhou, Xu-guo; Zhang, You-jun			Pyrosequencing the Bemisia tabaci Transcriptome Reveals a Highly Diverse Bacterial Community and a Robust System for Insecticide Resistance	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; Q-BIOTYPE; ACYRTHOSIPHON-PISUM; IMMUNE-RESPONSE; TREHALASE ACTIVITY; BROWN PLANTHOPPER; CROSS-RESISTANCE; GENE-EXPRESSION; PEA APHIDS; B-BIOTYPE	Background: Bemisia tabaci (Gennadius) is a phloem-feeding insect poised to become one of the major insect pests in open field and greenhouse production systems throughout the world. The high level of resistance to insecticides is a main factor that hinders continued use of insecticides for suppression of B. tabaci. Despite its prevalence, little is known about B. tabaci at the genome level. To fill this gap, an invasive B. tabaci B biotype was subjected to pyrosequencing-based transcriptome analysis to identify genes and gene networks putatively involved in various physiological and toxicological processes. Methodology and Principal Findings: Using Roche 454 pyrosequencing, 857,205 reads containing approximately 340 megabases were obtained from the B. tabaci transcriptome. De novo assembly generated 178,669 unigenes including 30,980 from insects, 17,881 from bacteria, and 129,808 from the nohit. A total of 50,835 (28.45%) unigenes showed similarity to the non-redundant database in GenBank with a cut-off E-value of 10-5. Among them, 40,611 unigenes were assigned to one or more GO terms and 6,917 unigenes were assigned to 288 known pathways. De novo metatranscriptome analysis revealed highly diverse bacterial symbionts in B. tabaci, and demonstrated the host-symbiont cooperation in amino acid production. In-depth transcriptome analysis indentified putative molecular markers, and genes potentially involved in insecticide resistance and nutrient digestion. The utility of this transcriptome was validated by a thiamethoxam resistance study, in which annotated cytochrome P450 genes were significantly overexpressed in the resistant B. tabaci in comparison to its susceptible counterparts. Conclusions: This transcriptome/metatranscriptome analysis sheds light on the molecular understanding of symbiosis and insecticide resistance in an agriculturally important phloem-feeding insect pest, and lays the foundation for future functional genomics research of the B. tabaci complex. Moreover, current pyrosequencing effort greatly enriched the existing whitefly EST database, and makes RNAseq a viable option for future genomic analysis.	[Xie, Wen; Wu, Qing-jun; Wang, Shao-li; Yang, Xin; Yang, Ni-na; Li, Ru-mei; Jiao, Xiao-guo; Pan, Hui-peng; Liu, Bai-ming; Su, Qi; Xu, Bao-yun; Zhang, You-jun] Chinese Acad Agr Sci, Dept Plant Protect, Inst Vegetables & Flowers, Beijing 100193, Peoples R China; [Meng, Qing-shu; Hu, Song-nian] Chinese Acad Sci, Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China; [Zhou, Xu-guo] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; University of Kentucky	Xie, W (corresponding author), Chinese Acad Agr Sci, Dept Plant Protect, Inst Vegetables & Flowers, Beijing 100193, Peoples R China.	husn@big.ac.cn; xuguozhou@uky.edu; zhangyj@mail.caas.net.cn	Yang, Xin/AAG-5375-2020; Zhang, Youjun/AAY-7948-2020; Hu, Songnian/C-6509-2013	Zhang, Youjun/0000-0003-3508-6695; XIE, WEN/0000-0002-3220-1072; Hu, Songnian/0000-0003-3966-3111	National Science Fund for Distinguished Young Scholars [31025020]; 973 Program [2009 CB119200]; National Natural Science Foundation of China [30900153]; Key Laboratory of Biology and Genetic Improvement of Horticultural Crops, Ministry of Agriculture, People's Republic of China	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Biology and Genetic Improvement of Horticultural Crops, Ministry of Agriculture, People's Republic of China	This research was supported by the National Science Fund for Distinguished Young Scholars (31025020), the 973 Program (2009 CB119200), the National Natural Science Foundation of China (no. 30900153), and the Key Laboratory of Biology and Genetic Improvement of Horticultural Crops, Ministry of Agriculture, People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Baldwin WS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-169; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Becker A, 1996, EXPERIENTIA, V52, P433, DOI 10.1007/BF01919312; Behura SK, 2006, MOL ECOL, V15, P3087, DOI 10.1111/j.1365-294X.2006.03014.x; Bensadia F, 2006, J INSECT PHYSIOL, V52, P146, DOI 10.1016/j.jinsphys.2005.09.011; Bextine B, 2009, CDFAS PIERC DIS CONT, P3; BOUSH GM, 1967, J ECON ENTOMOL, V60, P918, DOI 10.1093/jee/60.4.918; Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; Brumin M, 2011, INSECT SCI, V18, P57, DOI 10.1111/j.1744-7917.2010.01396.x; Burke G, 2010, ISME J, V4, P242, DOI 10.1038/ismej.2009.114; Casida JE, 2011, J AGR FOOD CHEM, V59, P2923, DOI 10.1021/jf102438c; Chang A, 2009, NUCLEIC ACIDS RES, V37, pD588, DOI 10.1093/nar/gkn820; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Chiel E, 2007, B ENTOMOL RES, V97, P407, DOI 10.1017/S0007485307005159; Chu D, 2006, FLA ENTOMOL, V89, P168, DOI 10.1653/0015-4040(2006)89[168:TIOTEQ]2.0.CO;2; CLEGG JS, 1961, SCIENCE, V134, P54, DOI 10.1126/science.134.3471.54; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; *DFCI, DFCI GEN IND SOFTW T; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Elbaz M, 2010, B ENTOMOL RES, V100, P581, DOI 10.1017/S0007485309990630; Erdogan C, 2008, CROP PROT, V27, P600, DOI 10.1016/j.cropro.2007.09.002; Feng YT, 2009, J APPL ENTOMOL, V133, P466, DOI 10.1111/j.1439-0418.2009.01383.x; Feng YT, 2010, PEST MANAG SCI, V66, P313, DOI 10.1002/ps.1877; Ferrari J, 2004, ECOL ENTOMOL, V29, P60, DOI 10.1111/j.1365-2311.2004.00574.x; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; FRIEDMAN S, 1978, ANNU REV ENTOMOL, V23, P389, DOI 10.1146/annurev.en.23.010178.002133; Fukatsu T, 2001, APPL ENVIRON MICROB, V67, P1284, DOI 10.1128/AEM.67.3.1284-1291.2001; Ghanim M, 2009, PEST MANAG SCI, V65, P939, DOI 10.1002/ps.1795; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Gorman K, 2007, PEST MANAG SCI, V63, P555, DOI 10.1002/ps.1364; Gottlieb Y, 2010, J VIROL, V84, P9310, DOI 10.1128/JVI.00423-10; Hail D, 2011, ENVIRON ENTOMOL, V40, P23, DOI 10.1603/EN10115; Hansen AK, 2011, P NATL ACAD SCI USA, V108, P2849, DOI 10.1073/pnas.1013465108; Hao OJ, 2002, CHEMOSPHERE, V46, P797, DOI 10.1016/S0045-6535(01)00182-5; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; Hlavica P, 2011, J INORG BIOCHEM, V105, P1354, DOI 10.1016/j.jinorgbio.2011.05.003; Honda H, 2006, TOXICOL LETT, V161, P108, DOI 10.1016/j.toxlet.2005.08.004; Horowitz AR, 2004, J ECON ENTOMOL, V97, P2051, DOI 10.1603/0022-0493-97.6.2051; Indiragandhi P, 2007, J APPL MICROBIOL, V103, P2664, DOI 10.1111/j.1365-2672.2007.03506.x; Jaworski DC, 2010, INSECT MOL BIOL, V19, P617, DOI 10.1111/j.1365-2583.2010.01037.x; Jeschke P, 2008, PEST MANAG SCI, V64, P1084, DOI 10.1002/ps.1631; Jones DR, 2003, EUR J PLANT PATHOL, V109, P195, DOI 10.1023/A:1022846630513; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Karunker I, 2008, INSECT BIOCHEM MOLEC, V38, P634, DOI 10.1016/j.ibmb.2008.03.008; Karunker I, 2009, INSECT BIOCHEM MOLEC, V39, P697, DOI 10.1016/j.ibmb.2009.08.006; Kontsedalov S, 2008, PEST MANAG SCI, V64, P789, DOI 10.1002/ps.1595; Labbe R, 2011, INSECT MOL BIOL, V20, P243, DOI 10.1111/j.1365-2583.2010.01064.x; Lamelas A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002357; Leshkowitz D, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-79; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Lindh JM, 2005, APPL ENVIRON MICROB, V71, P7217, DOI 10.1128/AEM.71.11.7217-7223.2005; Liu ZW, 2009, J NEUROCHEM, V108, P498, DOI 10.1111/j.1471-4159.2008.05790.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahadav A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-342; Maienfisch P, 2001, PEST MANAG SCI, V57, P906, DOI 10.1002/ps.365; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mittapalli O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013708; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Moran NA, 2005, P NATL ACAD SCI USA, V102, P16919, DOI 10.1073/pnas.0507029102; Morin S, 2000, VIROLOGY, V276, P404, DOI 10.1006/viro.2000.0549; Morin S, 1999, VIROLOGY, V256, P75, DOI 10.1006/viro.1999.9631; Nauen R, 2005, ARCH INSECT BIOCHEM, V58, P200, DOI 10.1002/arch.20043; O'Neil ST, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-310; Olafson PU, 2010, ARCH INSECT BIOCHEM, V74, P179, DOI 10.1002/arch.20372; Oliveira MRV, 2001, CROP PROT, V20, P709, DOI 10.1016/S0261-2194(01)00108-9; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Pan HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030760; Parkinson John, 2009, V533, P1, DOI 10.1007/978-1-60327-136-3_1; Pauchet Y, 2009, INSECT BIOCHEM MOLEC, V39, P403, DOI 10.1016/j.ibmb.2009.04.001; Peng X, 2011, INSECT MOL BIOL, V20, P745, DOI 10.1111/j.1365-2583.2011.01104.x; Perring TM, 2001, CROP PROT, V20, P725, DOI 10.1016/S0261-2194(01)00109-0; Pidiyar VJ, 2004, AM J TROP MED HYG, V70, P597, DOI 10.4269/ajtmh.2004.70.597; Priya NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030768; Puinean AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000999; Qi WH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-172; Ramsey JS, 2010, INSECT MOL BIOL, V19, P155, DOI 10.1111/j.1365-2583.2009.00973.x; Rauch N, 2003, ARCH INSECT BIOCHEM, V54, P165, DOI 10.1002/arch.10114; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Roditakis E, 2009, PEST MANAG SCI, V65, P313, DOI 10.1002/ps.1690; Russell JA, 2005, APPL ENVIRON MICROB, V71, P7987, DOI 10.1128/AEM.71.12.7987-7994.2005; Shatters RG, 2009, J ECON ENTOMOL, V102, P750, DOI 10.1603/029.102.0236; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007; Tatun N, 2008, INSECT BIOCHEM MOLEC, V38, P788, DOI 10.1016/j.ibmb.2008.05.003; Tatun N, 2008, J INSECT PHYSIOL, V54, P351, DOI 10.1016/j.jinsphys.2007.10.006; Thao ML, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-25; Thao ML, 2004, APPL ENVIRON MICROB, V70, P3401, DOI 10.1128/AEM.70.6.3401-3406.2004; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Wang XW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-458; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang ZY, 2010, PEST MANAG SCI, V66, P1360, DOI 10.1002/ps.2023; Xu J, 2010, B ENTOMOL RES, V100, P359, DOI 10.1017/S0007485310000015; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Zagrobelny M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-574; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang FJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-303; Zhang LP, 2005, J APPL ENTOMOL, V129, P121, DOI 10.1111/j.1439-0418.2005.00950.x; Zheng RC, 2007, RES MICROBIOL, V158, P258, DOI 10.1016/j.resmic.2006.12.007; Zou Z, 2008, INSECT BIOCHEM MOLEC, V38, P677, DOI 10.1016/j.ibmb.2008.03.009; Zouache K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006388	106	59	78	4	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35181	10.1371/journal.pone.0035181	http://dx.doi.org/10.1371/journal.pone.0035181			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558125	Green Submitted, Green Published, gold			2022-12-27	WOS:000305340200008
J	Campbell, AL; Shih, HP; Xu, J; Gross, MK; Kioussi, C				Campbell, Adam L.; Shih, Hung-Ping; Xu, Jun; Gross, Michael K.; Kioussi, Chrissa			Regulation of Motility of Myogenic Cells in Filling Limb Muscle Anlagen by Pitx2	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; ACTIN-BASED MOTILITY; PRECURSOR CELLS; MOUSE EMBRYO; GENE-EXPRESSION; SIGNAL-TRANSDUCTION; ENA/VASP PROTEINS; BINDING PROTEIN; SKELETAL-MUSCLE; C-MET	Cells of the ventrolateral dermomyotome delaminate and migrate into the limb buds where they give rise to all muscles of the limbs. The migratory cells proliferate and form myoblasts, which withdraw from the cell cycle to become terminally differentiated myocytes. The myogenic lineage colonizes pre-patterned regions to form muscle anlagen as muscle fibers are assembled. The regulatory mechanisms that control the later steps of this myogenic program are not well understood. The homeodomain transcription factor Pitx2 is expressed specifically in the muscle lineage from the migration of precursors to adult muscle. Ablation of Pitx2 results in distortion, rather than loss, of limb muscle anlagen, suggesting that its function becomes critical during the colonization of, and/or fiber assembly in, the anlagen. Microarrays were used to identify changes in gene expression in flow-sorted migratory muscle precursors, labeled by Lbx1(EGFP/+), which resulted from the loss of Pitx2. Very few genes showed changes in expression. Many small-fold, yet significant, changes were observed in genes encoding cytoskeletal and adhesion proteins which play a role in cell motility. Myogenic cells from genetically-tagged mice were cultured and subjected to live cell-tracking analysis using time-lapse imaging. Myogenic cells lacking Pitx2 were smaller, more symmetrical, and had more actin bundling. They also migrated about half of the total distance and velocity. Decreased motility may prevent myogenic cells from filling pre-patterned regions of the limb bud in a timely manner. Altered shape may prevent proper assembly of higher-order fibers within anlagen. Pitx2 therefore appears to regulate muscle anlagen development by appropriately balancing expression of cytoskeletal and adhesion molecules.	[Campbell, Adam L.; Xu, Jun; Gross, Michael K.; Kioussi, Chrissa] Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Shih, Hung-Ping] Univ Calif San Diego, Dept Pediat, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Oregon State University; University of California System; University of California San Diego	Campbell, AL (corresponding author), Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA.	chrissa.kioussi@oregonstate.edu	Xu, Jun/K-1233-2016	Xu, Jun/0000-0003-4221-5563; Kioussi, Chrissa/0000-0001-8226-9908	National Institutes of Health-National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH-NIAMS) [AR054406]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH-NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health-National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH-NIAMS) grant AR054406 to CK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Arthur WT, 2002, BIOL RES, V35, P239, DOI 10.4067/S0716-97602002000200016; BANDMAN E, 1992, DEV BIOL, V154, P273, DOI 10.1016/0012-1606(92)90067-Q; Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Bass MD, 2007, J CELL BIOL, V177, P527, DOI 10.1083/jcb.200610076; Bershadsky A, 1996, CURR BIOL, V6, P1279, DOI 10.1016/S0960-9822(02)70714-8; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Blaxall BC, 2003, PHYSIOL GENOMICS, V15, P105, DOI 10.1152/physiolgenomics.00087.2003; BOBER E, 1994, DEVELOPMENT, V120, P603; Bugnard E, 2005, CELL MOTIL CYTOSKEL, V60, P1, DOI 10.1002/cm.20042; Campbell ID, 2004, TRENDS BIOCHEM SCI, V29, P429, DOI 10.1016/j.tibs.2004.06.005; Carlier MF, 2003, BIOESSAYS, V25, P336, DOI 10.1002/bies.10257; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; Cox D, 2010, NAT REV DRUG DISCOV, V9, P804, DOI 10.1038/nrd3266; Daub H, 2001, J BIOL CHEM, V276, P1677, DOI 10.1074/jbc.C000635200; DAVID G, 1993, DEVELOPMENT, V119, P841; Dietrich S, 1999, DEVELOPMENT, V126, P1621; Disatnik MH, 1999, J BIOL CHEM, V274, P32486, DOI 10.1074/jbc.274.45.32486; Dixson JD, 2003, J MOL EVOL, V56, P1, DOI 10.1007/s00239-002-2374-5; Dong LQ, 1999, J BIOL CHEM, V274, P8117, DOI 10.1074/jbc.274.12.8117; Dovas A, 2006, J CELL SCI, V119, P2837, DOI 10.1242/jcs.03020; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Engleka KA, 2005, DEV BIOL, V280, P396, DOI 10.1016/j.ydbio.2005.02.002; Feoktistov I, 2000, MOL PHARMACOL, V58, P903, DOI 10.1124/mol.58.5.903; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Frey N, 2000, P NATL ACAD SCI USA, V97, P14632, DOI 10.1073/pnas.260501097; Gage PJ, 1999, DEVELOPMENT, V126, P4643; Gail M, 1973, Ciba Found Symp, V14, P287; Garcia-Espana A, 2008, GENOMICS, V91, P326, DOI 10.1016/j.ygeno.2007.12.005; Gersdorff N, 2006, HISTOCHEM CELL BIOL, V126, P705, DOI 10.1007/s00418-006-0200-7; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; GOULDING M, 1994, DEVELOPMENT, V120, P957; Gross MK, 2000, DEVELOPMENT, V127, P413; Gu JG, 1999, J CELL BIOL, V146, P389, DOI 10.1083/jcb.146.2.389; Gunning PW, 2001, J CELL SCI, V114, P513; GURDON JB, 1988, NATURE, V336, P772, DOI 10.1038/336772a0; HAYASHI K, 1995, DEVELOPMENT, V121, P661; HAYWARD LJ, 1988, J CELL BIOL, V106, P2077, DOI 10.1083/jcb.106.6.2077; Hilton T, 2010, J BIOL CHEM, V285, P11129, DOI 10.1074/jbc.M109.087429; Holaska JM, 2006, HUM MOL GENET, V15, P3459, DOI 10.1093/hmg/ddl423; Howe AK, 2005, P NATL ACAD SCI USA, V102, P14320, DOI 10.1073/pnas.0507072102; Hu M, 2010, P NATL ACAD SCI USA, V107, P2956, DOI 10.1073/pnas.0915033107; Hubberstey AV, 2002, FASEB J, V16, P487, DOI 10.1096/fj.01-0659rev; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jain MK, 1998, CIRC RES, V83, P980, DOI 10.1161/01.RES.83.10.980; Jin L, 2009, J BIOL CHEM, V284, P2121, DOI 10.1074/jbc.M806095200; Jourdain L, 1997, BIOCHEMISTRY-US, V36, P10817, DOI 10.1021/bi971491b; Jungers KA, 2005, GENE EXPR PATTERNS, V5, P609, DOI 10.1016/j.modgep.2005.03.004; KAMATH K, 2010, METHOD CELL BIOL, V97, P1; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; KIM CW, 1994, MOL BIOL CELL, V5, P797, DOI 10.1091/mbc.5.7.797; KIM E, 1989, MOL CELL BIOL, V9, P1875, DOI 10.1128/MCB.9.5.1875; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Kioussi C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002179; Kitamura K, 1999, DEVELOPMENT, V126, P5749; KORNBERG L, 1992, J BIOL CHEM, V267, P23439; Lee C, 2007, DEVELOPMENT, V134, P1431, DOI 10.1242/dev.02828; Leu SJ, 2003, J BIOL CHEM, V278, P33801, DOI 10.1074/jbc.M305862200; LEWIS SA, 1985, J CELL BIOL, V101, P852, DOI 10.1083/jcb.101.3.852; Lilly B, 2010, ARTERIOSCL THROM VAS, V30, P694, DOI 10.1161/ATVBAHA.109.200741; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Locascio A, 2001, CURR OPIN GENET DEV, V11, P464, DOI 10.1016/S0959-437X(00)00218-5; Lu MF, 1999, NATURE, V401, P276, DOI 10.1038/45797; Mandicourt G, 2007, J BIOL CHEM, V282, P1830, DOI 10.1074/jbc.M605666200; Mao XH, 2001, BLOOD, V97, P324, DOI 10.1182/blood.V97.1.324; Mennerich D, 1998, MECH DEVELOP, V73, P147, DOI 10.1016/S0925-4773(98)00046-X; Mikhailov A, 1998, CELL MOTIL CYTOSKEL, V41, P325, DOI 10.1002/(SICI)1097-0169(1998)41:4<325::AID-CM5>3.0.CO;2-D; Miyasaka KY, 2007, P NATL ACAD SCI USA, V104, P11274, DOI 10.1073/pnas.0702000104; Nagae S, 2007, DEV DYNAM, V236, P534, DOI 10.1002/dvdy.21030; NELSON WJ, 1985, J CELL BIOL, V100, P1726, DOI 10.1083/jcb.100.5.1726; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Reinhard M, 2001, TRENDS BIOCHEM SCI, V26, P243, DOI 10.1016/S0968-0004(00)01785-0; Ruan K, 2009, CELL MOL LIFE SCI, V66, P2219, DOI 10.1007/s00018-009-0013-7; Saba JD, 2004, CIRC RES, V94, P724, DOI 10.1161/01.RES.0000122383.60368.24; SASSOON DA, 1988, DEVELOPMENT, V104, P155; Schafer K, 1999, NAT GENET, V23, P213, DOI 10.1038/13843; Schevzov G, 2008, J BIOL CHEM, V283, P275, DOI 10.1074/jbc.M704392200; Schmetsdorf S, 2009, EUR J NEUROSCI, V29, P1096, DOI 10.1111/j.1460-9568.2009.06661.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shih HP, 2008, ACTA HISTOCHEM, V110, P97, DOI 10.1016/j.acthis.2007.08.004; Shih HP, 2007, P NATL ACAD SCI USA, V104, P5907, DOI 10.1073/pnas.0701122104; Shih HP, 2007, GENE EXPR PATTERNS, V7, P441, DOI 10.1016/j.modgep.2006.11.004; SINGH IS, 1991, BIOCHEM BIOPH RES CO, V178, P221, DOI 10.1016/0006-291X(91)91802-J; Small JV, 2002, NAT REV MOL CELL BIO, V3, P957, DOI 10.1038/nrm971; SUTHERLAND AE, 1991, DEVELOPMENT, V113, P339; Tachikawa K, 2008, NEUROSCI RES, V60, P135, DOI 10.1016/j.neures.2007.10.006; Takada F, 2001, P NATL ACAD SCI USA, V98, P1595, DOI 10.1073/pnas.041609698; Tremblay P, 1998, DEV BIOL, V203, P49, DOI 10.1006/dbio.1998.9041; Venters SJ, 2004, DEV DYNAM, V229, P591, DOI 10.1002/dvdy.20016; WANG D, 1986, J CELL BIOL, V103, P1903, DOI 10.1083/jcb.103.5.1903; Wang SY, 2009, J BIOL CHEM, V284, P913, DOI 10.1074/jbc.M804129200; Weernink PAO, 2004, EUR J PHARMACOL, V500, P87, DOI 10.1016/j.ejphar.2004.07.014; Wei Q, 2002, MOL BIOL CELL, V13, P683, DOI 10.1091/mbc.01-07-0358; YAGAMIHIROMASA T, 1995, NATURE, V377, P652, DOI 10.1038/377652a0; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zhang HY, 1996, DEV DYNAM, V205, P348, DOI 10.1002/(SICI)1097-0177(199603)205:3<348::AID-AJA13>3.0.CO;2-0; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004; Zilberman Y, 2009, J CELL SCI, V122, P3531, DOI 10.1242/jcs.046813	101	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35822	10.1371/journal.pone.0035822	http://dx.doi.org/10.1371/journal.pone.0035822			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558231	Green Published, gold			2022-12-27	WOS:000305336000062
J	Farnung, BO; Brun, CM; Arora, R; Lorenzi, LE; Azzalin, CM				Farnung, Benjamin O.; Brun, Catherine M.; Arora, Rajika; Lorenzi, Luca E.; Azzalin, Claus M.			Telomerase Efficiently Elongates Highly Transcribing Telomeres in Human Cancer Cells	PLOS ONE			English	Article							REPEAT-CONTAINING RNA; MAMMALIAN-CELLS; CHROMOSOME ENDS; TERRA; TRANSCRIPTION; YEAST; DNA; INHIBITOR; SILENCE	RNA polymerase II transcribes the physical ends of linear eukaryotic chromosomes into a variety of long non-coding RNA molecules including telomeric repeat-containing RNA (TERRA). Since TERRA discovery, advances have been made in the characterization of TERRA biogenesis and regulation; on the contrary its associated functions remain elusive. Most of the biological roles so far proposed for TERRA are indeed based on in vitro experiments carried out using short TERRA-like RNA oligonucleotides. In particular, it has been suggested that TERRA inhibits telomerase activity. We have exploited two alternative cellular systems to test whether TERRA and/or telomere transcription influence telomerase-mediated telomere elongation in human cancer cells. In cells lacking the two DNA methyltransferases DNMT1 and DNMT3b, TERRA transcription and steady-state levels are greatly increased while telomerase is able to elongate telomeres normally. Similarly, telomerase can efficiently elongate transgenic inducible telomeres whose transcription has been experimentally augmented. Our data challenge the current hypothesis that TERRA functions as a general inhibitor of telomerase and suggest that telomere length homeostasis is maintained independently of TERRA and telomere transcription.	[Farnung, Benjamin O.; Brun, Catherine M.; Arora, Rajika; Lorenzi, Luca E.; Azzalin, Claus M.] ETH, Inst Biochem, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Farnung, BO (corresponding author), ETH, Inst Biochem, Zurich, Switzerland.	claus.azzalin@bc.biol.ethz.ch	azzalin, claus M/K-3898-2015	azzalin, claus M/0000-0002-9396-1980; Arora, Rajika/0000-0001-9396-3671	European Research Council (BFTERRA); Swiss National Science Foundation [3100A0-120090, PP00P3-123356]; Fondazione Cariplo [2008-2507]; Boehringer Ingelheim Fonds	European Research Council (BFTERRA)(European Research Council (ERC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondazione Cariplo(Fondazione Cariplo); Boehringer Ingelheim Fonds(Boehringer Ingelheim)	This work was funded by the European Research Council (BFTERRA), the Swiss National Science Foundation (3100A0-120090 and PP00P3-123356) and Fondazione Cariplo (2008-2507). CMB received a fellowship from Boehringer Ingelheim Fonds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora R, 2012, RNA IN PRESS; Arora R, 2011, PROG MOL SUBCELL BIO, V51, P65, DOI 10.1007/978-3-642-16502-3_4; Azzalin CM, 2008, CELL CYCLE, V7, P1161, DOI 10.4161/cc.7.9.5836; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Azzalin CM, 2007, NATURE, V448, P1001, DOI 10.1038/4481001a; Azzalin CM, 2012, NUCLEUS; Bah A, 2012, NUCLEIC ACIDS RES, V40, P2995, DOI 10.1093/nar/gkr1153; Baird DM, 2003, NAT GENET, V33, P203, DOI 10.1038/ng1084; BARNETT MA, 1993, NUCLEIC ACIDS RES, V21, P27, DOI 10.1093/nar/21.1.27; Chawla R, 2011, EMBO J, V30, P4047, DOI 10.1038/emboj.2011.280; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; Damm K, 2001, EMBO J, V20, P6958, DOI 10.1093/emboj/20.24.6958; Farnung BO, 2010, TRANSCR-AUSTIN, V1, P140, DOI 10.4161/trns.1.3.13191; Flynn RL, 2011, NATURE, V471, P532, DOI 10.1038/nature09772; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Greenwood J, 2012, NUCLEIC ACIDS RES, V40, P2956, DOI 10.1093/nar/gkr1155; Iglesias N, 2011, EMBO REP, V12, P587, DOI 10.1038/embor.2011.73; Kim NW, 1997, NUCLEIC ACIDS RES, V25, P2595, DOI 10.1093/nar/25.13.2595; Luke B, 2009, EMBO J, V28, P2503, DOI 10.1038/emboj.2009.166; Luke B, 2008, MOL CELL, V32, P465, DOI 10.1016/j.molcel.2008.10.019; Nergadze SG, 2009, RNA, V15, P2186, DOI 10.1261/rna.1748309; Ottaviani A, 2008, BIOCHIMIE, V90, P93, DOI 10.1016/j.biochi.2007.07.022; Porro A, 2010, MOL CELL BIOL, V30, P4808, DOI 10.1128/MCB.00460-10; Poulet A, 2012, NUCLEIC ACIDS RES, V40, P2566, DOI 10.1093/nar/gkr1116; Redon S, 2010, NUCLEIC ACIDS RES, V38, P5797, DOI 10.1093/nar/gkq296; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; SANDELL LL, 1994, P NATL ACAD SCI USA, V91, P12061, DOI 10.1073/pnas.91.25.12061; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Vrbsky J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000986; Yehezkel S, 2008, HUM MOL GENET, V17, P2776, DOI 10.1093/hmg/ddn177; Zhao Y, 2009, CELL, V138, P463, DOI 10.1016/j.cell.2009.05.026	32	54	56	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35714	10.1371/journal.pone.0035714	http://dx.doi.org/10.1371/journal.pone.0035714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558207	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000052
J	McCabe, R; Bullenkamp, J; Hansson, L; Lauber, C; Martinez-Leal, R; Rossler, W; Salize, HJ; Svensson, B; Torres-Gonzalez, F; van den Brink, R; Wiersma, D; Priebe, S				McCabe, Rosemarie; Bullenkamp, Jens; Hansson, Lars; Lauber, Christoph; Martinez-Leal, Rafael; Roessler, Wulf; Salize, Hans Joachim; Svensson, Bengt; Torres-Gonzalez, Francisco; van den Brink, Rob; Wiersma, Durk; Priebe, Stefan			The Therapeutic Relationship and Adherence to Antipsychotic Medication in Schizophrenia	PLOS ONE			English	Article							2-WAY COMMUNICATION CHECKLIST; MENTAL-HEALTH-CARE; WORKING ALLIANCE; HELPING ALLIANCE; CASE-MANAGEMENT; PSYCHOTHERAPY; PHARMACOTHERAPY; PERSPECTIVES; VARIABLES; OUTCOMES	Objective: Previous research has shown that a better therapeutic relationship (TR) predicts more positive attitudes towards antipsychotic medication, but did not address whether it is also linked with actual adherence. This study investigated whether the TR is associated with adherence to antipsychotics in patients with schizophrenia. Methods: 134 clinicians and 507 of their patients with schizophrenia or a related psychotic disorder participated in a European multi-centre study. A logistic regression model examined how the TR as rated by patients and by clinicians is associated with medication adherence, adjusting for clinician clustering and symptom severity. Results: Patient and clinician ratings of the TR were weakly inter-correlated (r(s) = 0.13, p = 0.004), but each was independently linked with better adherence. After adjusting for patient rated TR and symptom severity, each unit increase in clinician rated TR was associated with an increase of the odds ratio of good compliance by 65.9% (95% CI: 34.6% to 104.5%). After adjusting for clinician rated TR and symptom severity, for each unit increase in patient rated TR the odds ratio of good compliance was increased by 20.8% (95% CI: 4.4% to 39.8%). Conclusions: A better TR is associated with better adherence to medication among patients with schizophrenia. Patients' and clinicians' perspectives of the TR are both important, but may reflect distinct aspects.	[McCabe, Rosemarie; Priebe, Stefan] Queen Mary Univ London, Unit Social & Community Psychiat, London, England; [Bullenkamp, Jens; Salize, Hans Joachim] Cent Inst Mental Hlth, D-6800 Mannheim, Germany; [Hansson, Lars; Svensson, Bengt] Lund Univ, Dept Hlth Sci, Lund, Sweden; [Lauber, Christoph] Univ Liverpool, Dept Psychiat, Liverpool L69 3BX, Merseyside, England; [Martinez-Leal, Rafael] Fdn Villablanca, Intellectual Disabil Dual Diag Res Unit, Reus, Spain; [Roessler, Wulf] Psychiat Univ Hosp, Dept Gen & Social Psychiat, Zurich, Switzerland; [Torres-Gonzalez, Francisco] Univ Granada, Dept Psychiat, Granada, Spain; [van den Brink, Rob; Wiersma, Durk] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands	University of London; Queen Mary University London; Central Institute of Mental Health; Lund University; University of Liverpool; University of Granada; University of Groningen	McCabe, R (corresponding author), Queen Mary Univ London, Unit Social & Community Psychiat, London, England.	r.mccabe@qmul.ac.uk	Martínez-Leal, Rafael/B-4073-2009; McCabe, Rose/A-9802-2013	Martínez-Leal, Rafael/0000-0002-1333-7951; Priebe, Stefan/0000-0001-9864-3394; McCabe, Rose/0000-0003-2041-7383; Rossler, Wulf/0000-0003-0049-4533	Research Directorate of the European Commission [QLG5-CT-2002-01938]	Research Directorate of the European Commission	The study was funded by the Research Directorate of the European Commission within Framework Programme 5 (QLG5-CT-2002-01938). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnicot K, 2010, ACTA PSYCHIAT SCAND, P1; Bentall R, 2012, J CONSULT C IN PRESS; BRENNER MH, 1995, MED CARE, V33, pAS236; BUCHANAN A, 1992, PSYCHOL MED, V22, P787, DOI 10.1017/S0033291700038228; Calsyn Robert J, 2004, Care Manag J, V5, P199, DOI 10.1891/cmaj.2004.5.4.199; Catty J, 2007, ACTA PSYCHIAT SCAND, V116, P238, DOI 10.1111/j.1600-0447.2007.01070.x; CLARKIN JF, 1987, HOSP COMMUNITY PSYCH, V38, P871; Day JC, 2005, ARCH GEN PSYCHIAT, V62, P717, DOI 10.1001/archpsyc.62.7.717; Donohoe G, 2001, EUR PSYCHIAT, V16, P293, DOI 10.1016/S0924-9338(01)00581-8; FRANK AF, 1990, ARCH GEN PSYCHIAT, V47, P228; Gaudiano BA, 2006, J CONSULT CLIN PSYCH, V74, P671, DOI 10.1037/0022-006X.74.4.671; GEHRS M, 1994, PSYCHOSOC REHABIL J, V18, P43, DOI 10.1037/h0095517; Holzinger A, 2002, J NERV MENT DIS, V190, P597, DOI 10.1097/00005053-200209000-00004; HORVATH AO, 1991, J COUNS PSYCHOL, V38, P139, DOI 10.1037/0022-0167.38.2.139; Junghan UM, 2007, BRIT J PSYCHIAT, V191, P543, DOI 10.1192/bjp.bp.107.037978; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Klinkenberg WD, 1998, COMMUNITY MENT HLT J, V34, P569, DOI 10.1023/A:1018758917277; Krupnick JL, 1996, J CONSULT CLIN PSYCH, V64, P532, DOI 10.1037/0022-006X.64.3.532; Lacro JP, 2002, J CLIN PSYCHIAT, V63, P892, DOI 10.4088/JCP.v63n1007; Martin DJ, 2000, J CONSULT CLIN PSYCH, V68, P438, DOI 10.1037//0022-006X.68.3.438; McCabe R, 2003, EUR PSYCHIAT, V18, P220, DOI 10.1016/S0924-9338(03)00061-0; MCGUFFIN P, 1991, ARCH GEN PSYCHIAT, V48, P764; NEALE MS, 1995, PSYCHIATR SERV, V46, P719; PRIEBE S, 1993, J NERV MENT DIS, V181, P552, DOI 10.1097/00005053-199309000-00004; Priebe S, 2007, BRIT J PSYCHIAT, V191, P420, DOI 10.1192/bjp.bp.107.036939; SOLOMON P, 1995, J MENT HEALTH ADMIN, V22, P126, DOI 10.1007/BF02518753; Strachey J, STANDARD EDITION COM; Svensson B, 1999, J NERV MENT DIS, V187, P579, DOI 10.1097/00005053-199909000-00008; van Os J, 2008, ACTA PSYCHIAT SCAND, V118, P322, DOI 10.1111/j.1600-0447.2008.01228.x; Van Os J, 2004, BRIT J PSYCHIAT, V184, P79, DOI 10.1192/bjp.184.1.79; Velligan DI, 2006, SCHIZOPHRENIA BULL, V32, P724, DOI 10.1093/schbul/sbj075; Velligan DI, 2003, PSYCHIAT SERV, V54, P665, DOI 10.1176/appi.ps.54.5.665; Weiss M, 1997, J CLIN PSYCHIAT, V58, P196, DOI 10.4088/JCP.v58n0504; WOLFE BE, 1988, J CONSULT CLIN PSYCH, V56, P448, DOI 10.1037/0022-006X.56.3.448	34	70	70	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36080	10.1371/journal.pone.0036080	http://dx.doi.org/10.1371/journal.pone.0036080			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TJ	22558336	Green Accepted, Green Published, gold			2022-12-27	WOS:000305336000122
J	Qiu, M; Wang, Q; Chu, Y; Yuan, ZP; Song, HY; Chen, ZW; Wu, ZW				Qiu, Min; Wang, Qin; Chu, Ying; Yuan, Zhongping; Song, Hongyong; Chen, Zhiwei; Wu, Zhiwei			Lignosulfonic Acid Exhibits Broadly Anti-HIV-1 Activity - Potential as a Microbicide Candidate for the Prevention of HIV-1 Sexual Transmission	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DEXTRAN SULFATE; ENVELOPE GLYCOPROTEINS; V3 REGION; BINDING; INFECTION; GP120; HEPARIN; INHIBITION; CELLS	Some secondary metabolites from plants show to have potent inhibitory activities against microbial pathogens, such as human immunodeficiency virus (HIV), herpes simplex virus (HSV), Treponema pallidum, Neisseria gonorrhoeae, etc. Here we report that lignosulfonic acid (LSA), a polymeric lignin derivative, exhibits potent and broad activity against HIV-1 isolates of diverse subtypes including two North America strains and a number of Chinese clinical isolates values ranging from 21.4 to 633 nM. Distinct from other polyanions, LSA functions as an entry inhibitor with multiple targets on viral gp120 as well as on host receptor CD4 and co-receptors CCR5/CXCR4. LSA blocks viral entry as determined by time-of-drug addiction and cell-cell fusion assays. Moreover, LSA inhibits CD4-gp120 interaction by blocking the binding of antibodies specific for CD4-binding sites (CD4bs) and for the V3 loop of gp120. Similarly, LSA interacts with CCR5 and CXCR4 via its inhibition of specific anti-CCR5 and anti-CXCR4 antibodies, respectively. Interestingly, the combination of LSA with AZT and Nevirapine exhibits synergism in viral inhibition. For the purpose of microbicide development, LSA displays low in vitro cytotoxicity to human genital tract epithelial cells, does not stimulate NF-kappa B activation and has no significant up-regulation of IL-1 alpha/beta and IL-8 as compared with N-9. Lastly, LSA shows no adverse effect on the epithelial integrity and the junctional protein expression. Taken together, our findings suggest that LSA can be a potential candidate for tropical microbicide.	[Qiu, Min; Wang, Qin; Chu, Ying; Yuan, Zhongping; Song, Hongyong; Wu, Zhiwei] Nanjing Univ, Sch Med, Ctr Publ Hlth Res, Nanjing 210008, Peoples R China; [Wu, Zhiwei] Nanjing Univ, State Key Lab Analyt Chem Life Sci, Nanjing 210008, Peoples R China; [Chen, Zhiwei] Univ Hong Kong, Li Ka Shing Fac Med, AIDS Inst, Hong Kong, Hong Kong, Peoples R China	Nanjing University; Nanjing University; University of Hong Kong	Qiu, M (corresponding author), Nanjing Univ, Sch Med, Ctr Publ Hlth Res, Nanjing 210008, Peoples R China.	zchenai@hku.hk; wzhw@nju.edu.cn	Chen, Zhiwei/B-7793-2019	Chen, Zhiwei/0000-0002-4511-2888	National Science and Technology Major Project Grant [2012ZX10001007-009-001]; National Science Foundation of China [30870124]; International Collaborative Research Grant from the Ministry of Sciences and Technology of China [2009DFA31260]	National Science and Technology Major Project Grant; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Collaborative Research Grant from the Ministry of Sciences and Technology of China	This study was supported by a National Science and Technology Major Project Grant (Grant No. 2012ZX10001007-009-001), and a grant from National Science Foundation of China (Grant No. 30870124) and an International Collaborative Research Grant from the Ministry of Sciences and Technology of China (Grant No. 2009DFA31260) (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABA M, 1988, ANTIVIR RES, V9, P335, DOI 10.1016/0166-3542(88)90035-6; BATINIC D, 1992, J BIOL CHEM, V267, P6664; CALLAHAN LN, 1991, J VIROL, V65, P1543, DOI 10.1128/JVI.65.3.1543-1550.1991; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chou T.C., 1991, CALCUSYN WINDOWS SOF; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; Crublet E, 2008, J BIOL CHEM, V283, P15193, DOI 10.1074/jbc.M800066200; Daelemans D, 2005, MOL PHARMACOL, V67, P1574, DOI 10.1124/mol.104.010249; Fichorova RN, 2004, BIOL REPROD, V71, P761, DOI 10.1095/biolreprod.104.029603; GOODSELL DS, 1990, PROTEINS, V8, P195, DOI 10.1002/prot.340080302; GORNY MK, 1992, J VIROL, V66, P7538, DOI 10.1128/JVI.66.12.7538-7542.1992; Harrop HA, 1998, GLYCOBIOLOGY, V8, P131, DOI 10.1093/glycob/8.2.131; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huskens D, 2009, ANTIVIR RES, V84, P38, DOI 10.1016/j.antiviral.2009.07.013; ITO M, 1987, ANTIVIR RES, V7, P361, DOI 10.1016/0166-3542(87)90018-0; JOHNSON VA, 1990, TECHNIQUES HIV RES, P71; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; LEDERMAN S, 1989, J IMMUNOL, V143, P1149; Lee B, 1999, J BIOL CHEM, V274, P9617, DOI 10.1074/jbc.274.14.9617; Li L, 2010, ANTIMICROB AGENTS CH, V54, P1700, DOI 10.1128/AAC.01046-09; LORENTSEN KJ, 1989, ANN INTERN MED, V111, P561, DOI 10.7326/0003-4819-111-7-561; LYNCH G, 1994, J LEUKOCYTE BIOL, V56, P266, DOI 10.1002/jlb.56.3.266; Mesquita PMM, 2009, J INFECT DIS, V200, P599, DOI 10.1086/600867; MITSUYA H, 1988, SCIENCE, V240, P646, DOI 10.1126/science.2452480; Mondor I, 1998, J VIROL, V72, P3623, DOI 10.1128/JVI.72.5.3623-3634.1998; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Moulard M, 2000, J VIROL, V74, P1948, DOI 10.1128/JVI.74.4.1948-1960.2000; NAHMIAS AJ, 1964, J BACTERIOL, V87, P1060, DOI 10.1128/JB.87.5.1060-1066.1964; NAKASHIMA H, 1995, ANTIVIR CHEM CHEMOTH, V6, P271, DOI 10.1177/095632029500600410; PARISH CR, 1990, J IMMUNOL, V145, P1188; Pattyn F, 2003, NUCLEIC ACIDS RES, V31, P122, DOI 10.1093/nar/gkg011; Raghuraman A, 2007, BIOMACROMOLECULES, V8, P1759, DOI 10.1021/bm0701651; RIDER CC, 1994, BIOCHEMISTRY-US, V33, P6974, DOI 10.1021/bi00188a029; RODERIQUEZ G, 1995, J VIROL, V69, P2233, DOI 10.1128/JVI.69.4.2233-2239.1995; Roehr B, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5538; Rusconi S, 1996, ANTIMICROB AGENTS CH, V40, P234, DOI 10.1128/AAC.40.1.234; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Shang H, 2011, J BIOL CHEM, V286, P14531, DOI 10.1074/jbc.M111.224527; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Tao W, 2008, AIDS RES HUM RETROV, V24, P925, DOI 10.1089/aid.2008.0043; Tufaro F, 1997, TRENDS MICROBIOL, V5, P257, DOI 10.1016/S0966-842X(97)01057-3; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; WITVROUW M, 1994, ANTIVIR CHEM CHEMOTH, V5, P345, DOI 10.1177/095632029400500601; Wu ZW, 2003, J INFECT DIS, V188, P1473, DOI 10.1086/379248; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884	50	13	14	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35906	10.1371/journal.pone.0035906	http://dx.doi.org/10.1371/journal.pone.0035906			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558266	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000082
J	Wilkinson, FL; Holley, RJ; Langford-Smith, KJ; Badrinath, S; Liao, AY; Langford-Smith, A; Cooper, JD; Jones, SA; Wraith, JE; Wynn, RF; Merry, CLR; Bigger, BW				Wilkinson, Fiona L.; Holley, Rebecca J.; Langford-Smith, Kia J.; Badrinath, Soumya; Liao, Aiyin; Langford-Smith, Alex; Cooper, Jonathan D.; Jones, Simon A.; Wraith, J. Ed; Wynn, Rob F.; Merry, Catherine L. R.; Bigger, Brian W.			Neuropathology in Mouse Models of Mucopolysaccharidosis Type I, IIIA and IIIB	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; LYSOSOMAL STORAGE DISORDERS; ALPHA-L-IDURONIDASE; SYNDROME TYPE-B; SANFILIPPO-SYNDROME; MICROGLIAL ACTIVATION; TARGETED DISRUPTION; DISEASE; BRAIN; MICE	Mucopolysaccharide diseases (MPS) are caused by deficiency of glycosaminoglycan (GAG) degrading enzymes, leading to GAG accumulation. Neurodegenerative MPS diseases exhibit cognitive decline, behavioural problems and shortened lifespan. We have characterised neuropathological changes in mouse models of MPSI, IIIA and IIIB to provide a better understanding of these events. Wild-type (WT), MPSI, IIIA and IIIB mouse brains were analysed at 4 and 9 months of age. Quantitative immunohistochemistry showed significantly increased lysosomal compartment, GM2 ganglioside storage, neuroinflammation, decreased and mislocalised synaptic vesicle associated membrane protein, (VAMP2), and decreased post-synaptic protein, Homer-1, in layers II/III-VI of the primary motor, somatosensory and parietal cortex. Total heparan sulphate (HS), was significantly elevated, and abnormally N-, 6-O and 2-O sulphated compared to WT, potentially altering HS-dependent cellular functions. Neuroinflammation was confirmed by significantly increased MCP-1, MIP-1 alpha, IL-1 alpha, using cytometric bead arrays. An overall genotype effect was seen in all parameters tested except for synaptophysin staining, neuronal cell number and cortical thickness which were not significantly different from WT. MPSIIIA and IIIB showed significantly more pronounced pathology than MPSI in lysosomal storage, astrocytosis, microgliosis and the percentage of 2-O sulphation of HS. We also observed significant time progression of all genotypes from 4-9 months in lysosomal storage, astrocytosis, microgliosis and synaptic disorganisation but not GM2 gangliosidosis. Individual genotype*time differences were disparate, with significant progression from 4 to 9 months only seen for MPSIIIB with lysosomal storage, MPSI with astrocytocis and MPSIIIA with microgliosis as well as neuronal loss. Transmission electron microscopy of MPS brains revealed dystrophic axons, axonal storage, and extensive lipid and lysosomal storage. These data lend novel insight to MPS neuropathology, suggesting that MPSIIIA and IIIB have more pronounced neuropathology than MPSI, yet all are still progressive, at least in some aspects of neuropathology, from 4-9 months.	[Wilkinson, Fiona L.; Langford-Smith, Kia J.; Badrinath, Soumya; Liao, Aiyin; Langford-Smith, Alex; Bigger, Brian W.] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England; [Holley, Rebecca J.; Merry, Catherine L. R.] Univ Manchester, Sch Mat, Manchester, Lancs, England; [Cooper, Jonathan D.] Kings Coll London, Inst Psychiat, MRC Ctr Neurodegenerat Res, Ctr Cellular Basis Behav, London, England; [Cooper, Jonathan D.] Kings Coll London, Inst Psychiat, MRC Ctr Neurodegenerat Res, Pediat Storage Disorders Lab,Dept Neurosci, London, England; [Wynn, Rob F.] Royal Manchester Childrens Hosp, Blood & Marrow Transplant Unit, Manchester M27 1HA, Lancs, England; [Jones, Simon A.; Wraith, J. Ed] St Marys Hosp, Manchester M13 0JH, Lancs, England	University of Manchester; University of Manchester; University of London; King's College London; University of London; King's College London; Royal Manchester Children's Hospital; University of Manchester	Wilkinson, FL (corresponding author), Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England.	Brian.Bigger@manchester.ac.uk	Langford-Smith, Alex/H-5249-2011; Langford-Smith, Alex/K-7624-2017; Badrinath, Soumya/AGK-8855-2022; Cooper, Jonathan/V-9962-2019; Cooper, Jonathan/C-8117-2009; Bigger, Brian/I-3553-2012	Langford-Smith, Alex/0000-0001-7006-0592; Langford-Smith, Alex/0000-0001-7006-0592; Cooper, Jonathan/0000-0003-1339-4750; Cooper, Jonathan/0000-0003-1339-4750; Bigger, Brian/0000-0002-9708-1112; merry, catherine/0000-0002-3490-2809; Wilkinson, Fiona/0000-0002-0358-3489	Mucopolysaccharidosis Society (United Kingdom); Lady Shauna Gosling Trust; National Institute of Health Research Manchester Biomedical Research Centre; Human Frontier Science Program; Medical Research Council; Biotechnology and Biological Sciences Research Council; Wellcome Fund; University of Manchester	Mucopolysaccharidosis Society (United Kingdom); Lady Shauna Gosling Trust; National Institute of Health Research Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Human Frontier Science Program(Human Frontier Science Program); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Fund(Burroughs Wellcome Fund); University of Manchester	This study was funded by grants awarded to BWB by the Mucopolysaccharidosis Society (United Kingdom), the Lady Shauna Gosling Trust and supported by the National Institute of Health Research Manchester Biomedical Research Centre. RJH and CLRM would like to acknowledge funding from The Human Frontier Science Program and The Medical Research Council. The Bioimaging Facility microscopes used in this study were purchased with grants from Biotechnology and Biological Sciences Research Council, Wellcome and the University of Manchester Strategic Fund. The funders had no role in the study design, data collection and analysis, decision to publish or in preparation of the manuscript.	Ausseil J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002296; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bhaumik M, 1999, GLYCOBIOLOGY, V9, P1389, DOI 10.1093/glycob/9.12.1389; Blackhall FH, 2001, BRIT J CANCER, V85, P1094, DOI 10.1054/bjoc.2001.2054; Canal MM, 2010, BEHAV BRAIN RES, V209, P212, DOI 10.1016/j.bbr.2010.01.045; Centonze D, 2009, J NEUROSCI, V29, P3442, DOI 10.1523/JNEUROSCI.5804-08.2009; Clarke LA, 1997, HUM MOL GENET, V6, P503, DOI 10.1093/hmg/6.4.503; Clarke Lorne A., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000550; CONSTANTOPOULOS G, 1978, J NEUROCHEM, V30, P965, DOI 10.1111/j.1471-4159.1978.tb12388.x; Crawley AC, 2006, BRAIN RES, V1104, P1, DOI 10.1016/j.brainres.2006.05.079; Deakin JA, 2008, GLYCOBIOLOGY, V18, P483, DOI 10.1093/glycob/cwn028; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; DiRosario J, 2009, J NEUROSCI RES, V87, P978, DOI 10.1002/jnr.21912; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Foa L, 2009, J NEUROCHEM, V108, P1, DOI 10.1111/j.1471-4159.2008.05726.x; Fraser J, 2002, CLIN GENET, V62, P418, DOI 10.1034/j.1399-0004.2002.620512.x; Gallagher JT, 2006, BIOCHEM SOC T, V34, P438, DOI 10.1042/BST0340438; Heldermon CD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000772; Hemsley KM, 2009, EUR J NEUROSCI, V29, P1197, DOI 10.1111/j.1460-9568.2009.06666.x; Hemsley KM, 2008, GENES BRAIN BEHAV; Hochuli M, 2003, NMR BIOMED, V16, P224, DOI 10.1002/nbm.833; Holley RJ, 2011, J BIOL CHEM, V286, P37515, DOI 10.1074/jbc.M111.287474; Jaubert PJ, 2007, GENES BRAIN BEHAV, V6, P141, DOI 10.1111/j.1601-183X.2006.00240.x; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; King B, 2006, MOL GENET METAB, V87, P107, DOI 10.1016/j.ymgme.2005.09.026; Langford-Smith A, 2011, GENES BRAIN BEHAV, V10, P673, DOI 10.1111/j.1601-183X.2011.00706.x; Langford-Smith A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025717; Larsen KE, 2002, HISTOL HISTOPATHOL, V17, P897, DOI 10.14670/HH-17.897; Li HH, 1999, P NATL ACAD SCI USA, V96, P14505, DOI 10.1073/pnas.96.25.14505; Malinowska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014192; Malinowska M, 2009, MOL GENET METAB, V98, P235, DOI 10.1016/j.ymgme.2009.06.013; McGlynn R, 2004, J COMP NEUROL, V480, P415, DOI 10.1002/cne.20355; Neufeld EF, 2007, MUCOPOLYSACCHARIDOSE; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Ohmi K, 2003, P NATL ACAD SCI USA, V100, P1902, DOI 10.1073/pnas.252784899; Paxinos F, 2004, MOUSE BRAIN STEREOTA; Perrimon N, 2001, SEMIN CELL DEV BIOL, V12, P65, DOI 10.1006/scdb.2000.0237; Prasad VK, 2008, BLOOD, V112, P2979, DOI 10.1182/blood-2008-03-140830; Pye DA, 1998, J BIOL CHEM, V273, P22936, DOI 10.1074/jbc.273.36.22936; Sadir R, 2001, J BIOL CHEM, V276, P8288, DOI 10.1074/jbc.M008110200; Savas PS, 2004, MOL GENET METAB, V82, P273, DOI 10.1016/j.ymgme.2004.05.005; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Szumlinski KK, 2005, GENES BRAIN BEHAV, V4, P273, DOI 10.1111/j.1601-183X.2005.00120.x; Taylor KR, 2006, FASEB J, V20, P9, DOI 10.1096/fj.05-4682rev; Tomatsu S, MOL GENET METAB, V99, P124; Tyynela J, 2004, BRAIN PATHOL, V14, P349; Valstar MJ, 2008, J INHERIT METAB DIS, V31, P240, DOI 10.1007/s10545-008-0838-5; Vitry S, 2009, MOL CELL NEUROSCI, V41, P8, DOI 10.1016/j.mcn.2009.01.001; Wada R, 2000, P NATL ACAD SCI USA, V97, P10954, DOI 10.1073/pnas.97.20.10954; Walkley SU, 2009, BBA-MOL CELL RES, V1793, P726, DOI 10.1016/j.bbamcr.2008.11.014; Walkley SU, 2004, SEMIN CELL DEV BIOL, V15, P433, DOI 10.1016/j.semcdb.2004.03.002; Wong KD, 2004, MOL GENET METAB, V82, P192, DOI 10.1016/j.ymgme.2004.04.011; Wraith J E, 2002, Semin Neonatol, V7, P75, DOI 10.1053/siny.2001.0088; Yamaguchi Y, 2010, PROG MOL BIOL TRANSL, V93, P133, DOI 10.1016/S1877-1173(10)93007-X	55	126	130	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35787	10.1371/journal.pone.0035787	http://dx.doi.org/10.1371/journal.pone.0035787			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558223	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000060
J	Brug, J; van Stralen, MM; te Velde, SJ; Chinapaw, MJM; De Bourdeaudhuij, I; Lien, N; Bere, E; Maskini, V; Singh, AS; Maes, L; Moreno, L; Jan, N; Kovacs, E; Lobstein, T; Manios, Y				Brug, Johannes; van Stralen, Maartje M.; te Velde, Saskia J.; Chinapaw, Mai J. M.; De Bourdeaudhuij, Ilse; Lien, Nanna; Bere, Elling; Maskini, Victoria; Singh, Amika S.; Maes, Lea; Moreno, Luis; Jan, Natasa; Kovacs, Eva; Lobstein, Tim; Manios, Yannis			Differences in Weight Status and Energy-Balance Related Behaviors among Schoolchildren across Europe: The ENERGY-Project	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SLEEP DURATION; PRO CHILDREN; OVERWEIGHT; OBESITY; ADOLESCENTS; DESIGN; PREVENTION; YOUTH; DETERMINANTS	Background: Current data on the prevalence of overweight and energy-balance behaviors among European children is necessary to inform overweight prevention interventions. Methodology/Principal Findings: A school-based survey among 10-12 year old children was conducted in seven European countries using a standardized protocol. Weight, height, and waist circumference were measured; Engagement in physical activity, sedentary and dietary behaviors, and sleep duration were self-reported. Descriptive analyses were conducted, looking at differences according to country, gender, and parental education. 7234 children (52% girls; 11.6 +/- 0.7 years) participated. 25.8% and 5.4% of boys, and 21.8% and 4.1% of girls were overweight (including obese) and obese (according to International Obesity Task Force criteria), respectively. Higher prevalence of overweight/obesity was observed in Greece, Hungary, Slovenia and Spain than in Belgium, Netherlands and Norway. Large differences between countries were found in intakes of sugar-sweetened beverages, breakfast, active transport, TV and computer time. More favorable overweight status and behavior patterns were found in girls than boys and in children of higher educated parents than in children of lower educated parents. Conclusions/Significance: High levels and striking differences in overweight status and potential risk behaviors were found among schoolchildren across Europe.	[Brug, Johannes; te Velde, Saskia J.] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Brug, Johannes; van Stralen, Maartje M.; te Velde, Saskia J.; Chinapaw, Mai J. M.; Singh, Amika S.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [van Stralen, Maartje M.; Chinapaw, Mai J. M.; Singh, Amika S.] Vrije Univ Amsterdam, Med Ctr, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [De Bourdeaudhuij, Ilse] Univ Ghent, Dept Movement & Sport Sci, Ghent, Belgium; [Lien, Nanna] Univ Oslo, Dept Nutr, N-0316 Oslo, Norway; [Bere, Elling] Univ Agder, Dept Publ Hlth Sport & Nutr, Kristiansand, Norway; [Maskini, Victoria; Manios, Yannis] Harokopio Univ, Dept Nutr & Dietet, Athens, Greece; [Maes, Lea] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium; [Moreno, Luis] Univ Zaragoza, GENUD Growth Exercise Nutr & Dev Res Grp EU Cienc, E-50009 Zaragoza, Spain; [Jan, Natasa] Slovenian Heart Fdn, Ljubljana, Slovenia; [Kovacs, Eva] Univ Pecs, Dept Paediat, Pecs, Hungary; [Lobstein, Tim] IASO, London, England	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Ghent University; University of Oslo; University of Agder; Harokopio University Athens; Ghent University; University of Zaragoza; University of Pecs	Brug, J (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands.	j.brug@vumc.nl	Paw, Mai Chin A/N-1665-2019; Brug, Johannes/A-8242-2018; Akkal, Maureen/P-6919-2014; Manios, Yannis/AAM-8953-2021; Singh, Amika/F-5033-2012; De+Bourdeaudhuij, Ilse/AAC-5528-2019; Maes, Lea/D-6014-2013; Moreno, Luis/S-1780-2019	Paw, Mai Chin A/0000-0001-6259-2441; Brug, Johannes/0000-0002-1904-7349; Manios, Yannis/0000-0001-6486-114X; De+Bourdeaudhuij, Ilse/0000-0001-9969-7597; Moreno, Luis/0000-0003-0454-653X; Lobstein, Tim/0000-0003-4102-0545; van Stralen, Maartje/0000-0001-5534-4271; te Velde, Saskia/0000-0002-4674-8052	European Commission [223254]; Netherlands Organization for Health Research and Development [50-50150-98-002]; EMGO Institute for Health and Care Research	European Commission(European CommissionEuropean Commission Joint Research Centre); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); EMGO Institute for Health and Care Research	The ENERGY-project is funded by the Seventh Framework Programme (CORDIS FP7) of the European Commission, HEALTH (FP7-HEALTH-2007-B), Grant agreement no. 223254. The content of this article reflects only the authors' views and the European Community is not liable for any use that may be made of the information contained therein. In the Netherlands, the ENERGY-project was additionally supported by a grant from the Netherlands Organization for Health Research and Development (Grant number 50-50150-98-002). The contribution of MvS was supported by a fellowship of the EMGO Institute for Health and Care Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnekow V., 2008, INEQUALITIES YOUNG P; Bleich SN, 2011, INT J OBESITY, V35, P1, DOI 10.1038/ijo.2010.252; Borrestad LAB, 2011, PREV MED, V52, P133, DOI 10.1016/j.ypmed.2010.12.006; Brug J, 2010, PUBLIC HEALTH NUTR, V13, P1676, DOI 10.1017/S1368980010002211; Brug J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-276; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Central Bureau of Statistics the Netherlands (CBS), 2010, TRENDR 2010 LAND JEU; Chen XL, 2008, OBESITY, V16, P265, DOI 10.1038/oby.2007.63; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Delva J, 2006, J ADOLESCENT HEALTH, V39, P536, DOI 10.1016/j.jadohealth.2006.02.013; Douthwaite W, IDENTIFYING MOST IMP; Fredriks AM, 2005, ACTA PAEDIATR, V94, P496, DOI [10.1080/08035250410024240, 10.1111/j.1651-2227.2005.tb01923.x]; Gordon-Larsen P, 2003, OBES RES, V11, P121, DOI 10.1038/oby.2003.20; Gorely T, 2004, INT J BEHAV MED, V11, P152, DOI 10.1207/s15327558ijbm1103_4; Haug E, 2009, INT J PUBLIC HEALTH, V54, P167, DOI 10.1007/s00038-009-5408-6; Jansen W, 2010, J HUM NUTR DIET, V23, P85, DOI 10.1111/j.1365-277X.2009.01027.x; Jansen W, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-257; Klepp KI, 2005, ANN NUTR METAB, V49, P212, DOI 10.1159/000087245; Lean M., 2010, OBESITY EPIDEMIOLOGY, P59; Lien N, 2010, PUBLIC HEALTH NUTR, V13, P1680, DOI 10.1017/S1368980010002223; Lobstein T, 2003, Obes Rev, V4, P195, DOI 10.1046/j.1467-789X.2003.00116.x; Maffeis C, 2000, EUR J PEDIATR, V159, pS35, DOI 10.1007/PL00014361; Reilly J.J., 2010, OBESITY EPIDEMIOLOGY, P27; Rennie KL, 2005, BEST PRACT RES CL EN, V19, P343, DOI 10.1016/j.beem.2005.04.003; Rokholm B, 2010, OBES REV, V11, P835, DOI 10.1111/j.1467-789X.2010.00810.x; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Singh AS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-136; Swinburn BA, 2004, PUBLIC HEALTH NUTR, V7, P123, DOI 10.1079/PHN2003585; te Velde SJ, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-31; te Velde SJ, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-16; Van der Horst K, 2007, MED SCI SPORT EXER, V39, P1241, DOI 10.1249/mss.0b013e318059bf35; van Stralen MM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-65; Wang YF, 2007, PUBLIC HEALTH NUTR, V10, P927, DOI 10.1017/S1368980007658005; Yngve A, 2008, EUR J PUBLIC HEALTH, V18, P126, DOI 10.1093/eurpub/ckm099	37	207	207	8	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e34742	10.1371/journal.pone.0034742	http://dx.doi.org/10.1371/journal.pone.0034742			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558098	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345200013
J	Domingues, CP; Nolasco, R; Dubert, J; Queiroga, H				Domingues, Carla P.; Nolasco, Rita; Dubert, Jesus; Queiroga, Henrique			Model-Derived Dispersal Pathways from Multiple Source Populations Explain Variability of Invertebrate Larval Supply	PLOS ONE			English	Article							CRAB CARCINUS-MAENAS; DIEL VERTICAL MIGRATION; TIDAL STREAM TRANSPORT; CORAL-REEF FISH; CALLINECTES-SAPIDUS; MARINE POPULATIONS; GENE FLOW; BENTHIC INVERTEBRATES; RETENTION MECHANISM; SEASCAPE GENETICS	Background: Predicting the spatial and temporal patterns of marine larval dispersal and supply is a challenging task due to the small size of the larvae and the variability of oceanographic processes. Addressing this problem requires the use of novel approaches capable of capturing the inherent variability in the mechanisms involved. Methodology/Principal Findings: In this study we test whether dispersal and connectivity patterns generated from a biophysical model of larval dispersal of the crab Carcinus maenas, along the west coast of the Iberian Peninsula, can predict the highly variable daily pattern of wind-driven larval supply to an estuary observed during the peak reproductive season (March-June) in 2006 and 2007. Cross-correlations between observed and predicted supply were significant (p < 0.05) and strong, ranging from 0.34 to 0.81 at time lags of -6 to + 5 d. Importantly, the model correctly predicted observed cross-shelf distributions (Pearson r = 0.82, p < 0.001, and r = 0.79, p < 0.01, in 2006 and 2007) and indicated that all supply events were comprised of larvae that had been retained within the inner shelf; larvae transported to the outer shelf and beyond never recruited. Estimated average dispersal distances ranged from 57 to 198 km and were only marginally affected by mortality. Conclusions/Significance: The high degree of predicted demographic connectivity over relatively large geographic scales is consistent with the lack of genetic structuring in C. maenas along the Iberian Peninsula. These findings indicate that the dynamic nature of larval dispersal can be captured by mechanistic biophysical models, which can be used to provide meaningful predictions of the patterns and causes of fine-scale variability in larval supply to marine populations.	[Domingues, Carla P.; Nolasco, Rita; Dubert, Jesus; Queiroga, Henrique] Univ Aveiro, Ctr Estudos Ambiente & Mar CESAM, P-3800 Aveiro, Portugal; [Domingues, Carla P.; Queiroga, Henrique] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Nolasco, Rita; Dubert, Jesus] Univ Aveiro, Dept Fis, P-3800 Aveiro, Portugal	Universidade de Aveiro; Universidade de Aveiro; Universidade de Aveiro	Domingues, CP (corresponding author), Univ Aveiro, Ctr Estudos Ambiente & Mar CESAM, Campus Univ Santiago, P-3800 Aveiro, Portugal.	cdomingues@ua.pt	Dubert, Jesus/B-7517-2008; Domingues, Carla/F-7503-2010; Nolasco, Rita TS/D-1809-2019; Queiroga, Henrique/C-5134-2008; Dubert, Jesus/B-2803-2009	Queiroga, Henrique/0000-0002-2338-0013; Dubert, Jesus/0000-0002-3338-6777; nolasco, maria rita/0000-0003-1942-8800	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/21593/2005]; FCT under European Regional Development Fund [PTDC/BIA-BDE/65425/2006, PTDC/MAR/65760/2006]; Fundação para a Ciência e a Tecnologia [PTDC/MAR/65760/2006, PTDC/BIA-BDE/65425/2006] Funding Source: FCT	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT under European Regional Development Fund; Fundação para a Ciência e a Tecnologia	Fundacao para a Ciencia e a Tecnologia (FCT) supported a PhD grant to CPD (SFRH/BD/21593/2005). This work is part of the "Connect - Connectivity of marine populations assessed with genetic and numerical modeling tools'' (No. PTDC/BIA-BDE/65425/2006) and "ISCAD - Inner shelf circulation and dispersion patterns: Interactions with estuarine systems" (No. PTDC/MAR/65760/2006) research projects, both funded by FCT under the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken CM, 2007, MAR ECOL PROG SER, V339, P13, DOI 10.3354/meps339013; Becker BJ, 2007, P NATL ACAD SCI USA, V104, P3267, DOI 10.1073/pnas.0611651104; Carr SD, 2008, FISH OCEANOGR, V17, P1, DOI 10.1111/j.1365-2419.2007.00447.x; Chatfield C, 1996, ANAL TIME SERIES DAT, V5; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; da Silva A M, 1994, ATLAS SURFACE MARINE; DEVRIES MC, 1994, MAR BIOL, V118, P403, DOI 10.1007/BF00350297; DOHERTY PJ, 1995, ECOLOGY, V76, P2373, DOI 10.2307/2265814; Domingues CP, 2011, HEREDITY, V106, P832, DOI 10.1038/hdy.2010.126; Domingues CP, 2011, MAR ECOL PROG SER, V425, P113, DOI 10.3354/meps08992; Domingues CP, 2010, MAR ECOL PROG SER, V410, P111, DOI 10.3354/meps08610; dos Santos A, 2008, MAR ECOL PROG SER, V359, P171, DOI 10.3354/meps07341; Ellien C, 2004, J PLANKTON RES, V26, P117, DOI 10.1093/plankt/fbh018; Erftemeijer PLA, 2009, MAR ECOL PROG SER, V390, P167, DOI 10.3354/meps08173; FORWARD RB, 1994, J EXP MAR BIOL ECOL, V182, P183, DOI 10.1016/0022-0981(94)90050-7; Galindo HM, 2006, CURR BIOL, V16, P1622, DOI 10.1016/j.cub.2006.06.052; Galindo HM, 2010, MOL ECOL, V19, P3692, DOI 10.1111/j.1365-294X.2010.04694.x; HELLBERG ME, 1994, EVOLUTION, V48, P1829, DOI 10.1111/j.1558-5646.1994.tb02218.x; Hunt HL, 1997, MAR ECOL PROG SER, V155, P269, DOI 10.3354/meps155269; Incze LS, 2000, FISH OCEANOGR, V9, P99, DOI 10.1046/j.1365-2419.2000.00125.x; Jackson GA, 1981, AM NATURALIST, V118; James MK, 2002, P ROY SOC B-BIOL SCI, V269, P2079, DOI 10.1098/rspb.2002.2128; KORDOS LM, 1993, MAR BIOL, V117, P227, DOI 10.1007/BF00345667; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; Levitus S., 1994, WORLD OCEAN ATLAS 19, V4; Levitus S., 1994, WORLD OCEAN ATLAS 19, V3; Marchesiello P, 2001, OCEAN MODEL, V3, P1, DOI 10.1016/s1463-5003(00)00013-5; Marta-Almeida M, 2006, CONT SHELF RES, V26, P385, DOI 10.1016/j.csr.2005.11.011; Marta-Almeida M, 2006, MAR ECOL PROG SER, V307, P1, DOI 10.3354/meps307001; Metaxas A, 2009, BIOL BULL-US, V216, P257, DOI 10.1086/BBLv216n3p257; Miller TJ, 2007, MAR ECOL PROG SER, V347, P127, DOI 10.3354/meps06973; Morgan Steven G., 1995, P279; Morgan SG, 2009, ECOLOGY, V90, P3489, DOI 10.1890/08-1550.1; Morgan SG, 2009, MAR ECOL PROG SER, V380, P173, DOI 10.3354/meps07913; Nagaraj M., 1993, Scientia Marina, V57, P1; OKUBO A, 1994, BIOPHYSICS MARINE LA, P5; Oliveira PB, 2009, CONT SHELF RES, V29, P759, DOI 10.1016/j.csr.2008.08.004; Paris CB, 2004, LIMNOL OCEANOGR, V49, P1964, DOI 10.4319/lo.2004.49.6.1964; Peliz A, 2007, J MARINE SYST, V68, P215, DOI 10.1016/j.jmarsys.2006.11.007; Peliz A, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2007JC004159; Peterson W, 1998, J MARINE SYST, V15, P313, DOI 10.1016/S0924-7963(97)00082-1; Pfeiffer-Herbert AS, 2007, LIMNOLOGY OCEANOGRAP, V52, P11; Pineda J, 2000, OCEANOGR E PAC, V1, P84; Queiroga H, 2006, MAR ECOL PROG SER, V307, P21, DOI 10.3354/meps307021; QUEIROGA H, 1994, MAR ECOL PROG SER, V111, P63, DOI 10.3354/meps111063; Queiroga H, 1996, J PLANKTON RES, V18, P1981, DOI 10.1093/plankt/18.11.1981; Queiroga H, 1998, HYDROBIOLOGIA, V375-76, P137, DOI 10.1023/A:1017004921555; Queiroga H, 1997, MAR ECOL PROG SER, V149, P121, DOI 10.3354/meps149121; Reyns NB, 2007, FISH OCEANOGR, V16, P257, DOI 10.1111/j.1365-2419.2007.00420.x; Rice A.L., 1975, Bulletin of the British Museum (Natural History) Zoology, V28, P103; ROUGHGARDEN J, 1985, ECOLOGY, V66, P54, DOI 10.2307/1941306; Sale Peter F., 2006, P3, DOI 10.1016/B978-012088781-1/50004-2; Santos AMP, 2004, CONT SHELF RES, V24, P149, DOI 10.1016/j.csr.2003.10.004; Shanks AL, 2003, ECOL APPL, V13, pS159; Shanks AL, 1998, MAR ECOL PROG SER, V168, P57, DOI 10.3354/meps168057; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; SHULMAN MJ, 1995, EVOLUTION, V49, P897, DOI 10.1111/j.1558-5646.1995.tb02325.x; Siegel DA, 2008, P NATL ACAD SCI USA, V105, P8974, DOI 10.1073/pnas.0802544105; Siegel DA, 2003, MAR ECOL PROG SER, V260, P83, DOI 10.3354/meps260083; Sotka EE, 2004, MOL ECOL, V13, P2143, DOI 10.1111/j.1365-294X.2004.02225.x; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; TANKERSLEY RA, 1995, MAR BIOL, V122, P391, DOI 10.1007/BF00350871; THORROLD SR, 1994, MAR ECOL PROG SER, V112, P75, DOI 10.3354/meps112075; Watson JR, 2010, MAR ECOL PROG SER, V401, P31, DOI 10.3354/meps08376; Welch JM, 2001, MAR BIOL, V139, P911; Werner FE, 2007, OCEANOGRAPHY, V20, P54, DOI 10.5670/oceanog.2007.29; Wing SR, 1995, MAR ECOL PROG SER, V128, P199, DOI 10.3354/meps128199; WOOSTER WS, 1976, J MAR RES, V34, P131	69	29	29	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35794	10.1371/journal.pone.0035794	http://dx.doi.org/10.1371/journal.pone.0035794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558225	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345200079
J	Lee, J; Sandford, AJ; Connett, JE; Yan, J; Mui, T; Li, YX; Daley, D; Anthonisen, NR; Brooks-Wilson, A; Man, SFP; Sin, DD				Lee, Jee; Sandford, Andrew J.; Connett, John E.; Yan, Jin; Mui, Tammy; Li, Yuexin; Daley, Denise; Anthonisen, Nicholas R.; Brooks-Wilson, Angela; Man, S. F. Paul; Sin, Don D.			The Relationship between Telomere Length and Mortality in Chronic Obstructive Pulmonary Disease (COPD)	PLOS ONE			English	Article							SHORTENS TELOMERES; QUANTITATIVE PCR; CANCER; SMOKING; RISK; INTERVENTION; HEALTH; CARE	Some have suggested that chronic obstructive pulmonary disease (COPD) is a disease of accelerated aging. Aging is characterized by shortening of telomeres. The relationship of telomere length to important clinical outcomes such as mortality, disease progression and cancer in COPD is unknown. Using quantitative polymerase chain reaction (qPCR), we measured telomere length of peripheral leukocytes in 4,271 subjects with mild to moderate COPD who participated in the Lung Health Study (LHS). The subjects were followed for approximately 7.5 years during which time their vital status, FEV1 and smoking status were ascertained. Using multiple regression methods, we determined the relationship of telomere length to cancer and total mortality in these subjects. We also measured telomere length in healthy "mid-life" volunteers and patients with more severe COPD. The LHS subjects had significantly shorter telomeres than those of healthy "mid-life" volunteers (p<.001). Compared to individuals in the 4th quartile of relative telomere length (i.e. longest telomere group), the remaining participants had significantly higher risk of cancer mortality (Hazard ratio, HR, 1.48; p = 0.0324) and total mortality (HR, 1.29; p = 0.0425). Smoking status did not make a significant difference in peripheral blood cells telomere length. In conclusion, COPD patients have short leukocyte telomeres, which are in turn associated increased risk of total and cancer mortality. Accelerated aging is of particular relevance to cancer mortality in COPD.	[Lee, Jee; Sandford, Andrew J.; Yan, Jin; Mui, Tammy; Li, Yuexin; Daley, Denise; Man, S. F. Paul; Sin, Don D.] Univ British Columbia, Providence Heart & Lung Inst, St Pauls Hosp, UBC James Hogg Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Lee, Jee; Sandford, Andrew J.; Yan, Jin; Mui, Tammy; Li, Yuexin; Daley, Denise; Man, S. F. Paul; Sin, Don D.] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Connett, John E.] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA; [Anthonisen, Nicholas R.] Univ Manitoba, Fac Med, Winnipeg, MB, Canada; [Brooks-Wilson, Angela] British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada	St. Paul's Hospital; University of British Columbia; University of Saskatchewan; University of British Columbia; University of Minnesota System; University of Minnesota Twin Cities; University of Manitoba; British Columbia Cancer Agency	Lee, J (corresponding author), Univ British Columbia, Providence Heart & Lung Inst, St Pauls Hosp, UBC James Hogg Res Ctr, Vancouver, BC V5Z 1M9, Canada.	don.sin@hli.ubc.ca	Brooks-Wilson, Angela/E-9399-2012; Sin, Don/AAC-2219-2021	Brooks-Wilson, Angela/0000-0003-1009-6408; 	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The study was funded by the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Anthonisen NR, 2005, ANN INTERN MED, V142, P233, DOI 10.7326/0003-4819-142-4-200502150-00005; Capezzone M, 2008, J CLIN ENDOCR METAB, V93, P3950, DOI 10.1210/jc.2008-0372; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Halaschek-Wiener J, 2008, MECH AGEING DEV, V129, P638, DOI 10.1016/j.mad.2008.07.004; HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Horn T, 2010, HEREDITY, V105, P497, DOI 10.1038/hdy.2010.113; Houben JMJ, 2009, RESP MED, V103, P230, DOI 10.1016/j.rmed.2008.09.003; Lee J, 2011, CURR OPIN PULM MED, V17, P90, DOI 10.1097/MCP.0b013e328341cead; LEVY MZ, 1992, J MOL BIOL, V225, P951, DOI 10.1016/0022-2836(92)90096-3; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Mapel DW, 2000, ARCH INTERN MED, V160, P2653, DOI 10.1001/archinte.160.17.2653; Morla M, 2006, EUR RESPIR J, V27, P525, DOI 10.1183/09031936.06.00087005; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Mui TSY, 2009, J AM GERIATR SOC, V57, P2372, DOI 10.1111/j.1532-5415.2009.02589.x; Munoz P, 2006, CELL CYCLE, V5, P718, DOI 10.4161/cc.5.7.2636; Savale L, 2009, AM J RESP CRIT CARE, V179, P566, DOI 10.1164/rccm.200809-1398OC; Shen M, 2011, LUNG CANCER, V73, P133, DOI 10.1016/j.lungcan.2010.11.009; Sin Don D, 2006, BMC Pulm Med, V6, P3, DOI 10.1186/1471-2466-6-3; Soriano JB, 2005, CHEST, V128, P2099, DOI 10.1378/chest.128.4.2099; Strandberg TE, 2011, J GERONTOL A-BIOL, V66, P815, DOI 10.1093/gerona/glr064; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897	25	63	64	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35567	10.1371/journal.pone.0035567	http://dx.doi.org/10.1371/journal.pone.0035567			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558169	gold, Green Published			2022-12-27	WOS:000305345200048
J	Martinez, J; Duplouy, A; Woolfit, M; Vavre, F; O'Neill, SL; Varaldi, J				Martinez, Julien; Duplouy, Anne; Woolfit, Megan; Vavre, Fabrice; O'Neill, Scott L.; Varaldi, Julien			Influence of the Virus LbFV and of Wolbachia in a Host-Parasitoid Interaction	PLOS ONE			English	Article							MUTUALISTIC RELATIONSHIPS; DROSOPHILA-MELANOGASTER; GENETIC INTERACTIONS; BACTERIAL SYMBIONTS; IMMUNE-RESPONSE; SUPERPARASITISM; RESISTANCE; INFECTION; SIMULANS; APHIDS	Symbionts are widespread and might have a substantial effect on the outcome of interactions between species, such as in host-parasitoid systems. Here, we studied the effects of symbionts on the outcome of host-parasitoid interactions in a four-partner system, consisting of the parasitoid wasp Leptopilina boulardi, its two hosts Drosophila melanogaster and D. simulans, the wasp virus LbFV, and the endosymbiotic bacterium Wolbachia. The virus is known to manipulate the superparasitism behavior of the parasitoid whereas some Wolbachia strains can reproductively manipulate and/or confer pathogen protection to Drosophila hosts. We used two nuclear backgrounds for both Drosophila species, infected with or cured of their respective Wolbachia strains, and offered them to L. boulardi of one nuclear background, either infected or uninfected by the virus. The main defence mechanism against parasitoids, i.e. encapsulation, and other important traits of the interaction were measured. The results showed that virus-infected parasitoids are less frequently encapsulated than uninfected ones. Further experiments showed that this viral effect involved both a direct protective effect against encapsulation and an indirect effect of superparasitism. Additionally, the Wolbachia strain wAu affected the encapsulation ability of its Drosophila host but the direction of this effect was strongly dependent on the presence/absence of LbFV. Our results confirmed the importance of heritable symbionts in the outcome of antagonistic interactions.	[Martinez, Julien; Vavre, Fabrice; Varaldi, Julien] Univ Lyon 1, CNRS, UMR5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Duplouy, Anne] Univ Helsinki, Dept Biol & Environm Sci, Helsinki, Finland; [Woolfit, Megan; O'Neill, Scott L.] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; University of Helsinki; Monash University	Martinez, J (corresponding author), Univ Lyon 1, CNRS, UMR5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France.	julien.martinez@univ-lyon1.fr; anne.duplouy@helsinki.fi	Martinez, Julien/AAW-6287-2020; vavre, fabrice/N-2945-2017; O'Neill, Scott L/B-3568-2009; O'Neill, Scott/R-9560-2019; Woolfit, Megan/G-2809-2010; Duplouy, Anne/J-2182-2015	Martinez, Julien/0000-0001-8210-2921; vavre, fabrice/0000-0003-0909-2936; O'Neill, Scott L/0000-0002-4131-3615; O'Neill, Scott/0000-0002-4131-3615; Duplouy, Anne/0000-0002-7147-5199; varaldi, julien/0000-0002-2100-1542	Australian Research Council [DP0772992]; Centre National de la Recherche Scientifique [UMR CNRS 5558]	Australian Research Council(Australian Research Council); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	Prof. O'Neill's Australian Research Council grant (DP0772992), Centre National de la Recherche Scientifique (UMR CNRS 5558). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asgari S, 1998, P NATL ACAD SCI USA, V95, P3690, DOI 10.1073/pnas.95.7.3690; Beckage NE, 1998, PARASITOLOGY, V116, pS57, DOI 10.1017/S0031182000084948; Bezier A, 2009, SCIENCE, V323, P926, DOI 10.1126/science.1166788; Carton Y, 1997, PARASITOL TODAY, V13, P218, DOI 10.1016/S0169-4758(97)01058-2; Carton Y, 2001, IMMUNOGENETICS, V52, P157; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Chevalier F, 2010, PLOS ONE, V6; David J, 1962, DROSOPH INF SERV, V36, P128; Drezen JM, 2006, ICOPA XI: PROCEEDINGS OF THE 11TH INTERNATIONAL CONGRESS OF PARASITOLOGY, P59; Dubuffet A, 2007, HEREDITY, V98, P21, DOI 10.1038/sj.hdy.6800893; Dupas S, 1998, J HERED, V89, P306, DOI 10.1093/jhered/89.4.306; Dupas S, 2003, HEREDITY, V90, P84, DOI 10.1038/sj.hdy.6800182; Ferrari J, 2011, PHILOS T R SOC B, V366, P1389, DOI 10.1098/rstb.2010.0226; Fleury F, 2004, GENETICA, V120, P181, DOI 10.1023/B:GENE.0000017640.78087.9e; Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398; Fytrou A, 2006, P R SOC B, V273, P791, DOI 10.1098/rspb.2005.3383; Gandon S, 2006, AM NAT, V167, pE1, DOI 10.1086/498398; Gilbert SF, 2010, PHILOS T R SOC B, V365, P671, DOI 10.1098/rstb.2009.0245; GIORDANENGO P, 1990, ENTOMOL EXP APPL, V56, P155, DOI 10.1007/BF00163458; Glaser RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011977; Goodrich-Blair H, 2007, MOL MICROBIOL, V64, P260, DOI 10.1111/j.1365-2958.2007.05671.x; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hegazi E, 2008, J INVERTEBR PATHOL, V98, P79, DOI 10.1016/j.jip.2008.02.009; Hoffmann AA, 1996, HEREDITY, V76, P1, DOI 10.1038/hdy.1996.1; HOFFMANN AA, 1986, EVOLUTION, V40, P692, DOI 10.1111/j.1558-5646.1986.tb00531.x; Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043; Jaenike J, 2010, SCIENCE, V329, P212, DOI 10.1126/science.1188235; Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531; Kinuthia W, 1999, J INSECT PHYSIOL, V45, P501, DOI 10.1016/S0022-1910(98)00164-4; Kraaijeveld AR, 2001, P ROY SOC B-BIOL SCI, V268, P259, DOI 10.1098/rspb.2000.1354; Mercot H, 2004, GENETICA, V120, P51, DOI 10.1023/B:GENE.0000017629.31383.8f; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656; Patot S, 2010, MOL ECOL, V19, P2995, DOI 10.1111/j.1365-294X.2010.04686.x; Patot S, 2009, APPL ENVIRON MICROB, V75, P703, DOI 10.1128/AEM.01778-08; Renault S, 2005, J INSECT PHYSIOL, V51, P137, DOI 10.1016/j.jinsphys.2004.08.002; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Schneider DS, 2008, SCIENCE, V322, P1199, DOI 10.1126/science.1167450; Sicard M, 2010, NATURWISSENSCHAFTEN, V97, P819, DOI 10.1007/s00114-010-0699-2; Stasiak K, 2005, J INSECT PHYSIOL, V51, P103, DOI 10.1016/j.jinsphys.2004.07.004; Sternberg ED, 2011, INFECT GENET EVOL, V11, P399, DOI 10.1016/j.meegid.2010.11.017; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Thomas P, 2011, DEV COMP IMMUNOL, V35, P360, DOI 10.1016/j.dci.2010.11.007; Varaldi J, 2003, SCIENCE, V302, P1930, DOI 10.1126/science.1088798; Varaldi J, 2005, PARASITOLOGY, V131, P161, DOI 10.1017/S0031182005007602; Varaldi J, 2006, J INSECT PHYSIOL, V52, P1202, DOI 10.1016/j.jinsphys.2006.09.002; Volkoff AN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000923; Vorburger C, 2010, BIOL LETTERS, V6, P109, DOI 10.1098/rsbl.2009.0642; Vorburger C, 2009, EVOLUTION, V63, P1439, DOI 10.1111/j.1558-5646.2009.00660.x; Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355; Xie JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012149; Yamada R, 2007, GENETICS, V177, P801, DOI 10.1534/genetics.106.068486; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	57	21	21	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35081	10.1371/journal.pone.0035081	http://dx.doi.org/10.1371/journal.pone.0035081			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558118	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345200024
J	Stock, RP; Brewer, J; Wagner, K; Ramos-Cerrillo, B; Duelund, L; Jernshoj, KD; Olsen, LF; Bagatolli, LA				Stock, Roberto P.; Brewer, Jonathan; Wagner, Kerstin; Ramos-Cerrillo, Blanca; Duelund, Lars; Jernshoj, Kit Drescher; Olsen, Lars Folke; Bagatolli, Luis A.			Sphingomyelinase D Activity in Model Membranes: Structural Effects of in situ Generation of Ceramide-1-Phosphate	PLOS ONE			English	Article							GIANT UNILAMELLAR VESICLES; 2-PHOTON FLUORESCENCE MICROSCOPY; PHOSPHOLIPASE A(2) ENZYMES; BROWN RECLUSE SPIDER; LOXOSCELES-RECLUSA; LAURDAN FLUORESCENCE; INFLAMMATORY RESPONSE; CERAMIDE 1-PHOSPHATE; LATERAL ORGANIZATION; DERMONECROTIC TOXIN	The toxicity of Loxosceles spider venom has been attributed to a rare enzyme, sphingomyelinase D, which transforms sphingomyelin to ceramide-1-phosphate. The bases of its inflammatory and dermonecrotic activity, however, remain unclear. In this work the effects of ceramide-1-phosphate on model membranes were studied both by in situ generation of this lipid using a recombinant sphingomyelinase D from the spider Loxosceles laeta and by pre-mixing it with sphingomyelin and cholesterol. The systems of choice were large unilamellar vesicles for bulk studies (enzyme kinetics, fluorescence spectroscopy and dynamic light scattering) and giant unilamellar vesicles for fluorescence microscopy examination using a variety of fluorescent probes. The influence of membrane lateral structure on the kinetics of enzyme activity and the consequences of enzyme activity on the structure of target membranes containing sphingomyelin were examined. The findings indicate that: 1) ceramide-1-phosphate (particularly lauroyl ceramide-1-phosphate) can be incorporated into sphingomyelin bilayers in a concentration-dependent manner and generates coexistence of liquid disordered/solid ordered domains, 2) the activity of sphingomyelinase D is clearly influenced by the supramolecular organization of its substrate in membranes and, 3) in situ ceramide-1-phosphate generation by enzymatic activity profoundly alters the lateral structure and morphology of the target membranes.	[Stock, Roberto P.; Ramos-Cerrillo, Blanca] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico; [Stock, Roberto P.; Brewer, Jonathan; Wagner, Kerstin; Bagatolli, Luis A.] Univ So Denmark, Membrane Biophys & Biophoton Grp, Dept Biochem & Mol Biol, Ctr Biomembrane Phys,MEMPHYS, Odense, Denmark; [Duelund, Lars] Univ So Denmark, Ctr Biomembrane Phys, Dept Phys Chem & Pharm, MEMPHYS, Odense, Denmark; [Jernshoj, Kit Drescher; Olsen, Lars Folke] Univ So Denmark, Dept Biochem & Mol Biol, Cellular Complex Grp CelCom, Odense, Denmark	Universidad Nacional Autonoma de Mexico; University of Southern Denmark; University of Southern Denmark; University of Southern Denmark	Stock, RP (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico.	bagatolli@memphys.sdu.dk	Duelund, Lars/AHB-2952-2022; Duelund, Lars/AAC-7110-2019; Brewer, Jonathan/C-7079-2012; Bagatolli, Luis/L-5159-2016	Duelund, Lars/0000-0002-3786-2822; Brewer, Jonathan/0000-0002-3444-1715; Bagatolli, Luis/0000-0002-4727-8611; Olsen, Lars Folke/0000-0001-7391-2340; Jernshoj, Kit Drescher/0000-0003-3697-2170	Forskningsradet for Natur og Univers (FNU) [272-08-0575]; Danish National Research Foundation; Mexican Consejo Nacional de Ciencia y Tecnologia (CONACyT) [146899]; Danish Research Council for Technology and Innovation (project NaKIM); European Community [236688]	Forskningsradet for Natur og Univers (FNU)(Danish Natural Science Research Council); Danish National Research Foundation(Danmarks Grundforskningsfond); Mexican Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Danish Research Council for Technology and Innovation (project NaKIM); European Community(European Commission)	This research was supported by Forskningsradet for Natur og Univers (FNU) research grant 272-08-0575 and the Danish National Research Foundation (which supports MEMPHYS - Center for Biomembrane Physics). Dr. Stock was supported by a sabbatical grant from the Mexican Consejo Nacional de Ciencia y Tecnologia (CONACyT, 146899). Dr. Jernshoj and Dr. Olsen acknowledges support from the Danish Research Council for Technology and Innovation (project NaKIM). Dr. Wagner was supported by the European Community's Seventh Framework Program FP7/2007-2013 under grant agreement no. 236688. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGELOVA MI, 1992, PROG COLL POL SCI S, V89, P127; Bagatolli LA, 2000, BIOPHYS J, V78, P290, DOI 10.1016/S0006-3495(00)76592-1; Bagatolli LA, 2000, BIOPHYS J, V79, P434, DOI 10.1016/S0006-3495(00)76305-3; Bagatolli LA, 2006, BBA-BIOMEMBRANES, V1758, P1541, DOI 10.1016/j.bbamem.2006.05.019; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BELL JD, 1989, J BIOL CHEM, V264, P12194; Binford GJ, 2009, MOL BIOL EVOL, V26, P547, DOI 10.1093/molbev/msn274; Brewer J, 2010, BBA-BIOMEMBRANES, V1798, P1301, DOI 10.1016/j.bbamem.2010.02.024; Chaim OM, 2011, BBA-MOL CELL BIOL L, V1811, P84, DOI 10.1016/j.bbalip.2010.11.005; Chaves-Moreira D, 2009, J CELL BIOCHEM, V107, P655, DOI 10.1002/jcb.22148; Chiantia S, 2006, BIOPHYS J, V90, P4500, DOI 10.1529/biophysj.106.081026; Chioato L, 2003, TOXICON, V42, P869, DOI 10.1016/j.toxicon.2003.11.027; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Dragulev B, 2007, J INVEST DERMATOL, V127, P1267, DOI 10.1038/sj.jid.5700812; Dragulev B, 2007, J INVEST DERMATOL, V127, P1264, DOI 10.1038/sj.jid.5700644; DRESSLER KA, 1990, J BIOL CHEM, V265, P14917; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; El Alwani M, 2006, PHARMACOL THERAPEUT, V112, P171, DOI 10.1016/j.pharmthera.2006.04.004; Epand RM, 2003, BIOPHYS J, V84, P3102, DOI 10.1016/S0006-3495(03)70035-6; Fidorra M, 2006, BIOPHYS J, V90, P4437, DOI 10.1529/biophysj.105.077107; FINSY R, 1992, PART PART SYST CHAR, V9, P125, DOI 10.1002/ppsc.19920090117; Fiske CH, 1925, J BIOL CHEM, V66, P375; FORRESTER LJ, 1978, ARCH BIOCHEM BIOPHYS, V187, P355, DOI 10.1016/0003-9861(78)90046-2; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Gomes MTR, 2011, TOXICON, V57, P574, DOI 10.1016/j.toxicon.2011.01.001; Gomez-Munoz A, 2004, FEBS LETT, V562, P5, DOI 10.1016/S0014-5793(04)00211-X; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hinkovska-Galcheva VT, 1998, J BIOL CHEM, V273, P33203, DOI 10.1074/jbc.273.50.33203; Hogan CJ, 2004, ANN EMERG MED, V44, P608, DOI 10.1016/j.annemergmed.2004.08.028; Ibarguren M, 2010, BBA-BIOMEMBRANES, V1798, P1735, DOI 10.1016/j.bbamem.2010.06.004; Isbister GK, 2011, LANCET, V378, P2039, DOI 10.1016/S0140-6736(10)62230-1; JAIN MK, 1989, BIOCHIM BIOPHYS ACTA, V1002, P127, DOI 10.1016/0005-2760(89)90281-6; Jensen LB, 2005, BIOPHYS J, V88, P2692, DOI 10.1529/biophysj.104.056457; Kini RM, 2005, TOXICON, V45, P1147, DOI 10.1016/j.toxicon.2005.02.018; Kini RM, 2003, TOXICON, V42, P827, DOI 10.1016/j.toxicon.2003.11.002; Kooijman EE, 2008, BIOPHYS J, V94, P4320, DOI 10.1529/biophysj.107.121046; Kubiak J, 2011, BIOPHYS J, V100, P978, DOI 10.1016/j.bpj.2011.01.012; KURPIEWSKI G, 1981, BIOCHIM BIOPHYS ACTA, V678, P467, DOI 10.1016/0304-4165(81)90128-8; Lee S, 2005, BIOCHEM J, V391, P317, DOI 10.1042/BJ20050043; Lohse B, 2008, J AM CHEM SOC, V130, P14372, DOI 10.1021/ja805030w; MAGGIO B, 1994, BBA-BIOMEMBRANES, V1190, P137, DOI 10.1016/0005-2736(94)90043-4; Marsh D, 1996, BBA-REV BIOMEMBRANES, V1286, P183, DOI 10.1016/S0304-4157(96)00009-3; Meseth U, 1999, BIOPHYS J, V76, P1619, DOI 10.1016/S0006-3495(99)77321-2; Montes LR, 2007, BIOPHYS J, V93, P3548, DOI 10.1529/biophysj.107.116228; Morrow MR, 2009, BIOPHYS J, V96, P2216, DOI 10.1016/j.bpj.2008.11.060; Mouritsen OG, 2005, FRONT COLLECT, P1, DOI 10.1007/b138577; Olvera A, 2006, TOXICON, V48, P64, DOI 10.1016/j.toxicon.2006.04.010; PARASASSI T, 1994, BIOPHYS J, V66, P763, DOI 10.1016/S0006-3495(94)80852-5; PARASASSI T, 1991, BIOPHYS J, V60, P179, DOI 10.1016/S0006-3495(91)82041-0; PARASASSI T, 1995, BIOPHYS J, V68, P1895, DOI 10.1016/S0006-3495(95)80367-X; PARASASSI T, 1990, BIOPHYS J, V57, P1179, DOI 10.1016/S0006-3495(90)82637-0; Parasassi T, 1998, J FLUORESC, V8, P365, DOI 10.1023/A:1020528716621; PARASASSI T, 1994, BIOPHYS J, V66, P120, DOI 10.1016/S0006-3495(94)80763-5; Pedrosa MD, 2002, BIOCHEM BIOPH RES CO, V298, P638, DOI 10.1016/S0006-291X(02)02521-4; Pettus BJ, 2004, CURR MOL MED, V4, P405, DOI 10.2174/1566524043360573; Pettus BJ, 2004, J BIOL CHEM, V279, P11320, DOI 10.1074/jbc.M309262200; Pott T, 2008, CHEM PHYS LIPIDS, V154, P115, DOI 10.1016/j.chemphyslip.2008.03.008; Ramos-Cerrillo B, 2004, TOXICON, V44, P507, DOI 10.1016/j.toxicon.2004.06.013; Ramu Y, 2006, NATURE, V442, P696, DOI 10.1038/nature04880; Subbaiah PV, 2003, J LIPID RES, V44, P1574, DOI 10.1194/jlr.M300103-JLR200; Tambourgi DV, 2007, MOL IMMUNOL, V44, P576, DOI 10.1016/j.molimm.2006.02.002; Tambourgi DV, 2010, TOXICON, V56, P1113, DOI 10.1016/j.toxicon.2010.01.021; van Blitterswijk WJ, 2003, BIOCHEM J, V369, P199, DOI 10.1042/BJ20021528; van Meeteren LA, 2004, J BIOL CHEM, V279, P10833, DOI 10.1074/jbc.C300563200; van Meeteren LA, 2007, J INVEST DERMATOL, V127, P1266, DOI 10.1038/sj.jid.5700745; VERNON LP, 1992, PHARMACOL THERAPEUT, V54, P269, DOI 10.1016/0163-7258(92)90003-I	66	21	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e36003	10.1371/journal.pone.0036003	http://dx.doi.org/10.1371/journal.pone.0036003			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558302	gold, Green Published, Green Submitted			2022-12-27	WOS:000305345200108
J	Wesolowski, A; Eagle, N; Noor, AM; Snow, RW; Buckee, CO				Wesolowski, Amy; Eagle, Nathan; Noor, Abdisalan M.; Snow, Robert W.; Buckee, Caroline O.			Heterogeneous Mobile Phone Ownership and Usage Patterns in Kenya	PLOS ONE			English	Article							HEALTH; MALARIA	The rapid adoption of mobile phone technologies in Africa is offering exciting opportunities for engaging with high-risk populations through mHealth programs, and the vast volumes of behavioral data being generated as people use their phones provide valuable data about human behavioral dynamics in these regions. Taking advantage of these opportunities requires an understanding of the penetration of mobile phones and phone usage patterns across the continent, but very little is known about the social and geographical heterogeneities in mobile phone ownership among African populations. Here, we analyze a survey of mobile phone ownership and usage across Kenya in 2009 and show that distinct regional, gender-related, and socioeconomic variations exist, with particularly low ownership among rural communities and poor people. We also examine patterns of phone sharing and highlight the contrasting relationships between ownership and sharing in different parts of the country. This heterogeneous penetration of mobile phones has important implications for the use of mobile technologies as a source of population data and as a public health tool in sub-Saharan Africa.	[Wesolowski, Amy] Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15213 USA; [Eagle, Nathan; Buckee, Caroline O.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Noor, Abdisalan M.] KEMRI Wellcome Trust Univ Oxford Collaborat Progr, Malaria Publ Hlth & Epidemiol Grp, Ctr Geog Med, Nairobi, Kenya; [Noor, Abdisalan M.; Snow, Robert W.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Buckee, Caroline O.] Harvard Univ, Sch Publ Hlth, Ctr Communicable Dis Dynam, Boston, MA 02115 USA	Carnegie Mellon University; Harvard University; Harvard T.H. Chan School of Public Health; University of Oxford; Harvard University; Harvard T.H. Chan School of Public Health	Wesolowski, A (corresponding author), Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15213 USA.	cbuckee@hsph.harvard.edu	Snow, Robert William/AFR-1436-2022	Snow, Robert William/0000-0003-3725-6088	Models of Infectious Disease Agent Study program [1U54GM088558]; Wellcome Trust [095127, 079080]; Kenya Medical Research Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	Models of Infectious Disease Agent Study program; Wellcome Trust(Wellcome TrustEuropean Commission); Kenya Medical Research Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	COB was supported by the Models of Infectious Disease Agent Study program (cooperative agreement 1U54GM088558). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health. AMN is supported by the Wellcome Trust as an Intermediate Research Fellow (#095127). RWS is supported by the Wellcome Trust as Principal Research Fellow (#079080). AMN and RWS also acknowledge support from the Kenya Medical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akter S, 2010, Yearb Med Inform, P94; Blumenstock JE, 2009, MOBILE DIVIDES GENDE; CIA, 2009, CIA WORLD FACTB 2010; Eagle N, 2010, SCIENCE, V328, P1029, DOI 10.1126/science.1186605; Estrin D, 2010, SCIENCE, V330, P759, DOI 10.1126/science.1196187; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; James J, 2007, SOC INDIC RES, V84, P117, DOI 10.1007/s11205-006-9079-x; Kamanga A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-96; Lester R, 2008, LANCET INFECT DIS, V8, P738, DOI 10.1016/S1473-3099(08)70265-2; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Meankaew P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-237; Tamrat T, 2012, MATERN CHILD HLTH J, V16, P1092, DOI 10.1007/s10995-011-0836-3; Tatem AJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-287; United Nations Foundation, 2009, MHEALTH DEV OPP MOB; Wesolowski A, 2010, AAAI C P; Zurovac D, 2011, LANCET, V378, P795, DOI 10.1016/S0140-6736(11)60783-6	17	126	128	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35319	10.1371/journal.pone.0035319	http://dx.doi.org/10.1371/journal.pone.0035319			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558140	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345200032
J	Winkler, C; Raab, J; Grallert, H; Ziegler, AG				Winkler, Christiane; Raab, Jennifer; Grallert, Harald; Ziegler, Anette-Gabriele			Lack of Association of Type 2 Diabetes Susceptibility Genotypes and Body Weight on the Development of Islet Autoimmunity and Type 1 Diabetes	PLOS ONE			English	Article							ANTIBODY STANDARDIZATION PROGRAM; HHEX-IDE; AUTOANTIBODIES; ASSAYS; LOCI; PATHOGENESIS; PREVALENCE; PRO12ALA; CHILDREN; PARENTS	Aim: To investigate whether type 2 diabetes susceptibility genes and body weight influence the development of islet autoantibodies and the rate of progression to type 1 diabetes. Methods: Genotyping for single nucleotide polymorphisms (SNP) of the type 2 diabetes susceptibility genes CDKAL1, CDKN2A/2B, FTO, HHEX-IDE, HMGA2, IGF2BP2, KCNJ11, KCNQ1, MTNR1B, PPARG, SLC30A8 and TCF7L2 was obtained in 1350 children from parents with type 1 diabetes participating in the BABYDIAB study. Children were prospectively followed from birth for islet autoantibodies and type 1 diabetes. Data on weight and height were obtained at 9 months, 2, 5, 8, 11, and 14 years of age. Results: None of type 2 diabetes risk alleles at the CDKAL1, CDKN2A/2B, FTO, HHEX-IDE, HMGA2, IGF2BP2, KCNJ11, KCNQ1, MTNR1B, PPARG and SLC30A8 loci were associated with the development of islet autoantibodies or diabetes. The type 2 diabetes susceptible genotype of TCF7L2 was associated with a lower risk of islet autoantibodies (7% vs. 12% by age of 10 years, P = 0.015, P-corrected = 0.18). Overweight children at seroconversion did not progress to diabetes faster than non-overweight children (HR: 1.08; 95% CI: 0.48-2.45, P>0.05). Conclusions: These findings do not support an association of type 2 diabetes risk factors with islet autoimmunity or acceleration of diabetes in children with a family history of type 1 diabetes.	[Winkler, Christiane; Ziegler, Anette-Gabriele] Helmholtz Zentrum Munchen, Diabet Res Inst, Neuherberg, Germany; [Winkler, Christiane; Raab, Jennifer; Ziegler, Anette-Gabriele] Helmholtz Zentrum Munchen, Forschergrp Diabet eV, Neuherberg, Germany; [Grallert, Harald] Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Neuherberg, Germany; [Ziegler, Anette-Gabriele] Univ Technol Munich, Forschergrp Diabet, Klinikum Rechts Isar, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Winkler, C (corresponding author), Helmholtz Zentrum Munchen, Diabet Res Inst, Neuherberg, Germany.	anette-g.ziegler@helmholtz-muenchen.de	Ziegler, Anette-Gabriele/M-4614-2014; Grallert, Harald/B-3424-2013	Ziegler, Anette-Gabriele/0000-0002-6290-5548; Raab, Jennifer/0000-0002-5411-5511	Helmholtz Zentrum Munchen; Competence Network for Diabetes mellitus; Federal Ministry of Education and Research [FKZ 01GI0805-07]; JDRF [17-2012-16]	Helmholtz Zentrum Munchen(Helmholtz Association); Competence Network for Diabetes mellitus; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); JDRF(Juvenile Diabetes Research Foundation)	The work was supported by grants from the Helmholtz Zentrum Munchen, the Competence Network for Diabetes mellitus funded by the Federal Ministry of Education and Research (FKZ 01GI0805-07), and the JDRF (No. 17-2012-16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach P, 2009, DIABETOLOGIA, V52, P1881, DOI 10.1007/s00125-009-1438-0; American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Cecil JE, 2005, DIABETOLOGIA, V48, P1496, DOI 10.1007/s00125-005-1817-0; Dabelea D, 2006, DIABETES CARE, V29, P290, DOI 10.2337/diacare.29.02.06.dc05-1339; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Field SF, 2007, DIABETOLOGIA, V50, P212, DOI 10.1007/s00125-006-0506-y; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; Knip M, 2008, PEDIATR DIABETES, V9, P46, DOI 10.1111/j.1399-5448.2007.00344.x; Krischer J, 2007, PEDIATR DIABETES, V8, P286; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Lampasona V, 2011, CLIN CHEM, V57, P1693, DOI 10.1373/clinchem.2011.170662; Libman IM, 2003, DIABETES CARE, V26, P2876, DOI 10.2337/diacare.26.10.2876; Libman IM, 2003, DIABETES CARE, V26, P2871, DOI 10.2337/diacare.26.10.2871; Raj SM, 2009, DIABETOLOGIA, V52, P2109, DOI 10.1007/s00125-009-1391-y; Schenker M, 1999, DIABETOLOGIA, V42, P671, DOI 10.1007/s001250051214; Schlosser M, 2010, DIABETOLOGIA, V53, P2611, DOI 10.1007/s00125-010-1915-5; Torn C, 2008, DIABETOLOGIA, V51, P846, DOI 10.1007/s00125-008-0967-2; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Winkler C, 2009, DIABETOLOGIA, V52, P2072, DOI 10.1007/s00125-009-1461-1; Winkler C, 2010, DIABETES, V59, P2063, DOI 10.2337/db10-0099; Winkler C, 2009, J CLIN ENDOCR METAB, V94, P4113, DOI 10.1210/jc.2009-0970; Zhao JH, 2010, DIABETES, V59, P751, DOI 10.2337/db09-0972; Ziegler AG, 1999, DIABETES, V48, P460, DOI 10.2337/diabetes.48.3.460	24	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35410	10.1371/journal.pone.0035410	http://dx.doi.org/10.1371/journal.pone.0035410			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558147	gold, Green Submitted, Green Published			2022-12-27	WOS:000305345200037
J	Njauw, CNJ; Kim, I; Piris, A; Gabree, M; Taylor, M; Lane, AM; DeAngelis, MM; Gragoudas, E; Duncan, LM; Tsao, H				Njauw, Ching-Ni Jenny; Kim, Ivana; Piris, Adriano; Gabree, Michele; Taylor, Michael; Lane, Anne Marie; DeAngelis, Margaret M.; Gragoudas, Evangelos; Duncan, Lyn M.; Tsao, Hensin			Germline BAP1 Inactivation Is Preferentially Associated with Metastatic Ocular Melanoma and Cutaneous-Ocular Melanoma Families	PLOS ONE			English	Article							CDKN2A CARRIER PROBABILITY; UVEAL MELANOMA; MUTATIONS; MESOTHELIOMA; PREDISPOSE; MENINGIOMA; MODEL	Background: BAP1 has been shown to be a target of both somatic alteration in high-risk ocular melanomas (OM) and germline inactivation in a few individuals from cancer-prone families. These findings suggest that constitutional BAP1 changes may predispose individuals to metastatic OM and that familial permeation of deleterious alleles could delineate a new cancer syndrome. Design: To characterize BAP1's contribution to melanoma risk, we sequenced BAP1 in a set of 100 patients with OM, including 50 metastatic OM cases and 50 matched non-metastatic OM controls, and 200 individuals with cutaneous melanoma (CM) including 7 CM patients from CM-OM families and 193 CM patients from CM-non-OM kindreds. Results: Germline BAP1 mutations were detected in 4/50 patients with metastatic OM and 0/50 cases of non-metastatic OM (8% vs. 0%, p = 0.059). Since 2/4 of the BAP1 carriers reported a family history of CM, we analyzed 200 additional hereditary CM patients and found mutations in 2/7 CM probands from CM-OM families and 1/193 probands from CM-non-OM kindreds (29% vs. 0.52%, p = .003). Germline mutations co-segregated with both CM and OM phenotypes and were associated with the presence of unique nevoid melanomas and highly atypical nevoid melanoma-like melanocytic proliferations (NEMMPs). Interestingly, 7/14 germline variants identified to date reside in C-terminus suggesting that the BRCA1 binding domain is important in cancer predisposition. Conclusion: Germline BAP1 mutations are associated with a more aggressive OM phenotype and a recurrent phenotypic complex of cutaneous/ocular melanoma, atypical melanocytic proliferations and other internal neoplasms (ie. COMMON syndrome), which could be a useful clinical marker for constitutive BAP1 inactivation.	[Njauw, Ching-Ni Jenny; Taylor, Michael; Tsao, Hensin] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Kim, Ivana; Lane, Anne Marie; Gragoudas, Evangelos] Massachusetts Eye & Ear Infirm, Retina Serv, Boston, MA 02114 USA; [Piris, Adriano; Duncan, Lyn M.] Massachusetts Gen Hosp, Dept Pathol, Div Dermatopathol, Boston, MA 02114 USA; [Gabree, Michele; Tsao, Hensin] Massachusetts Gen Hosp, Massachusetts Gen Hosp Canc Ctr, Boston, MA 02114 USA; [DeAngelis, Margaret M.] Univ Utah, Sch Med, John A Moran Eye Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT USA; [Tsao, Hensin] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Utah System of Higher Education; University of Utah; Harvard University; Massachusetts General Hospital	Njauw, CNJ (corresponding author), Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA.	htsao@partners.org	Njauw, Ching-Ni/H-8046-2012; DeAngelis, e/J-7863-2015; Ferris, Laura/I-7689-2012	Kim, Ivana/0000-0003-0310-6129	National Institutes of Health [K24 CA14920, P50 CA93683]; American Skin Association; American Cancer Society; NATIONAL CANCER INSTITUTE [P50CA093683, K24CA149202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Skin Association; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported in part by the National Institutes of Health (K24 CA14920 and P50 CA93683), the American Skin Association, the American Cancer Society, and the generous philanthropic donors to the MGH Millennium Melanoma Fund and the MEEI Melanoma Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman MH, 2011, J MED GENET, V48, P856, DOI 10.1136/jmedgenet-2011-100156; Bott M, 2011, NAT GENET, V43, P668, DOI 10.1038/ng.855; Buecher B, 2010, FAM CANCER, V9, P663, DOI 10.1007/s10689-010-9379-9; CAGIANUT B, 1972, KLIN MONATSBL AUGENH, V161, P407; Eletr ZM, 2011, CELL BIOCHEM BIOPHYS, V60, P3, DOI 10.1007/s12013-011-9184-6; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Niendorf KB, 2006, J MED GENET, V43, P501, DOI 10.1136/jmg.2005.032441; Prescher G, 1996, LANCET, V347, P1222; Singh AD, 2011, OPHTHALMOLOGY, V118, P1881, DOI 10.1016/j.ophtha.2011.01.040; Testa JR, 2011, NAT GENET, V43, P1022, DOI 10.1038/ng.912; Torres EM, 2010, CELL, V143, P71, DOI 10.1016/j.cell.2010.08.038; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Wang WY, 2010, CANCER RES, V70, P552, DOI 10.1158/0008-5472.CAN-09-2653; Wiesner T, 2011, NAT GENET, V43, P1018, DOI 10.1038/ng.910; Zhao XS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1421	16	175	175	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35295	10.1371/journal.pone.0035295	http://dx.doi.org/10.1371/journal.pone.0035295			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545102	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343200023
J	van Eekelen, M; Runtuwene, V; Masselink, W; den Hertog, J				van Eekelen, Mark; Runtuwene, Vincent; Masselink, Wouter; den Hertog, Jeroen			Pair-Wise Regulation of Convergence and Extension Cell Movements by Four Phosphatases via RhoA	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; FAS-MEDIATED APOPTOSIS; TISSUE POLARITY GENE; ZEBRAFISH GASTRULATION; XENOPUS-LAEVIS; GROWTH-FACTOR; MICE LACKING; PDZ-DOMAIN; TYROSINE PHOSPHORYLATION; VERTEBRATE GASTRULATION	Various signaling pathways regulate shaping of the main body axis during early vertebrate development. Here, we focused on the role of protein-tyrosine phosphatase signaling in convergence and extension cell movements. We identified Ptpn20 as a structural paralogue of PTP-BL and both phosphatases were required for normal gastrulation cell movements. Interestingly, knockdowns of PTP-BL and Ptpn20 evoked similar developmental defects as knockdown of RPTP alpha and PTP epsilon. Co-knockdown of RPTP alpha and PTP-BL, but not Ptpn20, had synergistic effects and conversely, PTP epsilon and Ptpn20, but not PTP-BL, cooperated, demonstrating the specificity of our approach. RPTP alpha and PTP epsilon knockdowns were rescued by constitutively active RhoA, whereas PTP-BL and Ptpn20 knockdowns were rescued by dominant negative RhoA. Consistently, RPTP alpha and PTP-BL had opposite effects on RhoA activation, both in a PTP-dependent manner. Downstream of the PTPs, we identified NGEF and Arhgap29, regulating RhoA activation and inactivation, respectively, in convergence and extension cell movements. We propose a model in which two phosphatases activate RhoA and two phosphatases inhibit RhoA, resulting in proper cell polarization and normal convergence and extension cell movements.	[van Eekelen, Mark; Runtuwene, Vincent; Masselink, Wouter; den Hertog, Jeroen] Hubrecht Inst, Utrecht, Netherlands; [van Eekelen, Mark; Runtuwene, Vincent; Masselink, Wouter; den Hertog, Jeroen] Univ Med Ctr Utrecht, Utrecht, Netherlands; [den Hertog, Jeroen] Inst Biol, Leiden, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	van Eekelen, M (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	j.denhertog@hubrecht.eu		Masselink, Wouter/0000-0002-4085-3206	Marie Curie Research Training Network [PTPNET/MRTN-CT-2006-035830]; Research Council for Earth and Life Sciences [ALW 815.02.007]; Netherlands Organisation for Scientific Research (NWO)	Marie Curie Research Training Network(European Commission); Research Council for Earth and Life Sciences(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by a Marie Curie Research Training Network (PTPNET/MRTN-CT-2006-035830) and a grant from the Research Council for Earth and Life Sciences (ALW 815.02.007) with financial aid from the Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATALIOTIS P, 1995, DEVELOPMENT, V121, P3099; Boutros M, 1999, MECH DEVELOP, V83, P27, DOI 10.1016/S0925-4773(99)00046-5; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Chae J, 1999, DEVELOPMENT, V126, P5421; Chan J, 2001, DEV BIOL, V234, P470, DOI 10.1006/dbio.2001.0281; Conway G, 1997, P NATL ACAD SCI USA, V94, P3082, DOI 10.1073/pnas.94.7.3082; Dunah AW, 2005, NAT NEUROSCI, V8, P458, DOI 10.1038/nn1416; Edouard T, 2007, CELL MOL LIFE SCI, V64, P1585, DOI 10.1007/s00018-007-6509-0; Egea J, 2005, NEURON, V47, P515, DOI 10.1016/j.neuron.2005.06.029; Elchebly M, 1999, NAT GENET, V21, P330, DOI 10.1038/6859; Feiguin F, 2001, DEV CELL, V1, P93, DOI 10.1016/S1534-5807(01)00010-7; Fodero-Tavoletti MT, 2005, BIOCHEM J, V389, P343, DOI 10.1042/BJ20041932; Ghil JS, 1999, INT J DEV BIOL, V43, P329; Gubb D, 1999, GENE DEV, V13, P2315, DOI 10.1101/gad.13.17.2315; Hammerschmidt M, 1996, DEVELOPMENT, V123, P143; Hatta K, 1996, DEV DYNAM, V205, P183, DOI 10.1002/(SICI)1097-0177(199602)205:2<183::AID-AJA9>3.0.CO;2-E; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Heisenberg CP, 1996, DEVELOPMENT, V123, P191; Jenny A, 2003, EMBO J, V22, P4409, DOI 10.1093/emboj/cdg424; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Jones TL, 1998, P NATL ACAD SCI USA, V95, P576, DOI 10.1073/pnas.95.2.576; Jopling C, 2005, EMBO REP, V6, P426, DOI 10.1038/sj.embor.7400386; Jopling C, 2007, PLOS GENET, V3, P2468, DOI 10.1371/journal.pgen.0030225; Jopling C, 2007, MECH DEVELOP, V124, P129, DOI 10.1016/j.mod.2006.10.003; Jorgensen C, 2009, SCIENCE, V326, P1502, DOI 10.1126/science.1176615; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Keys DN, 2002, DEV BIOL, V246, P329, DOI 10.1006/dbio.2002.0656; Kilian B, 2003, MECH DEVELOP, V120, P467, DOI 10.1016/S0925-4773(03)00004-2; KLINGENSMITH J, 1989, DEV BIOL, V134, P130, DOI 10.1016/0012-1606(89)90084-5; Knoll B, 2004, J NEUROSCI, V24, P6248, DOI 10.1523/JNEUROSCI.0985-04.2004; Li H, 2008, DEV BIOL, V316, P458, DOI 10.1016/j.ydbio.2008.01.001; Li Y, 2000, INT J CANCER, V87, P473, DOI 10.1002/1097-0215(20000815)87:4<473::AID-IJC3>3.0.CO;2-1; Lin D, 1999, J BIOL CHEM, V274, P3726, DOI 10.1074/jbc.274.6.3726; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; Miyagi C, 2004, J CELL BIOL, V166, P975, DOI 10.1083/jcb.200403110; Montcouquiol M, 2003, J NEUROSCI, V23, P9469; Murdoch JN, 2003, HUM MOL GENET, V12, P87, DOI 10.1093/hmg/ddg014; Myers DC, 2002, DEV BIOL, V243, P81, DOI 10.1006/dbio.2001.0523; Oates AC, 1999, MECH DEVELOP, V83, P77, DOI 10.1016/S0925-4773(99)00036-2; Palmer A, 2002, MOL CELL, V9, P725, DOI 10.1016/S1097-2765(02)00488-4; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Saras J, 1997, J BIOL CHEM, V272, P24333, DOI 10.1074/jbc.272.39.24333; Saunders AE, 2010, CELL SIGNAL, V22, P339, DOI 10.1016/j.cellsig.2009.10.003; Sepich DS, 2000, GENESIS, V27, P159, DOI 10.1002/1526-968X(200008)27:4<159::AID-GENE50>3.0.CO;2-T; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; SolnicaKrezel L, 1996, DEVELOPMENT, V123, P67; Stenzel N, 2009, J CELL SCI, V122, P3374, DOI 10.1242/jcs.046854; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Symes K, 1996, P NATL ACAD SCI USA, V93, P9641, DOI 10.1073/pnas.93.18.9641; Syverud K, 2007, APPITA J, V60, P286; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Taylor J, 1998, GENETICS, V150, P199; THISSE C, 1993, DEVELOPMENT, V119, P1203; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; Ungefroren H, 1998, CANCER RES, V58, P1741; van Eekelen M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012573; van Eekelen M, 2010, DEV BIOL, V340, P626, DOI 10.1016/j.ydbio.2010.02.026; VINSON CR, 1989, NATURE, V338, P263, DOI 10.1038/338263a0; von der Hardt S, 2007, CURR BIOL, V17, P475, DOI 10.1016/j.cub.2007.02.013; Wallace MJ, 1999, NAT GENET, V21, P334, DOI 10.1038/6866; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Wansink DG, 2004, PHYSIOL GENOMICS, V19, P50, DOI 10.1152/physiolgenomics.00079.2004; WARGA RM, 1990, DEVELOPMENT, V108, P569; Westerfield M, 1995, ZEBRAFISH BOOK; Ybot-Gonzalez P, 2007, DEVELOPMENT, V134, P3203, DOI 10.1242/dev.008177; Zhang Y, 2007, J BIOL CHEM, V282, P31103, DOI 10.1074/jbc.M704430200	68	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35913	10.1371/journal.pone.0035913	http://dx.doi.org/10.1371/journal.pone.0035913			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545146	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343200066
J	Wong, SSY; Ritner, C; Ramachandran, S; Aurigui, J; Pitt, C; Chandra, P; Ling, VB; Yabut, O; Bernstein, HS				Wong, Sharon S. Y.; Ritner, Carissa; Ramachandran, Sweta; Aurigui, Julian; Pitt, Cameron; Chandra, Piyanka; Ling, Vivian B.; Yabut, Odessa; Bernstein, Harold S.			miR-125b Promotes Early Germ Layer Specification through Lin28/let-7d and Preferential Differentiation of Mesoderm in Human Embryonic Stem Cells	PLOS ONE			English	Article							REPROGRAMMING FACTOR LIN28; SMALL RNAS; MICRORNAS; LIN-28; GENE; CARDIOGENESIS; EXPRESSION; BIOLOGY; MOUSE	Unlike other essential organs, the heart does not undergo tissue repair following injury. Human embryonic stem cells (hESCs) grow indefinitely in culture while maintaining the ability to differentiate into many tissues of the body. As such, they provide a unique opportunity to explore the mechanisms that control human tissue development, as well as treat diseases characterized by tissue loss, including heart failure. MicroRNAs are small, non-coding RNAs that are known to play critical roles in the regulation of gene expression. We profiled the expression of microRNAs during hESC differentiation into myocardial precursors and cardiomyocytes (CMs), and determined clusters of human microRNAs that are specifically regulated during this process. We determined that miR-125b overexpression results in upregulation of the early cardiac transcription factors, GATA4 and Nkx2-5, and accelerated progression of hESC-derived myocardial precursors to an embryonic CM phenotype. We used an in silico approach to identify Lin28 as a target of miR-125b, and validated this interaction using miR-125b knockdown. Anti-miR-125b inhibitor experiments also showed that miR-125b controls the expression of miRNA let-7d, likely through the negative regulatory effects of Lin28 on let-7. We then determined that miR-125b overexpression inhibits the expression of Nanog and Oct4 and promotes the onset of Brachyury expression, suggesting that miR-125b controls the early events of human CM differentiation by inhibiting hESC pluripotency and promoting mesodermal differentiation. These studies identified miR-125b as an important regulator of hESC differentiation in general, and the development of hESC-derived mesoderm and cardiac muscle in particular. Manipulation of miR-125b-mediated pathways may provide a novel approach to directing the differentiation of hESC-derived CMs for cell therapy applications.	[Wong, Sharon S. Y.; Ritner, Carissa; Aurigui, Julian; Yabut, Odessa; Bernstein, Harold S.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Ramachandran, Sweta; Chandra, Piyanka; Ling, Vivian B.; Bernstein, Harold S.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Pitt, Cameron; Bernstein, Harold S.] Univ Calif San Francisco, Grad Program Biomed Sci, San Francisco, CA 94143 USA; [Bernstein, Harold S.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Wong, SSY (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.	harold.bernstein@ucsf.edu		Ritner, Carissa/0000-0002-4968-6838	Public Health Service (PHS) Grant from National Heart, Lung and Blood Institutes (NHLBI) [HL085377]; Comprehensive Research Grant from the California Institute for Regenerative Medicine [RC1-00104]; National Research Service Award (NRSA) from NHLBI [HL007544]; Initiative for Maximizing Student Diversity (IMSD) fellowship from National Institute for General Medical Science (NIGMS) [GM56847]; American Pediatric Society/Society for Pediatric Research (APS/SPR) research fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL085377] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056847] Funding Source: NIH RePORTER	Public Health Service (PHS) Grant from National Heart, Lung and Blood Institutes (NHLBI); Comprehensive Research Grant from the California Institute for Regenerative Medicine; National Research Service Award (NRSA) from NHLBI; Initiative for Maximizing Student Diversity (IMSD) fellowship from National Institute for General Medical Science (NIGMS); American Pediatric Society/Society for Pediatric Research (APS/SPR) research fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Public Health Service (PHS) Grant (HL085377) from National Heart, Lung and Blood Institutes (NHLBI), and a Comprehensive Research Grant (RC1-00104) from the California Institute for Regenerative Medicine to HSB. SSYW and OY were supported by an National Research Service Award (NRSA) (HL007544) from NHLBI. CP was supported by an Initiative for Maximizing Student Diversity (IMSD) fellowship (GM56847) from National Institute for General Medical Science (NIGMS). PC was supported by an American Pediatric Society/Society for Pediatric Research (APS/SPR) research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Chien KR, 2008, SCIENCE, V322, P1494, DOI 10.1126/science.1163267; Darr H, 2009, STEM CELLS, V27, P352, DOI 10.1634/stemcells.2008-0720; Epting CL, 2008, J CELL PHYSIOL, V217, P250, DOI 10.1002/jcp.21500; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Ge YJ, 2011, J CELL BIOL, V192, P69, DOI 10.1083/jcb.201007165; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guan Y, 2011, INT J CANCER, V128, P2274, DOI 10.1002/ijc.25575; Hagen JW, 2008, CELL CYCLE, V7, P2327, DOI 10.4161/cc.6447; Hlaing M, 2004, J BIOL CHEM, V279, P43625, DOI 10.1074/jbc.M408391200; HOLM S, 1979, SCAND J STAT, V6, P65; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; King FW, 2009, STEM CELLS DEV, V18, P1441, DOI 10.1089/scd.2009.0012; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Mallanna SK, 2010, DEV BIOL, V344, P16, DOI 10.1016/j.ydbio.2010.05.014; Mizuno Y, 2008, BIOCHEM BIOPH RES CO, V368, P267, DOI 10.1016/j.bbrc.2008.01.073; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Rajabi Hasan, 2010, Genes Cancer, V1, P62; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Ritner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016004; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Shi L, 2010, BRAIN RES, V1312, P120, DOI 10.1016/j.brainres.2009.11.056; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Wu LG, 2005, MOL CELL BIOL, V25, P9198, DOI 10.1128/MCB.25.21.9198-9208.2005; Yang XJ, 2010, CANCER RES, V70, P9463, DOI 10.1158/0008-5472.CAN-10-2388; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang LA, 2011, CELL STEM CELL, V8, P294, DOI 10.1016/j.stem.2011.01.014; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; Zhong XM, 2010, J BIOL CHEM, V285, P41961, DOI 10.1074/jbc.M110.169607	41	33	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e36121	10.1371/journal.pone.0036121	http://dx.doi.org/10.1371/journal.pone.0036121			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545159	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343200080
J	Xiao, LH; Zhang, LC; Yang, G; Zhu, HL; He, YK				Xiao, Lihong; Zhang, Liechi; Yang, Ge; Zhu, Honglin; He, Yikun			Transcriptome of Protoplasts Reprogrammed into Stem Cells in Physcomitrella patens	PLOS ONE			English	Article							ARABIDOPSIS SHOOT MERISTEM; CYCLIN-DEPENDENT KINASE; FALSE DISCOVERY RATE; DIFFERENTIAL EXPRESSION; MESOPHYLL PROTOPLASTS; APICAL MERISTEM; LAND PLANTS; GENES; THALIANA; FATE	Background: Differentiated plant cells can retain the capacity to be reprogrammed into pluripotent stem cells during regeneration. This capacity is associated with both cell cycle reactivation and acquisition of specific cellular characters. However, the molecular mechanisms underlying the reprogramming of protoplasts into stem cells remain largely unknown. Protoplasts of the moss Physcomitrella patens easily regenerate into protonema and therefore provide an ideal system to explore how differentiated cells can be reprogrammed to produce stem cells. Principal findings: We obtained genome-wide digital gene expression tag profiles within the first three days of P. patens protoplast reprogramming. At four time-points during protoplast reprogramming, the transcript levels of 4827 genes changed more than four-fold and their expression correlated with the reprogramming phase. Gene ontology (GO) and pathway enrichment analysis of differentially expressed genes (DEGs) identified a set of significantly enriched GO terms and pathways, most of which were associated with photosynthesis, protein synthesis and stress responses. DEGs were grouped into six clusters that showed specific expression patterns using a K-means clustering algorithm. An investigation of function and expression patterns of genes identified a number of key candidate genes and pathways in early stages of protoplast reprogramming, which provided important clues to reveal the molecular mechanisms responsible for protoplast reprogramming. Conclusions: We identified genes that show highly dynamic changes in expression during protoplast reprogramming into stem cells in P. patens. These genes are potential targets for further functional characterization and should be valuable for exploration of the mechanisms of stem cell reprogramming. In particular, our data provides evidence that protoplasts of P. patens are an ideal model system for elucidation of the molecular mechanisms underlying differentiated plant cell reprogramming.	[Xiao, Lihong; Zhang, Liechi; Yang, Ge; He, Yikun] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Zhu, Honglin] Beijing Comp Ctr, Beijing, Peoples R China	Capital Normal University	Xiao, LH (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China.	yhe@cnu.edu.ac.cn		Zhu, Honglin/0000-0003-3249-9494	Ministry of Science and Technology of China [2007CB948201, 2009ZX08009-058B]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants from the Ministry of Science and Technology of China (2007CB948201 and 2009ZX08009-058B to YH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida M, 1999, DEVELOPMENT, V126, P1563; ASHTON NW, 1977, MOL GEN GENET, V154, P87, DOI 10.1007/BF00265581; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Babbitt CC, 2010, GENOME BIOL EVOL, V2, P67, DOI 10.1093/gbe/evq002; Balazadeh S, 2010, PLANT J, V62, P250, DOI 10.1111/j.1365-313X.2010.04151.x; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bray EA, 2004, J EXP BOT, V55, P2331, DOI 10.1093/jxb/erh270; Byrne ME, 2003, CURR OPIN GENET DEV, V13, P551, DOI 10.1016/j.gde.2003.08.008; COCKING EC, 1960, NATURE, V187, P962, DOI 10.1038/187962a0; Costa S, 2007, TRENDS CELL BIOL, V17, P101, DOI 10.1016/j.tcb.2006.12.005; Cove D, 2000, J PLANT GROWTH REGUL, V19, P275, DOI 10.1007/s003440000031; Cuming AC, 2007, NEW PHYTOL, V176, P275, DOI 10.1111/j.1469-8137.2007.02187.x; DEBEAUJON I, 1992, PLANT CELL REP, V12, P37, DOI 10.1007/BF00232420; Decker EL, 2006, PLANT BIOLOGY, V8, P397, DOI 10.1055/s-2006-923952; den Boer BGW, 2000, TRENDS CELL BIOL, V10, P245, DOI 10.1016/S0962-8924(00)01765-7; Deveaux Y, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-291; DeYoung BJ, 2006, PLANT J, V45, P1, DOI 10.1111/j.1365-313X.2005.02592.x; Feher A, 2002, BIOLOGIA, V57, P5; Ferreira FJ, 2005, CURR OPIN PLANT BIOL, V8, P518, DOI 10.1016/j.pbi.2005.07.013; Frank W, 2005, PLANT BIOLOGY, V7, P220, DOI 10.1055/s-2005-865645; Gallois JL, 2004, GENE DEV, V18, P375, DOI 10.1101/gad.291204; Gilbert SF, 2006, DEV BIOL; Grafi G, 2004, TRENDS BIOTECHNOL, V22, P388, DOI 10.1016/j.tibtech.2004.06.001; Grewal SIS, 2004, CURR OPIN CELL BIOL, V16, P230, DOI 10.1016/j.ceb.2004.04.002; GRIMSLEY NH, 1977, MOL GEN GENET, V154, P97, DOI 10.1007/BF00265582; Haecker A, 2004, DEVELOPMENT, V131, P657, DOI 10.1242/dev.00963; Harrison CJ, 2009, CURR BIOL, V19, P461, DOI 10.1016/j.cub.2009.02.050; Hord CLH, 2006, PLANT CELL, V18, P1667, DOI 10.1105/tpc.105.036871; Ishikawa M, 2011, PLANT CELL, V23, P2924, DOI 10.1105/tpc.111.088005; Jang G, 2011, DEVELOPMENT, V138, P2273, DOI 10.1242/dev.060582; Johnston JS, 1999, AM J BOT, V86, P609, DOI 10.2307/2656569; Kamiya N, 2003, PLANT J, V35, P429, DOI 10.1046/j.1365-313X.2003.01816.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Masip M, 2010, MOL HUM REPROD, V16, P856, DOI 10.1093/molehr/gaq059; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; McKay R, 2000, NATURE, V406, P361, DOI 10.1038/35019186; Menand B, 2007, SCIENCE, V316, P1477, DOI 10.1126/science.1142618; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nardmann J, 2006, MOL BIOL EVOL, V23, P2492, DOI 10.1093/molbev/msl125; Nikovics K, 2006, PLANT CELL, V18, P2929, DOI 10.1105/tpc.106.045617; Ondrej V, 2009, MOL CELLS, V27, P443, DOI 10.1007/s10059-009-0057-4; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; Park SO, 2005, DEVELOPMENT, V132, P841, DOI 10.1242/dev.01654; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Reski R, 1998, BOT ACTA, V111, P1; Richardt S, 2007, PLANT PHYSIOL, V143, P1452, DOI 10.1104/pp.107.095760; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sablowski R, 2007, CURR OPIN PLANT BIOL, V10, P639, DOI 10.1016/j.pbi.2007.07.001; Sarkar AK, 2007, NATURE, V446, P811, DOI 10.1038/nature05703; Schulz P, 2000, J PLANT PHYSIOL, V156, P768, DOI 10.1016/S0176-1617(00)80246-1; Schween G, 2003, P NATL ACAD SCI USA, V105, P2415; Slack JMW, 2008, SCIENCE, V322, P1498, DOI 10.1126/science.1162782; TAKEBE I, 1971, NATURWISSENSCHAFTEN, V58, P318, DOI 10.1007/BF00624737; TAKEBE I, 1969, P NATL ACAD SCI USA, V64, P843, DOI 10.1073/pnas.64.3.843; Tessadori F, 2004, TRENDS PLANT SCI, V9, P147, DOI 10.1016/j.tplants.2004.01.008; Tessadori F, 2007, J CELL SCI, V120, P1200, DOI 10.1242/jcs.000026; Trajkovski I, 2008, J BIOMED INFORM, V41, P588, DOI 10.1016/j.jbi.2007.12.001; ULRICH I, 1991, PROTOPLASMA, V165, P212, DOI 10.1007/BF01322292; Umeda M, 2005, PLANT CELL PHYSIOL, V46, P1437, DOI 10.1093/pcp/pci170; van Driel R, 2004, EXP CELL RES, V296, P86, DOI 10.1016/j.yexcr.2004.03.009; Wang QQ, 2010, GENOMICS, V96, P369, DOI 10.1016/j.ygeno.2010.08.009; Wang XQ, 2009, PLANT PHYSIOL, V149, P1739, DOI 10.1104/pp.108.131714; Wang XQ, 2008, PLANTA, V228, P167, DOI 10.1007/s00425-008-0727-z; Won SK, 2009, PLANT PHYSIOL, V150, P1459, DOI 10.1104/pp.109.140905; Wurschum T, 2006, PLANT CELL, V18, P295, DOI 10.1105/tpc.105.038398; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472; Xiao SQ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-544; Zeeberg BR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-168; Zhao J, 2001, J BIOL CHEM, V276, P22772, DOI 10.1074/jbc.M101756200; Zuo JR, 2002, PLANT J, V30, P349, DOI 10.1046/j.1365-313X.2002.01289.x	73	27	30	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35961	10.1371/journal.pone.0035961	http://dx.doi.org/10.1371/journal.pone.0035961			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545152	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343200072
J	Savignon, T; Costa, E; Tenorio, F; Manhaes, AC; Barradas, PC				Savignon, Tiago; Costa, Everton; Tenorio, Frank; Manhaes, Alex C.; Barradas, Penha C.			Prenatal Hypoxic-Ischemic Insult Changes the Distribution and Number of NADPH-Diaphorase Cells in the Cerebellum	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; RAT SUPERIOR COLLICULUS; PERINATAL BRAIN-DAMAGE; KINASE-IV ACTIVITY; NEWBORN PIGLETS; NEURONAL NUCLEI; PURKINJE-CELLS; DEVELOPMENTAL NEUROPATHOLOGY; CORTICAL DEVELOPMENT; CEREBRAL-CORTEX	Astrogliosis, oligodendroglial death and motor deficits have been observed in the offspring of female rats that had their uterine arteries clamped at the 18th gestational day. Since nitric oxide has important roles in several inflammatory and developmental events, here we evaluated NADPH-diaphorase (NADPH-d) distribution in the cerebellum of rats submitted to this hypoxia-ischemia (HI) model. At postnatal (P) day 9, Purkinje cells of SHAM and non-manipulated (NM) animals showed NADPH-d+ labeling both in the cell body and dendritic arborization in folia 1 to 8, while HI animals presented a weaker labeling in both cellular structures. NADPH-d+ labeling in the molecular (ML), and in both the external and internal granular layer, was unaffected by HI at this age. At P23, labeling in Purkinje cells was absent in all three groups. Ectopic NADPH-d+ cells in the ML of folia 1 to 4 and folium 10 were present exclusively in HI animals. This labeling pattern was maintained up to P90 in folium 10. In the cerebellar white matter (WM), at P9 and P23, microglial (ED1+) NADPH-d+ cells, were observed in all groups. At P23, only HI animals presented NADPH-d labeling in the cell body and processes of reactive astrocytes (GFAP+). At P9 and P23, the number of NADPH-d+ cells in the WM was higher in HI animals than in SHAM and NM ones. At P45 and at P90 no NADPH-d+ cells were observed in the WM of the three groups. Our results indicate that HI insults lead to long-lasting alterations in nitric oxide synthase expression in the cerebellum. Such alterations in cerebellar differentiation might explain, at least in part, the motor deficits that are commonly observed in this model.	[Savignon, Tiago; Costa, Everton; Tenorio, Frank; Barradas, Penha C.] Univ Estado Rio de Janeiro, Dept Farmacol & Psicobiol, Inst Biol Roberto Alcantara Gomes, BR-20550011 Rio De Janeiro, Brazil; [Manhaes, Alex C.] Univ Estado Rio de Janeiro, Dept Ciencias Fisiol, Inst Biol Roberto Alcantara Gomes, BR-20550011 Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro	Savignon, T (corresponding author), Univ Estado Rio de Janeiro, Dept Farmacol & Psicobiol, Inst Biol Roberto Alcantara Gomes, BR-20550011 Rio De Janeiro, Brazil.	penhabarradas@gmail.com	Barradas, Penha C/K-9779-2016; ManhÃes, Alex C/F-5499-2011	ManhÃes, Alex C/0000-0003-4629-8343; Barradas, Penha/0000-0002-5868-4447	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Sub-reitoria de Pos-Graduacao e Pesquisa da Universidade do Estado do Rio de Janeiro (SR2/UERJ)	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sub-reitoria de Pos-Graduacao e Pesquisa da Universidade do Estado do Rio de Janeiro (SR2/UERJ)	Support contributed by: Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Sub-reitoria de Pos-Graduacao e Pesquisa da Universidade do Estado do Rio de Janeiro (SR2/UERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADINOLFI M, 1993, EXP CLIN IMMUNOGENET, V10, P103; AKBARIAN S, 1993, ARCH GEN PSYCHIAT, V50, P169; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; ALTMAN J, 1969, J COMP NEUROL, V136, P269, DOI 10.1002/cne.901360303; ALTMAN J, 1972, J COMP NEUROL, V145, P353, DOI 10.1002/cne.901450305; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Biran V, 2011, NEUROBIOL DIS, V41, P138, DOI 10.1016/j.nbd.2010.09.001; BLOMFIELD S, 1970, NATURE, V227, P1224, DOI 10.1038/2271224a0; Blomgren K, 2006, FREE RADICAL BIO MED, V40, P388, DOI 10.1016/j.freeradbiomed.2005.08.040; Bodensteiner JB, 2005, J CHILD NEUROL, V20, P139, DOI 10.1177/08830738050200021101; Bolanos JP, 1999, BBA-BIOENERGETICS, V1411, P415, DOI 10.1016/S0005-2728(99)00030-4; Brazel CY, 2004, DEV NEUROSCI-BASEL, V26, P266, DOI 10.1159/000082143; Bredt DS, 1999, FREE RADICAL RES, V31, P577, DOI 10.1080/10715769900301161; BREDT DS, 1994, NEURON, V13, P301, DOI 10.1016/0896-6273(94)90348-4; BRUNING G, 1993, J NEUROSCI RES, V36, P580, DOI 10.1002/jnr.490360510; Calabrese V, 2006, ANTIOXID REDOX SIGN, V8, P444, DOI 10.1089/ars.2006.8.444; Catania MV, 2001, J NEUROSCI, V21, P7664, DOI 10.1523/JNEUROSCI.21-19-07664.2001; Contestabile A, 2012, CEREBELLUM, V11, P50, DOI 10.1007/s12311-010-0234-1; Cramer KS, 1996, J NEUROSCI, V16, P7995; DERMON CR, 1994, NEUROREPORT, V5, P1941, DOI 10.1097/00001756-199410000-00025; Folkerth RD, 2004, J NEUROPATH EXP NEUR, V63, P990, DOI 10.1093/jnen/63.9.990; Fukumura D, 2001, P NATL ACAD SCI USA, V98, P2604, DOI 10.1073/pnas.041359198; GALLY JA, 1990, P NATL ACAD SCI USA, V87, P3547, DOI 10.1073/pnas.87.9.3547; GIUILI G, 1994, DEV BRAIN RES, V81, P269, DOI 10.1016/0165-3806(94)90313-1; Golan H, 2004, J NEUROSCI RES, V78, P430, DOI 10.1002/jnr.20269; Gross WL, 1996, P NATL ACAD SCI USA, V93, P5604, DOI 10.1073/pnas.93.11.5604; Haynes V, 2003, IUBMB LIFE, V55, P599, DOI 10.1080/15216540310001628681; HESS DT, 1993, NATURE, V366, P562, DOI 10.1038/366562a0; Hirai H, 2000, J NEUROSCI, V20, P5217, DOI 10.1523/JNEUROSCI.20-14-05217.2000; HOPE BT, 1991, P NATL ACAD SCI USA, V88, P2811, DOI 10.1073/pnas.88.7.2811; Iadecola C, 1997, J NEUROSCI, V17, P9157; Kashiwagi K, 2003, MOL BRAIN RES, V112, P126, DOI 10.1016/S0169-328X(03)00058-5; Kaur C, 2006, INVEST OPHTH VIS SCI, V47, P1126, DOI 10.1167/iovs.05-0518; Kobayashi M, 2000, JPN J OPHTHALMOL, V44, P235, DOI 10.1016/S0021-5155(99)00220-8; KUONEN DR, 1988, J NEUROCHEM, V50, P1017, DOI 10.1111/j.1471-4159.1988.tb10567.x; LEVITON A, 1993, DEV MED CHILD NEUROL, V35, P553; MA LJ, 1991, NEUROSCI LETT, V132, P23, DOI 10.1016/0304-3940(91)90423-Q; Marin-Padilla M, 1999, J NEUROPATH EXP NEUR, V58, P407, DOI 10.1097/00005072-199905000-00001; MarinPadilla M, 1997, J NEUROPATH EXP NEUR, V56, P219, DOI 10.1097/00005072-199703000-00001; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Mazur M, 2010, J NEUROSURG-PEDIATR, V6, P206, DOI 10.3171/2010.5.PEDS1032; Mishra OP, 2006, NEUROCHEM RES, V31, P1463, DOI 10.1007/s11064-006-9204-x; Mishra OP, 2004, NEUROSCIENCE, V123, P179, DOI 10.1016/j.neuroscience.2003.08.008; Mishra OP, 2002, NEUROSCIENCE, V115, P985, DOI 10.1016/S0306-4522(02)00275-0; Nelson KB, 2003, PEDIATR RES, V53, P600, DOI 10.1203/01.PDR.0000056802.22454.AB; NGUYEN T, 1992, P NATL ACAD SCI USA, V89, P3030, DOI 10.1073/pnas.89.7.3030; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Peng JHF, 2005, DEV BRAIN RES, V156, P87, DOI 10.1016/j.devbrainres.2005.02.002; Pisu MB, 2003, DEV BRAIN RES, V145, P229, DOI 10.1016/j.devbrainres.2003.08.007; Pundik S, 2006, METAB BRAIN DIS, V21, P309, DOI 10.1007/s11011-006-9031-4; Rees S, 1997, DEV BRAIN RES, V103, P103, DOI 10.1016/S0165-3806(97)81787-7; REYNOLDS R, 1988, DEVELOPMENT, V102, P409; Robinson S, 2005, NEUROBIOL DIS, V18, P568, DOI 10.1016/j.nbd.2004.10.024; ROSKAMS AJ, 1994, NEURON, V13, P289; Santacana M, 1998, DEV BRAIN RES, V111, P205, DOI 10.1016/S0165-3806(98)00140-0; Saxon DW, 1996, J COMP NEUROL, V371, P41; SAXON DW, 1994, NEUROREPORT, V5, P809, DOI 10.1097/00001756-199403000-00018; SCHILLING K, 1994, NEUROSCIENCE, V59, P893, DOI 10.1016/0306-4522(94)90293-3; Sotelo C, 2009, NEUROSCIENCE, V162, P589, DOI 10.1016/j.neuroscience.2008.12.035; TANAKA M, 1994, NEUROREPORT, V5, P2049, DOI 10.1097/00001756-199410270-00015; Tenorio F, 1996, INT J DEV NEUROSCI, V14, P1, DOI 10.1016/0736-5748(95)00085-2; TENORIO F, 1995, J NEUROSCI RES, V42, P633, DOI 10.1002/jnr.490420505; Tenorio F, 1998, NEUROREPORT, V9, P145, DOI 10.1097/00001756-199801050-00029; Vexler ZS, 2009, DEV NEUROSCI-BASEL, V31, P378, DOI 10.1159/000232556; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; WILLIAMS CV, 1994, J NEUROSCI, V14, P1746, DOI 10.1523/JNEUROSCI.14-03-01746.1994; Wilson MA, 1997, TRENDS NEUROSCI, V20, P102, DOI 10.1016/S0166-2236(96)01023-5; Yan XX, 1996, CEREB CORTEX, V6, P737, DOI 10.1093/cercor/6.5.737; Yan XX, 1997, NEUROSCI LETT, V230, P125, DOI 10.1016/S0304-3940(97)00497-7; YAN XX, 1993, NEUROREPORT, V4, P1227, DOI 10.1097/00001756-199309000-00004; Zhang RL, 2001, ANN NEUROL, V50, P602, DOI 10.1002/ana.1249; ZHANG RL, 1994, J NEUROL SCI, V125, P3, DOI 10.1016/0022-510X(94)90234-8; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhang ZG, 2002, J CEREBR BLOOD F MET, V22, P379, DOI 10.1097/00004647-200204000-00002; Zubrow AB, 2002, NEUROSCI LETT, V335, P5, DOI 10.1016/S0304-3940(02)01138-2; Zubrow AB, 2002, BRAIN RES, V954, P60, DOI 10.1016/S0006-8993(02)03342-5	76	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35786	10.1371/journal.pone.0035786	http://dx.doi.org/10.1371/journal.pone.0035786			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22540005	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341000071
J	Hossaini, M; Goos, JAC; Kohli, SK; Holstege, JC				Hossaini, Mehdi; Goos, Jacqueline A. C.; Kohli, Somesh K.; Holstege, Jan C.			Distribution of Glycine/GABA Neurons in the Ventromedial Medulla with Descending Spinal Projections and Evidence for an Ascending Glycine/GABA Projection	PLOS ONE			English	Article							NUCLEUS RAPHE MAGNUS; RNA-CONTAINING NEURONS; DORSAL-HORN NEURONS; BRAIN-STEM NEURONS; EXPRESSING C-FOS; PERIAQUEDUCTAL GRAY; CYTOARCHITECTONIC ORGANIZATION; GLUTAMATE-DECARBOXYLASE; GABAERGIC NEURONS; PAIN-CONTROL	The ventromedial medulla (VM), subdivided in a rostral (RVM) and a caudal (CVM) part, has a powerful influence on the spinal cord. In this study, we have identified the distribution of glycine and GABA containing neurons in the VM with projections to the cervical spinal cord, the lumbar dorsal horn, and the lumbar ventral horn. For this purpose, we have combined retrograde tracing using fluorescent microspheres with fluorescent in situ hybridization (FISH) for glycine transporter 2 (GlyT2) and GAD67 mRNAs to identify glycinergic and/or GABAergic (Gly/GABA) neurons. Since the results obtained with FISH for GlyT2, GAD67, or GlyT2+GAD67 mRNAs were not significantly different, we concluded that glycine and GABA coexisted in the various projection neurons. After injections in the cervical cord, we found that 29% +/- 1 (SEM) of the retrogradely labeled neurons in the VM were Gly/GABA (RVM: 43%; CVM: 21%). After lumbar dorsal horn injections 31% +/- 3 of the VM neurons were Gly/GABA (RVM: 45%; CVM: 12%), and after lumbar ventral horn injections 25% +/- 2 were Gly/GABA (RVM: 35%; CVM: 17%). In addition, we have identified a novel ascending Gly/GABA pathway originating from neurons in the area around the central canal (CC) throughout the spinal cord and projecting to the RVM, emphasizing the interaction between the ventromedial medulla and the spinal cord. The present study has now firmly established that GABA and glycine are present in many VM neurons that project to the spinal cord. These neurons strongly influence spinal processing, most notably the inhibition of nociceptive transmission.	[Hossaini, Mehdi; Goos, Jacqueline A. C.; Kohli, Somesh K.; Holstege, Jan C.] Erasmus Univ, Dept Neurosci, Med Ctr, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Hossaini, M (corresponding author), Erasmus Univ, Dept Neurosci, Med Ctr, Rotterdam, Netherlands.	j.holstege@erasmusmc.nl			The Netherlands Organization of Scientific Research (NWO) [017.003.030]	The Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was supported by a Mozaiek grant (Nr. 017.003.030) from The Netherlands Organization of Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida A, 2000, EUR J PAIN, V4, P373, DOI 10.1053/eujp.2000.0193; Antal M, 1996, NEUROSCIENCE, V73, P509, DOI 10.1016/0306-4522(96)00063-2; BEITZ AJ, 1982, NEUROSCIENCE, V7, P2753, DOI 10.1016/0306-4522(82)90098-7; BEITZ AJ, 1982, J NEUROSCI, V2, P829; BLESSING WW, 1990, NEUROSCIENCE, V37, P171, DOI 10.1016/0306-4522(90)90202-F; CHAOUCH A, 1983, J COMP NEUROL, V214, P309, DOI 10.1002/cne.902140308; Chase M.H., 2005, PRINCIPLES PRACTICE, P154; Chery N, 1999, J NEUROSCI, V19, P7342, DOI 10.1523/JNEUROSCI.19-17-07342.1999; Dostrovsky J. O., 2006, WALL MELZACKS TXB PA, P187; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; FIELDS HL, 1991, ANNU REV NEUROSCI, V14, P219, DOI 10.1146/annurev.neuro.14.1.219; Foo H, 2003, J NEUROSCI, V23, P1933; Gao KM, 2000, J NEUROPHYSIOL, V84, P1719, DOI 10.1152/jn.2000.84.4.1719; HEADLEY PM, 1978, BRAIN RES, V145, P185, DOI 10.1016/0006-8993(78)90809-0; Heinricher MM, 2009, BRAIN RES REV, V60, P214, DOI 10.1016/j.brainresrev.2008.12.009; HEINRICHER MM, 1994, NEUROSCIENCE, V63, P279, DOI 10.1016/0306-4522(94)90022-1; HOLSTEGE JC, 1991, BRAIN RES, V566, P308, DOI 10.1016/0006-8993(91)91715-D; Holstege JC, 1996, PROG BRAIN RES, V107, P159; HOLSTEGE JC, 1991, J NEUROSCI, V11, P159; HONDA CN, 1985, BRAIN RES, V340, P285, DOI 10.1016/0006-8993(85)90925-4; HONDA CN, 1985, J NEUROPHYSIOL, V53, P1059, DOI 10.1152/jn.1985.53.4.1059; Hopman AHN, 1998, J HISTOCHEM CYTOCHEM, V46, P771, DOI 10.1177/002215549804600611; Hossaini M, 2011, NEUROSCIENCE, V196, P265, DOI 10.1016/j.neuroscience.2011.08.050; Hossaini M, 2007, BRAIN RES, V1142, P61, DOI 10.1016/j.brainres.2007.01.078; Hossaini M, 2010, PAIN, V151, P356, DOI 10.1016/j.pain.2010.07.023; HYLDEN JLK, 1983, LIFE SCI, V33, P789, DOI 10.1016/0024-3205(83)90785-3; JONES BE, 1991, J COMP NEUROL, V313, P349, DOI 10.1002/cne.903130210; JONES BE, 1985, J COMP NEUROL, V242, P56, DOI 10.1002/cne.902420105; JORDAN LM, 1978, PAIN, V5, P135, DOI 10.1016/0304-3959(78)90035-0; Kato G, 2006, J NEUROSCI, V26, P1787, DOI 10.1523/JNEUROSCI.4856-05.2006; KATZ LC, 1990, NEUROSCIENCE, V34, P511, DOI 10.1016/0306-4522(90)90159-2; KAUFMAN DL, 1991, J NEUROCHEM, V56, P720, DOI 10.1111/j.1471-4159.1991.tb08211.x; KWIAT GC, 1992, SOMATOSENS MOT RES, V9, P157, DOI 10.3109/08990229209144768; Lefler Y, 2008, J COMP NEUROL, V506, P960, DOI 10.1002/cne.21586; LUQUE JM, 1995, NEUROSCIENCE, V64, P525, DOI 10.1016/0306-4522(94)00404-S; Mason P, 2001, ANNU REV NEUROSCI, V24, P737, DOI 10.1146/annurev.neuro.24.1.737; MCGOWAN MK, 1993, BRAIN RES, V620, P86, DOI 10.1016/0006-8993(93)90274-Q; MCGOWAN MK, 1993, BRAIN RES, V607, P39, DOI 10.1016/0006-8993(93)91487-D; MOLANDER C, 1989, J COMP NEUROL, V289, P375, DOI 10.1002/cne.902890303; MOLANDER C, 1984, J COMP NEUROL, V230, P133, DOI 10.1002/cne.902300112; Morgan MM, 2008, PAIN, V140, P376, DOI 10.1016/j.pain.2008.09.009; MORI S, 1989, BRAIN RES, V505, P66, DOI 10.1016/0006-8993(89)90116-9; NAHIN RL, 1983, J COMP NEUROL, V220, P321, DOI 10.1002/cne.902200306; NAHIN RL, 1986, NEUROSCI LETT, V65, P271, DOI 10.1016/0304-3940(86)90273-9; Nason MW, 2004, J NEUROPHYSIOL, V92, P510, DOI 10.1152/jn.00089.2004; NESS TJ, 1987, J NEUROPHYSIOL, V57, P1867, DOI 10.1152/jn.1987.57.6.1867; NESS TJ, 1989, BRAIN RES, V486, P301, DOI 10.1016/0006-8993(89)90516-7; Neubert MJ, 2004, PAIN, V110, P158, DOI 10.1016/j.pain.2004.03.017; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; POTREBIC SB, 1994, J NEUROSCI, V14, P1655, DOI 10.1523/JNEUROSCI.14-03-01655.1994; Poyatos I, 1997, MOL BRAIN RES, V49, P63, DOI 10.1016/S0169-328X(97)00124-1; REICHLING DB, 1990, J COMP NEUROL, V302, P370, DOI 10.1002/cne.903020213; SKAGERBERG G, 1985, NEUROSCIENCE, V15, P445, DOI 10.1016/0306-4522(85)90225-8; SORKIN LS, 1993, BRAIN RES, V618, P95, DOI 10.1016/0006-8993(93)90433-N; Stornetta RL, 1999, J COMP NEUROL, V407, P367; TAAL W, 1994, NEUROREPORT, V5, P2225, DOI 10.1097/00001756-199411000-00005; Tanaka I, 2004, NEUROSCI RES, V49, P165, DOI 10.1016/j.neures.2004.02.007; TODD AJ, 1990, J COMP NEUROL, V296, P496, DOI 10.1002/cne.902960312; URBAN MO, 1994, NEUROSCI LETT, V174, P21, DOI 10.1016/0304-3940(94)90109-0; URBAN MO, 1994, BRAIN RES, V652, P9, DOI 10.1016/0006-8993(94)90311-5; Vanegas H, 2004, BRAIN RES REV, V46, P295, DOI 10.1016/j.brainresrev.2004.07.004; Vanegas H, 2004, NEUROSCI LETT, V361, P225, DOI 10.1016/j.neulet.2003.12.002; Vetrivelan R, 2009, J NEUROSCI, V29, P9361, DOI 10.1523/JNEUROSCI.0737-09.2009; Wang CC, 1999, J COMP NEUROL, V415, P341, DOI 10.1002/(SICI)1096-9861(19991220)415:3<341::AID-CNE3>3.0.CO;2-7; Zeilhofer HU, 2012, PHYSIOL REV, V92, P193, DOI 10.1152/physrev.00043.2010; Zeilhofer HU, 2005, J COMP NEUROL, V482, P123, DOI 10.1002/cne.20349; Zhuo M, 1997, J NEUROPHYSIOL, V78, P746, DOI 10.1152/jn.1997.78.2.746	68	41	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35293	10.1371/journal.pone.0035293	http://dx.doi.org/10.1371/journal.pone.0035293			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558137	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340200012
J	Chen, MQ; Zhang, AH; Zhang, Q; Zhang, BC; Nan, J; Li, X; Liu, N; Qu, H; Lu, CM; Sudmorgen; Zhou, YH; Xu, ZH; Bai, SN				Chen, Mei-Qin; Zhang, Ai-Hong; Zhang, Quan; Zhang, Bao-Cai; Nan, Jie; Li, Xia; Liu, Na; Qu, Hong; Lu, Cong-Ming; Sudmorgen; Zhou, Yi-Hua; Xu, Zhi-Hong; Bai, Shu-Nong			Arabidopsis NMD3 Is Required for Nuclear Export of 60S Ribosomal Subunits and Affects Secondary Cell Wall Thickening	PLOS ONE			English	Article							EXTRARIBOSOMAL FUNCTIONS; GENE-EXPRESSION; PROTEIN; BIOSYNTHESIS; TRANSLATION; COORDINATION; DEPOSITION; NUCLEOLUS; CELLULOSE; ADAPTER	NMD3 is required for nuclear export of the 60S ribosomal subunit in yeast and vertebrate cells, but no corresponding function of NMD3 has been reported in plants. Here we report that Arabidopsis thaliana NMD3 (AtNMD3) showed a similar function in the nuclear export of the 60S ribosomal subunit. Interference with AtNMD3 function by overexpressing a truncated dominant negative form of the protein lacking the nuclear export signal sequence caused retainment of the 60S ribosomal subunits in the nuclei. More interestingly, the transgenic Arabidopsis with dominant negative interference of AtNMD3 function showed a striking failure of secondary cell wall thickening, consistent with the altered expression of related genes and composition of cell wall components. Observation of a significant decrease of rough endoplasmic reticulum (RER) in the differentiating interfascicular fiber cells of the transgenic plant stems suggested a link between the defective nuclear export of 60S ribosomal subunits and the abnormal formation of the secondary cell wall. These findings not only clarified the evolutionary conservation of NMD3 functions in the nuclear export of 60S ribosomal subunits in yeast, animals and plants, but also revealed a new facet of the regulatory mechanism underlying secondary cell wall thickening in Arabidopsis. This new facet is that the nuclear export of 60S ribosomal subunits and the formation of RER may play regulatory roles in coordinating protein synthesis in cytoplasm and transcription in nuclei.	[Chen, Mei-Qin; Li, Xia; Liu, Na; Xu, Zhi-Hong; Bai, Shu-Nong] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, PKU Yale Joint Res Ctr Agr & Plant Mol Biol, Beijing 100871, Peoples R China; [Chen, Mei-Qin; Li, Xia; Liu, Na; Xu, Zhi-Hong; Bai, Shu-Nong] Natl Ctr Plant Gene Res, Beijing, Peoples R China; [Zhang, Bao-Cai; Zhou, Yi-Hua] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Gen, Beijing, Peoples R China	Peking University; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Chen, MQ (corresponding author), Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, PKU Yale Joint Res Ctr Agr & Plant Mol Biol, Beijing 100871, Peoples R China.	shunongb@pku.edu.cn	Zhang, Baocai/AFS-9696-2022; Zhang, Baocai/AFW-3565-2022; Nan, Jie/I-5327-2013	Zhang, Baocai/0000-0002-3239-7263; Nan, Jie/0000-0003-1054-5082	Minstry of Sciences and Technology (MST) [J00-A-005, G19990116]; National Natural Science Fundation of China (NSFC) [30070361]	Minstry of Sciences and Technology (MST); National Natural Science Fundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by grants to SB from Minstry of Sciences and Technology (MST)(J00-A-005, G19990116) and National Natural Science Fundation of China (NSFC)(30070361), and to ZX from MST and NSFC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Bai SL, 2004, PLANTA, V220, P230, DOI 10.1007/s00425-004-1342-2; Blanvillain R, 2008, GENETICS, V180, P1493, DOI 10.1534/genetics.108.094896; Bonawitz ND, 2010, ANNU REV GENET, V44, P337, DOI 10.1146/annurev-genet-102209-163508; Byrne ME, 2009, TRENDS PLANT SCI, V14, P512, DOI 10.1016/j.tplants.2009.06.009; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Conlon HE, 2010, METHODS MOL BIOL; Degenhardt RF, 2008, PLANT PHYSIOL, V147, P128, DOI 10.1104/pp.107.111799; Ferreyra MLF, 2010, PLANT PHYSIOL, V153, P1878, DOI 10.1104/pp.110.157057; Fujikura U, 2009, PLANT J, V59, P499, DOI 10.1111/j.1365-313X.2009.03886.x; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Haasen D, 1999, PLANT J, V20, P695, DOI 10.1046/j.1365-313X.1999.00644.x; Harholt J, 2010, PLANT PHYSIOL, V153, P384, DOI 10.1104/pp.110.156588; Hedges J, 2005, EMBO J, V24, P567, DOI 10.1038/sj.emboj.7600547; Ho JHN, 2000, J CELL BIOL, V151, P1057, DOI 10.1083/jcb.151.5.1057; HOEBLER C, 1989, J AGR FOOD CHEM, V37, P360, DOI 10.1021/jf00086a020; Horiguchi G, 2011, PLANT J, V65, P724, DOI 10.1111/j.1365-313X.2010.04457.x; Imai A, 2008, PLANT J, V56, P881, DOI 10.1111/j.1365-313X.2008.03647.x; Johnson AW, 2002, TRENDS BIOCHEM SCI, V27, P580, DOI 10.1016/S0968-0004(02)02208-9; Karl T, 1999, CURR GENET, V34, P419, DOI 10.1007/s002940050416; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; Kressler D, 2010, BBA-MOL CELL RES, V1803, P673, DOI 10.1016/j.bbamcr.2009.10.009; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Li M, 2009, PLANT J, V60, P1055, DOI 10.1111/j.1365-313X.2009.04022.x; Lindstrom MS, 2009, BIOCHEM BIOPH RES CO, V379, P167, DOI 10.1016/j.bbrc.2008.12.083; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; Nishimura T, 2005, PLANT CELL, V17, P2940, DOI 10.1105/tpc.105.036533; Obst J.R., 1988, METHOD ENZYMOL, V161, P87, DOI 10.1016/0076-6879(88)61014-7; Pauly M, 2008, PLANT J, V54, P559, DOI 10.1111/j.1365-313X.2008.03463.x; Pinon V, 2008, DEVELOPMENT, V135, P1315, DOI 10.1242/dev.016469; R Core Team, 2018, R LANG ENV STAT COMP; Roberts K, 2001, PLANT PHYSIOL, V125, P127, DOI 10.1104/pp.125.1.127; Rogers LA, 2004, NEW PHYTOL, V164, P17, DOI 10.1111/j.1469-8137.2004.01143.x; Rosado A, 2010, PLANT CELL, V22, P143, DOI 10.1105/tpc.109.068320; Sarkar P, 2009, J EXP BOT, V60, P3615, DOI 10.1093/jxb/erp245; Saxena IM, 2008, BIOCH MOL BIOL CELLU; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Sticklen MB, 2008, NAT REV GENET, V9, P433, DOI 10.1038/nrg2336; Szakonyi D, 2011, PLANT J, V65, P269, DOI 10.1111/j.1365-313X.2010.04422.x; Szymanski DB, 2009, CURR BIOL, V19, pR800, DOI 10.1016/j.cub.2009.07.056; Taylor NG, 2008, NEW PHYTOL, V178, P239, DOI 10.1111/j.1469-8137.2008.02385.x; Trotta CR, 2003, EMBO J, V22, P2841, DOI 10.1093/emboj/cdg249; Tzafrir I, 2004, PLANT PHYSIOL, V135, P1206, DOI 10.1104/pp.104.045179; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; VANLIJSEBETTENS M, 1994, EMBO J, V13, P3378, DOI 10.1002/j.1460-2075.1994.tb06640.x; Wang DH, 2010, PLANT J, V61, P862, DOI 10.1111/j.1365-313X.2009.04114.x; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; West M, 2005, MOL CELL BIOL, V25, P3802, DOI 10.1128/MCB.25.9.3802-3813.2005; WESTAFER JM, 1976, CYTOBIOS, V15, P111; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8; Xu CR, 2005, P NATL ACAD SCI USA, V102, P14469, DOI 10.1073/pnas.0503143102; Yang CY, 2007, PLANT CELL, V19, P534, DOI 10.1105/tpc.106.046391; Yao Y, 2008, DEVELOPMENT, V135, P1325, DOI 10.1242/dev.017913; Ye ZH, 2002, INT REV CYTOL, V220, P225; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zanetti ME, 2005, PLANT PHYSIOL, V138, P624, DOI 10.1104/pp.105.059477; Zemp I, 2007, FEBS LETT, V581, P2783, DOI 10.1016/j.febslet.2007.05.013; Zhong RQ, 2007, CURR OPIN PLANT BIOL, V10, P564, DOI 10.1016/j.pbi.2007.09.001	59	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35904	10.1371/journal.pone.0035904	http://dx.doi.org/10.1371/journal.pone.0035904			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558264	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000080
J	Cheng, CC; Lian, WS; Hsiao, FSH; Liu, IH; Lin, SP; Lee, YH; Chang, CC; Xiao, GY; Huang, HY; Cheng, CF; Cheng, WTK; Wu, SC				Cheng, Chun-Chun; Lian, Wei-Shiung; Hsiao, Felix Shih-Hsiang; Liu, I-Hsuan; Lin, Shau-Ping; Lee, Yen-Hua; Chang, Chia-Chun; Xiao, Guan-Yu; Huang, Hsin-Yi; Cheng, Ching-Feng; Cheng, Winston Teng-Kuei; Wu, Shinn-Chih			Isolation and Characterization of Novel Murine Epiphysis Derived Mesenchymal Stem Cells	PLOS ONE			English	Article							MARROW STROMAL CELLS; HUMAN UMBILICAL-CORD; BONE-MARROW; PROGENITOR CELLS; IN-VITRO; ADIPOSE-TISSUE; FRACTURE REPAIR; INBRED MICE; DIFFERENTIATION; CULTURE	Background: While bone marrow (BM) is a rich source of mesenchymal stem cells (MSCs), previous studies have shown that MSCs derived from mouse BM (BMMSCs) were difficult to manipulate as compared to MSCs derived from other species. The objective of this study was to find an alternative murine MSCs source that could provide sufficient MSCs. Methodology/Principal Findings: In this study, we described a novel type of MSCs that migrates directly from the mouse epiphysis in culture. Epiphysis-derived MSCs (EMSCs) could be extensively expanded in plastic adherent culture, and they had a greater ability for clonogenic formation and cell proliferation than BMMSCs. Under specific induction conditions, EMSCs demonstrated multipotency through their ability to differentiate into adipocytes, osteocytes and chondrocytes. Immunophenotypic analysis demonstrated that EMSCs were positive for CD29, CD44, CD73, CD105, CD166, Sca-1 and SSEA-4, while negative for CD11b, CD31, CD34 and CD45. Notably, EMSCs did not express major histocompatibility complex class I (MHC I) or MHC II under our culture system. EMSCs also successfully suppressed the proliferation of splenocytes triggered by concanavalin A (Con A) or allogeneic splenocytes, and decreased the expression of IL-1, IL-6 and TNF-alpha in Con A-stimulated splenocytes suggesting their anti-inflammatory properties. Moreover, EMSCs enhanced fracture repair, ameliorated necrosis in ischemic skin flap, and improved blood perfusion in hindlimb ischemia in the in vivo experiments. Conclusions/Significances: These results indicate that EMSCs, a new type of MSCs established by our simple isolation method, are a preferable alternative for mice MSCs due to their better growth and differentiation potentialities.	[Cheng, Chun-Chun; Hsiao, Felix Shih-Hsiang; Lin, Shau-Ping; Wu, Shinn-Chih] Natl Taiwan Univ, Inst Biotechnol, Taipei 10764, Taiwan; [Lian, Wei-Shiung; Cheng, Ching-Feng] Tzu Chi Univ, Dept Pediat, Hualien, Taiwan; [Lian, Wei-Shiung; Cheng, Ching-Feng] Tzu Chi Univ, Tzu Chi Gen Hosp, Dept Med Res, Hualien, Taiwan; [Lian, Wei-Shiung; Cheng, Ching-Feng] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Liu, I-Hsuan; Lee, Yen-Hua; Chang, Chia-Chun; Xiao, Guan-Yu; Huang, Hsin-Yi; Cheng, Winston Teng-Kuei; Wu, Shinn-Chih] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei 10764, Taiwan; [Liu, I-Hsuan] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10764, Taiwan; [Cheng, Winston Teng-Kuei] Tunghai Univ, Dept Anim Sci & Biotechnol, Taichung 40704, Taiwan	National Taiwan University; Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; Tunghai University	Cheng, CC (corresponding author), Natl Taiwan Univ, Inst Biotechnol, Taipei 10764, Taiwan.	scw01@ntu.edu.tw	Liu, I-Hsuan/D-9043-2017; CHENG, Ching-Feng/AAB-8861-2019; Hsiao, Shih-Hsiang/AAB-7325-2022; Cheng, Ching-Feng/AAB-8523-2019	Liu, I-Hsuan/0000-0002-4524-3263; CHENG, Ching-Feng/0000-0003-0104-0146; Lee, Yen-Hua/0000-0001-8812-6094; Wu, Shinn-Chih/0000-0001-8881-1550; Lin, Shau-Ping/0000-0003-3423-991X; Chang, Chia Chun/0000-0001-7942-6300	National Taiwan University [97similar to99R0066-41]; Council of Agriculture [99AS-1.2.3-ST-aM]	National Taiwan University(National Taiwan University); Council of Agriculture	This work was supported by grants from National Taiwan University (97 similar to 99R0066-41) and Council of Agriculture (99AS-1.2.3-ST-aM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsalameh S, 2004, ARTHRITIS RHEUM-US, V50, P1522, DOI 10.1002/art.20269; Baxter MA, 2004, STEM CELLS, V22, P675, DOI 10.1634/stemcells.22-5-675; Ben-Ami E, 2011, AUTOIMMUN REV, V10, P410, DOI 10.1016/j.autrev.2011.01.005; Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Callicott RJ, 2006, COMPARATIVE MED, V56, P17; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Castillo MD, 2008, CTS-CLIN TRANSL SCI, V1, P27, DOI 10.1111/j.1752-8062.2008.00018.x; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chao KC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001451; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Cho SW, 2007, CIRCULATION, V116, P2409, DOI 10.1161/CIRCULATIONAHA.106.687038; Dar A, 2012, CIRCULATION, V125, P87, DOI 10.1161/CIRCULATIONAHA.111.048264; DiGirolamo CM, 1999, BRIT J HAEMATOL, V107, P275, DOI 10.1046/j.1365-2141.1999.01715.x; Epting CL, 2008, J CELL PHYSIOL, V217, P250, DOI 10.1002/jcp.21500; Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x; Eslaminejad MB, 2006, DEV GROWTH DIFFER, V48, P361, DOI 10.1111/j.1440-169x.2006.00874.x; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Granero-Molto F, 2011, STEM CELLS, V29, P1537, DOI 10.1002/stem.697; Granero-Molto F, 2009, STEM CELLS, V27, P1887, DOI 10.1002/stem.103; Greco SJ, 2007, STEM CELLS DEV, V16, P811, DOI 10.1089/scd.2007.0011; Gronthos S, 1996, J Hematother, V5, P15, DOI 10.1089/scd.1.1996.5.15; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Hisanaga E, 2008, ENDOCR J, V55, P535, DOI 10.1507/endocrj.K07E-173; Holmes C, 2007, STEM CELLS, V25, P1339, DOI 10.1634/stemcells.2006-0644; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Hsiao FSH, 2010, CELL PROLIFERAT, V43, P235, DOI 10.1111/j.1365-2184.2010.00674.x; in 'tAnker PS, 2003, BLOOD, V102, P1548, DOI 10.1182/blood-2003-04-1291; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Kitano Y, 2000, EXP HEMATOL, V28, P1460, DOI 10.1016/S0301-472X(00)00551-8; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Lapi Simone, 2008, BMC Res Notes, V1, P53, DOI 10.1186/1756-0500-1-53; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Li ZL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020526; Lian WS, 2011, LIFE SCI, V88, P455, DOI 10.1016/j.lfs.2010.12.020; Lopatina T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017899; Lu P, 2004, J NEUROSCI RES, V77, P174, DOI 10.1002/jnr.20148; Meirelles LD, 2003, BRIT J HAEMATOL, V123, P702, DOI 10.1046/j.1365-2141.2003.04669.x; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Moorefield EC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026535; Nadri S, 2007, INT J DEV BIOL, V51, P723, DOI 10.1387/ijdb.072352ns; Nagano M, 2007, BLOOD, V110, P151, DOI 10.1182/blood-2006-10-047092; Nagano M, 2010, STEM CELLS DEV, V19, P1195, DOI 10.1089/scd.2009.0447; Nakamura Y, 2010, BLOOD, V116, P1422, DOI 10.1182/blood-2009-08-239194; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Ozbey O, 2010, HISTOL HISTOPATHOL, V25, P1437, DOI 10.14670/HH-25.1437; Patel SA, 2008, ARCH IMMUNOL THER EX, V56, P1, DOI 10.1007/s00005-008-0001-x; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Peters R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015689; Phinney DG, 1999, J CELL BIOCHEM, V72, P570; Phinney Donald G., 2008, V449, P171, DOI 10.1007/978-1-60327-169-1_12; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Sakaguchi Y, 2004, BLOOD, V104, P2728, DOI 10.1182/blood-2003-12-4452; Shapiro F, 2008, EUR CELLS MATER, V15, P53, DOI 10.22203/eCM.v015a05; Sun SK, 2003, STEM CELLS, V21, P527, DOI 10.1634/stemcells.21-5-527; Taguchi K, 2005, BIOCHEM BIOPH RES CO, V331, P31, DOI 10.1016/j.bbrc.2005.03.119; Talens-Visconti R, 2006, WORLD J GASTROENTERO, V12, P5834, DOI 10.3748/wjg.v12.i36.5834; Toutain CE, 2009, CIRC RES, V104, P245, DOI 10.1161/CIRCRESAHA.108.182410; Tuli R, 2003, STEM CELLS, V21, P681, DOI 10.1634/stemcells.21-6-681; Uccelli A, 2011, LANCET NEUROL, V10, P649, DOI 10.1016/S1474-4422(11)70121-1; Uysal AC, 2009, PLAST RECONSTR SURG, V124, P804, DOI 10.1097/PRS.0b013e3181b17bb4; UZUKA M, 1981, BIOCHIM BIOPHYS ACTA, V673, P387, DOI 10.1016/0304-4165(81)90470-0; Williams JT, 1999, AM SURGEON, V65, P22; Wilson A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-229; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Yoshimura H, 2007, CELL TISSUE RES, V327, P449, DOI 10.1007/s00441-006-0308-z; Zanini C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028175; Zeng LP, 2006, STEM CELLS, V24, P2355, DOI 10.1634/stemcells.2005-0551; Zhang YQ, 2012, MOL BIOL REP, V39, P285, DOI 10.1007/s11033-011-0737-y; Zhao SM, 2010, STEM CELLS DEV, V19, P607, DOI 10.1089/scd.2009.0345; Zhu H, 2010, NAT PROTOC, V5, P550, DOI 10.1038/nprot.2009.238; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	77	27	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36085	10.1371/journal.pone.0036085	http://dx.doi.org/10.1371/journal.pone.0036085			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558340	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336000124
J	Krauland, MG; Hotopp, JCD; Riley, DR; Daugherty, SC; Marsh, JW; Messonnier, NE; Mayer, LW; Tettelin, H; Harrison, LH				Krauland, Mary G.; Hotopp, Julie C. Dunning; Riley, David R.; Daugherty, Sean C.; Marsh, Jane W.; Messonnier, Nancy E.; Mayer, Leonard W.; Tettelin, Herve; Harrison, Lee H.			Whole Genome Sequencing to Investigate the Emergence of Clonal Complex 23 Neisseria meningitidis Serogroup Y Disease in the United States	PLOS ONE			English	Article							HIDDEN MARKOV MODEL; GENETIC-CHARACTERIZATION; MENINGOCOCCAL DISEASE; PILIN GLYCOSYLATION; SIGNAL PEPTIDES; VACCINE; IDENTIFICATION; ALIGNMENT; STRAIN; CORE	In the United States, serogroup Y, ST-23 clonal complex Neisseria meningitidis was responsible for an increase in meningococcal disease incidence during the 1990s. This increase was accompanied by antigenic shift of three outer membrane proteins, with a decrease in the population that predominated in the early 1990s as a different population emerged later in that decade. To understand factors that may have been responsible for the emergence of serogroup Y disease, we used whole genome pyrosequencing to investigate genetic differences between isolates from early and late N. meningitidis populations, obtained from meningococcal disease cases in Maryland in the 1990s. The genomes of isolates from the early and late populations were highly similar, with 1231 of 1776 shared genes exhibiting 100% amino acid identity and an average pi(N) = 0.0033 and average pi(S) = 0.0216. However, differences were found in predicted proteins that affect pilin structure and antigen profile and in predicted proteins involved in iron acquisition and uptake. The observed changes are consistent with acquisition of new alleles through horizontal gene transfer. Changes in antigen profile due to the genetic differences found in this study likely allowed the late population to emerge due to escape from population immunity. These findings may predict which antigenic factors are important in the cyclic epidemiology of meningococcal disease.	[Krauland, Mary G.; Marsh, Jane W.; Harrison, Lee H.] Univ Pittsburgh, Sch Med, Infect Dis Epidemiol Res Unit, Pittsburgh, PA 15260 USA; [Krauland, Mary G.; Marsh, Jane W.; Harrison, Lee H.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA; [Hotopp, Julie C. Dunning; Riley, David R.; Daugherty, Sean C.; Tettelin, Herve] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Messonnier, Nancy E.; Mayer, Leonard W.] Ctr Dis Control & Prevent, Meningitis & Vaccine Preventable Dis Branch, Atlanta, GA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Maryland; University of Maryland Baltimore; Centers for Disease Control & Prevention - USA	Krauland, MG (corresponding author), Univ Pittsburgh, Sch Med, Infect Dis Epidemiol Res Unit, Pittsburgh, PA 15260 USA.	mgk8@pitt.edu	Dunning Hotopp, Julie/E-7762-2010	Dunning Hotopp, Julie/0000-0003-3862-986X; Krauland, Mary/0000-0002-1548-6221	Centers for Disease Control and Prevention; Sanofi Pasteur	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Sanofi Pasteur	This study was supported by a cooperative agreement from the Centers for Disease Control and Prevention and a grant from Sanofi Pasteur. Sanofi Pasteur had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHTMAN M, 1995, TRENDS MICROBIOL, V3, P186, DOI 10.1016/S0966-842X(00)88918-0; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angiuoli SV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-272; [Anonymous], 2009, VACCINE, DOI DOI 10.1016/j.vaccine.2009.04.063; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bennett JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-652; Budroni S, 2011, P NATL ACAD SCI USA, V108, P4494, DOI 10.1073/pnas.1019751108; Carbonnelle E, 2006, MOL MICROBIOL, V61, P1510, DOI 10.1111/j.1365-2958.2006.05341.x; Castillo-Ramirez S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002129; Cehovin A, 2010, VACCINE, V28, P4817, DOI 10.1016/j.vaccine.2010.04.065; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chou AC, 2008, J MED MICROBIOL, V57, P839, DOI 10.1099/jmm.0.47612-0; Comanducci M, 2002, J EXP MED, V195, P1445, DOI 10.1084/jem.20020407; Crabtree Jonathan, 2007, V408, P93, DOI 10.1007/978-1-59745-547-3_6; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delcher Arthur L, 2003, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1003s00; Didelot X, 2009, MICROBIOL-SGM, V155, P3176, DOI 10.1099/mic.0.031534-0; Hotopp JCD, 2006, PLOS GENET, V2, P208, DOI 10.1371/journal.pgen.0020021; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egan A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-524; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; Gupta S, 1996, NAT MED, V2, P437, DOI 10.1038/nm0496-437; Harrison LH, 2006, J INFECT DIS, V193, P1266, DOI 10.1086/501371; Hotopp JCD, 2006, MICROBIOL-SGM, V152, P3733, DOI 10.1099/mic.0.29261-0; Hsu CA, 2008, PROTEOMICS, V8, P2115, DOI 10.1002/pmic.200700574; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jackson Lisa A., 1993, Morbidity and Mortality Weekly Report, V42, P21; Jiang HQ, 2010, VACCINE, V28, P6086, DOI 10.1016/j.vaccine.2010.06.083; Joseph B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018441; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kahler CM, 2001, INFECT IMMUN, V69, P1687, DOI 10.1128/IAI.69.3.1687-1696.2001; KROGH A, 1994, NUCLEIC ACIDS RES, V22, P4768, DOI 10.1093/nar/22.22.4768; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Leimkugel J, 2007, PLOS MED, V4, P535, DOI 10.1371/journal.pmed.0040101; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; McEllistrem MC, 2004, EMERG INFECT DIS, V10, P451; MOORE PS, 1992, CLIN INFECT DIS, V14, P515, DOI 10.1093/clinids/14.2.515; NASSIF X, 1993, MOL MICROBIOL, V8, P719, DOI 10.1111/j.1365-2958.1993.tb01615.x; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; Peng JP, 2008, GENOMICS, V91, P78, DOI 10.1016/j.ygeno.2007.10.004; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Power PM, 2003, MOL MICROBIOL, V49, P833, DOI 10.1046/j.1365-2958.2003.03602.x; Power PM, 2000, MICROBIOL-UK, V146, P967, DOI 10.1099/00221287-146-4-967; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Riley DR, 2011, BIOINFORMATICS; Rosenstein NE, 1999, J INFECT DIS, V180, P1894, DOI 10.1086/315158; RUDEL T, 1995, NATURE, V373, P357, DOI 10.1038/373357a0; Salzberg S, 1998, J COMPUT BIOL, V5, P667, DOI 10.1089/cmb.1998.5.667; Schoen C, 2008, P NATL ACAD SCI USA, V105, P3473, DOI 10.1073/pnas.0800151105; Schuchat A, 2001, EMERG INFECT DIS, V7, P92, DOI 10.3201/eid0701.010114; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhu PX, 2001, P NATL ACAD SCI USA, V98, P5234, DOI 10.1073/pnas.061386098	56	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35699	10.1371/journal.pone.0035699	http://dx.doi.org/10.1371/journal.pone.0035699			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558202	Green Published, Green Accepted, gold			2022-12-27	WOS:000305336000048
J	Lee, CC; Ho, HC; Su, YC; Chiu, BCH; Su, YC; Lee, YD; Chou, P; Chien, SH; Huang, YS				Lee, Ching-Chih; Ho, Hsu-Chueh; Su, Yu-Chieh; Chiu, Brian C-H; Su, Yung-Cheng; Lee, Yi-Da; Chou, Pesus; Chien, Sou-Hsin; Huang, Yung-Sung			Increased Risk of Vascular Events in Emergency Room Patients Discharged Home with Diagnosis of Dizziness or Vertigo: A 3-Year Follow-Up Study	PLOS ONE			English	Article							STROKE INCIDENCE; ISCHEMIC-STROKE; POPULATION; MANIFESTATION; DIZZY	Background: Dizziness and vertigo symptoms are commonly seen in emergency room (ER). However, these patients are often discharged without a definite diagnosis. Conflicting data regarding the vascular event risk among the dizziness or vertigo patients have been reported. This study aims to determine the risk of developing stroke or cardiovascular events in ER patients discharged home with a diagnosis of dizziness or vertigo. Methodology: A total of 25,757 subjects with at least one ER visit in 2004 were identified. Of those, 1,118 patients were discharged home with a diagnosis of vertigo or dizziness. A Cox proportional hazard model was performed to compare the three-year vascular event-free survival rates between the dizziness/vertigo patients and those without dizziness/vertigo after adjusting for confounding and risk factors. Results: We identified 52 (4.7%) vascular events in patients with dizziness/vertigo and 454 (1.8%) vascular events in patients without dizziness/vertigo. ER patients discharged home with a diagnosis of vertigo or dizziness had 2-fold (95% confidence interval [CI], 1.35-2.96; p<0.001) higher risk of stroke or cardiovascular events after adjusting for patient characteristics, comorbidities, urbanization level of residence, individual socio-economic status, and initially taking medications after the onset of dizziness or vertigo during the first year. Conclusions: ER patients discharged home with a diagnosis of dizziness or vertigo were at a increased risk of developing subsequent vascular events than those without dizziness/vertigo after the onset of dizziness or vertigo. Further studies are warranted for developing better diagnostic and follow-up strategies in increased risk patients.	[Lee, Ching-Chih; Chou, Pesus] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Lee, Ching-Chih; Chou, Pesus] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Lee, Ching-Chih; Ho, Hsu-Chueh] Buddhist Dalin Tzu Chi Gen Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Lee, Yi-Da] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Cardiol, Chiayi, Taiwan; [Su, Yu-Chieh] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Hematol Oncol, Chiayi, Taiwan; [Lee, Ching-Chih; Su, Yu-Chieh] Buddhist Dalin Tzu Chi Gen Hosp, Ctr Canc, Chiayi, Taiwan; [Su, Yung-Cheng] Buddhist Dalin Tzu Chi Gen Hosp, Dept Emergency Med, Chiayi, Taiwan; [Huang, Yung-Sung] Buddhist Dalin Tzu Chi Gen Hosp, Div Neurol, Dept Internal Med, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Ctr Clin Epidemiol & Biostat, Chiayi, Taiwan; [Chien, Sou-Hsin] Buddhist Dalin Tzu Chi Gen Hosp, Dept Surg, Div Plast Surg, Chiayi, Taiwan; [Lee, Ching-Chih; Ho, Hsu-Chueh; Su, Yu-Chieh; Su, Yung-Cheng; Chien, Sou-Hsin] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Chiu, Brian C-H] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; University of Chicago	Lee, CC (corresponding author), Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan.	enttcd2@hotamil.com; enttcd@hotamil.com	Su, Yu-Chieh/M-7867-2013	Su, Yu-Chieh/0000-0002-1771-9017	National Health Research Institutes [100363]	National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan)	This study is based in part on data from the National Health Insurance Research Database provided by the Bureau of National Health Insurance, Department of Health and managed by the National Health Research Institutes (Serial No. 100363). The interpretation and conclusions contained herein do not represent those of the aforementioned institutions.	Bos MJ, 2007, JAMA-J AM MED ASSOC, V298, P2877, DOI 10.1001/jama.298.24.2877; Chase M, 2011, AM J EMERG IN PRESS; Chen CY, 2007, PEDIATRICS, V119, pE435, DOI 10.1542/peds.2006-1477; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; DALLARA J, 1994, AM J EMERG MED, V12, P421, DOI 10.1016/0735-6757(94)90052-3; Engstrom G, 2001, STROKE, V32, P1098, DOI 10.1161/01.STR.32.5.1098; Finnegan JR, 2000, PREV MED, V31, P205, DOI 10.1006/pmed.2000.0702; Karatas M, 2008, NEUROLOGIST, V14, P355, DOI 10.1097/NRL.0b013e31817533a3; Kerber KA, 2006, STROKE, V37, P2484, DOI 10.1161/01.STR.0000240329.48263.0d; Kerber KA, 2010, J EVAL CLIN PRACT, V16, P186, DOI 10.1111/j.1365-2753.2009.01133.x; Kim AS, 2011, ANN EMERG MED, V57, P34, DOI 10.1016/j.annemergmed.2010.06.559; Lee H, 2006, NEUROLOGY, V67, P1178, DOI 10.1212/01.wnl.0000238500.02302.b4; Lee HY, 2004, J NEUROL SCI, V222, P105, DOI 10.1016/j.jns.2004.04.005; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; MADLONKAY DJ, 1985, J FAM PRACTICE, V21, P109; McFadden E, 2009, STROKE, V40, P1070, DOI 10.1161/STROKEAHA.108.533414; Molshatzki N, 2011, MED CARE, V49, P673, DOI 10.1097/MLR.0b013e318222a508; Moon SY, 2006, J KOREAN MED SCI, V21, P539, DOI 10.3346/jkms.2006.21.3.539; National Health Insurance Research Database, 2009, NAT HLTH INS RES DAT; Newman-Toker DE, 2008, MAYO CLIN PROC, V83, P765, DOI 10.4065/83.7.765; Newman-Toker DE, 2006, NAT CLIN PRACT NEURO, V2, P167, DOI 10.1038/ncpneuro0125; NHI, 2008, NHI PROF; Schappert SM, 2006, VITAL HLTH STAT, V13, P1; Schneider AT, 2003, JAMA-J AM MED ASSOC, V289, P343, DOI 10.1001/jama.289.3.343; Seok JI, 2008, J CLIN NEUROL, V4, P107, DOI 10.3988/jcn.2008.4.3.107; Sheu JJ, 2010, STROKE, V41, P244, DOI 10.1161/STROKEAHA.109.567735	26	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35923	10.1371/journal.pone.0035923	http://dx.doi.org/10.1371/journal.pone.0035923			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558272	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336000086
J	Mandeville, JS; Bourassa, P; Thomas, TJ; Tajmir-Riahi, HA				Mandeville, Jean-Sebastian; Bourassa, Phillipe; Thomas, Thekkumkattil John; Tajmir-Riahi, Heidar-Ali			Biogenic and Synthetic Polyamines Bind Cationic Dendrimers	PLOS ONE			English	Article							POLYAMIDOAMINE DENDRIMERS; GROWTH-INHIBITION; PAMAM DENDRIMERS; TRANSFER-RNA; CELL-GROWTH; IN-VITRO; ANALOGS; CANCER; METABOLISM; EXPRESSION	Biogenic polyamines are essential for cell growth and differentiation, while polyamine analogues exert antitumor activity in multiple experimental model systems, including breast and lung cancer. Dendrimers are widely used for drug delivery in vitro and in vivo. We report the bindings of biogenic polyamines, spermine (spm), and spermidine (spmd), and their synthetic analogues, 3,7,11,15-tetrazaheptadecane. 4HCl (BE-333) and 3,7,11,15,19-pentazahenicosane.5HCl (BE-3333) to dendrimers of different compositions, mPEG-PAMAM (G3), mPEG-PAMAM (G4) and PAMAM (G4). FTIR and UV-visible spectroscopic methods as well as molecular modeling were used to analyze polyamine binding mode, the binding constant and the effects of polyamine complexation on dendrimer stability and conformation. Structural analysis showed that polyamines bound dendrimers through both hydrophobic and hydrophilic contacts with overall binding constants of Kspm-mPEG-G3 = 7.6 x 10(4) M-1, Kspm-mPEG-PAMAM-G4 = 4.6 x 10(4) M-1, Kspm-PAMAM-G4 = 6.6x10(4) M-1, Kspmd-mPEG-G3 = 1.0x10(5) M-1, Kspmd-mPEG-PAMAM-G4 = 5.5x10(4) M-1, Kspmd-PAMAM-G4 = 9.2 x 10(4) M-1, KBE-333-mPEG-G3 = 4.2x10(4) M-1, KBe-333-mPEG-PAMAM-G4 = 3.2 x 10(4) M-1, KBE-333-PAMAM-G4 = 3.6 x 10(4) M-1, KBE-3333-mPEG-G3 = 2.2x10(4) M-1, KBe-3333-mPEG-PAMAM-G4 = 2.4 x 10(4) M-1, KBE-3333-PAMAM-G4 = 2.3 x 10(4) M-1. Biogenic polyamines showed stronger affinity toward dendrimers than those of synthetic polyamines, while weaker interaction was observed as polyamine cationic charges increased. The free binding energies calculated from docking studies were: -3.2 (spermine), -3.5 (spermidine) and -3.03 (BE-3333) kcal/mol, with the following order of binding affinity: spermidine-PAMAM-G-4>spermine-PAMMAM-G4>BE-3333-PAMAM-G4 consistent with spectroscopic data. Our results suggest that dendrimers can act as carrier vehicles for delivering antitumor polyamine analogues to target tissues.	[Mandeville, Jean-Sebastian; Bourassa, Phillipe; Tajmir-Riahi, Heidar-Ali] Univ Quebec Trois Rivieres, Dept Chim Biol, Trois Rivieres, PQ GA9 5H7, Canada; [Thomas, Thekkumkattil John] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ 08903 USA; [Thomas, Thekkumkattil John] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, New Brunswick, NJ USA	University of Quebec; University of Quebec Trois Rivieres; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Mandeville, JS (corresponding author), Univ Quebec Trois Rivieres, Dept Chim Biol, CP 500, Trois Rivieres, PQ GA9 5H7, Canada.	tajmirri@uqtr.ca	Bourassa, Philippe/H-7281-2012	Bourassa, Philippe/0000-0003-2662-2118				Abderrezak A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033102; BERGERON RJ, 1994, J MED CHEM, V37, P3464, DOI 10.1021/jm00047a004; BERGERON RJ, 1988, J MED CHEM, V31, P1183, DOI 10.1021/jm00401a019; Casero RA, 2001, J MED CHEM, V44, P1, DOI 10.1021/jm000084m; Cohen S.S., 1998, GUIDE POLYAMINES, V1st ed.; Connors K, BINDING CONSTANTS ME; D'Agostino L, 2005, FEBS J, V272, P3777, DOI 10.1111/j.1742-4658.2005.04782.x; DAVIDSON NE, 1993, CANCER RES, V53, P2071; Dubeau S, 2010, BIOMACROMOLECULES, V11, P1507, DOI 10.1021/bm100144v; Esseminea J, 2011, INT J BIOL MACROMOL, V49; Faaland CA, 2000, BIOCHEM CELL BIOL, V78, P415, DOI 10.1139/bcb-78-4-415; Froehlich E, 2011, BIOMACROMOLECULES, V12, P511, DOI 10.1021/bm1013102; Galeazzi S, 2010, BIOMACROMOLECULES, V11, P182, DOI 10.1021/bm901055a; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Ha HC, 1997, P NATL ACAD SCI USA, V94, P11557, DOI 10.1073/pnas.94.21.11557; Ha HC, 1998, P NATL ACAD SCI USA, V95, P11140, DOI 10.1073/pnas.95.19.11140; Hardy JG, 2006, BIOCONJUGATE CHEM, V17, P172, DOI 10.1021/bc050212r; Hawke CJ, 1999, J CHEM SOC PERK T, P1287; HEBY O, 1981, DIFFERENTIATION, V19, P1, DOI 10.1111/j.1432-0436.1981.tb01123.x; Hu JJ, 2010, J PHYS CHEM B, V114, P7148, DOI 10.1021/jp1007889; Huang Y, 2004, MOL CANCER RES, V2, P81; Huang Y, 2006, J BIOL CHEM, V281, P19055, DOI 10.1074/jbc.M600910200; Iyer J, 1998, MACROMOLECULES, V31, P8757, DOI 10.1021/ma980654g; JANSEN JFGA, 1994, SCIENCE, V266, P1226, DOI 10.1126/science.266.5188.1226; JANSEN JFGA, 1995, J AM CHEM SOC, V117, P4417, DOI 10.1021/ja00120a032; JEVPRASCSPHANT R, 2000, INT J PHARMACEUT, V252, P263; Klajnert B, 2007, NEW DEV MUTATION RES, P217; Klajnert B., 2007, DENDRIMERS MED; Kojima C, 2000, BIOCONJUGATE CHEM, V11, P910, DOI 10.1021/bc0000583; Kono K, 1999, BIOCONJUGATE CHEM, V10, P1115, DOI 10.1021/bc990082k; Lee CC, 2005, NAT BIOTECHNOL, V23, P1517, DOI 10.1038/nbt1171; Maiti PK, 2004, MACROMOLECULES, V37, P6236, DOI 10.1021/ma035629b; Malik N, 2000, J CONTROL RELEASE, V65, P133, DOI 10.1016/S0168-3659(99)00246-1; MARTON LJ, 1995, ANNU REV PHARMACOL, V35, P55, DOI 10.1146/annurev.pa.35.040195.000415; McCloskey DE, 2003, J BIOL CHEM, V278, P13881, DOI 10.1074/jbc.M205689200; N'soukpoe-Kossi CN, 2008, BIOMACROMOLECULES, V9, P2712, DOI 10.1021/bm800412r; N'soukpoe-Kossi CN, 2009, BIOCHEM CELL BIOL, V87, P621, DOI [10.1139/O09-036, 10.1139/o09-036]; Ouameur AA, 2004, J BIOL CHEM, V279, P42041, DOI 10.1074/jbc.M406053200; Ouameur AA, 2010, RNA, V16, P1968, DOI 10.1261/rna.1994310; Patri AK, 2002, CURR OPIN CHEM BIOL, V6, P466, DOI 10.1016/S1367-5931(02)00347-2; PEGG AE, 1988, CANCER RES, V48, P759; Popescu MC, 2006, J PHYS CHEM B, V110, P14198, DOI 10.1021/jp061311k; Singh P, 2008, BIOCONJUGATE CHEM, V19, P2239, DOI 10.1021/bc800125u; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Thomas T, 2001, CELL MOL LIFE SCI, V58, P244, DOI 10.1007/PL00000852; Thomas T, 2003, J CELL MOL MED, V7, P113, DOI 10.1111/j.1582-4934.2003.tb00210.x; Thomas T, 2002, ONCOL RES, V13, P123; Tkachenko AG, 2003, BIOCHEMISTRY-MOSCOW+, V68, P850, DOI 10.1023/A:1025790729797; Tomalia DA, 2005, PROG POLYM SCI, V30, P294, DOI 10.1016/j.progpolymsci.2005.01.007; Twyman LJ, 1999, TETRAHEDRON LETT, V40, P1743, DOI 10.1016/S0040-4039(98)02680-X; Zhuo RX, 1999, J CONTROL RELEASE, V57, P249, DOI 10.1016/S0168-3659(98)00120-5	51	6	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36087	10.1371/journal.pone.0036087	http://dx.doi.org/10.1371/journal.pone.0036087			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558341	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000125
J	Studds, CE; DeLuca, WV; Baker, ME; King, RS; Marra, PP				Studds, Colin E.; DeLuca, William V.; Baker, Matthew E.; King, Ryan S.; Marra, Peter P.			Land Cover and Rainfall Interact to Shape Waterbird Community Composition	PLOS ONE			English	Article							CHESAPEAKE BAY; COASTAL URBANIZATION; NITROGEN EXPORT; MARINE; NUTRIENT; ABUNDANCE; CLIMATE; EUTROPHICATION; INDICATORS; INTEGRITY	Human land cover can degrade estuaries directly through habitat loss and fragmentation or indirectly through nutrient inputs that reduce water quality. Strong precipitation events are occurring more frequently, causing greater hydrological connectivity between watersheds and estuaries. Nutrient enrichment and dissolved oxygen depletion that occur following these events are known to limit populations of benthic macroinvertebrates and commercially harvested species, but the consequences for top consumers such as birds remain largely unknown. We used non-metric multidimensional scaling (MDS) and structural equation modeling (SEM) to understand how land cover and annual variation in rainfall interact to shape waterbird community composition in Chesapeake Bay, USA. The MDS ordination indicated that urban subestuaries shifted from a mixed generalist-specialist community in 2002, a year of severe drought, to generalist-dominated community in 2003, of year of high rainfall. The SEM revealed that this change was concurrent with a sixfold increase in nitrate-N concentration in subestuaries. In the drought year of 2002, waterbird community composition depended only on the direct effect of urban development in watersheds. In the wet year of 2003, community composition depended both on this direct effect and on indirect effects associated with high nitrate-N inputs to northern parts of the Bay, particularly in urban subestuaries. Our findings suggest that increased runoff during periods of high rainfall can depress water quality enough to alter the composition of estuarine waterbird communities, and that this effect is compounded in subestuaries dominated by urban development. Estuarine restoration programs often chart progress by monitoring stressors and indicators, but rarely assess multivariate relationships among them. Estuarine management planning could be improved by tracking the structure of relationships among land cover, water quality, and waterbirds. Unraveling these complex relationships may help managers identify and mitigate ecological thresholds that occur with increasing human land cover.	[Studds, Colin E.; Marra, Peter P.] Smithsonian Inst, Natl Zool Pk, Migratory Bird Ctr, Smithsonian Conservat Biol Inst, Washington, DC 20008 USA; [DeLuca, William V.] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA; [Baker, Matthew E.] Univ Maryland, Dept Geog & Environm Syst, Baltimore, MD 21201 USA; [King, Ryan S.] Baylor Univ, Dept Biol, Ctr Reservoir & Aquat Syst, Waco, TX 76798 USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; University of Massachusetts System; University of Massachusetts Amherst; University System of Maryland; University of Maryland Baltimore; Baylor University	Studds, CE (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia.	c.studds@uq.edu.au	Studds, Colin/C-3701-2012; Baker, Matthew/I-2839-2014	Studds, Colin/0000-0001-5715-1692; Marra, Peter/0000-0002-0508-7577; DeLuca, William/0000-0002-5099-2293; Baker, Matthew/0000-0001-5069-0204	United States Environmental Protection Agency's (USEPA) Science to Achieve Results (STAR) Estuarine and Great Lakes (EaGLe) program [R-82868401]; USEPA	United States Environmental Protection Agency's (USEPA) Science to Achieve Results (STAR) Estuarine and Great Lakes (EaGLe) program; USEPA(United States Environmental Protection Agency)	This study was funded by a grant from the United States Environmental Protection Agency's (USEPA) Science to Achieve Results (STAR) Estuarine and Great Lakes (EaGLe) program to the Atlantic Slope Consortium, USEPA Agreement #R-82868401. Although the research described in this article was funded by the USEPA, it was not subjected to the Agency's peer and policy review and therefore does not necessarily reflect the views of the Agency and no official endorsement should be inferred. The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker JG, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021852; [Anonymous], AMOS VERSION 19; Bollen K. A., 1993, TESTING STRUCTURAL E; Boyer EW, 2002, BIOGEOCHEMISTRY, V57, P137, DOI 10.1023/A:1015709302073; Brinker DF, 2007, WATERBIRDS, V30, P93, DOI 10.1675/1524-4695(2007)030[0093:CSITCB]2.0.CO;2; Bulleri F, 2010, J APPL ECOL, V47, P26, DOI 10.1111/j.1365-2664.2009.01751.x; Bundy MH, 2003, ESTUARIES, V26, P365, DOI 10.1007/BF02695974; Chesapeake Bay Foundation, 2010, 2010 STAT BAY; Chesney E. J., 1989, POPULATION BIOL BAY, P184; CONNELL DW, 1984, CHEM ECOTOXICOLOGY P; DeLuca WV, 2008, BIOL CONSERV, V141, P2669, DOI 10.1016/j.biocon.2008.07.023; DeLuca WV, 2004, WETLANDS, V24, P837, DOI 10.1672/0277-5212(2004)024[0837:IOLUOT]2.0.CO;2; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Erwin RM, 1996, ESTUARIES, V19, P213, DOI 10.2307/1352226; Essington TE, 2010, ECOSYSTEMS, V13, P1035, DOI 10.1007/s10021-010-9372-z; FAITH DP, 1989, BIOL CONSERV, V50, P77, DOI 10.1016/0006-3207(89)90006-2; Fear JM, 2007, ESTUAR COAST, V30, P1027, DOI 10.1007/BF02841393; Gosselink J.G., 2000, WETLANDS; Haas K, 2007, ECOLOGY, V88, P2915, DOI 10.1890/06-1981.1; Howarth RW, 2006, BIOGEOCHEMISTRY, V79, P163, DOI 10.1007/s10533-006-9010-1; Howarth RW, 2002, ESTUARIES, V25, P656, DOI 10.1007/BF02804898; Jordan TE, 2003, ESTUARIES, V26, P226, DOI 10.1007/BF02695964; Jung S, 2003, ESTUAR COAST SHELF S, V58, P335, DOI 10.1016/S0272-7714(03)00085-4; Kaushal SS, 2008, ENVIRON SCI TECHNOL, V42, P5872, DOI 10.1021/es800264f; Kennish MJ, 2002, ENVIRON CONSERV, V29, P78, DOI 10.1017/S0376892902000061; King RS, 2004, ENVIRON SCI TECHNOL, V38, P6546, DOI 10.1021/es049059m; King RS, 2005, ECOL APPL, V15, P137, DOI 10.1890/04-0481; King RS, 2007, ESTUAR COAST, V30, P469, DOI 10.1007/BF02819393; Kloskowski J, 2010, NATURWISSENSCHAFTEN, V97, P673, DOI 10.1007/s00114-010-0684-9; Langland M. J., 2004, 20045259 US GEOL SUR; Lawrie RA, 2010, ESTUAR COAST SHELF S, V87, P237, DOI 10.1016/j.ecss.2010.01.020; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lyons JE, 2008, J WILDLIFE MANAGE, V72, P1683, DOI 10.2193/2008-141; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Miller DC, 2002, MAR BIOL, V140, P287, DOI 10.1007/s002270100702; Nichols JD, 2000, AUK, V117, P393, DOI 10.1642/0004-8038(2000)117[0393:ADOAFE]2.0.CO;2; O'Connell TJ, 2000, ECOL APPL, V10, P1706, DOI 10.2307/2641233; Oksanen J., 2016, R PACKAG; Paerl HW, 2009, ESTUAR COAST, V32, P593, DOI 10.1007/s12237-009-9158-8; Paracuellos M, 2004, WATERBIRDS, V27, P446, DOI 10.1675/1524-4695(2004)027[0446:FATDOA]2.0.CO;2; Preston S. D., 1999, 994054 US GEOL SURV; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rabalais NN, 2009, ICES J MAR SCI, V66, P1528, DOI 10.1093/icesjms/fsp047; Ronicke H, 2008, FUND APPL LIMNOL, V172, P111, DOI 10.1127/1863-9135/2008/0172-0111; Rudstam LG, 2004, ECOL APPL, V14, P149, DOI 10.1890/03-5010; Seo Dong Cheol, 2008, Archives of Agronomy and Soil Science, V54, P249, DOI 10.1080/03650340701679075; Shields CA, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006360; Shipley B., 2000, CAUSE CORRELATIONS B; Somers CM, 2007, WATERBIRDS, V30, P241, DOI 10.1675/1524-4695(2007)30[241:IBDCAH]2.0.CO;2; Thorpe AS, 2011, J APPL ECOL, V48, P275, DOI 10.1111/j.1365-2664.2011.01972.x; Thrush SF, 2008, ECOL APPL, V18, P12, DOI 10.1890/07-0436.1; Traut AH, 2004, LANDSCAPE URBAN PLAN, V69, P69, DOI 10.1016/j.landurbplan.2003.08.009; *USEPA, 2000, MULT LAND CHAR CONS; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Wazniak CE, 2007, ECOL APPL, V17, pS64, DOI 10.1890/05-1554.1	56	11	12	3	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35969	10.1371/journal.pone.0035969	http://dx.doi.org/10.1371/journal.pone.0035969			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558286	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336000093
J	Thomas, DC; Ahmed, A; Gilberger, TW; Sharma, P				Thomas, Divya Catherine; Ahmed, Anwar; Gilberger, Tim Wolf; Sharma, Pushkar			Regulation of Plasmodium falciparum Glideosome Associated Protein 45 (PfGAP45) Phosphorylation	PLOS ONE			English	Article							B-LIKE ENZYME; ERYTHROCYTE INVASION; MALARIA PARASITES; CELL INVASION; MYOSIN; KINASE; IDENTIFICATION; MEMBRANE; COMPLEX; TRANSFECTION	The actomyosin motor complex of the glideosome provides the force needed by apicomplexan parasites such as Toxoplasma gondii (Tg) and Plasmodium falciparum (Pf) to invade their host cells and for gliding motility of their motile forms. Glideosome Associated Protein 45 (PfGAP45) is an essential component of the glideosome complex as it facilitates anchoring and effective functioning of the motor. Dissection of events that regulate PfGAP45 may provide insights into how the motor and the glideosome operate. We found that PfGAP45 is phosphorylated in response to Phospholipase C (PLC) and calcium signaling. It is phosphorylated by P. falciparum kinases Protein Kinase B (PfPKB) and Calcium Dependent Protein Kinase 1 (PfCDPK1), which are calcium dependent enzymes, at S89, S103 and S149. The Phospholipase C pathway influenced the phosphorylation of S103 and S149. The phosphorylation of PfGAP45 at these sites is differentially regulated during parasite development. The localization of PfGAP45 and its association may be independent of the phosphorylation of these sites. PfGAP45 regulation in response to calcium fits in well with the previously described role of calcium in host cell invasion by malaria parasite.	[Thomas, Divya Catherine; Ahmed, Anwar; Sharma, Pushkar] Natl Inst Immunol, Eukaryot Gene Express Lab, New Delhi 110067, India; [Gilberger, Tim Wolf] Bernhard Nocht Inst Trop Med, Dept Mol Parasitol, Hamburg, Germany; [Gilberger, Tim Wolf] McMaster Univ, MG DeGroote Inst Infect Dis Res, Hamilton, ON, Canada; [Gilberger, Tim Wolf] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Bernhard Nocht Institut fur Tropenmedizin; McMaster University; McMaster University	Thomas, DC (corresponding author), Natl Inst Immunol, Eukaryot Gene Express Lab, New Delhi 110067, India.	pushkar@nii.ac.in	Ahmed, Anwar/ADH-1445-2022; Ahmed, Anwar/AAL-7789-2021	Ahmed, Anwar/0000-0001-8147-714X; Gilberger, Tim-Wolf/0000-0002-7965-8272	Department of Science and Technology, India; Signalling in life cycle stages of malaria parasites (MALSIG); European Union; Bundesministerium fur Bildung und Forschung, Germany [IND 09/024]; National Institutes of Health from National Insitute of Allergies and Infectious Diseases [R01AI075459]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075459] Funding Source: NIH RePORTER	Department of Science and Technology, India(Department of Science & Technology (India)); Signalling in life cycle stages of malaria parasites (MALSIG); European Union(European Commission); Bundesministerium fur Bildung und Forschung, Germany(Federal Ministry of Education & Research (BMBF)); National Institutes of Health from National Insitute of Allergies and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	PS is a recipient of Swarnajayanti Fellowship Grant from Department of Science and Technology, India and his laboratory is supported by "Signalling in life cycle stages of malaria parasites (MALSIG)'' project funded by European Union under FP7 and an Indo-German collaborative grant by Department of Biotechnology, India and Bundesministerium fur Bildung und Forschung (IND 09/024), Germany. This work was also supported in part by National Institutes of Health Grant R01AI075459 from National Insitute of Allergies and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum J, 2006, J BIOL CHEM, V281, P5197, DOI 10.1074/jbc.M509807200; Beraldo FH, 2005, J PINEAL RES, V39, P224, DOI 10.1111/j.1600-079X.2005.00249.x; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Bullen HE, 2009, J BIOL CHEM, V284, P25353, DOI 10.1074/jbc.M109.036772; Daher W, 2009, CURR OPIN MICROBIOL, V12, P408, DOI 10.1016/j.mib.2009.06.008; Fauquenoy S, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.008953, 10.1074/mcp.A111.008953]; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Frenal K, 2010, CELL HOST MICROBE, V8, P343, DOI 10.1016/j.chom.2010.09.002; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Gaur D, 2004, INT J PARASITOL, V34, P1413, DOI 10.1016/j.ijpara.2004.10.010; Gazarini ML, 2003, J CELL BIOL, V161, P103, DOI 10.1083/jcb.200212130; Gilk SD, 2009, EUKARYOT CELL, V8, P190, DOI 10.1128/EC.00201-08; Green JL, 2006, J MOL BIOL, V355, P933, DOI 10.1016/j.jmb.2005.11.027; Green JL, 2008, J BIOL CHEM, V283, P30980, DOI 10.1074/jbc.M803129200; Hotta CT, 2003, BRAZ J MED BIOL RES, V36, P1583, DOI 10.1590/S0100-879X2003001100016; Jones ML, 2009, MOL BIOCHEM PARASIT, V168, P55, DOI 10.1016/j.molbiopara.2009.06.007; Jones ML, 2006, MOL BIOCHEM PARASIT, V147, P74, DOI 10.1016/j.molbiopara.2006.01.009; Kato N, 2008, NAT CHEM BIOL, V4, P347, DOI 10.1038/nchembio.87; Keeley A, 2004, TRENDS CELL BIOL, V14, P528, DOI 10.1016/j.tcb.2004.08.002; Kumar A, 2004, J BIOL CHEM, V279, P24255, DOI 10.1074/jbc.M312855200; Luo Y, 2005, MOL CANCER THER, V4, P977, DOI 10.1158/1535-7163.MCT-05-0005; Mamoun CB, 2001, MOL MICROBIOL, V39, P26, DOI 10.1046/j.1365-2958.2001.02222.x; Marks AR, 1997, AM J PHYSIOL-HEART C, V272, pH597, DOI 10.1152/ajpheart.1997.272.2.H597; Nebl T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002222; Raabe AC, 2011, CELL MICROBIOL, V13, P955, DOI 10.1111/j.1462-5822.2011.01591.x; Rees-Channer RR, 2006, MOL BIOCHEM PARASIT, V149, P113, DOI 10.1016/j.molbiopara.2006.04.008; Singh S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000746; Struck NS, 2005, J CELL SCI, V118, P5603, DOI 10.1242/jcs.02673; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; Vaid A, 2008, J BIOL CHEM, V283, P5589, DOI 10.1074/jbc.M708465200; Vaid A, 2006, J BIOL CHEM, V281, P27126, DOI 10.1074/jbc.M601914200; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Winter D, 2009, ANAL BIOCHEM, V393, P41, DOI 10.1016/j.ab.2009.06.022; WU YM, 1995, P NATL ACAD SCI USA, V92, P973, DOI 10.1073/pnas.92.4.973; Yeoman JA, 2011, EUKARYOT CELL, V10, P556, DOI 10.1128/EC.00244-10	37	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35855	10.1371/journal.pone.0035855	http://dx.doi.org/10.1371/journal.pone.0035855			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558243	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000067
J	Boomsma, RA; Geenen, DL				Boomsma, Robert A.; Geenen, David L.			Mesenchymal Stem Cells Secrete Multiple Cytokines That Promote Angiogenesis and Have Contrasting Effects on Chemotaxis and Apoptosis	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; H9C2 CELLS; CHEMOKINE RECEPTORS; INHIBIT APOPTOSIS; STROMAL CELLS; BAD; PHOSPHORYLATION; MIGRATION; PATHWAY; SURVIVAL	We have previously shown that mesenchymal stem cells (MSC) improve function upon integration in ischemic myocardium. We examined whether specific cytokines and growth factors produced by MSCs are able to affect angiogenesis, cellular migration and apoptosis. Conditioned media (CM) was prepared by culturing MSC for 48 hours. CM displayed significantly elevated levels of VEGF, Monocyte Chemoattractant Protein-1 (MCP-1), macrophage inflammatory protein-1 alpha (MIP-1 alpha), MIP-1 beta and monokine induced by IFN-gamma (MIG) compared to control media. MSC contained RNA for these factors as detected by RT-PCR. CM was able to induce angiogenesis in canine vascular endothelial cells. MCP-1 and MIP-1 alpha increased cell migration of MSC while VEGF reduced it. H9c2 cells treated with CM under hypoxic conditions for 24 hours displayed a 16% reduction in caspase-3 activity compared to controls. PI 3-kinase c inhibitor had no effect on controls but reversed the effect of CM on caspase-3 activity. MCP-1 alone mimicked the protective effect of CM while the PI 3-K gamma inhibitor did not reverse the effect of MCP-1. CM reduced phospho-BAD (Ser112) and phospho-Akt (Ser473) while increasing phospho-Akt (Thr308). MCP-1 reduced the level of phospho-Akt (Ser473) while having no effect on the other two; the PI 3-K gamma inhibitor did not alter the MCP-1 effect. ERK 1/2 phosphorylation was reduced in CM treated H9c2 cells, and inhibition of ERK 1/2 reduced the phosphorylation of Akt (Ser473), Akt (Thr308) and Bad (Ser112). In conclusion, MSC synthesize and secrete multiple paracrine factors that are able to affect MSC migration, promote angiogenesis and reduce apoptosis. While both MCP-1 and PI3-kinase are involved in the protective effect, they are independent of each other. It is likely that multiple pro-survival factors in addition to MCP-1 are secreted by MSC which act on divergent intracellular signaling pathways.	[Boomsma, Robert A.] Trinity Christian Coll, Dept Biol, Palos Hts, IL USA; [Boomsma, Robert A.; Geenen, David L.] Univ Illinois, Dept Med, Cardiol Sect, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Boomsma, RA (corresponding author), Trinity Christian Coll, Dept Biol, Palos Hts, IL USA.	geenen@uic.edu			Illinois Department of Public Health; National Heart, Lung, and Blood Institute [RO1 HL071046]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071046] Funding Source: NIH RePORTER	Illinois Department of Public Health; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was support by the Illinois Department of Public Health and the National Heart, Lung, and Blood Institute RO1 HL071046. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai H, 1996, J BIOL CHEM, V271, P21814, DOI 10.1074/jbc.271.36.21814; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Boomsma RA, 2007, INT J CARDIOL, V122, P17, DOI 10.1016/j.ijcard.2006.11.022; Borchi E, 2009, J CELL MOL MED, V13, P2724, DOI 10.1111/j.1582-4934.2008.00485.x; Burchfield JS, 2008, FIBROGENESIS TISSUE, V1, DOI 10.1186/1755-1536-1-4; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Dimmeler S, 2005, J CLIN INVEST, V115, P572, DOI 10.1172/JCI200524283; Dramsi S, 2002, J BIOL CHEM, V277, P6399, DOI 10.1074/jbc.M109990200; Duronio V, 2008, BIOCHEM J, V415, P333, DOI 10.1042/BJ20081056; Fiedler J, 2005, BIOCHEM BIOPH RES CO, V334, P561, DOI 10.1016/j.bbrc.2005.06.116; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; Liu CH, 2005, CYTOKINE, V32, P270, DOI 10.1016/j.cyto.2005.11.003; Liu JH, 2008, AM J PHYSIOL-HEART C, V295, pH1956, DOI 10.1152/ajpheart.00407.2008; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; Ma J, 2007, BLOOD, V109, P987, DOI 10.1182/blood-2006-07-036400; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Mishima Y, 2008, J ORTHOP RES, V26, P1407, DOI 10.1002/jor.20668; Morimoto H, 2006, CIRC RES, V99, P891, DOI 10.1161/01.RES.0000246113.82111.2d; Parcellier A, 2008, CELL SIGNAL, V20, P21, DOI 10.1016/j.cellsig.2007.07.010; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Schichor C, 2006, EXP NEUROL, V199, P301, DOI 10.1016/j.expneurol.2005.11.027; Schmal H, 2007, CYTOTHERAPY, V9, P69, DOI 10.1080/14653240601011557; Schuleri KH, 2008, AM J PHYSIOL-HEART C, V294, pH2002, DOI 10.1152/ajpheart.00762.2007; She QB, 2005, CANCER CELL, V8, P287, DOI 10.1016/j.ccr.2005.09.006; Singla DK, 2008, AM J PHYSIOL-HEART C, V295, pH907, DOI 10.1152/ajpheart.00279.2008; Singla DK, 2007, AM J PHYSIOL-HEART C, V293, pH1590, DOI 10.1152/ajpheart.00431.2007; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; Sze SK, 2007, MOL CELL PROTEOMICS, V6, P1680, DOI 10.1074/mcp.M600393-MCP200; Tan Y, 2000, J BIOL CHEM, V275, P25865, DOI 10.1074/jbc.M004199200; Tang JM, 2006, EUR J CARDIO-THORAC, V30, P353, DOI 10.1016/j.ejcts.2006.02.070; Tarzami ST, 2005, BIOCHEM BIOPH RES CO, V335, P1008, DOI 10.1016/j.bbrc.2005.07.168; Wang Lei, 2002, Hematology, V7, P113; Wymann MP, 2003, BIOCHEM SOC T, V31, P275, DOI 10.1042/bst0310275; Zhou LM, 2006, CIRC RES, V98, P1177, DOI 10.1161/01.RES.0000220106.64661.71; Zhu Y, 2002, J NEUROSCI, V22, P3898, DOI 10.1523/JNEUROSCI.22-10-03898.2002	35	231	251	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35685	10.1371/journal.pone.0035685	http://dx.doi.org/10.1371/journal.pone.0035685			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558198	Green Published, gold			2022-12-27	WOS:000305345200066
J	Chi, A; Liao, ZX; Nguyen, NP; Xu, JH; Welsh, JS; Jang, SY; Howe, C; Komaki, R				Chi, Alexander; Liao, Zhongxing; Nguyen, Nam P.; Xu, Jiahong; Welsh, James S.; Jang, Si Young; Howe, Carol; Komaki, Ritsuko			Dosimetric Selection for Helical Tomotherapy Based Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer or Lung Metastases	PLOS ONE			English	Article							BODY RADIATION-THERAPY; TOXICITY; VOLUME; TUMORS; IMRT	Background: No selection criteria for helical tomotherapy (HT) based stereotactic ablative radiotherapy (SABR) to treat early stage non-small cell lung cancer (NSCLC) or solitary lung metastases has been established. In this study, we investigate the dosimetric selection criteria for HT based SABR delivering 70 Gy in 10 fractions to avoid severe toxicity in the treatment of centrally located lesions when adequate target dose coverage is desired. Materials and Methods: 78 HT-SABR plans for solitary lung lesions were created to prescribe 70 Gy in 10 fractions to the planning target volume (PTV). The PTV was set to have >= 95% PTV receiving 70 Gy in each case. The cases for which dose constraints for >= 1 OAR could not be met without compromising the target dose coverage were compared with cases for which all target and OAR dose constraints were met. Results: There were 23 central lesions for which OAR dose constraints could not be met without compromising PTV dose coverage. Comparing to cases for which optimal HT-based SABR plans were generated, they were associated with larger tumor size (5.72 +/- 1.96 cm vs. 3.74 +/- 1.49 cm, p < 0.0001), higher lung dose, increased number of immediately adjacent OARs (3.45 +/- 1.34 vs. 1.66 +/- 0.81, p < 0.0001), and shorter distance to the closest OARs (GTV: 0.26 +/- 0.22 cm vs. 0.88 +/- 0.54 cm, p < 0.0001; PTV 0.19 +/- 0.18 cm vs. 0.48 +/- 0.36 cm, p = 0.0001). Conclusion: Delivery of 70 Gy in 10 fractions with HT to meet all the given OAR and PTV dose constraints are most likely when the following parameters are met: lung lesions <= 3.78 cm (11.98 cc), <= 2 immediately adjacent OARs which are >= 0.45 cm from the gross lesion and >= 0.21 cm from the PTV.	[Chi, Alexander; Nguyen, Nam P.; Jang, Si Young] W Virginia Univ, Dept Radiat Oncol, Morgantown, WV USA; [Liao, Zhongxing; Komaki, Ritsuko] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Xu, Jiahong] Westat An Employee Owned Res Corp, Rockville, MD USA; [Welsh, James S.] Louisiana State Univ, Dept Radiat Oncol, Shreveport, LA 71105 USA; [Howe, Carol] Univ Arizona, Med Lib, Tucson, AZ USA	West Virginia University; University of Texas System; UTMD Anderson Cancer Center; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; University of Arizona	Chi, A (corresponding author), W Virginia Univ, Dept Radiat Oncol, Morgantown, WV USA.	achiaz2010@gmail.com		Howe, Carol/0000-0002-7911-4160				Baisden JM, 2007, INT J RADIAT ONCOL, V68, P1229, DOI 10.1016/j.ijrobp.2007.03.024; Cattaneo GM, 2008, RADIOTHER ONCOL, V88, P310, DOI 10.1016/j.radonc.2008.06.006; Chi A, 2011, INT J RADIAT ONCOL, V81, P856, DOI 10.1016/j.ijrobp.2010.11.051; Chi A, 2011, AM J CLIN ONCOL-CANC, V34, P432, DOI 10.1097/COC.0b013e3181df4b3f; Chi A, 2010, RADIOTHER ONCOL, V94, P1, DOI 10.1016/j.radonc.2009.12.008; Fakiris AJ, 2009, INT J RADIAT ONCOL, V75, P677, DOI 10.1016/j.ijrobp.2008.11.042; Fenwick JD, 2006, SEMIN RADIAT ONCOL, V16, P199, DOI 10.1016/j.semradonc.2006.04.002; Gutierrez AN, 2011, MED DOSIM, V36, P126, DOI 10.1016/j.meddos.2010.02.003; Kanagaki B, 2007, PHYS MED BIOL, V52, P243, DOI 10.1088/0031-9155/52/1/016; Kirkpatrick JP, 2010, INT J RADIAT ONCOL, V76, pS42, DOI 10.1016/j.ijrobp.2009.04.095; Milano MT, 2009, RADIOTHER ONCOL, V91, P301, DOI 10.1016/j.radonc.2009.03.005; Nagata Y, 2011, INT J RADIAT ONCOL, V79, P660, DOI 10.1016/j.ijrobp.2010.10.004; Onimaru R, 2003, INT J RADIAT ONCOL, V56, P126, DOI 10.1016/S0360-3016(03)00095-6; Onishi H, 2007, J THORAC ONCOL, V2, pS94, DOI 10.1097/JTO.0b013e318074de34; Oshiro Y, 2010, STRAHLENTHER ONKOL, V186, P274, DOI 10.1007/s00066-010-2072-y; Peulen H, 2011, RADIOTHER ONCOL, V101, P260, DOI 10.1016/j.radonc.2011.09.012; Ricardi U, 2012, LUNG CANCER, V75, P77, DOI 10.1016/j.lungcan.2011.04.021; Rodrigues G, 2006, RADIOTHER ONCOL, V80, P374, DOI 10.1016/j.radonc.2006.07.005; Sahgal A, 2010, INT J RADIAT ONCOL, V77, P548, DOI 10.1016/j.ijrobp.2009.05.023; Sheng K, 2006, INT J RADIAT ONCOL, V65, P917, DOI 10.1016/j.ijrobp.2006.02.038; Solberg TD, 2012, PRACT RADIAT ONCOL, V2, P2, DOI 10.1016/j.prro.2011.06.014; Song SY, 2009, LUNG CANCER, V66, P89, DOI 10.1016/j.lungcan.2008.12.016; Stauder MC, 2011, RADIOTHER ONCOL, V99, P166, DOI 10.1016/j.radonc.2011.04.002; Sterzing F, 2008, STRAHLENTHER ONKOL, V184, P8, DOI 10.1007/s00066-008-1778-6; Sterzing F, 2010, INT J RADIAT ONCOL, V76, P1266, DOI 10.1016/j.ijrobp.2009.07.1686; Timmerman R, 2006, J CLIN ONCOL, V24, P4833, DOI 10.1200/JCO.2006.07.5937; Timmerman R, 2011, FRONT RADIAT THER ON, V43, P395, DOI 10.1159/000322503; Timmerman R, 2010, JAMA-J AM MED ASSOC, V303, P1070, DOI 10.1001/jama.2010.261; Tome WA, 2002, MED PHYS, V29, P1590, DOI 10.1118/1.1485060; Xia TY, 2006, INT J RADIAT ONCOL, V66, P117, DOI 10.1016/j.ijrobp.2006.04.013	30	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35809	10.1371/journal.pone.0035809	http://dx.doi.org/10.1371/journal.pone.0035809			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558228	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345200081
J	Hultin, H; Lindholm, C; Moller, J				Hultin, Hanna; Lindholm, Christina; Moller, Jette			Is There an Association between Long-Term Sick Leave and Disability Pension and Unemployment beyond the Effect of Health Status? - A Cohort Study	PLOS ONE			English	Article							POPULATION-BASED COHORT; FINNISH PUBLIC-SECTOR; FOLLOW-UP; PERMANENT DISABILITY; JOB TERMINATION; PRIVATE-SECTOR; YOUNG PERSONS; RISK-FACTORS; ABSENCE; PREDICTORS	Background: Studies have shown that long-term sick leave is a strong predictor of disability pension. However, few have aimed to disentangle the effect of sick leave and of health status. The objective of this study was to investigate whether there is an association between long-term sick leave and disability pension and unemployment, when taking health status into account. Methods/Principal Findings: The study was based on the Stockholm Public Health Cohort, restricted to 13,027 employed individuals (45.9% men) aged 18-59 in 2002 and followed until 2007. Hazard ratios (HR) with 95% Confidence Interval (CI) were estimated by Cox regression models adjusting for socio-demographic factors and five measures of health status. Having been on long-term sick leave increased the risk of disability pension (HR 4.01; 95% CI 3.19-5.05) and long-term unemployment (HR 1.45; 95% CI 1.05-2.00), after adjustment for health status. The analyses of long-term sick leave due to specific illness showed that the increased risk for long-term unemployment was confined to the group on sick leave due to musculoskeletal (HR 1.70 95% CI 1.00-2.89) and mental illness (HR 1.80 95% CI 1.13-2.88) and further that there was an increased risk for short-term unemployment in the group on sick leave due to mental illness (HR1.57 95% CI 1.09-2.26). Conclusions/Significance: Long-term sick leave increases the risks of both disability pension and unemployment even when taking health status into account. The results support the hypothesis that long-term sick leave may start a process of marginalization from the labor market.	[Hultin, Hanna; Moller, Jette] Karolinska Inst, Dept Publ Hlth Sci, Div Publ Hlth Epidemiol, Stockholm, Sweden; [Lindholm, Christina] Karolinska Inst, Dept Clin Neurosci, Div Insurance Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Hultin, H (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Div Publ Hlth Epidemiol, Stockholm, Sweden.	hanna.hultin@ki.se		Hultin, Hanna/0000-0002-4531-4885; Moller, Jette/0000-0001-9513-5896	AFA Insurance; Swedish Research Council	AFA Insurance; Swedish Research Council(Swedish Research CouncilEuropean Commission)	The study was funded by AFA Insurance and The Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publich, or preparation of the manuscript.	Alexanderson K, 2004, SCAND J PUBLIC HEALT, V32, P3, DOI 10.1080/14034950410003826; Alexanderson K, 2011, J EPIDEMIOL COMMUNIT; Alexanderson Kristina A E, 2005, Work, V25, P115; Borg K, 2004, SCAND J PUBLIC HEALT, V32, P272, DOI 10.1080/14034940310019524; Borg K, 2001, SCAND J PUBLIC HEALT, V29, P104, DOI 10.1177/14034948010290020701; Bratberg E, 2009, HEALTH PLACE, V15, P308, DOI 10.1016/j.healthplace.2008.06.004; Bryngelson A, 2009, SCAND J PUBLIC HEALT, V37, P839, DOI 10.1177/1403494809346871; Bultmann U, 2008, EUR J PUBLIC HEALTH, V18, P232, DOI 10.1093/eurpub/ckm132; Floderus B, 2005, J REHABIL MED, V37, P291, DOI 10.1080/16501970510034422; Gjesdal S, 2004, EUR J PUBLIC HEALTH, V14, P398, DOI 10.1093/eurpub/14.4.398; Gjesdal S, 2003, SCAND J PUBLIC HEALT, V31, P246, DOI 10.1080/14034940210165154; Gjesdal S, 2002, EUR J PUBLIC HEALTH, V12, P180, DOI 10.1093/eurpub/12.3.180; Gjesdal S, 2009, SCAND J PUBLIC HEALT, V37, P387, DOI 10.1177/1403494809103994; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; HESSELIUS P, 2007, J SOCIO-ECON, V36, P288, DOI DOI 10.1016/J.S0CEC.2005.11.037; Jusot F, 2008, J EPIDEMIOL COMMUN H, V62, P332, DOI 10.1136/jech.2007.060772; Karlsson Nadine, 2006, Work, V27, P173; Karlsson NE, 2008, EUR J PUBLIC HEALTH, V18, P224, DOI 10.1093/eurpub/ckm128; Karpansalo M, 2002, J OCCUP ENVIRON MED, V44, P930, DOI 10.1097/00043764-200210000-00012; Kivimaki M, 2007, J EPIDEMIOL COMMUN H, V61, DOI 10.1136/jech.2006.055426; Kivimaki M, 2004, J EPIDEMIOL COMMUN H, V58, P710, DOI 10.1136/jech.2003.015842; Koopmans PC, 2008, OCCUP ENVIRON MED, V65, P494, DOI 10.1136/oem.2007.034322; Krause N, 1997, SCAND J WORK ENV HEA, V23, P403, DOI 10.5271/sjweh.262; Labriola Merete, 2007, Int J Med Sci, V4, P153; Laine S, 2009, J EPIDEMIOL COMMUN H, V63, P24, DOI 10.1136/jech.2007.071407; Lindholm C, 2002, J EPIDEMIOL COMMUN H, V56, P188, DOI 10.1136/jech.56.3.188; Lund T, 2008, OCCUP ENVIRON MED, V65, P28, DOI 10.1136/oem.2006.031393; Mykletun A, 2006, AM J PSYCHIAT, V163, P1412, DOI 10.1176/appi.ajp.163.8.1412; Neovius K, 2010, INT J OBESITY, V34, P75, DOI 10.1038/ijo.2009.178; Pietilainen O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025004; Ropponen A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-678; Sieurin L, 2009, SCAND J PUBLIC HEALT, V37, P50, DOI 10.1177/1403494808097171; *STAT SWED, 1982, SWED SOC CLASS, P4; Upmark M, 2001, SCAND J PUBLIC HEALT, V29, P96, DOI 10.1177/14034948010290020601; Vaez M, 2007, SOC PSYCH PSYCH EPID, V42, P381, DOI 10.1007/s00127-007-0189-9; Vahtera J, 2010, OCCUP ENVIRON MED, V67, P479, DOI 10.1136/oem.2008.045096; Virtanen M, 2006, OCCUP ENVIRON MED, V63, P212, DOI 10.1136/oem.2005.020297; Virtanen P, 2005, AM J EPIDEMIOL, V161, P840, DOI 10.1093/aje/kwi107; Wallman T, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-104	39	61	63	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35614	10.1371/journal.pone.0035614	http://dx.doi.org/10.1371/journal.pone.0035614			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VP	22558176	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345200053
J	Laukaitis, CM; Mauss, C; Karn, RC				Laukaitis, Christina M.; Mauss, Corina; Karn, Robert C.			Congenic Strain Analysis Reveals Genes That Are Rapidly Evolving Components of a Prezygotic Isolation Mechanism Mediating Incipient Reinforcement	PLOS ONE			English	Article							ANDROGEN-BINDING-PROTEIN; AMINO-ACID SITES; MUS-MUSCULUS; SEXUAL ISOLATION; GENUS MUS; EVOLUTIONARY RELATIONSHIPS; MAXIMUM-LIKELIHOOD; POSITIVE SELECTION; STEROID-BINDING; HOUSE MOUSE	Two decades ago, we developed a congenic strain of Mus musculus, called b-congenic, by replacing the androgen-binding protein Abpa27(a) allele in the C3H/HeJ genome with the Abpa27(b) allele from DBA/2J. We and other researchers used this b-congenic strain and its C3H counterpart, the a-congenic strain, to test the hypothesis that, given the choice between signals from two strains with different a27 alleles on the same genetic background, test subjects would prefer the homosubspecific one. It was our purpose in undertaking this study to characterize the segment transferred from DBA to the C3H background in producing the b-congenic strain on which a role for ABPA27 in behavior has been predicated. We determined the size of the chromosome 7 segment transferred from DBA and the genes it contains that might influence preference. We found that the "functional'' DBA segment is about 1% the size of the mouse haploid genome and contains at least 29 genes expressed in salivary glands, however, only three of these encode proteins identified in the mouse salivary proteome. At least two of the three genes Abpa27, Abpbg26 and Abpbg27 encoding the subunits of androgen-binding protein ABP dimers evolved under positive selection and the third one may have also. In the sense that they are subunits of the same two functional entities, the ABP dimers, we propose that their evolutionary histories might not be independent of each other.	[Laukaitis, Christina M.; Mauss, Corina; Karn, Robert C.] Univ Arizona, Coll Med, Dept Med, Tucson, AZ 85719 USA	University of Arizona	Laukaitis, CM (corresponding author), Univ Arizona, Coll Med, Dept Med, Tucson, AZ 85719 USA.	cmlaukai@email.arizona.edu	Laukaitis, Christina M/AAL-5865-2021; Laukaitis, Christina/AAW-2510-2020; Laukaitis, Christina/ABF-1739-2021	Laukaitis, Christina M/0000-0003-1466-7941; 	University of Arizona SPORE in GI Cancer [P50 CA95060]; Cancer Center Support Grant [CA023074]; NATIONAL CANCER INSTITUTE [P50CA095060, P30CA023074] Funding Source: NIH RePORTER	University of Arizona SPORE in GI Cancer; Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	ML received salary support from the University of Arizona SPORE in GI Cancer (P50 CA95060). Laboratory space was supported by Cancer Center Support Grant (CA023074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152; Bimova B, 2005, BIOL J LINN SOC, V84, P349, DOI 10.1111/j.1095-8312.2005.00439.x; Bimova BV, 2011, MOL ECOL, V20, P2403, DOI 10.1111/j.1365-294X.2011.05106.x; Callebaut I, 2000, ANN NY ACAD SCI, V923, P90; Chevret P, 2005, BIOL J LINN SOC, V84, P417, DOI 10.1111/j.1095-8312.2005.00444.x; DLOUHY SR, 1986, BIOCHEM GENET, V24, P743, DOI 10.1007/BF00499007; DLOUHY SR, 1987, GENETICS, V115, P535; Emes RD, 2004, GENOME RES, V14, P1516, DOI 10.1101/gr.2540304; Hwang JM, 1997, J HERED, V88, P93, DOI 10.1093/oxfordjournals.jhered.a023083; Karn RC, 1998, BIOCHEM GENET, V36, P105, DOI 10.1023/A:1018708404789; Karn RC, 1999, BIOCHEM GENET, V37, P187, DOI 10.1023/A:1018786622052; Karn RC, 2003, BIOCHEMISTRY-US, V42, P7162, DOI 10.1021/bi027424l; Karn RC, 2002, MOL BIOL EVOL, V19, P462, DOI 10.1093/oxfordjournals.molbev.a004102; KARN RC, 1991, J HERED, V82, P453, DOI 10.1093/oxfordjournals.jhered.a111127; Karn RC, 2008, MOL BIOL EVOL, V25, P2301, DOI 10.1093/molbev/msn182; Karn RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020979; Karn RC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012638; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Laukaitis C, 2012, EVOLUTION H IN PRESS; Laukaitis CM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-46; Laukaitis CM, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-40; Laukaitis CM, 2003, MAMM GENOME, V14, P679, DOI 10.1007/s00335-003-2291-y; Laukaitis CM, 1997, EVOLUTION, V51, P2000, DOI [10.2307/2411020, 10.1111/j.1558-5646.1997.tb05121.x]; NAVEIRA H, 1992, GENETICS, V130, P205; Nielsen R, 1998, GENETICS, V148, P929; SHE JX, 1990, BIOL J LINN SOC, V41, P83, DOI 10.1111/j.1095-8312.1990.tb00823.x; Suzuki H, 2004, MOL PHYLOGENET EVOL, V33, P626, DOI 10.1016/j.ympev.2004.08.003; Talley HM, 2001, EVOLUTION, V55, P631, DOI 10.1554/0014-3820(2001)055[0631:FPFMSI]2.0.CO;2; Treister NS, 2005, J DENT RES, V84, P160, DOI 10.1177/154405910508400210; Tucker PK, 2005, BIOL J LINN SOC, V84, P653, DOI 10.1111/j.1095-8312.2005.00462.x; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2000, MOL BIOL EVOL, V17, P1446, DOI 10.1093/oxfordjournals.molbev.a026245	34	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35898	10.1371/journal.pone.0035898	http://dx.doi.org/10.1371/journal.pone.0035898			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558260	gold, Green Published, Green Submitted			2022-12-27	WOS:000305345200091
J	Long, XB; Hu, S; Wang, N; Zhen, HT; Cui, YH; Liu, Z				Long, Xiao-Bo; Hu, Shuang; Wang, Nan; Zhen, Hong-Tao; Cui, Yong-Hua; Liu, Zheng			Clara Cell 10-kDa Protein Gene Transfection Inhibits NF-kappa B Activity in Airway Epithelial Cells	PLOS ONE			English	Article							VIRUS-INDUCED ASTHMA; CHRONIC RHINOSINUSITIS; TRANSCRIPTION FACTOR; ACTIVATION; INTERLEUKIN-8; INFLAMMATION; EXPRESSION; CYTOKINE; UTEROGLOBIN; MECHANISMS	Background: Clara cell 10-kDa protein (CC10) is a multifunctional protein with anti-inflammatory and immunomodulatory effects. Induction of CC10 expression by gene transfection may possess potential therapeutic effect. Nuclear factor kappa B (NF-kappa B) plays a key role in the inflammatory processes of airway diseases. Method/ Results: To investigate potential therapeutic effect of CC10 gene transfection in controlling airway inflammation and the underlying intracellular mechanisms, in this study, we constructed CC10 plasmid and transfected it into bronchial epithelial cell line BEAS-2B cells and CC10 knockout mice. In BEAS-2B cells, CC10's effect on interleukin (IL)-1 beta induced IL-8 expression was explored by means of RT-PCR and ELISA and its effect on NF-kappa B classical signaling pathway was studied by luciferase reporter, western blot, and immunoprecipitation assay. The effect of endogenous CC10 on IL-1 beta evoked IL-8 expression was studied by means of nasal explant culture. In mice, CC10's effect on IL-1 beta induced IL-8 and nuclear p65 expression was examined by immunohistochemistry. First, we found that the CC10 gene transfer could inhibit IL-1 beta induced IL-8 expression in BEAS-2B cells. Furthermore, we found that CC10 repressed IL-1 beta induced NF-kappa B activation by inhibiting the phosphorylation of I kappa B-alpha but not I kappa B kinase-alpha/beta in BEAS-2B cells. Nevertheless, we did not observe a direct interaction between CC10 and p65 subunit in BEAS-2B cells. In nasal explant culture, we found that IL-1 beta induced IL-8 expression was inversely correlated with CC10 levels in human sinonasal mucosa. In vivo study revealed that CC10 gene transfer could attenuate the increase of IL-8 and nuclear p65 staining in nasal epithelial cells in CC10 knockout mice evoked by IL-1 beta administration. Conclusion: These results indicate that CC10 gene transfer may inhibit airway inflammation through suppressing the activation of NF-kappa B, which may provide us a new consideration in the therapy of airway inflammation.	[Long, Xiao-Bo; Hu, Shuang; Wang, Nan; Zhen, Hong-Tao; Cui, Yong-Hua; Liu, Zheng] Huazhong Univ Sci & Technol, Dept Otolaryngol Head & Neck Surg, Tongji Med Coll, Tongji Hosp, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Long, XB (corresponding author), Huazhong Univ Sci & Technol, Dept Otolaryngol Head & Neck Surg, Tongji Med Coll, Tongji Hosp, Wuhan 430074, Peoples R China.	zhengliuent@hotmail.com			program for New Century Excellent Talents in University from State Education Ministry [NCET-07-0326]; National Nature Science Foundation of China (NSFC) [30872847, 81020108018]	program for New Century Excellent Talents in University from State Education Ministry(Program for New Century Excellent Talents in University (NCET)); National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the program for New Century Excellent Talents in University from State Education Ministry (NCET-07-0326) and the National Nature Science Foundation of China (NSFC) grant 30872847 and 81020108018 to Dr. Zheng Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asokananthan N, 2002, J IMMUNOL, V169, P4572, DOI 10.4049/jimmunol.169.8.4572; Atsuta J, 1997, AM J RESP CELL MOL, V17, P571, DOI 10.1165/ajrcmb.17.5.2685; Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Barnes PJ, 2006, LAB INVEST, V86, P867, DOI 10.1038/labinvest.3700456; Benson M, 2007, ALLERGY, V62, P178, DOI 10.1111/j.1398-9995.2006.01264.x; Chen LC, 2001, J IMMUNOL, V167, P3025, DOI 10.4049/jimmunol.167.6.3025; Chung KF, 1999, THORAX, V54, P825, DOI 10.1136/thx.54.9.825; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gibson PG, 2001, CHEST, V119, P1329, DOI 10.1378/chest.119.5.1329; GRIMM S, 1993, BIOCHEM J, V290, P297, DOI 10.1042/bj2900297; Hart LA, 1998, AM J RESP CRIT CARE, V158, P1585, DOI 10.1164/ajrccm.158.5.9706116; Holgate Stephen T, 2004, Proc Am Thorac Soc, V1, P93, DOI 10.1513/pats.2306034; Hung CH, 2004, J ALLERGY CLIN IMMUN, V114, P664, DOI 10.1016/j.jaci.2004.05.042; Janssen-Heininger YMW, 2000, FREE RADICAL BIO MED, V28, P1317, DOI 10.1016/S0891-5849(00)00218-5; Liu Z, 2009, ALLERGY, V64, P149, DOI 10.1111/j.1398-9995.2008.01847.x; Lu X, 2009, ALLERGY, V64, P104, DOI 10.1111/j.1398-9995.2008.01829.x; Mills PR, 1999, AM J RESP CRIT CARE, V160, pS38, DOI 10.1164/ajrccm.160.supplement_1.11; MUKAIDA N, 1989, J IMMUNOL, V143, P1366; Mukherjee AB, 1999, CELL MOL LIFE SCI, V55, P771, DOI 10.1007/s000180050331; Mutsaers SE, 1997, INT J BIOCHEM CELL B, V29, P5, DOI 10.1016/S1357-2725(96)00115-X; Newton R, 1997, FEBS LETT, V418, P135, DOI 10.1016/S0014-5793(97)01362-8; Polito AJ, 1998, J ALLERGY CLIN IMMUN, V102, P714, DOI 10.1016/S0091-6749(98)70008-9; Poynter ME, 2002, AM J PATHOL, V160, P1325, DOI 10.1016/S0002-9440(10)62559-X; Riccio AN, 2002, CLIN EXP ALLERGY, V32, P422, DOI 10.1046/j.1365-2222.2002.01315.x; SCHRODER JM, 1987, J IMMUNOL, V139, P3474; Sha Q, 2004, AM J RESP CELL MOL, V31, P358, DOI 10.1165/rcmb.2003-0388OC; SHUTE J, 1994, CLIN EXP ALLERGY, V24, P203, DOI 10.1111/j.1365-2222.1994.tb00220.x; Shute JK, 1997, AM J RESP CRIT CARE, V155, P1877, DOI 10.1164/ajrccm.155.6.9196089; Singh G, 2000, ANN NY ACAD SCI, V923, P43; Suzuki Hideaki, 2002, ALLERGY, V1, P117; Taraska JW, 2010, NEURON, V66, P170, DOI 10.1016/j.neuron.2010.02.002; Teran LM, 1997, AM J RESP CRIT CARE, V155, P1362, DOI 10.1164/ajrccm.155.4.9105080; VANVYVE T, 1995, J ALLERGY CLIN IMMUN, V95, P60, DOI 10.1016/S0091-6749(95)70153-2; Wang H, 2008, AM J RHINOL, V22, P343, DOI 10.2500/ajr.2008.22.3184; Wang H, 2010, AM J RESP CRIT CARE, V181, P908, DOI 10.1164/rccm.200904-0597OC; Wark PAB, 2002, EUR RESPIR J, V19, P68, DOI 10.1183/09031936.02.00226302; Zhang ZJ, 1997, SCIENCE, V276, P1408, DOI 10.1126/science.276.5317.1408	38	23	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35960	10.1371/journal.pone.0035960	http://dx.doi.org/10.1371/journal.pone.0035960			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558282	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345200096
J	Wu, YJ; Li, Q; Zhou, XH; Yu, JR; Mu, YC; Munker, S; Xu, CF; Shen, Z; Mullenbach, R; Liu, Y; Li, L; Gretz, N; Zieker, D; Li, J; Matsuzaki, K; Li, YM; Dooley, S; Weng, HL				Wu, Yijun; Li, Qi; Zhou, Xinhui; Yu, Jiren; Mu, Yunchuan; Munker, Stefan; Xu, Chengfu; Shen, Zhe; Muellenbach, Roman; Liu, Yan; Li, Li; Gretz, Norbert; Zieker, Derek; Li, Jun; Matsuzaki, Kouichi; Li, Youming; Dooley, Steven; Weng, Honglei			Decreased Levels of Active SMAD2 Correlate with Poor Prognosis in Gastric Cancer	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN COLORECTAL-CANCER; TGF-BETA; TARGETED DISRUPTION; SIGNAL-TRANSDUCTION; TUMOR SUPPRESSION; CELL; PHOSPHORYLATION; CARCINOMA	Background: TGF-beta plays a dual role in the progression of human cancer. During the early stages of carcinogenesis, TGF-beta functions as a tumor suppressor. During the late stages of tumor development, however, TGF-beta can promote tumor growth and metastasis. A shift in Smad2/3 phosphorylation from the carboxy terminus to linker sites is a key event determining biological function of TGF-beta in colorectal and hepatocellular carcinoma. In the present study, we investigated the potential role of differential Smad2/3 phosphorylation in gastric adenocarcinoma. Methodology: Immunohistochemical staining with anti-P-Smad2/3C and P-Smad2/3L antibodies was performed on 130 paraffin-embedded gastric adenocarcinoma specimens. The relationship between P-Smad2/3C and P-Smad2/3L immunohistochemical score and clinicopathologic characteristics of patients was analyzed. Real time PCR was used to measure mRNA expression of Smad2 and Smad3 in cancer and surrounding non-tumor tissue. Principal Findings: No significant P-Smad2L and/ or P-Smad3L positive staining was detected in the majority of specimens (positive staining in 18/130 samples). Positive P-Smad2/3L staining was not associated with a decrease in carboxyterminal phosphorylation staining. Loss of P-Smad2C remarkably correlated with depth of tumor infiltration and poor differentiation of cancer cells in patients with gastric cancer. No correlation was detectable between P-Smad3C and clinicopathologic characteristics of gastric adenocarcinoma. However, co-staining analysis revealed that P-Smad3C co-localised with alpha-SMA and collagen I in gastric cancer cells, indicating a potential link between P-Smad3C and epithelial-to-mesenchymal transition of cancer. Real time PCR demonstrated reduced mRNA expression of Smad2 in gastric cancer when compared with surrounding non-tumor tissue in 15/16 patients. Conclusions: Loss of P-Smad2C tightly correlated with cancer invasion and poor differentiation in gastric cancer. Contrary to colorectal and hepatocellular carcinoma, canonical carboxy-terminal phosphorylation, but not linker phosphorylation, of Smad2 is critical for gastric cancer.	[Wu, Yijun; Yu, Jiren; Mu, Yunchuan] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Gen Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Qi; Munker, Stefan; Muellenbach, Roman; Liu, Yan; Dooley, Steven; Weng, Honglei] Univ Heidelberg, Fac Med Mannheim, Med Clin, D-6800 Mannheim, Germany; [Zhou, Xinhui] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Gynecol, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Chengfu; Shen, Zhe; Li, Youming] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China; [Muellenbach, Roman] Univ Saarland, Saarland Univ Hosp, Dept Med 2, D-6650 Homburg, Germany; [Li, Li; Gretz, Norbert] Univ Heidelberg, Med Res Ctr, Med Fac Mannheim, D-6800 Mannheim, Germany; [Zieker, Derek; Li, Jun] Univ Tubingen, Tubingen, Germany; [Matsuzaki, Kouichi] Kansai Med Univ, Dept Gastroenterol, Osaka, Japan; [Matsuzaki, Kouichi] Kansai Med Univ, Dept Hepatol, Osaka, Japan	Zhejiang University; Ruprecht Karls University Heidelberg; Zhejiang University; Zhejiang University; Saarland University; Universitatsklinikum des Saarlandes; Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; Kansai Medical University; Kansai Medical University	Wu, YJ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Gen Surg, Hangzhou 310003, Zhejiang, Peoples R China.	wu1jun@sina.com; honglei.weng@medma.uni-heidelberg.de	Xu, Cheng/GXH-4815-2022; Dooley, Steven/T-6491-2018	Xu, Cheng/0000-0003-1000-733X; Dooley, Steven/0000-0002-4840-6240; Liebe, Roman/0000-0002-3199-5595; Ma, Han/0000-0001-9985-3035	Health Bureau of Zhejiang province of China [2009A065]; Else-Kroner Fresenius; BMBF [0313082L, 01GN0987]; Deutsche Forschungsgemeinschaft [DO373/6-1, DO 373/8-1, LA997/5-1]; Dietmar Hopp Stiftung GmbH	Health Bureau of Zhejiang province of China; Else-Kroner Fresenius; BMBF(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Dietmar Hopp Stiftung GmbH	The study was supported by the Health Bureau of Zhejiang province of China, 2009A065 (Y.J.W.); Else-Kroner Fresenius (H.L.W., S.D.); BMBF "Hepatosys'' 0313082L, "Virtual liver'' and "cell therapy'' 01GN0987 (S.D.); Deutsche Forschungsgemeinschaft DO373/6-1, DO 373/8-1 (S.D.) and LA997/5-1 (S.D.); and the Dietmar Hopp Stiftung GmbH (S.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; Datto MB, 1999, MOL CELL BIOL, V19, P2495; Fukuchi M, 2006, J SURG ONCOL, V94, P51, DOI 10.1002/jso.20565; Furukawa F, 2003, HEPATOLOGY, V38, P879, DOI 10.1053/jhep.2003.50384; Han SU, 2004, ONCOGENE, V23, P1333, DOI 10.1038/sj.onc.1207259; Hoot KE, 2010, J CLIN INVEST, V120, P3606, DOI 10.1172/JCI43304; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Ju WJ, 2006, MOL CELL BIOL, V26, P654, DOI 10.1128/MCB.26.2.654-667.2006; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Li X, 2008, J CLIN LAB ANAL, V22, P164, DOI 10.1002/jcla.20236; Lin Y, 2006, J GASTROEN HEPATOL, V21, P432, DOI 10.1111/j.1440-1746.2005.03939.x; Maggio-Price L, 2006, CANCER RES, V66, P828, DOI 10.1158/0008-5472.CAN-05-2448; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Matsuzaki K, 2011, CELL TISSUE RES; Matsuzaki K, 2007, HEPATOLOGY, V46, P48, DOI 10.1002/hep.21672; Matsuzaki K, 2006, J GASTROENTEROL, V41, P295, DOI 10.1007/s00535-006-1795-0; Matsuzaki K, 2011, CARCINOGENESIS, V32, P1578, DOI 10.1093/carcin/bgr172; Matsuzaki K, 2009, CANCER RES, V69, P5321, DOI 10.1158/0008-5472.CAN-08-4203; Meulmeester E, 2011, J PATHOL, V223, P205, DOI 10.1002/path.2785; Moustakas A, 2001, J CELL SCI, V114, P4359; Murata M, 2009, HEPATOLOGY, V49, P1203, DOI 10.1002/hep.22765; Petersen M, 2010, ONCOGENE, V29, P1351, DOI 10.1038/onc.2009.426; Sekimoto G, 2007, CANCER RES, V67, P5090, DOI 10.1158/0008-5472.CAN-06-4629; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shinto O, 2010, BRIT J CANCER, V102, P844, DOI 10.1038/sj.bjc.6605561; Shinto O, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-652; Sodir NM, 2006, CANCER RES, V66, P8430, DOI 10.1158/0008-5472.CAN-06-1437; Souchelnytskyi S, 1997, J BIOL CHEM, V272, P28107, DOI 10.1074/jbc.272.44.28107; Tang B, 2007, CANCER RES, V67, P8643, DOI 10.1158/0008-5472.CAN-07-0982; UEMURA M, 2005, MOL BIOL CELL; Warneke VS, 2011, J CLIN ONCOL, V29, P2364, DOI 10.1200/JCO.2010.34.4358; Wu WKK, 2010, CANCER LETT, V295, P144, DOI 10.1016/j.canlet.2010.04.025; Xie W, 2003, CANCER J, V9, P302, DOI 10.1097/00130404-200307000-00013; Xie W, 2002, CANCER RES, V62, P497; Yamagata H, 2005, CANCER RES, V65, P157; Yang L, 2008, CANCER RES, V68, P9107, DOI 10.1158/0008-5472.CAN-08-2556; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zhang YJ, 2009, CANCER LETT, V275, P102, DOI 10.1016/j.canlet.2008.10.017; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4	44	19	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35684	10.1371/journal.pone.0035684	http://dx.doi.org/10.1371/journal.pone.0035684			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539990	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341000056
J	Yan, YX; Gong, YW; Guo, Y; Lv, Q; Guo, C; Zhuang, Y; Zhang, Y; Li, RX; Zhang, XZ				Yan, Yu-xian; Gong, Yuan-wei; Guo, Yong; Lv, Qi; Guo, Chun; Zhuang, Yan; Zhang, Yuan; Li, Ruixin; Zhang, Xi-zheng			Mechanical Strain Regulates Osteoblast Proliferation through Integrin-Mediated ERK Activation	PLOS ONE			English	Article							GROWTH-FACTOR-I; SIGNAL-TRANSDUCTION PATHWAYS; MESENCHYMAL STEM-CELLS; EXTRACELLULAR-MATRIX; SHEAR-STRESS; BONE-CELLS; INSULIN; EXPRESSION; PROTEIN; KINASE	Mechanical strain plays a critical role in the proliferation, differentiation and maturation of bone cells. As mechanical receptor cells, osteoblasts perceive and respond to stress force, such as those associated with compression, strain and shear stress. However, the underlying molecular mechanisms of this process remain unclear. Using a four-point bending device, mouse MC3T3-E1 cells was exposed to mechanical tensile strain. Cell proliferation was determined to be most efficient when stimulated once a day by mechanical strain at a frequency of 0.5 Hz and intensities of 2500 mu epsilon with once a day, and a periodicity of 1 h/day for 3 days. The applied mechanical strain resulted in the altered expression of 1992 genes, 41 of which are involved in the mitogen-activated protein kinase (MAPK) signaling pathway. Activation of ERK by mechanical strain promoted cell proliferation and inactivation of ERK by PD98059 suppressed proliferation, confirming that ERK plays an important role in the response to mechanical strain. Furthermore, the membrane-associated receptors integrin beta 1 and integrin beta 5 were determined to regulate ERK activity and the proliferation of mechanical strain-treated MC3T3-E1 cells in opposite ways. The knockdown of integrin beta 1 led to the inhibition of ERK activity and cell proliferation, whereas the knockdown of integrin beta 5 led to the enhancement of both processes. This study proposes a novel mechanism by which mechanical strain regulates bone growth and remodeling.	[Yan, Yu-xian; Gong, Yuan-wei; Guo, Yong; Guo, Chun; Li, Ruixin; Zhang, Xi-zheng] Acad Mil Med Sci, Inst Med Equipment, Tianjin, Peoples R China; [Yan, Yu-xian; Lv, Qi; Zhuang, Yan; Zhang, Yuan] Peoples Armed Police Forces, Coll Med, Expt Management Ctr, Tianjin, Peoples R China	Academy of Military Medical Sciences - China	Yan, YX (corresponding author), Acad Mil Med Sci, Inst Med Equipment, Tianjin, Peoples R China.	z56787@sohu.com		Lv, Qi/0000-0001-9076-7042	National Natural Science Foundation of China [10832012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation Key Program of China (No. 10832012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batra NN, 2005, J BIOMECH, V38, P1909, DOI 10.1016/j.jbiomech.2004.08.009; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Bikle DD, 1999, J BONE MINER METAB, V17, P233, DOI 10.1007/s007740050090; Brancaccio M, 2003, NAT MED, V9, P68, DOI 10.1038/nm805; Burr DB, 1996, BONE, V18, P405, DOI 10.1016/8756-3282(96)00028-2; CARVALHO RS, 1995, ARCH ORAL BIOL, V40, P257, DOI 10.1016/0003-9969(95)98814-F; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Dufour C, 2007, EXP CELL RES, V313, P394, DOI 10.1016/j.yexcr.2006.10.021; Duquette TL, 2010, J ORTHOP SPORT PHYS, V40, P834, DOI 10.2519/jospt.2010.0421; Ehrlich PJ, 2002, OSTEOPOROSIS INT, V13, P688, DOI 10.1007/s001980200095; Fan M, 2006, J CELL PHYSIOL, V207, P454, DOI 10.1002/jcp.20581; FROST HM, 1992, BONE MINER, V19, P257, DOI 10.1016/0169-6009(92)90875-E; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; GOHEL AR, 1995, J HISTOCHEM CYTOCHEM, V43, P1085, DOI 10.1177/43.11.7560891; Goodyear LJ, 1996, AM J PHYSIOL-ENDOC M, V271, pE403, DOI 10.1152/ajpendo.1996.271.2.E403; Hatton JP, 2003, J BONE MINER RES, V18, P58, DOI 10.1359/jbmr.2003.18.1.58; HILLAM RA, 1995, J BONE MINER RES, V10, P683; Hu SH, 2004, AM J PHYSIOL-CELL PH, V287, pC1184, DOI 10.1152/ajpcell.00224.2004; HUGHESFULFORD M, 2004, SCI STKE, V249, pRE12; Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359; Isaksson H, 2006, J BIOMECH, V39, P1507, DOI 10.1016/j.jbiomech.2005.01.037; Joshi A, 2009, J NEPAL MED ASSOC, V48, P99, DOI 10.31729/jnma.176; Kapur S, 2003, BONE, V32, P241, DOI 10.1016/S8756-3282(02)00979-1; Kasten A, 2010, J CELL BIOCHEM, V111, P1586, DOI 10.1002/jcb.22890; Katz S, 2006, INT J BIOCHEM CELL B, V38, P2082, DOI 10.1016/j.biocel.2006.05.018; Kusumi A, 2009, J BONE MINER METAB, V27, P653, DOI 10.1007/s00774-009-0085-3; Lal H, 2007, J MOL CELL CARDIOL, V43, P137, DOI 10.1016/j.yjmcc.2007.05.012; Lau KHW, 2006, J BIOL CHEM, V281, P9576, DOI 10.1074/jbc.M509205200; Lee DY, 2010, J BIOL CHEM, V285, P30, DOI 10.1074/jbc.M109.010512; Liedert A, 2006, BIOCHEM BIOPH RES CO, V349, P1, DOI 10.1016/j.bbrc.2006.07.214; Liu J, 2006, BIOCHEM BIOPH RES CO, V348, P1167, DOI 10.1016/j.bbrc.2006.07.175; Luan XH, 2007, J HISTOCHEM CYTOCHEM, V55, P127, DOI 10.1369/jhc.6A7018.2006; Martin TJ, 2006, NAT MED, V12, P612, DOI 10.1038/nm0606-612; Matziolis Doerte, 2011, Open Orthop J, V5, P1, DOI 10.2174/1874325001105010001; Owan I, 1997, AM J PHYSIOL-CELL PH, V273, pC810, DOI 10.1152/ajpcell.1997.273.3.C810; Papachroni KK, 2006, TRENDS MOL MED, V15, P1471; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Pavalko FM, 2003, J CELL BIOCHEM, V88, P104, DOI 10.1002/jcb.10284; Perrien DS, 2006, J CLIN ENDOCR METAB, V91, P1848, DOI 10.1210/jc.2005-2423; Pommerenke H, 2002, J BONE MINER RES, V17, P603, DOI 10.1359/jbmr.2002.17.4.603; Puklin-Faucher E, 2009, J BIOL CHEM, V284, P36557, DOI 10.1074/jbc.M109.041194; Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721; Rubin J, 2002, J BONE MINER RES, V17, P1452, DOI 10.1359/jbmr.2002.17.8.1452; Rubin J, 2006, GENE, V367, P1, DOI 10.1016/j.gene.2005.10.028; Sakata T, 2004, J BONE MINER RES, V19, P436, DOI 10.1359/JBMR.0301241; Shyy JY, 2002, CIRC RES, V91, P769, DOI 10.1161/01.RES.0000038487.19924.18; Silver FH, 2002, BIOMECH MODEL MECHAN, V1, P219, DOI 10.1007/s10237-002-0017-9; Sowa H, 2002, J BIOL CHEM, V277, P36024, DOI 10.1074/jbc.M206030200; Takahiro K, 2007, J CELL BIOCHEM, V101, P1266; Viola V, 2006, MOL CELL BIOL, V7, P265; Wang C, 2011, J BONE MINER METAB, V29, P466, DOI 10.1007/s00774-010-0244-6; Wang LA, 2010, CELL PHYSIOL BIOCHEM, V26, P1093, DOI 10.1159/000323987; Wiesmann Anne, 2006, Head Face Med, V2, P8, DOI 10.1186/1746-160X-2-8; Wozniak M, 2000, J BONE MINER RES, V15, P1731, DOI 10.1359/jbmr.2000.15.9.1731; Xi YT, 2006, EUR J HEART FAIL, V8, P16, DOI 10.1016/j.ejheart.2005.05.014; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Yoshida K, 2002, P NATL ACAD SCI USA, V99, P4580, DOI 10.1073/pnas.062053399; Zhao G, 2000, ENDOCRINOLOGY, V141, P2674, DOI 10.1210/en.141.7.2674; Ziros PG, 2002, J BIOL CHEM, V277, P23934, DOI 10.1074/jbc.M109881200	60	92	108	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35709	10.1371/journal.pone.0035709	http://dx.doi.org/10.1371/journal.pone.0035709			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539993	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341000059
J	Cepeda, GD; Blanco-Bercial, L; Bucklin, A; Beron, CM; Vinas, MD				Cepeda, Georgina D.; Blanco-Bercial, Leocadio; Bucklin, Ann; Beron, Corina M.; Vinas, Maria D.			Molecular Systematic of Three Species of Oithona (Copepoda, Cyclopoida) from the Atlantic Ocean: Comparative Analysis Using 28S rDNA	PLOS ONE			English	Article							CALANUS-FINMARCHICUS; SPAWNING AREA; SEA; PHYLOGENY; SIMILIS; 34-DEGREES-S-41-DEGREES-S; ASSEMBLAGES; CRUSTACEA; SEQUENCE; LARVAE	Species of Oithona (Copepoda, Cyclopoida) are highly abundant, ecologically important, and widely distributed throughout the world oceans. Although there are valid and detailed descriptions of the species, routine species identifications remain challenging due to their small size, subtle morphological diagnostic traits, and the description of geographic forms or varieties. This study examined three species of Oithona (O. similis, O. atlantica and O. nana) occurring in the Argentine sector of the South Atlantic Ocean based on DNA sequence variation of a 575 base-pair region of 28S rDNA, with comparative analysis of these species from other North and South Atlantic regions. DNA sequence variation clearly resolved and discriminated the species, and revealed low levels of intraspecific variation among North and South Atlantic populations of each species. The 28S rDNA region was thus shown to provide an accurate and reliable means of identifying the species throughout the sampled domain. Analysis of 28S rDNA variation for additional species collected throughout the global ocean will be useful to accurately characterize biogeographical distributions of the species and to examine phylogenetic relationships among them.	[Cepeda, Georgina D.; Vinas, Maria D.] Inst Nacl Invest & Desarrollo Pesquero INIDEP, Mar Del Plata, Buenos Aires, Argentina; [Cepeda, Georgina D.; Beron, Corina M.] Ctr Estudios Biodiversidad & Biotecnol CEBB CIB F, Mar Del Plata, Buenos Aires, Argentina; [Cepeda, Georgina D.; Beron, Corina M.; Vinas, Maria D.] Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina; [Cepeda, Georgina D.; Vinas, Maria D.] Univ Nacl Mar del Plata, IIMyC, Fac Ciencias Exactas & Nat, Consejo Nacl Invest Cient & Tecn, Mar Del Plata, Buenos Aires, Argentina; [Blanco-Bercial, Leocadio; Bucklin, Ann] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National Fisheries Research & Development Institute (INIDEP); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Mar del Plata; University of Connecticut	Cepeda, GD (corresponding author), Inst Nacl Invest & Desarrollo Pesquero INIDEP, Mar Del Plata, Buenos Aires, Argentina.	gcepeda@fiba.org.ar	Blanco-Bercial, Leocadio/G-5441-2013; Blanco-Bercial, Leocadio/N-4061-2019	Blanco-Bercial, Leocadio/0000-0003-0658-7183; Blanco-Bercial, Leocadio/0000-0003-0658-7183; Beron, Corina/0000-0002-0365-3571; Bucklin, Ann/0000-0003-3750-9348	Instituto Nacional de Investigacion y Desarrollo Pesquero, Fundacion para Investigaciones Biologicas Aplicadas; Agencia Nacional de Promocion Cientifica y Tecnologica [15227/03]; Universidad Nacional de Mar del Plata [15/E269]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Department of Marine Sciences at the University of Connecticut; Alfred P. Sloan Foundation	Instituto Nacional de Investigacion y Desarrollo Pesquero, Fundacion para Investigaciones Biologicas Aplicadas; Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Universidad Nacional de Mar del Plata(National University of La Plata); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Department of Marine Sciences at the University of Connecticut; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	This work was partially supported by Instituto Nacional de Investigacion y Desarrollo Pesquero, Fundacion para Investigaciones Biologicas Aplicadas; Agencia Nacional de Promocion Cientifica y Tecnologica [Grant No. 15227/03 to M.D.V.]; Universidad Nacional de Mar del Plata [Grant No. 15/E269 to M.D.V.]; and a PhD. fellowship from Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) to G.C. Additional support was provided by the Department of Marine Sciences at the University of Connecticut, and by the Alfred P. Sloan Foundation (Marine Barcode of Life project, MarBOL). This study is a contribution from the Census of Marine Zooplankton (CMarZ, see www.CMarZ.org), an ocean realm field project of the Census of Marine Life. This is INIDEP contribution N 1736. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antacli JC, 2010, J SEA RES, V63, P71, DOI 10.1016/j.seares.2009.09.004; Berasategui AD, 2006, ESTUAR COAST SHELF S, V66, P483, DOI 10.1016/j.ecss.2005.09.014; Bik HM, BMC EVOLUTIONARY BIO, V10, P353; Boltovskoy D, 2011, ENVIRON SCI POLICY, V14, P578, DOI 10.1016/j.envsci.2011.03.007; Borchiellini C, 2004, MOL PHYLOGENET EVOL, V32, P823, DOI 10.1016/j.ympev.2004.02.021; Bradford-Grieve Janet M., 1999, P869; Brown L, 2010, EUR J PHYCOL, V45, P375, DOI 10.1080/09670262.2010.495164; Bucklin A., 2000, P533, DOI 10.1016/B978-012327645-2/50012-8; Bucklin A, 2000, ICES J MAR SCI, V57, P1592, DOI 10.1006/jmsc.2000.0957; Castellani C, 2007, J PLANKTON RES, V29, P1051, DOI 10.1093/plankt/fbm079; Claus C., 1866, SCHRIFTEN GESELLSCHA, VSupplement, P1; Claus C, 1863, FREILEBENDEN COPEPOD, DOI [10.5962/bhl.title.58676, DOI 10.5962/BHL.TITLE.58676]; Dana J.D., 1853, CRUSTACEA US EXPLORI; Di Mauro R, 2009, BRAZ J OCEANOGR, V57, P205, DOI 10.1590/S1679-87592009000300004; Dvoretsky VG, 2009, MAR ECOL PROG SER, V385, P165, DOI 10.3354/meps07984; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Farran G. P, 1908, 2 REPORT COPEPODA IR, V2, P1; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferrari F.D., 1980, SMITHSON CONTR ZOOL, V312, P1, DOI [10.5479/si.00810282.312, DOI 10.5479/SI.00810282.312]; Fish CJ, 1936, BIOL BULL-US, V71, P168, DOI 10.2307/1537414; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fruohtl F., 1920, Sitzungsberichte der Akademie der Wissenschaften in Wien, V129, P463; Gallienne CP, 2001, J PLANKTON RES, V23, P1421, DOI 10.1093/plankt/23.12.1421; Giesbrecht W, 1892, FAUNA FLORA GOLFES N, V19, P1, DOI [10.5962/bhl.title.59541, DOI 10.5962/BHL.TITLE.59541]; Goetze E, 2003, P ROY SOC B-BIOL SCI, V270, P2321, DOI 10.1098/rspb.2003.2505; Hayward CJ, 2011, AQUACULTURE, V320, P178, DOI 10.1016/j.aquaculture.2010.10.039; Holznagel WE, 2010, MOL PHYLOGENET EVOL, V57, P1017, DOI 10.1016/j.ympev.2010.09.021; Jukes T.H., 1969, MAMMALIAN PROTEIN ME; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Machida RJ, 2002, MAR BIOTECHNOL, V4, P406, DOI 10.1007/s10126-002-0033-x; Marques E., 1966, Revue de Zoologie et de Botanique Africaines, V73, P1; Marrari M, 2004, ICES J MAR SCI, V61, P667, DOI 10.1016/j.icesjms.2004.03.025; Mazzocchi MG, 1995, ATLAS MARINE ZOOPLAN, P23; Mori T, 1964, PELAGIC COPEPODS NEI; Nielsen TG, 2002, MAR ECOL PROG SER, V236, P301, DOI 10.3354/meps236301; Nielsen TG, 1996, MAR ECOL PROG SER, V139, P79, DOI 10.3354/meps139079; NISHIDA S, 1977, Bulletin of Plankton Society of Japan, V24, P119; Nishida S., 1985, B OCEAN RES I U TOKY, V20, P1; Ortman B. D., 2008, THESIS U CONNECTICUT; PAFFENHOFER GA, 1993, J PLANKTON RES, V15, P37, DOI 10.1093/plankt/15.1.37; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ramirez F. C., 1966, Physis Buenos Aires, V26, P285; Ramirez F. C., 1971, Revta Mus La Plata (Zool), V11, P73; Razouls C., 2005, DIVERSITE REPARTITIO; Sabatini Marina, 2009, Revista de Investigacion y Desarrollo Pesquero, V19, P5; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Selifonova ZP, 2009, INLAND WATER BIOL, V2, P30, DOI 10.1134/S1995082909010052; Shuvalov VS, 1980, COPEPOD CYCLOPOIDS F; Sonnenberg R, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-6; Struck TH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-57; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ueda H, 2011, J NAT HIST, V45, P2069, DOI DOI 10.1080/00222933.2011.574801; Unal E, 2010, PROG OCEANOGR, V87, P175, DOI 10.1016/j.pocean.2010.09.017; Vinas MD, 2002, MAR FRESHWATER RES, V53, P1031, DOI 10.1071/MF00105; Vinas MD, 2000, ARCH FISH MAR RES, V48, P242; Vinas MD, 1996, ARCH FISH MAR RES, V43, P231; Voznesensky M, 2004, J EXP MAR BIOL ECOL, V311, P37, DOI 10.1016/j.jembe.2004.04.017; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Williams JA, 2006, J PLANKTON RES, V28, P1055, DOI 10.1093/plankt/fbl039	62	21	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35861	10.1371/journal.pone.0035861	http://dx.doi.org/10.1371/journal.pone.0035861			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558245	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336000068
J	Seki, S; Mazur, P				Seki, Shinsuke; Mazur, Peter			Ultra-Rapid Warming Yields High Survival of Mouse Oocytes Cooled to-196 degrees C in Dilutions of a Standard Vitrification Solution	PLOS ONE			English	Article							INTRACELLULAR ICE FORMATION; EMBRYOS; CRYOPRESERVATION; RECRYSTALLIZATION; BLASTOCYSTS; SPERMATOZOA	Intracellular ice is generally lethal. One way to avoid it is to vitrify cells; that is, to convert cell water to a glass rather than to ice. The belief has been that this requires both the cooling rate and the concentration of glass-inducing solutes be very high. But high solute concentrations can themselves be damaging. However, the findings we report here on the vitrification of mouse oocytes are not in accord with the first belief that cooling needs to be extremely rapid. The important requirement is that the warming rate be extremely high. We subjected mouse oocytes in the vitrification solution EAFS 10/10 to vitrification procedures using a broad range of cooling and warming rates. Morphological survivals exceeded 80% when they were warmed at the highest rate (117,000 degrees C/min) even when the prior cooling rate was as low as 880 degrees C/min. Functional survival was >81% and 54% with the highest warming rate after cooling at 69,000 and 880 degrees C/min, respectively. Our findings are also contrary to the second belief. We show that a high percentage of mouse oocytes survive vitrification in media that contain only half the usual concentration of solutes, provided they are warmed extremely rapidly; that is, >100,000 degrees C/min. Again, the cooling rate is of less consequence.	[Seki, Shinsuke; Mazur, Peter] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Fundamental & Appl Cryobiol Grp, Knoxville, TN 37920 USA; [Seki, Shinsuke] Tokyo Univ Marine Sci & Technol, Tokyo, Japan	University of Tennessee System; University of Tennessee Knoxville; Tokyo University of Marine Science & Technology	Seki, S (corresponding author), Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Fundamental & Appl Cryobiol Grp, Knoxville, TN 37920 USA.	pmazur@utk.edu			National Institutes of Health [R01-RR018470]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR018470] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011201] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grant R01-RR018470 to P. Mazur, Principal Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An TZ, 1999, CRYOBIOLOGY, V38, P27, DOI 10.1006/cryo.1998.2141; Borini A., 2009, PRESERVATION HUMAN O; FAHY GM, 1987, BIOPHYSICS ORGAN CRY, P265; KARLSSON JOM, 1993, BIOPHYS J, V65, P2524, DOI 10.1016/S0006-3495(93)81319-5; Kleinhans FW, 2010, CRYOBIOLOGY, V61, P231, DOI 10.1016/j.cryobiol.2010.06.011; Kuwayama M, 2005, REPROD BIOMED ONLINE, V11, P608, DOI 10.1016/S1472-6483(10)61169-8; Kuwayama M, 2007, THERIOGENOLOGY, V67, P73, DOI 10.1016/j.theriogenology.2006.09.014; LANDA V, 1990, FOLIA BIOL-PRAGUE, V36, P153; Lane M, 2001, MOL REPROD DEV, V58, P342, DOI 10.1002/1098-2795(200103)58:3&lt;342::AID-MRD13&gt;3.0.CO;2-X; Lee HJ, 2010, REPROD BIOMED ONLINE, V20, P201, DOI 10.1016/j.rbmo.2009.11.012; LEIBO SP, 1993, CRYO-LETT, V14, P133; Macas E, 2011, REPROD BIOMED ONLINE, V22, P376, DOI 10.1016/j.rbmo.2011.01.004; Martino A, 1996, BIOL REPROD, V54, P1059, DOI 10.1095/biolreprod54.5.1059; Matsumoto H, 2001, CRYOBIOLOGY, V42, P139, DOI 10.1006/cryo.2001.2309; Mazur P, 2005, CRYOBIOLOGY, V51, P29, DOI 10.1016/j.cryobiol.2005.04.008; Mazur P, 2008, BIOL REPROD, V78, P2, DOI 10.1095/biolreprod.107.064113; Mazur P, 2007, CRYOBIOLOGY, V55, P158, DOI 10.1016/j.cryobiol.2007.06.007; Mazur P, 2011, CRYOBIOLOGY, V62, P1, DOI 10.1016/j.cryobiol.2010.10.159; Nakagata N, 1997, BIOL REPROD, V57, P1050, DOI 10.1095/biolreprod57.5.1050; Noyes N, 2009, REPROD BIOMED ONLINE, V18, P769, DOI 10.1016/S1472-6483(10)60025-9; Papis K, 1999, CRYO-LETT, V20, P203; Pedro P, 1997, J REPROD DEVELOP, V51, P235; RALL WF, 1987, CRYOBIOLOGY, V24, P387, DOI 10.1016/0011-2240(87)90042-3; Seki S, 2008, BIOL REPROD, V79, P727, DOI 10.1095/biolreprod.108.069401; Seki S, 2008, CRYOBIOLOGY, V56, P171, DOI 10.1016/j.cryobiol.2008.02.001; Seki S, 2009, CRYOBIOLOGY, V59, P75, DOI 10.1016/j.cryobiol.2009.04.012; Vajta G, 1998, MOL REPROD DEV, V51, P53, DOI 10.1002/(SICI)1098-2795(199809)51:1&lt;53::AID-MRD6&gt;3.0.CO;2-V; Vanderzwalmen P, 2009, REPROD BIOMED ONLINE, V19, P700, DOI 10.1016/j.rbmo.2009.09.011; WHITTINGHAM DG, 1972, SCIENCE, V178, P411, DOI 10.1126/science.178.4059.411; YAMAUCHI Y, 2005, CRYOBIOLOGY, V51, P400; Yavin S, 2009, HUM REPROD, V24, P797, DOI 10.1093/humrep/den397	31	73	75	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36058	10.1371/journal.pone.0036058	http://dx.doi.org/10.1371/journal.pone.0036058			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558325	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336000115
J	Liu, W; Vogt, CA; Luo, JY; He, GM; Frank, KA; Liu, JG				Liu, Wei; Vogt, Christine A.; Luo, Junyan; He, Guangming; Frank, Kenneth A.; Liu, Jianguo			Drivers and Socioeconomic Impacts of Tourism Participation in Protected Areas	PLOS ONE			English	Article							WOLONG NATURE-RESERVE; HOUSEHOLD STRATEGIES; ECOTOURISM; CONSERVATION; MANAGEMENT; FRAMEWORK; BENEFITS; HABITAT; CYCLE; MODEL	Nature-based tourism has the potential to enhance global biodiversity conservation by providing alternative livelihood strategies for local people, which may alleviate poverty in and around protected areas. Despite the popularity of the concept of nature-based tourism as an integrated conservation and development tool, empirical research on its actual socioeconomic benefits, on the distributional pattern of these benefits, and on its direct driving factors is lacking, because relevant long-term data are rarely available. In a multi-year study in Wolong Nature Reserve, China, we followed a representative sample of 220 local households from 1999 to 2007 to investigate the diverse benefits that these households received from recent development of nature-based tourism in the area. Within eight years, the number of households directly participating in tourism activities increased from nine to sixty. In addition, about two-thirds of the other households received indirect financial benefits from tourism. We constructed an empirical household economic model to identify the factors that led to household-level participation in tourism. The results reveal the effects of local households' livelihood assets (i.e., financial, human, natural, physical, and social capitals) on the likelihood to participate directly in tourism. In general, households with greater financial (e.g., income), physical (e.g., access to key tourism sites), human (e.g., education), and social (e.g., kinship with local government officials) capitals and less natural capital (e.g., cropland) were more likely to participate in tourism activities. We found that residents in households participating in tourism tended to perceive more non-financial benefits in addition to more negative environmental impacts of tourism compared with households not participating in tourism. These findings suggest that socioeconomic impact analysis and change monitoring should be included in nature-based tourism management systems for long-term sustainability of protected areas.	[Liu, Wei; Luo, Junyan; He, Guangming; Frank, Kenneth A.; Liu, Jianguo] Michigan State Univ, Dept Fisheries & Wildlife, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48824 USA; [Vogt, Christine A.] Michigan State Univ, Dept Commun Agr Recreat & Resource Studies, E Lansing, MI 48824 USA; [Frank, Kenneth A.] Michigan State Univ, Dept Counseling Educ Psychol & Special Educ, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Liu, W (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48824 USA.	wliu@helppanda.org	Liu, Jianguo/G-5211-2015	Liu, Jianguo/0000-0001-6344-0087	National Science Foundation (NSF) [0709717, OISE-0729709]; National Aeronautics and Space Administration (NASA) [NNX08AL04G]	National Science Foundation (NSF)(National Science Foundation (NSF)); National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA))	Funding for this research was provided by National Science Foundation (NSF Award Numbers 0709717 and OISE-0729709) and National Aeronautics and Space Administration (NASA Award Number NNX08AL04G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An L, 2002, ECOL ECON, V42, P445, DOI 10.1016/S0921-8009(02)00126-X; An L, 2001, ECOL MODEL, V140, P31, DOI 10.1016/S0304-3800(01)00267-8; [Anonymous], 2010, CONSERVATION TOURISM; Balmford A, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000144; Berkes F, 2004, CONSERV BIOL, V18, P621, DOI 10.1111/j.1523-1739.2004.00077.x; Bookbinder MP, 1998, CONSERV BIOL, V12, P1399, DOI 10.1046/j.1523-1739.1998.97229.x; Brown K, 2002, GEOGR J, V168, P6, DOI 10.1111/1475-4959.00034; Buckley R, 2011, ANNU REV ENV RESOUR, V36, P397, DOI 10.1146/annurev-environ-041210-132637; BUTLER RW, 1980, CAN GEOGR-GEOGR CAN, V24, P5, DOI 10.1111/j.1541-0064.1980.tb00970.x; Butler RW, 2006, TOURISM AREA LIFE CY; Coria J, 2012, ECOL ECON, V73, P47, DOI 10.1016/j.ecolecon.2011.10.024; Department for International Development (DFID), 1999, SUST LIV GUID SHEETS; Ellis F, 1998, J DEV STUD, V35, P1, DOI 10.1080/00220389808422553; Ellis Frank, 2000, RURAL LIVELIHOODS DI; ESRI, 2009, ARCGIS 9 3; Ghimire KB, SOCIAL CHANGE CONSER; Ghimire KB, 1994, CONSERVATION SOCIAL; Grumbine RE, 2011, BIOL CONSERV, V144, P1347, DOI 10.1016/j.biocon.2011.03.006; Haggblade S., 2007, TRANSFORMING RURAL N; He GM, 2008, ENVIRON MANAGE, V42, P1017, DOI 10.1007/s00267-008-9214-3; Hirano K., 2001, HLTH SERVICES OUTCOM, V2, P259, DOI [10.1023/A:1020371312283, DOI 10.1023/A:1020371312283]; Hughes R., 2001, INTEGRATING CONSERVA; IUCN, 2006, SICH GIANT PAND SANC; IUCN and UNEP-WCMC, 2011, WORLD DAT PROT AR WD; Kinzig AP, 2011, SCIENCE, V334, P603, DOI 10.1126/science.1210297; Kiss A, 2004, TRENDS ECOL EVOL, V19, P232, DOI 10.1016/j.tree.2004.03.010; Kruger O, 2005, BIODIVERS CONSERV, V14, P579, DOI 10.1007/s10531-004-3917-4; Li C., 1992, ANIMAL PLANT RESOURC; Li C, 1992, ANIMAL PLANT RESOURC; Li W., 1989, CHINAS NATURE RESERV; Li WJ, 2001, AMBIO, V30, P62, DOI 10.1639/0044-7447(2001)030[0062:EMICSN]2.0.CO;2; Liu JG, 2003, SCIENCE, V300, P1240, DOI 10.1126/science.1078868; Liu JG, 2003, NATURE, V421, P530, DOI 10.1038/nature01359; Liu JG, 1999, POPUL ENVIRON, V21, P45, DOI 10.1023/A:1022101026466; Liu JG, 1999, CONSERV BIOL, V13, P1360, DOI 10.1046/j.1523-1739.1999.98418.x; Liu JG, 2001, SCIENCE, V292, P98, DOI 10.1126/science.1058104; Liu JG, 2008, P NATL ACAD SCI USA, V105, P9477, DOI 10.1073/pnas.0706436105; Liu JG, 2008, SCIENCE, V319, P37, DOI 10.1126/science.1150416; Liu JG, 2007, SCIENCE, V317, P1513, DOI 10.1126/science.1144004; Lovejoy TE, 2006, TRENDS ECOL EVOL, V21, P329, DOI 10.1016/j.tree.2006.04.005; MA, 2005, ECOSYSTEMS HUMAN WEL; McShane T.O., 2004, GETTING BIODIVERSITY, P49; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Newsome D., 2012, NATURAL AREA TOURISM, V2nd edn, DOI [10.21832/9781845413835, DOI 10.21832/9781845413835]; Reardon T., 2007, TRANSFORMING RURAL N, P115; ROSENBAUM PR, 1987, J AM STAT ASSOC, V82, P387, DOI 10.2307/2289440; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Ross K.A., 2009, ENCYCL DATABASE SYST, P532, DOI [DOI 10.1007/978-0-387-39940-9_565, 10.1007/978-0-387-39940-9]; Rural Survey Department of National Bureau of Statistics, 2000, POV MON REP RUR CHIN; Rural Survey Department of National Bureau of Statistics, 2007, POV MON REP RUR CHIN; Salafsky N, 2000, WORLD DEV, V28, P1421, DOI 10.1016/S0305-750X(00)00031-0; Schaller G.B., 1985, GIANT PANDAS WOLONG; Schaller GB, 1994, LAST PANDA; Scheyvens R, 1999, TOURISM MANAGE, V20, P245, DOI 10.1016/S0261-5177(98)00069-7; Scoones I., 1998, Working Paper - Institute of Development Studies, University of Sussex; Secretariat of the Convention on Biological Diversity, 2010, GLOB BIOD OUTL 3; Sekercioglu CH, 2002, ENVIRON CONSERV, V29, P282, DOI 10.1017/S0376892902000206; Singh I., 1986, Agricultural household models. Extensions, applications, and policy, P17; Spiteri A, 2006, ENVIRON MANAGE, V37, P1, DOI 10.1007/s00267-004-0311-7; Stem CJ, 2003, SOC NATUR RESOUR, V16, P387, DOI 10.1080/08941920309177; Su BR, 2011, TOURISM MANAGE, V32, P1438, DOI 10.1016/j.tourman.2010.12.005; Timothy D. J., 2002, Tourism and development: concepts and issues, P149; UNED-UK, 1999, GEND TOUR WOM EMPL P; United Nations World Tourism Organization, 2001, TOUR 2020 VIS; UNWTO, 2010, TOUR MILL DEV GOALS; Vina A, 2011, AMBIO, V40, P274, DOI 10.1007/s13280-010-0098-0; Wallace C, 2002, SOCIOLOGY, V36, P275, DOI 10.1177/0038038502036002003; Walpole MJ, 2000, ANN TOURISM RES, V27, P559, DOI 10.1016/S0160-7383(99)00088-2; Weaver DB, 2007, TOURISM MANAGE, V28, P1168, DOI 10.1016/j.tourman.2007.03.004; Wells MP., 2004, GETTING BIODIVERSITY, P232, DOI [10.7312/mcsh12764-013, DOI 10.7312/MCSH12764-013]; Wheelock J, 1996, J ECON ISSUES, V30, P143, DOI 10.1080/00213624.1996.11505770; Wolong Administration Bureau, 2009, WOL NAT NAT RES EC D; Wolong Administration Bureau, 2004, CHRON WOL NAT RES; Wolong Administration Bureau Department of Social and Economic Development, 2006, ANN REP RUR EC WOL N; Wolong Nature Reserve Administration Bureau Department of Biology at Nanchong Normal University Conservation Bureau of Sichuan Department of Forestry, 1987, WOL VEG RES PLANTS; Wunder S, 2000, ECOL ECON, V32, P465, DOI 10.1016/S0921-8009(99)00119-6; Wunder S, 2005, PAYMENTS ENV SERVICE, DOI DOI 10.17528/CIFOR/001760; Xie Y, 2004, CHINAS PROTECTED ARE; Zhong LS, 2008, TOURISM MANAGE, V29, P841, DOI 10.1016/j.tourman.2007.10.002	79	98	102	2	164	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35420	10.1371/journal.pone.0035420	http://dx.doi.org/10.1371/journal.pone.0035420			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VP	22558149	Green Submitted, gold, Green Published			2022-12-27	WOS:000305345200039
J	Masini, MA; Albi, E; Barmo, C; Bonfiglio, T; Bruni, L; Canesi, L; Cataldi, S; Curcio, F; D'Amora, M; Ferri, I; Goto, K; Kawano, F; Lazzarini, R; Loreti, E; Nakai, N; Ohira, T; Ohira, Y; Palmero, S; Prato, P; Ricci, F; Scarabelli, L; Shibaguchi, T; Spelat, R; Strollo, F; Ambesi-Impiombato, FS				Masini, Maria Angela; Albi, Elisabetta; Barmo, Cristina; Bonfiglio, Tommaso; Bruni, Lara; Canesi, Laura; Cataldi, Samuela; Curcio, Francesco; D'Amora, Marta; Ferri, Ivana; Goto, Katsumasa; Kawano, Fuminori; Lazzarini, Remo; Loreti, Elisabetta; Nakai, Naoya; Ohira, Takashi; Ohira, Yoshinobu; Palmero, Silvio; Prato, Paola; Ricci, Franco; Scarabelli, Linda; Shibaguchi, Tsubasa; Spelat, Renza; Strollo, Felice; Ambesi-Impiombato, Francesco Saverio			The Impact of Long-Term Exposure to Space Environment on Adult Mammalian Organisms: A Study on Mouse Thyroid and Testis	PLOS ONE			English	Article							SIMULATED MICROGRAVITY; THYROTROPIN RECEPTOR; HORMONE RECEPTOR; LIPID RAFTS; RAT TESTIS; CELL; SPERMATOGENESIS; GROWTH; MICE; TESTOSTERONE	Hormonal changes in humans during spaceflight have been demonstrated but the underlying mechanisms are still unknown. To clarify this point thyroid and testis/epididymis, both regulated by anterior pituitary gland, have been analyzed on long-term space-exposed male C57BL/10 mice, either wild type or pleiotrophin transgenic, overexpressing osteoblast stimulating factor-1. Glands were submitted to morphological and functional analysis. In thyroids, volumetric ratios between thyrocytes and colloid were measured. cAMP production in 10(-7) M and 10(-8) M thyrotropin-treated samples was studied. Thyrotropin receptor and caveolin-1 were quantitized by immunoblotting and localized by immunofluorescence. In space-exposed animals, both basal and thyrotropin-stimulated cAMP production were always higher. Also, the structure of thyroid follicles appeared more organized, while thyrotropin receptor and caveolin-1 were overexpressed. Unlike the control samples, in the space samples thyrotropin receptor and caveolin-1 were both observed at the intracellular junctions, suggesting their interaction in specific cell membrane microdomains. In testes, immunofluorescent reaction for 3 beta-steroid dehydrogenase was performed and the relative expressions of hormone receptors and interleukin-1 beta were quantified by RT-PCR. Epididymal sperm number was counted. In space-exposed animals, the presence of 3 beta and 17 beta steroid dehydrogenase was reduced. Also, the expression of androgen and follicle stimulating hormone receptors increased while lutenizing hormone receptor levels were not affected. The interleukin 1 beta expression was upregulated. The tubular architecture was altered and the sperm cell number was significantly reduced in spaceflight mouse epididymis (approx. -90% vs. laboratory and ground controls), indicating that the space environment may lead to degenerative changes in seminiferous tubules. Space-induced changes of structure and function of thyroid and testis/epididymis could be responsible for variations of hormone levels in human during space missions. More research, hopefully a reflight of MDS, would be needed to establish whether the space environment acts directly on the peripheral glands or induces changes in the hypotalamus-pituitary-glandular axis.	[Masini, Maria Angela; Barmo, Cristina; Bonfiglio, Tommaso; Bruni, Lara; Canesi, Laura; D'Amora, Marta; Prato, Paola; Scarabelli, Linda] Univ Genoa, DIPTERIS, Genoa, Italy; [Albi, Elisabetta; Cataldi, Samuela; Lazzarini, Remo] Univ Perugia, Dept Clin & Expt Med, I-06100 Perugia, Italy; [Curcio, Francesco; Spelat, Renza; Ambesi-Impiombato, Francesco Saverio] Univ Udine, Dept Clin & Biol Sci, I-33100 Udine, Italy; [Ferri, Ivana; Loreti, Elisabetta] Univ Perugia, Inst Pathol Anat & Histol, I-06100 Perugia, Italy; [Goto, Katsumasa] Toyohashi SOZO Univ, Sch Hlth Sci, Aichi, Japan; [Kawano, Fuminori; Nakai, Naoya; Ohira, Yoshinobu] Osaka Univ, Grad Sch Med, Osaka, Japan; [Ohira, Takashi; Ohira, Yoshinobu; Shibaguchi, Tsubasa] Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan; [Palmero, Silvio] Univ Genoa, DIBIO, Genoa, Italy; [Ricci, Franco] ENEA CR Casaccia, Rome, Italy; [Strollo, Felice] INRCA IRCCS, Rome, Italy	University of Genoa; University of Perugia; University of Udine; University of Perugia; Osaka University; Osaka University; University of Genoa; Italian National Agency New Technical Energy & Sustainable Economics Development; IRCCS INRCA	Masini, MA (corresponding author), Univ Genoa, DIPTERIS, Genoa, Italy.	ambesi@uniud.it	Spelat, Renza/AAZ-2980-2021; Bonfiglio, Tommaso/AAB-2579-2019; Strollo, Felice/AAZ-4861-2020; Goto, Katsumasa/T-6789-2019; Curcio, Francesco/K-4669-2014; d'Amora, Marta/A-1226-2014; Albi, Elisabetta/K-3369-2016	Spelat, Renza/0000-0001-5794-8976; Goto, Katsumasa/0000-0001-5380-4561; Canesi, Laura/0000-0003-2061-3819; Albi, Elisabetta/0000-0002-5745-5343; CURCIO, Francesco/0000-0002-9070-4807; d'Amora, Marta/0000-0001-6234-8078	ASI (Agenzia Spaziale Italiana)	ASI (Agenzia Spaziale Italiana)(Agenzia Spaziale Italiana (ASI))	The authors acknowledge that this work has been partially funded by ASI (Agenzia Spaziale Italiana). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Albi E, 2011, ASTROBIOLOGY, V11, P57, DOI 10.1089/ast.2010.0519; Albi E, 2010, ASTROBIOLOGY, V10, P811, DOI 10.1089/ast.2010.0461; AMANN RP, 1992, J APPL PHYSIOL, V73, pS174, DOI 10.1152/jappl.1992.73.2.S174; Guazzone VA, 2009, MICROSC RES TECHNIQ, V72, P620, DOI 10.1002/jemt.20704; Bergh A, 2001, BIOL REPROD, V64, P13, DOI 10.1095/biolreprod64.1.13; Calebiro D, 2006, MOL ENDOCRINOL, V20, P3196, DOI 10.1210/me.2005-0493; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Cancedda R, 2002, J GRAVIT PHYSL, V9, P337; Cascianelli G, 2008, MOL BIOL CELL, V19, P5289, DOI 10.1091/mbc.E08-05-0517; COONS AH, 1955, J EXP MED, V102, P49, DOI 10.1084/jem.102.1.49; Del Conte E, 1975, CELL PATHOL, V18, P297; Dufau ML, 1998, ANNU REV PHYSIOL, V60, P461, DOI 10.1146/annurev.physiol.60.1.461; Elmlinger MW, 2001, CLIN CHEM LAB MED, V39, P973, DOI 10.1515/CCLM.2001.158; FEDOROVA N. L., 1967, KOSM BIOL MED, V1, P28; Graves PN, 1996, ENDOCRINOLOGY, V137, P3915, DOI 10.1210/en.137.9.3915; Hartoft-Nielsen ML, 2005, J ANAT, V207, P117, DOI 10.1111/j.1469-7580.2005.00442.x; Helmreich DL, 2005, NEUROENDOCRINOLOGY, V81, P183, DOI 10.1159/000087001; Kamiya H, 2003, J ANDROL, V24, P885; Kholodenko BN, 2008, CELL, V133, P566, DOI 10.1016/j.cell.2008.04.033; Latif R, 2007, ENDOCRINOLOGY, V148, P3164, DOI 10.1210/en.2006-1580; Latif R, 2003, ENDOCRINOLOGY, V144, P4725, DOI 10.1210/en.2003-0932; Lee PA, 1998, J UROLOGY, V160, P1155, DOI 10.1016/S0022-5347(01)62724-1; Li GX, 2001, J VET MED SCI, V63, P373, DOI 10.1292/jvms.63.373; Loukil L Hadjkacem, 2005, Arch Inst Pasteur Tunis, V82, P47; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu NZ, 2006, PHARMACOL REV, V58, P782, DOI 10.1124/pr.58.4.9; Lysiak JJ, 2003, BIOL REPROD, V69, P202, DOI 10.1095/biolreprod.102.013318; Masuda H, 1997, BIOCHEM BIOPH RES CO, V238, P528, DOI 10.1006/bbrc.1997.7188; McLachlan RI, 2002, J ANDROL, V23, P149; MERRILL AH, 1992, J APPL PHYSIOL, V73, pS132, DOI 10.1152/jappl.1992.73.2.S132; MIDGLEY J E M, 1985, Nuclear Medizin, V24, P57; Miguel J, 1978, PHYSIOLOGIST, V21, P80; Motabagani MAH, 2007, CHINESE J PHYSIOL, V50, P199; Neves SR, 2008, CELL, V133, P666, DOI 10.1016/j.cell.2008.04.025; Ozen OA, 2005, TOXICOL IND HEALTH, V21, P249, DOI 10.1191/0748233705th235oa; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Philpott D E, 1985, Physiologist, V28, pS211; PHILPOTT DE, 1983, SCAN ELECTRON MICROS, P1345; SAPP WJ, 1992, ADV SPACE RES-SERIES, V12, P179, DOI 10.1016/0273-1177(92)90106-8; SAPP WJ, 1990, FASEB J, V4, P101, DOI 10.1096/fasebj.4.1.2295370; Serova L V, 1989, Physiologist, V32, pS29; Serova Lyubov V., 1993, Physiologist, V36, P31; Sharma CS, 2008, MOL CELL BIOCHEM, V313, P71, DOI 10.1007/s11010-008-9743-3; Simoni M, 1997, ENDOCR REV, V18, P739, DOI 10.1210/er.18.6.739; Tash JS, 2002, J APPL PHYSIOL, V92, P1191, DOI 10.1152/japplphysiol.00931.2001; Uva B M, 2005, J Endocrinol Invest, V28, P84; VASSART G, 1992, ENDOCR REV, V13, P596, DOI 10.1210/er.13.3.596; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Yang XB, 2003, J BONE MINER RES, V18, P47, DOI 10.1359/jbmr.2003.18.1.47; ZIRKIN BR, 1989, ENDOCRINOLOGY, V124, P3043, DOI 10.1210/endo-124-6-3043	50	28	31	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35418	10.1371/journal.pone.0035418	http://dx.doi.org/10.1371/journal.pone.0035418			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558148	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345200038
J	Abramson, DH; Marr, BP; Brodie, SE; Dunkel, I; Palioura, S; Gobin, YP				Abramson, David H.; Marr, Brian P.; Brodie, Scott E.; Dunkel, Ira; Palioura, Sotiria; Gobin, Y. Pierre			Ophthalmic Artery Chemosurgery for Less Advanced Intraocular Retinoblastoma: Five Year Review	PLOS ONE			English	Review							RADIATION-THERAPY; CHEMOTHERAPY; MANAGEMENT; CHEMOREDUCTION; RADIOTHERAPY; OTOTOXICITY; FAILURE	Background: Ophthalmic artery chemosurgery (OAC) for retinoblastoma was introduced by us 5 years ago for advanced intraocular retinoblastoma. Because the success was higher than with existing alternatives and systemic side effects limited we have now treated less advanced intraocular retinoblastoma (Reese-Ellsworth (RE) I-III and International Classification Retinoblastoma (ICRB) B and C). Methodology/Principal Findings: Retrospective review of 5 year experience in eyes with Reese Ellsworth (Table 1) I (7 eyes), II (6 eyes) or III (6 eyes) and/or International Classification (Table 2) B (19 eyes) and C (11 eyes) treated with OAC (melphalan with or without topotecan) introduced directly into the ophthalmic artery. Patient survival was 100%. Ocular event-free survival was 100% for Reese-Ellsworth Groups I, II and III (and 96% for ICRB B and C) at a median of 16 months follow-up. One ICRB Group C (Reese-Ellsworth Vb) eye could not be treated on the second attempt for technical reasons and was therefore enucleated. No patient required a port and only one patient required transfusion of blood products. The electroretinogram (ERG) was unchanged or improved in 14/19 eyes. Conclusions/Significance: Ophthalmic artery chemosurgery for retinoblastoma that was Reese-Ellsworth I, II and III (or International Classification B or C) was associated with high success (100% of treatable eyes were retained) and limited toxicity with results that equal or exceed conventional therapy with less toxicity.	[Abramson, David H.; Marr, Brian P.; Brodie, Scott E.; Palioura, Sotiria] Mem Sloan Kettering Canc Ctr, Ophthalm Oncol Serv, New York, NY 10021 USA; [Brodie, Scott E.] Mt Sinai Sch Med, Dept Ophthalmol, New York, NY USA; [Dunkel, Ira] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; [Palioura, Sotiria] Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02114 USA; [Gobin, Y. Pierre] Weill Cornell Med Coll, Dept Radiol, New York, NY USA; [Gobin, Y. Pierre] Weill Cornell Med Coll, Dept Neurosurg, New York, NY USA	Memorial Sloan Kettering Cancer Center; Icahn School of Medicine at Mount Sinai; Memorial Sloan Kettering Cancer Center; Harvard University; Massachusetts Eye & Ear Infirmary; Cornell University; Cornell University	Abramson, DH (corresponding author), Mem Sloan Kettering Canc Ctr, Ophthalm Oncol Serv, 1275 York Ave, New York, NY 10021 USA.	abramsod@mskcc.org		Dunkel, Ira/0000-0001-8091-6067; Brodie, Scott/0000-0002-3303-4552	Fund for Ophthalmic Knowledge; Alcon Research Institute	Fund for Ophthalmic Knowledge; Alcon Research Institute(Novartis)	This work was supported by grants from the Fund for Ophthalmic Knowledge and the Alcon Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson DH, 2008, OPHTHALMOLOGY, V115, P1398, DOI 10.1016/j.ophtha.2007.12.014; Abramson DH, 2010, BRIT J OPHTHALMOL, V94, P396, DOI 10.1136/bjo.2009.174268; Abramson DH, 2010, ARCH OPHTHALMOL-CHIC, V128, P370, DOI 10.1001/archophthalmol.2010.7; Abramson DH, 2004, OPHTHALMOLOGY, V111, P984, DOI 10.1016/j.ophtha.2003.08.035; ABRAMSON DH, 1981, ARCH OPHTHALMOL-CHIC, V99, P1761; Bhagat SP, 2010, INT J PEDIATR OTORHI, V74, P1156, DOI 10.1016/j.ijporl.2010.07.004; Brodie SE, 2009, DOC OPHTHALMOL, V119, P13, DOI 10.1007/s10633-008-9164-3; CASSADY JR, 1969, RADIOLOGY, V93, P405, DOI 10.1148/93.2.405; EGBERT PR, 1978, ARCH OPHTHALMOL-CHIC, V96, P1826; Friedman DL, 2000, J CLIN ONCOL, V18, P12, DOI 10.1200/JCO.2000.18.1.12; Gobin YP, 2011, ARCH OPHTHALMOL-CHIC, V129, P732, DOI 10.1001/archophthalmol.2011.5; Gombos DS, 2007, OPHTHALMOLOGY, V114, P1378, DOI 10.1016/j.ophtha.2007.03.074; Gunduz K, 2004, OPHTHALMOLOGY, V111, P1917, DOI 10.1016/j.ophtha.2004.04.016; Hernandez JC, 1996, INT J RADIAT ONCOL, V35, P125, DOI 10.1016/S0360-3016(96)85020-6; Jehanne M, 2009, PEDIATR BLOOD CANCER, V52, P637, DOI 10.1002/pbc.21898; KANEKO A, 1990, Rinsho Ganka, V44, P289; Kim Jeong Hun, 2003, Korean J Ophthalmol, V17, P35; Kim JW, 2007, DRUGS, V67, P2173, DOI 10.2165/00003495-200767150-00005; MCCORMICK B, 1988, INT J RADIAT ONCOL, V15, P567, DOI 10.1016/0360-3016(88)90296-9; Munier FL, 2011, RETINA-J RET VIT DIS, V31, P566, DOI 10.1097/IAE.0b013e318203c101; Oktay K, 2009, NEW ENGL J MED, V185, P2430; Liberman PHP, 2011, CLIN TRANSL ONCOL, V13, P348, DOI 10.1007/s12094-011-0665-2; REESE AB, 1958, ARCH OPHTHALMOL-CHIC, V60, P897; Rizzuti AE, 2008, ARCH OPHTHALMOL-CHIC, V126, P862, DOI 10.1001/archopht.126.6.862; Shields CL, 2011, ARCH OPHTHALMOL-CHIC, V150, pE1; Suzuki S, 2011, OPHTHALMOLOGY, V118, P2081, DOI 10.1016/j.ophtha.2011.03.013; Toral-Martinnon Rene, 2006, Cir Cir, V74, P79; Vajzovic LM, 2011, CLIN OPHTHALMOL, V5, P171, DOI 10.2147/OPTH.S12665	28	46	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e34120	10.1371/journal.pone.0034120	http://dx.doi.org/10.1371/journal.pone.0034120			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545080	gold, Green Published			2022-12-27	WOS:000305343200003
J	Benova, L; Fielding, K; Greig, J; Nyang'wa, BT; Casas, EC; da Fonseca, MS; du Cros, P				Benova, Lenka; Fielding, Katherine; Greig, Jane; Nyang'wa, Bern-Thomas; Casas, Esther Carrillo; da Fonseca, Marcio Silveira; du Cros, Philipp			Association of BMI Category Change with TB Treatment Mortality in HIV-Positive Smear-Negative and Extrapulmonary TB Patients in Myanmar and Zimbabwe	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; RISK-FACTORS; SETTINGS; THERAPY; HAART; RATES; GAIN	Objective: The HIV epidemic has increased the proportion of patients with smear-negative and extrapulmonary tuberculosis (TB) diagnoses, with related higher rates of poor TB treatment outcomes. Unlike in smear-positive pulmonary TB, no interim markers of TB treatment progress are systematically used to identify individuals most at risk of mortality. The objective of this study was to assess the association of body mass index (BMI) change at 1 month (+/- 15 days) from TB treatment start with mortality among HIV-positive individuals with smear-negative and extrapulmonary TB. Methods and Findings: A retrospective cohort study of adult HIV-positive new TB patients in Medecins Sans Frontieres (MSF) treatment programmes in Myanmar and Zimbabwe was conducted using Cox proportional hazards regression to estimate the association between BMI category change and mortality. A cohort of 1090 TB patients (605 smear-negative and 485 extrapulmonary) was followed during TB treatment with mortality rate of 28.9 per 100 person-years. In multivariable analyses, remaining severely underweight or moving to a lower BMI category increased mortality (adjusted hazard ratio 4.05, 95% confidence interval 2.77-5.91, p<0.001) compared with remaining in the same or moving to a higher BMI category. Conclusions: We found a strong association between BMI category change during the first month of TB treatment and mortality. BMI category change could be used to identify individuals most at risk of mortality during TB treatment among smear-negative and extrapulmonary patients.	[Benova, Lenka; Fielding, Katherine] London Sch Hyg & Trop Med, London WC1, England; [Greig, Jane; Nyang'wa, Bern-Thomas; du Cros, Philipp] Med Sans Frontieres, London, England; [Casas, Esther Carrillo; da Fonseca, Marcio Silveira] Med Sans Frontieres, Amsterdam, Netherlands	University of London; London School of Hygiene & Tropical Medicine; Doctors Without Borders; Doctors Without Borders	Benova, L (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	lenka.benova@lshtm.ac.uk	Nyang'wa, Bern-Thomas/AAA-9545-2022	Nyang'wa, Bern-Thomas/0000-0001-9915-5878; Greig, Jane/0000-0003-2732-0023; du Cros, Philipp/0000-0002-3599-029X; Fielding, Katherine/0000-0002-6524-3754	M�decins Sans Fronti�res [OCA_pilot_00_Greig] Funding Source: researchfish; MRC [G0700837] Funding Source: UKRI; Medical Research Council [G0700837] Funding Source: Medline	M�decins Sans Fronti�res; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahoua L, 2011, J INT AIDS SOC, V14, DOI [10.1186/1758-2652-1114-1182., DOI 10.1186/1758-2652-1114-1182]; [Anonymous], 2011, GLOB TUB CONTR 2011; [Anonymous], IMPR DIAGN TREATM SM, DOI DOI 10.1186/s12879-016-1967-3; Bernabe-Ortiz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018474; Dembele M, 2008, EUR RESPIR J, V32, P1668, DOI 10.1183/09031936.00106308; Dimairo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011849; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Glynn JR, 2010, AIDS, V24, P1067, DOI 10.1097/QAD.0b013e328337b100; Hanrahan CF, 2010, AIDS, V24, P1501, DOI 10.1097/QAD.0b013e32833a2a4a; Kang'ombe C, 2000, T ROY SOC TROP MED H, V94, P305, DOI 10.1016/S0035-9203(00)90335-3; Khan A, 2006, AM J RESP CRIT CARE, V174, P344, DOI 10.1164/rccm.200511-1834OC; Krapp F, 2008, INT J TUBERC LUNG D, V12, P1153; Kruyt ML, 1999, B WORLD HEALTH ORGAN, V77, P386; Lawn SD, 2011, INT J TUBERC LUNG D, V15, P571, DOI 10.5588/ijtld.10.0483; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lawn SD, 2010, LANCET INFECT DIS, V10, P489, DOI 10.1016/S1473-3099(10)70078-5; Maher D, 2005, TUBERCULOSIS DEATHS; Ramos JM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-215; Maro I, 2010, INT J TUBERC LUNG D, V14, P1447; Mossdorf E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-98; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; Mukherjee Abhijit, 2009, Indian J Tuberc, V56, P144; Mupere E, 2010, ANN EPIDEMIOL, V20, P210, DOI 10.1016/j.annepidem.2009.11.001; Nahid P, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-1; Nakanjako D, 2010, INT J TUBERC LUNG D, V14, P1621; Nicholas S, 2009, 5 IAS C HIV PATH TRE; Semba RD, 2010, FOOD NUTR BULL, V31, pS345, DOI 10.1177/15648265100314S404; Waitt CJ, 2011, INT J TUBERC LUNG D, V15, P871, DOI 10.5588/ijtld.10.0352; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; *WHO, 2009, GLOB TUB CONTR SHORT; World Health Organization, 2011, ZIMB TUB COUNTR PROF; World Health Organization, 2011, MYANM TUB COUNTR PRO	33	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35948	10.1371/journal.pone.0035948	http://dx.doi.org/10.1371/journal.pone.0035948			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545150	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000305343200070
J	Cohen, L; Azriel-Tamir, H; Arotsker, N; Sekler, I; Hershfinkel, M				Cohen, Limor; Azriel-Tamir, Hagit; Arotsker, Natan; Sekler, Israel; Hershfinkel, Michal			Zinc Sensing Receptor Signaling, Mediated by GPR39, Reduces Butyrate-Induced Cell Death in HT29 Colonocytes via Upregulation of Clusterin	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; HISTONE DEACETYLASE INHIBITORS; COLON-CANCER CELLS; SODIUM-BUTYRATE; EXTRACELLULAR ZINC; NA+/H+ EXCHANGER; NEURONAL APOPTOSIS; APICAL NHE; EXPRESSION; PROTEIN	Zinc enhances epithelial proliferation, protects the digestive epithelial layer and has profound antiulcerative and antidiarrheal roles in the colon. Despite the clinical significance of this ion, the mechanisms linking zinc to these cellular processes are poorly understood. We have previously identified an extracellular Zn2+ sensing G-protein coupled receptor (ZnR) that activates Ca2+ signaling in colonocytes, but its molecular identity as well as its effects on colonocytes' survival remained elusive. Here, we show that Zn2+, by activation of the ZnR, protects HT29 colonocytes from butyrate induced cell death. Silencing of the G-protein coupled receptor GPR39 expression abolished ZnR-dependent Ca2+ release and Zn2+-dependent survival of butyrate-treated colonocytes. Importantly, GPR39 also mediated ZnR-dependent upregulation of Na+/H+ exchange activity as this activity was found in native colon tissue but not in tissue obtained from GPR39 knock-out mice. Although ZnR-dependent upregulation of Na+/H+ exchange reduced the cellular acid load induced by butyrate, it did not rescue HT29 cells from butyrate induced cell death. ZnR/GPR39 activation however, increased the expression of the antiapoptotic protein clusterin in butyrate-treated cells. Furthermore, silencing of clusterin abolished the Zn2+-dependent survival of HT29 cells. Altogether, our results demonstrate that extracellular Zn2+, acting through ZnR, regulates intracellular pH and clusterin expression thereby enhancing survival of HT29 colonocytes. Moreover, we identify GPR39 as the molecular moiety of ZnR in HT29 and native colonocytes.	[Cohen, Limor; Azriel-Tamir, Hagit; Arotsker, Natan; Hershfinkel, Michal] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Morphol, Beer Sheva, Israel; [Sekler, Israel] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol, Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Cohen, L (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Morphol, Beer Sheva, Israel.	hmichal@bgu.ac.il		Hershfinkel, Michal/0000-0003-1652-1989	Israeli Science Foundation [585/05, 513/09]; German Israeli Foundation [912-90.11/2006]	Israeli Science Foundation(Israel Science Foundation); German Israeli Foundation(German-Israeli Foundation for Scientific Research and Development)	This work was supported by the Israeli Science Foundation grants 585/05 and 513/09 and the German Israeli Foundation grant 912-90.11/2006 (to MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenman E, 2000, J NEUROCHEM, V75, P1878, DOI 10.1046/j.1471-4159.2000.0751878.x; Azriel-Tamir H, 2004, J BIOL CHEM, V279, P51804, DOI 10.1074/jbc.M406581200; Bachmann O, 2004, AM J PHYSIOL-GASTR L, V287, pG125, DOI 10.1152/ajpgi.00332.2003; Besser L, 2009, J NEUROSCI, V29, P2890, DOI 10.1523/JNEUROSCI.5093-08.2009; Bordonaro M, 2008, CELL CYCLE, V7, P1178, DOI 10.4161/cc.7.9.5818; BOYARSKY G, 1988, AM J PHYSIOL, V255, pC857, DOI 10.1152/ajpcell.1988.255.6.C857; Chu JS, 2002, AM J PHYSIOL-CELL PH, V283, pC358, DOI 10.1152/ajpcell.01380.2000; Cima RR, 2006, AM J PHYSIOL-GASTR L, V290, pG250, DOI 10.1152/ajpgi.00501.2004; Clarke JM, 2012, CARCINOGENESIS, V33, P197, DOI 10.1093/carcin/bgr254; Codd R, 2009, INT J BIOCHEM CELL B, V41, P736, DOI 10.1016/j.biocel.2008.05.026; Comalada M, 2006, J CANCER RES CLIN, V132, P487, DOI 10.1007/s00432-006-0092-x; Coradini D, 2000, CELL PROLIFERAT, V33, P139, DOI 10.1046/j.1365-2184.2000.00173.x; Criswell T, 2005, J BIOL CHEM, V280, P14212, DOI 10.1074/jbc.M412569200; Djeu JY, 2009, ADV CANCER RES, V105, P77, DOI 10.1016/S0065-230X(09)05005-2; Dubi N, 2008, CARCINOGENESIS, V29, P1692, DOI 10.1093/carcin/bgn027; Frazzini V, 2007, MOL MED, V13, P356, DOI 10.2119/2007-00047.Frazzini; Guan YF, 2006, AM J PHYSIOL-GASTR L, V291, pG689, DOI 10.1152/ajpgi.00342.2005; Hakkoum D, 2008, J NEUROCHEM, V106, P1791, DOI 10.1111/j.1471-4159.2008.05519.x; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Han BH, 2001, NAT MED, V7, P338, DOI 10.1038/85487; Hershfinkel M, 2001, P NATL ACAD SCI USA, V98, P11749, DOI 10.1073/pnas.201193398; Hershfinkel M, 2006, MOL BIOL METAL HOMEO; Hershfinkel M, 2007, MOL MED, V13, P331, DOI 10.2119/2006-00038.Hershfinkel; Hofmanova J, 2005, EUR J NUTR, V44, P40, DOI 10.1007/s00394-004-0490-2; Hogstrand C, 2009, TRENDS MOL MED, V15, P101, DOI 10.1016/j.molmed.2009.01.004; Holst B, 2007, ENDOCRINOLOGY, V148, P13, DOI 10.1210/en.2006-0933; John S, 2011, ONCOL REP, V25, P769, DOI 10.3892/or.2010.1124; Joseph J, 2004, ONCOGENE, V23, P6304, DOI 10.1038/sj.onc.1207852; Kaisman-Elbaz T, 2009, J CELL PHYSIOL, V220, P222, DOI 10.1002/jcp.21754; KEEPERS YP, 1991, EUR J CANCER, V27, P897, DOI 10.1016/0277-5379(91)90142-Z; Kim YS, 2007, J NUTR, V137, p2576S, DOI 10.1093/jn/137.11.2576S; Krishnan S, 2003, AM J PHYSIOL-CELL PH, V285, pC1246, DOI 10.1152/ajpcell.00598.2002; Lambert DW, 2002, BRIT J CANCER, V86, P1262, DOI 10.1038/sj.bjc.6600264; Liu JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019638; Mazzarelli P, 2009, ADV CANCER RES, V105, P45, DOI 10.1016/S0065-230X(09)05003-9; Medina V, 1997, CANCER RES, V57, P3697; Moechars D, 2006, GASTROENTEROLOGY, V131, P1131, DOI 10.1053/j.gastro.2006.07.009; Opoka W, 2010, J PHYSIOL PHARMACOL, V61, P581; Pajak B, 2007, ADV MED SCI-POLAND, V52, P83; Pajak Beata, 2006, Postepy Hig Med Dosw (Online), V60, P45; Pal S, 2004, PFLUG ARCH EUR J PHY, V448, P296, DOI 10.1007/s00424-004-1256-7; Park KS, 2003, AM J PHYSIOL-GASTR L, V19, P19; Paroder V, 2006, P NATL ACAD SCI USA, V103, P7270, DOI 10.1073/pnas.0602365103; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Roy MJ, 2009, NUTRITION, V25, P1193, DOI 10.1016/j.nut.2009.04.008; Ruemmele FM, 1999, CELL DEATH DIFFER, V6, P729, DOI 10.1038/sj.cdd.4400545; Scharlau D, 2009, MUTAT RES-REV MUTAT, V682, P39, DOI 10.1016/j.mrrev.2009.04.001; Schultheiss Gerhard, 2002, Biological Procedures Online, V3, P70, DOI 10.1251/bpo25; Sensi SL, 2006, BIOGERONTOLOGY, V7, P367, DOI 10.1007/s10522-006-9051-9; Shannan B, 2006, CELL DEATH DIFFER, V13, P12, DOI 10.1038/sj.cdd.4401779; Sharir H, 2005, BIOCHEM BIOPH RES CO, V332, P845, DOI 10.1016/j.bbrc.2005.05.036; Sharir H, 2010, J BIOL CHEM, V285, P26097, DOI 10.1074/jbc.M110.107490; Tang Y, 2011, AUTOPHAGY, V7, P235, DOI 10.4161/auto.7.2.14277; Tang Y, 2011, INT J CANCER, V128, P847, DOI 10.1002/ijc.25638; Taylor KM, 2008, ENDOCRINOLOGY, V149, P4912, DOI 10.1210/en.2008-0351; Thamilselvan V, 2003, J SURG RES, V110, P255, DOI 10.1016/S0022-4804(03)00028-3; Thangaraju M, 2009, CANCER RES, V69, P2826, DOI 10.1158/0008-5472.CAN-08-4466; Valentine RA, 2007, J BIOL CHEM, V282, P14389, DOI 10.1074/jbc.M701752200; Vidyasagar S, 2002, J PHYSIOL-LONDON, V539, P163, DOI 10.1113/jphysiol.2001.013056; Waldecker M, 2008, J NUTR BIOCHEM, V19, P587, DOI 10.1016/j.jnutbio.2007.08.002; Wilson AJ, 2010, CANCER RES, V70, P609, DOI 10.1158/0008-5472.CAN-09-2327; Xiao M, 2012, EXP CELL RES, V318, P43, DOI 10.1016/j.yexcr.2011.10.006; Yasuda SI, 2007, J RECEPT SIG TRANSD, V27, P235, DOI 10.1080/10799890701506147; Yu DCW, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-276; Zhang Y, 2010, CHEM-BIOL INTERACT, V185, P174, DOI 10.1016/j.cbi.2010.03.035; Zhang Y, 2007, MOL MED, V13, P350, DOI 10.2119/2007-00042.Zhang; Zhong B, 2010, MOL CANCER THER, V9, P1831, DOI 10.1158/1535-7163.MCT-09-0880	68	36	37	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35482	10.1371/journal.pone.0035482	http://dx.doi.org/10.1371/journal.pone.0035482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545109	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343200029
J	Vedin, I; Cederholm, T; Freund-Levi, Y; Basun, H; Garlind, A; Irving, GF; Eriksdotter-Jonhagen, M; Wahlund, LO; Dahlman, I; Palmblad, J				Vedin, Inger; Cederholm, Tommy; Freund-Levi, Yvonne; Basun, Hans; Garlind, Anita; Irving, Gerd Faxen; Eriksdotter-Jonhagen, Maria; Wahlund, Lars-Olof; Dahlman, Ingrid; Palmblad, Jan			Effects of DHA- Rich n-3 Fatty Acid Supplementation on Gene Expression in Blood Mononuclear Leukocytes: The OmegAD Study	PLOS ONE			English	Article							FISH-OIL SUPPLEMENTATION; NF-KAPPA-B; OMEGA-3-FATTY-ACID DOCOSAHEXAENOIC ACID; TUMOR-NECROSIS-FACTOR; CYTOKINE PRODUCTION; ALZHEIMER-DISEASE; SORTING PROTEIN; RECEPTOR; TRANSCRIPTION; RISK	Background: Dietary fish oil, rich in n-3 fatty acids (n-3 FAs), e. g. docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), regulate inflammatory reactions by various mechanisms, e. g. gene activation. However, the effects of long-term treatment with DHA and EPA in humans, using genome wide techniques, are poorly described. Hence, our aim was to determine the effects of 6 mo of dietary supplementation with an n-3 FA preparation rich in DHA on global gene expression in peripheral blood mononuclear cells. Methods and Findings: In the present study, blood samples were obtained from a subgroup of 16 patients originating from the randomized double-blind, placebo-controlled OmegAD study, where 174 Alzheimer disease (AD) patients received daily either 1.7 g of DHA and 0.6 g EPA or placebo for 6 months. In blood samples obtained from 11 patients receiving n-3 FA and five placebo, expressions of approximately 8000 genes were assessed by gene array. Significant changes were confirmed by real-time PCR. At 6 months, the n-3 FAs group displayed significant rises of DHA and EPA plasma concentrations, as well as up-and down-regulation of nine and ten genes, respectively, was noticed. Many of these genes are involved in inflammation regulation and neurodegeneration, e. g. CD63, MAN2A1, CASP4, LOC399491, NAIP, and SORL1 and in ubiqutination processes, e. g. ANAPC5 and UBE2V1. Down-regulations of ANAPC5 and RHOB correlated to increases of plasma DHA and EPA levels. Conclusions: We suggest that 6 months of dietary n-3 FA supplementation	[Vedin, Inger; Dahlman, Ingrid; Palmblad, Jan] Karolinska Inst, Karolinska Univ Hosp, Dept Med, Stockholm, Sweden; [Freund-Levi, Yvonne; Garlind, Anita; Irving, Gerd Faxen; Eriksdotter-Jonhagen, Maria; Wahlund, Lars-Olof] Karolinska Inst, Karolinska Univ Hosp, Dept Neurobiol Caring Sci & Soc, Stockholm, Sweden; [Cederholm, Tommy; Basun, Hans] Univ Uppsala Hosp, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [Basun, Hans] Univ Uppsala Hosp, Div Geriatr, Uppsala, Sweden; [Cederholm, Tommy] Univ Uppsala Hosp, Div Clin Nutr & Metab, Uppsala, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital	Vedin, I (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Dept Med, Stockholm, Sweden.	inger.vedin@ki.se	Eriksdotter, Maria/I-5427-2015	Eriksdotter, Maria/0000-0003-2498-4000; Dahlman, Ingrid/0000-0003-3819-5977; wahlund, lars-olof/0000-0002-9905-8426; Freund-Levi, Yvonne/0000-0001-6863-6679	Swedish Medical Research Council [19X-05991, 71XS-13135]; Swedish Association against Rheumatism; Karolinska Institutet; Huddinge University Hospital; Funds of A Wiberg; Uggla; N Svartz; Vardal; Swedish Cancer Society; Cancer Society of Stockholm; Swedish Alzheimer Foundation; Stockholm County Council; King Gustaf V: s 80-year	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Association against Rheumatism; Karolinska Institutet(Karolinska Institutet); Huddinge University Hospital(Karolinska Institutet); Funds of A Wiberg; Uggla; N Svartz; Vardal; Swedish Cancer Society(Swedish Cancer Society); Cancer Society of Stockholm; Swedish Alzheimer Foundation; Stockholm County Council(Stockholm County Council); King Gustaf V: s 80-year	This study was supported by grants from The Swedish Medical Research Council (19X-05991, 71XS-13135), The Swedish Association against Rheumatism, Karolinska Institutet, Huddinge University Hospital, the Funds of A Wiberg, King Gustaf V: s 80-year, Uggla, N Svartz, Vardal, Swedish Cancer Society, Cancer Society of Stockholm, Swedish Alzheimer Foundation and the Regional Agreement on Medical Training and Clinical Research (ALF) between Stockholm County Council and the Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Barberger-Gateau P, 2002, BRIT MED J, V325, P932, DOI 10.1136/bmj.325.7370.932; Barcelo-Coblijn G, 2003, P NATL ACAD SCI USA, V100, P11321, DOI 10.1073/pnas.1734008100; Berger Alvin, 2002, Lipids Health Dis, V1, P2, DOI 10.1186/1476-511X-1-2; Blok WL, 1997, EUR J CLIN INVEST, V27, P1003, DOI 10.1046/j.1365-2362.1997.2240775.x; BOBERG M, 1985, CLIN SCI, V68, P581, DOI 10.1042/cs0680581; Bouwens M, 2009, AM J CLIN NUTR, V90, P415, DOI 10.3945/ajcn.2009.27680; Calder PC, 2006, PROSTAG LEUKOTR ESS, V75, P197, DOI 10.1016/j.plefa.2006.05.012; Chiarugi A, 2003, J NEUROCHEM, V85, P306, DOI 10.1046/j.1471-4159.2003.01684.x; Christie LA, 2007, NEUROBIOL DIS, V26, P165, DOI 10.1016/j.nbd.2006.12.017; Dahlman I, 2005, AM J CLIN NUTR, V81, P1275; Davidson LA, 2004, CANCER RES, V64, P6797, DOI 10.1158/0008-5472.CAN-04-1068; de Urquiza AM, 2000, SCIENCE, V290, P2140, DOI 10.1126/science.290.5499.2140; ENDRES S, 1989, NEW ENGL J MED, V320, P265, DOI 10.1056/NEJM198902023200501; Farzaneh-Far R, 2010, JAMA-J AM MED ASSOC, V303, P250, DOI 10.1001/jama.2009.2008; Freund-Levi Y, 2006, ARCH NEUROL-CHICAGO, V63, P1402, DOI 10.1001/archneur.63.10.1402; Gorjao R, 2006, CLIN NUTR, V25, P923, DOI 10.1016/j.clnu.2006.03.004; Hart D, 2008, J IMMUNOL, V181, P8053, DOI 10.4049/jimmunol.181.11.8053; Hernandez D, 2002, NEPHROL DIAL TRANSPL, V17, P897, DOI 10.1093/ndt/17.5.897; Infante J, 2007, DEMENT GERIATR COGN, V23, P215, DOI 10.1159/000099471; Jacobson TA, 2006, AM J CARDIOL, V98, p61I, DOI 10.1016/j.amjcard.2005.12.028; Jakobsen CH, 2008, J LIPID RES, V49, P2089, DOI 10.1194/jlr.M700389-JLR200; Kaleem M, 2007, NEURODEGENER DIS, V4, P376, DOI 10.1159/000105158; Kew S, 2004, AM J CLIN NUTR, V79, P674; Kitajka K, 2002, P NATL ACAD SCI USA, V99, P2619, DOI 10.1073/pnas.042698699; Kothapalli KSD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000370; Lakshmanan U, 2007, J IMMUNOL, V179, P8480, DOI 10.4049/jimmunol.179.12.8480; Ma QL, 2007, J NEUROSCI, V27, P14299, DOI 10.1523/JNEUROSCI.3593-07.2007; MEYDANI SN, 1993, J CLIN INVEST, V92, P105, DOI 10.1172/JCI116537; Mori Trevor A, 2004, Curr Atheroscler Rep, V6, P461, DOI 10.1007/s11883-004-0087-5; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P940, DOI 10.1001/archneur.60.7.940; Mutch DM, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-17; Narayanan BA, 2003, CANCER RES, V63, P972; Narayanan BA, 2001, INT J ONCOL, V19, P1255; Perez SE, 2010, J NEUROSCI RES, V88, P1026, DOI 10.1002/jnr.22266; Puskas LG, 2003, P NATL ACAD SCI USA, V100, P1580, DOI 10.1073/pnas.0337683100; Rodriguez PL, 2007, CELL SIGNAL, V19, P2361, DOI 10.1016/j.cellsig.2007.07.021; Rojas CV, 2003, INVEST OPHTH VIS SCI, V44, P3170, DOI 10.1167/iovs.02-1138; Schaefer EJ, 2006, ARCH NEUROL-CHICAGO, V63, P1545, DOI 10.1001/archneur.63.11.1545; Scherzer CR, 2004, ARCH NEUROL-CHICAGO, V61, P1200, DOI 10.1001/archneur.61.8.1200; Simopoulos AP, 2002, J AM COLL NUTR, V21, P495, DOI 10.1080/07315724.2002.10719248; Trebble T, 2003, BRIT J NUTR, V90, P405, DOI 10.1079/BJN2003892; Trottestam H, 2008, PEDIAT BLOOD CANC; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vedin I, 2004, FASEB J, V18, pA501; Vedin I, 2008, AM J CLIN NUTR, V87, P1616, DOI 10.1093/ajcn/87.6.1616; Verlengia R, 2004, J NUTR BIOCHEM, V15, P657, DOI 10.1016/j.jnutbio.2004.04.008; Verlengia R, 2004, LIPIDS, V39, P857, DOI 10.1007/s11745-004-1307-2; Yukioka F, 2008, NEUROCHEM INT, V52, P683, DOI 10.1016/j.neuint.2007.08.017; Zhao GX, 2005, BIOCHEM BIOPH RES CO, V336, P909, DOI 10.1016/j.bbrc.2005.08.204	50	62	62	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35425	10.1371/journal.pone.0035425	http://dx.doi.org/10.1371/journal.pone.0035425			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545106	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343200027
J	Zwingenberger, AL; Kent, MS; Liu, RW; Kukis, DL; Wisner, ER; DeNardo, SJ; Taylor, SL; Chen, XC; Lam, KS				Zwingenberger, Allison L.; Kent, Michael S.; Liu, Ruiwu; Kukis, David L.; Wisner, Erik R.; DeNardo, Sally J.; Taylor, Sandra L.; Chen, Xiucui; Lam, Kit S.			In-Vivo Biodistribution and Safety of Tc-99m-LLP2A-HYNIC in Canine Non-Hodgkin Lymphoma	PLOS ONE			English	Article							B-CELL LYMPHOMA; CANCER-THERAPY; RADIOIMMUNOTHERAPY; DOSIMETRY; INTEGRIN; PHARMACOKINETICS; TOSITUMOMAB; EXPRESSION; PEPTIDE	Theranostic agents are critical for improving the diagnosis and treatment of non-Hodgkin Lymphoma (NHL). The peptidomimetic LLP2A is a novel peptide receptor radiotherapy candidate for treating NHL that expresses the activated alpha 4 beta 1 integrin. Tumor-bearing dogs are an excellent model of human NHL with similar clinical characteristics, behavior, and compressed clinical course. Canine in vivo imaging studies will provide valuable biodistribution and affinity information that reflects a diverse clinical population of lymphoma. This may also help to determine potential dose-limiting radiotoxicity to organs in human clinical trials. To validate this construct in a naturally occurring model of NHL, we performed in-vivo molecular targeted imaging and biodistribution in 3 normal dogs and 5 NHL bearing dogs. Tc-99m-LLP2A-HYNIC-PEG and Tc-99m-LLP2A-HYNIC were successfully synthesized and had very good labeling efficiency and radiochemical purity. Tc-99m-LLP2A-HYNIC and Tc-99m-LLP2A-HYNIC-PEG had biodistribution in keeping with their molecular size, with Tc-99m-LLP2A-HYNIC-PEG remaining longer in the circulation, having higher tissue uptake, and having more activity in the liver compared to Tc-99m-LLP2A-HYNIC. Tc-99m-LLP2A-HYNIC was mainly eliminated through the kidneys with some residual activity. Radioactivity was reduced to near-background levels at 6 hours after injection. In NHL dogs, tumor showed moderately increased activity over background, with tumor activity in B-cell lymphoma dogs decreasing after chemotherapy. This compound is promising in the development of targeted drug-delivery radiopharmaceuticals and may contribute to translational work in people affected by non-Hodgkin lymphoma.	[Zwingenberger, Allison L.; Kent, Michael S.; Wisner, Erik R.] Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA; [Liu, Ruiwu; Lam, Kit S.] Univ Calif Davis, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Kukis, David L.] Univ Calif Davis, Ctr Mol & Genome Imaging, Davis, CA 95616 USA; [DeNardo, Sally J.; Lam, Kit S.] Univ Calif Davis, Med Ctr, Dept Internal Med, Div Hematol Oncol, Sacramento, CA 95817 USA; [Taylor, Sandra L.; Chen, Xiucui] Univ Calif Davis, Sch Med, Clin & Translat Sci Ctr, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Zwingenberger, AL (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA.	azwingen@ucdavis.edu		Taylor, Sandra/0000-0001-7811-812X; Kent, Michael/0000-0002-7703-7720	National Co-operative Drug Discovery Group [U19CA113298]; NATIONAL CANCER INSTITUTE [U19CA113298, P30CA093373] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024146] Funding Source: NIH RePORTER	National Co-operative Drug Discovery Group; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding was supplied by National Co-operative Drug Discovery Group grant U19CA113298 (http://dtp.nci.nih.gov/branches/gcob/gcob_web3.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennink RJ, 2008, J NUCL MED, V49, P1380, DOI 10.2967/jnumed.108.051755; Berry CR, 2006, TXB VET NUCL MED; Blanco E, 2009, EXP BIOL MED, V234, P123, DOI 10.3181/0808-MR-250; Brannon-Peppas L, 2004, ADV DRUG DELIVER REV, V56, P1649, DOI 10.1016/j.addr.2004.02.014; Davies AJ, 2007, ONCOGENE, V26, P3614, DOI 10.1038/sj.onc.1210378; DeNardo SJ, 2009, J NUCL MED, V50, P625, DOI 10.2967/jnumed.108.056903; DENARDO SJ, 1991, NUCL MED BIOL, V18, P621, DOI 10.1016/0883-2897(91)90032-G; DeNardo SJ, 2003, CLIN CANCER RES, V9, p3854S; Denardo SJ, 2009, J NUCL MED; Dillman RO, 2006, CLIN EXP MED, V6, P1, DOI 10.1007/s10238-006-0087-6; Drillenburg P, 2000, BLOOD, V95, P1900, DOI 10.1182/blood.V95.6.1900; Erwin WD, 1996, NUCL MED BIOL, V23, P525, DOI 10.1016/0969-8051(96)00036-4; Finn WG, 2001, HUM PATHOL, V32, P66, DOI 10.1053/hupa.2001.20891; Hamidi M, 2006, DRUG DELIV, V13, P399, DOI 10.1080/10717540600814402; Holzmann B, 1998, CURR TOP MICROBIOL, V231, P125; Jaspars LH, 1996, J PATHOL, V178, P36, DOI 10.1002/(SICI)1096-9896(199601)178:1<36::AID-PATH426>3.0.CO;2-S; Padilla L, 2008, J NUCL MED, V49, P446, DOI 10.2967/jnumed.107.046722; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; Peng L, 2008, MOL CANCER THER, V7, P432, DOI 10.1158/1535-7163.MCT-07-0575; Peng L, 2006, NAT CHEM BIOL, V2, P381, DOI 10.1038/nchembio798; Reubi JC, 2005, J NUCL MED, V46, p67S; Vail DM, 2000, CANCER INVEST, V18, P781, DOI 10.3109/07357900009012210; Wahl RL, 2003, SEMIN ONCOL, V30, P31, DOI 10.1053/sonc.2003.23799; Williams LE, 2008, MED PHYS, V35, P3062, DOI 10.1118/1.2938520; Zwingenberger AL, 2011, VET IMMUNOLOGY UNPUB	25	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e34404	10.1371/journal.pone.0034404	http://dx.doi.org/10.1371/journal.pone.0034404			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545083	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343200006
J	Cornejo-Juarez, P; Perez-Jimenez, C; Silva-Sanchez, J; Velazquez-Acosta, C; Gonzalez-Lara, F; Reyna-Flores, F; Sanchez-Perez, A; Volkow-Fernandez, P				Cornejo-Juarez, Patricia; Perez-Jimenez, Carolina; Silva-Sanchez, Jesus; Velazquez-Acosta, Consuelo; Gonzalez-Lara, Fernanda; Reyna-Flores, Fernando; Sanchez-Perez, Alejandro; Volkow-Fernandez, Patricia			Molecular Analysis and Risk Factors for Escherichia coli Producing Extended-Spectrum beta-Lactamase Bloodstream Infection in Hematological Malignancies	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE; NOSOCOMIAL INFECTIONS; EPIDEMIOLOGY; ESBL; ENTEROBACTERIACEAE; BACTEREMIA; RESISTANCE; OUTCOMES; IMPACT; DNA	Introduction: Patients with hematologic malignancies have greater risk-factors for primary bloodstream infections (BSI). Methods: From 2004-2009, we analyzed bacteremia caused by extended-spectrum beta-lactamase Escherichia coli (ESBL-EC) (n = 100) and we compared with bacteremia caused by cephalosporin-susceptible E. coli (n = 100) in patients with hematologic malignancies. Objective: To assess the clinical features, risk factors, and outcome of ESBL-EC BSI in patients with hematologic malignancies, and to study the molecular epidemiology of ESBL-EC isolates. Results: The main diagnosis was acute leukemia in 115 patients (57.5%). Death-related E. coli infection was significantly increased with ESBL-EC (34% vs. control group, 19%; p = 0.03). Treatment for BSI was considered appropriate in 64 patients with ESBL-EC (mean survival, 245 +/- 345 days), and in 45 control patients this was 443 +/- 613 (p = 0.03). In patients not receiving appropriate antimicrobial treatment, survival was significantly decreased in cases compared with controls (26 +/- 122 vs. 276 +/- 442; p = 0.001). Fifty six of the ESBL-EC isolates were characterized by molecular analysis: 47 (84%) expressed CTX-M-15, two (3.6%) SHV, and seven (12.5%) did not correspond to either of these two ESBL enzymes. No TLA-1 enzyme was detected. Conclusions: Patients who had been previously hospitalized and who received cephalosporins during the previous month, have an increased risk of ESBL-EC bacteremia. Mortality was significantly increased in patients with ESBL-EC BSI. A polyclonal trend was detected, which reflects non-cross transmission of multiresistant E. coli isolates.	[Cornejo-Juarez, Patricia; Perez-Jimenez, Carolina; Velazquez-Acosta, Consuelo; Gonzalez-Lara, Fernanda; Volkow-Fernandez, Patricia] Secretaria Salud Ssa, Inst Nacl Cancerol INCan, Dept Infect Dis, Mexico City, DF, Mexico; [Silva-Sanchez, Jesus; Reyna-Flores, Fernando; Sanchez-Perez, Alejandro] Ssa, CISEI, INSP, Dept Epidemiol Diag, Cuernavaca, Morelos, Mexico	Instituto Nacional de Cancerologia (INCAN)	Cornejo-Juarez, P (corresponding author), Secretaria Salud Ssa, Inst Nacl Cancerol INCan, Dept Infect Dis, Mexico City, DF, Mexico.	patcornejo@yahoo.com		Perez-Jimenez, Carolina/0000-0002-0212-9436; Silva-Sanchez, Jesus/0000-0002-6580-2990	CONACYT (Consejo Nacional de Ciencia y Tecnologia) [SALUD-2003-C01-009]	CONACYT (Consejo Nacional de Ciencia y Tecnologia)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This project had partial support from CONACYT (Consejo Nacional de Ciencia y Tecnologia) SALUD-2003-C01-009 for molecular characterization of ESBL-EC producers. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpaka PE, 2010, W INDIAN MED J, V59, P591; Blot F, 2000, SUPPORT CARE CANCER, V8, P287, DOI 10.1007/s005200000150; Chen CY, 2010, EPIDEMIOL INFECT, V138, P1044, DOI 10.1017/S0950268809991208; Chong Y, 2010, INT J INFECT DIS, V14, pE171, DOI 10.1016/j.ijid.2010.01.004; *CLIN LAB STAND I, 2006, PERF STAND ANT SUSC; Coque T M, 2008, Euro Surveill, V13; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Garza-Gonzalez E, 2011, J MED MICROBIOL, V60, P84, DOI 10.1099/jmm.0.022970-0; Garza-Ramos U, 2007, SALUD PUBLICA MEXICO, V49, P415, DOI 10.1590/S0036-36342007000600008; Gudiol C, 2010, J ANTIMICROB CHEMOTH, V65, P333, DOI 10.1093/jac/dkp411; Hu BJ, 2010, CURR MED RES OPIN, V26, P1443, DOI 10.1185/03007991003769068; Hyle EP, 2005, ARCH INTERN MED, V165, P1375, DOI 10.1001/archinte.165.12.1375; Kaufmann ME, 1988, METHODS MOL MED, V15, P17; KIESER T, 1984, PLASMID, V12, P19, DOI 10.1016/0147-619X(84)90063-5; Lautenbach E, 2001, CLIN INFECT DIS, V32, P1162, DOI 10.1086/319757; Miranda G, 2004, J CLIN MICROBIOL, V42, P30, DOI 10.1128/JCM.42.1.30-35.2004; Mosqueda-Gomez JL, 2008, INT J INFECT DIS, V12, P653, DOI 10.1016/j.ijid.2008.03.008; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Pena C, 2008, J HOSP INFECT, V68, P116, DOI 10.1016/j.jhin.2007.11.012; Pena C, 2006, CLIN MICROBIOL INFEC, V12, P279, DOI 10.1111/j.1469-0691.2005.01358.x; Perez F, 2007, CURR OPIN PHARMACOL, V7, P459, DOI 10.1016/j.coph.2007.08.003; Ramphal R, 2006, CLIN INFECT DIS, V42, pS164, DOI 10.1086/500663; Rodriguez-Bano J, 2008, CLIN MICROBIOL INFEC, V14, P180, DOI 10.1111/j.1469-0691.2007.01884.x; Silva J, 2001, J CLIN MICROBIOL, V39, P3193, DOI 10.1128/JCM.39.9.3193-3196.2001; Silva-Sanchez J, 2011, ARCH MED RES, V42, P156, DOI 10.1016/j.arcmed.2011.02.004; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Trecarichi EM, 2009, J INFECTION, V58, P299, DOI 10.1016/j.jinf.2009.02.002; Valverde A, 2004, J CLIN MICROBIOL, V42, P4769, DOI 10.1128/JCM.42.10.4769-4775.2004; Wang FD, 2005, CHEMOTHERAPY, V51, P147, DOI 10.1159/000085623; Wu UI, 2011, EUR J CLIN MICROBIOL, V30, P33, DOI 10.1007/s10096-010-1048-2; Yu Wen-Liang, 2006, Journal of Microbiology Immunology and Infection, V39, P264	31	41	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35780	10.1371/journal.pone.0035780	http://dx.doi.org/10.1371/journal.pone.0035780			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22540004	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341000070
J	Su, Y; Yang, WB; Li, S; Ye, ZJ; Shi, HZ; Zhou, Q				Su, Yuan; Yang, Wei-Bing; Li, Shi; Ye, Zhi-Jian; Shi, Huan-Zhong; Zhou, Qiong			Effect of Angiogenesis Inhibitor Bevacizumab on Survival in Patients with Cancer: A Meta-Analysis of the Published Literature	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; CELL-LUNG-CANCER; PHASE-III TRIAL; COOPERATIVE-ONCOLOGY-GROUP; GROWTH-FACTOR ANTIBODY; LEUKEMIA GROUP-B; 1ST-LINE TREATMENT; DOUBLE-BLIND; PLUS BEVACIZUMAB; INTERFERON-ALPHA	Bevacizumab is a recombinant humanized monoclonal antibody against vascular endothelial growth factor which has been used in conjunction with other anti-cancer agents in the treatment of patients with many cancers. It remains controversial whether bevacizumab can prolong survival in cancer patients. This meta-analysis was therefore performed to evaluate effect of bevacizumab on survival in cancer patients. PubMed, EMBASE, and Web of Science databases were searched for English-language studies of randomized controlled trials comparing bevacizumab with control therapy published through February 8, 2012. Progression-free survival, overall survival, and one-year survival rate were analyzed using random- or fixed-effects model. Thirty one assessable randomized controlled trials were identified. A significant improvement in progression-free survival in cancer patients was attributable to bevacizumab compared with control therapy (hazard ratio, 0.72; 95% confidence interval, 0.68 to 0.76; p<0.001). Overall survival was also significantly longer in patients were treated with bevacizumab (hazard ratio, 0.87; 95% confidence interval, 0.83 to 0.91; p<0.001). The significant benefit in one-year survival rate was further seen in cancer patients receiving bevacizumab (odds ratio, 1.30; 95% confidence interval, 1.20 to 1.41; p<0.001). Current evidences showed that bevacizumab prolong progression-free survival and overall survival, and increase one-year survival rate in cancer patients as compared with control therapy.	[Su, Yuan; Yang, Wei-Bing; Li, Shi; Ye, Zhi-Jian; Shi, Huan-Zhong; Zhou, Qiong] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Key Lab Pulm Dis,Hlth Minist,Dept Resp Dis, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Su, Y (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Key Lab Pulm Dis,Hlth Minist,Dept Resp Dis, Wuhan 430074, Peoples R China.	shihuanzhong@sina.com; zhouqiongtj@126.com			National Science Fund for Distinguished Young Scholars [30925032]; Natural Science Foundation of Hubei Province, China [QJX2010-7]; Health Department of Hubei Province [2009cdb399]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Natural Science Foundation of Hubei Province, China(Natural Science Foundation of Hubei Province); Health Department of Hubei Province	This study was supported by a grant from National Science Fund for Distinguished Young Scholars (No. 30925032), and from Natural Science Foundation of Hubei Province, China (No. QJX2010-7), and from Health Department of Hubei Province (No. 2009cdb399). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra CJ, 2009, J CLIN ONCOL, V27, P3385, DOI 10.1200/JCO.2009.21.9220; Blumenschein GR, 2011, ANN ONCOL, V22, P2057, DOI 10.1093/annonc/mdq731; Brahmer JR, 2011, J THORAC ONCOL, V6, P103, DOI 10.1097/JTO.0b013e3181fa8efd; Brufsky AM, 2011, J CLIN ONCOL, V29, P4286, DOI 10.1200/JCO.2010.34.1255; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; Chang GC, 2011, ASIA-PAC J CLIN ONCO, V7, P34, DOI 10.1111/j.1743-7563.2011.01400.x; Chang JWC, 2011, ASIA-PAC J CLIN ONCO, V7, P13, DOI 10.1111/j.1743-7563.2011.01398.x; Clarke MJ., 2001, SYSTEMATIC REV HLTH, P109; Cortes J, 2011, ANN ONCOL       1004; Di Lorenzo G, 2008, EUR UROL, V54, P1089, DOI 10.1016/j.eururo.2008.01.082; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Escudier B, 2010, J CLIN ONCOL, V28, P2144, DOI 10.1200/JCO.2009.26.7849; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; Gerber HP, 2005, CANCER RES, V65, P671; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Gray R, 2009, J CLIN ONCOL, V27, P4966, DOI 10.1200/JCO.2008.21.6630; Gressett SM, 2009, ANN PHARMACOTHER, V43, P490, DOI 10.1345/aph.1L426; Grignol VP, 2011, J IMMUNOTHER, V34, P509, DOI 10.1097/CJI.0b013e31821dcefd; Hapani S, 2009, LANCET ONCOL, V10, P559, DOI 10.1016/S1470-2045(09)70112-3; Hecht JR, 2009, J CLIN ONCOL, V27, P672, DOI 10.1200/JCO.2008.19.8135; Herbst RS, 2007, J CLIN ONCOL, V25, P4743, DOI 10.1200/JCO.2007.12.3026; Herbst RS, 2011, LANCET, V377, P1846, DOI 10.1016/S0140-6736(11)60545-X; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hochster HS, 2008, J CLIN ONCOL, V26, P3523, DOI 10.1200/JCO.2007.15.4138; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Hurwitz HI, 2009, ONCOLOGIST, V14, P22, DOI 10.1634/theoncologist.2008-0213; Hurwitz HI, 2005, J CLIN ONCOL, V23, P3502, DOI 10.1200/JCO.2005.10.017; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jiang J, 2009, LUNG CANCER, V65, P214, DOI 10.1016/j.lungcan.2008.11.011; Johnson DH, 2004, J CLIN ONCOL, V22, P2184, DOI 10.1200/JCO.2004.11.022; Jubb AM, 2006, J CLIN ONCOL, V24, P217, DOI 10.1200/JCO.2005.01.5388; Kabbinavar F, 2003, J CLIN ONCOL, V21, P60, DOI 10.1200/JCO.2003.10.066; Kabbinavar FF, 2008, ONCOLOGIST, V13, P1021, DOI 10.1634/theoncologist.2008-0003; Kabbinavar FF, 2005, J CLIN ONCOL, V23, P3697, DOI 10.1200/JCO.2005.05.112; Kabbinavar FF, 2005, J CLIN ONCOL, V23, P3706, DOI 10.1200/JCO.2005.00.232; Kemeny NE, 2011, ONCOLOGY-BASEL, V80, P153, DOI 10.1159/000324704; Kemeny NE, 2011, J CLIN ONCOL, V29, P884, DOI 10.1200/JCO.2010.32.5977; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kindler HL, 2010, J CLIN ONCOL, V28, P3617, DOI 10.1200/JCO.2010.28.1386; Kreisl TN, 2011, NEURO-ONCOLOGY, V13, P1143, DOI 10.1093/neuonc/nor091; Levin VA, 2011, INT J RADIAT ONCOL, V79, P1487, DOI 10.1016/j.ijrobp.2009.12.061; Martin M, 2011, LANCET ONCOL, V12, P369, DOI 10.1016/S1470-2045(11)70037-7; McGonigle KF, 2011, CANCER-AM CANCER SOC, V117, P3731, DOI 10.1002/cncr.25967; Melichar B, 2008, ANN ONCOL, V19, P1470, DOI 10.1093/annonc/mdn161; Miles DW, 2010, J CLIN ONCOL, V28, P3239, DOI 10.1200/JCO.2008.21.6457; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Miller KD, 2005, J CLIN ONCOL, V23, P792, DOI 10.1200/JCO.2005.05.098; Moehler M, 2009, WORLD J GASTROENTERO, V15, P449, DOI 10.3748/wjg.15.449; Mok TSK, 2011, ASIA-PAC J CLIN ONCO, V7, P4, DOI 10.1111/j.1743-7563.2011.01397.x; Moroney JW, 2011, CLIN CANCER RES, V17, P6840, DOI 10.1158/1078-0432.CCR-11-0666; Nalluri SR, 2008, JAMA-J AM MED ASSOC, V300, P2277, DOI 10.1001/jama.2008.656; Negrier S, 2011, LANCET ONCOL, V12, P673, DOI 10.1016/S1470-2045(11)70124-3; Ning YM, 2010, J CLIN ONCOL, V28, P2070, DOI 10.1200/JCO.2009.25.4524; Ohtsu A, 2011, J CLIN ONCOL, V29, P3968, DOI 10.1200/JCO.2011.36.2236; Okines A, 2009, BRIT J CANCER, V101, P1033, DOI 10.1038/sj.bjc.6605259; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Picus J, 2011, CANCER-AM CANCER SOC, V117, P526, DOI 10.1002/cncr.25421; Pivot X, 2011, EUR J CANCER, V47, P2387, DOI 10.1016/j.ejca.2011.06.018; Pope WB, 2011, AM J NEURORADIOL, V32, P882, DOI 10.3174/ajnr.A2385; Price Nancy, 2004, Clin Colorectal Cancer, V4, P89; Price TJ, 2011, J CLIN ONCOL, V29, P2675, DOI 10.1200/JCO.2010.34.5520; Ramalingam SS, 2008, J CLIN ONCOL, V26, P60, DOI 10.1200/JCO.2007.13.1144; Ranpura V, 2011, JAMA-J AM MED ASSOC, V305, P487, DOI 10.1001/jama.2011.51; Ranpura V, 2010, AM J HYPERTENS, V23, P460, DOI 10.1038/ajh.2010.25; Rastogi P, 2011, CLIN BREAST CANCER, V11, P228, DOI 10.1016/j.clbc.2011.04.001; Reardon DA, 2011, CANCER-AM CANCER SOC, V117, P5351, DOI 10.1002/cncr.26188; Reardon DA, 2011, J NEURO-ONCOL, V103, P371, DOI 10.1007/s11060-010-0403-6; Reck M, 2009, J CLIN ONCOL, V27, P1227, DOI 10.1200/JCO.2007.14.5466; Rini BI, 2004, CLIN CANCER RES, V10, P2584, DOI 10.1158/1078-0432.CCR-03-0605; Rini BI, 2010, J CLIN ONCOL, V28, P2137, DOI 10.1200/JCO.2009.26.5561; Rini BI, 2008, J CLIN ONCOL, V26, P5422, DOI 10.1200/JCO.2008.16.9847; Robert NJ, 2011, J CLIN ONCOL, V29, P1252, DOI 10.1200/JCO.2010.28.0982; Robertson JD, 2009, CLIN COLORECTAL CANC, V8, P59, DOI 10.3816/CCC.2009.n.010; Salama JK, 2011, ANN ONCOL, V22, P2304, DOI 10.1093/annonc/mdq736; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Scappaticci FA, 2007, JNCI-J NATL CANCER I, V99, P1232, DOI 10.1093/jnci/djm086; Sehgal R, 2011, CLIN COLORECTAL CANC, V10, P117, DOI 10.1016/j.clcc.2011.03.008; Shih T, 2006, CLIN THER, V28, P1779, DOI 10.1016/j.clinthera.2006.11.015; Soria JC, 2011, J CLIN ONCOL, V29, P4442, DOI 10.1200/JCO.2011.37.2623; Spigel DR, 2011, J CLIN ONCOL, V29, P2215, DOI 10.1200/JCO.2010.29.3423; Stathopoulos GP, 2010, ONCOLOGY-BASEL, V78, P376, DOI 10.1159/000320520; Stein WD, 2008, ONCOLOGIST, V13, P1055, DOI 10.1634/theoncologist.2008-0016; Tebbutt NC, 2010, J CLIN ONCOL, V28, P3191, DOI 10.1200/JCO.2009.27.7723; Tol J, 2009, NEW ENGL J MED, V360, P563, DOI 10.1056/NEJMoa0808268; Van Cutsem E, 2009, J CLIN ONCOL, V27, P2231, DOI 10.1200/JCO.2008.20.0238; Van Meter MEM, 2010, CURR OPIN ONCOL, V22, P586, DOI 10.1097/CCO.0b013e32833edc0c; Varker KA, 2007, ANN SURG ONCOL, V14, P2367, DOI 10.1245/s10434-007-9389-5; Vredenburgh JJ, 2011, CLIN CANCER RES, V17, P4119, DOI 10.1158/1078-0432.CCR-11-0120; Wong NS, 2011, CLIN COLORECTAL CANC, V10, P210, DOI 10.1016/j.clcc.2011.03.018; Wu SH, 2010, J AM SOC NEPHROL, V21, P1381, DOI 10.1681/ASN.2010020167; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491; Yardley DA, 2011, CLIN BREAST CANCER, V11, P297, DOI 10.1016/j.clbc.2011.04.002; Zhi JG, 2011, CANCER CHEMOTH PHARM, V68, P1199, DOI 10.1007/s00280-011-1606-z	97	19	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35629	10.1371/journal.pone.0035629	http://dx.doi.org/10.1371/journal.pone.0035629			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539986	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341000052
J	Harding, G; Harris, JM; Bloj, M				Harding, Glen; Harris, Julie M.; Bloj, Marina			Learning to Use Illumination Gradients as an Unambiguous Cue to Three Dimensional Shape	PLOS ONE			English	Article							SURFACE CURVATURE; COLOR-PERCEPTION; VISUAL SLANT; LOCAL SHAPE; DEPTH; STIMULUS; PERSPECTIVE; INTEGRATION; TEXTURE; LIGHT	The luminance and colour gradients across an image are the result of complex interactions between object shape, material and illumination. Using such variations to infer object shape or surface colour is therefore a difficult problem for the visual system. We know that changes to the shape of an object can affect its perceived colour, and that shading gradients confer a sense of shape. Here we investigate if the visual system is able to effectively utilise these gradients as a cue to shape perception, even when additional cues are not available. We tested shape perception of a folded card object that contained illumination gradients in the form of shading and more subtle effects such as inter-reflections. Our results suggest that observers are able to use the gradients to make consistent shape judgements. In order to do this, observers must be given the opportunity to learn suitable assumptions about the lighting and scene. Using a variety of different training conditions, we demonstrate that learning can occur quickly and requires only coarse information. We also establish that learning does not deliver a trivial mapping between gradient and shape; rather learning leads to the acquisition of assumptions about lighting and scene parameters that subsequently allow for gradients to be used as a shape cue. The perceived shape is shown to be consistent for convex and concave versions of the object that exhibit very different shading, and also similar to that delivered by outline, a largely unrelated cue to shape. Overall our results indicate that, although gradients are less reliable than some other cues, the relationship between gradients and shape can be quickly assessed and the gradients therefore used effectively as a visual shape cue.	[Harding, Glen; Bloj, Marina] Univ Bradford, Bradford Sch Optometry & Vis Sci, Bradford BD7 1DP, W Yorkshire, England; [Harris, Julie M.] Univ St Andrews, Sch Psychol, Vis Lab, St Andrews, Fife, Scotland	University of Bradford; University of St Andrews	Harding, G (corresponding author), Univ Bradford, Bradford Sch Optometry & Vis Sci, Bradford BD7 1DP, W Yorkshire, England.	m.bloj@bradford.ac.uk		Harris, Julie/0000-0002-3497-4503; Bloj, Marina/0000-0001-9251-0750	EPSRC (Engineering and Physical Sciences Research Council - UK) [EP/G038597/1, EP/G038708/1]; Engineering and Physical Sciences Research Council [EP/G038597/1, EP/G038708/1] Funding Source: researchfish; EPSRC [EP/G038708/1, EP/G038597/1] Funding Source: UKRI	EPSRC (Engineering and Physical Sciences Research Council - UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The research was funded by the EPSRC (Engineering and Physical Sciences Research Council - UK) via grant EP/G038597/1 to MB and grant EP/G038708/1 to JMH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WJ, 2007, J VISION, V7, DOI 10.1167/7.11.11; Adams WJ, 2004, J VISION, V4, P921, DOI 10.1167/4.10.7; Ames A, 1951, PSYCHOL MONOGR, V67, P324; Belhumeur PN, 1999, INT J COMPUT VISION, V35, P33, DOI 10.1023/A:1008154927611; Bloj M, 2004, J VISION, V4, P735, DOI 10.1167/4.9.6; Bloj MG, 1999, NATURE, V402, P877, DOI 10.1038/47245; Boyaci H, 2003, J VISION, V3, P541, DOI 10.1167/3.8.2; Boyaci H, 2006, VISUAL NEUROSCI, V23, P311, DOI 10.1017/S0952523806233431; Brainard D. H., 1996, HUMAN COLOR VISION; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brewster D., 1826, EDINBURGH J SCI, V4, P99; BULTHOFF HH, 1988, J OPT SOC AM A, V5, P1749, DOI 10.1364/JOSAA.5.001749; CHAPARRO A, 1993, NATURE, V361, P348, DOI 10.1038/361348a0; Clark WC, 1955, CAN J PSYCHOLOGY, V9, P247, DOI 10.1037/h0083643; CURRAN W, 1994, VISION RES, V34, P1863, DOI 10.1016/0042-6989(94)90310-7; ERENS RGF, 1993, PERCEPT PSYCHOPHYS, V54, P145, DOI 10.3758/BF03211750; ERENS RGF, 1993, PERCEPT PSYCHOPHYS, V54, P334, DOI 10.3758/BF03205268; FORSYTH D, 1990, IMAGE VISION COMPUT, V8, P42, DOI 10.1016/0262-8856(90)90055-A; FREEMAN RB, 1966, J EXP PSYCHOL, V71, P170, DOI 10.1037/h0022816; Gerhard HE, 2010, J VISION, V10, DOI 10.1167/10.9.1; Giesel M, 2010, J VISION, V10, DOI 10.1167/10.9.10; Harding G, 2012, VIS SCI SOC IN PRESS; Hillis JM, 2004, J VISION, V4, P967, DOI 10.1167/4.12.1; Horn Berthold K. P., 1975, PSYCHOL COMPUTER VIS, P115; KLEFFNER DA, 1992, PERCEPT PSYCHOPHYS, V52, P18, DOI 10.3758/BF03206757; KNILL DC, 1991, NATURE, V351, P228, DOI 10.1038/351228a0; KOENDERINK JJ, 1980, OPT ACTA, V27, P981, DOI 10.1080/713820338; LANGER MS, 1994, J OPT SOC AM A, V11, P467, DOI 10.1364/JOSAA.11.000467; Lovell PG, 2012, J VISION, V12, DOI 10.1167/12.1.1; Mach E., 1886, ANAL SENSATIONS; Maloney LT, 2002, J VISION, V2, DOI 10.1167/2.6.6; Mamassian P, 2001, COGNITION, V81, pB1, DOI 10.1016/S0010-0277(01)00116-0; MINGOLLA E, 1986, BIOL CYBERN, V53, P137, DOI 10.1007/BF00342882; MITCHISON GJ, 1984, VISION RES, V24, P1063, DOI 10.1016/0042-6989(84)90084-1; NAYAR SK, 1991, INT J COMPUT VISION, V6, P173, DOI 10.1007/BF00115695; Nefs HT, 2006, ACTA PSYCHOL, V121, P297, DOI 10.1016/j.actpsy.2005.08.001; OLSON RK, 1974, PERCEPT PSYCHOPHYS, V15, P509, DOI 10.3758/BF03199293; Pentland A., 1988, Second International Conference on Computer Vision (IEEE Cat. No.88CH2664-1), P404, DOI 10.1109/CCV.1988.590017; PENTLAND AP, 1984, IEEE T PATTERN ANAL, V6, P170, DOI 10.1109/TPAMI.1984.4767501; PERRONE JA, 1982, PERCEPTION, V11, P641, DOI 10.1068/p110641; RAMACHANDRAN VS, 1988, NATURE, V331, P163, DOI 10.1038/331163a0; Ruppertsberg AI, 2008, BEHAV RES METHODS, V40, P304, DOI 10.3758/BRM.40.1.304; Ruppertsberg AI, 2008, J VISION, V8, DOI 10.1167/8.9.3; Saunders JA, 2006, J VISION, V6, P933, DOI 10.1167/6.9.7; SCHWARTZ BJ, 1983, B PSYCHONOMIC SOC, V21, P456, DOI 10.3758/BF03330007; SMITH AH, 1967, PERCEPT MOTOR SKILL, V24, P167, DOI 10.2466/pms.1967.24.1.167; STEVENS KA, 1981, ARTIF INTELL, V17, P47, DOI 10.1016/0004-3702(81)90020-5; STEVENS KA, 1987, BIOL CYBERN, V56, P355, DOI 10.1007/BF00319515; Sun J, 1998, NAT NEUROSCI, V1, P183, DOI 10.1038/630; Todd JT, 2005, VISION RES, V45, P1501, DOI 10.1016/j.visres.2005.01.003; Todd JT, 2003, PERCEPT PSYCHOPHYS, V65, P31, DOI 10.3758/BF03194781; TODD JT, 1983, J EXP PSYCHOL HUMAN, V9, P583, DOI 10.1037/0096-1523.9.4.583; van Doorn AJ, 2011, J VISION, V11, DOI 10.1167/11.3.21; van Ee R, 2003, J OPT SOC AM A, V20, P1398, DOI 10.1364/JOSAA.20.001398; Wagemans J, 2010, I-PERCEPTION, V1, P159, DOI 10.1068/i0401; ZIMMERMAN GL, 1995, J OPT SOC AM A, V12, P17, DOI 10.1364/JOSAA.12.000017	56	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35950	10.1371/journal.pone.0035950	http://dx.doi.org/10.1371/journal.pone.0035950			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UL	22558279	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340200032
J	Dahia, CL; Mahoney, E; Wylie, C				Dahia, Chitra Lekha; Mahoney, Eric; Wylie, Christopher			Shh Signaling from the Nucleus Pulposus Is Required for the Postnatal Growth and Differentiation of the Mouse Intervertebral Disc	PLOS ONE			English	Article							SONIC HEDGEHOG; LIMB DEVELOPMENT; COLLAGEN GENE; EXPRESSION; INHIBITION; SOX9; DEGENERATION; CHONDROCYTES; INDUCTION; BLOCKADE	Intervertebral discs (IVD) are essential components of the vertebral column. They maintain separation, and provide shock absorbing buffers, between adjacent vertebrae, while also allowing movements between them. Each IVD consists of a central semi-liquid nucleus pulposus (NP) surrounded by a multi-layered fibrocartilagenous annulus fibrosus (AF). Although the IVDs grow and differentiate after birth along with the vertebral column, little is known about the mechanism of this. Understanding the signals that control normal IVD growth and differentiation would also provide potential therapies for degenerative disc disease, which is the major cause of lower back pain and affects a large proportion of the population. In this work, we show that during postnatal growth of the mouse, Sonic hedgehog (Shh) signaling from the NP cells controls many aspects of growth and differentiation of both the NP cells themselves and of the surrounding AF, and that it acts, at least partly, by regulating other signaling pathways in the NP and AF. Recent studies have shown that the NP cells arise from the embryonic notochord, which acts as a major signaling center in the embryo. This work shows that this notochord-derived tissue continues to carry out a major signaling function in the postnatal body and that the IVDs are signaling centers, in addition to their already known functions in the mechanics of vertebral column function.	[Dahia, Chitra Lekha; Mahoney, Eric] Cincinnati Childrens Hosp Med Ctr, Div Orthopaed Surg, Cincinnati, OH 45229 USA; [Wylie, Christopher] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Dahia, CL (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Orthopaed Surg, Cincinnati, OH 45229 USA.	Chitra.Dahia@cchmc.org; Christopher.Wylie@cchmc.org			Orthopaedic Research and Education Foundation (OREF) Career Development Grant [11-228]	Orthopaedic Research and Education Foundation (OREF) Career Development Grant	This work was supported by an Orthopaedic Research and Education Foundation (OREF) Career Development Grant to CD (Grant number 11-228; http://www.oref.org/site/PageServer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastida MF, 2009, DEVELOPMENT, V136, P3779, DOI 10.1242/dev.036418; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; CAPDEVILA J, 1994, EMBO J, V13, P71, DOI 10.1002/j.1460-2075.1994.tb06236.x; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Choi KS, 2011, P NATL ACAD SCI USA, V108, P9484, DOI 10.1073/pnas.1007566108; Choi KS, 2008, DEV DYNAM, V237, P3953, DOI 10.1002/dvdy.21805; Dahia CL, 2011, SPINE, V36, P1071, DOI 10.1097/BRS.0b013e3181f7a3ca; Dahia CL, 2009, SPINE, V34, P447, DOI 10.1097/BRS.0b013e3181990c64; Dahia CL, 2009, SPINE, V34, P456, DOI 10.1097/BRS.0b013e3181913e98; Dassule HR, 2000, DEVELOPMENT, V127, P4775; DEYO RA, 1987, SPINE, V12, P264, DOI 10.1097/00007632-198704000-00013; DiPaola CP, 2005, J ORTHOP RES, V23, P1112, DOI 10.1016/j.orthres.2005.03.008; Dray N, 2010, SCIENCE, V329, P339, DOI 10.1126/science.1188913; Faure E, 2000, CELL TISSUE RES, V300, P89, DOI 10.1007/s004410000183; Faure S, 2002, DEV BIOL, V244, P44, DOI 10.1006/dbio.2002.0579; Frymoyer John W., 1996, P8; Hirsinger E, 1997, DEVELOPMENT, V124, P4605; Ireland D, 2009, BIOSCIENCE HORIZONS, V1, P83; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Maeda Y, 2007, P NATL ACAD SCI USA, V104, P6382, DOI 10.1073/pnas.0608449104; McMahon AP, 2000, CELL, V100, P185, DOI 10.1016/S0092-8674(00)81555-X; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; POONI JS, 1986, SURG RADIOL ANAT, V8, P175, DOI 10.1007/BF02427846; Sanz-Ezquerro JJ, 2000, DEVELOPMENT, V127, P4811; Surace EM, 2006, MOL THER, V13, P573, DOI 10.1016/j.ymthe.2005.10.010; Tew SR, 2008, BIOCHEM J, V414, P231, DOI 10.1042/BJ20080262; Urban JPG, 2003, ARTHRITIS RES THER, V5, P120, DOI 10.1186/ar629	31	61	64	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35944	10.1371/journal.pone.0035944	http://dx.doi.org/10.1371/journal.pone.0035944			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558278	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336000090
J	Esposito, DL; Aru, F; Lattanzio, R; Morgano, A; Abbondanza, M; Malekzadeh, R; Bishehsari, F; Valanzano, R; Russo, A; Piantelli, M; Moschetta, A; Lotti, LV; Mariani-Costantini, R				Esposito, Diana L.; Aru, Federica; Lattanzio, Rossano; Morgano, Annalisa; Abbondanza, Michela; Malekzadeh, Reza; Bishehsari, Faraz; Valanzano, Rosa; Russo, Antonio; Piantelli, Mauro; Moschetta, Antonio; Lotti, Lavinia Vittoria; Mariani-Costantini, Renato			The Insulin Receptor Substrate 1 (Irs1) in Intestinal Epithelial Differentiation and in Colorectal Cancer	PLOS ONE			English	Article							GROWTH-FACTOR-I; COLON-CARCINOMA-CELLS; IGF-I; NUCLEAR TRANSLOCATION; BETA-CATENIN; STEM-CELL; EXPRESSION; MUTATIONS; CACO-2; ADENOCARCINOMA	Colorectal cancer (CRC) is associated with lifestyle factors that affect insulin/IGF signaling, of which the insulin receptor substrate 1 (IRS1) is a key transducer. We investigated expression, localization and pathologic correlations of IRS1 in cancer-uninvolved colonic epithelium, primary CRCs with paired liver metastases and in vitro polarizing Caco2 and HT29 cells. IRS1 mRNA and protein resulted higher, relative to paired mucosa, in adenomas of familial adenomatous polyposis patients and in CRCs that overexpressed c-MYC, beta-catenin, InsR beta, and IGF1R. Analysis of IRS1 immunostaining in 24 cases of primary CRC with paired colonic epithelium and hepatic metastasis showed that staining intensity was significantly higher in metastases relative to both primary CRC (P<0.01) and colonic epithelium (P<0.01). Primary and metastatic CRCs, compared to colonic epithelium, contained significantly higher numbers of IRS1-positive cells (P = 0.013 and P = 0.014, respectively). Pathologic correlations in 163 primary CRCs revealed that diffuse IRS1 staining was associated with tumors combining differentiated phenotype and aggressive markers (high Ki67, p53, and beta-catenin). In Caco 2 IRS1 and InsR were maximally expressed after polarization, while IGF1R was highest in pre-polarized cells. No nuclear IRS1 was detected, while, with polarization, phosphorylated IRS1 (pIRS1) shifted from the lateral to the apical plasma membrane and was expressed in surface cells only. In HT29, that carry mutations constitutively activating survival signaling, IRS1 and IGF1R decreased with polarization, while pIRS1 localized in nuclear spots throughout the course. Overall, these data provide evidence that IRS1 is modulated according to CRC differentiation, and support a role of IRS1 in CRC progression and liver metastatization.	[Esposito, Diana L.; Aru, Federica; Lattanzio, Rossano; Morgano, Annalisa; Bishehsari, Faraz; Piantelli, Mauro; Mariani-Costantini, Renato] Univ G dAnnunzio, Aging Res Ctr, Unit Gen Pathol, Chieti, Italy; [Esposito, Diana L.; Mariani-Costantini, Renato] Univ G DAnnunzio, Dept Med Oral & Biotechnol Sci, Chieti, Italy; [Morgano, Annalisa; Moschetta, Antonio] Consorzio Mario Negri Sud, Dept Translat Pharmacol, Lab Lipid Metab & Canc, Chieti, Italy; [Abbondanza, Michela; Lotti, Lavinia Vittoria] Univ Roma La Sapienza, Dept Expt Med, Rome, Italy; [Malekzadeh, Reza; Bishehsari, Faraz] Univ Tehran, Shariati Hosp, Digest Dis Res Ctr, Tehran, Iran; [Valanzano, Rosa] Univ Florence, Dept Clin Physiopathol, Florence, Italy; [Russo, Antonio] Univ Palermo, Dept Surg & Oncol Sci, Palermo, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Consorzio Mario Negri Sud; Sapienza University Rome; Tehran University of Medical Sciences; University of Tehran; University of Florence; University of Palermo	Esposito, DL (corresponding author), Univ G dAnnunzio, Aging Res Ctr, Unit Gen Pathol, Chieti, Italy.	rmc@unich.it	Malekzadeh, Reza/U-1382-2017; Lattanzio, Rossano/K-1927-2018; Mariani-Costantini, Renato/B-6637-2012; Moschetta, Antonio/K-6211-2016; Moschetta, Antonio/AAC-5295-2022	Malekzadeh, Reza/0000-0002-9820-6335; Lattanzio, Rossano/0000-0001-9803-4476; Mariani-Costantini, Renato/0000-0002-4440-1848; Malekzadeh, Reza/0000-0003-1043-3814; Moschetta, Antonio/0000-0003-2123-6074; Bishehsari, Faraz/0000-0001-5644-2586; Piantelli, Mauro/0000-0003-0154-482X	Associazione Italiana per la Ricerca sul Cancro [IG 9168]; Italian Ministry for Scientific Research	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Italian Ministry for Scientific Research(Ministry of Education, Universities and Research (MIUR))	Associazione Italiana per la Ricerca sul Cancro (http://www.airc.it/), IG 9168 (2009); Italian Ministry for Scientific Research (http://www.istruzione.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksic T, 2010, CANCER RES, V70, P6412, DOI 10.1158/0008-5472.CAN-10-0052; Bach SP, 2000, CARCINOGENESIS, V21, P469, DOI 10.1093/carcin/21.3.469; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Bishehsari F, 2006, ANN ONCOL, V17, pVII91, DOI 10.1093/annonc/mdl959; Bommer GT, 2010, J BIOL CHEM, V285, P1928, DOI 10.1074/jbc.M109.060319; Carraway Coralie A Carothers, 2007, Sci STKE, V2007, pre3, DOI 10.1126/stke.3812007re3; Center MM, 2009, CA-CANCER J CLIN, V59, P366, DOI 10.3322/caac.20038; Chang Q, 2002, CANCER RES, V62, P6035; CHANTRET I, 1988, CANCER RES, V48, P1936; Chen J, 2005, J BIOL CHEM, V280, P29912, DOI 10.1074/jbc.M504516200; Chiang JM, 2010, INT J COLORECTAL DIS, V25, P941, DOI 10.1007/s00384-010-0958-x; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dearth RK, 2007, CELL CYCLE, V6, P705, DOI 10.4161/cc.6.6.4035; Drakas R, 2004, P NATL ACAD SCI USA, V101, P9272, DOI 10.1073/pnas.0403328101; Durai R, 2005, INT J COLORECTAL DIS, V20, P203, DOI 10.1007/s00384-004-0675-4; Ewton DZ, 2002, INT J CANCER, V98, P665, DOI 10.1002/ijc.10229; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Giovannucci E, 2001, J NUTR, V131, p3109S, DOI 10.1093/jn/131.11.3109S; Giovannucci E, 2010, CA-CANCER J CLIN, V60, P207, DOI 10.3322/caac.20078; GUO YS, 1992, GASTROENTEROLOGY, V102, P1101; Half E, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-22; Haydon AMM, 2006, GUT, V55, P689, DOI 10.1136/gut.2005.081547; Howarth GS, 2003, J NUTR, V133, P2109, DOI 10.1093/jn/133.7.2109; Ilyas M, 1997, P NATL ACAD SCI USA, V94, P10330, DOI 10.1073/pnas.94.19.10330; Jhawer M, 2008, CANCER RES, V68, P1953, DOI 10.1158/0008-5472.CAN-07-5659; Johnson .T, 2007, ALIMENT PHARM THER, V26, P161, DOI 10.1111/j.1365-2036.2007.03371.x; Kawasaki H, 1998, CANCER RES, V58, P5071; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; MACDONALD RS, 1993, J RECEPTOR RES, V13, P1093, DOI 10.3109/10799899309063266; Mahdavinia M, 2008, J CELL PHYSIOL, V216, P543, DOI 10.1002/jcp.21428; Modica S, 2009, GUT, V58, P1250, DOI 10.1136/gut.2008.158386; Ngo TH, 2002, CANCER CAUSE CONTROL, V13, P929, DOI 10.1023/A:1021911517010; Peruzzi F, 1999, MOL CELL BIOL, V19, P7203, DOI 10.1128/mcb.19.10.7203; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Prisco M, 2002, J BIOL CHEM, V277, P32078, DOI 10.1074/jbc.M204658200; Ramocki NM, 2008, ENDOCRINOLOGY, V149, P261, DOI 10.1210/en.2007-0869; Reinmuth N, 2002, LAB INVEST, V82, P1377, DOI 10.1097/01.LAB.0000032411.41603.C2; REMACLEBONNET M, 1992, INT J CANCER, V52, P910, DOI 10.1002/ijc.2910520614; ROUSSET M, 1986, BIOCHIMIE, V68, P1035, DOI 10.1016/S0300-9084(86)80177-8; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; Saaf AM, 2007, MOL BIOL CELL, V18, P4245, DOI 10.1091/mbc.E07-04-0309; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Sanchez-Arago M, 2010, CARCINOGENESIS, V31, P567, DOI 10.1093/carcin/bgq012; Sandhu MS, 2002, J NATL CANCER I, V94, P972; Sehat B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000628; Serhan MF, 2010, GEN COMP ENDOCR, V167, P228, DOI 10.1016/j.ygcen.2010.03.010; Shaw LM, 2001, MOL CELL BIOL, V21, P5082, DOI 10.1128/MCB.21.15.5082-5093.2001; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Simmons JG, 2007, AM J PHYSIOL-GASTR L, V293, pG995, DOI 10.1152/ajpgi.00537.2006; Tu X, 2003, HORM METAB RES, V35, P734; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Wang J, 2007, MOL CANCER THER, V6, P1143, DOI 10.1158/1535-7163.MCT-06-0555; Wang Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010456; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Wu A, 2008, ONCOGENE, V27, P397, DOI 10.1038/sj.onc.1210636; Wu A, 2003, J CELL PHYSIOL, V195, P453, DOI 10.1002/jcp.10261; Yang GY, 2008, CANCER SCI, V99, P879, DOI 10.1111/j.1349-7006.2008.00762.x; Yang J, 2006, J BIOL CHEM, V281, P17751, DOI 10.1074/jbc.M600831200; Yokoyama S, 2010, BMC SURG, V10, DOI 10.1186/1471-2482-10-8; Yuan ZQ, 2003, ONCOGENE, V22, P6304, DOI 10.1038/sj.onc.1206609; ZARRILLI R, 1994, CELL GROWTH DIFFER, V5, P1085	63	45	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36190	10.1371/journal.pone.0036190	http://dx.doi.org/10.1371/journal.pone.0036190			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558377	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000149
J	Johnson, AR; Lao, S; Wang, TW; Galanko, JA; Zeisel, SH				Johnson, Amy R.; Lao, Sai; Wang, Tongwen; Galanko, Joseph A.; Zeisel, Steven H.			Choline Dehydrogenase Polymorphism rs12676 Is a Functional Variation and Is Associated with Changes in Human Sperm Cell Function	PLOS ONE			English	Article							RAT-LIVER MITOCHONDRIA; MOUSE SPERM; BETAINE; MOTILITY; ZINC; REPRODUCTION; METABOLISM; STRESS; KINASE; HOMOCYSTEINE	Approximately 15% of couples are affected by infertility and up to half of these cases arise from male factor infertility. Unidentified genetic aberrations such as chromosomal deletions, translocations and single nucleotide polymorphisms (SNPs) may be the underlying cause of many cases of idiopathic male infertility. Deletion of the choline dehydrogenase (Chdh) gene in mice results in decreased male fertility due to diminished sperm motility; sperm from Chdh 2/2 males have decreased ATP concentrations likely stemming from abnormal sperm mitochondrial morphology and function in these cells. Several SNPs have been identified in the human CHDH gene that may result in altered CHDH enzymatic activity. rs12676 (G233T), a non-synonymous SNP located in the CHDH coding region, is associated with increased susceptibility to dietary choline deficiency and risk of breast cancer. We now report evidence that this SNP is also associated with altered sperm motility patterns and dysmorphic mitochondrial structure in sperm. Sperm produced by men who are GT or TT for rs12676 have 40% and 73% lower ATP concentrations, respectively, in their sperm. rs12676 is associated with decreased CHDH protein in sperm and hepatocytes. A second SNP located in the coding region of IL17BR, rs1025689, is linked to altered sperm motility characteristics and changes in choline metabolite concentrations in sperm.	[Johnson, Amy R.; Lao, Sai; Wang, Tongwen; Zeisel, Steven H.] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27515 USA; [Galanko, Joseph A.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC USA; [Wang, Tongwen; Zeisel, Steven H.] Univ N Carolina, Gillings Sch Global Publ Hlth, Inst Nutr Res, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Johnson, AR (corresponding author), Univ N Carolina, Dept Nutr, Chapel Hill, NC 27515 USA.	steven_zeisel@unc.edu			National Institutes of Health [DK055865, DK056350]; Balchem Corporation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350, R01DK055865] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Balchem Corporation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was funded by The National Institutes of Health grants DK055865 and DK056350 to SHZ. ARJ is the recipient of the Balchem Corporation Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker MA, 2004, J CELL SCI, V117, P211, DOI 10.1242/jcs.00842; Barratt CDJaC, SPERM CELL PRODUCTIO; BROWN BW, 1994, REPROD NUTR DEV, V34, P89, DOI 10.1051/rnd:19940201; Chern MK, 2000, BIOCHEM PHARMACOL, V60, P1629, DOI 10.1016/S0006-2952(00)00469-X; Cooper TG, 2003, MICROSC RES TECHNIQ, V61, P28, DOI 10.1002/jemt.10314; Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048; Craig SAS, 2004, AM J CLIN NUTR, V80, P539; da Costa KA, 2006, FASEB J, V20, P1336, DOI 10.1096/fj.06-5734com; Danshina PV, 2009, BIOL REPROD; deKretser DM, 1997, LANCET, V349, P787, DOI 10.1016/S0140-6736(96)08341-9; DERIDDER JJ, 1973, BIOCHIM BIOPHYS ACTA, V291, P557, DOI 10.1016/0005-2736(73)90507-5; Eddy EM, 2003, MICROSC RES TECHNIQ, V61, P103, DOI 10.1002/jemt.10320; ELIASSON R, 1971, LIFE SCI, V10, P1317, DOI 10.1016/0024-3205(71)90331-6; FAVIER AE, 1992, BIOL TRACE ELEM RES, V32, P363, DOI 10.1007/BF02784623; Ferlin A, 2007, REPROD BIOMED ONLINE, V14, P734, DOI 10.1016/S1472-6483(10)60677-3; Foresta C, 2002, BIOL REPROD, V67, P967, DOI 10.1095/biolreprod.102.003822; FRASER LR, 1977, J EXP ZOOL, V202, P439, DOI 10.1002/jez.1402020314; GARCIAPEREZ A, 1991, J MEMBRANE BIOL, V119, P1, DOI 10.1007/BF01868535; Garrido N, 2004, ASIAN J ANDROL, V6, P59; GEER BW, 1967, BIOL BULL-US, V133, P548, DOI 10.2307/1539917; Goldberg E, 2009, J ANDROL; HAUBRICH DR, 1981, J NEUROCHEM, V37, P476, DOI 10.1111/j.1471-4159.1981.tb00480.x; Holt WV, 2000, THERIOGENOLOGY, V53, P47, DOI 10.1016/S0093-691X(99)00239-3; HONG CY, 1986, INT J ANDROL, V9, P118, DOI 10.1111/j.1365-2605.1986.tb00874.x; HUACUJA L, 1973, LIFE SCI, V13, P1383, DOI 10.1016/0024-3205(73)90159-8; Huang SB, 2003, BIOCHEM BIOPH RES CO, V309, P344, DOI 10.1016/j.bbrc.2003.08.010; Institute of Medicine National Academy of Sciences USA, 1998, CHOL DIET REF INT FO, P390; Johnson AR, 2010, FASEB J, V24, P2752, DOI 10.1096/fj.09-153718; Koc H, 2002, ANAL CHEM, V74, P4734, DOI 10.1021/ac025624x; KOSKINEN E, 1989, J VET MED A, V36, P110, DOI 10.1111/j.1439-0442.1989.tb00710.x; Kvist U, 1980, Acta Physiol Scand Suppl, V486, P1; KVIST U, 1990, INT J ANDROL, V13, P245, DOI 10.1111/j.1365-2605.1990.tb01028.x; LERUDULIER D, 1984, SCIENCE, V224, P1064, DOI 10.1126/science.224.4653.1064; LIN CS, 1986, J PROTEIN CHEM, V5, P193, DOI 10.1007/BF01025488; Ma XJ, 2006, J CLIN ONCOL, V24, P4611, DOI 10.1200/JCO.2006.06.6944; Mann PJG, 1937, BIOCHEM J, V31, P869, DOI 10.1042/bj0310869; MCGRADY AV, 1984, ARCH ANDROLOGY, V13, P1; Michel V, 2009, FASEB J, V23, P2749, DOI 10.1096/fj.08-121491; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Mukai C, 2004, BIOL REPROD, V71, P540, DOI 10.1095/biolreprod.103.026054; NEVO AC, 1970, J THEOR BIOL, V26, P11, DOI 10.1016/S0022-5193(70)80027-3; O'Rand MG, 2009, BIOL REPROD, V80, P279, DOI 10.1095/biolreprod.108.072942; PORTER RK, 1992, J BIOL CHEM, V267, P14637; PORTER RK, 1993, BIOCHIM BIOPHYS ACTA, V1141, P269, DOI 10.1016/0005-2728(93)90052-H; PORTER TJ, 1990, J BIOL CHEM, V265, P414; PRASAD AS, 1995, NUTRITION, V11, P93; SANCHEZPARTIDA LG, 1992, REPROD FERT DEVELOP, V4, P113, DOI 10.1071/RD9920113; SANSTEAD HH, 1967, AM J CLIN NUTR, V20, P422, DOI 10.1093/ajcn/20.5.422; Sikka SC, 1995, J ANDROL, V16, P464; STEEGERSTHEUNISSEN RP, 1995, AM J OBSTET GYNECOL, V172, P1436, DOI 10.1016/0002-9378(95)90474-3; STEVEN FS, 1982, INT J ANDROL, V5, P401, DOI 10.1111/j.1365-2605.1982.tb00270.x; Storey BT, 2008, INT J DEV BIOL, V52, P427, DOI 10.1387/ijdb.072522bs; SUAREZ SS, 1987, BIOL REPROD, V36, P1191, DOI 10.1095/biolreprod36.5.1191; THAKKAR JK, 1984, BIOL REPROD, V30, P679, DOI 10.1095/biolreprod30.3.679; TOMBES RM, 1985, CELL, V41, P325, DOI 10.1016/0092-8674(85)90085-6; VANPELT AMM, 1991, ENDOCRINOLOGY, V128, P697, DOI 10.1210/endo-128-2-697; Wang Z, 2007, CLIN CANCER RES, V13, P6327, DOI 10.1158/1078-0432.CCR-07-0310; Xu XR, 2008, FASEB J, V22, P2045, DOI 10.1096/fj.07-101279; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Yeung CH, 1999, BIOL REPROD, V61, P1062, DOI 10.1095/biolreprod61.4.1062; Yeung CH, 2000, BIOL REPROD, V63, P612, DOI 10.1095/biolreprod63.2.612; Zeisel SH, 2000, NUTRITION, V16, P669, DOI 10.1016/S0899-9007(00)00349-X; Zeisel SH, 2005, AM J CLIN NUTR, V82, P719, DOI 10.1093/ajcn/82.4.719; Zeisel SH, 2003, J NUTR, V133, P1302	64	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36047	10.1371/journal.pone.0036047	http://dx.doi.org/10.1371/journal.pone.0036047			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558321	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336000112
J	Kirby, BJ; Jodari, M; Loftus, MS; Gakhar, G; Pratt, ED; Chanel-Vos, C; Gleghorn, JP; Santana, SM; Liu, H; Smith, JP; Navarro, VN; Tagawa, ST; Bander, NH; Nanus, DM; Giannakakou, P				Kirby, Brian J.; Jodari, Mona; Loftus, Matthew S.; Gakhar, Gunjan; Pratt, Erica D.; Chanel-Vos, Chantal; Gleghorn, Jason P.; Santana, Steven M.; Liu, He; Smith, James P.; Navarro, Vicente N.; Tagawa, Scott T.; Bander, Neil H.; Nanus, David M.; Giannakakou, Paraskevi			Functional Characterization of Circulating Tumor Cells with a Prostate-Cancer-Specific Microfluidic Device	PLOS ONE			English	Article							MEMBRANE ANTIGEN-EXPRESSION; DOCETAXEL PLUS PREDNISONE; BREAST-CANCER; CARCINOMA-CELLS; LYMPH-NODE; PHASE-I; RESISTANT; SURVIVAL; MITOXANTRONE; THERAPY	Cancer metastasis accounts for the majority of cancer-related deaths owing to poor response to anticancer therapies. Molecular understanding of metastasis- associated drug resistance remains elusive due to the scarcity of available tumor tissue. Isolation of circulating tumor cells (CTCs) from the peripheral blood of patients has emerged as a valid alternative source of tumor tissue that can be subjected to molecular characterization. However, issues with low purity and sensitivity have impeded adoption to clinical practice. Here we report a novel method to capture and molecularly characterize CTCs isolated from castrate-resistant prostate cancer patients (CRPC) receiving taxane chemotherapy. We have developed a geometrically enhanced differential immunocapture (GEDI) microfluidic device that combines an anti-prostate specific membrane antigen (PSMA) antibody with a 3D geometry that captures CTCs while minimizing nonspecific leukocyte adhesion. Enumeration of GEDI-captured CTCs (defined as intact, nucleated PSMA+/CD45- cells) revealed a median of 54 cells per ml identified in CRPC patients versus 3 in healthy donors. Direct comparison with the commercially available CellSearch (R) revealed a 2-400 fold higher sensitivity achieved with the GEDI device. Confocal microscopy of patient-derived GEDI-captured CTCs identified the TMPRSS2:ERG fusion protein, while sequencing identified specific androgen receptor point mutation (T868A) in blood samples spiked with only 50 PC C4-2 cells. On-chip treatment of patient-derived CTCs with docetaxel and paclitaxel allowed monitoring of drug-target engagement by means of microtubule bundling. CTCs isolated from docetaxel-resistant CRPC patients did not show any evidence of drug activity. These measurements constitute the first functional assays of drug-target engagement in living circulating tumor cells and therefore have the potential to enable longitudinal monitoring of target response and inform the development of new anticancer agents.	[Kirby, Brian J.; Pratt, Erica D.; Gleghorn, Jason P.; Santana, Steven M.; Smith, James P.] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA; [Kirby, Brian J.; Pratt, Erica D.; Gleghorn, Jason P.; Santana, Steven M.; Smith, James P.] Cornell Univ, Ithaca, NY USA; [Jodari, Mona; Loftus, Matthew S.; Gakhar, Gunjan; Chanel-Vos, Chantal; Tagawa, Scott T.; Nanus, David M.; Giannakakou, Paraskevi] Weill Cornell Med Coll, Dept Med, Div Hematol & Med Oncol, New York, NY USA; [Jodari, Mona; Loftus, Matthew S.; Gakhar, Gunjan; Chanel-Vos, Chantal; Liu, He; Navarro, Vicente N.; Tagawa, Scott T.; Bander, Neil H.; Nanus, David M.; Giannakakou, Paraskevi] New York Presbyterian Hosp, New York, NY USA; [Liu, He; Navarro, Vicente N.; Bander, Neil H.; Nanus, David M.] Weill Cornell Med Coll, Dept Urol, New York, NY USA	Cornell University; Cornell University; Cornell University; NewYork-Presbyterian Hospital; Cornell University	Kirby, BJ (corresponding author), Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.	bk88@cornell.edu; pag2015@med.cornell.edu	Gleghorn, Jason/AAG-3355-2020; Kirby, Brian/D-4139-2012; Pratt, Erica/H-6566-2015	Gleghorn, Jason/0000-0003-1283-2966; Kirby, Brian/0000-0002-7479-9738; Smith, James/0000-0001-7432-126X; Pratt, Erica/0000-0002-5868-6020; Giannakakou, Paraskevi/0000-0001-7378-262X	US National Institutes of Health [R01 CA137020-01, U54 CA143876]; NIH Physical Sciences Oncology Center at Cornell; New York Office of Science, Technology, and Research; Weill Cornell Clinical and Translational Science Center; Creativity Award from the Prostate Cancer Foundation; Genitourinary Oncology Research Fund; NRSA postdoctoral fellowship; National Science Foundation Graduate Research Fellowships; NATIONAL CANCER INSTITUTE [R01CA137020, U54CA143876] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Physical Sciences Oncology Center at Cornell; New York Office of Science, Technology, and Research; Weill Cornell Clinical and Translational Science Center; Creativity Award from the Prostate Cancer Foundation; Genitourinary Oncology Research Fund; NRSA postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowships(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the US National Institutes of Health (R01 CA137020-01 and U54 CA143876) (PG), the NIH Physical Sciences Oncology Center at Cornell (BK, PG DN), New York Office of Science, Technology, and Research (BK), the Weill Cornell Clinical and Translational Science Center (DN, PG BK) a Creativity Award from the Prostate Cancer Foundation (PG and DN) and support from the Genitourinary Oncology Research Fund (DN). CCV is a recipient of an NRSA postdoctoral fellowship. EP and SS were supported by National Science Foundation Graduate Research Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar NH, 2012, ADV UROL, V2012, DOI 10.1155/2012/973820; Ananias HJK, 2009, PROSTATE, V69, P1101, DOI 10.1002/pros.20957; Attard G, 2009, J CLIN PATHOL, V62, P373, DOI 10.1136/jcp.2008.061515; Attard G, 2011, CURR OPIN GENET DEV, V21, P50, DOI 10.1016/j.gde.2010.10.010; Bander NH, 2003, SEMIN ONCOL, V30, P667, DOI 10.1016/S0093-7754(03)00358-0; Chang SS, 1999, CANCER RES, V59, P3192; Clark J, 2008, ONCOGENE, V27, P1993, DOI 10.1038/sj.onc.1210843; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Coumans FAW, 2010, ANN ONCOL, V21, P1851, DOI 10.1093/annonc/mdq030; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Danila DC, 2007, CLIN CANCER RES, V13, P7053, DOI 10.1158/1078-0432.CCR-07-1506; Danila DC, 2011, CLIN CANCER RES, V17, P3903, DOI 10.1158/1078-0432.CCR-10-2650; Darshan MS, 2011, CANC RES; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; EXTRA JM, 1993, CANCER RES, V53, P1037; Gleghorn JP, 2010, LAB CHIP, V10, P27, DOI 10.1039/b917959c; Gostner JM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-45; Gradilone A, 2011, J CELL MOL MED, V15, P1066, DOI 10.1111/j.1582-4934.2011.01285.x; Haber DA, 2011, CELL, V145, P19, DOI 10.1016/j.cell.2011.03.026; Haffner MC, 2009, HUM PATHOL, V40, P1754, DOI 10.1016/j.humpath.2009.06.003; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; HOROSZEWICZ JS, 1987, ANTICANCER RES, V7, P927; ISRAELI RS, 1994, CANCER RES, V54, P6306; ISRAELI RS, 1994, CANCER RES, V54, P1807; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Komlodi-Pasztor E, 2011, NAT REV CLIN ONCOL, V8, DOI 10.1038/nrclinonc.2010.228-c2; Krivacic RT, 2004, P NATL ACAD SCI USA, V101, P10501, DOI 10.1073/pnas.0404036101; Maheswaran S, 2010, CURR OPIN GENET DEV, V20, P96, DOI 10.1016/j.gde.2009.12.002; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marcus AI, 2005, J BIOL CHEM, V280, P11569, DOI 10.1074/jbc.M413471200; McDaid HM, 2002, CLIN CANCER RES, V8, P2035; Meng SD, 2004, CLIN CANCER RES, V10, P8152, DOI 10.1158/1078-0432.CCR-04-1110; Munz M, 2009, CANCER RES, V69, P5627, DOI 10.1158/0008-5472.CAN-09-0654; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Park K, 2010, NEOPLASIA, V12, P590, DOI 10.1593/neo.10726; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Racila E, 1998, P NATL ACAD SCI USA, V95, P4589, DOI 10.1073/pnas.95.8.4589; Riethdorf S, 2010, ANN NY ACAD SCI, V1210, P66, DOI 10.1111/j.1749-6632.2010.05779.x; Scher HI, 2011, J CLIN ONCOL, V29, P2191, DOI 10.1200/JCO.2010.32.8815; Scher HI, 2009, LANCET ONCOL, V10, P233, DOI 10.1016/S1470-2045(08)70340-1; Silver DA, 1997, CLIN CANCER RES, V3, P81; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Stott SL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000403; Sweat SD, 1998, UROLOGY, V52, P637, DOI 10.1016/S0090-4295(98)00278-7; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; Wicha MS, 2011, J CLIN ONCOL, V29, P1508, DOI 10.1200/JCO.2010.34.0026; Wright GL, 1996, UROLOGY, V48, P326, DOI 10.1016/S0090-4295(96)00184-7; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021; Zieglschmid V, 2005, CRIT REV CL LAB SCI, V42, P155, DOI 10.1080/10408360590913696	54	176	186	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35976	10.1371/journal.pone.0035976	http://dx.doi.org/10.1371/journal.pone.0035976			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558290	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336000094
J	Sakai, JT; Dalwani, MS; Gelhorn, HL; Mikulich-Gilbertson, SK; Crowley, TJ				Sakai, Joseph T.; Dalwani, Manish S.; Gelhorn, Heather L.; Mikulich-Gilbertson, Susan K.; Crowley, Thomas J.			A Behavioral Test of Accepting Benefits that Cost Others: Associations with Conduct Problems and Callous-Unemotionality	PLOS ONE			English	Article							TRAITS; ADOLESCENTS; SUBSTANCE; ALTRUISM; IMPULSIVITY; CHILDREN; SCALE; RISK	Background: Youth with conduct problems (CP) often make decisions which value self-interest over the interests of others. Self-benefiting behavior despite loss to others is especially common among youth with CP and callous-unemotional traits (CU). Such behavioral tendencies are generally measured using self- or observer-report. We are unaware of attempts to measure this tendency with a behavioral paradigm. Methods/Principal Findings: In our AlAn's (altruism-antisocial) game a computer program presents subjects with a series of offers in which they will receive money but a planned actual charity donation will be reduced; subjects decide to accept or reject each offer. We tested (1) whether adolescent patients with CP (n = 20) compared with adolescent controls (n = 19) differed on AlAn's game outcomes, (2) whether youths with CP and CU differed significantly from controls without CP or CU, and (3) whether AlAn's game outcomes correlated significantly with CP and separately, CU severity. Patients with CP and CU compared with controls without these problems took significantly more money for themselves and left significantly less money in the charity donation; AlAn's game outcomes were significantly correlated with CU, but not CP. Conclusions/Significance: In the AlAn's game adolescents with conduct problems and CU traits, compared with controls without CP/CU, are disposed to benefit themselves while costing others even in a novel situation, devoid of peer influences, where anonymity is assured, reciprocity or retribution are impossible, intoxication is absent and when the "other" to be harmed is considered beneficent. AlAn's game outcomes are associated with measures of CU. Results suggest that the AlAn's game provides an objective means of capturing information about CU traits. The AlAn's game, which was designed for future use in the MRI environment, may be used in studies attempting to identify the neural correlates of self-benefiting decision-making.	[Sakai, Joseph T.; Dalwani, Manish S.; Mikulich-Gilbertson, Susan K.; Crowley, Thomas J.] Univ Colorado, Dept Psychiat, Aurora, CO 80045 USA; [Gelhorn, Heather L.] United BioSource Corp, Bethesda, MD USA	University of Colorado System; University of Colorado Anschutz Medical Campus; United Biosource Corporation	Sakai, JT (corresponding author), Univ Colorado, Dept Psychiat, Anschutz Med Campus, Aurora, CO 80045 USA.	joseph.sakai@ucdenver.edu	Sakai, Joseph/AAH-5984-2020	Sakai, Joseph/0000-0003-1600-6100	Kane Family Foundation; National Institute on Drug Abuse/National Institutes of Health [DA009842, DA011015]; NATIONAL INSTITUTE ON DRUG ABUSE [P60DA011015, R37DA009842, R01DA009842] Funding Source: NIH RePORTER	Kane Family Foundation; National Institute on Drug Abuse/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This project was supported by Kane Family Foundation and Grants DA009842 and DA011015 from the National Institute on Drug Abuse/National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T. M., 1991, MANUAL SELF REPORT 1; [Anonymous], 1991, MANUAL CHILD BEHAV C; Blair RJR, 2005, J CHILD PSYCHOL PSYC, V46, P327, DOI 10.1111/j.1469-7610.2004.00356.x; Blair RJR, 2003, BRIT J PSYCHIAT, V182, P5, DOI 10.1192/bjp.182.1.5; Caputo AA, 1999, CRIM JUSTICE BEHAV, V26, P338, DOI 10.1177/0093854899026003004; Crowley TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012835; Crowley TJ, 2006, J AM ACAD CHILD PSY, V45, P175, DOI 10.1097/01.chi.0000188893.60551.31; Crowley TJ, 2001, J AM ACAD CHILD PSY, V40, P265, DOI 10.1097/00004583-200103000-00005; CROWNE DP, 1960, J CONSULT PSYCHOL, V24, P349, DOI 10.1037/h0047358; Eckel CC, 1996, GAME ECON BEHAV, V16, P181, DOI 10.1006/game.1996.0081; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2004, NATURE, V432, P449, DOI 10.1038/432449a; Fisher L, 1998, J ABNORM CHILD PSYCH, V26, P511, DOI 10.1023/A:1022655919743; Frick P J, 1999, Clin Child Fam Psychol Rev, V2, P149; Frick P.J., 2004, INVENTORY CALLOUS UN, DOI DOI 10.1037/T62639-000; Frick P. J., PROPOSAL DSM 5 CHILD; Frick PJ, 2008, J CHILD PSYCHOL PSYC, V49, P359, DOI 10.1111/j.1469-7610.2007.01862.x; Frick Paul J, 2006, Curr Psychiatry Rep, V8, P59, DOI 10.1007/s11920-006-0082-3; Frick PJ, 2003, DEV PSYCHOL, V39, P246, DOI 10.1037/0012-1649.39.2.246; Frick PJ., 2001, ANTISOCIAL PROCESS S; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; Hardy CL, 2006, PERS SOC PSYCHOL B, V32, P1402, DOI 10.1177/0146167206291006; Hare R. D., 2003, HARE PSYCHOPATHY CHE, V2nd; Hein G, 2008, CURR OPIN NEUROBIOL, V18, P153, DOI 10.1016/j.conb.2008.07.012; Hoaken PNS, 2003, ADDICT BEHAV, V28, P1533, DOI 10.1016/j.addbeh.2003.08.033; HOFFMAN E, 1994, GAME ECON BEHAV, V7, P346, DOI 10.1006/game.1994.1056; Hollingshead August B., 1958, SOCIAL CLASS MENTAL; Jones HR, 1993, LONGITUDINAL DATA SE; Kimonis ER, 2008, INT J LAW PSYCHIAT, V31, P241, DOI 10.1016/j.ijlp.2008.04.002; List JA, 1998, J ECON BEHAV ORGAN, V37, P193, DOI 10.1016/S0167-2681(98)00084-5; Little J., 2004, ECON BULL, V3, P1; Loney BR, 2003, J CLIN CHILD ADOLESC, V32, P66, DOI 10.1207/15374420360533077; Ma HK, 2003, J GENET PSYCHOL, V164, P267, DOI 10.1080/00221320309597983; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Montague PR, 2007, NAT NEUROSCI, V10, P137, DOI 10.1038/nn0207-137; Munoz LC, 2008, J ABNORM CHILD PSYCH, V36, P15, DOI 10.1007/s10802-007-9137-0; Munoz LC, 2007, SCAND J PSYCHOL, V48, P299, DOI 10.1111/j.1467-9450.2007.00560.x; Munoz LC, 2009, J AM ACAD CHILD PSY, V48, P554, DOI 10.1097/CHI.0b013e31819c2419; Murphy JJ, 2005, ENVIRON RESOUR ECON, V30, P313, DOI 10.1007/s10640-004-3332-z; NEWMAN JP, 1987, J ABNORM PSYCHOL, V96, P145, DOI 10.1037/0021-843X.96.2.145; Pardini DA, 2003, J AM ACAD CHILD PSY, V42, P364, DOI 10.1097/00004583-200303000-00018; Roose A, 2010, ASSESSMENT, V17, P44, DOI 10.1177/1073191109344153; Rowe R, 2010, J CHILD PSYCHOL PSYC, V51, P688, DOI 10.1111/j.1469-7610.2009.02199.x; SAWYER J, 1966, AM J SOCIOL, V71, P407, DOI 10.1086/224129; SPSS Inc, 2009, SPSS WIND VERS 17; Thompson LL, 2006, ASSESSMENT, V13, P3, DOI 10.1177/1073191105282247; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Viding E, 2005, J CHILD PSYCHOL PSYC, V46, P592, DOI 10.1111/j.1469-7610.2004.00393.x; Vitacco MJ, 2003, ASSESSMENT, V10, P143, DOI 10.1177/1073191103010002005; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; Woodworth M, 2008, CHILD CARE HLTH DEV, V34, P234, DOI 10.1111/j.1365-2214.2007.00792.x; Zimbardo P. G., 2007, LUCIFER EFFECT UNDER	52	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36158	10.1371/journal.pone.0036158	http://dx.doi.org/10.1371/journal.pone.0036158			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TJ	22558367	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336000142
J	Schwartz, SR; Rees, H; Mehta, S; Venter, WDF; Taha, TE; Black, V				Schwartz, Sheree R.; Rees, Helen; Mehta, Shruti; Venter, Willem Daniel Francois; Taha, Taha E.; Black, Vivian			High Incidence of Unplanned Pregnancy after Antiretroviral Therapy Initiation: Findings from a Prospective Cohort Study in South Africa	PLOS ONE			English	Article							CONTRACEPTIVE USE; HORMONAL CONTRACEPTION; WOMEN; PREVENTION; INTENTIONS; FERTILITY	Background: Increased fertility rates in HIV-infected women receiving antiretroviral therapy (ART) have been attributed to improved immunological function; it is unknown to what extent the rise in pregnancy rates is due to unintended pregnancies. Methods: Non-pregnant women ages 18-35 from four public-sector ART clinics in Johannesburg, South Africa, were enrolled into a prospective cohort and followed from August 2009-March 2011. Fertility intentions, contraception and pregnancy status were measured longitudinally at participants' routine ART clinic visits. Findings: Of the 850 women enrolled, 822 (97%) had at least one follow-up visit and contributed 745.2 person-years (PY) at-risk for incident pregnancy. Overall, 170 pregnancies were detected in 161 women (incidence rate [IR]: 21.6/100 PY [95% confidence interval (CI): 18.5-25.2]). Of the 170 pregnancies, 105 (62%) were unplanned. Unmet need for contraception was 50% higher in women initiating ART in the past year as compared to women on ART> 1 year (prevalence ratio 1.5 [95% CI: 1.1-2.0]); by two years post-ART initiation, nearly one quarter of women had at least one unplanned pregnancy. Cumulative incidence of pregnancy was equally high among recent ART initiators and ART experienced participants: 23.9% [95% CI: 16.4-34.1], 15.9% [12.0-20.8], and 21.0% [16.8-26.1] for women on ART 0-1 yr, >1 yr-2 yrs, and >2 yrs respectively (log-rank, p = 0.54). Eight hormonal contraceptive failures were detected [IR: 4.4 [95% CI: 2.2-8.9], 7/8 among women using injectable methods. Overall 47% (80/170) of pregnancies were not carried to term. Conclusions: Rates of unintended pregnancies among women on ART are high, including women recently initiating ART with lower CD4 counts and higher viral loads. A substantial burden of pregnancy loss was observed. Integration of contraceptive services and counselling into ART care is necessary to reduce maternal and child health risks related to mistimed and unwanted pregnancies. Further research into injectable contraceptive failures on ART is warranted.	[Schwartz, Sheree R.; Rees, Helen; Venter, Willem Daniel Francois; Black, Vivian] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa; [Schwartz, Sheree R.; Mehta, Shruti; Taha, Taha E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	University of Witwatersrand; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Schwartz, SR (corresponding author), Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa.	sschwartz@wrhi.ac.za		Taha, Taha/0000-0001-9814-4894; Venter, Willem/0000-0002-4157-732X; Rees, Helen/0000-0003-1442-6734	United States Centers for Disease Control and Prevention (CDC) public health dissertation [1R36PS001584-01]; Johns Hopkins Bloomberg School of Public Health [1R36PS001584-01]; Johns Hopkins Bloomberg School of Public Health Global Field Experience Fund; PEPFAR (President's Emergency Plan For AIDS Relief); United States Agency for International Development; NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION [R36PS001584] Funding Source: NIH RePORTER	United States Centers for Disease Control and Prevention (CDC) public health dissertation(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Johns Hopkins Bloomberg School of Public Health(Johns Hopkins University); Johns Hopkins Bloomberg School of Public Health Global Field Experience Fund(Johns Hopkins University); PEPFAR (President's Emergency Plan For AIDS Relief); United States Agency for International Development(United States Agency for International Development (USAID)); NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study received funding from the United States Centers for Disease Control and Prevention (CDC) public health dissertation grant 1R36PS001584-01. SS received support from grant 1R36PS001584-01, the Department of Epidemiology Doctoral Student Fund at the Johns Hopkins Bloomberg School of Public Health, and the Johns Hopkins Bloomberg School of Public Health Global Field Experience Fund. The research was conducted in clinics supported by PEPFAR (President's Emergency Plan For AIDS Relief) and the United States Agency for International Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cejtin HE, 2006, OBSTET GYNECOL, V108, P1423, DOI 10.1097/01.AOG.0000245442.29969.5c; Cooper D, 2009, AIDS BEHAV, V13, pS38, DOI 10.1007/s10461-009-9550-1; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Coutsoudis A, 2010, AIDS, V24, P2859, DOI 10.1097/QAD.0b013e32834041b7; Department of Health SA, 2004, NAT ANT TREATM GUID; Desgrees-du-Lou A, 2002, INT J STD AIDS, V13, P462, DOI 10.1258/09564620260079617; El-Ibiary SY, 2008, EUR J CONTRACEP REPR, V13, P123, DOI 10.1080/13625180701829952; Gray RH, 1998, LANCET, V351, P98, DOI 10.1016/S0140-6736(97)09381-1; Heffron R, 2012, LANCET INFECT DIS, V12, P19, DOI 10.1016/S1473-3099(11)70247-X; Homsy J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004149; Kaida A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013868; Kaida A, 2011, AM J PUBLIC HEALTH, V101, P350, DOI 10.2105/AJPH.2009.177469; Karim SSA, 2011, AIDS, V25, P957, DOI 10.1097/QAD.0b013e32834541d9; Makumbi FE, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/519492; Morrison CS, 2007, AIDS, V21, P85, DOI 10.1097/QAD.0b013e3280117c8b; Myer L, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000229; Nattabi B, 2009, AIDS BEHAV, V13, P949, DOI 10.1007/s10461-009-9537-y; Ngure K, 2009, AIDS, V23, pS89, DOI 10.1097/01.aids.0000363781.50580.03; Polis CB, 2010, AIDS, V24, P1937, DOI 10.1097/QAD.0b013e32833b3282; Reid SE, 2010, JAIDS-J ACQ IMM DEF, V53, P606, DOI 10.1097/QAI.0b013e3181bc4869; Reynolds HW, 2006, SEX TRANSM DIS, V33, P350, DOI 10.1097/01.olq.0000194602.01058.e1; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI [10.1002/9780470316696, DOI 10.1002/9780470316696]; Schwartz SR, 2012, AIDS BEHAV, V16, P69, DOI 10.1007/s10461-011-9981-3; Stringer EM, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.03.031; Sweat MD, 2004, AIDS, V18, P1661, DOI 10.1097/01.aids.0000131353.06784.8f; Trussell J, 2004, CONTRACEPTIVE TECHNO; UNAIDS, 2010, UNAIDS REP GLOB AIDS; World Health Organization, 2010, PMTCT STRAT VIS 2010; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	29	104	106	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36039	10.1371/journal.pone.0036039	http://dx.doi.org/10.1371/journal.pone.0036039			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558319	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336000110
J	Sun, Y; Lim, Y; Li, F; Liu, S; Lu, JJ; Haberberger, R; Zhong, JH; Zhou, XF				Sun, Ying; Lim, Yoon; Li, Fang; Liu, Shen; Lu, Jian-Jun; Haberberger, Rainer; Zhong, Jin-Hua; Zhou, Xin-Fu			ProBDNF Collapses Neurite Outgrowth of Primary Neurons by Activating RhoA	PLOS ONE			English	Article							P75 NEUROTROPHIN RECEPTOR; MYELIN-ASSOCIATED GLYCOPROTEIN; NERVE GROWTH-FACTOR; SPINAL-CORD-INJURY; AXON REGENERATION; NOGO RECEPTOR; PRO-BDNF; SIGNAL-TRANSDUCTION; PERIPHERAL-NERVE; SENSORY NEURONS	Background: Neurons extend their dendrites and axons to build functional neural circuits, which are regulated by both positive and negative signals during development. Brain-derived neurotrophic factor (BDNF) is a positive regulator for neurite outgrowth and neuronal survival but the functions of its precursor (proBDNF) are less characterized. Methodology/Principal Findings: Here we show that proBDNF collapses neurite outgrowth in murine dorsal root ganglion (DRG) neurons and cortical neurons by activating RhoA via the p75 neurotrophin receptor (p75NTR). We demonstrated that the receptor proteins for proBDNF, p75NTR and sortilin, were highly expressed in cultured DRG or cortical neurons. ProBDNF caused a dramatic neurite collapse in a dose-dependent manner and this effect was about 500 fold more potent than myelin-associated glycoprotein. Neutralization of endogenous proBDNF by using antibodies enhanced neurite outgrowth in vitro and in vivo, but this effect was lost in p75NTR(-/-) mice. The neurite outgrowth of cortical neurons from p75NTR deficient (p75NTR(-/-)) mice was insensitive to proBDNF. There was a time-dependent reduction of length and number of filopodia in response to proBDNF which was accompanied with a polarized RhoA activation in growth cones. Moreover, proBDNF treatment of cortical neurons resulted in a time-dependent activation of RhoA but not Cdc42 and the effect was absent in p75NTR(-/-) neurons. Rho kinase (ROCK) and the collapsin response mediator protein-2 (CRMP-2) were also involved in the proBDNF action. Conclusions: proBDNF has an opposing role in neurite outgrowth to that of mature BDNF. Our observations suggest that proBDNF collapses neurites outgrowth and filopodial growth cones by activating RhoA through the p75NTR signaling pathway.	[Sun, Ying; Lim, Yoon; Li, Fang; Liu, Shen] Flinders Univ S Australia, Dept Human Physiol, Adelaide, SA 5001, Australia; [Sun, Ying; Lim, Yoon; Li, Fang; Liu, Shen; Haberberger, Rainer] Flinders Univ S Australia, Ctr Neurosci, Adelaide, SA 5001, Australia; [Haberberger, Rainer] Flinders Univ S Australia, Dept Anat & Histol, Adelaide, SA 5001, Australia; [Lim, Yoon; Liu, Shen; Lu, Jian-Jun; Zhong, Jin-Hua; Zhou, Xin-Fu] Univ S Australia, Sansom Inst, Div Hlth Sci, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia	Flinders University South Australia; Flinders University South Australia; Flinders University South Australia; University of South Australia	Sun, Y (corresponding author), Flinders Univ S Australia, Dept Human Physiol, Adelaide, SA 5001, Australia.	Xin-Fu.Zhou@unisa.edu.au	zhou, xin-fu/F-4119-2013; zhou, xin-fu/G-6643-2011; Zhou, Xiaofang/C-6169-2013	zhou, xin-fu/0000-0002-8687-0175; Zhou, Xiaofang/0000-0001-6343-1455; Haberberger, Rainer Viktor/0000-0001-8043-3786; Lim, Yoon/0000-0003-1110-1969	National Health and Medical Research Council (NHMRC ) [595937]; Australian Postgraduate Award at Flinders University; Central South University of China	National Health and Medical Research Council (NHMRC ); Australian Postgraduate Award at Flinders University; Central South University of China	This work was supported by National Health and Medical Research Council (NHMRC grants 595937). Ying Sun was supported by an Australian Postgraduate Award at Flinders University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Miao Yang and Fang Li for helpful suggestions. Fang Li was a visiting scholar from Central South University of China.	Ahmed Z, 2006, FASEB J, V20, P1939, DOI 10.1096/fj.05-5339fje; Bastian I, 2011, HISTOCHEM CELL BIOL, V135, P37, DOI 10.1007/s00418-010-0772-0; Benson MD, 2005, P NATL ACAD SCI USA, V102, P10694, DOI 10.1073/pnas.0504021102; Bentley CA, 2000, J NEUROSCI, V20, P7706; Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; Bradke F, 2000, CURR BIOL, V10, P1467, DOI 10.1016/S0960-9822(00)00807-1; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Fahnestock M, 2004, J NEUROCHEM, V89, P581, DOI 10.1111/j.1471-4159.2004.02360.x; Fan YJ, 2008, EUR J NEUROSCI, V27, P2380, DOI 10.1111/j.1460-9568.2008.06215.x; Fry EJ, 2007, NEURON, V53, P649, DOI 10.1016/j.neuron.2007.02.009; Fujita Y, 2011, EMBO J, V30, P1389, DOI 10.1038/emboj.2011.55; Gallo G, 2000, J NEUROBIOL, V44, P159, DOI 10.1002/1097-4695(200008)44:2<159::AID-NEU6>3.0.CO;2-H; Gehler S, 2004, J NEUROSCI, V24, P4363, DOI 10.1523/JNEUROSCI.0404-04.2004; Grados-Munro EM, 2003, J NEUROSCI RES, V74, P479, DOI 10.1002/jnr.10803; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kater S. B., 1995, Current Opinion in Neurobiology, V5, P68, DOI 10.1016/0959-4388(95)80089-1; Kenchappa RS, 2006, NEURON, V50, P219, DOI 10.1016/j.neuron.2006.03.011; Koshimizu H, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-27; Kuhn TB, 2000, J NEUROBIOL, V44, P126, DOI 10.1002/1097-4695(200008)44:2<126::AID-NEU4>3.0.CO;2-Z; Lee JK, 2010, J NEUROSCI, V30, P10899, DOI 10.1523/JNEUROSCI.2269-10.2010; Lee JK, 2010, NEURON, V66, P663, DOI 10.1016/j.neuron.2010.05.002; Lee JK, 2004, J NEUROSCI, V24, P6209, DOI 10.1523/JNEUROSCI.1643-04.2004; Lee JK, 2011, EXP NEUROL; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Liu XX, 2009, BIOCHEM BIOPH RES CO, V382, P795, DOI 10.1016/j.bbrc.2009.03.115; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Marler KJM, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-30; Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038; McGee AW, 2003, TRENDS NEUROSCI, V26, P193, DOI 10.1016/S0166-2236(03)00062-6; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Nagappan G, 2009, P NATL ACAD SCI USA, V106, P1267, DOI 10.1073/pnas.0807322106; Naska S, 2010, MOL CELL NEUROSCI, V45, P108, DOI 10.1016/j.mcn.2010.05.015; Nguyen N, 2009, NEUROCHEM RES, V34, P942, DOI 10.1007/s11064-008-9848-9; Park KJ, 2010, NAT NEUROSCI, V13, P559, DOI 10.1038/nn.2513; Singh KK, 2008, NAT NEUROSCI, V11, P649, DOI 10.1038/nn.2114; Song XY, 2009, LIFE SCI, V84, P61, DOI 10.1016/j.lfs.2008.10.013; Song XY, 2004, J NEUROSCI, V24, P542, DOI 10.1523/JNEUROSCI.4281-03.2004; Tang XQ, 2004, J NEUROSCI, V24, P819, DOI 10.1523/JNEUROSCI.1263-03.2004; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Tomita K, 2007, GLIA, V55, P1199, DOI 10.1002/glia.20533; Walsh GS, 1999, J NEUROSCI, V19, P4155; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Wang H, 2006, EUR J NEUROSCI, V24, P2444, DOI 10.1111/j.1460-9568.2006.05138.x; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang YJ, 2010, NEUROTOX RES, V17, P257, DOI 10.1007/s12640-009-9098-x; Wong I, 2010, BRAIN BEHAV IMMUN, V24, P585, DOI 10.1016/j.bbi.2010.01.001; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Woo NH, 2005, NAT NEUROSCI, V8, P1069, DOI 10.1038/nn1510; Woolf CJ, 2002, SCIENCE, V297, P1132, DOI 10.1126/science.1076247; Wu D, 2008, J BIOL CHEM, V283, P416, DOI 10.1074/jbc.M703177200; Wu LLY, 2010, J BIOL CHEM, V285, P5614, DOI 10.1074/jbc.M109.073197; Xu ZQ, 2011, EUR J NEUROSCI, V33, P1376, DOI 10.1111/j.1460-9568.2011.07635.x; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; Yang F, 2009, J CELL BIOL, V185, P727, DOI 10.1083/jcb.200811147; Yang JM, 2009, NAT NEUROSCI, V12, P113, DOI 10.1038/nn.2244; Yano H, 2009, J NEUROSCI, V29, P14790, DOI 10.1523/JNEUROSCI.2059-09.2009; Zhang G, 2011, J NEUROSCI, V31, P1664, DOI 10.1523/JNEUROSCI.3829-10.2011; Zheng BH, 2003, NEURON, V38, P213, DOI 10.1016/S0896-6273(03)00225-3; Zhou XF, 2004, J NEUROCHEM, V91, P704, DOI 10.1111/j.1471-4159.2004.02775.x; Zhou XF, 2007, J NEUROSCI RES, V85, P1601, DOI 10.1002/jnr.21220	66	80	86	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35883	10.1371/journal.pone.0035883	http://dx.doi.org/10.1371/journal.pone.0035883			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558255	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000305336000074
J	Swearingen, MC; Porwollik, S; Desai, PT; McClelland, M; Ahmer, BMM				Swearingen, Matthew C.; Porwollik, Steffen; Desai, Prerak T.; McClelland, Michael; Ahmer, Brian M. M.			Virulence of 32 Salmonella Strains in Mice	PLOS ONE			English	Article							ENTERICA SEROTYPE TYPHIMURIUM; CAMELS CAMELUS-DROMEDARIUS; REFERENCE COLLECTION; INFECTION; SEROVAR; IDENTIFICATION; COLONIZATION; ABORTUSOVIS; ATTENUATION; PERSISTENCE	Virulence and persistence in the BALB/c mouse gut was tested for 32 strains of Salmonella enterica for which genome sequencing is complete or underway, including 17 serovars within subspecies I (enterica), and two representatives of each of the other five subspecies. Only serovar Paratyphi C strain BAA1715 and serovar Typhimurium strain 14028 were fully virulent in mice. Three divergent atypical Enteritidis strains were not virulent in BALB/c, but two efficiently persisted. Most of the other strains in all six subspecies persisted in the mouse intestinal tract for several weeks in multiple repeat experiments although the frequency and level of persistence varied considerably. Strains with heavily degraded genomes persisted very poorly, if at all. None of the strains tested provided immunity to Typhimurium infection. These data greatly expand on the known significant strain-to-strain variation in mouse virulence and highlight the need for comparative genomic and phenotypic studies.	[Swearingen, Matthew C.; Ahmer, Brian M. M.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Porwollik, Steffen; Desai, Prerak T.; McClelland, Michael] Vaccine Res Inst San Diego, San Diego, CA USA; [McClelland, Michael] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA USA	University System of Ohio; Ohio State University; University of California System; University of California Irvine	Swearingen, MC (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12Th Ave, Columbus, OH 43210 USA.	ahmer.1@osu.edu	Ahmer, Brian M. M./F-2228-2010; Desai, Prerak/ABF-8529-2020	Ahmer, Brian M. M./0000-0002-4267-7322; McClelland, Michael/0000-0003-1788-9347	National Institute of Allergy and Infectious Disease [R01AI075093, R01AI073971, R01AI097116]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097116, R01AI073971, R01AI075093] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by award numbers R01AI075093 (MM) and R01AI073971 and R01AI097116 (BMMA) from the National Institute of Allergy and Infectious Disease. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angkititrakul Sunpetch, 2005, Southeast Asian J Trop Med Public Health, V36, P1510; ARCHER G. T. L., 1957, JOUR HYG, V55, P513; BARBER C, 1975, ZBL BAKT-INT J MED M, V230, P452; BELTRAN P, 1991, J GEN MICROBIOL, V137, P601, DOI 10.1099/00221287-137-3-601; BESZNYAK I, 1965, ARCH SURG-CHICAGO, V91, P1023; Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4; BOYD EF, 1993, J GEN MICROBIOL, V139, P1125, DOI 10.1099/00221287-139-6-1125; COLLINS FM, 1968, J BACTERIOL, V95, P1343, DOI 10.1128/JB.95.4.1343-1349.1968; Crawford RW, 2008, INFECT IMMUN, V76, P5341, DOI 10.1128/IAI.00786-08; Crawford RW, 2010, J BACTERIOL, V192, P2981, DOI 10.1128/JB.01620-09; Crawford RW, 2010, P NATL ACAD SCI USA, V107, P4353, DOI 10.1073/pnas.1000862107; Dima V F, 1989, Arch Roum Pathol Exp Microbiol, V48, P299; Enriquez C, 2001, Rev Environ Health, V16, P117; Estevan M, 2006, VET MICROBIOL, V118, P124, DOI 10.1016/j.vetmic.2006.07.004; FRANKLIN J, 1968, LAB ANIM CARE, V18, P92; Gonzalez-Escobedo G, 2011, NAT REV MICROBIOL, V9, P9, DOI 10.1038/nrmicro2490; Guibourdenche M, 2009, RES MICROBIOL; HOWARD JG, 1961, NATURE, V191, P87, DOI 10.1038/191087a0; JOSEPH P G, 1984, Southeast Asian Journal of Tropical Medicine and Public Health, V15, P326; Kingsley RA, 2003, INFECT IMMUN, V71, P629, DOI 10.1128/IAI.71.2.629-640.2003; KULKARNI V. B., 1966, INDIAN J PATHOL BACTERIOL, V9, P272; Lan RT, 2009, INFECT GENET EVOL, V9, P996, DOI 10.1016/j.meegid.2009.04.011; LAVERGNE GM, 1977, LAB ANIM SCI, V27, P806; Lazarus R, 2007, SCAND J INFECT DIS, V39, P257, DOI 10.1080/00365540600818037; LEE JA, 1974, J HYG-CAMBRIDGE, V72, P185, DOI 10.1017/S0022172400023391; MacLennan CA, 2010, SCIENCE, V328, P508, DOI 10.1126/science.1180346; Magnino S, 2009, INT J FOOD MICROBIOL, V134, P163, DOI 10.1016/j.ijfoodmicro.2009.07.001; MARGARD WL, 1963, J BACTERIOL, V85, P1451, DOI 10.1128/JB.85.6.1451-1452.1963; Molla B, 2004, TROP ANIM HEALTH PRO, V36, P451, DOI 10.1023/B:TROP.0000035013.01459.c9; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; Monack DM, 2011, CURR OPIN MICROBIOL; MUKKUR TKS, 1991, J MED MICROBIOL, V34, P57, DOI 10.1099/00222615-34-1-57; Nairz M, 2009, CELL MICROBIOL, V11, P1365, DOI 10.1111/j.1462-5822.2009.01337.x; Ogunsanmi A O, 2001, Afr J Med Med Sci, V30, P115; Porta A, 2010, J BACTERIOL, V192, P1999, DOI 10.1128/JB.00990-09; RAY K, 1983, INDIAN J MED RES, V77, P602; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roux CM, 2010, INFECT IMMUN, V78, P1520, DOI 10.1128/IAI.00887-09; SHIMI A, 1979, LAB ANIM, V13, P33, DOI 10.1258/002367779781071258; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Uzzau S, 2005, INFECT IMMUN, V73, P4302, DOI 10.1128/IAI.73.7.4302-4308.2005; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; Warwick C, 2001, J ROY SOC MED, V94, P124, DOI 10.1177/014107680109400306; Weening EH, 2005, INFECT IMMUN, V73, P3358, DOI 10.1128/IAI.73.6.3358-3366.2005; WERNERY U, 1992, BRIT VET J, V148, P445, DOI 10.1016/0007-1935(92)90031-U	45	18	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36043	10.1371/journal.pone.0036043	http://dx.doi.org/10.1371/journal.pone.0036043			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558320	Green Published, gold			2022-12-27	WOS:000305336000111
J	Zeng, H; Li, LF; Chen, JX				Zeng, Heng; Li, Lanfang; Chen, Jian-Xiong			Overexpression of Angiopoietin-1 Increases CD133+/c-kit+ Cells and Reduces Myocardial Apoptosis in db/db Mouse Infarcted Hearts	PLOS ONE			English	Article							PROGENITOR CELLS; BONE-MARROW; ISCHEMIA/REPERFUSION INJURY; CD31(+) CELLS; TOPCARE-AMI; ANGIOGENESIS; ACTIVATION; EXPRESSION; APELIN; TISSUE	Hematopoietic progenitor CD133(+)/c-kit(+) cells have been shown to be involved in myocardial healing following myocardial infarction (MI). Previously we demonstrated that angiopoietin-1(Ang-1) is beneficial in the repair of diabetic infarcted hearts. We now investigate whether Ang-1 affects CD133(+)/c-kit(+) cell recruitment to the infarcted myocardium thereby mediating cardiac repair in type II (db/db) diabetic mice. db/db mice were administered either adenovirus Ang-1 (Ad-Ang-1) or Ad-beta-gal systemically immediately after ligation of the left anterior descending coronary artery ( LAD). Overexpression of Ang-1 resulted in a significant increase in CXCR-4/SDF-1 alpha expression and promoted CD133(+)/c-kit(+), CD133(+)/CXCR-4(+) and CD133(+)/SDF-1 alpha(+) cell recruitment into ischemic hearts. Overexpression of Ang-1 led to significant increases in number of CD31(+) and smooth muscle-like cells and VEGF expression in bone marrow ( BM). This was accompanied by significant decreases in cardiac apoptosis and fibrosis and an increase in myocardial capillary density. Ang-1 also upregulated Jagged-1, Notch3 and apelin expression followed by increases in arteriole formation in the infarcted myocardium. Furthermore, overexpression of Ang-1 resulted in a significant improvement of cardiac functional recovery after 14 days of ischemia. Our data strongly suggest that Ang-1 attenuates cardiac apoptosis and promotes cardiac repair by a mechanism involving in promoting CD133(+)/c-kit(+) cells and angiogenesis in diabetic db/db mouse infarcted hearts.	[Zeng, Heng; Li, Lanfang; Chen, Jian-Xiong] Univ Mississippi Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center	Zeng, H (corresponding author), Univ Mississippi Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA.	JChen3@umc.edu			United States National Institutes of Health [HL102042]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102042] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by a grant from the United States National Institutes of Health, HL102042. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Arboleda-Velasquez JF, 2008, P NATL ACAD SCI USA, V105, P4856, DOI 10.1073/pnas.0709867105; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Barcelos LS, 2009, CIRC RES, V104, P1095, DOI 10.1161/CIRCRESAHA.108.192138; Britten MB, 2003, CIRCULATION, V108, P2212, DOI 10.1161/01.CIR.0000095788.78169.AF; Chen JX, 2008, ARTERIOSCL THROM VAS, V28, P1606, DOI 10.1161/ATVBAHA.108.169235; Chen JX, 2007, AM J PHYSIOL-HEART C, V292, pH1664, DOI 10.1152/ajpheart.01138.2006; Chen JX, 2008, DIABETES, V57, P3335, DOI 10.2337/db08-0503; Chen JX, 2004, J APPL PHYSIOL, V96, P612, DOI 10.1152/japplphysiol.00728.2003; Dallabrida SM, 2008, FASEB J, V22, P3010, DOI 10.1096/fj.07-100966; Dichgans M, 2007, LANCET NEUROL, V6, P149, DOI 10.1016/S1474-4422(07)70028-5; Doi H, 2009, BIOCHEM BIOPH RES CO, V381, P654, DOI 10.1016/j.bbrc.2009.02.116; Eyries M, 2008, CIRC RES, V103, P432, DOI 10.1161/CIRCRESAHA.108.179333; Frederick JR, 2010, CIRCULATION, V122, pS107, DOI 10.1161/CIRCULATIONAHA.109.930404; Glass CE, 2010, HEART FAIL REV, V15, P581, DOI 10.1007/s10741-010-9172-8; High FA, 2009, J CLIN INVEST, V119, P1986, DOI 10.1172/JCI38922; Hu CH, 2010, CLIN EXP PHARMACOL P, V37, P551, DOI 10.1111/j.1440-1681.2010.05347.x; Hu XF, 2007, CIRCULATION, V116, P654, DOI 10.1161/CIRCULATIONAHA.106.672451; Invernici G, 2008, CYTOTECHNOLOGY, V58, P43, DOI 10.1007/s10616-008-9167-7; Isner JM, 1999, J CLIN INVEST, V103, P1231, DOI 10.1172/JCI6889; Joussen AM, 2002, AM J PATHOL, V160, P1683, DOI 10.1016/S0002-9440(10)61115-7; Joutel A, 2010, J CLIN INVEST, V120, P433, DOI 10.1172/JCI39733; Kidoya H, 2008, EMBO J, V27, P522, DOI 10.1038/sj.emboj.7601982; Kim H, 2010, CIRC RES, V107, P602, DOI 10.1161/CIRCRESAHA.110.218396; Kim SW, 2011, REGEN MED, V6, P335, DOI [10.2217/RME.11.24, 10.2217/rme.11.24]; Kim SW, 2010, J AM COLL CARDIOL, V56, P593, DOI 10.1016/j.jacc.2010.01.070; Kunduzova O, 2008, FASEB J, V22, P4146, DOI 10.1096/fj.07-104018; Morrow D, 2008, CARDIOVASC RES, V79, P313, DOI 10.1093/cvr/cvn108; Morrow D, 2007, ARTERIOSCL THROM VAS, V27, P1289, DOI 10.1161/ATVBAHA.107.142778; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; ODOWD BF, 1993, GENE, V136, P355, DOI 10.1016/0378-1119(93)90495-O; Papapetropoulos A, 2000, J BIOL CHEM, V275, P9102, DOI 10.1074/jbc.275.13.9102; Quazi R, 2009, CARDIOL REV, V17, P283, DOI 10.1097/CRD.0b013e3181b3fe0d; Schachinger V, 2004, J AM COLL CARDIOL, V44, P1690, DOI 10.1016/j.jacc.2004.08.014; Suchting Steven, 2007, Novartis Found Symp, V283, P77; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Takahashi K, 2003, MOL THER, V8, P584, DOI 10.1016/S1525-0016(03)00230-2; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Thum T, 2007, DIABETES, V56, P666, DOI 10.2337/db06-0699; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Tuo QH, 2008, AM J PHYSIOL-HEART C, V294, pH2547, DOI 10.1152/ajpheart.01250.2007; Voo S, 2009, J INTERN MED, V265, P238, DOI 10.1111/j.1365-2796.2008.02011.x; Yoon YS, 2005, CIRCULATION, V111, P2073, DOI 10.1161/01.CIR.0000162472.52990.36; Zeng XJ, 2009, PEPTIDES, V30, P1144, DOI 10.1016/j.peptides.2009.02.010; Zubair AC, 2010, CYTOTHERAPY, V12, P178, DOI 10.3109/14653240903493409	45	38	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35905	10.1371/journal.pone.0035905	http://dx.doi.org/10.1371/journal.pone.0035905			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558265	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000081
J	Marshall-Pescini, S; Passalacqua, C; Petrazzini, MEM; Valsecchi, P; Prato-Previde, E				Marshall-Pescini, Sarah; Passalacqua, Chiara; Petrazzini, Maria Elena Miletto; Valsecchi, Paola; Prato-Previde, Emanuela			Do Dogs (Canis lupus familiaris) Make Counterproductive Choices Because They Are Sensitive to Human Ostensive Cues?	PLOS ONE			English	Article							DIFFERENTIAL SENSITIVITY; HUMAN-COMMUNICATION; HUMAN INFANTS; INFORMATION CONFLICT; WOLVES; TRANSMISSION; MECHANISMS; CULTURE; IMITATE	Dogs appear to be sensitive to human ostensive communicative cues in a variety of situations, however there is still a measure of controversy as to the way in which these cues influence human-dog interactions. There is evidence for instance that dogs can be led into making evaluation errors in a quantity discrimination task, for example losing their preference for a larger food quantity if a human shows a preference for a smaller one, yet there is, so far, no explanation for this phenomenon. Using a modified version of this task, in the current study we investigated whether non-social, social or communicative cues (alone or in combination) cause dogs to go against their preference for the larger food quantity. Results show that dogs' evaluation errors are indeed caused by a social bias, but, somewhat contrary to previous studies, they highlight the potent effect of stimulus enhancement (handling the target) in influencing the dogs' response. A mild influence on the dog's behaviour was found only when different ostensive cues (and no handling of the target) were used in combination, suggesting their cumulative effect. The discussion addresses possible motives for discrepancies with previous studies suggesting that both the intentionality and the directionality of the action may be important in causing dogs' social biases.	[Marshall-Pescini, Sarah; Passalacqua, Chiara; Petrazzini, Maria Elena Miletto; Prato-Previde, Emanuela] Univ Milan, Dept Biomed Sci & Technol, I-20133 Milan, Italy; [Valsecchi, Paola] Univ Parma, Dept Evolutionary & Funct Biol, I-43100 Parma, Italy	University of Milan; University of Parma	Marshall-Pescini, S (corresponding author), Univ Milan, Dept Biomed Sci & Technol, I-20133 Milan, Italy.	sarah.marshall@unimi.it	miletto petrazzini, maria elena/GSO-3842-2022	miletto petrazzini, maria elena/0000-0002-5204-5863; Valsecchi, Paola/0000-0002-0491-9845; Marshall-Pescini, Sarah/0000-0002-5944-4701	Milan University	Milan University	This research was supported by a doctoral and post-doctoral grant from Milan University to Chiara Passalacqua and Sarah Marshall-Pescini. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brugger A, 2007, CHILD DEV, V78, P806, DOI 10.1111/j.1467-8624.2007.01034.x; Cladiere N, PSYCHOL B IN PRESS; Csibra G, 2011, PHILOS T R SOC B, V366, P1149, DOI 10.1098/rstb.2010.0319; Fiset S, 2010, SCIENCE, V329, DOI [10.1126/science.1184045, 10.1126/science.1187748]; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Franz M, 2010, P ROY SOC B-BIOL SCI, V277, P3363, DOI 10.1098/rspb.2010.0705; Galef BG, 2001, ANIM BEHAV, V61, P3, DOI 10.1006/anbe.2000.1557; Giraldeau LA, 2002, PHILOS T R SOC B, V357, P1559, DOI 10.1098/rstb.2002.1065; HEYES CM, 1994, BIOL REV, V69, P207, DOI 10.1111/j.1469-185X.1994.tb01506.x; Hopper LM, 2011, ANIM BEHAV, V81, P1195, DOI 10.1016/j.anbehav.2011.03.002; Hoppitt W, 2008, ADV STUD BEHAV, V38, P105, DOI 10.1016/S0065-3454(08)00003-X; Kaminski J, 2012, DEVELOPMENTAL SCI, V15, P222, DOI 10.1111/j.1467-7687.2011.01120.x; Kaminski J, 2011, ANIM BEHAV, V81, P195, DOI 10.1016/j.anbehav.2010.10.001; Kendal RL, 2004, BEHAV ECOL, V15, P269, DOI 10.1093/beheco/arh008; Kupan K, 2011, ANIM COGN, V14, P259, DOI 10.1007/s10071-010-0359-0; Laland KN, 1998, BEHAV ECOL, V9, P493, DOI 10.1093/beheco/9.5.493; Laland KN, 2004, LEARN BEHAV, V32, P4; Lyons DE, 2007, PNAS, V104, P1158; Lyons DE, 2011, PHILOS T R SOC B, V366, P1158, DOI 10.1098/rstb.2010.0335; Marshall-Pescini S, 2011, ANIM COGN, V14, P137, DOI 10.1007/s10071-010-0340-y; Marshall-Pescini S, 2008, ANIM COGN, V11, P449, DOI 10.1007/s10071-007-0135-y; Mersmann D, 2011, ETHOLOGY, V117, P675, DOI 10.1111/j.1439-0310.2011.01919.x; Nielsen M, 2006, DEV PSYCHOL, V42, P555, DOI 10.1037/0012-1649.42.3.555; Pongracz P, 2004, J COMP PSYCHOL, V118, P375, DOI 10.1037/0735-7036.118.4.375; Prato-Previde E, 2008, ANIM COGN, V11, P167, DOI 10.1007/s10071-007-0102-7; Price EE, 2009, P ROY SOC B-BIOL SCI, V276, P3377, DOI 10.1098/rspb.2009.0640; Range F, 2007, CURR BIOL, V17, P868, DOI 10.1016/j.cub.2007.04.026; Range F, 2009, APPL ANIM BEHAV SCI, V120, P170, DOI 10.1016/j.applanim.2009.05.012; Rieucau G, 2011, PHILOS T R SOC B, V366, P949, DOI 10.1098/rstb.2010.0325; Southgate V, 2009, DEVELOPMENTAL SCI, V12, P1013, DOI 10.1111/j.1467-7687.2009.00861.x; Szetei V, 2003, APPL ANIM BEHAV SCI, V83, P141, DOI 10.1016/S0168-1591(03)00114-X; Tennie C, 2009, ANIM BEHAV, V77, P1491, DOI 10.1016/j.anbehav.2009.03.008; Topal J, 2008, SCIENCE, V321, P1831, DOI 10.1126/science.1161437; Topal J, 2010, SCIENCE, V329, DOI 10.1126/science.1184152; Topal J, 2009, SCIENCE, V325, P1269, DOI 10.1126/science.1176960; van Bergen Y, 2004, P ROY SOC B-BIOL SCI, V271, P957, DOI 10.1098/rspb.2004.2684; WHITEN A, 1992, ADV STUD BEHAV, V21, P239, DOI 10.1016/S0065-3454(08)60146-1; Woodward AL, 1998, COGNITION, V69, P1, DOI 10.1016/S0010-0277(98)00058-4; WOODWARD AL, 1999, INFANT BEHAV DEV, V17, P515	39	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35437	10.1371/journal.pone.0035437	http://dx.doi.org/10.1371/journal.pone.0035437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558150	Green Published, gold			2022-12-27	WOS:000305345200040
J	Ogilvie, LA; Caplin, J; Dedi, C; Diston, D; Cheek, E; Bowler, L; Taylor, H; Ebdon, J; Jones, BV				Ogilvie, Lesley A.; Caplin, Jonathan; Dedi, Cinzia; Diston, David; Cheek, Elizabeth; Bowler, Lucas; Taylor, Huw; Ebdon, James; Jones, Brian V.			Comparative (Meta)genomic Analysis and Ecological Profiling of Human Gut-Specific Bacteriophage phi B124-14	PLOS ONE			English	Article							COMPARATIVE METAGENOMIC ANALYSIS; BACTEROIDES-FRAGILIS; FECAL POLLUTION; COMPUTATIONAL TOOL; PLASMIDS RESIDENT; MOBILE METAGENOME; TRACKING SOURCES; VIRAL COMMUNITY; DNA-SEQUENCES; HOST STRAINS	Bacteriophage associated with the human gut microbiome are likely to have an important impact on community structure and function, and provide a wealth of biotechnological opportunities. Despite this, knowledge of the ecology and composition of bacteriophage in the gut bacterial community remains poor, with few well characterized gut-associated phage genomes currently available. Here we describe the identification and in-depth (meta) genomic, proteomic, and ecological analysis of a human gut-specific bacteriophage (designated phi B124-14). In doing so we illuminate a fraction of the biological dark matter extant in this ecosystem and its surrounding eco-genomic landscape, identifying a novel and uncharted bacteriophage gene-space in this community. phi B124-14 infects only a subset of closely related gut-associated Bacteroides fragilis strains, and the circular genome encodes functions previously found to be rare in viral genomes and human gut viral metagenome sequences, including those which potentially confer advantages upon phage and/or host bacteria. Comparative genomic analyses revealed phi B124-14 is most closely related to phi B40-8, the only other publically available Bacteroides sp. phage genome, whilst comparative metagenomic analysis of both phage failed to identify any homologous sequences in 136 non-human gut metagenomic datasets searched, supporting the human gut-specific nature of this phage. Moreover, a potential geographic variation in the carriage of these and related phage was revealed by analysis of their distribution and prevalence within 151 human gut microbiomes and viromes from Europe, America and Japan. Finally, ecological profiling of phi B124-14 and phi B40-8, using both gene-centric alignment-driven phylogenetic analyses, as well as alignment-free gene-independent approaches was undertaken. This not only verified the human gut-specific nature of both phage, but also indicated that these phage populate a distinct and unexplored ecological landscape within the human gut microbiome.	[Ogilvie, Lesley A.; Dedi, Cinzia; Jones, Brian V.] Univ Brighton, Sch Pharm & Biomol Sci, Ctr Biomed & Hlth Sci Res, Brighton, E Sussex, England; [Caplin, Jonathan; Diston, David; Taylor, Huw; Ebdon, James] Univ Brighton, Sch Environm & Technol, Brighton, E Sussex, England; [Cheek, Elizabeth] Univ Brighton, Sch Comp Engn & Math, Brighton, E Sussex, England; [Bowler, Lucas] Univ Sussex, Sussex Prote Ctr, Brighton, E Sussex, England	University of Brighton; University of Brighton; University of Brighton; University of Sussex	Ogilvie, LA (corresponding author), Univ Brighton, Sch Pharm & Biomol Sci, Ctr Biomed & Hlth Sci Res, Brighton, E Sussex, England.	B.V.Jones@Brighton.ac.uk		Ogilvie, Lesley/0000-0001-9794-2915; Bowler, Lucas/0000-0002-7004-8021; Jones, Brian/0000-0002-1211-9186; Ebdon, James/0000-0003-0649-8076	Medical Research Council [93344/G0901553]; Hospital Infection Society; Royal Society; Society for Applied Microbiology; University of Brighton; European Union; MRC [G0901553] Funding Source: UKRI; Medical Research Council [G0901553] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Hospital Infection Society; Royal Society(Royal Society of London); Society for Applied Microbiology; University of Brighton; European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Dr. Lesley Ogilvie is supported by funding from the Medical Research Council (Grant ID number 93344/G0901553 awarded to Dr. B. V. Jones). Research in the laboratory of Dr. B. V. Jones is also supported by funding from the Hospital Infection Society, The Royal Society, The Society for Applied Microbiology, The University of Brighton, and the European Union (FP7 Marie Curie IAPP scheme). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barr JJ, 2010, FEMS MICROBIOL ECOL, V74, P631, DOI 10.1111/j.1574-6941.2010.00967.x; BERGAN T, 1968, ACTA PATHOL MIC SC, V74, P421; Birge E.A., 2000, BACTERIAL BACTERIOPH, V4th ed.; Blanch AR, 2006, APPL ENVIRON MICROB, V72, P5915, DOI 10.1128/AEM.02453-05; Borysowski J, 2006, EXP BIOL MED, V231, P366, DOI 10.1177/153537020623100402; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Brockhurst Michael A., 2006, BMC Ecology, V6, P19, DOI 10.1186/1472-6785-6-19; CARRERAS CW, 1995, ANNU REV BIOCHEM, V64, P721, DOI 10.1146/annurev.bi.64.070195.003445; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Chirico N, 2010, P ROY SOC B-BIOL SCI, V277, P3809, DOI 10.1098/rspb.2010.1052; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Deschavanne P, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-163; Duhaime MB, 2011, ISME J, V5, P107, DOI 10.1038/ismej.2010.94; Ebdon J, 2007, WATER RES, V41, P3683, DOI 10.1016/j.watres.2006.12.020; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Escartin F, 2008, P NATL ACAD SCI USA, V105, P9948, DOI 10.1073/pnas.0801356105; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gomez P, 2011, SCIENCE, V332, P106, DOI 10.1126/science.1198767; Gomez-Donate M, 2011, ENVIRON MICROBIOL, V13, P1622, DOI 10.1111/j.1462-2920.2011.02474.x; Gorski A, 2006, FEMS IMMUNOL MED MIC, V46, P313, DOI 10.1111/j.1574-695X.2006.00044.x; Goudie AD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-615; Grabow WOK, 2001, WATER SA, V27, P251; Groth AC, 2004, J MOL BIOL, V335, P667, DOI 10.1016/j.jmb.2003.09.082; HAGGARDLJUNGQUIST E, 1992, J BACTERIOL, V174, P1462, DOI 10.1128/jb.174.5.1462-1477.1992; Hanlon GW, 2007, INT J ANTIMICROB AG, V30, P118, DOI 10.1016/j.ijantimicag.2007.04.006; Hawkins SA, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-97; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; ISO, 2001, 107054 ISO; Johnson ZI, 2004, GENOME RES, V14, P2268, DOI 10.1101/gr.2433104; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; Jones BV, 2007, MOL BIOSYST, V3, P749, DOI 10.1039/b705657e; Jones BV, 2007, NAT METHODS, V4, P55, DOI 10.1038/NMETH964; Jones BV, 2010, GUT MICROBES, V1, P415, DOI 10.4161/gmic.1.6.14087; Jones BV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-46; Joo J, 2006, P ROY SOC B-BIOL SCI, V273, P1843, DOI 10.1098/rspb.2006.3512; Kang S, 2010, INFLAMM BOWEL DIS, V16, P2034, DOI 10.1002/ibd.21319; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kunin V, 2008, GENOME RES, V18, P293, DOI 10.1101/gr.6835308; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lee JE, 2009, APPL ENVIRON MICROB, V75, P7107, DOI 10.1128/AEM.00464-09; Lepage P, 2008, GUT, V57, DOI 10.1136/gut.2007.134668; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Lima-Mendez G, 2008, BIOINFORMATICS, V24, P863, DOI 10.1093/bioinformatics/btn043; LINDEROTH NA, 1991, NUCLEIC ACIDS RES, V19, P7207, DOI 10.1093/nar/19.25.7207; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Man SM, 2011, NAT REV GASTRO HEPAT, V8, P152, DOI 10.1038/nrgastro.2011.3; Martosella J, 2005, J PROTEOME RES, V4, P1522, DOI 10.1021/pr050088l; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mikoulinskaia GV, 2009, FEBS J, V276, P7329, DOI 10.1111/j.1742-4658.2009.07443.x; Niemz A, 2011, TRENDS BIOTECHNOL, V29, P240, DOI 10.1016/j.tibtech.2011.01.007; Nnane DE, 2011, WATER RES, V45, P2235, DOI 10.1016/j.watres.2011.01.018; Ogilvie LA, 2012, BIOENGINEERED, V3, P13, DOI 10.4161/bbug.3.1.17883; Park S, 2011, BIOTECHNOL ADV, V29, P830, DOI 10.1016/j.biotechadv.2011.06.017; Payan A, 2005, APPL ENVIRON MICROB, V71, P5659, DOI 10.1128/AEM.71.9.5659-5662.2005; PRUSS GJ, 1975, J MOL BIOL, V98, P465, DOI 10.1016/S0022-2836(75)80080-5; Puig A, 1999, APPL ENVIRON MICROB, V65, P1772; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Queralt N, 2003, CURR MICROBIOL, V46, P163, DOI 10.1007/s00284-002-3813-7; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Rocha EPC, 2002, TRENDS GENET, V18, P291, DOI 10.1016/S0168-9525(02)02690-2; Rohwer F, 2003, CELL, V113, P141, DOI 10.1016/S0092-8674(03)00276-9; Rohwer F, 2009, ENVIRON MICROBIOL, V11, P2771, DOI 10.1111/j.1462-2920.2009.02101.x; Roucourt B, 2009, ENVIRON MICROBIOL, V11, P2789, DOI 10.1111/j.1462-2920.2009.02029.x; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sandaa RA, 2009, ENVIRON MICROBIOL, V11, P2585, DOI 10.1111/j.1462-2920.2009.01983.x; SANTOS MA, 1991, NUCLEIC ACIDS RES, V19, P5442, DOI 10.1093/nar/19.19.5442; Scott AE, 2007, ENVIRON MICROBIOL, V9, P2341, DOI 10.1111/J.1462-2920.2007.01351.x; Scott TM, 2002, APPL ENVIRON MICROB, V68, P5796, DOI 10.1128/AEM.68.12.5796-5803.2002; Shapiro OH, 2010, ISME J, V4, P327, DOI 10.1038/ismej.2009.118; Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI [10.1099/ijs.0.02360-0, 10.1099/00207713-52-3-1043]; Stern A, 2010, SYST BIOL, V59, P212, DOI 10.1093/sysbio/syp104; Sun SL, 2011, NUCLEIC ACIDS RES, V39, pD546, DOI 10.1093/nar/gkq1102; Suzuki Haruo, 2008, Nucleic Acids Res, V36, pe147, DOI 10.1093/nar/gkn753; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TARTERA C, 1987, APPL ENVIRON MICROB, V53, P1632, DOI 10.1128/AEM.53.7.1632-1637.1987; Teeling H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-163; Teeling H, 2004, ENVIRON MICROBIOL, V6, P938, DOI 10.1111/j.1462-2920.2004.00624.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; Vijayavel K, 2010, WATER RES, V44, P3714, DOI 10.1016/j.watres.2010.04.012; Waldor MK, 2005, PHAGES THEIR ROLE BA; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; WARREN RAJ, 1980, ANNU REV MICROBIOL, V34, P137, DOI 10.1146/annurev.mi.34.100180.001033; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156; YAMAMOTO KR, 1970, VIROLOGY, V40, P734, DOI 10.1016/0042-6822(70)90218-7; Yooseph S, 2007, PLOS BIOL, V5, pe16, DOI DOI 10.1371/journal.pbio.0050016; Zafar N, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-12; Zaneveld JR, 2010, NUCLEIC ACIDS RES, V38, P3869, DOI 10.1093/nar/gkq066; Zhang T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/journal.pbio.0040003	92	42	43	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35053	10.1371/journal.pone.0035053	http://dx.doi.org/10.1371/journal.pone.0035053			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558115	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345200021
J	Patel, MV; Ghosh, M; Fahey, JV; Wira, CR				Patel, Mickey V.; Ghosh, Mimi; Fahey, John V.; Wira, Charles R.			Uterine Epithelial Cells Specifically Induce Interferon-Stimulated Genes in Response to Polyinosinic-Polycytidylic Acid Independently of Estradiol	PLOS ONE			English	Article							FEMALE REPRODUCTIVE-TRACT; HERPES-SIMPLEX-VIRUS; DOUBLE-STRANDED-RNA; INNATE IMMUNITY; CHEMOKINE PRODUCTION; ANTIVIRAL RESPONSES; VIRAL REPLICATION; HIV-1 REPLICATION; TYPE-1 INFECTION; MESSENGER-RNA	Interferon beta (IFN beta) is an antiviral cytokine secreted in response to pathogenic exposure that creates a restrictive intracellular environment through the action of downstream interferon-stimulated genes (ISG). The objective of this study was to examine the expression of IFN beta and ISG in both human uterine epithelial cells (UEC) and the ECC-1 uterine epithelial cell line and determine if expression changes with TLR stimulation and hormone exposure. Stimulation of primary uterine epithelial cells and ECC-1 cells with the TLR3 agonist poly (I: C) induced the mRNA expression of IFN beta, MxA, OAS2 and PKR. Other TLR agonists including imiquimod and CpG had no effect on either IFN beta or ISG expression. In contrast to ECC-1 cell responses which were slower, maximal IFNb upregulation in UEC occurred 3 hours post-stimulation and preceded the ISG response which peaked approximately 12 hours after poly (I: C) exposure. Unexpectedly, estradiol, either alone or prior to treatment with poly (I: C), had no effect on IFN beta or ISG expression. Blockade of the IFN receptor abrogated the upregulation of MxA, OAS2 and PKR. Furthermore, neutralizing antibodies against IFN beta partially inhibited the upregulation of all three ISG. Estradiol, directly and in the presence of poly (I: C) had no effect on IFN beta and ISG expression. These results indicate that uterine epithelial cells are important sentinels of the innate immune system and demonstrate that uterine epithelial cells are capable of mounting a rapid IFN-mediated antiviral response that is independent of estradiol and is therefore potentially sustained throughout the menstrual cycle to aid in the defense of the uterus against potential pathogens.	[Patel, Mickey V.; Ghosh, Mimi; Fahey, John V.; Wira, Charles R.] Dartmouth Med Sch, Dept Physiol & Neurobiol, Lebanon, NH USA	Dartmouth College	Patel, MV (corresponding author), Dartmouth Med Sch, Dept Physiol & Neurobiol, Lebanon, NH USA.	mickey.patel@dartmouth.edu			National Institute of Health [AI51877, AI071761]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071761, P01AI051877, R01AI102838, R56AI071761] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by AI51877 and AI071761 (awarded to Dr. Wira) from National Institute of Health (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson ME, 1999, EUR J BIOCHEM, V264, P806, DOI 10.1046/j.1432-1327.1999.00661.x; Akhtar LN, 2010, J IMMUNOL, V185, P2393, DOI 10.4049/jimmunol.0903563; Andersen JM, 2006, BIOL REPROD, V74, P824, DOI 10.1095/biolreprod.105.048629; Austin BA, 2005, J IMMUNOL, V175, P1100, DOI 10.4049/jimmunol.175.2.1100; Axtell RC, 2011, TRENDS IMMUNOL, V32, P272, DOI 10.1016/j.it.2011.03.008; Bisbal C, 2007, BIOCHIMIE, V89, P789, DOI 10.1016/j.biochi.2007.02.006; Bode JG, 2007, ARCH BIOCHEM BIOPHYS, V462, P254, DOI 10.1016/j.abb.2007.03.033; Brand S, 2005, AM J PHYSIOL-GASTR L, V289, pG960, DOI 10.1152/ajpgi.00126.2005; Brand S, 2005, BIOCHEM BIOPH RES CO, V331, P543, DOI 10.1016/j.bbrc.2005.04.004; Clerzius G, 2009, J VIROL, V83, P10119, DOI 10.1128/JVI.02457-08; Conrady CD, 2011, J VIROL, V85, P1625, DOI 10.1128/JVI.01715-10; Damdinsuren B, 2003, ANN SURG ONCOL, V10, P1184, DOI 10.1245/ASO.2003.03.010; Dogusan Z, 2008, DIABETES, V57, P1236, DOI 10.2337/db07-0844; Escribese MM, 2008, BLOOD, V112, P4574, DOI 10.1182/blood-2008-04-148692; Fahey JV, 2008, MUCOSAL IMMUNOL, V1, P317, DOI 10.1038/mi.2008.20; Fahey JV, 2005, HUM REPROD, V20, P1439, DOI 10.1093/humrep/deh806; Fahey JV, 2002, J INFECT DIS, V185, P1606, DOI 10.1086/340512; Farnell YZ, 2003, J STEROID BIOCHEM, V84, P453, DOI 10.1016/S0960-0760(03)00066-9; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Ghosh M, 2010, IMMUNOLOGY, V129, P207, DOI 10.1111/j.1365-2567.2009.03165.x; Haller O, 2007, BIOCHIMIE, V89, P812, DOI 10.1016/j.biochi.2007.04.015; Hart KM, 2009, J REPROD IMMUNOL, V80, P33, DOI 10.1016/j.jri.2008.12.004; Hovanessian AG, 2007, BIOCHIMIE, V89, P779, DOI 10.1016/j.biochi.2007.02.003; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim CH, 2010, ARCH DERMATOL RES, V302, P301, DOI 10.1007/s00403-009-1012-0; Ku CC, 2011, IMMUNOL CELL BIOL, V89, P173, DOI 10.1038/icb.2010.83; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Lesmeister MJ, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-74; Maitra RK, 1998, J VIROL, V72, P1146, DOI 10.1128/JVI.72.2.1146-1152.1998; Martinand C, 1999, J VIROL, V73, P290, DOI 10.1128/JVI.73.1.290-296.1999; Mo B, 2006, BIOL REPROD, V75, P387, DOI 10.1095/biolreprod.106.051870; Mordstein M, 2010, J VIROL, V84, P5670, DOI 10.1128/JVI.00272-10; Murphy JA, 2003, J VIROL, V77, P9337, DOI 10.1128/JVI.77.17.9337-9345.2003; Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926; Nazli A, 2009, ANTIVIR RES, V81, P103, DOI 10.1016/j.antiviral.2008.10.005; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Novick D, 2000, J INTERF CYTOK RES, V20, P971, DOI 10.1089/10799900050198417; Nurkkala M, 2007, J REPROD IMMUNOL, V73, P148, DOI 10.1016/j.jri.2006.09.001; Pauli EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000196; Pentecost BT, 1998, J STEROID BIOCHEM, V64, P25, DOI 10.1016/S0960-0760(97)00140-4; Pioli PA, 2004, INFECT IMMUN, V72, P5799, DOI 10.1128/IAI.72.10.5799-5806.2004; PITHA PM, 1994, ANTIVIR RES, V24, P205, DOI 10.1016/0166-3542(94)90068-X; Rintahaka J, 2008, J IMMUNOL, V180, P1749, DOI 10.4049/jimmunol.180.3.1749; Schaefer TM, 2004, IMMUNOLOGY, V112, P428, DOI 10.1111/j.1365-2567.2004.01898.x; Schaefer TM, 2005, J IMMUNOL, V174, P992, DOI 10.4049/jimmunol.174.2.992; Schindler C.W., 2011, J BIOL CHEM; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Sen GC, 2007, CURR TOP MICROBIOL, V316, P233; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Trapp S, 2009, J VIROL, V83, P884, DOI 10.1128/JVI.00023-08; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Vlotides G, 2004, BIOCHEM BIOPH RES CO, V320, P1007, DOI 10.1016/j.bbrc.2004.06.051; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Wira CR, 2010, AM J REPROD IMMUNOL, V63, P544, DOI 10.1111/j.1600-0897.2010.00842.x; Yao XD, 2011, J GEN VIROL, V92, P1981, DOI 10.1099/vir.0.030296-0; Zhang SY, 2008, IMMUNOL REV, V226, P29, DOI 10.1111/j.1600-065X.2008.00698.x	58	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35654	10.1371/journal.pone.0035654	http://dx.doi.org/10.1371/journal.pone.0035654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558189	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345200061
J	Adhikari, BN; Savory, EA; Vaillancourt, B; Childs, KL; Hamilton, JP; Day, B; Buell, CR				Adhikari, Bishwo N.; Savory, Elizabeth A.; Vaillancourt, Brieanne; Childs, Kevin L.; Hamilton, John P.; Day, Brad; Buell, C. Robin			Expression Profiling of Cucumis sativus in Response to Infection by Pseudoperonospora cubensis	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; DOWNY MILDEW INFECTION; GENE-EXPRESSION; RNA-SEQ; DISEASE RESISTANCE; PLANT; TRANSCRIPTOME; ACCUMULATION; ARABIDOPSIS; GENOME	The oomycete pathogen, Pseudoperonospora cubensis, is the causal agent of downy mildew on cucurbits, and at present, no effective resistance to this pathogen is available in cultivated cucumber (Cucumis sativus). To better understand the host response to a virulent pathogen, we performed expression profiling throughout a time course of a compatible interaction using whole transcriptome sequencing. As described herein, we were able to detect the expression of 15,286 cucumber genes, of which 14,476 were expressed throughout the infection process from 1 day post-inoculation (dpi) to 8 dpi. A large number of genes, 1,612 to 3,286, were differentially expressed in pair-wise comparisons between time points. We observed the rapid induction of key defense related genes, including catalases, chitinases, lipoxygenases, peroxidases, and protease inhibitors within 1 dpi, suggesting detection of the pathogen by the host. Co-expression network analyses revealed transcriptional networks with distinct patterns of expression including down-regulation at 2 dpi of known defense response genes suggesting coordinated suppression of host responses by the pathogen. Comparative analyses of cucumber gene expression patterns with that of orthologous Arabidopsis thaliana genes following challenge with Hyaloperonospora arabidopsidis revealed correlated expression patterns of single copy orthologs suggesting that these two dicot hosts have similar transcriptional responses to related pathogens. In total, the work described herein presents an in-depth analysis of the interplay between host susceptibility and pathogen virulence in an agriculturally important pathosystem.	[Adhikari, Bishwo N.; Vaillancourt, Brieanne; Childs, Kevin L.; Hamilton, John P.; Buell, C. Robin] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Savory, Elizabeth A.; Day, Brad] Michigan State Univ, Dept Plant Pathol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Adhikari, BN (corresponding author), Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA.	buell@msu.edu	Hamilton, John P/G-1379-2016; Adhikari, Bishwo/E-8144-2013; Childs, Kevin/C-9513-2014	Hamilton, John P/0000-0002-8682-5526; Adhikari, Bishwo/0000-0003-1594-8470; Buell, C Robin/0000-0002-6727-4677; Vaillancourt, Brieanne/0000-0002-6795-5173; Childs, Kevin/0000-0002-3680-062X; Day, Brad/0000-0002-9880-4319; Adhikari, Bishwo/0000-0003-4840-9609; Savory, Elizabeth/0000-0002-6016-9962	United States Department of Agriculture National Institute for Food and Agriculture [2009-65109-05719, 2011-67011-30758]; National Science Foundation Faculty Early Career Development Award [IOS-0641319]	United States Department of Agriculture National Institute for Food and Agriculture(United States Department of Agriculture (USDA)); National Science Foundation Faculty Early Career Development Award(National Science Foundation (NSF))	Phytopathogen work in the laboratory of CRB was supported by a grant from the United States Department of Agriculture National Institute for Food and Agriculture (2009-65109-05719). Work in the laboratory of BD was supported by a grant from the United States Department of Agriculture National Institute for Food and Agriculture (2011-67011-30758) and in part by a National Science Foundation Faculty Early Career Development Award (IOS-0641319). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 2010, J AM SOC HORTIC SCI, V135, P291, DOI 10.21273/JASHS.135.4.291; Arauz LF, 2010, PHYTOPATHOLOGY, V100, P959, DOI 10.1094/PHYTO-100-9-0959; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Baysal T, 2007, ENZYME MICROB TECH, V40, P491, DOI 10.1016/j.enzmictec.2006.11.025; Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Bernoux M, 2008, PLANT CELL, V20, P2252, DOI 10.1105/tpc.108.058685; Boddu J, 2007, MOL PLANT MICROBE IN, V20, P1364, DOI 10.1094/MPMI-20-11-1364; Brader G, 2007, MOL PLANT MICROBE IN, V20, P589, DOI 10.1094/MPMI-20-5-0589; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Coates ME, 2010, ANNU REV PHYTOPATHOL, V48, P329, DOI 10.1146/annurev-phyto-080508-094422; Cohen Y, 2003, PHYTOPARASITICA, V31, P458, DOI 10.1007/BF02979739; Colucci S. J., 2006, P CUC 2006; Criswell A, 2008, THESIS NCSU; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gaulin E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001723; Guo SG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-384; Gupta S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009030; Hammerschmidt R, 1999, ANNU REV PHYTOPATHOL, V37, P285, DOI 10.1146/annurev.phyto.37.1.285; Hammerschmidt R, 1999, PHYSIOL MOL PLANT P, V55, P77, DOI 10.1006/pmpp.1999.0215; Hilaire E, 2001, MOL PLANT MICROBE IN, V14, P1411, DOI 10.1094/MPMI.2001.14.12.1411; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Huibers RP, 2009, MOL PLANT MICROBE IN, V22, P1104, DOI 10.1094/MPMI-22-9-1104; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Knepper Caleb, 2010, Arabidopsis Book, V8, pe012, DOI 10.1199/tab.0124; Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lebeda A, 2002, ACTA HORTIC, P137, DOI 10.17660/ActaHortic.2002.588.20; Lebeda A, 2003, Z PFLANZENK PFLANZEN, V110, P337; Lebeda A., 2004, ACTA FYTOTECH ZOOTEC, V7, P170; Lebeda A, 2011, J PHYTOPATHOL, V159, P589, DOI 10.1111/j.1439-0434.2011.01811.x; Li JW, 2011, PLANT CELL REP, V30, P345, DOI 10.1007/s00299-010-0959-9; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lough TJ, 2006, ANNU REV PLANT BIOL, V57, P203, DOI 10.1146/annurev.arplant.56.032604.144145; Miranda M, 2007, MOL PLANT MICROBE IN, V20, P816, DOI 10.1094/MPMI-20-7-0816; Olczak-Woltman H, 2009, J APPL GENET, V50, P1, DOI 10.1007/BF03195645; Phuntumart V, 2006, PLANT SCI, V171, P555, DOI 10.1016/j.plantsci.2006.05.014; Polesani M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-142; Polesani M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-117; Ren Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005795; Runge F, 2011, EUR J PLANT PATHOL, V129, P135, DOI 10.1007/s10658-010-9714-x; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sarris P, 2009, PLANT PATHOL, V58, P933, DOI 10.1111/j.1365-3059.2009.02093.x; Savory E, 2012, PLOS ONE IN PRESS; Savory EA, 2011, MOL PLANT PATHOL, V12, P217, DOI 10.1111/j.1364-3703.2010.00670.x; Shetty NV, 2002, SCI HORTIC-AMSTERDAM, V94, P231, DOI 10.1016/S0304-4238(02)00013-4; Sticher L, 1997, ANNU REV PHYTOPATHOL, V35, P235, DOI 10.1146/annurev.phyto.35.1.235; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Takemoto Daigo, 2001, Journal of General Plant Pathology, V67, P89, DOI 10.1007/PL00013005; Taler D, 2004, PLANT CELL, V16, P172, DOI 10.1105/tpc.016352; Tanurdzic M, 2004, PLANT CELL, V16, pS61, DOI 10.1105/tpc.016667; THOMAS CE, 1987, PHYTOPATHOLOGY, V77, P1621, DOI 10.1094/Phyto-77-1621; Tian MY, 2011, MOL PLANT MICROBE IN, V24, P543, DOI 10.1094/MPMI-08-10-0185; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Varbanova M, 2011, PLANT PHYSIOL, V157, P1056, DOI 10.1104/pp.111.184358; Volk GM, 2003, J AM SOC HORTIC SCI, V128, P8, DOI 10.21273/JASHS.128.1.0008; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang W, 2011, NATURE, V470, P110, DOI 10.1038/nature09766; Wehner T.C., 2010, CUCURBI GENET COOP R, V28, P105; Woycicki R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022728; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	63	42	47	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e34954	10.1371/journal.pone.0034954	http://dx.doi.org/10.1371/journal.pone.0034954			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545095	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343200017
J	Johnston, CA; Doe, CQ; Prehoda, KE				Johnston, Christopher A.; Doe, Chris Q.; Prehoda, Kenneth E.			Structure of an Enzyme-Derived Phosphoprotein Recognition Domain	PLOS ONE			English	Article							ASYMMETRIC CELL-DIVISION; GUANYLATE KINASE DOMAINS; SPINDLE ORIENTATION; PROTEIN; BINDING; POLARITY; ACTIVATION; MECHANISM; EVOLUTION; HOMOLOG	Membrane Associated Guanylate Kinases (MAGUKs) contain a protein interaction domain (GK(dom)) derived from the enzyme Guanylate Kinase (GK(enz)). Here we show that GK(dom) from the MAGUK Discs large (Dlg) is a phosphoprotein recognition domain, specifically recognizing the phosphorylated form of the mitotic spindle orientation protein Partner of Inscuteable (Pins). We determined the structure of the Dlg-Pins complex to understand the dramatic transition from nucleotide kinase to phosphoprotein recognition domain. The structure reveals that the region of the GK(dom) that once served as the GMP binding domain (GBD) has been co-opted for protein interaction. Pins makes significantly more contact with the GBD than does GMP, but primarily with residues that are conserved between enzyme and domain revealing the versatility of the GBD as a platform for nucleotide and protein interactions. Mutational analysis reveals that the GBD is also used to bind the GK ligand MAP1a, suggesting that this is a common mode of MAGUK complex assembly. The GK(enz) undergoes a dramatic closing reaction upon GMP binding but the protein-bound GK(dom) remains in the 'open' conformation indicating that the dramatic conformational change has been lost in the conversion from nucleotide kinase to phosphoprotein recognition domain.	[Johnston, Christopher A.; Doe, Chris Q.; Prehoda, Kenneth E.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Johnston, Christopher A.; Doe, Chris Q.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; [Johnston, Christopher A.; Doe, Chris Q.] Univ Oregon, Howard Hughes Med Inst, Eugene, OR 97403 USA	University of Oregon; University of Oregon; Howard Hughes Medical Institute; University of Oregon	Johnston, CA (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	prehoda@molbio.uoregon.edu		Prehoda, Ken/0000-0003-4214-6158	National Institutes of Health [GM087457]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health grant GM087457. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwood SX, 2007, J CELL SCI, V120, P3200, DOI 10.1242/jcs.014902; Atwood SX, 2009, CURR BIOL, V19, P723, DOI 10.1016/j.cub.2009.03.056; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Blaszczyk J, 2001, J MOL BIOL, V307, P247, DOI 10.1006/jmbi.2000.4427; Bornberg-Bauer E, 2010, CURR OPIN STRUC BIOL, V20, P390, DOI 10.1016/j.sbi.2010.02.005; Brenman JE, 1998, J NEUROSCI, V18, P8805; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; de Mendoza A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-93; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Hanson JA, 2007, P NATL ACAD SCI USA, V104, P18055, DOI 10.1073/pnas.0708600104; Harms MJ, 2010, CURR OPIN STRUCT BIO; Harris BZ, 2001, J CELL SCI, V114, P3219; Johnston CA, 2011, P NATL ACAD IN PRESS; Johnston CA, 2009, CELL, V138, P1150, DOI 10.1016/j.cell.2009.07.041; Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Li YH, 2002, J BIOL CHEM, V277, P4159, DOI 10.1074/jbc.M110792200; Lye MF, 2010, J BIOL CHEM, V285, P13907, DOI 10.1074/jbc.M109.093674; Marcette J, 2009, BIOCHEMISTRY-US, V48, P10014, DOI 10.1021/bi901160f; Masuko N, 1999, J BIOL CHEM, V274, P5782, DOI 10.1074/jbc.274.9.5782; Mathew D, 2002, CURR BIOL, V12, P531, DOI 10.1016/S0960-9822(02)00758-3; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; Naisbitt S, 1997, J NEUROSCI, V17, P5687; Nipper RW, 2007, P NATL ACAD SCI USA, V104, P14306, DOI 10.1073/pnas.0701812104; Olsen O, 2003, J BIOL CHEM, V278, P6873, DOI 10.1074/jbc.M210165200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Prehoda KE, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001388; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Qian Y, 2006, J BIOL CHEM, V281, P35757, DOI 10.1074/jbc.M607057200; Reese ML, 2007, NAT STRUCT MOL BIOL, V14, P155, DOI 10.1038/nsmb1195; Ricketson D, 2010, P NATL ACAD SCI USA, V107, P20964, DOI 10.1073/pnas.1007025107; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Sekulic N, 2002, J BIOL CHEM, V277, P30236, DOI 10.1074/jbc.M204668200; Siegrist SE, 2007, GENE DEV, V21, P483, DOI 10.1101/gad.1511207; Smith NR, 2011, MOL CELL, V43, P540, DOI 10.1016/j.molcel.2011.06.030; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Velthuis AJWT, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-129; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; Yu FW, 2006, NEURON, V51, P13, DOI 10.1016/j.neuron.2006.06.016; Zhu JW, 2011, EMBO J, V30, P4986, DOI 10.1038/emboj.2011.428	45	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e36014	10.1371/journal.pone.0036014	http://dx.doi.org/10.1371/journal.pone.0036014			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545154	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343200074
J	Kukshal, V; Khanam, T; Chopra, D; Singh, N; Sanyal, S; Ramachandran, R				Kukshal, Vandna; Khanam, Taran; Chopra, Deepti; Singh, Nidhi; Sanyal, Sabyasachi; Ramachandran, Ravishankar			M. tuberculosis Sliding beta-Clamp Does Not Interact Directly with the NAD(+) -Dependent DNA Ligase	PLOS ONE			English	Article							CELL NUCLEAR ANTIGEN; MYCOBACTERIUM-TUBERCULOSIS; POLYMERASE-III; CRYSTAL-STRUCTURE; SUBUNIT; PCNA; IDENTIFICATION; REPLICATION; RV3014C; COMPLEX	The sliding beta-clamp, an important component of the DNA replication and repair machinery, is drawing increasing attention as a therapeutic target. We report the crystal structure of the M. tuberculosis beta-clamp (Mtb beta-clamp) to 3.0 angstrom resolution. The protein crystallized in the space group C222(1) with cell-dimensions a = 72.7, b = 234.9 & c = 125.1 angstrom respectively. Mtb beta-clamp is a dimer, and exhibits head-to-tail association similar to other bacterial clamps. Each monomer folds into three domains with similar structures respectively and associates with its dimeric partner through 6 salt-bridges and about 21 polar interactions. Affinity experiments involving a blunt DNA duplex, primed-DNA and nicked DNA respectively show that Mtb beta-clamp binds specifically to primed DNA about 1.8 times stronger compared to the other two substrates and with an apparent K-d of 300 nM. In bacteria like E. coli, the beta-clamp is known to interact with subunits of the clamp loader, NAD(+) -dependent DNA ligase (LigA) and other partners. We tested the interactions of the Mtb beta-clamp with MtbLigA and the gamma-clamp loader subunit through radioactive gel shift assays, size exclusion chromatography, yeast-two hybrid experiments and also functionally. Intriguingly while Mtb beta-clamp interacts in vitro with the gamma-clamp loader, it does not interact with MtbLigA unlike in bacteria like E. coli where it does. Modeling studies involving earlier peptide complexes reveal that the peptide-binding site is largely conserved despite lower sequence identity between bacterial clamps. Overall the results suggest that other as-yet-unidentified factors may mediate interactions between the clamp, LigA and DNA in mycobacteria.	[Kukshal, Vandna; Khanam, Taran; Chopra, Deepti; Ramachandran, Ravishankar] CSIR, Cent Drug Res Inst, Mol & Struct Biol Div, Lucknow, Uttar Pradesh, India; [Singh, Nidhi; Sanyal, Sabyasachi] CSIR, Cent Drug Res Inst, Drug Target Discovery & Dev Div, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Kukshal, V (corresponding author), CSIR, Cent Drug Res Inst, Mol & Struct Biol Div, Lucknow, Uttar Pradesh, India.	r_ravishankar@cdri.res.in	Sanyal, Sabyasachi/E-8034-2010	Sanyal, Sabyasachi/0000-0002-8603-3828; KHANAM, TARAN/0000-0003-0923-2302; kukshal, vandna/0000-0002-6207-2638	Department of Biotechnology, India [GAP0018]; Council of Scientific and Industrial Research (CSIR), India [NWP0038]; CSIR	Department of Biotechnology, India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This study was funded by the Department of Biotechnology, India (Grant No. GAP0018) and the Council of Scientific and Industrial Research (CSIR), India (Grant No. NWP0038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Richard Bowater (School of Biological Sciences, University of East Anglia) for the E. coli LigA clone. We also thank Dr. Penny Beuning (Department of Chemistry and Chemical Biology, Northeastern University) and Dr. Linda Bloom (Department of Biochemistry and Molecular Biology, University of Florida) for plasmid constructs that helped standardize the purification of the E. coli beta-clamp. VK, TK and NS are recipients of fellowships from CSIR. This communication bears the CDRI No. 8222	Aniukwu J, 2008, GENE DEV, V22, P512, DOI 10.1101/gad.1631908; Argiriadi MA, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Burnouf DY, 2004, J MOL BIOL, V335, P1187, DOI 10.1016/j.jmb.2003.11.049; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; de Saro FJL, 2003, EMBO J, V22, P6408, DOI 10.1093/emboj/cdg603; de Saro FJL, 2001, P NATL ACAD SCI USA, V98, P8376, DOI 10.1073/pnas.121009498; DeLano W.L., PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Georgescu RE, 2008, P NATL ACAD SCI USA, V105, P11116, DOI 10.1073/pnas.0804754105; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Gomes XV, 2000, EMBO J, V19, P3811, DOI 10.1093/emboj/19.14.3811; Gong CL, 2004, J BIOL CHEM, V279, P20594, DOI 10.1074/jbc.M401841200; Gui WJ, 2011, BIOCHEM BIOPH RES CO, V405, P272, DOI 10.1016/j.bbrc.2011.01.027; Hingorani MM, 1998, J BIOL CHEM, V273, P24550, DOI 10.1074/jbc.273.38.24550; Jeruzalmi D, 2001, CELL, V106, P417, DOI 10.1016/S0092-8674(01)00462-7; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kurz M, 2004, J BACTERIOL, V186, P3508, DOI 10.1128/JB.186.11.3508-3515.2004; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Levin DS, 2000, CURR BIOL, V10, P919, DOI 10.1016/S0960-9822(00)00619-9; Matsumiya S, 2001, PROTEIN SCI, V10, P17, DOI 10.1110/ps.36401; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pascal JM, 2006, MOL CELL, V24, P279, DOI 10.1016/j.molcel.2006.08.015; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Srivastava SK, 2007, PROTEINS, V69, P97, DOI 10.1002/prot.21457; Srivastava SK, 2005, J BIOL CHEM, V280, P30273, DOI 10.1074/jbc.M503780200; Srivastava SK, 2005, NUCLEIC ACIDS RES, V33, P7090, DOI 10.1093/nar/gki1006; Tom S, 2001, J BIOL CHEM, V276, P24817, DOI 10.1074/jbc.M101673200; Weller GR, 2002, SCIENCE, V297, P1686, DOI 10.1126/science.1074584; Wijffels G, 2004, BIOCHEMISTRY-US, V43, P5661, DOI 10.1021/bi036229j	33	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35702	10.1371/journal.pone.0035702	http://dx.doi.org/10.1371/journal.pone.0035702			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545130	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343200050
J	Adler, JM; Hershfield, HE				Adler, Jonathan M.; Hershfield, Hal E.			Mixed Emotional Experience Is Associated with and Precedes Improvements in Psychological Well-Being	PLOS ONE			English	Article							POSITIVE PSYCHOLOGY; NARRATIVE IDENTITY; MENTAL-HEALTH; THERAPY; STRESS; PSYCHOTHERAPY; PERSONALITY; HAPPINESS; COHERENCE; EXPOSURE	Background: The relationships between positive and negative emotional experience and physical and psychological well-being have been well-documented. The present study examines the prospective positive relationship between concurrent positive and negative emotional experience and psychological well-being in the context of psychotherapy. Methods: 47 adults undergoing psychotherapy completed measures of psychological well-being and wrote private narratives that were coded by trained raters for emotional content. Results: The specific concurrent experience of happiness and sadness was associated with improvements in psychological well-being above and beyond the impact of the passage of time, personality traits, or the independent effects of happiness and sadness. Changes in mixed emotional experience preceded improvements in well-being. Conclusions: Experiencing happiness alongside sadness in psychotherapy may be a harbinger of improvement in psychological well-being.	[Adler, Jonathan M.] Franklin W Olin Coll Engn, Dept Psychol, Needham, MA USA; [Hershfield, Hal E.] NYU, Stern Sch Business, Dept Mkt, New York, NY USA	Franklin W. Olin College of Engineering; New York University	Adler, JM (corresponding author), Franklin W Olin Coll Engn, Dept Psychol, Needham, MA USA.	jadler@olin.edu	Hershfield, Hal/J-2919-2016	Hershfield, Hal/0000-0002-1507-7022	Foley Family Foundation at Northwestern University	Foley Family Foundation at Northwestern University	The present study was funded by a grant from the Foley Family Foundation to Dan P. McAdams at Northwestern University, who oversaw data collection but was not involved in study design, data analysis, or preparation of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler JM, 2012, J PERS SOC PSYCHOL, V102, P367, DOI 10.1037/a0025289; Adler JM, 2008, PSYCHOTHER RES, V18, P719, DOI 10.1080/10503300802326020; BAGBY RM, 1995, J PERS DISORD, V9, P224, DOI 10.1521/pedi.1995.9.3.224; Bonanno GA, 1997, J ABNORM PSYCHOL, V106, P126, DOI 10.1037/0021-843X.106.1.126; Coifman K. G., 2007, J HAPPINESS STUD, V8, P371, DOI [10.1007/s10902-006-9014-5, DOI 10.1007/S10902-006-9014-5]; Cook T.C., 1979, QUASIEXPERIMENTATION; Costa PT, 2005, J AFFECT DISORDERS, V89, P45, DOI 10.1016/j.jad.2005.06.010; Davis MC, 2004, J PERS, V72, P1133, DOI 10.1111/j.1467-6494.2004.00293.x; Diener E., 1999, WELL BEING FDN HEDON, P213, DOI DOI 10.1037/0003-066X.61.4.305; Duckworth AL, 2005, ANNU REV CLIN PSYCHO, V1, P629, DOI 10.1146/annurev.clinpsy.1.102803.144154; Duckworth AL, 2010, SOC PSYCHOL PERS SCI, V1, P311, DOI 10.1177/1948550609359707; Duncan BL, 2000, J PSYCHOTHER INTEGR, V10, P169, DOI 10.1023/A:1009448200244; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Elliott R, 2008, PSYCHOTHER RES, V18, P239, DOI 10.1080/10503300802074513; Ersner-Hershfield H, 2008, J PERS SOC PSYCHOL, V94, P158, DOI 10.1037/0022-3514.94.1.158; FOA EB, 1995, J TRAUMA STRESS, V8, P675, DOI 10.1007/BF02102894; FOA EB, 1986, PSYCHOL BULL, V99, P20, DOI 10.1037/0033-2909.99.1.20; Folkman S, 2000, CURR DIR PSYCHOL SCI, V9, P115, DOI 10.1111/1467-8721.00073; Fredrickson BL, 2001, AM PSYCHOL, V56, P218, DOI 10.1037/0003-066X.56.3.218; Greenberg L., 1987, EMOTION PSYCHOTHERAP; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Hayes AM, 2005, INT J BEHAV MED, V12, P111, DOI 10.1207/s15327558ijbm1202_9; Hemenover SH, 2003, PSYCHOL HUMAN STRENG, P211, DOI [DOI 10.1037/10566-015, 10.1037/10566-015]; Hershfield HE, SOC PSYCHOL IN PRESS; John OP, BIG 5 TRAIT TAXONOMY; Kazdin AE, 2007, ANNU REV CLIN PSYCHO, V3, P1, DOI 10.1146/annurev.clinpsy.3.022806.091432; Kendall P, 2004, BERGIN GARFIELDS HDB, P16; Lambert MJ, 2004, BERGIN GARFIELDS HDB; Larsen JT, 2011, J PERS SOC PSYCHOL, V100, P1095, DOI 10.1037/a0021846; Larsen JT, 2001, J PERS SOC PSYCHOL, V81, P684, DOI 10.1037//0022-3514.81.4.684; Laurenceau JP, 2007, CLIN PSYCHOL REV, V27; Lazarus R.S., 1991, EMOTION ADAPTATION; Lysaker PH, 2005, PSYCHIATR REHABIL J, V29, P66, DOI 10.2975/29.2005.66.68; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; Mayne TJ, 1999, COGNITION EMOTION, V13, P601, DOI 10.1080/026999399379203; McAdams DP, 2010, ANNU REV PSYCHOL, V61, P517, DOI 10.1146/annurev.psych.093008.100507; McAdams DP, 1997, J PERS SOC PSYCHOL, V72, P678, DOI 10.1037/0022-3514.72.3.678; Ong AD, 2006, J PERS SOC PSYCHOL, V91, P730, DOI 10.1037/0022-3514.91.4.730; Pennebaker JW, 1997, PSYCHOL SCI, V8, P162, DOI 10.1111/j.1467-9280.1997.tb00403.x; PENNEBAKER JW, 1988, J CONSULT CLIN PSYCH, V56, P239, DOI 10.1037/0022-006X.56.2.239; Pinsof WM, 2008, FAM PROCESS, V47, P281, DOI 10.1111/j.1545-5300.2008.00254.x; Pinsof WM, 2009, PSYCHOTHER RES, V19, P143, DOI 10.1080/10503300802669973; Pinsof WM, 2009, HDB FAMILY PSYCHOL; Pinsof WM, CONFIRMING IN PRESS; Rafaeli E, 2006, MOTIV EMOTION, V30, P1, DOI 10.1007/s11031-006-9004-2; RAUDENBUSH SW, 2004, HLM6 HIERARCHICAL LI; Ryan RM, 2001, ANNU REV PSYCHOL, V52, P141, DOI 10.1146/annurev.psych.52.1.141; Ryff CD, 2000, PERS SOC PSYCHOL REV, V4, P30, DOI 10.1207/S15327957PSPR0401_4; Santor DA, 1997, J PERS SOC PSYCHOL, V73, P1354, DOI 10.1037/0022-3514.73.6.1354; Seligman MEP, 2006, AM PSYCHOL, V61, P774, DOI 10.1037/0003-066X.61.8.774; Selye, 1956, STRESS LIFE; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Singer JA, 2004, J PERS, V72, P437, DOI 10.1111/j.0022-3506.2004.00268.x; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P629, DOI 10.1001/archpsyc.62.6.629; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wood AM, 2010, CLIN PSYCHOL REV, V30, P819, DOI 10.1016/j.cpr.2010.06.003; Zautra AJ, 2000, J PERS, V68, P927, DOI 10.1111/1467-6494.00121; Zautra AJ, 2002, COGNITION EMOTION, V16, P309, DOI 10.1080/02699930143000257	59	44	45	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35633	10.1371/journal.pone.0035633	http://dx.doi.org/10.1371/journal.pone.0035633			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UP	22539987	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341000053
J	Buyske, S; Wu, Y; Carty, CL; Cheng, IN; Assimes, TL; Dumitrescu, L; Hindorff, LA; Mitchell, S; Ambite, JL; Boerwinkle, E; Buzkova, P; Carlson, CS; Cochran, B; Duggan, D; Eaton, CB; Fesinmeyer, MD; Franceschini, N; Haessler, J; Jenny, N; Kang, HM; Kooperberg, C; Lin, Y; Le Marchand, L; Matise, TC; Robinson, JG; Rodriguez, C; Schumacher, FR; Voight, BF; Young, A; Manolio, TA; Mohlke, KL; Haiman, CA; Peters, U; Crawford, DC; North, KE				Buyske, Steven; Wu, Ying; Carty, Cara L.; Cheng, Iona; Assimes, Themistocles L.; Dumitrescu, Logan; Hindorff, Lucia A.; Mitchell, Sabrina; Ambite, Jose Luis; Boerwinkle, Eric; Buzkova, Petra; Carlson, Chris S.; Cochran, Barbara; Duggan, David; Eaton, Charles B.; Fesinmeyer, Megan D.; Franceschini, Nora; Haessler, Jeffrey; Jenny, Nancy; Kang, Hyun Min; Kooperberg, Charles; Lin, Yi; Le Marchand, Loic; Matise, Tara C.; Robinson, Jennifer G.; Rodriguez, Carlos; Schumacher, Fredrick R.; Voight, Benjamin F.; Young, Alicia; Manolio, Teri A.; Mohlke, Karen L.; Haiman, Christopher A.; Peters, Ulrike; Crawford, Dana C.; North, Kari E.			Evaluation of the Metabochip Genotyping Array in African Americans and Implications for Fine Mapping of GWAS-Identified Loci: The PAGE Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COMMON; CHOLESTEROL; IMPUTATION; VARIANT; TOOL	The Metabochip is a custom genotyping array designed for replication and fine mapping of metabolic, cardiovascular, and anthropometric trait loci and includes low frequency variation content identified from the 1000 Genomes Project. It has 196,725 SNPs concentrated in 257 genomic regions. We evaluated the Metabochip in 5,863 African Americans; 89% of all SNPs passed rigorous quality control with a call rate of 99.9%. Two examples illustrate the value of fine mapping with the Metabochip in African-ancestry populations. At CELSR2/PSRC1/SORT1, we found the strongest associated SNP for LDL-C to be rs12740374 (p = 3.5x10(-11)), a SNP indistinguishable from multiple SNPs in European ancestry samples due to high correlation. Its distinct signal supports functional studies elsewhere suggesting a causal role in LDL-C. At CETP we found rs17231520, with risk allele frequency 0.07 in African Americans, to be associated with HDL-C (p = 7.2x10(-36)). This variant is very rare in Europeans and not tagged in common GWAS arrays, but was identified as associated with HDL-C in African Americans in a single-gene study. Our results, one narrowing the risk interval and the other revealing an associated variant not found in Europeans, demonstrate the advantages of high-density genotyping of common and rare variation for fine mapping of trait loci in African American samples.	[Buyske, Steven] Rutgers State Univ, Dept Stat & Biostat, Piscataway, NJ 08855 USA; [Wu, Ying; Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Carty, Cara L.; Carlson, Chris S.; Fesinmeyer, Megan D.; Haessler, Jeffrey; Kooperberg, Charles; Lin, Yi; Young, Alicia; Peters, Ulrike] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Cheng, Iona; Le Marchand, Loic] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA; [Assimes, Themistocles L.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Dumitrescu, Logan; Crawford, Dana C.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN USA; [Hindorff, Lucia A.; Manolio, Teri A.] NHGRI, Off Populat Genom, NIH, Bethesda, MD 20892 USA; [Mitchell, Sabrina; Crawford, Dana C.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Ambite, Jose Luis] Univ So Calif, Inst Informat Sci, Los Angeles, CA USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Ctr Human Genet, Houston, TX USA; [Buzkova, Petra] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Cochran, Barbara] Baylor Coll Med, Sponsored Programs, Houston, TX 77030 USA; [Duggan, David] Translat Genom Res Inst, Phoenix, AZ USA; [Eaton, Charles B.] Brown Univ, Ctr Primary Care & Prevent, Dept Family Med & Epidemiol, Alpert Med Sch, Providence, RI 02912 USA; [Franceschini, Nora; North, Kari E.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Jenny, Nancy] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA; [Kang, Hyun Min] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Buyske, Steven; Matise, Tara C.] Rutgers State Univ, Dept Genet, Piscataway, NJ USA; [Robinson, Jennifer G.] Univ Iowa, Dept Epidemiol & Med, Iowa City, IA USA; [Rodriguez, Carlos] Wake Forest Univ, Bowman Gray Sch Med, Div Publ Hlth Sci, Winston Salem, NC USA; [Schumacher, Fredrick R.; Haiman, Christopher A.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Voight, Benjamin F.] Broad Inst Harvard & MIT, Cambridge, MA USA; [Mohlke, Karen L.; North, Kari E.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA	Rutgers State University New Brunswick; University of North Carolina; University of North Carolina Chapel Hill; Fred Hutchinson Cancer Center; Cancer Research Center of Hawaii; University of Hawaii System; Stanford University; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Vanderbilt University; University of Southern California; University of Texas System; University of Texas Health Science Center Houston; University of Washington; University of Washington Seattle; Baylor College of Medicine; Translational Genomics Research Institute; Brown University; University of North Carolina; University of North Carolina Chapel Hill; University of Vermont; University of Michigan System; University of Michigan; Rutgers State University New Brunswick; University of Iowa; Wake Forest University; Wake Forest Baptist Medical Center; University of Southern California; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of North Carolina; University of North Carolina Chapel Hill	Buyske, S (corresponding author), Rutgers State Univ, Dept Stat & Biostat, Piscataway, NJ 08855 USA.	kari_north@unc.edu	Crawford, Dana/C-1054-2012; Crawford, Dana/O-5578-2019; Schumacher, Fredrick/R-6043-2019; Assimes, Themistocles Leonard/D-9696-2015; Carty, Cara/B-8683-2013; , Jennifer/AAD-8336-2019	Crawford, Dana/0000-0002-6437-6248; Schumacher, Fredrick/0000-0002-3073-7463; Assimes, Themistocles Leonard/0000-0003-2349-0009; Buyske, Steven/0000-0001-8539-5416; Ambite, Jose Luis/0000-0003-0087-080X; Voight, Benjamin/0000-0002-6205-9994; Fesinmeyer, Megan/0000-0003-2003-4251; Mitchell, Sabrina/0000-0001-7930-2447; Eaton, Charles/0000-0002-7723-9461	National Human Genome Research Institute (NHGRI) [U01HG004803, U01HG004798, U01HG004802, U01HG004790, U01HG004801]; NHLBI [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022]; National Cancer Institute [R37CA54281, R01 CA63, P01CA33619, U01CA136792, U01CA98758]; National Heart, Lung, and Blood Institute (NHLBI) (NIH); U.S. Department of Health and Human Services [N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 44221]; National Institutes of Mental Health; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055022, N01HC055021, N01HC055020, N01HC055015, N01HC055019, N01HC055016, N01HC055018] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U01CA098758, U01CA136792, P30CA015704, P01CA033619, R37CA054281] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R41HL055019, R42HL055018, R41HL055018, R01HL104199] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004798, U01HG004802, U01HG004801, U01HG004803, U01HG004790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178] Funding Source: NIH RePORTER; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH [N01WH022110] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute (NHLBI) (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); U.S. Department of Health and Human Services; National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Population Architecture Using Genomics and Epidemiology (PAGE) program is funded by the National Human Genome Research Institute (NHGRI), supported by U01HG004803 (Causal Variants Across the Life Course, known as CALiCo), U01HG004798 (Epidemiologic Architecture of Genes Linked to Environment, known as EAGLE), U01HG004802 (the Multiethnic Cohort, known as MEC), U01HG004790 (Women's Health Initiative, known as WHI), and U01HG004801 (Coordinating Center). The Atherosclerosis Risk in Communities (ARIC) Study is carried out as a collaborative study supported by NHLBI contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022. The Multiethnic Cohort (MEC) study is funded through the National Cancer Institute (R37CA54281, R01 CA63, P01CA33619, U01CA136792, and U01CA98758). The Women's Health Initiative (WHI) program is funded by the National Heart, Lung, and Blood Institute (NHLBI) (NIH) and by U.S. Department of Health and Human Services through contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, and 44221. The National Institutes of Mental Health also contributes to the support for the Coordinating Center. NHGRI collaborators (LAH and TAM) assisted in the study design, analysis, and preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; BERGLUND G, 1993, J INTERN MED, V233, P45, DOI 10.1111/j.1365-2796.1993.tb00647.x; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Dumitrescu L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002138; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Giannoulatou E, 2008, BIOINFORMATICS, V24, P2209, DOI 10.1093/bioinformatics/btn386; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hindorff LA, 2011, CATALOG PUBLISHED GE; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300; Liu EY, 2012, GENET EPIDEMIOL, V36, P107, DOI 10.1002/gepi.21603; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Matise TC, 2011, AM J EPIDEMIOL; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ritchie ME, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-68; Rosenberg NA, 2010, NAT REV GENET, V11, P356, DOI 10.1038/nrg2760; Sanna S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002198; Sung YJ, 2012, HUM HERED, V73, P18, DOI 10.1159/000334084; Teo YY, 2010, NAT REV GENET, V11, P149, DOI 10.1038/nrg2731; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thompson JF, 2004, CLIN GENET, V66, P223, DOI 10.1111/j.1399-0004.2004.00289.x; Tomlinson IPM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002105; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Weale ME, 2010, METHODS MOL BIOL, V628, P341, DOI 10.1007/978-1-60327-367-1_19; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wood AR, 2011, HUM MOL GENET, V20, P4082, DOI 10.1093/hmg/ddr328	38	52	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35651	10.1371/journal.pone.0035651	http://dx.doi.org/10.1371/journal.pone.0035651			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539988	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341000054
J	Joers, V; Seneczko, K; Goecks, NC; Kamp, TJ; Hacker, TA; Brunner, KG; Engle, JW; Barnhart, TE; Nickles, RJ; Holden, JE; Emborg, ME				Joers, Valerie; Seneczko, Kailie; Goecks, Nichole C.; Kamp, Timothy J.; Hacker, Timothy A.; Brunner, Kevin G.; Engle, Jonathan W.; Barnhart, Todd E.; Nickles, R. Jerome; Holden, James E.; Emborg, Marina E.			Nonuniform Cardiac Denervation Observed by C-11-meta-Hydroxyephedrine PET in 6-OHDA-Treated Monkeys	PLOS ONE			English	Article							MULTIPLE SYSTEM ATROPHY; NONMOTOR SYMPTOMS QUESTIONNAIRE; PURE AUTONOMIC FAILURE; PARKINSONS-DISEASE; SYMPATHETIC DENERVATION; CHEMICAL SYMPATHECTOMY; ORTHOSTATIC HYPOTENSION; HEART-TRANSPLANTATION; RHESUS-MONKEYS; 6-HYDROXYDOPAMINE	Parkinson's disease presents nonmotor complications such as autonomic dysfunction that do not respond to traditional anti-parkinsonian therapies. The lack of established preclinical monkey models of Parkinson's disease with cardiac dysfunction hampers development and testing of new treatments to alleviate or prevent this feature. This study aimed to assess the feasibility of developing a model of cardiac dysautonomia in nonhuman primates and preclinical evaluations tools. Five rhesus monkeys received intravenous injections of 6-hydroxydopamine (total dose: 50 mg/kg). The animals were evaluated before and after with a battery of tests, including positron emission tomography with the norepinephrine analog C-11-meta-hydroxyephedrine. Imaging 1 week after neurotoxin treatment revealed nearly complete loss of specific radioligand uptake. Partial progressive recovery of cardiac uptake found between 1 and 10 weeks remained stable between 10 and 14 weeks. In all five animals, examination of the pattern of uptake (using Logan plot analysis to create distribution volume maps) revealed a persistent region-specific significant loss in the inferior wall of the left ventricle at 10 (P<0.001) and 14 weeks (P<0.01) relative to the anterior wall. Blood levels of dopamine, norepinephrine (P<0.05), epinephrine, and 3,4-dihydroxyphenylacetic acid (P<0.01) were notably decreased after 6-hydroxydopamine at all time points. These results demonstrate that systemic injection of 6-hydroxydopamine in nonhuman primates creates a nonuniform but reproducible pattern of cardiac denervation as well as a persistent loss of circulating catecholamines, supporting the use of this method to further develop a monkey model of cardiac dysautonomia.	[Joers, Valerie; Seneczko, Kailie; Goecks, Nichole C.; Brunner, Kevin G.; Holden, James E.; Emborg, Marina E.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Preclin Parkinsons Res Program, Madison, WI 53706 USA; [Joers, Valerie; Emborg, Marina E.] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA; [Kamp, Timothy J.; Hacker, Timothy A.] Univ Wisconsin, Dept Med, Madison, WI USA; [Engle, Jonathan W.; Barnhart, Todd E.; Nickles, R. Jerome; Holden, James E.; Emborg, Marina E.] Univ Wisconsin, Dept Med Phys, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Joers, V (corresponding author), Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Preclin Parkinsons Res Program, Madison, WI 53706 USA.	emborg@primate.wisc.edu	Joers, Valerie/S-2455-2019; Kamp, Timothy/ABD-1343-2020	Joers, Valerie/0000-0001-6743-6587; Kamp, Timothy/0000-0003-2103-7876; Engle, Jonathan W/0000-0002-3399-7228; Barnhart, Todd/0000-0002-9981-2150	Clinical and Translational Science Award (CTSA) program; National Center for Research Resources (NCRR) [1UL1RR025011]; National Center for Advancing Translational Sciences (NCATS) [9U54TR000021]; WNPRC NIH [P51RR000167]; University of Wisconsin Graduate School, Medical School, and Medical Physics Department; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011, P51RR000167] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER	Clinical and Translational Science Award (CTSA) program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); WNPRC NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin Graduate School, Medical School, and Medical Physics Department; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was supported in part by the Clinical and Translational Science Award (CTSA) program, previously through the National Center for Research Resources (NCRR) grant 1UL1RR025011, and now by the National Center for Advancing Translational Sciences (NCATS), grant 9U54TR000021. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health (NIH). The authors also acknowledge the support of WNPRC NIH base grant P51RR000167, and the faculty startup funds from the University of Wisconsin Graduate School, Medical School, and Medical Physics Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amino T, 2005, BRAIN PATHOL, V15, P29, DOI 10.1111/j.1750-3639.2005.tb00097.x; Bai J, 2008, CAN J PHYSIOL PHARM, V86, P700, DOI [10.1139/Y08-075, 10.1139/y08-075]; Bengel FM, 1999, CIRCULATION, V99, P1866, DOI 10.1161/01.CIR.99.14.1866; Berding G, 2003, EUR J NUCL MED MOL I, V30, P127, DOI 10.1007/s00259-002-1019-7; Braak H, 2000, J NEUROL, V247, P3; Braune S, 1998, ACTA NEUROL SCAND, V97, P307, DOI 10.1111/j.1600-0404.1998.tb05958.x; Buendia-Fuentes F, 2011, TRANSPL P, V43, P2247, DOI 10.1016/j.transproceed.2011.05.020; Cersosimo MG, 2008, MOVEMENT DISORD, V23, P1065, DOI 10.1002/mds.22051; Chaudhuri KR, 2006, MOVEMENT DISORD, V21, P916, DOI 10.1002/mds.20844; Deguchi K, 2002, J NEUROL SCI, V199, P31, DOI 10.1016/S0022-510X(02)00079-5; Emborg ME, 2006, NEUROBIOL DIS, V23, P281, DOI 10.1016/j.nbd.2006.03.010; Emborg ME, 2007, ILAR J, V48, P339, DOI 10.1093/ilar.48.4.339; Emborg ME, 2004, J NEUROSCI METH, V139, P121, DOI 10.1016/j.jneumeth.2004.08.004; Emborg ME, 1998, J COMP NEUROL, V401, P253; Emborg ME, 2009, NEUROBIOL DIS; GAUTHIER P, 1972, CIRC RES, V31, P207, DOI 10.1161/01.RES.31.2.207; Goldstein DS, 2008, CLIN AUTON RES, V18, P115, DOI 10.1007/s10286-008-0464-1; Goldstein DS, 2007, CLIN AUTON RES, V17, P118, DOI 10.1007/s10286-007-0396-1; Goldstein DS, 2006, CLIN AUTON RES, V16, P46, DOI 10.1007/s10286-006-0317-8; Goldstein DS, 2000, ANN INTERN MED, V133, P338, DOI 10.7326/0003-4819-133-5-200009050-00009; Goldstein DS, 2003, LANCET NEUROL, V2, P669, DOI 10.1016/S1474-4422(03)00555-6; GOLDSTEIN DS, 1991, J HYPERTENS, V9, P417, DOI 10.1097/00004872-199105000-00005; Goldstein DS, 2003, J PHARMACOL EXP THER, V306, P855, DOI 10.1124/jpet.103.051714; Gross DR, 2009, ANIMAL MODELS IN CARDIOVASCULAR RESEARCH, THIRD EDITION, P55, DOI 10.1007/978-0-387-95962-7_3; Ishizaki F, 1996, No To Shinkei, V48, P443; Jost WH, 2003, J NEUROL, V250, P28, DOI 10.1007/s00415-003-1105-z; Kawamura M, 1999, NEUROCHEM RES, V24, P25, DOI 10.1023/A:1020919828028; KAYE DM, 1993, CIRCULATION, V88, P1110, DOI 10.1161/01.CIR.88.3.1110; King A.E., 2010, MOVEMENT DISORD, V26, P1218; Li ST, 2002, ANN NEUROL, V52, P220, DOI 10.1002/ana.10236; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Martignoni E, 1995, J NEURAL TRANSM-SUPP, P11; Martinez-Martin P, 2007, MOVEMENT DISORD, V22, P1623, DOI 10.1002/mds.21586; Mathias CJ, 1998, CLIN NEUROSCI, V5, P153; NADEAU RA, 1971, CAN J PHYSIOL PHARM, V49, P36, DOI 10.1139/y71-005; Oka H, 2006, J NEUROL SCI, V241, P59, DOI 10.1016/j.jns.2005.10.014; Orimo S, 1999, J NEUROL NEUROSUR PS, V67, P189, DOI 10.1136/jnnp.67.2.189; Orimo S, 2005, ACTA NEUROPATHOL, V109, P583, DOI 10.1007/s00401-005-0995-7; Orimo S, 2002, J NEUROL NEUROSUR PS, V73, P776, DOI 10.1136/jnnp.73.6.776; PODRID PJ, 1990, CIRCULATION, V82, P103; PORTER CC, 1963, J PHARMACOL EXP THER, V140, P308; PORTER CC, 1965, J PHARMACOL EXP THER, V150, P17; Post KK, 2008, PARKINSONISM RELAT D, V14, P524, DOI 10.1016/j.parkreldis.2008.03.008; Pursiainen V, 2002, J NEUROL, V249, P1535, DOI 10.1007/s00415-002-0884-0; Raffel DM, 2006, J NUCL MED, V47, P1769; RAJPUT AH, 1976, J NEUROL NEUROSUR PS, V39, P1092, DOI 10.1136/jnnp.39.11.1092; ROSENSPIRE KC, 1990, J NUCL MED, V31, P1328; Sakata M, 2002, BRAIN RES, V928, P194, DOI 10.1016/S0006-8993(01)03402-3; Slack K, 2010, PARKINSONS DIS-US, V2010, DOI 10.4061/2010/427810; Sleeper MM, 2008, J AM ASSOC LAB ANIM, V47, P22; Suzuki M, 2007, NEUROREPORT, V18, P1867, DOI 10.1097/WNR.0b013e3282f1ab33; Swanson CR, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-91; Takatsu H, 2000, J NUCL MED, V41, P71; Taki J, 2000, EUR J NUCL MED, V27, P566, DOI 10.1007/s002590050544; Tipre DN, 2005, J NUCL MED, V46, P1775; Valappil RA, 2010, MOVEMENT DISORD, V25, P2296, DOI 10.1002/mds.23348	56	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35371	10.1371/journal.pone.0035371	http://dx.doi.org/10.1371/journal.pone.0035371			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539969	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341000034
J	McKinnon, NK; Bali, M; Akabas, MH				McKinnon, Nicole K.; Bali, Moez; Akabas, Myles H.			Length and Amino Acid Sequence of Peptides Substituted for the 5-HT3A Receptor M3M4 Loop May Affect Channel Expression and Desensitization	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; GATED ION-CHANNEL; X-RAY-STRUCTURE; 5-HYDROXYTRYPTAMINE TYPE-3; SEROTONIN-RECEPTOR; CHLORIDE CHANNEL; CYTOPLASMIC LOOP; NG108-15 CELLS; CONDUCTANCE; CA2+	5-HT3A receptors are pentameric neurotransmitter-gated ion channels in the Cys-loop receptor family. Each subunit contains an extracellular domain, four transmembrane segments (M1, M2, M3, M4) and a 115 residue intracellular loop between M3 and M4. In contrast, the M3M4 loop in prokaryotic homologues is <15 residues. To investigate the limits of M3M4 loop length and composition on channel function we replaced the 5-HT3A M3M4 loop with two to seven alanine residues (5-HT3A-A(n) (=) (2-7)). Mutants were expressed in Xenopus laevis oocytes and characterized using two electrode voltage clamp recording. All mutants were functional. The 5-HT EC50's were at most 5-fold greater than wild-type (WT). The desensitization rate differed significantly among the mutants. Desensitization rates for 5-HT3A-A(2), 5-HT3A-A(4), 5-HT3A-A(6), and 5-HT3A-A(7) were similar to WT. In contrast, 5-HT3A-A(3) and 5-HT3A-A(5) had desensitization rates at least an order of magnitude faster than WT. The one Ala loop construct, 5-HT3A-A(1), entered a non-functional state from which it did not recover after the first 5-HT application. These results suggest that the large M3M4 loop of eukaryotic Cys-loop channels is not required for receptor assembly or function. However, loop length and amino acid composition can effect channel expression and desensitization. We infer that the cytoplasmic ends of the M3 and M4 segments may undergo conformational changes during channel gating and desensitization and/or the loop may influence the position and mobility of these segments as they undergo gating-induced conformational changes. Altering structure or conformational mobility of the cytoplasmic ends of M3 and M4 may be the basis by which phosphorylation or protein binding to the cytoplasmic loop alters channel function.	[McKinnon, Nicole K.; Bali, Moez; Akabas, Myles H.] Yeshiva Univ, Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY USA; [Akabas, Myles H.] Yeshiva Univ, Albert Einstein Coll Med, Dept Neurosci, Bronx, NY USA; [Akabas, Myles H.] Yeshiva Univ, Albert Einstein Coll Med, Dept Med, Bronx, NY USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	McKinnon, NK (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY USA.	myles.akabas@einstein.yu.edu		McKinnon, Nicole/0000-0002-7177-1924; Akabas, Myles/0000-0001-8781-7846	National Institutes of Health [NS030808]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030808] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported in part by a grant from the National Institutes of Health (http://www.nih.gov/), NS030808 to MHA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Akabas MH, 2004, INT REV NEUROBIOL, V62, P1, DOI 10.1016/S0074-7742(04)62001-0; Bar-Lev DD, 2011, J BIOL CHEM, V286, P43830, DOI 10.1074/jbc.M111.282715; Barnes NM, 2009, NEUROPHARMACOLOGY, V56, P273, DOI 10.1016/j.neuropharm.2008.08.003; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Boyd GW, 2002, MOL CELL NEUROSCI, V21, P38, DOI 10.1006/mcne.2002.1160; Connolly CN, 2008, MOL MEMBR BIOL, V25, P293, DOI 10.1080/09687680801898503; Corradi J, 2009, BIOPHYS J, V97, P1335, DOI 10.1016/j.bpj.2009.06.018; CULLY DF, 1994, NATURE, V371, P707, DOI 10.1038/371707a0; Davies PA, 1999, NATURE, V397, P359, DOI 10.1038/16941; Deeb TZ, 2007, J BIOL CHEM, V282, P6172, DOI 10.1074/jbc.M607698200; DILGER JP, 1991, BIOCHIM BIOPHYS ACTA, V1063, P253, DOI 10.1016/0005-2736(91)90379-M; Gunthorpe MJ, 2000, J PHYSIOL-LONDON, V522, P187, DOI 10.1111/j.1469-7793.2000.00187.x; Hales TG, 2006, J BIOL CHEM, V281, P8062, DOI 10.1074/jbc.M513222200; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Hu XQ, 2008, NEUROPHARMACOLOGY, V54, P1153, DOI 10.1016/j.neuropharm.2008.03.009; Hu XQ, 2006, J BIOL CHEM, V281, P21781, DOI 10.1074/jbc.M600676200; Hu XQ, 2005, J PHYSIOL-LONDON, V568, P381, DOI 10.1113/jphysiol.2005.092866; Ilegems E, 2005, CHEMBIOCHEM, V6, P2180, DOI 10.1002/cbic.200500191; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Jansen M, 2008, J GEN PHYSIOL, V131, P137, DOI 10.1085/jgp.200709896; Jones S, 2003, NEUROSCIENCE, V119, P629, DOI 10.1016/S0306-4522(03)00202-1; Jones S, 1998, J PHYSIOL-LONDON, V510, P361, DOI 10.1111/j.1469-7793.1998.361bk.x; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Kracun S, 2008, BRIT J PHARMACOL, V153, P1474, DOI 10.1038/sj.bjp.0707676; Krzywkowski K, 2008, P NATL ACAD SCI USA, V105, P722, DOI 10.1073/pnas.0708454105; Lansdell SJ, 2005, MOL PHARMACOL, V68, P1431, DOI 10.1124/mol.105.017459; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Livesey MR, 2008, J BIOL CHEM, V283, P19301, DOI 10.1074/jbc.M802406200; Lo WY, 2008, J BIOL CHEM, V283, P29740, DOI 10.1074/jbc.M802856200; Lobitz N, 2001, MOL PHARMACOL, V59, P844, DOI 10.1124/mol.59.4.844; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; McKinnon NK, 2011, J GEN PHYSIOL, V138, P453, DOI 10.1085/jgp.201110686; Millar NS, 2008, BRIT J PHARMACOL, V153, pS177, DOI 10.1038/sj.bjp.0707661; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Moroni M, 2011, J NEUROSCI, V31, P14095, DOI 10.1523/JNEUROSCI.1985-11.2011; Noam Y, 2008, J PHYSIOL-LONDON, V586, P3629, DOI 10.1113/jphysiol.2008.153486; O'Toole KK, 2011, J BIOL CHEM, V286, P37990, DOI 10.1074/jbc.M111.258012; Peters JA, 2004, BIOCHEM SOC T, V32, P547, DOI 10.1042/BST0320547; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Reeves DC, 2005, J NEUROSCI, V25, P9358, DOI 10.1523/JNEUROSCI.1045-05.2005; Reeves DC, 2001, J BIOL CHEM, V276, P42035, DOI 10.1074/jbc.M106066200; Solt K, 2007, J NEUROSCI, V27, P13151, DOI 10.1523/JNEUROSCI.3772-07.2007; Sun H, 2008, J PHYSIOL-LONDON, V586, P751, DOI 10.1113/jphysiol.2007.136440; Tasneem A, 2005, GENOME BIOL, V6; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; van Hooft JA, 2003, J NEUROPHYSIOL, V89, P1864, DOI 10.1152/jn.00948.2002; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Xu M, 1996, J GEN PHYSIOL, V107, P195, DOI 10.1085/jgp.107.2.195; YAKEL JL, 1993, P NATL ACAD SCI USA, V90, P5030, DOI 10.1073/pnas.90.11.5030	53	20	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35563	10.1371/journal.pone.0035563	http://dx.doi.org/10.1371/journal.pone.0035563			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539982	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341000048
J	Ishii, S; Karlamangla, AS; Bote, M; Irwin, MR; Jacobs, DR; Cho, HJ; Seeman, TE				Ishii, Shinya; Karlamangla, Arun S.; Bote, Marcos; Irwin, Michael R.; Jacobs, David R., Jr.; Cho, Hyong Jin; Seeman, Teresa E.			Gender, Obesity and Repeated Elevation of C-Reactive Protein: Data from the CARDIA Cohort	PLOS ONE			English	Article							ARTERY RISK DEVELOPMENT; PUBLIC-HEALTH PRACTICE; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; YOUNG-ADULTS; SOCIOECONOMIC-STATUS; HORMONE-THERAPY; SEX-DIFFERENCES; MARKERS; INFLAMMATION	C-reactive Protein (CRP) measurements above 10 mg/L have been conventionally treated as acute inflammation and excluded from epidemiologic studies of chronic inflammation. However, recent evidence suggest that such CRP elevations can be seen even with chronic inflammation. The authors assessed 3,300 participants in The Coronary Artery Risk Development in Young Adults study, who had two or more CRP measurements between 1992/3 and 2005/6 to a) investigate characteristics associated with repeated CRP elevation above 10 mg/L; b) identify subgroups at high risk of repeated elevation; and c) investigate the effect of different CRP thresholds on the probability of an elevation being one-time rather than repeated. 225 participants (6.8%) had one-time and 103 (3.1%) had repeated CRP elevation above 10 mg/L. Repeated elevation was associated with obesity, female gender, low income, and sex hormone use. The probability of an elevation above 10 mg/L being one-time rather than repeated was lowest (51%) in women with body mass index above 31 kg/m(2), compared to 82% in others. These findings suggest that CRP elevations above 10 mg/L in obese women are likely to be from chronic rather than acute inflammation, and that CRP thresholds above 10 mg/L may be warranted to distinguish acute from chronic inflammation in obese women.	[Ishii, Shinya] Univ Tokyo, Dept Geriatr Med, Bunkyo Ku, Tokyo, Japan; [Karlamangla, Arun S.; Seeman, Teresa E.] Univ Calif Los Angeles, Dept Med, Div Geriatr, Los Angeles, CA 90024 USA; [Bote, Marcos] Univ Murcia, Dept Sociol & Social Policy, Murcia, Spain; [Irwin, Michael R.; Cho, Hyong Jin] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Cousins Ctr Psychoneuroimmunol, Los Angeles, CA USA; [Jacobs, David R., Jr.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA	University of Tokyo; University of California System; University of California Los Angeles; University of Murcia; University of California System; University of California Los Angeles; University of Minnesota System; University of Minnesota Twin Cities	Ishii, S (corresponding author), Univ Tokyo, Dept Geriatr Med, Bunkyo Ku, Tokyo, Japan.	sishii76@gmail.com	Cho, Joshua Hyong-Jin/B-9934-2014; Irwin, Michael R./H-4870-2013; Bote, Marcos/AAB-1950-2019	Cho, Joshua Hyong-Jin/0000-0002-8629-8500; Irwin, Michael R./0000-0002-1502-8431; Bote, Marcos/0000-0002-9178-3105; Jacobs, David/0000-0002-7232-0543	National Institute on Aging of National Institutes of Health [P30 AG028748, 5R01 AG26105-3, P30 AG017265]; VA Greater Los Angeles Healthcare System Geriatric Research, Education and Clinical Center; VA Advanced Geriatrics Fellowship; NATIONAL INSTITUTE ON AGING [R01AG026105, P30AG017265, P30AG028748] Funding Source: NIH RePORTER	National Institute on Aging of National Institutes of Health; VA Greater Los Angeles Healthcare System Geriatric Research, Education and Clinical Center(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); VA Advanced Geriatrics Fellowship; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grant P30 AG028748, 5R01 AG26105-3 to A. K. and P30 AG017265 to T. E. S. from the National Institute on Aging of National Institutes of Health, and VA Greater Los Angeles Healthcare System Geriatric Research, Education and Clinical Center; and VA Advanced Geriatrics Fellowship to S. I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley DE, 2006, BRAIN BEHAV IMMUN, V20, P498, DOI 10.1016/j.bbi.2005.10.003; Bazzano LA, 2003, ANN INTERN MED, V138, P891, DOI 10.7326/0003-4819-138-11-200306030-00010; Bjorntorp P, 2001, Obes Rev, V2, P73, DOI 10.1046/j.1467-789x.2001.00027.x; Black PH, 2003, BRAIN BEHAV IMMUN, V17, P350, DOI 10.1016/S0889-1591(03)00048-5; Calabro P, 2005, J AM COLL CARDIOL, V46, P1112, DOI 10.1016/j.jacc.2005.06.017; Cartier A, 2009, AM J CLIN NUTR, V89, P1307, DOI 10.3945/ajcn.2008.27030; Chenillot O, 2000, CLIN CHEM LAB MED, V38, P1003, DOI 10.1515/CCLM.2000.149; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cushman M, 2005, CIRCULATION, V112, P25, DOI 10.1161/CIRCULATIONAHA.104.504159; Cutter G R, 1991, Control Clin Trials, V12, p1S, DOI 10.1016/0197-2456(91)90002-4; Falagas ME, 2006, LANCET INFECT DIS, V6, P438, DOI 10.1016/S1473-3099(06)70523-0; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Goldstein D.S., 1995, STRESS CATECHOLAMINE; Greenfield JR, 2004, CIRCULATION, V109, P3022, DOI 10.1161/01.CIR.0000130640.77501.79; Groblewska M, 2008, CLIN CHEM LAB MED, V46, P1423, DOI 10.1515/CCLM.2008.278; Hamer M, 2010, CLIN CHEM, V56, P132, DOI 10.1373/clinchem.2009.130740; Harrell FE, 2001, REGRESSION MODELING; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Heikkila K, 2007, J EPIDEMIOL COMMUN H, V61, P824, DOI 10.1136/jech.2006.051292; Hu PF, 2006, ATHEROSCLEROSIS, V185, P347, DOI 10.1016/j.atherosclerosis.2005.06.011; Karlamangla AS, 2005, SOC SCI MED, V60, P999, DOI 10.1016/j.socscimed.2004.06.056; Khera A, 2009, J CLIN ENDOCR METAB, V94, P3251, DOI 10.1210/jc.2008-2406; Lakoski SG, 2005, AM HEART J, V150, P907, DOI 10.1016/j.ahj.2004.11.025; Lloyd-Jones DM, 2007, CIRCULATION, V115, P1004, DOI 10.1161/CIRCULATIONAHA.106.648642; Lukanova A, 2004, EUR J ENDOCRINOL, V150, P161, DOI 10.1530/eje.0.1500161; Macintyre S, 1997, J Health Psychol, V2, P315, DOI 10.1177/135910539700200304; Muir KW, 1999, STROKE, V30, P981, DOI 10.1161/01.STR.30.5.981; Myers GL, 2004, CIRCULATION, V110, pE545, DOI 10.1161/01.CIR.0000148980.87579.5E; Nazmi A, 2008, BRAZ J MED BIOL RES, V41, P357, DOI 10.1590/S0100-879X2008000500003; O'Connor MF, 2009, BRAIN BEHAV IMMUN, V23, P887, DOI 10.1016/j.bbi.2009.04.005; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Ray KK, 2005, J AM COLL CARDIOL, V46, P1417, DOI 10.1016/j.jacc.2005.08.024; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Ridker PM, 2004, CIRCULATION, V109, P1955, DOI 10.1161/01.CIR.0000125690.80303.A8; RODGERS JR, 1993, J HUM RESOUR, V28, P25, DOI 10.2307/146087; Ruhl CE, 2004, AM J CLIN NUTR, V80, P576; SIDNEY S, 1991, AM J EPIDEMIOL, V133, P1231, DOI 10.1093/oxfordjournals.aje.a115835; Siemes C, 2006, J CLIN ONCOL, V24, P5216, DOI 10.1200/JCO.2006.07.1381; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131	41	62	63	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36062	10.1371/journal.pone.0036062	http://dx.doi.org/10.1371/journal.pone.0036062			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558327	gold, Green Published, Green Submitted			2022-12-27	WOS:000305340200035
J	Campbell, P; McIntyre, P; Quinn, H; Hueston, L; Gilbert, GL; McVernon, J				Campbell, Patricia; McIntyre, Peter; Quinn, Helen; Hueston, Linda; Gilbert, Gwendolyn L.; McVernon, Jodie			Increased Population Prevalence of Low Pertussis Toxin Antibody Levels in Young Children Preceding a Record Pertussis Epidemic in Australia	PLOS ONE			English	Article							BORDETELLA-PERTUSSIS; SEROEPIDEMIOLOGY; INFECTION; VACCINE; IMMUNIZATION; DISEASES; SAMPLE; WALES; AGE	Background: Cross-sectional serosurveys using IgG antibody to pertussis toxin (IgG-PT) are increasingly being used to estimate trends in recent infection independent of reporting biases. Methods/Principal Findings: We compared the age-specific seroprevalence of various levels of IgG-PT in cross-sectional surveys using systematic collections of residual sera from Australian diagnostic laboratories in 1997/8, 2002 and 2007 with reference to both changes in the pertussis vaccine schedule and the epidemic cycle, as measured by disease notifications. A progressive decline in high-level (>= 62.5 EU/ml) IgG-PT prevalence from 19% (95% CI 16-22%) in 1997/98 to 12% (95% CI 11-14%) in 2002 and 5% (95% CI 4-6%) in 2007 was consistent with patterns of pertussis notifications in the year prior to each collection. Concomitantly, the overall prevalence of undetectable (< 5 EU/ml) levels increased from 17% (95% CI 14-20%) in 1997/98 to 38% (95% CI 36-40%) in 2007 but among children aged 1-4 years, from 25% (95% CI 17-34%) in 1997/98 to 62% (95% CI 56-68%) in 2007. This change followed withdrawal of the 18-month booster dose in 2003 and preceded record pertussis notifications from 2008 onwards. Conclusions/Significance: Population seroprevalence of high levels of IgG-PT is accepted as a reliable indicator of pertussis disease activity over time within and between countries with varying diagnostic practices, especially in unimmunised age groups. Our novel findings suggest that increased prevalence of undetectable IgG-PT is an indicator of waning immunity useful for population level monitoring following introduction of acellular vaccines and/or schedule changes.	[Campbell, Patricia; McVernon, Jodie] Univ Melbourne, Vaccine & Immunisat Res Grp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Campbell, Patricia; McVernon, Jodie] Univ Melbourne, Melbourne Sch Populat Hlth, Parkville, Vic 3052, Australia; [McIntyre, Peter; Quinn, Helen] Childrens Hosp Westmead, Natl Ctr Immunisat Res & Surveillance Vaccine Pre, Sydney, NSW, Australia; [Hueston, Linda; Gilbert, Gwendolyn L.] Westmead Hosp, Inst Clin Pathol & Med Res, Ctr Infect Dis & Microbiol Publ Hlth, Sydney, NSW, Australia	Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; University of Sydney; University of Sydney	Campbell, P (corresponding author), Univ Melbourne, Vaccine & Immunisat Res Grp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.	pca@student.unimelb.edu.au; j.mcvernon@unimelb.edu.au	McIntyre, Peter/GNM-5277-2022; Gilbert, Gwendolyn/B-7733-2013	McIntyre, Peter/0000-0001-5808-7450; Gilbert, Gwendolyn/0000-0001-7490-6727; Campbell, Patricia/0000-0003-4013-9835; McVernon, Jodie/0000-0001-9774-1961	National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS); National Health and Medical Research Council of Australia Career Development Award; Australian Postgraduate Award	National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS); National Health and Medical Research Council of Australia Career Development Award(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government)	Serosurveys conducted by the Centre for Infectious Diseases and Microbiology - Public Health (CIDM) are funded by the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS) as a core surveillance activity. GlaxoSmithKline (GSK) provided antigen for the assay, however, all testing and analysis was conducted at CIDM and NCIRS. JMcV is supported by a National Health and Medical Research Council of Australia Career Development Award. PC is supported by an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews R, 1997, Commun Dis Intell, V21, P145; Australian Bureau of Statistics, 2011, AUSTR DEM STAT TABL; Australian Government Department of Health, 2004, AUSTR NAT NOT DIS CA; Australian Government Department of Health and Ageing, 2011, NAT NOT DIS SURV SYS; Cagney M, 2006, EPIDEMIOL INFECT, V134, P1208, DOI 10.1017/S095026880600625X; Crowcroft NS, 2006, LANCET, V367, P1926, DOI 10.1016/S0140-6736(06)68848-X; de Greeff SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014183; de Melker HE, 2000, J CLIN MICROBIOL, V38, P800, DOI 10.1128/JCM.38.2.800-806.2000; de Melker HE, 2006, J INFECTION, V53, P106, DOI 10.1016/j.jinf.2005.10.020; Giammanco A, 2003, VACCINE, V21, P1924, DOI 10.1016/S0264-410X(02)00823-X; Giuliano M, 1998, J PEDIATR-US, V132, P983, DOI 10.1016/S0022-3476(98)70395-6; Guiso Nicole, 2011, Vaccine, V29, P1115, DOI 10.1016/j.vaccine.2010.12.010; Hallander HO, 2009, APMIS, V117, P912, DOI 10.1111/j.1600-0463.2009.02554.x; Hallander HO, 2005, VACCINE, V23, P5359, DOI 10.1016/j.vaccine.2005.06.009; Hueston L, 2007, NSW PUBLIC HLTH B, V18, P67; Hull B, 2009, COMMUN DIS INTELL, V33, P170; Kelly H, 2002, VACCINE, V20, P3130, DOI 10.1016/S0264-410X(02)00255-4; Kretzschmar M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000291; Lavine JS, 2011, P NATL ACAD SCI USA, V108, P7259, DOI 10.1073/pnas.1014394108; McIntyre Peter, 2003, N S W Public Health Bull, V14, P69, DOI 10.1071/NB03022; Nardone A, 2004, VACCINE, V22, P1314, DOI 10.1016/j.vaccine.2003.08.039; Pebody RG, 2005, EPIDEMIOL INFECT, V133, P159, DOI 10.1017/S0950268804003012; Quinn HE, 2010, EPIDEMIOL INFECT, V138, P426, DOI 10.1017/S0950268809990707; Quinn HE, 2007, COMMUN DIS INTELL, V31, P205; Quinn HE, 2011, B WORLD HEALTH ORGAN, V89, P666, DOI 10.2471/BLT.11.086538; RAMSAY MEB, 1993, EPIDEMIOL INFECT, V111, P41, DOI 10.1017/S095026880005665X; Rendi-Wagner P, 2010, VACCINE, V28, P3285, DOI 10.1016/j.vaccine.2010.02.104; RUSHWORTH RL, 1991, MED J AUSTRALIA, V154, P828, DOI 10.5694/j.1326-5377.1991.tb121376.x; Spokes Paula J, 2010, N S W Public Health Bull, V21, P167, DOI 10.1071/NB10031; Storsaeter J, 2003, VACCINE, V21, P3542, DOI 10.1016/S0264-410X(03)00407-9; Torvaldsen S, 2003, PEDIATR INFECT DIS J, V22, P956, DOI 10.1097/01.inf.0000095198.75170.b6; Wang CQ, 2011, PEDIATR INFECT DIS J, V30, P593, DOI 10.1097/INF.0b013e31820eaf88; World Health Organization, 2010, IMM VACC BIOL PERT	33	62	67	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35874	10.1371/journal.pone.0035874	http://dx.doi.org/10.1371/journal.pone.0035874			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558249	Green Published, gold			2022-12-27	WOS:000305336000071
J	LeSauter, J; Lambert, CM; Robotham, MR; Model, Z; Silver, R; Weaver, DR				LeSauter, Joseph; Lambert, Christopher M.; Robotham, Margaret R.; Model, Zina; Silver, Rae; Weaver, David R.			Antibodies for Assessing Circadian Clock Proteins in the Rodent Suprachiasmatic Nucleus	PLOS ONE			English	Article							CASEIN KINASE 1; STRIA TERMINALIS; GENE-EXPRESSION; MPER2 PROTEIN; PER1 PROTEIN; BED NUCLEUS; RHYTHMS; CELLS; SCN; OSCILLATOR	Research on the mechanisms underlying circadian rhythmicity and the response of brain and body clocks to environmental and physiological challenges requires assessing levels of circadian clock proteins. Too often, however, it is difficult to acquire antibodies that specifically and reliably label these proteins. Many of these antibodies also lack appropriate validation. The goal of this project was to generate and characterize antibodies against several circadian clock proteins. We examined mice and hamsters at peak and trough times of clock protein expression in the suprachiasmatic nucleus (SCN). In addition, we confirmed specificity by testing the antibodies on mice with targeted disruption of the relevant genes. Our results identify antibodies against PER1, PER2, BMAL1 and CLOCK that are useful for assessing circadian clock proteins in the SCN by immunocytochemistry.	[LeSauter, Joseph; Robotham, Margaret R.; Model, Zina; Silver, Rae] Columbia Univ, Barnard Coll, Dept Psychol, New York, NY 10027 USA; [Lambert, Christopher M.; Weaver, David R.] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA USA; [Silver, Rae] Columbia Univ, Dept Psychol, New York, NY 10027 USA; [Silver, Rae] Columbia Univ Hlth Sci, Dept Pathol & Cell Biol, New York, NY USA	Columbia University; University of Massachusetts System; University of Massachusetts Worcester; Columbia University; Columbia University	LeSauter, J (corresponding author), Columbia Univ, Barnard Coll, Dept Psychol, New York, NY 10027 USA.	David.weaver@umassmed.edu		Weaver, David/0000-0001-7941-6719; LeSauter, Joseph/0000-0002-2963-1901; Silver, Rae/0000-0001-8633-739X	NIH [NS37919, MH075045, NS056125]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037919, R01NS056125] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants NS37919 and MH075045 to R.S. and NS056125 to D.R.W. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Beaule C, 2011, J BIOL RHYTHM, V26, P561, DOI 10.1177/0748730411416329; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Bur IM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015316; Carr AJF, 2000, PARTIAL CLONING SYRI; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Etchegaray JP, 2009, MOL CELL BIOL, V29, P3853, DOI 10.1128/MCB.00338-09; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Foley NC, 2011, EUR J NEUROSCI, V33, P1851, DOI 10.1111/j.1460-9568.2011.07682.x; Hastings M H, 1999, J Neurosci, V19, pRC11; Hood S, 2010, J NEUROSCI, V30, P14046, DOI 10.1523/JNEUROSCI.2128-10.2010; Jilg A, 2005, EUR J NEUROSCI, V22, P2845, DOI 10.1111/j.1460-9568.2005.04485.x; Lamont EW, 2005, P NATL ACAD SCI USA, V102, P4180, DOI 10.1073/pnas.0500901102; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee HM, 2011, P NATL ACAD SCI USA, V108, P16451, DOI 10.1073/pnas.1107178108; Lemos DR, 2007, ENDOCRINOLOGY, V148, P5811, DOI 10.1210/en.2007-0610; LeSauter J, 2003, BRAIN RES, V964, P279, DOI 10.1016/S0006-8993(02)04084-2; Loh DH, 2011, J BIOL RHYTHM, V26, P200, DOI 10.1177/0748730411401740; Maywood ES, 2011, J NEUROSCI, V31, P1539, DOI 10.1523/JNEUROSCI.4107-10.2011; Maywood ES, 2003, J NEUROENDOCRINOL, V15, P329, DOI 10.1046/j.1365-2826.2003.00971.x; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; Meng QJ, 2008, NEURON, V58, P78, DOI 10.1016/j.neuron.2008.01.019; Munoz M, 2005, J BIOL RHYTHM, V20, P3, DOI 10.1177/0748730404272858; Quintero JE, 2003, J NEUROSCI, V23, P8070; Ramanathan C, 2008, NEUROSCIENCE, V156, P48, DOI 10.1016/j.neuroscience.2008.07.020; Ramanathan C, 2006, BRAIN RES, V1073, P348, DOI 10.1016/j.brainres.2005.11.082; Ramanathan C, 2010, NEUROSCIENCE, V170, P758, DOI 10.1016/j.neuroscience.2010.07.053; Ramanathan C, 2008, NEUROSCI LETT, V441, P86, DOI 10.1016/j.neulet.2008.06.019; Ramanathan C, 2010, NEUROSCI LETT, V473, P220, DOI 10.1016/j.neulet.2010.02.051; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Resuehr HES, 2009, MOL CELL ENDOCRINOL, V311, P120, DOI 10.1016/j.mce.2009.07.005; Saper CB, 2009, J HISTOCHEM CYTOCHEM, V57, P1, DOI 10.1369/jhc.2008.952770; Schrader JA, 2010, NEUROSCIENCE, V171, P513, DOI 10.1016/j.neuroscience.2010.08.057; Schrader JA, 2011, J BIOL RHYTHM, V26, P363, DOI 10.1177/0748730411409714; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Sheynzon P, 2005, CELL TISSUE RES, V321, P211, DOI 10.1007/s00441-005-1150-4; Tamaru T, 2000, J NEUROSCI, V20, P7525; Tavakoli-Nezhad M, 2007, J BIOL RHYTHM, V22, P81, DOI 10.1177/0748730406296717; Verwey M, 2009, EUR J NEUROSCI, V29, P2217, DOI 10.1111/j.1460-9568.2009.06766.x; von Gall C, 2002, NAT NEUROSCI, V5, P234, DOI 10.1038/nn806; von Gall C, 2003, EUR J NEUROSCI, V18, P125, DOI 10.1046/j.1460-9568.2003.02735.x; Walton KM, 2009, J PHARMACOL EXP THER, V330, P430, DOI 10.1124/jpet.109.151415; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Wyse CA, 2010, BRAIN RES, V1337, P21, DOI 10.1016/j.brainres.2010.03.113; Yan LL, 2004, EUR J NEUROSCI, V19, P1105, DOI 10.1111/j.1460-9568.2004.03189.x; Yasuo S, 2008, EUR J NEUROSCI, V28, P2443, DOI 10.1111/j.1460-9568.2008.06541.x	46	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35938	10.1371/journal.pone.0035938	http://dx.doi.org/10.1371/journal.pone.0035938			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558277	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000089
J	Lin, MT; Huang, KH; Huang, CL; Huang, YJ; Tsai, GCE; Lane, HY				Lin, Ming-Teng; Huang, Kuo-Hao; Huang, Chieh-Liang; Huang, Yu-Jhen; Tsai, Guochuan E.; Lane, Hsien-Yuan			MET and AKT Genetic Influence on Facial Emotion Perception	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; HEPATOCYTE GROWTH-FACTOR; SCHIZOPHRENIA-PATIENTS; AUTISM; ASSOCIATION; RECOGNITION; AMYGDALA; VARIANT; BRAIN; LOCALIZATION	Background: Facial emotion perception is a major social skill, but its molecular signal pathway remains unclear. The MET/AKT cascade affects neurodevelopment in general populations and face recognition in patients with autism. This study explores the possible role of MET/AKT cascade in facial emotion perception. Methods: One hundred and eighty two unrelated healthy volunteers (82 men and 100 women) were recruited. Four single nucleotide polymorphisms (SNP) of MET (rs2237717, rs41735, rs42336, and rs1858830) and AKT rs1130233 were genotyped and tested for their effects on facial emotion perception. Facial emotion perception was assessed by the face task of Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT). Thorough neurocognitive functions were also assessed. Results: Regarding MET rs2237717, individuals with the CT genotype performed better in facial emotion perception than those with TT (p = 0.016 by ANOVA, 0.018 by general linear regression model [GLM] to control for age, gender, and education duration), and showed no difference with those with CC. Carriers with the most common MET CGA haplotype (frequency = 50.5%) performed better than non-carriers of CGA in facial emotion perception (p = 0.018, df = 1, F = 5.69, p = 0.009 by GLM). In MET rs2237717/AKT rs1130233 interaction, the C carrier/G carrier group showed better facial emotion perception than those with the TT/AA genotype (p = 0.035 by ANOVA, 0.015 by GLM), even when neurocognitive functions were controlled (p = 0.046 by GLM). Conclusions: To our knowledge, this is the first study to suggest that genetic factors can affect performance of facial emotion perception. The findings indicate that MET variances and MET/AKT interaction may affect facial emotion perception, implicating that the MET/AKT cascade plays a significant role in facial emotion perception. Further replication studies are needed.	[Lin, Ming-Teng; Huang, Kuo-Hao; Huang, Yu-Jhen; Lane, Hsien-Yuan] China Med Univ, Inst Clin Med Sci, Taichung, Taiwan; [Lin, Ming-Teng] Zhudong Vet Hosp, Dept Psychiat, Hsinchu, Taiwan; [Huang, Kuo-Hao; Huang, Chieh-Liang; Huang, Yu-Jhen; Lane, Hsien-Yuan] China Med Univ Hosp, Dept Psychiat, Taichung, Taiwan; [Tsai, Guochuan E.] Harbor UCLA Med Ctr, Dept Psychiat, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute	Lin, MT (corresponding author), China Med Univ, Inst Clin Med Sci, Taichung, Taiwan.	hylane@gmail.com			National Science Council, Taiwan [NSC-97-2314-B-039-006-MY3, NSC-98-2627-B-039-001]; National Health Research Institutes, Taiwan [NHRI-EX-100-9904NI]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH100-TD-B-111-004]; China Medical University Hospital, Taiwan [DMR-98-093, DMR-98-095]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); Taiwan Department of Health Clinical Trial and Research Center of Excellence; China Medical University Hospital, Taiwan	This work was funded by the National Science Council, Taiwan (NSC-97-2314-B-039-006-MY3, NSC-98-2627-B-039-001), National Health Research Institutes, Taiwan (NHRI-EX-100-9904NI), Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH100-TD-B-111-004), and China Medical University Hospital, Taiwan (DMR-98-093 and DMR-98-095). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association. American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Barbour T, 2010, SCHIZOPHR RES, V123, P126, DOI 10.1016/j.schres.2010.07.023; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Battaglia M, 2007, GENES BRAIN BEHAV, V6, P364, DOI 10.1111/j.1601-183X.2006.00265.x; Beevers CG, 2009, J ABNORM PSYCHOL, V118, P670, DOI 10.1037/a0016198; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Burdick KE, 2010, AM J PSYCHIAT, V167, P436, DOI 10.1176/appi.ajp.2009.09050615; Campbell DB, 2007, ANN NEUROL, V62, P243, DOI 10.1002/ana.21180; Campbell DB, 2006, P NATL ACAD SCI USA, V103, P16834, DOI 10.1073/pnas.0605296103; Campbell DB, 2008, AUTISM RES, V1, P159, DOI 10.1002/aur.27; Chan RCK, 2010, PSYCHIAT RES, V178, P381, DOI 10.1016/j.psychres.2009.03.035; Chen WJ, 1998, AM J PSYCHIAT, V155, P1214, DOI 10.1176/ajp.155.9.1214; Clarke GM, 2007, AM J HUM GENET, V81, P995, DOI 10.1086/521952; Cohen J., 1988, STAT POWER ANAL BEHA; Dawson G, 2005, DEV PSYCHOPATHOL, V17, P679, DOI 10.1017/S0954579405050327; Dawson G, 2005, DEV NEUROPSYCHOL, V27, P403, DOI 10.1207/s15326942dn2703_6; Eack SM, 2010, SCHIZOPHRENIA BULL, V36, P370, DOI 10.1093/schbul/sbn091; Edwards J, 2001, SCHIZOPHR RES, V48, P235, DOI 10.1016/S0920-9964(00)00099-2; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Fakra E, 2009, ARCH GEN PSYCHIAT, V66, P33, DOI 10.1001/archpsyc.66.1.33; Hahn CG, 2006, NAT MED, V12, P824, DOI 10.1038/nm1418; Heuer L, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.48; Hofer A, 2009, EUR PSYCHIAT, V24, P27, DOI 10.1016/j.eurpsy.2008.06.008; HONDA S, 1995, MOL BRAIN RES, V32, P197, DOI 10.1016/0169-328X(95)00075-4; Hossain MA, 2002, J NEUROCHEM, V81, P365, DOI 10.1046/j.1471-4159.2002.00837.x; Ieraci A, 2002, P NATL ACAD SCI USA, V99, P15200, DOI 10.1073/pnas.222362099; Ihnen GH, 1998, PSYCHIAT RES, V80, P275, DOI 10.1016/S0165-1781(98)00079-1; Iidaka T, 2005, J NEUROSCI, V25, P6460, DOI 10.1523/JNEUROSCI.5261-04.2005; Judson MC, 2011, J NEURODEV DISORD, V3, P282, DOI 10.1007/s11689-011-9081-8; Judson MC, 2009, J COMP NEUROL, V513, P511, DOI 10.1002/cne.21969; Karam CS, 2010, TRENDS PHARMACOL SCI, V31, P381, DOI 10.1016/j.tips.2010.05.004; Kee KS, 2009, SCHIZOPHR RES, V107, P61, DOI 10.1016/j.schres.2008.08.016; Kee KS, 2003, SCHIZOPHRENIA BULL, V29, P487, DOI 10.1093/oxfordjournals.schbul.a007021; Kee KS, 2004, SCHIZOPHR RES, V67, P87, DOI 10.1016/S0920-9964(03)00217-2; Kern RS, 2008, AM J PSYCHIAT, V165, P214, DOI 10.1176/appi.ajp.2007.07010043; Kern RS, 2004, SCHIZOPHR RES, V72, P11, DOI 10.1016/j.schres.2004.09.004; Kvajo M, 2010, CURR TOP BEHAV NEURO, V4, P629, DOI 10.1007/7854_2010_41; Lelli-Chiesa G, 2011, PSYCHOL MED, V41, P779, DOI 10.1017/S0033291710001431; Leppanen JM, 2008, SCHIZOPHR RES, V99, P270, DOI 10.1016/j.schres.2007.11.003; Li HJ, 2010, PROG NEURO-PSYCHOPH, V34, P393, DOI 10.1016/j.pnpbp.2010.01.007; Li HJ, 2010, SCHIZOPHRENIA BULL, V36, P1029, DOI 10.1093/schbul/sbn190; Lin CH, 2003, MOL PHARMACOL, V63, P44, DOI 10.1124/mol.63.1.44; Liu YL, 2006, PSYCHIAT GENET, V16, P39, DOI 10.1097/01.ypg.0000180681.80546.f3; Lo CH, 2010, BIOL PSYCHOL, V83, P79, DOI 10.1016/j.biopsycho.2009.11.002; Mandal MK, 1998, SCHIZOPHRENIA BULL, V24, P399, DOI 10.1093/oxfordjournals.schbul.a033335; Marder SR, 2004, SCHIZOPHR RES, V72, P5, DOI 10.1016/j.schres.2004.09.010; Mayer JD, MAYER SALOVEY CARUSO; Mayer JD, 2003, EMOTION, V3, P97, DOI 10.1037/1528-3542.3.1.97; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nicodemus KK, 2010, ARCH GEN PSYCHIAT, V67, P991, DOI 10.1001/archgenpsychiatry.2010.117; Pantazopoulos H, 2010, ARCH GEN PSYCHIAT, V67, P155, DOI 10.1001/archgenpsychiatry.2009.196; Pierce CA, 2004, EDUC PSYCHOL MEAS, V64, P916, DOI 10.1177/0013164404264848; Pinkham Amy E, 2007, Cogn Neuropsychiatry, V12, P198; Powell EM, 2001, NEURON, V30, P79, DOI 10.1016/S0896-6273(01)00264-1; Rametti G, 2009, EUR ARCH PSY CLIN N, V259, P203, DOI 10.1007/s00406-008-0852-5; Rzhetsky A, 2007, P NATL ACAD SCI USA, V104, P11694, DOI 10.1073/pnas.0704820104; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Sasson NJ, 2006, J AUTISM DEV DISORD, V36, P381, DOI 10.1007/s10803-006-0076-3; Schwab SG, 2005, BIOL PSYCHIAT, V58, P446, DOI 10.1016/j.biopsych.2005.05.005; Sousa I, 2009, EUR J HUM GENET, V17, P749, DOI 10.1038/ejhg.2008.215; Sun W, 2002, MOL BRAIN RES, V103, P36, DOI 10.1016/S0169-328X(02)00168-7; Tan HY, 2008, J CLIN INVEST, V118, P2200, DOI [10.1172/JCI3472S, 10.1172/JCI34725]; Thanseem I, 2010, NEUROSCI RES, V68, P137, DOI 10.1016/j.neures.2010.06.014; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Wechsler D., 1991, WISC 3 WECHSLER INTE; Wechsler D., 1997, WECHSLER ADULT INTEL; Whittaker JF, 2001, PSYCHOL MED, V31, P499, DOI 10.1017/S0033291701003701; Wilhelm O, 2010, J PERS SOC PSYCHOL, V99, P530, DOI 10.1037/a0019972; Xiao GH, 2001, P NATL ACAD SCI USA, V98, P247, DOI 10.1073/pnas.011532898; Xu MQ, 2007, J CLIN PSYCHIAT, V68, P1358, DOI 10.4088/JCP.v68n0906; Zaja RH, 2008, CURR OPIN PSYCHIATR, V21, P441, DOI 10.1097/YCO.0b013e328305e5fd; Zhou X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027428	73	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36143	10.1371/journal.pone.0036143	http://dx.doi.org/10.1371/journal.pone.0036143			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558359	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000137
J	Mancini, E; Castiglione, F; Bernaschi, M; de Luca, A; Sloot, PMA				Mancini, Emiliano; Castiglione, Filippo; Bernaschi, Massimo; de Luca, Andrea; Sloot, Peter M. A.			HIV Reservoirs and Immune Surveillance Evasion Cause the Failure of Structured Treatment Interruptions: A Computational Study	PLOS ONE			English	Article							CELLULAR-AUTOMATA APPROACH; ANTIRETROVIRAL THERAPY; VIRAL LOAD; IN-VIVO; INFECTION; DYNAMICS; HAART; MODEL; OPTIMIZATION; SIMULATION	Continuous antiretroviral therapy is currently the most effective way to treat HIV infection. Unstructured interruptions are quite common due to side effects and toxicity, among others, and cannot be prevented. Several attempts to structure these interruptions failed due to an increased morbidity compared to continuous treatment. The cause of this failure is poorly understood and often attributed to drug resistance. Here we show that structured treatment interruptions would fail regardless of the emergence of drug resistance. Our computational model of the HIV infection dynamics in lymphoid tissue inside lymph nodes, demonstrates that HIV reservoirs and evasion from immune surveillance themselves are sufficient to cause the failure of structured interruptions. We validate our model with data from a clinical trial and show that it is possible to optimize the schedule of interruptions to perform as well as the continuous treatment in the absence of drug resistance. Our methodology enables studying the problem of treatment optimization without having impact on human beings. We anticipate that it is feasible to steer new clinical trials using computational models.	[Mancini, Emiliano; Sloot, Peter M. A.] Univ Amsterdam, Amsterdam, Netherlands; [Castiglione, Filippo; Bernaschi, Massimo] CNR, Inst Comp Applicat Mauro Picone, Rome, Italy; [de Luca, Andrea] Catholic Univ, Inst Clin Infect Dis, Rome, Italy; [de Luca, Andrea] Siena Univ Hosp, Infect Dis Unit, Siena, Italy; [Sloot, Peter M. A.] Natl Res Univ ITMO, St Petersburg, Russia; [Sloot, Peter M. A.] Nanyang Technol Univ, Singapore, Singapore	University of Amsterdam; Consiglio Nazionale delle Ricerche (CNR); Istituto per le Applicazioni del Calcolo "Mauro Picone" (IAC-CNR); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Siena; University Hospital of Siena; ITMO University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Mancini, E (corresponding author), Univ Amsterdam, Amsterdam, Netherlands.	E.Mancini@uva.nl	Sloot, Peter/B-3078-2014; De Luca, Andrea/G-8810-2011; Mancini, Emiliano/ABC-1704-2020; Castiglione, Filippo/B-1366-2010	Sloot, Peter/0000-0002-3848-5395; De Luca, Andrea/0000-0002-9561-9193; Castiglione, Filippo/0000-0002-1442-3552	European Union under the EC [FP6-2004-IST-4, 028069]	European Union under the EC	Partial support from the European Union under the EC contract FP6-2004-IST-4, No. 028069 (ImmunoGrid) http://igrid-ext.cryst.bbk.ac.uk/immunogrid/site/. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananworanich J, 2003, AIDS, V17, pF33, DOI 10.1097/00002030-200310170-00001; Ananworanich J, 2006, LANCET, V368, P459, DOI 10.1016/S0140-6736(06)69153-8; Aviran S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000883; Bernaschi M, 2001, COMPUT BIOL MED, V31, P303, DOI 10.1016/S0010-4825(01)00011-7; Burkhead E, 2009, B MATH BIOL, V71, P25, DOI 10.1007/s11538-008-9351-0; Castiglione F, 2007, BIOINFORMATICS, V23, P3350, DOI 10.1093/bioinformatics/btm408; Castiglione F, 2005, INT J MOD PHYS C, V16, P1869, DOI 10.1142/S0129183105008394; Castiglione F, 2004, AIDS RES HUM RETROV, V20, P1314, DOI 10.1089/aid.2004.20.1314; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; dos Santos RMZ, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.168102; Dybul M, 2001, P NATL ACAD SCI USA, V98, P15161, DOI 10.1073/pnas.261568398; Dybul M, 2003, 10 C RETR OPP INF; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Ferreira J, 2011, COMPUT METH PROG BIO, V104, P50, DOI 10.1016/j.cmpb.2011.07.011; Garcia F, 2003, AIDS, V17, P43, DOI 10.1097/00002030-200301030-00007; Garcia F, 2001, AIDS, V15, pF29, DOI 10.1097/00002030-200106150-00002; Girard MP, 2012, CURR OPIN HIV AIDS, V7, P4, DOI 10.1097/COH.0b013e32834ddc96; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Kranzer K, 2011, TROP MED INT HEALTH, V16, P134; Kranzer K, 2010, JAIDS-J ACQ IMM DEF, V55, pE17, DOI 10.1097/QAI.0b013e3181f275fd; Kwon HD, 2007, APPL MATH COMPUT, V188, P1193, DOI 10.1016/j.amc.2006.10.071; Lafeuillade A, 2001, J ACQ IMMUN DEF SYND, V28, P197, DOI 10.1097/00126334-200110010-00015; Lambert-Niclot S, 2011, J INFECT DIS, V204, P1211, DOI 10.1093/infdis/jir518; Lundgren JD, 2008, J INFECT DIS, V197, P1145, DOI 10.1086/529523; Mei S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-118; Nowak MA., 2000, VIRUS DYNAMICS MATH; Paci P, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-56; Paci P, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-172; Palladini A, 2010, CANCER RES, V70, P7755, DOI 10.1158/0008-5472.CAN-10-0701; PANDEY RB, 1990, J STAT PHYS, V61, P235, DOI 10.1007/BF01013962; Papasavvas E, 2000, J INFECT DIS, V182, P766, DOI 10.1086/315748; Pensierosoa S, 2009, P NATL ACAD SCI USA, V106, P7939, DOI 10.1073/pnas.0901702106; Perelson AS, 1999, SIAM REV, V41, P3, DOI 10.1137/S0036144598335107; Ruskin HJ, 2002, PHYSICA A, V311, P213, DOI 10.1016/S0378-4371(02)00832-4; Shi V, 2008, J THEOR BIOL, V253, P24, DOI 10.1016/j.jtbi.2007.11.005; Simon V, 2003, NAT REV MICROBIOL, V1, P181, DOI 10.1038/nrmicro772; Sloot P, 2002, LECT NOTES COMPUT SC, V2493, P282; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; University of Washington, 2011, PARTNERS PREP STUDY; Wu Y, 2012, J MATH BIOL, V64, P495, DOI 10.1007/s00285-011-0422-8	43	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36108	10.1371/journal.pone.0036108	http://dx.doi.org/10.1371/journal.pone.0036108			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558348	Green Published, gold			2022-12-27	WOS:000305336000129
J	Papaleo, E; Renzetti, G; Tiberti, M				Papaleo, Elena; Renzetti, Giulia; Tiberti, Matteo			Mechanisms of Intramolecular Communication in a Hyperthermophilic Acylaminoacyl Peptidase: A Molecular Dynamics Investigation	PLOS ONE			English	Article							PROLYL ENDOPEPTIDASE INHIBITOR; TRANSFER-RNA SYNTHETASE; BETA-PROPELLER DOMAIN; ACYLPEPTIDE HYDROLASE; PROTEIN DYNAMICS; ENZYME; FLEXIBILITY; IDENTIFICATION; STABILIZATION; INACTIVATION	Protein dynamics and the underlying networks of intramolecular interactions and communicating residues within the three-dimensional (3D) structure are known to influence protein function and stability, as well as to modulate conformational changes and allostery. Acylaminoacyl peptidase (AAP) subfamily of enzymes belongs to a unique class of serine proteases, the prolyl oligopeptidase (POP) family, which has not been thoroughly investigated yet. POPs have a characteristic multidomain three-dimensional architecture with the active site at the interface of the C-terminal catalytic domain and a beta-propeller domain, whose N-terminal region acts as a bridge to the hydrolase domain. In the present contribution, protein dynamics signatures of a hyperthermophilic acylaminoacyl peptidase (AAP) of the prolyl oligopeptidase (POP) family, as well as of a deletion variant and alanine mutants (I12A, V13A, V16A, L19A, I20A) are reported. In particular, we aimed at identifying crucial residues for long range communications to the catalytic site or promoting the conformational changes to switch from closed to open ApAAP conformations. Our investigation shows that the N-terminal alpha 1-helix mediates structural intramolecular communication to the catalytic site, concurring to the maintenance of a proper functional architecture of the catalytic triad. Main determinants of the effects induced by alpha 1-helix are a subset of hydrophobic residues (V16, L19 and I20). Moreover, a subset of residues characterized by relevant interaction networks or coupled motions have been identified, which are likely to modulate the conformational properties at the interdomain interface.	[Papaleo, Elena; Renzetti, Giulia; Tiberti, Matteo] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy	University of Milano-Bicocca	Papaleo, E (corresponding author), Univ Copenaghen, Copenaghen Bioctr, Dept Biol, Copenaghen, Denmark.	elena.papaleo@unimib.it	Tiberti, Matteo/AGU-8969-2022; Papaleo, Elena/M-6629-2014	Papaleo, Elena/0000-0002-7376-5894; , Elena/0000-0003-2296-898X	CASPUR (Consorzio Interuniversitario per le Applicazioni di Supercalcolo per Universita e Ricerca)	CASPUR (Consorzio Interuniversitario per le Applicazioni di Supercalcolo per Universita e Ricerca)	This research was supported by CASPUR (Consorzio Interuniversitario per le Applicazioni di Supercalcolo per Universita e Ricerca) Standard HPC Grant 2010 and 2011 to Dr. Papaleo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CA, 1999, FEBS LETT, V458, P278, DOI 10.1016/S0014-5793(99)01166-7; Ackerman SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017459; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Armenta-Medina D, 2011, PROTEINS, V79, P1662, DOI 10.1002/prot.22995; Bae E, 2005, J BIOL CHEM, V280, P30943, DOI 10.1074/jbc.M504216200; Bartlam M, 2004, STRUCTURE, V12, P1481, DOI 10.1016/j.str.2004.05.019; Bosshard HR, 2004, J MOL RECOGNIT, V17, P1, DOI 10.1002/jmr.657; Camps J, 2009, BIOINFORMATICS, V25, P1709, DOI 10.1093/bioinformatics/btp304; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; D'Amico S, 2003, J MOL BIOL, V332, P981, DOI 10.1016/j.jmb.2003.07.014; Daniel RM, 2008, EXTREMOPHILES, V12, P51, DOI 10.1007/s00792-007-0089-7; Daniel RM, 2010, BIOCHEM J, V425, P353, DOI 10.1042/BJ20091254; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dodson GG, 2008, EMBO REP, V9, P144, DOI 10.1038/sj.embor.7401160; Echave J, 2010, PROTEINS, V78, P173, DOI 10.1002/prot.22553; ERLANDSSON R, 1991, ONCOGENE, V6, P1293; Estabrook RA, 2005, P NATL ACAD SCI USA, V102, P994, DOI 10.1073/pnas.0409128102; Esteban-Martin S, 2010, J AM CHEM SOC, V132, P4626, DOI 10.1021/ja906995x; Feller G, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/32/323101; Fuhrmans M, 2010, THEOR CHEM ACC, V125, P335, DOI 10.1007/s00214-009-0590-4; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Gao RJ, 2003, J MOL CATAL B-ENZYM, V24-5, P1, DOI 10.1016/S1381-1177(03)00064-X; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P15711, DOI 10.1073/pnas.0704459104; Ghosh A, 2011, J BIOL CHEM, V286, P37721, DOI 10.1074/jbc.M111.246702; Harmat V, 2011, J BIOL CHEM, V286, P1987, DOI 10.1074/jbc.M110.169862; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HUNENBERGER PH, 1995, J MOL BIOL, V252, P492, DOI 10.1006/jmbi.1995.0514; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kamerlin SCL, 2010, PROTEINS, V78, P1339, DOI 10.1002/prot.22654; Kappel C, 2010, BIOPHYS J, V99, P1596, DOI 10.1016/j.bpj.2010.06.032; Kiss AL, 2008, J STRUCT BIOL, V162, P312, DOI 10.1016/j.jsb.2008.01.012; Kormos BL, 2007, J STRUCT BIOL, V157, P500, DOI 10.1016/j.jsb.2006.10.022; Kumar S, 2002, CHEMBIOCHEM, V3, P604, DOI 10.1002/1439-7633(20020703)3:7<604::AID-CBIC604>3.0.CO;2-X; Kwasigroch JM, 2002, BIOINFORMATICS, V18, P1701, DOI 10.1093/bioinformatics/18.12.1701; Law AB, 2009, J AM CHEM SOC, V131, P6322, DOI 10.1021/ja809915a; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Lonquety M, 2007, COMPUT SYST BIOINF, P1; Lukman S, 2010, FEBS LETT, V584, P1235, DOI 10.1016/j.febslet.2010.02.035; Lwin TZ, 2007, J MOL BIOL, V373, P1334, DOI 10.1016/j.jmb.2007.07.080; Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012; Maguid S, 2008, GENE, V422, P7, DOI 10.1016/j.gene.2008.06.002; Marcos E, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000738; Markwick PRL, 2009, J AM CHEM SOC, V131, P16968, DOI 10.1021/ja907476w; Mayer KL, 2003, NAT STRUCT BIOL, V10, P962, DOI 10.1038/nsb991; Morain P, 2002, CNS DRUG REV, V8, P31; Morra G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000323; Nashine VC, 2010, CURR OPIN CHEM BIOL, V14, P644, DOI 10.1016/j.cbpa.2010.07.020; Pace CN, 2000, PROTEIN SCI, V9, P1395; Papaleo E, 2011, CURR PROTEIN PEPT SC, V12, P657, DOI 10.2174/1389203711109070657; Papaleo E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024214; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Rhoades E, 2003, P NATL ACAD SCI USA, V100, P3197, DOI 10.1073/pnas.2628068100; Richards PG, 2000, MOL PHARMACOL, V58, P577, DOI 10.1124/mol.58.3.577; Sacquin-Mora S, 2010, BIOPHYS J, V99, P3412, DOI 10.1016/j.bpj.2010.09.026; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Seeber M, 2011, J COMPUT CHEM, V32, P1183, DOI 10.1002/jcc.21688; Shan L, 2005, P NATL ACAD SCI USA, V102, P3599, DOI 10.1073/pnas.0408286102; Silvestre-Ryan J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002023; SOKOLIK CW, 1994, PROTEIN SCI, V3, P126; Suel GM, 2003, NAT STRUCT BIOL, V10, P232, DOI 10.1038/nsb0303-232; Sumida JP, 2008, J BIOL CHEM, V283, P6728, DOI 10.1074/jbc.M707485200; Szeltner Z, 2002, J BIOL CHEM, V277, P44597, DOI 10.1074/jbc.M207386200; Tarrago T, 2009, FEBS LETT, V583, P3344, DOI 10.1016/j.febslet.2009.09.036; Tiberti M, 2011, J STRUCT BIOL, V174, P69, DOI 10.1016/j.jsb.2011.01.006; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; TOIDE K, 1995, J NEUROCHEM, V65, P234; TSOU CL, 1995, BBA-PROTEIN STRUCT M, V1253, P151, DOI 10.1016/0167-4838(95)00172-5; TSUNASAWA S, 1975, J BIOCHEM, V77, P89; Van Elzen R, 2011, CNS NEUROL DISORD-DR, V10, P297, DOI 10.2174/187152711794653814; Villali J, 2010, CURR OPIN CHEM BIOL, V14, P636, DOI 10.1016/j.cbpa.2010.08.007; Vishveshwara S, 2009, CURR PROTEIN PEPT SC, V10, P146, DOI 10.2174/138920309787847590; Yamaguchi M, 1999, BIOCHEM BIOPH RES CO, V263, P139, DOI 10.1006/bbrc.1999.1289; Yang GY, 2009, BBA-PROTEINS PROTEOM, V1794, P94, DOI 10.1016/j.bbapap.2008.09.007; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4; Zhang HF, 2005, ACTA BIOCH BIOPH SIN, V37, P613, DOI 10.1111/j.1745-7270.2005.00085.x; Zhang ZM, 2008, BBA-PROTEINS PROTEOM, V1784, P1176, DOI 10.1016/j.bbapap.2008.05.011	77	34	34	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35686	10.1371/journal.pone.0035686	http://dx.doi.org/10.1371/journal.pone.0035686			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558199	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336000047
J	Castronovo, J; Gobel, SM				Castronovo, Julie; Goebel, Silke M.			Impact of High Mathematics Education on the Number Sense	PLOS ONE			English	Article							NUMERICAL ESTIMATION; REPRESENTATIONAL CHANGE; INTRAPARIETAL SULCUS; NEURAL EFFICIENCY; SEX-DIFFERENCES; TASK CONTENT; MAGNITUDE; DISCRIMINATION; CHILDREN; ORIGINS	In adult number processing two mechanisms are commonly used: approximate estimation of quantity and exact calculation. While the former relies on the approximate number sense (ANS) which we share with animals and preverbal infants, the latter has been proposed to rely on an exact number system (ENS) which develops later in life following the acquisition of symbolic number knowledge. The current study investigated the influence of high level math education on the ANS and the ENS. Our results showed that the precision of non-symbolic quantity representation was not significantly altered by high level math education. However, performance in a symbolic number comparison task as well as the ability to map accurately between symbolic and non-symbolic quantities was significantly better the higher mathematics achievement. Our findings suggest that high level math education in adults shows little influence on their ANS, but it seems to be associated with a better anchored ENS and better mapping abilities between ENS and ANS.	[Castronovo, Julie] Univ Hull, Dept Psychol, Kingston Upon Hull HU6 7RX, N Humberside, England; [Goebel, Silke M.] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England	University of Hull; University of York - UK	Castronovo, J (corresponding author), Univ Hull, Dept Psychol, Kingston Upon Hull HU6 7RX, N Humberside, England.	J.Castronovo@hull.ac.uk	Goebel, Silke/A-8046-2011	Goebel, Silke/0000-0001-8845-6026	Belgian National Fund for Scientific Research (Belgium)	Belgian National Fund for Scientific Research (Belgium)(Fonds de la Recherche Scientifique - FNRS)	This study was funded by Belgian National Fund for Scientific Research (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari D, 2006, BRAIN RES, V1067, P181, DOI 10.1016/j.brainres.2005.10.083; Ansari D, 2005, NEUROREPORT, V16, P1769, DOI 10.1097/01.wnr.0000183905.23396.f1; Ansari D, 2008, NAT REV NEUROSCI, V9, P278, DOI 10.1038/nrn2334; Ansari D, 2006, J COGNITIVE NEUROSCI, V18, P1820, DOI 10.1162/jocn.2006.18.11.1820; Ashcraft MH, 2012, J EXP CHILD PSYCHOL, V111, P246, DOI 10.1016/j.jecp.2011.08.005; ATKINSON J, 1976, PERCEPTION, V5, P335, DOI 10.1068/p050335; Barth H, 2009, COGNITIVE DEV, V24, P248, DOI 10.1016/j.cogdev.2009.04.001; Booth JL, 2006, DEV PSYCHOL, V42, P189, DOI 10.1037/0012-1649.41.6.189; Brannon EM, 2000, J EXP PSYCHOL ANIM B, V26, P31, DOI 10.1037/0097-7403.26.1.31; Briars D.J., 1988, CHILDRENS COUNTING C, P63; BUCKLEY PB, 1974, J EXP PSYCHOL, V103, P1131, DOI 10.1037/h0037361; Butterworth B., 2005, HDB MATH COGNITION, V1st, P455; Butterworth B, 2010, TRENDS COGN SCI, V14, P534, DOI 10.1016/j.tics.2010.09.007; Cantlon JF, 2006, PLOS BIOL, V4, P844, DOI 10.1371/journal.pbio.0040125; Carey S, 2001, MIND LANG, V16, P37, DOI 10.1111/1468-0017.00155; Carey S., 2009, ORIGIN CONCEPTS; Castronovo J, 2007, J EXP PSYCHOL HUMAN, V33, P1089, DOI 10.1037/0096-1523.33.5.1089; Church RM., 1984, ANIMAL COGNITION, P445; Crollen V, 2011, EXP PSYCHOL, V58, P39, DOI 10.1027/1618-3169/a000064; De Smedt B, 2009, J EXP CHILD PSYCHOL, V103, P469, DOI 10.1016/j.jecp.2009.01.010; DEHAENE S, 1990, J EXP PSYCHOL HUMAN, V16, P626, DOI 10.1037/0096-1523.16.3.626; DEHAENE S, 1993, J COGNITIVE NEUROSCI, V5, P390, DOI 10.1162/jocn.1993.5.4.390; Dehaene S., 1997, NUMBER SENSE; Dehaene S., 2007, ATTENTION PERFORM, P527, DOI DOI 10.1093/ACPROF:OSO/9780199231447.003.0024; Dehaene S, 2009, ANN NY ACAD SCI, V1156, P232, DOI 10.1111/j.1749-6632.2009.04469.x; Delvenne JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017743; Dowker A., 2005, INDIVIDUAL DIFFERENC; Droit-Volet S, 2003, J EXP CHILD PSYCHOL, V84, P63, DOI 10.1016/S0022-0965(02)00180-7; Ebersbach M, 2008, J EXP CHILD PSYCHOL, V99, P1, DOI 10.1016/j.jecp.2007.08.006; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Frank MC, 2008, COGNITION, V108, P819, DOI 10.1016/j.cognition.2008.04.007; Gebuis T, 2011, BEHAV RES METHODS, V43, P981, DOI 10.3758/s13428-011-0097-5; Gelman R., 1978, CHILDS UNDERSTANDING; Gilmore C, 2010, COGNITION, DOI [10.1016/j.cognition.2010.02.002, DOI 10.1016/J.COGNITI0N.2010.02.002]; Girelli L, 2000, J EXP CHILD PSYCHOL, V76, P104, DOI 10.1006/jecp.2000.2564; Haier RJ, 1995, DEV NEUROPSYCHOL, V11, P405, DOI 10.1080/87565649509540629; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Halberda J, 2008, DEV PSYCHOL, V44, P1457, DOI 10.1037/a0012682; Hauser MD, 2002, COGNITION, V86, pB23, DOI 10.1016/S0010-0277(02)00158-0; Holloway ID, 2009, J EXP CHILD PSYCHOL, V103, P17, DOI 10.1016/j.jecp.2008.04.001; Iuculano T, 2008, DEVELOPMENTAL SCI, V11, P669, DOI 10.1111/j.1467-7687.2008.00716.x; Izard V, 2008, PLOS BIOL, V6, P275, DOI 10.1371/journal.pbio.0060011; Izard V, 2009, P NATL ACAD SCI USA, V106, P10382, DOI 10.1073/pnas.0812142106; JACKSON M, 1986, CORTEX, V22, P611, DOI 10.1016/S0010-9452(86)80020-X; Jordan KE, 2006, J EXP CHILD PSYCHOL, V95, P215, DOI 10.1016/j.jecp.2006.05.004; Kadosh RC, 2007, NEURON, V53, P307, DOI 10.1016/j.neuron.2006.12.025; LeFevre JA, 2003, STUD MATH TH LEARN, P203; Lipton JS, 2003, PSYCHOL SCI, V14, P396, DOI 10.1111/1467-9280.01453; Mazzocco MMM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023749; Mazzocco MMM, 2011, CHILD DEV, V82, P1224, DOI 10.1111/j.1467-8624.2011.01608.x; McCrink K, 2010, COGNITION, DOI [10.1016/j.cognition.2010.05.003, DOI 10.1016/J.COGNITI0N.2010.05.003]; Mercure E, 2011, FRONT HUM NEUROSCI, V5, DOI [10.3389/fnhum.2011.00006, 10.3389/fnhum.2011.00062]; MOYER RS, 1967, NATURE, V215, P1519, DOI 10.1038/2151519a0; Mundy E, 2009, J EXP CHILD PSYCHOL, V103, P490, DOI 10.1016/j.jecp.2009.02.003; Neubauer AC, 2005, COGNITIVE BRAIN RES, V25, P217, DOI 10.1016/j.cogbrainres.2005.05.011; Neubauer AC, 2002, INTELLIGENCE, V30, P515, DOI 10.1016/S0160-2896(02)00091-0; Nieder A, 2004, P NATL ACAD SCI USA, V101, P7457, DOI 10.1073/pnas.0402239101; Opfer JE, 2007, COGNITIVE PSYCHOL, V55, P169, DOI 10.1016/j.cogpsych.2006.09.002; Passolunghi MC, 2007, COGNITIVE DEV, V22, P165, DOI 10.1016/j.cogdev.2006.09.001; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Piazza M, 2010, COGNITION, DOI [10.1016/j.cognition.2010.03.012, DOI 10.1016/J.COGNITI0N.2010.03.012]; Piazza M, 2007, NEURON, V53, P293, DOI 10.1016/j.neuron.2006.11.022; Piazza M, 2010, TRENDS COGN SCI, V14, P542, DOI 10.1016/j.tics.2010.09.008; Piazza M, 2009, NEUROSCIENTIST, V15, P261, DOI 10.1177/1073858409333073; Pica P, 2004, SCIENCE, V306, P499, DOI 10.1126/science.1102085; Rips LJ, 2008, BEHAV BRAIN SCI, V31, P623, DOI 10.1017/S0140525X08005566; Rivera SM, 2005, CEREB CORTEX, V15, P1779, DOI 10.1093/cercor/bhi055; Rousselle L, 2007, COGNITION, V102, P361, DOI 10.1016/j.cognition.2006.01.005; Rubinsten O, 2002, J EXP CHILD PSYCHOL, V81, P74, DOI 10.1006/jecp.2001.2645; Schneider M, 2008, COGNITIVE DEV, V23, P409, DOI 10.1016/j.cogdev.2008.07.002; Schneider M, 2009, J EDUC PSYCHOL, V101, P359, DOI 10.1037/a0013840; Siegler RS, 2004, CHILD DEV, V75, P428, DOI 10.1111/j.1467-8624.2004.00684.x; Siegler RS, 2003, PSYCHOL SCI, V14, P237, DOI 10.1111/1467-9280.02438; Spelke ES, 2007, DEVELOPMENTAL SCI, V10, P89, DOI 10.1111/j.1467-7687.2007.00569.x; Thompson CA, 2008, J EXP CHILD PSYCHOL, V101, P20, DOI 10.1016/j.jecp.2008.02.003; TZELGOV J, 1992, J EXP PSYCHOL LEARN, V18, P166, DOI 10.1037/0278-7393.18.1.166; Verguts T, 2004, J COGNITIVE NEUROSCI, V16, P1493, DOI 10.1162/0898929042568497; Watson DG, 2006, PERCEPT PSYCHOPHYS, V68, P319, DOI 10.3758/BF03193679; Watson DG, 1999, COGNITIVE NEUROPSYCH, V16, P609, DOI 10.1080/026432999380663; Whalen J, 1999, PSYCHOL SCI, V10, P130, DOI 10.1111/1467-9280.00120; Wilkinson G. S, 2006, WRAT4 WIDE RANGE ACH, V4th; Xu F, 2000, COGNITION, V74, pB1, DOI 10.1016/S0010-0277(99)00066-9	82	99	100	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e33832	10.1371/journal.pone.0033832	http://dx.doi.org/10.1371/journal.pone.0033832			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VP	22558077	gold, Green Submitted, Green Published			2022-12-27	WOS:000305345200004
J	Donker, T; Wallinga, J; Slack, R; Grundmann, H				Donker, Tjibbe; Wallinga, Jacco; Slack, Richard; Grundmann, Hajo			Hospital Networks and the Dispersal of Hospital-Acquired Pathogens by Patient Transfer	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; LIFE EXPECTANCY; COMMUNITY; TRANSMISSION; DETERMINANT; INFECTIONS; ENGLAND; MRSA	Hospital-acquired infections (HAI) are often seen as preventable incidents that result from unsafe practices or poor hospital hygiene. This however ignores the fact that transmissibility is not only a property of the causative organisms but also of the hosts who can translocate bacteria when moving between hospitals. In an epidemiological sense, hospitals become connected through the patients they share. We here postulate that the degree of hospital connectedness crucially influences the rates of infections caused by hospital-acquired bacteria. To test this hypothesis, we mapped the movement of patients based on the UK-NHS Hospital Episode Statistics and observed that the proportion of patients admitted to a hospital after a recent episode in another hospital correlates with the hospital-specific incidence rate of MRSA bacteraemia as recorded by mandatory reporting. We observed a positive correlation between hospital connectedness and MRSA bacteraemia incidence rate that is significant for all financial years since 2001 except for 2008-09. All years combined, this correlation is positive and significantly different from zero (partial correlation coefficient r = 0.33 (0.28 to 0.38)). When comparing the referral pattern for English hospitals with referral patterns observed in the Netherlands, we predict that English hospitals more likely see a swifter and more sustained spread of HAIs. Our results indicate that hospitals cannot be viewed as individual units but rather should be viewed as connected elements of larger modular networks. Our findings stress the importance of cooperative effects that will have a bearing on the planning of health care systems, patient management and hospital infection control.	[Donker, Tjibbe; Grundmann, Hajo] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, NL-9713 AV Groningen, Netherlands; [Donker, Tjibbe; Wallinga, Jacco; Grundmann, Hajo] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Wallinga, Jacco] Univ Med Ctr Utrecht, Julius Ctr Hlth Res & Primary Care, Utrecht, Netherlands; [Slack, Richard] Hlth Protect Agcy, Nottingham, England	University of Groningen; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Health Protection Agency	Donker, T (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, NL-9713 AV Groningen, Netherlands.	hajo.grundmann@rivm.nl	Wallinga, Jacco/C-4382-2018	Wallinga, Jacco/0000-0003-1725-5627; Donker, Tjibbe/0000-0001-9022-4240	National Institute for Public Health and the Environment (RIVM); Dutch Ministry of Health, Welfare and Sport	National Institute for Public Health and the Environment (RIVM); Dutch Ministry of Health, Welfare and Sport	This study was funded by the Strategic Research Fund of the National Institute for Public Health and the Environment (RIVM) and the Dutch Ministry of Health, Welfare and Sport. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Anderson TK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026798; Ansari F, 2009, CLIN INFECT DIS, V49, P1496, DOI 10.1086/644617; Baquero F, 2004, NAT REV MICROBIOL, V2, P510, DOI 10.1038/nrmicro909; Clauset A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026132; Cooper BS, 2004, P NATL ACAD SCI USA, V101, P10223, DOI 10.1073/pnas.0401324101; Cunningham JB, 2005, J HOSP INFECT, V61, P189, DOI 10.1016/j.jhin.2005.04.014; *DEP HLTH, 2007, HOSP ORG SPEC MIX MR; Department of Health website, MRSA SURV SYST RES; Donker T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000715; Dziekan G, 2000, J HOSP INFECT, V46, P263, DOI 10.1053/jhin.2000.0846; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Eveillard M, 2001, INFECT CONT HOSP EP, V22, P693, DOI 10.1086/501847; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Halwani M, 2006, J HOSP INFECT, V63, P39, DOI 10.1016/j.jhin.2005.10.012; Hao DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028322; Harbarth S, 2000, J HOSP INFECT, V46, P43, DOI 10.1053/jhin.2000.0798; Health Protection Agency, HLTH PROT AG MAND SU; Higgins A, 2010, J HOSP INFECT, V75, P120, DOI 10.1016/j.jhin.2009.12.014; Huang S, 2010, INFECT CONT HOSP EP, V31, P1160, DOI 10.1086/656747; Iwashyna TJ, 2009, MED CARE, V47, P787, DOI 10.1097/MLR.0b013e318197b1f5; Karkada UH, 2011, INTENS CARE MED, V37; Natarajan M, 2006, J QUANT CRIMINOL, V22, P171, DOI 10.1007/s10940-006-9007-x; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Raleigh VS, 1997, J EPIDEMIOL COMMUN H, V51, P649, DOI 10.1136/jech.51.6.649; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Robotham JV, 2007, J HOSP INFECT, V65, P93, DOI 10.1016/S0195-6701(07)60023-1; Salathe M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000736; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Vicca AF, 1999, J HOSP INFECT, V43, P109, DOI 10.1053/jhin.1999.0246; Woods LM, 2005, J EPIDEMIOL COMMUN H, V59, P115, DOI 10.1136/jech.2003.013003	32	72	72	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35002	10.1371/journal.pone.0035002	http://dx.doi.org/10.1371/journal.pone.0035002			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558106	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345200017
J	Johansson, AS; Vestling, M; Zetterstrom, P; Lang, L; Leinartaite, L; Karlstrom, M; Danielsson, J; Marklund, SL; Oliveberg, M				Johansson, Ann-Sofi; Vestling, Monika; Zetterstrom, Per; Lang, Lisa; Leinartaite, Lina; Karlstrom, Mikael; Danielsson, Jens; Marklund, Stefan L.; Oliveberg, Mikael			Cytotoxicity of Superoxide Dismutase 1 in Cultured Cells Is Linked to Zn2+ Chelation	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MAGNETIC-RESONANCE RELAXATION; MODEL-FREE APPROACH; DISULFIDE REDUCTION; MOTOR-NEURONS; CONFORMATIONAL STABILITY; ZINC DEPRIVATION; AMYLOID-BETA; FAMILIAL ALS; METAL-IONS	Neurodegeneration in protein-misfolding disease is generally assigned to toxic function of small, soluble protein aggregates. Largely, these assignments are based on observations of cultured neural cells where the suspect protein material is titrated directly into the growth medium. In the present study, we use this approach to shed light on the cytotoxic action of the metalloenzyme Cu/Zn superoxide dismutase 1 (SOD1), associated with misfolding and aggregation in amyotrophic lateral sclerosis (ALS). The results show, somewhat unexpectedly, that the toxic species of SOD1 in this type of experimental setting is not an aggregate, as typically observed for proteins implicated in other neuro-degenerative diseases, but the folded and fully soluble apo protein. Moreover, we demonstrate that the toxic action of apoSOD1 relies on the protein's ability to chelate Zn2+ ions from the growth medium. The decreased cell viability that accompanies this extraction is presumably based on disturbed Zn2+ homeostasis. Consistently, mutations that cause global unfolding of the apoSOD1 molecule or otherwise reduce its Zn2+ affinity abolish completely the cytotoxic response. So does the addition of surplus Zn2+. Taken together, these observations point at a case where the toxic response of cultured cells might not be related to human pathology but stems from the intrinsic limitations of a simplified cell model. There are several ways proteins can kill cultured neural cells but all of these need not to be relevant for neurodegenerative disease.	[Johansson, Ann-Sofi; Lang, Lisa; Leinartaite, Lina; Karlstrom, Mikael; Danielsson, Jens; Oliveberg, Mikael] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; [Vestling, Monika] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Zetterstrom, Per; Marklund, Stefan L.] Umea Univ, Dept Med Biosci, Umea, Sweden	Stockholm University; Umea University; Umea University	Johansson, AS (corresponding author), Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden.	mikael@dbb.su.se	Zetterström, Per/AAL-5018-2020; Danielsson, Jens/AAG-6915-2021	Zetterström, Per/0000-0001-8718-3249; Danielsson, Jens/0000-0002-6048-6896	Swedish Research Council; Swedish Brain Foundation; Knut and Alice Wallenberg Foundation; Hallsten Foundation; Kempe Foundation; Ahlen stiftelsen; Stohnes stiftelse; Stiftelsen for gamla tjanarinnor; Palle Ferbs minnesfond; EC [RII3-026145]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Hallsten Foundation; Kempe Foundation; Ahlen stiftelsen; Stohnes stiftelse; Stiftelsen for gamla tjanarinnor; Palle Ferbs minnesfond; EC(European CommissionEuropean Commission Joint Research Centre)	The work was supported by the Swedish Research Council (www.vr.se), the Swedish Brain Foundation (www.hjarnfonden.se), the Knut and Alice Wallenberg Foundation (www.wallenberg.com/kaw), the Hallsten Foundation, and the Kempe Foundation (www.kempe.com). Additionally, grants have been received from Ahlen stiftelsen (www.ahlen-stiftelsen.se), Stohnes stiftelse (http://home.swipnet.se/similar to w-125115), Stiftelsen for gamla tjanarinnor and Palle Ferbs minnesfond. NMR time at CERM was funded by the 6th Framework Program of the EC (Contract #RII3-026145, EU-NMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler M, 1999, NEUROTOXICOLOGY, V20, P571; ARSLAN P, 1985, J BIOL CHEM, V260, P2719; Baglioni S, 2006, J NEUROSCI, V26, P8160, DOI 10.1523/JNEUROSCI.4809-05.2006; Banci L, 2003, BIOCHEMISTRY-US, V42, P9543, DOI 10.1021/bi034324m; Banci L, 2000, BIOCHEMISTRY-US, V39, P9108, DOI 10.1021/bi000067z; BANCI L, 1991, EUR J BIOCHEM, V196, P123, DOI 10.1111/j.1432-1033.1991.tb15794.x; Banci L, 2002, PROTEIN SCI, V11, P2479, DOI 10.1110/ps.0210802; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; BERTINI I, 1994, EUR BIOPHYS J BIOPHY, V23, P167, DOI 10.1007/BF01007608; BIEDLER JL, 1978, CANCER RES, V38, P3751; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Colvin RA, 2003, EUR J PHARMACOL, V479, P171, DOI 10.1016/j.ejphar.2003.08.067; Cozzolino M, 2008, J BIOL CHEM, V283, P866, DOI 10.1074/jbc.M705657200; Crow JP, 1997, J NEUROCHEM, V69, P1936; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Ding WQ, 2008, CANCER LETT, V271, P251, DOI 10.1016/j.canlet.2008.06.011; Dong J, 2003, BIOCHEMISTRY-US, V42, P2768, DOI 10.1021/bi0272151; Durer ZAO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005004; Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008; Ermilova IP, 2005, NEUROSCI LETT, V379, P42, DOI 10.1016/j.neulet.2004.12.045; Estevez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Giulian D, 1998, J BIOL CHEM, V273, P29719, DOI 10.1074/jbc.273.45.29719; Hashemi M, 2007, EUR J PHARMACOL, V557, P9, DOI 10.1016/j.ejphar.2006.11.010; Hou X, 2005, BIOCHEMISTRY-US, V44, P11618, DOI 10.1021/bi050700m; Ilinskaya ON, 2002, PROTEIN SCI, V11, P2522, DOI 10.1110/ps.0216702; Jonsson PA, 2008, ANN NEUROL, V63, P671, DOI 10.1002/ana.21356; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; Kabashi E, 2004, J NEUROCHEM, V89, P1325, DOI 10.1111/j.1471-4159.2004.02453.x; Kayatekin C, 2010, J MOL BIOL, V398, P320, DOI 10.1016/j.jmb.2010.02.034; Klink TA, 2000, J BIOL CHEM, V275, P17463, DOI 10.1074/jbc.M001132200; Leinartaite L, 2010, J AM CHEM SOC, V132, P13495, DOI 10.1021/ja1057136; LEPOCK JR, 1990, J BIOL CHEM, V265, P21612; Lindberg MJ, 2005, P NATL ACAD SCI USA, V102, P9754, DOI 10.1073/pnas.0501957102; Lindberg MJ, 2002, P NATL ACAD SCI USA, V99, P16607, DOI 10.1073/pnas.262527099; Lindberg MJ, 2004, P NATL ACAD SCI USA, V101, P15893, DOI 10.1073/pnas.0403979101; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Lulloff SJ, 2004, J LAB CLIN MED, V144, P208, DOI 10.1016/j.lab.2004.07.007; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; Marks PA, 2001, CURR OPIN ONCOL, V13, P477, DOI 10.1097/00001622-200111000-00010; Meerarani P, 2000, AM J CLIN NUTR, V71, P81; Minicozzi V, 2008, J BIOL CHEM, V283, P10784, DOI 10.1074/jbc.M707109200; Niwa J, 2007, J BIOL CHEM, V282, P28087, DOI 10.1074/jbc.M704465200; Nordlund A, 2009, P NATL ACAD SCI USA, V106, P9667, DOI 10.1073/pnas.0812046106; Otsu K, 2004, BIOCHEM J, V377, P241, DOI 10.1042/BJ20030935; Paoletti P, 1997, J NEUROSCI, V17, P5711; PARGE HE, 1992, P NATL ACAD SCI USA, V89, P6109, DOI 10.1073/pnas.89.13.6109; Ravits J, 2007, NEUROLOGY, V68, P1576, DOI 10.1212/01.wnl.0000261045.57095.56; Sandelin E, 2007, J BIOL CHEM, V282, P21230, DOI 10.1074/jbc.M700765200; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Shen H, 2008, NUTR RES, V28, P406, DOI 10.1016/j.nutres.2008.02.011; SHIBATA N, 1994, NEUROSCI LETT, V179, P149, DOI 10.1016/0304-3940(94)90956-3; Shibata N, 1996, DEV NEUROSCI-BASEL, V18, P492, DOI 10.1159/000111445; Smith AP, 2007, AMYOTROPH LATERAL SC, V8, P131, DOI 10.1080/17482960701249241; Sohnle PG, 2000, ANTIMICROB AGENTS CH, V44, P139, DOI 10.1128/AAC.44.1.139-142.2000; Stathopulos PB, 2006, J BIOL CHEM, V281, P6184, DOI 10.1074/jbc.M509496200; Suhy DA, 1999, J BIOL CHEM, V274, P9183, DOI 10.1074/jbc.274.14.9183; Thiagalingam S, 2003, ANN NY ACAD SCI, V983, P84, DOI 10.1111/j.1749-6632.2003.tb05964.x; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; TUMILOWICZ JJ, 1970, CANCER RES, V30, P2110; Tummala H, 2005, J BIOL CHEM, V280, P17725, DOI 10.1074/jbc.M501705200; Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Wang Q, 2008, PLOS BIOL, V6, P1508, DOI 10.1371/journal.pbio.0060170; Wogulis M, 2005, J NEUROSCI, V25, P1071, DOI 10.1523/JNEUROSCI.2381-04.2005; Yui S, 2002, MEDIAT INFLAMM, V11, P165, DOI 10.1080/09622935020138208	71	14	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e36104	10.1371/journal.pone.0036104	http://dx.doi.org/10.1371/journal.pone.0036104			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558346	gold, Green Published, Green Submitted			2022-12-27	WOS:000305345200116
J	Adekambi, T; Ibegbu, CC; Kalokhe, AS; Yu, TW; Ray, SM; Rengarajan, J				Adekambi, Toidi; Ibegbu, Chris C.; Kalokhe, Ameeta S.; Yu, Tianwei; Ray, Susan M.; Rengarajan, Jyothi			Distinct Effector Memory CD4(+) T Cell Signatures in Latent Mycobacterium tuberculosis Infection, BCG Vaccination and Clinically Resolved Tuberculosis	PLOS ONE			English	Article							IMMUNE-RESPONSES; PD-1 EXPRESSION; DIFFERENTIATION; ANTIGENS; HIV; INTERLEUKIN-7; POPULATION; MENINGITIS; IMMUNOLOGY; PHENOTYPE	Two billion people worldwide are estimated to be latently infected with Mycobacterium tuberculosis (Mtb) and are at risk for developing active tuberculosis since Mtb can reactivate to cause TB disease in immune-compromised hosts. Individuals with latent Mtb infection (LTBI) and BCG-vaccinated individuals who are uninfected with Mtb, harbor antigen-specific memory CD4(+) T cells. However, the differences between long-lived memory CD4(+) T cells induced by latent Mtb infection (LTBI) versus BCG vaccination are unclear. In this study, we characterized the immune phenotype and functionality of antigen-specific memory CD4(+) T cells in healthy BCG-vaccinated individuals who were either infected (LTBI) or uninfected (BCG) with Mtb. Individuals were classified into LTBI and BCG groups based on IFN-gamma ELISPOT using cell wall antigens and ESAT-6/CFP-10 peptides. We show that LTBI individuals harbored high frequencies of late-stage differentiated (CD45RA(-)CD27(-)) antigen-specific effector memory CD4(+) T cells that expressed PD-1. In contrast, BCG individuals had primarily early-stage (CD45RA(-)CD27(+)) cells with low PD-1 expression. CD27(+) and CD27(-) as well as PD-1(+) and PD-1 2 antigen-specific subsets were polyfunctional, suggesting that loss of CD27 expression and up-regulation of PD-1 did not compromise their capacity to produce IFN-gamma, TNF-alpha and IL-2. PD-1 was preferentially expressed on CD27(-) antigen-specific CD4(+) T cells, indicating that PD-1 is associated with the stage of differentiation. Using statistical models, we determined that CD27 and PD-1 predicted LTBI versus BCG status in healthy individuals and distinguished LTBI individuals from those who had clinically resolved Mtb infection after anti-tuberculosis treatment. This study shows that CD4(+) memory responses induced by latent Mtb infection, BCG vaccination and clinically resolved Mtb infection are immunologically distinct. Our data suggest that differentiation into CD27(-)PD-1(+) subsets in LTBI is driven by Mtb antigenic stimulation in vivo and that CD27 and PD-1 have the potential to improve our ability to evaluate true LTBI status.	[Adekambi, Toidi; Ibegbu, Chris C.; Kalokhe, Ameeta S.; Rengarajan, Jyothi] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Kalokhe, Ameeta S.; Ray, Susan M.; Rengarajan, Jyothi] Emory Univ, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA; [Yu, Tianwei] Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA USA	Emory University; Emory University; Emory University; Rollins School Public Health	Adekambi, T (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	jrengar@emory.edu		Ray, Susan/0000-0002-6327-088X; Yu, Tianwei/0000-0003-2502-1628	A Center For AIDS Research (CFAR) Immunology Core grant [P30A01050409]; Emory-CFAR R03 Developmental grant; pilot project grant awarded from the the National Institutes of Health U19 CCHI Grant [AI057266]; Emory Global Health Institute Faculty Distinction Award; National Institute of Allergy and Infectious Diseases [T32AI074492]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI074492, U19AI057266] Funding Source: NIH RePORTER	A Center For AIDS Research (CFAR) Immunology Core grant; Emory-CFAR R03 Developmental grant; pilot project grant awarded from the the National Institutes of Health U19 CCHI Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory Global Health Institute Faculty Distinction Award; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the following funding sources: A Center For AIDS Research (CFAR) Immunology Core grant P30A01050409 (to Emory University), an Emory-CFAR R03 Developmental grant (to JR and SMR), a pilot project grant awarded (to JR) from the the National Institutes of Health U19 CCHI Grant AI057266 (Rafi Ahmed), an Emory Global Health Institute Faculty Distinction Award (to JR) and a T32AI074492 award (to ASK) from National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Attiyah R, 2004, CLIN EXP IMMUNOL, V138, P139, DOI 10.1111/j.1365-2249.2004.02609.x; [Anonymous], 2000, Am J Respir Crit Care Med, V161, pS221; [Anonymous], 1996, MMWR Recomm Rep, V45, P1; [Anonymous], 2011, GLOB TUB CONTR; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barry CE, 1996, TRENDS MICROBIOL, V4, P275, DOI 10.1016/0966-842X(96)10031-7; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Bennett DE, 2008, AM J RESP CRIT CARE, V177, P348, DOI 10.1164/rccm.200701-057OC; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; Bloom Barry R., 1994, P531; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Callan MFC, 1998, J EXP MED, V187, P1395, DOI 10.1084/jem.187.9.1395; Chiacchio T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027539; Commandeur S, 2011, EUR J IMMUNOL, V41, P2925, DOI 10.1002/eji.201141602; Commandeur S, 2011, CLIN VACCINE IMMUNOL, V18, P676, DOI 10.1128/CVI.00492-10; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Corbett EL, 1996, BRIT J HOSP MED, V56, P200; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Day CL, 2008, J INFECT DIS, V197, P990, DOI 10.1086/529048; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; Delogu G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018315; Di Mitri D, 2011, J IMMUNOL, V187, P2093, DOI 10.4049/jimmunol.1100978; Duraiswamy J, 2011, J IMMUNOL, V186, P4200, DOI 10.4049/jimmunol.1001783; Fletcher JM, 2005, J IMMUNOL, V175, P8218, DOI 10.4049/jimmunol.175.12.8218; Flynn JL, 2004, TUBERCULOSIS, V84, P93, DOI 10.1016/j.tube.2003.08.010; Fritsch RD, 2005, J IMMUNOL, V175, P6489, DOI 10.4049/jimmunol.175.10.6489; Geldmacher C, 2010, J EXP MED, V207, P2869, DOI 10.1084/jem.20100090; Geng E, 2002, NEW ENGL J MED, V346, P1453, DOI 10.1056/NEJMoa012972; GERDES J, 1984, J IMMUNOL, V133, P1710; Goletti D, 2010, EUR RESPIR J, V36, P135, DOI 10.1183/09031936.00140009; Harari A, 2005, J IMMUNOL, V174, P1037, DOI 10.4049/jimmunol.174.2.1037; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Horsburgh CR, 2011, NEW ENGL J MED, V364, P1441, DOI 10.1056/NEJMcp1005750; Hougardy JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000926; Jurado JO, 2008, J IMMUNOL, V181, P116, DOI 10.4049/jimmunol.181.1.116; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kaufmann SHE, 2005, TRENDS IMMUNOL, V26, P660, DOI 10.1016/j.it.2005.09.012; Klenerman P, 2005, NAT IMMUNOL, V6, P873, DOI 10.1038/ni1241; Lewinsohn DA, 2007, PLOS PATHOG, V3, P1240, DOI 10.1371/journal.ppat.0030127; Libri V, 2011, IMMUNOLOGY, V132, P326, DOI 10.1111/j.1365-2567.2010.03386.x; Lin PL, 2009, INFECT IMMUN, V77, P4631, DOI 10.1128/IAI.00592-09; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; McShane H, 2005, INT J STD AIDS, V16, P95, DOI 10.1258/0956462053057576; Mueller H, 2008, CYTOKINE, V43, P143, DOI 10.1016/j.cyto.2008.05.002; Petrovas C, 2007, BLOOD, V110, P928, DOI 10.1182/blood-2007-01-069112; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RAVIGLIONE MC, 1995, JAMA-J AM MED ASSOC, V273, P220, DOI 10.1001/jama.273.3.220; RODRIGUES LC, 1993, INT J EPIDEMIOL, V22, P1154, DOI 10.1093/ije/22.6.1154; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sauce D, 2007, AIDS, V21, P2005, DOI 10.1097/QAD.0b013e3282eee548; Schiott A, 2004, IMMUNOLOGY, V113, P363, DOI 10.1111/j.1365-2567.2004.01974.x; Schuck SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005590; Soares AP, 2008, J IMMUNOL, V180, P3569, DOI 10.4049/jimmunol.180.5.3569; Sonnenberg P, 2005, J INFECT DIS, V191, P150, DOI 10.1086/426827; Sterne JAC, 1998, INT J TUBERC LUNG D, V2, P200; Streitz M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000735; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Torrado E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002196; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Wilkinson KA, 2010, EUR J IMMUNOL, V40, P2139, DOI 10.1002/eji.201040731; Young DB, 2009, TRENDS MICROBIOL, V17, P183, DOI 10.1016/j.tim.2009.02.005; ZWEIG MH, 1993, CLIN CHEM, V39, P561	69	62	65	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e36046	10.1371/journal.pone.0036046	http://dx.doi.org/10.1371/journal.pone.0036046			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545156	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343200076
J	Boumart, Z; Roche, SM; Lalande, F; Virlogeux-Payant, I; Hennequet-Antier, C; Menanteau, P; Gabriel, I; Weill, FX; Velge, P; Chemaly, M				Boumart, Zineb; Roche, Sylvie M.; Lalande, Francoise; Virlogeux-Payant, Isabelle; Hennequet-Antier, Christelle; Menanteau, Pierrette; Gabriel, Irene; Weill, Francois-Xavier; Velge, Philippe; Chemaly, Marianne			Heterogeneity of Persistence of Salmonella enterica Serotype Senftenberg Strains Could Explain the Emergence of this Serotype in Poultry Flocks	PLOS ONE			English	Article							GEL-ELECTROPHORESIS; LISTERIA-MONOCYTOGENES; SEROVAR SENFTENBERG; FIELD STRAINS; LOW-VIRULENCE; CELL-LINE; ENTERITIDIS; INFECTION; OUTBREAK; TYPHIMURIUM	Salmonella enterica serotype Senftenberg (S. Senftenberg) has recently become more frequent in poultry flocks. Moreover some strains have been implicated in severe clinical cases. To explain the causes of this emergence in farm animals, 134 S. Senftenberg isolates from hatcheries, poultry farms and human clinical cases were analyzed. Persistent and non-persistent strains were identified in chicks. The non-persistent strains disappeared from ceca a few weeks post inoculation. This lack of persistence could be related to the disappearance of this serotype from poultry farms in the past. In contrast, persistent S. Senftenberg strains induced an intestinal asymptomatic carrier state in chicks similar to S. Enteritidis, but a weaker systemic infection than S. Enteritidis in chicks and mice. An in vitro analysis showed that the low infectivity of S. Senftenberg is in part related to its low capacity to invade enterocytes and thus to translocate the intestinal barrier. The higher capacity of persistent than non-persistent strains to colonize and persist in the ceca of chickens could explain the increased persistence of S. Senftenberg in poultry flocks. This trait might thus present a human health risk as these bacteria could be present in animals before slaughter and during food processing.	[Boumart, Zineb; Roche, Sylvie M.; Virlogeux-Payant, Isabelle; Menanteau, Pierrette; Velge, Philippe] INRA, Infectiol Anim & Sante Publ UR1282, F-37380 Nouzilly, France; [Boumart, Zineb; Lalande, Francoise; Chemaly, Marianne] ANSES, Lab Ploufragan Plouzane, Unite Hyg & Qual Prod Avicoles & Porcins, Ploufragan, France; [Hennequet-Antier, Christelle; Gabriel, Irene] INRA, Rech Avicoles UR83, F-37380 Nouzilly, France; [Weill, Francois-Xavier] Inst Pasteur, Ctr Natl Reference Salmonella, Unite Bacteries Pathogenes Enter, Paris, France; [Roche, Sylvie M.; Virlogeux-Payant, Isabelle; Menanteau, Pierrette; Velge, Philippe] Univ Tours, Agents Transmissibles & Infectiol IFR136, Tours, France	INRAE; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ploufragan-Plouzane Niort Laboratory; INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universite de Tours	Boumart, Z (corresponding author), INRA, Infectiol Anim & Sante Publ UR1282, F-37380 Nouzilly, France.	Philippe.Velge@tours.inra.fr	velge, philippe/AAK-4165-2021; Virlogeux-Payant, Isabelle/H-5800-2013	Weill, Francois-Xavier/0000-0001-9941-5799; Virlogeux-Payant, Isabelle/0000-0003-4149-0168	Institut National de Recherche Agronomique (INRA); French agency for food, environmental and occupational health safety (Anses); Anses	Institut National de Recherche Agronomique (INRA); French agency for food, environmental and occupational health safety (Anses); Anses	This work was supported by grants from the Institut National de Recherche Agronomique (INRA) and the French agency for food, environmental and occupational health safety (Anses). Zineb Boumart holds a Doctoral fellowship funded by Anses and INRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AllenVercoe E, 1997, FEMS MICROBIOL LETT, V153, P33, DOI 10.1111/j.1574-6968.1997.tb10460.x; Amy M, 2004, RES MICROBIOL, V155, P543, DOI 10.1016/j.resmic.2004.03.005; [Anonymous], 2007, EFSA J, V101, P1; [Anonymous], 2010, EFSA J, V8, P1503; Berger CN, 2009, ISME J, V3, P261, DOI 10.1038/ismej.2008.95; Borsoi A, 2011, BRAZ J MICROBIOL, V42, P266, DOI 10.1590/S1517-83822011000100034; Chadfield MS, 2003, VET MICROBIOL, V92, P49, DOI 10.1016/S0378-1135(02)00290-0; EISENSTEIN TK, 1984, J INFECT DIS, V150, P425, DOI 10.1093/infdis/150.3.425; Gal-Mor O, 2010, EMERG INFECT DIS, V16, P1754, DOI 10.3201/eid1611.100100; GOODLAD RA, 1991, GASTROENTEROLOGY, V101, P1235, DOI 10.1016/0016-5085(91)90072-S; Hamada S, 1959, JAPANESE J VET RES, V6, P181; Hu QH, 2008, J CLIN MICROBIOL, V46, P1330, DOI 10.1128/JCM.01255-07; Hume ME, 2003, POULTRY SCI, V82, P1100, DOI 10.1093/ps/82.7.1100; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; KAWAGUCHI T, 1987, CANCER RES, V47, P4460; Kay RS, 2007, INFECT CONT HOSP EP, V28, P805, DOI 10.1086/518458; Kerouanton A, 2007, FOODBORNE PATHOG DIS, V4, P293, DOI 10.1089/fpd.2007.0090; Kidgell C, 2002, INFECT GENET EVOL, V2, P39, DOI 10.1016/S1567-1348(02)00089-8; LEcuyer PB, 1996, CLIN INFECT DIS, V23, P734, DOI 10.1093/clinids/23.4.734; Liebana E, 2001, J CLIN MICROBIOL, V39, P3609, DOI 10.1128/JCM.39.10.3609-3616.2001; Martinez-Urtaza J, 2004, J FOOD PROTECT, V67, P256, DOI 10.4315/0362-028X-67.2.256; Martinez-Urtaza J, 2003, J FOOD PROTECT, V66, P226, DOI 10.4315/0362-028X-66.2.226; PARDON P, 1986, ANN INST PASTEUR MIC, V137B, P47, DOI 10.1016/S0769-2609(86)80093-X; Pedersen TB, 2008, AVIAN PATHOL, V37, P421, DOI 10.1080/03079450802216561; Pezzoli L, 2007, EUROSURVEILLANCE, V12; Pezzoli L, 2008, FOODBORNE PATHOG DIS, V5, P661, DOI 10.1089/fpd.2008.0103; Rabsch W, 2001, MICROBES INFECT, V3, P237, DOI 10.1016/S1286-4579(01)01375-2; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Roche SM, 2005, APPL ENVIRON MICROB, V71, P6039, DOI 10.1128/AEM.71.10.6039-6048.2005; Rushdy AA, 1998, EPIDEMIOL INFECT, V120, P125, DOI 10.1017/S0950268897008546; Sadeyen JR, 2004, MICROBES INFECT, V6, P1278, DOI 10.1016/j.micinf.2004.07.005; Skov MN, 2002, AVIAN DIS, V46, P265, DOI 10.1637/0005-2086(2002)046[0265:TSRTSE]2.0.CO;2; Temoin S, 2008, MICROBIOL-SGM, V154, P939, DOI 10.1099/mic.0.2007/011106-0; Van Immerseel F, 2002, DEV COMP IMMUNOL, V26, P355, DOI 10.1016/S0145-305X(01)00084-2; Velge P, 2005, VET RES, V36, P267, DOI 10.1051/vetres:2005005; Voetsch AC, 2004, CLIN INFECT DIS, V38, pS127, DOI 10.1086/381578; Williams J, 2008, BRIT POULTRY SCI, V49, P329, DOI 10.1080/00071660802123351; Withanage GSK, 2005, BRIT POULTRY SCI, V46, P261, DOI 10.1080/00071660500098608	38	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35782	10.1371/journal.pone.0035782	http://dx.doi.org/10.1371/journal.pone.0035782			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545136	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343200056
J	Sabin, LL; Knapp, AB; MacLeod, WB; Phiri-Mazala, G; Kasimba, J; Hamer, DH; Gill, CJ				Sabin, Lora L.; Knapp, Anna B.; MacLeod, William B.; Phiri-Mazala, Grace; Kasimba, Joshua; Hamer, Davidson H.; Gill, Christopher J.			Costs and Cost-Effectiveness of Training Traditional Birth Attendants to Reduce Neonatal Mortality in the Lufwanyama Neonatal Survival Study (LUNESP)	PLOS ONE			English	Article							DEATHS	Background: The Lufwanyama Neonatal Survival Project ("LUNESP") was a cluster randomized, controlled trial that showed that training traditional birth attendants (TBAs) to perform interventions targeting birth asphyxia, hypothermia, and neonatal sepsis reduced all-cause neonatal mortality by 45%. This companion analysis was undertaken to analyze intervention costs and cost-effectiveness, and factors that might improve cost-effectiveness. Methods and Findings: We calculated LUNESP's financial and economic costs and the economic cost of implementation for a forecasted ten-year program (2011-2020). In each case, we calculated the incremental cost per death avoided and disability-adjusted life years (DALYs) averted in real 2011 US dollars. The forecasted 10-year program analysis included a base case as well as 'conservative' and 'optimistic' scenarios. Uncertainty was characterized using one-way sensitivity analyses and a multivariate probabilistic sensitivity analysis. The estimated financial and economic costs of LUNESP were $118,574 and $127,756, respectively, or $49,469 and $53,550 per year. Fixed costs accounted for nearly 90% of total costs. For the 10-year program, discounted total and annual program costs were $256,455 and $26,834 respectively; for the base case, optimistic, and conservative scenarios, the estimated cost per death avoided was $1,866, $591, and $3,024, and cost per DALY averted was $74, $24, and $120, respectively. Outcomes were robust to variations in local costs, but sensitive to variations in intervention effect size, number of births attended by TBAs, and the extent of foreign consultants' participation. Conclusions: Based on established guidelines, the strategy of using trained TBAs to reduce neonatal mortality was 'highly cost effective'. We strongly recommend consideration of this approach for other remote rural populations with limited access to health care.	[Sabin, Lora L.; Knapp, Anna B.; MacLeod, William B.; Hamer, Davidson H.; Gill, Christopher J.] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA; [Sabin, Lora L.; MacLeod, William B.; Hamer, Davidson H.; Gill, Christopher J.] Boston Univ, Sch Publ Hlth, Dept Int Hlth, Boston, MA USA; [Phiri-Mazala, Grace; Kasimba, Joshua] Lufwanyama Dist Hlth Management Team, Kalulushi, Zambia; [Kasimba, Joshua; Hamer, Davidson H.] Zambia Ctr Appl Hlth Res & Dev, Lusaka, Zambia; [Hamer, Davidson H.] Boston Univ, Sch Med, Dept Med, Infect Dis Sect, Boston, MA 02118 USA	Boston University; Boston University; University of Zambia; Boston University	Sabin, LL (corresponding author), Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA.	lsabin@bu.edu	Hamer, Davidson Howes/J-2020-2019; MacLeod, William Bentley/A-8699-2009	Hamer, Davidson Howes/0000-0002-4700-1495; MacLeod, William Bentley/0000-0002-9726-7654; MacLeod, William/0000-0001-8003-8874; gill, christopher/0000-0003-3353-0617	Boston University; Office of Health and Nutrition of the United States Agency for International Development [GHS-A-00-03-00020-00]; NIH/NIAIDS [K23 AI 62208]; American Academy of Pediatrics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI062208] Funding Source: NIH RePORTER	Boston University; Office of Health and Nutrition of the United States Agency for International Development(United States Agency for International Development (USAID)); NIH/NIAIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Academy of Pediatrics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a cooperative agreement between Boston University and the Office of Health and Nutrition of the United States Agency for International Development, GHS-A-00-03-00020-00. NIH/NIAIDS K23 AI 62208 supported Dr. Gill's effort. Additional support for the neonatal resuscitation protocol intervention was provided by a Neonatal Resuscitation Program Grant from the American Academy of Pediatrics, which also contributed toward the costs of Dr. Guerina's travels to Zambia, some of the field office expenditures, and purchase of safe delivery kits. UNICEF also kindly provided safe delivery kits. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], INT DRUG PRIC IND GU; [Anonymous], HIST EXCH RAT; Bang Abhay T, 2005, J Perinatol, V25 Suppl 1, pS108, DOI 10.1038/sj.jp.7211278; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Beigi RH, 2009, CLIN INFECT DIS, V49, P1784, DOI 10.1086/649013; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bureau of Labor Statistics, CONS PRIC IND ALL UR; Carlo WA, 2009, J PEDIATR-US, V154, P504, DOI 10.1016/j.jpeds.2008.10.005; Darmstadt GL, 2009, INT J GYNECOL OBSTET, V107, pS89, DOI 10.1016/j.ijgo.2009.07.010; Edejer T, 2003, MAKING CHOICES HLTH; Gill CJ, BMJ, V342, pd346; Gold MR, 1996, COST EFFECTIVENESS H; Halton KA, PLOS ONE, V5; Hutton G, 2009, B WORLD HEALTH ORGAN, V87, P123, DOI 10.2471/BLT.08.051961; Int Mon Fund, 2011, WOR ECON OUTLOOK, P1; International Monetary Fund, WORLD EC OUTL DAT; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; McCabe CJ, PLOS ONE, V5; Montagu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017155; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Narman N, 2007, SAMJ S AFR MED J, V97, P733; Sicuri E, PLOS ONE, V5; Trading Economics, POP DENS PEOPL SQ KM; WHO-CHOICE, CHOOSING INT ARE COS; Wilford R, 2011, HLTH POLICY PLAN ADV, P1; World Health Organization, 2001, MACR HLTH INV HLTH E	26	22	22	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35560	10.1371/journal.pone.0035560	http://dx.doi.org/10.1371/journal.pone.0035560			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545117	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343200037
J	Havik, B; Degenhardt, FA; Johansson, S; Fernandes, CPD; Hinney, A; Scherag, A; Lybaek, H; Djurovic, S; Christoforou, A; Ersland, KM; Giddaluru, S; O'Donovan, MC; Owen, MJ; Craddock, N; Muhleisen, T; Mattheisen, M; Schimmelmann, BG; Renner, T; Warnke, A; Herpertz-Dahlmann, B; Sinzig, J; Albayrak, O; Rietschel, M; Nothen, MM; Bramham, CR; Werge, T; Hebebrand, J; Haavik, J; Andreassen, OA; Cichon, S; Steen, VM; Le Hellard, S				Havik, Bjarte; Degenhardt, Franziska A.; Johansson, Stefan; Fernandes, Carla P. D.; Hinney, Anke; Scherag, Andre; Lybaek, Helle; Djurovic, Srdjan; Christoforou, Andrea; Ersland, Kari M.; Giddaluru, Sudheer; O'Donovan, Michael C.; Owen, Michael J.; Craddock, Nick; Muehleisen, ThomasW.; Mattheisen, Manuel; Schimmelmann, Benno G.; Renner, Tobias; Warnke, Andreas; Herpertz-Dahlmann, Beate; Sinzig, Judith; Albayrak, Oezguer; Rietschel, Marcella; Noethen, Markus M.; Bramham, Clive R.; Werge, Thomas; Hebebrand, Johannes; Haavik, Jan; Andreassen, Ole A.; Cichon, Sven; Steen, Vidar M.; Le Hellard, Stephanie			DCLK1 Variants Are Associated across Schizophrenia and Attention Deficit/Hyperactivity Disorder	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; VAL66MET POLYMORPHISM; DOUBLECORTIN-LIKE; BIPOLAR DISORDER; BDNF; DEFICIT; KINASE; GENES; ENDOPHENOTYPE; GENETICS	Doublecortin and calmodulin like kinase 1 (DCLK1) is implicated in synaptic plasticity and neurodevelopment. Genetic variants in DCLK1 are associated with cognitive traits, specifically verbal memory and general cognition. We investigated the role of DCLK1 variants in three psychiatric disorders that have neuro-cognitive dysfunctions: schizophrenia (SCZ), bipolar affective disorder (BP) and attention deficit/hyperactivity disorder (ADHD). We mined six genome wide association studies (GWASs) that were available publically or through collaboration; three for BP, two for SCZ and one for ADHD. We also genotyped the DCLK1 region in additional samples of cases with SCZ, BP or ADHD and controls that had not been whole-genome typed. In total, 9895 subjects were analysed, including 5308 normal controls and 4,587 patients (1,125 with SCZ, 2,496 with BP and 966 with ADHD). Several DCLK1 variants were associated with disease phenotypes in the different samples. The main effect was observed for rs7989807 in intron 3, which was strongly associated with SCZ alone and even more so when cases with SCZ and ADHD were combined (P-value = 4x10(-5) and 4x10(-6), respectively). Associations were also observed with additional markers in intron 3 (combination of SCZ, ADHD and BP), intron 19 (SCZ+BP) and the 3'UTR (SCZ+BP). Our results suggest that genetic variants in DCLK1 are associated with SCZ and, to a lesser extent, with ADHD and BP. Interestingly the association is strongest when SCZ and ADHD are considered together, suggesting common genetic susceptibility. Given that DCLK1 variants were previously found to be associated with cognitive traits, these results are consistent with the role of DCLK1 in neurodevelopment and synaptic plasticity.	[Havik, Bjarte; Fernandes, Carla P. D.; Christoforou, Andrea; Ersland, Kari M.; Giddaluru, Sudheer; Cichon, Sven; Steen, Vidar M.; Le Hellard, Stephanie] Univ Bergen, Dept Clin Med, Dr E Martens Res Grp Biol Psychiat, Bergen, Norway; [Havik, Bjarte; Johansson, Stefan; Lybaek, Helle; Christoforou, Andrea; Ersland, Kari M.; Giddaluru, Sudheer; Steen, Vidar M.; Le Hellard, Stephanie] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Degenhardt, Franziska A.; Muehleisen, ThomasW.; Mattheisen, Manuel; Noethen, Markus M.; Cichon, Sven] Univ Bonn, Dept Genom, Life & Brain Ctr, Bonn, Germany; [Degenhardt, Franziska A.; Muehleisen, ThomasW.; Mattheisen, Manuel; Noethen, Markus M.; Cichon, Sven] Univ Bonn, Inst Human Genet, Bonn, Germany; [Johansson, Stefan; Bramham, Clive R.; Haavik, Jan] Univ Bergen, Dept Biomed, Bergen, Norway; [Hinney, Anke; Albayrak, Oezguer; Hebebrand, Johannes] Univ Duisburg Essen, Dept Child & Adolescent Psychiat, Essen, Germany; [Scherag, Andre] Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Djurovic, Srdjan; Andreassen, Ole A.] Univ Oslo, Inst Psychiat, Oslo, Norway; [O'Donovan, Michael C.; Owen, Michael J.; Craddock, Nick] Cardiff Univ, Dept Psychol Med & Neurol, MRC Ctr Neuropsychiat Genet & Genom, Neurosci & Mental Hlth Res Inst, Cardiff, S Glam, Wales; [Mattheisen, Manuel] Univ Bonn, IMBIE, Bonn, Germany; [Schimmelmann, Benno G.] Univ Hosp Child & Adolescent Psychiat Bern, Bern, Switzerland; [Renner, Tobias; Warnke, Andreas] Univ Wurzburg, Dept Child & Adolescent Psychiat, Wurzburg, Germany; [Herpertz-Dahlmann, Beate] Rhein Westfal TH Aachen, Univ Clin, Dept Child & Adolescent Psychiat Psychosomat & Ps, Aachen, Germany; [Sinzig, Judith] Univ Cologne, Dept Child & Adolescent Psychiat & Psychotherapy, D-50931 Cologne, Germany; [Sinzig, Judith] LVR Klin Bonn, Dept Child & Adolescent Psychiat & Psychotherapy, Bonn, Germany; [Rietschel, Marcella] Univ Bonn, Dept Psychiat, Bonn, Germany; [Noethen, Markus M.] German Ctr Neurodegenerat Disorders DZNE, Bonn, Germany; [Werge, Thomas] Copenhagen Univ Hosp, Res Inst Biol Psychiat, iPSYCH, Roskilde, Denmark; [Haavik, Jan] Haukeland Hosp, Div Psychiat, N-5021 Bergen, Norway; [Andreassen, Ole A.] Univ Oslo, Inst Clin Med, Div Mental Hlth & Addict, Oslo Univ Hosp, Oslo, Norway; [Cichon, Sven] Forschungszentrum Julich, Inst Neurosci & Med INM 1, D-52425 Julich, Germany	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bonn; University of Bonn; University of Bergen; University of Duisburg Essen; University of Duisburg Essen; University of Oslo; Cardiff University; University of Bonn; University of Bern; University Hospital of Bern; University of Wurzburg; RWTH Aachen University; RWTH Aachen University Hospital; University of Cologne; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); University of Copenhagen; University of Bergen; Haukeland University Hospital; University of Oslo; Helmholtz Association; Research Center Julich	Havik, B (corresponding author), Univ Bergen, Dept Clin Med, Dr E Martens Res Grp Biol Psychiat, Bergen, Norway.	stephanie.hellard@med.uib.no	Werge, Thomas/G-7263-2012; Degenhardt, Franziska/H-4169-2017; Haavik, Jan/ABE-1535-2020; O'Donovan, Michael C/P-7005-2018; Mattheisen, Manuel/B-4949-2012; Renner, Tobias J/I-2120-2013; Haavik, Jan/AAI-3974-2020; Andreassen, Ole A./AAY-7531-2020; Mattheisen, Manuel/S-3725-2019; Scherag, Andre/B-3805-2014; Cichon, Sven/H-8803-2013; Cichon, Sven/B-9618-2014; Johansson, Stefan/C-4394-2011; Hinney, Anke/D-6953-2011; Bramham, Clive/Q-1854-2018	O'Donovan, Michael C/0000-0001-7073-2379; Mattheisen, Manuel/0000-0002-8442-493X; Haavik, Jan/0000-0001-7865-2808; Mattheisen, Manuel/0000-0002-8442-493X; Cichon, Sven/0000-0002-9475-086X; Cichon, Sven/0000-0002-9475-086X; Johansson, Stefan/0000-0002-2298-7008; Hinney, Anke/0000-0001-5659-0706; Ersland, Kari Merete/0000-0003-3674-4151; Scherag, Andre/0000-0002-9406-4704; Djurovic, Srdjan/0000-0002-8140-8061; Nothen, Markus/0000-0002-8770-2464; Sinzig, Judith/0000-0002-3693-3318; Le Hellard, Stephanie/0000-0002-8085-051X; Bramham, Clive/0000-0001-5958-7115; Andreassen, Ole A./0000-0002-4461-3568	Bergen Research Foundation; University of Bergen; FUGE/Research Council of Norway; FUGE program of the Research Council of Norway; Research Council of Norway [151904, 183327, 175345]; Helse Vest RHF (Western Norway Regional Health Authority); Dr. Einar Martens Fund; DFG (Deutsche Forschungsgemeinschaft) [He 1446/9-1]; German Federal Ministry of Education and Research (BMBF), within the context of the National Genome Research Network 2 (NGFN-2); National Genome Research Network plus (NGFNplus); Integrated Genome Research Network (IG) MooDS [01GS08144, 01GS08147]; European Community [245009]; Alfried Krupp von Bohlen und Halbach-Stiftung; Medical Research Council [G0801418B] Funding Source: researchfish	Bergen Research Foundation; University of Bergen; FUGE/Research Council of Norway(Research Council of Norway); FUGE program of the Research Council of Norway; Research Council of Norway(Research Council of Norway); Helse Vest RHF (Western Norway Regional Health Authority); Dr. Einar Martens Fund; DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF), within the context of the National Genome Research Network 2 (NGFN-2)(Federal Ministry of Education & Research (BMBF)); National Genome Research Network plus (NGFNplus); Integrated Genome Research Network (IG) MooDS; European Community(European Commission); Alfried Krupp von Bohlen und Halbach-Stiftung; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by a grant from the Bergen Research Foundation and the University of Bergen to S.L.H. The genotyping of the Norwegian ADHD sample was performed on the Sequenom platform in CIGENE (FUGE/Research Council of Norway-funded national SNP platform) and the SCOPE sample was genotyped using the infrastructure provided by the Norwegian Microarray Consortium FUGE technology platform (www.microarray.no), funded by the FUGE program of the Research Council of Norway. The study was also supported by grants from the Research Council of Norway (incl. FUGE grant nos. 151904 and 183327, and Psykisk Helse grant no. 175345), Helse Vest RHF (Western Norway Regional Health Authority) and Dr. Einar Martens Fund. The GWAS of the German ADHD samples was supported by the grant He 1446/9-1 of the DFG (Deutsche Forschungsgemeinschaft). This study was also supported by the German Federal Ministry of Education and Research (BMBF), within the context of the National Genome Research Network 2 (NGFN-2), the National Genome Research Network plus (NGFNplus), and the Integrated Genome Research Network (IG) MooDS (grant 01GS08144 to S. C. and M.N.N., grant 01GS08147 to M. R.) and the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 245009 to J.H. and O.A. M.M.N. also received support from the Alfried Krupp von Bohlen und Halbach-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; APA, 1994, DIAGN STAT MAN MENT; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Banaschewski T, 2010, EUR CHILD ADOLES PSY, V19, P237, DOI 10.1007/s00787-010-0090-z; Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; Bradley WEC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009401; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Burgess HA, 2002, J BIOL CHEM, V277, P17696, DOI 10.1074/jbc.M111981200; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen Zhe-Yu, 2008, Novartis Found Symp, V289, P180; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Cichon S, 2011, AM J HUM GENET, V88, P396, DOI [10.1016/j.ajhg.2011.01.017, 10.1016/j.ajhg.2011.03.001]; Cichon S, 2009, AM J PSYCHIAT, V166, P540, DOI 10.1176/appi.ajp.2008.08091354; de la Serna E, 2010, SCHIZOPHR RES, V116, P159, DOI 10.1016/j.schres.2009.09.001; Esslinger C, 2009, SCIENCE, V324, P605, DOI 10.1126/science.1167768; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Green MJ, 2011, MOL PSYCHIATR, V16, P960, DOI 10.1038/mp.2010.88; Gur RE, 2007, SCHIZOPHRENIA BULL, V33, P49, DOI 10.1093/schbul/sbl055; Halmoy A, 2010, J CLIN PSYCHIAT, V71, P48, DOI 10.4088/JCP.08m04722ora; Hansen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000873; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Hasler G, 2006, BIOL PSYCHIAT, V60, P93, DOI 10.1016/j.biopsych.2005.11.006; Havik B, 2011, BIOL PSYCHIAT; Hebebrand J, 2006, MOL PSYCHIATR, V11, P196, DOI 10.1038/sj.mp.4001761; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Hennah W, 2009, MOL PSYCHIATR, V14, P865, DOI 10.1038/mp.2008.22; Hinney A, 2011, AM J MED GENETICSIN; Ingason A, 2011, MOL PSYCHIATR, V16, P17, DOI 10.1038/mp.2009.101; Kalkstein S, 2010, CURR TOP BEHAV NEURO, V4, P373, DOI 10.1007/7854_2010_42; Kuntsi J, 2006, NEUROMOL MED, V8, P461, DOI 10.1385/NMM:8:4:461; Le Hellard S, 2010, MOL PSYCHIATR, V15, P463, DOI 10.1038/mp.2008.110; Le Hellard S, 2009, MOL PSYCHIATR, V14, P308, DOI 10.1038/sj.mp.4002133; Le Hellard S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007534; Lin PT, 2000, J NEUROSCI, V20, P9152; Maydell RJ, 2009, AFR J PSYCHIATRY, V12, P144; McIntyre R, 2009, CNS SPECTRUMS, V14, P8, DOI 10.1017/S1092852900024822; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Neale BM, 2008, AM J MED GENET B, V147B, P1337, DOI 10.1002/ajmg.b.30866; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; O'Donovan MC, 2009, HUM GENET, V126, P3, DOI 10.1007/s00439-009-0703-0; Owen MJ, 2007, SCHIZOPHRENIA BULL, V33, P905, DOI 10.1093/schbul/sbm053; Palo OM, 2007, HUM MOL GENET, V16, P2517, DOI 10.1093/hmg/ddm207; Pedotti P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-124; Prathikanti S, 2005, BRIT MED BULL, V73-74, P107, DOI 10.1093/bmb/ldh055; Rietschel M, 2011, MOL PSYCHIAT; Rybakowski JK, 2008, PHARMACOGENOMICS, V9, P1589, DOI 10.2217/14622416.9.11.1589; Savitz JB, 2005, NEUROMOL MED, V7, P275, DOI 10.1385/NMM:7:4:275; Schenk GJ, 2011, PHYSIOL BEHAV, V102, P323, DOI 10.1016/j.physbeh.2010.11.024; Schenk GJ, 2010, PHYSIOL BEHAV, V101, P541, DOI 10.1016/j.physbeh.2010.08.002; Schimmelmann BG, 2007, J NEURAL TRANSM, V114, P523, DOI 10.1007/s00702-006-0616-1; Sharp SI, 2009, NEUROPHARMACOLOGY, V57, P590, DOI 10.1016/j.neuropharm.2009.08.011; Smith M, 2002, CYTOGENET GENOME RES, V98, P233, DOI 10.1159/000071040; Tanaka T, 2006, CEREB CORTEX, V16, pI69, DOI 10.1093/cercor/bhk005; Vreugdenhil E, 2007, EUR J NEUROSCI, V25, P635, DOI 10.1111/j.1460-9568.2007.05318.x; Wibrand K, 2006, EUR J NEUROSCI, V23, P1501, DOI 10.1111/j.1460-9568.2006.04687.x; Williams HJ, 2011, HUM MOL GENET, V20, P387, DOI 10.1093/hmg/ddq471; Williams NM, 2010, LANCET, V376, P1401, DOI 10.1016/S0140-6736(10)61109-9; Xia K, 2012, BIOINFORMATICS, V28, P451, DOI 10.1093/bioinformatics/btr678; Yatham LN, 2010, BIPOLAR DISORD, V12, P351, DOI 10.1111/j.1399-5618.2010.00830.x	60	20	21	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35424	10.1371/journal.pone.0035424	http://dx.doi.org/10.1371/journal.pone.0035424			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539971	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000305341000036
J	Li, ZQ; Ding, W; Sun, SJ; Li, J; Pan, J; Zhao, C; Wu, WR; Si, WK				Li, Zhi-Qiang; Ding, Wei; Sun, Shi-Jun; Li, Jun; Pan, Jing; Zhao, Chen; Wu, Wei-Ru; Si, Wei-Ke			Cyr61/CCN1 Is Regulated by Wnt/beta-Catenin Signaling and Plays an Important Role in the Progression of Hepatocellular Carcinoma	PLOS ONE			English	Article							SQUAMOUS-CELL-CARCINOMA; TISSUE-GROWTH-FACTOR; CANCER-CELLS; TUMOR PROGRESSION; GENE-EXPRESSION; PATHWAY; TARGET; CTGF; CARCINOGENESIS; IDENTIFICATION	Abnormal activation of the canonical Wnt signaling pathway has been implicated in carcinogenesis. Transcription of Wnt target genes is regulated by nuclear beta-catenin, whose over-expression is observed in Hepatocellular Carcinoma (HCC) tissue. Cyr61, a member of the CCN complex family of multifunctional proteins, is also found over-expressed in many types of tumor and plays dramatically different roles in tumorigenesis. In this study, we investigated the relationship between Cyr61 and beta-catenin in HCC. We found that while Cyr61 protein was not expressed at a detectable level in the liver tissue of healthy individuals, its expression level was elevated in the HCC and HCC adjacent tissues and was markedly increased in cancer-adjacent hepatic cirrhosis tissue. Over-expression of Cyr61 was positively correlated with increased levels of beta-catenin in human HCC samples. Activation of b-catenin signaling elevated the mRNA level of Cyr61 in HepG2 cells, while inhibition of beta-catenin signaling reduced both mRNA and protein levels of Cyr61. We identified two TCF4-binding elements in the promoter region of human Cyr61 gene and demonstrated that beta-catenin/TCF4 complex specifically bound to the Cyr61 promoter in vivo and directly regulated its promoter activity. Furthermore, we found that over-expression of Cyr61 in HepG2 cells promoted the progression of HCC xenografts in SCID mice. These findings indicate that Cyr61 is a direct target of beta-catenin signaling in HCC and may play an important role in the progression of HCC.	[Li, Zhi-Qiang; Ding, Wei; Li, Jun; Pan, Jing; Zhao, Chen; Wu, Wei-Ru; Si, Wei-Ke] Third Mil Med Univ, Dept Clin Hematol, Chongqing, Peoples R China; [Ding, Wei] PLA, KunMing Gen Hosp, Dept Clin Lab, Kunming, Peoples R China; [Sun, Shi-Jun] Third Mil Med Univ, Southwest Hosp, Chongqing, Peoples R China	Army Medical University; Kunming General Hospital; Army Medical University	Li, ZQ (corresponding author), Third Mil Med Univ, Dept Clin Hematol, Chongqing, Peoples R China.	weikesi2004@hotmail.com			National Natural Science Foundation of China [30672393]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (grant 30672393). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austinat M, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-21; Babic AM, 1998, P NATL ACAD SCI USA, V95, P6355, DOI 10.1073/pnas.95.11.6355; Chien WW, 2004, J BIOL CHEM, V279, P53087, DOI 10.1074/jbc.M410254200; D'Antonio KB, 2010, J UROLOGY, V183, P1604, DOI 10.1016/j.juro.2009.12.006; Deng YZ, 2007, J BIOL CHEM, V282, P36571, DOI 10.1074/jbc.M704141200; Dhar A., 2010, Experimental Oncology, V32, P2; Dong H, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-5; Du QA, 2006, CANCER RES, V66, P7024, DOI 10.1158/0008-5472.CAN-05-4110; Feng P, 2008, INT J BIOCHEM CELL B, V40, P98, DOI 10.1016/j.biocel.2007.06.020; Haque I, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-8; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hirasaki S, 2001, HEPATOL RES, V19, P294, DOI 10.1016/S1386-6346(00)00101-7; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Ladwa R, 2011, J CLIN PATHOL, V64, P58, DOI 10.1136/jcp.2010.082768; Lau LF, 2011, CELL MOL LIFE SCI, V68, P3149, DOI 10.1007/s00018-011-0778-3; Lee HS, 2007, LIFE SCI, V80, P690, DOI 10.1016/j.lfs.2006.10.024; Lin MT, 2008, J BIOL CHEM, V283, P15807, DOI 10.1074/jbc.M708933200; Lin MT, 2007, J BIOL CHEM, V282, P34594, DOI 10.1074/jbc.M706600200; Maeta N, 2007, ONCOLOGY-BASEL, V73, P118, DOI 10.1159/000121000; Monga SPS, 2011, INT J BIOCHEM CELL B, V43, P1021, DOI 10.1016/j.biocel.2009.09.001; Nejak-Bowen KN, 2011, SEMIN CANCER BIOL, V21, P44, DOI 10.1016/j.semcancer.2010.12.010; Nguyen N, 2006, CANCER RES, V66, P2658, DOI 10.1158/0008-5472.CAN-05-2082; Renard CA, 2007, CANCER RES, V67, P901, DOI 10.1158/0008-5472.CAN-06-2344; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; Song JY, 2008, INT J GYNECOL CANCER, V18, P1051, DOI 10.1111/j.1525-1438.2007.01164.x; Song PP, 2010, BIOSCI TRENDS, V4, P283; Tong XJ, 2004, ONCOGENE, V23, P4847, DOI 10.1038/sj.onc.1207628; Torisu Y, 2008, CANCER SCI, V99, P1139, DOI 10.1111/j.1349-7006.2008.00814.x; Tsai MS, 2002, ONCOGENE, V21, P964, DOI 10.1038/sj/onc/1205131; Wagner RT, 2010, STEM CELLS, V28, P1794, DOI 10.1002/stem.502; Wang BS, 2005, ONCOGENE, V24, P3999, DOI 10.1038/sj.onc.1208550; Wei D, 2008, J 4 MIL MED U, V29; Wei D, 2008, ACTA ACAD MED MILITA, V30, P378; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Xie D, 2004, CANCER RES, V64, P1987, DOI 10.1158/0008-5472.CAN-03-0666; Xie D, 2004, CLIN CANCER RES, V10, P2072, DOI 10.1158/1078-0432.CCR-0659-03; Xie JJ, 2011, INT J MOL MED, V27, P429, DOI 10.3892/ijmm.2011.603; Xu L, 2001, CANCER RES, V61, P3176; Xu LF, 2000, GENE DEV, V14, P585; Yang W, 2008, CANCER RES, V68, P4287, DOI 10.1158/0008-5472.CAN-07-6691; Zeng ZJ, 2004, WORLD J GASTROENTERO, V10, P3414	41	25	33	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35754	10.1371/journal.pone.0035754	http://dx.doi.org/10.1371/journal.pone.0035754			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22540002	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341000068
J	Bailleul, AM; Hall, BK; Horner, JR				Bailleul, Alida M.; Hall, Brian K.; Horner, John R.			First Evidence of Dinosaurian Secondary Cartilage in the Post-Hatching Skull of Hypacrosaurus stebingeri (Dinosauria, Ornithischia)	PLOS ONE			English	Article							MEMBRANE BONES; CHONDROID TISSUE; CHICK-EMBRYO; ONTOGENY; GROWTH; REPAIR; MORPHOGENESIS; TRICERATOPS; VERTEBRATES; HISTOLOGY	Bone and calcified cartilage can be fossilized and preserved for hundreds of millions of years. While primary cartilage is fairly well studied in extant and fossilized organisms, nothing is known about secondary cartilage in fossils. In extant birds, secondary cartilage arises after bone formation during embryonic life at articulations, sutures and muscular attachments in order to accommodate mechanical stress. Considering the phylogenetic inclusion of birds within the Dinosauria, we hypothesized a dinosaurian origin for this "avian" tissue. Therefore, histological thin sectioning was used to investigate secondary chondrogenesis in disarticulated craniofacial elements of several post-hatching specimens of the non-avian dinosaur Hypacrosaurus stebingeri (Ornithischia, Lambeosaurinae). Secondary cartilage was found on three membrane bones directly involved with masticatory function: (1) as nodules on the dorso-caudal face of a surangular; and (2) on the bucco-caudal face of a maxilla; and (3) between teeth as islets in the alveolar processes of a dentary. Secondary chondrogenesis at these sites is consistent with the locations of secondary cartilage in extant birds and with the induction of the cartilage by different mechanical factors -stress generated by the articulation of the quadrate, stress of a ligamentous or muscular insertion, and stress of tooth formation. Thus, our study reveals the first evidence of "avian" secondary cartilage in a non-avian dinosaur. It pushes the origin of this "avian" tissue deep into dinosaurian ancestry, suggesting the creation of the more appropriate term "dinosaurian" secondary cartilage.	[Bailleul, Alida M.; Horner, John R.] Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA; [Bailleul, Alida M.; Horner, John R.] Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA; [Hall, Brian K.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Dalhousie University	Bailleul, AM (corresponding author), Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA.	alida.bailleul@msu.montana.edu			NSERC of Canada [A5056]; Australian Research Grants Committee [J044823]	NSERC of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Australian Research Grants Committee	Two of the authors, A. M. B and J.R.H., are indebted to Gerry Ohrstrom for funding. B. K. H. was supported by NSERC of Canada (Grant A5056) and by the Australian Research Grants Committee, grant no. J044823. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardack D., 1971, BIOL LAMPREYS, V1, P67; BARRETO C, 1993, SCIENCE, V262, P2020, DOI 10.1126/science.262.5142.2020; Bloom W., 1986, TXB HISTOLOGY; Buxton PG, 2003, DEVELOPMENT, V130, P4729, DOI 10.1242/dev.00610; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; COULY GF, 1993, DEVELOPMENT, V117, P409; de Ricqles A., 1975, ANN PALEONTOL, V61, P51; Enlow D. H., 1990, FACIAL GROWTH; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; Goodwin MB, 2004, PALEOBIOLOGY, V30, P253, DOI 10.1666/0094-8373(2004)030<0253:CHOPOM>2.0.CO;2; Goret-Nicaise M, 1986, THESIS UCL BOLOGNA; GORETNICAISE M, 1984, ARCH ANAT MICROSC MO, V73, P291; HALL B. K., 1967, AUST J ZOOL, V15, P685, DOI 10.1071/ZO9670685; HALL B K, 1968, Australian Journal of Zoology, V16, P795, DOI 10.1071/ZO9680795; Hall B.K., 2015, BONES CARTILAGE DEV; HALL BK, 1968, HISTOCHEMISTRY, V16, P206, DOI 10.1007/BF00307849; HALL BK, 1986, J EMBRYOL EXP MORPH, V93, P133; HALL BK, 1985, J EXP ZOOL, V233, P359, DOI 10.1002/jez.1402330304; Hall BK, 2000, WENN GR INT, V76, P101; HALL BK, 1975, ANAT RECORD, V181, P55, DOI 10.1002/ar.1091810105; HALL BK, 1971, CLIN ORTHOP RELAT R, P249; HALL BK, 1971, CLIN ORTHOP RELAT R, P182, DOI 10.1097/00003086-197107000-00015; Hall BK, 1997, ENCY HUMAN BIOL, V2; Holliday CM, 2009, ANAT REC, V292, P1246, DOI 10.1002/ar.20982; Horner JR, 2011, CR PALEVOL, V10, P439, DOI 10.1016/j.crpv.2011.04.006; Horner JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007626; Horner John R., 1994, P312; Horner JR, 2001, PALEOBIOLOGY, V27, P39, DOI 10.1666/0094-8373(2001)027<0039:COOSEA>2.0.CO;2; IRWIN CR, 1986, J ANAT, V146, P53; Lamm ET, 2007, MICROSC MICROANAL, V13, P50, DOI 10.1017/S1431927607075368; LENGELE B, 1990, J CRAN GENET DEV BIO, V10, P103; Lengele B, 1996, ANAT EMBRYOL, V193, P505; Lengele B, 1996, ANAT REC, V246, P377, DOI 10.1002/(SICI)1097-0185(199611)246:3<377::AID-AR9>3.0.CO;2-V; MURRAY P. D. F., 1963, AUSTRALIAN JOUR ZOOL, V11, P368, DOI 10.1071/ZO9630368; Murray P. D. F., 1965, Australian Journal of Zoology, V13, P351, DOI 10.1071/ZO9650351; Scannella JB, 2010, J VERTEBR PALEONTOL, V30, P1157, DOI 10.1080/02724634.2010.483632; Scheyer TM, 2007, J ANAT, V211, P737, DOI 10.1111/j.1469-7580.2007.00815.x; TRAN S, 1989, ACTA ANAT, V135, P200; Tumarkin-Deratzian Allison R., 2010, P251; Vickaryous MK, 2008, J MORPHOL, V269, P398, DOI 10.1002/jmor.10575	40	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36112	10.1371/journal.pone.0036112	http://dx.doi.org/10.1371/journal.pone.0036112			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558351	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340200042
J	Bourdais, A; Bidard, F; Zickler, D; Berteaux-Lecellier, V; Silar, P; Espagne, E				Bourdais, Anne; Bidard, Frederique; Zickler, Denise; Berteaux-Lecellier, Veronique; Silar, Philippe; Espagne, Eric			Wood Utilization Is Dependent on Catalase Activities in the Filamentous Fungus Podospora anserina	PLOS ONE			English	Article							BETA-OXIDATION; GENOME SEQUENCE; NADPH; IDENTIFICATION; MITOCHONDRIA; MICROBODIES; PEROXIDASE; MECHANISMS; MUTANTS; SYSTEMS	Catalases are enzymes that play critical roles in protecting cells against the toxic effects of hydrogen peroxide. They are implicated in various physiological and pathological conditions but some of their functions remain unclear. In order to decipher the role(s) of catalases during the life cycle of Podospora anserina, we analyzed the role of the four monofunctional catalases and one bifunctional catalase-peroxidase genes present in its genome. The five genes were deleted and the phenotypes of each single and all multiple mutants were investigated. Intriguingly, although the genes are differently expressed during the life cycle, catalase activity is dispensable during both vegetative growth and sexual reproduction in laboratory conditions. Catalases are also not essential for cellulose or fatty acid assimilation. In contrast, they are strictly required for efficient utilization of more complex biomass like wood shavings by allowing growth in the presence of lignin. The secreted CATB and cytosolic CAT2 are the major catalases implicated in peroxide resistance, while CAT2 is the major player during complex biomass assimilation. Our results suggest that P. anserina produces external H2O2 to assimilate complex biomass and that catalases are necessary to protect the cells during this process. In addition, the phenotypes of strains lacking only one catalase gene suggest that a decrease of catalase activity improves the capacity of the fungus to degrade complex biomass.	[Bourdais, Anne; Bidard, Frederique; Zickler, Denise; Berteaux-Lecellier, Veronique; Silar, Philippe; Espagne, Eric] Univ Paris Sud, Inst Genet & Microbiol, UMR 8621, Orsay, France; [Bourdais, Anne; Bidard, Frederique; Zickler, Denise; Berteaux-Lecellier, Veronique; Silar, Philippe] CNRS, F-91405 Orsay, France; [Bourdais, Anne] CNRS, UMR 6061, Inst Genet & Dev Rennes, Rennes, France; [Bourdais, Anne] UEB Univ Rennes 1, IFR 140, Fac Med, Rennes, France; [Berteaux-Lecellier, Veronique] CRIOBE, USR CNRS EPHE 3278, Lab Excellence CORAIL, Moorea, France; [Silar, Philippe] Univ Paris Diderot, UFR Sci Vivant, Paris, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); UDICE-French Research Universities; Universite Paris Cite	Bourdais, A (corresponding author), Univ Paris Sud, Inst Genet & Microbiol, UMR 8621, Orsay, France.	eric.espagne@igmors.u-psud.fr	Espagne, Eric/AAF-9794-2019; Berteaux-Lecellier, Veronique/O-4767-2018; Espagne, Eric/GMX-2417-2022; BERTEAUX-LECELLIER, Veronique/P-6456-2019	Berteaux-Lecellier, Veronique/0000-0003-2152-6231; BERTEAUX-LECELLIER, Veronique/0000-0003-2152-6231; Espagne, Eric/0000-0002-5813-498X; silar, philippe/0000-0003-0104-987X	Universite Paris Sud 11/Centre National de la Recherche Scientifique (UMR) [8621]; Agence Nationale de la Recherche [ANR-05-Blan-0385-02]	Universite Paris Sud 11/Centre National de la Recherche Scientifique (UMR); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by intramural grants from Universite Paris Sud 11/Centre National de la Recherche Scientifique (UMR 8621) and from "Agence Nationale de la Recherche'' grant no ANR-05-Blan-0385-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Aguirre J, 2005, TRENDS MICROBIOL, V13, P111, DOI 10.1016/j.tim.2005.01.007; Belinky PA, 2003, APPL ENVIRON MICROB, V69, P6500, DOI 10.1128/AEM.69.11.6500-6506.2003; BERTEAUXLECELLIER V, 1995, CELL, V81, P1043, DOI 10.1016/S0092-8674(05)80009-1; Boisnard S, 2009, FUNGAL GENET BIOL, V46, P55, DOI 10.1016/j.fgb.2008.10.006; Bonnet C, 2006, MOL MICROBIOL, V62, P157, DOI 10.1111/j.1365-2958.2006.05353.x; Brun S, 2009, MOL MICROBIOL, V74, P480, DOI 10.1111/j.1365-2958.2009.06878.x; Cabiscol Elisa, 2000, International Microbiology, V3, P3; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; Chen DR, 2008, MOL BIOL CELL, V19, P308, DOI 10.1091/mbc.E07-08-0735; Coppin E, 2002, MOL MICROBIOL, V43, P1255, DOI 10.1046/j.1365-2958.2002.02819.x; CORPAS FJ, 2009, EMERGENT FUNCTIONS P, P97; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Dashtban M, 2009, INT J BIOL SCI, V5, P578, DOI 10.7150/ijbs.5.578; DEBUCHY R, 1985, EMBO J, V4, P3553, DOI 10.1002/j.1460-2075.1985.tb04116.x; Djordjevic VB, 2004, INT REV CYTOL, V237, P57, DOI 10.1016/S0074-7696(04)37002-6; DOLPHIN D, 1971, P NATL ACAD SCI USA, V68, P614, DOI 10.1073/pnas.68.3.614; Espagne E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r77; Giles SS, 2006, EUKARYOT CELL, V5, P1447, DOI 10.1128/EC.00098-06; Gournas C, 2011, FUNGAL GENET BIOL, V48, P840, DOI 10.1016/j.fgb.2011.03.004; Grant CM, 2001, MOL MICROBIOL, V39, P533, DOI 10.1046/j.1365-2958.2001.02283.x; Grissa I, 2010, FUNGAL BIOL-UK, V114, P766, DOI 10.1016/j.funbio.2010.07.002; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Kawasaki L, 1997, J BACTERIOL, V179, P3284, DOI 10.1128/jb.179.10.3284-3292.1997; Kersten P, 2007, FUNGAL GENET BIOL, V44, P77, DOI 10.1016/j.fgb.2006.07.007; KIONKA C, 1985, J BACTERIOL, V161, P153, DOI 10.1128/JB.161.1.153-157.1985; Kirkman HN, 2007, TRENDS BIOCHEM SCI, V32, P44, DOI 10.1016/j.tibs.2006.11.003; Klotz MG, 1997, MOL BIOL EVOL, V14, P951, DOI 10.1093/oxfordjournals.molbev.a025838; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Krishnan N, 2008, FREE RADICAL BIO MED, V44, P671, DOI 10.1016/j.freeradbiomed.2007.10.054; Kunau WH, 1995, PROG LIPID RES, V34, P267, DOI 10.1016/0163-7827(95)00011-9; Lara-Ortiz T, 2003, MOL MICROBIOL, V50, P1241, DOI 10.1046/j.1365-2958.2003.03800.x; LECELLIER G, 1994, CURR GENET, V25, P122, DOI 10.1007/BF00309536; Maggio-Hall LA, 2004, MOL MICROBIOL, V54, P1173, DOI 10.1111/j.1365-2958.2004.04340.x; Malagnac F, 2004, FUNGAL GENET BIOL, V41, P982, DOI 10.1016/j.fgb.2004.07.008; Malagnac Fabienne, 2008, Commun Integr Biol, V1, P180; Managadze D, 2010, PROTEOMICS, V10, P3222, DOI 10.1002/pmic.201000095; Martinez AT, 2005, INT MICROBIOL, V8, P195; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Michan S, 2003, EUKARYOT CELL, V2, P798, DOI 10.1128/EC.2.4.798-808.2003; Michan S, 2002, FREE RADICAL BIO MED, V33, P521, DOI 10.1016/S0891-5849(02)00909-7; Minard KL, 2001, FREE RADICAL BIO MED, V31, P832, DOI 10.1016/S0891-5849(01)00666-9; Morel M, 2009, CELL MOL LIFE SCI, V66, P3711, DOI 10.1007/s00018-009-0104-5; Passardi F, 2007, GENE, V397, P101, DOI 10.1016/j.gene.2007.04.016; Peraza-Reyes L, 2008, TRAFFIC, V9, P1998, DOI 10.1111/j.1600-0854.2008.00812.x; Reiser K, 2010, CURR GENET, V56, P139, DOI 10.1007/s00294-009-0286-2; Ruprich-Robert G, 2002, GENETICS, V161, P1089; Schliebs W, 2006, EUKARYOT CELL, V5, P1490, DOI 10.1128/EC.00113-06; Scott B, 2008, CURR OPIN MICROBIOL, V11, P488, DOI 10.1016/j.mib.2008.10.008; Shary S, 2008, APPL ENVIRON MICROB, V74, P7252, DOI 10.1128/AEM.01997-08; Silar P, 1999, GENETICS, V151, P87; SILAR P, 1994, J MOL BIOL, V235, P231, DOI 10.1016/S0022-2836(05)80029-4; Silar P, 2005, MYCOL RES, V109, P137, DOI 10.1017/S0953756204002230; ten Have R, 2001, CHEM REV, V101, P3397, DOI 10.1021/cr000115l; Wei DS, 2010, APPL ENVIRON MICROB, V76, P2091, DOI 10.1128/AEM.02929-09; Wesenberg D, 2003, BIOTECHNOL ADV, V22, P161, DOI 10.1016/j.biotechadv.2003.08.011; Zamocky M, 2009, BIOCHEM SOC T, V37, P772, DOI 10.1042/BST0370772; Zintel S, 2011, AGING-US, V3, P768, DOI 10.18632/aging.100360	58	32	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e29820	10.1371/journal.pone.0029820	http://dx.doi.org/10.1371/journal.pone.0029820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558065	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336000001
J	Eswaramoorthy, S; Poulain, S; Hienerwadel, R; Bremond, N; Sylvester, MD; Zhang, YB; Berthomieu, C; Van der Lelie, D; Matin, A				Eswaramoorthy, Subramaniam; Poulain, Sebastien; Hienerwadel, Rainer; Bremond, Nicolas; Sylvester, Matthew D.; Zhang, Yian-Biao; Berthomieu, Catherine; Van der Lelie, Daniel; Matin, A.			Crystal Structure of ChrR-A Quinone Reductase with the Capacity to Reduce Chromate	PLOS ONE			English	Article							PSEUDOMONAS-PUTIDA; ENZYME; PROTEIN; IMPROVEMENT; URANIUM; STRESS; SYSTEM	The Escherichia coli ChrR enzyme is an obligatory two-electron quinone reductase that has many applications, such as in chromate bioremediation. Its crystal structure, solved at 2.2 angstrom resolution, shows that it belongs to the flavodoxin superfamily in which flavin mononucleotide (FMN) is firmly anchored to the protein. ChrR crystallized as a tetramer, and size exclusion chromatography showed that this is the oligomeric form that catalyzes chromate reduction. Within the tetramer, the dimers interact by a pair of two hydrogen bond networks, each involving Tyr128 and Glu146 of one dimer and Arg125 and Tyr85 of the other; the latter extends to one of the redox FMN cofactors. Changes in each of these amino acids enhanced chromate reductase activity of the enzyme, showing that this network is centrally involved in chromate reduction.	[Eswaramoorthy, Subramaniam; Zhang, Yian-Biao] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Poulain, Sebastien; Sylvester, Matthew D.; Matin, A.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Poulain, Sebastien; Bremond, Nicolas; Berthomieu, Catherine] CEA, DSV IBEB, Lab Interact Prot Met, St Paul Les Durance, France; [Poulain, Sebastien; Hienerwadel, Rainer; Bremond, Nicolas; Berthomieu, Catherine] CNRS, UMR Biol Vegetale & Microbiol Environm, St Paul Les Durance, France; [Poulain, Sebastien; Bremond, Nicolas; Berthomieu, Catherine] Univ Aix Marseille, St Paul Les Durance, France; [Hienerwadel, Rainer] Univ Aix Marseille, Lab Genet & Biophys Plantes, Marseille, France; [Hienerwadel, Rainer] CEA, DSV IBEB, Marseille, France; [Van der Lelie, Daniel] RTI Int, Discovery & Analyt Sci, Res Triangle Pk, NC USA	United States Department of Energy (DOE); Brookhaven National Laboratory; Stanford University; CEA; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; CEA; UDICE-French Research Universities; Aix-Marseille Universite; CEA; Research Triangle Institute	Eswaramoorthy, S (corresponding author), Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA.	a.matin@stanford.edu	Matin, AC/A-1315-2007; Berthomieu, Catherine/AAX-9559-2021	Matin, AC/0000-0003-4468-980X; Berthomieu, Catherine/0000-0001-8784-5396	European Commission [FP7-PEOPLE-2007-4-1-IOF-ENV-219786]; DTRA under DOE prime [BO742081, DEAC02-98CH10886]; Brookhaven National Laboratory; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007328] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); DTRA under DOE prime; Brookhaven National Laboratory(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Marie Curie International Outgoing Fellowship No. FP7-PEOPLE-2007-4-1-IOF-ENV-219786 from the European Commission. SE was supported by an award from DTRA BO742081 under DOE prime contract No. DEAC02-98CH10886 with Brookhaven National Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerley DF, 2006, J BACTERIOL, V188, P3371, DOI 10.1128/JB.188.9.3371-3381.2006; Ackerley DF, 2004, ENVIRON MICROBIOL, V6, P851, DOI 10.1111/j.1462-2920.2004.00639.x; Ackerley DF, 2004, APPL ENVIRON MICROB, V70, P873, DOI 10.1128/AEM.70.2.873-882.2004; Agarwal R, 2006, ACTA CRYSTALLOGR D, V62, P383, DOI [10.1107/S0907444906001600, 10.1107/S0904777906001600]; Barak Y, 2006, MOL CANCER THER, V5, P97, DOI 10.1158/1535-7163.MCT-05-0365; Barak Y, 2006, APPL ENVIRON MICROB, V72, P7074, DOI 10.1128/AEM.01334-06; Barak Y, 2008, ISME J, V2, P171, DOI 10.1038/ismej.2007.100; Binter A, 2009, FEBS J, V276, P5263, DOI 10.1111/j.1742-4658.2009.07222.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carey J, 2007, PROTEIN SCI, V16, P2301, DOI 10.1110/ps.073018907; Deller S, 2006, BIOCHEMISTRY-US, V45, P7083, DOI 10.1021/bi052478r; Devi MP, 2011, CLEAN-SOIL AIR WATER, V39, P900, DOI 10.1002/clen.201000588; Fredrickson JK, 2008, GEOBIOLOGY, V6, P245, DOI 10.1111/j.1472-4669.2008.00146.x; Gihring TM, 2011, APPL ENVIRON MICROB, V77, P5955, DOI 10.1128/AEM.00220-11; Gonzalez CF, 2005, J BIOL CHEM, V280, P22590, DOI 10.1074/jbc.M501654200; Gonzalez CF, 2003, ACTA BIOTECHNOL, V23, P233, DOI 10.1002/abio.200390030; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keyhan M, 2004, TARGETS IMPROVEMENT; KUIPERS OP, 1991, NUCLEIC ACIDS RES, V19, P4558, DOI 10.1093/nar/19.16.4558; Lovley DR, ADV MICROB PHYSL, V59, P1; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Park CH, 2000, APPL ENVIRON MICROB, V66, P1788, DOI 10.1128/AEM.66.5.1788-1795.2000; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Puzon GJ, 2002, BIOCHEM BIOPH RES CO, V294, P76, DOI 10.1016/S0006-291X(02)00438-2; Scherr KE, 2010, J BIOTECHNOL, V150, pS47, DOI 10.1016/j.jbiotec.2010.08.129; SHI XL, 1990, FEBS LETT, V276, P189, DOI 10.1016/0014-5793(90)80539-U; Thorne SH, 2009, MOL CANCER THER, V8, P333, DOI 10.1158/1535-7163.MCT-08-0707; Wall JD, 2006, ANNU REV MICROBIOL, V60, P149, DOI 10.1146/annurev.micro.59.030804.121357; Ye J, 2007, FEBS LETT, V581, P3996, DOI 10.1016/j.febslet.2007.07.039	29	44	50	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36017	10.1371/journal.pone.0036017	http://dx.doi.org/10.1371/journal.pone.0036017			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558308	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000101
J	Maisch, T; Shimizu, T; Li, YF; Heinlin, J; Karrer, S; Morfill, G; Zimmermann, JL				Maisch, Tim; Shimizu, Tetsuji; Li, Yang-Fang; Heinlin, Julia; Karrer, Sigrid; Morfill, Gregor; Zimmermann, Julia L.			Decolonisation of MRSA, S-aureus and E-coli by Cold-Atmospheric Plasma Using a Porcine Skin Model In Vitro	PLOS ONE			English	Article							ANIMAL-MODEL; RESISTANT; STERILIZATION; EFFICACY; BIOFILMS; PIG	In the last twenty years new antibacterial agents approved by the U.S. FDA decreased whereas in parallel the resistance situation of multi-resistant bacteria increased. Thus, community and nosocomial acquired infections of resistant bacteria led to a decrease in the efficacy of standard therapy, prolonging treatment time and increasing healthcare costs. Therefore, the aim of this work was to demonstrate the applicability of cold atmospheric plasma for decolonisation of Gram-positive (Methicillin-resistant Staphylococcus aureus (MRSA), Methicillin-sensitive Staphylococcus aureus) and Gram-negative bacteria (E. coli) using an ex vivo pig skin model. Freshly excised skin samples were taken from six month old female pigs (breed: Pietrain). After application of pure bacteria on the surface of the explants these were treated with cold atmospheric plasma for up to 15 min. Two different plasma devices were evaluated. A decolonisation efficacy of 3 log(10) steps was achieved already after 6 min of plasma treatment. Longer plasma treatment times achieved a killing rate of 5 log(10) steps independently from the applied bacteria strains. Histological evaluations of untreated and treated skin areas upon cold atmospheric plasma treatment within 24 h showed no morphological changes as well as no significant degree of necrosis or apoptosis determined by the TUNEL-assay indicating that the porcine skin is still vital. This study demonstrates for the first time that cold atmospheric plasma is able to very efficiently kill bacteria applied to an intact skin surface using an ex vivo porcine skin model. The results emphasize the potential of cold atmospheric plasma as a new possible treatment option for decolonisation of human skin from bacteria in patients in the future without harming the surrounding tissue.	[Maisch, Tim; Heinlin, Julia; Karrer, Sigrid] Regensburg Univ Hosp, Dept Dermatol, Regensburg, Bavaria, Germany; [Shimizu, Tetsuji; Li, Yang-Fang; Morfill, Gregor; Zimmermann, Julia L.] Max Planck Inst Extraterr Phys, D-37075 Garching, Bavaria, Germany	University of Regensburg; Max Planck Society	Maisch, T (corresponding author), Regensburg Univ Hosp, Dept Dermatol, Regensburg, Bavaria, Germany.	tim.maisch@klinik.uni-regensburg.de	Shimizu, Tetsuji/L-1478-2018	Shimizu, Tetsuji/0000-0001-9432-1152; Li, Yangfang/0000-0002-5346-3741	Max Planck Institute for Extraterrestrial Physics, Garching, Germany [M.TT.A.EXT00002]	Max Planck Institute for Extraterrestrial Physics, Garching, Germany	Dr. Tim Maisch was supported by a grant (M.TT.A.EXT00002) of the Max Planck Institute for Extraterrestrial Physics, Garching, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651; Boyce JM, 2002, INFECT CONT HOSP EP, V23, pS3, DOI 10.1086/503164; Buehlmann M, 2008, INFECT CONT HOSP EP, V29, P510, DOI 10.1086/588201; Burts ML, 2009, AM J INFECT CONTROL, V37, P729, DOI 10.1016/j.ajic.2009.03.010; BUSH LW, 1986, J CLIN MICROBIOL, V24, P343, DOI 10.1128/JCM.24.3.343-348.1986; Cotter JJ, 2011, J HOSP INFECT, V78, P204, DOI 10.1016/j.jhin.2011.03.019; EARSS MT, 2009, EARSS ANN REP 2008, P55; Ermolaeva SA, 2011, J MED MICROBIOL, V60, P75, DOI 10.1099/jmm.0.020263-0; Johnson PDR, 2005, MED J AUSTRALIA, V183, P509, DOI 10.5694/j.1326-5377.2005.tb07151.x; Joshi SG, 2010, AM J INFECT CONTROL, V38, P293, DOI 10.1016/j.ajic.2009.11.002; Kelly-Wintenberg K, 1998, J IND MICROBIOL BIOT, V20, P69, DOI 10.1038/sj.jim.2900482; Kim PY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024104; Klevens RM, 2006, CLIN INFECT DIS, V42, P389, DOI 10.1086/499367; KONG MG, 2009, NEW J PHYS, V11, DOI DOI 10.1088/1367-2630/11/11/115012; Krishna BVS, 2010, J HOSP INFECT, V74, P199, DOI 10.1016/j.jhin.2009.08.022; Lademann O, 2011, SKIN PHARMACOL PHYS, V24, P284, DOI 10.1159/000329913; Lee K, 2006, J MICROBIOL, V44, P269; Liebmann J, 2011, NITRIC OXIDE-BIOL CH, V24, P8, DOI 10.1016/j.niox.2010.09.005; Maisch T, 2007, PHOTOCH PHOTOBIO SCI, V6, P545, DOI 10.1039/b614770d; Messager S, 2004, J HOSP INFECT, V58, P115, DOI 10.1016/j.jhin.2004.06.001; Meyer W, 1978, Curr Probl Dermatol, V7, P39; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; Morfill GE, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115019; Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452; Schacht V, 2002, ARCH DERMATOL RES, V294, P341, DOI 10.1007/s00403-002-0346-7; Shimizu T, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/2/023026; Simon GA, 2000, SKIN PHARMACOL APPL, V13, P229, DOI 10.1159/000029928; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; Zimmermann JL, 2011, J PHYS D, V44, P1	29	135	137	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e34610	10.1371/journal.pone.0034610	http://dx.doi.org/10.1371/journal.pone.0034610			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558091	Green Published, gold			2022-12-27	WOS:000305336000014
J	Schechter, LM; Valenta, JC; Schneider, DJ; Collmer, A; Sakk, E				Schechter, Lisa M.; Valenta, Joy C.; Schneider, David J.; Collmer, Alan; Sakk, Eric			Functional and Computational Analysis of Amino Acid Patterns Predictive Type III Secretion System Substrates in Pseudomonas syringae	PLOS ONE			English	Article							PV. TOMATO DC3000; EFFECTOR PROTEINS; YERSINIA-ENTEROCOLITICA; MESSENGER-RNA; PROTEOMIC ANALYSIS; VIRULENCE FACTORS; ESCHERICHIA-COLI; EUKARYOTIC CELLS; HRPL REGULON; PLANT-CELLS	Bacterial type III secretion systems (T3SSs) deliver proteins called effectors into eukaryotic cells. Although N-terminal amino acid sequences are required for translocation, the mechanism of substrate recognition by the T3SS is unknown. Almost all actively deployed T3SS substrates in the plant pathogen Pseudomonas syringae pathovar tomato strain DC3000 possess characteristic patterns, including (i) greater than 10% serine within the first 50 amino acids, (ii) an aliphatic residue or proline at position 3 or 4, and (iii) a lack of acidic amino acids within the first 12 residues. Here, the functional significance of the P. syringae T3SS substrate compositional patterns was tested. A mutant AvrPto effector protein lacking all three patterns was secreted into culture and translocated into plant cells, suggesting that the compositional characteristics are not absolutely required for T3SS targeting and that other recognition mechanisms exist. To further analyze the unique properties of T3SS targeting signals, we developed a computational algorithm called TEREE (Type III Effector Relative Entropy Evaluation) that distinguishes DC3000 T3SS substrates from other proteins with a high sensitivity and specificity. Although TEREE did not efficiently identify T3SS substrates in Salmonella enterica, it was effective in another P. syringae strain and Ralstonia solanacearum. Thus, the TEREE algorithm may be a useful tool for identifying new effector genes in plant pathogens. The nature of T3SS targeting signals was additionally investigated by analyzing the N-terminus of FtsX, a putative membrane protein that was classified as a T3SS substrate by TEREE. Although the first 50 amino acids of FtsX were unable to target a reporter protein to the T3SS, an AvrPto protein substituted with the first 12 amino acids of FtsX was translocated into plant cells. These results show that the T3SS targeting signals are highly mutable and that secretion may be directed by multiple features of substrates.	[Schechter, Lisa M.; Valenta, Joy C.] Univ Missouri, Dept Biol, St Louis, MO 63121 USA; [Schneider, David J.] ARS, Plant Microbe Interact Res Unit, Robert W Holley Ctr Agr & Hlth, USDA, Ithaca, NY USA; [Schneider, David J.; Collmer, Alan] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY USA; [Sakk, Eric] Morgan State Univ, Dept Comp Sci, Baltimore, MD 21239 USA	University of Missouri System; University of Missouri Saint Louis; United States Department of Agriculture (USDA); Cornell University; Morgan State University	Schechter, LM (corresponding author), Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA.	schechterl@umsl.edu	Schneider, David J/H-2236-2012	Schneider, David J/0000-0002-2124-8385	University of Misssouri-St. Louis; National Science Foundation [DBI-0077622]; United States Department of Agriculture-Agriculture Research Service [1907-21000-017-00]	University of Misssouri-St. Louis; National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture-Agriculture Research Service(United States Department of Agriculture (USDA))	This work was supported by start-up research funds from the University of Misssouri-St. Louis, National Science Foundation award DBI-0077622, and United States Department of Agriculture-Agriculture Research Service project 1907-21000-017-00. The funders had no role in study design, data collection and analysis, decison to publish, or preparation of the manuscript.	Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Akopyan K, 2011, P NATL ACAD SCI USA, V108, P1639, DOI 10.1073/pnas.1013888108; Amer AAA, 2011, J BACTERIOL, V193, P6683, DOI 10.1128/JB.00210-11; Anderson DM, 1997, SCIENCE, V278, P1140, DOI 10.1126/science.278.5340.1140; Anderson DM, 1999, P NATL ACAD SCI USA, V96, P12839, DOI 10.1073/pnas.96.22.12839; Arnold R, 2010, MICROBES INFECT, V12, P346, DOI 10.1016/j.micinf.2010.02.003; Arnold R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000376; Badea L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-30; Blaylock B, 2008, MOL MICROBIOL, V70, P1210, DOI 10.1111/j.1365-2958.2008.06474.x; Boyd AP, 2000, J BACTERIOL, V182, P4811, DOI 10.1128/JB.182.17.4811-4821.2000; Buchko GW, 2010, MOL BIOSYST, V6, P2448, DOI 10.1039/c0mb00097c; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Chang JH, 2005, P NATL ACAD SCI USA, V102, P2549, DOI 10.1073/pnas.0409660102; Cheng LW, 1997, MOL MICROBIOL, V24, P757, DOI 10.1046/j.1365-2958.1997.3831750.x; Cover TM, 1991, ELEMENTS INFORM THEO, Vxxii; Cunnac S, 2009, CURR OPIN MICROBIOL, V12, P53, DOI 10.1016/j.mib.2008.12.003; CUPPELS DA, 1986, APPL ENVIRON MICROB, V51, P323, DOI 10.1128/AEM.51.2.323-327.1986; Dawson JE, 2009, P NATL ACAD SCI USA, V106, P8543, DOI 10.1073/pnas.0809138106; DEFEYTER R, 1990, GENE, V88, P65, DOI 10.1016/0378-1119(90)90060-5; Deng WY, 2010, J BIOL CHEM, V285, P6790, DOI 10.1074/jbc.M109.086603; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Ferreira AO, 2006, MOL PLANT MICROBE IN, V19, P1167, DOI 10.1094/MPMI-19-1167; Fouts DE, 2003, MOL PLANT MICROBE IN, V16, P43, DOI 10.1094/MPMI.2003.16.1.43; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Gauthier A, 2003, J BACTERIOL, V185, P6747, DOI 10.1128/JB.185.23.6747-6755.2003; Gazi AD, 2009, CELL MICROBIOL, V11, P719, DOI 10.1111/j.1462-5822.2009.01297.x; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Goss JW, 2004, J BACTERIOL, V186, P6320, DOI 10.1128/JB.186.18.6320-6324.2004; Grant SR, 2006, ANNU REV MICROBIOL, V60, P425, DOI 10.1146/annurev.micro.60.080805.142251; Greenberg JT, 2003, CURR OPIN MICROBIOL, V6, P20, DOI 10.1016/S1369-5274(02)00004-8; Guttman DS, 2002, SCIENCE, V295, P1722, DOI 10.1126/science.295.5560.1722; Ham JH, 1998, P NATL ACAD SCI USA, V95, P10206, DOI 10.1073/pnas.95.17.10206; Higashide W, 2006, J BACTERIOL, V188, P2411, DOI 10.1128/JB.188.7.2411-2420.2006; HUYNH TV, 1989, SCIENCE, V245, P1374, DOI 10.1126/science.2781284; KING EO, 1954, J LAB CLIN MED, V44, P301; Kvitko BH, 2007, J BACTERIOL, V189, P8059, DOI 10.1128/JB.01146-07; Kvitko BH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000388; Lan LF, 2006, MOL PLANT MICROBE IN, V19, P976, DOI 10.1094/MPMI-19-0976; Lee SH, 2004, MOL MICROBIOL, V51, P483, DOI 10.1046/j.1365-2958.2003.03840.x; Lee VT, 2002, J BACTERIOL, V184, P3740, DOI 10.1128/JB.184.13.3740-3745.2002; Lewis JD, 2009, SEMIN CELL DEV BIOL, V20, P1055, DOI 10.1016/j.semcdb.2009.06.003; Lilic M, 2006, MOL CELL, V21, P653, DOI 10.1016/j.molcel.2006.01.026; Lindeberg M, 2006, MOL PLANT MICROBE IN, V19, P1151, DOI 10.1094/MPMI-19-1151; Lloyd SA, 2002, MOL MICROBIOL, V43, P51, DOI 10.1046/j.1365-2958.2002.02738.x; Lloyd SA, 2001, MOL MICROBIOL, V39, P520, DOI 10.1046/j.1365-2958.2001.02271.x; Lower M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005917; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Mason SJ, 2002, Q J ROY METEOR SOC, V128, P2145, DOI 10.1256/003590002320603584; McDermott JE, 2011, INFECT IMMUN; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mudgett MB, 2000, P NATL ACAD SCI USA, V97, P13324, DOI 10.1073/pnas.230450797; Mukaihara T, 2010, MOL PLANT MICROBE IN, V23, P251, DOI 10.1094/MPMI-23-3-0251; Mukaihara T, 2009, MICROBIOL-SGM, V155, P2235, DOI 10.1099/mic.0.027763-0; Niemann GS, 2011, INFECT IMMUN, V79, P33, DOI 10.1128/IAI.00771-10; Petnicki-Ocwieja T, 2002, P NATL ACAD SCI USA, V99, P7652, DOI 10.1073/pnas.112183899; Poueymiro M, 2009, CURR OPIN MICROBIOL, V12, P44, DOI 10.1016/j.mib.2008.11.008; Ramamurthi KS, 2003, MOL MICROBIOL, V50, P1189, DOI 10.1046/j.1365-2958.2003.03772.x; Roden JA, 2004, P NATL ACAD SCI USA, V101, P16624, DOI 10.1073/pnas.0407383101; Russmann H, 2002, MOL MICROBIOL, V46, P769, DOI 10.1046/j.1365-2958.2002.03196.x; Sakk E, 2005, COMPUTATIONAL IDENTI, P191; Sambrook J., 2001, MOL CLONING LAB MANU; Samudrala R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000375; Schechter LM, 2006, MOL PLANT MICROBE IN, V19, P1180, DOI 10.1094/MPMI-19-1180; Schechter LM, 2004, J BACTERIOL, V186, P543, DOI 10.1128/JB.186.2.543-555.2004; Schesser K, 1996, J BACTERIOL, V178, P7227, DOI 10.1128/jb.178.24.7227-7233.1996; Schmidt KL, 2004, J BACTERIOL, V186, P785, DOI 10.1128/JB.186.3.785-793.2004; Sorg JA, 2005, J BACTERIOL, V187, P7090, DOI 10.1128/JB.187.20.7090-7102.2005; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; Spaeth KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000579; Srikanth CV, 2011, CELL MOL LIFE SCI, V68, P3687, DOI 10.1007/s00018-011-0841-0; Subtil A, 2005, MOL MICROBIOL, V56, P1636, DOI 10.1111/j.1365-2958.2005.04647.x; Sun YH, 2007, J BIOL CHEM, V282, P33897, DOI 10.1074/jbc.C700181200; Tay DMM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S7-S4; Vencato M, 2006, MOL PLANT MICROBE IN, V19, P1193, DOI 10.1094/MPMI-19-1193; Vidal JE, 2008, CELL MICROBIOL, V10, P1975, DOI 10.1111/j.1462-5822.2008.01181.x; Wang YJ, 2011, BIOINFORMATICS, V27, P777, DOI 10.1093/bioinformatics/btr021; Wehling MD, 2004, J BACTERIOL, V186, P3621, DOI 10.1128/JB.186.11.3621-3630.2004; Woestyn S, 1996, MOL MICROBIOL, V20, P1261, DOI 10.1111/j.1365-2958.1996.tb02645.x; Yang Y, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S47; Young BM, 2002, J BACTERIOL, V184, P1324, DOI 10.1128/JB.184.5.1324-1334.2002; Zhang SP, 2002, INFECT IMMUN, V70, P3843, DOI 10.1128/IAI.70.7.3843-3855.2002; Zhou DG, 2001, MOL MICROBIOL, V39, P248, DOI 10.1046/j.1365-2958.2001.02230.x; Zong N, 2008, PLANT SIGNAL BEHAV, V3, P583, DOI 10.4161/psb.3.8.5741	84	19	20	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36038	10.1371/journal.pone.0036038	http://dx.doi.org/10.1371/journal.pone.0036038			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558318	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336000109
J	Xiong, YW; Wang, P; Lan, RT; Ye, CY; Wang, H; Ren, J; Jing, HQ; Wang, YT; Zhou, ZM; Bai, XM; Cui, ZG; Luo, X; Zhao, AL; Wang, Y; Zhang, SM; Sun, H; Wang, L; Xu, JG				Xiong, Yanwen; Wang, Ping; Lan, Ruiting; Ye, Changyun; Wang, Hua; Ren, Jun; Jing, Huaiqi; Wang, Yiting; Zhou, Zhemin; Bai, Xuemei; Cui, Zhigang; Luo, Xia; Zhao, Ailan; Wang, Yan; Zhang, Shaomin; Sun, Hui; Wang, Lei; Xu, Jianguo			A Novel Escherichia coli O157:H7 Clone Causing a Major Hemolytic Uremic Syndrome Outbreak in China	PLOS ONE			English	Article							SHIGA-TOXIN; HEMORRHAGIC COLITIS; O157-H7; VIRULENCE; SEQUENCE; STRAINS; O157H7; SECRETION; GENOTYPES; PROFILES	An Escherichia coli O157:H7 outbreak in China in 1999 caused 177 deaths due to hemolytic uremic syndrome. Sixteen outbreak associated isolates were found to belong to a new clone, sequence type 96 (ST96), based on multilocus sequence typing of 15 housekeeping genes. Whole genome sequencing of an outbreak isolate, Xuzhou21, showed that the isolate is phylogenetically closely related to the Japan 1996 outbreak isolate Sakai, both of which share the most recent common ancestor with the US outbreak isolate EDL933. The levels of IL-6 and IL-8 of peripheral blood mononuclear cells induced by Xuzhou21 and Sakai were significantly higher than that induced by EDL933. Xuzhou21 also induced a significantly higher level of IL-8 than Sakai while both induced similar levels of IL-6. The expression level of Shiga toxin 2 in Xuzhou21 induced by mitomycin C was 68.6 times of that under non-inducing conditions, twice of that induced in Sakai (32.7 times) and 15 times higher than that induced in EDL933 (4.5 times). Our study shows that ST96 is a novel clone and provided significant new insights into the evolution of virulence of E. coli O157:H7.	[Xiong, Yanwen; Wang, Ping; Ye, Changyun; Jing, Huaiqi; Wang, Yiting; Bai, Xuemei; Cui, Zhigang; Luo, Xia; Zhao, Ailan; Wang, Yan; Zhang, Shaomin; Sun, Hui; Xu, Jianguo] Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Lan, Ruiting] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Wang, Hua] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Ren, Jun] Anhui Prov Ctr Dis Control & Prevent, Hefei, Anhui, Peoples R China; [Zhou, Zhemin; Wang, Lei] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; University of New South Wales Sydney; Jiangsu Provincial Center for Disease Control & Prevention; Nankai University	Xiong, YW (corresponding author), Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	xujianguo@icdc.cn	Zhou, Zhemin/AAX-5539-2020; wang, yiting/GYU-5306-2022; Wang, Lei/C-5176-2009	Zhou, Zhemin/0000-0001-9783-0366; Wang, Lei/0000-0003-4427-0881; Lan, Ruiting/0000-0001-9834-5258	National Key Programs for Infectious Diseases of China [2008ZX10004-001, 2008ZX10004-009, 2009ZX10004-101]; Ministry of Science and Technology, People's Republic of China [2005CB522904]	National Key Programs for Infectious Diseases of China; Ministry of Science and Technology, People's Republic of China(Ministry of Science and Technology, China)	This work was supported by grants (2008ZX10004-001, 2008ZX10004-009 and 2009ZX10004-101) from the National Key Programs for Infectious Diseases of China and the grant (2005CB522904) from the Ministry of Science and Technology, People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Ali GS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010167; Abu-Ali GS, 2010, MICROBIOL-SGM, V156, P408, DOI 10.1099/mic.0.033126-0; BELL BP, 1994, JAMA-J AM MED ASSOC, V272, P1349, DOI 10.1001/jama.272.17.1349; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; CHAPMAN PA, 1994, J MED MICROBIOL, V40, P424, DOI 10.1099/00222615-40-6-424; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Davis BM, 2002, EMBO J, V21, P4240, DOI 10.1093/emboj/cdf427; Eklund M, 2002, J CLIN MICROBIOL, V40, P4585, DOI 10.1128/JCM.40.12.4585-4593.2002; Eppinger M, 2011, P NATL ACAD SCI USA, V108, P20142, DOI 10.1073/pnas.1107176108; Eppinger M, 2011, APPL ENVIRON MICROB, V77, P2916, DOI 10.1128/AEM.02554-10; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Feng L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004053; Feng PCH, 2007, EMERG INFECT DIS, V13, P1701, DOI 10.3201/eid1311.070381; Ferens WA, 2011, FOODBORNE PATHOG DIS, V8, P465, DOI 10.1089/fpd.2010.0673; Frank AC, 2005, MOL BIOL EVOL, V22, P1325, DOI 10.1093/molbev/msi124; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Grant J, 2008, EMERG INFECT DIS, V14, P1633, DOI 10.3201/eid1410.071341; Guessous F, 2005, INFECT IMMUN, V73, P8306, DOI 10.1128/IAI.73.12.8306-8316.2005; Gyles CL, 2007, J ANIM SCI, V85, pE45, DOI 10.2527/jas.2006-508; Hussein HS, 2007, J ANIM SCI, V85, pE63, DOI 10.2527/jas.2006-421; Kobayashi M, 1999, AM J TROP MED HYG, V61, P625, DOI 10.4269/ajtmh.1999.61.625; Kulasekara BR, 2009, INFECT IMMUN, V77, P3713, DOI 10.1128/IAI.00198-09; Lacher DW, 2007, J BACTERIOL, V189, P342, DOI 10.1128/JB.01472-06; Laing CR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-287; Litalien C, 1999, PEDIATR NEPHROL, V13, P840, DOI 10.1007/s004670050712; LOUISE CB, 1995, J INFECT DIS, V172, P1397, DOI 10.1093/infdis/172.5.1397; Manning SD, 2008, P NATL ACAD SCI USA, V105, P4868, DOI 10.1073/pnas.0710834105; Michino H, 1999, AM J EPIDEMIOL, V150, P787, DOI 10.1093/oxfordjournals.aje.a010082; Murata A, 1998, CYTOKINE, V10, P544, DOI 10.1006/cyto.1997.0329; Nakagawa S, 2003, BIOCHEM BIOPH RES CO, V310, P1194, DOI 10.1016/j.bbrc.2003.09.145; Neupane M, 2011, MICROB PATHOGENESIS, V51, P466, DOI 10.1016/j.micpath.2011.07.009; Orth D, 2007, DIAGN MICR INFEC DIS, V59, P235, DOI 10.1016/j.diagmicrobio.2007.04.013; OSTROFF SM, 1989, J INFECT DIS, V160, P994, DOI 10.1093/infdis/160.6.994; Persson S, 2007, J CLIN MICROBIOL, V45, P2020, DOI 10.1128/JCM.02591-06; Proulx F, 1998, PEDIATR INFECT DIS J, V17, P899, DOI 10.1097/00006454-199810000-00010; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; TESH VL, 1993, INFECT IMMUN, V61, P3392, DOI 10.1128/IAI.61.8.3392-3402.1993; Thorpe CM, 1999, INFECT IMMUN, V67, P5985, DOI 10.1128/IAI.67.11.5985-5993.1999; Wang Hua, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P938; Wang P, 2011, J CLIN MICROBIOL, V49, P1594, DOI 10.1128/JCM.02530-10; Xu Jianguo, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P114; Yang Z, 2004, APPL ENVIRON MICROB, V70, P6846, DOI 10.1128/AEM.70.11.6846-6854.2004; Ye CY, 2010, J CLIN MICROBIOL, V48, P419, DOI 10.1128/JCM.00614-09; Zhou ZM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008700	49	51	59	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36144	10.1371/journal.pone.0036144	http://dx.doi.org/10.1371/journal.pone.0036144			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558360	Green Published, gold			2022-12-27	WOS:000305336000138
J	Yabuki, M; Cummings, WJ; Leppard, JB; Immormino, RM; Wood, CL; Allison, DS; Gray, PW; Tjoelker, LW; Maizels, N				Yabuki, Munehisa; Cummings, W. Jason; Leppard, John B.; Immormino, Robert M.; Wood, Christi L.; Allison, Daniel S.; Gray, Patrick W.; Tjoelker, Larry W.; Maizels, Nancy			Antibody Discovery Ex Vivo Accelerated by the LacO/Lacl Regulatory Network	PLOS ONE			English	Article							GENE CONVERSION; RAD51 PARALOGS; CHICKEN; CELLS; HUMANIZATION; GENERATION; EXPRESSION	Monoclonal antibodies (mAbs) can be potent and highly specific therapeutics, diagnostics and research reagents. Nonetheless, mAb discovery using current in vivo or in vitro approaches can be costly and time-consuming, with no guarantee of success. We have established a platform for rapid discovery and optimization of mAbs ex vivo. This DTLacO platform derives from a chicken B cell line that has been engineered to enable rapid selection and seamless maturation of high affinity mAbs. We have validated the DTLacO platform by generation of high affinity and specific mAbs to five cell surface targets, the receptor tyrosine kinases VEGFR2 and TIE2, the glycoprotein TROP2, the small TNF receptor family member FN14, and the G protein-coupled receptor FZD10. mAb discovery is rapid and humanization is straightforward, establishing the utility of the DTLacO platform for identification of mAbs for therapeutic and other applications.	[Yabuki, Munehisa; Cummings, W. Jason; Immormino, Robert M.; Maizels, Nancy] Univ Washington, Sch Med, Dept Immunol, Seattle, WA USA; [Yabuki, Munehisa; Cummings, W. Jason; Leppard, John B.; Wood, Christi L.; Allison, Daniel S.; Tjoelker, Larry W.] XORI Corp, Seattle, WA USA; [Gray, Patrick W.] Accelerator Corp, Seattle, WA USA; [Maizels, Nancy] Univ Washington, Sch Med, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Yabuki, M (corresponding author), Omeros Corp, Seattle, WA 98101 USA.	maizels@u.washington.edu			NIH [R01 GM41712, U54 AI081680]; Fred Hutchinson Cancer Research Center; XORI Corporation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI081680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039799, R01GM041712] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fred Hutchinson Cancer Research Center; XORI Corporation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by NIH R01 GM41712 (NM), U54 AI081680 (NM), and the Fred Hutchinson Cancer Research Center Molecular Diagnostics Pilot Program (NM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was also supported by XORI Corporation who, through the employment of MY, WJC, JBL, CLW, DSA and LWT, were involved with providing funds for selection and characterization of some antibodies.	Almagro JC, 2008, FRONT BIOSCI-LANDMRK, V13, P1619, DOI 10.2741/2786; Arakawa H, 2004, DEV DYNAM, V229, P458, DOI 10.1002/dvdy.10495; Bratkovic T, 2010, CELL MOL LIFE SCI, V67, P749, DOI 10.1007/s00018-009-0192-2; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Chiarella P, 2008, BIOTECHNOL LETT, V30, P1303, DOI 10.1007/s10529-008-9706-5; Cubas R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-253; Cumbers SJ, 2002, NAT BIOTECHNOL, V20, P1129, DOI 10.1038/nbt752; Cummings WJ, 2007, PLOS BIOL, V5, P2145, DOI 10.1371/journal.pbio.0050246; Cummings WJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004075; Ferrara N, 2010, CYTOKINE GROWTH F R, V21, P21, DOI 10.1016/j.cytogfr.2009.11.003; FOOTE J, 1992, J MOL BIOL, V224, P487, DOI 10.1016/0022-2836(92)91010-M; Grandea AG, 2010, P NATL ACAD SCI USA, V107, P12658, DOI 10.1073/pnas.0911806107; Hammond PW, 2010, MABS-AUSTIN, V2, P157, DOI 10.4161/mabs.2.2.11301; Hatanaka A, 2005, MOL CELL BIOL, V25, P1124, DOI 10.1128/MCB.25.3.1124-1134.2005; Huang Z, 2010, PROTEIN CELL, V1, P638, DOI 10.1007/s13238-010-0078-y; Kajita M, 2010, J BIOSCI BIOENG, V109, P407, DOI 10.1016/j.jbiosc.2009.09.050; Katoh M, 2007, STEM CELL REV, V3, P30, DOI 10.1007/s12015-007-0006-6; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Maizels N, 2005, ANNU REV GENET, V39, P23, DOI 10.1146/annurev.genet.39.073003.110544; Nishibori N, 2006, MOL IMMUNOL, V43, P634, DOI 10.1016/j.molimm.2005.04.002; Ordinario EC, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-98; REYNAUD CA, 1989, CELL, V59, P171, DOI 10.1016/0092-8674(89)90879-9; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; Robinett CC, 1996, J CELL BIOL, V135, P1685, DOI 10.1083/jcb.135.6.1685; Sale JE, 2001, NATURE, V412, P921, DOI 10.1038/35091100; Seo H, 2005, NAT BIOTECHNOL, V23, P731, DOI 10.1038/nbt1092; Smith AM, 2009, P NATL ACAD SCI USA, V106, P5099, DOI 10.1073/pnas.0810588106; Tsurushita N, 2004, J IMMUNOL METHODS, V295, P9, DOI 10.1016/j.jim.2004.08.018; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6; Yabuki M, 2005, NAT IMMUNOL, V6, P730, DOI 10.1038/ni1215; Yabuki M, 2009, J IMMUNOL, V182, P408, DOI 10.4049/jimmunol.182.1.408	33	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36032	10.1371/journal.pone.0036032	http://dx.doi.org/10.1371/journal.pone.0036032			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558313	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000104
J	Zheng, Q; Zhang, R; Fogg, PCM; Beatty, JT; Wang, Y; Jiao, NZ				Zheng, Qiang; Zhang, Rui; Fogg, Paul C. M.; Beatty, J. Thomas; Wang, Yu; Jiao, Nianzhi			Gain and Loss of Phototrophic Genes Revealed by Comparison of Two Citromicrobium Bacterial Genomes	PLOS ONE			English	Article							AGROBACTERIUM-TUMEFACIENS; HORIZONTAL TRANSFER; EARLY EVOLUTION; DIVERSITY; SEQUENCE; BATHYOMARINUM; APPARATUS; PROTEINS; PLASMID; ELEMENT	Proteobacteria are thought to have diverged from a phototrophic ancestor, according to the scattered distribution of phototrophy throughout the proteobacterial clade, and so the occurrence of numerous closely related phototrophic and chemotrophic microorganisms may be the result of the loss of genes for phototrophy. A widespread form of bacterial phototrophy is based on the photochemical reaction center, encoded by puf and puh operons that typically are in a 'photosynthesis gene cluster' (abbreviated as the PGC) with pigment biosynthesis genes. Comparison of two closely related Citromicrobial genomes (98.1% sequence identity of complete 16S rRNA genes), Citromicrobium sp. JL354, which contains two copies of reaction center genes, and Citromicrobium strain JLT1363, which is chemotrophic, revealed evidence for the loss of phototrophic genes. However, evidence of horizontal gene transfer was found in these two bacterial genomes. An incomplete PGC (pufLMC-puhCBA) in strain JL354 was located within an integrating conjugative element, which indicates a potential mechanism for the horizontal transfer of genes for phototrophy.	[Zheng, Qiang; Zhang, Rui; Wang, Yu; Jiao, Nianzhi] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Fogg, Paul C. M.; Beatty, J. Thomas] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada	Xiamen University; University of British Columbia	Zheng, Q (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	jiao@xmu.edu.cn	Wang, Yu/F-9095-2011	Wang, Yu/0000-0001-6100-1312; Fogg, Paul/0000-0001-5324-4293	National Basic Research Program of China [2011CB808800]; National Natural Science Foundation of China [91028001, 41076063, 40906059]; State Oceanic Administration [201105021]; Canadian Natural Sciences and Engineering Research Council; Canadian Institutes of Health; Program for New Century Excellent Talents in University (NCET) [09-0683]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Oceanic Administration; Canadian Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Program for New Century Excellent Talents in University (NCET)(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Basic Research Program of China (grant No. 2011CB808800); the National Natural Science Foundation of China project (91028001, 41076063, 40906059); and the State Oceanic Administration project (201105021, this does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials); and Canadian Natural Sciences and Engineering Research Council and Canadian Institutes of Health Research grants to JTB. RZ was supported by the Program for New Century Excellent Talents in University (NCET 09-0683). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Backert S, 2008, TRENDS MICROBIOL, V16, P409, DOI 10.1016/j.tim.2008.07.001; Beatty JT, 2002, PHOTOSYNTH RES, V73, P109, DOI 10.1023/A:1020493518379; BLANKENSHIP RE, 1992, PHOTOSYNTH RES, V33, P91, DOI 10.1007/BF00039173; Boltner D, 2002, J BACTERIOL, V184, P5158, DOI 10.1128/JB.184.18.5158-5169.2002; BUKHARI AI, 1975, P NATL ACAD SCI USA, V72, P4399, DOI 10.1073/pnas.72.11.4399; Burrus V, 2006, PLASMID, V55, P173, DOI 10.1016/j.plasmid.2006.01.001; Christie PJ, 1997, J BACTERIOL, V179, P3085, DOI 10.1128/jb.179.10.3085-3094.1997; CRAIG NL, 1995, SCIENCE, V270, P253, DOI 10.1126/science.270.5234.253; Davison J, 1999, PLASMID, V42, P73, DOI 10.1006/plas.1999.1421; Des Marais DJ, 2000, SCIENCE, V289, P1703; Fogg PCM, 2011, VIROLOGY, V421, P211, DOI 10.1016/j.virol.2011.09.028; Hacker J, 2001, EMBO REP, V2, P376, DOI 10.1093/embo-reports/kve097; Hochhut B, 2000, J BACTERIOL, V182, P2043, DOI 10.1128/JB.182.7.2043-2047.2000; Igarashi N, 2001, J MOL EVOL, V52, P333, DOI 10.1007/s002390010163; Jiao NZ, 2007, ENVIRON MICROBIOL, V9, P3091, DOI 10.1111/j.1462-2920.2007.01419.x; Jiao NZ, 2010, ISME J, V4, P595, DOI 10.1038/ismej.2009.135; Jiao NZ, 2010, J BACTERIOL, V192, P1169, DOI 10.1128/JB.01504-09; Koblizek M, 2003, ARCH MICROBIOL, V180, P327, DOI 10.1007/s00203-003-0596-6; Koblizek M, 2007, ENVIRON MICROBIOL, V9, P2401, DOI 10.1111/j.1462-2920.2007.01354.x; Kolber ZS, 2001, SCIENCE, V292, P2492, DOI 10.1126/science.1059707; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lang AS, 2007, TRENDS MICROBIOL, V15, P54, DOI 10.1016/j.tim.2006.12.001; Lang AS, 2010, NUCLEIC ACIDS MOL BI, V25, P15, DOI 10.1007/978-3-642-12617-8_2; Liu ZY, 2003, J BACTERIOL, V185, P3259, DOI 10.1128/JB.185.11.3259-3269.2003; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; MARRS B, 1974, P NATL ACAD SCI USA, V71, P971, DOI 10.1073/pnas.71.3.971; Morgan GJ, 2002, J MOL BIOL, V317, P337, DOI 10.1006/jmbi.2002.5437; Nagashima KVP, 1997, J MOL EVOL, V45, P131, DOI 10.1007/PL00006212; Newton RJ, 2010, ISME J, V4, P784, DOI 10.1038/ismej.2009.150; Polz MF, 2006, PHILOS T R SOC B, V361, P2009, DOI 10.1098/rstb.2006.1928; Ravatn R, 1998, J BACTERIOL, V180, P4360, DOI 10.1128/JB.180.17.4360-4369.1998; Schroder G, 2005, TRENDS MICROBIOL, V13, P336, DOI 10.1016/j.tim.2005.05.008; Spring S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004866; Swingley WD, 2007, J BACTERIOL, V189, P683, DOI 10.1128/JB.01390-06; Swingley Wesley D., 2009, V28, P17; TAYLOR AL, 1963, P NATL ACAD SCI USA, V50, P1043, DOI 10.1073/pnas.50.6.1043; Ventura M, 2009, APPL ENVIRON MICROB, V75, P6929, DOI 10.1128/AEM.01112-09; Wagner-Dobler I, 2006, ANNU REV MICROBIOL, V60, P255, DOI 10.1146/annurev.micro.60.080805.142115; Wagner-Dobler I, 2010, ISME J, V4, P61, DOI 10.1038/ismej.2009.94; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Wozniak RAF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000786; Xiong J, 2000, SCIENCE, V289, P1724, DOI 10.1126/science.289.5485.1724; Yeo HJ, 2004, J BACTERIOL, V186, P1919, DOI 10.1128/JB.186.7.1919-1926.2004; Yurkov VV, 1999, J BACTERIOL, V181, P4517, DOI 10.1128/JB.181.15.4517-4525.1999; Zeng YH, 2007, LETT APPL MICROBIOL, V45, P639, DOI 10.1111/j.1472-765X.2007.02247.x; Zheng Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025050; Zheng QA, 2011, J BACTERIOL, V193, P2074, DOI 10.1128/JB.00121-11; Zhu J, 2000, J BACTERIOL, V182, P3885, DOI 10.1128/JB.182.14.3885-3895.2000	49	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35790	10.1371/journal.pone.0035790	http://dx.doi.org/10.1371/journal.pone.0035790			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558224	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336000061
J	Arango-Gonzalez, B; Schatz, A; Bolz, S; Eslava-Schmalbach, J; Willmann, G; Zhour, A; Zrenner, E; Fischer, MD; Gekeler, F				Arango-Gonzalez, Blanca; Schatz, Andreas; Bolz, Sylvia; Eslava-Schmalbach, Javier; Willmann, Gabriel; Zhour, Ahmad; Zrenner, Eberhart; Fischer, M. Dominik; Gekeler, Florian			Effects of Combined Ketamine/Xylazine Anesthesia on Light Induced Retinal Degeneration in Rats	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; FACTOR-KAPPA-B; IN-VIVO; DAMAGE; KETAMINE; NEUROPROTECTION; RHODOPSIN; XYLAZINE; EXPRESSION; MICE	Objectives: To explore the effect of ketamine-xylazine anesthesia on light-induced retinal degeneration in rats. Methods: Rats were anesthetized with ketamine and xylazine (100 and 5 mg, respectively) for 1 h, followed by a recovery phase of 2 h before exposure to 16,000 lux of environmental illumination for 2 h. Functional assessment by electroretinography (ERG) and morphological assessment by in vivo imaging (optical coherence tomography), histology (hematoxylin/eosin staining, TUNEL assay) and immunohistochemistry (GFAP and rhodopsin staining) were performed at baseline (ERG), 36 h, 7 d and 14 d post-treatment. Non-anesthetized animals treated with light damage served as controls. Results: Ketamine-xylazine pre-treatment preserved retinal function and protected against light-induced retinal degeneration. In vivo retinal imaging demonstrated a significant increase of outer nuclear layer (ONL) thickness in the non-anesthetized group at 36 h (p<0.01) and significant reduction one week (p<0.01) after light damage. In contrast, ketamine-xylazine pre-treated animals showed no significant alteration of total retinal or ONL thickness at either time point (p>0.05), indicating a stabilizing and/or protective effect with regard to phototoxicity. Histology confirmed light-induced photoreceptor cell death and Muller cells gliosis in non-anesthetized rats, especially in the superior hemiretina, while ketamine-xylazine treated rats showed reduced photoreceptor cell death (TUNEL staining: p<0.001 after 7 d), thicker ONL and longer IS/OS. Fourteen days after light damage, a reduction of standard flash induced a-wave amplitudes and a-wave slopes (p = 0.01) and significant alterations in parameters of the scotopic sensitivity function (e. g. Vmax of the Naka Rushton fit p = 0.03) were observed in non-treated vs. ketamine-xylazine treated animals. Conclusions: Our results suggest that pre-treatment with ketamine-xylazine anesthesia protects retinas against light damage, reducing photoreceptor cell death. These data support the notion that anesthesia with ketamine-xylazine provides neuroprotective effects in light-induced cell damage.	[Arango-Gonzalez, Blanca; Schatz, Andreas; Bolz, Sylvia; Willmann, Gabriel; Zhour, Ahmad; Zrenner, Eberhart; Fischer, M. Dominik; Gekeler, Florian] Ctr Ophthalmol, Div Expt Ophthalmol, Tubingen, Germany; [Eslava-Schmalbach, Javier] Univ Nacl Colombia, Clin Res Inst, Bogota, Colombia	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Universidad Nacional de Colombia	Arango-Gonzalez, B (corresponding author), Ctr Ophthalmol, Div Expt Ophthalmol, Tubingen, Germany.	Dominik.Fischer@med.uni-tuebingen.de	Arango-Gonzalez, Blanca/AAR-7427-2021; Eslava-Schmalbach, Javier/O-3954-2019	Arango-Gonzalez, Blanca/0000-0002-9045-182X; Eslava-Schmalbach, Javier/0000-0003-1502-2918	Okuvision GmbH, Reutlingen, Germany; Charlotte and Tistou Kerstan Foundation; fortune Program; University of Tuebingen; Karin and Ewald Hochbaum Foundation	Okuvision GmbH, Reutlingen, Germany; Charlotte and Tistou Kerstan Foundation; fortune Program; University of Tuebingen; Karin and Ewald Hochbaum Foundation	This work was supported by Okuvision GmbH, Reutlingen, Germany (through institution); Charlotte and Tistou Kerstan Foundation (Dr. Arango-Gonzalez), fortune Program, University of Tuebingen and Karin and Ewald Hochbaum Foundation (Dr. Fischer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzolini C, 2001, AM J OPHTHALMOL, V132, P348, DOI 10.1016/S0002-9394(01)01005-4; Barkana Y, 2004, BRAIN RES BULL, V62, P447, DOI 10.1016/S0361-9230(03)00071-6; Capraro AJ, 2001, PEDIATR EMERG CARE, V17, P447, DOI 10.1097/00006565-200112000-00012; Ferro MM, 2007, BRAZ J MED BIOL RES, V40, P89, DOI 10.1590/S0100-879X2006005000053; Fischer MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007507; GALLANOSA AG, 1981, CLIN TOXICOL, V18, P663, DOI 10.3109/15563658108990293; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GOSSSAMPSON MA, 1991, LAB ANIM, V25, P360, DOI 10.1258/002367791780810074; GREEN CJ, 1981, LAB ANIM, V15, P163, DOI 10.1258/002367781780959107; Grimm C, 2000, NAT GENET, V25, P63, DOI 10.1038/75614; Grimm C, 2001, INVEST OPHTH VIS SCI, V42, P497; Grimm C, 2000, MOL VIS, V6, P252; Gyulai Ferenc E, 2004, Curr Opin Anaesthesiol, V17, P397, DOI 10.1097/00001503-200410000-00008; Hans P, 2001, Curr Opin Anaesthesiol, V14, P491, DOI 10.1097/00001503-200110000-00005; Hans P, 2000, EUROPEAN J ANAESTHES, P17; Keller C, 2001, INVEST OPHTH VIS SCI, V42, P476; LAVAIL MM, 1987, CURR EYE RES, V6, P825, DOI 10.3109/02713688709034850; Messias A, 2008, DOC OPHTHALMOL, V117, P41; Messias A, 2008, DOC OPHTHALMOL, V116, P177, DOI 10.1007/s10633-007-9081-x; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P536, DOI 10.1113/jphysiol.1966.sp008001; Organisciak DT, 2010, PROG RETIN EYE RES, V29, P113, DOI 10.1016/j.preteyeres.2009.11.004; Ozden S, 2004, J NEUROTRAUM, V21, P73, DOI 10.1089/089771504772695968; Paquet-Durand F, 2004, BRAIN RES, V1011, P33, DOI 10.1016/j.brainres.2004.02.060; Pfenninger E, 1997, ANAESTHESIST, V46, pS47, DOI 10.1007/PL00002465; RAPP LM, 1992, INVEST OPHTH VIS SCI, V33, P3367; Rozza A, 2000, J NEUROSCI METH, V101, P165, DOI 10.1016/S0165-0270(00)00266-1; Sakai T, 2000, CAN J ANAESTH, V47, P1019, DOI 10.1007/BF03024876; Schatz A, 2011, J NEUROSCI METH, V195, P128, DOI 10.1016/j.jneumeth.2010.10.030; Schifilliti D, 2010, CNS DRUGS, V24, P893, DOI 10.2165/11584760-000000000-00000; Shoulson I, 1998, MOVEMENT DISORD, V13, P46; Tang JXX, 2011, CURR OPIN ANESTHESIO, V24, P389, DOI 10.1097/ACO.0b013e32834871c5; Vaughan DK, 2002, PHOTOCHEM PHOTOBIOL, V75, P547, DOI 10.1562/0031-8655(2002)075<0547:EFACRO>2.0.CO;2; Welters ID, 2010, ANESTH ANALG, V110, P934, DOI 10.1213/ANE.0b013e3181c95cfa; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Wu TH, 2002, INVEST OPHTH VIS SCI, V43, P2834; Youssef PN, 2011, EYE, V25, P1, DOI 10.1038/eye.2010.149; Zandieh S, 2003, SPINAL CORD, V41, P16, DOI 10.1038/sj.sc.3101400; Zeng HY, 2008, MOL VIS, V14, P1075	38	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35687	10.1371/journal.pone.0035687	http://dx.doi.org/10.1371/journal.pone.0035687			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558200	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345200067
J	Crouzier, L; Dubois, C; Edwards, SL; Lauridsen, LH; Wengel, J; Veedu, RN				Crouzier, Lucile; Dubois, Camille; Edwards, Stacey L.; Lauridsen, Lasse H.; Wengel, Jesper; Veedu, Rakesh N.			Efficient Reverse Transcription Using Locked Nucleic Acid Nucleotides towards the Evolution of Nuclease Resistant RNA Aptamers	PLOS ONE			English	Article							DNA-POLYMERASE; EMERGING CLASS; LNA; LIGANDS; SELEX; THERAPEUTICS; RECOGNITION; DIAGNOSTICS; MOLECULES; DUPLEXES	Background: Modified nucleotides are increasingly being utilized in the de novo selection of aptamers for enhancing their drug-like character and abolishing the need for time consuming trial-and-error based post-selection modifications. Locked nucleic acid (LNA) is one of the most prominent and successful nucleic acid analogues because of its remarkable properties, and widely explored as building blocks in therapeutic oligonucleotides. Evolution of LNA-modified RNA aptamers requires an efficient reverse transcription method for PCR enrichment of the selected RNA aptamer candidates. Establishing this key step is a pre-requisite for performing LNA-modified RNA aptamer selection. Methodology: In this study three different reverse transcriptases were investigated towards the enzymatic recognition of LNA nucleotides. Both incorporation as well as reading capabilities of the LNA nucleotides was investigated to fully understand the limitations of the enzymatic recognition. Conclusions: We found that SuperScript (R) III Reverse Transcriptase is an efficient enzyme for the recognition of LNA nucleotides, making it a prime candidate to be used in de novo selection of LNA containing RNA aptamers	[Crouzier, Lucile; Dubois, Camille; Edwards, Stacey L.; Lauridsen, Lasse H.; Veedu, Rakesh N.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia; [Crouzier, Lucile; Dubois, Camille] Inst Polytech LaSalle Beauvais, Beauvais, France; [Lauridsen, Lasse H.] Scion DTU, Novo Nordisk Fdn Ctr Biosustainabil, Horsholm, Denmark; [Wengel, Jesper] Univ So Denmark, Dept Chem & Phys, Nucle Acid Ctr, Odense, Denmark	University of Queensland; UniLaSalle; Technical University of Denmark; University of Southern Denmark	Crouzier, L (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia.	rakesh@uq.edu.au	Edwards, Stacey/A-4980-2011; wengel, jesper/K-1177-2013	Edwards, Stacey/0000-0001-7428-4139; Wengel, Jesper/0000-0001-9835-1009	University of Queensland Fellowship [2009001762]; University of Queensland Early Career Research Grant [2010002143]; EU [ERC-2010-AdG_20100317]	University of Queensland Fellowship; University of Queensland Early Career Research Grant; EU(European Commission)	The work was supported by the University of Queensland Fellowship (Project ID: 2009001762) and The University of Queensland Early Career Research Grant (ID: 2010002143) to RNV. JW acknowledges the funding from EU (ERC-2010-AdG_20100317). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Famulok M, 2007, CHEM REV, V107, P3715, DOI 10.1021/cr0306743; Gopinath SCB, 2007, ANAL BIOANAL CHEM, V387, P171, DOI 10.1007/s00216-006-0826-2; Jayasena SD, 1999, CLIN CHEM, V45, P1628; KLUG SJ, 1994, MOL BIOL REP, V20, P97, DOI 10.1007/BF00996358; Koshkin AA, 1998, TETRAHEDRON, V54, P3607, DOI 10.1016/S0040-4020(98)00094-5; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; Nimjee SM, 2005, ANNU REV MED, V56, P555, DOI 10.1146/annurev.med.56.062904.144915; Obika S, 1998, TETRAHEDRON LETT, V39, P5401, DOI 10.1016/S0040-4039(98)01084-3; Petersen M, 2003, TRENDS BIOTECHNOL, V21, P74, DOI 10.1016/S0167-7799(02)00038-0; Ruckman J, 1998, J BIOL CHEM, V273, P20556, DOI 10.1074/jbc.273.32.20556; Singh SK, 1998, CHEM COMMUN, P455, DOI 10.1039/a708608c; Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Veedu RN, 2008, J AM CHEM SOC, V130, P8124, DOI 10.1021/ja801389n; Veedu RN, 2007, CHEMBIOCHEM, V8, P490, DOI 10.1002/cbic.200600501; Veedu RN, 2010, BIOORG MED CHEM LETT, V20, P6565, DOI 10.1016/j.bmcl.2010.09.044; Veedu RN, 2010, CHEM BIODIVERS, V7, P536, DOI 10.1002/cbdv.200900343; Veedu RN, 2009, RNA BIOL, V6, P321, DOI 10.4161/rna.6.3.8807; Veedu RN, 2009, ORG BIOMOL CHEM, V7, P1404, DOI 10.1039/b819946a; Veedu RN, 2009, MOL BIOSYST, V5, P787, DOI 10.1039/b905513b; Wengel J, 1999, ACCOUNTS CHEM RES, V32, P301, DOI 10.1021/ar980051p	22	25	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35990	10.1371/journal.pone.0035990	http://dx.doi.org/10.1371/journal.pone.0035990			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558297	Green Published, gold			2022-12-27	WOS:000305345200106
J	Leach, MC; Klaus, K; Miller, AL; di Perrotolo, MS; Sotocinal, SG; Flecknell, PA				Leach, Matthew C.; Klaus, Kristel; Miller, Amy L.; di Perrotolo, Maud Scotto; Sotocinal, Susana G.; Flecknell, Paul A.			The Assessment of Post-Vasectomy Pain in Mice Using Behaviour and the Mouse Grimace Scale	PLOS ONE			English	Article							ACTION CODING SYSTEM; POSTOPERATIVE PAIN; 2 STRAINS; LAPAROTOMY; CARPROFEN; MOVEMENT; ADULTS; RAT	Background: Current behaviour-based pain assessments for laboratory rodents have significant limitations. Assessment of facial expression changes, as a novel means of pain scoring, may overcome some of these limitations. The Mouse Grimace Scale appears to offer a means of assessing post-operative pain in mice that is as effective as manual behavioural-based scoring, without the limitations of such schemes. Effective assessment of post-operative pain is not only critical for animal welfare, but also the validity of science using animal models. Methodology/Principal Findings: This study compared changes in behaviour assessed using both an automated system ("HomeCageScan") and using manual analysis with changes in facial expressions assessed using the Mouse Grimace Scale (MGS). Mice (n = 6/group) were assessed before and after surgery (scrotal approach vasectomy) and either received saline, meloxicam or bupivacaine. Both the MGS and manual scoring of pain behaviours identified clear differences between the pre and post surgery periods and between those animals receiving analgesia (20 mg/kg meloxicam or 5 mg/kg bupivacaine) or saline post-operatively. Both of these assessments were highly correlated with those showing high MGS scores also exhibiting high frequencies of pain behaviours. Automated behavioural analysis in contrast was only able to detect differences between the pre and post surgery periods. Conclusions: In conclusion, both the Mouse Grimace Scale and manual scoring of pain behaviours are assessing the presence of post-surgical pain, whereas automated behavioural analysis could be detecting surgical stress and/or post-surgical pain. This study suggests that the Mouse Grimace Scale could prove to be a quick and easy means of assessing post-surgical pain, and the efficacy of analgesic treatment in mice that overcomes some of the limitations of behaviour-based assessment schemes.	[Leach, Matthew C.; Klaus, Kristel; Miller, Amy L.; di Perrotolo, Maud Scotto; Flecknell, Paul A.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Leach, Matthew C.; Klaus, Kristel; Miller, Amy L.; di Perrotolo, Maud Scotto; Flecknell, Paul A.] Newcastle Univ, Comparat Biol Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Sotocinal, Susana G.] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Sotocinal, Susana G.] McGill Univ, Alan Edwards Ctr Res Pain, Montreal, PQ, Canada	Newcastle University - UK; Newcastle University - UK; McGill University; McGill University	Leach, MC (corresponding author), Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	Matthew.Leach@Newcastle.ac.uk		Flecknell, Paul/0000-0002-1075-1129	NC3Rs; BBSRC; Wellcome Trust; AFSTAL; Laboratory Animals Ltd; AFSTAL (the French Laboratory Animal Science Association); National Centre for the Replacement [G1100563/1] Funding Source: researchfish	NC3Rs(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); AFSTAL; Laboratory Animals Ltd; AFSTAL (the French Laboratory Animal Science Association); National Centre for the Replacement	Dr. Leach was supported by the NC3Rs (www.nc3rs.org.uk), the BBSRC (www.bbsrc.ac.uk) and the Wellcome Trust (www.wellcome.ac.uk). Ms. Scotto received support from AFSTAL (www.afstal.com) and Laboratory Animals Ltd (www.lal.org.uk). Dr. Miller was supported by the NC3Rs (www.nc3rs.org.uk). The animals used in this study were donated by Charles River (www.criver.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. The commercial organizations AFSTAL (the French Laboratory Animal Science Association) and Laboratory Animals Ltd provided financial support for Ms. Scotto in the form of a training scholarship. The commercial organization Charles River UK donated the animals used in the study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Affaitati G, 2002, FUND CLIN PHARMACOL, V16, P23, DOI 10.1046/j.1472-8206.2002.00068.x; BaronCohen S, 1997, VIS COGN, V4, P311, DOI 10.1080/713756761; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; Deyo KS, 2004, PAIN, V107, P16, DOI 10.1016/S0304-3959(03)00263-X; Dickinson AL, 2009, LAB ANIM-UK, V43, P357, DOI 10.1258/la.2009.009005; Ekman P., 2002, FACIAL ACTION CODING; Flecknell P, 2011, PAIN, V152, P963, DOI 10.1016/j.pain.2011.01.030; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; Leach MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0013347; Leach MC, 2009, RES VET SCI, V87, P336, DOI 10.1016/j.rvsc.2009.02.001; Lints-Martindale AC, 2007, PAIN MED, V8, P678, DOI 10.1111/j.1526-4637.2007.00358.x; Miller AL, 2011, APPL ANIM BEHAV SCI, V131, P138, DOI 10.1016/j.applanim.2011.02.007; National Research Council of the National Academies, 2009, REC ALL PAIN LAB AN; Parr LA, 2010, AM J PHYS ANTHROPOL, V143, P625, DOI 10.1002/ajpa.21401; Roughan JV, 2006, APPL ANIM BEHAV SCI, V96, P327, DOI 10.1016/j.applanim.2005.06.012; Roughan JV, 2004, BEHAV PHARMACOL, V15, P461, DOI 10.1097/00008877-200411000-00002; Roughan JV, 2001, PAIN, V90, P65, DOI 10.1016/S0304-3959(00)00387-0; Sotocinal SG, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-55; Vick SJ, 2007, J NONVERBAL BEHAV, V31, P1, DOI 10.1007/s10919-006-0017-z; Wright-Williams SL, 2007, PAIN, V130, P108, DOI 10.1016/j.pain.2006.11.003	20	130	131	1	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35656	10.1371/journal.pone.0035656	http://dx.doi.org/10.1371/journal.pone.0035656			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558191	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345200063
J	Chuang, JH; Huang, AS; Huang, WT; Liu, MT; Chou, JH; Chang, FY; Chiu, WT				Chuang, Jen-Hsiang; Huang, Angela S.; Huang, Wan-Ting; Liu, Ming-Tsan; Chou, Jih-Haw; Chang, Feng-Yee; Chiu, Wen-Ta			Nationwide Surveillance of Influenza during the Pandemic (2009-10) and Post-Pandemic (2010-11) Periods in Taiwan	PLOS ONE			English	Article							VIRUS; EPIDEMIOLOGY; FEATURES; HEALTH	Introduction: Although WHO declared the world moving into the post-pandemic period on August 10, 2010, influenza A(H1N1) 2009 virus continued to circulate globally. Its impact was expected to continue during the 2010-11 influenza season. This study describes the nationwide surveillance findings of the pandemic and post-pandemic influenza periods in Taiwan and assesses the impact of influenza A(H1N1) 2009 during the post-pandemic period. Methods: The Influenza Laboratory Surveillance Network consisted of 12 contract laboratories for collecting and testing samples with acute respiratory tract infections. Surveillance of emergency room visits and outpatient department visits for influenza-like illness (ILI) were conducted using the Real-Time Outbreak and Disease Surveillance system and the National Health Insurance program data, respectively. Hospitalized cases with severe complications and deaths were reported to the National Notifiable Disease Surveillance System. Results: During the 2009-10 influenza season, pandemic A(H1N1) 2009 was the predominant circulating strain and caused 44 deaths. However, the 2010-11 influenza season began with A(H3N2) being the predominant circulating strain, changing to A(H1N1) 2009 in December 2010. Emergency room and outpatient department ILI surveillance displayed similar trends. By March 31, 2011, there were 1,751 cases of influenza with severe complications; 50.1% reported underlying diseases. Of the reported cases, 128 deaths were associated with influenza. Among these, 93 (72.6%) were influenza A(H1N1) 2009 and 30 (23.4%) A(H3N2). Compared to the pandemic period, during the immediate post-pandemic period, increased number of hospitalizations and deaths were observed, and the patients were consistently older. Conclusions: Reemergence of influenza A(H1N1) 2009 during the 2010-11 influenza season had an intense activity with age distribution shift. To further mitigate the impact of future influenza epidemics, Taiwan must continue its multifaceted influenza surveillance systems, remain flexible with antiviral use policies, and revise the vaccine policies to include the population most at risk.	[Chuang, Jen-Hsiang; Huang, Wan-Ting] Ctr Dis Control, Epidem Intelligence Ctr, Taipei, Taiwan; [Chuang, Jen-Hsiang] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Chuang, Jen-Hsiang] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Huang, Angela S.] Ctr Dis Control, Field Epidemiol Training Program, Taipei, Taiwan; [Liu, Ming-Tsan] Ctr Dis Control, Res & Diagnost Ctr, Taipei, Taiwan; [Chou, Jih-Haw] Ctr Dis Control, Deputy Director Gen Off, Taipei, Taiwan; [Chang, Feng-Yee] Ctr Dis Control, Director Gen Off, Taipei, Taiwan; [Chang, Feng-Yee] Natl Def Med Ctr, Dept Internal Med, Taipei, Taiwan; [Chiu, Wen-Ta] Ministers Off, Dept Hlth, Taipei, Taiwan; [Chiu, Wen-Ta] Taipei Med Univ, Sch Med, Taipei, Taiwan	Centers For Disease Control - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Centers For Disease Control - Taiwan; Centers For Disease Control - Taiwan; Centers For Disease Control - Taiwan; Centers For Disease Control - Taiwan; National Defense Medical Center; Taipei Medical University	Chuang, JH (corresponding author), Ctr Dis Control, Epidem Intelligence Ctr, Taipei, Taiwan.	fychang@cdc.gov.tw	Chuang, Jen-Hsiang/G-4356-2010; Huang, Wan-Ting/E-3497-2010	Chuang, Jen-Hsiang/0000-0002-7114-3418; Huang, Wan-Ting/0000-0002-4344-9567	Centers for Disease Control, Department of Health, Taipei, Taiwan, Republic of China [DOH100-DC-2036]	Centers for Disease Control, Department of Health, Taipei, Taiwan, Republic of China	This work was supported in part by the grants [DOH100-DC-2036] from the Centers for Disease Control, Department of Health, Taipei, Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	[Anonymous], 2011, Wkly Epidemiol Rec, V86, P222; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P61; Athanasiou M, 2011, EUROSURVEILLANCE, V16, P14; Australia Department of Health and Ageing, 2011, FACT SHEET IMM PROV; Benner David G., 2010, OPENING GOD0; Bolotin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030279; Buehler JW, 2003, EMERG INFECT DIS, V9, P1197, DOI 10.3201/eid0910.030231; Bureau of National Health Insurance, 2009, CAT ILLN PAT; Central Weather Bureau, 2011, MONTHL REP CLIM SYST; Chien YS, 2010, J INFECTION, V60, P168, DOI 10.1016/j.jinf.2009.12.012; Ellis J, 2011, EUROSURVEILLANCE, V16, P2; Espino JU, 2001, J AM MED INFORM ASSN, P164; Health Protection Agency, 2011, SURV INFL OTH RESP V; Health Protection Agency, 2011, FREQ ASK QUEST INFL; Ho YC, 2009, J INFECTION, V58, P439, DOI 10.1016/j.jinf.2009.03.007; Hsieh Yu-Chia, 2005, Journal of Microbiology Immunology and Infection, V38, P238; Huang W T, 2010, Euro Surveill, V15, P19575; Huang WT, 2010, VACCINE, V28, P7161, DOI 10.1016/j.vaccine.2010.08.069; Iezzoni LI, 1997, ANN INTERN MED, V127, P666, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00048; Lai SK, 2010, TAIWAN EPIDEMIOLOGY, V26, P251; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; Mytton OT, 2011, EPIDEMIOL INFECT, P1; Shih SR, 2005, J CLIN MICROBIOL, V43, P1651, DOI 10.1128/JCM.43.4.1651-1661.2005; Steel J, 2011, J VIROL, V85, P1400, DOI 10.1128/JVI.02186-10; Su CP, 2010, TAIWAN EPIDEMIOLOGY, V26, P275; Tsui FC, 2003, J AM MED INFORM ASSN, V10, P399, DOI 10.1197/jamia.M1345; Viasus D, 2012, CLIN MICROBIOL INFEC, V18, pE55, DOI 10.1111/j.1469-0691.2011.03753.x; Wang M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016809; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004; WHO, 2009, 8 WHO; Yang JR, 2010, ANTIVIR RES, V88, P256, DOI 10.1016/j.antiviral.2010.09.014; Yang JR, 2010, VIRUS RES, V151, P33, DOI 10.1016/j.virusres.2010.03.011	34	54	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e36120	10.1371/journal.pone.0036120	http://dx.doi.org/10.1371/journal.pone.0036120			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545158	Green Published, gold			2022-12-27	WOS:000305343200079
J	Robert, JM; Campbell, RJ; Bell, CM				Robert, Joshua M.; Campbell, Robert J.; Bell, Chaim M.			Variation in Prices Charged to Patients for Specialty Intraocular Lenses Inserted during Universally Covered Cataract Surgery	PLOS ONE			English	Article							CARE	Background: Patients often pay for specialty intraocular lenses (IOLs) for cataract surgery covered by universal insurance. This practice creates the potential for inequitable pricing where the medical service provider is also the retailer. We measured the variation in prices between cataract surgeons for the same IOL and associated testing. Methods: We telephoned every cataract surgeon in Ontario, Canada, and asked their price for the most common type of specialty IOL as a prospective patient. We measured the total prices quoted and variation between providers. Results: We contacted 404 ophthalmologists. There were 256 that performed cataract surgery but 127 offered the most commonly employed specialty IOL and would provide a price to patients over the telephone. We obtained prices from all 127 ophthalmologists. Prices for the same lens and associated testing varied substantially between ophthalmologists from $358 to $2790 (median $615, interquartile range $528-$915). There was variation in all components of the total out-of-pocket price, including the price for the IOL itself, charges for uninsured eye measurements, and non-specific supplemental fees. Conclusion: Although cataract surgery is covered by public health insurance, some ophthalmologists charge much more than others for the same specialty IOL and associated testing. Greater access to price information and better regulatory control could help ensure patients receive fair value for out-of-pocket health expenses.	[Robert, Joshua M.; Bell, Chaim M.] Univ Toronto, Fac Med, Toronto, ON, Canada; [Campbell, Robert J.] Hop Hotel Dieu, Dept Ophthalmol, Kingston, ON, Canada; [Campbell, Robert J.] Queens Univ, Kingston, ON, Canada; [Campbell, Robert J.; Bell, Chaim M.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Bell, Chaim M.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Bell, Chaim M.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Bell, Chaim M.] St Michaels Hosp, Dept Med, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada	University of Toronto; Queens University - Canada; Queens University - Canada; University of Toronto; University of Toronto; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Robert, JM (corresponding author), Univ Toronto, Fac Med, Toronto, ON, Canada.	bellc@smh.ca	Bell, Chaim/C-4611-2015	Bell, Chaim/0000-0002-3778-9469; Robert, Joshua/0000-0002-6871-0039	Canadian Institutes of Health Research; Canadian Patient Safety Institute Chair in Patient Safety and Continuity of Care	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Patient Safety Institute Chair in Patient Safety and Continuity of Care	CB is supported by a Canadian Institutes of Health Research and Canadian Patient Safety Institute Chair in Patient Safety and Continuity of Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, COS STAT VAL UN SERV; [Anonymous], 2010, SCHED BEN PHYS SERV; Asbell PA, 2005, LANCET, V365, P599; College of Physicians and Surgeons of Ontario, 2010, PUBL REG; Finlayson SRG, 1999, MED CARE, V37, P204, DOI 10.1097/00005650-199902000-00010; Gellad WF, 2009, HEALTH SERV RES, V44, P606, DOI 10.1111/j.1475-6773.2008.00917.x; Gooi M, 2008, APPL HEALTH ECON HEA, V6, P19, DOI 10.2165/00148365-200806010-00002; Ong-Tone L, 2010, CAN J OPHTHALMOL, V45, P121, DOI 10.3129/i09-239; Peachey D, 2010, VALUATION UNINSURED; Redelmeier DA, 2000, ARCH INTERN MED, V160, P1417, DOI 10.1001/archinte.160.10.1417; Schwartz LM, 2005, BMJ-BRIT MED J, V331, P821, DOI 10.1136/bmj.38614.449016.DE; Slade SG, 2010, CATARACT REFRACT JAN, P40; TELSER LG, 1973, AM ECON REV, V63, P40; Vogel L, 2011, CAN MED ASSOC J, V183, P650, DOI 10.1503/cmaj.109-3828; Wait Time Alliance, 2010, STILL WAIT	15	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35179	10.1371/journal.pone.0035179	http://dx.doi.org/10.1371/journal.pone.0035179			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545100	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343200021
J	Zhu, XL; Chen, C; Ye, D; Guan, DN; Ye, L; Jin, JL; Zhao, H; Chen, YT; Wang, ZY; Wang, X; Xu, Y				Zhu, Xiaolei; Chen, Cong; Ye, Dan; Guan, Dening; Ye, Lan; Jin, Jiali; Zhao, Hui; Chen, Yanting; Wang, Zhongyuan; Wang, Xin; Xu, Yun			Diammonium Glycyrrhizinate Upregulates PGC-1 alpha and Protects against A beta(1-42)-Induced Neurotoxicity	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; ENERGY-METABOLISM; 18-BETA-GLYCYRRHETINIC ACID; MITOCHONDRIAL DYSFUNCTION; OXIDATIVE STRESS; BETA; PGC-1; CYTOTOXICITY; COACTIVATORS; EXPRESSION	Mitochondrial dysfunction is a hallmark of beta-amyloid (A beta)-induced neurotoxicity in Alzheimer's disease (AD), and is considered an early event in AD pathology. Diammonium glycyrrhizinate (DG), the salt form of Glycyrrhizin, is known for its anti-inflammatory effects, resistance to biologic oxidation and membranous protection. In the present study, the neuroprotective effects of DG on A beta(1-42)-induced toxicity and its potential mechanisms in primary cortical neurons were investigated. Exposure of neurons to 2 mu M A beta(1-42) resulted in significant viability loss and cell apoptosis. Accumulation of reactive oxygen species (ROS), decreased mitochondrial membrane potential, and activation of caspase-9 and caspase-3 were also observed after A beta(1-42) exposure. All these effects induced by A beta(1-42) were markedly reversed by DG treatment. In addition, DG could alleviate lipid peroxidation and partially restore the mitochondrial function in A beta(1-42)-induced AD mice. DG also significantly increased the PGC-1 alpha expression in vivo and in vitro, while knocking down PGC-1 alpha partially blocked the protective effects, which indicated that PGC-1 alpha contributed to the neuroprotective effects of DG. Furthermore, DG significantly decreased the escape latency and search distance and increased the target crossing times of A beta(1-42)-induced AD mice in the Morris water maze test. Therefore, these results demonstrated that DG could attenuate A beta(1-42)-induced neuronal injury by preventing mitochondrial dysfunction and oxidative stress and improved cognitive impairment in A beta(1-42)-induced AD mice, indicating that DG exerted potential beneficial effects on AD.	[Zhu, Xiaolei; Wang, Zhongyuan; Wang, Xin; Xu, Yun] Nanjing Univ Chinese Med, Dept Neurol, Nanjing Drum Tower Hosp Clin Coll Tradit Chinese, Nanjing, Jiangsu, Peoples R China; [Zhu, Xiaolei; Chen, Cong; Ye, Dan; Guan, Dening; Ye, Lan; Jin, Jiali; Zhao, Hui; Chen, Yanting; Wang, Zhongyuan; Wang, Xin; Xu, Yun] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Neurol, Nanjing 210008, Peoples R China; [Xu, Yun] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [Xu, Yun] Jiangsu Key Lab Mol Med, Nanjing, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine; Nanjing University; Nanjing University	Zhu, XL (corresponding author), Nanjing Univ Chinese Med, Dept Neurol, Nanjing Drum Tower Hosp Clin Coll Tradit Chinese, Nanjing, Jiangsu, Peoples R China.	xuyun20042001@yahoo.com.cn		Schirmer, Claire/0000-0002-7994-1190	National Natural Science Foundation of China [30971010, 30670739, 81171085]; Health Department of Jiangsu Province of China [LJ 201101]; National Natural Science Foundation of Jiangsu Province of China [BK2009037]; Ministry of Science and Technology in China [2009CB521906)]; Science and Technology Achievement transformation Foundation of Jiangsu Province [BA2009124]; Nanjing Municipal Bureau of Health [ZKX08030]; Postgraduate Innovation Project of Jiangsu Province of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Health Department of Jiangsu Province of China; National Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Ministry of Science and Technology in China(Ministry of Science and Technology, China); Science and Technology Achievement transformation Foundation of Jiangsu Province; Nanjing Municipal Bureau of Health; Postgraduate Innovation Project of Jiangsu Province of China	This study was supported by the National Natural Science Foundation of China (30971010, 30670739 and 81171085), Outstanding Researcher Program (LJ 201101) of Health Department of Jiangsu Province of China, the National Natural Science Foundation (BK2009037) of Jiangsu Province of China, 973 Fund from the Ministry of Science and Technology in China (2009CB521906), Science and Technology Achievement transformation Foundation of Jiangsu Province (BA2009124) (Y. Xu), Key Project of Nanjing Municipal Bureau of Health (ZKX08030) (D.N. Guan) and the Postgraduate Innovation Project of Jiangsu Province of China (X.L. Zhu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JW, 2001, J NEUROSCI RES, V65, P45, DOI 10.1002/jnr.1126; Arjumand W, 2011, LIFE SCI, V89, P422, DOI 10.1016/j.lfs.2011.06.016; Feng C, 2007, INT IMMUNOPHARMACOL, V7, P1292, DOI 10.1016/j.intimp.2007.05.011; Fiore C, 2008, PHYTOTHER RES, V22, P141, DOI 10.1002/ptr.2295; Gumpricht E, 2005, J BIOL CHEM, V280, P10556, DOI 10.1074/jbc.M411673200; Hauptmann S, 2006, EXP GERONTOL, V41, P668, DOI 10.1016/j.exger.2006.03.012; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; ISHIKAWA A, 1990, BIOCHEM BIOPH RES CO, V167, P876, DOI 10.1016/0006-291X(90)90605-M; Jeong HG, 2002, PHARMACOL RES, V46, P221, DOI 10.1016/S1043-6618(02)00121-4; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2009, MOL ENDOCRINOL, V23, P2, DOI 10.1210/me.2008-0344; Liu C, 2011, ACTA BIOCH BIOPH SIN, V43, P248, DOI 10.1093/abbs/gmr007; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Michaelis M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019705; Miranda S, 2000, PROG NEUROBIOL, V62, P633, DOI 10.1016/S0301-0082(00)00015-0; Pallas M, 2009, CURR NEUROVASC RES, V6, P70, DOI 10.2174/156720209787466019; Qin W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004183; Rasouri S, 2007, M S-MED SCI, V23, P840, DOI 10.1051/medsci/20072310840; Saura CA, 2011, REV NEUROSCIENCE, V22, P153, DOI 10.1515/RNS.2011.018; Scott Bitner R, 2011, BIOCH PHARM; Selkoe DJ, 2000, ANN NY ACAD SCI, V924, P17; Sheng BY, 2012, J NEUROCHEM, V120, P419, DOI 10.1111/j.1471-4159.2011.07581.x; Shoag J, 2010, ARTERIOSCL THROM VAS, V30, P662, DOI 10.1161/ATVBAHA.108.181636; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Sultana R, 2010, J ALZHEIMERS DIS, V19, P341, DOI 10.3233/JAD-2010-1222; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; Wareski P, 2009, J BIOL CHEM, V284, P21379, DOI 10.1074/jbc.M109.018911; Winner B, 2011, EUR J NEUROSCI, V33, P1139, DOI 10.1111/j.1460-9568.2011.07613.x; Xu Y, 2004, MOL ENDOCRINOL, V18, P86, DOI 10.1210/me.2003-0262; YAMAMURA Y, 1995, BIOL PHARM BULL, V18, P337, DOI 10.1248/bpb.18.337; Yoshida T, 2006, CYTOKINE, V33, P317, DOI 10.1016/j.cyto.2006.03.001; Zhu HR, 2010, NEUROPHARMACOLOGY, V59, P70, DOI 10.1016/j.neuropharm.2010.03.017	34	41	47	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35823	10.1371/journal.pone.0035823	http://dx.doi.org/10.1371/journal.pone.0035823			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22540007	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341000073
J	Chen, Y; Xu, XQ; Liu, X; Yu, MQ; Liu, BF; Zhang, GS				Chen, Yin; Xu, Xiangqing; Liu, Xin; Yu, Minquan; Liu, Bi-Feng; Zhang, Guisen			Synthesis and Evaluation of a Series of 2-Substituted-5-Thiopropylpiperazine (Piperidine)-1,3,4-Oxadiazoles Derivatives as Atypical Antipsychotics	PLOS ONE			English	Article							INDUCED WEIGHT-GAIN; DOPAMINE D-3; ARYLPIPERAZINE DERIVATIVES; SEROTONIN RECEPTORS; 5-HT1A RECEPTORS; SCHIZOPHRENIA; DRUGS; LIGANDS; AGENTS; IDENTIFICATION	Background: It is important to develop novel antipsychotics that can effectively treat schizophrenia with minor side-effects. The aim of our work is to develop novel antipsychotics that act on dopamine D-2 and D-3, serotonin 5-HT1A and 5-HT2A receptors with low affinity for the serotonin 5-HT2C and H-1 receptors, which can effectively cure positive symptoms, negative symptoms and cognitive impairment without the weight gain side-effect. Methodology/Principal Findings: A series of 2-substituted-5-thiopropylpiperazine (piperidine) -1,3,4-oxadiazoles derivatives have been synthesized and the target compounds were evaluated for binding affinities to D-2, 5-HT1A and 5-HT2A receptors. Preliminary results indicated that compounds 14, 16 and 22 exhibited high affinities to D-2, 5-HT1A and 5-HT2A receptors among these compounds. Further binding tests showed that compound 22 had high affinity for D-3 receptor, and low affinity for serotonin 5-HT2C and H-1 receptors. In addition, compound 22 inhibited apomorphine-induced climbing behavior and MK-801-induced hyperactivity with no extrapyramidal symptoms liability in mice. Moreover, compound 22 exhibited acceptable pharmacokinetic properties. Conclusions/Significance: Compound 22 showed an atypical antipsychotic activity without liability for extrapyramidal symptoms. We anticipate compound 22 to be useful for developing a novel class of drug for the treatment of schizophrenia.	[Chen, Yin; Liu, Xin; Liu, Bi-Feng; Zhang, Guisen] Huazhong Univ Sci & Technol, Dept Syst Biol, Wuhan 430074, Peoples R China; [Xu, Xiangqing; Yu, Minquan; Zhang, Guisen] Jiangsu Nhwa Pharmaceut Co Ltd, Xuzhou, Jiangsu, Peoples R China	Huazhong University of Science & Technology	Chen, Y (corresponding author), Huazhong Univ Sci & Technol, Dept Syst Biol, Wuhan 430074, Peoples R China.	gszhang@mail.hust.edu.cn			Jiangsu Nhwa Pharmaceutical; National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program'' [2012ZX09103-101-010]; Jiangsu Nhwa Pharmaceutical Co., Ltd.	Jiangsu Nhwa Pharmaceutical; National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program''; Jiangsu Nhwa Pharmaceutical Co., Ltd.	This study was supported by Jiangsu Nhwa Pharmaceutical, who played a role in study design, data collection and analysis, decision to publish and preparation of the manuscript, and the National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program'' (2012ZX09103-101-010), who had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by Jiangsu Nhwa Pharmaceutical Co., Ltd., who played a role in study design, data collection and analysis, decision to publish and preparation of the manuscript. Dr. Xu, Dr. Yu and Dr. Zhang are research staff of Jiangsu Nhwa Pharmaceutical Co., Ltd. Jiangsu Nhwa Pharmaceutical holds the patent of new compounds (patent number: CN201110082555.1) and developed those compounds. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Abdel-Aziz M, 2009, EUR J MED CHEM, V44, P3480, DOI 10.1016/j.ejmech.2009.01.032; Ablordeppey SY, 2008, BIOORGAN MED CHEM, V16, P7291, DOI 10.1016/j.bmc.2008.06.030; BALDESSARINI RJ, 1980, ANNU REV NEUROSCI, V3, P23, DOI 10.1146/annurev.ne.03.030180.000323; Bezard E, 2003, NAT MED, V9, P762, DOI 10.1038/nm875; BOYD AE, 1978, PSYCHONEUROENDOCRINO, V3, P113, DOI 10.1016/0306-4530(78)90001-X; Buckland PR, 2005, AM J PSYCHIAT, V162, P613, DOI 10.1176/appi.ajp.162.3.613; Butini S, 2009, J MED CHEM, V52, P151, DOI 10.1021/jm800689g; Campbell M, 1999, BRIT J CLIN PHARMACO, V47, P13, DOI 10.1046/j.1365-2125.1999.00849.x; Campiani G, 2004, J MED CHEM, V47, P143, DOI 10.1021/jm0309811; COSTALL B, 1978, EUR J PHARMACOL, V50, P39, DOI 10.1016/0014-2999(78)90251-0; DINI S, 1991, AGENTS ACTIONS, V33, P181, DOI 10.1007/BF01993161; Doria JS, 2011, BIOORGAN MED CHEM, V19, P5031; Frecentese F, 2010, EUR J MED CHEM, V45, P752, DOI 10.1016/j.ejmech.2009.11.023; Gaonkar SL, 2006, EUR J MED CHEM, V41, P841, DOI 10.1016/j.ejmech.2006.03.002; Garzya V, 2007, BIOORG MED CHEM LETT, V17, P400, DOI 10.1016/j.bmcl.2006.10.036; GLENNON RA, 1988, J MED CHEM, V31, P1968, DOI 10.1021/jm00118a018; Jones CA, 2008, NEUROPHARMACOLOGY, V55, P1056, DOI 10.1016/j.neuropharm.2008.05.025; Joshi S, 2002, SYNTHETIC COMMUN, V32, P111, DOI 10.1081/SCC-120001516; Khisti RT, 1998, NEUROSCI LETT, V251, P85, DOI 10.1016/S0304-3940(98)00479-0; Kim SF, 2007, P NATL ACAD SCI USA, V104, P3456, DOI 10.1073/pnas.0611417104; Kroeze WK, 2003, NEUROPSYCHOPHARMACOL, V28, P519, DOI 10.1038/sj.npp.1300027; LEWINE RRJ, 1983, SCHIZOPHRENIA BULL, V9, P368, DOI 10.1093/schbul/9.3.368; Li XR, 2010, J CHEM RES, P410, DOI 10.3184/030823410X12790364267642; Liu F, 2008, BIOORGAN MED CHEM, V16, P3632, DOI 10.1016/j.bmc.2008.02.006; LOWE JA, 1991, J MED CHEM, V34, P1860, DOI 10.1021/jm00110a016; MARDER SR, 1991, SCHIZOPHR RES, V4, P81, DOI 10.1016/0920-9964(91)90027-O; Meltzer HY, 2003, PROG NEURO-PSYCHOPH, V27, P1159, DOI 10.1016/j.pnpbp.2003.09.010; Meltzer HY, 2004, CNS SPECTRUMS, V9, P15, DOI 10.1017/S1092852900025098; Meltzer HY, 2004, CURR OPIN PHARMACOL, V4, P53, DOI 10.1016/j.coph.2003.09.010; MELTZER HY, 1989, J PHARMACOL EXP THER, V251, P238; Millan MJ, 2008, J PHARMACOL EXP THER, V324, P600, DOI 10.1124/jpet.107.132563; Millan MJ, 2000, J PHARMACOL EXP THER, V295, P853; Mission NAD, 1969, US3808223, Patent No. 3808223; Morphy R, 2009, CURR PHARM DESIGN, V15, P587, DOI 10.2174/138161209787315594; Neves G, 2010, BIOORGAN MED CHEM, V18, P1925, DOI 10.1016/j.bmc.2010.01.040; Obniska J, 2006, EUR J MED CHEM, V41, P874, DOI 10.1016/j.ejmech.2006.03.001; Ohno Yukihiro, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P148; Politis M, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000976; Pramanik SS, 1998, J INDIAN CHEM SOC, V75, P53; Rao MEB, 2011, ASIAN J CHEM, V23, P2648; Reavill C, 1999, BRIT J PHARMACOL, V126, P572, DOI 10.1038/sj.bjp.0702350; Reynolds Gavin P, 2006, J Psychopharmacol, V20, P15, DOI 10.1177/1359786806066040; Roth BL, 2004, PSYCHOPHARMACOLOGY, V174, P17, DOI 10.1007/s00213-003-1683-8; Schultz SH, 2007, AM FAM PHYSICIAN, V75, P1821; Shapiro DA, 2003, NEUROPSYCHOPHARMACOL, V28, P1400, DOI 10.1038/sj.npp.1300203; Tamminga CA, 1997, CAN J PSYCHIAT, V42, P265, DOI 10.1177/070674379704200304; Turilli O., 1963, ANN CHIMICA, V53, P1687; Vohora D, 2007, CURR OPIN INVEST DR, V8, P531; Wong EHF, 2010, PHARMACOL THERAPEUT, V126, P173, DOI 10.1016/j.pharmthera.2010.02.001; Wood MD, 2001, NEUROPHARMACOLOGY, V41, P186, DOI 10.1016/S0028-3908(01)00054-5; Xiberas X, 2001, BRIT J PSYCHIAT, V179, P503, DOI 10.1192/bjp.179.6.503	51	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35186	10.1371/journal.pone.0035186	http://dx.doi.org/10.1371/journal.pone.0035186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558126	gold, Green Published, Green Submitted			2022-12-27	WOS:000305340200009
J	Kim, SH; Xiao, S; Shive, H; Collins, PL; Samal, SK				Kim, Shin-Hee; Xiao, Sa; Shive, Heather; Collins, Peter L.; Samal, Siba K.			Replication, Neurotropism, and Pathogenicity of Avian Paramyxovirus Serotypes 1-9 in Chickens and Ducks	PLOS ONE			English	Article							NEWCASTLE-DISEASE VIRUS; COMPLETE GENOME SEQUENCE; HEMAGGLUTININ-NEURAMINIDASE PROTEINS; FUSION PROTEIN; PROTECTIVE IMMUNITY; CLEAVAGE SITE; YUCAIPA; INFECTION; VIRULENCE; POULTRY	Avian paramyxovirus (APMV) serotypes 1-9 have been isolated from many different avian species. APMV-1 (Newcastle disease virus) is the only well-characterized serotype, because of the high morbidity, mortality, and economic loss caused by highly virulent strains. Very little is known about the pathogenesis, replication, virulence, and tropism of the other APMV serotypes. Here, this was evaluated for prototypes strains of APMV serotypes 2-9 in cell culture and in chickens and ducks. In cell culture, only APMV-1, -3 and -5 induced syncytium formation. In chicken DF1 cells, APMV-3 replicated with an efficiency approaching that of APMV-1, while APMV-2 and -5 replicated to lower, intermediate titers and the others were much lower. Mean death time (MDT) assay in chicken eggs and intracerebral pathogenicity index (ICPI) test in 1-day-old SPF chicks demonstrated that APMV types 2-9 were avirulent. Evaluation of replication in primary neuronal cells in vitro as well as in the brains of 1-day-old chicks showed that, among types 2-9, only APMV-3 was neurotropic, although this virus was not neurovirulent. Following intranasal infection of 1-day-old and 2-week-old chickens, replication of APMV types 2-9 was mostly restricted to the respiratory tract, although APMV-3 was neuroinvasive and neurotropic (but not neurovirulent) and also was found in the spleen. Experimental intranasal infection of 3-week-old mallard ducks with the APMVs did not produce any clinical signs (even for APMV-1) and exhibited restricted viral replication of the APMVs (including APMV-1) to the upper respiratory tract regardless of their isolation source, indicating avirulence of APMV types 1-9 in mallard ducks. The link between the presence of a furin cleavage site in the F protein, syncytium formation, systemic spread, and virulence that has been well-established with APMV-1 pathotypes was not evident with the other APMV serotypes.	[Kim, Shin-Hee; Xiao, Sa; Samal, Siba K.] Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA; [Shive, Heather] NCI, Expt Transplantat & Immunol Branch, NIH, Bethesda, MD 20892 USA; [Collins, Peter L.] NIAID, Infect Dis Lab, Bethesda, MD 20892 USA	University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kim, SH (corresponding author), Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA.	ssamal@umd.edu			National Institute of Allergy and Infection Diseases (NIAID) [N01A060009]; NIAID, National Institutes of Health Intramural Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000938] Funding Source: NIH RePORTER	National Institute of Allergy and Infection Diseases (NIAID); NIAID, National Institutes of Health Intramural Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by National Institute of Allergy and Infection Diseases (NIAID) contract no N01A060009 (85% support) and NIAID, National Institutes of Health Intramural Research Program (15% support). The views expressed herein do not necessarily reflect the official policies of the Department of Health and Human Services, nor does mention of trade names, commercial practices, or organizations imply endorsement by the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander D.J., 1989, LAB MANUAL ISOLATION; Alexander D.J., 2003, DIS POULTRY, V11th, P88, DOI [10.1080/03079457.2011., DOI 10.1080/03079457.2011]; ALEXANDER DJ, 1982, WORLD POULTRY SCI J, V38, P97, DOI 10.1079/WPS19820008; Alexander DJ, 2000, REV SCI TECH OIE, V19, P443, DOI 10.20506/rst.19.2.1231; BANKOWSKI RA, 1981, AVIAN DIS, V25, P517, DOI 10.2307/1589944; Bukreyev A, 2008, CURR OPIN MOL THER, V10, P46; CALAIN P, 1993, J VIROL, V67, P4822, DOI 10.1128/JVI.67.8.4822-4830.1993; Chen JD, 2005, AVIAN DIS, V49, P170, DOI 10.1637/7270-090101R1; de Leeuw OS, 2005, J GEN VIROL, V86, P1759, DOI 10.1099/vir.0.80822-0; DENG RT, 1995, VIROLOGY, V209, P457, DOI 10.1006/viro.1995.1278; HOFSTAD MS, 1950, CORNELL VET, V40, P190; Khattar SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016776; Kim SH, 2011, J VIROL, V85, P8582, DOI 10.1128/JVI.00652-11; Kumar S, 2008, VIRUS RES, V137, P189, DOI 10.1016/j.virusres.2008.07.012; Kumar S, 2011, J VIROL, V85, P6521, DOI 10.1128/JVI.00367-11; Kumar S, 2010, VET RES, V41, DOI 10.1051/vetres/2010042; Lamb RA, 2006, VIROLOGY, V344, P30, DOI 10.1016/j.virol.2005.09.007; LIPKIND MA, 1979, VET REC, V105, P577; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; Melanson VR, 2004, J VIROL, V78, P13053, DOI 10.1128/JVI.78.23.13053-13061.2004; Miller PJ, 2010, J VIROL, V84, P11496, DOI 10.1128/JVI.00822-10; Nayak B, 2012, VACCINE, V30, P2220, DOI 10.1016/j.vaccine.2011.12.090; Nayak B, 2008, VIROL J, V5, DOI [10.1186/1743-422X-5-124, 10.1186/1743-422x-5-124]; NEROME K, 1978, J GEN VIROL, V38, P293, DOI 10.1099/0022-1317-38-2-293; Paldurai A, 2009, VIRUS RES, V142, P144, DOI 10.1016/j.virusres.2009.02.003; PASICK JMM, 1994, J VIROL, V68, P2915, DOI 10.1128/JVI.68.5.2915-2928.1994; Pedersen JC, 2004, J CLIN MICROBIOL, V42, P2329, DOI 10.1128/JCM.42.5.2329-2334.2004; REED L. J., 1938, AMER JOUR HYG, V27, P493; Samal SK, 2011, BIOLOGY OF PARAMYXOVIRUSES, P69; Samuel AS, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-38; Samuel AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009269; Samuel AS, 2009, VIRUS RES, V142, P10, DOI 10.1016/j.virusres.2008.12.016; Shi SH, 2011, ARCH VIROL, V156, P405, DOI 10.1007/s00705-010-0866-y; Subbiah M, 2008, VIRUS RES, V137, P40, DOI 10.1016/j.virusres.2008.05.012; Subbiah M, 2011, J VIROL, V85, P5394, DOI 10.1128/JVI.02696-10; Subbiah M, 2010, AVIAN DIS, V54, P1050, DOI 10.1637/9380-041910-Reg.1; Teng MN, 2001, VIROLOGY, V289, P283, DOI 10.1006/viro.2001.1138; TUMOVA B, 1979, RES VET SCI, V27, P135, DOI 10.1016/S0034-5288(18)32817-0; Waning DL, 2002, J VIROL, V76, P9284, DOI 10.1128/JVI.76.18.9284-9297.2002; Warke A, 2008, AVIAN DIS, V52, P694, DOI 10.1637/8390-070308-RESNOTE.1; Xiao S, 2012, J VIROL, V86, P3828, DOI 10.1128/JVI.06765-11; Xiao S, 2010, VIRUS RES, V150, P61, DOI 10.1016/j.virusres.2010.02.015; Xiao S, 2009, VIRUS RES, V145, P80, DOI 10.1016/j.virusres.2009.06.003; Zhang GZ, 2006, AVIAN DIS, V50, P386, DOI 10.1637/7502-010906R1.1; Zou J, 2005, VIRUS GENES, V30, P13, DOI 10.1007/s11262-004-4577-x	45	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e34927	10.1371/journal.pone.0034927	http://dx.doi.org/10.1371/journal.pone.0034927			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558104	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340200007
J	Blum, ID; Lamont, EW; Rodrigues, T; Abizaid, A				Blum, Ian David; Lamont, Elaine Waddington; Rodrigues, Trevor; Abizaid, Alfonso			Isolating Neural Correlates of the Pacemaker for Food Anticipation	PLOS ONE			English	Article							HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; ENTRAINABLE CIRCADIAN OSCILLATOR; MIDBRAIN RAPHE NUCLEI; C-FOS EXPRESSION; SUPRACHIASMATIC NUCLEUS; FEEDING SCHEDULES; BRAIN-STEM; NEURONAL ACTIVATION; BEHAVIORAL AROUSAL; STRIA TERMINALIS	Mice fed a single daily meal at intervals within the circadian range exhibit food anticipatory activity. Previous investigations strongly suggest that this behaviour is regulated by a circadian pacemaker entrained to the timing of fasting/refeeding. The neural correlate(s) of this pacemaker, the food entrainable oscillator (FEO), whether found in a neural network or a single locus, remain unknown. This study used a canonical property of circadian pacemakers, the ability to continue oscillating after removal of the entraining stimulus, to isolate activation within the neural correlates of food entrainable oscillator from all other mechanisms driving food anticipatory activity. It was hypothesized that continued anticipatory activation of central nuclei, after restricted feeding and a return to ad libitum feeding, would elucidate a neural representation of the signaling circuits responsible for the timekeeping component of the food entrainable oscillator. Animals were entrained to a temporally constrained meal then placed back on ad libitum feeding for several days until food anticipatory activity was abolished. Activation of nuclei throughout the brain was quantified using stereological analysis of c-FOS expressing cells and compared against both ad libitum fed and food entrained controls. Several hypothalamic and brainstem nuclei remained activated at the previous time of food anticipation, implicating them in the timekeeping mechanism necessary to track previous meal presentation. This study also provides a proof of concept for an experimental paradigm useful to further investigate the anatomical and molecular substrates of the FEO.	[Blum, Ian David; Lamont, Elaine Waddington; Rodrigues, Trevor; Abizaid, Alfonso] Carleton Univ, Dept Neurosci, Ottawa, ON K1S 5B6, Canada	Carleton University	Blum, ID (corresponding author), Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada.	alfonso_abizaid@carleton.ca	Blum, Ian D/B-3768-2012	Abizaid, Alfonso/0000-0001-9303-3511; Blum, Ian David/0000-0001-6999-8364	Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Foundation for Innovation (CFI)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation)	This project was funded by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC, www.nserc-crsng.gc.ca/) and the Canada Foundation for Innovation (CFI, www.innovation.ca/) awarded to AA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizaid A, 2005, EUR J NEUROSCI, V21, P1536, DOI 10.1111/j.1460-9568.2005.03964.x; Acosta-Galvan G., 2011, P NATL ACAD SCI; Acosta-Galvan G, 2011, P NATL ACAD SCI USA, V108, P5813, DOI 10.1073/pnas.1015551108; Angeles-Castellanos M, 2005, AM J PHYSIOL-REG I, V288, pR678, DOI 10.1152/ajpregu.00590.2004; Angeles-Castellanos M, 2004, AM J PHYSIOL-REG I, V286, pR158, DOI 10.1152/ajpregu.00216.2003; BEALER SL, 1986, AM J PHYSIOL, V250, pR18, DOI 10.1152/ajpregu.1986.250.1.R18; BLOCK M, 1976, J COMP PHYSIOL, V109, P235, DOI 10.1007/BF00663606; Blum ID, 2012, NEUROSCI BIOBEHAV R, V36, P254, DOI 10.1016/j.neubiorev.2011.06.003; Blum ID, 2009, NEUROSCIENCE, V164, P351, DOI 10.1016/j.neuroscience.2009.08.009; BOLLES RC, 1965, J COMP PHYSIOL PSYCH, V60, P290, DOI 10.1037/h0022308; Boudaba C, 1996, J NEUROSCI, V16, P7151; BOULOS Z, 1980, BEHAV BRAIN RES, V1, P39, DOI 10.1016/S0166-4328(80)80049-0; Challet E, 1997, BRAIN RES, V770, P228, DOI 10.1016/S0006-8993(97)00796-8; Challet E, 2009, EUR J NEUROSCI, V30, P1676, DOI 10.1111/j.1460-9568.2009.06962.x; Choi DC, 2006, FRONT NEUROENDOCRIN, V27, P51, DOI 10.1016/j.yfrne.2006.03.105; Choi SJ, 1998, J NEUROSCI, V18, P3843; CLARKE JD, 1986, PHYSIOL BEHAV, V36, P105, DOI 10.1016/0031-9384(86)90082-X; COLEMAN GJ, 1982, PHYSIOL BEHAV, V29, P107, DOI 10.1016/0031-9384(82)90373-0; Cullinan WE, 1996, J COMP NEUROL, V368, P88; Cullinan WE, 2008, BRAIN STRUCT FUNCT, V213, P63, DOI 10.1007/s00429-008-0192-2; Davidson AJ, 2006, AM J PHYSIOL-REG I, V290, pR1524, DOI 10.1152/ajpregu.00073.2006; Davidson AJ, 2003, GENES BRAIN BEHAV, V2, P32, DOI 10.1034/j.1601-183X.2003.00005.x; Davidson AJ, 1998, J BIOL RHYTHM, V13, P422, DOI 10.1177/074873098129000246; Davidson AJ, 2000, AM J PHYSIOL-REG I, V278, pR1296, DOI 10.1152/ajpregu.2000.278.5.R1296; Davidson AJ, 2009, EUR J NEUROSCI, V30, P1658, DOI 10.1111/j.1460-9568.2009.06961.x; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Dong HW, 2001, J COMP NEUROL, V436, P430, DOI 10.1002/cne.1079; Escobar C, 1998, AM J PHYSIOL-REG I, V274, pR1309, DOI 10.1152/ajpregu.1998.274.5.R1309; Escobar C, 2007, EUR J NEUROSCI, V26, P2804, DOI 10.1111/j.1460-9568.2007.05893.x; Escobar C, 2009, EUR J NEUROSCI, V30, P1665, DOI 10.1111/j.1460-9568.2009.06972.x; Faulconbridge LF, 2008, BRAIN RES, V1218, P151, DOI 10.1016/j.brainres.2008.04.068; Glass JD, 2003, J NEUROSCI, V23, P7451; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Guido ME, 1999, J BIOL RHYTHM, V14, P275, DOI 10.1177/074873099129000687; Guilding C, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-28; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hayes MR, 2009, ENDOCRINOLOGY, V150, P2654, DOI 10.1210/en.2008-1479; Herman JP, 2002, PHARMACOL BIOCHEM BE, V71, P457, DOI 10.1016/S0091-3057(01)00681-5; Hirota T, 2004, ZOOL SCI, V21, P359, DOI 10.2108/zsj.21.359; Hood S, 2010, J NEUROSCI, V30, P14046, DOI 10.1523/JNEUROSCI.2128-10.2010; JACOBS BL, 1978, BRAIN RES, V147, P149, DOI 10.1016/0006-8993(78)90779-5; Johnstone LE, 2006, CELL METAB, V4, P313, DOI 10.1016/j.cmet.2006.08.003; Kalsbeek A, 2010, J NEUROENDOCRINOL, V22, P362, DOI 10.1111/j.1365-2826.2010.01956.x; Lamont EW, 2007, NEUROSCIENCE, V144, P402, DOI 10.1016/j.neuroscience.2006.09.027; Landry GJ, 2006, AM J PHYSIOL-REG I, V290, pR1527, DOI 10.1152/ajpregu.00874.2005; Landry GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024187; LeSauter J, 2009, P NATL ACAD SCI USA, V106, P13582, DOI 10.1073/pnas.0906426106; Mistlberger RE, 2006, CURR BIOL, V16, pR968, DOI 10.1016/j.cub.2006.10.020; Mistlberger RE, 2011, PHYSIOL BEHAV, V104, P535, DOI 10.1016/j.physbeh.2011.04.015; Mistlberger RE, 2009, EUR J NEUROSCI, V30, P1718, DOI 10.1111/j.1460-9568.2009.06965.x; MISTLBERGER RE, 1992, BEHAV BRAIN RES, V47, P159, DOI 10.1016/S0166-4328(05)80122-6; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; Moga MM, 1997, J COMP NEUROL, V389, P508, DOI 10.1002/(SICI)1096-9861(19971222)389:3<508::AID-CNE11>3.0.CO;2-H; MORI T, 1983, PHYSIOL BEHAV, V30, P259, DOI 10.1016/0031-9384(83)90016-1; Moriya T, 2009, EURO J NEUROSCI, V7, P1447; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Poulin AM, 2008, BRAIN RES, V1227, P128, DOI 10.1016/j.brainres.2008.06.039; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Ramos EJB, 2005, NUTRITION, V21, P269, DOI 10.1016/j.nut.2004.06.021; Ribeiro AC, 2007, P NATL ACAD SCI USA, V104, P20078, DOI 10.1073/pnas.0710096104; ROSENWASSER AM, 1984, PHYSIOL BEHAV, V32, P25, DOI 10.1016/0031-9384(84)90064-7; Sanchez E, 2008, ENDOCRINOLOGY, V149, P4329, DOI 10.1210/en.2008-0411; Carneiro BTS, 2009, CHRONOBIOL INT, V26, P1273, DOI 10.3109/07420520903404480; Schmidt Tiffany M, 2008, Cellscience, V5, P77; Skibicka KP, 2010, ENDOCR J, V57, pS518; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P545, DOI 10.1016/S0163-1047(79)90332-7; STEPHAN FK, 1984, PHYSIOL BEHAV, V32, P663, DOI 10.1016/0031-9384(84)90323-8; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P346, DOI 10.1016/S0163-1047(79)90415-1; Sutton GM, 2010, FASEB J, V24, P862, DOI 10.1096/fj.09-142000; Sutton GM, 2008, J NEUROSCI, V28, P12946, DOI 10.1523/JNEUROSCI.3615-08.2008; Takase LF, 2008, BRAIN RES, V1200, P10, DOI 10.1016/j.brainres.2008.01.036; TSURUMI C, 1995, MOL CELL BIOL, V15, P5682; Valassi E, 2008, NUTR METAB CARDIOVAS, V18, P158, DOI 10.1016/j.numecd.2007.06.004; Varcoe TJ, 2008, BRAIN RES, V1209, P19, DOI 10.1016/j.brainres.2008.02.091; Verwey M, 2011, NEUROSCIENCE, V192, P304, DOI 10.1016/j.neuroscience.2011.07.016; Verwey M, 2009, EUR J NEUROSCI, V30, P1650, DOI 10.1111/j.1460-9568.2009.06960.x; Verwey M, 2008, NEUROSCI LETT, V440, P54, DOI 10.1016/j.neulet.2008.05.043; Verwey M, 2012, J MOL NEUROSCI, V46, P258, DOI 10.1007/s12031-011-9529-z; Verwey M, 2009, EUR J NEUROSCI, V29, P2217, DOI 10.1111/j.1460-9568.2009.06766.x; WATSON RE, 1986, PEPTIDES, V7, P155, DOI 10.1016/0196-9781(86)90076-8; Webb IC, 2010, NEUROSCIENCE, V166, P739, DOI 10.1016/j.neuroscience.2010.01.014; Williams DL, 2009, AM J PHYSIOL-REG I, V297, pR1238, DOI 10.1152/ajpregu.00182.2009; Woods SC, 2004, AM J PHYSIOL-GASTR L, V286, pG7, DOI 10.1152/ajpgi.00448.2003; Ziegler DR, 2002, J COMP NEUROL, V448, P217, DOI 10.1002/cne.10257	87	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36117	10.1371/journal.pone.0036117	http://dx.doi.org/10.1371/journal.pone.0036117			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558352	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336000131
J	Mizuochi, C; Fraser, ST; Biasch, K; Horio, Y; Kikushige, Y; Tani, K; Akashi, K; Tavian, M; Sugiyama, D				Mizuochi, Chiyo; Fraser, Stuart T.; Biasch, Katia; Horio, Yuka; Kikushige, Yoshikane; Tani, Kenzaburo; Akashi, Koichi; Tavian, Manuela; Sugiyama, Daisuke			Intra-Aortic Clusters Undergo Endothelial to Hematopoietic Phenotypic Transition during Early Embryogenesis	PLOS ONE			English	Article							STEM-CELLS; DEFINITIVE HEMATOPOIESIS; AORTIC ENDOTHELIUM; MATURATION; THYMOCYTES; SELECTION; LINEAGE; REVEAL; RUNX1; CBFA2	Intra-aortic clusters (IACs) attach to floor of large arteries and are considered to have recently acquired hematopoietic stem cell (HSC)-potential in vertebrate early mid-gestation embryos. The formation and function of IACs is poorly understood. To address this issue, IACs were characterized by immunohistochemistry and flow cytometry in mouse embryos. Immunohistochemical analysis revealed that IACs simultaneously express the surface antigens CD31, CD34 and c-Kit. As embryos developed from 9.5 to 10.5 dpc, IACs up-regulate the hematopoietic markers CD41 and CD45 while down-regulating the endothelial surface antigen VE-cadherin/CD144, suggesting that IACs lose endothelial phenotype after 9.5 dpc. Analysis of the hematopoietic potential of IACs revealed a significant change in macrophage CFC activity from 9.5 to 10.5 dpc. To further characterize IACs, we isolated IACs based on CD45 expression. Correspondingly, the expression of hematopoietic transcription factors in the CD45(neg) fraction of IACs was significantly up-regulated. These results suggest that the transition from endothelial to hematopoietic phenotype of IACs occurs after 9.5 dpc.	[Mizuochi, Chiyo; Horio, Yuka; Sugiyama, Daisuke] Kyushu Univ, Dept Hematopoiet Stem Cells, SSP Stem Cell Unit, Fac Med Sci, Fukuoka 812, Japan; [Fraser, Stuart T.] Univ Sydney, Sch Med Sci, Disciplines Physiol Anat & Histol, Lab Blood Cell Dev, Camperdown, NSW, Australia; [Biasch, Katia; Tavian, Manuela] INSERM, U682, Strasbourg, France; [Kikushige, Yoshikane; Akashi, Koichi] Kyushu Univ, Dept Med & Biosyst Sci, Grad Sch Med Sci, Fukuoka 812, Japan; [Tani, Kenzaburo] Kyushu Univ, Med Inst Bioregulat, Dept Mol Genet, Fukuoka 812, Japan	Kyushu University; University of Sydney; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Kyushu University; Kyushu University	Mizuochi, C (corresponding author), Kyushu Univ, Dept Hematopoiet Stem Cells, SSP Stem Cell Unit, Fac Med Sci, Fukuoka 812, Japan.	ds-mons@yb3.so-net.ne.jp	Tavian, Manuela/S-3201-2019; Tavian, Manuela/E-4210-2018	Tavian, Manuela/0000-0003-4746-3240; Tavian, Manuela/0000-0003-4746-3240; Biasch, Katia/0000-0002-0834-8330; Fraser, Stuart/0000-0003-3795-9461	Ministry of Education, Science, Sports and Culture; Japan Society for the Promotion of Science	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported in part by the Project for Realization of Regenerative Medicine, Special Coordination Funds for Promoting Science and Technology of the Ministry of Education, Science, Sports and Culture (www.mext.go.jp/english); and SAKURA program of the Japan Society for the Promotion of Science (www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Byth KF, 1996, J EXP MED, V183, P1707, DOI 10.1084/jem.183.4.1707; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Dieterlen-Lievre F, 2006, TRENDS CARDIOVAS MED, V16, P128, DOI 10.1016/j.tcm.2006.02.005; Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; Fraser ST, 2003, DEV GROWTH DIFFER, V45, P63; Garcia-Porrero JA, 1998, DEV COMP IMMUNOL, V22, P303, DOI 10.1016/S0145-305X(98)00006-8; GARCIAPORRERO JA, 1995, ANAT EMBRYOL, V192, P427; Godin I, 2002, NAT REV IMMUNOL, V2, P593, DOI 10.1038/nri857; Goyama S, 2008, CELL STEM CELL, V3, P207, DOI 10.1016/j.stem.2008.06.002; Jaffredo T, 2005, INT J DEV BIOL, V49, P269, DOI 10.1387/ijdb.041948tj; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Kumano K, 2003, IMMUNITY, V18, P699, DOI 10.1016/S1074-7613(03)00117-1; Matsubara A, 2005, J EXP MED, V202, P1483, DOI 10.1084/jem.20051325; McKinney-Freeman SL, 2009, BLOOD, V114, P268, DOI 10.1182/blood-2008-12-193888; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Mee PJ, 1999, EUR J IMMUNOL, V29, P2923, DOI 10.1002/(SICI)1521-4141(199909)29:09<2923::AID-IMMU2923>3.3.CO;2-P; Mikkola HKA, 2006, DEVELOPMENT, V133, P3733, DOI 10.1242/dev.02568; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; North T, 1999, DEVELOPMENT, V126, P2563; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; O'Rahilly R., 1987, DEV STAGES HUMAN EMB; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Rybtsov S, 2011, J EXP MED, V208, P1305, DOI 10.1084/jem.20102419; Sasaki T, 2010, DEVELOPMENT, V137, P3941, DOI 10.1242/dev.051359; Sugiyama D, 2006, TRENDS CARDIOVAS MED, V16, P45, DOI 10.1016/j.tcm.2005.11.006; Sugiyama D, 2005, STEM CELLS DEV, V14, P687, DOI 10.1089/scd.2005.14.687; Sugiyama D, 2003, BLOOD, V101, P4733, DOI 10.1182/blood-2002-09-2799; Takakura N, 1998, IMMUNITY, V9, P677, DOI 10.1016/S1074-7613(00)80665-2; Taoudi S, 2008, CELL STEM CELL, V3, P99, DOI 10.1016/j.stem.2008.06.004; Tavian M, 2005, EXP HEMATOL, V33, P1062, DOI 10.1016/j.exphem.2005.06.025; Theiler K, 1972, HOUSE MOUSE DEV NORM; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Wood HB, 1997, BLOOD, V90, P2300; Yoder MC, 1997, IMMUNITY, V7, P335, DOI 10.1016/S1074-7613(00)80355-6; Yokomizo T, 2010, DEVELOPMENT, V137, P3651, DOI 10.1242/dev.051094; Yuasa H, 2005, EMBO J, V24, P1976, DOI 10.1038/sj.emboj.7600679; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	42	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35763	10.1371/journal.pone.0035763	http://dx.doi.org/10.1371/journal.pone.0035763			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558218	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336000058
J	Raju, G; Srinivas, R; Reddy, VS; Idris, MM; Kamal, A; Nagesh, N				Raju, Gajjela; Srinivas, Ragampeta; Reddy, Vangala Santhosh; Idris, Mohammed M.; Kamal, Ahmed; Nagesh, Narayana			Interaction of Pyrrolobenzodiazepine (PBD) Ligands with Parallel Intermolecular G-Quadruplex Complex Using Spectroscopy and ESI-MS	PLOS ONE			English	Article							MASS-SPECTROMETRY; G-QUARTETS; DNA; BINDING; SEQUENCE; TELOMERASE; PROMOTER; DESIGN; RECOGNITION; DERIVATIVES	Studies on ligand interaction with quadruplex DNA, and their role in stabilizing the complex at concentration prevailing under physiological condition, has attained high interest. Electrospray ionization mass spectrometry (ESI-MS) and spectroscopic studies in solution were used to evaluate the interaction of PBD and TMPyP4 ligands, stoichiometry and selectivity to G-quadruplex DNA. Two synthetic ligands from PBD family, namely pyrene-linked pyrrolo[2,1-c][1,4]benzodiazepine hybrid (PBD1), mixed imine-amide pyrrolobenzodiazepine dimer (PBD2) and 5,10,15,20-tetrakis(N-methyl-4-pyridyl) porphyrin (TMPyP4) were studied. G-rich single-stranded oligonucleotide d(5'GGGGTTGGGG39') designated as d(T(2)G(8)), from the telomeric region of Tetrahymena Glaucoma, was considered for the interaction with ligands. ESI-MS and spectroscopic methods viz., circular dichroism (CD), UV-Visible, and fluorescence were employed to investigate the G-quadruplex structures formed by d(T(2)G(8)) sequence and its interaction with PBD and TMPyP4 ligands. From ESI-MS spectra, it is evident that the majority of quadruplexes exist as d(T(2)G(8))(2) and d(T(2)G(8))(4) forms possessing two to ten cations in the centre, thereby stabilizing the complex. CD band of PBD1 and PBD2 showed hypo and hyperchromicity, on interaction with quadruplex DNA, indicating unfolding and stabilization of quadruplex DNA complex, respectively. UV-Visible and fluorescence experiments suggest that PBD1 bind externally where as PBD2 intercalate moderately and bind externally to G-quadruplex DNA. Further, melting experiments using SYBR Green indicate that PBD1 unfolds and PBD2 stabilizes the G-quadruplex complex. ITC experiments using d(T(2)G(8)) quadruplex with PBD ligands reveal that PBD1 and PBD2 prefer external/loop binding and external/intercalative binding to quadruplex DNA, respectively. From experimental results it is clear that the interaction of PBD2 and TMPyP4 impart higher stability to the quadruplex complex.	[Raju, Gajjela; Srinivas, Ragampeta] Indian Inst Chem Technol, Natl Ctr Mass Spectrometry, Hyderabad 500007, Andhra Pradesh, India; [Reddy, Vangala Santhosh; Kamal, Ahmed] Indian Inst Chem Technol, Div Organ Chem, Hyderabad 500007, Andhra Pradesh, India; [Idris, Mohammed M.; Nagesh, Narayana] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Raju, G (corresponding author), Indian Inst Chem Technol, Natl Ctr Mass Spectrometry, Hyderabad 500007, Andhra Pradesh, India.	nagesh@ccmb.res.in		Nagesh, Narayana/0000-0002-8998-8013; Gajjela, Raju/0000-0002-3715-4762	UGC; CSIR, New Delhi	UGC(University Grants Commission, India); CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	The authors thank Dr. J. S. Yadav, Director, IICT, Hyderabad and Dr. Ch Mohan Rao, Director, CCMB for their encouragement and support. G. R. and V.S.R thank UGC and CSIR, New Delhi for the award of Senior Research Fellowships.	Brown A, 2009, INT J MOL SCI, V10, P3457, DOI 10.3390/ijms10083457; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Chaires JB, 2001, METHOD ENZYMOL, V340, P3; Chaires JB, 2006, ARCH BIOCHEM BIOPHYS, V453, P26, DOI 10.1016/j.abb.2006.03.027; Cipolla L, 2009, ANTI-CANCER AGENT ME, V9, P1, DOI 10.2174/187152009787047743; Clark GR, 2003, J AM CHEM SOC, V125, P4066, DOI 10.1021/ja0297988; Cui XJ, 2011, J MASS SPECTROM, V46, P849, DOI 10.1002/jms.1959; Davis JT, 2004, ANGEW CHEM INT EDIT, V43, P668, DOI 10.1002/anie.200300589; Dixon IM, 2005, CHEMBIOCHEM, V6, P123, DOI 10.1002/cbic.200400113; El Bakali J, 2009, BIOORG MED CHEM LETT, V19, P3434, DOI 10.1016/j.bmcl.2009.05.025; Fukuda H, 2002, P NATL ACAD SCI USA, V99, P12685, DOI 10.1073/pnas.152456899; Giglio S, 2003, NUCLEIC ACIDS RES, V31, P15; Gonzalez JM, 2005, EXTREMOPHILES, V9, P75, DOI 10.1007/s00792-004-0417-0; Hadjivassileva T, 2005, J ANTIMICROB CHEMOTH, V56, P513, DOI 10.1093/jac/dki256; Han FXG, 1999, J AM CHEM SOC, V121, P3561, DOI 10.1021/ja984153m; Han HY, 2001, J AM CHEM SOC, V123, P8902, DOI 10.1021/ja002179j; Hofstadler SA, 2006, NAT REV DRUG DISCOV, V5, P585, DOI 10.1038/nrd2083; Hopton SR, 2011, BIOCHEMISTRY-US, V50, P4720, DOI 10.1021/bi102017e; HURLEY LH, 1989, J MED CHEM, V32, P2027, DOI 10.1021/jm00129a001; Hyun KM, 1997, BBA-GEN SUBJECTS, V1334, P312, DOI 10.1016/S0304-4165(96)00111-0; Kamal A, 2004, BIOORG MED CHEM LETT, V14, P471, DOI 10.1016/j.bmcl.2003.10.050; Kamal A, 2002, J MED CHEM, V45, P4679, DOI 10.1021/jm020124h; Kamal A, 2011, CHEMMEDCHEM, V6, P1665, DOI 10.1002/cmdc.201100207; Kamal A, 2011, EUR J MED CHEM, V46, P3820, DOI 10.1016/j.ejmech.2011.05.050; Kamal A, 2011, BIOORGAN MED CHEM, V19, P2565, DOI 10.1016/j.bmc.2011.03.015; Keating LR, 2004, BIOCHEMISTRY-US, V43, P15891, DOI 10.1021/bi0483209; Kim MY, 2002, J AM CHEM SOC, V124, P2098, DOI 10.1021/ja017308q; Koeppel F, 2001, NUCLEIC ACIDS RES, V29, P1087, DOI 10.1093/nar/29.5.1087; Kraus GA, 1999, TETRAHEDRON LETT, V40, P2039, DOI 10.1016/S0040-4039(99)00087-8; Ladbury JE, 1996, CHEM BIOL, V3, P791, DOI 10.1016/S1074-5521(96)90063-0; LAUGHLAN G, 1994, SCIENCE, V265, P520, DOI 10.1126/science.8036494; Lavie A, 2008, J GEN VIROL, V89, P1672, DOI 10.1099/vir.0.2008/000273-0; Lubitz I, 2007, BIOCHEMISTRY-US, V46, P12925, DOI 10.1021/bi701301u; Nagesh N, 2003, J BIOCHEM BIOPH METH, V57, P65, DOI 10.1016/S0165-022X(03)00081-2; NAGESH N, 1995, J BIOCHEM BIOPH METH, V30, P1, DOI 10.1016/0165-022X(94)00057-K; Nagesh N, 2007, NUCLEOS NUCLEOT NUCL, V26, P303, DOI 10.1080/15257770701257590; Nagesh N, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/146418; Nagesh N, 2010, BIOPHYS J, V98, P2628, DOI 10.1016/j.bpj.2010.02.050; Patel DJ, 2007, NUCLEIC ACIDS RES, V35, P7429, DOI 10.1093/nar/gkm711; Qiu B, 2011, J MASS SPECTROM, V46, P587, DOI 10.1002/jms.1928; Rangan A, 2001, J BIOL CHEM, V276, P4640, DOI 10.1074/jbc.M005962200; Reddy BSP, 2000, ANTI-CANCER DRUG DES, V15, P225; Reddy TVK, 2011, INT J SYST EVOL MICR, V61, P76, DOI 10.1099/ijs.0.020446-0; Ren JS, 1999, BIOCHEMISTRY-US, V38, P16067, DOI 10.1021/bi992070s; Rettig M, 2010, ORG BIOMOL CHEM, V8, P3179, DOI 10.1039/c001893g; Rettig M, 2009, BIOCHEMISTRY-US, V48, P12223, DOI 10.1021/bi901655t; Rettig M, 2009, BIOORGAN MED CHEM, V17, P919, DOI 10.1016/j.bmc.2008.11.033; Reyes S, 2011, ORG BIOMOL CHEM, V9, P3041, DOI 10.1039/c0ob00925c; Rezler EM, 2003, ANNU REV PHARMACOL, V43, P359, DOI 10.1146/annurev.pharmtox.43.100901.135733; Rosu F, 2002, RAPID COMMUN MASS SP, V16, P1729, DOI 10.1002/rcm.778; Rosu F, 2010, NUCLEIC ACIDS RES, V38, P5217, DOI 10.1093/nar/gkq208; Rujan IN, 2005, NUCLEIC ACIDS RES, V33, P2022, DOI 10.1093/nar/gki345; SUH D, 1995, BIOORGAN MED CHEM, V3, P723, DOI 10.1016/0968-0896(95)00053-J; Tajmir-Riahi HA, 2005, J IRAN CHEM SOC, V2, P78, DOI 10.1007/BF03247200; Thurston D. E., 1993, MOL ASPECTS ANTICANC, P54; Todd AK, 2007, NUCLEIC ACIDS RES, V35, P5799, DOI 10.1093/nar/gkm609; Tuntiwechapikul W, 2001, J AM CHEM SOC, V123, P5606, DOI 10.1021/ja0156439; Viglasky V, 2010, BIOCHEMISTRY-US, V49, P2110, DOI 10.1021/bi902099u; Wang LH, 2011, ORG BIOMOL CHEM, V9, P2648, DOI 10.1039/c0ob00961j; WILLIAMSON JR, 1994, ANNU REV BIOPH BIOM, V23, P703, DOI 10.1146/annurev.bb.23.060194.003415; Yuan G, 2011, MASS SPECTROM REV, V30, P1121, DOI 10.1002/mas.20315	61	19	20	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35920	10.1371/journal.pone.0035920	http://dx.doi.org/10.1371/journal.pone.0035920			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558271	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336000085
J	van Eerde, AM; Duran, K; van Riel, E; de Kovel, CGF; Koeleman, BPC; Knoers, NVAM; Renkema, KY; van der Horst, HJR; Bokenkamp, A; van Hagen, JM; van den Berg, LH; Wolffenbuttel, KP; van den Hoek, J; Feitz, WF; de Jong, TPVM; Giltay, JC; Wijmenga, C				van Eerde, Albertien M.; Duran, Karen; van Riel, Els; de Kovel, Carolien G. F.; Koeleman, Bobby P. C.; Knoers, Nine V. A. M.; Renkema, Kirsten Y.; van der Horst, Henricus J. R.; Bokenkamp, Arend; van Hagen, Johanna M.; van den Berg, Leonard H.; Wolffenbuttel, Katja P.; van den Hoek, Joop; Feitz, Wouter F.; de Jong, Tom P. V. M.; Giltay, Jacques C.; Wijmenga, Cisca			Genes in the Ureteric Budding Pathway: Association Study on Vesico-Ureteral Reflux Patients	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; KIDNEY BRANCHING MORPHOGENESIS; UROPLAKIN-III GENE; TRACT MALFORMATIONS; COMPLEX TRAITS; LINKAGE; MUTATIONS; DISEASE; ROBO2; POLYMORPHISM	Vesico-ureteral reflux (VUR) is the retrograde passage of urine from the bladder to the urinary tract and causes 8.5% of end-stage renal disease in children. It is a complex genetic developmental disorder, in which ectopic embryonal ureteric budding is implicated in the pathogenesis. VUR is part of the spectrum of Congenital Anomalies of the Kidney and Urinary Tract (CAKUT). We performed an extensive association study for primary VUR using a two-stage, case-control design, investigating 44 candidate genes in the ureteric budding pathway in 409 Dutch VUR patients. The 44 genes were selected from the literature and a set of 567 single nucleotide polymorphisms (SNPs) capturing their genetic variation was genotyped in 207 cases and 554 controls. The 14 SNPs with p<0.005 were included in a follow-up study in 202 cases and 892 controls. Of the total cohort, similar to 50% showed a clear-cut primary VUR phenotype and similar to 25% had both a duplex collecting system and VUR. We also looked for association in these two extreme phenotype groups. None of the SNPs reached a significant p-value. Common genetic variants in four genes (GREM1, EYA1, ROBO2 and UPK3A) show a trend towards association with the development of primary VUR (GREM1, EYA1, ROBO2) or duplex collecting system (EYA1 and UPK3A). SNPs in three genes (TGFB1, GNB3 and VEGFA) have been shown to be associated with VUR in other populations. Only the result of rs1800469 in TGFB1 hinted at association in our study. This is the first extensive study of common variants in the genes of the ureteric budding pathway and the genetic susceptibility to primary VUR.	[van Eerde, Albertien M.; Duran, Karen; van Riel, Els; de Kovel, Carolien G. F.; Koeleman, Bobby P. C.; Knoers, Nine V. A. M.; Renkema, Kirsten Y.; Giltay, Jacques C.; Wijmenga, Cisca] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [van der Horst, Henricus J. R.] Vrije Univ Amsterdam Med Ctr, Dept Pediat Urol, Amsterdam, Netherlands; [Bokenkamp, Arend] Vrije Univ Amsterdam Med Ctr, Dept Pediat Nephrol, Amsterdam, Netherlands; [van Hagen, Johanna M.] Vrije Univ Amsterdam Med Ctr, Dept Human Genet, Amsterdam, Netherlands; [van den Berg, Leonard H.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, Utrecht, Netherlands; [Wolffenbuttel, Katja P.; van den Hoek, Joop] Erasmus MC, Sophia Childrens Hosp, Dept Pediat Urol, Rotterdam, Netherlands; [Feitz, Wouter F.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, Pediat Urol Ctr, NL-6525 ED Nijmegen, Netherlands; [de Jong, Tom P. V. M.] Univ Med Ctr Utrecht, Pediat Renal Ctr, Amsterdam, Netherlands; [de Jong, Tom P. V. M.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Wijmenga, Cisca] Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Wijmenga, Cisca] Univ Groningen, NL-9700 AB Groningen, Netherlands	Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; University of Groningen	van Eerde, AM (corresponding author), Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands.	a.vaneerde@umcutrecht.nl	Feitz, W.F.J./H-8028-2014; Wijmenga, Cisca/D-2173-2009; de Jong, Tom/AAG-5659-2020; Renkema, Kirsten Y./V-2385-2019; Wijmenga, Cisca/AAE-7719-2019; de Kovel, Carolien/AAI-3531-2021	Wijmenga, Cisca/0000-0002-5635-1614; de Kovel, Carolien/0000-0002-7818-1396; van Eerde, Albertien M./0000-0001-5953-5956; Renkema, Kirsten/0000-0003-3922-9382; de Jong, Tom P.V.M./0000-0002-9091-1099	Nuts-Ohra [0801-061]; Dutch Kidney Foundation [C02.2009]	Nuts-Ohra; Dutch Kidney Foundation	The study was supported by a grant from Nuts-Ohra (0801-061, http://www.fondsnutsohra.nl). Collecting of samples was partly supported by a grant from the Dutch Kidney Foundation (C02.2009, http://www.nierstichting.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhak S, 1997, NAT GENET, V15, P157, DOI 10.1038/ng0297-157; [Anonymous], 1996, LANCET, V348, P725; Bertoli-Avella AM, 2008, J AM SOC NEPHROL, V19, P825, DOI 10.1681/ASN.2007060692; Briggs CE, 2010, EUR J HUM GENET, V18, P245, DOI 10.1038/ejhg.2009.142; BURGER RH, 1972, J UROLOGY, V108, P249, DOI 10.1016/S0022-5347(17)60702-X; Chang EH, 2004, HUM MUTAT, V23, P582, DOI 10.1002/humu.20048; CHAPMAN CJ, 1985, AM J MED GENET, V20, P577, DOI 10.1002/ajmg.1320200403; Conte ML, 2008, PEDIATR NEPHROL, V23, P587, DOI 10.1007/s00467-007-0675-z; Cordell HJ, 2010, J AM SOC NEPHROL, V21, P113, DOI 10.1681/ASN.2009060624; Feather SA, 2000, AM J HUM GENET, V66, P1420, DOI 10.1086/302864; Giltay JC, 2004, J UROLOGY, V171, P931, DOI 10.1097/01.ju.0000094802.50650.3d; Grieshammer U, 2004, DEV CELL, V6, P709, DOI 10.1016/S1534-5807(04)00108-X; Hains DS, 2010, J UROLOGY, V183, P2077, DOI 10.1016/j.juro.2009.12.095; Hollowell JG, 2002, J UROLOGY, V168, P2138, DOI 10.1016/S0022-5347(05)64337-6; Hu P, 2000, J CELL BIOL, V151, P961, DOI 10.1083/jcb.151.5.961; Ichikawa I, 2002, KIDNEY INT, V61, P889, DOI 10.1046/j.1523-1755.2002.00188.x; Jenkins D, 2005, J AM SOC NEPHROL, V16, P2141, DOI 10.1681/ASN.2004090776; Jiang SS, 2004, KIDNEY INT, V66, P10, DOI 10.1111/j.1523-1755.2004.00703.x; Kaefer M, 2000, PEDIATRICS, V105, P800, DOI 10.1542/peds.105.4.800; Kelly H, 2007, J MED GENET, V44, P710, DOI 10.1136/jmg.2007.051086; Kelly H, 2005, EUR J HUM GENET, V13, P500, DOI 10.1038/sj.ejhg.5201322; Kuroda S, 2007, J UROLOGY, V178, P1650, DOI 10.1016/j.juro.2007.03.199; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Lu BC, 2009, NAT GENET, V41, P1295, DOI 10.1038/ng.476; Lu WN, 2007, AM J HUM GENET, V80, P616, DOI 10.1086/512735; MACKIE GG, 1975, J UROLOGY, V114, P274, DOI 10.1016/S0022-5347(17)67007-1; McCarthy MI, 2008, DIABETES, V57, P2889, DOI 10.2337/db08-0343; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Michos O, 2007, DEVELOPMENT, V134, P2397, DOI 10.1242/dev.02861; MIDDLETON GW, 1975, J UROLOGY, V114, P36, DOI 10.1016/S0022-5347(17)66937-4; Miklovicova D, 2005, PEDIATR NEPHROL, V20, P1136, DOI 10.1007/s00467-005-1896-7; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Murawski IJ, 2006, CLIN GENET, V69, P105, DOI 10.1111/j.1399-0004.2005.00562.x; Murawski IJ, 2008, PEDIATR NEPHROL, V23, P1021, DOI 10.1007/s00467-007-0704-y; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; NOE HN, 1992, J UROLOGY, V148, P1869, DOI 10.1016/S0022-5347(17)37053-2; NOE HN, 1992, J UROLOGY, V148, P1739, DOI 10.1016/S0022-5347(17)37017-9; Pasch A, 2004, NEPHROL DIAL TRANSPL, V19, P3172, DOI 10.1093/ndt/gfh514; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Sanna-Cherchi S, 2005, J AM SOC NEPHROL, V16, P1781, DOI 10.1681/ASN.2004121034; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; Schonfelder EM, 2006, AM J KIDNEY DIS, V47, P1004, DOI 10.1053/j.ajkd.2006.02.177; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Schuchardt A, 1996, DEVELOPMENT, V122, P1919; Sims-Lucas S, 2009, AM J PHYSIOL-RENAL, V297, pF1208, DOI 10.1152/ajprenal.00262.2009; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Smith RJH, 2010, GENEREVIEWS     0323; Solari V, 2005, J UROLOGY, V174, P1609, DOI 10.1097/01.ju.0000179385.64585.dc; van der Zanden LFM, 2011, NAT GENET, V43, P48, DOI 10.1038/ng.721; van Eerde AM, 2007, PEDIATR NEPHROL, V22, P1129, DOI 10.1007/s00467-007-0492-4; van Es MA, 2007, LANCET NEUROL, V6, P869, DOI 10.1016/S1474-4422(07)70222-3; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Williams G, 2008, J AM SOC NEPHROL, V19, P847, DOI 10.1681/ASN.2007020245; WINTER RM, 2006, WINTER BARAITSER DYS; Woolf AS, 2002, PEDIATR DEVEL PATHOL, V5, P108, DOI 10.1007/s10024-001-0141-z; Xu PX, 1999, NAT GENET, V23, P113, DOI 10.1038/12722; Yim HE, 2007, PEDIATR RES, V62, P183, DOI 10.1203/PDR.0b013e31809871f1; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zagradisnik B, 2004, ANN GENET-PARIS, V47, P209, DOI 10.1016/j.anngen.2004.04.003; Zu SL, 2009, PEDIATR NEPHROL, V24, P1501, DOI 10.1007/s00467-009-1179-9	62	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e31327	10.1371/journal.pone.0031327	http://dx.doi.org/10.1371/journal.pone.0031327			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558067	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336000002
J	Charlton, BD; Filippi, P; Fitch, WT				Charlton, Benjamin D.; Filippi, Piera; Fitch, W. Tecumseh			Do Women Prefer More Complex Music around Ovulation?	PLOS ONE			English	Article							MENSTRUAL-CYCLE; AESTHETIC PREFERENCE; SEXUAL SELECTION; HUMAN MALES; EVOLUTION; VOICE; ATTRACTIVENESS; FREQUENCIES; CONCEPTION; PERCEPTION	The evolutionary origins of music are much debated. One theory holds that the ability to produce complex musical sounds might reflect qualities that are relevant in mate choice contexts and hence, that music is functionally analogous to the sexually-selected acoustic displays of some animals. If so, women may be expected to show heightened preferences for more complex music when they are most fertile. Here, we used computer-generated musical pieces and ovulation predictor kits to test this hypothesis. Our results indicate that women prefer more complex music in general; however, we found no evidence that their preference for more complex music increased around ovulation. Consequently, our findings are not consistent with the hypothesis that a heightened preference/bias in women for more complex music around ovulation could have played a role in the evolution of music. We go on to suggest future studies that could further investigate whether sexual selection played a role in the evolution of this universal aspect of human culture.	[Charlton, Benjamin D.; Fitch, W. Tecumseh] Univ Vienna, Dept Cognit Biol, Vienna, Austria; [Filippi, Piera] Univ Palermo, Dept Philosophy & Mus, Palermo, Italy	University of Vienna; University of Palermo	Charlton, BD (corresponding author), Univ Vienna, Dept Cognit Biol, Vienna, Austria.	benjamin.charlton@univie.ac.at		Charlton, Benjamin/0000-0002-0218-7177	European Research Council Advanced Grant SOMACCA [230604]	European Research Council Advanced Grant SOMACCA	BDC was supported by a European Research Council Advanced Grant SOMACCA (No. 230604) awarded to WTF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, FRACTALS CHAOS POWER; Apicella CL, 2009, P ROY SOC B-BIOL SCI, V276, P1077, DOI 10.1098/rspb.2008.1542; Beauvois MW, 2007, MUSIC PERCEPT, V24, P247, DOI 10.1525/MP.2007.24.3.247; Chapin H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013812; Darwin C., 1871, P423; Evans S, 2006, BIOL PSYCHOL, V72, P160, DOI 10.1016/j.biopsycho.2005.09.003; Evans S, 2008, PHYSIOL BEHAV, V93, P783, DOI 10.1016/j.physbeh.2007.11.033; Falk D, 2000, ORIGINS OF MUSIC, P197; Feinberg DR, 2006, HORM BEHAV, V49, P215, DOI 10.1016/j.yhbeh.2005.07.004; Feinberg DR, 2005, ANIM BEHAV, V69, P561, DOI 10.1016/j.anbehav.2004.06.012; Fitch WT, 2007, MUSIC PERCEPT, V25, P43, DOI 10.1525/mp.2007.25.1.43; Fitch WT, 2006, COGNITION, V100, P173, DOI 10.1016/j.cognition.2005.11.009; Gaab N, 2003, J COGNITIVE NEUROSCI, V15, P810, DOI 10.1162/089892903322370735; Gangestad SW, 2008, P ROY SOC B-BIOL SCI, V275, P991, DOI 10.1098/rspb.2007.1425; Gangestad SW, 2007, J PERS SOC PSYCHOL, V92, P151, DOI 10.1037/0022-3514.92.1.151; Haselton MG, 2006, HUM NATURE-INT BIOS, V17, P50, DOI 10.1007/s12110-006-1020-0; HEYDUK RG, 1975, PERCEPT PSYCHOPHYS, V17, P84, DOI 10.3758/BF03204003; KONECNI VJ, 1976, J EXP PSYCHOL HUMAN, V2, P347, DOI 10.1037/0096-1523.2.3.347; LONGUETHIGGINS HC, 1984, MUSIC PERCEPT, V1, P424; Lynch CD, 2006, PAEDIATR PERINAT EP, V20, P3, DOI 10.1111/j.1365-3016.2006.00765.x; McDermott J, 2005, MUSIC PERCEPT, V23, P29, DOI 10.1525/mp.2005.23.1.29; McDermott J, 2008, NATURE, V453, P287, DOI 10.1038/453287a; MEADOWCROFT JM, 1987, COMMUN RES, V14, P204, DOI 10.1177/009365087014002004; Merker B, 2000, ORIGINS OF MUSIC, P315; Miller G, 2000, ORIGINS OF MUSIC, P329; Nettl Bruno, 1956, MUSIC PRIMITIVE CULT; North A. C., 1995, PSYCHOMUSICOLOGY, V14, P77, DOI DOI 10.1037/H0094090; Orr M.G., 2001, PSYCHOL MUSIC, V29, P108, DOI DOI 10.1177/0305735601292002; Orr MG, 2005, MUSIC PERCEPT, V22, P583, DOI 10.1525/mp.2005.22.4.583; Pinker S., 1997, MIND WORKS; Ryan MJ, 1998, SCIENCE, V281, P1999, DOI 10.1126/science.281.5385.1999; Sanders G, 1998, NEUROPSYCHOLOGIA, V36, P869, DOI 10.1016/S0028-3932(98)00022-0; Sluming VA, 2000, EVOL HUM BEHAV, V21, P1; SMITH JD, 1990, COGNITION, V34, P279, DOI 10.1016/0010-0277(90)90007-7; SMITH JM, 1991, TRENDS ECOL EVOL, V6, P146, DOI 10.1016/0169-5347(91)90055-3; Steck L, 1975, J EXPT PSYCHOL HUMAN, V1, P170; Trehub SE, 2003, NAT NEUROSCI, V6, P669, DOI 10.1038/nn1084; TREHUB SE, 2001, MUSIC SCI, P37; TURINO T, 1983, LAT AM MUSIC REV, V4, P81, DOI 10.2307/780281; VITZ PC, 1966, J EXP PSYCHOL, V71, P74, DOI 10.1037/h0022619; WILCOX AJ, 1995, NEW ENGL J MED, V333, P1517, DOI 10.1056/NEJM199512073332301; Ziv N, 2009, CREATIVITY RES J, V21, P125, DOI 10.1080/10400410802633764; [No title captured]	43	14	14	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35626	10.1371/journal.pone.0035626	http://dx.doi.org/10.1371/journal.pone.0035626			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VP	22558181	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000305345200056
J	Kuo, YR; Chen, CC; Goto, S; Huang, YT; Wang, CT; Tsai, CC; Chen, CL				Kuo, Yur-Ren; Chen, Chien-Chang; Goto, Shigeru; Huang, Yu-Ting; Wang, Chun-Ting; Tsai, Chia-Chun; Chen, Chao-Long			Immunomodulatory Effects of Bone Marrow-Derived Mesenchymal Stem Cells in a Swine Hemi-Facial Allotransplantation Model	PLOS ONE			English	Article							COMPOSITE TISSUE ALLOGRAFT; T-CELLS; SURVIVAL; MODULATION; INHIBIT; PLAY	Background: In this study, we investigated whether the infusion of bone marrow-derived mesenchymal stem cells (MSCs), combined with transient immunosuppressant treatment, could suppress allograft rejection and modulate T-cell regulation in a swine orthotopic hemi-facial composite tissue allotransplantation (CTA) model. Methodology/Principal Findings: Outbred miniature swine underwent hemi-facial allotransplantation (day 0). Group-I (n = 5) consisted of untreated control animals. Group-II (n = 3) animals received MSCs alone (given on days -1, +1, +3, +7, +14, and +21). Group-III (n = 3) animals received CsA (days 0 to +28). Group-IV (n = 5) animals received CsA (days 0 to +28) and MSCs (days -1, +1, +3, +7, +14, and +21). The transplanted face tissue was observed daily for signs of rejection. Biopsies of donor tissues and recipient blood sample were obtained at specified predetermined times (per 2 weeks post-transplant) or at the time of clinically evident rejection. Our results indicated that the MSC-CsA group had significantly prolonged allograft survival compared to the other groups (P<0.001). Histological examination of the MSC-CsA group displayed the lowest degree of rejection in alloskin and lymphoid gland tissues. TNF-alpha expression in circulating blood revealed significant suppression in the MSC and MSC-CsA treatment groups, as compared to that in controls. IHC staining showed CD45 and IL-6 expression were significantly decreased in MSC-CsA treatment groups compared to controls. The number of CD4+/CD25+ regulatory T-cells and IL-10 expressions in the circulating blood significantly increased in the MSC-CsA group compared to the other groups. IHC staining of alloskin tissue biopsies revealed a significant increase in the numbers of foxp3(+)T-cells and TGF-beta 1 positive cells in the MSC-CsA group compared to the other groups. Conclusions: These results demonstrate that MSCs significantly prolong hemifacial CTA survival. Our data indicate the MSCs did not only suppress inflammation and acute rejection of CTA, but also modulate T-cell regulation and related cytokines expression.	[Kuo, Yur-Ren; Chen, Chien-Chang; Huang, Yu-Ting; Wang, Chun-Ting; Tsai, Chia-Chun] Kaohsiung Chang Gung Mem Hosp, Ctr Composite Tissue Allotransplantat, Kaohsiung, Taiwan; [Kuo, Yur-Ren; Chen, Chien-Chang; Goto, Shigeru; Huang, Yu-Ting; Wang, Chun-Ting; Tsai, Chia-Chun; Chen, Chao-Long] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Kuo, Yur-Ren; Chen, Chien-Chang; Huang, Yu-Ting; Wang, Chun-Ting; Tsai, Chia-Chun] Kaohsiung Chang Gung Mem Hosp, Dept Plast & Reconstruct Surg, Kaohsiung, Taiwan; [Goto, Shigeru; Chen, Chao-Long] Kaohsiung Chang Gung Mem Hosp, Liver Transplantat Program, Kaohsiung, Taiwan; [Goto, Shigeru; Chen, Chao-Long] Kaohsiung Chang Gung Mem Hosp, Dept Surg, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Kuo, YR (corresponding author), Kaohsiung Chang Gung Mem Hosp, Ctr Composite Tissue Allotransplantat, Kaohsiung, Taiwan.	t1207816@ms22.hinet.net			Chang Gung Research Project, Taiwan [CMRPG-850081, CMRPG-860452]; Kaohsiung Chang Gung Memorial Hospital	Chang Gung Research Project, Taiwan; Kaohsiung Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported in part by Contract No. grant CMRPG-850081 and CMRPG-860452 from the Chang Gung Research Project, Taiwan (Internal funding from Kaohsiung Chang Gung Memorial Hospital). No external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Amarnath S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018885; Cendales LC, 2008, AM J TRANSPLANT, V8, P1396, DOI 10.1111/j.1600-6143.2008.02243.x; English K, 2009, CLIN EXP IMMUNOL, V156, P149, DOI 10.1111/j.1365-2249.2009.03874.x; Kakinuma S, 2009, J GASTROENTEROL, V44, P167, DOI 10.1007/s00535-008-2297-z; Kim YH, 2011, MOL MED, V17, P697, DOI 10.2119/molmed.2010.00098; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Kuo YR, 2011, PLAST RECONSTR SURG, V128, p661E, DOI 10.1097/PRS.0b013e318230c60b; Kuo YR, 2011, PLAST RECONSTR SURG, V127, P569, DOI 10.1097/PRS.0b013e318200a92c; Kuo YR, 2009, TRANSPLANTATION, V87, P1769, DOI 10.1097/TP.0b013e3181a664f1; Kuo Yur-Ren, 2006, Chang Gung Med J, V29, P268; Kuo YR, 2009, J SURG RES, V153, P317, DOI 10.1016/j.jss.2008.05.034; Kuo YR, 2009, J SURG RES, V153, P268, DOI 10.1016/j.jss.2008.03.050; LEE WPA, 1991, PLAST RECONSTR SURG, V87, P401, DOI 10.1097/00006534-199103000-00001; Mathes DW, 2003, TRANSPLANTATION, V75, P25, DOI 10.1097/00007890-200301150-00005; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Parekkadan B, 2008, STEM CELLS, V26, P1913, DOI 10.1634/stemcells.2007-0790; Patel SA, 2008, ARCH IMMUNOL THER EX, V56, P1, DOI 10.1007/s00005-008-0001-x; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Sbano P, 2008, ARCH DERMATOL RES, V300, P115, DOI 10.1007/s00403-007-0827-9	20	48	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35459	10.1371/journal.pone.0035459	http://dx.doi.org/10.1371/journal.pone.0035459			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558153	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345200042
J	Luchetti, F; Canonico, B; Arcangeletti, M; Guescini, M; Cesarini, E; Stocchi, V; Degli Esposti, M; Papa, S				Luchetti, Francesca; Canonico, Barbara; Arcangeletti, Marcella; Guescini, Michele; Cesarini, Erica; Stocchi, Vilberto; Degli Esposti, Mauro; Papa, Stefano			Fas Signalling Promotes Intercellular Communication in T Cells	PLOS ONE			English	Article							MEMBRANE NANOTUBES; SURFACE MOLECULES; IMMUNE CELLS; TROGOCYTOSIS; VESICLES; FRAGMENTS; PROTEINS; CAPTURE; LIGAND; DEATH	Cell-to-cell communication is a fundamental process for development and maintenance of multicellular organisms. Diverse mechanisms for the exchange of molecular information between cells have been documented, such as the exchange of membrane fragments (trogocytosis), formation of tunneling nanotubes (TNTs) and release of microvesicles (MVs). In this study we assign to Fas signalling a pivotal role for intercellular communication in CD4+ T cells. Binding of membrane-bound FasL to Fas expressing target cells triggers a well-characterized pro-apoptotic signalling cascade. However, our results, pairing up flow cytometric studies with confocal microscopy data, highlight a new social dimension for Fas/FasL interactions between CD4+ T cells. Indeed, FasL enhances the formation of cell conjugates (8 fold of increase) in an early time-frame of stimulation (30 min), and this phenomenon appears to be a crucial step to prime intercellular communication. Our findings show that this communication mainly proceeds along a cytosolic material exchange (ratio of exchange >10, calculated as ratio of stimulated cells signal divided by that recorded in control cells) via TNTs and MVs release. In particular, inhibition of TNTs genesis by pharmacological agents (Latruculin A and Nocodazole) markedly reduced this exchange (inhibition percentage: >40% and >50% respectively), suggesting a key role for TNTs in CD4+ T cells communication. Although MVs are present in supernatants from PHA-activated T cells, Fas treatment also leads to a significant increase in the amount of released MVs. In fact, the co-culture performed between MVs and untreated cells highlights a higher presence of MVs in the medium (1.4 fold of increase) and a significant MVs uptake (6 fold of increase) by untreated T lymphocytes. We conclude that Fas signalling induces intercellular communication in CD4+ T cells by different mechanisms that seem to start concomitantly with the main pathway (programmed cell death) promoted by FasL.	[Luchetti, Francesca; Canonico, Barbara; Arcangeletti, Marcella; Cesarini, Erica; Papa, Stefano] Univ Urbino Carlo Bo, Dept Earth Life & Environm Sci, Urbino, Italy; [Guescini, Michele; Stocchi, Vilberto] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, Italy; [Degli Esposti, Mauro] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Degli Esposti, Mauro] IIT Genova, Genoa, Italy	University of Urbino; University of Urbino; University of Manchester; Istituto Italiano di Tecnologia - IIT	Luchetti, F (corresponding author), Univ Urbino Carlo Bo, Dept Earth Life & Environm Sci, Urbino, Italy.	francesca.luchetti@uniurb.it	sourisseau, marion/M-7542-2014; Guescini, Michele/L-1297-2019	Guescini, Michele/0000-0001-9372-7038; Canonico, Barbara/0000-0003-3383-715X; Degli Esposti, Mauro/0000-0002-0977-119X	University of Urbino	University of Urbino	The research was supported by University of Urbino. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkwright PD, 2010, CELL RES, V20, P72, DOI 10.1038/cr.2009.112; Aucher A, 2008, BLOOD, V111, P5621, DOI 10.1182/blood-2008-01-134155; Belting M, 2008, J CELL BIOL, V183, P1187, DOI 10.1083/jcb.200810038; Blott EJ, 2001, J CELL SCI, V114, P2405; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Canonico B, 2012, CYTOM PART A, V81A, P5, DOI 10.1002/cyto.a.21151; Canonico B, 2010, CYTOM PART B-CLIN CY, V78B, P267, DOI 10.1002/cyto.b.20510; Daubeuf S, 2006, NAT PROTOC, V1, P2536, DOI 10.1038/nprot.2006.400; Daubeuf S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008716; Daubeuf S, 2009, CYTOM PART A, V75A, P380, DOI 10.1002/cyto.a.20679; Davis DM, 2008, NAT REV MOL CELL BIO, V9, P431, DOI 10.1038/nrm2399; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Domhan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021283; FUKUDA M, 1991, J BIOL CHEM, V266, P21327; Fulcher DA, 1999, IMMUNOL CELL BIOL, V77, P559, DOI 10.1046/j.1440-1711.1999.00870.x; Guescini M, 2010, EXP CELL RES, V316, P1977, DOI 10.1016/j.yexcr.2010.04.006; Gurke S, 2008, HISTOCHEM CELL BIOL, V129, P539, DOI 10.1007/s00418-008-0412-0; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Herr I, 2000, ONCOGENE, V19, P4255, DOI 10.1038/sj.onc.1203776; Hudrisier D, 2007, J IMMUNOL, V178, P3637, DOI 10.4049/jimmunol.178.6.3637; Hwang I, 2000, J EXP MED, V191, P1137, DOI 10.1084/jem.191.7.1137; Hwang IY, 2003, P NATL ACAD SCI USA, V100, P6670, DOI 10.1073/pnas.1131852100; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; Kassahn D, 2009, CELL DEATH DIFFER, V16, P115, DOI 10.1038/cdd.2008.133; Lee TH, 2011, SEMIN IMMUNOPATHOL, V33, P455, DOI 10.1007/s00281-011-0250-3; LeMaoult J, 2007, HUM IMMUNOL, V68, P240, DOI 10.1016/j.humimm.2006.11.001; LORBER MI, 1982, J IMMUNOL, V128, P2798; Luchetti F, 2009, FREE RADICAL BIO MED, V46, P339, DOI 10.1016/j.freeradbiomed.2008.09.017; Onfelt B, 2004, J IMMUNOL, V173, P1511, DOI 10.4049/jimmunol.173.3.1511; Onfelt B, 2006, J IMMUNOL, V177, P8476, DOI 10.4049/jimmunol.177.12.8476; Ouasti S, 2007, CELL DEATH DIFFER, V14, P453, DOI 10.1038/sj.cdd.4402043; Poupot M, 2003, J IMMUNOL, V171, P2517, DOI 10.4049/jimmunol.171.5.2517; Puaux AL, 2006, EUR J IMMUNOL, V36, P779, DOI 10.1002/eji.200535407; Quesenberry PJ, 2010, ADV DRUG DELIVER REV, V62, P1141, DOI 10.1016/j.addr.2010.06.001; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Sarkar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007140; Sourisseau M, 2007, J VIROL, V81, P1000, DOI 10.1128/JVI.01629-06; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Sowinski S, 2011, METHODS, V53, P27, DOI 10.1016/j.ymeth.2010.04.002; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Suss G, 1996, J EXP MED, V183, P1789, DOI 10.1084/jem.183.4.1789; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Veranic P, 2008, BIOPHYS J, V95, P4416, DOI 10.1529/biophysj.108.131375; Wang Y, 2011, CELL DEATH DIFFER, V18, P732, DOI 10.1038/cdd.2010.147; Waschbisch A, 2009, J NEUROIMMUNOL, V209, P131, DOI 10.1016/j.jneuroim.2009.02.005; Watkins SC, 2005, IMMUNITY, V23, P309, DOI 10.1016/j.immuni.2005.08.009; Zhang J, 2004, CELL MOL IMMUNOL, V1, P186	51	35	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35766	10.1371/journal.pone.0035766	http://dx.doi.org/10.1371/journal.pone.0035766			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558220	gold, Green Submitted, Green Published			2022-12-27	WOS:000305345200076
J	Feng, T; Cong, YZ; Alexander, K; Elson, CO				Feng, Ting; Cong, Yingzi; Alexander, Katie; Elson, Charles O.			Regulation of Toll-like Receptor 5 Gene Expression and Function on Mucosal Dendritic Cells	PLOS ONE			English	Article							BACTERIAL FLAGELLIN; T-CELLS; INNATE IMMUNITY; HUMAN INTESTINE; RETINOIC-ACID; SALMONELLA; MICROBIOTA; ADJUVANT; DISEASE; TLR5	Toll-like receptor (TLR) 5 has been shown to maintain intestinal homeostasis and regulate host defense against enterobacterial infection. However, how TLR5 expression is regulated and its function in the intestine have not been fully elucidated. Here we demonstrate that mucosal dendritic cells (DCs), but not splenic DCs, express high levels of TLR5 protein. Alternatively spliced Tlr5 transcripts were identified but it did not explain the selective expression of TLR5 on mucosal DCs. Treatment with various bacterial ligands downregulated BMDC TLR5 expression, while retinoic acid and host stromal cell-derived signals promoted TLR5 expression in a TGF-beta-independent mechanism. Signaling through TLR5 restrained regulatory T (Treg) cell generation, and accordingly, TLR5(-/-) mice displayed increased frequencies of Foxp3(+) Treg cells in the intestinal lamina propria. Our data indicate that bacterial and host factors differentially regulate DC TLR5 expression. TLR5 signaling regulates immune responses towards the microbiota via modulation of the Treg/effector T cell balance.	[Feng, Ting; Cong, Yingzi; Alexander, Katie; Elson, Charles O.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Feng, Ting; Cong, Yingzi; Alexander, Katie; Elson, Charles O.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Cong, Yingzi] Univ Texas Med Branch, Dept Microbiol Immunol, Galveston, TX USA; [Cong, Yingzi] Univ Texas Med Branch, Dept Pathol, Galveston, TX USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Feng, T (corresponding author), Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA.	coelson@uab.edu		Cong, Yingzi/0000-0003-4167-7395	National Institutes of Health (NIH) [DK071176, DK079918, RR20136]; Digestive Diseases Research Development Center [DK064400]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR020136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079918, R24DK064400, P01DK071176] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Diseases Research Development Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) grants DK071176 and DK079918, Digestive Diseases Research Development Center grant DK064400, and NIH RR20136. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Anz D, 2010, J IMMUNOL, V184, P939, DOI 10.4049/jimmunol.0901245; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bates JT, 2009, J IMMUNOL, V182, P7539, DOI 10.4049/jimmunol.0804225; Blumberg RS, 2009, DIGEST DIS, V27, P455, DOI 10.1159/000235851; Bosshart H, 2007, ANN NY ACAD SCI, V1096, P1, DOI 10.1196/annals.1397.064; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Cario E, 2005, GUT, V54, P1182, DOI 10.1136/gut.2004.062794; Cario E, 2010, INFLAMM BOWEL DIS, V16, P1583, DOI 10.1002/ibd.21282; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Elson CO, 2007, GASTROENTEROLOGY, V132, P2359, DOI 10.1053/j.gastro.2007.03.104; Feng T, 2010, J IMMUNOL IN PRESS; Feng T, 2010, J EXP MED, V207, P1321, DOI 10.1084/jem.20092253; Fitzgerald KA, 2006, CELL, V125, P834, DOI 10.1016/j.cell.2006.05.014; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Gewirtz AT, 2006, CURR OPIN GASTROEN, V22, P8, DOI 10.1097/01.mog.0000194791.59337.28; Goodman WA, 2009, J IMMUNOL, V183, P3170, DOI 10.4049/jimmunol.0803721; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Jordan T, 2002, TRENDS PLANT SCI, V7, P392, DOI 10.1016/S1360-1385(02)02311-7; Kelsall BL, 2005, IMMUNOL REV, V206, P132, DOI 10.1111/j.0105-2896.2005.00292.x; Konrad A, 2006, GASTROENTEROLOGY, V130, P2050, DOI 10.1053/j.gastro.2006.02.055; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; McSorley SJ, 2002, J IMMUNOL, V169, P3914, DOI 10.4049/jimmunol.169.7.3914; Means TK, 2003, J IMMUNOL, V170, P5165, DOI 10.4049/jimmunol.170.10.5165; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Qin HW, 2009, J IMMUNOL, V183, P97, DOI 10.4049/jimmunol.0801986; Rakoff-Nahoum S, 2008, MUCOSAL IMMUNOL, V1, pS10, DOI 10.1038/mi.2008.49; Sanders CJ, 2006, J IMMUNOL, V177, P2810, DOI 10.4049/jimmunol.177.5.2810; Santaolalla R, 2012, CURR OPIN GASTROEN, V28, P124, DOI 10.1097/MOG.0b013e3283506559; Sebastiani G, 2000, GENOMICS, V64, P230, DOI 10.1006/geno.2000.6115; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; Strober W, 2009, IMMUNITY, V31, P377, DOI 10.1016/j.immuni.2009.09.001; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Targan SR, 2005, GASTROENTEROLOGY, V128, P2020, DOI 10.1053/j.gastro.2005.03.046; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Van Maele L, 2010, J IMMUNOL, V185, P1177, DOI 10.4049/jimmunol.1000115; Vijay-Kumar M, 2008, J IMMUNOL, V180, P8280, DOI 10.4049/jimmunol.180.12.8280; Zeng H, 2003, J IMMUNOL, V171, P3668, DOI 10.4049/jimmunol.171.7.3668; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	47	27	30	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35918	10.1371/journal.pone.0035918	http://dx.doi.org/10.1371/journal.pone.0035918			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545147	gold, Green Submitted, Green Published			2022-12-27	WOS:000305343200067
J	Gomez, A; Luckey, D; Yeoman, CJ; Marietta, EV; Miller, MEB; Murray, JA; White, BA; Taneja, V				Gomez, Andres; Luckey, David; Yeoman, Carl J.; Marietta, Eric V.; Miller, Margret E. Berg; Murray, Joseph A.; White, Bryan A.; Taneja, Veena			Loss of Sex and Age Driven Differences in the Gut Microbiome Characterize Arthritis-Susceptible*0401 Mice but Not Arthritis-Resistant*0402 Mice	PLOS ONE			English	Article							GENETIC SUSCEPTIBILITY; FECAL MICROFLORA; RIBOSOMAL-RNA; SP-NOV.; ARTHRITIS; IMMUNITY; BIFIDOBACTERIUM; MECHANISMS; EXPRESSION; DIVERSITY	Background: HLA-DRB1* 0401 is associated with susceptibility, while HLA-DRB1* 0402 is associated with resistance to developing rheumatoid arthritis (RA) and collagen-induced arthritis in humans and transgenic mice respectively. The influence of gut-joint axis has been suggested in RA, though not yet proven. Methodology/Principal Findings: We have used HLA transgenic mice carrying arthritis susceptible and -resistant HLA-DR genes to explore if genetic factors and their interaction with gut flora gut can be used to predict susceptibility to develop arthritis. Pyrosequencing of the 16S rRNA gene from the fecal microbiomes of DRB1*0401 and DRB1*0402 transgenic mice revealed that the guts of *0401 mice is dominated by a Clostridium-like bacterium, whereas the guts of *0402 mice are enriched for members of the Porphyromonadaceae family and Bifidobacteria. DRB1*0402 mice harbor a dynamic sex and age-influenced gut microbiome while DRB1*0401 mice did not show age and sex differences in gut microbiome even though they had altered gut permeability. Cytokine transcripts, measured by rtPCR, in jejuna showed differential TH17 regulatory network gene transcripts in *0401 and *0402 mice. Conclusions/Significance: We have demonstrated for the first time that HLA genes in association with the gut microbiome may determine the immune environment and that the gut microbiome might be a potential biomarker as well as contributor for susceptibility to arthritis. Identification of pathogenic commensal bacteria would provide new understanding of disease pathogenesis, thereby leading to novel approaches for therapy.	[Gomez, Andres; Yeoman, Carl J.; Miller, Margret E. Berg; White, Bryan A.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Luckey, David; Murray, Joseph A.; Taneja, Veena] Mayo Clin, Dept Immunol, Rochester, MN USA; [Marietta, Eric V.; Murray, Joseph A.] Mayo Clin, Dept Gasteroenterol, Rochester, MN USA; [Taneja, Veena] Mayo Clin, Dept Rheumatol, Rochester, MN USA; [White, Bryan A.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Illinois System; University of Illinois Urbana-Champaign	Gomez, A (corresponding author), Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.	bwhitw44@illinois.edu; taneja.veena@mayo.edu	Yeoman, Carl/ABA-1906-2021	Yeoman, Carl/0000-0002-8775-7879; Berg, Margret/0000-0002-0411-1619; Taneja, Veena/0000-0003-2401-694X; murray, joseph/0000-0003-1941-9090	seed funds from the Mayo Clinic/Illinois Alliance for Technology based Healthcare; Department of Defense	seed funds from the Mayo Clinic/Illinois Alliance for Technology based Healthcare; Department of Defense(United States Department of Defense)	The study was supported by seed funds from the Mayo Clinic/Illinois Alliance for Technology based Healthcare and a grant from Department of Defense to VT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alauzet C, 2007, INT J SYST EVOL MICR, V57, P2216, DOI 10.1099/ijs.0.65173-0; Amirzargar A, 1998, EUR J IMMUNOGENET, V25, P297, DOI 10.1046/j.1365-2370.1998.00101.x; Baba N, 2008, J LEUKOCYTE BIOL, V84, P468, DOI 10.1189/jlb.0108017; BENNO Y, 1992, MICROBIOL IMMUNOL, V36, P683, DOI 10.1111/j.1348-0421.1992.tb02071.x; Caselli M, 2010, GUT MICROBES, V1, P367, DOI 10.4161/gmic.1.6.14390; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; Chervonsky AV, 2010, NAT IMMUNOL, V11, P28, DOI 10.1038/ni.1801; Chow J, ADV IMMUNOL, V107, P243; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; De Palma G, 2010, CURR ISSUES MOL BIOL, V12, P1; FINEGOLD SM, 1983, NORMAL INDIGENOUS IN, P3; Fuentes S, 2008, FEMS MICROBIOL ECOL, V63, P65, DOI 10.1111/j.1574-6941.2007.00411.x; Geluk A, 1998, P NATL ACAD SCI USA, V95, P10797, DOI 10.1073/pnas.95.18.10797; Greetham HL, 2004, ANAEROBE, V10, P301, DOI 10.1016/j.anaerobe.2004.06.004; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Ito T, 2011, EXP CELL RES, V317, P613, DOI 10.1016/j.yexcr.2010.12.018; Kelsall BL, 2005, IMMUNOL REV, V206, P132, DOI 10.1111/j.0105-2896.2005.00292.x; Kempsell KE, 2000, INFECT IMMUN, V68, P6012, DOI 10.1128/IAI.68.10.6012-6026.2000; Klareskog L, 2006, NAT CLIN PRACT RHEUM, V2, P425, DOI 10.1038/ncprheum0249; KOUSKOFF V, 1993, J IMMUNOL METHODS, V166, P287, DOI 10.1016/0022-1759(93)90370-M; Kovacs A, 2011, MICROB ECOL, V61, P423, DOI 10.1007/s00248-010-9787-2; Kverka M, 2011, CLIN EXP IMMUNOL, V163, P250, DOI 10.1111/j.1365-2249.2010.04286.x; LANGENDIJK PS, 1995, APPL ENVIRON MICROB, V61, P3069, DOI 10.1128/AEM.61.8.3069-3075.1995; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; Lugering A, 2005, AM J PATHOL, V166, P1647, DOI 10.1016/S0002-9440(10)62475-3; Mangin I, 2004, FEMS MICROBIOL ECOL, V50, P25, DOI 10.1016/j.femsec.2004.05.005; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Matsumoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023652; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; McDonald KG, 2011, IMMUN AGEING, V8, DOI 10.1186/1742-4933-8-1; Moen K, 2006, CLIN EXP RHEUMATOL, V24, P656; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mueller S, 2006, APPL ENVIRON MICROB, V72, P1027, DOI 10.1128/AEM.72.2.1027-1033.2006; Nenadic O, 2007, J STAT SOFTW, V20; Ng SC, 2009, INFLAMM BOWEL DIS, V15, P300, DOI 10.1002/ibd.20602; Picco P, 2000, CLIN EXP RHEUMATOL, V18, P773; Round JL, 2010, J AUTOIMMUN, V34, pJ220, DOI 10.1016/j.jaut.2009.11.007; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Sait LC, 2007, INT IMMUNOL, V19, P257, DOI 10.1093/intimm/dxl142; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; So JS, 2008, MOL IMMUNOL, V45, P2690, DOI 10.1016/j.molimm.2007.12.010; Taneja V, 2003, J IMMUNOL, V171, P4431, DOI 10.4049/jimmunol.171.8.4431; Taneja V, 2008, J IMMUNOL, V181, P2869, DOI 10.4049/jimmunol.181.4.2869; Taneja V, 2007, ARTHRITIS RHEUM-US, V56, P69, DOI 10.1002/art.22213; Vaahtovuo J, 2003, FEMS MICROBIOL ECOL, V44, P131, DOI 10.1016/S0168-6496(02)00460-9; Vaahtovuo J, 2008, J RHEUMATOL, V35, P1500; Ventura M, 2009, FRONT BIOSCI-LANDMRK, V14, P3214, DOI 10.2741/3445; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Zaph C, 2010, J CLIN INVEST, V120, P4182, DOI 10.1172/JCI45263; [No title captured]	53	152	161	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e36095	10.1371/journal.pone.0036095	http://dx.doi.org/10.1371/journal.pone.0036095			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22553482	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343200077
J	Luhmann, UFO; Lange, CA; Robbie, S; Munro, PMG; Cowing, JA; Armer, HEJ; Luong, V; Carvalho, LS; MacLaren, RE; Fitzke, FW; Bainbridge, JWB; Ali, RR				Luhmann, Ulrich F. O.; Lange, Clemens A.; Robbie, Scott; Munro, Peter M. G.; Cowing, Jill A.; Armer, Hannah E. J.; Vy Luong; Carvalho, Livia S.; MacLaren, Robert E.; Fitzke, Frederick W.; Bainbridge, James W. B.; Ali, Robin R.			Differential Modulation of Retinal Degeneration by Ccl2 and Cx3cr1 Chemokine Signalling	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; MACULAR DEGENERATION; MICROGLIAL CELLS; TRANSENDOTHELIAL MIGRATION; LESION FORMATION; DENDRITIC CELLS; ANIMAL-MODEL; MICE; MACROPHAGES; BLOOD	Microglia and macrophages are recruited to sites of retinal degeneration where local cytokines and chemokines determine protective or neurotoxic microglia responses. Defining the role of Ccl2-Ccr2 and Cx3cl1-Cx3cr1 signalling for retinal pathology is of particular interest because of its potential role in age-related macular degeneration (AMD). Ccl2, Ccr2, and Cx3cr1 signalling defects impair macrophage trafficking, but have, in several conflicting studies, been reported to show different degrees of age-related retinal degeneration. Ccl2/Cx3cr1 double knockout (CCDKO) mice show an early onset retinal degeneration and have been suggested as a model for AMD. In order to understand phenotypic discrepancies in different chemokine knockout lines and to study how defects in Ccl2 and/or Cx3cr1 signalling contribute to the described early onset retinal degeneration, we defined primary and secondary pathological events in CCDKO mice. To control for genetic background variability, we compared the original phenotype with that of single Ccl2, Cx3cr1 and Ccl2/Cx3cr1 double knockout mice obtained from backcrosses of CCDKO with C57Bl/6 mice. We found that the primary pathological event in CCDKO mice develops in the inferior outer nuclear layer independently of light around postnatal day P14. RPE and vascular lesions develop secondarily with increasing penetrance with age and are clinically similar to retinal telangiectasia not to choroidal neovascularisation. Furthermore, we provide evidence that a third autosomal recessive gene causes the degeneration in CCDKO mice and in all affected re-derived lines and subsequently demonstrated co-segregation of the naturally occurring RD8 mutation in the Crb1 gene. By comparing CCDKO mice with re-derived CCl2(-/-)/Crb1(Rd8/RD8), Cx3cr1(-/-)/Crb1(Rd8/RD8) and CCl2(-/-)/Cx3cr1(-/-)/Crb1(Rd8/RD8) mice, we observed a differential modulation of the retinal phenotype by genetic background and both chemokine signalling pathways. These findings indicate that CCDKO mice are not a model of AMD, but a model for an inherited retinal degeneration that is differentially modulated by Ccl2-Ccr2 and Cx3cl1-Cx3cr1 chemokine signalling.	[Luhmann, Ulrich F. O.; Lange, Clemens A.; Robbie, Scott; Cowing, Jill A.; Carvalho, Livia S.; MacLaren, Robert E.; Bainbridge, James W. B.; Ali, Robin R.] UCL Inst Ophthalmol, Dept Genet, London, England; [Munro, Peter M. G.; Armer, Hannah E. J.] UCL Inst Ophthalmol, Imaging Unit, London, England; [Vy Luong; Fitzke, Frederick W.] UCL Inst Ophthalmol, Dept Visual Sci, London, England; [Robbie, Scott; MacLaren, Robert E.; Bainbridge, James W. B.; Ali, Robin R.] UCL Inst Ophthalmol, Moorfields Eye Hosp, Natl Hlth Sci Fdn Trust, Natl Inst Hlth & Res Biomed Res,Ctr Ophthalmol, London, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Luhmann, UFO (corresponding author), UCL Inst Ophthalmol, Dept Genet, London, England.	u.luhmann@ucl.ac.uk	Luhmann, Ulrich/D-8905-2012; Carvalho, Livia/B-4984-2013	Carvalho, Livia/0000-0002-3909-5778; Ali, Robin/0000-0003-3126-6517; Bainbridge, James/0000-0003-1318-8201; MacLaren, Robert/0000-0002-3096-4682	Wellcome Trust [074617/Z/04/Z]; National Institute for Health Research [NIHR-RP-011-003, NF-SI-0508-10130] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by the Wellcome Trust fellowship 074617/Z/04/Z (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Blomster LV, 2011, MOL CELL NEUROSCI, V48, P236, DOI 10.1016/j.mcn.2011.08.004; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chan CC, 2008, OPHTHALMIC RES, V40, P124, DOI 10.1159/000119862; Chen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022818; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Combadiere C, 2003, CIRCULATION, V107, P1009, DOI 10.1161/01.CIR.0000057548.68243.42; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Cook DN, 2001, MOL CELL BIOL, V21, P3159, DOI 10.1128/MCB.21.9.3159-3165.2001; Dzenko KA, 2005, MICROVASC RES, V70, P53, DOI 10.1016/j.mvr.2005.04.005; Eter N, 2008, INVEST OPHTH VIS SCI, V49, P3649, DOI 10.1167/iovs.07-1322; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Guillemin GJ, 2004, J LEUKOCYTE BIOL, V75, P388, DOI 10.1189/jlb.0303114; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Henderson RH, 2011, BRIT J OPHTHALMOL, V95, P811, DOI 10.1136/bjo.2010.186882; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Hughes EH, 2003, INVEST OPHTH VIS SCI, V44, P2229, DOI 10.1167/iovs.02-0824; Jaissle GB, 2010, GRAEF ARCH CLIN EXP, V248, P1063, DOI 10.1007/s00417-009-1253-9; Joly S, 2009, AM J PATHOL, V174, P2310, DOI 10.2353/ajpath.2009.090023; Jonas JB, 2010, ARCH OPHTHALMOL-CHIC, V128, P1281, DOI 10.1001/archophthalmol.2010.227; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lange CAK, 2011, AM J OPHTHALMOL, V152, P406, DOI 10.1016/j.ajo.2011.02.014; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; Lee JE, 2008, INVEST OPHTH VIS SCI, V49, P4169, DOI 10.1167/iovs.08-2076; Liang KJ, 2009, INVEST OPHTH VIS SCI, V50, P4444, DOI 10.1167/iovs.08-3357; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Marchesi F, 2010, J NEUROIMMUNOL, V224, P39, DOI 10.1016/j.jneuroim.2010.05.007; McKay GJ, 2011, HUM MUTAT, V32, P1407, DOI 10.1002/humu.21577; McMenamin PG, 1999, BRIT J OPHTHALMOL, V83, P598, DOI 10.1136/bjo.83.5.598; Mehalow AK, 2003, HUM MOL GENET, V12, P2179, DOI 10.1093/hmg/ddg232; Nakazawa T, 2007, P NATL ACAD SCI USA, V104, P2425, DOI 10.1073/pnas.0608167104; Neale BM, 2010, P NATL ACAD SCI USA, V107, P7395, DOI 10.1073/pnas.0912019107; Ng TF, 2001, INVEST OPHTH VIS SCI, V42, P3301; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; RANDOLPH GJ, 1995, J IMMUNOL, V155, P3610; Raoul W, 2008, OPHTHAL RES, V40, P115, DOI 10.1159/000119860; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Robertson MJ, 2002, INVEST OPHTH VIS SCI, V43, P2250; Ross RJ, 2008, EXP EYE RES, V86, P675, DOI 10.1016/j.exer.2008.01.014; Rutar M, 2011, INVEST OPHTH VIS SCI, V52, P2379, DOI 10.1167/iovs.10-6010; Seidler S, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-30; Shu XH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027433; Silverman MD, 2003, INVEST OPHTH VIS SCI, V44, P1608, DOI 10.1167/iovs.02-0233; Tou JS, 2004, FASEB J, V18, P1297, DOI 10.1096/fj.04-1862fje; Tsutsumi C, 2003, J LEUKOCYTE BIOL, V74, P25, DOI 10.1189/jlb.0902436; Tuo JS, 2007, INVEST OPHTH VIS SCI, V48, P3827, DOI 10.1167/iovs.07-0051; Tuo JS, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.01.009; Tuo JS, 2009, AM J PATHOL, V175, P799, DOI 10.2353/ajpath.2009.090089; van de Pavert SA, 2004, J CELL SCI, V117, P4169, DOI 10.1242/jcs.01301; van de Pavert SA, 2007, GLIA, V55, P1486, DOI 10.1002/glia.20561; West JB, 2010, RESP PHYSIOL NEUROBI, V170, P202, DOI 10.1016/j.resp.2009.12.010; Xu HP, 2008, AGING CELL, V7, P58, DOI 10.1111/j.1474-9726.2007.00351.x; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001; Zerbib J, 2011, EXP EYE RES, V93, P382, DOI 10.1016/j.exer.2011.05.005; Zhou YD, 2011, EXP EYE RES, V93, P636, DOI 10.1016/j.exer.2011.07.017	63	53	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35551	10.1371/journal.pone.0035551	http://dx.doi.org/10.1371/journal.pone.0035551			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545116	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343200036
J	Schumacher, T; Krohn, M; Hofrichter, J; Lange, C; Stenzel, J; Steffen, J; Dunkelmann, T; Paarmann, K; Frohlich, C; Uecker, A; Plath, AS; Sommer, A; Bruning, T; Heinze, HJ; Pahnke, J				Schumacher, Toni; Krohn, Markus; Hofrichter, Jacqueline; Lange, Cathleen; Stenzel, Jan; Steffen, Johannes; Dunkelmann, Tina; Paarmann, Kristin; Froehlich, Christina; Uecker, Annekathrin; Plath, Anne-Sophie; Sommer, Alexandra; Bruening, Thomas; Heinze, Hans-Jochen; Pahnke, Jens			ABC Transporters B1, C1 and G2 Differentially Regulate Neuroregeneration in Mice	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; AMYLOID-PRECURSOR-PROTEIN; NEURAL STEM-CELLS; MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; IN-VIVO; INCREASED SENSITIVITY; ADULT NEUROGENESIS; PROLIFERATION; EXPRESSION	Background: ATP-binding cassette (ABC) transporters are essential regulators of organismic homeostasis, and are particularly important in protecting the body from potentially harmful exogenous substances. Recently, an increasing number of in vitro observations have indicated a functional role of ABC transporters in the differentiation and maintenance of stem cells. Therefore, we sought to determine brain-related phenotypic changes in animals lacking the expression of distinct ABC transporters (ABCB1, ABCG2 or ABCC1). Methodology and Principal Findings: Analyzing adult neurogenesis in ABC transporter-deficient animals in vivo and neuronal stem/progenitor cells in vitro resulted in complex findings. In vivo, the differentiation of neuronal progenitors was hindered in ABC transporter-deficient mice (ABCB1(0/0)) as evidenced by lowered numbers of doublecortin(+) (-36%) and calretinin(+) (-37%) cells. In vitro, we confirmed that this finding is not connected to the functional loss of single neural stem/progenitor cells (NSPCs). Furthermore, assessment of activity, exploratory behavior, and anxiety levels revealed behavioral alterations in ABCB1(0/0) and ABCC1(0/0) mice, whereas ABCG2(0/0) mice were mostly unaffected. Conclusion and Significance: Our data show that single ABC transporter-deficiency does not necessarily impair neuronal progenitor homeostasis on the single NSPC level, as suggested by previous studies. However, loss of distinct ABC transporters impacts global brain homeostasis with far ranging consequences, leading to impaired neurogenic functions in vivo and even to distinct behavioral phenotypes. In addition to the known role of ABC transporters in proteopathies such as Parkinson's disease and Alzheimer's disease, our data highlight the importance of understanding the general function of ABC transporters for the brain's homeostasis and the regeneration potential.	[Schumacher, Toni; Krohn, Markus; Hofrichter, Jacqueline; Lange, Cathleen; Stenzel, Jan; Steffen, Johannes; Dunkelmann, Tina; Paarmann, Kristin; Froehlich, Christina; Uecker, Annekathrin; Plath, Anne-Sophie; Sommer, Alexandra; Bruening, Thomas; Heinze, Hans-Jochen; Pahnke, Jens] Univ Rostock, Dept Neurol, NRL, Magdeburg, Germany; [Schumacher, Toni; Krohn, Markus; Hofrichter, Jacqueline; Lange, Cathleen; Stenzel, Jan; Steffen, Johannes; Dunkelmann, Tina; Paarmann, Kristin; Froehlich, Christina; Uecker, Annekathrin; Plath, Anne-Sophie; Sommer, Alexandra; Bruening, Thomas; Heinze, Hans-Jochen; Pahnke, Jens] Univ Magdeburg, Dept Neurol, NRL, D-39106 Magdeburg, Germany; [Krohn, Markus; Plath, Anne-Sophie; Sommer, Alexandra; Bruening, Thomas; Heinze, Hans-Jochen; Pahnke, Jens] German Ctr Neurodegenerat Dis DZNE, Magdeburg, Germany; [Heinze, Hans-Jochen; Pahnke, Jens] LIN, Magdeburg, Germany	University of Rostock; Otto von Guericke University; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Leibniz Institut fur Neurobiologie (LIN)	Schumacher, T (corresponding author), Univ Rostock, Dept Neurol, NRL, Magdeburg, Germany.	jens.pahnke@gmail.com	Steffen, Johannes/AAK-3044-2021; Steffen, Johannes/K-4020-2012; Krohn, Markus/AAV-3151-2020; Pahnke, Jens/G-1757-2010; Krohn, Markus/AAD-5511-2019	Steffen, Johannes/0000-0002-0647-4157; Steffen, Johannes/0000-0002-0647-4157; Krohn, Markus/0000-0002-5345-9048; Pahnke, Jens/0000-0001-7355-4213; Krohn, Markus/0000-0002-5345-9048; Bruning, Thomas/0000-0002-7060-6564; Schumacher, Toni/0000-0001-7077-1300	University of Rostock (Landesgraduiertenforderung Mecklenburg-Vorpommern)	University of Rostock (Landesgraduiertenforderung Mecklenburg-Vorpommern)	T.S., J.H., C. L., and J.S. were supported by a study grant of the University of Rostock (Landesgraduiertenforderung Mecklenburg-Vorpommern). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alison MR, 2003, J PATHOL, V200, P547, DOI 10.1002/path.1411; Arendash GW, 2001, BRAIN RES, V891, P42, DOI 10.1016/S0006-8993(00)03186-3; Bates SE, 2001, J BIOENERG BIOMEMBR, V33, P503, DOI 10.1023/A:1012879205914; BECKER KF, 1992, HORM METAB RES, V24, P210, DOI 10.1055/s-2007-1003295; Borovski T, 2011, CANCER RES, V71, P634, DOI 10.1158/0008-5472.CAN-10-3220; Bye N, 2011, J NEUROSCI RES, V89, P986, DOI 10.1002/jnr.22635; Charrier C, 2006, NEUROSCIENCE, V138, P5, DOI 10.1016/j.neuroscience.2005.10.046; CHAUDHARY PM, 1991, CELL, V66, P85, DOI 10.1016/0092-8674(91)90141-K; Conrad CD, 1997, BRAIN RES, V759, P76, DOI 10.1016/S0006-8993(97)00236-9; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; CRUZ APM, 1994, PHARMACOL BIOCHEM BE, V49, P171, DOI 10.1016/0091-3057(94)90472-3; Dean M, 2005, ANNU REV GENOM HUM G, V6, P123, DOI 10.1146/annurev.genom.6.080604.162122; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Errijgers V, 2007, GENES BRAIN BEHAV, V6, P552, DOI 10.1111/j.1601-183X.2006.00282.x; Ferrari Daniela, 2010, Curr Protoc Stem Cell Biol, VChapter 2, DOI 10.1002/9780470151808.sc02d06s15; Ferreira MJ, 2010, J BACTERIOL, V192, P5312, DOI 10.1128/JB.00832-10; Gisin J, 2010, J BACTERIOL, V192, P5943, DOI 10.1128/JB.00742-10; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; Islam MO, 2005, FEBS LETT, V579, P3473, DOI 10.1016/j.febslet.2005.05.019; Islam MO, 2005, NEUROSCI RES, V52, P75, DOI 10.1016/j.neures.2005.01.013; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Kandasamy M, J NEUROPATHOL EXP NE, V69, P717; KARTNER N, 1983, CANCER RES, V43, P4413; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Komitova M, 2005, STROKE, V36, P1278, DOI 10.1161/01.STR.0000166197.94147.59; Korte SM, 2001, NEUROSCI BIOBEHAV R, V25, P117, DOI 10.1016/S0149-7634(01)00002-1; Kozak L, 2002, J BIOL CHEM, V277, P33580, DOI 10.1074/jbc.M205415200; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Krohn M, 2011, J CLIN INVEST, V121, P3924, DOI 10.1172/JCI57867; Krupa DJ, 2001, J NEUROSCI, V21, P5752, DOI 10.1523/JNEUROSCI.21-15-05752.2001; Lechner A, 2002, BIOCHEM BIOPH RES CO, V293, P670, DOI 10.1016/S0006-291X(02)00275-9; Lee YJ, 2005, J PHARMACOL EXP THER, V312, P44, DOI 10.1124/jpet.104.073320; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Lin TT, 2006, CELL RES, V16, P857, DOI 10.1038/sj.cr.7310107; Linton KJ, 2007, PHYSIOLOGY, V22, P122, DOI 10.1152/physiol.00046.2006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Maldonado E, 2000, PROG NEURO-PSYCHOPH, V24, P463, DOI 10.1016/S0278-5846(99)00112-8; Manuel M, 2007, DEVELOPMENT, V134, P545, DOI 10.1242/dev.02764; Mineur YS, 2002, BRAIN RES BULL, V57, P41, DOI 10.1016/S0361-9230(01)00635-9; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Pahnke J, 2009, FORTSCHR NEUROL PSYC, V77, pS21, DOI 10.1055/s-0028-1109601; Pahnke J, 2008, CURR ALZHEIMER RES, V5, P396, DOI 10.2174/156720508785132262; Pahnke J, 2009, NEUROSCI BIOBEHAV R, V33, P1099, DOI 10.1016/j.neubiorev.2009.05.006; Panwala CM, 1998, J IMMUNOL, V161, P5733; Rodgers RJ, 1997, NEUROSCI BIOBEHAV R, V21, P801, DOI 10.1016/S0149-7634(96)00058-9; Sarkadi B, 2004, FEBS LETT, V567, P116, DOI 10.1016/j.febslet.2004.03.123; Saurin W, 1999, J MOL EVOL, V48, P22, DOI 10.1007/PL00006442; Scheffler K, 2011, CURR ALZHEIMER RES, V8, P781, DOI 10.2174/156720511797633179; Schinkel AH, 1997, P NATL ACAD SCI USA, V94, P4028, DOI 10.1073/pnas.94.8.4028; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; Schmidt A, 2012, J ALZHEIMER IN PRESS; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Shruster A, 2011, J NEUROCHEM, V116, P522, DOI 10.1111/j.1471-4159.2010.07131.x; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Soontornmalai A, 2006, NEUROSCIENCE, V138, P159, DOI 10.1016/j.neuroscience.2005.11.011; Steiner B, 2006, GLIA, V54, P805, DOI 10.1002/glia.20407; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; Wijnholds J, 1997, NAT MED, V3, P1275, DOI 10.1038/nm1197-1275; WOLF NS, 1993, EXP HEMATOL, V21, P614; Yamamoto A, 2009, J NEUROSCI RES, V87, P2615, DOI 10.1002/jnr.22094; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008	70	38	39	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35613	10.1371/journal.pone.0035613	http://dx.doi.org/10.1371/journal.pone.0035613			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545122	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343200042
J	Stemberger, C; Dreher, S; Tschulik, C; Piossek, C; Bet, J; Yamamoto, TN; Schiemann, M; Neuenhahn, M; Martin, K; Schlapschy, M; Skerra, A; Schmidt, T; Edinger, M; Riddell, SR; Germeroth, L; Busch, DH				Stemberger, Christian; Dreher, Stefan; Tschulik, Claudia; Piossek, Christine; Bet, Jeannette; Yamamoto, Tori N.; Schiemann, Matthias; Neuenhahn, Michael; Martin, Klaus; Schlapschy, Martin; Skerra, Arne; Schmidt, Thomas; Edinger, Matthias; Riddell, Stanley R.; Germeroth, Lothar; Busch, Dirk H.			Novel Serial Positive Enrichment Technology Enables Clinical Multiparameter Cell Sorting	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; ONE-STEP PURIFICATION; REGULATORY T-CELLS; F-AB FRAGMENT; ADOPTIVE TRANSFER; CRYSTAL-STRUCTURE; ANTIBODY; LYMPHOCYTES; TRANSPLANTATION; IMMUNOTHERAPY	A general obstacle for clinical cell preparations is limited purity, which causes variability in the quality and potency of cell products and might be responsible for negative side effects due to unwanted contaminants. Highly pure populations can be obtained best using positive selection techniques. However, in many cases target cell populations need to be segregated from other cells by combinations of multiple markers, which is still difficult to achieve - especially for clinical cell products. Therefore, we have generated low-affinity antibody-derived Fab-fragments, which stain like parental antibodies when multimerized via Strep-tag and Strep-Tactin, but can subsequently be removed entirely from the target cell population. Such reagents can be generated for virtually any antigen and can be used for sequential positive enrichment steps via paramagnetic beads. First protocols for multiparameter enrichment of two clinically relevant cell populations, CD4(high)/CD25(high)/CD45RA(high) 'regulatory T cells' and CD8(high)/CD62L(high)/CD45RA(neg) 'central memory T cells', have been established to determine quality and efficacy parameters of this novel technology, which should have broad applicability for clinical cell sorting as well as basic research.	[Stemberger, Christian; Dreher, Stefan; Bet, Jeannette; Schiemann, Matthias; Neuenhahn, Michael; Busch, Dirk H.] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Munich, Germany; [Stemberger, Christian; Dreher, Stefan; Bet, Jeannette; Riddell, Stanley R.; Busch, Dirk H.] Tech Univ Munich, Inst Adv Study, Focus Grp Clin Cell Proc & Purificat, Munich, Germany; [Schlapschy, Martin; Skerra, Arne] Tech Univ Munich, Munich Ctr Integrated Prot Sci CIPS M, Freising Weihenstephan, Germany; [Schlapschy, Martin; Skerra, Arne] Tech Univ Munich, Lehrstuhl Biol Chem, Freising Weihenstephan, Germany; [Tschulik, Claudia; Piossek, Christine; Schmidt, Thomas; Germeroth, Lothar] Stage Cell Therapeut, Gottingen, Germany; [Schiemann, Matthias; Busch, Dirk H.] Helmholtz Ctr Munich Neuherberg, Clin Cooperat Grp Antigen Specif Immunotherapy, Munich, Germany; [Martin, Klaus] German Heart Ctr Munich, Inst Anaesthesiol, Munich, Germany; [Edinger, Matthias] Univ Hosp Regensburg, Dept Hematol & Oncol, Regensburg, Germany; [Yamamoto, Tori N.; Riddell, Stanley R.] Fred Hutchinson Canc Res Ctr, Program Immunol, Seattle, WA 98104 USA; [Neuenhahn, Michael; Busch, Dirk H.] DZIF Natl Ctr Infect Res, Munich, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; German Heart Centre Munich; University of Regensburg; Fred Hutchinson Cancer Center; German Center for Infection Research	Stemberger, C (corresponding author), Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Munich, Germany.	dirk.busch@mikrobio.med.tum.de	Skerra, Arne/A-2269-2013	Edinger, Matthias/0000-0003-2889-2533; Skerra, Arne/0000-0002-5717-498X	National Institutes of Health (NIH) [CA18029]; German Federal Ministry of Education and Research in the framework of the Leading-Edge Cluster m4 Munich;  [SFB 576 (TP-A8)];  [SFB 456 (TP-B13)];  [TR-SFB 36 (TP-B10/13)]; NATIONAL CANCER INSTITUTE [R01CA136551, P01CA018029] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Federal Ministry of Education and Research in the framework of the Leading-Edge Cluster m4 Munich; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the SFB 576 (TP-A8), SFB 456 (TP-B13), TR-SFB 36 (TP-B10/13), National Institutes of Health (NIH) CA18029 and by the German Federal Ministry of Education and Research in the framework of the Leading-Edge Cluster m4 Munich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Attarwala H, 2010, J Young Pharm, V2, P332, DOI 10.4103/0975-1483.66810; Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; Bes C, 2003, J BIOL CHEM, V278, P14265, DOI 10.1074/jbc.M210694200; Chatenoud L, 2003, NAT REV IMMUNOL, V3, P123, DOI 10.1038/nri1000; Cobbold M, 2005, J EXP MED, V202, P379, DOI 10.1084/jem.20040613; Cohen JL, 2002, J EXP MED, V196, P401, DOI 10.1084/jem.20020090; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Fiedler M, 1999, PROTEIN EXPRES PURIF, V17, P421, DOI 10.1006/prep.1999.1142; Heslop HE, 1996, NAT MED, V2, P551, DOI 10.1038/nm0596-551; Hoffmann P, 2006, BLOOD, V108, P4260, DOI 10.1182/blood-2006-06-027409; Kjer-Nielsen L, 2004, P NATL ACAD SCI USA, V101, P7675, DOI 10.1073/pnas.0402295101; Knabel M, 2002, NAT MED, V8, P631, DOI 10.1038/nm0602-631; Kohm AP, 2006, J IMMUNOL, V176, P3301, DOI 10.4049/jimmunol.176.6.3301; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; NADALI G, 1995, INT J CLIN LAB RES, V25, P121, DOI 10.1007/BF02592552; ORLANDI R, 1989, P NATL ACAD SCI USA, V86, P3833, DOI 10.1073/pnas.86.10.3833; Randolph DA, 2006, ANNU REV MED, V57, P381, DOI 10.1146/annurev.med.57.121304.131337; RIDDELL SR, 1992, SCIENCE, V257, P238; Riley JL, 2009, IMMUNITY, V30, P656, DOI 10.1016/j.immuni.2009.04.006; ROONEY CM, 1995, LANCET, V345, P9, DOI 10.1016/S0140-6736(95)91150-2; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Schiweck W, 1997, J MOL BIOL, V268, P934, DOI 10.1006/jmbi.1997.1006; Schlapschy M, 2004, PROTEIN ENG DES SEL, V17, P847, DOI 10.1093/protein/gzh098; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Schmitt A, 2011, TRANSFUSION, V51, P591, DOI 10.1111/j.1537-2995.2010.02940.x; SKERRA A, 1994, GENE, V141, P79, DOI 10.1016/0378-1119(94)90131-7; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; Taylor PA, 2002, BLOOD, V99, P3493, DOI 10.1182/blood.V99.10.3493; Turtle CJ, 2011, CURR OPIN IMMUNOL, V23, P299, DOI 10.1016/j.coi.2010.12.012; Yang SC, 2011, CANCER IMMUNOL IMMUN, V60, P739, DOI 10.1007/s00262-011-0977-7	31	49	66	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35798	10.1371/journal.pone.0035798	http://dx.doi.org/10.1371/journal.pone.0035798			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545138	Green Published, gold			2022-12-27	WOS:000305343200058
J	Wang, H; Ren, YS; Bai, LJ; Zhang, WS; Tian, J				Wang, Hu; Ren, Yanshuang; Bai, Lijun; Zhang, Wensheng; Tian, Jie			Morphometry Based on Effective and Accurate Correspondences of Localized Patterns (MEACOLP)	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; ATROPHY; BRAIN; CLASSIFICATION; VENTRICLES; DIAGNOSIS	Local features in volumetric images have been used to identify correspondences of localized anatomical structures for brain morphometry. However, the correspondences are often sparse thus ineffective in reflecting the underlying structures, making it unreliable to evaluate specific morphological differences. This paper presents a morphometry method (MEACOLP) based on correspondences with improved effectiveness and accuracy. A novel two-level scale-invariant feature transform is used to enhance the detection repeatability of local features and to recall the correspondences that might be missed in previous studies. Template patterns whose correspondences could be commonly identified in each group are constructed to serve as the basis for morphometric analysis. A matching algorithm is developed to reduce the identification errors by comparing neighboring local features and rejecting unreliable matches. The two-sample t-test is finally adopted to analyze specific properties of the template patterns. Experiments are performed on the public OASIS database to clinically analyze brain images of Alzheimer's disease (AD) and normal controls (NC). MEACOLP automatically identifies known morphological differences between AD and NC brains, and characterizes the differences well as the scaling and translation of underlying structures. Most of the significant differences are identified in only a single hemisphere, indicating that AD-related structures are characterized by strong anatomical asymmetry. In addition, classification trials to differentiate AD subjects from NC confirm that the morphological differences are reliably related to the groups of interest.	[Wang, Hu; Bai, Lijun; Zhang, Wensheng; Tian, Jie] Chinese Acad Sci, Inst Automat, State Key Lab Management & Control Complex Syst, Beijing, Peoples R China; [Ren, Yanshuang] Chinese Acad Tradit Med, Guanganmen Hosp, Dept Radiol, Beijing, Peoples R China; [Tian, Jie] Xidian Univ, Sch Elect Engn, Life Sci Res Ctr, Xian, Peoples R China	Chinese Academy of Sciences; Institute of Automation, CAS; China Academy of Chinese Medical Sciences; Guang'anmen Hospital, CACMS; Xidian University	Wang, H (corresponding author), Chinese Acad Sci, Inst Automat, State Key Lab Management & Control Complex Syst, Beijing, Peoples R China.	yanshr2006@163.com	Bai, Lijun/C-5119-2015; yongbei, Zhu/L-7015-2016; Tian, Jie/H-1190-2011	Bai, Lijun/0000-0001-8790-5424; Tian, Jie/0000-0003-0498-0432	Chinese Academy of Sciences [KGCX2-YW-129]; Project for the National Key Basic Research and Development Program (973) [2011CB707700]; National Natural Science Foundation of China [81071217, 81071141]; Major Research Plan of the National Natural Science Foundation of China [90924026]; Basic research on the 12th Five-Year Plan Project [0101050302]	Chinese Academy of Sciences(Chinese Academy of Sciences); Project for the National Key Basic Research and Development Program (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Research Plan of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic research on the 12th Five-Year Plan Project	This paper is supported by the Knowledge Innovation Program of the Chinese Academy of Sciences under grant No. KGCX2-YW-129, the Project for the National Key Basic Research and Development Program (973) under Grant No. 2011CB707700, the National Natural Science Foundation of China under Grant Nos. 81071217, 81071141, the Major Research Plan of the National Natural Science Foundation of China under Grant No. 90924026, and the Basic research on the 12th Five-Year Plan Project under Grant No. 0101050302. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bookstein FL, 2001, NEUROIMAGE, V14, P1454, DOI 10.1006/nimg.2001.0770; Chetelat G, 2008, BRAIN, V131, P60, DOI 10.1093/brain/awm288; Chetelat G, 2003, NEUROIMAGE, V18, P525, DOI 10.1016/S1053-8119(02)00026-5; Cheung W, 2009, IEEE T IMAGE PROCESS, V18, P2012, DOI 10.1109/TIP.2009.2024578; Cooke MA, 2008, SCHIZOPHR RES, V103, P40, DOI 10.1016/j.schres.2008.04.022; Cuingnet R, 2011, NEUROIMAGE, V56, P766, DOI 10.1016/j.neuroimage.2010.06.013; Davatzikos C, 2008, NEUROIMAGE, V41, P1220, DOI 10.1016/j.neuroimage.2008.03.050; Desikan RS, 2009, BRAIN, V132, P2048, DOI 10.1093/brain/awp123; Fan Y, 2007, IEEE T MED IMAGING, V26, P93, DOI 10.1109/TMI.2006.886812; Ferrarini L, 2006, NEUROIMAGE, V32, P1060, DOI 10.1016/j.neuroimage.2006.05.048; Gaser C, 2001, NEUROIMAGE, V13, P1140, DOI 10.1006/nimg.2001.0771; Jubault T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008247; Lao ZQ, 2004, NEUROIMAGE, V21, P46, DOI 10.1016/j.neuroimage.2003.09.027; Lowe D., 1999, P INT C COMP VIS, V2, P1150, DOI DOI 10.1109/ICCV.1999.790410; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Mechelli A, 2005, CURR MED IMAGING, V1, P105, DOI 10.2174/1573405054038726; Mikolajczyk K, 2005, INT J COMPUT VISION, V65, P43, DOI 10.1007/s11263-005-3848-x; Mikolajczyk K, 2005, IEEE T PATTERN ANAL, V27, P1615, DOI 10.1109/TPAMI.2005.188; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Pengas G, 2010, NEUROBIOL AGING, V31, P25, DOI 10.1016/j.neurobiolaging.2008.03.014; Pereira JMS, 2010, NEUROIMAGE, V49, P2205, DOI 10.1016/j.neuroimage.2009.10.068; Postelnicu G, 2009, IEEE T MED IMAGING, V28, P508, DOI 10.1109/TMI.2008.2004426; Rankin KP, 2006, BRAIN, V129, P2945, DOI 10.1093/brain/awl254; Scovanner P., 2007, P 15 ACM INT C MULT, P357, DOI DOI 10.1145/1291233.1291311; Se S, 2002, INT J ROBOT RES, V21, P735, DOI 10.1177/027836402761412467; SLANSKY I, 1995, NEURORADIOLOGY, V37, P270; Sluimer JD, 2009, EUR RADIOL, V19, P2826, DOI 10.1007/s00330-009-1512-5; Thompson PM, 2004, NEUROIMAGE, V22, P1754, DOI 10.1016/j.neuroimage.2004.03.040; Toews M, 2007, IEEE T MED IMAGING, V26, P497, DOI 10.1109/TMI.2007.892510; Toews M, 2010, NEUROIMAGE, V49, P2318, DOI 10.1016/j.neuroimage.2009.10.032; Whitwell JL, 2007, BRAIN, V130, P1777, DOI 10.1093/brain/awm112	34	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35745	10.1371/journal.pone.0035745	http://dx.doi.org/10.1371/journal.pone.0035745			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22540000	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341000066
J	Angelini, S; My, L; Bouveret, E				Angelini, Sandra; My, Laetitia; Bouveret, Emmanuelle			Disrupting the Acyl Carrier Protein/SpoT Interaction In Vivo: Identification of ACP Residues Involved in the Interaction and Consequence on Growth	PLOS ONE			English	Article							TANDEM AFFINITY PURIFICATION; SPOT-DEPENDENT ACCUMULATION; AMINO-ACID-RESIDUES; ESCHERICHIA-COLI; PHOSPHOLIPID-SYNTHESIS; BINDING; SYNTHASE; SYSTEM; REVEAL; MUTAGENESIS	In bacteria, Acyl Carrier Protein (ACP) is the central cofactor for fatty acid biosynthesis. It carries the acyl chain in elongation and must therefore interact successively with all the enzymes of this pathway. Yet, ACP also interacts with proteins of diverse unrelated function. Among them, the interaction with SpoT has been proposed to be involved in regulating ppGpp levels in the cell in response to fatty acid synthesis inhibition. In order to better understand this mechanism, we screened for ACP mutants unable to interact with SpoT in vivo by bacterial two-hybrid, but still functional for fatty acid synthesis. The position of the selected mutations indicated that the helix II of ACP is responsible for the interaction with SpoT. This suggested a mechanism of recognition similar to one used for the enzymes of fatty acid synthesis. Consistently, the interactions tested by bacterial two-hybrid of ACP with fatty acid synthesis enzymes were also affected by the mutations that prevented the interaction with SpoT. Yet, interestingly, the corresponding mutant strains were viable, and the phenotypes of one mutant suggested a defect in growth regulation.	[Angelini, Sandra; My, Laetitia; Bouveret, Emmanuelle] Aix Marseille Univ, CNRS, Lab Macromol Syst Engn LISM, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Angelini, S (corresponding author), Aix Marseille Univ, CNRS, Lab Macromol Syst Engn LISM, Marseille, France.	bouveret@imm.cnrs.fr		Angelini, Sandra/0000-0002-8671-8018; Bouveret, Emmanuelle/0000-0001-5511-6375; MY, Laetitia/0000-0002-7876-1809	Fondation pour la Recherche Medicale; Centre National de la Recherche Scientifique (CNRS); ANR (French National Research Agency) [ANR-09-JCJC-0018]	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); ANR (French National Research Agency)(French National Research Agency (ANR))	SA was funded by a grant from the Fondation pour la Recherche Medicale (http://www.frm.org). The work was funded by the Centre National de la Recherche Scientifique (CNRS) and by ANR (French National Research Agency) grant LipidStress (ANR-09-JCJC-0018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson GC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023479; Babu M, 2010, STRUCTURE, V18, P1450, DOI 10.1016/j.str.2010.08.015; BACHMANN BJ, 1996, ESCHERICHIA COLI SAL, P2460; Battesti A, 2006, MOL MICROBIOL, V62, P1048, DOI 10.1111/j.1365-2958.2006.05442.x; Battesti A, 2009, J BACTERIOL, V191, P616, DOI 10.1128/JB.01195-08; Battesti A, 2008, PROTEOMICS, V8, P4768, DOI 10.1002/pmic.200800270; Borgaro JG, 2011, BIOCHEMISTRY-US, V50, P10678, DOI 10.1021/bi201199x; Bouveret E, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P231; Burckstummer T, 2006, NAT METHODS, V3, P1013, DOI 10.1038/nmeth968; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Byers DM, 2007, BIOCHEM CELL BIOL, V85, P649, DOI 10.1139/O07-109; Chan DI, 2010, BIOCHEM J, V430, P1, DOI 10.1042/BJ20100462; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Lay NR, 2007, J BIOL CHEM, V282, P20319, DOI 10.1074/jbc.M703789200; De Lay NR, 2006, J BACTERIOL, V188, P287, DOI 10.1128/JB.188.1.287-296.2006; den Blaauwen T, 2001, MOL MICROBIOL, V42, P1179, DOI 10.1046/j.1365-2958.2001.02691.x; Flaman AS, 2001, J BIOL CHEM, V276, P35934, DOI 10.1074/jbc.M101849200; Gully D, 2006, PROTEOMICS, V6, P282, DOI 10.1002/pmic.200500115; Gully D, 2003, FEBS LETT, V548, P90, DOI 10.1016/S0014-5793(03)00746-4; Heath RJ, 1996, J BIOL CHEM, V271, P10996, DOI 10.1074/jbc.271.18.10996; Hogg T, 2004, CELL, V117, P57, DOI 10.1016/S0092-8674(04)00260-0; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; KIM YM, 1990, PROTEINS, V8, P377, DOI 10.1002/prot.340080411; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Parris KD, 2000, STRUCT FOLD DES, V8, P883, DOI 10.1016/S0969-2126(00)00178-7; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Rafi S, 2006, J BIOL CHEM, V281, P39285, DOI 10.1074/jbc.M608758200; Rock CO, 1996, BBA-LIPID LIPID MET, V1302, P1, DOI 10.1016/0005-2760(96)00056-2; ROCK CO, 1982, J BACTERIOL, V152, P1298; Roujeinikova A, 2002, STRUCTURE, V10, P825, DOI 10.1016/S0969-2126(02)00775-X; Roujeinikova A, 2007, J MOL BIOL, V365, P135, DOI 10.1016/j.jmb.2006.09.049; SEYFZADEH M, 1993, P NATL ACAD SCI USA, V90, P11004, DOI 10.1073/pnas.90.23.11004; Shanklin J, 2000, PROTEIN EXPRES PURIF, V18, P355, DOI 10.1006/prep.2000.1206; SPIRA B, 1995, J BACTERIOL, V177, P4053, DOI 10.1128/jb.177.14.4053-4058.1995; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; ULRICH AK, 1983, J BACTERIOL, V154, P221, DOI 10.1128/JB.154.1.221-230.1983; Vinella D, 2005, MOL MICROBIOL, V56, P958, DOI 10.1111/j.1365-2958.2005.04601.x; Volkmann G, 2010, J BIOL CHEM, V285, P8605, DOI 10.1074/jbc.M109.060863; Wahl A, 2011, MOL MICROBIOL, V80, P1260, DOI 10.1111/j.1365-2958.2011.07641.x; Worsham LAS, 2003, BIOCHEMISTRY-US, V42, P167, DOI 10.1021/bi0261950; XIAO H, 1991, J BIOL CHEM, V266, P5980; Zeghouf M, 2004, J PROTEOME RES, V3, P463, DOI 10.1021/pr034084x; Zhang YM, 2003, J LIPID RES, V44, P1, DOI 10.1194/jlr.R200016-JLR200; Zhang YQ, 2003, J BIOL CHEM, V278, P10417, DOI 10.1074/jbc.M211044200	46	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36111	10.1371/journal.pone.0036111	http://dx.doi.org/10.1371/journal.pone.0036111			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558350	Green Submitted, Green Published, gold			2022-12-27	WOS:000305340200041
J	Bateman, BT; Shaw, KM; Kuklina, EV; Callaghan, WM; Seely, EW; Hernandez-Diaz, S				Bateman, Brian T.; Shaw, Kate M.; Kuklina, Elena V.; Callaghan, William M.; Seely, Ellen W.; Hernandez-Diaz, Sonia			Hypertension in Women of Reproductive Age in the United States: NHANES 1999-2008	PLOS ONE			English	Article							ANTIHYPERTENSIVE MEDICATION USE; MAJOR CONGENITAL-MALFORMATIONS; EARLY-PREGNANCY; RISK-FACTORS; DISPARITIES; PREVALENCE; TRENDS; US; DISORDERS; AWARENESS	Objective: To examine the epidemiology of hypertension in women of reproductive age. Methods: Using NHANES from 1999-2008, we identified 5,521 women age 20-44 years old. Hypertension status was determined using blood pressure measurements and/or self-reported medication use. Results: The estimated prevalence of hypertension in women of reproductive age was 7.7% (95% confidence interval (CI): 6.9%-8.5%). The prevalence of anti-hypertensive pharmacologic therapy was 4.2% (95% CI 3.5%-4.9%). The prevalence of hypertension was relatively stable across the study period; the age and race adjusted odds of hypertension in 2007-2008 did not differ significantly from 1999-2000 (odds ratio 1.2, CI 0.8 to 1.7, p = 0.45). Significant independent risk factors associated with hypertension included older age, non-Hispanic black race (compared to non-Hispanic whites), diabetes mellitus, chronic kidney disease, and higher body mass index. The most commonly used antihypertensive medications included diuretics, angiotensin-converting enzyme inhibitors (ACE), and beta blockers. Conclusion: Hypertension occurs in about 8% of women of reproductive age. There are remarkable differences in the prevalence of hypertension between racial/ethnic groups. Obesity is a risk factor of particular importance in this population because it affects over 30% of young women in the U. S., is associated with more than 4 fold increased risk of hypertension, and is potentially modifiable.	[Bateman, Brian T.] Harvard Univ, Massachusetts Gen Hosp, Div Obstet Anesthesia, Sch Med,Dept Anesthesia Crit Care & Pain Med, Boston, MA 02115 USA; [Shaw, Kate M.; Kuklina, Elena V.] Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; [Callaghan, William M.] Ctr Dis Control & Prevent, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; [Seely, Ellen W.] Harvard Univ, Brigham & Womens Hosp, Dept Med, Sch Med, Boston, MA 02115 USA; [Hernandez-Diaz, Sonia] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Bateman, BT (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Div Obstet Anesthesia, Sch Med,Dept Anesthesia Crit Care & Pain Med, Boston, MA 02115 USA.	BBateman@partners.org	Kuklina, Elena/AAF-3532-2020	Kuklina, Elena/0000-0002-9686-6495; Shaw, Kate/0000-0002-1087-2457	National Institutes of Health [GM007592]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL096141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health T32 training grant GM007592 (BTB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG Committee on Practice Bulletins, 2001, Obstet Gynecol, V98, P177; Ananth CV, 1995, ACTA OBSTET GYN SCAN, V74, P788, DOI 10.3109/00016349509021198; Ashaye MO, 2003, ETHNIC DIS, V13, P456; Bateman BT, 2006, NEUROLOGY, V67, P424, DOI 10.1212/01.wnl.0000228277.84760.a2; Beilin LJ, 2006, HYPERTENSION, V47, P1035, DOI 10.1161/01.HYP.0000218586.21932.3c; Caton AR, 2009, HYPERTENSION, V54, P63, DOI 10.1161/HYPERTENSIONAHA.109.129098; ChasanTaber L, 1996, CIRCULATION, V94, P483, DOI 10.1161/01.CIR.94.3.483; Cooper WO, 2006, NEW ENGL J MED, V354, P2443, DOI 10.1056/NEJMoa055202; Daviglus ML, 2004, JAMA-J AM MED ASSOC, V292, P1588, DOI 10.1001/jama.292.13.1588; Davis RL, 2011, PHARMACOEPIDEM DR S, V20, P138, DOI 10.1002/pds.2068; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Fields LE, 2004, HYPERTENSION, V44, P398, DOI 10.1161/01.HYP.0000142248.54761.56; Finer LB, 2006, PERSPECT SEX REPRO H, V38, P90, DOI 10.1363/3809006; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Ford ES, 2007, J AM COLL CARDIOL, V50, P2128, DOI 10.1016/j.jacc.2007.05.056; Frieden Thomas R, 2011, MMWR Suppl, V60, P1; Gilbert WM, 2007, J REPROD MED, V52, P1046; Gillespie C., 2011, Morbidity and Mortality Weekly Report, V60, P103; Halperin RO, 2008, AM J HYPERTENS, V21, P148, DOI 10.1038/ajh.2007.36; Hertz RP, 2005, ARCH INTERN MED, V165, P2098, DOI 10.1001/archinte.165.18.2098; Hsiao Chun-Ju, 2010, Natl Health Stat Report, P1; Jain L, 1997, J Perinatol, V17, P425; Kallen BAJ, 2003, REPROD TOXICOL, V17, P255, DOI 10.1016/S0890-6238(03)00012-1; Kim SY, 2007, OBESITY, V15, P986, DOI 10.1038/oby.2007.621; Kuklina EV, 2009, OBSTET GYNECOL, V113, P1299, DOI 10.1097/AOG.0b013e3181a45b25; Lennestal R, 2009, EUR J CLIN PHARMACOL, V65, P615, DOI 10.1007/s00228-009-0620-0; Li DK, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5931; LIM KG, 1987, BRIT MED J, V294, P1057, DOI 10.1136/bmj.294.6579.1057; Martin JW, 2010, NATIVE AMERICANS, CHRISTIANITY, AND THE RESHAPING OF THE AMERICAN RELIGIOUS LANDSCAPE, P1; Nakhai-Pour HR, 2010, BIRTH DEFECTS RES B, V89, P147, DOI 10.1002/bdrb.20238; Podymow T, 2008, HYPERTENSION, V51, P960, DOI 10.1161/HYPERTENSIONAHA.106.075895; REY E, 1994, AM J OBSTET GYNECOL, V171, P410, DOI 10.1016/0002-9378(94)90276-3; Samadi AR, 1996, OBSTET GYNECOL, V87, P557, DOI 10.1016/0029-7844(95)00480-7; Saydah S., 2007, Morbidity and Mortality Weekly Report, V56, P161; SIBAI BM, 1983, OBSTET GYNECOL, V61, P571; Sibai BM, 1998, NEW ENGL J MED, V339, P667, DOI 10.1056/NEJM199809033391004; Sibai BM, 2002, OBSTET GYNECOL, V100, P369, DOI 10.1016/S0029-7844(02)02128-2; WOODS JW, 1988, HYPERTENSION, V11, pS11; Yoder SR, 2009, AM J MED, V122, P890, DOI 10.1016/j.amjmed.2009.03.036	39	75	77	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36171	10.1371/journal.pone.0036171	http://dx.doi.org/10.1371/journal.pone.0036171			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558371	Green Submitted, Green Published, gold			2022-12-27	WOS:000305340200047
J	Bertram, S; Heurich, A; Lavender, H; Gierer, S; Danisch, S; Perin, P; Lucas, JM; Nelson, PS; Pohlmann, S; Soilleux, EJ				Bertram, Stephanie; Heurich, Adeline; Lavender, Hayley; Gierer, Stefanie; Danisch, Simon; Perin, Paula; Lucas, Jared M.; Nelson, Peter S.; Poehlmann, Stefan; Soilleux, Elizabeth J.			Influenza and SARS-Coronavirus Activating Proteases TMPRSS2 and HAT Are Expressed at Multiple Sites in Human Respiratory and Gastrointestinal Tracts	PLOS ONE			English	Article							TRYPSIN-LIKE PROTEASE; SPIKE-PROTEIN; VIRUS HEMAGGLUTININ; SERINE-PROTEASE; NEUTRALIZING ANTIBODIES; PROTEOLYTIC ACTIVATION; FUNCTIONAL RECEPTOR; TISSUE DISTRIBUTION; A VIRUS; PATHOGENESIS	The type II transmembrane serine proteases TMPRSS2 and HAT activate influenza viruses and the SARS-coronavirus (TMPRSS2) in cell culture and may play an important role in viral spread and pathogenesis in the infected host. However, it is at present largely unclear to what extent these proteases are expressed in viral target cells in human tissues. Here, we show that both HAT and TMPRSS2 are coexpressed with 2,6-linked sialic acids, the major receptor determinant of human influenza viruses, throughout the human respiratory tract. Similarly, coexpression of ACE2, the SARS-coronavirus receptor, and TMPRSS2 was frequently found in the upper and lower aerodigestive tract, with the exception of the vocal folds, epiglottis and trachea. Finally, activation of influenza virus was conserved between human, avian and porcine TMPRSS2, suggesting that this protease might activate influenza virus in reservoir-, intermediate- and human hosts. In sum, our results show that TMPRSS2 and HAT are expressed by important influenza and SARS-coronavirus target cells and could thus support viral spread in the human host.	[Bertram, Stephanie; Heurich, Adeline; Gierer, Stefanie; Poehlmann, Stefan] German Primate Ctr, Gottingen, Germany; [Lavender, Hayley] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxfabs, Oxford OX3 9DU, England; [Danisch, Simon; Perin, Paula] Hannover Med Sch, Inst Virol, D-3000 Hannover, Germany; [Lucas, Jared M.; Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Soilleux, Elizabeth J.] Univ Oxford, John Radcliffe Hosp, Dept Cellular Pathol, Oxford OX3 9DU, England	Deutsches Primatenzentrum (DPZ); University of Oxford; Hannover Medical School; Fred Hutchinson Cancer Center; University of Oxford	Bertram, S (corresponding author), German Primate Ctr, Gottingen, Germany.	s.poehlmann@dpz.eu; Elizabeth.Soilleux@ndcls.ox.ac.uk	Pöhlmann, Stefan/H-2395-2011	Pöhlmann, Stefan/0000-0001-6086-9136; Soilleux, Elizabeth Jane/0000-0002-4032-7249; Lavender, Hayley/0000-0001-9996-8107	NIHR Biomedical Research Centre Programme; German Federal Ministry of Education and Research (BMBF) via the project Ecology and Pathogenesis of SARS, an Archetypical Zoonosis [01KIO701, 01KIO703]; National Cancer Institute (NCI) [P01CA085859]; NATIONAL CANCER INSTITUTE [P01CA085859] Funding Source: NIH RePORTER	NIHR Biomedical Research Centre Programme(National Institute for Health Research (NIHR)); German Federal Ministry of Education and Research (BMBF) via the project Ecology and Pathogenesis of SARS, an Archetypical Zoonosis; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	HL is funded by the NIHR Biomedical Research Centre Programme. SB, AH, SG and SP were supported by the German Federal Ministry of Education and Research (BMBF) via the project Ecology and Pathogenesis of SARS, an Archetypical Zoonosis (project codes 01KIO701, 01KIO703). PSN was supported by National Cancer Institute (NCI) grant P01CA085859. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergeron E, 2005, BIOCHEM BIOPH RES CO, V326, P554, DOI 10.1016/j.bbrc.2004.11.063; Bertram S, 2011, J VIROL, V85, P13363, DOI 10.1128/JVI.05300-11; Bertram S, 2010, J VIROL, V84, P10016, DOI 10.1128/JVI.00239-10; Bertram S, 2010, REV MED VIROL, V20, P298, DOI 10.1002/rmv.657; Bottcher-Friebertshauser E, 2011, J VIROL, V85, P1554, DOI 10.1128/JVI.01294-10; BOSCH FX, 1981, VIROLOGY, V113, P725, DOI 10.1016/0042-6822(81)90201-4; Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06; Chaipan C, 2009, J VIROL, V83, P3200, DOI 10.1128/JVI.02205-08; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Ding YQ, 2004, J PATHOL, V203, P622, DOI 10.1002/path.1560; Drickamer K, 1998, TRENDS BIOCHEM SCI, V23, P321, DOI 10.1016/S0968-0004(98)01246-8; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Glowacka I, 2011, J VIROL, V85, P4122, DOI 10.1128/JVI.02232-10; Gu J, 2005, J EXP MED, V202, P415, DOI 10.1084/jem.20050828; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; He YX, 2004, J IMMUNOL, V173, P4050, DOI 10.4049/jimmunol.173.6.4050; Hofmann H, 2004, J VIROL, V78, P6134, DOI 10.1128/JVI.78.12.6134-6142.2004; HORIMOTO T, 1994, J VIROL, V68, P3120, DOI 10.1128/JVI.68.5.3120-3128.1994; Ito T, 2001, J VIROL, V75, P4439, DOI 10.1128/JVI.75.9.4439-4443.2001; Jacquinet E, 2000, FEBS LETT, V468, P93, DOI 10.1016/S0014-5793(00)01196-0; Jacquinet E, 2001, EUR J BIOCHEM, V268, P2687, DOI 10.1046/j.1432-1327.2001.02165.x; Kido H, 2012, BBA-PROTEINS PROTEOM, V1824, P186, DOI 10.1016/j.bbapap.2011.07.001; Kim TS, 2006, MOL CELL BIOL, V26, P965, DOI 10.1128/MCB.26.3.965-975.2006; Kuiken T, 2008, VACCINE, V26, pD59, DOI 10.1016/j.vaccine.2008.07.025; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Lin BY, 1999, CANCER RES, V59, P4180; Lucas J, 2008, J PATHOL, V215, P118, DOI 10.1002/path.2330; Matsuyama S, 2010, J VIROL, V84, P12658, DOI 10.1128/JVI.01542-10; Mossel EC, 2008, VIROLOGY, V372, P127, DOI 10.1016/j.virol.2007.09.045; Nelli RK, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-4; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nicholls JM, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-73; Parrish CR, 2005, ANNU REV MICROBIOL, V59, P553, DOI 10.1146/annurev.micro.59.030804.121059; Pulford K, 1997, BLOOD, V89, P1394, DOI 10.1182/blood.V89.4.1394; Ren XF, 2006, J GEN VIROL, V87, P1691, DOI 10.1099/vir.0.81749-0; Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115; Shulla A, 2011, J VIROL, V85, P873, DOI 10.1128/JVI.02062-10; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Simmons G, 2011, VIROLOGY, V413, P265, DOI 10.1016/j.virol.2011.02.020; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Skowronski DA, 2005, ANNU REV MED, V56, P357, DOI 10.1146/annurev.med.56.091103.134135; Takahashi M, 2001, HISTOCHEM CELL BIOL, V115, P181; Tedoldl S, 2006, J PATHOL, V209, P454, DOI 10.1002/path.2002; To KF, 2004, J PATHOL, V203, P740, DOI 10.1002/path.1597; Vaarala MH, 2001, INT J CANCER, V94, P705, DOI 10.1002/ijc.1526; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; WALSH JJ, 1961, ARCH INTERN MED, V108, P376, DOI 10.1001/archinte.1961.03620090048006; Wang W, 2008, J VIROL METHODS, V153, P111, DOI 10.1016/j.jviromet.2008.07.015; Yao L, 2008, FASEB J, V22, P733, DOI 10.1096/fj.06-7880com; Yao YX, 2004, J INFECT DIS, V190, P91, DOI 10.1086/421280; Young B, 2006, WHEATERS FUNCTIONAL; ZHIRNOV OP, 1984, VOP VIRUSOL+, P491; ZHIRNOV OP, 1984, J GEN VIROL, V65, P191, DOI 10.1099/0022-1317-65-1-191; Zhirnov OP, 2011, APROTININ SIMILAR PR	54	270	279	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35876	10.1371/journal.pone.0035876	http://dx.doi.org/10.1371/journal.pone.0035876			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558251	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340200027
J	Chen, WT; Hong, CJ; Lin, YT; Chang, WH; Huang, HT; Liao, JY; Chang, YJ; Hsieh, YF; Cheng, CY; Liu, HC; Chen, YR; Cheng, IH				Chen, Wei-Ting; Hong, Chen-Jee; Lin, Ya-Tzu; Chang, Wen-Han; Huang, He-Ting; Liao, Jhih-Ying; Chang, Yu-Jen; Hsieh, Yi-Fang; Cheng, Chih-Ya; Liu, Hsiu-Chih; Chen, Yun-Ru; Cheng, Irene H.			Amyloid-Beta (A beta) D7H Mutation Increases Oligomeric A beta 42 and Alters Properties of A beta-Zinc/Copper Assemblies	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; PROTOFIBRIL FORMATION; CEREBRAL-HEMORRHAGE; CROSS-LINKING; BINDING-SITE; PEPTIDE; COPPER; ZINC; AGGREGATION	Amyloid precursor protein (APP) mutations associated with familial Alzheimer's disease (AD) usually lead to increases in amyloid beta-protein (A beta) levels or aggregation. Here, we identified a novel APP mutation, located within the A beta sequence (A beta(D7H)), in a Taiwanese family with early onset AD and explored the pathogenicity of this mutation. Cellular and biochemical analysis reveal that this mutation increased A beta production, A beta 42/40 ratio and prolonged A beta 42 oligomer state with higher neurotoxicity. Because the D7H mutant A beta has an additional metal ion-coordinating residue, histidine, we speculate that this mutation may promote susceptibility of A beta to ion. When co-incubated with Zn2+ or Cu2+, A beta(D7H) aggregated into low molecular weight oligomers. Together, the D7H mutation could contribute to AD pathology through a "double punch'' effect on elevating both A beta production and oligomerization. Although the pathogenic nature of this mutation needs further confirmation, our findings suggest that the A beta N-terminal region potentially modulates APP processing and A beta aggregation, and further provides a genetic indication of the importance of Zn2+ and Cu2+ in the etiology of AD.	[Chen, Wei-Ting; Hong, Chen-Jee; Lin, Ya-Tzu; Chang, Wen-Han; Huang, He-Ting; Liao, Jhih-Ying; Hsieh, Yi-Fang; Cheng, Irene H.] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Hong, Chen-Jee] Natl Yang Ming Univ, Div Psychiat, Taipei 112, Taiwan; [Hong, Chen-Jee; Cheng, Chih-Ya] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Liu, Hsiu-Chih] Natl Yang Ming Univ, Div Neurol, Taipei 112, Taiwan; [Cheng, Irene H.] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan; [Chang, Yu-Jen; Chen, Yun-Ru] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Chen, Wei-Ting] Natl Yang Ming Univ, Taiwan Int Grad Program Mol Med, Taipei 112, Taiwan; [Hong, Chen-Jee] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Liu, Hsiu-Chih] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Chen, WT (corresponding author), Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan.	yrchen@gate.sinica.edu.tw; hjcheng@ym.edu.tw	Chen, Yun-Ru/C-9304-2014; CHEN, WEI-TING/AFL-9663-2022	Chen, Yun-Ru/0000-0002-6596-6338; CHEN, WEI-TING/0000-0003-2730-9529	Taiwan National Health Research Institutes [NHRI-EX100-9816NC]; Taiwan National Science Council [NSC97-2320-B-010-027-MY3, NSC100-2320-B-010-020]; Taiwan Ministry of Education Aim for Top University Grant; Taipei Veterans General Hospital [V97C1-098]; Molecular Medicine Program; Taiwan International Graduate Program; Institute of Biomedical Sciences, Academia Sinica; Genomics Research Center, Academia Sinica, National Science Council [98-2320-B-001-020-MY3]	Taiwan National Health Research Institutes; Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Taiwan Ministry of Education Aim for Top University Grant; Taipei Veterans General Hospital(Taipei Veterans General Hospital); Molecular Medicine Program; Taiwan International Graduate Program; Institute of Biomedical Sciences, Academia Sinica(Academia Sinica - Taiwan); Genomics Research Center, Academia Sinica, National Science Council	This work was supported by Taiwan National Health Research Institutes NHRI-EX100-9816NC, Taiwan National Science Council grants NSC97-2320-B-010-027-MY3 and NSC100-2320-B-010-020, Taiwan Ministry of Education Aim for Top University Grant (for IHC); Taipei Veterans General Hospital grant V97C1-098 (for CJH); Molecular Medicine Program, Taiwan International Graduate Program, Institute of Biomedical Sciences, Academia Sinica (for WTC); and Genomics Research Center, Academia Sinica, National Science Council grant 98-2320-B-001-020-MY3 (for YRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo KM, 2011, J BIOL CHEM, V286, P8252, DOI 10.1074/jbc.M110.128512; Atwood CS, 2004, BIOCHEMISTRY-US, V43, P560, DOI 10.1021/bi0358824; Barnham KJ, 2004, FASEB J, V18, P1427, DOI 10.1096/fj.04-1890fje; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; BURDICK D, 1992, J BIOL CHEM, V267, P546; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Chen WT, 2011, J BIOL CHEM, V286, P9646, DOI 10.1074/jbc.M110.177246; Cheng IH, 2004, NAT MED, V10, P1190, DOI 10.1038/nm1123; Clements A, 1996, J NEUROCHEM, V66, P740; Dahms SO, 2012, J MOL BIOL, V416, P438, DOI 10.1016/j.jmb.2011.12.057; Dai XL, 2010, J MOL NEUROSCI, V41, P66, DOI 10.1007/s12031-009-9282-8; De Jonghe C, 1998, NEUROBIOL DIS, V5, P281, DOI 10.1006/nbdi.1998.0202; Di Fede G, 2009, SCIENCE, V323, P1473, DOI 10.1126/science.1168979; Duce JA, 2010, CELL, V142, P857, DOI 10.1016/j.cell.2010.08.014; Duce JA, 2010, PROG NEUROBIOL, V92, P1, DOI 10.1016/j.pneurobio.2010.04.003; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Faux NG, 2010, J ALZHEIMERS DIS, V20, P509, DOI 10.3233/JAD-2010-1390; FELSENSTEIN KM, 1994, NAT GENET, V6, P251, DOI 10.1038/ng0394-251; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Grabowski TJ, 2001, ANN NEUROL, V49, P697, DOI 10.1002/ana.1009; Guerreiro RJ, 2010, NEUROBIOL AGING, V31, P725, DOI 10.1016/j.neurobiolaging.2008.06.012; HAAN J, 1990, ARCH NEUROL-CHICAGO, V47, P965, DOI 10.1001/archneur.1990.00530090035010; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hegde ML, 2009, J ALZHEIMERS DIS, V17, P457, DOI 10.3233/JAD-2009-1068; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; Hori Y, 2007, J BIOL CHEM, V282, P4916, DOI 10.1074/jbc.M608220200; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; Jan A, 1992, NAT PROTOC, V5, P1186; Karr JW, 2005, BIOCHEMISTRY-US, V44, P5478, DOI 10.1021/bi047611e; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LeVine H, 2002, ARCH BIOCHEM BIOPHYS, V404, P106; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Maruyama K, 1996, BIOCHEM BIOPH RES CO, V227, P730, DOI 10.1006/bbrc.1996.1577; Miller Y, 2010, P NATL ACAD SCI USA, V107, P9490, DOI 10.1073/pnas.0913114107; Minicozzi V, 2008, J BIOL CHEM, V283, P10784, DOI 10.1074/jbc.M707109200; Nair NG, 2010, J ALZHEIMERS DIS, V20, P57, DOI 10.3233/JAD-2010-1346; Nakamura M, 2007, BIOCHEMISTRY-US, V46, P12737, DOI 10.1021/bi701079z; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Olofsson A, 2007, BIOCHEM J, V404, P63, DOI 10.1042/BJ20061561; Pedersen JT, 2011, J BIOL CHEM, V286, P26952, DOI 10.1074/jbc.M111.220863; Phinney AL, 2003, P NATL ACAD SCI USA, V100, P14193, DOI 10.1073/pnas.2332851100; Schmidt M, 2009, P NATL ACAD SCI USA, V106, P19813, DOI 10.1073/pnas.0905007106; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shin BK, 2011, J PHYS CHEM A, V115, P9590, DOI 10.1021/jp200379m; Smith DG, 2007, BBA-BIOMEMBRANES, V1768, P1976, DOI 10.1016/j.bbamem.2007.02.002; Smith DP, 2007, BIOCHEMISTRY-US, V46, P2881, DOI 10.1021/bi0620961; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Tougu V, 2008, J NEUROCHEM, V104, P1249, DOI 10.1111/j.1471-4159.2007.05061.x; Tougu V, 2011, METALLOMICS, V3, P250, DOI 10.1039/c0mt00073f; Tougu V, 2009, J NEUROCHEM, V110, P1784, DOI 10.1111/j.1471-4159.2009.06269.x; Wang CY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015349; Zheng W, 2009, FASEB J, V23, P4207, DOI 10.1096/fj.09-135749; Zhou L, 2011, EMBO MOL MED, V3, P291, DOI 10.1002/emmm.201100138	55	45	46	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35807	10.1371/journal.pone.0035807	http://dx.doi.org/10.1371/journal.pone.0035807			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558227	Green Submitted, gold, Green Published			2022-12-27	WOS:000305340200022
J	Petrlova, J; Kalai, T; Maezawa, I; Altman, R; Harishchandra, G; Hong, HS; Bricarello, DA; Parikh, AN; Lorigan, GA; Jin, LW; Hideg, K; Voss, JC				Petrlova, Jitka; Kalai, Tamas; Maezawa, Izumi; Altman, Robin; Harishchandra, Ghimire; Hong, Hyun-Seok; Bricarello, Daniel A.; Parikh, Atul N.; Lorigan, Gary A.; Jin, Lee-Way; Hideg, Kalman; Voss, John C.			The Influence of Spin-Labeled Fluorene Compounds on the Assembly and Toxicity of the A beta Peptide	PLOS ONE			English	Article							INTRACELLULAR AMYLOID-BETA; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; CIRCULAR-DICHROISM; IN-VIVO; CYTOTOXICITY; BRAIN; DYSFUNCTION; INHIBITION; NITROXIDES	Background: The deposition and oligomerization of amyloid beta (A beta) peptide plays a key role in the pathogenesis of Alzheimer's disease (AD). A beta peptide arises from cleavage of the membrane-associated domain of the amyloid precursor protein (APP) by beta and gamma secretases. Several lines of evidence point to the soluble A beta oligomer (A beta O) as the primary neurotoxic species in the etiology of AD. Recently, we have demonstrated that a class of fluorene molecules specifically disrupts the A beta O species. Methodology/Principal Findings: To achieve a better understanding of the mechanism of action of this disruptive ability, we extend the application of electron paramagnetic resonance (EPR) spectroscopy of site-directed spin labels in the A beta peptide to investigate the binding and influence of fluorene compounds on A beta O structure and dynamics. In addition, we have synthesized a spin-labeled fluorene (SLF) containing a pyrroline nitroxide group that provides both increased cell protection against A beta O toxicity and a route to directly observe the binding of the fluorene to the A beta O assembly. We also evaluate the ability of fluorenes to target multiple pathological processes involved in the neurodegenerative cascade, such as their ability to block A beta O toxicity, scavenge free radicals and diminish the formation of intracellular A beta O species. Conclusions: Fluorene modified with pyrroline nitroxide may be especially useful in counteracting A beta peptide toxicity, because they posses both antioxidant properties and the ability to disrupt A beta O species.	[Petrlova, Jitka; Altman, Robin; Voss, John C.] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Kalai, Tamas; Hideg, Kalman] Univ Pecs, Inst Organ & Med Chem, Pecs, Hungary; [Maezawa, Izumi; Hong, Hyun-Seok; Jin, Lee-Way] Miami Univ, Dept Pathol, MIND, Oxford, OH 45056 USA; [Harishchandra, Ghimire; Lorigan, Gary A.] Miami Univ, Dept Chem & Biochem, Oxford, OH 45056 USA; [Bricarello, Daniel A.; Parikh, Atul N.] Univ Calif Davis, Dept Appl Sci, Davis, CA 95616 USA	University of California System; University of California Davis; University of Pecs; University System of Ohio; Miami University; University System of Ohio; Miami University; University of California System; University of California Davis	Petrlova, J (corresponding author), Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA.	jcvoss@ucdavis.edu	PARIKH, ATUL/T-8268-2019; PARIKH, ATUL N/D-2243-2014	PARIKH, ATUL N/0000-0002-5927-4968; Voss, John/0000-0001-9279-209X	U.S. National Institutes of Health [R01 AG029246]; Hungarian National Research Fund OTKA [T81123]; NATIONAL INSTITUTE ON AGING [R01AG029246] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hungarian National Research Fund OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by grants from the U.S. National Institutes of Health (R01 AG029246) and the Hungarian National Research Fund OTKA T81123. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; BERLINER LJ, 1982, ANAL BIOCHEM, V119, P450, DOI 10.1016/0003-2697(82)90612-1; Cai LS, 2007, CURR MED CHEM, V14, P19, DOI 10.2174/092986707779313471; Farooqui AA, 1997, NEUROCHEM INT, V30, P517; Glebska J, 2001, BIOMETALS, V14, P159, DOI 10.1023/A:1016689607579; Hideg K, 2007, CARDIOVASC TOXICOL, V7, P160, DOI 10.1007/s12012-007-0019-z; Hong HS, 2007, BRAIN RES, V1130, P223, DOI 10.1016/j.brainres.2006.10.093; Hong HS, 2010, NEUROBIOL AGING, V31, P1690, DOI 10.1016/j.neurobiolaging.2008.09.019; Hong HS, 2009, J NEUROCHEM, V108, P1097, DOI 10.1111/j.1471-4159.2008.05866.x; Jin LW, 2004, AM J PATHOL, V164, P975, DOI 10.1016/S0002-9440(10)63185-9; Kalai T, 2011, EUR J MED CHEM, V46, P1348, DOI 10.1016/j.ejmech.2011.01.059; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lam MA, 2008, CHEM RES TOXICOL, V21, P2111, DOI 10.1021/tx800183t; Lee CW, 2003, NUCL MED BIOL, V30, P573, DOI 10.1016/S0969-8051(03)00050-7; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li J, 2011, BIOPHYS J, V100, P1076, DOI 10.1016/j.bpj.2010.12.3741; Liao MQ, 2007, FEBS LETT, V581, P1161, DOI 10.1016/j.febslet.2007.02.026; Likhtenstein G.I, 1993, BIOPHYSICAL LABELING, P46; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Maezawa I, 2004, J NEUROCHEM, V91, P1312, DOI 10.1111/j.1471-4159.2004.02818.x; Maezawa I, 2008, J NEUROCHEM, V104, P457, DOI 10.1111/j.1471-4159.2007.04972.x; Maezawa I, 2006, J NEUROCHEM, V98, P57, DOI 10.1111/j.1471-4159.2006.03862.x; Mandal R, 2007, J PHARMACOL EXP THER, V323, P119, DOI 10.1124/jpet.107.127167; Pardridge WM, 2007, DRUG DISCOV TODAY, V12, P54, DOI 10.1016/j.drudis.2006.10.013; Petrlova J, 2011, PROTEINS, V79, P402, DOI 10.1002/prot.22891; SOPHER BL, 1994, MOL BRAIN RES, V26, P207, DOI 10.1016/0169-328X(94)90092-2; Twomey P, 1997, FREE RADICAL BIO MED, V22, P909, DOI 10.1016/S0891-5849(96)00477-7; Wu J., 2009, J BIOL CHEM	32	16	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35443	10.1371/journal.pone.0035443	http://dx.doi.org/10.1371/journal.pone.0035443			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558151	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000305340200017
J	Sammarco, PW; Brazeau, DA; Sinclair, J				Sammarco, Paul W.; Brazeau, Daniel A.; Sinclair, James			Genetic Connectivity in Scleractinian Corals across the Northern Gulf of Mexico: Oil/Gas Platforms, and Relationship to the Flower Garden Banks	PLOS ONE			English	Article							LENGTH POLYMORPHISM AFLP; TUBASTRAEA-COCCINEA; MISSISSIPPI RIVER; POPULATION ALLOCATION; SPECIES BOUNDARIES; NORTHWESTERN GULF; DISPERSAL; CNIDARIA; FLORIDA; BIOGEOGRAPHY	The 3,000 oil/gas structures currently deployed in the northern Gulf of Mexico (GOM) provide hard substratum for marine organisms in a region where such has been rare since the Holocene. The major exception to this are the Flower Garden Banks (FGB). Corals are known to have colonized oil/gas platforms around the FGB, facilitating biogeographic expansion. We ask the question, what are the patterns of genetic affinity in these coral populations. We sampled coral tissue from populations of two species occurring on oil and gas platforms: Madracis decactis (hermatype) and Tubastraea coccinea (invasive ahermatype). We sampled 28 platforms along four transects from 20 km offshore to the continental shelf edge off 1) Matagorda Island, TX; 2) Lake Sabine, TX; 3) Terrebonne Bay, LA; and 4) Mobile, AL. The entire population of M. decactis was sampled between depths of 5 m and 37 m. T. coccinea populations were sub-sampled. Genetic variation was assessed using the PCR-based Amplified Fragment Length Polymorphisms (AFLPs). Data were analyzed via AFLPOP and STRUCTURE. Genetic connectivity among M. decactis platform populations was highest near the FGB and decreased to the east. Connectivity increased again in the eastern sector, indicating isolation between the populations from different sides of the Mississippi River (Transects 3 and 4). A point-drop in genetic affinity (relatedness) at the shelf edge south of Terrebonne Bay, LA indicated a population differing from all others in the northern GOM. Genetic affinities among T. coccinea were highest in the west and decreased to the east. Very low genetic affinities off Mobile, AL indicated a dramatic difference between those populations and those west of the Mississippi River, apparently a formidable barrier to larval dispersal.	[Sammarco, Paul W.] Louisiana Univ Marine Consortium LUMCON, Chauvin, LA 70344 USA; [Sammarco, Paul W.] Louisiana State Univ, Dept Oceanog & Coastal Sci, A&M Coll, Baton Rouge, LA 70803 USA; [Brazeau, Daniel A.] SUNY Buffalo, Pharmaceut Genet Lab, Dept Pharmaceut Sci, Buffalo, NY 14260 USA; [Sinclair, James] Bur Ocean Energy Management Regulat & Enforcement, Environm Sect, Gulf Mexico OCS Reg & Atlantic Activ, US Dept Interior, New Orleans, LA USA	Louisiana State University System; Louisiana State University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; United States Department of the Interior	Sammarco, PW (corresponding author), Louisiana Univ Marine Consortium LUMCON, Chauvin, LA 70344 USA.	psammarco@lumcon.edu						Adamkewicz SL, 1996, AM MALACOL BULL, V13, P97; Adams CL, 1996, THESIS TEXAS A M U C; Amar KO, 2008, MAR BIOTECHNOL, V10, P350, DOI 10.1007/s10126-007-9069-2; Aronson RB, 2007, ECOL STUDIES; ATCHISON AD, 2006, P 10 INT COR REEF S; Atchison AD, 2005, THESIS LOUISIANA STA; Atchison AD, 2008, J EXP MAR BIOL ECOL, V365, P1, DOI 10.1016/j.jembe.2008.07.002; AYRE DJ, 1986, MAR BIOL, V90, P187, DOI 10.1007/BF00569126; Bassim KM, 2003, MAR BIOL, V142, P241, DOI 10.1007/S00227-002-0953-z; Bassim KM, 2002, MAR BIOL, V140, P479, DOI 10.1007/s00227-001-0722-4; Baums IB, 2005, MOL ECOL, V14, P1377, DOI 10.1111/j.1365-294X.2005.02489.x; Bensch S, 2005, MOL ECOL, V14, P2899, DOI 10.1111/j.1365-294X.2005.02655.x; Bergstrom DM, 2009, J APPL ECOL, V46, P73, DOI 10.1111/j.1365-2664.2008.01601.x; Bernatchez L, 2000, CAN J FISH AQUAT SCI, V57, P1, DOI 10.1139/cjfas-57-1-1; Blears MJ, 1998, J IND MICROBIOL BIOT, V21, P99, DOI 10.1038/sj.jim.2900537; Boland G.S., 2002, P GULF MEX FISH FISH; Boland GS, 2000, COMMUNICATION; Brandley MC, 2010, MOL PHYLOGENET EVOL, V57, P552, DOI 10.1016/j.ympev.2010.07.015; Brazeau DA, 2005, MAR BIOL, V147, P1141, DOI 10.1007/s00227-005-0022-5; Brazeau DA, AQUAT BIOL; Brazeau DA, 2008, P 11 INT COR REEF S; BRIGHT T J, 1991, Northeast Gulf Science, V12, P55; BRIGHT TJ, 1984, B MAR SCI, V34, P461; CAIRNS SD, 2000, STUDIES NATURAL HIST, V75, P1; Casey M, 2009, CBS NEWS        0113; Dagg M, 2008, CONT SHELF RES, V28, P1127, DOI 10.1016/j.csr.2008.02.013; Dagg MJ, 2003, J MARINE SYST, V43, P133, DOI 10.1016/j.jmarsys.2003.09.002; de Paula AF, 2004, B MAR SCI, V74, P175; Deslarzes K, 2000, COMMUNICATION; Deslarzes Kenneth J. P., 2007, V192, P126; DOKKEN QR, 2002, LONG TERM MONITORING; DOKKEN QR, 1999, LONG TERM MONITORING; Driessen PK, 1989, PETROLEUM STRUCTURES, P3; Duchesne P, 2002, MOL ECOL NOTES, V2, P380, DOI 10.1046/j.1471-8286.2002.00251.x; Edmondson CH, 1941, OCC PAP BISHOP MUS, V18, P283; Fenner D, 2004, CORAL REEFS, V23, P505, DOI 10.1007/s00338-004-0422-x; Fenner D, 2001, B MAR SCI, V69, P1175; Fenner D, 1999, B MAR SCI, V64, P143; Fitzhugh K, 1999, INVERTEBR BIOL, V118, P357, DOI 10.2307/3227007; Fukami H, 2004, EVOLUTION, V58, P324, DOI 10.1111/j.0014-3820.2004.tb01648.x; Futuyma D. J., 1988, EVOLUTIONARY BIOL; Gallaway BJ, 1981, 10BS8227 USFWS OFF B; GITTINGS SR, 1992, B MAR SCI, V51, P420; Glynn PW, 2008, MAR BIOL, V153, P529, DOI 10.1007/s00227-007-0827-5; Hagman Derek K., 1998, Gulf of Mexico Science, V16, P170; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; He TH, 2004, MOL ECOL, V13, P1099, DOI 10.1111/j.1365-294X.2004.02120.x; Hellberg ME, 2007, CORAL REEFS, V26, P463, DOI 10.1007/s00338-007-0205-2; Hellberg ME, 2002, B MAR SCI, V70, P273; Hewitt CL, 2005, BIOL INVASIONS, V7, P251, DOI 10.1007/s10530-004-0739-y; Hickerson E. L., 2006, EOS T AM GEOPHYS U S, V87; HODGSON G, 1990, CORAL REEFS, V9, P41, DOI 10.1007/BF00686720; Humann P., 2002, REEF CORAL IDENTIFIC; LaJeunesse TC, 2005, CORAL REEFS, V24, P157, DOI 10.1007/s00338-004-0436-4; Lang JC, 1972, COMMUNICATION; Lohrenz SE, 2008, CONT SHELF RES, V28, P1466, DOI 10.1016/j.csr.2007.06.019; Lopez JV, 1999, BIOL BULL-US, V196, P80, DOI 10.2307/1543170; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Lugo-Fernandez A, 2010, CONT SHELF RES, V30, P1226, DOI 10.1016/j.csr.2010.03.014; Lugo-Fernandez A, 2001, CONT SHELF RES, V21, P47, DOI 10.1016/S0278-4343(00)00072-8; Lugo-Fernandez Alexis, 2006, Gulf of Mexico Science, V24, P61; MAC ARTHUR ROBERT H., 1967; Maltagliati F, 2002, B MAR SCI, V71, P473; McGuire MP, 1998, CORAL REEFS, V17, P369, DOI 10.1007/s003380050141; Mettler L.E., 1988, POPULATION GENETICS; Mueller UG, 1999, TRENDS ECOL EVOL, V14, P389, DOI 10.1016/S0169-5347(99)01659-6; National Oceanic and Atmospheric Administration, 2008, FLOW GARD BANKS 2008; Oey L-Y, 2005, GEOPHYS MONGRAPH SER; Olascoaga MJ, 2010, NONLINEAR PROC GEOPH, V17, P685, DOI 10.5194/npg-17-685-2010; Pagad S, 2007, TUBASTRAEA COCCINEA; Pritchard JK, 2000, GENETICS, V155, P945; Pyron RA, 2010, J BIOGEOGR, V37, P2005, DOI 10.1111/j.1365-2699.2010.02336.x; Rabalais NN, 1996, ESTUARIES, V19, P386, DOI 10.2307/1352458; Reggio V. C., 1989, PETROLEUM STRUCTURES, P47; REZAK R, 1983, REEFS BANKS NW GULF; Rezak R., 1985, REEFS BANKS NW GULF; Sammarco, 2011, UNPUB; Sammarco, 2011, IN PRESS; Sammarco P.W., 2007, P AUSTR MAR SCI ASS; Sammarco P.W., GULF DRILLI IN PRESS; Sammarco P.W., 2007, P MIN MAN SERV INF T; Sammarco PW, 2010, AQUAT INVASIONS, V5, P131, DOI 10.3391/ai.2010.5.2.02; Sammarco Paul W., 1994, Coastal and Estuarine Studies, V45, P35; SAMMARCO PW, 1989, LIMNOL OCEANOGR, V34, P896, DOI 10.4319/lo.1989.34.5.0896; Sammarco PW, 2004, MAR ECOL PROG SER, V280, P129, DOI 10.3354/meps280129; Sammarco PW, 2007, ASS MAR LABS CAR AML; Sammarco PW, 1973, COMMUNICATION; Sammarco PW, 2008, GULF DRILLING PLATFO; Sammarco PW, 2002, GULF DRILLING PLATFO; Sammarco PW, 2005, GULF DRILLING PLATFO; Sammarco PW, 2003, GULF DRILLING PLATFO; Schmahl G. P., 2005, 3 INT S DEEP SEA COR; SCHMAHL GP, 2003, P US DEP INT MIN MAN; Schmahl GP, 2006, EOS T AM GEOPHYS U S, V87; Shearer T, 2008, 2008 OC SCI M WAT GL; Shinn EA, 1974, P INT C ART REEFS MA, P91; Simberloff D, 2000, B MAR SCI, V66, P567; Sunnucks P, 2000, TRENDS ECOL EVOL, V15, P199, DOI 10.1016/S0169-5347(00)01825-5; Tunnell JW, 2009, GULF MEXICO ORIGINS; VanToai TT, 1997, CROP SCI, V37, P1370, DOI 10.2135/cropsci1997.0011183X003700040056x; Vermeij MJA, 2006, MAR ECOL PROG SER, V310, P119, DOI 10.3354/meps310119; Vermeij MJA, 2005, CORAL REEFS, V24, P442, DOI 10.1007/s00338-005-0489-z; Vermeij MJA, 2003, MAR ECOL PROG SER, V247, P75, DOI 10.3354/meps247075; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Weersing K, 2009, MAR ECOL PROG SER, V393, P1, DOI 10.3354/meps08287; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960	106	40	44	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e30144	10.1371/journal.pone.0030144	http://dx.doi.org/10.1371/journal.pone.0030144			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558066	Green Submitted, Green Published, gold			2022-12-27	WOS:000305340200001
J	Baxter, I; Hermans, C; Lahner, B; Yakubova, E; Tikhonova, M; Verbruggen, N; Chao, DY; Salt, DE				Baxter, Ivan; Hermans, Christian; Lahner, Brett; Yakubova, Elena; Tikhonova, Marina; Verbruggen, Nathalie; Chao, Dai-yin; Salt, David E.			Biodiversity of Mineral Nutrient and Trace Element Accumulation in Arabidopsis thaliana	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; METAL HYPERACCUMULATION; FUNCTIONAL GENOMICS; NATURAL VARIATION; LEAF IONOME; TOLERANCE; IDENTIFICATION; MAGNESIUM; QTL; POPULATION	In order to grow on soils that vary widely in chemical composition, plants have evolved mechanisms for regulating the elemental composition of their tissues to balance the mineral nutrient and trace element bioavailability in the soil with the requirements of the plant for growth and development. The biodiversity that exists within a species can be utilized to investigate how regulatory mechanisms of individual elements interact and to identify genes important for these processes. We analyzed the elemental composition (ionome) of a set of 96 wild accessions of the genetic model plant Arabidopsis thaliana grown in hydroponic culture and soil using inductively coupled plasma mass spectrometry (ICP-MS). The concentrations of 17-19 elements were analyzed in roots and leaves from plants grown hydroponically, and leaves and seeds from plants grown in artificial soil. Significant genetic effects were detected for almost every element analyzed. We observed very few correlations between the elemental composition of the leaves and either the roots or seeds. There were many pairs of elements that were significantly correlated with each other within a tissue, but almost none of these pairs were consistently correlated across tissues and growth conditions, a phenomenon observed in several previous studies. These results suggest that the ionome of a plant tissue is variable, yet tightly controlled by genes and genexenvironment interactions. The dataset provides a valuable resource for mapping studies to identify genes regulating elemental accumulation. All of the ionomic data is available at www.ionomicshub.org.	[Baxter, Ivan] ARS, Plant Genet Res Unit, Donald Danforth Plant Sci Ctr, USDA, St Louis, MO 63132 USA; [Baxter, Ivan; Lahner, Brett; Yakubova, Elena; Tikhonova, Marina; Chao, Dai-yin; Salt, David E.] Purdue Univ, Ctr Plant Stress Physiol, W Lafayette, IN 47907 USA; [Hermans, Christian; Verbruggen, Nathalie] Univ Libre Bruxelles, Lab Plant Physiol & Mol Genet, Brussels, Belgium; [Chao, Dai-yin; Salt, David E.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland	Donald Danforth Plant Science Center; United States Department of Agriculture (USDA); Purdue University System; Purdue University; Purdue University West Lafayette Campus; Universite Libre de Bruxelles; University of Aberdeen	Baxter, I (corresponding author), ARS, Plant Genet Res Unit, Donald Danforth Plant Sci Ctr, USDA, St Louis, MO 63132 USA.	ivan.baxter@ars.usda.gov	Baxter, Ivan R/A-1052-2009; Chao, Daiyin/A-5213-2013; Chao, Dai-Yin/GYV-5944-2022	Baxter, Ivan R/0000-0001-6680-1722; Verbruggen, Nathalie/0000-0003-2296-5404; ?, ??/0000-0003-2832-4800	National Institutes of Health, National Institute of General Medicine [R01 GM78536-01A1]; Indiana 21st Century Research and Technology Fund [912010479]; Belgian Science Policy Office (BelSPo) [IAPVI/33]; United States Department of Agriculture-Agricultural Research Service; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078536] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of General Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Indiana 21st Century Research and Technology Fund; Belgian Science Policy Office (BelSPo)(Belgian Federal Science Policy Office); United States Department of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was funded by a grant from the National Institutes of Health, the National Institute of General Medicine (R01 GM78536-01A1) awarded to Dr. Salt, Dr. Guerinot and Dr. Baxter, the Indiana 21st Century Research and Technology Fund (912010479) to Dr. Salt, the Belgian Science Policy Office (BelSPo project IAPVI/33) to Dr. Verbruggen and United States Department of Agriculture-Agricultural Research Service Intramural funds to Dr. Baxter. Dr. Hermans is currently a research associate of the Fonds National de la Recherche Scientifique (FNRS-FRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; BAKER AJM, 1987, NEW PHYTOL, V106, P93; Baxter I, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000004; Baxter I, 2007, PLANT PHYSIOL, V143, P600, DOI 10.1104/pp.106.092528; Baxter I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001193; Baxter I, 2010, BRIEF FUNCT GENOMICS, V9, P149, DOI 10.1093/bfgp/elp055; Baxter I, 2009, CURR OPIN PLANT BIOL, V12, P381, DOI 10.1016/j.pbi.2009.05.002; Baxter I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000492; Baxter IR, 2008, P NATL ACAD SCI USA, V105, P12081, DOI 10.1073/pnas.0804175105; Becker A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015993; Bradshaw HD, 2005, NEW PHYTOL, V167, P81, DOI 10.1111/j.1469-8137.2005.01408.x; Brady KU, 2005, ANNU REV ECOL EVOL S, V36, P243, DOI 10.1146/annurev.ecolsys.35.021103.105730; Broadley MR, 2010, NEW PHYTOL, V186, P270, DOI 10.1111/j.1469-8137.2009.03145.x; Broadley MR, 2008, PLANT PHYSIOL, V146, P1707, DOI 10.1104/pp.107.114645; Buescher E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011081; Chao DY, 2011, PLANT CELL, V23, P1061, DOI 10.1105/tpc.110.079095; Courbot M, 2007, PLANT PHYSIOL, V144, P1052, DOI 10.1104/pp.106.095133; DeRose-Wilson L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022832; Ding GD, 2010, ANN BOT-LONDON, V105, P1221, DOI 10.1093/aob/mcq050; Durrett TP, 2007, PLANT PHYSIOL, V144, P197, DOI 10.1104/pp.107.097162; Galpaz N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015198; Ghandilyan A, 2009, NEW PHYTOL, V184, P180, DOI 10.1111/j.1469-8137.2009.02953.x; Ghandilyan A, 2009, J EXP BOT, V60, P1409, DOI 10.1093/jxb/erp084; Hanikenne M, 2008, NATURE, V453, P391, DOI 10.1038/nature06877; Hermans C, 2011, NEW PHYTOL, V192, P428, DOI 10.1111/j.1469-8137.2011.03814.x; Hoffmann MH, 2002, J BIOGEOGR, V29, P125, DOI 10.1046/j.1365-2699.2002.00647.x; Karley AJ, 2009, CURR OPIN PLANT BIOL, V12, P291, DOI 10.1016/j.pbi.2009.04.013; Klein MA, 2009, GENOME, V52, P677, DOI [10.1139/G09-039, 10.1139/g09-039]; Kobayashi Y, 2008, PLANT PHYSIOL, V148, P969, DOI 10.1104/pp.108.119933; Lahner B, 2003, NAT BIOTECHNOL, V21, P1215, DOI 10.1038/nbt865; Lexer C, 2003, MOL ECOL, V12, P1225, DOI 10.1046/j.1365-294X.2003.01803.x; Liu J, 2009, PLANT SOIL, V320, P255, DOI 10.1007/s11104-009-9891-6; Loudet O, 2007, NAT GENET, V39, P896, DOI 10.1038/ng2050; Lowry DB, 2009, NEW PHYTOL, V183, P776, DOI 10.1111/j.1469-8137.2009.02901.x; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Morrissey J, 2009, PLANT CELL; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Prinzenberg AE, 2010, PLANT PHYSIOL, V154, P1361, DOI 10.1104/pp.110.161398; Rus A, 2006, PLOS GENET, V2, P1964, DOI 10.1371/journal.pgen.0020210; Salt DE, 2008, ANNU REV PLANT BIOL, V59, P709, DOI 10.1146/annurev.arplant.59.032607.092942; Sankaran RP, 2009, THEOR APPL GENET, V119, P241, DOI 10.1007/s00122-009-1033-2; Turner TL, 2010, NAT GENET, V42, P260, DOI 10.1038/ng.515; Verbruggen N, 2009, NEW PHYTOL, V181, P759, DOI 10.1111/j.1469-8137.2008.02748.x; Vreugdenhil D, 2004, PLANT CELL ENVIRON, V27, P828, DOI 10.1111/j.1365-3040.2004.01189.x; Watanabe T, 2007, NEW PHYTOL, V174, P516, DOI 10.1111/j.1469-8137.2007.02078.x; Waters BM, 2008, NEW PHYTOL, V179, P1033, DOI 10.1111/j.1469-8137.2008.02544.x; Waters BM, 2008, NEW PHYTOL, V177, P389, DOI 10.1111/j.1469-8137.2007.02288.x; White PJ, 2009, NEW PHYTOL, V182, P49, DOI 10.1111/j.1469-8137.2008.02738.x	48	71	78	3	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35121	10.1371/journal.pone.0035121	http://dx.doi.org/10.1371/journal.pone.0035121			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558123	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000025
J	Faisca, PFN; Travasso, RDM; Parisi, A; Rey, A				Faisca, Patricia F. N.; Travasso, Rui D. M.; Parisi, Andrea; Rey, Antonio			Why Do Protein Folding Rates Correlate with Metrics of Native Topology?	PLOS ONE			English	Article							SINGLE-DOMAIN PROTEINS; TOPOMER SEARCH MODEL; TRANSITION-STATE; CONTACT ORDER; NONNATIVE INTERACTIONS; LATTICE MODEL; KINETICS; MECHANISM; PRINCIPLES; NUCLEUS	For almost 15 years, the experimental correlation between protein folding rates and the contact order parameter has been under scrutiny. Here, we use a simple simulation model combined with a native-centric interaction potential to investigate the physical roots of this empirical observation. We simulate a large set of circular permutants, thus eliminating dependencies of the folding rate on other protein properties (e.g. stability). We show that the rate-contact order correlation is a consequence of the fact that, in high contact order structures, the contact order of the transition state ensemble closely mirrors the contact order of the native state. This happens because, in these structures, the native topology is represented in the transition state through the formation of a network of tertiary interactions that are distinctively long-ranged.	[Faisca, Patricia F. N.; Travasso, Rui D. M.; Parisi, Andrea] Univ Lisbon, Ctr Fis Mat Condensada, P-1699 Lisbon, Portugal; [Faisca, Patricia F. N.; Parisi, Andrea] Univ Lisbon, Dept Fis, P-1699 Lisbon, Portugal; [Travasso, Rui D. M.] Univ Coimbra, Dept Fis, P-3000 Coimbra, Portugal; [Travasso, Rui D. M.] Univ Coimbra, Ctr Fis Computac, Coimbra, Portugal; [Travasso, Rui D. M.] Univ Coimbra, Ctr Ophthalmol & Vis Sci, Inst Biomed Res Light & Image IBILI, Fac Med, Coimbra, Portugal; [Rey, Antonio] Univ Complutense, Fac Ciencias Quim, Dept Quim Fis 1, E-28040 Madrid, Spain	Universidade de Lisboa; Universidade de Lisboa; Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Complutense University of Madrid	Faisca, PFN (corresponding author), Univ Lisbon, Ctr Fis Mat Condensada, P-1699 Lisbon, Portugal.	patricia.fn.faisca@gmail.com	Parisi, Andrea/H-9783-2013; Travasso, Rui/B-8342-2018; Rey, Antonio/G-7099-2012; Faisca, Patricia/E-9758-2010	Parisi, Andrea/0000-0003-2972-9770; Travasso, Rui/0000-0001-6078-0721; Rey, Antonio/0000-0002-8901-4198; Faisca, Patricia/0000-0002-2493-2748	Fundacao para a Ciencia e a Tecnologia [PTDC/FIS/113638/2009]; Conselho de Reitores das Universidades Portuguesas (Accao Integrada Luso-Espanhola) [E-16/09]; Ministerio de Ciencia e Innovacion [FIS2009-13364-C02-02]; Accion Integrada Hispano-Portuguesa [HP-2008-0065]	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Conselho de Reitores das Universidades Portuguesas (Accao Integrada Luso-Espanhola); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Accion Integrada Hispano-Portuguesa	This work was supported by Fundacao para a Ciencia e a Tecnologia (PTDC/FIS/113638/2009); Conselho de Reitores das Universidades Portuguesas (Accao Integrada Luso-Espanhola E-16/09); Ministerio de Ciencia e Innovacion (FIS2009-13364-C02-02); and Accion Integrada Hispano-Portuguesa (HP-2008-0065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABKEVICH VI, 1994, J CHEM PHYS, V101, P6052, DOI 10.1063/1.467320; ABKEVICH VI, 1994, BIOCHEMISTRY-US, V33, P10026, DOI 10.1021/bi00199a029; Barrick D, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/015001; Best RB, 2010, P NATL ACAD SCI USA, V107, P1088, DOI 10.1073/pnas.0910390107; Bruscolini P, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.038103; Bueno M, 2006, J MOL BIOL, V359, P813, DOI 10.1016/j.jmb.2006.03.067; CAMACHO CJ, 1993, P NATL ACAD SCI USA, V90, P6369, DOI 10.1073/pnas.90.13.6369; Chan HS, 2011, ANNU REV PHYS CHEM, V62, P301, DOI 10.1146/annurev-physchem-032210-103405; Cho SS, 2006, P NATL ACAD SCI USA, V103, P586, DOI 10.1073/pnas.0509768103; Chodera JD, 2007, J CHEM THEORY COMPUT, V3, P26, DOI 10.1021/ct0502864; Clementi C, 2001, J MOL BIOL, V311, P879, DOI 10.1006/jmbi.2001.4871; Daggett V, 2003, NAT REV MOL CELL BIO, V4, P497, DOI 10.1038/nrm1126; Debe DA, 1999, P NATL ACAD SCI USA, V96, P2596, DOI 10.1073/pnas.96.6.2596; DILL KA, 1995, PROTEIN SCI, V4, P561; Du R, 1998, J CHEM PHYS, V108, P334, DOI 10.1063/1.475393; Faisca PFN, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2973624; Faisca PFN, 2010, PROTEIN SCI, V19, P2196, DOI 10.1002/pro.498; Faisca PFN, 2002, J CHEM PHYS, V116, P7231, DOI 10.1063/1.1466833; Fersht AR, 2000, P NATL ACAD SCI USA, V97, P1525, DOI 10.1073/pnas.97.4.1525; Gutin AM, 1996, PHYS REV LETT, V77, P5433, DOI 10.1103/PhysRevLett.77.5433; Hubner IA, 2005, J MOL BIOL, V349, P424, DOI 10.1016/j.jmb.2005.03.050; Ivankov DN, 2003, PROTEIN SCI, V12, P2057, DOI 10.1110/ps.0302503; Kaya H, 2003, PROTEINS, V52, P524, DOI 10.1002/prot.10478; Klimov DK, 1998, J MOL BIOL, V282, P471, DOI 10.1006/jmbi.1998.1997; Klimov DK, 1998, FOLD DES, V3, P127, DOI 10.1016/S1359-0278(98)00018-2; LAU KF, 1989, MACROMOLECULES, V22, P3986, DOI 10.1021/ma00200a030; Li L, 2000, NAT STRUCT BIOL, V7, P336; Lindorff-Larsen K, 2005, TRENDS BIOCHEM SCI, V30, P13, DOI 10.1016/j.tibs.2004.11.008; Lindorff-Larsen K, 2004, NAT STRUCT MOL BIOL, V11, P443, DOI 10.1038/nsmb765; Makarov DE, 2003, PROTEIN SCI, V12, P17, DOI 10.1110/ps.0220003; Makarov DE, 2002, P NATL ACAD SCI USA, V99, P3535, DOI 10.1073/pnas.052713599; Mirny LA, 1996, FOLD DES, V1, P103, DOI 10.1016/S1359-0278(96)00019-3; Munoz V, 1999, P NATL ACAD SCI USA, V96, P11311, DOI 10.1073/pnas.96.20.11311; Paci E, 2003, P NATL ACAD SCI USA, V100, P394, DOI 10.1073/pnas.232704999; Plaxco KW, 2000, BIOCHEMISTRY-US, V39, P11177, DOI 10.1021/bi000200n; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; SHAKHNOVICH EI, 1994, PHYS REV LETT, V72, P3907, DOI 10.1103/PhysRevLett.72.3907; Sosnick TR, 2008, PROTEIN SCI, V17, P1308, DOI 10.1110/ps.036319.108; Travasso RDM, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3485286; Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591; Wallin S, 2005, PROTEIN SCI, V14, P1643, DOI 10.1110/ps.041317705; Weikl TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P67, DOI 10.1016/j.abb.2007.06.018	42	18	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35599	10.1371/journal.pone.0035599	http://dx.doi.org/10.1371/journal.pone.0035599			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558173	gold, Green Published, Green Accepted			2022-12-27	WOS:000305336000038
J	Skouloudaki, K; Walz, G				Skouloudaki, Kassiani; Walz, Gerd			YAP1 Recruits c-Abl to Protect Angiomotin-Like 1 from Nedd4-Mediated Degradation	PLOS ONE			English	Article							YES-ASSOCIATED PROTEIN; WW DOMAIN; HIPPO PATHWAY; COILED-COIL; ORGAN SIZE; PHOSPHORYLATION; FAMILY; UBIQUITINATION; STABILITY; COMPLEX	Background: Tissue development and organ growth require constant remodeling of cell-cell contacts formed between epithelial cells. The Hippo signaling cascade curtails organ growth by excluding the transcriptional co-activator Yes Associated Protein 1 (YAP1) from the nucleus. Angiomotin family members recruit YAP1 to tight junctions [1], but whether YAP1 plays a specific role outside of the nucleus is currently unknown. Methodology/Principal Findings: The present study demonstrates that the E3 ubiquitin ligase Nedd4.2 targets Angiomotin-like 1 (AMOTL1), a family member that promotes the formation of epithelial tight junctions, for ubiquitin-dependent degradation. Unexpectedly, YAP1 antagonizes the function of Nedd4.2, and protects AMOTL1 against Nedd4.2-mediated degradation. YAP1 recruits c-Abl, a tyrosine kinase that binds and phosphorylates Nedd4.2 on tyrosine residues, thereby modifying its ubiquitin-ligase activity. Conclusions/Significance: Our results uncover a novel function for cytoplasmic YAP1. YAP1 recruits c-Abl to protect AMOTL1 against Nedd4.2-mediated degradation. Thus, YAP1, excluded from the nucleus, contributes to the maintenance of tight junctions.	[Skouloudaki, Kassiani; Walz, Gerd] Univ Hosp Freiburg, Div Renal, Freiburg, Germany; [Walz, Gerd] Ctr Biol Signaling Studies Bioss, Freiburg, Germany	University of Freiburg	Skouloudaki, K (corresponding author), Stockholm Univ, Wenner Gren Inst, S-10691 Stockholm, Sweden.	gerd.walz@uniklinik-freiburg.de			Deutsche Forschungsgemeinschaft (DFG) [WA 597, SFB 592]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (DFG WA 597, SFB 592). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhandari D, 2009, MOL BIOL CELL, V20, P1324, DOI 10.1091/mbc.E08-03-0308; Bratt A, 2002, GENE, V298, P69, DOI 10.1016/S0378-1119(02)00928-9; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Chen CL, 2010, P NATL ACAD SCI USA, V107, P15810, DOI 10.1073/pnas.1004060107; Chen HI, 1997, J BIOL CHEM, V272, P17070, DOI 10.1074/jbc.272.27.17070; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Fu X, P NATL ACAD SCI US, V107, P4579; Gagne V, 2009, CELL MOTIL CYTOSKEL, V66, P754, DOI 10.1002/cm.20405; Grzeschik NA, 2010, CURR BIOL, V20, P573, DOI 10.1016/j.cub.2010.01.055; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Kasanov J, 2001, CHEM BIOL, V8, P231, DOI 10.1016/S1074-5521(01)00005-9; Ko HS, 2010, P NATL ACAD SCI USA, V107, P16691, DOI 10.1073/pnas.1006083107; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Matter K, 2005, CURR OPIN CELL BIOL, V17, P453, DOI 10.1016/j.ceb.2005.08.003; Nikko E, 2008, EMBO REP, V9, P1216, DOI 10.1038/embor.2008.199; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Patrie KM, 2005, BBA-MOL CELL RES, V1745, P131, DOI 10.1016/j.bbamcr.2005.05.011; Pires JR, 2001, J MOL BIOL, V314, P1147, DOI 10.1006/jmbi.2000.5199; Raikwar NS, 2010, AM J PHYSIOL-RENAL, V299, pF436, DOI 10.1152/ajprenal.00674.2009; Robinson BS, 2010, CURR BIOL, V20, P582, DOI 10.1016/j.cub.2010.03.019; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Schlosser A, 2005, ANAL CHEM, V77, P5243, DOI 10.1021/ac050232m; Skouloudaki K, 2009, P NATL ACAD SCI USA, V106, P8579, DOI 10.1073/pnas.0811691106; SUDOL M, 1994, ONCOGENE, V9, P2145; Sugihara-Mizuno Y, 2007, GENES CELLS, V12, P473, DOI 10.1111/j.1365-2443.2007.01066.x; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhao B, GENES DEV, V25, P51; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001; Zheng YJ, 2009, CIRC RES, V105, P260, DOI 10.1161/CIRCRESAHA.109.195156	39	30	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35735	10.1371/journal.pone.0035735	http://dx.doi.org/10.1371/journal.pone.0035735			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558212	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336000054
J	Tavel, L; Jaquillard, L; Karsisiotis, AI; Saab, F; Jouvensal, L; Brans, A; Delmas, AF; Schoentgen, F; Cadene, M; Damblon, C				Tavel, Laurette; Jaquillard, Lucie; Karsisiotis, Andreas I.; Saab, Fabienne; Jouvensal, Laurence; Brans, Alain; Delmas, Agnes F.; Schoentgen, Francoise; Cadene, Martine; Damblon, Christian			Ligand Binding Study of Human PEBP1/RKIP: Interaction with Nucleotides and Raf-1 Peptides Evidenced by NMR and Mass Spectrometry	PLOS ONE			English	Article							KINASE INHIBITOR PROTEIN; PROSTATE-CANCER METASTASIS; CRYSTAL-STRUCTURE; BOVINE BRAIN; N-REGION; RKIP; EXPRESSION; SUPPRESSION; ACTIVATION; MECHANISM	Backgroound: Human Phosphatidylethanolamine binding protein 1 (hPEBP1) also known as Raf kinase inhibitory protein RKIP), affects various cellular processes, and is implicated in metastasis formation and Alzheimer's disease. Human PEBP1 has also been shown to inhibit the Raf/MEK/ERK pathway. Numerous reports concern various mammalian PEBP1 binding ligands. However, since PEBP1 proteins from many different species were investigated, drawing general conclusions regarding human PEBP1 binding properties is rather difficult. Moreover, the binding site of Raf-1 on hPEBP1 is still unknown. Methods/Findings: In the present study, we investigated human PEBP1 by NMR to determine the binding site of four different ligands: GTP, FMN, and one Raf-1 peptide in tri-phosphorylated and non-phosphorylated forms. The study was carried out by NMR in near physiological conditions, allowing for the identification of the binding site and the determination of the affinity constants K-D for different ligands. Native mass spectrometry was used as an alternative method for measuring KD values. Conclusions/Significance: Our study demonstrates and/or confirms the binding of hPEBP1 to the four studied ligands. All of them bind to the same region centered on the conserved ligand-binding pocket of hPEBP1. Although the affinities for GTP and FMN decrease as pH, salt concentration and temperature increase from pH 6.5/NaCl 0 mM/20 degrees C to pH 7.5/NaCl 100 mM/30 degrees C, both ligands clearly do bind under conditions similar to what is found in cells regarding pH, salt concentration and temperature. In addition, our work confirms that residues in the vicinity of the pocket rather than those within the pocket seem to be required for interaction with Raf-1.	[Tavel, Laurette; Damblon, Christian] Univ Liege, Dept Chem, Liege, Belgium; [Jaquillard, Lucie; Karsisiotis, Andreas I.; Saab, Fabienne; Jouvensal, Laurence; Delmas, Agnes F.; Cadene, Martine] CNRS, CBM, F-45071 Orleans, France; [Saab, Fabienne] Univ Orleans, ICOA, CNRS FR 2708, UMR 7311, Orleans, France; [Brans, Alain] Univ Liege, CIP, Liege, Belgium; [Schoentgen, Francoise] Univ Paris 06, IMPMC, Paris, France	University of Liege; Centre National de la Recherche Scientifique (CNRS); CEA; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; CNRS - Institute of Chemistry (INC); University of Liege; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD)	Tavel, L (corresponding author), Univ Liege, Dept Chem, Liege, Belgium.	c.damblon@ulg.ac.be	Karsisiotis, Andreas Ioannis/G-3622-2013	Cadene, Martine/0000-0003-4936-2662; Karsisiotis, Andreas Ioannis/0000-0001-7413-5045; Brans, Alain/0000-0003-4001-2762	ANR (Agence Nationale pour la Recherche) [ANR-08-BLAN- 0033]; La Ligue contre le cancer; Canceropole Grand Ouest [AO2007-2010]; CNRS (Centre National de la Recherche Scientifique); Regions Bretagne, Centre, Pays de la Loire et Poitou-Charentes [AO2007-2010]; Patrimoine de l'ULg; EU-NMR [RII3-026145]	ANR (Agence Nationale pour la Recherche)(French National Research Agency (ANR)); La Ligue contre le cancer(Ligue nationale contre le cancer); Canceropole Grand Ouest; CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); Regions Bretagne, Centre, Pays de la Loire et Poitou-Charentes(Region Nouvelle-Aquitaine); Patrimoine de l'ULg; EU-NMR	This research was supported by ANR (Agence Nationale pour la Recherche; http://www.agencenationale-recherche.fr/) grant ANR-08-BLAN- 0033 including a post-doctoral fellowship to LT, "La Ligue contre le cancer" (http://www.ligue-cancer.net), "Canceropole Grand Ouest" (AO2007-2010; http://www.canceropole-grandouest.com), CNRS (Centre National de la Recherche Scientifique; http://www.cnrs.fr), "Regions Bretagne, Centre, Pays de la Loire et Poitou-Charentes (AO2007-2010; http://www.bretagne.fr; http://www.regioncentre.fr; http://www.paysdelaloire.fr; http://www.poitou-charentes.fr), "Patrimoine de l'ULg" (http://www.ulg.ac.be) and the EU-NMR program (RII3-026145). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atmanene C, 2009, MED SCI MONITOR, V15, P178; Banfield MJ, 1998, STRUCTURE, V6, P1245, DOI 10.1016/S0969-2126(98)00125-7; BUCQUOY S, 1994, EUR J BIOCHEM, V225, P1203, DOI 10.1111/j.1432-1033.1994.1203b.x; Chatterjee D, 2004, J BIOL CHEM, V279, P17515, DOI 10.1074/jbc.M313816200; Corbit KC, 2003, J BIOL CHEM, V278, P13061, DOI 10.1074/jbc.M210015200; Dadvar P, 2009, CHEMBIOCHEM, V10, P2654, DOI 10.1002/cbic.200900452; Dahl A, 2003, RAPID COMMUN MASS SP, V17, P2195, DOI 10.1002/rcm.1183; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; Farmer BT, 1996, J BIOMOL NMR, V7, P59; Fu Z, 2003, J NATL CANCER I, V95, P878, DOI 10.1093/jnci/95.12.878; Granovsky AE, 2009, MOL CELL BIOL, V29, P1306, DOI 10.1128/MCB.01271-08; Hagan S, 2005, CLIN CANCER RES, V11, P7392, DOI 10.1158/1078-0432.CCR-05-0283; Hahm JR, 2010, BMB REP, V43, P337, DOI 10.5483/BMBRep.2010.43.5.337; Hickox DM, 2002, BIOL REPROD, V67, P917, DOI 10.1095/biolreprod.101.001446; Jaquillard L, J AM SOC MA IN RPESS; Keller ET, 2004, CANCER LETT, V207, P131, DOI 10.1016/j.canlet.2004.02.006; Keller ET, 2004, ANTI-CANCER DRUG, V15, P663, DOI 10.1097/01.cad.0000136877.89057.b9; Klysik J, 2008, CELL SIGNAL, V20, P1, DOI 10.1016/j.cellsig.2007.07.003; Kroslak T, 2001, J BIOL CHEM, V276, P39772, DOI 10.1074/jbc.M106991200; Lee HC, 2006, GASTROENTEROLOGY, V131, P1208, DOI 10.1053/j.gastro.2006.07.012; LIMBACH PA, 1995, J AM SOC MASS SPECTR, V6, P27, DOI 10.1016/1044-0305(94)00086-F; Lorenz K, 2003, NATURE, V426, P574, DOI 10.1038/nature02158; Maki M, 2002, J NEUROPATH EXP NEUR, V61, P176, DOI 10.1093/jnen/61.2.176; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; Moffit JS, 2007, J ANDROL, V28, P883, DOI 10.2164/jandrol.107.002964; Odabaei G, 2004, ADV CANCER RES, V91, P169, DOI 10.1016/S0065-230X(04)91005-6; Park S, 2006, FEBS LETT, V580, P6405, DOI 10.1016/j.febslet.2006.10.054; Rath O, 2008, CELL SIGNAL, V20, P935, DOI 10.1016/j.cellsig.2008.01.012; Ribas C, 2007, BBA-BIOMEMBRANES, V1768, P913, DOI 10.1016/j.bbamem.2006.09.019; Sagisaka T, 2010, BRAIN RES, V1327, P107, DOI 10.1016/j.brainres.2010.02.071; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Schoentgen F, 2010, INT J HIGH THROUGHPU, V2010, P81, DOI [10.2147/IJHTS.S9157, DOI 10.2147/IJHTS.S9157]; Serre L, 1998, STRUCTURE, V6, P1255, DOI 10.1016/S0969-2126(98)00126-9; Shemon AN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010479; Shemon AN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006028; Simister PC, 2011, FOR IMMUNOPATHOL DIS, V1, P59, DOI [10.1615/ForumImmunDisTher.v2.i1.70, DOI 10.1615/FORUMIMMUNDISTHER.V2.I1.70]; Trakul N, 2005, J BIOL CHEM, V280, P24931, DOI 10.1074/jbc.M413929200; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Yeung K, 2000, MOL CELL BIOL, V20, P3079, DOI 10.1128/MCB.20.9.3079-3085.2000; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Yeung KC, 2001, MOL CELL BIOL, V21, P7207, DOI 10.1128/MCB.21.21.7207-7217.2001; Yi CY, 2011, BIOMOL NMR ASSIGN, V5, P63, DOI 10.1007/s12104-010-9268-z; Zhu ST, 2005, CHEM BIOL, V12, P981, DOI 10.1016/j.chembiol.2005.07.007; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	46	18	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36187	10.1371/journal.pone.0036187	http://dx.doi.org/10.1371/journal.pone.0036187			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558375	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336000148
J	Yan, CG; Wang, XM; Cao, J; Wu, M; Gao, HW				Yan, Chunguang; Wang, Ximo; Cao, Jay; Wu, Min; Gao, Hongwei			CCAAT/Enhancer-Binding Protein gamma Is a Critical Regulator of IL-1 beta-Induced IL-6 Production in Alveolar Epithelial Cells	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; ACUTE LUNG INJURY; NF-KAPPA-B; C/EBP FAMILY; II CELLS; PROINFLAMMATORY CYTOKINES; AERUGINOSA INFECTION; INTERLEUKIN-6; EXPRESSION; MICE	CCAAT/enhancer binding protein gamma (C/EBP gamma) is a member of the C/EBP family of transcription factors, which lacks known activation domains. C/EBP gamma was originally described as an inhibitor of C/EBP transactivation potential. However, previous study demonstrates that C/EBP gamma augments the C/EBP beta stimulatory activity in lipopolysaccharide induction of IL-6 promoter in a B lymphoblast cell line. These data indicate a complexing functional role for C/EBP gamma in regulating gene expression. Furthermore, the expression and function of C/EBP gamma during inflammation are still largely unknown. In this study, we demonstrate that C/EBP gamma activation was induced by IL-1 beta treatment in lung epithelial cells. Importantly, we demonstrate for the first time that C/EBP gamma plays a critical role in regulating IL-1 beta-induced IL-6 expression in both mouse primary alveolar type II epithelial cells and a lung epithelial cell line, MLE12. We further provide the evidence that C/EBP gamma inhibits IL-6 expression by inhibiting C/EBP gamma but not NF-kappa B stimulatory activity in MLE12 cells. These findings suggest that C/EBP gamma is a key transcription factor that regulates the IL-6 expression in alveolar epithelial cells, and may play an important regulatory role in lung inflammatory responses.	[Yan, Chunguang; Gao, Hongwei] Harvard Univ, Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med,Sch Med, Boston, MA 02115 USA; [Yan, Chunguang; Wu, Min] Univ N Dakota, Dept Biochem & Mol Biol, Grand Forks, ND 58201 USA; [Wang, Ximo] Nankai Univ, Affiliated Hosp, Tianjin Union Med Ctr, Dept Surg, Tianjin 300071, Peoples R China; [Cao, Jay] ARS, Grand Forks Human Nutr Res Ctr, USDA, Grand Forks, ND USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of North Dakota Grand Forks; Nankai University; United States Department of Agriculture (USDA)	Yan, CG (corresponding author), Harvard Univ, Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med,Sch Med, Boston, MA 02115 USA.	min.wu@med.und.edu; hgao@zeus.bwh.harvard.edu	Yan, Chunguang/ABE-5021-2021		NIH [5R01HL092905-04, 3R01HL092905-02S1]; USDA Agricultural Research Service (ARS) [5450-51000-046-00D]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092905] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA Agricultural Research Service (ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by NIH grants 5R01HL092905-04 and 3R01HL092905-02S1 (HG) and the USDA Agricultural Research Service (ARS) program "Mineral Intakes for Optimal Bone Development and Health," Current Research Information System (CRIS) no. 5450-51000-046-00D (JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 2008, BRIT J CANCER, V99, P781, DOI 10.1038/sj.bjc.6604544; AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Anastasov N, 2009, HAEMATOLOGICA; Beck-Schimmer B, 1998, INFLAMM RES, V47, P308, DOI 10.1007/s000110050334; Bless NM, 2000, J IMMUNOL, V164, P2650, DOI 10.4049/jimmunol.164.5.2650; BRETZ JD, 1994, P NATL ACAD SCI USA, V91, P7306, DOI 10.1073/pnas.91.15.7306; Chung Kian F., 2005, Current Drug Targets - Inflammation and Allergy, V4, P619, DOI 10.2174/156801005774912806; COOPER C, 1995, NUCLEIC ACIDS RES, V23, P4371, DOI 10.1093/nar/23.21.4371; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Fujinami Y, NEUROCHEM INT, V56, P487; Gao HW, 2006, J IMMUNOL, V177, P612, DOI 10.4049/jimmunol.177.1.612; Gao HW, 2002, J BIOL CHEM, V277, P38827, DOI 10.1074/jbc.M206224200; GRAHAM RC, 1965, J HISTOCHEM CYTOCHEM, V13, P150, DOI 10.1177/13.2.150; Hu HM, 2000, J BIOL CHEM, V275, P16373, DOI 10.1074/jbc.M910269199; Kaisho T, 1999, J EXP MED, V190, P1573, DOI 10.1084/jem.190.11.1573; Kannan S, 2006, CELL DEATH DIFFER, V13, P311, DOI 10.1038/sj.cdd.4401736; Kannan S, 2008, J IMMUNOL, V180, P2396, DOI 10.4049/jimmunol.180.4.2396; Kannan S, 2006, EUR J IMMUNOL, V36, P1739, DOI 10.1002/eji.200635973; Kannan S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004891; KINOSHITA S, 1992, P NATL ACAD SCI USA, V89, P1473, DOI 10.1073/pnas.89.4.1473; Kramer F, 2008, MOL IMMUNOL, V45, P2678, DOI 10.1016/j.molimm.2007.12.017; Maitra U, 2011, J IMMUNOL, V186, P4467, DOI 10.4049/jimmunol.1003300; Mason RJ, 2006, RESPIROLOGY, V11, pS12, DOI 10.1111/j.1440-1843.2006.00800.x; MILLER BE, 1987, EXP LUNG RES, V12, P135, DOI 10.3109/01902148709062837; Rice WR, 2002, AM J PHYSIOL-LUNG C, V283, pL256, DOI 10.1152/ajplung.00302.2001; Sato K, 2002, J INFECT DIS, V185, P1139, DOI 10.1086/340040; STEIN B, 1993, MOL CELL BIOL, V13, P3964, DOI 10.1128/MCB.13.7.3964; Teiken JM, 2008, ANAT REC, V291, P114, DOI 10.1002/ar.20625; Thorley AJ, 2005, AM J RESP CELL MOL, V32, P262, DOI 10.1165/rcmb.2004-0196OC; Thorley AJ, 2007, J IMMUNOL, V178, P463, DOI 10.4049/jimmunol.178.1.463; Vanderbilt JN, 2003, AM J RESP CELL MOL, V29, P661, DOI 10.1165/rcmb.2002-0227OC; Whitsett JA, 2010, ANNU REV MED, V61, P105, DOI 10.1146/annurev.med.60.041807.123500; Wu M, 2003, GENE THER, V10, P1429, DOI 10.1038/sj.gt.3302009; Wu M, 2005, NANOMED-NANOTECHNOL, V1, P67, DOI 10.1016/j.nano.2004.11.011; Yan CG, 2010, J BIOL CHEM, V285, P37227, DOI 10.1074/jbc.M110.132084; Zafarana G, 2000, EMBO J, V19, P5856, DOI 10.1093/emboj/19.21.5856	38	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35492	10.1371/journal.pone.0035492	http://dx.doi.org/10.1371/journal.pone.0035492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558159	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336000033
J	Yang, XY; Wang, W; Qin, JJ; Wang, MH; Sharma, H; Buolamwini, JK; Wang, H; Zhang, RW				Yang, Xinyi; Wang, Wei; Qin, Jiang-Jiang; Wang, Ming-Hai; Sharma, Horrick; Buolamwini, John K.; Wang, Hui; Zhang, Ruiwen			JKA97, a Novel Benzylidene Analog of Harmine, Exerts Anti-Cancer Effects by Inducing G1 Arrest, Apoptosis, and p53-Independent Up-Regulation of p21	PLOS ONE			English	Article							NATURAL-PRODUCTS; DEPENDENT KINASES; EVOLVING ROLE; IN-VITRO; INHIBITOR	JKA97, a benzylidene analog of harmine, has been found to be a promising drug candidate for human cancer therapy, although the underlying molecular mechanisms have not been fully demonstrated. In this study, we evaluated the effects of JKA97 on human breast cancer cells in vitro and in vivo. JKA97 inhibited the growth and proliferation of MCF7 (p53 wildtype), MCF7 (p53 knockdown), and MDA-MB-468 (p53 mutant) cells in a dose-dependent manner. Treatment with JKA97 arrested breast cancer cells in G1 phase and induced apoptosis. JKA97 also significantly suppressed the growth of MCF7 and MDA-MB-468 xenograft tumors. It regulated the expression levels of G1 phase regulators, such as p21, p27, cyclinE, and cylinD1. JKA97 activated p21 transcription, independent of p53, but had little effect on p21 protein stability/degradation. In summary, our results suggest that JKA97 inhibits human breast cancer cell growth through activating p21, independent of p53, which provides a basis for developing this compound as a novel drug for human breast cancer therapy.	[Yang, Xinyi; Wang, Wei; Qin, Jiang-Jiang; Zhang, Ruiwen] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Amarillo, TX 79106 USA; [Wang, Wei; Wang, Ming-Hai; Zhang, Ruiwen] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Canc Biol Ctr, Amarillo, TX USA; [Wang, Ming-Hai] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Biomed Sci, Amarillo, TX USA; [Sharma, Horrick; Buolamwini, John K.] Univ Tennessee, Hlth Sci Ctr, Coll Pharm, Dept Pharmaceut Sci, Memphis, TN USA; [Wang, Hui] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; University of Tennessee System; University of Tennessee Health Science Center; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Yang, XY (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Amarillo, TX 79106 USA.	ruiwen.zhang@ttuhsc.edu	Qin, Jiangjiang/AAM-9553-2020	Qin, Jiangjiang/0000-0002-8559-616X	NIH [R01 CA112029, R01 CA121211, R01 CA91980, R15 CA100102]; Susan G. Komen for the Cure [BCTR070731]; NATIONAL CANCER INSTITUTE [R01CA121211, R01CA112029, R01CA091980, R15CA100102] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	R.Z. was supported by NIH grants R01 CA112029 and R01 CA121211 and a grant from Susan G. Komen for the Cure (BCTR070731). M.H.W. was supported by NIH grant R01 CA91980. J.K.B. was supported by NIH grant R15 CA100102. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; ESKELINEN M, 1994, ANTICANCER RES, V14, P699; Gartel AL, 2002, MOL CANCER THER, V1, P639; HARPER JW, 1993, CELL, V75, P805; Ishida J, 1999, BIOORG MED CHEM LETT, V9, P3319, DOI 10.1016/S0960-894X(99)00598-3; Janssen A, 2011, ONCOGENE, V30, P2799, DOI 10.1038/onc.2011.30; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang KH, 1999, EXP CELL RES, V253, P403, DOI 10.1006/excr.1999.4644; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Luo WJ, 2008, J BIOL CHEM, V283, P8624, DOI 10.1074/jbc.M707860200; Ma Y, 2010, PHYTOTHER RES, V24, P146, DOI 10.1002/ptr.2860; Mishra BB, 2011, EUR J MED CHEM, V46, P4769, DOI 10.1016/j.ejmech.2011.07.057; Nathanson KL, 2011, ANNU REV MED, V62, P295, DOI 10.1146/annurev-med-010910-110221; Oakman C, 2010, NAT REV CLIN ONCOL, V7, P725, DOI 10.1038/nrclinonc.2010.170; Song YC, 2004, BIOCHEM BIOPH RES CO, V317, P128, DOI 10.1016/j.bbrc.2004.03.019; Wang W, 2008, BRIT J CANCER, V98, P792, DOI 10.1038/sj.bjc.6604227; Wang W, 2007, CANCER CHEMOTH PHARM, V59, P589, DOI 10.1007/s00280-006-0300-z; Wang W, 2010, BREAST CANCER RES TR, V123, P321, DOI 10.1007/s10549-009-0638-0; Wang W, 2009, LUNG CANCER, V65, P306, DOI 10.1016/j.lungcan.2008.11.016; Wang W, 2009, CLIN CANCER RES, V15, P3511, DOI 10.1158/1078-0432.CCR-08-2689; Wang W, 2009, CANCER LETT, V278, P241, DOI 10.1016/j.canlet.2009.01.005; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Zhang Z, 2004, J BIOL CHEM, V279, P16000, DOI 10.1074/jbc.M312264200	25	43	44	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e34303	10.1371/journal.pone.0034303	http://dx.doi.org/10.1371/journal.pone.0034303			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558087	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336000012
J	Churyukanov, M; Plaghki, L; Legrain, V; Mouraux, A				Churyukanov, Maxim; Plaghki, Leon; Legrain, Valery; Mouraux, Andre			Thermal Detection Thresholds of A delta- and C-Fibre Afferents Activated by Brief CO2 Laser Pulses Applied onto the Human Hairy Skin	PLOS ONE			English	Article							EVOKED BRAIN POTENTIALS; WARM FIBERS; NOCICEPTIVE AFFERENTS; CEREBRAL POTENTIALS; INCREMENTAL CHANGES; SURFACE-AREAS; PAIN; LASER; RESPONSES; MONKEY	Brief high-power laser pulses applied onto the hairy skin of the distal end of a limb generate a double sensation related to the activation of A delta- and C-fibres, referred to as first and second pain. However, neurophysiological and behavioural responses related to the activation of C-fibres can be studied reliably only if the concomitant activation of A delta- fibres is avoided. Here, using a novel CO2 laser stimulator able to deliver constant-temperature heat pulses through a feedback regulation of laser power by an online measurement of skin temperature at target site, combined with an adaptive staircase algorithm using reaction-time to distinguish between responses triggered by A delta- and C-fibre input, we show that it is possible to estimate robustly and independently the thermal detection thresholds of A delta- fibres (46.9 +/- 1.7 degrees C) and C-fibres (39.8 +/- 1.7 degrees C). Furthermore, we show that both thresholds are dependent on the skin temperature preceding and/or surrounding the test stimulus, indicating that the A delta- and C-fibre afferents triggering the behavioural responses to brief laser pulses behave, at least partially, as detectors of a change in skin temperature rather than as pure level detectors. Most importantly, our results show that the difference in threshold between A delta- and C-fibre afferents activated by brief laser pulses can be exploited to activate C-fibres selectively and reliably, provided that the rise in skin temperature generated by the laser stimulator is well-controlled. Our approach could constitute a tool to explore, in humans, the physiological and pathophysiological mechanisms involved in processing C-and A delta- fibre input, respectively.	[Churyukanov, Maxim; Plaghki, Leon; Mouraux, Andre] Catholic Univ Louvain, Inst Neurosci IONS, B-1200 Brussels, Belgium; [Churyukanov, Maxim] IM Sechenov First Moscow State Med Univ, Dept Nervous Dis, Moscow, Russia; [Churyukanov, Maxim] Inst Gen Pathol & Pathophysiol RAMS, Lab Pathophysiol Pain, Moscow, Russia; [Legrain, Valery] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium	Universite Catholique Louvain; Sechenov First Moscow State Medical University; Russian Academy of Medical Sciences; Institute of General Pathology & Pathophysiology, RAMS; Ghent University	Churyukanov, M (corresponding author), Catholic Univ Louvain, Inst Neurosci IONS, B-1200 Brussels, Belgium.	andre.mouraux@uclouvain.be	Чурюканов, Максим/G-9255-2018; El-Deredy, Wael/H-6521-2015; Mouraux, Andre/F-3724-2012	Чурюканов, Максим/0000-0001-6542-1963; El-Deredy, Wael/0000-0002-9822-1092; Mouraux, Andre/0000-0003-1056-5980	Russian Federation; IASP Early Career Research Grant; Marie Curie European Reintegration Grant (ERG)	Russian Federation(Russian Federation); IASP Early Career Research Grant; Marie Curie European Reintegration Grant (ERG)(European Commission)	MC acknowledges support from the bursary of President of the Russian Federation for an internship abroad. VL is a fellow of the Research Foundation Flanders, Belgium (FWO). AM acknowledges support from the IASP Early Career Research Grant, and from a Marie Curie European Reintegration Grant (ERG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner U, 2005, PAIN, V116, P1, DOI 10.1016/j.pain.2005.04.021; BJERRING P, 1988, J NEUROL NEUROSUR PS, V51, P43, DOI 10.1136/jnnp.51.1.43; Bragard D, 1996, NEUROSCI LETT, V209, P81, DOI 10.1016/0304-3940(96)12604-5; BROMM B, 1983, NEUROSCI LETT, V43, P109, DOI 10.1016/0304-3940(83)90137-4; BROMM B, 1984, HUM NEUROBIOL, V3, P33; BROMM B, 1984, EXP BRAIN RES, V55, P158; CAMPBELL JN, 1983, BRAIN RES, V266, P203, DOI 10.1016/0006-8993(83)90650-9; CARMON A, 1976, EXP BRAIN RES, V25, P103; Cruccu G, 2004, EUR J NEUROL, V11, P153, DOI 10.1111/j.1468-1331.2004.00791.x; DARIANSMITH I, 1979, J NEUROPHYSIOL, V42, P1316, DOI 10.1152/jn.1979.42.5.1316; DARIANSMITH I, 1979, J NEUROPHYSIOL, V42, P1297, DOI 10.1152/jn.1979.42.5.1297; HALLIN RG, 1982, J NEUROL NEUROSUR PS, V45, P313, DOI 10.1136/jnnp.45.4.313; HARDY JD, 1956, J APPL PHYSIOL, V9, P257, DOI 10.1152/jappl.1956.9.2.257; HARDY JD, 1951, SCIENCE, V114, P149, DOI 10.1126/science.114.2954.149; JOHNSON KO, 1979, J NEUROPHYSIOL, V42, P1332, DOI 10.1152/jn.1979.42.5.1332; LAMOTTE RH, 1978, J NEUROPHYSIOL, V41, P509, DOI 10.1152/jn.1978.41.2.509; Magerl W, 1999, PAIN, V82, P127, DOI 10.1016/S0304-3959(99)00061-5; MEYER RA, 1976, IEEE T BIO-MED ENG, V23, P54, DOI 10.1109/TBME.1976.324616; MEYER RA, 1981, BRAIN RES, V224, P149, DOI 10.1016/0006-8993(81)91124-0; MEYER RA, 1981, SCIENCE, V213, P1527, DOI 10.1126/science.7280675; Mouraux A, 2007, PAIN, V129, P321, DOI 10.1016/j.pain.2006.10.018; Mouraux A, 2004, PAIN, V112, P16, DOI 10.1016/j.pain.2004.05.024; Mouraux A, 2003, CLIN NEUROPHYSIOL, V114, P710, DOI 10.1016/S1388-2457(03)00027-0; Nahra H, 2003, EUR J PAIN, V7, P189, DOI 10.1016/S1090-3801(02)00099-X; OCHOA J, 1969, ACTA NEUROPATHOL, V13, P197, DOI 10.1007/BF00690642; Opsommer E, 2001, CLIN NEUROPHYSIOL, V112, P1868, DOI 10.1016/S1388-2457(01)00622-8; Opsommer E, 1999, NEUROPHYSIOL CLIN, V29, P411, DOI 10.1016/S0987-7053(00)87265-2; Peng YB, 2003, BRAIN RES, V976, P217, DOI 10.1016/S0006-8993(03)02718-5; Plaghki L, 2003, NEUROPHYSIOL CLIN, V33, P269, DOI 10.1016/j.neucli.2003.10.003; Plaghki L., 2002, INT C SERIES, V1232, P181; Plaghki Leon, 2005, Curr Opin Investig Drugs, V6, P58; Plaghki L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010269; Treede RD, 2003, J NEUROL, V250, P1152, DOI 10.1007/s00415-003-0237-7; TREEDE RD, 1995, J PHYSIOL-LONDON, V483, P747, DOI 10.1113/jphysiol.1995.sp020619; Zaitsev AV, 2002, HUMAN PHYSL, V28, P494	35	75	76	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35817	10.1371/journal.pone.0035817	http://dx.doi.org/10.1371/journal.pone.0035817			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558230	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345200083
J	Longcore, T; Rich, C; Mineau, P; MacDonald, B; Bert, DG; Sullivan, LM; Mutrie, E; Gauthreaux, SA; Avery, ML; Crawford, RL; Manville, AM; Travis, ER; Drake, D				Longcore, Travis; Rich, Catherine; Mineau, Pierre; MacDonald, Beau; Bert, Daniel G.; Sullivan, Lauren M.; Mutrie, Erin; Gauthreaux, Sidney A., Jr.; Avery, Michael L.; Crawford, Robert L.; Manville, Albert M., II; Travis, Emilie R.; Drake, David			An Estimate of Avian Mortality at Communication Towers in the United States and Canada	PLOS ONE			English	Article							FLORIDA TELEVISION TOWER; BIRD MORTALITY; NOCTURNAL MIGRANTS; GUY WIRES; MIGRATION; REMOVAL; WEATHER; LIGHTS; HEIGHT; RADAR	Avian mortality at communication towers in the continental United States and Canada is an issue of pressing conservation concern. Previous estimates of this mortality have been based on limited data and have not included Canada. We compiled a database of communication towers in the continental United States and Canada and estimated avian mortality by tower with a regression relating avian mortality to tower height. This equation was derived from 38 tower studies for which mortality data were available and corrected for sampling effort, search efficiency, and scavenging where appropriate. Although most studies document mortality at guyed towers with steady-burning lights, we accounted for lower mortality at towers without guy wires or steady-burning lights by adjusting estimates based on published studies. The resulting estimate of mortality at towers is 6.8 million birds per year in the United States and Canada. Bootstrapped subsampling indicated that the regression was robust to the choice of studies included and a comparison of multiple regression models showed that incorporating sampling, scavenging, and search efficiency adjustments improved model fit. Estimating total avian mortality is only a first step in developing an assessment of the biological significance of mortality at communication towers for individual species or groups of species. Nevertheless, our estimate can be used to evaluate this source of mortality, develop subsequent per-species mortality estimates, and motivate policy action.	[Longcore, Travis; Rich, Catherine] Urban Wildlands Grp, Los Angeles, CA USA; [Longcore, Travis] Univ So Calif, Spatial Sci Inst, Los Angeles, CA USA; [Mineau, Pierre; Bert, Daniel G.; Mutrie, Erin] Environm Canada, Sci & Technol Branch, Natl Wildlife Res Ctr, Ottawa, ON K1A 0H3, Canada; [Sullivan, Lauren M.] Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90024 USA; [Gauthreaux, Sidney A., Jr.] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; [Avery, Michael L.] Wildlife Serv, Natl Wildlife Res Ctr, Florida Field Stn, USDA, Gainesville, FL USA; [Manville, Albert M., II] US Fish & Wildlife Serv, Div Migratory Bird Management, Arlington, VA USA; [Travis, Emilie R.; Drake, David] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI USA	University of Southern California; Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada; University of California System; University of California Los Angeles; Clemson University; United States Department of Agriculture (USDA); United States Department of the Interior; US Fish & Wildlife Service; University of Wisconsin System; University of Wisconsin Madison	Longcore, T (corresponding author), Urban Wildlands Grp, Los Angeles, CA USA.	longcore@urbanwildlands.org	Longcore, Travis/A-4978-2008; Bert, Daniel/A-5666-2013; Gauthreaux, Sidney/Q-3930-2019	Longcore, Travis/0000-0002-1039-2613; Bert, Daniel/0000-0001-7922-6907; 	American Bird Conservancy; Defenders of Wildlife	American Bird Conservancy; Defenders of Wildlife	Collaborators from The Urban Wildlands Group were supported in the early stages of this research by the American Bird Conservancy (www.abcbirds.org) and Defenders of Wildlife (www.defenders.org). The Canadian Wildlife Service (www.ec.gc.ca) purchased the NAV CANADA dataset. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronoff A, 1949, LINNAEAN NEWS LETT, V3, P1; AVERY M, 1972, Prairie Naturalist, V4, P87; AVERY M, 1977, WILSON BULL, V89, P291; AVERY M L, 1975, Proceedings of the North Dakota Academy of Science, V27, P40; AVERY M L, 1978, American Birds, V32, P1114; Avery M. L., 1979, BIRD CONTROL SEMINAR, V8, P3; Avery M.L., 1980, FWSOBS8054; Baird J., 1970, CHICKADEE, V40, P17; Baird J., 1971, CHICKADEE, V41, P20; BEAUCHAMP JJ, 1973, ECOLOGY, V54, P1403, DOI 10.2307/1934208; BELLROSE FRANK C., 1959, ILLINOIS NAT HIST SURV BULL, V27, P235; Bierly M.L., 1973, MIGRANT, V44, P5; Bocetti CI, 2011, WILSON J ORNITHOL, V123, P176, DOI 10.1676/09-168.1; Boso B., 1965, Transactions of the Kansas Academy of Science, V68, P131, DOI 10.2307/3626355; BREWER RICHARD, 1958, AUK, V75, P400; Brown J. A. Harvie, 1880, Zool, P161; Caldwell L. D., 1966, Jack Pine Warbler, V44, P117; Carter J.H. III., 1976, Chat, V40, P1; COCHRAN W. W., 1958, WILSON BULL, V70, P378; Commission for Environmental Cooperation, 1997, EC REG N AM COMM PER; CRAWFORD R L, 1971, Oriole, V36, P33; CRAWFORD RL, 1981, J MAMMAL, V62, P651, DOI 10.2307/1380421; CRAWFORD RL, 1981, WILSON BULL, V93, P189; Crawford RL, 2001, J FIELD ORNITHOL, V72, P380, DOI 10.1648/0273-8570-72.3.380; Crawford RL, 2004, MISCELLANEOUS PUBLIC, V14, P1; Dickerman Robert W., 1998, Western Birds, V29, P122; DUAN N, 1983, J AM STAT ASSOC, V78, P605, DOI 10.2307/2288126; Ganier A.F., 1962, MIGRANT, V33, P58; Gastman EA, 1886, AM NAT, V20, P981; Gauthreaux SA, 2003, AUK, V120, P266, DOI 10.1642/0004-8038(2003)120[0266:ROABC]2.0.CO;2; Gauthreaux Sidney A. Jr., 2006, P67; Gehring J, 2011, J WILDLIFE MANAGE, V75, P848, DOI 10.1002/jwmg.99; Gehring J, 2009, ECOL APPL, V19, P505, DOI 10.1890/07-1708.1; Ginter DL, 2004, SOUTHWEST NAT, V49, P414, DOI 10.1894/0038-4909(2004)049<0414:AMDFMA>2.0.CO;2; Goodpasture K.A., 1975, Migrant, V46, P49; Goodpasture K.A., 1986, Migrant, V57, P70; Goodpasture K.A., 1976, Migrant, V47, P8; Goodpasture K.A., 1984, Migrant, V55, P53; Goodpasture K.A., 1987, Migrant, V58, P85; Goodpasture K.A., 1978, Migrant, V49, P53; Goodpasture K.A., 1974, MIGRANT, V45, P29; Goodpasture K.A., 1974, MIGRANT, V45, P57; Herron Joey, 1997, Redstart, V64, P114; Johnson GD, 2001, SETAC 22 N AM ANN M; Johnston D.W., 1955, ORIOLE, V20, P17; Karlsson J., 1977, Anser, V16, P203; Kemper Charles, 1996, Passenger Pigeon, V58, P219; Kerlinger P, 2010, WILSON J ORNITHOL, V122, P744, DOI 10.1676/06-075.1; Kostecke RM, 2001, J FIELD ORNITHOL, V72, P439, DOI 10.1648/0273-8570-72.3.439; Laskey A. E., 1963, Migrant, V34, P15; Laskey A. R., 1967, Migrant, V38, P43; LASKEY A R, 1969, Migrant, V40, P25; Laskey A. R., 1971, Migrant, V42, P15; Laskey A. R., 1964, Migrant, V35, P95; Laskey A. R., 1968, Migrant, V39, P25; Laskey A. R., 1963, Migrant, V34, P65; LASKEY A R, 1969, Migrant, V40, P79; Laskey A. R., 1956, MIGRANT, V27, P66; LASKEY AMELIA R., 1960, MIGRANT, V31, P61; LASKEY AMELIA R., 1957, MIGRANT, V28, P54; Laskey M. R., 1962, Migrant, V33, P7; Longcore T, 2005, SCI BASIS ESTABLISH; Longcore T, 2008, AUK, V125, P485, DOI 10.1525/auk.2008.06253; Manville, 2001, CELL TOWERS WIRELESS, P75; Manville AM, 2001, P WORKSH HELD CHARL, P85; Manville II A.M., 2005, USDAFOREST SERVICE G, P1051; Mayfield H., 1967, AUDUBON MAGAZINE, V69, P61; Mineau P, 2002, ENVIRON TOXICOL CHEM, V21, P1497, DOI 10.1897/1551-5028(2002)021&lt;1497:ETPOBM&gt;2.0.CO;2; MINEAU P, 1988, FIELD METHODS STUDY, P13; Morris SR, 2003, NORTHEAST NAT, V10, P67, DOI 10.2307/3858673; Morrison M., 2002, NRELSR50030876; Mosman D., 1975, IOWA BIRD LIFE, V45, P88; Munro J. A., 1924, Canadian Field Naturalist, V38, P141; Munro JA, 1924, CAN FIELD NAT, V38, P171; NICHOLSON CP, 2005, ASSESSMENT PREDICTIO; Nielsen LA, 2006, CLEAR CHANNEL NO COL; Orbach DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013912; Overing R., 1936, WILSON B, V48, P222; Piatt JF, 1996, AM FISH S S, V18, P712; Ponce C, 2010, ANIM CONSERV, V13, P603, DOI 10.1111/j.1469-1795.2010.00387.x; ROBBINS CS, 1989, P NATL ACAD SCI USA, V86, P7658, DOI 10.1073/pnas.86.19.7658; Sawyer P.J., 1961, NEW HAMPSHIRE AUDUBO, V14, P46; SEETS JW, 1977, WILSON BULL, V89, P422; Shire G. G., 2000, COMMUNICATION TOWERS; Smallwood KS, 2007, J WILDLIFE MANAGE, V71, P2781, DOI 10.2193/2007-006; Smallwood KS, 2010, J WILDLIFE MANAGE, V74, P1089, DOI 10.2193/2009-266; Spofford W. R., 1949, Wilson Bulletin Baltimore, V61, P86; Squires W. A., 1918, Condor Hollywood, V20, DOI 10.2307/1362354; Stoddard H. L., 1967, Bulletin Tall Timbers Research Station, VNo. 8, P1; Stoddard HL, 1962, B TALL TIMBERS RES S, V1, P1; STRNAD F V, 1975, Loon, V47, P16; TAYLOR W K, 1974, Florida Field Naturalist, V2, P40; TAYLOR WK, 1973, WILSON BULL, V85, P42; Thompson C., 2009, TUNDRA TROPICS CONNE, P262; TORDOFF HARRISON B., 1956, UNIV KANSAS PUBL MUS NAT HIST, V10, P1; Travis E., 2009, THESIS U WISCONSIN M, P1; US Fish and Wildlife Service, 2008, BIRDS CONS CONC 2008; Van Gelder R. G., 1956, Transactions of the Kansas Academy of Science, V59, P220; Velie E. D., 1963, Flicker, V35, P79; Williams TC, 2001, AUK, V118, P389, DOI 10.1642/0004-8038(2001)118[0389:BMTAMP]2.0.CO;2; Young EA, 2001, BIRD MORTALITY KTKA; Young EA, 2000, AVIAN SURVEYS WIND T; [No title captured]	103	71	75	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e34025	10.1371/journal.pone.0034025	http://dx.doi.org/10.1371/journal.pone.0034025			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558082	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345200007
J	Mingels, AM; Joosen, IA; Versteylen, MO; Laufer, EM; Winkens, MH; Wildberger, JE; Van Dieijen-Visser, MP; Hofstra, L				Mingels, Alma M.; Joosen, Ivo A.; Versteylen, Mathijs O.; Laufer, Eduard M.; Winkens, Mark H.; Wildberger, Joachim E.; Van Dieijen-Visser, Marja P.; Hofstra, Leonard			High-Sensitivity Cardiac Troponin T: Risk Stratification Tool in Patients with Symptoms of Chest Discomfort	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; INCIDENT HEART-FAILURE; C-REACTIVE PROTEIN; MYOCARDIAL-INFARCTION; CARDIOVASCULAR EVENTS; COMPUTED-TOMOGRAPHY; AMERICAN-COLLEGE; EARLY-DIAGNOSIS; ASSAY; ASSOCIATION	Background: Recent studies have demonstrated the association between increased concentrations of high-sensitivity cardiac troponin T (hs-cTnT) and the incidence of myocardial infarction, heart failure, and mortality. However, most prognostic studies to date focus on the value of hs-cTnT in the elderly or general population. The value of hs-cTnT in symptomatic patients visiting the outpatient department remains unclear. The aim of this study was to investigate the prognostic value of hs-cTnT as a biomarker in patients with symptoms of chest discomfort suspected for coronary artery disease and to assess its additional value in combination with other risk stratification tools in predicting cardiac events. Methods: We studied 1,088 patients (follow-up 2.2 +/- 0.8 years) with chest discomfort who underwent coronary calcium scoring and coronary CT-angiography. Traditional cardiovascular risk factors and concentrations of hs-cTnT, N-terminal pro-brain-type natriuretic peptide (NT-proBNP) and high-sensitivity C-reactive protein (hsCRP) were assessed. Study endpoint was the occurrence of late coronary revascularization (>90 days), acute coronary syndrome, and cardiac mortality. Results: Hs-cTnT was a significant predictor for the composite endpoint (highest quartile [Q4]>6.7 ng/L, HR 3.55; 95%CI 1.88-6.70; P<0.001). Survival analysis showed that hs-cTnT had significant predictive value on top of current risk stratification tools (Chi-square change P<0.01). In patients with hs-cTnT in Q4 versus, Q4, a 2- to 3-fold increase in cardiovascular risk was noticed, either when corrected for high or low Framingham risk score, coronary calcium scoring, or CT-angiography assessment (HR 3.11; 2.73; 2.47; respectively; all P<0.01). This was not the case for hsCRP and NT-proBNP. Conclusions: Hs-cTnT is a useful prognostic biomarker in patients with chest discomfort suspected for coronary artery disease. In addition, hs-cTnT was an independent predictor for cardiac events when corrected for cardiovascular risk profiling, calcium score and CT-angiography results.	[Mingels, Alma M.; Van Dieijen-Visser, Marja P.] Maastricht Univ, Med Ctr, Dept Clin Chem, Maastricht, Netherlands; [Joosen, Ivo A.; Versteylen, Mathijs O.; Laufer, Eduard M.; Winkens, Mark H.] Maastricht Univ, Med Ctr, Dept Cardiol, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Wildberger, Joachim E.] Maastricht Univ, Med Ctr, Dept Radiol, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Hofstra, Leonard] Cardiol Ctr Netherlands, Utrecht, Netherlands	Maastricht University; Maastricht University; Maastricht University	Mingels, AM (corresponding author), Maastricht Univ, Med Ctr, Dept Clin Chem, Maastricht, Netherlands.	l.hofstra@cardiologiecentra.nl		Wildberger, Joachim/0000-0002-4810-6854				AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Alehagen U, 2010, CLIN CHEM, V56, P1718, DOI 10.1373/clinchem.2009.141341; Austen W G, 1975, Circulation, V51, P5; Braunwald E, 2002, J AM COLL CARDIOL, V40, P1366, DOI 10.1016/S0735-1097(02)02336-7; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; de Lemos JA, 2010, JAMA-J AM MED ASSOC, V304, P2503, DOI 10.1001/jama.2010.1768; deFilippi CR, 2010, JAMA-J AM MED ASSOC, V304, P2494, DOI 10.1001/jama.2010.1708; Fox KF, 2001, EUR HEART J, V22, P228, DOI 10.1053/euhj.2000.2289; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Hadamitzky M, 2009, JACC-CARDIOVASC IMAG, V2, P404, DOI 10.1016/j.jcmg.2008.11.015; Hendel RC, 2006, J AM COLL CARDIOL, V48, P1475, DOI 10.1016/j.jacc.2006.07.003; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kavsak PA, 2009, CLIN CHEM, V55, P1809, DOI 10.1373/clinchem.2009.127241; Keller T, 2009, NEW ENGL J MED, V361, P868, DOI 10.1056/NEJMoa0903515; Korosoglou G, 2011, HEART, V97, P823, DOI 10.1136/hrt.2010.193201; Laufer EM, 2010, ARTERIOSCL THROM VAS, V30, P1269, DOI 10.1161/ATVBAHA.109.200394; Lindahl B, 2010, AM HEART J, V160, P224, DOI 10.1016/j.ahj.2010.05.023; Omland T, 2009, NEW ENGL J MED, V361, P2538, DOI 10.1056/NEJMoa0805299; Otsuka T, 2010, AM HEART J, V159, P972, DOI 10.1016/j.ahj.2010.02.036; Raff Gilbert L, 2009, J Cardiovasc Comput Tomogr, V3, P122, DOI 10.1016/j.jcct.2009.01.001; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Ridker PM, 2007, J AM COLL CARDIOL, V49, P2129, DOI 10.1016/j.jacc.2007.02.052; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; Vasile VC, 2010, CLIN CHEM, V56, P1086, DOI 10.1373/clinchem.2009.140616; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994	27	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35059	10.1371/journal.pone.0035059	http://dx.doi.org/10.1371/journal.pone.0035059			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558116	gold, Green Published, Green Submitted			2022-12-27	WOS:000305345200022
J	Quilez, J; Martinez, V; Woolliams, JA; Sanchez, A; Pong-Wong, R; Kennedy, LJ; Quinnell, RJ; Ollier, WER; Roura, X; Ferrer, L; Altet, L; Francino, O				Quilez, Javier; Martinez, Veronica; Woolliams, John A.; Sanchez, Armand; Pong-Wong, Ricardo; Kennedy, Lorna J.; Quinnell, Rupert J.; Ollier, William E. R.; Roura, Xavier; Ferrer, Lluis; Altet, Laura; Francino, Olga			Genetic Control of Canine Leishmaniasis: Genome-Wide Association Study and Genomic Selection Analysis	PLOS ONE			English	Article							SLC11A1 FORMERLY NRAMP1; VISCERAL LEISHMANIASIS; KALA-AZAR; CLASS-II; SUSCEPTIBILITY; INFECTION; IDENTIFICATION; CHAGASI; DISEASE; LOCUS	Background: The current disease model for leishmaniasis suggests that only a proportion of infected individuals develop clinical disease, while others are asymptomatically infected due to immune control of infection. The factors that determine whether individuals progress to clinical disease following Leishmania infection are unclear, although previous studies suggest a role for host genetics. Our hypothesis was that canine leishmaniasis is a complex disease with multiple loci responsible for the progression of the disease from Leishmania infection. Methodology/Principal Findings: Genome-wide association and genomic selection approaches were applied to a population-based case-control dataset of 219 dogs from a single breed (Boxer) genotyped for similar to 170,000 SNPs. Firstly, we aimed to identify individual disease loci; secondly, we quantified the genetic component of the observed phenotypic variance; and thirdly, we tested whether genome-wide SNP data could accurately predict the disease. Conclusions/Significance: We estimated that a substantial proportion of the genome is affecting the trait and that its heritability could be as high as 60%. Using the genome-wide association approach, the strongest associations were on chromosomes 1, 4 and 20, although none of these were statistically significant at a genome-wide level and after correcting for genetic stratification and lifestyle. Amongst these associations, chromosome 4:61.2-76.9 Mb maps to a locus that has previously been associated with host susceptibility to human and murine leishmaniasis, and genomic selection estimated markers in this region to have the greatest effect on the phenotype. We therefore propose these regions as candidates for replication studies. An important finding of this study was the significant predictive value from using the genomic information. We found that the phenotype could be predicted with an accuracy of similar to 0.29 in new samples and that the affection status was correctly predicted in 60% of dogs, significantly higher than expected by chance, and with satisfactory sensitivity-specificity values (AUC = 0.63).	[Quilez, Javier; Martinez, Veronica; Sanchez, Armand] Univ Autonoma Barcelona, Dept Genet Anim, Ctr Recerca Agrigen CRAG, E-08193 Barcelona, Spain; [Sanchez, Armand; Altet, Laura; Francino, Olga] Univ Autonoma Barcelona, Dept Ciencia Anim & Aliments, Fac Vet, Serv Vet Genet Mol, E-08193 Barcelona, Spain; [Woolliams, John A.; Pong-Wong, Ricardo] Univ Edinburgh, Roslin Inst, Easter Bush, Scotland; [Woolliams, John A.; Pong-Wong, Ricardo] Univ Edinburgh, R D SVS, Easter Bush, Scotland; [Kennedy, Lorna J.; Ollier, William E. R.] Univ Manchester, CIGMR, Manchester, Lancs, England; [Quinnell, Rupert J.] Univ Leeds, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England; [Roura, Xavier; Ferrer, Lluis] Univ Autonoma Barcelona, Hosp Clin Vet, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); Autonomous University of Barcelona; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Manchester; University of Leeds; Autonomous University of Barcelona	Quilez, J (corresponding author), Univ Autonoma Barcelona, Dept Genet Anim, Ctr Recerca Agrigen CRAG, E-08193 Barcelona, Spain.	javier.quilez@cragenomica.es	ferrer, lluis/ABE-5179-2020; Francino, Olga/K-5683-2017; Quilez, Javier/J-7107-2015; Kennedy, Lorna/AAK-8767-2020; Sanchez, Armand/L-7905-2015; Roura, Xavier/I-2848-2015	ferrer, lluis/0000-0003-1537-0074; Francino, Olga/0000-0002-9022-3835; Quilez, Javier/0000-0002-0108-2672; Kennedy, Lorna/0000-0002-3087-4548; Sanchez, Armand/0000-0001-9160-1124; Pong-Wong, Ricardo/0000-0001-9808-2742	European Commission (LUPA) [GA-201370]; "Centre for Research in Agrigenomics" from the Spanish Ministry of Science and Innovation [CSD2007-00036]; BBSRC [BBS/E/D/05191132] Funding Source: UKRI; MRC [G0900753, G0100594, G0600237, G0901461] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/05191132] Funding Source: researchfish; Medical Research Council [G0100594, G0901461, G0900753, G0600237] Funding Source: researchfish	European Commission (LUPA)(European CommissionEuropean Commission Joint Research Centre); "Centre for Research in Agrigenomics" from the Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the European Commission (LUPA, GA-201370) as well as by the Consolider-Ingenio 2010 Programme CSD2007-00036 "Centre for Research in Agrigenomics" from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRANCHES P, 1991, J PARASITOL, V77, P557, DOI 10.2307/3283159; Altet L, 2002, INFECT IMMUN, V70, P2763, DOI 10.1128/IAI.70.6.2763-2771.2002; [Anonymous], 2005, 3 WORLD C LEISHM PAL; Badalova J, 2002, GENES IMMUN, V3, P187, DOI 10.1038/sj.gene.6363838; Baneth G, 2008, VET J, V175, P14, DOI 10.1016/j.tvjl.2006.11.011; Barber RM, 2011, J HERED, V102, pS40, DOI 10.1093/jhered/esr048; Beebe AM, 1997, GENES IMMUN, V6, P557; Blackwell JM, 2009, PARASITE IMMUNOL, V31, P254, DOI 10.1111/j.1365-3024.2009.01102.x; Blackwell JM, 1996, PARASITOLOGY, V112, pS67, DOI 10.1017/S0031182000076678; Bucheton B, 2003, AM J HUM GENET, V73, P1052, DOI 10.1086/379084; Bucheton B, 2002, MICROBES INFECT, V4, P1449, DOI 10.1016/S1286-4579(02)00027-8; CABELLO PH, 1995, AM J TROP MED HYG, V52, P364, DOI 10.4269/ajtmh.1995.52.364; Cortes E, 2005, INF VET          SEP, P28; Cutler G, 2007, GENOME RES, V17, P1743, DOI 10.1101/gr.6754607; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; Dodman NH, 2010, MOL PSYCHIATR, V15, P8, DOI 10.1038/mp.2009.111; Downs LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021452; FAGHIRI Z, 1995, HUM HERED, V45, P258, DOI 10.1159/000154309; Francino O, 2006, GENES IMMUN, V137, P221; Goldstein O, 2010, MOL VIS, V16, P1549; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Havelkova H, 2006, GENES IMMUN, V7, P220, DOI 10.1038/sj.gene.6364290; Ibrahim ME, 1999, AM J TROP MED HYG, V61, P941, DOI 10.4269/ajtmh.1999.61.941; Jakobsson M, 2008, GENES IMMUN, V451, P1003; Jamieson SE, 2006, GENES IMMUN, V8, P90; Jeronimo SMB, 2007, GENES IMMUN, V8, P539, DOI 10.1038/sj.gene.6364422; Jeronimo SMB, 2007, J INFECT DIS, V196, P1261, DOI 10.1086/521682; Jeronimo SMB, 2004, SCAND J INFECT DIS, V36, P443, DOI 10.1080/00365540410020451; Karplus TM, 2002, INFECT IMMUN, V70, P6919, DOI 10.1128/IAI.70.12.6919-6925.2002; Kidd JM, 2008, GENES IMMUN, V453, P64; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lipoldova M, 2006, NAT REV GENET, V7, P294, DOI 10.1038/nrg1832; Madsen MB, 2011, J HERED, V102, pS62, DOI 10.1093/jhered/esr041; Martinez V, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-57; Mausberg TB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020042; Meddeb-Garnaoui A, 2001, HUM IMMUNOL, V62, P509, DOI 10.1016/S0198-8859(01)00237-3; Meurs KM, 2010, HUM GENET, V128, P315, DOI 10.1007/s00439-010-0855-y; Meuwissen THE, 2001, GENETICS, V157, P1819; Miller E, 2007, PLOS GENET, V3; Miranda S, 2008, RES VET SCI, V85, P35, DOI 10.1016/j.rvsc.2007.09.003; Mogensen MS, 2011, J HERED, V102, pS81, DOI 10.1093/jhered/esr021; Mohamed HS, 2004, EUR J HUM GENET, V12, P66, DOI 10.1038/sj.ejhg.5201089; Neff MW, 2006, CELL, V124, P229, DOI 10.1016/j.cell.2006.01.008; Olsson M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001332; Ostrander EA, 2005, GENOME RES, V15, P1706, DOI 10.1101/gr.3736605; Peacock C, 2002, GENES IMMUN, V3, P350, DOI 10.1038/sj.gene.6363852; Peacock CS, 2001, GENET EPIDEMIOL, V20, P383, DOI 10.1002/gepi.8; PONG-WONG R., 2010, BMC P S1, V4, pS4, DOI DOI 10.1186/1753-6561-4-S1-S4; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinnell RJ, 2003, IMMUNOGENETICS, V55, P23, DOI 10.1007/s00251-003-0545-1; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Roque JB, 2011, J HERED, V102, pS74, DOI 10.1093/jhered/esr054; Sakthianandeswaren A, 2009, TRENDS PARASITOL, V25, P383, DOI 10.1016/j.pt.2009.05.004; Salih MA, 2007, GENES IMMUN, V8, P75, DOI 10.1038/sj.gene.6364353; Sanchez-Robert E, 2008, VET IMMUNOL IMMUNOP, V125, P168, DOI 10.1016/j.vetimm.2008.04.010; Sanchez-Robert E, 2005, J HERED, V96, P755, DOI 10.1093/jhered/esi111; Sanchez-Robert E, 2008, VET RES, V39, DOI 10.1051/vetres:2008013; Solano-Gallego L, 2001, J CLIN MICROBIOL, V39, P560, DOI 10.1128/JCM.39.2.560-563.2001; Solano-Gallego L, 2000, VET PARASITOL, V90, P37, DOI 10.1016/S0304-4017(00)00223-5; Tsai KL, 2011, MAMM GENOME; Vaysse A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002316; Vladimirov V, 2003, INFECT IMMUN, V71, P2041, DOI 10.1128/IAI.71.4.2041-2046.2003; Wilbe M, 2010, NAT GENET, V42, P250, DOI 10.1038/ng.525; Wood SH, 2009, IMMUNOGENETICS, V61, P765, DOI 10.1007/s00251-009-0402-y; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; ZIJLSTRA EE, 1994, AM J TROP MED HYG, V51, P826, DOI 10.4269/ajtmh.1994.51.826	68	26	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35349	10.1371/journal.pone.0035349	http://dx.doi.org/10.1371/journal.pone.0035349			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558142	Green Published, gold			2022-12-27	WOS:000305345200033
J	Yang, BH; Li, HP; Zhang, T; He, XJ; Xu, SY				Yang, Baohui; Li, Haopeng; Zhang, Ting; He, Xijing; Xu, Siyue			The Incidence of Adjacent Segment Degeneration after Cervical Disc Arthroplasty (CDA): A Meta Analysis of Randomized Controlled Trials	PLOS ONE			English	Review							TERM-FOLLOW-UP; INTERBODY FUSION; CLINICAL-OUTCOMES; ANTERIOR; SPINE; REPLACEMENT; PROSTHESIS; DISKECTOMY; RADICULOPATHY; MALALIGNMENT	Background: Cervical disc arthroplasty is being used as an alternative degenerative disc disease treatment with fusion of the cervical spine in order to preserve motion. However, whether replacement arthoplasty in the spine achieves its primary patient centered objective of lowering the frequency of adjacent segment degeneration is not verified yet. Methodology: We conducted a meta-analysis according to the guidelines of the Cochrane Collaboration using databases including PubMed, Cochrane Central Register of Controlled Trials and Embase. The inclusion criteria were: 1) Randomized, controlled study of degenerative disc disease of the cervical spine involving single segment or double segments using Cervical disc arthroplasty (CDA) with anterior cervical discectomy and fusion (ACDF) as controls; 2) A minimum of two-year follow-up using imaging and clinical analyses; 3) Definite diagnostic evidences for "adjacent segment degeneration" and "adjacent segment disease"; 4) At least a minimum of 30 patients per population. Two authors independently selected trials; assessed methodological quality, extracted data and the results were pooled. Results: No study has specifically compared the results of adjacent segment degenerative; Two papers describing 140 patients with 162 symptomatic cervical segment disorders and compared the rate of postoperative adjacent segment disease development between CDA and ACDF treatments, three publications describing the rate of adjacent-segment surgery including 1273 patients with symptomatic cervical segments. The result of the meta-analysis indicates that there were fewer the rate of adjacent segment disease and the rate for adjacent-segment surgery comparing CDA with ACDF, but the difference was not statistically significant. Conclusions: Based on available evidence, it cannot be concluded, that CDA can significantly reduce the postoperative rate of the adjacent segment degenerative and adjacent segment disease. However, due to some limitations, the results of this meta-analysis should be cautiously accepted, and further studies are needed.	[Yang, Baohui; Li, Haopeng; Zhang, Ting; He, Xijing; Xu, Siyue] Xi An Jiao Tong Univ, Affiliated Hosp 2, Medcal Coll, Dept Orthopaed Surg, Xian 710049, Shaanxi Provinc, Peoples R China	Xi'an Jiaotong University	Yang, BH (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Medcal Coll, Dept Orthopaed Surg, Xian 710049, Shaanxi Provinc, Peoples R China.	LHP-3993@163.com	He, Xijing/AAE-7424-2021; Li, Hao/GPS-9834-2022	He, Xijing/0000-0002-0465-5376; 				BABA H, 1993, SPINE, V18, P2167, DOI 10.1097/00007632-199311000-00004; BOHLMAN HH, 1993, J BONE JOINT SURG AM, V75A, P1298, DOI 10.2106/00004623-199309000-00005; Burkus JK, 2010, J NEUROSURG-SPINE, V13, P308, DOI 10.3171/2010.3.SPINE09513; CLEMENTS DH, 1990, SPINE, V15, P1023, DOI 10.1097/00007632-199015100-00008; Coric D, 2011, J NEUROSURG-SPINE, V15, P348, DOI 10.3171/2011.5.SPINE10769; DEPALMA AF, 1972, SURG GYNECOL OBSTETR, V134, P755; DiAngelo Denis J, 2004, Neurosurg Focus, V17, pE7; Eck JC, 2002, SPINE, V27, P2431, DOI 10.1097/00007632-200211150-00003; Elsawaf A, 2009, NEUROSURG REV, V32, P215, DOI 10.1007/s10143-008-0164-2; Fuller DA, 1998, SPINE, V23, P1649, DOI 10.1097/00007632-199808010-00006; Garrido BJ, 2010, J SPINAL DISORD TECH, V23, P367, DOI 10.1097/BSD.0b013e3181bb8568; GOFFIN J, 1995, J SPINAL DISORD, V8, P500; Goffin J, 2004, J SPINAL DISORD TECH, V17, P79, DOI 10.1097/00024720-200404000-00001; Goffin J, 2002, NEUROSURGERY, V51, P840, DOI 10.1227/01.NEU.0000026100.14273.B3; GORE DR, 1984, SPINE, V9, P667, DOI 10.1097/00007632-198410000-00002; GORE DR, 1986, SKELETAL RADIOL, V15, P556, DOI 10.1007/BF00361055; HERKOWITZ HN, 1990, SPINE, V15, P1026, DOI 10.1097/00007632-199015100-00009; Higgins JPT, COCHRANE HDB SYSTEMA, P4; Hilibrand Alan S, 2004, Spine J, V4, p190S, DOI 10.1016/j.spinee.2004.07.007; Hilibrand AS, 1999, J BONE JOINT SURG AM, V81A, P519, DOI 10.2106/00004623-199904000-00009; Hongyan Z, 2004, NEUROSURGERY, V55, P447; Jawahar A, 2010, SPINE J, V10, P1043, DOI 10.1016/j.spinee.2010.08.014; Katsuura A, 2001, EUR SPINE J, V10, P320, DOI 10.1007/s005860000243; Kolstad F, 2005, EUR J RADIOL, V55, P415, DOI 10.1016/j.ejrad.2005.02.005; LUNSFORD LD, 1980, J NEUROSURG, V53, P1, DOI 10.3171/jns.1980.53.1.0001; Matsunaga S, 1999, SPINE, V24, P670, DOI 10.1097/00007632-199904010-00011; McAfee PC, 2003, J SPINAL DISORD TECH, V16, P384, DOI 10.1097/00024720-200308000-00010; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Puttlitz CM, 2004, SPINE, V29, P2809, DOI 10.1097/01.brs.0000147739.42354.a9; ROBINSON RA, 1955, B JOHNS HOPKINS HOSP, V96, P223; Sasso RC, 2011, J BONE JOINT SURG AM, V93A, P1684, DOI [10.2106/JBJS.J.00476, 10.2106/JBJSJ.00476]; Sears WR, 2007, J SPINAL DISORD TECH, V20, P1, DOI 10.1097/01.bsd.0000211262.13250.f8; Shim CS, 2006, J SPINAL DISORD TECH, V19, P465, DOI 10.1097/01.bsd.0000211235.76093.6b; Song KJ, 2011, EUR SPINE J, V20, P1940, DOI 10.1007/s00586-011-1864-9; [孙宇 SUN Yu], 2011, [中国脊柱脊髓杂志, Chinese Journal of Spine and Spinal Cord], V21, P474; TAKESHIMA T, 2002, SPINE, V27, P348; WILLIAMS JL, 1968, J BONE JOINT SURG AM, VA 50, P277, DOI 10.2106/00004623-196850020-00006; Wu W, 1996, ACTA RADIOL, V37, P614; Zoega B, 1998, Eur Spine J, V7, P302, DOI 10.1007/s005860050079	39	57	62	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35032	10.1371/journal.pone.0035032	http://dx.doi.org/10.1371/journal.pone.0035032			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558112	gold, Green Submitted, Green Published			2022-12-27	WOS:000305345200019
J	Jeong, E; Jo, H; Kim, TG; Ban, C				Jeong, Euiyoung; Jo, Hunho; Kim, Tae Gyun; Ban, Changill			Characterization of Multi-Functional Properties and Conformational Analysis of MutS2 from Thermotoga maritima MSB8	PLOS ONE			English	Article							DNA MISMATCH REPAIR; THERMUS-THERMOPHILUS MUTS2; X-RAY-SCATTERING; CRYSTAL-STRUCTURE; NUCLEASE ACTIVITY; CATALYTIC DOMAIN; PROTEIN; ENDONUCLEASE; RECOMBINATION; RESOLUTION	The MutS2 homologues have received attention because of their unusual activities that differ from those of MutS. In this work, we report on the functional characteristics and conformational diversities of Thermotoga maritima MutS2 (TmMutS2). Various biochemical features of the protein were demonstrated via diverse techniques such as scanning probe microscopy (SPM), ATPase assays, analytical ultracentrifugation, DNA binding assays, size chromatography, and limited proteolytic analysis. Dimeric TmMutS2 showed the temperature-dependent ATPase activity. The non-specific nicking endonuclease activities of TmMutS2 were inactivated in the presence of nonhydrolytic ATP (ADPnP) and enhanced by the addition of TmMutL. In addition, TmMutS2 suppressed the TmRecA-mediated DNA strand exchange reaction in a TmMutL-dependent manner. We also demonstrated that small-angle X-ray scattering (SAXS) analysis of dimeric TmMutS2 exhibited nucleotide- and DNA-dependent conformational transitions. Particularly, TmMutS2-ADPnP showed the most compressed form rather than apo-TmMutS2 and the TmMutS2-ADP complex, in accordance with the results of biochemical assays. In the case of the DNA-binding complexes, the stretched conformation appeared in the TmMutS2-four-way junction (FWJ)-DNA complex. Convergences of biochemical-and SAXS analysis provided abundant information for TmMutS2 and clarified ambiguous experimental results.	[Jeong, Euiyoung; Jo, Hunho; Kim, Tae Gyun; Ban, Changill] Pohang Univ Sci & Technol, Dept Chem, Pohang, Gyungbuk, South Korea	Pohang University of Science & Technology (POSTECH)	Jeong, E (corresponding author), Pohang Univ Sci & Technol, Dept Chem, Pohang, Gyungbuk, South Korea.	ciban@postech.ac.kr	Ban, Changill/F-5426-2013		National Research Foundation of Korea [NRF-20110013431]; KOSEF through the Center for Electro-Photo Behaviors in Advanced Molecular Systems [20110007166]	National Research Foundation of Korea(National Research Foundation of Korea); KOSEF through the Center for Electro-Photo Behaviors in Advanced Molecular Systems	This work was supported by the National Research Foundation of Korea [NRF-20110013431] and by KOSEF through the Center for Electro-Photo Behaviors in Advanced Molecular Systems [20110007166]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Diercks T, 2008, J MOL BIOL, V383, P1156, DOI 10.1016/j.jmb.2008.09.005; Eisen JA, 1998, NUCLEIC ACIDS RES, V26, P4291, DOI 10.1093/nar/26.18.4291; Feigin L.A., 1987, STRUCTURE ANAL SMALL; Friedhoff P, 2001, J BIOL CHEM, V276, P23581, DOI 10.1074/jbc.M101694200; Fukui K, 2004, J BIOCHEM, V135, P375, DOI 10.1093/jb/mvh045; Fukui K, 2007, NUCLEIC ACIDS RES, V35, P850, DOI 10.1093/nar/gkl735; Fukui Kenji, 2011, Mol Biol Int, V2011, P691735, DOI 10.4061/2011/691735; Fukui K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019053; Fukui K, 2008, J BIOL CHEM, V283, P33417, DOI 10.1074/jbc.M806755200; Fukui K, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm575; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Guan C, 2005, NUCLEIC ACIDS RES, V33, P6225, DOI 10.1093/nar/gki921; Gui WJ, 2011, J STRUCT BIOL, V174, P282, DOI 10.1016/j.jsb.2011.01.008; Hadden JM, 2001, NAT STRUCT BIOL, V8, P62; Hagedoorn M, 1999, UUCS199903; Hall MC, 1999, J BIOL CHEM, V274, P1306, DOI 10.1074/jbc.274.3.1306; Harmon FG, 1998, GENE DEV, V12, P1134, DOI 10.1101/gad.12.8.1134; Hopfner KP, 2000, STRUCTURE, V8, pR237, DOI 10.1016/S0969-2126(00)00545-1; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jang DS, 2006, FEBS LETT, V580, P4166, DOI 10.1016/j.febslet.2006.06.069; Joshi A, 2000, NUCLEIC ACIDS RES, V28, P853, DOI 10.1093/nar/28.4.853; Jun SH, 2006, FEBS J, V273, P1609, DOI 10.1111/j.1742-4658.2006.05190.x; Kang J, 2005, J BACTERIOL, V187, P3528, DOI 10.1128/JB.187.10.3528-3537.2005; Kim TG, 2009, BMB REP, V42, P53, DOI 10.5483/BMBRep.2009.42.1.053; Kim TG, 2009, J BIOCHEM, V145, P199, DOI 10.1093/jb/mvn157; Kolodner RD, 2007, P NATL ACAD SCI USA, V104, P12953, DOI 10.1073/pnas.0705698104; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Koussevitzky S, 2007, SCIENCE, V316, P715, DOI 10.1126/science. 1140516; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krukenberg KA, 2008, STRUCTURE, V16, P755, DOI 10.1016/j.str.2008.01.021; Lagunavicius A, 2003, J MOL BIOL, V326, P1051, DOI 10.1016/S0022-2836(03)00020-2; Lattuada M, 2003, J COLLOID INTERF SCI, V268, P96, DOI 10.1016/j.jcis.2003.07.028; Lin Z, 2007, NUCLEIC ACIDS RES, V35, P7591, DOI 10.1093/nar/gkm921; Malik HS, 2000, TRENDS BIOCHEM SCI, V25, P414, DOI 10.1016/S0968-0004(00)01623-6; Molloy S, 2005, NAT REV MICROBIOL, V3, P191, DOI 10.1038/nrmicro1123; Moreira D, 1999, TRENDS BIOCHEM SCI, V24, P298, DOI 10.1016/S0968-0004(99)01419-X; Nagar B, 2005, STRUCTURE, V13, P169, DOI 10.1016/j.str.2005.01.001; Nakagawa T, 1999, P NATL ACAD SCI USA, V96, P14186, DOI 10.1073/pnas.96.25.14186; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Neylon C, 2008, EUR BIOPHYS J BIOPHY, V37, P531, DOI 10.1007/s00249-008-0259-2; Nollmann M, 2004, MOL CELL, V16, P127, DOI 10.1016/j.molcel.2004.09.027; Pinto AV, 2005, MOL CELL, V17, P113, DOI 10.1016/j.molcel.2004.11.035; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Scott DJ, 2002, J MOL BIOL, V315, P1179, DOI 10.1006/jmbi.2001.5306; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Sun HB, 2000, ANAL CHEM, V72, P3138, DOI 10.1021/ac991263i; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svetlanov A, 2008, GENETICS, V178, P1937, DOI 10.1534/genetics.107.084798; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vijayvargia R, 2002, CURR MICROBIOL, V44, P224, DOI 10.1007/s00284-001-0025-5; Wang G, 2005, MOL MICROBIOL, V58, P166, DOI 10.1111/j.1365-2958.2005.04833.x; Wang HX, 2002, J BIOL CHEM, V277, P26136, DOI 10.1074/jbc.M200357200; Watanabe N, 2003, J BIOL CHEM, V278, P26102, DOI 10.1074/jbc.M303518200; Whitby MC, 2005, BIOCHEM SOC T, V33, P1451, DOI 10.1042/BST0331451; WORTH L, 1994, P NATL ACAD SCI USA, V91, P3238, DOI 10.1073/pnas.91.8.3238	59	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e34529	10.1371/journal.pone.0034529	http://dx.doi.org/10.1371/journal.pone.0034529			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545085	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343200008
J	Popugaeva, E; Witkowski, PT; Schlegel, M; Ulrich, RG; Auste, B; Rang, A; Kruger, DH; Klempa, B				Popugaeva, Elena; Witkowski, Peter T.; Schlegel, Mathias; Ulrich, Rainer G.; Auste, Brita; Rang, Andreas; Krueger, Detlev H.; Klempa, Boris			Dobrava-Belgrade Hantavirus from Germany Shows Receptor Usage and Innate Immunity Induction Consistent with the Pathogenicity of the Virus in Humans	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; RENAL SYNDROME; MAXIMUM-LIKELIHOOD; APODEMUS-AGRARIUS; CELLULAR ENTRY; EXPRESSION; INFECTION; CELLS; MOUSE; REASSORTMENT	Background: Dobrava-Belgrade virus (DOBV) is a European hantavirus causing hemorrhagic fever with renal syndrome (HFRS) in humans with fatality rates of up to 12%. DOBV-associated clinical cases typically occur also in the northern part of Germany where the virus is carried by the striped field mouse (Apodemus agrarius). However, the causative agent responsible for human illness has not been previously isolated. Methodology/Principal Findings: Here we report on characterization of a novel cell culture isolate from Germany obtained from a lung tissue of "spillover" infected yellow necked mouse (A. flavicollis) trapped near the city of Greifswald. Phylogenetic analyses demonstrated close clustering of the new strain, designated Greifswald/Aa (GRW/Aa) with the nucleotide sequence obtained from a northern German HFRS patient. The virus was effectively blocked by specific antibodies directed against beta 3 integrins and Decay Accelerating Factor (DAF) indicating that the virus uses same receptors as the highly pathogenic Hantaan virus (HTNV). In addition, activation of selected innate immunity markers as interferon beta and lambda and antiviral protein MxA after viral infection of A549 cells was investigated and showed that the virus modulates the first-line antiviral response in a similar way as HTNV. Conclusions/Significance: In summary, our study reveals novel data on DOBV receptor usage and innate immunity induction in relationship to virus pathogenicity and underlines the potency of German DOBV strains to act as human pathogen.	[Popugaeva, Elena; Witkowski, Peter T.; Auste, Brita; Rang, Andreas; Krueger, Detlev H.; Klempa, Boris] Charite, Inst Virol, Berlin, Germany; [Schlegel, Mathias; Ulrich, Rainer G.] Inst Novel & Emerging Infect Dis, Friedrich Loeffler Inst, Greifswald, Germany; [Klempa, Boris] Slovak Acad Sci, Inst Virol, Bratislava, Slovakia	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Friedrich Loeffler Institute; Slovak Academy of Sciences	Popugaeva, E (corresponding author), Charite, Inst Virol, Helmut Ruska Haus, Berlin, Germany.	boris.klempa@charite.de	Popugaeva, Elena/M-7886-2016; Schlegel, Mathias/AAO-6644-2021; Klempa, Boris/J-8876-2012; Klempa, Boris/N-3096-2019	Klempa, Boris/0000-0002-6931-1224; Klempa, Boris/0000-0002-6931-1224; Witkowski, Peter T./0000-0002-6167-8945	Deutsche Forschungsgemeinschaft (Research Training Group 1121) [KR1293/9-1]; European Commission (European Virus Archive) [228292]; Slovak Research and Development Agency [DO7RP-0008-09]; Slovak scientific grant agency VEGA [2/0189/09]	Deutsche Forschungsgemeinschaft (Research Training Group 1121)(German Research Foundation (DFG)); European Commission (European Virus Archive)(European Commission); Slovak Research and Development Agency(Slovak Research and Development Agency); Slovak scientific grant agency VEGA(Vedecka grantova agentura MSVVaS SR a SAV (VEGA))	The current work was funded by Deutsche Forschungsgemeinschaft (Research Training Group 1121 and grant no. KR1293/9-1), European Commission (European Virus Archive, FP7 CAPACITIES project - GA no 228292), Slovak Research and Development Agency (DO7RP-0008-09), and Slovak scientific grant agency VEGA (grant no. 2/0189/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens IG, 2006, EXP CELL RES, V312, P925, DOI 10.1016/j.yexcr.2005.11.036; Avsic-Zupanc T, 1999, CLIN INFECT DIS, V28, P860, DOI 10.1086/515185; Black WC, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-102; Choi Y, 2008, VIROLOGY, V381, P178, DOI 10.1016/j.virol.2008.08.035; Dzagurova TK, 2012, CLIN INFECT DIS, V54, pE1, DOI 10.1093/cid/cir746; Elgh F, 1997, J CLIN MICROBIOL, V35, P1122, DOI 10.1128/JCM.35.5.1122-1130.1997; Emonet SF, 2007, NAT PROTOC, V2, P340, DOI 10.1038/nprot.2006.453; Flohr F, 1999, FEBS LETT, V463, P24, DOI 10.1016/S0014-5793(99)01598-7; Frese M, 1996, J VIROL, V70, P915, DOI 10.1128/JVI.70.2.915-923.1996; Gavrilovskaya IN, 1999, J VIROL, V73, P3951, DOI 10.1128/JVI.73.5.3951-3959.1999; Gavrilovskaya IN, 2002, ARCH VIROL, V147, P1913, DOI 10.1007/s00705-002-0852-0; Gavrilovskaya IN, 1998, P NATL ACAD SCI USA, V95, P7074, DOI 10.1073/pnas.95.12.7074; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Haller O, 2011, J INTERF CYTOK RES, V31, P79, DOI 10.1089/jir.2010.0076; Handke W, 2009, J IMMUNOL, V182, P2849, DOI 10.4049/jimmunol.0802893; Heider H, 2001, J VIROL METHODS, V96, P17, DOI 10.1016/S0166-0934(01)00314-7; Henderson WW, 1995, VIROLOGY, V214, P602, DOI 10.1006/viro.1995.0071; Holzinger D, 2007, J VIROL, V81, P7776, DOI 10.1128/JVI.00546-06; Kanerva M, 1996, VIROLOGY, V224, P55, DOI 10.1006/viro.1996.0506; Khaiboullina SF, 2005, J MED VIROL, V75, P267, DOI 10.1002/jmv.20266; Kirsanovs S, 2010, VIRUS GENES, V41, P319, DOI 10.1007/s11262-010-0523-2; Klempa B, 2006, EMERG INFECT DIS, V12, P838, DOI 10.3201/eid1205.051487; Klempa B, 2003, J VIROL, V77, P804, DOI 10.1128/JVI.77.1.804-809.2003; Klempa B, 2005, J CLIN MICROBIOL, V43, P2756, DOI 10.1128/JCM.43.6.2756-2763.2005; Klempa B, 2004, J CLIN MICROBIOL, V42, P1322, DOI 10.1128/JCM.42.3.1322-1325.2004; Klempa B, 2008, EMERG INFECT DIS, V14, P617, DOI 10.3201/eid1404.071310; Kramski M, 2007, CLIN CHEM, V53, P1899, DOI 10.1373/clinchem.2007.093245; Kraus AA, 2005, INTERVIROLOGY, V48, P255, DOI 10.1159/000084603; Kraus AA, 2004, J VIROL, V78, P6143, DOI 10.1128/JVI.78.12.6143-6150.2004; Krautkramer E, 2008, J VIROL, V82, P4257, DOI 10.1128/JVI.02210-07; Kruger DH, 2011, HUM VACCINES, V7, P685, DOI 10.4161/hv.7.6.15197; Kruger DH, 2011, MOL DETECTION HUMAN, P631; Mackow ER, 2009, THROMB HAEMOSTASIS, V102, P1030, DOI 10.1160/TH09-09-0640; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Matthys V, 2011, J VIROL, V85, P4752, DOI 10.1128/JVI.01945-10; Nam JH, 2003, VIRUS GENES, V26, P31, DOI 10.1023/A:1022373904357; Nemirov K, 1999, J GEN VIROL, V80, P371, DOI 10.1099/0022-1317-80-2-371; Papa A, 2001, EUR J EPIDEMIOL, V17, P189, DOI 10.1023/A:1017987104363; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prescott J, 2005, J VIROL, V79, P15007, DOI 10.1128/JVI.79.24.15007-15015.2005; Prescott J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011159; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Raymond T, 2005, P NATL ACAD SCI USA, V102, P1163, DOI 10.1073/pnas.0406743102; Razzauti M, 2009, J GEN VIROL, V90, P1923, DOI 10.1099/vir.0.011304-0; Rodriguez LL, 1998, VIROLOGY, V242, P99, DOI 10.1006/viro.1997.8990; Schlegel M, 2009, EMERG INFECT DIS, V15, P2017, DOI 10.3201/eid1512.090923; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schonrich G, 2008, IMMUNOL REV, V225, P163, DOI 10.1111/j.1600-065X.2008.00694.x; Stewart PL, 2007, TRENDS MICROBIOL, V15, P500, DOI 10.1016/j.tim.2007.10.001; Stoltz M, 2010, J VIROL, V84, P9140, DOI 10.1128/JVI.00717-10; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terajima M, 2011, VIRUSES-BASEL, V3, P1059, DOI 10.3390/v3071059	53	27	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35587	10.1371/journal.pone.0035587	http://dx.doi.org/10.1371/journal.pone.0035587			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545121	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343200041
J	Watanabe, N; Wada, M; Irukayama-Tomobe, Y; Ogata, Y; Tsujino, N; Suzuki, M; Furutani, N; Sakurai, T; Yamamoto, M				Watanabe, Noriya; Wada, Mari; Irukayama-Tomobe, Yoko; Ogata, Yousuke; Tsujino, Natsuko; Suzuki, Mika; Furutani, Naoki; Sakurai, Takeshi; Yamamoto, Miyuki			A Single Nucleotide Polymorphism of the Neuropeptide B/W Receptor-1 Gene Influences the Evaluation of Facial Expressions	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; ANXIETY-RELATED TRAITS; HUMAN AMYGDALA; SEROTONIN TRANSPORTER; PREFRONTAL CORTEX; EMOTIONAL INTENSITY; REGULATORY REGION; RAT-BRAIN; ACTIVATION; GPR7	Neuropeptide B/W receptor-1 (NPBWR1) is expressed in discrete brain regions in rodents and humans, with particularly strong expression in the limbic system, including the central nucleus of the amygdala. Recently, Nagata-Kuroiwa et al. reported that Npbwr1(-/-) mice showed changes in social behavior, suggesting that NPBWR1 plays important roles in the emotional responses of social interactions. The human NPBWR1 gene has a single nucleotide polymorphism at nucleotide 404 (404A>T; SNP rs33977775). This polymorphism results in an amino acid change, Y135F. The results of an in vitro experiment demonstrated that this change alters receptor function. We investigated the effect of this variation on emotional responses to stimuli of showing human faces with four categories of emotional expressions (anger, fear, happiness, and neutral). Subjects' emotional levels on seeing these faces were rated on scales of hedonic valence, emotional arousal, and dominance (V-A-D). A significant genotype difference was observed in valence evaluation; the 404AT group perceived facial expressions more pleasantly than did the 404AA group, regardless of the category of facial expression. Statistical analysis of each combination of [V-A-D and facial expression] also showed that the 404AT group tended to feel less submissive to an angry face than did the 404AA group. Thus, a single nucleotide polymorphism of NPBWR1 seems to affect human behavior in a social context.	[Watanabe, Noriya; Wada, Mari; Irukayama-Tomobe, Yoko; Ogata, Yousuke; Yamamoto, Miyuki] Univ Tsukuba, Tsukuba, Ibaraki, Japan; [Watanabe, Noriya; Ogata, Yousuke] Japan Soc Promot Sci, Tokyo, Japan; [Watanabe, Noriya] Tamagawa Univ, Grad Sch Engn, Machida, Tokyo, Japan; [Irukayama-Tomobe, Yoko] Univ Tsukuba, Ctr Behav Mol Genet, Program 1, Tokyo, Japan; [Tsujino, Natsuko; Suzuki, Mika; Furutani, Naoki; Sakurai, Takeshi] Kanazawa Univ, Fac Med, Dept Mol Neurosci & Integrat Physiol, Kanazawa, Ishikawa, Japan; [Sakurai, Takeshi] Japan Sci & Technol Agcy, Exploratory Res Adv Technol Yanagisawa Orphan Rec, Tokyo, Japan	University of Tsukuba; Japan Society for the Promotion of Science; University of Tsukuba; Kanazawa University; Japan Science & Technology Agency (JST)	Watanabe, N (corresponding author), Univ Tsukuba, Tsukuba, Ibaraki, Japan.	tsakurai@med.kanazawa-u.ac.jp; yamamoto444@gmail.com		Watanabe, Noriya/0000-0002-7847-6338; Ogata, Yousuke/0000-0003-4613-7435	University of Tsukuba; Ministry of Education, Culture, Sports, Science and Technology of Japan; John D. and Catherine T. MacArthur Foundation Research Network on Early Experience and Brain Development; Grants-in-Aid for Scientific Research [23300082, 24700322] Funding Source: KAKEN	University of Tsukuba; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); John D. and Catherine T. MacArthur Foundation Research Network on Early Experience and Brain Development; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the 21st Center of Excellence program of the University of Tsukuba, and a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan. NW and YO were supported by Grant-in-Aid for Japan Society for the Promotion of Science Fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Development of the MacBrain Face Stimulus Set was overseen by Nim Tottenham and supported by the John D. and Catherine T. MacArthur Foundation Research Network on Early Experience and Brain Development (tott0006@tc.umn.edu).	ADOLPHS R, 1995, J NEUROSCI, V15, P5879; Adolphs R, 2010, ANN NY ACAD SCI, V1191, P42, DOI 10.1111/j.1749-6632.2010.05445.x; Anders S, 2008, SOC COGN AFFECT NEUR, V3, P233, DOI 10.1093/scan/nsn017; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Bradley M. M., 1999, C1 U FLOR CTR RES PS, V30, P25; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Brezillon S, 2003, J BIOL CHEM, V278, P776, DOI 10.1074/jbc.M206396200; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Costa P.T., 2008, SAGE HDB PERSONALITY, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9, 10.4135/9781849200479.N9]; Cunningham WA, 2004, J COGNITIVE NEUROSCI, V16, P1717, DOI 10.1162/0898929042947919; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Eysenck H, MANUAL MAUDSLEY PERS; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Garavan H, 2001, NEUROREPORT, V12, P2779, DOI 10.1097/00001756-200108280-00036; Goldman-Rakic PSBC, 1999, PRIMATE MESOCORTICAL, P403; Hamann S, 2002, NEUROREPORT, V13, P15, DOI 10.1097/00001756-200201210-00008; Hamann SB, 2002, PSYCHOL SCI, V13, P135, DOI 10.1111/1467-9280.00425; Heinz A, 2005, NAT NEUROSCI, V8, P20, DOI 10.1038/nn1366; Hondo Mari, 2008, V46, P239, DOI 10.1007/400_2007_056; Iidaka T, 2005, J NEUROSCI, V25, P6460, DOI 10.1523/JNEUROSCI.5261-04.2005; Kalin NH, 2004, J NEUROSCI, V24, P5506, DOI 10.1523/JNEUROSCI.0292-04.2004; Katsuragi S, 1999, BIOL PSYCHIAT, V45, P368, DOI 10.1016/S0006-3223(98)00090-0; Kennedy DP, 2009, NAT NEUROSCI, V12, P1226, DOI 10.1038/nn.2381; Kim H, 2003, NEUROREPORT, V14, P2317, DOI 10.1097/00001756-200312190-00006; Kitamura Y, 2006, BRAIN RES, V1093, P123, DOI 10.1016/j.brainres.2006.03.041; Krugel LK, 2009, P NATL ACAD SCI USA, V106, P17951, DOI 10.1073/pnas.0905191106; Lang PJ, 2006, PROG BRAIN RES, V156, P3, DOI 10.1016/S0079-6123(06)56001-7; Lee DK, 1999, MOL BRAIN RES, V71, P96, DOI 10.1016/S0169-328X(99)00171-0; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; LEWIS DA, 1992, J NEURAL TRANSM-GEN, P179; Liberzon I, 2003, NEUROPSYCHOPHARMACOL, V28, P726, DOI 10.1038/sj.npp.1300113; Mehrabian A, 1996, INT J AGING HUM DEV, V42, P251, DOI 10.2190/1QCY-VETT-JJAY-3EY1; Melke J, 2003, ARCH GEN PSYCHIAT, V60, P1017, DOI 10.1001/archpsyc.60.10.1017; Mellado M, 1998, J IMMUNOL, V161, P805; MORA F, 1980, BRAIN RES BULL, V5, P111, DOI 10.1016/0361-9230(80)90181-1; Nagata-Kuroiwa R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016972; Nelson RJ, 2007, NAT REV NEUROSCI, V8, P536, DOI 10.1038/nrn2174; ODOWD BF, 1995, GENOMICS, V28, P84, DOI 10.1006/geno.1995.1109; Phan KL, 2004, NEUROIMAGE, V21, P768, DOI 10.1016/j.neuroimage.2003.09.072; Phelps EA, 2006, ANNU REV PSYCHOL, V57, P27, DOI 10.1146/annurev.psych.56.091103.070234; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Posner J, 2005, DEV PSYCHOPATHOL, V17, P715, DOI 10.1017/S0954579405050340; ROLLS ET, 1980, BRAIN RES, V194, P339, DOI 10.1016/0006-8993(80)91216-0; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; RUSSELL JA, 1977, J RES PERS, V11, P273, DOI 10.1016/0092-6566(77)90037-X; Sabatinelli D, 2005, NEUROIMAGE, V24, P1265, DOI 10.1016/j.neuroimage.2004.12.015; Salimpoor VN, 2011, NAT NEUROSCI, V14, P257, DOI 10.1038/nn.2726; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Sharot T, 2009, CURR BIOL, V19, P2077, DOI 10.1016/j.cub.2009.10.025; Tanaka H, 2003, P NATL ACAD SCI USA, V100, P6251, DOI 10.1073/pnas.0837789100; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Williams LM, 2004, HUM BRAIN MAPP, V21, P64, DOI 10.1002/hbm.10154; Williams MA, 2004, EXP BRAIN RES, V154, P403, DOI 10.1007/s00221-003-1740-x; Williams MA, 2005, NEUROIMAGE, V24, P417, DOI 10.1016/j.neuroimage.2004.08.017; WILLIAMS SM, 1993, CEREB CORTEX, V3, P199, DOI 10.1093/cercor/3.3.199; Wright CI, 2001, NEUROREPORT, V12, P379, DOI 10.1097/00001756-200102120-00039; Yang TT, 2002, NEUROREPORT, V13, P1737, DOI 10.1097/00001756-200210070-00009	60	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35390	10.1371/journal.pone.0035390	http://dx.doi.org/10.1371/journal.pone.0035390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545105	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343200026
J	DeSantis, LRG; Tracy, RAB; Koontz, CS; Roseberry, JC; Velasco, MC				DeSantis, Larisa R. G.; Tracy, Rachel A. Beavins; Koontz, Cassandra S.; Roseberry, John C.; Velasco, Matthew C.			Mammalian Niche Conservation through Deep Time	PLOS ONE			English	Article							GEOGRAPHIC RANGE SIZES; PLEISTOCENE MAMMALS; CLIMATE-CHANGE; HABITAT FRAGMENTATION; FOSSIL HORSES; SPECIES-LEVEL; EXTINCTIONS; HERITABILITY; EVOLUTION; ENVIRONMENTS	Climate change alters species distributions, causing plants and animals to move north or to higher elevations with current warming. Bioclimatic models predict species distributions based on extant realized niches and assume niche conservation. Here, we evaluate if proxies for niches (i.e., range areas) are conserved at the family level through deep time, from the Eocene to the Pleistocene. We analyze the occurrence of all mammalian families in the continental USA, calculating range area, percent range area occupied, range area rank, and range polygon centroids during each epoch. Percent range area occupied significantly increases from the Oligocene to the Miocene and again from the Pliocene to the Pleistocene; however, mammalian families maintain statistical concordance between rank orders across time. Families with greater taxonomic diversity occupy a greater percent of available range area during each epoch and net changes in taxonomic diversity are significantly positively related to changes in percent range area occupied from the Eocene to the Pleistocene. Furthermore, gains and losses in generic and species diversity are remarkably consistent with similar to 2.3 species gained per generic increase. Centroids demonstrate southeastern shifts from the Eocene through the Pleistocene that may correspond to major environmental events and/or climate changes during the Cenozoic. These results demonstrate range conservation at the family level and support the idea that niche conservation at higher taxonomic levels operates over deep time and may be controlled by life history traits. Furthermore, families containing megafauna and/or terminal Pleistocene extinction victims do not incur significantly greater declines in range area rank than families containing only smaller taxa and/or only survivors, from the Pliocene to Pleistocene. Collectively, these data evince the resilience of families to climate and/or environmental change in deep time, the absence of terminal Pleistocene "extinction prone'' families, and provide valuable insights to understanding mammalian responses to current climate change.	[DeSantis, Larisa R. G.; Tracy, Rachel A. Beavins; Roseberry, John C.] Vanderbilt Univ, Dept Earth & Environm Sci, Nashville, TN 37235 USA; [Koontz, Cassandra S.; Velasco, Matthew C.] Vanderbilt Univ, Dept Anthropol, Nashville, TN USA	Vanderbilt University; Vanderbilt University	DeSantis, LRG (corresponding author), Vanderbilt Univ, Dept Earth & Environm Sci, Nashville, TN 37235 USA.	larisa.desantis@vanderbilt.edu		Velasco, Matthew/0000-0001-8784-7076; DeSantis, Larisa/0000-0003-1159-9154	Vanderbilt University	Vanderbilt University	Funding was provided by Vanderbilt University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alroy J, 2001, SCIENCE, V292, P1893, DOI 10.1126/science.1059342; [Anonymous], 1999, WALKERS MAMMALS WORL; Barnosky AD, 2004, SCIENCE, V306, P70, DOI 10.1126/science.1101476; BEYER HL, 2009, GEOSPATIAL MODELLING; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; DeSantis LG, 2011, BIOTROPICA, V43, P746, DOI 10.1111/j.1744-7429.2011.00761.x; DeSantis LRG, 2007, COUR FOR SEKENBG, V258, P147; DeSantis LRG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005750; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Faith JT, 2009, P NATL ACAD SCI USA, V106, P20641, DOI 10.1073/pnas.0908153106; Hadly EA, 2009, P NATL ACAD SCI USA, V106, P19707, DOI 10.1073/pnas.0901648106; Haug GH, 2005, NATURE, V433, P821, DOI 10.1038/nature03332; Hunt G, 2005, AM NAT, V166, P129, DOI 10.1086/430722; Janis CM, 2008, EVOLUTION OF TERTIARY MAMMALS OF NORTH AMERICA, VOL 2, P1, DOI 10.1017/CBO9780511541438; Janis CM, 2000, P NATL ACAD SCI USA, V97, P7899, DOI 10.1073/pnas.97.14.7899; Janis CM, 1998, TERRESTRIAL CARNIVOR; JENKINS S H, 1979, Mammalian Species, P1, DOI 10.2307/3503787; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Lyons SK, 2010, PHILOS T R SOC B, V365, P3681, DOI 10.1098/rstb.2010.0263; Lyons SK, 2004, EVOL ECOL RES, V6, P339; Lyons SK, 2003, J MAMMAL, V84, P385, DOI 10.1644/1545-1542(2003)084<0385:AQAOTR>2.0.CO;2; MacFadden BJ, 2005, SCIENCE, V307, P1728, DOI 10.1126/science.1105458; MACFADDEN BJ, 1994, TRENDS ECOL EVOL, V9, P481, DOI 10.1016/0169-5347(94)90313-1; Martin PS, 1984, QUATERNARY EXTINCTIO; Martinez-Meyer E, 2004, GLOBAL ECOL BIOGEOGR, V13, P305, DOI 10.1111/j.1466-822X.2004.00107.x; MCNAB BK, 1963, AM NAT, V97, P133, DOI 10.1086/282264; Paleobiology Database, 2010, MAMM PAL DAT ONL ARC; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Peres CA, 2001, CONSERV BIOL, V15, P1490, DOI 10.1046/j.1523-1739.2001.01089.x; Peterson AT, 2011, J BIOGEOGR, V38, P817, DOI 10.1111/j.1365-2699.2010.02456.x; Post E, 2004, P NATL ACAD SCI USA, V101, P9286, DOI 10.1073/pnas.0305029101; Reynolds PS, 2002, J MAMMAL, V83, P321, DOI 10.1644/1545-1542(2002)083<0321:HBIAGT>2.0.CO;2; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Sax DF, 2002, AM NAT, V160, P766, DOI 10.1086/343877; Waldron A, 2007, AM NAT, V170, P221, DOI 10.1086/518963; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Webb TJ, 2003, AM NAT, V161, P553, DOI 10.1086/368296; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	42	16	16	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35624	10.1371/journal.pone.0035624	http://dx.doi.org/10.1371/journal.pone.0035624			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539985	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341000051
J	Anger, GJ; Cressman, AM; Piquette-Miller, M				Anger, Gregory J.; Cressman, Alex M.; Piquette-Miller, Micheline			Expression of ABC Efflux Transporters in Placenta from Women with Insulin-Managed Diabetes	PLOS ONE			English	Article							CANCER RESISTANCE PROTEIN; P-GLYCOPROTEIN EXPRESSION; FUNCTIONAL-ACTIVITY; GLUCOSE-TOLERANCE; BILIARY-EXCRETION; BIRTH-WEIGHT; PREGNANCY; GLYBURIDE; MELLITUS; LIPOPROTEIN	Drug efflux transporters in the placenta can significantly influence the materno-fetal transfer of a diverse array of drugs and other xenobiotics. To determine if clinically important drug efflux transporter expression is altered in pregnancies complicated by gestational diabetes mellitus (GDM-I) or type 1 diabetes mellitus (T1DM-I), we compared the expression of multidrug resistance protein 1 (MDR1), multidrug resistance-associated protein 2 (MRP2) and the breast cancer resistance protein (BCRP) via western blotting and quantitative real-time polymerase chain reaction in samples obtained from insulin-managed diabetic pregnancies to healthy term-matched controls. At the level of mRNA, we found significantly increased expression of MDR1 in the GDM-I group compared to both the T1DM-I (p<0.01) and control groups (p<0.05). Significant changes in the placental protein expression of MDR1, MRP2, and BCRP were not detected (p>0.05). Interestingly, there was a significant, positive correlation observed between plasma hemoglobin A1c levels (a retrospective marker of glycemic control) and both BCRP protein expression (r = 0.45, p<0.05) and BCRP mRNA expression (r = 0.58, p<0.01) in the insulin-managed DM groups. Collectively, the data suggest that the expression of placental efflux transporters is not altered in pregnancies complicated by diabetes when hyperglycemia is managed; however, given the relationship between BCRP expression and plasma hemoglobin A1c levels it is plausible that their expression could change in poorly managed diabetes.	[Anger, Gregory J.; Cressman, Alex M.; Piquette-Miller, Micheline] Univ Toronto, Dept Pharmaceut Sci, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Cressman, Alex M.; Piquette-Miller, Micheline] Univ Toronto, Fac Med, Dept Pharmacol & Toxicol, Toronto, ON, Canada	University of Toronto; University of Toronto	Anger, GJ (corresponding author), Univ Toronto, Dept Pharmaceut Sci, Leslie Dan Fac Pharm, Toronto, ON, Canada.	m.piquette.miller@utoronto.ca		Piquette-Miller, Micheline/0000-0002-3847-8224	Canadian Institutes of Health Research (CIHR) [57688, MGC-13299]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	The work described here was supported by an operating grant from Canadian Institutes of Health Research (CIHR) (CIHR #57688; www.cihr-irsc.gc.ca). Human specimens were obtained from a BioBank program that was also supported by a grant from CIHR (CIHR #MGC-13299). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2007, DRUG METAB DISPOS, V35, P1873, DOI 10.1124/dmd.107.014969; Anger GJ, 2011, DRUG METAB DISPOS, V39, P1850, DOI 10.1124/dmd.111.040626; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Ceckova M, 2006, CLIN EXP PHARMACOL P, V33, P58, DOI 10.1111/j.1440-1681.2006.04324.x; CLARSON C, 1989, PLACENTA, V10, P275, DOI 10.1016/0143-4004(89)90028-3; Couch SC, 1998, J DIABETES COMPLICAT, V12, P1, DOI 10.1016/S1056-8727(97)00007-X; Cunningham F, 2001, WILLIAMS OBSTET, pMcGraw; Damm P, 2009, INT J GYNECOL OBSTET, V104, pS25, DOI 10.1016/j.ijgo.2008.11.025; Durr D, 2000, CLIN PHARMACOL THER, V68, P598, DOI 10.1067/mcp.2000.112240; Evseenko DA, 2006, AM J PHYSIOL-REG I, V290, pR1357, DOI 10.1152/ajpregu.00630.2005; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gedeon C, 2008, PLACENTA, V29, P39, DOI 10.1016/j.placenta.2007.08.004; Gil S, 2005, PLACENTA, V26, P268, DOI 10.1016/j.placenta.2004.05.013; GWILT PR, 1991, CLIN PHARMACOKINET, V20, P477, DOI 10.2165/00003088-199120060-00004; Jaeggi ET, 2011, CIRCULATION, V124, P1747, DOI 10.1161/CIRCULATIONAHA.111.026120; Janvilisri T, 2003, J BIOL CHEM, V278, P20645, DOI 10.1074/jbc.M301358200; Jonker JW, 2000, JNCI-J NATL CANCER I, V92, P1651, DOI 10.1093/jnci/92.20.1651; Karcaaltincaba D, 2010, J MATERN-FETAL NEO M, V23, P1193, DOI 10.3109/14767050903511586; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; KNOPP RH, 1986, BIOL NEONATE, V50, P297, DOI 10.1159/000242614; KNOPP RH, 1977, CLIN RES, V25, pA126; Koukkou E, 1996, J CLIN PATHOL, V49, P634, DOI 10.1136/jcp.49.8.634; Kucuk M, 2009, J DIABETES COMPLICAT, V23, P25, DOI 10.1016/j.jdiacomp.2007.04.002; Langer O, 2005, AM J OBSTET GYNECOL, V192, P134, DOI 10.1016/j.ajog.2004.07.011; Langer O, 2000, NEW ENGL J MED, V343, P1134, DOI 10.1056/NEJM200010193431601; Lankas GR, 1998, REPROD TOXICOL, V12, P457, DOI 10.1016/S0890-6238(98)00027-6; LAURINI RN, 1987, PLACENTA, V8, P153, DOI 10.1016/0143-4004(87)90018-X; Mason CW, 2011, DRUG METAB DISPOS, V39, P1000, DOI 10.1124/dmd.111.038166; May K, 2008, DRUG METAB DISPOS, V36, P740, DOI 10.1124/dmd.107.019448; Meier Y, 2006, HEPATOLOGY, V44, P62, DOI 10.1002/hep.21214; Merino G, 2005, MOL PHARMACOL, V67, P1765, DOI 10.1124/mol.105.011080; Merino G, 2005, MOL PHARMACOL, V67, P1758, DOI 10.1124/mol.104.010439; Molsa M, 2005, CLIN PHARMACOL THER, V78, P123, DOI 10.1016/j.clpt.2005.04.014; Murphy HR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1680; NAEYE RL, 1987, HUM PATHOL, V18, P387, DOI 10.1016/S0046-8177(87)80170-3; Nelson DM, 2011, PLACENTA, V32, P195, DOI 10.1016/j.placenta.2010.12.008; Nielsen GL, 2007, DIABETIC MED, V24, P384, DOI 10.1111/j.1464-5491.2007.02103.x; Nummi S, 1972, Acta Obstet Gynecol Scand Suppl, V17, P1; Onkamo P, 1999, DIABETOLOGIA, V42, P1395, DOI 10.1007/s001250051309; Owen A, 2005, BRIT J CLIN PHARMACO, V59, P365, DOI 10.1111/j.1365-2125.2005.02229.x; Pascolo L, 2003, BIOCHEM BIOPH RES CO, V303, P259, DOI 10.1016/S0006-291X(03)00327-9; Pavek P, 2005, J PHARMACOL EXP THER, V312, P144, DOI 10.1124/jpet.104.073916; Pollex E, 2008, PLACENTA, V29, P743, DOI 10.1016/j.placenta.2008.05.001; RAHBAR S, 1969, BIOCHEM BIOPH RES CO, V36, P838, DOI 10.1016/0006-291X(69)90685-8; SCHUETZ EG, 1995, J PHARMACOL EXP THER, V275, P1011; Silverman BL, 1998, DIABETES CARE, V21, pB142; SILVERMAN BL, 1995, DIABETES CARE, V18, P611, DOI 10.2337/diacare.18.5.611; Simon C, 2007, ACTA NEUROL SCAND, V115, P232, DOI 10.1111/j.1600-0404.2006.00761.x; Smit JW, 1999, J CLIN INVEST, V104, P1441, DOI 10.1172/JCI7963; SPELLACY WN, 1985, OBSTET GYNECOL, V66, P158; St-Pierre MV, 2000, AM J PHYSIOL-REG I, V279, pR1495, DOI 10.1152/ajpregu.2000.279.4.R1495; Tanabe M, 2001, J PHARMACOL EXP THER, V297, P1137; van Herwaarden AE, 2006, CARCINOGENESIS, V27, P123, DOI 10.1093/carcin/bgi176; WINICK M, 1967, J PEDIATR-US, V71, P216, DOI 10.1016/S0022-3476(67)80075-1; World Health Organisation, 2011, FACT SHEET 312 DIAB; Zamek-Gliszczynski MJ, 2006, MOL PHARMACOL, V70, P2127, DOI 10.1124/mol.106.026955; Zhou L, 2008, MOL PHARMACOL, V73, P949, DOI 10.1124/mol.107.041616	57	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35027	10.1371/journal.pone.0035027	http://dx.doi.org/10.1371/journal.pone.0035027			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558111	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336000023
J	Duan, KM; McCullough, WM; Surette, MG; Ware, T; Song, JZ				Duan, Kangmin; McCullough, William M.; Surette, Michael G.; Ware, Tony; Song, Jiuzhou			Comprehensive Analysis of Gene-Environmental Interactions with Temporal Gene Expression Profiles in Pseudomonas aeruginosa	PLOS ONE			English	Article							REGULATORY NETWORKS; MODULATION; MOTIFS	To explore gene-environment interactions, based on temporal gene expression information, we analyzed gene and treatment information intensively and inferred interaction networks accordingly. The main idea is that gene expression reflects the response of genes to environmental factors, assuming that variations of gene expression occur under different conditions. Then we classified experimental conditions into several subgroups based on the similarity of temporal gene expression profiles. This procedure is useful because it allows us to combine diverse gene expression data as they become available, and, especially, allowing us to lay the regulatory relationships on a concrete biological basis. By estimating the activation points, we can visualize the gene behavior, and obtain a consensus gene activation order, and hence describe conditional regulatory relationships. The estimation of activation points and building of synthetic genetic networks may result in important new insights in the ongoing endeavor to understand the complex network of gene regulation.	[Duan, Kangmin] Univ Manitoba, Dept Med Microbiol, Dept Biol, Winnipeg, MB, Canada; [McCullough, William M.; Surette, Michael G.] McMaster Univ, Farncombe Family Digest Hlth Res Inst, Dept Med, Hamilton, ON, Canada; [Ware, Tony] Univ Calgary, Dept Math & Stat, Calgary, AB T2N 1N4, Canada; [Song, Jiuzhou] Univ Maryland, Anim Sci Ctr, Dept Anim & Avian Sci, College Pk, MD 20742 USA	University of Manitoba; McMaster University; University of Calgary; University System of Maryland; University of Maryland College Park	Duan, KM (corresponding author), Univ Manitoba, Dept Med Microbiol, Dept Biol, Winnipeg, MB, Canada.	songj88@umd.edu	Song, Jiuzhou/AAD-6440-2020	Duan, Kangmin/0000-0002-3016-786X	Canadian Cystic Fibrosis Foundation	Canadian Cystic Fibrosis Foundation	This research was supported by a grant from the Canadian Cystic Fibrosis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arda HE, 2010, BRIEF FUNCT GENOMICS, V9, P4, DOI 10.1093/bfgp/elp049; Banerjee N, 2002, CURR OPIN MICROBIOL, V5, P313, DOI 10.1016/S1369-5274(02)00322-3; Bickel DR, 2005, BIOINFORMATICS, V21, P1121, DOI 10.1093/bioinformatics/bti140; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; de Jong H, 2003, BIOINFORMATICS, V19, P336, DOI 10.1093/bioinformatics/btf851; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Duan KM, 2003, MOL MICROBIOL, V50, P1477, DOI 10.1046/j.1365-2958.2003.03803.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fabry-Asztalos L, 2008, BIOORGAN MED CHEM, V16, P2903, DOI 10.1016/j.bmc.2007.12.055; Hache H, 2009, EURASIP J BIOINFORM, DOI 10.1155/2009/617281; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Heller MJ, 2002, ANNU REV BIOMED ENG, V4, P129, DOI 10.1146/annurev.bioeng.4.020702.153438; Hempel S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-292; Huang MC, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3385468; Kalir S, 2001, SCIENCE, V292, P2080, DOI 10.1126/science.1058758; Lin K, 2010, METHODS MOL BIOL, V673, P253, DOI 10.1007/978-1-60761-842-3_17; Lin YY, 2008, GENE DEV, V22, P2062, DOI 10.1101/gad.1679508; Logan MR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-336; Malcom JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021541; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Ooi BNS, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-13; Pe'er D, 2001, Bioinformatics, V17 Suppl 1, pS215; Shen LX, 2008, J MICROBIOL, V46, P441, DOI 10.1007/s12275-008-0054-x; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Shimamura T, 2010, BIOINFORMATICS, V26, P1064, DOI 10.1093/bioinformatics/btq080; Smolen P, 2000, B MATH BIOL, V62, P247, DOI 10.1006/bulm.1999.0155; Summer G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S18; SZALLASI Z, 1999, PAC S BIOC, V4, P5; Takahashi H, 2011, OMICS, V15, P15, DOI 10.1089/omi.2010.0074; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Taylor Ronald C., 2011, International Journal of Computational Biology and Drug Design, V4, P56, DOI 10.1504/IJCBDD.2011.038657; THOMAS R, 1995, B MATH BIOL, V57, P247, DOI 10.1007/BF02460618; Waaijenborg S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-315; Wang L, 2009, CANCER RES, V69, P9490, DOI 10.1158/0008-5472.CAN-09-2183; Weaver D C, 1999, Pac Symp Biocomput, P112; Xu R, 2011, INTEGR BIOL-UK, V3, P368, DOI 10.1039/c0ib00087f; Zou M, 2005, BIOINFORMATICS, V21, P71, DOI 10.1093/bioinformatics/bth463	37	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35993	10.1371/journal.pone.0035993	http://dx.doi.org/10.1371/journal.pone.0035993			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558298	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336000096
J	Erb, M; Hoffmann-Enger, B; Deppe, H; Soeberdt, M; Haefeli, RH; Rummey, C; Feurer, A; Gueven, N				Erb, Michael; Hoffmann-Enger, Barbara; Deppe, Holger; Soeberdt, Michael; Haefeli, Roman H.; Rummey, Christian; Feurer, Achim; Gueven, Nuri			Features of Idebenone and Related Short-Chain Quinones that Rescue ATP Levels under Conditions of Impaired Mitochondrial Complex I	PLOS ONE			English	Article							BRAIN MITOCHONDRIA; LIPID-PEROXIDATION; NAD(P)H-QUINONE OXIDOREDUCTASE-1; COENZYME-Q; INHIBITION; METABOLISM; MECHANISMS; REDUCTION; CHEMISTRY; SUBSTRATE	Short-chain quinones have been investigated as therapeutic molecules due to their ability to modulate cellular redox reactions, mitochondrial electron transfer and oxidative stress, which are pathologically altered in many mitochondrial and neuromuscular disorders. Recently, we and others described that certain short-chain quinones are able to bypass a deficiency in complex I by shuttling electrons directly from the cytoplasm to complex III of the mitochondrial respiratory chain to produce ATP. Although this energy rescue activity is highly interesting for the therapy of disorders associated with complex I dysfunction, no structure-activity-relationship has been reported for short-chain quinones so far. Using a panel of 70 quinones, we observed that the capacity for this cellular energy rescue as well as their effect on lipid peroxidation was influenced more by the physicochemical properties (in particular logD) of the whole molecule than the quinone moiety itself. Thus, the observed correlations allow us to explain the differential biological activities and therapeutic potential of short-chain quinones for the therapy of disorders associated with mitochondrial complex I dysfunction and/or oxidative stress.	[Erb, Michael; Hoffmann-Enger, Barbara; Deppe, Holger; Soeberdt, Michael; Haefeli, Roman H.; Rummey, Christian; Feurer, Achim; Gueven, Nuri] Santhera Pharmaceut, Liestal, Switzerland; [Haefeli, Roman H.] Univ Basel, Biozentrum, Basel, Switzerland	University of Basel	Erb, M (corresponding author), Santhera Pharmaceut, Liestal, Switzerland.	nuri.gueven@santhera.com	Soeberdt, Michael/AAP-8617-2020	Soeberdt, Michael/0000-0003-2594-9901; Guven, Nuri/0000-0003-3782-767X; Rummey, Christian/0000-0003-4911-911X				Adikesavan AK, 2007, CANCER RES, V67, P7966, DOI 10.1158/0008-5472.CAN-06-4480; Becker C, 2010, EXPERT OPIN DRUG MET, V6, P1437, DOI 10.1517/17425255.2010.530656; Boutin JA, 2005, CHEM-BIOL INTERACT, V151, P213, DOI 10.1016/j.cbi.2005.01.002; Carelli V, 2011, BRAIN, V134, DOI 10.1093/brain/awr180; Chan TS, 2002, FREE RADICAL RES, V36, P421, DOI 10.1080/10715760290021270; Colucci MA, 2008, ORG BIOMOL CHEM, V6, P637, DOI 10.1039/b715270a; Courdier-Fruh I, 2006, MUSCLE NERVE, V33, P753, DOI 10.1002/mus.20549; Dragan M, 2006, BRAIN RES, V1078, P9, DOI 10.1016/j.brainres.2006.01.068; Ernster, 1967, METHOD ENZYMOL, V10, P309, DOI [DOI 10.1016/0076-6879(67)10059-1, 10.1016/0076-6879(67)10059-1]; Esposti MD, 1996, ARCH BIOCHEM BIOPHYS, V330, P395, DOI 10.1006/abbi.1996.0267; FATO R, 2008, BIOCHIM BIOPHYS ACTA, V1787, P384; Feurer A, 2012, Patent No. [WO/2012/022468, 2012022468]; Feurer A, 2012, Patent No. [WO/2012/ 022467, 2012022467]; Genova MW, 2003, EXP BIOL MED, V228, P506, DOI 10.1177/15353702-0322805-14; Giorgio V, 2011, BIOCHIM BIOPHYS ACTA, V1817, P363; Haefeli RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017963; Haginoya K, 2009, J NEUROL SCI, V278, P112, DOI 10.1016/j.jns.2008.11.008; Ikejiri Y, 1996, NEUROLOGY, V47, P583, DOI 10.1212/WNL.47.2.583; Jauslin ML, 2002, HUM MOL GENET, V11, P3055, DOI 10.1093/hmg/11.24.3055; King MS, 2009, BIOCHEMISTRY-US, V48, P2053, DOI 10.1021/bi802282h; Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170; Long DJ, 2000, CHEM-BIOL INTERACT, V129, P99, DOI 10.1016/S0009-2797(00)00200-3; MONKS TJ, 1992, TOXICOL APPL PHARM, V112, P2, DOI 10.1016/0041-008X(92)90273-U; Mordente A, 1998, CHEM RES TOXICOL, V11, P54, DOI 10.1021/tx970136j; Napolitano A, 2000, NEUROL SCI, V21, pS981, DOI 10.1007/s100720070015; OBRIEN PJ, 1991, CHEM-BIOL INTERACT, V80, P1, DOI 10.1016/0009-2797(91)90029-7; Pink JJ, 2000, J BIOL CHEM, V275, P5416, DOI 10.1074/jbc.275.8.5416; Ranganathan S, 2009, HUM MOL GENET, V18, P27, DOI 10.1093/hmg/ddn310; Rauchova H, 2008, J BIOENERG BIOMEMBR, V40, P85, DOI 10.1007/s10863-008-9134-1; Rauchova H, 2006, BIOCHEM BIOPH RES CO, V339, P362, DOI 10.1016/j.bbrc.2005.11.035; Ross D, 2000, CHEM-BIOL INTERACT, V129, P77, DOI 10.1016/S0009-2797(00)00199-X; SUGIYAMA Y, 1985, J PHARMACOBIO-DYNAM, V8, P1006; SUNO M, 1984, BIOCHEM BIOPH RES CO, V125, P1046, DOI 10.1016/0006-291X(84)91389-5; SUNO M, 1989, ARCH GERONTOL GERIAT, V8, P291, DOI 10.1016/0167-4943(89)90010-1; TSURUO Y, 1994, JPN J PHARMACOL, V65, P285, DOI 10.1254/jjp.65.285	35	60	65	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36153	10.1371/journal.pone.0036153	http://dx.doi.org/10.1371/journal.pone.0036153			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558363	Green Published, gold			2022-12-27	WOS:000305336000140
J	Krejci, P; Aklian, A; Kaucka, M; Sevcikova, E; Prochazkova, J; Masek, JK; Mikolka, P; Pospisilova, T; Spoustova, T; Weis, M; Paznekas, WA; Wolf, JH; Gutkind, JS; Wilcox, WR; Kozubik, A; Jabs, EW; Bryja, V; Salazar, L; Vesela, I; Balek, L				Krejci, Pavel; Aklian, Anie; Kaucka, Marketa; Sevcikova, Eva; Prochazkova, Jirina; Masek, Jan Kukla; Mikolka, Pavol; Pospisilova, Tereza; Spoustova, Tereza; Weis, MaryAnn; Paznekas, William A.; Wolf, Joshua H.; Gutkind, J. Silvio; Wilcox, William R.; Kozubik, Alois; Jabs, Ethylin Wang; Bryja, Vitezslav; Salazar, Lisa; Vesela, Iva; Balek, Lukas			Receptor Tyrosine Kinases Activate Canonical WNT/beta-Catenin Signaling via MAP Kinase/LRP6 Pathway and Direct beta-Catenin Phosphorylation	PLOS ONE			English	Article							WNT; FGFR3; MUTATIONS; MECHANISM; INSULIN	Receptor tyrosine kinase signaling cooperates with WNT/beta-catenin signaling in regulating many biological processes, but the mechanisms of their interaction remain poorly defined. We describe a potent activation of WNT/beta-catenin by FGFR2, FGFR3, EGFR and TRKA kinases, which is independent of the PI3K/AKT pathway. Instead, this phenotype depends on ERK MAP kinase-mediated phosphorylation of WNT co-receptor LRP6 at Ser1490 and Thr1572 during its Golgi network-based maturation process. This phosphorylation dramatically increases the cellular response to WNT. Moreover, FGFR2, FGFR3, EGFR and TRKA directly phosphorylate beta-catenin at Tyr142, which is known to increase cytoplasmic beta-catenin concentration via release of beta-catenin from membranous cadherin complexes. We conclude that signaling via ERK/LRP6 pathway and direct beta-catenin phosphorylation at Tyr142 represent two mechanisms used by various receptor tyrosine kinase systems to activate canonical WNT signaling.	[Krejci, Pavel; Aklian, Anie; Wilcox, William R.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Krejci, Pavel; Kaucka, Marketa; Sevcikova, Eva; Prochazkova, Jirina; Masek, Jan Kukla; Mikolka, Pavol; Pospisilova, Tereza; Spoustova, Tereza; Kozubik, Alois; Bryja, Vitezslav; Vesela, Iva; Balek, Lukas] Masaryk Univ, Dept Anim Physiol & Immunol, Inst Expt Biol, Brno, Czech Republic; [Krejci, Pavel; Kozubik, Alois; Bryja, Vitezslav] Inst Biophys AS CR, Dept Cytokinet, Brno, Czech Republic; [Weis, MaryAnn] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA; [Paznekas, William A.; Jabs, Ethylin Wang] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Wolf, Joshua H.; Gutkind, J. Silvio] NIH, Oral & Pharyngeal Canc Branch, Bethesda, MD 20892 USA; [Wilcox, William R.] Univ Calif Los Angeles, Sch Med, Dept Pediat, Los Angeles, CA 90024 USA; [Salazar, Lisa] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA	Cedars Sinai Medical Center; Masaryk University Brno; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; University of Washington; University of Washington Seattle; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Irvine	Krejci, P (corresponding author), Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA.	krejcip@sci.muni.cz	Kaucka, Marketa/AAG-2000-2021; Krejčí, Pavel/I-4285-2014; Bryja, Vítězslav/P-4217-2019; Masek, Jan/I-9029-2014; Gutkind, J. Silvio/J-1201-2016; Kozubík, Alois/H-1954-2014; Mikolka, Pavol/X-6080-2018; Mašek, Jan/N-3169-2019; Bryja, Vít?zslav/H-1925-2014; Medalova, Jirina/D-7528-2012	Kaucka, Marketa/0000-0002-8781-9769; Bryja, Vítězslav/0000-0002-9136-5085; Gutkind, J. Silvio/0000-0002-5150-4482; Mikolka, Pavol/0000-0001-8485-4748; Mašek, Jan/0000-0003-2904-3808; Bryja, Vít?zslav/0000-0002-9136-5085; Renzova, Tereza/0000-0003-3928-7195; Vesela, Iva/0000-0001-5751-0130; Krejci, Pavel/0000-0003-0618-9134; Jabs, Ethylin/0000-0001-8983-5466	National Institutes of Health (NIH) [5P01HD022657-21A]; NIH GCRC [M01-RR00425]; Ministry of Education, Youth and Sports of the Czech Republic [MSM0021622430]; Grant Agency of the Czech Republic [301/09/0587, 204/09/H058, 204/09/J030, 305/11/0752]; Winnick Family Research Scholars award; EMBO; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH GCRC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Winnick Family Research Scholars award; EMBO(European Molecular Biology Organization (EMBO)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by: National Institutes of Health (NIH) 5P01HD022657-21A, NIH GCRC Grant M01-RR00425 (www.nih.gov/); Ministry of Education, Youth and Sports of the Czech Republic (MSM0021622430) (www.msmt.cz/); Grant Agency of the Czech Republic (301/09/0587, 204/09/H058, 204/09/J030, 305/11/0752) (www.gacr.cz); Winnick Family Research Scholars award (WRW) (www.winnickfamilyfoundation.com); and EMBO Installation grant (VB) (www.embo.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; Cervenka I, 2011, MOL CELL BIOL, V31, P179, DOI 10.1128/MCB.00550-10; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Hernandez S, 2009, MODERN PATHOL, V22, P848, DOI 10.1038/modpathol.2009.46; Krejci P, 2010, BONE, V47, P102, DOI 10.1016/j.bone.2010.03.021; Krejci P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003961; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Mi KH, 2006, J BIOL CHEM, V281, P4787, DOI 10.1074/jbc.M508657200; Ng SW, 2009, J BIOL CHEM, V284, P24767, DOI 10.1074/jbc.M109.011692; Niehrs C, 2010, CELL MOL LIFE SCI, V67, P2551, DOI 10.1007/s00018-010-0329-3; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Wesche J, 2011, BIOCHEM J, V437, P199, DOI 10.1042/BJ20101603; Wilcox WR, 1998, AM J MED GENET, V78, P274, DOI 10.1002/(SICI)1096-8628(19980707)78:3<274::AID-AJMG14>3.0.CO;2-C; Wolf J, 2008, FEBS LETT, V582, P255, DOI 10.1016/j.febslet.2007.12.013; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Yuan HD, 1999, J BIOL CHEM, V274, P30419, DOI 10.1074/jbc.274.43.30419; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185	24	110	115	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35826	10.1371/journal.pone.0035826	http://dx.doi.org/10.1371/journal.pone.0035826			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558232	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336000063
J	Schotter, ER; Blythe, HI; Kirkby, JA; Rayner, K; Holliman, NS; Liversedge, SP				Schotter, Elizabeth R.; Blythe, Hazel I.; Kirkby, Julie A.; Rayner, Keith; Holliman, Nicolas S.; Liversedge, Simon P.			Binocular Coordination: Reading Stereoscopic Sentences in Depth	PLOS ONE			English	Article							EYE-MOVEMENTS; GAZE-SHIFTS; VERGENCE; PERCEPTION; CONJUGATE; DYNAMICS	The present study employs a stereoscopic manipulation to present sentences in three dimensions to subjects as they read for comprehension. Subjects read sentences with (a) no depth cues, (b) a monocular depth cue that implied the sentence loomed out of the screen (i.e., increasing retinal size), (c) congruent monocular and binocular (retinal disparity) depth cues (i.e., both implied the sentence loomed out of the screen) and (d) incongruent monocular and binocular depth cues (i.e., the monocular cue implied the sentence loomed out of the screen and the binocular cue implied it receded behind the screen). Reading efficiency was mostly unaffected, suggesting that reading in three dimensions is similar to reading in two dimensions. Importantly, fixation disparity was driven by retinal disparity; fixations were significantly more crossed as readers progressed through the sentence in the congruent condition and significantly more uncrossed in the incongruent condition. We conclude that disparity depth cues are used on-line to drive binocular coordination during reading.	[Schotter, Elizabeth R.; Rayner, Keith] Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA; [Blythe, Hazel I.; Liversedge, Simon P.] Univ Southampton, Dept Psychol, Southampton SO9 5NH, Hants, England; [Kirkby, Julie A.] Bournemouth Univ, Dept Psychol, Bournemouth, Dorset, England; [Holliman, Nicolas S.] Univ Durham, Sch Engn & Comp Sci, Durham, England	University of California System; University of California San Diego; University of Southampton; Bournemouth University; Durham University	Schotter, ER (corresponding author), Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA.	eschotter@ucsd.edu	Schotter, Elizabeth/O-9950-2017	Kirkby, Julie/0000-0001-6502-0676	Experimental Psychology Society; Dean of Social Sciences at the University of California San Diego; Economic and Social Research Council [ES/I032398/1]; Leverhulme Trust [F/00 180/AN]; National Institutes of Health [HD26765, HD051030, DC000041]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD051030] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026765, R37HD026765] Funding Source: NIH RePORTER; ESRC [ES/I032398/1] Funding Source: UKRI	Experimental Psychology Society; Dean of Social Sciences at the University of California San Diego; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Leverhulme Trust(Leverhulme Trust); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by a study visit travel grant from the Experimental Psychology Society, (http://www.eps.ac.uk/index.php/study-visit-grants); a study visit travel grant from the Dean of Social Sciences at the University of California San Diego (https://sswebapp.ucsd.edu/travelfund/); grant number ES/I032398/1 from the Economic and Social Research Council (http://www.esrc.ac.uk/); grant number F/00 180/AN from the Leverhulme Trust, and grants HD26765, HD051030, and DC000041 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison RS, 2000, VISION RES, V40, P1869, DOI 10.1016/S0042-6989(00)00034-1; Blythe HI, 2006, VISION RES, V46, P3898, DOI 10.1016/j.visres.2006.06.006; Blythe HI, 2010, VISION RES, V50, P1559, DOI 10.1016/j.visres.2010.05.011; Blythe HI, OPHTHAL PHYSL OPT; Busettini C, 1996, J NEUROPHYSIOL, V75, P1392, DOI 10.1152/jn.1996.75.4.1392; Busettini C, 2001, J NEUROPHYSIOL, V85, P1129, DOI 10.1152/jn.2001.85.3.1129; Collewijn H, 1997, VISION RES, V37, P1049, DOI 10.1016/S0042-6989(96)00245-3; COLLEWIJN H, 1995, VISION RES, V35, P3335, DOI 10.1016/0042-6989(95)00082-P; COLLEWIJN H, 1988, J PHYSIOL-LONDON, V404, P157, DOI 10.1113/jphysiol.1988.sp017284; DEUBEL H, 1995, VISION RES, V35, P529, DOI 10.1016/0042-6989(94)00146-D; EGGERT T, 1995, VISION RES, V35, P3493, DOI 10.1016/0042-6989(95)00147-7; ERKELENS CJ, 1995, VISION RES, V35, P3297, DOI 10.1016/0042-6989(95)00077-R; Hendriks AW, 1996, ACTA PSYCHOL, V92, P131, DOI 10.1016/0001-6918(95)00011-9; Hoffman DM, 2008, J VISION, V8, DOI 10.1167/8.3.33; Juhasz BJ, 2006, Q J EXP PSYCHOL, V59, P1614, DOI 10.1080/17470210500497722; KENYON RV, 1978, VISION RES, V18, P545, DOI 10.1016/0042-6989(78)90201-8; Kirkby JA, 2008, PSYCHOL BULL, V134, P742, DOI 10.1037/a0012979; Kirkby JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027105; Kirkby JA, 2010, VISION RES, V50, P171, DOI 10.1016/j.visres.2009.11.008; Knapen T, 2006, VISION RES, V46, P3381, DOI 10.1016/j.visres.2006.03.027; Liversedge SP, 2006, CURR BIOL, V16, P1726, DOI 10.1016/j.cub.2006.07.051; Liversedge SP, 2006, VISION RES, V46, P2363, DOI 10.1016/j.visres.2006.01.013; Liversedge SP, 2000, TRENDS COGN SCI, V4, P6, DOI 10.1016/S1364-6613(99)01418-7; Mon-Williams M, 1998, HUM FACTORS, V40, P42, DOI 10.1518/001872098779480622; Nuthmann A, 2009, J VISION, V9, DOI 10.1167/9.5.31; ONO H, 1978, VISION RES, V18, P735, DOI 10.1016/0042-6989(78)90152-9; Popple AV, 1998, VISION RES, V38, P319, DOI 10.1016/S0042-6989(97)00166-1; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; RAYNER K, 1979, PERCEPTION, V8, P21, DOI 10.1068/p080021; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Schor C, 1999, OPHTHAL PHYSL OPT, V19, P134, DOI 10.1046/j.1475-1313.1999.00409.x; Schotter ER, 2012, ATTEN PERCEPT PSYCHO, V74, P5, DOI 10.3758/s13414-011-0219-2; Sylvestre PA, 2002, J NEUROPHYSIOL, V87, P257, DOI 10.1152/jn.00919.2000; van Ee R, 2005, VISION RES, V45, P29, DOI 10.1016/j.visres.2004.07.039; ZEE DS, 1992, J NEUROPHYSIOL, V68, P1624, DOI 10.1152/jn.1992.68.5.1624	35	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35608	10.1371/journal.pone.0035608	http://dx.doi.org/10.1371/journal.pone.0035608			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TJ	22558174	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000305336000039
J	Sikweyiya, Y; Jewkes, R				Sikweyiya, Yandisa; Jewkes, Rachel			Perceptions and Experiences of Research Participants on Gender-Based Violence Community Based Survey: Implications for Ethical Guidelines	PLOS ONE			English	Article							DOMESTIC VIOLENCE; QUESTIONNAIRES; FEMALES	Objective: To explore how survey respondents perceived their experiences and the impact of participating in a survey, and to assess adverse consequences resulting from participation. Design: Qualitative study involving purposefully selected participants who had participated in a household-based survey. Methods: This qualitative study was nested within a survey that investigated the prevalence of gender-based violence perpetration and victimization with adult men and women in South Africa. 13 male- and 10 female-in-depth interviews were conducted with survey respondents. Results: A majority of informants, without gender- differences, perceived the survey interview as a rare opportunity to share their adverse and or personal experiences in a 'safe' space. Gender-differences were noted in reporting perceptions of risks involved with survey participation. Some women remained fearful after completing the survey, that should breach of confidentiality or full survey content disclosure occur, they may be victimized by partners as a punishment for survey participation without men's approval. A number of informants generally discussed their survey participation with others. However, among women with interpersonal violence history or currently in abusive relationships, full survey content disclosure was done with fear; the partner responses were negative, and few women reported receiving threatening remarks but none reported being assaulted. In contrast no man reported adverse reaction by others. Informants with major life adversities reported that the survey had made them to relive the experiences causing them sadness and pain at the time. No informant perceived the survey as emotionally harmful or needed professional support because of survey questions. Rather the vast majority perceived benefit from survey participation. Conclusion: Whilst no informant felt answering the survey questions had caused them emotional or physical harm, some were distressed and anxious, albeit temporarily. Research protocols need to put in place safeguards where appropriate so that this group receives support and protection.	[Sikweyiya, Yandisa; Jewkes, Rachel] S African MRC, Gender & Hlth Res Unit, Pretoria, South Africa; [Jewkes, Rachel] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa	South African Medical Research Council; University of Witwatersrand	Sikweyiya, Y (corresponding author), S African MRC, Gender & Hlth Res Unit, Pretoria, South Africa.	ysikweyiya@mrc.ac.za		Jewkes, Rachel/0000-0002-4330-6267	South African Medical Research Council	South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the baseline funds of the South African Medical Research Council. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black Michele C, 2006, Violence Vict, V21, P445, DOI 10.1891/vivi.21.4.445; Campbell R., 2002, EMOTIONALLY INVOLVED; Dahlgren L., 2004, QUALITATIVE METHODOL, DOI 10.1016/j.socscimed.2003.10.033; Deprince AP., 2006, J TRAUMA PRACTICE, V3, P23, DOI [DOI 10.1300/J189V03N04_02, 10.1300/J189v03n04_02]; Edwards KM, 2009, PSYCHOL WOMEN QUART, V33, P225, DOI 10.1111/j.1471-6402.2009.01492.x; Ellsberg M, 2002, LANCET, V359, P1599, DOI 10.1016/S0140-6736(02)08521-5; Ellsberg M, 2001, STUD FAMILY PLANN, V32, P1, DOI 10.1111/j.1728-4465.2001.00001.x; Glaser BG, 1967, DISCOVERY GROUNDED; Griffin MG, 2003, J TRAUMA STRESS, V16, P221, DOI 10.1023/A:1023735821900; Hennink M., 2020, QUALITATIVE RES METH; Jewkes R, 2000, REPROD HEALTH MATTER, V8, P93, DOI 10.1016/S0968-8080(00)90010-7; Jewkes R, 2007, ETHICAL ISSUES INT B, P350; Johnson LE, 2003, J TRAUMA STRESS, V16, P567, DOI 10.1023/B:JOTS.0000004080.50361.f3; Jorm AF, 2007, PSYCHOL MED, V37, P917, DOI 10.1017/S0033291706009779; Kassam-Adams N, 2002, GEN HOSP PSYCHIAT, V24, P336, DOI 10.1016/S0163-8343(02)00200-1; Kuyper L, 2011, ARCH SEX BEHAV; Machisa M., 2011, WAR HOME GENDER BASE; MOUTON J, 1990, BASIC CONCEPTS METHO; Rojas A, 2007, J SEX MARITAL THER, V33, P193, DOI 10.1080/00926230701267795; Rosenbaum Alan, 2006, Violence Vict, V21, P404, DOI 10.1891/vivi.21.4.404; Savell JK, 2006, J SEX MARITAL THER, V32, P161, DOI 10.1080/00926230500442326; Sikweyiya Y, 2007, AGENDA, V74, P48; Sikweyiya Y, 2011, CULT HEALTH SEX, V13, P1091, DOI 10.1080/13691058.2011.604429; Silverman D., 2002, INTERPRETING QUALITA; Wasunna A, 2007, ETHICAL ISSUES INT B, P355; WHO, 2001, WHOEIPGPE992; Widom Cathy Spatz, 2005, Account Res, V12, P115, DOI 10.1080/08989620590957193; Wood K, 2007, MED ANTHROPOL Q, V21, P277, DOI 10.1525/maq.2007.21.3.277; Ybarra ML, 2009, J ADOLESCENT HEALTH, V45, P499, DOI 10.1016/j.jadohealth.2009.03.009	29	35	35	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35495	10.1371/journal.pone.0035495	http://dx.doi.org/10.1371/journal.pone.0035495			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TJ	22558160	Green Published, gold			2022-12-27	WOS:000305336000034
J	Ben-Yehoshua, LJ; Beider, K; Shimoni, A; Ostrovsky, O; Samookh, M; Peled, A; Nagler, A				Ben-Yehoshua, Liat Josefsberg; Beider, Katia; Shimoni, Avichai; Ostrovsky, Olga; Samookh, Michal; Peled, Amnon; Nagler, Arnon			Characterization of Cyclin E Expression in Multiple Myeloma and Its Functional Role in Seliciclib-Induced Apoptotic Cell Death	PLOS ONE			English	Article							DEPENDENT KINASE INHIBITOR; MEDIATED DRUG-RESISTANCE; UBIQUITIN-PROTEASOME PATHWAY; R-ROSCOVITINE; DOWN-REGULATION; IN-VIVO; MOLECULAR CLASSIFICATION; CANCER-THERAPY; BREAST-CANCER; CAM-DR	Multiple Myeloma (MM) is a lymphatic neoplasm characterized by clonal proliferation of malignant plasma cell that eventually develops resistance to chemotherapy. Drug resistance, differentiation block and increased survival of the MM tumor cells result from high genomic instability. Chromosomal translocations, the most common genomic alterations in MM, lead to dysregulation of cyclin D, a regulatory protein that governs the activation of key cell cycle regulator - cyclin dependent kinase (CDK). Genomic instability was reported to be affected by over expression of another CDK regulator - cyclin E (CCNE). This occurs early in tumorigenesis in various lymphatic malignancies including CLL, NHL and HL. We therefore sought to investigate the role of cyclin E in MM. CCNE1 expression was found to be heterogeneous in various MM cell lines (hMMCLs). Incubation of hMMCLs with seliciclib, a selective CDK-inhibitor, results in apoptosis which is accompanied by down regulation of MCL1 and p27. Ectopic over expression of CCNE1 resulted in reduced sensitivity of the MM tumor cells in comparison to the paternal cell line, whereas CCNE1 silencing with siRNA increased the cell sensitivity to seliciclib. Adhesion to FN of hMMCLs was prevented by seliciclib, eliminating adhesion-mediated drug resistance of MM cells. Combination of seliciclib with flavopiridol effectively reduced CCNE1 and CCND1 protein levels, increased subG1 apoptotic fraction and promoted MM cell death in BMSCs co-culture conditions, therefore over-coming stroma-mediated protection. We suggest that seliciclib may be considered as essential component of modern anti MM drug combination therapy.	[Ben-Yehoshua, Liat Josefsberg; Beider, Katia; Shimoni, Avichai; Ostrovsky, Olga; Samookh, Michal; Peled, Amnon; Nagler, Arnon] Guy Weinshtock Multiple Myeloma Fdn, Chaim Sheba Med Ctr, Dept Hematol & Bone Marrow Transplantat, Tel Hashomer, Israel	Chaim Sheba Medical Center	Ben-Yehoshua, LJ (corresponding author), Guy Weinshtock Multiple Myeloma Fdn, Chaim Sheba Med Ctr, Dept Hematol & Bone Marrow Transplantat, Tel Hashomer, Israel.	arnon.nagler@sheba.health.gov.il			Guy Weinshtock Multiple Myeloma Foundation; Ministry of Immigration, Israel	Guy Weinshtock Multiple Myeloma Foundation; Ministry of Immigration, Israel	This work was supported by The Guy Weinshtock Multiple Myeloma Foundation Jacqueline Seroussi Grant Award (AN) and by a returning scientist grant from the Ministry of Immigration, Israel (LJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akli S, 2003, CANCER BIOL THER, V2, pS38; Appleyard MVCL, 2009, INT J CANCER, V124, P465, DOI 10.1002/ijc.23938; Barille-Nion Sophie, 2003, Hematology Am Soc Hematol Educ Program, P248; Baughn LB, 2006, CANCER RES, V66, P7661, DOI 10.1158/0008-5472.CAN-06-1098; Benson C, 2007, BRIT J CANCER, V96, P29, DOI 10.1038/sj.bjc.6603509; Bergsagel PL, 2005, BLOOD, V106, P296, DOI 10.1182/blood-2005-01-0034; Bergsagel PL, 2003, CLIN CANCER RES, V9, P533; Caldon CE, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-2; Chen-Kiang S, 2003, IMMUNOL REV, V194, P39, DOI 10.1034/j.1600-065X.2003.00065.x; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Conroy A, 2009, CANCER CHEMOTH PHARM, V64, P723, DOI 10.1007/s00280-008-0921-5; Dai Y, 2006, CELL CYCLE, V5, P437, DOI 10.4161/cc.5.4.2441; Damiano JS, 1999, BLOOD, V93, P1658, DOI 10.1182/blood.V93.5.1658; Derenne S, 2002, BLOOD, V100, P194, DOI 10.1182/blood.V100.1.194; Domina AM, 2004, ONCOGENE, V23, P5301, DOI 10.1038/sj.onc.1207692; Filipits M, 2003, CLIN CANCER RES, V9, P820; Fonseca R, 2009, LEUKEMIA, V23, P2210, DOI 10.1038/leu.2009.174; Gojo I, 2002, CLIN CANCER RES, V8, P3527; GrayBablin J, 1996, P NATL ACAD SCI USA, V93, P15215, DOI 10.1073/pnas.93.26.15215; Hahntow IN, 2004, LEUKEMIA, V18, P747, DOI 10.1038/sj.leu.2403295; Hardan I, 2004, EXP HEMATOL, V32, P254, DOI 10.1016/j.exphem.2003.12.001; Hazlehurst LA, 2003, CANCER RES, V63, P7900; Hazlehurst LA, 2001, CANCER METAST REV, V20, P43, DOI 10.1023/A:1013156407224; Hideshima T, 2001, CANCER RES, V61, P3071; Hiromura K, 1999, J CLIN INVEST, V103, P597, DOI 10.1172/JCI5461; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; Kumar S, 2010, CANCER TREAT REV, V36, pS3, DOI 10.1016/S0305-7372(10)70006-2; Le Gouill S, 2004, CELL CYCLE, V3, P1259; Lokhorst HM, 1999, BRIT J HAEMATOL, V106, P18; MacCallum DE, 2005, CANCER RES, V65, P5399, DOI 10.1158/0008-5472.CAN-05-0233; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Mazumder S, 2004, CURR CANCER DRUG TAR, V4, P65, DOI 10.2174/1568009043481669; Mazumder S, 2000, ONCOGENE, V19, P2828, DOI 10.1038/sj.onc.1203623; Minella AC, 2008, GENE DEV, V22, P1677, DOI 10.1101/gad.1650208; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; Moroy T, 2004, INT J BIOCHEM CELL B, V36, P1424, DOI 10.1016/S1357-2725(03)00432-1; Noborio-Hatano K, 2009, ONCOGENE, V28, P231, DOI 10.1038/onc.2008.385; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Parker BW, 1998, BLOOD, V91, P458, DOI 10.1182/blood.V91.2.458.458_458_465; Podar K, 2009, LEUKEMIA, V23, P10, DOI 10.1038/leu.2008.259; Polager S, 2008, TRENDS CELL BIOL, V18, P528, DOI 10.1016/j.tcb.2008.08.003; Pratt G, 2002, J CLIN PATHOL-MOL PA, V55, P273, DOI 10.1136/mp.55.5.273; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Raje N, 2005, BLOOD, V106, P1042, DOI 10.1182/blood-2005-01-0320; Raynaud FI, 2005, CLIN CANCER RES, V11, P4875, DOI 10.1158/1078-0432.CCR-04-2264; Semenov I, 2002, LEUKEMIA RES, V26, P271, DOI 10.1016/S0145-2126(01)00103-5; Senderowicz AM, 1999, INVEST NEW DRUG, V17, P313, DOI 10.1023/A:1006353008903; Shain KH, 2009, CANCER RES, V69, P1009, DOI 10.1158/0008-5472.CAN-08-2419; Shaughnessy JD, 2003, IMMUNOL REV, V194, P140, DOI 10.1034/j.1600-065X.2003.00054.x; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Tong WG, 2010, J CLIN ONCOL, V28, P3015, DOI 10.1200/JCO.2009.26.1347; Trakhtenbrot L, GENES CHROMOSOMES CA, V49, P17; UCHIYAMA H, 1992, BLOOD, V80, P2306; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Whittaker SR, 2004, CANCER RES, V64, P262, DOI 10.1158/0008-5472.CAN-03-0110; Zhan F, 2006, BLOOD, V108, P2020, DOI 10.1182/blood-2005-11-013458; Zhang B, 2002, BLOOD, V99, P1885, DOI 10.1182/blood.V99.6.1885; Zhou Y, 2009, LEUKEMIA, V23, P1941, DOI 10.1038/leu.2009.160	61	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e33856	10.1371/journal.pone.0033856	http://dx.doi.org/10.1371/journal.pone.0033856			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558078	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345200005
J	Dhabhar, FS; Saul, AN; Holmes, TH; Daugherty, C; Neri, E; Tillie, JM; Kusewitt, D; Oberyszyn, TM				Dhabhar, Firdaus S.; Saul, Alison N.; Holmes, Tyson H.; Daugherty, Christine; Neri, Eric; Tillie, Jean M.; Kusewitt, Donna; Oberyszyn, Tatiana M.			High-Anxious Individuals Show Increased Chronic Stress Burden, Decreased Protective Immunity, and Increased Cancer Progression in a Mouse Model of Squamous Cell Carcinoma	PLOS ONE			English	Article							REGULATORY T-CELLS; IN-VIVO; PSYCHOSOCIAL FACTORS; PERSONALITY-TRAITS; BREAST-CANCER; GROWTH-FACTOR; SKIN-CANCER; ULTRAVIOLET-RADIATION; SOCIAL-ISOLATION; TUMOR-GROWTH	In spite of widespread anecdotal and scientific evidence much remains to be understood about the long-suspected connection between psychological factors and susceptibility to cancer. The skin is the most common site of cancer, accounting for nearly half of all cancers in the US, with approximately 2-3 million cases of non-melanoma cancers occurring each year worldwide. We hypothesized that a high-anxious, stress-prone behavioral phenotype would result in a higher chronic stress burden, lower protective-immunity, and increased progression of the immuno-responsive skin cancer, squamous cell carcinoma. SKH1 mice were phenotyped as high-or low-anxious at baseline, and subsequently exposed to ultraviolet-B light (1 minimal erythemal dose (MED), 3 times/week, 10-weeks). The significant strengths of this cancer model are that it uses a normal, immunocompetent, outbred strain, without surgery/injection of exogenous tumor cells/cell lines, and produces lesions that resemble human tumors. Tumors were counted weekly (primary outcome), and tissues collected during early and late phases of tumor development. Chemokine/cytokine gene-expression was quantified by PCR, tumor-infiltrating helper (Th), cytolytic (CTL), and regulatory (Treg) T cells by immunohistochemistry, lymph node T and B cells by flow cytometry, adrenal and plasma corticosterone and tissue vascular-endothelial-growth-factor (VEGF) by ELISA. High-anxious mice showed a higher tumor burden during all phases of tumor development. They also showed: higher corticosterone levels (indicating greater chronic stress burden), increased CCL22 expression and Treg infiltration (increased tumor-recruited immuno-suppression), lower CTACK/CCL27, IL-12, and IFN-gamma gene-expression and lower numbers of tumor infiltrating Th and CTLs (suppressed protective immunity), and higher VEGF concentrations (increased tumor angiogenesis/invasion/metastasis). These results suggest that the deleterious effects of high trait anxiety could be: exacerbated by life-stressors, accentuated by the stress of cancer diagnosis/treatment, and mediate increased tumor progression and/or metastasis. Therefore, it may be beneficial to investigate the use of chemotherapy-compatible anxiolytic treatments immediately following cancer diagnosis, and during cancer treatment/survivorship.	[Dhabhar, Firdaus S.; Holmes, Tyson H.; Neri, Eric; Tillie, Jean M.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Dhabhar, Firdaus S.] Stanford Univ, Stanford Canc Inst, Stanford, CA 94305 USA; [Dhabhar, Firdaus S.] Stanford Univ, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [Saul, Alison N.; Daugherty, Christine; Oberyszyn, Tatiana M.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Kusewitt, Donna] Univ Texas MD Anderson Canc Ctr, Dept Carcinogenesis, Smithville, TX USA	Stanford University; Stanford Cancer Institute; Stanford University; Stanford University; University System of Ohio; Ohio State University; University of Texas System; UTMD Anderson Cancer Center	Dhabhar, FS (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.	dhabhar@gmail.com		Oberyszyn, Tatiana/0000-0002-5308-0855	National Institutes of Health [CA107498]; NATIONAL CANCER INSTITUTE [R01CA107498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for these studies was provided by National Institutes of Health grant CA107498 (FSD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarstad HJ, 2002, ACTA OTO-LARYNGOL, V122, P892, DOI 10.1080/0036554021000028066; Afsaroglu E, 2010, J BUON, V15, P303; Alcocer-Gonzalez JM, 2006, VIRAL IMMUNOL, V19, P481, DOI 10.1089/vim.2006.19.481; Ando N, 2009, SUPPORT CARE CANCER, V17, P1361, DOI 10.1007/s00520-009-0593-7; [Anonymous], SECT SKIN CANC FACTS; Antoni MH, 2006, NAT REV CANCER, V6, P240, DOI 10.1038/nrc1820; Armstrong BK, 2001, J PHOTOCH PHOTOBIO B, V63, P8, DOI 10.1016/S1011-1344(01)00198-1; Aro AR, 2005, PSYCHOL MED, V35, P1515, DOI 10.1017/S0033291705005313; Augustine AA, 2008, J RES PERS, V42, P1448, DOI 10.1016/j.jrp.2008.06.006; Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; Ben-Eliyahu S, 2000, NEUROIMMUNOMODULAT, V8, P154, DOI 10.1159/000054276; BERKENBOSCH F, 1991, J STEROID BIOCHEM, V40, P639, DOI 10.1016/0960-0760(91)90286-E; Bleiker EMA, 2008, JNCI-J NATL CANCER I, V100, P213, DOI 10.1093/jnci/djm280; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Brigman JL, 2009, BEHAV PHARMACOL, V20, P204, DOI 10.1097/FBP.0b013e32830c368c; BROWNE RH, 1995, STAT MED, V14, P1933, DOI 10.1002/sim.4780141709; Byrne SN, 2005, PHOTOCHEM PHOTOBIOL, V81, P1366, DOI 10.1562/2005-04-20-Ra-495; CANFIELD PJ, 1986, PATHOLOGY, V18, P337, DOI 10.3109/00313028609059487; Cavigelli SA, 2006, HORM BEHAV, V50, P454, DOI 10.1016/j.yhbeh.2006.06.001; Chida Y, 2008, NAT CLIN PRACT ONCOL, V5, P466, DOI 10.1038/ncponc1134; Cohen J.E., 1988, STAT POWER ANAL BEHA; Correia D, 2009, PROG NEURO-PSYCHOPH, V33, P880, DOI 10.1016/j.pnpbp.2009.04.015; Crawley Jacqueline N., 2007, WHATS WRONG MY MOUSE; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dahl AA, 2010, FUTURE ONCOL, V6, P691, DOI 10.2217/FON.10.31; DEGRUIJL FR, 1995, BIOESSAYS, V17, P651, DOI 10.1002/bies.950170711; Dhabhar FS, 2010, BRAIN BEHAV IMMUN, V24, P127, DOI 10.1016/j.bbi.2009.09.004; Dhabhar FS, 2009, NEUROIMMUNOMODULAT, V16, P300, DOI 10.1159/000216188; Dhabhar FS, 1999, P NATL ACAD SCI USA, V96, P1059, DOI 10.1073/pnas.96.3.1059; DHABHAR FS, 1995, J NEUROIMMUNOL, V56, P77, DOI 10.1016/0165-5728(94)00135-B; Dhabhar FS, 1997, BRAIN BEHAV IMMUN, V11, P286, DOI 10.1006/brbi.1997.0508; DIGHE AS, 1994, IMMUNITY, V1, P447, DOI 10.1016/1074-7613(94)90087-6; Elamin I, 2008, ACTA DERMATOVEN ALP, V17, P55; Ferrucci LM, 2011, J PSYCHOSOC ONCOL, V29, P121, DOI 10.1080/07347332.2010.548445; FISHER MS, 1977, P NATL ACAD SCI USA, V74, P1688, DOI 10.1073/pnas.74.4.1688; FREDRIKSON M, 1993, BRAIN BEHAV IMMUN, V7, P79, DOI 10.1006/brbi.1993.1008; Fujieda S, 1999, CANCER LETT, V136, P1, DOI 10.1016/S0304-3835(98)00281-X; GALLAGHER RP, 1995, ARCH DERMATOL, V131, P164, DOI 10.1001/archderm.131.2.164; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; GLAVIN GB, 1994, NEUROSCI BIOBEHAV R, V18, P223, DOI 10.1016/0149-7634(94)90027-2; Granstein RD, 2004, CUTIS, V74, P4; GREENBERG PD, 1991, ADV IMMUNOL, V49, P281; Gunaydin RO, 2011, HEAD NECK; HALLIDAY GM, 1995, WORLD J SURG, V19, P352, DOI 10.1007/BF00299157; Hansen PE, 2005, CANCER-AM CANCER SOC, V103, P1082, DOI 10.1002/cncr.20871; Heffner KL, 2003, BRAIN BEHAV IMMUN, V17, pS109; Hermes GL, 2009, P NATL ACAD SCI USA, V106, P22393, DOI 10.1073/pnas.0910753106; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; Homey B, 2002, NAT MED, V8, P157, DOI 10.1038/nm0202-157; JACOBSEN PB, 1993, HEALTH PSYCHOL, V12, P469, DOI 10.1037/0278-6133.12.6.469; Karagas MR, 2001, BRIT J CANCER, V85, P683, DOI 10.1054/bjoc.2001.1931; KIM J, 1995, J IMMUNOL, V155, P2240; KLIGMAN LH, 1981, JNCI-J NATL CANCER I, V67, P1289; Kraemer HC, 2006, ARCH GEN PSYCHIAT, V63, P484, DOI 10.1001/archpsyc.63.5.484; Kripke M L, 1978, Natl Cancer Inst Monogr, P179; KRIPKE ML, 1984, IMMUNOL REV, V80, P87, DOI 10.1111/j.1600-065X.1984.tb00496.x; KRIPKE ML, 1976, J NATL CANCER I, V57, P211, DOI 10.1093/jnci/57.1.211; KRIPKE ML, 1994, CANCER RES, V54, P6102; Kruk J, 2004, CANCER DETECT PREV, V28, P399, DOI 10.1016/j.cdp.2004.07.009; Kruk J, 2011, STRESS; KVETNANSKY R, 1993, ENDOCRINOLOGY, V133, P1411, DOI 10.1210/en.133.3.1411; Kyzas PA, 2005, CLIN CANCER RES, V11, P1434, DOI 10.1158/1078-0432.CCR-04-1870; Levi B, 2011, BRAIN BEHAV IMMUN, V25, P727, DOI 10.1016/j.bbi.2011.01.014; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Lord K, 2011, CLIN ONCOLOGY; Lotfi R, 2007, J IMMUNOTHER, V30, P16, DOI 10.1097/01.cji.0000211324.53396.f6; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Lutgendorf SK, 2003, CLIN CANCER RES, V9, P4514; Lutgendorf SK, 2008, BRAIN BEHAV IMMUN, V22, P890, DOI 10.1016/j.bbi.2007.12.012; Lutgendorf SK, 2011, BRAIN BEHAV IMMUN, V25, P250, DOI 10.1016/j.bbi.2010.10.012; Maleki S, 2011, HEAD NECK PATHOL, V5, P117, DOI 10.1007/s12105-011-0247-1; Manchanda P, 2006, ORAL DIS, V12, P455, DOI 10.1111/j.1601-0825.2005.01220.x; Maruyama T, 2010, DIS ESOPHAGUS, V23, P422, DOI 10.1111/j.1442-2050.2009.01029.x; Mauri C, 2008, TRENDS IMMUNOL, V29, P34, DOI 10.1016/j.it.2007.10.004; McCarron P, 2003, J EPIDEMIOL COMMUN H, V57, P888, DOI 10.1136/jech.57.11.888; McCullagh P, 1989, GEN LINEAR MODELS; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Milliken GA, 1998, ANAL MESSY DATA; Mizukami Y, 2008, INT J CANCER, V122, P2286, DOI 10.1002/ijc.23392; Morales J, 1999, P NATL ACAD SCI USA, V96, P14470, DOI 10.1073/pnas.96.25.14470; MORISON WL, 1979, BRIT J DERMATOL, V101, P513, DOI 10.1111/j.1365-2133.1979.tb15094.x; Mozhui K, 2010, J NEUROSCI, V30, P5357, DOI 10.1523/JNEUROSCI.5017-09.2010; Nakaya N, 2010, AM J EPIDEMIOL, V172, P377, DOI 10.1093/aje/kwq046; Ortonne JP, 2002, BRIT J DERMATOL, V146, P20, DOI 10.1046/j.1365-2133.146.s61.6.x; Parker J, 2004, J AM ACAD DERMATOL, V51, P919, DOI 10.1016/j.jaad.2004.08.042; PATEL A, 1995, J DERMATOL SCI, V9, P12, DOI 10.1016/0923-1811(94)00344-E; Pereira DB, 2010, BRAIN BEHAV IMMUN, V24, P210, DOI 10.1016/j.bbi.2009.08.008; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; Poschke I, 2011, CANCER IMMUNOL IMMUN, V60, P1161, DOI 10.1007/s00262-011-1012-8; Price MA, 2001, CANCER-AM CANCER SOC, V91, P679, DOI 10.1002/1097-0142(20010215)91:4<679::AID-CNCR1051>3.0.CO;2-W; Rammal H, 2008, BRAIN BEHAV IMMUN, V22, P1156, DOI 10.1016/j.bbi.2008.06.005; Reiss Y, 2001, J EXP MED, V194, P1541, DOI 10.1084/jem.194.10.1541; RILEY V, 1975, SCIENCE, V189, P465, DOI 10.1126/science.168638; RILEY V, 1981, SCIENCE, V212, P1100, DOI 10.1126/science.7233204; ROMERDAHL CA, 1988, CANCER RES, V48, P2325; SAPOLSKY RM, 1985, ENDOCRINOLOGY, V117, P662, DOI 10.1210/endo-117-2-662; Saul AN, 2005, JNCI-J NATL CANCER I, V97, P1760, DOI 10.1093/jnci/dji401; Schioppa T, 2011, P NATL ACAD SCI USA, V108, P10662, DOI 10.1073/pnas.1100994108; Schwarz A, 1996, J INVEST DERMATOL, V106, P1187, DOI 10.1111/1523-1747.ep12347944; Segerstrom SC, 2003, BRAIN BEHAV IMMUN, V17, pS92; Seki S, 2011, ORAL ONCOL, V47, P588, DOI 10.1016/j.oraloncology.2011.04.013; Sen A., 1990, REGRESSION ANAL THEO; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Shevach EM, 2004, NAT MED, V10, P900, DOI 10.1038/nm0904-900; Shi XY, 2004, INT J CANCER, V110, P570, DOI 10.1002/ijc.20145; Sloan EK, 2010, CANCER RES, V70, P7042, DOI 10.1158/0008-5472.CAN-10-0522; Sood AK, 2011, CANCER PREV RES, V4, P481, DOI 10.1158/1940-6207.CAPR-10-0358; Sood AK, 2010, J CLIN INVEST, V120, P1515, DOI 10.1172/JCI40802; Spiegel D, 1996, HARVARD REV PSYCHIAT, V4, P10, DOI 10.3109/10673229609030518; TEMOSHOK L, 1987, CANCER SURV, V6, P545; TEMOSHOK L, 1985, SOC SCI MED, V20, P833, DOI 10.1016/0277-9536(85)90338-7; TEMOSHOK L, 1987, ANN NY ACAD SCI, V496, P501, DOI 10.1111/j.1749-6632.1987.tb35807.x; Temoshok LR, 2004, PSYCHO-ONCOLOGY, V13, P460, DOI 10.1002/pon.813; Temoshok LR, 2000, ANN NY ACAD SCI, V917, P446; Thaker PH, 2008, SEMIN CANCER BIOL, V18, P164, DOI 10.1016/j.semcancer.2007.12.005; Thaker PH, 2007, CELL CYCLE, V6, P430, DOI 10.4161/cc.6.4.3829; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Toes REM, 1999, J EXP MED, V189, P753, DOI 10.1084/jem.189.5.753; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Turri MG, 2001, CURR BIOL, V11, P725, DOI 10.1016/S0960-9822(01)00206-8; Vairaktaris E, 2007, ORAL SURG ORAL MED O, V104, P796, DOI 10.1016/j.tripleo.2006.12.029; van Kranen H J, 1999, J Epidemiol, V9, pS58; Viswanathan K, 2005, INT IMMUNOL, V17, P1059, DOI 10.1093/intimm/dxh286; VOEST EE, 1995, J NATL CANCER I, V87, P581, DOI 10.1093/jnci/87.8.581; Wang Y, 2011, J CELL MOL MED; Wills S, 2011, CONNECT E LEARN, P1	127	46	47	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e33069	10.1371/journal.pone.0033069	http://dx.doi.org/10.1371/journal.pone.0033069			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558071	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345200001
J	Kamper, N; Kessler, J; Temme, S; Wegscheid, C; Winkler, J; Koch, N				Kamper, Nadine; Kessler, Jorg; Temme, Sebastian; Wegscheid, Claudia; Winkler, Johannes; Koch, Norbert			A Novel BAT3 Sequence Generated by Alternative RNA Splicing of Exon 11B Displays Cell Type-Specific Expression and Impacts on Subcellular Localization	PLOS ONE			English	Article							SCYTHE REGULATES APOPTOSIS; B-ASSOCIATED TRANSCRIPT-3; PROTEIN; RECEPTOR; SIGNAL; IDENTIFICATION; MHC	Background: The human lymphocyte antigen (HLA) encoded BAT3/BAG6 recently attracted interest as a regulator of protein targeting and degradation, a function that could be exerted in the cytosol and in the nucleus. The BAT3 gene was described to consist of 25 exons. Diversity of transcripts can be generated by alternative RNA splicing, which may control subcellular distribution of BAT3. Methodology/Principal Findings: By cDNA sequencing we identified a novel alternatively spliced sequence of the BAT3 gene located between exons 11 and 12, which was designated as exon 11B. Using PCR and colony hybridization we identified six cDNA variants, which were produced by RNA splicing of BAT3 exons 5, 11B and 24. In four examined cell types the content of BAT3 splice variants was examined. Most of the cDNA clones from monocyte-derived dendritic cells contain exon 11B, whereas this sequence was almost absent in the B lymphoma Raji. Exon 5 was detected in most and exon 24 in approximately half of the cDNA clones. The subcellular distribution of endogenous BAT3 largely correlates with a cell type specific splicing pattern. In cells transfected with BAT3 variants, full-length and Delta 24 BAT3 displayed nearly exclusive nuclear staining, whereas variants deleted of exon 11B showed substantial cytosolic expression. We show here that BAT3 is mainly expressed in the cytosol of Raji cells, while other cell types displayed both cytosolic and nuclear staining. Export of BAT3 from the nucleus to the cytosol is inhibited by treatment with leptomycin B, indicating that the Crm1 pathway is involved. Nuclear expression of BAT3 containing exon 11B suggests that this sequence plays a role for nuclear retention of the protein. Conclusions/Significance: Cell type-specific subcellular expression of BAT3 suggests distinct functions in the cytosol and in the nucleus. Differential expression of BAT3 variants may reconcile the multiple roles described for BAT3.	[Kamper, Nadine; Kessler, Jorg; Temme, Sebastian; Wegscheid, Claudia; Winkler, Johannes; Koch, Norbert] Univ Bonn, Inst Genet, Div Immunobiol, Bonn, Germany	University of Bonn	Kamper, N (corresponding author), Univ Bonn, Inst Genet, Div Immunobiol, Bonn, Germany.	nadine.kaemper@uni-bonn.de		Winkler, Johannes/0000-0001-7309-8342	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANERJI J, 1990, P NATL ACAD SCI USA, V87, P2374, DOI 10.1073/pnas.87.6.2374; Birbach A, 2002, J BIOL CHEM, V277, P10842, DOI 10.1074/jbc.M112475200; Chu CT, 2007, J NEUROPATH EXP NEUR, V66, P873, DOI 10.1097/nen.0b013e318156a3d7; Deakin JE, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-281; DEGLIESPOSTI MA, 1992, IMMUNOGENETICS, V36, P345; Desmots F, 2005, MOL CELL BIOL, V25, P10329, DOI 10.1128/MCB.25.23.10329-10337.2005; Desmots F, 2008, J BIOL CHEM, V283, P3264, DOI 10.1074/jbc.M706419200; Doong H, 2002, CANCER LETT, V188, P25, DOI 10.1016/S0304-3835(02)00456-1; Ensminger AW, 2010, INFECT IMMUN, V78, P3905, DOI 10.1128/IAI.00344-10; Fu Z, 2006, MOL CELL BIOL, V26, P8639, DOI 10.1128/MCB.00816-06; Gastpar R, 2005, CANCER RES, V65, P5238, DOI 10.1158/0008-5472.CAN-04-3804; GAYNOR EC, 1994, J CELL BIOL, V127, P653, DOI 10.1083/jcb.127.3.653; Hertel KJ, 2008, J BIOL CHEM, V283, P1211, DOI 10.1074/jbc.R700035200; Hessa T, 2011, NATURE, V475, P394, DOI 10.1038/nature10181; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; House AE, 2008, J BIOL CHEM, V283, P1217, DOI 10.1074/jbc.R700031200; Huang YH, 2002, NUCLEIC ACIDS RES, V30, P186, DOI 10.1093/nar/30.1.186; Hui LJ, 2004, ONCOGENE, V23, P3013, DOI 10.1038/sj.onc.1207362; Hung SL, 2005, P NATL ACAD SCI USA, V102, P4134, DOI 10.1073/pnas.0409500102; JOHNSON JP, 1981, EUR J IMMUNOL, V11, P825, DOI 10.1002/eji.1830111015; Kamper N, 2012, FASEB J, V26, P104, DOI 10.1096/fj.11-189670; Kikukawa Y, 2005, FEBS J, V272, P6373, DOI 10.1111/j.1742-4658.2005.05032.x; Kohl K, 2007, EUR J CELL BIOL, V86, P719, DOI 10.1016/j.ejcb.2007.06.007; Kumar R, 2004, BIOCHEM BIOPH RES CO, V323, P1293, DOI 10.1016/j.bbrc.2004.09.006; Lehner B, 2004, GENOMICS, V83, P153, DOI 10.1016/S0888-7543(03)00235-0; Leznicki P, 2010, J CELL SCI, V123, P2170, DOI 10.1242/jcs.066738; Lynch KW, 2007, ADV EXP MED BIOL, V623, P161, DOI 10.1007/978-0-387-77374-2_10; Manchen ST, 2001, BIOCHEM BIOPH RES CO, V287, P1075, DOI 10.1006/bbrc.2001.5701; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; MILNER CM, 2000, HLA HLTH DIS, P35; Minami R, 2007, BIOCHEM J, V405, P495, DOI 10.1042/BJ20061886; Sasaki T, 2007, GENE DEV, V21, P848, DOI 10.1101/gad.1534107; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Strambio-De-Castillia C, 2010, NAT REV MOL CELL BIO, V11, P490, DOI 10.1038/nrm2928; Thress K, 1999, EMBO J, V18, P5486, DOI 10.1093/emboj/18.20.5486; Thress K, 1998, EMBO J, V17, P6135, DOI 10.1093/emboj/17.21.6135; Thress K, 2001, EMBO J, V20, P1033, DOI 10.1093/emboj/20.5.1033; Tsukahara T, 2009, CANCER SCI, V100, P47, DOI 10.1111/j.1349-7006.2008.00991.x; Vandiedonck C, 2004, P NATL ACAD SCI USA, V101, P15464, DOI 10.1073/pnas.0406756101; von Strandmann EP, 2007, IMMUNITY, V27, P965, DOI 10.1016/j.immuni.2007.10.010; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Wang SC, 2005, ANN NY ACAD SCI, V1059, P11, DOI 10.1196/annals.1339.002; WATANABE M, 1983, TRANSPLANTATION, V36, P712, DOI 10.1097/00007890-198336060-00025; Webster JC, 2001, P NATL ACAD SCI USA, V98, P6865, DOI 10.1073/pnas.121455098; Williams P, 2008, J VIROL, V82, P10946, DOI 10.1128/JVI.01403-08; Winkler J, 2003, THESIS BONN U GERMAN; Winnefeld M, 2006, EXP CELL RES, V312, P2500, DOI 10.1016/j.yexcr.2006.04.020; Wu YH, 2004, J BIOL CHEM, V279, P19264, DOI 10.1074/jbc.M307049200; Xu Q, 2003, NUCLEIC ACIDS RES, V31, P5635, DOI 10.1093/nar/gkg786	49	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35972	10.1371/journal.pone.0035972	http://dx.doi.org/10.1371/journal.pone.0035972			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558287	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345200099
J	van der Kam, S; Swarthout, T; Niragira, O; Froud, A; Sompwe, EM; Mills, C; Roll, S; Tinnemann, P; Shanks, L				van der Kam, Saskia; Swarthout, Todd; Niragira, Oscar; Froud, Alyson; Sompwe, Eric Mukomena; Mills, Clair; Roll, Stephanie; Tinnemann, Peter; Shanks, Leslie			Ready-to-Use Therapeutic Food for Catch-Up Growth in Children after an Episode of Plasmodium falciparum Malaria: An Open Randomised Controlled Trial	PLOS ONE			English	Article							NUTRITIONAL-STATUS; SUPPLEMENTATION; INFECTION; MORTALITY	Background: Catch-up growth after an infection is essential for children to maintain good nutritional status. To prevent malnutrition, WHO recommends that children are given one additional healthy meal per day during the 2 weeks after onset of illness. We investigated to what extent ready-to-use therapeutic food (RUTF) promotes catch-up growth in children after an acute, uncomplicated episode of Plasmodium falciparum malaria. Methods: We did an open randomised trial of children aged 6-59 months with confirmed malaria who attended a Medecins Sans Frontieres-supported outpatient clinic in Katanga Province, Democratic Republic of Congo. All children received a clinical examination and malaria treatment. Patients were then randomly assigned to either an RUTF group, who received daily supplemental RUTF (a high-protein peanut-based paste) for 14 days, or to a control group, who received no supplemental food. Children were weighed at baseline and on days 14 and 28. The primary outcome was mean weight change after 14 days' RUTF. Analysis was by intention-to-treat. Results: 93 children received RUTF and 87 received no food supplementation. At day 14, the RUTF group had a mean weight gain of 353 g compared with 189 g in the control group (difference 164 [95%CI 52-277], p = 0.005). However, at day 28 there was no statistically significant difference between the groups (539 g versus 414 g, respectively [p = 0.053]). Similarly, rate of weight gain per kg bodyweight per day was significantly higher at day 14 in the RUTF group (2.4 g/kg per day versus 1.3 g/kg per day, p = 0.005) but at day 28 was 1.9 g/kg per day in the RUTF group versus 1.5 g/kg per day in the control group (p = 0.076). Conclusions: Children receiving RUTF for 14 days after effective treatment of an uncomplicated malaria episode had a faster weight gain than children not given supplementation, reducing the period that children were at risk of malnutrition.	[van der Kam, Saskia; Swarthout, Todd; Froud, Alyson; Shanks, Leslie] Med Sans Frontieres, Amsterdam, Netherlands; [Niragira, Oscar] Med Sans Frontieres, Lubumbashi, DEM REP CONGO; [Sompwe, Eric Mukomena] Minist Sante, Div Prov Katanga, Lubumbashi, DEM REP CONGO; [Mills, Clair] Univ Auckland, Auckland 1, New Zealand; [Roll, Stephanie; Tinnemann, Peter] Charite Univ Med Ctr, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany	Doctors Without Borders; University of Auckland; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	van der Kam, S (corresponding author), Med Sans Frontieres, Amsterdam, Netherlands.	saskia.vd.kam@amsterdam.msf.org		Roll, Stephanie/0000-0003-1191-3289; van der Kam, Saskia/0000-0002-3608-8054; Tinnemann, Peter/0000-0003-3071-9772; Swarthout, Todd/0000-0001-5285-7039				Bahwere P, 2004, PEDIATR INFECT DIS J, V23, P739, DOI 10.1097/01.inf.0000135663.17018.51; Bhutta ZA, 2006, J PEDIATR GASTR NUTR, V43, pS13, DOI 10.1097/01.mpg.0000255846.77034.ed; BROWN KH, 1990, AM J CLIN NUTR, V52, P1005, DOI 10.1093/ajcn/52.6.1005; Friedman JF, 2003, J INFECT DIS, V188, P449, DOI 10.1086/376596; Goulet O, 2006, J PEDIATR GASTR NUTR, V43, pS1, DOI 10.1097/01.mpg.0000255843.54164.af; Hoare S, 1996, BRIT J NUTR, V76, P479, DOI 10.1079/BJN19960057; Isanaka S, 2009, JAMA-J AM MED ASSOC, V301, P277, DOI 10.1001/jama.2008.1018; Klarkowski DB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000206; Nyakeriga AM, 2004, AM J CLIN NUTR, V80, P1604, DOI 10.1093/ajcn/80.6.1604; ROWLAND MGM, 1988, AM J CLIN NUTR, V47, P134, DOI 10.1093/ajcn/47.1.134; ROWLAND MGM, 1977, BRIT J NUTR, V37, P441, DOI 10.1079/BJN19770047; Scrimshaw NS, 1997, AM J CLIN NUTR, V66, P464; Shiff C, 1996, T ROY SOC TROP MED H, V90, P262, DOI 10.1016/S0035-9203(96)90240-0; Tomkins A, 1989, 4 ACCSCN UN; WHITEHEAD RG, 1977, AM J CLIN NUTR, V30, P1545, DOI 10.1093/ajcn/30.9.1545; WHO, WHO FOOD WAT HLTH MA; WHO UNICEF, WHO UNICEF WORLD MAL	17	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35006	10.1371/journal.pone.0035006	http://dx.doi.org/10.1371/journal.pone.0035006			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558108	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345200018
J	Clarke, CL; Graham, JD				Clarke, Christine L.; Graham, J. Dinny			Non-Overlapping Progesterone Receptor Cistromes Contribute to Cell-Specific Transcriptional Outcomes	PLOS ONE			English	Article							ESTROGEN PLUS PROGESTIN; BREAST-CANCER CELLS; ANDROGEN-RECEPTOR; ER-ALPHA; GLUCOCORTICOID-RECEPTOR; POSTMENOPAUSAL WOMEN; RESPONSE ELEMENTS; NUCLEAR RECEPTORS; HUMAN ENDOMETRIUM; GENE ACTIVATION	The transcriptional effects of the ovarian hormone progesterone are pleiotropic, and binding to DNA of the nuclear progesterone receptor (PR), a ligand-activated transcription factor, results in diverse outcomes in a range of target tissues. To determine whether distinct patterns of genomic interaction of PR contribute to the cell specificity of the PR transcriptome, we have compared the genomic binding sites for PR in breast cancer cells and immortalized normal breast cells. PR binding was correlated with transcriptional outcome in both cell lines, with 60% of progestin-regulated genes associated with one or more PR binding regions. There was a remarkably low overlap between the PR cistromes of the two cell lines, and a similarly low overlap in transcriptional targets. A conserved PR binding element was identified in PR binding regions from both cell lines, but there were distinct patterns of enrichment of known cofactor binding motifs, with FOXA1 sites over-represented in breast cancer cell binding regions and NF1 and AP-1 motifs uniquely enriched in the immortalized normal line. Downstream analyses suggested that differential cofactor availability may generate these distinct PR cistromes, indicating that cofactor levels may modulate PR specificity. Taken together these data suggest that cell-specificity of PR binding is determined by the coordinated effects of key binding cofactors.	[Clarke, Christine L.; Graham, J. Dinny] Univ Sydney, Westmead Hosp, Westmead Millennium Inst, Westmead Inst Canc Res,Sydney Med Sch Westmead, Westmead, NSW 2145, Australia	University of Sydney; Westmead Institute for Medical Research	Clarke, CL (corresponding author), Univ Sydney, Westmead Hosp, Westmead Millennium Inst, Westmead Inst Canc Res,Sydney Med Sch Westmead, Westmead, NSW 2145, Australia.	dinny.graham@sydney.edu.au		Clarke, Christine/0000-0001-7568-111X	National Health and Medical Research Council of Australia [570865]; National Breast Cancer Foundation of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation of Australia	The work was supported by National Health and Medical Research Council of Australia project grant 570865 and the National Breast Cancer Foundation of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ace Christopher I, 2004, Reprod Biol Endocrinol, V2, P54, DOI 10.1186/1477-7827-2-54; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bailey TL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-179; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Beguelin W, 2010, MOL CELL BIOL, V30, P5456, DOI 10.1128/MCB.00012-10; Belikov S, 2009, MOL CELL BIOL, V29, P5413, DOI 10.1128/MCB.00368-09; Beral V, 2011, JNCI-J NATL CANCER I, V103, P296, DOI 10.1093/jnci/djq527; Bernardo GM, 2010, DEVELOPMENT, V137, P2045, DOI 10.1242/dev.043299; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Borthwick JM, 2003, MOL HUM REPROD, V9, P19, DOI 10.1093/molehr/gag004; Bravieri R, 1997, NUCLEIC ACIDS RES, V25, P2888, DOI 10.1093/nar/25.14.2888; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chlebowski RT, 2010, JAMA-J AM MED ASSOC, V304, P1684, DOI 10.1001/jama.2010.1500; Cicatiello L, 2004, MOL CELL BIOL, V24, P7260, DOI 10.1128/MCB.24.16.7260-7274.2004; Cirillo LA, 2007, J MOL BIOL, V366, P720, DOI 10.1016/j.jmb.2006.11.087; CLARKE CL, 1990, ENDOCR REV, V11, P266, DOI 10.1210/edrv-11-2-266; CLARKE CL, 1987, ENDOCRINOLOGY, V121, P1123, DOI 10.1210/endo-121-3-1123; Faivre EJ, 2008, MOL ENDOCRINOL, V22, P823, DOI 10.1210/me.2007-0437; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Graham JD, 2009, ENDOCRINOLOGY, V150, P3318, DOI 10.1210/en.2008-1630; Graham JD, 1997, ENDOCR REV, V18, P502, DOI 10.1210/er.18.4.502; Graham JD, 2005, MOL ENDOCRINOL, V19, P2713, DOI 10.1210/me.2005-0126; GRAHAM JD, 1995, CANCER RES, V55, P5063; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hubler TR, 2004, CELL STRESS CHAPERON, V9, P243, DOI 10.1379/CSC-32R.1; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Joseph R, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.109; Kao LC, 2002, ENDOCRINOLOGY, V143, P2119, DOI 10.1210/en.143.6.2119; Krum SA, 2008, MOL ENDOCRINOL, V22, P2393, DOI 10.1210/me.2008-0100; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LIEBERMAN BA, 1993, MOL ENDOCRINOL, V7, P515, DOI 10.1210/me.7.4.515; Liu Z, 2001, P NATL ACAD SCI USA, V98, P12426, DOI 10.1073/pnas.231474798; LONGACRE TA, 1986, AM J SURG PATHOL, V10, P382, DOI 10.1097/00000478-198606000-00003; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; MacQuarrie KL, 2011, TRENDS GENET, V27, P141, DOI 10.1016/j.tig.2011.01.001; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murtagh J, 2003, J MAMMARY GLAND BIOL, V8, P241, DOI 10.1023/A:1025909109843; Nelson CC, 1999, MOL ENDOCRINOL, V13, P2090, DOI 10.1210/me.13.12.2090; ONATE SA, 1995, SCIENCE, V270, P1354; Vicent GP, 2010, J BIOL CHEM, V285, P2622, DOI 10.1074/jbc.M109.060848; Vicent GP, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000567; PIERROU S, 1994, EMBO J, V13, P5002, DOI 10.1002/j.1460-2075.1994.tb06827.x; Rayasam GV, 2005, MOL CELL BIOL, V25, P2406, DOI 10.1128/MCB.25.6.2406-2418.2005; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Richer JK, 2002, J BIOL CHEM, V277, P5209, DOI 10.1074/jbc.M110090200; Roschke AV, 2003, CANCER RES, V63, P8634; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Scarpin Katherine M, 2009, Nucl Recept Signal, V7, pe009, DOI 10.1621/nrs.07009; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; STREULI CH, 1995, J BIOL CHEM, V270, P21639, DOI 10.1074/jbc.270.37.21639; Tang QZ, 2011, CANCER RES, V71, P6940, DOI 10.1158/0008-5472.CAN-11-2091; Tseng L, 2003, DNA CELL BIOL, V22, P633, DOI 10.1089/104454903770238102; Vicent GP, 2006, ANN NY ACAD SCI, V1089, P59, DOI 10.1196/annals.1386.025; Vicent GP, 2010, MOL ENDOCRINOL, V24, P2088, DOI 10.1210/me.2010-0027; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Yin P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029021	65	64	68	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35859	10.1371/journal.pone.0035859	http://dx.doi.org/10.1371/journal.pone.0035859			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545144	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343200064
J	Kirsch, W; Herbort, O; Butz, MV; Kunde, W				Kirsch, Wladimir; Herbort, Oliver; Butz, Martin V.; Kunde, Wilfried			Influence of Motor Planning on Distance Perception within the Peripersonal Space	PLOS ONE			English	Article							TOOL-USE; LINE BISECTION; REPRESENTATION; PLASTICITY; MOVEMENTS; EXTENT; SIZE	We examined whether movement costs as defined by movement magnitude have an impact on distance perception in near space. In Experiment 1, participants were given a numerical cue regarding the amplitude of a hand movement to be carried out. Before the movement execution, the length of a visual distance had to be judged. These visual distances were judged to be larger, the larger the amplitude of the concurrently prepared hand movement was. In Experiment 2, in which numerical cues were merely memorized without concurrent movement planning, this general increase of distance with cue size was not observed. The results of these experiments indicate that visual perception of near space is specifically affected by the costs of planned hand movements.	[Kirsch, Wladimir; Kunde, Wilfried] Univ Wurzburg, Dept Psychol, Wurzburg, Germany; [Herbort, Oliver; Butz, Martin V.] Univ Tubingen, Dept Comp Sci, Tubingen, Germany	University of Wurzburg; Eberhard Karls University of Tubingen	Kirsch, W (corresponding author), Univ Wurzburg, Dept Psychol, Wurzburg, Germany.	kirsch@psychologie.uni-wuerzburg.de		Kunde, Wilfried/0000-0001-6256-8011	German Research Council (DFG) [KI 1620/1-1]; DFG; University of Wuerzburg within the funding program Open Access Publishing	German Research Council (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); University of Wuerzburg within the funding program Open Access Publishing	This research was supported by grant KI 1620/1-1 awarded to WLK by the German Research Council (DFG). The publication was funded by the DFG and the University of Wuerzburg within the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berti A, 2000, J COGNITIVE NEUROSCI, V12, P415, DOI 10.1162/089892900562237; Bhalla M, 1999, J EXP PSYCHOL HUMAN, V25, P1076, DOI 10.1037/0096-1523.25.4.1076; Caparos S, 2010, J EXP PSYCHOL HUMAN, V36, P1080, DOI 10.1037/a0020367; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Desmurget M, 2005, J EXP PSYCHOL HUMAN, V31, P1510, DOI 10.1037/0096-1523.31.6.1510; Fajen BR, 2007, ECOL PSYCHOL, V19, P383, DOI 10.1080/10407410701557877; Farne A, 2000, NEUROREPORT, V11, P1645, DOI 10.1097/00001756-200006050-00010; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Gamberini L, 2008, NEUROPSYCHOLOGIA, V46, P1298, DOI 10.1016/j.neuropsychologia.2007.12.016; Gevers W, 2005, PSYCHOL SCI, V47, P10; Ghahramani Z, 1996, J NEUROSCI, V16, P7085; GORDON J, 1994, EXP BRAIN RES, V99, P97, DOI 10.1007/BF00241415; Hamburger K, 2010, ATTEN PERCEPT PSYCHO, V72, P1045, DOI 10.3758/APP.72.4.1045; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Holmes NP, 2004, NEUROSCI LETT, V372, P62, DOI 10.1016/j.neulet.2004.09.024; Iriki A, 1996, NEUROREPORT, V7, P2325; Ito Y, 2004, MEM COGNITION, V32, P662, DOI 10.3758/BF03195857; Jewell G, 2000, NEUROPSYCHOLOGIA, V38, P93, DOI 10.1016/S0028-3932(99)00045-7; Ladavas E, 2002, TRENDS COGN SCI, V6, P17, DOI 10.1016/S1364-6613(00)01814-3; Ladavas E, 2008, COGN NEUROPSYCHOL, V25, P1099, DOI 10.1080/02643290802359113; Linkenauger SA, 2009, J EXP PSYCHOL HUMAN, V35, P1649, DOI 10.1037/a0016875; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Longo MR, 2007, EXP BRAIN RES, V177, P285, DOI 10.1007/s00221-007-0855-x; Longo MR, 2006, NEUROPSYCHOLOGIA, V44, P977, DOI 10.1016/j.neuropsychologia.2005.09.003; Lourenco SF, 2009, COGNITION, V112, P451, DOI 10.1016/j.cognition.2009.05.011; Maravita A, 2002, COGNITION, V83, pB25, DOI 10.1016/S0010-0277(02)00003-3; Maravita A, 2001, NEUROPSYCHOLOGIA, V39, P580, DOI 10.1016/S0028-3932(00)00150-0; Proffitt DR, 2006, PERSPECT PSYCHOL SCI, V1, P110, DOI 10.1111/j.1745-6916.2006.00008.x; Proffitt DR, 2003, PSYCHOL SCI, V14, P106, DOI 10.1111/1467-9280.t01-1-01427; Proffitt DR, 2008, EMBODIMENT EGO SPACE, P179; Rosenbaum DA, 2008, PSYCHON B REV, V15, P1100, DOI 10.3758/PBR.15.6.1100; Schwarz W, 2004, PERCEPT PSYCHOPHYS, V66, P651, DOI 10.3758/BF03194909; Sheerer E., 1984, COGNITION MOTOR PROC, P77, DOI [10.1007/978-3-642-69382-3_6, DOI 10.1007/978-3-642-69382-3_6]; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; Van der Heijden AHC, 1999, COGNITIVE CONTRIBUTI, V129, P19; Vindras P, 1998, J EXP PSYCHOL HUMAN, V24, P569, DOI 10.1037/0096-1523.24.2.569; Witt JK, 2008, PSYCHON B REV, V15, P581, DOI 10.3758/PBR.15.3.581; Witt JK, 2011, J EXP PSYCHOL HUMAN, V37, P1148, DOI 10.1037/a0021933; Witt JK, 2010, J EXP PSYCHOL HUMAN, V36, P1153, DOI 10.1037/a0019947; Witt JK, 2009, PERCEPTION, V38, P1328, DOI 10.1068/p6325; Witt JK, 2008, J EXP PSYCHOL HUMAN, V34, P1479, DOI 10.1037/a0010781; Witt JK, 2005, PSYCHOL SCI, V16, P937, DOI 10.1111/j.1467-9280.2005.01640.x; Witt JK, 2005, J EXP PSYCHOL HUMAN, V31, P880, DOI 10.1037/0096-1523.31.5.880	43	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e34880	10.1371/journal.pone.0034880	http://dx.doi.org/10.1371/journal.pone.0034880			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VE	22545092	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343200015
J	Deo, S; Topp, SM; Garcia, A; Soldner, M; Sokat, KY; Chipukuma, J; Wamulume, CS; Reid, SE; Swann, J				Deo, Sarang; Topp, Stephanie M.; Garcia, Ariel; Soldner, Mallory; Sokat, Kezban Yagci; Chipukuma, Julien; Wamulume, Chibesa S.; Reid, Stewart E.; Swann, Julie			Modeling the Impact of Integrating HIV and Outpatient Health Services on Patient Waiting Times in an Urban Health Clinic in Zambia	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; GLOBAL HEALTH; SCALE-UP; CARE; AFRICA; PROGRAMS; LESSONS; MALAWI	Background: Rapid scale up of HIV treatment programs in sub-Saharan Africa has refueled the long-standing health policy debate regarding the merits and drawbacks of vertical and integrated system. Recent pilots of integrating outpatient and HIV services have shown an improvement in some patient outcomes but deterioration in waiting times, which can lead to worse health outcomes in the long run. Methods: A pilot intervention involving integration of outpatient and HIV services in an urban primary care facility in Lusaka, Zambia was studied. Data on waiting time of patients during two seven-day periods before and six months after the integration were collected using a time and motion study. Statistical tests were conducted to investigate whether the two observation periods differed in operational details such as staffing, patient arrival rates, mix of patients etc. A discrete event simulation model was constructed to facilitate a fair comparison of waiting times before and after integration. The simulation model was also used to develop alternative configurations of integration and to estimate the resulting waiting times. Results: Comparison of raw data showed that waiting times increased by 32% and 36% after integration for OPD and ART patients respectively (p<0.01). Using simulation modeling, we found that a large portion of this increase could be explained by changes in operational conditions before and after integration such as reduced staff availability (p<0.01) and longer breaks between consecutive patients (p<0.05). Controlling for these differences, integration of services, per se, would have resulted in a significant decrease in waiting times for OPD and a moderate decrease for HIV services. Conclusions: Integrating health services has the potential of reducing waiting times due to more efficient use of resources. However, one needs to ensure that other operational factors such as staff availability are not adversely affected due to integration.	[Deo, Sarang] Indian Sch Business Hyderbad, Hyderabad, Andhra Pradesh, India; [Topp, Stephanie M.; Chipukuma, Julien; Reid, Stewart E.] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Topp, Stephanie M.] Univ Melbourne, Nossal Inst Global Hlth, Melbourne, Vic, Australia; [Garcia, Ariel; Soldner, Mallory; Swann, Julie] Georgia Inst Technol Dept, Stewart Sch Ind & Syst Engn, Atlanta, GA USA; [Sokat, Kezban Yagci] Northwestern Univ, Evanston, IL USA; [Wamulume, Chibesa S.] Lusaka Hlth Dist, Lusaka, Zambia; [Topp, Stephanie M.; Reid, Stewart E.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA	Indian School of Business (ISB); University of Melbourne; Northwestern University; University of Alabama System; University of Alabama Birmingham	Deo, S (corresponding author), Indian Sch Business Hyderbad, Hyderabad, Andhra Pradesh, India.	sarang_deo@isb.edu	Topp, Stephanie M/H-3923-2019; Deo, Sarang/B-5895-2015	Topp, Stephanie M/0000-0002-3448-7983; Deo, Sarang/0000-0002-3233-6014; Swann, Julie/0000-0003-2151-4396; Reid, Stewart/0000-0001-7779-4820	U.S. Department of Health and Human Services; Centers for Disease Control and Prevention [U62/.CCU12354]	U.S. Department of Health and Human Services; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The work reported herein was supported in part by the President's Emergency Plan for AIDS Relief through a multi-country grant to the Elizabeth Glaser Pediatric AIDS Foundation from the U.S. Department of Health and Human Services and Centers for Disease Control and Prevention's Global AIDS Program (cooperative agreement U62/.CCU12354). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atun RA, 2008, HLTH SYSTEMS POLICY; Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Bleich SN, 2009, B WORLD HEALTH ORGAN, V87, P271, DOI 10.2471/BLT.07.050401; Brugha R, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-19; Colebunders R, 2007, AIDS CARE, V19, P149, DOI 10.1080/09540120600762078; Doherty T, 2010, TROP MED INT HEALTH, V15, P296, DOI 10.1111/j.1365-3156.2009.02454.x; England R, 2007, BRIT MED J; England R, 2007, BRIT MED J, V335, P565, DOI 10.1136/bmj.39335.520463.94; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Frenk J, 2006, BRIDGING DIVIDE COMP; Garrett L, 2007, FOREIGN AFF, V86, P14; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Harris JB, 2008, INT J TUBERC LUNG D, V12, P773; Lawn JE, 2008, LANCET, V372, P917, DOI 10.1016/S0140-6736(08)61402-6; Levine R, 2009, JAIDS-J ACQ IMM DEF, V52, pS3, DOI 10.1097/QAI.0b013e3181bbc807; Pfeiffer J, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-3; Price JE, 2009, AIDS CARE, V21, P608, DOI 10.1080/09540120802310957; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Shumbusho F, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000163; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Topp SM, 2011, B WORLD HEALTH ORGAN, V89, P328, DOI 10.2471/BLT.10.084442; Topp SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011522; Wagner G, 2007, AIDS PATIENT CARE ST, V21, P871, DOI 10.1089/apc.2007.0008; World Health Organization, 2010, UN ACC SCAL PRIOR HI	24	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35479	10.1371/journal.pone.0035479	http://dx.doi.org/10.1371/journal.pone.0035479			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UP	22545108	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000305341000039
J	Gosemann, JH; Kuebler, JF; Pozzobon, M; Neunaber, C; Hensel, JHK; Ghionzoli, M; de Coppi, P; Ure, BM; Holze, G				Gosemann, Jan-Hendrik; Kuebler, Joachim F.; Pozzobon, Michela; Neunaber, Claudia; Hensel, Julia H. K.; Ghionzoli, Marco; de Coppi, Paolo; Ure, Benno M.; Holze, Gesine			Activation of Regulatory T Cells during Inflammatory Response Is Not an Exclusive Property of Stem Cells	PLOS ONE			English	Article							BACTERIAL CLEARANCE; THERAPY; SEPSIS; DIFFERENTIATION; LYMPHOCYTE; SURVIVAL; BIOLOGY; FUTURE	Background: Sepsis and systemic-inflammatory-response-syndrome (SIRS) remain major causes for fatalities on intensive care units despite up-to-date therapy. It is well accepted that stem cells have immunomodulatory properties during inflammation and sepsis, including the activation of regulatory T cells and the attenuation of distant organ damage. Evidence from recent work suggests that these properties may not be exclusively attributed to stem cells. This study was designed to evaluate the immunomodulatory potency of cellular treatment during acute inflammation in a model of sublethal endotoxemia and to investigate the hypothesis that immunomodulations by cellular treatment during inflammatory response is not stem cell specific. Methodology/Principal Findings: Endotoxemia was induced via intra-peritoneal injection of lipopolysaccharide (LPS) in wild type mice (C3H/HeN). Mice were treated with either vital or homogenized amniotic fluid stem cells (AFS) and sacrificed for specimen collection 24 h after LPS injection. Endpoints were plasma cytokine levels (BD (TM) Cytometric Bead Arrays), T cell subpopulations (flow-cytometry) and pulmonary neutrophil influx (immunohistochemistry). To define stem cell specific effects, treatment with either vital or homogenized human-embryonic-kidney-cells (HEK) was investigated in a second subset of experiments. Mice treated with homogenized AFS cells showed significantly increased percentages of regulatory T cells and Interleukin-2 as well as decreased amounts of pulmonary neutrophils compared to saline-treated controls. These results could be reproduced in mice treated with vital HEK cells. No further differences were observed between plasma cytokine levels of endotoxemic mice. Conclusions/Significance: The results revealed that both AFS and HEK cells modulate cellular immune response and distant organ damage during sublethal endotoxemia. The observed effects support the hypothesis, that immunomodulations are not exclusive attributes of stem cells.	[Gosemann, Jan-Hendrik; Kuebler, Joachim F.; Hensel, Julia H. K.; Ure, Benno M.; Holze, Gesine] Hannover Med Sch, Ctr Pediat Surg Hannover, D-3000 Hannover, Germany; [Gosemann, Jan-Hendrik; Kuebler, Joachim F.; Hensel, Julia H. K.; Ure, Benno M.; Holze, Gesine] Bult Childrens Hosp, D-3000 Hannover, Germany; [Pozzobon, Michela] Univ Padua, Stem Cell Proc Lab, Clin Pediat Oncohematol, Padua, Italy; [Neunaber, Claudia] Hannover Med Sch, Trauma Dept, D-3000 Hannover, Germany; [Ghionzoli, Marco; de Coppi, Paolo] Great Ormond St Hosp Sick Children, Surg Unit, UCL Inst Child Hlth, London, England	Hannover Medical School; University of Padua; Hannover Medical School; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Gosemann, JH (corresponding author), Hannover Med Sch, Ctr Pediat Surg Hannover, D-3000 Hannover, Germany.	gosemann.jan@mh-hannover.de	Neunaber, Claudia/AAJ-1490-2021; Pozzobon, Michela/X-7504-2019; Pozzobon, Michela/G-7974-2018	Neunaber, Claudia/0000-0002-8537-2238; Pozzobon, Michela/0000-0001-9213-402X; Pozzobon, Michela/0000-0001-9213-402X; De Coppi, Paolo/0000-0002-1659-0207; Ghionzoli, Marco/0000-0002-3128-737X	"TUI Stiftung", Hannover; Great Ormond Street Hospital Charity; Great Ormond Street Hospital Childrens Charity [V1230] Funding Source: researchfish	"TUI Stiftung", Hannover; Great Ormond Street Hospital Charity; Great Ormond Street Hospital Childrens Charity	This study was financially supported by the "TUI Stiftung", Hannover. PDC is supported by the Great Ormond Street Hospital Charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Becker C, 2006, MED MICROBIOL IMMUN, V195, P113, DOI 10.1007/s00430-006-0017-y; Beyersdorf N, 2005, J EXP MED, V202, P445, DOI 10.1084/jem.20051060; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Bollini S, 2011, STEM CELLS DEV, V20, P1985, DOI 10.1089/scd.2010.0424; Chou HS, 2011, HEPATOLOGY, V53, P1007, DOI 10.1002/hep.24162; Cribbs SK, 2011, AM J MED SCI, V341, P325, DOI 10.1097/MAJ.0b013e3181f30dee; D'Alessio FR, 2009, J CLIN INVEST, V119, P2898, DOI 10.1172/JCI36498; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Gonzalez-Rey E, 2009, GUT, V58, P929, DOI 10.1136/gut.2008.168534; Gosemann JH, 2010, INJURY, V41, P1060, DOI 10.1016/j.injury.2010.05.021; Grisafi D, 2008, STEM CELLS DEV, V17, P953, DOI 10.1089/scd.2007.0188; Heuer JG, 2005, J IMMUNOL, V174, P7141, DOI 10.4049/jimmunol.174.11.7141; Hilfiker A, 2011, LANGENBECK ARCH SURG, V396, P489, DOI 10.1007/s00423-011-0762-2; Jeong JO, 2011, CIRC RES, V108, P1340, DOI 10.1161/CIRCRESAHA.110.239848; Jones S, 2007, J IMMUNOL, V179, P2824, DOI 10.4049/jimmunol.179.5.2824; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kronsteiner B, 2011, CELL IMMUNOL, V267, P30, DOI 10.1016/j.cellimm.2010.11.001; Li L, 2011, J CELL PHYSIOL, V226, P1860, DOI 10.1002/jcp.22511; Lodi D, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-9; Maccario R, 2005, HAEMATOLOGICA, V90, P516; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mei SHJ, 2010, AM J RESP CRIT CARE, V182, P1047, DOI 10.1164/rccm.201001-0010OC; Monneret G, 2010, EXPERT REV ANTI-INFE, V8, P1109, DOI [10.1586/eri.10.107, 10.1586/ERI.10.107]; Moorefield EC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026535; Nelson BH, 2004, J IMMUNOL, V172, P3983, DOI 10.4049/jimmunol.172.7.3983; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Perin L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009357; Pietropaoli A, 2009, J CLIN INVEST, V119, P2891, DOI 10.1172/JCI40880; Pozzobon M, 2010, PEDIATR SURG INT, V26, P3, DOI 10.1007/s00383-009-2478-8; Rota C, 2011, STEM CELLS DEV; Selmani Z, 2008, STEM CELLS, V26, P212, DOI 10.1634/stemcells.2007-0554; Shaw SWS, 2011, CURR OPIN OBSTET GYN, V23, P109, DOI 10.1097/GCO.0b013e32834457b1; Shi M, 2011, CLIN EXP IMMUNOL, V164, P1, DOI 10.1111/j.1365-2249.2011.04327.x; Toda A, 2006, J LEUKOCYTE BIOL, V80, P458, DOI 10.1189/jlb.0206095; Tsai K.S., 2011, GASTROENTEROLOGY; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Uccelli A, 2011, CURR STEM CELL RES T, V6, P69, DOI 10.2174/157488811794480744; Venet F, 2009, J IMMUNOL, V183, P3472, DOI 10.4049/jimmunol.0804119; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Yang HR, 2009, HEPATOLOGY, V50, P1981, DOI 10.1002/hep.23202; Zani A, 2009, J PEDIATR SURG, V44, P659, DOI 10.1016/j.jpedsurg.2008.12.012	43	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35512	10.1371/journal.pone.0035512	http://dx.doi.org/10.1371/journal.pone.0035512			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539976	Green Published, gold			2022-12-27	WOS:000305341000042
J	Dou, YC; Wang, J; Yang, JL; Zhang, C				Dou, Yongchao; Wang, Jun; Yang, Jialiang; Zhang, Chi			L1pred: A Sequence-Based Prediction Tool for Catalytic Residues in Enzymes with the L1-logreg Classifier	PLOS ONE			English	Article							FUNCTIONALLY IMPORTANT RESIDUES; EVOLUTIONARY CONSERVATION; PROTEIN-SEQUENCE; ENTROPY; IDENTIFICATION; SELECTION; ACCURATE; CONSURF; SITES	To understand enzyme functions, identifying the catalytic residues is a usual first step. Moreover, knowledge about catalytic residues is also useful for protein engineering and drug-design. However, to experimentally identify catalytic residues remains challenging for reasons of time and cost. Therefore, computational methods have been explored to predict catalytic residues. Here, we developed a new algorithm, L1pred, for catalytic residue prediction, by using the L1-logreg classifier to integrate eight sequence-based scoring functions. We tested L1pred and compared it against several existing sequence-based methods on carefully designed datasets Data604 and Data63. With ten-fold cross-validation, L1pred showed the area under precision-recall curve (AUPR) and the area under ROC curve (AUC) of 0.2198 and 0.9494 on the training dataset, Data604, respectively. In addition, on the independent test dataset, Data63, it showed the AUPR and AUC values of 0.2636 and 0.9375, respectively. Compared with other sequence-based methods, L1pred showed the best performance on both datasets. We also analyzed the importance of each attribute in the algorithm, and found that all the scores contributed more or less equally to the L1pred performance.	[Dou, Yongchao; Zhang, Chi] Univ Nebraska, Sch Biol Sci, Ctr Plant Sci & Innovat, Lincoln, NE 68508 USA; [Wang, Jun] Sci Comp Key Lab Shanghai Univ, Shanghai, Peoples R China; [Wang, Jun] Shanghai Normal Univ, Dept Math, Shanghai, Peoples R China; [Yang, Jialiang] Chinese Acad Sci, MPI Inst Computat Biol, Shanghai, Peoples R China	University of Nebraska System; University of Nebraska Lincoln; Shanghai Key Laboratory of Scalable Computing & System; Shanghai Normal University; Chinese Academy of Sciences; Max Planck Society	Dou, YC (corresponding author), Univ Nebraska, Sch Biol Sci, Ctr Plant Sci & Innovat, Lincoln, NE 68508 USA.	czhang5@unl.edu	Zhang, Chi/C-4996-2009	Zhang, Chi/0000-0002-1827-8137; Yang, Jialiang/0000-0003-4689-8672	National Natural Science Foundation of China [10731040]; Shanghai Leading Academic Discipline Project [S30405]; Innovation Program of Shanghai Municipal Education Commission [09zz134]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission)	This work was partially supported by the National Natural Science Foundation of China (No. 10731040), Shanghai Leading Academic Discipline Project (No. S30405) and Innovation Program of Shanghai Municipal Education Commission (No. 09zz134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ahmad S, 2003, BIOINFORMATICS, V19, P1849, DOI 10.1093/bioinformatics/btg249; Alterovitz R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-197; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; Bartlett GJ, 2002, J MOL BIOL, V324, P105, DOI 10.1016/S0022-2836(02)01036-7; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brylinski M, 2007, PLOS COMPUT BIOL, V3, P909, DOI 10.1371/journal.pcbi.0030094; Caffrey DR, 2004, PROTEIN SCI, V13, P190, DOI 10.1110/ps.03323604; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; Chea E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-153; Cilia E, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-115; Dou YC, 2010, AMINO ACIDS, V39, P1353, DOI 10.1007/s00726-010-0587-2; Dou YC, 2010, J THEOR BIOL, V262, P317, DOI 10.1016/j.jtbi.2009.09.030; Dou YC, 2009, PROTEIN J, V28, P29, DOI 10.1007/s10930-008-9161-0; Dukka BKC, 2008, BIOINFORMATICS, V24, P2308, DOI 10.1093/bioinformatics/btn454; Fischer JD, 2008, BIOINFORMATICS, V24, P613, DOI 10.1093/bioinformatics/btm626; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Gong S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000179; Greenshtein E, 2004, BERNOULLI, V10, P971, DOI 10.3150/bj/1106314846; Gutteridge A, 2003, J MOL BIOL, V330, P719, DOI 10.1016/S0022-2836(03)00515-1; Innis CA, 2003, J MOL BIOL, V337, P053; Kato T, 2010, BIOINFORMATICS, V26, P2698, DOI 10.1093/bioinformatics/btq519; Koh KM, 2007, J MACH LEARN RES, V8, P1519; La D, 2005, PROTEINS, V58, P309, DOI 10.1002/prot.20321; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Liu XS, 2008, AMINO ACIDS, V34, P643, DOI 10.1007/s00726-007-0017-2; Liu ZP, 2010, BIOINFORMATICS, V26, P1616, DOI 10.1093/bioinformatics/btq253; Lopez G, 2007, NUCLEIC ACIDS RES, V35, pW573, DOI 10.1093/nar/gkm297; Buslje CM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000978; Mayrose I, 2004, MOL BIOL EVOL, V21, P1781, DOI 10.1093/molbev/msh194; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mesa AD, 2003, J MOL BIOL, V326, P1289, DOI 10.1016/S0022-2836(02)01451-1; Mihalek I, 2004, J MOL BIOL, V336, P1265, DOI 10.1016/j.jmb.2003.12.078; Mirny LA, 1999, J MOL BIOL, V291, P177, DOI 10.1006/jmbi.1999.2911; Panchenko AR, 2004, PROTEIN SCI, V13, P884, DOI 10.1110/ps.03465504; Pande S, 2007, 2007 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN BIOINFORMATICS AND COMPUTATIONAL BIOLOGY, P247; Pei JM, 2001, BIOINFORMATICS, V17, P700, DOI 10.1093/bioinformatics/17.8.700; Petrova NV, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-312; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Sankararaman S, 2008, BIOINFORMATICS, V24, P2445, DOI 10.1093/bioinformatics/btn474; Sankararaman S, 2010, BIOINFORMATICS, V26, P617, DOI 10.1093/bioinformatics/btq008; Sterner B, 2007, J COMPUT BIOL, V14, P1058, DOI 10.1089/cmb.2007.0042; SWEET RM, 1983, J MOL BIOL, V171, P479, DOI 10.1016/0022-2836(83)90041-4; Tang YR, 2008, PROTEIN ENG DES SEL, V21, P295, DOI 10.1093/protein/gzn003; TAYLOR WR, 1986, J THEOR BIOL, V119, P205, DOI 10.1016/S0022-5193(86)80075-3; Tong WX, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000266; Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146; van de Geer SA, 2008, ANN STAT, V36, P614, DOI 10.1214/009053607000000929; Vergara IA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-265; Wang K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-385; WILLIAMSON R, 1995, J THEOR BIOL, V24, P908; Ye K, 2008, BIOINFORMATICS, V24, P908, DOI 10.1093/bioinformatics/btn057; Youn E, 2007, PROTEIN SCI, V16, P216, DOI 10.1110/ps.062523907; Zhang SW, 2008, AMINO ACIDS, V35, P495, DOI 10.1007/s00726-007-0586-0; Zhang T, 2008, BIOINFORMATICS, V24, P2329, DOI 10.1093/bioinformatics/btn433; Zhao P, 2006, J MACH LEARN RES, V7, P2541	57	18	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35666	10.1371/journal.pone.0035666	http://dx.doi.org/10.1371/journal.pone.0035666			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558194	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000045
J	Ma, Y; Dai, HL; Wang, LM; Zhu, LJ; Zou, HB; Kong, XM				Ma, Yi; Dai, HuiLi; Wang, LiMin; Zhu, LiJun; Zou, HanBing; Kong, XianMing			Consent for Use of Clinical Leftover Biosample: A Survey among Chinese Patients and the General Public	PLOS ONE			English	Article							STORED BIOLOGICAL SAMPLES; INFORMED-CONSENT; RESEARCH PARTICIPANTS; FUTURE-RESEARCH; HEALTH SYSTEM; BIOBANK; BANKING; REFORM; UK	Background: Storage of leftover biosamples generates rich biobanks for future studies, saving time and money and limiting physical impact to sample donors. Objective: To investigate the attitudes of Chinese patients and the general public on providing consent for storage and use of leftover biosamples. Design, Setting and Participants: Cross-sectional surveys were conducted among randomly selected patients admitted to a Shanghai city hospital (n = 648) and members of the general public (n = 492) from May 2010 to July 2010. Main Outcome Measures: Face-to-face interviews collected respondents-report of their willingness to donate residual biosample, trust in medical institutions, motivation for donation, concerns of donated sample use, expectations for research results return, and so on. Results: The response rate was 83.0%. Of the respondents, 89.1% stated that they completely understood or understood most of questions. Willingness to donate residual sample was stated by 64.7%, of which 16.7% desired the option to withdraw their donations anytime afterwards. Only 42.3% of respondents stated they "trust'' or "strongly trust'' medical institutions, the attitude of trusting or strongly trusting medical institutions were significantly associated with willingness to donate in the general public group.(p<0.05) The overall assent rate for future research without specific consents was also low (12.1%). Hepatitis B virus carriers were significantly less willing than non-carriers to donate biosamples (32.1% vs. 64.7%, p<0.001). Conclusions: Low levels of public trust in medical institutions become serious obstacle for biosample donation and biobanking in China. Efforts to increase public understanding of human medical research and biosample usage and trust in the ethical purposes of biobanking are urgently needed. These efforts will be greatly advanced by the impending legislation on biobanking procedures and intent, and our results may help guide the structure of such law.	[Ma, Yi; Dai, HuiLi; Kong, XianMing] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Biobank, Shanghai 200030, Peoples R China; [Wang, LiMin; Zhu, LiJun; Zou, HanBing] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Sci & Study, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Ma, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Biobank, Shanghai 200030, Peoples R China.	dr.xmkong@gmail.com			Shanghai Renji Hospital	Shanghai Renji Hospital	This study was funded by Shanghai Renji Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, LANCET, V376, P657, DOI 10.1016/S0140-6736(10)61315-3; Campbell AV, 2007, KINGS LAW J, V18, P227, DOI [10.1080/09615768.2007.11427675, DOI 10.1080/09615768.2007.11427675]; Chen DT, 2005, ARCH INTERN MED, V165, P652, DOI 10.1001/archinte.165.6.652; Elger BS, 2006, EMBO REP, V7, P661, DOI 10.1038/sj.embor.7400740; Fan M, 2008, WASHINGTON POST 0110; Fitzpatrick PE, 2009, BJU INT, V104, P209, DOI 10.1111/j.1464-410X.2009.08666.x; Forsberg JS, 2009, EUR J HUM GENET, V17, P1544, DOI 10.1038/ejhg.2009.87; Hansson MG, 2009, BRIT J CANCER, V100, P8, DOI 10.1038/sj.bjc.6604795; Hansson MG, 2006, LANCET ONCOL, V7, P266, DOI 10.1016/S1470-2045(06)70618-0; Henderson G, 2008, GENET MED, V10, P193, DOI 10.1097/GIM.0b013e318164e4f5; Hu SL, 2008, LANCET, V372, P1846, DOI 10.1016/S0140-6736(08)61368-9; Jefford M, 2008, LANCET ONCOL, V9, P485, DOI 10.1016/S1470-2045(08)70128-1; Kaufman DJ, 2009, AM J HUM GENET, V85, P643, DOI 10.1016/j.ajhg.2009.10.002; Kiehntopf M, 2011, HUM GENET, V130, P369, DOI 10.1007/s00439-011-1068-8; Knoppers BM., 2007, KINGS LAW J, V18, P291, DOI [10.1080/09615768.2007.11427678, DOI 10.1080/09615768.2007.11427678]; Malone T, 2002, J NATL CANCER I, V94, P769; Matsui K, 2005, J MED ETHICS, V31, P385, DOI 10.1136/jme.2004.009530; McHale J, 2007, LANCET ONCOL, V8, P266, DOI 10.1016/S1470-2045(07)70077-3; Salvaterra E, 2008, EMBO REP, V9, P307, DOI 10.1038/embor.2008.41; Shan J, 2007, CHINA DAILY     0901; Tupasela A, 2010, SCAND J PUBLIC HEALT, V38, P46, DOI 10.1177/1403494809353824; Tutton R, 2004, TRENDS BIOTECHNOL, V22, P284, DOI 10.1016/j.tibtech.2004.04.007; Vermeulen E, 2009, BRIT J CANCER, V101, P1505, DOI 10.1038/sj.bjc.6605339; Wagstaff A, 2009, HEALTH ECON, V18, pS7, DOI 10.1002/hec.1518; Wang S S, 2001, Community Genet, V4, P18, DOI 10.1159/000051152; Wendler D, 2006, BMJ-BRIT MED J, V332, P544, DOI 10.1136/bmj.332.7540.544; Wendler D, 2002, ARCH INTERN MED, V162, P1457, DOI 10.1001/archinte.162.13.1457; Wendler David, 2005, IRB, V27, P1; Willison DJ, 2009, BMC MED ETHICS, V10, DOI 10.1186/1472-6939-10-10	29	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36050	10.1371/journal.pone.0036050	http://dx.doi.org/10.1371/journal.pone.0036050			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558323	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000113
J	Kim, SE; Kim, JH; Min, BH; Bae, YM; Hong, ST; Choi, MH				Kim, Sung Eun; Kim, Jae-Hwan; Min, Byung-Hoon; Bae, Young Mee; Hong, Sung-Tae; Choi, Min-Ho			Crude Extracts of Caenorhabditis elegans Suppress Airway Inflammation in a Murine Model of Allergic Asthma	PLOS ONE			English	Article							TRICHURIS-SUIS THERAPY; IFN-GAMMA; PARASITE INFECTION; HELMINTH INFECTION; CONTROLLED-TRIAL; ASCARIS-SUUM; RESPONSES; DISEASE; ATOPY; MICE	Epidemiological studies suggest an inverse relationship between helminth infections and allergic disease, and several helminth-derived products have been shown to suppress allergic responses in animals. This study was undertaken to evaluate the effect of a crude extract of Caenorhabditis elegans on allergic airway inflammation in a murine model of asthma. Allergic airway inflammation was induced in BALB/c mice by sensitization with ovalbumin. The effect of the C. elegans crude extract on the development of asthma and on established asthma was evaluated by analyzing airway hyperresponsiveness, serum antibody titers, lung histology and cell counts and cytokine levels in the bronchoalveolar lavage fluid. The role of IFN-gamma in the suppression of asthma by the C. elegans crude extract was investigated in IFN-gamma knockout and wild-type mice. When mice were sensitized with ovalbumin together with the crude extract of C. elegans, cellular infiltration into the lung was dramatically reduced in comparison with the ovalbumin-treated group. Treatment of mice with the C. elegans crude extract significantly decreased methacholine-induced airway hyperresponsiveness and the total cell counts and levels of IL-4, IL-5 and IL-13 in the bronchoalveolar lavage fluid but increased the levels of IFN-gamma and IL-12. Sensitization with the C. elegans crude extract significantly diminished the IgE and IgG1 responses but provoked elevated IgG2a levels. However, the suppressive effect of the C. elegans crude extract was abolished in IFN-gamma knockout mice, and the Th2 responses in these mice were as strong as those in wild-type mice sensitized with ovalbumin. The crude extract of C. elegans also suppressed the airway inflammation associated with established asthma. This study provides new insights into immune modulation by the C. elegans crude extract, which suppressed airway inflammation in mice not only during the development of asthma but also after its establishment by skewing allergen-induced Th2 responses to Th1 responses.	[Kim, Sung Eun; Kim, Jae-Hwan; Min, Byung-Hoon; Bae, Young Mee; Hong, Sung-Tae; Choi, Min-Ho] Seoul Natl Univ, Coll Med, Dept Parasitol & Trop Med, Seoul, South Korea; [Kim, Sung Eun; Kim, Jae-Hwan; Min, Byung-Hoon; Bae, Young Mee; Hong, Sung-Tae; Choi, Min-Ho] Seoul Natl Univ, Inst Endem Dis, Med Res Ctr, Seoul, South Korea; [Min, Byung-Hoon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, SE (corresponding author), Seoul Natl Univ, Coll Med, Dept Parasitol & Trop Med, Seoul, South Korea.	mhchoi@snu.ac.kr	Hong, Sung-Tae/J-5723-2012; Bae, Young-Mee/J-5502-2012	Hong, Sung-Tae/0000-0002-0300-1944	Korea Research Foundation; Korean Government (MOEHRD) [KRF-2007-313-E00166]	Korea Research Foundation(National Research Foundation of Korea); Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government)	This research was supported by the Korea Research Foundation Grant funded by the Korean Government (MOEHRD) (KRF-2007-313-E00166). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adisakwattana P, 2009, ADV EXP MED BIOL, V666, P95; Araujo CA, 2008, CYTOKINE, V44, P335, DOI 10.1016/j.cyto.2008.09.005; Araujo MIAS, 2004, J INFECT DIS, V190, P1797, DOI 10.1086/425017; Bosnjak B, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-114; Capron M, 2011, ALLERGY, V66, P16, DOI 10.1111/j.1398-9995.2011.02624.x; Choi MH, 2011, CLIN EXP ALLERGY, V41, P697, DOI 10.1111/j.1365-2222.2011.03746.x; Cooper PJ, 2006, LANCET, V367, P1598, DOI 10.1016/S0140-6736(06)68697-2; Dagoye D, 2003, AM J RESP CRIT CARE, V167, P1369, DOI 10.1164/rccm.200210-1204OC; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; Erb KJ, 2009, TRENDS IMMUNOL, V30, P75, DOI 10.1016/j.it.2008.11.005; Falcone FH, 2005, TRENDS PARASITOL, V21, P157, DOI 10.1016/j.pt.2005.02.002; Fallon PG, 2007, NAT REV IMMUNOL, V7, P220, DOI 10.1038/nri2039; Feary JR, 2010, CLIN EXP ALLERGY, V40, P299, DOI 10.1111/j.1365-2222.2009.03433.x; Finkelman FD, 2008, J ALLERGY CLIN IMMUN, V121, P334, DOI 10.1016/j.jaci.2007.11.028; Flohr C, 2009, CLIN EXP ALLERGY, V39, P20, DOI 10.1111/j.1365-2222.2008.03134.x; Harnett William, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000720; Hartmann S, 2003, INT J PARASITOL, V33, P1291, DOI 10.1016/S0020-7519(03)00163-2; Inman MD, 2010, CLIN EXP ALLERGY, V40, P524, DOI 10.1111/j.1365-2222.2010.03485.x; Itami DM, 2005, CLIN EXP ALLERGY, V35, P873, DOI 10.1111/j.1365-2222.2005.02268.x; Kitagaki K, 2006, J IMMUNOL, V177, P1628, DOI 10.4049/jimmunol.177.3.1628; Koch M, 2006, AM J RESP CELL MOL, V35, P211, DOI 10.1165/rcmb.2005-0293OC; Kradin RL, 2006, ARCH PATHOL LAB MED, V130, P718; Lack G, 1996, J IMMUNOL, V157, P1432; Leonardi-Bee J, 2006, AM J RESP CRIT CARE, V174, P514, DOI 10.1164/rccm.200603-331OC; Mangan NE, 2006, J IMMUNOL, V176, P138, DOI 10.4049/jimmunol.176.1.138; Markaki M, 2010, BIOTECHNOL J, V5, P1261, DOI 10.1002/biot.201000183; Marsland BJ, 2005, IMMUNOL CELL BIOL, V83, P40, DOI [10.1111/j.1440-1711.2004.01303.x, 10.1111/j.1440-1711.2005.01303.x]; McInnes IB, 2003, J IMMUNOL, V171, P2127, DOI 10.4049/jimmunol.171.4.2127; Medeiros M, 2003, J ALLERGY CLIN IMMUN, V111, P947, DOI 10.1067/mai.2003.1381; Melendez AJ, 2007, NAT MED, V13, P1375, DOI 10.1038/nm1654; Palmer LJ, 2002, AM J RESP CRIT CARE, V165, P1489, DOI 10.1164/rccm.2107020; Peters-Golden M, 2004, AM J RESP CELL MOL, V31, P3, DOI 10.1165/rcmb.f279; Pinelli E, 2008, CLIN EXP ALLERGY, V38, P649, DOI 10.1111/j.1365-2222.2007.02908.x; Schierack P, 2003, INFECT IMMUN, V71, P2422, DOI 10.1128/IAI.71.5.2422-2429.2003; Schnoeller C, 2008, J IMMUNOL, V180, P4265, DOI 10.4049/jimmunol.180.6.4265; Summers RW, 2005, GASTROENTEROLOGY, V128, P825, DOI 10.1053/j.gastro.2005.01.005; Summers RW, 2005, GUT, V54, P87, DOI 10.1136/gut.2004.041749; Tang CB, 2001, J IMMUNOL, V166, P1471, DOI 10.4049/jimmunol.166.3.1471; van den Biggelaar AHJ, 2004, J INFECT DIS, V189, P892, DOI 10.1086/381767; Wang CC, 2001, CLIN EXP ALLERGY, V31, P495, DOI 10.1046/j.1365-2222.2001.01044.x; Wohlleben G, 2004, INT IMMUNOL, V16, P585, DOI 10.1093/intimm/dxh062; Yoshida M, 2002, AM J RESP CRIT CARE, V166, P451, DOI 10.1164/rccm.200202-095OC; Yu M, 2011, J CLIN INVEST, V121, P3133, DOI 10.1172/JCI43598	43	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35447	10.1371/journal.pone.0035447	http://dx.doi.org/10.1371/journal.pone.0035447			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558152	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345200041
J	Williams, JD; Boyko, CB				Williams, Jason D.; Boyko, Christopher B.			The Global Diversity of Parasitic Isopods Associated with Crustacean Hosts (Isopoda: Bopyroidea and Cryptoniscoidea)	PLOS ONE			English	Review							BOPYRID ISOPOD; PROBOPYRUS-PANDALICOLA; PARALOMIS-GRANULOSA; ORTHIONE-GRIFFENIS; ARGEIA-PUGETTENSIS; PALAEMONETES-PUGIO; LIRIOPSIS-PYGMAEA; BEAGLE CHANNEL; GRASS SHRIMP; DECAPODA	Parasitic isopods of Bopyroidea and Cryptoniscoidea (commonly referred to as epicarideans) are unique in using crustaceans as both intermediate and definitive hosts. In total, 795 epicarideans are known, representing similar to 7.7% of described isopods. The rate of description of parasitic species has not matched that of free-living isopods and this disparity will likely continue due to the more cryptic nature of these parasites. Distribution patterns of epicarideans are influenced by a combination of their definitive (both benthic and pelagic species) and intermediate (pelagic copepod) host distributions, although host specificity is poorly known for most species. Among epicarideans, nearly all species in Bopyroidea are ectoparasitic on decapod hosts. Bopyrids are the most diverse taxon (605 species), with their highest diversity in the North West Pacific (139 species), East Asian Sea (120 species), and Central Indian Ocean (44 species). The diversity patterns of Cryptoniscoidea (99 species, endoparasites of a diverse assemblage of crustacean hosts) are distinct from bopyrids, with the greatest diversity of cryptoniscoids in the North East Atlantic (18 species) followed by the Antarctic, Mediterranean, and Arctic regions (13, 12, and 8 species, respectively). Dajidae (54 species, ectoparasites of shrimp, mysids, and euphausids) exhibits highest diversity in the Antarctic (7 species) with 14 species in the Arctic and North East Atlantic regions combined. Entoniscidae (37 species, endoparasites within anomuran, brachyuran and shrimp hosts) show highest diversity in the North West Pacific (10 species) and North East Atlantic (8 species). Most epicarideans are known from relatively shallow waters, although some bopyrids are known from depths below 4000 m. Lack of parasitic groups in certain geographic areas is likely a sampling artifact and we predict that the Central Indian Ocean and East Asian Sea (in particular, the Indo-Malay-Philippines Archipelago) hold a wealth of undescribed species, reflecting our knowledge of host diversity patterns.	[Williams, Jason D.] Hofstra Univ, Dept Biol, Hempstead, NY 11550 USA; [Boyko, Christopher B.] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Boyko, Christopher B.] Dowling Coll, Dept Biol, Oakdale, NY USA	Hofstra University; American Museum of Natural History (AMNH)	Williams, JD (corresponding author), Hofstra Univ, Dept Biol, Hempstead, NY 11550 USA.	biojdw@hofstra.edu						Adkison DL, REV ENTONISCINAE; An J, 2011, TAXONOMY PARASITIC I; An JM, 2009, INTEGR COMP BIOL, V49, P95, DOI 10.1093/icb/icp022; ANDERSON G, 1990, J CRUSTACEAN BIOL, V10, P284, DOI 10.2307/1548487; Arnott SA, 2001, J MAR BIOL ASSOC UK, V81, P171, DOI 10.1017/S002531540100354X; BLOWER SM, 1988, OECOLOGIA, V75, P512, DOI 10.1007/BF00776413; BOURDON R, 1983, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V5, P845; BOURDON R, 1968, Memoires du Museum National d'Histoire Naturelle Serie A Zoologie, V50, P77; Boxshall G, 2005, MARINE PARASITOLOGY, P123, DOI 10.1079/9780643090255.0123; Boyko CB, 2004, B MAR SCI, V74, P353; Boyko CB, 2003, J CRUSTACEAN BIOL, V23, P795, DOI 10.1651/C-2398; Boyko CB, 2012, CRUSTACEAN ISSUES BI, P271; Boyko CB, ZOOTAXA IN PRESS; Boyko Christopher B., 2009, Crustacean Issues, V18, P197; Brandt A, 2003, INVERTEBR SYST, V17, P893, DOI 10.1071/IS02032; Brandt A, 2007, DEEP-SEA RES PT II, V54, P1760, DOI 10.1016/j.dsr2.2007.07.015; Calado R, 2005, J EXP MAR BIOL ECOL, V321, P13, DOI 10.1016/j.jembe.2004.12.038; Carpenter KE, 2005, ENVIRON BIOL FISH, V72, P467, DOI 10.1007/s10641-004-3154-4; Chaplin-Ebanks SA, 2007, J PARASITOL, V93, P73, DOI 10.1645/GE-3537.1; Chapman JW, 2012, BIOL INVASIONS, V14, P1221, DOI 10.1007/s10530-011-0151-3; Chu KH, 1996, J NAT HIST, V30, P835, DOI 10.1080/00222939600770461; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; COYLE KO, 1981, CAN J FISH AQUAT SCI, V38, P1438, DOI 10.1139/f81-190; Deslandes, 1724, HIST ACAD ROYALE SCI, V1722, P19; Dreyer H, 2001, ZOOL-ANAL COMPLEX SY, V103, P157; DUMBAULD B., 2004, P S EC LARG BIOT TID, P53; Dumbauld BR, 2011, ESTUAR COAST, V34, P336, DOI 10.1007/s12237-010-9316-z; Fabricius J.C., 1798, SUPPLEMENTUM ENTOMOL; Feldman KL, 2000, ESTUARIES, V23, P141, DOI 10.2307/1352824; Griffen BD, 2009, MAR ECOL PROG SER, V391, P73, DOI 10.3354/meps08228; Hoeg J, 1997, P 1 INT WORKSH DEM I; Hosie AM, 2008, ZOOTAXA, P1; Itani G., 2004, P S EC LARG BIOT TID, P33; Jarrin JRM, 2008, J CRUSTACEAN BIOL, V28, P613, DOI 10.1651/08-2976.1; JAY CV, 1989, AM MIDL NAT, V121, P68, DOI 10.2307/2425657; Johnson WS, 2001, ADV MAR BIOL, V39, P105, DOI 10.1016/S0065-2881(01)39009-0; Kensley B, 2001, CRUSTACEAN ISS, V13, P205; Kensley B., 1989, GUIDE MARINE ISOPOD; Kuris A. M., 2005, Second International Symposium on Biological Control of Arthropods, Davos, Switzerland, 12-16 September, 2005, P102; Lafferty KD, 1996, ECOLOGY, V77, P1989, DOI 10.2307/2265695; Lester RJG, 2006, FISH DISEASES AND DISORDERS, VOL 1: PROTOZOAN AND METAZOAN INFECTIONS, 2ND EDITION, P466, DOI 10.1079/9780851990156.0466; Lovrich GA, 2004, DIS AQUAT ORGAN, V58, P71, DOI 10.3354/dao058071; MARKHAM J C, 1985, Memoirs of the Hourglass Cruises, V7, P1; Markham JC, 2005, J CRUSTACEAN BIOL, V25, P413, DOI 10.1651/C-2566; MARKHAM JC, 1986, CRUSTACEAN BIOGEOGRA, P143, DOI DOI 10.1201/9781315140674-7; Markham John C., 1992, Proceedings of the San Diego Society of Natural History, V17, P1; Markham John C., 2010, Memoirs of the Queensland Museum, V54, P151; Martin J.W., 2001, UPDATED CLASSIFICATI, VVolume 39, P1; McDermott JJ, 2010, J EXP MAR BIOL ECOL, V394, P2, DOI 10.1016/j.jembe.2010.06.022; McDermott JJ, 2009, J NAT HIST, V43, P785, DOI 10.1080/00222930802702480; Miyashita Y., 1941, Japanese Journal of Zoology, V9, P251; Nielsen SO, 1965, SARSIA, V18, P38; OBRIEN J, 1985, CRUSTACEAN ISSUES 3, P191; OWENS L, 1995, MAR ECOL PROG SER, V122, P159, DOI 10.3354/meps122159; OWENS L, 1993, AUST J MAR FRESH RES, V44, P381, DOI 10.1071/MF9930381; Owens L., 1985, P105; OWENS L, 1991, J PLANKTON RES, V13, P779, DOI 10.1093/plankt/13.4.779; Paradiso ML, 2004, CRUSTACEANA, V77, P397, DOI 10.1163/1568540041643355; Pascual S, 2002, J WILDLIFE DIS, V38, P473, DOI 10.7589/0090-3558-38.2.473; Penha-Lopes G, 2011, ENVIRON POLLUT, V159, P636, DOI 10.1016/j.envpol.2010.09.029; Peresan L, 2005, J NAT HIST, V39, P311, DOI 10.1080/0022293042000200103; Pernet B, 2008, MAR BIOL, V153, P1127, DOI 10.1007/s00227-007-0884-9; Rajkumar M, 2011, CHIN J OCEANOL LIMN, V29, P136, DOI 10.1007/s00343-011-9923-y; RASMUSSEN E, 1973, Ophelia, V11, P1; REINHARD EG, 1945, J PARASITOL, V31, P198, DOI 10.2307/3272543; REINHARD EG, 1949, BIOL BULL, V96, P17, DOI 10.2307/1537997; Repetto M, 2012, MAR FRESHWATER RES, V63, P60, DOI 10.1071/MF11158; Schotte M, 2011, WORLD MARINE FRESHWA; Shields JD, 1996, INT J PARASITOL, V26, P261, DOI 10.1016/0020-7519(95)00126-3; SHIELDS JD, 1985, J INVERTEBR PATHOL, V45, P122, DOI 10.1016/0022-2011(85)90060-6; Shiino S. M., 1952, NATURAL SCI, V1, P33; Shiino SM., 1965, B MUSEUM NATL HIST N, V37, P462; Shimomura M, 2008, P BIOL SOC WASH, V121, P326, DOI 10.2988/07-09.1; Smit NJ, 2004, ADV PARASIT, V58, P289, DOI 10.1016/S0065-308X(04)58005-3; Smith AE, 2008, J CRUSTACEAN BIOL, V28, P228, DOI 10.1651/0278-0372(2008)028[0228:PSAEOT]2.0.CO;2; SOMERS IF, 1991, AUST J MAR FRESH RES, V42, P349; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Trilles Jean-Paul, 1999, Memoires de l' Institut Oceanographique (Monaco), V19, P279; Vinuesa JH, 2010, MAR BIOL RES, V6, P608, DOI 10.1080/17451000903478327; Wells S., 1995, GLOBAL REPRESENTATIV; Wienberg Rasmussen H., 2008, B MIZUNAMI FOSSIL MU, V34, P31; Williams JD, 2006, ZOOSYSTEMA, V28, P285; Williams JD, 2011, INTEGR ZOOL, V6, P13, DOI 10.1111/j.1749-4877.2010.00226.x; Williams JD, 2010, EXP PARASITOL, V125, P23, DOI 10.1016/j.exppara.2009.09.012; Williams JD, 2009, INTEGR COMP BIOL, V49, P114, DOI 10.1093/icb/icp021; Williams JD, 2004, P CALIFORNIA ACAD SC, V55, P435; Williamson CJ, 2009, J ENVIRON SCI HEAL B, V44, P810, DOI 10.1080/03601230903238426; Wilson GDF, 2008, HYDROBIOLOGIA, V595, P231, DOI 10.1007/s10750-007-9019-z	88	90	94	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35350	10.1371/journal.pone.0035350	http://dx.doi.org/10.1371/journal.pone.0035350			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558143	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345200034
J	Yu, Y; Jiang, DH; Xie, JT; Cheng, JS; Li, GQ; Yi, XH; Fu, YP				Yu, Yang; Jiang, Daohong; Xie, Jiatao; Cheng, Jiasen; Li, Guoqing; Yi, Xianhong; Fu, Yanping			Ss-Sl2, a Novel Cell Wall Protein with PAN Modules, Is Essential for Sclerotial Development and Cellular Integrity of Sclerotinia sclerotiorum	PLOS ONE			English	Article							ENZYME-MEDIATED INTEGRATION; HEPATOCYTE GROWTH-FACTOR; COAGULATION-FACTOR-XI; ELONGATION-FACTOR TU; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; APPLE DOMAINS; WORONIN BODY; KLUYVEROMYCES-MARXIANUS; ASPERGILLUS-NIDULANS; FUNCTIONAL-ANALYSIS	The sclerotium is an important dormant body for many plant fungal pathogens. Here, we reported that a protein, named Ss-Sl2, is involved in sclerotial development of Sclerotinia sclerotiorum. Ss-Sl2 does not show significant homology with any protein of known function. Ss-Sl2 contains two putative PAN modules which were found in other proteins with diverse adhesion functions. Ss-Sl2 is a secreted protein, during the initial stage of sclerotial development, copious amounts of Ss-Sl2 are secreted and accumulated on the cell walls. The ability to maintain the cellular integrity of RNAi-mediated Ss-Sl2 silenced strains was reduced, but the hyphal growth and virulence of Ss-Sl2 silenced strains were not significantly different from the wild strain. Ss-Sl2 silenced strains could form interwoven hyphal masses at the initial stage of sclerotial development, but the interwoven hyphae could not consolidate and melanize. Hyphae in these interwoven bodies were thin-walled, and arranged loosely. Co-immunoprecipitation and yeast two-hybrid experiments showed that glyceraldehyde-3-phosphate dehydrogenase (GAPDH), Woronin body major protein (Hex1) and elongation factor 1-alpha interact with Ss-Sl2. GAPDH-knockdown strains showed a similar phenotype in sclerotial development as Ss-Sl2 silenced strains. Hex1-knockdown strains showed similar impairment in maintenance of hyphal integrity as Ss-Sl2 silenced strains. The results suggested that Ss-Sl2 functions in both sclerotial development and cellular integrity of S. sclerotiorum.	[Yu, Yang; Jiang, Daohong; Li, Guoqing] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Hubei Province, Peoples R China; [Yu, Yang; Jiang, Daohong; Xie, Jiatao; Cheng, Jiasen; Li, Guoqing; Yi, Xianhong; Fu, Yanping] Huazhong Agr Univ, Prov Key Lab Plant Pathol Hubei Prov, Coll Plant Sci & Technol, Wuhan, Hubei Province, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Yu, Y (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Hubei Province, Peoples R China.	yanpingfu@mail.hzau.edu.cn	Abbas, Aqleem/M-9403-2016	Abbas, Aqleem/0000-0001-9174-9700	National Natural Science Foundation of China [31071647]; Special Fund for Agro-scientific Research in the Public Interest [201103016]; earmarked fund for China Agriculture Research System [nycytx-00514]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; earmarked fund for China Agriculture Research System	This research was supported by National Natural Science Foundation of China (31071647), the Special Fund for Agro-scientific Research in the Public Interest (Grant No.201103016) and the earmarked fund for China Agriculture Research System (nycytx-00514). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Barbosa MS, 2006, INFECT IMMUN, V74, P382, DOI 10.1128/IAI.74.1.382-389.2006; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BOLAND GJ, 1994, CAN J PLANT PATHOL, V16, P93, DOI 10.1080/07060669409500766; Bolton MD, 2006, MOL PLANT PATHOL, V7, P1, DOI 10.1111/J.1364-3703.2005.00316.X; Brecht S, 2001, J BIOL CHEM, V276, P4119, DOI 10.1074/jbc.M008294200; Brown Philip J., 2003, Journal of Structural and Functional Genomics, V4, P227, DOI 10.1023/B:JSFG.0000016118.87333.03; Brown PJ, 2000, MOL BIOCHEM PARASIT, V107, P91, DOI 10.1016/S0166-6851(00)00179-1; Butler MJ, 2009, MYCOLOGIA, V101, P296, DOI 10.3852/08-120; Chen CB, 2005, MOL MICROBIOL, V55, P299, DOI 10.1111/j.1365-2958.2004.04390.x; Chen CB, 2004, MOL PLANT MICROBE IN, V17, P404, DOI 10.1094/MPMI.2004.17.4.404; Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; CHET I, 1975, ANNU REV PHYTOPATHOL, V13, P169, DOI 10.1146/annurev.py.13.090175.001125; Dallo SF, 2002, MOL MICROBIOL, V46, P1041, DOI 10.1046/j.1365-2958.2002.03207.x; Dhavale T, 2007, MYCOTA, P87; Egea L, 2007, INT J BIOCHEM CELL B, V39, P1190, DOI 10.1016/j.biocel.2007.03.008; Erental A., 2008, Fungal Biology Reviews, V22, P6, DOI 10.1016/j.fbr.2007.10.001; Erental A, 2007, MOL PLANT MICROBE IN, V20, P944, DOI 10.1094/MPMI-20-8-0944; FERNANDES PA, 1992, BIOCHIM BIOPHYS ACTA, V1159, P67, DOI 10.1016/0167-4838(92)90076-P; Gaulin E, 2002, J CELL SCI, V115, P4565, DOI 10.1242/jcs.00138; Gozalbo D, 1998, INFECT IMMUN, V66, P2052, DOI 10.1128/IAI.66.5.2052-2059.1998; Granato D, 2004, INFECT IMMUN, V72, P2160, DOI 10.1128/IAI.72.4.2160-2169.2004; Harel A, 2006, MOL PLANT MICROBE IN, V19, P682, DOI 10.1094/MPMI-19-0682; HOOYKAAS PJJ, 1979, J GEN MICROBIOL, V110, P99, DOI 10.1099/00221287-110-1-99; Jedd G, 2000, NAT CELL BIOL, V2, P226, DOI 10.1038/35008652; Jurick WM, 2007, FUNGAL GENET BIOL, V44, P521, DOI 10.1016/j.fgb.2006.11.005; Jurick WM, 2004, PHYSIOL MOL PLANT P, V64, P155, DOI 10.1016/j.pmpp.2004.07.004; Kang Z.S, 1995, ULTRASTRUCTURE PLANT; KOSASIH BD, 1975, ANN BOT-LONDON, V39, P185, DOI 10.1093/oxfordjournals.aob.a084928; Langfelder K, 1998, MED MICROBIOL IMMUN, V187, P79, DOI 10.1007/s004300050077; Langfelder K, 2003, FUNGAL GENET BIOL, V38, P143, DOI 10.1016/S1087-1845(02)00526-1; Lazarovits G, 2000, PESTIC BIOCHEM PHYS, V67, P54, DOI 10.1006/pest.2000.2474; Li MY, 2009, MYCOLOGIA, V101, P34, DOI 10.3852/08-114; LU SW, 1994, P NATL ACAD SCI USA, V91, P12649, DOI 10.1073/pnas.91.26.12649; MARKHAM P, 1987, FEMS MICROBIOL LETT, V46, P1; Mateos FV, 1997, MOL PLANT MICROBE IN, V10, P1045, DOI 10.1094/MPMI.1997.10.9.1045; MCMULLEN BA, 1991, BIOCHEMISTRY-US, V30, P2056, DOI 10.1021/bi00222a008; Momany M, 2002, MYCOLOGIA, V94, P260, DOI 10.2307/3761802; Moreira RF, 1998, MICROBIOL-SGM, V144, P681, DOI 10.1099/00221287-144-3-681; Nguyen QB, 2008, MOL MICROBIOL, V68, P1348, DOI 10.1111/j.1365-2958.2008.06242.x; Pitarch A, 2002, MOL CELL PROTEOMICS, V1, P967, DOI 10.1074/mcp.M200062-MCP200; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Rollins JA, 2003, MOL PLANT MICROBE IN, V16, P785, DOI 10.1094/MPMI.2003.16.9.785; Roper M, 2010, P NATL ACAD SCI USA, V107, P17474, DOI 10.1073/pnas.1003577107; SHI Z, 1995, PHYTOPATHOLOGY, V85, P329, DOI 10.1094/Phyto-85-329; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Soundararajan S, 2004, PLANT CELL, V16, P1564, DOI 10.1105/tpc.020677; Starratt AN, 2002, CAN J MICROBIOL, V48, P320, DOI 10.1139/w02-017; STEADMAN JR, 1979, PHYTOPATHOLOGY, V69, P904, DOI 10.1094/Phyto-69-904; Tenney K, 2000, FUNGAL GENET BIOL, V31, P205, DOI 10.1006/fgbi.2000.1230; Tordai H, 1999, FEBS LETT, V461, P63, DOI 10.1016/S0014-5793(99)01416-7; TOWNSEND B. B., 1954, TRANS BRIT MYCOL SOC, V37, P213; TRINCI APJ, 1973, PROTOPLASMA, V80, P57, DOI 10.1007/BF01666351; Weld RJ, 2006, J MICROBIOL METH, V65, P202, DOI 10.1016/j.mimet.2005.07.010; WILLETTS HJ, 1992, MYCOL RES, V96, P801, DOI 10.1016/S0953-7562(09)81027-7; YELTON MM, 1984, P NATL ACAD SCI-BIOL, V81, P1470, DOI 10.1073/pnas.81.5.1470; Zhou HJ, 1999, BIOCHEMISTRY-US, V38, P14793, DOI 10.1021/bi9908641; ZHU JK, 1994, PLANT CELL, V6, P393, DOI 10.1105/tpc.6.3.393	59	36	40	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e34962	10.1371/journal.pone.0034962	http://dx.doi.org/10.1371/journal.pone.0034962			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558105	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345200016
J	Berthier, K; Leippert, F; Fumagalli, L; Arlettaz, R				Berthier, Karine; Leippert, Fabio; Fumagalli, Luca; Arlettaz, Raphael			Massive Nest-Box Supplementation Boosts Fecundity, Survival and Even Immigration without Altering Mating and Reproductive Behaviour in a Rapidly Recovered Bird Population	PLOS ONE			English	Article							CONSPECIFIC BROOD PARASITISM; EXTRA-PAIR FERTILIZATIONS; HOOPOE UPUPA-EPOPS; COMPUTER-PROGRAM; PATERNITY; MICROSATELLITE; CONSERVATION; BOTTLENECKS; EXPLORATION; EXTINCTION	Habitat restoration measures may result in artificially high breeding density, for instance when nest-boxes saturate the environment, which can negatively impact species' demography. Potential risks include changes in mating and reproductive behaviour such as increased extra-pair paternity, conspecific brood parasitism, and polygyny. Under particular cicumstances, these mechanisms may disrupt reproduction, with populations dragged into an extinction vortex. With the use of nuclear microsatellite markers, we investigated the occurrence of these potentially negative effects in a recovered population of a rare secondary cavity-nesting farmland bird of Central Europe, the hoopoe (Upupa epops). High intensity farming in the study area has resulted in a total eradication of cavity trees, depriving hoopoes from breeding sites. An intensive nest-box campaign rectified this problem, resulting in a spectacular population recovery within a few years only. There was some concern, however, that the new, high artificially-induced breeding density might alter hoopoe mating and reproductive behaviour. As the species underwent a serious demographic bottleneck in the 1970-1990s, we also used the microsatellite markers to reconstitute the demo-genetic history of the population, looking in particular for signs of genetic erosion. We found i) a low occurrence of extra-pair paternity, polygyny and conspecific brood parasitism, ii) a high level of neutral genetic diversity (mean number of alleles and expected heterozygosity per locus: 13.8 and 83%, respectively) and, iii) evidence for genetic connectivity through recent immigration of individuals from well differentiated populations. The recent increase in breeding density did thus not induce so far any noticeable detrimental changes in mating and reproductive behaviour. The demographic bottleneck undergone by the population in the 1970s-1990s was furthermore not accompanied by any significant drop in neutral genetic diversity. Finally, genetic data converged with a concomitant demographic study to evidence that immigration strongly contributed to local population recovery.	[Berthier, Karine; Leippert, Fabio; Arlettaz, Raphael] Univ Bern, Conservat Biol Div, Inst Ecol & Evolut, Bern, Switzerland; [Arlettaz, Raphael] Swiss Ornithol Inst, Valais Field Stn, Nat Ctr, Salgesch, Switzerland; [Fumagalli, Luca] Univ Lausanne, Dept Ecol & Evolut, Lab Conservat Biol, Lausanne, Switzerland; [Berthier, Karine] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Bern; Swiss Ornithological Institute; University of Lausanne; University of Sydney	Berthier, K (corresponding author), Univ Bern, Conservat Biol Div, Inst Ecol & Evolut, Bern, Switzerland.	raphael.arlettaz@iee.unibe.ch	Arlettaz, Raphaël/O-2182-2016	Arlettaz, Raphaël/0000-0001-6360-5339; Fumagalli, Luca/0000-0002-6648-2570; Berthier, Karine/0000-0002-2260-7968				ANDERSSON M, 1982, AM NAT, V120, P1, DOI 10.1086/283965; Arlettaz R, 2010, BIOSCIENCE, V60, P835, DOI 10.1525/bio.2010.60.10.10; Arlettaz R, 2010, J ORNITHOL, V151, P889, DOI 10.1007/s10336-010-0527-7; Belkhir K, 2001, 5000 CNRS UMR U MONT; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cornuet JM, 1996, GENETICS, V144, P2001; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; de Valpine P, 2008, AM NAT, V172, P547, DOI 10.1086/590956; Dubois NS, 2006, P ROY SOC B-BIOL SCI, V273, P1751, DOI 10.1098/rspb.2006.3509; Dunham J, 1999, CONS ECOL, V3; Eadie J, 1998, BEHAVIORAL ECOLOGY AND CONSERVATION BIOLOGY, P306; EADIE JM, 1992, AM NAT, V140, P621, DOI 10.1086/285431; Estoup A, 2001, GENETICS, V159, P1671; Evans SR, 2008, CONSERV BIOL, V22, P1016, DOI 10.1111/j.1523-1739.2008.00972.x; Fournier J, 2001, IBIS, V143, P2, DOI 10.1111/j.1474-919X.2001.tb04163.x; GOWATY PA, 1991, ANIM BEHAV, V41, P661, DOI 10.1016/S0003-3472(05)80904-2; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; JOHNSON LS, 1991, CONDOR, V93, P784, DOI 10.2307/1368219; JOHNSON LS, 1993, ANIM BEHAV, V46, P1111, DOI 10.1006/anbe.1993.1301; JOHNSON LS, 1993, J ANIM ECOL, V62, P669, DOI 10.2307/5387; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Keller V, 2001, LISTE ROUGE OISEAUX; KETTERSON ED, 1994, ANNU REV ECOL SYST, V25, P601, DOI 10.1146/annurev.es.25.110194.003125; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Lyon BE, 2008, ANNU REV ECOL EVOL S, V39, P343, DOI 10.1146/annurev.ecolsys.39.110707.173354; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Martin-Vivaldi M, 2002, IBIS, V144, P236, DOI 10.1046/j.1474-919X.2002.00044.x; MARUYAMA T, 1985, GENETICS, V111, P675; MOLLER AP, 1989, BEHAV ECOL SOCIOBIOL, V25, P33, DOI 10.1007/BF00299708; NEI M, 1978, GENETICS, V89, P583; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pope LC, 2000, MOL ECOL, V9, P2041, DOI 10.1046/j.1365-294X.2000.01110.x; Power HW, 1998, OX ORN SER, V9, P376; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reichlin TS, 2009, J ORNITHOL, V150, P393, DOI 10.1007/s10336-008-0361-3; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schaub M, 2012, OECOLOGIA, V168, P97, DOI 10.1007/s00442-011-2070-5; SEMEL B, 1988, CONDOR, V90, P920, DOI 10.2307/1368849; Semel B, 2001, ANIM BEHAV, V61, P787, DOI 10.1006/anbe.2000.1657; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; Stewart SLM, 2010, BEHAV ECOL SOCIOBIOL, V64, P463, DOI 10.1007/s00265-009-0862-y; Sunnucks P, 2011, EMU, V111, P19, DOI 10.1071/MU10008; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439; Westneat DF, 1997, BEHAV ECOL SOCIOBIOL, V41, P205, DOI 10.1007/s002650050381	49	26	29	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e36028	10.1371/journal.pone.0036028	http://dx.doi.org/10.1371/journal.pone.0036028			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545155	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343200075
J	Canovas, A; Pena, RN; Gallardo, D; Ramirez, O; Amills, M; Quintanilla, R				Canovas, Angela; Pena, Ramona N.; Gallardo, David; Ramirez, Oscar; Amills, Marcel; Quintanilla, Raquel			Segregation of Regulatory Polymorphisms with Effects on the Gluteus Medius Transcriptome in a Purebred Pig Population	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; INTRAMUSCULAR FAT-CONTENT; GENE-EXPRESSION; ARCHITECTURE; SERUM; LDL	Background: The main goal of the present study was to analyse the genetic architecture of mRNA expression in muscle, a tissue with an outmost economic importance for pig breeders. Previous studies have used F-2 crosses to detect porcine expression QTL (eQTL), so they contributed with data that mostly represents the between-breed component of eQTL variation. Herewith, we have analysed eQTL segregation in an outbred Duroc population using two groups of animals with divergent fatness profiles. This approach is particularly suitable to analyse the within-breed component of eQTL variation, with a special emphasis on loci involved in lipid metabolism. Methodology/Principal Findings: GeneChip Porcine Genome arrays (Affymetrix) were used to determine the mRNA expression levels of gluteus medius samples from 105 Duroc barrows. A whole-genome eQTL scan was carried out with a panel of 116 microsatellites. Results allowed us to detect 613 genome-wide significant eQTL unevenly distributed across the pig genome. A clear predominance of trans-over cis-eQTL, was observed. Moreover, 11 trans-regulatory hotspots affecting the expression levels of four to 16 genes were identified. A Gene Ontology study showed that regulatory polymorphisms affected the expression of muscle development and lipid metabolism genes. A number of positional concordances between eQTL and lipid trait QTL were also found, whereas limited evidence of a linear relationship between muscle fat deposition and mRNA levels of eQTL regulated genes was obtained. Conclusions/Significance: Our data provide substantial evidence that there is a remarkable amount of within-breed genetic variation affecting muscle mRNA expression. Most of this variation acts in trans and influences biological processes related with muscle development, lipid deposition and energy balance. The identification of the underlying causal mutations and the ascertainment of their effects on phenotypes would allow gaining a fundamental perspective about how complex traits are built at the molecular level.	[Canovas, Angela; Pena, Ramona N.; Quintanilla, Raquel] IRTA, Lleida, Spain; [Gallardo, David; Ramirez, Oscar] Univ Autonoma Barcelona, Fac Vet, Dept Ciencia Anim & Aliments, E-08193 Barcelona, Spain; [Amills, Marcel] Univ Autonoma Barcelona, Dept Genet Anim, Ctr Recerca Agrigen CRAG, E-08193 Barcelona, Spain	IRTA; Autonomous University of Barcelona; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG)	Canovas, A (corresponding author), IRTA, Lleida, Spain.	romi.pena@prodan.udl.cat; Raquel.Quintanilla@irta.cat	Pena, Romi/C-7756-2011; Amills, Marcel/D-4908-2019; Quintanilla, Raquel/I-8997-2012; Ramirez, Oscar/E-7293-2012; Amills, Marcel/C-7156-2008; Cánovas, Angela/AAG-6282-2020	Pena, Romi/0000-0002-3558-7302; Amills, Marcel/0000-0002-8999-0770; Quintanilla, Raquel/0000-0003-3274-3434; Ramirez, Oscar/0000-0001-5164-6790; 	Spanish Ministry of Science [GEN2003-20658-C05-05, AGL2007-66707-C02-01, AGL2010-22208-C02-01]; INIA (Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria)	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); INIA (Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria)(Instituto de Investigacion Agropecuaria (INIA))	This project has been funded by the Spanish Ministry of Science (projects GEN2003-20658-C05-05, AGL2007-66707-C02-01 and AGL2010-22208-C02-01). AC received a predoctoral scholarship from INIA (Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balistreri CR, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/802078; Canovas A, 2009, J ANIM SCI, V87, P3905, DOI 10.2527/jas.2009-2091; Casellas J, 2010, J ANIM SCI, V88, P2246, DOI 10.2527/jas.2009-2205; Cheung VG, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000480; Cheung VG, 2009, NAT REV GENET, V10, P595, DOI 10.1038/nrg2630; Christodoulides C, 2006, J CELL SCI, V119, P2613, DOI 10.1242/jcs.02975; de Koning DJ, 1999, GENETICS, V152, P1679; de Koning DJ, 2003, J ANIM SCI, V81, P2155; Duan S, 2008, AM J HUM GENET, V82, P1101, DOI 10.1016/j.ajhg.2008.03.006; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Gallardo D, 2009, ANIM GENET, V40, P410, DOI 10.1111/j.1365-2052.2009.01854.x; Gallardo D, 2012, ANIM GENET IN PRESS; Gallardo D, 2008, PHYSIOL GENOMICS, V35, P199, DOI 10.1152/physiolgenomics.90249.2008; Georges M, 2007, ANNU REV GENOM HUM G, V8, P131, DOI 10.1146/annurev.genom.8.080706.092408; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Gomez-Abellan P, 2008, INT J OBESITY, V32, P121, DOI 10.1038/sj.ijo.0803689; Hu ZL, 2007, NUCLEIC ACIDS RES, V35, pD604, DOI 10.1093/nar/gkl946; Hu ZL, 2007, MAMM GENOME, V18, P1, DOI 10.1007/s00335-006-0105-8; Huang Chin-Chang, 2009, Acta Neurol Taiwan, V18, P287; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Liaubet L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-548; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Morris DL, 2011, CURR OPIN CLIN NUTR, V14, P341, DOI 10.1097/MCO.0b013e328347970b; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Nagamine Y, 2003, GENETICS, V164, P629; Ponsuksili S, 2011, J LIPID RES, V52, P668, DOI 10.1194/jlr.M013342; Ponsuksili S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-367; Quintanilla R, 2011, J ANIM SCI, V89, P2963, DOI 10.2527/jas.2011-3974; Sato S, 2006, ANIM GENET, V37, P113, DOI 10.1111/j.1365-2052.2005.01397.x; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Seaton G, 2006, P 8 WCGALP, V27, P633; Steibel JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016766; Tomaszewski M, 2009, ARTERIOSCL THROM VAS, V29, P1316, DOI 10.1161/ATVBAHA.109.185355; Wimmers K, 2010, BRIEF FUNCT GENOMICS, V9, P251, DOI 10.1093/bfgp/elq003; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Xu XJ, 2008, BIOINFORMATICS, V24, P137, DOI 10.1093/bioinformatics/btm541; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222; Zhang W, 2008, AM J HUM GENET, V82, P631, DOI 10.1016/j.ajhg.2007.12.015	40	20	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35583	10.1371/journal.pone.0035583	http://dx.doi.org/10.1371/journal.pone.0035583			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545120	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343200040
J	Deneke, C; Rudorf, S; Valleriani, A				Deneke, Carlus; Rudorf, Sophia; Valleriani, Angelo			Transient Phenomena in Gene Expression after Induction of Transcription	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; MESSENGER-RNA; ESCHERICHIA-COLI; TRANSLATION; REVEALS; CELLS	When transcription of a gene is induced by a stimulus, the number of its mRNA molecules changes with time. Here we discuss how this time evolution depends on the shape of the mRNA lifetime distribution. Analysis of the statistical properties of this change reveals transient effects on polysomes, ribosomal profiles, and rate of protein synthesis. Our studies reveal that transient phenomena in gene expression strongly depend on the specific form of the mRNA lifetime distribution.	[Deneke, Carlus; Rudorf, Sophia; Valleriani, Angelo] Max Planck Inst Colloids & Interfaces, Dept Theory & Biosyst, Potsdam, Germany	Max Planck Society	Deneke, C (corresponding author), Max Planck Inst Colloids & Interfaces, Dept Theory & Biosyst, Potsdam, Germany.	angelo.valleriani@mpikg.mpg.de		Rudorf, Sophia/0000-0001-7653-3733; Deneke, Carlus/0000-0002-2509-4950; Valleriani, Angelo/0000-0001-6591-5824				Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Belasco JG, 2010, NAT REV MOL CELL BIO, V11, P467, DOI 10.1038/nrm2917; BERG OG, 1978, J THEOR BIOL, V71, P587, DOI 10.1016/0022-5193(78)90326-0; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Brandt F, 2009, CELL, V136, P261, DOI 10.1016/j.cell.2008.11.016; Cox D., 1962, RENEWAL THEORY; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; IOST I, 1995, EMBO J, V14, P3252, DOI 10.1002/j.1460-2075.1995.tb07328.x; JACQUES N, 1990, MOL MICROBIOL, V4, P1063, DOI 10.1111/j.1365-2958.1990.tb00679.x; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; Lewis PJ, 2000, EMBO J, V19, P710, DOI 10.1093/emboj/19.4.710; Liang ST, 2000, J BACTERIOL, V182, P3037, DOI 10.1128/JB.182.11.3037-3044.2000; Mitarai N, 2008, J MOL BIOL, V382, P236, DOI 10.1016/j.jmb.2008.06.068; Nagar A, 2011, J STAT PHYS, V145, P1385, DOI 10.1007/s10955-011-0347-z; Nevo-Dinur K, 2011, SCIENCE, V331, P1081, DOI 10.1126/science.1195691; Rading MM, 2011, J STAT PHYS, V145, P1, DOI 10.1007/s10955-011-0305-9; Selinger DW, 2003, GENOME RES, V13, P216, DOI 10.1101/gr.912603; Steglich C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r54; TAYLOR H., 1998, INTRO STOCHASTIC MOD; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Valleriani A, 2010, EPL, P89; Valleriani A, 2011, PHYS REV E, V83; ZHANG G, 2009, PLOS ONE, V4, pNIL33; Zhang G, 2010, NUCLEIC ACIDS RES, V38, P4778, DOI 10.1093/nar/gkq196	27	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35044	10.1371/journal.pone.0035044	http://dx.doi.org/10.1371/journal.pone.0035044			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22558114	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341000018
J	Johannesen, E; Hoines, AS; Dolgov, AV; Fossheim, M				Johannesen, Edda; Hoines, Age S.; Dolgov, Andrey V.; Fossheim, Maria			Demersal Fish Assemblages and Spatial Diversity Patterns in the Arctic-Atlantic Transition Zone in the Barents Sea	PLOS ONE			English	Article							SPECIES-RICHNESS; BIODIVERSITY; RANGE; SCALE; SIZE; CATCHABILITY; GRADIENTS; COMMUNITY; TRAWL	Direct and indirect effects of global warming are expected to be pronounced and fast in the Arctic, impacting terrestrial, freshwater and marine ecosystems. The Barents Sea is a high latitude shelf Sea and a boundary area between arctic and boreal faunas. These faunas are likely to respond differently to changes in climate. In addition, the Barents Sea is highly impacted by fisheries and other human activities. This strong human presence places great demands on scientific investigation and advisory capacity. In order to identify basic community structures against which future climate related or other human induced changes could be evaluated, we analyzed species composition and diversity of demersal fish in the Barents Sea. We found six main assemblages that were separated along depth and temperature gradients. There are indications that climate driven changes have already taken place, since boreal species were found in large parts of the Barents Sea shelf, including also the northern Arctic area. When modelling diversity as a function of depth and temperature, we found that two of the assemblages in the eastern Barents Sea showed lower diversity than expected from their depth and temperature. This is probably caused by low habitat complexity and the distance to the pool of boreal species in the western Barents Sea. In contrast coastal assemblages in south western Barents Sea and along Novaya Zemlya archipelago in the Eastern Barents Sea can be described as diversity "hotspots"; the South-western area had high density of species, abundance and biomass, and here some species have their northern distribution limit, whereas the Novaya Zemlya area has unique fauna of Arctic, coastal demersal fish. (see Information S1 for abstract in Russian).	[Johannesen, Edda] Inst Marine Res, Ecosyst Proc Res Grp, N-5024 Bergen, Norway; [Hoines, Age S.] Inst Marine Res, Pelag Fish Res Grp, N-5024 Bergen, Norway; [Dolgov, Andrey V.] Polar Res Inst Marine Fisheries & Oceanog, Lab Trophol, Murmansk, Russia; [Fossheim, Maria] Inst Marine Res, Ecosyst Proc Res Grp, Tromso, Norway	Institute of Marine Research - Norway; Institute of Marine Research - Norway; Research lnstitute of Fisheries & Oceanography; Institute of Marine Research - Norway	Johannesen, E (corresponding author), Inst Marine Res, Ecosyst Proc Res Grp, POB 1870, N-5024 Bergen, Norway.	eddaj@imr.no	Fossheim, Maria/B-7134-2014; Dolgov, Andrey/D-3708-2012	Dolgov, Andrey/0000-0002-4806-3284	Russian Federation; government in Russian; government in Norway; Norwegian Research Council (NRC) [200793/S30]	Russian Federation(Russian Federation); government in Russian; government in Norway; Norwegian Research Council (NRC)(Research Council of Norway)	The data collecting took place on a joint survey supported by governmental funding from the Russian Federation and Norway. The scientific work and cooperation was also funded by the governments in Russian and Norway, part of this through a project funded by the Norwegian Research Council (NRC contract number 200793/S30). No further external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriashev A.P., 1995, VOP IKHTIOL, V35, P81; Andriyashev A. P., 1954, FISHES NO SEAS USSR; [Anonymous], 2009, IMR PINRO JOINT REPO; Arctic Climate Impact Assessment (ACIA), ARCT CLIM IMP ASS AC; Berg LS, 1939, P DED SCI ACT NM KNI, P207; BERGSTAD OA, 1987, FISH RES, V5, P119, DOI 10.1016/0165-7836(87)90037-3; Bergstad OA, 2002, ENCY OCEAN SCI, P710; Burgos GE, 1989, THESIS U BERGEN; Byrkjedal I, 2007, POLAR RES, V26, P135, DOI 10.1111/J.1751-8369.2007.00030.x; Carrara R, 2010, ECOGRAPHY, V33, P942, DOI 10.1111/j.1600-0587.2009.05756.x; Chernova NV, 1994, ENV ECOSYSTEMS F JOS, P177; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Clifford H.T., 1975, INTRO NUMERICAL CLAS; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; Danovaro R, 2008, ECOGRAPHY, V31, P231, DOI 10.1111/j.0906-7590.2008.5484.x; Dinter WP., 2001, BIOGEOGRAPHY OSPAR M; Dolgov, 2006, J ICHTHYOL+, V46, P139, DOI [10.1134/S0032945206020019, DOI 10.1134/S0032945206020019]; Dolgov A., 2004, INVESTIGATIONS PINRO, P230; Dolgov AV, 2010, 2009E ICES CM; Dolgov AV, 2011, BARENTS SEA ECOSYSTE, P193; Dulvy NK, 2004, FISH FISH, V5, P255, DOI 10.1111/j.1467-2679.2004.00158.x; Ehrich S, 2009, FISH OCEANOGR, V18, P36, DOI 10.1111/j.1365-2419.2008.00495.x; EKMAN S, 1967, ZOOGEOGRAPHY SEA; Ellis JR, 2000, ESTUAR COAST SHELF S, V51, P299, DOI 10.1006/ecss.2000.0677; ENGAS A, 1989, J CONSEIL, V45, P269; Essipov V. K., 1952, FISHES KARA SEA; Evans KL, 2005, BIOL REV, V80, P1, DOI 10.1017/S1464793104006517; FIELD JG, 1982, MAR ECOL PROG SER, V8, P37, DOI 10.3354/meps008037; Fisher JAD, 2010, ECOLOGY, V91, P2499, DOI 10.1890/09-1914.1; Fossheim A, 2006, MAR BIOL RES, V2, P260, DOI 10.1080/17451000600815698; Fraser HM, 2007, ICES J MAR SCI, V64, P1800, DOI 10.1093/icesjms/fsm145; Gabriel Wendy L., 1992, Journal of Northwest Atlantic Fishery Science, V14, P29; GAUCH HG, 1981, J ECOL, V69, P537, DOI 10.2307/2259682; Gorley C.K., 2006, GETTING STARTED PRIM; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Gratwicke B, 2005, J FISH BIOL, V66, P650, DOI 10.1111/j.0022-1112.2005.00629.x; Greenstreet SPR, 2008, ICES J MAR SCI, V65, P1515, DOI 10.1093/icesjms/fsn102; Harley SJ, 2001, CAN J FISH AQUAT SCI, V58, P1569, DOI 10.1139/cjfas-58-8-1569; Hillebrand H, 2004, MAR ECOL PROG SER, V273, P251, DOI 10.3354/meps273251; Hjermann DO, 2007, MAR ECOL PROG SER, V339, P283, DOI 10.3354/meps339283; Hopkins CC, 1990, POLAR RES, V10, P12; Jakobsen T., 2011, BARENTS SEA ECOSYSTE; Jennings S, 1999, J ANIM ECOL, V68, P617, DOI 10.1046/j.1365-2656.1999.00312.x; Johannesen E, 2012, ICES J MAR SCI, V69, P880, DOI 10.1093/icesjms/fss046; Karamushko OV, 2008, J ICHTHYOL, V48, P293; Karamushko OV, 2003, J ICHTHYOL+, V43, P464; Kendall VJ, 2006, DEEP-SEA RES PT I, V53, P506, DOI 10.1016/j.dsr.2005.12.005; Knijn RJ, 1993, 194 ICES COOP, P268; Levitus S, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039847; LOENG H, 1991, POLAR RES, V10, P5, DOI 10.1111/j.1751-8369.1991.tb00630.x; Macpherson E, 2002, P ROY SOC B-BIOL SCI, V269, P1715, DOI 10.1098/rspb.2002.2091; MACPHERSON E, 1994, ECOGRAPHY, V17, P242, DOI 10.1111/j.1600-0587.1994.tb00099.x; Magurran AE, 2010, TRENDS ECOL EVOL, V25, P574, DOI 10.1016/j.tree.2010.06.016; Mecklenburg Catherine W., 2011, Marine Biodiversity, V41, P109, DOI 10.1007/s12526-010-0070-z; Narayanaswamy BE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014295; Norcross BL, 2010, DEEP-SEA RES PT II, V57, P57, DOI 10.1016/j.dsr2.2009.08.006; Ojaveer H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012467; Oksanen J., MULTIVARIATE ANAL EC; Pinnegar J, 2010, CHARTING PROGR, P378; Reiss H, 2010, ICES J MAR SCI, V67, P278, DOI 10.1093/icesjms/fsp253; Rice J, 1996, ICES J MAR SCI, V53, P1214, DOI 10.1006/jmsc.1996.0146; Smirnov OV, 2000, P FIN SESS PINRO SCI, P79; Smith JM, 2012, ECOL INDIC, V13, P253, DOI 10.1016/j.ecolind.2011.06.009; Smith KF, 2002, GLOBAL ECOL BIOGEOGR, V11, P313, DOI 10.1046/j.1466-822X.2002.00286.x; Sousa P, 2005, FISH RES, V75, P120, DOI 10.1016/j.fishres.2005.03.012; Stefansdottir L, 2010, FISH OCEANOGR, V19, P42, DOI 10.1111/j.1365-2419.2009.00527.x; Thrush SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011899; Wienerroither R, 2011, IMR PINRO JOINT REPO, V1-2011; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zenkevich L.A, 1963, BIOL SEAS USSR	71	44	48	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2012	7	4							e34924	10.1371/journal.pone.0034924	http://dx.doi.org/10.1371/journal.pone.0034924			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WC	22545093	Green Published, Green Submitted, gold			2022-12-27	WOS:000305347400025
J	Shen, DW; Alain, C				Shen, Dawei; Alain, Claude			Implicit Temporal Expectation Attenuates Auditory Attentional Blink	PLOS ONE			English	Article							ELECTROPHYSIOLOGICAL EVIDENCE; SELECTIVE-ATTENTION; P300; TASK; PROBABILITY; SUPPRESSION; ALLOCATION; INTERVAL; SURPRISE; MASKING	Attentional blink (AB) describes a phenomenon whereby correct identification of a first target impairs the processing of a second target (i.e., probe) nearby in time. Evidence suggests that explicit attention orienting in the time domain can attenuate the AB. Here, we used scalp-recorded, event-related potentials to examine whether auditory AB is also sensitive to implicit temporal attention orienting. Expectations were set up implicitly by varying the probability (i.e., 80% or 20%) that the probe would occur at the +2 or +8 position following target presentation. Participants showed a significant AB, which was reduced with the increased probe probability at the +2 position. The probe probability effect was paralleled by an increase in P3b amplitude elicited by the probe. The results suggest that implicit temporal attention orienting can facilitate short-term consolidation of the probe and attenuate auditory AB.	[Shen, Dawei; Alain, Claude] Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada; [Alain, Claude] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Alain, Claude] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; University of Toronto	Shen, DW (corresponding author), Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada.	dshen@rotman-baycrest.on.ca			Canadian Institutes of Health Research [737103912]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research, 737103912 [http://www.cihr-irsc.gc.ca/e/193.html]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAIN C, 1994, PERCEPT PSYCHOPHYS, V56, P501, DOI 10.3758/BF03206947; Alain C, 2000, FRONT BIOSCI-LANDMRK, V5, pD202, DOI 10.2741/Alain; ALHO K, 1986, PSYCHOPHYSIOLOGY, V23, P189, DOI 10.1111/j.1469-8986.1986.tb00617.x; Arnell KM, 2006, PERCEPT PSYCHOPHYS, V68, P447, DOI 10.3758/BF03193689; BROADBENT DE, 1987, PERCEPT PSYCHOPHYS, V42, P105, DOI 10.3758/BF03210498; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Dell'Acqua R, 2003, PSYCHOPHYSIOLOGY, V40, P629, DOI 10.1111/1469-8986.00064; Doherty JR, 2005, J NEUROSCI, V25, P8259, DOI 10.1523/JNEUROSCI.1821-05.2005; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; Du F, 2010, EXP BRAIN RES, V205, P115, DOI 10.1007/s00221-010-2345-9; DUNCANJOHNSON CC, 1977, PSYCHOPHYSIOLOGY, V14, P456, DOI 10.1111/j.1469-8986.1977.tb01312.x; Ecker UKH, 2010, J EXP PSYCHOL LEARN, V36, P170, DOI 10.1037/a0017891; Geng JJ, 2005, PERCEPT PSYCHOPHYS, V67, P1252, DOI 10.3758/BF03193557; Giesbrecht B, 1998, J EXP PSYCHOL HUMAN, V24, P1454, DOI 10.1037/0096-1523.24.5.1454; Gonsalvez CJ, 2002, PSYCHOPHYSIOLOGY, V39, P388, DOI 10.1017/S0048577201393137; HILLYARD SA, 1973, SCIENCE, V182, P177, DOI 10.1126/science.182.4108.177; JOHNSON R, 1980, PSYCHOPHYSIOLOGY, V17, P167, DOI 10.1111/j.1469-8986.1980.tb00131.x; JOHNSON R, 1986, PSYCHOPHYSIOLOGY, V23, P367, DOI 10.1111/j.1469-8986.1986.tb00649.x; Jolicoeur P, 1998, COGNITIVE PSYCHOL, V36, P138, DOI 10.1006/cogp.1998.0684; Kahneman D., 1973, ATTENTION EFFORT; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; KRAMER A, 1986, PSYCHOPHYSIOLOGY, V23, P33, DOI 10.1111/j.1469-8986.1986.tb00590.x; Kranczioch C, 2003, COGNITIVE BRAIN RES, V17, P177, DOI 10.1016/S0926-6410(03)00092-2; Los SA, 2005, J EXP PSYCHOL GEN, V134, P52, DOI 10.1037/0096-3445.134.1.52; Martens S, 2005, MEM COGNITION, V33, P234, DOI 10.3758/BF03195312; Miniussi C, 1999, BRAIN, V122, P1507, DOI 10.1093/brain/122.8.1507; Muller-Gethmann H, 2003, PSYCHOPHYSIOLOGY, V40, P597, DOI 10.1111/1469-8986.00061; Nieuwenstein MR, 2005, J EXP PSYCHOL HUMAN, V31, P1463, DOI 10.1037/0096-1523.31.6.1463; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; Picton TW, 2000, CLIN NEUROPHYSIOL, V111, P53, DOI 10.1016/S1388-2457(99)00227-8; POLICH J, 1987, ELECTROEN CLIN NEURO, V68, P311, DOI 10.1016/0168-5597(87)90052-9; Ptito A, 2008, PSYCHOPHYSIOLOGY, V45, P794, DOI 10.1111/j.1469-8986.2008.00677.x; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Rimmele J, 2011, J COGNITIVE NEUROSCI, V23, P1136, DOI 10.1162/jocn.2010.21437; Rohenkohl G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014620; RUCHKIN DS, 1987, PSYCHOPHYSIOLOGY, V24, P87, DOI 10.1111/j.1469-8986.1987.tb01867.x; Seiffert AE, 1997, J EXP PSYCHOL HUMAN, V23, P1061, DOI 10.1037/0096-1523.23.4.1061; SHAW ML, 1978, J EXP PSYCHOL HUMAN, V4, P586, DOI 10.1037/0096-1523.4.4.586; SHAW ML, 1977, J EXP PSYCHOL HUMAN, V3, P201, DOI 10.1037/0096-1523.3.2.201; Shen DW, 2006, PERCEPT PSYCHOPHYS, V68, P228, DOI 10.3758/BF03193672; Shen D, 2011, EXP BRAIN RES, V215, P285, DOI 10.1007/s00221-011-2897-3; Shen DW, 2010, PSYCHOPHYSIOLOGY, V47, P184, DOI 10.1111/j.1469-8986.2009.00924.x; Shen DW, 2008, PERCEPT PSYCHOPHYS, V70, P896, DOI 10.3758/PP.70.5.896; SQUIRES KC, 1976, SCIENCE, V193, P1142, DOI 10.1126/science.959831; Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656; Vogel EK, 2002, PSYCHON B REV, V9, P739, DOI 10.3758/BF03196329; Zhang DX, 2008, EXP BRAIN RES, V185, P287, DOI 10.1007/s00221-007-1153-3	47	22	22	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36031	10.1371/journal.pone.0036031	http://dx.doi.org/10.1371/journal.pone.0036031			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TJ	22558312	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000103
J	Singer, F; Houltz, B; Latzin, P; Robinson, P; Gustafsson, P				Singer, Florian; Houltz, Birgitta; Latzin, Philipp; Robinson, Paul; Gustafsson, Per			A Realistic Validation Study of a New Nitrogen Multiple-Breath Washout System	PLOS ONE			English	Article							FUNCTIONAL RESIDUAL CAPACITY; ULTRASONIC FLOW METER; LUNG CLEARANCE INDEX; VENTILATION INHOMOGENEITY; IN-VITRO; RESPONSE-TIME; CHILDREN; DISEASE; VOLUME; FLOWMETER	Background: For reliable assessment of ventilation inhomogeneity, multiple-breath washout (MBW) systems should be realistically validated. We describe a new lung model for in vitro validation under physiological conditions and the assessment of a new nitrogen (N-2) MBW system. Methods: The N2MBW setup indirectly measures the N2 fraction (FN2) from main-stream carbon dioxide (CO2) and side-stream oxygen (O-2) signals: F-N2 = 1-F-O2-F-CO2-F-Argon. For in vitro N2MBW, a double chamber plastic lung model was filled with water, heated to 37 degrees C, and ventilated at various lung volumes, respiratory rates, and F-CO2. In vivo N2MBW was undertaken in triplets on two occasions in 30 healthy adults. Primary N2MBW outcome was functional residual capacity (FRC). We assessed in vitro error (root[difference](2)) between measured and model FRC (100-4174 mL), and error between tests of in vivo FRC, lung clearance index (LCI), and normalized phase III slope indices (S-acin and S-cond). Results: The model generated 145 FRCs under BTPS conditions and various breathing patterns. Mean (SD) error was 2.3 (1.7)%. In 500 to 4174 mL FRCs, 121 (98%) of FRCs were within 5%. In 100 to 400 mL FRCs, the error was better than 7%. In vivo FRC error between tests was 10.1 (8.2)%. LCI was the most reproducible ventilation inhomogeneity index. Conclusion: The lung model generates lung volumes under the conditions encountered during clinical MBW testing and enables realistic validation of MBW systems. The new N2MBW system reliably measures lung volumes and delivers reproducible LCI values.	[Singer, Florian; Latzin, Philipp] Univ Childrens Hosp Bern, Dept Paediat, Div Resp Med, Bern, Switzerland; [Houltz, Birgitta] Sahlgrens Univ Hosp, East Hosp, Dept Clin Physiol, Gothenburg, Sweden; [Robinson, Paul] Childrens Hosp Westmead, Dept Paediat, Sydney, NSW, Australia; [Gustafsson, Per] Cent Hosp, Dept Paediat, Skoevde, Sweden	University of Bern; University Hospital of Bern; Sahlgrenska University Hospital; University of Sydney	Singer, F (corresponding author), Univ Childrens Hosp Bern, Dept Paediat, Div Resp Med, Bern, Switzerland.	florian.singer@insel.ch	Robinson, Paul D/AAT-8318-2020; Singer, Florian/AAO-1460-2021; Singer, Florian/O-7651-2015; Latzin, Philipp/F-2206-2017	Singer, Florian/0000-0003-3471-5664; Singer, Florian/0000-0003-3471-5664; Robinson, Paul/0000-0001-7397-105X; Latzin, Philipp/0000-0002-5239-1571	European Union [270194]; Vastra Gotaland Region Research Council, Sweden; European Respiratory Society [81-2011]; Federal Department of Economic Affairs Switzerland; Commission for Technology and Innovation (CTI); Innovation Promotion Agency [11661.1]	European Union(European Commission); Vastra Gotaland Region Research Council, Sweden; European Respiratory Society; Federal Department of Economic Affairs Switzerland; Commission for Technology and Innovation (CTI); Innovation Promotion Agency	This research project received funding from the European Union Seventh Framework Programme FP7/2007-2013 under grant agreement no 270194, as part of the Airway Disease PRedicting Outcomes through Patient Specific Computational Modelling (AirPROM) project (www.airprom.eu). It also received funding from the Vastra Gotaland Region Research Council, Sweden. The authors acknowledge the support of the European Respiratory Society, Fellowship STRTF fellowship no81-2011, and the Federal Department of Economic Affairs Switzerland, Commission for Technology and Innovation (CTI), Innovation Promotion Agency (http://www.bbt.admin.ch/kti/), unrestricted educational grant no. 11661.1 PFLS-LS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin R, 2011, EUR RESPIR J, V37, P806, DOI 10.1183/09031936.00072510; Amin R, 2010, THORAX, V65, P379, DOI 10.1136/thx.2009.125831; ARIELI R, 1981, J APPL PHYSIOL, V51, P1417, DOI 10.1152/jappl.1981.51.6.1417; Aurora P, 2011, AM J RESP CRIT CARE, V183, P752, DOI 10.1164/rccm.200911-1646OC; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BRUNNER JX, 1985, J APPL PHYSIOL, V59, P1008, DOI 10.1152/jappl.1985.59.3.1008; CRAWFORD ABH, 1989, J APPL PHYSIOL, V66, P2502, DOI 10.1152/jappl.1989.66.6.2502; Downie SR, 2007, THORAX, V62, P684, DOI 10.1136/thx.2006.069682; Farmery AD, 2000, J APPL PHYSIOL, V89, P581, DOI 10.1152/jappl.2000.89.2.581; Frey U, 2000, EUR RESPIR J, V16, P731, DOI 10.1034/j.1399-3003.2000.16d28.x; Fuchs SI, 2006, PEDIATR PULM, V41, P1218, DOI 10.1002/ppul.20524; Fuchs SI, 2009, PEDIATR PULM, V44, P1180, DOI 10.1002/ppul.21093; Green K, 2012, THORAX, V67, P49, DOI 10.1136/thoraxjnl-2011-200726; Gustafsson PM, 2003, EUR RESPIR J, V22, P972, DOI 10.1183/09031936.03.00049502; Hall GL, 2011, EUR RESPIR J, V37, P757, DOI 10.1183/09031936.00163310; Hall GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023932; HLASTALA MP, 1973, J APPL PHYSIOL, V34, P670, DOI 10.1152/jappl.1973.34.5.670; Horsley AR, 2008, THORAX, V63, P135, DOI 10.1136/thx.2007.082628; Kraemer R, 2005, AM J RESP CRIT CARE, V171, P371, DOI 10.1164/rccm.200407-948OC; Latzin P, 2007, PEDIATR PULM, V42, P888, DOI 10.1002/ppul.20674; LUNDIN G, 1953, Acta Physiol Scand Suppl, V111, P130; Pillow JJ, 2004, EUR RESPIR J, V23, P763, DOI 10.1183/09031936.04.00091504; Proquitte H, 2006, CRIT CARE MED, V34, P1789, DOI 10.1097/01.CCM.0000220065.93507.AB; Robinson PD, 2009, RESPIRATION, V78, P339, DOI 10.1159/000225373; Robinson PD, 2010, EUR RESPIR J, V36, ps843; Schibler A, 2004, INTENS CARE MED, V30, P127, DOI 10.1007/s00134-003-2028-0; Schibler A, 2001, PEDIATR RES, V49, P581, DOI 10.1203/00006450-200104000-00022; Schibler A, 2002, EUR RESPIR J, V20, P912, DOI 10.1183/09031936.02.00226002; Schmalisch G, 2001, EUR RESPIR J, V17, P100, DOI 10.1183/09031936.01.17101000; Singer F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017588; Stanojevic S, 2008, AM J RESP CRIT CARE, V177, P253, DOI 10.1164/rccm.200708-1248OC; Verbanck S, 1999, AM J RESP CRIT CARE, V159, P1545, DOI 10.1164/ajrccm.159.5.9809017; Verbanck S, 1998, AM J RESP CRIT CARE, V157, P1573, DOI 10.1164/ajrccm.157.5.9710042; Verbanck S, 1997, J APPL PHYSIOL, V83, P1907, DOI 10.1152/jappl.1997.83.6.1907; Verbanck S, 2012, J APPL PHYSIOL, V112, P782, DOI 10.1152/japplphysiol.01221.2011; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Wauer J, 2003, PHYSIOL MEAS, V24, P355, DOI 10.1088/0967-3334/24/2/311	37	89	90	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36083	10.1371/journal.pone.0036083	http://dx.doi.org/10.1371/journal.pone.0036083			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558338	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336000123
J	Arnold, T; Mealey, C; Leahey, H; Miller, AW; Hall-Spencer, JM; Milazzo, M; Maers, K				Arnold, Thomas; Mealey, Christopher; Leahey, Hannah; Miller, A. Whitman; Hall-Spencer, Jason M.; Milazzo, Marco; Maers, Kelly			Ocean Acidification and the Loss of Phenolic Substances in Marine Plants	PLOS ONE			English	Article							EELGRASS ZOSTERA-MARINA; CARBON-DIOXIDE; INORGANIC CARBON; WASTING DISEASE; CO2 ENRICHMENT; ELEVATED CO2; PROTEIN COMPETITION; CONDENSED TANNINS; CAFFEIC ACID; GROWTH	Rising atmospheric CO2 often triggers the production of plant phenolics, including many that serve as herbivore deterrents, digestion reducers, antimicrobials, or ultraviolet sunscreens. Such responses are predicted by popular models of plant defense, especially resource availability models which link carbon availability to phenolic biosynthesis. CO2 availability is also increasing in the oceans, where anthropogenic emissions cause ocean acidification, decreasing seawater pH and shifting the carbonate system towards further CO2 enrichment. Such conditions tend to increase seagrass productivity but may also increase rates of grazing on these marine plants. Here we show that high CO2 / low pH conditions of OA decrease, rather than increase, concentrations of phenolic protective substances in seagrasses and eurysaline marine plants. We observed a loss of simple and polymeric phenolics in the seagrass Cymodocea nodosa near a volcanic CO2 vent on the Island of Vulcano, Italy, where pH values decreased from 8.1 to 7.3 and pCO(2) concentrations increased ten-fold. We observed similar responses in two estuarine species, Ruppia maritima and Potamogeton perfoliatus, in in situ Free-Ocean-Carbon-Enrichment experiments conducted in tributaries of the Chesapeake Bay, USA. These responses are strikingly different than those exhibited by terrestrial plants. The loss of phenolic substances may explain the higher-than-usual rates of grazing observed near undersea CO2 vents and suggests that ocean acidification may alter coastal carbon fluxes by affecting rates of decomposition, grazing, and disease. Our observations temper recent predictions that seagrasses would necessarily be "winners" in a high CO2 world.	[Arnold, Thomas; Mealey, Christopher; Leahey, Hannah; Maers, Kelly] Dickinson Coll, Dept Biol Sci, Carlisle, PA 17013 USA; [Arnold, Thomas; Miller, A. Whitman] Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA; [Hall-Spencer, Jason M.] Univ Plymouth, Sch Marine Sci & Engn, Plymouth PL4 8AA, Devon, England; [Milazzo, Marco] Univ Palermo, Dipartimento Sci Terra & Mare, Palermo, Italy	Dickinson College; Smithsonian Institution; Smithsonian Environmental Research Center; University of Plymouth; University of Palermo	Arnold, T (corresponding author), Dickinson Coll, Dept Biol Sci, Carlisle, PA 17013 USA.	arnoldt@dickinson.edu	Milazzo, Marco/AAY-9990-2021; Milazzo, Marco/F-8596-2012; Hall-Spencer, Jason/AFN-7866-2022; Miller, Whitman/C-7811-2017	Milazzo, Marco/0000-0002-2202-0542; Hall-Spencer, Jason/0000-0002-6915-2518; Miller, Whitman/0000-0003-0484-182X	NASA [09-GCCE-0139]; Smithsonian Institution; EU [265103]; Dickinson College	NASA(National Aeronautics & Space Administration (NASA)); Smithsonian Institution(Smithsonian Institution); EU(European Commission); Dickinson College	This work was funded by an award from NASA (09-GCCE-0139), a senior postdoctoral fellowship award from the Smithsonian Institution to T. M. A., the EU 'Mediterranean Sea Acidification under a changing climate' project (MedSeA; grant agreement 265103), and Research and Development grants to T. M. A. from Dickinson College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Hady HH, 2007, EGYPTIAN J AQUATIC R, V33, P103; Alcoverro T, 1999, MAR ECOL PROG SER, V187, P121, DOI 10.3354/meps187121; Arnold T, 2004, NEW PHYTOL, V164, P157, DOI 10.1111/j.1469-8137.2004.01157.x; Arnold TA, 2008, AQUAT BOT, V89, P27, DOI 10.1016/j.aquabot.2008.02.001; Arnold TM, 2002, J CHEM ECOL, V28, P1919, DOI 10.1023/A:1020737609151; ARNOLD TM, 1995, MAR ECOL PROG SER, V123, P177, DOI 10.3354/meps123177; Barbehenn RV, 2011, PHYTOCHEMISTRY, V72, P1551, DOI 10.1016/j.phytochem.2011.01.040; BARBERI F, 1974, EARTH PLANET SC LETT, V21, P269, DOI 10.1016/0012-821X(74)90161-7; BAUBRON JC, 1990, NATURE, V344, P51, DOI 10.1038/344051a0; Bazzaz Fakhri A., 1997, P1, DOI 10.1016/B978-012083490-7/50002-5; BECCALUVA L, 1985, EARTH PLANET SC LETT, V74, P187, DOI 10.1016/0012-821X(85)90021-4; Beer S, 1996, MAR ECOL PROG SER, V141, P199, DOI 10.3354/meps141199; Beer S, 1997, AQUAT BOT, V56, P277, DOI 10.1016/S0304-3770(96)01109-6; Bennett RN, 1994, TANSLEY REV, P617; Bidart-Bouzat MG, 2008, J INTEGR PLANT BIOL, V50, P1339, DOI 10.1111/j.1744-7909.2008.00751.x; Bjork M, 1997, MAR BIOL, V129, P363, DOI 10.1007/s002270050176; Bortolus A, 1998, ESTUARIES, V21, P710, DOI 10.2307/1353275; BRYANT JP, 1983, OIKOS, V40, P357, DOI 10.2307/3544308; BUCHSBAUM RN, 1990, AQUAT BOT, V37, P291, DOI 10.1016/0304-3770(90)90075-V; Cai WJ, 1998, LIMNOL OCEANOGR, V43, P657, DOI 10.4319/lo.1998.43.4.0657; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Coley PD, 2002, OECOLOGIA, V133, P62, DOI 10.1007/s00442-002-1005-6; Cronin G, 2003, OECOLOGIA, V137, P32, DOI 10.1007/s00442-003-1315-3; Den Hartog C., 1996, SEAGRASS BIOL, P307; Den Hartog C, 2006, SEAGRASSES BIOL ECOL; Dickson A.G., 1994, HDB METHODS ANAL VAR; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dorenbosch M, 2011, FRESHWATER BIOL, V56, P1783, DOI 10.1111/j.1365-2427.2011.02618.x; ELKIN RG, 1991, J SCI FOOD AGR, V57, P543, DOI 10.1002/jsfa.2740570407; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; GIACCONE G, 1969, Giornale Botanico Italiano, V103, P353; Goecker ME, 2005, MAR ECOL PROG SER, V286, P239, DOI 10.3354/meps286239; Hagerman AE, 1986, PLANT FLAVONOIDS BIO, P67; HARRISON PG, 1982, MAR BIOL, V67, P225, DOI 10.1007/BF00401288; HARRISON PG, 1985, MAR BIOL, V90, P117, DOI 10.1007/BF00428222; HARRISON PG, 1980, MAR BIOL, V61, P21, DOI 10.1007/BF00410338; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Hughes AR, 2009, FRONT ECOL ENVIRON, V7, P242, DOI 10.1890/080041; Idestam-Almquist J, 1998, OIKOS, V81, P323, DOI 10.2307/3547052; Invers O, 2001, J EXP MAR BIOL ECOL, V265, P203, DOI 10.1016/S0022-0981(01)00332-X; Jiang ZJ, 2010, J INTEGR PLANT BIOL, V52, P904, DOI 10.1111/j.1744-7909.2010.00991.x; Jones CG, 1999, OIKOS, V86, P27, DOI 10.2307/3546567; Keller J, 1980, AEOLIAN ISLANDS ACTI, P29; Kerrison P, 2011, ESTUAR COAST SHELF S, P1; Lindroth RL, 2010, J CHEM ECOL, V36, P2, DOI 10.1007/s10886-009-9731-4; Martin S, 2008, BIOL LETTERS, V4, P689, DOI 10.1098/rsbl.2008.0412; Mattson WJ, 2005, OIKOS, V111, P337, DOI 10.1111/j.0030-1299.2005.13634.x; MCMILLAN C, 1984, AQUAT BOT, V20, P351, DOI 10.1016/0304-3770(84)90099-8; Meehan TD, 2010, SOIL BIOL BIOCHEM, V42, P1132, DOI 10.1016/j.soilbio.2010.03.019; Michot T.C., 1997, ITE Symposium, V30, P93; MICHOT TC, 1994, WETLANDS, V14, P276, DOI 10.1007/BF03160633; MUEHLSTEIN LK, 1992, CAN J BOT, V70, P2081, DOI 10.1139/b92-258; NICHOLSON RL, 1992, ANNU REV PHYTOPATHOL, V30, P369, DOI 10.1146/annurev.py.30.090192.002101; Palacios SL, 2007, MAR ECOL PROG SER, V344, P1, DOI 10.3354/meps07084; Penuelas J, 1997, PHOTOSYNTHETICA, V33, P313, DOI 10.1023/A:1022120431279; Penuelas J, 1998, TRENDS ECOL EVOL, V13, P20, DOI 10.1016/S0169-5347(97)01235-4; Prado P, 2011, MAR ECOL PROG SER, V429, P45, DOI 10.3354/meps09076; QUACKENBUSH RC, 1986, AQUAT BOT, V24, P83, DOI 10.1016/0304-3770(86)90119-1; RAVN H, 1989, BIOCHEM SYST ECOL, V17, P175, DOI 10.1016/0305-1978(89)90076-8; RAVN H, 1994, OPHELIA, V40, P51, DOI 10.1080/00785326.1994.10429550; Ross C, 2008, AQUAT BOT, V88, P134, DOI 10.1016/j.aquabot.2007.09.003; Royal Society, 2005, OC AC DUE INCR ATM C; Sedwick P, 1996, MAR CHEM, V53, P147, DOI 10.1016/0304-4203(96)00020-5; Stamp N, 2003, Q REV BIOL, V78, P23, DOI 10.1086/367580; Steele L, 2005, MAR ECOL PROG SER, V303, P123, DOI 10.3354/meps303123; Stiling P, 2007, GLOBAL CHANGE BIOL, V13, P1823, DOI 10.1111/j.1365-2486.2007.01392.x; Swain T., 1979, Herbivores: their interaction with secondary plant metabolites, P657; Tomas F, 2011, ECOLOGY, V92, P1807, DOI 10.1890/10-2095.1; Valentine JF, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P463; VALIELA I, 1979, NATURE, V280, P55, DOI 10.1038/280055a0; Valkama E, 2007, GLOBAL CHANGE BIOL, V13, P184, DOI 10.1111/j.1365-2486.2006.01284.x; VERGEER LHT, 1995, AQUAT BOT, V52, P35, DOI 10.1016/0304-3770(95)00480-N; Vergeer LHT, 1997, AQUAT BOT, V58, P65, DOI 10.1016/S0304-3770(96)01115-1; Verges A, 2008, OECOLOGIA, V155, P751, DOI 10.1007/s00442-007-0943-4; Verges A, 2007, MAR ECOL PROG SER, V343, P107, DOI 10.3354/meps06885; Vizzini S, 2010, J ECOL, V98, P1284, DOI 10.1111/j.1365-2745.2010.01730.x; Waldbusser GG, 2011, ESTUAR COAST, V34, P221, DOI 10.1007/s12237-010-9307-0; Yao WS, 1998, DEEP-SEA RES PT I, V45, P1383, DOI 10.1016/S0967-0637(98)00018-1	80	139	140	1	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35107	10.1371/journal.pone.0035107	http://dx.doi.org/10.1371/journal.pone.0035107			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558120	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345200025
J	Donners, MMPC; Wolfs, IMJ; Stoger, LJ; van der Vorst, EPC; Pottgens, CCH; Heymans, S; Schroen, B; Gijbels, MJJ; de Winther, MPJ				Donners, Marjo M. P. C.; Wolfs, Ine M. J.; Stoger, Lauran J.; van der Vorst, Emiel P. C.; Pottgens, Chantal C. H.; Heymans, Stephane; Schroen, Blanche; Gijbels, Marion J. J.; de Winther, Menno P. J.			Hematopoietic miR155 Deficiency Enhances Atherosclerosis and Decreases Plaque Stability in Hyperlipidemic Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; INFLAMMATORY RESPONSE; LIPID UPTAKE; MICRORNA-155; MACROPHAGES; INHIBITION; ACTIVATION; CYTOKINES; MIR-155	microRNA-155 (miR155) is a central regulator of immune responses that is induced by inflammatory mediators. Although miR155 is considered to be a pro-inflammatory microRNA, in vitro reports show anti-inflammatory effects in lipid-loaded cells. In this study we examined the role of miR155 in atherosclerosis in vivo using bone marrow transplantation from miR155 deficient or wildtype mice to hyperlipidemic mice. Hematopoietic deficiency of miR155 enhanced atherosclerotic plaque development and decreased plaque stability, as evidenced by increased myeloid inflammatory cell recruitment to the plaque. The increased inflammatory state was mirrored by a decrease in circulating CD4(+)CD25(+)FoxP3(+) regulatory T cells, and an increase in granulocytes (CD11b(+)Ly6G(+)) in blood of miR155(-/-) transplanted mice. Moreover, we show for the first time a crucial role of miR155 in monocyte subset differentiation, since hematopoietic deficiency of miR155 increases the 'inflammatory' monocyte subset (CD11b(+)Ly6G(-)Ly6C(hi)) and reduces 'resident' monocytes (CD11b(+)Ly6G(-)Ly6C(low)) in the circulation. Furthermore, cytokine production by resident peritoneal macrophages of miR155(-/-) transplanted hyperlipidemic mice was skewed towards a more pro-inflammatory state since anti-inflammatory IL-10 production was reduced. In conclusion, in this hyperlipidemic mouse model miR155 acts as an anti-inflammatory, atheroprotective microRNA. Additionally, besides a known role in lymphoid cell development, we show a crucial role of miR155 in myeloid lineage differentiation.	[Donners, Marjo M. P. C.; Wolfs, Ine M. J.; Stoger, Lauran J.; van der Vorst, Emiel P. C.; Pottgens, Chantal C. H.; Gijbels, Marion J. J.; de Winther, Menno P. J.] Maastricht Univ, Dept Mol Genet, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Gijbels, Marion J. J.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Pathol, Maastricht, Netherlands; [Heymans, Stephane; Schroen, Blanche] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Cardiol, Maastricht, Netherlands; [de Winther, Menno P. J.] Acad Med Ctr Amsterdam, Dept Med Biochem, Amsterdam, Netherlands	Maastricht University; Maastricht University; Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam	Donners, MMPC (corresponding author), Maastricht Univ, Dept Mol Genet, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands.	Marjo.donners@maastrichtuniversity.nl	Stöger, Lauran/AAE-9667-2021; Stoger, Lauran/AAX-5117-2021; de Winther, Menno/E-8721-2012	Stöger, Lauran/0000-0002-4705-4837; de Winther, Menno/0000-0002-4038-6636; Heymans, Stephane/0000-0001-9477-7803	Netherlands Heart Foundation (Dr. E. Dekker post-doctoral fellow grant) [2007T034]; Dr. E. Dekker Established Investigator grant [2007T067]; NWO-VIDI [917.066.329]; National Health Service (NHS) [2009B025]	Netherlands Heart Foundation (Dr. E. Dekker post-doctoral fellow grant); Dr. E. Dekker Established Investigator grant; NWO-VIDI(Netherlands Organization for Scientific Research (NWO)); National Health Service (NHS)	Dr. Donners and Dr. de Winther and Dr. Schroen are supported by the Netherlands Heart Foundation (Dr. E. Dekker post-doctoral fellow grant 2007T034 to Dr. Donners; Dr. E. Dekker Established Investigator grant 2007T067 and NWO-VIDI grant 917.066.329 to Dr. de Winther; and National Health Service (NHS) 2009B025 research grant to Dr. Schroen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Chen T, 2011, INT J CARDIOL, V147, P446, DOI 10.1016/j.ijcard.2010.10.133; Chen T, 2009, CARDIOVASC RES, V83, P131, DOI 10.1093/cvr/cvp121; Ding YZ, 2003, J IMMUNOL, V170, P1383, DOI 10.4049/jimmunol.170.3.1383; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Goossens P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022327; Goossens P, 2010, CELL METAB, V12, P142, DOI 10.1016/j.cmet.2010.06.008; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Huang RS, 2010, J INVEST MED, V58, P961, DOI 10.231/JIM.0b013e3181ff46d7; Kanters E, 2003, J CLIN INVEST, V112, P1176, DOI 10.1172/JCI18580; Kleemann R, 2008, CARDIOVASC RES, V79, P360, DOI 10.1093/cvr/cvn120; Kohlhaas S, 2009, J IMMUNOL, V182, P2578, DOI 10.4049/jimmunol.0803162; Kurowska-Stolarska M, 2011, P NATL ACAD SCI USA, V108, P11193, DOI 10.1073/pnas.1019536108; Li AC, 2004, J CLIN INVEST, V114, P1564, DOI 10.1172/JCI200418730; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Schroen B, 2011, CARDIOVASC RES; Tili E, 2009, INT REV IMMUNOL, V28, P264, DOI 10.1080/08830180903093796; Whyte CS, 2011, J LEUKOCYTE BIOL, V90, P845, DOI 10.1189/jlb.1110644; Wolfs IMJ, 2011, THROMB HAEMOSTASIS, V106, P763, DOI 10.1160/TH11-05-0320; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228	22	124	129	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35877	10.1371/journal.pone.0035877	http://dx.doi.org/10.1371/journal.pone.0035877			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558252	gold, Green Published, Green Submitted			2022-12-27	WOS:000305345200090
J	Duerr, AE; Miller, TA; Lanzone, M; Brandes, D; Cooper, J; O'Malley, K; Maisonneuve, C; Tremblay, J; Katzner, T				Duerr, Adam E.; Miller, Tricia A.; Lanzone, Michael; Brandes, Dave; Cooper, Jeff; O'Malley, Kieran; Maisonneuve, Charles; Tremblay, Junior; Katzner, Todd			Testing an Emerging Paradigm in Migration Ecology Shows Surprising Differences in Efficiency between Flight Modes	PLOS ONE			English	Article							FIELD OBSERVATIONS; SOUTHERN ISRAEL; SOARING FLIGHT; BIRD MORTALITY; WIND; SPEED; STRATEGIES; VULTURES; THERMALS; BEHAVIOR	To maximize fitness, flying animals should maximize flight speed while minimizing energetic expenditure. Soaring speeds of large-bodied birds are determined by flight routes and tradeoffs between minimizing time and energetic costs. Large raptors migrating in eastern North America predominantly glide between thermals that provide lift or soar along slopes or ridgelines using orographic lift (slope soaring). It is usually assumed that slope soaring is faster than thermal gliding because forward progress is constant compared to interrupted progress when birds pause to regain altitude in thermals. We tested this slope-soaring hypothesis using high-frequency GPS-GSM telemetry devices to track golden eagles during northbound migration. In contrast to expectations, flight speed was slower when slope soaring and eagles also were diverted from their migratory path, incurring possible energetic costs and reducing speed of progress towards a migratory endpoint. When gliding between thermals, eagles stayed on track and fast gliding speeds compensated for lack of progress during thermal soaring. When thermals were not available, eagles minimized migration time, not energy, by choosing energetically expensive slope soaring instead of waiting for thermals to develop. Sites suited to slope soaring include ridges preferred for wind-energy generation, thus avian risk of collision with wind turbines is associated with evolutionary trade-offs required to maximize fitness of time-minimizing migratory raptors.	[Duerr, Adam E.; Miller, Tricia A.; Katzner, Todd] W Virginia Univ, Div Forestry & Nat Resources, Morgantown, WV 26506 USA; [Miller, Tricia A.] Penn State Univ, Riparia, University Pk, PA 16802 USA; [Lanzone, Michael] Cellular Tracking Technol LLC, Somerset, PA USA; [Brandes, Dave] Lafayette Coll, Dept Civil & Environm Engn, Acopian Engn Ctr, Easton, PA 18042 USA; [Cooper, Jeff] Virginia Dept Game & Inland Fisheries, Fredericksburg, VA USA; [O'Malley, Kieran] W Virginia Div Nat Resources, Romney, WV USA; [Maisonneuve, Charles] Minist Ressources Nat & Faune, Rimouski, PQ, Canada; [Tremblay, Junior] Minist Ressources Nat & Faune, Quebec City, PQ, Canada; [Katzner, Todd] US Forest Serv, USDA, Timber & Watershed Lab, Parsons, WV USA	West Virginia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Lafayette College; United States Department of Agriculture (USDA); United States Forest Service	Duerr, AE (corresponding author), W Virginia Univ, Div Forestry & Nat Resources, Morgantown, WV 26506 USA.	adam.duerr@mail.wvu.edu	Duerr, Adam/J-5545-2019; Tremblay, Junior A./AAX-7353-2020	Duerr, Adam/0000-0002-6145-8897; Tremblay, Junior A./0000-0003-4930-0939; Katzner, Todd/0000-0003-4503-8435	Pennsylvania State Wildlife [T-12, T47-R-1]; United States Department of Energy [DE-EE0003538]; Virginia Department of Game and Inland Fisheries; Invenergy LLC; West Virginia Division of Natural Resources	Pennsylvania State Wildlife; United States Department of Energy(United States Department of Energy (DOE)); Virginia Department of Game and Inland Fisheries; Invenergy LLC; West Virginia Division of Natural Resources	Funding was received from Pennsylvania State Wildlife Grants T-12 and T47-R-1, United States Department of Energy grant DE-EE0003538, the Virginia Department of Game and Inland Fisheries, Invenergy LLC, and the West Virginia Division of Natural Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript that are not represented through coauthorship of this manuscript.	Alerstam T, 1998, J AVIAN BIOL, V29, P343, DOI 10.2307/3677155; Barrios L, 2004, J APPL ECOL, V41, P72, DOI 10.1111/j.1365-2664.2004.00876.x; Bevan RM, 1995, PHILOS T R SOC B, V350, P119, DOI 10.1098/rstb.1995.0146; Bildstein KL, 2009, IBIS, V151, P382, DOI 10.1111/j.1474-919X.2009.00919.x; Bird DM., 2007, RAPTOR RES MANAGEMEN; Bohrer G, 2012, ECOL LETT, V15, P96, DOI 10.1111/j.1461-0248.2011.01713.x; Broun M., 1943, AUK, V60, P487; Elliot D. L., 1986, WIND ENERGY RESOURCE; Gillies JA, 2011, J AVIAN BIOL, V42, P377, DOI 10.1111/j.1600-048X.2011.05105.x; HEDENSTROM A, 1995, PHILOS T ROY SOC B, V348, P471, DOI 10.1098/rstb.1995.0082; HEDENSTROM A, 1993, PHILOS T ROY SOC B, V342, P353, DOI 10.1098/rstb.1993.0164; Hedenstrom A, 2002, BEHAV ECOL SOCIOBIOL, V52, P308, DOI 10.1007/s00265-002-0504-0; Katzner T, 2012, AUK, V129, P168, DOI 10.1525/auk.2011.11078; Kendeigh S.C., 1977, GRANIVOROUS BIRDS EC, P127, DOI [10.1515/isspar-2015-0001, DOI 10.1515/ISSPAR-2015-0001]; Kerlinger P., 1989, FLIGHT STRATEGIES MI; Kjellen N, 2001, J AVIAN BIOL, V32, P57, DOI 10.1034/j.1600-048X.2001.320108.x; Klaassen RHG, 2008, BEHAV ECOL SOCIOBIOL, V62, P1427, DOI 10.1007/s00265-008-0572-x; Leshem Y, 1996, IBIS, V138, P667, DOI 10.1111/j.1474-919X.1996.tb04768.x; Mellone U, 2011, J AVIAN BIOL, V42, P468, DOI 10.1111/j.1600-048X.2011.05454.x; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19050, DOI 10.1073/pnas.0808918105; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; PENNYCUICK CJ, 1978, OIKOS, V30, P165, DOI 10.2307/3543476; PENNYCUICK CJ, 1972, IBIS, V114, P178, DOI 10.1111/j.1474-919X.1972.tb02603.x; Pennycuick CJ, 1998, J AVIAN BIOL, V29, P33, DOI 10.2307/3677338; Sapir N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013956; Sergio F, 2007, BEHAV ECOL, V18, P811, DOI 10.1093/beheco/arm052; Shamoun-Baranes J, 2003, J AVIAN BIOL, V34, P97, DOI 10.1034/j.1600-048X.2003.03079.x; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Smallwood KS, 2008, J WILDLIFE MANAGE, V72, P215, DOI 10.2193/2007-032; Spaar R, 1996, J AVIAN BIOL, V27, P289, DOI 10.2307/3677260; Spaar R, 1997, CONDOR, V99, P458, DOI 10.2307/1369952; Strandberg R, 2008, ARDEA, V96, P159, DOI 10.5253/078.096.0202; Teter S, 2003, AM HAWKWATCHER, P9; Thorup K, 2003, P ROY SOC B-BIOL SCI, V270, pS8, DOI 10.1098/rsbl.2003.0014	34	65	65	2	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35548	10.1371/journal.pone.0035548	http://dx.doi.org/10.1371/journal.pone.0035548			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558166	gold, Green Published			2022-12-27	WOS:000305345200047
J	Labarrere, CA; Woods, JR; Hardin, JW; Campana, GL; Ortiz, MA; Jaeger, BR; Baldridge, LA; Pitts, DE; Kirlin, PC				Labarrere, Carlos A.; Woods, John R.; Hardin, James W.; Campana, Gonzalo L.; Ortiz, Miguel A.; Jaeger, Beate R.; Baldridge, Lee Ann; Pitts, Douglas E.; Kirlin, Philip C.			Value of the First Post-Transplant Biopsy for Predicting Long-Term Cardiac Allograft Vasculopathy (CAV) and Graft Failure in Heart Transplant Patients	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; ENDOTHELIAL ACTIVATION; BOOTSTRAP METHODS; RISK; PHENOTYPE; REJECTION; ADHESION; PROTEIN; INJURY; AREA	Background: Cardiac allograft vasculopathy (CAV) is the principal cause of long-term graft failure following heart transplantation. Early identification of patients at risk of CAV is essential to target invasive follow-up procedures more effectively and to establish appropriate therapies. We evaluated the prognostic value of the first heart biopsy (median: 9 days post-transplant) versus all biopsies obtained within the first three months for the prediction of CAV and graft failure due to CAV. Methods and Findings: In a prospective cohort study, we developed multivariate regression models evaluating markers of atherothrombosis (fibrin, antithrombin and tissue plasminogen activator [tPA]) and endothelial activation (intercellular adhesion molecule-1) in serial biopsies obtained during the first three months post-transplantation from 172 patients (median follow-up = 6.3 years; min = 0.37 years, max = 16.3 years). Presence of fibrin was the dominant predictor in first-biopsy models (Odds Ratio [OR] for one-and 10-year graft failure due to CAV = 38.70, p = 0.002, 95% CI = 4.00-374.77; and 3.99, p = 0.005, 95% CI = 1.53-10.40) and loss of tPA was predominant in three-month models (OR for one-and 10-year graft failure due to CAV = 1.81, p = 0.025, 95% CI = 1.08-3.03; and 1.31, p = 0.001, 95% CI = 1.12-1.55). First-biopsy and three-month models had similar predictive and discriminative accuracy and were comparable in their capacities to correctly classify patient outcomes, with the exception of 10-year graft failure due to CAV in which the three-month model was more predictive. Both models had particularly high negative predictive values (e. g., First-biopsy vs. three-month models: 99% vs. 100% at 1-year and 96% vs. 95% at 10-years). Conclusions: Patients with absence of fibrin in the first biopsy and persistence of normal tPA in subsequent biopsies rarely develop CAV or graft failure during the next 10 years and potentially could be monitored less invasively. Presence of early risk markers in the transplanted heart may be secondary to ischemia/reperfusion injury, a potentially modifiable factor.	[Labarrere, Carlos A.; Woods, John R.; Campana, Gonzalo L.; Ortiz, Miguel A.] Indiana Univ, Hlth Methodist Hosp, Methodist Res Inst, Indianapolis, IN 46204 USA; [Hardin, James W.] Univ S Carolina, Columbia, SC 29208 USA; [Jaeger, Beate R.] Dr Stein & Kollegen, Monchengladbach, Germany; [Baldridge, Lee Ann] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN USA; [Pitts, Douglas E.] St Vincent Hosp, St Vincent Med Grp, Indianapolis, IN USA; [Kirlin, Philip C.] Indiana Univ, Hlth Methodist Hosp, Transplant Ctr, Indianapolis, IN 46204 USA	Indiana University System; Indiana University-Purdue University Indianapolis; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis	Labarrere, CA (corresponding author), Indiana Univ, Hlth Methodist Hosp, Methodist Res Inst, Indianapolis, IN 46204 USA.	clabarrere@iuhealth.org	Hardin, James/P-4772-2019; Hardin, James W/Q-7617-2016	Hardin, James/0000-0003-0506-5500; Hardin, James W/0000-0003-0506-5500	Showalter Foundation; Methodist Research Institute	Showalter Foundation; Methodist Research Institute	The study was supported by the Showalter Foundation and the Methodist Research Institute. The funders had no involvement in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript.	Austin PC, 2004, AM STAT, V58, P131, DOI 10.1198/0003130043277; Begg CB, 2000, STAT MED, V19, P1997, DOI 10.1002/1097-0258(20000815)19:15<1997::AID-SIM511>3.0.CO;2-C; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harrell FE, 2001, REGRESSION MODELING, P87, DOI 10.1007/978-1-4757-3462-1; Kfoury AG, 2009, J HEART LUNG TRANSPL, V28, P781, DOI 10.1016/j.healun.2009.04.035; Labarrere CA, 2011, AM J TRANSPLANT, V11, P528, DOI 10.1111/j.1600-6143.2010.03401.x; Labarrere CA, 2000, CIRCULATION, V102, P1549, DOI 10.1161/01.CIR.102.13.1549; Labarrere CA, 2000, JAMA-J AM MED ASSOC, V284, P457, DOI 10.1001/jama.284.4.457; LABARRERE CA, 1995, NEW ENGL J MED, V333, P1111, DOI 10.1056/NEJM199510263331704; Labarrere CA, 1997, JAMA-J AM MED ASSOC, V278, P1169, DOI 10.1001/jama.278.14.1169; Labarrere CA, 2002, LANCET, V360, P1462, DOI 10.1016/S0140-6736(02)11473-5; Labarrere CA, 2001, AM J CARDIOL, V87, P425, DOI 10.1016/S0002-9149(00)01395-3; Labarrere CA, 2012, TRANSL RES, V159, P238, DOI 10.1016/j.trsl.2012.01.018; Massberg S, 1999, BLOOD, V94, P3829, DOI 10.1182/blood.V94.11.3829.423k35_3829_3838; Mehra MR, 2006, AM J TRANSPLANT, V6, P1248, DOI 10.1111/j.1600-6143.2006.01314.x; Mengel M, 2010, AM J TRANSPLANT, V10, P2105, DOI 10.1111/j.1600-6143.2010.03182.x; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pham MX, 2010, NEW ENGL J MED, V362, P1890, DOI 10.1056/NEJMoa0912965; Rahmani M, 2006, CIRC RES, V99, P801, DOI 10.1161/01.RES.0000246086.93555.f3; Rao DA, 2008, CRIT REV IMMUNOL, V28, P229, DOI 10.1615/CritRevImmunol.v28.i3.40; Revelo MP, 2011, J HEART LUNG TRANSPL, V30, P144, DOI 10.1016/j.healun.2010.06.019; Schisterman EF, 2005, EPIDEMIOLOGY, V16, P73, DOI 10.1097/01.ede.0000147512.81966.ba; Schmauss D, 2008, CIRCULATION, V117, P2131, DOI 10.1161/CIRCULATIONAHA.107.711911; Shibata M, 2001, CIRCULATION, V103, P1799, DOI 10.1161/01.CIR.103.13.1799; Sis B, 2010, CURR OPIN ORGAN TRAN, V15, P42, DOI 10.1097/MOT.0b013e3283352a50; Stewart S, 2005, J HEART LUNG TRANSPL, V24, P1710, DOI 10.1016/j.healun.2005.03.019; Stork S, 2006, J HEART LUNG TRANSPL, V25, P1103, DOI 10.1016/j.healun.2006.05.009; Tzoulaki I, 2009, JAMA-J AM MED ASSOC, V302, P2345, DOI 10.1001/jama.2009.1757; Valantine HA, 2003, TRANSPLANTATION, V76, P891, DOI 10.1097/01.TP.0000080981.90718.EB; Wiedemann D, 2010, TRANSPLANTATION, V89, P824, DOI 10.1097/TP.0b013e3181ccd822; Wu GW, 2009, J HEART LUNG TRANSPL, V28, P417, DOI 10.1016/j.healun.2009.01.015; Yen MH, 2002, CIRCULATION, V106, P1379, DOI 10.1161/01.CIR.0000028588.73765.B4	33	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e36100	10.1371/journal.pone.0036100	http://dx.doi.org/10.1371/journal.pone.0036100			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558345	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345200115
J	Lee, BH; Hwang, DM; Palaniyar, N; Grinstein, S; Philpott, DJ; Hu, J				Lee, Benjamin H.; Hwang, David M.; Palaniyar, Nades; Grinstein, Sergio; Philpott, Dana J.; Hu, Jim			Activation of P2X(7) Receptor by ATP Plays an Important Role in Regulating Inflammatory Responses during Acute Viral Infection	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; INFLUENZA-VIRUS INFECTION; EXTRACELLULAR ATP; AIRWAY INFLAMMATION; ADENOVIRAL VECTORS; EPITHELIAL-CELLS; GENE-TRANSFER; OXIDIZED ATP; LUNG INJURY; MACROPHAGE	Acute viral infection causes damages to the host due to uncontrolled viral replication but even replication deficient viral vectors can induce systemic inflammatory responses. Indeed, overactive host innate immune responses to viral vectors have led to devastating consequences. Macrophages are important innate immune cells that recognize viruses and induce inflammatory responses at the early stage of infection. However, tissue resident macrophages are not easily activated by the mere presence of virus suggesting that their activation requires additional signals from other cells in the tissue in order to trigger inflammatory responses. Previously, we have shown that the cross-talk between epithelial cells and macrophages generates synergistic inflammatory responses during adenoviral vector infection. Here, we investigated whether ATP is involved in the activation of macrophages to induce inflammatory responses during an acute adenoviral infection. Using a macrophage-epithelial cell co-culture system we demonstrated that ATP signaling through P2X(7) receptor (P2X(7)R) is required for induction of inflammatory mediators. We also showed that ATP-P2X(7)R signaling regulates inflammasome activation as inhibition or deficiency of P2X(7)R as well as caspase-1 significantly reduced IL-1 beta secretion. Furthermore, we found that intranasal administration of replication deficient adenoviral vectors in mice caused a high mortality in wild-type mice with symptoms of acute respiratory distress syndrome but the mice deficient in P2X(7)R or caspase-1 showed increased survival. In addition, wild-type mice treated with apyrase or inhibitors of P2X(7)R or caspase-1 showed higher rates of survival. The improved survival in the P2X(7)R deficient mice correlated with diminished levels of IL-1 beta and IL-6 and reduced neutrophil infiltration in the early phase of infection. These results indicate that ATP, released during viral infection, is an important inflammatory regulator that activates the inflammasome pathway and regulates inflammatory responses.	[Lee, Benjamin H.; Palaniyar, Nades; Grinstein, Sergio; Hu, Jim] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Hwang, David M.] Toronto Gen Hosp, Univ Hlth Network, Toronto, ON, Canada; [Lee, Benjamin H.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Hwang, David M.; Palaniyar, Nades; Hu, Jim] Univ Toronto, Dept Lab Med & Pathol, Toronto, ON, Canada; [Grinstein, Sergio] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Philpott, Dana J.] Univ Toronto, Dept Immunol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Lee, BH (corresponding author), Hosp Sick Children, Res Inst, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	jim.hu@utoronto.ca		Hu, Jim/0000-0001-9134-7103; Palaniyar, Nades/0000-0002-2170-8548	Canadian Institute of Health Research; Cystic Fibrosis Canada; National Science and Engineering Research Council	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Canada; National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was partially funded by grants to JH from the Canadian Institute of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) and from Cystic Fibrosis Canada (http://www.cysticfibrosis.ca/en/index.php). BHL received studentships from both the Cystic Fibrosis Canada and the National Science and Engineering Research Council (http://www.nserc-crsng.gc.ca/Professors-Professeurs/Index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adriouch S, 2002, J IMMUNOL, V169, P4108, DOI 10.4049/jimmunol.169.8.4108; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Beigi RD, 2003, BRIT J PHARMACOL, V140, P507, DOI 10.1038/sj.bjp.0705470; BEYER EC, 1991, J BIOL CHEM, V266, P7971; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Bours Martijn Jan Leo, 2011, Front Biosci (Schol Ed), V3, P1443; Cao HB, 2004, VIRAL IMMUNOL, V17, P327, DOI 10.1089/0882824041857111; Chen J, 2007, ANNU REV IMMUNOL, V25, P443, DOI 10.1146/annurev.immunol.25.022106.141706; Cicko S, 2010, J IMMUNOL, V185, P688, DOI 10.4049/jimmunol.0904042; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Fukuyama S, 2011, CURR OPIN IMMUNOL, V23, P481, DOI 10.1016/j.coi.2011.07.016; Gasse P, 2009, AM J RESP CRIT CARE, V179, P903, DOI 10.1164/rccm.200808-1274OC; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Kanneganti TD, 2010, NAT REV IMMUNOL, V10, P688, DOI 10.1038/nri2851; Kuzmin AI, 1997, GENE THER, V4, P309, DOI 10.1038/sj.gt.3300377; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Lee BH, 2010, IMMUNOL LETT, V134, P93, DOI 10.1016/j.imlet.2010.09.003; Maines TR, 2008, IMMUNOL REV, V225, P68, DOI 10.1111/j.1600-065X.2008.00690.x; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; McGaraughty S, 2007, NEUROSCIENCE, V146, P1817, DOI 10.1016/j.neuroscience.2007.03.035; Muller T, 2011, AM J RESP CELL MOL, V44, P456, DOI 10.1165/rcmb.2010-0129OC; MURGIA M, 1993, J BIOL CHEM, V268, P8199; Muruve DA, 2004, HUM GENE THER, V15, P1157, DOI 10.1089/hum.2004.15.1157; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Pang IK, 2011, TRENDS IMMUNOL, V32, P34, DOI 10.1016/j.it.2010.11.004; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Pfeiffer ZA, 2007, FREE RADICAL BIO MED, V42, P1506, DOI 10.1016/j.freeradbiomed.2007.02.010; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Riteau N, 2010, AM J RESP CRIT CARE, V182, P774, DOI 10.1164/rccm.201003-0359OC; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Rouse BT, 2010, NAT REV IMMUNOL, V10, P514, DOI 10.1038/nri2802; Schmitz N, 2005, J VIROL, V79, P6441, DOI 10.1128/JVI.79.10.6441-6448.2005; Shayakhmetov DM, 2000, J VIROL, V74, P10274, DOI 10.1128/JVI.74.22.10274-10286.2000; Taylor SRJ, 2009, J AM SOC NEPHROL, V20, P1275, DOI 10.1681/ASN.2008060559; TERAMOTO S, 1995, HUM GENE THER, V6, P1045, DOI 10.1089/hum.1995.6.8-1045; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Weber FC, 2010, J EXP MED, V207, P2609, DOI 10.1084/jem.20092489; Wilhelm K, 2010, NAT MED, V16, P1434, DOI 10.1038/nm.2242; Zhang X, 2008, J PATHOL, V214, P161, DOI 10.1002/path.2284; Zsengeller Z, 2000, J VIROL, V74, P9655, DOI 10.1128/JVI.74.20.9655-9667.2000	48	74	76	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35812	10.1371/journal.pone.0035812	http://dx.doi.org/10.1371/journal.pone.0035812			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558229	Green Submitted, gold, Green Published			2022-12-27	WOS:000305345200082
J	Meng, L; Yang, L; Zhao, XX; Zhang, L; Zhu, HZ; Liu, C; Tan, WH				Meng, Ling; Yang, Liu; Zhao, Xiangxuan; Zhang, Lucy; Zhu, Haizhen; Liu, Chen; Tan, Weihong			Targeted Delivery of Chemotherapy Agents Using a Liver Cancer-Specific Aptamer	PLOS ONE			English	Article							MOLECULAR RECOGNITION; SYSTEMATIC EVOLUTION; DRUG-DELIVERY; DOXORUBICIN; BINDING; CELLS; DNA; ELUCIDATION; CONJUGATE; LIGANDS	Background: Using antibody/aptamer-drug conjugates can be a promising method for decreasing toxicity, while increasing the efficiency of chemotherapy. Methodology/Principal Findings: In this study, the antitumor agent Doxorubicin (Dox) was incorporated into the modified DNA aptamer TLS11a-GC, which specifically targets LH86, a human hepatocellular carcinoma cell line. Cell viability tests demonstrated that the TLS11a-GC-Dox conjugates exhibited both potency and target specificity. Importantly, intercalating Dox into the modified aptamer inhibited nonspecific uptake of membrane-permeable Dox to the non-target cell line. Since the conjugates are selective for cells that express higher amounts of target proteins, both criteria noted above are met, making TLS11a-GC-Dox conjugates potential candidates for targeted delivery to liver cancer cells. Conclusions/Significance: Considering the large number of available aptamers that have specific targets for a wide variety of cancer cells, this novel aptamer-drug intercalation method will have promising implications for chemotherapeutics in general.	[Meng, Ling; Yang, Liu; Zhao, Xiangxuan; Zhang, Lucy; Liu, Chen; Tan, Weihong] Univ Florida, Dept Chem, Shands Canc Ctr, Gainesville, FL 32611 USA; [Meng, Ling; Yang, Liu; Zhao, Xiangxuan; Zhang, Lucy; Liu, Chen; Tan, Weihong] Univ Florida, Dept Physiol & Funct Gen, Ctr Res Bio Nano Interface, Gainesville, FL USA; [Meng, Ling; Yang, Liu; Zhao, Xiangxuan; Zhang, Lucy; Liu, Chen; Tan, Weihong] Univ Florida, Coll Med, Dept Pathol Immunol, Gainesville, FL USA; [Meng, Ling; Yang, Liu; Zhao, Xiangxuan; Zhang, Lucy; Liu, Chen; Tan, Weihong] Univ Florida, Coll Med, Lab Med, Gainesville, FL USA; [Zhu, Haizhen] Hunan Univ, Coll Chem & Chem Engn, State Key Lab Chemo Biosensing & Chemometr, Changsha, Peoples R China	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Hunan University	Meng, L (corresponding author), Univ Florida, Dept Chem, Shands Canc Ctr, Gainesville, FL 32611 USA.	liu@pathology.ufl.edu; tan@chem.ufl.edu	Tan, Weihong/A-5412-2008; Tan, Weihong/AAA-4536-2020	Tan, Weihong/0000-0002-8066-1524; 	National Institutes of Health (NIH) [GM066137, GM079359, CA133086]; NATIONAL CANCER INSTITUTE [R01CA133086] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079359, R01GM066137] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) GM066137, GM079359, and CA133086. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagalkot V, 2006, ANGEW CHEM INT EDIT, V45, P8149, DOI 10.1002/anie.200602251; Blank M, 2001, J BIOL CHEM, V276, P16464, DOI 10.1074/jbc.M100347200; Carter PJ, 2008, CANCER J, V14, P154, DOI 10.1097/PPO.0b013e318172d704; CHAIRES JB, 1990, BIOCHEMISTRY-US, V29, P6145, DOI 10.1021/bi00478a006; Chari RVJ, 2008, ACCOUNTS CHEM RES, V41, P98, DOI 10.1021/ar700108g; Chen HW, 2008, CHEMMEDCHEM, V3, P991, DOI 10.1002/cmdc.200800030; Chu TC, 2006, CANCER RES, V66, P5989, DOI 10.1158/0008-5472.CAN-05-4583; Daniels DA, 2003, P NATL ACAD SCI USA, V100, P15416, DOI 10.1073/pnas.2136683100; Farokhzad OC, 2004, CANCER RES, V64, P7668, DOI 10.1158/0008-5472.CAN-04-2550; Farokhzad OC, 2006, P NATL ACAD SCI USA, V103, P6315, DOI 10.1073/pnas.0601755103; Flinders J, 2004, CHEMBIOCHEM, V5, P62, DOI 10.1002/cbic.200300701; Haj HTB, 2003, CHEM-BIOL INTERACT, V145, P349, DOI 10.1016/S0009-2797(03)00061-9; Huang YF, 2009, CHEMBIOCHEM, V10, P862, DOI 10.1002/cbic.200800805; HUSAIN N, 1993, J PHYS CHEM-US, V97, P10857, DOI 10.1021/j100143a054; Kuo MT, 2010, ONCOTARGET, V1, P246, DOI 10.18632/oncotarget.135; Lee Y, 2008, BIOCONJUGATE CHEM, V19, P525, DOI 10.1021/bc700382z; LIPSCOMB LA, 1994, BIOCHEMISTRY-US, V33, P3649, DOI 10.1021/bi00178a023; Mallikaratchy P, 2008, CHEMMEDCHEM, V3, P425, DOI 10.1002/cmdc.200700260; Mallikaratchy P, 2007, MOL CELL PROTEOMICS, V6, P2230, DOI 10.1074/mcp.M700026-MCP200; Mann AP, 2011, ONCOTARGET, V2, P298; Patel DJ, 1997, J MOL BIOL, V272, P645, DOI 10.1006/jmbi.1997.1281; Seigneuric R, 2011, ONCOTARGET, V2, P557, DOI 10.18632/oncotarget.297; Shangguan D, 2008, J PROTEOME RES, V7, P2133, DOI 10.1021/pr700894d; Shangguan DH, 2008, ANAL CHEM, V80, P721, DOI 10.1021/ac701962v; Shangguan D, 2006, P NATL ACAD SCI USA, V103, P11838, DOI 10.1073/pnas.0602615103; Tang ZW, 2007, ANAL CHEM, V79, P4900, DOI 10.1021/ac070189y; Tang ZW, 2009, CLIN CHEM, V55, P813, DOI 10.1373/clinchem.2008.113514; Wall DM, 2010, ONCOTARGET, V1, P721; Yan Q, 1997, BIOSPECTROSCOPY, V3, P307, DOI 10.1002/(SICI)1520-6343(1997)3:4<307::AID-BSPY6>3.0.CO;2-0; Zhang LF, 2007, CHEMMEDCHEM, V2, P1268, DOI 10.1002/cmdc.200700121; Zhu HZ, 2007, GASTROENTEROLOGY, V133, P1649, DOI 10.1053/j.gastro.2007.09.017	31	88	91	10	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e33434	10.1371/journal.pone.0033434	http://dx.doi.org/10.1371/journal.pone.0033434			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558072	gold, Green Published, Green Submitted			2022-12-27	WOS:000305345200002
J	Nunez, R; Cooperrider, K; Wassmann, J				Nunez, Rafael; Cooperrider, Kensy; Wassmann, Juerg			Number Concepts without Number Lines in an Indigenous Group of Papua New Guinea	PLOS ONE			English	Article							MENTAL REPRESENTATION; DISTINCT INTUITIONS; SPACE; OKSAPMIN; NEGLECT; WESTERN; SCALE; LOG	Background: The generic concept of number line, which maps numbers to unidimensional space, is a fundamental concept in mathematics, but its cognitive origins are uncertain. Two defining criteria of the number line are that (i) there is a mapping of each individual number (or numerosity) under consideration onto a specific location on the line, and (ii) that the mapping defines a unidimensional space representing numbers with a metric - a distance function. It has been proposed that the number line is based on a spontaneous universal human intuition, rooted directly in brain evolution, that maps number magnitude to linear space with a metric. To date, no culture lacking this intuition has been documented. Methodology/Principal Findings: By means of a number line task, we investigated the universality proposal with the Yupno of Papua New Guinea. Unschooled adults did exhibit a number-to-space mapping (criterion i) but, strikingly, despite having precise cardinal number concepts, they located numbers only on the endpoints, thus failing to use the extent of the line. The produced mapping was bi-categorical and metric-free, in violation of criterion ii. In contrast, Yupnos with scholastic experience used the extent of the segment according to known standards, but they did so not as evenly as western controls, exhibiting a bias towards the endpoints. Conclusions/Significance: Results suggest that cardinal number concepts can exist independently from number line representations. They also suggest that the number line mapping, although ubiquitous in the modern world, is not universally spontaneous, but rather seems to be learned through - and continually reinforced by - specific cultural practices.	[Nunez, Rafael; Cooperrider, Kensy] Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA; [Wassmann, Juerg] Heidelberg Univ, Inst Ethnol, Heidelberg, Germany	University of California System; University of California San Diego; Ruprecht Karls University Heidelberg	Nunez, R (corresponding author), Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA.	nunez@cogsci.ucsd.edu			University of California San Diego (UCSD) (Academic Senate Grant) [COG386G-07427A]; Institute for Advanced Studies in Berlin fellowship; UCSD Friends of the International Center fellowship; Marsilius Kolleg Heidelberg	University of California San Diego (UCSD) (Academic Senate Grant); Institute for Advanced Studies in Berlin fellowship; UCSD Friends of the International Center fellowship; Marsilius Kolleg Heidelberg	This work was supported by the University of California San Diego (UCSD) (Academic Senate Grant COG386G-07427A to RN), an Institute for Advanced Studies in Berlin fellowship (RN), a UCSD Friends of the International Center fellowship (KC), and the Marsilius Kolleg Heidelberg (JW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari D, 2008, NAT REV NEUROSCI, V9, P278, DOI 10.1038/nrn2334; Booth JL, 2006, DEV PSYCHOL, V42, P189, DOI 10.1037/0012-1649.41.6.189; Butterworth B., 1999, MATH BRAIN; Campbell JID, 2004, HDB MATH COGNITION; de Hevia MD, 2010, PSYCHOL SCI, V21, P653, DOI 10.1177/0956797610366091; de Hevia MD, 2009, COGNITION, V110, P198, DOI 10.1016/j.cognition.2008.11.003; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Dehaene S, 2008, SCIENCE, V320, P1217, DOI 10.1126/science.1156540; Dehaene S, 2009, SCIENCE, V323, DOI 10.1126/science.1164878; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Fischer MH, 2008, CORTEX, V44, P386, DOI 10.1016/j.cortex.2007.08.004; Galton F., 1880, NATURE, V21, P252, DOI [10.1038/021252a0, DOI 10.1038/021252A0]; Gebuis T, 2011, COGNITION, V121, P248, DOI 10.1016/j.cognition.2010.09.008; Gevers W, 2003, COGNITION, V87, pB87, DOI 10.1016/S0010-0277(02)00234-2; Gobel SM, 2006, NEUROPSYCHOLOGIA, V44, P860, DOI 10.1016/j.neuropsychologia.2005.09.007; Kadosh RC, 2009, BEHAV BRAIN SCI, V32, P313, DOI 10.1017/S0140525X09990938; Keck V., 2005, SOCIAL DISCORD BODIL; Napier J, 1616, DESCRIPTION ADMIRABL; Nunez R, 2011, COGNITION, V120, P225, DOI 10.1016/j.cognition.2011.05.001; Nunez Rafael, 2009, Biology Theory, V4, P68, DOI 10.1162/biot.2009.4.1.68; Nunez RE, 2011, J CROSS CULT PSYCHOL, V42, P651, DOI 10.1177/0022022111406097; Pica P, 2004, SCIENCE, V306, P499, DOI 10.1126/science.1102085; Priftis K, 2006, J COGNITIVE NEUROSCI, V18, P680, DOI 10.1162/jocn.2006.18.4.680; Rips LJ, 2008, BEHAV BRAIN SCI, V31, P623, DOI 10.1017/S0140525X08005566; Robson E., 2008, MATH ANCIENT IRAK; SAXE GB, 1982, CHILD DEV, V53, P1242, DOI 10.2307/1129012; SAXE GB, 1981, CHILD DEV, V52, P306; Siegler RS, 2004, CHILD DEV, V75, P428, DOI 10.1111/j.1467-8624.2004.00684.x; Stromer C., 1932, VERLAG INT Z ANTHROP, V11, P1; Wallis John, 1685, TREATISE ALGEBRA BOT; WASSMANN J, 1994, J CROSS CULT PSYCHOL, V25, P78, DOI 10.1177/0022022194251005; Wassmann J., 1993, IDEAL LEICHT GEBEUGT; Zorzi M, 2002, NATURE, V417, P138, DOI 10.1038/417138a	34	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35662	10.1371/journal.pone.0035662	http://dx.doi.org/10.1371/journal.pone.0035662			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VP	22558193	Green Published, gold			2022-12-27	WOS:000305345200064
J	Pecci, A; Biino, G; Fierro, T; Bozzi, V; Mezzasoma, A; Noris, P; Ramenghi, U; Loffredo, G; Fabris, F; Momi, S; Magrini, U; Pirastu, M; Savoia, A; Balduini, C; Gresele, P				Pecci, Alessandro; Biino, Ginevra; Fierro, Tiziana; Bozzi, Valeria; Mezzasoma, Annamaria; Noris, Patrizia; Ramenghi, Ugo; Loffredo, Giuseppe; Fabris, Fabrizio; Momi, Stefania; Magrini, Umberto; Pirastu, Mario; Savoia, Anna; Balduini, Carlo; Gresele, Paolo		Italian Registry MYH9-Releated Dis	Alteration of Liver Enzymes Is a Feature of the Myh9-Related Disease Syndrome	PLOS ONE			English	Article							MYOSIN HEAVY-CHAIN; MAY-HEGGLIN; FECHTNER-SYNDROME; INHERITED THROMBOCYTOPENIAS; DIAGNOSTIC ALGORITHM; EPSTEIN-SYNDROME; MYH9 MUTATIONS; CELL MOTILITY; IIA; MACROTHROMBOCYTOPENIA	Background: MYH9-related disease (MYH9-RD) is a rare autosomal dominant genetic syndrome characterized by congenital thrombocytopenia associated with the risk of developing progressive nephropathy, sensorineural deafness, and presenile cataract. During the collection of a large case-series of patients with MYH9-RD we noticed several cases with unexplained elevation of liver enzymes. Our aim was to evaluate if the alteration of liver tests is a feature of the MYH9-RD and to define its clinical significance. Methods and Findings: Data concerning liver tests, prospectively recorded in the Italian Registry for MYH9-RD, were collected and compared with those of three control populations: patients with autoimmune thrombocytopenia, patients with inherited thrombocytopenias other than MYH9-RD, and the participants to a large epidemiologic survey in an Italian geographic isolate. Thirty-eight of 75 evaluable MYH9-RD patients (50.7%) showed an elevation of ALT and/or AST, and 17 of 63 (27.0%) an increase of GGT. The increases ranged from 1.9 +/- 0.7 to 2.7 +/- 1.6 fold the upper normal limit. The prevalence of liver test alterations was significantly higher in MYH9-RD patients than in each of the control populations, with odds ratios ranging from 8.2 (95% CIs 2.2-44.8) to 24.7 (14.8-40.8). Clinical follow-up and more detailed liver studies of a subset of patients, including ultrasound liver scan, liver elastography and liver biopsy in one case, did not show any significant structural damage or evolution towards liver insufficiency. Conclusions: Elevation of liver enzymes is a frequent and previously unrecognized feature of the MYH9-RD syndrome; however, this defect does not appear to have poor prognostic value.	[Pecci, Alessandro; Bozzi, Valeria; Noris, Patrizia; Balduini, Carlo] IRCCS Policlin San Matteo Fdn, Dept Internal Med, Pavia, Italy; [Pecci, Alessandro; Bozzi, Valeria; Noris, Patrizia; Balduini, Carlo] Univ Pavia, I-27100 Pavia, Italy; [Biino, Ginevra] CNR, Inst Mol Genet, I-27100 Pavia, Italy; [Fierro, Tiziana; Mezzasoma, Annamaria; Momi, Stefania; Gresele, Paolo] Univ Perugia, Dept Internal Med, Div Internal & Cardiovasc Med, I-06100 Perugia, Italy; [Ramenghi, Ugo] Univ Turin, Dept Pediat, I-10124 Turin, Italy; [Loffredo, Giuseppe] Pausilipon Hosp, Dept Oncol, Naples, Italy; [Fabris, Fabrizio] Univ Padua, Dept Med Sci, Padua, Italy; [Magrini, Umberto] Univ Pavia, Dept Pathol, I-27100 Pavia, Italy; [Pirastu, Mario] CNR, Inst Populat Genet, Sassari, Italy; [Savoia, Anna] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Genet Lab, Trieste, Italy	IRCCS Fondazione San Matteo; University of Pavia; University of Pavia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Perugia; University of Turin; University of Padua; University of Pavia; Consiglio Nazionale delle Ricerche (CNR); IRCCS Burlo Garofolo	Pecci, A (corresponding author), IRCCS Policlin San Matteo Fdn, Dept Internal Med, Pavia, Italy.	grespa@unipg.it	Savoia, Anna/B-6463-2014; Pecci, Alessandro/E-9288-2012; Savoia, Anna/AIC-4560-2022; Gresele, Paolo/F-6775-2013; Biino, Ginevra/B-5334-2013; gresele, paolo/AAG-8019-2019; Bozzi, Valeria/K-7569-2016	Savoia, Anna/0000-0002-2407-2696; Pecci, Alessandro/0000-0001-9202-7013; Savoia, Anna/0000-0002-2407-2696; Gresele, Paolo/0000-0001-5365-8445; Biino, Ginevra/0000-0002-9936-946X; Bozzi, Valeria/0000-0002-1054-6491; Noris, Patrizia/0000-0002-5035-3707	Fondazione Cassa di Risparmio di Perugia [2010.020.161, 2009.010.0478, 2011.0137.021]	Fondazione Cassa di Risparmio di Perugia(Fondazione Cassa Risparmio Perugia)	This study was supported, in part, by grants from Fondazione Cassa di Risparmio di Perugia (Protocol nr. 2010.020.161, nr. 2009.010.0478 and nr. 2011.0137.021) to PG. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angius A, 2001, HUM GENET, V109, P198, DOI 10.1007/s004390100557; Balduini CL, 2011, BRIT J HAEMATOL, V154, P161, DOI 10.1111/j.1365-2141.2011.08716.x; Balduini CL, 2003, HAEMATOLOGICA, V88, P582; Bhadriraju K, 2004, EXP CELL RES, V300, P259, DOI 10.1016/j.yexcr.2004.06.033; Biino G, 2011, HAEMATOL-HEMATOL J, V96, P96, DOI 10.3324/haematol.2010.029934; Burt RA, 2008, THROMB RES, V122, P861, DOI 10.1016/j.thromres.2008.06.011; Chan W, 2005, J BIOL CHEM, V280, P23741, DOI 10.1074/jbc.M502767200; D'Apolito M, 2002, GENE, V286, P215, DOI 10.1016/S0378-1119(02)00455-9; GERSHONIBARUCH R, 1988, AM J MED GENET, V31, P357, DOI 10.1002/ajmg.1320310213; Gresele P, 2009, HAEMATOL-HEMATOL J, V94, P663, DOI 10.3324/haematol.2008.002246; Heath KE, 2001, AM J HUM GENET, V69, P1033, DOI 10.1086/324267; Herrema H, 2006, MOL BIOL CELL, V17, P3291, DOI 10.1091/mbc.E06-01-0067; Jacobelli J, 2004, NAT IMMUNOL, V5, P531, DOI 10.1038/ni1065; Kelley MJ, 2000, NAT GENET, V26, P106, DOI 10.1038/79069; Kunishima S, 2003, LAB INVEST, V83, P115, DOI 10.1097/01.LAB.0000050960.48774.17; Margall-Ducos G, 2007, J CELL SCI, V120, P3633, DOI 10.1242/jcs.016907; Noris P, 2004, HAEMATOLOGICA, V89, P1219; Noris P, 2011, BLOOD, V117, P6673, DOI 10.1182/blood-2011-02-336537; Pecci A, 2002, BRIT J HAEMATOL, V117, P164, DOI 10.1046/j.1365-2141.2002.03385.x; Pecci A, 2008, NEPHROL DIAL TRANSPL, V23, P2690, DOI 10.1093/ndt/gfn277; Pecci A, 2008, HUM MUTAT, V29, P409, DOI 10.1002/humu.20661; ROCCA B, 1993, BRIT J HAEMATOL, V85, P423, DOI 10.1111/j.1365-2141.1993.tb03193.x; Savoia A, 2001, BLOOD, V97, P1330, DOI 10.1182/blood.V97.5.1330; Savoia A, 2010, THROMB HAEMOSTASIS, V103, P826, DOI 10.1160/TH09-08-0593; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Seri M, 2000, NAT GENET, V26, P103; Seri M, 2003, MEDICINE, V82, P203, DOI 10.1097/00005792-200305000-00006; Subramanian VS, 2010, AM J PHYSIOL-GASTR L, V298, pG267, DOI 10.1152/ajpgi.00435.2009; Toren A, 1999, AM J HUM GENET, V65, P1711, DOI 10.1086/302654; Torok N, 1996, J CELL PHYSIOL, V167, P422; TSUKADA N, 1995, HEPATOLOGY, V21, P1106, DOI 10.1002/hep.1840210433; TSUKADA N, 1994, P NATL ACAD SCI USA, V91, P6919, DOI 10.1073/pnas.91.15.6919; WATANABE S, 1991, LIVER, V11, P185	33	34	38	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35986	10.1371/journal.pone.0035986	http://dx.doi.org/10.1371/journal.pone.0035986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558294	gold, Green Published, Green Submitted			2022-12-27	WOS:000305345200103
J	Land, TG; Landau, AS; Manning, SE; Purtill, JK; Pickett, K; Wakschlag, L; Dukic, VM				Land, Thomas G.; Landau, Anna S.; Manning, Susan E.; Purtill, Jane K.; Pickett, Kate; Wakschlag, Lauren; Dukic, Vanja M.			Who Underreports Smoking on Birth Records: A Monte Carlo Predictive Model with Validation	PLOS ONE			English	Article							URINARY COTININE LEVELS; SELF-REPORTED MEASURES; MATERNAL SMOKING; PRENATAL SMOKING; PREGNANT SMOKERS; LUNG-FUNCTION; WEIGHT; WOMEN; NICOTINE; VALIDITY	Background: Research has shown that self-reports of smoking during pregnancy may underestimate true prevalence. However, little is known about which populations have higher rates of underreporting. Availability of more accurate measures of smoking during pregnancy could greatly enhance the usefulness of existing studies on the effects of maternal smoking offspring, especially in those populations where underreporting may lead to underestimation of the impact of smoking during pregnancy. Methods and Findings: In this paper, we develop a statistical Monte Carlo model to estimate patterns of underreporting of smoking during pregnancy, and apply it to analyze the smoking self-report data from birth certificates in the state of Massachusetts. Our results illustrate non-uniform patterns of underreporting of smoking during pregnancy among different populations. Estimates of likely underreporting of smoking during pregnancy were highest among mothers who were college-educated, married, aged 30 years or older, employed full-time, and planning to breastfeed. The model's findings are validated and compared to an existing underreporting adjustment approach in the Maternal and Infant Smoking Study of East Boston (MISSEB). Conclusions: The validation results show that when biological assays are not available, the Monte Carlo method proposed can provide a more accurate estimate of the smoking status during pregnancy than self-reports alone. Such methods hold promise for providing a better assessment of the impact of smoking during pregnancy.	[Land, Thomas G.; Landau, Anna S.; Manning, Susan E.; Purtill, Jane K.] Massachusetts Dept Publ Hlth, Boston, MA USA; [Dukic, Vanja M.] Univ Colorado, Dept Appl Math, Boulder, CO 80309 USA; [Pickett, Kate] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Wakschlag, Lauren] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Massachusetts Department of Public Health; University of Colorado System; University of Colorado Boulder; University of York - UK; Northwestern University; Feinberg School of Medicine	Land, TG (corresponding author), Massachusetts Dept Publ Hlth, Boston, MA USA.	Thomas.land@state.ma.us	Dukic, Vanja/AAI-1494-2020	Dukic, Vanja/0000-0002-0348-0834	NIDA [R21DA027624-01];  [R01DA15223]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015223, R21DA027624] Funding Source: NIH RePORTER; National Institute for Health Research [CSA/03/07/014] Funding Source: researchfish	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by NIDA Grant R21DA027624-01 to VMD and LW, as well as R01DA15223 to LW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AM, 2008, PUBLIC HEALTH REP, V123, P586, DOI 10.1177/003335490812300508; [Anonymous], 2009, MASSCHIP MASS COMM H; Arnold CL, 2001, PREV MED, V32, P313, DOI 10.1006/pmed.2000.0815; Centers for Disease Control and Prevention, 2009, HLTH RISKS US BEH RI; Dempsey D, 2002, J PHARMACOL EXP THER, V301, P594, DOI 10.1124/jpet.301.2.594; Donahue SMA, 2010, OBSTET GYNECOL, V115, P357, DOI 10.1097/AOG.0b013e3181cbd5f5; Dukic VM, 2007, NICOTINE TOB RES, V9, P453, DOI 10.1080/14622200701239530; Dukic VM, 2009, INT J ENV RES PUB HE, V6, P1744, DOI 10.3390/ijerph6061744; Ershoff DH, 1999, AM J PREV MED, V17, P161, DOI 10.1016/S0749-3797(99)00071-9; Eskanazi B, 1995, AM J PUBLIC HEALTH, V85, P395; HANRAHAN JP, 1992, AM REV RESPIR DIS, V145, P1129, DOI 10.1164/ajrccm/145.5.1129; Honein MA, 2001, PUBLIC HEALTH REP, V116, P327, DOI 10.1016/S0033-3549(04)50054-7; Jauniaux E, 1999, OBSTET GYNECOL, V93, P25, DOI 10.1016/S0029-7844(98)00318-4; Kendrick S, 1995, AM J PUBLIC HEALTH, V85, P217; KOTELCHUCK M, 1994, AM J PUBLIC HEALTH, V84, P1486, DOI 10.2105/AJPH.84.9.1486; Lawrence T, 2003, ADDICTION, V98, P1315, DOI 10.1046/j.1360-0443.2003.00485.x; LI CQ, 1993, JAMA-J AM MED ASSOC, V269, P1519, DOI 10.1001/jama.269.12.1519; MATHAI M, 1990, AUST NZ J OBSTET GYN, V30, P33, DOI 10.1111/j.1479-828X.1990.tb03192.x; Nelson DE, 2001, SOZ PRAVENTIV MED, V46, pS3; Ogburn PL, 1999, AM J OBSTET GYNECOL, V181, P736, DOI 10.1016/S0002-9378(99)70521-1; Orr ST, 2005, MATERN CHILD HLTH J, V9, P245, DOI 10.1007/s10995-005-0010-x; Rebagliato M, 1998, AM J OBSTET GYNECOL, V178, P568, DOI 10.1016/S0002-9378(98)70440-5; Suplee PD, 2005, JOGNN-J OBST GYN NEO, V34, P703, DOI 10.1177/0884217505281861; TAGER IB, 1995, AM J RESP CRIT CARE, V152, P977, DOI 10.1164/ajrccm.152.3.7663813; The Institute of Medicine of the National Academies, 1985, P CANC TREATM S, P1; U.S. Department of Health and Human Services, 2001, WOM SMOK REP SURG GE; WINDSOR RA, 1986, HEALTH EDUC QUART, V13, P131, DOI 10.1177/109019818601300203; WINDSOR RA, 1993, AM J PUBLIC HEALTH, V83, P201, DOI 10.2105/AJPH.83.2.201	28	21	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e34853	10.1371/journal.pone.0034853	http://dx.doi.org/10.1371/journal.pone.0034853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VE	22545091	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343200014
J	Shukla, A; Burton, NM; Jayaraman, PS; Gaston, K				Shukla, Anshuman; Burton, Nicholas M.; Jayaraman, Padma-Sheela; Gaston, Kevin			The Proline Rich Homeodomain Protein PRH/Hhex Forms Stable Oligomers That Are Highly Resistant to Denaturation	PLOS ONE			English	Article							MESSENGER-RNA TRANSPORT; NUCLEAR ARCHITECTURE; HEMATOPOIETIC-CELLS; DNA-BINDING; TRANSCRIPTION; THERMOSTABILITY; LOCALIZATION; MECHANISMS; EXPRESSION; REGULATOR	Background: Many transcription factors control gene expression by binding to specific DNA sequences at or near the genes that they regulate. However, some transcription factors play more global roles in the control of gene expression by altering the architecture of sections of chromatin or even the whole genome. The ability to form oligomeric protein assemblies allows many of these proteins to manipulate extensive segments of DNA or chromatin via the formation of structures such as DNA loops or protein-DNA fibres. Principal Findings: Here we show that the proline rich homeodomain protein PRH/Hhex forms predominantly octameric and/or hexadecameric species in solution as well as larger assemblies. We show that these assemblies are highly stable resisting denaturation by temperature and chemical denaturants. Conclusion: These data indicate that PRH is functionally and structurally related to the Lrp/AsnC family of proteins, a group of proteins that are known to act globally to control gene expression in bacteria and archaea.	[Shukla, Anshuman; Jayaraman, Padma-Sheela] Univ Birmingham, Sch Med, Inst Biomed Res, Birmingham, W Midlands, England; [Burton, Nicholas M.; Gaston, Kevin] Univ Bristol, Sch Biochem, Bristol, Avon, England	University of Birmingham; University of Bristol	Shukla, A (corresponding author), Univ Birmingham, Sch Med, Inst Biomed Res, Birmingham, W Midlands, England.	Kevin.Gaston@Bristol.ac.uk	Burton, Nick/C-7064-2013; Gaston, Kevin/K-9237-2019	Gaston, Kevin/0000-0002-7349-5513; /0000-0002-6500-9095	Wellcome Trust [076527]	Wellcome Trust(Wellcome TrustEuropean Commission)	Funding was provided by the Wellcome Trust grant reference 076527. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	D'Elia AV, 2002, J CLIN ENDOCR METAB, V87, P1376, DOI 10.1210/jc.87.3.1376; de los Rios S, 2007, J MOL BIOL, V366, P1589, DOI 10.1016/j.jmb.2006.12.032; Gerk LP, 2000, J MOL BIOL, V299, P805, DOI 10.1006/jmbi.2000.3706; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Guidry JJ, 2000, PROTEIN SCI, V9, P2109, DOI 10.1110/ps.9.11.2109; Guiral M, 2001, J BIOL CHEM, V276, P2961, DOI 10.1074/jbc.M004948200; Jankovic D, 2008, BLOOD, V111, P5672, DOI 10.1182/blood-2007-09-108175; Kaiser TE, 2008, SCIENCE, V322, P1713, DOI 10.1126/science.1165216; Misteli T, 2005, BIOESSAYS, V27, P477, DOI 10.1002/bies.20226; Nichols NM, 2001, BIOCHEMISTRY-US, V40, P3847, DOI 10.1021/bi002088z; Noy P, 2010, MOL CELL BIOL, V30, P2120, DOI 10.1128/MCB.01511-09; Puppin C, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-192; Shevtsov SP, 2011, NAT CELL BIOL, V13, P167, DOI 10.1038/ncb2157; Soufi A, 2008, BIOCHEM J, V412, P399, DOI 10.1042/BJ20080035; Soufi A, 2006, J MOL BIOL, V358, P943, DOI 10.1016/j.jmb.2006.02.020; Soufi A, 2010, NUCLEIC ACIDS RES, V38, P7513, DOI 10.1093/nar/gkq659; Soufi A, 2009, NUCLEIC ACIDS RES, V37, P3288, DOI 10.1093/nar/gkp197; Swingler TE, 2004, J BIOL CHEM, V279, P34938, DOI 10.1074/jbc.M404488200; Thaw P, 2006, NUCLEIC ACIDS RES, V34, P1439, DOI 10.1093/nar/gkl009; THOMAS JO, 1975, P NATL ACAD SCI USA, V72, P2626, DOI 10.1073/pnas.72.7.2626; Topisirovic I, 2003, MOL CELL BIOL, V23, P8992, DOI 10.1128/MCB.23.24.8992-9002.2003; Topisirovic I, 2003, EMBO J, V22, P689, DOI 10.1093/emboj/cdg069; Van den Burg B, 1998, P NATL ACAD SCI USA, V95, P2056, DOI 10.1073/pnas.95.5.2056; Williams H, 2008, J MOL BIOL, V383, P10, DOI 10.1016/j.jmb.2008.08.004; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084	25	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35984	10.1371/journal.pone.0035984	http://dx.doi.org/10.1371/journal.pone.0035984			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22540015	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341000081
J	Morandi, L; de Biase, D; Visani, M; Cesari, V; De Maglio, G; Pizzolitto, S; Pession, A; Tallini, G				Morandi, Luca; de Biase, Dario; Visani, Michela; Cesari, Valentina; De Maglio, Giovanna; Pizzolitto, Stefano; Pession, Annalisa; Tallini, Giovanni			Allele Specific Locked Nucleic Acid Quantitative PCR (ASLNAqPCR): An Accurate and Cost-Effective Assay to Diagnose and Quantify KRAS and BRAF Mutation	PLOS ONE			English	Article							K-RAS MUTATIONS; COLORECTAL-CARCINOMA; LUNG-CANCER; GENE; ADENOCARCINOMAS; ACTIVATION; RESISTANCE; CETUXIMAB	The use of tyrosine kinase inhibitors (TKIs) requires the testing for hot spot mutations of the molecular effectors downstream the membrane-bound tyrosine kinases since their wild type status is expected for response to TKI therapy. We report a novel assay that we have called Allele Specific Locked Nucleic Acid quantitative PCR (ASLNAqPCR). The assay uses LNA-modified allele specific primers and LNA-modified beacon probes to increase sensitivity, specificity and to accurately quantify mutations. We designed primers specific for codon 12/13 KRAS mutations and BRAF V600E, and validated the assay with 300 routine samples from a variety of sources, including cytology specimens. All were analyzed by ASLNAqPCR and Sanger sequencing. Discordant cases were pyrosequenced. ASLNAqPCR correctly identified BRAF and KRAS mutations in all discordant cases and all had a mutated/wild type DNA ratio below the analytical sensitivity of the Sanger method. ASLNAqPCR was 100% specific with greater accuracy, positive and negative predictive values compared with Sanger sequencing. The analytical sensitivity of ASLNAqPCR is 0.1%, allowing quantification of mutated DNA in small neoplastic cell clones. ASLNAqPCR can be performed in any laboratory with real-time PCR equipment, is very cost-effective and can easily be adapted to detect hot spot mutations in other oncogenes.	[Morandi, Luca; de Biase, Dario; Visani, Michela; Cesari, Valentina; Tallini, Giovanni] Univ Bologna, AUSL Osped Bellaria, Sez Anat Istol & Citol Patol M Malpighi, Dipartimento Ematol & Sci Oncol L & A Seragnoli, Bologna, Italy; [de Biase, Dario; Visani, Michela; Cesari, Valentina; Pession, Annalisa] Univ Bologna, Dipartimento Patol Sperimentale, I-40126 Bologna, Italy; [De Maglio, Giovanna; Pizzolitto, Stefano] Univ Santa Maria Misericordia, SOC Anat Patol Azienda Osped, Udine, Italy	University of Bologna; University of Bologna; Hospital Santa Maria della Misericordia	Morandi, L (corresponding author), Univ Bologna, AUSL Osped Bellaria, Sez Anat Istol & Citol Patol M Malpighi, Dipartimento Ematol & Sci Oncol L & A Seragnoli, Bologna, Italy.	morandi@ausl.bologna.it; giovanni.tallini@unibo.it	de Biase, Dario/B-9274-2012; Visani, Michela/K-5597-2016; Morandi, Luca/A-3191-2016; Tallini, Giovanni/F-7850-2013	de Biase, Dario/0000-0002-0609-8817; Visani, Michela/0000-0002-9051-2231; Morandi, Luca/0000-0002-3810-9760; Tallini, Giovanni/0000-0003-0113-6682; Pession, Annalisa/0000-0001-9035-9698	Regione Friuli Venezia Giulia [1897, 2008]; ASLNAqPCR; Italian Government MURST [20074zw8la]; Vanini-Cavagnino; Centro Interdipartimentale di Ricerca sul Cancro G. Prodi, University of Bologna, Bologna, Italy	Regione Friuli Venezia Giulia(Regione Friuli Venezia Giulia); ASLNAqPCR; Italian Government MURST; Vanini-Cavagnino; Centro Interdipartimentale di Ricerca sul Cancro G. Prodi, University of Bologna, Bologna, Italy	This study was supported by: a public grant (1897, 2008) given by the Regione Friuli Venezia Giulia to Alphagenics Diaco Biotechnologies S.r.l., Area Science Park, Basovizza-Building Q1, Trieste Italy (to LM). Alphagenics used a very limited amount of this publicly funded grant to support the authors' work by providing free of charge primers and probes for the initial experimental work that lead to the development of ASLNAqPCR; and an Italian Government MURST grant [grant number 20074zw8la] to GT. DdB is supported with Vanini-Cavagnino grants from the Centro Interdipartimentale di Ricerca sul Cancro G. Prodi, University of Bologna, Bologna, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: LM is a consultant for Alphagenics Biotechnologies S.r.l. Two pending patents related to ASLNAqPCR were filed with the European Patent Office and are currently under review: 1) WO2011104695 (A2) 2011-09-01 for KRAS mutation detection; 2) WO2011104694 (A2) 2011-09-01 for BRAF mutation detection. Alphagenics used a very limited amount of this publicly funded grant to support the authors' work by providing free of charge primers and probes. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Arcila M, 2011, J MOL DIAGN, V13, P64, DOI 10.1016/j.jmoldx.2010.11.005; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Deng GR, 2004, CLIN CANCER RES, V10, P191, DOI 10.1158/1078-0432.CCR-1118-3; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Farber L, 2011, VIRCHOWS ARCH, V459, P487, DOI 10.1007/s00428-011-1158-y; Goranova TE, 2011, CLIN EXP METASTAS, V28, P427, DOI 10.1007/s10585-011-9381-0; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; HRUBAN RH, 1993, AM J PATHOL, V143, P545; James MR, 2006, CLIN CHEM, V52, P1675, DOI 10.1373/clinchem.2006.070169; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kim IJ, 2007, J MOL DIAGN, V9, P55, DOI 10.2353/jmoldx.2007.060072; Kubota K, 2006, APPL ENVIRON MICROB, V72, P5311, DOI 10.1128/AEM.03039-05; Latorra D, 2003, HUM MUTAT, V22, P79, DOI 10.1002/humu.10228; Leboeuf R, 2008, J CLIN ENDOCR METAB, V93, P2194, DOI 10.1210/jc.2007-2825; LIIKANEN E, 2002, OFF J EUR COMMUN L, V131, P17; Linardou H, 2008, LANCET ONCOL, V9, P962, DOI 10.1016/S1470-2045(08)70206-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchetti A, 2009, NEOPLASIA, V11, P1084, DOI 10.1593/neo.09814; Morandi L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-48; MURRAY A, 1993, Q J MED, V86, P831; Neumann J, 2009, PATHOL RES PRACT, V205, P858, DOI 10.1016/j.prp.2009.07.010; Paik PK, 2011, J CLIN ONCOL, V29, P2046, DOI 10.1200/JCO.2010.33.1280; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2009, CLIN CANCER RES, V15, P5317, DOI 10.1158/1078-0432.CCR-09-0913; Sun Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003701; Sundstrom M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-660; van Krieken JHJM, 2008, VIRCHOWS ARCH, V453, P417, DOI 10.1007/s00428-008-0665-y; Xing M, 2004, J CLIN ENDOCR METAB, V89, P1365, DOI 10.1210/jc.2003-031488; Xing MZ, 2004, J CLIN ENDOCR METAB, V89, P2867, DOI 10.1210/jc.2003-032050; Zhou X, 2011, STAT METHODS DIAGNOS	34	48	55	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36084	10.1371/journal.pone.0036084	http://dx.doi.org/10.1371/journal.pone.0036084			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558339	gold, Green Published, Green Submitted			2022-12-27	WOS:000305340200040
J	Johnson, KR; Longo-Guess, CM; Gagnon, LH				Johnson, Kenneth R.; Longo-Guess, Chantal M.; Gagnon, Leona H.			Mutations of the Mouse ELMO Domain Containing 1 Gene (Elmod1) Link Small GTPase Signaling to Actin Cytoskeleton Dynamics in Hair Cell Stereocilia	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; INNER-EAR; PHOSPHATIDYLINOSITOL PHOSPHATASE; COCHLEAR STEREOCILIA; RHO GTPASES; MYOSIN-XVA; DEAFNESS; MEMBRANE; BUNDLES; DIFFERENTIATION	Stereocilia, the modified microvilli projecting from the apical surfaces of the sensory hair cells of the inner ear, are essential to the mechanoelectrical transduction process underlying hearing and balance. The actin-filled stereocilia on each hair cell are tethered together by fibrous links to form a highly patterned hair bundle. Although many structural components of hair bundles have been identified, little is known about the signaling mechanisms that regulate their development, morphology, and maintenance. Here, we describe two naturally occurring, allelic mutations that result in hearing and balance deficits in mice, named roundabout (rda) and roundabout-2J (rda(2J)). Positional cloning identified both as mutations of the mouse ELMOdomain containing 1 gene (Elmod1), a poorly characterized gene with no previously reported mutant phenotypes. The rda mutation is a 138 kb deletion that includes exons 1-5 of Elmod1, and rda(2J) is an intragenic duplication of exons 3-8 of Elmod1. The deafness associated with these mutations is caused by cochlear hair cell dysfunction, as indicated by conspicuous elongations and fusions of inner hair cell stereocilia and progressive degeneration of outer hair cell stereocilia. Mammalian ELMO-family proteins are known to be involved in complexes that activate small GTPases to regulate the actin cytoskeleton during phagocytosis and cell migration. ELMOD1 and ELMOD2 recently were shown to function as GTPase-activating proteins (GAPs) for the Arf family of small G proteins. Our finding connecting ELMOD1 deficiencies with stereocilia dysmorphologies thus establishes a link between the Ras superfamily of small regulatory GTPases and the actin cytoskeleton dynamics of hair cell stereocilia.	[Johnson, Kenneth R.; Longo-Guess, Chantal M.; Gagnon, Leona H.] Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Johnson, KR (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	ken.johnson@jax.org			National Institute On Deafness And Other Communication Disorders (NIDCD) [R01DC004301]; National Cancer Institute (NCI) [CA34196]; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004301] Funding Source: NIH RePORTER	National Institute On Deafness And Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This project was supported by grant number R01DC004301 from the National Institute On Deafness And Other Communication Disorders (NIDCD). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIDCD or the National Institutes of Health (NIH). Jackson Laboratory Shared Services are supported by grant number CA34196 from the National Cancer Institute (NCI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; Belyantseva IA, 2003, P NATL ACAD SCI USA, V100, P13958, DOI 10.1073/pnas.2334417100; Bowzard JB, 2007, J BIOL CHEM, V282, P17568, DOI 10.1074/jbc.M701347200; Brzostowski Joseph A., 2009, Communicative & Integrative Biology, V2, P337; D'Angelo R, 2007, MOL BIOL CELL, V18, P4780, DOI 10.1091/mbc.E06-12-1144; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Donaldson JG, 2005, BIOCHEM SOC T, V33, P1276, DOI 10.1042/BST0331276; Fettiplace R, 2006, NAT REV NEUROSCI, V7, P19, DOI 10.1038/nrn1828; Frolenkov GI, 2004, NAT REV GENET, V5, P489, DOI 10.1038/nrg1377; Gagnon LH, 2006, J NEUROSCI, V26, P10188, DOI 10.1523/JNEUROSCI.2166-06.2006; Goodyear RJ, 2005, J COMP NEUROL, V485, P75, DOI 10.1002/cne.20513; Goodyear RJ, 2003, J NEUROSCI, V23, P9208; Grimsley CM, 2006, J BIOL CHEM, V281, P5928, DOI 10.1074/jbc.M510647200; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Grimsley-Myers CM, 2009, J NEUROSCI, V29, P15859, DOI 10.1523/JNEUROSCI.3998-09.2009; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hertzano R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002309; Hilpela P, 2004, CURR TOP MICROBIOL, V282, P117; Hiramoto K, 2006, EXP CELL RES, V312, P4205, DOI 10.1016/j.yexcr.2006.09.006; Isik N, 2008, DEV CELL, V15, P590, DOI 10.1016/j.devcel.2008.08.006; JOHNSON KR, 1992, GENOMICS, V12, P503, DOI 10.1016/0888-7543(92)90441-T; KALTENBACH JA, 1994, J COMP NEUROL, V350, P187, DOI 10.1002/cne.903500204; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Kikkawa Y, 2005, HUM MOL GENET, V14, P391, DOI 10.1093/hmg/ddi035; Kitajiri S, 2004, J CELL BIOL, V166, P559, DOI 10.1083/jcb.200402007; Kollmar R, 1999, CURR OPIN NEUROBIOL, V9, P394, DOI 10.1016/S0959-4388(99)80059-2; Komander D, 2008, MOL BIOL CELL, V19, P4837, DOI 10.1091/mbc.E08-04-0345; Krebs A, 2001, J CELL SCI, V114, P3663; Lefevre G, 2008, DEVELOPMENT, V135, P1427, DOI 10.1242/dev.012922; LeMasurier M, 2005, NEURON, V48, P403, DOI 10.1016/j.neuron.2005.10.017; Li CC, 2007, MOL BIOL CELL, V18, P4420, DOI 10.1091/mbc.E07-02-0149; Lin HW, 2005, CURR OPIN CELL BIOL, V17, P55, DOI 10.1016/j.ceb.2004.12.005; Lynch ED, 1997, SCIENCE, V278, P1315, DOI 10.1126/science.278.5341.1315; Lyons BL, 2006, INVEST OPHTH VIS SCI, V47, P1201, DOI 10.1167/iovs.05-1161; Manor U, 2011, CURR BIOL, V21, P167, DOI 10.1016/j.cub.2010.12.046; Manor U, 2008, SEMIN CELL DEV BIOL, V19, P502, DOI 10.1016/j.semcdb.2008.07.006; Mburu P, 2003, NAT GENET, V34, P421, DOI 10.1038/ng1208; Mburu P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011627; Muller U, 2001, TRENDS CELL BIOL, V11, P334, DOI 10.1016/S0962-8924(01)02046-3; Myers KR, 2008, TRENDS CELL BIOL, V18, P184, DOI 10.1016/j.tcb.2008.02.002; Oganesian A, 2003, P NATL ACAD SCI USA, V100, P7563, DOI 10.1073/pnas.1336511100; Pataky F, 2004, P NATL ACAD SCI USA, V101, P2601, DOI 10.1073/pnas.0308620100; Peng AW, 2009, J NEUROSCI, V29, P15083, DOI 10.1523/JNEUROSCI.2782-09.2009; Petit C, 2009, NAT NEUROSCI, V12, P703, DOI 10.1038/nn.2330; Prosser HM, 2008, MOL CELL BIOL, V28, P1702, DOI 10.1128/MCB.01282-07; Quinlan AR, 2010, GENOME RES, V20, P623, DOI 10.1101/gr.102970.109; Rzadzinska A, 2005, CELL MOTIL CYTOSKEL, V62, P157, DOI 10.1002/cm.20094; SAKAGUCHI H, 2008, CELL MOTIL CYTOSKELE; Santarius M, 2006, BIOCHEM J, V398, P1, DOI 10.1042/BJ20060565; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schneider ME, 2002, NATURE, V418, P837, DOI 10.1038/418837a; Scott CC, 2005, J CELL BIOL, V169, P139, DOI 10.1083/jcb.200412162; Sechi AS, 2000, J CELL SCI, V113, P3685; Seifert RA, 2003, EXP CELL RES, V287, P374, DOI 10.1016/S0014-4827(03)00121-6; Sekerkova G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002032; Self T, 1999, DEV BIOL, V214, P331, DOI 10.1006/dbio.1999.9424; Shin JB, 2007, NEURON, V53, P371, DOI 10.1016/j.neuron.2006.12.021; Takenawa T, 2001, BBA-MOL CELL BIOL L, V1533, P190, DOI 10.1016/S1388-1981(01)00165-2; TAYLOR BA, 1994, GENOMICS, V21, P626, DOI 10.1006/geno.1994.1323; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Ueda S, 2008, J NEUROSCI RES, V86, P3052, DOI 10.1002/jnr.21763; Vollrath MA, 2007, ANNU REV NEUROSCI, V30, P339, DOI 10.1146/annurev.neuro.29.051605.112917; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Yan D, 2006, J MOL BIOL, V357, P755, DOI 10.1016/j.jmb.2006.01.017; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Zampini V, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001048; Zhang DS, 2012, NATURE, V481, P520, DOI 10.1038/nature10745; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9; Zhou Z, 2001, DEV CELL, V1, P477, DOI 10.1016/S1534-5807(01)00058-2	72	28	29	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36074	10.1371/journal.pone.0036074	http://dx.doi.org/10.1371/journal.pone.0036074			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558334	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000120
J	Miyazaki, Y; Ikeda, Y; Shiraishi, K; Fujimoto, SN; Aoyama, H; Yoshimura, K; Inui, M; Hoshijima, M; Kasahara, H; Aoki, H; Matsuzaki, M				Miyazaki, Yosuke; Ikeda, Yasuhiro; Shiraishi, Kozo; Fujimoto, Shizuka N.; Aoyama, Hidekazu; Yoshimura, Koichi; Inui, Makoto; Hoshijima, Masahiko; Kasahara, Hideko; Aoki, Hiroki; Matsuzaki, Masunori			Heart Failure-Inducible Gene Therapy Targeting Protein Phosphatase 1 Prevents Progressive Left Ventricular Remodeling	PLOS ONE			English	Article							CALCIUM CYCLING DEFECTS; ADENOASSOCIATED VIRUS; CARDIAC DYSFUNCTION; NATRIURETIC PEPTIDE; INHIBITION; PHOSPHOLAMBAN; EXPRESSION; PHOSPHODIESTERASE; SUPPRESSION; INFARCTION	Background: The targeting of Ca2+ cycling has emerged as a potential therapy for the treatment of severe heart failure. These approaches include gene therapy directed at overexpressing sarcoplasmic reticulum (SR) Ca2+ ATPase, or ablation of phospholamban (PLN) and associated protein phosphatase 1 (PP1) protein complexes. We previously reported that PP1 beta, one of the PP1 catalytic subunits, predominantly suppresses Ca2+ uptake in the SR among the three PP1 isoforms, thereby contributing to Ca2+ downregulation in failing hearts. In the present study, we investigated whether heart-failure-inducible PP1 beta-inhibition by adeno-associated viral-9 (AAV9) vector mediated gene therapy is beneficial for preventing disease progression in genetic cardiomyopathic mice. Methods: We created an adeno-associated virus 9 (AAV9) vector encoding PP1b short-hairpin RNA (shRNA) or negative control (NC) shRNA. A heart failure inducible gene expression system was employed using the B-type natriuretic protein (BNP) promoter conjugated to emerald-green fluorescence protein (EmGFP) and the shRNA sequence. AAV9 vectors (AAV9-BNP- EmGFP-PP1 beta shRNA and AAV9-BNP-EmGFP-NCshRNA) were injected into the tail vein (2x10(11) GC/mouse) of muscle LIM protein deficient mice (MLPKO), followed by serial analysis of echocardiography, hemodynamic measurement, biochemical and histological analysis at 3 months. Results: In the MLPKO mice, BNP promoter activity was shown to be increased by detecting both EmGFP expression and the induced reduction of PP1b by 25% in the myocardium. Inducible PP1 beta shRNA delivery preferentially ameliorated left ventricular diastolic function and mitigated adverse ventricular remodeling. PLN phosphorylation was significantly augmented in the AAV9-BNP-EmGFP-PP1 beta shRNA injected hearts compared with the AAV9-BNP-EmGFP-NCshRNA group. Furthermore, BNP production was reduced, and cardiac interstitial fibrosis was abrogated at 3 months. Conclusion: Heart failure-inducible molecular targeting of PP1b has potential as a novel therapeutic strategy for heart failure.	[Miyazaki, Yosuke; Ikeda, Yasuhiro; Shiraishi, Kozo; Fujimoto, Shizuka N.; Aoyama, Hidekazu; Matsuzaki, Masunori] Yamaguchi Univ, Dept Med & Clin Sci, Div Cardiol, Grad Sch Med, Ube, Yamaguchi 755, Japan; [Yoshimura, Koichi] Yamaguchi Univ, Grad Sch Med, Dept Surg & Clin Sci, Ube, Yamaguchi 755, Japan; [Inui, Makoto] Yamaguchi Univ, Grad Sch Med, Dept Pharmacol, Ube, Yamaguchi 755, Japan; [Hoshijima, Masahiko] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Kasahara, Hideko] Univ Florida, Dept Physiol & Funct Genom, Gainesville, FL USA; [Aoki, Hiroki] Kurume Univ, Cardiovasc Res Inst, Kurume, Fukuoka 830, Japan	Yamaguchi University; Yamaguchi University; Yamaguchi University; University of California System; University of California San Diego; State University System of Florida; University of Florida; Kurume University	Miyazaki, Y (corresponding author), Yamaguchi Univ, Dept Med & Clin Sci, Div Cardiol, Grad Sch Med, Ube, Yamaguchi 755, Japan.	ysikeda-ymg@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology-Japan (MEXT-Japan) [17590739, 21590932, 19209030, 21390241]; Grants-in-Aid for Scientific Research [22390050, 21390241] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology-Japan (MEXT-Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for scientific research from Ministry of Education, Culture, Sports, Science and Technology-Japan (MEXT-Japan) [grant numbers 17590739 and 21590932 to YI, and 19209030 and 21390241 to MM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antos CL, 2001, CIRC RES, V89, P997, DOI 10.1161/hh2301.100003; Aoyama H, 2011, CARDIOVASC RES, V89, P79, DOI 10.1093/cvr/cvq252; Bell CL, 2011, J CLIN INVEST, V121, P2427, DOI 10.1172/JCI57367; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bish LT, 2008, HUM GENE THER, V19, P1359, DOI 10.1089/hum.2008.123; Chu D, 2003, J THORAC CARDIOV SUR, V126, P671, DOI 10.1016/S0022-5223(03)00082-5; CRUICKSHANK JM, 1993, CARDIOVASC DRUG THER, V7, P655, DOI 10.1007/BF00877818; Dulak J, 2006, CELL BIOCHEM BIOPHYS, V44, P31, DOI 10.1385/CBB:44:1:031; El-Armouche A, 2008, CARDIOVASC RES, V80, P396, DOI 10.1093/cvr/cvn208; Grote-Wessels S, 2008, CARDIOVASC RES, V79, P464, DOI 10.1093/cvr/cvn113; Gwathmey JK, 2010, J MOL CELL CARDIOL; Hajjar RJ, 2008, J CARD FAIL, V14, P355, DOI 10.1016/j.cardfail.2008.02.005; He Q, 2001, HYPERTENSION, V37, P478, DOI 10.1161/01.HYP.37.2.478; Hoshijima M, 2002, NAT MED, V8, P864, DOI 10.1038/nm739; Hoshijima M, 2006, J AM COLL CARDIOL, V48, pA15, DOI 10.1016/j.jacc.2006.06.070; Hoshijima M, 2011, CIRC-HEART FAIL, V4, P89, DOI 10.1161/CIRCHEARTFAILURE.110.957258; Huang BY, 1999, CIRC RES, V85, P848, DOI 10.1161/01.RES.85.9.848; Ikeda Y, HEART FAILURE PATHOP, P27; Ikeda Y, 2008, PHYSIOLOGY, V23, P6, DOI 10.1152/physiol.00033.2007; Iwanaga Y, 2004, J CLIN INVEST, V113, P727, DOI 10.1172/JCI200418716; Jessup M, 2011, CIRCULATION; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; Maisel AS, 2003, J AM COLL CARDIOL, V41, P2010, DOI 10.1016/S0735-1097(03)00405-4; Matsuura K, 2009, J CLIN INVEST, V119, P2204, DOI 10.1172/JCI37456; Mays LE, 2011, MOL THER, V19, P16, DOI 10.1038/mt.2010.250; Miyamoto MI, 2000, P NATL ACAD SCI USA, V97, P793, DOI 10.1073/pnas.97.2.793; Neumann J, 1997, J MOL CELL CARDIOL, V29, P265, DOI 10.1006/jmcc.1996.0271; Nicolaou P, 2009, CIRC RES, V104, P1012, DOI 10.1161/CIRCRESAHA.108.189811; Niwano K, 2008, MOL THER, V16, P1026, DOI 10.1038/mt.2008.61; Njeim Mario T, 2010, Arch Cardiovasc Dis, V103, P477, DOI 10.1016/j.acvd.2010.04.004; Pacak CA, 2006, CIRC RES, V99, pE3, DOI 10.1161/01.RES.0000237661.18885.f6; Pathak A, 2005, CIRC RES, V96, P756, DOI 10.1161/01.RES.0000161256.85833.fa; Paul A, HUMAN CARDIAC TISSUE; Toriyama M, 2006, J CELL BIOL, V175, P147, DOI 10.1083/jcb.200604160; Wittkopper K, 2011, CARDIOVASC RES; Wittopper K, 2010, J CLIN INVEST, V120, P617, DOI 10.1172/JCI40545; Wong CY, 2011, AM J MED, V124, P136, DOI 10.1016/j.amjmed.2010.08.017; Yamada M, 2006, FASEB J, V20, P1197, DOI 10.1096/fj.05-5299fje	38	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35875	10.1371/journal.pone.0035875	http://dx.doi.org/10.1371/journal.pone.0035875			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558250	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000072
J	Parsi, S; Soltani, BM; Hosseini, E; Tousi, SE; Mowla, SJ				Parsi, Sepideh; Soltani, Bahram M.; Hosseini, Ebrahim; Tousi, Samaneh E.; Mowla, Seyed J.			Experimental Verification of a Predicted Intronic MicroRNA in Human NGFR Gene with a Potential Pro-Apoptotic Function	PLOS ONE			English	Article							P75 NEUROTROPHIN RECEPTOR; MURINE RETINOBLASTOMA; EXPRESSION PROFILES; HUMAN PROSTATE; HOST GENES; WEB SERVER; P75(NTR); CELLS; CANCER; GROWTH	Neurotrophins (NTs) are a family of secreted growth factor proteins primarily involved in the regulation of survival and appropriate development of neural cells, functioning by binding to their specific (TrkA, TtkB, and TrkC) and/or common NGFR receptor. NGFR is the common receptor of NTs, binding with low-affinity to all members of the family. Among different functions assigned to NGFR, it is also involved in apoptosis induction and tumorigenesis processes. Interestingly, some of the functions of NGFR appear to be ligand-independent, suggesting a probable involvement of non-coding RNA residing within the sequence of the gene. Here, we are reporting the existence of a conserved putative microRNA, named Hsa-mir-6165 [EBI accession#: FR873488]. Transfection of a DNA segment corresponding to the pre-mir-6165 sequence in Hela cell line caused the generation of mature exogenous mir-6165 (a similar to 200,000 fold overexpression). Furthermore, using specific primers, we succeeded to detect the endogenous expression of mir-6165 in several glioma cell lines and glioma primary tumors known to express NGFR. Similar to the pro-apoptotic role of NGFR in some cell types, overexpression of premir-6165 in U87 cell line resulted in an elevated rate of apoptosis. Moreover, coordinated with the increased level of mir-6165 in the transfected U87 cell line, two of its predicted target genes (Pkd1 and DAGLA) were significantly down-regulated. The latter findings suggest that some of the previously attributed functions of NGFR could be explained indirectly by co-transcription of mir-6165 in the cells.	[Parsi, Sepideh; Soltani, Bahram M.; Hosseini, Ebrahim; Tousi, Samaneh E.; Mowla, Seyed J.] Tarbiat Modares Univ, Fac Biol Sci, Dept Mol Genet, Tehran, Iran	Tarbiat Modares University	Parsi, S (corresponding author), Tarbiat Modares Univ, Fac Biol Sci, Dept Mol Genet, Tehran, Iran.	soltanib@modares.ac.ir	Ekhteraei-Tousi, Samaneh/AAE-9228-2020; Soltani, Bahram/ABH-2649-2021	Soltani, Bahram/0000-0003-2468-901X; Mowla, Seyed Javad/0000-0002-3300-6332; Parsi, Sepideh/0000-0001-6396-5190; Ekhteraei-Tousi, Samaneh/0000-0002-8123-8058				Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; ANDREWS PW, 1984, LAB INVEST, V50, P147; Antonov AV, 2009, NUCLEIC ACIDS RES, V37, pW323, DOI 10.1093/nar/gkp313; Aranha MM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-514; Barker PA, 2009, NEURON, V62, P3, DOI 10.1016/j.neuron.2009.04.005; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Battini L, 2006, J AM SOC NEPHROL, V17, P3049, DOI 10.1681/ASN.2006030234; Bentwich I, 2005, FEBS LETT, V579, P5904, DOI 10.1016/j.febslet.2005.09.040; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Blochl A, 2007, J NEUROCHEM, V102, P289, DOI 10.1111/j.1471-4159.2007.04496.x; Boletta A, 2000, MOL CELL, V6, P1267, DOI 10.1016/S1097-2765(00)00123-4; Cantarella G, 2002, FASEB J, V16, P1307, DOI 10.1096/fj.01-1000fje; Caporali A, 2008, CIRC RES, V103, pE15, DOI 10.1161/CIRCRESAHA.108.177386; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dimaras H, 2006, MOL CARCINOGEN, V45, P333, DOI 10.1002/mc.20179; Dimaras H, 2008, INT J CANCER, V122, P2023, DOI 10.1002/ijc.23356; Gao XG, 2007, MOL CELL NEUROSCI, V36, P501, DOI 10.1016/j.mcn.2007.08.013; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Gkirtzou K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011843; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guate JL, 1999, BJU INT, V84, P495; Helvik SA, 2007, BIOINFORMATICS, V23, P142, DOI 10.1093/bioinformatics/btl570; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Jiang P, 2007, NUCLEIC ACIDS RES, V35, pW339, DOI 10.1093/nar/gkm368; Jin HF, 2007, NEOPLASIA, V9, P471, DOI 10.1593/neo.07175; Johnston ALM, 2007, PLOS BIOL, V5, P1723, DOI 10.1371/journal.pbio.0050212; Kanik AB, 1996, J CUTAN PATHOL, V23, P205, DOI 10.1111/j.1600-0560.1996.tb01468.x; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Knudsen S, 1999, BIOINFORMATICS, V15, P356, DOI 10.1093/bioinformatics/15.5.356; Krygier S, 2001, MOL CARCINOGEN, V31, P46, DOI 10.1002/mc.1038; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li L, 2010, MAMM GENOME, V21, P1, DOI 10.1007/s00335-009-9241-2; Lin S, BIOCH BIOPHYS RES CO, V310, P754; Lin SL, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/26818; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lutter D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-224; Malakootian M, 2010, MOL CARCINOGEN, V49, P818, DOI 10.1002/mc.20658; Maniatis T., 1982, MOL CLONING LAB MANU; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Marchetti D, 2004, J CELL BIOCHEM, V91, P206, DOI 10.1002/jcb.10649; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Musiyenko A, 2008, J MOL MED, V86, P313, DOI 10.1007/s00109-007-0296-9; Oulas A, 2009, NUCLEIC ACIDS RES, V37, P3276, DOI 10.1093/nar/gkp120; Oulas A, 2009, IEEE T INF TECHNOL B, V13, P67, DOI 10.1109/TITB.2008.2007086; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; Ramos A, 2007, J NEUROSCI, V27, P1498, DOI 10.1523/JNEUROSCI.4806-06.2007; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Ritchie W, 2008, BIOINFORMATICS, V24, P1394, DOI 10.1093/bioinformatics/btn137; Rocha AS, 2006, HUM PATHOL, V37, P562, DOI 10.1016/j.humpath.2005.12.016; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Salis MB, 2004, DIABETOLOGIA, V47, P1055, DOI 10.1007/s00125-004-1424-5; Sewer A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-267; Stephan H, 2008, PEDIATR BLOOD CANCER, V50, P218, DOI 10.1002/pbc.21369; Tyagi S, 2008, BIOCHEM BIOPH RES CO, V372, P831, DOI 10.1016/j.bbrc.2008.05.134; Vilar M, 2009, J CELL SCI, V122, P3351, DOI 10.1242/jcs.055061; Wang SY, 2000, AM J PATHOL, V157, P1247, DOI 10.1016/S0002-9440(10)64640-8; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Weber MJ, 2005, FEBS J, V272, P59, DOI 10.1111/j.1432-1033.2004.04389.x; Yoon BJ, 2007, IEEE SIGNAL PROC MAG, V24, P64; Zhao DY, 2010, ARTIF INTELL MED, V49, P127, DOI 10.1016/j.artmed.2010.03.004; Zhou J, 2009, ANNU REV PHYSIOL, V71, P83, DOI 10.1146/annurev.physiol.70.113006.100621	64	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35561	10.1371/journal.pone.0035561	http://dx.doi.org/10.1371/journal.pone.0035561			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558167	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000036
J	Yang, JM; Xian, M; Su, SZ; Zhao, G; Nie, QJ; Jiang, XL; Zheng, YN; Liu, W				Yang, Jianming; Xian, Mo; Su, Sizheng; Zhao, Guang; Nie, Qingjuan; Jiang, Xinglin; Zheng, Yanning; Liu, Wei			Enhancing Production of Bio-Isoprene Using Hybrid MVA Pathway and Isoprene Synthase in E-coli	PLOS ONE			English	Article							METHYLERYTHRITOL PHOSPHATE-PATHWAY; MEVALONATE PATHWAY; BIOSYNTHESIS; BACTERIA; INTEGRATION; BIOREACTOR	The depleting petroleum reserve, increasingly severe energy crisis, and global climate change are reigniting enthusiasm for seeking sustainable technologies to replace petroleum as a source of fuel and chemicals. In this paper, the efficiency of the MVA pathway on isoprene production has been improved as follows: firstly, in order to increase MVA production, the source of the "upper pathway'' which contains HMG-CoA synthase, acetyl-CoA acetyltransferase and HMG-CoA reductase to covert acetyl-CoA into MVA has been changed from Saccharomyces cerevisiae to Enterococcus faecalis; secondly, to further enhance the production of MVA and isoprene, a alanine 110 of the mvaS gene has been mutated to a glycine. The final genetic strain YJM25 containing the optimized MVA pathway and isoprene synthase from Populus alba can accumulate isoprene up to 6.3 g/L after 40 h of fed-batch cultivation.	[Yang, Jianming; Xian, Mo; Zhao, Guang; Jiang, Xinglin; Zheng, Yanning; Liu, Wei] Chinese Acad Sci, Ctr Biomat, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao, Peoples R China; [Su, Sizheng] China Risun Coal Chem Grp Ltd, Beijing Risun Chem Technol Inst, Dept Biochem, Beijing, Peoples R China; [Nie, Qingjuan] Qingdao Agr Univ, Foreign Languages Sch, Coll English Off, Qingdao, Peoples R China	Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Qingdao Agricultural University	Yang, JM (corresponding author), Chinese Acad Sci, Ctr Biomat, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao, Peoples R China.	xianmo@qibebt.ac.cn	zheng, yonghong/H-3700-2012; zhao, guang/E-4702-2013	zhao, guang/0000-0003-0002-5972; Jiang, Xinglin/0000-0002-4935-8025				Alianell G.A., 2010, Isoprene compositions and methods of use, Patent No. [US2010/0099932 A1, 20100099932]; Anthony JR, 2009, METAB ENG, V11, P13, DOI 10.1016/j.ymben.2008.07.007; Campos N, 2001, BIOCHEM J, V353, P59, DOI 10.1042/bj3530059; Chen HT, 2008, KOREAN J CHEM ENG, V25, P1082, DOI 10.1007/s11814-008-0177-0; Chen XA, 2006, BIOCHEM ENG J, V28, P215, DOI 10.1016/j.bej.2005.03.005; Clomburg JM, 2010, APPL MICROBIOL BIOT, V86, P419, DOI 10.1007/s00253-010-2446-1; DiGiacomo A.A., 1961, CHEM ENG PROG, V57, P3540; Eisenreich W, 2004, CELL MOL LIFE SCI, V61, P1401, DOI 10.1007/s00018-004-3381-z; Eroglu E, 2010, BIORESOURCE TECHNOL, V101, P2359, DOI 10.1016/j.biortech.2009.11.043; Ghimire GP, 2009, APPL ENVIRON MICROB, V75, P7291, DOI 10.1128/AEM.01402-09; Jiang XYJ, 2012, PLOS ONE, DOI 30210.31371/journal.pone.0030267; Julsing MK, 2007, APPL MICROBIOL BIOT, V75, P1377, DOI 10.1007/s00253-007-0953-5; Kilonzo P, 2009, J BIOTECHNOL, V143, P60, DOI 10.1016/j.jbiotec.2009.06.007; Kim SJ, 2006, APPL MICROBIOL BIOT, V72, P982, DOI 10.1007/s00253-006-0359-9; Kuhlman TE, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1193; Lindberg P, 2010, METAB ENG, V12, P70, DOI 10.1016/j.ymben.2009.10.001; Loreto F, 2001, PLANT PHYSIOL, V127, P1781, DOI 10.1104/pp.010497; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Newman JD, 2006, BIOTECHNOL BIOENG, V95, P684, DOI 10.1002/bit.21017; Penuelas J, 2005, PLANT CELL ENVIRON, V28, P278, DOI 10.1111/j.1365-3040.2004.01250.x; Pfleger BF, 2007, METAB ENG, V9, P30, DOI 10.1016/j.ymben.2006.08.002; Pitera DJ, 2007, METAB ENG, V9, P193, DOI 10.1016/j.ymben.2006.11.002; REIS T, 1972, CHEM PROCESS ENG, V53, P68; Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138; Rodriguez-Concepion M, 2004, CURR PHARM DESIGN, V10, P2391, DOI 10.2174/1381612043384006; Rodriguez-Villalon A, 2008, J BIOTECHNOL, V135, P78, DOI 10.1016/j.jbiotec.2008.02.023; ROHMER M, 1993, BIOCHEM J, V295, P517, DOI 10.1042/bj2950517; Sacchettini JC, 1997, SCIENCE, V277, P1788, DOI 10.1126/science.277.5333.1788; Sambrook J., 2001, MOL CLONING LAB MANU; Sanadze G, 1957, REP AKAD NAUK GRUZSS, V19, p[19, 83]; Sanadze G.A., 1956, REP AKAD NAUK GRUZSS, V17, P429; SCHWARZ MK, 1994, THESIS ETH ZURICH SW; Seemann M, 2002, TETRAHEDRON LETT, V43, P1413, DOI 10.1016/S0040-4039(02)00003-5; Steinbuchel A, 2003, CURR OPIN MICROBIOL, V6, P261, DOI 10.1016/S1369-5274(03)00061-4; Steussy CN, 2006, BIOCHEMISTRY-US, V45, P14407, DOI 10.1021/bi061505q; Steussy CN, 2005, BIOCHEMISTRY-US, V44, P14256, DOI 10.1021/bi051487x; Tabata K, 2004, BIOTECHNOL LETT, V26, P1487, DOI 10.1023/B:BILE.0000044449.08268.7d; TERRY GM, 1995, J EXP BOT, V46, P1629, DOI 10.1093/jxb/46.10.1629; Ushio S., 1972, CHEM ENG PROG, V79; Xue JF, 2011, APPL ENVIRON MICROB, V77, P2399, DOI 10.1128/AEM.02341-10; Yoon SH, 2009, J BIOTECHNOL, V140, P218, DOI 10.1016/j.jbiotec.2009.01.008; Zhao YG, 2011, ABSTR APPL ANAL, DOI 10.1155/2011/390543	42	86	100	6	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e33509	10.1371/journal.pone.0033509	http://dx.doi.org/10.1371/journal.pone.0033509			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558074	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000005
J	Zhang, S; Zhang, YX; Ma, KM				Zhang, Shuang; Zhang, Yuxin; Ma, Keming			Disruption of Ant-Aphid Mutualism in Canopy Enhances the Abundance of Beetles on the Forest Floor	PLOS ONE			English	Article							COMMUNITY-WIDE IMPACT; INTRAGUILD INTERACTIONS; LASIUS FULIGINOSUS; ARGENTINE ANTS; FOOD-WEB; BIODIVERSITY; PLANTS; CONSEQUENCES; COMPETITION; COLEOPTERA	Ant-aphid mutualism is known to play a key role in the structure of the arthropod community in the tree canopy, but its possible ecological effects for the forest floor are unknown. We hypothesized that aphids in the canopy can increase the abundance of ants on the forest floor, thus intensifying the impacts of ants on other arthropods on the forest floor. We tested this hypothesis in a deciduous temperate forest in Beijing, China. We excluded the aphid-tending ants Lasius fuliginosus from the canopy using plots of varying sizes, and monitored the change in the abundance of ants and other arthropods on the forest floor in the treated and control plots. We also surveyed the abundance of ants and other arthropods on the forest floor to explore the relationships between ants and other arthropods in the field. Through a three-year experimental study, we found that the exclusion of ants from the canopy significantly decreased the abundance of ants on the forest floor, but increased the abundance of beetles, although the effect was only significant in the large ant-exclusion plot (80*60 m). The field survey showed that the abundance of both beetles and spiders was negatively related to the abundance of ants. These results suggest that aphids located in the tree canopy have indirect negative effects on beetles by enhancing the ant abundance on the forest floor. Considering that most of the beetles in our study are important predators, the ant-aphid mutualism can have further trophic cascading effects on the forest floor food web.	[Zhang, Shuang; Zhang, Yuxin; Ma, Keming] Chinese Acad Sci, State Key Lab Urban & Reg Ecol, Res Ctr Ecoenvironm Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	Zhang, S (corresponding author), Chinese Acad Sci, State Key Lab Urban & Reg Ecol, Res Ctr Ecoenvironm Sci, Beijing, Peoples R China.	mkm@rcees.ac.cn	Zhang, Yuxin/A-8223-2008	Zhang, Yuxin/0000-0003-0968-6558	National Natural Science Foundation of China [30900185, 30870459]; Special Fund for Forestry-scientific Research in the Public Interest [200904005]; State Key Laboratory of Urban and Regional Ecology [SKLURE2008-1-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Forestry-scientific Research in the Public Interest; State Key Laboratory of Urban and Regional Ecology	This study was supported by National Natural Science Foundation of China (30900185, 30870459), Special Fund for Forestry-scientific Research in the Public Interest (200904005), and State Key Laboratory of Urban and Regional Ecology Grant (SKLURE2008-1-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando Y, 2011, ECOL ENTOMOL, V36, P643, DOI 10.1111/j.1365-2311.2011.01303.x; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Bonser R, 1998, ECOL ENTOMOL, V23, P15, DOI 10.1046/j.1365-2311.1998.00103.x; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; BUCKLEY RC, 1987, ANNU REV ECOL SYST, V18, P111, DOI 10.1146/annurev.es.18.110187.000551; Byk J, 2011, POPUL ECOL, V53, P327, DOI 10.1007/s10144-010-0240-7; Cardoso P, 2007, ECOL ENTOMOL, V32, P516, DOI 10.1111/j.1365-2311.2007.00894.x; Chamberlain SA, 2009, ECOLOGY, V90, P2384, DOI 10.1890/08-1490.1; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; Folgarait PJ, 1998, BIODIVERS CONSERV, V7, P1221, DOI 10.1023/A:1008891901953; Gonzalez-Megias A, 2008, ECOSCIENCE, V15, P429, DOI 10.2980/15-4-3105; Hawes C, 2002, OECOLOGIA, V131, P612, DOI 10.1007/s00442-002-0916-6; HENGEVELD R, 1980, NETH J ZOOL, V30, P555, DOI 10.1163/002829679X00188; Hopkins GW, 1999, J INSECT CONSERV, V3, P25, DOI 10.1023/A:1009626405307; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Kalnihs M, 2007, LATVIJAS ENTOMOLOGS, V44, P95; Kaminski LA, 2010, AM NAT, V176, P322, DOI 10.1086/655427; Kaplan I, 2005, ECOLOGY, V86, P1640, DOI 10.1890/04-0016; Kay AD, 2010, ECOLOGY, V91, P57, DOI 10.1890/09-0908.1; Lenoir L, 2003, OECOLOGIA, V134, P423, DOI 10.1007/s00442-002-1143-x; Littell RC, SAS MIXED MODELS, P440; Moya-Larano J, 2007, ECOLOGY, V88, P1454, DOI 10.1890/05-1474; O'Dowd DJ, 2003, ECOL LETT, V6, P812, DOI 10.1046/j.1461-0248.2003.00512.x; Pringle EG, 2011, ECOLOGY, V92, P37, DOI 10.1890/10-0234.1; Quinet Y, 1997, BEHAV PROCESS, V40, P75, DOI 10.1016/S0376-6357(97)00773-0; Reber A, 2008, ECOL LETT, V11, P682, DOI 10.1111/j.1461-0248.2008.01177.x; Rosumek FB, 2009, OECOLOGIA, V160, P537, DOI 10.1007/s00442-009-1309-x; Rowles AD, 2009, OECOLOGIA, V161, P161, DOI 10.1007/s00442-009-1368-z; RYTI RT, 1992, AM MIDL NAT, V127, P190, DOI 10.2307/2426334; Sanders D, 2007, OECOLOGIA, V150, P611, DOI 10.1007/s00442-006-0538-5; Sanders D, 2011, J ANIM ECOL, V80, P569, DOI 10.1111/j.1365-2656.2010.01796.x; Sanders D, 2011, OIKOS, V120, P418, DOI 10.1111/j.1600-0706.2010.18924.x; Stadler B, 2002, ECOL LETT, V5, P216, DOI 10.1046/j.1461-0248.2002.00300.x; Stadler B, 2005, ANNU REV ECOL EVOL S, V36, P345, DOI 10.1146/annurev.ecolsys.36.091704.175531; Styrsky JD, 2007, P ROY SOC B-BIOL SCI, V274, P151, DOI 10.1098/rspb.2006.3701; Trager MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014308; Wardle DA, 2011, ECOLOGY, V92, P645, DOI 10.1890/10-1223.1; WAY MJ, 1963, ANNU REV ENTOMOL, V8, P307, DOI 10.1146/annurev.en.08.010163.001515; Wilder SM, 2011, P NATL ACAD SCI USA, V108, P20639, DOI 10.1073/pnas.1115263108; Wilder SM, 2011, ECOLOGY, V92, P325, DOI 10.1890/10-0623.1; Wimp GM, 2001, ECOLOGY, V82, P440, DOI 10.1890/0012-9658(2001)082[0440:BCOPAH]2.0.CO;2; Zelikova TJ, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00073.1; Zhang S, 2012, BASIC APPL ECOL, V13, P116, DOI 10.1016/j.baae.2012.02.002; Zhang S, 2012, ARTHROPOD-PLANT INTE, V6, P307, DOI 10.1007/s11829-011-9172-1; Zhang YX, 2006, OIKOS, V115, P81, DOI 10.1111/j.2006.0030-1299.15021.x	45	7	7	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35468	10.1371/journal.pone.0035468	http://dx.doi.org/10.1371/journal.pone.0035468			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558156	gold, Green Published, Green Submitted			2022-12-27	WOS:000305345200043
J	Loeb, KR; Asgari, MM; Hawes, SE; Feng, QH; Stern, JE; Jiang, MJ; Argenyi, ZB; de Villiers, EM; Kiviat, NB				Loeb, Keith R.; Asgari, Maryam M.; Hawes, Stephen E.; Feng, Qinghua; Stern, Joshua E.; Jiang, Mingjun; Argenyi, Zsolt B.; de Villiers, Ethel-Michele; Kiviat, Nancy B.			Analysis of Tp53 Codon 72 Polymorphisms, Tp53 Mutations, and HPV Infection in Cutaneous Squamous Cell Carcinomas	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; NONMELANOMA SKIN-CANCER; P53 GENE-MUTATIONS; IMMUNOCOMPETENT INDIVIDUALS; LUNG-CANCER; E6 PROTEINS; ARG72PRO POLYMORPHISM; INDUCED MUTAGENESIS; INDUCED APOPTOSIS; MUTANT P53	Background: Non-melanoma skin cancers are one of the most common human malignancies accounting for 2-3% of tumors in the US and represent a significant health burden. Epidemiology studies have implicated Tp53 mutations triggered by UV exposure, and human papilloma virus (HPV) infection to be significant causes of non-melanoma skin cancer. However, the relationship between Tp53 and cutaneous HPV infection is not well understood in skin cancers. In this study we assessed the association of HPV infection and Tp53 polymorphisms and mutations in lesional specimens with squamous cell carcinomas. Methods: We studied 55 cases of histologically confirmed cutaneous squamous cell carcinoma and 41 controls for the presence of HPV infection and Tp53 genotype (mutations and polymorphism). Results: We found an increased number of Tp53 mutations in the squamous cell carcinoma samples compared with perilesional or control samples. There was increased frequency of homozygous Tp53-72R polymorphism in cases with squamous cell carcinomas, while the Tp53-72P allele (Tp53-72R/P and Tp53-72P/P) was more frequent in normal control samples. Carcinoma samples positive for HPV showed a decreased frequency of Tp53 mutations compared to those without HPV infection. In addition, carcinoma samples with a Tp53-72P allele showed an increased incidence of Tp53 mutations in comparison carcinomas samples homozygous for Tp53-72R. Conclusions: These studies suggest there are two separate pathways (HPV infection and Tp53 mutation) leading to cutaneous squamous cell carcinomas stratified by the Tp53 codon-72 polymorphism. The presence of a Tp53-72P allele is protective against cutaneous squamous cell carcinoma, and carcinoma specimens with Tp53-72P are more likely to have Tp53 mutations. In contrast Tp53-72R is a significant risk factor for cutaneous squamous cell carcinoma and is frequently associated with HPV infection instead of Tp53 mutations. Heterozygosity for Tp53-72R/P is protective against squamous cell carcinomas, possibly reflecting a requirement for both HPV infection and Tp53 mutations.	[Loeb, Keith R.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Loeb, Keith R.; Feng, Qinghua; Stern, Joshua E.; Argenyi, Zsolt B.; Kiviat, Nancy B.] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Asgari, Maryam M.; Hawes, Stephen E.] Univ Washington, Dept Epidemiol, Sch Med, Seattle, WA 98195 USA; [Argenyi, Zsolt B.] Univ Washington, Div Dermatol, Sch Med, Seattle, WA 98195 USA; [Kiviat, Nancy B.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [de Villiers, Ethel-Michele] Deutsch Krebsforschungszentrum, Div Characterizat Tumorviruses, D-6900 Heidelberg, Germany; [Jiang, Mingjun] Natl Acad Med Sci, Inst Dermatol, Nanjing, Jiangsu, Peoples R China	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Helmholtz Association; German Cancer Research Center (DKFZ); Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Dermatology - CAMS	Loeb, KR (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	nbk@u.washington.edu	Asgari, Maryam/O-4947-2016		National Institute of Environmental Health Sciences [K08-ES00382]; National Institute of Health [F32 AR47552]; National Cancer Institute [R01 CA084087]; Ministry of Health, Berlin; NATIONAL CANCER INSTITUTE [R01CA084087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR047552] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K08ES000382] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ministry of Health, Berlin; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by grants from the National Institute of Environmental Health Sciences (K08-ES00382, KRL), National Institute of Health (F32 AR47552, MMA) and the National Cancer Institute (R01 CA084087, NBK) as well as the Ministry of Health, Berlin (EMV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Alam M, 2001, NEW ENGL J MED, V344, P975, DOI 10.1056/NEJM200103293441306; Alotaibi L, 2006, J CLIN VIROL, V36, P133, DOI 10.1016/j.jcv.2006.02.007; AMSTAD P, 1994, MOL CARCINOGEN, V10, P181, DOI 10.1002/mc.2940100402; Andersson K, 2008, CANCER EPIDEM BIOMAR, V17, P189, DOI 10.1158/1055-9965.EPI-07-0405; ARENDS MJ, 1993, HUM PATHOL, V24, P432, DOI 10.1016/0046-8177(93)90093-V; ARMSTRONG BK, 1995, DERMATOL CLIN, V13, P583, DOI 10.1016/S0733-8635(18)30064-0; Arron ST, 2011, J INVEST DERMATOL; Asgari MM, 2008, J INVEST DERMATOL, V128, P1409, DOI 10.1038/sj.jid.5701227; Azzam GA, 2011, CELL CYCLE, V10, P1352, DOI 10.4161/cc.10.9.15344; Bastiaens MT, 2001, MOL CARCINOGEN, V30, P56, DOI 10.1002/1098-2744(200101)30:1<56::AID-MC1013>3.0.CO;2-2; Bavinck JNB, 2010, CANCER RES, V70, P9777, DOI 10.1158/0008-5472.CAN-10-0352; Bendesky A, 2007, MUTAT RES-FUND MOL M, V619, P38, DOI 10.1016/j.mrfmmm.2007.01.001; Bin X, 2010, CANCER GENET CYTOGEN, V202, P76, DOI 10.1016/j.cancergencyto.2010.02.014; Brachmann RK, 1996, P NATL ACAD SCI USA, V93, P4091, DOI 10.1073/pnas.93.9.4091; Brant O, 2007, ANTICANCER RES, V27, P3301; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; Caceres DD, 2009, LUNG, V187, P110, DOI 10.1007/s00408-008-9133-3; Cairey-Remonnay S, 2002, J INVEST DERMATOL, V118, P1026, DOI 10.1046/j.1523-1747.2002.01787.x; de Oliveira WRP, 2004, INT J DERMATOL, V43, P489, DOI 10.1111/j.1365-4632.2004.02289.x; DITTMER D, 1993, NAT GENET, V4, P42, DOI 10.1038/ng0593-42; Dokianakis DN, 2000, INT J MOL MED, V5, P405; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Durinck S, 2011, CANCER DISCOV, V1, P137, DOI 10.1158/2159-8290.CD-11-0028; Fallai C, 2009, INT J RADIAT ONCOL, V75, P1053, DOI 10.1016/j.ijrobp.2008.12.088; Fei JW, 2008, INT J CANCER, V123, P108, DOI 10.1002/ijc.23506; Fei JW, 2005, CELL CYCLE, V4, P689, DOI 10.4161/cc.4.5.1653; Feltkamp MCW, 2008, J CLIN VIROL, V43, P353, DOI 10.1016/j.jcv.2008.09.009; Forslund O, 1999, J GEN VIROL, V80, P2437, DOI 10.1099/0022-1317-80-9-2437; Forslund O, 2007, J GEN VIROL, V88, P2662, DOI 10.1099/vir.0.82911-0; Forslund O, 2007, J INFECT DIS, V196, P876, DOI 10.1086/521031; Frank AK, 2011, MOL CELL BIOL, V31, P1201, DOI 10.1128/MCB.01136-10; Galic V, 2007, GENE CHROMOSOME CANC, V46, P239, DOI 10.1002/gcc.20407; Garcia-Zuazaga Jorge, 2008, Adv Dermatol, V24, P33, DOI 10.1016/j.yadr.2008.09.007; Guan B, 2011, CANCER RES, V71, P6718, DOI 10.1158/0008-5472.CAN-11-1562; Hainaut P, 1998, NUCLEIC ACIDS RES, V26, P205, DOI 10.1093/nar/26.1.205; Hainaut P, 2000, ADV CANCER RES, V77, P81; Han JL, 2006, MOL CARCINOGEN, V45, P694, DOI 10.1002/mc.20190; HARRIS CC, 1993, SCIENCE, V262, P1980, DOI 10.1126/science.8266092; Harwood CA, 2000, J MED VIROL, V61, P289, DOI 10.1002/1096-9071(200007)61:3&lt;289::AID-JMV2&gt;3.0.CO;2-Z; HAUSEN HZ, 1991, VIROLOGY, V184, P9, DOI 10.1016/0042-6822(91)90816-T; Hjortsberg L, 2008, P53 MUTATION HDB 2 0; Hoffmann M, 2009, ONCOL REP, V21, P809, DOI 10.3892/or_00000288; Hu YC, 2005, CLIN CANCER RES, V11, P2502, DOI 10.1158/1078-0432.CCR-04-1913; Jackson S, 2000, GENE DEV, V14, P3065, DOI 10.1101/gad.182100; Jha P, 2011, EXP MOL PATHOL, V90, P167, DOI 10.1016/j.yexmp.2010.11.002; Jonason AS, 1996, P NATL ACAD SCI USA, V93, P14025, DOI 10.1073/pnas.93.24.14025; Karagas MR, 2006, J NATL CANCER I, V98, P389, DOI 10.1093/jnci/djj092; Kiviat NB, 1999, SEMIN CANCER BIOL, V9, P397, DOI 10.1006/scbi.1999.0143; Koushik A, 2006, INT J CANCER, V119, P1863, DOI 10.1002/ijc.22057; KUBO Y, 1994, J INVEST DERMATOL, V102, P440, DOI 10.1111/1523-1747.ep12373002; Lee JM, 2006, MUTAT RES-FUND MOL M, V594, P181, DOI 10.1016/j.mrfmmm.2005.09.003; Leverrier S, 2007, APOPTOSIS, V12, P549, DOI 10.1007/s10495-006-0004-1; Li CY, 2008, J INVEST DERMATOL, V128, P1585, DOI 10.1038/sj.jid.5701186; Li FL, 2010, CANCER-AM CANCER SOC, V116, P2350, DOI 10.1002/cncr.25072; Li XQ, 1996, J VIROL, V70, P4509, DOI 10.1128/JVI.70.7.4509-4516.1996; Li Y, 2009, LUNG CANCER, V66, P15, DOI 10.1016/j.lungcan.2008.12.009; LORINCZ AT, 1992, OBSTET GYNECOL, V79, P328, DOI 10.1097/00006250-199203000-00002; Mantovani F, 2007, NAT STRUCT MOL BIOL, V14, P912, DOI 10.1038/nsmb1306; Marin MC, 2000, NAT GENET, V25, P47, DOI 10.1038/75586; McGregor JM, 1997, ONCOGENE, V15, P1737, DOI 10.1038/sj.onc.1201339; McGregor JM, 2002, J INVEST DERMATOL, V119, P84, DOI 10.1046/j.1523-1747.2002.01655.x; MILLER DL, 1994, J AM ACAD DERMATOL, V30, P774, DOI 10.1016/S0190-9622(08)81509-5; Mitra S, 2007, J CLIN PATHOL, V60, P1040, DOI 10.1136/jcp.2005.034835; Mojtahedi Z, 2010, BRAZ J OTORHINOLAR, V76, P316, DOI 10.1590/S1808-86942010000300008; Moshinsky DJ, 1997, P NATL ACAD SCI USA, V94, P2266, DOI 10.1073/pnas.94.6.2266; Nan H, 2008, BRIT J DERMATOL, V159, P314, DOI 10.1111/j.1365-2133.2008.08624.x; O'Connor DP, 2001, J CLIN PATHOL, V54, P539, DOI 10.1136/jcp.54.7.539; Orth G, 1987, PAPOVAVIRIDAE; Pantelis A, 2007, ONCOL REP, V17, P1243; Patel AS, 2008, J INVEST DERMATOL, V128, P2888, DOI 10.1038/jid.2008.162; Piao JM, 2011, LUNG CANC; PRESTON DS, 1992, NEW ENGL J MED, V327, P1649, DOI 10.1056/NEJM199212033272307; Purdie KJ, 2005, J INVEST DERMATOL, V125, P98, DOI 10.1111/j.0022-202X.2005.23635.x; REES J, 1994, J INVEST DERMATOL, V103, P747, DOI 10.1111/1523-1747.ep12412256; Ren ZP, 1996, ONCOGENE, V12, P765; Ren ZP, 1997, AM J PATHOL, V150, P1791; Rollison DE, 2008, INT J CANCER, V123, P2337, DOI 10.1002/ijc.23795; ROWE DE, 1992, J AM ACAD DERMATOL, V26, P976, DOI 10.1016/0190-9622(92)70144-5; Sakamuro D, 1997, ONCOGENE, V15, P887, DOI 10.1038/sj.onc.1201263; Salvioli S, 2005, CELL CYCLE, V4, P1264, DOI 10.4161/cc.4.9.1978; Schwartz JL, 2011, ENVIRON MOL MUTAGEN, V52, P77, DOI 10.1002/em.20635; Siddique M, 2006, ONCOGENE, V25, P3489, DOI 10.1038/sj.onc.1209405; Sjalander A, 1996, HUM HERED, V46, P41, DOI 10.1159/000154324; Stefanaki I, 2007, BRIT J DERMATOL, V156, P357, DOI 10.1111/j.1365-2133.2006.07645.x; Storey A, 1998, NATURE, V393, P229, DOI 10.1038/30400; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Strauss BS, 1997, CARCINOGENESIS, V18, P1445, DOI 10.1093/carcin/18.8.1445; Struijk L, 2008, J GEN VIROL, V89, P2303, DOI 10.1099/vir.0.83317-0; Szybka M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-278; Szymanowska A, 2006, LUNG CANCER, V52, P9, DOI 10.1016/j.lungcan.2005.12.007; Thomas M, 1999, MOL CELL BIOL, V19, P1092; Underbrink MP, 2008, J VIROL, V82, P10408, DOI 10.1128/JVI.00902-08; Vasiljevic N, 2008, J GEN VIROL, V89, P2467, DOI 10.1099/vir.0.2008/001925-0; Walker KK, 1996, P NATL ACAD SCI USA, V93, P15335, DOI 10.1073/pnas.93.26.15335; Waterboer T, 2008, BRIT J DERMATOL, V159, P457, DOI 10.1111/j.1365-2133.2008.08621.x; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Yang WJ, 2008, MOL CARCINOGEN, V47, P100, DOI 10.1002/mc.20368; YUTSUDO M, 1994, J CLIN MICROBIOL, V32, P1076, DOI 10.1128/JCM.32.4.1076-1078.1994; Zawlik I, 2009, BRAIN PATHOL, V19, P188, DOI 10.1111/j.1750-3639.2008.00170.x; Zhu F, 2010, CANCER RES, V70, P5851, DOI 10.1158/0008-5472.CAN-09-4646; ZIEGLER A, 1993, P NATL ACAD SCI USA, V90, P4216, DOI 10.1073/pnas.90.9.4216	102	13	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e34422	10.1371/journal.pone.0034422	http://dx.doi.org/10.1371/journal.pone.0034422			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545084	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343200007
J	Majumder, M; Tutunea-Fatan, E; Xin, XP; Rodriguez-Torres, M; Torres-Garcia, J; Wiebe, R; Timoshenko, AV; Bhattacharjee, RN; Chambers, AF; Lala, PK				Majumder, Mousumi; Tutunea-Fatan, Elena; Xin, Xiping; Rodriguez-Torres, Mauricio; Torres-Garcia, Jose; Wiebe, Ryan; Timoshenko, Alexander V.; Bhattacharjee, Rabindra N.; Chambers, Ann F.; Lala, Peeyush K.			Co-Expression of alpha 9 beta 1 Integrin and VEGF-D Confers Lymphatic Metastatic Ability to a Human Breast Cancer Cell Line MDA-MB-468LN	PLOS ONE			English	Article							GROWTH-FACTOR-C; VASCULAR CHANNEL FORMATION; GENE-EXPRESSION PROFILES; ENDOTHELIAL-CELLS; PROGNOSTIC-SIGNIFICANCE; INDUCED ANGIOGENESIS; PROTEIN OSTEOPONTIN; TUMOR-METASTASIS; MELANOMA-CELLS; LUNG-CANCER	Introduction and Objectives: Lymphatic metastasis is a common occurrence in human breast cancer, mechanisms remaining poorly understood. MDA-MB-468LN (468LN), a variant of the MDA-MB-468GFP (468GFP) human breast cancer cell line, produces extensive lymphatic metastasis in nude mice. 468LN cells differentially express alpha 9 beta 1 integrin, a receptor for lymphangiogenic factors VEGF-C/-D. We explored whether (1) differential production of VEGF-C/-D by 468LN cells provides an autocrine stimulus for cellular motility by interacting with alpha 9 beta 1 and a paracrine stimulus for lymphangiogenesis in vitro as measured with capillary-like tube formation by human lymphatic endothelial cells (HMVEC-dLy); (2) differential expression of alpha 9 also promotes cellular motility/invasiveness by interacting with macrophage derived factors; (3) stable knock-down of VEGF-D or alpha 9 in 468LN cells abrogates lymphangiogenesis and lymphatic metastasis in vivo in nude mice. Results: A comparison of expression of cyclo-oxygenase (COX)-2 (a VEGF-C/-D inducer), VEGF-C/-D and their receptors revealed little COX-2 expression by either cells. However, 468LN cells showed differential VEGF-D and alpha 9 beta 1 expression, VEGF-D secretion, proliferative, migratory/invasive capacities, latter functions being stimulated further with VEGF-D. The requirement of alpha 9 beta 1 for native and VEGF-D-stimulated proliferation, migration and Erk activation was demonstrated by treating with alpha 9 beta 1 blocking antibody or knock-down of alpha 9. An autocrine role of VEGF-D in migration was shown by its impairment by silencing VEGF-D and restoration with VEGF-D. 468LN cells and their soluble products stimulated tube formation, migration/invasiveness of HMVEC-dLy cell in a VEGF-D dependent manner as indicated by the loss of stimulation by silencing VEGF-D in 468LN cells. Furthermore, 468LN cells showed alpha 9-dependent stimulation of migration/invasiveness by macrophage products. Finally, capacity for intra-tumoral lymphangiogenesis and lymphatic metastasis in nude mice was completely abrogated by stable knock-down of either VEGF-D or alpha 9 in 468LN cells. Conclusion: Differential capacity for VEGF-D production and alpha 9 beta 1 integrin expression by 468LN cells jointly contributed to their lymphatic metastatic phenotype.	[Majumder, Mousumi; Tutunea-Fatan, Elena; Xin, Xiping; Rodriguez-Torres, Mauricio; Torres-Garcia, Jose; Wiebe, Ryan; Timoshenko, Alexander V.; Bhattacharjee, Rabindra N.; Lala, Peeyush K.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada; [Timoshenko, Alexander V.] Univ Western Ontario, Dept Biol, London, ON, Canada; [Chambers, Ann F.] Univ Western Ontario, Dept Med Biophys, London, ON, Canada; [Chambers, Ann F.; Lala, Peeyush K.] Univ Western Ontario, Dept Oncol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Majumder, M (corresponding author), Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada.	pklala@uwo.ca	Timoshenko, Alexander/H-9873-2019; Chambers, Ann F/L-6285-2015	Timoshenko, Alexander/0000-0002-4237-513X; Chambers, Ann F/0000-0002-9509-5123	Ontario Institute of Cancer Research; Canadian Breast Cancer Foundation (CBCF), Ontario Chapter; Translational Breast Cancer Research Unit (TBCRU); Cancer Research Technology Transfer (CaRTT) of the London Regional Cancer Program; Fellowship of the CBCF; Canada Research Chairs Program	Ontario Institute of Cancer Research; Canadian Breast Cancer Foundation (CBCF), Ontario Chapter; Translational Breast Cancer Research Unit (TBCRU); Cancer Research Technology Transfer (CaRTT) of the London Regional Cancer Program; Fellowship of the CBCF; Canada Research Chairs Program(Canada Research Chairs)	The Ontario Institute of Cancer Research and the Canadian Breast Cancer Foundation (CBCF), Ontario Chapter, for grant support to PKL. ETF is supported by scholarships from the Translational Breast Cancer Research Unit (TBCRU) and Cancer Research Technology Transfer (CaRTT) of the London Regional Cancer Program and RNB by a Fellowship of the CBCF. AFC is Canada Research Chair in Oncology, supported by the Canada Research Chairs Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan AL, 2006, AM J PATHOL, V169, P233, DOI 10.2353/ajpath.2006.051152; Allen MD, 2011, J PATHOL, V223, P646, DOI 10.1002/path.2833; Basu GD, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1626; Belien JAM, 1999, J CLIN PATHOL, V52, P184, DOI 10.1136/jcp.52.3.184; Bertl E, 2006, MOL CANCER THER, V5, P575, DOI 10.1158/1535-7163.MCT-05-0324; Bhattacharjee RN, 2010, CANCER SCI, V101, P2026, DOI 10.1111/j.1349-7006.2010.01647.x; Decaestecker C, 2007, MED RES REV, V27, P149, DOI 10.1002/med.20078; Gimi B, 2006, NEOPLASIA, V8, P207, DOI 10.1593/neo.05547; Gu Y, 2008, CLIN EXP METASTAS, V25, P717, DOI 10.1007/s10585-008-9180-4; Hedley BD, 2008, INT J CANCER, V123, P526, DOI 10.1002/ijc.23542; Henriksen K, 2003, J BIOL CHEM, V278, P48745, DOI 10.1074/jbc.M309193200; Hong YK, 2004, FASEB J, V18, P1111, DOI 10.1096/fj.03-1179fje; Hu Z, 2005, CLIN CANCER RES, V11, P4646, DOI 10.1158/1078-0432.CCR-04-2013; Huang XZ, 2000, MOL CELL BIOL, V20, P5208, DOI 10.1128/MCB.20.14.5208-5215.2000; Iivanainen E, 2003, FASEB J, V17, P1609, DOI 10.1096/fj.02-0939com; Jadeski LC, 1999, AM J PATHOL, V155, P1381, DOI 10.1016/S0002-9440(10)65240-6; Ji Rui-Cheng, 2006, Lymphatic Research and Biology, V4, P83, DOI 10.1089/lrb.2006.4.83; Khodarev NN, 2003, J CELL SCI, V116, P1013, DOI 10.1242/jcs.00281; Leidenius M, 2007, AM J CLIN PATHOL, V128, P759; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Lin CH, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/351010; Liu TC, 2011, INT J ONCOL, V38, P1349, DOI 10.3892/ijo.2011.946; MACKIE EJ, 1987, P NATL ACAD SCI USA, V84, P4621, DOI 10.1073/pnas.84.13.4621; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Marchio S, 1999, J BIOL CHEM, V274, P27617, DOI 10.1074/jbc.274.39.27617; Martinetti A, 2004, ENDOCR-RELAT CANCER, V11, P771, DOI 10.1677/erc.1.00775; McColl BK, 2007, FASEB J, V21, P1088, DOI 10.1096/fj.06-7060com; Mikhaylova M, 2008, NEOPLASIA, V10, P380, DOI 10.1593/neo.07854; Mohammed RAA, 2007, BRIT J CANCER, V96, P1092, DOI 10.1038/sj.bjc.6603678; Nishimichi N, 2009, J BIOL CHEM, V284, P14769, DOI 10.1074/jbc.M901515200; Oommen S, 2011, J BIOL CHEM, V286, P1083, DOI 10.1074/jbc.M110.175158; Pan MR, 2009, J CELL SCI, V122, P3358, DOI 10.1242/jcs.050005; Pandit TS, 2009, INT J ONCOL, V35, P297, DOI 10.3892/ijo_00000340; Partanen TA, 2000, FASEB J, V14, P2087, DOI 10.1096/fj.99-1049com; Rodenhiser DI, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2121; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Rozic JG, 2001, INT J CANCER, V93, P497, DOI 10.1002/ijc.1376; Rudland PS, 2002, CANCER RES, V62, P3417; Saharinen P, 2004, TRENDS IMMUNOL, V25, P387, DOI 10.1016/j.it.2004.05.003; Shang T, 1999, J LEUKOCYTE BIOL, V66, P809, DOI 10.1002/jlb.66.5.809; Shields JD, 2007, ONCOGENE, V26, P2997, DOI 10.1038/sj.onc.1210114; Sleeman JP, 2009, INT J CANCER, V125, P2747, DOI 10.1002/ijc.24702; Sonvilla G, 2008, CARCINOGENESIS, V29, P15, DOI 10.1093/carcin/bgm202; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Tanno S, 2004, LUNG CANCER, V46, P11, DOI 10.1016/j.lungcan.2004.03.006; Timoshenko AV, 2007, BRIT J CANCER, V97, P1090, DOI 10.1038/sj.bjc.6603993; Timoshenko AV, 2006, BRIT J CANCER, V94, P1154, DOI 10.1038/sj.bjc.6603067; Truong PT, 2008, EUR J CANCER, V44, P1670, DOI 10.1016/j.ejca.2008.05.011; Tuck AB, 2007, J CELL BIOCHEM, V102, P859, DOI 10.1002/jcb.21520; Van der Auwera I, 2004, CLIN CANCER RES, V10, P7965, DOI 10.1158/1078-0432.CCR-04-0063; Vantyghem SA, 2005, CLIN EXP METASTAS, V22, P351, DOI 10.1007/s10585-005-0745-1; Vlahakis NE, 2005, J BIOL CHEM, V280, P4544, DOI 10.1074/jbc.M412816200; Vlahakis NE, 2007, J BIOL CHEM, V282, P15187, DOI 10.1074/jbc.M609323200; Watari K, 2008, BIOCHEM BIOPH RES CO, V377, P826, DOI 10.1016/j.bbrc.2008.10.077; Wissmann C, 2006, CLIN CANCER RES, V12, P6865, DOI 10.1158/1078-0432.CCR-06-1800; Xu J, 2008, CANCER GENET CYTOGEN, V181, P1, DOI 10.1016/j.cancergencyto.2007.05.030; Yang WT, 2002, CANCER, V94, P2855, DOI 10.1002/cncr.10553; Zeng YP, 2004, CLIN CANCER RES, V10, P5137, DOI 10.1158/1078-0432.CCR-03-0434	58	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35094	10.1371/journal.pone.0035094	http://dx.doi.org/10.1371/journal.pone.0035094			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545097	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343200019
J	Govind, V; Sharma, KR; Maudsley, AA; Arheart, KL; Saigal, G; Sheriff, S				Govind, Varan; Sharma, Khema R.; Maudsley, Andrew A.; Arheart, Kristopher L.; Saigal, Gaurav; Sheriff, Sulaiman			Comprehensive Evaluation of Corticospinal Tract Metabolites in Amyotrophic Lateral Sclerosis Using Whole-Brain H-1 MR Spectroscopy	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; MOTOR-NEURON DISEASES; N-ACETYLASPARTATE; DIFFUSION-TENSOR; ALS; CORTEX; DEGENERATION; THERAPY; NAA	Changes in the distribution of the proton magnetic resonance spectroscopy (MRS) observed metabolites N-acetyl aspartate (NAA), total-choline (Cho), and total-creatine (Cre) in the entire intracranial corticospinal tract (CST) including the primary motor cortex were evaluated in patients with amyotrophic lateral sclerosis (ALS). The study included 38 sporadic definite-ALS subjects and 70 age-matched control subjects. All received whole-brain MR imaging and spectroscopic imaging scans at 3T and clinical neurological assessments including percentage maximum forced vital capacity (FVC) and upper motor neuron (UMN) function. Differences in each individual metabolite and its ratio distributions were evaluated in the entire intracranial CST and in five segments along the length of the CST (at the levels of precentral gyrus (PCG), centrum semiovale (CS), corona radiata (CR), posterior limb of internal capsule (PLIC) and cerebral peduncle (CP)). Major findings included significantly decreased NAA and increased Cho and Cho/NAA in the entire intracranial CST, with the largest differences for Cho/NAA in all the groups. Significant correlations between Cho/NAA in the entire intracranial CST and the right finger tap rate were noted. Of the ten bilateral CST segments, significantly decreased NAA in 4 segments, increased Cho in 5 segments and increased Cho/NAA in all the segments were found. Significant left versus right CST asymmetries were found only in ALS for Cho/NAA in the CS. Among the significant correlations found between Cho/NAA and the clinical assessments included the left-PCG versus FVC and right finger tap rate, left -CR versus FVC and right finger tap rate, and left PLIC versus FVC and right foot tap rate. These results demonstrate that a significant and bilaterally asymmetric alteration of metabolites occurs along the length of the entire intracranial CST in ALS, and the MRS metrics in the segments correlate with measures of disease severity and UMN function.	[Govind, Varan; Maudsley, Andrew A.; Saigal, Gaurav; Sheriff, Sulaiman] Univ Miami, Sch Med, Dept Radiol, Miami, FL USA; [Sharma, Khema R.] Univ Miami, Sch Med, Dept Neurol, Miami, FL USA; [Arheart, Kristopher L.] Univ Miami, Sch Med, Dept Epidemiol, Miami, FL USA	University of Miami; University of Miami; University of Miami	Govind, V (corresponding author), Univ Miami, Sch Med, Dept Radiol, Miami, FL USA.	VGovind@med.miami.edu		Maudsley, Andrew/0000-0001-7653-3063; Govind, Varan/0000-0002-1205-5194	Stanley Glaser Foundation; National Institutes of Health [R01 NS060874]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060874] Funding Source: NIH RePORTER	Stanley Glaser Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the Stanley Glaser Foundation and National Institutes of Health grant R01 NS060874. The data processing software used was developed under R01 EB000822. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2001, NEURORADIOLOGY, V43, P537, DOI 10.1007/s002340000521; Block W, 1998, ARCH NEUROL-CHICAGO, V55, P931, DOI 10.1001/archneur.55.7.931; Block W, 2002, AMINO ACIDS, V23, P317, DOI 10.1007/s00726-001-0144-0; Bowen BC, 2000, AM J NEURORADIOL, V21, P647; Bradley WG, 1999, J NEUROL SCI, V169, P84, DOI 10.1016/S0022-510X(99)00221-X; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Chan S, 1999, RADIOLOGY, V212, P763, DOI 10.1148/radiology.212.3.r99au35763; Charil A, 2009, AMYOTROPH LATERAL SC, V10, P269, DOI 10.3109/17482960902777339; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; Ellis CM, 1998, NEUROLOGY, V51, P1104, DOI 10.1212/WNL.51.4.1104; Filippi M, 2010, EUR J NEUROL, V17, P526, DOI 10.1111/j.1468-1331.2010.02951.x; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Gredal O, 1997, NEUROLOGY, V48, P878, DOI 10.1212/WNL.48.4.878; Kalra S, 1998, NEUROREPORT, V9, P1757, DOI 10.1097/00001756-199806010-00016; Kalra S, 2006, J NEUROL, V253, P1060, DOI 10.1007/s00415-006-0162-7; Kalra S, 2006, ARCH NEUROL-CHICAGO, V63, P1144, DOI 10.1001/archneur.63.8.1144; Kato S, 2008, ACTA NEUROPATHOL, V115, P97, DOI 10.1007/s00401-007-0308-4; Kaufmann P, 2004, NEUROLOGY, V62, P1753, DOI 10.1212/01.WNL.0000125182.17874.59; Kent-Braun JA, 1998, MUSCLE NERVE, V21, P762, DOI 10.1002/(SICI)1097-4598(199806)21:6<762::AID-MUS8>3.0.CO;2-5; Maudsley AA, 2006, NMR BIOMED, V19, P492, DOI 10.1002/nbm.1025; Maudsley AA, 2010, NMR BIOMED, V23, P251, DOI 10.1002/nbm.1445; Mitsumoto H, 2007, NEUROLOGY, V68, P1402, DOI 10.1212/01.wnl.0000260065.57832.87; Naganska E, 2011, FOLIA NEUROPATHOL, V49, P1; Oishi K, 2009, NEUROIMAGE, V46, P486, DOI 10.1016/j.neuroimage.2009.01.002; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Pohl C, 2001, ARCH NEUROL-CHICAGO, V58, P729, DOI 10.1001/archneur.58.5.729; Pyra T, 2010, AMYOTROPH LATERAL SC, V11, P157, DOI 10.3109/17482960902756473; Rooney WD, 1998, NEUROLOGY, V50, P1800, DOI 10.1212/WNL.50.6.1800; Rule RR, 2004, AMYOTROPH LATERAL SC, V5, P141, DOI 10.1080/14660820410017109; Sarchielli P, 2001, NEURORADIOLOGY, V43, P189, DOI 10.1007/s002340000472; Schuff N, 2001, MAGN RESON MED, V45, P513, DOI 10.1002/1522-2594(200103)45:3<513::AID-MRM1067>3.0.CO;2-D; Sharma KR, 2011, NMR BIOMED, V24, P1270, DOI 10.1002/nbm.1687; SIMMONS ML, 1991, NEUROSCIENCE, V45, P37, DOI 10.1016/0306-4522(91)90101-S; Sivak S, 2010, NEURORADIOLOGY, V52, P1079, DOI 10.1007/s00234-010-0685-6; SMITH SA, 1994, J MAGN RESON SER A, V106, P75, DOI 10.1006/jmra.1994.1008; Turner Martin R, 2010, Expert Opin Med Diagn, V4, P483, DOI 10.1517/17530059.2010.536836; Unrath A, 2007, J NEUROL, V254, P1099, DOI 10.1007/s00415-006-0495-2; Wang SM, 2006, RADIOLOGY, V239, P831, DOI 10.1148/radiol.2393050573; Yin H, 2004, J NEUROL, V251, P1249, DOI 10.1007/s00415-004-0526-9; Zhang YJ, 2010, NEUROIMAGE, V52, P1289, DOI 10.1016/j.neuroimage.2010.05.049	42	33	34	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35607	10.1371/journal.pone.0035607	http://dx.doi.org/10.1371/journal.pone.0035607			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539984	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341000050
J	Laskaris, P; Sekine, T; Wellington, EMH				Laskaris, Paris; Sekine, Takuya; Wellington, Elizabeth M. H.			Diversity Analysis of Streptomycetes and Associated Phosphotranspherase Genes in Soil	PLOS ONE			English	Article							16S RDNA; AMINOGLYCOSIDE ANTIBIOTICS; AMINOTRANSFERASE GENES; RESISTANCE; IDENTIFICATION; BIOSYNTHESIS; BACTERIA; CLADE; PCR; ACTINOBACTERIA	An attempt was made to verify the observation that Streptomyces griseus was prevalent in soil based on isolation work. A genus-specific PCR was developed for Streptomyces based on the housekeeping gene atpD and used to investigate species diversity within selected soils. The presence of S. griseus was investigated to determine coexistence of resistance-only streptomycin phosphotransferase (strA) in the same soil as streptomycin producers. Two additional PCR-based assays were developed; one specific for strA in association with production, the other for more diverse strA and other related phosphotranferases. Both the S. griseus atpD and strA genes were below the PCR detection limit in all soils examined. A number of more diverse phosphotransferase genes were amplified, a minority of which may be associated with streptomycin production. We conclude that neither streptomycin producers nor S. griseus are prevalent in the fresh or chitin and starch-amended soils examined (less than 0.1% of soil actinobacteria). One of the soil sites had received plantomycin (active ingredient: streptomycin) and diversity studies suggested that this altered the streptomycete populations present in the soil.	[Laskaris, Paris; Sekine, Takuya; Wellington, Elizabeth M. H.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick	Laskaris, P (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	plaskaris@ufl.edu		Wellington, ELizabeth/0000-0002-4329-0699	United Kingdom Biotechnology and Biological Sciences Research Council [BBSRC BB/F003498/1]; European Union [222625, KBBE-2007-3-3-05]; Biotechnology and Biological Sciences Research Council [BB/F003498/1] Funding Source: researchfish; BBSRC [BB/F003498/1] Funding Source: UKRI	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project was supported by grants from the United Kingdom Biotechnology and Biological Sciences Research Council (grant reference: BBSRC BB/F003498/1) and the European Union's 7th Framework Programme for Research and Technological Development (grant agreement no. 222625 METAEXPLORE, EU FP7 Theme KBBE-2007-3-3-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AS, 2002, J IND MICROBIOL BIOT, V29, P60, DOI 10.1038/sj.jim.7000260; Anderson AS, 2001, INT J SYST EVOL MICR, V51, P797, DOI 10.1099/00207713-51-3-797; Aoki R, 2008, BIOSCI BIOTECH BIOCH, V72, P1388, DOI 10.1271/bbb.80033; Babalola OO, 2009, ENVIRON MICROBIOL, V11, P566, DOI 10.1111/j.1462-2920.2008.01809.x; Baltz RH, 2006, J IND MICROBIOL BIOT, V33, P507, DOI 10.1007/s10295-005-0077-9; Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; Borjesson S, 2009, INT J ENVIRON HEAL R, V19, P219, DOI 10.1080/09603120802449593; Calvo-Bado L, COMMUNICATION; Casjens S, 1998, ANNU REV GENET, V32, P339, DOI 10.1146/annurev.genet.32.1.339; Chanal A, 2006, ENVIRON MICROBIOL, V8, P514, DOI 10.1111/j.1462-2920.2005.00921.x; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Davelos AL, 2004, MICROB ECOL, V48, P601, DOI 10.1007/s00248-004-0031-9; DSMZ, 2012, CAT MICR; Egan S, 2001, ANTON LEEUW INT J G, V79, P127, DOI 10.1023/A:1010296220929; Euzeby J. P., 2012, LIST PROKARYOTIC NAM; Garcia C, 2004, SITE DESCRIPTION; Gharaibeh R, 2003, J BASIC MICROB, V43, P301, DOI 10.1002/jobm.200390033; Goodfellow M, 2007, ANTON LEEUW INT J G, V92, P173, DOI 10.1007/s10482-007-9146-6; Gundlapally SR, 2006, MICROB ECOL, V52, P345, DOI 10.1007/s00248-006-9011-6; Guo YP, 2008, INT J SYST EVOL MICR, V58, P149, DOI 10.1099/ijs.0.65224-0; Hain T, 1997, INT J SYST BACTERIOL, V47, P202, DOI 10.1099/00207713-47-1-202; Hanage WP, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-6; Holmes AJ, 2000, FEMS MICROBIOL ECOL, V33, P111, DOI 10.1016/S0168-6496(00)00051-9; Jones D, 1944, SCIENCE, V100, P103, DOI 10.1126/science.100.2588.103; Kataoka M, 1997, FEMS MICROBIOL LETT, V151, P249, DOI 10.1016/S0378-1097(97)00169-9; Kim BJ, 2004, INT J SYST EVOL MICR, V54, P593, DOI 10.1099/ijs.0.02941-0; KORMANEC J, 1992, GENE, V114, P133, DOI 10.1016/0378-1119(92)90719-6; Kumar Y, 2008, INT J SYST EVOL MICR, V58, P1369, DOI 10.1099/ijs.0.65408-0; Lanoot B, 2005, RES MICROBIOL, V156, P755, DOI 10.1016/j.resmic.2005.01.017; Laskaris P, 2010, ENVIRON MICROBIOL, V12, P783, DOI 10.1111/j.1462-2920.2009.02125.x; Liu ZH, 2005, INT J SYST EVOL MICR, V55, P1605, DOI 10.1099/ijs.0.63654-0; Manome A, 2008, PLANT PATHOL, V57, P887, DOI 10.1111/j.1365-3059.2008.01881.x; McManus PS, 2002, ANNU REV PHYTOPATHOL, V40, P443, DOI 10.1146/annurev.phyto.40.120301.093927; Metcalfe AC, 2002, APPL ENVIRON MICROB, V68, P5042, DOI 10.1128/AEM.68.10.5042-5050.2002; Monciardini P, 2002, FEMS MICROBIOL ECOL, V42, P419, DOI 10.1111/j.1574-6941.2002.tb01031.x; Mun HS, 2007, SYST APPL MICROBIOL, V30, P401, DOI 10.1016/j.syapm.2007.01.003; Nagaya A, 2005, BIOSCI BIOTECH BIOCH, V69, P1389, DOI 10.1271/bbb.69.1389; Pontiroli A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017916; Qu XS, 2008, PHYTOPATHOLOGY, V98, P405, DOI 10.1094/PHYTO-98-4-0405; Riesenfeld CS, 2004, ENVIRON MICROBIOL, V6, P981, DOI 10.1111/j.1462-2920.2004.00664.x; Rong XY, 2010, INT J SYST EVOL MICR, V60, P696, DOI 10.1099/ijs.0.012419-0; Schlatter DC, 2010, APPL ENVIRON MICROB, V76, P2009, DOI 10.1128/AEM.02320-09; Smith JJ, 2006, MICROB ECOL, V51, P413, DOI 10.1007/s00248-006-9022-3; Stach JEM, 2003, ENVIRON MICROBIOL, V5, P828, DOI 10.1046/j.1462-2920.2003.00483.x; Staley JT, 2006, PHILOS T R SOC B, V361, P1899, DOI 10.1098/rstb.2006.1914; SUNDIN GW, 1995, CAN J MICROBIOL, V41, P792, DOI 10.1139/m95-109; Tamegai H, 2006, BIOSCI BIOTECH BIOCH, V70, P1711, DOI 10.1271/bbb.60045; Tolba S, 2002, FEMS MICROBIOL ECOL, V42, P269, DOI 10.1111/j.1574-6941.2002.tb01017.x; Tolba S, 2004, DISTRIBUTION STREPTO; Valenzuela-Encinas C, 2009, EXTREMOPHILES, V13, P609, DOI 10.1007/s00792-009-0244-4; Wang Y, 1999, J IND MICROBIOL BIOT, V23, P178, DOI 10.1038/sj.jim.2900723; WILLIAMS ST, 1983, J GEN MICROBIOL, V129, P1743; Wink J.M., 2012, COMPENDIUM ACTINOBAC	53	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35756	10.1371/journal.pone.0035756	http://dx.doi.org/10.1371/journal.pone.0035756			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22540003	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341000069
J	Cortes-Romero, C; Martinez-Hernandez, A; Mellado-Mojica, E; Lopez, MG; Simpson, J				Cortes-Romero, Celso; Martinez-Hernandez, Aida; Mellado-Mojica, Erika; Lopez, Mercedes G.; Simpson, June			Molecular and Functional Characterization of Novel Fructosyltransferases and Invertases from Agave tequilana	PLOS ONE			English	Article							SUCROSE-FRUCTAN 6-FRUCTOSYLTRANSFERASE; CELL-WALL INVERTASE; X-RAY-DIFFRACTION; PERENNIAL RYEGRASS; EXTRACELLULAR INVERTASE; NEUTRAL INVERTASE; EXPRESSION; GENE; 1-FRUCTOSYLTRANSFERASE; SUBSTRATE	Fructans are the main storage polysaccharides found in Agave species. The synthesis of these complex carbohydrates relies on the activities of specific fructosyltransferase enzymes closely related to the hydrolytic invertases. Analysis of Agave tequilana transcriptome data led to the identification of ESTs encoding putative fructosyltransferases and invertases. Based on sequence alignments and structure/function relationships, two different genes were predicted to encode 1-SST and 6G-FFT type fructosyltransferases, in addition, 4 genes encoding putative cell wall invertases and 4 genes encoding putative vacuolar invertases were also identified. Probable functions for each gene, were assigned based on conserved amino acid sequences and confirmed for 2 fructosyltransferases and one invertase by analyzing the enzymatic activity of recombinant Agave protein s expressed and purified from Pichia pastoris. The genome organization of the fructosyltransferase/invertase genes, for which the corresponding cDNA contained the complete open reading frame, was found to be well conserved since all genes were shown to carry a 9 bp mini-exon and all showed a similar structure of 8 exons/7 introns with the exception of a cell wall invertase gene which has 7 exons and 6 introns. Fructosyltransferase genes were strongly expressed in the storage organs of the plants, especially in vegetative stages of development and to lower levels in photosynthetic tissues, in contrast to the invertase genes where higher levels of expression were observed in leaf tissues and in mature plants.	[Cortes-Romero, Celso; Simpson, June] Cinvestav Irapuato, Dept Plant Genet Engn, Guanajuato, Mexico; [Martinez-Hernandez, Aida] Sihochac, Colegio Postgraduados Campus Campeche, Champoton, Campeche, Mexico; [Mellado-Mojica, Erika; Lopez, Mercedes G.] Cinvestav Irapuato, Dept Biochem & Biotechnol, Guanajuato, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Colegio de Postgraduados - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Cortes-Romero, C (corresponding author), Cinvestav Irapuato, Dept Plant Genet Engn, Guanajuato, Mexico.	jsimpson@ira.cinvestav.mx	Simpson, June/I-1057-2012	Simpson, June/0000-0002-1891-4914; Martinez-Hernandez, Aida/0000-0003-1784-670X; Mellado-Mojica, Erika/0000-0002-7845-1085	Fondos Mixtos from Guanajuato State [GTO-04-C02-143]; Fondos Mixtos from Campeche State [CAMP-2006-C01-23821]; CONCYTEG [08-03-K662-076 A05]; CONACyT [203505, 203555]	Fondos Mixtos from Guanajuato State; Fondos Mixtos from Campeche State; CONCYTEG; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Financial support was obtained from Fondos Mixtos from Guanajuato State under grant number GTO-04-C02-143, Fondos Mixtos from Campeche State under grant number CAMP-2006-C01-23821, CONCYTEG under grant number 08-03-K662-076 A05 and doctoral fellowships CONACyT 203505 and 203555 to CCR and EMM respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenbach D, 2004, FEBS LETT, V567, P214, DOI 10.1016/j.febslet.2004.04.064; Arrizon J, 2010, FOOD CHEM, V122, P123, DOI 10.1016/j.foodchem.2010.02.028; Avila-Fernandez A, 2007, PLANT SCI, V173, P478, DOI 10.1016/j.plantsci.2007.07.009; Bocock PN, 2008, PLANTA, V227, P565, DOI 10.1007/s00425-007-0639-3; Bournay AS, 1996, NUCLEIC ACIDS RES, V24, P2347, DOI 10.1093/nar/24.12.2347; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; De Coninck B, 2005, PLANT CELL ENVIRON, V28, P432, DOI 10.1111/j.1365-3040.2004.01281.x; De Roover J, 2000, PLANTA, V210, P808, DOI 10.1007/s004250050683; FELSENSTEIN J, 1986, ANN STAT, V14, P1304, DOI 10.1214/aos/1176350146; Francki MG, 2006, GENOME, V49, P1081, DOI 10.1139/G06-066; Fujishima M, 2005, NEW PHYTOL, V165, P513, DOI 10.1111/j.1469-8137.2004.01231.x; Curbelo YG, 2009, CUBAN J AGR SCI, V43, P169; Hayes MA, 2010, PLANT PHYSIOL, V153, P211, DOI 10.1104/pp.110.154765; HENDRY GAF, 1993, NEW PHYTOL, V123, P3; Henson CA, 1996, PLANT PHYSIOL, V110, P639, DOI 10.1104/pp.110.2.639; Ji XM, 2005, PLANT MOL BIOL, V59, P945, DOI 10.1007/s11103-005-2415-8; Ji XM, 2005, J MOL EVOL, V60, P615, DOI 10.1007/s00239-004-0242-1; Ji XM, 2007, NEW PHYTOL, V173, P50, DOI 10.1111/j.1469-8137.2006.01896.x; Ji XM, 2010, PLANT CELL ENVIRON, V33, P926, DOI 10.1111/j.1365-3040.2010.02130.x; Kawakami A, 2002, BIOSCI BIOTECH BIOCH, V66, P2297, DOI 10.1271/bbb.66.2297; Lara MEB, 2004, PLANT CELL, V16, P1276, DOI 10.1105/tpc.018929; Lasseur B, 2009, PLANT PHYSIOL, V149, P327, DOI 10.1104/pp.108.125559; Lasseur B, 2006, J EXP BOT, V57, P2719, DOI 10.1093/jxb/erl034; Le Roy K, 2007, PLANT PHYSIOL, V145, P616, DOI 10.1104/pp.107.105049; Le Roy K, 2007, NEW PHYTOL, V176, P317, DOI 10.1111/j.1469-8137.2007.02174.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez MG, 2003, J AGR FOOD CHEM, V51, P7835, DOI 10.1021/jf030383v; Mancilla-Margalli NA, 2006, J AGR FOOD CHEM, V54, P7832, DOI 10.1021/jf060354v; PILONSMITS EAH, 1995, PLANT PHYSIOL, V107, P125, DOI 10.1104/pp.107.1.125; Qi XP, 2007, PLANT MOL BIOL, V64, P575, DOI 10.1007/s11103-007-9177-4; Reiffova K, 2006, J CHROMATOGR A, V1110, P214, DOI 10.1016/j.chroma.2006.01.039; Ritsema T, 2004, PLANT MOL BIOL, V54, P853, DOI 10.1007/s11103-004-0276-1; Ritsema T, 2006, PLANT J, V48, P228, DOI 10.1111/j.1365-313X.2006.02862.x; Roitsch T, 2003, J EXP BOT, V54, P513, DOI 10.1093/jxb/erg050; Sambrook J., 2001, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schroeven L, 2009, J EXP BOT, V60, P3687, DOI 10.1093/jxb/erp208; Seo PJ, 2011, PLANT J, V65, P418, DOI 10.1111/j.1365-313X.2010.04432.x; Sherson SM, 2003, J EXP BOT, V54, P525, DOI 10.1093/jxb/erg055; SHIOMI N, 1989, J PLANT PHYSIOL, V134, P151, DOI 10.1016/S0176-1617(89)80048-3; Shiomi N., 2008, Journal of Applied Glycoscience, V55, P25, DOI 10.5458/jag.55.25; Simpson J, 2011, GCB BIOENERGY, V3, P25, DOI 10.1111/j.1757-1707.2010.01079.x; Sturm A, 1999, PLANT PHYSIOL, V121, P1, DOI 10.1104/pp.121.1.1; Taliercio E, 2010, MOL BIOL REP, V37, P3915, DOI 10.1007/s11033-010-0048-8; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Ueno K, 2005, NEW PHYTOL, V165, P813, DOI 10.1111/j.1469-8137.2004.01294.x; Van den Ende W, 2011, PLANT PHYSIOL, V155, P603, DOI 10.1104/pp.110.162222; Van den Ende W, 2009, FEBS J, V276, P5788, DOI 10.1111/j.1742-4658.2009.07316.x; Verhaest M, 2005, PLANT J, V41, P400, DOI 10.1111/j.1365-313X.2004.02304.x; Verhaest M, 2004, ACTA CRYSTALLOGR D, V60, P553, DOI 10.1107/S0907444903029317; Verhaest M, 2007, NEW PHYTOL, V174, P90, DOI 10.1111/j.1469-8137.2007.01988.x; Vijn I, 1999, PLANT PHYSIOL, V120, P351, DOI 10.1104/pp.120.2.351; Wang N, 1998, PLANT PHYSIOL, V116, P709, DOI 10.1104/pp.116.2.709; Wei JZ, 2001, J PLANT PHYSIOL, V158, P1203, DOI 10.1078/0176-1617-00241; Wingler A, 2004, NEW PHYTOL, V161, P781, DOI 10.1111/j.1469-8137.2004.00996.x; Xiang L, 2011, PLANT SIGNAL BEHAV, V6, P1567, DOI 10.4161/psb.6.10.17036; Yildiz S, 2011, FOOD REV INT, V27, P16, DOI 10.1080/87559129.2010.518295	58	25	26	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35878	10.1371/journal.pone.0035878	http://dx.doi.org/10.1371/journal.pone.0035878			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558253	Green Submitted, gold, Green Published			2022-12-27	WOS:000305340200028
J	Duan, ZW; Xie, P; Li, W; Wang, PY				Duan, Zhao-Wen; Xie, Ping; Li, Wei; Wang, Peng-Ye			Are Coiled-Coils of Dimeric Kinesins Unwound during Their Walking on Microtubule?	PLOS ONE			English	Article							NCD MOTOR PROTEIN; CRYSTAL-STRUCTURE; YEAST KAR3; NECK; HEAD; MECHANISM; MOVEMENT; ROTATION; BINDING; DOMAIN	Dimeric kinesin motor proteins such as homodimeric kinesin-1, homodimeric Ncd and heterodimeric Kar3/Vik1are composed of two head domains which are connected together by a rod-shaped, coiled-coil stalk. Despite the extensive and intensive studies on structures, kinetics, dynamics and walking mechanism of the dimers, whether their coiled-coils are unwound or not during their walking on the microtubule is still an unclear issue. Here, we try to clarify this issue by using molecular dynamics simulations. Our simulation results showed that, for Ncd, a large change in potential of mean force is required to unwind the coiled-coil by only several pairs of residues. For both Ncd and kinesin-1, the force required to initiate the coiled-coil unwinding is larger than that required for unfolding of the single alpha-helix that forms the coiled-coil or is larger than that required to unwind the DNA duplex, which is higher than the unbinding force of the kinesin head from the microtubule in strong microtubule-binding states. Based on these results and the comparison of the sequence between the coiled-coil of Kar3/Vik1 and those of Ncd and kinesin-1, it was deduced that the coiled-coil of the Kar3/Vik1 should also be very stable. Thus, we concluded that the coiled-coils of kinesin-1, Ncd and Kar3/Vik1 are almost impossible to unwind during their walking on the microtubule.	[Duan, Zhao-Wen] Chinese Acad Sci, Inst Phys, Key Lab Soft Matter Phys, Beijing 100080, Peoples R China; Chinese Acad Sci, Inst Phys, Beijing Natl Lab Condensed Matter Phys, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Physics, CAS; Chinese Academy of Sciences; Institute of Physics, CAS	Duan, ZW (corresponding author), Chinese Acad Sci, Inst Phys, Key Lab Soft Matter Phys, POB 603, Beijing 100080, Peoples R China.	pxie@aphy.iphy.ac.cn	Duan, Zhaowen/AHE-6206-2022	Wang, Peng-Ye/0000-0002-9765-0610	National Natural Science Foundation of China [10974248, 10834014]; National Basic Research Program of China (973 Program) [2009CB930704]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (Grant Nos. 10974248 and 10834014) and the National Basic Research Program of China (973 Program) (Grant No. 2009CB930704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allingham JS, 2007, CELL, V128, P1161, DOI 10.1016/j.cell.2006.12.046; Alonso MC, 2007, SCIENCE, V316, P120, DOI 10.1126/science.1136985; Altman D, 2004, CELL, V116, P737, DOI 10.1016/S0092-8674(04)00211-9; Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Barrett JG, 2000, MOL BIOL CELL, V11, P2373, DOI 10.1091/mbc.11.7.2373; Bartels C, 2000, CHEM PHYS LETT, V331, P446, DOI 10.1016/S0009-2614(00)01215-X; Bornschlogl T, 2009, P NATL ACAD SCI USA, V106, P6992, DOI 10.1073/pnas.0812620106; Cai DW, 2007, J CELL BIOL, V176, P51, DOI 10.1083/jcb.200605097; Chu HMA, 2005, EMBO J, V24, P3214, DOI 10.1038/sj.emboj.7600790; Cross RA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-107; ENDOW SA, 1994, EMBO J, V13, P2708, DOI 10.1002/j.1460-2075.1994.tb06561.x; Endres NF, 2006, NATURE, V439, P875, DOI 10.1038/nature04320; EssevazRoulet B, 1997, P NATL ACAD SCI USA, V94, P11935, DOI 10.1073/pnas.94.22.11935; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Gulick AM, 1998, BIOCHEMISTRY-US, V37, P1769, DOI 10.1021/bi972504o; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; Heuston E, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-19; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hirose K, 1998, J MOL BIOL, V278, P389, DOI 10.1006/jmbi.1998.1709; Hou RZ, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/3/036003; Howard J, 1996, ANNU REV PHYSIOL, V58, P703, DOI 10.1146/annurev.ph.58.030196.003415; Hua W, 2002, SCIENCE, V295, P844, DOI 10.1126/science.1063089; Hwang W, 2008, STRUCTURE, V16, P62, DOI 10.1016/j.str.2007.11.008; Ito M, 2006, BIOCHEMISTRY-US, V45, P3315, DOI 10.1021/bi051480f; Kaseda K, 2003, NAT CELL BIOL, V5, P1079, DOI 10.1038/ncb1067; Kozielski F, 1999, STRUCTURE, V7, P1407, DOI 10.1016/S0969-2126(00)80030-1; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Kutys ML, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000980; Manning BD, 1999, J CELL BIOL, V144, P1219, DOI 10.1083/jcb.144.6.1219; Manning BD, 2000, TRENDS CELL BIOL, V10, P281, DOI 10.1016/S0962-8924(00)01774-8; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Miyazono Y, 2010, EMBO J, V29, P93, DOI 10.1038/emboj.2009.319; Paci E, 2000, P NATL ACAD SCI USA, V97, P6521, DOI 10.1073/pnas.100124597; PAGE BD, 1994, J CELL BIOL, V124, P507, DOI 10.1083/jcb.124.4.507; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rief M, 1999, J MOL BIOL, V286, P553, DOI 10.1006/jmbi.1998.2466; Sablin EP, 1996, NATURE, V380, P555, DOI 10.1038/380555a0; Sablin EP, 1998, NATURE, V395, P813, DOI 10.1038/27463; Scholey JM, 1996, J CELL BIOL, V133, P1, DOI 10.1083/jcb.133.1.1; Shastry S, 2010, CURR BIOL, V20, P939, DOI 10.1016/j.cub.2010.03.065; Sosa H, 1997, CELL, V90, P217, DOI 10.1016/S0092-8674(00)80330-X; Sproul LR, 2005, CURR BIOL, V15, P1420, DOI 10.1016/j.cub.2005.06.066; Thormahlen M, 1998, J STRUCT BIOL, V122, P30, DOI 10.1006/jsbi.1998.3986; Tomishige M, 2000, J CELL BIOL, V151, P1081, DOI 10.1083/jcb.151.5.1081; Tripet B, 2002, J STRUCT BIOL, V137, P220, DOI 10.1006/jsbi.2002.4475; Uemura S, 2002, P NATL ACAD SCI USA, V99, P5977, DOI 10.1073/pnas.092546199; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Wade RH, 2000, NAT STRUCT BIOL, V7, P456, DOI 10.1038/75850; WALKER RA, 1990, NATURE, V347, P780, DOI 10.1038/347780a0; Wendt TG, 2002, EMBO J, V21, P5969, DOI 10.1093/emboj/cdf622; Woehlke G, 2007, CELL, V128, P1033, DOI 10.1016/j.cell.2007.03.003; Xie P, 2008, BBA-BIOENERGETICS, V1777, P1195, DOI 10.1016/j.bbabio.2008.04.040; Xie P, 2007, J MOL BIOL, V366, P976, DOI 10.1016/j.jmb.2006.10.081; Xie P, 2006, BIOPHYS CHEM, V122, P90, DOI 10.1016/j.bpc.2006.02.010; Xie P, 2010, INT J BIOL SCI, V6, P665, DOI 10.7150/ijbs.6.665; YANG JT, 1989, CELL, V56, P879, DOI 10.1016/0092-8674(89)90692-2; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yun M, 2003, EMBO J, V22, P5382, DOI 10.1093/emboj/cdg531	60	11	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36071	10.1371/journal.pone.0036071	http://dx.doi.org/10.1371/journal.pone.0036071			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558333	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000119
J	Newton, PK; Mason, J; Bethel, K; Bazhenova, LA; Nieva, J; Kuhn, P				Newton, Paul K.; Mason, Jeremy; Bethel, Kelly; Bazhenova, Lyudmila A.; Nieva, Jorge; Kuhn, Peter			A Stochastic Markov Chain Model to Describe Lung Cancer Growth and Metastasis	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; DISEASE; PROGRESSION; NETWORKS; BLOOD	A stochastic Markov chain model for metastatic progression is developed for primary lung cancer based on a network construction of metastatic sites with dynamics modeled as an ensemble of random walkers on the network. We calculate a transition matrix, with entries (transition probabilities) interpreted as random variables, and use it to construct a circular bidirectional network of primary and metastatic locations based on postmortem tissue analysis of 3827 autopsies on untreated patients documenting all primary tumor locations and metastatic sites from this population. The resulting 50 potential metastatic sites are connected by directed edges with distributed weightings, where the site connections and weightings are obtained by calculating the entries of an ensemble of transition matrices so that the steady-state distribution obtained from the long-time limit of the Markov chain dynamical system corresponds to the ensemble metastatic distribution obtained from the autopsy data set. We condition our search for a transition matrix on an initial distribution of metastatic tumors obtained from the data set. Through an iterative numerical search procedure, we adjust the entries of a sequence of approximations until a transition matrix with the correct steady-state is found (up to a numerical threshold). Since this constrained linear optimization problem is underdetermined, we characterize the statistical variance of the ensemble of transition matrices calculated using the means and variances of their singular value distributions as a diagnostic tool. We interpret the ensemble averaged transition probabilities as (approximately) normally distributed random variables. The model allows us to simulate and quantify disease progression pathways and timescales of progression from the lung position to other sites and we highlight several key findings based on the model.	[Newton, Paul K.; Mason, Jeremy] Univ So Calif, Dept Aerosp & Mech Engn, Los Angeles, CA 90089 USA; [Newton, Paul K.; Mason, Jeremy] Univ So Calif, Dept Math, Los Angeles, CA 90089 USA; [Bethel, Kelly] Scripps Clin Torrey Pines, La Jolla, CA USA; [Bazhenova, Lyudmila A.] UCSD Moores Canc Ctr, La Jolla, CA USA; [Nieva, Jorge] Billings Clin, Billings, MT USA; [Kuhn, Peter] Scripps Res Inst, La Jolla, CA 92037 USA	University of Southern California; University of Southern California; Scripps Research Institute; Scripps Research Institute	Newton, PK (corresponding author), Univ So Calif, Dept Aerosp & Mech Engn, Los Angeles, CA 90089 USA.	newton@usc.edu	Nieva, Jorge/AAE-3634-2022	Nieva, Jorge/0000-0003-1605-4719; Mason, Jeremy/0000-0002-5933-5003; Bethel, Kelly/0000-0002-7005-8641; Bazhenova, Lyudmila/0000-0001-8764-4359	National Cancer Institute [U54CA143906]; NATIONAL CANCER INSTITUTE [U54CA143906] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This manuscript was supported by National Cancer Institute Award No. U54CA143906. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashworth T. R, 1869, AUST MED J, V14, P146, DOI DOI 10.1038/SJ.BJC.6604218; Balthrop J, 2004, SCIENCE, V304, P527, DOI 10.1126/science.1095845; BUTLER TP, 1975, CANCER RES, V35, P512; Chen LL, 2009, BRIT J CANCER, V101, P749, DOI 10.1038/sj.bjc.6605214; Cristofanilli M, 2005, J CLIN ONCOL, V23, P1420, DOI 10.1200/JCO.2005.08.140; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; CSISZAR I, 1991, ANN STAT, V19, P2032, DOI 10.1214/aos/1176348385; Diaconis P, 2009, B AM MATH SOC, V46, P179; Disibio G, 2008, ARCH PATHOL LAB MED, V132, P931, DOI 10.1043/1543-2165(2008)132[931:MPOCRF]2.0.CO;2; Doucet A, 2001, STAT ENG IN, P3; Ewing J, 1929, NEOPLASTIC DIS TXB T; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gamerman D, 2006, MARKOV CHAIN MONTE C; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Golub GH., 2013, MATRIX COMPUTATIONS; Grinstead C, 2011, INTRO PROBABILITY; Gzyl H., 2003, AIP Conference Proceedings, P361, DOI 10.1063/1.1570553; Gzyl H, 2003, BAY INF MAX ENTR MET, pCP617; Hsieh HB, 2006, BIOSENS BIOELECTRON, V21, P1893, DOI 10.1016/j.bios.2005.12.024; Kalnay E., 2003, ATMOSPHERIC MODELING, DOI DOI 10.1017/CBO9780511802270; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Marrinucci D, 2007, HUM PATHOL, V38, P1468; Marrinucci D, 2009, ARCH PATHOL LAB MED, V133, P1468, DOI 10.1043/1543-2165-133.9.1468; Newman M.E.J., 2010, NETWORKS INTRO; Newman M, 2008, PHYS TODAY, V61, P33, DOI 10.1063/1.3027989; Newman MEJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.108701; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, P NATL ACAD SCI USA, V99, P2566, DOI 10.1073/pnas.012582999; NORTON L, 1988, CANCER RES, V48, P7067; Norton L, 2006, NAT MED, V12, P875, DOI 10.1038/nm0806-875; Okumura Y, 2009, ANN THORAC SURG, V87, P1669, DOI 10.1016/j.athoracsur.2009.03.073; Paget S, 1989, LANCET, V8, P98, DOI [DOI 10.1016/S0140-6736(00)49915-0, 10.1016/S0140-6736(00)49915-0]; Paterlini-Brechot P, 2007, CANCER LETT, V253, P180, DOI 10.1016/j.canlet.2006.12.014; Redner S, 2001, GUIDE 1 PASSAGE TIME; SALSBURY AJ, 1975, CANCER TREAT REV, V2, P55, DOI 10.1016/S0305-7372(75)80015-6; Smerage JB, 2006, BRIT J CANCER, V94, P8, DOI 10.1038/sj.bjc.6602871; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Weinberg RA, 2006, BIOL CANC; WEISS L, 1983, CANCER METAST REV, V2, P111, DOI 10.1007/BF00048965; Wojtkiewicz S., 2001, 19 AIAA APPL AER C, P1455	40	45	45	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e34637	10.1371/journal.pone.0034637	http://dx.doi.org/10.1371/journal.pone.0034637			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558094	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336000015
J	Scantlebury, M; Danek-Gontard, M; Bateman, PW; Bennett, NC; Manjerovic, MB; Joubert, KE; Waterman, JM				Scantlebury, Michael; Danek-Gontard, Marine; Bateman, Philip W.; Bennett, Nigel C.; Manjerovic, Mary-Beth; Joubert, Kenneth E.; Waterman, Jane M.			Seasonal Patterns of Body Temperature Daily Rhythms in Group-Living Cape Ground Squirrels Xerus inauris	PLOS ONE			English	Article							COMMON SPINY MICE; NONSHIVERING THERMOGENESIS; AETHOMYS-NAMAQUENSIS; THALLOMYS-PAEDULCUS; HEAT-PRODUCTION; WATER ECONOMY; THERMOREGULATION; RODENTIA; HETEROTHERMY; PHOTOPERIOD	Organisms respond to cyclical environmental conditions by entraining their endogenous biological rhythms. Such physiological responses are expected to be substantial for species inhabiting arid environments which incur large variations in daily and seasonal ambient temperature (T-a). We measured core body temperature (T-b) daily rhythms of Cape ground squirrels Xerus inauris inhabiting an area of Kalahari grassland for six months from the Austral winter through to the summer. Squirrels inhabited two different areas: an exposed flood plain and a nearby wooded, shady area, and occurred in different social group sizes, defined by the number of individuals that shared a sleeping burrow. Of a suite of environmental variables measured, maximal daily T-a provided the greatest explanatory power for mean T-b whereas sunrise had greatest power for T-b acrophase. There were significant changes in mean T-b and T-b acrophase over time with mean T-b increasing and T-b acrophase becoming earlier as the season progressed. Squirrels also emerged from their burrows earlier and returned to them later over the measurement period. Greater increases in T-b, sometimes in excess of 5 degrees C, were noted during the first hour post emergence, after which T-b remained relatively constant. This is consistent with observations that squirrels entered their burrows during the day to 'offload' heat. In addition, greater T-b amplitude values were noted in individuals inhabiting the flood plain compared with the woodland suggesting that squirrels dealt with increased environmental variability by attempting to reduce their T-a-T-b gradient. Finally, there were significant effects of age and group size on T-b with a lower and less variable T-b in younger individuals and those from larger group sizes. These data indicate that Cape ground squirrels have a labile T-b which is sensitive to a number of abiotic and biotic factors and which enables them to be active in a harsh and variable environment.	[Scantlebury, Michael; Bateman, Philip W.; Bennett, Nigel C.] Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, ZA-0002 Pretoria, South Africa; [Scantlebury, Michael; Danek-Gontard, Marine] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [Manjerovic, Mary-Beth; Waterman, Jane M.] Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA; [Joubert, Kenneth E.] Univ Pretoria, Fac Vet Sci, Dept Paraclin Sci, Pharmacol Sect, ZA-0002 Pretoria, South Africa; [Waterman, Jane M.] Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada	University of Pretoria; Queens University Belfast; State University System of Florida; University of Central Florida; University of Pretoria; University of Manitoba	Scantlebury, M (corresponding author), Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, ZA-0002 Pretoria, South Africa.	m.scantlebury@qub.ac.uk	Bateman, Bill/B-7751-2019; Bennett, Nigel/E-4238-2010	Bateman, Bill/0000-0002-3036-5479; Joubert, Kenneth/0000-0003-0656-2090; Bennett, Nigel/0000-0001-9748-2947	National Research Foundation [IBN0130600]; Natural Science and Engineering Research Council of Canada; National Research Foundation-SAR Chair; University of Pretoria PDRF	National Research Foundation; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Foundation-SAR Chair; University of Pretoria PDRF	This research was funded by a National Research Foundation Grant IBN0130600 and a Natural Science and Engineering Research Council of Canada Discovery Grant to JMW, a National Research Foundation-SAR Chair to NCB and a University of Pretoria PDRF to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Angilletta Michael J Jr, 2010, Front Biosci (Elite Ed), V2, P861; Aschoff J., 1982, COMPANION ANIMAL PHY, P173; BENNETT AF, 1984, PHYSIOL ZOOL, V57, P57, DOI 10.1086/physzool.57.1.30155968; Berteaux D, 1996, OIKOS, V76, P330, DOI 10.2307/3546205; Boyles JG, 2011, PHYSIOL BIOCHEM ZOOL, V84, P115, DOI 10.1086/656724; Canals M, 1998, ACTA THERIOL, V43, P337, DOI 10.4098/AT.arch.98-45; Cowling R.M., 2004, VEGETATION SO AFRICA; Fick LG, 2009, COMP BIOCHEM PHYS A, V152, P334, DOI 10.1016/j.cbpa.2008.11.004; Gilbert C, 2007, AM J PHYSIOL-REG I, V293, pR867, DOI 10.1152/ajpregu.00081.2007; GOLIGHTLY RT, 1978, ECOLOGY, V59, P897, DOI 10.2307/1938542; Gur Hakan, 2010, Hacettepe Journal of Biology and Chemistry, V38, P247; Haim A, 2005, CHRONOBIOL INT, V22, P59, DOI 10.1081/CBI-200038144; Haim A, 1996, J THERM BIOL, V21, P37, DOI 10.1016/0306-4565(96)81275-7; HAIM A, 1987, S AFR J ZOOL, V22, P45; HAIM A, 1990, J EXP ZOOL, V256, P237, DOI 10.1002/jez.1402560302; Haim Abraham, 1994, Polish Ecological Studies, V20, P357; HARRI M, 1988, J THERM BIOL, V13, P169, DOI 10.1016/0306-4565(88)90029-0; HAYES JP, 1992, PHYSIOL ZOOL, V65, P742, DOI 10.1086/physzool.65.4.30158537; HELDMAIER G, 1989, J BIOL RHYTHM, V4, P251, DOI 10.1177/074873048900400211; HERZIGSTRASCHIL B, 1979, FOLIA ZOOL, V28, P119; HERZIGSTRASCHIL B, 1978, Z SAUGETIERKD, V43, P262; Hetem RS, 2010, J COMP PHYSIOL B, V180, P1111, DOI 10.1007/s00360-010-0480-z; Hillegass MA, 2008, BEHAV ECOL, V19, P1006, DOI 10.1093/beheco/arn070; Hudson J.W., 1972, Symposia Zool Soc Lond, VNo. 31, P191; Huey R.B., 1990, Cold Spring Harbor Monograph Series, V19, P37; Jackson CR, 2009, J ZOOL, V278, P299, DOI 10.1111/j.1469-7998.2009.00575.x; Joubert KE, 2011, J S AFR VET ASSOC, V82, P94; Kauffman AS, 2003, PHYSIOL BEHAV, V79, P247, DOI 10.1016/S0031-9384(03)00115-X; Kenagy G. J., 1982, VERTEBRATE CIRCADIAN; Kenagy GJ, 2002, REV CHIL HIST NAT, V75, P567; Kinahan AA, 2007, PHYSIOL BEHAV, V92, P560, DOI 10.1016/j.physbeh.2007.05.001; Kotze J, 2008, PHYSIOL BEHAV, V93, P215, DOI 10.1016/j.physbeh.2007.08.016; Levy O, 2011, PHYSIOL BIOCHEM ZOOL, V84, P175, DOI 10.1086/658171; Long RA, 2005, J MAMMAL, V86, P314, DOI 10.1644/BRG-224.1; Lovegrove BG, 2009, J COMP PHYSIOL B, V179, P451, DOI 10.1007/s00360-008-0329-x; LOVEGROVE BG, 1994, AUST J ZOOL, V42, P65, DOI 10.1071/ZO9940065; LOVEGROVE BG, 1991, J THERM BIOL, V16, P199, DOI 10.1016/0306-4565(91)90026-X; MADISON DM, 1984, BEHAV ECOL SOCIOBIOL, V15, P9, DOI 10.1007/BF00310209; Manjerovic MB, 2010, THESIS U CENTRAL FLO; MINORS DS, 1989, BIOL RHYTHMS CLIN PR, P272; Morgan E, 2004, BIOL RHYTHM RES, V35, P3, DOI 10.1080/09291010412331313205; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; Ostrowski S, 2006, J EXP BIOL, V209, P1421, DOI 10.1242/jeb.02151; Ostrowski S, 2003, J EXP BIOL, V206, P1471, DOI 10.1242/jeb.00275; Pavlicek Tomas, 2003, Israel Journal of Earth Sciences, V52, P1, DOI 10.1560/QD0A-9T22-4FGL-FGH6; Pettitt BA, 2008, J ZOOL, V276, P291, DOI 10.1111/j.1469-7998.2008.00491.x; Piccione G, 2002, J THERM BIOL, V27, P333, DOI 10.1016/S0306-4565(01)00076-6; Piccione G, 2009, J THERM BIOL, V34, P171, DOI 10.1016/j.jtherbio.2009.01.004; REFINETTI R, 1992, PHYSIOL BEHAV, V51, P613, DOI 10.1016/0031-9384(92)90188-8; Refinetti R, 1999, J THERM BIOL, V24, P477, DOI 10.1016/S0306-4565(99)00077-7; ROOD JP, 1980, J WILDLIFE MANAGE, V44, P500, DOI 10.2307/3807988; ROVERUD RC, 1991, PHYSIOL ZOOL, V64, P1527, DOI 10.1086/physzool.64.6.30158228; Scantlebury M, 2008, J COMP PHYSIOL B, V178, P887, DOI 10.1007/s00360-008-0277-5; Scantlebury M, 2006, FUNCT ECOL, V20, P166, DOI 10.1111/j.1365-2435.2006.01074.x; Scantlebury M, 2003, FUNCT ECOL, V17, P178, DOI 10.1046/j.1365-2435.2003.00717.x; Scantlebury M, 2010, J ZOOL, V281, P132, DOI 10.1111/j.1469-7998.2010.00687.x; Scantlebury M, 2009, COMP BIOCHEM PHYS A, V154, P551, DOI 10.1016/j.cbpa.2009.08.021; Schwimmer H, 2010, CHRONOBIOL INT, V27, P1401, DOI 10.3109/07420528.2010.505355; Shanas U, 2002, COMP BIOCHEM PHYS A, V132, P287, DOI 10.1016/S1095-6433(02)00033-8; Sharpe PB, 1999, J THERM BIOL, V24, P265, DOI 10.1016/S0306-4565(99)00021-2; Signer C, 2011, FUNCT ECOL, V25, P537, DOI 10.1111/j.1365-2435.2010.01806.x; Sothern R., 1972, PHYSIOL TEACH, V1, P1; Spiegel M, 2004, J THERM BIOL, V29, P635, DOI 10.1016/j.jtherbio.2004.08.037; STRASCHIL B, 1975, S AFR J SCI, V71, P215; TURK A, 1988, OECOLOGIA, V76, P544, DOI 10.1007/BF00397867; Unck CE, 2009, ANIM BEHAV, V78, P625, DOI 10.1016/j.anbehav.2009.05.028; VAN ZYL J. H. M., 1965, ZOOL AFRICANA, V1, P55; VANHEERDEN J, 1987, J ARID ENVIRON, V13, P83; Walsberg GE, 2000, BIOSCIENCE, V50, P109, DOI 10.1641/0006-3568(2000)050[0109:SMIHDS]2.3.CO;2; Warnecke L, 2008, NATURWISSENSCHAFTEN, V95, P73, DOI 10.1007/s00114-007-0293-4; Waterman JM, 1996, J MAMMAL, V77, P134, DOI 10.2307/1382715; Waterman JM, 1998, ANIM BEHAV, V56, P459, DOI 10.1006/anbe.1998.0780; WATERMAN JM, 1995, ETHOLOGY, V101, P130, DOI 10.1111/j.1439-0310.1995.tb00352.x; Wilson WA, 2010, J COMP PHYSIOL B, V180, P1099, DOI 10.1007/s00360-010-0472-z; WOLLNIK F, 1995, J COMP PHYSIOL B, V165, P171; Wooden KM, 2004, J EXP BIOL, V207, P41, DOI 10.1242/jeb.00717; Wooden KM, 2002, J EXP BIOL, V205, P2099; Yerushalmi S, 2009, ECOL LETT, V12, P970, DOI 10.1111/j.1461-0248.2009.01343.x	79	6	6	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36053	10.1371/journal.pone.0036053	http://dx.doi.org/10.1371/journal.pone.0036053			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558324	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000114
J	Hu, J; Xie, CQ; Ma, HY; Yang, B; Ma, PX; Chen, YE				Hu, Jiang; Xie, Changqing; Ma, Haiyun; Yang, Bo; Ma, Peter X.; Chen, Y. Eugene			Construction of Vascular Tissues with Macro-Porous Nano-Fibrous Scaffolds and Smooth Muscle Cells Enriched from Differentiated Embryonic Stem Cells	PLOS ONE			English	Article							GROWTH-FACTOR; TRANSGENIC MICE; SM22 ALPHA; BETA; CONTRIBUTES; EXPRESSION; PROMOTER; PDGF	Vascular smooth muscle cells (SMCs) have been broadly used for constructing tissue-engineered blood vessels. However, the availability of mature SMCs from donors or patients is very limited. Derivation of SMCs by differentiating embryonic stem cells (ESCs) has been reported, but not widely utilized in vascular tissue engineering due to low induction efficiency and, hence, low SMC purity. To address these problems, SMCs were enriched from retinoic acid induced mouse ESCs with LacZ genetic labeling under the control of SM22 alpha promoter as the positive sorting marker in the present study. The sorted SMCs were characterized and then cultured on three-dimensional macro-porous nano-fibrous scaffolds in vitro or implanted subcutaneously into nude mice after being seeded on the scaffolds. Our data showed that the LacZ staining, which reflected the corresponding SMC marker SM22 alpha expression level, was efficient as a positive selection marker to dramatically enrich SMCs and eliminate other cell types. After the sorted cells were seeded into the three-dimensional nano-fibrous scaffolds, continuous retinoic acid treatment further enhanced the SMC marker gene expression level while inhibited pluripotent maker gene expression level during the in vitro culture. Meanwhile, after being implanted subcutaneously into nude mice, the implanted cells maintained the positive LacZ staining within the constructs and no teratoma formation was observed. In conclusion, our results demonstrated the potential of SMCs derived from ESCs as a promising cell source for therapeutic vascular tissue engineering and disease model applications.	[Hu, Jiang; Ma, Haiyun; Ma, Peter X.] Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [Xie, Changqing; Chen, Y. Eugene] Univ Michigan, Dept Internal Med, Ctr Cardiovasc, Ann Arbor, MI 48109 USA; [Yang, Bo] Univ Michigan, Dept Cardiac Surg, Ctr Cardiovasc, Ann Arbor, MI 48109 USA; [Ma, Peter X.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Ma, Peter X.] Univ Michigan, Ctr Macromol Sci & Engn, Ann Arbor, MI 48109 USA; [Ma, Peter X.] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Hu, J (corresponding author), Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.	mapx@umich.edu; echenum@umich.edu	X, Peter/E-4895-2011; Hu, Jiang/D-7904-2012	Yang, Bo/0000-0002-2158-9155	Cardiovascular Center at University of Michigan; National Institutes of Health [HL092421, HL068878, DE015384, DE017689]; AHA National Scientific Development Grant [09SDG2260023]; Richard H. Kingery Endowed Collegiate; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL092421, R01HL068878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015384, R01DE017689] Funding Source: NIH RePORTER	Cardiovascular Center at University of Michigan; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA National Scientific Development Grant; Richard H. Kingery Endowed Collegiate; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work is partially funded by an Inaugural Grant (YEC and PXM) from the Cardiovascular Center at University of Michigan and by the National Institutes of Health (HL092421 and HL068878: YEC; DE015384 and DE017689: PXM). CX is supported by an AHA National Scientific Development Grant (09SDG2260023). YEC is an AHA established investigator (0840025N). PXM is partially supported by the Richard H. Kingery Endowed Collegiate Professorship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; Chen SY, 2004, CIRC RES, V94, P1195, DOI 10.1161/01.RES.0000126897.41658.81; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Hishikawa K, 1999, EUR J PHARMACOL, V385, P287, DOI 10.1016/S0014-2999(99)00763-3; Hu JA, 2010, BIOMATERIALS, V31, P7971, DOI 10.1016/j.biomaterials.2010.07.028; Huang HR, 2006, BIOCHEM BIOPH RES CO, V351, P321, DOI 10.1016/j.bbrc.2006.09.171; Huang HR, 2010, J BIOL CHEM, V285, P9383, DOI [10.1074/jbc.M110.101543, 10.1074/jbc.M109.095612]; Kim S, 1997, MOL CELL BIOL, V17, P2266, DOI 10.1128/MCB.17.4.2266; Li L, 1996, CIRC RES, V78, P188, DOI 10.1161/01.RES.78.2.188; Li L, 1996, J CELL BIOL, V132, P849, DOI 10.1083/jcb.132.5.849; Moessler H, 1996, DEVELOPMENT, V122, P2415; Niklason LE, 2001, J VASC SURG, V33, P628, DOI 10.1067/mva.2001.111747; Oishi K, 2002, J PHYSIOL-LONDON, V540, P139, DOI 10.1113/jphysiol.2001.013278; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pera MF, 2010, NATURE, V465, P713, DOI 10.1038/nature09228; Poot M, 1997, CYTOMETRY, V28, P36, DOI 10.1002/(SICI)1097-0320(19970501)28:1<36::AID-CYTO4>3.0.CO;2-F; SCHWARTZ SM, 1995, CIRC RES, V77, P445, DOI 10.1161/01.RES.77.3.445; Shen JB, 2010, CIRC RES, V106, P1351, DOI 10.1161/CIRCRESAHA.109.213900; Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004; Sinha S, 2006, STEM CELLS, V24, P1678, DOI 10.1634/stemcells.2006-0002; Srivastava S, 2003, AM J PHYSIOL-HEART C, V285, pH1190, DOI 10.1152/ajpheart.00280.2003; Wei GB, 2006, J CONTROL RELEASE, V112, P103, DOI 10.1016/j.jconrel.2006.01.011; Xie CQ, 2009, STEM CELLS DEV, V18, P741, DOI 10.1089/scd.2008.0179; Xie CQ, 2011, BIOMATERIALS, V32, P4369, DOI 10.1016/j.biomaterials.2011.02.049; Xie CQ, 2011, STEM CELLS DEV, V20, P205, DOI 10.1089/scd.2010.0283; Xu ZC, 2008, BIOMATERIALS, V29, P1464, DOI 10.1016/j.biomaterials.2007.11.037; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yang Maozhou, 2010, Int J Physiol Pathophysiol Pharmacol, V2, P12; Zhang JCL, 2001, MOL CELL BIOL, V21, P1336, DOI 10.1128/MCB.2001.21.4.1336-1344.2001	29	15	15	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35580	10.1371/journal.pone.0035580	http://dx.doi.org/10.1371/journal.pone.0035580			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545119	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343200039
J	Bruetto, RG; Rodrigues, FB; Torres, US; Otaviano, AP; Zanetta, DMT; Burdmann, EA				Bruetto, Rosana G.; Rodrigues, Fernando B.; Torres, Ulysses S.; Otaviano, Ana P.; Zanetta, Dirce M. T.; Burdmann, Emmanuel A.			Renal Function at Hospital Admission and Mortality Due to Acute Kidney Injury after Myocardial Infarction	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; LONG-TERM PROGNOSIS; SERUM CREATININE; CARDIAC-SURGERY; RISK-FACTOR; OUTCOMES; DISEASE; FAILURE; ASSOCIATION; DEFINITION	Background: The role of an impaired estimated glomerular filtration rate (eGFR) at hospital admission in the outcome of acute kidney injury (AKI) after acute myocardial infarction (AMI) has been underreported. The aim of this study was to assess the influence of an admission eGFR<60 mL/min/1.73 m(2) on the incidence and early and late mortality of AMI-associated AKI. Methods: A prospective study of 828 AMI patients was performed. AKI was defined as a serum creatinine increase of >= 50% from the time of admission (RIFLE criteria) in the first 7 days of hospitalization. Patients were divided into subgroups according to their eGFR upon hospital admission (MDRD formula, mL/min/1.73 m(2)) and the development of AKI: eGFR >= 60 without AKI, eGFR<60 without AKI, eGFR >= 60 with AKI and eGFR<60 with AKI. Results: Overall, 14.6% of the patients in this study developed AKI. The admission eGFR had no impact on the incidence of AKI. However, the admission eGFR was associated with the outcome of AMI-associated AKI. The adjusted hazard ratios (AHR, Cox multivariate analysis) for 30-day mortality were 2.00 (95% CI 1.11-3.61) for eGFR, 60 without AKI, 4.76 (95% CI 2.45-9.26) for eGFR >= 60 with AKI and 6.27 (95% CI 3.20-12.29) for eGFR, 60 with AKI. Only an admission eGFR of <60 with AKI was significantly associated with a 30-day to 1-year mortality hazard (AHR 3.05, 95% CI 1.50-6.19). Conclusions: AKI development was associated with an increased early mortality hazard in AMI patients with either preserved or impaired admission eGFR. Only the association of impaired admission eGFR and AKI was associated with an increased hazard for late mortality among these patients.	[Bruetto, Rosana G.; Torres, Ulysses S.; Burdmann, Emmanuel A.] Hosp Base, Div Nephrol, Sao Jose do Rio Preto Med Sch FAMERP, Sao Paulo, Brazil; [Rodrigues, Fernando B.] Hosp Base, Dept Internal Med, Sao Jose do Rio Preto Med Sch FAMERP, Div Emergency, Sao Paulo, Brazil; [Rodrigues, Fernando B.] Hosp Base, Chest Pain Ctr, Sao Jose do Rio Preto Med Sch FAMERP, Sao Paulo, Brazil; [Otaviano, Ana P.] Hosp Base, Div Cardiol, Sao Jose do Rio Preto Med Sch FAMERP, Sao Paulo, Brazil; [Zanetta, Dirce M. T.] Univ Sao Paulo, Sch Publ Hlth, Sao Paulo, Brazil	Universidade de Sao Paulo	Bruetto, RG (corresponding author), Hosp Base, Div Nephrol, Sao Jose do Rio Preto Med Sch FAMERP, Sao Paulo, Brazil.	burdmann@usp.br	Zanetta, Dirce M T/G-4950-2013; Burdmann, Emmanuel/AAY-1966-2020; Torres, Ulysses S./E-6034-2011; Burdmann, Emmanuel/B-7023-2009; Otaviano, Ana Paula/D-6505-2018	Torres, Ulysses S./0000-0002-1911-9090; Burdmann, Emmanuel/0000-0002-7644-8579; Otaviano, Ana Paula/0000-0002-3745-0297; Zanetta, Dirce Maria/0000-0002-7273-5087	Foundation for the Support of Research in the State of Sao Paulo (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP), Brazil; National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq), Brazil; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil [0076/2007]; Foundation for the Support of Research in the State of Sao Paulo (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP) [2008/57115-6]	Foundation for the Support of Research in the State of Sao Paulo (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP), Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Foundation for the Support of Research in the State of Sao Paulo (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	EAB is partially supported by grants from Foundation for the Support of Research in the State of Sao Paulo (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP), Brazil, and from the National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq), Brazil. RGB received a master's degree grant from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil (process 0076/2007). UST received a young investigator award (process 2008/57115-6) from Foundation for the Support of Research in the State of Sao Paulo (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali T, 2007, J AM SOC NEPHROL, V18, P1292, DOI 10.1681/ASN.2006070756; Amin AP, 2010, AM HEART J, V160, P1065, DOI 10.1016/j.ahj.2010.08.007; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bouzas-Mosquera A, 2009, ARCH INTERN MED, V169, P87, DOI 10.1001/archinternmed.2008.554; Cheitlin MD, 1997, J AM COLL CARDIOL, V29, P862, DOI 10.1016/S0735-1097(96)90000-5; CHERTOW GM, 1995, ARCH INTERN MED, V155, P1505, DOI 10.1001/archinte.155.14.1505; Coca SG, 2012, J THORAC CARDIOV SUR, V143, P495, DOI 10.1016/j.jtcvs.2011.09.023; Collins AJ, 2009, AM J KIDNEY DIS, V53, pS1, DOI 10.1053/j.ajkd.2008.10.005; Doi K, 2011, CRIT CARE MED, V39, P2464, DOI 10.1097/CCM.0b013e318225761a; Goldberg A, 2005, AM HEART J, V150, P330, DOI 10.1016/j.ahj.2004.09.055; Goldberg A, 2009, KIDNEY INT, V76, P900, DOI 10.1038/ki.2009.295; Goldenberg I, 2010, ARCH INTERN MED, V170, P888, DOI 10.1001/archinternmed.2010.95; Grams ME, 2010, J AM SOC NEPHROL, V21, P1757, DOI 10.1681/ASN.2010010128; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; Huang TM, 2011, J AM SOC NEPHROL, V22, P156, DOI 10.1681/ASN.2010050553; Inrig JK, 2008, NEPHROL DIAL TRANSPL, V23, P934, DOI 10.1093/ndt/gfm689; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; James MT, 2010, LANCET, V376, P2096, DOI 10.1016/S0140-6736(10)61271-8; Khosla N, 2009, CLIN J AM SOC NEPHRO, V4, P1914, DOI 10.2215/CJN.01690309; Kolli H, 2010, RENAL FAILURE, V32, P1066, DOI 10.3109/0886022X.2010.510616; Lazaros G, 2012, INT J CARDIOL, V155, P97, DOI 10.1016/j.ijcard.2010.10.024; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lombardi R, 2008, RENAL FAILURE, V30, P155, DOI 10.1080/08860220701808129; Marenzi G, 2010, CRIT CARE MED, V38, P438, DOI 10.1097/CCM.0b013e3181b9eb3b; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Newsome BB, 2008, ARCH INTERN MED, V168, P609, DOI 10.1001/archinte.168.6.609; Parikh CR, 2008, ARCH INTERN MED, V168, P987, DOI 10.1001/archinte.168.9.987; Reddan DN, 2005, NEPHROL DIAL TRANSPL, V20, P2105, DOI 10.1093/ndt/gfh981; Rodrigues FB, 2010, CLIN J AM SOC NEPHRO, V5, P1530, DOI 10.2215/CJN.01260210; Ronco C, 2008, J AM COLL CARDIOL, V52, P1527, DOI 10.1016/j.jacc.2008.07.051; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Shlipak MG, 2002, ANN INTERN MED, V137, P555, DOI 10.7326/0003-4819-137-7-200210010-00006; Singh P, 2010, CLIN J AM SOC NEPHRO, V5, P1690, DOI 10.2215/CJN.00830110; Skott M, 2010, NEPHROL DIAL TRANSPL, V25, P3509, DOI 10.1093/ndt/gfq281; Szummer K, 2010, J INTERN MED, V268, P40, DOI 10.1111/j.1365-2796.2009.02204.x; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; Waikar SS, 2008, CLIN J AM SOC NEPHRO, V3, P844, DOI 10.2215/CJN.05191107; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1143, DOI 10.1681/ASN.2005091017; Wu VC, 2011, KIDNEY INT, V80, P1222, DOI 10.1038/ki.2011.259	40	35	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35496	10.1371/journal.pone.0035496	http://dx.doi.org/10.1371/journal.pone.0035496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539974	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341000040
J	Sezaki, T; Inada, K; Sogabe, T; Kakuda, K; Tomiyama, L; Matsuno, Y; Ichikawa, T; Matsuo, M; Ueda, K; Kioka, N				Sezaki, Takuhito; Inada, Kohki; Sogabe, Takayuki; Kakuda, Kumiyo; Tomiyama, Lucia; Matsuno, Yohsuke; Ichikawa, Takafumi; Matsuo, Michinori; Ueda, Kazumitsu; Kioka, Noriyuki			Role of Dlg5/lp-dlg, a Membrane-Associated Guanylate Kinase Family Protein, in Epithelial-Mesenchymal Transition in LLc-PK1 Renal Epithelial Cells	PLOS ONE			English	Article							TGF-BETA RECEPTOR; DLG5 R30Q; SMAD7; VINEXIN; ACTIVATION; EXPRESSION; MECHANISM; GROWTH; TRAF6; IDENTIFICATION	Discs large homolog 5 (Dlg5) is a member of the membrane-associated guanylate kinase adaptor family of proteins, some of which are involved in the regulation of epithelial-to-mesenchymal transition (EMT). Dlg5 has been described as a susceptibility gene for Crohn's disease; however, the physiological function of Dlg5 is unknown. We show here that transforming growth factor-beta (TGF-beta)-induced EMT suppresses Dlg5 expression in LLc-PK1 cells. Depletion of Dlg5 expression by knockdown promoted the expression of the mesenchymal marker proteins, fibronectin and alpha-smooth muscle actin, and suppressed the expression of E-cadherin. In addition, activation of JNK and p38, which are stimulated by TGF-beta, was enhanced by Dlg5 depletion. Furthermore, inhibition of the TGF-beta receptor suppressed the effects of Dlg5 depletion. These observations suggest that Dlg5 is involved in the regulation of TGF-beta receptor-dependent signals and EMT.	[Sezaki, Takuhito; Inada, Kohki; Sogabe, Takayuki; Kakuda, Kumiyo; Tomiyama, Lucia; Matsuno, Yohsuke; Ichikawa, Takafumi; Matsuo, Michinori; Ueda, Kazumitsu; Kioka, Noriyuki] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto, Japan; [Ueda, Kazumitsu] Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Sakyo Ku, Kyoto, Japan	Kyoto University; Kyoto University	Sezaki, T (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto, Japan.	nkioka@kais.kyoto-u.ac.jp		Ichikawa, Takafumi/0000-0002-0490-4176; Ueda, Kazumitsu/0000-0003-2980-6078; Kioka, Noriyuki/0000-0002-2708-537X	Mishima Kaiun Memorial Foundation; Asahi Glass Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Bio-oriented Technology Research Advancement Institution; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [09J02878] Funding Source: KAKEN	Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); Asahi Glass Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Bio-oriented Technology Research Advancement Institution; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Mishima Kaiun Memorial Foundation; the Asahi Glass Foundation; a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; a grant from the Bio-oriented Technology Research Advancement Institution; and Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Biank V, 2007, AM J GASTROENTEROL, V102, P391, DOI 10.1111/j.1572-0241.2006.01011.x; Boirivant M, 2006, GASTROENTEROLOGY, V131, P1786, DOI 10.1053/j.gastro.2006.09.016; Browning BL, 2008, J MED GENET, V45, P36, DOI 10.1136/jmg.2007.050773; Chang YJ, 2010, CELL CYCLE, V9, P1990, DOI 10.4161/cc.9.10.11730; Chen CL, 2010, EXP CELL RES, V316, P1109, DOI 10.1016/j.yexcr.2010.02.022; Cullen G, 2007, INFLAMM BOWEL DIS, V13, P1369, DOI 10.1002/ibd.20220; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Friedrichs F, 2008, J MOL MED, V86, P423, DOI 10.1007/s00109-008-0307-5; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kioka N, 1999, J CELL BIOL, V144, P59, DOI 10.1083/jcb.144.1.59; Kioka N, 2002, CELL STRUCT FUNCT, V27, P1, DOI 10.1247/csf.27.1; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Li Y, 2010, J DERMATOL SCI, V60, P105, DOI 10.1016/j.jdermsci.2010.08.003; Lin Z, 2009, DIS MARKERS, V27, P193, DOI [10.1155/2009/167534, 10.3233/DMA-2009-0662]; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Lv ZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022806; Masszi A, 2003, AM J PHYSIOL-RENAL, V284, pF911, DOI 10.1152/ajprenal.00183.2002; Medici D, 2011, BIOCHEM J, V437, P515, DOI 10.1042/BJ20101500; Mitsushima M, 2006, GENES CELLS, V11, P971, DOI 10.1111/j.1365-2443.2006.00995.x; Monteleone G, 2001, J CLIN INVEST, V108, P601, DOI 10.1172/JCI200112821; Mu Y, 2011, CELL TISSUE RES; Mu YB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1332; Nakamura H, 1998, FEBS LETT, V433, P63, DOI 10.1016/S0014-5793(98)00882-5; Nakamura T, 2004, ONCOGENE, V23, P2385, DOI 10.1038/sj.onc.1207392; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nechiporuk T, 2007, DEV CELL, V13, P338, DOI 10.1016/j.devcel.2007.07.017; Neurath MF, 1996, J EXP MED, V183, P2605, DOI 10.1084/jem.183.6.2605; Pallet N, 2012, J TRANSPLANT, V2012, DOI 10.1155/2012/348604; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; Reichert M, 2000, J BIOL CHEM, V275, P9492, DOI 10.1074/jbc.275.13.9492; Ryeom SW, 2000, MOL BIOL CELL, V11, P1687, DOI 10.1091/mbc.11.5.1687; Smolen GA, 2010, GENE DEV, V24, P2654, DOI 10.1101/gad.1989110; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Stoll M, 2004, NAT GENET, V36, P476, DOI 10.1038/ng1345; Taniuchi K, 2005, CANCER RES, V65, P105; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Torok P, 2009, AM J GASTROENTEROL, V104, P1723, DOI 10.1038/ajg.2009.184; Umemoto T, 2009, CANCER LETT, V279, P22, DOI 10.1016/j.canlet.2009.01.017; Ura S, 2001, GENES CELLS, V6, P519, DOI 10.1046/j.1365-2443.2001.00439.x; Van Limbergen J, 2009, ANNU REV GENOM HUM G, V10, P89, DOI 10.1146/annurev-genom-082908-150013; Wakabayashi M, 2003, J BIOL CHEM, V278, P21709, DOI 10.1074/jbc.M211004200; Wang H, 2001, FEBS LETT, V503, P91, DOI 10.1016/S0014-5793(01)02699-0; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Yamashita H, 2011, J BIOL CHEM, V286, P3907, DOI 10.1074/jbc.M110.145409; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zuo W, 2009, MOL BIOL CELL, V20, P1020, DOI 10.1091/mbc.E08-09-0898	54	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35519	10.1371/journal.pone.0035519	http://dx.doi.org/10.1371/journal.pone.0035519			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539977	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341000043
J	Teotonio, H; Carvalho, S; Manoel, D; Roque, M; Chelo, IM				Teotonio, Henrique; Carvalho, Sara; Manoel, Diogo; Roque, Miguel; Chelo, Ivo M.			Evolution of Outcrossing in Experimental Populations of Caenorhabditis elegans	PLOS ONE			English	Article							INBREEDING DEPRESSION; C. ELEGANS; LINKAGE DISEQUILIBRIUM; DELETERIOUS MUTATION; NATURAL-POPULATIONS; SELF-FERTILIZATION; GENETIC DIVERSITY; LINKED SITES; LIFE-SPAN; SELECTION	Caenorhabditis elegans can reproduce exclusively by self-fertilization. Yet, males can be maintained in laboratory populations, a phenomenon that continues to puzzle biologists. In this study we evaluated the role of males in facilitating adaptation to novel environments. For this, we contrasted the evolution of a fitness component exclusive to outcrossing in experimental populations of different mating systems. We introgressed a modifier of outcrossing into a hybrid population derived from several wild isolates to transform the wild-type androdioecious mating system into a dioecious mating system. By genotyping 375 single-nucleotide polymorphisms we show that the two populations had similar standing genetic diversity available for adaptation, despite the occurrence of selection during their derivation. We then performed replicated experimental evolution under the two mating systems from starting conditions of either high or low levels of diversity, under defined environmental conditions of discrete non-overlapping generations, constant density at high population sizes (N = 10(4)), no obvious spatial structure and abundant food resources. During 100 generations measurements of sex ratios and male competitive performance showed: 1) adaptation to the novel environment; 2) directional selection on male frequency under androdioecy; 3) optimal outcrossing rates of 0.5 under androdioecy; 4) the existence of initial inbreeding depression; and finally 5) that the strength of directional selection on male competitive performance does not depend on male frequencies. Taken together, these results suggest that androdioecious males are maintained at intermediate frequencies because outcrossing is adaptive.	[Teotonio, Henrique; Carvalho, Sara; Manoel, Diogo; Roque, Miguel; Chelo, Ivo M.] Inst Gulbenkian Ciencias, Oeiras, Portugal	Instituto Gulbenkian de Ciencia	Teotonio, H (corresponding author), Inst Gulbenkian Ciencias, Oeiras, Portugal.	teotonio@igc.gulbenkian.pt	Chelo, Ivo M/I-3080-2012; Carvalho, Sara/H-9826-2013	Chelo, Ivo M/0000-0002-5414-6625; Teotonio, Henrique/0000-0003-1057-6882; Carvalho, Sara/0000-0001-7788-8309; Manoel, Diogo/0000-0002-0353-1742	Fundacao para a Ciencia e a Tecnologia [PPCDT/BIA-BDE/61127/2004]; European Research Council [stERC/2009-243285]	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); European Research Council(European Research Council (ERC)European Commission)	Fundacao para a Ciencia e a Tecnologia (PPCDT/BIA-BDE/61127/2004); European Research Council (stERC/2009-243285). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2011, J GERONTOL A-BIOL, V66, P1300, DOI 10.1093/gerona/glr143; Anderson JL, 2010, J HERED, V101, pS62, DOI 10.1093/jhered/esq003; Barriere A, 2005, CURR BIOL, V15, P1176, DOI 10.1016/j.cub.2005.06.022; Bendesky A, 2011, NATURE, V472, P313, DOI 10.1038/nature09821; Bradic M., 2011, MOL METHODS EVOLUTIO; Burt A, 2000, EVOLUTION, V54, P337; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; CHARLESWORTH D, 1990, EVOLUTION, V44, P870, DOI 10.1111/j.1558-5646.1990.tb03811.x; Chasnov JR, 2007, P NATL ACAD SCI USA, V104, P6730, DOI 10.1073/pnas.0608050104; Chasnov JR, 2002, GENETICS, V160, P983; CHRISTIANSEN FB, 1989, THEOR POPUL BIOL, V35, P307, DOI 10.1016/0040-5809(89)90003-8; Christiansen FB, 1998, THEOR POPUL BIOL, V53, P199, DOI 10.1006/tpbi.1997.1358; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Cutter AD, 2005, J EVOLUTION BIOL, V18, P27, DOI 10.1111/j.1420-9101.2004.00804.x; Cutter AD, 2003, J EVOLUTION BIOL, V16, P812, DOI 10.1046/j.1420-9101.2003.00596.x; Cutter AD, 2003, GENET RES, V81, P91, DOI 10.1017/S001667230300613X; Cutter AD, 2003, MOL BIOL EVOL, V20, P665, DOI 10.1093/molbev/msg072; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; Denver DR, 2010, GENOME RES, V20, P1663, DOI 10.1101/gr.108191.110; Dolgin ES, 2007, EVOLUTION, V61, P1339, DOI 10.1111/j.1558-5646.2007.00118.x; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fisher RA, 1930, GENETICAL THEORY NAT; Garcia LR, 2007, GENETICS, V175, P1761, DOI 10.1534/genetics.106.068304; Gems D, 1996, NATURE, V379, P723, DOI 10.1038/379723a0; Gloria-Soria A, 2008, CURR BIOL, V18, P1694, DOI 10.1016/j.cub.2008.09.043; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; HILL WG, 1981, GENET RES, V38, P209, DOI 10.1017/S0016672300020553; HODGKIN J, 1983, GENETICS, V103, P43; JOHNSON TE, 1993, GENETICS, V134, P465; LaMunyon CW, 2007, J HERED, V98, P67, DOI 10.1093/jhered/esl052; LaMunyon CW, 2002, P ROY SOC B-BIOL SCI, V269, P1125, DOI 10.1098/rspb.2002.1996; LANDE R, 1985, EVOLUTION, V39, P24, DOI [10.2307/2408514, 10.1111/j.1558-5646.1985.tb04077.x]; LANDE R, 1994, EVOLUTION, V48, P965, DOI 10.1111/j.1558-5646.1994.tb05286.x; LANDE R, 1977, GENETICS, V86, P485; Lipton J, 2004, J NEUROSCI, V24, P7427, DOI 10.1523/JNEUROSCI.1746-04.2004; Lynch M., 1998, GENETICS ANAL QUANTI; Manoel D, 2007, P ROY SOC B-BIOL SCI, V274, P417, DOI 10.1098/rspb.2006.3739; Morran LT, 2011, SCIENCE, V333, P216, DOI 10.1126/science.1206360; Morran LT, 2009, NATURE, V462, P350, DOI 10.1038/nature08496; Morran LT, 2009, EVOLUTION, V63, P1473, DOI 10.1111/j.1558-5646.2009.00652.x; Murray RL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-99; Murray RL, 2011, J EXP BIOL, V214, P1740, DOI 10.1242/jeb.053181; Nordborg M, 2000, GENETICS, V154, P923; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; R Development Core Team, 2006, R LANG ENV STAT COMP; Rockman MV, 2010, SCIENCE, V330, P372, DOI 10.1126/science.1194208; Rockman MV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000419; SCHEDL T, 1988, GENETICS, V119, P43; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Seidel HS, 2008, SCIENCE, V319, P589, DOI 10.1126/science.1151107; Simon JM, 2002, P NATL ACAD SCI USA, V99, P1598, DOI 10.1073/pnas.032225799; Sivasundar A, 2005, CURR BIOL, V15, P1598, DOI 10.1016/j.cub.2005.08.034; Stewart AD, 2002, GENETICS, V160, P975; Stiernagle T., 1999, MAINTENANCE C ELEGAN; Teotonio H, 2006, EVOLUTION, V60, P1300, DOI 10.1111/j.0014-3820.2006.tb01207.x; Venables WN., 2002, MODERN APPL STAT S 4; Wegewitz Viktoria, 2008, BMC Ecology, V8, P12, DOI 10.1186/1472-6785-8-12; Weir BS., 1996, GENETIC DATA ANAL; ZIEHE M, 1989, GENETICS, V121, P861	60	59	59	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35811	10.1371/journal.pone.0035811	http://dx.doi.org/10.1371/journal.pone.0035811			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22540006	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341000072
J	Renga, B; Francisci, D; D'Amore, C; Schiaroli, E; Mencarelli, A; Cipriani, S; Baldelli, F; Fiorucci, S				Renga, Barbara; Francisci, Daniela; D'Amore, Claudio; Schiaroli, Elisabetta; Mencarelli, Andrea; Cipriani, Sabrina; Baldelli, Franco; Fiorucci, Stefano			The HIV Matrix Protein p17 Subverts Nuclear Receptors Expression and Induces a STAT1-Dependent Proinflammatory Phenotype in Monocytes	PLOS ONE			English	Article							DENDRITIC CELLS; DOWN-REGULATION; ACTIVATION; MACROPHAGES; INDUCTION; CD4(+); CD36; INFLAMMATION; PATHOGENESIS; METABOLISM	Background: Long-term remission of HIV-1 disease can be readily achieved by combinations of highly effective antiretroviral therapy (HAART). However, a residual persistent immune activation caused by circulating non infectious particles or viral proteins is observed under HAART and might contribute to an higher risk of non-AIDS pathologies and death in HIV infected persons. A sustained immune activation supports lipid dysmetabolism and increased risk for development of accelerated atehrosclerosis and ischemic complication in virologically suppressed HIV-infected persons receiving HAART. Aim: While several HIV proteins have been identified and characterized for their ability to maintain immune activation, the role of HIV-p17, a matrix protein involved in the viral replication, is still undefined. Results: Here, we report that exposure of macrophages to recombinant human p17 induces the expression of proinflammatory and proatherogenic genes (MCP-1, ICAM-1, CD40, CD86 and CD36) while downregulating the expression of nuclear receptors (FXR and PPAR gamma) that counter-regulate the proinflammatory response and modulate lipid metabolism in these cells. Exposure of macrophage cell lines to p17 activates a signaling pathway mediated by Rack-1/Jak-1/STAT-1 and causes a promoter-dependent regulation of STAT-1 target genes. These effects are abrogated by sera obtained from HIV-infected persons vaccinated with a p17 peptide. Ligands for FXR and PPAR gamma counteract the effects of p17. Conclusions: The results of this study show that HIV p17 highjacks a Rack-1/Jak-1/STAT-1 pathway in macrophages, and that the activation of this pathway leads to a simultaneous dysregulation of immune and metabolic functions. The binding of STAT-1 to specific responsive elements in the promoter of PPAR gamma and FXR and MCP-1 shifts macrophages toward a pro-atherogenetic phenotype characterized by high levels of expression of the scavenger receptor CD36. The present work identifies p17 as a novel target in HIV therapy and grounds the development of anti-p17 small molecules or vaccines.	[Renga, Barbara; D'Amore, Claudio; Mencarelli, Andrea; Cipriani, Sabrina; Fiorucci, Stefano] Univ Perugia, Dipartimento Med Clin & Sperimentale, I-06100 Perugia, Italy; [Francisci, Daniela; Schiaroli, Elisabetta; Baldelli, Franco] Univ Perugia, Dipartimento Med Clin & Sci Biochim, I-06100 Perugia, Italy	University of Perugia; University of Perugia	Renga, B (corresponding author), Univ Perugia, Dipartimento Med Clin & Sperimentale, I-06100 Perugia, Italy.	fiorucci@unipg.it	schiaroli, elisabetta/N-9098-2015; Fiorucci, Stefano/I-1251-2012	schiaroli, elisabetta/0000-0002-3216-4144; D'Amore, Claudio/0000-0001-9217-9404	Medestea, Turin, Italy	Medestea, Turin, Italy	This study was in part supported by Medestea, Turin, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bovolenta C, 1999, BLOOD, V94, P4202, DOI 10.1182/blood.V94.12.4202.424k22_4202_4209; BUKRINSKY MI, 1993, NATURE, V365, P666, DOI 10.1038/365666a0; Calza L, 2009, JAIDS-J ACQ IMM DEF, V50, P430, DOI 10.1097/QAI.0b013e31819a292c; Chinetti-Gbaguidi G, 2009, BBA-MOL CELL BIOL L, V1791, P486, DOI 10.1016/j.bbalip.2009.01.009; CHOUDHURY AM, 1992, MICROBIOL IMMUNOL, V36, P833, DOI 10.1111/j.1348-0421.1992.tb02085.x; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; De Francesco MA, 2011, J BIOL CHEM, V286, P19541, DOI 10.1074/jbc.M110.191270; Dong XH, 2005, CELL, V120, P663, DOI 10.1016/j.cell.2004.12.023; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Esser MT, 2001, J VIROL, V75, P1152, DOI 10.1128/JVI.75.3.1152-1164.2001; Fang C, 2004, BIOCHEM PHARMACOL, V67, P1389, DOI 10.1016/j.bcp.2003.12.012; Fantuzzi L, 2000, J LEUKOCYTE BIOL, V68, P391; Fiorentini S, 2006, NEW MICROBIOL, V29, P1; Fiorentini S, 2004, BIOPOLYMERS, V76, P334, DOI 10.1002/bip.20130; Fiorentini S, 2008, P NATL ACAD SCI USA, V105, P3867, DOI 10.1073/pnas.0800370105; Fiorentini S, 2010, PHARMACOL THERAPEUT, V128, P433, DOI 10.1016/j.pharmthera.2010.08.005; Fiorucci S, 2010, CURR MOL MED, V10, P579; Fiorucci S, 2010, PROG LIPID RES, V49, P171, DOI 10.1016/j.plipres.2009.11.001; Frank DA, 1999, NAT MED, V5, P444, DOI 10.1038/7445; FREED EO, 1994, J VIROL, V68, P5311, DOI 10.1128/JVI.68.8.5311-5320.1994; Giagulli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017831; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Haffar OK, 2000, J MOL BIOL, V299, P359, DOI 10.1006/jmbi.2000.3768; Harvey EJ, 2007, ARTERIOSCL THROM VAS, V27, P806, DOI 10.1161/01.ATV.0000258867.79411.96; Herbein G., 2002, Current Molecular Medicine (Hilversum), V2, P723, DOI 10.2174/1566524023361844; Ho W Z, 1994, Immunol Ser, V60, P569; Hogan JC, 2001, BIOCHEM BIOPH RES CO, V287, P484, DOI 10.1006/bbrc.2001.5606; Hong C, 2008, CURR OPIN GENET DEV, V18, P461, DOI 10.1016/j.gde.2008.07.016; Huang JW, 2006, BIOCHEM BIOPH RES CO, V350, P227, DOI 10.1016/j.bbrc.2006.09.035; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Lievens D, 2009, THROMB HAEMOSTASIS, V102, P206, DOI 10.1160/TH09-01-0029; Linton MF, 2003, INT J OBESITY, V27, pS35, DOI 10.1038/sj.ijo.0802498; Magnani M, 2003, J LEUKOCYTE BIOL, V74, P764, DOI 10.1189/jlb.0403156; Marini E, 2008, CELL MICROBIOL, V10, P655, DOI 10.1111/j.1462-5822.2007.01073.x; Meroni L, 2005, JAIDS-J ACQ IMM DEF, V38, P310; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Mujawar Z, 2006, PLOS BIOL, V4, P1970, DOI 10.1371/journal.pbio.0040365; Muthumani K, 2005, INT IMMUNOL, V17, P103, DOI 10.1093/intimm/dxh190; MYERS CL, 1992, AM J PHYSIOL, V263, pC767, DOI 10.1152/ajpcell.1992.263.4.C767; Nicholson AC, 2001, ANN NY ACAD SCI, V947, P224; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Popovic M, 2005, P NATL ACAD SCI USA, V102, P14807, DOI 10.1073/pnas.0506857102; Ren ZG, 2002, LAB INVEST, V82, P245, DOI 10.1038/labinvest.3780418; Renga B, 2011, BBA-GENE REGUL MECH, V1809, P157, DOI 10.1016/j.bbagrm.2011.01.008; Renga Barbara, 2009, Biochim Biophys Acta, V1792, P564, DOI 10.1016/j.bbadis.2009.04.004; Sekhar RV, 2010, EXPERT OPIN PHARMACO, V11, P1845, DOI 10.1517/14656566.2010.487484; Suttles J, 2009, SEMIN IMMUNOL, V21, P257, DOI 10.1016/j.smim.2009.05.011; Usacheva A, 2003, J IMMUNOL, V171, P2989, DOI 10.4049/jimmunol.171.6.2989; Varga T, 2008, EUR J CLIN INVEST, V38, P695, DOI 10.1111/j.1365-2362.2008.02022.x; Wahl SM, 2003, J LEUKOCYTE BIOL, V74, P726, DOI 10.1189/jlb.0503220; Yang B, 2009, MICROVASC RES, V77, P212, DOI 10.1016/j.mvr.2008.11.003; Yang YB, 2010, J MED VIROL, V82, P735, DOI 10.1002/jmv.21720; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P139, DOI 10.1161/ATVBAHA.108.179283; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037	55	21	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35924	10.1371/journal.pone.0035924	http://dx.doi.org/10.1371/journal.pone.0035924			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558273	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340200031
J	Brocato, R; Josleyn, M; Ballantyne, J; Vial, P; Hooper, JW				Brocato, Rebecca; Josleyn, Matthew; Ballantyne, John; Vial, Pablo; Hooper, Jay W.			DNA Vaccine-Generated Duck Polyclonal Antibodies as a Postexposure Prophylactic to Prevent Hantavirus Pulmonary Syndrome (HPS)	PLOS ONE			English	Article							ARGENTINE HEMORRHAGIC-FEVER; TO-PERSON TRANSMISSION; ANDES VIRUS; INCUBATION PERIOD; NEUTRALIZING ANTIBODIES; PROTECTS HAMSTERS; IMMUNE PLASMA; INFECTION; IGY; IMMUNOGLOBULINS	Andes virus (ANDV) is the predominant cause of hantavirus pulmonary syndrome (HPS) in South America and the only hantavirus known to be transmitted person-to-person. There are no vaccines, prophylactics, or therapeutics to prevent or treat this highly pathogenic disease (case-fatality 35-40%). Infection of Syrian hamsters with ANDV results in a disease that closely mimics human HPS in incubation time, symptoms of respiratory distress, and disease pathology. Here, we evaluated the feasibility of two postexposure prophylaxis strategies in the ANDV/hamster lethal disease model. First, we evaluated a natural product, human polyclonal antibody, obtained as fresh frozen plasma (FFP) from a HPS survivor. Second, we used DNA vaccine technology to manufacture a polyclonal immunoglobulin-based product that could be purified from the eggs of vaccinated ducks (Anas platyrhynchos). The natural "despeciation" of the duck IgY (i.e., Fc removed) results in an immunoglobulin predicted to be minimally reactogenic in humans. Administration of >= 5,000 neutralizing antibody units (NAU)/kg of FFP-protected hamsters from lethal disease when given up to 8 days after intranasal ANDV challenge. IgY/IgYDFc antibodies purified from the eggs of DNA-vaccinated ducks effectively neutralized ANDV in vitro as measured by plaque reduction neutralization tests (PRNT). Administration of 12,000 NAU/kg of duck egg-derived IgY/IgYDFc protected hamsters when administered up to 8 days after intranasal challenge and 5 days after intramuscular challenge. These experiments demonstrate that convalescent FFP shows promise as a postexposure HPS prophylactic. Moreover, these data demonstrate the feasibility of using DNA vaccine technology coupled with the duck/egg system to manufacture a product that could supplement or replace FFP. The DNA vaccine-duck/egg system can be scaled as needed and obviates the necessity of using limited blood products obtained from a small number of HPS survivors. This is the first report demonstrating the in vivo efficacy of any antiviral product produced using DNA vaccine-duck/egg system.	[Brocato, Rebecca; Josleyn, Matthew; Hooper, Jay W.] USA, Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA; [Ballantyne, John] Aldevron LLC, Fargo, ND USA; [Vial, Pablo] Clin Alemana Univ Desarrollo, Sch Med, Inst Sci, Santiago, Chile	Universidad del Desarrollo	Brocato, R (corresponding author), USA, Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA.	jay.w.hooper@us.army.mil	Hooper, Jay/K-2362-2017; Brocato, Rebecca L/H-1236-2019	Hooper, Jay/0000-0002-4475-0415; Brocato, Rebecca L/0000-0003-4377-0710	Military Infectious Disease Research Program (MIDRP), Program Area T; Chemical Biological Medical Systems (CBMS); National Institutes of Health [U01AI045452]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI045452] Funding Source: NIH RePORTER	Military Infectious Disease Research Program (MIDRP), Program Area T; Chemical Biological Medical Systems (CBMS); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the Military Infectious Disease Research Program (MIDRP), Program Area T; by Chemical Biological Medical Systems (CBMS) and by National Institutes of Health U01AI045452. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouzid K, 2006, VACCINE, V24, P4615, DOI 10.1016/j.vaccine.2005.08.085; BAUR X, 1995, ALLERGY, V50, P604, DOI 10.1111/j.1398-9995.1995.tb01208.x; Campen MJ, 2006, VIROLOGY, V356, P45, DOI 10.1016/j.virol.2006.07.044; Casadevall A, 2002, NAT BIOTECHNOL, V20, P114, DOI 10.1038/nbt0202-114; Chiou VYN, 2008, CLIN TOXICOL, V46, P539, DOI 10.1080/15563650701771973; de Almeida CMC, 2008, TOXICON, V52, P293, DOI 10.1016/j.toxicon.2008.05.022; Cova L, 2005, J CLIN VIROL, V34, pS70, DOI 10.1016/S1386-6532(05)80013-7; Custer DM, 2003, J VIROL, V77, P9894, DOI 10.1128/JVI.77.18.9894-9905.2003; ENRIA DA, 1984, LANCET, V2, P255, DOI 10.1016/S0140-6736(84)90299-X; FDA, 2010, APPR PROD IMM GLOB; Figueiredo LTM, 2009, EMERG INFECT DIS, V15, P561, DOI 10.3201/eid1504.080289; GREY HM, 1967, J IMMUNOL, V98, P820; Hammerbeck CD, 2010, NEW GENERATION VACCI, P905; Health CMo, 2011, EP REP HANT CHIL; Hooper JW, 2008, J VIROL, V82, P1332, DOI 10.1128/JVI.01822-07; Hooper JW, 2001, J VIROL, V75, P8469, DOI 10.1128/JVI.75.18.8469-8477.2001; Hooper JW, 2001, VIROLOGY, V289, P6, DOI 10.1006/viro.2001.1133; Hooper JW, 1999, VIROLOGY, V255, P269, DOI 10.1006/viro.1998.9586; Humphrey BD, 2004, DEV COMP IMMUNOL, V28, P665, DOI 10.1016/j.dci.2003.11.003; Ibrahim ESM, 2008, VACCINE, V26, P2073, DOI 10.1016/j.vaccine.2008.02.046; Lundquist AL, 2007, LIVER TRANSPLANT, V13, P647, DOI 10.1002/lt.21098; Lundqvist ML, 2006, DEV COMP IMMUNOL, V30, P93, DOI 10.1016/j.dci.2005.06.019; MAIZTEGUI JI, 1979, LANCET, V2, P1216; Martinez VP, 2010, EMERG INFECT DIS, V16, P1853, DOI 10.3201/eid1612.091170; Martinez VP, 2005, EMERG INFECT DIS, V11, P1848, DOI 10.3201/eid1112.050501; Meenatchisundaram S, 2008, TOXICON, V52, P221, DOI 10.1016/j.toxicon.2008.04.179; Nguyen HH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010152; Padula PJ, 1998, VIROLOGY, V241, P323, DOI 10.1006/viro.1997.8976; Padula PJ, 2000, J CLIN MICROBIOL, V38, P3029, DOI 10.1128/JCM.38.8.3029-3035.2000; QUARRE JP, 1995, J ALLERGY CLIN IMMUN, V95, P922, DOI 10.1016/S0091-6749(95)70144-3; Rollier C, 2000, VACCINE, V18, P3091, DOI 10.1016/S0264-410X(00)00130-4; Rollier C, 2000, J VIROL, V74, P4908, DOI 10.1128/JVI.74.10.4908-4911.2000; Safronetz D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002426; Safronetz D, 2009, J VIROL, V83, P7285, DOI 10.1128/JVI.00373-09; Smith JJ, 2004, PEDIATR INFECT DIS J, V23, P974, DOI 10.1097/01.inf.0000142011.98248.15; Vial PA, 2006, EMERG INFECT DIS, V12, P1271, DOI 10.3201/eid1708.051127; Wahl-Jensen V, 2007, J VIROL, V81, P7449, DOI 10.1128/JVI.00238-07; WARR GW, 1995, IMMUNOL TODAY, V16, P392, DOI 10.1016/0167-5699(95)80008-5; Young JC, 2000, AM J TROP MED HYG, V62, P714, DOI 10.4269/ajtmh.2000.62.714	39	32	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35996	10.1371/journal.pone.0035996	http://dx.doi.org/10.1371/journal.pone.0035996			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558299	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336000097
J	Novais, SC; De Coen, W; Amorim, MJB				Novais, Sara C.; De Coen, Wim; Amorim, Monica J. B.			Gene Expression Responses Linked to Reproduction Effect Concentrations (EC10,20,50,90) of Dimethoate, Atrazine and Carbendazim, in Enchytraeus albidus	PLOS ONE			English	Article							FUNCTIONAL GENOMICS; EXPOSURE; BIOTRANSFORMATION; MICROARRAY; BIOMARKERS; MECHANISM; HORMONE; CELLS; RATS; TOOL	Background: Molecular mechanisms of response to pesticides are scarce and information on such responses from soil invertebrates is almost inexistent. Enchytraeus albidus (Oligochaeta) is a standard soil ecotoxicology model species for which effects of many pesticides are known on survival, reproduction and avoidance behaviour. With the recent microarray development additional information can be retrieved on the molecular effects. Methodology/Principal Findings: Experiments were performed to investigate the transcription responses of E. albidus when exposed to three pesticides - dimethoate (insecticide), atrazine (herbicide) and carbendazim (fungicide) - in a range of concentrations that inhibited reproduction by 10%, 20%, 50% and 90% (EC10, EC20, EC50 and EC90, respectively). The goal of this study was to further identify key biological processes affected by each compound and if dose-related. All three pesticides significantly affected biological processes like translation, regulation of the cell cycle or general response to stress. Intracellular signalling and microtubule-based movement were affected by dimethoate and carbendazim whereas atrazine affected lipid and steroid metabolism (also by dimethoate) or carbohydrate metabolism (also by carbendazim). Response to DNA damage/DNA repair was exclusively affected by carbendazim. Conclusions: Changes in gene expression were significantly altered after 2 days of exposure in a dose-related manner. The mechanisms of response were comparable with the ones for mammals, suggesting across species conserved modes of action. The present results indicate the potential of using gene expression in risk assessment and the advantage as early markers.	[Novais, Sara C.; Amorim, Monica J. B.] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Novais, Sara C.; Amorim, Monica J. B.] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal; [De Coen, Wim] Univ Antwerp, Dept Biol EBT, B-2020 Antwerp, Belgium	Universidade de Aveiro; Universidade de Aveiro; University of Antwerp	Novais, SC (corresponding author), Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal.	sara.novais@ua.pt	Novais, Sara C/A-9032-2012; Amorim, Mónica J.B./G-8590-2011	Novais, Sara C/0000-0003-1306-3396; Amorim, Mónica J.B./0000-0001-8137-3295	FEDER-Fundo Europeu de Desenvolvimento Regional; National funding through FCT-Fundacao para a Ciencia e Tecnologia [FCOMP-01-0124-FEDER-008944, PTDC/BIA-BEC/103716/2008]; Sara Novais [SFRH/BD/36253/2007]; Fundação para a Ciência e a Tecnologia [PTDC/BIA-BEC/103716/2008] Funding Source: FCT	FEDER-Fundo Europeu de Desenvolvimento Regional; National funding through FCT-Fundacao para a Ciencia e Tecnologia; Sara Novais; Fundação para a Ciência e a Tecnologia	This study was sponsored by the funding FEDER-Fundo Europeu de Desenvolvimento Regional through COMPETE-Programa Operacional Factores de Competitividade, and by National funding through FCT-Fundacao para a Ciencia e Tecnologia, within the research project NANOkA FCOMP-01-0124-FEDER-008944 (Refa. FCT PTDC/BIA-BEC/103716/2008) and through a PhD grant to Sara Novais (SFRH/BD/36253/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amorim MJB, 2008, ENVIRON INT, V34, P363, DOI 10.1016/j.envint.2007.08.010; Amorim MJB, 2011, ENVIRON TOXICOL CHEM, V30, P1395, DOI 10.1002/etc.512; Astiz M, 2009, LIPIDS, V44, P703, DOI 10.1007/s11745-009-3323-5; Bisson M, 2002, TOXICOL APPL PHARM, V180, P110, DOI 10.1006/taap.2002.9377; Brattsand G, 2000, BRIT J CANCER, V83, P311, DOI 10.1054/bjoc.2000.1264; Brodkin MA, 2007, ENVIRON TOXICOL CHEM, V26, P80, DOI 10.1897/05-469.1; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; DAVIDSE LC, 1986, ANNU REV PHYTOPATHOL, V24, P43, DOI 10.1146/annurev.py.24.090186.000355; DAVIDSE LC, 1977, J CELL BIOL, V72, P174, DOI 10.1083/jcb.72.1.174; DEBRABANDER M, 1976, JNCI-J NATL CANCER I, V56, P357, DOI 10.1093/jnci/56.2.357; Dell'Omo G, 1999, ENVIRON TOXICOL CHEM, V18, P237, DOI [10.1897/1551-5028(1999)018&lt;0237:SPITCS&gt;2.3.CO;2, 10.1002/etc.5620180220]; Didden W, 2001, ECOTOX ENVIRON SAFE, V50, P25, DOI 10.1006/eesa.2001.2075; Domingues I, 2007, CHEMOSPHERE, V69, P145, DOI 10.1016/j.chemosphere.2007.04.013; Frasco MF, 2002, FISH PHYSIOL BIOCHEM, V26, P149, DOI 10.1023/A:1025457831923; Gomes SIL, 2012, COMP BIOCHEM PHYS C, V155, P219, DOI 10.1016/j.cbpc.2011.08.008; Hecker M, 2005, TOXICOL SCI, V86, P273, DOI 10.1093/toxsci/kfi203; Henle F. G. J, 1837, ARCH ANAT PHYSL MED, V1837, P74; IPCS, 1989, ENV HLTH CRIT DIM EN; ISO, 2004, SOIL QUAL EFF POLL E; Janer G, 2007, ECOTOXICOLOGY, V16, P145, DOI 10.1007/s10646-006-0110-4; Kobeticova K, 2009, ENVIRON POLLUT, V157, P704, DOI 10.1016/j.envpol.2008.09.032; Kumar A, 2010, ECOTOX ENVIRON SAFE, V73, P1503, DOI 10.1016/j.ecoenv.2010.07.016; Kumar AS, 2004, ONCOGENE, V23, P3454, DOI 10.1038/sj.onc.1207473; Laws SC, 2003, TOXICOL SCI, V76, P190, DOI 10.1093/toxsci/kfg223; Loureiro S, 2009, ENVIRON POLLUT, V157, P625, DOI 10.1016/j.envpol.2008.08.010; McMullin TS, 2004, TOXICOL SCI, V79, P278, DOI 10.1093/toxsci/kfh127; Nota B, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-236; Novais SC, 2012, ECOTOXICOLOGY, V21, P213, DOI 10.1007/s10646-011-0780-4; Novais SC, 2010, CHEMOSPHERE, V79, P233, DOI 10.1016/j.chemosphere.2010.01.011; Novais SC, 2012, PLOS ONE IN PRESS; Novais SC, 2011, 21 ANN M SETAC EUR M; Novais SC, 2012, ENV TOXICOL CH UNPUB; OECD, 2004, GUID TEST CHEM; Owen J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-266; Reichert K, 2005, CHEMOSPHERE, V61, P229, DOI 10.1016/j.chemosphere.2005.01.077; Rombke J, 2002, CHEMOSPHERE, V46, P1117, DOI 10.1016/S0045-6535(01)00113-8; Sanchez BC, 2011, J APPL TOXICOL, V31, P108, DOI 10.1002/jat.1553; SHERMAN H, 1975, TOXICOL APPL PHARM, V32, P305, DOI 10.1016/0041-008X(75)90221-5; Stout EP, 2010, P NATL ACAD SCI USA, V107, P11859, DOI 10.1073/pnas.1006074107; Svendsen C, 2008, ENVIRON SCI TECHNOL, V42, P4208, DOI 10.1021/es702745d; Swain S, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-32; Takahashi M, 2002, CANCER RES, V62, P6598; Tchounwou PB, 2001, MOL CELL BIOCHEM, V222, P49, DOI 10.1023/A:1017903005541; Thornton BJ, 2010, CHEMOSPHERE, V81, P235, DOI 10.1016/j.chemosphere.2010.06.032; Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887; Walsh LP, 2000, J ENDOCRINOL, V167, P253, DOI 10.1677/joe.0.1670253; Wu SB, 2011, OXIDATIVE STRESS VER; Yamada T, 2005, TOXICOL APPL PHARM, V205, P11, DOI 10.1016/j.taap.2004.09.002; Zaya RM, 2011, AQUAT TOXICOL, V104, P254, DOI 10.1016/j.aquatox.2011.04.022; Zhang Y, 2008, BMB REP, V41, P765, DOI 10.5483/BMBRep.2008.41.11.765	52	18	18	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36068	10.1371/journal.pone.0036068	http://dx.doi.org/10.1371/journal.pone.0036068			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558331	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000118
J	Torres, M; Cartier, L; Matamala, JM; Hernandez, N; Woehlbier, U; Hetz, C				Torres, Mauricio; Cartier, Luis; Manuel Matamala, Jose; Hernandez, Nancy; Woehlbier, Ute; Hetz, Claudio			Altered Prion Protein Expression Pattern in CSF as a Biomarker for Creutzfeldt-Jakob Disease	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; DIAGNOSTIC-CRITERIA; CLINICAL-DIAGNOSIS; 14-3-3-PROTEIN; CJD	Creutzfeldt-Jakob disease (CJD) is the most frequent human Prion-related disorder (PrD). The detection of 14-3-3 protein in the cerebrospinal fluid (CSF) is used as a molecular diagnostic criterion for patients clinically compatible with CJD. However, there is a pressing need for the identification of new reliable disease biomarkers. The pathological mechanisms leading to accumulation of 14-3-3 protein in CSF are not fully understood, however neuronal loss followed by cell lysis is assumed to cause the increase in 14-3-3 levels, which also occurs in conditions such as brain ischemia. Here we investigated the relation between the levels of 14-3-3 protein, Lactate dehydrogenase (LDH) activity and expression of the prion protein (PrP) in CSF of sporadic and familial CJD cases. Unexpectedly, we found normal levels of LDH activity in CJD cases with moderate levels of 14-3-3 protein. Increased LDH activity was only observed in a percentage of the CSF samples that also exhibited high 14-3-3 levels. Analysis of the PrP expression pattern in CSF revealed a reduction in PrP levels in all CJD cases, as well as marked changes in its glycosylation pattern. PrP present in CSF of CJD cases was sensitive to proteases. The alterations in PrP expression observed in CJD cases were not detected in other pathologies affecting the nervous system, including cases of dementia and tropical spastic paraparesis/HTLV-1 associated myelopathy (HAM/TSP). Time course analysis in several CJD patients revealed that 14-3-3 levels in CSF are dynamic and show a high degree of variability during the end stage of the disease. Post-mortem analysis of brain tissue also indicated that 14-3-3 protein is upregulated in neuronal cells, suggesting that its expression is modulated during the course of the disease. These results suggest that a combined analysis of 14-3-3 and PrP expression pattern in CSF is a reliable biomarker to confirm the clinical diagnosis of CJD patients and follow disease progression.	[Torres, Mauricio; Manuel Matamala, Jose; Hernandez, Nancy; Woehlbier, Ute; Hetz, Claudio] Univ Chile, Fac Med, Neurosci Biomed Inst, Santiago 7, Chile; [Torres, Mauricio; Manuel Matamala, Jose; Hernandez, Nancy; Woehlbier, Ute; Hetz, Claudio] Univ Chile, Ctr Mol Studies Cell, Inst Biomed Sci, Santiago, Chile; [Cartier, Luis; Manuel Matamala, Jose] Univ Chile, Fac Med, Dept Neurol Sci, Santiago 7, Chile; [Hetz, Claudio] Neurounion Biomed Fdn, Santiago, Chile; [Hetz, Claudio] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Universidad de Chile; Universidad de Chile; Universidad de Chile; Harvard University; Harvard T.H. Chan School of Public Health	Torres, M (corresponding author), Univ Chile, Fac Med, Neurosci Biomed Inst, Santiago 7, Chile.	lcartier@med.uchile.cl; chetz@med.uchile.cl	Hetz, Claudio/I-1900-2013; Hetz, Claudio/ABD-7514-2021	Hetz, Claudio/0000-0001-7724-1767; Woehlbier, Ute/0000-0003-3114-9708; Matamala, Jose Manuel/0000-0001-9062-5642; Hernandez Villegas, Nancy C./0000-0002-3982-7553; Torres-Gutierrez, Mauricio Andres/0000-0002-5081-9044	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1100176, 3110067]; Programa Fondo de Investigacion Avanzado en Areas Prioritarias (FONDAP) [15010006]; Millennium Institute [P09-015-F]; Alzheimer's Association; The Michael J Fox Foundation for Parkinson Research; ALS Therapy Alliance; North American spinal society; International Center for Genetic Engineering and Biotechnology, Italy; Comision Nacional de Investigacion Cientifica y Tecnologica, Gobierno de Chile (CONICYT)	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Programa Fondo de Investigacion Avanzado en Areas Prioritarias (FONDAP)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); Millennium Institute(Takeda Pharmaceutical Company Ltd); Alzheimer's Association(Alzheimer's Association); The Michael J Fox Foundation for Parkinson Research; ALS Therapy Alliance; North American spinal society; International Center for Genetic Engineering and Biotechnology, Italy; Comision Nacional de Investigacion Cientifica y Tecnologica, Gobierno de Chile (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported primarily by the Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT grant no. 1100176); Programa Fondo de Investigacion Avanzado en Areas Prioritarias (FONDAP grant no. 15010006); Millennium Institute no. P09-015-F (to CH) and Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT grant no. 3110067 to UW). In addition the authors thank support by Alzheimer's Association, The Michael J Fox Foundation for Parkinson Research, ALS Therapy Alliance, North American spinal society and International Center for Genetic Engineering and Biotechnology, Italy (to CH); and Comision Nacional de Investigacion Cientifica y Tecnologica, Gobierno de Chile (CONICYT Doctoral fellowship to MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi R, 2011, NAT MED, V17, P175, DOI 10.1038/nm.2294; Baxter HC, 2002, NEUROSCIENCE, V109, P5, DOI 10.1016/S0306-4522(01)00492-4; Beaudry P, 1999, DEMENT GERIATR COGN, V10, P40, DOI 10.1159/000017095; Berg D, 2003, NAT REV NEUROSCI, V4, P752, DOI 10.1038/nrn1197; Bieschke J, 2000, P NATL ACAD SCI USA, V97, P5468, DOI 10.1073/pnas.97.10.5468; BROWN P, 1992, J NEUROL SCI, V112, P65, DOI 10.1016/0022-510X(92)90133-6; BUDKA H, 1995, BRAIN PATHOL, V5, P459, DOI 10.1111/j.1750-3639.1995.tb00625.x; Burkhard PR, 2001, NEUROLOGY, V56, P1528, DOI 10.1212/WNL.56.11.1528; Castellani RJ, 2004, NEUROLOGY, V63, P436, DOI 10.1212/01.WNL.0000135153.96325.3B; Chapman T, 2000, NEUROLOGY, V55, P1396, DOI 10.1212/WNL.55.9.1396; Chen SZ, 2003, MOL CELL NEUROSCI, V22, P227, DOI 10.1016/S1044-7431(02)00014-3; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; De Castro-Costa CM, 2006, AIDS RES HUM RETROV, V22, P931, DOI 10.1089/aid.2006.22.931; Edgeworth JA, 2011, LANCET, V377, P487, DOI 10.1016/S0140-6736(10)62308-2; FANTL WJ, 1994, NATURE, V371, P612, DOI 10.1038/371612a0; GALVEZ S, 1987, REV MED CHILE, V115, P1148; Geschwind MD, 2003, ARCH NEUROL-CHICAGO, V60, P813, DOI 10.1001/archneur.60.6.813; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hetz C, 2005, J NEUROSCI, V25, P2793, DOI 10.1523/JNEUROSCI.4090-04.2005; Hetz C, 2003, EMBO J, V22, P5435, DOI 10.1093/emboj/cdg537; Hetz CA, 2006, CURR MOL MED, V6, P37, DOI 10.2174/156652406775574578; Hetz C, 2007, J BIOL CHEM, V282, P12725, DOI 10.1074/jbc.M611909200; Hsich G, 1996, NEW ENGL J MED, V335, P924, DOI 10.1056/NEJM199609263351303; Huang N, 2003, NEUROLOGY, V61, P354, DOI 10.1212/01.WNL.0000078890.89473.ED; JONES DHA, 1995, J MOL BIOL, V245, P375, DOI 10.1006/jmbi.1994.0031; Kretzschmar HA, 1996, ARCH NEUROL-CHICAGO, V53, P913, DOI 10.1001/archneur.1996.00550090125018; Lemstra AW, 2000, NEUROLOGY, V55, P514, DOI 10.1212/WNL.55.4.514; MARTIN H, 1994, J NEUROCHEM, V63, P2259; Meyne F, 2009, J ALZHEIMERS DIS, V17, P863, DOI 10.3233/JAD-2009-1110; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Poser S, 1999, BRAIN, V122, P2345, DOI 10.1093/brain/122.12.2345; PRUSINER SB, 1994, ANN NEUROL, V35, P385, DOI 10.1002/ana.410350404; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Russelakis-Carneiro M, 2004, AM J PATHOL, V165, P1839, DOI 10.1016/S0002-9440(10)63439-6; Safar JG, 2005, P NATL ACAD SCI USA, V102, P3501, DOI 10.1073/pnas.0409651102; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Soto C, TRENDS BIOCH SCI, V36, P151; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; TAGLIAVINI F, 1992, BIOCHEM BIOPH RES CO, V184, P1398, DOI 10.1016/S0006-291X(05)80038-5; Torres M, PLOS ONE, V5; Tuite MF, 2010, NAT REV MOL CELL BIO, V11, P823, DOI 10.1038/nrm3007; Watt NT, 2005, BIOCHEM SOC T, V33, P1123, DOI 10.1042/BST20051123; Westermark GT, 2010, TRENDS MOL MED, V16, P501, DOI 10.1016/j.molmed.2010.08.004; Wiltfang J, 1999, J NEUROCHEM, V73, P2485, DOI 10.1046/j.1471-4159.1999.0732485.x; Wong BS, 2001, J PATHOL, V194, P9, DOI 10.1002/path.872; Zerr I, 2002, APMIS, V110, P88, DOI 10.1034/j.1600-0463.2002.100111.x; Zerr I, 1998, ANN NEUROL, V43, P32, DOI 10.1002/ana.410430109	47	27	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36159	10.1371/journal.pone.0036159	http://dx.doi.org/10.1371/journal.pone.0036159			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558368	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000143
J	Xiong, XJ; Frank, DN; Robertson, CE; Hung, SS; Markle, J; Canty, AJ; Mccoy, KD; Macpherson, AJ; Poussier, P; Danska, JS; Parkinson, J				Xiong, Xuejian; Frank, Daniel N.; Robertson, Charles E.; Hung, Stacy S.; Markle, Janet; Canty, Angelo J.; McCoy, Kathy D.; Macpherson, Andrew J.; Poussier, Philippe; Danska, Jayne S.; Parkinson, John			Generation and Analysis of a Mouse Intestinal Metatranscriptome through Illumina Based RNA-Sequencing	PLOS ONE			English	Article							ESCHERICHIA-COLI; FUNCTIONAL-ANALYSIS; COG DATABASE; PROTEIN; COMMUNITY; REVEALS; CONSERVATION; MICROBIOTA; EXPRESSION; PHYLOGENY	With the advent of high through-put sequencing (HTS), the emerging science of metagenomics is transforming our understanding of the relationships of microbial communities with their environments. While metagenomics aims to catalogue the genes present in a sample through assessing which genes are actively expressed, metatranscriptomics can provide a mechanistic understanding of community inter-relationships. To achieve these goals, several challenges need to be addressed from sample preparation to sequence processing, statistical analysis and functional annotation. Here we use an inbred non-obese diabetic (NOD) mouse model in which germ-free animals were colonized with a defined mixture of eight commensal bacteria, to explore methods of RNA extraction and to develop a pipeline for the generation and analysis of metatranscriptomic data. Applying the Illumina HTS platform, we sequenced 12 NOD cecal samples prepared using multiple RNA-extraction protocols. The absence of a complete set of reference genomes necessitated a peptide-based search strategy. Up to 16% of sequence reads could be matched to a known bacterial gene. Phylogenetic analysis of the mapped ORFs revealed a distribution consistent with ribosomal RNA, the majority from Bacteroides or Clostridium species. To place these HTS data within a systems context, we mapped the relative abundance of corresponding Escherichia coli homologs onto metabolic and protein-protein interaction networks. These maps identified bacterial processes with components that were well-represented in the datasets. In summary this study highlights the potential of exploiting the economy of HTS platforms for metatranscriptomics.	[Xiong, Xuejian; Hung, Stacy S.; Parkinson, John] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Frank, Daniel N.] Univ Colorado, Div Infect Dis, Aurora, CO USA; [Robertson, Charles E.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Hung, Stacy S.; Parkinson, John] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Markle, Janet; Poussier, Philippe; Danska, Jayne S.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Markle, Janet; Danska, Jayne S.] Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON M5G 1X8, Canada; [Canty, Angelo J.] McMaster Univ, Dept Math & Stat, Hamilton, ON, Canada; [McCoy, Kathy D.; Macpherson, Andrew J.] Univ Bern, Dept Klin Forsch, Bern, Switzerland; [Poussier, Philippe] Univ Toronto, Sunnybrook Hlth Sci Ctr, Res Inst, Toronto, ON, Canada; [Danska, Jayne S.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Parkinson, John] Univ Toronto, Dept Biochem, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University; University of Bern; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto	Xiong, XJ (corresponding author), Hosp Sick Children, Program Mol Struct & Funct, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	jparkin@sickkids.ca	Parkinson, John/A-4424-2008; McCoy, Kathy/ABD-5814-2021; Markle, Janet/X-1975-2019	Parkinson, John/0000-0001-9815-1189; Markle, Janet/0000-0003-2189-4368; ROBERTSON, CHARLES/0000-0002-4136-4121	Canadian Institute of Health Research operating grant [82940]; Genome Canada; Ontario Genomics Institute -"Genome-Environment Interactions in type 1 diabetes''; Juvenile Diabetes Research Foundation [17-2011-520]; National Institutes of Health [R21HG005964]; Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award; Hospital for Sick Children Research Training Centre; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG005964] Funding Source: NIH RePORTER	Canadian Institute of Health Research operating grant(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); Ontario Genomics Institute -"Genome-Environment Interactions in type 1 diabetes''; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award(Canadian Institutes of Health Research (CIHR)); Hospital for Sick Children Research Training Centre; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors would like to acknowledge support from the following sources: Canadian Institute of Health Research operating grant - CTP-82940 (to JP, SSH and XX); Genome Canada and the Ontario Genomics Institute -"Genome-Environment Interactions in type 1 diabetes'' (to JSD, AJC and PP); Juvenile Diabetes Research Foundation - #17-2011-520 (to JSD, AJC, DNF, JP and PP); National Institutes of Health Grant R21HG005964 (to DNF and CER); Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award (to JM); and the Hospital for Sick Children Research Training Centre (to SSH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; Bennett WE, 2009, J IMMUNOL METHODS, V349, P56, DOI 10.1016/j.jim.2009.07.013; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berardini TZ, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI 10.1093/nar/gkp1018; Booijink CCGM, 2010, APPL ENVIRON MICROB, V76, P5533, DOI 10.1128/AEM.00502-10; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Dewhirst FE, 1999, APPL ENVIRON MICROB, V65, P3287; Frank DN, 2008, CURR OPIN GASTROEN, V24, P4, DOI 10.1097/MOG.0b013e3282f2b0e8; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Gifford SM, 2011, ISME J, V5, P461, DOI 10.1038/ismej.2010.141; Gilbert JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015545; Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Giongo A, 2011, ISME J, V5, P82, DOI 10.1038/ismej.2010.92; Green ML, 2006, NUCLEIC ACIDS RES, V34, P3687, DOI 10.1093/nar/gkl438; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Hung SS, 2010, BIOINFORMATICS, V26, P1690, DOI 10.1093/bioinformatics/btq266; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Letunic I, 2008, TRENDS BIOCHEM SCI, V33, P101, DOI 10.1016/j.tibs.2008.01.001; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marchetti A, 2012, P NATL ACAD SCI USA, V109, pE317, DOI 10.1073/pnas.1118408109; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mitra S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S21; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nam YD, 2009, INT J FOOD MICROBIOL, V130, P140, DOI 10.1016/j.ijfoodmicro.2009.01.007; Parrish JR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r130; Peregrin-Alvarez JM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000523; Peregrin-Alvarez JM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r63; Peregrin-Alvarez JM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r238; Peterson DA, 2008, CELL HOST MICROBE, V3, P417, DOI 10.1016/j.chom.2008.05.001; Poretslcy RS, 2009, J VIS EXP; Poroyko V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012459; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Radax R, 2012, ENV MICROBIOL; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Robertson BR, 2005, INT J SYST EVOL MICR, V55, P1199, DOI 10.1099/ijs.0.63472-0; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Schloss PD, 2003, CURR OPIN BIOTECH, V14, P303, DOI 10.1016/S0958-1669(03)00067-3; Shi YM, 2009, NATURE, V459, P266, DOI 10.1038/nature08055; Smith K, 2007, SEMIN IMMUNOL, V19, P59, DOI 10.1016/j.smim.2006.10.002; Stewart FJ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r26; Stewart FJ, 2012, ENVIRON MICROBIOL, V14, P23, DOI 10.1111/j.1462-2920.2010.02400.x; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Valles SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031828; van Dongen S, GRAPH CLUSTERING FLO; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weckx S, 2011, APPL ENVIRON MICROB, V77, P618, DOI 10.1128/AEM.02028-10; Xiong YY, 2010, NAT GENET, V42, P1043, DOI 10.1038/ng.711; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001; Yellaboina S, 2007, GENOME RES, V17, P527, DOI 10.1101/gr.5900607; Yooseph S, 2007, PLOS BIOL, V5, pe16, DOI DOI 10.1371/journal.pbio.0050016; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	66	45	48	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36009	10.1371/journal.pone.0036009	http://dx.doi.org/10.1371/journal.pone.0036009			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558305	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336000100
J	Xu, CY; Schooler, SS; Van Klinken, RD				Xu, Cheng-Yuan; Schooler, Shon S.; Van Klinken, Rieks D.			Differential Influence of Clonal Integration on Morphological and Growth Responses to Light in Two Invasive Herbs	PLOS ONE			English	Article							ALTERNANTHERA-PHILOXEROIDES; PHYSIOLOGICAL INTEGRATION; COMPETITIVE ABILITY; ALLIGATOR WEED; PHENOTYPIC PLASTICITY; RAMETS; PLANTS; AVAILABILITY; DISTURBANCE; ALLOCATION	Background and aims: In contrast to seeds, high sensitivity of vegetative fragments to unfavourable environments may limit the expansion of clonal invasive plants. However, clonal integration promotes the establishment of propagules in less suitable habitats and may facilitate the expansion of clonal invaders into intact native communities. Here, we examine the influence of clonal integration on the morphology and growth of ramets in two invasive plants, Alternanthera philoxeroides and Phyla canescens, under varying light conditions. Methods: In a greenhouse experiment, branches, connected ramets and severed ramets of the same mother plant were exposed under full sun and 85% shade and their morphological and growth responses were assessed. Key results: The influence of clonal integration on the light reaction norm (connectionxlight interaction) of daughter ramets was species-specific. For A. philoxeroides, clonal integration evened out the light response (total biomass, leaf mass per area, and stem number, diameter and length) displayed in severed ramets, but these connectionxlight interactions were largely absent for P. canescens. Nevertheless, for both species, clonal integration overwhelmed light effect in promoting the growth of juvenile ramets during early development. Also, vertical growth, as an apparent shade acclimation response, was more prevalent in severed ramets than in connected ramets. Finally, unrooted branches displayed smaller organ size and slower growth than connected ramets, but the pattern of light reaction was similar, suggesting mother plants invest in daughter ramets prior to their own branches. Conclusions: Clonal integration modifies light reaction norms of morphological and growth traits in a species-specific manner for A. philoxeroides and P. canescens, but it improves the establishment of juvenile ramets of both species in light-limiting environments by promoting their growth during early development. This factor may be partially responsible for their ability to successfully colonize native plant communities.	[Xu, Cheng-Yuan; Schooler, Shon S.; Van Klinken, Rieks D.] CSIRO Ecosyst Sci, Brisbane, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Xu, CY (corresponding author), CSIRO Ecosyst Sci, Dutton Pk, Brisbane, Qld, Australia.	chengyuan.xu@csiro.au	van Klinken, Rieks D/B-1772-2009; Xu, Cheng-Yuan/C-2096-2008; Schooler, Shon/AAE-9369-2019	van Klinken, Rieks D/0000-0002-7578-8977; Xu, Chengyuan/0000-0002-0970-9994	South East Queensland Water Ltd; Land and Water Australia through the Defeating the Weed Menace Program	South East Queensland Water Ltd; Land and Water Australia through the Defeating the Weed Menace Program	This work was supported by South East Queensland Water Ltd (http://www.seqwater.com.au/public/home), and Land and Water Australia through the Defeating the Weed Menace Program (http://lwa.gov.au/programs/defeating-weed-menace). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPERT P, 1991, ECOLOGY, V72, P69, DOI 10.2307/1938903; ALPERT P, 1990, AM J BOT, V77, P1648, DOI 10.2307/2444496; ALPERT P, 1986, OECOLOGIA, V70, P227, DOI 10.1007/BF00379244; Alpert P, 1996, J ECOL, V84, P395, DOI 10.2307/2261201; Alpert P, 1997, EFFECTS CLONAL INTEG, P99; Alpert P, DIVISION LABOUR CLON; Alpert P, 1995, ABSTR BOT, V19, P11; Amsberry L, 2000, ECOL APPL, V10, P1110, DOI 10.1890/1051-0761(2000)010[1110:CIATEO]2.0.CO;2; BLOOM AJ, 1985, ANNU REV ECOL SYST, V16, P363, DOI 10.1146/annurev.es.16.110185.002051; BOYD CE, 1987, J AQUAT PLANT MANAGE, V25, P1; Brewer JS, 1996, OIKOS, V77, P107, DOI 10.2307/3545590; Brezina S, 2006, FLORA, V201, P461, DOI 10.1016/j.flora.2005.10.003; Burgin S, 2008, WEED BIOL MANAG, V8, P284, DOI 10.1111/j.1445-6664.2008.00306.x; Cohen AN, 1998, SCIENCE, V279, P555, DOI 10.1126/science.279.5350.555; DEKROON H, 1995, J ECOL, V83, P143, DOI 10.2307/2261158; DONG M, 1993, NEW PHYTOL, V124, P291, DOI 10.1111/j.1469-8137.1993.tb03819.x; DONG M, 1995, OECOLOGIA, V101, P282, DOI 10.1007/BF00328813; EARL J, 2003, DISTRIBUTION IMPACTS; Geng YP, 2007, BIOL INVASIONS, V9, P245, DOI 10.1007/s10530-006-9029-1; HARTNETT DC, 1983, ECOLOGY, V64, P779, DOI 10.2307/1937201; Herben T, 2004, EVOL ECOL, V18, P493, DOI 10.1007/s10682-004-5141-9; Holm L., 1997, WORLD WEEDS NATURAL; HUTCHINGS MJ, 1994, ADV ECOL RES, V25, P159, DOI 10.1016/S0065-2504(08)60215-9; Hutchings MJ, 1997, TRENDS ECOL EVOL, V12, P390, DOI 10.1016/S0169-5347(97)87382-X; Julien M., 1995, BIOL AUSTR WEEDS VOL, P1; Julien MH, 2012, AUSTR J BOT IN PRESS; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Liu FH, 2007, FLORA, V202, P106, DOI 10.1016/j.flora.2006.05.004; Liu J, 2008, PHOTOSYNTHETICA, V46, P299, DOI 10.1007/s11099-008-0054-4; LONGSTRETH DJ, 1984, BOT GAZ, V145, P105, DOI 10.1086/337432; LUCY M, 1995, LIPPIA PHYLA CANESCE; Macdonald MJ, 2008, ECOLOGY PHYLA CANESC; Matlaga DP, 2009, AM J BOT, V96, P431, DOI 10.3732/ajb.0800164; Maurer DA, 2002, OECOLOGIA, V131, P279, DOI 10.1007/s00442-002-0886-8; McCosker RO, 1994, LIPPIA PHYLA NODIFLO; Mooney H.A., 2000, INVASIVE SPECIES CHA; OBORNY B, 1994, J ECOL, V82, P341, DOI 10.2307/2261302; Otfinowski R, 2008, PLANT ECOL, V199, P235, DOI 10.1007/s11258-008-9428-8; Pan XY, 2006, ACTA OECOL, V30, P333, DOI 10.1016/j.actao.2006.03.003; Peltzer DA, 2002, AM J BOT, V89, P494, DOI 10.3732/ajb.89.3.494; Pennings SC, 2000, ECOLOGY, V81, P709; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Pysek P, CLONALITY PLANT INVA; Reardon-Smith K. M, 2011, DISTURBANCE RESILIEN; Roiloa SR, 2006, PHYSIOL PLANTARUM, V128, P662, DOI 10.1111/j.1399-3054.2006.00790.x; Roiloa SR, 2006, FUNCT PLANT BIOL, V33, P961, DOI 10.1071/FP06018; Roiloa SR, 2010, BIOL INVASIONS, V12, P1815, DOI 10.1007/s10530-009-9592-3; Saitoh T, 2006, ANN BOT-LONDON, V98, P657, DOI 10.1093/aob/mcl147; Sculthorpe CD., 1967, BIOL AQUATIC VASCULA; SHUMWAY SW, 1995, ANN BOT-LONDON, V76, P225, DOI 10.1006/anbo.1995.1091; SPENCER N R, 1976, Aquatic Botany, V2, P177, DOI 10.1016/0304-3770(76)90019-X; Tessier JT, 2007, AM J BOT, V94, P25, DOI 10.3732/ajb.94.1.25; Valladares F, 2000, ECOLOGY, V81, P1925, DOI 10.1890/0012-9658(2000)081[1925:PPRTLO]2.0.CO;2; Wang N, 2008, ANN BOT-LONDON, V101, P671, DOI 10.1093/aob/mcn005; Wilson JRU, 2007, ENVIRON EXP BOT, V60, P20, DOI 10.1016/j.envexpbot.2006.06.003; Xu CY, 2010, J ECOL, V98, P833, DOI 10.1111/j.1365-2745.2010.01668.x; Zhang XQ, 2006, FLORA, V201, P547, DOI 10.1016/j.flora.2005.12.002	57	23	23	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35873	10.1371/journal.pone.0035873	http://dx.doi.org/10.1371/journal.pone.0035873			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558248	Green Published, gold			2022-12-27	WOS:000305336000070
J	Yang, CJ; Chalasani, G; Ng, YH; Robbins, PD				Yang, Chenjie; Chalasani, Geetha; Ng, Yue-Harn; Robbins, Paul D.			Exosomes Released from Mycoplasma Infected Tumor Cells Activate Inhibitory B Cells	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; MALIGNANT-TRANSFORMATION; CYTOKINE SECRETION; MEMBRANE-VESICLES; DENDRITIC CELLS; MACROPHAGES; FERMENTANS; EXPRESSION; RESPONSES; IMMUNOSUPPRESSION	Mycoplasmas cause numerous human diseases and are common opportunistic pathogens in cancer patients and immunocompromised individuals. Mycoplasma infection elicits various host immune responses. Here we demonstrate that mycoplasma-infected tumor cells release exosomes (myco+ exosomes) that specifically activate splenic B cells and induce splenocytes cytokine production. Induction of cytokines, including the proinflammatory IFN-gamma and the anti-inflammatory IL-10, was largely dependent on the presence of B cells. B cells were the major IL-10 producers. In splenocytes from B cell deficient mu MT mice, induction of IFN-gamma+ T cells by myco+ exosomes was greatly increased compared with wild type splenocytes. In addition, anti-CD3-stimulated T cell proliferation was greatly inhibited in the presence of myco+ exosome-treated B cells. Also, anti-CD3-stimulated T cell signaling was impaired by myco+ exosome treatment. Proteomic analysis identified mycoplasma proteins in exosomes that potentially contribute to the effects. Our results demonstrate that mycoplasma-infected tumor cells release exosomes carrying mycoplasma components that preferentially activate B cells, which in turn, are able to inhibit T cell activity. These results suggest that mycoplasmas infecting tumor cells can exploit the exosome pathway to disseminate their own components and modulate the activity of immune cells, in particular, activate B cells with inhibitory activity.	[Yang, Chenjie; Robbins, Paul D.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Pittsburgh, PA 15260 USA; [Chalasani, Geetha; Ng, Yue-Harn] Univ Pittsburgh, Sch Med, Dept Med, Renal Electrolyte Div, Pittsburgh, PA USA; [Chalasani, Geetha; Ng, Yue-Harn] Univ Pittsburgh, Sch Med, Dept Immunol, Renal Electrolyte Div, Pittsburgh, PA USA; [Chalasani, Geetha; Ng, Yue-Harn] Univ Pittsburgh, Sch Med, Thomas E Starzl Transplantat Inst, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yang, CJ (corresponding author), Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Pittsburgh, PA 15260 USA.	probb@pitt.edu			Department of Defense [17-03-1-0488, 17-03-0412]; National Institutes of Health [U01 NS058451, P30 AG024827, R21 AG033907]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS058451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024827, R21AG033907] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by Department of Defense grants 17-03-1-0488 and 17-03-0412 and U01 NS058451, P30 AG024827 and R21 AG033907 grants from the National Institutes of Health to P.D.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beatty WL, 2001, EUR J CELL BIOL, V80, P31, DOI 10.1078/0171-9335-00131; BENNETT RH, 1977, AM J VET RES, V38, P1731; BERGQUIST LM, 1974, INFECT IMMUN, V9, P410, DOI 10.1128/IAI.9.2.410-415.1974; Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Bhatnagar S, 2007, J BIOL CHEM, V282, P25779, DOI 10.1074/jbc.M702277200; BLANCHARD A, 1994, ANNU REV MICROBIOL, V48, P687, DOI 10.1146/annurev.mi.48.100194.003351; Brenner C, 1997, INFECT IMMUN, V65, P4322, DOI 10.1128/IAI.65.10.4322-4329.1997; Burdin N, 1997, METHODS, V11, P98, DOI 10.1006/meth.1996.0393; CASSELL GH, 1981, NEW ENGL J MED, V304, P80, DOI 10.1056/NEJM198101083040204; Chan PJ, 1996, GYNECOL ONCOL, V63, P258, DOI 10.1006/gyno.1996.0316; Clayton A, 2008, J IMMUNOL, V180, P7249, DOI 10.4049/jimmunol.180.11.7249; Clayton A, 2007, CANCER RES, V67, P7458, DOI 10.1158/0008-5472.CAN-06-3456; COLE BC, 1990, INFECT IMMUN, V58, P228, DOI 10.1128/IAI.58.1.228-236.1990; Denzer K, 2000, J CELL SCI, V113, P3365; Feng SH, 1999, MOL CELL BIOL, V19, P7995; Flanagan BF, 1998, NAT MED, V4, P133, DOI 10.1038/nm0298-133a; Garcia J, 1998, J BIOL CHEM, V273, P34391, DOI 10.1074/jbc.273.51.34391; Gong MM, 2008, MOL CANCER THER, V7, P530, DOI 10.1158/1535-7163.MCT-07-2191; HERBELIN A, 1994, INFECT IMMUN, V62, P4690, DOI 10.1128/IAI.62.10.4690-4694.1994; Huang S, 2001, WORLD J GASTROENTERO, V7, P266; Kim SH, 2007, J IMMUNOL, V179, P2242, DOI 10.4049/jimmunol.179.4.2242; Kim SH, 2005, J IMMUNOL, V174, P6440, DOI 10.4049/jimmunol.174.10.6440; KOSTYAL DA, 1994, INFECT IMMUN, V62, P3793, DOI 10.1128/IAI.62.9.3793-3800.1994; KOSTYAL DA, 1995, INFECT IMMUN, V63, P3858, DOI 10.1128/IAI.63.10.3858-3863.1995; Liu CR, 2006, J IMMUNOL, V176, P1375, DOI 10.4049/jimmunol.176.3.1375; MACPHERSON I, 1966, NATURE, V210, P1343, DOI 10.1038/2101343a0; Madan R, 2009, J IMMUNOL, V183, P2312, DOI 10.4049/jimmunol.0900185; Namiki K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006872; PATON GR, 1965, NATURE, V207, P43, DOI 10.1038/207043a0; PIETSCH K, 1994, MICROBIOL-UK, V140, P2043, DOI 10.1099/13500872-140-8-2043; Quah BJC, 2007, J LEUKOCYTE BIOL, V82, P1070, DOI 10.1189/jlb.0507277; Rawadi G, 1996, J IMMUNOL, V156, P670; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Rieger A, 2008, NAT REV IMMUNOL, V8, P486, DOI 10.1038/nri2315-c1; ROTTEM S, 1993, TRENDS BIOTECHNOL, V11, P143, DOI 10.1016/0167-7799(93)90089-R; SCHMIDHAUSER C, 1990, J CELL SCI, V95, P499; SUGIMURA K, 1992, MICROBIOL IMMUNOL, V36, P667, DOI 10.1111/j.1348-0421.1992.tb02069.x; Tarshis M, 2004, CURR MICROBIOL, V49, P136, DOI 10.1007/s00284-004-4298-3; Taylor DD, 2003, CLIN CANCER RES, V9, P5113; Taylor DD, 2005, BRIT J CANCER, V92, P305, DOI 10.1038/sj.bjc.6602316; Thery C, 2002, NAT IMMUNOL, V3, P1156, DOI 10.1038/ni854; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; TSAI S, 1995, P NATL ACAD SCI USA, V92, P10197, DOI 10.1073/pnas.92.22.10197; Valenti R, 2006, CANCER RES, V66, P9290, DOI 10.1158/0008-5472.CAN-06-1819; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Yu SH, 2007, J IMMUNOL, V178, P6867, DOI 10.4049/jimmunol.178.11.6867; Zhang BX, 1997, P SOC EXP BIOL MED, V214, P359; Zhang SM, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-116; ZuritaSalinas CS, 1996, FEMS IMMUNOL MED MIC, V15, P123, DOI 10.1111/j.1574-695X.1996.tb00062.x	50	51	55	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36138	10.1371/journal.pone.0036138	http://dx.doi.org/10.1371/journal.pone.0036138			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558358	Green Published, Green Accepted, gold			2022-12-27	WOS:000305336000136
J	Zachary, CB; Gustavsson, M				Zachary, Christopher B.; Gustavsson, Morgan			TRASER - Total Reflection Amplification of Spontaneous Emission of Radiation	PLOS ONE			English	Article							PULSED DYE-LASER; PORT-WINE STAINS; HAIR REMOVAL; RUBY-LASER	Background and Objective: Light and lasers in medical therapy have made dramatic strides since their invention five decades ago. However, the manufacture of lasers can be complex and expensive which often makes treatments limited and costly. Further, no single laser will provide the correct parameters to treat all things. Hence, laser specialists often need multiple devices to practice their specialty. A new concept is described herein that has the potential to replace many lasers and light sources with a single 'tunable' device. Study Design/Material and Methods: This device amplifies spontaneous emission of radiation by capturing and retaining photons through total internal reflection, hence the acronym Total Reflection Amplification of Spontaneous Emission of Radiation, or TRASER. Results: Specific peaks of light can be produced in a reproducible manner with high peak powers of variable pulse durations, a large spot size, and high repetition rate. Conclusion: Considering the characteristics and parameters of Traser technology, it is possible that this one device would likely be able to replace the pulsed dye laser and many other light based systems.	[Zachary, Christopher B.] Univ Calif Irvine, Dept Dermatol, Irvine, CA 92717 USA; [Gustavsson, Morgan] Rockport Consulting Serv Inc, Newport Beach, CA USA	University of California System; University of California Irvine	Zachary, CB (corresponding author), Univ Calif Irvine, Dept Dermatol, Irvine, CA 92717 USA.	czachary@uci.edu	Zachary, Christopher B/ABG-1196-2021					ANDERSON RR, 1983, SCIENCE, V220, P524, DOI 10.1126/science.6836297; BOULNOIS J-L, 1986, Lasers in Medical Science, V1, P47, DOI 10.1007/BF02030737; Campos VB, 2000, LASER SURG MED, V26, P177, DOI 10.1002/(SICI)1096-9101(2000)26:2<177::AID-LSM8>3.3.CO;2-A; Dierickx CC, 1998, ARCH DERMATOL, V134, P837, DOI 10.1001/archderm.134.7.837; Kauvar ANB, 2006, LASER SURG MED, V38, P808, DOI 10.1002/lsm.20373; Lakowicz JR, 1992, PRINCIPLES FLUORESCE; MORELLI JG, 1986, LASER SURG MED, V6, P94, DOI 10.1002/lsm.1900060119; TAN OT, 1990, PLAST RECONSTR SURG, V86, P1112, DOI 10.1097/00006534-199012000-00011; Tanghetti E, 2006, LASER SURG MED, V38, P16, DOI 10.1002/lsm.20273; Weiss RA, 2011, LASER SURG MED, V43, P92, DOI 10.1002/lsm.21032	10	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35899	10.1371/journal.pone.0035899	http://dx.doi.org/10.1371/journal.pone.0035899			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558261	gold, Green Published			2022-12-27	WOS:000305336000078
J	Fernandes, H; Franklin, E; Jollivet, F; Bliedtner, K; Khan, AR				Fernandes, Humberto; Franklin, Edward; Jollivet, Florence; Bliedtner, Katharina; Khan, Amir R.			Mapping the Interactions between a RUN Domain from DENND5/Rab6IP1 and Sorting Nexin 1	PLOS ONE			English	Article							TRANS-GOLGI NETWORK; RAB6-INTERACTING PROTEIN-1; RAB PROTEINS; BINDING; RETROMER; IDENTIFICATION; GTPASES; MECHANISMS; CURVATURE; APPARATUS	Eukaryotic cells have developed a diverse repertoire of Rab GTPases to regulate vesicle trafficking pathways. Together with their effector proteins, Rabs mediate various aspects of vesicle formation, tethering, docking and fusion, but details of the biological roles elicited by effectors are largely unknown. Human Rab6 is involved in the trafficking of vesicles at the level of Golgi via interactions with numerous effector proteins. We have previously determined the crystal structure of Rab6 in complex with DENND5, alternatively called Rab6IP1, which comprises two RUN domains (RUN1 and RUN2) separated by a PLAT domain. The structure of Rab6/RUN1-PLAT (Rab6/R1P) revealed the molecular basis for Golgi recruitment of DENND5 via the RUN1 domain, but the functional role of the RUN2 domain has not been well characterized. Here we show that a soluble DENND5 construct encompassing the RUN2 domain binds to the N-terminal region of sorting nexin 1 by surface plasmon resonance analyses.	[Fernandes, Humberto; Franklin, Edward; Jollivet, Florence; Bliedtner, Katharina; Khan, Amir R.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland	Trinity College Dublin	Fernandes, H (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland.	Amir.Khan@tcd.ie		Khan, Amir/0000-0003-1176-6952; Franklin, Edward/0000-0003-0843-9635	Science Foundation Ireland [07.IN1.B975]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by Science Foundation Ireland grant number 07.IN1.B975 to ARK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleem AM, 2008, J MOL BIOL, V376, P193, DOI 10.1016/j.jmb.2007.11.086; Angers CG, 2011, SEMIN CELL DEV BIOL, V22, P18, DOI 10.1016/j.semcdb.2010.07.003; Bateman A, 1999, CURR BIOL, V9, pR588, DOI 10.1016/S0960-9822(99)80380-7; Bergbrede T, 2009, J BIOL CHEM, V284, P2628, DOI 10.1074/jbc.M806003200; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Bujny MV, 2007, J CELL SCI, V120, P2010, DOI 10.1242/jcs.003111; Bycroft M, 1999, EMBO J, V18, P297, DOI 10.1093/emboj/18.2.297; Callebaut I, 2001, TRENDS BIOCHEM SCI, V26, P79, DOI 10.1016/S0968-0004(00)01730-8; Carlton J, 2004, CURR BIOL, V14, P1791, DOI 10.1016/j.cub.2004.09.077; Collins BM, 2008, TRAFFIC, V9, P366, DOI 10.1111/j.1600-0854.2007.00688.x; Fernandes H, 2011, ACTA CRYSTALLOGR F, V67, P556, DOI 10.1107/S174430911100724X; Fernandes H, 2009, BIOCHEM SOC T, V37, P1037, DOI 10.1042/BST0371037; Fukuda M, 2011, CELL STRUCT FUNCT, V36, P155, DOI 10.1247/csf.11001; Goody RS, 2005, CELL MOL LIFE SCI, V62, P1657, DOI 10.1007/s00018-005-4486-8; Gullapalli A, 2004, MOL BIOL CELL, V15, P2143, DOI 10.1091/mbc.E03-09-0711; Janoueix-Lerosey I, 1998, EUR J BIOCHEM, V252, P290, DOI 10.1046/j.1432-1327.1998.2520290.x; JANOUEIXLEROSEY I, 1995, J BIOL CHEM, V270, P14801, DOI 10.1074/jbc.270.24.14801; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kukimoto-Niino M, 2006, J BIOL CHEM, V281, P31843, DOI 10.1074/jbc.M604960200; Kurten RC, 2001, J CELL SCI, V114, P1743; Lee MTG, 2009, TRAFFIC, V10, P1377, DOI 10.1111/j.1600-0854.2009.00942.x; Leung KF, 2006, J LIPID RES, V47, P467, DOI 10.1194/jlr.R500017-JLR200; Levivier E, 2001, BIOCHEM BIOPH RES CO, V287, P688, DOI 10.1006/bbrc.2001.5652; Miserey-Lenkei S, 2007, TRAFFIC, V8, P1385, DOI 10.1111/j.1600-0854.2007.00612.x; Opdam FJM, 2000, J CELL SCI, V113, P2725; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pylypenko O, 2007, EMBO J, V26, P4788, DOI 10.1038/sj.emboj.7601889; Recacha R, 2009, STRUCTURE, V17, P21, DOI 10.1016/j.str.2008.10.014; Seaman MNJ, 2002, MOL BIOL CELL, V13, P2826, DOI 10.1091/mbc.02-05-0064; Seet LF, 2006, BBA-MOL CELL BIOL L, V1761, P878, DOI 10.1016/j.bbalip.2006.04.011; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; VANWEERING JR, 2009, SEMIN CELL DEV BIOL; Wang SR, 2003, BRAIN RES REV, V41, P13, DOI 10.1016/S0165-0173(02)00217-5; Wassmer T, 2009, DEV CELL, V17, P110, DOI 10.1016/j.devcel.2009.04.016; Willenborg C, 2011, J CELL BIOL, V195, P71, DOI 10.1083/jcb.201011112; Yoshida H, 2011, FEBS LETT, V585, P1707, DOI 10.1016/j.febslet.2011.05.011; Yoshimura S, 2010, J CELL BIOL, V191, P367, DOI 10.1083/jcb.201008051; Young J, 2010, J MOL BIOL, V397, P69, DOI 10.1016/j.jmb.2010.01.009; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	41	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35637	10.1371/journal.pone.0035637	http://dx.doi.org/10.1371/journal.pone.0035637			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558185	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345200058
J	Ivliev, AE; 't Hoen, PAC; van Roon-Mom, WMC; Peters, DJM; Sergeeva, MG				Ivliev, Alexander E.; 't Hoen, Peter A. C.; van Roon-Mom, Willeke M. C.; Peters, Dorien J. M.; Sergeeva, Marina G.			Exploring the Transcriptome of Ciliated Cells Using In Silico Dissection of Human Tissues	PLOS ONE			English	Article							NETWORK ANALYSIS; MICROARRAY DATA; GENE; DISEASE; COEXPRESSION; EXPRESSION; CILIUM; ROLES; CONSERVATION; ORGANIZATION	Cilia are cell organelles that play important roles in cell motility, sensory and developmental functions and are involved in a range of human diseases, known as ciliopathies. Here, we search for novel human genes related to cilia using a strategy that exploits the previously reported tendency of cell type-specific genes to be coexpressed in the transcriptome of complex tissues. Gene coexpression networks were constructed using the noise-resistant WGCNA algorithm in 12 publicly available microarray datasets from human tissues rich in motile cilia: airways, fallopian tubes and brain. A cilia-related coexpression module was detected in 10 out of the 12 datasets. A consensus analysis of this module's gene composition recapitulated 297 known and predicted 74 novel cilia-related genes. 82% of the novel candidates were supported by tissue-specificity expression data from GEO and/or proteomic data from the Human Protein Atlas. The novel findings included a set of genes (DCDC2, DYX1C1, KIAA0319) related to a neurological disease dyslexia suggesting their potential involvement in ciliary functions. Furthermore, we searched for differences in gene composition of the ciliary module between the tissues. A multidrug-and-toxin extrusion transporter MATE2 (SLC47A2) was found as a brain-specific central gene in the ciliary module. We confirm the localization of MATE2 in cilia by immunofluorescence staining using MDCK cells as a model. While MATE2 has previously gained attention as a pharmacologically relevant transporter, its potential relation to cilia is suggested for the first time. Taken together, our large-scale analysis of gene coexpression networks identifies novel genes related to human cell cilia.	[Ivliev, Alexander E.; Sergeeva, Marina G.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia; ['t Hoen, Peter A. C.; van Roon-Mom, Willeke M. C.; Peters, Dorien J. M.] Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Leiden, Netherlands	Lomonosov Moscow State University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Ivliev, AE (corresponding author), Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia.	sergeeva@genebee.msu.ru	van Roon-Mom, Willeke/Y-3039-2018; Hoen, Peter A 't/D-3950-2018; Sergeeva, Marina/G-3439-2012; Peters, Dorien/AFH-8507-2022	van Roon-Mom, Willeke/0000-0002-3035-0533; Hoen, Peter A 't/0000-0003-4450-3112; Peters, Dorien/0000-0001-6974-7143; Sergeeva, Marina/0000-0003-3424-6431	Russian Foundation for Basic Research [RFBR-10-04-01385-a]; European Community's Seventh Framework Programme; ENGAGE project [HEALTH-F4-2007-201413]; Centre for Medical Systems Biology	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); European Community's Seventh Framework Programme(European Commission); ENGAGE project(General Electric); Centre for Medical Systems Biology	This research was supported by the Russian Foundation for Basic Research (grant RFBR-10-04-01385-a). Dr.'t Hoen was funded through the European Community's Seventh Framework Programme (FP7/2007-2013), ENGAGE project, grant agreement HEALTH-F4-2007-201413, and the Centre for Medical Systems Biology within the framework of The Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzelius BA, 2004, J PATHOL, V204, P470, DOI 10.1002/path.1652; Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Arnaiz O, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-547; Arnaiz O, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap022; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Barrera NP, 2004, AM J PHYSIOL-CELL PH, V287, pC1114, DOI 10.1152/ajpcell.00343.2003; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Becker-Heck A, 2011, NAT GENET, V43, P79, DOI 10.1038/ng.727; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Christensen ST, 2007, TRAFFIC, V8, P97, DOI 10.1111/j.1600-0854.2006.00516.x; Davis EE, 2006, DEV CELL, V11, P9, DOI 10.1016/j.devcel.2006.06.009; de la Fuente A, 2010, TRENDS GENET, V26, P326, DOI 10.1016/j.tig.2010.05.001; Del Bigio MR, 2010, ACTA NEUROPATHOL, V119, P55, DOI 10.1007/s00401-009-0624-y; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Efimenko E, 2005, DEVELOPMENT, V132, P1923, DOI 10.1242/dev.01775; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Geschwind DH, 2009, NATURE, V461, P908, DOI 10.1038/nature08537; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Glazer AM, 2010, DEV BIOL, V337, P148, DOI 10.1016/j.ydbio.2009.10.025; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Ibanez-Tallon I, 2003, HUM MOL GENET, V12, pR27, DOI 10.1093/hmg/ddg061; Inglis PN, 2006, TRENDS GENET, V22, P491, DOI 10.1016/j.tig.2006.07.006; Ivliev AE, 2008, NUCLEIC ACIDS RES, V36, pW327, DOI 10.1093/nar/gkn213; Ivliev AE, 2010, CANCER RES, V70, P10060, DOI 10.1158/0008-5472.CAN-10-2465; Jelier R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r96; Koepsell H, 2007, PHARM RES-DORDR, V24, P1227, DOI 10.1007/s11095-007-9254-z; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Lim WK, 2007, BIOINFORMATICS, V23, pI282, DOI 10.1093/bioinformatics/btm201; Marshall WF, 2008, J CELL BIOL, V180, P17, DOI 10.1083/jcb.200710085; Massinen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020580; Masuda S, 2006, J AM SOC NEPHROL, V17, P2127, DOI 10.1681/ASN.2006030205; McClintock TS, 2008, PHYSIOL GENOMICS, V32, P198, DOI 10.1152/physiolgenomics.00128.2007; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Naik MU, 2011, INT J BIOCHEM CELL B, V43, P120, DOI 10.1016/j.biocel.2010.10.003; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Palmer RE, 2002, CANCER CELL, V2, P497, DOI 10.1016/S1535-6108(02)00205-2; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Petryshen TL, 2009, CURR PSYCHIAT REP, V11, P149, DOI 10.1007/s11920-009-0023-z; Prieto C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003911; Ross AJ, 2007, AM J RESP CELL MOL, V37, P169, DOI 10.1165/rcmb.2006-0466OC; Stewart AJ, 2007, NEUROENDOCRINOLOGY, V86, P243, DOI 10.1159/000107795; Stolc V, 2005, P NATL ACAD SCI USA, V102, P3703, DOI 10.1073/pnas.0408358102; Torkko JM, 2008, J CELL SCI, V121, P1193, DOI 10.1242/jcs.015495; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Yonezawa A, 2011, BRIT J PHARMACOL, V164, P1817, DOI 10.1111/j.1476-5381.2011.01394.x; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang JH, 2005, GENOMICS, V85, P297, DOI 10.1016/j.ygeno.2004.11.004	55	61	62	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35618	10.1371/journal.pone.0035618	http://dx.doi.org/10.1371/journal.pone.0035618			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558177	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345200054
J	Munneke, J; Belopolsky, AV; Theeuwes, J				Munneke, Jaap; Belopolsky, Artem V.; Theeuwes, Jan			Shifting Attention within Memory Representations Involves Early Visual Areas	PLOS ONE			English	Article							SPATIAL SELECTIVE ATTENTION; WORKING-MEMORY; MENTAL-IMAGERY; RETINOTOPIC ORGANIZATION; ORIENTING ATTENTION; NEURAL MECHANISMS; CORTICAL AREAS; BRAIN ACTIVITY; LOCATIONS; PET	Prior studies have shown that spatial attention modulates early visual cortex retinotopically, resulting in enhanced processing of external perceptual representations. However, it is not clear whether the same visual areas are modulated when attention is focused on, and shifted within a working memory representation. In the current fMRI study participants were asked to memorize an array containing four stimuli. After a delay, participants were presented with a verbal cue instructing them to actively maintain the location of one of the stimuli in working memory. Additionally, on a number of trials a second verbal cue instructed participants to switch attention to the location of another stimulus within the memorized representation. Results of the study showed that changes in the BOLD pattern closely followed the locus of attention within the working memory representation. A decrease in BOLD-activity (V1-V3) was observed at ROIs coding a memory location when participants switched away from this location, whereas an increase was observed when participants switched towards this location. Continuous increased activity was obtained at the memorized location when participants did not switch. This study shows that shifting attention within memory representations activates the earliest parts of visual cortex (including V1) in a retinotopic fashion. We conclude that even in the absence of visual stimulation, early visual areas support shifting of attention within memorized representations, similar to when attention is shifted in the outside world. The relationship between visual working memory and visual mental imagery is discussed in light of the current findings.	[Munneke, Jaap; Belopolsky, Artem V.; Theeuwes, Jan] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands; [Munneke, Jaap] Univ Trento, Ctr Mind Brain Sci CIMeC, Trento, Italy	Vrije Universiteit Amsterdam; University of Trento	Munneke, J (corresponding author), Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands.	Jaap.Munneke@unitn.it	Theeuwes, Jan/B-6862-2008; Theeuwes, Jan/ABF-3771-2020	Theeuwes, Jan/0000-0002-5849-7721; Belopolsky, Artem/0000-0003-3606-2134; Munneke, Jaap/0000-0002-3117-6186	Netherlands Organization for Scientific Research (NWO) [451-08-017]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was funded by a grant from the Netherlands Organization for Scientific Research (NWO-Veni grant 451-08-017; http://www.nwo.nl/) to Artem V. Belopolsky. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awh E, 1998, J EXP PSYCHOL HUMAN, V24, P780, DOI 10.1037/0096-1523.24.3.780; Awh E, 1999, PSYCHOL SCI, V10, P433, DOI 10.1111/1467-9280.00182; Baddeley AD, 2000, J EXP PSYCHOL GEN, V129, P126, DOI 10.1037//0096-3445.129.1.126; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Belopolsky AV, 2011, NEUROPSYCHOLOGIA, V49, P1605, DOI 10.1016/j.neuropsychologia.2010.12.045; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Di Russo F, 2003, CEREB CORTEX, V13, P486, DOI 10.1093/cercor/13.5.486; Epstein R, 1998, J COGNITIVE NEUROSCI, V10, P20; FARAH MJ, 1989, TRENDS NEUROSCI, V12, P395, DOI 10.1016/0166-2236(89)90079-9; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Ganis G, 2004, COGNITIVE BRAIN RES, V20, P226, DOI 10.1016/j.cogbrainres.2004.02.012; Griffin IC, 2003, J COGNITIVE NEUROSCI, V15, P1176, DOI 10.1162/089892903322598139; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Hickey C, 2009, J COGNITIVE NEUROSCI, V21, P760, DOI 10.1162/jocn.2009.21039; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Jensen O, 2002, CEREB CORTEX, V12, P877, DOI 10.1093/cercor/12.8.877; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Keogh R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029221; Klein I, 2004, COGNITIVE BRAIN RES, V22, P26, DOI 10.1016/j.cogbrainres.2004.07.006; KOSSLYN SM, 1995, NEUROPSYCHOLOGIA, V33, P1335, DOI 10.1016/0028-3932(95)00067-D; KOSSLYN SM, 1993, J COGNITIVE NEUROSCI, V5, P263, DOI 10.1162/jocn.1993.5.3.263; Kosslyn SM, 2001, NAT REV NEUROSCI, V2, P635, DOI 10.1038/35090055; Kuo BC, 2009, J NEUROSCI, V29, P8032, DOI 10.1523/JNEUROSCI.0952-09.2009; Lebedev MA, 2004, PLOS BIOL, V2, P1919, DOI 10.1371/journal.pbio.0020365; Lepsien J, 2005, NEUROIMAGE, V26, P733, DOI 10.1016/j.neuroimage.2005.02.026; Lepsien J, 2007, CEREB CORTEX, V17, P2072, DOI 10.1093/cercor/bhl116; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P887, DOI 10.1037/0096-1523.20.4.887; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Mangun GR, 1997, HUM BRAIN MAPP, V5, P273, DOI 10.1002/(SICI)1097-0193(1997)5:4<273::AID-HBM12>3.0.CO;2-F; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; Matsukura M, 2007, PERCEPT PSYCHOPHYS, V69, P1422, DOI 10.3758/BF03192957; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; Mcnab F, 2008, NEUROPSYCHOLOGIA, V46, P2668, DOI 10.1016/j.neuropsychologia.2008.04.023; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Nobre AC, 2004, J COGNITIVE NEUROSCI, V16, P363, DOI 10.1162/089892904322926700; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Postle BR, 2006, NEUROSCIENCE, V139, P23, DOI 10.1016/j.neuroscience.2005.06.005; Ristic J, 2002, PSYCHON B REV, V9, P507, DOI 10.3758/BF03196306; Roth JK, 2006, CEREB CORTEX, V16, P1595, DOI 10.1093/cercor/bhj096; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Slotnick SD, 2012, COGN NEUROSCI-UK, V3, P14, DOI 10.1080/17588928.2011.578210; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Super H, 2001, SCIENCE, V293, P120, DOI 10.1126/science.1060496; Talairach J., 1988, COPLANAR STEREOTAXIC; Theeuwes J, 2007, J EXP PSYCHOL HUMAN, V33, P1335, DOI 10.1037/0096-1523.33.6.1335; Theeuwes J, 2009, ACTA PSYCHOL, V132, P106, DOI 10.1016/j.actpsy.2009.01.005; Thompson WL, 2009, PSYCHOL SCI, V20, P1245, DOI 10.1111/j.1467-9280.2009.02440.x; Van der Stigchel S, 2006, NEUROSCI BIOBEHAV R, V30, P666, DOI 10.1016/j.neubiorev.2005.12.001; Woldorff MG, 1997, HUM BRAIN MAPP, V5, P280, DOI 10.1002/(SICI)1097-0193(1997)5:4<280::AID-HBM13>3.0.CO;2-I	50	13	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35528	10.1371/journal.pone.0035528	http://dx.doi.org/10.1371/journal.pone.0035528			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VP	22558165	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345200046
J	Saldana, A; Pineda, V; Martinez, I; Santamaria, G; Santamaria, AM; Miranda, A; Calzada, JE				Saldana, Azael; Pineda, Vanessa; Martinez, Inri; Santamaria, Giovanna; Maria Santamaria, Ana; Miranda, Aracelis; Calzada, Jose E.			A New Endemic Focus of Chagas Disease in the Northern Region of Veraguas Province, Western Half Panama, Central America	PLOS ONE			English	Article							TRIATOMA-DIMIDIATA LATREILLE; TRYPANOSOMA-CRUZI; RHODNIUS-PALLESCENS; ECOLOGICAL ASPECTS; LATIN-AMERICA; COSTA-RICA; REDUVIIDAE; EPIDEMIOLOGY; CHALLENGES; INFECTION	Background: Chagas disease was originally reported in Panama in 1931. Currently, the best knowledge of this zoonosis is restricted to studies done in historically endemic regions. However, little is known about the distribution and epidemiology of Chagas disease in other rural areas of the country. Methods and Findings: A cross-sectional descriptive study was carried out between May 2005 - July 2008 in four rural communities of the Santa Fe District, Veraguas Province. The study included an entomologic search to collect triatomines, bloodmeal type identification and infection rate with trypanosomes in collected vectors using a dot-blot and PCR analysis, genotyping of circulating Trypanosoma cruzi (mini-exon gene PCR analysis) and the detection of chagasic antibodies among inhabitants. The vector Rhodnius pallescens was more frequently found in La Culaca and El Pantano communities (788 specimens), where it was a sporadic household visitor. These triatomines presented darker coloration and larger sizescompared with typical specimens collected in Central Panama. Triatoma dimidiata was more common in Sabaneta de El Macho (162 specimens). In one small sub-region (El Macho), 60% of the houses were colonized by this vector. Of the examined R. pallescens, 54.7.0% (88/161) had fed on Didelphis marsupialis, and 24.6% (34/138) of T. dimidiata specimens collected inside houses were positive for human blood. R. pallescens presented an infection index with T. cruzi of 17.7% (24/136), with T. rangeli of 12.5% (17/136) and 50.7% (69/136) were mixed infections. In 117 T. dimidiata domestic specimens the infection index with T. cruzi was 21.4%. Lineage I of T. cruzi was confirmed circulating in these vectors. A T. cruzi infection seroprevalence of 2.3% (24/1,056) was found in this population. Conclusions: This is the first report of Chagas disease endemicity in Santa Fe District, and it should be considered a neglected public health problem in this area of Panama.	[Saldana, Azael; Pineda, Vanessa; Maria Santamaria, Ana; Miranda, Aracelis; Calzada, Jose E.] ICGES, Secc Parasitol, Panama City, Panama; [Saldana, Azael] Univ Panama, Fac Med, CIDEP, Panama City, Panama; [Martinez, Inri] Minist Salud MINSA, Ctr Salud Santa Fe, Santiago, Veraguas, Panama; [Santamaria, Giovanna] Hosp Dr Luis Fabrega, Minist Salud Panama MINSA, Santiago, Veraguas, Panama	Universidad de Panama	Saldana, A (corresponding author), ICGES, Secc Parasitol, Panama City, Panama.	jcalzada@gorgas.gob.pa		Saldana, Azael/0000-0002-5653-1332	UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) [A304558]; Network for Research and Training of Tropical Diseases in Central America (NeTropica) [7-R-2008]; Instituto Conmemorativo Gorgas de Estudios de la Salud (ICGES); Sistema Nacional de Investigacion (SNI), SENACYT (Secretaria Nacional de Ciencia y Tecnologia), Panama	UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR); Network for Research and Training of Tropical Diseases in Central America (NeTropica); Instituto Conmemorativo Gorgas de Estudios de la Salud (ICGES); Sistema Nacional de Investigacion (SNI), SENACYT (Secretaria Nacional de Ciencia y Tecnologia), Panama	This investigation received financial support from UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) (A304558), Network for Research and Training of Tropical Diseases in Central America (NeTropica) (7-R-2008), Instituto Conmemorativo Gorgas de Estudios de la Salud (ICGES) and from the Sistema Nacional de Investigacion (SNI), SENACYT (Secretaria Nacional de Ciencia y Tecnologia), Panama. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bacigalupo A, 2010, MEM I OSWALDO CRUZ, V105, P633, DOI 10.1590/S0074-02762010000500006; Calzada JE, 2006, AM J TROP MED HYG, V74, P762, DOI 10.4269/ajtmh.2006.74.762; Calzada JE, 2010, AM J TROP MED HYG, V82, P580, DOI 10.4269/ajtmh.2010.09-0397; Vasquez Ana Maria de, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P217, DOI 10.1590/S0036-46652004000400008; Dias JCP, 2002, MEM I OSWALDO CRUZ, V97, P603, DOI 10.1590/S0074-02762002000500002; Gaunt M, 2000, MEM I OSWALDO CRUZ, V95, P557, DOI 10.1590/S0074-02762000000400019; Moreno ML, 2010, ACTA TROP, V113, P257, DOI 10.1016/j.actatropica.2009.11.007; Mendez E, 1979, REV MED PANAMA, V4, P258; Moncayo A, 2009, MEM I OSWALDO CRUZ, V104, P17, DOI 10.1590/S0074-02762009000900005; Noireau F, 1997, MEM I OSWALDO CRUZ, V92, P583, DOI 10.1590/S0074-02761997000500003; Pineda V, 2008, REV INST MED TROP SP, V50, P113, DOI 10.1590/S0036-46652008000200009; PIPKIN AC, 1968, J MED ENTOMOL, V5, P107, DOI 10.1093/jmedent/5.1.107; Ponce C, 2007, MEM I OSWALDO CRUZ, V102, P41, DOI 10.1590/S0074-02762007005000082; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Roellig DM, 2008, EMERG INFECT DIS, V14, P1123, DOI 10.3201/eid1407.080175; Rojas ME, 2008, CAD SAUDE PUBLICA, V24, P2323, DOI 10.1590/S0102-311X2008001000013; Saldana A, 1995, SCAND J IMMUNOL, V42, P644, DOI 10.1111/j.1365-3083.1995.tb03707.x; Samudio F, 2007, ACTA TROP, V101, P178, DOI 10.1016/j.actatropica.2006.12.008; Sousa OE, 2006, MEM I OSWALDO CRUZ, V101, P455, DOI 10.1590/S0074-02762006000400018; SOUSA OE, 1973, AM J TROP MED HYG, V22, P18, DOI 10.4269/ajtmh.1973.22.18; SOUSA OE, 1971, AM J TROP MED HYG, V20, P405, DOI 10.4269/ajtmh.1971.20.405; Souto RP, 1996, MOL BIOCHEM PARASIT, V83, P141, DOI 10.1016/S0166-6851(96)02755-7; Dias FBS, 2008, MEM I OSWALDO CRUZ, V103, P824, DOI 10.1590/S0074-02762008000800014; Tarleton RL, 2007, PLOS MED, V4, P1852, DOI 10.1371/journal.pmed.0040332; WHITLAW JT, 1978, AM J TROP MED HYG, V27, P873, DOI 10.4269/ajtmh.1978.27.873; Zeledon R, 2006, MEM I OSWALDO CRUZ, V101, P75, DOI 10.1590/S0074-02762006000100014; Zeledon R, 2008, MEM I OSWALDO CRUZ, V103, P619, DOI 10.1590/S0074-02762008000600020; Zeledon R, 2006, MEM I OSWALDO CRUZ, V101, P379, DOI 10.1590/S0074-02762006000400006	28	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e34657	10.1371/journal.pone.0034657	http://dx.doi.org/10.1371/journal.pone.0034657			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558095	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345200012
J	Purdy, MA; Lara, J; Khudyakov, YE				Purdy, Michael A.; Lara, James; Khudyakov, Yury E.			The Hepatitis E Virus Polyproline Region Is Involved in Viral Adaptation	PLOS ONE			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; MOLECULAR RECOGNITION FEATURES; WEB SERVER; HYPERVARIABLE REGION; SECONDARY STRUCTURE; PREDICTION; DISORDER; BINDING; DISCOVERY; ALIGNMENT	Genomes of hepatitis E virus (HEV), rubivirus and cutthroat virus (CTV) contain a region of high proline density and low amino acid (aa) complexity, named the polyproline region (PPR). In HEV genotypes 1, 3 and 4, it is the only region within the non-structural open reading frame (ORF1) with positive selection (4-10 codons with dN/dS>1). This region has the highest density of sites with homoplasy values >0.5. Genotypes 3 and 4 show similar to 3-fold increase in homoplastic density (HD) in the PPR compared to any other region in ORF1, genotype 1 does not exhibit significant HD (p>0.0001). PPR sequence divergence was found to be 2-fold greater for HEV genotypes 3 and 4 than for genotype 1. The data suggest the PPR plays an important role in host-range adaptation. Although the PPR appears to be hypervariable and homoplastic, it retains as much phylogenetic signal as any other similar sized region in the ORF1, indicating that convergent evolution operates within the major HEV phylogenetic lineages. Analyses of sequence-based secondary structure and the tertiary structure identify PPR as an intrinsically disordered region (IDR), implicating its role in regulation of replication. The identified propensity for the disorder-to-order state transitions indicates the PPR is involved in protein-protein interactions. Furthermore, the PPR of all four HEV genotypes contains seven putative linear binding motifs for ligands involved in the regulation of a wide number of cellular signaling processes. Structure-based analysis of possible molecular functions of these motifs showed the PPR is prone to bind a wide variety of ligands. Collectively, these data suggest a role for the PPR in HEV adaptation. Particularly as an IDR, the PPR likely contributes to fine tuning of viral replication through protein-protein interactions and should be considered as a target for development of novel anti-viral drugs.	[Purdy, Michael A.; Lara, James; Khudyakov, Yury E.] Ctr Dis Control & Prevent, Natl Ctr HIV Hepatitis STD TB Prevent, Div Viral Hepatitis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Purdy, MA (corresponding author), Ctr Dis Control & Prevent, Natl Ctr HIV Hepatitis STD TB Prevent, Div Viral Hepatitis, Atlanta, GA 30333 USA.	mup3@cdc.gov			Division of Viral Hepatitis, Center for Disease Control	Division of Viral Hepatitis, Center for Disease Control	This research was funded completely with programmatic funds from the Division of Viral Hepatitis, Center for Disease Control. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors conceived of this project, conducted experiments as conceived and analyzed the data. No outside influence was used to modify our data or conclusions in any way.	Arankalle VA, 2006, J VIRAL HEPATITIS, V13, P742, DOI 10.1111/j.1365-2893.2006.00759.x; Arankalle VA, 1999, J GEN VIROL, V80, P1691, DOI 10.1099/0022-1317-80-7-1691; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Batts W, 2011, VIRUS RES, V158, P116, DOI 10.1016/j.virusres.2011.03.019; Chatterjee R, 1997, AFRICAN STRAINS HEPA; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dosztanyi Z, 2006, J PROTEOME RES, V5, P2985, DOI 10.1021/pr060171o; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; EMERSON SU, 2004, VIRUS TAXONOMY, P853; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768; Khuroo MS, 2011, VIRUS RES, V161, P3, DOI 10.1016/j.virusres.2011.02.007; KOONIN EV, 1992, P NATL ACAD SCI USA, V89, P8259, DOI 10.1073/pnas.89.17.8259; KOONIN EV, 1993, CRIT REV BIOCHEM MOL, V28, P375, DOI 10.3109/10409239309078440; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Legrand-Abravanel F, 2009, EMERG INFECT DIS, V15, P110, DOI 10.3201/eid1501.080296; Li X, 2011, MUTAT RES; Liu HQ, 2009, J VIROL, V83, P1981, DOI 10.1128/JVI.01897-08; Meng XJ, 2011, VIRUS RES, V161, P23, DOI 10.1016/j.virusres.2011.01.016; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; NCBI, 2011, PFAM12526 DUF3729 CO; Nguyen HT, 2011, J GEN VIROL, DOI [10.1099/vir.1090.037259-037250, DOI 10.1099/VIR.1090.037259-037250]; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Pudupakam RS, 2011, J VIROL, V85, P10031, DOI 10.1128/JVI.00763-11; Pudupakam RS, 2009, J VIROL, V83, P384, DOI 10.1128/JVI.01854-08; Puigbo P, 2007, BIOINFORMATICS, V23, P1556, DOI 10.1093/bioinformatics/btm135; Purcell Robert H, 2010, J Infect Dis, V202, P819, DOI 10.1086/655900; Purdy MA, 2011, VIRUS RES, V161, P31, DOI 10.1016/j.virusres.2011.04.030; Ren S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S26; Ropp SL, 2000, ARCH VIROL, V145, P1321, DOI 10.1007/s007050070093; Roy A, 2011, RECOGNIZING PR UNPUB; Roy A, 2011, JOVE-J VIS EXP, DOI 10.3791/3259; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schlessinger A, 2007, BIOINFORMATICS, V23, P2376, DOI 10.1093/bioinformatics/btm349; Shukla P, 2011, P NATL ACAD SCI USA, V108, P2438, DOI 10.1073/pnas.1018878108; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Takahashi M, 2011, J GEN VIROL, V92, P902, DOI 10.1099/vir.0.029470-0; Teshale EH, 2010, CLIN INFECT DIS, V51, P328, DOI 10.1086/653943; Tettamanzi MC, 2006, PROTEIN SCI, V15, P498, DOI 10.1110/ps.051901806; Tompa P, 2003, BIOESSAYS, V25, P847, DOI 10.1002/bies.10324; Tsai CJ, 2001, PROTEINS, V44, P418, DOI 10.1002/prot.1107; TSAREV SA, 1992, P NATL ACAD SCI USA, V89, P559, DOI 10.1073/pnas.89.2.559; Tzeng WP, 2001, VIROLOGY, V289, P63, DOI 10.1006/viro.2001.1088; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Vucetic S, 2003, PROTEINS, V52, P573, DOI 10.1002/prot.10437; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	66	60	61	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35974	10.1371/journal.pone.0035974	http://dx.doi.org/10.1371/journal.pone.0035974			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545153	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343200073
J	Yurchenko, E; Shio, MT; Huang, TC; Martins, MD; Szyf, M; Levings, MK; Olivier, M; Piccirillo, CA				Yurchenko, Ekaterina; Shio, Marina T.; Huang, Tony C.; Martins, Maria Da Silva; Szyf, Moshe; Levings, Megan K.; Olivier, Martin; Piccirillo, Ciriaco A.			Inflammation-Driven Reprogramming of CD4(+)Foxp3(+) Regulatory T Cells into Pathogenic Th1/Th17 T Effectors Is Abrogated by mTOR Inhibition in vivo	PLOS ONE			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; TRANSCRIPTION FACTOR FOXP3; LEISHMANIA-MAJOR; CUTTING EDGE; TH17 CELLS; LINEAGE; T(H)17; DIFFERENTIATION; GENERATION; EXPRESSION	While natural CD4(+)Foxp3(+) regulatory T (nT(REG)) cells have long been viewed as a stable and distinct lineage that is committed to suppressive functions in vivo, recent evidence supporting this notion remains highly controversial. We sought to determine whether Foxp3 expression and the nT(REG) cell phenotype are stable in vivo and modulated by the inflammatory microenvironment. Here, we show that Foxp3(+) nT(REG) cells from thymic or peripheral lymphoid organs reveal extensive functional plasticity in vivo. We show that nT(REG) cells readily lose Foxp3 expression, destabilizing their phenotype, in turn, enabling them to reprogram into Th1 and Th17 effector cells. nT(REG) cell reprogramming is a characteristic of the entire Foxp3(+) nT(REG) population and the stable Foxp3(NEG) T-REG cell phenotype is associated with a methylated foxp3 promoter. The extent of nT(REG) cell reprogramming is modulated by the presence of effector T cell-mediated signals, and occurs independently of variation in IL-2 production in vivo. Moreover, the gut microenvironment or parasitic infection favours the reprogramming of Foxp3(+) T-REG cells into effector T cells and promotes host immunity. IL-17 is predominantly produced by reprogrammed Foxp3(+) nT(REG) cells, and precedes Foxp3 down-regulation, a process accentuated in mesenteric sites. Lastly, mTOR inhibition with the immunosuppressive drug, rapamycin, stabilizes Foxp3 expression in T-REG cells and strongly inhibits IL-17 but not ROR gamma t expression in reprogrammed Foxp3(-) T-REG cells. Overall, inflammatory signals modulate mTOR signalling and influence the stability of the Foxp3(+) nT(REG) cell phenotype.	[Yurchenko, Ekaterina; Shio, Marina T.; Martins, Maria Da Silva; Olivier, Martin; Piccirillo, Ciriaco A.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Yurchenko, Ekaterina; Shio, Marina T.; Martins, Maria Da Silva; Olivier, Martin; Piccirillo, Ciriaco A.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Huang, Tony C.; Szyf, Moshe; Olivier, Martin] McGill Univ, Dept Pharmacol, Montreal, PQ H3A 2T5, Canada; [Levings, Megan K.] Univ British Columbia, Dept Surg, Child & Family Res Inst, Vancouver, BC V6T 1W5, Canada; [Piccirillo, Ciriaco A.] McGill Univ, Res Inst, Ctr Hlth, FOCIS Ctr Excellence, Montreal, PQ, Canada	McGill University; McGill University; McGill University; Child & Family Research Institute; University of British Columbia; McGill University	Yurchenko, E (corresponding author), McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada.	Ciro.piccirillo@mcgill.ca	Shio, Marina Tiemi/E-6466-2019	Shio, Marina Tiemi/0000-0002-2494-6816; Levings, Megan/0000-0002-0305-5790	Canadian Institutes for Health Research [MOP 67211, MOP 84037]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	The authors acknowledge the financial support of the Canadian Institutes for Health Research (MOP 67211 and MOP 84037 to C. A. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Allan SE, 2008, MOL THER, V16, P194, DOI 10.1038/sj.mt.6300341; Ayyoub M, 2009, P NATL ACAD SCI USA, V106, P8635, DOI 10.1073/pnas.0900621106; Battaglia M, 2006, J IMMUNOL, V177, P8338, DOI 10.4049/jimmunol.177.12.8338; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Beriou G, 2009, BLOOD, V113, P4240, DOI 10.1182/blood-2008-10-183251; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Contreras I, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001148; d'Hennezel E, 2009, NEW ENGL J MED, V361, P1710, DOI 10.1056/NEJMc0907093; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Duarte JH, 2009, EUROPEAN J IMMUNOLOG, V9999; Ehrchen JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000871; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Horwitz DA, 2008, TRENDS IMMUNOL, V29, P429, DOI 10.1016/j.it.2008.06.005; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Joshi PB, 2002, MOL BIOCHEM PARASIT, V120, P33, DOI 10.1016/S0166-6851(01)00432-7; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Kopf H, 2007, INT IMMUNOPHARMACOL, V7, P1819, DOI 10.1016/j.intimp.2007.08.027; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; MOMBAERTS P, 1993, CELL, V75, P275, DOI 10.1016/0092-8674(93)80069-Q; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Piccirillo CA, 2001, J IMMUNOL, V167, P1137, DOI 10.4049/jimmunol.167.3.1137; Piccirillo CA, 2008, CURR OPIN IMMUNOL, V20, P655, DOI 10.1016/j.coi.2008.09.006; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Sgouroudis E, 2008, J IMMUNOL, V181, P6283, DOI 10.4049/jimmunol.181.9.6283; Strauss L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005994; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Wu WH, 2006, EUR J IMMUNOL, V36, P3238, DOI 10.1002/eji.200636472; Wu WH, 2009, CAN J MICROBIOL, V55, P705, DOI [10.1139/W09-017, 10.1139/w09-017]; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	51	89	94	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35572	10.1371/journal.pone.0035572	http://dx.doi.org/10.1371/journal.pone.0035572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545118	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343200038
J	Ye, SD; Tan, L; Yang, RQ; Fang, B; Qu, S; Schulze, EN; Song, HY; Ying, QL; Li, P				Ye, Shoudong; Tan, Li; Yang, Rongqing; Fang, Bo; Qu, Su; Schulze, Eric N.; Song, Houyan; Ying, Qilong; Li, Ping			Pleiotropy of Glycogen Synthase Kinase-3 Inhibition by CHIR99021 Promotes Self-Renewal of Embryonic Stem Cells from Refractory Mouse Strains	PLOS ONE			English	Article							BETA-CATENIN; C-MYC; TYROSINE PHOSPHORYLATION; PREVENT DIFFERENTIATION; EFFICIENT DERIVATION; TUMOR-SUPPRESSOR; PLURIPOTENCY; ESTABLISHMENT; LOCALIZATION; ACTIVATION	Background: Inhibition of glycogen synthase kinase-3 (GSK-3) improves the efficiency of embryonic stem (ES) cell derivation from various strains of mice and rats, as well as dramatically promotes ES cell self-renewal potential. beta-catenin has been reported to be involved in the maintenance of self-renewal of ES cells through TCF dependent and independent pathway. But the intrinsic difference between ES cell lines from different species and strains has not been characterized. Here, we dissect the mechanism of GSK-3 inhibition by CHIR99021 in mouse ES cells from refractory mouse strains. Methodology/Principal Findings: We found that CHIR99021, a GSK-3 specific inhibitor, promotes self-renewal of ES cells from recalcitrant C57BL/6 (B6) and BALB/c mouse strains through stabilization of beta-catenin and c-Myc protein levels. Stabilized beta-catenin promoted ES self-renewal through two mechanisms. First, beta-catenin translocated into the nucleus to maintain stem cell pluripotency in a lymphoid-enhancing factor/T-cell factor-independent manner. Second, beta-catenin binds plasma membrane-localized E-cadherin, which ensures a compact, spherical morphology, a hallmark of ES cells. Further, elevated c-Myc protein levels did not contribute significantly to CH-mediated ES cell self-renewal. Instead, the role of c-Myc is dependent on its transformation activity and can be replaced by N-Myc but not L-Myc. beta-catenin and c-Myc have similar effects on ES cells derived from both B6 and BALB/c mice. Conclusions/Significance: Our data demonstrated that GSK-3 inhibition by CH promotes self-renewal of mouse ES cells with non-permissive genetic backgrounds by regulation of multiple signaling pathways. These findings would be useful to improve the availability of normally non-permissive mouse strains as research tools.	[Ye, Shoudong; Yang, Rongqing; Fang, Bo; Qu, Su; Song, Houyan; Li, Ping] Shanghai Med Coll, Minist Educ, Key Lab Mol Med, Shanghai, Peoples R China; [Tan, Li] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Schulze, Eric N.; Ying, Qilong] Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA	Fudan University; University of Southern California	Ye, SD (corresponding author), Shanghai Med Coll, Minist Educ, Key Lab Mol Med, Shanghai, Peoples R China.	lp0030@hotmail.com	Tan, Li/AAN-2456-2021	Tan, Li/0000-0001-5961-0450	National Key Basic Research Program [2011CBA01100]; Shanghai Municipal Natural Science Foundation [09ZR1404000]	National Key Basic Research Program(National Basic Research Program of China); Shanghai Municipal Natural Science Foundation	This work was supported in part by the National Key Basic Research Program 2011CBA01100 and the Shanghai Municipal Natural Science Foundation 09ZR1404000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Batlle-Morera L, 2008, GENESIS, V46, P758, DOI 10.1002/dvg.20442; Bechard M, 2009, MOL CELL BIOL, V29, P2092, DOI 10.1128/MCB.01405-08; Bijur GN, 2003, NEUROREPORT, V14, P2415, DOI 10.1097/00001756-200312190-00025; Brook FA, 1997, P NATL ACAD SCI USA, V94, P5709, DOI 10.1073/pnas.94.11.5709; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Evans PM, 2010, MOL CELL BIOL, V30, P372, DOI 10.1128/MCB.00063-09; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; GARLAND LG, 1981, N-S ARCH PHARMACOL, V318, P88; Gertsenstein M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011260; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Hao J, 2006, DEV BIOL, V290, P81, DOI 10.1016/j.ydbio.2005.11.011; Iijima S, 2010, CELL REPROGRAM, V12, P679, DOI 10.1089/cell.2010.0018; KAWASE E, 1994, INT J DEV BIOL, V38, P385; Kelly KF, 2011, CELL STEM CELL, V8, P214, DOI 10.1016/j.stem.2010.12.010; Kiyonari H, 2010, GENESIS, V48, P317, DOI 10.1002/dvg.20614; Larue L, 1996, DEVELOPMENT, V122, P3185; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; Lluis F, 2008, CELL STEM CELL, V3, P493, DOI 10.1016/j.stem.2008.08.017; Lyashenko N, 2011, NAT CELL BIOL, V13, P753, DOI 10.1038/ncb2260; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; NAU MM, 1985, NATURE, V318, P69, DOI 10.1038/318069a0; Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Piedra J, 2001, J BIOL CHEM, V276, P20436, DOI 10.1074/jbc.M100194200; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Sato H, 2009, GENESIS, V47, P414, DOI 10.1002/dvg.20514; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; SCHWAB M, 1984, NATURE, V308, P288, DOI 10.1038/308288a0; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sineva GS, 2010, BIOL CELL, V102, P549, DOI 10.1042/BC20100016; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Smith KN, 2010, CELL STEM CELL, V7, P343, DOI 10.1016/j.stem.2010.06.023; Sokol SY, 2011, DEVELOPMENT, V138, P4341, DOI 10.1242/dev.066209; Soncin F, 2009, STEM CELLS, V27, P2069, DOI 10.1002/stem.134; Stepniak E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002949; Sumi T, 2007, ONCOGENE, V26, P5564, DOI 10.1038/sj.onc.1210353; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takao Y, 2007, BIOCHEM BIOPH RES CO, V353, P699, DOI 10.1016/j.bbrc.2006.12.072; Tam WL, 2008, STEM CELLS, V26, P2019, DOI 10.1634/stemcells.2007-1115; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Umehara H, 2007, STEM CELLS, V25, P2705, DOI 10.1634/stemcells.2007-0086; Varlakhanova NV, 2010, DIFFERENTIATION, V80, P9, DOI 10.1016/j.diff.2010.05.001; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	54	58	60	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35892	10.1371/journal.pone.0035892	http://dx.doi.org/10.1371/journal.pone.0035892			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22540008	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341000074
J	Hawksworth, JS; Graybill, JC; Brown, TS; Wallace, SM; Davis, TA; Tadaki, DK; Elster, EA				Hawksworth, Jason S.; Graybill, J. Christopher; Brown, Trevor S.; Wallace, Shannon M.; Davis, Thomas A.; Tadaki, Doug K.; Elster, Eric A.			Lymphocyte Modulation with FTY720 Improves Hemorrhagic Shock Survival in Swine	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; T-LYMPHOCYTES; SPHINGOSINE 1-PHOSPHATE; CELL; NEUTROPHIL; SPHINGOSINE-1-PHOSPHATE; TRAUMA; RECEPTORS; ADHESION; ANERGY	The inflammatory response to severe traumatic injury results in significant morbidity and mortality. Lymphocytes have recently been identified as critical mediators of the early innate immune response to ischemia-reperfusion injury. Experimental manipulation of lymphocytes following hemorrhagic shock may prevent secondary immunologic injury in surgical and trauma patients. The objective of this study is to evaluate the lymphocyte sequestration agent FTY720 as an immunomodulator following experimental hemorrhagic shock in a swine liver injury model. Yorkshire swine were anesthetized and underwent a grade III liver injury with uncontrolled hemorrhage to induce hemorrhagic shock. Experimental groups were treated with a lymphocyte sequestration agent, FTY720, (n = 9) and compared to a vehicle control group (n = 9). Animals were observed over a 3 day survival period after hemorrhage. Circulating total leukocyte and neutrophil counts were measured. Central lymphocytes were evaluated with mesenteric lymph node and spleen immunohistochemistry (IHC) staining for CD3. Lung tissue infiltrating neutrophils were analyzed with myeloperoxidase (MPO) IHC staining. Relevant immune-related gene expression from liver tissue was quantified using RT-PCR. The overall survival was 22.2% in the vehicle control and 66.7% in the FTY720 groups (p = 0.081), and reperfusion survival (period after hemorrhage) was 25% in the vehicle control and 75% in the FTY720 groups (p = 0.047). CD3(+) lymphocytes were significantly increased in mesenteric lymph nodes and spleen in the FTY720 group compared to vehicle control, indicating central lymphocyte sequestration. Lymphocyte disruption significantly decreased circulating and lung tissue infiltrating neutrophils, and decreased expression of liver immune-related gene expression in the FTY720 treated group. There were no observed infectious or wound healing complications. Lymphocyte sequestration with FTY720 improves survival in experimental hemorrhagic shock using a porcine liver injury model. These results support a novel and clinically relevant lymphocyte immunomodulation strategy to ameliorate secondary immune injury in hemorrhagic shock.	[Hawksworth, Jason S.; Graybill, J. Christopher; Brown, Trevor S.; Davis, Thomas A.; Tadaki, Doug K.; Elster, Eric A.] USN, Regenerat Med Dept, Operat & Undersea Med Directorate, Med Res Ctr, Silver Spring, MD 20910 USA; [Hawksworth, Jason S.; Graybill, J. Christopher; Elster, Eric A.] Walter Reed Natl Mil Med Ctr, Dept Surg, Bethesda, MD USA; [Tadaki, Doug K.; Elster, Eric A.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Wallace, Shannon M.] Walter Reed Army Inst Res, Dept Diagnost Pathol, Silver Spring, MD USA	United States Department of Defense; United States Navy; Walter Reed National Military Medical Center; Uniformed Services University of the Health Sciences - USA; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Hawksworth, JS (corresponding author), USN, Regenerat Med Dept, Operat & Undersea Med Directorate, Med Res Ctr, Silver Spring, MD 20910 USA.	doug.tadaki@med.navy.mil; eric.elster1@med.navy.mil	Brown, Trevor/K-4703-2012; Elster, Eric/ABG-6091-2021; Brown, Trevor/F-7392-2015	Brown, Trevor/0000-0001-7042-785X; Brown, Trevor/0000-0001-7042-785X; Elster, Eric/0000-0002-0981-2748	Office of Naval Research (work unit number 603729N.02914.W280.A0515)	Office of Naval Research (work unit number 603729N.02914.W280.A0515)(Office of Naval Research)	This work was supported by the Office of Naval Research (work unit number 603729N.02914.W280.A0515). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud F, 2006, TRANSFUSION MED, V16, P290, DOI 10.1111/j.1365-3148.2006.00678.x; Bandyopadhyay G, 2007, CRIT CARE MED, V35, P794, DOI 10.1097/01.CCM.0000256847.61085.A5; BOTHA AJ, 1995, J TRAUMA, V39, P411; Brinkmann V, 2004, AM J TRANSPLANT, V4, P1019, DOI 10.1111/j.1600-6143.2004.00476.x; Brinkmann V, 2002, CURR OPIN IMMUNOL, V14, P569, DOI 10.1016/S0952-7915(02)00374-6; Brinkmann V, 2001, TRANSPLANTATION, V72, P764, DOI 10.1097/00007890-200109150-00002; Burne MJ, 2001, J CLIN INVEST, V108, P1283, DOI 10.1172/JCI200112080; Caldwell CC, 2007, J LEUKOCYTE BIOL, V82, P457, DOI 10.1189/jlb.0107062; Cohen JA, N ENGL J MED, V362, P402; De AK, 2000, CLIN IMMUNOL, V96, P52, DOI 10.1006/clim.2000.4879; Dragun D, 2004, KIDNEY INT, V65, P1076, DOI 10.1111/j.1523-1755.2004.00478.x; Harlan JM, 2002, CRIT CARE MED, V30, pS214, DOI 10.1097/00003246-200205001-00007; Hawksworth JS, 2009, J THROMB HAEMOST, V7, P1663, DOI 10.1111/j.1538-7836.2009.03562.x; Hawksworth JS, 2009, J SURG RES, V151, P267; Horie Y, 1999, MICROCIRCULATION, V6, P267; Huang YF, 2007, CELL IMMUNOL, V248, P4, DOI 10.1016/j.cellimm.2007.03.009; Kappos L, N ENGL J MED, V362, P387; Kokura S, 2000, CIRC RES, V86, P1237, DOI 10.1161/01.RES.86.12.1237; Kokura S, 2000, MICROCIRCULATION, V7, P13, DOI 10.1038/sj.mn.7300088; Koyrakh L, 2005, AM J TRANSPLANT, V5, P529, DOI 10.1111/j.1600-6143.2005.00754.x; Le Moine O, 2000, HEPATOLOGY, V31, P1266, DOI 10.1053/jhep.2000.7881; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Matzinger P, 1998, SEMIN IMMUNOL, V10, P399, DOI 10.1006/smim.1998.0143; Moore FA, 2004, POSTINJURY MULTIPLE; Nugent D, 2000, PLATELETS, V11, P226; Pallister I, 2002, CRIT CARE MED, V30, P1717, DOI 10.1097/00003246-200208000-00007; Peters SLM, 2007, CURR OPIN PHARMACOL, V7, P186, DOI 10.1016/j.coph.2006.09.008; Rabb H, 1997, KIDNEY INT, V51, P1463, DOI 10.1038/ki.1997.200; Rabb H, 2000, AM J PHYSIOL-RENAL, V279, pF525, DOI 10.1152/ajprenal.2000.279.3.F525; Rhee P, 2000, J TRAUMA, V49, P611, DOI 10.1097/00005373-200010000-00007; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Spolarics Z, 2003, CRIT CARE MED, V31, P1722, DOI 10.1097/01.CCM.0000063579.43470.AA; Takada M, 1997, J CLIN INVEST, V100, P1199, DOI 10.1172/JCI119632; Weaver TA, 2007, TRANSPLANTATION, V84, P1545, DOI 10.1097/01.tp.0000296680.75175.67; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; WINDSOR ACJ, 1993, BRIT J SURG, V80, P10, DOI 10.1002/bjs.1800800106; Yonekawa K, 2005, J LEUKOCYTE BIOL, V77, P129, DOI 10.1189/jlb.0804460; Zhao Y, 2004, AM J TRANSPLANT, V4, P1399, DOI 10.1111/j.1600-6143.2004.00527.x; Zwacka RM, 1997, J CLIN INVEST, V100, P279, DOI 10.1172/JCI119533	39	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e34224	10.1371/journal.pone.0034224	http://dx.doi.org/10.1371/journal.pone.0034224			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558085	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340200004
J	Szyszka, P; Stierle, JS; Biergans, S; Galizia, CG				Szyszka, Paul; Stierle, Jacob S.; Biergans, Stephanie; Galizia, C. Giovanni			The Speed of Smell: Odor-Object Segregation within Milliseconds	PLOS ONE			English	Article							DYNAMIC PROPERTIES; APIS-MELLIFERA; DROSOPHILA; MIXTURES; HONEYBEES; DISCRIMINATION; SIMILARITY; COMPONENTS; PHEROMONE; STIMULUS	Segregating objects from background, and determining which of many concurrent stimuli belong to the same object, remains one of the most challenging unsolved problems both in neuroscience and in technical applications. While this phenomenon has been investigated in depth in vision and audition it has hardly been investigated in olfaction. We found that for honeybees a 6-ms temporal difference in stimulus coherence is sufficient for odor-object segregation, showing that the temporal resolution of the olfactory system is much faster than previously thought.	[Szyszka, Paul; Stierle, Jacob S.; Biergans, Stephanie; Galizia, C. Giovanni] Univ Constance, Dept Biol, Constance, Germany	University of Konstanz	Szyszka, P (corresponding author), Univ Constance, Dept Biol, Constance, Germany.	paul.szyszka@uni-konstanz.de	Galizia, C Giovanni/A-1771-2009; Biergans, Stephanie/H-4595-2019; Szyszka, Paul/ABC-7508-2020	Galizia, C Giovanni/0000-0001-8292-6031; Biergans, Stephanie/0000-0002-0120-1301; Szyszka, Paul/0000-0003-2043-6656	Bundesministerium fur Bildung und Forschung [01GQ0931]; Deutsche Forschungsgemeinschaft	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Bundesministerium fur Bildung und Forschung (01GQ0931 to PS and CGG) and Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Ache BW, 2005, NEURON, V48, P417, DOI 10.1016/j.neuron.2005.10.022; Andersson MN, 2011, J CHEM ECOL, V37, P899, DOI 10.1007/s10886-011-9995-3; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Blake Randolph, 2005, Behav Cogn Neurosci Rev, V4, P21, DOI 10.1177/1534582305276839; BREGMAN AS, 1978, CAN J PSYCHOL, V32, P19, DOI 10.1037/h0081664; Broome BM, 2006, NEURON, V51, P467, DOI 10.1016/j.neuron.2006.07.018; Carde RT, 2008, J CHEM ECOL, V34, P854, DOI 10.1007/s10886-008-9484-5; Carlyon RP, 2004, TRENDS COGN SCI, V8, P465, DOI 10.1016/j.tics.2004.08.008; Chandra S, 1998, J EXP BIOL, V201, P3113; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Deisig N, 2003, LEARN MEMORY, V10, P199, DOI 10.1101/lm.55803; Ditzen M, 2003, CHEM SENSES, V28, P781, DOI 10.1093/chemse/bjg070; Eschbach C, 2011, CHEM SENSES, V36, P613, DOI 10.1093/chemse/bjr016; French AS, 2011, J NEUROSCI, V31, P861, DOI 10.1523/JNEUROSCI.5243-10.2011; HOPFIELD JF, 1989, BEHAV NEUROSCI, V103, P329, DOI 10.1037/0735-7044.103.2.329; HOPFIELD JJ, 1991, P NATL ACAD SCI USA, V88, P6462, DOI 10.1073/pnas.88.15.6462; Jinks A, 2001, PHYSIOL BEHAV, V72, P51, DOI 10.1016/S0031-9384(00)00407-8; Justus KA, 2005, J NEUROPHYSIOL, V93, P2233, DOI 10.1152/jn.00888.2004; Justus KA, 2002, PHYSIOL ENTOMOL, V27, P58, DOI 10.1046/j.1365-3032.2002.00269.x; Lachnit H, 2004, ADV STUD BEHAV, V34, P241, DOI 10.1016/S0065-3454(04)34006-4; Linster C, 1999, PHYSIOL BEHAV, V66, P701, DOI 10.1016/S0031-9384(99)00007-4; MURLIS J, 1992, ANNU REV ENTOMOL, V37, P505, DOI 10.1146/annurev.en.37.010192.002445; Riffell JA, 2008, J CHEM ECOL, V34, P837, DOI 10.1007/s10886-008-9490-7; Schuckel J, 2008, J COMP PHYSIOL A, V194, P483, DOI 10.1007/s00359-008-0322-6; Schuckel J, 2009, J NEUROPHYSIOL, V102, P214, DOI 10.1152/jn.00162.2009; Sekuler AB, 2001, PSYCHOL SCI, V12, P437, DOI 10.1111/1467-9280.00382; Smith BH, 1998, PHYSIOL BEHAV, V65, P397, DOI 10.1016/S0031-9384(98)00142-5; Spors H, 2006, J NEUROSCI, V26, P1247, DOI 10.1523/JNEUROSCI.3100-05.2006; Stevenson RJ, 2007, PERCEPTION, V36, P1821, DOI 10.1068/p5563; Szyszka P, 2011, J NEUROSCI, V31, P7229, DOI 10.1523/JNEUROSCI.6668-10.2011; Treisman A, 1996, CURR OPIN NEUROBIOL, V6, P171, DOI 10.1016/S0959-4388(96)80070-5; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Vetter RS, 2006, CHEM SENSES, V31, P359, DOI 10.1093/chemse/bjj040; Vickers NJ, 2000, BIOL BULL, V198, P203, DOI 10.2307/1542524	35	52	53	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36096	10.1371/journal.pone.0036096	http://dx.doi.org/10.1371/journal.pone.0036096			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558344	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336000128
J	Lu, ZM; Zhou, J; Wang, XH; Guan, ZP; Bai, H; Liu, ZJ; Su, N; Pan, KF; Ji, JF; Deng, DJ				Lu, Zhe-Ming; Zhou, Jing; Wang, Xiuhong; Guan, Zhenpo; Bai, Hua; Liu, Zhao-Jun; Su, Na; Pan, Kaifeng; Ji, Jiafu; Deng, Dajun			Nucleosomes Correlate with In Vivo Progression Pattern of De Novo Methylation of p16 CpG Islands in Human Gastric Carcinogenesis	PLOS ONE			English	Article							ABERRANT DNA METHYLATION; CHROMATIN ACCESSIBILITY; HUMAN CANCERS; HUMAN TISSUES; GENE; P16(INK4A); INHIBITION; OCCUPANCY; DYSPLASIA; POSITIONS	Background: The exact relationship between nucleosome positioning and methylation of CpG islands in human pathogenesis is unknown. Methodology/Principal Findings: In the present study, we characterized the nucleosome position within the p16 CpG island and established a seeding methylation-specific PCR (sMSP) assay based on bisulfite modification to enrich the p16 alleles containing methylated-CpG at the methylation "seeding'' sites within its intron-1 in gastric carcinogenesis. The sMSP-positive rate in primary gastric carcinoma (GC) samples (36/40) was significantly higher than that observed in gastritis (19/45) or normal samples (7/13) (P < 0.01). Extensive clone sequencing of these sMSP products showed that the density of methylated-CpGs in p16 CpG islands increased gradually along with the severity of pathological changes in gastric tissues. In gastritis lesions the methylation was frequently observed in the region corresponding to the exon-1 coding-nucleosome and the 5'UTR-nucleosome; the methylation was further extended to the region corresponding to the promoter-nucleosome in GC samples. Only few methylated-CpG sites were randomly detected within p16 CpG islands in normal tissues. The significantly inversed relationship between the p16 exon-1 methylation and its transcription was observed in GC samples. An exact p16 promoter-specific 83 bp-MSP assay confirms the result of sMSP (33/55 vs. 1/6, P < 0.01). In addition, p16 methylation in chronic gastritis lesions significantly correlated with H. pylori infection; however, such correlation was not observed in GC specimens. Conclusions/Significance: It was determined that de novo methylation was initiated in the coding region of p16 exon-1 in gastritis, then progressed to its 5'UTR, and ultimately to the proximal promoter in GCs. Nucleosomes may function as the basic extension/progression unit of de novo methylation of p16 CpG islands in vivo.	[Lu, Zhe-Ming; Zhou, Jing; Wang, Xiuhong; Guan, Zhenpo; Bai, Hua; Liu, Zhao-Jun; Su, Na; Deng, Dajun] Peking Univ, Key Lab Carcinogenesis & Translat Res, Canc Hosp & Inst, Minist Educ,Div Canc Etiol, Beijing 100871, Peoples R China; [Pan, Kaifeng] Peking Univ, Canc Hosp & Inst, Dept Epidemiol, Beijing 100871, Peoples R China; [Ji, Jiafu] Peking Univ, Canc Hosp & Inst, Dept Surg, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Lu, ZM (corresponding author), Peking Univ, Key Lab Carcinogenesis & Translat Res, Canc Hosp & Inst, Minist Educ,Div Canc Etiol, Beijing 100871, Peoples R China.	zheminglu@163.com; dengdajun@bjmu.edu.cn	Deng, Dajun/D-4605-2009; liu, zhao/GXV-6141-2022	Deng, Dajun/0000-0001-5161-5943; JI, JIAFU/0000-0001-6878-5543	National Natural Science Foundation of China [90919015, 81071630, 30921140311]; National Basic Research Program of China [2010CB529303, 2011CB504201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China [Grant #90919015, 81071630, and 30921140311]; and National Basic Research Program of China [Grant #2010CB529303 and 2011CB504201]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai H, 2003, MUTAT RES-GEN TOX EN, V535, P73, DOI 10.1016/S1383-5718(02)00288-7; Bai H, 2008, CHINESE J CANCER RES, V20, P237, DOI 10.1007/s11670-008-0237-3; Belinsky SA, 1998, P NATL ACAD SCI USA, V95, P11891, DOI 10.1073/pnas.95.20.11891; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Cao J, 2009, CLIN CANCER RES, V15, P5178, DOI 10.1158/1078-0432.CCR-09-0580; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Cruickshank M, 2008, BIOCHEM BIOPH RES CO, V367, P349, DOI 10.1016/j.bbrc.2007.12.121; Deng DJ, 2010, CHINESE J CANCER RES, V22, P245, DOI 10.1007/s11670-010-0245-y; Deng DJ, 2010, ADV GENET, V71, P125, DOI [10.1016/S0065-2660(10)71005-1, 10.1016/B978-0-12-380864-6.00005-5]; Deng DJ, 2000, WORLD J GASTROENTERO, V6, P613; Deng DJ, 2000, J AGR FOOD CHEM, V48, P2495, DOI 10.1021/jf990967q; Dong CX, 2009, INT J CANCER, V124, P434, DOI 10.1002/ijc.23891; Eads C, 2002, METHOD MOL BIOL, V200, P53; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Egger G, 2007, CANCER RES, V67, P346, DOI 10.1158/0008-5472.CAN-06-2845; Fatemi M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni180; Francis J, 2006, MOL ENDOCRINOL, V20, P3133, DOI 10.1210/me.2006-0126; GONZALEZZULUETA M, 1995, CANCER RES, V55, P4531; HERMAN JG, 1995, CANCER RES, V55, P4525; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hinshelwood RA, 2009, HUM MOL GENET, V18, P3098, DOI 10.1093/hmg/ddp251; Jeong S, 2009, MOL CELL BIOL, V29, P5366, DOI 10.1128/MCB.00484-09; Li QA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013732; Lin JC, 2007, CANCER CELL, V12, P432, DOI 10.1016/j.ccr.2007.10.014; Liu ZQ, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-81; Luo DY, 2006, LAB INVEST, V86, P591, DOI 10.1038/labinvest.3700415; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Perri F, 2007, AM J GASTROENTEROL, V102, P1361, DOI 10.1111/j.1572-0241.2007.01284.x; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Sun Y, 2004, CLIN CANCER RES, V10, P5087, DOI 10.1158/1078-0432.CCR-03-0622; Ushijima T, 2005, NAT REV CANCER, V5, P223, DOI 10.1038/nrc1571; WANG KH, 1983, ACTA BIOL EXP SINICA, V16, P257; Wong DJ, 1999, MOL CELL BIOL, V19, P5642; Yan PS, 2003, CANCER RES, V63, P6178; Yang P, 2012, CANCER EPIDEM BIOMAR, V21, P182, DOI 10.1158/1055-9965.EPI-11-0784; Yao JY, 2010, J BIOL CHEM, V285, P18828, DOI 10.1074/jbc.M109.077974; Zhou J, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-67	39	13	18	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35928	10.1371/journal.pone.0035928	http://dx.doi.org/10.1371/journal.pone.0035928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558275	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345200094
J	Magland, JF; Zhang, N; Rajapakse, CS; Wehrli, FW				Magland, Jeremy F.; Zhang, Ning; Rajapakse, Chamith S.; Wehrli, Felix W.			Computationally-Optimized Bone Mechanical Modeling from High-Resolution Structural Images	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; TRABECULAR BONE; COMPUTED-TOMOGRAPHY; ELASTIC PROPERTIES; DISTAL RADIUS; MR-IMAGES; VOLUME; STRENGTH; FRACTURE; MEN	Image-based mechanical modeling of the complex micro-structure of human bone has shown promise as a non-invasive method for characterizing bone strength and fracture risk in vivo. In particular, elastic moduli obtained from image-derived micro-finite element (mu FE) simulations have been shown to correlate well with results obtained by mechanical testing of cadaveric bone. However, most existing large-scale finite-element simulation programs require significant computing resources, which hamper their use in common laboratory and clinical environments. In this work, we theoretically derive and computationally evaluate the resources needed to perform such simulations (in terms of computer memory and computation time), which are dependent on the number of finite elements in the image-derived bone model. A detailed description of our approach is provided, which is specifically optimized for mu FE modeling of the complex three-dimensional architecture of trabecular bone. Our implementation includes domain decomposition for parallel computing, a novel stopping criterion, and a system for speeding up convergence by pre-iterating on coarser grids. The performance of the system is demonstrated on a dual quad-core Xeon 3.16 GHz CPUs equipped with 40 GB of RAM. Models of distal tibia derived from 3D in-vivo MR images in a patient comprising 200,000 elements required less than 30 seconds to converge (and 40 MB RAM). To illustrate the system's potential for large-scale mu FE simulations, axial stiffness was estimated from high-resolution micro-CT images of a voxel array of 90 million elements comprising the human proximal femur in seven hours CPU time. In conclusion, the system described should enable image-based finite-element bone simulations in practical computation times on high-end desktop computers with applications to laboratory studies and clinical imaging.	[Magland, Jeremy F.; Zhang, Ning; Rajapakse, Chamith S.; Wehrli, Felix W.] Univ Penn, Dept Radiol, Lab Struct NMR Imaging, Med Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania	Magland, JF (corresponding author), Univ Penn, Dept Radiol, Lab Struct NMR Imaging, Med Ctr, Philadelphia, PA 19104 USA.	Jeremy.Magland@gmail.com			National Institutes of Health [R01 AR55647, R01 AR55356, K25 AR 060283]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K25AR060283, R01AR055647] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health grants R01 AR55647, R01 AR55356 and K25 AR 060283. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MF, 2004, ACM IEEE P SC2004 HI; Arbenz P, 2008, SCALABLE MULTILEVEL; Arbenz P, 2007, LECT NOTES COMPUT SC, V4699, P240; Bekas C, 2010, CONCURR COMP-PRACT E, V22, P2282, DOI 10.1002/cpe.1591; Bern M., 1992, COMPUT EUCLIDEAN GEO, V1, P23, DOI DOI 10.1142/9789814355858; Bevill G, 2006, BONE, V39, P1218, DOI 10.1016/j.bone.2006.06.016; Bevill G, 2009, BONE, V44, P579, DOI 10.1016/j.bone.2008.11.020; Boutroy S, 2008, J BONE MINER RES, V23, P392, DOI 10.1359/JBMR.071108; Boutry N, 2003, RADIOLOGY, V227, P708, DOI 10.1148/radiol.2273020420; Dalzell N, 2009, OSTEOPOROSIS INT, V20, P1683, DOI 10.1007/s00198-008-0833-6; Danilov S, 2004, OCEAN MODEL, V6, P125, DOI 10.1016/S1463-5003(02)00063-X; DEMPSTER WT, 1952, AM J ANAT, V91, P331, DOI 10.1002/aja.1000910302; GOULET RW, 1994, J BIOMECH, V27, P375, DOI 10.1016/0021-9290(94)90014-0; Hendrickson B, 1993, SAND922765 SAND NAT; Hou TY, 1997, J COMPUT PHYS, V134, P169, DOI 10.1006/jcph.1997.5682; HUGHES TJR, 1983, COMPUT METHOD APPL M, V36, P241, DOI 10.1016/0045-7825(83)90115-9; HUGHES TJR, 1987, COMPUT METHOD APPL M, V61, P215, DOI 10.1016/0045-7825(87)90005-3; Hwang SN, 2002, MAGN RESON MED, V47, P948, DOI 10.1002/mrm.10138; JAWORSKI ZFG, 1981, ORTHOP CLIN N AM, V12, P485; Kabel J, 1999, J BIOMECH, V32, P673, DOI 10.1016/S0021-9290(99)00045-7; Ladd AJC, 1998, J ORTHOP RES, V16, P622, DOI 10.1002/jor.1100160516; MacNeil JA, 2008, BONE, V42, P1203, DOI 10.1016/j.bone.2008.01.017; Magland JF, 2010, MAGN RESON MED, V63, P719, DOI 10.1002/mrm.22213; Magland JF, 2009, J MAGN RESON IMAGING, V29, P118, DOI 10.1002/jmri.21551; Magland JF, 2008, ACAD RADIOL, V15, P1482, DOI 10.1016/j.acra.2008.05.015; MCCULLOCH A, 1992, CRIT REV BIOMED ENG, V20, P427; Muller R, 2004, OSTEOPOROS INT; Podshivalov L, 2011, BONE, V48, P693, DOI 10.1016/j.bone.2010.12.022; Rajapakse CS, 2010, BONE, V47, P556, DOI 10.1016/j.bone.2010.05.039; Recker R, 2004, J BONE MINER RES, V19, P1628, DOI 10.1359/JBMR.040710; Saad Y., 1996, ITERATIVE METHODS SP, DOI 10.1137/1.9780898718003; Saha PK, 2005, P SOC PHOTO-OPT INS, V5746, P12; Silva MJ, 1998, J ORTHOPAED RES, V16, P300, DOI 10.1002/jor.1100160305; Teng S.-H., 1999, ALGORITHMS PARALLEL, V105, P247; Ulrich D, 1997, ST HEAL T, V40, P97; Van Rietbergen B, 1999, J BIOMECH, V32, P443; Van Rietbergen B, 2003, J BONE MINER RES, V18, P1781, DOI 10.1359/jbmr.2003.18.10.1781; VanRietbergen B, 1996, INT J NUMER METH ENG, V39, P2743, DOI 10.1002/(SICI)1097-0207(19960830)39:16<2743::AID-NME974>3.0.CO;2-A; VANRIETBERGEN B, 1995, J BIOMECH, V28, P69, DOI 10.1016/0021-9290(95)80008-5; VICO L, 1988, AM J PHYSIOL, V255, pR243, DOI 10.1152/ajpregu.1988.255.2.R243; Vilayphiou N, 2011, J BONE MINER RES, V26, P965, DOI 10.1002/jbmr.297; Vilayphiou N, 2010, BONE, V46, P1030, DOI 10.1016/j.bone.2009.12.015; Wehrli FW, 2007, J MAGN RESON IMAGING, V25, P390, DOI 10.1002/jmri.20807; Wehrli FW, 2010, J BONE MINER RES, V25, P1406, DOI 10.1002/jbmr.33; Wehrli FW, 1998, RADIOLOGY, V206, P347, DOI 10.1148/radiology.206.2.9457185; Zhang XH, 2008, J BONE MINER RES, V23, P1426, DOI [10.1359/jbmr.080405, 10.1359/JBMR.080405]; Zienkiewicz OC, FINITE ELEMENT METHO, VSixth; Zikan V, 2011, OSTEOPOROSIS INT, V22, P391	48	22	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35525	10.1371/journal.pone.0035525	http://dx.doi.org/10.1371/journal.pone.0035525			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558164	gold, Green Published, Green Submitted			2022-12-27	WOS:000305345200045
J	Riley, ED; Neilands, TB; Moore, K; Cohen, J; Bangsberg, DR; Havlir, D				Riley, Elise D.; Neilands, Torsten B.; Moore, Kelly; Cohen, Jennifer; Bangsberg, David R.; Havlir, Diane			Social, Structural and Behavioral Determinants of Overall Health Status in a Cohort of Homeless and Unstably Housed HIV-Infected Men	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; SELF-RATED HEALTH; QUALITY-OF-LIFE; UNITED-STATES; LOS-ANGELES; ALCOHOL-PROBLEMS; MEDICAL-CARE; PREVENTION; WOMEN; RISK	Background: Previous studies indicate multiple influences on the overall health of HIV-infected persons; however, few assess and rank longitudinal changes in social and structural barriers that are disproportionately found in impoverished populations. We empirically ranked factors that longitudinally impact the overall health status of HIV-infected homeless and unstably housed men. Methods and Findings: Between 2002 and 2008, a cohort of 288 HIV+ homeless and unstably housed men was recruited and followed over time. The population was 60% non-Caucasian and the median age was 41 years; 67% of study participants reported recent drug use and 20% reported recent homelessness. At baseline, the median CD4 cell count was 349 cells/mu l and 18% of eligible persons (CD4<350) took antiretroviral therapy (ART). Marginal structural models were used to estimate the population-level effects of behavioral, social, and structural factors on overall physical and mental health status (measured by the SF-36), and targeted variable importance (tVIM) was used to empirically rank factors by their influence. After adjusting for confounding, and in order of their influence, the three factors with the strongest negative effects on physical health were unmet subsistence needs, Caucasian race, and no reported source of instrumental support. The three factors with the strongest negative effects on mental health were unmet subsistence needs, not having a close friend/confidant, and drug use. ART adherence >90% ranked 5th for its positive influence on mental health, and viral load ranked 4th for its negative influence on physical health. Conclusions: The inability to meet food, hygiene, and housing needs was the most powerful predictor of poor physical and mental health among homeless and unstably housed HIV-infected men in an urban setting. Impoverished persons will not fully benefit from progress in HIV medicine until these barriers are overcome, a situation that is likely to continue fueling the US HIV epidemic.	[Riley, Elise D.; Neilands, Torsten B.; Cohen, Jennifer; Havlir, Diane] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Moore, Kelly] Univ Calif Berkeley, Dept Biostat, Berkeley, CA 94720 USA; [Bangsberg, David R.] Harvard Univ, Ragon Inst, Boston, MA 02115 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	Riley, ED (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	eriley@epi-center.ucsf.edu			National Institutes of Health [DA15605, MH54907, UL1 RR024131]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH087227, R01MH054907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015605] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health DA15605, MH54907, and UL1 RR024131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aidala AA, 2007, AIDS BEHAV, V11, pS1, DOI 10.1007/s10461-007-9302-z; [Anonymous], 2002, INT J DRUG POLICY, DOI DOI 10.1016/S0955-3959(02)00082-8; Armstrong D G, 1995, J Foot Ankle Surg, V34, P563; Bamberger JD, 2000, AM J PUBLIC HEALTH, V90, P699, DOI 10.2105/AJPH.90.5.699; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Beckles Gloria L., 2011, Morbidity and Mortality Weekly Report, V60, P13; Bembom O, 2009, STAT MED, V28, P152, DOI 10.1002/sim.3414; Bobashev GV, 2009, J URBAN HEALTH, V86, pS32, DOI 10.1007/s11524-009-9368-1; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Braveman PA, 2010, AM J PUBLIC HEALTH, V100, pS186, DOI 10.2105/AJPH.2009.166082; Buchanan David, 2009, Am J Public Health, V99 Suppl 3, pS675, DOI 10.2105/AJPH.2008.137810; BURNAM MA, 1988, EVALUATION REV, V12, P117, DOI 10.1177/0193841X8801200202; Cheng WS, 2010, J PSYCHOACTIVE DRUGS, V42, P11, DOI 10.1080/02791072.2010.10399781; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Culhane DP, 2008, EUROPEAN J HOMELESSN, V2, P97; Das-Douglas M, 2009, AIDS BEHAV, V13, P1, DOI 10.1007/s10461-008-9401-5; DeNavas-Walt C, 2011, INCOME POVERTY HLTH; Denning P. H., 2010, COMMUNITIES CRISIS I; Este JA, 2010, ANTIVIR RES, V85, P25, DOI 10.1016/j.antiviral.2009.10.007; Friedman MS, 2009, AIDS CARE, V21, P692, DOI 10.1080/09540120802513709; Gelberg L, 2000, HEALTH SERV RES, V34, P1273; Gelberg L, 1997, AM J PUBLIC HEALTH, V87, P217, DOI 10.2105/AJPH.87.2.217; Gielen AC, 2001, SOC SCI MED, V52, P315, DOI 10.1016/S0277-9536(00)00135-0; Gorbach PM, 2009, J URBAN HEALTH, V86, pS63, DOI 10.1007/s11524-009-9370-7; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; Holtgrave DR, 2010, INT J CLIN PRACT, V64, P678, DOI 10.1111/j.1742-1241.2010.02381.x; Hwang SW, 2009, J URBAN HEALTH, V86, P791, DOI 10.1007/s11524-009-9388-x; Idler EL, 2000, AM J EPIDEMIOL, V152, P874, DOI 10.1093/aje/152.9.874; Jenness SM, 2011, AM J PUBLIC HEALTH, V101, P745, DOI 10.2105/AJPH.2009.181883; Kidder DP, 2007, AM J PUBLIC HEALTH, V97, P2238, DOI 10.2105/AJPH.2006.090209; Kidder DP, 2007, AIDS BEHAV, V11, pS149, DOI 10.1007/s10461-007-9249-0; Kim TW, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-19; Kipke MD, 2007, AIDS BEHAV, V11, pS56, DOI 10.1007/s10461-006-9204-5; La Fleur F, 2010, HEALTH, V15, P491; Larimer ME, 2009, JAMA-J AM MED ASSOC, V301, P1349, DOI 10.1001/jama.2009.414; Leaver CA, 2007, AIDS BEHAV, V11, pS85, DOI 10.1007/s10461-007-9246-3; Marshall BDL, 2011, PREV SCI, V12, P173, DOI 10.1007/s11121-010-0197-y; Moore KL, 2009, STAT MED, V28, P39, DOI 10.1002/sim.3445; MOSSEY JM, 1982, AM J PUBLIC HEALTH, V72, P800, DOI 10.2105/AJPH.72.8.800; Nelson KM, 2010, J URBAN HEALTH, V87, P642, DOI 10.1007/s11524-010-9434-8; *NIAAA, 1995, NIH PUBL; Nord M, 2011, PUBLIC HEALTH NUTR, P1; Parker RG, 2000, AIDS, V14, pS22, DOI 10.1097/00002030-200006001-00004; Rajgopal R, 2002, J NUTR EDUC BEHAV, V34, P26, DOI 10.1016/S1499-4046(06)60225-X; Riley ED, 2003, QUAL LIFE RES, V12, P1051, DOI 10.1023/A:1026166021386; Riley ED, 2011, AM J EPIDEMIOL, V174, P526, DOI 10.1093/aje/kwr208; Riley ED, 2011, AM J EPIDEMIOL, V174, P515, DOI 10.1093/aje/kwr209; Riley ED, 2011, AIDS CARE, V23, P822, DOI 10.1080/09540121.2010.538660; Riley ED, 2010, J URBAN HEALTH, V87, P534, DOI 10.1007/s11524-010-9468-y; Riley Elise D, 2007, Curr HIV/AIDS Rep, V4, P181, DOI 10.1007/s11904-007-0026-5; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Sadowski LS, 2009, JAMA-J AM MED ASSOC, V301, P1771, DOI 10.1001/jama.2009.561; Schneider E., 2006, Morbidity and Mortality Weekly Report, V55, P589; Sinisi SE, 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1069; Sterk CE, 2007, AM J PREV MED, V32, pS177, DOI 10.1016/j.amepre.2007.02.020; Sumartojo E, 2000, AIDS, V14, pS3, DOI 10.1097/00002030-200006001-00002; Tsui JI, 2007, AIDS BEHAV, V11, P603, DOI 10.1007/s10461-006-9157-8; van der Laan MJ, 2006, INT J BIOSTAT, V2, P11, DOI [10.2202/1557-4679.1043, DOI 10.2202/1557-4679.1043]; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WHO, 2010, ANT THER HIV INF AD; Wolitski RJ, 2010, AIDS BEHAV, V14, P493, DOI 10.1007/s10461-009-9643-x; Wong YL, 2005, ADMIN SOC WORK, V30, P67; ZIMMERMAN M, 1988, ARCH GEN PSYCHIAT, V45, P738	64	35	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35207	10.1371/journal.pone.0035207	http://dx.doi.org/10.1371/journal.pone.0035207			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VP	22558128	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345200029
J	Zhang, SF; Wei, JN; Kang, L				Zhang, Sufang; Wei, Jianing; Kang, Le			Transcriptional Analysis of Arabidopsis thaliana Response to Lima Bean Volatiles	PLOS ONE			English	Article							PLANT DEFENSE; TALKING TREES; COMMUNICATION; ETHYLENE; JASMONATE; EXPRESSION; GROWTH; GENES; RESISTANCE; CHEMISTRY	Background: Exposure of plants to herbivore-induced plant volatiles (HIPVs) alters their resistance to herbivores. However, the whole-genome transcriptional responses of treated plants remain unknown, and the signal pathways that produce HIPVs are also unclear. Methodology/Principal Findings: Time course patterns of the gene expression of Arabidopsis thaliana exposed to Lima bean volatiles were examined using Affymetrix ATH1 genome arrays. Results showed that A. thaliana received and responded to leafminer-induced volatiles from Lima beans through up-regulation of genes related to the ethylene (ET) and jasmonic acid pathways. Time course analysis revealed strong and partly qualitative differences in the responses between exposure at 24 and that at 48 h. Further experiments using either A. thaliana ET mutant ein2-1 or A. thaliana jasmonic acid mutant coi1-2 indicated that both pathways are involved in the volatile response process but that the ET pathway is indispensable for detecting volatiles. Moreover, transcriptional comparisons showed that plant responses to larval feeding do not merely magnify the volatile response process. Finally, (Z)-3-hexen-ol, ocimene, (3E)-4,8-dimethyl-1,3,7-nonatriene, and (3E, 7E)-4,8,12-trimethyl-1,3,7,11-tridecatetraene triggered responses in A. thaliana similar to those induced by the entire suite of Lima bean volatiles after 24 and 48 h. Conclusions/Significance: This study shows that the transcriptional responses of plants to HIPVs become stronger as treatment time increases and that ET signals are critical during this process.	[Zhang, Sufang; Wei, Jianing; Kang, Le] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Zhang, Sufang] Chinese Acad Forestry, Key Lab Forest Protect, Res Inst Forest Ecol Environm & Protect, State Forestry Adm, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF	Zhang, SF (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	lkang@ioz.ac.cn	Kang, Le/ABD-1116-2022; Wei, Jianing/L-7575-2019	Kang, Le/0000-0003-4262-2329; Wei, Jianing/0000-0002-8517-2164	National Basic Research Program of China (973 Program) [2012CB114105]; National Nature Science Foundation of China [30921063]; Chinese Academy of Sciences [KSCX2-EW-N-5, KSCX2-YW-N-045]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	The research was supported by the the National Basic Research Program of China (973 Program) (No. 2012CB114105), and National Nature Science Foundation of China (30921063), the Chinese Academy of Sciences (Project No. KSCX2-EW-N-5 and KSCX2-YW-N-045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura G, 2000, BIOCHEM BIOPH RES CO, V277, P305, DOI 10.1006/bbrc.2000.3672; Arimura G, 2000, NATURE, V406, P512, DOI 10.1038/35020072; BALDWIN IT, 1983, SCIENCE, V221, P277, DOI 10.1126/science.221.4607.277; Baldwin IT, 2006, SCIENCE, V311, P812, DOI 10.1126/science.1118446; Bate NJ, 1998, PLANT J, V16, P561, DOI 10.1046/j.1365-313x.1998.00324.x; Blande JD, 2010, ECOL LETT, V13, P1172, DOI 10.1111/j.1461-0248.2010.01510.x; BRUIN J, 1992, EXPERIENTIA, V48, P525, DOI 10.1007/BF01928181; De Vos M, 2005, MOL PLANT MICROBE IN, V18, P923, DOI 10.1094/MPMI-18-0923; Dicke M, 2001, BIOCHEM SYST ECOL, V29, P979, DOI 10.1016/S0305-1978(01)00044-8; Donaldson JR, 2006, NEW PHYTOL, V169, P561, DOI 10.1111/j.1469-8137.2005.01613.x; Dong HP, 2004, PLANT PHYSIOL, V136, P3628, DOI 10.1104/pp.104.048900; Dotterl S, 2006, J CHROMATOGR A, V1113, P231, DOI 10.1016/j.chroma.2006.02.011; Dudareva N, 1996, PLANT CELL, V8, P1137, DOI 10.1105/tpc.8.7.1137; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ellis C, 2001, PLANT CELL, V13, P1025, DOI 10.1105/tpc.13.5.1025; Engelberth J, 2004, P NATL ACAD SCI USA, V101, P1781, DOI 10.1073/pnas.0308037100; FARMER EE, 1990, P NATL ACAD SCI USA, V87, P7713, DOI 10.1073/pnas.87.19.7713; Fine PVA, 2006, ECOLOGY, V87, pS150, DOI 10.1890/0012-9658(2006)87[150:TGTAHS]2.0.CO;2; FOWLER SV, 1985, AM NAT, V126, P181, DOI 10.1086/284408; Frost CJ, 2008, NEW PHYTOL, V180, P722, DOI 10.1111/j.1469-8137.2008.02599.x; Frost CJ, 2008, PLANT PHYSIOL, V146, P818, DOI 10.1104/pp.107.113027; Glazebrook J, 2001, CURR OPIN PLANT BIOL, V4, P301, DOI 10.1016/S1369-5266(00)00177-1; Glinwood R, 2004, ECOL ENTOMOL, V29, P188, DOI 10.1111/j.0307-6946.2004.00582.x; Godard KA, 2008, PHYTOCHEMISTRY, V69, P1838, DOI 10.1016/j.phytochem.2008.02.011; Heil M, 2007, P NATL ACAD SCI USA, V104, P5467, DOI 10.1073/pnas.0610266104; Heil M, 2006, ECOL LETT, V9, P813, DOI 10.1111/j.1461-0248.2006.00932.x; Heil M, 2010, TRENDS ECOL EVOL, V25, P137, DOI 10.1016/j.tree.2009.09.010; Himanen SJ, 2010, NEW PHYTOL, V186, P722, DOI 10.1111/j.1469-8137.2010.03220.x; Holopainen JK, 2004, TRENDS PLANT SCI, V9, P529, DOI 10.1016/j.tplants.2004.09.006; Kang L, 2009, ANNU REV ENTOMOL, V54, P127, DOI 10.1146/annurev.ento.54.110807.090507; Karban R, 2000, OECOLOGIA, V125, P66, DOI 10.1007/PL00008892; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kessler A, 2006, OECOLOGIA, V148, P280, DOI 10.1007/s00442-006-0365-8; Kost C, 2006, J ECOL, V94, P619, DOI 10.1111/j.1365-2745.2006.01120.x; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Paschold A, 2006, PLANT J, V45, P275, DOI 10.1111/j.1365-313X.2005.02623.x; RHOADES DF, 1983, ACS SYM SER, V208, P55; ROMAN G, 1995, GENETICS, V139, P1393; Ruther J, 2005, J CHEM ECOL, V31, P2217, DOI 10.1007/s10886-005-6413-8; Shulaev V, 1997, NATURE, V385, P718, DOI 10.1038/385718a0; Ton J, 2007, PLANT J, V49, P16, DOI 10.1111/j.1365-313X.2006.02935.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Hulten M, 2006, P NATL ACAD SCI USA, V103, P5602, DOI 10.1073/pnas.0510213103; Walker L, 1998, CURR OPIN PLANT BIOL, V1, P434, DOI 10.1016/S1369-5266(98)80269-0; Xu LH, 2002, PLANT CELL, V14, P1919, DOI 10.1105/tpc.003368; Zhang SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011064	47	11	15	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35867	10.1371/journal.pone.0035867	http://dx.doi.org/10.1371/journal.pone.0035867			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558246	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345200089
J	Hou, HL; Zhang, YY; Huang, Y; Yi, QY; Lv, L; Zhang, TW; Chen, DW; Hao, QM; Shi, QH				Hou, Heli; Zhang, Yingyin; Huang, Yun; Yi, Qiyi; Lv, Lei; Zhang, Tianwei; Chen, Dawei; Hao, Qiaomei; Shi, Qinghua			Inhibitors of Phosphatidylinositol 3 '-Kinases Promote Mitotic Cell Death in HeLa Cells	PLOS ONE			English	Article							INDUCED APOPTOSIS; OVARIAN-CANCER; AUTOPHAGY; PACLITAXEL; KINASE; PHOSPHORYLATION; CATASTROPHE; MECHANISMS; PATHWAY; 3-METHYLADENINE	The phosphatidylinositol 3-kinase (PI3K) pathway plays an important role in many biological processes, including cell cycle progression, cell growth, survival, actin rearrangement and migration, and intracellular vesicular transport. However, the involvement of the PI3K pathway in the regulation of mitotic cell death remains unclear. In this study, we treated HeLa cells with the PI3K inhibitors, 3-methyladenine (3-MA, as well as a widely used autophagy inhibitor) and wortmannin to examine their effects on cell fates using live cell imaging. Treatment with 3-MA decreased cell viability in a time-and dose-dependent manner and was associated with caspase-3 activation. Interestingly, 3-MA-induced cell death was not affected by RNA interference-mediated knockdown (KD) of beclin1 (an essential protein for autophagy) in HeLa cells, or by deletion of atg5 (an essential autophagy gene) in mouse embryonic fibroblasts (MEFs). These data indicate that cell death induced by 3-MA occurs independently of its ability to inhibit autophagy. The results from live cell imaging studies showed that the inhibition of PI3Ks increased the occurrence of lagging chromosomes and cell cycle arrest and cell death in prometaphase. Furthermore, PI3K inhibitors promoted nocodazole-induced mitotic cell death and reduced mitotic slippage. Overexpression of Akt (the downstream target of PI3K) antagonized PI3K inhibitor-induced mitotic cell death and promoted nocodazole-induced mitotic slippage. These results suggest a novel role for the PI3K pathway in regulating mitotic progression and preventing mitotic cell death and provide justification for the use of PI3K inhibitors in combination with anti-mitotic drugs to combat cancer.	[Hou, Heli; Zhang, Yingyin; Huang, Yun; Yi, Qiyi; Lv, Lei; Zhang, Tianwei; Chen, Dawei; Hao, Qiaomei; Shi, Qinghua] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China; [Zhang, Yingyin; Zhang, Tianwei; Shi, Qinghua] Hefei Natl Lab Phys Sci Microscale, Hefei, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS	Hou, HL (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China.	qshi@ustc.edu.cn	Shi, Qinghua/N-2950-2013; Huang, Yun/AGX-8953-2022; Chen, Dawei/V-4296-2019	Huang, Yun/0000-0001-5987-1319; Chen, Dawei/0000-0002-8201-0549; Yi, Qiyi/0000-0001-5143-8828; Lv, Lei/0000-0002-1889-7018; Lv, Lei/0000-0001-8132-1073	National Natural Science Foundation of China [30711120571, 30725013]; National High Technology Research and Development Program of China [2006AA02Z4B4]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by grants from National Natural Science Foundation of China (Grants 30711120571 and 30725013), and National High Technology Research and Development Program of China (2006AA02Z4B4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan LA, 2007, MOL CELL, V26, P301, DOI 10.1016/j.molcel.2007.03.019; Bacus SS, 2001, ONCOGENE, V20, P147, DOI 10.1038/sj.onc.1204062; BAGULEY BC, 1995, EUR J CANCER, V31A, P230, DOI 10.1016/0959-8049(94)00472-H; Basu A, 2003, FEBS LETT, V538, P41, DOI 10.1016/S0014-5793(03)00131-5; Bowles DW, 2011, EXPERT OPIN INV DRUG, V20, P507, DOI 10.1517/13543784.2011.562192; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; Castedo M, 2004, ONCOGENE, V23, P4362, DOI 10.1038/sj.onc.1207572; Cimini D, 2002, J CELL SCI, V115, P507; Cogswell JP, 2000, CELL GROWTH DIFFER, V11, P615; Deacon K, 2003, MOL BIOL CELL, V14, P2071, DOI 10.1091/mbc.e02-10-0653; DeLuca JG, 2002, J CELL BIOL, V159, P549, DOI 10.1083/jcb.200208159; Elis W, 2008, MOL CANCER RES, V6, P614, DOI 10.1158/1541-7786.MCR-07-0262; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Ito S, 2007, INT J ONCOL, V31, P261; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim SH, 2007, ANN NY ACAD SCI, V1095, P82, DOI 10.1196/annals.1397.012; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Mhaidat NM, 2007, CLIN CANCER RES, V13, P1308, DOI 10.1158/1078-0432.CCR-06-2216; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Niikura Y, 2007, J CELL BIOL, V178, P283, DOI 10.1083/jcb.200702134; Orth JD, 2008, MOL CANCER THER, V7, P3480, DOI 10.1158/1535-7163.MCT-08-0684; Park SJ, 2004, J BIOL CHEM, V279, P51057, DOI 10.1074/jbc.M406543200; Rao XT, 2008, MUTAT RES-FUND MOL M, V646, P41, DOI 10.1016/j.mrfmmm.2008.09.004; Reagan-Shaw S, 2006, CANCER RES, V66, P1062, DOI 10.1158/0008-5472.CAN-05-1018; Salah-Eldin AE, 2003, INT J CANCER, V103, P53, DOI 10.1002/ijc.10782; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P1153, DOI 10.1038/cdd.2008.47; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Xu R, 2011, CANCER LETT, V306, P151, DOI 10.1016/j.canlet.2011.02.042; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245	38	47	52	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35665	10.1371/journal.pone.0035665	http://dx.doi.org/10.1371/journal.pone.0035665			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545128	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343200048
J	Mas, VR; Archer, KJ; Dumur, CI; Scian, MJ; Suh, JL; King, AL; Wardius, ME; Straub, JA; Posner, MP; Brayman, K; Maluf, DG				Mas, Valeria R.; Archer, Kellie J.; Dumur, Catherine I.; Scian, Mariano J.; Suh, Jihee L.; King, Anne L.; Wardius, Megan E.; Straub, Julie A.; Posner, Marc P.; Brayman, Kenneth; Maluf, Daniel G.			Reduced Expression of Inflammatory Genes in Deceased Donor Kidneys Undergoing Pulsatile Pump Preservation	PLOS ONE			English	Article							DELAYED GRAFT FUNCTION; EXPANDED CRITERIA DONORS; COLD-STORAGE; MACHINE PERFUSION; ORGAN DONATION; TRANSPLANTATION; CREATININE; ALGORITHM; SURVIVAL	Background: The use of expanded criteria donor kidneys (ECD) had been associated with worse outcomes. Whole gene expression of pre-implantation allograft biopsies from deceased donor kidneys (DDKs) was evaluated to compare the effect of pulsatile pump preservation (PPP) vs. cold storage preservation (CSP) on standard and ECD kidneys. Methodology/Principal Findings: 99 pre-implantation DDK biopsies were studied using gene expression with GeneChips. Kidneys transplant recipients were followed post transplantation for 35.8 months (range = 24-62). The PPP group included 60 biopsies (cold ischemia time (CIT) = 1,367+/-509 minutes) and the CSP group included 39 biopsies (CIT = 1,022+/-485 minutes) (P<0.001). Donor age (42.0 +/- 14.6 vs. 34.1 +/- 14.2 years, P=0.009) and the percentage of ECD kidneys (PPP = 35% vs. CSP = 12.8%, P = 0.012) were significantly different between groups. A two-sample t-test was performed, and probe sets having a P<0.001 were considered significant. Probe set level linear models were fit using cold ischemia time and CSP/PPP as independent variables to determine significant probe sets (P<0.001) between groups after adjusting for cold ischemia time. Thus, 43 significant genes were identified (P<0.001). Over-expression of genes associated with inflammation (CD86, CD209, CLEC4, EGFR2, TFF3, among others) was observed in the CSP group. Cell-to-cell signaling and interaction, and antigen presentation were the most important pathways with genes significantly over-expressed in CSP kidneys. When the analysis was restricted to ECD kidneys, genes involved in inflammation were also differentially up-regulated in ECD kidneys undergoing CSP. However, graft survival at the end of the study was similar between groups (P=0.2). Moreover, the incidence of delayed graft function was not significant between groups. Conclusions/Significance: Inflammation was the most important up-regulated pattern associated with pre-implantation biopsies undergoing CSP even when the PPP group has a larger number of ECD kidneys. No significant difference was observed in delayed graft function incidence and graft function post-transplantation. These findings support the use of PPP in ECD donor kidneys.	[Mas, Valeria R.; Scian, Mariano J.; Suh, Jihee L.] Univ Virginia, Translat Genom Transplant Lab, Charlottesville, VA 22903 USA; [Archer, Kellie J.] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA USA; [Dumur, Catherine I.] Virginia Commonwealth Univ, Dept Pathol, Richmond, VA USA; [King, Anne L.; Posner, Marc P.] Virginia Commonwealth Univ, Transplant Div, Dept Surg, Richmond, VA USA; [Wardius, Megan E.; Straub, Julie A.; Brayman, Kenneth; Maluf, Daniel G.] Univ Virginia, Dept Surg, Transplant Div, Charlottesville, VA USA	University of Virginia; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; University of Virginia	Mas, VR (corresponding author), Univ Virginia, Translat Genom Transplant Lab, Charlottesville, VA 22903 USA.	vrm3n@Virginia.edu	Dumur, Catherine/AAH-9489-2020	Archer, Kellie/0000-0003-1555-5781; Dumur, Catherine/0000-0003-3975-9332	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK080074]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080074] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The research results included in this report were supported by a National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant, R01DK080074. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], UNOS POL 3 5 1 EXP C; Edwards EB, 2004, TRANSPLANTATION, V77, P1411, DOI 10.1097/01.TP.0000123080.19145.59; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Irish WD, 2010, AM J TRANSPLANT, V10, P2279, DOI 10.1111/j.1600-6143.2010.03179.x; Kennedy RE, 2006, BIOINFORMATICS, V22, P1272, DOI 10.1093/bioinformatics/btl108; Kennedy RE, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-154; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Matsuno N, 2010, TRANSPL P, V42, P155, DOI 10.1016/j.transproceed.2009.11.024; Matsuokaa L, 2006, AM J TRANSPLANT, V6, P1473, DOI 10.1111/j.1600-6143.2006.01323.x; McFarlane PA, 2010, SEMIN DIALYSIS, V23, P516, DOI 10.1111/j.1525-139X.2010.00740.x; Metzger RA, 2003, AM J TRANSPLANT, V3, P114, DOI 10.1034/j.1600-6143.3.s4.11.x; Moers C, 2009, NEW ENGL J MED, V360, P7, DOI 10.1056/NEJMoa0802289; Mueller TF, 2011, SEMIN IMMUNOPATHOL, V33, P185, DOI 10.1007/s00281-011-0248-x; Nace G, 2012, J INNATE IMMUN, V4, P6, DOI 10.1159/000334245; Nathan HM, 2003, AM J TRANSPLANT, V3, P29, DOI 10.1034/j.1600-6143.3.s4.4.x; Pascual J, 2008, AM J KIDNEY DIS, V52, P553, DOI 10.1053/j.ajkd.2008.06.005; Perico N, 2004, LANCET, V364, P1814, DOI 10.1016/S0140-6736(04)17406-0; Port FK, 2002, TRANSPLANTATION, V74, P1281, DOI 10.1097/00007890-200211150-00014; Port FK, 2003, AM J TRANSPLANT, V3, P7, DOI 10.1034/j.1600-6143.3.s4.2.x; Remuzzi G, 2006, NEW ENGL J MED, V354, P343, DOI 10.1056/NEJMoa052891; Schnitzler MA, 2003, TRANSPLANTATION, V75, P1940, DOI 10.1097/01.TP.0000076381.16276.1B; Schold JD, 2005, AM J TRANSPLANT, V5, P1681, DOI 10.1111/j.1600-6143.2005.00910.x; Sellers MT, 2000, CLIN TRANSPLANT, V14, P543, DOI 10.1034/j.1399-0012.2000.140605.x; Shah AP, 2008, TRANSPLANTATION, V86, P1006, DOI 10.1097/TP.0b013e318187b978; Siedlecki A, 2011, AM J TRANSPLANT, V11, P2279, DOI 10.1111/j.1600-6143.2011.03754.x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sung Randall S, 2005, Clin Transpl, P37; Treckmann J, 2011, TRANSPL INT, V24, P548, DOI 10.1111/j.1432-2277.2011.01232.x; Tullius SG, 2009, NEW ENGL J MED, V360, P78, DOI 10.1056/NEJMe0809215; VANDERVLIET JA, 1983, ARCH SURG-CHICAGO, V118, P1166; Wight JP, 2003, CLIN TRANSPLANT, V17, P293, DOI 10.1034/j.1399-0012.2003.00077.x; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Yarlagadda SG, 2009, NEPHROL DIAL TRANSPL, V24, P1039, DOI 10.1093/ndt/gfn667; Zhang L, 2002, J MOL BIOL, V317, P225, DOI 10.1006/jmbi.2001.5350	34	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35526	10.1371/journal.pone.0035526	http://dx.doi.org/10.1371/journal.pone.0035526			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545113	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343200033
J	Ramos-Mejia, V; Montes, R; Bueno, C; Ayllon, V; Real, PJ; Rodriguez, R; Menendez, P				Ramos-Mejia, Veronica; Montes, Rosa; Bueno, Clara; Ayllon, Veronica; Real, Pedro J.; Rodriguez, Rene; Menendez, Pablo			Residual Expression of the Reprogramming Factors Prevents Differentiation of iPSC Generated from Human Fibroblasts and Cord Blood CD34+Progenitors	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; LEUKAPHERESIS PRODUCTS; HEMATOPOIETIC-CELLS; PERIPHERAL-BLOOD; INDUCTION; CD34(+); TRANSPLANTATION; TRANSDUCTION; DERIVATION; EFFICIENCY	Human induced pluripotent stem cells (hiPSC) have been generated from different tissues, with the age of the donor, tissue source and specific cell type influencing the reprogramming process. Reprogramming hematopoietic progenitors to hiPSC may provide a very useful cellular system for modelling blood diseases. We report the generation and complete characterization of hiPSCs from human neonatal fibroblasts and cord blood (CB)-derived CD34+ hematopoietic progenitors using a single polycistronic lentiviral vector containing an excisable cassette encoding the four reprogramming factors Oct4, Klf4, Sox2 and c-myc (OKSM). The ectopic expression of OKSM was fully silenced upon reprogramming in some hiPSC clones and was not reactivated upon differentiation, whereas other hiPSC clones failed to silence the transgene expression, independently of the cell type/tissue origin. When hiPSC were induced to differentiate towards hematopoietic and neural lineages those hiPSC which had silenced OKSM ectopic expression displayed good hematopoietic and early neuroectoderm differentiation potential. In contrast, those hiPSC which failed to switch off OKSM expression were unable to differentiate towards either lineage, suggesting that the residual expression of the reprogramming factors functions as a developmental brake impairing hiPSC differentiation. Successful adenovirus-based Cre-mediated excision of the provirus OKSM cassette in CB-derived CD34+ hiPSC with residual transgene expression resulted in transgene-free hiPSC clones with significantly improved differentiation capacity. Overall, our findings confirm that residual expression of reprogramming factors impairs hiPSC differentiation.	[Ramos-Mejia, Veronica; Montes, Rosa; Bueno, Clara; Ayllon, Veronica; Real, Pedro J.; Rodriguez, Rene; Menendez, Pablo] Univ Granada Junta de Andalucia Genom, Ctr Pfizer, Oncol Res GENyO, Granada, Spain	Pfizer; University of Granada	Ramos-Mejia, V (corresponding author), Univ Granada Junta de Andalucia Genom, Ctr Pfizer, Oncol Res GENyO, Granada, Spain.	veronica.ramos@genyo.es; pablo.menendez@genyo.es	Bujan, Pablo Menendez/W-3736-2017; Ayllon, Veronica/L-7069-2014; Ramos-Mejia, Veronica/C-4338-2017; Rodriguez, Rene/P-2168-2018; Real, Pedro J./ABH-3493-2021; Real, Pedro J./K-2994-2014	Bujan, Pablo Menendez/0000-0001-9372-1007; Ayllon, Veronica/0000-0002-7322-9282; Ramos-Mejia, Veronica/0000-0002-8013-4273; Rodriguez, Rene/0000-0002-0768-7306; Real, Pedro J./0000-0001-7968-5353	Junta de Andalucia/Fondo Europeo de Desarrollo Regional [P08-CTS-3678]; Fondo de Investigaciones Sanitarias/Fondo Europeo de Desarrollo Regional [PI10/00449, CP07/00059, PI11/00119, CP09/0063]; Ministerio Espanol de Innovacion y Ciencia [PLE-2009-0111]; Spanish Association Against Cancer [CI110023]; Incoming International Marie Curie Fellowship [PIIF-GA-2009-236430]	Junta de Andalucia/Fondo Europeo de Desarrollo Regional; Fondo de Investigaciones Sanitarias/Fondo Europeo de Desarrollo Regional; Ministerio Espanol de Innovacion y Ciencia; Spanish Association Against Cancer; Incoming International Marie Curie Fellowship	P.M. was supported The Junta de Andalucia/Fondo Europeo de Desarrollo Regional (P08-CTS-3678), The Fondo de Investigaciones Sanitarias/Fondo Europeo de Desarrollo Regional (PI10/00449), The Ministerio Espanol de Innovacion y Ciencia (PLE-2009-0111) and The Spanish Association Against Cancer (CI110023). V. R-M: was supported by Incoming International Marie Curie Fellowship (PIIF-GA-2009-236430). C. B & P.J.R. were supported by the The Fondo de Investigaciones Sanitarias/Fondo Europeo de Desarrollo Regional (CP07/00059 and PI11/00119 and CP09/0063, respectively). R. R. was supported by The Spanish Association Against Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barroso-delJesus A, 2008, MOL CELL BIOL, V28, P6609, DOI 10.1128/MCB.00398-08; Broxmeyer HE, 2010, CELL STEM CELL, V6, P21, DOI 10.1016/j.stem.2009.12.008; Bueno C, 2008, LEUKEMIA, V22, P1475, DOI 10.1038/leu.2008.134; Bueno C, 2012, CELL RES IN PRESS; Bueno C, 2010, STEM CELL REV REP, V6, P215, DOI 10.1007/s12015-010-9118-5; Bueno C, 2009, CARCINOGENESIS, V30, P1628, DOI 10.1093/carcin/bgp169; Calvanese V, 2012, NUCLEIC ACIDS RES, V40, P116, DOI 10.1093/nar/gkr685; Calvanese V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003294; Catalina P, 2009, LEUKEMIA RES, V33, P980, DOI 10.1016/j.leukres.2008.08.028; Catalina P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-76; Catalina P, 2007, CELL BIOL INT, V31, P861, DOI 10.1016/j.cellbi.2007.03.012; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Cortes JL, 2008, STEM CELLS DEV, V17, P255, DOI 10.1089/scd.2007.0157; Cortes JL, 2009, HUM REPROD, V24, P1844, DOI 10.1093/humrep/dep107; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Fussner E, 2011, EMBO J, V30, P1778, DOI 10.1038/emboj.2011.96; Giorgetti A, 2009, CELL STEM CELL, V5, P353, DOI 10.1016/j.stem.2009.09.008; Gutierrez-Aranda I, 2010, STEM CELLS, V28, P1568, DOI 10.1002/stem.471; Haase A, 2009, CELL STEM CELL, V5, P434, DOI 10.1016/j.stem.2009.08.021; Hanley PJ, 2010, CYTOTHERAPY, V12, P713, DOI 10.3109/14653249.2010.517518; Hasegawa K, 2010, STEM CELLS, V28, P1338, DOI 10.1002/stem.466; Hotta A, 2008, J CELL BIOCHEM, V105, P940, DOI 10.1002/jcb.21912; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim PG, 2009, CYTOTHERAPY, V11, P980, DOI 10.3109/14653240903348319; Liang GY, 2010, J BIOL CHEM, V285, P25516, DOI 10.1074/jbc.M110.142059; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Menendez P, 2004, MOL THER, V10, P1109, DOI 10.1016/j.ymthe.2004.08.016; Menendez P, 2006, CYTOTHERAPY, V8, P530, DOI 10.1080/14653240601026654; Menendez P, 2005, CURR GENE THER, V5, P375, DOI 10.2174/1566523054546198; Menendez P, 2002, BRIT J HAEMATOL, V119, P135, DOI 10.1046/j.1365-2141.2002.03794.x; Menendez P, 2002, TRANSFUSION, V42, P1159, DOI 10.1046/j.1537-2995.2002.00190.x; Menendez P, 2001, LEUKEMIA, V15, P430, DOI 10.1038/sj.leu.2402051; Menendez P, 2001, J BIOL REG HOMEOS AG, V15, P53; Menendez P, 2009, J EXP MED, V206, P3131, DOI 10.1084/jem.20091050; Montes R, 2011, BLOOD, V117, P4746, DOI 10.1182/blood-2010-12-322230; Montes R, 2009, CELL RES, V19, P698, DOI 10.1038/cr.2009.35; Muller LUW, 2009, MOL THER, V17, P947, DOI 10.1038/mt.2009.72; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Ramos-Mejia V, 2012, STEM CELLS IN PRESS; Ramos-Mejia V, 2010, MOL THER, V18, P2173, DOI 10.1038/mt.2010.179; RAMOSMEJIA V, 2011, STEM CELLS DEV; Rastegar M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006810; Rubio R, 2010, CANCER RES, V70, P4185, DOI 10.1158/0008-5472.CAN-09-4640; Sanchez L, 2012, TISSUE EN C IN PRESS; Shojaei F, 2008, EXP HEMATOL, V36, P1436, DOI 10.1016/j.exphem.2008.06.001; Sommer CA, 2010, STEM CELLS, V28, P64, DOI 10.1002/stem.255; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Subramanyam D, 2009, NAT BIOTECHNOL, V27, P997, DOI 10.1038/nbt1109-997; Suhr ST, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008124, 10.1371/journal.pone.0014095]; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takenaka C, 2010, EXP HEMATOL, V38, P154, DOI 10.1016/j.exphem.2009.11.003; Wang L, 2005, EXP HEMATOL, V33, P987, DOI 10.1016/j.exphem.2005.06.002; Wang LS, 2005, J EXP MED, V201, P1603, DOI 10.1084/jem.20041888; Wang LS, 2004, IMMUNITY, V21, P31, DOI 10.1016/j.immuni.2004.06.006; Ye ZH, 2009, BLOOD, V114, P5473, DOI 10.1182/blood-2009-04-217406; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	62	52	55	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35824	10.1371/journal.pone.0035824	http://dx.doi.org/10.1371/journal.pone.0035824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545141	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343200061
J	Chen, HF; Lin, LN; Chen, YX; Wan, JX; Luo, J; Zhang, CZ; Li, XJ; Hu, YM; Mai, JR; Chen, W; Lin, ZN; Lin, YC				Chen, Hui-Feng; Lin, Li-Na; Chen, Yu-Xi; Wan, Jian-Xin; Luo, Jie; Zhang, Chen-Zi; Li, Xiao-Jie; Hu, Yao-Ming; Mai, Jian-Rong; Chen, Wen; Lin, Zhong-Ning; Lin, Yu-Chun			Identification and Functional Analysis of Variant Haplotypes in the 5 '-Flanking Region of Protein Phosphatase 2A-B delta Gene	PLOS ONE			English	Article							REGULATORY SUBUNIT; GREATWALL KINASE; PP2A COMPLEXES; HAN CHINESE; B-SUBUNITS; 2A; FAMILY; TRANSCRIPTION; APOPTOSIS; CLONING	Serine-threonine protein phosphatase 2A (PP2A) is a trimeric holoenzyme that plays an integral role in the regulation of cell growth, differentiation, and apoptosis. The substrate specificity and (sub) cellular localization of the PP2A holoenzymes are highly regulated by interaction with a family of regulatory B subunits (PP2A-Bs). The regulatory subunit PP2A-B/PR55 delta (PP2A-B delta) is involving in the dephosphorylation of PP2A substrates and is crucial for controlling entry into and exit from mitosis. The molecular mechanisms involved in the regulation of expression of PP2A-B delta gene (PPP2R2D) remain largely unknown. To explore genetic variations in the 5'-flanking region of PPP2R2D gene as well as their frequent haplotypes in the Han Chinese population and determine whether such variations have an impact on transcriptional activity, DNA samples were collected from 70 healthy Chinese donors and sequenced for identifying genetic variants in the 5'-flanking region of PPP2R2D. Four genetic variants were identified in the 1836 bp 5'-flanking region of PPP2R2D. Linkage disequilibrium (LD) patterns and haplotype profiles were constructed for the genetic variants. Using serially truncated human PPP2R2D promoter luciferase constructs, we found that a 601 bp (-540 nt to +61 nt) fragment constitutes the core promoter region. The subcloning of individual 5'-flanking fragment revealed the existence of three haplotypes in the distal promoter of PPP2R2D. The luciferase reporter assay showed that different haplotypes exhibited distinct promoter activities. The EMSA revealed that the -462 G>A variant influences DNA-protein interactions involving the nuclear factor 1 (NF1). In vitro reporter gene assay indicated that cotransfection of NF1/B expression plasmid could positively regulate the activity of PPP2R2D proximal promoter. Introduction of exogenous NF1/B expression plasmid further confirmed that the NF1 involves in the regulation of PPP2R2D gene expression. Our findings suggest that functional genetic variants and their haplotypes in the 5'-flanking region of PPP2R2D are critical for transcriptional regulation of PP2A-B delta.	[Chen, Hui-Feng; Lin, Li-Na; Chen, Yu-Xi; Luo, Jie; Zhang, Chen-Zi; Li, Xiao-Jie; Hu, Yao-Ming; Mai, Jian-Rong; Chen, Wen; Lin, Zhong-Ning; Lin, Yu-Chun] Sun Yat Sen Univ, Sch Publ Hlth, Fac Prevent Med, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Wan, Jian-Xin] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Med Inspect, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Chen, HF (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Fac Prevent Med, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou 510275, Guangdong, Peoples R China.	linzhn@mail.sysu.edu.cn; linych@mail.sysu.edu.cn			National Natural Science Foundation of China [NSFC 81172705, 81072334, 30771832]; Chinese Ministry of Education [109126]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20090171110052]; Natural Science Foundation of Guangdong Province [S2011020002769]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by National Natural Science Foundation of China (NSFC 81172705, 81072334, 30771832), the Key Project of Chinese Ministry of Education (No. 109126), the Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 20090171110052) and the Key Project of Natural Science Foundation of Guangdong Province (S2011020002769). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA N, 1995, EUR J BIOCHEM, V230, P766, DOI 10.1111/j.1432-1033.1995.tb20619.x; Chen CM, 2009, AM J MED GENET B, V150B, P124, DOI 10.1002/ajmg.b.30785; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Chen W, 2005, CANCER RES, V65, P8183, DOI 10.1158/0008-5472.CAN-05-1103; Clifford RJ, 2004, ANN NY ACAD SCI, V1020, P101, DOI 10.1196/annals.1310.011; Dagda RK, 2005, J BIOL CHEM, V280, P27375, DOI 10.1074/jbc.M503693200; Dagda RK, 2003, J BIOL CHEM, V278, P24976, DOI 10.1074/jbc.M302832200; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Dupont WD, 2010, CANCER, V116, P8, DOI 10.1002/cncr.24702; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Gharbi-Ayachi A, 2010, SCIENCE, V330, P1673, DOI 10.1126/science.1197048; Grochola LF, 2009, CLIN CANCER RES, V15, P6301, DOI 10.1158/1078-0432.CCR-09-0797; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Hagedorn C, 2009, ARTERIOSCL THROM VAS, V29, P1638, DOI 10.1161/ATVBAHA.109.193532; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; Kimura R, 2011, NEUROSCI LETT, V487, P354, DOI 10.1016/j.neulet.2010.10.055; KRUSE U, 1994, J MOL BIOL, V238, P860, DOI 10.1006/jmbi.1994.1343; Lazarus R, 2002, IMMUNOL REV, V190, P9, DOI 10.1034/j.1600-065X.2002.19002.x; Lechward K, 2001, ACTA BIOCHIM POL, V48, P921; Lin CH, 2010, HUM GENET, V128, P205, DOI 10.1007/s00439-010-0843-2; Lin ZN, 2008, HUM MUTAT, V29, P113, DOI 10.1002/humu.20610; MAYER RE, 1991, BIOCHEMISTRY-US, V30, P3589, DOI 10.1021/bi00229a001; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; Mochida S, 2010, SCIENCE, V330, P1670, DOI 10.1126/science.1195689; Mochida S, 2009, EMBO J, V28, P2777, DOI 10.1038/emboj.2009.238; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Plasari G, 2009, MOL CELL BIOL, V29, P6006, DOI 10.1128/MCB.01921-08; Ruediger R, 2001, ONCOGENE, V20, P10, DOI 10.1038/sj.onc.1204059; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Sablina AA, 2010, CANCER RES, V70, P10474, DOI 10.1158/0008-5472.CAN-10-2855; SANTORO C, 1988, NATURE, V334, P218, DOI 10.1038/334218a0; Schonthal AH, 2001, CANCER LETT, V170, P1, DOI 10.1016/S0304-3835(01)00561-4; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; Sontag E, 1996, NEURON, V17, P1201, DOI 10.1016/S0896-6273(00)80250-0; Strack S, 1999, FEBS LETT, V460, P462, DOI 10.1016/S0014-5793(99)01377-0; Strack S, 2002, J BIOL CHEM, V277, P20750, DOI 10.1074/jbc.M202992200; Strack S, 1998, J COMP NEUROL, V392, P515; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Turowski P, 1999, MOL BIOL CELL, V10, P1997, DOI 10.1091/mbc.10.6.1997; Van Kanegan MJ, 2005, J BIOL CHEM, V280, P36029, DOI 10.1074/jbc.M506986200; Vazquez A, 2011, INT J CANCER, V128, P2335, DOI 10.1002/ijc.25582; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; Voets E, 2010, CELL CYCLE, V9, P3591, DOI 10.4161/cc.9.17.12832; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Zhao Y, 1997, J BIOL CHEM, V272, P8256, DOI 10.1074/jbc.272.13.8256; ZOLNIEROWICZ S, 1994, BIOCHEMISTRY-US, V33, P11858, DOI 10.1021/bi00205a023	49	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35524	10.1371/journal.pone.0035524	http://dx.doi.org/10.1371/journal.pone.0035524			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539979	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341000045
J	Krober, W; Bohnke, M; Welk, E; Wirth, C; Bruelheide, H				Kroeber, Wenzel; Boehnke, Martin; Welk, Erik; Wirth, Christian; Bruelheide, Helge			Leaf Trait-Environment Relationships in a Subtropical Broadleaved Forest in South-East China	PLOS ONE			English	Article							BROAD-LEAVED FOREST; FUNCTIONAL TRAITS; RAIN-FOREST; LIMITING SIMILARITY; PLANT-COMMUNITIES; TRADE-OFF; LIFE-SPAN; GROWTH; DIVERSITY; DECOMPOSABILITY	Although trait analyses have become more important in community ecology, trait-environment correlations have rarely been studied along successional gradients. We asked which environmental variables had the strongest impact on intraspecific and interspecific trait variation in the community and which traits were most responsive to the environment. We established a series of plots in a secondary forest in the Chinese subtropics, stratified by successional stages that were defined by the time elapsed since the last logging activities. On a total of 27 plots all woody plants were recorded and a set of individuals of every species was analysed for leaf traits, resulting in a trait matrix of 26 leaf traits for 122 species. A Fourth Corner Analysis revealed that the mean values of many leaf traits were tightly related to the successional gradient. Most shifts in traits followed the leaf economics spectrum with decreasing specific leaf area and leaf nutrient contents with successional time. Beside succession, few additional environmental variables resulted in significant trait relationships, such as soil moisture and soil C and N content as well as topographical variables. Not all traits were related to the leaf economics spectrum, and thus, to the successional gradient, such as stomata size and density. By comparing different permutation models in the Fourth Corner Analysis, we found that the trait-environment link was based more on the association of species with the environment than of the communities with species traits. The strong species-environment association was brought about by a clear gradient in species composition along the succession series, while communities were not well differentiated in mean trait composition. In contrast, intraspecific trait variation did not show close environmental relationships. The study confirmed the role of environmental trait filtering in subtropical forests, with traits associated with the leaf economics spectrum being the most responsive ones.	[Kroeber, Wenzel; Boehnke, Martin; Welk, Erik; Bruelheide, Helge] Univ Halle Wittenberg, Inst Biol Geobot, Halle, Germany; [Kroeber, Wenzel; Boehnke, Martin; Welk, Erik; Bruelheide, Helge] Univ Halle Wittenberg, Bot Garden, Halle, Germany; [Wirth, Christian] Univ Leipzig, Inst Biol Special Bot & Funct Biodivers Res 1, Leipzig, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Leipzig University	Krober, W (corresponding author), Univ Halle Wittenberg, Inst Biol Geobot, Halle, Germany.	helge.bruelheide@botanik.uni-halle.de	Wirth, Christian/A-4446-2016; Bruelheide, Helge/G-3907-2013; WELK, Erik/AGL-4971-2022	Bruelheide, Helge/0000-0003-3135-0356; Welk, Erik/0000-0002-2685-3795	German Science Foundation (DFG) [FOR 891/1, BR 1698/9-1]; Sino-German Centre for Research Promotion in Beijing [GZ 524, 592, 698, 699]	German Science Foundation (DFG)(German Research Foundation (DFG)); Sino-German Centre for Research Promotion in Beijing	The study was funded by the German Science Foundation (DFG FOR 891/1, BR 1698/9-1, www.dfg.de) and by travel grants by the Sino-German Centre for Research Promotion in Beijing (GZ 524, 592, 698 and 699, http://www.sinogermanscience.org.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2007, ECOL LETT, V10, P135, DOI 10.1111/j.1461-0248.2006.01006.x; Aiba S, 2001, FOREST ECOL MANAG, V140, P163, DOI 10.1016/S0378-1127(00)00325-X; Alexander RM, 1997, NATURE, V386, P327, DOI 10.1038/386327a0; Alonso D, 2006, TRENDS ECOL EVOL, V21, P451, DOI 10.1016/j.tree.2006.03.019; [Anonymous], 1954, VEGETATIO; BEERLING DJ, 1993, BIOL J LINN SOC, V48, P343, DOI 10.1111/j.1095-8312.1993.tb02096.x; Belyea LR, 1999, OIKOS, V86, P402, DOI 10.2307/3546646; Bohnke M, 2012, TREES-STRUCT FUNCT, V26, P641, DOI 10.1007/s00468-011-0632-0; Bohnke M, 2012, ECOSPHERE UNPUB; Bruelheide H, 2011, ECOL MONOGR, V81, P25, DOI 10.1890/09-2172.1; Canas MS, 1997, J ENVIRON MANAGE, V49, P167, DOI 10.1006/jema.1995.0090; CARPENTER SB, 1975, CAN J BOT, V53, P1153, DOI 10.1139/b75-137; Cavender-Bares J, 2005, NEW PHYTOL, V168, P597, DOI 10.1111/j.1469-8137.2005.01555.x; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Deng F, 2008, FOREST ECOL MANAG, V255, P1820, DOI 10.1016/j.foreco.2007.12.004; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Dray S, 2008, ECOLOGY, V89, P3400, DOI 10.1890/08-0349.1; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; FANG J-Y, 1988, Ecological Research, V3, P37, DOI 10.1007/BF02348693; Fortunel C, 2009, ECOLOGY, V90, P598, DOI 10.1890/08-0418.1; Fyllas NM, 2009, BIOGEOSCIENCES, V6, P2677, DOI 10.5194/bg-6-2677-2009; GINDEL I, 1969, ECOLOGY, V50, P263, DOI 10.2307/1934854; Grime JP, 2006, J VEG SCI, V17, P255, DOI 10.1111/j.1654-1103.2006.tb02444.x; Guariguata MR, 2001, FOREST ECOL MANAG, V148, P185, DOI 10.1016/S0378-1127(00)00535-1; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hu Z, 2008, FRONT BIOL CHINA, V3, P45, DOI DOI 10.1007/S11515-008-0011-4; Hubbell Stephen P., 2001, V32, pi; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; INOUYE RS, 1987, ECOLOGY, V68, P12, DOI 10.2307/1938801; Kitao M, 1999, PHOTOSYNTHETICA, V36, P31, DOI 10.1023/A:1007058418199; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Kouwenberg LLR, 2007, REV MINERAL GEOCHEM, V66, P215, DOI 10.2138/rmg.2007.66.9; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Kurokawa H, 2008, ECOLOGY, V89, P2645, DOI 10.1890/07-1352.1; Lambers H., 2008, PLANT PHYSL ECOLOGY; Lang AC, 2010, FOREST ECOL MANAG, V260, P1708, DOI 10.1016/j.foreco.2010.08.015; Lebrija-Trejos E, 2010, ECOLOGY, V91, P386, DOI 10.1890/08-1449.1; Legendre P, 1997, ECOLOGY, V78, P547; Legendre P, 2009, ECOLOGY, V90, P663, DOI 10.1890/07-1880.1; Leps J, 2011, ECOGRAPHY, V34, P856, DOI 10.1111/j.1600-0587.2010.06904.x; Lusk CH, 2011, J ECOL, V99, P491, DOI 10.1111/j.1365-2745.2010.01766.x; Lusk CH, 2007, NEW PHYTOL, V176, P764, DOI 10.1111/j.1469-8137.2007.02264.x; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Mason NWH, 2011, J VEG SCI, V22, P6, DOI 10.1111/j.1654-1103.2010.01223.x; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; McGlone MS, 2004, NEW ZEAL J BOT, V42, P1, DOI 10.1080/0028825X.2004.9512887; MOORE P, 1980, NATURE, V285, P535, DOI 10.1038/285535a0; Mutke J., 2005, Plant diversity and complexity patterns: local, regional and global dimensions. Proceedings of an International Symposium held at the Royal Danish Academy of Sciences and Letters in Copenhagen, Denmark, 25-28 May, 2003, P521; Oksanen JF, 2010, VEGAN COMMUNITY ECOL; Ordonez JC, 2009, GLOBAL ECOL BIOGEOGR, V18, P137, DOI 10.1111/j.1466-8238.2008.00441.x; PACALA SW, 1994, AM NAT, V143, P222, DOI 10.1086/285602; Pavoine S, 2011, J ECOL, V99, P165, DOI 10.1111/j.1365-2745.2010.01743.x; Peppe DJ, 2011, NEW PHYTOL, V190, P724, DOI 10.1111/j.1469-8137.2010.03615.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Poorter L, 2008, ECOLOGY, V89, P1908, DOI 10.1890/07-0207.1; Poorter L, 2004, PLANT BIOLOGY, V6, P746, DOI 10.1055/s-2004-821269; POPMA J, 1988, OECOLOGIA, V75, P625, DOI 10.1007/BF00776429; Reich PB, 1999, ECOLOGY, V80, P1955, DOI 10.1890/0012-9658(1999)080[1955:GOLTRA]2.0.CO;2; REICH PB, 1992, ECOL MONOGR, V62, P365, DOI 10.2307/2937116; Sasaki T, 2009, ECOLOGY, V90, P2598, DOI 10.1890/08-1850.1; Sterck FJ, 2006, AM NAT, V167, P758, DOI 10.1086/503056; Tomasevic M, 2011, ECOL INDIC, V11, P1689, DOI 10.1016/j.ecolind.2011.04.017; Valiente-Banuet A, 2007, ECOL LETT, V10, P1029, DOI 10.1111/j.1461-0248.2007.01100.x; Violle C, 2009, J PLANT ECOL-UK, V2, P87, DOI 10.1093/jpe/rtp007; von Oheimb G, 2011, FOREST ECOL MANAG, V261, P499, DOI 10.1016/j.foreco.2010.10.035; Wang XH, 2007, FOREST ECOL MANAG, V245, P76, DOI 10.1016/j.foreco.2007.03.043; Webb CT, 2010, ECOL LETT, V13, P267, DOI 10.1111/j.1461-0248.2010.01444.x; Weiher E, 1999, J VEG SCI, V10, P609, DOI 10.2307/3237076; Weiher E., 1999, ECOLOGICAL ASSEMBLY, DOI DOI 10.1017/CBO9780511542237; Wilson PJ, 1999, NEW PHYTOL, V143, P155, DOI 10.1046/j.1469-8137.1999.00427.x; Wirth C, 2009, ECOL STUD-ANAL SYNTH, V207, P465, DOI 10.1007/978-3-540-92706-8_21; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright IJ, 2002, NEW PHYTOL, V155, P403, DOI 10.1046/j.1469-8137.2002.00479.x; Wright SJ, 2011, ECOLOGY, V92, P1616, DOI 10.1890/10-1558.1; Wright S Joseph, 2010, Ecology, V91, P3664, DOI 10.1890/09-2335.1; Yu MingJian, 2001, Journal of Zhejiang University (Agriculture and Life Sciences), V27, P375; Yuan ZYY, 2009, GLOBAL ECOL BIOGEOGR, V18, P532, DOI 10.1111/j.1466-8238.2009.00474.x	78	58	61	6	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35742	10.1371/journal.pone.0035742	http://dx.doi.org/10.1371/journal.pone.0035742			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539999	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341000065
J	Kushawaha, PK; Gupta, R; Tripathi, CDP; Sundar, S; Dube, A				Kushawaha, Pramod Kumar; Gupta, Reema; Tripathi, Chandra Dev Pati; Sundar, Shyam; Dube, Anuradha			Evaluation of Leishmania donovani Protein Disulfide Isomerase as a Potential Immunogenic Protein/Vaccine Candidate against Visceral Leishmaniasis	PLOS ONE			English	Article							INTERFERON-GAMMA PRODUCTION; CONFERS PROTECTIVE IMMUNITY; NITRIC-OXIDE SYNTHASE; INDIAN KALA-AZAR; BALB/C MICE; IFN-GAMMA; T-CELLS; CUTANEOUS LEISHMANIASIS; SODIUM STIBOGLUCONATE; PENTAVALENT ANTIMONY	In Leishmania species, Protein disulfide isomerase (PDI) - a redox chaperone, is reported to be involved in its virulence and survival. This protein has also been identified, through proteomics, as a Th1 stimulatory protein in the soluble lysate of a clinical isolate of Leishmania donovani (LdPDI). In the present study, the molecular characterization of LdPDI was carried out and the immunogenicity of recombinant LdPDI (rLdPDI) was assessed by lymphocyte proliferation assay (LTT), nitric oxide (NO) production, estimation of Th1 cytokines (IFN-gamma and IL-12) as well as IL-10 in PBMCs of cured/endemic/infected Leishmania patients and cured L. donovani infected hamsters. A significantly higher proliferative response against rLdPDI as well as elevated levels of IFN-gamma and IL-12 were observed. The level of IL-10 was found to be highly down regulated in response to rLdPDI. A significant increase in the level of NO production in stimulated hamster macrophages as well as IgG2 antibody and a low level of IgG1 in cured patient's serum was observed. Higher level of IgG2 antibody indicated its Th1 stimulatory potential. The efficacy of pcDNA-LdPDI construct was further evaluated for its prophylactic potential. Vaccination with this construct conferred remarkably good prophylactic efficacy (similar to 90%) and generated a robust cellular immune response with significant increases in the levels of iNOS transcript as well as TNF-alpha, IFN-gamma and IL-12 cytokines. This was further supported by the high level of IgG2 antibody in vaccinated animals. The in vitro as well as in vivo results thus indicate that LdPDI may be exploited as a potential vaccine candidate against visceral Leishmaniasis (VL).	[Kushawaha, Pramod Kumar; Gupta, Reema; Tripathi, Chandra Dev Pati; Dube, Anuradha] Cent Drug Res Inst, Div Parasitol, Lucknow 226001, Uttar Pradesh, India; [Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Dept Med, Varanasi 221005, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Banaras Hindu University (BHU)	Kushawaha, PK (corresponding author), Cent Drug Res Inst, Div Parasitol, Lucknow 226001, Uttar Pradesh, India.	anuradha_dube@hotmail.com	TRIPATHI, CHANDRA DEV/S-5617-2019	Dube, Anuradha/0000-0002-5122-400X	Department of Biotechnology, New Delhi; CSIR-CDRI [SIP-0026]; University Grants Commission, New Delhi, India; UGC, New Delhi	Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India); CSIR-CDRI(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, New Delhi, India(University Grants Commission, India); UGC, New Delhi(University Grants Commission, India)	This work was supported by Department of Biotechnology, New Delhi and CSIR-CDRI's Supra-institutional network project (SIP-0026). PKK and RG are the recipients of fellowships from University Grants Commission, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We express our sincere gratitude to the Director CDRI for his keen interest and for providing facilities for the experiments. Financial support for senior research fellowship to P.K. and R.G. from UGC, New Delhi is gratefully acknowledged. This has CDRI communication number - 8225.	Afrin F, 2002, INFECT IMMUN, V70, P6697, DOI 10.1128/IAI.70.12.6697-6706.2002; Ali N, 1997, J PARASITOL, V83, P70, DOI 10.2307/3284319; [Anonymous], 1998, TDR News, P2; Armijos RX, 2004, VACCINE, V22, P1320, DOI 10.1016/j.vaccine.2003.06.002; ASSREUY J, 1994, EUR J IMMUNOL, V24, P672, DOI 10.1002/eji.1830240328; Bacellar O, 1996, J INFECT DIS, V173, P1515, DOI 10.1093/infdis/173.6.1515; Basu R, 2005, J IMMUNOL, V174, P7160, DOI 10.4049/jimmunol.174.11.7160; BELOSEVIC M, 1989, J IMMUNOL, V143, P266; Ben Achour Y, 2002, INFECT IMMUN, V70, P3576, DOI 10.1128/IAI.70.7.3576-3585.2002; Bhowmick S, 2007, VACCINE, V25, P6544, DOI 10.1016/j.vaccine.2007.05.042; Bretscher P A, 1997, Behring Inst Mitt, P153; BURNS JM, 1991, J IMMUNOL, V146, P742; Campos-Neto A, 2001, INFECT IMMUN, V69, P4103, DOI 10.1128/IAI.69.6.4103-4108.2001; Carter KC, 2003, ANTIMICROB AGENTS CH, V47, P1529, DOI 10.1128/AAC.47.5.1529-1535.2003; CARVALHO EM, 1992, J INFECT DIS, V165, P535, DOI 10.1093/infdis/165.3.535; CARVALHO EM, 1981, INFECT IMMUN, V33, P498, DOI 10.1128/IAI.33.2.498-500.1981; CARVALHO EM, 1989, J CLIN INVEST, V83, P860, DOI 10.1172/JCI113969; COX GJM, 1993, J VIROL, V67, P5664, DOI 10.1128/JVI.67.9.5664-5667.1993; CROFT SL, 1988, T ROY SOC TROP MED H, V82, P856, DOI 10.1016/0035-9203(88)90017-X; Desjeux P, 2003, ANN TROP MED PARASIT, V97, P3, DOI 10.1179/000349803225002499; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; DING AH, 1988, J IMMUNOL, V141, P2407; Donnelly JJ, 1997, ANNU REV IMMUNOL, V15, P617, DOI 10.1146/annurev.immunol.15.1.617; Dube A, 2005, PARASITOL RES, V96, P216, DOI 10.1007/s00436-005-1339-1; Fernandes AP, 2008, VACCINE, V26, P5888, DOI 10.1016/j.vaccine.2008.05.095; GALVAOCASTRO B, 1984, CLIN EXP IMMUNOL, V56, P58; Garg R, 2006, VACCINE, V24, P2900, DOI 10.1016/j.vaccine.2005.12.053; Garg R, 2005, CLIN EXP IMMUNOL, V140, P149, DOI 10.1111/j.1365-2249.2005.02745.x; GHALIB HW, 1993, J CLIN INVEST, V92, P324, DOI 10.1172/JCI116570; GHOSE AC, 1980, CLIN EXP IMMUNOL, V40, P318; GREGORY RL, 1987, INFECT IMMUN, V55, P2409, DOI 10.1128/IAI.55.10.2409-2415.1987; Gupta SK, 2007, PROTEOMICS, V7, P816, DOI 10.1002/pmic.200600725; Gurunathan S, 1997, J EXP MED, V186, P1137, DOI 10.1084/jem.186.7.1137; Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2; HOLADAY BJ, 1991, J IMMUNOL, V147, P1653; HOWARD JG, 1984, PHILOS T R SOC B, V307, P87, DOI 10.1098/rstb.1984.0111; Jaafari MR, 2006, VACCINE, V24, P5708, DOI 10.1016/j.vaccine.2006.04.062; KARP CL, 1993, J CLIN INVEST, V91, P1644, DOI 10.1172/JCI116372; Kemp K, 1999, CLIN EXP IMMUNOL, V116, P500; Kemp Kare, 2000, Archivum Immunologiae et Therapiae Experimentalis, V48, P173; KEMP M, 1993, INFECT IMMUN, V61, P1069, DOI 10.1128/IAI.61.3.1069-1073.1993; Khoshgoo N, 2008, VACCINE, V26, P5822, DOI 10.1016/j.vaccine.2008.08.065; Kimura T, 2005, J BIOL CHEM, V280, P31438, DOI 10.1074/jbc.M503377200; Kumari S, 2008, VACCINE; Kumari S, 2008, VACCINE, V26, P4813, DOI 10.1016/j.vaccine.2008.06.102; Kumari S, 2008, PROTEOM CLIN APPL, V2, P372, DOI 10.1002/prca.200780017; LIEW FY, 1990, IMMUNOLOGY, V71, P556; LIEW FY, 1990, J IMMUNOL, V145, P4306; LIEW FY, 1991, EUR J IMMUNOL, V21, P3009, DOI 10.1002/eji.1830211216; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Meek B, 2002, FEBS LETT, V522, P104, DOI 10.1016/S0014-5793(02)02911-3; Melby PC, 1998, INFECT IMMUN, V66, P2135, DOI 10.1128/IAI.66.5.2135-2142.1998; Melby PC, 2001, J IMMUNOL, V166, P1912, DOI 10.4049/jimmunol.166.3.1912; Miles SA, 2005, J EXP MED, V201, P747, DOI 10.1084/jem.20041470; Modabber F, 1995, ANN TROP MED PARASIT, V89, P83, DOI 10.1080/00034983.1995.11813017; Murray HW, 2000, J INFECT DIS, V182, P1497, DOI 10.1086/315890; MURRAY HW, 1988, J INFECT DIS, V157, P973, DOI 10.1093/infdis/157.5.973; Noben-Trauth N, 2003, J IMMUNOL, V170, P5152, DOI 10.4049/jimmunol.170.10.5152; Padilla A, 2003, J BIOL CHEM, V278, P1872, DOI 10.1074/jbc.M210322200; Perez-Victoria FJ, 2003, ANTIMICROB AGENTS CH, V47, P2397, DOI 10.1128/AAC.47.8.2397-2403.2003; REINER SL, 1994, J EXP MED, V179, P447, DOI 10.1084/jem.179.2.447; RODRIGUES V, 1992, PARASITE IMMUNOL, V14, P49, DOI 10.1111/j.1365-3024.1992.tb00005.x; RUSSO DM, 1991, J IMMUNOL, V147, P3575; Samant M, 2009, J IMMUNOL, V183, P470, DOI 10.4049/jimmunol.0900265; SCOTT P, 1987, ANN INST PASTEUR IMM, V138, P771, DOI 10.1016/S0769-2625(87)80036-3; SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188; Sinha PK, 2005, INDIAN J MED RES, V121, P407; Sundar S, 2001, TROP MED INT HEALTH, V6, P849, DOI 10.1046/j.1365-3156.2001.00778.x; Sundar S, 2000, CLIN INFECT DIS, V31, P1104, DOI 10.1086/318121; TANG DC, 1992, NATURE, V356, P152, DOI 10.1038/356152a0; Tewary P, 2005, J INFECT DIS, V191, P2130, DOI 10.1086/430348; Tian Yu, 2004, Chinese Journal of Parasitology and Parasitic Diseases, V22, P294; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Walker PS, 1998, HUM GENE THER, V9, P1899, DOI 10.1089/hum.1998.9.13-1899; Wanasen N, 2008, INT J PARASITOL, V38, P417, DOI 10.1016/j.ijpara.2007.08.010; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; Zierhut M, 1998, IMMUNOL TODAY, V19, P148, DOI 10.1016/S0167-5699(97)01229-2; ZWINGENBERGER K, 1990, CLIN IMMUNOL IMMUNOP, V57, P242, DOI 10.1016/0090-1229(90)90038-R	80	39	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35670	10.1371/journal.pone.0035670	http://dx.doi.org/10.1371/journal.pone.0035670			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539989	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341000055
J	Pan, LL; Li, YL; Jia, LX; Qin, YW; Qi, GM; Cheng, JZ; Qi, YF; Li, HH; Du, J				Pan, Lili; Li, Yulin; Jia, Lixin; Qin, Yanwen; Qi, Guanming; Cheng, Jizhong; Qi, Yongfen; Li, Huihua; Du, Jie			Cathepsin S Deficiency Results in Abnormal Accumulation of Autophagosomes in Macrophages and Enhances Ang II-Induced Cardiac Inflammation	PLOS ONE			English	Article							NF-KAPPA-B; HEART-DISEASE; CYSTEINE CATHEPSINS; HEMODYNAMIC STRESS; CELL-DEATH; EXPRESSION; MECHANISMS; FIBROSIS; MICE; METALLOPROTEINASES	Background: Cathepsin S (Cat S) is overexpressed in human atherosclerotic and aneurysmal tissues and may contributes to degradation of extracellular matrix, especially elastin, in inflammatory diseases. We aimed to define the role of Cat S in cardiac inflammation and fibrosis induced by angiotensin II (Ang II) in mice. Methods and Results: Cat S-knockout (Cat S-/-) and littermate wild-type (WT) C57BL/6J mice were infused continuously with Ang II (750 ng/kg/min) or saline for 7 days. Cat S-/- mice showed severe cardiac fibrosis, including elevated expression of collagen I and alpha-smooth muscle actin (alpha-SMA), as compared with WT mice. Moreover, macrophage infiltration and expression of inflammatory cytokines (tumor necrosis factor alpha, transforming growth factor beta and interleukin 1 beta) were significantly greater in Cat S-/- than WT hearts. These Ang II-induced effects in Cat S-/- mouse hearts was associated with abnormal accumulation of autophagosomes and reduced clearance of damaged mitochondria, which led to increased levels of reactive oxygen species (ROS) and activation of nuclear factor-kappa B (NF-kappa B) in macrophages. Conclusion: Cat S in lysosomes is essential for mitophagy processing in macrophages, deficiency in Cat S can increase damaged mitochondria and elevate ROS levels and NF-kappa B activity in hypertensive mice, so it regulates cardiac inflammation and fibrosis.	[Pan, Lili; Li, Yulin; Jia, Lixin; Qin, Yanwen; Qi, Guanming; Cheng, Jizhong; Qi, Yongfen; Du, Jie] Capital Med Univ, Beijing An Zhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis Beijin, Beijing, Peoples R China; [Du, Jie] Minist Educ, Key Lab Remodeling Related Cardiovasc Dis, Beijing, Peoples R China; [Li, Huihua] Capital Med Univ, Dept Pathol, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Pan, LL (corresponding author), Capital Med Univ, Beijing An Zhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis Beijin, Beijing, Peoples R China.	jdu@bcm.edu	Qin, Yanwen/AAM-6961-2020; Li, yulin/AGZ-5611-2022	Qin, Yanwen/0000-0002-5185-9726; 	Chinese Ministry of Science and Technology [2012CB517802, 2012CB945104]; National Science Foundation of China [30888004, 31090363]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by grants from the Chinese Ministry of Science and Technology (2012CB517802 and 2012CB945104) and from the National Science Foundation of China (30888004 and 31090363). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badenhorst D, 2003, CARDIOVASC RES, V57, P632, DOI 10.1016/S0008-6363(02)00733-2; Blyszczuk P, 2009, CIRC RES, V105, P912, DOI 10.1161/CIRCRESAHA.109.199802; Bruckner AL, 2004, SEMIN CUTAN MED SURG, V23, P116, DOI 10.1016/j.sder.2004.01.005; Burns-Kurtis CL, 2004, CARDIOVASC RES, V62, P610, DOI 10.1016/j.cardiores.2004.02.002; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; Dada LA, 2011, J CLIN INVEST, V121, P1683, DOI 10.1172/JCI57748; De Meyer GRY, 2009, BBA-MOL CELL RES, V1793, P1485, DOI 10.1016/j.bbamcr.2008.12.011; de Nooijer R, 2009, ARTERIOSCL THROM VAS, V29, P188, DOI 10.1161/ATVBAHA.108.181578; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Gustafsson AB, 2009, CIRC RES, V104, P150, DOI 10.1161/CIRCRESAHA.108.187427; Huang CY, 2001, J CEREBR BLOOD F MET, V21, P163, DOI 10.1097/00004647-200102000-00008; Huang XR, 2010, HYPERTENSION, V55, P1165, DOI 10.1161/HYPERTENSIONAHA.109.147611; Kania G, 2009, TRENDS CARDIOVAS MED, V19, P247, DOI 10.1016/j.tcm.2010.02.005; Karioti A, 2008, PHYTOMEDICINE, V15, P1125, DOI 10.1016/j.phymed.2008.02.018; Knaapen MWM, 2001, CARDIOVASC RES, V51, P304, DOI 10.1016/S0008-6363(01)00290-5; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; Koike M, 2000, J NEUROSCI, V20, P6898, DOI 10.1523/JNEUROSCI.20-18-06898.2000; Kostin S, 2003, CIRC RES, V92, P715, DOI 10.1161/01.RES.0000067471.95890.5C; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liu J, 2006, ATHEROSCLEROSIS, V184, P302, DOI 10.1016/j.atherosclerosis.2005.05.012; Lutgens SPM, 2006, J PATHOL, V210, P334, DOI 10.1002/path.2054; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Nishida K, 2009, CELL DEATH DIFFER, V16, P31, DOI 10.1038/cdd.2008.163; Pieper GM, 2001, ANTIOXID REDOX SIGN, V3, P81, DOI 10.1089/152308601750100542; Porrello ER, 2009, HYPERTENSION, V53, P1032, DOI 10.1161/HYPERTENSIONAHA.108.128488; Pozgan U, 2010, BIOL CHEM, V391, P571, DOI 10.1515/BC.2010.035; Rothermel BA, 2008, CIRC RES, V103, P1363, DOI 10.1161/CIRCRESAHA.108.186551; Ryter Stefan W, 2010, Proc Am Thorac Soc, V7, P40, DOI 10.1513/pats.200909-100JS; Sasaki T, 2010, ATHEROSCLEROSIS, V210, P430, DOI 10.1016/j.atherosclerosis.2009.12.031; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Shacka JJ, 2007, J NEUROSCI, V27, P2081, DOI 10.1523/JNEUROSCI.5577-06.2007; SHAH PK, 1995, CIRCULATION, V92, P1565; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Stahl S, 2007, BBA-PROTEINS PROTEOM, V1774, P1237, DOI 10.1016/j.bbapap.2007.07.004; Sukhova GK, 2003, J CLIN INVEST, V111, P897, DOI 10.1172/JCI200314915; Sukhova GK, 1998, J CLIN INVEST, V102, P576, DOI 10.1172/JCI181; Usher MG, 2010, J CLIN INVEST, V120, P3350, DOI 10.1172/JCI41080; Wang WS, 2005, J AM SOC NEPHROL, V16, P1371, DOI 10.1681/ASN.2004121070; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Yadav A, AM J PHYSL CELL PHYS, V299, pC488; Yang CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021971; Zheng T, 2005, J IMMUNOL, V174, P8106, DOI 10.4049/jimmunol.174.12.8106; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523; Zhu JH, 2011, METHODS MOL BIOL, V793, P325, DOI 10.1007/978-1-61779-328-8_21	49	72	76	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35315	10.1371/journal.pone.0035315	http://dx.doi.org/10.1371/journal.pone.0035315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558139	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340200014
J	Janel-Bintz, R; Wagner, J; Haracska, L; Mah-Becherel, MCM; Bichara, M; Fuchs, RP; Cordonnier, AM				Janel-Bintz, Regine; Wagner, Jerome; Haracska, Lajos; Mah-Becherel, Marcia Chia Miao; Bichara, Marc; Fuchs, Robert P.; Cordonnier, Agnes M.			Evidence for a Rad18-Independent Frameshift Mutagenesis Pathway in Human Cell-Free Extracts	PLOS ONE			English	Article							DNA-POLYMERASE-ETA; FREE REPLICATIVE BYPASS; TRANSLESION SYNTHESIS; POL-ETA; LESION BYPASS; SACCHAROMYCES-CEREVISIAE; PCNA MONOUBIQUITINATION; DAMAGE TOLERANCE; NUCLEAR ANTIGEN; YEAST	Bypass of replication blocks by specialized DNA polymerases is crucial for cell survival but may promote mutagenesis and genome instability. To gain insight into mutagenic sub-pathways that coexist in mammalian cells, we examined N-2-acetylaminofluorene (AAF)-induced frameshift mutagenesis by means of SV40-based shuttle vectors containing a single adduct. We found that in mammalian cells, as previously observed in E. coli, modification of the third guanine of two target sequences, 5'-GGG-3' (3G) and 5'-GGCGCC-3' (NarI site), induces -1 and -2 frameshift mutations, respectively. Using an in vitro assay for translesion synthesis, we investigated the biochemical control of these events. We showed that Pol eta, but neither Pol iota nor Pol zeta, plays a major role in the frameshift bypass of the AAF adduct located in the 3G sequence. By complementing PCNA-depleted extracts with either a wild-type or a non-ubiquitinatable form of PCNA, we found that this Pol eta-mediated pathway requires Rad18 and ubiquitination of PCNA. In contrast, when the AAF adduct is located within the NarI site, TLS is only partially dependent upon Pol eta and Rad18, unravelling the existence of alternative pathways that concurrently bypass this lesion.	[Janel-Bintz, Regine; Wagner, Jerome; Mah-Becherel, Marcia Chia Miao; Bichara, Marc; Cordonnier, Agnes M.] Univ Strasbourg, Biotechnol & Signalisat Cellulaire UMR7242, Ecole Super Biotechnol Strasbourg, Illkirch Graffenstaden, France; [Haracska, Lajos] Hungarian Acad Sci, Biol Res Ctr, Inst Genet, H-6701 Szeged, Hungary; [Fuchs, Robert P.] UPR3081 Genome Instabil & Carcinogenesis, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Hungarian Academy of Sciences; Hungarian Biological Research Center; UDICE-French Research Universities; Aix-Marseille Universite	Janel-Bintz, R (corresponding author), Univ Strasbourg, Biotechnol & Signalisat Cellulaire UMR7242, Ecole Super Biotechnol Strasbourg, Illkirch Graffenstaden, France.	agnes.cordonnier@unistra.fr	Wagner, Jerome/C-3746-2009; Cordonnier, Agnes M/I-5083-2016	Wagner, Jerome/0000-0002-7478-1925; Cordonnier, Agnes M/0000-0002-4216-3524	l'Institut National du Cancer [PLBIO]; la Ligue Regionale contre le Cancer; EU IPA Cross-border Cooperation Programme [HUSRB/1002/214/126]	l'Institut National du Cancer [PLBIO]; la Ligue Regionale contre le Cancer; EU IPA Cross-border Cooperation Programme	This work was supported by l'Institut National du Cancer [PLBIO2010], la Ligue Regionale contre le Cancer and by the grant EU IPA Cross-border Cooperation Programme (HUSRB/1002/214/126) (LH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baynton K, 1998, MOL CELL BIOL, V18, P960, DOI 10.1128/MCB.18.2.960; Baynton K, 1999, MOL MICROBIOL, V34, P124, DOI 10.1046/j.1365-2958.1999.01583.x; BELGUISEVALLADIER P, 1995, J MOL BIOL, V249, P903, DOI 10.1006/jmbi.1995.0347; Bienko M, 2010, MOL CELL, V37, P396, DOI 10.1016/j.molcel.2009.12.039; Bresson A, 2002, EMBO J, V21, P3881, DOI 10.1093/emboj/cdf363; Broughton BC, 2002, P NATL ACAD SCI USA, V99, P815, DOI 10.1073/pnas.022473899; Chen YW, 2008, P NATL ACAD SCI USA, V105, P16578, DOI 10.1073/pnas.0808589105; Cordonnier AM, 1999, MOL CELL BIOL, V19, P2206; FUCHS RPP, 1981, NATURE, V294, P657, DOI 10.1038/294657a0; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Gohler T, 2011, J CELL BIOL, V192, P219, DOI 10.1083/jcb.201008076; Gueranger Q, 2008, DNA REPAIR, V7, P1551, DOI 10.1016/j.dnarep.2008.05.012; Hendel A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002262; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; HUSCHTSCHA LI, 1983, J CELL SCI, V63, P77; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Krijger PHL, 2011, DNA REPAIR, V10, P1051, DOI 10.1016/j.dnarep.2011.08.005; Masutani C, 2000, EMBO J, V19, P3100, DOI 10.1093/emboj/19.12.3100; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Napolitano R, 2000, EMBO J, V19, P6259, DOI 10.1093/emboj/19.22.6259; Napolitano RL, 1997, CHEM RES TOXICOL, V10, P667, DOI 10.1021/tx970018w; Nikolaishvili-Feinberg N, 2008, BIOCHEMISTRY-US, V47, P4141, DOI 10.1021/bi702329h; Pages V, 2009, GENE DEV, V23, P1438, DOI 10.1101/gad.1793409; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Sabbioneda S, 2008, MOL BIOL CELL, V19, P5193, DOI 10.1091/mbc.E08-07-0724; Schmutz V, 2007, DNA REPAIR, V6, P1726, DOI 10.1016/j.dnarep.2007.06.003; Schmutz V, 2010, NUCLEIC ACIDS RES, V38, P6456, DOI 10.1093/nar/gkq403; Shiomi N, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl979; STARY A, 1992, J GEN VIROL, V73, P1679, DOI 10.1099/0022-1317-73-7-1679; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; THOMAS DC, 1995, J BIOL CHEM, V270, P21226, DOI 10.1074/jbc.270.36.21226; VEAUTE X, 1993, SCIENCE, V261, P598, DOI 10.1126/science.8342022; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Yoon JH, 2010, P NATL ACAD SCI USA, V107, P14116, DOI 10.1073/pnas.1007795107; Yoon JH, 2010, GENE DEV, V24, P123, DOI 10.1101/gad.1872810; Yoon JH, 2009, P NATL ACAD SCI USA, V106, P18219, DOI 10.1073/pnas.0910121106; Yuan FH, 2000, J BIOL CHEM, V275, P8233, DOI 10.1074/jbc.275.11.8233; Zheleva DI, 2000, BIOCHEMISTRY-US, V39, P7388, DOI 10.1021/bi992498r	40	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36004	10.1371/journal.pone.0036004	http://dx.doi.org/10.1371/journal.pone.0036004			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558303	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000098
J	Zhang, WH; Kramer, EM; Davis, CC				Zhang, Wenheng; Kramer, Elena M.; Davis, Charles C.			Similar Genetic Mechanisms Underlie the Parallel Evolution of Floral Phenotypes	PLOS ONE			English	Article							CYCLOIDEA-LIKE GENES; CYC-LIKE GENES; SYMMETRY GENES; MOLECULAR EVOLUTION; EXPRESSION PATTERNS; FLOWER SYMMETRY; TCP DOMAIN; ZYGOMORPHY; PHYLOGENY; DIVERSIFICATION	The repeated origin of similar phenotypes is invaluable for studying the underlying genetics of adaptive traits; molecular evidence, however, is lacking for most examples of such similarity. The floral morphology of neotropical Malpighiaceae is distinctive and highly conserved, especially with regard to symmetry, and is thought to result from specialization on oil-bee pollinators. We recently demonstrated that CYCLOIDEA2-like genes (CYC2A and CYC2B) are associated with the development of the stereotypical floral zygomorphy that is critical to this plant-pollinator mutualism. Here, we build on this developmental framework to characterize floral symmetry in three clades of Malpighiaceae that have independently lost their oil bee association and experienced parallel shifts in their floral morphology, especially in regard to symmetry. We show that in each case these species exhibit a loss of CYC2B function, and a strikingly similar shift in the expression of CYC2A that is coincident with their shift in floral symmetry. These results indicate that similar floral phenotypes in this large angiosperm clade have evolved via parallel genetic changes from an otherwise highly conserved developmental program.	[Zhang, Wenheng; Kramer, Elena M.; Davis, Charles C.] Harvard Univ Herbaria, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University	Zhang, WH (corresponding author), Harvard Univ Herbaria, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	cdavis@oeb.harvard.edu	Zhang, Wenheng/B-1715-2013		National Science Foundation [DEB-0544039]; AToL [EF 04-31242]	National Science Foundation(National Science Foundation (NSF)); AToL	This work was funded by National Science Foundation Grants DEB-0544039 and AToL EF 04-31242 (to C.C.D.) www.nsf.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ANDERSON W R, 1990, Memoirs of the New York Botanical Garden, V64, P210; ANDERSON WR, 1979, BIOTROPICA, V11, P219, DOI 10.2307/2388042; Anderson WR, 2002, DIOECY MALPIGHIACEAE; Araujo VA, 2006, NEOTROP ENTOMOL, V35, P30, DOI 10.1590/S1519-566X2006000100005; Broholm SK, 2008, P NATL ACAD SCI USA, V105, P9117, DOI 10.1073/pnas.0801359105; Busch A, 2007, P NATL ACAD SCI USA, V104, P16714, DOI 10.1073/pnas.0705338104; Chapman MA, 2008, MOL BIOL EVOL, V25, P1260, DOI 10.1093/molbev/msn001; Citerne H, 2010, ADV BOT RES, V54, P85, DOI 10.1016/S0065-2296(10)54003-5; Citerne HL, 2006, P NATL ACAD SCI USA, V103, P12017, DOI 10.1073/pnas.0600986103; Citerne HL, 2003, PLANT PHYSIOL, V131, P1042, DOI 10.1104/pp.102.016311; Citerne HL, 2000, ANN BOT-LONDON, V86, P167, DOI 10.1006/anbo.2000.1178; Cubas P, 1999, PLANT J, V18, P215, DOI 10.1046/j.1365-313X.1999.00444.x; Cubas P, 2001, CURR BIOL, V11, P1050, DOI 10.1016/S0960-9822(01)00295-0; Davis CC, 2004, INT J PLANT SCI, V165, pS107, DOI 10.1086/383337; Davis CC, 2002, P NATL ACAD SCI USA, V99, P6833, DOI 10.1073/pnas.102175899; Davis CC, 2002, AM J BOT, V89, P699, DOI 10.3732/ajb.89.4.699; Davis CC, 2010, AM J BOT, V97, P2031, DOI 10.3732/ajb.1000146; Donoghue MJ, 1998, TRENDS PLANT SCI, V3, P311, DOI 10.1016/S1360-1385(98)01278-3; Du ZY, 2008, J SYST EVOL, V46, P23, DOI 10.3724/SP.J.1002.2008.07059; Eichler A, 1878, MALPIGHIACEEN BLUT 2; Endress PK, 2001, CURR OPIN PLANT BIOL, V4, P86, DOI 10.1016/S1369-5266(00)00140-0; Feng XZ, 2006, P NATL ACAD SCI USA, V103, P4970, DOI 10.1073/pnas.0600681103; Fukuda T, 2003, J MOL EVOL, V57, P588, DOI 10.1007/s00239-003-2498-2; Gao Q, 2008, DEV GENES EVOL, V218, P341, DOI 10.1007/s00427-008-0227-y; Gubitz T, 2003, MOL BIOL EVOL, V20, P1537, DOI 10.1093/molbev/msg166; Hileman LC, 2003, P NATL ACAD SCI USA, V100, P12814, DOI 10.1073/pnas.1835725100; Hileman LC, 2003, MOL BIOL EVOL, V20, P591, DOI 10.1093/molbev/msg063; Howarth DG, 2005, INT J PLANT SCI, V166, P357, DOI 10.1086/428634; Howarth DG, 2006, P NATL ACAD SCI USA, V103, P9101, DOI 10.1073/pnas.0602827103; Howarth DG, 2011, ANN BOT-LONDON, V107, P1521, DOI 10.1093/aob/mcr049; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo D, 1996, NATURE, V383, P794, DOI 10.1038/383794a0; Luo D, 1999, CELL, V99, P367, DOI 10.1016/S0092-8674(00)81523-8; Maddison D. R., 2003, MACCLADE 4 ANAL PHYL; Maddison WP, 2019, MESQUITE MODULAR SYS; Michener C.D., 2000, BEES WORLD, V1st, DOI DOI 10.7171/JBT.12-2303-004; Neal PR, 1998, ANNU REV ECOL SYST, V29, P345, DOI 10.1146/annurev.ecolsys.29.1.345; Oakley RV, 2007, PLANT PHYSIOL, V145, P961, DOI 10.1104/pp.107.107086; Pang HB, 2010, J SYST EVOL, V48, P309, DOI 10.1111/j.1759-6831.2010.00091.x; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Preston JC, 2011, P NATL ACAD SCI USA, V108, P2343, DOI 10.1073/pnas.1011361108; Preston JC, 2009, NEW PHYTOL, V182, P751, DOI 10.1111/j.1469-8137.2009.02794.x; Preston JC, 2009, TRENDS PLANT SCI, V14, P147, DOI 10.1016/j.tplants.2008.12.005; Ree RH, 2004, MOL BIOL EVOL, V21, P321, DOI 10.1093/molbev/msh022; Reeves PA, 2003, MOL BIOL EVOL, V20, P1997, DOI 10.1093/molbev/msg211; Sargent RD, 2004, P ROY SOC B-BIOL SCI, V271, P603, DOI 10.1098/rspb.2003.2644; Sigrist MR, 2004, ANN BOT-LONDON, V94, P33, DOI 10.1093/aob/mch108; Smith JF, 2004, MOL PHYLOGENET EVOL, V31, P765, DOI 10.1016/j.ympev.2003.09.012; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Song CF, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-244; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stebbins GL, 1974, FLOWERING PLANT EVOL; STEVENS PF, 2001, ANGIOSPERM PHYLOGENY; VOGEL S, 1990, Memoirs of the New York Botanical Garden, V55, P130; Vogel S., 1974, TROPISCHE SUBTROPISC, V7, P283, DOI DOI 10.1002/FEDR.19770880110; Wang Z, 2008, P NATL ACAD SCI USA, V105, P10414, DOI 10.1073/pnas.0803291105; Westerkamp C, 2007, ANN BOT-LONDON, V100, P361, DOI 10.1093/aob/mcm123; Yampolsky C., 1922, BIBLIOTHECA GENETICA, V3, P1; Zhang WH, 2010, P NATL ACAD SCI USA, V107, P6388, DOI 10.1073/pnas.0910155107; Zhou XR, 2008, NEW PHYTOL, V178, P532, DOI 10.1111/j.1469-8137.2008.02384.x	62	22	23	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36033	10.1371/journal.pone.0036033	http://dx.doi.org/10.1371/journal.pone.0036033			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558314	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336000105
J	Alkire, BC; Vincent, JR; Burns, CT; Metzler, IS; Farmer, PE; Meara, JG				Alkire, Blake C.; Vincent, Jeffrey R.; Burns, Christy Turlington; Metzler, Ian S.; Farmer, Paul E.; Meara, John G.			Obstructed Labor and Caesarean Delivery: The Cost and Benefit of Surgical Intervention	PLOS ONE			English	Article							MATERNAL MORTALITY; STATISTICAL LIFE; HEALTH; RISK; AVAILABILITY; SERVICES; DEATH; EMOC; AGE	Background: Although advances in the reduction of maternal mortality have been made, up to 273,000 women will die this year from obstetric etiologies. Obstructed labor (OL), most commonly treated with Caesarean delivery, has been identified as a major contributor to global maternal morbidity and mortality. We used economic and epidemiological modeling to estimate the cost per disability-adjusted life-year (DALY) averted and benefit-cost ratio of treating OL with Caesarean delivery for 49 countries identified as providing an insufficient number of Caesarean deliveries to meet demand. Methods and Findings: Using publicly available data and explicit economic assumptions, we estimated that the cost per DALY (3,0,0) averted for providing Caesarean delivery for OL ranged widely, from $251 per DALY averted in Madagascar to $3,462 in Oman. The median cost per DALY averted was $304. Benefit-cost ratios also varied, from 0.6 in Zimbabwe to 69.9 in Gabon. The median benefit-cost ratio calculated was 6.0. The main limitation of this study is an assumption that lack of surgical capacity is the main factor responsible for DALYs from OL. Conclusions: Using the World Health Organization's cost-effectiveness standards, investing in Caesarean delivery can be considered "highly cost-effective" for 48 of the 49 countries included in this study. Furthermore, in 46 of the 49 included countries, the benefit-cost ratio was greater than 1.0, implying that investment in Caesarean delivery is a viable economic proposition. While Caesarean delivery alone is not sufficient for combating OL, it is necessary, cost-effective by WHO standards, and ultimately economically favorable in the vast majority of countries included in this study.	[Alkire, Blake C.] Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02115 USA; [Alkire, Blake C.; Metzler, Ian S.; Meara, John G.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Program Global Surg & Social Change, Boston, MA USA; [Vincent, Jeffrey R.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Vincent, Jeffrey R.] Duke Univ, Sanford Sch Publ Policy, Durham, NC USA; [Burns, Christy Turlington] Columbia Univ, Dept Populat & Family Hlth, Mailman Sch Publ Hlth, New York, NY USA; [Meara, John G.] Childrens Hosp, Dept Plast & Oral Surg, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Duke University; Duke University; Columbia University; Harvard University; Boston Children's Hospital	Alkire, BC (corresponding author), Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02115 USA.	john.meara@childrens.harvard.edu	Alkire, Blake/AAY-6463-2020	Meara, John G./0000-0003-4369-3209				AbouZahr C, 2003, BRIT MED BULL, V67, P1, DOI 10.1093/bmb/ldg015; AbouZhar, 2003, GLOBAL BURDEN OBSTRU; Aldy JE, 2008, REV ECON STAT, V90, P573, DOI 10.1162/rest.90.3.573; Alkire B, 2011, WORLD J SURG, V35, P1194, DOI 10.1007/s00268-011-1055-1; Anand S, 1997, J HEALTH ECON, V16, P685, DOI 10.1016/S0167-6296(97)00005-2; Chhabra S., 2000, Journal of Obstetrics and Gynaecology (Abingdon), V20, P151; Farmer PE, 2008, WORLD J SURG, V32, P533, DOI 10.1007/s00268-008-9525-9; Fournier P, 2009, B WORLD HEALTH ORGAN, V87, P30, DOI 10.2471/BLT.07.047076; Government of Australia Access Economics, 2008, HLTH NAT VAL STAT LI; Graham WJ, 2006, MATERNAL PERINATAL C, P499; Hammitt JK, 2007, REV ENV ECON POLICY, V1, P228, DOI 10.1093/reep/rem015; Hammitt JK, 2011, J BENEFIT-COST ANAL, V2, DOI 10.2202/2152-2812.1009; Hofmeyr GJ, 2004, INT J GYNECOL OBSTET, V85, pS62, DOI 10.1016/j.ijgo.2004.01.011; Islam MT, 2005, INT J GYNECOL OBSTET, V91, P298, DOI 10.1016/j.ijgo.2005.06.029; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P3, DOI 10.1596/978-0-8213-6179-5/Chpt-1; Jamison DT, 2008, CHALLENGE DIS; Jamisse L, 2004, INT J GYNECOL OBSTET, V85, P203, DOI 10.1016/j.ijgo.2004.01.005; Kayongo M, 2006, INT J GYNECOL OBSTET, V92, P308, DOI 10.1016/j.ijgo.2005.12.003; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Lerberghe WV, 2005, WORLD HLTH REPORT 20; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Maine D, 2007, LANCET, V370, P1380, DOI 10.1016/S0140-6736(07)61580-3; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; MATHERS CSC, GLOBAL BURDEN DIS 20; Melah G S, 2003, J Obstet Gynaecol, V23, P369, DOI 10.1080/01443610310001119510; Murray C.J, 1996, GLOBAL BURDEN DIS CO; Murray CJL, 1997, J HEALTH ECON, V16, P703, DOI 10.1016/S0167-6296(97)00004-0; NAVOT D, 1991, LANCET, V337, P1375, DOI 10.1016/0140-6736(91)93060-M; Neilson JP, 2003, BRIT MED BULL, V67, P191, DOI 10.1093/bmb/ldg018; Nyamtema AS, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-30; Paxton A, 2006, INT J GYNECOL OBSTET, V93, P300, DOI 10.1016/j.ijgo.2006.01.030; Pearson L, 2005, INT J GYNECOL OBSTET, V88, P208, DOI 10.1016/j.ijgo.2004.09.027; Pitt C, 2010, LANCET, V376, P1485, DOI 10.1016/S0140-6736(10)61302-5; Robinson LA, 2007, REV ENV ECON POLICY, V1, P283, DOI 10.1093/reep/rem018; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Sachs J., 2001, MACROECONOMICS HLTH; Shek KL, 2010, J UROLOGY, V184, P629, DOI 10.1016/j.juro.2010.03.135; Souza JP, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-71; United Nations Statistics Division, 2011, UN DAT WORLD INF; Viscusi WK, 2003, J RISK UNCERTAINTY, V27, P5, DOI 10.1023/A:1025598106257; Viscusi WK, 2006, QUANTIFYING VALUING, P1029; Wall LL, 2006, LANCET, V368, P1201, DOI 10.1016/S0140-6736(06)69476-2; Warf BC, 2011, J NEUROSURG-PEDIATR, V8, P509, DOI 10.3171/2011.8.PEDS11163; WHO, 2010, WOR HEALT REP, P1; WHO, 2010, TRENDS MAT MORT 1990; WHO, 2002, RED RISKS PROM HLTH; Wilhelmson K., 2006, IMPACT EC GROWTH INV; World Bank, 2011, WORLD BANK OP DAT	49	63	64	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e34595	10.1371/journal.pone.0034595	http://dx.doi.org/10.1371/journal.pone.0034595			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558089	gold, Green Published			2022-12-27	WOS:000305345200009
J	Brown, WD; Muntz, GA; Ladowski, AJ				Brown, William D.; Muntz, Gregory A.; Ladowski, Alexander J.			Low Mate Encounter Rate Increases Male Risk Taking in a Sexually Cannibalistic Praying Mantis	PLOS ONE			English	Article							MATING-BEHAVIOR; COURTSHIP; SACRIFICE; SELECTION; STRATEGY	Male praying mantises are forced into the ultimate trade-off of mating versus complete loss of future reproduction if they fall prey to a female. The balance of this trade-off will depend both on (1) the level of predatory risk imposed by females and (2) the frequency of mating opportunities for males. We report the results of a set of experiments that examine the effects of these two variables on male risk-taking behavior and the frequency of sexual cannibalism in the praying mantis Tenodera sinensis. We experimentally altered the rate at which males encountered females and measured male approach and courtship behavior under conditions of high and low risk of being attacked by females. We show that male risk taking depends on prior access to females. Males with restricted access to females showed greater risk-taking behavior. When males were given daily female encounters, they responded to greater female-imposed risk by slowing their rate of approach and remained a greater distance from a potential mate. In contrast, males without recent access to mates were greater risk-takers; they approached females more rapidly and to closer proximity, regardless of risk. In a second experiment, we altered male encounter rate with females and measured rates of sexual cannibalism when paired with hungry or well-fed females. Greater risk-taking behavior by males with low mate encounter rates resulted in high rates of sexual cannibalism when these males were paired with hungry females.	[Brown, William D.; Muntz, Gregory A.; Ladowski, Alexander J.] SUNY Coll Fredonia, Dept Biol, Fredonia, NY 14063 USA	State University of New York (SUNY) System; SUNY Fredonia	Brown, WD (corresponding author), SUNY Coll Fredonia, Dept Biol, Fredonia, NY 14063 USA.	William.Brown@fredonia.edu	Brown, William/GXN-2777-2022		Holmberg Foundation; Department of Biology, SUNY Fredonia	Holmberg Foundation; Department of Biology, SUNY Fredonia	This work was supported by funding from the Holmberg Foundation to GAM and by the Department of Biology, SUNY Fredonia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MCB, 1996, SCIENCE, V271, P70, DOI 10.1126/science.271.5245.70; Andrade MCB, 2003, BEHAV ECOL, V14, P531, DOI 10.1093/beheco/arg015; Barry KL, 2008, BEHAV ECOL, V19, P710, DOI 10.1093/beheco/arm156; Barry KL, 2010, ANIM BEHAV, V80, P163, DOI 10.1016/j.anbehav.2010.04.020; Barry KL, 2010, ANIM BEHAV, V79, P1165, DOI 10.1016/j.anbehav.2010.02.025; Barry KL, 2009, J ETHOL, V27, P377, DOI 10.1007/s10164-008-0130-z; BIRKHEAD TR, 1988, BEHAVIOUR, V106, P112, DOI 10.1163/156853988X00115; BUSKIRK RE, 1984, AM NAT, V123, P612, DOI 10.1086/284227; CORRETTE BJ, 1990, J EXP BIOL, V148, P147; GOULD SJ, 1984, NAT HIST, V93, P10; Holwell GI, 2007, J ZOOL, V271, P255, DOI 10.1111/j.1469-7998.2006.00263.x; Hurd LE, 2004, J CHEM ECOL, V30, P155, DOI 10.1023/B:JOEC.0000013188.79411.18; HURD LE, 1994, OIKOS, V69, P193, DOI 10.2307/3546137; Jensen D, 2009, INVERTEBR SYST, V23, P409, DOI 10.1071/IS09004; KYNASTON SE, 1994, ANIM BEHAV, V47, P739, DOI 10.1006/anbe.1994.1103; Lelito JP, 2006, AM NAT, V168, P263, DOI 10.1086/505757; Lelito JP, 2008, BEHAV ECOL SOCIOBIOL, V63, P313, DOI 10.1007/s00265-008-0663-8; LISKE E, 1987, ANIM BEHAV, V35, P1524, DOI 10.1016/S0003-3472(87)80024-6; Maxwell MR, 2010, ANN ENTOMOL SOC AM, V103, P120, DOI 10.1603/008.103.0115; Maxwell MR, 1999, PRAYING MANTIDS, P69; Roeder KD, 1935, BIOL BULL-US, V69, P203, DOI 10.2307/1537420; West B. T., 2007, LINEAR MIXED MODELS	22	16	18	0	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35377	10.1371/journal.pone.0035377	http://dx.doi.org/10.1371/journal.pone.0035377			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558146	gold, Green Published, Green Submitted			2022-12-27	WOS:000305345200036
J	Flachner, B; Lorincz, Z; Carotti, A; Nicolotti, O; Kuchipudi, P; Remez, N; Sanz, F; Tovari, J; Szabo, MJ; Bertok, B; Cseh, S; Mestres, J; Dorma, G				Flachner, Beata; Loerincz, Zsolt; Carotti, Angelo; Nicolotti, Orazio; Kuchipudi, Praveena; Remez, Nikita; Sanz, Ferran; Tovari, Jozsef; Szabo, Miklos J.; Bertok, Bela; Cseh, Sandor; Mestres, Jordi; Dorma, Gyoergy			A Chemocentric Approach to the Identification of Cancer Targets	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; PROTEIN-COUPLED RECEPTORS; IN-SILICO PHARMACOLOGY; DRUG DISCOVERY; COLORECTAL-CANCER; COLON-CANCER; ACCESSIBLE DATABASE; THERAPY; EXPRESSION; FAMILY	A novel chemocentric approach to identifying cancer-relevant targets is introduced. Starting with a large chemical collection, the strategy uses the list of small molecule hits arising from a differential cytotoxicity screening on tumor HCT116 and normal MRC-5 cell lines to identify proteins associated with cancer emerging from a differential virtual target profiling of the most selective compounds detected in both cell lines. It is shown that this smart combination of differential in vitro and in silico screenings (DIVISS) is capable of detecting a list of proteins that are already well accepted cancer drug targets, while complementing it with additional proteins that, targeted selectively or in combination with others, could lead to synergistic benefits for cancer therapeutics. The complete list of 115 proteins identified as being hit uniquely by compounds showing selective antiproliferative effects for tumor cell lines is provided.	[Flachner, Beata; Loerincz, Zsolt; Cseh, Sandor; Dorma, Gyoergy] TargetEx, Dunakeszi, Hungary; [Carotti, Angelo; Nicolotti, Orazio] Univ Bari Aldo Moro, Dept Med Chem, Bari, Italy; [Kuchipudi, Praveena; Remez, Nikita; Sanz, Ferran; Mestres, Jordi] Univ Pompeu Fabra, Barcelona, Catalonia, Spain; [Kuchipudi, Praveena; Remez, Nikita; Sanz, Ferran; Mestres, Jordi] IMIM Hosp Mar Res Inst, Barcelona, Catalonia, Spain; [Tovari, Jozsef] Natl Inst Oncol, Budapest, Hungary; [Szabo, Miklos J.; Bertok, Bela] AMRI Hungary Zrt, Budapest, Hungary	Universita degli Studi di Bari Aldo Moro; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); National Institute of Oncology Hungary	Flachner, B (corresponding author), TargetEx, Dunakeszi, Hungary.	jmestres@imim.es; dorman@target-ex.com	Remez, Nikita/N-9804-2015; Mestres, Jordi/B-3673-2009; Sanz, Ferran/B-3852-2009; Gasull, Martina/J-4076-2019; Nicolotti, Orazio/F-3209-2012	Remez, Nikita/0000-0002-6033-7137; Mestres, Jordi/0000-0002-5202-4501; Sanz, Ferran/0000-0002-7534-7661; Dorman, Gyorgy/0000-0001-7702-2206; Nicolotti, Orazio/0000-0001-6533-5539	European Comission (CancerGrid) [FP-6 LCHC-CT-2006-037559]	European Comission (CancerGrid)	This work was supported by a grant from the European Comission (CancerGrid, FP-6 LCHC-CT-2006-037559), http://ec.europa.eu/research/fp6/index_en.cfm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Areias FM, 2010, BIOORGAN MED CHEM, V18, P3043, DOI 10.1016/j.bmc.2010.03.048; Baurin N, 2004, J CHEM INF COMP SCI, V44, P643, DOI 10.1021/ci034260m; Beck HC, 2010, ELECTROPHORESIS, V31, P2714, DOI 10.1002/elps.201000033; Benson ML, 2008, NUCLEIC ACIDS RES, V36, pD674, DOI 10.1093/nar/gkm911; Block P, 2006, NUCLEIC ACIDS RES, V34, pD522, DOI 10.1093/nar/gkj039; Caldwell JS, 2007, ADV CANCER RES, V96, P145, DOI 10.1016/S0065-230X(06)96006-0; Cases M, 2005, CURR TOP MED CHEM, V5, P763, DOI 10.2174/1568026054637665; Clark RD, 1997, J CHEM INF COMP SCI, V37, P1181, DOI 10.1021/ci970282v; Cleveland AG, 2009, CARCINOGENESIS, V30, P1581, DOI 10.1093/carcin/bgp132; D'Errico I, 2008, CELL MOL LIFE SCI, V65, P1523, DOI 10.1007/s00018-008-7552-1; de Bono JS, 2003, BREAST CANCER RES, V5, P154, DOI 10.1186/bcr597; Ekins S, 2007, BRIT J PHARMACOL, V152, P9, DOI 10.1038/sj.bjp.0707305; Furney SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn482; Gleeson MP, 2011, NAT REV DRUG DISCOV, V10, P197, DOI 10.1038/nrd3367; Gregori-Puigjane E, 2006, J CHEM INF MODEL, V46, P1615, DOI 10.1021/ci0600509; Gundem G, 2010, NAT METHODS, V7, P92, DOI 10.1038/nmeth0210-92; Harmar AJ, 2009, NUCLEIC ACIDS RES, V37, pD680, DOI 10.1093/nar/gkn728; Heijink DM, 2011, ONCOGENE, V30, P2026, DOI 10.1038/onc.2010.578; Heng HH, 2010, CURR DRUG TARGETS, V11, P1304; Iorns E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005120; Janakiram NB, 2009, CANCER PREV RES, V2, P52, DOI 10.1158/1940-6207.CAPR-08-0140; Jensen NH, 2008, COMB CHEM HIGH T SCR, V11, P420, DOI 10.2174/138620708784911483; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kamb A, 2007, NAT REV DRUG DISCOV, V6, P115, DOI 10.1038/nrd2155; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Khelwatty SA, 2011, INT J ONCOL, V39, P483, DOI 10.3892/ijo.2011.1054; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Le Tourneau C, 2008, CANCER TREAT REV, V34, P37, DOI 10.1016/j.ctrv.2007.09.003; Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999; Liu W, 2009, CURR OPIN DRUG DISC, V12, P98; Lou JR, 2006, CANCER EPIDEM BIOMAR, V15, P1598, DOI 10.1158/1055-9965.EPI-06-0216; Macarulla Teresa, 2009, Eur J Cancer, V45 Suppl 1, P79, DOI 10.1016/S0959-8049(09)70019-X; Manning BD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.263pe15; Marks PA, 2004, CELL CYCLE, V3, P534; Melnick JS, 2006, P NATL ACAD SCI USA, V103, P3153, DOI 10.1073/pnas.0511292103; Menashe I, 2010, CANCER RES, V70, P4453, DOI 10.1158/0008-5472.CAN-09-4502; Mestres J, 2011, CLIN PHARMACOL THER, V90, P662, DOI 10.1038/clpt.2011.177; Molnar L, 2006, BIOORG MED CHEM LETT, V16, P1037, DOI 10.1016/j.bmcl.2005.10.079; PAGE B, 1993, INT J ONCOL, V3, P473; Papp A, 2006, J CHEM INF MODEL, V46, P1898, DOI 10.1021/ci060074f; Plouffe D, 2008, P NATL ACAD SCI USA, V105, P9059, DOI 10.1073/pnas.0802982105; Poroikov VV, 2003, J CHEM INF COMP SCI, V43, P228, DOI 10.1021/ci020048r; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Slater K, 2001, CURR OPIN BIOTECH, V12, P70, DOI 10.1016/S0958-1669(00)00177-4; Slattery ML, 2006, INT J CANCER, V118, P3140, DOI 10.1002/ijc.21791; Vecchione L, 2011, EXP CELL RES, V317, P2765, DOI 10.1016/j.yexcr.2011.08.021; Vidal D, 2011, METHODS MOL BIOL, V672, P489, DOI 10.1007/978-1-60761-839-3_19; Vidal D, 2010, MOL INFORM, V29, P543, DOI 10.1002/minf.201000055; Wang YL, 2010, NUCLEIC ACIDS RES, V38, pD255, DOI 10.1093/nar/gkp965; Wehler TC, 2008, ONCOL REP, V19, P697; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Yde CW, 2009, ANTI-CANCER DRUG, V20, P723, DOI 10.1097/CAD.0b013e32832ec041	56	16	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35582	10.1371/journal.pone.0035582	http://dx.doi.org/10.1371/journal.pone.0035582			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558171	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345200050
J	Hugrass, L; Crewther, D				Hugrass, Laila; Crewther, David			Willpower and Conscious Percept: Volitional Switching in Binocular Rivalry	PLOS ONE			English	Article							EYE-MOVEMENTS; OPTOKINETIC NYSTAGMUS; ATTENTIONAL CONTROL; VISUAL COMPETITION; VOLUNTARY CONTROL; AWARENESS; MOTION; ALTERNATIONS; BISTABILITY; DOMINANCE	When dissimilar images are presented to the left and right eyes, awareness switches spontaneously between the two images, such that one of the images is suppressed from awareness while the other is perceptually dominant. For over 170 years, it has been accepted that even though the periods of dominance are subject to attentional processes, we have no inherent control over perceptual switching. Here, we revisit this issue in response to evidence that top-down attention can target perceptually suppressed 'vision for action' representations in the dorsal stream. We investigated volitional control over rivalry between apparent motion (AM), drifting (DM) and stationary (ST) grating pairs. Observers demonstrated a remarkable ability to generate intentional switches in the AM and D conditions, but not in the ST condition. Corresponding switches in the pursuit direction of optokinetic nystagmus verified this finding objectively. We showed it is unlikely that intentional perceptual switches were triggered by saccadic eye movements, because their frequency was reduced substantially in the volitional condition and did not change around the time of perceptual switches. Hence, we propose that synergy between dorsal and ventral stream representations provides the missing link in establishing volitional control over rivalrous conscious percepts.	[Hugrass, Laila; Crewther, David] Swinburne Univ Technol, Ctr Human Psychopharmacol, Hawthorn, Vic 3122, Australia	Swinburne University of Technology	Hugrass, L (corresponding author), Swinburne Univ Technol, Ctr Human Psychopharmacol, Hawthorn, Vic 3122, Australia.	lhugrass@swin.edu.au	Hugrass, Laila/D-1885-2018	Hugrass, Laila/0000-0002-2126-6460				Alais D, 2010, VISION RES, V50, P929, DOI 10.1016/j.visres.2010.03.010; Andrews TJ, 2002, VISION RES, V42, P301, DOI 10.1016/S0042-6989(01)00286-3; Anstis S. M., 1983, COLOUR VISION PHYSL, P155; Beets IAM, 2010, VISION RES, V50, P2633, DOI 10.1016/j.visres.2010.10.004; BLAKE R, 1989, PSYCHOL REV, V96, P145, DOI 10.1037/0033-295X.96.1.145; BLAKE R, 1992, VISUAL NEUROSCI, V8, P469, DOI 10.1017/S0952523800004971; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; CAVANAGH P, 1984, INVEST OPHTH VIS SCI, V25, P463; Chong SC, 2005, J VISION, V5, P1004, DOI 10.1167/5.11.6; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Crick F, 1996, NATURE, V379, P485, DOI 10.1038/379485a0; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Fang F, 2005, NAT NEUROSCI, V8, P1380, DOI 10.1038/nn1537; Goodale MA, 2004, CURR OPIN NEUROBIOL, V14, P203, DOI 10.1016/j.conb.2004.03.002; Hancock S, 2007, PERCEPTION, V36, P288, DOI 10.1068/p5494; Hohwy J, 2008, COGNITION, V108, P687, DOI 10.1016/j.cognition.2008.05.010; Klink PC, 2008, J VISION, V8, DOI 10.1167/8.5.16; Kohler A, 2008, VISION RES, V48, P1096, DOI 10.1016/j.visres.2007.11.020; Konen CS, 2005, EXP BRAIN RES, V165, P203, DOI 10.1007/s00221-005-2289-7; LACK LC, 1974, PERCEPT PSYCHOPHYS, V15, P193, DOI 10.3758/BF03205846; Lee SH, 1999, VISION RES, V39, P1447, DOI 10.1016/S0042-6989(98)00269-7; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; Logothetis NK, 1998, PHILOS T R SOC B, V353, P1801, DOI 10.1098/rstb.1998.0333; Logothetis NK, 1996, NATURE, V380, P621, DOI 10.1038/380621a0; LOGOTHETIS NK, 1990, VISION RES, V30, P829, DOI 10.1016/0042-6989(90)90052-M; LOGOTHETIS NK, 1990, VISION RES, V30, P1409, DOI 10.1016/0042-6989(90)90022-D; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Lunghi C, 2010, CURR BIOL, V20, pR143, DOI 10.1016/j.cub.2009.12.015; Madelain L, 2003, J VISION, V3, P642, DOI 10.1167/3.11.1; Maruya K, 2007, PSYCHOL SCI, V18, P1090, DOI 10.1111/j.1467-9280.2007.02030.x; Meng M, 2004, J VISION, V4, P539, DOI 10.1167/4.7.2; Moreno-Bote R, 2007, J NEUROPHYSIOL, V98, P1125, DOI 10.1152/jn.00116.2007; Ooi TL, 1999, PERCEPTION, V28, P551, DOI 10.1068/p2923; Paffen CLE, 2006, PSYCHOL SCI, V17, P752, DOI 10.1111/j.1467-9280.2006.01777.x; SCHALL JD, 1993, VISION RES, V33, P2057, DOI 10.1016/0042-6989(93)90004-G; Slotnick SD, 2005, COGNITIVE BRAIN RES, V24, P97, DOI 10.1016/j.cogbrainres.2004.12.008; Sun FC, 2002, BRAIN RES, V944, P56, DOI 10.1016/S0006-8993(02)02706-3; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; van Dam LCJ, 2006, VISION RES, V46, P787, DOI 10.1016/j.visres.2005.10.011; van Dam LCJ, 2006, J VISION, V6, P1172, DOI 10.1167/6.11.3; van Ee R, 2005, VISION RES, V45, P41, DOI 10.1016/j.visres.2004.07.030; van Ee R, 2006, VISION RES, V46, P3129, DOI 10.1016/j.visres.2006.03.017; van Ee R, 2009, J OPT SOC AM A, V26, P2612, DOI 10.1364/JOSAA.26.002612; van Ee R, 2009, J NEUROSCI, V29, P11641, DOI 10.1523/JNEUROSCI.0873-09.2009; von Helmholtz H, 1866, TREATISE PHYSL OPTIC; Watanabe M, 2011, SCIENCE, V334, P829, DOI 10.1126/science.1203161; Wheatstone C., 1838, PHILOS T ROY SOC LON, P371, DOI DOI 10.1098/RSTL.1838.0019; Wilson HR, 2003, J VISION	51	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35963	10.1371/journal.pone.0035963	http://dx.doi.org/10.1371/journal.pone.0035963			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VP	22558283	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345200097
J	Ma, YL; Wang, WY; Zhang, J; Lu, YL; Wu, WY; Yan, H; Wang, YP				Ma, Yanling; Wang, Wenyi; Zhang, Jie; Lu, Youli; Wu, Wenyu; Yan, Hong; Wang, Yiping			Hyperlipidemia and Atherosclerotic Lesion Development in Ldlr-Deficient Mice on a Long-Term High-Fat Diet	PLOS ONE			English	Article							PLASMA-CHOLESTEROL LEVELS; RECEPTOR KNOCKOUT MICE; REDUCES ATHEROSCLEROSIS; INNOMINATE-ARTERY; APOLIPOPROTEIN-E; ATHEROGENESIS; AGONIST; EXPRESSION; CHOLATE; INSULIN	Background: Mice deficient in the LDL receptor (Ldlr(-/-) mice) have been widely used as a model to mimic human atherosclerosis. However, the time-course of atherosclerotic lesion development and distribution of lesions at specific time-points are yet to be established. The current study sought to determine the progression and distribution of lesions in Ldlr(-/-) mice. Methodology/Principal Findings: Ldlr-deficient mice fed regular chow or a high-fat (HF) diet for 0.5 to 12 months were analyzed for atherosclerotic lesions with en face and cross-sectional imaging. Mice displayed significant individual differences in lesion development when fed a chow diet, whereas those on a HF diet developed lesions in a time-dependent and site-selective manner. Specifically, mice subjected to the HF diet showed slight atherosclerotic lesions distributed exclusively in the aortic roots or innominate artery before 3 months. Lesions extended to the thoracic aorta at 6 months and abdominal aorta at 9 months. Cross-sectional analysis revealed the presence of advanced lesions in the aortic sinus after 3 months in the group on the HF diet and in the innominate artery at 6 to 9 months. The HF diet additionally resulted in increased total cholesterol, LDL, glucose, and HBA1c levels, along with the complication of obesity. Conclusions/Significance: Ldlr-deficient mice on the HF diet tend to develop site-selective and size-specific atherosclerotic lesions over time. The current study should provide information on diet induction or drug intervention times and facilitate estimation of the appropriate locations of atherosclerotic lesions in Ldlr(-/-) mice.	[Ma, Yanling; Wang, Wenyi; Zhang, Jie; Wu, Wenyu; Yan, Hong; Wang, Yiping] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China; [Lu, Youli] Shanghai Xuhui Cent Hosp, Cent Lab, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Ma, YL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China.	ypwang@mail.shcnc.ac.cn	MA, YAN/HHN-2912-2022	Ma, Yanling/0000-0003-0829-3285; Yan, Hong/0000-0001-6665-4419	Shanghai Committee of Science and Technology, China [11ZR1444800]; National Basic Research Program of China [2009CB930300]	Shanghai Committee of Science and Technology, China(Shanghai Science & Technology Committee); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the grant from the Shanghai Committee of Science and Technology, China (No. 11ZR1444800), and National Basic Research Program of China (No. 2009CB930300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abela GS, 2010, J CLIN LIPIDOL, V4, P156, DOI 10.1016/j.jacl.2010.03.003; Abela GS, 2009, AM J CARDIOL, V103, P959, DOI 10.1016/j.amjcard.2008.12.019; Chira EC, 2007, ATHEROSCLEROSIS, V195, P100, DOI 10.1016/j.atherosclerosis.2006.12.012; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Game BA, 2007, ATHEROSCLEROSIS, V192, P85, DOI 10.1016/j.atherosclerosis.2006.06.025; Getz GS, 2006, ARTERIOSCL THROM VAS, V26, P242, DOI 10.1161/01.ATV.0000201071.49029.17; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Graham TL, 2005, ATHEROSCLEROSIS, V181, P29, DOI 10.1016/j.atherosclerosis.2004.12.028; Hartvigsen K, 2007, ARTERIOSCL THROM VAS, V27, P878, DOI 10.1161/01.ATV.0000258790.35810.02; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; ISHIBASHI S, 1994, J CLIN INVEST, V93, P1885, DOI 10.1172/JCI117179; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Lichtman AH, 1999, ARTERIOSCL THROM VAS, V19, P1938, DOI 10.1161/01.ATV.19.8.1938; Merat S, 1999, ARTERIOSCL THROM VAS, V19, P1223, DOI 10.1161/01.ATV.19.5.1223; Moore RE, 2003, ARTERIOSCL THROM VAS, V23, P1914, DOI 10.1161/01.ATV.0000092328.66882.F5; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; Peng D, 2009, ATHEROSCLEROSIS, V203, P59, DOI 10.1016/j.atherosclerosis.2008.05.058; Rader DJ, 2008, NATURE, V451, P904, DOI 10.1038/nature06796; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; REDDICK RL, 1994, ARTERIOSCLER THROMB, V14, P141, DOI 10.1161/01.ATV.14.1.141; Rosenfeld ME, 2000, ARTERIOSCL THROM VAS, V20, P2587, DOI 10.1161/01.ATV.20.12.2587; Schreyer SA, 2003, ATHEROSCLEROSIS, V171, P49, DOI 10.1016/j.atherosclerosis.2003.07.010; Sehayek E, 2001, J LIPID RES, V42, P1250; Sharabi Y, 2000, PATHOBIOLOGY, V68, P270, DOI 10.1159/000055937; TANGIRALA RK, 1995, J LIPID RES, V36, P2320; Terasaka N, 2003, FEBS LETT, V536, P6, DOI 10.1016/S0014-5793(02)03578-0; Teupser D, 2003, ARTERIOSCL THROM VAS, V23, P1907, DOI 10.1161/01.ATV.0000090126.34881.B1; VanderLaan PA, 2004, ARTERIOSCL THROM VAS, V24, P12, DOI 10.1161/01.ATV.0000105054.43931.f0; Vedre A, 2009, ATHEROSCLEROSIS, V203, P89, DOI 10.1016/j.atherosclerosis.2008.06.027; Vergnes L, 2003, J BIOL CHEM, V278, P42774, DOI 10.1074/jbc.M306022200; Wang WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023425; Wu L, 2006, J LIPID RES, V47, P2215, DOI 10.1194/jlr.M600146-JLR200; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570	35	65	65	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35835	10.1371/journal.pone.0035835	http://dx.doi.org/10.1371/journal.pone.0035835			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558236	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345200085
J	Egami, Y; Araki, N				Egami, Youhei; Araki, Nobukazu			Rab20 Regulates Phagosome Maturation in RAW264 Macrophages during Fc Gamma Receptor-Mediated Phagocytosis	PLOS ONE			English	Article							PROTEINS; GTPASES; CELLS; MACROPINOCYTOSIS; LOCALIZATION; 3-KINASE; FUSION	Rab20, a member of the Rab GTPase family, is known to be involved in membrane trafficking, however its implication in Fc gamma R-mediated phagocytosis is unclear. We examined the spatiotemporal localization of Rab20 during phagocytosis of IgG-opsonized erythrocytes (IgG-Es) in RAW264 macrophages. By the live-cell imaging of fluorescent protein-fused Rab20, it was shown that Rab20 was transiently associated with the phagosomal membranes. During the early stage of phagosome formation, Rab20 was not localized on the membranes of phagocytic cups, but was gradually recruited to the newly formed phagosomes. Although Rab20 was colocalized with Rab5 to some extent, the association of Rab20 with the phagosomes persisted even after the loss of Rab5 from the phagosomal membranes. Then, Rab20 was colocalized with Rab7 and Lamp1, late endosomal/lysosomal markers, on the internalized phagosomes. Moreover, our analysis of Rab20 mutant expression revealed that the maturation of phagosomes was significantly delayed in cells expressing the GDP-bound mutant Rab20-T19N. These data suggest that Rab20 is an important component of phagosome and regulates the phagosome maturation during Fc gamma R-mediated phagocytosis.	[Egami, Youhei; Araki, Nobukazu] Kagawa Univ, Sch Med, Dept Histol & Cell Biol, Miki, Kagawa, Japan	Kagawa University	Egami, Y (corresponding author), Kagawa Univ, Sch Med, Dept Histol & Cell Biol, Miki, Kagawa, Japan.	naraki@med.kagawa-u.ac.jp		Araki, Nobukazu/0000-0001-6160-210X	Japan Society for the Promotion of Science [22790188, 23390039]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant-in-Aid for Young Scientists (B) #22790188 and partially by a Grant-in-Aid for Scientific Research (B) #23390039 from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amillet JM, 2006, HUM PATHOL, V37, P256, DOI 10.1016/j.humpath.2005.10.017; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Araki N, 2007, EXP CELL RES, V313, P1496, DOI 10.1016/j.yexcr.2007.02.012; Brighouse A, 2010, CELL MOL LIFE SCI, V67, P3449, DOI 10.1007/s00018-010-0436-1; Cardoso CMP, 2010, TRAFFIC, V11, P221, DOI 10.1111/j.1600-0854.2009.01013.x; Curtis Lisa M., 2005, Nephron Physiology, V100, P31; Das Sarma J, 2008, CELL COMMUN ADHES, V15, P65, DOI 10.1080/15419060802014305; Downey GP, 1999, J BIOL CHEM, V274, P28436, DOI 10.1074/jbc.274.40.28436; Egami Y, 2011, J CELL SCI; Egami Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006689; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Henry RM, 2004, J CELL BIOL, V164, P185, DOI 10.1083/jcb.200307080; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; LUTCKE A, 1994, J CELL SCI, V107, P3437; May RC, 2001, J CELL SCI, V114, P1061; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Rogers LD, 2007, P NATL ACAD SCI USA, V104, P18520, DOI 10.1073/pnas.0705801104; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; Seto S, 2011, TRAFFIC, V12, P407, DOI 10.1111/j.1600-0854.2011.01165.x; Smith AC, 2007, J CELL BIOL, V176, P263, DOI 10.1083/jcb.200611056; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stuart LM, 2007, NATURE, V445, P95, DOI 10.1038/nature05380; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Vieira OV, 2003, MOL CELL BIOL, V23, P2501, DOI 10.1128/MCB.23.7.2501-2514.2003; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	29	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35663	10.1371/journal.pone.0035663	http://dx.doi.org/10.1371/journal.pone.0035663			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545127	Green Submitted, gold, Green Published			2022-12-27	WOS:000305343200047
J	Padmanabhan, P; Dixit, NM				Padmanabhan, Pranesh; Dixit, Narendra M.			Viral Kinetics Suggests a Reconciliation of the Disparate Observations of the Modulation of Claudin-1 Expression on Cells Exposed to Hepatitis C Virus	PLOS ONE			English	Article							IN-VITRO; SUPERINFECTION EXCLUSION; ANTIVIRAL THERAPY; INFECTION; ENTRY; INTERFERON; CD81; ASSOCIATION; CORECEPTOR; ANTIBODIES	The tight junction protein claudin-1 (CLDN1) is necessary for hepatitis C virus (HCV) entry into target cells. Recent studies have made disparate observations of the modulation of the expression of CLDN1 on cells following infection by HCV. In one study, the mean CLDN1 expression on cells exposed to HCV declined, whereas in another study HCV infected cells showed increased CLDN1 expression compared to uninfected cells. Consequently, the role of HCV in modulating CLDN1 expression, and hence the frequency of cellular superinfection, remains unclear. Here, we present a possible reconciliation of these disparate observations. We hypothesized that viral kinetics and not necessarily HCV-induced receptor modulation underlies these disparate observations. To test this hypothesis, we constructed a mathematical model of viral kinetics in vitro that mimicked the above experiments. Model predictions provided good fits to the observed evolution of the distribution of CLDN1 expression on cells following exposure to HCV. Cells with higher CLDN1 expression were preferentially infected and outgrown by cells with lower CLDN1 expression, resulting in a decline of the mean CLDN1 expression with time. At the same time, because the susceptibility of cells to infection increased with CLDN1 expression, infected cells tended to have higher CLDN1 expression on average than uninfected cells. Our study thus presents an explanation of the disparate observations of CLDN1 expression following HCV infection and points to the importance of considering viral kinetics in future studies of receptor expression on cells exposed to HCV.	[Padmanabhan, Pranesh; Dixit, Narendra M.] Indian Inst Sci, Dept Chem Engn, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Padmanabhan, P (corresponding author), Indian Inst Sci, Dept Chem Engn, Bangalore 560012, Karnataka, India.	narendra@chemeng.iisc.ernet.in	Padmanabhan, Pranesh/AAQ-2286-2020	Padmanabhan, Pranesh/0000-0001-5569-8731	Department of Biotechnology Centre of Excellence for Research on Hepatitis C Virus, India	Department of Biotechnology Centre of Excellence for Research on Hepatitis C Virus, India	This work was supported by the Department of Biotechnology Centre of Excellence for Research on Hepatitis C Virus, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiwijaya BS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000745; Beauchemin CAA, 2008, J THEOR BIOL, V254, P439, DOI 10.1016/j.jtbi.2008.05.031; Brimacombe CL, 2011, J VIROL, V85, P596, DOI 10.1128/JVI.01592-10; Colombatto P, 2008, CLIN PHARMACOL THER, V84, P212, DOI 10.1038/clpt.2008.21; Cormier EG, 2004, P NATL ACAD SCI USA, V101, P7270, DOI 10.1073/pnas.0402253101; Dahari H, 2007, HEPATOLOGY, V46, P16, DOI 10.1002/hep.21657; Dahari H, 2007, J VIROL, V81, P750, DOI 10.1128/JVI.01304-06; Dahari H, 2009, J VIROL, V83, P6383, DOI 10.1128/JVI.02612-08; DebRoy S, 2010, MATH BIOSCI, V225, P141, DOI 10.1016/j.mbs.2010.02.005; Dixit N. M., 2008, FUTURE HIV THER, V2, P375; Dixit NM, 2004, NATURE, V432, P922, DOI 10.1038/nature03153; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Farquhar MJ, 2012, J VIROL, V86, P4305, DOI 10.1128/JVI.06996-11; Fofana I, 2010, GASTROENTEROLOGY, V139, P953, DOI 10.1053/j.gastro.2010.05.073; Guedj J, 2011, HEPATOLOGY, V53, P1801, DOI 10.1002/hep.24272; Harris HJ, 2008, J VIROL, V82, P5007, DOI 10.1128/JVI.02286-07; Harris HJ, 2010, J BIOL CHEM, V285, P21092, DOI 10.1074/jbc.M110.104836; Herrmann E, 2003, HEPATOLOGY, V37, P1351, DOI 10.1053/jhep.2003.50218; Hsu CS, 2011, P NATL ACAD SCI USA, V108, P3719, DOI 10.1073/pnas.1100349108; Kannan RP, 2011, J VIROL, V85, P7989, DOI 10.1128/JVI.00280-11; KELLAM P, 1995, J VIROL, V69, P669, DOI 10.1128/JVI.69.2.669-674.1995; Krieger SE, 2010, HEPATOLOGY, V51, P1144, DOI 10.1002/hep.23445; Krishnan SM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001072; Liu SF, 2009, J VIROL, V83, P2011, DOI 10.1128/JVI.01888-08; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Moutouh L, 1996, P NATL ACAD SCI USA, V93, P6106, DOI 10.1073/pnas.93.12.6106; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Padmanabhan P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002307; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Reynolds GM, 2008, HEPATOLOGY, V47, P418, DOI 10.1002/hep.22028; Rong LB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000544; Rong L, 2010, CRIT REV IMMUNOL, V30, P131, DOI 10.1615/CritRevImmunol.v30.i2.30; Sabahi A, 2010, VIROLOGY, V407, P110, DOI 10.1016/j.virol.2010.07.026; Sainz B, 2006, J VIROL, V80, P10253, DOI 10.1128/JVI.01059-06; Sainz Jr. B, NAT MED, V18, P281; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Schaller T, 2007, J VIROL, V81, P4591, DOI 10.1128/JVI.02144-06; Timpe JM, 2008, HEPATOLOGY, V47, P17, DOI 10.1002/hep.21959; Tscherne DM, 2007, J VIROL, V81, P3693, DOI 10.1128/JVI.01748-06; Walters KA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000269; Yu XM, 2009, ANTIMICROB AGENTS CH, V53, P4311, DOI 10.1128/AAC.00495-09; Zeisel MB, 2011, J HEPATOL, V54, P566, DOI 10.1016/j.jhep.2010.10.014; Zeuzem S, 2001, GASTROENTEROLOGY, V120, P1438, DOI 10.1053/gast.2001.24006; Zhong J, 2006, J VIROL, V80, P11082, DOI 10.1128/JVI.01307-06	45	6	6	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e36107	10.1371/journal.pone.0036107	http://dx.doi.org/10.1371/journal.pone.0036107			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545157	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343200078
J	Purcell, J; Vasconcellos-Neto, J; Gonzaga, MO; Fletcher, JA; Aviles, L				Purcell, Jessica; Vasconcellos-Neto, Joao; Gonzaga, Marcelo O.; Fletcher, Jeffrey A.; Aviles, Leticia			Spatio-Temporal Differentiation and Sociality in Spiders	PLOS ONE			English	Article							ANELOSIMUS-JABAQUARA ARANEAE; PHYLOGENETIC ANALYSIS; LINYPHIID SPIDERS; EVOLUTION; SOLITARY; INSIGHTS; THERIDIIDAE; HYMENOPTERA; COMMUNITY; ANTS	Species that differ in their social system, and thus in traits such as group size and dispersal timing, may differ in their use of resources along spatial, temporal, or dietary dimensions. The role of sociality in creating differences in habitat use is best explored by studying closely related species or socially polymorphic species that differ in their social system, but share a common environment. Here we investigate whether five sympatric Anelosimus spider species that range from nearly solitary to highly social differ in their use of space and in their phenology as a function of their social system. By studying these species in Serra do Japi, Brazil, we find that the more social species, which form larger, longer-lived colonies, tend to live inside the forest, where sturdier, longer lasting vegetation is likely to offer better support for their nests. The less social species, which form single-family groups, in contrast, tend to occur on the forest edge where the vegetation is less robust. Within these two microhabitats, species with longer-lived colonies tend to occupy the potentially more stable positions closer to the core of the plants, while those with smaller and shorter-lived colonies build their nests towards the branch tips. The species further separate in their use of common habitat due to differences in the timing of their reproductive season. These patterns of habitat use suggest that the degree of sociality can enable otherwise similar species to differ from one another in ways that may facilitate their co-occurrence in a shared environment, a possibility that deserves further consideration.	[Purcell, Jessica; Fletcher, Jeffrey A.; Aviles, Leticia] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Purcell, Jessica] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Vasconcellos-Neto, Joao] Univ Estadual Campinas, Inst Biol, Dept Zool, Sao Paulo, Brazil; [Gonzaga, Marcelo O.] Univ Fed Uberlandia, Inst Biol, BR-38400 Uberlandia, MG, Brazil	University of British Columbia; University of Lausanne; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Federal de Uberlandia	Purcell, J (corresponding author), Univ British Columbia, Dept Zool, Vancouver, BC, Canada.	Jessica.Purcell@unil.ch	Aviles, Leticia/AAL-8190-2020; Hymenoptera, Inct/I-2210-2013; Gonzaga, Marcelo O/A-4805-2013; Purcell, Jessica/A-2445-2013; Neto, João Vasconcellos/I-6258-2017	Gonzaga, Marcelo O/0000-0003-0093-1801; Purcell, Jessica/0000-0001-8568-4162; Neto, João Vasconcellos/0000-0001-9306-7594	Natural Sciences and Engineering Research Council of Canada Discovery Grant; Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico grant; INCT/HYMPAR-Sudeste grant; USA National Science Foundation Post-Doctoral fellowship; USA National Science Foundation (NSF) Graduate Research Fellowship; Swiss National Science Foundation [31003A-125306]	Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico grant; INCT/HYMPAR-Sudeste grant; USA National Science Foundation Post-Doctoral fellowship(National Science Foundation (NSF)); USA National Science Foundation (NSF) Graduate Research Fellowship(National Science Foundation (NSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This project was funded by a Natural Sciences and Engineering Research Council of Canada Discovery Grant to LA: http://www.nserc-crsng.gc.ca/; a Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico grant to JV: http://agencia.fapesp.br/25; a INCT/HYMPAR-Sudeste grant to MOG and JV: http://www.hympar.ufscar.br/. JF was supported by an USA National Science Foundation Post-Doctoral fellowship, and JP was supported by an USA National Science Foundation (NSF) Graduate Research Fellowship. http://www.nsf.gov/. JP was also supported by grant 31003A-125306 from the Swiss National Science Foundation: http://www.snf.ch/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2006, J NAT HIST, V40, P2681, DOI 10.1080/00222930601110752; Agnarsson I, 2006, ZOOL J LINN SOC-LOND, V146, P453, DOI 10.1111/j.1096-3642.2006.00213.x; Agnarsson I, 2005, ZOOL SCR, V34, P389, DOI 10.1111/j.1463-6409.2005.00189.x; Agnarsson I, 2007, MOL PHYLOGENET EVOL, V43, P833, DOI 10.1016/j.ympev.2006.09.011; Agnarsson I, 2006, EVOLUTION, V60, P2342; Anderson C, 2001, BIOL REV, V76, P211, DOI 10.1017/S1464793101005656; Aviles L, 2007, AM NAT, V170, P783, DOI 10.1086/521965; Aviles Leticia, 1997, P476; Campon FF, 2008, ANIM BEHAV, V75, P1063, DOI 10.1016/j.anbehav.2007.08.021; Chapman Thomas W., 2008, P57, DOI 10.1007/978-3-540-75957-7_3; Eickwort GC, 1996, BEHAV ECOL SOCIOBIOL, V38, P227, DOI 10.1007/s002650050236; Fernandez-Marin H, 2006, NATURWISSENSCHAFTEN, V93, P17, DOI 10.1007/s00114-005-0048-z; Fischer ML, 2005, J MED ENTOMOL, V42, P756, DOI 10.1603/0022-2585(2005)042[0756:MOBLIA]2.0.CO;2; Furey FE, 1998, ANIM BEHAV, V55, P727, DOI 10.1006/anbe.1997.0648; Gause G. F., 1934, STRUGGLE EXISTENCE; Gonzaga MD, 1999, J ARACHNOL, V27, P432; Gonzaga MO, 2001, INSECT SOC, V48, P94, DOI 10.1007/PL00001765; Guevara J, 2007, ECOLOGY, V88, P2015, DOI 10.1890/06-0995.1; Guevara J, 2011, BEHAV ECOL, V22, P630, DOI 10.1093/beheco/arr022; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Harwood JD, 2003, J ANIM ECOL, V72, P745, DOI 10.1046/j.1365-2656.2003.00746.x; Henschel JR, 1998, J ARACHNOL, V26, P61; Herberstein ME, 1998, ACTA OECOL, V19, P67, DOI 10.1016/S1146-609X(98)80009-X; JARVIS JUM, 1994, TRENDS ECOL EVOL, V9, P47, DOI 10.1016/0169-5347(94)90267-4; Jeanne R.L., 1991, P191; Jones TC, 2007, ANIM BEHAV, V73, P195, DOI 10.1016/j.anbehav.2006.06.006; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Krebs CJ., 1999, ECOLOGICAL METHODOLO; LeBrun EG, 2005, OECOLOGIA, V142, P643, DOI 10.1007/s00442-004-1763-4; LIN N, 1972, Q REV BIOL, V47, P131, DOI 10.1086/407216; Lubin Y, 2007, ADV STUD BEHAV, V37, P83, DOI 10.1016/S0065-3454(07)37003-4; Marques ESA, 1998, J ARACHNOL, V26, P227; Masuko K, 2010, ENTOMOL SCI, V13, P191, DOI 10.1111/j.1479-8298.2010.00383.x; Mitri S, 2011, P NATL ACAD SCI USA, V108, P10839, DOI 10.1073/pnas.1100292108; MORELLATO L P C, 1989, Revista Brasileira de Botanica, V12, P85; MORELLATO LPC, 1992, HIST NATURAL SERRA J, P112; Pike Nathan, 2008, P37, DOI 10.1007/978-3-540-75957-7_2; Pinto HS, 1992, HIST NATURAL SERRA J, P30; Plateaux-Quenu C, 2000, INSECT SOC, V47, P263, DOI 10.1007/PL00001713; Powers KS, 2007, J ANIM ECOL, V76, P995, DOI 10.1111/j.1365-2656.2007.01267.x; Purcell J, 2008, P ROY SOC B-BIOL SCI, V275, P2617, DOI 10.1098/rspb.2008.0582; Purcell J, 2007, J ANIM ECOL, V76, P590, DOI 10.1111/j.1365-2656.2007.01228.x; Purcell J, 2011, BIOL REV, V86, P475, DOI 10.1111/j.1469-185X.2010.00156.x; SAVOLAINEN R, 1988, OIKOS, V51, P135, DOI 10.2307/3565636; Schluter D, 1996, PHILOS T R SOC B, V351, P807, DOI 10.1098/rstb.1996.0075; Schwarz MP, 2007, ANNU REV ENTOMOL, V52, P127, DOI 10.1146/annurev.ento.51.110104.150950; Siepielski AM, 2010, ECOLOGY, V91, P3153, DOI 10.1890/10-0154.1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wcislo WT, 1997, TRENDS ECOL EVOL, V12, P468, DOI 10.1016/S0169-5347(97)01198-1; WCISLO WT, 1984, BEHAV ECOL SOCIOBIOL, V15, P157, DOI 10.1007/BF00299384; Wise DH, 1993, SPIDERS ECOLOGICAL W; Yip EC, 2008, P NATL ACAD SCI USA, V105, P11818, DOI 10.1073/pnas.0710603105; Zammit J, 2008, INSECT SOC, V55, P74, DOI 10.1007/s00040-007-0972-3	53	13	15	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e34592	10.1371/journal.pone.0034592	http://dx.doi.org/10.1371/journal.pone.0034592			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545086	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343200009
J	Belaguli, NS; Zhang, M; Garcia, AH; Berger, DH				Belaguli, Narasimhaswamy S.; Zhang, Mao; Garcia, Andres-Hernandez; Berger, David H.			PIAS1 Is a GATA4 SUMO Ligase That Regulates GATA4-Dependent Intestinal Promoters Independent of SUMO Ligase Activity and GATA4 Sumoylation	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GATA-4; CARDIAC GENE-EXPRESSION; MOUSE SMALL-INTESTINE; BINDING PROTEIN GENE; MUTUAL COFACTORS; DIFFERENTIATION; REPRESSION; HNF-1-ALPHA; MAINTENANCE; ACTIVATE	GATA4 confers cell type-specific gene expression on genes expressed in cardiovascular, gastro-intestinal, endocrine and neuronal tissues by interacting with various ubiquitous and cell-type-restricted transcriptional regulators. By using yeast two-hybrid screening approach, we have identified PIAS1 as an intestine-expressed GATA4 interacting protein. The physical interaction between GATA4 and PIAS1 was confirmed in mammalian cells by coimmunoprecipitation and two-hybrid analysis. The interacting domains were mapped to the second zinc finger and the adjacent C-terminal basic region of GATA4 and the RING finger and the adjoining C-terminal 60 amino acids of PIAS1. PIAS1 and GATA4 synergistically activated IFABP and SI promoters but not LPH promoters suggesting that PIAS1 differentially activates GATA4 targeted promoters. In primary murine enterocytes PIAS1 was recruited to the GATA4-regulated IFABP promoter. PIAS1 promoted SUMO-1 modification of GATA4 on lysine 366. However, sumoylation was not required for the nuclear localization and stability of GATA4. Further, neither GATA4 sumoylation nor the SUMO ligase activity of PIAS1 was required for coactivation of IFABP promoter by GATA4 and PIAS1. Together, our results demonstrate that PIAS1 is a SUMO ligase for GATA4 that differentially regulates GATA4 transcriptional activity independent of SUMO ligase activity and GATA4 sumoylation.	[Belaguli, Narasimhaswamy S.; Zhang, Mao; Garcia, Andres-Hernandez; Berger, David H.] Baylor Coll Med, Michael E DeBakey Dept Surg, Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA	Baylor College of Medicine	Belaguli, NS (corresponding author), Baylor Coll Med, Michael E DeBakey Dept Surg, Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA.	elaguli@bcm.edu; dhb@bcm.edu	HERNANDEZ-GARCIA, ANDRES/B-9051-2014; HERNANDEZ-GARCIA, ANDRES/B-6346-2008	HERNANDEZ-GARCIA, ANDRES/0000-0002-5343-5513; 	Veterans Affairs	Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Veterans Affairs Merit Review Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri S, 2009, ONCOGENE, V28, P3033, DOI 10.1038/onc.2009.159; Agnihotri S, 2011, J EXP MED, V208, P689, DOI 10.1084/jem.20102099; Battle MA, 2008, GASTROENTEROLOGY, V135, P1676, DOI 10.1053/j.gastro.2008.07.074; Belaguli NS, 2007, AM J PHYSIOL-GASTR L, V292, pG1520, DOI 10.1152/ajpgi.00236.2006; Belaguli NS, 2010, NEOPLASIA, V12, P856, DOI 10.1593/neo.10224; Belaguli NS, 2000, MOL CELL BIOL, V20, P7550, DOI 10.1128/MCB.20.20.7550-7558.2000; Benoit YD, 2010, AM J PHYSIOL-GASTR L, V298, pG504, DOI 10.1152/ajpgi.00265.2009; Beuling E, 2008, DEV BIOL, V322, P179, DOI 10.1016/j.ydbio.2008.07.022; Beuling E, 2011, GASTROENTEROLOGY, V140, P1219, DOI 10.1053/j.gastro.2011.01.033; Bosse T, 2006, MOL CELL BIOL, V26, P9060, DOI 10.1128/MCB.00124-06; Boudreau F, 2002, J BIOL CHEM, V277, P31909, DOI 10.1074/jbc.M204622200; Brown CO, 2004, J BIOL CHEM, V279, P10659, DOI 10.1074/jbc.M301648200; Charron F, 2001, GENE DEV, V15, P2702, DOI 10.1101/gad.915701; Dai YS, 2002, J BIOL CHEM, V277, P24390, DOI 10.1074/jbc.M202490200; Demarque MD, 2011, GASTROENTEROLOGY, V140, P286, DOI 10.1053/j.gastro.2010.10.002; Divine JK, 2004, AM J PHYSIOL-GASTR L, V287, pG1086, DOI 10.1152/ajpgi.00421.2003; Divine JK, 2006, AM J PHYSIOL-GASTR L, V291, pG297, DOI 10.1152/ajpgi.00422.2003; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Escaffit F, 2005, J CELL PHYSIOL, V203, P15, DOI 10.1002/jcp.20189; Fang RX, 2006, GENE EXPR PATTERNS, V6, P426, DOI 10.1016/j.modgep.2005.09.003; Fang RX, 2001, AM J PHYSIOL-GASTR L, V280, pG58, DOI 10.1152/ajpgi.2001.280.1.G58; Fluck CE, 2004, MOL ENDOCRINOL, V18, P1144, DOI 10.1210/me.2003-0342; Gao XP, 1998, MOL CELL BIOL, V18, P2901, DOI 10.1128/MCB.18.5.2901; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Guo J, 2009, J BIOL CHEM, V284, P134, DOI 10.1074/jbc.M806133200; Holmstrom S, 2003, P NATL ACAD SCI USA, V100, P15758, DOI 10.1073/pnas.2136933100; Iniguez-Lluhi JA, 2000, MOL CELL BIOL, V20, P6040, DOI 10.1128/MCB.20.16.6040-6050.2000; Jian OY, 2009, MOL CELL, V34, P145, DOI 10.1016/j.molcel.2009.03.013; Komatsu T, 2004, MOL ENDOCRINOL, V18, P2451, DOI 10.1210/me.2004-0173; Krasinski SD, 2001, AM J PHYSIOL-GASTR L, V281, pG69, DOI 10.1152/ajpgi.2001.281.1.G69; Liang QR, 2001, MOL CELL BIOL, V21, P7460, DOI 10.1128/MCB.21.21.7460-7469.2001; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Peterkin T, 2005, SEMIN CELL DEV BIOL, V16, P83, DOI 10.1016/j.semcdb.2004.10.003; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; Snow JW, 2010, J BIOL CHEM, V285, P28064, DOI 10.1074/jbc.M109.096909; Stielow B, 2008, MOL CELL, V29, P742, DOI 10.1016/j.molcel.2007.12.032; Suda N, 2011, ENDOCRINOLOGY, V152, P2266, DOI 10.1210/en.2010-1232; Sumi K, 2007, MOL CELL BIOL, V27, P4248, DOI 10.1128/MCB.01894-06; Svensson EC, 1999, P NATL ACAD SCI USA, V96, P956, DOI 10.1073/pnas.96.3.956; Takahashi H, 2005, J BIOL CHEM, V280, P5611, DOI 10.1074/jbc.M408130200; Takaya T, 2008, J BIOL CHEM, V283, P9828, DOI 10.1074/jbc.M707391200; Tan JA, 2002, J BIOL CHEM, V277, P16993, DOI 10.1074/jbc.M109217200; Tremblay JJ, 1999, MOL ENDOCRINOL, V13, P1388, DOI 10.1210/me.13.8.1388; Tremblay JJ, 2003, J BIOL CHEM, V278, P22128, DOI 10.1074/jbc.M213149200; Trivedi CM, 2010, DEV CELL, V19, P450, DOI 10.1016/j.devcel.2010.08.012; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Valin A, 2007, BIOCHEM SOC T, V35, P1393, DOI 10.1042/BST0351393; van Wering HM, 2004, AM J PHYSIOL-GASTR L, V287, pG899, DOI 10.1152/ajpgi.00150.2004; Viger RS, 2008, MOL ENDOCRINOL, V22, P781, DOI 10.1210/me.2007-0513; Wang J, 2005, MOL CELL BIOL, V25, P9829, DOI 10.1128/MCB.25.22.9829-9844.2005; Wang J, 2004, J BIOL CHEM, V279, P49091, DOI 10.1074/jbc.M407494200; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7	56	9	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35717	10.1371/journal.pone.0035717	http://dx.doi.org/10.1371/journal.pone.0035717			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539995	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341000061
J	Bethge, A; Schumacher, U; Wree, A; Wedemann, G				Bethge, Anja; Schumacher, Udo; Wree, Andreas; Wedemann, Gero			Are Metastases from Metastases Clinical Relevant? Computer Modelling of Cancer Spread in a Case of Hepatocellular Carcinoma	PLOS ONE			English	Article							BREAST-CANCER; PRIMARY TUMORS; CELLS; SURVIVAL; GROWTH; PERSPECTIVES; PROGNOSIS; PATTERNS	Background: Metastasis formation remains an enigmatic process and one of the main questions recently asked is whether metastases are able to generate further metastases. Different models have been proposed to answer this question; however, their clinical significance remains unclear. Therefore a computer model was developed that permits comparison of the different models quantitatively with clinical data and that additionally predicts the outcome of treatment interventions. Methods: The computer model is based on discrete events simulation approach. On the basis of a case from an untreated patient with hepatocellular carcinoma and its multiple metastases in the liver, it was evaluated whether metastases are able to metastasise and in particular if late disseminated tumour cells are still capable to form metastases. Additionally, the resection of the primary tumour was simulated. The simulation results were compared with clinical data. Results: The simulation results reveal that the number of metastases varies significantly between scenarios where metastases metastasise and scenarios where they do not. In contrast, the total tumour mass is nearly unaffected by the two different modes of metastasis formation. Furthermore, the results provide evidence that metastasis formation is an early event and that late disseminated tumour cells are still capable of forming metastases. Simulations also allow estimating how the resection of the primary tumour delays the patient's death. Conclusion: The simulation results indicate that for this particular case of a hepatocellular carcinoma late metastases, i.e., metastases from metastases, are irrelevant in terms of total tumour mass. Hence metastases seeded from metastases are clinically irrelevant in our model system. Only the first metastases seeded from the primary tumour contribute significantly to the tumour burden and thus cause the patient's death.	[Bethge, Anja; Wedemann, Gero] Univ Appl Sci Stralsund, Inst Appl Comp Sci, Competence Ctr Bioinformat, Stralsund, Germany; [Schumacher, Udo] Univ Med Ctr Hamburg Eppendorf, Inst Anat & Expt Morphol, Hamburg, Germany; [Wree, Andreas] Univ Rostock, Inst Anat, Rostock, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Rostock	Bethge, A (corresponding author), Univ Appl Sci Stralsund, Inst Appl Comp Sci, Competence Ctr Bioinformat, Stralsund, Germany.	gero.wedemann@fh-stralsund.de	Wedemann, Gero/A-6384-2009	Wedemann, Gero/0000-0001-7869-774X	Institute for Applied Computer Science, University of Applied Sciences Stralsund	Institute for Applied Computer Science, University of Applied Sciences Stralsund	The work was funded by the Institute for Applied Computer Science, University of Applied Sciences Stralsund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ARA, 2008, NAT REV CANCER, V8, P227, DOI 10.1038/nrc2329; Barbolosi D, 2009, MATH BIOSCI, V218, P1, DOI 10.1016/j.mbs.2008.11.008; Bernhardt P, 2003, MED PHYS, V30, P3227, DOI 10.1118/1.1628851; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chen LL, 2008, PHYSICA A, V387, P3162, DOI 10.1016/j.physa.2008.01.116; Cormio G, 2003, INT J GYNECOL CANCER, V13, P125, DOI 10.1046/j.1525-1438.2003.13054.x; Engel J, 2010, EUR UROL, V57, P754, DOI 10.1016/j.eururo.2009.12.034; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Greten TF, 2005, BRIT J CANCER, V92, P1862, DOI 10.1038/sj.bjc.6602590; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Huang Sui, 2006, Breast Dis, V26, P27; Iwasaki H, 2009, CANCER SCI, V100, P1166, DOI 10.1111/j.1349-7006.2009.01177.x; Iwata K, 2000, J THEOR BIOL, V203, P177, DOI 10.1006/jtbi.2000.1075; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Kesmodel SB, 2006, SURG REV INTEGRATED, P61; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Koch G, 2009, J PHARMACOKINET PHAR, V36, P179, DOI 10.1007/s10928-009-9117-9; Meng SD, 2004, CLIN CANCER RES, V10, P8152, DOI 10.1158/1078-0432.CCR-04-1110; Michaelson JS, 2009, CANCER-AM CANCER SOC, V115, P5095, DOI 10.1002/cncr.24592; Monteiro J, 2010, EUR J CANCER, V46, P1198, DOI 10.1016/j.ejca.2010.02.030; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; OKUDA K, 1985, CANCER, V56, P918, DOI 10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E; PAGET S, 1989, CANCER METAST REV, V8, P98; PATANAPHAN V, 1988, SOUTHERN MED J, V81, P1109, DOI 10.1097/00007611-198809000-00011; Pavelic SK, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-22; Pons Fernando, 2005, HPB (Oxford), V7, P35, DOI 10.1080/13651820410024058; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Sinek JP, 2009, J MATH BIOL, V58, P485, DOI 10.1007/s00285-008-0214-y; Stoecklein NH, 2010, INT J CANCER, V126, P589, DOI 10.1002/ijc.24916; Stuart KE, 1996, CANCER, V77, P2217, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2217::AID-CNCR6>3.0.CO;2-M; Wedemann G, METHODS MOL IN PRESS; Weinberg RA, 2006, BIOL CANC	33	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35689	10.1371/journal.pone.0035689	http://dx.doi.org/10.1371/journal.pone.0035689			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539992	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341000058
J	Ling, HY; Edwards, AM; Gantier, MP; DeBoer, KD; Neale, AD; Hamill, JD; Walmsley, AM				Ling, Huai-Yian; Edwards, Aaron M.; Gantier, Michael P.; DeBoer, Kathleen D.; Neale, Alan D.; Hamill, John D.; Walmsley, Amanda M.			An Interspecific Nicotiana Hybrid as a Useful and Cost-Effective Platform for Production of Animal Vaccines	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; PLANT-MADE VACCINES; IMMUNE-RESPONSE; TRANSIENT EXPRESSION; PROTECTIVE IMMUNITY; CHALLENGE INFECTION; PANDEMIC INFLUENZA; INNATE IMMUNITY; TABACUM L.; TOBACCO	The use of transgenic plants to produce novel products has great biotechnological potential as the relatively inexpensive inputs of light, water, and nutrients are utilised in return for potentially valuable bioactive metabolites, diagnostic proteins and vaccines. Extensive research is ongoing in this area internationally with the aim of producing plant-made vaccines of importance for both animals and humans. Vaccine purification is generally regarded as being integral to the preparation of safe and effective vaccines for use in humans. However, the use of crude plant extracts for animal immunisation may enable plant-made vaccines to become a cost-effective and efficacious approach to safely immunise large numbers of farm animals against diseases such as avian influenza. Since the technology associated with genetic transformation and large-scale propagation is very well established in Nicotiana, the genus has attributes well-suited for the production of plant-made vaccines. However the presence of potentially toxic alkaloids in Nicotiana extracts impedes their use as crude vaccine preparations. In the current study we describe a Nicotiana tabacum and N. glauca hybrid that expresses the HA glycoprotein of influenza A in its leaves but does not synthesize alkaloids. We demonstrate that injection with crude leaf extracts from these interspecific hybrid plants is a safe and effective approach for immunising mice. Moreover, this antigen-producing alkaloid-free, transgenic interspecific hybrid is vigorous, with a high capacity for vegetative shoot regeneration after harvesting. These plants are easily propagated by vegetative cuttings and have the added benefit of not producing viable pollen, thus reducing potential problems associated with bio-containment. Hence, these Nicotiana hybrids provide an advantageous production platform for partially purified, plant-made vaccines which may be particularly well suited for use in veterinary immunization programs.	[Ling, Huai-Yian; Edwards, Aaron M.; Neale, Alan D.; Walmsley, Amanda M.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia; [Gantier, Michael P.] Ctr Canc Res, Monash Inst Med Res, Melbourne, Vic, Australia; [DeBoer, Kathleen D.] Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic 3004, Australia; [Hamill, John D.] Univ Melbourne, Dept Forest & Ecosyst Sci, Creswick, Vic, Australia	Monash University; Monash University; University of Melbourne	Ling, HY (corresponding author), Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia.	john.hamill@unimelb.edu.au; Amanda.Walmsley@monash.edu.au	Gantier, Michael/B-7512-2011; Gantier, Michael/H-7954-2019	Gantier, Michael/0000-0003-3740-698X; Gantier, Michael/0000-0003-3740-698X	Australian Research Council; Faculty of Science from Monash University; Dow AgroScience, LLC	Australian Research Council(Australian Research Council); Faculty of Science from Monash University; Dow AgroScience, LLC	H-YL received an International Post Graduate Award from the Australian Research Council and scholarship fees and a Faculty of Science Postgraduate Publication Award from Monash University. This research was supported by a Linkage Grant from the Australian Research Council and Dow AgroScience, LLC to JDH and AMW. www.monash.edu.au, www.arc.gov.au/, www.dowagro.com/au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: This research was supported by a linkage grant from the Australina Research Council and Dow AgroScience LLC. The constructs and antibody reagents were obtained from Dow AgroScience LLC under a material transfer agreement. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Allen GC, 2006, NAT PROTOC, V1, P2320, DOI 10.1038/nprot.2006.384; BALDWIN IT, 1989, J CHEM ECOL, V15, P1661, DOI 10.1007/BF01012392; Beclin C, 2002, CURR BIOL, V12, P684, DOI 10.1016/S0960-9822(02)00792-3; Boyce TG, 2000, BIOMED PHARMACOTHER, V54, P210, DOI 10.1016/S0753-3322(00)89027-7; Cane KA, 2005, FUNCT PLANT BIOL, V32, P305, DOI 10.1071/FP04008; CHAPLIN JF, 1975, CROP SCI, V15, P282, DOI 10.2135/cropsci1975.0011183X001500020048x; Chen J, 2007, AM J PHYSIOL-GASTR L, V293, pG568, DOI 10.1152/ajpgi.00201.2007; Chintapakorn Y, 2003, PLANT MOL BIOL, V53, P87, DOI 10.1023/B:PLAN.0000009268.45851.95; Collins GB, 1979, NICOTIANA PROCEDURES; D'Aoust MA, 2008, PLANT BIOTECHNOL J, V6, P930, DOI 10.1111/j.1467-7652.2008.00384.x; D'Aoust MA, 2010, PLANT BIOTECHNOL J, V8, P607, DOI 10.1111/j.1467-7652.2009.00496.x; DeBoer K.D., 2010, THESIS MONASH U MELB; DeBoer KD, 2009, PLANT MOL BIOL, V69, P299, DOI 10.1007/s11103-008-9425-2; Driscoll P, 1972, SOZIAL PRAVENTIVMEDI, V17, P211; Gantier MP, 2010, MONITORING INNATE IM, P21; Gleba Y, 2007, CURR OPIN BIOTECH, V18, P134, DOI 10.1016/j.copbio.2007.03.002; HAMILL JD, 1985, THEOR APPL GENET, V71, P486, DOI 10.1007/BF00251193; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; HOOD EE, 1993, TRANSGENIC RES, V2, P208, DOI 10.1007/BF01977351; Huber VC, 2006, CLIN VACCINE IMMUNOL, V13, P981, DOI 10.1128/CVI.00156-06; Janssens S, 2003, CLIN MICROBIOL REV, V16, P637, DOI 10.1128/CMR.16.4.637-646.2003; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Kilbourne ED, 2004, VIRAL IMMUNOL, V17, P350, DOI 10.1089/0882824041857076; Kirk DD, 2004, EXPERT OPIN BIOL TH, V4, P947, DOI 10.1517/14712598.4.6.947; Lee ST, 2006, NEUROTOXICOL TERATOL, V28, P220, DOI 10.1016/j.ntt.2005.12.010; Ling HY, 2010, EXPERT REV VACCINES, V9, P971, DOI [10.1586/erv.10.87, 10.1586/ERV.10.87]; Marillonnet S, 2005, NAT BIOTECHNOL, V23, P718, DOI 10.1038/nbt1094; Marillonnet S, 2004, P NATL ACAD SCI USA, V101, P6852, DOI 10.1073/pnas.0400149101; MASON HS, 1992, P NATL ACAD SCI USA, V89, P11745, DOI 10.1073/pnas.89.24.11745; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Menassa R, 2001, MOL BREEDING, V8, P177, DOI 10.1023/A:1013376407362; Menassa R, 2007, PLANT BIOTECHNOL J, V5, P50, DOI 10.1111/j.1467-7652.2006.00214.x; Mett V, 2008, INFLUENZA OTHER RESP, V2, P33, DOI 10.1111/j.1750-2659.2008.00037.x; Musiychuk K, 2007, INFLUENZA OTHER RESP, V1, P19, DOI 10.1111/j.1750-2659.2006.00005.x; NI M, 1995, PLANT J, V7, P661, DOI 10.1046/j.1365-313X.1995.7040661.x; Noah DL, 2009, CLIN VACCINE IMMUNOL, V16, P558, DOI 10.1128/CVI.00368-08; OKAMOTO M, 1994, PHARMACOL TOXICOL, V75, P1, DOI 10.1111/j.1600-0773.1994.tb00316.x; Pelosi A, 2011, CURR DRUG DELIV, V8, P612, DOI 10.2174/156720111797635513; PENTAL D, 1984, HEREDITY, V53, P79, DOI 10.1038/hdy.1984.64; Rigano MM, 2009, VACCINE, V27, P3463, DOI 10.1016/j.vaccine.2009.01.120; Rivera E, 2003, VACCINE, V21, P1149, DOI 10.1016/S0264-410X(02)00518-2; SAITOH F, 1985, PHYTOCHEMISTRY, V24, P477, DOI 10.1016/S0031-9422(00)80751-7; Sambrook J., 2001, MOL CLONING LAB MANU; SAUNDERS JW, 1979, PLANT PHYSIOL, V64, P236, DOI 10.1104/pp.64.2.236; SCHLUPMANN H, 1993, PLANTA, V191, P470, DOI 10.1007/BF00195748; Shoji T, 2010, PLANT CELL, V22, P3390, DOI 10.1105/tpc.110.078543; Shoji Y, 2009, VACCINE, V27, P1087, DOI 10.1016/j.vaccine.2008.11.108; Shoji Y, 2008, VACCINE, V26, P2930, DOI 10.1016/j.vaccine.2008.03.045; Shoji Y, 2009, VACCINE, V27, P3467, DOI 10.1016/j.vaccine.2009.01.051; Sinclair SJ, 2004, FUNCT PLANT BIOL, V31, P721, DOI 10.1071/FP03242; Sinclair SJ, 2000, PLANT MOL BIOL, V44, P603, DOI 10.1023/A:1026590521318; SISSON VA, 1990, BEITR TABAKFORSCH, V14, P327, DOI 10.2478/cttr-2013-0610; Song XM, 2009, VACCINE, V27, P51, DOI 10.1016/j.vaccine.2008.10.030; Soulet D, 2003, J CELL BIOL, V162, P257, DOI 10.1083/jcb.200301097; Spitsin S, 2009, VACCINE, V27, P1289, DOI 10.1016/j.vaccine.2008.12.050; Stanekova Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-351; Steppuhn A, 2004, PLOS BIOL, V2, P1074, DOI 10.1371/journal.pbio.0020217; Tremblay R, 2010, BIOTECHNOL ADV, V28, P214, DOI 10.1016/j.biotechadv.2009.11.008; Trojak-Goluch A, 2007, PLANT BREEDING, V126, P201, DOI 10.1111/j.1439-0523.2007.01341.x; Trojak-Goluch A, 2003, J APPL GENET, V44, P45; Vermij P, 2006, NAT BIOTECHNOL, V24, P1301, DOI 10.1038/nbt1106-1301; Walmsley AM, 2000, CURR OPIN BIOTECH, V11, P126, DOI 10.1016/S0958-1669(00)00070-7; Walmsley AM, 2003, CURR OPIN BIOTECH, V14, P145, DOI 10.1016/S0958-1669(03)00026-0; Zimmermann S, 1998, J IMMUNOL, V160, P3627	64	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35688	10.1371/journal.pone.0035688	http://dx.doi.org/10.1371/journal.pone.0035688			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539991	Green Published, gold			2022-12-27	WOS:000305341000057
J	Pfeuty, B				Pfeuty, Benjamin			Strategic Cell-Cycle Regulatory Features That Provide Mammalian Cells with Tunable G1 Length and Reversible G1 Arrest	PLOS ONE			English	Article							RESTRICTION POINT; CDK INHIBITORS; G(1) PHASE; FATE DETERMINATION; DEPENDENT KINASES; SENESCENCE; PROTEIN; PROGRESSION; ROLES; P53	Transitions between consecutive phases of the eukaryotic cell cycle are driven by the catalytic activity of selected sets of cyclin-dependent kinases (Cdks). Yet, their occurrence and precise timing is tightly scheduled by a variety of means including Cdk association with inhibitory/adaptor proteins (CKIs). Here we focus on the regulation of G1-phase duration by the end of which cells of multicelled organisms must decide whether to enter S phase or halt, and eventually then, differentiate, senesce or die to obey the homeostatic rules of their host. In mammalian cells, entry in and progression through G1 phase involve sequential phosphorylation and inactivation of the retinoblastoma Rb proteins, first, by cyclin D-Cdk4,6 with the help of CKIs of the Cip/Kip family and, next, by the cyclin E-Cdk2 complexes that are negatively regulated by Cip/Kip proteins. Using a dynamical modeling approach, we show that the very way how the Rb and Cip/Kip regulatory modules interact differentially with cyclin D-Cdk4,6 and cyclin E-Cdk2 provides to mammalian cells a powerful means to achieve an exquisitely-sensitive control of G1-phase duration and fully reversible G1 arrests. Consistently, corruption of either one of these two modules precludes G1 phase elongation and is able to convert G1 arrests from reversible to irreversible. This study unveils fundamental design principles of mammalian G1-phase regulation that are likely to confer to mammalian cells the ability to faithfully control the occurrence and timing of their division process in various conditions.	Univ Lille 1 Sci & Technol, Lab Phys Lasers Atomes & Mol, CNRS, UMR8523, Villeneuve, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Lille - ISITE; Universite de Lille	Pfeuty, B (corresponding author), Univ Lille 1 Sci & Technol, Lab Phys Lasers Atomes & Mol, CNRS, UMR8523, Villeneuve, France.	benjamin.pfeuty@univ-lille1.fr	pfeuty, benjamin/R-6825-2018		Ministry of Higher Education and Research; Nord-Pas de Calais Regional Council; FEDER (European fund for regional development) through the Contrat de Projets Etat-Region (CPER)	Ministry of Higher Education and Research(Ministry of Higher Education & Scientific Research (MHESR)); Nord-Pas de Calais Regional Council(Region Hauts-de-France); FEDER (European fund for regional development) through the Contrat de Projets Etat-Region (CPER)	This work was supported by Ministry of Higher Education and Research, Nord-Pas de Calais Regional Council and FEDER (European fund for regional development) through the Contrat de Projets Etat-Region (CPER). 2007-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afraimovich VS, 2008, PLOS COMPUT BIOL, V4, P05; Aguda BD, 2003, CELL CYCLE, V2, P538, DOI 10.4161/cc.2.6.550; Aguda BD, 1999, CELL PROLIFERAT, V32, P321, DOI 10.1046/j.1365-2184.1999.3250321.x; Baghdassarian N, 1999, BLOOD, V36, P689; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Blagosklonny MV, 2003, EMBO REP, V4, P358, DOI 10.1038/sj.embor.embor806; Blain SW, 2008, CELL CYCLE, V7, P892, DOI 10.4161/cc.7.7.5637; Blomen VA, 2007, CELL MOL LIFE SCI, V64, P3084, DOI 10.1007/s00018-007-7271-z; Busse D, 2000, J BIOL CHEM, V275, P6987, DOI 10.1074/jbc.275.10.6987; CAVANAUGH AH, 1995, NATURE, V374, P177, DOI 10.1038/374177a0; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Coverley D, 2002, NAT CELL BIOL, V4, P523, DOI 10.1038/ncb813; Csikasz-Nagy A, 2006, BIOPHYS J, V90, P4361, DOI 10.1529/biophysj.106.081240; David-Pfeuty T, 2006, BBA-REV CANCER, V1765, P38, DOI 10.1016/j.bbcan.2005.08.008; David-Pfeuty T, 2001, ONCOGENE, V20, P5951, DOI 10.1038/sj.onc.1204741; Escote X, 2004, NAT CELL BIOL, V6, P997, DOI 10.1038/ncb1174; Ezhevsky SA, 2001, MOL CELL BIOL, V21, P4773, DOI 10.1128/MCB.21.14.4773-4784.2001; Fuse T, 1996, BIOCHEM BIOPH RES CO, V225, P759, DOI 10.1006/bbrc.1996.1247; Gerard C, 2009, P NATL ACAD SCI USA, V106, P21643, DOI 10.1073/pnas.0903827106; Gros C, 2009, COGN COMPUT, V1, P77, DOI 10.1007/s12559-008-9000-9; Guantes R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000235; Guckenheimer J, 2013, APPL MATH SCI, V42; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; HARPER JW, 1993, CELL, V75, P805; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; HARTWELL LH, 1974, SCIENCE, V183, P46, DOI 10.1126/science.183.4120.46; HOFFMAN BD, 1991, CYTOMETRY, V12, P26, DOI 10.1002/cyto.990120105; Izhikevich M, 2006, DYNAMICAL SYSTEMS NE; James MK, 2008, MOL CELL BIOL, V28, P498, DOI 10.1128/MCB.02171-06; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Khan SH, 2008, CANCER RES, V58, P396; Kuchina A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002273; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Lane ME, 1996, CELL, V87, P1225, DOI 10.1016/S0092-8674(00)81818-8; Lange C, 2010, CELL CYCLE, V9, P1893, DOI 10.4161/cc.9.10.11598; Lefresne J, 1998, DEV GROWTH DIFFER, V40, P497; Linke SP, 1996, GENE DEV, V10, P934, DOI 10.1101/gad.10.8.934; Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; MCKINNEY JD, 1995, MOL CELL BIOL, V15, P2509; Mitsuhashi T, 2001, P NATL ACAD SCI USA, V98, P6435, DOI 10.1073/pnas.111051398; Novak M, 2004, J THEOR BIOL, V230, P563, DOI 10.1016/j.jtbi.2004.04.039; OUHIBI N, 1994, INT J DEV BIOL, V38, P731; Pajalunga D, 2007, J CELL BIOL, V176, P807, DOI 10.1083/jcb.200608109; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; Pfeuty B, 2008, CELL CYCLE, V7, P3246, DOI 10.4161/cc.7.20.6853; Pfeuty B, 2007, PHYS BIOL, V4, P194, DOI 10.1088/1478-3975/4/3/006; Pfeuty B, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002329; Salomoni P, 2010, TRENDS CELL BIOL, V20, P233, DOI 10.1016/j.tcb.2010.01.006; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; STEINMAN RA, 1994, ONCOGENE, V9, P3389; Swat M, 2004, BIOINFORMATICS, V20, P1506, DOI 10.1093/bioinformatics/bth110; Toettcher JE, 2009, P NATL ACAD SCI USA, V106, P785, DOI 10.1073/pnas.0806196106; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Tyson JJ, 2002, BIOESSAYS, V24, P1095, DOI 10.1002/bies.10191; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Yao G, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.19; Zhang HS, 2001, ONCOGENE, V20, P3134, DOI 10.1038/sj.onc.1204338; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	61	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35291	10.1371/journal.pone.0035291	http://dx.doi.org/10.1371/journal.pone.0035291			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22558136	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341000030
J	Malek, A; Nunez, LE; Magistri, M; Brambilla, L; Jovic, S; Carbone, GM; Moris, F; Catapano, CV				Malek, Anastasia; Nunez, Luz-Elena; Magistri, Marco; Brambilla, Lara; Jovic, Sandra; Carbone, Giuseppina M.; Moris, Francisco; Catapano, Carlo V.			Modulation of the Activity of Sp Transcription Factors by Mithramycin Analogues as a New Strategy for Treatment of Metastatic Prostate Cancer	PLOS ONE			English	Article							PRODUCER STREPTOMYCES-ARGILLACEUS; ACCELERATES TUMOR-FORMATION; ENDOTHELIAL GROWTH-FACTOR; CELL-CYCLE PROGRESSION; PANCREATIC-CANCER; COMBINATORIAL BIOSYNTHESIS; TOLFENAMIC ACID; ANTITUMOR-ACTIVITY; ANDROGEN RECEPTOR; DRUG MITHRAMYCIN	Deregulated activity of transcription factors (TFs) of the Sp/KLF family, like Sp1, Sp3 and Sp4, and consequent overexpression of Sp-regulated genes occur frequently in human cancers. This provides the rationale for development of inhibitors of Sp TFs as cancer therapeutics. Mithramycin A (MTM-A) is a natural polyketide that binds GC-rich DNA sequences, inhibits activity of Sp TFs and exhibits potent antitumor activity in experimental systems. However, clinical use of MTM-A is limited by the severe toxicity of the compound. Here, we studied two MTM-A analogues, which had been generated by genetically engineering of the MTM-A biosynthetic pathway, and evaluated their activity in human prostate cancer in cell cultures and mouse models. The compounds, named MTM-SDK and MTM-SK, were highly effective in vitro inhibiting proliferation of prostate cancer cells and transcription of Sp-regulated genes by blocking binding of Sp proteins to the gene promoters When administered to mice, both compounds were well tolerated with maximum tolerated doses of MTM-SDK and MTM-SK, respectively, 4- and 32- fold higher than MTM-A. After systemic administration, both compounds were cleared rapidly from the bloodstream but maintained plasma levels well above the active concentrations required in vitro for inhibition of Sp TF activity and cell proliferation. Consistently, MTM-SDK and MTM-SK inhibited transcription of Sp regulated genes in prostate tumor xenografts and exhibited potent antitumor activity in subcutaneous and metastatic tumor xenograft models with no or minimal toxicity. Taken together, these data indicate that MTM-SDK and MTM-SK possess significantly improved pharmacological and toxicological properties compared to MTM-A and represent promising drugs for treatment of advanced prostate cancer.	[Malek, Anastasia; Magistri, Marco; Brambilla, Lara; Jovic, Sandra; Carbone, Giuseppina M.; Catapano, Carlo V.] Oncol Res Inst, Bellinzona, Switzerland; [Malek, Anastasia; Magistri, Marco; Brambilla, Lara; Jovic, Sandra; Carbone, Giuseppina M.; Catapano, Carlo V.] Oncol Inst So Switzerland IOSI, Bellinzona, Switzerland; [Nunez, Luz-Elena; Moris, Francisco] EntreChem SL, Oviedo, Spain	Institute of Oncology Research (IOR); Institute of Oncology Research (IOR)	Malek, A (corresponding author), Oncol Res Inst, Bellinzona, Switzerland.	carlo.catapano@irb.unisi.ch	Malek, Anastasia V/R-8804-2016	Malek, Anastasia V/0000-0001-5334-7292; Brambilla, Lara/0000-0003-0054-4297; Catapano, Carlo V./0000-0002-7079-557X	Fondazione Ticinese per la Ricerca sul Cancro; Swiss National Science Foundation; Swiss Cancer League	Fondazione Ticinese per la Ricerca sul Cancro; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League	This work was supported by the Fondazione Ticinese per la Ricerca sul Cancro, Swiss National Science Foundation and Swiss Cancer League to CVC and GMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahim M, 2002, J BIOL CHEM, V277, P28815, DOI 10.1074/jbc.M203828200; Abdelrahim M, 2007, CANCER RES, V67, P3286, DOI 10.1158/0008-5472.CAN-06-3831; Abdelrahim M, 2006, J NATL CANCER I, V98, P855, DOI 10.1093/jnci/djj232; Albertini V, 2006, NUCLEIC ACIDS RES, V34, P1721, DOI 10.1093/nar/gkl063; Barcelo F, 2007, NUCLEIC ACIDS RES, V35, P2215, DOI 10.1093/nar/gkm037; Barcelo F, 2010, BIOCHEMISTRY-US, V49, P10543, DOI 10.1021/bi101398s; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Bond GL, 2006, CANCER RES, V66, P5104, DOI 10.1158/0008-5472.CAN-06-0180; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Calabresi P., 1991, PHARM BASIS THERAPEU; Chadalapaka G, 2008, CANCER RES, V68, P5345, DOI 10.1158/0008-5472.CAN-07-6805; Chintharlapalli S, 2007, CANCER RES, V67, P2816, DOI 10.1158/0008-5472.CAN-06-3735; Chun JY, 2007, MOL CANCER THER, V6, P2572, DOI 10.1158/1535-7163.MCT-07-0172; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Frank DA, 2009, IDRUGS, V12, P29; Gao Y, 2011, CANCER RES, V71, P5182, DOI 10.1158/0008-5472.CAN-10-2016; Gibson M, 2005, J AM CHEM SOC, V127, P17594, DOI 10.1021/ja055750t; Grohar PJ, 2011, JNCI-J NATL CANCER I, V103, P962, DOI 10.1093/jnci/djr156; Husbeck B, 2006, MOL CANCER THER, V5, P2078, DOI 10.1158/1535-7163.MCT-06-0056; Ishibashi H, 2000, CANCER RES, V60, P6531; Jemal A, 2011, CA CANC J CLIN; Jia ZL, 2007, CANCER RES, V67, P4878, DOI 10.1158/0008-5472.CAN-06-3494; Jia ZL, 2010, CANCER RES, V70, P1111, DOI 10.1158/0008-5472.CAN-09-3282; Jutooru I, 2010, J BIOL CHEM, V285, P25332, DOI 10.1074/jbc.M109.095240; Jutooru I, 2010, MOL PHARMACOL, V78, P226, DOI 10.1124/mol.110.064451; Kunderfranco P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010547; Lombo F, 2006, APPL MICROBIOL BIOT, V73, P1, DOI 10.1007/s00253-006-0511-6; Lou Z, 2005, CANCER RES, V65, P1007; Malek A, 2010, CLIN EXP METASTAS, V27, P261, DOI 10.1007/s10585-010-9324-1; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; MILLER DM, 1987, AM J MED SCI, V294, P388, DOI 10.1097/00000441-198711000-00015; Napoli S, 2009, EMBO J, V28, P1708, DOI 10.1038/emboj.2009.139; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Papineni S, 2009, CARCINOGENESIS, V30, P1193, DOI 10.1093/carcin/bgp092; Perez M, 2008, CHEMBIOCHEM, V9, P2295, DOI 10.1002/cbic.200800299; Post SM, 2010, CANCER CELL, V18, P220, DOI 10.1016/j.ccr.2010.07.010; Previdi S, 2010, GYNECOL ONCOL, V118, P182, DOI 10.1016/j.ygyno.2010.03.020; Remsing LL, 2003, BIOCHEMISTRY-US, V42, P8313, DOI 10.1021/bi034091z; Remsing LL, 2003, J AM CHEM SOC, V125, P5745, DOI 10.1021/ja034162h; Remsing LL, 2002, J AM CHEM SOC, V124, P1606, DOI 10.1021/ja0105156; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; SASTRY M, 1993, BIOCHEMISTRY-US, V32, P6588, DOI 10.1021/bi00077a012; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; SNYDER RC, 1991, BIOCHEMISTRY-US, V30, P4290, DOI 10.1021/bi00231a027; Trefzer A, 2002, J AM CHEM SOC, V124, P6056, DOI 10.1021/ja017385l; Vignati S, 2006, NEOPLASIA, V8, P851, DOI 10.1593/neo.06433; Willoughby JA, 2009, J BIOL CHEM, V284, P2203, DOI 10.1074/jbc.M804491200; Yuan HQ, 2008, BIOCHEM PHARMACOL, V75, P2112, DOI 10.1016/j.bcp.2008.03.005	49	41	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35130	10.1371/journal.pone.0035130	http://dx.doi.org/10.1371/journal.pone.0035130			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22545098	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336200024
J	Chung, STL; Li, RW; Levi, DM				Chung, Susana T. L.; Li, Roger W.; Levi, Dennis M.			Learning to Identify Near-Acuity Letters, either with or without Flankers, Results in Improved Letter Size and Spacing Limits in Adults with Amblyopia	PLOS ONE			English	Article							CONTRAST-DEFINED LETTERS; STRABISMIC AMBLYOPIA; CONTOUR INTEGRATION; LETTER-RECOGNITION; VISUAL-ACUITY; READING SPEED; PSYCHOPHYSICS; SENSITIVITY; VISION; DISCRIMINATION	Amblyopia is a developmental abnormality that results in deficits for a wide range of visual tasks, most notably, the reduced ability to see fine details, the loss in contrast sensitivity especially for small objects and the difficulty in seeing objects in clutter (crowding). The primary goal of this study was to evaluate whether crowding can be ameliorated in adults with amblyopia through perceptual learning using a flanked letter identification task that was designed to reduce crowding, and if so, whether the improvements transfer to untrained visual functions: visual acuity, contrast sensitivity and the size of visual span (the amount of information obtained in one fixation). To evaluate whether the improvements following this training task were specific to training with flankers, we also trained another group of adult observers with amblyopia using a single letter identification task that was designed to improve letter contrast sensitivity, not crowding. Following 10,000 trials of training, both groups of observers showed improvements in the respective training task. The improvements generalized to improved visual acuity, letter contrast sensitivity, size of the visual span, and reduced crowding. The magnitude of the improvement for each of these measurements was similar in the two training groups. Perceptual learning regimens aimed at reducing crowding or improving letter contrast sensitivity are both effective in improving visual acuity, contrast sensitivity for near-acuity objects and reducing the crowding effect, and could be useful as a clinical treatment for amblyopia.	[Chung, Susana T. L.; Li, Roger W.; Levi, Dennis M.] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; [Chung, Susana T. L.; Li, Roger W.; Levi, Dennis M.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Chung, STL (corresponding author), Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA.	s.chung@berkeley.edu	Levi, Dennis/J-7836-2019	Levi, Dennis/0000-0002-5350-8639; Chung, Susana/0000-0003-2729-1808; Li, Roger/0000-0002-1666-0543	National Institutes of Health [R01-EY012810, R01-EY01728]; NATIONAL EYE INSTITUTE [R01EY001728, R01EY012810] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by research grants R01-EY012810 and R01-EY01728 from the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; Astle AT, 2011, INVEST OPHTH VIS SCI, V52, P7195, DOI 10.1167/iovs.11-7584; Beckmann P. J., 1998, THESIS U MINNESOTA; Bonneh YS, 2004, VISION RES, V44, P3099, DOI 10.1016/j.visres.2004.07.031; BRADLEY A, 1981, INVEST OPHTH VIS SCI, V21, P467; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chung STL, 2005, VISION RES, V45, P1399, DOI 10.1016/j.visres.2004.11.021; Chung STL, 2004, VISION RES, V44, P695, DOI 10.1016/j.visres.2003.09.028; Chung STL, 2008, VISION RES, V48, P2739, DOI 10.1016/j.visres.2008.09.009; Chung STL, 2007, VISION RES, V47, P3150, DOI 10.1016/j.visres.2007.08.017; Chung STL, 2006, VISION RES, V46, P3853, DOI 10.1016/j.visres.2006.06.014; CIUFREDA KJ, 1987, OPHTHAL PHYSL OPT, V7, P461, DOI 10.1111/j.1475-1313.1987.tb00779.x; Dosher BA, 1998, P NATL ACAD SCI USA, V95, P13988, DOI 10.1073/pnas.95.23.13988; Fahle M, 1996, INVEST OPHTH VIS SCI, V37, P869; FLOM MC, 1963, J OPT SOC AM, V53, P1026, DOI 10.1364/JOSA.53.001026; Hariharan S, 2005, VISION RES, V45, P617, DOI 10.1016/j.visres.2004.09.035; HESS RF, 1977, VISION RES, V17, P1049, DOI 10.1016/0042-6989(77)90009-8; Hess RF, 1997, VISION RES, V37, P3145, DOI 10.1016/S0042-6989(96)00281-7; Hess RF, 2001, VISION RES, V41, P2285, DOI 10.1016/S0042-6989(01)00099-2; Huang CB, 2008, P NATL ACAD SCI USA, V105, P4068, DOI 10.1073/pnas.0800824105; Hussain Z, 2012, J NEUROSCI, V32, P474, DOI 10.1523/JNEUROSCI.3845-11.2012; Kozma P, 2003, VISUAL NEUROSCI, V20, P577, DOI 10.1017/S0952523803205113; LEGGE GE, 1989, VISION RES, V29, P989, DOI 10.1016/0042-6989(89)90114-4; Legge GE, 2001, VISION RES, V41, P725, DOI 10.1016/S0042-6989(00)00295-9; Legge GE, 2007, J VIS, V7, P91; Levi DM, 2007, J VISION, V7, DOI 10.1167/7.2.21; Levi DM, 2008, VISION RES, V48, P635, DOI 10.1016/j.visres.2007.12.009; Levi DM, 2007, VISION RES, V47, P512, DOI 10.1016/j.visres.2006.10.014; Levi DM, 2011, J VISION, V11, DOI 10.1167/11.1.10; Levi DM, 2009, VISION RES, V49, P2535, DOI 10.1016/j.visres.2009.02.010; Levi DM, 2009, PHILOS T R SOC B, V364, P399, DOI 10.1098/rstb.2008.0203; LEVI DM, 1977, INVEST OPHTH VIS SCI, V16, P90; LEVI DM, 1982, NATURE, V298, P268, DOI 10.1038/298268a0; Levi DM, 2002, VISION RES, V42, P1379, DOI 10.1016/S0042-6989(02)00061-5; LEVI DM, 1985, VISION RES, V25, P979, DOI 10.1016/0042-6989(85)90208-1; LEVI DM, 1983, VISION RES, V23, P1005, DOI 10.1016/0042-6989(83)90011-1; Li RW, 2005, INVEST OPHTH VIS SCI, V46, P3161, DOI 10.1167/iovs.05-0286; Li RW, 2004, NAT NEUROSCI, V7, P178, DOI 10.1038/nn1183; Liu XY, 2011, INVEST OPHTH VIS SCI, V52, P1531, DOI 10.1167/iovs.10-6355; Loudon SE, 2006, INVEST OPHTH VIS SCI, V47, P4393, DOI 10.1167/iovs.05-1428; Lu ZL, 2004, J VISION, V4, P44, DOI 10.1167/4.1.5; Mansouri B, 2005, VISION RES, V45, P2449, DOI 10.1016/j.visres.2005.02.018; McKee SP, 2003, J VISION, V3, P380, DOI 10.1167/3.5.5; Pediat Eye Dis Investigator Grp, 2003, ARCH OPHTHALMOL-CHIC, V121, P603; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Polat U, 2004, P NATL ACAD SCI USA, V101, P6692, DOI 10.1073/pnas.0401200101; Polat U, 2009, VISION RES, V49, P2599, DOI 10.1016/j.visres.2009.07.008; RENTSCHLER I, 1985, EXP BRAIN RES, V60, P270; Scheiman MM, 2005, ARCH OPHTHALMOL-CHIC, V123, P437; Selenow A., 1991, AMBLYOPIA BASIC CLIN; STUART JA, 1962, AM J OPHTHALMOL, V53, P471, DOI 10.1016/0002-9394(62)94878-X; Sun GJ, 2010, J VISION, V10, DOI 10.1167/10.5.16; Webber AL, 2008, OPTOMETRY VISION SCI, V85, P1074, DOI 10.1097/OPX.0b013e31818b9911; Wong EH, 2001, VISION RES, V41, P2951, DOI 10.1016/S0042-6989(01)00189-4; WOOD ICJ, 1983, OPHTHAL PHYSL OPT, V3, P337, DOI 10.1111/j.1475-1313.1983.tb00622.x; Xiao LQ, 2008, CURR BIOL, V18, P1922, DOI 10.1016/j.cub.2008.10.030; Yu DY, 2010, VISION RES, V50, P36, DOI 10.1016/j.visres.2009.10.005; Zhang JY, 2010, J NEUROSCI, V30, P12323, DOI 10.1523/JNEUROSCI.0704-10.2010; Zhou YF, 2006, VISION RES, V46, P739, DOI 10.1016/j.visres.2005.07.031	59	32	33	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35829	10.1371/journal.pone.0035829	http://dx.doi.org/10.1371/journal.pone.0035829			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558234	Green Published, gold			2022-12-27	WOS:000305340200024
J	Jelsbak, L; Thomsen, LE; Wallrodt, I; Jensen, PR; Olsen, JE				Jelsbak, Lotte; Thomsen, Line Elnif; Wallrodt, Inke; Jensen, Peter Ruhdal; Olsen, John Elmerdahl			Polyamines Are Required for Virulence in Salmonella enterica Serovar Typhimurium	PLOS ONE			English	Article							III SECRETION SYSTEM; PATHOGENICITY ISLAND 2; BACTERIAL SIGNAL MOLECULE; CAENORHABDITIS-ELEGANS; ESCHERICHIA-COLI; EPITHELIAL-CELLS; GENE-EXPRESSION; ENVIRONMENTAL-REGULATION; INTRACELLULAR SURVIVAL; EFFECTOR PROTEINS	Sensing and responding to environmental cues is a fundamental characteristic of bacterial physiology and virulence. Here we identify polyamines as novel environmental signals essential for virulence of Salmonella enterica serovar Typhimurium, a major intracellular pathogen and a model organism for studying typhoid fever. Central to its virulence are two major virulence loci Salmonella Pathogenicity Island 1 and 2 (SPI1 and SPI2). SPI1 promotes invasion of epithelial cells, whereas SPI2 enables S. Typhimurium to survive and proliferate within specialized compartments inside host cells. In this study, we show that an S. Typhimurium polyamine mutant is defective for invasion, intracellular survival, killing of the nematode Caenorhabditis elegans and systemic infection of the mouse model of typhoid fever. Virulence of the mutant could be restored by genetic complementation, and invasion and intracellular survival could, as well, be complemented by the addition of exogenous putrescine and spermidine to the bacterial cultures prior to infection. Interestingly, intracellular survival of the polyamine mutant was significantly enhanced above the wild type level by the addition of exogenous putrescine and spermidine to the bacterial cultures prior to infection, indicating that these polyamines function as an environmental signal that primes S. Typhimurium for intracellular survival. Accordingly, experiments addressed at elucidating the roles of these polyamines in infection revealed that expression of genes from both of the major virulence loci SPI1 and SPI2 responded to exogenous polyamines and was reduced in the polyamine mutant. Together our data demonstrate that putrescine and spermidine play a critical role in controlling virulence in S. Typhimurium most likely through stimulation of expression of essential virulence loci. Moreover, our data implicate these polyamines as key signals in S. Typhimurium virulence.	[Jelsbak, Lotte; Thomsen, Line Elnif; Wallrodt, Inke; Olsen, John Elmerdahl] Univ Copenhagen, Fac Life Sci, Dept Vet Dis Biol, Frederiksberg, Denmark; [Jensen, Peter Ruhdal] Tech Univ Denmark, Dept Syst Biol, Ctr Syst Microbiol, DK-2800 Lyngby, Denmark	University of Copenhagen; Technical University of Denmark	Jelsbak, L (corresponding author), Univ Copenhagen, Fac Life Sci, Dept Vet Dis Biol, Frederiksberg, Denmark.	loj@life.ku.dk	Olsen, John Elmerdahl/N-9271-2019; jensen, Peter Ruhdal/AAC-4891-2019	Jensen, Peter Ruhdal/0000-0003-2080-2070; Thomsen, Line Elnif/0000-0001-5460-9178; Jelsbak, Lotte/0000-0002-6642-7424; Olsen, John Elmerdahl/0000-0001-6225-6587	Danish Research Council for Technology and Production [274-07-0328]	Danish Research Council for Technology and Production	This study was supported by the Danish Research Council for Technology and Production through grant no. 274-07-0328. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay A, 2000, CURR BIOL, V10, P1539, DOI 10.1016/S0960-9822(00)00830-7; Bajaj V, 1996, MOL MICROBIOL, V22, P703, DOI 10.1046/j.1365-2958.1996.d01-1718.x; Barbagallo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027226; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Brown NF, 2005, PLOS PATHOG, V1, P252, DOI 10.1371/journal.ppat.0010032; Carlson PE, 2009, J BACTERIOL, V191, P6855, DOI 10.1128/JB.00995-09; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Chattopadhyay MK, 2003, P NATL ACAD SCI USA, V100, P2261, DOI 10.1073/pnas.2627990100; Cirillo DM, 1998, MOL MICROBIOL, V30, P175, DOI 10.1046/j.1365-2958.1998.01048.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deiwick J, 1999, MOL MICROBIOL, V31, P1759, DOI 10.1046/j.1365-2958.1999.01312.x; Deiwick J, 2006, INFECT IMMUN, V74, P6965, DOI 10.1128/IAI.00648-06; Durand JMB, 2003, MOL MICROBIOL, V47, P519, DOI 10.1046/j.1365-2958.2003.03314.x; Ellermeier JR, 2007, CURR OPIN MICROBIOL, V10, P24, DOI 10.1016/j.mib.2006.12.002; ENOMOTO M, 1974, VIROLOGY, V60, P503, DOI 10.1016/0042-6822(74)90344-4; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Fass E, 2009, CURR OPIN MICROBIOL, V12, P199, DOI 10.1016/j.mib.2009.01.004; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; GROISMAN EA, 1993, EMBO J, V12, P3779, DOI 10.1002/j.1460-2075.1993.tb06056.x; Guiney DG, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00129; GUTNICK D, 1969, J BACTERIOL, V100, P215, DOI 10.1128/JB.100.1.215-219.1969; Guy RL, 2000, MOL MICROBIOL, V37, P1417, DOI 10.1046/j.1365-2958.2000.02092.x; Hautefort I, 2008, CELL MICROBIOL, V10, P958, DOI 10.1111/j.1462-5822.2007.01099.x; Hensel M, 1997, MOL MICROBIOL, V24, P155, DOI 10.1046/j.1365-2958.1997.3271699.x; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; Higashi K, 2006, J BIOL CHEM, V281, P9527, DOI 10.1074/jbc.M513752200; Hopkins SA, 2000, CELL MICROBIOL, V2, P59; Ibarra JA, 2010, MICROBIOL-SGM, V156, P1120, DOI 10.1099/mic.0.032896-0; Ibarra JA, 2009, CELL MICROBIOL, V11, P1579, DOI 10.1111/j.1462-5822.2009.01368.x; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; Igarashi K., 2009, INT J BIOCH CELL BIO; Jelsbak L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012752; Jelsbak L, 2010, INT J MED MICROBIOL, V300, P229, DOI 10.1016/j.ijmm.2009.07.003; KANIGA K, 1995, J BACTERIOL, V177, P3965, DOI 10.1128/jb.177.14.3965-3971.1995; KANIGA K, 1995, J BACTERIOL, V177, P7078, DOI 10.1128/jb.177.24.7078-7085.1995; Knodler L.A., 2010, P NATL ACAD SCI US; Labrousse A, 2000, CURR BIOL, V10, P1543, DOI 10.1016/S0960-9822(00)00833-2; Lober S, 2006, INT J MED MICROBIOL, V296, P435, DOI 10.1016/j.ijmm.2006.05.001; Mastroeni P, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001840; McGinnis MW, 2009, FEMS MICROBIOL LETT, V299, P166, DOI 10.1111/j.1574-6968.2009.01744.x; Nasrallah GK, 2011, J BACTERIOL, V193, P4346, DOI 10.1128/JB.01506-10; Ochman H, 1996, INFECT IMMUN, V64, P5410, DOI 10.1128/IAI.64.12.5410-5412.1996; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Osborne SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021648; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pizarro-Cerda J, 2004, MOL MICROBIOL, V52, P1827, DOI 10.1111/j.1365-2958.2004.04122.x; Russo BC, 2011, INFECT IMMUN, V79, P3665, DOI 10.1128/IAI.00135-11; Rytkonen A, 2007, P NATL ACAD SCI USA, V104, P3502, DOI 10.1073/pnas.0610095104; SCHNABEL H, 1990, SCIENCE, V250, P686, DOI 10.1126/science.250.4981.686; Shah P, 2008, MOL MICROBIOL, V68, P4, DOI 10.1111/j.1365-2958.2008.06126.x; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; Shea JE, 1999, INFECT IMMUN, V67, P213, DOI 10.1128/IAI.67.1.213-219.1999; Steele-Mortimer O, 2002, CELL MICROBIOL, V4, P43, DOI 10.1046/j.1462-5822.2002.00170.x; Stein MA, 1996, MOL MICROBIOL, V20, P151, DOI 10.1111/j.1365-2958.1996.tb02497.x; Sturgill G, 2004, MOL MICROBIOL, V51, P437, DOI 10.1046/j.1365-2958.2003.03835.x; Tenor JL, 2004, CURR BIOL, V14, P1018, DOI 10.1016/j.cub.2004.05.050; Terui Y, 2007, J BACTERIOL, V189, P2359, DOI 10.1128/JB.01562-06; Terui Y, 2009, J BACTERIOL, V191, P5348, DOI 10.1128/JB.00387-09; Thompson A, 2006, J BIOL CHEM, V281, P30112, DOI 10.1074/jbc.M605616200; Thomsen LE, 2006, APPL ENVIRON MICROB, V72, P1700, DOI 10.1128/AEM.72.2.1700-1701.2006; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; Viala JPM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022397; WALLIS TS, 1995, INFECT IMMUN, V63, P2755, DOI 10.1128/IAI.63.7.2755-2761.1995; Watson KG, 2010, CELL MICROBIOL, V12, P1389, DOI 10.1111/j.1462-5822.2010.01511.x; WATSON PR, 1995, INFECT IMMUN, V63, P2743, DOI 10.1128/IAI.63.7.2743-2754.1995; Wortham BW, 2010, ENVIRON MICROBIOL, V12, P2034, DOI 10.1111/j.1462-2920.2010.02219.x; Zhou L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001291	68	81	82	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36149	10.1371/journal.pone.0036149	http://dx.doi.org/10.1371/journal.pone.0036149			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558361	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340200043
J	Siegel, AJ; Freedman, C; Page, RE				Siegel, Adam J.; Freedman, Colin; Page, Robert E., Jr.			Ovarian Control of Nectar Collection in the Honey Bee (Apis mellifera)	PLOS ONE			English	Article							DIVISION-OF-LABOR; SUCROSE RESPONSE THRESHOLDS; REPRODUCTIVE GROUND-PLAN; FORAGING BEHAVIOR; GENOTYPE; RESPONSIVENESS; L.; TACTILE	Honey bees are a model system for the study of division of labor. Worker bees demonstrate a foraging division of labor (DOL) by biasing collection towards carbohydrates (nectar) or protein (pollen). The Reproductive ground-plan hypothesis of Amdam et al. proposes that foraging DOL is regulated by the networks that controlled foraging behavior during the reproductive life cycle of honey bee ancestors. Here we test a proposed mechanism through which the ovary of the facultatively sterile worker impacts foraging bias. The proposed mechanism suggests that the ovary has a regulatory effect on sucrose sensitivity, and sucrose sensitivity impacts nectar loading. We tested this mechanism by measuring worker ovary size (ovariole number), sucrose sensitivity, and sucrose solution load size collected from a rate-controlled artificial feeder. We found a significant interaction between ovariole number and sucrose sensitivity on sucrose solution load size when using low concentration nectar. This supports our proposed mechanism. As nectar and pollen loading are not independent, a mechanism impacting nectar load size would also impact pollen load size.	[Siegel, Adam J.; Freedman, Colin; Page, Robert E., Jr.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Siegel, Adam J.] Hebrew Univ Jerusalem, Dept Ecol Evolut & Behav, Alexander Silberman Inst Life Sci, Jerusalem, Israel; [Page, Robert E., Jr.] Arizona State Univ, Coll Liberal Arts & Sci, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Hebrew University of Jerusalem; Arizona State University; Arizona State University-Tempe	Siegel, AJ (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	adam.siegel@mail.huji.ac.il			The National Institute of Aging (NIA) [P01 AG22500]; NATIONAL INSTITUTE ON AGING [P01AG022500] Funding Source: NIH RePORTER	The National Institute of Aging (NIA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was funded by a grant from The National Institute of Aging (NIA P01 AG22500) to REP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdam GV, 2006, NATURE, V439, P76, DOI 10.1038/nature04340; Amdam GV, 2005, EXP GERONTOL, V40, P939, DOI 10.1016/j.exger.2005.08.004; Amdam GV, 2004, P NATL ACAD SCI USA, V101, P11350, DOI 10.1073/pnas.0403073101; Curtis KS, 2005, PHYSIOL BEHAV, V86, P281, DOI 10.1016/j.physbeh.2005.08.002; Mujagic S, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00046; Mujagic S, 2009, J COMP PHYSIOL A, V195, P325, DOI 10.1007/s00359-008-0409-0; NUNEZ JA, 1971, ACTA CIENT VENEZ, V22, P101; Nunez JA, 1996, BEE WORLD, V77, P182, DOI 10.1080/0005772X.1996.11099313; NUNEZ JA, 1982, J APICULT RES, V21, P139, DOI 10.1080/00218839.1982.11100531; Oster G.F., 1978, Monographs in Population Biology, pi; Pacini E, 2003, PLANT SYST EVOL, V238, P7, DOI 10.1007/s00606-002-0277-y; Page RE, 1998, J COMP PHYSIOL A, V182, P489, DOI 10.1007/s003590050196; Page RE, 2000, J HERED, V91, P474, DOI 10.1093/jhered/91.6.474; Page RE, 2006, CURR TOP DEV BIOL, V74, P253, DOI 10.1016/S0070-2153(06)74008-X; Pankiw T, 1999, J COMP PHYSIOL A, V185, P207, DOI 10.1007/s003590050379; Pankiw T, 2000, BEHAV ECOL SOCIOBIOL, V47, P265, DOI 10.1007/s002650050664; Pankiw T, 2003, J COMP PHYSIOL A, V189, P675, DOI 10.1007/s00359-003-0442-y; Pankiw T, 2001, J COMP PHYSIOL A, V187, P293, DOI 10.1007/s003590100201; Rueppell O, 2008, J INSECT BEHAV, V21, P317, DOI 10.1007/s10905-008-9135-2; Scheiner R, 2004, APIDOLOGIE, V35, P133, DOI 10.1051/apido:2004001; Scheiner R, 2001, NEUROBIOL LEARN MEM, V76, P138, DOI 10.1006/nlme.2000.3996; Scheiner R, 2001, BEHAV BRAIN RES, V120, P67, DOI 10.1016/S0166-4328(00)00359-4; Seeley T., 1995, WISDOM HIVE SOCIAL P; Siegel AJ, 2012, ANIM BEHAV, V83, P653, DOI 10.1016/j.anbehav.2011.12.009; THAN TT, 1994, PHYSIOL BEHAV, V56, P237, DOI 10.1016/0031-9384(94)90189-9; Tsuruda JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003397; Winston M.L., 1991, BIOL HONEY BEE	27	10	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e33465	10.1371/journal.pone.0033465	http://dx.doi.org/10.1371/journal.pone.0033465			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558073	gold, Green Published, Green Submitted			2022-12-27	WOS:000305340200003
J	Du, J; Zhou, NN; Liu, HX; Jiang, F; Wang, YB; Hu, CY; Qi, H; Zhong, CY; Wang, XR; Li, Z				Du, Juan; Zhou, Nannan; Liu, Hongxia; Jiang, Fei; Wang, Yubang; Hu, Chunyan; Qi, Hong; Zhong, Caiyun; Wang, Xinru; Li, Zhong			Arsenic Induces Functional Re-Expression of Estrogen Receptor alpha by Demethylation of DNA in Estrogen Receptor-Negative Human Breast Cancer	PLOS ONE			English	Article							CELL-PROLIFERATION; GENE-EXPRESSION; TRIOXIDE; METHYLATION; INHIBITION; ACTIVATION; RESISTANCE; METHYLTRANSFERASE; MECHANISMS	Estrogen receptor a (ER alpha) is a marker predictive for response of breast cancers to endocrine therapy. About 30% of breast cancers, however, are hormone-independent because of lack of ER alpha expression. New strategies are needed for re-expression of ER alpha and sensitization of ER-negative breast cancer cells to selective ER modulators. The present report shows that arsenic trioxide induces reactivated ER alpha, providing a target for therapy with ER antagonists. Exposure of ER-negative breast cancer cells to arsenic trioxide leads to re-expression of ER alpha mRNA and functional ER alpha protein in in vitro and in vivo. Luciferase reporter gene assays and 3-(4,5-dimethylthiazol-2-yl)- 5-(3-carboxymethoxyphenyl)- 2-(4-sulfophenyl)- 2H-tetrazolium (MTS) assays show that, upon exposure to arsenic trioxide, formerly unresponsive, ER-negative MDA-MB-231 breast cancer cells become responsive to ER antagonists, 4-hydroxytamoxifen and ICI 182,780. Furthermore, methylation-specific PCR and bisulfite-sequencing PCR assays show that arsenic trioxide induces partial demethylation of the ER alpha promoter. A methyl donor, S-adenosylmethionine (SAM), reduces the degree of arsenic trioxide-induced re-expression of ER alpha and demethylation. Moreover, Western blot and ChIP assays show that arsenic trioxide represses expression of DNMT1 and DNMT3a along with partial dissociation of DNMT1 from the ER alpha promoter. Thus, arsenic trioxide exhibits a previously undefined function which induces re-expression ER alpha in ER-negative breast cancer cells through demethylation of the ER alpha promoter. These findings could provide important information regarding the application of therapeutic agents targeting epigenetic changes in breast cancers and potential implication of arsenic trioxide as a new drug for the treatment of ER-negative human breast cancer.	[Du, Juan; Zhou, Nannan; Jiang, Fei; Wang, Yubang; Qi, Hong; Zhong, Caiyun; Wang, Xinru; Li, Zhong] Nanjing Med Univ, Sch Publ Hlth, Minist Educ, Key Lab Modern Toxicol, Nanjing, Peoples R China; [Wang, Xinru; Li, Zhong] Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Peoples R China; [Liu, Hongxia; Hu, Chunyan; Zhong, Caiyun; Li, Zhong] Nanjing Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Nanjing, Peoples R China; [Wang, Yubang] Safety Assessment & Res Ctr Drugs, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Du, J (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Minist Educ, Key Lab Modern Toxicol, Nanjing, Peoples R China.	uiuclz@126.com	Wang, Xin/AAN-8435-2021	Wang, Xin/0000-0002-4457-7376	National Natural Science Foundation of China [30972507, 30901186]; National High Technology Research and Development Program of China (863 Program) [2010AA023001]; Qing Lan Project; Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA023001] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Qing Lan Project(Jiangsu Polytech Institute); Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by grant from the National Natural Science Foundation of China (30972507, 30901186), the National High Technology Research and Development Program of China (863 Program) (2010AA023001), Qing Lan Project (to ZL) and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECHTHOLD A, 1994, EUR J BIOCHEM, V224, P431, DOI 10.1111/j.1432-1033.1994.00431.x; Billam M, 2009, CANC BIOL THER, P8; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Cai X, 2000, LEUKEMIA, V14, P262, DOI 10.1038/sj.leu.2401650; Chen GQ, 1997, BLOOD, V89, P3345; Chow SKY, 2004, J ENDOCRINOL, V182, P325, DOI 10.1677/joe.0.1820325; COMPERE SJ, 1981, CELL, V25, P233, DOI 10.1016/0092-8674(81)90248-8; CROOKS PA, 1984, J PHARM PHARMACOL, V36, P85, DOI 10.1111/j.2042-7158.1984.tb02999.x; Cui X, 2006, HUM PATHOL, V37, P298, DOI 10.1016/j.humpath.2005.10.013; Davison K, 2002, SEMIN HEMATOL, V39, P3, DOI 10.1053/shem.2002.33610; Fishman J, 1995, ANN NY ACAD SCI, V768, P91, DOI 10.1111/j.1749-6632.1995.tb12113.x; Giacinti L, 2006, ONCOLOGIST, V11, P1, DOI 10.1634/theoncologist.11-1-1; Gonzalez-Fraile MI, 2002, BRIT J HAEMATOL, V117, P890, DOI 10.1046/j.1365-2141.2002.03502.x; Hu Y, 1998, MUTAT RES-DNA REPAIR, V408, P203, DOI 10.1016/S0921-8777(98)00035-4; JOHNSTON SRD, 1992, ANN ONCOL, V3, P503, DOI 10.1093/oxfordjournals.annonc.a058251; Kito M, 2003, CANCER SCI, V94, P1010, DOI 10.1111/j.1349-7006.2003.tb01393.x; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Lapidus RG, 1998, CANCER RES, V58, P2515; Lapidus RG, 1998, J MAMMARY GLAND BIOL, V3, P85, DOI 10.1023/A:1018778403001; Li Jin-Qing, 2004, Ai Zheng, V23, P626; Li Q, 2009, MOL PHARMACOL, V76, P1072, DOI 10.1124/mol.109.056291; Liu HQ, 2010, J NUTR BIOCHEM, V21, P390, DOI 10.1016/j.jnutbio.2009.01.016; Mass MJ, 1997, MUTAT RES-REV MUTAT, V386, P263, DOI 10.1016/S1383-5742(97)00008-2; MCGUIRE WL, 1978, SEMIN ONCOL, V5, P428; OTTAVIANO YL, 1994, CANCER RES, V54, P2552; Platet N, 2004, CRIT REV ONCOL HEMAT, V51, P55, DOI 10.1016/j.critrevonc.2004.02.001; Polyak K, 2007, J CLIN INVEST, V117, P3155, DOI 10.1172/JCI33295; PRICE JE, 1990, CANCER RES, V50, P717; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; ROODI N, 1995, JNCI-J NATL CANCER I, V87, P446, DOI 10.1093/jnci/87.6.446; Sharma D, 2006, CANCER RES, V66, P6370, DOI 10.1158/0008-5472.CAN-06-0402; Stoica A, 2000, ENDOCRINOLOGY, V141, P3595, DOI 10.1210/en.141.10.3595; Takeyoshi M, 2002, TOXICOL LETT, V126, P91, DOI 10.1016/S0378-4274(01)00446-5; Tong Hongyan, 2002, Zhonghua Xue Ye Xue Za Zhi, V23, P638; Vahter M, 2002, TOXICOLOGY, V181, P211, DOI 10.1016/S0300-483X(02)00285-8; WAALKES MP, 1988, CHEM-BIOL INTERACT, V66, P189, DOI 10.1016/0009-2797(88)90071-3; Wang Ming-Ming, 2008, Ai Zheng, V27, P1150; Widschwendter M, 2002, ONCOGENE, V21, P5462, DOI 10.1038/sj.onc.1205606; Yang L, 2009, CHIN J CANCER, V28, P209; Yang XW, 2001, CANCER RES, V61, P7025; Yang XW, 2000, CANCER RES, V60, P6890; Zhang P, 2000, Zhonghua Xue Ye Xue Za Zhi, V21, P67; Zhang WJ, 2011, ONCOL REP, V26, P621, DOI 10.3892/or.2011.1352	43	49	50	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35957	10.1371/journal.pone.0035957	http://dx.doi.org/10.1371/journal.pone.0035957			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558281	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336000091
J	Bayard, S; Langenier, MC; De Cock, VC; Scholz, S; Dauvilliers, Y				Bayard, Sophie; Langenier, Muriel Croisier; De Cock, Valerie Cochen; Scholz, Sabine; Dauvilliers, Yves			Executive Control of Attention in Narcolepsy	PLOS ONE			English	Article							QUALITY-OF-LIFE; HYPOCRETIN-1 OREXIN-A; NEUROLOGICAL CONDITIONS; DECISION-MAKING; CATAPLEXY; INTELLIGENCE; HYPERSOMNIAS; SLEEPINESS; DIVERSITY; DEFICITS	Background: Narcolepsy with cataplexy (NC) is a disabling sleep disorder characterized by early loss of hypocretin neurons that project to areas involved in the attention network. We characterized the executive control of attention in drug-free patients with NC to determine whether the executive deficits observed in patients with NC are specific to the disease itself or whether they reflect performance changes due to the severity of excessive daytime sleepiness. Methodology: Twenty-two patients with NC compared to 22 patients with narcolepsy without cataplexy (NwC) matched for age, gender, intellectual level, objective daytime sleepiness and number of sleep onset REM periods (SOREMPs) were studied. Thirty-two matched healthy controls were included. All participants underwent a standardized interview, completed questionnaires, and neuropsychological tests. All patients underwent a polysomnography followed by multiple sleep latency tests (MSLT), with neuropsychological evaluation performed the same day between MSLT sessions. Principal Findings: Irrespective of diagnosis, patients reported higher self-reported attentional complaints associated with the intensity of depressive symptoms. Patients with NC performed slower and more variably on simple reaction time tasks than patients with NwC, who did not differ from controls. Patients with NC and NwC generally performed slower, reacted more variably, and made more errors than controls on executive functioning tests. Individual profile analyses showed a clear heterogeneity of the severity of executive deficit. This severity was related to objective sleepiness, higher number of SOREMPs on the MSLT, and lower intelligence quotient. The nature and severity of the executive deficits were unrelated to NC and NwC diagnosis. Conclusions: We demonstrated that drug-free patients with NC and NwC complained of attention deficit, with altered executive control of attention being explained by the severity of objective sleepiness and global intellectual level. Further studies are needed to explore whether medications that promote wakefulness can improve the executive functions in narcolepsy.	[Bayard, Sophie; De Cock, Valerie Cochen; Dauvilliers, Yves] CHU Montpellier, Hop Gui de Chauliac, Dept Neurol, Natl Reference Network Narcolepsy, Montpellier, France; [Bayard, Sophie; Langenier, Muriel Croisier; De Cock, Valerie Cochen; Scholz, Sabine; Dauvilliers, Yves] Univ Montpellier I, INSERM, U1061, Montpellier, France	Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Bayard, S (corresponding author), CHU Montpellier, Hop Gui de Chauliac, Dept Neurol, Natl Reference Network Narcolepsy, Montpellier, France.	bayardsophie@yahoo.fr		Bayard, Sophie/0000-0003-0767-4924; Dauvilliers, yves/0000-0003-0683-6506	Montpellier Teaching Hospital at the Regional Delegation for Clinical Research and Innovation [AOI UF8190]	Montpellier Teaching Hospital at the Regional Delegation for Clinical Research and Innovation	Study financed by the Montpellier Teaching Hospital (AOI UF8190) at the Regional Delegation for Clinical Research and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUIRRE M, 1985, J CLIN EXP NEUROPSYC, V7, P14, DOI 10.1080/01688638508401239; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; Baddeley Alan, 1996, Quarterly Journal of Experimental Psychology Section A Human Experimental Psychology, V49, P5, DOI 10.1080/027249896392784; Bassetti C, 2003, SLEEP MED, V4, P7, DOI 10.1016/S1389-9457(02)00191-0; Bayard S, 2011, SLEEP, V34, P99, DOI 10.1093/sleep/34.1.99; Beck A.T., 1998, INVENTAIRE DEPRESSIO; Becker PM, 2004, PSYCHOPHARMACOLOGY, V171, P133, DOI 10.1007/s00213-003-1508-9; BROUGHTON WA, 1994, SLEEP, V17, pS45, DOI 10.1093/sleep/17.suppl_8.S45; Collette F, 2005, HUM BRAIN MAPP, V25, P409, DOI 10.1002/hbm.20118; Collette F, 2002, NEUROSCI BIOBEHAV R, V26, P105, DOI 10.1016/S0149-7634(01)00063-X; Dauvilliers Y, 2003, J NEUROL NEUROSUR PS, V74, P1667, DOI 10.1136/jnnp.74.12.1667; Dauvilliers Y, 2007, LANCET, V369, P499, DOI 10.1016/S0140-6736(07)60237-2; de Lecea L, 2006, J NEUROSCI, V26, P10372, DOI 10.1523/JNEUROSCI.3118-06.2006; Delazer M, 2011, NEUROPSYCHOLOGY, V25, P477, DOI 10.1037/a0022357; Diamond Adele, ANNU REV PSYCHOL, V64, P135, DOI [DOI 10.1146/annurev-clinpsy-032813-153724, 10.1146/annurev-psych-113011-143750, DOI 10.1146/ANNUREV-PSYCH-113011-143750]; Dodel R, 2004, SLEEP, V27, P1123, DOI 10.1093/sleep/27.6.1123; Dodel R, 2007, SLEEP MED, V8, P733, DOI 10.1016/j.sleep.2006.10.010; Ervik S, 2006, ACTA NEUROL SCAND, V114, P198, DOI 10.1111/j.1600-0404.2006.00594.x; Fernandez-Duque D, 2001, J CLIN EXP NEUROPSYC, V23, P74, DOI 10.1076/jcen.23.1.74.1217; Friedman NP, 2006, PSYCHOL SCI, V17, P172, DOI 10.1111/j.1467-9280.2006.01681.x; Fronczek R, 2006, SLEEP, V29, P187; Fulda S, 2001, SLEEP MED REV, V5, P423, DOI 10.1053/smrv.2001.0157; HENRY GK, 1993, SLEEP, V16, P123, DOI 10.1093/sleep/16.2.123; Iber C., 2007, AASM MANUAL SCORING; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kanbayashi T, 2002, J SLEEP RES, V11, P91, DOI 10.1046/j.1365-2869.2002.00284.x; Littner MR, 2005, SLEEP, V28, P113, DOI 10.1093/sleep/28.1.113; Mackinnon A, 2005, ENCEPHALE, V31, P31; Mignot E, 2002, ARCH NEUROL-CHICAGO, V59, P1553, DOI 10.1001/archneur.59.10.1553; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Naumann A, 2006, J SLEEP RES, V15, P329, DOI 10.1111/j.1365-2869.2006.00533.x; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-8; Norman DA, 1984, CONSCIOUSNESS SELF R, P1; POLLAK CP, 1992, SLEEP, V15, P202, DOI 10.1093/sleep/15.3.202; Ratcliff R, 2009, PSYCHON B REV, V16, P742, DOI 10.3758/PBR.16.4.742; Rieger M, 2003, SLEEP, V26, P36; Ripley B, 2001, NEUROLOGY, V57, P2253, DOI 10.1212/WNL.57.12.2253; Strauss E, 2006, COMPENDIUM NEUROPSYC; Sturm W, 2001, NEUROIMAGE, V14, pS76, DOI 10.1006/nimg.2001.0839; Teixeira VG, 2004, SLEEP MED, V5, P477, DOI 10.1016/j.sleep.2004.07.001; Thiel CM, 2004, NEUROIMAGE, V21, P318, DOI 10.1016/j.neuroimage.2003.08.044; Van Der Linden M, 1989, QUESTIONNAIRE AUTOEV; Verstraeten E, 2004, SLEEP MED REV, V8, P257, DOI 10.1016/j.smrv.2004.01.001; Vignatelli L, 2004, SLEEP MED, V5, P467, DOI 10.1016/j.sleep.2004.04.003; Zimmermann P., 2005, TESTBATTERIE AUFMERK	45	48	48	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e33525	10.1371/journal.pone.0033525	http://dx.doi.org/10.1371/journal.pone.0033525			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VP	22558075	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345200003
J	Cantsilieris, S; White, SJ; Richardson, AJ; Guymer, RH; Baird, PN				Cantsilieris, Stuart; White, Stefan J.; Richardson, Andrea J.; Guymer, Robyn H.; Baird, Paul N.			Comprehensive Analysis of Copy Number Variation of Genes at Chromosome 1 and 10 Loci Associated with Late Age Related Macular Degeneration	PLOS ONE			English	Article							C-REACTIVE PROTEIN; FACTOR-H CFH; SEGMENTAL DUPLICATIONS; CFHR1-CFHR3 DELETION; POLYMORPHISM; RISK; REARRANGEMENTS; SUSCEPTIBILITY; PREDISPOSES; HAPLOTYPE	Copy Number Variants (CNVs) are now recognized as playing a significant role in complex disease etiology. Age-related macular degeneration (AMD) is the most common cause of irreversible vision loss in the western world. While a number of genes and environmental factors have been associated with both risk and protection in AMD, the role of CNVs has remained largely unexplored. We analyzed the two major AMD risk-associated regions on chromosome 1q32 and 10q26 for CNVs using Multiplex Ligation-dependant Probe Amplification. The analysis targeted nine genes in these two key regions, including the Complement Factor H (CFH) gene, the 5 CFH-related (CFHR) genes representing a known copy number "hotspot", the F13B gene as well as the ARMS2 and HTRA1 genes in 387 cases of late AMD and 327 controls. No copy number variation was detected at the ARMS2 and HTRA1 genes in the chromosome 10 region, nor for the CFH and F13B genes at the chromosome 1 region. However, significant association was identified for the CFHR3-1 deletion in AMD cases (p = 2.38x10(-12)) OR = 0.31, CI-0.95 (0.23-0.44), for both neovascular disease (nAMD) (p = 8.3x10(-9)) OR = 0.36 CI-0.95 (0.25-0.52) and geographic atrophy (GA) (p = 1.5x10(-6)) OR = 0.36 CI-0.95 (0.25-0.52) compared to controls. In addition, a significant association with deletion of CFHR1-4 was identified only in patients who presented with bilateral GA (p = 0.02) (OR = 7.6 CI-0.95 1.38-41.8). This is the first report of a phenotype specific association of a CNV for a major subtype of AMD and potentially allows for pre-diagnostic identification of individuals most likely to proceed to this end stage of disease.	[Cantsilieris, Stuart; Richardson, Andrea J.; Guymer, Robyn H.; Baird, Paul N.] Univ Melbourne, Ctr Eye Res Australia, Royal Victorian Eye & Ear Hosp, Melbourne, Vic, Australia; [Cantsilieris, Stuart; White, Stefan J.] Monash Inst Med Res, Ctr Reprod & Dev, Melbourne, Vic, Australia	Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; Monash University	Cantsilieris, S (corresponding author), Univ Melbourne, Ctr Eye Res Australia, Royal Victorian Eye & Ear Hosp, Melbourne, Vic, Australia.	pnb@unimelb.edu.au		Guymer, Robyn/0000-0002-9441-4356; Baird, Paul/0000-0002-1305-3502	National Health and Medical Research Council (NHMRC) Centre for Clinical Research Excellence [529923]; NHMRC [1008979]	National Health and Medical Research Council (NHMRC) Centre for Clinical Research Excellence(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the National Health and Medical Research Council (NHMRC) Centre for Clinical Research Excellence #529923-Translational Clinical Research in Major Eye Diseases and NHMRC Project Grant #1008979 and NHMRC practitioner fellowship (RHG). CERA and MIMR receives Operational Infrastructure Support from the Victorian Government. The information contained in this manuscript has not been published before. The authors have no financial interests or involvements with companies regarding this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrera-Abeleda MA, 2006, J MED GENET, V43, P582, DOI 10.1136/jmg.2005.038315; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Bhattacharya T, 2009, NAT MED, V15, P1112, DOI 10.1038/nm1009-1112; Campbell CD, 2011, AM J HUM GENET, V88, P317, DOI 10.1016/j.ajhg.2011.02.004; Casilli F, 2002, HUM MUTAT, V20, P218, DOI 10.1002/humu.10108; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Field SF, 2009, NAT MED, V15, P1115, DOI 10.1038/nm1009-1115; Fritsche LG, 2008, NAT GENET, V40, P892, DOI 10.1038/ng.170; Fritsche LG, 2010, HUM MOL GENET, V19, P4694, DOI 10.1093/hmg/ddq399; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Guymer RH, 2006, MED J AUST, V184; Hageman GS, 2006, ANN MED, V38, P592, DOI 10.1080/07853890601097030; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Hebecker M, 2010, MOL IMMUNOL, V47, P1347, DOI 10.1016/j.molimm.2009.12.005; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Hughes AE, 2010, NAT GENET, V42, P555, DOI 10.1038/ng0710-555; Janssen B, 2005, NEUROGENETICS, V6, P29, DOI 10.1007/s10048-004-0204-1; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Klein R, 2011, ARCH OPHTHALMOL-CHIC, V129, P75, DOI 10.1001/archophthalmol.2010.318; Kubista KE, 2011, MOL VIS, V17, P2080; Laine M, 2007, J IMMUNOL, V178, P3831, DOI 10.4049/jimmunol.178.6.3831; Mamtani M, 2010, GENES IMMUN, V11, P155, DOI 10.1038/gene.2009.71; Marques RB, 2010, PLOS ONE, V5; McKinney C, 2010, ANN RHEUM DIS, V69, P1711, DOI 10.1136/ard.2009.123588; Mihlan M, 2009, MOL IMMUNOL, V46, P335, DOI 10.1016/j.molimm.2008.10.029; Moore I, 2010, BLOOD, V115, P379, DOI 10.1182/blood-2009-05-221549; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Notini AJ, 2008, CYTOGENET GENOME RES, V123, P270, DOI 10.1159/000184717; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2010, NAT GENET, V42, P553, DOI 10.1038/ng0710-553; Resnikoff S, 2008, B WORLD HEALTH ORGAN, V86, P63, DOI 10.2471/BLT.07.041210; Richardson AJ, 2010, INVEST OPHTH VIS SCI, V51, P4932, DOI 10.1167/iovs.09-5114; Robman L, 2010, OPHTHALMOLOGY, V117, P1982, DOI 10.1016/j.ophtha.2010.02.003; Saugier-Veber P, 2006, EUR J HUM GENET, V14, P1009, DOI 10.1038/sj.ejhg.5201661; Sawitzke J, 2011, OPHTHALMOLO IN PRESS; Schmid-Kubista KE, 2009, INVEST OPHTH VIS SCI, V50, P5070, DOI 10.1167/iovs.09-3975; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sivakumaran TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025598; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; White S, 2002, AM J HUM GENET, V71, P365, DOI 10.1086/341942; White SJ, 2007, CYTOGENET GENOME RES, V118, P19, DOI 10.1159/000106437; White SJ, 2004, METHOD CELL BIOL, V75, P751; White SJ, 2004, HUM MUTAT, V24, P86, DOI 10.1002/humu.20054; Zhao J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002079; Zipfel PF, 2007, PLOS GENET, V3, P387, DOI 10.1371/journal.pgen.0030041	51	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35255	10.1371/journal.pone.0035255	http://dx.doi.org/10.1371/journal.pone.0035255			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558131	gold, Green Published, Green Submitted			2022-12-27	WOS:000305345200031
J	Comin, A; Stegeman, A; Marangon, S; Klinkenberg, D				Comin, Arianna; Stegeman, Arjan; Marangon, Stefano; Klinkenberg, Don			Evaluating Surveillance Strategies for the Early Detection of Low Pathogenicity Avian Influenza Infections	PLOS ONE			English	Article							CHICKENS; POULTRY; PROGRAM; VACCINATION; OUTBREAK; VIRUSES; AFRICA; SPREAD; EUROPE; ASIA	In recent years, the early detection of low pathogenicity avian influenza (LPAI) viruses in poultry has become increasingly important, given their potential to mutate into highly pathogenic viruses. However, evaluations of LPAI surveillance have mainly focused on prevalence and not on the ability to act as an early warning system. We used a simulation model based on data from Italian LPAI epidemics in turkeys to evaluate different surveillance strategies in terms of their performance as early warning systems. The strategies differed in terms of sample size, sampling frequency, diagnostic tests, and whether or not active surveillance (i.e., routine laboratory testing of farms) was performed, and were also tested under different epidemiological scenarios. We compared surveillance strategies by simulating within-farm outbreaks. The output measures were the proportion of infected farms that are detected and the farm reproduction number (Rh). The first one provides an indication of the sensitivity of the surveillance system to detect within-farm infections, whereas Rh reflects the effectiveness of outbreak detection (i.e., if detection occurs soon enough to bring an epidemic under control). Increasing the sampling frequency was the most effective means of improving the timeliness of detection (i.e., it occurs earlier), whereas increasing the sample size increased the likelihood of detection. Surveillance was only effective in preventing an epidemic if actions were taken within two days of sampling. The strategies were not affected by the quality of the diagnostic test, although performing both serological and virological assays increased the sensitivity of active surveillance. Early detection of LPAI outbreaks in turkeys can be achieved by increasing the sampling frequency for active surveillance, though very frequent sampling may not be sustainable in the long term. We suggest that, when no LPAI virus is circulating yet and there is a low risk of virus introduction, a less frequent sampling approach might be admitted, provided that the surveillance is intensified as soon as the first outbreak is detected.	[Comin, Arianna; Marangon, Stefano] Ist Zooprofilatt Sperimentale Venezie, Padua, Italy; [Stegeman, Arjan; Klinkenberg, Don] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands	IZS delle Venezie; Utrecht University	Comin, A (corresponding author), Ist Zooprofilatt Sperimentale Venezie, Padua, Italy.	acomin@izsvenezie.it		Klinkenberg, Don/0000-0002-9449-6873; Comin, Arianna/0000-0002-1765-1825; Marangon, Stefano/0000-0002-3158-4243	EU Commission [SSPE-CT-2007-044429]; Italian Ministry of Health	EU Commission(European CommissionEuropean Commission Joint Research Centre); Italian Ministry of Health(Ministry of Health, Italy)	This study has been performed with support from the EU Commission (grant SSPE-CT-2007-044429: Improved diagnosis and early warning systems for avian influenza outbreak management - FLUTEST) and the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey BL, 2003, AVIAN DIS, V47, P1099, DOI 10.1637/0005-2086-47.s3.1099; Alba A, 2010, PREV VET MED, V97, P107, DOI 10.1016/j.prevetmed.2010.09.002; Alexander DJ, 2007, AVIAN DIS, V51, P161, DOI 10.1637/7602-041306R.1; Brown IH, 2010, AVIAN DIS, V54, P187, DOI 10.1637/8949-053109-Reg.1; Capua I, 2007, VACCINE, V25, P4987, DOI 10.1016/j.vaccine.2007.01.113; Comin A, 2011, ZOONOSES PUBLIC HLTH, V58, P244, DOI 10.1111/j.1863-2378.2010.01343.x; Comin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026935; DEFRA, 2008, LOW PATH AV INFL GER; Elbers ARW, COMMUNICATION; European Commission, 2010, OFFICIAL J EUROPEA L, VL 166, P22; European Commission, 2005, OFF J EUR UNION L, VL 274, P105; European Commission, 2006, OFFICIAL J EUROPEAN, V10, P16; Fischer EAJ, 2005, PREV VET MED, V67, P283, DOI 10.1016/j.prevetmed.2004.12.002; Food and Agriculture Organization of the United Nations, 2008, BIOS HIGHL PATH AV I; Gonzales JL, 2010, INFLUENZA OTHER RESP, V4, P91, DOI 10.1111/j.1750-2659.2009.00126.x; Gonzales JL, 2011, VET MICROBIOLOGY; Graat EAM, 2001, VET MICROBIOL, V79, P193, DOI 10.1016/S0378-1135(00)00356-4; Klinkenberg D, 2011, RISK ANAL, V31, P1260, DOI 10.1111/j.1539-6924.2011.01582.x; Marangon S, 2005, WAG UR FRON, V8, P33; Mulatti P, 2010, EPIDEMIOL INFECT, V138, P813, DOI 10.1017/S0950268809991038; R Core Team, 2018, R LANG ENV STAT COMP; Spackman E, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-331; Spickler AR, 2008, AVIAN PATHOL, V37, P555, DOI 10.1080/03079450802499118; Suarez DL, 2004, EMERG INFECT DIS, V10, P693, DOI 10.3201/eid1004.030396; Tumpey TM, 2004, AVIAN DIS, V48, P167, DOI 10.1637/7103; Van der Goot JA, 2003, EPIDEMIOL INFECT, V131, P1003, DOI 10.1017/S0950268803001067; van der Goot JA, 2010, VACCINE, V28, P1771, DOI 10.1016/j.vaccine.2009.12.009; Welby S, 2010, AVIAN DIS, V54, P597, DOI 10.1637/8749-033009-Reg.1	28	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35956	10.1371/journal.pone.0035956	http://dx.doi.org/10.1371/journal.pone.0035956			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545151	gold, Green Published			2022-12-27	WOS:000305343200071
J	Lu, N; Liu, JX; Liu, J; Zhang, CY; Jiang, FQ; Wu, H; Chen, LQ; Zeng, WJ; Cao, XH; Yan, TD; Wang, GH; Zhou, H; Lin, BZ; Yan, XM; Zhang, XK; Zeng, JZ				Lu, Na; Liu, Jinxing; Liu, Jie; Zhang, Chunyun; Jiang, Fuquan; Wu, Hua; Chen, Liqun; Zeng, Wenjun; Cao, Xihua; Yan, Tingdong; Wang, Guanghui; Zhou, Hu; Lin, Bingzhen; Yan, Xiaomei; Zhang, Xiao-kun; Zeng, Jin-Zhang			Antagonist Effect of Triptolide on AKT Activation by Truncated Retinoid X Receptor-alpha	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; KAPPA-B ACTIVATION; L-TYPE PROTEASE; RXR-ALPHA; CANCER-CELLS; INDUCED APOPTOSIS; TRIPTERYGIUM-WILFORDII; 9-CIS-RETINOIC ACID; SERINE-260 IMPAIRS; EPITHELIAL-CELLS	Background: Retinoid X receptor-alpha (RXR alpha) is a key member of the nuclear receptor superfamily. We recently demonstrated that proteolytic cleavage of RXR alpha resulted in production of a truncated product, tRXR alpha, which promotes cancer cell survival by activating phosphatidylinositol-3-OH kinase (PI3K)/AKT pathway. However, how the tRXR alpha-mediated signaling pathway in cancer cells is regulated remains elusive. Methodology/Principal Findings: We screened a natural product library for tRXR alpha targeting leads and identified that triptolide, an active component isolated from traditional Chinese herb Trypterygium wilfordii Hook F, could modulate tRXR alpha-mediated cancer cell survival pathway in vitro and in animals. Our results reveal that triptolide strongly induces cancer cell apoptosis dependent on intracellular tRXR alpha expression levels, demonstrating that tRXR alpha serves as an important intracellular target of triptolide. We show that triptolide selectively induces tRXR alpha degradation and inhibits tRXR alpha-dependent AKT activity without affecting the full-length RXR alpha. Interestingly, such effects of triptolide are due to its activation of p38. Although triptolide also activates Erk1/2 and MAPK pathways, the effects of triptolide on tRXR alpha degradation and AKT activity are only reversed by p38 siRNA and p38 inhibitor. In addition, the p38 inhibitor potently inhibits tRXR alpha interaction with p85 alpha leading to AKT inactivation. Our results demonstrate an interesting novel signaling interplay between p38 and AKT through tRXR alpha mediation. We finally show that targeting tRXR alpha by triptolide strongly activates TNF alpha death signaling and enhances the anticancer activity of other chemotherapies Conclusions/Significance: Our results identify triptolide as a new xenobiotic regulator of the tRXR alpha-dependent survival pathway and provide new insight into the mechanism by which triptolide acts to induce apoptosis of cancer cells. Triptolide represents one of the most promising therapeutic leads of natural products of traditional Chinese medicine with unfortunate side-effects. Our findings will offer new strategies to develop improved triptolide analogs for cancer therapy.	[Lu, Na; Liu, Jinxing; Liu, Jie; Zhang, Chunyun; Jiang, Fuquan; Wu, Hua; Chen, Liqun; Zeng, Wenjun; Yan, Tingdong; Wang, Guanghui; Zhang, Xiao-kun; Zeng, Jin-Zhang] Xiamen Univ, Sch Pharmaceut Sci, Xiamen, Peoples R China; [Lu, Na; Liu, Jinxing; Liu, Jie; Zhang, Chunyun; Jiang, Fuquan; Wu, Hua; Chen, Liqun; Zeng, Wenjun; Yan, Tingdong; Wang, Guanghui; Zhang, Xiao-kun; Zeng, Jin-Zhang] Xiamen Univ, Inst Biomed Res, Xiamen, Peoples R China; [Cao, Xihua; Zhou, Hu; Lin, Bingzhen; Zhang, Xiao-kun] Sanford Burnham Med Res Inst, Ctr Canc, La Jolla, CA USA; [Yan, Xiaomei] Xiamen Univ, Coll Chem & Chem Engn, Dept Biol Chem, Key Lab Analyt Sci,Key Lab Chem Biol Fujian Prov, Xiamen, Peoples R China	Xiamen University; Xiamen University; Sanford Burnham Prebys Medical Discovery Institute; Xiamen University	Lu, N (corresponding author), Xiamen Univ, Sch Pharmaceut Sci, Xiamen, Peoples R China.	xzhang@burnham.org; jzzeng@xmu.edu.cn	Wu, Hua/W-4204-2019; Zeng, JZ/G-3377-2010		National Natural Science Foundation of China [NSFC: 30971445, 90913015, 91129302]; NSFC/Hong Kong Research Grants Council [NSFC/RGC: 30931160431/N_HKU 735/09]; Natural Science Foundation of Fujian Province [2009J01198]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC/Hong Kong Research Grants Council(Hong Kong Research Grants CouncilNational Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province)	This work was supported by National Natural Science Foundation of China (NSFC: 30971445, 90913015 and 91129302), NSFC/Hong Kong Research Grants Council (NSFC/RGC: 30931160431/N_HKU 735/09) and Natural Science Foundation of Fujian Province (2009J01198). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 2002, HEPATOLOGY, V35, P332, DOI 10.1053/jhep.2002.31164; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Carter BZ, 2008, BLOOD, V111, P3742, DOI 10.1182/blood-2007-05-091504; Carter BZ, 2006, BLOOD, V108, P630, DOI 10.1182/blood-2005-09-3898; Chang WT, 2001, J BIOL CHEM, V276, P2221, DOI 10.1074/jbc.M009713200; Chen BJ, 2001, LEUKEMIA LYMPHOMA, V42, P253, DOI 10.3109/10428190109064582; Corson TW, 2007, CELL, V130, P769, DOI 10.1016/j.cell.2007.08.021; Dawson MI, 2002, CURR MED CHEM, V9, P623, DOI 10.2174/0929867023370789; Fidler JM, 2003, MOL CANCER THER, V2, P855; Fidler JM, 2002, TRANSPLANTATION, V74, P445, DOI 10.1097/00007890-200208270-00004; Germain P, 2006, PHARMACOL REV, V58, P760, DOI 10.1124/pr.58.4.7; HSIANG YH, 1988, CANCER RES, V48, P1722; Huang JP, 2002, CANCER RES, V62, P4812; Jiang XH, 2001, ONCOGENE, V20, P8009, DOI 10.1038/sj.onc.1204981; Kiviharju TM, 2002, CLIN CANCER RES, V8, P2666; Kunz C, 2009, PLOS BIOL, V7, P967, DOI 10.1371/journal.pbio.1000091; Lee KY, 2002, EXP MOL MED, V34, P462, DOI 10.1038/emm.2002.64; Lee KY, 1999, J BIOL CHEM, V274, P13451, DOI 10.1074/jbc.274.19.13451; Lefebvre P, 2010, TRENDS ENDOCRIN MET, V21, P676, DOI 10.1016/j.tem.2010.06.009; Leuenroth SJ, 2008, CANCER RES, V68, P5257, DOI 10.1158/0008-5472.CAN-07-6207; Li M, 2001, DEVELOPMENT, V128, P675; Liu J, 2008, CANCER RES, V68, P8871, DOI 10.1158/0008-5472.CAN-08-1972; Macoritto M, 2008, J BIOL CHEM, V283, P4943, DOI 10.1074/jbc.M707517200; Matsushima-Nishiwaki R, 2001, CANCER RES, V61, P7675; MatsushimaNishiwaki R, 1996, BIOCHEM BIOPH RES CO, V225, P946, DOI 10.1006/bbrc.1996.1276; Nagaya T, 1998, J BIOL CHEM, V273, P33166, DOI 10.1074/jbc.273.50.33166; Nakamura M, 2007, J HEPATOL, V46, P77, DOI 10.1016/j.jhep.2006.07.032; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Nomura Y, 1999, BIOCHEM BIOPH RES CO, V254, P388, DOI 10.1006/bbrc.1998.9941; Olson JM, 2004, TRENDS MOL MED, V10, P125, DOI 10.1016/j.molmed.2004.01.007; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Phillips PA, 2007, CANCER RES, V67, P9407, DOI 10.1158/0008-5472.CAN-07-1077; Picard E, 1999, J NATL CANCER I, V91, P1059, DOI 10.1093/jnci/91.12.1059; Qiu Daoming, 2003, Drugs R D, V4, P1, DOI 10.2165/00126839-200304010-00001; Takiyama Y, 2004, J CLIN ENDOCR METAB, V89, P5851, DOI 10.1210/jc.2003-032036; Tillman DM, 1999, CLIN CANCER RES, V5, P425; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wan CK, 2006, CANCER LETT, V241, P31, DOI 10.1016/j.canlet.2005.10.001; Westerheide SD, 2006, J BIOL CHEM, V281, P9616, DOI 10.1074/jbc.M512044200; Yamazaki K, 2007, GUT, V56, P1557, DOI 10.1136/gut.2007.129858; Yan TD, 2010, CANCER RES, V70, P2285, DOI 10.1158/0008-5472.CAN-09-2968; Yang SM, 2003, MOL CANCER THER, V2, P65; Zeisig BB, 2007, CANCER CELL, V12, P36, DOI 10.1016/j.ccr.2007.06.006; Zhao GH, 2000, AM J PHYSIOL-LUNG C, V279, pL958, DOI 10.1152/ajplung.2000.279.5.L958; Zhong C, 2003, CANCER BIOL THER, V2, P179, DOI 10.4161/cbt.2.2.281; Zhou H, 2010, CANCER CELL, V17, P560, DOI 10.1016/j.ccr.2010.04.023; Zhu J, 2007, CANCER CELL, V12, P23, DOI 10.1016/j.ccr.2007.06.004	48	17	20	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35722	10.1371/journal.pone.0035722	http://dx.doi.org/10.1371/journal.pone.0035722			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545132	gold, Green Submitted, Green Published			2022-12-27	WOS:000305343200052
J	Zhuang, PW; Zhang, YJ; Cui, GZ; Bian, YH; Zhang, MX; Zhang, JB; Liu, Y; Yang, XP; Isaiah, AO; Lin, YX; Jiang, YB				Zhuang, Pengwei; Zhang, Yanjun; Cui, Guangzhi; Bian, Yuhong; Zhang, Mixia; Zhang, Jinbao; Liu, Yang; Yang, Xinpeng; Isaiah, Adejobi Oluwaniyi; Lin, Yingxue; Jiang, Yongbo			Direct Stimulation of Adult Neural Stem/Progenitor Cells In Vitro and Neurogenesis In Vivo by Salvianolic Acid B	PLOS ONE			English	Article							TRANSIENT GLOBAL-ISCHEMIA; CEREBRAL-ISCHEMIA; STEM-CELLS; CHINESE MEDICINE; PROGENITOR CELLS; SPATIAL MEMORY; DENTATE GYRUS; BRAIN-INJURY; EXERCISE; NEURONS	Background: Small molecules have been shown to modulate the neurogenesis processes. In search for new therapeutic drugs, the herbs used in traditional medicines for neurogenesis are promising candidates. Methodology and Principal Findings: We selected a total of 45 natural compounds from Traditional Chinese herbal medicines which are extensively used in China to treat stroke clinically, and tested their proliferation-inducing activities on neural stem/progenitor cells (NSPCs). The screening results showed that salvianolic acid B (Sal B) displayed marked effects on the induction of proliferation of NSPCs. We further demonstrated that Sal B promoted NSPCs proliferation in dose-and time-dependent manners. To explore the molecular mechanism, PI3K/Akt, MEK/ERK and Notch signaling pathways were investigated. Cell proliferation assay demonstrated that Ly294002 (PI3K/Akt inhibitor), but neither U0126 (ERK inhibitor) nor DAPT (Notch inhibitor) inhibited the Sal B-induced proliferation of cells. Western Blotting results showed that stimulation of NSPCs with Sal B enhanced the phosphorylation of Akt, and Ly294002 abolished this effect, confirming the role of Akt in Sal B mediated proliferation of NSPCs. Rats exposed to transient cerebral ischemia were treated for 4 weeks with Sal B from the 7th day after stroke. BrdU incorporation assay results showed that exposure Sal B could maintain the proliferation of NSPCs after cerebral ischemia. Morris water maze test showed that delayed post-ischemic treatment with Sal B improved cognitive impairment after stroke in rats. Significance: Sal B could maintain the NSPCs self-renew and promote proliferation, which was mediated by PI3K/Akt signal pathway. And delayed post-ischemic treatment with Sal B improved cognitive impairment after stroke in rats. These findings suggested that Sal B may act as a potential drug in treatment of brain injury or neurodegenerative diseases.	[Zhuang, Pengwei; Zhang, Yanjun; Cui, Guangzhi; Zhang, Mixia; Zhang, Jinbao; Liu, Yang; Yang, Xinpeng; Isaiah, Adejobi Oluwaniyi; Lin, Yingxue; Jiang, Yongbo] Tianjin Univ Tradit Chinese Med, Chinese Mat Med Coll, Key Lab Tradit Chinese Med Pharmacol, Tianjin State Key Lab Modern Chinese Med, Tianjin, Peoples R China; [Bian, Yuhong] Tianjin Univ Tradit Chinese Med, Chinese Med Coll, Tianjin, Peoples R China	Tianjin University of Traditional Chinese Medicine; China Medical University; Tianjin University of Traditional Chinese Medicine	Zhuang, PW (corresponding author), Tianjin Univ Tradit Chinese Med, Chinese Mat Med Coll, Key Lab Tradit Chinese Med Pharmacol, Tianjin State Key Lab Modern Chinese Med, Tianjin, Peoples R China.	zyjsunye@163.com			National Natural Science Foundation of China [30873395, 30472177]; National Basic Research Program of China [2011CB505302]; National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program" [2012ZX09101202]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0973]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program"; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Natural Science Foundation of China (nos. 30873395 and 30472177), National Basic Research Program of China (no. 2011CB505302), National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program" (2012ZX09101202) and the Program for Changjiang Scholars and Innovative Research Team in University (no. IRT0973). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruel-Jungerman E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007901; Canales JJ, 2010, BEHAV PHARMACOL, V21, P379, DOI 10.1097/FBP.0b013e32833e16b6; Chan CB, 2011, J NEUROSCI, V31, P8083, DOI 10.1523/JNEUROSCI.1129-11.2011; Chen T, 2011, BRAIN RES BULL, V84, P163, DOI 10.1016/j.brainresbull.2010.11.015; Choi YS, 2008, GLIA, V56, P791, DOI 10.1002/glia.20653; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; Doyle KP, 2008, NEUROPHARMACOLOGY, V55, P310, DOI 10.1016/j.neuropharm.2008.01.005; Du GH, 2000, J ASIAN NAT PROD RES, V2, P145, DOI 10.1080/10286020008039903; Duncan P, 2003, STROKE, V34, P2173, DOI 10.1161/01.STR.0000083699.95351.F2; Feigin VL, 2007, STROKE, V38, P1734, DOI 10.1161/STROKEAHA.107.487132; Heurteaux C, 2010, NEUROPHARMACOLOGY, V58, P987, DOI 10.1016/j.neuropharm.2010.01.001; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Jacobs S, 2006, P NATL ACAD SCI USA, V103, P3902, DOI 10.1073/pnas.0511294103; Ji XY, 2000, ACTA PHARMACOL SIN, V21, P1089; Jiang M, 2011, AM J CHINESE MED, V39, P111, DOI 10.1142/S0192415X11008683; Johnson MA, 2009, BMB REP, V42, P245, DOI 10.5483/BMBRep.2009.42.5.245; Kee NJ, 2001, EXP BRAIN RES, V136, P313, DOI 10.1007/s002210000591; Khodosevich K, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-18; Kim DH, 2011, NEUROPHARMACOLOGY, V61, P1432, DOI 10.1016/j.neuropharm.2011.08.038; Kim H, 2005, NEUROL RES, V27, P287, DOI 10.1179/016164105X25234; Kim SJ, 2008, J BIOL CHEM, V283, P14497, DOI 10.1074/jbc.M708373200; Kwakkel G, 2004, STROKE, V35, P2529, DOI 10.1161/01.STR.0000143153.76460.7d; Lavenex PB, 2009, HIPPOCAMPUS, V19, P8, DOI 10.1002/hipo.20485; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Leker RR, 2009, J NEURAL TRANSM, V116, P1397, DOI 10.1007/s00702-009-0329-3; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Liu JL, 1998, J NEUROSCI, V18, P7768; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mook-Jung I, 2001, J NEUROSCI RES, V63, P509, DOI 10.1002/jnr.1045; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; NITATORI T, 1995, J NEUROSCI, V15, P1001; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Quintard H, 2011, NEUROPHARMACOLOGY, V61, P622, DOI 10.1016/j.neuropharm.2011.05.003; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Shioda N, 2009, INT REV NEUROBIOL, V85, P375, DOI 10.1016/S0074-7742(09)85026-5; Takagi Y, 1999, BRAIN RES, V831, P283, DOI 10.1016/S0006-8993(99)01411-0; Tang MK, 2006, BEHAV PHARMACOL, V17, P493, DOI 10.1097/00008877-200609000-00015; Tang MK, 2002, PHYTOMEDICINE, V9, P405, DOI 10.1078/09447110260571634; Wang CM, 2011, NEUROSCI LETT, V488, P70, DOI 10.1016/j.neulet.2010.10.079; Weiss S, 1996, TRENDS NEUROSCI, V19, P387, DOI 10.1016/S0166-2236(96)10035-7; Wu B, 2007, STROKE, V38, P1973, DOI 10.1161/STROKEAHA.106.473165; Xu M, 2007, BIOMED CHROMATOGR, V21, P1052, DOI 10.1002/bmc.852; Yabe T, 2010, NEUROSCIENCE, V165, P515, DOI 10.1016/j.neuroscience.2009.10.023; Yagita Y, 2001, STROKE, V32, P1890, DOI 10.1161/01.STR.32.8.1890; Yonemori F, 1996, J CEREBR BLOOD F MET, V16, P973, DOI 10.1097/00004647-199609000-00022; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630	49	72	84	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35636	10.1371/journal.pone.0035636	http://dx.doi.org/10.1371/journal.pone.0035636			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545124	gold, Green Submitted, Green Published			2022-12-27	WOS:000305343200044
J	Cheng, FY; Huang, X; Sarangi, A; Ketova, T; Cooper, MK; Ying, LTT; Chiang, C				Cheng, Frances Y.; Huang, Xi; Sarangi, Anuraag; Ketova, Tatiana; Cooper, Michael K.; Ying Litingtung; Chiang, Chin			Widespread Contribution of Gdf7 Lineage to Cerebellar Cell Types and Implications for Hedgehog-Driven Medulloblastoma Formation	PLOS ONE			English	Article							EXPRESSING NEURAL PROGENITORS; SONIC HEDGEHOG; ROOF PLATE; CHOROID-PLEXUS; RHOMBIC-LIP; N-MYC; MOUSE CEREBELLUM; VERTEBRATE CNS; CREST CELLS; STEM-CELLS	The roof plate is a specialized embryonic midline tissue of the central nervous system that functions as a signaling center regulating dorsal neural patterning. In the developing hindbrain, roof plate cells express Gdf7 and previous genetic fate mapping studies showed that these cells contribute mostly to non-neural choroid plexus epithelium. We demonstrate here that constitutive activation of the Sonic hedgehog signaling pathway in the Gdf7 lineage invariably leads to medulloblastoma. Lineage tracing analysis reveals that Gdf7-lineage cells not only are a source of choroid plexus epithelial cells, but are also present in the cerebellar rhombic lip and contribute to a subset of cerebellar granule neuron precursors, the presumed cell-of-origin for Sonic hedgehog-driven medulloblastoma. We further show that Gdf7-lineage cells also contribute to multiple neuronal and glial cell types in the cerebellum, including glutamatergic granule neurons, unipolar brush cells, Purkinje neurons, GABAergic interneurons, Bergmann glial cells, and white matter astrocytes. These findings establish hindbrain roof plate as a novel source of diverse neural cell types in the cerebellum that is also susceptible to oncogenic transformation by deregulated Sonic hedgehog signaling.	[Cheng, Frances Y.; Huang, Xi; Ketova, Tatiana; Ying Litingtung; Chiang, Chin] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37235 USA; [Sarangi, Anuraag; Cooper, Michael K.] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN USA; [Chiang, Chin] Vanderbilt Univ, Neurosci Program, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Cheng, FY (corresponding author), Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37235 USA.	chin.chiang@vanderbilt.edu	Huang, Xi/C-2409-2017	Huang, Xi/0000-0002-7177-7525	National Institutes of Health (NIH) [T32 GM007347, NS 042205]; Children's Brain Tumor Foundation; Vanderbilt-Ingram Cancer Center [P30 CA068485]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS074638, R01NS042205] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Brain Tumor Foundation; Vanderbilt-Ingram Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) T32 GM007347, the Children's Brain Tumor Foundation, Vanderbilt-Ingram Cancer Center Support Grant P30 CA068485, and NIH NS 042205. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder J, 1999, NAT NEUROSCI, V2, P535, DOI 10.1038/9189; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Awatramani R, 2003, NAT GENET, V35, P70, DOI 10.1038/ng1228; Banka S, 2007, CHILD NERV SYST, V23, P587, DOI 10.1007/s00381-006-0249-6; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Chizhikov VV, 2006, DEVELOPMENT, V133, P2793, DOI 10.1242/dev.02441; Chizhikov VV, 2010, P NATL ACAD SCI USA, V107, P10725, DOI 10.1073/pnas.0910786107; Chizhikov VV, 2004, NAT REV NEUROSCI, V5, P808, DOI 10.1038/nrn1520; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Currle DS, 2005, DEVELOPMENT, V132, P3549, DOI 10.1242/dev.01915; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dang L, 2006, ONCOGENE, V25, P487, DOI 10.1038/sj.onc.1209074; Due-Tonnessen BJ, 2007, PEDIATR NEUROSURG, V43, P92, DOI 10.1159/000098379; Dymecki SM, 1998, DEV BIOL, V201, P57, DOI 10.1006/dbio.1998.8971; Englund C, 2006, J NEUROSCI, V26, P9184, DOI 10.1523/JNEUROSCI.1610-06.2006; Filippidis AS, 2011, CHILD NERV SYST, V27, P27, DOI 10.1007/s00381-010-1227-6; Fujimura M, 2004, CHILDS NERVOUS SYSTE, P20; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Gilbertson R, 2008, ORIGINS MEDULLOBLAST; Hatton BA, 2006, CANCER RES, V66, P8655, DOI 10.1158/0008-5472.CAN-06-1621; Huang X, 2010, J VISUALIZED EXPT; Huang X, 2009, DEVELOPMENT, V136, P2535, DOI 10.1242/dev.033795; Hunter NL, 2007, DEVELOPMENT, V134, P3449, DOI 10.1242/dev.003095; INOUYE M, 1980, J COMP NEUROL, V194, P499, DOI 10.1002/cne.901940302; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kenney AM, 2004, DEVELOPMENT, V131, P217, DOI 10.1242/dev.00891; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; Kessler JD, 2009, GENE DEV, V23, P157, DOI 10.1101/gad.1759909; Kool M, 2012, ACTA NEUROPATHOLOGIC; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Landsberg RL, 2005, NEURON, V48, P933, DOI 10.1016/j.neuron.2005.11.031; Lang S-S, 2011, WORLD NEUROSURGERY; Lee KJ, 2000, NATURE, V403, P734, DOI 10.1038/35001507; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Lo LC, 2005, P NATL ACAD SCI USA, V102, P7192, DOI 10.1073/pnas.0502581102; Machold R, 2005, NEURON, V48, P17, DOI 10.1016/j.neuron.2005.08.028; Millonig JH, 2000, NATURE, V403, P764, DOI 10.1038/35001573; Monuki ES, 2001, NEURON, V32, P591, DOI 10.1016/S0896-6273(01)00504-9; Northcott PA, 2011, ACTA NEUROPATHOLOGIC; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Rao G, 2004, ONCOGENE, V23, P6156, DOI 10.1038/sj.onc.1207818; Rao G, 2003, NEOPLASIA, V5, P198, DOI 10.1016/S1476-5586(03)80052-0; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Sillitoe RV, 2007, ANNU REV CELL DEV BI, V23, P549, DOI 10.1146/annurev.cellbio.23.090506.123237; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Taylor MD, 2011, ACTA NEUROPATHOLOGIC; Thomas WD, 2009, ONCOGENE, V28, P1605, DOI 10.1038/onc.2009.3; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; Wallace VA, 1999, CURR BIOL, V9, P445, DOI 10.1016/S0960-9822(99)80195-X; Wang VY, 2005, NEURON, V48, P31, DOI 10.1016/j.neuron.2005.08.024; Ward RJ, 2009, CANCER RES, V69, P4682, DOI 10.1158/0008-5472.CAN-09-0342; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916; Zhang Y, 2010, BRAIN STRUCT FUNCT, V215, P115, DOI 10.1007/s00429-010-0278-5	58	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e35541	10.1371/journal.pone.0035541	http://dx.doi.org/10.1371/journal.pone.0035541			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UP	22539980	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341000046
J	Shiryaev, SA; Thomsen, ER; Cieplak, P; Chudin, E; Cheltsov, AV; Chee, MS; Kozlov, IA; Strongin, AY				Shiryaev, Sergey A.; Thomsen, Elliot R.; Cieplak, Piotr; Chudin, Eugene; Cheltsov, Anton V.; Chee, Mark S.; Kozlov, Igor A.; Strongin, Alex Y.			New Details of HCV NS3/4A Proteinase Functionality Revealed by a High-Throughput Cleavage Assay	PLOS ONE			English	Article							HEPATITIS-C VIRUS; IN-VITRO SELECTION; SUBSTRATE-SPECIFICITY; SERINE PROTEINASE; PROTEASE; NS4A; ACTIVATION; DOMAIN; IDENTIFICATION; DETERMINANTS	Background: The hepatitis C virus (HCV) genome encodes a long polyprotein, which is processed by host cell and viral proteases to the individual structural and non-structural (NS) proteins. HCV NS3/4A serine proteinase (NS3/4A) is a non-covalent heterodimer of the N-terminal, similar to 180-residue portion of the 631-residue NS3 protein with the NS4A co-factor. NS3/4A cleaves the polyprotein sequence at four specific regions. NS3/4A is essential for viral replication and has been considered an attractive drug target. Methodology/Principal Findings: Using a novel multiplex cleavage assay and over 2,660 peptide sequences derived from the polyprotein and from introducing mutations into the known NS3/4A cleavage sites, we obtained the first detailed fingerprint of NS3/4A cleavage preferences. Our data identified structural requirements illuminating the importance of both the short-range (P1-P1') and long-range (P6-P5) interactions in defining the NS3/4A substrate cleavage specificity. A newly observed feature of NS3/4A was a high frequency of either Asp or Glu at both P5 and P6 positions in a subset of the most efficient NS3/4A substrates. In turn, aberrations of this negatively charged sequence such as an insertion of a positively charged or hydrophobic residue between the negatively charged residues resulted in inefficient substrates. Because NS5B misincorporates bases at a high rate, HCV constantly mutates as it replicates. Our analysis revealed that mutations do not interfere with polyprotein processing in over 5,000 HCV isolates indicating a pivotal role of NS3/4A proteolysis in the virus life cycle. Conclusions/Significance: Our multiplex assay technology in light of the growing appreciation of the role of proteolytic processes in human health and disease will likely have widespread applications in the proteolysis research field and provide new therapeutic opportunities.	[Shiryaev, Sergey A.; Cieplak, Piotr; Cheltsov, Anton V.; Strongin, Alex Y.] Sanford Burnham Med Res Inst, Inflammatory & Infect Dis Ctr, La Jolla, CA 92037 USA; [Thomsen, Elliot R.; Chudin, Eugene; Chee, Mark S.; Kozlov, Igor A.] Prognosys Biosci Inc, R&D Dept, La Jolla, CA USA	Sanford Burnham Prebys Medical Discovery Institute	Shiryaev, SA (corresponding author), Sanford Burnham Med Res Inst, Inflammatory & Infect Dis Ctr, La Jolla, CA 92037 USA.	strongin@sanfordburnham.org	Strongin, Alex/R-6609-2019	Strongin, Alex/0000-0003-3765-3016	NIH [R43GM085884, R01GM98835, R01CA83017, R01CA157328]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by the NIH grants R43GM085884 (IAK), R01GM98835 (PC), and R01CA83017 and R01CA157328 (AYS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barbato G, 1999, J MOL BIOL, V289, P371, DOI 10.1006/jmbi.1999.2745; BARTENSCHLAGER R, 1993, J VIROL, V67, P3835, DOI 10.1128/JVI.67.7.3835-3844.1993; Bartenschlager R, 1999, J VIRAL HEPATITIS, V6, P165, DOI 10.1046/j.1365-2893.1999.00152.x; Bartenschlager R, 2000, J GEN VIROL, V81, P1631, DOI 10.1099/0022-1317-81-7-1631; BARTENSCHLAGER R, 1995, J VIROL, V69, P198, DOI 10.1128/JVI.69.1.198-205.1995; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett F, 2010, BIOORG MED CHEM LETT, V20, P2617, DOI 10.1016/j.bmcl.2010.02.063; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Case D.A., 2022, AMBER 2020; Chayama K, 2011, J GASTROEN HEPATOL, V26, P83, DOI 10.1111/j.1440-1746.2010.06550.x; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Dubuisson J, 2007, WORLD J GASTROENTERO, V13, P2406, DOI 10.3748/wjg.v13.i17.2406; Fan XF, 2009, HEPATOLOGY, V50, P1765, DOI 10.1002/hep.23290; Gawlik K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005031; GRAKOUI A, 1993, J VIROL, V67, P2832, DOI 10.1128/JVI.67.5.2832-2843.1993; GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993; Hagel M, 2011, NAT CHEM BIOL, V7, P22, DOI 10.1038/NCHEMBIO.492; Hellen CUT, 1999, J VIRAL HEPATITIS, V6, P79, DOI 10.1046/j.1365-2893.1999.00150.x; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Kim JL, 1996, CELL, V87, P343, DOI 10.1016/S0092-8674(00)81351-3; Koch JO, 1997, VIROLOGY, V237, P78, DOI 10.1006/viro.1997.8760; Kurz M, 2001, CHEMBIOCHEM, V2, P666, DOI 10.1002/1439-7633(20010903)2:9<666::AID-CBIC666>3.0.CO;2-#; Kwong AD, 2011, NAT BIOTECHNOL, V29, P993, DOI 10.1038/nbt.2020; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; LIN C, 1995, J VIROL, V69, P4373, DOI 10.1128/JVI.69.7.4373-4380.1995; Lin RT, 2006, J VIROL, V80, P6072, DOI 10.1128/JVI.02495-05; MARTELL M, 1992, J VIROL, V66, P3225, DOI 10.1128/JVI.66.5.3225-3229.1992; Martin MM, 2011, BIOL CHEM, V392, P927, DOI 10.1515/BC.2011.076; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Morikawa K, 2011, J VIRAL HEPATITIS, V18, P305, DOI 10.1111/j.1365-2893.2011.01451.x; Pietschmann T, 2001, J VIROL, V75, P1252, DOI 10.1128/JVI.75.3.1252-1264.2001; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Schregel V, 2009, P NATL ACAD SCI USA, V106, P5342, DOI 10.1073/pnas.0810950106; Shimizu Y, 1996, J VIROL, V70, P127, DOI 10.1128/JVI.70.1.127-132.1996; Shiryaev SA, 2006, BIOCHEM J, V393, P503, DOI 10.1042/BJ20051374; Shiryaev SA, 2007, J VIROL, V81, P4501, DOI 10.1128/JVI.02719-06; Steinkuhler C, 1996, J VIROL, V70, P6694; Stempniak M, 1997, J VIROL, V71, P2881, DOI 10.1128/JVI.71.4.2881-2886.1997; Suzuki R, 1999, INTERVIROLOGY, V42, P145, DOI 10.1159/000024973; Tsui V, 2001, BIOPOLYMERS, V56, P275, DOI 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E; Urbani A, 1997, J BIOL CHEM, V272, P9204; Wang WY, 2004, J VIROL, V78, P700, DOI 10.1128/JVI.78.2.700-709.2004; Zhang RM, 1997, J VIROL, V71, P6208, DOI 10.1128/JVI.71.8.6208-6213.1997; Zhu HM, 2011, PROTEINS, V79, P2428, DOI 10.1002/prot.23064	48	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35759	10.1371/journal.pone.0035759	http://dx.doi.org/10.1371/journal.pone.0035759			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22768327	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000057
J	Li, Z; Zhao, ZJ; Zhu, XQ; Ren, QS; Nie, FF; Gao, JM; Gao, XJ; Yang, TB; Zhou, WL; Shen, JL; Wang, Y; Lu, FL; Chen, XG; Hide, G; Ayala, FJ; Lun, ZR				Li, Zhi; Zhao, Zhi-Jun; Zhu, Xing-Quan; Ren, Qing-Shi; Nie, Fang-Fang; Gao, Jiang-Mei; Gao, Xiao-Jie; Yang, Ting-Bao; Zhou, Wen-Liang; Shen, Ji-Long; Wang, Yong; Lu, Fang-Li; Chen, Xiao-Guang; Hide, Geoff; Ayala, Francisco J.; Lun, Zhao-Rong			Differences in iNOS and Arginase Expression and Activity in the Macrophages of Rats Are Responsible for the Resistance against T. gondii Infection	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ACTIVATED MURINE MACROPHAGES; L-ARGININE METABOLISM; TOXOPLASMA-GONDII; PERITONEAL-MACROPHAGES; POLYAMINE LEVELS; RH STRAIN; CELLS; MECHANISMS; IMMUNITY	Toxoplasma gondii infects humans and warm blooded animals causing devastating disease worldwide. It has long been a mystery as to why the peritoneal macrophages of rats are naturally resistant to T. gondii infection while those of mice are not. Here, we report that high expression levels and activity of inducible nitric oxide synthase (iNOS) and low levels of arginase-1 (Arg 1) activity in the peritoneal macrophages of rats are responsible for their resistance against T. gondii infection, due to high nitric oxide and low polyamines within these cells. The opposite situation was observed in the peritoneal macrophages of mice. This discovery of the opposing functions of iNOS and Arg 1 in rodent peritoneal macrophages may lead to a better understanding of the resistance mechanisms of mammals, particularly humans and livestock, against T. gondii and other intracellular pathogens.	[Li, Zhi; Zhao, Zhi-Jun; Ren, Qing-Shi; Nie, Fang-Fang; Gao, Jiang-Mei; Gao, Xiao-Jie; Yang, Ting-Bao; Zhou, Wen-Liang; Lu, Fang-Li; Lun, Zhao-Rong] Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Li, Zhi; Zhao, Zhi-Jun; Ren, Qing-Shi; Nie, Fang-Fang; Gao, Jiang-Mei; Gao, Xiao-Jie; Yang, Ting-Bao; Zhou, Wen-Liang; Lu, Fang-Li; Lun, Zhao-Rong] Sun Yat Sen Univ, Key Lab Trop Dis Control, Minist Educ, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Zhu, Xing-Quan; Lun, Zhao-Rong] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou, Peoples R China; [Shen, Ji-Long] Anhui Med Univ, Dept Pathogen Biol, Hefei, Anhui, Peoples R China; [Wang, Yong] Nanjing Med Univ, Dept Pathogen Biol, Nanjing, Jiangsu, Peoples R China; [Chen, Xiao-Guang] So Med Univ, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China; [Hide, Geoff; Lun, Zhao-Rong] Univ Salford, Sch Environm & Life Sci, Ctr Parasitol & Dis, Salford M5 4WT, Lancs, England; [Ayala, Francisco J.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Zhao, Zhi-Jun] Ningxia Med Univ, Affiliated Hosp, Yinchuan, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Anhui Medical University; Nanjing Medical University; Southern Medical University - China; University of Salford; University of California System; University of California Irvine; Ningxia Medical University	Li, Z (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	lsslzr@mail.sysu.edu.cn		Hide, Geoff/0000-0002-3608-0175	National Basic Research Program of China (973 Program) [2010CB530000]; National Special Research Programs for Non-Profit Trades (Agriculture) [200803017]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Special Research Programs for Non-Profit Trades (Agriculture)	The work was supported by National Basic Research Program of China (973 Program) (No. 2010CB530000) and the National Special Research Programs for Non-Profit Trades (Agriculture) (No. 200803017), http://www.973.gov.cn/English/Index.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallahi OMS, 2001, CELL MOL LIFE SCI, V58, P1350, DOI 10.1007/PL00000947; ADAMS LB, 1990, J IMMUNOL, V144, P2725; Blachier F, 1997, NITRIC OXIDE-BIOL CH, V1, P268, DOI 10.1006/niox.1997.0127; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Cavailles P, 2006, P NATL ACAD SCI USA, V103, P744, DOI 10.1073/pnas.0506643103; Chang CI, 1998, AM J PHYSIOL-HEART C, V274, pH342, DOI 10.1152/ajpheart.1998.274.1.H342; CHINCHILLA M, 1982, J PARASITOL, V68, P952, DOI 10.2307/3281014; CHINCHILLA M, 1978, INFECT IMMUN, V19, P999, DOI 10.1128/IAI.19.3.999-1012.1978; COOK HT, 1994, AM J PHYSIOL-RENAL, V267, pF646, DOI 10.1152/ajprenal.1994.267.4.F646; Cook T, 2007, MICROBIOL-SGM, V153, P1123, DOI 10.1099/mic.0.2006/001768-0; CORRALIZA IM, 1994, J IMMUNOL METHODS, V174, P231, DOI 10.1016/0022-1759(94)90027-2; Da Gama LM, 2004, MICROBES INFECT, V6, P1287, DOI 10.1016/j.micinf.2004.07.008; Davis AS, 2007, PLOS PATHOG, V3, P1887, DOI 10.1371/journal.ppat.0030186; De Champs C, 1998, PARASITE, V5, P215, DOI 10.1051/parasite/1998053215; DING AH, 1988, J IMMUNOL, V141, P2407; Dubey JP, 1998, VET PARASITOL, V77, P1, DOI 10.1016/S0304-4017(97)00227-6; Dubey JP, 1999, J PARASITOL, V85, P657, DOI 10.2307/3285739; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; GAZZINELLI RT, 1992, J IMMUNOL, V148, P1792; Gobert AP, 2002, J IMMUNOL, V168, P6002, DOI 10.4049/jimmunol.168.12.6002; Gobert AP, 2002, J IMMUNOL, V168, P4692, DOI 10.4049/jimmunol.168.9.4692; Hayashi S, 1996, J IMMUNOL, V156, P1476; Hesse M, 2001, J IMMUNOL, V167, P6533, DOI 10.4049/jimmunol.167.11.6533; Homan WL, 2000, INT J PARASITOL, V30, P69, DOI 10.1016/S0020-7519(99)00170-8; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; JAMES SL, 1995, MICROBIOL REV, V59, P533, DOI 10.1128/MMBR.59.4.533-547.1995; Jenkinson CP, 1996, COMP BIOCHEM PHYS B, V114, P107, DOI 10.1016/0305-0491(95)02138-8; Kempf MC, 1999, MED MICROBIOL IMMUN, V187, P137, DOI 10.1007/s004300050085; Kmonickova E, 2007, NITRIC OXIDE-BIOL CH, V17, P160, DOI 10.1016/j.niox.2007.06.006; KRAHENBUHL JL, 1975, EXP PARASITOL, V37, P83, DOI 10.1016/0014-4894(75)90055-7; LANGERMANS JAM, 1992, J IMMUNOL, V148, P568; Luder CGK, 2003, INT J PARASITOL, V33, P833, DOI 10.1016/S0020-7519(03)00092-4; LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211; LUFT BJ, 1993, NEW ENGL J MED, V329, P995, DOI 10.1056/NEJM199309303291403; MCCABE RE, 1986, INFECT IMMUN, V52, P151, DOI 10.1128/IAI.52.1.151-155.1986; Mullner N, 2002, INT J BIOCHEM CELL B, V34, P1080, DOI 10.1016/S1357-2725(02)00028-6; Munder M, 1998, J IMMUNOL, V160, P5347; Nishikawa Y, 2003, INT J PARASITOL, V33, P1525, DOI 10.1016/S0020-7519(03)00204-2; Roberts SC, 2004, J BIOL CHEM, V279, P23668, DOI 10.1074/jbc.M402042200; Seabra SH, 2004, J PARASITOL, V90, P455, DOI 10.1645/GE-179R; Seabra SJ, 2002, EXP PARASITOL, V100, P62, DOI 10.1006/expr.2001.4675; Sergent W, 2005, INFECT IMMUN, V73, P6990, DOI 10.1128/IAI.73.10.6990-6997.2005; Stempin CC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/683485; von Bargen K, 2011, INFECT IMMUN, V79, P2098, DOI 10.1128/IAI.00983-10; WANG WW, 1995, BIOCHEM BIOPH RES CO, V210, P1009, DOI 10.1006/bbrc.1995.1757; Yap GS, 1999, J EXP MED, V189, P1083, DOI 10.1084/jem.189.7.1083; Zenner L, 1998, EXP PARASITOL, V90, P86, DOI 10.1006/expr.1998.4301	49	79	87	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35834	10.1371/journal.pone.0035834	http://dx.doi.org/10.1371/journal.pone.0035834			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558235	Green Accepted, Green Published, gold			2022-12-27	WOS:000305345200084
J	Savory, EA; Zou, C; Adhikari, BN; Hamilton, JP; Buell, CR; Shiu, SH; Day, B				Savory, Elizabeth A.; Zou, Cheng; Adhikari, Bishwo N.; Hamilton, John P.; Buell, C. Robin; Shiu, Shin-Han; Day, Brad			Alternative Splicing of a Multi-Drug Transporter from Pseudoperonospora cubensis Generates an RXLR Effector Protein That Elicits a Rapid Cell Death	PLOS ONE			English	Review							PHYTOPHTHORA-SOJAE; GENOME SEQUENCE; AVIRULENCE; ARABIDOPSIS; EXPRESSION; EVOLUTION; GENES; LOCUS; POLYMORPHISMS; MECHANISMS	Pseudoperonospora cubensis, an obligate oomycete pathogen, is the causal agent of cucurbit downy mildew, a foliar disease of global economic importance. Similar to other oomycete plant pathogens, Ps. cubensis has a suite of RXLR and RXLR-like effector proteins, which likely function as virulence or avirulence determinants during the course of host infection. Using in silico analyses, we identified 271 candidate effector proteins within the Ps. cubensis genome with variable RXLR motifs. In extending this analysis, we present the functional characterization of one Ps. cubensis effector protein, RXLR protein 1 (PscRXLR1), and its closest Phytophthora infestans ortholog, PITG_17484, a member of the Drug/Metabolite Transporter (DMT) superfamily. To assess if such effector-non-effector pairs are common among oomycete plant pathogens, we examined the relationship(s) among putative ortholog pairs in Ps. cubensis and P. infestans. Of 271 predicted Ps. cubensis effector proteins, only 109 (41%) had a putative ortholog in P. infestans and evolutionary rate analysis of these orthologs shows that they are evolving significantly faster than most other genes. We found that PscRXLR1 was up-regulated during the early stages of infection of plants, and, moreover, that heterologous expression of PscRXLR1 in Nicotiana benthamiana elicits a rapid necrosis. More interestingly, we also demonstrate that PscRXLR1 arises as a product of alternative splicing, making this the first example of an alternative splicing event in plant pathogenic oomycetes transforming a non-effector gene to a functional effector protein. Taken together, these data suggest a role for PscRXLR1 in pathogenicity, and, in total, our data provide a basis for comparative analysis of candidate effector proteins and their non-effector orthologs as a means of understanding function and evolutionary history of pathogen effectors.	[Savory, Elizabeth A.; Day, Brad] Michigan State Univ, Dept Plant Pathol, E Lansing, MI 48824 USA; [Zou, Cheng; Adhikari, Bishwo N.; Hamilton, John P.; Buell, C. Robin; Shiu, Shin-Han] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Savory, EA (corresponding author), Michigan State Univ, Dept Plant Pathol, E Lansing, MI 48824 USA.	bday@msu.edu	Shiu, Shin-Han/R-6117-2016; Hamilton, John P/G-1379-2016	Shiu, Shin-Han/0000-0001-6470-235X; Hamilton, John P/0000-0002-8682-5526; Buell, C Robin/0000-0002-6727-4677; Adhikari, Bishwo/0000-0003-4840-9609; Savory, Elizabeth/0000-0002-6016-9962; zou, cheng/0000-0001-9325-9465; Day, Brad/0000-0002-9880-4319; Vaillancourt, Brieanne/0000-0002-6795-5173	National Science Foundation [IOS-0641319]; United States Department of Agriculture Agriculture and Food Research Initiative (AFRI)	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture Agriculture and Food Research Initiative (AFRI)	Work in the laboratory of BD is supported by a grant from the National Science Foundation (IOS-0641319). EAS is supported by a United States Department of Agriculture Agriculture and Food Research Initiative (AFRI) pre-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Chandran D, 2009, PLANT PHYSIOL, V149, P1435, DOI 10.1104/pp.108.132985; Chaparro-Garcia A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016608; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Costanzo S, 2007, CURR GENET, V52, P115, DOI 10.1007/s00294-007-0144-z; de Wit PJGM, 2009, MOL PLANT PATHOL, V10, P735, DOI 10.1111/j.1364-3703.2009.00591.x; Dong SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005556; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Franke I, 2003, J BACTERIOL, V185, P1161, DOI 10.1128/JB.185.4.1161-1166.2003; Gurlebeck D, 2009, MOL PLANT PATHOL, V10, P175, DOI 10.1111/j.1364-3703.2008.00519.x; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Halterman DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010536; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Jack DL, 2001, EUR J BIOCHEM, V268, P3620, DOI 10.1046/j.1432-1327.2001.02265.x; Jacobs KA, 1997, GENE, V198, P289, DOI 10.1016/S0378-1119(97)00330-2; Jiang RHY, 2008, P NATL ACAD SCI USA, V105, P4874, DOI 10.1073/pnas.0709303105; Jin P, 2003, PLANT PHYSIOL, V133, P1072, DOI 10.1104/pp.103.025999; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Knepper C, 2011, PLANT PHYSIOL, V156, P286, DOI 10.1104/pp.110.169656; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levesque CA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r73; Liu TL, 2011, PLANT PHYSIOL, V155, P490, DOI 10.1104/pp.110.166470; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Mansfield JW, 2009, MOL PLANT PATHOL, V10, P721, DOI 10.1111/j.1364-3703.2009.00576.x; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Oh SK, 2009, PLANT CELL, V21, P2928, DOI 10.1105/tpc.109.068247; Qutob D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005066; Rafiqi M, 2010, PLANT CELL, V22, P2017, DOI 10.1105/tpc.109.072983; Rehmany AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/tpc.105.031807; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Savory EA, 2011, MOL PLANT PATHOL, V12, P217, DOI 10.1111/j.1364-3703.2010.00670.x; Schornack S, 2010, P NATL ACAD SCI USA, V107, P17421, DOI 10.1073/pnas.1008491107; Schornack S, 2009, MOL PLANT PATHOL, V10, P795, DOI 10.1111/j.1364-3703.2009.00593.x; Shan LB, 2000, PLANT CELL, V12, P2323, DOI 10.1105/tpc.12.12.2323; Shan WX, 2004, MOL PLANT MICROBE IN, V17, P394, DOI 10.1094/MPMI.2004.17.4.394; Shen DY, 2011, CAN J MICROBIOL, V57, P84, DOI [10.1139/W10-103, 10.1139/w10-103]; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Tian MY, 2011, MOL PLANT MICROBE IN, V24, P543, DOI 10.1094/MPMI-08-10-0185; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Win J, 2006, FUNGAL GENET BIOL, V43, P20, DOI 10.1016/j.fgb.2005.10.003; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037; Win J, 2011, METHODS MOL BIOL, V712, P181, DOI 10.1007/978-1-61737-998-7_15; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	60	45	46	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2012	7	4							e34701	10.1371/journal.pone.0034701	http://dx.doi.org/10.1371/journal.pone.0034701			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955IH	22545137	Green Published, gold, Green Submitted			2022-12-27	WOS:000305010500024
J	Lu, C; Stewart, DJ; Lee, JJ; Ji, L; Ramesh, R; Jayachandran, G; Nunez, MI; Wistuba, II; Erasmus, JJ; Hicks, ME; Grimm, EA; Reuben, JM; Baladandayuthapani, V; Templeton, NS; McMannis, JD; Roth, JA				Lu, Charles; Stewart, David J.; Lee, J. Jack; Ji, Lin; Ramesh, Rajagopal; Jayachandran, Gitanjali; Nunez, Maria I.; Wistuba, Ignacio I.; Erasmus, Jeremy J.; Hicks, Marshall E.; Grimm, Elizabeth A.; Reuben, James M.; Baladandayuthapani, Veerabhadran; Templeton, Nancy S.; McMannis, John D.; Roth, Jack A.			Phase I Clinical Trial of Systemically Administered TUSC2(FUS1)-Nanoparticles Mediating Functional Gene Transfer in Humans	PLOS ONE			English	Article							HOMOZYGOUS DELETION REGION; HUMAN-CHROMOSOME 3P21.3; TUMOR-SUPPRESSOR GENES; LUNG-CANCER CELLS; ADENOVIRUS VECTOR; DNA COMPLEXES; FUS1 PROTEIN; EXPRESSION; P53; LIPOSOME	Background: Tumor suppressor gene TUSC2/FUS1 (TUSC2) is frequently inactivated early in lung cancer development. TUSC2 mediates apoptosis in cancer cells but not normal cells by upregulation of the intrinsic apoptotic pathway. No drug strategies currently exist targeting loss-of-function genetic abnormalities. We report the first in-human systemic gene therapy clinical trial of tumor suppressor gene TUSC2. Methods: Patients with recurrent and/or metastatic lung cancer previously treated with platinum-based chemotherapy were treated with escalating doses of intravenous N-[1-(2,3-dioleoyloxy)propyl]-N,N,N-trimethylammonium chloride (DOTAP): cholesterol nanoparticles encapsulating a TUSC2 expression plasmid (DOTAP: chol-TUSC2) every 3 weeks. Results: Thirty-one patients were treated at 6 dose levels (range 0.01 to 0.09 milligrams per kilogram). The MTD was determined to be 0.06 mg/kg. Five patients achieved stable disease (2.6-10.8 months, including 2 minor responses). One patient had a metabolic response on positron emission tomography (PET) imaging. RT-PCR analysis detected TUSC2 plasmid expression in 7 of 8 post-treatment tumor specimens but not in pretreatment specimens and peripheral blood lymphocyte controls. Proximity ligation assay, performed on paired biopsies from 3 patients, demonstrated low background TUSC2 protein staining in pretreatment tissues compared with intense (10-25 fold increase) TUSC2 protein staining in post-treatment tissues. RT-PCR gene expression profiling analysis of apoptotic pathway genes in two patients with high post-treatment levels of TUSC2 mRNA and protein showed significant post-treatment changes in the intrinsic apoptotic pathway. Twenty-nine genes of the 82 tested in the apoptosis array were identified by Igenuity Pathway Analysis to be significantly altered post-treatment in both patients (Pearson correlation coefficient 0.519; p<0.01). Conclusions: DOTAP: chol-TUSC2 can be safely administered intravenously in lung cancer patients and results in uptake of the gene by human primary and metastatic tumors, transgene and gene product expression, specific alterations in TUSC2-regulated pathways, and anti-tumor effects (to our knowledge for the first time for systemic DOTAP: cholesterol nanoparticle gene therapy).	[Lu, Charles; Stewart, David J.; Lee, J. Jack; Ji, Lin; Jayachandran, Gitanjali; Nunez, Maria I.; Wistuba, Ignacio I.; Erasmus, Jeremy J.; Hicks, Marshall E.; Grimm, Elizabeth A.; Reuben, James M.; Baladandayuthapani, Veerabhadran; McMannis, John D.; Roth, Jack A.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Ramesh, Rajagopal] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA; [Ramesh, Rajagopal] Stephenson Canc Ctr, Oklahoma City, OK USA; [Templeton, Nancy S.] Gradalis Inc, Carrollton, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Lu, C (corresponding author), Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.	clu@mdanderson.org	Templeton, Nancy S/C-9565-2011; Lee, Jack/P-7331-2019; Center, Univ of Texas-M D Anderson Cancer/AAE-8182-2019	Lee, Jack/0000-0002-4584-929X; Center, Univ of Texas-M D Anderson Cancer/0000-0001-5469-9214	National Institutes of Health through M. D. Anderson's Cancer Center [CA-016672]; Biostatistics Resource Group; Clinical Trials Support Resource; Clinical and Translational Research Center; Protocol Review and Monitoring Shared Resources, the Commonwealth Phase I Study IV DOTAP [RO1 CA 113450 RR]; Genprex, Inc.; NATIONAL CANCER INSTITUTE [P50CA070907, R01CA113450, P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health through M. D. Anderson's Cancer Center; Biostatistics Resource Group; Clinical Trials Support Resource; Clinical and Translational Research Center; Protocol Review and Monitoring Shared Resources, the Commonwealth Phase I Study IV DOTAP; Genprex, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by the National Institutes of Health through M. D. Anderson's Cancer Center Support Grant CA-016672 - Lung Program, Research Histopathology Facility; Biostatistics Resource Group; Clinical Trials Support Resource; Clinical and Translational Research Center; and Protocol Review and Monitoring Shared Resources, the Commonwealth Phase I Study IV DOTAP (JAR), RO1 CA 113450 RR), and a generous donation from the Helen & Jin Ryu Fund for Gene Therapy (JAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CL: Patent-TUSC2 Therapeutic Response Markers (pending), Co-Inventor JAR: Consultancy, grants, stock: Genprex, Inc.; Patents pending and issued: TUSC2/FUS1 NST: Novel DNA: liposome complexes for increased systemic delivery and gene expression. United States Letters Patent No. 6,413,544 B1 issued July 2, 2002. United States Patent No. 6,770,291 B2 issued August 3, 2004. International Publication Number: WO 98/07408. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aksentijevich I, 1996, HUM GENE THER, V7, P1111, DOI 10.1089/hum.1996.7.9-1111; BISHOP JM, 1991, CELL, V64, P235, DOI 10.1016/0092-8674(91)90636-D; Buvoli M, 2002, GENE THER, V9, P227, DOI 10.1038/sj.gt.3301640; Clayman GL, 1998, J CLIN ONCOL, V16, P2221, DOI 10.1200/JCO.1998.16.6.2221; Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Deng WG, 2007, CANCER RES, V67, P709, DOI 10.1158/0008-5472.CAN-06-3463; Du LQ, 2009, MOL CANCER RES, V7, P1234, DOI 10.1158/1541-7786.MCR-08-0507; Firozi P, 2010, GENE THER, V17, P1484, DOI 10.1038/gt.2010.97; HEARING P, 1983, CELL, V33, P695, DOI 10.1016/0092-8674(83)90012-0; Ito I, 2004, CANCER GENE THER, V11, P733, DOI 10.1038/sj.cgt.7700756; Ito I, 2003, MOL THER, V7, P409, DOI 10.1016/S1525-0016(03)00004-2; Ji L, 2002, CANCER RES, V62, P2715; Ji L, 2008, J THORAC ONCOL, V3, P327, DOI 10.1097/JTO.0b013e31816bce65; Ji Lin, 2005, Future Oncol, V1, P79, DOI 10.1517/14796694.1.1.79; Lerman MI, 2000, CANCER RES, V60, P6116; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; McLachlan G, 2000, GENE THER, V7, P384, DOI 10.1038/sj.gt.3301097; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; OQUIGLEY J, 1990, BIOMETRICS, V46, P33, DOI 10.2307/2531628; Prudkin L, 2008, CLIN CANCER RES, V14, P41, DOI 10.1158/1078-0432.CCR-07-1252; Puri A, 2009, CRIT REV THER DRUG, V26, P523, DOI 10.1615/CritRevTherDrugCarrierSyst.v26.i6.10; Ramesh R, 2001, MOL THER, V3, P337, DOI 10.1006/mthe.2001.0266; Roth JA, 2006, EXPERT OPIN BIOL TH, V6, P55, DOI 10.1517/14712598.6.1.55; Roth JA, 1996, NAT MED, V2, P985, DOI 10.1038/nm0996-985; Simberg D, 2005, HUM GENE THER, V16, P1087, DOI 10.1089/hum.2005.16.1087; Simberg D, 2007, P NATL ACAD SCI USA, V104, P932, DOI 10.1073/pnas.0610298104; Swisher SG, 1999, J NATL CANCER I, V91, P763, DOI 10.1093/jnci/91.9.763; Templeton NS, 1997, NAT BIOTECHNOL, V15, P647, DOI 10.1038/nbt0797-647; Tousignant JD, 2000, HUM GENE THER, V11, P2493, DOI 10.1089/10430340050207984; Uno F, 2004, CANCER RES, V64, P2969, DOI 10.1158/0008-5472.CAN-03-3702; WILKINSON GWG, 1992, NUCLEIC ACIDS RES, V20, P2233, DOI 10.1093/nar/20.9.2233; Wistuba II, 1999, ONCOGENE, V18, P643, DOI 10.1038/sj.onc.1202349; Yang JP, 1997, GENE THER, V4, P950, DOI 10.1038/sj.gt.3300485	33	213	218	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e34833	10.1371/journal.pone.0034833	http://dx.doi.org/10.1371/journal.pone.0034833			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558101	gold, Green Submitted, Green Published			2022-12-27	WOS:000305345200014
J	Kelleher, RJ; Geigenmuller, U; Hovhannisyan, H; Trautman, E; Pinard, R; Rathmell, B; Carpenter, R; Margulies, D				Kelleher, Raymond J., III; Geigenmueller, Ute; Hovhannisyan, Hayk; Trautman, Edwin; Pinard, Robert; Rathmell, Barbara; Carpenter, Randall; Margulies, David			High-Throughput Sequencing of mGluR Signaling Pathway Genes Reveals Enrichment of Rare Variants in Autism	PLOS ONE			English	Article							COPY-NUMBER VARIATION; ACTIVATED PROTEIN-KINASES; LONG-TERM DEPRESSION; DE-NOVO; SYNAPTIC PLASTICITY; LEARNING-DEFICITS; MOUSE MODEL; MUTATIONS; HOMER; DISEASE	Identification of common molecular pathways affected by genetic variation in autism is important for understanding disease pathogenesis and devising effective therapies. Here, we test the hypothesis that rare genetic variation in the metabotropic glutamate-receptor (mGluR) signaling pathway contributes to autism susceptibility. Single-nucleotide variants in genes encoding components of the mGluR signaling pathway were identified by high-throughput multiplex sequencing of pooled samples from 290 non-syndromic autism cases and 300 ethnically matched controls on two independent next-generation platforms. This analysis revealed significant enrichment of rare functional variants in the mGluR pathway in autism cases. Higher burdens of rare, potentially deleterious variants were identified in autism cases for three pathway genes previously implicated in syndromic autism spectrum disorder, TSC1, TSC2, and SHANK3, suggesting that genetic variation in these genes also contributes to risk for non-syndromic autism. In addition, our analysis identified HOMER1, which encodes a postsynaptic density-localized scaffolding protein that interacts with Shank3 to regulate mGluR activity, as a novel autism-risk gene. Rare, potentially deleterious HOMER1 variants identified uniquely in the autism population affected functionally important protein regions or regulatory sequences and co-segregated closely with autism among children of affected families. We also identified rare ASD-associated coding variants predicted to have damaging effects on components of the Ras/MAPK cascade. Collectively, these findings suggest that altered signaling downstream of mGluRs contributes to the pathogenesis of non-syndromic autism.	[Kelleher, Raymond J., III] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Kelleher, Raymond J., III] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Kelleher, Raymond J., III] Harvard Univ, Sch Med, Program Neurosci, Boston, MA USA; [Geigenmueller, Ute; Hovhannisyan, Hayk; Trautman, Edwin; Pinard, Robert; Margulies, David] Correlagen Diagnost Inc, Waltham, MA USA; [Rathmell, Barbara; Carpenter, Randall] Seaside Therapeut, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Kelleher, RJ (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	kelleher@helix.mgh.harvard.edu	Sala, Carlo/A-2493-2009	Sala, Carlo/0000-0003-0662-9523; Crater, Glenn/0000-0002-1159-1323	Pew Scholars Program in Biomedical Sciences; John Merck Scholars Fund; NIMH [K02 MH087796]; Simons Foundation Autism Research Initiative; NATIONAL INSTITUTE OF MENTAL HEALTH [U24MH081810, K02MH087796] Funding Source: NIH RePORTER	Pew Scholars Program in Biomedical Sciences; John Merck Scholars Fund; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation Autism Research Initiative; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	RJK was supported by awards from the Pew Scholars Program in Biomedical Sciences, the John Merck Scholars Fund, the NIMH (K02 MH087796), and the Simons Foundation Autism Research Initiative. These funding institutions had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Seaside Therapeutics and Correlagen Diagnostics contributed funding for this study. These companies had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript due to their employment of one or more of the authors of the study.	Abankwa D, 2008, EMBO J, V27, P727, DOI 10.1038/emboj.2008.10; Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aoki Y, 2008, HUM MUTAT, V29, P992, DOI 10.1002/humu.20748; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Berkel S, 2010, NAT GENET, V42, P489, DOI 10.1038/ng.589; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Chen JM, 2006, HUM GENET, V120, P1, DOI 10.1007/s00439-006-0180-7; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; Costa RM, 2002, NATURE, V415, P526, DOI 10.1038/nature711; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; El-Fishawy P, 2010, PSYCHIAT CLIN N AM, V33, P83, DOI 10.1016/j.psc.2009.12.002; Gai X, 2011, MOL PSYCHIATR; Gallagher SM, 2004, J NEUROSCI, V24, P4859, DOI 10.1523/JNEUROSCI.5407-03.2004; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hamdan FF, 2009, NEW ENGL J MED, V360, P599, DOI 10.1056/NEJMoa0805392; Hayashi MK, 2009, CELL, V137, P159, DOI 10.1016/j.cell.2009.01.050; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Krueger DD, ANN REV MED; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Nava C, 2007, J MED GENET, V44, P763, DOI 10.1136/jmg.2007.050450; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Ronesi JA, 2008, J NEUROSCI, V28, P543, DOI 10.1523/JNEUROSCI.5019-07.2008; Ronesi JA, 2012, NAT NEUROSCI, V15, P431, DOI 10.1038/nn.3033; Rumbaugh G, 2006, P NATL ACAD SCI USA, V103, P4344, DOI 10.1073/pnas.0600084103; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Schaaf CP, 2011, HUM MOL GENET, V20, P3366, DOI 10.1093/hmg/ddr243; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Thusberg J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/humu.21445; Toro R, 2010, TRENDS GENET, V26, P363, DOI 10.1016/j.tig.2010.05.007; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Wiznitzer M, 2004, J CHILD NEUROL, V19, P675, DOI 10.1177/08830738040190090701; Xiao B, 2000, CURR OPIN NEUROBIOL, V10, P370, DOI 10.1016/S0959-4388(00)00087-8; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104	53	114	116	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35003	10.1371/journal.pone.0035003	http://dx.doi.org/10.1371/journal.pone.0035003			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558107	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000020
J	Zhang, XN; Jaramillo, M; Singh, S; Kumta, P; Banerjee, I				Zhang, Xinan; Jaramillo, Maria; Singh, Satish; Kumta, Prashant; Banerjee, Ipsita			Analysis of Regulatory Network Involved in Mechanical Induction of Embryonic Stem Cell Differentiation	PLOS ONE			English	Article							HEPATOCYTE NUCLEAR FACTOR-3-BETA; ENRICHED TRANSCRIPTION FACTORS; GENE-EXPRESSION DATA; LIVER DEVELOPMENT; HOMEOBOX GENE; ENDODERM; COMMITMENT; BINDING	Embryonic stem cells are conventionally differentiated by modulating specific growth factors in the cell culture media. Recently the effect of cellular mechanical microenvironment in inducing phenotype specific differentiation has attracted considerable attention. We have shown the possibility of inducing endoderm differentiation by culturing the stem cells on fibrin substrates of specific stiffness [1]. Here, we analyze the regulatory network involved in such mechanically induced endoderm differentiation under two different experimental configurations of 2-dimensional and 3-dimensional culture, respectively. Mouse embryonic stem cells are differentiated on an array of substrates of varying mechanical properties and analyzed for relevant endoderm markers. The experimental data set is further analyzed for identification of co-regulated transcription factors across different substrate conditions using the technique of bi-clustering. Overlapped bi-clusters are identified following an optimization formulation, which is solved using an evolutionary algorithm. While typically such analysis is performed at the mean value of expression data across experimental repeats, the variability of stem cell systems reduces the confidence on such analysis of mean data. Bootstrapping technique is thus integrated with the bi-clustering algorithm to determine sets of robust bi-clusters, which is found to differ significantly from corresponding bi-clusters at the mean data value. Analysis of robust bi-clusters reveals an overall similar network interaction as has been reported for chemically induced endoderm or endodermal organs but with differences in patterning between 2-dimensional and 3-dimensional culture. Such analysis sheds light on the pathway of stem cell differentiation indicating the prospect of the two culture configurations for further maturation.	[Zhang, Xinan] Cent China Normal Univ, Sch Math & Stat, Wuhan, Peoples R China; [Zhang, Xinan; Singh, Satish; Kumta, Prashant; Banerjee, Ipsita] Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15261 USA; [Jaramillo, Maria; Kumta, Prashant; Banerjee, Ipsita] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Kumta, Prashant] Univ Pittsburgh, Dept Mech Engn & Mat Sci, Pittsburgh, PA USA; [Kumta, Prashant] Univ Pittsburgh, Ctr Complex Engn Multifunct Mat, Pittsburgh, PA USA	Central China Normal University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zhang, XN (corresponding author), Cent China Normal Univ, Sch Math & Stat, Wuhan, Peoples R China.	ipb1@pitt.edu			National Institutes of Health [DP2 116520]; Oak Ridge Associated Universities; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oak Ridge Associated Universities; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The authors acknowledge support from National Institutes of Health New Innovator Award DP2 116520 and Oak Ridge Associated Universities Ralph Powe Junior Faculty Enhancement Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah A, 2006, NEUROCOMPUTING, V69, P1882, DOI 10.1016/j.neucom.2006.02.018; Anderson WJ, 2008, DEV DYNAM, V237, P504, DOI 10.1002/dvdy.21437; Banerjee I, 2006, COMBUST FLAME, V144, P619, DOI 10.1016/j.combustflame.2005.10.001; Banerjee I, 2003, CHEM ENG SCI, V58, P4537, DOI 10.1016/S0009-2509(03)00343-9; Banerjee I, 2010, BIOINFORMATICS, V26, P1332, DOI 10.1093/bioinformatics/btq139; Barbera JPM, 2000, DEVELOPMENT, V127, P2433; Bieniasz LK, 2006, ANAL CHEM, V78, P8430, DOI 10.1021/ac061167z; Cao L, 2011, DIFFERENTIATION, V81, P1, DOI 10.1016/j.diff.2010.09.182; Cheng Y, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P93; COCKELL M, 1995, MOL CELL BIOL, V15, P1933; Costa RH, 2003, HEPATOLOGY, V38, P1331, DOI 10.1016/j.hep.2003.09.034; Denson LA, 2000, GENE, V246, P311, DOI 10.1016/S0378-1119(00)00082-2; Denton AM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-294; Divina F, 2006, IEEE T KNOWL DATA EN, V18, P590, DOI 10.1109/TKDE.2006.74; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Getz G, 2000, P NATL ACAD SCI USA, V97, P12079, DOI 10.1073/pnas.210134797; Goldberg D.E., 1989, GENETIC ALGORITHMS S; HARTIGAN JA, 1972, J AM STAT ASSOC, V67, P123, DOI 10.2307/2284710; HERBST RS, 1991, NEW BIOL, V3, P289; Hochreiter S, 2010, BIOINFORMATICS, V26, P1520, DOI 10.1093/bioinformatics/btq227; Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]; Jaramillo M, 2011, INDUCING ENDODERM DI; Lehner F, 2010, WORLD J GASTROENTERO, V16, P3919, DOI 10.3748/wjg.v16.i31.3919; Lopez-Sanchez C, 2009, INT J DEV BIOL, V53, P1445, DOI 10.1387/ijdb.072417cl; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Morrison GM, 2008, CELL STEM CELL, V3, P402, DOI 10.1016/j.stem.2008.07.021; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; NAGY P, 1994, J CELL BIOL, V126, P223, DOI 10.1083/jcb.126.1.223; Orling J, 1977, NEDERL AKAD WETENSCH, V39, P8; PANI L, 1992, MOL CELL BIOL, V12, P3723, DOI 10.1128/MCB.12.9.3723; Reiss DJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-280; Rojas A, 2010, DEV BIOL, V346, P346, DOI 10.1016/j.ydbio.2010.07.032; Sill M, 2011, BIOINFORMATICS, V27, P2089, DOI 10.1093/bioinformatics/btr322; STINE R, 1989, SOCIOL METHOD RES, V18, P243, DOI 10.1177/0049124189018002003; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wang H, 2002, P 2002 ACM SIGMOD IN, P418; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Yang E, 2007, BIOINFORMATICS, V23, P2306, DOI 10.1093/bioinformatics/btm335	40	308	314	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35700	10.1371/journal.pone.0035700	http://dx.doi.org/10.1371/journal.pone.0035700			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558203	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000305336000049
J	Zhang, YG; Li, F; Liu, S; Wang, H; Mahavadi, S; Murthy, KS; Khalili, K; Hu, WH				Zhang, Yonggang; Li, Fang; Liu, Shu; Wang, Hong; Mahavadi, Sunila; Murthy, Karnam S.; Khalili, Kamel; Hu, Wenhui			MEKK1-MKK4-JNK-AP1 Pathway Negatively Regulates Rgs4 Expression in Colonic Smooth Muscle Cells	PLOS ONE			English	Article							NF-KAPPA-B; MESSENGER-RNA EXPRESSION; PROTEIN-KINASE PATHWAYS; JUN NH2-TERMINAL KINASE; NECROSIS-FACTOR-ALPHA; P38 MAPK; SIGNAL-TRANSDUCTION; TERMINAL KINASE; JNK ACTIVATION; ANGIOTENSIN-II	Background: Regulator of G-protein Signaling 4 (RGS4) plays an important role in regulating smooth muscle contraction, cardiac development, neural plasticity and psychiatric disorder. However, the underlying regulatory mechanisms remain elusive. Our recent studies have shown that upregulation of Rgs4 by interleukin (IL)-1 beta is mediated by the activation of NFkB signaling and modulated by extracellular signal-regulated kinases, p38 mitogen-activated protein kinase, and phosphoinositide-3 kinase. Here we investigate the effect of the c-Jun N-terminal kinase (JNK) pathway on Rgs4 expression in rabbit colonic smooth muscle cells. Methodology/Principal Findings: Cultured cells at first passage were treated with or without IL-1 beta (10 ng/ml) in the presence or absence of the selective JNK inhibitor (SP600125) or JNK small hairpin RNA (shRNA). The expression levels of Rgs4 mRNA and protein were determined by real-time RT-PCR and Western blot respectively. SP600125 or JNK shRNA increased Rgs4 expression in the absence or presence of IL-1 beta stimulation. Overexpression of MEKK1, the key upstream kinase of JNK, inhibited Rgs4 expression, which was reversed by co-expression of JNK shRNA or dominant-negative mutants for MKK4 or JNK. Both constitutive and inducible upregulation of Rgs4 expression by SP600125 was significantly inhibited by pretreatment with the transcription inhibitor, actinomycin D. Dual reporter assay showed that pretreatment with SP600125 sensitized the promoter activity of Rgs4 in response to IL-1 beta. Mutation of the AP1-binding site within Rgs4 promoter increased the promoter activity. Western blot analysis confirmed that IL-1 beta treatment increased the phosphorylation of JNK, ATF-2 and c-Jun. Gel shift and chromatin immunoprecipitation assays validated that IL-1 beta increased the in vitro and ex vivo binding activities of AP1 within rabbit Rgs4 promoter. Conclusion/Significance: Activation of MEKK1-MKK4-JNK-AP1 signal pathway plays a tonic inhibitory role in regulating Rgs4 transcription in rabbit colonic smooth muscle cells. This negative regulation may aid in maintaining the transient level of RGS4 expression.	[Zhang, Yonggang; Li, Fang; Liu, Shu; Wang, Hong; Khalili, Kamel; Hu, Wenhui] Temple Univ, Dept Neurosci, Sch Med, Philadelphia, PA 19122 USA; [Mahavadi, Sunila; Murthy, Karnam S.] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Virginia Commonwealth University	Zhang, YG (corresponding author), Temple Univ, Dept Neurosci, Sch Med, Philadelphia, PA 19122 USA.	whu@temple.edu	Song, Yajun/GQQ-0476-2022; Song, Yajun/F-3714-2011; Yang, Ruifu/A-2273-2011	Song, Yajun/0000-0002-6628-2747; Song, Yajun/0000-0002-6628-2747; Yang, Ruifu/0000-0003-3219-7269	National Institutes of Diabetes and Digestive and Kidney Diseases [DK075964, DK015564]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK015564, R01DK075964, R37DK015564] Funding Source: NIH RePORTER	National Institutes of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by grant DK075964 (WH) and DK015564 (KM) from the National Institutes of Diabetes and Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Bachar O, 2004, EUR J IMMUNOL, V34, P1196, DOI 10.1002/eji.200324569; Bansal G, 2007, PHARMACOL THERAPEUT, V116, P473, DOI 10.1016/j.pharmthera.2007.09.005; Barona I, 2011, J PHARM PHARMACOL, V63, P657, DOI 10.1111/j.2042-7158.2011.01253.x; Bashari D, 2011, CELL SIGNAL, V23, P65, DOI 10.1016/j.cellsig.2010.08.004; Bode AM, 2007, MOL CARCINOGEN, V46, P591, DOI 10.1002/mc.20348; Bodenstein J, 2007, MOL PHARMACOL, V71, P1040, DOI 10.1124/mol.106.029397; Bongalon S, 2004, J VASC RES, V41, P412, DOI 10.1159/000081247; Bowden NA, 2007, SCHIZOPHR RES, V89, P165, DOI 10.1016/j.schres.2006.09.003; Cao WB, 2004, J PHARMACOL EXP THER, V311, P60, DOI 10.1124/jpet.104.068023; Cao WB, 2003, AM J PHYSIOL-GASTR L, V285, pG86, DOI 10.1152/ajpgi.00156.2002; Cho H, 2003, BIOCHEM J, V371, P973, DOI 10.1042/BJ20021769; Chowdari KV, 2008, SCHIZOPHRENIA BULL, V34, P118, DOI 10.1093/schbul/sbm042; Chung FY, 2008, ARCH PHARM RES, V31, P1437, DOI 10.1007/s12272-001-2128-8; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; Cook AK, 2000, AM J PHYSIOL-GASTR L, V278, pG429, DOI 10.1152/ajpgi.2000.278.3.G429; Costigan M, 2003, MOL CELL NEUROSCI, V24, P106, DOI 10.1016/S1044-7431(03)00135-0; Davies JS, 2011, J BIOL CHEM, V286, P15227, DOI 10.1074/jbc.M110.201996; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Ding GX, 2010, WORLD J PEDIATR, V6, P169, DOI 10.1007/s12519-010-0033-2; Ding L, 2007, GENE, V401, P46, DOI 10.1016/j.gene.2007.07.002; Erdely HA, 2006, SYNAPSE, V59, P472, DOI 10.1002/syn.20265; Gerthoffer WT, 2005, AM J PHYSIOL-GASTR L, V288, pG849, DOI 10.1152/ajpgi.00530.2004; Ginnan R, 2006, AM J PHYSIOL-CELL PH, V290, pC1583, DOI 10.1152/ajpcell.00390.2005; Gold SJ, 2003, EUR J NEUROSCI, V17, P971, DOI 10.1046/j.1460-9568.2003.02529.x; Gonzalo S, 2011, NEUROGASTROENT MOTIL, V23, pe80, DOI 10.1111/j.1365-2982.2010.01632.x; Gonzalo S, 2010, NEUROGASTROENT MOTIL, V22, P564, DOI 10.1111/j.1365-2982.2009.01439.x; Grillet N, 2003, J NEUROSCI, V23, P10613; Guikema BJ, 2005, FREE RADICAL BIO MED, V38, P597, DOI 10.1016/j.freeradbiomed.2004.11.022; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Hallsworth MP, 2001, AM J RESP CRIT CARE, V164, P688, DOI 10.1164/ajrccm.164.4.2011004; Hao JM, 2006, J MOL CELL CARDIOL, V41, P51, DOI 10.1016/j.yjmcc.2006.04.003; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Hendriks-Balk MC, 2008, EUR J PHARMACOL, V600, P1, DOI 10.1016/j.ejphar.2008.09.041; Hirst SJ, 2002, AM J RESP CRIT CARE, V165, P1161, DOI 10.1164/ajrccm.165.8.2107158; Hu W, 2006, BIOCHEM BIOPH RES CO, V343, P1038, DOI 10.1016/j.bbrc.2006.03.079; Hu WH, 2008, BIOCHEM J, V412, P35, DOI 10.1042/BJ20080042; Hu WH, 2007, AM J PHYSIOL-CELL PH, V293, pC1991, DOI 10.1152/ajpcell.00300.2007; Hu WH, 2009, AM J PHYSIOL-CELL PH, V296, pC1310, DOI 10.1152/ajpcell.00573.2008; Hu WH, 1999, J BIOL CHEM, V274, P30603, DOI 10.1074/jbc.274.43.30603; Hu YH, 1997, ARTERIOSCL THROM VAS, V17, P2808, DOI 10.1161/01.ATV.17.11.2808; Huang CF, 1997, P NATL ACAD SCI USA, V94, P6159, DOI 10.1073/pnas.94.12.6159; Huang J, 2005, AM J PHYSIOL-GASTR L, V288, pG23, DOI 10.1152/ajpgi.00305.2004; Huang J, 2007, AM J PHYSIOL-CELL PH, V292, pC200, DOI 10.1152/ajpcell.00103.2006; Ihara E, 2007, AM J PHYSIOL-GASTR L, V293, pG699, DOI 10.1152/ajpgi.00214.2007; Ihara E, 2009, MOL PHARMACOL, V75, P1031, DOI 10.1124/mol.108.049858; Il Jeong S, 2011, J PHARM PHARMACOL, V63, P245, DOI 10.1111/j.2042-7158.2010.01212.x; Je HD, 2001, J PHYSIOL-LONDON, V537, P567, DOI 10.1111/j.1469-7793.2001.00567.x; Jiang SN, 2011, AM J PHYSIOL-GASTR L, V301, pG454, DOI 10.1152/ajpgi.00148.2011; Jung YD, 2002, CYTOKINE, V18, P206, DOI 10.1006/cyto.2002.1034; Jung Young D., 2001, Angiogenesis, V4, P155, DOI 10.1023/A:1012291524723; Kattoulas E, 2011, PSYCHOL MED, P1; Khan I., 2006, Inflammopharmacology, V14, P28, DOI 10.1007/s10787-006-1507-7; Kim J, 2005, EUR J PHARMACOL, V514, P209, DOI 10.1016/j.ejphar.2005.03.030; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Kloss S, 2004, MOL PHARMACOL, V65, P1440, DOI 10.1124/mol.65.6.1440; Kordowska J, 2006, J BIOMED SCI, V13, P159, DOI 10.1007/s11373-005-9060-8; Krumins AM, 2004, J BIOL CHEM, V279, P2593, DOI 10.1074/jbc.M311600200; Lawler S, 1998, CURR BIOL, V8, P1387, DOI 10.1016/S0960-9822(98)00019-0; Lee CW, 2006, J CELL PHYSIOL, V207, P174, DOI 10.1002/jcp.20549; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Lee PCW, 2011, MOL CELL, V43, P392, DOI 10.1016/j.molcel.2011.05.034; Lee TS, 2002, CELL SIGNAL, V14, P989, DOI 10.1016/S0898-6568(02)00032-3; Lee YR, 2006, J PHARMACOL SCI, V100, P119, DOI 10.1254/jphs.FP0050777; Levitt P, 2006, BIOL PSYCHIAT, V60, P534, DOI 10.1016/j.biopsych.2006.04.028; Li F, 2010, AM J PHYSIOL-CELL PH, V299, pC1418, DOI 10.1152/ajpcell.00093.2010; Li F, 2010, GENE, V451, P45, DOI 10.1016/j.gene.2009.11.010; Liang D, 2001, MOL BRAIN RES, V96, P94, DOI 10.1016/S0169-328X(01)00287-X; Liang KC, 2007, J CELL PHYSIOL, V211, P759, DOI 10.1002/jcp.20992; Lin TC, 2009, EPILEPSY BEHAV, V14, P316, DOI 10.1016/j.yebeh.2008.12.005; Lipska BK, 2006, HUM MOL GENET, V15, P2804, DOI 10.1093/hmg/ddl222; Liu J, 2006, MOL CELL, V21, P467, DOI 10.1016/j.molcel.2005.12.020; Luo SF, 2008, TOXICOL APPL PHARM, V232, P396, DOI 10.1016/j.taap.2008.07.019; Mittmann C, 2002, CARDIOVASC RES, V55, P778, DOI 10.1016/S0008-6363(02)00459-5; Mittmann C, 2001, N-S ARCH PHARMACOL, V363, P456; Ni YG, 1999, J NEUROSCI, V19, P3674; Oltmanns U, 2003, BRIT J PHARMACOL, V139, P1228, DOI 10.1038/sj.bjp.0705345; Ortega-Perez I, 2005, J BIOL CHEM, V280, P20867, DOI 10.1074/jbc.M501898200; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Park SU, 2006, WORLD J GASTROENTERO, V12, P2259, DOI 10.3748/wjg.v12.i14.2259; Patten M, 2003, N-S ARCH PHARMACOL, V368, P360, DOI 10.1007/s00210-003-0798-0; Patten M, 2002, CARDIOVASC RES, V53, P156, DOI 10.1016/S0008-6363(01)00443-6; Pepperl DJ, 1998, BIOCHEM BIOPH RES CO, V243, P52, DOI 10.1006/bbrc.1997.8056; Ray RM, 2011, AM J PHYSIOL-GASTR L, V300, pG761, DOI 10.1152/ajpgi.00405.2010; Reusch HP, 1997, BIOCHEM BIOPH RES CO, V237, P239, DOI 10.1006/bbrc.1997.7121; Rivero G, 2012, NEUROPHARMACOLOGY, V62, P1044, DOI 10.1016/j.neuropharm.2011.10.015; Romero DG, 2007, J ENDOCRINOL, V194, P429, DOI 10.1677/JOE-07-0153; Salinthone S, 2004, AM J PHYSIOL-GASTR L, V287, pG627, DOI 10.1152/ajpgi.00462.2003; Singer CA, 2003, AM J PHYSIOL-LUNG C, V285, pL1087, DOI 10.1152/ajplung.00409.2002; Somara S, 2010, AM J PHYSIOL-GASTR L, V299, pG1164, DOI 10.1152/ajpgi.00479.2009; Song HJ, 2006, MOL CELLS, V21, P42; Sze KL, 2008, BIOCHEM J, V410, P575, DOI 10.1042/BJ20070901; Takata Y, 2008, P NATL ACAD SCI USA, V105, P4277, DOI 10.1073/pnas.0708647105; Taniyama Y, 2004, AM J PHYSIOL-CELL PH, V287, pC494, DOI 10.1152/ajpcell.00439.2003; van Gemert NG, 2006, BRAIN RES, V1093, P161, DOI 10.1016/j.brainres.2006.03.083; Van Gemert NG, 2006, STRESS, V9, P165, DOI 10.1080/10253890600966169; Wang CC, 2005, AM J PHYSIOL-LUNG C, V288, pL227, DOI 10.1152/ajplung.00224.2004; Wang JC, 2010, FEBS LETT, V584, P4570, DOI 10.1016/j.febslet.2010.10.052; Wang Q, 2011, J BIOL CHEM, V286, P7854, DOI 10.1074/jbc.M110.160911; Weston CR, 2002, SCIENCE, V296, P2345, DOI 10.1126/science.1073344; Wullaert A, 2006, BIOCHEM PHARMACOL, V72, P1090, DOI 10.1016/j.bcp.2006.07.003; Xie GX, 2007, J MOL BIOL, V366, P349, DOI 10.1016/j.jmb.2006.11.045; Yamboliev IA, 2000, AM J PHYSIOL-HEART C, V278, pH1899, DOI 10.1152/ajpheart.2000.278.6.H1899; Yang CM, 2002, CELL SIGNAL, V14, P899, DOI 10.1016/S0898-6568(02)00037-2; Yang JQ, 2010, J BIOL CHEM, V285, P29760, DOI 10.1074/jbc.M110.121459; Zarnegar P, 2006, NEUROSCI LETT, V396, P197, DOI 10.1016/j.neulet.2005.11.040; Zhang Y, 2004, CLIN EXP ALLERGY, V34, P1480, DOI 10.1111/j.1365-2222.2004.02040.x; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814	110	23	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35646	10.1371/journal.pone.0035646	http://dx.doi.org/10.1371/journal.pone.0035646			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545125	Green Published, gold			2022-12-27	WOS:000305343200045
J	Li, ZR; Carlow, CKS				Li, Zhiru; Carlow, Clotilde K. S.			Characterization of Transcription Factors That Regulate the Type IV Secretion System and Riboflavin Biosynthesis in Wolbachia of Brugia malayi	PLOS ONE			English	Article							ANAPLASMA-PHAGOCYTOPHILUM; MACROFILARICIDAL ACTIVITY; INTRACELLULAR BACTERIA; LEGIONELLA-PNEUMOPHILA; ENDOSYMBIOTIC BACTERIA; DOXYCYCLINE TREATMENT; GENE CLUSTERS; EXPRESSION; PROTEIN; ENDOBACTERIA	The human filarial parasite Brugia malayi harbors an endosymbiotic bacterium Wolbachia (wBm) that is required for parasite survival. Consequently, targeting wBm is a promising approach for anti-filarial drug development. The Type IV secretion system (T4SS) plays an important role in bacteria-host interactions and is under stringent regulation by transcription factors. In wBm, most T4SS genes are contained in two operons. We show the wBm is active since the essential assembly factor virB8-1, is transcribed in adult worms and larval stages, and VirB8-1 is present in parasite lysates. We also identify two transcription factors (wBmxR1 and wBmxR2) that bind to the promoter region of several genes of the T4SS. Gel shift assays show binding of wBmxR1 to regions upstream of the virB9-2 and wBmxR2 genes, whereas wBmxR2 binds to virB4-2 and wBmxR1 promoter regions. Interestingly, both transcription factors bind to the promoter of the ribA gene that precedes virB8-1, the first gene in operon 1 of the wBm T4SS. RT-PCR reveals ribA and virB8-1 genes are co-transcribed as one operon, indicating the ribA gene and T4SS operon 1 are co-regulated by both wBmxR1 and wBmxR2. RibA encodes a bi-functional enzyme that catalyzes two essential steps in riboflavin (Vitamin B2) biosynthesis. Importantly, the riboflavin pathway is absent in B. malayi. We demonstrate the pathway is functional in wBm, and observe vitamin B2 supplementation partially rescues filarial parasites treated with doxycycline, indicating Wolbachia may supply the essential vitamin to its worm host. This is the first characterization of a transcription factor(s) from wBm and first report of co-regulation of genes of the T4SS and riboflavin biosynthesis pathway. In addition, our results demonstrate a requirement of vitamin B2 for worm health and fertility, and imply a nutritional role of the symbiont for the filarial parasite host.	[Li, Zhiru; Carlow, Clotilde K. S.] New England Biolabs Inc, Div Parasitol, Ipswich, MA USA	New England Biolabs	Carlow, CKS (corresponding author), New England Biolabs Inc, Div Parasitol, Ipswich, MA USA.	carlow@neb.com		Hide, Geoff/0000-0002-3608-0175	New England Biolabs	New England Biolabs	This work was funded by New England Biolabs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas CA, 2011, MICROBIOL MOL BIOL R, V75, P321, DOI 10.1128/MMBR.00030-10; Altman E, 2008, J BACTERIOL, V190, P1985, DOI 10.1128/JB.01493-07; Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Aravind L, 2005, FEMS MICROBIOL REV, V29, P231, DOI 10.1016/j.fmrre.2004.12.008; Baron Christian, 2007, Infectious Disorders - Drug Targets, V7, P19, DOI 10.2174/187152607780090685; Baron C, 2006, BIOCHEM CELL BIOL, V84, P890, DOI 10.1139/O06-148; Bennett GM, 2012, FLY, V6; Bennuru S, 2011, P NATL ACAD SCI USA, V108, P9649, DOI 10.1073/pnas.1011481108; Bermingham J, 2009, APPL ENVIRON MICROB, V75, P7294, DOI 10.1128/AEM.01472-09; Cheng ZH, 2008, J BACTERIOL, V190, P2096, DOI 10.1128/JB.01813-07; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Darby AC, 2012, GENOME RES, V22, P2467, DOI 10.1101/gr.138420.112; de Jong MF, 2008, MOL MICROBIOL, V70, P1378, DOI 10.1111/j.1365-2958.2008.06487.x; Debrah AY, 2007, TROP MED INT HEALTH, V12, P1433, DOI 10.1111/j.1365-3156.2007.01949.x; Debrah AY, 2006, PLOS PATHOG, V2, P829, DOI 10.1371/journal.ppat.0020092; Debrah Alexander Yaw, 2006, Filaria J, V5, P1, DOI 10.1186/1475-2883-5-1; Debrah Alexander Yaw, 2011, J Parasitol Res, V2011, P201617, DOI 10.1155/2011/201617; Felix C, 2008, RES MICROBIOL, V159, P481, DOI 10.1016/j.resmic.2008.05.007; Fernandez-Lopez R, 2005, MICROBIOL-SGM, V151, P3517, DOI 10.1099/mic.0.28216-0; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Hilleringmann M, 2006, MICROBIOL-SGM, V152, P2919, DOI 10.1099/mic.0.28984-0; Hoerauf A, 2000, LANCET, V355, P1242, DOI 10.1016/S0140-6736(00)02095-X; Hoerauf A, 2001, LANCET, V357, P1415, DOI 10.1016/S0140-6736(00)04581-5; Hoerauf A, 2009, PARASITOL RES, V104, P437, DOI 10.1007/s00436-008-1217-8; Hoerauf A, 2008, PARASITOL RES, V103, P279, DOI 10.1007/s00436-008-0964-x; Hosokawa T, 2010, P NATL ACAD SCI USA, V107, P769, DOI 10.1073/pnas.0911476107; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KOZEK WJ, 1977, J PARASITOL, V63, P992, DOI 10.2307/3279832; Lamelas A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002357; Li ZR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001411; Llosa M, 2009, MOL MICROBIOL, V73, P141, DOI 10.1111/j.1365-2958.2009.06751.x; Mand S, 2009, AM J TROP MED HYG, V81, P702, DOI 10.4269/ajtmh.2009.09-0155; Martinez-Nunez C, 2010, J BACTERIOL, V192, P5603, DOI 10.1128/JB.00567-10; Masui S, 2000, J BACTERIOL, V182, P6529, DOI 10.1128/JB.182.22.6529-6531.2000; Mathews SA, 1999, FEBS LETT, V458, P354, DOI 10.1016/S0014-5793(99)01182-5; McGarry HF, 2004, MOL BIOCHEM PARASIT, V135, P57, DOI 10.1016/j.molbiopara.2004.01.006; McGraw EA, 2004, CURR OPIN MICROBIOL, V7, P67, DOI 10.1016/j.mib.2003.12.003; Miller MA, 1972, EXPT MOL GENETICS; Nakabachi A, 1999, J INSECT PHYSIOL, V45, P1, DOI 10.1016/S0022-1910(98)00104-8; Narita S, 2007, APPL ENVIRON MICROB, V73, P4332, DOI 10.1128/AEM.00145-07; Ohashi N, 2002, INFECT IMMUN, V70, P2128, DOI 10.1128/IAI.70.4.2128-2138.2002; Paschos A, 2011, INFECT IMMUN, V79, P1033, DOI 10.1128/IAI.00993-10; Pichon S, 2009, BIOCHEM BIOPH RES CO, V385, P557, DOI 10.1016/j.bbrc.2009.05.118; Rances E, 2008, J BACTERIOL, V190, P5020, DOI 10.1128/JB.00377-08; Rao RU, 2002, EXP PARASITOL, V101, P77, DOI 10.1016/S0014-4894(02)00019-X; Rikihisa Y, 2010, CELL MICROBIOL, V12, P1213, DOI 10.1111/j.1462-5822.2010.01500.x; Rikihisa Y, 2009, ANN NY ACAD SCI, V1166, P106, DOI 10.1111/j.1749-6632.2009.04527.x; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Sunish IP, 2011, TROP BIOMED, V28, P569; Taylor MJ, 2005, LANCET, V365, P2116, DOI 10.1016/S0140-6736(05)66591-9; Taylor MJ, 1999, EXP PARASITOL, V91, P356, DOI 10.1006/expr.1998.4383; Wang XQ, 2007, J BACTERIOL, V189, P4880, DOI 10.1128/JB.00318-07; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; Wu B, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000475; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Zechner EL, 2012, PHILOS T R SOC B, V367, P1073, DOI 10.1098/rstb.2011.0207; Zientz E, 2004, MICROBIOL MOL BIOL R, V68, P745, DOI 10.1128/MMBR.68.4.745-770.2004; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544; Zusman T, 2007, MOL MICROBIOL, V63, P1508, DOI 10.1111/j.1365-2958.2007.05604.x	62	79	87	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51597	10.1371/journal.pone.0051597	http://dx.doi.org/10.1371/journal.pone.0051597			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	22558235	Green Submitted, gold, Green Published			2022-12-27	WOS:000312201900107
J	Lee, MS; Jung, JI; Kwon, SH; Lee, SM; Morita, K; Her, S				Lee, Mi-Sook; Jung, Jae-In; Kwon, Seung-Hae; Lee, Sang-Mok; Morita, Kyoji; Her, Song			TIMP-2 Fusion Protein with Human Serum Albumin Potentiates Anti-Angiogenesis-Mediated Inhibition of Tumor Growth by Suppressing MMP-2 Expression	PLOS ONE			English	Article							TISSUE INHIBITOR; IN-VIVO; MATRIX-METALLOPROTEINASE; CELL-PROLIFERATION; ESCHERICHIA-COLI; DOWN-REGULATION; APOPTOSIS; ACTIVATION; CANCER; THERAPY	TIMP-2 protein has been intensively studied as a promising anticancer candidate agent, but the in vivo mechanism underlying its anticancer effect has not been clearly elucidated by previous works. In this study, we investigated the mechanism underlying the anti-tumor effects of a TIMP-2 fusion protein conjugated with human serum albumin (HSA/TIMP-2). Systemic administration of HSA/TIMP-2 effectively inhibited tumor growth at a minimum effective dose of 60 mg/kg. The suppressive effect of HSA/TIMP-2 was accompanied by a marked reduction of in vivo vascularization. The anti-angiogenic activity of HSA/TIMP-2 was directly confirmed by CAM assays. In HSA/TIMP-2-treated tumor tissues, MMP-2 expression was profoundly decreased without a change in MT1-MMP expression of PECAM-1-positive cells. MMP-2 mRNA was also decreased by HSA/TIMP-2 treatment of human umbilical vein endothelial cells. Zymographic analysis showed that HSA/TIMP-2 substantially decreased extracellular pro-MMP-2 activity (94-99% reduction) and moderately decreased active MMP-2 activity (10-24% reduction), suggesting MT1-MMP-independent MMP-2 modulation. Furthermore, HSA/TIMP-2 had no effect on in vitro active MMP-2 activity and in vivo MMP-2 activity. These studies show that HSA/TIMP-2 potentiates anti-angiogenic activity by modulating MMP-2 expression, but not MMP-2 activity, to subsequently suppress tumor growth, suggesting an important role for MMP-2 expression rather than MMP-2 activity in anti-angiogenesis.	[Lee, Mi-Sook; Jung, Jae-In; Kwon, Seung-Hae; Her, Song] Korea Basic Sci Inst, Chuncheon Ctr, Div Bioimaging, Chunchon, South Korea; [Lee, Sang-Mok] BiocurePharm, Daejeon Bio Venture Town, Taejon, South Korea; [Morita, Kyoji] Shikoku Univ, Sch Hlth Sci, Dept Nursing, Neuropharmacol Lab, Tokushima, Japan	Korea Basic Science Institute (KBSI)	Lee, MS (corresponding author), Kyung Hee Univ, Coll Oriental Med, Dept Basic Oriental Med Sci, Seoul, South Korea.	swher@kbsi.re.kr		CORBETTA, MAURIZIO/0000-0001-8295-3304	Korea Basic Science Institute grant [T31901]	Korea Basic Science Institute grant	This study was supported by a Korea Basic Science Institute grant (T31901) to SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG JS, 1992, J CLIN PATHOL, V45, P1116, DOI 10.1136/jcp.45.12.1116; Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Bourboulia D, 2011, AM J PATHOL, V179, P2589, DOI 10.1016/j.ajpath.2011.07.035; Bremer C, 2001, NAT MED, V7, P743, DOI 10.1038/89126; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Chetty C, 2010, INT J CANCER, V127, P1081, DOI 10.1002/ijc.25134; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Fassina G, 2000, CLIN EXP METASTAS, V18, P111, DOI 10.1023/A:1006797522521; Fernandez CA, 2010, J BIOL CHEM, V285, P41886, DOI 10.1074/jbc.M110.166439; Ferrara N, 2004, ONCOLOGIST, V9, P2, DOI 10.1634/theoncologist.9-suppl_1-2; Folkman J, 2003, SEMIN CANCER BIOL, V13, P159, DOI 10.1016/S1044-579X(02)00133-5; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; Hajitou A, 2001, CANCER RES, V61, P3450; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Higashi S, 1999, J BIOL CHEM, V274, P10497, DOI 10.1074/jbc.274.15.10497; Hoegy SE, 2001, J BIOL CHEM, V276, P3203, DOI 10.1074/jbc.M008157200; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Imren S, 1996, CANCER RES, V56, P2891; Itoh T, 1998, CANCER RES, V58, P1048; Jiang YF, 2002, ONCOGENE, V21, P2245, DOI 10.1038/sj.onc.1205291; Kang WK, 2007, PROTEIN EXPRES PURIF, V53, P331, DOI 10.1016/j.pep.2007.02.001; Kargiotis O, 2008, ONCOGENE, V27, P4830, DOI 10.1038/onc.2008.122; Kim JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009364; Kwon GT, 2011, J NUTR BIOCH; Laemmel E, 2004, J VASC RES, V41, P400, DOI 10.1159/000081209; Lafleur Marc A, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S1462399403006628; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lee Mi-Sook, 2010, [Journal of Life Science, 생명과학회지], V20, P1738; Lee MS, 2011, J PHARM PHARM SCI, V14, P368, DOI 10.18433/J3H88D; Lee MS, 2010, BIOCHEM BIOPH RES CO, V394, P348, DOI 10.1016/j.bbrc.2010.03.009; Lee S, 2008, ANGEW CHEM INT EDIT, V47, P2804, DOI 10.1002/anie.200705240; Li H, 2001, HUM GENE THER, V12, P515, DOI 10.1089/104303401300042429; Lovelock JD, 2005, AM J PHYSIOL-HEART C, V288, pH461, DOI 10.1152/ajpheart.00402.2004; Morita K, 2009, J MOL NEUROSCI, V38, P31, DOI 10.1007/s12031-008-9156-5; MURPHY AN, 1993, J CELL PHYSIOL, V157, P351, DOI 10.1002/jcp.1041570219; Murphy FR, 2002, J BIOL CHEM, V277, P11069, DOI 10.1074/jbc.M111490200; NEGRO A, 1995, FEBS LETT, V360, P52, DOI 10.1016/0014-5793(95)00073-I; Nishida Y, 2008, CANCER RES, V68, P9096, DOI 10.1158/0008-5472.CAN-08-2522; Park JY, 2009, ANAL BIOCHEM, V394, P217, DOI 10.1016/j.ab.2009.07.040; Preaux AM, 2002, HEPATOLOGY, V36, P615, DOI 10.1053/jhep.2002.35279; Rho SB, 2007, J CELL BIOCHEM, V101, P57, DOI 10.1002/jcb.21127; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; Shapiro S, 2010, AM J PHYSIOL-CELL PH, V298, pC942, DOI 10.1152/ajpcell.00305.2009; Steinbrenner H, 2003, BIOCHEM BIOPH RES CO, V308, P486, DOI 10.1016/S0006-291X(03)01430-X; STETLERSTEVENSON WG, 1990, J BIOL CHEM, V265, P13933; Storgard Chris, 2004, V294, P123; Streit M, 1999, P NATL ACAD SCI USA, V96, P14888, DOI 10.1073/pnas.96.26.14888; Sun Jun, 2009, J Mol Signal, V4, P4, DOI 10.1186/1750-2187-4-4; Uemura S, 2001, CIRC RES, V88, P1291, DOI 10.1161/hh1201.092042; VARMUS H, 1988, SCIENCE, V240, P1427, DOI 10.1126/science.3287617; VAUPEL P, 1989, CANCER RES, V49, P6449; Williamson RA, 2000, METH MOL B, V151, P257, DOI 10.1385/1-59259-046-2:257; Wingfield PT, 1999, J BIOL CHEM, V274, P21362, DOI 10.1074/jbc.274.30.21362; Yi Y, 2005, CURR GENE THER, V5, P25, DOI 10.2174/1566523052997514	57	152	154	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35710	10.1371/journal.pone.0035710	http://dx.doi.org/10.1371/journal.pone.0035710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22792291	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343200051
J	Tian, DL; Peiffer, M; Shoemaker, E; Tooker, J; Haubruge, E; Francis, F; Luthe, DS; Felton, GW				Tian, Donglan; Peiffer, Michelle; Shoemaker, Erica; Tooker, John; Haubruge, Eric; Francis, Frederic; Luthe, Dawn S.; Felton, Gary W.			Salivary Glucose Oxidase from Caterpillars Mediates the Induction of Rapid and Delayed-Induced Defenses in the Tomato Plant	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; TRANSCRIPTIONAL RESPONSES; HELICOVERPA-ARMIGERA; GLANDULAR TRICHOMES; GENE-EXPRESSION; HOST-PLANT; CROSS-TALK; ARMS-RACE; JASMONATE; HERBIVORY	Caterpillars produce oral secretions that may serve as cues to elicit plant defenses, but in other cases these secretions have been shown to suppress plant defenses. Ongoing work in our laboratory has focused on the salivary secretions of the tomato fruitworm, Helicoverpa zea. In previous studies we have shown that saliva and its principal component glucose oxidase acts as an effector by suppressing defenses in tobacco. In this current study, we report that saliva elicits a burst of jasmonic acid (JA) and the induction of late responding defense genes such as proteinase inhibitor 2 (Pin2). Transcripts encoding early response genes associated with the JA pathway were not affected by saliva. We also observed a delayed response to saliva with increased densities of Type VI glandular trichomes in newly emerged leaves. Proteomic analysis of saliva revealed glucose oxidase (GOX) was the most abundant protein identified and we confirmed that it plays a primary role in the induction of defenses in tomato. These results suggest that the recognition of GOX in tomato may represent a case for effector-triggered immunity. Examination of saliva from other caterpillar species indicates that saliva from the noctuids Spodoptera exigua and Heliothis virescens also induced Pin2 transcripts.	[Tian, Donglan; Peiffer, Michelle; Shoemaker, Erica; Tooker, John; Luthe, Dawn S.; Felton, Gary W.] Penn State Univ, Dept Entomol, Ctr Chem Ecol, University Pk, PA 16802 USA; [Haubruge, Eric; Francis, Frederic] Univ Liege, Gembloux Agrobio Tech, Liege, Belgium; [Luthe, Dawn S.] Penn State Univ, Dept Crop & Soil Sci, Ctr Chem Ecol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Liege; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Tian, DL (corresponding author), Penn State Univ, Dept Entomol, Ctr Chem Ecol, University Pk, PA 16802 USA.	gwf10@psu.edu	Felton, Gary W./E-8575-2013; Tooker, John/P-6421-2014; Han, Xingguo/K-7552-2016	Tooker, John/0000-0002-9303-6699; Haubruge, Eric/0000-0002-8138-0476; Han, Xingguo/0000-0002-1836-975X	United States Department of Agriculture and Food Research Initiative program [2010-65105-20639, 2011-67013-30352]	United States Department of Agriculture and Food Research Initiative program	Support by the United States Department of Agriculture and Food Research Initiative program (2010-65105-20639 and 2011-67013-30352) awarded to GWF and DSL made this research possible. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 1999, ECOLOGY, V80, P1713, DOI 10.1890/0012-9658(1999)080[1713:IRTHIW]2.0.CO;2; Al-Ghazi Y, 2009, PLANT CELL PHYSIOL, V50, P1364, DOI 10.1093/pcp/pcp084; Alborn HT, 1997, SCIENCE, V276, P945, DOI 10.1126/science.276.5314.945; Alborn HT, 2003, J CHEM ECOL, V29, P1357, DOI 10.1023/A:1024209302628; Arimura G, 2005, BBA-MOL CELL BIOL L, V1734, P91, DOI 10.1016/j.bbalip.2005.03.001; Bassel GW, 2004, PLANT PHYSIOL, V136, P2782, DOI 10.1104/pp.103.034876; Bede JC, 2006, PLANT MOL BIOL, V60, P519, DOI 10.1007/s11103-005-4923-y; Bjorkman C, 2008, NEW PHYTOL, V179, P176, DOI 10.1111/j.1469-8137.2008.02442.x; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Bonaventure G, 2011, TRENDS PLANT SCI, V16, P294, DOI 10.1016/j.tplants.2011.01.006; Boughton AJ, 2005, J CHEM ECOL, V31, P2211, DOI 10.1007/s10886-005-6228-7; Brooks DM, 2005, MOL PLANT PATHOL, V6, P629, DOI [10.1111/j.1364-3703.2005.00311.x, 10.1111/J.1364-3703.2005.00311.X]; Campos ML, 2009, J EXP BOT, V60, P4346, DOI 10.1093/jxb/erp270; Celorio-Mancera MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026676; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chung SH, 2011, J CHEM ECOL, V37, P378, DOI 10.1007/s10886-011-9937-0; CONSTABEL CP, 1995, P NATL ACAD SCI USA, V92, P407, DOI 10.1073/pnas.92.2.407; Dalin P, 2003, OECOLOGIA, V134, P112, DOI 10.1007/s00442-002-1093-3; Delphia CM, 2006, PLANT SIGNAL BEHAV, V1, P243, DOI 10.4161/psb.1.5.3279; Diaz J, 2002, PLANT PHYSIOL, V129, P1341, DOI 10.1104/pp.001453; Diez-Diaz M, 2004, PHYTOCHEMISTRY, V65, P1919, DOI 10.1016/j.phytochem.2004.06.007; Diezel C, 2009, PLANT PHYSIOL, V150, P1576, DOI 10.1104/pp.109.139550; DOARES SH, 1995, PLANT PHYSIOL, V108, P1741, DOI 10.1104/pp.108.4.1741; Eichenseer H, 1999, ARCH INSECT BIOCHEM, V42, P99, DOI 10.1002/(SICI)1520-6327(199909)42:1&lt;99::AID-ARCH10&gt;3.0.CO;2-B; Eichenseer H, 2002, J INSECT PHYSIOL, V48, P311, DOI 10.1016/S0022-1910(01)00178-0; Eichenseer H, 2010, J CHEM ECOL, V36, P885, DOI 10.1007/s10886-010-9830-2; Engelberth J, 2004, P NATL ACAD SCI USA, V101, P1781, DOI 10.1073/pnas.0308037100; Farmer EE, 2007, NATURE, V448, P659, DOI 10.1038/448659a; Felton Gary W., 2008, P369, DOI 10.1007/978-1-4020-8182-8_18; Felton GW, 2005, P NATL ACAD SCI USA, V102, P18771, DOI 10.1073/pnas.0509895102; FELTON GW, 1989, J CHEM ECOL, V15, P2667, DOI 10.1007/BF01014725; Felton GW, 1999, CURR BIOL, V9, P317, DOI 10.1016/S0960-9822(99)80140-7; FELTON GW, 1993, J CHEM ECOL, V19, P1553, DOI 10.1007/BF00984896; FELTON GW, 1992, J CHEM ECOL, V18, P571, DOI 10.1007/BF00987820; Grant MR, 2009, SCIENCE, V324, P750, DOI 10.1126/science.1173771; Gurr GM, 2002, ENTOMOL EXP APPL, V103, P35, DOI 10.1023/A:1019819722203; Halitschke R, 2003, PLANT PHYSIOL, V131, P1894, DOI 10.1104/pp.102.018184; Harmel N, 2008, INSECT MOL BIOL, V17, P165, DOI 10.1111/j.1365-2583.2008.00790.x; Holeski LM, 2007, J EVOLUTION BIOL, V20, P2092, DOI 10.1111/j.1420-9101.2007.01434.x; Howe G-A, 1996, PLANT CELL; Howe GA, 2004, J PLANT GROWTH REGUL, V23, P223, DOI 10.1007/s00344-004-0030-6; Howe GA, 1996, PLANT CELL, V8, P2067, DOI 10.1105/tpc.8.11.2067; Jia YL, 1999, PLANT MOL BIOL, V40, P455, DOI 10.1023/A:1006213324555; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kaloshian I, 2005, ANNU REV PHYTOPATHOL, V43, P491, DOI 10.1146/annurev.phyto.43.040204.135944; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; Korth KL, 1997, PLANT PHYSIOL, V115, P1299, DOI 10.1104/pp.115.4.1299; Lawrence SD, 2007, J CHEM ECOL, V33, P1041, DOI 10.1007/s10886-007-9285-2; Leitner M, 2005, NEW PHYTOL, V167, P597, DOI 10.1111/j.1469-8137.2005.01426.x; Li L, 2004, PLANT CELL, V16, P126, DOI 10.1105/tpc.017954; LIGHTNER J, 1993, MOL GEN GENET, V241, P595, DOI 10.1007/BF00279902; Lin L, 2008, J CHEM ECOL, V34, P353, DOI 10.1007/s10886-008-9439-x; Liu F, 2004, J CHEM ECOL, V30, P2439, DOI 10.1007/s10886-004-7944-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mithofer A, 2008, PLANT PHYSIOL, V146, P825, DOI 10.1104/pp.107.113118; Mori N, 2001, J INSECT PHYSIOL, V47, P749, DOI 10.1016/S0022-1910(00)00171-2; Musser RO, 2005, ARCH INSECT BIOCHEM, V58, P128, DOI 10.1002/arch.20039; Musser RO, 2002, NATURE, V416, P599, DOI 10.1038/416599a; Narvaez-Vasquez J, 2005, P NATL ACAD SCI USA, V102, P12974, DOI 10.1073/pnas.0505248102; Narvaez-Vasquez J, 2004, PLANTA, V218, P360, DOI 10.1007/s00425-003-1115-3; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Orozco-Cardenas M, 1999, P NATL ACAD SCI USA, V96, P6553, DOI 10.1073/pnas.96.11.6553; Orozco-Cardenas ML, 2001, PLANT CELL, V13, P179, DOI 10.1105/tpc.13.1.179; Orozco-Cardenas ML, 2002, PLANT PHYSIOL, V130, P487, DOI 10.1104/pp.008375; PAUTOT V, 1993, P NATL ACAD SCI USA, V90, P9906, DOI 10.1073/pnas.90.21.9906; Pearce G, 2003, J BIOL CHEM, V278, P30044, DOI 10.1074/jbc.M304159200; Peiffer M, 2005, ARCH INSECT BIOCHEM, V58, P106, DOI 10.1002/arch.20034; Peiffer M, 2009, J CHEM ECOL, V35, P326, DOI 10.1007/s10886-009-9604-x; Qu N, 2004, PLANT PHYSIOL, V135, P539, DOI 10.1104/pp.103.037036; Rasmann S, 2012, PLANT PHYSIOL, V158, P854, DOI 10.1104/pp.111.187831; Rose USR, 2005, PLANTA, V222, P327, DOI 10.1007/s00425-005-1528-2; Rotenberg D, 2006, J VIROL METHODS, V138, P49, DOI 10.1016/j.jviromet.2006.07.017; RYAN CA, 1990, ANNU REV PHYTOPATHOL, V28, P425, DOI 10.1146/annurev.py.28.090190.002233; Sagi M, 2004, PLANT CELL, V16, P616, DOI 10.1105/tpc.019398; Schmelz EA, 2006, P NATL ACAD SCI USA, V103, P8894, DOI 10.1073/pnas.0602328103; Schmelz EA, 2003, P NATL ACAD SCI USA, V100, P10552, DOI 10.1073/pnas.1633615100; Schmidt DD, 2005, PLANT PHYSIOL, V138, P1763, DOI 10.1104/pp.105.061192; Simmons AT, 2004, AUST J ENTOMOL, V43, P196, DOI 10.1111/j.1440-6055.2004.00414.x; TAYLOR BH, 1993, PLANT MOL BIOL, V23, P1005, DOI 10.1007/BF00021815; Thaler J-S, 2001, ECOLOGICAL ENTOMOLOG; Thaler JS, 2004, ECOLOGY, V85, P48, DOI 10.1890/02-0710; Thaler JS, 2002, OECOLOGIA, V131, P227, DOI 10.1007/s00442-002-0885-9; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Thipyapong P, 2007, MOLECULES, V12, P1569, DOI 10.3390/12081569; Tooker JF, 2005, J CHEM ECOL, V31, P2753, DOI 10.1007/s10886-005-8553-2; Traw MB, 2002, OECOLOGIA, V131, P526, DOI 10.1007/s00442-002-0924-6; Vandenabeele S, 2003, P NATL ACAD SCI USA, V100, P16113, DOI 10.1073/pnas.2136610100; Vellosillo T, 2010, PLANT PHYSIOL, V154, P444, DOI 10.1104/pp.110.161273; Victoriano E, 2002, ARTHROPOD STRUCT DEV, V31, P15, DOI 10.1016/S1467-8039(02)00013-0; VINCENT R, 1983, ANAL BIOCHEM, V135, P355, DOI 10.1016/0003-2697(83)90696-6; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; Weech MH, 2008, J EXP BOT, V59, P2437, DOI 10.1093/jxb/ern108; Yoshinaga N, 2007, J CHEM ECOL, V33, P1376, DOI 10.1007/s10886-007-9321-2	93	96	107	3	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36168	10.1371/journal.pone.0036168	http://dx.doi.org/10.1371/journal.pone.0036168			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558369	gold, Green Published			2022-12-27	WOS:000305340200046
J	Zhang, X; Tiewsiri, K; Kain, W; Huang, LH; Wang, P				Zhang, Xin; Tiewsiri, Kasorn; Kain, Wendy; Huang, Lihua; Wang, Ping			Resistance of Trichoplusia ni to Bacillus thuringiensis Toxin Cry1Ac Is Independent of Alteration of the Cadherin-Like Receptor for Cry Toxins	PLOS ONE			English	Article							DIAMONDBACK MOTH LEPIDOPTERA; HELIOTHIS-VIRESCENS; INSECT RESISTANCE; CABBAGE-LOOPER; MANDUCA-SEXTA; BT TOXINS; BINDING; MEMBRANE; PROTEIN; MECHANISM	Alteration of binding sites for Bacillus thuringiensis (Bt) toxins in insect midgut is the major mechanism of high-level resistance to Bt toxins in insects. The midgut cadherin is known to be a major binding protein for Bt Cry1A toxins and linkage of Bt-resistance to cadherin gene mutations has been identified in lepidopterans. The resistance to Bt toxin Cry1Ac evolved in greenhouse populations of Trichoplusia ni has been identified to be associated with the down-regulation of an aminopeptidase N (APN1) gene by a trans-regulatory mechanism and the resistance gene has been mapped to the locus of an ABC transporter (ABCC2) gene. However, whether cadherin is also involved with Cry1Ac-resistance in T. ni requires to be understood. Here we report that the Cry1Ac-resistance in T. ni is independent of alteration of the cadherin. The T. ni cadherin cDNA was cloned and the cadherin sequence showed characteristic features known to cadherins from Lepidoptera. Various T. ni cadherin gene alleles were identified and genetic linkage analysis of the cadherin alleles with Cry1Ac-resistance showed no association of the cadherin gene with the Cry1Ac-resistance in T. ni. Analysis of cadherin transcripts showed no quantitative difference between the susceptible and Cry1Ac-resistant T. ni larvae. Quantitative proteomic analysis of midgut BBMV proteins by iTRAQ-2D-LC-MS/MS determined that there was no quantitative difference in cadherin content between the susceptible and the resistant larvae and the cadherin only accounted for 0.0014% (mol%) of the midgut BBMV proteins, which is 1/300 of APN1 in molar ratio. The cadherin from both the susceptible and resistant larvae showed as a 200-kDa Cry1Ac-binding protein by toxin overlay binding analysis, and nano-LC-MS/MS analysis of the 200-kDa cadherin determined that there is no quantitative difference between the susceptible and resistant larvae. Results from this study indicate that the Cry1Ac-resistance in T. ni is independent of cadherin alteration.	[Zhang, Xin; Tiewsiri, Kasorn; Kain, Wendy; Huang, Lihua; Wang, Ping] Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA	Cornell University	Zhang, X (corresponding author), Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA.	pingwang@cornell.edu			Agriculture and Food Research Initiative Competitive from the USDA National Institute of Food and Agriculture [2008-35302-18806]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	Agriculture and Food Research Initiative Competitive from the USDA National Institute of Food and Agriculture; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by Agriculture and Food Research Initiative Competitive Grant no. 2008-35302-18806 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Bagla P, 2010, SCIENCE, V327, P1439, DOI 10.1126/science.327.5972.1439; Baxter SW, 2011, GENETICS, V189, P675, DOI 10.1534/genetics.111.130971; Baxter SW, 2005, INSECT MOL BIOL, V14, P327, DOI 10.1111/j.1365-2583.2005.00563.x; Bell RA., 1981, USDA TECH B, P599; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bravo A, 2004, BBA-BIOMEMBRANES, V1667, P38, DOI 10.1016/j.bbamem.2004.08.013; Bravo A, 2002, BBA-BIOMEMBRANES, V1562, P63, DOI 10.1016/S0005-2736(02)00360-7; Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Caccia S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009975; Dorsch JA, 2002, INSECT BIOCHEM MOLEC, V32, P1025, DOI 10.1016/S0965-1748(02)00040-1; Federici BA, 2005, J INVERTEBR PATHOL, V89, P30, DOI 10.1016/j.jip.2005.06.007; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Flannagan RD, 2005, INSECT BIOCHEM MOLEC, V35, P33, DOI 10.1016/j.ibmb.2004.10.001; Gahan LJ, 2007, J ECON ENTOMOL, V100, P187, DOI 10.1603/0022-0493(2007)100[187:APCRSO]2.0.CO;2; Gahan LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001248; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Gomez I, 2001, J BIOL CHEM, V276, P28906, DOI 10.1074/jbc.M103007200; Gonzalez-Cabrera J, 2003, INSECT BIOCHEM MOLEC, V33, P929, DOI 10.1016/S0965-1748(03)00099-7; Griffitts JS, 2005, BIOESSAYS, V27, P614, DOI 10.1002/bies.20239; Gunning RV, 2005, APPL ENVIRON MICROB, V71, P2558, DOI 10.1128/AEM.71.5.2558-2563.2005; Hayakawa T, 2004, FEBS LETT, V576, P331, DOI 10.1016/j.febslet.2004.09.029; Heckel DG, 2007, J INVERTEBR PATHOL, V95, P192, DOI 10.1016/j.jip.2007.03.008; Hua G, 2004, J BIOL CHEM, V279, P28051, DOI 10.1074/jbc.M400237200; Huang FN, 2007, J ECON ENTOMOL, V100, P164, DOI 10.1603/0022-0493(2007)100[164:SBLCRT]2.0.CO;2; Ibrahim Mohamed A, 2010, Bioeng Bugs, V1, P31, DOI 10.4161/bbug.1.1.10519; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Janmaat AF, 2003, P ROY SOC B-BIOL SCI, V270, P2263, DOI 10.1098/rspb.2003.2497; Jimenez CR, 2001, CURR PROTOC PROTEIN, DOI [DOI 10.1002/0471140864.PS1604S14, 10.1002/0471140864.ps1604s14]; Jurat-Fuentes JL, 2004, BIOCHEMISTRY-US, V43, P14299, DOI 10.1021/bi048500i; Jurat-Fuentes JL, 2004, EUR J BIOCHEM, V271, P3127, DOI 10.1111/j.1432-1033.2004.04238.x; Jurat-Fuentes JL, 2006, J INVERTEBR PATHOL, V92, P166, DOI 10.1016/j.jip.2006.01.010; Jurat-Fuentes JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017606; Kain WC, 2004, J ECON ENTOMOL, V97, P2073, DOI 10.1603/0022-0493-97.6.2073; Ma G, 2005, INSECT BIOCHEM MOLEC, V35, P729, DOI 10.1016/j.ibmb.2005.02.011; Morin S, 2003, P NATL ACAD SCI USA, V100, P5004, DOI 10.1073/pnas.0831036100; Nagamatsu Y, 1999, FEBS LETT, V460, P385, DOI 10.1016/S0014-5793(99)01327-7; Oppert B, 1999, ARCH INSECT BIOCHEM, V42, P1, DOI 10.1002/(SICI)1520-6327(199909)42:1&lt;1::AID-ARCH2&gt;3.0.CO;2-#; Pacheco S, 2009, J BIOL CHEM, V284, P32750, DOI 10.1074/jbc.M109.024968; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Rahman MM, 2004, P NATL ACAD SCI USA, V101, P2696, DOI 10.1073/pnas.0306669101; Redding Alyssa M., 2006, Briefings in Functional Genomics & Proteomics, V5, P133, DOI 10.1093/bfgp/ell025; RINALDINI L M, 1954, J Physiol, V123, P20; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; SHELTON AM, 1993, J ECON ENTOMOL, V86, P697, DOI 10.1093/jee/86.3.697; Soberon M, 2007, SCIENCE, V318, P1640, DOI 10.1126/science.1146453; Tabashnik BE, 2003, J ECON ENTOMOL, V96, P1031, DOI 10.1603/0022-0493-96.4.1031; TABASHNIK BE, 1990, J ECON ENTOMOL, V83, P1671, DOI 10.1093/jee/83.5.1671; Tabashnik BE, 1998, PHILOS T R SOC B, V353, P1751, DOI 10.1098/rstb.1998.0327; Tabashnik BE, 2006, J ECON ENTOMOL, V99, P1525, DOI 10.1603/0022-0493-99.5.1525; Tabashnik Bruce E, 2011, Nat Biotechnol, V29, P1128, DOI 10.1038/nbt.1988; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Tiewsiri K, 2011, P NATL ACAD SCI USA, V108, P14037, DOI 10.1073/pnas.1102555108; Wang P, 1997, J BIOL CHEM, V272, P16663, DOI 10.1074/jbc.272.26.16663; Wang P, 2007, APPL ENVIRON MICROB, V73, P1199, DOI 10.1128/AEM.01834-06; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3; Xie RY, 2005, J BIOL CHEM, V280, P8416, DOI 10.1074/jbc.M408403200; Xu XJ, 2005, APPL ENVIRON MICROB, V71, P948, DOI 10.1128/AEM.71.2.948-954.2005; Yang YJ, 2007, APPL ENVIRON MICROB, V73, P6939, DOI 10.1128/AEM.01703-07; Zhang X, 2005, CELL DEATH DIFFER, V12, P1407, DOI 10.1038/sj.cdd.4401675; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103	62	308	314	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e35991	10.1371/journal.pone.0035991	http://dx.doi.org/10.1371/journal.pone.0035991			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22558203	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339400010
J	Zhang, YJ; Dai, X; Wang, XH; Maituohuti, A; Cui, YJ; Rehemu, A; Wang, QG; Meng, WW; Luo, T; Guo, R; Li, B; Abudurexiti, A; Song, YJ; Yang, RF; Cao, HL				Zhang, Yujiang; Dai, Xiang; Wang, Xinhui; Maituohuti, Abulimiti; Cui, Yujun; Rehemu, Azhati; Wang, Qiguo; Meng, Weiwei; Luo, Tao; Guo, Rong; Li, Bing; Abudurexiti, Abulikemu; Song, Yajun; Yang, Ruifu; Cao, Hanli			Dynamics of Yersinia pestis and Its Antibody Response in Great Gerbils (Rhombomys opimus) by Subcutaneous Infection	PLOS ONE			English	Article							EXPERIMENTAL PLAGUE; RODENTS; HISTORY; SYSTEM; AGENT; MODEL	Background: Rhombomys opimus (great gerbil) is a reservoir of Yersinia pestis in the natural plague foci of Central Asia. Great gerbils are highly resistant to Y. pestis infection. The coevolution of great gerbils and Y. pestis is believed to play an important role in the plague epidemics in Central Asia plague foci. However, the dynamics of Y. pestis infection and the corresponding antibody response in great gerbils have not been evaluated. In this report, animal experiments were employed to investigate the bacterial load in both the liver and spleen of infected great gerbils. The dynamics of the antibody response to the F1 capsule antigen of Y. pestis was also determined. Methodology: Captured great gerbils that tested negative for both anti-F1 antibodies and bacterial isolation were infected subcutaneously with different doses (10(5) to 10(11) CFU) of a Y. pestis strain isolated from a live great gerbil during routine plague surveillance in the Junggar Basin, Xinjiang, China. The clinical manifestations, changes in body weight, anal temperature, and gross anatomy of the infected animals were observed. The blood cell count, bacterial load, and anti-F1 antibody titers were determined at different time points after infection using a blood analyzer, plate counts, and an indirect hemagglutination assay, respectively. Conclusions/Significance: The dynamics of bacterial load and the anti-F1 antibody concentration in great gerbils are highly variable among individuals. The Y. pestis infection in great gerbils could persist as long as 15 days. They act as an appropriate reservoir for plague in the Junggar Basin, which is part of the natural plague foci in Central Asia. The dynamics of the Y. pestis susceptibility of great gerbil will improve the understanding of its variable resistance, which would facilitate the development of more effective countermeasures for controlling plague epidemics in this focus.	[Cui, Yujun; Song, Yajun; Yang, Ruifu] Beijing Inst Microbiol & Epidemiol, Lab Analyt Microbiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Zhang, Yujiang; Dai, Xiang; Wang, Xinhui; Maituohuti, Abulimiti; Rehemu, Azhati; Wang, Qiguo; Meng, Weiwei; Luo, Tao; Guo, Rong; Li, Bing; Abudurexiti, Abulikemu; Cao, Hanli] Ctr Dis Control & Prevent Xinjiang Uygur Autonomo, Urumqi, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Yang, RF (corresponding author), Beijing Inst Microbiol & Epidemiol, Lab Analyt Microbiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	ruifuyang@gmail.com; chl2621215@126.com	Song, Yajun/GQQ-0476-2022; Song, Yajun/F-3714-2011; Yang, Ruifu/A-2273-2011	Song, Yajun/0000-0002-6628-2747; Song, Yajun/0000-0002-6628-2747; Yang, Ruifu/0000-0003-3219-7269	National Natural Science Foundation of China [30960348]; Science and Technology of Xinjiang Uygur Autonomous Region; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK015564, R01DK075964, R37DK015564] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology of Xinjiang Uygur Autonomous Region; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Natural Science Foundation of China (contract no. 30960348) and Science and Technology of Xinjiang Uygur Autonomous Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimov AP, 2004, CLIN MICROBIOL REV, V17, P434, DOI 10.1128/CMR.17.2.434-464.2004; Begon M, 2006, EMERG INFECT DIS, V12, P268; Biggins DE, 2001, J MAMMAL, V82, P906, DOI 10.1644/1545-1542(2001)082&lt;0906:IOIPON&gt;2.0.CO;2; Bizanov G, 2007, J INFECTION, V54, P198, DOI 10.1016/j.jinf.2006.02.012; CHRISTIE A B, 1982, Ecology of Disease, V1, P111; Cully JF, 2001, J MAMMAL, V82, P894, DOI 10.1644/1545-1542(2001)082&lt;0894:ICOSPI&gt;2.0.CO;2; Davis S, 2007, EPIDEMIOL INFECT, V135, P740, DOI 10.1017/S095026880600759X; Davis S, 2007, J R SOC INTERFACE, V4, P649, DOI 10.1098/rsif.2006.0208; Davis S, 2004, SCIENCE, V304, P736, DOI 10.1126/science.1095854; Dennis DT., 1999, PLAGUE MANUAL EPIDEM; DUNAEV GS, 1982, ZH MIKROB EPID IMMUN, P50; EIDSON M, 1991, J AM VET MED ASSOC, V199, P1191; Ergaliev K Kh, 1990, Genetika, V26, P103; Fang X, 1990, NATURAL PLAGUE FOCI; Gage KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI 10.1146/annurev.ento.50.071803.130337; Guryev V, 2009, FEBS LETT, V583, P1668, DOI 10.1016/j.febslet.2009.04.020; Isin Zh.M., 1986, Journal of Hygiene Epidemiology Microbiology and Immunology (Prague), V31, P307; ISIN ZM, 1987, ZH MIKROB EPID IMMUN, P84; Kagramanov V S, 1999, Zh Mikrobiol Epidemiol Immunobiol, P13; Kausrud KL, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-112; MENKENS GE, 1991, J MAMMAL, V72, P328, DOI 10.2307/1382103; Nham T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034714; Park S, 2007, J R SOC INTERFACE, V4, P57, DOI 10.1098/rsif.2006.0160; Randall JA, 2005, BEHAV ECOL, V16, P961, DOI 10.1093/beheco/ari078; Rena TRD, 2006, CHI J ZOONOSIS, V22, P1086; Watson RP, 2001, VET PATHOL, V38, P165, DOI 10.1354/vp.38-2-165; WILLIAMS JE, 1983, EXPERIENTIA, V39, P408, DOI 10.1007/BF01963151; Zhang Yu-Jiang, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P136; Zhao XN, 2011, J GEN VIROL, V92, P216, DOI 10.1099/vir.0.026328-0; ZYKIN LF, 1989, ZH MIKROB EPID IMMUN, P36	30	23	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46820	10.1371/journal.pone.0046820	http://dx.doi.org/10.1371/journal.pone.0046820			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	22545125	Green Submitted, Green Published, gold			2022-12-27	WOS:000309827300064
J	Shiryaev, SA; Cheltsov, AV; Strongin, AY				Shiryaev, Sergey A.; Cheltsov, Anton V.; Strongin, Alex Y.			Probing of Exosites Leads to Novel Inhibitor Scaffolds of HCV NS3/4A Proteinase	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; WEST-NILE-VIRUS; SERINE-PROTEASE INHIBITORS; NS4A COFACTOR PEPTIDE; IN-VITRO RESISTANCE; MACROCYCLIC INHIBITORS; POLYMERASE INHIBITORS; ANTIVIRAL THERAPY; DRUG-RESISTANCE; DENGUE-VIRUS	Background: Hepatitis C is a treatment-resistant disease affecting millions of people worldwide. The hepatitis C virus (HCV) genome is a single-stranded RNA molecule. After infection of the host cell, viral RNA is translated into a polyprotein that is cleaved by host and viral proteinases into functional, structural and non-structural, viral proteins. Cleavage of the polyprotein involves the viral NS3/4A proteinase, a proven drug target. HCV mutates as it replicates and, as a result, multiple emerging quasispecies become rapidly resistant to anti-virals, including NS3/4A inhibitors. Methodology/Principal Findings: To circumvent drug resistance and complement the existing anti-virals, NS3/4A inhibitors, which are additional and distinct from the FDA-approved telaprevir and boceprevir alpha-ketoamide inhibitors, are required. To test potential new avenues for inhibitor development, we have probed several distinct exosites of NS3/4A which are either outside of or partially overlapping with the active site groove of the proteinase. For this purpose, we employed virtual ligand screening using the 275,000 compound library of the Developmental Therapeutics Program (NCI/NIH) and the X-ray crystal structure of NS3/4A as a ligand source and a target, respectively. As a result, we identified several novel, previously uncharacterized, nanomolar range inhibitory scaffolds, which suppressed of the NS3/4A activity in vitro and replication of a sub-genomic HCV RNA replicon with a luciferase reporter in human hepatocarcinoma cells. The binding sites of these novel inhibitors do not significantly overlap with those of alpha-ketoamides. As a result, the most common resistant mutations, including V36M, R155K, A156T, D168A and V170A, did not considerably diminish the inhibitory potency of certain novel inhibitor scaffolds we identified. Conclusions/Significance: Overall, the further optimization of both the in silico strategy and software platform we developed and lead compounds we identified may lead to advances in novel anti-virals.	[Shiryaev, Sergey A.; Strongin, Alex Y.] Sanford Burnham Med Res Inst, Inflammatory & Infect Dis Ctr, La Jolla, CA USA; [Cheltsov, Anton V.] Q MOL LLC, R&D Dept, San Diego, CA USA	Sanford Burnham Prebys Medical Discovery Institute	Shiryaev, SA (corresponding author), Sanford Burnham Med Res Inst, Inflammatory & Infect Dis Ctr, La Jolla, CA USA.	anton@q-mol.com; strongin@sanfordburnham.org	Strongin, Alex/R-6609-2019	Strongin, Alex/0000-0003-3765-3016	National Institutes of Health [R01CA83017, R01CA157328]; NIAID [HHSN272201000009C]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by National Institutes of Health grants R01CA83017 and R01CA157328 to Alex Y. Strongin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Marintha Heil (Southern Research Institute, Birmingham, AL) for performing tests in human hepatocarcinoma cell line Huh7 ET (luc-ubi-neo/ET) that exhibits a sub-genomic HCV RNA replicon with a firefly luciferase reporter (NIAID Contract No. HHSN272201000009C). The authors are also grateful to Drs. Nicholas Cosford and Robert Ardecky (Sanford-Burnham Medical Research Institute, La Jolla, CA) for their expert support in performing our study.	Barbato G, 1999, J MOL BIOL, V289, P371, DOI 10.1006/jmbi.1999.2745; BARTENSCHLAGER R, 1993, J VIROL, V67, P3835, DOI 10.1128/JVI.67.7.3835-3844.1993; Bennett F, 2010, BIOORG MED CHEM LETT, V20, P2617, DOI 10.1016/j.bmcl.2010.02.063; Buhler S, 2012, LIVER INT, V32, P9, DOI 10.1111/j.1478-3231.2011.02701.x; Chen X, 2002, J CHEM INF COMP SCI, V42, P1407, DOI 10.1021/ci025531g; Chevaliez S., 2006, HEPATITIS C VIRUSES, V1, P5; Cubero M, 2008, VIROLOGY, V370, P237, DOI 10.1016/j.virol.2007.10.006; Delang L, 2011, ANTIMICROB AGENTS CH, V55, P4103, DOI 10.1128/AAC.00294-11; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Fan XF, 2009, HEPATOLOGY, V50, P1765, DOI 10.1002/hep.23290; Flores MV, 2009, BBA-PROTEINS PROTEOM, V1794, P1441, DOI 10.1016/j.bbapap.2009.06.004; Fonseca-Coronado S, 2012, J CLIN MICROBIOL, V50, P281, DOI 10.1128/JCM.05842-11; Fusco DN, 2012, ANNU REV MED, V63, P373, DOI 10.1146/annurev-med-042010-085715; Gawlik K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005031; GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993; Hagel M, 2011, NAT CHEM BIOL, V7, P22, DOI 10.1038/NCHEMBIO.492; Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011; He Y, 2008, ANTIMICROB AGENTS CH, V52, P1101, DOI 10.1128/AAC.01149-07; Hinrichsen H, 2004, GASTROENTEROLOGY, V127, P1347, DOI 10.1053/j.gastro.2004.08.002; Hiraga N, 2011, HEPATOLOGY, V54, P781, DOI 10.1002/hep.24460; Jesudian Arun B, 2012, Gastroenterol Hepatol (N Y), V8, P91; Johnston PA, 2007, ASSAY DRUG DEV TECHN, V5, P737, DOI 10.1089/adt.2007.101; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kieffer TL, 2007, HEPATOLOGY, V46, P631, DOI 10.1002/hep.21781; Kieffer TL, 2010, J ANTIMICROB CHEMOTH, V65, P202, DOI 10.1093/jac/dkp388; Kim JL, 1996, CELL, V87, P343, DOI 10.1016/S0092-8674(00)81351-3; Kuntzen T, 2008, HEPATOLOGY, V48, P1769, DOI 10.1002/hep.22549; Kwo PY, 2011, GUT LIVER, V5, P406, DOI 10.5009/gnl.2011.5.4.406; Kwong AD, 1999, ANTIVIR RES, V41, P65; Kwong AD, 2011, NAT BIOTECHNOL, V29, P993, DOI 10.1038/nbt.2020; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Lenz O, 2010, ANTIMICROB AGENTS CH, V54, P1878, DOI 10.1128/AAC.01452-09; Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200; Lin C, 2004, J BIOL CHEM, V279, P17508, DOI 10.1074/jbc.M313020200; Lin C, 2005, J BIOL CHEM, V280, P36784, DOI 10.1074/jbc.M506462200; LIN C, 1995, J VIROL, V69, P4373, DOI 10.1128/JVI.69.7.4373-4380.1995; Liverton NJ, 2010, ANTIMICROB AGENTS CH, V54, P305, DOI 10.1128/AAC.00677-09; Llinas-Brunet M, 2004, J MED CHEM, V47, P1605, DOI 10.1021/jm0342414; Ma C, 2011, ACS COMB SCI, V13, P223, DOI 10.1021/co100033m; Malcolm BA, 2006, ANTIMICROB AGENTS CH, V50, P1013, DOI 10.1128/AAC.50.3.1013-1020.2006; Manns MP, 2007, NAT REV DRUG DISCOV, V6, P991, DOI 10.1038/nrd2411; Margeridon-Thermet S, 2010, VIRUSES-BASEL, V2, P2696, DOI 10.3390/v2122696; MARTELL M, 1992, J VIROL, V66, P3225, DOI 10.1128/JVI.66.5.3225-3229.1992; Morikawa K, 2011, J VIRAL HEPATITIS, V18, P305, DOI 10.1111/j.1365-2893.2011.01451.x; Nicholls A, 2010, J MED CHEM, V53, P3862, DOI 10.1021/jm900818s; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Ortqvist P, 2010, ANTIVIR THER, V15, P841, DOI 10.3851/IMP1655; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Pietschmann T, 2002, J VIROL, V76, P4008, DOI 10.1128/JVI.76.8.4008-4021.2002; Raboisson P, 2008, BIOORG MED CHEM LETT, V18, P4853, DOI 10.1016/j.bmcl.2008.07.088; Romano KP, 2010, P NATL ACAD SCI USA, V107, P20986, DOI 10.1073/pnas.1006370107; Rong LB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000544; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1767, DOI 10.1053/j.gastro.2007.02.037; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Schaefer EAK, 2012, GASTROENTEROLOGY, V142, P1340, DOI 10.1053/j.gastro.2012.02.015; Seiwert SD, 2008, ANTIMICROB AGENTS CH, V52, P4432, DOI 10.1128/AAC.00699-08; Shimizu Y, 1996, J VIROL, V70, P127, DOI 10.1128/JVI.70.1.127-132.1996; Shiryaev SA, 2007, J VIROL, V81, P4501, DOI 10.1128/JVI.02719-06; Shiryaev SA, 2007, PROTEIN EXPRES PURIF, V52, P334, DOI 10.1016/j.pep.2006.11.009; Shiryaev SA, 2007, BIOCHEM J, V401, P743, DOI 10.1042/BJ20061136; Shiryaev SA, 2011, ASSAY DRUG DEV TECHN, V9, P69, DOI 10.1089/adt.2010.0309; Sidique S, 2009, BIOORG MED CHEM LETT, V19, P5773, DOI 10.1016/j.bmcl.2009.07.150; Stempniak M, 1997, J VIROL, V71, P2881, DOI 10.1128/JVI.71.4.2881-2886.1997; Susser S, 2009, HEPATOLOGY, V50, P1709, DOI 10.1002/hep.23192; Urbani A, 1999, BIOCHEMISTRY-US, V38, P5206, DOI 10.1021/bi982773u; Venkatraman S, 2009, BIOORG MED CHEM LETT, V19, P180, DOI 10.1016/j.bmcl.2008.10.124; Vermehren J, 2012, J VIRAL HEPATITIS, V19, P120, DOI 10.1111/j.1365-2893.2011.01449.x; Vermehren J, 2011, EUR J MED RES, V16, P303, DOI 10.1186/2047-783X-16-7-303; Vicenti I, 2012, J ANTIMICROB CHEMOTH, V67, P984, DOI 10.1093/jac/dkr581; Welsch C, 2012, GUT, V61, P36, DOI 10.1136/gutjnl-2012-302144; Wolynes PG, 1997, P NATL ACAD SCI USA, V94, P6170, DOI 10.1073/pnas.94.12.6170; Zhou Y, 2008, ANTIMICROB AGENTS CH, V52, P110, DOI 10.1128/AAC.00863-07; Zhu HM, 2011, PROTEINS, V79, P2428, DOI 10.1002/prot.23064	75	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2012	7	7							e40029	10.1371/journal.pone.0040029	http://dx.doi.org/10.1371/journal.pone.0040029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968GX	22768327	Green Submitted, gold, Green Published			2022-12-27	WOS:000305966500040
J	Li, Y; Farooq, M; Sheng, DL; Chandramouli, C; Lan, T; Mahajan, NK; Kini, RM; Hong, YH; Lisowsky, T; Ge, RW				Li, Yan; Farooq, Muhammad; Sheng, Donglai; Chandramouli, Chanchal; Lan, Tian; Mahajan, Nilesh K.; Kini, R. Manjunatha; Hong, Yunhan; Lisowsky, Thomas; Ge, Ruowen			Augmenter of Liver Regeneration (alr) Promotes Liver Outgrowth during Zebrafish Hepatogenesis	PLOS ONE			English	Article							HEPATIC STIMULATOR SUBSTANCE; DISULFIDE RELAY SYSTEM; MITOCHONDRIAL SULFHYDRYL OXIDASE; INTERMEMBRANE SPACE; RESPIRATORY-CHAIN; PROTEIN IMPORT; CYTOCHROME-C; GENE; HEPATOPOIETIN; YEAST	Augmenter of Liver Regeneration (ALR) is a sulfhydryl oxidase carrying out fundamental functions facilitating protein disulfide bond formation. In mammals, it also functions as a hepatotrophic growth factor that specifically stimulates hepatocyte proliferation and promotes liver regeneration after liver damage or partial hepatectomy. Whether ALR also plays a role during vertebrate hepatogenesis is unknown. In this work, we investigated the function of alr in liver organogenesis in zebrafish model. We showed that alr is expressed in liver throughout hepatogenesis. Knockdown of alr through morpholino antisense oligonucleotide (MO) leads to suppression of liver outgrowth while overexpression of alr promotes liver growth. The small-liver phenotype in alr morphants results from a reduction of hepatocyte proliferation without affecting apoptosis. When expressed in cultured cells, zebrafish Alr exists as dimer and is localized in mitochondria as well as cytosol but not in nucleus or secreted outside of the cell. Similar to mammalian ALR, zebrafish Alr is a flavin-linked sulfhydryl oxidase and mutation of the conserved cysteine in the CxxC motif abolishes its enzymatic activity. Interestingly, overexpression of either wild type Alr or enzyme-inactive Alr(C131S) mutant promoted liver growth and rescued the liver growth defect of alr morphants. Nevertheless, alr(C131S) is less efficacious in both functions. Meantime, high doses of alr MOs lead to widespread developmental defects and early embryonic death in an alr sequence-dependent manner. These results suggest that alr promotes zebrafish liver outgrowth using mechanisms that are dependent as well as independent of its sulfhydryl oxidase activity. This is the first demonstration of a developmental role of alr in vertebrate. It exemplifies that a low-level sulfhydryl oxidase activity of Alr is essential for embryonic development and cellular survival. The dose-dependent and partial suppression of alr expression through MO-mediated knockdown allows the identification of its late developmental role in vertebrate liver organogenesis.	[Li, Yan; Farooq, Muhammad; Sheng, Donglai; Chandramouli, Chanchal; Lan, Tian; Mahajan, Nilesh K.; Kini, R. Manjunatha; Hong, Yunhan; Ge, Ruowen] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Farooq, Muhammad] King Saud Univ, Coll Sci, Dept Zool, Riyadh 11451, Saudi Arabia; [Kini, R. Manjunatha] Virginia Commonwealth Univ, Med Coll Virginia, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Lisowsky, Thomas] MultiBIND Biotec GmbH, Cologne, Germany	National University of Singapore; King Saud University; Virginia Commonwealth University	Li, Y (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsgerw@nus.edu.sg	He, Zheng-Guo/P-3647-2014; Ge, Ruowen/D-8352-2012; Kini, Manjunatha/H-8029-2012; Chandramouli, Chanchal/AAF-2848-2020; Hong, Yunhan/D-4197-2009; Farooq, Muhammad/G-9838-2013; Li, Zhi-Yong/G-9701-2011; Li, Zhi-Yong/G-9701-2011	Ge, Ruowen/0000-0002-0750-7336; Farooq, Muhammad/0000-0001-9891-2443; Kini, Manjunatha/0000-0002-6100-3251; Zhang, Yuesheng/0000-0002-0976-2875; Li, Zhi-Yong/0000-0003-3039-8833; Li, Zhi-Yong/0000-0002-6814-9165	Singapore Biomedical Research Council [BMRC/01/1/21/18/068]; Ministry of Education [R-154-000-475-112]; NCI NIH HHS [CA120533, R01 CA124627, R01 CA120533, P30 CA016056] Funding Source: Medline	Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Ministry of Education; NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by the Singapore Biomedical Research Council grant BMRC/01/1/21/18/068 and Ministry of Education grant R-154-000-475-112 to Dr. Ge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 2005, J MOL BIOL, V353, P937, DOI 10.1016/j.jmb.2005.08.049; Bihlmaier K, 2007, J CELL BIOL, V179, P389, DOI 10.1083/jcb.200707123; Cao Y, 2009, FREE RADICAL BIO MED, V47, P1057, DOI 10.1016/j.freeradbiomed.2009.07.017; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; Chen XX, 2003, J BIOL CHEM, V278, P49022, DOI 10.1074/jbc.M304057200; Chu J, 2009, HEPATOLOGY, V50, P1656, DOI 10.1002/hep.23157; Daithankar VN, 2010, BIOCHEMISTRY-US, V49, P6737, DOI 10.1021/bi100912m; Daithankar VN, 2009, BIOCHEMISTRY-US, V48, P4828, DOI 10.1021/bi900347v; Di Fonzo A, 2009, AM J HUM GENET, V84, P594, DOI 10.1016/j.ajhg.2009.04.004; Farooq M, 2008, DEV BIOL, V317, P336, DOI 10.1016/j.ydbio.2008.02.034; Farrell SR, 2005, BIOCHEMISTRY-US, V44, P1532, DOI 10.1021/bi0479555; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Gandhi CR, 1999, HEPATOLOGY, V29, P1435, DOI 10.1002/hep.510290522; Gandhi CR, 2009, J CELL PHYSL; Gatzidou E, 2006, WORLD J GASTROENTERO, V12, P4951, DOI 10.3748/wjg.v12.i31.4951; GHOSH C, 1994, CELL BIOL TOXICOL, V10, P167, DOI 10.1007/BF00757560; HAGIYA M, 1994, P NATL ACAD SCI USA, V91, P8142, DOI 10.1073/pnas.91.17.8142; HE FH, 1993, HEPATOLOGY, V17, P225, DOI 10.1016/0270-9139(93)90081-W; Hofhaus G, 1999, EUR J CELL BIOL, V78, P349, DOI 10.1016/S0171-9335(99)80069-7; Ilowski M, 2011, BIOCHEM BIOPH RES CO, V404, P148, DOI 10.1016/j.bbrc.2010.11.083; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kondili VG, 2005, DIGEST DIS SCI, V50, P297, DOI 10.1007/s10620-005-1598-9; Korzh S, 2001, MECH DEVELOP, V103, P137, DOI 10.1016/S0925-4773(01)00330-6; LABRECQUE DR, 1975, J PHYSIOL-LONDON, V248, P273, DOI 10.1113/jphysiol.1975.sp010973; Lange H, 2001, EMBO REP, V2, P715, DOI 10.1093/embo-reports/kve161; Lee JE, 2000, FEBS LETT, V477, P62, DOI 10.1016/S0014-5793(00)01767-1; Levitan A, 2004, J BIOL CHEM, V279, P20002, DOI 10.1074/jbc.M312877200; Li Y, 2002, EUR J BIOCHEM, V269, P3888, DOI 10.1046/j.1432-1033.2002.03054.x; Li Y, 2000, J BIOL CHEM, V275, P37443, DOI 10.1074/jbc.M004373200; Liatsos GD, 2003, DIGEST DIS SCI, V48, P1929, DOI 10.1023/A:1026157901805; LISOWSKY T, 1995, GENOMICS, V29, P690, DOI 10.1006/geno.1995.9950; LISOWSKY T, 1992, MOL GEN GENET, V232, P58, DOI 10.1007/BF00299137; Lisowsky T, 2001, DIGEST LIVER DIS, V33, P173, DOI 10.1016/S1590-8658(01)80074-8; Lu CR, 2002, FASEB J, V16, P90, DOI 10.1096/fj.01-0506fje; Lu J, 2002, WORLD J GASTROENTERO, V8, P353; McClure KD, 2008, DEV BIOL, V319, P68, DOI 10.1016/j.ydbio.2008.04.004; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Passeri MJ, 2009, HEPATOLOGY, V49, P443, DOI 10.1002/hep.22667; Sadler KC, 2007, P NATL ACAD SCI USA, V104, P1570, DOI 10.1073/pnas.0610774104; Shin D, 2007, DEVELOPMENT, V134, P2041, DOI 10.1242/dev.000281; Tanigawa K, 2000, J GASTROENTEROL, V35, P112, DOI 10.1007/s005350050023; Thasler WE, 2005, HISTOPATHOLOGY, V47, P57, DOI 10.1111/j.1365-2559.2005.02172.x; Thirunavukkarasu C, 2008, J HEPATOL, V48, P578, DOI 10.1016/j.jhep.2007.12.010; Tokatlidis K, 2005, CELL, V121, P965, DOI 10.1016/j.cell.2005.06.019; Wang CP, 2006, WORLD J GASTROENTERO, V12, P4859; Wang G, 1999, J BIOL CHEM, V274, P11469, DOI 10.1074/jbc.274.17.11469; Wang WZ, 2007, BIOCHEMISTRY-US, V46, P3246, DOI 10.1021/bi602499t; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Wiedenmann J, 2009, IUBMB LIFE, V61, P1029, DOI 10.1002/iub.256; Yabu T, 2001, FISHERIES SCI, V67, P333, DOI 10.1046/j.1444-2906.2001.00233.x; Yang XM, 1997, SCI CHINA SER C, V40, P642, DOI 10.1007/BF02882695	52	150	169	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30835	10.1371/journal.pone.0030835	http://dx.doi.org/10.1371/journal.pone.0030835			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22905149	gold, Green Published			2022-12-27	WOS:000301703800034
J	Li, YY; Zhu, RN; Qian, Y; Deng, J				Li, Yuyun; Zhu, Runan; Qian, Yuan; Deng, Jie			The Characteristics of Blood Glucose and WBC Counts in Peripheral Blood of Cases of Hand Foot and Mouth Disease in China: A Systematic Review	PLOS ONE			English	Review							ENTEROVIRUS 71; OUTBREAK; INFECTIONS; MALAYSIA; TAIWAN; MANIFESTATIONS	Background: Outbreaks of Hand Foot and Mouth Disease (HFMD) have occurred in many parts of the world especially in China. We aimed to summarize the characteristics of the levels of blood glucose and white blood cell (WBC) counts in cases of HFMD in Mainland China and Taiwan, using meta-analysis based on systematic review of published articles. Methods: We systematically reviewed published studies, from the MEDLINE and WANFANG Data, about the levels of blood glucose and WBC counts in cases of HFMD until 15(th) June 2011, and quantitatively summarized the characteristics of them using meta-analysis. Results: In total, 37 studies were included in this review. In Mainland China and Taiwan, generally, the average level of blood glucose, the prevalence of hyperglycemia, WBC counts and the prevalence of leukocytosis increased with the severity of the illness. There was no significant difference in the prevalence of leukocytosis between ANS (autonomic nervous system dysregulation)/PE (pulmonary edema) group and CNS (central nervous system) group, and in the average level of blood glucose between healthy controls and mild cases of HFMD. WBC counts in cases infected by EV71 were less than those in cases infected by CA16. Conclusions: our analyses indicated that blood glucose and WBC counts increased with the severity of HFMD disease, which would help doctors to manage patients efficiently.	[Li, Yuyun; Zhu, Runan; Qian, Yuan; Deng, Jie] Capital Inst Pediat, Virol Lab, Beijing, Peoples R China	Capital Institute of Pediatrics (CIP)	Li, YY (corresponding author), Capital Inst Pediat, Virol Lab, Beijing, Peoples R China.	qybds1129@163.com	He, Zheng-Guo/P-3647-2014; Ge, Ruowen/D-8352-2012; Kini, Manjunatha/H-8029-2012; Chandramouli, Chanchal/AAF-2848-2020; Hong, Yunhan/D-4197-2009; Farooq, Muhammad/G-9838-2013; Li, Zhi-Yong/G-9701-2011; Li, Zhi-Yong/G-9701-2011	Ge, Ruowen/0000-0002-0750-7336; Farooq, Muhammad/0000-0001-9891-2443; Kini, Manjunatha/0000-0002-6100-3251; Zhang, Yuesheng/0000-0002-0976-2875; Li, Zhi-Yong/0000-0003-3039-8833; Li, Zhi-Yong/0000-0002-6814-9165	NCI NIH HHS [CA120533, R01 CA124627, R01 CA120533, P30 CA016056] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abubakar S, 1999, SCAND J INFECT DIS, V31, P331, DOI 10.1080/00365549950163734; AbuBakar S, 2009, EMERG INFECT DIS, V15, P79, DOI 10.3201/eid1501.080264; Ahmad K, 2000, LANCET, V356, P1338, DOI 10.1016/S0140-6736(05)74253-7; ALEXANDER JP, 1994, J INFECT DIS, V169, P905, DOI 10.1093/infdis/169.4.905; Chang LY, 1999, LANCET, V354, P1682, DOI 10.1016/S0140-6736(99)04434-7; Chen JH, 2010, ACTA ACAD MEDICINAE, V32, P363; Chen WB, 2000, 5 DIAGNOSTICS; Chu PY, 2001, ARCH VIROL, V146, P589, DOI 10.1007/s007050170164; Cui LD, 2011, CHINA PRAC MED, V6, P50; Dai W, 2011, CHINESE COMMUNITY DO, V13, P88; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ding NZ, 2009, VIRUS RES, V145, P157, DOI 10.1016/j.virusres.2009.06.006; Fan XC, 2009, ANHUI MED J, V30, P253; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hsia SH, 2005, PEDIATR INFECT DIS J, V24, P331, DOI 10.1097/01.inf.0000157219.19674.98; Huang S, 2008, ANHUI MED J, V29, P361; Huang YF, 2003, J INFECTION, V46, P238, DOI 10.1053/jinf.2002.1117; Jiang J, 2010, J QILU NURSING, V16, P119; Kehle J, 2003, J NEUROVIROL, V9, P126, DOI 10.1080/13550280390173364; Li CC, 2002, SCAND J INFECT DIS, V34, P104, DOI 10.1080/00365540110077119; Li JM, 2009, CHIN PEDIAT EMERG ME, V16, P142; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Li Q., 2010, ANHUI MED J, V31, P1410; Li SH, 2010, CHIN PECIATR EMERG M, V17, P49; Li SH, 2010, CHIN J CLIN INFECT D, V3, P337; [李玉芬 Li Yufen], 2010, [临床儿科杂志, Journal of Chinical Pediatrics], V28, P1011; Liao Y, 2010, JILIN MED J, P4075; Lin TY, 2003, EMERG INFECT DIS, V9, P291, DOI 10.3201/eid0903.020285; Lin TY, 2003, CLIN INFECT DIS, V36, P269, DOI 10.1086/345905; Lin TY, 2002, ACTA PAEDIATR, V91, P632, DOI 10.1080/080352502760069016; Liu J, 2009, ANHUI MED J, V30, P261; Liu X, 2010, CHIN J MED ULTRASOUN, V7, P1844; Liu Ying-xia, 2008, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V22, P475; Lu CY, 2002, J MED VIROL, V67, P217, DOI 10.1002/jmv.2210; Luo LP, 2010, J N CHINA COAL MED U, V12, P356; Mai LL, 2011, CHINESE J NEW CLIN M, V4, P356; MANTEL N, 1959, J NATL CANCER I, V22, P719; [毛国顺 MAO Guoshun], 2008, [中华传染病杂志, Chinese Journal of Infections Diseases], V26, P387; [毛月燕 MAO Yue-yan], 2009, [中华传染病杂志, Chinese Journal of Infections Diseases], V27, P35; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; Qian N, 2010, THESIS QINGDAO U, P17; Shen Q, 2011, J MED RES, V40, P93; Shimizu H, 1999, JPN J INFECT DIS, V52, P12; Tang LP, 2009, CHIN J M ISDIAGN, V9, P6840; Verbruggen SCAT, 2007, CLIN NUTR, V26, P677, DOI 10.1016/j.clnu.2007.08.012; Wang HC, 2010, CHINA CLIN PRAC MED, V4, P155; Wang JR, 2002, J CLIN MICROBIOL, V40, P10, DOI 10.1128/JCM.40.1.10-15.2002; Wang SM, 2003, J INFECT DIS, V188, P564, DOI 10.1086/376998; Wei XL, 2010, SHANDONG MED J, V50, P70; World Health Organization, 2017, GUID DRINK WAT QUAL, VFourth, DOI 10.1016/S1462-0758(00)00006-6; Yan ZW, 2011, CHIN J GEN PRACT, V10, P343; Yang T, 2010, ACTA MEDCINAE SINICA, V23, P68; Yu LX, 2011, CHIN PEDIAT EMERG ME, V18, P57; [岳保珠 Yue Baozhu], 2010, [中国全科医学, Chinese General Practice], V13, P2239; Zhang GH, 2010, CHINA CLIN PRAC MED, V4, P132; Zhang JH, 2010, CHINESE FOREIGN MED, V8, P12; Zhang Shou-Bin, 2008, Zhongguo Dang Dai Er Ke Za Zhi, V10, P38; Zhao H., 2008, J CLIN PEDIAT, V26, P467; Zheng NH, 2011, CHINA MODERN DOCTOR, V49, P126; Zhou AR, 2000, 5 BIOCH; [周大明 Zhou Daming], 2010, [重庆医科大学学报, Acta Universitatis Scientiae Medicinae Chongqing], V35, P1724	63	150	169	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29003	10.1371/journal.pone.0029003	http://dx.doi.org/10.1371/journal.pone.0029003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22905149	Green Published, Green Submitted, gold			2022-12-27	WOS:000301123400018
J	Li, YQ; He, ZG				Li, Yuqing; He, Zheng-Guo			The Mycobacterial LysR-Type Regulator OxyS Responds to Oxidative Stress and Negatively Regulates Expression of the Catalase-Peroxidase Gene	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATOR; PATHOGENIC MYCOBACTERIA; TUBERCULOSIS; KATG; FURA; SENSITIVITY; SMEGMATIS; MACROPHAGES; RESISTANCE; PROTEINS	Protection against oxidative stress is one of the primary defense mechanisms contributing to the survival of Mycobacterium tuberculosis in the host. In this study, we provide evidence that OxyS, a LysR-type transcriptional regulator functions as an oxidative stress response regulator in mycobacteria. Overexpression of OxyS lowers expression of the catalase-peroxidase (KatG) gene in M. smegmatis. OxyS binds directly with the katG promoter region and a conserved, GC-rich T-N-11-A motif for OxyS binding was successfully characterized in the core binding site. Interestingly, the DNA-binding activity of OxyS was inhibited by H2O2, but not by dithiothreitol. Cys25, which is situated at the DNA-binding domain of OxyS, was found to have a regulatory role for the DNA-binding ability of OxyS in response to oxidative stress. In contrast, the other three cysteine residues in OxyS do not appear to have this function. Furthermore, the mycobacterial strain over-expressing OxyS had a higher sensitivity to H2O2. Thus, OxyS responds to oxidative stress through a unique cysteine residue situated in its DNA-binding domain and negatively regulates expression of the katG gene. These findings uncover a specific regulatory mechanism for mycobacterial adaptation to oxidative stress.	[Li, Yuqing; He, Zheng-Guo] Huazhong Agr Univ, Natl Key Lab Agr Microbiol, Ctr Prote Res, Coll Life Sci & Technol, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University	He, ZG (corresponding author), Huazhong Agr Univ, Natl Key Lab Agr Microbiol, Ctr Prote Res, Coll Life Sci & Technol, Wuhan, Hubei, Peoples R China.	hezhengguo@mail.hzau.edu.cn	He, Zheng-Guo/P-3647-2014; Ge, Ruowen/D-8352-2012; Kini, Manjunatha/H-8029-2012; Chandramouli, Chanchal/AAF-2848-2020; Hong, Yunhan/D-4197-2009; Farooq, Muhammad/G-9838-2013; Li, Zhi-Yong/G-9701-2011; Li, Zhi-Yong/G-9701-2011	Ge, Ruowen/0000-0002-0750-7336; Farooq, Muhammad/0000-0001-9891-2443; Kini, Manjunatha/0000-0002-6100-3251; Zhang, Yuesheng/0000-0002-0976-2875; Li, Zhi-Yong/0000-0003-3039-8833; Li, Zhi-Yong/0000-0002-6814-9165	National Natural Science Foundation of China [31025002, 30930003]; Fundamental Research Funds for the Central Universities [2011PY140]; Hubei Chutian Scholar Program; NCI NIH HHS [CA120533, R01 CA124627, R01 CA120533, P30 CA016056] Funding Source: Medline	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Hubei Chutian Scholar Program; NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Natural Science Foundation of China (31025002, 30930003), the Fundamental Research Funds for the Central Universities (2011PY140) and Hubei Chutian Scholar Program (to Z-GH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Chen H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001602; CHRISTMAN MF, 1989, P NATL ACAD SCI USA, V86, P3484, DOI 10.1073/pnas.86.10.3484; DERETIC V, 1995, MOL MICROBIOL, V17, P889, DOI 10.1111/j.1365-2958.1995.mmi_17050889.x; Dhandayuthapani S, 1996, J BACTERIOL, V178, P3641, DOI 10.1128/jb.178.12.3641-3649.1996; Domenech P, 2001, MICROBES INFECT, V3, P713, DOI 10.1016/S1286-4579(01)01422-8; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Guo MM, 2009, GENOME RES, V19, P1301, DOI 10.1101/gr.086595.108; He ZG, 2003, J BIOL CHEM, V278, P29538, DOI 10.1074/jbc.M304318200; Italiani VCS, 2011, J BACTERIOL, V193, P1734, DOI 10.1128/JB.01339-10; Jittawuttipoka T, 2009, J BACTERIOL, V191, P7372, DOI 10.1128/JB.00788-09; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; Lee HI, 2010, J BIOCHEM, V147, P511, DOI 10.1093/jb/mvp197; Li YQ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-242; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Manca C, 1999, INFECT IMMUN, V67, P74, DOI 10.1128/IAI.67.1.74-79.1999; Master S, 2001, J BACTERIOL, V183, P4033, DOI 10.1128/JB.183.13.4033-4039.2001; Milano A, 2001, J BACTERIOL, V183, P6801, DOI 10.1128/JB.183.23.6801-6806.2001; Muraoka S, 2003, J MOL BIOL, V328, P555, DOI 10.1016/S0022-2836(03)00312-7; Nguyen L, 2005, TRENDS CELL BIOL, V15, P269, DOI 10.1016/j.tcb.2005.03.009; Pagan-Ramos E, 1998, J BACTERIOL, V180, P4856; Pym AS, 2001, MOL MICROBIOL, V40, P879, DOI 10.1046/j.1365-2958.2001.02427.x; Sala C, 2003, J BACTERIOL, V185, P5357, DOI 10.1128/JB.185.18.5357-5362.2003; Sala C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-33; SHERMAN DR, 1995, P NATL ACAD SCI USA, V92, P6625, DOI 10.1073/pnas.92.14.6625; Singh A, 2007, P NATL ACAD SCI USA, V104, P11562, DOI 10.1073/pnas.0700490104; Sreevatsan S, 1996, J CLIN MICROBIOL, V34, P2007, DOI 10.1128/JCM.34.8.2007-2010.1996; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Yu K., 1999, Tubercle and Lung Disease, V79, P191, DOI 10.1054/tuld.1998.0203; Zahrt TC, 2001, MOL MICROBIOL, V39, P1174, DOI 10.1046/j.1365-2958.2001.02321.x; Zhang H, 2008, FEBS J, V275, P753, DOI 10.1111/j.1742-4658.2007.06241.x; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	36	150	169	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30186	10.1371/journal.pone.0030186	http://dx.doi.org/10.1371/journal.pone.0030186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22905149	Green Published, gold, Green Submitted			2022-12-27	WOS:000301454400077
